Citrus Sinensis ID: 039137

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830-------840-------850-------860-------870-------880-------890-------900-------910--
Protein Sequence
MDSPTLKNNKVIISLVFPLILFVVLDFSLAISSNSAEEAHALVKWKASLEVHSRSLLHSWSLSSVNATKISPCAWSGIFCNHAERVVGINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNSTTFRDAPLEALQGNKGLYGDIRGFPSCMSYKKASRKIWIVIVFPLLGMVALFIALTGFFFIFHQRKNDSQTQQSSFGNTPGLRSVLTFEGKIVYEEIISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFEV
Secondary Structure (PSIPRED)
cccccccHHHHHHHHHHHHHHHHHHHHHHHcccccHHHHHHHHHHHHcccccccccccccccccccccccccccccEEEccccccEEEEEccccccEEEEccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEcccccccccccHHccccccccEEEccccccccccccccccccccccEEccccEEEEccccccccccccccccccccEEEEccccccccccccccEEccccEEEEEcccccccccccccEEcccccccccccccccccccccEEEccccEEEEcccccccccccccEEEccccEEcccccccccccccccEEEcccccccccccccccccccccEEEccccEEcccccHHHHccccccccccccccccccccHHHHccccccEEEcccccccccccHHHHccccccccccccccccccccHHHHccccccEEEcccccccccccHHHHcccccccccccccccccccHHHHHccccccEEcccccccccccccccccccccccccccccccccccccccccccccccccEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccHHHHHHHHcccccccEEccccccEEEEEEcccccEEEEEEEccccccccccccHHHHHHHHHHHcccccccccHHHEEEcccccEEEEccccccccccccccccccccccHHHHHHHHHHHHHHHcccccccccccEEEcccccccccccccEEEEccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHccccccccccccHHHHHHHHHHHHHcc
Secondary Structure Prediction (SSPRO)
cccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccHHHHHHHHHHHHcccccccccccccccccccccccccccEEEEEcccccEEEEEEccccccccccHHHHHccccccEEEcccccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHccccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHccccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHcccccEEEEEccccccccccHHHccccccEEEEEcEccEEccccHHHHHcccccEEEEEEccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHcccccEEEEEcccccccccccHHHHccccccEEEcccccccccccHHHHcccccEEEEEcccccccccccccccccccHHHHcccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccEEEEEccccccHHHHHHHHHcccHccEEEccccEEEEEEEcccccEEEEEEcccccccccccccHHHHHHHHHHHHHHHHHHHHHHEEcccccccEEEEEccccccHHHHHccccccccccHHHHHHHHHHHHHHHHHHHccccccEEEEEcccccEEEccccHHHHHHHcHHHEccccccccEEEEcccccccccHHEEEEEcccccHHHHHHHHHHHHccccccccEEEEEccccccHHHHcccccccccccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHcccc
Coil and Loop (DISEMBL)
mdsptlknnkvIISLVFPLILFVVLDFSLAISSNSAEEAHALVKWKASLEVHSRSLLHSWslssvnatkispcawsgifcnhaeRVVGINLTSISLngtllefsfssfphlvyldlynnelfgiippqisnlsnleyldfsanklfgqipsgiglLTHLTVLHISrnwlsgsiphevgqlTVLNQLaldsnflngsiprslgnLTHVVILYLYnnsffgsipqeignlkslFDLELCINQLsgaiplsisnltnLRFLFLYHNElsgiipqeiGNLKKLNSLLLAKnhfrgtvpksfrNLTDLVKLRLNQnyltgnisetfgtypnltfidlsnnsffgeilsdwgrcpqlslldvsinnisgsipleigESLQLQyldlssnyivgeiptqlgniiylnrlslsgnklsgciprelgslinleyldlsannlsnfvpesLGSLVKLYYLNLshnklsqqipieldnlihlseldlshnflgekISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDisynklegqipnsttfrdaplealqgnkglygdirgfpscmsykkasRKIWIVIVFPLLGMVALFIALTGFFFIfhqrkndsqtqqssfgntpglrsvLTFEGKIVYEEIISATndfnaehcigkgghgsvyrakvpsgeifavkkfhsplpgemsfQQEEFLNEIQALTEIRHRNIVkfygfcshpkhsFIIYEYlesgsldkilcndasakelgwtQRLNVIKGVADALFYlhnncfppivhrdissknvlldlgyeahvsdfgiakflnpdssnwselagthgyvapeLAYTLkvtekcdvySFGVLALEVikgkhprdflfemsssssnmniemldsrlpypslhVQKKLMSIMQVAFScldqnpesrptmKRVSQLLCEKIFEV
Flexible Loop (DISEMBL)
mdsptlknnkVIISLVFPLILFVVLDFSLAISSNSAEEAHALVKWKASLEVHSRSLLHSWSLSSVNATKISPCAWSGIFCNHAERVVGINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHfrgtvpksfrnlTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNSTTFRDAPLEALQGNKGLYGDIRGFPSCMSYKKASRKIWIVIVFPLLGMVALFIALTGFFFIFHQRKNDSQtqqssfgntpgLRSVLTFEGKIVYEEIISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLdqnpesrptmKRVSQLLCEKIFEV
Low Complexity Region (SEG)
MDSPTLKNNKVIISLVFPLILFVVLDFSLAISSNSAEEAHALVKWKASLEVhsrsllhswslssVNATKISPCAWSGIFCNHAERVVGINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGnlkklnslllaknHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNSTTFRDAPLEALQGNKGLYGDIRGFPSCMSYKKASRKIWIVIVFPLLGMVALFIALTGFFFIFHQRKNDSQTQQSSFGNTPGLRSVLTFEGKIVYEEIISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEmsssssnmnIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFEV
Disordered region (IsUnstruct)
********NKVIISLVFPLILFVVLDFSLAISSNSAEEAHALVKWKASLEVHSRSLLHSWSLSSVNATKISPCAWSGIFCNHAERVVGINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNSTTFRDAPLEALQGNKGLYGDIRGFPSCMSYKKASRKIWIVIVFPLLGMVALFIALTGFFFIFHQ****************GLRSVLTFEGKIVYEEIISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLF*****************LPYPSLHVQKKLMSIMQVAFSCL************************
Disordered Region (DISOPRED)
***********IISLVFPLILFVVLDFSLAISSNSAEEAHALVKWKASLEV*SR*LLHSWSLSSVNATKISPCAWSGIFCNHAERVVGINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNSTTFRDAPLEALQGNKGLYGD*********************VFPLLGMVALFIALTGFFFIFH********************SVLTFEGKIVYEEIISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGE****QEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE*
Disordered Region (DISEMBL)
MDSPTLKNNKVIISLVFPLILFVVLDFSLAISSNSAEEAHALVKWKASLEVHSRSLLHSWSLSSVNATKISPCAWSGIFCNHAERVVGINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNSTTFRDAPLEALQGNKGLYGDIRGFPSCMSYKKASRKIWIVIVFPLLGMVALFIALTGFFFIFHQRK***********NTPGLRSVLTFEGKIVYEEIISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFEV
Disordered Region (DISPRO)
*DSPTLKNNKVIISLVFPLILFVVLDFSLAISSNSAEEAHALVKWKASLEVHSRSLLHSWSLSSVNATKISPCAWSGIFCNHAERVVGINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNSTTFRDAPLEALQGNKGLYGDIRGFPSCMSYKKASRKIWIVIVFPLLGMVALFIALTGFFFIFHQRKNDS*********TPGLRSVLTFEGKIVYEEIISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPG**SFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF**
Transmembrane Helix (TMHMM)
iiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
iiiiiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
iiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MDSPTLKNNKVIISLVFPLILFVVLDFSLAISSNSAEEAHALVKWKASLEVHSRSLLHSWSLSSVNATKISPCAWSGIFCNHAERVVGINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNSTTFRDAPLEALQGNKGLYGDIRGFPSCMSYKKASRKIWIVIVFPLLGMVALFIALTGFFFIFHQRKNDSQTQQSSFGNTPGLRSVLTFEGKIVYEEIISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFEV
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	912	2.2.26 [Sep-21-2011]
Q8VZG8	1045	Probable LRR receptor-lik	yes	no	0.871	0.760	0.471	0.0
Q9LP24	1120	Probable leucine-rich rep	no	no	0.893	0.727	0.457	0.0
Q9SHI2	1101	Leucine-rich repeat recep	no	no	0.870	0.721	0.348	1e-136
Q9LVP0	1102	Probable leucine-rich rep	no	no	0.887	0.734	0.359	1e-132
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.883	0.645	0.352	1e-130
Q9FIZ3	1252	LRR receptor-like serine/	no	no	0.889	0.647	0.350	1e-128
Q9M2Z1	1002	Leucine-rich repeat recep	no	no	0.923	0.840	0.340	1e-127
Q9LHP4	1141	Receptor-like protein kin	no	no	0.889	0.710	0.357	1e-126
C0LGV1	1135	LRR receptor-like serine/	no	no	0.851	0.684	0.344	1e-125
O49318	1124	Probable leucine-rich rep	no	no	0.862	0.700	0.353	1e-125

>sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3

 Score =  740 bits (1910), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 395/837 (47%), Positives = 545/837 (65%), Gaps = 42/837 (5%)

Query: 104  SFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLH 163
            SF +   LV L L+ N L G IP +I NL NL  L    N L G+IPS  G L ++T+L+
Sbjct: 209  SFGNLTKLVNLYLFINSLSGSIPSEIGNLPNLRELCLDRNNLTGKIPSSFGNLKNVTLLN 268

Query: 164  ISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQ 223
            +  N LSG IP E+G +T L+ L+L +N L G IP +LGN+  + +L+LY N   GSIP 
Sbjct: 269  MFENQLSGEIPPEIGNMTALDTLSLHTNKLTGPIPSTLGNIKTLAVLHLYLNQLNGSIPP 328

Query: 224  EIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLK------ 277
            E+G ++S+ DLE+  N+L+G +P S   LT L +LFL  N+LSG IP  I N        
Sbjct: 329  ELGEMESMIDLEISENKLTGPVPDSFGKLTALEWLFLRDNQLSGPIPPGIANSTELTVLQ 388

Query: 278  ------------------KLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISE 319
                              KL +L L  NHF G VPKS R+   L+++R   N  +G+ISE
Sbjct: 389  LDTNNFTGFLPDTICRGGKLENLTLDDNHFEGPVPKSLRDCKSLIRVRFKGNSFSGDISE 448

Query: 320  TFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLD 379
             FG YP L FIDLSNN+F G++ ++W +  +L    +S N+I+G+IP EI    QL  LD
Sbjct: 449  AFGVYPTLNFIDLSNNNFHGQLSANWEQSQKLVAFILSNNSITGAIPPEIWNMTQLSQLD 508

Query: 380  LSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPE 439
            LSSN I GE+P  + NI  +++L L+GN+LSG IP  +  L NLEYLDLS+N  S+ +P 
Sbjct: 509  LSSNRITGELPESISNINRISKLQLNGNRLSGKIPSGIRLLTNLEYLDLSSNRFSSEIPP 568

Query: 440  SLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLN 499
            +L +L +LYY+NLS N L Q IP  L  L  L  LDLS+N L  +ISS+   +++LE+L+
Sbjct: 569  TLNNLPRLYYMNLSRNDLDQTIPEGLTKLSQLQMLDLSYNQLDGEISSQFRSLQNLERLD 628

Query: 500  LSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNSTTFRDAPLEALQGNKGLYGDI-- 557
            LS+NNLSG IP  F++M  L H+D+S+N L+G IP++  FR+AP +A +GNK L G +  
Sbjct: 629  LSHNNLSGQIPPSFKDMLALTHVDVSHNNLQGPIPDNAAFRNAPPDAFEGNKDLCGSVNT 688

Query: 558  -RGFPSC--MSYKKA--SRKIWIVIVFPLLGMVALFIALTGFFFIFHQRKN--DSQTQQS 610
             +G   C   S KK+   R + I I+ P++G + +     G F  F +R    +  T   
Sbjct: 689  TQGLKPCSITSSKKSHKDRNLIIYILVPIIGAIIILSVCAGIFICFRKRTKQIEEHTDSE 748

Query: 611  SFGNTPGLRSVLTFEGKIVYEEIISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKF 670
            S G T    S+ +F+GK+ Y+EII AT +F+ ++ IG GGHG VY+AK+P+  I AVKK 
Sbjct: 749  SGGET---LSIFSFDGKVRYQEIIKATGEFDPKYLIGTGGHGKVYKAKLPNA-IMAVKKL 804

Query: 671  HSPLPGEMS--FQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKI 728
            +      +S    ++EFLNEI+ALTEIRHRN+VK +GFCSH +++F++YEY+E GSL K+
Sbjct: 805  NETTDSSISNPSTKQEFLNEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSLRKV 864

Query: 729  LCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDF 788
            L ND  AK+L W +R+NV+KGVA AL Y+H++  P IVHRDISS N+LL   YEA +SDF
Sbjct: 865  LENDDEAKKLDWGKRINVVKGVAHALSYMHHDRSPAIVHRDISSGNILLGEDYEAKISDF 924

Query: 789  GIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLF 848
            G AK L PDSSNWS +AGT+GYVAPELAY +KVTEKCDVYSFGVL LEVIKG+HP D + 
Sbjct: 925  GTAKLLKPDSSNWSAVAGTYGYVAPELAYAMKVTEKCDVYSFGVLTLEVIKGEHPGDLVS 984

Query: 849  EMSSSSSNMNIEML---DSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVS 902
             +SSS  +  + +    D RLP P+  ++++++ I++VA  CL  +P++RPTM  +S
Sbjct: 985  TLSSSPPDATLSLKSISDHRLPEPTPEIKEEVLEILKVALLCLHSDPQARPTMLSIS 1041

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1

 Score =  701 bits (1808), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 391/855 (45%), Positives = 548/855 (64%), Gaps = 40/855 (4%)

Query: 82   HAERVVGINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFS 141
            + E +  + L+   L G++   S  +  +L  L L+ N L G IPP++ N+ ++  L+ S
Sbjct: 268  NMESMTNLALSQNKLTGSIPS-SLGNLKNLTLLSLFQNYLTGGIPPKLGNIESMIDLELS 326

Query: 142  ANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSL 201
             NKL G IPS +G L +LT+L++  N+L+G IP E+G +  +  L L++N L GSIP S 
Sbjct: 327  NNKLTGSIPSSLGNLKNLTILYLYENYLTGVIPPELGNMESMIDLQLNNNKLTGSIPSSF 386

Query: 202  GNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLY 261
            GNL ++  LYLY N   G IPQE+GN++S+ +L+L  N+L+G++P S  N T L  L+L 
Sbjct: 387  GNLKNLTYLYLYLNYLTGVIPQELGNMESMINLDLSQNKLTGSVPDSFGNFTKLESLYLR 446

Query: 262  HNELSGIIPQEIGNLKKLNSLLLAKN------------------------HFRGTVPKSF 297
             N LSG IP  + N   L +L+L  N                        H  G +PKS 
Sbjct: 447  VNHLSGAIPPGVANSSHLTTLILDTNNFTGFFPETVCKGRKLQNISLDYNHLEGPIPKSL 506

Query: 298  RNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVS 357
            R+   L++ R   N  TG+I E FG YP+L FID S+N F GEI S+W + P+L  L +S
Sbjct: 507  RDCKSLIRARFLGNKFTGDIFEAFGIYPDLNFIDFSHNKFHGEISSNWEKSPKLGALIMS 566

Query: 358  INNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPREL 417
             NNI+G+IP EI    QL  LDLS+N + GE+P  +GN+  L+RL L+GN+LSG +P  L
Sbjct: 567  NNNITGAIPTEIWNMTQLVELDLSTNNLFGELPEAIGNLTNLSRLRLNGNQLSGRVPAGL 626

Query: 418  GSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLS 477
              L NLE LDLS+NN S+ +P++  S +KL+ +NLS NK    IP  L  L  L++LDLS
Sbjct: 627  SFLTNLESLDLSSNNFSSEIPQTFDSFLKLHDMNLSRNKFDGSIP-RLSKLTQLTQLDLS 685

Query: 478  HNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNST 537
            HN L  +I S++  ++SL+KL+LS+NNLSGLIP  FE M  L ++DIS NKLEG +P++ 
Sbjct: 686  HNQLDGEIPSQLSSLQSLDKLDLSHNNLSGLIPTTFEGMIALTNVDISNNKLEGPLPDTP 745

Query: 538  TFRDAPLEALQGNKGLYGDI--RGFPSCMSYKKASRK----IWIVIVFPLLGMVALFIAL 591
            TFR A  +AL+ N GL  +I  +    C   KK  +     +WI++  P+LG V + +++
Sbjct: 746  TFRKATADALEENIGLCSNIPKQRLKPCRELKKPKKNGNLVVWILV--PILG-VLVILSI 802

Query: 592  TGFFFIFHQRKNDSQTQQSSFGNTPGLRSVLTFEGKIVYEEIISATNDFNAEHCIGKGGH 651
                F +  RK   Q  +++   T    S+ + +GK  Y++II +TN+F+  H IG GG+
Sbjct: 803  CANTFTYCIRKRKLQNGRNTDPETGENMSIFSVDGKFKYQDIIESTNEFDPTHLIGTGGY 862

Query: 652  GSVYRAKVPSGEIFAVKKFHSPLPGEMS--FQQEEFLNEIQALTEIRHRNIVKFYGFCSH 709
              VYRA +    I AVK+ H  +  E+S    ++EFLNE++ALTEIRHRN+VK +GFCSH
Sbjct: 863  SKVYRANL-QDTIIAVKRLHDTIDEEISKPVVKQEFLNEVKALTEIRHRNVVKLFGFCSH 921

Query: 710  PKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRD 769
             +H+F+IYEY+E GSL+K+L ND  AK L WT+R+NV+KGVA AL Y+H++   PIVHRD
Sbjct: 922  RRHTFLIYEYMEKGSLNKLLANDEEAKRLTWTKRINVVKGVAHALSYMHHDRITPIVHRD 981

Query: 770  ISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYS 829
            ISS N+LLD  Y A +SDFG AK L  DSSNWS +AGT+GYVAPE AYT+KVTEKCDVYS
Sbjct: 982  ISSGNILLDNDYTAKISDFGTAKLLKTDSSNWSAVAGTYGYVAPEFAYTMKVTEKCDVYS 1041

Query: 830  FGVLALEVIKGKHPRDFLFEMSSSSSN-MNIEML-DSRLPYPSLHVQKKLMSIMQVAFSC 887
            FGVL LE+I GKHP D +  +SSS    +++  + D R+  P    ++KL+ ++++A  C
Sbjct: 1042 FGVLILELIIGKHPGDLVSSLSSSPGEALSLRSISDERVLEPRGQNREKLLKMVEMALLC 1101

Query: 888  LDQNPESRPTMKRVS 902
            L  NPESRPTM  +S
Sbjct: 1102 LQANPESRPTMLSIS 1116

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2

 Score =  484 bits (1247), Expect = e-136,   Method: Compositional matrix adjust.
 Identities = 315/903 (34%), Positives = 460/903 (50%), Gaps = 109/903 (12%)

Query: 104  SFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLH 163
            S +    L  +    N   G+IP +IS   +L+ L  + N L G +P  +  L +LT L 
Sbjct: 182  SMAKLRQLRIIRAGRNGFSGVIPSEISGCESLKVLGLAENLLEGSLPKQLEKLQNLTDLI 241

Query: 164  ISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQ 223
            + +N LSG IP  VG ++ L  LAL  N+  GSIPR +G LT +  LYLY N   G IP+
Sbjct: 242  LWQNRLSGEIPPSVGNISRLEVLALHENYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPR 301

Query: 224  EIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLL 283
            EIGNL    +++   NQL+G IP    ++ NL+ L L+ N L G IP+E+G L  L  L 
Sbjct: 302  EIGNLIDAAEIDFSENQLTGFIPKEFGHILNLKLLHLFENILLGPIPRELGELTLLEKLD 361

Query: 284  LAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILS 343
            L+ N   GT+P+  + L  LV L+L  N L G I    G Y N + +D+S NS  G I +
Sbjct: 362  LSINRLNGTIPQELQFLPYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPA 421

Query: 344  DWGR------------------------CPQLSLLDVSINNISGSIPLEI---------- 369
             + R                        C  L+ L +  N ++GS+P+E+          
Sbjct: 422  HFCRFQTLILLSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTALE 481

Query: 370  --------------GESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPR 415
                          G+   L+ L L++N   GEIP ++GN+  +   ++S N+L+G IP+
Sbjct: 482  LHQNWLSGNISADLGKLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPK 541

Query: 416  ELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELD 475
            ELGS + ++ LDLS N  S ++ + LG LV L  L LS N+L+ +IP    +L  L EL 
Sbjct: 542  ELGSCVTIQRLDLSGNKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMELQ 601

Query: 476  LSHNFLGEKISSRICRMESLE-KLNLSYNNLSGLIPRCFEEMH----------------- 517
            L  N L E I   + ++ SL+  LN+S+NNLSG IP     +                  
Sbjct: 602  LGGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIP 661

Query: 518  -------GLLHIDISYNKLEGQIPNSTTFRDAPLEALQGNKGLYGDIRGFPSCMSYKKAS 570
                    LL  +IS N L G +P++  F+        GN GL    R     +     S
Sbjct: 662  ASIGNLMSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGLCNSQRSHCQPLVPHSDS 721

Query: 571  RKIWIV----------IVFPLLGMVALFIALTGFFFIFHQRKN-----DSQTQQSSFGNT 615
            +  W++          I   ++G V L I   G  +   +R+      + QT+       
Sbjct: 722  KLNWLINGSQRQKILTITCIVIGSVFL-ITFLGLCWTIKRREPAFVALEDQTK------- 773

Query: 616  PGLRSVLTFEGK-IVYEEIISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPL 674
            P +     F  K   Y+ ++ AT +F+ +  +G+G  G+VY+A++  GE+ AVKK +S  
Sbjct: 774  PDVMDSYYFPKKGFTYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNS-- 831

Query: 675  PGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDAS 734
             GE +     F  EI  L +IRHRNIVK YGFC H   + ++YEY+  GSL + L     
Sbjct: 832  RGEGASSDNSFRAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEK 891

Query: 735  AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL 794
               L W  R  +  G A+ L YLH++C P IVHRDI S N+LLD  ++AHV DFG+AK +
Sbjct: 892  NCLLDWNARYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLI 951

Query: 795  NPD-SSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP-------RDF 846
            +   S + S +AG++GY+APE AYT+KVTEKCD+YSFGV+ LE+I GK P        D 
Sbjct: 952  DLSYSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGGDL 1011

Query: 847  LFEMSSSSSNM--NIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQL 904
            +  +  S  NM   IEM D+RL         ++  ++++A  C   +P SRPTM+ V  +
Sbjct: 1012 VNWVRRSIRNMIPTIEMFDARLDTNDKRTVHEMSLVLKIALFCTSNSPASRPTMREVVAM 1071

Query: 905  LCE 907
            + E
Sbjct: 1072 ITE 1074

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1

 Score =  474 bits (1219), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 317/881 (35%), Positives = 465/881 (52%), Gaps = 72/881 (8%)

Query: 83   AERVVGINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSA 142
             E +V + L    L+G L +        L  + L+ NE  G IP +ISN ++LE L    
Sbjct: 216  CESLVMLGLAQNQLSGELPK-EIGMLKKLSQVILWENEFSGFIPREISNCTSLETLALYK 274

Query: 143  NKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLG 202
            N+L G IP  +G L  L  L++ RN L+G+IP E+G L+   ++    N L G IP  LG
Sbjct: 275  NQLVGPIPKELGDLQSLEFLYLYRNGLNGTIPREIGNLSYAIEIDFSENALTGEIPLELG 334

Query: 203  NLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYH 262
            N+  + +LYL+ N   G+IP E+  LK+L  L+L IN L+G IPL    L  L  L L+ 
Sbjct: 335  NIEGLELLYLFENQLTGTIPVELSTLKNLSKLDLSINALTGPIPLGFQYLRGLFMLQLFQ 394

Query: 263  NELSGIIPQEIGNLKKLNSLLLAKNH------------------------FRGTVPKSFR 298
            N LSG IP ++G    L  L ++ NH                          G +P    
Sbjct: 395  NSLSGTIPPKLGWYSDLWVLDMSDNHLSGRIPSYLCLHSNMIILNLGTNNLSGNIPTGIT 454

Query: 299  NLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSI 358
                LV+LRL +N L G          N+T I+L  N F G I  + G C  L  L ++ 
Sbjct: 455  TCKTLVQLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVGNCSALQRLQLAD 514

Query: 359  NNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELG 418
            N  +G +P EIG   QL  L++SSN + GE+P+++ N   L RL +  N  SG +P E+G
Sbjct: 515  NGFTGELPREIGMLSQLGTLNISSNKLTGEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVG 574

Query: 419  SLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLS-ELDLS 477
            SL  LE L LS NNLS  +P +LG+L +L  L +  N  +  IP EL +L  L   L+LS
Sbjct: 575  SLYQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLS 634

Query: 478  HNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNST 537
            +N L  +I   +  +  LE L L+ NNLSG IP  F  +  LL  + SYN L G IP   
Sbjct: 635  YNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIP--- 691

Query: 538  TFRDAPLEALQGNKGLYG-------DIRGFPSCMSYKKA----SRKIWIVIVFPLLGMVA 586
              R+  + +  GN+GL G         + F    S  K     S KI  +    + G+  
Sbjct: 692  LLRNISMSSFIGNEGLCGPPLNQCIQTQPFAPSQSTGKPGGMRSSKIIAITAAVIGGVSL 751

Query: 587  LFIALTGFFFIFHQRKNDSQTQQSSFGNTPGLRSVLTF----EGKIVYEEIISATNDFNA 642
            + IAL     ++  R+       S+    P   S+  +    EG   ++++++AT++F+ 
Sbjct: 752  MLIAL----IVYLMRRPVRTVASSAQDGQPSEMSLDIYFPPKEG-FTFQDLVAATDNFDE 806

Query: 643  EHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQE-EFLNEIQALTEIRHRNIV 701
               +G+G  G+VY+A +P+G   AVKK  S   G  +   +  F  EI  L  IRHRNIV
Sbjct: 807  SFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFRAEILTLGNIRHRNIV 866

Query: 702  KFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNC 761
            K +GFC+H   + ++YEY+  GSL +IL +D S   L W++R  +  G A  L YLH++C
Sbjct: 867  KLHGFCNHQGSNLLLYEYMPKGSLGEIL-HDPSCN-LDWSKRFKIALGAAQGLAYLHHDC 924

Query: 762  FPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN-PDSSNWSELAGTHGYVAPELAYTLK 820
             P I HRDI S N+LLD  +EAHV DFG+AK ++ P S + S +AG++GY+APE AYT+K
Sbjct: 925  KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPHSKSMSAIAGSYGYIAPEYAYTMK 984

Query: 821  VTEKCDVYSFGVLALEVIKGKHP--------------RDFLFEMSSSSSNMNIEMLDSRL 866
            VTEK D+YS+GV+ LE++ GK P              R ++   + SS      +LD+RL
Sbjct: 985  VTEKSDIYSYGVVLLELLTGKAPVQPIDQGGDVVNWVRSYIRRDALSSG-----VLDARL 1039

Query: 867  PYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCE 907
                  +   +++++++A  C   +P +RP+M++V  +L E
Sbjct: 1040 TLEDERIVSHMLTVLKIALLCTSVSPVARPSMRQVVLMLIE 1080

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  465 bits (1196), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 314/892 (35%), Positives = 464/892 (52%), Gaps = 86/892 (9%)

Query: 89   INLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQ 148
            ++L++ SL G++ E  F     L  L L+NN L G + P ISNL+NL++L    N L G+
Sbjct: 365  LDLSNNSLAGSIPEALFE-LVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGK 423

Query: 149  IPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVV 208
            +P  I  L  L VL +  N  SG IP E+G  T L  + +  N   G IP S+G L  + 
Sbjct: 424  LPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKELN 483

Query: 209  ILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGI 268
            +L+L  N   G +P  +GN   L  L+L  NQLSG+IP S   L  L  L LY+N L G 
Sbjct: 484  LLHLRQNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGN 543

Query: 269  IPQEIGNLKKLNSLLLAKNHFRGTV-----------------------PKSFRNLTDLVK 305
            +P  + +L+ L  + L+ N   GT+                       P    N  +L +
Sbjct: 544  LPDSLISLRNLTRINLSHNRLNGTIHPLCGSSSYLSFDVTNNGFEDEIPLELGNSQNLDR 603

Query: 306  LRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSI 365
            LRL +N LTG I  T G    L+ +D+S+N+  G I      C +L+ +D++ N +SG I
Sbjct: 604  LRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPI 663

Query: 366  PLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEY 425
            P  +G+  QL  L LSSN  V  +PT+L N   L  LSL GN L+G IP+E+G+L  L  
Sbjct: 664  PPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNV 723

Query: 426  LDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHL-SELDLSHNFLGEK 484
            L+L  N  S  +P+++G L KLY L LS N L+ +IP+E+  L  L S LDLS+N     
Sbjct: 724  LNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGD 783

Query: 485  ISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNSTTFRDAPL 544
            I S I  +  LE L+LS+N L+G +P    +M  L ++++S+N L G++     F   P 
Sbjct: 784  IPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKL--KKQFSRWPA 841

Query: 545  EALQGNKGLYGDIRGFPSCMSYKK-------ASRKIWIVIVFPLLGMVALFIALTGFFF- 596
            ++  GN GL G       C   +        ++R + I+     L  + L I +   FF 
Sbjct: 842  DSFLGNTGLCGS--PLSRCNRVRSNNKQQGLSARSVVIISAISALTAIGLMILVIALFFK 899

Query: 597  ----IFHQRKNDSQTQQSSFGNTPGLRSVLTFEG----KIVYEEIISATNDFNAEHCIGK 648
                 F +  + S    SS  ++      L   G     I +E+I+ AT++ + E  IG 
Sbjct: 900  QRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLSEEFMIGS 959

Query: 649  GGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCS 708
            GG G VY+A++ +GE  AVKK    L  +     + F  E++ L  IRHR++VK  G+CS
Sbjct: 960  GGSGKVYKAELENGETVAVKKI---LWKDDLMSNKSFSREVKTLGRIRHRHLVKLMGYCS 1016

Query: 709  HPKH--SFIIYEYLESGSLDKILCNDASAKE-----LGWTQRLNVIKGVADALFYLHNNC 761
                  + +IYEY+++GS+   L  D    E     L W  RL +  G+A  + YLH++C
Sbjct: 1017 SKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDC 1076

Query: 762  FPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL------NPDSSNWSELAGTHGYVAPEL 815
             PPIVHRDI S NVLLD   EAH+ DFG+AK L      N DS+ W   A ++GY+APE 
Sbjct: 1077 VPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTW--FACSYGYIAPEY 1134

Query: 816  AYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLF--------------EMSSSSSNMNIE- 860
            AY+LK TEK DVYS G++ +E++ GK P D +F              E++ S+ +  I+ 
Sbjct: 1135 AYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMVRWVETHLEVAGSARDKLIDP 1194

Query: 861  MLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFEV 912
             L   LP+     +     ++++A  C   +P+ RP+ ++     C+ +  V
Sbjct: 1195 KLKPLLPFE----EDAACQVLEIALQCTKTSPQERPSSRQA----CDSLLHV 1238

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2

 Score =  460 bits (1184), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 306/873 (35%), Positives = 465/873 (53%), Gaps = 62/873 (7%)

Query: 89   INLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQ 148
            ++L++ +L G + +  F     L  L L NN L G +   ISNL+NL+      N L G+
Sbjct: 366  LDLSNNTLTGQIPDSLFQ-LVELTNLYLNNNSLEGTLSSSISNLTNLQEFTLYHNNLEGK 424

Query: 149  IPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVV 208
            +P  IG L  L ++++  N  SG +P E+G  T L ++    N L+G IP S+G L  + 
Sbjct: 425  VPKEIGFLGKLEIMYLYENRFSGEMPVEIGNCTRLQEIDWYGNRLSGEIPSSIGRLKDLT 484

Query: 209  ILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGI 268
             L+L  N   G+IP  +GN   +  ++L  NQLSG+IP S   LT L    +Y+N L G 
Sbjct: 485  RLHLRENELVGNIPASLGNCHQMTVIDLADNQLSGSIPSSFGFLTALELFMIYNNSLQGN 544

Query: 269  IPQEIGNLKKLN-----------------------SLLLAKNHFRGTVPKSFRNLTDLVK 305
            +P  + NLK L                        S  + +N F G +P      T+L +
Sbjct: 545  LPDSLINLKNLTRINFSSNKFNGSISPLCGSSSYLSFDVTENGFEGDIPLELGKSTNLDR 604

Query: 306  LRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSI 365
            LRL +N  TG I  TFG    L+ +D+S NS  G I  + G C +L+ +D++ N +SG I
Sbjct: 605  LRLGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVI 664

Query: 366  PLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEY 425
            P  +G+   L  L LSSN  VG +PT++ ++  +  L L GN L+G IP+E+G+L  L  
Sbjct: 665  PTWLGKLPLLGELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNA 724

Query: 426  LDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHL-SELDLSHNFLGEK 484
            L+L  N LS  +P ++G L KL+ L LS N L+ +IP+E+  L  L S LDLS+N    +
Sbjct: 725  LNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGR 784

Query: 485  ISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNSTTFRDAPL 544
            I S I  +  LE L+LS+N L G +P    +M  L ++++SYN LEG++     F     
Sbjct: 785  IPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKL--KKQFSRWQA 842

Query: 545  EALQGNKGLYGDIRGFPSCMSYKK----ASRKIWIVIVFPLLGMVALFIALTGFFF---- 596
            +A  GN GL G      +    K     + + + I+     L  +AL + +   FF    
Sbjct: 843  DAFVGNAGLCGSPLSHCNRAGSKNQRSLSPKTVVIISAISSLAAIALMVLVIILFFKQNH 902

Query: 597  -IFHQ-RKNDSQTQQSSFGNTPGLRSVLTFEGKIVYEEIISATNDFNAEHCIGKGGHGSV 654
             +F + R  +S    +S  +   L S    +  I +++I+ AT+  N E  IG GG G V
Sbjct: 903  DLFKKVRGGNSAFSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKV 962

Query: 655  YRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKH-- 712
            Y+A++ +GE  AVKK    L  +     + F  E++ L  IRHR++VK  G+CS      
Sbjct: 963  YKAELKNGETIAVKKI---LWKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKADGL 1019

Query: 713  SFIIYEYLESGSL-DKILCNDASAKE--LGWTQRLNVIKGVADALFYLHNNCFPPIVHRD 769
            + +IYEY+ +GS+ D +  N+ + K+  LGW  RL +  G+A  + YLH +C PPIVHRD
Sbjct: 1020 NLLIYEYMANGSVWDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRD 1079

Query: 770  ISSKNVLLDLGYEAHVSDFGIAKFL--NPDSSNWSE--LAGTHGYVAPELAYTLKVTEKC 825
            I S NVLLD   EAH+ DFG+AK L  N D++  S    AG++GY+APE AY+LK TEK 
Sbjct: 1080 IKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPEYAYSLKATEKS 1139

Query: 826  DVYSFGVLALEVIKGKHPRDFLFEMSSS-------------SSNMNIEMLDSRLPYPSLH 872
            DVYS G++ +E++ GK P + +F+  +               S    +++DS L      
Sbjct: 1140 DVYSMGIVLMEIVTGKMPTEAMFDEETDMVRWVETVLDTPPGSEAREKLIDSELKSLLPC 1199

Query: 873  VQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
             ++    ++++A  C    P+ RP+ ++ S+ L
Sbjct: 1200 EEEAAYQVLEIALQCTKSYPQERPSSRQASEYL 1232

Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M2Z1|BAME2_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM2 OS=Arabidopsis thaliana GN=BAM2 PE=1 SV=1

 Score =  458 bits (1178), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 329/965 (34%), Positives = 473/965 (49%), Gaps = 123/965 (12%)

Query: 38  EAHALVKWKASLEVHSRS-LLHSWSLSSVNATKISPCAWSGIFCNHAER-VVGINLTSIS 95
           E HAL+  K+S  +   S LL SW+LS+      + C+W+G+ C+ + R V  ++L+ ++
Sbjct: 27  ELHALLSLKSSFTIDEHSPLLTSWNLST------TFCSWTGVTCDVSLRHVTSLDLSGLN 80

Query: 96  LNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNL----------------------- 132
           L+GTL     +  P L  L L  N++ G IPPQISNL                       
Sbjct: 81  LSGTL-SSDVAHLPLLQNLSLAANQISGPIPPQISNLYELRHLNLSNNVFNGSFPDELSS 139

Query: 133 --SNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDS 190
              NL  LD   N L G +P  +  LT L  LH+  N+ SG IP   G   VL  LA+  
Sbjct: 140 GLVNLRVLDLYNNNLTGDLPVSLTNLTQLRHLHLGGNYFSGKIPATYGTWPVLEYLAVSG 199

Query: 191 NFLNGSIPRSLGNLTHVVILYL-YNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSI 249
           N L G IP  +GNLT +  LY+ Y N+F   +P EIGNL  L   +     L+G IP  I
Sbjct: 200 NELTGKIPPEIGNLTTLRELYIGYYNAFENGLPPEIGNLSELVRFDAANCGLTGEIPPEI 259

Query: 250 SNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLN 309
             L  L  LFL  N  +G I QE+G +  L S+ L+ N F G +P SF  L +L  L L 
Sbjct: 260 GKLQKLDTLFLQVNAFTGTITQELGLISSLKSMDLSNNMFTGEIPTSFSQLKNLTLLNLF 319

Query: 310 QNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEI 369
           +N L G I E  G  P L  + L  N+F G I    G   +L +LD+S N ++G++P  +
Sbjct: 320 RNKLYGAIPEFIGEMPELEVLQLWENNFTGSIPQKLGENGRLVILDLSSNKLTGTLPPNM 379

Query: 370 GESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLD-- 427
               +L  L    N++ G IP  LG    L R+ +  N L+G IP+EL  L  L  ++  
Sbjct: 380 CSGNRLMTLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKELFGLPKLSQVELQ 439

Query: 428 -----------------------LSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIE 464
                                  LS N LS  +P ++G+L  +  L L  NK S  IP E
Sbjct: 440 DNYLTGELPISGGGVSGDLGQISLSNNQLSGSLPAAIGNLSGVQKLLLDGNKFSGSIPPE 499

Query: 465 LDNLIHLSELDLSHNFLGEKISSRICR------------------------MESLEKLNL 500
           +  L  LS+LD SHN    +I+  I R                        M+ L  LNL
Sbjct: 500 IGRLQQLSKLDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGDIPNELTGMKILNYLNL 559

Query: 501 SYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNSTTFRDAPLEALQGNKGLYGDIRGF 560
           S N+L G IP     M  L  +D SYN L G +P++  F      +  GN  L G   G 
Sbjct: 560 SRNHLVGSIPVTIASMQSLTSVDFSYNNLSGLVPSTGQFSYFNYTSFVGNSHLCGPYLGP 619

Query: 561 PSCMSYK------KASRKIWIVIVFPLLGMVALFIALTGFFFIFHQRKNDSQTQQSSFGN 614
               +++       A+ K+ +V+      MV   +A      I   R   + ++  ++  
Sbjct: 620 CGKGTHQSHVKPLSATTKLLLVLGLLFCSMVFAIVA------IIKARSLRNASEAKAWRL 673

Query: 615 TPGLRSVLTFEGKIVYEEIISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPL 674
           T   R   T +            +    ++ IGKGG G VY+  +P G++ AVK+  +  
Sbjct: 674 TAFQRLDFTCD---------DVLDSLKEDNIIGKGGAGIVYKGTMPKGDLVAVKRLATMS 724

Query: 675 PGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDAS 734
            G  S     F  EIQ L  IRHR+IV+  GFCS+ + + ++YEY+ +GSL ++L +   
Sbjct: 725 HG--SSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVL-HGKK 781

Query: 735 AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL 794
              L W  R  +    A  L YLH++C P IVHRD+ S N+LLD  +EAHV+DFG+AKFL
Sbjct: 782 GGHLHWNTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFL 841

Query: 795 NPDSSN--WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP--------- 843
               ++   S +AG++GY+APE AYTLKV EK DVYSFGV+ LE+I GK P         
Sbjct: 842 QDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGKKPVGEFGDGVD 901

Query: 844 -RDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVS 902
              ++  M+ S+ +  ++++D RL    +H   ++  +  VA  C+++    RPTM+ V 
Sbjct: 902 IVQWVRSMTDSNKDCVLKVIDLRLSSVPVH---EVTHVFYVALLCVEEQAVERPTMREVV 958

Query: 903 QLLCE 907
           Q+L E
Sbjct: 959 QILTE 963

Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1

 Score =  453 bits (1166), Expect = e-126,   Method: Compositional matrix adjust.
 Identities = 303/847 (35%), Positives = 450/847 (53%), Gaps = 36/847 (4%)

Query: 86   VVGINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKL 145
            V+G+  TS+S N   L  S      L  L +Y   + G IP  + N S L  L    N L
Sbjct: 230  VLGLAETSVSGN---LPSSLGKLKKLETLSIYTTMISGEIPSDLGNCSELVDLFLYENSL 286

Query: 146  FGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLT 205
             G IP  IG LT L  L + +N L G IP E+G  + L  + L  N L+GSIP S+G L+
Sbjct: 287  SGSIPREIGQLTKLEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLNLLSGSIPSSIGRLS 346

Query: 206  HVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNEL 265
             +    + +N F GSIP  I N  SL  L+L  NQ+SG IP  +  LT L   F + N+L
Sbjct: 347  FLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQISGLIPSELGTLTKLTLFFAWSNQL 406

Query: 266  SGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYP 325
             G IP  + +   L +L L++N   GT+P     L +L KL L  N L+G I +  G   
Sbjct: 407  EGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLRNLTKLLLISNSLSGFIPQEIGNCS 466

Query: 326  NLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYI 385
            +L  + L  N   GEI S  G   +++ LD S N + G +P EIG   +LQ +DLS+N +
Sbjct: 467  SLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGSCSELQMIDLSNNSL 526

Query: 386  VGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLV 445
             G +P  + ++  L  L +S N+ SG IP  LG L++L  L LS N  S  +P SLG   
Sbjct: 527  EGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVSLNKLILSKNLFSGSIPTSLGMCS 586

Query: 446  KLYYLNLSHNKLSQQIPIELDNLIHLS-ELDLSHNFLGEKISSRICRMESLEKLNLSYNN 504
             L  L+L  N+LS +IP EL ++ +L   L+LS N L  KI S+I  +  L  L+LS+N 
Sbjct: 587  GLQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRLTGKIPSKIASLNKLSILDLSHNM 646

Query: 505  LSG-LIPRCFEEMHGLLHIDISYNKLEGQIPNSTTFRDAPLEALQGNKGLYGDIRGFPSC 563
            L G L P     +  L+ ++ISYN   G +P++  FR    + L+GNK L    +   SC
Sbjct: 647  LEGDLAP--LANIENLVSLNISYNSFSGYLPDNKLFRQLSPQDLEGNKKLCSSTQD--SC 702

Query: 564  -MSYKK---------ASRKIWIVIVFPLLGMVALFIALTGFFFIFHQRKNDSQTQQSSFG 613
             ++Y+K         ASR   + +   LL  + + + + G   +   R+N    + S  G
Sbjct: 703  FLTYRKGNGLGDDGDASRTRKLRLTLALLITLTVVLMILGAVAVIRARRNIDNERDSELG 762

Query: 614  NTPGLRSVLTFEGKIVYEEIISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSP 673
             T   +     +     ++II    + N    IGKG  G VYRA V +GE+ AVKK    
Sbjct: 763  ETYKWQFTPFQKLNFSVDQIIRCLVEPNV---IGKGCSGVVYRADVDNGEVIAVKKLWPA 819

Query: 674  L-----PGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKI 728
            +       +    ++ F  E++ L  IRH+NIV+F G C +     ++Y+Y+ +GSL  +
Sbjct: 820  MVNGGHDEKTKNVRDSFSAEVKTLGTIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSL 879

Query: 729  LCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDF 788
            L ++     L W  R  ++ G A  L YLH++C PPIVHRDI + N+L+ L +E +++DF
Sbjct: 880  L-HERRGSSLDWDLRYRILLGAAQGLAYLHHDCLPPIVHRDIKANNILIGLDFEPYIADF 938

Query: 789  GIAKFLNP-DSSNWSE-LAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDF 846
            G+AK ++  D    S  +AG++GY+APE  Y++K+TEK DVYS+GV+ LEV+ GK P D 
Sbjct: 939  GLAKLVDEGDIGRCSNTVAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDP 998

Query: 847  LFEMS------SSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKR 900
                          +  ++E+LDS L   +     ++M ++  A  C++ +P+ RPTMK 
Sbjct: 999  TVPEGIHLVDWVRQNRGSLEVLDSTLRSRTEAEADEMMQVLGTALLCVNSSPDERPTMKD 1058

Query: 901  VSQLLCE 907
            V+ +L E
Sbjct: 1059 VAAMLKE 1065

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGV1|RCH1_ARATH LRR receptor-like serine/threonine-protein kinase RCH1 OS=Arabidopsis thaliana GN=RCH1 PE=2 SV=1

 Score =  450 bits (1157), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 299/867 (34%), Positives = 457/867 (52%), Gaps = 90/867 (10%)

Query: 118  NNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEV 177
            N+EL G IP +I N  NL+ L  +A K+ G +P  +G L+ L  L +    LSG IP E+
Sbjct: 212  NSELSGKIPEEIGNCRNLKVLGLAATKISGSLPVSLGQLSKLQSLSVYSTMLSGEIPKEL 271

Query: 178  GQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELC 237
            G  + L  L L  N L+G++P+ LG L ++  + L+ N+  G IP+EIG +KSL  ++L 
Sbjct: 272  GNCSELINLFLYDNDLSGTLPKELGKLQNLEKMLLWQNNLHGPIPEEIGFMKSLNAIDLS 331

Query: 238  INQLSGAIPLSISNLTNLRFLFLYHN------------------------ELSGIIPQEI 273
            +N  SG IP S  NL+NL+ L L  N                        ++SG+IP EI
Sbjct: 332  MNYFSGTIPKSFGNLSNLQELMLSSNNITGSIPSILSNCTKLVQFQIDANQISGLIPPEI 391

Query: 274  GNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLS 333
            G LK+LN  L  +N   G +P       +L  L L+QNYLTG++        NLT + L 
Sbjct: 392  GLLKELNIFLGWQNKLEGNIPDELAGCQNLQALDLSQNYLTGSLPAGLFQLRNLTKLLLI 451

Query: 334  NNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQL 393
            +N+  G I  + G C  L  L +  N I+G IP  IG    L +LDLS N + G +P ++
Sbjct: 452  SNAISGVIPLEIGNCTSLVRLRLVNNRITGEIPKGIGFLQNLSFLDLSENNLSGPVPLEI 511

Query: 394  GNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLS 453
             N   L  L+LS N L G +P  L SL  L+ LD+S+N+L+  +P+SLG L+ L  L LS
Sbjct: 512  SNCRQLQMLNLSNNTLQGYLPLSLSSLTKLQVLDVSSNDLTGKIPDSLGHLISLNRLILS 571

Query: 454  HNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLE-KLNLSYNNLSGLIPR- 511
             N  + +IP  L +  +L  LDLS N +   I   +  ++ L+  LNLS+N+L G IP  
Sbjct: 572  KNSFNGEIPSSLGHCTNLQLLDLSSNNISGTIPEELFDIQDLDIALNLSWNSLDGFIPER 631

Query: 512  ----------------------CFEEMHGLLHIDISYNKLEGQIPNSTTFRDAPLEALQG 549
                                      +  L+ ++IS+N+  G +P+S  FR      ++G
Sbjct: 632  ISALNRLSVLDISHNMLSGDLSALSGLENLVSLNISHNRFSGYLPDSKVFRQLIGAEMEG 691

Query: 550  NKGLYGDIRGFPSC-------MSYKKASRKIWIVIVFPLLGMVALFIALTGFFFIFHQRK 602
            N GL    +GF SC       ++ ++      + I   LL  V   +A+ G   +   ++
Sbjct: 692  NNGLCS--KGFRSCFVSNSSQLTTQRGVHSHRLRIAIGLLISVTAVLAVLGVLAVIRAKQ 749

Query: 603  -----NDSQTQQS--SFGNTPGLRSVLTFEGKIVYEEIISATNDFNAEHCIGKGGHGSVY 655
                 NDS+T ++  ++  TP  +  L F  + V + ++         + IGKG  G VY
Sbjct: 750  MIRDDNDSETGENLWTWQFTPFQK--LNFTVEHVLKCLVEG-------NVIGKGCSGIVY 800

Query: 656  RAKVPSGEIFAVKK-FHSPLPG-----EMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSH 709
            +A++P+ E+ AVKK +   +P      + S  ++ F  E++ L  IRH+NIV+F G C +
Sbjct: 801  KAEMPNREVIAVKKLWPVTVPNLNEKTKSSGVRDSFSAEVKTLGSIRHKNIVRFLGCCWN 860

Query: 710  PKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRD 769
                 ++Y+Y+ +GSL  +L   +    LGW  R  +I G A  L YLH++C PPIVHRD
Sbjct: 861  KNTRLLMYDYMSNGSLGSLLHERSGVCSLGWEVRYKIILGAAQGLAYLHHDCVPPIVHRD 920

Query: 770  ISSKNVLLDLGYEAHVSDFGIAKFLN----PDSSNWSELAGTHGYVAPELAYTLKVTEKC 825
            I + N+L+   +E ++ DFG+AK ++      SSN   +AG++GY+APE  Y++K+TEK 
Sbjct: 921  IKANNILIGPDFEPYIGDFGLAKLVDDGDFARSSN--TIAGSYGYIAPEYGYSMKITEKS 978

Query: 826  DVYSFGVLALEVIKGKHP-----RDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSI 880
            DVYS+GV+ LEV+ GK P      D L  +       +I+++D  L        +++M  
Sbjct: 979  DVYSYGVVVLEVLTGKQPIDPTIPDGLHIVDWVKKIRDIQVIDQGLQARPESEVEEMMQT 1038

Query: 881  MQVAFSCLDQNPESRPTMKRVSQLLCE 907
            + VA  C++  PE RPTMK V+ +L E
Sbjct: 1039 LGVALLCINPIPEDRPTMKDVAAMLSE 1065

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1

 Score =  448 bits (1152), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 299/847 (35%), Positives = 452/847 (53%), Gaps = 60/847 (7%)

Query: 116  LYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPH 175
            L+ N+  G IP  I NL++LE L    N L G IPS IG +  L  L++ +N L+G+IP 
Sbjct: 260  LWQNKFSGFIPKDIGNLTSLETLALYGNSLVGPIPSEIGNMKSLKKLYLYQNQLNGTIPK 319

Query: 176  EVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLE 235
            E+G+L+ + ++    N L+G IP  L  ++ + +LYL+ N   G IP E+  L++L  L+
Sbjct: 320  ELGKLSKVMEIDFSENLLSGEIPVELSKISELRLLYLFQNKLTGIIPNELSKLRNLAKLD 379

Query: 236  LCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPK 295
            L IN L+G IP    NLT++R L L+HN LSG+IPQ +G    L  +  ++N   G +P 
Sbjct: 380  LSINSLTGPIPPGFQNLTSMRQLQLFHNSLSGVIPQGLGLYSPLWVVDFSENQLSGKIPP 439

Query: 296  SFRNLTDLVKLRLNQNYLTGNI-----------------SETFGTYP-------NLTFID 331
                 ++L+ L L  N + GNI                 +   G +P       NL+ I+
Sbjct: 440  FICQQSNLILLNLGSNRIFGNIPPGVLRCKSLLQLRVVGNRLTGQFPTELCKLVNLSAIE 499

Query: 332  LSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPT 391
            L  N F G +  + G C +L  L ++ N  S ++P EI +   L   ++SSN + G IP+
Sbjct: 500  LDQNRFSGPLPPEIGTCQKLQRLHLAANQFSSNLPNEISKLSNLVTFNVSSNSLTGPIPS 559

Query: 392  QLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLN 451
            ++ N   L RL LS N   G +P ELGSL  LE L LS N  S  +P ++G+L  L  L 
Sbjct: 560  EIANCKMLQRLDLSRNSFIGSLPPELGSLHQLEILRLSENRFSGNIPFTIGNLTHLTELQ 619

Query: 452  LSHNKLSQQIPIELDNLIHLS-ELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIP 510
            +  N  S  IP +L  L  L   ++LS+N    +I   I  +  L  L+L+ N+LSG IP
Sbjct: 620  MGGNLFSGSIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYLSLNNNHLSGEIP 679

Query: 511  RCFEEMHGLLHIDISYNKLEGQIPNSTTFRDAPLEALQGNKGLYGD-IR-------GFPS 562
              FE +  LL  + SYN L GQ+P++  F++  L +  GNKGL G  +R        +P 
Sbjct: 680  TTFENLSSLLGCNFSYNNLTGQLPHTQIFQNMTLTSFLGNKGLCGGHLRSCDPSHSSWPH 739

Query: 563  CMSYKKASR---KIWIVIVFPLLGMVALFIALTGFFFIFHQRKNDSQTQQSSFGNTPGLR 619
              S K  S    +I I++   + G+  L IA+   F     R     T        P  +
Sbjct: 740  ISSLKAGSARRGRIIIIVSSVIGGISLLLIAIVVHFL----RNPVEPTAPYVHDKEPFFQ 795

Query: 620  SVLTF---EGKIVYEEIISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFH---SP 673
                +   + +   ++I+ AT  F+  + +G+G  G+VY+A +PSG+  AVKK       
Sbjct: 796  ESDIYFVPKERFTVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKKLESNREG 855

Query: 674  LPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSH--PKHSFIIYEYLESGSLDKILCN 731
                 +     F  EI  L +IRHRNIV+ Y FC H     + ++YEY+  GSL ++L +
Sbjct: 856  NNNNSNNTDNSFRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRGSLGELL-H 914

Query: 732  DASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIA 791
               +  + W  R  +  G A+ L YLH++C P I+HRDI S N+L+D  +EAHV DFG+A
Sbjct: 915  GGKSHSMDWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLA 974

Query: 792  KFLN-PDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFL--- 847
            K ++ P S + S +AG++GY+APE AYT+KVTEKCD+YSFGV+ LE++ GK P   L   
Sbjct: 975  KVIDMPLSKSVSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAPVQPLEQG 1034

Query: 848  FEMSSSSSN------MNIEMLDSRLPYPSLHV-QKKLMSIMQVAFSCLDQNPESRPTMKR 900
             ++++ + N      +  E+LD  L      V    ++++ ++A  C   +P  RPTM+ 
Sbjct: 1035 GDLATWTRNHIRDHSLTSEILDPYLTKVEDDVILNHMITVTKIAVLCTKSSPSDRPTMRE 1094

Query: 901  VSQLLCE 907
            V  +L E
Sbjct: 1095 VVLMLIE 1101

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	912
359491512	1078	PREDICTED: probable LRR receptor-like se	0.958	0.810	0.485	0.0
225456159	1038	PREDICTED: probable LRR receptor-like se	0.957	0.841	0.476	0.0
225456161	1037	PREDICTED: probable LRR receptor-like se	0.957	0.841	0.470	0.0
147767326	1032	hypothetical protein VITISV_008862 [Viti	0.880	0.778	0.528	0.0
147772402	996	hypothetical protein VITISV_022117 [Viti	0.877	0.803	0.528	0.0
359491509	1032	PREDICTED: probable LRR receptor-like se	0.895	0.791	0.518	0.0
255545702	1008	receptor protein kinase, putative [Ricin	0.967	0.875	0.468	0.0
224108393	968	predicted protein [Populus trichocarpa]	0.953	0.898	0.471	0.0
224108397	968	predicted protein [Populus trichocarpa]	0.953	0.898	0.471	0.0
255563971	1003	receptor protein kinase, putative [Ricin	0.940	0.855	0.442	0.0

>gi|359491512|ref|XP_002278614.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  860 bits (2223), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 485/998 (48%), Positives = 619/998 (62%), Gaps = 124/998 (12%)

Query: 31   ISSNSAEEAHALVKWKASLEVHSRSLLHSWSL----------SSVNATKISPCAWSGIFC 80
            + S+S EE  AL+KWK++L  H+ S L SW+L          S+ + T   PC W GI C
Sbjct: 53   MKSDSNEETQALLKWKSTLHNHNHSFLLSWTLYPDPNNSTNSSTHHGTATGPCKWYGISC 112

Query: 81   NHAERVVGINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDF 140
            NHA  V+ INLT   L GTL  FSFSSFP+L Y+D+  N L G IPPQI  LS L+YLD 
Sbjct: 113  NHAGSVIRINLTESGLRGTLQAFSFSSFPNLAYVDVCINNLSGPIPPQIGLLSKLKYLDL 172

Query: 141  SANKLFGQIPSGIGLLTHLTVLHI---------------------------SRNWLSGSI 173
            S N+  G IP  IGLLT+L VLH+                             N LSGSI
Sbjct: 173  STNQFSGGIPPEIGLLTNLEVLHLLALYTNQLEGSIPASLGNLSNLASLYLYENQLSGSI 232

Query: 174  PHEVGQLTVLNQLALDSNFLNGSIPRS------------------------LGNLTH--- 206
            P E+G L  L ++  D+N L G IP +                        +GNLT    
Sbjct: 233  PPEMGNLANLVEIYSDTNNLTGLIPSTFGNLKRLTTLYLFNNQLSGHIPPEIGNLTSLQG 292

Query: 207  ---------------------VVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAI 245
                                 + +L+LY N   G IP EIGNLKSL DLEL  NQL+G+I
Sbjct: 293  ISLYANNLSGPIPASLGDLSGLTLLHLYANQLSGPIPPEIGNLKSLVDLELSENQLNGSI 352

Query: 246  PLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGT------------- 292
            P S+ NLTNL  LFL  N LSG  P+EIG L KL  L +  N   G+             
Sbjct: 353  PTSLGNLTNLEILFLRDNHLSGYFPKEIGKLHKLVVLEIDTNRLSGSLPEGICQGGSLVR 412

Query: 293  -----------VPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEI 341
                       +PKS +N  +L +     N LTGNISE  G  PNL +IDLS N F GE+
Sbjct: 413  FTVSDNLLSGPIPKSMKNCRNLTRALFGGNQLTGNISEVVGDCPNLEYIDLSYNRFHGEL 472

Query: 342  LSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNR 401
              +WGRCPQL  L+++ N+I+GSIP + G S  L  LDLSSN++VGEIP ++G++  L  
Sbjct: 473  SHNWGRCPQLQRLEMAGNDITGSIPEDFGISTNLTLLDLSSNHLVGEIPKKMGSLTSLLE 532

Query: 402  LSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQI 461
            L L+ N+LSG IP ELGSL +L +LDLSAN L+  + E+LG+ + L+YLNLS+NKLS +I
Sbjct: 533  LKLNDNQLSGSIPPELGSLFSLAHLDLSANRLNGSITENLGACLNLHYLNLSNNKLSNRI 592

Query: 462  PIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLH 521
            P ++  L HLS+LDLSHN L  +I  +I  +ESLE LNLS+NNLSG IP+ FEEM GL  
Sbjct: 593  PAQMGKLSHLSQLDLSHNLLSGEIPPQIEGLESLENLNLSHNNLSGFIPKAFEEMRGLSD 652

Query: 522  IDISYNKLEGQIPNSTTFRDAPLEALQGNKGLYGDIRGFPSCMSYKKASR-------KIW 574
            IDISYN+L+G IPNS  FRDA +E L+GNK L G+++G   C +   A +       KI 
Sbjct: 653  IDISYNQLQGPIPNSKAFRDATIELLKGNKDLCGNVKGLQPCKNDSGAGQQPVKKGHKIV 712

Query: 575  IVIVFPLLGMVALFIALTGFFFIFHQRKNDSQTQQSSFGNTPGLRSVLTFEGKIVYEEII 634
             +IVFPLLG + L  A  G F I  + K   + ++    N   L S+ TF+G+ +YEEII
Sbjct: 713  FIIVFPLLGALVLLFAFIGIFLIAERTKRTPEIEEGDVQND--LFSISTFDGRAMYEEII 770

Query: 635  SATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTE 694
             AT DF+  +CIGKGGHGSVY+A++ SG I AVKK ++    +M+  Q +F NE++ALTE
Sbjct: 771  KATKDFDPMYCIGKGGHGSVYKAELSSGNIVAVKKLYAS-DIDMA-NQRDFFNEVRALTE 828

Query: 695  IRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADAL 754
            I+HRNIVK  GFCSHP+HSF++YEYLE GSL  +L  +  AK+LGW  R+N+IKGVA AL
Sbjct: 829  IKHRNIVKLLGFCSHPRHSFLVYEYLERGSLAAMLSRE-EAKKLGWATRINIIKGVAHAL 887

Query: 755  FYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPE 814
             Y+H++C PPIVHRDISS N+LLD  YE H+SDFG AK L  DSSN S LAGT GYVAPE
Sbjct: 888  SYMHHDCSPPIVHRDISSNNILLDSQYEPHISDFGTAKLLKLDSSNQSALAGTFGYVAPE 947

Query: 815  LAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNI---EMLDSRLPYPSL 871
             AYT+KVTEK DVYSFGV+ LEVIKG+HP D +  +S S    NI   +MLD RLP  + 
Sbjct: 948  HAYTMKVTEKTDVYSFGVITLEVIKGRHPGDQILSLSVSPEKENIVLEDMLDPRLPPLTA 1007

Query: 872  HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI 909
              + +++SI+ +A +CL  NPESRPTMK +SQ+L ++I
Sbjct: 1008 QDEGEVISIINLATACLSVNPESRPTMKIISQMLSQRI 1045

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225456159|ref|XP_002278561.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  854 bits (2206), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 484/1016 (47%), Positives = 624/1016 (61%), Gaps = 143/1016 (14%)

Query: 31   ISSNSAEEAHALVKWKASLEVHSRSLLHSWSLSSVNAT--------KISPCAWSGIFCNH 82
            +SS S EE  AL+KWKASL+ H+ S L SW L   N+T          SPC W GI CNH
Sbjct: 27   VSSYSNEETQALLKWKASLQNHNHSSLLSWDLYPNNSTNSSTHLGTATSPCKWYGISCNH 86

Query: 83   AERVVGINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSA 142
            A  V+ INLT   LNGTL++FSFSSFP+L Y+D+  N L G IPPQI  L  L+YLD S 
Sbjct: 87   AGSVIKINLTESGLNGTLMDFSFSSFPNLAYVDISMNNLSGPIPPQIGLLFELKYLDLSI 146

Query: 143  NKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLG 202
            N+  G IPS IGLLT+L VLH+ +N L+GSIPHE+GQL  L +LAL +N L GSIP SLG
Sbjct: 147  NQFSGGIPSEIGLLTNLEVLHLVQNQLNGSIPHEIGQLASLYELALYTNQLEGSIPASLG 206

Query: 203  NLTHVV------------------------------------------------ILYLYN 214
            NL+++                                                 +LYL+N
Sbjct: 207  NLSNLASLYLYENQLSGSIPPEMGNLTNLVEIYSNNNNLTGPIPSTFGNLKRLTVLYLFN 266

Query: 215  NSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIG 274
            NS  G IP EIGNLKSL +L L  N LSG IP+S+ +L+ L  L LY N+LSG IPQEIG
Sbjct: 267  NSLSGPIPPEIGNLKSLQELSLYENNLSGPIPVSLCDLSGLTLLHLYANQLSGPIPQEIG 326

Query: 275  NLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSN 334
            NLK L  L L++N   G++P S  NLT+L  L L  N L+G I +  G    L  +++  
Sbjct: 327  NLKSLVDLELSENQLNGSIPTSLGNLTNLEILFLRDNQLSGYIPQEIGKLHKLVVLEIDT 386

Query: 335  NSFFGEI--------------LSD----------------------------------WG 346
            N  FG +              +SD                                   G
Sbjct: 387  NQLFGSLPEGICQAGSLVRFAVSDNHLSGPIPKSLKNCRNLTRALFQGNRLTGNISEVVG 446

Query: 347  RCPQLSLLDVSIN------------------------NISGSIPLEIGESLQLQYLDLSS 382
             CP L  +D+S N                        NI+GSIP + G S  L  LDLSS
Sbjct: 447  DCPNLEFIDLSYNRFHGELSHNWGRCPQLQRLEIAGNNITGSIPEDFGISTNLTLLDLSS 506

Query: 383  NYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLG 442
            N++VGEIP ++G++  L  L L+ N+LSG IP ELGSL +LEYLDLSAN L+  +PE LG
Sbjct: 507  NHLVGEIPKKMGSLTSLLGLILNDNQLSGSIPPELGSLSHLEYLDLSANRLNGSIPEHLG 566

Query: 443  SLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSY 502
              + L+YLNLS+NKLS  IP+++  L HLS+LDLSHN L   I  +I  ++SLE L+LS+
Sbjct: 567  DCLDLHYLNLSNNKLSHGIPVQMGKLSHLSQLDLSHNLLAGGIPPQIQGLQSLEMLDLSH 626

Query: 503  NNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNSTTFRDAPLEALQGNKGLYGDIRGFPS 562
            NNL G IP+ FE+M  L ++DISYN+L+G IP+S  FR+A +E L+GNK L G+++G   
Sbjct: 627  NNLCGFIPKAFEDMPALSYVDISYNQLQGPIPHSNAFRNATIEVLKGNKDLCGNVKGLQP 686

Query: 563  C-------MSYKKASRKIWIVIVFPLLGMVALFIALTGFFFIFHQRKNDSQTQQSSFGNT 615
            C           K S K+  +I+FPLLG + L  A  G F I  +R+   + ++    N 
Sbjct: 687  CKYGFGVDQQPVKKSHKVVFIIIFPLLGALVLLFAFIGIFLIAERRERTPEIEEGDVQND 746

Query: 616  PGLRSVLTFEGKIVYEEIISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLP 675
              L S+  F+G+ +YEEII AT DF+  +CIGKGGHGSVY+A++PS  I AVKK H P  
Sbjct: 747  --LFSISNFDGRTMYEEIIKATKDFDPMYCIGKGGHGSVYKAELPSSNIVAVKKLH-PSD 803

Query: 676  GEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASA 735
             EM+  Q++FLNEI+ALTEI+HRNIVK  GFCSHP+H F++YEYLE GSL  IL  +  A
Sbjct: 804  TEMA-NQKDFLNEIRALTEIKHRNIVKLLGFCSHPRHKFLVYEYLERGSLATILSRE-EA 861

Query: 736  KELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN 795
            K+LGW  R+N+IKGVA AL Y+H++C PPIVHRD+SS N+LLD  YEAH+SDFG AK L 
Sbjct: 862  KKLGWATRVNIIKGVAHALAYMHHDCSPPIVHRDVSSNNILLDSQYEAHISDFGTAKLLK 921

Query: 796  PDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSS 855
             DSSN S LAGT GY+APELAYT+KVTEK DV+SFGV+ALEVIKG+HP D +  +S S  
Sbjct: 922  LDSSNQSILAGTFGYLAPELAYTMKVTEKTDVFSFGVIALEVIKGRHPGDQILSLSVSPE 981

Query: 856  NMNI---EMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEK 908
              NI   +MLD RLP  +   + ++++I++ A  CL  NP+SRPTM+ VSQ+L ++
Sbjct: 982  KDNIALEDMLDPRLPPLTPQDEGEVIAILKQAIECLKANPQSRPTMQTVSQMLSQR 1037

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225456161|ref|XP_002278590.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  844 bits (2181), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 478/1017 (47%), Positives = 625/1017 (61%), Gaps = 144/1017 (14%)

Query: 31   ISSNSAEEAHALVKWKASLEVHSRSLLHSWSLSSVN--------ATKISPCAWSGIFCNH 82
            +SS S EE  AL+KWKA+L  H+ S L SW+L   N         T++SPC W GI CNH
Sbjct: 27   VSSYSNEETQALLKWKATLHNHNHSSLLSWTLYPNNFTNSSTHLGTEVSPCKWYGISCNH 86

Query: 83   AERVVGINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSA 142
            A  V+ INLT   L GTL  FSFSSFP+L Y+D+  N L G IPPQI  LS L+YLD S 
Sbjct: 87   AGSVIRINLTESGLGGTLQAFSFSSFPNLAYVDISMNNLSGPIPPQIGLLSKLKYLDLSI 146

Query: 143  NKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLG 202
            N+  G IP  IGLLT+L VLH+ +N L+GSIPHE+GQLT L +LAL +N L GSIP SLG
Sbjct: 147  NQFSGGIPPEIGLLTNLEVLHLVQNQLNGSIPHEIGQLTSLYELALYTNQLEGSIPASLG 206

Query: 203  NLT------------------------------------------------HVVILYLYN 214
            NL+                                                H+ +LYL+N
Sbjct: 207  NLSNLASLYLYENQLSGSIPPEMGNLTNLVQLYSDTNNLTGPIPSTFGNLKHLTVLYLFN 266

Query: 215  NSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIG 274
            NS  G IP EIGNLKSL  L L  N LSG IP+S+ +L+ L  L LY N+LSG IPQEIG
Sbjct: 267  NSLSGPIPPEIGNLKSLQGLSLYGNNLSGPIPVSLCDLSGLTLLHLYANQLSGPIPQEIG 326

Query: 275  NLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSN 334
            NLK L  L L++N   G++P S  NLT+L  L L  N L+G   +  G    L  +++  
Sbjct: 327  NLKSLVDLELSENQLNGSIPTSLGNLTNLEILFLRDNRLSGYFPQEIGKLHKLVVLEIDT 386

Query: 335  NSFFGEI--------------LSD----------------------------------WG 346
            N  FG +              +SD                                   G
Sbjct: 387  NQLFGSLPEGICQGGSLERFTVSDNHLSGPIPKSLKNCRNLTRALFQGNRLTGNVSEVVG 446

Query: 347  RCPQLSLLDVSI------------------------NNISGSIPLEIGESLQLQYLDLSS 382
             CP L  +D+S                         NNI+GSIP + G S  L  LDLSS
Sbjct: 447  DCPNLEFIDLSYNRFHGELSHNWGRCPQLQRLEIAGNNITGSIPEDFGISTNLILLDLSS 506

Query: 383  NYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLG 442
            N++VGEIP ++G++  L  L L+ N+LSG IP ELGSL +LEYLDLSAN L+  +PE LG
Sbjct: 507  NHLVGEIPKKMGSLTSLLGLILNDNQLSGSIPPELGSLSHLEYLDLSANRLNGSIPEHLG 566

Query: 443  SLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSY 502
              + L+YLNLS+NKLS  IP+++  L HLS+LDLSHN L   I ++I  +ESLE L+LS+
Sbjct: 567  DCLDLHYLNLSNNKLSHGIPVQMGKLSHLSQLDLSHNLLTGGIPAQIQGLESLEMLDLSH 626

Query: 503  NNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNSTTFRDAPLEALQGNKGLYGDIRGFPS 562
            NNL G IP+ FE+M  L ++DISYN+L+G IP+S  FR+A +E L+GNK L G+++G   
Sbjct: 627  NNLCGFIPKAFEDMPALSYVDISYNQLQGPIPHSNAFRNATIEVLKGNKDLCGNVKGLQP 686

Query: 563  C-------MSYKKASRKIWIVIVFPLLGMVALFIALTGFFFIFHQRKNDSQTQQSSFGNT 615
            C           K S K+  +I+FPLLG + L  A  G F I  +R+   + ++    N 
Sbjct: 687  CKYGFGVDQQPVKKSHKVVFIIIFPLLGALVLLSAFIGIFLIAERRERTPEIEEGDVQNN 746

Query: 616  PGLRSVLTFEGKIVYEEIISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLP 675
              L S+ TF+G+ +YEEII AT DF+  +CIGKGGHGSVY+A++PSG I AVKK H   P
Sbjct: 747  --LLSISTFDGRAMYEEIIKATKDFDPMYCIGKGGHGSVYKAELPSGNIVAVKKLH---P 801

Query: 676  GEMSF-QQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDAS 734
             +M    Q++FLN+++A+TEI+HRNIV+  GFCS+P+HSF++YEYLE GSL  IL  +  
Sbjct: 802  SDMDMANQKDFLNKVRAMTEIKHRNIVRLLGFCSYPRHSFLVYEYLERGSLATILSRE-E 860

Query: 735  AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL 794
            AK+LGW  R+ +IKGVA AL Y+H++C PPIVHRDISS N+LLD  YEAH+S+ G AK L
Sbjct: 861  AKKLGWATRVKIIKGVAHALSYMHHDCSPPIVHRDISSNNILLDSQYEAHISNLGTAKLL 920

Query: 795  NPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS 854
              DSSN S+LAGT GYVAPE AYT+KVTEK DVYSFGV+ALEVIKG+HP D +  +S S 
Sbjct: 921  KVDSSNQSKLAGTVGYVAPEHAYTMKVTEKTDVYSFGVIALEVIKGRHPGDQILSISVSP 980

Query: 855  SNMNI--EMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI 909
                +  +MLD RLP  +   + ++++I+++A +CL+ NP+SRPTM+ +SQ+L ++I
Sbjct: 981  EKNIVLKDMLDPRLPPLTPQDEGEVVAIIKLATACLNANPQSRPTMEIISQMLSQRI 1037

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147767326|emb|CAN68996.1| hypothetical protein VITISV_008862 [Vitis vinifera]

 Score =  822 bits (2122), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 441/835 (52%), Positives = 579/835 (69%), Gaps = 32/835 (3%)

Query: 104  SFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLH 163
            S  +  +L  L L  N+L G+IPP++ NL+ L  L  +AN L G IPS +G L  LT+L 
Sbjct: 201  SLGNLSNLTNLYLDENKLSGLIPPEMGNLTKLVELCLNANNLTGPIPSTLGNLKSLTLLR 260

Query: 164  ISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQ 223
            +  N LSG IP E+G L  L  L+L SN+L+G IP SLG+L+ +  L L++N   G IPQ
Sbjct: 261  LYNNQLSGPIPTEIGNLKHLRNLSLSSNYLSGPIPMSLGDLSGLKSLQLFDNQLSGPIPQ 320

Query: 224  EIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLL 283
            E+GNL+SL DLE+  NQL+G+IP S+ NL NL  L+L  N+LS  IP EIG L KL  L 
Sbjct: 321  EMGNLRSLVDLEISQNQLNGSIPTSLGNLINLEILYLRDNKLSSSIPPEIGKLHKLVELE 380

Query: 284  LAKNHFRG------------------------TVPKSFRNLTDLVKLRLNQNYLTGNISE 319
            +  N   G                         +P+S +N   L + RL +N LTGNISE
Sbjct: 381  IDTNQLSGFLPEGICQGGSLENFTVFDNFLIGPIPESLKNCPSLARARLQRNQLTGNISE 440

Query: 320  TFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLD 379
             FG  PNL  I+LSNN F+GE+  +WGRC +L  LD++ NNI+GSIP + G S QL  L+
Sbjct: 441  AFGVCPNLYHINLSNNKFYGELSQNWGRCHKLQWLDIAGNNITGSIPADFGISTQLTVLN 500

Query: 380  LSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPE 439
            LSSN++VGEIP +LG++  L +L L+ N+LSG IP ELGSL +L YLDLS N L+  +PE
Sbjct: 501  LSSNHLVGEIPKKLGSVSSLWKLILNDNRLSGNIPPELGSLADLGYLDLSGNRLNGSIPE 560

Query: 440  SLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLN 499
             LG+ + L YLNLS+NKLS  IP+++  L HLS LDLSHN L  +I S+I  ++SLEKLN
Sbjct: 561  HLGNCLDLNYLNLSNNKLSHGIPVQMGKLSHLSLLDLSHNLLTGEIPSQIQGLQSLEKLN 620

Query: 500  LSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNSTTFRDAPLEALQGNKGLYGDIRG 559
            LS+NNLSG+IP+ FE+MHGL  +DISYN L+G IPNS  F++  +E LQGNKGL G ++G
Sbjct: 621  LSHNNLSGIIPKAFEDMHGLWQVDISYNDLQGSIPNSEAFQNVTIEVLQGNKGLCGSVKG 680

Query: 560  FPSC--MSYKKASRKIWIVIVFPLLGMVALFIALTGFFFIFHQRKNDSQTQQSSFGNTPG 617
               C   S  K + K   +I+F LLG + +  A  G   I   R+N ++ +++    T  
Sbjct: 681  LQPCENRSATKGTHKAVFIIIFSLLGALLILSAFIGISLISQGRRN-AKMEKAGDVQTEN 739

Query: 618  LRSVLTFEGKIVYEEIISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGE 677
            L S+ TF+G+  YE II AT DF+  +CIG+GGHGSVY+A++PSG I AVKK H     +
Sbjct: 740  LFSISTFDGRTTYEAIIEATKDFDPMYCIGEGGHGSVYKAELPSGNIVAVKKLHR-FDID 798

Query: 678  MSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE 737
            M+  Q++F+NEI+ALTEI+HRNIVK  GFCSH +HSF++YEYLE GSL  IL  +  AKE
Sbjct: 799  MA-HQKDFMNEIRALTEIKHRNIVKLLGFCSHSRHSFLVYEYLERGSLGTILSKELQAKE 857

Query: 738  LGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPD 797
            +GW  R+N+IKGVA AL YLH++C PPIVHRDISS NVLLD  YEAHVSDFG AKFL  D
Sbjct: 858  VGWGTRVNIIKGVAHALSYLHHDCVPPIVHRDISSNNVLLDSKYEAHVSDFGTAKFLKLD 917

Query: 798  SSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNM 857
            SSNWS LAGT+GYVAPELAYT+KVTEKCDVYSFGVLALEV++G+HP D +  +S+S    
Sbjct: 918  SSNWSTLAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVMRGRHPGDLISSLSASPGKD 977

Query: 858  NI---EMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI 909
            N+   ++LD RLP P+L  + ++MS++Q+A +CL+ +P+SRPTM+ VSQ+L ++I
Sbjct: 978  NVVLKDVLDPRLPPPTLRDEAEVMSVIQLATACLNGSPQSRPTMQMVSQMLSQRI 1032

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147772402|emb|CAN73988.1| hypothetical protein VITISV_022117 [Vitis vinifera]

 Score =  820 bits (2118), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 443/839 (52%), Positives = 568/839 (67%), Gaps = 39/839 (4%)

Query: 104 SFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLH 163
           S  +  +L YL LY N+L   IPP++ NL+NL  +    N L G IPS  G L  LTVL+
Sbjct: 162 SLGNLSNLAYLYLYENQLSDSIPPEMGNLTNLVEIYSDTNNLIGPIPSTFGNLKRLTVLY 221

Query: 164 ISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQ 223
           +  N LSG IP E+G L  L  L+L  N L+G IP SLG+L+ + +L+LY N   G IPQ
Sbjct: 222 LFNNRLSGHIPPEIGNLKSLQGLSLYENNLSGPIPASLGDLSGLTLLHLYANQLSGPIPQ 281

Query: 224 EIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKL---- 279
           EIGNLKSL DLEL  NQL+G+IP S+ NLTNL  LFL  N+LSG IPQEIG L KL    
Sbjct: 282 EIGNLKSLVDLELSENQLNGSIPTSLGNLTNLETLFLRDNQLSGYIPQEIGKLHKLVVLE 341

Query: 280 ---NSLL-----------------LAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISE 319
              N L                  ++ NH  G +PKS +N  +L +     N LTGNISE
Sbjct: 342 IDTNQLFGSLPEGICQGGSLERFTVSDNHLSGPIPKSLKNCKNLTRALFGGNQLTGNISE 401

Query: 320 TFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLD 379
             G  PNL +I++S NSF GE+  +WGR P+L  L+++ NNI+GSIP + G S  L  LD
Sbjct: 402 VVGDCPNLEYINVSYNSFHGELSHNWGRYPRLQRLEMAWNNITGSIPEDFGISTDLTLLD 461

Query: 380 LSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPE 439
           LSSN++ GEIP ++G++  L +L L+ N+LSG IP ELGSL +L YLDLSAN L+  +PE
Sbjct: 462 LSSNHLFGEIPKKMGSVTSLWKLILNDNQLSGNIPPELGSLADLGYLDLSANRLNGSIPE 521

Query: 440 SLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLN 499
            LG  + L YLNLS+NKLS  IP+++  L HLS+LDLSHN L   I  +I  ++SLE LN
Sbjct: 522 HLGDCLGLNYLNLSNNKLSHGIPVQMGKLGHLSQLDLSHNLLTGDIPPQIEGLQSLENLN 581

Query: 500 LSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNSTTFRDAPLEALQGNKGLYGDIRG 559
           LS+NNLSG IP+ FEEM GL  +DISYN+L+G IPNS  FRDA +EAL+GNKGL G+++ 
Sbjct: 582 LSHNNLSGFIPKAFEEMLGLSDVDISYNQLQGPIPNSKAFRDATIEALKGNKGLCGNVKR 641

Query: 560 FPSC-------MSYKKASRKIWIVIVFPLLGMVALFIALTGFFFIFHQRKNDSQTQQSSF 612
              C           K S K+  +I+FPLLG + L  A  G F I  +R+   + ++   
Sbjct: 642 LRPCKYGSGVDQQPVKKSHKVVFIIIFPLLGALVLLFAFIGIFLIAARRERTPEIKEGEV 701

Query: 613 GNTPGLRSVLTFEGKIVYEEIISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHS 672
            N   L S+ TF+G+ +YEEII AT DF+  +CIGKGGHGSVY+A++PS  I AVKK H 
Sbjct: 702 QND--LFSISTFDGRTMYEEIIKATKDFDPMYCIGKGGHGSVYKAELPSSNIVAVKKLH- 758

Query: 673 PLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCND 732
           P   EM+  Q++FLNEI+ALTEI+HRNIVK  GFCSHP+H F++YEYLE GSL  IL  +
Sbjct: 759 PSDTEMA-NQKDFLNEIRALTEIKHRNIVKLLGFCSHPRHKFLVYEYLERGSLATILSRE 817

Query: 733 ASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK 792
             AK+LGW  R+N+IKGVA AL Y+H++C PPIVHRDISS N+LLD  YEAH+SDFG AK
Sbjct: 818 -EAKKLGWATRVNIIKGVAHALAYMHHDCSPPIVHRDISSNNILLDSQYEAHISDFGTAK 876

Query: 793 FLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS 852
            L  DSSN S LAGT GY+APELAYT+KVTEK DV+SFGV+ALEVIKG+HP D +  +S 
Sbjct: 877 LLKLDSSNQSILAGTFGYLAPELAYTMKVTEKTDVFSFGVIALEVIKGRHPGDQILSLSV 936

Query: 853 SSSNMNI---EMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEK 908
           S    NI   +MLD RLP  +   + ++++I++ A  CL  NP+SRPTM+ VSQ+L ++
Sbjct: 937 SPEKDNIALEDMLDPRLPPLTPQDEGEVIAIIKQATECLKANPQSRPTMQTVSQMLSQR 995

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359491509|ref|XP_002278522.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  812 bits (2098), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 441/850 (51%), Positives = 582/850 (68%), Gaps = 33/850 (3%)

Query: 89   INLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQ 148
            ++L +  L GT+   S  +  +L  L L  N+L G+IPP++ NL+ L  L  +AN L G 
Sbjct: 187  LSLYTNKLEGTI-PASLGNLSNLTNLYLDENKLSGLIPPEMGNLTKLVELCLNANNLTGP 245

Query: 149  IPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVV 208
            IPS +G L  LT+L +  N LSG IP E+G L  L  L+L SN+L+G IP SLG+L+ + 
Sbjct: 246  IPSTLGNLKSLTLLRLYNNQLSGPIPTEIGNLKHLRNLSLSSNYLSGPIPMSLGDLSGLK 305

Query: 209  ILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGI 268
             L L++N   G IPQE+GNL+SL DLE+  NQL+G+IP  + NL NL  L+L  N+LS  
Sbjct: 306  SLQLFDNQLSGPIPQEMGNLRSLVDLEISQNQLNGSIPTLLGNLINLEILYLRDNKLSSS 365

Query: 269  IPQEIGNLKKLNSLLLAKNHFRG------------------------TVPKSFRNLTDLV 304
            IP EIG L KL  L +  N   G                         +P+S +N   L 
Sbjct: 366  IPPEIGKLHKLVELEIDTNQLSGFLPEGICQGGSLENFTVFDNFLIGPIPESLKNCPSLA 425

Query: 305  KLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGS 364
            + RL  N LTGNISE FG  PNL  I+LSNN F+GE+  +WGRC +L  LD++ NNI+GS
Sbjct: 426  RARLQGNQLTGNISEAFGVCPNLYHINLSNNKFYGELSQNWGRCHKLQWLDIAGNNITGS 485

Query: 365  IPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLE 424
            IP + G S QL  L+LSSN++VGEIP +LG++  L +L L+ N+LSG IP ELGSL +L 
Sbjct: 486  IPADFGISTQLTVLNLSSNHLVGEIPKKLGSVSSLWKLILNDNRLSGNIPPELGSLADLG 545

Query: 425  YLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEK 484
            YLDLS N L+  +PE LG+ + L YLNLS+NKLS  IP+++  L HLS LDLSHN L  +
Sbjct: 546  YLDLSGNRLNGSIPEHLGNCLDLNYLNLSNNKLSHGIPVQMGKLSHLSLLDLSHNLLTGE 605

Query: 485  ISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNSTTFRDAPL 544
            I S+I  ++SLEKLNLS+NNLSG+IP+ FE+MHGL  +DISYN L+G IPNS  F++  +
Sbjct: 606  IPSQIQGLQSLEKLNLSHNNLSGIIPKAFEDMHGLWQVDISYNDLQGSIPNSEAFQNVTI 665

Query: 545  EALQGNKGLYGDIRGFPSC--MSYKKASRKIWIVIVFPLLGMVALFIALTGFFFIFHQRK 602
            E LQGNKGL G ++G   C   S  K + K   +I+F LLG + +  A  G   I   R+
Sbjct: 666  EVLQGNKGLCGSVKGLQPCENRSATKGTHKAVFIIIFSLLGALLILSAFIGISLISQGRR 725

Query: 603  NDSQTQQSSFGNTPGLRSVLTFEGKIVYEEIISATNDFNAEHCIGKGGHGSVYRAKVPSG 662
            N ++ +++    T  L S+ TF+G+  YE II AT DF+  +CIG+GGHGSVY+A++PSG
Sbjct: 726  N-AKMEKAGDVQTENLFSISTFDGRTTYEAIIEATKDFDPMYCIGEGGHGSVYKAELPSG 784

Query: 663  EIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLES 722
             I AVKK H     +M+  Q++F+NEI+ALTEI+HRNIVK  GFCSH +HSF++YEYLE 
Sbjct: 785  NIVAVKKLHR-FDIDMA-HQKDFVNEIRALTEIKHRNIVKLLGFCSHSRHSFLVYEYLER 842

Query: 723  GSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYE 782
            GSL  IL  +  AKE+GW  R+N+IKGV+ AL YLH++C PPIVHRDISS NVLLD  YE
Sbjct: 843  GSLGTILSKELQAKEVGWGTRVNIIKGVSHALSYLHHDCVPPIVHRDISSNNVLLDSKYE 902

Query: 783  AHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKH 842
            AHVSDFG AKFL  DSSNWS LAGT+GYVAPELAYT+KVTEKCDVYSFGVLALEV++G+H
Sbjct: 903  AHVSDFGTAKFLKLDSSNWSTLAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVMRGRH 962

Query: 843  PRDFLFEMSSSSSNMNI---EMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMK 899
            P D +  +S S    N+   ++LD RLP P+   + ++ S++Q+A +CL+ +P+SRPTM+
Sbjct: 963  PGDLISSLSDSPGKDNVVLKDVLDPRLPPPTFRDEAEVTSVIQLATACLNGSPQSRPTMQ 1022

Query: 900  RVSQLLCEKI 909
             VSQ+L ++I
Sbjct: 1023 MVSQMLSQRI 1032

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255545702|ref|XP_002513911.1| receptor protein kinase, putative [Ricinus communis] gi|223546997|gb|EEF48494.1| receptor protein kinase, putative [Ricinus communis]

 Score =  809 bits (2089), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 466/994 (46%), Positives = 617/994 (62%), Gaps = 112/994 (11%)

Query: 22   FVVLDFSLAISSNSAEEAHALVKWKASLEVHSRSLLHSWSLSSVNAT----KISPCAWSG 77
            F V+  +  I+S+SAE+A++L+KW A+L     S    W L   N+T    K SPC W G
Sbjct: 17   FGVMYAAFNIASDSAEQANSLLKWAATLHNQKYSNRSPWPLLPENSTNPNAKTSPCTWLG 76

Query: 78   IFCNHAERVVGINLTSISLNGTLLEFSFSSFP------------------------HLVY 113
            + CN    VV INLT+  LNGTL E SFS+FP                         L++
Sbjct: 77   LSCNRGGSVVRINLTTSGLNGTLHELSFSAFPDLEFLDLSCNSLSSTIPLEITQLPKLIF 136

Query: 114  LDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSI 173
            LDL +N+L G+IPP I  L+NL  L  SAN+L G IPS +G LT L  LH+  N  SGSI
Sbjct: 137  LDLSSNQLSGVIPPDIGLLTNLNTLRLSANRLDGSIPSSVGNLTELAWLHLYDNRFSGSI 196

Query: 174  PHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLF- 232
            P E+G L  L +L +D+N L GSIP + G+LT +V L+LYNN   G IPQE+G+LKSL  
Sbjct: 197  PSEMGNLKNLVELFMDTNLLTGSIPSTFGSLTKLVQLFLYNNQLSGHIPQELGDLKSLTS 256

Query: 233  -----------------------------------------------DLELCINQLSGAI 245
                                                           +LEL  N+L+G+I
Sbjct: 257  LSLFGNNLSGPIPASLGGLTSLTILHLYQNQLSGTIPKELGNLNSLSNLELSENKLTGSI 316

Query: 246  PLSISNLTNLRFLFLYHNELSGIIPQEIGNL------------------------KKLNS 281
            P S+ NL+ L  LFL +N+LSG IP++I NL                        K L +
Sbjct: 317  PASLGNLSRLELLFLKNNQLSGPIPEQIANLSKLSLLQLQSNQLTGYLPQNICQSKVLQN 376

Query: 282  LLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEI 341
              +  N   G +PKS R+   LV+L L  N   GNISE FG YP L F+D+  N F GEI
Sbjct: 377  FSVNDNRLEGPIPKSMRDCKSLVRLHLEGNQFIGNISEDFGVYPYLQFVDIRYNKFHGEI 436

Query: 342  LSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNR 401
             S WG CP L  L +S NNISG IP EIG + +LQ LD SSN +VG IP +LG +  L R
Sbjct: 437  SSKWGMCPHLGTLLISGNNISGIIPPEIGNAARLQGLDFSSNQLVGRIPKELGKLTSLVR 496

Query: 402  LSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQI 461
            ++L  N+LS  +P E GSL +LE LDLSAN  +  +P ++G+LVKL YLNLS+N+ SQ+I
Sbjct: 497  VNLEDNQLSDGVPSEFGSLTDLESLDLSANRFNQSIPGNIGNLVKLNYLNLSNNQFSQEI 556

Query: 462  PIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLH 521
            PI+L  L+HLS+LDLS NFL  +I S +  M+SLE LNLS NNLSG IP   +EMHGL  
Sbjct: 557  PIQLGKLVHLSKLDLSQNFLIGEIPSELSGMQSLEVLNLSRNNLSGFIPGDLKEMHGLSS 616

Query: 522  IDISYNKLEGQIPNSTTFRDAPLEALQGNKGLYGDIRGFPSCM-------SYKKASRKIW 574
            IDISYNKLEG +P++  F+++ +EA QGNKGL G ++G   C        S  K  ++++
Sbjct: 617  IDISYNKLEGPVPDNKAFQNSSIEAFQGNKGLCGHVQGLQPCKPSSTEQGSSIKFHKRLF 676

Query: 575  IVIVFPLLGMVALFIALTGFFFIFHQRKNDSQTQQSSFGNTPGLRSVLTFEGKIVYEEII 634
            +VI  PL G   L ++  G  F   +R  ++   + S   +  +  + +F+GK +++EII
Sbjct: 677  LVISLPLFGAF-LILSFLGVLFFQSKRSKEALEAEKSSQESEEILLITSFDGKSMHDEII 735

Query: 635  SATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTE 694
             AT+ FN  +CIGKGG GSVY+AK+ SG   AVKK H        +Q+ EF +EI+ALTE
Sbjct: 736  EATDSFNDIYCIGKGGCGSVYKAKLSSGSTVAVKKLHQSHDAWKPYQK-EFWSEIRALTE 794

Query: 695  IRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADAL 754
            I+HRNIVKFYGFCS+  +SF++YE +E GSL  IL ++ +AKEL W +R N+IKGVA+AL
Sbjct: 795  IKHRNIVKFYGFCSYSAYSFLVYECIEKGSLATILRDNEAAKELEWFKRANIIKGVANAL 854

Query: 755  FYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPE 814
             Y+H++C PPIVHRDISSKN+LLD   EA VSDFGIA+ LN DSS+ + LAGT GY+APE
Sbjct: 855  SYMHHDCSPPIVHRDISSKNILLDSENEARVSDFGIARILNLDSSHRTALAGTFGYMAPE 914

Query: 815  LAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNI---EMLDSRLPYPSL 871
            LAY++ VTEKCDVYSFGVLALEVI GKHP + +  +SSSSS   +    ++D RLP+PS 
Sbjct: 915  LAYSIVVTEKCDVYSFGVLALEVINGKHPGEIISSISSSSSTRKMLLENIVDLRLPFPSP 974

Query: 872  HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
             VQ +L++I+ +AF+CL+ NP+ RPTM+ +  +L
Sbjct: 975  EVQVELVNILNLAFTCLNSNPQVRPTMEMICHML 1008

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224108393|ref|XP_002333399.1| predicted protein [Populus trichocarpa] gi|222836439|gb|EEE74846.1| predicted protein [Populus trichocarpa]

 Score =  770 bits (1987), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 423/897 (47%), Positives = 581/897 (64%), Gaps = 27/897 (3%)

Query: 31  ISSNSAEEAHALVKWKASLEVHSRSLLHSWSLSSVNATKISPC-AWSGIFCNHAERVVGI 89
           ++  + +EA AL+KWKASL+  S+SLL SW          SPC  W GI C+ +  V  +
Sbjct: 55  VAGGNIKEAEALLKWKASLDNQSQSLLSSW-------VGTSPCIDWIGITCDGSGSVANL 107

Query: 90  NLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQI 149
                 L GTL +F+FSSFP+L  LDL NN + G +P  I NLS +  L    N L G I
Sbjct: 108 TFPHFGLRGTLYDFNFSSFPNLSVLDLSNNSIHGTLPSHIGNLSKITQLGLCYNDLTGSI 167

Query: 150 PSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVI 209
           PS IG L  +T L + RN  SGSIPHE+G+LT L++L+L  N L GSIP S+GNL ++  
Sbjct: 168 PSEIGSLKSITDLVLCRNLFSGSIPHEIGKLTSLSRLSLAVNNLTGSIPSSIGNLKNLSN 227

Query: 210 LYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGII 269
           L+L++N   G IP EIG LKSL  L L  N+L G +PL ++NLT+L+   L  NE +G +
Sbjct: 228 LFLWDNKLSGRIPSEIGQLKSLVGLSLANNKLHGPLPLEMNNLTHLKQFHLSDNEFTGHL 287

Query: 270 PQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTF 329
           PQE+ +   L +L +A N+F G++PKS +N T L +LRL++N LTGNISE FG YP+L +
Sbjct: 288 PQEVCHGGVLENLTVANNYFSGSIPKSLKNCTSLHRLRLDRNQLTGNISEDFGIYPHLDY 347

Query: 330 IDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEI 389
           +DLS N+F+GE+   WG    ++ L +S NN+SG IP E+G++ QLQ +DLSSN++ G I
Sbjct: 348 VDLSYNNFYGELSLKWGDYRNITSLKISNNNVSGEIPAELGKATQLQLIDLSSNHLEGTI 407

Query: 390 PTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYY 449
             +LG +  L  L+LS N LSG IP ++  L +L+ LDL++NNLS  +P+ LG    L  
Sbjct: 408 SKELGGLKLLYNLTLSNNHLSGAIPSDIKMLSSLKILDLASNNLSGSIPKQLGECSNLLL 467

Query: 450 LNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLI 509
           LNL+ NK +  IP E+  L  L +LDLS NFL ++I  ++ +++ LE LN+S+N LSGLI
Sbjct: 468 LNLTDNKFTNSIPQEIGFLRSLQDLDLSCNFLAQEIPWQLGQLQMLETLNVSHNMLSGLI 527

Query: 510 PRCFEEMHGLLHIDISYNKLEGQIPNSTTFRDAPLEALQGNKGLYGDIRGFPSC------ 563
           PR F+++  L  +DIS NKL+G IP+   F +A  EAL+ N G+ G+  G   C      
Sbjct: 528 PRTFKDLLSLTVVDISSNKLQGPIPDIKAFHNASFEALRDNMGICGNASGLKPCNLPKSS 587

Query: 564 MSYKKASRKIWIVIVFPLLGMVALFIALTGFFFIFHQRKNDSQTQQSSFGNTPGLRSVLT 623
            + K+ S K+ I+IV PLLG + L I + G  FI  QR    + +  +      L ++L 
Sbjct: 588 RTVKRKSNKLVILIVLPLLGSLLLVIVVIGALFILRQRARKRKAEPGNIEQDRNLFTILG 647

Query: 624 FEGKIVYEEIISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQE 683
            +GK++YE II+AT +FN+ +CIG+GG+G VY+A +P   + AVKK H     ++S   +
Sbjct: 648 HDGKLLYENIIAATEEFNSNYCIGEGGYGIVYKAVMPEERVVAVKKLHRSQTDKLS-DFK 706

Query: 684 EFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQR 743
            F  E+  L  IRHRNIVK YGFCSH KHSF++YE++E GSL KI+  +  A EL W +R
Sbjct: 707 AFETEVCVLANIRHRNIVKLYGFCSHAKHSFLVYEFIERGSLRKIITTEEQAIELDWMKR 766

Query: 744 LNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSE 803
           LNV+KG+A AL YLH++  PPI+HRDI+S NVLLDL YEAHVSDFG A+ L PDSSNW+ 
Sbjct: 767 LNVVKGMAGALSYLHHSSSPPIIHRDITSNNVLLDLEYEAHVSDFGTARMLMPDSSNWTS 826

Query: 804 LAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS----------- 852
            AGT GY APELAYT+KVTEKCDVYSFGV+ +EV+ G+HP D +  +SS           
Sbjct: 827 FAGTFGYTAPELAYTMKVTEKCDVYSFGVVTMEVMMGRHPGDLISTLSSQATSSSSSMPP 886

Query: 853 -SSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEK 908
            S   +  ++LD R+  P     +  + IM++A +CL  NP+SRPTM R+S  L  K
Sbjct: 887 ISQQTLLKDVLDQRISLPKKGAAEGAVHIMKIALACLHPNPQSRPTMGRISSELATK 943

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224108397|ref|XP_002333400.1| predicted protein [Populus trichocarpa] gi|222836440|gb|EEE74847.1| predicted protein [Populus trichocarpa]

 Score =  765 bits (1976), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 423/897 (47%), Positives = 586/897 (65%), Gaps = 27/897 (3%)

Query: 31  ISSNSAEEAHALVKWKASLEVHSRSLLHSWSLSSVNATKISPCA-WSGIFCNHAERVVGI 89
           ++  + +E  AL+KWKASL+  S+SLL SW          SPC  W GI C+ +  V  +
Sbjct: 55  VAGGNIKETEALLKWKASLDNQSQSLLSSW-------VGTSPCINWIGITCDGSGSVANL 107

Query: 90  NLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQI 149
              +  L GTL +F+FSSFP+L  LDL NN + G IP  I NLS +  L    N L G I
Sbjct: 108 TFPNFGLRGTLYDFNFSSFPNLSILDLSNNSIHGTIPSHIGNLSKITQLGLCYNDLTGSI 167

Query: 150 PSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVI 209
           PS IG L  +T L + RN LSGSIPHE+G+LT L++L+L  N L GSIP S+GNL  + I
Sbjct: 168 PSEIGSLKSITDLVLCRNLLSGSIPHEIGKLTSLSRLSLAVNNLTGSIPSSIGNLKKLSI 227

Query: 210 LYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGII 269
           L+L+ N+  G IP EIG LKSL  + L  N+L G +PL ++NLT+L+ L +  NE +G +
Sbjct: 228 LFLWGNNLSGHIPSEIGQLKSLVSMSLANNKLHGPLPLEMNNLTHLKQLHVSENEFTGHL 287

Query: 270 PQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTF 329
           PQE+ +   L +L  A N+F G++P+S +N T L +LRL+ N LTGNISE FG YP+L +
Sbjct: 288 PQEVCHGGVLENLTAANNYFSGSIPESLKNCTSLHRLRLDGNQLTGNISEDFGIYPHLDY 347

Query: 330 IDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEI 389
           +DLS N+F+GE+   W     ++ L +S NN++G IP E+G++ QLQ +DLSSN++ G I
Sbjct: 348 VDLSYNNFYGELSLKWEDYCNITSLKISNNNVAGEIPAELGKATQLQLIDLSSNHLEGTI 407

Query: 390 PTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYY 449
           P +LG +  L  L+LS N LSG IP ++  L +L+ LDL++NNLS  +P+ LG    L  
Sbjct: 408 PKELGGLKLLYSLTLSNNHLSGAIPSDIKMLSSLKILDLASNNLSGSIPKQLGECSNLLL 467

Query: 450 LNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLI 509
           LNLS+NK ++ IP E+  L  L +L LS NFL  +I  ++ +++ LE LN+S+N LSGLI
Sbjct: 468 LNLSNNKFTKSIPQEIGFLRSLQDLVLSCNFLAREIPWQLGQLQMLETLNVSHNVLSGLI 527

Query: 510 PRCFEEMHGLLHIDISYNKLEGQIPNSTTFRDAPLEALQGNKGLYGDIRGFPSC------ 563
           P  F+++  L  +DISYN+L+G IP+   F +AP EA + N G+ G+  G   C      
Sbjct: 528 PSSFKQLLSLTAVDISYNELQGPIPDIKAFLNAPFEAYRDNMGVCGNASGLKPCNLPKSS 587

Query: 564 MSYKKASRKIWIVIVFPLLGMVALFIALTGFFFIFHQRKNDSQTQQSSFGNTPGLRSVLT 623
            + K+   K+ I+IV PLLG + L   L G FFI HQR    + +  +      L +VL 
Sbjct: 588 RTLKRKGNKLVILIVLPLLGSLLLVFVLIGAFFILHQRARKRKAEPGNIEQDRNLFTVLG 647

Query: 624 FEGKIVYEEIISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQE 683
            +GK++YE II+AT +FN+ +CIG+GG+G VY+A +P   + AVKK H     ++S   +
Sbjct: 648 HDGKLLYENIIAATEEFNSNYCIGEGGYGIVYKAVMPPERVVAVKKLHQSQTDKLS-NFK 706

Query: 684 EFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQR 743
            F  E++ L  IRHRNIVK YGFCSH KHSF++YE +E GSL KI+ ++  A EL W +R
Sbjct: 707 AFETEVRVLANIRHRNIVKLYGFCSHAKHSFLVYELIERGSLRKIITSEEQAIELDWMKR 766

Query: 744 LNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSE 803
           LNV+KG+A AL YLH++C PPI+HRDI+S N+LLDL YEAHVSDFG A+ L PDSSNW+ 
Sbjct: 767 LNVVKGMAGALSYLHHSCSPPIIHRDITSNNILLDLEYEAHVSDFGTARLLMPDSSNWTS 826

Query: 804 LAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNI---- 859
            AGT GY APELAYT+KVTEKCDVYSFGV+ +EV+ G+HP D +  +SS +S+ +     
Sbjct: 827 FAGTFGYTAPELAYTMKVTEKCDVYSFGVVTMEVMMGRHPGDLISTISSQASSSSSSKPP 886

Query: 860 --------EMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEK 908
                   ++LD R+  P     + ++ IM++A +CL  NP+SRPTM R+S  L  K
Sbjct: 887 ISQQTLLKDVLDQRISLPKKGAAEGVVHIMKIALACLHPNPQSRPTMGRISSELATK 943

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255563971|ref|XP_002522985.1| receptor protein kinase, putative [Ricinus communis] gi|223537797|gb|EEF39415.1| receptor protein kinase, putative [Ricinus communis]

 Score =  760 bits (1963), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 423/956 (44%), Positives = 573/956 (59%), Gaps = 98/956 (10%)

Query: 42  LVKWKASLEVHSRSLLHSWSLSSVNATKISPC-AWSGIFCNHAERVVGINLTSISLNGTL 100
           L+ WKA+L+  S+S L SW+  S       PC +W GI CN A  V  I+L    L GTL
Sbjct: 38  LLGWKATLDNQSQSFLSSWASGS-------PCNSWFGIHCNEAGSVTNISLRDSGLTGTL 90

Query: 101 LEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLT 160
              SFSSFP+L+ L+  NN  +G IPP ++NLS L  LD S NK+ G IP  IG+L  LT
Sbjct: 91  QSLSFSSFPNLIRLNFSNNSFYGSIPPTVANLSKLNILDLSVNKISGSIPQEIGMLRSLT 150

Query: 161 VLHISRNWLSGSIPHEVGQLTVLN------------------------QLALDSNFLNGS 196
            + +S N+L+GS+P  +G LT L                          + L +N+L G+
Sbjct: 151 YIDLSNNFLNGSLPPSIGNLTQLPILYIHMCELSGSIPDEIGLMRSAIDIDLSTNYLTGT 210

Query: 197 IPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLR 256
           +P S+GNLT +  L+L  N   GSIPQEIG LKSL  L    N LSG IP S+ NLT L 
Sbjct: 211 VPTSIGNLTKLEYLHLNQNQLSGSIPQEIGMLKSLIQLAFSYNNLSGPIPSSVGNLTALT 270

Query: 257 FLFLYHNELSGIIPQEIGNLKKLNSLLLA------------------------------- 285
            L+L +N  +G IP EIG L+KL  L L                                
Sbjct: 271 GLYLSNNSFTGSIPPEIGMLRKLTQLFLEYNELSGTLPSEMNNFTSLEVVIIYSNRFTGP 330

Query: 286 -----------------KNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLT 328
                            +N+F G +P+S RN + LV+ RL +N LTGNISE FG YP L 
Sbjct: 331 LPQDICIGGRLSALSVNRNNFSGPIPRSLRNCSSLVRARLERNQLTGNISEDFGIYPQLK 390

Query: 329 FIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGE 388
           ++DLS N   GE+   W     LS L +S NNISG IP E+G + QLQ L  SSN+++GE
Sbjct: 391 YLDLSGNKLHGELTWKWEDFGNLSTLIMSENNISGIIPAELGNATQLQSLHFSSNHLIGE 450

Query: 389 IPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLY 448
           IP +LG +  L  LSL  NKLSG IP E+G L +L  LDL+ NNLS  +P+ LG   KL 
Sbjct: 451 IPKELGKLRLL-ELSLDDNKLSGSIPEEIGMLSDLGSLDLAGNNLSGAIPKQLGDCSKLM 509

Query: 449 YLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGL 508
           +LNLS+NK S+ IP+E+ N+  L  LDLS+N L  +I  ++ +++ +E LNLS N LSG 
Sbjct: 510 FLNLSNNKFSESIPLEVGNIDSLESLDLSYNLLTGEIPEQLGKLQRMETLNLSNNLLSGS 569

Query: 509 IPRCFEEMHGLLHIDISYNKLEGQIPNSTTFRDAPLEALQGNKGLYGDIRGFPSCMS--- 565
           IP+ F+ + GL  ++ISYN LEG IP    F++AP EAL+ NK L G+     +C+S   
Sbjct: 570 IPKSFDYLSGLTTVNISYNDLEGPIPPIKAFQEAPFEALRDNKNLCGNNSKLKACVSPAI 629

Query: 566 ---YKKASRKIWIVIVFPLLGMVALFIALTGFFFIFHQRKNDSQTQQS--SFGNTPGLRS 620
               +K     + +I+ P+L  + L + L G FFI  QR  +++   S     +   + +
Sbjct: 630 IKPVRKKGETEYTLILIPVLCGLFLLVVLIGGFFIHRQRMRNTKANSSLEEEAHLEDVYA 689

Query: 621 VLTFEGKIVYEEIISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSF 680
           V + +  + YE I+ AT +F++++CIG GG+G VY+  +P+G + AVKK H    GE++ 
Sbjct: 690 VWSRDRDLHYENIVEATEEFDSKYCIGVGGYGIVYKVVLPTGRVVAVKKLHQSQNGEIT- 748

Query: 681 QQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGW 740
             + F NEI  L  IRHRNIVK +GFCSHP+HSF++Y+++E GSL   L N+  A EL W
Sbjct: 749 DMKAFRNEICVLMNIRHRNIVKLFGFCSHPRHSFLVYDFIERGSLRNTLSNEEEAMELDW 808

Query: 741 TQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN 800
            +RLNV+KGVA+AL Y+H++C PPI+HRDISS NVLLD  +EAHVSDFG A+ L PDSSN
Sbjct: 809 FKRLNVVKGVANALSYMHHDCSPPIIHRDISSSNVLLDSEFEAHVSDFGTARLLMPDSSN 868

Query: 801 WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMN-- 858
           W+  AGT GY APELAYT+ V EKCDVYSFGV+  E I G+HP D +  + S+SS  +  
Sbjct: 869 WTSFAGTFGYTAPELAYTMMVNEKCDVYSFGVVTFETIMGRHPADLISSVMSTSSLSSPV 928

Query: 859 ------IEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEK 908
                  +++D RLP P   V + L+S+ ++A +CL  NP+SRPTM++VS  L +K
Sbjct: 929 DQHILFKDVIDQRLPTPEDKVGEGLVSVARLALACLSTNPQSRPTMRQVSSYLVDK 984

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	912
TAIR|locus:2138268	1045	AT4G08850 [Arabidopsis thalian	0.891	0.777	0.455	3.2e-184
TAIR|locus:2011339	1120	AT1G35710 [Arabidopsis thalian	0.885	0.721	0.451	2.1e-180
TAIR|locus:2020417	1101	AT1G17230 [Arabidopsis thalian	0.876	0.725	0.368	3.7e-126
TAIR|locus:2160791	1102	AT5G63930 [Arabidopsis thalian	0.868	0.718	0.367	1.5e-120
TAIR|locus:2156349	1252	GSO2 "GASSHO 2" [Arabidopsis t	0.870	0.634	0.363	1.4e-119
TAIR|locus:2085949	1141	AT3G24240 [Arabidopsis thalian	0.850	0.680	0.352	9.8e-119
TAIR|locus:2154344	1135	AT5G48940 [Arabidopsis thalian	0.861	0.692	0.355	8.8e-118
TAIR|locus:2046525	1124	AT2G33170 [Arabidopsis thalian	0.794	0.645	0.374	2.5e-113
TAIR|locus:2025545	1029	AT1G08590 [Arabidopsis thalian	0.536	0.475	0.336	1.2e-112
TAIR|locus:2167948	966	ERL1 "ERECTA-like 1" [Arabidop	0.879	0.830	0.339	3.8e-112

TAIR|locus:2138268 AT4G08850 [Arabidopsis thaliana (taxid:3702)]

 Score = 1787 (634.1 bits), Expect = 3.2e-184, P = 3.2e-184
 Identities = 379/832 (45%), Positives = 523/832 (62%)

Query:    85 RVVGINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANK 144
             ++V + L   SL+G++      + P+L  L L  N L G IP    NL N+  L+   N+
Sbjct:   215 KLVNLYLFINSLSGSIPS-EIGNLPNLRELCLDRNNLTGKIPSSFGNLKNVTLLNMFENQ 273

Query:   145 LFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNL 204
             L G+IP  IG +T L  L +  N L+G IP  +G +  L  L L  N LNGSIP  LG +
Sbjct:   274 LSGEIPPEIGNMTALDTLSLHTNKLTGPIPSTLGNIKTLAVLHLYLNQLNGSIPPELGEM 333

Query:   205 THVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNE 264
               ++ L +  N   G +P   G L +L  L L  NQLSG IP  I+N T L  L L  N 
Sbjct:   334 ESMIDLEISENKLTGPVPDSFGKLTALEWLFLRDNQLSGPIPPGIANSTELTVLQLDTNN 393

Query:   265 LSGIIPQEIGXXXXXXXXXXXXXHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTY 324
              +G +P  I              HF G VPKS R+   L+++R   N  +G+ISE FG Y
Sbjct:   394 FTGFLPDTICRGGKLENLTLDDNHFEGPVPKSLRDCKSLIRVRFKGNSFSGDISEAFGVY 453

Query:   325 PNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNY 384
             P L FIDLSNN+F G++ ++W +  +L    +S N+I+G+IP EI    QL  LDLSSN 
Sbjct:   454 PTLNFIDLSNNNFHGQLSANWEQSQKLVAFILSNNSITGAIPPEIWNMTQLSQLDLSSNR 513

Query:   385 IVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSL 444
             I GE+P  + NI  +++L L+GN+LSG IP  +  L NLEYLDLS+N  S+ +P +L +L
Sbjct:   514 ITGELPESISNINRISKLQLNGNRLSGKIPSGIRLLTNLEYLDLSSNRFSSEIPPTLNNL 573

Query:   445 VKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNN 504
              +LYY+NLS N L Q IP  L  L  L  LDLS+N L  +ISS+   +++LE+L+LS+NN
Sbjct:   574 PRLYYMNLSRNDLDQTIPEGLTKLSQLQMLDLSYNQLDGEISSQFRSLQNLERLDLSHNN 633

Query:   505 LSGLIPRCFEEMHGLLHIDISYNKLEGQIPNSTTFRDAPLEALQGNKGLYGDI---RGFP 561
             LSG IP  F++M  L H+D+S+N L+G IP++  FR+AP +A +GNK L G +   +G  
Sbjct:   634 LSGQIPPSFKDMLALTHVDVSHNNLQGPIPDNAAFRNAPPDAFEGNKDLCGSVNTTQGLK 693

Query:   562 SCM--SYKKA--SRKIWIVIVFPLLGMVALFIALTGFFFIFHQRKN--DSQTQQSSFGNT 615
              C   S KK+   R + I I+ P++G + +     G F  F +R    +  T   S G T
Sbjct:   694 PCSITSSKKSHKDRNLIIYILVPIIGAIIILSVCAGIFICFRKRTKQIEEHTDSESGGET 753

Query:   616 PGLRSVLTFEGKIVYEEIISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLP 675
                 S+ +F+GK+ Y+EII AT +F+ ++ IG GGHG VY+AK+P+  I AVKK +    
Sbjct:   754 ---LSIFSFDGKVRYQEIIKATGEFDPKYLIGTGGHGKVYKAKLPNA-IMAVKKLNETTD 809

Query:   676 GEMS--FQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDA 733
               +S    ++EFLNEI+ALTEIRHRN+VK +GFCSH +++F++YEY+E GSL K+L ND 
Sbjct:   810 SSISNPSTKQEFLNEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSLRKVLENDD 869

Query:   734 SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKF 793
              AK+L W +R+NV+KGVA AL Y+H++  P IVHRDISS N+LL   YEA +SDFG AK 
Sbjct:   870 EAKKLDWGKRINVVKGVAHALSYMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTAKL 929

Query:   794 LNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEXXXX 853
             L PDSSNWS +AGT+GYVAPELAY +KVTEKCDVYSFGVL LEVIKG+HP D +      
Sbjct:   930 LKPDSSNWSAVAGTYGYVAPELAYAMKVTEKCDVYSFGVLTLEVIKGEHPGDLVSTLSSS 989

Query:   854 XXXXXIEML---DSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVS 902
                  + +    D RLP P+  ++++++ I++VA  CL  +P++RPTM  +S
Sbjct:   990 PPDATLSLKSISDHRLPEPTPEIKEEVLEILKVALLCLHSDPQARPTMLSIS 1041

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016020 "membrane" evidence=IDA

GO:0009506 "plasmodesma" evidence=IDA

GO:0006857 "oligopeptide transport" evidence=RCA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

TAIR|locus:2011339 AT1G35710 [Arabidopsis thaliana (taxid:3702)]

 Score = 1751 (621.4 bits), Expect = 2.1e-180, P = 2.1e-180
 Identities = 373/827 (45%), Positives = 512/827 (61%)

Query:    90 NLTSISLNGTLLEFSF----SSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKL 145
             NLT +SL    L         +   ++ L+L NN+L G IP  + NL NL  L    N L
Sbjct:   295 NLTLLSLFQNYLTGGIPPKLGNIESMIDLELSNNKLTGSIPSSLGNLKNLTILYLYENYL 354

Query:   146 FGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLT 205
              G IP  +G +  +  L ++ N L+GSIP   G L  L  L L  N+L G IP+ LGN+ 
Sbjct:   355 TGVIPPELGNMESMIDLQLNNNKLTGSIPSSFGNLKNLTYLYLYLNYLTGVIPQELGNME 414

Query:   206 HVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNEL 265
              ++ L L  N   GS+P   GN   L  L L +N LSGAIP  ++N ++L  L L  N  
Sbjct:   415 SMINLDLSQNKLTGSVPDSFGNFTKLESLYLRVNHLSGAIPPGVANSSHLTTLILDTNNF 474

Query:   266 SGIIPQEIGXXXXXXXXXXXXXHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYP 325
             +G  P+ +              H  G +PKS R+   L++ R   N  TG+I E FG YP
Sbjct:   475 TGFFPETVCKGRKLQNISLDYNHLEGPIPKSLRDCKSLIRARFLGNKFTGDIFEAFGIYP 534

Query:   326 NLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYI 385
             +L FID S+N F GEI S+W + P+L  L +S NNI+G+IP EI    QL  LDLS+N +
Sbjct:   535 DLNFIDFSHNKFHGEISSNWEKSPKLGALIMSNNNITGAIPTEIWNMTQLVELDLSTNNL 594

Query:   386 VGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLV 445
              GE+P  +GN+  L+RL L+GN+LSG +P  L  L NLE LDLS+NN S+ +P++  S +
Sbjct:   595 FGELPEAIGNLTNLSRLRLNGNQLSGRVPAGLSFLTNLESLDLSSNNFSSEIPQTFDSFL 654

Query:   446 KLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNL 505
             KL+ +NLS NK    IP  L  L  L++LDLSHN L  +I S++  ++SL+KL+LS+NNL
Sbjct:   655 KLHDMNLSRNKFDGSIP-RLSKLTQLTQLDLSHNQLDGEIPSQLSSLQSLDKLDLSHNNL 713

Query:   506 SGLIPRCFEEMHGLLHIDISYNKLEGQIPNSTTFRDAPLEALQGNKGLYGDI--RGFPSC 563
             SGLIP  FE M  L ++DIS NKLEG +P++ TFR A  +AL+ N GL  +I  +    C
Sbjct:   714 SGLIPTTFEGMIALTNVDISNNKLEGPLPDTPTFRKATADALEENIGLCSNIPKQRLKPC 773

Query:   564 MSYKKASRK----IWIVIVFPLLGMVALFIALTGFFFIFHQRKNDSQTQQSSFGNTPGLR 619
                KK  +     +WI++  P+LG++ + +++    F +  RK   Q  +++   T    
Sbjct:   774 RELKKPKKNGNLVVWILV--PILGVLVI-LSICANTFTYCIRKRKLQNGRNTDPETGENM 830

Query:   620 SVLTFEGKIVYEEIISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMS 679
             S+ + +GK  Y++II +TN+F+  H IG GG+  VYRA +    I AVK+ H  +  E+S
Sbjct:   831 SIFSVDGKFKYQDIIESTNEFDPTHLIGTGGYSKVYRANLQD-TIIAVKRLHDTIDEEIS 889

Query:   680 --FQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE 737
                 ++EFLNE++ALTEIRHRN+VK +GFCSH +H+F+IYEY+E GSL+K+L ND  AK 
Sbjct:   890 KPVVKQEFLNEVKALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLLANDEEAKR 949

Query:   738 LGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPD 797
             L WT+R+NV+KGVA AL Y+H++   PIVHRDISS N+LLD  Y A +SDFG AK L  D
Sbjct:   950 LTWTKRINVVKGVAHALSYMHHDRITPIVHRDISSGNILLDNDYTAKISDFGTAKLLKTD 1009

Query:   798 SSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEXXXX--XX 855
             SSNWS +AGT+GYVAPE AYT+KVTEKCDVYSFGVL LE+I GKHP D +          
Sbjct:  1010 SSNWSAVAGTYGYVAPEFAYTMKVTEKCDVYSFGVLILELIIGKHPGDLVSSLSSSPGEA 1069

Query:   856 XXXIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVS 902
                  + D R+  P    ++KL+ ++++A  CL  NPESRPTM  +S
Sbjct:  1070 LSLRSISDERVLEPRGQNREKLLKMVEMALLCLQANPESRPTMLSIS 1116

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)]

 Score = 1239 (441.2 bits), Expect = 3.7e-126, P = 3.7e-126
 Identities = 304/826 (36%), Positives = 424/826 (51%)

Query:   104 SFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLH 163
             S  +   L  L L+ N   G IP +I  L+ ++ L    N+L G+IP  IG L     + 
Sbjct:   254 SVGNISRLEVLALHENYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPREIGNLIDAAEID 313

Query:   164 ISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQ 223
              S N L+G IP E G +  L  L L  N L G IPR LG LT +  L L  N   G+IPQ
Sbjct:   314 FSENQLTGFIPKEFGHILNLKLLHLFENILLGPIPRELGELTLLEKLDLSINRLNGTIPQ 373

Query:   224 EIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGXXXXXXXXX 283
             E+  L  L DL+L  NQL G IP  I   +N   L +  N LSG IP             
Sbjct:   374 ELQFLPYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCRFQTLILLS 433

Query:   284 XXXXHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILS 343
                    G +P+  +    L KL L  N LTG++        NLT ++L  N   G I +
Sbjct:   434 LGSNKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTALELHQNWLSGNISA 493

Query:   344 DWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLS 403
             D G+   L  L ++ NN +G IP EIG   ++   ++SSN + G IP +LG+ + + RL 
Sbjct:   494 DLGKLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSCVTIQRLD 553

Query:   404 LSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPI 463
             LSGNK SG I +ELG L+ LE L LS N L+  +P S G L +L  L L  N LS+ IP+
Sbjct:   554 LSGNKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLLSENIPV 613

Query:   464 ELDNLIHLS-ELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHI 522
             EL  L  L   L++SHN L   I   +  ++ LE L L+ N LSG IP     +  LL  
Sbjct:   614 ELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGNLMSLLIC 673

Query:   523 DISYNKLEGQIPNSTTFRDAPLEALQGNKGLYGDIRGFPSCMSYKKASRKIWIV------ 576
             +IS N L G +P++  F+        GN GL    R     +     S+  W++      
Sbjct:   674 NISNNNLVGTVPDTAVFQRMDSSNFAGNHGLCNSQRSHCQPLVPHSDSKLNWLINGSQRQ 733

Query:   577 ----IVFPLLGMVALFIALTGFFFIFHQRKNDSQTQQSSFGNTPGLRSVLTFEGK-IVYE 631
                 I   ++G V L I   G  +   +R+      +      P +     F  K   Y+
Sbjct:   734 KILTITCIVIGSVFL-ITFLGLCWTIKRREPAFVALEDQ--TKPDVMDSYYFPKKGFTYQ 790

Query:   632 EIISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQA 691
              ++ AT +F+ +  +G+G  G+VY+A++  GE+ AVKK +S   GE +     F  EI  
Sbjct:   791 GLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNSR--GEGASSDNSFRAEIST 848

Query:   692 LTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVA 751
             L +IRHRNIVK YGFC H   + ++YEY+  GSL + L        L W  R  +  G A
Sbjct:   849 LGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIALGAA 908

Query:   752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPD-SSNWSELAGTHGY 810
             + L YLH++C P IVHRDI S N+LLD  ++AHV DFG+AK ++   S + S +AG++GY
Sbjct:   909 EGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMSAVAGSYGY 968

Query:   811 VAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP-------RDFL--FEXXXXXXXXXIEM 861
             +APE AYT+KVTEKCD+YSFGV+ LE+I GK P        D +             IEM
Sbjct:   969 IAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGGDLVNWVRRSIRNMIPTIEM 1028

Query:   862 LDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCE 907
              D+RL         ++  ++++A  C   +P SRPTM+ V  ++ E
Sbjct:  1029 FDARLDTNDKRTVHEMSLVLKIALFCTSNSPASRPTMREVVAMITE 1074

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)]

 Score = 1186 (422.6 bits), Expect = 1.5e-120, P = 1.5e-120
 Identities = 305/829 (36%), Positives = 444/829 (53%)

Query:   106 SSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHIS 165
             S+   L  L LY N+L G IP ++ +L +LE+L    N L G IP  IG L++   +  S
Sbjct:   262 SNCTSLETLALYKNQLVGPIPKELGDLQSLEFLYLYRNGLNGTIPREIGNLSYAIEIDFS 321

Query:   166 RNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEI 225
              N L+G IP E+G +  L  L L  N L G+IP  L  L ++  L L  N+  G IP   
Sbjct:   322 ENALTGEIPLELGNIEGLELLYLFENQLTGTIPVELSTLKNLSKLDLSINALTGPIPLGF 381

Query:   226 GNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGXXXXXXXXXXX 285
               L+ LF L+L  N LSG IP  +   ++L  L +  N LSG IP  +            
Sbjct:   382 QYLRGLFMLQLFQNSLSGTIPPKLGWYSDLWVLDMSDNHLSGRIPSYLCLHSNMIILNLG 441

Query:   286 XXHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDW 345
               +  G +P        LV+LRL +N L G          N+T I+L  N F G I  + 
Sbjct:   442 TNNLSGNIPTGITTCKTLVQLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREV 501

Query:   346 GRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLS 405
             G C  L  L ++ N  +G +P EIG   QL  L++SSN + GE+P+++ N   L RL + 
Sbjct:   502 GNCSALQRLQLADNGFTGELPREIGMLSQLGTLNISSNKLTGEVPSEIFNCKMLQRLDMC 561

Query:   406 GNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIEL 465
              N  SG +P E+GSL  LE L LS NNLS  +P +LG+L +L  L +  N  +  IP EL
Sbjct:   562 CNNFSGTLPSEVGSLYQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPREL 621

Query:   466 DNLIHLS-ELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDI 524
              +L  L   L+LS+N L  +I   +  +  LE L L+ NNLSG IP  F  +  LL  + 
Sbjct:   622 GSLTGLQIALNLSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNF 681

Query:   525 SYNKLEGQIPNSTTFRDAPLEALQGNKGLYG-------DIRGF-PSCMSYKKA---SRKI 573
             SYN L G IP     R+  + +  GN+GL G         + F PS  + K     S KI
Sbjct:   682 SYNSLTGPIP---LLRNISMSSFIGNEGLCGPPLNQCIQTQPFAPSQSTGKPGGMRSSKI 738

Query:   574 WIVIVFPLLGMVALF-IALTGFFFIFHQRKNDSQTQQSSFGNTPGLRSV-LTFEGK--IV 629
              I I   ++G V+L  IAL     ++  R+       S+    P   S+ + F  K    
Sbjct:   739 -IAITAAVIGGVSLMLIAL----IVYLMRRPVRTVASSAQDGQPSEMSLDIYFPPKEGFT 793

Query:   630 YEEIISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEE-FLNE 688
             ++++++AT++F+    +G+G  G+VY+A +P+G   AVKK  S   G  +   +  F  E
Sbjct:   794 FQDLVAATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFRAE 853

Query:   689 IQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIK 748
             I  L  IRHRNIVK +GFC+H   + ++YEY+  GSL +IL +D S   L W++R  +  
Sbjct:   854 ILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEIL-HDPSCN-LDWSKRFKIAL 911

Query:   749 GVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN-PDSSNWSELAGT 807
             G A  L YLH++C P I HRDI S N+LLD  +EAHV DFG+AK ++ P S + S +AG+
Sbjct:   912 GAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPHSKSMSAIAGS 971

Query:   808 HGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP-------RDFLFEXXXXXXXXXIE 860
             +GY+APE AYT+KVTEK D+YS+GV+ LE++ GK P        D +           + 
Sbjct:   972 YGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPIDQGGDVVNWVRSYIRRDALS 1031

Query:   861 --MLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCE 907
               +LD+RL      +   +++++++A  C   +P +RP+M++V  +L E
Sbjct:  1032 SGVLDARLTLEDERIVSHMLTVLKIALLCTSVSPVARPSMRQVVLMLIE 1080

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1177 (419.4 bits), Expect = 1.4e-119, P = 1.4e-119
 Identities = 301/827 (36%), Positives = 445/827 (53%)

Query:    86 VVGINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKL 145
             +  + L + SL GTL   S S+  +L    LY+N L G +P +I  L  LE +    N+ 
Sbjct:   387 LTNLYLNNNSLEGTLSS-SISNLTNLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENRF 445

Query:   146 FGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLT 205
              G++P  IG  T L  +    N LSG IP  +G+L  L +L L  N L G+IP SLGN  
Sbjct:   446 SGEMPVEIGNCTRLQEIDWYGNRLSGEIPSSIGRLKDLTRLHLRENELVGNIPASLGNCH 505

Query:   206 HVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNEL 265
              + ++ L +N   GSIP   G L +L    +  N L G +P S+ NL NL  +    N+ 
Sbjct:   506 QMTVIDLADNQLSGSIPSSFGFLTALELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKF 565

Query:   266 SGIIPQEIGXXXXXXXXXXXXXHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYP 325
             +G I    G              F G +P      T+L +LRL +N  TG I  TFG   
Sbjct:   566 NGSISPLCGSSSYLSFDVTENG-FEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKIS 624

Query:   326 NLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYI 385
              L+ +D+S NS  G I  + G C +L+ +D++ N +SG IP  +G+   L  L LSSN  
Sbjct:   625 ELSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKF 684

Query:   386 VGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLV 445
             VG +PT++ ++  +  L L GN L+G IP+E+G+L  L  L+L  N LS  +P ++G L 
Sbjct:   685 VGSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLS 744

Query:   446 KLYYLNLSHNKLSQQIPIELDNLIHL-SELDLSHNFLGEKISSRICRMESLEKLNLSYNN 504
             KL+ L LS N L+ +IP+E+  L  L S LDLS+N    +I S I  +  LE L+LS+N 
Sbjct:   745 KLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQ 804

Query:   505 LSGLIPRCFEEMHGLLHIDISYNKLEGQIPNSTTFRDAPLEALQGNKGLYGDIRGF---P 561
             L G +P    +M  L ++++SYN LEG++     F     +A  GN GL G         
Sbjct:   805 LVGEVPGQIGDMKSLGYLNLSYNNLEGKLKKQ--FSRWQADAFVGNAGLCGSPLSHCNRA 862

Query:   562 SCMSYKKASRKIWIVI-VFPLLGMVALFIALTGFFF-----IFHQRK--NDSQTQQSSFG 613
                + +  S K  ++I     L  +AL + +   FF     +F + +  N + +  SS  
Sbjct:   863 GSKNQRSLSPKTVVIISAISSLAAIALMVLVIILFFKQNHDLFKKVRGGNSAFSSNSSSS 922

Query:   614 NTPGLRSVLTFEGKIVYEEIISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSP 673
               P L S    +  I +++I+ AT+  N E  IG GG G VY+A++ +GE  AVKK    
Sbjct:   923 QAP-LFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKI--- 978

Query:   674 LPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKH--SFIIYEYLESGSL-DKILC 730
             L  +     + F  E++ L  IRHR++VK  G+CS      + +IYEY+ +GS+ D +  
Sbjct:   979 LWKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLHA 1038

Query:   731 NDASAKE--LGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDF 788
             N+ + K+  LGW  RL +  G+A  + YLH +C PPIVHRDI S NVLLD   EAH+ DF
Sbjct:  1039 NENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDF 1098

Query:   789 GIAKFL--NPDSSNWSE--LAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPR 844
             G+AK L  N D++  S    AG++GY+APE AY+LK TEK DVYS G++ +E++ GK P 
Sbjct:  1099 GLAKILTGNYDTNTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPT 1158

Query:   845 DFLFEXXXXXXXXXIEMLDSRLPYPSLHVQKKLM-SIMQVAFSCLDQ 890
             + +F+           +LD+  P P    ++KL+ S ++    C ++
Sbjct:  1159 EAMFDEETDMVRWVETVLDT--P-PGSEAREKLIDSELKSLLPCEEE 1202

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009553 "embryo sac development" evidence=IMP

GO:0008544 "epidermis development" evidence=IGI

GO:0009790 "embryo development" evidence=IGI

TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)]

 Score = 1169 (416.6 bits), Expect = 9.8e-119, P = 9.8e-119
 Identities = 286/811 (35%), Positives = 434/811 (53%)

Query:   111 LVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLS 170
             LV L LY N L G IP +I  L+ LE L    N L G IP  IG  ++L ++ +S N LS
Sbjct:   276 LVDLFLYENSLSGSIPREIGQLTKLEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLNLLS 335

Query:   171 GSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKS 230
             GSIP  +G+L+ L +  +  N  +GSIP ++ N + +V L L  N   G IP E+G L  
Sbjct:   336 GSIPSSIGRLSFLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQISGLIPSELGTLTK 395

Query:   231 LFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGXXXXXXXXXXXXXHFR 290
             L       NQL G+IP  +++ T+L+ L L  N L+G IP  +                 
Sbjct:   396 LTLFFAWSNQLEGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLRNLTKLLLISNSLS 455

Query:   291 GTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQ 350
             G +P+   N + LV+LRL  N +TG I    G+   + F+D S+N   G++  + G C +
Sbjct:   456 GFIPQEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGSCSE 515

Query:   351 LSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLS 410
             L ++D+S N++ GS+P  +     LQ LD+S+N   G+IP  LG ++ LN+L LS N  S
Sbjct:   516 LQMIDLSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVSLNKLILSKNLFS 575

Query:   411 GCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYY-LNLSHNKLSQQIPIELDNLI 469
             G IP  LG    L+ LDL +N LS  +P  LG +  L   LNLS N+L+ +IP ++ +L 
Sbjct:   576 GSIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRLTGKIPSKIASLN 635

Query:   470 HLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKL 529
              LS LDLSHN L   ++  +  +E+L  LN+SYN+ SG +P         L   +S   L
Sbjct:   636 KLSILDLSHNMLEGDLAP-LANIENLVSLNISYNSFSGYLP------DNKLFRQLSPQDL 688

Query:   530 EGQIPNSTTFRDAPLEALQGNKGLYGDIRGFPSCMSYKKASRKIWIVIVFPLLGMVALFI 589
             EG     ++ +D+     +   GL GD  G  S       +RK+ + +   LL  + + +
Sbjct:   689 EGNKKLCSSTQDSCFLTYRKGNGL-GD-DGDAS------RTRKLRLTLA--LLITLTVVL 738

Query:   590 ALTGFFFIFHQRKNDSQTQQSSFGNTPGLRSVLTFEGKIVYEEIISATNDFNAEHCIGKG 649
              + G   +   R+N    + S  G T   +     +     ++II    + N    IGKG
Sbjct:   739 MILGAVAVIRARRNIDNERDSELGETYKWQFTPFQKLNFSVDQIIRCLVEPNV---IGKG 795

Query:   650 GHGSVYRAKVPSGEIFAVKKFHSPLPG----EMSFQ-QEEFLNEIQALTEIRHRNIVKFY 704
               G VYRA V +GE+ AVKK    +      E +   ++ F  E++ L  IRH+NIV+F 
Sbjct:   796 CSGVVYRADVDNGEVIAVKKLWPAMVNGGHDEKTKNVRDSFSAEVKTLGTIRHKNIVRFL 855

Query:   705 GFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP 764
             G C +     ++Y+Y+ +GSL  +L ++     L W  R  ++ G A  L YLH++C PP
Sbjct:   856 GCCWNRNTRLLMYDYMPNGSLGSLL-HERRGSSLDWDLRYRILLGAAQGLAYLHHDCLPP 914

Query:   765 IVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP-DSSNWSE-LAGTHGYVAPELAYTLKVT 822
             IVHRDI + N+L+ L +E +++DFG+AK ++  D    S  +AG++GY+APE  Y++K+T
Sbjct:   915 IVHRDIKANNILIGLDFEPYIADFGLAKLVDEGDIGRCSNTVAGSYGYIAPEYGYSMKIT 974

Query:   823 EKCDVYSFGVLALEVIKGKHPRD------FLFEXXXXXXXXXIEMLDSRLPYPSLHVQKK 876
             EK DVYS+GV+ LEV+ GK P D                   +E+LDS L   +     +
Sbjct:   975 EKSDVYSYGVVVLEVLTGKQPIDPTVPEGIHLVDWVRQNRGSLEVLDSTLRSRTEAEADE 1034

Query:   877 LMSIMQVAFSCLDQNPESRPTMKRVSQLLCE 907
             +M ++  A  C++ +P+ RPTMK V+ +L E
Sbjct:  1035 MMQVLGTALLCVNSSPDERPTMKDVAAMLKE 1065

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000041 "transition metal ion transport" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0010359 "regulation of anion channel activity" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2154344 AT5G48940 [Arabidopsis thaliana (taxid:3702)]

 Score = 1160 (413.4 bits), Expect = 8.8e-118, P = 8.8e-118
 Identities = 300/844 (35%), Positives = 435/844 (51%)

Query:    91 LTSISLNGTLL--EF--SFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLF 146
             L S+S+  T+L  E      +   L+ L LY+N+L G +P ++  L NLE +    N L 
Sbjct:   253 LQSLSVYSTMLSGEIPKELGNCSELINLFLYDNDLSGTLPKELGKLQNLEKMLLWQNNLH 312

Query:   147 GQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTH 206
             G IP  IG +  L  + +S N+ SG+IP   G L+ L +L L SN + GSIP  L N T 
Sbjct:   313 GPIPEEIGFMKSLNAIDLSMNYFSGTIPKSFGNLSNLQELMLSSNNITGSIPSILSNCTK 372

Query:   207 VVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELS 266
             +V   +  N   G IP EIG LK L       N+L G IP  ++   NL+ L L  N L+
Sbjct:   373 LVQFQIDANQISGLIPPEIGLLKELNIFLGWQNKLEGNIPDELAGCQNLQALDLSQNYLT 432

Query:   267 GIIPQEIGXXXXXXXXXXXXXHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPN 326
             G +P  +                 G +P    N T LV+LRL  N +TG I +  G   N
Sbjct:   433 GSLPAGLFQLRNLTKLLLISNAISGVIPLEIGNCTSLVRLRLVNNRITGEIPKGIGFLQN 492

Query:   327 LTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIV 386
             L+F+DLS N+  G +  +   C QL +L++S N + G +PL +    +LQ LD+SSN + 
Sbjct:   493 LSFLDLSENNLSGPVPLEISNCRQLQMLNLSNNTLQGYLPLSLSSLTKLQVLDVSSNDLT 552

Query:   387 GEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVK 446
             G+IP  LG++I LNRL LS N  +G IP  LG   NL+ LDLS+NN+S  +PE L  +  
Sbjct:   553 GKIPDSLGHLISLNRLILSKNSFNGEIPSSLGHCTNLQLLDLSSNNISGTIPEELFDIQD 612

Query:   447 L-YYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNL 505
             L   LNLS N L   IP  +  L  LS LD+SHN L   +S+                 L
Sbjct:   613 LDIALNLSWNSLDGFIPERISALNRLSVLDISHNMLSGDLSA-----------------L 655

Query:   506 SGLIPRCFEEMHGLLHIDISYNKLEGQIPNSTTFRDAPLEALQGNKGLYGDIRGFPSCM- 564
             SGL          L+ ++IS+N+  G +P+S  FR      ++GN GL    +GF SC  
Sbjct:   656 SGL--------ENLVSLNISHNRFSGYLPDSKVFRQLIGAEMEGNNGLCS--KGFRSCFV 705

Query:   565 ---SYKKASRKIW---IVIVFPLLGMVALFIALTGFFFIFHQRKNDSQTQQSSFGNTPGL 618
                S     R +    + I   LL  V   +A+ G   +   ++       S  G     
Sbjct:   706 SNSSQLTTQRGVHSHRLRIAIGLLISVTAVLAVLGVLAVIRAKQMIRDDNDSETGENLWT 765

Query:   619 RSVLTFEG-KIVYEEIISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHS-PLPG 676
                  F+      E ++    + N    IGKG  G VY+A++P+ E+ AVKK     +P 
Sbjct:   766 WQFTPFQKLNFTVEHVLKCLVEGNV---IGKGCSGIVYKAEMPNREVIAVKKLWPVTVPN 822

Query:   677 -----EMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCN 731
                  + S  ++ F  E++ L  IRH+NIV+F G C +     ++Y+Y+ +GSL  +L  
Sbjct:   823 LNEKTKSSGVRDSFSAEVKTLGSIRHKNIVRFLGCCWNKNTRLLMYDYMSNGSLGSLLHE 882

Query:   732 DASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIA 791
              +    LGW  R  +I G A  L YLH++C PPIVHRDI + N+L+   +E ++ DFG+A
Sbjct:   883 RSGVCSLGWEVRYKIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPDFEPYIGDFGLA 942

Query:   792 KFLNP-DSSNWSE-LAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP-----R 844
             K ++  D +  S  +AG++GY+APE  Y++K+TEK DVYS+GV+ LEV+ GK P      
Sbjct:   943 KLVDDGDFARSSNTIAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDPTIP 1002

Query:   845 DFLFEXXXXXXXXXIEMLDSRLPY-PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ 903
             D L           I+++D  L   P   V++ +M  + VA  C++  PE RPTMK V+ 
Sbjct:  1003 DGLHIVDWVKKIRDIQVIDQGLQARPESEVEE-MMQTLGVALLCINPIPEDRPTMKDVAA 1061

Query:   904 LLCE 907
             +L E
Sbjct:  1062 MLSE 1065

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)]

 Score = 1118 (398.6 bits), Expect = 2.5e-113, P = 2.5e-113
 Identities = 281/751 (37%), Positives = 399/751 (53%)

Query:   114 LDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSI 173
             L LY N L G IP +I N+ +L+ L    N+L G IP  +G L+ +  +  S N LSG I
Sbjct:   282 LALYGNSLVGPIPSEIGNMKSLKKLYLYQNQLNGTIPKELGKLSKVMEIDFSENLLSGEI 341

Query:   174 PHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFD 233
             P E+ +++ L  L L  N L G IP  L  L ++  L L  NS  G IP    NL S+  
Sbjct:   342 PVELSKISELRLLYLFQNKLTGIIPNELSKLRNLAKLDLSINSLTGPIPPGFQNLTSMRQ 401

Query:   234 LELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGXXXXXXXXXXXXXHFRGTV 293
             L+L  N LSG IP  +   + L  +    N+LSG IP  I                 G +
Sbjct:   402 LQLFHNSLSGVIPQGLGLYSPLWVVDFSENQLSGKIPPFICQQSNLILLNLGSNRIFGNI 461

Query:   294 PKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSL 353
             P        L++LR+  N LTG          NL+ I+L  N F G +  + G C +L  
Sbjct:   462 PPGVLRCKSLLQLRVVGNRLTGQFPTELCKLVNLSAIELDQNRFSGPLPPEIGTCQKLQR 521

Query:   354 LDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCI 413
             L ++ N  S ++P EI +   L   ++SSN + G IP+++ N   L RL LS N   G +
Sbjct:   522 LHLAANQFSSNLPNEISKLSNLVTFNVSSNSLTGPIPSEIANCKMLQRLDLSRNSFIGSL 581

Query:   414 PRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLS- 472
             P ELGSL  LE L LS N  S  +P ++G+L  L  L +  N  S  IP +L  L  L  
Sbjct:   582 PPELGSLHQLEILRLSENRFSGNIPFTIGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQI 641

Query:   473 ELDLSHN-FLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEG 531
              ++LS+N F GE I   I  +  L  L+L+ N+LSG IP  FE +  LL  + SYN L G
Sbjct:   642 AMNLSYNDFSGE-IPPEIGNLHLLMYLSLNNNHLSGEIPTTFENLSSLLGCNFSYNNLTG 700

Query:   532 QIPNSTTFRDAPLEALQGNKGLYGD-IRG-------FPSCMSYKKAS--RKIWIVIVFPL 581
             Q+P++  F++  L +  GNKGL G  +R        +P   S K  S  R   I+IV  +
Sbjct:   701 QLPHTQIFQNMTLTSFLGNKGLCGGHLRSCDPSHSSWPHISSLKAGSARRGRIIIIVSSV 760

Query:   582 LGMVALFIALTGFFFIFHQRKNDSQTQQSSFGNTPGLR-SVLTFEGK--IVYEEIISATN 638
             +G ++L +      F+   R     T        P  + S + F  K     ++I+ AT 
Sbjct:   761 IGGISLLLIAIVVHFL---RNPVEPTAPYVHDKEPFFQESDIYFVPKERFTVKDILEATK 817

Query:   639 DFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQE---EFLNEIQALTEI 695
              F+  + +G+G  G+VY+A +PSG+  AVKK  S   G  +        F  EI  L +I
Sbjct:   818 GFHDSYIVGRGACGTVYKAVMPSGKTIAVKKLESNREGNNNNSNNTDNSFRAEILTLGKI 877

Query:   696 RHRNIVKFYGFCSHP--KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADA 753
             RHRNIV+ Y FC H     + ++YEY+  GSL ++L +   +  + W  R  +  G A+ 
Sbjct:   878 RHRNIVRLYSFCYHQGSNSNLLLYEYMSRGSLGELL-HGGKSHSMDWPTRFAIALGAAEG 936

Query:   754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN-PDSSNWSELAGTHGYVA 812
             L YLH++C P I+HRDI S N+L+D  +EAHV DFG+AK ++ P S + S +AG++GY+A
Sbjct:   937 LAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVIDMPLSKSVSAVAGSYGYIA 996

Query:   813 PELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
             PE AYT+KVTEKCD+YSFGV+ LE++ GK P
Sbjct:   997 PEYAYTMKVTEKCDIYSFGVVLLELLTGKAP 1027

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006486 "protein glycosylation" evidence=RCA

TAIR|locus:2025545 AT1G08590 [Arabidopsis thaliana (taxid:3702)]

 Score = 681 (244.8 bits), Expect = 1.2e-112, Sum P(2) = 1.2e-112
 Identities = 167/496 (33%), Positives = 255/496 (51%)

Query:    66 NATKISP---CAWSGIFCNHAERVVGINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELF 122
             NAT  S    C W+G+ C+    V  + L++++L+G + +    SFP L  LDL NN   
Sbjct:    56 NATTFSELVHCHWTGVHCDANGYVAKLLLSNMNLSGNVSD-QIQSFPSLQALDLSNNAFE 114

Query:   123 GIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTV 182
               +P  +SNL++L+ +D S N  FG  P G+G+ T LT ++ S N  SG +P ++G  T 
Sbjct:   115 SSLPKSLSNLTSLKVIDVSVNSFFGTFPYGLGMATGLTHVNASSNNFSGFLPEDLGNATT 174

Query:   183 LNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLS 242
             L  L     +  GS+P S  NL ++  L L  N+F G +P+ IG L SL  + L  N   
Sbjct:   175 LEVLDFRGGYFEGSVPSSFKNLKNLKFLGLSGNNFGGKVPKVIGELSSLETIILGYNGFM 234

Query:   243 GAIPLSISNLTNLRFLFLYHNELSGIIPQEIGXXXXXXXXXXXXXHFRGTVPKSFRNLTD 302
             G IP     LT L++L L    L+G IP  +G                G +P+    +T 
Sbjct:   235 GEIPEEFGKLTRLQYLDLAVGNLTGQIPSSLGQLKQLTTVYLYQNRLTGKLPRELGGMTS 294

Query:   303 LVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNIS 362
             LV L L+ N +TG I    G   NL  ++L  N   G I S     P L +L++  N++ 
Sbjct:   295 LVFLDLSDNQITGEIPMEVGELKNLQLLNLMRNQLTGIIPSKIAELPNLEVLELWQNSLM 354

Query:   363 GSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLIN 422
             GS+P+ +G++  L++LD+SSN + G+IP+ L     L +L L  N  SG IP E+ S   
Sbjct:   355 GSLPVHLGKNSPLKWLDVSSNKLSGDIPSGLCYSRNLTKLILFNNSFSGQIPEEIFSCPT 414

Query:   423 LEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLG 482
             L  + +  N++S  +P   G L  L +L L+ N L+ +IP ++     LS +D+S N L 
Sbjct:   415 LVRVRIQKNHISGSIPAGSGDLPMLQHLELAKNNLTGKIPDDIALSTSLSFIDISFNHLS 474

Query:   483 EKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNS-TTFRD 541
               +SS I    +L+    S+NN +G IP   ++   L  +D+S+N   G IP    +F  
Sbjct:   475 S-LSSSIFSSPNLQTFIASHNNFAGKIPNQIQDRPSLSVLDLSFNHFSGGIPERIASFEK 533

Query:   542 APLEALQGNKGLYGDI 557
                  L+ N+ L G+I
Sbjct:   534 LVSLNLKSNQ-LVGEI 548

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010067 "procambium histogenesis" evidence=ISS

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2167948 ERL1 "ERECTA-like 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1090 (388.8 bits), Expect = 3.8e-112, Sum P(2) = 3.8e-112
 Identities = 283/833 (33%), Positives = 420/833 (50%)

Query:    90 NLTSISLNGTLLEFSF----SSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKL 145
             NL SI L G  L         +   LVYLDL  N L+G IP  IS L  LE L+   N+L
Sbjct:    96 NLQSIDLQGNKLAGQIPDEIGNCASLVYLDLSENLLYGDIPFSISKLKQLETLNLKNNQL 155

Query:   146 FGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLT 205
              G +P+ +  + +L  L ++ N L+G I   +    VL  L L  N L G++   +  LT
Sbjct:   156 TGPVPATLTQIPNLKRLDLAGNHLTGEISRLLYWNEVLQYLGLRGNMLTGTLSSDMCQLT 215

Query:   206 HVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNEL 265
              +    +  N+  G+IP+ IGN  S   L++  NQ++G IP +I  L  +  L L  N L
Sbjct:   216 GLWYFDVRGNNLTGTIPESIGNCTSFQILDISYNQITGEIPYNIGFL-QVATLSLQGNRL 274

Query:   266 SGIIPQEIGXXXXXXXXXXXXXHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYP 325
             +G IP+ IG                G +P    NL+   KL L+ N LTG I    G   
Sbjct:   275 TGRIPEVIGLMQALAVLDLSDNELVGPIPPILGNLSFTGKLYLHGNMLTGPIPSELGNMS 334

Query:   326 NLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYI 385
              L+++ L++N   G I  + G+  QL  L+++ N + G IP  I     L   ++  N +
Sbjct:   335 RLSYLQLNDNKLVGTIPPELGKLEQLFELNLANNRLVGPIPSNISSCAALNQFNVHGNLL 394

Query:   386 VGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLV 445
              G IP    N+  L  L+LS N   G IP ELG +INL+ LDLS NN S  +P +LG L 
Sbjct:   395 SGSIPLAFRNLGSLTYLNLSSNNFKGKIPVELGHIINLDKLDLSGNNFSGSIPLTLGDLE 454

Query:   446 KLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNL 505
              L  LNLS N LS Q+P E  NL  +  +D+S N L   I + + ++++L  L L+ N L
Sbjct:   455 HLLILNLSRNHLSGQLPAEFGNLRSIQMIDVSFNLLSGVIPTELGQLQNLNSLILNNNKL 514

Query:   506 SGLIPRCFEEMHGLLHIDISYNKLEGQIPNSTTF-RDAPLEALQGNKGLYGDIRGFPSCM 564
              G IP        L+++++S+N L G +P    F R AP   + GN  L G+  G   C 
Sbjct:   515 HGKIPDQLTNCFTLVNLNVSFNNLSGIVPPMKNFSRFAPASFV-GNPYLCGNWVG-SICG 572

Query:   565 SYKKA---SRKIWIVIVFPLLGMVALFIALTGFFFIFHQRKNDSQTQQSSFGNTPGLRS- 620
                K+   SR   I IV   LG++ L   +   F   ++     +  Q S     GL   
Sbjct:   573 PLPKSRVFSRGALICIV---LGVITLLCMI---FLAVYKSMQQKKILQGSSKQAEGLTKL 626

Query:   621 -VLTFEGKI-VYEEIISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEM 678
              +L  +  I  +++I+  T + N +  IG G   +VY+  + S    A+K+ ++  P  +
Sbjct:   627 VILHMDMAIHTFDDIMRVTENLNEKFIIGYGASSTVYKCALKSSRPIAIKRLYNQYPHNL 686

Query:   679 SFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKEL 738
                  EF  E++ +  IRHRNIV  +G+   P  + + Y+Y+E+GSL  +L       +L
Sbjct:   687 ----REFETELETIGSIRHRNIVSLHGYALSPTGNLLFYDYMENGSLWDLLHGSLKKVKL 742

Query:   739 GWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS 798
              W  RL +  G A  L YLH++C P I+HRDI S N+LLD  +EAH+SDFGIAK +    
Sbjct:   743 DWETRLKIAVGAAQGLAYLHHDCTPRIIHRDIKSSNILLDENFEAHLSDFGIAKSIPASK 802

Query:   799 SNWSE-LAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDF---LFEXXXXX 854
             ++ S  + GT GY+ PE A T ++ EK D+YSFG++ LE++ GK   D    L +     
Sbjct:   803 THASTYVLGTIGYIDPEYARTSRINEKSDIYSFGIVLLELLTGKKAVDNEANLHQLILSK 862

Query:   855 XX--XXIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
                   +E +D  +    + +   +    Q+A  C  +NP  RPTM  VS++L
Sbjct:   863 ADDNTVMEAVDPEVTVTCMDLGH-IRKTFQLALLCTKRNPLERPTMLEVSRVL 914

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010103 "stomatal complex morphogenesis" evidence=IGI;RCA

GO:0009553 "embryo sac development" evidence=IGI

GO:0048481 "ovule development" evidence=IGI;RCA

GO:0016020 "membrane" evidence=IDA

GO:0001708 "cell fate specification" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009827 "plant-type cell wall modification" evidence=RCA

GO:0009860 "pollen tube growth" evidence=RCA

GO:0009886 "post-embryonic morphogenesis" evidence=RCA

GO:0009909 "regulation of flower development" evidence=RCA

GO:0009965 "leaf morphogenesis" evidence=RCA

GO:0048441 "petal development" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

GO:0048507 "meristem development" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	912
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-136
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-48
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-47
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	3e-45
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	6e-43
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	8e-43
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	4e-42
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-42
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-41
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	6e-40
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-31
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-29
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	6e-29
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	4e-28
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	6e-28
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	9e-28
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	5e-27
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-26
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-25
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-25
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-25
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-25
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-25
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-25
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-25
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-25
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	5e-25
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	5e-25
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-24
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-24
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-24
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-24
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-24
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	8e-24
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-23
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-23
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	6e-23
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-22
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-22
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	5e-22
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	6e-22
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	6e-22
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-21
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-21
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-21
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-21
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-21
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	5e-21
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	5e-21
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	7e-21
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	7e-21
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	8e-21
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	9e-21
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-20
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-20
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-20
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-20
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	7e-20
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-19
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-19
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-19
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-19
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	7e-19
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	9e-19
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	9e-19
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-18
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-18
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-18
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-18
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-18
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-18
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-18
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-18
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	4e-18
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	4e-18
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	5e-18
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	5e-18
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	5e-18
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	7e-18
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	9e-18
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-17
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-17
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-17
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-17
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-17
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-17
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-17
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	4e-17
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	4e-17
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	5e-17
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	5e-17
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	6e-17
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	8e-17
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-16
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-16
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-16
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-16
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-16
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-16
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-16
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	4e-16
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	5e-16
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	7e-16
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-15
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-15
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-15
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-15
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-15
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-15
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	4e-15
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	5e-15
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	5e-15
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	8e-15
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	9e-15
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	9e-15
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-14
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-14
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-14
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-14
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-14
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-14
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	5e-14
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	6e-14
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	6e-14
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	7e-14
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-13
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-13
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-13
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-13
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-13
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-13
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	3e-13
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	5e-13
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	5e-13
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	5e-13
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	6e-13
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	6e-13
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	7e-13
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	7e-13
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	8e-13
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	8e-13
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	8e-13
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-12
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-12
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-12
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-12
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	3e-12
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-12
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-12
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-12
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	3e-12
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-12
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-12
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	6e-12
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	7e-12
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	8e-12
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-11
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-11
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-11
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-11
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-11
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-11
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-11
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-11
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-11
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	5e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	8e-11
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-10
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-10
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-10
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-10
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-10
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-10
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	5e-10
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	6e-10
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	7e-10
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	7e-10
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	9e-10
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-09
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-09
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-09
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-09
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-09
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-09
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-09
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-09
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	3e-09
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	3e-09
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-09
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	3e-09
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-09
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	4e-09
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	5e-09
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	5e-09
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	5e-09
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	6e-09
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	6e-09
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	7e-09
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	7e-09
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	8e-09
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	9e-09
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	9e-09
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	9e-09
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-08
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-08
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-08
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-08
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-08
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-08
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-08
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-08
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-08
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-08
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-08
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-08
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-08
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-08
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-08
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	4e-08
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	4e-08
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-08
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	4e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	5e-08
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	5e-08
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	6e-08
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	6e-08
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	6e-08
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	7e-08
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	7e-08
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	7e-08
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	7e-08
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	8e-08
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	9e-08
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	9e-08
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	9e-08
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	9e-08
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-07
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-07
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-07
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	1e-07
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	2e-07
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-07
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-07
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-07
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-07
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-07
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-07
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-07
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-07
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-07
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-07
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-07
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	3e-07
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	3e-07
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-07
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-07
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	4e-07
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	4e-07
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	4e-07
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	4e-07
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	4e-07
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	5e-07
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	5e-07
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	5e-07
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	5e-07
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	8e-07
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	8e-07
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-06
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-06
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-06
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-06
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	2e-06
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-06
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-06
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-06
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-06
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	3e-06
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-06
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-06
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	5e-06
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	5e-06
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	5e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	7e-06
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	8e-06
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-05
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-05
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-05
pfam08263	42	pfam08263, LRRNT_2, Leucine rich repeat N-terminal	1e-05
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-05
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	2e-05
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-05
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-05
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-05
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-05
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-05
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	4e-05
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	4e-05
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	4e-05
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	5e-05
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	6e-05
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	6e-05
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-04
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-04
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-04
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-04
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-04
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	4e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	4e-04
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	5e-04
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	6e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.001
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	0.001
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.002
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	0.002
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.003
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	0.004
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	0.004
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	0.004

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  431 bits (1111), Expect = e-136
 Identities = 319/977 (32%), Positives = 477/977 (48%), Gaps = 127/977 (12%)

Query: 18  PLILFVVLDFSLAISSNSAEEAHALVKWKASLEVHSRSLLHSWSLSSVNATKISPCAWSG 77
           P ++F++    L  S   AEE   L+ +K+S+    +  L +W+ S+        C W G
Sbjct: 10  PYLIFMLFFLFLNFSMLHAEELELLLSFKSSINDPLK-YLSNWNSSA------DVCLWQG 62

Query: 78  IFCNHAERVVGINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQIS------- 130
           I CN++ RVV I+L+  +++G +    F   P++  ++L NN+L G IP  I        
Sbjct: 63  ITCNNSSRVVSIDLSGKNISGKISSAIFR-LPYIQTINLSNNQLSGPIPDDIFTTSSSLR 121

Query: 131 --NLSN--------------LEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIP 174
             NLSN              LE LD S N L G+IP+ IG  + L VL +  N L G IP
Sbjct: 122 YLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIP 181

Query: 175 HEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDL 234
           + +  LT L  L L SN L G IPR LG +  +  +YL  N+  G IP EIG L SL  L
Sbjct: 182 NSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHL 241

Query: 235 ELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVP 294
           +L  N L+G IP S+ NL NL++LFLY N+LSG IP  I +L+KL SL L+ N   G +P
Sbjct: 242 DLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIP 301

Query: 295 KSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLL 354
           +    L +L  L L  N  TG I     + P L  + L +N F GEI  + G+   L++L
Sbjct: 302 ELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVL 361

Query: 355 DVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIP 414
           D+S NN++G IP  +  S  L  L L SN + GEIP  LG    L R+ L  N  SG +P
Sbjct: 362 DLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELP 421

Query: 415 RELGSLINLEYLDLSANNLS---------------------NF---VPESLGSLVKLYYL 450
            E   L  + +LD+S NNL                       F   +P+S GS  +L  L
Sbjct: 422 SEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENL 480

Query: 451 NLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIP 510
           +LS N+ S  +P +L +L  L +L LS N L  +I   +   + L  L+LS+N LSG IP
Sbjct: 481 DLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIP 540

Query: 511 RCFEEMHGLLHIDISYNKLEGQIP--------------------NSTTFRDAPL----EA 546
             F EM  L  +D+S N+L G+IP                     S     A L     A
Sbjct: 541 ASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASA 600

Query: 547 LQGNKGLYGD--IRGFPSCMSYKKASRKIWIVIVFPLLGMVALFIALTGFFFIFHQRKND 604
           + GN  L G     G P C   +K     W   +   LG   L +AL  F F+F + +N+
Sbjct: 601 VAGNIDLCGGDTTSGLPPCKRVRKT--PSWWFYITCTLG-AFLVLALVAFGFVFIRGRNN 657

Query: 605 SQTQQSSFGNTPGLRSVLTFEGK----IVYEEIISATNDFNAEHCIGKGGHGSVYRAKVP 660
            + ++    N  G   +  F+ K    I   +I+S+  +   E+ I +G  G+ Y+ K  
Sbjct: 658 LELKRVE--NEDGTWELQFFDSKVSKSITINDILSSLKE---ENVISRGKKGASYKGKSI 712

Query: 661 SGEI-FAVKKFH--SPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIY 717
              + F VK+ +  + +P           +EI  + +++H NIVK  G C   K +++I+
Sbjct: 713 KNGMQFVVKEINDVNSIP----------SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762

Query: 718 EYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLL 777
           EY+E  +L ++L N      L W +R  +  G+A AL +LH  C P +V  ++S + +++
Sbjct: 763 EYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIII 816

Query: 778 DLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEV 837
           D   E H+    +   L  D+  +   A    YVAPE   T  +TEK D+Y FG++ +E+
Sbjct: 817 DGKDEPHLR-LSLPGLLCTDTKCFISSA----YVAPETRETKDITEKSDIYGFGLILIEL 871

Query: 838 IKGKHPRDFLFEMSSS--------SSNMNIEM-LDSRLPYPSLHVQKKLMSIMQVAFSCL 888
           + GK P D  F +  S         S+ +++M +D  +       Q +++ +M +A  C 
Sbjct: 872 LTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCT 931

Query: 889 DQNPESRPTMKRVSQLL 905
             +P +RP    V + L
Sbjct: 932 ATDPTARPCANDVLKTL 948

Length = 968

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  171 bits (436), Expect = 3e-48
 Identities = 81/265 (30%), Positives = 125/265 (47%), Gaps = 20/265 (7%)

Query: 645 CIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKF 703
            +G G  G+VY+AK   +G+I AVK        E S + +    EI+ L  + H NIV+ 
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKIL--KKRSEKSKKDQTARREIRILRRLSHPNIVRL 63

Query: 704 YGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFP 763
                   H +++ EY E G L   L   +    L   +   +   +   L YLH+N   
Sbjct: 64  IDAFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLHSN--- 117

Query: 764 PIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPE-LAYTLKVT 822
            I+HRD+  +N+LLD      ++DFG+AK L   SS+ +   GT  Y+APE L       
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177

Query: 823 EKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQ 882
            K DV+S GV+  E++ GK P  F    S  +    ++++   L  P    + K  S  +
Sbjct: 178 PKVDVWSLGVILYELLTGKPP--F----SGENILDQLQLIRRILGPPLEFDEPKWSSGSE 231

Query: 883 VAFS----CLDQNPESRPTMKRVSQ 903
            A      CL+++P  RPT + + Q
Sbjct: 232 EAKDLIKKCLNKDPSKRPTAEEILQ 256

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  169 bits (431), Expect = 2e-47
 Identities = 70/261 (26%), Positives = 120/261 (45%), Gaps = 20/261 (7%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G+G  G VY A+   +G++ A+K        ++   +E  L EI+ L +++H NIV+ Y
Sbjct: 7   LGEGSFGKVYLARDKKTGKLVAIKVIK---KKKIKKDRERILREIKILKKLKHPNIVRLY 63

Query: 705 GFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP 764
                    +++ EY E G L  +L       E    +    ++ +  AL YLH+     
Sbjct: 64  DVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSE---DEARFYLRQILSALEYLHSKG--- 117

Query: 765 IVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEK 824
           IVHRD+  +N+LLD      ++DFG+A+ L+P     +   GT  Y+APE+       + 
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTT-FVGTPEYMAPEVLLGKGYGKA 176

Query: 825 CDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNM--NIEMLDSRLPYPSLHVQKKLMSIMQ 882
            D++S GV+  E++ GK P    F        +   I       P P   +  +   +++
Sbjct: 177 VDIWSLGVILYELLTGKPP----FPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIR 232

Query: 883 VAFSCLDQNPESRPTMKRVSQ 903
                L ++PE R T +   Q
Sbjct: 233 ---KLLVKDPEKRLTAEEALQ 250

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  161 bits (410), Expect = 3e-45
 Identities = 74/257 (28%), Positives = 119/257 (46%), Gaps = 51/257 (19%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G+GG G+VY A+   +G+  A+K         +    EE L EI+ L ++ H NIVK Y
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLL---EELLREIEILKKLNHPNIVKLY 57

Query: 705 GFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP 764
           G      H +++ EY E GSL  +L  +    +L   + L ++  + + L YLH+N    
Sbjct: 58  GVFEDENHLYLVMEYCEGGSLKDLLKEN--EGKLSEDEILRILLQILEGLEYLHSN---G 112

Query: 765 IVHRDISSKNVLLDLG-YEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPE-LAYTLKVT 822
           I+HRD+  +N+LLD    +  ++DFG++K L  D S    + GT  Y+APE L      +
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172

Query: 823 EKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQ 882
           EK D++S GV+             L+E+                             +  
Sbjct: 173 EKSDIWSLGVI-------------LYELP---------------------------ELKD 192

Query: 883 VAFSCLDQNPESRPTMK 899
           +    L ++PE RP+ K
Sbjct: 193 LIRKMLQKDPEKRPSAK 209

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  156 bits (398), Expect = 6e-43
 Identities = 80/276 (28%), Positives = 120/276 (43%), Gaps = 40/276 (14%)

Query: 646 IGKGGHGSVYRAK-----VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNI 700
           +G+G  G VY+              AVK            Q EEFL E + + ++ H NI
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLK---EDASEQQIEEFLREARIMRKLDHPNI 63

Query: 701 VKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
           VK  G C+  +   I+ EY+  G L   L      KEL  +  L+    +A  + YL + 
Sbjct: 64  VKLLGVCTEEEPLMIVMEYMPGGDLLDYL-RKNRPKELSLSDLLSFALQIARGMEYLESK 122

Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV-----APEL 815
                +HRD++++N L+       +SDFG+++ L  D           G +     APE 
Sbjct: 123 ---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD----DYYKVKGGKLPIRWMAPES 175

Query: 816 AYTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEMLD-----SRLPYP 869
               K T K DV+SFGVL  E+   G+ P      MS      N E+L+      RLP P
Sbjct: 176 LKEGKFTSKSDVWSFGVLLWEIFTLGEEPYP---GMS------NAEVLEYLKKGYRLPKP 226

Query: 870 SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
             +   +L  +M     C  ++PE RPT   + ++L
Sbjct: 227 P-NCPPELYKLML---QCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  156 bits (397), Expect = 8e-43
 Identities = 78/276 (28%), Positives = 122/276 (44%), Gaps = 40/276 (14%)

Query: 646 IGKGGHGSVYRAKV-----PSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNI 700
           +G+G  G VY+  +      +    AVK       G    ++EEFL E   + ++ H NI
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLK---EGASEEEREEFLEEASIMKKLSHPNI 63

Query: 701 VKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
           V+  G C+  +  +I+ EY+  G L   L      ++L     L +   +A  + YL + 
Sbjct: 64  VRLLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLESK 121

Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV-----APEL 815
            F   VHRD++++N L+       +SDFG+++ +  D           G +     APE 
Sbjct: 122 NF---VHRDLAARNCLVTENLVVKISDFGLSRDIYEDD---YYRKRGGGKLPIKWMAPES 175

Query: 816 AYTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEMLDS-----RLPYP 869
               K T K DV+SFGVL  E+   G+ P      MS      N E+L+      RLP P
Sbjct: 176 LKDGKFTSKSDVWSFGVLLWEIFTLGEQP---YPGMS------NEEVLELLEDGYRLPRP 226

Query: 870 SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
             +   +L  +M     C   +PE RPT   + + L
Sbjct: 227 -ENCPDELYELML---QCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  154 bits (391), Expect = 4e-42
 Identities = 87/270 (32%), Positives = 133/270 (49%), Gaps = 24/270 (8%)

Query: 639 DFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH 697
            F     IGKGG G VY+A+   +G+  A+K     +  E   ++E+ +NEIQ L + +H
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKV----IKLESKEKKEKIINEIQILKKCKH 56

Query: 698 RNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYL 757
            NIVK+YG        +I+ E+   GSL  +L   ++ + L  +Q   V K +   L YL
Sbjct: 57  PNIVKYYGSYLKKDELWIVMEFCSGGSLKDLL--KSTNQTLTESQIAYVCKELLKGLEYL 114

Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAY 817
           H+N    I+HRDI + N+LL    E  + DFG++  L+ D+   + + GT  ++APE+  
Sbjct: 115 HSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLS-DTKARNTMVGTPYWMAPEVIN 170

Query: 818 TLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKL 877
                 K D++S G+ A+E+ +GK P     E+      M      +    P L    + 
Sbjct: 171 GKPYDYKADIWSLGITAIELAEGKPP---YSELPP----MKALFKIATNGPPGLR-NPEK 222

Query: 878 MSIMQVAF--SCLDQNPESRPTMKRVSQLL 905
            S     F   CL +NPE RPT     QLL
Sbjct: 223 WSDEFKDFLKKCLQKNPEKRPT---AEQLL 249

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  154 bits (391), Expect = 4e-42
 Identities = 79/276 (28%), Positives = 124/276 (44%), Gaps = 41/276 (14%)

Query: 646 IGKGGHGSVYRAK----VPSGEIF-AVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNI 700
           +G+G  G VY+ K        ++  AVK            Q EEFL E + + ++ H N+
Sbjct: 7   LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLK---EDASEQQIEEFLREARIMRKLDHPNV 63

Query: 701 VKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
           VK  G C+  +  +I+ EY+E G L   L    +  +L  +  L+    +A  + YL + 
Sbjct: 64  VKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLESK 121

Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV-----APEL 815
                +HRD++++N L+       +SDFG+++ L  D           G +     APE 
Sbjct: 122 ---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY----RKRGGKLPIRWMAPES 174

Query: 816 AYTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEML-----DSRLPYP 869
               K T K DV+SFGVL  E+   G+ P      MS      N E+L       RLP P
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEIFTLGEQPYP---GMS------NEEVLEYLKNGYRLPQP 225

Query: 870 SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
             +   +L  +M     C  ++PE RPT   + ++L
Sbjct: 226 P-NCPPELYDLML---QCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  151 bits (384), Expect = 4e-41
 Identities = 74/281 (26%), Positives = 122/281 (43%), Gaps = 43/281 (15%)

Query: 646 IGKGGHGSVYRAKVPSGEIF----AVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIV 701
           +G+G  G VY+ K+   +      AVK   +        ++++FL E + + ++ H N+V
Sbjct: 3   LGEGAFGEVYKGKLKGKDGKTTEVAVK---TLKEDASEEERKDFLKEARVMKKLGHPNVV 59

Query: 702 KFYGFCSHPKHSFIIYEYLESGSLDKIL------CNDASAKELGWTQRLNVIKGVADALF 755
           +  G C+  +  +++ EY+E G L   L              L     L+    +A  + 
Sbjct: 60  RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119

Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV---- 811
           YL +      VHRD++++N L+       +SDFG+++ +  D         T G +    
Sbjct: 120 YLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYY---RKKTGGKLPIRW 173

Query: 812 -APELAYTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEMLD-----S 864
            APE       T K DV+SFGVL  E+   G  P      +S      N E+L+      
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATP---YPGLS------NEEVLEYLRKGY 224

Query: 865 RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
           RLP P  +   +L  +M    SC   +PE RPT   + + L
Sbjct: 225 RLPKPE-YCPDELYELML---SCWQLDPEDRPTFSELVERL 261

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  148 bits (375), Expect = 6e-40
 Identities = 78/272 (28%), Positives = 124/272 (45%), Gaps = 32/272 (11%)

Query: 644 HCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVK 702
             +G+G  GSVY A    +GE+ AVK     L G+   + E    EI+ L+ ++H NIV+
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKS--VELSGDSEEELEALEREIRILSSLQHPNIVR 63

Query: 703 FYGFCSHPKHSF--IIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVA----DALFY 756
           +YG     + +   I  EY+  GSL  +L       E        VI+       + L Y
Sbjct: 64  YYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPE-------PVIRKYTRQILEGLAY 116

Query: 757 LHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSE--LAGTHGYVAPE 814
           LH+N    IVHRDI   N+L+D      ++DFG AK L    +      + GT  ++APE
Sbjct: 117 LHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE 173

Query: 815 LAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMN-IEMLDSRLPYPSLHV 873
           +    +     D++S G   +E+  GK P     E+ +  + +  I         P  H+
Sbjct: 174 VIRGEEYGRAADIWSLGCTVIEMATGKPP---WSELGNPMAALYKIGSSGEPPEIPE-HL 229

Query: 874 QKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
            ++    ++    CL ++P+ RPT     +LL
Sbjct: 230 SEEAKDFLR---KCLRRDPKKRPT---ADELL 255

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  123 bits (311), Expect = 3e-31
 Identities = 74/271 (27%), Positives = 122/271 (45%), Gaps = 35/271 (12%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           IGKG  G VY  +    G+++ +K+    L      ++E+ LNE++ L ++ H NI+K+Y
Sbjct: 8   IGKGSFGKVYLVRRKSDGKLYVLKE--IDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 705 GFCSHPKHSFIIYEYLESGSLDKILCNDASAKE-------LGW-TQRLNVIKGVADALFY 756
                     I+ EY + G L + +       +       L W  Q       +  AL Y
Sbjct: 66  ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ-------LCLALKY 118

Query: 757 LHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELA 816
           LH+     I+HRDI  +N+ L       + DFGI+K L+        + GT  Y++PEL 
Sbjct: 119 LHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELC 175

Query: 817 YTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLD-SRLPYPSL--HV 873
                  K D++S G +  E+   KHP    FE      N+    L   +  YP +    
Sbjct: 176 QNKPYNYKSDIWSLGCVLYELCTLKHP----FE----GENLLELALKILKGQYPPIPSQY 227

Query: 874 QKKLMSIMQVAFSCLDQNPESRPTMKRVSQL 904
             +L +++    S L ++PE RP++ ++ Q 
Sbjct: 228 SSELRNLVS---SLLQKDPEERPSIAQILQS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  118 bits (298), Expect = 2e-29
 Identities = 73/256 (28%), Positives = 118/256 (46%), Gaps = 23/256 (8%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFL-NEIQALTEIRHRNIVKF 703
           IG+G  G VY+A    +G+  A+KK        +  Q +E + NEI  + + +H NIV +
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMR------LRKQNKELIINEILIMKDCKHPNIVDY 80

Query: 704 YGFCSHPKHSFIIYEYLESGSL-DKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
           Y         +++ EY++ GSL D I  N     E    Q   V + V   L YLH+   
Sbjct: 81  YDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNE---PQIAYVCREVLQGLEYLHSQ-- 135

Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVT 822
             ++HRDI S N+LL       ++DFG A  L  + S  + + GT  ++APE+       
Sbjct: 136 -NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYG 194

Query: 823 EKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQ 882
            K D++S G++ +E+ +G+ P             +    L +    P L   +K     +
Sbjct: 195 PKVDIWSLGIMCIEMAEGEPPY---LREPP----LRALFLITTKGIPPLKNPEKWSPEFK 247

Query: 883 -VAFSCLDQNPESRPT 897
                CL ++PE RP+
Sbjct: 248 DFLNKCLVKDPEKRPS 263

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  116 bits (293), Expect = 6e-29
 Identities = 74/273 (27%), Positives = 123/273 (45%), Gaps = 24/273 (8%)

Query: 638 NDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
           +D      +G+G  G VY+ +  P+G+I+A+KK H     E    +++ L E++ L    
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEF---RKQLLRELKTLRSCE 57

Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQR-LNVI-KGVADAL 754
              +VK YG         I+ EY++ GSL  +L      K     +  L  I + +   L
Sbjct: 58  SPYVVKCYGAFYKEGEISIVLEYMDGGSLADLL-----KKVGKIPEPVLAYIARQILKGL 112

Query: 755 FYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPE 814
            YLH      I+HRDI   N+L++   E  ++DFGI+K L       +   GT  Y++PE
Sbjct: 113 DYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPE 170

Query: 815 LAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQ 874
                  +   D++S G+  LE   GK P     + S        E++ +    P   + 
Sbjct: 171 RIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSF------FELMQAICDGPPPSLP 224

Query: 875 KKLMSIMQVAF--SCLDQNPESRPTMKRVSQLL 905
            +  S     F  +CL ++P+ RP+    ++LL
Sbjct: 225 AEEFSPEFRDFISACLQKDPKKRPS---AAELL 254

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  113 bits (286), Expect = 4e-28
 Identities = 74/265 (27%), Positives = 121/265 (45%), Gaps = 26/265 (9%)

Query: 645 CIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKF 703
            IG+G  G VY+   + +G+  A+K+    L        +  + EI  L  ++H NIVK+
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQIS--LEKIKEEALKSIMQEIDLLKNLKHPNIVKY 64

Query: 704 YGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVA---DALFYLHNN 760
            G        +II EY E+GSL +I+      K+ G      V   V      L YLH  
Sbjct: 65  IGSIETSDSLYIILEYAENGSLRQII------KKFGPFPESLVAVYVYQVLQGLAYLHEQ 118

Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLK 820
               ++HRDI + N+L        ++DFG+A  LN  S + + + GT  ++APE+     
Sbjct: 119 ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSG 175

Query: 821 VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSI 880
            +   D++S G   +E++ G  P    ++++  ++   I   D   P P   +  +L   
Sbjct: 176 ASTASDIWSLGCTVIELLTGNPP---YYDLNPMAALFRIVQDD-HPPLPE-GISPELKDF 230

Query: 881 MQVAFSCLDQNPESRPTMKRVSQLL 905
           +     C  ++P  RPT K   QLL
Sbjct: 231 LM---QCFQKDPNLRPTAK---QLL 249

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  113 bits (284), Expect = 6e-28
 Identities = 81/269 (30%), Positives = 132/269 (49%), Gaps = 34/269 (12%)

Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           +G G  G V+  K       A+K       G MS  +++F+ E + + ++ H N+V+ YG
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIRE---GAMS--EDDFIEEAKVMMKLSHPNLVQLYG 66

Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
            C+  +  FI+ EY+ +G L   L       +LG    L++   V +A+ YL +N F   
Sbjct: 67  VCTKQRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLESNGF--- 121

Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPELAYTLKVT 822
           +HRD++++N L+       VSDFG+A+++  D    S+  GT     +  PE+    + +
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ--GTKFPVKWAPPEVFDYSRFS 179

Query: 823 EKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEMLDS-----RLPYPSLHVQKK 876
            K DV+SFGVL  EV  +GK P    +E  S     N E+++S     RL  P L     
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKMP----YERFS-----NSEVVESVSAGYRLYRPKLAP--- 227

Query: 877 LMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
              +  + +SC  + PE RP  K++   L
Sbjct: 228 -TEVYTIMYSCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  112 bits (283), Expect = 9e-28
 Identities = 68/262 (25%), Positives = 121/262 (46%), Gaps = 17/262 (6%)

Query: 639 DFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHR 698
           +F  E  +G G  G V+     +    A+K   S    +   +Q++F  E+QAL  +RH+
Sbjct: 7   EFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKS----DDLLKQQDFQKEVQALKRLRHK 62

Query: 699 NIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLH 758
           +++  +  CS  +  +II E +E GSL          + L     +++   VA+ + YL 
Sbjct: 63  HLISLFAVCSVGEPVYIITELMEKGSL-LAFLRSPEGQVLPVASLIDMACQVAEGMAYLE 121

Query: 759 NNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT 818
                  +HRD++++N+L+       V+DFG+A+ +  D    S+    + + APE A  
Sbjct: 122 EQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASH 178

Query: 819 LKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKL 877
              + K DV+SFG+L  E+   G+ P    +   ++    +      R+P P+   Q   
Sbjct: 179 GTFSTKSDVWSFGILLYEMFTYGQVP----YPGMNNHEVYDQITAGYRMPCPAKCPQ--- 231

Query: 878 MSIMQVAFSCLDQNPESRPTMK 899
             I ++   C    PE RP+ K
Sbjct: 232 -EIYKIMLECWAAEPEDRPSFK 252

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  110 bits (278), Expect = 5e-27
 Identities = 76/272 (27%), Positives = 133/272 (48%), Gaps = 25/272 (9%)

Query: 638 NDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
             F+    +G+G +GSVY+A    +G++ A+K         +    +E + EI  L +  
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVV------PVEEDLQEIIKEISILKQCD 56

Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFY 756
              IVK+YG        +I+ EY  +GS+  I+    + K L   +   ++      L Y
Sbjct: 57  SPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIM--KITNKTLTEEEIAAILYQTLKGLEY 114

Query: 757 LHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELA 816
           LH+N     +HRDI + N+LL+   +A ++DFG++  L    +  + + GT  ++APE+ 
Sbjct: 115 LHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVI 171

Query: 817 YTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKK 876
             +    K D++S G+ A+E+ +GK P     ++    +   I M+ ++ P P+L   +K
Sbjct: 172 QEIGYNNKADIWSLGITAIEMAEGKPP---YSDIHPMRA---IFMIPNKPP-PTLSDPEK 224

Query: 877 LMSIMQVAF--SCLDQNPESRPTMKRVSQLLC 906
             S     F   CL ++PE RP+     QLL 
Sbjct: 225 -WSPEFNDFVKKCLVKDPEERPS---AIQLLQ 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  108 bits (271), Expect = 3e-26
 Identities = 81/274 (29%), Positives = 135/274 (49%), Gaps = 30/274 (10%)

Query: 643 EHCIGKGGHGSVYRA--KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNI 700
           +  IG G  G V+R   K+P  +  AV    +  PG    Q+++FL+E   + +  H NI
Sbjct: 10  QKVIGAGEFGEVFRGILKMPGRKEVAVA-IKTLKPGYTEKQRQDFLSEASIMGQFSHHNI 68

Query: 701 VKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
           ++  G  +  K + II EY+E+G+LDK L +     E    Q + +++G+A  + YL + 
Sbjct: 69  IRLEGVVTKFKPAMIITEYMENGALDKYLRDHDG--EFSSYQLVGMLRGIAAGMKYLSDM 126

Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPELAY 817
            +   VHRD++++N+L++   E  VSDFG+++ L  D       +G      + APE   
Sbjct: 127 NY---VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIA 183

Query: 818 TLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDS-----RLPYPSL 871
             K T   DV+SFG++  EV+  G+ P    ++MS      N E++ +     RLP P  
Sbjct: 184 YRKFTSASDVWSFGIVMWEVMSFGERP---YWDMS------NHEVMKAINDGFRLPAP-- 232

Query: 872 HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
                  ++ Q+   C  Q+   RP    +  LL
Sbjct: 233 --MDCPSAVYQLMLQCWQQDRARRPRFVDIVNLL 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  106 bits (267), Expect = 1e-25
 Identities = 72/210 (34%), Positives = 105/210 (50%), Gaps = 18/210 (8%)

Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFL-----NEIQALTEIRHRN 699
           IG G  GSVY      SGE+ AVK+   P     S  ++  +      EI  L E++H N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 700 IVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHN 759
           IV++ G      H  I  EY+  GS+  +L N  + +E   T   N ++ +   L YLHN
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEE---TLVRNFVRQILKGLNYLHN 124

Query: 760 NCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWS------ELAGTHGYVAP 813
                I+HRDI   N+L+D      +SDFGI+K L  +S +         L G+  ++AP
Sbjct: 125 R---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181

Query: 814 ELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           E+      T K D++S G L +E++ GKHP
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  106 bits (267), Expect = 2e-25
 Identities = 85/281 (30%), Positives = 129/281 (45%), Gaps = 50/281 (17%)

Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQ------EEFLNEIQALTEIRHR 698
           IG G  G VY A  + +GE+ AVK        E+  Q       +E  +E++ L  ++H 
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVK--------EIRIQDNDPKTIKEIADEMKVLELLKHP 59

Query: 699 NIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVA----DAL 754
           N+VK+YG   H +  +I  EY   G+L+++L       E G     +VI+       + L
Sbjct: 60  NLVKYYGVEVHREKVYIFMEYCSGGTLEELL-------EHGRILDEHVIRVYTLQLLEGL 112

Query: 755 FYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSE----LAGTHGY 810
            YLH++    IVHRDI   N+ LD      + DFG A  L  +++   E    LAGT  Y
Sbjct: 113 AYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAY 169

Query: 811 VAPELAYTLKVTEK---CDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNM-NIEMLDSRL 866
           +APE+    K        D++S G + LE+  GK P     E+ +    M ++     + 
Sbjct: 170 MAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWS---ELDNEFQIMFHVGA-GHKP 225

Query: 867 PYPSLHVQKKLMSIMQVAF--SCLDQNPESRPTMKRVSQLL 905
           P P        +S     F   CL+ +P+ RPT    S+LL
Sbjct: 226 PIP----DSLQLSPEGKDFLDRCLESDPKKRPT---ASELL 259

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  106 bits (267), Expect = 2e-25
 Identities = 73/270 (27%), Positives = 125/270 (46%), Gaps = 25/270 (9%)

Query: 645 CIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFL-NEIQALTEIRHRNIVK 702
            IGKG  G+V + +    G+I   K+      G M+ ++++ L +E+  L E++H NIV+
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKILVWKEIDY---GNMTEKEKQQLVSEVNILRELKHPNIVR 63

Query: 703 FYG-FCSHPKHS-FIIYEYLESGSLDKILCNDASAKE-LGWTQRLNVIKGVADALFYLHN 759
           +Y         + +I+ EY E G L +++      ++ +       ++  +  AL+  HN
Sbjct: 64  YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123

Query: 760 NCFPP--IVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAY 817
              P   ++HRD+   N+ LD      + DFG+AK L  DSS      GT  Y++PE   
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLN 183

Query: 818 TLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSS-NMNI-EMLDSRLPYPSLHVQK 875
            +   EK D++S G L  E+     P    F   +       I E    R+PY       
Sbjct: 184 HMSYDEKSDIWSLGCLIYELCALSPP----FTARNQLQLASKIKEGKFRRIPY---RYSS 236

Query: 876 KLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
           +L  +++   S L+ +P+ RP+     +LL
Sbjct: 237 ELNEVIK---SMLNVDPDKRPS---TEELL 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  106 bits (266), Expect = 2e-25
 Identities = 82/274 (29%), Positives = 127/274 (46%), Gaps = 41/274 (14%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPL-PGEMSFQQEEFLNEIQALTEIRHRNIVKF 703
           IG G +G VY+A+ + +GE+ A+K     L PG+     E    EI  L E RH NIV +
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVI--KLEPGD---DFEIIQQEISMLKECRHPNIVAY 65

Query: 704 YGFCSHPKHS--FIIYEYLESGSLDKILC-NDASAKELGWTQRLNVIKGVADALFYLHNN 760
           +G  S+ +    +I+ EY   GSL  I         EL   Q   V +     L YLH  
Sbjct: 66  FG--SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSEL---QIAYVCRETLKGLAYLHET 120

Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLK 820
                +HRDI   N+LL    +  ++DFG++  L    +      GT  ++APE+A   +
Sbjct: 121 ---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVER 177

Query: 821 V---TEKCDVYSFGVLALEVIKGK------HPRDFLFEMSSSSSNMNIEMLDSRLPYPSL 871
                 KCD+++ G+ A+E+ + +      HP   LF +S S+            P P L
Sbjct: 178 KGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSN-----------FPPPKL 226

Query: 872 HVQKKLMSIMQVAF--SCLDQNPESRPTMKRVSQ 903
             ++K   +    F   CL ++P+ RPT  ++ Q
Sbjct: 227 KDKEKWSPVFH-DFIKKCLTKDPKKRPTATKLLQ 259

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  106 bits (266), Expect = 2e-25
 Identities = 84/286 (29%), Positives = 137/286 (47%), Gaps = 55/286 (19%)

Query: 643 EHCIGKGGHGSVYRA--KVPS-GEIF-AVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHR 698
           E  IG G  G V R   K+P   EI  A+K       G    Q+ +FL E   + +  H 
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLK---AGSSDKQRLDFLTEASIMGQFDHP 65

Query: 699 NIVKFYGFCSHPKHSFIIYEYLESGSLDKIL-CNDASAKELGWTQRLNVIKGVADALFYL 757
           NI++  G  +  +   II EY+E+GSLDK L  ND    +    Q + +++G+A  + YL
Sbjct: 66  NIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDG---KFTVGQLVGMLRGIASGMKYL 122

Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG------YV 811
               +   VHRD++++N+L++      VSDFG+++ L    + ++    T G      + 
Sbjct: 123 SEMNY---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYT----TKGGKIPIRWT 175

Query: 812 APE-LAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDS----- 864
           APE +AY  K T   DV+SFG++  EV+  G+ P    ++MS      N +++ +     
Sbjct: 176 APEAIAYR-KFTSASDVWSFGIVMWEVMSYGERP---YWDMS------NQDVIKAVEDGY 225

Query: 865 RLPYP-----SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
           RLP P     +L+         Q+   C  ++   RPT  ++   L
Sbjct: 226 RLPPPMDCPSALY---------QLMLDCWQKDRNERPTFSQIVSTL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  105 bits (265), Expect = 2e-25
 Identities = 81/273 (29%), Positives = 115/273 (42%), Gaps = 36/273 (13%)

Query: 646 IGKGGHGSV----YRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIV 701
           +G G  GSV    Y  K       AVK         ++  ++EFL E   + ++ H  IV
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLK---QEHIAAGKKEFLREASVMAQLDHPCIV 59

Query: 702 KFYGFCSHPKHSFI-IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
           +  G C       + + E    G L K L                +   VA  + YL + 
Sbjct: 60  RLIGVCKGE--PLMLVMELAPLGPLLKYLKKRREIPVS---DLKELAHQVAMGMAYLESK 114

Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG-----YVAPEL 815
            F   VHRD++++NVLL   ++A +SDFG+++ L   S  +   A T G     + APE 
Sbjct: 115 HF---VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR--ATTAGRWPLKWYAPEC 169

Query: 816 AYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDS--RLPYPSLH 872
               K + K DV+S+GV   E    G  P     EM  +     I ML+S  RLP P   
Sbjct: 170 INYGKFSSKSDVWSYGVTLWEAFSYGAKPYG---EMKGAEV---IAMLESGERLPRPEEC 223

Query: 873 VQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
            Q ++ SIM    SC    PE RPT   +    
Sbjct: 224 PQ-EIYSIML---SCWKYRPEDRPTFSELESTF 252

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  109 bits (271), Expect = 2e-25
 Identities = 76/271 (28%), Positives = 127/271 (46%), Gaps = 25/271 (9%)

Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH-RNIVKFY 704
           +G+G  G VY A+    ++ A+K     L  +     E FL EIQ L  + H  NIVK Y
Sbjct: 8   LGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEV-ERFLREIQILASLNHPPNIVKLY 64

Query: 705 GFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP 764
            F       +++ EY++ GSL+ +L        L  ++ L ++  +  AL YLH+     
Sbjct: 65  DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--- 121

Query: 765 IVHRDISSKNVLLD-LGYEAHVSDFGIAKFLNPDSSN------WSELAGTHGYVAPELAY 817
           I+HRDI  +N+LLD  G    + DFG+AK L    S        S   GT GY+APE+  
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181

Query: 818 TL---KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEML------DSRLPY 868
            L     +   D++S G+   E++ G  P  F  E +SS+++  ++++          P 
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPP--FEGEKNSSATSQTLKIILELPTPSLASPL 239

Query: 869 PSLHVQKKLMSIMQVAFSCLDQNPESRPTMK 899
              + +    +   +    L ++P++R +  
Sbjct: 240 SPSNPELISKAASDLLKKLLAKDPKNRLSSS 270

Length = 384

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  105 bits (263), Expect = 3e-25
 Identities = 73/268 (27%), Positives = 120/268 (44%), Gaps = 29/268 (10%)

Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           IGKG  G VY+  +      AVK   S LP +    + +FL E + L +  H NIVK  G
Sbjct: 3   IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPD---LKRKFLQEAEILKQYDHPNIVKLIG 59

Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHN-NCFPP 764
            C   +  +I+ E +  GSL   L        L   + L +    A  + YL + NC   
Sbjct: 60  VCVQKQPIYIVMELVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYLESKNC--- 114

Query: 765 IVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH----GYVAPELAYTLK 820
            +HRD++++N L+       +SDFG+++    +   ++   G       + APE     +
Sbjct: 115 -IHRDLAARNCLVGENNVLKISDFGMSR--EEEGGIYTVSDGLKQIPIKWTAPEALNYGR 171

Query: 821 VTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEMLDS--RLPYPSLHVQKKL 877
            T + DV+S+G+L  E    G  P      MS+  +    E ++S  R+P P     +++
Sbjct: 172 YTSESDVWSYGILLWETFSLGDTPYP---GMSNQQTR---ERIESGYRMPAPQ-LCPEEI 224

Query: 878 MSIMQVAFSCLDQNPESRPTMKRVSQLL 905
             +M     C   +PE+RP+   +   L
Sbjct: 225 YRLML---QCWAYDPENRPSFSEIYNEL 249

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  104 bits (262), Expect = 5e-25
 Identities = 70/262 (26%), Positives = 126/262 (48%), Gaps = 21/262 (8%)

Query: 639 DFNAEHCIGKGGHGSVYRAKVPS-GEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH 697
           DF   + IGKG  G V++    +   ++A+K+    L      ++EE ++E + L ++  
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQID--LSKMNRREREEAIDEARVLAKLDS 58

Query: 698 RNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDAS---AKELGWTQRLNVIKGVADAL 754
             I+++Y          I+ EY E+G L K+L         ++  W   + ++ G+A   
Sbjct: 59  SYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA--- 115

Query: 755 FYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPE 814
            +LH+     I+HRDI S N+ LD      + D G+AK L+ +++  + + GT  Y++PE
Sbjct: 116 -HLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPE 171

Query: 815 LAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQ 874
           L       EK DV++ GV+  E   GKHP D     +++   + ++++    P  S   Q
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHPFD-----ANNQGALILKIIRGVFPPVS---Q 223

Query: 875 KKLMSIMQVAFSCLDQNPESRP 896
                + Q+   CL ++   RP
Sbjct: 224 MYSQQLAQLIDQCLTKDYRQRP 245

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  105 bits (263), Expect = 5e-25
 Identities = 73/261 (27%), Positives = 124/261 (47%), Gaps = 33/261 (12%)

Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           +G G  G V+          AVK      PG MS   E FL E Q + ++RH  +V+ Y 
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTLK---PGTMS--PEAFLQEAQIMKKLRHDKLVQLYA 68

Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
            CS  +  +I+ EY+  GSL   L +    K+L   Q +++   +A+ + YL +  +   
Sbjct: 69  VCSEEEPIYIVTEYMSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRNY--- 124

Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG------YVAPELAYTL 819
           +HRD++++N+L+       ++DFG+A+ +  D     E     G      + APE A   
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLARLIEDD-----EYTAREGAKFPIKWTAPEAANYG 179

Query: 820 KVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEMLDS--RLPYPSLHVQKK 876
           + T K DV+SFG+L  E++  G+ P          ++   +E ++   R+P P    +  
Sbjct: 180 RFTIKSDVWSFGILLTEIVTYGRVP------YPGMTNREVLEQVERGYRMPRPPNCPE-- 231

Query: 877 LMSIMQVAFSCLDQNPESRPT 897
              +  +   C D++PE RPT
Sbjct: 232 --ELYDLMLQCWDKDPEERPT 250

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  103 bits (260), Expect = 1e-24
 Identities = 70/268 (26%), Positives = 112/268 (41%), Gaps = 20/268 (7%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G  G V +    P+G+I AVK     +   +   Q++ L E+  L +     IV FY
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAI---QKQILRELDILHKCNSPYIVGFY 65

Query: 705 GFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP 764
           G   +     I  EY++ GSLDKIL        +       +   V   L YLH      
Sbjct: 66  GAFYNNGDISICMEYMDGGSLDKIL--KEVQGRIPERILGKIAVAVLKGLTYLHEKH--K 121

Query: 765 IVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEK 824
           I+HRD+   N+L++   +  + DFG++  L    +      GT  Y+APE       + K
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK--TFVGTSSYMAPERIQGNDYSVK 179

Query: 825 CDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVA 884
            D++S G+  +E+  G+ P        +   +   E+L   +  P   +     S     
Sbjct: 180 SDIWSLGLSLIELATGRFPYPP----ENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQD 235

Query: 885 F--SCLDQNPESRPTMKRVSQLLCEKIF 910
           F   CL ++P  RP+     + L E  F
Sbjct: 236 FVNLCLIKDPRERPSY----KELLEHPF 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score =  103 bits (257), Expect = 2e-24
 Identities = 77/262 (29%), Positives = 129/262 (49%), Gaps = 20/262 (7%)

Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           +G G  G V+  K  +    A+K  +    G MS  +E+F+ E + + ++ H  +V+ YG
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAINE---GAMS--EEDFIEEAKVMMKLSHPKLVQLYG 66

Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
            C+  K  +I+ E++E+G L   L       +L     L++ + V + + YL  N F   
Sbjct: 67  VCTQQKPLYIVTEFMENGCLLNYL--RQRQGKLSKDMLLSMCQDVCEGMEYLERNSF--- 121

Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAG-THGYVAPELAYTLKVTEK 824
           +HRD++++N L+       VSDFG+ +++  D    S  A     +  PE+    K + K
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181

Query: 825 CDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQV 883
            DV+SFGVL  EV  +GK P    FE  S+   + +     RL  P L      M++ +V
Sbjct: 182 SDVWSFGVLMWEVFTEGKMP----FEKKSNYEVVEMISRGFRLYRPKL----ASMTVYEV 233

Query: 884 AFSCLDQNPESRPTMKRVSQLL 905
            +SC  + PE RPT   + + +
Sbjct: 234 MYSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score =  103 bits (258), Expect = 2e-24
 Identities = 84/279 (30%), Positives = 137/279 (49%), Gaps = 38/279 (13%)

Query: 643 EHCIGKGGHGSVYRA--KVPSG-EIF-AVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHR 698
           E  IG G  G V R   K+P   EIF A+K   S   G    Q+ +FL+E   + +  H 
Sbjct: 9   EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKS---GYTEKQRRDFLSEASIMGQFDHP 65

Query: 699 NIVKFYGFCSHPKHSFIIYEYLESGSLDKIL-CNDASAKELGWTQRLNVIKGVADALFYL 757
           NI+   G  +  +   II E++E+G+LD  L  ND    +    Q + +++G+A  + YL
Sbjct: 66  NIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYL 122

Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG-----YVA 812
               +   VHRD++++N+L++      VSDFG+++FL  D+S+ +  +   G     + A
Sbjct: 123 SEMNY---VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTA 179

Query: 813 PELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDSRLPYP-- 869
           PE     K T   DV+S+G++  EV+  G+ P    ++MS+      IE  D RLP P  
Sbjct: 180 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERP---YWDMSNQDVINAIEQ-DYRLPPPMD 235

Query: 870 ---SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
              +LH         Q+   C  ++  +RP   ++   L
Sbjct: 236 CPTALH---------QLMLDCWQKDRNARPKFGQIVSTL 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score =  103 bits (257), Expect = 3e-24
 Identities = 66/227 (29%), Positives = 114/227 (50%), Gaps = 19/227 (8%)

Query: 677 EMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAK 736
           E S  ++EF+ E + + ++ H  +V+ YG C+  +  +I+ EY+ +G L   L      K
Sbjct: 38  EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYL--REHGK 95

Query: 737 ELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP 796
               +Q L + K V + + YL +  F   +HRD++++N L+D      VSDFG+++++  
Sbjct: 96  RFQPSQLLEMCKDVCEGMAYLESKQF---IHRDLAARNCLVDDQGCVKVSDFGLSRYVLD 152

Query: 797 DSSNWSELAGTHGYV---APELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSS 852
           D   ++   G+   V    PE+    K + K DV++FGVL  EV   GK P    +E  +
Sbjct: 153 DE--YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMP----YERFN 206

Query: 853 SSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMK 899
           +S  +       RL  P L  +K    +  + +SC  +  E RPT +
Sbjct: 207 NSETVEKVSQGLRLYRPHLASEK----VYAIMYSCWHEKAEERPTFQ 249

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  102 bits (257), Expect = 4e-24
 Identities = 75/260 (28%), Positives = 118/260 (45%), Gaps = 32/260 (12%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH---RNIV 701
           IG+G +G+VYR K VP+G + A+K  +   P        +   E+  L+++R     NI 
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTP---DDDVSDIQREVALLSQLRQSQPPNIT 65

Query: 702 KFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNC 761
           K+YG        +II EY E GS+  ++   A      +     +I+ V  AL Y+H   
Sbjct: 66  KYYGSYLKGPRLWIIMEYAEGGSVRTLM--KAGPIAEKYISV--IIREVLVALKYIHKV- 120

Query: 762 FPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKV 821
              ++HRDI + N+L+       + DFG+A  LN +SS  S   GT  ++APE+     +
Sbjct: 121 --GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEV-----I 173

Query: 822 TE------KCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQK 875
           TE      K D++S G+   E+  G  P        S        ML  +   P L    
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATGNPPY-------SDVDAFRAMMLIPKSKPPRLEDNG 226

Query: 876 KLMSIMQVAFSCLDQNPESR 895
               + +   +CLD+ P+ R
Sbjct: 227 YSKLLREFVAACLDEEPKER 246

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  101 bits (254), Expect = 8e-24
 Identities = 77/284 (27%), Positives = 122/284 (42%), Gaps = 28/284 (9%)

Query: 638 NDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFH-SPLPGEMSFQQEEFLNEIQALTEI 695
           +D+     IG G    VY A  +P+ E  A+K+         +    +E   E+QA+++ 
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSV----DELRKEVQAMSQC 56

Query: 696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALF 755
            H N+VK+Y         +++  YL  GSL  I+ +      L       V+K V   L 
Sbjct: 57  NHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLE 116

Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSE----LAGTHGYV 811
           YLH+N     +HRDI + N+LL       ++DFG++  L        +      GT  ++
Sbjct: 117 YLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWM 173

Query: 812 APELAYTLK-VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPS 870
           APE+   +     K D++SFG+ A+E+  G  P             M + ML  +   PS
Sbjct: 174 APEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP-------MKVLMLTLQNDPPS 226

Query: 871 LHVQKKLM----SIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF 910
           L           S  ++   CL ++P  RPT     +LL  K F
Sbjct: 227 LETGADYKKYSKSFRKMISLCLQKDPSKRPT---AEELLKHKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 99.8 bits (249), Expect = 3e-23
 Identities = 72/258 (27%), Positives = 124/258 (48%), Gaps = 27/258 (10%)

Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           +G G  G V+     +    AVK      PG M    ++FL E Q + ++RH  +++ Y 
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLK---PGTMD--PKDFLAEAQIMKKLRHPKLIQLYA 68

Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
            C+  +  +I+ E ++ GSL + L   A  + L   Q +++   VA  + YL    +   
Sbjct: 69  VCTLEEPIYIVTELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQNY--- 124

Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPELAYTLKVT 822
           +HRD++++NVL+       V+DFG+A+ +  D     E  G      + APE A   + +
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE--GAKFPIKWTAPEAALYNRFS 182

Query: 823 EKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDS--RLPYPSLHVQKKLMS 879
            K DV+SFG+L  E++  G+ P          ++   ++ +D   R+P P     K+L  
Sbjct: 183 IKSDVWSFGILLTEIVTYGRMP------YPGMTNAEVLQQVDQGYRMPCPP-GCPKELYD 235

Query: 880 IMQVAFSCLDQNPESRPT 897
           IM     C  ++P+ RPT
Sbjct: 236 IML---DCWKEDPDDRPT 250

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  100 bits (250), Expect = 3e-23
 Identities = 79/267 (29%), Positives = 131/267 (49%), Gaps = 34/267 (12%)

Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQ----EEFLNEIQALTEIRHRNI 700
           IG+G  G+VY A  V +G+  A++        +M+ QQ    E  +NEI  + E ++ NI
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIR--------QMNLQQQPKKELIINEILVMRENKNPNI 79

Query: 701 VKFYGFCSHPKHSFIIYEYLESGSLDKIL---CNDASAKELGWTQRLNVIKGVADALFYL 757
           V +          +++ EYL  GSL  ++   C D         Q   V +    AL +L
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG-------QIAAVCRECLQALEFL 132

Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAY 817
           H+N    ++HRDI S N+LL +     ++DFG    + P+ S  S + GT  ++APE+  
Sbjct: 133 HSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 189

Query: 818 TLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKL 877
                 K D++S G++A+E+I+G+ P  +L E     + +    L +    P L   +KL
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPP--YLNE-----NPLRALYLIATNGTPELQNPEKL 242

Query: 878 MSIMQVAFS-CLDQNPESRPTMKRVSQ 903
            +I +   + CLD + E R + K + Q
Sbjct: 243 SAIFRDFLNRCLDMDVEKRGSAKELLQ 269

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 99.2 bits (248), Expect = 6e-23
 Identities = 78/270 (28%), Positives = 121/270 (44%), Gaps = 23/270 (8%)

Query: 638 NDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
             F    CIGKG  G VY+A    + ++ A+K        E   + E+   EIQ L++ R
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLE---EAEDEIEDIQQEIQFLSQCR 57

Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGS-LDKILCNDASAKELGWTQRLNVIKGVADALF 755
              I K+YG        +II EY   GS LD +         + +     +++ V   L 
Sbjct: 58  SPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAF-----ILREVLLGLE 112

Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           YLH       +HRDI + N+LL    +  ++DFG++  L    S  +   GT  ++APE+
Sbjct: 113 YLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEV 169

Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQK 875
                  EK D++S G+ A+E+ KG+ P        S    M +  L  +   PSL   K
Sbjct: 170 IKQSGYDEKADIWSLGITAIELAKGEPPL-------SDLHPMRVLFLIPKNNPPSLEGNK 222

Query: 876 KLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
                      CL+++P+ RP+ K   +LL
Sbjct: 223 FSKPFKDFVSLCLNKDPKERPSAK---ELL 249

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 99.2 bits (247), Expect = 1e-22
 Identities = 65/206 (31%), Positives = 105/206 (50%), Gaps = 26/206 (12%)

Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQ----EEFLNEIQALTEIRHRNI 700
           IG+G  G+VY A  V +G+  A+K        +M+ QQ    E  +NEI  + E +H NI
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIK--------QMNLQQQPKKELIINEILVMRENKHPNI 78

Query: 701 VKFYGFCSHPKHSFIIYEYLESGSLDKIL---CNDASAKELGWTQRLNVIKGVADALFYL 757
           V +          +++ EYL  GSL  ++   C D         Q   V +    AL +L
Sbjct: 79  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG-------QIAAVCRECLQALEFL 131

Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAY 817
           H+N    ++HRDI S N+LL +     ++DFG    + P+ S  S + GT  ++APE+  
Sbjct: 132 HSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 188

Query: 818 TLKVTEKCDVYSFGVLALEVIKGKHP 843
                 K D++S G++A+E+++G+ P
Sbjct: 189 RKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 98.3 bits (245), Expect = 1e-22
 Identities = 73/283 (25%), Positives = 129/283 (45%), Gaps = 40/283 (14%)

Query: 646 IGKGGHGSVYRAKVPSG------EIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRN 699
           +G+G  G V+  +          E+ AVK        +    +++F  E + LT  +H N
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDA---RKDFEREAELLTNFQHEN 69

Query: 700 IVKFYGFCSHPKHSFIIYEYLESGSLDKIL-----------CNDASAKELGWTQRLNVIK 748
           IVKFYG C+      +++EY+E G L+K L             D+   EL  +Q L +  
Sbjct: 70  IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129

Query: 749 GVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH 808
            +A  + YL +  F   VHRD++++N L+       + DFG+++  +  ++++  + G  
Sbjct: 130 QIASGMVYLASQHF---VHRDLATRNCLVGYDLVVKIGDFGMSR--DVYTTDYYRVGGHT 184

Query: 809 ----GYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLD 863
                ++ PE     K T + DV+SFGV+  E+   GK P    + +S+      IE + 
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP---WYGLSNEEV---IECIT 238

Query: 864 S-RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
             RL         ++  IM     C  ++P+ R  +K + + L
Sbjct: 239 QGRLLQRPRTCPSEVYDIML---GCWKRDPQQRINIKDIHERL 278

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 96.0 bits (239), Expect = 5e-22
 Identities = 74/280 (26%), Positives = 123/280 (43%), Gaps = 43/280 (15%)

Query: 639 DFNAEHCIGKGGHGSVYRAKVPS-GEIFAVKKFHSPLPGEMSFQQ-EEFLNEIQALTEIR 696
           DF     +GKG +GSVY+ K  S  + +A+K+      G MS ++ E+ +NEI+ L  + 
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDL---GSMSQKEREDAVNEIRILASVN 57

Query: 697 HRNIVKFYGFCSHPKHSF-------IIYEYLESGSLDKILCNDASAK-----ELGWTQRL 744
           H NI+ +       K +F       I+ EY   G L K +      +     +  W   +
Sbjct: 58  HPNIISY-------KEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFI 110

Query: 745 NVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSEL 804
            +++G    L  LH      I+HRD+ S N+LL       + D GI+K L  + +     
Sbjct: 111 QLLRG----LQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK--TQ 161

Query: 805 AGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDS 864
            GT  Y+APE+      + K D++S G L  E+     P    FE + S  ++  ++   
Sbjct: 162 IGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPP----FE-ARSMQDLRYKVQRG 216

Query: 865 RLP-YPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ 903
           + P  P ++ Q     +     S L   P+ RP   ++  
Sbjct: 217 KYPPIPPIYSQ----DLQNFIRSMLQVKPKLRPNCDKILA 252

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 96.5 bits (240), Expect = 6e-22
 Identities = 74/282 (26%), Positives = 124/282 (43%), Gaps = 39/282 (13%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVK--KFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVK 702
           +G G   S Y+A+ V +G + AVK   +      E     E    EI+ +  + H +I++
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 703 FYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
             G      H  +  E++  GS+  +L    + KE      +N  + +   L YLH N  
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKE---AVIINYTEQLLRGLSYLHEN-- 122

Query: 763 PPIVHRDISSKNVLLD-LGYEAHVSDFGIAKFLNPDSSNWSE----LAGTHGYVAPELAY 817
             I+HRD+   N+L+D  G    ++DFG A  L    +   E    L GT  ++APE+  
Sbjct: 123 -QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR 181

Query: 818 TLKVTEKCDVYSFGVLALEVIKGKHPRD---------FLFEMSSSSSNMNIEMLDSRLPY 868
             +    CDV+S G + +E+   K P +          +F+++S+++  +I         
Sbjct: 182 GEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSI--------- 232

Query: 869 PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF 910
           P  H+   L     V   CL+  PE RP  +   +LL   +F
Sbjct: 233 PE-HLSPGLRD---VTLRCLELQPEDRPPSR---ELLKHPVF 267

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 96.7 bits (240), Expect = 6e-22
 Identities = 77/263 (29%), Positives = 131/263 (49%), Gaps = 26/263 (9%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           IG+G  G+V+ A  V +G+  A+K+ +     +   ++E  +NEI  + E+++ NIV F 
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINL----QKQPKKELIINEILVMKELKNPNIVNFL 82

Query: 705 GFCSHPKHSFIIYEYLESGSLDKIL---CNDASAKELGWTQRLNVIKGVADALFYLHNNC 761
                    F++ EYL  GSL  ++   C D +       Q   V +    AL +LH N 
Sbjct: 83  DSFLVGDELFVVMEYLAGGSLTDVVTETCMDEA-------QIAAVCRECLQALEFLHAN- 134

Query: 762 FPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKV 821
              ++HRDI S NVLL +     ++DFG    + P+ S  S + GT  ++APE+      
Sbjct: 135 --QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 192

Query: 822 TEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIM 881
             K D++S G++A+E+++G+ P  +L E     + +    L +    P L   +KL  I 
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPP--YLNE-----NPLRALYLIATNGTPELQNPEKLSPIF 245

Query: 882 QVAFS-CLDQNPESRPTMKRVSQ 903
           +   + CL+ + E R + K + Q
Sbjct: 246 RDFLNRCLEMDVEKRGSAKELLQ 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 94.8 bits (236), Expect = 1e-21
 Identities = 80/283 (28%), Positives = 120/283 (42%), Gaps = 64/283 (22%)

Query: 645 CIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
            IGKG  G V       G+  AVK        + S   + FL E   +T +RH N+V+  
Sbjct: 13  TIGKGEFGDVMLG-DYRGQKVAVKCLK-----DDSTAAQAFLAEASVMTTLRHPNLVQLL 66

Query: 705 GFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP 764
           G        +I+ EY+  GSL   L +   A  +   Q+L     V + + YL    F  
Sbjct: 67  GVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAV-ITLAQQLGFALDVCEGMEYLEEKNF-- 123

Query: 765 IVHRDISSKNVLLDLGYEAHVSDFGIAK--FLNPDSS----NWSELAGTHGYVAPELAYT 818
            VHRD++++NVL+     A VSDFG+AK      DS      W+         APE    
Sbjct: 124 -VHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT---------APEALRE 173

Query: 819 LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSL------- 871
            K + K DV+SFG+L  E+        + F                R+PYP +       
Sbjct: 174 KKFSTKSDVWSFGILLWEI--------YSF---------------GRVPYPRIPLKDVVP 210

Query: 872 HVQK--KLMS-------IMQVAFSCLDQNPESRPTMKRVSQLL 905
           HV+K  ++ +       + +V   C + +P  RPT K++ + L
Sbjct: 211 HVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQL 253

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 95.0 bits (236), Expect = 1e-21
 Identities = 78/275 (28%), Positives = 127/275 (46%), Gaps = 32/275 (11%)

Query: 643 EHCIGKGGHGSVY--RAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNI 700
           E  IG G  G V   R K+P      V    +   G    Q+ +FL+E   + +  H NI
Sbjct: 9   EKVIGAGEFGEVCSGRLKLPGKREIPVA-IKTLKAGYTEKQRRDFLSEASIMGQFDHPNI 67

Query: 701 VKFYGFCSHPKHSFIIYEYLESGSLDKIL-CNDASAKELGWTQRLNVIKGVADALFYLHN 759
           +   G  +  K   I+ EY+E+GSLD  L  +D    +    Q + +++G+A  + YL +
Sbjct: 68  IHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDG---QFTVIQLVGMLRGIASGMKYLSD 124

Query: 760 NCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPELA 816
             +   VHRD++++N+L++      VSDFG+++ L  D        G      + APE  
Sbjct: 125 MGY---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 181

Query: 817 YTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDSRLPYP-----S 870
              K T   DV+S+G++  EV+  G+ P    +EMS+      IE    RLP P     +
Sbjct: 182 AYRKFTSASDVWSYGIVMWEVMSYGERP---YWEMSNQDVIKAIEE-GYRLPAPMDCPAA 237

Query: 871 LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
           LH         Q+   C  ++   RP  +++  +L
Sbjct: 238 LH---------QLMLDCWQKDRNERPKFEQIVSIL 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 95.6 bits (238), Expect = 1e-21
 Identities = 69/269 (25%), Positives = 122/269 (45%), Gaps = 31/269 (11%)

Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           +G G  G VY+A+     +FA  K       E   + E+F+ EI  L+E +H NIV  Y 
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEE---ELEDFMVEIDILSECKHPNIVGLYE 69

Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
              +    +I+ E+ + G+LD I+      + L   Q   V + + +AL +LH++    +
Sbjct: 70  AYFYENKLWILIEFCDGGALDSIM--LELERGLTEPQIRYVCRQMLEALNFLHSH---KV 124

Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAY--TLKVTE 823
           +HRD+ + N+LL L  +  ++DFG++              GT  ++APE+    T K   
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNP 184

Query: 824 ---KCDVYSFGVLALEVIKGK------HPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQ 874
              K D++S G+  +E+ + +      +P   L ++  S            L  PS    
Sbjct: 185 YDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEP--------PTLDQPS-KWS 235

Query: 875 KKLMSIMQVAFSCLDQNPESRPTMKRVSQ 903
                 ++   SCL ++P+ RPT   + +
Sbjct: 236 SSFNDFLK---SCLVKDPDDRPTAAELLK 261

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 94.7 bits (235), Expect = 2e-21
 Identities = 76/269 (28%), Positives = 126/269 (46%), Gaps = 34/269 (12%)

Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           +G G  G V+          AVK      PG MS   E FL E Q + ++RH  +V+ Y 
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLK---PGTMS--PESFLEEAQIMKKLRHDKLVQLYA 68

Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
             S  +  +I+ EY+  GSL   L  D   + L     +++   VA  + Y+    +   
Sbjct: 69  VVSE-EPIYIVTEYMSKGSLLDFL-KDGEGRALKLPNLVDMAAQVAAGMAYIERMNY--- 123

Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPELAYTLKVT 822
           +HRD+ S N+L+  G    ++DFG+A+ +  + + ++   G      + APE A   + T
Sbjct: 124 IHRDLRSANILVGDGLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFT 181

Query: 823 EKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEMLDS-----RLPYPSLHVQKK 876
            K DV+SFG+L  E++ KG+ P   +          N E+L+      R+P P    Q  
Sbjct: 182 IKSDVWSFGILLTELVTKGRVPYPGM---------NNREVLEQVERGYRMPCP----QDC 228

Query: 877 LMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
            +S+ ++   C  ++PE RPT + +   L
Sbjct: 229 PISLHELMLQCWKKDPEERPTFEYLQSFL 257

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 94.8 bits (236), Expect = 3e-21
 Identities = 77/271 (28%), Positives = 111/271 (40%), Gaps = 33/271 (12%)

Query: 646 IGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G+G  GSV + ++  +G IFA  K  +  P     +Q   L E++     +   IVK+Y
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFA-LKTITTDPNPDLQKQ--ILRELEINKSCKSPYIVKYY 65

Query: 705 GFCSHPKHS--FIIYEYLESGSLDKIL------CNDASAKELGWTQRLNVIKGVADALFY 756
           G       S   I  EY E GSLD I             K LG      + + V   L Y
Sbjct: 66  GAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG-----KIAESVLKGLSY 120

Query: 757 LHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELA 816
           LH+     I+HRDI   N+LL    +  + DFG++  L   +S      GT  Y+APE  
Sbjct: 121 LHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELV--NSLAGTFTGTSFYMAPERI 175

Query: 817 YTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLD--SRLPYPSLHVQ 874
                +   DV+S G+  LEV + + P    F          IE+L     +P P L  +
Sbjct: 176 QGKPYSITSDVWSLGLTLLEVAQNRFP----FPPEGEPPLGPIELLSYIVNMPNPELKDE 231

Query: 875 KKLM-----SIMQVAFSCLDQNPESRPTMKR 900
                            CL+++P  RPT   
Sbjct: 232 PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWD 262

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 93.2 bits (231), Expect = 5e-21
 Identities = 75/269 (27%), Positives = 124/269 (46%), Gaps = 34/269 (12%)

Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           +G+G  G V+          A+K      PG MS   E FL E Q + ++RH  +V+ Y 
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMS--PEAFLQEAQVMKKLRHEKLVQLYA 68

Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
             S  +  +I+ EY+  GSL   L  +   K L   Q +++   +A  + Y+    +   
Sbjct: 69  VVSE-EPIYIVTEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERMNY--- 123

Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPELAYTLKVT 822
           VHRD+ + N+L+       V+DFG+A+ +  + + ++   G      + APE A   + T
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFT 181

Query: 823 EKCDVYSFGVLALEV-IKGKHPRDFLFEMSSSSSNMNIEMLDS-----RLPYPSLHVQKK 876
            K DV+SFG+L  E+  KG+ P   +         +N E+LD      R+P P     + 
Sbjct: 182 IKSDVWSFGILLTELTTKGRVPYPGM---------VNREVLDQVERGYRMPCPP----EC 228

Query: 877 LMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
             S+  +   C  + PE RPT + +   L
Sbjct: 229 PESLHDLMCQCWRKEPEERPTFEYLQAFL 257

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 93.3 bits (232), Expect = 5e-21
 Identities = 79/270 (29%), Positives = 121/270 (44%), Gaps = 34/270 (12%)

Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQE---EFLNEIQALTEIRHRNIV 701
           +G G  GSVY    +  G+ FAVK+    L  +    QE   +   EI  L++++H NIV
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKE--VSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65

Query: 702 KFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNC 761
           ++ G      + +I  E +  GSL K+L    S  E          + +   L YLH+  
Sbjct: 66  QYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPE---PVIRLYTRQILLGLEYLHDR- 121

Query: 762 FPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL-----A 816
               VHRDI   N+L+D      ++DFG+AK +   S   S   G+  ++APE+      
Sbjct: 122 --NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS-FKGSPYWMAPEVIAQQGG 178

Query: 817 YTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYP-SLHVQK 875
           Y L      D++S G   LE+  GK P   L  +++      I       P P  L  + 
Sbjct: 179 YGLAA----DIWSLGCTVLEMATGKPPWSQLEGVAAV---FKIGRSKELPPIPDHLSDEA 231

Query: 876 KLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
           K   I++    CL ++P  RPT    ++LL
Sbjct: 232 KDF-ILK----CLQRDPSLRPT---AAELL 253

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 93.6 bits (233), Expect = 7e-21
 Identities = 73/274 (26%), Positives = 119/274 (43%), Gaps = 35/274 (12%)

Query: 646 IGKGGHGSVYRAKVP-----SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNI 700
           +G+G  G V   +       +GE  AVK  +     +    + +F  EI+ L  + H NI
Sbjct: 12  LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQ---HRSDFEREIEILRTLDHENI 68

Query: 701 VKFYGFC--SHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLH 758
           VK+ G C     +   +I EYL SGSL   L       ++   + L     +   + YL 
Sbjct: 69  VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLG 126

Query: 759 NNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS----SNWSELAGTHGYVAPE 814
           +      +HRD++++N+L++      +SDFG+AK L  D           +    Y APE
Sbjct: 127 SQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APE 182

Query: 815 LAYTLKVTEKCDVYSFGVLALEVI----KGKHP-RDFLFEMSSSSSNMN----IEMLDS- 864
              T K +   DV+SFGV   E+       + P  +FL  +  +   M     +E+L   
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEG 242

Query: 865 -RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPT 897
            RLP P      ++  +M+    C +  P+ RP+
Sbjct: 243 ERLPRPP-SCPDEVYDLMK---LCWEAEPQDRPS 272

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 94.0 bits (233), Expect = 7e-21
 Identities = 63/206 (30%), Positives = 105/206 (50%), Gaps = 26/206 (12%)

Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQ----EEFLNEIQALTEIRHRNI 700
           IG+G  G+VY A  + +G+  A+K        +M+ QQ    E  +NEI  + E ++ NI
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIK--------QMNLQQQPKKELIINEILVMRENKNPNI 78

Query: 701 VKFYGFCSHPKHSFIIYEYLESGSLDKIL---CNDASAKELGWTQRLNVIKGVADALFYL 757
           V +          +++ EYL  GSL  ++   C D         Q   V +    AL +L
Sbjct: 79  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG-------QIAAVCRECLQALDFL 131

Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAY 817
           H+N    ++HRDI S N+LL +     ++DFG    + P+ S  S + GT  ++APE+  
Sbjct: 132 HSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 188

Query: 818 TLKVTEKCDVYSFGVLALEVIKGKHP 843
                 K D++S G++A+E+++G+ P
Sbjct: 189 RKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 92.2 bits (230), Expect = 8e-21
 Identities = 69/262 (26%), Positives = 116/262 (44%), Gaps = 39/262 (14%)

Query: 646 IGKGGHGSVYRA-KVPSGEIFAVK---KFHSPLPGEMSFQQEEF-LNEIQALTEIRHRNI 700
           +GKG  G V    K  +G+++A+K   K        +  ++ E  L E   L+ I H  I
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKK-----IIKRKEVEHTLTERNILSRINHPFI 55

Query: 701 VK-FYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVAD---ALFY 756
           VK  Y F +  +  +++ EY   G L   L  +    E    +        A+   AL Y
Sbjct: 56  VKLHYAFQT-EEKLYLVLEYAPGGELFSHLSKEGRFSE-ERARFY-----AAEIVLALEY 108

Query: 757 LHNNCFPPIVHRDISSKNVLLDLGYEAHV--SDFGIAK-FLNPDSSNWSELAGTHGYVAP 813
           LH+     I++RD+  +N+LLD   + H+  +DFG+AK   +  S   +   GT  Y+AP
Sbjct: 109 LHSL---GIIYRDLKPENILLD--ADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLAP 162

Query: 814 ELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHV 873
           E+       +  D +S GVL  E++ GK P    F  +     +  ++L   L +P   +
Sbjct: 163 EVLLGKGYGKAVDWWSLGVLLYEMLTGKPP----FY-AEDRKEIYEKILKDPLRFPE-FL 216

Query: 874 QKKLMSIMQVAFSCLDQNPESR 895
             +   ++      L ++P  R
Sbjct: 217 SPEARDLIS---GLLQKDPTKR 235

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 92.3 bits (229), Expect = 9e-21
 Identities = 73/267 (27%), Positives = 127/267 (47%), Gaps = 38/267 (14%)

Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           IG G  G V+          A+K       G MS  +E+F+ E Q + ++ H  +V+ YG
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIRE---GAMS--EEDFIEEAQVMMKLSHPKLVQLYG 66

Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDAS--AKELGWTQRLNVIKGVADALFYLHNNCFP 763
            C+      +++E++E G L   L       ++E      L+V +G+A    YL ++   
Sbjct: 67  VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMA----YLESSNV- 121

Query: 764 PIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG------YVAPELAY 817
             +HRD++++N L+       VSDFG+ +F+  D     +   + G      + +PE+  
Sbjct: 122 --IHRDLAARNCLVGENQVVKVSDFGMTRFVLDD-----QYTSSTGTKFPVKWSSPEVFS 174

Query: 818 TLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEMLDS--RLPYPSLHVQ 874
             K + K DV+SFGVL  EV  +GK P +      + S++  +E +++  RL  P L  Q
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVFSEGKTPYE------NRSNSEVVETINAGFRLYKPRLASQ 228

Query: 875 KKLMSIMQVAFSCLDQNPESRPTMKRV 901
               S+ ++   C  + PE RP+   +
Sbjct: 229 ----SVYELMQHCWKERPEDRPSFSLL 251

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 93.1 bits (231), Expect = 1e-20
 Identities = 81/287 (28%), Positives = 139/287 (48%), Gaps = 47/287 (16%)

Query: 646 IGKGGHGSVYRAKV----PSGE--IFAVKKFHSP-LPGEMSFQQEEFLNEIQALTEIRHR 698
           +G+G  G V+ A+     P+ +  + AVK    P L     FQ+E  L     LT ++H 
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL-----LTNLQHE 67

Query: 699 NIVKFYGFCSHPKHSFIIYEYLESGSLDKIL---CNDA----------SAKELGWTQRLN 745
           +IVKFYG C       +++EY++ G L+K L     DA          +  ELG +Q L+
Sbjct: 68  HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127

Query: 746 VIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELA 805
           +   +A  + YL +  F   VHRD++++N L+       + DFG+++  +  S+++  + 
Sbjct: 128 IASQIASGMVYLASQHF---VHRDLATRNCLVGANLLVKIGDFGMSR--DVYSTDYYRVG 182

Query: 806 GTH----GYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIE 860
           G       ++ PE     K T + DV+SFGV+  E+   GK P    F++S++     IE
Sbjct: 183 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP---WFQLSNT---EVIE 236

Query: 861 MLDSR--LPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
            +     L  P +   K++  IM     C  + P+ R  +K + ++L
Sbjct: 237 CITQGRVLERPRV-CPKEVYDIM---LGCWQREPQQRLNIKEIYKIL 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 92.9 bits (231), Expect = 2e-20
 Identities = 76/258 (29%), Positives = 130/258 (50%), Gaps = 26/258 (10%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQ-EEFLNEIQALTEIRHRNIVKF 703
           IG G  G+VY A+ V + E+ A+KK      G+ S ++ ++ + E++ L ++RH N +++
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMS--YSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80

Query: 704 YGFCSHPKHS-FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
            G C   +H+ +++ EY   GS   IL  +   K L   +   +  G    L YLH++  
Sbjct: 81  KG-CYLREHTAWLVMEYC-LGSASDIL--EVHKKPLQEVEIAAICHGALQGLAYLHSHE- 135

Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTL--- 819
              +HRDI + N+LL       ++DFG A  ++P +S      GT  ++APE+   +   
Sbjct: 136 --RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANS----FVGTPYWMAPEVILAMDEG 189

Query: 820 KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMS 879
           +   K DV+S G+  +E+ + K P   LF M++ S+  +I   DS    P+L        
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPP---LFNMNAMSALYHIAQNDS----PTLSSNDWSDY 242

Query: 880 IMQVAFSCLDQNPESRPT 897
                 SCL + P+ RP+
Sbjct: 243 FRNFVDSCLQKIPQDRPS 260

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 91.4 bits (227), Expect = 3e-20
 Identities = 79/273 (28%), Positives = 141/273 (51%), Gaps = 28/273 (10%)

Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSP--LPGEMSFQQEEFL----NEIQALTEIRHR 698
           IGKG +G VY A  V +GE+ AVK+   P  + G    +Q++ +    +EI+ L ++ H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 699 NIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE---LGWTQRLNVIKGVADALF 755
           NIV++ GF +  ++  I  EY+  GS+   L      +E     +T++  V++G+A    
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ--VLEGLA---- 122

Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELA--GTHGYVAP 813
           YLH+     I+HRD+ + N+L+D      +SDFGI+K  +    N   ++  G+  ++AP
Sbjct: 123 YLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP 179

Query: 814 EL--AYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSL 871
           E+  +Y+   + K D++S G + LE+  G+ P     +  + ++   +    S  P P  
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWS---DEEAIAAMFKLGNKRSAPPIPP- 235

Query: 872 HVQKKLMSI-MQVAFSCLDQNPESRPTMKRVSQ 903
            V   L  + +    +C   NP++RPT + + Q
Sbjct: 236 DVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 91.1 bits (226), Expect = 3e-20
 Identities = 77/293 (26%), Positives = 129/293 (44%), Gaps = 57/293 (19%)

Query: 639 DFNAEHCIGKGGHGSVYRAKVPS-GEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH 697
           D   +H +G G +G VY           AVK        E + + EEFL E   + EI+H
Sbjct: 7   DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKH 61

Query: 698 RNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYL 757
            N+V+  G C+     +II E++  G+L   L  + + +E+     L +   ++ A+ YL
Sbjct: 62  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYL 120

Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPE 814
               F   +HRD++++N L+   +   V+DFG+++ +  D+  ++  AG      + APE
Sbjct: 121 EKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE 175

Query: 815 -LAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSL-- 871
            LAY  K + K DV++FGVL  E+          + MS               PYP +  
Sbjct: 176 SLAYN-KFSIKSDVWAFGVLLWEIAT--------YGMS---------------PYPGIDL 211

Query: 872 -HVQKKL-------------MSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF 910
             V + L               + ++  +C   NP  RP+   + Q   E +F
Sbjct: 212 SQVYELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAF-ETMF 263

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 91.2 bits (226), Expect = 7e-20
 Identities = 72/259 (27%), Positives = 128/259 (49%), Gaps = 24/259 (9%)

Query: 644 HCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVK 702
           H IG G  G+VY A    + E+ AVKK  S    + + + ++ + E++ L +++H N ++
Sbjct: 27  HEIGHGSFGAVYFATNSHTNEVVAVKKM-SYSGKQTNEKWQDIIKEVKFLQQLKHPNTIE 85

Query: 703 FYGFCSHPKHS-FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNC 761
           + G C   +H+ +++ EY    + D +   +   K L   +   +  G    L YLH++ 
Sbjct: 86  YKG-CYLKEHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHSHN 141

Query: 762 FPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKV 821
              ++HRDI + N+LL    +  ++DFG A   +P +S      GT  ++APE+   +  
Sbjct: 142 ---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS----FVGTPYWMAPEVILAMDE 194

Query: 822 TE---KCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLM 878
            +   K DV+S G+  +E+ + K P   LF M++ S+  +I   DS    P+L   +   
Sbjct: 195 GQYDGKVDVWSLGITCIELAERKPP---LFNMNAMSALYHIAQNDS----PTLQSNEWTD 247

Query: 879 SIMQVAFSCLDQNPESRPT 897
           S       CL + P+ RP 
Sbjct: 248 SFRGFVDYCLQKIPQERPA 266

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 89.7 bits (222), Expect = 1e-19
 Identities = 71/269 (26%), Positives = 126/269 (46%), Gaps = 34/269 (12%)

Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           +G+G  G V+          A+K      PG M    E FL E Q + ++RH  +V  Y 
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLK---PGTMM--PEAFLQEAQIMKKLRHDKLVPLYA 68

Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
             S  +  +I+ E++  GSL   L  +   K L   Q +++   +AD + Y+    +   
Sbjct: 69  VVSE-EPIYIVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIADGMAYIERMNY--- 123

Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPELAYTLKVT 822
           +HRD+ + N+L+       ++DFG+A+ +  + + ++   G      + APE A   + T
Sbjct: 124 IHRDLRAANILVGDNLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFT 181

Query: 823 EKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEMLDS-----RLPYPSLHVQKK 876
            K DV+SFG+L  E++ KG+ P   +         +N E+L+      R+P P    Q  
Sbjct: 182 IKSDVWSFGILLTELVTKGRVPYPGM---------VNREVLEQVERGYRMPCP----QGC 228

Query: 877 LMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
             S+ ++   C  ++P+ RPT + +   L
Sbjct: 229 PESLHELMKLCWKKDPDERPTFEYIQSFL 257

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 88.9 bits (221), Expect = 2e-19
 Identities = 72/262 (27%), Positives = 119/262 (45%), Gaps = 37/262 (14%)

Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQ-------EEFLNEIQALTEIRH 697
           IGKG  G V    K  + ++FA+K         M+ Q+          LNE + L E+ H
Sbjct: 8   IGKGAFGKVCIVQKRDTKKMFAMK--------YMNKQKCVEKGSVRNVLNERRILQELNH 59

Query: 698 RNIVKF-YGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFY 756
             +V   Y F       +++ + L  G L   L       E     +  + + +  AL Y
Sbjct: 60  PFLVNLWYSFQDEEN-MYLVVDLLLGGDLRYHLSQKVKFSEE--QVKFWICE-IVLALEY 115

Query: 757 LHNNCFPPIVHRDISSKNVLLD-LGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           LH+     I+HRDI   N+LLD  G+  H++DF IA  + PD+   +  +GT GY+APE+
Sbjct: 116 LHSK---GIIHRDIKPDNILLDEQGH-VHITDFNIATKVTPDTLT-TSTSGTPGYMAPEV 170

Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIE--MLDSRLPYPSLHV 873
                 +   D +S GV A E ++GK P    +   S +    I      + + YP+   
Sbjct: 171 LCRQGYSVAVDWWSLGVTAYECLRGKRP----YRGHSRTIRDQIRAKQETADVLYPATWS 226

Query: 874 QKKLMSIMQVAFSCLDQNPESR 895
            + + +I ++    L+++P+ R
Sbjct: 227 TEAIDAINKL----LERDPQKR 244

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 88.9 bits (220), Expect = 2e-19
 Identities = 78/275 (28%), Positives = 124/275 (45%), Gaps = 32/275 (11%)

Query: 638 NDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
           +D+     +G G +G VY+A  + +GE+ AVK        + S  Q+E    I  + E +
Sbjct: 9   HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQE----IFMVKECK 64

Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFY 756
           H NIV ++G     +  +I  EY   GSL  I        EL   Q   V +     L Y
Sbjct: 65  HCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSEL---QIAYVCRETLQGLAY 121

Query: 757 LHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELA 816
           LH+      +HRDI   N+LL    +  ++DFG+A  +    +      GT  ++APE+A
Sbjct: 122 LHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVA 178

Query: 817 YTLK---VTEKCDVYSFGVLALEVIKGK------HPRDFLFEMSSSSSNMNIEMLDSRLP 867
              K     + CD+++ G+ A+E+ + +      HP   LF M  S SN     L  +  
Sbjct: 179 AVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM--SKSNFQPPKLKDKTK 236

Query: 868 Y-PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
           +  + H   K+          L +NP+ RPT +R+
Sbjct: 237 WSSTFHNFVKI---------SLTKNPKKRPTAERL 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 88.2 bits (218), Expect = 3e-19
 Identities = 72/262 (27%), Positives = 119/262 (45%), Gaps = 19/262 (7%)

Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           +G G  G V+     +    AVK      PG MS Q   FL E   +  ++H  +V+ Y 
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLK---PGTMSVQA--FLEEANLMKTLQHDKLVRLYA 68

Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
             +  +  +II EY+  GSL   L +D   K L   + ++    +A+ + Y+    +   
Sbjct: 69  VVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIERKNY--- 124

Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH-GYVAPELAYTLKVTEK 824
           +HRD+ + NVL+       ++DFG+A+ +  +     E A     + APE       T K
Sbjct: 125 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 184

Query: 825 CDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQV 883
            DV+SFG+L  E++  GK P    +   S+S  M+      R+P    +   +L  IM+ 
Sbjct: 185 SDVWSFGILLYEIVTYGKIP----YPGMSNSDVMSALQRGYRMPRME-NCPDELYDIMK- 238

Query: 884 AFSCLDQNPESRPTMKRVSQLL 905
             +C  +  E RPT   +  +L
Sbjct: 239 --TCWKEKAEERPTFDYLQSVL 258

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 88.2 bits (218), Expect = 7e-19
 Identities = 72/258 (27%), Positives = 127/258 (49%), Gaps = 26/258 (10%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQ-EEFLNEIQALTEIRHRNIVKF 703
           IG G  G+VY A+ V + E+ A+KK      G+ S ++ ++ + E++ L ++RH N +++
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKM--SYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80

Query: 704 YGFCSHPKHS-FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
            G C   +H+ +++ EY    + D +   +   K L   +   V  G    L YLH++  
Sbjct: 81  RG-CYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHSH-- 134

Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVT 822
             ++HRD+ + N+LL       + DFG A  + P +       GT  ++APE+   +   
Sbjct: 135 -NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX----FVGTPYWMAPEVILAMDEG 189

Query: 823 E---KCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMS 879
           +   K DV+S G+  +E+ + K P   LF M++ S+  +I   +S    P+L        
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPP---LFNMNAMSALYHIAQNES----PALQSGHWSEY 242

Query: 880 IMQVAFSCLDQNPESRPT 897
                 SCL + P+ RPT
Sbjct: 243 FRNFVDSCLQKIPQDRPT 260

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 87.4 bits (217), Expect = 9e-19
 Identities = 69/295 (23%), Positives = 128/295 (43%), Gaps = 48/295 (16%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEF----LNEIQALTEIRHRNI 700
           IG+G +G VY+A+   +GEI A+KK       ++ F+ E      L EI+ L E+ H NI
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKI------KLRFESEGIPKTALREIKLLKELNHPNI 60

Query: 701 VKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
           +K      H    ++++E++++  L K++      + L  +   + +  +   L + H++
Sbjct: 61  IKLLDVFRHKGDLYLVFEFMDT-DLYKLI--KDRQRGLPESLIKSYLYQLLQGLAFCHSH 117

Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLK 820
               I+HRD+  +N+L++      ++DFG+A+        ++    T  Y APEL    K
Sbjct: 118 ---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDK 174

Query: 821 V-TEKCDVYSFGVLALEVIK------GKHPRDFLF---------------EMSSSSSNMN 858
             +   D++S G +  E++       GK   D LF               + +S + N  
Sbjct: 175 GYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234

Query: 859 IEMLD-SRLPYPSL--HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF 910
                 + +P P L  +   + + ++      L  +P  R T     Q L    F
Sbjct: 235 FSFPKKAGMPLPKLFPNASPQALDLLS---QMLHYDPHKRIT---AEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 86.9 bits (216), Expect = 9e-19
 Identities = 75/286 (26%), Positives = 117/286 (40%), Gaps = 42/286 (14%)

Query: 636 ATNDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTE 694
            T  F     IG+G +G VY+A+   +G++ A+K         +  ++EE   E   L +
Sbjct: 4   PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDI-----IEDEEEEIKEEYNILRK 58

Query: 695 I-RHRNIVKFYGFCSHPKHS------FIIYEYLESGSLDKILCNDASAKELGWTQRLN-- 745
              H NI  FYG              +++ E    GS+      D         +RL   
Sbjct: 59  YSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSV-----TDLVKGLRKKGKRLKEE 113

Query: 746 ----VIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNW 801
               +++     L YLH N    ++HRDI  +N+LL    E  + DFG++  L+      
Sbjct: 114 WIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRR 170

Query: 802 SELAGTHGYVAPEL-----AYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSN 856
           +   GT  ++APE+             + DV+S G+ A+E+  GK P   L +M      
Sbjct: 171 NTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP---LCDMHP---- 223

Query: 857 MNIEMLDSRLPYPSLHVQKKLMSIMQVAF--SCLDQNPESRPTMKR 900
           M       R P P+L    +  S     F   CL +N E RP M+ 
Sbjct: 224 MRALFKIPRNPPPTLK-SPENWSKKFNDFISECLIKNYEQRPFMEE 268

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 87.4 bits (216), Expect = 1e-18
 Identities = 60/201 (29%), Positives = 100/201 (49%), Gaps = 16/201 (7%)

Query: 646 IGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQ--EEFLNEIQALTEIRHRNIVK 702
           IG+G  G V  A+   SG   AVK        ++  QQ  E   NE+  + + +H+N+V+
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMM------DLRKQQRRELLFNEVVIMRDYQHQNVVE 82

Query: 703 FYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
            Y      +  +++ E+L+ G+L  I+    S   L   Q   V + V  AL YLH+   
Sbjct: 83  MYKSYLVGEELWVLMEFLQGGALTDIV----SQTRLNEEQIATVCESVLQALCYLHSQ-- 136

Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVT 822
             ++HRDI S ++LL L     +SDFG    ++ D      L GT  ++APE+       
Sbjct: 137 -GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYG 195

Query: 823 EKCDVYSFGVLALEVIKGKHP 843
            + D++S G++ +E++ G+ P
Sbjct: 196 TEVDIWSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 87.0 bits (215), Expect = 1e-18
 Identities = 70/257 (27%), Positives = 115/257 (44%), Gaps = 19/257 (7%)

Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           IGKG  G V++     + ++ A+K        E   + E+   EI  L++     + K+Y
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLE---EAEDEIEDIQQEITVLSQCDSPYVTKYY 68

Query: 705 GFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP 764
           G        +II EYL  GS   +L     A      Q   ++K +   L YLH+     
Sbjct: 69  GSYLKGTKLWIIMEYLGGGSALDLL----RAGPFDEFQIATMLKEILKGLDYLHSE---K 121

Query: 765 IVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEK 824
            +HRDI + NVLL    +  ++DFG+A  L       +   GT  ++APE+        K
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSK 181

Query: 825 CDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVA 884
            D++S G+ A+E+ KG+ P       +S    M +  L  +   P+L   +      +  
Sbjct: 182 ADIWSLGITAIELAKGEPP-------NSDMHPMRVLFLIPKNNPPTL-TGEFSKPFKEFI 233

Query: 885 FSCLDQNPESRPTMKRV 901
            +CL+++P  RPT K +
Sbjct: 234 DACLNKDPSFRPTAKEL 250

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 86.6 bits (214), Expect = 1e-18
 Identities = 80/279 (28%), Positives = 128/279 (45%), Gaps = 38/279 (13%)

Query: 639 DFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGE--MSFQQEEFLNEIQALTEI 695
           DF     IG G +G VY+A+ V +GE+ A+K      PGE     QQE     I  + + 
Sbjct: 10  DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE-PGEDFAVVQQE-----IIMMKDC 63

Query: 696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALF 755
           +H NIV ++G        +I  E+   GSL  I        E    Q   V +     L+
Sbjct: 64  KHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSES---QIAYVSRETLQGLY 120

Query: 756 YLHNNCFPPIVHRDISSKNVLL-DLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPE 814
           YLH+      +HRDI   N+LL D G+   ++DFG++  +    +      GT  ++APE
Sbjct: 121 YLHSK---GKMHRDIKGANILLTDNGH-VKLADFGVSAQITATIAKRKSFIGTPYWMAPE 176

Query: 815 LAYTLK---VTEKCDVYSFGVLALEVIKGK------HPRDFLFEMSSSSSNMNIEMLDSR 865
           +A   +     + CD+++ G+ A+E+ + +      HP   LF M  + SN     L  +
Sbjct: 177 VAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM--TKSNFQPPKLKDK 234

Query: 866 LPYP-SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ 903
           + +  S H   K+          L +NP+ RPT +++ Q
Sbjct: 235 MKWSNSFHHFVKM---------ALTKNPKKRPTAEKLLQ 264

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 85.6 bits (212), Expect = 2e-18
 Identities = 60/205 (29%), Positives = 93/205 (45%), Gaps = 13/205 (6%)

Query: 645 CIGKGGHGSVYRA-KVPSGEIFAVKKFH-SPLPGEMSFQQEEFLNEIQALTEIRHRNIVK 702
            +G+G  G VY    V +G   AVK+    P   E   +      EIQ L  ++H  IV+
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 703 FYGFCSHPKHSFIIYEYLESGSL-DKILCNDASAKELGWTQRLNVIKGVADALFYLHNNC 761
           +YG     +   I  EY+  GS+ D++    A  + +       +++GV     YLH+N 
Sbjct: 69  YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGV----EYLHSN- 123

Query: 762 FPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP---DSSNWSELAGTHGYVAPELAYT 818
              IVHRDI   N+L D      + DFG +K L       +    + GT  +++PE+   
Sbjct: 124 --MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISG 181

Query: 819 LKVTEKCDVYSFGVLALEVIKGKHP 843
                K DV+S G   +E++  K P
Sbjct: 182 EGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 86.0 bits (213), Expect = 3e-18
 Identities = 79/271 (29%), Positives = 125/271 (46%), Gaps = 29/271 (10%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G  GSV + K +P+G + A K  H      +   +++ L E+Q + E R   IV FY
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSV---RKQILRELQIMHECRSPYIVSFY 69

Query: 705 GFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADA----LFYLHNN 760
           G   +  +  +  E+++ GSLD+I       K+ G    + ++  +A A    L YL+N 
Sbjct: 70  GAFLNENNICMCMEFMDCGSLDRIY------KKGG-PIPVEILGKIAVAVVEGLTYLYNV 122

Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIA-KFLNPDSSNWSELAGTHGYVAPELAYTL 819
               I+HRDI   N+L++   +  + DFG++ + +N   S      GT  Y++PE     
Sbjct: 123 --HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN---SIADTFVGTSTYMSPERIQGG 177

Query: 820 KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMS-SSSSNMNIEMLDSRL---PYPSLHVQK 875
           K T K DV+S G+  +E+  GK P  F           M I  L  ++   P P L    
Sbjct: 178 KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSD 237

Query: 876 KLMSIMQVAFSCLDQNPESRPTMKRVSQLLC 906
               +     +CL ++P  RPT     Q LC
Sbjct: 238 FPEDLRDFVDACLLKDPTERPT----PQQLC 264

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 85.4 bits (212), Expect = 3e-18
 Identities = 76/289 (26%), Positives = 124/289 (42%), Gaps = 51/289 (17%)

Query: 646 IGKGGHGSVYRAKVPS-GEIFAVK--KFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVK 702
           I KG +G V+ AK  S G+I+A+K  K    +  +    Q   L E   L++ +   +VK
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKAD-MIRKNQVDQ--VLTERDILSQAQSPYVVK 57

Query: 703 FYGFCSHPKHSFIIYEYLESGSLDKILCN-----DASAKELGWTQRLNVIKGVADALFYL 757
            Y      K+ +++ EYL  G L  +L N     +  A+          I  +  AL YL
Sbjct: 58  LYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVAR--------IYIAEIVLALEYL 109

Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHV--SDFGIAKF--------LNPDSSNWSELAGT 807
           H+N    I+HRD+   N+L+D     H+  +DFG++K         LN D      + GT
Sbjct: 110 HSN---GIIHRDLKPDNILID--SNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGT 164

Query: 808 HGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSN-MNIEMLDSRL 866
             Y+APE+      ++  D +S G +  E + G  P    F   +      NI  L+ ++
Sbjct: 165 PDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPP----FHGETPEEIFQNI--LNGKI 218

Query: 867 PYPS----LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
            +P           L+S +      L  +PE R   K + ++     F+
Sbjct: 219 EWPEDVEVSDEAIDLISKL------LVPDPEKRLGAKSIEEIKNHPFFK 261

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 86.0 bits (213), Expect = 3e-18
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 20/203 (9%)

Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQ--EEFLNEIQALTEIRHRNIVK 702
           IG+G  G V  A    +G   AVKK       ++  QQ  E   NE+  + + +H NIV+
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKM------DLRKQQRRELLFNEVVIMRDYQHPNIVE 80

Query: 703 FYGFCSH--PKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
            Y   S+      +++ E+LE G+L  I+    +   +   Q   V   V  AL +LH  
Sbjct: 81  MYS--SYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIATVCLAVLKALSFLHAQ 134

Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLK 820
               ++HRDI S ++LL       +SDFG    ++ +      L GT  ++APE+   L 
Sbjct: 135 ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLP 191

Query: 821 VTEKCDVYSFGVLALEVIKGKHP 843
              + D++S G++ +E++ G+ P
Sbjct: 192 YGTEVDIWSLGIMVIEMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 86.3 bits (213), Expect = 3e-18
 Identities = 71/257 (27%), Positives = 127/257 (49%), Gaps = 24/257 (9%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQ-EEFLNEIQALTEIRHRNIVKF 703
           IG G  G+VY A+ V + E+ A+KK      G+ S ++ ++ + E++ L  I+H N +++
Sbjct: 33  IGHGSFGAVYFARDVRTNEVVAIKKM--SYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90

Query: 704 YGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFP 763
            G       ++++ EY    + D +   +   K L   +   +  G    L YLH++   
Sbjct: 91  KGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHSH--- 144

Query: 764 PIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTE 823
            ++HRDI + N+LL    +  ++DFG A   +P +S      GT  ++APE+   +   +
Sbjct: 145 NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS----FVGTPYWMAPEVILAMDEGQ 200

Query: 824 ---KCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSI 880
              K DV+S G+  +E+ + K P   LF M++ S+  +I   +S    P+L   +     
Sbjct: 201 YDGKVDVWSLGITCIELAERKPP---LFNMNAMSALYHIAQNES----PTLQSNEWSDYF 253

Query: 881 MQVAFSCLDQNPESRPT 897
                SCL + P+ RPT
Sbjct: 254 RNFVDSCLQKIPQDRPT 270

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 85.2 bits (211), Expect = 4e-18
 Identities = 72/278 (25%), Positives = 120/278 (43%), Gaps = 31/278 (11%)

Query: 646 IGKGGHGSVYRAKVPSGE------IFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRN 699
           +G+G  G V+ AK    E      +  VK        +    Q EF  E+    ++ H+N
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT---KDENLQSEFRRELDMFRKLSHKN 69

Query: 700 IVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE------LGWTQRLNVIKGVADA 753
           +V+  G C   +  ++I EY + G L + L    S  E      L   Q++ +   +A  
Sbjct: 70  VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129

Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG---Y 810
           + +L N  F   VHRD++++N L+    E  VS   ++K  +  +S + +L        +
Sbjct: 130 MDHLSNARF---VHRDLAARNCLVSSQREVKVSLLSLSK--DVYNSEYYKLRNALIPLRW 184

Query: 811 VAPELAYTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEMLDSRLPYP 869
           +APE       + K DV+SFGVL  EV  +G+ P    + +S       ++     LP P
Sbjct: 185 LAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELP---FYGLSDEEVLNRLQAGKLELPVP 241

Query: 870 SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCE 907
                 +L  +M     C   NP+ RP+   +   L E
Sbjct: 242 E-GCPSRLYKLMT---RCWAVNPKDRPSFSELVSALGE 275

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 85.4 bits (212), Expect = 4e-18
 Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 25/205 (12%)

Query: 646 IGKGGHGSVYRAKV-PSGEIFAVKKFHSP-LPGEMSFQQEEFLNEIQALTEIRHRNIVKF 703
           IG+G HG V++AK   +GE  A+KK     L G +     + L EI+AL   +H  +VK 
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGI---PNQALREIKALQACQHPYVVKL 64

Query: 704 YGFCSHPKHSFIIYEYLESGSLDKILCN------DASAKELGWTQRLNVIKGVADALFYL 757
                H     ++ EY+ S  L ++L +      +A  K   + + L  +KGVA    Y+
Sbjct: 65  LDVFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVK--SYMRML--LKGVA----YM 115

Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN-WSELAGTHGYVAPELA 816
           H N    I+HRD+   N+L+       ++DFG+A+  + +    +S    T  Y APEL 
Sbjct: 116 HAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELL 172

Query: 817 Y-TLKVTEKCDVYSFGVLALEVIKG 840
           Y   K     D+++ G +  E++ G
Sbjct: 173 YGARKYDPGVDLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 84.4 bits (209), Expect = 5e-18
 Identities = 59/220 (26%), Positives = 102/220 (46%), Gaps = 20/220 (9%)

Query: 686 LNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSL-DKILCNDA---SAKELGWT 741
           LNEI  L+ ++H NI+ +Y          I  EY   G+L DKI+         + + W 
Sbjct: 47  LNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW- 105

Query: 742 QRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNW 801
                +  +  A+ Y+H      I+HRDI + N+ L       + DFGI+K L  + S  
Sbjct: 106 ----YLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA 158

Query: 802 SELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEM 861
             + GT  Y++PEL   +K   K D+++ G +  E++  K      F+ ++  + +   +
Sbjct: 159 ETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKR----TFDATNPLNLVVKIV 214

Query: 862 LDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
             +  P  S++  +    ++ +  S L Q+PE RPT   V
Sbjct: 215 QGNYTPVVSVYSSE----LISLVHSLLQQDPEKRPTADEV 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 85.1 bits (210), Expect = 5e-18
 Identities = 61/201 (30%), Positives = 100/201 (49%), Gaps = 16/201 (7%)

Query: 646 IGKGGHGSVYRAKV-PSGEIFAVKKFHSPLPGEMSFQQ--EEFLNEIQALTEIRHRNIVK 702
           IG+G  G V  A V  SG++ AVKK       ++  QQ  E   NE+  + + +H N+V+
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKM------DLRKQQRRELLFNEVVIMRDYQHENVVE 81

Query: 703 FYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
            Y         +++ E+LE G+L  I+ +    +E      L V+K    AL  LH    
Sbjct: 82  MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLK----ALSVLHAQ-- 135

Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVT 822
             ++HRDI S ++LL       +SDFG    ++ +      L GT  ++APEL   L   
Sbjct: 136 -GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYG 194

Query: 823 EKCDVYSFGVLALEVIKGKHP 843
            + D++S G++ +E++ G+ P
Sbjct: 195 PEVDIWSLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 84.8 bits (211), Expect = 5e-18
 Identities = 56/209 (26%), Positives = 100/209 (47%), Gaps = 30/209 (14%)

Query: 645 CIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEF----LNEIQALTEIRHRN 699
            +G+G +G VY+A+   +GEI A+KK        +  ++E      L EI  L E++H N
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKIR------LDNEEEGIPSTALREISLLKELKHPN 59

Query: 700 IVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRL--NVIKGVADALFYL 757
           IVK        +  ++++EY +   L K L            + +   +++G+A    Y 
Sbjct: 60  IVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLA----YC 114

Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL-- 815
           H++    I+HRD+  +N+L++      ++DFG+A+        ++    T  Y APE+  
Sbjct: 115 HSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILL 171

Query: 816 ---AYTLKVTEKCDVYSFGVLALEVIKGK 841
               Y+  V    D++S G +  E+I GK
Sbjct: 172 GSKHYSTAV----DIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 85.1 bits (210), Expect = 7e-18
 Identities = 87/294 (29%), Positives = 129/294 (43%), Gaps = 42/294 (14%)

Query: 631 EEIISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQ 690
           E +   T+ +     IGKG +G VY+         A  K   P+  ++  + E   N +Q
Sbjct: 15  ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI-SDVDEEIEAEYNILQ 73

Query: 691 ALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKIL--CNDASAKEL-----GWTQR 743
           +L    H N+VKFYG        F   + L  G L  +L  CN  S  EL        QR
Sbjct: 74  SLPN--HPNVVKFYGM-------FYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR 124

Query: 744 LN------VIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPD 797
           L+      ++ G    L +LHNN    I+HRD+   N+LL       + DFG++  L   
Sbjct: 125 LDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 181

Query: 798 SSNWSELAGTHGYVAPEL-----AYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS 852
               +   GT  ++APE+      Y      +CDV+S G+ A+E+  G  P   LF+M  
Sbjct: 182 RLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPP---LFDMHP 238

Query: 853 SSSNMNIEMLDSRLPYPSL-HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
             +   I     R P P+L H +K   S       CL ++ E+RP+   V+ LL
Sbjct: 239 VKTLFKI----PRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPS---VTHLL 285

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 84.3 bits (208), Expect = 9e-18
 Identities = 72/287 (25%), Positives = 136/287 (47%), Gaps = 48/287 (16%)

Query: 646 IGKGGHGSVYRAK----VPSGE--IFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRN 699
           +G+G  G V+ A+    +P  +  + AVK     L       +++F  E + LT ++H++
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKA----LKEASESARQDFQREAELLTVLQHQH 68

Query: 700 IVKFYGFCSHPKHSFIIYEYLESGSLDKIL------------CNDASAKELGWTQRLNVI 747
           IV+FYG C+  +   +++EY+  G L++ L              D +  +L   Q L + 
Sbjct: 69  IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128

Query: 748 KGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGT 807
             +A  + YL +  F   VHRD++++N L+  G    + DFG+++ +   S+++  + G 
Sbjct: 129 SQIASGMVYLASLHF---VHRDLATRNCLVGQGLVVKIGDFGMSRDIY--STDYYRVGGR 183

Query: 808 H----GYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNI--- 859
                 ++ PE     K T + D++SFGV+  E+   GK P    +++S++ +   I   
Sbjct: 184 TMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP---WYQLSNTEAIECITQG 240

Query: 860 -EMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
            E+   R   P ++       IMQ    C  + P+ R  +K +   L
Sbjct: 241 RELERPRTCPPEVYA------IMQ---GCWQREPQQRMVIKDIHSRL 278

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 83.8 bits (207), Expect = 1e-17
 Identities = 78/270 (28%), Positives = 116/270 (42%), Gaps = 40/270 (14%)

Query: 646 IGKGGHGSVYRAKVPSGEIFAVKK--FHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKF 703
           +GKG +G+VY      G++ AVK+    +        + E+   E+  L  ++H NIV++
Sbjct: 8   LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67

Query: 704 YGFCSHPKHSFIIYEYLESGSLDKILCNDASAKEL---GWTQRLNVIKGVADALFYLHNN 760
            G C       I  E++  GS+  IL       E     +T++  ++ GVA    YLHNN
Sbjct: 68  LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQ--ILDGVA----YLHNN 121

Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG----------- 809
           C   +VHRDI   NV+L       + DFG A+ L      W  L GTH            
Sbjct: 122 C---VVHRDIKGNNVMLMPNGIIKLIDFGCARRL-----AWVGLHGTHSNMLKSMHGTPY 173

Query: 810 YVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYP 869
           ++APE+        K D++S G    E+  GK P   L  M   ++   I     R   P
Sbjct: 174 WMAPEVINESGYGRKSDIWSIGCTVFEMATGKPP---LASMDRLAAMFYIG--AHRGLMP 228

Query: 870 SLHVQKKLMSIMQVAF--SCLDQNPESRPT 897
            L       S   + F  SCL ++   RP+
Sbjct: 229 RL---PDSFSAAAIDFVTSCLTRDQHERPS 255

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 84.0 bits (208), Expect = 1e-17
 Identities = 76/303 (25%), Positives = 140/303 (46%), Gaps = 52/303 (17%)

Query: 632 EIISATNDFNAEHCIGKGGHGSVYRAKV--PSGE-------IFAVKKFHSPLPGEMSFQQ 682
           EI  +   F  E  +G+G  G VY+ ++  P+         I  +K+   P        Q
Sbjct: 1   EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPK------VQ 52

Query: 683 EEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQ 742
           +EF  E + +++++H NIV   G C+  + + +++EYL  G L + L  ++   ++G   
Sbjct: 53  QEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAES 112

Query: 743 R-------------LNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFG 789
                         L++   +A  + YL ++ F   VHRD++++N L+  G    +SDFG
Sbjct: 113 GDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHF---VHRDLAARNCLVGEGLTVKISDFG 169

Query: 790 IAKFLNPDSSNWSELAGTH----GYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPR 844
           +++ +   S+++  +         ++ PE     K T + D++SFGV+  E+   G  P 
Sbjct: 170 LSRDIY--SADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPY 227

Query: 845 DFLFEMSSSSSNMNIEMLDSR--LPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVS 902
            + F     S+   IEM+ SR  LP P      ++ ++M     C ++ P  RP  K + 
Sbjct: 228 -YGF-----SNQEVIEMIRSRQLLPCPE-DCPARVYALMI---ECWNEIPARRPRFKDIH 277

Query: 903 QLL 905
             L
Sbjct: 278 TRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 83.6 bits (206), Expect = 1e-17
 Identities = 73/259 (28%), Positives = 117/259 (45%), Gaps = 23/259 (8%)

Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           IGKG  G V++     + ++ A+K        E   + E+   EI  L++     + K+Y
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLE---EAEDEIEDIQQEITVLSQCDSPYVTKYY 68

Query: 705 GFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP 764
           G        +II EYL  GS   +L        L  TQ   +++ +   L YLH+     
Sbjct: 69  GSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSE---K 121

Query: 765 IVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEK 824
            +HRDI + NVLL    E  ++DFG+A  L       +   GT  ++APE+        K
Sbjct: 122 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK 181

Query: 825 CDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSL--HVQKKLMSIMQ 882
            D++S G+ A+E+ KG+ P        S    M +  L  +   P+L  +  K L   ++
Sbjct: 182 ADIWSLGITAIELAKGEPPH-------SELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVE 234

Query: 883 VAFSCLDQNPESRPTMKRV 901
              +CL++ P  RPT K +
Sbjct: 235 ---ACLNKEPSFRPTAKEL 250

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 83.7 bits (208), Expect = 1e-17
 Identities = 63/214 (29%), Positives = 112/214 (52%), Gaps = 39/214 (18%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEF----LNEIQALTEIRHRNI 700
           IG+G +G VY+A+   +GE+ A+KK        M  ++E F    + EI+ L ++RH NI
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKI------RMENEKEGFPITAIREIKLLQKLRHPNI 60

Query: 701 VKFYGFC-SHPKHS-FIIYEYLE---SGSLD--KILCNDASAKELGWTQRLNVIKGVADA 753
           V+      S  K S ++++EY++   +G LD  ++   ++  K   + ++L  ++G+   
Sbjct: 61  VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIK--CYMKQL--LEGLQ-- 114

Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSS-NWSELAGTHGYVA 812
             YLH+N    I+HRDI   N+L++      ++DFG+A+     +S +++    T  Y  
Sbjct: 115 --YLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRP 169

Query: 813 PEL-----AYTLKVTEKCDVYSFGVLALEVIKGK 841
           PEL      Y  +V    D++S G +  E+  GK
Sbjct: 170 PELLLGATRYGPEV----DMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 86.8 bits (215), Expect = 2e-17
 Identities = 54/148 (36%), Positives = 74/148 (50%), Gaps = 11/148 (7%)

Query: 114 LDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSI 173
           L L N  L G IP  IS L +L+ ++ S N + G IP  +G +T L VL +S N  +GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 174 PHEVGQLTVLNQLALDSNFLNGSIPRSLGN-LTHVVILYLYNNSFFGSIPQEIGNLKSLF 232
           P  +GQLT L  L L+ N L+G +P +LG  L H       +N+    IP          
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP---------- 532

Query: 233 DLELCINQLSGAIPLSISNLTNLRFLFL 260
            L  C   LS    + I+   ++ FLFL
Sbjct: 533 GLRACGPHLSVGAKIGIAFGVSVAFLFL 560

Length = 623

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 82.9 bits (205), Expect = 2e-17
 Identities = 70/280 (25%), Positives = 123/280 (43%), Gaps = 33/280 (11%)

Query: 637 TNDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKK---FHSPLPGEMS--FQQEEFLNEIQ 690
             +F  E  IGKG    VY+A  +  G + A+KK   F      EM     +++ L EI 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIF------EMMDAKARQDCLKEID 54

Query: 691 ALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRL-NVIKG 749
            L ++ H N++K+           I+ E  ++G L +++ +    K L   + +      
Sbjct: 55  LLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQ 114

Query: 750 VADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG 809
           +  AL ++H+     I+HRDI   NV +       + D G+ +F +  ++    L GT  
Sbjct: 115 LCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY 171

Query: 810 YVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRL--- 866
           Y++PE  +      K D++S G L  E+   + P    F        MN+  L  ++   
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDK----MNLYSLCKKIEKC 223

Query: 867 ---PYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ 903
              P P+ H  ++L  ++     C++ +PE RP +  V Q
Sbjct: 224 DYPPLPADHYSEELRDLVSR---CINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 82.8 bits (204), Expect = 3e-17
 Identities = 72/257 (28%), Positives = 115/257 (44%), Gaps = 19/257 (7%)

Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           IGKG  G VY+     + E+ A+K        E   + E+   EI  L++     I ++Y
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLE---EAEDEIEDIQQEITVLSQCDSPYITRYY 68

Query: 705 GFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP 764
           G        +II EYL  GS   +L        L  T    +++ +   L YLH+     
Sbjct: 69  GSYLKGTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDYLHSE---R 121

Query: 765 IVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEK 824
            +HRDI + NVLL    +  ++DFG+A  L       +   GT  ++APE+        K
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFK 181

Query: 825 CDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVA 884
            D++S G+ A+E+ KG+ P       +S    M +  L  +   P+L  Q       +  
Sbjct: 182 ADIWSLGITAIELAKGEPP-------NSDLHPMRVLFLIPKNSPPTLEGQYS-KPFKEFV 233

Query: 885 FSCLDQNPESRPTMKRV 901
            +CL+++P  RPT K +
Sbjct: 234 EACLNKDPRFRPTAKEL 250

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 82.2 bits (204), Expect = 4e-17
 Identities = 62/231 (26%), Positives = 101/231 (43%), Gaps = 35/231 (15%)

Query: 638 NDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVK---KFHSPLPGEMSFQQEEFLNEIQALT 693
           +DF     IG+G   +V  AK   + + +A+K   K    L  E   + +    E + LT
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQ--LIKEK--KVKYVKIEKEVLT 56

Query: 694 EI-RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVAD 752
            +  H  I+K Y      ++ + + EY  +G L + +    S  E   T+       +  
Sbjct: 57  RLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEK-CTR--FYAAEILL 113

Query: 753 ALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELA------- 805
           AL YLH+     I+HRD+  +N+LLD      ++DFG AK L+P+SS  S          
Sbjct: 114 ALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170

Query: 806 -------------GTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
                        GT  YV+PEL       +  D+++ G +  +++ GK P
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 82.1 bits (203), Expect = 4e-17
 Identities = 54/208 (25%), Positives = 93/208 (44%), Gaps = 17/208 (8%)

Query: 646 IGKGGHGSVYRAK-VPSGE----IFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNI 700
           +G G  G+VY+   +P GE      A+K        +     +E L+E   +  + H ++
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPK---ANKEILDEAYVMASVDHPHV 71

Query: 701 VKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
           V+  G C   +   +I + +  G L   + N      +G    LN    +A  + YL   
Sbjct: 72  VRLLGICLSSQVQ-LITQLMPLGCLLDYVRNHKD--NIGSQYLLNWCVQIAKGMSYLEEK 128

Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH--GYVAPELAYT 818
               +VHRD++++NVL+       ++DFG+AK L+ D   +    G     ++A E    
Sbjct: 129 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH 185

Query: 819 LKVTEKCDVYSFGVLALEVIK-GKHPRD 845
              T K DV+S+GV   E++  G  P +
Sbjct: 186 RIYTHKSDVWSYGVTVWELMTFGAKPYE 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 81.7 bits (202), Expect = 5e-17
 Identities = 68/261 (26%), Positives = 109/261 (41%), Gaps = 25/261 (9%)

Query: 646 IGKGGHGSVYRA--KVPSGEIF--AVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIV 701
           +G G  G V R       G++   AVK        ++S   ++FL E   +  + H N++
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLK---SDKLSDIMDDFLKEAAIMHSLDHENLI 59

Query: 702 KFYGFC-SHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
           + YG   +HP    ++ E    GSL   L  DA       +   +    +A+ + YL + 
Sbjct: 60  RLYGVVLTHP--LMMVTELAPLGSLLDRLRKDALG-HFLISTLCDYAVQIANGMRYLESK 116

Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWS---ELAGTHGYVAPELAY 817
            F   +HRD++++N+LL    +  + DFG+ + L  +  ++     L     + APE   
Sbjct: 117 RF---IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLR 173

Query: 818 TLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKK 876
           T   +   DV+ FGV   E+   G+ P      +S S     I+    RL  P    Q  
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFTYGEEP---WAGLSGSQILKKIDKEGERLERPEACPQD- 229

Query: 877 LMSIMQVAFSCLDQNPESRPT 897
              I  V   C   NP  RPT
Sbjct: 230 ---IYNVMLQCWAHNPADRPT 247

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 81.8 bits (202), Expect = 5e-17
 Identities = 74/277 (26%), Positives = 136/277 (49%), Gaps = 29/277 (10%)

Query: 643 EHCIGKGGHGSVY--RAKVPSGEIFAVKK--FHSPLPGEMSFQQEE----FLNEIQALTE 694
           EH +G G  G VY  R K     + A+K+   H+P  G+   ++++     ++E+  + E
Sbjct: 6   EH-LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKE 64

Query: 695 -IRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWT---QRL-NVIKG 749
            +RH NIV++Y         +I+ + +E   L +      S KE       +R+ N+   
Sbjct: 65  QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHF---NSLKEKKQRFTEERIWNIFVQ 121

Query: 750 VADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG 809
           +  AL YLH      IVHRD++  N++L    +  ++DFG+AK   P+S   S + GT  
Sbjct: 122 MVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTS-VVGTIL 178

Query: 810 YVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRL-PY 868
           Y  PE+       EK DV++FG +  ++   + P  F    S++  ++  +++++   P 
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP--F---YSTNMLSLATKIVEAVYEPL 233

Query: 869 PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
           P     + +  ++    SCL  + E+RP + +VS ++
Sbjct: 234 PEGMYSEDVTDVIT---SCLTPDAEARPDIIQVSAMI 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 81.2 bits (200), Expect = 6e-17
 Identities = 68/269 (25%), Positives = 121/269 (44%), Gaps = 30/269 (11%)

Query: 646 IGKGGHGSVYRAKVPS-GEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           IG+G  G V+  ++ +     AVK     LP ++   + +FL E + L +  H NIV+  
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDL---KAKFLQEARILKQYSHPNIVRLI 59

Query: 705 GFCSHPKHSFIIYEYLESGSLDKILCNDAS---AKELGWTQRLNVIKGVADALFYLHNNC 761
           G C+  +  +I+ E ++ G     L  +      KEL     + +++  A  + YL +  
Sbjct: 60  GVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKEL-----IQMVENAAAGMEYLESKH 114

Query: 762 FPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH----GYVAPELAY 817
               +HRD++++N L+       +SDFG+++    +   ++   G       + APE   
Sbjct: 115 ---CIHRDLAARNCLVTEKNVLKISDFGMSR--EEEDGVYASTGGMKQIPVKWTAPEALN 169

Query: 818 TLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKK 876
             + + + DV+SFG+L  E    G  P      +S+  +   IE    RLP P L     
Sbjct: 170 YGRYSSESDVWSFGILLWEAFSLGAVPYA---NLSNQQTREAIEQ-GVRLPCPEL-CPDA 224

Query: 877 LMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
           +  +M+    C + +P  RP+   V Q L
Sbjct: 225 VYRLME---RCWEYDPGQRPSFSTVHQEL 250

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 80.8 bits (199), Expect = 8e-17
 Identities = 69/265 (26%), Positives = 114/265 (43%), Gaps = 24/265 (9%)

Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           +GKG  G V++  +      AVK     LP E+  +   FL+E + L +  H NIVK  G
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIK---FLSEARILKQYDHPNIVKLIG 59

Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHN-NCFPP 764
            C+  +  +I+ E +  G     L       EL   Q +      A  + YL + NC   
Sbjct: 60  VCTQRQPIYIVMELVPGGDFLSFL--RKKKDELKTKQLVKFALDAAAGMAYLESKNC--- 114

Query: 765 IVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPELAYTLKV 821
            +HRD++++N L+       +SDFG+++    D   +S          + APE     + 
Sbjct: 115 -IHRDLAARNCLVGENNVLKISDFGMSR--QEDDGIYSSSGLKQIPIKWTAPEALNYGRY 171

Query: 822 TEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSI 880
           + + DV+S+G+L  E    G  P      M++  +   +E    R+  P       +  +
Sbjct: 172 SSESDVWSYGILLWETFSLGVCPYP---GMTNQQAREQVEK-GYRMSCPQ-KCPDDVYKV 226

Query: 881 MQVAFSCLDQNPESRPTMKRVSQLL 905
           MQ    C D  PE+RP    + + L
Sbjct: 227 MQ---RCWDYKPENRPKFSELQKEL 248

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 81.6 bits (201), Expect = 1e-16
 Identities = 61/201 (30%), Positives = 101/201 (50%), Gaps = 16/201 (7%)

Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQ--EEFLNEIQALTEIRHRNIVK 702
           IG+G  G V  A +  +G+  AVKK       ++  QQ  E   NE+  + +  H N+V 
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKM------DLRKQQRRELLFNEVVIMRDYHHENVVD 83

Query: 703 FYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
            Y         +++ E+LE G+L  I+ +    +E   T  L+V++    AL YLHN   
Sbjct: 84  MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLR----ALSYLHNQ-- 137

Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVT 822
             ++HRDI S ++LL       +SDFG    ++ +      L GT  ++APE+   L   
Sbjct: 138 -GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYG 196

Query: 823 EKCDVYSFGVLALEVIKGKHP 843
            + D++S G++ +E+I G+ P
Sbjct: 197 TEVDIWSLGIMVIEMIDGEPP 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 80.8 bits (200), Expect = 1e-16
 Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 19/204 (9%)

Query: 644 HCIGKGGHGSVYRAKV-PSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVK 702
             +G+G +G V + +   +GEI A+KKF      E    ++  L E++ L ++RH NIV 
Sbjct: 7   GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDV--KKTALREVKVLRQLRHENIVN 64

Query: 703 FYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
                      ++++EY+E   L+ +   +AS   L      + I  +  A+ Y H++  
Sbjct: 65  LKEAFRRKGRLYLVFEYVERTLLELL---EASPGGLPPDAVRSYIWQLLQAIAYCHSH-- 119

Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN-PDSSNWSELAGTHGYVAPEL-----A 816
             I+HRDI  +N+L+       + DFG A+ L    +S  ++   T  Y APEL      
Sbjct: 120 -NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTN 178

Query: 817 YTLKVTEKCDVYSFGVLALEVIKG 840
           Y   V    DV++ G +  E++ G
Sbjct: 179 YGKPV----DVWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 80.7 bits (199), Expect = 2e-16
 Identities = 80/283 (28%), Positives = 128/283 (45%), Gaps = 39/283 (13%)

Query: 646 IGKGGHGSV--YR---AKVPSGEIFAVKKFHSPLPGEMSFQQEE-FLNEIQALTEIRHRN 699
           +G+G  G V  Y    A   +GE+ AVK     L  E   Q    +  EI  L  + H N
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKT----LKRECGQQNTSGWKKEINILKTLYHEN 67

Query: 700 IVKFYGFCSHP--KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYL 757
           IVK+ G CS    K   +I EY+  GSL   L       +L   Q L   + + + + YL
Sbjct: 68  IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHKLNLAQLLLFAQQICEGMAYL 123

Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG----YVAP 813
           H+  +   +HRD++++NVLLD      + DFG+AK + P+   +  +         + A 
Sbjct: 124 HSQHY---IHRDLAARNVLLDNDRLVKIGDFGLAKAV-PEGHEYYRVREDGDSPVFWYAV 179

Query: 814 ELAYTLKVTEKCDVYSFGVLALEVI-----KGKHPRDFLFEMSSSSSNMN----IEMLDS 864
           E     K +   DV+SFGV   E++     K   P+ F   +      M     IE+L+ 
Sbjct: 180 ECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLER 239

Query: 865 --RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
             RLP P  +  +++  +M+   +C +   + RPT + +  +L
Sbjct: 240 GMRLPCPK-NCPQEVYILMK---NCWETEAKFRPTFRSLIPIL 278

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 80.3 bits (198), Expect = 2e-16
 Identities = 77/274 (28%), Positives = 121/274 (44%), Gaps = 41/274 (14%)

Query: 646 IGKGGHGSVYRAKVPSGEI-FAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +GKG +G VY A+  S ++  A+K+    +P   S   +    EI   + ++HRNIV++ 
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKE----IPERDSRYVQPLHEEIALHSYLKHRNIVQYL 71

Query: 705 GFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP 764
           G  S      I  E +  GSL  +L +     +      +   K + + L YLH+N    
Sbjct: 72  GSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---Q 128

Query: 765 IVHRDISSKNVLLDLGYEA--HVSDFGIAKFL---NPDSSNWSELAGTHGYVAPELAYTL 819
           IVHRDI   NVL++  Y     +SDFG +K L   NP +  ++   GT  Y+APE     
Sbjct: 129 IVHRDIKGDNVLVNT-YSGVVKISDFGTSKRLAGINPCTETFT---GTLQYMAPE----- 179

Query: 820 KVTEK--------CDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNM-NIEMLDSRLPYP- 869
            V +K         D++S G   +E+  GK P     E+    + M  + M       P 
Sbjct: 180 -VIDKGPRGYGAPADIWSLGCTIVEMATGKPP---FIELGEPQAAMFKVGMFKIHPEIPE 235

Query: 870 SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ 903
           SL  + K          C + +P+ R +   + Q
Sbjct: 236 SLSAEAK-----NFILRCFEPDPDKRASAHDLLQ 264

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 80.0 bits (198), Expect = 2e-16
 Identities = 69/209 (33%), Positives = 95/209 (45%), Gaps = 29/209 (13%)

Query: 646 IGKGGHGSVYRAKV-PSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G GG G V   KV      FA+K        E   QQE   +E + L E  H  IVK Y
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETG-QQEHIFSEKEILEECNHPFIVKLY 59

Query: 705 GFCSHPKHSFIIYEYLESGSL-----DKILCNDASAKELGWTQRLNVIKGVADALFYLHN 759
                 K+ +++ EY   G L     D+ L ++ +A+          I  V  A  YLHN
Sbjct: 60  RTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFY--------IACVVLAFEYLHN 111

Query: 760 NCFPPIVHRDISSKNVLLDL-GYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL--- 815
                I++RD+  +N+LLD  GY   + DFG AK L      W+   GT  YVAPE+   
Sbjct: 112 R---GIIYRDLKPENLLLDSNGY-VKLVDFGFAKKLKSGQKTWT-FCGTPEYVAPEIILN 166

Query: 816 -AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
             Y   V    D +S G+L  E++ G+ P
Sbjct: 167 KGYDFSV----DYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 79.2 bits (195), Expect = 3e-16
 Identities = 70/263 (26%), Positives = 115/263 (43%), Gaps = 26/263 (9%)

Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSF------QQEEFLNEIQALTEIRHRN 699
           IG+G  G +Y AK  S     V K       E+        ++E    E+  L +++H N
Sbjct: 8   IGEGSFGKIYLAKAKSDSEHCVIK-------EIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 700 IVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHN 759
           IV F+         FI+ EY + G L K + N          Q L+    ++  L ++H+
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLMKRI-NRQRGVLFSEDQILSWFVQISLGLKHIHD 119

Query: 760 NCFPPIVHRDISSKNVLLDL-GYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT 818
                I+HRDI S+N+ L   G  A + DFGIA+ LN          GT  Y++PE+   
Sbjct: 120 R---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQN 176

Query: 819 LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLM 878
                K D++S G +  E+   KHP    FE  ++   + +++        S +  + L 
Sbjct: 177 RPYNNKTDIWSLGCVLYELCTLKHP----FE-GNNLHQLVLKICQGYFAPISPNFSRDLR 231

Query: 879 SIMQVAFSCLDQNPESRPTMKRV 901
           S++   F     +P  RP++  +
Sbjct: 232 SLISQLFKV---SPRDRPSITSI 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 79.2 bits (195), Expect = 3e-16
 Identities = 71/263 (26%), Positives = 122/263 (46%), Gaps = 28/263 (10%)

Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           IG+G  G+V + +  +G+  AVK     +  +       FL E   +T++ H+N+V+  G
Sbjct: 14  IGEGEFGAVLQGEY-TGQKVAVKNIKCDVTAQ------AFLEETAVMTKLHHKNLVRLLG 66

Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
              H    +I+ E +  G+L   L     A  +   Q L     VA+ + YL +     +
Sbjct: 67  VILH-NGLYIVMELMSKGNLVNFLRTRGRAL-VSVIQLLQFSLDVAEGMEYLESK---KL 121

Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKC 825
           VHRD++++N+L+     A VSDFG+A+ +     + S+L     + APE     K + K 
Sbjct: 122 VHRDLAARNILVSEDGVAKVSDFGLAR-VGSMGVDNSKLPVK--WTAPEALKHKKFSSKS 178

Query: 826 DVYSFGVLALEVI---KGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQ 882
           DV+S+GVL  EV    +  +P+  L E+          M         ++V   LM+   
Sbjct: 179 DVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEK-GYRMEPPEGCPADVYV---LMT--- 231

Query: 883 VAFSCLDQNPESRPTMKRVSQLL 905
              SC +  P+ RP+  ++ + L
Sbjct: 232 ---SCWETEPKKRPSFHKLREKL 251

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 78.9 bits (194), Expect = 4e-16
 Identities = 65/205 (31%), Positives = 95/205 (46%), Gaps = 25/205 (12%)

Query: 639 DFNAEHCIGKGGHGSV----YRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTE 694
           +      IGKG  G V    YR     G   AVK   +    +       FL E   +T+
Sbjct: 7   ELKLLQTIGKGEFGDVMLGDYR-----GNKVAVKCIKNDATAQ------AFLAEASVMTQ 55

Query: 695 IRHRNIVKFYGFCSHPKHS-FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADA 753
           +RH N+V+  G     K   +I+ EY+  GSL   L +   +  LG    L     V +A
Sbjct: 56  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEA 114

Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH-GYVA 812
           + YL  N F   VHRD++++NVL+     A VSDFG+ K    ++S+  +       + A
Sbjct: 115 MEYLEANNF---VHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTA 167

Query: 813 PELAYTLKVTEKCDVYSFGVLALEV 837
           PE     K + K DV+SFG+L  E+
Sbjct: 168 PEALREKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 79.3 bits (195), Expect = 5e-16
 Identities = 72/283 (25%), Positives = 130/283 (45%), Gaps = 42/283 (14%)

Query: 646 IGKGGHGSVYRAKV----PSGE--IFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRN 699
           +G+G  G V+ A+     P  +  + AVK     L       +++F  E + LT ++H +
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKT----LKDASDNARKDFHREAELLTNLQHEH 68

Query: 700 IVKFYGFCSHPKHSFIIYEYLESGSLDKIL----------CNDASAKELGWTQRLNVIKG 749
           IVKFYG C       +++EY++ G L+K L                 EL  +Q L++ + 
Sbjct: 69  IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128

Query: 750 VADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH- 808
           +A  + YL +  F   VHRD++++N L+       + DFG+++  +  S+++  + G   
Sbjct: 129 IAAGMVYLASQHF---VHRDLATRNCLVGENLLVKIGDFGMSR--DVYSTDYYRVGGHTM 183

Query: 809 ---GYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDS 864
               ++ PE     K T + DV+S GV+  E+   GK P    +++   S+N  IE +  
Sbjct: 184 LPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP---WYQL---SNNEVIECITQ 237

Query: 865 R--LPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
              L  P    ++    +  +   C  + P  R  +K +  LL
Sbjct: 238 GRVLQRPRTCPKE----VYDLMLGCWQREPHMRLNIKEIHSLL 276

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 78.9 bits (194), Expect = 7e-16
 Identities = 74/268 (27%), Positives = 126/268 (47%), Gaps = 28/268 (10%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G  G VY+AK   +G + A K   +    E+    E+++ EI+ L    H  IVK  
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL----EDYMVEIEILATCNHPYIVKLL 75

Query: 705 GFCSHPKHSFIIYEYLESGSLDKILCN-DASAKELGWTQRLNVIKGVADALFYLHNNCFP 763
           G        +I+ E+   G++D I+   D    E    Q   + + + +AL YLH+    
Sbjct: 76  GAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTE---PQIQVICRQMLEALQYLHSM--- 129

Query: 764 PIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAY--TLKV 821
            I+HRD+ + NVLL L  +  ++DFG++              GT  ++APE+    T+K 
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKD 189

Query: 822 TE---KCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKL- 877
           T    K D++S G+  +E+ + + P   L       + M + +  ++   P+L    K  
Sbjct: 190 TPYDYKADIWSLGITLIEMAQIEPPHHEL-------NPMRVLLKIAKSEPPTLSQPSKWS 242

Query: 878 MSIMQVAFSCLDQNPESRPTMKRVSQLL 905
           M       + LD++PE+RP+    +QLL
Sbjct: 243 MEFRDFLKTALDKHPETRPS---AAQLL 267

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 78.0 bits (192), Expect = 1e-15
 Identities = 67/255 (26%), Positives = 113/255 (44%), Gaps = 28/255 (10%)

Query: 661 SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI--IYE 718
           +GE  AVK      P        +   EI+ L  + H NIVK+ G C+    + I  I E
Sbjct: 32  TGEQVAVKSLK---PESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIME 88

Query: 719 YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLD 778
           +L SGSL + L  + +   L   Q+L     +   + YL +  +   VHRD++++NVL++
Sbjct: 89  FLPSGSLKEYLPRNKNKINL--KQQLKYAVQICKGMDYLGSRQY---VHRDLAARNVLVE 143

Query: 779 LGYEAHVSDFGIAKFLNPDSSNWS---ELAGTHGYVAPELAYTLKVTEKCDVYSFGVLAL 835
             ++  + DFG+ K +  D   ++   +L     + APE     K     DV+SFGV   
Sbjct: 144 SEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLY 203

Query: 836 EVI-----KGKHPRDFLFEMSSSSSNMNIEML------DSRLPYPSLHVQKKLMSIMQVA 884
           E++     +      FL  +  +   M +  L        RLP P  +  +++  +M+  
Sbjct: 204 ELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPP-NCPEEVYQLMR-- 260

Query: 885 FSCLDQNPESRPTMK 899
             C +  P  R T +
Sbjct: 261 -KCWEFQPSKRTTFQ 274

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 77.8 bits (191), Expect = 1e-15
 Identities = 73/275 (26%), Positives = 126/275 (45%), Gaps = 29/275 (10%)

Query: 640 FNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RH 697
           F     +G G +G VY+ + V +G++ A+K     + G+   ++EE   EI  L +   H
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD--VTGD---EEEEIKQEINMLKKYSHH 62

Query: 698 RNIVKFYG--FCSHP----KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVA 751
           RNI  +YG     +P       +++ E+  +GS+  ++ N      L       + + + 
Sbjct: 63  RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN-TKGNTLKEEWIAYICREIL 121

Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV 811
             L +LH +    ++HRDI  +NVLL    E  + DFG++  L+      +   GT  ++
Sbjct: 122 RGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWM 178

Query: 812 APELAYTLKVTE-----KCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRL 866
           APE+    +  +     K D++S G+ A+E+ +G  P   L +M      M    L  R 
Sbjct: 179 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP---LCDMHP----MRALFLIPRN 231

Query: 867 PYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
           P P L  +K          SCL +N   RPT +++
Sbjct: 232 PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQL 266

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 77.6 bits (192), Expect = 2e-15
 Identities = 65/216 (30%), Positives = 98/216 (45%), Gaps = 29/216 (13%)

Query: 638 NDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
           +DF     +G G  G V   +   SG+ +A+K        ++  Q E  LNE + L  IR
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLK-QVEHVLNEKRILQSIR 59

Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIK----GVAD 752
           H  +V  YG      + +++ EY+  G L   L       E        V +     V  
Sbjct: 60  HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPE-------PVARFYAAQVVL 112

Query: 753 ALFYLHNNCFPPIVHRDISSKNVLLD-LGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV 811
           AL YLH+     IV+RD+  +N+LLD  GY   ++DFG AK +      ++ L GT  Y+
Sbjct: 113 ALEYLHSL---DIVYRDLKPENLLLDSDGY-IKITDFGFAKRV--KGRTYT-LCGTPEYL 165

Query: 812 APEL----AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           APE+     Y   V    D ++ G+L  E++ G  P
Sbjct: 166 APEIILSKGYGKAV----DWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 77.1 bits (190), Expect = 2e-15
 Identities = 76/281 (27%), Positives = 124/281 (44%), Gaps = 45/281 (16%)

Query: 646 IGKGGHGSVYRAKVP-----SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNI 700
           +GKG  GSV   +       +GE+ AVKK        +     +F  EI+ L  ++H NI
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHL----RDFEREIEILKSLQHDNI 67

Query: 701 VKFYGFCSHP--KHSFIIYEYLESGSLDKILCNDASAKELGWTQRL-----NVIKGVADA 753
           VK+ G C     ++  ++ EYL  GSL   L      +E    ++L      + KG+   
Sbjct: 68  VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGME-- 122

Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG---Y 810
             YL +  +   VHRD++++N+L++      + DFG+ K L  D   +           +
Sbjct: 123 --YLGSKRY---VHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFW 177

Query: 811 VAPELAYTLKVTEKCDVYSFGVLALEVI----KGKHP-RDFLFEMSSSSSNMNI-----E 860
            APE     K +   DV+SFGV+  E+     K   P  +F+  M +      I     E
Sbjct: 178 YAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE 237

Query: 861 MLDS--RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMK 899
           +L +  RLP P      ++ +IM+    C + +P  RP+  
Sbjct: 238 LLKNNGRLPAP-PGCPAEIYAIMK---ECWNNDPSQRPSFS 274

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 77.4 bits (191), Expect = 2e-15
 Identities = 52/187 (27%), Positives = 90/187 (48%), Gaps = 24/187 (12%)

Query: 665 FAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGS 724
            AVK      P      +E+FL E++ L+ +   NI +  G C+      +I EY+E+G 
Sbjct: 49  VAVKV---LRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGD 105

Query: 725 LDKIL------CNDAS--AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVL 776
           L++ L       +  +  +K L ++  L +   +A  + YL +  F   VHRD++++N L
Sbjct: 106 LNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNF---VHRDLATRNCL 162

Query: 777 LDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAP------ELAYTLKVTEKCDVYSF 830
           +   Y   ++DFG+++  N  SS++  + G      P      E     K T K DV++F
Sbjct: 163 VGKNYTIKIADFGMSR--NLYSSDYYRVQGRA--PLPIRWMAWESVLLGKFTTKSDVWAF 218

Query: 831 GVLALEV 837
           GV   E+
Sbjct: 219 GVTLWEI 225

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 77.0 bits (189), Expect = 2e-15
 Identities = 68/266 (25%), Positives = 123/266 (46%), Gaps = 13/266 (4%)

Query: 639 DFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQ-QEEFLNEIQALTEIR 696
           +F  E  IG+G    VYRA  +  G   A+KK    +   M  + + + + EI  L ++ 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQ--IFDLMDAKARADCIKEIDLLKQLN 60

Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRL-NVIKGVADALF 755
           H N++K+Y          I+ E  ++G L +++ +    K L   + +      +  AL 
Sbjct: 61  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120

Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           ++H+     ++HRDI   NV +       + D G+ +F +  ++    L GT  Y++PE 
Sbjct: 121 HMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177

Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQK 875
            +      K D++S G L  E+   + P  +  +M+  S    IE  D   P PS H  +
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPF-YGDKMNLYSLCKKIEQCDYP-PLPSDHYSE 235

Query: 876 KLMSIMQVAFSCLDQNPESRPTMKRV 901
           +L  ++ +   C++ +PE RP +  V
Sbjct: 236 ELRQLVNM---CINPDPEKRPDITYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 76.0 bits (187), Expect = 4e-15
 Identities = 84/287 (29%), Positives = 127/287 (44%), Gaps = 49/287 (17%)

Query: 646 IGKGGHGSVYRAK------VPSGEI-FAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHR 698
           +G G  G VY           SG I  AVK       G    +++EFL E   ++   H 
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRK---GATDQEKKEFLKEAHLMSNFNHP 59

Query: 699 NIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE-----LGWTQRLNVIKGVADA 753
           NIVK  G C   +  +II E +E G L   L  DA  +      L   + L++   VA  
Sbjct: 60  NIVKLLGVCLLNEPQYIIMELMEGGDLLSYL-RDARVERFGPPLLTLKELLDICLDVAKG 118

Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDL-GYEA----HVSDFGIAKFLNPDSSNWSELAGTH 808
             YL    F   +HRD++++N L+   GY+A     + DFG+A+ +    S++    G  
Sbjct: 119 CVYLEQMHF---IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIY--KSDYYRKEGEG 173

Query: 809 ----GYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEML- 862
                ++APE     K T + DV+SFGVL  E++  G+ P           +  N E+L 
Sbjct: 174 LLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP---------YPALNNQEVLQ 224

Query: 863 ----DSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
                 RL  P  +   K+  +M    +C  Q+P  RPT  R+ ++L
Sbjct: 225 HVTAGGRLQKPE-NCPDKIYQLMT---NCWAQDPSERPTFDRIQEIL 267

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 75.8 bits (186), Expect = 5e-15
 Identities = 52/160 (32%), Positives = 82/160 (51%), Gaps = 14/160 (8%)

Query: 682 QEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWT 741
           ++E L E   + ++ +  IV+  G C   +   ++ E  E G L+K L  +    E   T
Sbjct: 40  KDELLREANVMQQLDNPYIVRMIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNIT 98

Query: 742 QRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNW 801
           +   ++  V+  + YL    F   VHRD++++NVLL   + A +SDFG++K L  D + +
Sbjct: 99  E---LVHQVSMGMKYLEETNF---VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY 152

Query: 802 SELAGTHG-----YVAPELAYTLKVTEKCDVYSFGVLALE 836
              A THG     + APE     K + K DV+SFGVL  E
Sbjct: 153 K--AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 75.6 bits (186), Expect = 5e-15
 Identities = 61/225 (27%), Positives = 107/225 (47%), Gaps = 20/225 (8%)

Query: 681 QQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGW 740
           ++EE   E+  L+ ++H NIV++        + +I+ +Y E G L K + N         
Sbjct: 42  EREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKI-NAQRGVLFPE 100

Query: 741 TQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN 800
            Q L+    +  AL ++H+     I+HRDI S+N+ L       + DFGIA+ LN    +
Sbjct: 101 DQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLN----S 153

Query: 801 WSELA----GTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSN 856
             ELA    GT  Y++PE+        K D+++ G +  E+   KH     FE + +  N
Sbjct: 154 TVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHA----FE-AGNMKN 208

Query: 857 MNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
           + ++++    P  S H    L +++   F    +NP  RP++  +
Sbjct: 209 LVLKIIRGSYPPVSSHYSYDLRNLVSQLFK---RNPRDRPSVNSI 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 75.5 bits (185), Expect = 8e-15
 Identities = 67/263 (25%), Positives = 114/263 (43%), Gaps = 21/263 (7%)

Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFH-SPLPGEMSFQQEEFLNEIQALTEIRHRNIVKF 703
           +G+G  G VY    V +G   A K+    P   E S +      EIQ L  ++H  IV++
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 704 YGFC--SHPKHSFIIY-EYLESGSL-DKILCNDASAKELGWTQRLNVIKGVADALFYLHN 759
           YG C     + +  I+ EY+  GS+ D++    A  + +       +++G++    YLH+
Sbjct: 70  YG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMS----YLHS 124

Query: 760 NCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP---DSSNWSELAGTHGYVAPELA 816
           N    IVHRDI   N+L D      + DFG +K L       +    + GT  +++PE+ 
Sbjct: 125 NM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI 181

Query: 817 YTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKK 876
                  K DV+S G   +E++  K P     E  + ++   I    +    PS H+ + 
Sbjct: 182 SGEGYGRKADVWSLGCTVVEMLTEKPP---WAEYEAMAAIFKIATQPTNPQLPS-HISEH 237

Query: 877 LMSIMQVAFSCLDQNPESRPTMK 899
               +   F      P +   ++
Sbjct: 238 ARDFLGCIFVEARHRPSAEELLR 260

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 75.4 bits (185), Expect = 9e-15
 Identities = 74/278 (26%), Positives = 131/278 (47%), Gaps = 35/278 (12%)

Query: 640 FNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RH 697
           F     +G G +G VY+ + V +G++ A+K            ++EE   EI  L +   H
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDV-----TEDEEEEIKLEINMLKKYSHH 72

Query: 698 RNIVKFYGFC---SHPKHS---FIIYEYLESGSLDKILCN-DASAKELGWTQRL--NVIK 748
           RNI  +YG     S P H    +++ E+  +GS+  ++ N   +A +  W   +   +++
Sbjct: 73  RNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILR 132

Query: 749 GVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH 808
           G+A    +LH +    ++HRDI  +NVLL    E  + DFG++  L+      +   GT 
Sbjct: 133 GLA----HLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTP 185

Query: 809 GYVAPELAYTLKVTE-----KCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLD 863
            ++APE+    +  +     + D++S G+ A+E+ +G  P   L +M      M    L 
Sbjct: 186 YWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPP---LCDMHP----MRALFLI 238

Query: 864 SRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
            R P P L  +K     +     CL +N  SRP+ +++
Sbjct: 239 PRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQL 276

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 75.1 bits (184), Expect = 9e-15
 Identities = 61/206 (29%), Positives = 93/206 (45%), Gaps = 15/206 (7%)

Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKF-HSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKF 703
           +G+G  G VY      +G   AVK+    P   E S +      EIQ L  +RH  IV++
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69

Query: 704 YGFCSHP--KHSFIIYEYLESGSL-DKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
           YG    P  K   I  EY+  GS+ D++    A  + +       +++GV     YLH+N
Sbjct: 70  YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGV----SYLHSN 125

Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP---DSSNWSELAGTHGYVAPELAY 817
               IVHRDI   N+L D      + DFG +K +       +    + GT  +++PE+  
Sbjct: 126 M---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVIS 182

Query: 818 TLKVTEKCDVYSFGVLALEVIKGKHP 843
                 K DV+S     +E++  K P
Sbjct: 183 GEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 74.5 bits (183), Expect = 1e-14
 Identities = 68/262 (25%), Positives = 122/262 (46%), Gaps = 20/262 (7%)

Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           +G G  G V+          A+K       G MS   E FL E   + +++H  +V+ Y 
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLK---QGSMS--PEAFLAEANLMKQLQHPRLVRLYA 68

Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
             +  +  +II EY+E+GSL   L      K L   + +++   +A+ + ++    +   
Sbjct: 69  VVTQ-EPIYIITEYMENGSLVDFLKTPEGIK-LTINKLIDMAAQIAEGMAFIERKNY--- 123

Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH-GYVAPELAYTLKVTEK 824
           +HRD+ + N+L+       ++DFG+A+ +  +     E A     + APE       T K
Sbjct: 124 IHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 183

Query: 825 CDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQV 883
            DV+SFG+L  E++  G+ P      M++     N+E    R+P P  +  ++L  +M+ 
Sbjct: 184 SDVWSFGILLTEIVTYGRIPYP---GMTNPEVIQNLERG-YRMPRPD-NCPEELYELMR- 237

Query: 884 AFSCLDQNPESRPTMKRVSQLL 905
              C  + PE RPT + +  +L
Sbjct: 238 --LCWKEKPEERPTFEYLRSVL 257

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 74.2 bits (182), Expect = 1e-14
 Identities = 69/261 (26%), Positives = 118/261 (45%), Gaps = 22/261 (8%)

Query: 646 IGKGGHGSVYRAKVPS-GEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +GKG +G V   +  + G+ + +KK +  L      +++    E Q L++++H NIV + 
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLN--LRNASRRERKAAEQEAQLLSQLKHPNIVAYR 65

Query: 705 -GFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFP 763
             +       +I+  + E G L   L  +   K L   Q +     +A AL YLH     
Sbjct: 66  ESWEGEDGLLYIVMGFCEGGDLYHKL-KEQKGKLLPENQVVEWFVQIAMALQYLHEK--- 121

Query: 764 PIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTE 823
            I+HRD+ ++NV L       V D GIA+ L       S L GT  Y++PEL        
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNY 181

Query: 824 KCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMN---IEMLDSRLPYPSLHVQKKLMSI 880
           K DV++ G    E+   KH        + ++ +MN     +++ +LP        +L  +
Sbjct: 182 KSDVWALGCCVYEMATLKH--------AFNAKDMNSLVYRIIEGKLPPMPKDYSPELGEL 233

Query: 881 MQVAFSCLDQNPESRPTMKRV 901
           +    + L + PE RP++K +
Sbjct: 234 IA---TMLSKRPEKRPSVKSI 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 74.4 bits (183), Expect = 2e-14
 Identities = 65/239 (27%), Positives = 113/239 (47%), Gaps = 27/239 (11%)

Query: 681 QQEEFLNEIQALTEI-RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASA---- 735
           ++E  ++E++ ++ +  H NIV   G C+      +I EY   G L   L     +    
Sbjct: 81  EREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTL 140

Query: 736 -KELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL 794
              L ++ +  V KG+A   F    NC    +HRD++++NVLL  G    + DFG+A+ +
Sbjct: 141 EDLLSFSYQ--VAKGMA---FLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDI 191

Query: 795 NPDSSNWSELAGTH---GYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEM 850
             D SN+           ++APE  +    T + DV+S+G+L  E+   G +P      M
Sbjct: 192 MND-SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYP---GM 247

Query: 851 SSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI 909
              S    +     R+  P  H   ++  IM+   +C D +P  RPT K++ QL+ +++
Sbjct: 248 PVDSKFYKLIKEGYRMAQPE-HAPAEIYDIMK---TCWDADPLKRPTFKQIVQLIGKQL 302

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 74.0 bits (182), Expect = 3e-14
 Identities = 73/300 (24%), Positives = 128/300 (42%), Gaps = 57/300 (19%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEF-LNEIQALTEIRHRNIVKF 703
           +G+G +G V + K   +G+I A+KKF   L  E     ++  + EI+ L ++RH N+V  
Sbjct: 9   VGEGSYGMVMKCKHKETGQIVAIKKF---LESEDDKMVKKIAMREIRMLKQLRHENLVNL 65

Query: 704 YGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQR--LNVIKGVADALFYLHNNC 761
                  K  ++++E+++   LD  L    +  +    ++    +++G+     + H++ 
Sbjct: 66  IEVFRRKKRLYLVFEFVDHTVLDD-LEKYPNGLDESRVRKYLFQILRGIE----FCHSH- 119

Query: 762 FPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAY-TLK 820
              I+HRDI  +N+L+       + DFG A+ L      +++   T  Y APEL     K
Sbjct: 120 --NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTK 177

Query: 821 VTEKCDVYSFGVLALEVIKG-------------------------KHPRDF----LFEMS 851
                D+++ G L  E++ G                         +H   F    LF   
Sbjct: 178 YGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237

Query: 852 SSSSNMNIEMLDSRLPYPSLHVQKKLMSIM-QVAFSCLDQNPESRPTMKRVSQLLCEKIF 910
                  IE L+ R P        KL  ++  +A  CL  +P+ RP+    SQLL  + F
Sbjct: 238 RLPEVKEIEPLEKRFP--------KLSGLVLDLAKQCLRIDPDDRPS---SSQLLHHEFF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 73.5 bits (180), Expect = 3e-14
 Identities = 67/262 (25%), Positives = 119/262 (45%), Gaps = 20/262 (7%)

Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           +G G  G V+ A        AVK      PG MS   E FL E   +  ++H  +VK + 
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMK---PGSMSV--EAFLAEANVMKTLQHDKLVKLHA 68

Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
             +  +  +II E++  GSL   L +D  +K+    + ++    +A+ + ++    +   
Sbjct: 69  VVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQ-PLPKLIDFSAQIAEGMAFIEQRNY--- 123

Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH-GYVAPELAYTLKVTEK 824
           +HRD+ + N+L+       ++DFG+A+ +  +     E A     + APE       T K
Sbjct: 124 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 183

Query: 825 CDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQV 883
            DV+SFG+L +E++  G+ P      MS+      +E    R+P P    ++    +  +
Sbjct: 184 SDVWSFGILLMEIVTYGRIPYP---GMSNPEVIRALER-GYRMPRPENCPEE----LYNI 235

Query: 884 AFSCLDQNPESRPTMKRVSQLL 905
              C    PE RPT + +  +L
Sbjct: 236 MMRCWKNRPEERPTFEYIQSVL 257

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 74.9 bits (184), Expect = 3e-14
 Identities = 66/266 (24%), Positives = 112/266 (42%), Gaps = 28/266 (10%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           IG G  G+VY+    P+G ++A+K  +      +  Q      EI+ L ++ H N+VK +
Sbjct: 82  IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQ---ICREIEILRDVNHPNVVKCH 138

Query: 705 GFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP 764
               H     ++ E+++ GSL+     D            +V + +   + YLH      
Sbjct: 139 DMFDHNGEIQVLLEFMDGGSLEGTHIADEQ-------FLADVARQILSGIAYLHRR---H 188

Query: 765 IVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP--DSSNWSELAGTHGYVAPE-----LAY 817
           IVHRDI   N+L++      ++DFG+++ L    D  N S   GT  Y++PE     L +
Sbjct: 189 IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS--VGTIAYMSPERINTDLNH 246

Query: 818 TLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKL 877
                   D++S GV  LE   G+ P     +   +S    I M     P       ++ 
Sbjct: 247 GAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQP--PEAPATASREF 304

Query: 878 MSIMQVAFSCLDQNPESRPTMKRVSQ 903
              +     CL + P  R +  ++ Q
Sbjct: 305 RHFISC---CLQREPAKRWSAMQLLQ 327

Length = 353

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 72.8 bits (178), Expect = 5e-14
 Identities = 59/206 (28%), Positives = 93/206 (45%), Gaps = 15/206 (7%)

Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFH-SPLPGEMSFQQEEFLNEIQALTEIRHRNIVKF 703
           +G+G  G VY      +G   AVK+    P   E S +      EIQ L  + H  IV++
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 704 YGFCSHPKHSF--IIYEYLESGSL-DKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
           YG    P      I  E++  GS+ D++    A  + +       +++GV+    YLH+N
Sbjct: 70  YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVS----YLHSN 125

Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP---DSSNWSELAGTHGYVAPELAY 817
               IVHRDI   N+L D      + DFG +K L       +    + GT  +++PE+  
Sbjct: 126 M---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS 182

Query: 818 TLKVTEKCDVYSFGVLALEVIKGKHP 843
                 K D++S G   +E++  K P
Sbjct: 183 GEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 76.0 bits (187), Expect = 6e-14
 Identities = 55/176 (31%), Positives = 80/176 (45%), Gaps = 25/176 (14%)

Query: 681 QQEEFLNEIQALTEIRHRNIVKFY--GFCSHPKHSFIIYEYLESGSLDKILCNDA--SAK 736
           Q+  F  E      + H NIV     G    P   F ++EY+   +L ++L  D    A 
Sbjct: 21  QRARFRRETALCARLYHPNIVALLDSGEAP-PGLLFAVFEYVPGRTLREVLAADGALPAG 79

Query: 737 ELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLL---DLGYEAHVSDFGIAKF 793
           E G   RL  +  V DAL   HN     IVHRD+  +N+++    +   A V DFGI   
Sbjct: 80  ETG---RL--MLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTL 131

Query: 794 LNPDSSNW--------SELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGK 841
           L P   +         +E+ GT  Y APE      VT   D+Y++G++ LE + G+
Sbjct: 132 L-PGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 72.9 bits (179), Expect = 6e-14
 Identities = 73/286 (25%), Positives = 105/286 (36%), Gaps = 66/286 (23%)

Query: 646 IGKGGHGSVYRAKV------PSGEIFAVKKFHSPLPGEMSFQQEE--FLNEIQALTEIRH 697
           +G G  G VY                AVK     LP E   +Q+E  FL E   +++  H
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKT----LP-ESCSEQDESDFLMEALIMSKFNH 68

Query: 698 RNIVKFYGFC--SHPKHSFIIYEYLESGSLDKIL----CNDASAKELGWTQRLNVIKGVA 751
           +NIV+  G      P+  FI+ E +  G L   L            L     L   + VA
Sbjct: 69  QNIVRLIGVSFERLPR--FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126

Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDL---GYEAHVSDFGIAKFLNPDSSNWSELAGTH 808
               YL  N F   +HRDI+++N LL     G  A ++DFG+A+          ++    
Sbjct: 127 KGCKYLEENHF---IHRDIAARNCLLTCKGPGRVAKIADFGMAR----------DIYRAS 173

Query: 809 GY------------VAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSN 856
            Y            + PE       T K DV+SFGVL  E+        F          
Sbjct: 174 YYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEI--------FSLGYMPYPGR 225

Query: 857 MNIEMLD-----SRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPT 897
            N E+++      RL  P    +     + ++   C    PE RP 
Sbjct: 226 TNQEVMEFVTGGGRLDPP----KGCPGPVYRIMTDCWQHTPEDRPN 267

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 72.3 bits (177), Expect = 7e-14
 Identities = 72/262 (27%), Positives = 119/262 (45%), Gaps = 20/262 (7%)

Query: 639 DFNAEHCIGKGGHG-SVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH 697
            +N    +G+G  G ++    V S + +A+K+   P   + S   E+   E   L +++H
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLP---KSSSAVEDSRKEAVLLAKMKH 57

Query: 698 RNIVKFYGFCSHPKHSFIIYEYLESGSL-DKILCNDASAKELGWTQRLNVIKGVADALFY 756
            NIV F        H +I+ EY + G L  KI       K       L     +   + +
Sbjct: 58  PNIVAFKESFEADGHLYIVMEYCDGGDLMQKI--KLQRGKLFPEDTILQWFVQMCLGVQH 115

Query: 757 LHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELA 816
           +H      ++HRDI SKN+ L    +  + DFG A+ L    +      GT  YV PE+ 
Sbjct: 116 IHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIW 172

Query: 817 YTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLD-SRLPYPSLHVQK 875
             +    K D++S G +  E+   KHP    F+ ++S  N+ +++   S  P PS H   
Sbjct: 173 ENMPYNNKSDIWSLGCILYELCTLKHP----FQ-ANSWKNLILKVCQGSYKPLPS-HYSY 226

Query: 876 KLMSIMQVAFSCLDQNPESRPT 897
           +L S+++  F    +NP SRP+
Sbjct: 227 ELRSLIKQMFK---RNPRSRPS 245

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 71.9 bits (176), Expect = 1e-13
 Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 17/206 (8%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVK---KFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIV 701
           +G G  G+V++   +P G+   +    K      G  +FQ  E  + + A+  + H  IV
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQ--EITDHMLAMGSLDHAYIV 72

Query: 702 KFYGFCSHPKHSFIIYEYLESGSL-DKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
           +  G C       ++ +    GSL D +  +  S   L   + LN    +A  ++YL  +
Sbjct: 73  RLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDS---LDPQRLLNWCVQIAKGMYYLEEH 128

Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN--WSELAGTHGYVAPELAYT 818
               +VHR+++++N+LL       ++DFG+A  L PD     +SE      ++A E    
Sbjct: 129 R---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILF 185

Query: 819 LKVTEKCDVYSFGVLALEVIK-GKHP 843
            + T + DV+S+GV   E++  G  P
Sbjct: 186 GRYTHQSDVWSYGVTVWEMMSYGAEP 211

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 73.7 bits (181), Expect = 2e-13
 Identities = 52/165 (31%), Positives = 74/165 (44%), Gaps = 22/165 (13%)

Query: 24  VLDFSLAISSNSAEEAHALVKWKASLEVHSRSLLHSWSLSSVNATKISPCA-----WSGI 78
           V +   A S    EE  AL   K+SL +  R     W     N     PC      WSG 
Sbjct: 359 VFEIITAESKTLLEEVSALQTLKSSLGLPLR---FGW-----NG---DPCVPQQHPWSGA 407

Query: 79  FCNHAER-----VVGINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLS 133
            C          + G+ L +  L G +     S   HL  ++L  N + G IPP + +++
Sbjct: 408 DCQFDSTKGKWFIDGLGLDNQGLRGFIPN-DISKLRHLQSINLSGNSIRGNIPPSLGSIT 466

Query: 134 NLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVG 178
           +LE LD S N   G IP  +G LT L +L+++ N LSG +P  +G
Sbjct: 467 SLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 71.7 bits (176), Expect = 2e-13
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 17/209 (8%)

Query: 639 DFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFL-NEIQALTEIR 696
           D      +G G  G V+  +   S   +A+K     +P  +  +QE+ + NE + L E+ 
Sbjct: 2   DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMA--IPEVIRLKQEQHVHNEKRVLKEVS 59

Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFY 756
           H  I++ +      +  +++ EY+  G L   L N   +     +  L     +  AL Y
Sbjct: 60  HPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEY 116

Query: 757 LHNNCFPPIVHRDISSKNVLLDLGYEAHV--SDFGIAKFLNPDSSNWSELAGTHGYVAPE 814
           LH+     IV+RD+  +N+LLD   E H+  +DFG AK L      W+ L GT  Y+APE
Sbjct: 117 LHSK---EIVYRDLKPENILLD--KEGHIKLTDFGFAKKLR--DRTWT-LCGTPEYLAPE 168

Query: 815 LAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           +  +    +  D ++ G+L  E++ G  P
Sbjct: 169 VIQSKGHNKAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 71.6 bits (175), Expect = 2e-13
 Identities = 65/264 (24%), Positives = 117/264 (44%), Gaps = 21/264 (7%)

Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           +G G  G VY+A+     + A  K       E   + E+++ EI  L    H NIVK   
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEE---ELEDYMVEIDILASCDHPNIVKLLD 69

Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
              +  + +I+ E+   G++D ++      + L   Q   V K   +AL YLH N    I
Sbjct: 70  AFYYENNLWILIEFCAGGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHEN---KI 124

Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTE-- 823
           +HRD+ + N+L  L  +  ++DFG++              GT  ++APE+       +  
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 184

Query: 824 ---KCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSI 880
              K DV+S G+  +E+ + + P   L       + M + +  ++   P+L    +  S 
Sbjct: 185 YDYKADVWSLGITLIEMAQIEPPHHEL-------NPMRVLLKIAKSEPPTLAQPSRWSSE 237

Query: 881 MQVAF-SCLDQNPESRPTMKRVSQ 903
            +     CL++N ++R T  ++ Q
Sbjct: 238 FKDFLKKCLEKNVDARWTTTQLLQ 261

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 73.3 bits (180), Expect = 3e-13
 Identities = 35/91 (38%), Positives = 49/91 (53%)

Query: 330 IDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEI 389
           + L N    G I +D  +   L  +++S N+I G+IP  +G    L+ LDLS N   G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 390 PTQLGNIIYLNRLSLSGNKLSGCIPRELGSL 420
           P  LG +  L  L+L+GN LSG +P  LG  
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGR 513

Length = 623

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 71.3 bits (175), Expect = 3e-13
 Identities = 75/297 (25%), Positives = 120/297 (40%), Gaps = 44/297 (14%)

Query: 639 DFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH 697
           DF     +G G  G V +    PSG I A K  H  +   +  Q    + E++ L E   
Sbjct: 2   DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQ---IIRELKVLHECNS 58

Query: 698 RNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE--LGWTQRLNVIKGVADALF 755
             IV FYG         I  E+++ GSLD++L       E  LG      +   V   L 
Sbjct: 59  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILG-----KISIAVLRGLT 113

Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           YL       I+HRD+   N+L++   E  + DFG++  L    +N     GT  Y++PE 
Sbjct: 114 YLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPER 169

Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHP----------------------RDFLFEMSSS 853
                 T + D++S G+  +E+  G++P                      ++    +S  
Sbjct: 170 LQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGH 229

Query: 854 SSN----MNI-EMLDSRLPYPSLHVQKKLMSIMQVAF--SCLDQNPESRPTMKRVSQ 903
             +    M I E+LD  +  P   +     S     F   CL +NP+ R  +K +++
Sbjct: 230 PPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTK 286

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 72.3 bits (177), Expect = 3e-13
 Identities = 81/249 (32%), Positives = 115/249 (46%), Gaps = 17/249 (6%)

Query: 90  NLTSISLNGTLLEFSFSS---FPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLF 146
            L S+ LN   L  + S      +L  LDL NN +  I P      SNL+ LD S NK+ 
Sbjct: 94  PLPSLDLNLNRLRSNISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKI- 152

Query: 147 GQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTH 206
             +PS +  L +L  L +S N LS  +P  +  L+ LN L L  N ++  +P  +  L+ 
Sbjct: 153 ESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSA 210

Query: 207 VVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELS 266
           +  L L NNS    +   + NLK+L  LEL  N+L   +P SI NL+NL  L L +N++S
Sbjct: 211 LEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS 268

Query: 267 GIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPN 326
            I    +G+L  L  L L+ N            L  +  L L    L   +         
Sbjct: 269 SISS--LGSLTNLRELDLSGNSL-------SNALPLIALLLLLLELLLNLLLTLKALELK 319

Query: 327 LTFIDLSNN 335
           L  I L+NN
Sbjct: 320 LNSILLNNN 328

Length = 394

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 72.5 bits (178), Expect = 5e-13
 Identities = 38/91 (41%), Positives = 53/91 (58%), Gaps = 2/91 (2%)

Query: 356 VSINN--ISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCI 413
           + ++N  + G IP +I +   LQ ++LS N I G IP  LG+I  L  L LS N  +G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 414 PRELGSLINLEYLDLSANNLSNFVPESLGSL 444
           P  LG L +L  L+L+ N+LS  VP +LG  
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGR 513

Length = 623

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 70.8 bits (173), Expect = 5e-13
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 15/209 (7%)

Query: 638 NDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
           +DF     +G G  G V + +  PSG I A K  H  +   +   + + + E+Q L E  
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAI---RNQIIRELQVLHECN 61

Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE--LGWTQRLNVIKGVADAL 754
              IV FYG         I  E+++ GSLD++L       E  LG    + V++G+A   
Sbjct: 62  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVS-IAVLRGLA--- 117

Query: 755 FYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPE 814
            YL       I+HRD+   N+L++   E  + DFG++  L    +N     GT  Y++PE
Sbjct: 118 -YLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPE 172

Query: 815 LAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
                  + + D++S G+  +E+  G++P
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 70.1 bits (172), Expect = 5e-13
 Identities = 64/215 (29%), Positives = 96/215 (44%), Gaps = 34/215 (15%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRN---IV 701
           IG+G  G+V +    PSG I AVK+  S +  +   +Q+  L ++  +  +R  +   IV
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEK---EQKRLLMDLDVV--MRSSDCPYIV 66

Query: 702 KFYGFCSHPKHSFIIYEYLESGSLDKI--LCNDASAKELGWTQRLNVIKGVA----DALF 755
           KFYG        +I  E ++  SLDK      +     +       ++  +A     AL 
Sbjct: 67  KFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPE----EILGKIAVATVKALN 121

Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           YL       I+HRD+   N+LLD      + DFGI+  L  DS   +  AG   Y+APE 
Sbjct: 122 YLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLV-DSIAKTRDAGCRPYMAPER 178

Query: 816 -------AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
                   Y +    + DV+S G+   EV  GK P
Sbjct: 179 IDPSARDGYDV----RSDVWSLGITLYEVATGKFP 209

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 72.2 bits (177), Expect = 6e-13
 Identities = 41/103 (39%), Positives = 61/103 (59%), Gaps = 1/103 (0%)

Query: 378 LDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFV 437
           L L +  + G IP  +  + +L  ++LSGN + G IP  LGS+ +LE LDLS N+ +  +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 438 PESLGSLVKLYYLNLSHNKLSQQIPIELDN-LIHLSELDLSHN 479
           PESLG L  L  LNL+ N LS ++P  L   L+H +  + + N
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525

Length = 623

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 70.0 bits (171), Expect = 6e-13
 Identities = 83/304 (27%), Positives = 132/304 (43%), Gaps = 56/304 (18%)

Query: 628 IVYEEIISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLN 687
           I+++     ++ +     IGKG +G V++         A  K   P+  ++  + E   N
Sbjct: 8   IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYN 66

Query: 688 EIQALTEIRHRNIVKFYG--FCSHPKHSFIIYEYLESGSLDKILCNDASAKEL--GWTQR 743
            ++AL++  H N+VKFYG  +    K+   ++  LE       LCN  S  +L  G+ +R
Sbjct: 67  ILKALSD--HPNVVKFYGMYYKKDVKNGDQLWLVLE-------LCNGGSVTDLVKGFLKR 117

Query: 744 LN---------VIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL 794
                      ++      L +LH N     +HRD+   N+LL       + DFG++  L
Sbjct: 118 GERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQL 174

Query: 795 NPDSSNWSELAGTHGYVAPEL---AYTLKVT--EKCDVYSFGVLALEVIKGK------HP 843
                  +   GT  ++APE+      L  T   +CDV+S G+ A+E+  G       HP
Sbjct: 175 TSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234

Query: 844 RDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAF--SCLDQNPESRPTMKRV 901
              LF++              R P P+LH Q +L S     F   CL ++ E RPT   V
Sbjct: 235 MRALFKI-------------PRNPPPTLH-QPELWSNEFNDFIRKCLTKDYEKRPT---V 277

Query: 902 SQLL 905
           S LL
Sbjct: 278 SDLL 281

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 70.4 bits (172), Expect = 7e-13
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 15/209 (7%)

Query: 638 NDFNAEHCIGKGGHGSVYR-AKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
           +DF     +G G  G V++ +  PSG I A K  H  +   +   + + + E+Q L E  
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAI---RNQIIRELQVLHECN 61

Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE--LGWTQRLNVIKGVADAL 754
              IV FYG         I  E+++ GSLD++L       E  LG    + VIKG    L
Sbjct: 62  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVS-IAVIKG----L 116

Query: 755 FYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPE 814
            YL       I+HRD+   N+L++   E  + DFG++  L    +N     GT  Y++PE
Sbjct: 117 TYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPE 172

Query: 815 LAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
                  + + D++S G+  +E+  G++P
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 70.1 bits (171), Expect = 7e-13
 Identities = 64/264 (24%), Positives = 116/264 (43%), Gaps = 23/264 (8%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVK---KFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIV 701
           +G G  G+VY+   VP GE   +    K  +   G  +    EF++E   +  + H ++V
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKA--NVEFMDEALIMASMDHPHLV 72

Query: 702 KFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNC 761
           +  G C  P    ++ + +  G L   +        +G    LN    +A  + YL    
Sbjct: 73  RLLGVCLSPTIQ-LVTQLMPHGCLLDYV--HEHKDNIGSQLLLNWCVQIAKGMMYLEER- 128

Query: 762 FPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH--GYVAPELAYTL 819
              +VHRD++++NVL+       ++DFG+A+ L  D   ++   G     ++A E  +  
Sbjct: 129 --RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR 186

Query: 820 KVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLM 878
           K T + DV+S+GV   E++  G  P D +     +    ++     RLP P +      +
Sbjct: 187 KFTHQSDVWSYGVTIWELMTFGGKPYDGI----PTREIPDLLEKGERLPQPPICT----I 238

Query: 879 SIMQVAFSCLDQNPESRPTMKRVS 902
            +  V   C   + +SRP  K ++
Sbjct: 239 DVYMVMVKCWMIDADSRPKFKELA 262

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 70.1 bits (172), Expect = 8e-13
 Identities = 63/218 (28%), Positives = 98/218 (44%), Gaps = 34/218 (15%)

Query: 639 DFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEE------FLNEIQA 691
           +F   + IG+G +G VYRA+   SGEI A+KK        +    E        L EI  
Sbjct: 8   EFEKLNRIGEGTYGIVYRARDTTSGEIVALKK--------VRMDNERDGIPISSLREITL 59

Query: 692 LTEIRHRNIVKFYGFC--SHPKHSFIIYEYLE---SGSLDKILC--NDASAKELGWTQRL 744
           L  +RH NIV+        H    F++ EY E   +  LD +    +++  K L     L
Sbjct: 60  LLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCL----ML 115

Query: 745 NVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSEL 804
            +++G+     YLH N    I+HRD+   N+LL       ++DFG+A+     +   +  
Sbjct: 116 QLLRGLQ----YLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPK 168

Query: 805 AGTHGYVAPELAY-TLKVTEKCDVYSFGVLALEVIKGK 841
             T  Y APEL       T   D+++ G +  E++  K
Sbjct: 169 VVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 69.2 bits (169), Expect = 8e-13
 Identities = 70/275 (25%), Positives = 118/275 (42%), Gaps = 26/275 (9%)

Query: 643 EHCIGKGGHGSVYRA--KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNI 700
           E  +G G  G + R   K+PS     V   H+   G    Q+  FL E   L +  H NI
Sbjct: 10  ERILGTGRFGELCRGCLKLPSKRELPVA-IHTLRAGCSDKQRRGFLAEALTLGQFDHSNI 68

Query: 701 VKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
           V+  G  +      I+ EY+ +G+LD  L       +L   Q + ++ G+A  + YL   
Sbjct: 69  VRLEGVITRGNTMMIVTEYMSNGALDSFL--RKHEGQLVAGQLMGMLPGLASGMKYLSEM 126

Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN--WSELAGTHG--YVAPELA 816
            +   VH+ +++  VL++      +S F     L  D S   ++ ++G     + APE  
Sbjct: 127 GY---VHKGLAAHKVLVNSDLVCKISGFRR---LQEDKSEAIYTTMSGKSPVLWAAPEAI 180

Query: 817 YTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDS-RLPYPSLHVQ 874
                +   DV+SFG++  EV+  G+ P    ++MS       +E  D  RLP P  +  
Sbjct: 181 QYHHFSSASDVWSFGIVMWEVMSYGERP---YWDMSGQDVIKAVE--DGFRLPAPR-NCP 234

Query: 875 KKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI 909
             L  +M     C  +    RP   ++  +L + +
Sbjct: 235 NLLHQLM---LDCWQKERGERPRFSQIHSILSKMV 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 69.5 bits (170), Expect = 8e-13
 Identities = 73/266 (27%), Positives = 119/266 (44%), Gaps = 33/266 (12%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +GKG +GSVY+    P+G   A+K+    L  E  F Q   + E+  L +     IV FY
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELD-ESKFNQ--IIMELDILHKAVSPYIVDFY 65

Query: 705 GFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYL---HNNC 761
           G        ++  EY+++GSLDK+     + + +       +   V   L +L   HN  
Sbjct: 66  GAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN-- 123

Query: 762 FPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPE------- 814
              I+HRD+   NVL++   +  + DFG++   N  +S      G   Y+APE       
Sbjct: 124 ---IIHRDVKPTNVLVNGNGQVKLCDFGVSG--NLVASLAKTNIGCQSYMAPERIKSGGP 178

Query: 815 ---LAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSL 871
                YT+    + DV+S G+  LE+  G++P  +  E  ++       ++D     P+L
Sbjct: 179 NQNPTYTV----QSDVWSLGLSILEMALGRYP--YPPETYANIFAQLSAIVDG--DPPTL 230

Query: 872 HVQKKLMSIMQVAFSCLDQNPESRPT 897
                  +   VA  CL++ P  RPT
Sbjct: 231 PSGYSDDAQDFVA-KCLNKIPNRRPT 255

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 68.9 bits (168), Expect = 1e-12
 Identities = 66/270 (24%), Positives = 123/270 (45%), Gaps = 15/270 (5%)

Query: 639 DFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEM--SFQQEEFLNEIQALTEI 695
           +F  E  IG+G    VYRA  +   +  A+KK       EM  +  +++ + EI  L ++
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQI---FEMMDAKARQDCVKEIDLLKQL 59

Query: 696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRL-NVIKGVADAL 754
            H N++K+           I+ E  ++G L +++      K L   + +      +  A+
Sbjct: 60  NHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAV 119

Query: 755 FYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPE 814
            ++H+     ++HRDI   NV +       + D G+ +F +  ++    L GT  Y++PE
Sbjct: 120 EHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176

Query: 815 LAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQ 874
             +      K D++S G L  E+   + P  +  +M+  S    IE  D   P P+ H  
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPF-YGDKMNLFSLCQKIEQCDYP-PLPTEHYS 234

Query: 875 KKLMSIMQVAFSCLDQNPESRPTMKRVSQL 904
           +KL  ++ +   C+  +P+ RP +  V Q+
Sbjct: 235 EKLRELVSM---CIYPDPDQRPDIGYVHQI 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 70.6 bits (173), Expect = 2e-12
 Identities = 37/93 (39%), Positives = 54/93 (58%)

Query: 182 VLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQL 241
            ++ L LD+  L G IP  +  L H+  + L  NS  G+IP  +G++ SL  L+L  N  
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478

Query: 242 SGAIPLSISNLTNLRFLFLYHNELSGIIPQEIG 274
           +G+IP S+  LT+LR L L  N LSG +P  +G
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 72/267 (26%), Positives = 110/267 (41%), Gaps = 31/267 (11%)

Query: 645 CIGKGGHGSVYRA--KVPSGEIF--AVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNI 700
           CIG+G  G VY+     P  E    AVK   +     +    E+FL E   + +  H +I
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVR---EKFLQEAYIMRQFDHPHI 69

Query: 701 VKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIK---GVADALFYL 757
           VK  G  +     +I+ E    G L   L               ++I     ++ AL YL
Sbjct: 70  VKLIGVITENP-VWIVMELAPLGELRSYL-----QVNKYSLDLASLILYSYQLSTALAYL 123

Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH--GYVAPEL 815
            +  F   VHRDI+++NVL+       + DFG++++L  D S +    G     ++APE 
Sbjct: 124 ESKRF---VHRDIAARNVLVSSPDCVKLGDFGLSRYLE-DESYYKASKGKLPIKWMAPES 179

Query: 816 AYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQ 874
               + T   DV+ FGV   E++  G  P      + ++     IE    RLP P     
Sbjct: 180 INFRRFTSASDVWMFGVCMWEILMLGVKP---FQGVKNNDVIGRIEN-GERLPMPPN-CP 234

Query: 875 KKLMSIMQVAFSCLDQNPESRPTMKRV 901
             L S+M     C   +P  RP    +
Sbjct: 235 PTLYSLMT---KCWAYDPSKRPRFTEL 258

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 68.3 bits (167), Expect = 2e-12
 Identities = 62/230 (26%), Positives = 108/230 (46%), Gaps = 39/230 (16%)

Query: 638 NDFNAEHCIGKGGHGSVYRAKVP---SGEIF---AVKKFHSPLPGEMSFQ-QEEFLNEIQ 690
           N+      IG+G  G V++A+ P     E F   AVK     L  E S   Q +F  E  
Sbjct: 5   NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKM----LKEEASADMQADFQREAA 60

Query: 691 ALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKIL--------CNDASAK------ 736
            + E  H NIVK  G C+  K   +++EY+  G L++ L        C+ + +       
Sbjct: 61  LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120

Query: 737 -----ELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIA 791
                 L  T++L + K VA  + YL    F   VHRD++++N L+       ++DFG++
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYLSERKF---VHRDLATRNCLVGENMVVKIADFGLS 177

Query: 792 KFLNPDSSNWSELAGTHG----YVAPELAYTLKVTEKCDVYSFGVLALEV 837
           +  N  S+++ + +        ++ PE  +  + T + DV+++GV+  E+
Sbjct: 178 R--NIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 68.8 bits (168), Expect = 3e-12
 Identities = 70/211 (33%), Positives = 105/211 (49%), Gaps = 8/211 (3%)

Query: 269 IPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLT 328
             + + NL  L SL L  N  R  + +    LT+L  L L+ N +T           NL 
Sbjct: 85  GSENLLNLLPLPSLDLNLNRLRSNISELL-ELTNLTSLDLDNNNITDIPPLIGLLKSNLK 143

Query: 329 FIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGE 388
            +DLS+N     + S     P L  LD+S N++S  +P  +     L  LDLS N  + +
Sbjct: 144 ELDLSDNKI-ESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGN-KISD 200

Query: 389 IPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLY 448
           +P ++  +  L  L LS N +   +   L +L NL  L+LS NN    +PES+G+L  L 
Sbjct: 201 LPPEIELLSALEELDLSNNSIIELLS-SLSNLKNLSGLELS-NNKLEDLPESIGNLSNLE 258

Query: 449 YLNLSHNKLSQQIPIELDNLIHLSELDLSHN 479
            L+LS+N++S    +   +L +L ELDLS N
Sbjct: 259 TLDLSNNQISSISSLG--SLTNLRELDLSGN 287

Length = 394

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 68.1 bits (166), Expect = 3e-12
 Identities = 71/294 (24%), Positives = 127/294 (43%), Gaps = 45/294 (15%)

Query: 646 IGKGGHGSVYRAKV------PSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRN 699
           +G+G  G V +A              AVK          S +  + L+E   L ++ H +
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKE---NASSSELRDLLSEFNLLKQVNHPH 64

Query: 700 IVKFYGFCSHPKHSFIIYEYLESGSLD-------KILC-------NDASAKELGWTQRLN 745
           ++K YG CS      +I EY + GSL        K+         N  S+      +R  
Sbjct: 65  VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124

Query: 746 VIKGV-------ADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS 798
            +  +       +  + YL       +VHRD++++NVL+  G +  +SDFG+++ +  + 
Sbjct: 125 TMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED 181

Query: 799 SNWSELAG--THGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSS 855
           S      G     ++A E  +    T + DV+SFGVL  E++  G +P    +   +   
Sbjct: 182 SYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP----YPGIAPER 237

Query: 856 NMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI 909
             N+     R+  P  +  +++ ++M    +C  Q P+ RPT   +S+ L EK+
Sbjct: 238 LFNLLKTGYRMERPE-NCSEEMYNLM---LTCWKQEPDKRPTFADISKEL-EKM 286

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 67.8 bits (166), Expect = 3e-12
 Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 28/214 (13%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH-RNIVKF 703
           +G+G +G V + + VP+G I AVK+  + +    S +Q+  L ++            V F
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRATVN---SQEQKRLLMDLDISMRSVDCPYTVTF 65

Query: 704 YGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIK----GVADALFYLHN 759
           YG        +I  E +++ SLDK         + G T   +++      +  AL YLH+
Sbjct: 66  YGALFREGDVWICMEVMDT-SLDKFYKK---VYDKGLTIPEDILGKIAVSIVKALEYLHS 121

Query: 760 NCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL---- 815
                ++HRD+   NVL++   +  + DFGI+ +L  DS   +  AG   Y+APE     
Sbjct: 122 KL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYL-VDSVAKTIDAGCKPYMAPERINPE 178

Query: 816 ----AYTLKVTEKCDVYSFGVLALEVIKGKHPRD 845
                Y +    K DV+S G+  +E+  G+ P D
Sbjct: 179 LNQKGYDV----KSDVWSLGITMIELATGRFPYD 208

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 68.2 bits (167), Expect = 3e-12
 Identities = 70/274 (25%), Positives = 114/274 (41%), Gaps = 62/274 (22%)

Query: 646 IGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEF---LNE--IQALTEIRHRN 699
           +GKG  G V  A++  + E++AVK     L  ++  Q ++    + E  + AL   +H  
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKV----LKKDVILQDDDVECTMTEKRVLALAG-KHPF 57

Query: 700 IVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIK---------GV 750
           + + +         F + EY+  G L            +   QR               +
Sbjct: 58  LTQLHSCFQTKDRLFFVMEYVNGGDL------------MFHIQRSGRFDEPRARFYAAEI 105

Query: 751 ADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHV--SDFGIAK--FLNPDSSNWSELAG 806
              L +LH      I++RD+   NVLLD   E H+  +DFG+ K   L   ++  S   G
Sbjct: 106 VLGLQFLHER---GIIYRDLKLDNVLLD--SEGHIKIADFGMCKEGILGGVTT--STFCG 158

Query: 807 THGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP-----RDFLFEMSSSSSNMNIEM 861
           T  Y+APE+          D ++ GVL  E++ G+ P      D LF+        +I  
Sbjct: 159 TPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQ--------SILE 210

Query: 862 LDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESR 895
            + R P     + K+  SI++   S L +NPE R
Sbjct: 211 DEVRYP---RWLSKEAKSILK---SFLTKNPEKR 238

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 67.6 bits (165), Expect = 3e-12
 Identities = 72/290 (24%), Positives = 112/290 (38%), Gaps = 55/290 (18%)

Query: 646 IGKGGHGSVYRAKVPSGEIFA---VKKFH-SPLPGEMSFQQEEFLNEIQALTEIRHRNIV 701
           IG G  G V   +   G   A   VK+   S  P E    Q  FL E+Q   E+ H N++
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDE----QLLFLQEVQPYRELNHPNVL 58

Query: 702 KFYGFCSHPKHSFIIYEYLESGSLDKIL--CNDASAKELGWTQRLNVIKGVADALFYLHN 759
           +  G C       ++ E+   G L   L       A+         +   VA  L +LH 
Sbjct: 59  QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118

Query: 760 NCFPPIVHRDISSKNVLLDLGYEAHVSDFGIA------KFLNPDSSNWSELAGTHGYVAP 813
             F   +H D++ +N  L       + D+G+A       +      +   L     ++AP
Sbjct: 119 ADF---IHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR----WLAP 171

Query: 814 ELA-------YTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS--SSNMNIEML-- 862
           EL             T+K +++S GV   E          LF  +        + ++L  
Sbjct: 172 ELVEIRGQDLLPKDQTKKSNIWSLGVTMWE----------LFTAADQPYPDLSDEQVLKQ 221

Query: 863 -----DSRLPYPSLHVQ--KKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
                D +LP P L ++   +   +MQ  F  LD  PE+RPT + V +LL
Sbjct: 222 VVREQDIKLPKPQLDLKYSDRWYEVMQ--FCWLD--PETRPTAEEVHELL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 67.5 bits (165), Expect = 3e-12
 Identities = 81/281 (28%), Positives = 128/281 (45%), Gaps = 44/281 (15%)

Query: 646 IGKGGHGSVYRAKV----PSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIV 701
           IGKG  G VY   +          AVK  +     E   + E+FL E   + +  H N++
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLE---EVEQFLKEGIIMKDFSHPNVL 59

Query: 702 KFYGFCSHPKHS-FIIYEYLESGSLDKILCNDA---SAKEL-GWTQRLNVIKGVADALFY 756
              G C   + S  ++  Y++ G L   + ++    + K+L G+   L V KG+     Y
Sbjct: 60  SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFG--LQVAKGME----Y 113

Query: 757 LHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG-----YV 811
           L +  F   VHRD++++N +LD  +   V+DFG+A+ +  D   +S    T       ++
Sbjct: 114 LASKKF---VHRDLAARNCMLDESFTVKVADFGLARDIY-DKEYYSVHNHTGAKLPVKWM 169

Query: 812 APELAYTLKVTEKCDVYSFGVLALEVI-KGKHP-RDFLFEMSSSSSNMNIEMLDS-RLPY 868
           A E   T K T K DV+SFGVL  E++ +G  P  D        S ++ + +L   RL  
Sbjct: 170 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV------DSFDITVYLLQGRRLLQ 223

Query: 869 PSLHVQKKLMSIMQVAFSCLDQNPESRPT----MKRVSQLL 905
           P  +    L  +M    SC    PE RPT    + R+ Q+ 
Sbjct: 224 PE-YCPDPLYEVML---SCWHPKPEMRPTFSELVSRIEQIF 260

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 67.8 bits (166), Expect = 3e-12
 Identities = 50/206 (24%), Positives = 100/206 (48%), Gaps = 28/206 (13%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKF----HSPLPGEMSFQQEEFLNEIQALTEIRHRNI 700
           IG+G +G V++ +   +G+I A+KKF      P+  +++      L EI+ L +++H N+
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIA------LREIRMLKQLKHPNL 62

Query: 701 VKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLH-N 759
           V         +   +++EY +   L+++   + + + +       +I     A+ + H +
Sbjct: 63  VNLIEVFRRKRKLHLVFEYCDHTVLNEL---EKNPRGVPEHLIKKIIWQTLQAVNFCHKH 119

Query: 760 NCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL---- 815
           NC    +HRD+  +N+L+    +  + DFG A+ L     ++++   T  Y APEL    
Sbjct: 120 NC----IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGD 175

Query: 816 -AYTLKVTEKCDVYSFGVLALEVIKG 840
             Y   V    DV++ G +  E++ G
Sbjct: 176 TQYGPPV----DVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 67.5 bits (165), Expect = 6e-12
 Identities = 63/208 (30%), Positives = 97/208 (46%), Gaps = 22/208 (10%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           IGKG +G V  A    +GE  A+KK +     E        L EI+ L  +RH +IV+  
Sbjct: 8   IGKGSYGVVCSAIDTHTGEKVAIKKINDVF--EHVSDATRILREIKLLRLLRHPDIVEIK 65

Query: 705 GFCSHP-----KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLH- 758
                P     K  ++++E +ES     I  ND    E        +++     L Y+H 
Sbjct: 66  HIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRA----LKYIHT 121

Query: 759 NNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK--FLN-PDSSNWSELAGTHGYVAPEL 815
            N F    HRD+  KN+L +   +  + DFG+A+  F + P +  W++   T  Y APEL
Sbjct: 122 ANVF----HRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 177

Query: 816 --AYTLKVTEKCDVYSFGVLALEVIKGK 841
             ++  K T   D++S G +  EV+ GK
Sbjct: 178 CGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 66.4 bits (162), Expect = 7e-12
 Identities = 50/193 (25%), Positives = 91/193 (47%), Gaps = 7/193 (3%)

Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           +G+G  G V+  +  + +   + K   P+      ++    NE Q L  + H NI+++Y 
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIK-QIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66

Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
                K   I+ EY   G+L + +        L     L+    +  AL ++H      I
Sbjct: 67  NFLEDKALMIVMEYAPGGTLAEYI-QKRCNSLLDEDTILHFFVQILLALHHVHTKL---I 122

Query: 766 VHRDISSKNVLLDLGYE-AHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEK 824
           +HRD+ ++N+LLD       + DFGI+K L+  S  ++ + GT  Y++PEL       +K
Sbjct: 123 LHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT-VVGTPCYISPELCEGKPYNQK 181

Query: 825 CDVYSFGVLALEV 837
            D+++ G +  E+
Sbjct: 182 SDIWALGCVLYEL 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 66.6 bits (163), Expect = 8e-12
 Identities = 64/299 (21%), Positives = 113/299 (37%), Gaps = 76/299 (25%)

Query: 646 IGKGGHGSVYR---AKVPSGEIF---AVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRN 699
           +G+G  G VY      V  GE     A+K  +         ++ EFLNE   + E    +
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN---ENASMRERIEFLNEASVMKEFNCHH 70

Query: 700 IVKFYGFCSHPKHSFIIYEYLESGSL----------DKILCNDASAKELGWTQRLNVIKG 749
           +V+  G  S  + + ++ E +  G L           +              + + +   
Sbjct: 71  VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGP---PTLQKFIQMAAE 127

Query: 750 VADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH- 808
           +AD + YL    F   VHRD++++N ++       + DFG+ + +    +++    G   
Sbjct: 128 IADGMAYLAAKKF---VHRDLAARNCMVAEDLTVKIGDFGMTRDIY--ETDYYRKGGKGL 182

Query: 809 ---GYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSR 865
               ++APE       T K DV+SFGV+             L+EM++ +           
Sbjct: 183 LPVRWMAPESLKDGVFTTKSDVWSFGVV-------------LWEMATLAE---------- 219

Query: 866 LPYPSL-------------HVQK------KLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
            PY  L             H+        KL+ +M++   C   NP+ RPT   +   L
Sbjct: 220 QPYQGLSNEEVLKFVIDGGHLDLPENCPDKLLELMRM---CWQYNPKMRPTFLEIVSSL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 68.3 bits (167), Expect = 1e-11
 Identities = 50/177 (28%), Positives = 71/177 (40%), Gaps = 28/177 (15%)

Query: 426 LDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKI 485
           L L    L  F+P  +  L  L  +NLS N +   IP  L ++  L  LDLS+N     I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 486 SSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNSTTFRDAPLE 545
              + ++ SL  LNL+ N+LSG +P     + G L        L     N T        
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVP---AALGGRL--------LHRASFNFTD------- 524

Query: 546 ALQGNKGLYGDIRGFPSCMSYKKASRKIWIVIVFPLLGMVALFIALTGFFFIFHQRK 602
               N GL G I G  +C  +     KI I       G+   F+ L      + +R+
Sbjct: 525 ----NAGLCG-IPGLRACGPHLSVGAKIGIA-----FGVSVAFLFLVICAMCWWKRR 571

Length = 623

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 65.7 bits (160), Expect = 1e-11
 Identities = 66/255 (25%), Positives = 117/255 (45%), Gaps = 20/255 (7%)

Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G  G+VY+A  + +  I AVK     +  E+   Q++ ++E++ L +     I+ FY
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVEL---QKQIMSELEILYKCDSPYIIGFY 65

Query: 705 GFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP 764
           G         I  E+++ GSLD  +        LG   R+ V   V   L YL +     
Sbjct: 66  GAFFVENRISICTEFMDGGSLD--VYRKIPEHVLG---RIAV--AVVKGLTYLWS---LK 115

Query: 765 IVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEK 824
           I+HRD+   N+L++   +  + DFG++  L   +S      GT+ Y+APE     +    
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV--NSIAKTYVGTNAYMAPERISGEQYGIH 173

Query: 825 CDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPY--PSLHVQKKLMSIMQ 882
            DV+S G+  +E+  G+ P   + +  +  S M +++L   +    P L V +     + 
Sbjct: 174 SDVWSLGISFMELALGRFPYPQIQK--NQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVH 231

Query: 883 VAFSCLDQNPESRPT 897
               C+ + P+ RP 
Sbjct: 232 FITQCMRKQPKERPA 246

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 65.6 bits (160), Expect = 2e-11
 Identities = 60/212 (28%), Positives = 91/212 (42%), Gaps = 33/212 (15%)

Query: 646 IGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEE--FLNEIQALTEIRHRNIVK 702
           +GKGG G V   +V  +G+++A KK        +  ++ E   LNE + L ++  R IV 
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKK---RLKKRKGEQMALNEKKILEKVSSRFIVS 57

Query: 703 F-YGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFY----- 756
             Y F +      ++   +  G L   + N     E G+ +        A A+FY     
Sbjct: 58  LAYAFETKDDLCLVM-TLMNGGDLKYHIYN---VGEPGFPE--------ARAIFYAAQII 105

Query: 757 -----LHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV 811
                LH      IV+RD+  +NVLLD      +SD G+A  L          AGT GY+
Sbjct: 106 CGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVEL-KGGKKIKGRAGTPGYM 161

Query: 812 APELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           APE+          D ++ G    E+I G+ P
Sbjct: 162 APEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 65.9 bits (161), Expect = 2e-11
 Identities = 56/211 (26%), Positives = 94/211 (44%), Gaps = 19/211 (9%)

Query: 638 NDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
            DF     +G+GG+G V+ A K  +GEI A+K+    L  +++ +    L E   LT  +
Sbjct: 1   KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLN-EVRHVLTERDILTTTK 59

Query: 697 HRNIVK-FYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVA--DA 753
              +VK  Y F    ++ ++  EY+  G    +L N     E     R  + +     DA
Sbjct: 60  SEWLVKLLYAF-QDDEYLYLAMEYVPGGDFRTLLNNLGVLSED--HARFYMAEMFEAVDA 116

Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK-FLNPDSSNWSELAGTHGYVA 812
           L  L        +HRD+  +N L+D      ++DFG++K  +   +S    + G+  Y+A
Sbjct: 117 LHELG------YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS----VVGSPDYMA 166

Query: 813 PELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           PE+          D +S G +  E + G  P
Sbjct: 167 PEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP 197

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 65.7 bits (161), Expect = 2e-11
 Identities = 52/208 (25%), Positives = 97/208 (46%), Gaps = 27/208 (12%)

Query: 646 IGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEF----LNEIQALTEIRHRNI 700
           +G+G +  VY+A+   +G I A+KK      GE    ++      L EI+ L E++H NI
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIK---LGERKEAKDGINFTALREIKLLQELKHPNI 64

Query: 701 VKFYGFCSHPKHSFIIYEYLESGSLDKILCN------DASAKELGWTQRLNVIKGVADAL 754
           +       H  +  +++E++E+  L+K++ +       A  K   +      ++G+    
Sbjct: 65  IGLLDVFGHKSNINLVFEFMET-DLEKVIKDKSIVLTPADIK--SYMLMT--LRGLE--- 116

Query: 755 FYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPE 814
            YLH+N    I+HRD+   N+L+       ++DFG+A+     +   +    T  Y APE
Sbjct: 117 -YLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPE 172

Query: 815 LAY-TLKVTEKCDVYSFGVLALEVIKGK 841
           L +         D++S G +  E++   
Sbjct: 173 LLFGARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 70/293 (23%), Positives = 126/293 (43%), Gaps = 55/293 (18%)

Query: 638 NDFNAEHCIGKGGHGSVYRAKVPSGEI---FAVKKFHSPLPGEMSFQQEEFLNEIQALTE 694
           ND   +  IG+G  G V +A++    +    A+K+       +      +F  E++ L +
Sbjct: 7   NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD---DHRDFAGELEVLCK 63

Query: 695 I-RHRNIVKFYGFCSHPKHSFIIYEYLESGSL------DKILCND-------ASAKELGW 740
           +  H NI+   G C H  + ++  EY   G+L       ++L  D       ++A  L  
Sbjct: 64  LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 123

Query: 741 TQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN 800
            Q L+    VA  + YL    F   +HRD++++N+L+   Y A ++DFG+++        
Sbjct: 124 QQLLHFAADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSR------GQ 174

Query: 801 WSELAGTHG-----YVAPE-LAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSS 853
              +  T G     ++A E L Y++  T   DV+S+GVL  E++  G  P          
Sbjct: 175 EVYVKKTMGRLPVRWMAIESLNYSVYTTNS-DVWSYGVLLWEIVSLGGTP---------- 223

Query: 854 SSNMNIEMLDSRLPY-----PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
              M    L  +LP        L+   ++  +M+    C  + P  RP+  ++
Sbjct: 224 YCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMR---QCWREKPYERPSFAQI 273

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 64.9 bits (159), Expect = 3e-11
 Identities = 49/211 (23%), Positives = 97/211 (45%), Gaps = 34/211 (16%)

Query: 645 CIGKGGHGSVYRAKVPS-GEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVK 702
            +G G  GSVY A+    GE+ A+KK         S+++   L E+++L ++  H NIVK
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKMKKKFY---SWEECMNLREVKSLRKLNEHPNIVK 62

Query: 703 FYGFCSHPKHSFIIYEYLESGSL-------DKILCNDASAKELGWTQRLNVIKGVADALF 755
                      + ++EY+E G+L            +++  +        ++I  +   L 
Sbjct: 63  LKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIR--------SIIYQILQGLA 113

Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           ++H + F    HRD+  +N+L+       ++DFG+A+ +      +++   T  Y APE+
Sbjct: 114 HIHKHGF---FHRDLKPENLLVSGPEVVKIADFGLAREIR-SRPPYTDYVSTRWYRAPEI 169

Query: 816 -----AYTLKVTEKCDVYSFGVLALEVIKGK 841
                +Y+  V    D+++ G +  E+   +
Sbjct: 170 LLRSTSYSSPV----DIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 64.4 bits (157), Expect = 3e-11
 Identities = 55/211 (26%), Positives = 86/211 (40%), Gaps = 35/211 (16%)

Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHR-----N 699
           I KG  GSVY A K  +G+ FA+K     L       + +  N ++A   I         
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKV----LKKSDMIAKNQVTN-VKAERAIMMIQGESPY 58

Query: 700 IVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELG-----WTQRLNVIKGVADAL 754
           + K Y       + +++ EYL  G    ++      K LG     W +    I  V   +
Sbjct: 59  VAKLYYSFQSKDYLYLVMEYLNGGDCASLI------KTLGGLPEDWAK--QYIAEVVLGV 110

Query: 755 FYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK--FLNPDSSNWSELAGTHGYVA 812
             LH      I+HRDI  +N+L+D      ++DFG+++    N          GT  Y+A
Sbjct: 111 EDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK------FVGTPDYLA 161

Query: 813 PELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           PE    +   +  D +S G +  E + G  P
Sbjct: 162 PETILGVGDDKMSDWWSLGCVIFEFLFGYPP 192

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 65.0 bits (158), Expect = 3e-11
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 42/226 (18%)

Query: 639 DFNAEHCIGKGGHGSVYRAKVP------SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQAL 692
           D   E  IG+G  G V RA +       +  I  +K+F S           +F  E++ L
Sbjct: 3   DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFAS------ENDHRDFAGELEVL 56

Query: 693 TEI-RHRNIVKFYGFCSHPKHSFIIYEYLESGSL------DKILCND-ASAKELGWT--- 741
            ++  H NI+   G C +  + +I  EY   G+L       ++L  D A AKE G     
Sbjct: 57  CKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTL 116

Query: 742 ---QRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS 798
              Q L     VA  + YL    F   +HRD++++NVL+     + ++DFG+++      
Sbjct: 117 TSQQLLQFASDVATGMQYLSEKQF---IHRDLAARNVLVGENLASKIADFGLSR------ 167

Query: 799 SNWSELAGTHG-----YVAPE-LAYTLKVTEKCDVYSFGVLALEVI 838
                +  T G     ++A E L Y++  T K DV+SFGVL  E++
Sbjct: 168 GEEVYVKKTMGRLPVRWMAIESLNYSVYTT-KSDVWSFGVLLWEIV 212

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 63.8 bits (155), Expect = 5e-11
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 20/207 (9%)

Query: 646 IGKGGHGSVYRA--KVPSGEI-FAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVK 702
           +G G  G V +   K+   +I  A+K   +         ++E + E + + ++ +  IV+
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKN---ENEKSVRDEMMREAEIMHQLDNPYIVR 59

Query: 703 FYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
             G C   +   ++ E    G L+K L       E+  +  + ++  V+  + YL    F
Sbjct: 60  MIGVC-EAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKNF 116

Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG-----YVAPELAY 817
              VHRD++++NVLL   + A +SDFG++K L  D S +   A + G     + APE   
Sbjct: 117 ---VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK--ARSAGKWPLKWYAPECIN 171

Query: 818 TLKVTEKCDVYSFGVLALEVIK-GKHP 843
             K + + DV+S+G+   E    G+ P
Sbjct: 172 FRKFSSRSDVWSYGITMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 65.6 bits (160), Expect = 8e-11
 Identities = 32/87 (36%), Positives = 45/87 (51%)

Query: 210 LYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGII 269
           L L N    G IP +I  L+ L  + L  N + G IP S+ ++T+L  L L +N  +G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 270 PQEIGNLKKLNSLLLAKNHFRGTVPKS 296
           P+ +G L  L  L L  N   G VP +
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAA 509

Length = 623

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 63.3 bits (154), Expect = 1e-10
 Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 42/215 (19%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEE------FLNEIQALTEIRHR 698
           IG+G +G VY+A+   + E  A+KK        +  +QE+       + EI  L E++H 
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKK--------IRLEQEDEGVPSTAIREISLLKEMQHG 61

Query: 699 NIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRL------NVIKGVAD 752
           NIV+        K  ++++EYL+   LD     D+S  +     RL       +++G+A 
Sbjct: 62  NIVRLQDVVHSEKRLYLVFEYLD---LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIA- 116

Query: 753 ALFYLHNNCFPPIVHRDISSKNVLLDLGYEA-HVSDFGIAKFLNPDSSNWSELAGTHGYV 811
              Y H++    ++HRD+  +N+L+D    A  ++DFG+A+        ++    T  Y 
Sbjct: 117 ---YCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYR 170

Query: 812 APEL-----AYTLKVTEKCDVYSFGVLALEVIKGK 841
           APE+      Y+  V    D++S G +  E++  K
Sbjct: 171 APEILLGSRHYSTPV----DIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 63.4 bits (155), Expect = 1e-10
 Identities = 56/204 (27%), Positives = 102/204 (50%), Gaps = 20/204 (9%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEF----LNEIQALTEIRHRNI 700
           I +G +G VYRA+   +GEI A+KK       +M  ++E F    L EI  L +++H NI
Sbjct: 13  IEEGTYGVVYRARDKKTGEIVALKKL------KMEKEKEGFPITSLREINILLKLQHPNI 66

Query: 701 V--KFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLH 758
           V  K     S+    +++ EY+E   L  ++  +   +    ++   ++  +   + +LH
Sbjct: 67  VTVKEVVVGSNLDKIYMVMEYVEH-DLKSLM--ETMKQPFLQSEVKCLMLQLLSGVAHLH 123

Query: 759 NNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAY- 817
           +N    I+HRD+ + N+LL+      + DFG+A+        +++L  T  Y APEL   
Sbjct: 124 DNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLG 180

Query: 818 TLKVTEKCDVYSFGVLALEVIKGK 841
             + +   D++S G +  E++  K
Sbjct: 181 AKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 63.1 bits (153), Expect = 1e-10
 Identities = 64/275 (23%), Positives = 113/275 (41%), Gaps = 31/275 (11%)

Query: 639 DFNAEHCIGKGGHGSVYRAK-VPSGE-------IFAVKKFHSPLPGEMSFQQEEFLNEIQ 690
           +F     +G G  G+VY+   +P GE       I  +++  SP         +E L+E  
Sbjct: 8   EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK------ANKEILDEAY 61

Query: 691 ALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGV 750
            +  + + ++ +  G C       I         LD +  +      +G    LN    +
Sbjct: 62  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQI 118

Query: 751 ADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH-- 808
           A  + YL       +VHRD++++NVL+       ++DFG+AK L  D   +    G    
Sbjct: 119 AKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPI 175

Query: 809 GYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDSRLP 867
            ++A E       T + DV+S+GV   E++  G  P D +     +S   +I     RLP
Sbjct: 176 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI----PASEISSILEKGERLP 231

Query: 868 YPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVS 902
            P +      M +++    C   + +SRP  + + 
Sbjct: 232 QPPICTIDVYMIMVK----CWMIDADSRPKFRELI 262

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 62.7 bits (153), Expect = 2e-10
 Identities = 66/234 (28%), Positives = 101/234 (43%), Gaps = 48/234 (20%)

Query: 640 FNAEHCIGKGGHGSVYRAKV---PSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
           +  E CIG+G +G VY+AK      G+ +A+KKF           Q     EI  L E++
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSA-CREIALLRELK 60

Query: 697 HRNIVKFYG-FCSHPKHS-FIIYEYLESGSL---------DKILCNDASAKELGWTQRLN 745
           H N+V     F  H   S +++++Y E              ++    +  K L W Q LN
Sbjct: 61  HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLW-QILN 119

Query: 746 VIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAH----VSDFGIAKFLNPDSSNW 801
              GV     YLH+N    ++HRD+   N+L+           + D G+A+  N      
Sbjct: 120 ---GVH----YLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPL 169

Query: 802 SELAG---THGYVAPELA-----YTLKVTEKCDVYSFG-----VLALEVI-KGK 841
           ++L     T  Y APEL      YT  +    D+++ G     +L LE I KG+
Sbjct: 170 ADLDPVVVTIWYRAPELLLGARHYTKAI----DIWAIGCIFAELLTLEPIFKGR 219

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 63.3 bits (154), Expect = 3e-10
 Identities = 32/89 (35%), Positives = 46/89 (51%)

Query: 306 LRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSI 365
           L L+   L G I        +L  I+LS NS  G I    G    L +LD+S N+ +GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 366 PLEIGESLQLQYLDLSSNYIVGEIPTQLG 394
           P  +G+   L+ L+L+ N + G +P  LG
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 61.9 bits (150), Expect = 3e-10
 Identities = 55/208 (26%), Positives = 99/208 (47%), Gaps = 14/208 (6%)

Query: 638 NDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
           N F     +G+G +G V + +   + EI A+KKF      E    +E  L E++ L  ++
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEV--KETTLRELKMLRTLK 58

Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKI--LCNDASAKELGWTQRLNVIKGVADAL 754
             NIV+           ++++EY+E   L+ +  + N    +++      + I  +  A+
Sbjct: 59  QENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVR-----SYIYQLIKAI 113

Query: 755 FYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS-SNWSELAGTHGYVAP 813
            + H N    IVHRDI  +N+L+       + DFG A+ L+  S +N++E   T  Y +P
Sbjct: 114 HWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSP 170

Query: 814 ELAYTLKVTEKCDVYSFGVLALEVIKGK 841
           EL       +  D++S G +  E+  G+
Sbjct: 171 ELLLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 62.9 bits (153), Expect = 4e-10
 Identities = 34/88 (38%), Positives = 47/88 (53%), Gaps = 1/88 (1%)

Query: 239 NQ-LSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSF 297
           NQ L G IP  IS L +L+ + L  N + G IP  +G++  L  L L+ N F G++P+S 
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486

Query: 298 RNLTDLVKLRLNQNYLTGNISETFGTYP 325
             LT L  L LN N L+G +    G   
Sbjct: 487 GQLTSLRILNLNGNSLSGRVPAALGGRL 514

Length = 623

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 61.4 bits (149), Expect = 4e-10
 Identities = 48/195 (24%), Positives = 92/195 (47%), Gaps = 9/195 (4%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           IG+G +G VY+A+   +GE+ A+KK    L  E        + EI  L E+ H NIVK  
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKELNHPNIVKLL 65

Query: 705 GFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP 764
                    ++++E+L    L K + + +    +      + +  +   L + H++    
Sbjct: 66  DVIHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCHSH---R 120

Query: 765 IVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKV-TE 823
           ++HRD+  +N+L++      ++DFG+A+        ++    T  Y APE+    K  + 
Sbjct: 121 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 180

Query: 824 KCDVYSFGVLALEVI 838
             D++S G +  E++
Sbjct: 181 AVDIWSLGCIFAEMV 195

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 61.9 bits (150), Expect = 5e-10
 Identities = 92/321 (28%), Positives = 134/321 (41%), Gaps = 24/321 (7%)

Query: 143 NKLFGQIPSGIGLLTHLTVLHISRNWL--SGSIPHEVGQLTVLNQLALDSNFLNGSIPRS 200
           N+L   + S   LL   ++  +    L     I    G   +LN L L S  LN +  RS
Sbjct: 48  NRLALNLSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRS 107

Query: 201 ----LGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLR 256
               L  LT++  L L NN+    IP  IG LKS        +    ++P  + NL NL+
Sbjct: 108 NISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLK 166

Query: 257 FLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGN 316
            L L  N+LS  +P+ + NL  LN+L L+ N     +P     L+ L +L L+ N +   
Sbjct: 167 NLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-E 223

Query: 317 ISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQ 376
           +  +     NL+ ++LSNN       S  G    L  LD+S N IS SI   +G    L+
Sbjct: 224 LLSSLSNLKNLSGLELSNNKLEDLPESI-GNLSNLETLDLSNNQIS-SIS-SLGSLTNLR 280

Query: 377 YLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNF 436
            LDLS N +   +P           L      L   +   L +L  LE    S    +N 
Sbjct: 281 ELDLSGNSLSNALP-----------LIALLLLLLELLLNLLLTLKALELKLNSILLNNNI 329

Query: 437 VPESLGSLVKLYYLNLSHNKL 457
           +     S  +   +  S N L
Sbjct: 330 LSNGETSSPEALSILESLNNL 350

Length = 394

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 61.4 bits (150), Expect = 6e-10
 Identities = 59/227 (25%), Positives = 93/227 (40%), Gaps = 59/227 (25%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEF----LNEIQALTEIRHRNI 700
           IG G +G V  A    +G   A+KK  +       F         L EI+ L  +RH NI
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKISNV------FDDLIDAKRILREIKLLRHLRHENI 61

Query: 701 VKFYGFCSHPK-HSF----IIYEYLESGSLDKILCNDASAKELGWTQRL----------N 745
           +        P    F    I+ E +E+  L K++ +          Q L           
Sbjct: 62  IGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKS---------PQPLTDDHIQYFLYQ 111

Query: 746 VIKGVADALFYLH--NNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSE 803
           +++G    L YLH  N     ++HRD+   N+L++   +  + DFG+A+ ++PD      
Sbjct: 112 ILRG----LKYLHSAN-----VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGF 162

Query: 804 LAG---THGYVAPEL-----AYTLKVTEKCDVYSFGVLALEVIKGKH 842
           L     T  Y APEL      YT  +    D++S G +  E++  K 
Sbjct: 163 LTEYVVTRWYRAPELLLSSSRYTKAI----DIWSVGCIFAELLTRKP 205

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 61.8 bits (150), Expect = 7e-10
 Identities = 48/184 (26%), Positives = 82/184 (44%), Gaps = 51/184 (27%)

Query: 746 VIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELA 805
           V KG++   F    NC    +HRD++++N+LL  G    + DFG+A+ +  D SN+    
Sbjct: 223 VAKGMS---FLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIRND-SNYVVKG 274

Query: 806 GTH---GYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEML 862
                  ++APE  +    T + DV+S+G+L  E          +F + SS         
Sbjct: 275 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWE----------IFSLGSS--------- 315

Query: 863 DSRLPYPSLHVQKKLMSIMQVAF-----------------SCLDQNPESRPTMKRVSQLL 905
               PYP + V  K   +++  +                 SC D +P  RPT K++ QL+
Sbjct: 316 ----PYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLI 371

Query: 906 CEKI 909
            +++
Sbjct: 372 EQQL 375

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 61.1 bits (148), Expect = 7e-10
 Identities = 66/295 (22%), Positives = 125/295 (42%), Gaps = 44/295 (14%)

Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSF--------------QQEEFLNEIQA 691
           +G+G  G V+  +    E F  K F   + G                   + +FL EI+ 
Sbjct: 13  LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72

Query: 692 LTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCN--------DASAKELGWTQR 743
           ++ ++  NI++    C       +I EY+E+G L++ L           A    + ++  
Sbjct: 73  MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132

Query: 744 LNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSE 803
           + +   +A  + YL +  F   VHRD++++N L+   Y   ++DFG+++  N  S ++  
Sbjct: 133 IFMATQIASGMKYLSSLNF---VHRDLATRNCLVGKNYTIKIADFGMSR--NLYSGDYYR 187

Query: 804 LAGTHGYVAP------ELAYTLKVTEKCDVYSFGVLALEVIK--GKHPRDFLFE---MSS 852
           + G    V P      E     K T   DV++FGV   E++    + P   L +   + +
Sbjct: 188 IQGRA--VLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIEN 245

Query: 853 SSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCE 907
           +      +     LP P+L       S+ ++  SC  +N + RP+ + +   L E
Sbjct: 246 TGEFFRDQGRQVYLPKPALCPD----SLYKLMLSCWRRNAKERPSFQEIHATLLE 296

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 60.8 bits (147), Expect = 9e-10
 Identities = 44/169 (26%), Positives = 83/169 (49%), Gaps = 18/169 (10%)

Query: 682 QEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCND------ASA 735
           + +FL EI+ ++ +++ NI++  G C       +I EY+E+G L++ L           A
Sbjct: 61  RNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHA 120

Query: 736 KELGWTQRLNVI---KGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK 792
             +      N++     +A  + YL +  F   VHRD++++N L+   Y   ++DFG+++
Sbjct: 121 NNIPSVSIANLLYMAVQIASGMKYLASLNF---VHRDLATRNCLVGNHYTIKIADFGMSR 177

Query: 793 FLNPDSSNWSELAGTH----GYVAPELAYTLKVTEKCDVYSFGVLALEV 837
             N  S ++  + G       ++A E     K T   DV++FGV   E+
Sbjct: 178 --NLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEM 224

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 60.2 bits (146), Expect = 1e-09
 Identities = 52/194 (26%), Positives = 89/194 (45%), Gaps = 44/194 (22%)

Query: 646 IGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEF----LNEIQALTEIRHRNI 700
           IG+G +G VY+A+   +GE+ A+KK        +  ++E F    + EI+ L ++ HRNI
Sbjct: 15  IGEGTYGQVYKARDKDTGELVALKKV------RLDNEKEGFPITAIREIKILRQLNHRNI 68

Query: 701 VKFYGFCSHPKHS----------FIIYEY--------LESGSLDKILCNDASAKELGWTQ 742
           V      +  + +          ++++EY        LESG +     +  S        
Sbjct: 69  VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKS-------- 120

Query: 743 RLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN-W 801
               +K + + L Y H   F   +HRDI   N+LL+   +  ++DFG+A+  N + S  +
Sbjct: 121 ---FMKQLLEGLNYCHKKNF---LHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPY 174

Query: 802 SELAGTHGYVAPEL 815
           +    T  Y  PEL
Sbjct: 175 TNKVITLWYRPPEL 188

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 60.1 bits (146), Expect = 1e-09
 Identities = 72/284 (25%), Positives = 113/284 (39%), Gaps = 58/284 (20%)

Query: 638 NDFNAEHCIGKGGHGSVYRAKV-PSGEIFAVKKFHSPLPGEMSFQQEE---FLNEIQALT 693
           ND      IG G  G VY+ +   +G + AVK+         +  +EE    L ++  + 
Sbjct: 15  NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMR------RTGNKEENKRILMDLDVVL 68

Query: 694 EIRHR--NIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLN------ 745
           +  H    IVK YG+       FI  E L S  LDK+L            +R+       
Sbjct: 69  K-SHDCPYIVKCYGYFITDSDVFICME-LMSTCLDKLL------------KRIQGPIPED 114

Query: 746 ----VIKGVADALFYL---HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS 798
               +   +  AL YL   H      ++HRD+   N+LLD      + DFGI+  L  DS
Sbjct: 115 ILGKMTVAIVKALHYLKEKHG-----VIHRDVKPSNILLDASGNVKLCDFGISGRL-VDS 168

Query: 799 SNWSELAGTHGYVAPELAYTLKVTEK----CDVYSFGVLALEVIKGKHPRDFLFEMSSSS 854
              +  AG   Y+APE         K     DV+S G+  +E+  G+ P    ++   + 
Sbjct: 169 KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP----YKNCKTE 224

Query: 855 SNMNIEMLDSRLPYPSLHVQKKLMSIMQVAF--SCLDQNPESRP 896
             +  ++L    P    +   +  S    +F   CL ++   RP
Sbjct: 225 FEVLTKILQEEPPSLPPN---EGFSPDFCSFVDLCLTKDHRKRP 265

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 59.6 bits (144), Expect = 1e-09
 Identities = 71/258 (27%), Positives = 114/258 (44%), Gaps = 21/258 (8%)

Query: 646 IGKGGHGSVY---RAKVPSGEIFAVKKFHSPLP-GEMSFQQEEFLN-EIQALTEIRHRNI 700
           +GKG  G+VY     K  + E   V K    +P GE++  +    N E Q L+++ H  I
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLK---EIPVGELNPNETVQANQEAQLLSKLDHPAI 64

Query: 701 VKFYGFCSHPKHSFIIYEYLESGSLD-KILCNDASAKELGWTQRLNVIKGVADALFYLHN 759
           VKF+          II EY E   LD K+     + K L   Q       +   + Y+H 
Sbjct: 65  VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ 124

Query: 760 NCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTL 819
                I+HRD+ +KN+ L       + DFG+++ L       +   GT  Y++PE     
Sbjct: 125 R---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQ 180

Query: 820 KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMS 879
               K D++S G +  E+    H     FE  +  S + + +++   P       ++L S
Sbjct: 181 GYDSKSDIWSLGCILYEMCCLAHA----FEGQNFLS-VVLRIVEGPTPSLPETYSRQLNS 235

Query: 880 IMQVAFSCLDQNPESRPT 897
           IMQ   S L+++P  RP+
Sbjct: 236 IMQ---SMLNKDPSLRPS 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 60.2 bits (146), Expect = 1e-09
 Identities = 50/158 (31%), Positives = 72/158 (45%), Gaps = 27/158 (17%)

Query: 706 FCSH--PKHSFIIYEYLESGSL-----DKILCNDASAKELGWTQRLNVIKGVADALFYLH 758
           FC+    +H F + EYL  G L          ++A A+         +I G    L +LH
Sbjct: 62  FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYA----AEIICG----LQFLH 113

Query: 759 NNCFPPIVHRDISSKNVLLDLGYEAHV--SDFGIAKFLNPDSSNWSELAGTHGYVAPELA 816
                 I++RD+   NVLLD   + H+  +DFG+ K         S   GT  Y+APE+ 
Sbjct: 114 KK---GIIYRDLKLDNVLLD--KDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEIL 168

Query: 817 YTLKVTEKCDVYSFGVLALEVIKGKHP-----RDFLFE 849
              K  E  D +SFGVL  E++ G+ P      D LF+
Sbjct: 169 KGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFD 206

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 59.6 bits (144), Expect = 2e-09
 Identities = 53/200 (26%), Positives = 88/200 (44%), Gaps = 9/200 (4%)

Query: 646 IGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALT-EIRHRNIVKF 703
           +GKG  G V+ A++  + + FA+K     +   M    E  + E + L+    H  +   
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVV-LMDDDVECTMVEKRVLSLAWEHPFLTHL 61

Query: 704 YGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFP 763
           Y      ++ F + EYL  G L   + +  S  +    +       +   L +LH+    
Sbjct: 62  YCTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAEIICGLQFLHSK--- 115

Query: 764 PIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTE 823
            IV+RD+   N+LLD      ++DFG+ K      +      GT  Y+APE+    K   
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNT 175

Query: 824 KCDVYSFGVLALEVIKGKHP 843
             D +SFGVL  E++ G+ P
Sbjct: 176 SVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 59.3 bits (144), Expect = 2e-09
 Identities = 49/187 (26%), Positives = 87/187 (46%), Gaps = 29/187 (15%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEF----LNEIQALTEIRHRNI 700
           IG+G  G V++A+   + +I A+KK        M  ++E F    L EI+ L  ++H N+
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKV------LMENEKEGFPITALREIKILQLLKHENV 73

Query: 701 VKFYGFCSHPKHS--------FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVAD 752
           V     C              ++++E+ E   L  +L N      L   ++  V+K + +
Sbjct: 74  VNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKK--VMKMLLN 130

Query: 753 ALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL----NPDSSNWSELAGTH 808
            L+Y+H N    I+HRD+ + N+L+       ++DFG+A+      N   + ++    T 
Sbjct: 131 GLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTL 187

Query: 809 GYVAPEL 815
            Y  PEL
Sbjct: 188 WYRPPEL 194

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 59.4 bits (144), Expect = 3e-09
 Identities = 69/250 (27%), Positives = 117/250 (46%), Gaps = 35/250 (14%)

Query: 662 GEIFAVKKFHSPLPGE---MSFQQEEFL---------NEIQALTEIRHRNIVKF-YGFCS 708
           G++F V+K   P  G+   M   ++  L          E   L E+ H  IVK  Y F +
Sbjct: 10  GKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT 69

Query: 709 HPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNV---IKGVADALFYLHNNCFPPI 765
             K  ++I ++L  G L   L     +KE+ +T+  +V   +  +A AL +LH+     I
Sbjct: 70  EGK-LYLILDFLRGGDLFTRL-----SKEVMFTEE-DVKFYLAELALALDHLHS---LGI 119

Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKC 825
           ++RD+  +N+LLD      ++DFG++K             GT  Y+APE+      T+  
Sbjct: 120 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSA 179

Query: 826 DVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAF 885
           D +SFGVL  E++ G  P    F+       M + +L ++L  P   +  +  S+++  F
Sbjct: 180 DWWSFGVLMFEMLTGSLP----FQGKDRKETMTM-ILKAKLGMPQF-LSPEAQSLLRALF 233

Query: 886 SCLDQNPESR 895
               +NP +R
Sbjct: 234 K---RNPANR 240

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 58.8 bits (142), Expect = 3e-09
 Identities = 74/284 (26%), Positives = 121/284 (42%), Gaps = 43/284 (15%)

Query: 646 IGKGGHGSVYRAKVPSGEIFA---VKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVK 702
           IG G  G V   +V SG   A   VK+       +   +Q +FL E Q    ++H N+++
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQ---EQMKFLEEAQPYRSLQHSNLLQ 59

Query: 703 FYGFCSHPKHSFIIYEYLESGSLDKIL--CNDAS--AKELGWTQRLNVIKGVADALFYLH 758
             G C+      ++ E+   G L   L  C  A     +    QR+     +A  L +LH
Sbjct: 60  CLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMAC--EIALGLLHLH 117

Query: 759 NNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK-------FLNPDSSNWSELAGTHGYV 811
            N F   +H D++ +N LL       + D+G++        ++ PD   W  L     ++
Sbjct: 118 KNNF---IHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQL-WVPLR----WI 169

Query: 812 APELA-------YTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLD 863
           APEL          +  T++ +V+S GV   E+ + G  P   L +    +  +  + L 
Sbjct: 170 APELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQL- 228

Query: 864 SRLPYPSLHV--QKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
            +LP P L +    +   +MQ    C  Q PE RP+ + V  LL
Sbjct: 229 -KLPKPRLKLPLSDRWYEVMQ---FCWLQ-PEQRPSAEEVHLLL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 60.6 bits (147), Expect = 3e-09
 Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 31/215 (14%)

Query: 646 IGKGGHGSVYRAKVPS-GEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           IGKGG G VY A  P      A+KK    L  E    ++ FL E +   ++ H  IV  Y
Sbjct: 10  IGKGGMGEVYLAYDPVCSRRVALKKIREDL-SENPLLKKRFLREAKIAADLIHPGIVPVY 68

Query: 705 GFCSHPKHSFIIYEYLESGSLDKILCN----DASAKELGWTQR----LNVIKGVADALFY 756
             CS     +    Y+E  +L  +L +    ++ +KEL         L++   +   + Y
Sbjct: 69  SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEY 128

Query: 757 LHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKF------------LNPDSSNWSEL 804
           +H+     ++HRD+   N+LL L  E  + D+G A F            ++  +  +S +
Sbjct: 129 VHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSM 185

Query: 805 A------GTHGYVAPELAYTLKVTEKCDVYSFGVL 833
                  GT  Y+APE    +  +E  D+Y+ GV+
Sbjct: 186 TIPGKIVGTPDYMAPERLLGVPASESTDIYALGVI 220

Length = 932

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 58.9 bits (142), Expect = 3e-09
 Identities = 54/226 (23%), Positives = 98/226 (43%), Gaps = 25/226 (11%)

Query: 684 EFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQR 743
           EFLNE   + E    ++V+  G  S  + + +I E +  G L   L +     E    Q 
Sbjct: 55  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQA 114

Query: 744 LNVIKG-------VADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP 796
              +K        +AD + YL+ N F   VHRD++++N ++   +   + DFG+ + +  
Sbjct: 115 PPSLKKMIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY- 170

Query: 797 DSSNWSELAGTH----GYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMS 851
             +++    G       +++PE       T   DV+SFGV+  E+    + P    ++  
Sbjct: 171 -ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP----YQGM 225

Query: 852 SSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPT 897
           S+   +   M    L  P  +    L  +M++   C   NP+ RP+
Sbjct: 226 SNEQVLRFVMEGGLLDKPD-NCPDMLFELMRM---CWQYNPKMRPS 267

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 58.9 bits (142), Expect = 3e-09
 Identities = 57/258 (22%), Positives = 106/258 (41%), Gaps = 66/258 (25%)

Query: 684 EFLNEIQALTEI-RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKIL------------- 729
           + ++E++ +  I +H+NI+   G C+     ++I EY   G+L + L             
Sbjct: 66  DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 125

Query: 730 CNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFG 789
                 +++ +   ++    VA  + YL +      +HRD++++NVL+       ++DFG
Sbjct: 126 IARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFG 182

Query: 790 IAKFLNPDSSNWSELAGTHG------YVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           +A+    D +N      T        ++APE  +    T + DV+SFGVL  E+      
Sbjct: 183 LAR----DVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI------ 232

Query: 844 RDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQK--KLM--------------SIMQVAFSC 887
               F +  S             PYP + V++  KL+               +  +   C
Sbjct: 233 ----FTLGGS-------------PYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDC 275

Query: 888 LDQNPESRPTMKRVSQLL 905
               P  RPT K++ + L
Sbjct: 276 WHAIPSHRPTFKQLVEDL 293

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 58.2 bits (141), Expect = 3e-09
 Identities = 60/232 (25%), Positives = 101/232 (43%), Gaps = 40/232 (17%)

Query: 683 EEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQ 742
             F      ++++ H+++VK YG C   ++  ++ EY++ G LD  L  + +   L W  
Sbjct: 46  LAFFETASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNVSLHW-- 102

Query: 743 RLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLL-----DLGYE--AHVSDFGIAKFLN 795
           +L+V K +A AL YL +     +VH ++  KN+L+     + GY     +SD GI   + 
Sbjct: 103 KLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVL 159

Query: 796 PDSSNWSELAGTHGYVAPELAYTL--KVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSS 852
                  E      ++APE        +T   D +SFG   LE+   G+ P      +S+
Sbjct: 160 SR----EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEP------LST 209

Query: 853 SSSNMNIEMLD-----SRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMK 899
            SS+   E         RLP P       L++       C   +P  RP+ +
Sbjct: 210 LSSS---EKERFYQDQHRLPMPDCAELANLIN------QCWTYDPTKRPSFR 252

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 58.5 bits (141), Expect = 3e-09
 Identities = 53/213 (24%), Positives = 94/213 (44%), Gaps = 30/213 (14%)

Query: 646 IGKGGHGSVYRAKVP------SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHR 698
           IG+G  G V +A++          I  +K++ S           +F  E++ L ++  H 
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS------KDDHRDFAGELEVLCKLGHHP 56

Query: 699 NIVKFYGFCSHPKHSFIIYEYLESGSL------DKILCND-------ASAKELGWTQRLN 745
           NI+   G C H  + ++  EY   G+L       ++L  D       ++A  L   Q L+
Sbjct: 57  NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116

Query: 746 VIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELA 805
               VA  + YL    F   +HRD++++N+L+   Y A ++DFG+++             
Sbjct: 117 FAADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 173

Query: 806 GTHGYVAPELAYTLKVTEKCDVYSFGVLALEVI 838
                    L Y++  T   DV+S+GVL  E++
Sbjct: 174 PVRWMAIESLNYSVYTT-NSDVWSYGVLLWEIV 205

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 58.5 bits (141), Expect = 4e-09
 Identities = 65/237 (27%), Positives = 107/237 (45%), Gaps = 29/237 (12%)

Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFL--NEIQALTEIRHRN--- 699
           IG+GG G VY   K  +G+++A+K         +  +Q E L  NE   L+ +   +   
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKK---RIKMKQGETLALNERIMLSLVSTGDCPF 58

Query: 700 -IVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDA--SAKELGWTQRLNVIKGVADALFY 756
            +   Y F +  K  FI+ + +  G L   L      S KE+ +     +I G    L +
Sbjct: 59  IVCMTYAFHTPDKLCFIL-DLMNGGDLHYHLSQHGVFSEKEMRFYAT-EIILG----LEH 112

Query: 757 LHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPE-L 815
           +HN     +V+RD+   N+LLD      +SD G+A   +    + S   GTHGY+APE L
Sbjct: 113 MHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--VGTHGYMAPEVL 167

Query: 816 AYTLKVTEKCDVYSFGVLALEVIKG-----KHPRDFLFEMSSSSSNMNIEMLDSRLP 867
                     D +S G +  ++++G     +H      E+   +  +N+E+ DS  P
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSP 224

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 59.0 bits (143), Expect = 5e-09
 Identities = 63/220 (28%), Positives = 100/220 (45%), Gaps = 32/220 (14%)

Query: 639 DFNAEHCIGKGGHGSVY--RAKVPSGEIFAVK---KFHSPLPGEMSFQQEEFLNEIQALT 693
           DF+    IG+G  G V   R K  S +++A+K   KF      + +F  EE   +I A  
Sbjct: 44  DFDVIKVIGRGAFGEVQLVRHKS-SKQVYAMKLLSKFEMIKRSDSAFFWEE--RDIMA-- 98

Query: 694 EIRHRN---IVK-FYGFCSHPKHSFIIYEYLESGSLDKILCN-DASAKELGWTQRLNVIK 748
              H N   IV+  Y F    K+ +++ EY+  G L  ++ N D   K   W +      
Sbjct: 99  ---HANSEWIVQLHYAF-QDDKYLYMVMEYMPGGDLVNLMSNYDIPEK---WARFY--TA 149

Query: 749 GVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELA-GT 807
            V  AL  +H+  F   +HRD+   N+LLD      ++DFG    ++ +     + A GT
Sbjct: 150 EVVLALDAIHSMGF---IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGT 206

Query: 808 HGYVAPELAYTLKVT----EKCDVYSFGVLALEVIKGKHP 843
             Y++PE+  +         +CD +S GV   E++ G  P
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 58.1 bits (140), Expect = 5e-09
 Identities = 60/220 (27%), Positives = 91/220 (41%), Gaps = 37/220 (16%)

Query: 640 FNAEHCIGKGGHGSVYRAKV-PSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHR 698
           F     +GKGG G V   +V  +G+++A KK       +   +    LNE Q L ++  R
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA-LNEKQILEKVNSR 60

Query: 699 NIVKF-YGFCSHPKHSFIIYEYLESGSLDKILCNDASAK-------ELGWTQRLNVIKGV 750
            +V   Y            YE  ++  L   L N    K       E G+ +        
Sbjct: 61  FVVSLAYA-----------YETKDALCLVLTLMNGGDLKFHIYHMGEAGFEE-------- 101

Query: 751 ADALFYLHNNCF-------PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSE 803
             A+FY    C          IV+RD+  +N+LLD      +SD G+A  + P+      
Sbjct: 102 GRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHV-PEGQTIKG 160

Query: 804 LAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
             GT GY+APE+    + T   D ++ G L  E+I G+ P
Sbjct: 161 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 58.0 bits (141), Expect = 5e-09
 Identities = 51/201 (25%), Positives = 96/201 (47%), Gaps = 29/201 (14%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGE---MSFQQEEFLNEIQALTEIR---HR 698
           IG+G +G+VY+A+ + +G   A+KK   PL  E   +S      L EI  L ++    H 
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLST-----LREIALLKQLESFEHP 61

Query: 699 NIVKFYGFCSHPKHS-----FIIYEYLE---SGSLDKILCNDASAKELGWTQRLNVIKGV 750
           NIV+    C  P+        +++E+++   +  L K          L      ++++ +
Sbjct: 62  NIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSK-----CPKPGLPPETIKDLMRQL 116

Query: 751 ADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGY 810
              + +LH++    IVHRD+  +N+L+    +  ++DFG+A+  + + +  S +  T  Y
Sbjct: 117 LRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV-TLWY 172

Query: 811 VAPELAYTLKVTEKCDVYSFG 831
            APE+          D++S G
Sbjct: 173 RAPEVLLQSSYATPVDMWSVG 193

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 57.7 bits (139), Expect = 6e-09
 Identities = 56/230 (24%), Positives = 99/230 (43%), Gaps = 25/230 (10%)

Query: 681 QQEEFLNEIQALTEIRHRNIVKFYGFC-------SHPKHSFIIYEYLESGSLDKILCNDA 733
           + E+FL+E   + E  H N+++  G C        +P    +I  +++ G L   L    
Sbjct: 43  EMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS-PVVILPFMKHGDLHSFLLYSR 101

Query: 734 SAKELGWTQRLNVIKGVAD---ALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGI 790
                 +     ++K + D    + YL +  F   +HRD++++N +L+      V+DFG+
Sbjct: 102 LGDCPQYLPTQMLVKFMTDIASGMEYLSSKSF---IHRDLAARNCMLNENMNVCVADFGL 158

Query: 791 A-KFLNPDSSNWSELAGTH-GYVAPELAYTLKVTEKCDVYSFGVLALEV-IKGKHPRDFL 847
           + K  N D      +A     ++A E       T K DV+SFGV   E+  +G+ P    
Sbjct: 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP---- 214

Query: 848 FEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPT 897
           +    +S   +     +RL  P       L  +  +  SC   NP+ RP+
Sbjct: 215 YPGVENSEIYDYLRQGNRLKQPP----DCLDGLYSLMSSCWLLNPKDRPS 260

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 57.5 bits (139), Expect = 6e-09
 Identities = 71/284 (25%), Positives = 118/284 (41%), Gaps = 38/284 (13%)

Query: 646 IGKGGHGSVYRA--KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKF 703
           +G+G  GSV         G    V      L      + EEFL+E   + +  H N++K 
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 704 YGFC------SHPKHSFIIYEYLESGSLDKILCNDASA---KELGWTQRLNVIKGVADAL 754
            G C             +I  +++ G L   L         ++L     L  +  +A  +
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126

Query: 755 FYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIA-KFLNPDSSNWSELAGTH-GYVA 812
            YL N  F   +HRD++++N +L       V+DFG++ K  + D      +A     ++A
Sbjct: 127 EYLSNRNF---IHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 183

Query: 813 PE-LAYTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEMLD-----SR 865
            E LA  +  T K DV++FGV   E+  +G          +      N E+ D     +R
Sbjct: 184 IESLADRV-YTSKSDVWAFGVTMWEIATRG---------QTPYPGVENHEIYDYLRHGNR 233

Query: 866 LPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI 909
           L  P      +L  +M   +SC   +P+ RPT  ++ ++L E I
Sbjct: 234 LKQPE-DCLDELYDLM---YSCWRADPKDRPTFTKLREVL-ENI 272

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 57.7 bits (139), Expect = 7e-09
 Identities = 64/241 (26%), Positives = 105/241 (43%), Gaps = 19/241 (7%)

Query: 639 DFNAEHCIGKGGHGSVYRAKVPSG----EIFAVKKFHSPLPGEMSFQQEEFLNEIQALTE 694
           +F     +G G +G V+  +  SG    +++A+K        + +   E    E Q L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 695 IRHRN--IVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKG-VA 751
           IR     +   Y F +  K   I+ +Y+  G L   L      KE    Q + +  G + 
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLIL-DYINGGELFTHLSQRERFKE----QEVQIYSGEIV 115

Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK-FLNPDSSNWSELAGTHGY 810
            AL +LH      I++RDI  +N+LLD      ++DFG++K F   +        GT  Y
Sbjct: 116 LALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEY 172

Query: 811 VAPELAYTLKV--TEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPY 868
           +AP++         +  D +S GVL  E++ G  P     E  +S + ++  +L S  PY
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE-KNSQAEISRRILKSEPPY 231

Query: 869 P 869
           P
Sbjct: 232 P 232

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 57.9 bits (140), Expect = 7e-09
 Identities = 63/217 (29%), Positives = 91/217 (41%), Gaps = 33/217 (15%)

Query: 639 DFNAEHCIGKGGHGSVYRAKVP-SGEIFAVK--KFHSPLPGEMSFQQEEFLNEIQALTEI 695
           DF     +G G  G V  AK   +GE +A+K  K    L  +M  Q +    E   L E+
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREIL--KMK-QVQHVAQEKSILMEL 75

Query: 696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKIL------CNDAS---AKELGWTQRLNV 746
            H  IV            + + E++  G L   L       ND +     E         
Sbjct: 76  SHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAE--------- 126

Query: 747 IKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAG 806
              +  A  YLH+     I++RD+  +N+LLD      V+DFG AK + PD +    L G
Sbjct: 127 ---LVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKV-PDRT--FTLCG 177

Query: 807 THGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           T  Y+APE+  +    +  D ++ GVL  E I G  P
Sbjct: 178 TPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 57.2 bits (138), Expect = 8e-09
 Identities = 53/227 (23%), Positives = 97/227 (42%), Gaps = 25/227 (11%)

Query: 683 EEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQ 742
           E F      ++++ H+++V  YG C     S ++ EY++ GSLD  L  + +   + W  
Sbjct: 44  ESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW-- 101

Query: 743 RLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSS--- 799
           +L V K +A AL +L +     + H ++ +KNVLL    +    +    K  +P  S   
Sbjct: 102 KLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV 158

Query: 800 ---NWSELAGTHGYVAPE-LAYTLKVTEKCDVYSFGVLALEVIKG-KHPRDFLFEMSSSS 854
                  L     +V PE +     ++   D +SFG    E+  G   P      +S+  
Sbjct: 159 LPKEI--LLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKP------LSALD 210

Query: 855 SNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
           S   ++  + R   P+     K   +  +   C+D  P+ RP+ + +
Sbjct: 211 SQKKLQFYEDRHQLPA----PKWTELANLINQCMDYEPDFRPSFRAI 253

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 57.8 bits (139), Expect = 9e-09
 Identities = 68/247 (27%), Positives = 110/247 (44%), Gaps = 35/247 (14%)

Query: 646 IGKGGHGSV--YRAKVPSGEIFAVKKFHSPLPGEMSFQQEEF---LNEIQALTEIRHRNI 700
           +GKG  G V   R K  SG+ +A+K     L  E+   ++E    L E + L   RH  +
Sbjct: 3   LGKGTFGKVILVREKA-SGKYYAMKI----LKKEVIIAKDEVAHTLTESRVLKNTRHPFL 57

Query: 701 VKF-YGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKG--VADALFYL 757
               Y F +  +  F++ EY+  G L   L     ++E  +++      G  +  AL YL
Sbjct: 58  TSLKYSFQTKDRLCFVM-EYVNGGELFFHL-----SRERVFSEDRTRFYGAEIVSALDYL 111

Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAY 817
           H+     IV+RD+  +N++LD      ++DFG+ K    D++      GT  Y+APE+  
Sbjct: 112 HSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLE 168

Query: 818 TLKVTEKCDVYSFGVLALEVIKGKHP-----RDFLFEMSSSSSNMNIEMLDSRLPYPSLH 872
                   D +  GV+  E++ G+ P      + LFE+        I M D + P     
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL--------ILMEDIKFPRTLSA 220

Query: 873 VQKKLMS 879
             K L+S
Sbjct: 221 DAKSLLS 227

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 57.7 bits (140), Expect = 9e-09
 Identities = 66/256 (25%), Positives = 107/256 (41%), Gaps = 61/256 (23%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           IG+G +G V  A   P+G   A+KK  SP   +   Q+   L EI+ L   +H NI+   
Sbjct: 13  IGEGAYGMVCSATHKPTGVKVAIKKI-SPFEHQTFCQRT--LREIKILRRFKHENIIGIL 69

Query: 705 ------GFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLN------VIKGVAD 752
                  F S     +I+ E +E+  L K++           TQ L+       +  +  
Sbjct: 70  DIIRPPSFESF-NDVYIVQELMET-DLYKLI----------KTQHLSNDHIQYFLYQILR 117

Query: 753 ALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWS---ELAGTHG 809
            L Y+H+     ++HRD+   N+LL+   +  + DFG+A+  +P+  +     E   T  
Sbjct: 118 GLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRW 174

Query: 810 YVAPELAYTLK-VTEKCDVYSFG-VLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLP 867
           Y APE+    K  T+  D++S G +LA                         EML +R  
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILA-------------------------EMLSNRPL 209

Query: 868 YPSLHVQKKLMSIMQV 883
           +P      +L  I+ V
Sbjct: 210 FPGKDYLHQLNLILGV 225

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 57.9 bits (140), Expect = 9e-09
 Identities = 69/249 (27%), Positives = 112/249 (44%), Gaps = 33/249 (13%)

Query: 638 NDFNAEHCIGKGGHGSVY--RAKVPSGEIFAVKKFHSPLPG---EMSFQQEEFLNEIQAL 692
            DF+ +  +G+G  G V   R K  +G+I+A+K     +      +SF +EE   +I ++
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKA-TGDIYAMKVMKKSVLLAQETVSFFEEE--RDILSI 57

Query: 693 TEIRHRN---IVKF-YGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIK 748
                 N   I +  Y F     + +++ EY   G L  +L       +    Q    + 
Sbjct: 58  -----SNSPWIPQLQYAF-QDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFY--LA 109

Query: 749 GVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSEL-AGT 807
            +  A+  +H   +   VHRDI  +NVL+D      ++DFG A  L  +    S+L  GT
Sbjct: 110 ELVLAIHSVHQMGY---VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGT 166

Query: 808 HGYVAPELAYTLKVTEK------CDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEM 861
             Y+APE+  T+    K      CD +S GV+A E+I G+ P     E +S+ +  NI  
Sbjct: 167 PDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP---FHEGTSAKTYNNIMN 223

Query: 862 LDSRLPYPS 870
               L +P 
Sbjct: 224 FQRFLKFPE 232

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 57.6 bits (139), Expect = 1e-08
 Identities = 66/262 (25%), Positives = 118/262 (45%), Gaps = 38/262 (14%)

Query: 646 IGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEF---LNEIQALTEIR-HRNI 700
           +GKG  G V  A++  SG ++AVK     L  ++  Q ++    + E + L+  R H  +
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKV----LKKDVILQDDDVECTMTEKRILSLARNHPFL 58

Query: 701 VKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
            + Y     P   F + E++  G L   + +   ++     +       +  AL +LH+ 
Sbjct: 59  TQLYCCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEITSALMFLHDK 115

Query: 761 CFPPIVHRDISSKNVLLDLGYEAH--VSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT 818
               I++RD+   NVLLD  +E H  ++DFG+ K    +    S   GT  Y+APE+   
Sbjct: 116 ---GIIYRDLKLDNVLLD--HEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQE 170

Query: 819 LKVTEKCDVYSFGVLALEVIKGKHP-----RDFLFEMSSSSSNMNIEMLDSRLPYPSLHV 873
           +      D ++ GVL  E++ G  P      D LFE           +L+  + YP+  +
Sbjct: 171 MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA----------ILNDEVVYPTW-L 219

Query: 874 QKKLMSIMQVAFSCLDQNPESR 895
            +  + I++   + + +NP  R
Sbjct: 220 SQDAVDILK---AFMTKNPTMR 238

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 57.6 bits (139), Expect = 1e-08
 Identities = 37/101 (36%), Positives = 53/101 (52%), Gaps = 8/101 (7%)

Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAP 813
           L +LH+     I++RD+   NV+LD      ++DFG+ K      +  S   GT  Y+AP
Sbjct: 109 LQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAP 165

Query: 814 ELAYTLKVTEKCDVYSFGVLALEVIKGKHP-----RDFLFE 849
           E+   LK T   D +SFGVL  E++ G+ P      D LFE
Sbjct: 166 EILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFE 206

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 56.9 bits (137), Expect = 1e-08
 Identities = 65/237 (27%), Positives = 107/237 (45%), Gaps = 29/237 (12%)

Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFL--NEIQALTEIRHRN--- 699
           IG+GG G VY   K  +G+++A+K         +  +Q E L  NE   L+ +   +   
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKK---RIKMKQGETLALNERIMLSLVSTGDCPF 58

Query: 700 -IVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDA--SAKELGWTQRLNVIKGVADALFY 756
            +   Y F +  K SFI+ + +  G L   L      S  E+ +     +I G    L +
Sbjct: 59  IVCMSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHGVFSEAEMRFYAA-EIILG----LEH 112

Query: 757 LHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPE-L 815
           +HN     +V+RD+   N+LLD      +SD G+A   +    + S   GTHGY+APE L
Sbjct: 113 MHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--VGTHGYMAPEVL 167

Query: 816 AYTLKVTEKCDVYSFGVLALEVIKG-----KHPRDFLFEMSSSSSNMNIEMLDSRLP 867
              +      D +S G +  ++++G     +H      E+   +  M +E+ DS  P
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP 224

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 57.9 bits (140), Expect = 1e-08
 Identities = 50/172 (29%), Positives = 82/172 (47%), Gaps = 31/172 (18%)

Query: 750 VADALFYL-HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH 808
           VA  + +L   NC    +HRD++++NVLL  G  A + DFG+A+ +  D SN+       
Sbjct: 221 VAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIMND-SNYVVKGNAR 275

Query: 809 ---GYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHP-------RDFLFEMSSSSSNM 857
               ++APE  +    T + DV+S+G+L  E+   GK P         F ++M      M
Sbjct: 276 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKF-YKMVKRGYQM 334

Query: 858 NIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI 909
                 SR  +       ++ SIM+    C +  P  RPT  ++SQL+  ++
Sbjct: 335 ------SRPDFAPP----EIYSIMK---MCWNLEPTERPTFSQISQLIQRQL 373

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 57.4 bits (139), Expect = 1e-08
 Identities = 65/307 (21%), Positives = 111/307 (36%), Gaps = 68/307 (22%)

Query: 645 CIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           C        + + K P+  + AVKK +     +   +      EI    +++H NI+ + 
Sbjct: 9   CFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKL--LQQEIITSRQLQHPNILPYV 65

Query: 705 GFCSHPKHS-FIIYEYLESGSLDKILCND--ASAKELGWTQRLNVIKGVADALFYLHNNC 761
                     +++   +  GS + +L         EL       ++K V +AL Y+H+  
Sbjct: 66  -TSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF---ILKDVLNALDYIHSKG 121

Query: 762 FPPIVHRDISSKNVLLDLGYEAHVSDFGIAK------------FLNPDSS----NWSELA 805
           F   +HR + + ++LL    +  +S    +                P SS     W    
Sbjct: 122 F---IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWL--- 175

Query: 806 GTHGYVAPELAYT--LKVTEKCDVYSFGVLA-------------------LEVIKGKHPR 844
                 +PE+         EK D+YS G+ A                   LE ++G  P 
Sbjct: 176 ------SPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPC 229

Query: 845 DF------LFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTM 898
                   L+E S S S  + E  ++R      + +       Q    CL ++PESRP+ 
Sbjct: 230 LLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPS- 288

Query: 899 KRVSQLL 905
              SQLL
Sbjct: 289 --ASQLL 293

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 56.9 bits (137), Expect = 1e-08
 Identities = 52/207 (25%), Positives = 96/207 (46%), Gaps = 21/207 (10%)

Query: 646 IGKGGHGSVYRAKVP-SGEIFAVKKFHSP-----LPGEMSFQQEEFLNEIQALTEIRHRN 699
           IG G +G+VY+A+ P SG   A+K          LP  +S  +E  L  ++ L    H N
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLP--LSTVREVAL--LKRLEAFDHPN 63

Query: 700 IVKFYGFCSHPKHS-----FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADAL 754
           IV+    C+  +        +++E+++     +   +      L      ++++     L
Sbjct: 64  IVRLMDVCATSRTDRETKVTLVFEHVDQDL--RTYLDKVPPPGLPAETIKDLMRQFLRGL 121

Query: 755 FYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPE 814
            +LH NC   IVHRD+  +N+L+  G +  ++DFG+A+  +   +  + +  T  Y APE
Sbjct: 122 DFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA-LTPVVVTLWYRAPE 177

Query: 815 LAYTLKVTEKCDVYSFGVLALEVIKGK 841
           +          D++S G +  E+ + K
Sbjct: 178 VLLQSTYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 56.9 bits (137), Expect = 1e-08
 Identities = 57/209 (27%), Positives = 98/209 (46%), Gaps = 20/209 (9%)

Query: 646 IGKGGHGSVYRAKVP-SGEIFAVKKFHSPL----PGE-MSFQQEEFLNEIQALTEIRHRN 699
           +GKGG G V   +V  +G+++A KK          GE M+  ++E L ++ +        
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPF------ 54

Query: 700 IVKF-YGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLH 758
           IV   Y F S   H  ++   +  G L K    +   + L   + ++    +   + +LH
Sbjct: 55  IVNLAYAFESK-THLCLVMSLMNGGDL-KYHIYNVGERGLEMERVIHYSAQITCGILHLH 112

Query: 759 NNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT 818
           +     IV+RD+  +NVLLD      +SD G+A  L  D    ++ AGT+GY+APE+   
Sbjct: 113 S---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVEL-KDGKTITQRAGTNGYMAPEILKE 168

Query: 819 LKVTEKCDVYSFGVLALEVIKGKHP-RDF 846
              +   D ++ G    E++ G+ P +D 
Sbjct: 169 EPYSYPVDWFAMGCSIYEMVAGRTPFKDH 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 56.9 bits (137), Expect = 1e-08
 Identities = 63/281 (22%), Positives = 117/281 (41%), Gaps = 39/281 (13%)

Query: 642 AEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIV 701
            E   GK   G +Y   +   ++ A+K        +   Q  EF  E   + E+ H NIV
Sbjct: 14  GECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQ---QWGEFQQEASLMAELHHPNIV 70

Query: 702 KFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQR--------------LNVI 747
              G  +  +   +++EYL  G L + L   +   ++G +                L++ 
Sbjct: 71  CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130

Query: 748 KGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGT 807
             +A  + YL ++ F   VH+D++++N+L+       +SD G+++ +   S+++  +   
Sbjct: 131 IQIAAGMEYLSSHFF---VHKDLAARNILIGEQLHVKISDLGLSREIY--SADYYRVQPK 185

Query: 808 H----GYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMN-IEML 862
                 ++ PE     K +   D++SFGV+  E+        F  +     SN   IEM+
Sbjct: 186 SLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS------FGLQPYYGFSNQEVIEMV 239

Query: 863 DSR--LPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
             R  LP        ++ S+M     C  + P  RP  K +
Sbjct: 240 RKRQLLPCSE-DCPPRMYSLMT---ECWQEGPSRRPRFKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 57.5 bits (139), Expect = 2e-08
 Identities = 28/77 (36%), Positives = 43/77 (55%)

Query: 265 LSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTY 324
           L G IP +I  L+ L S+ L+ N  RG +P S  ++T L  L L+ N   G+I E+ G  
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489

Query: 325 PNLTFIDLSNNSFFGEI 341
            +L  ++L+ NS  G +
Sbjct: 490 TSLRILNLNGNSLSGRV 506

Length = 623

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 57.2 bits (138), Expect = 2e-08
 Identities = 51/209 (24%), Positives = 98/209 (46%), Gaps = 28/209 (13%)

Query: 644 HCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVK 702
             +G G +GSV  A    +GE  A+KK   P   E+ F +  +  E+  L  ++H N++ 
Sbjct: 21  KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEI-FAKRAY-RELTLLKHMQHENVIG 78

Query: 703 FYG-FCSHPKHS-----FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFY 756
               F S          +++  Y+++  L KI+ +  S  ++ +     ++  +   L Y
Sbjct: 79  LLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHPLSEDKVQY-----LVYQMLCGLKY 132

Query: 757 LHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAG---THGYVAP 813
           +H+     I+HRD+   N+ ++   E  + DFG+A+  +      +E+ G   T  Y AP
Sbjct: 133 IHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHAD------AEMTGYVVTRWYRAP 183

Query: 814 ELAYT-LKVTEKCDVYSFGVLALEVIKGK 841
           E+    +   +  D++S G +  E++ GK
Sbjct: 184 EVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 56.3 bits (136), Expect = 2e-08
 Identities = 65/244 (26%), Positives = 107/244 (43%), Gaps = 23/244 (9%)

Query: 639 DFNAEHCIGKGGHGSVYRAKVPS----GEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTE 694
           +F     +G G +G V+  +       G+++A+K        + +   E    E Q L  
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 695 IRHRN--IVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVAD 752
           +R     +   Y F +  K   +I +Y+  G L   L       E   ++    I  +  
Sbjct: 61  VRRCPFLVTLHYAFQTDTK-LHLILDYVNGGELFTHLYQREHFTE---SEVRVYIAEIVL 116

Query: 753 ALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHV--SDFGIAK-FLNPDSSNWSELAGTHG 809
           AL +LH      I++RDI  +N+LLD   E HV  +DFG++K FL  +        GT  
Sbjct: 117 ALDHLHQL---GIIYRDIKLENILLD--SEGHVVLTDFGLSKEFLAEEEERAYSFCGTIE 171

Query: 810 YVAPELAYTLKV--TEKCDVYSFGVLALEVIKGKHPRDFLFE-MSSSSSNMNIEMLDSRL 866
           Y+APE+         +  D +S GVL  E++ G  P  F  +   +S S ++  +L S+ 
Sbjct: 172 YMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP--FTVDGEQNSQSEISRRILKSKP 229

Query: 867 PYPS 870
           P+P 
Sbjct: 230 PFPK 233

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 58.2 bits (140), Expect = 2e-08
 Identities = 68/296 (22%), Positives = 130/296 (43%), Gaps = 40/296 (13%)

Query: 630 YEEIISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEI 689
           Y++  S  N++     IG G  G V+  K    + F   K  S   G    ++ + + E+
Sbjct: 5   YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAIS-YRGLKEREKSQLVIEV 63

Query: 690 QALTEIRHRNIVKFYG-FCSHPKHS-FIIYEYLESGSLDKILCNDASAKELGWTQR---L 744
             + E++H+NIV++   F +      +I+ E+ ++G L + +      K  G  +    +
Sbjct: 64  NVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNI--QKCYKMFGKIEEHAIV 121

Query: 745 NVIKGVADALFYLHNNCFPP----IVHRDISSKNVLLDLGYE-----------------A 783
           ++ + +  AL Y HN    P    ++HRD+  +N+ L  G                   A
Sbjct: 122 DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIA 181

Query: 784 HVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAY--TLKVTEKCDVYSFGVLALEVIKGK 841
            + DFG++K +  +S   S   GT  Y +PEL    T    +K D+++ G +  E+  GK
Sbjct: 182 KIGDFGLSKNIGIESMAHS-CVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240

Query: 842 HPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPT 897
            P    F  +++ S +  E+       P L ++ K   +  +  + L+ + + RP+
Sbjct: 241 TP----FHKANNFSQLISELKRG----PDLPIKGKSKELNILIKNLLNLSAKERPS 288

Length = 1021

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 56.1 bits (135), Expect = 3e-08
 Identities = 57/246 (23%), Positives = 112/246 (45%), Gaps = 42/246 (17%)

Query: 684 EFLNEIQALTEI-RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKIL------------- 729
           + ++E++ +  I +H+NI+   G C+     ++I EY   G+L + L             
Sbjct: 63  DLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFD 122

Query: 730 CNDASAKELGWTQRLNVIKGVADALFYLHNN-CFPPIVHRDISSKNVLLDLGYEAHVSDF 788
                 ++L +   ++    VA  + YL +  C    +HRD++++NVL+       ++DF
Sbjct: 123 ITKVPEEQLSFKDLVSCAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADF 178

Query: 789 GIAKFLNPDSSNWSELAGTH---GYVAPELAYTLKVTEKCDVYSFGVLALEV--IKGKH- 842
           G+A+ ++ D   + + +       ++APE  +    T + DV+SFG+L  E+  + G   
Sbjct: 179 GLARGVH-DIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY 237

Query: 843 ---PRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMK 899
              P + LF++      M+          PS +   +L  +M+    C    P  RPT K
Sbjct: 238 PGIPVEELFKLLREGHRMD---------KPS-NCTHELYMLMR---ECWHAVPTQRPTFK 284

Query: 900 RVSQLL 905
           ++ + L
Sbjct: 285 QLVEAL 290

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 56.2 bits (135), Expect = 3e-08
 Identities = 69/266 (25%), Positives = 112/266 (42%), Gaps = 46/266 (17%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEF---LNEIQALTEIRHRNIV 701
           +GKG  G V   K   +G  +A+K     L  E+   ++E    L E + L   RH  + 
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKI----LKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 58

Query: 702 KF-YGFCSHPKHSFIIYEYLESGSL------DKILCNDASAKELGWTQRLNVIKGVADAL 754
              Y F +H +  F++ EY   G L      +++   D  A+  G          +  AL
Sbjct: 59  ALKYSFQTHDRLCFVM-EYANGGELFFHLSRERVFSED-RARFYG--------AEIVSAL 108

Query: 755 FYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPE 814
            YLH+     +V+RD+  +N++LD      ++DFG+ K    D +      GT  Y+APE
Sbjct: 109 DYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPE 166

Query: 815 LAYTLKVTEKCDVYSFGVLALEVIKGKHP-----RDFLFEMSSSSSNMNIEMLDSRLPYP 869
           +          D +  GV+  E++ G+ P      + LFE+        I M + R P  
Sbjct: 167 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL--------ILMEEIRFPRT 218

Query: 870 SLHVQKKLMSIMQVAFSCLDQNPESR 895
                K L+S        L ++P+ R
Sbjct: 219 LSPEAKSLLS------GLLKKDPKQR 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 56.0 bits (135), Expect = 3e-08
 Identities = 52/219 (23%), Positives = 100/219 (45%), Gaps = 22/219 (10%)

Query: 629 VYEEIISATNDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKK----FHSPLPGEMSFQQE 683
           ++  +   TN +     +G G  G V  A+   +G+  A+KK    F +P+  + +++  
Sbjct: 1   IFGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-- 58

Query: 684 EFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQR 743
               E++ L  +RH NI+        P         L    L ++L +    K+      
Sbjct: 59  ----ELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFL 114

Query: 744 LNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSE 803
             +++G    L Y+H+     +VHRD+   N+L++   +  + DFG+A+  +P  + +  
Sbjct: 115 YQILRG----LKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGY-- 165

Query: 804 LAGTHGYVAPELAYTL-KVTEKCDVYSFGVLALEVIKGK 841
              T  Y APE+  T  K   + D++S G +  E+++GK
Sbjct: 166 -VSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 56.1 bits (135), Expect = 4e-08
 Identities = 51/166 (30%), Positives = 79/166 (47%), Gaps = 4/166 (2%)

Query: 388 EIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKL 447
           +    L N++ L  L L+ N+L   I  EL  L NL  LDL  NN+++  P        L
Sbjct: 84  DGSENLLNLLPLPSLDLNLNRLRSNIS-ELLELTNLTSLDLDNNNITDIPPLIGLLKSNL 142

Query: 448 YYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSG 507
             L+LS NK+   +P  L NL +L  LDLS N L   +   +  + +L  L+LS N +S 
Sbjct: 143 KELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDL-SDLPKLLSNLSNLNNLDLSGNKIS- 199

Query: 508 LIPRCFEEMHGLLHIDISYNKLEGQIPNSTTFRDAPLEALQGNKGL 553
            +P   E +  L  +D+S N +   + + +  ++     L  NK  
Sbjct: 200 DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLE 245

Length = 394

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 55.7 bits (134), Expect = 4e-08
 Identities = 62/283 (21%), Positives = 120/283 (42%), Gaps = 36/283 (12%)

Query: 646 IGKGGHGSVYRA---KVPSGEI---FAVKKFHSPLPGEMSFQQE-EFLNEIQALTEIRHR 698
           +G+G  G VY      +  GE     AVK  +       S ++  EFLNE   +      
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNE----SASLRERIEFLNEASVMKGFTCH 69

Query: 699 NIVKFYGFCSHPKHSFIIYEYLESGSLDKILC-------NDASAKELGWTQRLNVIKGVA 751
           ++V+  G  S  + + ++ E +  G L   L        N+         + + +   +A
Sbjct: 70  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129

Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH--- 808
           D + YL+   F   VHRD++++N ++   +   + DFG+ + +    +++    G     
Sbjct: 130 DGMAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLP 184

Query: 809 -GYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDSRL 866
             ++APE       T   D++SFGV+  E+    + P    ++  S+   +   M    L
Sbjct: 185 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP----YQGLSNEQVLKFVMDGGYL 240

Query: 867 PYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI 909
             P  +  +++  +M++   C   NP+ RPT   +  LL + +
Sbjct: 241 DQPD-NCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLKDDL 279

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 55.4 bits (134), Expect = 4e-08
 Identities = 55/206 (26%), Positives = 96/206 (46%), Gaps = 25/206 (12%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           IG+G +G VY+A+   +GEI A+KK    L  E        + EI  L E+ H NIV+  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIR--LETEDEGVPSTAIREISLLKELNHPNIVRLL 64

Query: 705 GFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKG----VADALFYLHNN 760
                    ++++E+L+   L K +    S+   G    L  IK     +   + Y H++
Sbjct: 65  DVVHSENKLYLVFEFLDL-DLKKYM---DSSPLTGLDPPL--IKSYLYQLLQGIAYCHSH 118

Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL----- 815
               ++HRD+  +N+L+D      ++DFG+A+        ++    T  Y APE+     
Sbjct: 119 ---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSR 175

Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGK 841
            Y+  V    D++S G +  E++  +
Sbjct: 176 QYSTPV----DIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 54.9 bits (133), Expect = 4e-08
 Identities = 52/197 (26%), Positives = 88/197 (44%), Gaps = 33/197 (16%)

Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFY 756
           + N +K Y   +  K   +I +Y++ G L  +L  +    +L   +   +I+ + +AL  
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALND 124

Query: 757 LHNNCFPPIVHRDISSKNVLLDLGYEAHV--SDFGIAKFLNPDSSNWSELAGTHGYVAPE 814
           LH +    I+H DI  +NVL D   +  +   D+G+ K +   S       GT  Y +PE
Sbjct: 125 LHKH---NIIHNDIKLENVLYD-RAKDRIYLCDYGLCKIIGTPSC----YDGTLDYFSPE 176

Query: 815 LAYTLKVT-EKCDV----YSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSR---- 865
                K+     DV    ++ GVL  E++ GKHP    F+       +++E L  R    
Sbjct: 177 -----KIKGHNYDVSFDWWAVGVLTYELLTGKHP----FK-EDEDEELDLESLLKRQQKK 226

Query: 866 LPYPSLHVQKKLMSIMQ 882
           LP+   +V K     +Q
Sbjct: 227 LPFIK-NVSKNANDFVQ 242

Length = 267

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 55.8 bits (134), Expect = 5e-08
 Identities = 54/194 (27%), Positives = 89/194 (45%), Gaps = 18/194 (9%)

Query: 717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHN-NCFPPIVHRDISSKNV 775
           Y+      +  +L +D S + L     L+    VA  + +L + NC    VHRD++++NV
Sbjct: 214 YKGSNDSEVKNLLSDDGS-EGLTTLDLLSFTYQVARGMEFLASKNC----VHRDLAARNV 268

Query: 776 LLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPELAYTLKVTEKCDVYSFGV 832
           LL  G    + DFG+A+ +  D SN+     T     ++APE  +    T   DV+S+G+
Sbjct: 269 LLAQGKIVKICDFGLARDIMHD-SNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGI 327

Query: 833 LALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQN 891
           L  E+   G  P      M   S+  N      R+  P  H  +++  IM     C +  
Sbjct: 328 LLWEIFSLGGTPYP---GMIVDSTFYNKIKSGYRMAKPD-HATQEVYDIM---VKCWNSE 380

Query: 892 PESRPTMKRVSQLL 905
           PE RP+   +S ++
Sbjct: 381 PEKRPSFLHLSDIV 394

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 55.0 bits (132), Expect = 5e-08
 Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 23/213 (10%)

Query: 640 FNAEHCIGKGGHGSVYRAKV-PSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHR 698
           F     +GKGG G V   +V  +G+++A KK       +   +    LNE + L ++  R
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA-LNEKRILEKVNSR 60

Query: 699 NIVKFYGFCSHPKHSF-IIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYL 757
            +V    +    K +  ++   +  G L   + N  +    G+ ++         A+FY 
Sbjct: 61  FVVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNP---GFDEQ--------RAIFYA 108

Query: 758 HNNCF-------PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGY 810
              C          IV+RD+  +N+LLD      +SD G+A  + P+        GT GY
Sbjct: 109 AELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQI-PEGETVRGRVGTVGY 167

Query: 811 VAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           +APE+    K T   D +  G L  E+I+G+ P
Sbjct: 168 MAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 55.4 bits (133), Expect = 6e-08
 Identities = 64/244 (26%), Positives = 106/244 (43%), Gaps = 24/244 (9%)

Query: 638 NDFNAEHCIGKGGHGSVYRAKVPSGE-IFAVKKFHSPLPGEMSFQQEE--FLNEIQALTE 694
           +DF     IG+G  G V   K+   E I+A+K  +     EM  + E   F  E   L  
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNK---WEMLKRAETACFREERNVLVN 57

Query: 695 IRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCN--DASAKELGWTQRLNVIKGVAD 752
              + I   +       + +++ +Y   G L  +L    D   +++    R  + + V  
Sbjct: 58  GDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMA---RFYIAEMVL- 113

Query: 753 ALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELA-GTHGYV 811
           A+  +H   +   VHRDI   NVLLD+     ++DFG    +N D +  S +A GT  Y+
Sbjct: 114 AIHSIHQLHY---VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYI 170

Query: 812 APELAYTL-----KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRL 866
           +PE+   +     K   +CD +S GV   E++ G+ P    +  S   +   I   + R 
Sbjct: 171 SPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP---FYAESLVETYGKIMNHEERF 227

Query: 867 PYPS 870
            +PS
Sbjct: 228 QFPS 231

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 55.4 bits (133), Expect = 6e-08
 Identities = 70/343 (20%), Positives = 120/343 (34%), Gaps = 109/343 (31%)

Query: 646 IGKGGHGSVYRA------KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHR 698
           +G G  G V  A      K  S    AVK       G  + + +  ++E++ L  I  H 
Sbjct: 15  LGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKE---GATASEHKALMSELKILIHIGNHL 71

Query: 699 NIVKFYGFCSHPKHSF-IIYEYLESGSLDKIL---------CNDASAKELGWTQ------ 742
           N+V   G C+ P     +I E+ + G+L   L           + S K+ G  +      
Sbjct: 72  NVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQS 131

Query: 743 --RLNVIKGVADALFYLH-----NNCFPP------------------------------- 764
                +  G A  LF         +  PP                               
Sbjct: 132 RVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLA 191

Query: 765 ---IVHRDISSKNVLLDLGYEAHVSDFGIAK--FLNPDSSNWSELAGTHGYVAPELAYTL 819
               +HRD++++N+LL       + DFG+A+  + +PD            ++APE  +  
Sbjct: 192 SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDK 251

Query: 820 KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLM- 878
             T + DV+SFGVL  E+          F + +S             PYP + + ++   
Sbjct: 252 VYTTQSDVWSFGVLLWEI----------FSLGAS-------------PYPGVQINEEFCQ 288

Query: 879 ----------------SIMQVAFSCLDQNPESRPTMKRVSQLL 905
                            I ++  +C   +P+ RPT   + ++L
Sbjct: 289 RLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEIL 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 54.9 bits (132), Expect = 6e-08
 Identities = 58/224 (25%), Positives = 100/224 (44%), Gaps = 24/224 (10%)

Query: 685 FLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRL 744
           F      ++++ H ++   +G C     + ++ E++E G LD  L  +     + W  ++
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KI 120

Query: 745 NVIKGVADALFYLHNNCFPPIVHRDISSKNVLL-DLGYEAHVSDFGIAKFLNPDSS---- 799
            V + +A AL YL +     +VH ++ +KN+LL  LG     S F   K  +P  S    
Sbjct: 121 TVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEGTSPF--IKLSDPGVSFTAL 175

Query: 800 NWSELAGTHGYVAPE-LAYTLKVTEKCDVYSFGVLALEV-IKGKHPRDFLFEMSSSSSNM 857
           +  E      ++APE +     ++   D +SFG   LE+   G+ P   L E + S    
Sbjct: 176 SREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVP---LKERTPSEKER 232

Query: 858 NIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
             E    RLP PS    K+L +++     CL   P  RP+ + +
Sbjct: 233 FYEK-KHRLPEPSC---KELATLIS---QCLTYEPTQRPSFRTI 269

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 55.2 bits (133), Expect = 7e-08
 Identities = 54/214 (25%), Positives = 95/214 (44%), Gaps = 19/214 (8%)

Query: 639 DFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEF---LNE--IQAL 692
           DFN    +GKG  G V  A +  + E++A+K     L  ++  Q ++    + E  + AL
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKI----LKKDVIIQDDDVECTMVEKRVLAL 56

Query: 693 TEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVAD 752
              +   + + +         + + EY+  G L   +      KE      +     +A 
Sbjct: 57  PG-KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKE---PHAVFYAAEIAI 112

Query: 753 ALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK-FLNPDSSNWSELAGTHGYV 811
            LF+LH+     I++RD+   NV+LD      ++DFG+ K  +    +      GT  Y+
Sbjct: 113 GLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTT-RTFCGTPDYI 168

Query: 812 APELAYTLKVTEKCDVYSFGVLALEVIKGKHPRD 845
           APE+       +  D ++FGVL  E++ G+ P D
Sbjct: 169 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 55.0 bits (132), Expect = 7e-08
 Identities = 59/247 (23%), Positives = 106/247 (42%), Gaps = 48/247 (19%)

Query: 684 EFLNEIQALTEI-RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKIL------------- 729
           + ++E++ +  I +H+NI+   G C+     +++ EY   G+L + L             
Sbjct: 63  DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFD 122

Query: 730 -CNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDF 788
            C     ++L +   ++    VA  + YL +      +HRD++++NVL+       ++DF
Sbjct: 123 TCK-LPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADF 178

Query: 789 GIAKFLNPDSSNWSELAGTHG------YVAPELAYTLKVTEKCDVYSFGVLALEVIK-GK 841
           G+A+    D  N      T        ++APE  +    T + DV+SFGVL  E+   G 
Sbjct: 179 GLAR----DVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGG 234

Query: 842 HPR-----DFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRP 896
            P      + LF++      M+        P    H   +L  IM+    C    P  RP
Sbjct: 235 SPYPGIPVEELFKLLKEGHRMD-------KPANCTH---ELYMIMR---ECWHAVPSQRP 281

Query: 897 TMKRVSQ 903
           T K++ +
Sbjct: 282 TFKQLVE 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 54.9 bits (132), Expect = 7e-08
 Identities = 63/217 (29%), Positives = 90/217 (41%), Gaps = 40/217 (18%)

Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH----RNI 700
           IGKG  G VY+  K  +  I+A+K                   EI A  E+ H    RNI
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSK--------------KEIVAKKEVAHTIGERNI 46

Query: 701 VKFYGFCSHP-----KHSF-------IIYEYLESGSLDKILCNDASAKELGWTQRLNV-I 747
           +        P     K SF       ++ +Y+  G L   L  +    E     R    I
Sbjct: 47  LVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSE----DRAKFYI 102

Query: 748 KGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGT 807
             +  AL +LH      IV+RD+  +N+LLD      + DFG++K    D+   +   GT
Sbjct: 103 AELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGT 159

Query: 808 HGYVAPELAYTLK-VTEKCDVYSFGVLALEVIKGKHP 843
             Y+APE+    K  T+  D +S GVL  E+  G  P
Sbjct: 160 TEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 54.8 bits (132), Expect = 7e-08
 Identities = 62/223 (27%), Positives = 98/223 (43%), Gaps = 33/223 (14%)

Query: 638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEE--FLNEIQALTE 694
           +DF     IG+G  G V   K+  +G+++A+K  +     EM  + E   F  E   L  
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNK---WEMLKRAETACFREERDVLVN 57

Query: 695 IRHRNIVKF-YGFCSHPKHSFIIYEYLESGSLDKILCN--DASAKELGWTQRLNVIKGV- 750
              R I    Y F     + +++ +Y   G L  +L    D   +++    R  + + V 
Sbjct: 58  GDRRWITNLHYAF-QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMA---RFYLAEMVL 113

Query: 751 -ADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELA-GTH 808
             D++  L        VHRDI   NVLLD      ++DFG    L  D +  S +A GT 
Sbjct: 114 AIDSVHQLG------YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTP 167

Query: 809 GYVAPELAYTLKVTE--------KCDVYSFGVLALEVIKGKHP 843
            Y++PE+   L+  E        +CD +S GV   E++ G+ P
Sbjct: 168 DYISPEI---LQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 54.9 bits (132), Expect = 8e-08
 Identities = 64/260 (24%), Positives = 117/260 (45%), Gaps = 34/260 (13%)

Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEF---LNEIQALT-EIRHRNI 700
           +GKG  G V  A    + E++A+K     L  ++  Q ++    + E + L    +H  +
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKV----LKKDVILQDDDVDCTMTEKRILALAAKHPFL 58

Query: 701 VKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
              +         F + EY+  G L   +     +++    +       V  AL +LH +
Sbjct: 59  TALHCCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH 115

Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLK 820
               +++RD+   N+LLD      ++DFG+ K    +    +   GT  Y+APE+   L+
Sbjct: 116 ---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELE 172

Query: 821 VTEKCDVYSFGVLALEVIKGKHP-----RDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQK 875
                D ++ GVL  E++ G+ P      D LFE     S ++ ++L     YP + + K
Sbjct: 173 YGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFE-----SILHDDVL-----YP-VWLSK 221

Query: 876 KLMSIMQVAFSCLDQNPESR 895
           + +SI++ AF  + +NP  R
Sbjct: 222 EAVSILK-AF--MTKNPNKR 238

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 54.9 bits (132), Expect = 9e-08
 Identities = 60/244 (24%), Positives = 97/244 (39%), Gaps = 42/244 (17%)

Query: 662 GEIFAVKKFHSPLPGEMSF-QQEEFLNEIQALTEIRHRNIVK-----FYGFCS---HPKH 712
           G +F   K   P P  +   Q+   L E   L  + H ++++       G  +    P +
Sbjct: 80  GRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY 139

Query: 713 SFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISS 772
           S  +Y YL   S           + L   Q L + K + + L YLH      I+HRD+ +
Sbjct: 140 SSDLYTYLTKRS-----------RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKT 185

Query: 773 KNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGV 832
           +N+ ++   +  + D G A+F    +  +  LAGT    APE+    K   K D++S G+
Sbjct: 186 ENIFINDVDQVCIGDLGAAQF-PVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGI 244

Query: 833 LALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNP 892
           +             LFEM +  S +  E   S            L+ I+    S L  +P
Sbjct: 245 V-------------LFEMLAYPSTI-FEDPPSTPEEYVKSCHSHLLKII----STLKVHP 286

Query: 893 ESRP 896
           E  P
Sbjct: 287 EEFP 290

Length = 357

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 54.6 bits (131), Expect = 9e-08
 Identities = 61/218 (27%), Positives = 99/218 (45%), Gaps = 27/218 (12%)

Query: 646 IGKGGHGSV--YRAKVPSGEIFAVKKFHSPLPGEMSFQQEEF---LNEIQALTEIRHRNI 700
           +GKG  G V   R K  +G  +A+K     L  E+   ++E    + E + L   RH  +
Sbjct: 3   LGKGTFGKVILVREKA-TGRYYAMKI----LRKEVIIAKDEVAHTVTESRVLQNTRHPFL 57

Query: 701 VKF-YGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKG--VADALFYL 757
               Y F +H +  F++ EY   G L   L     ++E  +T+      G  +  AL YL
Sbjct: 58  TALKYAFQTHDRLCFVM-EYANGGELFFHL-----SRERVFTEERARFYGAEIVSALEYL 111

Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAY 817
           H+     +V+RDI  +N++LD      ++DFG+ K    D +      GT  Y+APE+  
Sbjct: 112 HSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 168

Query: 818 TLKVTEKCDVYSFGVLALEVIKGKHP-----RDFLFEM 850
                   D +  GV+  E++ G+ P      + LFE+
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL 206

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 54.4 bits (131), Expect = 9e-08
 Identities = 55/204 (26%), Positives = 100/204 (49%), Gaps = 18/204 (8%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKK--FHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVK 702
           IG+G +G+V++AK   + EI A+K+        G  S      L EI  L E++H+NIV+
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA----LREICLLKELKHKNIVR 63

Query: 703 FYGFCSHPKHSFIIYEYLESGSLDKIL--CNDASAKELGWTQRLNVIKGVADALFYLHNN 760
            Y      K   +++EY +   L K    CN     E+  +    ++KG+A    + H++
Sbjct: 64  LYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLA----FCHSH 118

Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLK 820
               ++HRD+  +N+L++   E  ++DFG+A+        +S    T  Y  P++ +  K
Sbjct: 119 ---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 175

Query: 821 V-TEKCDVYSFGVLALEVIKGKHP 843
           + +   D++S G +  E+     P
Sbjct: 176 LYSTSIDMWSAGCIFAELANAGRP 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 54.3 bits (131), Expect = 9e-08
 Identities = 63/288 (21%), Positives = 120/288 (41%), Gaps = 55/288 (19%)

Query: 644 HCIGKGGHGSVYRAKV-----PSGEI-FAVKKFHSPLPGEMSFQQ-EEFLNEIQALTEI- 695
             +G+G  G V +A+      P+     AVK     L  + + +   + ++E++ +  I 
Sbjct: 18  KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKM----LKDDATEKDLSDLVSEMEMMKMIG 73

Query: 696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKIL---------CNDASAKELGWTQRLNV 746
           +H+NI+   G C+     +++ EY   G+L   L          +    +    T     
Sbjct: 74  KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133

Query: 747 IKG----VADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWS 802
           +      VA  + +L +      +HRD++++NVL+   +   ++DFG+A+ ++       
Sbjct: 134 LVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIH---HIDY 187

Query: 803 ELAGTHG-----YVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPR-----DFLFEMS 851
               T+G     ++APE  +    T + DV+SFGVL  E+   G  P      + LF++ 
Sbjct: 188 YRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL 247

Query: 852 SSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMK 899
                M              +  ++L  +M+    C  + P  RPT K
Sbjct: 248 KEGYRME----------KPQNCTQELYHLMR---DCWHEVPSQRPTFK 282

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 55.0 bits (132), Expect = 1e-07
 Identities = 44/170 (25%), Positives = 80/170 (47%), Gaps = 11/170 (6%)

Query: 681 QQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGW 740
           Q+     E   L  I H +I++  G  ++ K + +I    ++     + C  A+ + +  
Sbjct: 126 QRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT----DLYCYLAAKRNIAI 181

Query: 741 TQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKF-LNPDSS 799
              L + + V  A+ YLH N    I+HRDI ++N+ ++   +  + DFG A F ++ +++
Sbjct: 182 CDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238

Query: 800 NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFE 849
            +   AGT    APEL          D++S G++  E+       D LFE
Sbjct: 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH---DSLFE 285

Length = 391

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 54.6 bits (132), Expect = 1e-07
 Identities = 67/320 (20%), Positives = 118/320 (36%), Gaps = 77/320 (24%)

Query: 638 NDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEE---FLNEIQALT 693
           +DF     IG+G  G V+  +   +G+++A+K     L      ++ +      E   L 
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKV----LRKSDMIKRNQIAHVRAERDILA 56

Query: 694 EIRHRNIVK-FYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNV------ 746
           +     IVK +Y F    +H +++ EY+  G L            +    R +V      
Sbjct: 57  DADSPWIVKLYYSF-QDEEHLYLVMEYMPGGDL------------MNLLIRKDVFPEETA 103

Query: 747 ---IKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHV--SDFGIAKFLNPDSSNW 801
              I  +  AL  +H   F   +HRDI   N+L+D   + H+  +DFG+ K +N      
Sbjct: 104 RFYIAELVLALDSVHKLGF---IHRDIKPDNILIDA--DGHIKLADFGLCKKMNKAKDRE 158

Query: 802 SEL-----------------------------AGTHGYVAPELAYTLKVTEKCDVYSFGV 832
             L                              GT  Y+APE+        +CD +S GV
Sbjct: 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGV 218

Query: 833 LALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSL-HVQKKLMSIMQVAFSCLDQN 891
           +  E++ G  P    +  +   +   I      L +P    V  + + ++      L  +
Sbjct: 219 ILYEMLYGFPP---FYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLIC---RLL-CD 271

Query: 892 PESRPTMKRVSQLLCEKIFE 911
           PE R  +    ++     F+
Sbjct: 272 PEDR--LGSFEEIKSHPFFK 289

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 54.2 bits (130), Expect = 1e-07
 Identities = 53/227 (23%), Positives = 102/227 (44%), Gaps = 39/227 (17%)

Query: 646 IGKGGHGSVYRAKV------PSGEI-FAVKKFHSPL-------PGEMSFQQEEFLNEIQA 691
           +G+G  G V+  +V      P+ +  F V+K    L       P      + +FL E++ 
Sbjct: 13  LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72

Query: 692 LTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCN----------------DASA 735
           L+ ++  NI++  G C       +I EY+E+G L++ L +                    
Sbjct: 73  LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132

Query: 736 KELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN 795
             + ++  L+V   +A  + YL +  F   VHRD++++N L+       ++DFG+++  N
Sbjct: 133 PAISYSSLLHVALQIASGMKYLSSLNF---VHRDLATRNCLVGENLTIKIADFGMSR--N 187

Query: 796 PDSSNWSELAGTH----GYVAPELAYTLKVTEKCDVYSFGVLALEVI 838
             + ++  + G       ++A E     K T   DV++FGV   E++
Sbjct: 188 LYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 49.1 bits (118), Expect = 1e-07
 Identities = 25/59 (42%), Positives = 32/59 (54%)

Query: 399 LNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKL 457
           L  L LS N+L+         L NL+ LDLS NNL++  PE+   L  L  L+LS N L
Sbjct: 2   LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 48.3 bits (116), Expect = 2e-07
 Identities = 23/58 (39%), Positives = 28/58 (48%)

Query: 422 NLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHN 479
           NL+ LDLS N L+     +   L  L  L+LS N L+   P     L  L  LDLS N
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58

Length = 60

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 54.1 bits (130), Expect = 2e-07
 Identities = 39/163 (23%), Positives = 65/163 (39%), Gaps = 46/163 (28%)

Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAK--FLNPDSSNWSELAGTHGYVAPELAYTLKVTE 823
           +HRD++++N+LL       + DFG+A+  + +PD     +      ++APE  +    T 
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTT 254

Query: 824 KCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLM----- 878
           + DV+SFGVL  E+          F + +S             PYP + + ++       
Sbjct: 255 QSDVWSFGVLLWEI----------FSLGAS-------------PYPGVQIDEEFCRRLKE 291

Query: 879 ------------SIMQVAFSCLDQNPESRPTMKRVSQLLCEKI 909
                        I  +   C   NPE RPT       L E +
Sbjct: 292 GTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSE----LVEIL 330

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 53.9 bits (129), Expect = 2e-07
 Identities = 58/244 (23%), Positives = 111/244 (45%), Gaps = 38/244 (15%)

Query: 684 EFLNEIQALTEI-RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKIL----------CND 732
           + ++E++ +  I +H+NI+   G C+     ++I EY   G+L + L          C +
Sbjct: 69  DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYN 128

Query: 733 AS---AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFG 789
            +    ++L +   ++    VA  + YL +      +HRD++++NVL+       ++DFG
Sbjct: 129 PTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFG 185

Query: 790 IAKFLNPDSSNWSELAGTH--GYVAPELAYTLKVTEKCDVYSFGVLALEV--IKGKH--- 842
           +A+ ++          G     ++APE  +    T + DV+SFGVL  E+  + G     
Sbjct: 186 LARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 245

Query: 843 -PRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
            P + LF++      M+          PS +   +L  +M+    C    P  RPT K++
Sbjct: 246 VPVEELFKLLKEGHRMD---------KPS-NCTNELYMMMR---DCWHAVPSQRPTFKQL 292

Query: 902 SQLL 905
            + L
Sbjct: 293 VEDL 296

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 53.4 bits (128), Expect = 2e-07
 Identities = 52/208 (25%), Positives = 92/208 (44%), Gaps = 13/208 (6%)

Query: 640 FNAEHCIGKGGHGSVYRAKV-PSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHR 698
           F     +GKGG G V   +V  +G+++A K+       +   +    LNE Q L ++  +
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA-LNEKQILEKVNSQ 60

Query: 699 NIVKFYGFCSHPKHSF-IIYEYLESGSLDKILCNDASAKELGWTQRLNVIKG--VADALF 755
            +V    +    K +  ++   +  G L   + N  +    G+ +   +     +   L 
Sbjct: 61  FVVNL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNP---GFEEERALFYAAEILCGLE 116

Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
            LH       V+RD+  +N+LLD      +SD G+A  + P+  +     GT GY+APE+
Sbjct: 117 DLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKI-PEGESIRGRVGTVGYMAPEV 172

Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
               + T   D +  G L  E+I+G+ P
Sbjct: 173 LNNQRYTLSPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 53.5 bits (128), Expect = 2e-07
 Identities = 61/267 (22%), Positives = 110/267 (41%), Gaps = 35/267 (13%)

Query: 646 IGKGGHGSVYRAK-VPSGE-------IFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH 697
           +G G  G+VY+   +P GE       I  +++  SP         +E L+E   +  +  
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPK------ANKEILDEAYVMAGVGS 68

Query: 698 RNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYL 757
             + +  G C       +         LD +  N      +G    LN    +A  + YL
Sbjct: 69  PYVCRLLGICLTSTVQLVTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYL 125

Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH--GYVAPEL 815
                  +VHRD++++NVL+       ++DFG+A+ L+ D + +    G     ++A E 
Sbjct: 126 EE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 182

Query: 816 AYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDS--RLPYPSLH 872
               + T + DV+S+GV   E++  G  P D         +    ++L+   RLP P + 
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMTFGAKPYD------GIPAREIPDLLEKGERLPQPPIC 236

Query: 873 VQKKLMSIMQVAFSCLDQNPESRPTMK 899
                M +++    C   + E RP  +
Sbjct: 237 TIDVYMIMVK----CWMIDSECRPRFR 259

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 53.9 bits (129), Expect = 2e-07
 Identities = 55/216 (25%), Positives = 96/216 (44%), Gaps = 21/216 (9%)

Query: 639 DFNAEHCIGKGGHGSVYRAKVPSGE-IFAVKKFHSPLPGEMSFQQEE--FLNEIQALTEI 695
           DF     IG+G  G V   K+ + + +FA+K  +     EM  + E   F  E   L   
Sbjct: 2   DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNK---WEMLKRAETACFREERDVLVNG 58

Query: 696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCN--DASAKELGWTQRLNVIKGVADA 753
            ++ I   +       + +++ +Y   G L  +L    D   +++       ++  + D+
Sbjct: 59  DNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAI-DS 117

Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELA-GTHGYVA 812
           +  LH       VHRDI   N+L+D+     ++DFG    L  D +  S +A GT  Y++
Sbjct: 118 VHQLH------YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 171

Query: 813 PELAYTL-----KVTEKCDVYSFGVLALEVIKGKHP 843
           PE+   +     K   +CD +S GV   E++ G+ P
Sbjct: 172 PEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 53.5 bits (128), Expect = 2e-07
 Identities = 48/154 (31%), Positives = 79/154 (51%), Gaps = 19/154 (12%)

Query: 750 VADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK-FLNPDSSNWSELAGTH 808
           ++ AL YLH      I++RD+   NVLLD      ++D+G+ K  L P  +  S   GT 
Sbjct: 105 ISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT-STFCGTP 160

Query: 809 GYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIE------ML 862
            Y+APE+          D ++ GVL  E++ G+ P D +   SS + + N E      +L
Sbjct: 161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV--GSSDNPDQNTEDYLFQVIL 218

Query: 863 DSRLPYP-SLHVQKKLMSIMQVAFSCLDQNPESR 895
           + ++  P SL V  K  S+++   S L+++P+ R
Sbjct: 219 EKQIRIPRSLSV--KAASVLK---SFLNKDPKER 247

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 53.5 bits (128), Expect = 2e-07
 Identities = 31/96 (32%), Positives = 50/96 (52%), Gaps = 3/96 (3%)

Query: 750 VADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG 809
           +A  LF+LH+     I++RD+   NV+LD      ++DFG+ K    D        GT  
Sbjct: 110 IAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPD 166

Query: 810 YVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRD 845
           Y+APE+       +  D ++FGVL  E++ G+ P +
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 53.2 bits (128), Expect = 2e-07
 Identities = 53/227 (23%), Positives = 103/227 (45%), Gaps = 25/227 (11%)

Query: 683 EEFLNEIQALTEIRHRNIVKFYGFC-----SHPKHSFIIYEYLESGSLDKILCNDASAKE 737
           +   NEI+ L  I   NI+K YGF        P+ S +I EY   G L ++L  +   K+
Sbjct: 63  DITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLS-LILEYCTRGYLREVLDKE---KD 118

Query: 738 LGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL-NP 796
           L +  +L++       L+ L+     P  +++++S + L+   Y+  +   G+ K L +P
Sbjct: 119 LSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSP 176

Query: 797 DSSNWSELAGTHGYVAPELAYTL--KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS 854
              N + +     Y + ++   +  + T K D+YS GV+  E+  GK P    FE  ++ 
Sbjct: 177 PFKNVNFMV----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIP----FENLTTK 228

Query: 855 SNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
              ++ +  +      L    ++  I++   +C   +   RP +K +
Sbjct: 229 EIYDLIINKNNSLKLPLDCPLEIKCIVE---ACTSHDSIKRPNIKEI 272

Length = 283

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 53.2 bits (128), Expect = 2e-07
 Identities = 51/205 (24%), Positives = 94/205 (45%), Gaps = 8/205 (3%)

Query: 639 DFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH 697
           D+     IG+G +G VY+ +   +G+I A+KK    L  E        + EI  L E++H
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIR--LESEEEGVPSTAIREISLLKELQH 58

Query: 698 RNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYL 757
            NIV            ++I+E+L S  L K L +    + +      + +  +   + + 
Sbjct: 59  PNIVCLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFC 117

Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPE-LA 816
           H+     ++HRD+  +N+L+D      ++DFG+A+        ++    T  Y APE L 
Sbjct: 118 HSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLL 174

Query: 817 YTLKVTEKCDVYSFGVLALEVIKGK 841
            + + +   D++S G +  E+   K
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 53.5 bits (128), Expect = 2e-07
 Identities = 54/212 (25%), Positives = 91/212 (42%), Gaps = 15/212 (7%)

Query: 639 DFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEF---LNEIQALTE 694
           DFN    +GKG  G V  A+   + E++A+K     L  ++  Q ++    + E + L  
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKI----LKKDVVIQDDDVECTMVEKRVLAL 56

Query: 695 IRHRNIVKFYGFCSHP-KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADA 753
                 +     C       + + EY+  G L   +      KE    Q +     ++  
Sbjct: 57  QDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKE---PQAVFYAAEISVG 113

Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAP 813
           LF+LH      I++RD+   NV+LD      ++DFG+ K    D        GT  Y+AP
Sbjct: 114 LFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAP 170

Query: 814 ELAYTLKVTEKCDVYSFGVLALEVIKGKHPRD 845
           E+       +  D +++GVL  E++ G+ P D
Sbjct: 171 EIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 53.9 bits (129), Expect = 3e-07
 Identities = 58/228 (25%), Positives = 95/228 (41%), Gaps = 30/228 (13%)

Query: 687 NEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNV 746
           +E+  L    H  IVK +          +I EY   G L+K +      KE      L  
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI--KQRLKE-----HLPF 166

Query: 747 IKGVADALFY--------LHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS 798
            +     LFY        +H+     ++HRD+ S N+ L       + DFG +K  + DS
Sbjct: 167 QEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYS-DS 222

Query: 799 SNW---SELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSS 855
            +    S   GT  Y+APEL    + ++K D++S GV+  E++    P    F+  S   
Sbjct: 223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP----FKGPSQRE 278

Query: 856 NMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ 903
            M   +     P+P   V   + +++      L +NP  RPT +++  
Sbjct: 279 IMQQVLYGKYDPFPC-PVSSGMKALLD---PLLSKNPALRPTTQQLLH 322

Length = 478

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 53.4 bits (128), Expect = 3e-07
 Identities = 64/245 (26%), Positives = 107/245 (43%), Gaps = 24/245 (9%)

Query: 639 DFNAEHCIGKGGHGSVYRAKVPSG----EIFAVKKFHSPLPGEMSFQQEEFLNEIQALTE 694
           +F     +G G +G V+  +  +G    +++A+K        + +   E    E   L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 695 IRHRN--IVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKG-VA 751
           +R     +   Y F +  K   I+ +Y+  G +   L    +  E      +    G + 
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLIL-DYVSGGEMFTHLYQRDNFSE----DEVRFYSGEII 115

Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHV--SDFGIAK-FLNPDSSNWSELAGTH 808
            AL +LH      IV+RDI  +N+LLD   E HV  +DFG++K FL+ +        GT 
Sbjct: 116 LALEHLHK---LGIVYRDIKLENILLD--SEGHVVLTDFGLSKEFLSEEKERTYSFCGTI 170

Query: 809 GYVAPELAYTLKVTEKC-DVYSFGVLALEVIKGKHPRDFLFE-MSSSSSNMNIEMLDSRL 866
            Y+APE+        K  D +S G+L  E++ G  P  F  E   ++ S ++  +L    
Sbjct: 171 EYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASP--FTLEGERNTQSEVSRRILKCDP 228

Query: 867 PYPSL 871
           P+PS 
Sbjct: 229 PFPSF 233

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 52.7 bits (126), Expect = 3e-07
 Identities = 69/300 (23%), Positives = 129/300 (43%), Gaps = 46/300 (15%)

Query: 632 EIISATNDFNAEHCIGKGGHGSVYRAKV---PSGE---IFAVKKFHSPLPGEMSFQQEEF 685
           EI  +T  F  E  +G+   G VY+  +     GE     A+K       G +   +EEF
Sbjct: 1   EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPL---REEF 55

Query: 686 LNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQR-- 743
            +E    + ++H NIV   G  +  +   +I+ Y     L + L   +   ++G T    
Sbjct: 56  KHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDK 115

Query: 744 -----------LNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK 792
                      ++++  +A  + +L ++    +VH+D++++NVL+       +SD G+  
Sbjct: 116 TVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGL-- 170

Query: 793 FLNPDSSNWSELAGTH----GYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFL 847
           F    ++++ +L G       +++PE     K +   D++S+GV+  EV   G  P    
Sbjct: 171 FREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP---- 226

Query: 848 FEMSSSSSNMNIEMLDSR--LPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
                 S+   IEM+ +R  LP P       + ++M     C ++ P  RP  K +   L
Sbjct: 227 --YCGYSNQDVIEMIRNRQVLPCPD-DCPAWVYTLM---LECWNEFPSRRPRFKDIHSRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 52.9 bits (127), Expect = 3e-07
 Identities = 64/235 (27%), Positives = 105/235 (44%), Gaps = 35/235 (14%)

Query: 646 IGKGGHGSVY--RAKVPSGEIFAVKKFHSPLPGEMSFQQEEF---LNEIQALTEIRHRNI 700
           +GKG  G V   R K  +G+ +A+K     L  E+   ++E    L E + L   RH  +
Sbjct: 3   LGKGTFGKVILVREKA-TGKYYAMKI----LKKEVIIAKDEVAHTLTESRVLQNTRHPFL 57

Query: 701 VKF-YGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKG--VADALFYL 757
               Y F +H +  F++ EY   G L   L     ++E  +++      G  +  AL YL
Sbjct: 58  TALKYSFQTHDRLCFVM-EYANGGELFFHL-----SRERVFSEDRARFYGAEIVSALGYL 111

Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAY 817
           H+     +V+RD+  +N++LD      ++DFG+ K    D +      GT  Y+APE+  
Sbjct: 112 HSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 168

Query: 818 TLKVTEKCDVYSFGVLALEVIKGKHP-----RDFLFEMSSSSSNMNIEMLDSRLP 867
                   D +  GV+  E++ G+ P      + LFE+        I M + R P
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL--------ILMEEIRFP 215

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 53.0 bits (127), Expect = 3e-07
 Identities = 28/81 (34%), Positives = 45/81 (55%), Gaps = 4/81 (4%)

Query: 765 IVHRDISSKNVLLDLGYEAHVS--DFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVT 822
           +++RD+  +N+LLD  Y+ H++  DFG+ K    D    +   GT  Y+APEL      T
Sbjct: 114 VIYRDLKPENILLD--YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYT 171

Query: 823 EKCDVYSFGVLALEVIKGKHP 843
           +  D ++ GVL  E++ G  P
Sbjct: 172 KAVDWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 52.5 bits (126), Expect = 4e-07
 Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 23/207 (11%)

Query: 646 IGKGGHGSVYRAKV-PSGEIFAVKKFHSPL----PGE-MSFQQEEFLNEIQALTEIRHRN 699
           +GKGG G V   +V  +G+++A KK          GE M+      LNE Q L ++  R 
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA------LNEKQILEKVNSRF 61

Query: 700 IVKFYGFCSHPKHSF-IIYEYLESGSLDKILCNDASAKELGWTQRLNVIKG--VADALFY 756
           +V    +    K +  ++   +  G L   + N  +    G+ +   V     +   L  
Sbjct: 62  VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNP---GFDEERAVFYAAEITCGLED 117

Query: 757 LHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELA 816
           LH      IV+RD+  +N+LLD      +SD G+A  + P+        GT GY+APE+ 
Sbjct: 118 LHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEI-PEGETIRGRVGTVGYMAPEVV 173

Query: 817 YTLKVTEKCDVYSFGVLALEVIKGKHP 843
              + T   D +  G L  E+I+GK P
Sbjct: 174 KNERYTFSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 52.7 bits (127), Expect = 4e-07
 Identities = 67/273 (24%), Positives = 106/273 (38%), Gaps = 41/273 (15%)

Query: 297 FRNLTDLVKLRLNQNYLTGN----ISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQ-- 350
              L  L  LRL  N L       ++      P+L  + LS N   G I        Q  
Sbjct: 19  LPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLN-ETGRIPRGLQSLLQGL 77

Query: 351 -----LSLLDVSINNIS--GSIPLE-IGESLQLQYLDLSSNYIVGEIPTQLG-----NII 397
                L  LD+S N +   G   LE +  S  LQ L L++N +       L         
Sbjct: 78  TKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPP 137

Query: 398 YLNRLSLSGNKLSGCIPRELGSLI----NLEYLDLSANNLSNF----VPESLGSLVKLYY 449
            L +L L  N+L G     L   +    +L+ L+L+ N + +     + E L +   L  
Sbjct: 138 ALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEV 197

Query: 450 LNLSHNKL----SQQIPIELDNLIHLSELDLSHNFLGEKISSRIC---RME--SLEKLNL 500
           L+L++N L    +  +   L +L  L  L+L  N L +  ++ +         SL  L+L
Sbjct: 198 LDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSL 257

Query: 501 SYNNLSGL----IPRCFEEMHGLLHIDISYNKL 529
           S N+++      +     E   LL +D+  NK 
Sbjct: 258 SCNDITDDGAKDLAEVLAEKESLLELDLRGNKF 290

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 53.3 bits (128), Expect = 4e-07
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 10/148 (6%)

Query: 765 IVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN--WSELAGTHGYVAPELAYTLKVT 822
           ++HRDI S N+LL       + DFG +K      S+       GT  YVAPE+      +
Sbjct: 164 MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS 223

Query: 823 EKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQ 882
           +K D++S GVL  E++  K P    F+  +    M+  +     P P   +  ++  I+ 
Sbjct: 224 KKADMFSLGVLLYELLTLKRP----FDGENMEEVMHKTLAGRYDPLPP-SISPEMQEIVT 278

Query: 883 VAFSCLDQNPESRPTMKRVSQLLCEKIF 910
              + L  +P+ RP+  ++  +   K+F
Sbjct: 279 ---ALLSSDPKRRPSSSKLLNMPICKLF 303

Length = 496

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 52.2 bits (125), Expect = 4e-07
 Identities = 31/90 (34%), Positives = 45/90 (50%), Gaps = 3/90 (3%)

Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAP 813
           L +LH      I++RD+  +NVLLD      +SD G+A  L    S     AGT G++AP
Sbjct: 110 LEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAP 166

Query: 814 ELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           EL    +     D ++ GV   E+I  + P
Sbjct: 167 ELLQGEEYDFSVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 52.6 bits (126), Expect = 4e-07
 Identities = 49/206 (23%), Positives = 94/206 (45%), Gaps = 25/206 (12%)

Query: 646 IGKGGHGSV-YRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +G+V       +G   A+KK + P   E+ F +  +  E++ L  ++H N++   
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSEL-FAKRAY-RELRLLKHMKHENVIGLL 80

Query: 705 GFCSHPK-----HSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHN 759
              +        H F +        L K++ ++  +++        ++KG    L Y+H 
Sbjct: 81  DVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKG----LKYIHA 136

Query: 760 NCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAG---THGYVAPELA 816
                I+HRD+   N+ ++   E  + DFG+A+  +      SE+ G   T  Y APE+ 
Sbjct: 137 ---AGIIHRDLKPGNLAVNEDCELKILDFGLARQTD------SEMTGYVVTRWYRAPEVI 187

Query: 817 YT-LKVTEKCDVYSFGVLALEVIKGK 841
              +  T+  D++S G +  E++ GK
Sbjct: 188 LNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 47.2 bits (113), Expect = 5e-07
 Identities = 21/60 (35%), Positives = 32/60 (53%)

Query: 470 HLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKL 529
           +L  LDLS+N L          + +L+ L+LS NNL+ + P  F  +  L  +D+S N L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 52.5 bits (126), Expect = 5e-07
 Identities = 52/230 (22%), Positives = 97/230 (42%), Gaps = 49/230 (21%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFH-SPLPGEMSFQQEEF---------LNEIQALTE 694
           +G+G +G V +A    +G+I A+KK     +  +++  ++           L E++ + E
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 695 IRHRNIVKFYG-FCSHPKHSFI--IYEYLESGSL-----DKILCNDASAKELGWTQRLNV 746
           I+H NI+     +    +  FI  + + + S  L      KI   ++  K +       +
Sbjct: 77  IKHENIMGLVDVYV---EGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILL----QI 128

Query: 747 IKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIA-KFLNPDSS------ 799
           + G+      LH   F   +HRD+S  N+ ++      ++DFG+A ++  P  S      
Sbjct: 129 LNGLNV----LHKWYF---MHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKD 181

Query: 800 -------NWSELAGTHGYVAPELAY-TLKVTEKCDVYSFGVLALEVIKGK 841
                    +    T  Y APEL     K     D++S G +  E++ GK
Sbjct: 182 ETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 52.3 bits (125), Expect = 5e-07
 Identities = 65/247 (26%), Positives = 99/247 (40%), Gaps = 53/247 (21%)

Query: 638 NDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQA----L 692
           +DF +   IG+G  G V    K  +G I+A+K        +    ++E +  I+A    L
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILR-----KADMLEKEQVAHIRAERDIL 55

Query: 693 TEIRHRNIVK-FYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVA 751
            E     +VK FY F    ++ ++I E+L  G +  +L    +  E         I    
Sbjct: 56  VEADGAWVVKMFYSF-QDKRNLYLIMEFLPGGDMMTLLMKKDTLSE---EATQFYIAETV 111

Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL--------------NPD 797
            A+  +H   F   +HRDI   N+LLD      +SDFG+   L              NP 
Sbjct: 112 LAIDAIHQLGF---IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPP 168

Query: 798 S-----------------SNWSELA----GTHGYVAPELAYTLKVTEKCDVYSFGVLALE 836
           S                  N  +LA    GT  Y+APE+       + CD +S GV+  E
Sbjct: 169 SDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228

Query: 837 VIKGKHP 843
           ++ G  P
Sbjct: 229 MLIGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 52.3 bits (125), Expect = 5e-07
 Identities = 35/109 (32%), Positives = 57/109 (52%), Gaps = 9/109 (8%)

Query: 753 ALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK-FLNPDSSNWSELAGTHGYV 811
           AL +LH      I++RD+   NVLLD      ++D+G+ K  L P  +  S   GT  Y+
Sbjct: 108 ALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT-STFCGTPNYI 163

Query: 812 APELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIE 860
           APE+    +     D ++ GVL  E++ G+ P    F++ + + +MN E
Sbjct: 164 APEILRGEEYGFSVDWWALGVLMFEMMAGRSP----FDIITDNPDMNTE 208

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 51.5 bits (124), Expect = 8e-07
 Identities = 58/233 (24%), Positives = 101/233 (43%), Gaps = 37/233 (15%)

Query: 634 ISATNDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEF----LNE 688
            S   D+     +G+G  G VY+A ++ +G + A+KK        M  +++ F    L E
Sbjct: 4   CSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKI------LMHNEKDGFPITALRE 57

Query: 689 IQALTEIRHRNIVKFYG-FCSHPKHS-------FIIYEYLESGSLDKILCNDASAKELGW 740
           I+ L +++H N+V         P  S       +++  Y++   L  +L N  S K L  
Sbjct: 58  IKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENP-SVK-LTE 114

Query: 741 TQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN 800
           +Q    +  + + + YLH N    I+HRDI + N+L+D      ++DFG+A+  +    N
Sbjct: 115 SQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPN 171

Query: 801 WSELAG-----------THGYVAPELAYTLK-VTEKCDVYSFGVLALEVIKGK 841
                G           T  Y  PEL    +  T   D++  G +  E+   +
Sbjct: 172 PKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 51.5 bits (123), Expect = 8e-07
 Identities = 56/200 (28%), Positives = 84/200 (42%), Gaps = 9/200 (4%)

Query: 646 IGKGGHGSVYRAKVPS-GEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKF- 703
           IGKG  G V  AK  S G  +AVK        +   Q          L  ++H  +V   
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 704 YGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFP 763
           Y F +  K  F++ +Y+  G L   L  +    E     R    + VA A+ YLH+    
Sbjct: 63  YSFQTAEKLYFVL-DYVNGGELFFHLQRERCFLEP--RARFYAAE-VASAIGYLHSL--- 115

Query: 764 PIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTE 823
            I++RD+  +N+LLD      ++DFG+ K         S   GT  Y+APE+        
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDR 175

Query: 824 KCDVYSFGVLALEVIKGKHP 843
             D +  G +  E++ G  P
Sbjct: 176 TVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 51.6 bits (123), Expect = 1e-06
 Identities = 36/159 (22%), Positives = 63/159 (39%), Gaps = 42/159 (26%)

Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAK--FLNPDSSNWSELAGTHGYVAPELAYTLKVTE 823
           +HRD++++N+LL       + DFG+A+  + +PD     +      ++APE  +    T 
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 260

Query: 824 KCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLM----- 878
           + DV+SFGVL  E+          F + +S             PYP + + ++       
Sbjct: 261 QSDVWSFGVLLWEI----------FSLGAS-------------PYPGVKIDEEFCRRLKE 297

Query: 879 ------------SIMQVAFSCLDQNPESRPTMKRVSQLL 905
                        + Q    C    P  RPT   + + L
Sbjct: 298 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 51.6 bits (123), Expect = 1e-06
 Identities = 58/216 (26%), Positives = 95/216 (43%), Gaps = 24/216 (11%)

Query: 639 DFNAEHCIGKGGHGSV--YRAKVPSGEIFAVK---KFHSPLPGEMSFQQEEFLNEIQALT 693
           D+     IG+G  G V   R K    +++A+K   KF      + +F  EE   +I A  
Sbjct: 44  DYEVVKVIGRGAFGEVQLVRHKSTR-KVYAMKLLSKFEMIKRSDSAFFWEE--RDIMAFA 100

Query: 694 EIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCN-DASAKELGWTQRLNVIKGVAD 752
                 +  FY F    ++ +++ EY+  G L  ++ N D   K   W +       V  
Sbjct: 101 N-SPWVVQLFYAF-QDDRYLYMVMEYMPGGDLVNLMSNYDVPEK---WARFYTA--EVVL 153

Query: 753 ALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELA-GTHGYV 811
           AL  +H+  F   +HRD+   N+LLD      ++DFG    +N +     + A GT  Y+
Sbjct: 154 ALDAIHSMGF---IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI 210

Query: 812 APELAYTLK----VTEKCDVYSFGVLALEVIKGKHP 843
           +PE+  +         +CD +S GV   E++ G  P
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 51.5 bits (123), Expect = 1e-06
 Identities = 59/249 (23%), Positives = 106/249 (42%), Gaps = 33/249 (13%)

Query: 598 FHQRKNDSQTQQSSFGNTPGLRSVLTFEGKIVYEEIISATNDFNAEHCIGKGGHGSVYRA 657
            H++K+   T++    N            K+ YE       DFN    +G G  G V  A
Sbjct: 9   LHKKKDSDSTKEPKRKN------------KMKYE-------DFNFIRTLGTGSFGRVILA 49

Query: 658 KVPSGEI--FAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI 715
              + +    A+K+F      +   Q +   +E + L  I H   V  YG      + ++
Sbjct: 50  TYKNEDFPPVAIKRFEKSKIIKQK-QVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108

Query: 716 IYEYLESGSLDKILC-NDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKN 774
           + E++  G     L  N     ++G      ++  + + L  L+      IV+RD+  +N
Sbjct: 109 VLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVL-IFEYLQSLN------IVYRDLKPEN 161

Query: 775 VLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLA 834
           +LLD      ++DFG AK +  D+  ++ L GT  Y+APE+   +   +  D ++ G+  
Sbjct: 162 LLLDKDGFIKMTDFGFAKVV--DTRTYT-LCGTPEYIAPEILLNVGHGKAADWWTLGIFI 218

Query: 835 LEVIKGKHP 843
            E++ G  P
Sbjct: 219 YEILVGCPP 227

Length = 340

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 50.6 bits (121), Expect = 1e-06
 Identities = 51/215 (23%), Positives = 99/215 (46%), Gaps = 43/215 (20%)

Query: 646 IGKGGHGSVYRAKV-PSGEIFAVKKFHSPLPGEMSFQQEE-----FLNEIQALTEIRHRN 699
           +G+G + +VY+ +   +GEI A+K+ H           EE      + EI  + E++H N
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIH--------LDAEEGTPSTAIREISLMKELKHEN 59

Query: 700 IVKFYGFCSHPKHSFIIYEYLES------------GSLDKILCNDASAKELGWTQRLNVI 747
           IV+ +          +++EY++             G+LD         K   +     ++
Sbjct: 60  IVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNT-----VKSFTY----QLL 110

Query: 748 KGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGT 807
           KG+A    + H N    ++HRD+  +N+L++   E  ++DFG+A+      + +S    T
Sbjct: 111 KGIA----FCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVT 163

Query: 808 HGYVAPELAYTLKV-TEKCDVYSFGVLALEVIKGK 841
             Y AP++    +  +   D++S G +  E+I G+
Sbjct: 164 LWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 50.4 bits (121), Expect = 2e-06
 Identities = 54/215 (25%), Positives = 86/215 (40%), Gaps = 29/215 (13%)

Query: 321 FGTYPNLTFIDLSNNSFFGE---ILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQ--- 374
                 L  +DLS+N+   +   +L    R   L  L ++ N +       + + L+   
Sbjct: 77  LTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLP 136

Query: 375 --LQYLDLSSNYIVGEIPTQLGNIIYLNR----LSLSGNKLSG----CIPRELGSLINLE 424
             L+ L L  N + G     L   +  NR    L+L+ N +       +   L +  NLE
Sbjct: 137 PALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLE 196

Query: 425 YLDLSANNL----SNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDN-----LIHLSELD 475
            LDL+ N L    ++ + E+L SL  L  LNL  N L+      L +      I L  L 
Sbjct: 197 VLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLS 256

Query: 476 LSHNFLGEKISSRICR----MESLEKLNLSYNNLS 506
           LS N + +  +  +       ESL +L+L  N   
Sbjct: 257 LSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFG 291

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 50.8 bits (121), Expect = 2e-06
 Identities = 56/218 (25%), Positives = 99/218 (45%), Gaps = 28/218 (12%)

Query: 640 FNAEHC-IGKGGHGSVYRAKVPSG---EIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI 695
           F  E C +G+G +G VY+AK   G     +A+K+       E +        EI  L E+
Sbjct: 2   FEYEGCKVGRGTYGHVYKAKRKDGKDDRDYALKQI------EGTGISMSACREIALLREL 55

Query: 696 RHRNIVKFYG-FCSHP-KHSFIIYEYLESGSLDKILCNDASAK-----ELGWTQRLNVIK 748
           +H N++     F SH  +  +++++Y E      I  + AS       +L      +++ 
Sbjct: 56  KHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLY 115

Query: 749 GVADALFYLHNNCFPPIVHRDISSKNVL-LDLGYE---AHVSDFGIAKFLNPDSSNWSEL 804
            + D + YLH N    ++HRD+   N+L +  G E     ++D G A+  N      ++L
Sbjct: 116 QILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 172

Query: 805 ---AGTHGYVAPELAYTLK-VTEKCDVYSFGVLALEVI 838
                T  Y APEL    +  T+  D+++ G +  E++
Sbjct: 173 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 50.8 bits (121), Expect = 2e-06
 Identities = 61/253 (24%), Positives = 116/253 (45%), Gaps = 31/253 (12%)

Query: 640 FNAEHC-IGKGGHGSVYRAKVPSGEI---FAVKKFHSPLPGEMSFQQEEFLNEIQALTEI 695
           F  E C +G+G +G VY+AK   G+    +A+K+       E +        EI  L E+
Sbjct: 2   FEYEGCKVGRGTYGHVYKAKRKDGKDEKEYALKQI------EGTGISMSACREIALLREL 55

Query: 696 RHRNIVKFYG-FCSHP-KHSFIIYEYLESGSLDKILCNDASAK-----ELGWTQRLNVIK 748
           +H N++     F SH  +  +++++Y E      I  + AS       +L  +   +++ 
Sbjct: 56  KHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLY 115

Query: 749 GVADALFYLHNNCFPPIVHRDISSKNVL-LDLGYE---AHVSDFGIAKFLNPDSSNWSEL 804
            + D + YLH N    ++HRD+   N+L +  G E     ++D G A+  N      ++L
Sbjct: 116 QILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 172

Query: 805 ---AGTHGYVAPELAYTLK-VTEKCDVYSFGVLALEVIKGK---HPRDFLFEMSSSSSNM 857
                T  Y APEL    +  T+  D+++ G +  E++  +   H R    + S+   + 
Sbjct: 173 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHD 232

Query: 858 NIEMLDSRLPYPS 870
            ++ + S + +P+
Sbjct: 233 QLDRIFSVMGFPA 245

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 50.0 bits (119), Expect = 3e-06
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 13/200 (6%)

Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 82

Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 83  DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 138

Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKV 821
             I+HRD+   N+ ++   E  + DFG+A+  + + + +     T  Y APE+    +  
Sbjct: 139 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHY 195

Query: 822 TEKCDVYSFGVLALEVIKGK 841
            +  D++S G +  E++ G+
Sbjct: 196 NQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 50.4 bits (120), Expect = 3e-06
 Identities = 57/231 (24%), Positives = 100/231 (43%), Gaps = 29/231 (12%)

Query: 630 YEEIIS-------ATNDFNAEHCIGKGGHGSVYRAKVPSGE-IFAVK---KFHSPLPGEM 678
           YE+I+           D++    IG+G  G V   +  S + ++A+K   KF      + 
Sbjct: 28  YEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDS 87

Query: 679 SFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCN-DASAKE 737
           +F  EE   +I A        +V+ +      K+ +++ EY+  G L  ++ N D   K 
Sbjct: 88  AFFWEE--RDIMAFAN--SPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK- 142

Query: 738 LGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPD 797
             W +       V  AL  +H+     ++HRD+   N+LLD      ++DFG    ++  
Sbjct: 143 --WAKFYTA--EVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET 195

Query: 798 SSNWSELA-GTHGYVAPELAYTLK----VTEKCDVYSFGVLALEVIKGKHP 843
                + A GT  Y++PE+  +         +CD +S GV   E++ G  P
Sbjct: 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 50.0 bits (119), Expect = 3e-06
 Identities = 55/200 (27%), Positives = 86/200 (43%), Gaps = 9/200 (4%)

Query: 646 IGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKF- 703
           IGKG  G V  AK    G+ +AVK     +      Q+         L  ++H  +V   
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 704 YGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFP 763
           Y F +  K  F++ +++  G L   L  + S  E    +       +A AL YLH+    
Sbjct: 63  YSFQTTEKLYFVL-DFVNGGELFFHLQRERSFPE---PRARFYAAEIASALGYLHS---I 115

Query: 764 PIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTE 823
            IV+RD+  +N+LLD      ++DFG+ K     S   +   GT  Y+APE+        
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN 175

Query: 824 KCDVYSFGVLALEVIKGKHP 843
             D +  G +  E++ G  P
Sbjct: 176 TVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 49.8 bits (119), Expect = 3e-06
 Identities = 45/152 (29%), Positives = 74/152 (48%), Gaps = 21/152 (13%)

Query: 753 ALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHV--SDFGIAKFLNPDSSNWSELAGTHGY 810
           AL +LH      I++RD+   NVLLD   E H+  +D+G+ K         S   GT  Y
Sbjct: 108 ALNFLHER---GIIYRDLKLDNVLLD--AEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNY 162

Query: 811 VAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIE------MLDS 864
           +APE+          D ++ GVL  E++ G+ P D +    S + + N E      +L+ 
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV--GMSDNPDQNTEDYLFQVILEK 220

Query: 865 RLPYP-SLHVQKKLMSIMQVAFSCLDQNPESR 895
           ++  P SL V  K  S+++     L+++P+ R
Sbjct: 221 QIRIPRSLSV--KASSVLK---GFLNKDPKER 247

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 50.5 bits (120), Expect = 3e-06
 Identities = 38/161 (23%), Positives = 71/161 (44%), Gaps = 19/161 (11%)

Query: 687 NEIQALTEIRHRNIVKFYGFCSHPKHSFII--------YEYLESGSLDKILCNDASAKEL 738
           NEI AL  + H NI+K         ++++I        Y ++   +       D   + L
Sbjct: 212 NEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAF------DWKDRPL 265

Query: 739 GWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIA-KFLNPD 797
               R  ++K +  A+ Y+H+     ++HRDI  +N+ L+   +  + DFG A  F    
Sbjct: 266 LKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKER 321

Query: 798 SSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVI 838
            +      GT    +PE+       E  D++S G++ L+++
Sbjct: 322 EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDML 362

Length = 501

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 49.3 bits (118), Expect = 5e-06
 Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 28/210 (13%)

Query: 645 CIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKF 703
            IG+G +G V  AK   + E  A+KK  +     +  ++   L EI+ L  + H N++  
Sbjct: 12  PIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRT--LREIKLLRHLDHENVIAI 69

Query: 704 YGFCSHP-KHSF----IIYEYLESGSLDKI------LCNDASAKELGWTQRLNVIKGVAD 752
                 P + +F    I+YE +++  L +I      L +D     L   Q L  +K    
Sbjct: 70  KDIMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQYFL--YQLLRGLK---- 122

Query: 753 ALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVA 812
              Y+H+     ++HRD+   N+LL+   +  + DFG+A+  +      +E   T  Y A
Sbjct: 123 ---YIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRA 176

Query: 813 PELAYTL-KVTEKCDVYSFGVLALEVIKGK 841
           PEL     + T   DV+S G +  E++  K
Sbjct: 177 PELLLNCSEYTTAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 48.9 bits (117), Expect = 5e-06
 Identities = 47/149 (31%), Positives = 67/149 (44%), Gaps = 24/149 (16%)

Query: 753 ALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHV--SDFGIAKFLNPDSSNWSELAGTHGY 810
            L YLH N    IV+RD+   N+LLD   E  V  +DFG+ K         S   GT  +
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDT--EGFVKIADFGLCKEGMGFGDRTSTFCGTPEF 167

Query: 811 VAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRL---- 866
           +APE+      T   D +  GVL  E++ G+ P    F           E+ DS +    
Sbjct: 168 LAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP----FPGDDEE-----EVFDSIVNDEV 218

Query: 867 PYPSLHVQKKLMSIMQVAFSCLDQNPESR 895
            YP   + ++ +SIM+     L +NPE R
Sbjct: 219 RYP-RFLSREAISIMR---RLLRRNPERR 243

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 49.2 bits (117), Expect = 5e-06
 Identities = 53/200 (26%), Positives = 89/200 (44%), Gaps = 9/200 (4%)

Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTE-IRHRNIVKF- 703
           IGKG  G V  A+  + E F   K           +++  ++E   L + ++H  +V   
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 704 YGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFP 763
           + F +  K  F++ +Y+  G L   L  +    E     R    + +A AL YLH+    
Sbjct: 63  FSFQTADKLYFVL-DYINGGELFYHLQRERCFLEP--RARFYAAE-IASALGYLHS---L 115

Query: 764 PIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTE 823
            IV+RD+  +N+LLD      ++DFG+ K     +   S   GT  Y+APE+ +      
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDR 175

Query: 824 KCDVYSFGVLALEVIKGKHP 843
             D +  G +  E++ G  P
Sbjct: 176 TVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 49.2 bits (117), Expect = 7e-06
 Identities = 45/155 (29%), Positives = 72/155 (46%), Gaps = 16/155 (10%)

Query: 755 FYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYV 811
           F    NC    VHRD++++NVL+  G    + DFG+A+ +  D SN+     T     ++
Sbjct: 254 FLASKNC----VHRDLAARNVLICEGKLVKICDFGLARDIMRD-SNYISKGSTFLPLKWM 308

Query: 812 APELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDSRLPYPS 870
           APE  +    T   DV+SFG+L  E+   G  P     E+  +    N      R+  P+
Sbjct: 309 APESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYP---ELPMNEQFYNAIKRGYRMAKPA 365

Query: 871 LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
            H   ++  IMQ    C ++  E RP   ++  L+
Sbjct: 366 -HASDEIYEIMQ---KCWEEKFEIRPDFSQLVHLV 396

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 48.6 bits (116), Expect = 8e-06
 Identities = 51/208 (24%), Positives = 94/208 (45%), Gaps = 20/208 (9%)

Query: 646 IGKGGHGSVYRAK---VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR-HRNIV 701
           +G+G +G V  A+       E  A+KK  +    ++  ++   L E++ L   R H+NI 
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRA--LRELKLLRHFRGHKNIT 65

Query: 702 KFYGF---CSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLH 758
             Y          +   +YE L    L +I+    S + L      + I  +   L Y+H
Sbjct: 66  CLYDMDIVFPGNFNELYLYEELMEADLHQII---RSGQPLTDAHFQSFIYQILCGLKYIH 122

Query: 759 NNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPD----SSNWSELAGTHGYVAPE 814
           +     ++HRD+   N+L++   E  + DFG+A+  + +    +   +E   T  Y APE
Sbjct: 123 S---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPE 179

Query: 815 LAYTLK-VTEKCDVYSFGVLALEVIKGK 841
           +  + +  T+  DV+S G +  E++  K
Sbjct: 180 IMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 48.3 bits (115), Expect = 1e-05
 Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 24/209 (11%)

Query: 646 IGKGGHGSVYRAK----VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIV 701
           +GKGG+G V++ +      +G+IFA+K                   E   L  ++H  IV
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63

Query: 702 KF-YGFCSHPKHSFIIYEYLESGSL------DKILCNDASAKELGWTQRLNVIKGVADAL 754
              Y F +  K  ++I EYL  G L      + I   D +   L           ++ AL
Sbjct: 64  DLIYAFQTGGK-LYLILEYLSGGELFMHLEREGIFMEDTACFYLS---------EISLAL 113

Query: 755 FYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPE 814
            +LH      I++RD+  +N+LLD      ++DFG+ K    + +      GT  Y+APE
Sbjct: 114 EHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPE 170

Query: 815 LAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           +       +  D +S G L  +++ G  P
Sbjct: 171 ILMRSGHGKAVDWWSLGALMYDMLTGAPP 199

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 47.8 bits (114), Expect = 1e-05
 Identities = 60/249 (24%), Positives = 107/249 (42%), Gaps = 46/249 (18%)

Query: 681 QQEEFLNEIQALTEIRHRNIVKFYGFCSH-PKHSFIIYEYLESGSLDKIL--CNDASA-K 736
           Q    L E   L  + H+NI+     C    +  F++Y Y+  G+L   L  C    A  
Sbjct: 51  QVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANN 110

Query: 737 ELGWTQRLNVIKG--VADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL 794
               + +  V     +A  + YLH      ++H+DI+++N ++D   +  ++D  +++ L
Sbjct: 111 PQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDL 167

Query: 795 NP-------DSSN----WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKH 842
            P       D+ N    W         +A E     + +   DV+SFGVL  E++  G+ 
Sbjct: 168 FPMDYHCLGDNENRPVKW---------MALESLVNKEYSSASDVWSFGVLLWELMTLGQT 218

Query: 843 PRDFL--FEMSSSSSNMNIEMLDS--RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTM 898
           P   +  FEM++         L    RL  P ++   +L ++M     C   +PE RP+ 
Sbjct: 219 PYVEIDPFEMAA--------YLKDGYRLAQP-INCPDELFAVMAC---CWALDPEERPSF 266

Query: 899 KRVSQLLCE 907
            ++ Q L +
Sbjct: 267 SQLVQCLTD 275

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 48.0 bits (114), Expect = 1e-05
 Identities = 69/281 (24%), Positives = 123/281 (43%), Gaps = 39/281 (13%)

Query: 646 IGKGGHGSVYRAKVP----SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIV 701
           +GKG  GSV  A++     S +  AVK   + +    S   EEFL E   + E  H N++
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI--FSSSDIEEFLREAACMKEFDHPNVI 64

Query: 702 KFYGFCSHPKHS------FIIYEYLESGSLDKILCNDASAKE---LGWTQRLNVIKGVAD 752
           K  G     +         +I  +++ G L   L      +E   L     +  +  +A 
Sbjct: 65  KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124

Query: 753 ALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNW------SELAG 806
            + YL +  F   +HRD++++N +L+      V+DFG++K +   S ++      S+L  
Sbjct: 125 GMEYLSSKNF---IHRDLAARNCMLNENMTVCVADFGLSKKIY--SGDYYRQGCASKLPV 179

Query: 807 THGYVAPE-LAYTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEMLDS 864
              ++A E LA  +  T   DV++FGV   E++ +G+ P    +    +S   N  +  +
Sbjct: 180 K--WLALESLADNVYTTHS-DVWAFGVTMWEIMTRGQTP----YAGVENSEIYNYLIKGN 232

Query: 865 RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
           RL  P       L  + ++   C    P+ RP+ + +   L
Sbjct: 233 RLKQPP----DCLEDVYELMCQCWSPEPKCRPSFQHLRDQL 269

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain

 Score = 42.7 bits (101), Expect = 1e-05
 Identities = 15/47 (31%), Positives = 26/47 (55%), Gaps = 5/47 (10%)

Query: 35 SAEEAHALVKWKASLEVHSRSLLHSWSLSSVNATKISPCAWSGIFCN 81
            ++  AL+ +K+SL       L SW+ SS +     PC+W+G+ C+
Sbjct: 1  LNDDRDALLAFKSSLNGDPSGALSSWNPSSSD-----PCSWTGVTCD 42

Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 47.7 bits (113), Expect = 2e-05
 Identities = 49/200 (24%), Positives = 88/200 (44%), Gaps = 13/200 (6%)

Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A      +  AVKK   P   +          E++ L  ++H N++   
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPF--QSLIHARRTYRELRLLKHMKHENVIGLL 80

Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 81  DVFT-PATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHS--- 136

Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKV 821
             I+HRD+   NV ++   E  + DFG+A+  + + + +     T  Y APE+    +  
Sbjct: 137 AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGY---VATRWYRAPEIMLNWMHY 193

Query: 822 TEKCDVYSFGVLALEVIKGK 841
            +  D++S G +  E++KGK
Sbjct: 194 NQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 46.9 bits (111), Expect = 2e-05
 Identities = 26/93 (27%), Positives = 46/93 (49%), Gaps = 5/93 (5%)

Query: 685 FLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRL 744
           F      + ++ H++IV  YG C     + ++ E++E G LD  +   +      W  + 
Sbjct: 51  FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KF 108

Query: 745 NVIKGVADALFYLHNNCFPPIVHRDISSKNVLL 777
            V K +A AL YL +     +VH ++ +KN+LL
Sbjct: 109 KVAKQLASALSYLEDK---DLVHGNVCTKNILL 138

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 47.7 bits (113), Expect = 2e-05
 Identities = 65/246 (26%), Positives = 99/246 (40%), Gaps = 53/246 (21%)

Query: 639 DFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQA----LT 693
           DF +   IG+G  G V    K  +G ++A+K        +    ++E +  I+A    L 
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILR-----KADMLEKEQVGHIRAERDILV 56

Query: 694 EIRHRNIVK-FYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVAD 752
           E     +VK FY F     + ++I E+L  G +  +L    +  E   TQ    I     
Sbjct: 57  EADSLWVVKMFYSF-QDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEE-TQFY--IAETVL 112

Query: 753 ALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK-------------------- 792
           A+  +H   F   +HRDI   N+LLD      +SDFG+                      
Sbjct: 113 AIDSIHQLGF---IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPS 169

Query: 793 ---FLNPDSS--------NWSELA----GTHGYVAPELAYTLKVTEKCDVYSFGVLALEV 837
              F N +S         N  +LA    GT  Y+APE+       + CD +S GV+  E+
Sbjct: 170 DFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229

Query: 838 IKGKHP 843
           + G  P
Sbjct: 230 LIGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 47.1 bits (112), Expect = 2e-05
 Identities = 63/234 (26%), Positives = 102/234 (43%), Gaps = 47/234 (20%)

Query: 638 NDFNAEHCIGKGGHGSVY--RAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEI-QALTE 694
            DF     I  G +G+VY  R K  + + FA+KK        ++ Q     N+I Q   E
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHK-ETRQRFAMKK--------INKQNLILRNQIQQVFVE 51

Query: 695 IRHRNIVKFYG-------FCSHP--KHSFIIYEYLESGSLDKILCN-DASAKELGWTQRL 744
              R+I+ F         FCS    +H  ++ EY+E G    +L N  A   ++    R+
Sbjct: 52  ---RDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMA---RM 105

Query: 745 NVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK------------ 792
              + V  AL YLHN     IVHRD+   N+L+       ++DFG++K            
Sbjct: 106 YFAETVL-ALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYE 161

Query: 793 -FLNPDSSNWS--ELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
             +  D+  +   ++ GT  Y+APE+       +  D ++ G++  E + G  P
Sbjct: 162 GHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 46.8 bits (111), Expect = 2e-05
 Identities = 64/286 (22%), Positives = 114/286 (39%), Gaps = 48/286 (16%)

Query: 646 IGKGGHGSVYRAKV---PSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVK 702
           IG G  G V  +++          VK+  +      S +Q EFL +      ++H NI++
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKA---NASSKEQNEFLQQGDPYRILQHPNILQ 59

Query: 703 FYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIK-GVADALFYLHNNC 761
             G C       +++EY E G L   L  +   +       L  +   +A  + ++H + 
Sbjct: 60  CLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN 119

Query: 762 FPPIVHRDISSKNVLLDLGYEAHVSDFGIA------KFLNPDSSNWSELAGTHGYVAPEL 815
           F   +H D++ +N  L       V D+GI        ++  +      L     ++APEL
Sbjct: 120 F---LHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR----WLAPEL 172

Query: 816 A-------YTLKVTEKCDVYSFGVLALEVIK-GKHP------RDFLFEMSSSSSNMNIEM 861
                    T + T+  +V++ GV   E+ +    P      R+ L        N  I+ 
Sbjct: 173 VGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVL--------NHVIKD 224

Query: 862 LDSRLPYPSLHV--QKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
              +L  P L +   ++   ++Q  F  L  +PE R T + V +LL
Sbjct: 225 QQVKLFKPQLELPYSERWYEVLQ--FCWL--SPEKRATAEEVHRLL 266

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 47.2 bits (113), Expect = 3e-05
 Identities = 65/249 (26%), Positives = 115/249 (46%), Gaps = 54/249 (21%)

Query: 646 IGKGGHGSVYRA--KVPSGEIFAVKK----FHSPLPGEMSFQQEEFLNEIQALTEIRHRN 699
           +GKG +G V++A  +  + E+ A+KK    F +    + +F++  FL   Q L +  H N
Sbjct: 15  LGKGAYGIVWKAIDRR-TKEVVALKKIFDAFRNATDAQRTFREIMFL---QELGD--HPN 68

Query: 700 IVKFYGFCSHP----KHSFIIYEYLES---GSLDKILCNDASAKELGWTQRLNVIKGVAD 752
           IVK            K  ++++EY+E+     +   +  D   + + + Q L  +K    
Sbjct: 69  IVKLLNV--IKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRYIMY-QLLKALK---- 121

Query: 753 ALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWS-----ELAGT 807
              Y+H+     ++HRD+   N+LL+      ++DFG+A+ L+    N       +   T
Sbjct: 122 ---YIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVAT 175

Query: 808 HGYVAPEL-----AYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMN-IEM 861
             Y APE+      YT  V    D++S G +  E++ GK P   LF     +S +N +E 
Sbjct: 176 RWYRAPEILLGSTRYTKGV----DMWSVGCILGEMLLGK-P---LFP---GTSTLNQLEK 224

Query: 862 LDSRLPYPS 870
           +   +  PS
Sbjct: 225 IIEVIGPPS 233

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 46.9 bits (112), Expect = 3e-05
 Identities = 57/259 (22%), Positives = 101/259 (38%), Gaps = 68/259 (26%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEF----LNEIQALTEIRHRNI 700
           +G G +G V  A    +G   A+KK   P      FQ          E++ L  + H N+
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLSRP------FQSAIHAKRTYRELRLLKHMDHENV 76

Query: 701 VKFYGFCSHPKHSFIIYE--YLES----GSLDKILCNDASAKELGWTQRLN------VIK 748
           +        P  S   ++  YL +      L+ I+            Q+L+      ++ 
Sbjct: 77  IGLLD-VFTPASSLEDFQDVYLVTHLMGADLNNIV----------KCQKLSDDHIQFLVY 125

Query: 749 GVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAG-- 806
            +   L Y+H+     I+HRD+   N+ ++   E  + DFG+A+  +       E+ G  
Sbjct: 126 QILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTD------DEMTGYV 176

Query: 807 -THGYVAPELAYT-LKVTEKCDVYSFGVLALEVIKGK-------H--------------P 843
            T  Y APE+    +   +  D++S G +  E++ GK       H               
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPD 236

Query: 844 RDFLFEMSSSSSNMNIEML 862
            + L ++SS S+   I+ L
Sbjct: 237 EELLQKISSESARNYIQSL 255

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 46.6 bits (110), Expect = 4e-05
 Identities = 58/244 (23%), Positives = 102/244 (41%), Gaps = 25/244 (10%)

Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           IG G  G V  A     G   AVKK   P   +   ++     E+  L  + H+NI+   
Sbjct: 29  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRA--YRELVLLKCVNHKNIISLL 86

Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P+ S   ++  YL    +D  LC      EL   +   ++  +   + +LH+   
Sbjct: 87  NVFT-PQKSLEEFQDVYLVMELMDANLCQ-VIHMELDHERMSYLLYQMLCGIKHLHS--- 141

Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNW--SELAGTHGYVAPELAYTLK 820
             I+HRD+   N+++       + DFG+A+      +N+  +    T  Y APE+   + 
Sbjct: 142 AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TACTNFMMTPYVVTRYYRAPEVILGMG 198

Query: 821 VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMN--IEMLDSRLPYPSLHVQKKLM 878
             E  D++S G +  E++KG      +F+ +      N  IE L +    PS     +L 
Sbjct: 199 YKENVDIWSVGCIMGELVKGS----VIFQGTDHIDQWNKVIEQLGT----PSAEFMNRLQ 250

Query: 879 SIMQ 882
             ++
Sbjct: 251 PTVR 254

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 46.2 bits (109), Expect = 4e-05
 Identities = 50/205 (24%), Positives = 93/205 (45%), Gaps = 27/205 (13%)

Query: 646 IGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEE-----FLNEIQALTEIRHRN 699
           +G+G + +VY+ K   +G++ A+K         +  Q+EE      + E   L  ++H N
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKV--------IRLQEEEGTPFTAIREASLLKGLKHAN 64

Query: 700 IVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNV---IKGVADALFY 756
           IV  +      +   +++EY+ +      LC     K  G     NV   +  +   L Y
Sbjct: 65  IVLLHDIIHTKETLTLVFEYVHTD-----LCQYMD-KHPGGLHPENVKLFLFQLLRGLSY 118

Query: 757 LHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELA 816
           +H      I+HRD+  +N+L+    E  ++DFG+A+  +  S  +S    T  Y  P++ 
Sbjct: 119 IHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVL 175

Query: 817 YTLKVTEKC-DVYSFGVLALEVIKG 840
                   C D++  G + +E+I+G
Sbjct: 176 LGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 46.3 bits (110), Expect = 4e-05
 Identities = 61/253 (24%), Positives = 109/253 (43%), Gaps = 51/253 (20%)

Query: 646 IGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           IG G  G V+    P  G+  A+KK  +     +S ++     E++ L   +H N++   
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKR--VFRELKMLCFFKHDNVLSAL 65

Query: 705 GFCSHP-----KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLN----------VIKG 749
                P     +  +++ E ++S  L KI+ +          Q L+          +++G
Sbjct: 66  DILQPPHIDPFEEIYVVTELMQS-DLHKIIVSP---------QPLSSDHVKVFLYQILRG 115

Query: 750 VADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSS-NWSELAGTH 808
               L YLH+     I+HRDI   N+L++      + DFG+A+   PD S + ++   T 
Sbjct: 116 ----LKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168

Query: 809 GYVAPELA-----YTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLD 863
            Y APE+      YT  V    D++S G +  E++  +     LF+  S    ++  ++ 
Sbjct: 169 YYRAPEILMGSRHYTSAV----DIWSVGCIFAELLGRR----ILFQAQSPIQQLD--LIT 218

Query: 864 SRLPYPSLHVQKK 876
             L  PSL   + 
Sbjct: 219 DLLGTPSLEAMRS 231

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 46.2 bits (110), Expect = 5e-05
 Identities = 64/254 (25%), Positives = 109/254 (42%), Gaps = 45/254 (17%)

Query: 640 FNAEHCIGKGGHGSVYRA-KVPSGEIFAVKK----FHSPLPGEMSFQQEEFLNEIQALTE 694
           +     IG G +G V  A    SG+  A+KK    F  P   + +      L E++ L  
Sbjct: 7   YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRT------LRELKILRH 60

Query: 695 IRHRNIVK----FYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE------LGWTQRL 744
            +H NI+          +  K  +++ + +ES  L  I+ +D    E      L   Q L
Sbjct: 61  FKHDNIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLY--QLL 117

Query: 745 NVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL--NPD--SSN 800
             +K       Y+H+     ++HRD+   N+L++   E  + DFG+A+ L  +P      
Sbjct: 118 RGLK-------YIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYF 167

Query: 801 WSELAGTHGYVAPELAYTL-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNI 859
            +E   T  Y APEL  +L + T   D++S G +  E++  +     LF   +      +
Sbjct: 168 MTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQ----LFPGKNYVH--QL 221

Query: 860 EMLDSRLPYPSLHV 873
           +++ S L  PS  V
Sbjct: 222 KLILSVLGSPSEEV 235

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 45.8 bits (108), Expect = 6e-05
 Identities = 45/207 (21%), Positives = 94/207 (45%), Gaps = 20/207 (9%)

Query: 646 IGKGGHGSVYRAK--VPSGEIFAVKKFHSPLPGE-MSFQQEEFLNEIQALTEIRHRNIVK 702
           IG+G +G V++A+     G   A+K+       E M       +  ++ L    H N+V+
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 703 FYGFCSHPKHS-----FIIYEYLE---SGSLDKILCNDASAKELGWTQRLNVIKGVADAL 754
            +  C+  +        +++E+++   +  LDK+        E        +++G    L
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV-PEPGVPTETIKDMMFQLLRG----L 123

Query: 755 FYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPE 814
            +LH++    +VHRD+  +N+L+    +  ++DFG+A+  +   +  + +  T  Y APE
Sbjct: 124 DFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-TSVVVTLWYRAPE 179

Query: 815 LAYTLKVTEKCDVYSFGVLALEVIKGK 841
           +          D++S G +  E+ + K
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 45.9 bits (109), Expect = 6e-05
 Identities = 58/210 (27%), Positives = 91/210 (43%), Gaps = 29/210 (13%)

Query: 646 IGKGGHGSVYRAKVPS-GEIFAVKKFHSPLPGEMSFQQEEFLNEIQA----------LTE 694
           IGKG  G V  AK  + G+ +AVK            Q++  L + +           L  
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVK----------VLQKKAILKKKEQKHIMAERNVLLKN 52

Query: 695 IRHRNIVKF-YGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADA 753
           ++H  +V   Y F +  K  F++ +Y+  G L   L  + S  E     R    + +A A
Sbjct: 53  VKHPFLVGLHYSFQTADKLYFVL-DYVNGGELFFHLQRERSFPEP--RARFYAAE-IASA 108

Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAP 813
           L YLH+     I++RD+  +N+LLD      ++DFG+ K     S   S   GT  Y+AP
Sbjct: 109 LGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAP 165

Query: 814 ELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           E+          D +  G +  E++ G  P
Sbjct: 166 EVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 45.0 bits (106), Expect = 1e-04
 Identities = 44/206 (21%), Positives = 93/206 (45%), Gaps = 27/206 (13%)

Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEE-----FLNEIQALTEIRHRNI 700
           +G+G + +VY+ +    +     K       E+  + EE      + E+  L +++H NI
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALK-------EIRLEHEEGAPCTAIREVSLLKDLKHANI 66

Query: 701 VKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIK----GVADALFY 756
           V  +      K   +++EYL+   L + L       + G +  ++ +K     +   L Y
Sbjct: 67  VTLHDIIHTEKSLTLVFEYLDK-DLKQYL------DDCGNSINMHNVKLFLFQLLRGLNY 119

Query: 757 LHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPE-L 815
            H      ++HRD+  +N+L++   E  ++DFG+A+  +  +  +S    T  Y  P+ L
Sbjct: 120 CHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDIL 176

Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGK 841
             +   + + D++  G +  E+  G+
Sbjct: 177 LGSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 45.2 bits (107), Expect = 1e-04
 Identities = 48/174 (27%), Positives = 74/174 (42%), Gaps = 38/174 (21%)

Query: 688 EIQALTEIRHRNIVKF---YGFCS-----HPKHSFIIYEYLESGSLDKILCNDASAKELG 739
           EI  L  I HR I+     Y + S      PK+   ++ Y++                L 
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSG------------PLP 183

Query: 740 WTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN--PD 797
             Q + + + + +AL YLH      I+HRD+ ++N+ LD    A + DFG A  L+  PD
Sbjct: 184 LEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240

Query: 798 SSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMS 851
           +      +GT    +PEL        K D++S G++             LFEMS
Sbjct: 241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLV-------------LFEMS 281

Length = 392

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 45.0 bits (106), Expect = 1e-04
 Identities = 43/204 (21%), Positives = 94/204 (46%), Gaps = 23/204 (11%)

Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEE-----FLNEIQALTEIRHRNI 700
           +G+G + +V++ +    E     K       E+  + EE      + E+  L +++H NI
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALK-------EIRLEHEEGAPCTAIREVSLLKDLKHANI 66

Query: 701 VKFYGFCSHPKHSFIIYEYLESGSLDKIL--CNDASAKELGWTQRLNVIKGVADALFYLH 758
           V  +      K   +++EYL+   L + +  C +  +          +++G+A    Y H
Sbjct: 67  VTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLA----YCH 121

Query: 759 NNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPE-LAY 817
                 ++HRD+  +N+L++   E  ++DFG+A+  +  +  +S    T  Y  P+ L  
Sbjct: 122 RR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLG 178

Query: 818 TLKVTEKCDVYSFGVLALEVIKGK 841
           + + + + D++  G +  E+  G+
Sbjct: 179 SSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 45.3 bits (107), Expect = 1e-04
 Identities = 39/132 (29%), Positives = 60/132 (45%), Gaps = 22/132 (16%)

Query: 710 PKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRD 769
           PK+   +Y YL            A  + LG  Q   V + +  A+ Y+H      I+HRD
Sbjct: 240 PKYRSDLYTYL-----------GARLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRD 285

Query: 770 ISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSE-----LAGTHGYVAPELAYTLKVTEK 824
           I ++NVL++   +  + DFG A F      +WS      +AGT    APE+      T  
Sbjct: 286 IKTENVLVNGPEDICLGDFGAACFAR---GSWSTPFHYGIAGTVDTNAPEVLAGDPYTPS 342

Query: 825 CDVYSFGVLALE 836
            D++S G++  E
Sbjct: 343 VDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 45.0 bits (107), Expect = 1e-04
 Identities = 66/248 (26%), Positives = 96/248 (38%), Gaps = 52/248 (20%)

Query: 638 NDFNAEHCIGKGGHGSVYR--AKVPSGEIFAVKKFHSPLPGEM--SFQQEEFLNEIQALT 693
           +DF +   IG+G  G V R   K  +G I+A+KK       EM    Q      E   L 
Sbjct: 1   DDFESIKVIGRGAFGEV-RLVQKKDTGHIYAMKKL---RKSEMLEKEQVAHVRAERDILA 56

Query: 694 EIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADA 753
           E  +  +VK Y       + ++I EYL  G +  +L    +  E    +    I     A
Sbjct: 57  EADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTE---EETRFYIAETILA 113

Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN------------------ 795
           +  +H   +   +HRDI   N+LLD      +SDFG+   L                   
Sbjct: 114 IDSIHKLGY---IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSN 170

Query: 796 -------PDSS-----NWSE----LA----GTHGYVAPELAYTLKVTEKCDVYSFGVLAL 835
                  P SS      W      LA    GT  Y+APE+       ++CD +S GV+  
Sbjct: 171 FLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMY 230

Query: 836 EVIKGKHP 843
           E++ G  P
Sbjct: 231 EMLVGYPP 238

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 43.4 bits (103), Expect = 3e-04
 Identities = 55/247 (22%), Positives = 89/247 (36%), Gaps = 73/247 (29%)

Query: 646 IGKGGHGSVY--RAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEI-QALTEIR------ 696
           +GKG  G V+  R K  +G++FA+K         +  ++    N++ + LTE        
Sbjct: 9   LGKGDVGRVFLVRLKG-TGKLFALKV--------LDKKEMIKRNKVKRVLTEQEILATLD 59

Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSL--------DKILCNDAS---AKELGWTQRLN 745
           H  +   Y       +  ++ +Y   G L         K L  + +   A E        
Sbjct: 60  HPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAE-------- 111

Query: 746 VIKGVADALFYLHNNCFPPIVHRDISSKNVLL-----------DLGYEAHVSD---FGIA 791
               V  AL YLH      IV+RD+  +N+LL           DL  ++ V         
Sbjct: 112 ----VLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKAL 164

Query: 792 KFLNPDSSNWSEL---------------AGTHGYVAPELAYTLKVTEKCDVYSFGVLALE 836
           +  +  SS  S                  GT  Y+APE+          D ++ G+L  E
Sbjct: 165 RKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYE 224

Query: 837 VIKGKHP 843
           ++ G  P
Sbjct: 225 MLYGTTP 231

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 43.5 bits (102), Expect = 3e-04
 Identities = 44/205 (21%), Positives = 97/205 (47%), Gaps = 25/205 (12%)

Query: 646 IGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEE-----FLNEIQALTEIRHRN 699
           +G+G + +V++ +   +  + A+K        E+  + EE      + E+  L  ++H N
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALK--------EIRLEHEEGAPCTAIREVSLLKNLKHAN 64

Query: 700 IVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQ--RLNVIKGVADALFYL 757
           IV  +      +   +++EYL+S  L + L N  +   +   +     +++G++    Y 
Sbjct: 65  IVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLS----YC 119

Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPE-LA 816
           H      I+HRD+  +N+L++   E  ++DFG+A+  +  +  +S    T  Y  P+ L 
Sbjct: 120 HKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLL 176

Query: 817 YTLKVTEKCDVYSFGVLALEVIKGK 841
            + + +   D++  G +  E+  G+
Sbjct: 177 GSTEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 38.7 bits (91), Expect = 4e-04
 Identities = 23/60 (38%), Positives = 28/60 (46%), Gaps = 4/60 (6%)

Query: 90  NLTSISLNGTLLEF----SFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKL 145
           NL S+ L+   L      +F   P+L  LDL  N L  I P   S L +L  LD S N L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 43.4 bits (102), Expect = 4e-04
 Identities = 49/225 (21%), Positives = 88/225 (39%), Gaps = 33/225 (14%)

Query: 643 EHCIGKGGHGSVYRAKVPSGEIF---AVKKFHSPLPGEM--------SFQQEEFLNEIQA 691
           +  IG GG G VY  +  S       AV K  +     +        +    + +   + 
Sbjct: 17  DKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKN 76

Query: 692 LTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKIL--CNDASAKELGWTQRL--NVI 747
           +  I H  I K+YG C   K   + Y ++    L+K++    +   +     ++L  N++
Sbjct: 77  IHNIDHLGIPKYYG-CGSFKRCRMYYRFI---LLEKLVENTKEIFKRIKCKNKKLIKNIM 132

Query: 748 KGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL---------NPDS 798
           K +   L Y+H +    I H DI  +N+++D     ++ D+GIA            + + 
Sbjct: 133 KDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQ 189

Query: 799 SNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
            +     GT  Y   +      VT + D+ S G   L+    K P
Sbjct: 190 KDLHR--GTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLP 232

Length = 294

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 43.3 bits (102), Expect = 5e-04
 Identities = 46/158 (29%), Positives = 75/158 (47%), Gaps = 14/158 (8%)

Query: 638 NDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLN---EIQALT 693
            DF+    IGKG  G V    K  +G+I+A+K   + L  EM F++++  +   E   L 
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMK---TLLKSEM-FKKDQLAHVKAERDVLA 56

Query: 694 EIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADA 753
           E     +V  Y      ++ ++I E+L  G L  +L    +  E     R  + + V  A
Sbjct: 57  ESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSED--VTRFYMAECVL-A 113

Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIA 791
           +  +H   F   +HRDI   N+L+D G    +SDFG++
Sbjct: 114 IEAVHKLGF---IHRDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 42.1 bits (99), Expect = 6e-04
 Identities = 41/160 (25%), Positives = 64/160 (40%), Gaps = 34/160 (21%)

Query: 699 NIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE---LGWTQRLNVIKGVADALF 755
           N+V  + +       F++ ++ E G L   +    +  E     W   + V      AL 
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVV------ALD 99

Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSEL-------AGTH 808
            LH      IV RD++  N+LLD      ++ F            WSE+       A  +
Sbjct: 100 ALHRE---GIVCRDLNPNNILLDDRGHIQLTYFS----------RWSEVEDSCDGEAVEN 146

Query: 809 GYVAPELAYTLKVTEKCDVYSFGVLALEVIKGK-----HP 843
            Y APE+    + TE CD +S G +  E++ GK     HP
Sbjct: 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHP 186

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 37.5 bits (88), Expect = 0.001
 Identities = 13/43 (30%), Positives = 23/43 (53%)

Query: 494 SLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNS 536
           +L+ L+LS N L+ +    F+ +  L  +D+S N L    P +
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEA 43

Length = 60

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 42.1 bits (99), Expect = 0.001
 Identities = 36/140 (25%), Positives = 55/140 (39%), Gaps = 46/140 (32%)

Query: 747 IKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGI---------AKFLNP- 796
           I  +  A+  +H   F   +HRDI   N+L+D      ++DFG+         +K+    
Sbjct: 107 IAELTCAIESVHKMGF---IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKG 163

Query: 797 -----DS----SNWSE------------------------LAGTHGYVAPELAYTLKVTE 823
                DS      WSE                        L GT  Y+APE+      T+
Sbjct: 164 DHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ 223

Query: 824 KCDVYSFGVLALEVIKGKHP 843
            CD +S GV+  E++ G+ P
Sbjct: 224 LCDWWSVGVILYEMLVGQPP 243

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 37.1 bits (87), Expect = 0.002
 Identities = 20/60 (33%), Positives = 28/60 (46%)

Query: 254 NLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYL 313
           NL+ L L +N L+ I       L  L  L L+ N+     P++F  L  L  L L+ N L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 41.2 bits (96), Expect = 0.002
 Identities = 57/255 (22%), Positives = 99/255 (38%), Gaps = 73/255 (28%)

Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQA---------LTEI 695
           +G G  G V  A KV +  ++A+K          + ++++ LN  Q          L E 
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMK----------TLRKKDVLNRNQVAHVKAERDILAEA 58

Query: 696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALF 755
            +  +VK Y       + + + +Y+  G +  +L       E+    R  + + +  A+ 
Sbjct: 59  DNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEV--LARFYIAE-LTLAIE 115

Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGI---------AKF-----------LN 795
            +H   F   +HRDI   N+L+DL     ++DFG+         +K+           + 
Sbjct: 116 SVHKMGF---IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSME 172

Query: 796 P-----DSSNWS----------------------ELAGTHGYVAPELAYTLKVTEKCDVY 828
           P     D SN                         L GT  Y+APE+      T+ CD +
Sbjct: 173 PSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWW 232

Query: 829 SFGVLALEVIKGKHP 843
           S GV+  E++ G+ P
Sbjct: 233 SVGVILFEMLVGQPP 247

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 36.4 bits (85), Expect = 0.003
 Identities = 23/63 (36%), Positives = 31/63 (49%), Gaps = 3/63 (4%)

Query: 227 NLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAK 286
           NLKSL    L  N+L+     +   L NL+ L L  N L+ I P+    L  L SL L+ 
Sbjct: 1   NLKSLD---LSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSG 57

Query: 287 NHF 289
           N+ 
Sbjct: 58  NNL 60

Length = 60

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 40.0 bits (94), Expect = 0.004
 Identities = 56/251 (22%), Positives = 94/251 (37%), Gaps = 46/251 (18%)

Query: 291 GTVPKSFRNLTDLVKLRLNQNYLTGNISETFG---TYPNLTFIDLSNNS-------FFGE 340
            ++ +       L +L L+ N L  +            +L  + L+NN           +
Sbjct: 71  QSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAK 130

Query: 341 ILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQ----LQYLDLSSNYIVGEIPTQLGNI 396
            L D    P L  L +  N + G+    + ++L+    L+ L+L++N I       L   
Sbjct: 131 GLKD--LPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEG 188

Query: 397 I----YLNRLSLSGN--------KLSGCIPRELGSLINLEYLDLSANNLSN-----FVPE 439
           +     L  L L+ N         L+  +     SL +LE L+L  NNL++         
Sbjct: 189 LKANCNLEVLDLNNNGLTDEGASALAETLA----SLKSLEVLNLGDNNLTDAGAAALASA 244

Query: 440 SLGSLVKLYYLNLSHNKL----SQQIPIELDNLIHLSELDLSHNFLGEKI-----SSRIC 490
            L   + L  L+LS N +    ++ +   L     L ELDL  N  GE+       S + 
Sbjct: 245 LLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLE 304

Query: 491 RMESLEKLNLS 501
               LE L + 
Sbjct: 305 PGNELESLWVK 315

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 38.9 bits (91), Expect = 0.004
 Identities = 24/86 (27%), Positives = 39/86 (45%), Gaps = 7/86 (8%)

Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKC 825
           +HR   S N+LL   ++  +   G   F  P+ S          ++APE+      TEK 
Sbjct: 33  LHRQAKSGNILL--TWDGLLKLDGSVAFKTPEQSR-----PDPYFMAPEVIQGQSYTEKA 85

Query: 826 DVYSFGVLALEVIKGKHPRDFLFEMS 851
           D+YS G+   E +  + P +   E+S
Sbjct: 86  DIYSLGITLYEALDYELPYNEERELS 111

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 40.1 bits (94), Expect = 0.004
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 36/218 (16%)

Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +G V+ A      +  AVKK     P  +    +  L EI+ +  + H NIVK Y
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSV----KHALREIKIIRRLDHDNIVKVY 68

Query: 705 ---GFCSHPKHS-----------FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGV 750
              G                   +I+ EY+E+  L  +L     ++E        +++G 
Sbjct: 69  EVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARLFMYQLLRG- 126

Query: 751 ADALFYLHNNCFPPIVHRDISSKNVLL---DLGYEAHVSDFGIAKFLNPDSSN---WSEL 804
              L Y+H+     ++HRD+   NV +   DL  +  + DFG+A+ ++P  S+    SE 
Sbjct: 127 ---LKYIHS---ANVLHRDLKPANVFINTEDLVLK--IGDFGLARIVDPHYSHKGYLSEG 178

Query: 805 AGTHGYVAPELAYTLK-VTEKCDVYSFGVLALEVIKGK 841
             T  Y +P L  +    T+  D+++ G +  E++ GK
Sbjct: 179 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	912
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.98
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.98
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.98
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.98
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.98
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.98
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.98
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.98
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.98
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.98
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.97
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.97
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.97
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.97
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.96
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.96
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.96
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.96
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.96
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.95
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.95
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.95
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.95
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.95
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.95
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.94
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.94
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.93
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.93
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.93
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.93
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.93
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.93
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.91
PLN00181	793	protein SPA1-RELATED; Provisional	99.9
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.9
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.89
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.89
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.89
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.89
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.88
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.88
PRK09188	365	serine/threonine protein kinase; Provisional	99.87
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.85
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.84
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.84
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.83
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.83
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.82
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.82
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.81
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.8
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.79
PRK12274	218	serine/threonine protein kinase; Provisional	99.78
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.78
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.77
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.77
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.77
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.76
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.76
PRK10345	210	hypothetical protein; Provisional	99.72
smart00090	237	RIO RIO-like kinase.	99.7
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.68
PRK14879	211	serine/threonine protein kinase; Provisional	99.67
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.67
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.65
PLN03150	623	hypothetical protein; Provisional	99.65
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.65
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.64
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.56
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.55
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.54
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.52
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.45
PLN03150	623	hypothetical protein; Provisional	99.44
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.42
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.42
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.42
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.41
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.38
KOG1243	690	consensus Protein kinase [General function predict	99.34
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.31
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.31
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.21
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.21
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.21
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	99.2
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.19
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.18
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.17
COG4248	637	Uncharacterized protein with protein kinase and he	99.17
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.14
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.14
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.13
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.13
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.11
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.1
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	99.09
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.06
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.05
KOG3087	229	consensus Serine/threonine protein kinase [General	99.02
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.02
PF08263	43	LRRNT_2: Leucine rich repeat N-terminal domain; In	99.0
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.93
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.92
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.82
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.81
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.79
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.79
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.71
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.61
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.6
PRK09902	216	hypothetical protein; Provisional	98.6
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.58
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.51
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.5
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.49

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=8.9e-108  Score=1027.73  Aligned_cols=842  Identities=34%  Similarity=0.556  Sum_probs=567.4

Q ss_pred             CHHHHHHHHHHHHhcccCCcccCCCcccCCCCCCCCCCCccceeEecCCCCeEEEeeccccccccccccccCCCCCccEE
Q 039137           35 SAEEAHALVKWKASLEVHSRSLLHSWSLSSVNATKISPCAWSGIFCNHAERVVGINLTSISLNGTLLEFSFSSFPHLVYL  114 (912)
Q Consensus        35 ~~~~~~all~~k~~~~~~~~~~l~~w~~~~~~~~~~~~C~w~gv~c~~~~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L  114 (912)
                      .++|+.||++||+++. +|.+.+.+|+.      ..+||.|.||+|+..++|+.+++.++.+.|.+ +.+|..+++|++|
T Consensus        27 ~~~~~~~l~~~~~~~~-~~~~~~~~w~~------~~~~c~w~gv~c~~~~~v~~L~L~~~~i~~~~-~~~~~~l~~L~~L   98 (968)
T PLN00113         27 HAEELELLLSFKSSIN-DPLKYLSNWNS------SADVCLWQGITCNNSSRVVSIDLSGKNISGKI-SSAIFRLPYIQTI   98 (968)
T ss_pred             CHHHHHHHHHHHHhCC-CCcccCCCCCC------CCCCCcCcceecCCCCcEEEEEecCCCccccC-ChHHhCCCCCCEE
Confidence            5789999999999995 67778899963      35899999999998889999999999888876 4568888888888


Q ss_pred             EccCCcccccCCcccc-CCCCCcEEeccccccccccc----------------------cccccccccceeecccccccC
Q 039137          115 DLYNNELFGIIPPQIS-NLSNLEYLDFSANKLFGQIP----------------------SGIGLLTHLTVLHISRNWLSG  171 (912)
Q Consensus       115 ~L~~n~l~~~~p~~~~-~l~~L~~L~Ls~n~l~~~~p----------------------~~~~~l~~L~~L~L~~n~l~~  171 (912)
                      +|++|+++|.+|..+. .+++|++|||++|++++.+|                      ..++.+++|++|+|++|.+.+
T Consensus        99 ~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~  178 (968)
T PLN00113         99 NLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVG  178 (968)
T ss_pred             ECCCCccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccc
Confidence            8888888888887654 66777777776666655444                      444445555555555555544


Q ss_pred             CCCccccCcccccEEEccCCcCCCCCCccCCCCccceeeeeccCCCcCccccccccccccceeecccccccCcccccccc
Q 039137          172 SIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISN  251 (912)
Q Consensus       172 ~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~  251 (912)
                      .+|..++++++|++|+|++|.+.+.+|..++++++|++|+|++|.+++.+|..++++++|++|++++|++++.+|..+++
T Consensus       179 ~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~  258 (968)
T PLN00113        179 KIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGN  258 (968)
T ss_pred             cCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhC
Confidence            55555555555555555555555455555555555555555555555555555555555555555555555555555555


Q ss_pred             ccccceeeeccccCcccCCcccCCccccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEE
Q 039137          252 LTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFID  331 (912)
Q Consensus       252 l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  331 (912)
                      +++|++|+|++|++++.+|..+.++++|++|++++|.+.+.+|..+.++++|+.|++++|.+++..|..+..+++|+.|+
T Consensus       259 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~  338 (968)
T PLN00113        259 LKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQ  338 (968)
T ss_pred             CCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEE
Confidence            55555555555555555555555555555555555555555555555555555555555555555555555555555555


Q ss_pred             ccCCcCcccccccCCCCCCCCEEeccCCccccccccccc------------------------ccccccEEEccCccccC
Q 039137          332 LSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIG------------------------ESLQLQYLDLSSNYIVG  387 (912)
Q Consensus       332 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~------------------------~~~~L~~L~L~~N~l~~  387 (912)
                      |++|.+.+..|..++.+++|+.|++++|++.+.+|..+.                        .+++|+.|++++|++++
T Consensus       339 L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~  418 (968)
T PLN00113        339 LWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSG  418 (968)
T ss_pred             CcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeee
Confidence            555555555555555555555555555555544444333                        33444444444444444


Q ss_pred             CCCccccccccccEEEccCCcccCCCccccccc-----------------------cccccccccCcccCcccccccccc
Q 039137          388 EIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSL-----------------------INLEYLDLSANNLSNFVPESLGSL  444 (912)
Q Consensus       388 ~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l-----------------------~~L~~L~Ls~N~l~~~~~~~~~~l  444 (912)
                      .+|..+.+++.|+.|++++|++++.+|..+..+                       ++|+.|++++|++++..|..|.++
T Consensus       419 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l  498 (968)
T PLN00113        419 ELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSL  498 (968)
T ss_pred             ECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCccChhhhhh
Confidence            444444444445555555554444444333222                       345555666666666667777788


Q ss_pred             ccccEEEecccccccccchhhhcccccceeeccccccCcccccccccccccccccccCccccCCCcccccccccceEEEc
Q 039137          445 VKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDI  524 (912)
Q Consensus       445 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l  524 (912)
                      ++|+.|+|++|++++.+|..+.++++|++|+|++|.+++.+|..|..+++|+.|+|++|++++.+|..+..++.|+.+++
T Consensus       499 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l  578 (968)
T PLN00113        499 SELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNI  578 (968)
T ss_pred             hccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEec
Confidence            88899999999998889999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCccccCCCCCccCCCCchhhhccCCcccCCcC--CCCccccccccccceEEEeehhhhhHHHHHHHHhhheeeeeecc
Q 039137          525 SYNKLEGQIPNSTTFRDAPLEALQGNKGLYGDIR--GFPSCMSYKKASRKIWIVIVFPLLGMVALFIALTGFFFIFHQRK  602 (912)
Q Consensus       525 s~N~l~~~~~~~~~~~~~~~~~l~~n~~~~~~~~--~~~~c~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~r~  602 (912)
                      ++|++.|.+|....|.......+.+|+++||...  +.++|.....  ...|.+++++++++++++++++++++++++|+
T Consensus       579 s~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  656 (968)
T PLN00113        579 SHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRK--TPSWWFYITCTLGAFLVLALVAFGFVFIRGRN  656 (968)
T ss_pred             cCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccc--cceeeeehhHHHHHHHHHHHHHHHHHHHHhhh
Confidence            9999999999988888888889999999998642  3566743222  22333344444444433333333333333332


Q ss_pred             cccccccCCCCCCCCccccc---ccCCcccHHHHHHHhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCc
Q 039137          603 NDSQTQQSSFGNTPGLRSVL---TFEGKIVYEEIISATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEM  678 (912)
Q Consensus       603 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~  678 (912)
                      .....+...  .........   .......+++   ....|...+.||+|+||+||+|+.. ++..||||++......  
T Consensus       657 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--  729 (968)
T PLN00113        657 NLELKRVEN--EDGTWELQFFDSKVSKSITIND---ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI--  729 (968)
T ss_pred             ccccccccc--ccccccccccccccchhhhHHH---HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc--
Confidence            211111000  000000000   0011122333   3356778889999999999999874 7899999998643211  


Q ss_pred             hHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHH
Q 039137          679 SFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLH  758 (912)
Q Consensus       679 ~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH  758 (912)
                            ..+|++.+++++|||||+++|++.+++..++||||+++|+|.++++      .++|.++.+|+.|+|+|++|||
T Consensus       730 ------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH  797 (968)
T PLN00113        730 ------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLH  797 (968)
T ss_pred             ------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhc
Confidence                  1246888999999999999999999999999999999999999993      3789999999999999999999


Q ss_pred             hCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHH
Q 039137          759 NNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVI  838 (912)
Q Consensus       759 ~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ell  838 (912)
                      .++.++|+||||||+||+++.++..++. ||.+......    ....+++.|+|||++.+..++.++|||||||++|||+
T Consensus       798 ~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~  872 (968)
T PLN00113        798 CRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELL  872 (968)
T ss_pred             cCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC----CCccccccccCcccccCCCCCcccchhhHHHHHHHHH
Confidence            6555599999999999999999888875 6655433211    2236789999999999999999999999999999999


Q ss_pred             hCCCCccchhcccccc---------ccchhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 039137          839 KGKHPRDFLFEMSSSS---------SNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI  909 (912)
Q Consensus       839 tg~~pf~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l  909 (912)
                      ||+.||+.........         ........++..............++.+++.+||+.||++||||+|+++.|++..
T Consensus       873 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  952 (968)
T PLN00113        873 TGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS  952 (968)
T ss_pred             hCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence            9999986322211100         0001112222222111122345567889999999999999999999999999875


Q ss_pred             h
Q 039137          910 F  910 (912)
Q Consensus       910 ~  910 (912)
                      .
T Consensus       953 ~  953 (968)
T PLN00113        953 R  953 (968)
T ss_pred             c
Confidence            3

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=5.4e-53  Score=531.29  Aligned_cols=444  Identities=39%  Similarity=0.569  Sum_probs=357.7

Q ss_pred             CeEEEeeccccccccccccccCCCCCccEEEccCCcccccCCccccCCCCCcEEeccccccccccccccccccccceeec
Q 039137           85 RVVGINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHI  164 (912)
Q Consensus        85 ~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L  164 (912)
                      ....+++..+.+.+.++ .+++++++|++|+|++|.+.+.+|..|+++++|++|+|++|++.+.+|..++.+++|++|+|
T Consensus       141 ~L~~L~Ls~n~~~~~~p-~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L  219 (968)
T PLN00113        141 NLETLDLSNNMLSGEIP-NDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYL  219 (968)
T ss_pred             CCCEEECcCCcccccCC-hHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEEC
Confidence            45567787777776553 45888999999999999998889989999999999999999988888988889999999999


Q ss_pred             ccccccCCCCccccCcccccEEEccCCcCCCCCCccCCCCccceeeeeccCCCcCccccccccccccceeecccccccCc
Q 039137          165 SRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGA  244 (912)
Q Consensus       165 ~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~  244 (912)
                      ++|.+++.+|..++++++|++|++++|.+++.+|..++++++|++|+|++|.+.+.+|..+.++++|+.|++++|++++.
T Consensus       220 ~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~  299 (968)
T PLN00113        220 GYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGE  299 (968)
T ss_pred             cCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccC
Confidence            99999888888888899999999999988888888888888888888888888888888888888888888888888888


Q ss_pred             cccccccccccceeeeccccCcccCCcccCCccccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCC
Q 039137          245 IPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTY  324 (912)
Q Consensus       245 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l  324 (912)
                      +|..+.++++|++|++++|.+++.+|..+.++++|+.|++++|.+.+.+|..+..+++|+.|++++|.+++..|..+..+
T Consensus       300 ~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~  379 (968)
T PLN00113        300 IPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSS  379 (968)
T ss_pred             CChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCc
Confidence            88888888888888888888888888888888888888888888887778777777788888887777776666665555


Q ss_pred             CCccEEEccCCcCcccccccCCCCCCCCEEeccCCccccccccc------------------------ccccccccEEEc
Q 039137          325 PNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLE------------------------IGESLQLQYLDL  380 (912)
Q Consensus       325 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~------------------------~~~~~~L~~L~L  380 (912)
                      ++|+.|++++|++.+..|..++.+++|+.|++++|++++.+|..                        +..+++|+.|+|
T Consensus       380 ~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  459 (968)
T PLN00113        380 GNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSL  459 (968)
T ss_pred             CCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEEC
Confidence            55555555555555555555555555555555555555444444                        444555555555


Q ss_pred             cCccccCCCCccccccccccEEEccCCcccCCCccccccccccccccccCcccCccccccccccccccEEEecccccccc
Q 039137          381 SSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQ  460 (912)
Q Consensus       381 ~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  460 (912)
                      ++|++.+.+|..+ ...+|+.|++++|++++..|..+..+++|+.|+|++|++.+.+|..+..+++|++|+|++|.+++.
T Consensus       460 ~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  538 (968)
T PLN00113        460 ARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQ  538 (968)
T ss_pred             cCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCccccc
Confidence            5555555555443 346678888888888888999999999999999999999999999999999999999999999999


Q ss_pred             cchhhhcccccceeeccccccCcccccccccccccccccccCccccCCCcccccccccceEEEccCCcccc
Q 039137          461 IPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEG  531 (912)
Q Consensus       461 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~  531 (912)
                      +|..|.++++|+.|+|++|++++.+|..+..+++|+.|++++|++++.+|.. ..+..+....+.+|+.-|
T Consensus       539 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~-~~~~~~~~~~~~~n~~lc  608 (968)
T PLN00113        539 IPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPST-GAFLAINASAVAGNIDLC  608 (968)
T ss_pred             CChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCc-chhcccChhhhcCCcccc
Confidence            9999999999999999999999999999999999999999999999998853 233344455667887444

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-45  Score=398.66  Aligned_cols=279  Identities=39%  Similarity=0.673  Sum_probs=231.5

Q ss_pred             CCcccHHHHHHHhcCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEE
Q 039137          625 EGKIVYEEIISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY  704 (912)
Q Consensus       625 ~~~~~~~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~  704 (912)
                      ...+.++|+..+++.|...+.||+|+||.||+|..++|+.||||++.......    ..+|..|++++.+++|||+|+++
T Consensus        62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~----~~eF~~Ei~~ls~l~H~Nlv~Ll  137 (361)
T KOG1187|consen   62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG----EREFLNEVEILSRLRHPNLVKLL  137 (361)
T ss_pred             cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc----hhHHHHHHHHHhcCCCcCcccEE
Confidence            44578999999999999999999999999999999999999999876543221    35599999999999999999999


Q ss_pred             EEEEcCC-eeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcE
Q 039137          705 GFCSHPK-HSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEA  783 (912)
Q Consensus       705 ~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  783 (912)
                      |||.+.+ +.++|||||++|+|+++++..... .++|.++.+||.++|+||+|||+.+.|+|+||||||+|||+|+++++
T Consensus       138 GyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a  216 (361)
T KOG1187|consen  138 GYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA  216 (361)
T ss_pred             EEEecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence            9999988 599999999999999999775544 89999999999999999999999988899999999999999999999


Q ss_pred             EEeccccccccCCCCCCcccc-ccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccc----------c
Q 039137          784 HVSDFGIAKFLNPDSSNWSEL-AGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMS----------S  852 (912)
Q Consensus       784 kl~Dfgla~~~~~~~~~~~~~-~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~----------~  852 (912)
                      ||+|||+|+............ .||.+|+|||++..+..+.|+|||||||++.|++||+.|.+...+..          .
T Consensus       217 KlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~  296 (361)
T KOG1187|consen  217 KLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL  296 (361)
T ss_pred             EccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence            999999996554312222223 89999999999999999999999999999999999998876322110          0


Q ss_pred             ccccchhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 039137          853 SSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEK  908 (912)
Q Consensus       853 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  908 (912)
                      .......+++|+++.............+.+++.+|++.+|.+||+|.||+++|++.
T Consensus       297 ~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~  352 (361)
T KOG1187|consen  297 LEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI  352 (361)
T ss_pred             HHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence            11114456666665422111114566688999999999999999999999999654

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-46  Score=379.93  Aligned_cols=253  Identities=26%  Similarity=0.403  Sum_probs=211.4

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCC-eeeE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPK-HSFI  715 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-~~~l  715 (912)
                      .+.+..+.||+|..|+||+++++ +++.+|+|.+....   .+..++++.+|+++++..+||+||.+||+|..++ ...+
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~---~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI  155 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNI---DPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISI  155 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccC---CHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEe
Confidence            34566789999999999999987 78999999995432   3346789999999999999999999999999988 5999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCCeEEcCCCcEEEecccccccc
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHN-NCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL  794 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  794 (912)
                      +||||++|+|++++..   .+++++....+|+.++++||.|||+ +   +||||||||+|||++..|.|||||||.+..+
T Consensus       156 ~mEYMDgGSLd~~~k~---~g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~l  229 (364)
T KOG0581|consen  156 CMEYMDGGSLDDILKR---VGRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGIL  229 (364)
T ss_pred             ehhhcCCCCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHh
Confidence            9999999999999943   3679999999999999999999996 5   9999999999999999999999999999877


Q ss_pred             CCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhH
Q 039137          795 NPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQ  874 (912)
Q Consensus       795 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  874 (912)
                      ...  ...+.+||..|||||.+.+..|+.++||||||+.++|+.+|+.||....+...........+.+...|..+.  .
T Consensus       230 vnS--~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~--~  305 (364)
T KOG0581|consen  230 VNS--IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPE--G  305 (364)
T ss_pred             hhh--hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCc--c
Confidence            544  557789999999999999999999999999999999999999998633111111112222333322222211  1


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          875 KKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       875 ~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ..++++..++..|+++||.+|||++|+++
T Consensus       306 ~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  306 EFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            46778999999999999999999999875

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.9e-46  Score=398.92  Aligned_cols=250  Identities=28%  Similarity=0.469  Sum_probs=220.0

Q ss_pred             cCCCCCceeeecCceEEEEEEe-CCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKV-PSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      .+|..++.||+|+|+.||+++. .+|+.||+|++.+....... +.+.+.+||++.+.|+|||||+++++|++.+.+|+|
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~-~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYiv   96 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPK-QREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIV   96 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcc-hHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEE
Confidence            5799999999999999999998 78999999999775544433 678899999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      .|+|+.++|..+++   ..+++++.+++.+.+||+.|+.|||++   +|+|||||..|++++++.+|||+|||+|..+..
T Consensus        97 LELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~  170 (592)
T KOG0575|consen   97 LELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY  170 (592)
T ss_pred             EEecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence            99999999999995   446799999999999999999999999   999999999999999999999999999999988


Q ss_pred             CCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHH
Q 039137          797 DSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKK  876 (912)
Q Consensus       797 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  876 (912)
                      +..+..+.+|||.|+|||++....++..+||||+||++|.|+.|++||+     .....+....+.......|.    ..
T Consensus       171 ~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFe-----tk~vkety~~Ik~~~Y~~P~----~l  241 (592)
T KOG0575|consen  171 DGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFE-----TKTVKETYNKIKLNEYSMPS----HL  241 (592)
T ss_pred             cccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcc-----cchHHHHHHHHHhcCccccc----cc
Confidence            8788888999999999999999999999999999999999999999986     11222333333334444443    34


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          877 LMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       877 ~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      +.+..++|.++|++||.+|||+++|++
T Consensus       242 s~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  242 SAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             CHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            556789999999999999999999875

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.2e-46  Score=381.71  Aligned_cols=257  Identities=27%  Similarity=0.413  Sum_probs=220.8

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCch---HHHHHHHHHHHHHhhcCCCccccEEEEEEcCC
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMS---FQQEEFLNEIQALTEIRHRNIVKFYGFCSHPK  711 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~  711 (912)
                      ..+.|.+.+.||+|+||.|-+|..+ +|+.||||+++.......+   .....+.+|+++|++++|||||+++++++.++
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            4567889999999999999999754 8999999999765433221   12334579999999999999999999999999


Q ss_pred             eeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCC---CcEEEecc
Q 039137          712 HSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLG---YEAHVSDF  788 (912)
Q Consensus       712 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~Df  788 (912)
                      ..||||||++||+|.+.+..   .+.+.+.....+++|++.|+.|||++   ||+||||||+|||+..+   ..+||+||
T Consensus       250 s~YmVlE~v~GGeLfd~vv~---nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDF  323 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVA---NKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDF  323 (475)
T ss_pred             ceEEEEEEecCccHHHHHHh---ccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEeccc
Confidence            99999999999999999844   34577788899999999999999999   99999999999999866   67999999


Q ss_pred             ccccccCCCCCCccccccccccccccccccCCC---CcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCC
Q 039137          789 GIAKFLNPDSSNWSELAGTHGYVAPELAYTLKV---TEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSR  865 (912)
Q Consensus       789 gla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~---~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  865 (912)
                      |+|+..+ ....+.+.+|||.|.|||++.+..+   ..++|+||+||++|-+++|.+||..    .........++..++
T Consensus       324 GlAK~~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~----~~~~~sl~eQI~~G~  398 (475)
T KOG0615|consen  324 GLAKVSG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSE----EYTDPSLKEQILKGR  398 (475)
T ss_pred             chhhccc-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccc----ccCCccHHHHHhcCc
Confidence            9999876 4566788999999999999986543   3488999999999999999999852    222233567778888


Q ss_pred             CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          866 LPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       866 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      +.+.+..+...+.+..++|.+|+..||++|||++|+++
T Consensus       399 y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  399 YAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             ccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            88888889999999999999999999999999998875

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-45  Score=392.07  Aligned_cols=258  Identities=30%  Similarity=0.512  Sum_probs=213.5

Q ss_pred             cCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCC-eeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPK-HSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-~~~lv  716 (912)
                      .+..+.+.+|+|+||+||+|.+.....||||++.........  .++|.+|+.++.+++|||||+++|+|.++. ..++|
T Consensus        41 ~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~--~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iV  118 (362)
T KOG0192|consen   41 DELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES--RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIV  118 (362)
T ss_pred             HHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH--HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEE
Confidence            344556679999999999999954444999999865444332  778999999999999999999999999887 79999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCC-eeecCCCCCCeEEcCCC-cEEEecccccccc
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP-IVHRDISSKNVLLDLGY-EAHVSDFGIAKFL  794 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-ivH~Dlk~~Nill~~~~-~~kl~Dfgla~~~  794 (912)
                      |||+++|+|.++++.. ....+++..+++|+.|||+||.|||++   + ||||||||+|||++.++ ++||+|||+++..
T Consensus       119 tEy~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~  194 (362)
T KOG0192|consen  119 TEYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREK  194 (362)
T ss_pred             EEeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceee
Confidence            9999999999999664 457899999999999999999999999   7 99999999999999997 9999999999876


Q ss_pred             CCCCCCccccccccccccccccc--cCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhh--ccCCCCCCC
Q 039137          795 NPDSSNWSELAGTHGYVAPELAY--TLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEM--LDSRLPYPS  870 (912)
Q Consensus       795 ~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~  870 (912)
                      .......+...||+.|||||++.  ...|+.|+||||||+++|||+||+.||......     .....+  ...+...+.
T Consensus       195 ~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~-----~~~~~v~~~~~Rp~~p~  269 (362)
T KOG0192|consen  195 VISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV-----QVASAVVVGGLRPPIPK  269 (362)
T ss_pred             ccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH-----HHHHHHHhcCCCCCCCc
Confidence            54434445578999999999999  568999999999999999999999998643321     111111  122222232


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          871 LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       871 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                      .    ....+..++.+||+.||.+||++.+++..|+....
T Consensus       270 ~----~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~  305 (362)
T KOG0192|consen  270 E----CPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS  305 (362)
T ss_pred             c----CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence            1    45668888999999999999999999999987654

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-45  Score=357.08  Aligned_cols=260  Identities=23%  Similarity=0.356  Sum_probs=213.0

Q ss_pred             cCCCCCceeeecCceEEEEEEe-CCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEE-EEcC-Ceee
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKV-PSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGF-CSHP-KHSF  714 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~-~~~~-~~~~  714 (912)
                      .+|++.++||+|+||+||++.. .+|..+|.|.+.-.  .-...++.....|+.++++|+|||||+++++ +.++ ...+
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~--~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln   96 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFG--MMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN   96 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchh--hccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence            4588899999999999999975 48999999999743  3334467789999999999999999999983 4444 4489


Q ss_pred             EEEeecCCCChhhHhhccC-CcccCCHHHHHHHHHHHHHHHHHHHhCCCCC--eeecCCCCCCeEEcCCCcEEEeccccc
Q 039137          715 IIYEYLESGSLDKILCNDA-SAKELGWTQRLNVIKGVADALFYLHNNCFPP--IVHRDISSKNVLLDLGYEAHVSDFGIA  791 (912)
Q Consensus       715 lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlk~~Nill~~~~~~kl~Dfgla  791 (912)
                      +|||+|.+|+|..+++..+ ..+.+++..+|+++.|++.||+++|++.. +  |.||||||.||+++.+|.|||+|||++
T Consensus        97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~-r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~  175 (375)
T KOG0591|consen   97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIP-RGTVMHRDIKPANIFLTANGVVKLGDFGLG  175 (375)
T ss_pred             HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcccc-ccceeeccCcchheEEcCCCceeeccchhH
Confidence            9999999999999996644 45669999999999999999999999432 5  999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCCh
Q 039137          792 KFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSL  871 (912)
Q Consensus       792 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  871 (912)
                      +.+..........+|||.||+||.+.+.+|+.||||||+||++|||+.-++||...     .....-..+....  +++.
T Consensus       176 r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~~L~~KI~qgd--~~~~  248 (375)
T KOG0591|consen  176 RFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLLSLCKKIEQGD--YPPL  248 (375)
T ss_pred             hHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHHHHHHHHHcCC--CCCC
Confidence            99877766677889999999999999999999999999999999999999998622     1111111222222  3333


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 039137          872 HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCE  907 (912)
Q Consensus       872 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  907 (912)
                      ....++..+.++|..|+..||+.||+...++..+..
T Consensus       249 p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  249 PDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             cHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence            345677889999999999999999985554444433

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-44  Score=366.19  Aligned_cols=200  Identities=30%  Similarity=0.508  Sum_probs=181.0

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      ..+|...+.||+|+||+||+|+++ ++..||||.+.....  ....++-+..|+.+++.++|||||++++++..++..|+
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l--~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l   86 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL--NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL   86 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc--CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence            467889999999999999999986 789999999976532  23356778899999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCC------CcEEEeccc
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLG------YEAHVSDFG  789 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~------~~~kl~Dfg  789 (912)
                      |||||.||+|.+|+++.   +.+++.+++.++.|+|.|+++||++   +||||||||+|||++..      -.+||+|||
T Consensus        87 VMEyC~gGDLs~yi~~~---~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG  160 (429)
T KOG0595|consen   87 VMEYCNGGDLSDYIRRR---GRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFG  160 (429)
T ss_pred             EEEeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccc
Confidence            99999999999999554   4689999999999999999999999   99999999999999865      458999999


Q ss_pred             cccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcc
Q 039137          790 IAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRD  845 (912)
Q Consensus       790 la~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~  845 (912)
                      +|+.+.+. ....+.+|+|-|||||++....|+.|+|+||+|+++|++++|+.||+
T Consensus       161 fAR~L~~~-~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~  215 (429)
T KOG0595|consen  161 FARFLQPG-SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFD  215 (429)
T ss_pred             hhhhCCch-hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcc
Confidence            99988743 44567899999999999999999999999999999999999999997

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-44  Score=381.53  Aligned_cols=253  Identities=30%  Similarity=0.506  Sum_probs=211.6

Q ss_pred             cCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIY  717 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  717 (912)
                      +.++..+.||+|.||+||.|++.....||+|.++....     ..+.|.+|+++|++|+|++||+++|+|..++..+|||
T Consensus       206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m-----~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt  280 (468)
T KOG0197|consen  206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM-----SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT  280 (468)
T ss_pred             HHHHHHHHhcCCccceEEEEEEcCCCcccceEEecccc-----ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence            34566789999999999999997777999999875421     4577899999999999999999999999988999999


Q ss_pred             eecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCC
Q 039137          718 EYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPD  797 (912)
Q Consensus       718 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  797 (912)
                      |||+.|+|.++++. .....+...+.+.++.|||+|++||+++   ++|||||.++||||+++..+||+|||+|+...++
T Consensus       281 E~m~~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~  356 (468)
T KOG0197|consen  281 EYMPKGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDD  356 (468)
T ss_pred             EecccCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCC
Confidence            99999999999965 4556789999999999999999999999   9999999999999999999999999999965544


Q ss_pred             CCCcc-ccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccC--CCCCCChhh
Q 039137          798 SSNWS-ELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDS--RLPYPSLHV  873 (912)
Q Consensus       798 ~~~~~-~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  873 (912)
                      ..... ...-+..|+|||.+....++.|||||||||+||||+| |+.||...      ......+.++.  +.+.|    
T Consensus       357 ~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~m------sn~ev~~~le~GyRlp~P----  426 (468)
T KOG0197|consen  357 EYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGM------SNEEVLELLERGYRLPRP----  426 (468)
T ss_pred             ceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCC------CHHHHHHHHhccCcCCCC----
Confidence            33322 2334568999999999999999999999999999999 99997521      11222233333  33333    


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 039137          874 QKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI  909 (912)
Q Consensus       874 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l  909 (912)
                      ..++..+.+++..||+.+|++|||++.+...+++..
T Consensus       427 ~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~  462 (468)
T KOG0197|consen  427 EGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF  462 (468)
T ss_pred             CCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence            345677899999999999999999999988887754

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=7.8e-43  Score=343.37  Aligned_cols=258  Identities=22%  Similarity=0.380  Sum_probs=207.8

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ++|+...++|+|+||+||+++++ +|+.||||++....  +.....+-.+||+.++++++|||+|.++++|...+..++|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese--dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV   79 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE--DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV   79 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC--ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence            56888999999999999999987 79999999997543  2333567789999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      +|||+..-|.++- +  ....++.+.+.++++|++.|+.|+|++   +++||||||+|||++.+|.+||||||.|+.+..
T Consensus        80 FE~~dhTvL~eLe-~--~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~  153 (396)
T KOG0593|consen   80 FEYCDHTVLHELE-R--YPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA  153 (396)
T ss_pred             eeecchHHHHHHH-h--ccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC
Confidence            9999985554443 2  334578899999999999999999999   999999999999999999999999999999887


Q ss_pred             CCCCcccccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCccchhcccccc------cc----------chh
Q 039137          797 DSSNWSELAGTHGYVAPELAYT-LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS------SN----------MNI  859 (912)
Q Consensus       797 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~------~~----------~~~  859 (912)
                      ....++..+.|..|+|||.+.+ .+|...+||||+||++.||++|++-|....+++...      ..          ...
T Consensus       154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~  233 (396)
T KOG0593|consen  154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP  233 (396)
T ss_pred             CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence            7778888999999999998877 789999999999999999999999875221111100      00          000


Q ss_pred             hhccCCCCCCC------hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          860 EMLDSRLPYPS------LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       860 ~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ....-++|.+.      ...+..+.-+.+++..|++.||++|++.+|++.
T Consensus       234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            00011112111      122334456889999999999999999999874

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-42  Score=353.79  Aligned_cols=245  Identities=26%  Similarity=0.378  Sum_probs=209.7

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      .++|++.++||+|+||+||.++.+ +++.||+|++++....... ..+...+|..++.+++||.||.++-.|++++..|+
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~-e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl  102 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKK-EVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL  102 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhh-hHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence            467999999999999999999865 7899999999876544432 56778899999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      |+||+.||.|..++.   ..+.+++..+.-++..|+.||.|||++   +|||||+||+|||+|.+|.++|+|||+++...
T Consensus       103 Vld~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~  176 (357)
T KOG0598|consen  103 VLDYLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDL  176 (357)
T ss_pred             EEeccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence            999999999999994   346799999999999999999999999   99999999999999999999999999999766


Q ss_pred             CCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHH
Q 039137          796 PDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQK  875 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  875 (912)
                      ..+....+.+||+.|||||++.+..|+.++|.||+|+++|||++|.+||..     .....+...+...+.+.++.   .
T Consensus       177 ~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~-----~~~~~~~~~I~~~k~~~~p~---~  248 (357)
T KOG0598|consen  177 KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA-----EDVKKMYDKILKGKLPLPPG---Y  248 (357)
T ss_pred             cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC-----ccHHHHHHHHhcCcCCCCCc---c
Confidence            666667778999999999999999999999999999999999999999851     12223333444444333322   1


Q ss_pred             HHHHHHHHHHHcccCCCCCCC
Q 039137          876 KLMSIMQVAFSCLDQNPESRP  896 (912)
Q Consensus       876 ~~~~l~~li~~cl~~dP~~RP  896 (912)
                      .+.+..+++.+.++.||++|.
T Consensus       249 ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  249 LSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             CCHHHHHHHHHHhccCHHHhc
Confidence            344577899999999999995

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-41  Score=360.28  Aligned_cols=265  Identities=26%  Similarity=0.404  Sum_probs=215.4

Q ss_pred             HHHHHHHhcCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEc
Q 039137          630 YEEIISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSH  709 (912)
Q Consensus       630 ~~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~  709 (912)
                      .+++....+++.+...||+|.||+||+|+|.  ..||||++.......  .+.+.|+.|+..+++-+|.||+-+.|||..
T Consensus       384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~--~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~  459 (678)
T KOG0193|consen  384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTP--EQLQAFKNEVAVLKKTRHENILLFMGACMN  459 (678)
T ss_pred             ccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCH--HHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence            3555566677889999999999999999983  358999998765443  378899999999999999999999999999


Q ss_pred             CCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccc
Q 039137          710 PKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFG  789 (912)
Q Consensus       710 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  789 (912)
                      +.. .+|+.+|+|.+|+.+++-.+  .+++..+.+.||+|||+|+.|||.+   +|+|||||..||++.++++|||+|||
T Consensus       460 p~~-AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFG  533 (678)
T KOG0193|consen  460 PPL-AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFG  533 (678)
T ss_pred             Cce-eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEeccc
Confidence            888 99999999999999996544  6789999999999999999999999   99999999999999999999999999


Q ss_pred             cccccC--CCCCCcccccccccccccccccc---CCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccC
Q 039137          790 IAKFLN--PDSSNWSELAGTHGYVAPELAYT---LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDS  864 (912)
Q Consensus       790 la~~~~--~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  864 (912)
                      ++..-.  ..........|...|||||++..   .+|+..+||||||+|+|||++|..||.    ....++  ...++..
T Consensus       534 Latvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys----i~~~dq--IifmVGr  607 (678)
T KOG0193|consen  534 LATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS----IQNRDQ--IIFMVGR  607 (678)
T ss_pred             ceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC----CCChhh--eEEEecc
Confidence            997432  22333445667888999998874   468999999999999999999999975    111111  1111111


Q ss_pred             CC--CCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          865 RL--PYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       865 ~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                      ..  +-..........++.+++..||.+++++||.+.+++..|++.+.
T Consensus       608 G~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  608 GYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             cccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence            11  11122234455678999999999999999999999999988765

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-41  Score=354.46  Aligned_cols=255  Identities=25%  Similarity=0.369  Sum_probs=214.6

Q ss_pred             HHHhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEEcCC
Q 039137          634 ISATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSHPK  711 (912)
Q Consensus       634 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~  711 (912)
                      .....+|.+++.||+|+|++|++|+.+ +++.||||++.+....... ..+.+.+|-+.|.+| .||.|++++-.|.+..
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~-KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~  147 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEK-KVKYVTREKEALTQLSGHPGIVKLYFTFQDEE  147 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhc-ccchhhHHHHHHHHhhCCCCeEEEEEEeeccc
Confidence            445678999999999999999999865 7999999998665443222 345677899999999 7999999999999999


Q ss_pred             eeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccc
Q 039137          712 HSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIA  791 (912)
Q Consensus       712 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla  791 (912)
                      ..|+|+||+++|+|.+++++.   +.+++..++.++.+|+.|++|||++   |||||||||+|||+|.+++++|+|||.|
T Consensus       148 sLYFvLe~A~nGdll~~i~K~---Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsA  221 (604)
T KOG0592|consen  148 SLYFVLEYAPNGDLLDLIKKY---GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSA  221 (604)
T ss_pred             ceEEEEEecCCCcHHHHHHHh---CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecccc
Confidence            999999999999999999654   5699999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCC-------------ccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccch
Q 039137          792 KFLNPDSSN-------------WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMN  858 (912)
Q Consensus       792 ~~~~~~~~~-------------~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~  858 (912)
                      +.+.+....             ...++||..|.+||++.+...++.+|+|+|||++|+|+.|++||....+     ....
T Consensus       222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne-----yliF  296 (604)
T KOG0592|consen  222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE-----YLIF  296 (604)
T ss_pred             ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH-----HHHH
Confidence            987643211             2458999999999999999999999999999999999999999963222     2233


Q ss_pred             hhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 039137          859 IEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQL  904 (912)
Q Consensus       859 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  904 (912)
                      ..++.-.+.+++..    ++.+.++|.+.+..||.+|+|++|+.+.
T Consensus       297 qkI~~l~y~fp~~f----p~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  297 QKIQALDYEFPEGF----PEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             HHHHHhcccCCCCC----CHHHHHHHHHHHccCccccccHHHHhhC
Confidence            44444555555433    3557789999999999999999887653

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.4e-40  Score=322.46  Aligned_cols=259  Identities=20%  Similarity=0.314  Sum_probs=208.5

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      .+|...+.+|+|.||.||+|++. +|+.||||+++.....+.  ......||+..++.++|+||+.++++|...+...+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdG--i~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lV   79 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDG--INRTALREIKLLQELKHPNIIELIDVFPHKSNLSLV   79 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccC--ccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEE
Confidence            47888999999999999999865 899999999986633221  345678999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      +|||+. +|+..++.  ....++..++..++.++++|++|+|++   .|+||||||.|+|++.+|.+||+|||+|+.+.+
T Consensus        80 fEfm~t-dLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~  153 (318)
T KOG0659|consen   80 FEFMPT-DLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGS  153 (318)
T ss_pred             EEeccc-cHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCC
Confidence            999987 99999943  346789999999999999999999999   999999999999999999999999999999988


Q ss_pred             CCCCccccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCccchhccccc---------------c--ccch
Q 039137          797 DSSNWSELAGTHGYVAPELAYTL-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS---------------S--SNMN  858 (912)
Q Consensus       797 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~---------------~--~~~~  858 (912)
                      ........+-|..|+|||.+.|. .|+..+||||.||++.||+-|.+-|....+....               .  ....
T Consensus       154 p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp  233 (318)
T KOG0659|consen  154 PNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP  233 (318)
T ss_pred             CCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence            77777777899999999988765 5899999999999999999988876422111100               0  0000


Q ss_pred             hhhccCCCCCCCh--hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 039137          859 IEMLDSRLPYPSL--HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQL  904 (912)
Q Consensus       859 ~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  904 (912)
                      .-..-...|.+..  .......+..+++.+|+..||.+|+|++|++++
T Consensus       234 dY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  234 DYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             cHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            0000011222211  122334557899999999999999999988763

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=3.4e-41  Score=378.08  Aligned_cols=259  Identities=25%  Similarity=0.427  Sum_probs=210.8

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC------CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP------SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP  710 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~  710 (912)
                      ..+....+.||+|+||+||+|+..      +...||||.++.....   ..+.+|.||++++..++|||||+++|+|.++
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~---~~~~dF~REaeLla~l~H~nIVrLlGVC~~~  561 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAEN---QARQDFRREAELLAELQHPNIVRLLGVCREG  561 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccH---HHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence            345566789999999999999742      4567999999754332   2678999999999999999999999999999


Q ss_pred             CeeeEEEeecCCCChhhHhhccC-------C----cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcC
Q 039137          711 KHSFIIYEYLESGSLDKILCNDA-------S----AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDL  779 (912)
Q Consensus       711 ~~~~lv~e~~~~g~L~~~l~~~~-------~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~  779 (912)
                      +..++|+|||..|||.++++...       .    ..+++..+.+.||.|||.|++||-++   .+|||||..+|+||.+
T Consensus       562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge  638 (774)
T KOG1026|consen  562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGE  638 (774)
T ss_pred             CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceecc
Confidence            99999999999999999995431       1    33488999999999999999999999   8999999999999999


Q ss_pred             CCcEEEeccccccccCCCCCCc-c-ccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhcccccccc
Q 039137          780 GYEAHVSDFGIAKFLNPDSSNW-S-ELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSN  856 (912)
Q Consensus       780 ~~~~kl~Dfgla~~~~~~~~~~-~-~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~  856 (912)
                      +..|||+|||+++..-..++.. . ...-..+|||||.+..++|+++||||||||+|||+++ |+.||....     .++
T Consensus       639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS-----n~E  713 (774)
T KOG1026|consen  639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS-----NQE  713 (774)
T ss_pred             ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc-----hHH
Confidence            9999999999999654332211 1 2234679999999999999999999999999999999 999975221     122


Q ss_pred             chhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 039137          857 MNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI  909 (912)
Q Consensus       857 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l  909 (912)
                      +..-+.+++. .+  .....+.+++.++..||+..|.+||+++||-.+|+...
T Consensus       714 VIe~i~~g~l-L~--~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~  763 (774)
T KOG1026|consen  714 VIECIRAGQL-LS--CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA  763 (774)
T ss_pred             HHHHHHcCCc-cc--CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence            2222223333 21  22456677999999999999999999999999998753

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-40  Score=360.40  Aligned_cols=253  Identities=25%  Similarity=0.386  Sum_probs=213.8

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCch-HHHHHHHHHHHHHhhcC-CCccccEEEEEEcCCe
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMS-FQQEEFLNEIQALTEIR-HRNIVKFYGFCSHPKH  712 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~-~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~  712 (912)
                      ...+|.+++.||+|+||+|+.|.+. +++.||+|++.+....... ...+.+.+|+.+++.++ ||||+++++++..+..
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            4568999999999999999999765 7899999977654221111 23456678999999998 9999999999999999


Q ss_pred             eeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCC-CcEEEeccccc
Q 039137          713 SFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLG-YEAHVSDFGIA  791 (912)
Q Consensus       713 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~Dfgla  791 (912)
                      .++||||+.+|+|.+++.+   .+++.+.++..+++|++.|++|+|++   +|+||||||+||+++.+ +++||+|||++
T Consensus        95 ~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             EEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            9999999999999999944   56788999999999999999999999   99999999999999999 99999999999


Q ss_pred             cccCCCCCCccccccccccccccccccCC-CC-cchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCC
Q 039137          792 KFLNPDSSNWSELAGTHGYVAPELAYTLK-VT-EKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYP  869 (912)
Q Consensus       792 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~-~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  869 (912)
                      .............+|++.|+|||++.+.. |+ .++||||+||++|.|++|+.||+.     .........+.......|
T Consensus       169 ~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d-----~~~~~l~~ki~~~~~~~p  243 (370)
T KOG0583|consen  169 AISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD-----SNVPNLYRKIRKGEFKIP  243 (370)
T ss_pred             cccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-----ccHHHHHHHHhcCCccCC
Confidence            98753445667889999999999999977 75 789999999999999999999973     122223333455555555


Q ss_pred             ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 039137          870 SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVS  902 (912)
Q Consensus       870 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl  902 (912)
                      ....   +.++..++.+|+..||.+|+|+.+++
T Consensus       244 ~~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  244 SYLL---SPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             CCcC---CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence            4332   66788999999999999999999987

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-42  Score=373.70  Aligned_cols=257  Identities=28%  Similarity=0.514  Sum_probs=217.1

Q ss_pred             cCCCCCceeeecCceEEEEEEeC----CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCee
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP----SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHS  713 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  713 (912)
                      ....+.++||.|.||+||+|+++    ....||||.++..   ..+.++.+|+.|+.+|.++.||||+++.|+....+..
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G---ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~Pv  705 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG---YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPV  705 (996)
T ss_pred             hheEEEEEEecccccceecccccCCCCcceeEEEeeeccC---ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCcee
Confidence            34567899999999999999875    3456999999754   4444788999999999999999999999999999999


Q ss_pred             eEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccc
Q 039137          714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKF  793 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  793 (912)
                      ++|.|||++|+|+.+++.+.  +++++.+...+.++||.|+.||.+.   ++|||||.++|||++.+..+|++|||+++.
T Consensus       706 MIiTEyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRv  780 (996)
T KOG0196|consen  706 MIITEYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV  780 (996)
T ss_pred             EEEhhhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceee
Confidence            99999999999999996654  6699999999999999999999999   999999999999999999999999999998


Q ss_pred             cCCCCC-Ccccccc--ccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhh-ccCCCCC
Q 039137          794 LNPDSS-NWSELAG--THGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEM-LDSRLPY  868 (912)
Q Consensus       794 ~~~~~~-~~~~~~g--~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~  868 (912)
                      +.++.. .++...|  ..+|+|||.+.-.+++.++||||+|++|||.++ |+.||   .++..+  +....+ .+.++|.
T Consensus       781 ledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPY---WdmSNQ--dVIkaIe~gyRLPp  855 (996)
T KOG0196|consen  781 LEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY---WDMSNQ--DVIKAIEQGYRLPP  855 (996)
T ss_pred             cccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcc---cccchH--HHHHHHHhccCCCC
Confidence            866653 3333444  468999999999999999999999999999988 99995   233322  222222 2334444


Q ss_pred             CChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 039137          869 PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE  911 (912)
Q Consensus       869 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~~  911 (912)
                      |    .+++..+.+++..||++|-.+||++.|++..|.+++.+
T Consensus       856 P----mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn  894 (996)
T KOG0196|consen  856 P----MDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN  894 (996)
T ss_pred             C----CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence            4    35667899999999999999999999999999998864

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-42  Score=363.04  Aligned_cols=365  Identities=26%  Similarity=0.275  Sum_probs=218.0

Q ss_pred             CccEEEccCCcccccCCccccCCCCCcEEeccccccccccccccccccccceeecccccccCCCCccccCcccccEEEcc
Q 039137          110 HLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALD  189 (912)
Q Consensus       110 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~  189 (912)
                      ..+.||+++|.+..+-+..|.++++|++++|..|.++ .||...+...+|+.|+|.+|.++..-.+++.-++.|+.||||
T Consensus        79 ~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLS  157 (873)
T KOG4194|consen   79 QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLS  157 (873)
T ss_pred             ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhh
Confidence            4456777777777666667777777777777777776 677766666667777777777776556667777777777777


Q ss_pred             CCcCCCCCCccCCCCccceeeeeccCCCcCccccccccccccceeecccccccCccccccccccccceeeeccccCcccC
Q 039137          190 SNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGII  269 (912)
Q Consensus       190 ~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  269 (912)
                      .|.|+..--++|..-.++++|+|++|+|+..-...|.++.+|..|.|++|+++...+..|.+|++|+.|+|..|+|.-.-
T Consensus       158 rN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive  237 (873)
T KOG4194|consen  158 RNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVE  237 (873)
T ss_pred             hchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeeh
Confidence            77777444456666666777777777776665666666666666666666666555556666666666666666666333


Q ss_pred             CcccCCccccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCcccccccCCCCC
Q 039137          270 PQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCP  349 (912)
Q Consensus       270 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  349 (912)
                      .-.|.+|++|+.|.|..|.+...-...|..+.++++|+|+.|+++.....++-++..|+.|+||+|.|..+.+..|+.++
T Consensus       238 ~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~Wsftq  317 (873)
T KOG4194|consen  238 GLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQ  317 (873)
T ss_pred             hhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcc
Confidence            44566666666666666666655555666666666666666666655555666666666666666666655555565555


Q ss_pred             CCCEEeccCCcccccccccccccccccEEEccCccccCCCCccccccccccEEEccCCcccCCCc---cccccccccccc
Q 039137          350 QLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIP---RELGSLINLEYL  426 (912)
Q Consensus       350 ~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L  426 (912)
                      +|++|+|++|+|+...+..|..+.+|++|+|++|.+...-...|..+++|++|+|++|.++..+.   ..|..|++|+.|
T Consensus       318 kL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL  397 (873)
T KOG4194|consen  318 KLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKL  397 (873)
T ss_pred             cceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhhe
Confidence            55555555555555555555555555555555555544333344444445555555554443332   123344444444


Q ss_pred             cccCcccCccccccccccccccEEEecccccccccchhhhcccccceeec
Q 039137          427 DLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDL  476 (912)
Q Consensus       427 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  476 (912)
                      +|.+|+|..+...+|.+++.|++|||.+|.|..+-|.+|..+ +|++|.+
T Consensus       398 ~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~  446 (873)
T KOG4194|consen  398 RLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVM  446 (873)
T ss_pred             eecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhh
Confidence            444444444444444444444444444444444444444444 4444443

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=4.3e-44  Score=364.23  Aligned_cols=413  Identities=30%  Similarity=0.447  Sum_probs=322.0

Q ss_pred             ccccCCCCCccEEEccCCcccccCCccccCCCCCcEEeccccccccccccccccccccceeecccccccCCCCccccCcc
Q 039137          102 EFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLT  181 (912)
Q Consensus       102 ~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~  181 (912)
                      ...+.++..+++|++++|++. ..|++++.+.+++.|+.++|++. ++|++++.+.+|+.|+.++|.+. ++|++++.+.
T Consensus        61 ~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~  137 (565)
T KOG0472|consen   61 REDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLL  137 (565)
T ss_pred             cHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHh
Confidence            345778999999999999998 78999999999999999999997 89999999999999999999999 8999999999


Q ss_pred             cccEEEccCCcCCCCCCccCCCCccceeeeeccCCCcCccccccccccccceeecccccccCccccccccccccceeeec
Q 039137          182 VLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLY  261 (912)
Q Consensus       182 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~  261 (912)
                      .|+.|+..+|+++ ++|+++.++.+|..|++.+|++....|+.+. |+.|++||...|.++ .+|..++.|.+|..|+|.
T Consensus       138 ~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~  214 (565)
T KOG0472|consen  138 DLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLR  214 (565)
T ss_pred             hhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhh
Confidence            9999999999998 8999999999999999999999955555555 999999999999998 788899999999999999


Q ss_pred             cccCcccCCcccCCccccchhhhccCccCCCCcccc-ccccccceEecccccccCCCCcccCCCCCccEEEccCCcCccc
Q 039137          262 HNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSF-RNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGE  340 (912)
Q Consensus       262 ~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  340 (912)
                      +|++. ..| +|.++..|++|+++.|+|. .+|.+. .++++|..|||.+|+++ ..|+.+.-+.+|+.||+|+|.+++ 
T Consensus       215 ~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~-  289 (565)
T KOG0472|consen  215 RNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISS-  289 (565)
T ss_pred             hcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCcccc-
Confidence            99999 466 8999999999999999998 566554 58999999999999999 567777889999999999999974 


Q ss_pred             ccccCCCCCCCCEEeccCCccccc-------------------------------------ccc-c---ccccccccEEE
Q 039137          341 ILSDWGRCPQLSLLDVSINNISGS-------------------------------------IPL-E---IGESLQLQYLD  379 (912)
Q Consensus       341 ~~~~~~~l~~L~~L~Ls~N~l~~~-------------------------------------~~~-~---~~~~~~L~~L~  379 (912)
                      .|..++++ .|+.|-+.+|.+...                                     .|. .   ...+.+.+.|+
T Consensus       290 Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~  368 (565)
T KOG0472|consen  290 LPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILD  368 (565)
T ss_pred             CCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhc
Confidence            66778898 999999999987520                                     000 0   01122345555


Q ss_pred             ccCccccCCCCcccccccc---ccEEEccCCccc-----------------------CCCccccccccccccccccCccc
Q 039137          380 LSSNYIVGEIPTQLGNIIY---LNRLSLSGNKLS-----------------------GCIPRELGSLINLEYLDLSANNL  433 (912)
Q Consensus       380 L~~N~l~~~~~~~l~~l~~---L~~L~L~~N~l~-----------------------~~~p~~~~~l~~L~~L~Ls~N~l  433 (912)
                      +++-+++ .+|........   ....+++.|++.                       +.+|..+..+++|..|+|++|-+
T Consensus       369 ~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~L  447 (565)
T KOG0472|consen  369 VSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLCELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLL  447 (565)
T ss_pred             ccccccc-cCCHHHHHHhhhcceEEEecccchHhhhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchh
Confidence            5555555 33333222222   444445555444                       24455555566666666666655


Q ss_pred             CccccccccccccccEEEecccccccccchhhhcccccceeeccccccCcccccccccccccccccccCccccCCCcccc
Q 039137          434 SNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCF  513 (912)
Q Consensus       434 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~  513 (912)
                      .. +|..++.+..|+.||+|.|++. .+|..+..+..|+.+-.++|++....+..+.+|.+|..|||.+|.+.. +|..+
T Consensus       448 n~-LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~-IPp~L  524 (565)
T KOG0472|consen  448 ND-LPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQ-IPPIL  524 (565)
T ss_pred             hh-cchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchhh-CChhh
Confidence            54 4555555556666666666664 555555555555555555566655666668888888999999888875 46678


Q ss_pred             cccccceEEEccCCccc
Q 039137          514 EEMHGLLHIDISYNKLE  530 (912)
Q Consensus       514 ~~l~~L~~l~ls~N~l~  530 (912)
                      +++++|++|++++|++.
T Consensus       525 gnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  525 GNMTNLRHLELDGNPFR  541 (565)
T ss_pred             ccccceeEEEecCCccC
Confidence            88899999999998887

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-41  Score=357.53  Aligned_cols=250  Identities=25%  Similarity=0.409  Sum_probs=211.7

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      ...|.....||+|+.|.||.|+.. +++.||||++......    ..+-+..|+.+|+..+|+|||++++.|...+..|+
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~----~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWV  347 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP----KKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWV  347 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC----chhhhHHHHHHHHhccchHHHHHHHHhcccceeEE
Confidence            356778889999999999999754 7889999998654332    45668899999999999999999999988899999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      |||||+||+|.|++..    ..+++.++..|++++++||+|||.+   +|+|||||.+|||++.+|.+||+|||++..+.
T Consensus       348 VMEym~ggsLTDvVt~----~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~  420 (550)
T KOG0578|consen  348 VMEYMEGGSLTDVVTK----TRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQIS  420 (550)
T ss_pred             EEeecCCCchhhhhhc----ccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccc
Confidence            9999999999999833    3489999999999999999999999   99999999999999999999999999999988


Q ss_pred             CCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHH
Q 039137          796 PDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQK  875 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  875 (912)
                      .........+|||.|||||++....|++|+||||||++.+||+.|++||-...+.    ...  ..+.......-.....
T Consensus       421 ~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl----rAl--yLIa~ng~P~lk~~~k  494 (550)
T KOG0578|consen  421 EEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL----RAL--YLIATNGTPKLKNPEK  494 (550)
T ss_pred             cccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH----HHH--HHHhhcCCCCcCCccc
Confidence            8777788899999999999999999999999999999999999999997311111    111  1111111111123345


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          876 KLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       876 ~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .+..+.+|+.+||+.||++||++.|+++
T Consensus       495 lS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  495 LSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             cCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            6678999999999999999999999886

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=5.2e-41  Score=354.93  Aligned_cols=248  Identities=25%  Similarity=0.408  Sum_probs=212.3

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ++|.+.+.||+|+||.||||+.+ +.+.||+|.+.+....  +...+.+.+|+++++.++||||+.++++|+...+.|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~--~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV   79 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRN--EKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV   79 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCc--hHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence            57888899999999999999876 7889999998765433  33567899999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      .||+.| +|..++   ...+.++++++..++.+++.||.|||+.   +|.|||+||+||+++.++.+|+||||+|+.+..
T Consensus        80 te~a~g-~L~~il---~~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~  152 (808)
T KOG0597|consen   80 TEYAVG-DLFTIL---EQDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST  152 (808)
T ss_pred             ehhhhh-hHHHHH---HhccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc
Confidence            999987 999999   4456799999999999999999999999   999999999999999999999999999998877


Q ss_pred             CCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHH
Q 039137          797 DSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKK  876 (912)
Q Consensus       797 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  876 (912)
                      .....+...|||-|||||...+.+|+..+|.||+||++||+++|++||-.     .........+......+|    ...
T Consensus       153 ~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-----~si~~Lv~~I~~d~v~~p----~~~  223 (808)
T KOG0597|consen  153 NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-----RSITQLVKSILKDPVKPP----STA  223 (808)
T ss_pred             CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-----HHHHHHHHHHhcCCCCCc----ccc
Confidence            76667788999999999999999999999999999999999999999841     111111122222222222    255


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          877 LMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       877 ~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      +..+..++...+.+||.+|.|-.+++.
T Consensus       224 S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  224 SSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             cHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            667889999999999999999888764

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-42  Score=362.59  Aligned_cols=389  Identities=24%  Similarity=0.217  Sum_probs=272.4

Q ss_pred             cEEEccCCcccccCCccccCC--CCCcEEeccccccccccccccccccccceeecccccccCCCCccccCcccccEEEcc
Q 039137          112 VYLDLYNNELFGIIPPQISNL--SNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALD  189 (912)
Q Consensus       112 ~~L~L~~n~l~~~~p~~~~~l--~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~  189 (912)
                      ..||.+.+.+...--..+..+  +.-+.||||+|++...-+..|.++++|+.++|..|.++ .||...+...+|+.|+|.
T Consensus        55 ~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~  133 (873)
T KOG4194|consen   55 RLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLR  133 (873)
T ss_pred             eeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeee
Confidence            467888887764322222222  23456888888888777888888888888888888888 788777777778888888


Q ss_pred             CCcCCCCCCccCCCCccceeeeeccCCCcCccccccccccccceeecccccccCccccccccccccceeeeccccCcccC
Q 039137          190 SNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGII  269 (912)
Q Consensus       190 ~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  269 (912)
                      +|.|+..-.+.+.-++.|+.|||+.|.++...-..|..-.++++|+|++|+|+..--..|..+.+|..|.|+.|+++...
T Consensus       134 ~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp  213 (873)
T KOG4194|consen  134 HNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLP  213 (873)
T ss_pred             ccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccC
Confidence            88887666667777778888888888877554456666667777777777777666667777777777777777777666


Q ss_pred             CcccCCccccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCcccccccCCCCC
Q 039137          270 PQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCP  349 (912)
Q Consensus       270 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  349 (912)
                      +..|.+|++|+.|+|..|+|.-.---.|..+++|+.|.|..|.|.......|..+.++++|+|+.|++......++-+++
T Consensus       214 ~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt  293 (873)
T KOG4194|consen  214 QRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLT  293 (873)
T ss_pred             HHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccc
Confidence            66677777777777777777744355677777777777777777777777777777777777777777766666777777


Q ss_pred             CCCEEeccCCcccccccccccccccccEEEccCccccCCCCccccccccccEEEccCCcccCCCcccccccccccccccc
Q 039137          350 QLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLS  429 (912)
Q Consensus       350 ~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls  429 (912)
                      .|+.|+||+|.|...-++.+....+|++|+|++|+|+...+..|..+..|++|+|++|+++..-...|..+++|+.|||+
T Consensus       294 ~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr  373 (873)
T KOG4194|consen  294 SLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLR  373 (873)
T ss_pred             hhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCc
Confidence            77777777777776666666666677777777777776666666667777777777777665555566666677777777


Q ss_pred             CcccCcccc---ccccccccccEEEecccccccccchhhhcccccceeeccccccCcccccccccccccccccccC
Q 039137          430 ANNLSNFVP---ESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSY  502 (912)
Q Consensus       430 ~N~l~~~~~---~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~  502 (912)
                      +|.|+..+-   ..|..|++|+.|.|-+|+|..+...+|.++++|++|||.+|.|..+-|++|..+ .|++|-++.
T Consensus       374 ~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nS  448 (873)
T KOG4194|consen  374 SNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNS  448 (873)
T ss_pred             CCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcc
Confidence            776665433   235556666666666666655555566666666666666666666666666666 555555543

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-40  Score=346.86  Aligned_cols=254  Identities=29%  Similarity=0.453  Sum_probs=202.0

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCC--ee
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPK--HS  713 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--~~  713 (912)
                      ..+|...+.||+|+||+||.+... +|+..|||.+.....   . ..+.+.+|+.++++++|||||+++|......  .+
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~---~-~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~   91 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS---P-TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEY   91 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccc---h-hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeee
Confidence            345788899999999999999876 489999999865411   1 2567889999999999999999999855444  68


Q ss_pred             eEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcC-CCcEEEecccccc
Q 039137          714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDL-GYEAHVSDFGIAK  792 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~Dfgla~  792 (912)
                      ++.|||+++|+|.+++.+...  .+++..++++++||++||+|||++   +||||||||+|||++. ++.+||+|||++.
T Consensus        92 ~i~mEy~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~  166 (313)
T KOG0198|consen   92 NIFMEYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAK  166 (313)
T ss_pred             EeeeeccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccc
Confidence            999999999999999965443  699999999999999999999999   9999999999999999 7999999999998


Q ss_pred             ccCCC---CCCccccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCC
Q 039137          793 FLNPD---SSNWSELAGTHGYVAPELAYTL-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPY  868 (912)
Q Consensus       793 ~~~~~---~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  868 (912)
                      .....   ........||+.|||||++..+ ....++||||+||++.||+||+.||....+.   .............| 
T Consensus       167 ~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~---~~~~~~ig~~~~~P-  242 (313)
T KOG0198|consen  167 KLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEE---AEALLLIGREDSLP-  242 (313)
T ss_pred             ccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcch---HHHHHHHhccCCCC-
Confidence            76631   1223457899999999999853 3445999999999999999999998642110   01111111111112 


Q ss_pred             CChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 039137          869 PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL  905 (912)
Q Consensus       869 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  905 (912)
                        ......+....+++.+|+..||++||||+++++.-
T Consensus       243 --~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp  277 (313)
T KOG0198|consen  243 --EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP  277 (313)
T ss_pred             --CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence              11223556688999999999999999999998754

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-39  Score=337.08  Aligned_cols=255  Identities=25%  Similarity=0.399  Sum_probs=211.6

Q ss_pred             hcCCCCCceeeecCceEEEEEEe-CCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKV-PSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      .++|++.+.||.|..++||+|+. +.++.||||++.-+....   ..+.+.+|+..|+.++||||++++..|..+...|+
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~---~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWv  101 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN---DLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWV  101 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh---hHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEE
Confidence            46799999999999999999985 478999999997654332   36789999999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ||+||.+|++.++++..-. ..+++..+..|.+++++||.|||.+   |.+|||||+.|||++.+|.|||+|||.+..+.
T Consensus       102 VmpfMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~  177 (516)
T KOG0582|consen  102 VMPFMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLF  177 (516)
T ss_pred             eehhhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeec
Confidence            9999999999999966543 3489999999999999999999999   99999999999999999999999999887665


Q ss_pred             CCCCCc----ccccccccccccccccc--CCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCC--
Q 039137          796 PDSSNW----SELAGTHGYVAPELAYT--LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLP--  867 (912)
Q Consensus       796 ~~~~~~----~~~~g~~~y~aPE~~~~--~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--  867 (912)
                      ....+.    ...+|++.|||||++..  ..|+.|+||||||++..|+.+|+.||....++..     ....+....|  
T Consensus       178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv-----Ll~tLqn~pp~~  252 (516)
T KOG0582|consen  178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV-----LLLTLQNDPPTL  252 (516)
T ss_pred             ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH-----HHHHhcCCCCCc
Confidence            544332    45689999999999543  3589999999999999999999999974443321     1111222221  


Q ss_pred             ----CCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          868 ----YPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       868 ----~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                          .+.+.......++.+++..|+.+||.+|||++++++
T Consensus       253 ~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  253 LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence                233344555668999999999999999999998764

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.1e-40  Score=346.13  Aligned_cols=259  Identities=25%  Similarity=0.374  Sum_probs=206.1

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC--Cee
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP--KHS  713 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~  713 (912)
                      .+.|+.+++||+|+||.||+|++. +|+.||+|++..+....  .......|||.++++|+||||+++.+...+.  +.+
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~--~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si  193 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKE--GFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI  193 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCC--cchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence            356788899999999999999864 89999999998665332  2456678999999999999999999999876  689


Q ss_pred             eEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccc
Q 039137          714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKF  793 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  793 (912)
                      |+|+|||++ +|.-++..  ..-.+++.++..++.|++.||+|+|++   +|+|||||.+|||+|.+|.+||+|||+|++
T Consensus       194 YlVFeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~  267 (560)
T KOG0600|consen  194 YLVFEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARF  267 (560)
T ss_pred             EEEEecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceee
Confidence            999999998 88887733  234699999999999999999999999   999999999999999999999999999998


Q ss_pred             cCCCCCC-ccccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCccchhccccc---------cccch----
Q 039137          794 LNPDSSN-WSELAGTHGYVAPELAYTL-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS---------SSNMN----  858 (912)
Q Consensus       794 ~~~~~~~-~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~---------~~~~~----  858 (912)
                      +...... ++..+-|..|+|||.+.|. .|+.++|+||.|||+.||++|++.|..-.++...         ..+..    
T Consensus       268 y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~  347 (560)
T KOG0600|consen  268 YTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS  347 (560)
T ss_pred             ccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence            8766543 7788899999999988764 6999999999999999999999998632221111         00000    


Q ss_pred             ----hhhccCCCCCCCh---hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          859 ----IEMLDSRLPYPSL---HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       859 ----~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                          .....+..++..-   .....+....+++..+|..||++|.||.++++
T Consensus       348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence                0111111122111   11223456788999999999999999998764

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-40  Score=348.08  Aligned_cols=260  Identities=20%  Similarity=0.319  Sum_probs=209.5

Q ss_pred             HHhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcC-CCccccEEEEEEcCC-
Q 039137          635 SATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR-HRNIVKFYGFCSHPK-  711 (912)
Q Consensus       635 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~-  711 (912)
                      ...++|++.++||.|+||.||+|+.+ +|+.||||++++.....   +.-.=+||+..++++. ||||+++.+++.+.+ 
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~---ee~~nLREvksL~kln~hpniikL~Evi~d~~~   83 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSW---EECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR   83 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccH---HHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc
Confidence            34678999999999999999999865 79999999998765432   3333469999999998 999999999998888 


Q ss_pred             eeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccc
Q 039137          712 HSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIA  791 (912)
Q Consensus       712 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla  791 (912)
                      ..|+|||||+. +|+++++.+  .+.+++.+++.|++||++||+|+|.+   |+.|||+||+|||+.....+||+|||+|
T Consensus        84 ~L~fVfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLA  157 (538)
T KOG0661|consen   84 ILYFVFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLA  157 (538)
T ss_pred             eEeeeHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccc
Confidence            99999999976 999999665  67899999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccccccccccc-ccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccc---------------cc
Q 039137          792 KFLNPDSSNWSELAGTHGYVAPELA-YTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS---------------SS  855 (912)
Q Consensus       792 ~~~~~~~~~~~~~~g~~~y~aPE~~-~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~---------------~~  855 (912)
                      +.+... ..++.++.|..|+|||++ ..+-|+.+.||||+|||++|+.+-++-|.+..+.+.-               ..
T Consensus       158 Rev~Sk-pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~e  236 (538)
T KOG0661|consen  158 REVRSK-PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPE  236 (538)
T ss_pred             cccccC-CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchh
Confidence            987543 557788999999999966 4667999999999999999999988877532221110               00


Q ss_pred             -cchhhhccCCCCCCC-----hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 039137          856 -NMNIEMLDSRLPYPS-----LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQL  904 (912)
Q Consensus       856 -~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  904 (912)
                       ......+.-++|...     ......+.+..++|.+|++.||.+||||+|+++.
T Consensus       237 g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  237 GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence             111112222222111     1122355678899999999999999999988764

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-39  Score=319.86  Aligned_cols=239  Identities=26%  Similarity=0.378  Sum_probs=209.1

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ++|++.+.||.|+||.|..++.+ +|..||+|++.+...-..+ +.+....|..+++.+.||.++++++.+.+.+..|+|
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklK-QveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLK-QVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHH-HHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            57899999999999999999977 7889999998765443333 556788999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||.+||-|..++   +..+++++..++-+|.||+.|++|||+.   +|++||+||+|||+|.+|.+||+|||.|+.+..
T Consensus       123 meyv~GGElFS~L---rk~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~  196 (355)
T KOG0616|consen  123 MEYVPGGELFSYL---RKSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG  196 (355)
T ss_pred             EeccCCccHHHHH---HhcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence            9999999999999   4456799999999999999999999999   999999999999999999999999999998753


Q ss_pred             CCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHH
Q 039137          797 DSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKK  876 (912)
Q Consensus       797 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  876 (912)
                      .   .-+.+|||.|+|||.+....+..++|-|||||++|||+.|.+||...     ........++..+..+|+..    
T Consensus       197 r---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~-----~~~~iY~KI~~~~v~fP~~f----  264 (355)
T KOG0616|consen  197 R---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDD-----NPIQIYEKILEGKVKFPSYF----  264 (355)
T ss_pred             c---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCC-----ChHHHHHHHHhCcccCCccc----
Confidence            3   55789999999999999999999999999999999999999998522     22445566777777777543    


Q ss_pred             HHHHHHHHHHcccCCCCCC
Q 039137          877 LMSIMQVAFSCLDQNPESR  895 (912)
Q Consensus       877 ~~~l~~li~~cl~~dP~~R  895 (912)
                      +.++.+++.+.++.|-.+|
T Consensus       265 s~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  265 SSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             CHHHHHHHHHHHhhhhHhh
Confidence            3457788999999999888

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-40  Score=343.23  Aligned_cols=250  Identities=28%  Similarity=0.440  Sum_probs=214.5

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      ...|+..+.||+|.||.||+|.+. +++.||+|++.......   ..+.+.+|+.++..++++||.++||.+..+...|+
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~d---eIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwi   88 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAED---EIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWI   88 (467)
T ss_pred             ccccccchhccccccceeeeeeeccccceEEEEEechhhcch---hhHHHHHHHHHHHhcCcchHHhhhhheeecccHHH
Confidence            346788899999999999999864 78999999997654433   56778899999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      +||||.||++.+.+   +....+++..+.-|++++..|+.|+|++   +.+|||||+.||++..+|.+|++|||.+..+.
T Consensus        89 iMey~~gGsv~~lL---~~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~  162 (467)
T KOG0201|consen   89 IMEYCGGGSVLDLL---KSGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLT  162 (467)
T ss_pred             HHHHhcCcchhhhh---ccCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeee
Confidence            99999999999999   3334458888999999999999999999   99999999999999999999999999999887


Q ss_pred             CCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHH
Q 039137          796 PDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQK  875 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  875 (912)
                      .......+++|||.|||||++.+..|+.|+||||||++.+||.+|.+|+....++       ..-+.-++-.+|.... .
T Consensus       163 ~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm-------rvlflIpk~~PP~L~~-~  234 (467)
T KOG0201|consen  163 NTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM-------RVLFLIPKSAPPRLDG-D  234 (467)
T ss_pred             chhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc-------eEEEeccCCCCCcccc-c
Confidence            7766668899999999999999989999999999999999999999997533332       2222223333343333 6


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          876 KLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       876 ~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .++.+.+++..|+++||+.||+|.++++
T Consensus       235 ~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  235 FSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             cCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            6778999999999999999999999875

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=1.6e-42  Score=352.75  Aligned_cols=428  Identities=31%  Similarity=0.431  Sum_probs=363.1

Q ss_pred             CCccEEEccCCcccccCCccccCCCCCcEEeccccccccccccccccccccceeecccccccCCCCccccCcccccEEEc
Q 039137          109 PHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLAL  188 (912)
Q Consensus       109 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l  188 (912)
                      ..++.|.+++|.++ .+.+.+.+|..|.+|++++|+++ +.|.+++.+..++.|+.++|.++ .+|++++++.+|..|++
T Consensus        45 v~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~  121 (565)
T KOG0472|consen   45 VDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDC  121 (565)
T ss_pred             cchhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhc
Confidence            45678999999998 56678999999999999999997 89999999999999999999999 99999999999999999


Q ss_pred             cCCcCCCCCCccCCCCccceeeeeccCCCcCccccccccccccceeecccccccCccccccccccccceeeeccccCccc
Q 039137          189 DSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGI  268 (912)
Q Consensus       189 ~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  268 (912)
                      ++|.+. .+|++++.+..|..|+..+|+++ ..|..++++.+|..|++.+|++....|..+ +|+.|++||+.+|.++ .
T Consensus       122 s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i-~m~~L~~ld~~~N~L~-t  197 (565)
T KOG0472|consen  122 SSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHI-AMKRLKHLDCNSNLLE-T  197 (565)
T ss_pred             ccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHH-HHHHHHhcccchhhhh-c
Confidence            999998 88999999999999999999998 789999999999999999999995555444 5999999999999998 6


Q ss_pred             CCcccCCccccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCcccccccCCCC
Q 039137          269 IPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRC  348 (912)
Q Consensus       269 ~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  348 (912)
                      +|+.++.+.+|+.|+|.+|++. ..| +|..+..|++|+++.|+|...+.+...+++++..|||..|++. +.|..+..+
T Consensus       198 lP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clL  274 (565)
T KOG0472|consen  198 LPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLL  274 (565)
T ss_pred             CChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHh
Confidence            8999999999999999999998 666 8999999999999999999777777789999999999999997 678888899


Q ss_pred             CCCCEEeccCCcccccccccccccccccEEEccCccccC-------------------------------------C-CC
Q 039137          349 PQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVG-------------------------------------E-IP  390 (912)
Q Consensus       349 ~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~-------------------------------------~-~~  390 (912)
                      .+|+.||+|+|.|+ ..|..++++ +|+.|-+.+|.+..                                     . .+
T Consensus       275 rsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~  352 (565)
T KOG0472|consen  275 RSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPS  352 (565)
T ss_pred             hhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCC
Confidence            99999999999999 678889999 99999999998731                                     0 01


Q ss_pred             c---cccccccccEEEccCCcccCCCccccccccc---cc------------------------cccccCcccCcccccc
Q 039137          391 T---QLGNIIYLNRLSLSGNKLSGCIPRELGSLIN---LE------------------------YLDLSANNLSNFVPES  440 (912)
Q Consensus       391 ~---~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~---L~------------------------~L~Ls~N~l~~~~~~~  440 (912)
                      .   ....+.+.+.|++++-+++ .+|+....-..   ..                        .+.+++|.++ .+|..
T Consensus       353 ~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~elPk~L~~lkelvT~l~lsnn~is-fv~~~  430 (565)
T KOG0472|consen  353 ESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLCELPKRLVELKELVTDLVLSNNKIS-FVPLE  430 (565)
T ss_pred             Ccccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHhhhhhhhHHHHHHHHHHHhhcCccc-cchHH
Confidence            1   1122346788999999988 44533221111   22                        3444444443 46777


Q ss_pred             ccccccccEEEecccccccccchhhhcccccceeeccccccCcccccccccccccccccccCccccCCCcccccccccce
Q 039137          441 LGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLL  520 (912)
Q Consensus       441 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~  520 (912)
                      +..+++|..|+|++|.+. .+|..++.+..|++||+|+|+|. .+|..+-.+..|+.+-.++|++....|..+.++.+|.
T Consensus       431 l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~  508 (565)
T KOG0472|consen  431 LSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLT  508 (565)
T ss_pred             HHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcc
Confidence            888899999999999996 78999999999999999999984 5777777778888888888999988888899999999


Q ss_pred             EEEccCCccccCCCCCccCCCCchhhhccCCc
Q 039137          521 HIDISYNKLEGQIPNSTTFRDAPLEALQGNKG  552 (912)
Q Consensus       521 ~l~ls~N~l~~~~~~~~~~~~~~~~~l~~n~~  552 (912)
                      +||+.+|.++..+|......+.....+.|||.
T Consensus       509 tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpf  540 (565)
T KOG0472|consen  509 TLDLQNNDLQQIPPILGNMTNLRHLELDGNPF  540 (565)
T ss_pred             eeccCCCchhhCChhhccccceeEEEecCCcc
Confidence            99999999998777665665555555666654

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=8.8e-39  Score=353.92  Aligned_cols=263  Identities=23%  Similarity=0.403  Sum_probs=206.2

Q ss_pred             HhcCCCCCceeeecCceEEEEEEe------CCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEE
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKV------PSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCS  708 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~  708 (912)
                      ..++|++.+.||+|+||.||+|.+      .+++.||+|++.....   ....+.+.+|+.+++.+ +||||+++++++.
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~   81 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT---ASEHKALMSELKILIHIGNHLNVVNLLGACT   81 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccc---hHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence            346899999999999999999974      2456899999864322   12456788999999999 8999999999987


Q ss_pred             cCC-eeeEEEeecCCCChhhHhhccCC-----------------------------------------------------
Q 039137          709 HPK-HSFIIYEYLESGSLDKILCNDAS-----------------------------------------------------  734 (912)
Q Consensus       709 ~~~-~~~lv~e~~~~g~L~~~l~~~~~-----------------------------------------------------  734 (912)
                      .++ ..++||||+++|+|.+++.....                                                     
T Consensus        82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (338)
T cd05102          82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ  161 (338)
T ss_pred             CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence            654 57899999999999999854321                                                     


Q ss_pred             ------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCC--Ccccccc
Q 039137          735 ------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSS--NWSELAG  806 (912)
Q Consensus       735 ------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~--~~~~~~g  806 (912)
                            ...+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.......  ......+
T Consensus       162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~  238 (338)
T cd05102         162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL  238 (338)
T ss_pred             hccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCC
Confidence                  23478889999999999999999999   999999999999999999999999999986543221  1123345


Q ss_pred             ccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccCCCCCCChhhHHHHHHHHHHHH
Q 039137          807 THGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAF  885 (912)
Q Consensus       807 ~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  885 (912)
                      ++.|+|||++.+..++.++|||||||++|||++ |..||.....    .........+......   ....+..+.+++.
T Consensus       239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~----~~~~~~~~~~~~~~~~---~~~~~~~l~~li~  311 (338)
T cd05102         239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI----NEEFCQRLKDGTRMRA---PENATPEIYRIML  311 (338)
T ss_pred             CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCc----cHHHHHHHhcCCCCCC---CCCCCHHHHHHHH
Confidence            678999999998899999999999999999997 9999853211    0011111111111111   1223456889999


Q ss_pred             HcccCCCCCCCCHHHHHHHHHHhhhc
Q 039137          886 SCLDQNPESRPTMKRVSQLLCEKIFE  911 (912)
Q Consensus       886 ~cl~~dP~~RPt~~evl~~L~~~l~~  911 (912)
                      +||+.||++|||+.|+++.|++.+.+
T Consensus       312 ~cl~~dp~~RPs~~el~~~l~~~~~~  337 (338)
T cd05102         312 ACWQGDPKERPTFSALVEILGDLLQE  337 (338)
T ss_pred             HHccCChhhCcCHHHHHHHHHHHHhc
Confidence            99999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2e-39  Score=311.23  Aligned_cols=264  Identities=23%  Similarity=0.369  Sum_probs=215.5

Q ss_pred             HhcCCCCCceeeecCceEEEEEE-eCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC----
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP----  710 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~----  710 (912)
                      ..++|++.+.+|+|+|+-||.++ ..+++.||+|++.-...    ...+..++|++..++++||||++++++...+    
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~----~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~   94 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQ----EDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG   94 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccch----HHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence            34689999999999999999998 44889999999976542    2577889999999999999999999886433    


Q ss_pred             -CeeeEEEeecCCCChhhHhhccCCcc-cCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecc
Q 039137          711 -KHSFIIYEYLESGSLDKILCNDASAK-ELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDF  788 (912)
Q Consensus       711 -~~~~lv~e~~~~g~L~~~l~~~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df  788 (912)
                       ...|++++|...|+|.+.+.+.+..+ .+++.++++|+.++++||++||+.. |+++||||||.||++.+++.+++.||
T Consensus        95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~  173 (302)
T KOG2345|consen   95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDL  173 (302)
T ss_pred             ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEec
Confidence             35899999999999999997655444 7999999999999999999999983 36999999999999999999999999


Q ss_pred             ccccccCCCCC---------Cccccccccccccccccc---cCCCCcchhHHHHHHHHHHHHhCCCCccchhcccccccc
Q 039137          789 GIAKFLNPDSS---------NWSELAGTHGYVAPELAY---TLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSN  856 (912)
Q Consensus       789 gla~~~~~~~~---------~~~~~~g~~~y~aPE~~~---~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~  856 (912)
                      |.++...-.-.         .+.....|..|+|||.+.   +...++++|||||||++|+|+.|..||+...+..   ..
T Consensus       174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G---gS  250 (302)
T KOG2345|consen  174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG---GS  250 (302)
T ss_pred             cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC---Ce
Confidence            99986542211         123456799999999875   3456889999999999999999999998665522   23


Q ss_pred             chhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 039137          857 MNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI  909 (912)
Q Consensus       857 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l  909 (912)
                      ....+....+.+|...  .+++.+.++|..|++.||.+||++.+++..+...+
T Consensus       251 laLAv~n~q~s~P~~~--~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  251 LALAVQNAQISIPNSS--RYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             EEEeeeccccccCCCC--CccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence            3334444444444332  26788999999999999999999999999887653

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-39  Score=335.06  Aligned_cols=256  Identities=25%  Similarity=0.366  Sum_probs=203.9

Q ss_pred             HHhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCC------ch----HHHHHHHHHHHHHhhcCCCccccE
Q 039137          635 SATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGE------MS----FQQEEFLNEIQALTEIRHRNIVKF  703 (912)
Q Consensus       635 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~------~~----~~~~~~~~Ei~~l~~l~h~niv~l  703 (912)
                      ..-++|++.+.||+|.||.|-+|+.. +++.||||++.+.....      ..    ...+...+||.+|++++|||||++
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            34588999999999999999999865 79999999986532210      00    112578899999999999999999


Q ss_pred             EEEEEcC--CeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCC
Q 039137          704 YGFCSHP--KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGY  781 (912)
Q Consensus       704 ~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~  781 (912)
                      +.+..++  +..|||+|||..|.+...-   .....+++.++++++++++.||+|||.+   +|+||||||+|+|++++|
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g  247 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDG  247 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCC
Confidence            9999776  5789999999988875543   2233399999999999999999999999   999999999999999999


Q ss_pred             cEEEeccccccccCCC-----CCCccccccccccccccccccCC----CCcchhHHHHHHHHHHHHhCCCCccchhcccc
Q 039137          782 EAHVSDFGIAKFLNPD-----SSNWSELAGTHGYVAPELAYTLK----VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS  852 (912)
Q Consensus       782 ~~kl~Dfgla~~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~----~~~~sDvwslG~vl~elltg~~pf~~~~~~~~  852 (912)
                      +|||+|||.+......     .......+|||.|+|||...++.    .+.+.||||+||+||.|+.|+.||-..+.   
T Consensus       248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~---  324 (576)
T KOG0585|consen  248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE---  324 (576)
T ss_pred             cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH---
Confidence            9999999999866322     12234578999999999887733    35688999999999999999999853222   


Q ss_pred             ccccchhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          853 SSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       853 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                        ......++...+.+|..  ....+.+.++|.+++.+||++|.+..+|..
T Consensus       325 --~~l~~KIvn~pL~fP~~--pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~  371 (576)
T KOG0585|consen  325 --LELFDKIVNDPLEFPEN--PEINEDLKDLIKRLLEKDPEQRITLPDIKL  371 (576)
T ss_pred             --HHHHHHHhcCcccCCCc--ccccHHHHHHHHHHhhcChhheeehhhhee
Confidence              22233344444444432  245567889999999999999999998864

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3e-39  Score=328.37  Aligned_cols=250  Identities=22%  Similarity=0.354  Sum_probs=211.5

Q ss_pred             hcCCCCCceeeecCceEEEEEEe-CCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKV-PSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      ..+|++.+.||+|+||.|-+|.. ..|+.||||.++++...+ +...-.+.+|+++|..|+||||+.++.+|+..+..++
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkd-eqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi  130 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKD-EQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI  130 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhccc-HHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence            45788899999999999999975 689999999998776543 2355678899999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ||||..+|.|+||+.   ..+.+++.+++++++||+.|+.|+|.+   ++||||||.+|||+|+++++||+|||++..+.
T Consensus       131 vMEYaS~GeLYDYiS---er~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~  204 (668)
T KOG0611|consen  131 VMEYASGGELYDYIS---ERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYA  204 (668)
T ss_pred             EEEecCCccHHHHHH---HhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhc
Confidence            999999999999994   446799999999999999999999999   99999999999999999999999999998775


Q ss_pred             CCCCCccccccccccccccccccCCC-CcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhH
Q 039137          796 PDSSNWSELAGTHGYVAPELAYTLKV-TEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQ  874 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  874 (912)
                      .. .-..+++|+|-|.+||.+.|.+| .+.+|.||+||++|.++.|..|||....     .....++..+.+..|.    
T Consensus       205 ~~-kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh-----k~lvrQIs~GaYrEP~----  274 (668)
T KOG0611|consen  205 DK-KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH-----KRLVRQISRGAYREPE----  274 (668)
T ss_pred             cc-cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH-----HHHHHHhhcccccCCC----
Confidence            43 45678899999999999999998 5799999999999999999999983211     1222233333332221    


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 039137          875 KKLMSIMQVAFSCLDQNPESRPTMKRVSQL  904 (912)
Q Consensus       875 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~  904 (912)
                       .+....-+|++|+-.+|++|.|+.+|...
T Consensus       275 -~PSdA~gLIRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  275 -TPSDASGLIRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             -CCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence             12335678999999999999999998754

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-38  Score=370.07  Aligned_cols=258  Identities=27%  Similarity=0.404  Sum_probs=209.7

Q ss_pred             cCCCCCceeeecCceEEEEEEeC--CCC----EEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCC
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP--SGE----IFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPK  711 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~  711 (912)
                      ...+..+.||+|+||.||.|...  ++.    .||||.+.+..   ...+..+|++|..+|+.++|||||+++|++-+..
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~---~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~  768 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS---SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG  768 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC---CHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence            45567789999999999999864  343    48999887543   2336789999999999999999999999999999


Q ss_pred             eeeEEEeecCCCChhhHhhccCC----cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEec
Q 039137          712 HSFIIYEYLESGSLDKILCNDAS----AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSD  787 (912)
Q Consensus       712 ~~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  787 (912)
                      ..++++|||++|+|..++++.+.    ...++..+.+.++.+||+|+.||+++   ++|||||.++|+|+++...|||+|
T Consensus       769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaD  845 (1025)
T KOG1095|consen  769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIAD  845 (1025)
T ss_pred             CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcc
Confidence            99999999999999999966422    44689999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCCCc-ccc-ccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccC
Q 039137          788 FGIAKFLNPDSSNW-SEL-AGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDS  864 (912)
Q Consensus       788 fgla~~~~~~~~~~-~~~-~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  864 (912)
                      ||+|+.+-..+... ... .-...|||||.+.++.++.|+|||||||++||++| |..||...    +..+.+..-....
T Consensus       846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~----~n~~v~~~~~~gg  921 (1025)
T KOG1095|consen  846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSR----SNFEVLLDVLEGG  921 (1025)
T ss_pred             cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCc----chHHHHHHHHhCC
Confidence            99999554332222 222 33468999999999999999999999999999999 99997511    1111122233344


Q ss_pred             CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 039137          865 RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI  909 (912)
Q Consensus       865 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l  909 (912)
                      +++.|.    .++..+.+++..||+.+|++||++..+++.+...+
T Consensus       922 RL~~P~----~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~  962 (1025)
T KOG1095|consen  922 RLDPPS----YCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS  962 (1025)
T ss_pred             ccCCCC----CCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence            555553    34556889999999999999999999999877654

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-39  Score=341.94  Aligned_cols=240  Identities=28%  Similarity=0.474  Sum_probs=199.2

Q ss_pred             CCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEEeecC
Q 039137          642 AEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLE  721 (912)
Q Consensus       642 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  721 (912)
                      ..+.||.|+-|.||.|+. .++.||||+++.-         +  ..+|.-+++|+||||+.|.|+|.....++||||||.
T Consensus       128 ELeWlGSGaQGAVF~Grl-~netVAVKKV~el---------k--ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa  195 (904)
T KOG4721|consen  128 ELEWLGSGAQGAVFLGRL-HNETVAVKKVREL---------K--ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCA  195 (904)
T ss_pred             hhhhhccCcccceeeeec-cCceehhHHHhhh---------h--hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccc
Confidence            457899999999999998 6788999997521         1  257889999999999999999999999999999999


Q ss_pred             CCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCCCc
Q 039137          722 SGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNW  801 (912)
Q Consensus       722 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  801 (912)
                      .|.|..++   +....++......|..+||.|+.|||.+   .|||||||.-|||+..+..|||+|||-++..... ...
T Consensus       196 ~GqL~~VL---ka~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-STk  268 (904)
T KOG4721|consen  196 QGQLYEVL---KAGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-STK  268 (904)
T ss_pred             cccHHHHH---hccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh-hhh
Confidence            99999999   4456788899999999999999999999   9999999999999999999999999999876554 444


Q ss_pred             cccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHHHHHH
Q 039137          802 SELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIM  881 (912)
Q Consensus       802 ~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  881 (912)
                      -.+.||..|||||++...+.++|+||||||||||||+||..||.......-   .....--.-.++.|    ..++..+.
T Consensus       269 MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI---IwGVGsNsL~LpvP----stcP~Gfk  341 (904)
T KOG4721|consen  269 MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI---IWGVGSNSLHLPVP----STCPDGFK  341 (904)
T ss_pred             hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee---EEeccCCcccccCc----ccCchHHH
Confidence            567899999999999999999999999999999999999999752211100   00000000112333    23455688


Q ss_pred             HHHHHcccCCCCCCCCHHHHHHHHHH
Q 039137          882 QVAFSCLDQNPESRPTMKRVSQLLCE  907 (912)
Q Consensus       882 ~li~~cl~~dP~~RPt~~evl~~L~~  907 (912)
                      -+++.||+..|..||++++++..|.-
T Consensus       342 lL~Kqcw~sKpRNRPSFrqil~HldI  367 (904)
T KOG4721|consen  342 LLLKQCWNSKPRNRPSFRQILLHLDI  367 (904)
T ss_pred             HHHHHHHhcCCCCCccHHHHHHHHhh
Confidence            89999999999999999999988753

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=6.6e-39  Score=340.51  Aligned_cols=247  Identities=26%  Similarity=0.340  Sum_probs=203.1

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeee
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSF  714 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  714 (912)
                      ..++|++..+||+|+||.||.|+-+ +|+.||+|++++..-.. ..+.+.++.|=.+|....+|.||+++-.|.+.+..|
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~-~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY  217 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLK-KNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY  217 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHh-hhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence            3578999999999999999999865 79999999998654332 225678889999999999999999999999999999


Q ss_pred             EEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccccccc
Q 039137          715 IIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL  794 (912)
Q Consensus       715 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  794 (912)
                      +||||++||++..++.+   .+.+++..++.++.+++-|++.+|+.   |++||||||+|+|+|..|++||+|||++.-+
T Consensus       218 LiMEylPGGD~mTLL~~---~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl  291 (550)
T KOG0605|consen  218 LIMEYLPGGDMMTLLMR---KDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL  291 (550)
T ss_pred             EEEEecCCccHHHHHHh---cCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchh
Confidence            99999999999999943   45799999999999999999999999   9999999999999999999999999998532


Q ss_pred             CC-----------------------CCC----C--------------------ccccccccccccccccccCCCCcchhH
Q 039137          795 NP-----------------------DSS----N--------------------WSELAGTHGYVAPELAYTLKVTEKCDV  827 (912)
Q Consensus       795 ~~-----------------------~~~----~--------------------~~~~~g~~~y~aPE~~~~~~~~~~sDv  827 (912)
                      ..                       +..    .                    ....+|||.|||||++.+..|+..+|.
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw  371 (550)
T KOG0605|consen  292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW  371 (550)
T ss_pred             hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence            11                       000    0                    012479999999999999999999999


Q ss_pred             HHHHHHHHHHHhCCCCccchhccccccccchhhhccCC--CCCCChhhHHHHHHHHHHHHHcccCCCCCCCC
Q 039137          828 YSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSR--LPYPSLHVQKKLMSIMQVAFSCLDQNPESRPT  897 (912)
Q Consensus       828 wslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt  897 (912)
                      ||+|||+|||+.|.+||.....     ......++..+  +.+|..  ...+.+..++|.+|+. ||++|.-
T Consensus       372 WSLG~ImyEmLvGyPPF~s~tp-----~~T~rkI~nwr~~l~fP~~--~~~s~eA~DLI~rll~-d~~~RLG  435 (550)
T KOG0605|consen  372 WSLGCIMYEMLVGYPPFCSETP-----QETYRKIVNWRETLKFPEE--VDLSDEAKDLITRLLC-DPENRLG  435 (550)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhhhccCCCc--CcccHHHHHHHHHHhc-CHHHhcC
Confidence            9999999999999999962222     22223333333  333332  3334678899999999 9999975

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8e-39  Score=345.79  Aligned_cols=249  Identities=24%  Similarity=0.381  Sum_probs=212.7

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      .-|++++.||+|+.|.|-.|++. +|+.+|||++.+..... ......+.+|+-+|+.+.||||++++++|+...+.|+|
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s-~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv   90 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELS-SSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV   90 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccc-cccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence            45889999999999999999875 89999999997653222 22456688999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      .||+++|-|.+++.   ..+++++.++.++++||+.|+.|+|..   +|+|||+||+|+|+|..+++||+|||+|..- .
T Consensus        91 lEyv~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe-~  163 (786)
T KOG0588|consen   91 LEYVPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLE-V  163 (786)
T ss_pred             EEecCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecc-c
Confidence            99999999999994   456799999999999999999999999   9999999999999999999999999999754 3


Q ss_pred             CCCCccccccccccccccccccCCC-CcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHH
Q 039137          797 DSSNWSELAGTHGYVAPELAYTLKV-TEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQK  875 (912)
Q Consensus       797 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  875 (912)
                      ++.-..+.+|+|.|.|||++.|.+| ..++||||-|||+|.|+||+.|||.     .........+..+.+..|    ..
T Consensus       164 ~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-----dNir~LLlKV~~G~f~MP----s~  234 (786)
T KOG0588|consen  164 PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-----DNIRVLLLKVQRGVFEMP----SN  234 (786)
T ss_pred             CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-----ccHHHHHHHHHcCcccCC----Cc
Confidence            4456678899999999999999998 5689999999999999999999971     111223334444555555    33


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          876 KLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       876 ~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .+.+..+++.+|+..||++|.|++||.+
T Consensus       235 Is~eaQdLLr~ml~VDp~~RiT~~eI~k  262 (786)
T KOG0588|consen  235 ISSEAQDLLRRMLDVDPSTRITTEEILK  262 (786)
T ss_pred             CCHHHHHHHHHHhccCccccccHHHHhh
Confidence            4566889999999999999999999876

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-38  Score=347.33  Aligned_cols=246  Identities=24%  Similarity=0.364  Sum_probs=211.5

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEEcCCee
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSHPKHS  713 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~  713 (912)
                      ..++|.+.++||+|+||+|++|..+ +++.||||++++...-... ..+..+.|..++... +||.+++++..|.+.++.
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d-~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l  444 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRD-EVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL  444 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccc-cHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence            3467999999999999999999987 7889999999887654433 567788899888888 599999999999999999


Q ss_pred             eEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccc
Q 039137          714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKF  793 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  793 (912)
                      |.||||+.||++..+.    ..+.+++..+.-++..|+.||+|||++   +|||||||.+|||+|.+|.+||+|||+++.
T Consensus       445 ~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe  517 (694)
T KOG0694|consen  445 FFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKE  517 (694)
T ss_pred             EEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccc
Confidence            9999999999955444    346799999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhh
Q 039137          794 LNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHV  873 (912)
Q Consensus       794 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  873 (912)
                      .-..+....+++|||.|||||++.+..|+.++|.|||||+||||+.|+.||..     ..+++....++.....+|..  
T Consensus       518 ~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~g-----ddEee~FdsI~~d~~~yP~~--  590 (694)
T KOG0694|consen  518 GMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPG-----DDEEEVFDSIVNDEVRYPRF--  590 (694)
T ss_pred             cCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCC-----CCHHHHHHHHhcCCCCCCCc--
Confidence            65455667889999999999999999999999999999999999999999862     22334445555666666643  


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCH
Q 039137          874 QKKLMSIMQVAFSCLDQNPESRPTM  898 (912)
Q Consensus       874 ~~~~~~l~~li~~cl~~dP~~RPt~  898 (912)
                        .+.+...++.+++.++|++|.-+
T Consensus       591 --ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  591 --LSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             --ccHHHHHHHHHHhccCcccccCC
Confidence              44567788999999999999865

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.2e-39  Score=308.70  Aligned_cols=252  Identities=28%  Similarity=0.408  Sum_probs=214.1

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      -++|++++.||+|-||.||.|+.+ ++-.||+|++.+..... .....++.+|+++-..|+||||++++++|.+....|+
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~-~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL   99 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILK-TQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL   99 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHH-hcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence            468999999999999999999876 77889999986554222 2245678999999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ++||.+.|.+...+... ...++++..+..++.|+|.|+.|+|.+   +|+||||||+|+|++..+.+|++|||.+....
T Consensus       100 ilEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p  175 (281)
T KOG0580|consen  100 ILEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP  175 (281)
T ss_pred             EEEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence            99999999999999543 345689999999999999999999999   99999999999999999999999999997654


Q ss_pred             CCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHH
Q 039137          796 PDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQK  875 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  875 (912)
                        .......+||..|.|||...+..++..+|+|++|++.||++.|.+||....     ..+....+...++.+|    ..
T Consensus       176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-----~~etYkrI~k~~~~~p----~~  244 (281)
T KOG0580|consen  176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-----HSETYKRIRKVDLKFP----ST  244 (281)
T ss_pred             --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-----hHHHHHHHHHccccCC----cc
Confidence              455677899999999999999999999999999999999999999986221     2223333333444444    23


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 039137          876 KLMSIMQVAFSCLDQNPESRPTMKRVSQL  904 (912)
Q Consensus       876 ~~~~l~~li~~cl~~dP~~RPt~~evl~~  904 (912)
                      .+....++|.+|+.++|.+|.+..|+++.
T Consensus       245 is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  245 ISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             cChhHHHHHHHHhccCccccccHHHHhhh
Confidence            45567899999999999999999998864

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-38  Score=348.31  Aligned_cols=261  Identities=28%  Similarity=0.417  Sum_probs=208.4

Q ss_pred             HHhcCCCCCceeeecCceEEEEEEeCC--C---CEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEc
Q 039137          635 SATNDFNAEHCIGKGGHGSVYRAKVPS--G---EIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSH  709 (912)
Q Consensus       635 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~--~---~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~  709 (912)
                      -..++..+.++||+|+||.||+|+++.  +   ..||||..+... .....+..+|.+|+++|+.++|||||+++|++..
T Consensus       154 l~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~-~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~  232 (474)
T KOG0194|consen  154 LSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSS-ELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL  232 (474)
T ss_pred             EeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccc-cccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC
Confidence            344566677999999999999998652  2   238999887422 1234478899999999999999999999999999


Q ss_pred             CCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccc
Q 039137          710 PKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFG  789 (912)
Q Consensus       710 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  789 (912)
                      ....++|||+|.||+|+++++...  ..++..+..+++.+.|.||+|||++   +++||||.++|+|++.++.+||+|||
T Consensus       233 ~~Pl~ivmEl~~gGsL~~~L~k~~--~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFG  307 (474)
T KOG0194|consen  233 EEPLMLVMELCNGGSLDDYLKKNK--KSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFG  307 (474)
T ss_pred             CCccEEEEEecCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccc
Confidence            999999999999999999995543  2689999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhc--cCCC
Q 039137          790 IAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEML--DSRL  866 (912)
Q Consensus       790 la~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~--~~~~  866 (912)
                      +++.............-+.+|+|||.+....|+.++|||||||++||+++ |..||......     .....+.  ..+.
T Consensus       308 Ls~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~-----~v~~kI~~~~~r~  382 (474)
T KOG0194|consen  308 LSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY-----EVKAKIVKNGYRM  382 (474)
T ss_pred             cccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH-----HHHHHHHhcCccC
Confidence            99754311111112234679999999999999999999999999999999 88897532211     1112221  2222


Q ss_pred             CCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          867 PYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       867 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                      +.+.    ..+..+..++.+||..||++||+|.++.+.++....
T Consensus       383 ~~~~----~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~  422 (474)
T KOG0194|consen  383 PIPS----KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEK  422 (474)
T ss_pred             CCCC----CCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHh
Confidence            2222    344567788889999999999999999999987653

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.9e-39  Score=343.13  Aligned_cols=253  Identities=25%  Similarity=0.395  Sum_probs=217.2

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCe-ee
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKH-SF  714 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-~~  714 (912)
                      .++|..++++|+|+||.++.++++ ++..|++|++........  .++...+|+.++++++|||||.+.+.|..++. .+
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~--~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~   80 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEP--ERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLC   80 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCch--hhHHHHHHHHHHHhccCCCeeeeccchhcCCceEE
Confidence            357899999999999999999876 788999999976554433  45578899999999999999999999999888 99


Q ss_pred             EEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccccccc
Q 039137          715 IIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL  794 (912)
Q Consensus       715 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  794 (912)
                      +||+||+||++.+.+.+.+ ...++++++..|+.|++.|+.|||+.   .|+|||||+.||+++.++.|||+|||+|+.+
T Consensus        81 Ivm~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l  156 (426)
T KOG0589|consen   81 IVMEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKIL  156 (426)
T ss_pred             EEEeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhc
Confidence            9999999999999996644 56799999999999999999999998   9999999999999999999999999999999


Q ss_pred             CCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCC-CCCCChhh
Q 039137          795 NPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSR-LPYPSLHV  873 (912)
Q Consensus       795 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  873 (912)
                      .+........+|||.||+||.+.+.+|..|+|||||||++|||++-+++|...     ........+.... .|.+    
T Consensus       157 ~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~-----~m~~Li~ki~~~~~~Plp----  227 (426)
T KOG0589|consen  157 NPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS-----NMSELILKINRGLYSPLP----  227 (426)
T ss_pred             CCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc-----chHHHHHHHhhccCCCCC----
Confidence            88876778899999999999999999999999999999999999999998621     1111122222222 1222    


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 039137          874 QKKLMSIMQVAFSCLDQNPESRPTMKRVSQL  904 (912)
Q Consensus       874 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  904 (912)
                      ..++.++..+|..|+..+|+.||++.+++..
T Consensus       228 ~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  228 SMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             ccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            3456678899999999999999999999876

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.3e-38  Score=314.18  Aligned_cols=258  Identities=25%  Similarity=0.284  Sum_probs=204.7

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEc--CCeee
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSH--PKHSF  714 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~~  714 (912)
                      ++|+..+.|++|+||.||+|+++ +++.||+|+++.......  -.-.-+|||.++.+.+|||||.+..+...  -+.+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~G--FPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy  153 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEG--FPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY  153 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCC--CcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence            56888999999999999999986 789999999986543221  23456799999999999999999998754  46799


Q ss_pred             EEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccccccc
Q 039137          715 IIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL  794 (912)
Q Consensus       715 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  794 (912)
                      +|||||++ +|..++....  +++...++.-+..|+++|++|||..   .|+|||||++|+|+...|.+||+|||+|+.+
T Consensus       154 ~VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y  227 (419)
T KOG0663|consen  154 IVMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREY  227 (419)
T ss_pred             eeHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhh
Confidence            99999998 9999995543  6799999999999999999999999   9999999999999999999999999999999


Q ss_pred             CCCCCCccccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCccchhcccccc------ccchhh-------
Q 039137          795 NPDSSNWSELAGTHGYVAPELAYTL-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS------SNMNIE-------  860 (912)
Q Consensus       795 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~------~~~~~~-------  860 (912)
                      +.....++..+-|..|+|||.+.+. .|+++.|+||+|||+.||+++++-|..-.+.....      ......       
T Consensus       228 gsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~  307 (419)
T KOG0663|consen  228 GSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE  307 (419)
T ss_pred             cCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence            8887778888999999999988765 58999999999999999999998875321111100      000000       


Q ss_pred             ------hccCCCCCCChh----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          861 ------MLDSRLPYPSLH----VQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       861 ------~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                            +.....++....    ....+..-.+++..++..||++|.||+|.++
T Consensus       308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence                  000111111000    0012355678999999999999999998764

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-38  Score=339.54  Aligned_cols=247  Identities=25%  Similarity=0.326  Sum_probs=202.2

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ++|++.+.||+|+||.||+|+.+ +++.||+|++....... ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   79 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIR-LKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYML   79 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhh-hHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEE
Confidence            47899999999999999999876 78999999986432111 11356688999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++|+|.+++..   .+.+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++.....
T Consensus        80 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  153 (291)
T cd05612          80 MEYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD  153 (291)
T ss_pred             EeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence            999999999999844   34688999999999999999999999   999999999999999999999999999986543


Q ss_pred             CCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHH
Q 039137          797 DSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKK  876 (912)
Q Consensus       797 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  876 (912)
                      .   .....|++.|+|||++.+..++.++|||||||++|||++|+.||.....     ......+.......+.    ..
T Consensus       154 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~-----~~~~~~i~~~~~~~~~----~~  221 (291)
T cd05612         154 R---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP-----FGIYEKILAGKLEFPR----HL  221 (291)
T ss_pred             C---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCcCCCc----cC
Confidence            2   2345689999999999998899999999999999999999999852211     1112222223333332    12


Q ss_pred             HHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 039137          877 LMSIMQVAFSCLDQNPESRPT-----MKRVSQ  903 (912)
Q Consensus       877 ~~~l~~li~~cl~~dP~~RPt-----~~evl~  903 (912)
                      +..+.+++.+||+.||.+||+     ++|+++
T Consensus       222 ~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         222 DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             CHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence            456789999999999999995     777664

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=4.2e-38  Score=345.61  Aligned_cols=244  Identities=21%  Similarity=0.281  Sum_probs=198.5

Q ss_pred             ceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEEeecCC
Q 039137          644 HCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLES  722 (912)
Q Consensus       644 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  722 (912)
                      +.||+|+||.||+|+.+ +|+.||+|++....... ......+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~   79 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIA-KDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999875 78999999986532211 12345678999999999999999999999999999999999999


Q ss_pred             CChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCCCcc
Q 039137          723 GSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWS  802 (912)
Q Consensus       723 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  802 (912)
                      |+|.+++..   .+.+++.++..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        80 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  153 (323)
T cd05571          80 GELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMK  153 (323)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCccc
Confidence            999999843   34689999999999999999999999   999999999999999999999999999976433333445


Q ss_pred             ccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHHHHHHH
Q 039137          803 ELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQ  882 (912)
Q Consensus       803 ~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  882 (912)
                      ...|++.|+|||++.+..++.++||||+||++|||++|+.||....     ..............++.    ..+..+.+
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~-----~~~~~~~~~~~~~~~p~----~~~~~~~~  224 (323)
T cd05571         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HEKLFELILMEEIRFPR----TLSPEAKS  224 (323)
T ss_pred             ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC-----HHHHHHHHHcCCCCCCC----CCCHHHHH
Confidence            5679999999999999999999999999999999999999985211     11111112222222222    23456889


Q ss_pred             HHHHcccCCCCCCC-----CHHHHHH
Q 039137          883 VAFSCLDQNPESRP-----TMKRVSQ  903 (912)
Q Consensus       883 li~~cl~~dP~~RP-----t~~evl~  903 (912)
                      ++.+||+.||++||     ++.++++
T Consensus       225 li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         225 LLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             HHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            99999999999999     7888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1e-37  Score=336.49  Aligned_cols=253  Identities=24%  Similarity=0.302  Sum_probs=200.4

Q ss_pred             CCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEEe
Q 039137          640 FNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYE  718 (912)
Q Consensus       640 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e  718 (912)
                      |+..+.||+|+||+||+|... +++.||+|++........ .....+.+|+++++.++|++|+++++++.+.+..++|||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~-~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR-KGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhh-hhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            677899999999999999864 799999999864432211 134567899999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCC
Q 039137          719 YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS  798 (912)
Q Consensus       719 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  798 (912)
                      |+++|+|.+++.... ...+++.++..++.|++.|++|||++   +|+||||||+||++++++.++|+|||++...... 
T Consensus        81 ~~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~-  155 (285)
T cd05631          81 IMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-  155 (285)
T ss_pred             ecCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-
Confidence            999999998874422 34588999999999999999999999   9999999999999999999999999999865432 


Q ss_pred             CCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHHH
Q 039137          799 SNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLM  878 (912)
Q Consensus       799 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  878 (912)
                      .......|++.|+|||++.+..++.++||||+||++|||++|+.||........ ..............++    ...+.
T Consensus       156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~----~~~s~  230 (285)
T cd05631         156 ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK-REEVDRRVKEDQEEYS----EKFSE  230 (285)
T ss_pred             CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh-HHHHHHHhhcccccCC----ccCCH
Confidence            223445789999999999999999999999999999999999999863211000 0001111111111111    22345


Q ss_pred             HHHHHHHHcccCCCCCCCC-----HHHHHH
Q 039137          879 SIMQVAFSCLDQNPESRPT-----MKRVSQ  903 (912)
Q Consensus       879 ~l~~li~~cl~~dP~~RPt-----~~evl~  903 (912)
                      .+.+++.+||+.||++||+     ++++++
T Consensus       231 ~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         231 DAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             HHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            6889999999999999997     677664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.8e-37  Score=332.11  Aligned_cols=246  Identities=22%  Similarity=0.335  Sum_probs=199.1

Q ss_pred             ceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEc----CCeeeEEEee
Q 039137          644 HCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSH----PKHSFIIYEY  719 (912)
Q Consensus       644 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~  719 (912)
                      ..||+|++|.||+|++ +|+.||||++....... ....+.+.+|+.++++++||||++++|++.+    ....++||||
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGH-KVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEecccccccc-HHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            6799999999999998 78999999987653322 2234678899999999999999999999876    3467899999


Q ss_pred             cCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCC
Q 039137          720 LESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSS  799 (912)
Q Consensus       720 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  799 (912)
                      +++|+|.+++..   .+.+++.++.+++.+++.|++|||+..  +++||||||+||++++++.+|++|||+++...... 
T Consensus       104 ~~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-  177 (283)
T PHA02988        104 CTRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-  177 (283)
T ss_pred             CCCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence            999999999954   346889999999999999999999832  78899999999999999999999999998654321 


Q ss_pred             Ccccccccccccccccccc--CCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhc--cCCCCCCChhhHH
Q 039137          800 NWSELAGTHGYVAPELAYT--LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEML--DSRLPYPSLHVQK  875 (912)
Q Consensus       800 ~~~~~~g~~~y~aPE~~~~--~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~  875 (912)
                        ....+++.|+|||++.+  ..++.++|||||||++|||++|+.||.....     ........  ..+.+.+    ..
T Consensus       178 --~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~-----~~~~~~i~~~~~~~~~~----~~  246 (283)
T PHA02988        178 --FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT-----KEIYDLIINKNNSLKLP----LD  246 (283)
T ss_pred             --ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHhcCCCCCCC----Cc
Confidence              23467899999999876  6789999999999999999999999863211     11111111  1122222    12


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 039137          876 KLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEK  908 (912)
Q Consensus       876 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  908 (912)
                      .+..+.+++.+||+.||++|||++|+++.|+..
T Consensus       247 ~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~  279 (283)
T PHA02988        247 CPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY  279 (283)
T ss_pred             CcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence            355688999999999999999999999999875

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-38  Score=345.06  Aligned_cols=247  Identities=22%  Similarity=0.313  Sum_probs=198.3

Q ss_pred             eeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEEeecCCCC
Q 039137          646 IGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGS  724 (912)
Q Consensus       646 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  724 (912)
                      ||+|+||.||+|+.. +++.||+|++....... ......+.+|+.+++.++||||+++++++..++..++||||+++|+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~   79 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVS-RSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGE   79 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence            699999999999876 68899999986432211 1245678899999999999999999999999999999999999999


Q ss_pred             hhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCCCcccc
Q 039137          725 LDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSEL  804 (912)
Q Consensus       725 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~  804 (912)
                      |.+++..   .+.+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++............
T Consensus        80 L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~  153 (312)
T cd05585          80 LFHHLQR---EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTF  153 (312)
T ss_pred             HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccc
Confidence            9999854   34689999999999999999999999   99999999999999999999999999998654333344456


Q ss_pred             ccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHHHHHHHHH
Q 039137          805 AGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVA  884 (912)
Q Consensus       805 ~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  884 (912)
                      .|++.|+|||++.+..++.++||||+||++|||++|+.||....     ...............+    ...+..+.+++
T Consensus       154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~-----~~~~~~~~~~~~~~~~----~~~~~~~~~li  224 (312)
T cd05585         154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN-----VNEMYRKILQEPLRFP----DGFDRDAKDLL  224 (312)
T ss_pred             cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC-----HHHHHHHHHcCCCCCC----CcCCHHHHHHH
Confidence            79999999999999999999999999999999999999985211     1111112222222222    22345678999


Q ss_pred             HHcccCCCCCCCCHHHHHHHHHHh
Q 039137          885 FSCLDQNPESRPTMKRVSQLLCEK  908 (912)
Q Consensus       885 ~~cl~~dP~~RPt~~evl~~L~~~  908 (912)
                      .+||+.||++||++..+.+.+...
T Consensus       225 ~~~L~~dp~~R~~~~~~~e~l~hp  248 (312)
T cd05585         225 IGLLSRDPTRRLGYNGAQEIKNHP  248 (312)
T ss_pred             HHHcCCCHHHcCCCCCHHHHHcCC
Confidence            999999999998755555555443

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-38  Score=321.38  Aligned_cols=260  Identities=23%  Similarity=0.370  Sum_probs=204.4

Q ss_pred             HHhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEc----
Q 039137          635 SATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSH----  709 (912)
Q Consensus       635 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~----  709 (912)
                      .....|...+.||+|+||.|+.|.++ +|+.||||++..+....  ...++..||+.+++.++|+||+.+.+++..    
T Consensus        19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~--~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~   96 (359)
T KOG0660|consen   19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQ--IDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRD   96 (359)
T ss_pred             eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhch--HHHHHHHHHHHHHHHhcCCCcceEEeeccccccc
Confidence            34456777899999999999999876 89999999998765443  357888999999999999999999999865    


Q ss_pred             -CCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecc
Q 039137          710 -PKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDF  788 (912)
Q Consensus       710 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df  788 (912)
                       -...|+|+|+|+. +|..+++   ....++...+..+++|+++||.|+|+.   +|+|||+||.|++++.+..+|||||
T Consensus        97 ~f~DvYiV~elMet-DL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DF  169 (359)
T KOG0660|consen   97 KFNDVYLVFELMET-DLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDF  169 (359)
T ss_pred             ccceeEEehhHHhh-HHHHHHH---cCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccc
Confidence             3568999999954 9999993   334589999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCC--CCCCccccccccccccccccc-cCCCCcchhHHHHHHHHHHHHhCCCCccchhcccc---------ccc-
Q 039137          789 GIAKFLNP--DSSNWSELAGTHGYVAPELAY-TLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS---------SSS-  855 (912)
Q Consensus       789 gla~~~~~--~~~~~~~~~g~~~y~aPE~~~-~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~---------~~~-  855 (912)
                      |+|+....  ....++..+.|..|.|||.+. ...|+.+.||||+||++.||++|++-|.+-.....         ... 
T Consensus       170 GLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~  249 (359)
T KOG0660|consen  170 GLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSE  249 (359)
T ss_pred             cceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCH
Confidence            99998754  234456788999999999764 56799999999999999999999998752111000         000 


Q ss_pred             --------cchhhhccCCCCCCCh----hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          856 --------NMNIEMLDSRLPYPSL----HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       856 --------~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                              ......+......+..    ..+...+...+++.+|+..||.+|+|++|.++
T Consensus       250 e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  250 EDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             HHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence                    0011111111111111    12233456889999999999999999999875

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-40  Score=311.76  Aligned_cols=253  Identities=23%  Similarity=0.377  Sum_probs=215.8

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      .+.|++.+.||+|+|+.||++.+. +|+.+|+|++........  ..+++.+|+.+.+.++||||+++.+.+.+....|+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~--~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl   87 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR--DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL   87 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc--cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence            467888899999999999998654 899999998865433322  46778899999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcC---CCcEEEecccccc
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDL---GYEAHVSDFGIAK  792 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~Dfgla~  792 (912)
                      |+|+|.|++|..-+..+   ...++..+-..++||+.+|+|+|.+   +|||||+||+|+++..   ..-+|++|||+|.
T Consensus        88 vFe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi  161 (355)
T KOG0033|consen   88 VFDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAI  161 (355)
T ss_pred             EEecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEE
Confidence            99999999995544221   4578889999999999999999999   9999999999999953   3459999999999


Q ss_pred             ccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChh
Q 039137          793 FLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLH  872 (912)
Q Consensus       793 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  872 (912)
                      .+. +...+..++|||+|||||++...+|+..+|||+-||++|-++.|.+||-.     .........++.....++..+
T Consensus       162 ~l~-~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~-----~~~~rlye~I~~g~yd~~~~~  235 (355)
T KOG0033|consen  162 EVN-DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD-----EDQHRLYEQIKAGAYDYPSPE  235 (355)
T ss_pred             EeC-CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC-----ccHHHHHHHHhccccCCCCcc
Confidence            887 55677889999999999999999999999999999999999999999841     122334556666677777767


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          873 VQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       873 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      +....++..+++.+|+..||.+|.|+.|.++
T Consensus       236 w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  236 WDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             cCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence            7888889999999999999999999998764

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-38  Score=326.01  Aligned_cols=260  Identities=26%  Similarity=0.431  Sum_probs=198.0

Q ss_pred             cCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhh--cCCCccccEEEEEEcCC----
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTE--IRHRNIVKFYGFCSHPK----  711 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~--l~h~niv~l~~~~~~~~----  711 (912)
                      ...+..+.||+|.||.||+|.+ +++.||||++...       +.+.|..|-+++..  ++|+||++++++-....    
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~-------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~  281 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQ-------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRM  281 (534)
T ss_pred             CchhhHHHhhcCccceeehhhc-cCceeEEEecCHH-------HHHHHHhHHHHHhccCccchhHHHhhchhccCCcccc
Confidence            4456778999999999999998 5699999998632       45566666666555  58999999999986655    


Q ss_pred             eeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCC------CCeeecCCCCCCeEEcCCCcEEE
Q 039137          712 HSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF------PPIVHRDISSKNVLLDLGYEAHV  785 (912)
Q Consensus       712 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~------~~ivH~Dlk~~Nill~~~~~~kl  785 (912)
                      .+++|+||.+.|+|.+|++.    ..++|....+|+..+++||+|||+..+      |+|+|||||.+|||+..|+++.|
T Consensus       282 eywLVt~fh~kGsL~dyL~~----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccI  357 (534)
T KOG3653|consen  282 EYWLVTEFHPKGSLCDYLKA----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCI  357 (534)
T ss_pred             ceeEEeeeccCCcHHHHHHh----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEe
Confidence            78999999999999999954    458999999999999999999998753      78999999999999999999999


Q ss_pred             eccccccccCCCCC--CccccccccccccccccccCC-C-----CcchhHHHHHHHHHHHHhCCCCc--------cchhc
Q 039137          786 SDFGIAKFLNPDSS--NWSELAGTHGYVAPELAYTLK-V-----TEKCDVYSFGVLALEVIKGKHPR--------DFLFE  849 (912)
Q Consensus       786 ~Dfgla~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~-~-----~~~sDvwslG~vl~elltg~~pf--------~~~~~  849 (912)
                      +|||+|..+.+...  .....+||.+|||||++.+.. +     -.+.||||+|.|+|||+++-..+        ...|+
T Consensus       358 aDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe  437 (534)
T KOG3653|consen  358 ADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE  437 (534)
T ss_pred             eccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence            99999998875433  233578999999999987653 2     23689999999999999854332        21222


Q ss_pred             ccccc----ccchhhh-ccCCCCCCChhhH--HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 039137          850 MSSSS----SNMNIEM-LDSRLPYPSLHVQ--KKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI  909 (912)
Q Consensus       850 ~~~~~----~~~~~~~-~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l  909 (912)
                      .....    ..+..-+ .++..|..+..+.  .....+.+.+..||+.||+.|.|+.-+.+++.++.
T Consensus       438 ~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~  504 (534)
T KOG3653|consen  438 AEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM  504 (534)
T ss_pred             HHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence            11111    1111111 1122222222221  23445889999999999999999999999988764

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-38  Score=334.45  Aligned_cols=264  Identities=23%  Similarity=0.359  Sum_probs=210.3

Q ss_pred             hcCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      .....++++||+|.||+|..+....+..||||+++.....   ..+.+|.+|+++|.+++||||++++|+|..++..++|
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~---~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI  613 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATK---NARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI  613 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccch---hHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence            4556778999999999999999877799999999865432   2468899999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      +|||++|+|.+++.+..... ...+...+|+.|||.|++||.+.   ++||||+.++|+|++.++++||+|||+++.+-.
T Consensus       614 ~EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lys  689 (807)
T KOG1094|consen  614 TEYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYS  689 (807)
T ss_pred             HHHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCccccccccc
Confidence            99999999999996654322 45667788999999999999999   999999999999999999999999999995543


Q ss_pred             CCCC--ccccccccccccccccccCCCCcchhHHHHHHHHHHHHh--CCCCccchhccccccccchhhhccCCCC-CCCh
Q 039137          797 DSSN--WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK--GKHPRDFLFEMSSSSSNMNIEMLDSRLP-YPSL  871 (912)
Q Consensus       797 ~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt--g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~  871 (912)
                      .+..  ....+-..+|||||.+.-+++++++|||+||+++||+++  .+.||....+...  .+...++.+.... .-..
T Consensus       690 g~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v--ven~~~~~~~~~~~~~l~  767 (807)
T KOG1094|consen  690 GDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV--VENAGEFFRDQGRQVVLS  767 (807)
T ss_pred             CCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH--HHhhhhhcCCCCcceecc
Confidence            3322  233455789999999999999999999999999999876  8889763322111  1111111111110 0001


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 039137          872 HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI  909 (912)
Q Consensus       872 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l  909 (912)
                      ...-++..+.+++.+||..|-++||+++++...|++..
T Consensus       768 ~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~  805 (807)
T KOG1094|consen  768 RPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA  805 (807)
T ss_pred             CCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence            12234556889999999999999999999999998864

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.8e-37  Score=338.11  Aligned_cols=263  Identities=21%  Similarity=0.362  Sum_probs=200.6

Q ss_pred             hcCCCCCceeeecCceEEEEEEeCC-----------------CCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCc
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVPS-----------------GEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRN  699 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n  699 (912)
                      .++|.+.+.||+|+||.||+|.+++                 +..||+|.+....   ......++.+|++++.+++|||
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~n   80 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA---NKNARNDFLKEVKILSRLKDPN   80 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC---CHHHHHHHHHHHHHHhhcCCCC
Confidence            3578999999999999999997532                 3369999986532   2224567999999999999999


Q ss_pred             cccEEEEEEcCCeeeEEEeecCCCChhhHhhccC----------------CcccCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 039137          700 IVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDA----------------SAKELGWTQRLNVIKGVADALFYLHNNCFP  763 (912)
Q Consensus       700 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~  763 (912)
                      |+++++++...+..++||||+++|+|.+++....                ....+++.++++++.|++.|++|||++   
T Consensus        81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---  157 (304)
T cd05096          81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---  157 (304)
T ss_pred             eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---
Confidence            9999999999999999999999999999884421                123478889999999999999999999   


Q ss_pred             CeeecCCCCCCeEEcCCCcEEEeccccccccCCCCCC--ccccccccccccccccccCCCCcchhHHHHHHHHHHHHh--
Q 039137          764 PIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN--WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK--  839 (912)
Q Consensus       764 ~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt--  839 (912)
                      +|+||||||+||+++.++.+||+|||+++........  .....++..|+|||++.+..++.++||||||+++|||++  
T Consensus       158 ~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~  237 (304)
T cd05096         158 NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC  237 (304)
T ss_pred             CccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence            9999999999999999999999999999865433211  123345788999999988889999999999999999987  


Q ss_pred             CCCCccchhccccccccchhhhccCC-CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 039137          840 GKHPRDFLFEMSSSSSNMNIEMLDSR-LPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCE  907 (912)
Q Consensus       840 g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  907 (912)
                      +..||........  ........... ...........+..+.+++.+||+.||++|||+.||.+.|++
T Consensus       238 ~~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         238 KEQPYGELTDEQV--IENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCCCCCcCCHHHH--HHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            5667642211000  00000000000 000000011234568899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=9.6e-38  Score=343.53  Aligned_cols=246  Identities=26%  Similarity=0.298  Sum_probs=201.8

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ++|++.+.||+|+||.||+|+++ +++.||+|++....... ....+.+.+|+.+++.++||||+++++++..++..++|
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILK-MKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhh-hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            57899999999999999999876 68999999986432111 11356788999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++|+|.+++..   .+.+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++.....
T Consensus        97 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  170 (329)
T PTZ00263         97 LEFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD  170 (329)
T ss_pred             EcCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence            999999999999844   34688899999999999999999999   999999999999999999999999999986643


Q ss_pred             CCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHH
Q 039137          797 DSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKK  876 (912)
Q Consensus       797 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  876 (912)
                      .   .....|++.|+|||++.+..++.++|||||||++|||++|+.||.....     ..............+..    .
T Consensus       171 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-----~~~~~~i~~~~~~~p~~----~  238 (329)
T PTZ00263        171 R---TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP-----FRIYEKILAGRLKFPNW----F  238 (329)
T ss_pred             C---cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH-----HHHHHHHhcCCcCCCCC----C
Confidence            2   2345789999999999999899999999999999999999999852111     11112222333333322    2


Q ss_pred             HHHHHHHHHHcccCCCCCCCC-----HHHHH
Q 039137          877 LMSIMQVAFSCLDQNPESRPT-----MKRVS  902 (912)
Q Consensus       877 ~~~l~~li~~cl~~dP~~RPt-----~~evl  902 (912)
                      +..+.+++.+||+.||.+||+     +++++
T Consensus       239 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll  269 (329)
T PTZ00263        239 DGRARDLVKGLLQTDHTKRLGTLKGGVADVK  269 (329)
T ss_pred             CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence            345789999999999999997     56655

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.1e-38  Score=305.91  Aligned_cols=256  Identities=24%  Similarity=0.370  Sum_probs=218.9

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCch----HHHHHHHHHHHHHhhc-CCCccccEEEEEEc
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMS----FQQEEFLNEIQALTEI-RHRNIVKFYGFCSH  709 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~----~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~  709 (912)
                      .-+.|...+.+|+|..++|.++.++ +|+.+|+|++.........    ...+.-.+|+.+++++ .||+|+.+.++++.
T Consensus        15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes   94 (411)
T KOG0599|consen   15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES   94 (411)
T ss_pred             HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence            3456888899999999999998765 7889999998654333222    2345567899999999 69999999999999


Q ss_pred             CCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccc
Q 039137          710 PKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFG  789 (912)
Q Consensus       710 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  789 (912)
                      +...++|+|.|+.|-|.|++   .+.-.+++.+.++|++|+..|++|||.+   +|||||+||+|||++++.++||+|||
T Consensus        95 ~sF~FlVFdl~prGELFDyL---ts~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFG  168 (411)
T KOG0599|consen   95 DAFVFLVFDLMPRGELFDYL---TSKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFG  168 (411)
T ss_pred             cchhhhhhhhcccchHHHHh---hhheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccc
Confidence            99999999999999999999   4445689999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCCCccccccccccccccccc------cCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhcc
Q 039137          790 IAKFLNPDSSNWSELAGTHGYVAPELAY------TLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLD  863 (912)
Q Consensus       790 la~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~  863 (912)
                      .|+.+.+. ......+|||+|.|||.+.      ...|+..+|+|+.||++|.++.|.+||-     .+..-.+..-++.
T Consensus       169 Fa~~l~~G-ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw-----HRkQmlMLR~Ime  242 (411)
T KOG0599|consen  169 FACQLEPG-EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW-----HRKQMLMLRMIME  242 (411)
T ss_pred             eeeccCCc-hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh-----HHHHHHHHHHHHh
Confidence            99988654 5567889999999999775      2358889999999999999999999973     1222334455667


Q ss_pred             CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          864 SRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       864 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      +...+.+..+.+.+....++|.+|++.||.+|.|++|+++
T Consensus       243 GkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  243 GKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             cccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            7888888888999999999999999999999999999875

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-37  Score=319.62  Aligned_cols=264  Identities=26%  Similarity=0.387  Sum_probs=209.2

Q ss_pred             HHHhcCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc--CCCccccEEEEEEcCC
Q 039137          634 ISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI--RHRNIVKFYGFCSHPK  711 (912)
Q Consensus       634 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l--~h~niv~l~~~~~~~~  711 (912)
                      .....+.++.+.||+|.||+||+|++ .|+.||||+|...       +.+.+.+|.++++..  +|+||+.+++.-..+.
T Consensus       207 RTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~sr-------dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~  278 (513)
T KOG2052|consen  207 RTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSR-------DERSWFRETEIYQTVMLRHENILGFIAADNKDN  278 (513)
T ss_pred             HhhhheeEEEEEecCccccceeeccc-cCCceEEEEeccc-------chhhhhhHHHHHHHHHhccchhhhhhhccccCC
Confidence            44567889999999999999999999 7999999999632       345567788887775  9999999999875543


Q ss_pred             ----eeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeeecCCCCCCeEEcCCCc
Q 039137          712 ----HSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNC-----FPPIVHRDISSKNVLLDLGYE  782 (912)
Q Consensus       712 ----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~Dlk~~Nill~~~~~  782 (912)
                          +.|+|++|.+.|+|.||+.+    ..++.+..++++..+|.||++||..-     .|.|.|||||..||++..++.
T Consensus       279 gs~TQLwLvTdYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~  354 (513)
T KOG2052|consen  279 GSWTQLWLVTDYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT  354 (513)
T ss_pred             CceEEEEEeeecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCc
Confidence                67999999999999999954    45889999999999999999999753     489999999999999999999


Q ss_pred             EEEeccccccccCCCC----CCccccccccccccccccccCC------CCcchhHHHHHHHHHHHHh----C------CC
Q 039137          783 AHVSDFGIAKFLNPDS----SNWSELAGTHGYVAPELAYTLK------VTEKCDVYSFGVLALEVIK----G------KH  842 (912)
Q Consensus       783 ~kl~Dfgla~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~------~~~~sDvwslG~vl~ellt----g------~~  842 (912)
                      +.|+|+|+|.......    ......+||-+|||||++.+.-      .-..+||||||.|+||+..    |      +.
T Consensus       355 C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~  434 (513)
T KOG2052|consen  355 CCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQL  434 (513)
T ss_pred             EEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcC
Confidence            9999999998776542    2345678999999999987542      1246899999999999984    2      45


Q ss_pred             CccchhccccccccchhhhccCCCC--C-CChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 039137          843 PRDFLFEMSSSSSNMNIEMLDSRLP--Y-PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI  909 (912)
Q Consensus       843 pf~~~~~~~~~~~~~~~~~~~~~~~--~-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l  909 (912)
                      ||...-+.+...+++..-+..+++.  . ..+...+....+.++++.||..+|..|-|+-.+.+.|.+..
T Consensus       435 Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~  504 (513)
T KOG2052|consen  435 PYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS  504 (513)
T ss_pred             CcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence            6654433333334443333333321  1 23345566778899999999999999999999999998765

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.6e-37  Score=345.42  Aligned_cols=261  Identities=26%  Similarity=0.412  Sum_probs=205.6

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC------CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEE
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP------SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCS  708 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~  708 (912)
                      ..++|++.+.||+|+||.||+|.+.      ++..||+|++......   ...+.+.+|+++++.+ +|+||+++++++.
T Consensus        36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~il~~l~~h~nIv~~~~~~~  112 (374)
T cd05106          36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT---DEREALMSELKILSHLGQHKNIVNLLGACT  112 (374)
T ss_pred             cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH---HHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence            4467999999999999999998742      3457999998754322   2456788999999999 8999999999999


Q ss_pred             cCCeeeEEEeecCCCChhhHhhccC-------------------------------------------------------
Q 039137          709 HPKHSFIIYEYLESGSLDKILCNDA-------------------------------------------------------  733 (912)
Q Consensus       709 ~~~~~~lv~e~~~~g~L~~~l~~~~-------------------------------------------------------  733 (912)
                      ..+..++||||+++|+|.+++....                                                       
T Consensus       113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (374)
T cd05106         113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS  192 (374)
T ss_pred             CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence            9999999999999999999885321                                                       


Q ss_pred             ------------CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCCC-
Q 039137          734 ------------SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN-  800 (912)
Q Consensus       734 ------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~-  800 (912)
                                  ...++++.++++++.||+.||+|||++   +|+||||||+||++++++.+||+|||+++........ 
T Consensus       193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~  269 (374)
T cd05106         193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV  269 (374)
T ss_pred             ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCccee
Confidence                        113478899999999999999999999   9999999999999999999999999999865433211 


Q ss_pred             -ccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccCCCCCCChhhHHHHH
Q 039137          801 -WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLM  878 (912)
Q Consensus       801 -~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  878 (912)
                       .....+++.|+|||++.+..++.++|||||||++|||++ |+.||.....     ................  ....+.
T Consensus       270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~-----~~~~~~~~~~~~~~~~--~~~~~~  342 (374)
T cd05106         270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV-----NSKFYKMVKRGYQMSR--PDFAPP  342 (374)
T ss_pred             eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccc-----cHHHHHHHHcccCccC--CCCCCH
Confidence             112335678999999988889999999999999999997 9999853211     0111111111111110  011245


Q ss_pred             HHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 039137          879 SIMQVAFSCLDQNPESRPTMKRVSQLLCEKI  909 (912)
Q Consensus       879 ~l~~li~~cl~~dP~~RPt~~evl~~L~~~l  909 (912)
                      ++.+++.+||+.||++|||+.+++++|++.+
T Consensus       343 ~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         343 EIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            6889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=3.1e-37  Score=345.18  Aligned_cols=260  Identities=25%  Similarity=0.394  Sum_probs=204.4

Q ss_pred             hcCCCCCceeeecCceEEEEEEe------CCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEEc
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKV------PSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSH  709 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~  709 (912)
                      .++|++.+.||+|+||.||+|++      .++..||||+++....   ....+.+.+|+.+++.+ +||||+++++++..
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~  110 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH---LTEREALMSELKVLSYLGNHINIVNLLGACTV  110 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC---cHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence            45799999999999999999963      2456899999864322   12456788999999999 89999999999999


Q ss_pred             CCeeeEEEeecCCCChhhHhhccCC-------------------------------------------------------
Q 039137          710 PKHSFIIYEYLESGSLDKILCNDAS-------------------------------------------------------  734 (912)
Q Consensus       710 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------  734 (912)
                      .+..++||||+++|+|.++++....                                                       
T Consensus       111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  190 (375)
T cd05104         111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR  190 (375)
T ss_pred             CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence            9999999999999999999854221                                                       


Q ss_pred             -----------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCC
Q 039137          735 -----------------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPD  797 (912)
Q Consensus       735 -----------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  797 (912)
                                       ...+++.++.+++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++.....
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~  267 (375)
T cd05104         191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRND  267 (375)
T ss_pred             cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence                             12478899999999999999999999   9999999999999999999999999999866433


Q ss_pred             CCC--ccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccCCCCCCChhhH
Q 039137          798 SSN--WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQ  874 (912)
Q Consensus       798 ~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  874 (912)
                      ...  .....++..|+|||++.+..++.++|||||||++|||++ |..||......     ......+........  ..
T Consensus       268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~-----~~~~~~~~~~~~~~~--~~  340 (375)
T cd05104         268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-----SKFYKMIKEGYRMLS--PE  340 (375)
T ss_pred             ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch-----HHHHHHHHhCccCCC--CC
Confidence            221  122334668999999999999999999999999999998 88887532111     011111111111100  01


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 039137          875 KKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI  909 (912)
Q Consensus       875 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l  909 (912)
                      ..+.++.+++.+||+.||++||+++|+++.|++.+
T Consensus       341 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~~  375 (375)
T cd05104         341 CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQL  375 (375)
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhhC
Confidence            12346889999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=7.5e-37  Score=326.73  Aligned_cols=262  Identities=21%  Similarity=0.319  Sum_probs=210.6

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ++|++.+.||+|+||.||+|+.+ +++.||+|.+....... ......+.+|+++++.++||||+++++++...+..++|
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMD-AKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV   80 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCC-HHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence            57899999999999999999875 78999999876432222 22456788999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccC-CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          717 YEYLESGSLDKILCNDA-SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      |||+++++|.+++.... ....+++.++..++.|++.|++|||++   +++|+||||+||+++.++.++++|||.+....
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~  157 (267)
T cd08228          81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence            99999999999885432 234578999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHH
Q 039137          796 PDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQK  875 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  875 (912)
                      ..........+++.|+|||.+.+..++.++||||+|+++|||++|+.||.....   .... ....... ...++.....
T Consensus       158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~---~~~~-~~~~~~~-~~~~~~~~~~  232 (267)
T cd08228         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLFS-LCQKIEQ-CDYPPLPTEH  232 (267)
T ss_pred             chhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc---cHHH-HHHHHhc-CCCCCCChhh
Confidence            443333445688899999999888899999999999999999999999742110   0001 1111111 1112212233


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 039137          876 KLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEK  908 (912)
Q Consensus       876 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  908 (912)
                      .+..+.+++.+||+.+|++||++.+|++.++.+
T Consensus       233 ~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         233 YSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             cCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            456688999999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.2e-37  Score=340.32  Aligned_cols=244  Identities=22%  Similarity=0.290  Sum_probs=198.4

Q ss_pred             ceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEEeecCC
Q 039137          644 HCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLES  722 (912)
Q Consensus       644 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  722 (912)
                      +.||+|+||.||+|+.+ +++.||+|++....... ......+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~   79 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIA-KDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNG   79 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999875 78999999987543222 22456788999999999999999999999999999999999999


Q ss_pred             CChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCCCcc
Q 039137          723 GSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWS  802 (912)
Q Consensus       723 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  802 (912)
                      |+|.+++..   ...+++.++..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        80 g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~  153 (328)
T cd05593          80 GELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMK  153 (328)
T ss_pred             CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccc
Confidence            999988843   34689999999999999999999999   999999999999999999999999999876433333344


Q ss_pred             ccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHHHHHHH
Q 039137          803 ELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQ  882 (912)
Q Consensus       803 ~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  882 (912)
                      ...|++.|+|||++.+..++.++||||+||++|||++|+.||.....     ..............+.    ..+..+.+
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~-----~~~~~~~~~~~~~~p~----~~~~~~~~  224 (328)
T cd05593         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELILMEDIKFPR----TLSADAKS  224 (328)
T ss_pred             cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH-----HHHHHHhccCCccCCC----CCCHHHHH
Confidence            56799999999999988899999999999999999999999852111     1111111112222222    23456789


Q ss_pred             HHHHcccCCCCCCC-----CHHHHHH
Q 039137          883 VAFSCLDQNPESRP-----TMKRVSQ  903 (912)
Q Consensus       883 li~~cl~~dP~~RP-----t~~evl~  903 (912)
                      ++.+||+.||++||     ++.|+++
T Consensus       225 li~~~L~~dP~~R~~~~~~~~~~il~  250 (328)
T cd05593         225 LLSGLLIKDPNKRLGGGPDDAKEIMR  250 (328)
T ss_pred             HHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence            99999999999997     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-37  Score=343.01  Aligned_cols=252  Identities=21%  Similarity=0.267  Sum_probs=203.4

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ++|++.+.||+|+||.||+|++. +++.||+|++....... ....+.+.+|+++++.++||||+++++++..++..|+|
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv   79 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFK-LNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLA   79 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhh-hhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEE
Confidence            46899999999999999999876 68999999986432211 11356788999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++|+|.+++..   ...+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++.....
T Consensus        80 ~e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~  153 (333)
T cd05600          80 MEYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT  153 (333)
T ss_pred             EeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence            999999999999943   34688999999999999999999999   999999999999999999999999999986543


Q ss_pred             CCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhc--cCCC--CCCChh
Q 039137          797 DSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEML--DSRL--PYPSLH  872 (912)
Q Consensus       797 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~--~~~~--~~~~~~  872 (912)
                         ......|++.|+|||++.+..++.++||||+||++|||++|..||......     .......  ....  +.....
T Consensus       154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-----~~~~~i~~~~~~~~~~~~~~~  225 (333)
T cd05600         154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN-----ETWENLKYWKETLQRPVYDDP  225 (333)
T ss_pred             ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHH-----HHHHHHHhccccccCCCCCcc
Confidence               234557899999999999989999999999999999999999998632110     0000000  0111  111100


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 039137          873 VQKKLMSIMQVAFSCLDQNPESRPTMKRVSQL  904 (912)
Q Consensus       873 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  904 (912)
                      ....+..+.+++.+|++.+|.+||+++++++.
T Consensus       226 ~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         226 RFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             ccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            12235568899999999999999999998853

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=5.5e-37  Score=327.39  Aligned_cols=256  Identities=22%  Similarity=0.366  Sum_probs=204.2

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC----CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCe
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP----SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKH  712 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~  712 (912)
                      .++|++.+.||+|+||.||+|.++    .+..||+|.++....   ....+.+.+|+..++.++||||+++++++...+.
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   80 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS---DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT   80 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC---HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence            356899999999999999999753    456899999875422   2245678899999999999999999999999999


Q ss_pred             eeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccccc
Q 039137          713 SFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK  792 (912)
Q Consensus       713 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  792 (912)
                      .++||||+++|+|.+++...  ...+++.+++.++.|++.|++|||++   +++||||||+||+++.++.++++|||.+.
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~  155 (266)
T cd05064          81 MMIVTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQ  155 (266)
T ss_pred             cEEEEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccc
Confidence            99999999999999998543  24689999999999999999999999   99999999999999999999999999876


Q ss_pred             ccCCCCCC-ccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccC-CCCCC
Q 039137          793 FLNPDSSN-WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDS-RLPYP  869 (912)
Q Consensus       793 ~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~  869 (912)
                      ........ .....++..|+|||.+.+..++.++|||||||++||+++ |+.||......     .......+. ..+.+
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~  230 (266)
T cd05064         156 EDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ-----DVIKAVEDGFRLPAP  230 (266)
T ss_pred             cccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-----HHHHHHHCCCCCCCC
Confidence            54322111 112234678999999999999999999999999999875 99998522111     111111111 11211


Q ss_pred             ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 039137          870 SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI  909 (912)
Q Consensus       870 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l  909 (912)
                          ...+..+.+++.+||+.+|++||+++++.+.|++.+
T Consensus       231 ----~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~~  266 (266)
T cd05064         231 ----RNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKMV  266 (266)
T ss_pred             ----CCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhhC
Confidence                224456889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.1e-37  Score=339.86  Aligned_cols=244  Identities=22%  Similarity=0.282  Sum_probs=197.5

Q ss_pred             ceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEEeecCC
Q 039137          644 HCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLES  722 (912)
Q Consensus       644 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  722 (912)
                      +.||+|+||.||+|+.+ +|+.||+|++....... ......+.+|+++++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~   79 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA-KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCC
Confidence            46999999999999875 78999999986542211 12345677899999999999999999999999999999999999


Q ss_pred             CChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCCCcc
Q 039137          723 GSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWS  802 (912)
Q Consensus       723 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  802 (912)
                      |+|.+++..   ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++...........
T Consensus        80 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~  153 (323)
T cd05595          80 GELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK  153 (323)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccc
Confidence            999988843   34688999999999999999999999   999999999999999999999999999875433333344


Q ss_pred             ccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHHHHHHH
Q 039137          803 ELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQ  882 (912)
Q Consensus       803 ~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  882 (912)
                      ...|++.|+|||++.+..++.++|||||||++|||++|+.||.....     ..............+.    ..+..+.+
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-----~~~~~~~~~~~~~~p~----~~~~~~~~  224 (323)
T cd05595         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----ERLFELILMEEIRFPR----TLSPEAKS  224 (323)
T ss_pred             cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH-----HHHHHHHhcCCCCCCC----CCCHHHHH
Confidence            56789999999999988999999999999999999999999852111     1111112222222222    23456789


Q ss_pred             HHHHcccCCCCCCC-----CHHHHHH
Q 039137          883 VAFSCLDQNPESRP-----TMKRVSQ  903 (912)
Q Consensus       883 li~~cl~~dP~~RP-----t~~evl~  903 (912)
                      ++.+||+.||++||     ++.++++
T Consensus       225 li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         225 LLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             HHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            99999999999998     7877764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=5.3e-37  Score=331.43  Aligned_cols=258  Identities=18%  Similarity=0.250  Sum_probs=198.8

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      .++|++.+.||+|+||+||+|+.+ +++.||+|++.......   ....+.+|+++++.++||||+++++++...+..++
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   80 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG---APCTAIREVSLLKNLKHANIVTLHDIIHTERCLTL   80 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCC---cchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence            357999999999999999999876 78999999986543221   24567789999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ||||+++ +|.+++...  ...+++.++..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus        81 v~e~~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~  154 (288)
T cd07871          81 VFEYLDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKS  154 (288)
T ss_pred             EEeCCCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence            9999985 898888432  23578899999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCCCcccccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCccchhcccc----------ccccch------
Q 039137          796 PDSSNWSELAGTHGYVAPELAYT-LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS----------SSSNMN------  858 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~----------~~~~~~------  858 (912)
                      ..........+++.|+|||++.+ ..++.++||||+||++|||++|+.||........          ......      
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07871         155 VPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSN  234 (288)
T ss_pred             CCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccc
Confidence            43333445678999999998865 5689999999999999999999999852110000          000000      


Q ss_pred             hh---hccCCCCCCC--hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          859 IE---MLDSRLPYPS--LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       859 ~~---~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .+   ...+......  ......+.+..+++.+|++.||.+|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            00   0000000000  001122356789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-37  Score=348.26  Aligned_cols=257  Identities=23%  Similarity=0.364  Sum_probs=212.1

Q ss_pred             hcCCCCCceeeecCceEEEEEEeCCC-CEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcC-CCccccEEEE-EEc----
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVPSG-EIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR-HRNIVKFYGF-CSH----  709 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~-~~~----  709 (912)
                      ..++++.+.|.+|||+.||.|....+ ..||+|++...    .+...+.+.+||++|+.|+ |+|||.+++. ...    
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~----de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~  111 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN----DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN  111 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC----CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence            35677889999999999999997755 99999998644    2336788999999999996 9999999993 221    


Q ss_pred             --CCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEec
Q 039137          710 --PKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSD  787 (912)
Q Consensus       710 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  787 (912)
                        .-.+++.||||++|.|-|++..+... .+++.++++|++++++|+++||.. .|+|+|||||-+|||+..++..||||
T Consensus       112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCD  189 (738)
T KOG1989|consen  112 NGVWEVLLLMEYCKGGSLVDFMNTRLQT-RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCD  189 (738)
T ss_pred             CceeEEEeehhhccCCcHHHHHHHHHhc-cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCc
Confidence              13568999999999999999654443 499999999999999999999997 45899999999999999999999999


Q ss_pred             cccccccCCCCCCc---------ccccccccccccccc---ccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccc
Q 039137          788 FGIAKFLNPDSSNW---------SELAGTHGYVAPELA---YTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSS  855 (912)
Q Consensus       788 fgla~~~~~~~~~~---------~~~~g~~~y~aPE~~---~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~  855 (912)
                      ||.|...-......         -....|+.|+|||++   .+.+.++|+|||+|||+||-|+...+||+         .
T Consensus       190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe---------~  260 (738)
T KOG1989|consen  190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFE---------E  260 (738)
T ss_pred             ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcC---------c
Confidence            99997433222111         123569999999966   57789999999999999999999999986         2


Q ss_pred             cchhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          856 NMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       856 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                      .....+++..+.+|+.  +.++..+.+||..||+.||.+||++-||+..+.++..
T Consensus       261 sg~laIlng~Y~~P~~--p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~  313 (738)
T KOG1989|consen  261 SGKLAILNGNYSFPPF--PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN  313 (738)
T ss_pred             CcceeEEeccccCCCC--ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence            2244566777766653  5677889999999999999999999999999988753

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=5.5e-37  Score=331.52  Aligned_cols=258  Identities=24%  Similarity=0.342  Sum_probs=201.0

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ++|++.+.||+|+||+||+|+++ +++.||+|++......  ....+.+.+|+++++.++||||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN--EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLV   78 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc--ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEE
Confidence            47899999999999999999986 6889999998754322  22456788999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||++++.+..+..   ....+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        79 ~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  152 (287)
T cd07848          79 FEYVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSE  152 (287)
T ss_pred             EecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence            99999987766542   234688999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCC-CccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhcccccc------ccchh---h------
Q 039137          797 DSS-NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS------SNMNI---E------  860 (912)
Q Consensus       797 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~------~~~~~---~------  860 (912)
                      ... ......|++.|+|||++.+..++.++||||+||++|||++|+.||..........      .....   .      
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07848         153 GSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP  232 (287)
T ss_pred             cccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc
Confidence            322 2334578999999999998889999999999999999999999985321110000      00000   0      


Q ss_pred             -hccCCCCC---CC----hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          861 -MLDSRLPY---PS----LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       861 -~~~~~~~~---~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                       ......+.   +.    ......+..+.+++.+||+.||++|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence             00000000   00    001123456899999999999999999998875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-37  Score=333.93  Aligned_cols=254  Identities=24%  Similarity=0.367  Sum_probs=222.0

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcC-CCccccEEEEEEcCCee
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR-HRNIVKFYGFCSHPKHS  713 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~  713 (912)
                      ....|++.+.||+|.||.||+++.+ +|+.+|+|.+.+....... ..+.+.+|+++|+++. |||||.+++++++....
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~-~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~  111 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKE-DREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV  111 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccc-cHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence            4567999999999999999999987 5999999999765543322 4578899999999998 99999999999999999


Q ss_pred             eEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCC----CcEEEeccc
Q 039137          714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLG----YEAHVSDFG  789 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~----~~~kl~Dfg  789 (912)
                      ++|||++.||.|.+.+...    .+++.++..++.|++.|++|||+.   +|+|||+||+|+++...    +.+|++|||
T Consensus       112 ~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG  184 (382)
T KOG0032|consen  112 YLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFG  184 (382)
T ss_pred             EEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence            9999999999999999554    399999999999999999999999   99999999999999643    479999999


Q ss_pred             cccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCC
Q 039137          790 IAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYP  869 (912)
Q Consensus       790 la~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  869 (912)
                      ++..... .......+||+.|+|||++.+..|+..+||||+||++|.|++|.+||....     .......+......+.
T Consensus       185 la~~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~-----~~~~~~~i~~~~~~f~  258 (382)
T KOG0032|consen  185 LAKFIKP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGET-----EFEIFLAILRGDFDFT  258 (382)
T ss_pred             CceEccC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCC-----hhHHHHHHHcCCCCCC
Confidence            9998877 566788999999999999999999999999999999999999999985221     1223335666666677


Q ss_pred             ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          870 SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       870 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ...+...+..+.++|..|+..||.+|+|+.++++
T Consensus       259 ~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  259 SEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             CCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence            7777788889999999999999999999999986

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.1e-36  Score=335.70  Aligned_cols=256  Identities=25%  Similarity=0.339  Sum_probs=202.9

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      .++|++.+.||+|+||.||+|+++ ++..||+|.+.....   ....+.+.+|++++++++||||+++++++..++..++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK---PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   80 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccC---HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            468999999999999999999876 688899999865321   2245679999999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ||||+++|+|.+++..   ...+++..+..++.|++.|++|||++.  +|+||||||+||+++.++.+||+|||++....
T Consensus        81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  155 (331)
T cd06649          81 CMEHMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  155 (331)
T ss_pred             EeecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence            9999999999999944   345889999999999999999999862  69999999999999999999999999997653


Q ss_pred             CCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhcccc--c--------cccchh------
Q 039137          796 PDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS--S--------SSNMNI------  859 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~--~--------~~~~~~------  859 (912)
                      ..  ......|++.|+|||++.+..++.++|||||||++|||++|+.||........  .        ......      
T Consensus       156 ~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (331)
T cd06649         156 DS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRP  233 (331)
T ss_pred             cc--ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccc
Confidence            32  22345689999999999998999999999999999999999999852111000  0        000000      


Q ss_pred             -------------------------hhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 039137          860 -------------------------EMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQL  904 (912)
Q Consensus       860 -------------------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  904 (912)
                                               ......  .+.......+.++.+++.+||+.||++|||++|+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEP--PPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             ccccccccccccccccchhHHHHHHHHHhCC--CcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                                     000000  0000011234568899999999999999999999764

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=7.6e-37  Score=332.93  Aligned_cols=258  Identities=19%  Similarity=0.267  Sum_probs=198.2

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      .++|++.+.||+|+||+||+|+.+ +++.||+|++.......   ....+.+|+.+++.++||||+++++++..++..++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   80 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG---TPFTAIREASLLKGLKHANIVLLHDIIHTKETLTL   80 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc---cchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEE
Confidence            478999999999999999999876 78999999986543221   23456789999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ||||++ +++.+++...  ...+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++....
T Consensus        81 v~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  154 (303)
T cd07869          81 VFEYVH-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKS  154 (303)
T ss_pred             EEECCC-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence            999996 5777777432  34588899999999999999999999   99999999999999999999999999997654


Q ss_pred             CCCCCcccccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccch-------hh-------
Q 039137          796 PDSSNWSELAGTHGYVAPELAYT-LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMN-------IE-------  860 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~-------~~-------  860 (912)
                      ..........+++.|+|||++.+ ..++.++||||+||++|||++|+.||....+.........       ..       
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (303)
T cd07869         155 VPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHS  234 (303)
T ss_pred             CCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhh
Confidence            43334445678999999998865 4578899999999999999999999863211100000000       00       


Q ss_pred             ---hccCCC--CCCChhhH-----HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          861 ---MLDSRL--PYPSLHVQ-----KKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       861 ---~~~~~~--~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                         ......  ..+.....     .....+.+++.+|++.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence               000000  00000000     11245779999999999999999998875

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.5e-37  Score=337.44  Aligned_cols=245  Identities=24%  Similarity=0.312  Sum_probs=197.4

Q ss_pred             ceeeecCceEEEEEEe----CCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEEee
Q 039137          644 HCIGKGGHGSVYRAKV----PSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEY  719 (912)
Q Consensus       644 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  719 (912)
                      +.||+|+||.||+|+.    .+++.||+|++..............+.+|+++++.++||||+++++++..++..|+||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            6799999999999975    357899999986532211122345677899999999999999999999999999999999


Q ss_pred             cCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCC
Q 039137          720 LESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSS  799 (912)
Q Consensus       720 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  799 (912)
                      +++++|.+++..   .+.+.+..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.......
T Consensus        82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (323)
T cd05584          82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT  155 (323)
T ss_pred             CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence            999999999843   34578899999999999999999999   999999999999999999999999999875443333


Q ss_pred             CccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHHHH
Q 039137          800 NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMS  879 (912)
Q Consensus       800 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  879 (912)
                      ......|++.|+|||++.+..++.++|||||||++|||++|+.||.....     ..............+.    ..+..
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~-----~~~~~~~~~~~~~~~~----~~~~~  226 (323)
T cd05584         156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR-----KKTIDKILKGKLNLPP----YLTPE  226 (323)
T ss_pred             cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH-----HHHHHHHHcCCCCCCC----CCCHH
Confidence            34456789999999999988899999999999999999999999863211     1112222233333332    12345


Q ss_pred             HHHHHHHcccCCCCCCC-----CHHHHHH
Q 039137          880 IMQVAFSCLDQNPESRP-----TMKRVSQ  903 (912)
Q Consensus       880 l~~li~~cl~~dP~~RP-----t~~evl~  903 (912)
                      +.+++.+||+.||++||     ++.++++
T Consensus       227 ~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         227 ARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             HHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            78999999999999999     7887765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=5.9e-37  Score=340.93  Aligned_cols=248  Identities=23%  Similarity=0.375  Sum_probs=194.5

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ++|+..+.||+|+||.||+|++. +++.||+|++....   .....+.+.+|+++++.++|+||+++++++...+..++|
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  150 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH---EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVL  150 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC---cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEE
Confidence            45677899999999999999876 78999999986432   222456789999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++|+|.+..       ..++..+..++.||+.||+|||++   +|+||||||+||++++++.+||+|||+++....
T Consensus       151 ~e~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~  220 (353)
T PLN00034        151 LEFMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ  220 (353)
T ss_pred             EecCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence            9999999986532       345678889999999999999999   999999999999999999999999999987654


Q ss_pred             CCCCcccccccccccccccccc-----CCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCCh
Q 039137          797 DSSNWSELAGTHGYVAPELAYT-----LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSL  871 (912)
Q Consensus       797 ~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  871 (912)
                      .........|+..|+|||++..     ...+.++|||||||++|||++|+.||..... ... ............+   .
T Consensus       221 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~-~~~-~~~~~~~~~~~~~---~  295 (353)
T PLN00034        221 TMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ-GDW-ASLMCAICMSQPP---E  295 (353)
T ss_pred             ccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-ccH-HHHHHHHhccCCC---C
Confidence            4333445678999999998743     2235689999999999999999999861110 000 0000000000111   1


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          872 HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       872 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .....+..+.++|.+||+.||++|||+.|+++
T Consensus       296 ~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~  327 (353)
T PLN00034        296 APATASREFRHFISCCLQREPAKRWSAMQLLQ  327 (353)
T ss_pred             CCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            11233456889999999999999999999876

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=4.9e-37  Score=337.71  Aligned_cols=244  Identities=23%  Similarity=0.320  Sum_probs=193.9

Q ss_pred             ceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEEcCCeeeEEEeecC
Q 039137          644 HCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSHPKHSFIIYEYLE  721 (912)
Q Consensus       644 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  721 (912)
                      +.||+|+||.||+|+.+ +++.||+|++........ ...+.+.+|+.++..+ +||||+++++++...+..++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~   79 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDD-EDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN   79 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcch-hHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCC
Confidence            46999999999999876 688999999876433222 2345677898888877 79999999999999999999999999


Q ss_pred             CCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCCCc
Q 039137          722 SGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNW  801 (912)
Q Consensus       722 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  801 (912)
                      +|+|.+++..   ...+++..++.++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++.........
T Consensus        80 ~~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~  153 (329)
T cd05618          80 GGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT  153 (329)
T ss_pred             CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcc
Confidence            9999988843   34689999999999999999999999   99999999999999999999999999997543333334


Q ss_pred             cccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccc----cchhhhccCCCCCCChhhHHHH
Q 039137          802 SELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSS----NMNIEMLDSRLPYPSLHVQKKL  877 (912)
Q Consensus       802 ~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~  877 (912)
                      ....|++.|+|||++.+..++.++|||||||++|||++|+.||+..........    .............+.    ..+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~----~~~  229 (329)
T cd05618         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLS  229 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCC----CCC
Confidence            456789999999999999999999999999999999999999853211111000    011112222222222    234


Q ss_pred             HHHHHHHHHcccCCCCCCCCH
Q 039137          878 MSIMQVAFSCLDQNPESRPTM  898 (912)
Q Consensus       878 ~~l~~li~~cl~~dP~~RPt~  898 (912)
                      ..+.+++.+||+.||++||++
T Consensus       230 ~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         230 VKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             HHHHHHHHHHhcCCHHHcCCC
Confidence            557789999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=8.7e-37  Score=328.35  Aligned_cols=249  Identities=24%  Similarity=0.319  Sum_probs=197.1

Q ss_pred             eeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEEeecCCCC
Q 039137          646 IGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGS  724 (912)
Q Consensus       646 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  724 (912)
                      ||+|+||+||+|.++ +++.||+|++....... ....+.+..|+++++.++||||+++.+++......++||||+++|+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~   79 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKK-RKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGD   79 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhh-hHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence            699999999999875 78899999986432221 1134567889999999999999999999999999999999999999


Q ss_pred             hhhHhhcc-CCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCCCccc
Q 039137          725 LDKILCND-ASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSE  803 (912)
Q Consensus       725 L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  803 (912)
                      |.+++... .....+++.++..++.|++.||+|||++   +|+||||||+||+++.++.++|+|||++............
T Consensus        80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~  156 (280)
T cd05608          80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKG  156 (280)
T ss_pred             HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccc
Confidence            99887443 2345689999999999999999999999   9999999999999999999999999999876544444445


Q ss_pred             cccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHHHHHHHH
Q 039137          804 LAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQV  883 (912)
Q Consensus       804 ~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  883 (912)
                      ..|++.|+|||++.+..++.++||||+|+++|||++|+.||........ ...............+    ...+..+.++
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~----~~~~~~~~~l  231 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKELKQRILNDSVTYP----DKFSPASKSF  231 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh-HHHHHHhhcccCCCCc----ccCCHHHHHH
Confidence            6789999999999999999999999999999999999999852111000 0001111111111111    2345568899


Q ss_pred             HHHcccCCCCCCC-----CHHHHHH
Q 039137          884 AFSCLDQNPESRP-----TMKRVSQ  903 (912)
Q Consensus       884 i~~cl~~dP~~RP-----t~~evl~  903 (912)
                      +.+||+.||++||     +++++++
T Consensus       232 i~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         232 CEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             HHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            9999999999999     6666664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=4.8e-37  Score=337.99  Aligned_cols=244  Identities=21%  Similarity=0.305  Sum_probs=194.4

Q ss_pred             ceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEEcCCeeeEEEeecC
Q 039137          644 HCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSHPKHSFIIYEYLE  721 (912)
Q Consensus       644 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  721 (912)
                      +.||+|+||.||+|+++ +++.||+|+++....... ...+.+.+|..++..+ +||||+++++++..++..|+||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~-~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~   79 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDD-EDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVS   79 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh-hHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence            46999999999999876 688999999875432221 1345678899999998 69999999999999999999999999


Q ss_pred             CCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCCCc
Q 039137          722 SGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNW  801 (912)
Q Consensus       722 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  801 (912)
                      +|+|.+++..   .+.+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.........
T Consensus        80 ~g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~  153 (329)
T cd05588          80 GGDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT  153 (329)
T ss_pred             CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCCcc
Confidence            9999988843   35689999999999999999999999   99999999999999999999999999987543333334


Q ss_pred             cccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhcccc----ccccchhhhccCCCCCCChhhHHHH
Q 039137          802 SELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS----SSSNMNIEMLDSRLPYPSLHVQKKL  877 (912)
Q Consensus       802 ~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~  877 (912)
                      ....|++.|+|||++.+..++.++||||+||++|||++|+.||+.......    ................+.    ..+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~----~~~  229 (329)
T cd05588         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPR----SLS  229 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCC----CCC
Confidence            456789999999999999999999999999999999999999863211110    000111112222223222    234


Q ss_pred             HHHHHHHHHcccCCCCCCCCH
Q 039137          878 MSIMQVAFSCLDQNPESRPTM  898 (912)
Q Consensus       878 ~~l~~li~~cl~~dP~~RPt~  898 (912)
                      ..+.+++.+|++.||.+||++
T Consensus       230 ~~~~~li~~~L~~dP~~R~~~  250 (329)
T cd05588         230 VKASSVLKGFLNKDPKERLGC  250 (329)
T ss_pred             HHHHHHHHHHhccCHHHcCCC
Confidence            557899999999999999983

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=5.1e-37  Score=338.36  Aligned_cols=248  Identities=22%  Similarity=0.297  Sum_probs=201.3

Q ss_pred             hcCCCCCceeeecCceEEEEEEeCC--CCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeee
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVPS--GEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSF  714 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  714 (912)
                      .++|++.+.||+|+||.||+|+++.  +..||+|++....... ....+.+.+|+++++.++||||+++++++.+++..+
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~  107 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIK-QKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY  107 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhh-hhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence            3579999999999999999998643  3689999986432211 113567889999999999999999999999999999


Q ss_pred             EEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccccccc
Q 039137          715 IIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL  794 (912)
Q Consensus       715 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  794 (912)
                      +||||+++|+|.+++...   ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++...
T Consensus       108 lv~Ey~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~  181 (340)
T PTZ00426        108 LVLEFVIGGEFFTFLRRN---KRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV  181 (340)
T ss_pred             EEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence            999999999999999543   4588999999999999999999999   9999999999999999999999999999865


Q ss_pred             CCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhH
Q 039137          795 NPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQ  874 (912)
Q Consensus       795 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  874 (912)
                      ...   .....||+.|+|||++.+..++.++||||+||++|||++|..||.....     .............++..   
T Consensus       182 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~~~~~i~~~~~~~p~~---  250 (340)
T PTZ00426        182 DTR---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP-----LLIYQKILEGIIYFPKF---  250 (340)
T ss_pred             CCC---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH-----HHHHHHHhcCCCCCCCC---
Confidence            432   2345789999999999988899999999999999999999999852211     11122222333333322   


Q ss_pred             HHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 039137          875 KKLMSIMQVAFSCLDQNPESRP-----TMKRVSQ  903 (912)
Q Consensus       875 ~~~~~l~~li~~cl~~dP~~RP-----t~~evl~  903 (912)
                       .+..+.+++.+|++.||++|+     +++++++
T Consensus       251 -~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~  283 (340)
T PTZ00426        251 -LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE  283 (340)
T ss_pred             -CCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence             234577899999999999995     7888765

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2e-36  Score=323.45  Aligned_cols=262  Identities=23%  Similarity=0.342  Sum_probs=211.0

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ++|++.+.||+|++|.||+|... +++.||||.+....... ....+++.+|+.+++.++||||+++++++..++..+++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMD-AKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV   80 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhh-HHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence            46888999999999999999864 88999999876432222 22456788999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhcc-CCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          717 YEYLESGSLDKILCND-ASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      |||+++++|.+++... .....+++.+++.++.|++.|++|||++   +++|+||||+||+++.++.++++|||++....
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd08229          81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence            9999999999988542 2345689999999999999999999999   99999999999999999999999999988765


Q ss_pred             CCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHH
Q 039137          796 PDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQK  875 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  875 (912)
                      ..........+++.|+|||++.+..++.++||||||+++|+|++|..||.....   ............  ..++.....
T Consensus       158 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~--~~~~~~~~~  232 (267)
T cd08229         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLYSLCKKIEQC--DYPPLPSDH  232 (267)
T ss_pred             cCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc---hHHHHhhhhhcC--CCCCCCccc
Confidence            443333455688999999999888899999999999999999999999742111   000000111111  111111223


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 039137          876 KLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEK  908 (912)
Q Consensus       876 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  908 (912)
                      .+..+.+++.+||+.||.+|||+.+|++.++++
T Consensus       233 ~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         233 YSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             ccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence            456788999999999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=7.6e-37  Score=335.94  Aligned_cols=247  Identities=25%  Similarity=0.333  Sum_probs=195.9

Q ss_pred             CCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHH---hhcCCCccccEEEEEEcCCeeeE
Q 039137          640 FNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQAL---TEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       640 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l---~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      |++.+.||+|+||.||+|.+. +++.||||++....... ....+.+.+|+.++   +.++||||+++++++...+..|+
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~l   79 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIA-RDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCF   79 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEE
Confidence            677899999999999999875 78999999986432111 11345566676655   56679999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ||||+++|+|..++..    ..+++.++..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus        80 v~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~  152 (324)
T cd05589          80 VMEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM  152 (324)
T ss_pred             EEcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence            9999999999988733    4589999999999999999999999   99999999999999999999999999987544


Q ss_pred             CCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHH
Q 039137          796 PDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQK  875 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  875 (912)
                      ..........|++.|+|||++.+..++.++|||||||++|||++|+.||.....     ..............+.    .
T Consensus       153 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~-----~~~~~~i~~~~~~~p~----~  223 (324)
T cd05589         153 GFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE-----EEVFDSIVNDEVRYPR----F  223 (324)
T ss_pred             CCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCCCCCC----C
Confidence            333344556789999999999998999999999999999999999999852211     1111122222222222    2


Q ss_pred             HHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 039137          876 KLMSIMQVAFSCLDQNPESRPT-----MKRVSQ  903 (912)
Q Consensus       876 ~~~~l~~li~~cl~~dP~~RPt-----~~evl~  903 (912)
                      .+..+.+++.+||+.||.+||+     +.++++
T Consensus       224 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         224 LSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence            3455788999999999999994     555543

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=9.1e-37  Score=312.40  Aligned_cols=262  Identities=21%  Similarity=0.312  Sum_probs=205.5

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCc-cccEEEEEEcCC---
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRN-IVKFYGFCSHPK---  711 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n-iv~l~~~~~~~~---  711 (912)
                      ...|+..++||+|+||+||+|+.+ +|+.||+|++......+  .......+|+.+++.++|+| |+++++++....   
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~E--G~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~   87 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEE--GVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHR   87 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEecccccc--CCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccc
Confidence            345777788999999999999876 78999999998665431  14456789999999999999 999999998776   


Q ss_pred             ---eeeEEEeecCCCChhhHhhccCCc-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEec
Q 039137          712 ---HSFIIYEYLESGSLDKILCNDASA-KELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSD  787 (912)
Q Consensus       712 ---~~~lv~e~~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  787 (912)
                         ..++|+||++. +|..++...... ..++...+..+++||++|++|||++   +|+||||||+||+++++|.+||+|
T Consensus        88 ~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaD  163 (323)
T KOG0594|consen   88 GIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLAD  163 (323)
T ss_pred             ccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeec
Confidence               78999999976 999999554322 3567789999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCCCccccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCccchhccccc---------c-cc
Q 039137          788 FGIAKFLNPDSSNWSELAGTHGYVAPELAYTL-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS---------S-SN  856 (912)
Q Consensus       788 fgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~---------~-~~  856 (912)
                      ||+|+...-+...+...++|..|+|||++.+. .|+...||||+||+++||+++++-|....+....         . ..
T Consensus       164 FGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~  243 (323)
T KOG0594|consen  164 FGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEK  243 (323)
T ss_pred             cchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCcc
Confidence            99999776565667788899999999998876 6899999999999999999999888632221100         0 00


Q ss_pred             chh---hhccCCCCCCChh-----hH---HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 039137          857 MNI---EMLDSRLPYPSLH-----VQ---KKLMSIMQVAFSCLDQNPESRPTMKRVSQL  904 (912)
Q Consensus       857 ~~~---~~~~~~~~~~~~~-----~~---~~~~~l~~li~~cl~~dP~~RPt~~evl~~  904 (912)
                      .+.   ...+...+++...     ..   .......+++.+|++.+|.+|.|++..++.
T Consensus       244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            000   0111111111111     11   112368899999999999999999988764

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=3.8e-37  Score=338.48  Aligned_cols=244  Identities=22%  Similarity=0.284  Sum_probs=197.2

Q ss_pred             ceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEEeecCC
Q 039137          644 HCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLES  722 (912)
Q Consensus       644 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  722 (912)
                      +.||+|+||.||+|+.. +++.||+|++....... ......+.+|+++++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~-~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   79 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVA-KDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG   79 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999865 78999999987543221 12345677899999999999999999999999999999999999


Q ss_pred             CChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCCCc
Q 039137          723 GSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHN-NCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNW  801 (912)
Q Consensus       723 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  801 (912)
                      |+|.+++..   ...+++.++..++.|++.||+|||+ +   +|+||||||+||+++.++.+||+|||+++.........
T Consensus        80 ~~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~  153 (325)
T cd05594          80 GELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM  153 (325)
T ss_pred             CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccc
Confidence            999998843   3468999999999999999999997 6   99999999999999999999999999987644333344


Q ss_pred             cccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHHHHHH
Q 039137          802 SELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIM  881 (912)
Q Consensus       802 ~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  881 (912)
                      ....|++.|+|||++.+..++.++||||+||++|||++|+.||.....     ..............+.    ..+..+.
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~-----~~~~~~i~~~~~~~p~----~~~~~~~  224 (325)
T cd05594         154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELILMEEIRFPR----TLSPEAK  224 (325)
T ss_pred             ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH-----HHHHHHHhcCCCCCCC----CCCHHHH
Confidence            456799999999999998999999999999999999999999852111     1111111122222222    2345678


Q ss_pred             HHHHHcccCCCCCCC-----CHHHHHH
Q 039137          882 QVAFSCLDQNPESRP-----TMKRVSQ  903 (912)
Q Consensus       882 ~li~~cl~~dP~~RP-----t~~evl~  903 (912)
                      +++.+||+.||++|+     ++.++++
T Consensus       225 ~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         225 SLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             HHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence            999999999999996     8888864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=6.3e-37  Score=335.68  Aligned_cols=240  Identities=24%  Similarity=0.379  Sum_probs=193.9

Q ss_pred             ceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEEcCCeeeEEEeecC
Q 039137          644 HCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSHPKHSFIIYEYLE  721 (912)
Q Consensus       644 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  721 (912)
                      +.||+|+||+||+|+.+ +++.||+|++....... ....+.+..|..++..+ +||||+++++++...+..|+||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~   79 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQ-DDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVN   79 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhh-ccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCC
Confidence            46999999999999876 68899999986432211 11345677888888877 69999999999999999999999999


Q ss_pred             CCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCCCc
Q 039137          722 SGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNW  801 (912)
Q Consensus       722 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  801 (912)
                      +|+|.+++..   ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.........
T Consensus        80 ~g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~  153 (320)
T cd05590          80 GGDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT  153 (320)
T ss_pred             CchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcc
Confidence            9999998843   34688999999999999999999999   99999999999999999999999999987644333334


Q ss_pred             cccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHHHHHH
Q 039137          802 SELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIM  881 (912)
Q Consensus       802 ~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  881 (912)
                      ....|++.|+|||++.+..++.++||||+||++|||++|+.||.....     ......+.......+.    ..+..+.
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-----~~~~~~i~~~~~~~~~----~~~~~~~  224 (320)
T cd05590         154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-----DDLFEAILNDEVVYPT----WLSQDAV  224 (320)
T ss_pred             cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-----HHHHHHHhcCCCCCCC----CCCHHHH
Confidence            456789999999999998999999999999999999999999862211     1111222222222222    2345678


Q ss_pred             HHHHHcccCCCCCCCCHH
Q 039137          882 QVAFSCLDQNPESRPTMK  899 (912)
Q Consensus       882 ~li~~cl~~dP~~RPt~~  899 (912)
                      +++.+|++.||++||++.
T Consensus       225 ~li~~~L~~dP~~R~~~~  242 (320)
T cd05590         225 DILKAFMTKNPTMRLGSL  242 (320)
T ss_pred             HHHHHHcccCHHHCCCCC
Confidence            999999999999999983

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.1e-36  Score=334.63  Aligned_cols=244  Identities=23%  Similarity=0.336  Sum_probs=197.1

Q ss_pred             CCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCC-CccccEEEEEEcCCeeeEE
Q 039137          639 DFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH-RNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h-~niv~l~~~~~~~~~~~lv  716 (912)
                      +|++.+.||+|+||.||+|+.+ +++.||+|++....... ....+.+..|++++..++| ++|+++++++...+..|+|
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv   79 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQ-DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV   79 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEE
Confidence            5888999999999999999876 67899999987543211 1245667889999999975 5688899999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++|+|.+++..   ...+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++.....
T Consensus        80 ~E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05587          80 MEYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF  153 (324)
T ss_pred             EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence            999999999998843   34588999999999999999999999   999999999999999999999999999875433


Q ss_pred             CCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHH
Q 039137          797 DSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKK  876 (912)
Q Consensus       797 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  876 (912)
                      .........|++.|+|||++.+..++.++||||+||++|||++|+.||.....     .............++.    ..
T Consensus       154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-----~~~~~~i~~~~~~~~~----~~  224 (324)
T cd05587         154 GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-----DELFQSIMEHNVSYPK----SL  224 (324)
T ss_pred             CCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----HHHHHHHHcCCCCCCC----CC
Confidence            33334456789999999999999999999999999999999999999862211     1112222223333322    23


Q ss_pred             HHHHHHHHHHcccCCCCCCCCH
Q 039137          877 LMSIMQVAFSCLDQNPESRPTM  898 (912)
Q Consensus       877 ~~~l~~li~~cl~~dP~~RPt~  898 (912)
                      +..+.+++.+||+.||.+|++.
T Consensus       225 ~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         225 SKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             CHHHHHHHHHHhhcCHHHcCCC
Confidence            4567899999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.4e-36  Score=338.62  Aligned_cols=259  Identities=25%  Similarity=0.402  Sum_probs=205.3

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC------CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcC-CCccccEEEEEEc
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP------SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR-HRNIVKFYGFCSH  709 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~  709 (912)
                      .++|++.+.||+|+||.||+|++.      .+..||||++.....   ....+.+.+|+++++.++ ||||+++++++.+
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~  112 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR---SSEKQALMSELKIMTHLGPHLNIVNLLGACTK  112 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC---hHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence            568999999999999999999752      234699999865432   224567899999999996 9999999999999


Q ss_pred             CCeeeEEEeecCCCChhhHhhccCC-------------------------------------------------------
Q 039137          710 PKHSFIIYEYLESGSLDKILCNDAS-------------------------------------------------------  734 (912)
Q Consensus       710 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------  734 (912)
                      .+..++||||+++|+|.++++....                                                       
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (400)
T cd05105         113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML  192 (400)
T ss_pred             CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence            9999999999999999998854211                                                       


Q ss_pred             --------------------------------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeE
Q 039137          735 --------------------------------------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVL  776 (912)
Q Consensus       735 --------------------------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nil  776 (912)
                                                            ...+++.++.+++.|++.|++|||+.   +|+||||||+||+
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nil  269 (400)
T cd05105         193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVL  269 (400)
T ss_pred             hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEE
Confidence                                                  12478889999999999999999999   9999999999999


Q ss_pred             EcCCCcEEEeccccccccCCCCC--CccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccc
Q 039137          777 LDLGYEAHVSDFGIAKFLNPDSS--NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSS  853 (912)
Q Consensus       777 l~~~~~~kl~Dfgla~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~  853 (912)
                      ++.++.+||+|||+++.......  ......+++.|+|||.+.+..++.++|||||||++|||++ |..||......   
T Consensus       270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~---  346 (400)
T cd05105         270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD---  346 (400)
T ss_pred             EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh---
Confidence            99999999999999986543222  1223456788999999998889999999999999999997 99997532110   


Q ss_pred             cccchhhhccC-CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 039137          854 SSNMNIEMLDS-RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI  909 (912)
Q Consensus       854 ~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l  909 (912)
                       .......... ..+.+    ...+..+.+++.+||+.||++|||+.++.++|++.+
T Consensus       347 -~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         347 -STFYNKIKSGYRMAKP----DHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             -HHHHHHHhcCCCCCCC----ccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence             0001111111 11111    233456889999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.1e-36  Score=324.17  Aligned_cols=255  Identities=27%  Similarity=0.470  Sum_probs=209.5

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      ...+|++.+.||+|+||.||+|..++++.+|+|.+.....    .....+.+|+++++.++||||+++++++...+..++
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL----LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI   79 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch----hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence            4567999999999999999999988899999999864322    135678899999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ||||+++++|.+++.... ...+++.+++.++.|++.|++|||++   +|+|+||+|+||++++++.+|++|||.+....
T Consensus        80 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~  155 (261)
T cd05148          80 ITELMEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIK  155 (261)
T ss_pred             EEeecccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcC
Confidence            999999999999995533 35689999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccC-CCCCCChhh
Q 039137          796 PDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDS-RLPYPSLHV  873 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  873 (912)
                      ..........+++.|+|||++.+..++.++||||||+++|+|++ |+.||.....     .......... +.+.+    
T Consensus       156 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~----  226 (261)
T cd05148         156 EDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN-----HEVYDQITAGYRMPCP----  226 (261)
T ss_pred             CccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH-----HHHHHHHHhCCcCCCC----
Confidence            43333334456778999999988889999999999999999998 8999853211     1111111111 11111    


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 039137          874 QKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCE  907 (912)
Q Consensus       874 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  907 (912)
                      ...+..+.+++.+||+.||.+|||++++.+.|+.
T Consensus       227 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         227 AKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence            2334568899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-37  Score=342.83  Aligned_cols=251  Identities=24%  Similarity=0.352  Sum_probs=204.4

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ++|++.+.||+|+||+||+|+.. +++.||+|++....... ......+.+|++++..++||||+++++++.+++..++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   79 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIK-RNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLV   79 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhh-ccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEE
Confidence            47899999999999999999876 78999999986432211 11456788999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++++|.+++...   ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++.....
T Consensus        80 ~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~  153 (350)
T cd05573          80 MEYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK  153 (350)
T ss_pred             EcCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence            9999999999999543   5689999999999999999999999   999999999999999999999999999986654


Q ss_pred             CC-----------------------------CCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccch
Q 039137          797 DS-----------------------------SNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFL  847 (912)
Q Consensus       797 ~~-----------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~  847 (912)
                      ..                             .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~  233 (350)
T cd05573         154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD  233 (350)
T ss_pred             cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence            33                             1223456899999999999999999999999999999999999998532


Q ss_pred             hccccccccchhhhcc--CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 039137          848 FEMSSSSSNMNIEMLD--SRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPT-MKRVSQ  903 (912)
Q Consensus       848 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~  903 (912)
                      ..     ......+..  .....+..  ...+..+.++|.+|+. ||.+||+ ++|+++
T Consensus       234 ~~-----~~~~~~i~~~~~~~~~p~~--~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~  284 (350)
T cd05573         234 TL-----QETYNKIINWKESLRFPPD--PPVSPEAIDLICRLLC-DPEDRLGSFEEIKS  284 (350)
T ss_pred             CH-----HHHHHHHhccCCcccCCCC--CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence            11     111111111  12222211  1145668899999997 9999999 999876

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.8e-37  Score=314.81  Aligned_cols=252  Identities=24%  Similarity=0.321  Sum_probs=194.1

Q ss_pred             CCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCC-----e
Q 039137          639 DFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPK-----H  712 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-----~  712 (912)
                      .|...+++|.|+||.||+|... +++.||||++-.+.....        +|+++|+.++|||||++.-+|....     .
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~kn--------rEl~im~~l~HpNIV~L~~~f~~~~~~d~~~   96 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKN--------RELQIMRKLDHPNIVRLLYFFSSSTESDEVY   96 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCc--------HHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence            4667799999999999999865 578999999876554332        7999999999999999998885432     3


Q ss_pred             eeEEEeecCCCChhhHhhcc-CCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCC-CcEEEecccc
Q 039137          713 SFIIYEYLESGSLDKILCND-ASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLG-YEAHVSDFGI  790 (912)
Q Consensus       713 ~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~Dfgl  790 (912)
                      ..+|||||+. +|.++++.. .....++.-.+.-+.+||++|++|||+.   +|+||||||.|+|+|.+ |.+||||||.
T Consensus        97 lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGS  172 (364)
T KOG0658|consen   97 LNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGS  172 (364)
T ss_pred             HHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCc
Confidence            4689999987 998888542 2345688889999999999999999998   99999999999999965 8999999999


Q ss_pred             ccccCCCCCCccccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCccchhcccc------------cc--c
Q 039137          791 AKFLNPDSSNWSELAGTHGYVAPELAYTL-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS------------SS--S  855 (912)
Q Consensus       791 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~------------~~--~  855 (912)
                      |+.+...... .....+.-|+|||.+.|. .|+.+.||||.|||+.||+-|++-|........            .+  .
T Consensus       173 AK~L~~~epn-iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~  251 (364)
T KOG0658|consen  173 AKVLVKGEPN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIK  251 (364)
T ss_pred             ceeeccCCCc-eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence            9988766544 556778999999988764 699999999999999999999998853111000            00  0


Q ss_pred             cchhh---hccCCCCCC---ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          856 NMNIE---MLDSRLPYP---SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       856 ~~~~~---~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .+...   ...+.+...   ........++..+++.+++..+|.+|.++.|++.
T Consensus       252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence            01111   001111111   1122334567899999999999999999998874

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-37  Score=325.51  Aligned_cols=255  Identities=25%  Similarity=0.410  Sum_probs=208.2

Q ss_pred             cCCCCCceeeecCceEEEEEEeC---CCC--EEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCe
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP---SGE--IFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKH  712 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~---~~~--~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~  712 (912)
                      +.....+.||+|.||.||+|.+.   .|+  .||||.-+.+-   .....+.|++|..+|+.++||||++++|+|.+ ..
T Consensus       389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~---t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P  464 (974)
T KOG4257|consen  389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC---TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QP  464 (974)
T ss_pred             hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC---ChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cc
Confidence            34566789999999999999753   343  47888776533   23357889999999999999999999999975 56


Q ss_pred             eeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccccc
Q 039137          713 SFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK  792 (912)
Q Consensus       713 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  792 (912)
                      .|+|||.++.|-|..|++.++  ..++......+++||+.||+|||++   ++|||||.++|||+.....||++|||+++
T Consensus       465 ~WivmEL~~~GELr~yLq~nk--~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR  539 (974)
T KOG4257|consen  465 MWIVMELAPLGELREYLQQNK--DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSR  539 (974)
T ss_pred             eeEEEecccchhHHHHHHhcc--ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhh
Confidence            899999999999999996544  4588899999999999999999999   99999999999999999999999999999


Q ss_pred             ccCCCCCCcc-ccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhc-cCCCCCC
Q 039137          793 FLNPDSSNWS-ELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEML-DSRLPYP  869 (912)
Q Consensus       793 ~~~~~~~~~~-~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~  869 (912)
                      .+.++..... ...-...|||||.+.-.+++.++|||.|||++||+++ |..||......     +....+- ..++|.|
T Consensus       540 ~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs-----DVI~~iEnGeRlP~P  614 (974)
T KOG4257|consen  540 YLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS-----DVIGHIENGERLPCP  614 (974)
T ss_pred             hccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc-----ceEEEecCCCCCCCC
Confidence            9876643322 2233568999999999999999999999999999998 99998633221     1111111 2344544


Q ss_pred             ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          870 SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       870 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                          +.+++.++.++.+||+++|.+||++.|+...|.+.+.
T Consensus       615 ----~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  615 ----PNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             ----CCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence                3456678899999999999999999999999998875

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=3e-36  Score=319.88  Aligned_cols=250  Identities=27%  Similarity=0.456  Sum_probs=201.8

Q ss_pred             cCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIY  717 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  717 (912)
                      ++|++.+.||+|+||.||+|+++++..+|+|.+.....     ..+.+.+|+++++.++||||+++++++...+..++||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   78 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM-----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVT   78 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc-----cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEE
Confidence            46888999999999999999988888999998763321     2467889999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCC
Q 039137          718 EYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPD  797 (912)
Q Consensus       718 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  797 (912)
                      ||+++|+|.+++....  ..+++..+..++.|++.|++|||++   +|+||||||+||++++++.+|++|||.++.....
T Consensus        79 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~  153 (256)
T cd05114          79 EFMENGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD  153 (256)
T ss_pred             EcCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCC
Confidence            9999999999985432  3588999999999999999999999   9999999999999999999999999999865432


Q ss_pred             CCC-ccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccC-CCCCCChhhH
Q 039137          798 SSN-WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDS-RLPYPSLHVQ  874 (912)
Q Consensus       798 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  874 (912)
                      ... .....++..|+|||++.+..++.++||||||+++|||++ |+.||.....     .......... ....+.    
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~-----~~~~~~i~~~~~~~~~~----  224 (256)
T cd05114         154 EYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN-----YEVVEMISRGFRLYRPK----  224 (256)
T ss_pred             ceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHHHCCCCCCCCC----
Confidence            211 122234568999999988889999999999999999999 8999852211     1111111111 111111    


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 039137          875 KKLMSIMQVAFSCLDQNPESRPTMKRVSQLLC  906 (912)
Q Consensus       875 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  906 (912)
                      ..+..+.+++.+||+.+|++||+++++++.|.
T Consensus       225 ~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         225 LASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             CCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            12356889999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.6e-36  Score=338.67  Aligned_cols=252  Identities=22%  Similarity=0.298  Sum_probs=195.2

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ++|++.+.||+|+||+||+|+.. +++.||+|++....... ......+.+|+.++..++||+|+++++++.+....|+|
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv   79 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLE-KEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLI   79 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHH-hhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEE
Confidence            47899999999999999999875 68999999986432111 12345678899999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++|+|.+++..   .+.+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        80 ~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~  153 (363)
T cd05628          80 MEFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK  153 (363)
T ss_pred             EcCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence            999999999999844   35689999999999999999999999   999999999999999999999999999875432


Q ss_pred             CCC-----------------------------------CccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCC
Q 039137          797 DSS-----------------------------------NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGK  841 (912)
Q Consensus       797 ~~~-----------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~  841 (912)
                      ...                                   ......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~  233 (363)
T cd05628         154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY  233 (363)
T ss_pred             cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence            110                                   012347899999999999989999999999999999999999


Q ss_pred             CCccchhccccccccchhhhcc--CCCCCCChhhHHHHHHHHHHHHHccc--CCCCCCCCHHHHHH
Q 039137          842 HPRDFLFEMSSSSSNMNIEMLD--SRLPYPSLHVQKKLMSIMQVAFSCLD--QNPESRPTMKRVSQ  903 (912)
Q Consensus       842 ~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~--~dP~~RPt~~evl~  903 (912)
                      .||.....     ......+..  ....++..  ...+..+.+++.+++.  .++..||+++|+++
T Consensus       234 ~Pf~~~~~-----~~~~~~i~~~~~~~~~p~~--~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~  292 (363)
T cd05628         234 PPFCSETP-----QETYKKVMNWKETLIFPPE--VPISEKAKDLILRFCCEWEHRIGAPGVEEIKT  292 (363)
T ss_pred             CCCCCCCH-----HHHHHHHHcCcCcccCCCc--CCCCHHHHHHHHHHcCChhhcCCCCCHHHHhC
Confidence            99852211     111111111  11222211  1123446667766443  33445689998875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=4.1e-36  Score=320.78  Aligned_cols=255  Identities=28%  Similarity=0.470  Sum_probs=205.8

Q ss_pred             cCCCCCceeeecCceEEEEEEeC----CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCee
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP----SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHS  713 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  713 (912)
                      ++|++.+.||+|+||+||+|.++    +...||+|.+.....   .....++.+|+..++.++||||+++++++...+..
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS---DKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV   80 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCC---hHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence            57899999999999999999875    245799998865432   22456788999999999999999999999999999


Q ss_pred             eEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccc
Q 039137          714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKF  793 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  793 (912)
                      ++||||+++++|.+++....  +.+++.++++++.|++.|++|||++   +|+|+||||+||++++++.++++|||++..
T Consensus        81 ~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~  155 (266)
T cd05033          81 MIITEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRR  155 (266)
T ss_pred             EEEEEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhc
Confidence            99999999999999985432  4689999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCCcc--ccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccC-CCCCC
Q 039137          794 LNPDSSNWS--ELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDS-RLPYP  869 (912)
Q Consensus       794 ~~~~~~~~~--~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~  869 (912)
                      .........  ...+++.|+|||.+.+..++.++||||||+++|||++ |..||.....     .......... ..+.+
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~  230 (266)
T cd05033         156 LEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-----QDVIKAVEDGYRLPPP  230 (266)
T ss_pred             ccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH-----HHHHHHHHcCCCCCCC
Confidence            752222211  2334678999999998889999999999999999998 9999742110     1111111111 11111


Q ss_pred             ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 039137          870 SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI  909 (912)
Q Consensus       870 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l  909 (912)
                          ...+..+.+++.+||+.+|++||+++|+++.|++.+
T Consensus       231 ----~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~  266 (266)
T cd05033         231 ----MDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI  266 (266)
T ss_pred             ----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence                123456889999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.5e-36  Score=341.06  Aligned_cols=251  Identities=21%  Similarity=0.300  Sum_probs=196.6

Q ss_pred             CCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEE
Q 039137          639 DFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIY  717 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  717 (912)
                      .|++.+.||+|+||+||+|+.. +++.||+|++....... ....+.+.+|+++++.++||||+++++++.+++..++||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~-~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~   80 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLN-RNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence            5888999999999999999865 78899999986432211 124567889999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCC
Q 039137          718 EYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPD  797 (912)
Q Consensus       718 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  797 (912)
                      ||+++|+|.+++.+   ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++++||+|||++......
T Consensus        81 E~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~  154 (381)
T cd05626          81 DYIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT  154 (381)
T ss_pred             ecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence            99999999999844   34588999999999999999999999   9999999999999999999999999997543110


Q ss_pred             CC-----------------------------------------------CccccccccccccccccccCCCCcchhHHHH
Q 039137          798 SS-----------------------------------------------NWSELAGTHGYVAPELAYTLKVTEKCDVYSF  830 (912)
Q Consensus       798 ~~-----------------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~sDvwsl  830 (912)
                      ..                                               ......||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (381)
T cd05626         155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV  234 (381)
T ss_pred             cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence            00                                               0123468999999999998889999999999


Q ss_pred             HHHHHHHHhCCCCccchhccccccccchhhhcc--CCCCCCChhhHHHHHHHHHHHHH--cccCCCCCCCCHHHHHH
Q 039137          831 GVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLD--SRLPYPSLHVQKKLMSIMQVAFS--CLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       831 G~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~--cl~~dP~~RPt~~evl~  903 (912)
                      ||++|||++|+.||......     ........  .....+.  ....+.++.+++.+  |+..+|.+||+++|+++
T Consensus       235 G~il~elltG~~Pf~~~~~~-----~~~~~i~~~~~~~~~~~--~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~  304 (381)
T cd05626         235 GVILFEMLVGQPPFLAPTPT-----ETQLKVINWENTLHIPP--QVKLSPEAVDLITKLCCSAEERLGRNGADDIKA  304 (381)
T ss_pred             hhHHHHHHhCCCCCcCCCHH-----HHHHHHHccccccCCCC--CCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence            99999999999998632110     11111111  1111211  11234557788877  55667777999999875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-37  Score=342.05  Aligned_cols=251  Identities=24%  Similarity=0.315  Sum_probs=198.7

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ++|++.+.||+|+||+||+|+.. +++.||||++....... ......+.+|+++++.++||||+++++++.+++..++|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv   79 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLE-KEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLI   79 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEE
Confidence            47899999999999999999876 68999999986432111 12345678899999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++|+|.+++..   ...+++.++..++.|++.||+|||++   +|+||||||+||+++.++.++|+|||++..+..
T Consensus        80 ~E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  153 (364)
T cd05599          80 MEYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK  153 (364)
T ss_pred             ECCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence            999999999999854   34589999999999999999999999   999999999999999999999999999875432


Q ss_pred             CCC--------------------------------------CccccccccccccccccccCCCCcchhHHHHHHHHHHHH
Q 039137          797 DSS--------------------------------------NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVI  838 (912)
Q Consensus       797 ~~~--------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ell  838 (912)
                      ...                                      ......||+.|+|||++.+..++.++|||||||++|||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~  233 (364)
T cd05599         154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML  233 (364)
T ss_pred             cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence            110                                      001235899999999999888999999999999999999


Q ss_pred             hCCCCccchhccccccccchhhhcc--CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 039137          839 KGKHPRDFLFEMSSSSSNMNIEMLD--SRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPT---MKRVSQ  903 (912)
Q Consensus       839 tg~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~evl~  903 (912)
                      +|..||......     ........  .....+..  ...+..+.+++.+|+. +|.+|++   ++|+++
T Consensus       234 ~G~~Pf~~~~~~-----~~~~~i~~~~~~~~~~~~--~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         234 VGYPPFCSDNPQ-----ETYRKIINWKETLQFPDE--VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             cCCCCCCCCCHH-----HHHHHHHcCCCccCCCCC--CCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            999998532111     11111111  11222211  1234567788999996 9999998   777654

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.5e-36  Score=333.24  Aligned_cols=244  Identities=22%  Similarity=0.348  Sum_probs=196.1

Q ss_pred             ceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEEcCCeeeEEEeecC
Q 039137          644 HCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSHPKHSFIIYEYLE  721 (912)
Q Consensus       644 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  721 (912)
                      +.||+|+||.||+|+.+ +++.||+|++....... ....+.+..|.+++..+ +||||+++++++..++..|+||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~   79 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQ-DDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVN   79 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhh-hhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCC
Confidence            46999999999999876 67899999986532211 11345677888888876 79999999999999999999999999


Q ss_pred             CCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCCCc
Q 039137          722 SGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNW  801 (912)
Q Consensus       722 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  801 (912)
                      +|+|.+++..   ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++..........
T Consensus        80 ~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  153 (321)
T cd05591          80 GGDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT  153 (321)
T ss_pred             CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCccc
Confidence            9999988843   34688999999999999999999999   99999999999999999999999999997654433344


Q ss_pred             cccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHHHHHH
Q 039137          802 SELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIM  881 (912)
Q Consensus       802 ~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  881 (912)
                      ....|++.|+|||++.+..++.++||||+||++|||++|+.||.....     ..............+.    ..+..+.
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~-----~~~~~~i~~~~~~~p~----~~~~~~~  224 (321)
T cd05591         154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-----DDLFESILHDDVLYPV----WLSKEAV  224 (321)
T ss_pred             cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH-----HHHHHHHHcCCCCCCC----CCCHHHH
Confidence            456789999999999998999999999999999999999999863211     1111222222222222    1235678


Q ss_pred             HHHHHcccCCCCCCC-------CHHHHHH
Q 039137          882 QVAFSCLDQNPESRP-------TMKRVSQ  903 (912)
Q Consensus       882 ~li~~cl~~dP~~RP-------t~~evl~  903 (912)
                      +++.+||+.||++||       ++.++++
T Consensus       225 ~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         225 SILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             HHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence            999999999999999       6776654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=4.6e-36  Score=352.71  Aligned_cols=263  Identities=24%  Similarity=0.379  Sum_probs=205.8

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++....... ....+++.+|+++++.++||||+++++++.+++..++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~-e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV   80 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSEN-PLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT   80 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccC-HHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence            57999999999999999999876 68999999987544322 22466799999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccC--------CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecc
Q 039137          717 YEYLESGSLDKILCNDA--------SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDF  788 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df  788 (912)
                      |||+++|+|.+++....        .....++.++++++.||+.||+|||++   +|+||||||+||+++.++.++|+||
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDF  157 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDW  157 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEec
Confidence            99999999999985421        123456788899999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCC------------------CCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhcc
Q 039137          789 GIAKFLNPDS------------------SNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEM  850 (912)
Q Consensus       789 gla~~~~~~~------------------~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~  850 (912)
                      |+++......                  .......||+.|+|||++.+..++.++||||+||++|||++|+.||......
T Consensus       158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~  237 (932)
T PRK13184        158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR  237 (932)
T ss_pred             CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence            9998652111                  0112346899999999999999999999999999999999999998521110


Q ss_pred             ccccccchhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHHhhh
Q 039137          851 SSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRP-TMKRVSQLLCEKIF  910 (912)
Q Consensus       851 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~l~  910 (912)
                          ..........  +.........+..+.+++.+|++.||++|| +++++.+.|+..+.
T Consensus       238 ----ki~~~~~i~~--P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq  292 (932)
T PRK13184        238 ----KISYRDVILS--PIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ  292 (932)
T ss_pred             ----hhhhhhhccC--hhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence                0000000000  000001123445688999999999999995 67777777776543

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1e-35  Score=317.91  Aligned_cols=262  Identities=23%  Similarity=0.340  Sum_probs=211.1

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ++|++.+.||+|++|.||+|... +++.||+|.++...... ....+.+.+|++++++++|++++++++++...+..++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv   80 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMD-AKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV   80 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccc-hhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            57999999999999999999887 89999999886432222 22467789999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccC-CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          717 YEYLESGSLDKILCNDA-SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      |||+++++|.+++.... ....+++.+++.++.+++.|++|||+.   +|+||||+|+||+++.++.++++|||.+....
T Consensus        81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~  157 (267)
T cd08224          81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence            99999999999985432 345589999999999999999999999   99999999999999999999999999998665


Q ss_pred             CCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHH
Q 039137          796 PDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQK  875 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  875 (912)
                      ..........+++.|+|||.+.+..++.++||||+|+++|+|++|+.||.....   ..............+  ......
T Consensus       158 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~--~~~~~~  232 (267)
T cd08224         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLYSLCKKIEKCDYP--PLPADH  232 (267)
T ss_pred             CCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc---cHHHHHhhhhcCCCC--CCChhh
Confidence            443333445688899999999888899999999999999999999999742110   000000011111111  111123


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 039137          876 KLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEK  908 (912)
Q Consensus       876 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  908 (912)
                      .+..+.+++.+||..+|++|||+.+++++|+++
T Consensus       233 ~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         233 YSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             cCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence            455688999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.6e-36  Score=333.21  Aligned_cols=244  Identities=23%  Similarity=0.338  Sum_probs=198.0

Q ss_pred             CCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEEcCCeeeEE
Q 039137          639 DFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv  716 (912)
                      +|++.+.||+|+||+||+|+.+ +++.||+|++....... ....+.+..|..++..+ +|++|+++++++...+..++|
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv   79 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQ-DDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFV   79 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEE
Confidence            5888999999999999999876 67899999987543221 11345567788888877 589999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++|+|.+++..   ...+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        80 ~E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~  153 (323)
T cd05616          80 MEYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW  153 (323)
T ss_pred             EcCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence            999999999998843   34588999999999999999999999   999999999999999999999999999976543


Q ss_pred             CCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHH
Q 039137          797 DSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKK  876 (912)
Q Consensus       797 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  876 (912)
                      .........|++.|+|||++.+..++.++|||||||++|||++|+.||.....     ......+......++.    ..
T Consensus       154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-----~~~~~~i~~~~~~~p~----~~  224 (323)
T cd05616         154 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----DELFQSIMEHNVAYPK----SM  224 (323)
T ss_pred             CCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCCCCCC----cC
Confidence            33344456789999999999999999999999999999999999999863211     1122222333333332    23


Q ss_pred             HHHHHHHHHHcccCCCCCCCCH
Q 039137          877 LMSIMQVAFSCLDQNPESRPTM  898 (912)
Q Consensus       877 ~~~l~~li~~cl~~dP~~RPt~  898 (912)
                      +..+.+++.+|++.||.+|++.
T Consensus       225 s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         225 SKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             CHHHHHHHHHHcccCHHhcCCC
Confidence            4567899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=5.6e-37  Score=336.87  Aligned_cols=240  Identities=24%  Similarity=0.309  Sum_probs=190.9

Q ss_pred             ceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHH-HHhhcCCCccccEEEEEEcCCeeeEEEeecC
Q 039137          644 HCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQ-ALTEIRHRNIVKFYGFCSHPKHSFIIYEYLE  721 (912)
Q Consensus       644 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  721 (912)
                      +.||+|+||+||+|+.+ +|+.||+|++......... ...++.+|.. +++.++||||+++++++..++..++||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~   79 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKK-EQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVN   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhh-HHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCC
Confidence            46999999999999876 7899999998643222111 2344455544 5678899999999999999999999999999


Q ss_pred             CCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCCCc
Q 039137          722 SGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNW  801 (912)
Q Consensus       722 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  801 (912)
                      +|+|.+++..   ...+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||++..........
T Consensus        80 ~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  153 (323)
T cd05575          80 GGELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTT  153 (323)
T ss_pred             CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcc
Confidence            9999998844   34688999999999999999999999   99999999999999999999999999987543333344


Q ss_pred             cccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHHHHHH
Q 039137          802 SELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIM  881 (912)
Q Consensus       802 ~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  881 (912)
                      ....|++.|+|||++.+..++.++|||||||++|||++|+.||....     ...............+.    ..+..+.
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~-----~~~~~~~i~~~~~~~~~----~~~~~~~  224 (323)
T cd05575         154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-----TAEMYDNILNKPLRLKP----NISVSAR  224 (323)
T ss_pred             ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC-----HHHHHHHHHcCCCCCCC----CCCHHHH
Confidence            45678999999999999999999999999999999999999985211     11111122222222221    2245678


Q ss_pred             HHHHHcccCCCCCCCCHH
Q 039137          882 QVAFSCLDQNPESRPTMK  899 (912)
Q Consensus       882 ~li~~cl~~dP~~RPt~~  899 (912)
                      +++.+|++.||.+||++.
T Consensus       225 ~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         225 HLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             HHHHHHhhcCHHhCCCCC
Confidence            999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=3.4e-36  Score=324.07  Aligned_cols=257  Identities=26%  Similarity=0.459  Sum_probs=205.7

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC------CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP------SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP  710 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~  710 (912)
                      .++|.+.+.||+|+||.||+|+..      +++.||+|++......   ...+.+.+|+++++.++||||+++++++...
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   80 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN---DARKDFEREAELLTNFQHENIVKFYGVCTEG   80 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCH---HHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence            356888999999999999999764      3478999998654322   2457889999999999999999999999999


Q ss_pred             CeeeEEEeecCCCChhhHhhccC-----------CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcC
Q 039137          711 KHSFIIYEYLESGSLDKILCNDA-----------SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDL  779 (912)
Q Consensus       711 ~~~~lv~e~~~~g~L~~~l~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~  779 (912)
                      ...++||||+++++|.+++....           ....+++.++..++.|++.|++|||++   +++||||||+||+++.
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~  157 (280)
T cd05049          81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGY  157 (280)
T ss_pred             CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcC
Confidence            99999999999999999996532           234578999999999999999999999   9999999999999999


Q ss_pred             CCcEEEeccccccccCCCCC--CccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhcccccccc
Q 039137          780 GYEAHVSDFGIAKFLNPDSS--NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSN  856 (912)
Q Consensus       780 ~~~~kl~Dfgla~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~  856 (912)
                      ++.++|+|||+++.......  ......+++.|+|||++.+..++.++||||||+++|||++ |..||.....     ..
T Consensus       158 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~-----~~  232 (280)
T cd05049         158 DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN-----EE  232 (280)
T ss_pred             CCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH-----HH
Confidence            99999999999976533221  1223345788999999999999999999999999999998 9999742111     11


Q ss_pred             chhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 039137          857 MNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCE  907 (912)
Q Consensus       857 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  907 (912)
                      ..........+.+.   ...+..+.+++.+||+.||++||++.|+++.|++
T Consensus       233 ~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         233 VIECITQGRLLQRP---RTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             HHHHHHcCCcCCCC---CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence            11111122221111   2234568899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.1e-36  Score=336.31  Aligned_cols=254  Identities=22%  Similarity=0.306  Sum_probs=198.7

Q ss_pred             CCCCCceeeecCceEEEEEEe----CCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEEcCCee
Q 039137          639 DFNAEHCIGKGGHGSVYRAKV----PSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSHPKHS  713 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~  713 (912)
                      +|++.+.||+|+||+||+|+.    .+++.||+|++............+.+.+|+.+++.+ +||+|+++++++..++..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            488899999999999999975    368899999986432222222456678899999999 599999999999999999


Q ss_pred             eEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccc
Q 039137          714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKF  793 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  793 (912)
                      ++||||+++|+|.+++..   ...+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            999999999999999844   34588999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCC-CCccccccccccccccccccCC-CCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCCh
Q 039137          794 LNPDS-SNWSELAGTHGYVAPELAYTLK-VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSL  871 (912)
Q Consensus       794 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~-~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  871 (912)
                      ..... .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||........ .............+.+. 
T Consensus       155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~-  232 (332)
T cd05614         155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT-QSEVSRRILKCDPPFPS-  232 (332)
T ss_pred             ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC-HHHHHHHHhcCCCCCCC-
Confidence            54332 2233457899999999988654 78899999999999999999999852211110 01111112222222221 


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 039137          872 HVQKKLMSIMQVAFSCLDQNPESRP-----TMKRVSQ  903 (912)
Q Consensus       872 ~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~  903 (912)
                         ..+..+.+++.+||+.||++||     +++++++
T Consensus       233 ---~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         233 ---FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             ---CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence               2345578899999999999999     6666654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.6e-36  Score=331.86  Aligned_cols=243  Identities=25%  Similarity=0.355  Sum_probs=192.5

Q ss_pred             ceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEEcCCeeeEEEeecC
Q 039137          644 HCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSHPKHSFIIYEYLE  721 (912)
Q Consensus       644 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  721 (912)
                      +.||+|+||+||+|+.. +++.||+|+++........ ..+.+..|..++... +||||+++++++...+..++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~   79 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDD-DVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLN   79 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhh-hHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence            46999999999999875 6889999998754322111 334455677776654 89999999999999999999999999


Q ss_pred             CCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCCCc
Q 039137          722 SGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNW  801 (912)
Q Consensus       722 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  801 (912)
                      +|+|.+++..   ...+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.........
T Consensus        80 gg~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~  153 (316)
T cd05592          80 GGDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA  153 (316)
T ss_pred             CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcc
Confidence            9999998843   34689999999999999999999999   99999999999999999999999999998654433444


Q ss_pred             cccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHHHHHH
Q 039137          802 SELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIM  881 (912)
Q Consensus       802 ~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  881 (912)
                      ....|++.|+|||++.+..++.++||||+||++|||++|+.||.....     ......+.......+.    ..+..+.
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~-----~~~~~~i~~~~~~~~~----~~~~~~~  224 (316)
T cd05592         154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-----DELFDSILNDRPHFPR----WISKEAK  224 (316)
T ss_pred             ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHcCCCCCCC----CCCHHHH
Confidence            556789999999999998899999999999999999999999863211     1111112222222221    2344577


Q ss_pred             HHHHHcccCCCCCCCCHH-HHH
Q 039137          882 QVAFSCLDQNPESRPTMK-RVS  902 (912)
Q Consensus       882 ~li~~cl~~dP~~RPt~~-evl  902 (912)
                      +++.+||+.||.+||++. +++
T Consensus       225 ~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         225 DCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             HHHHHHccCCHHHcCCChHHHH
Confidence            899999999999999875 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-38  Score=310.44  Aligned_cols=247  Identities=28%  Similarity=0.451  Sum_probs=211.8

Q ss_pred             CCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEEe
Q 039137          640 FNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYE  718 (912)
Q Consensus       640 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e  718 (912)
                      |.+.++||+|+||.||+|.++ +|+.+|||++....      ...++.+|+.+|++.+.|+||++||.+......|+|||
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s------DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME  108 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT------DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME  108 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc------hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence            567789999999999999876 79999999986432      56788999999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCC
Q 039137          719 YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS  798 (912)
Q Consensus       719 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  798 (912)
                      ||..|+..++++.  ..+++++.++..+++..++||+|||..   .=+|||||+.|||++.+|.+|++|||.|..+.+.-
T Consensus       109 YCGAGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM  183 (502)
T KOG0574|consen  109 YCGAGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM  183 (502)
T ss_pred             hcCCCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhH
Confidence            9999999999944  346799999999999999999999998   77999999999999999999999999998876655


Q ss_pred             CCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHHH
Q 039137          799 SNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLM  878 (912)
Q Consensus       799 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  878 (912)
                      ....+..|||.|||||++..-.|+.++||||+|+...||..|++||....++..      ..++....|.........+.
T Consensus       184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA------IFMIPT~PPPTF~KPE~WS~  257 (502)
T KOG0574|consen  184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA------IFMIPTKPPPTFKKPEEWSS  257 (502)
T ss_pred             HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce------eEeccCCCCCCCCChHhhhh
Confidence            566778999999999999999999999999999999999999999864433321      12222233322234455677


Q ss_pred             HHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          879 SIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       879 ~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ++.+++++|+-+.|++|-|+-++++
T Consensus       258 ~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  258 EFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             HHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            8999999999999999999988775

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=3.1e-36  Score=320.80  Aligned_cols=254  Identities=22%  Similarity=0.408  Sum_probs=205.8

Q ss_pred             hcCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      .++|++.+.||+|++|.||+|...++..||+|.+....     ...+.+.+|+.+++.++|+||+++++++...+..++|
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   79 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYII   79 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEE
Confidence            46789999999999999999998888899999876422     1356788999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++++|.+++... ....+++.+++.++.|++.|++|||+.   +++||||||+||+++.++.++++|||++.....
T Consensus        80 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05072          80 TEYMAKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIED  155 (261)
T ss_pred             EecCCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCC
Confidence            9999999999998543 334688899999999999999999999   999999999999999999999999999987643


Q ss_pred             CCCC-ccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccCCCCCCChhhH
Q 039137          797 DSSN-WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQ  874 (912)
Q Consensus       797 ~~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  874 (912)
                      .... .....++..|+|||++.+..++.++||||||+++|+|++ |+.||.....     ....... ......+..  .
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~-----~~~~~~~-~~~~~~~~~--~  227 (261)
T cd05072         156 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN-----SDVMSAL-QRGYRMPRM--E  227 (261)
T ss_pred             CceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH-----HHHHHHH-HcCCCCCCC--C
Confidence            3211 122345678999999988889999999999999999998 9999852111     0111111 111111111  1


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 039137          875 KKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCE  907 (912)
Q Consensus       875 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  907 (912)
                      ..+..+.+++.+||+.+|++||+++++.+.|++
T Consensus       228 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         228 NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            234568899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=4.5e-36  Score=330.65  Aligned_cols=199  Identities=28%  Similarity=0.421  Sum_probs=174.4

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      .++|++.+.||+|+||.||+|.++ ++..+|+|.+.....   ....+.+.+|+++++.++||||+++++++...+..++
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK---PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   80 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccC---HHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence            468999999999999999999876 688899998765422   2245678999999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ||||+++|+|.+++..   .+.+++..+..++.|++.|++|||+..  +|+|+||||+||+++.++.+||+|||++....
T Consensus        81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~  155 (333)
T cd06650          81 CMEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  155 (333)
T ss_pred             EEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence            9999999999999944   345788999999999999999999742  79999999999999999999999999997653


Q ss_pred             CCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcc
Q 039137          796 PDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRD  845 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~  845 (912)
                      ..  ......|++.|+|||++.+..++.++|||||||++|||++|+.||+
T Consensus       156 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~  203 (333)
T cd06650         156 DS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIP  203 (333)
T ss_pred             hh--ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence            32  2234568999999999998889999999999999999999999986

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=6e-37  Score=336.90  Aligned_cols=245  Identities=22%  Similarity=0.264  Sum_probs=191.7

Q ss_pred             ceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHH-HHHhhcCCCccccEEEEEEcCCeeeEEEeecC
Q 039137          644 HCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEI-QALTEIRHRNIVKFYGFCSHPKHSFIIYEYLE  721 (912)
Q Consensus       644 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  721 (912)
                      +.||+|+||+||+|+++ +++.||+|++......... ....+.+|. .+++.++||||+++++++...+..++||||++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~-~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~   79 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKK-EEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN   79 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhh-HHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCC
Confidence            46999999999999876 6788999998643221111 223344444 45678899999999999999999999999999


Q ss_pred             CCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCCCc
Q 039137          722 SGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNW  801 (912)
Q Consensus       722 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  801 (912)
                      +|+|.+++..   ...+++.++..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++.........
T Consensus        80 ~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~  153 (325)
T cd05602          80 GGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTT  153 (325)
T ss_pred             CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCc
Confidence            9999999844   34578889999999999999999999   99999999999999999999999999997644333344


Q ss_pred             cccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHHHHHH
Q 039137          802 SELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIM  881 (912)
Q Consensus       802 ~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  881 (912)
                      ....|++.|+|||++.+..++.++||||+||++|||++|+.||.....     ..............+    ...+..+.
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~i~~~~~~~~----~~~~~~~~  224 (325)
T cd05602         154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-----AEMYDNILNKPLQLK----PNITNSAR  224 (325)
T ss_pred             ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH-----HHHHHHHHhCCcCCC----CCCCHHHH
Confidence            556799999999999999999999999999999999999999852111     111111222222221    12345678


Q ss_pred             HHHHHcccCCCCCCCCHHHHHHH
Q 039137          882 QVAFSCLDQNPESRPTMKRVSQL  904 (912)
Q Consensus       882 ~li~~cl~~dP~~RPt~~evl~~  904 (912)
                      +++.+|++.||.+||++.+.+..
T Consensus       225 ~li~~~l~~~p~~R~~~~~~~~~  247 (325)
T cd05602         225 HLLEGLLQKDRTKRLGAKDDFME  247 (325)
T ss_pred             HHHHHHcccCHHHCCCCCCCHHH
Confidence            99999999999999998754433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=4.7e-36  Score=320.57  Aligned_cols=254  Identities=28%  Similarity=0.398  Sum_probs=202.0

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++......    ..+.+.+|+.++++++||||+++++++...+..++
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~----~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~i   83 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD----DFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWI   83 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc----hHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEE
Confidence            357999999999999999999864 7889999998643221    34567889999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ||||+++++|.++++.   ...+++.++..++.|++.|++|||++   +|+|||++|+||+++.++.++|+|||++....
T Consensus        84 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~  157 (267)
T cd06646          84 CMEYCGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKIT  157 (267)
T ss_pred             EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeec
Confidence            9999999999998843   34688999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCCccccccccccccccccc---cCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCCh-
Q 039137          796 PDSSNWSELAGTHGYVAPELAY---TLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSL-  871 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-  871 (912)
                      ..........+++.|+|||.+.   ...++.++||||+||++|||++|+.||.........     ..........+.. 
T Consensus       158 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~-----~~~~~~~~~~~~~~  232 (267)
T cd06646         158 ATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-----FLMSKSNFQPPKLK  232 (267)
T ss_pred             ccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh-----eeeecCCCCCCCCc
Confidence            4333334456889999999874   345788999999999999999999997422111100     0001111111110 


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 039137          872 HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL  905 (912)
Q Consensus       872 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  905 (912)
                      .....+..+.+++.+||+.||++|||++++++.+
T Consensus       233 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         233 DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            1122346788999999999999999999998643

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=5.4e-36  Score=323.08  Aligned_cols=256  Identities=23%  Similarity=0.417  Sum_probs=205.1

Q ss_pred             cCCCCCceeeecCceEEEEEEeCC------CCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCC
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVPS------GEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPK  711 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~  711 (912)
                      ++|++.+.||+|+||.||+|....      ...||+|.+....   ......++.+|++.++.++||||+++++++...+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~   81 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA---EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ   81 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC---CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence            478899999999999999997642      2579999886432   2224567899999999999999999999999989


Q ss_pred             eeeEEEeecCCCChhhHhhccCC-------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEc
Q 039137          712 HSFIIYEYLESGSLDKILCNDAS-------------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLD  778 (912)
Q Consensus       712 ~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~  778 (912)
                      ..+++|||+++++|.+++.....             ...+++.+++.++.|++.|++|||++   +++|+||||+||+++
T Consensus        82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~  158 (283)
T cd05048          82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVG  158 (283)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEc
Confidence            99999999999999999965321             14588899999999999999999999   999999999999999


Q ss_pred             CCCcEEEeccccccccCCCCC--CccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccc
Q 039137          779 LGYEAHVSDFGIAKFLNPDSS--NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSS  855 (912)
Q Consensus       779 ~~~~~kl~Dfgla~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~  855 (912)
                      +++.++|+|||++........  ......+++.|+|||++.+..++.++|||||||++|||++ |..||.....     .
T Consensus       159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~-----~  233 (283)
T cd05048         159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN-----Q  233 (283)
T ss_pred             CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH-----H
Confidence            999999999999976533221  1223456788999999988889999999999999999998 9999752211     1


Q ss_pred             cchhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 039137          856 NMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCE  907 (912)
Q Consensus       856 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  907 (912)
                      .....+.....+.   .....+.++.+++.+||+.||++||+++||++.|+.
T Consensus       234 ~~~~~i~~~~~~~---~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         234 EVIEMIRSRQLLP---CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHHHHcCCcCC---CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            1111111111111   112345678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.9e-37  Score=337.47  Aligned_cols=247  Identities=23%  Similarity=0.301  Sum_probs=198.2

Q ss_pred             ceeeecCceEEEEEEe----CCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEEee
Q 039137          644 HCIGKGGHGSVYRAKV----PSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEY  719 (912)
Q Consensus       644 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  719 (912)
                      +.||+|+||.||+++.    .+|+.||+|++......  ......+.+|++++++++||||+++++++..++..|+||||
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK--VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF   79 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh--hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence            6799999999999875    36889999998653221  11345577899999999999999999999999999999999


Q ss_pred             cCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCC
Q 039137          720 LESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSS  799 (912)
Q Consensus       720 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  799 (912)
                      +++|+|.+++..   ...+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++........
T Consensus        80 ~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~  153 (318)
T cd05582          80 LRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK  153 (318)
T ss_pred             CCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC
Confidence            999999999843   34589999999999999999999999   999999999999999999999999999986654433


Q ss_pred             CccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHHHH
Q 039137          800 NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMS  879 (912)
Q Consensus       800 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  879 (912)
                      ......|++.|+|||++.+..++.++|||||||++|||++|+.||.....     ..............+.    ..+..
T Consensus       154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-----~~~~~~i~~~~~~~p~----~~~~~  224 (318)
T cd05582         154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR-----KETMTMILKAKLGMPQ----FLSPE  224 (318)
T ss_pred             ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH-----HHHHHHHHcCCCCCCC----CCCHH
Confidence            44456789999999999988899999999999999999999999862211     1111122222222222    23455


Q ss_pred             HHHHHHHcccCCCCCCCCHHH--HHHHHHH
Q 039137          880 IMQVAFSCLDQNPESRPTMKR--VSQLLCE  907 (912)
Q Consensus       880 l~~li~~cl~~dP~~RPt~~e--vl~~L~~  907 (912)
                      +.+++.+||+.||++||++.+  +.+.++.
T Consensus       225 ~~~li~~~l~~~P~~R~~a~~~~~~~~~~~  254 (318)
T cd05582         225 AQSLLRALFKRNPANRLGAGPDGVEEIKRH  254 (318)
T ss_pred             HHHHHHHHhhcCHhHcCCCCCCCHHHHhCC
Confidence            788999999999999999666  4444443

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.1e-36  Score=331.31  Aligned_cols=244  Identities=24%  Similarity=0.327  Sum_probs=196.2

Q ss_pred             ceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEEcCCeeeEEEeecC
Q 039137          644 HCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSHPKHSFIIYEYLE  721 (912)
Q Consensus       644 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  721 (912)
                      +.||+|+||+||+|+++ +++.||+|++....... ....+.+.+|.++++.+ +||||+++++++...+..++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~   79 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQ-DDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVN   79 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh-hhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence            46999999999999876 68899999987532211 11345677888998888 69999999999999999999999999


Q ss_pred             CCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCCCc
Q 039137          722 SGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNW  801 (912)
Q Consensus       722 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  801 (912)
                      +|+|.+++.+   ...+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.........
T Consensus        80 ~~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  153 (318)
T cd05570          80 GGDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT  153 (318)
T ss_pred             CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcc
Confidence            9999988843   34689999999999999999999999   99999999999999999999999999987543333333


Q ss_pred             cccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHHHHHH
Q 039137          802 SELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIM  881 (912)
Q Consensus       802 ~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  881 (912)
                      ....|++.|+|||++.+..++.++||||+||++|+|++|+.||.....     ..............+.    ..+..+.
T Consensus       154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~-----~~~~~~i~~~~~~~~~----~~~~~~~  224 (318)
T cd05570         154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE-----DELFQSILEDEVRYPR----WLSKEAK  224 (318)
T ss_pred             cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH-----HHHHHHHHcCCCCCCC----cCCHHHH
Confidence            445789999999999999999999999999999999999999862211     1111122222222221    2345678


Q ss_pred             HHHHHcccCCCCCCCCH-----HHHHH
Q 039137          882 QVAFSCLDQNPESRPTM-----KRVSQ  903 (912)
Q Consensus       882 ~li~~cl~~dP~~RPt~-----~evl~  903 (912)
                      +++.+||+.||.+||++     .++++
T Consensus       225 ~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         225 SILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             HHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            99999999999999999     76654

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.8e-36  Score=334.14  Aligned_cols=256  Identities=26%  Similarity=0.399  Sum_probs=194.7

Q ss_pred             CCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC-----Ce
Q 039137          639 DFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP-----KH  712 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----~~  712 (912)
                      +|++.+.||+|+||.||+|+.. +++.||+|++.......  ....++.+|+++++.++||||+++++++...     ..
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   78 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHV--SDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD   78 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccc--hhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCce
Confidence            5888999999999999999875 78999999986433221  1345688999999999999999999998543     24


Q ss_pred             eeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccccc
Q 039137          713 SFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK  792 (912)
Q Consensus       713 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  792 (912)
                      .|+||||++ ++|.+++..   ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus        79 ~~lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~  151 (338)
T cd07859          79 IYVVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLAR  151 (338)
T ss_pred             EEEEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccc
Confidence            799999996 589888843   34689999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCC---Ccccccccccccccccccc--CCCCcchhHHHHHHHHHHHHhCCCCccchhccccc---------cc---
Q 039137          793 FLNPDSS---NWSELAGTHGYVAPELAYT--LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS---------SS---  855 (912)
Q Consensus       793 ~~~~~~~---~~~~~~g~~~y~aPE~~~~--~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~---------~~---  855 (912)
                      .......   ......|++.|+|||++.+  ..++.++|||||||++|||++|+.||.........         ..   
T Consensus       152 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  231 (338)
T cd07859         152 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPET  231 (338)
T ss_pred             ccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            6432221   1234578999999998875  57899999999999999999999998522110000         00   


Q ss_pred             ---------cchhhhccCCCCCC-ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          856 ---------NMNIEMLDSRLPYP-SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       856 ---------~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                               ......+....+.+ .......+..+.+++.+||+.||++|||++|+++
T Consensus       232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence                     00000001111111 0011122355789999999999999999999875

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=9.4e-37  Score=323.95  Aligned_cols=249  Identities=35%  Similarity=0.533  Sum_probs=191.9

Q ss_pred             CCceeeecCceEEEEEEeC-----CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          642 AEHCIGKGGHGSVYRAKVP-----SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       642 ~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      +.+.||.|+||.||+|++.     .+..|+||.+...   ......+.+.+|++.+++++||||++++|++...+..++|
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~---~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv   79 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS---SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV   79 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT---SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc---cccccceeeeeccccccccccccccccccccccccccccc
Confidence            4578999999999999875     3567999998542   2222478899999999999999999999999988889999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++|+|.+++... ....+++.++.+|+.|+++||+|||++   +++|+||+++||+++.++.+||+|||++.....
T Consensus        80 ~e~~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~  155 (259)
T PF07714_consen   80 MEYCPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISE  155 (259)
T ss_dssp             EE--TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred             cccccccccccccccc-ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence            9999999999999654 245689999999999999999999999   999999999999999999999999999987632


Q ss_pred             CCCC--ccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccCCCCCCChhh
Q 039137          797 DSSN--WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHV  873 (912)
Q Consensus       797 ~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  873 (912)
                      ....  .........|+|||.+.+..++.++||||||+++||+++ |+.||.....     ........+......+   
T Consensus       156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~-----~~~~~~~~~~~~~~~~---  227 (259)
T PF07714_consen  156 KSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN-----EEIIEKLKQGQRLPIP---  227 (259)
T ss_dssp             SSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH-----HHHHHHHHTTEETTSB---
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccc-----ccccccccccccceec---
Confidence            2111  223456788999999999889999999999999999999 7888752211     1111111111111111   


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 039137          874 QKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL  905 (912)
Q Consensus       874 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  905 (912)
                      ...+..+.+++.+||+.||++|||+.++++.|
T Consensus       228 ~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  228 DNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             TTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             cchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            12345578999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=4e-36  Score=331.23  Aligned_cols=262  Identities=24%  Similarity=0.395  Sum_probs=204.7

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC------CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEEc
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP------SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSH  709 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~  709 (912)
                      .++|++.+.||+|+||.||+|...      +++.||+|++.....   ....+.+.+|+++++++ +|+||+++++++..
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~   82 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT---ASEYKALMTELKILIHIGHHLNVVNLLGACTK   82 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC---HHHHHHHHHHHHHHHhhccCcchhheeeeEec
Confidence            457999999999999999999632      357899999864332   12346678999999999 79999999998865


Q ss_pred             C-CeeeEEEeecCCCChhhHhhccCC------------------------------------------------------
Q 039137          710 P-KHSFIIYEYLESGSLDKILCNDAS------------------------------------------------------  734 (912)
Q Consensus       710 ~-~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------  734 (912)
                      . ...+++|||+++++|.+++.....                                                      
T Consensus        83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (337)
T cd05054          83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG  162 (337)
T ss_pred             CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence            4 567899999999999998853221                                                      


Q ss_pred             ----cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCCC--cccccccc
Q 039137          735 ----AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN--WSELAGTH  808 (912)
Q Consensus       735 ----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~--~~~~~g~~  808 (912)
                          ...+++.++..++.||+.||+|||++   +|+||||||+||+++.++.++|+|||++..+......  .....++.
T Consensus       163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~  239 (337)
T cd05054         163 DELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL  239 (337)
T ss_pred             hHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence                13689999999999999999999999   9999999999999999999999999999876433221  22344567


Q ss_pred             ccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccCCCCCCChhhHHHHHHHHHHHHHc
Q 039137          809 GYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSC  887 (912)
Q Consensus       809 ~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  887 (912)
                      .|+|||++.+..++.++|||||||++|||++ |..||......    ...............   ......++.+++.+|
T Consensus       240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~----~~~~~~~~~~~~~~~---~~~~~~~~~~l~~~c  312 (337)
T cd05054         240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID----EEFCRRLKEGTRMRA---PEYATPEIYSIMLDC  312 (337)
T ss_pred             cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc----HHHHHHHhccCCCCC---CccCCHHHHHHHHHH
Confidence            8999999999999999999999999999998 99998521110    000011111111111   112345688999999


Q ss_pred             ccCCCCCCCCHHHHHHHHHHhhhc
Q 039137          888 LDQNPESRPTMKRVSQLLCEKIFE  911 (912)
Q Consensus       888 l~~dP~~RPt~~evl~~L~~~l~~  911 (912)
                      |+.+|++||++.|+++.|++.+.+
T Consensus       313 l~~~p~~RPs~~ell~~l~~~~~~  336 (337)
T cd05054         313 WHNNPEDRPTFSELVEILGDLLQE  336 (337)
T ss_pred             ccCChhhCcCHHHHHHHHHHHHhc
Confidence            999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-36  Score=324.89  Aligned_cols=254  Identities=24%  Similarity=0.301  Sum_probs=200.7

Q ss_pred             CCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEE
Q 039137          639 DFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIY  717 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  717 (912)
                      .|++.+.||+|+||+||++... +++.||+|++....... ......+.+|+.+++.++||||+++++++..++..++||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL   79 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhh-hhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEE
Confidence            4788899999999999999875 78999999986432211 113455778999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCC
Q 039137          718 EYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPD  797 (912)
Q Consensus       718 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  797 (912)
                      ||+++|+|.+++... ....+++.++..++.|++.|++|||+.   +|+||||||+||++++++.++|+|||++......
T Consensus        80 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05605          80 TLMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG  155 (285)
T ss_pred             eccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence            999999999888543 234689999999999999999999999   9999999999999999999999999999865432


Q ss_pred             CCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHH
Q 039137          798 SSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKL  877 (912)
Q Consensus       798 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  877 (912)
                      . ......|++.|+|||++.+..++.++||||+||++|||++|+.||......... .............+    ....+
T Consensus       156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~----~~~~~  229 (285)
T cd05605         156 E-TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR-EEVERRVKEDQEEY----SEKFS  229 (285)
T ss_pred             C-ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH-HHHHHHhhhccccc----CcccC
Confidence            2 223457899999999999888999999999999999999999998632110000 00001111111111    12345


Q ss_pred             HHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 039137          878 MSIMQVAFSCLDQNPESRP-----TMKRVSQ  903 (912)
Q Consensus       878 ~~l~~li~~cl~~dP~~RP-----t~~evl~  903 (912)
                      ..+.+++.+||+.||++||     +++++++
T Consensus       230 ~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         230 EAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             HHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence            5688999999999999999     7888754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=3.4e-36  Score=323.50  Aligned_cols=258  Identities=21%  Similarity=0.344  Sum_probs=202.8

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC------CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEc
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP------SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSH  709 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~  709 (912)
                      ..++|++.+.||+|+||.||+|.++      ++..||+|++....   ......++.+|+.+++.++||||+++++++..
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~   80 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   80 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            4678999999999999999999753      35679999875422   12245678899999999999999999999999


Q ss_pred             CCeeeEEEeecCCCChhhHhhccCC-------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCc
Q 039137          710 PKHSFIIYEYLESGSLDKILCNDAS-------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYE  782 (912)
Q Consensus       710 ~~~~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~  782 (912)
                      ....++||||+++++|.+++.....       ...+++.++..++.|++.|++|||+.   +++|+||||+||++++++.
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~  157 (277)
T cd05062          81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFT  157 (277)
T ss_pred             CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCC
Confidence            9999999999999999999854321       23467889999999999999999999   9999999999999999999


Q ss_pred             EEEeccccccccCCCCCCc--cccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchh
Q 039137          783 AHVSDFGIAKFLNPDSSNW--SELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNI  859 (912)
Q Consensus       783 ~kl~Dfgla~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~  859 (912)
                      ++++|||++..........  ....+++.|+|||++.+..++.++|||||||++|||++ |..||.....     .....
T Consensus       158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~-----~~~~~  232 (277)
T cd05062         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-----EQVLR  232 (277)
T ss_pred             EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHH
Confidence            9999999987654322211  12345678999999998889999999999999999999 7888752211     11111


Q ss_pred             hhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 039137          860 EMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCE  907 (912)
Q Consensus       860 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  907 (912)
                      .......+...   ...+..+.+++.+||+.||++|||+.|+++.|++
T Consensus       233 ~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         233 FVMEGGLLDKP---DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             HHHcCCcCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            11111111111   1234568899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.8e-36  Score=331.48  Aligned_cols=243  Identities=25%  Similarity=0.319  Sum_probs=193.3

Q ss_pred             ceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEEcCCeeeEEEeecC
Q 039137          644 HCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSHPKHSFIIYEYLE  721 (912)
Q Consensus       644 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  721 (912)
                      +.||+|+||.||+|+++ +++.||+|++........ ...+.+..|..++... +||+|+++++++...+..|+||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~   79 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLID-DDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLN   79 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhc-chHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCC
Confidence            46999999999999876 688999999875422111 1344566788887765 89999999999999999999999999


Q ss_pred             CCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCCCc
Q 039137          722 SGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNW  801 (912)
Q Consensus       722 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  801 (912)
                      +|+|.+++..   ...+++.++..++.|++.||+|||++   +|+||||||+||+++.++.++|+|||+++.........
T Consensus        80 ~g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  153 (316)
T cd05620          80 GGDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA  153 (316)
T ss_pred             CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCce
Confidence            9999998844   34688999999999999999999999   99999999999999999999999999987543333344


Q ss_pred             cccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHHHHHH
Q 039137          802 SELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIM  881 (912)
Q Consensus       802 ~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  881 (912)
                      ....|++.|+|||++.+..++.++||||+||++|||++|+.||.....     ..............+.    ..+.++.
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~-----~~~~~~~~~~~~~~~~----~~~~~~~  224 (316)
T cd05620         154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-----DELFESIRVDTPHYPR----WITKESK  224 (316)
T ss_pred             eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCCCCCC----CCCHHHH
Confidence            556789999999999999999999999999999999999999852211     1111111112222222    1344578


Q ss_pred             HHHHHcccCCCCCCCCHH-HHH
Q 039137          882 QVAFSCLDQNPESRPTMK-RVS  902 (912)
Q Consensus       882 ~li~~cl~~dP~~RPt~~-evl  902 (912)
                      +++.+||+.||++||++. +++
T Consensus       225 ~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         225 DILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             HHHHHHccCCHHHcCCChHHHH
Confidence            899999999999999984 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=6.5e-36  Score=318.67  Aligned_cols=255  Identities=26%  Similarity=0.414  Sum_probs=204.5

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      .+|++.+.||+|++|.||+|..+ +++.||+|++....     ...+++.+|++.++.++||||+++++++...+..++|
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII   80 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEE
Confidence            45888899999999999999865 58889999976431     1356788999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++++|.+++.... ...+++.+++.++.|++.|++|||++   +++||||||+||++++++.+||+|||.+.....
T Consensus        81 ~e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~  156 (263)
T cd05052          81 TEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  156 (263)
T ss_pred             EEeCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence            99999999999985432 34588999999999999999999999   999999999999999999999999999986643


Q ss_pred             CCCCc-cccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccCCCCCCChhhH
Q 039137          797 DSSNW-SELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQ  874 (912)
Q Consensus       797 ~~~~~-~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  874 (912)
                      ..... ....+++.|+|||.+.+..++.++||||||+++|||++ |..||.....     ... ...........  ...
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-----~~~-~~~~~~~~~~~--~~~  228 (263)
T cd05052         157 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQV-YELLEKGYRME--RPE  228 (263)
T ss_pred             ceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HHH-HHHHHCCCCCC--CCC
Confidence            32111 12234568999999998899999999999999999998 9999752111     001 11111111111  112


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 039137          875 KKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI  909 (912)
Q Consensus       875 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l  909 (912)
                      ..+..+.+++.+||+.||++||++.++.+.|++.+
T Consensus       229 ~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  263 (263)
T cd05052         229 GCPPKVYELMRACWQWNPSDRPSFAEIHQAFETMF  263 (263)
T ss_pred             CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhhC
Confidence            23456889999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8e-36  Score=317.60  Aligned_cols=254  Identities=24%  Similarity=0.437  Sum_probs=205.5

Q ss_pred             hcCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      .++|++.+.||+|++|.||+|...+++.||+|.+.....     ..+++.+|++++++++||||+++++++...+..++|
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   79 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIV   79 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeee
Confidence            456899999999999999999987788899999864321     356688999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++++|.+++.... ...+++.++..++.|++.|++|||+.   +|+||||||+||++++++.++|+|||++.....
T Consensus        80 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05068          80 TELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKE  155 (261)
T ss_pred             eecccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence            99999999999985433 34689999999999999999999999   999999999999999999999999999987653


Q ss_pred             CCCC-ccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccCCCCCCChhhH
Q 039137          797 DSSN-WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQ  874 (912)
Q Consensus       797 ~~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  874 (912)
                      .... ......+..|+|||+..+..++.++||||||+++|||++ |+.||.....     .... ..+......+.  ..
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~~~~-~~~~~~~~~~~--~~  227 (261)
T cd05068         156 DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN-----AEVL-QQVDQGYRMPC--PP  227 (261)
T ss_pred             CcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH-----HHHH-HHHHcCCCCCC--CC
Confidence            2211 111223457999999998889999999999999999999 9999852211     1111 11111111111  12


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 039137          875 KKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCE  907 (912)
Q Consensus       875 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  907 (912)
                      ..+..+.+++.+|++.+|.+||+++++.+.|++
T Consensus       228 ~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         228 GCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             cCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            234568899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.7e-36  Score=338.58  Aligned_cols=252  Identities=21%  Similarity=0.305  Sum_probs=200.9

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      .++|++.+.||+|+||.||+|+.+ +++.||+|++....... ....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIK-RSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            467999999999999999999876 68899999986422111 1134557789999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ||||+++|+|.+++..    ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++....
T Consensus       121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~  193 (370)
T cd05596         121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence            9999999999999843    2478889999999999999999999   99999999999999999999999999998664


Q ss_pred             CCCC-CccccccccccccccccccC----CCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCC--CCC
Q 039137          796 PDSS-NWSELAGTHGYVAPELAYTL----KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSR--LPY  868 (912)
Q Consensus       796 ~~~~-~~~~~~g~~~y~aPE~~~~~----~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~  868 (912)
                      .... ......|++.|+|||++.+.    .++.++|||||||++|||++|+.||.....     ......+....  ..+
T Consensus       194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----~~~~~~i~~~~~~~~~  268 (370)
T cd05596         194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-----VGTYSKIMDHKNSLTF  268 (370)
T ss_pred             CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH-----HHHHHHHHcCCCcCCC
Confidence            3322 22345799999999988653    378899999999999999999999852211     11112222211  222


Q ss_pred             CChhhHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 039137          869 PSLHVQKKLMSIMQVAFSCLDQNPES--RPTMKRVSQ  903 (912)
Q Consensus       869 ~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~  903 (912)
                      +.  ....+..+.+++.+|++.+|.+  ||+++|+++
T Consensus       269 ~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~  303 (370)
T cd05596         269 PD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKS  303 (370)
T ss_pred             CC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence            21  1224566889999999999988  999999865

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=9.6e-37  Score=334.82  Aligned_cols=240  Identities=25%  Similarity=0.312  Sum_probs=190.2

Q ss_pred             ceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHH-HHhhcCCCccccEEEEEEcCCeeeEEEeecC
Q 039137          644 HCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQ-ALTEIRHRNIVKFYGFCSHPKHSFIIYEYLE  721 (912)
Q Consensus       644 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  721 (912)
                      +.||+|+||.||+|++. +++.||+|++......... ....+.+|.. +++.++||||+++++++.+.+..++||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~-~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~   79 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKK-EQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVN   79 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhh-HHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCC
Confidence            46999999999999876 6889999998643221111 2344555554 6788899999999999999999999999999


Q ss_pred             CCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCCCc
Q 039137          722 SGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNW  801 (912)
Q Consensus       722 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  801 (912)
                      +|+|.+.+..   ...+++.++..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++.........
T Consensus        80 ~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  153 (321)
T cd05603          80 GGELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT  153 (321)
T ss_pred             CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcc
Confidence            9999888843   34588899999999999999999999   99999999999999999999999999987543333334


Q ss_pred             cccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHHHHHH
Q 039137          802 SELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIM  881 (912)
Q Consensus       802 ~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  881 (912)
                      ....|++.|+|||++.+..++.++||||+||++|||++|+.||....     .......+.......+.    .....+.
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~~~~~~~i~~~~~~~~~----~~~~~~~  224 (321)
T cd05603         154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-----VSQMYDNILHKPLQLPG----GKTVAAC  224 (321)
T ss_pred             ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC-----HHHHHHHHhcCCCCCCC----CCCHHHH
Confidence            45678999999999998889999999999999999999999985211     11112222222222222    2344578


Q ss_pred             HHHHHcccCCCCCCCCHH
Q 039137          882 QVAFSCLDQNPESRPTMK  899 (912)
Q Consensus       882 ~li~~cl~~dP~~RPt~~  899 (912)
                      +++.+|++.||.+||++.
T Consensus       225 ~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         225 DLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             HHHHHHccCCHhhcCCCC
Confidence            999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.5e-36  Score=330.05  Aligned_cols=243  Identities=24%  Similarity=0.337  Sum_probs=192.3

Q ss_pred             ceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEEcCCeeeEEEeecC
Q 039137          644 HCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSHPKHSFIIYEYLE  721 (912)
Q Consensus       644 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  721 (912)
                      +.||+|+||+||+|++. +++.||+|++........ ...+.+..|..++... +||||+++++++.+.+..++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~   79 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMD-DDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLN   79 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhc-chHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCC
Confidence            46999999999999876 678999999865422111 1344566777787764 89999999999999999999999999


Q ss_pred             CCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCCCc
Q 039137          722 SGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNW  801 (912)
Q Consensus       722 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  801 (912)
                      +|+|.+++..   ...+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++..........
T Consensus        80 ~g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  153 (316)
T cd05619          80 GGDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT  153 (316)
T ss_pred             CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCce
Confidence            9999999843   34688999999999999999999999   99999999999999999999999999987543333334


Q ss_pred             cccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHHHHHH
Q 039137          802 SELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIM  881 (912)
Q Consensus       802 ~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  881 (912)
                      ....|++.|+|||++.+..++.++||||+||++|||++|+.||.....     .............++.    .....+.
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-----~~~~~~i~~~~~~~~~----~~~~~~~  224 (316)
T cd05619         154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE-----EELFQSIRMDNPCYPR----WLTREAK  224 (316)
T ss_pred             eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCCCCCc----cCCHHHH
Confidence            456789999999999998899999999999999999999999852211     1111111111111221    2344578


Q ss_pred             HHHHHcccCCCCCCCCHH-HHH
Q 039137          882 QVAFSCLDQNPESRPTMK-RVS  902 (912)
Q Consensus       882 ~li~~cl~~dP~~RPt~~-evl  902 (912)
                      +++.+||+.||++||++. ++.
T Consensus       225 ~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         225 DILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             HHHHHHhccCHhhcCCChHHHH
Confidence            999999999999999997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.5e-36  Score=333.71  Aligned_cols=250  Identities=21%  Similarity=0.269  Sum_probs=195.1

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      ..+|++.+.||+|+||.||+|.+. +++.||+|+..          ...+.+|++++++++||||+++++++...+..++
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~----------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l  160 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ----------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCL  160 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh----------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence            367999999999999999999875 78899999642          2346789999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      |||++. ++|.+++..   ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus       161 v~e~~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~  233 (391)
T PHA03212        161 ILPRYK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPV  233 (391)
T ss_pred             EEecCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence            999986 588888743   34588999999999999999999999   99999999999999999999999999997543


Q ss_pred             CC-CCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccc-cc------------------
Q 039137          796 PD-SSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS-SS------------------  855 (912)
Q Consensus       796 ~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~-~~------------------  855 (912)
                      .. ........||+.|+|||++.+..++.++||||+||++|||++|+.||-........ ..                  
T Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~  313 (391)
T PHA03212        234 DINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF  313 (391)
T ss_pred             cccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhc
Confidence            22 12233467999999999999989999999999999999999999875211000000 00                  


Q ss_pred             -----cchhh----hcc--CCCCC--C-ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          856 -----NMNIE----MLD--SRLPY--P-SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       856 -----~~~~~----~~~--~~~~~--~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                           .....    ...  ...+.  + .......+.++.+++.+||+.||++|||++|+++
T Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        314 PIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             CcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence                 00000    000  00000  0 0111233557889999999999999999999875

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=8e-36  Score=322.95  Aligned_cols=258  Identities=19%  Similarity=0.305  Sum_probs=194.1

Q ss_pred             cCCCCCceeeecCceEEEEEEeC--CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc---CCCccccEEEEEEc---
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP--SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI---RHRNIVKFYGFCSH---  709 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l---~h~niv~l~~~~~~---  709 (912)
                      .+|++.+.||+|+||+||+|++.  +++.||+|++........  ....+.+|+.+++.+   +||||+++++++..   
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~   78 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG--MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   78 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCC--chHHHHHHHHHHHhhcccCCCCcceEEEEEecccC
Confidence            37999999999999999999863  467899999865433221  234556777777766   69999999999852   


Q ss_pred             --CCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEec
Q 039137          710 --PKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSD  787 (912)
Q Consensus       710 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  787 (912)
                        ....++||||++ ++|.+++.... ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|
T Consensus        79 ~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~D  153 (290)
T cd07862          79 DRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD  153 (290)
T ss_pred             CCCCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEcc
Confidence              356899999997 58988885432 34588999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccc-----------c
Q 039137          788 FGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSS-----------N  856 (912)
Q Consensus       788 fgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~-----------~  856 (912)
                      ||+++..... .......|++.|+|||++.+..++.++||||+||++|||++|++||...........           .
T Consensus       154 fg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~  232 (290)
T cd07862         154 FGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED  232 (290)
T ss_pred             ccceEeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhh
Confidence            9999865433 233455689999999999888899999999999999999999999863211100000           0


Q ss_pred             c------hhhhccCCCCCCC-hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          857 M------NIEMLDSRLPYPS-LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       857 ~------~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .      ...........+. ......+..+.+++.+|++.||++|||+.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            0      0000000000000 001123456789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=9.5e-36  Score=315.92  Aligned_cols=251  Identities=25%  Similarity=0.427  Sum_probs=202.0

Q ss_pred             cCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIY  717 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  717 (912)
                      ++|++.+.||+|+||+||.|+.+++..+|+|.+.....     ..+++.+|+.+++.++||||+++++++...+..++||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVT   78 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEE
Confidence            46888999999999999999887777899998864321     2467889999999999999999999999888999999


Q ss_pred             eecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCC
Q 039137          718 EYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPD  797 (912)
Q Consensus       718 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  797 (912)
                      ||+++|+|.+++....  ..+++.+++.++.|++.|++|||+.   +++|+||||+||+++.++.+||+|||.++.....
T Consensus        79 e~~~~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~  153 (256)
T cd05113          79 EYMSNGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD  153 (256)
T ss_pred             EcCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence            9999999999985432  3689999999999999999999999   9999999999999999999999999998865433


Q ss_pred             CCC-ccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccCCCCCCChhhHH
Q 039137          798 SSN-WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQK  875 (912)
Q Consensus       798 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  875 (912)
                      ... .....++..|+|||+..+..++.++||||||+++|||++ |..||......     ...............   ..
T Consensus       154 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~---~~  225 (256)
T cd05113         154 EYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS-----ETVEKVSQGLRLYRP---HL  225 (256)
T ss_pred             ceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-----HHHHHHhcCCCCCCC---CC
Confidence            211 112335568999999988889999999999999999998 99998522111     111111111111111   11


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 039137          876 KLMSIMQVAFSCLDQNPESRPTMKRVSQLLC  906 (912)
Q Consensus       876 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  906 (912)
                      .+..+.+++.+||+.||++||++.++++.++
T Consensus       226 ~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         226 ASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            2456889999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.3e-35  Score=315.09  Aligned_cols=251  Identities=27%  Similarity=0.423  Sum_probs=206.5

Q ss_pred             CCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEE
Q 039137          639 DFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIY  717 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  717 (912)
                      +|++.+.||+|++|.||+|+.+ +++.|++|.+......  ....+.+.+|+++++.++|||++++++++...+..++||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN--RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVM   78 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC--HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEE
Confidence            4788899999999999999876 7899999998643222  225677899999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCC
Q 039137          718 EYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPD  797 (912)
Q Consensus       718 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  797 (912)
                      ||+++++|.+++... ....+++.+++.++.|++.|++|||+.   +++|+||+|+||+++.++.++++|||++......
T Consensus        79 e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~  154 (256)
T cd08529          79 EYAENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN  154 (256)
T ss_pred             EeCCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence            999999999999653 235688999999999999999999999   9999999999999999999999999999876654


Q ss_pred             CCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHH
Q 039137          798 SSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKL  877 (912)
Q Consensus       798 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  877 (912)
                      ........+++.|+|||+..+..++.++||||||+++|+|++|+.||.....     ............+...   ...+
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~---~~~~  226 (256)
T cd08529         155 TNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ-----GALILKIIRGVFPPVS---QMYS  226 (256)
T ss_pred             cchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHcCCCCCCc---cccC
Confidence            4444455688999999999998899999999999999999999999862221     1111111112211111   1345


Q ss_pred             HHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          878 MSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       878 ~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ..+.+++.+||+.+|++||++.++++
T Consensus       227 ~~~~~~i~~~l~~~p~~Rp~~~~ll~  252 (256)
T cd08529         227 QQLAQLIDQCLTKDYRQRPDTFQLLR  252 (256)
T ss_pred             HHHHHHHHHHccCCcccCcCHHHHhh
Confidence            66889999999999999999999876

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=7.8e-36  Score=316.55  Aligned_cols=251  Identities=24%  Similarity=0.344  Sum_probs=204.3

Q ss_pred             CCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEE
Q 039137          639 DFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIY  717 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  717 (912)
                      +|++.+.||+|+||.||+++.. +++.||+|.+.....   ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   77 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS---SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVM   77 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc---hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEE
Confidence            5788999999999999999876 788999999864322   124567889999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCC
Q 039137          718 EYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPD  797 (912)
Q Consensus       718 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  797 (912)
                      ||++++++.+++... ....+++..++.++.|++.|++|||++   +|+|+||||+||++++++.++++|||.+......
T Consensus        78 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  153 (255)
T cd08219          78 EYCDGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP  153 (255)
T ss_pred             eeCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccc
Confidence            999999999988543 234578999999999999999999999   9999999999999999999999999999876544


Q ss_pred             CCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHH
Q 039137          798 SSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKL  877 (912)
Q Consensus       798 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  877 (912)
                      ........+++.|+|||++.+..++.++||||+|+++|+|++|..||+....     ...............+   ...+
T Consensus       154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~---~~~~  225 (255)
T cd08219         154 GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW-----KNLILKVCQGSYKPLP---SHYS  225 (255)
T ss_pred             ccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH-----HHHHHHHhcCCCCCCC---cccC
Confidence            3334456788999999999988899999999999999999999999862110     1111111111111111   1234


Q ss_pred             HHHHHHHHHcccCCCCCCCCHHHHHHH
Q 039137          878 MSIMQVAFSCLDQNPESRPTMKRVSQL  904 (912)
Q Consensus       878 ~~l~~li~~cl~~dP~~RPt~~evl~~  904 (912)
                      ..+.+++.+||+.||++||++.+++..
T Consensus       226 ~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         226 YELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            567899999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.4e-36  Score=341.22  Aligned_cols=251  Identities=21%  Similarity=0.287  Sum_probs=195.5

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++....... ....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv   79 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLM-RNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV   79 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHh-hhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEE
Confidence            36899999999999999999875 68999999986432111 11345678999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++|+|.+++..   .+.+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+|..+..
T Consensus        80 ~E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~  153 (376)
T cd05598          80 MDYIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  153 (376)
T ss_pred             EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence            999999999999944   34588899999999999999999999   999999999999999999999999999753210


Q ss_pred             CC-------------------------------------------CCccccccccccccccccccCCCCcchhHHHHHHH
Q 039137          797 DS-------------------------------------------SNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVL  833 (912)
Q Consensus       797 ~~-------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~v  833 (912)
                      ..                                           .......||+.|+|||++.+..++.++||||+||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi  233 (376)
T cd05598         154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  233 (376)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence            00                                           00113468999999999999999999999999999


Q ss_pred             HHHHHhCCCCccchhccccccccchhhhcc--CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCC---CHHHHHH
Q 039137          834 ALEVIKGKHPRDFLFEMSSSSSNMNIEMLD--SRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRP---TMKRVSQ  903 (912)
Q Consensus       834 l~elltg~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---t~~evl~  903 (912)
                      +|||++|+.||......     .....+..  .....+.  ....+..+.+++.+|+ .+|.+|+   ++.|+++
T Consensus       234 lyell~G~~Pf~~~~~~-----~~~~~i~~~~~~~~~~~--~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~  300 (376)
T cd05598         234 LYEMLVGQPPFLADTPA-----ETQLKVINWETTLHIPS--QAKLSREASDLILRLC-CGAEDRLGKNGADEIKA  300 (376)
T ss_pred             eeehhhCCCCCCCCCHH-----HHHHHHhccCccccCCC--CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence            99999999998632111     00011111  1111111  1123445677888876 5999999   7887764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-36  Score=339.79  Aligned_cols=251  Identities=22%  Similarity=0.309  Sum_probs=196.3

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ++|++.+.||+|+||+||+|+.+ +++.||+|++...... .....+.+.+|+++++.++||||+++++++.+++..|+|
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv   79 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMF-KKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLI   79 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHH-HhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEE
Confidence            47899999999999999999865 7899999998543211 112346688899999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++|+|.+++..   .+.+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        80 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~  153 (377)
T cd05629          80 MEFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK  153 (377)
T ss_pred             EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence            999999999999843   34688999999999999999999999   999999999999999999999999999863321


Q ss_pred             CCC-----------------------------------------------CccccccccccccccccccCCCCcchhHHH
Q 039137          797 DSS-----------------------------------------------NWSELAGTHGYVAPELAYTLKVTEKCDVYS  829 (912)
Q Consensus       797 ~~~-----------------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~sDvws  829 (912)
                      ...                                               ......||+.|+|||++.+..++.++||||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS  233 (377)
T cd05629         154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS  233 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence            000                                               001246899999999999989999999999


Q ss_pred             HHHHHHHHHhCCCCccchhccccccccchhhhcc--CCCCCCChhhHHHHHHHHHHHHHcccCCCCCC---CCHHHHHH
Q 039137          830 FGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLD--SRLPYPSLHVQKKLMSIMQVAFSCLDQNPESR---PTMKRVSQ  903 (912)
Q Consensus       830 lG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Pt~~evl~  903 (912)
                      +||++|||++|..||.....     .........  .....+..  ...+..+.+++.+|+. +|.+|   +++.|+++
T Consensus       234 lGvil~elltG~~Pf~~~~~-----~~~~~~i~~~~~~~~~p~~--~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~  304 (377)
T cd05629         234 LGAIMFECLIGWPPFCSENS-----HETYRKIINWRETLYFPDD--IHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKS  304 (377)
T ss_pred             cchhhhhhhcCCCCCCCCCH-----HHHHHHHHccCCccCCCCC--CCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhc
Confidence            99999999999999852211     011111111  12222211  1234567889999997 67665   58888765

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.6e-35  Score=315.31  Aligned_cols=255  Identities=25%  Similarity=0.413  Sum_probs=204.1

Q ss_pred             hcCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      .++|++.+.||+|+||+||+|+++++..||+|++.....     ..+.+.+|+++++.++||||+++++++. .+..++|
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv   78 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIV   78 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-----CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEE
Confidence            356999999999999999999987777899999864322     2457889999999999999999999875 4568999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++|+|.+++... ....+++.++..++.|++.||+|+|+.   +++|+||||+||++++++.++|+|||.++....
T Consensus        79 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~  154 (262)
T cd05071          79 TEYMSKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED  154 (262)
T ss_pred             EEcCCCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence            9999999999999543 234578999999999999999999999   999999999999999999999999999986644


Q ss_pred             CCCCc-cccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccCCCCCCChhhH
Q 039137          797 DSSNW-SELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQ  874 (912)
Q Consensus       797 ~~~~~-~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  874 (912)
                      ..... ....++..|+|||+..+..++.++||||||+++|||++ |..||......     ..... .....+.+  ...
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~-----~~~~~-~~~~~~~~--~~~  226 (262)
T cd05071         155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----EVLDQ-VERGYRMP--CPP  226 (262)
T ss_pred             cccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH-----HHHHH-HhcCCCCC--Ccc
Confidence            32221 23345678999999988889999999999999999999 88887522110     11111 11111111  112


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 039137          875 KKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI  909 (912)
Q Consensus       875 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l  909 (912)
                      ..+..+.+++.+|++.||++||+++++.+.|++.+
T Consensus       227 ~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~  261 (262)
T cd05071         227 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  261 (262)
T ss_pred             ccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence            34567889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.1e-36  Score=334.74  Aligned_cols=241  Identities=23%  Similarity=0.313  Sum_probs=191.4

Q ss_pred             ceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHH-HHhhcCCCccccEEEEEEcCCeeeEEEeecC
Q 039137          644 HCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQ-ALTEIRHRNIVKFYGFCSHPKHSFIIYEYLE  721 (912)
Q Consensus       644 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  721 (912)
                      +.||+|+||+||+|+.+ +|+.||+|++......... ....+.+|.. +++.++||||+++++++..++..++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~-~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~   79 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRK-EQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVN   79 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhh-HHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCC
Confidence            46999999999999875 7899999998653222111 3345555554 4677899999999999999999999999999


Q ss_pred             CCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCCCc
Q 039137          722 SGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNW  801 (912)
Q Consensus       722 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  801 (912)
                      +|+|.+++..   ...+++.++..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++.........
T Consensus        80 ~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~  153 (325)
T cd05604          80 GGELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT  153 (325)
T ss_pred             CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCc
Confidence            9999988843   34689999999999999999999999   99999999999999999999999999987544333334


Q ss_pred             cccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHHHHHH
Q 039137          802 SELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIM  881 (912)
Q Consensus       802 ~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  881 (912)
                      ....|++.|+|||++.+..++.++||||+||++|||++|+.||....     ................+    ..+..+.
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~-----~~~~~~~~~~~~~~~~~----~~~~~~~  224 (325)
T cd05604         154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD-----VAEMYDNILHKPLVLRP----GASLTAW  224 (325)
T ss_pred             ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC-----HHHHHHHHHcCCccCCC----CCCHHHH
Confidence            45678999999999999999999999999999999999999985211     11111222222222221    2345577


Q ss_pred             HHHHHcccCCCCCCCCHHH
Q 039137          882 QVAFSCLDQNPESRPTMKR  900 (912)
Q Consensus       882 ~li~~cl~~dP~~RPt~~e  900 (912)
                      +++.+|++.||.+||++.+
T Consensus       225 ~ll~~ll~~~p~~R~~~~~  243 (325)
T cd05604         225 SILEELLEKDRQRRLGAKE  243 (325)
T ss_pred             HHHHHHhccCHHhcCCCCC
Confidence            8999999999999998864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=5.4e-36  Score=328.73  Aligned_cols=244  Identities=23%  Similarity=0.342  Sum_probs=196.8

Q ss_pred             CCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcC-CCccccEEEEEEcCCeeeEE
Q 039137          639 DFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR-HRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv  716 (912)
                      +|+..+.||+|+||+||+|+.+ +++.||+|++....... ....+.+..|..+++.+. |++|+++++++...+..|+|
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv   79 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQ-DDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFV   79 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEE
Confidence            4778899999999999999876 78999999986532211 113456778888888885 67888899999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++|+|.+++..   ...+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        80 ~Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~  153 (323)
T cd05615          80 MEYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV  153 (323)
T ss_pred             EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence            999999999999843   34689999999999999999999999   999999999999999999999999999976543


Q ss_pred             CCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHH
Q 039137          797 DSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKK  876 (912)
Q Consensus       797 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  876 (912)
                      .........|++.|+|||++.+..++.++||||+||++|||++|+.||.....     .............++.    ..
T Consensus       154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-----~~~~~~i~~~~~~~p~----~~  224 (323)
T cd05615         154 DGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-----DELFQSIMEHNVSYPK----SL  224 (323)
T ss_pred             CCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCCCCCc----cC
Confidence            33334456789999999999998899999999999999999999999863211     1112222233333332    23


Q ss_pred             HHHHHHHHHHcccCCCCCCCCH
Q 039137          877 LMSIMQVAFSCLDQNPESRPTM  898 (912)
Q Consensus       877 ~~~l~~li~~cl~~dP~~RPt~  898 (912)
                      +..+.+++.+|++.||.+|++.
T Consensus       225 ~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         225 SKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             CHHHHHHHHHHcccCHhhCCCC
Confidence            3457889999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=8.9e-36  Score=343.40  Aligned_cols=249  Identities=22%  Similarity=0.264  Sum_probs=201.1

Q ss_pred             CCCCCceeeecCceEEEEEEeC-C-CCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          639 DFNAEHCIGKGGHGSVYRAKVP-S-GEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      .|.+.+.||+|++|.||+|... + ++.||+|++...    .......+.+|+.+++.++||||+++++++..++..|+|
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~----~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv  143 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN----DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI  143 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC----CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence            4889999999999999999754 3 677888876432    122445678899999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhcc-CCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          717 YEYLESGSLDKILCND-ASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      |||+++|+|.+++... ....++++.++..++.|++.||+|+|++   +|+||||||+||+++.++.+||+|||+++...
T Consensus       144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~  220 (478)
T PTZ00267        144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYS  220 (478)
T ss_pred             EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecC
Confidence            9999999999988543 2345688999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCC--CccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCC-CCCChh
Q 039137          796 PDSS--NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRL-PYPSLH  872 (912)
Q Consensus       796 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  872 (912)
                      ....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ............ +.+   
T Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-----~~~~~~~~~~~~~~~~---  292 (478)
T PTZ00267        221 DSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-----REIMQQVLYGKYDPFP---  292 (478)
T ss_pred             CccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCCCCCC---
Confidence            3321  23345689999999999999999999999999999999999999852111     111111111111 111   


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          873 VQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       873 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                       ...+..+.+++.+||+.||++||++++++.
T Consensus       293 -~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        293 -CPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             -ccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence             123456889999999999999999999864

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.9e-36  Score=339.27  Aligned_cols=250  Identities=21%  Similarity=0.301  Sum_probs=194.7

Q ss_pred             CCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEE
Q 039137          639 DFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIY  717 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  717 (912)
                      .|++.+.||+|+||+||+|+.. +++.||+|++...... .....+.+.+|+++++.++||||+++++++.+++..++||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~   80 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVL-LRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM   80 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhh-hHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence            5888999999999999999875 7889999998643211 1224567889999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCC
Q 039137          718 EYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPD  797 (912)
Q Consensus       718 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  797 (912)
                      ||+++|+|.+++.+.   +.+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||++......
T Consensus        81 E~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~  154 (382)
T cd05625          81 DYIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (382)
T ss_pred             eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence            999999999998443   4578899999999999999999999   9999999999999999999999999997532100


Q ss_pred             C-----------------------------------------------CCccccccccccccccccccCCCCcchhHHHH
Q 039137          798 S-----------------------------------------------SNWSELAGTHGYVAPELAYTLKVTEKCDVYSF  830 (912)
Q Consensus       798 ~-----------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwsl  830 (912)
                      .                                               .......||+.|+|||++.+..++.++||||+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (382)
T cd05625         155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV  234 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence            0                                               00112468999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCccchhccccccccchhhhc--cCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 039137          831 GVLALEVIKGKHPRDFLFEMSSSSSNMNIEML--DSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPT---MKRVSQ  903 (912)
Q Consensus       831 G~vl~elltg~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~evl~  903 (912)
                      ||++|||++|+.||......     .......  ......+.  ....+.+..+++.+|+ .+|++|++   ++|+++
T Consensus       235 Gvil~elltG~~Pf~~~~~~-----~~~~~i~~~~~~~~~p~--~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  304 (382)
T cd05625         235 GVILYEMLVGQPPFLAQTPL-----ETQMKVINWQTSLHIPP--QAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA  304 (382)
T ss_pred             hHHHHHHHhCCCCCCCCCHH-----HHHHHHHccCCCcCCCC--cccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence            99999999999998622111     1111111  11122221  1223455677777765 59999997   666553

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.6e-36  Score=336.47  Aligned_cols=254  Identities=20%  Similarity=0.302  Sum_probs=199.1

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeee
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSF  714 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  714 (912)
                      ..++|++.+.||+|+||.||+|+.+ +++.||+|++....... ....+.+.+|+.+++.++||||+++++++..++..|
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIK-RSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY  119 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence            4578999999999999999999876 68899999985422111 113456789999999999999999999999999999


Q ss_pred             EEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccccccc
Q 039137          715 IIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL  794 (912)
Q Consensus       715 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  794 (912)
                      +||||+++|+|.+++..    ..+++..+..++.||+.||+|||++   +|+||||||+||++++++.+||+|||++...
T Consensus       120 lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~  192 (370)
T cd05621         120 MVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKM  192 (370)
T ss_pred             EEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceec
Confidence            99999999999999843    2478899999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCC-CccccccccccccccccccCC----CCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCC--CC
Q 039137          795 NPDSS-NWSELAGTHGYVAPELAYTLK----VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSR--LP  867 (912)
Q Consensus       795 ~~~~~-~~~~~~g~~~y~aPE~~~~~~----~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~  867 (912)
                      ..... ......||+.|+|||++.+..    ++.++||||+||++|||++|+.||.....     ........+..  ..
T Consensus       193 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~-----~~~~~~i~~~~~~~~  267 (370)
T cd05621         193 DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL-----VGTYSKIMDHKNSLN  267 (370)
T ss_pred             ccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCcccC
Confidence            43322 223567999999999987543    77899999999999999999999852211     11111222211  22


Q ss_pred             CCChhhHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 039137          868 YPSLHVQKKLMSIMQVAFSCLDQNPES--RPTMKRVSQL  904 (912)
Q Consensus       868 ~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~  904 (912)
                      .+.  ....+..+.+++.+|+..+|.+  ||++.|+++.
T Consensus       268 ~p~--~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         268 FPE--DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             CCC--cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            221  1223455778888999865544  8899988753

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-35  Score=315.70  Aligned_cols=249  Identities=27%  Similarity=0.471  Sum_probs=200.8

Q ss_pred             cCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIY  717 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  717 (912)
                      .+|++.+.||+|+||.||+|+++++..+|+|++.....     ..+.+.+|+++++.++||||+++++++...+..++||
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT   78 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence            45889999999999999999988778899999864322     2456888999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCC
Q 039137          718 EYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPD  797 (912)
Q Consensus       718 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  797 (912)
                      ||+++++|.+++....  ..+++..++.++.|++.|++|||+.   +++||||||+||+++.++.+|++|||.++.....
T Consensus        79 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~  153 (256)
T cd05059          79 EYMANGCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD  153 (256)
T ss_pred             ecCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccc
Confidence            9999999999985433  3689999999999999999999999   9999999999999999999999999999865432


Q ss_pred             CCC-ccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccC-CCCCCChhhH
Q 039137          798 SSN-WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDS-RLPYPSLHVQ  874 (912)
Q Consensus       798 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  874 (912)
                      ... .....++..|+|||.+.+..++.++||||||+++||+++ |+.||+.....     ......... ..+.+    .
T Consensus       154 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~----~  224 (256)
T cd05059         154 QYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS-----EVVESVSAGYRLYRP----K  224 (256)
T ss_pred             cccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH-----HHHHHHHcCCcCCCC----C
Confidence            211 111223457999999998889999999999999999999 89998532111     111111111 11111    1


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 039137          875 KKLMSIMQVAFSCLDQNPESRPTMKRVSQLL  905 (912)
Q Consensus       875 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  905 (912)
                      ..+..+.+++.+||+.+|++|||+.|+++.|
T Consensus       225 ~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         225 LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            2455688999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.1e-35  Score=325.62  Aligned_cols=254  Identities=23%  Similarity=0.410  Sum_probs=201.9

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCC----EEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCe
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGE----IFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKH  712 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~  712 (912)
                      .+|++.+.||+|+||.||+|++. +++    .||+|++....   .....+++.+|+.+++.++||||++++|++... .
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~   82 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T   82 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence            57999999999999999999864 343    38999986432   122456788999999999999999999999764 5


Q ss_pred             eeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccccc
Q 039137          713 SFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK  792 (912)
Q Consensus       713 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  792 (912)
                      .++|+||+++|+|.+++...  ...+++..++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus        83 ~~~v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~  157 (316)
T cd05108          83 VQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAK  157 (316)
T ss_pred             ceeeeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccc
Confidence            78999999999999998543  24588899999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCCCc--cccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhcc--CCCC
Q 039137          793 FLNPDSSNW--SELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLD--SRLP  867 (912)
Q Consensus       793 ~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~--~~~~  867 (912)
                      .........  ....++..|+|||++.+..++.++||||||+++|||++ |+.||+.....      .......  ...+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~------~~~~~~~~~~~~~  231 (316)
T cd05108         158 LLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS------EISSILEKGERLP  231 (316)
T ss_pred             cccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHHhCCCCCC
Confidence            765433222  12234678999999999999999999999999999998 99998632110      0111111  1222


Q ss_pred             CCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          868 YPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       868 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                      .+.    .....+.+++.+||..||++||++.+++..+.+...
T Consensus       232 ~~~----~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~  270 (316)
T cd05108         232 QPP----ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  270 (316)
T ss_pred             CCC----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence            221    123457889999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2e-35  Score=319.31  Aligned_cols=259  Identities=24%  Similarity=0.428  Sum_probs=205.4

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC------CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP------SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP  710 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~  710 (912)
                      ..+|.+.+.||+|+||.||++...      ++..+|+|.+....    ....+.+.+|++++++++||||+++++++...
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS----DNARKDFHREAELLTNLQHEHIVKFYGVCVEG   79 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC----HHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            357889999999999999999742      34568999876432    22456789999999999999999999999999


Q ss_pred             CeeeEEEeecCCCChhhHhhccC----------CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCC
Q 039137          711 KHSFIIYEYLESGSLDKILCNDA----------SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLG  780 (912)
Q Consensus       711 ~~~~lv~e~~~~g~L~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~  780 (912)
                      +..++||||+++++|.+++....          ....+++.+++.++.|++.||+|||++   +++||||||+||+++++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~  156 (288)
T cd05093          80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN  156 (288)
T ss_pred             CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccC
Confidence            99999999999999999985432          223589999999999999999999999   99999999999999999


Q ss_pred             CcEEEeccccccccCCCCC--CccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccc
Q 039137          781 YEAHVSDFGIAKFLNPDSS--NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNM  857 (912)
Q Consensus       781 ~~~kl~Dfgla~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~  857 (912)
                      +.++|+|||++........  ......+++.|+|||++.+..++.++|||||||++|||++ |..||.....     ...
T Consensus       157 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~-----~~~  231 (288)
T cd05093         157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-----NEV  231 (288)
T ss_pred             CcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----HHH
Confidence            9999999999986543221  1123345778999999998889999999999999999998 8999752211     111


Q ss_pred             hhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          858 NIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       858 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                      .............   ...+.++.+++.+||+.||.+|||+.|+.+.|++...
T Consensus       232 ~~~i~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~  281 (288)
T cd05093         232 IECITQGRVLQRP---RTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK  281 (288)
T ss_pred             HHHHHcCCcCCCC---CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            1111111111111   1233568899999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.6e-35  Score=318.41  Aligned_cols=250  Identities=24%  Similarity=0.361  Sum_probs=199.3

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++.....   ....+++.+|++++++++||||+++++++..++..++|
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   77 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT---VELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISIC   77 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC---hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEE
Confidence            46888999999999999999864 788999999864321   22456788999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||++++++..+.       .+++..+..++.|++.|++|||+.   +|+|+||||+||+++.++.++|+|||++.....
T Consensus        78 ~e~~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~  147 (279)
T cd06619          78 TEFMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN  147 (279)
T ss_pred             EecCCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence            9999999996553       467888999999999999999999   999999999999999999999999999976543


Q ss_pred             CCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccc--hhhhccCCCCCCChhhH
Q 039137          797 DSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNM--NIEMLDSRLPYPSLHVQ  874 (912)
Q Consensus       797 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~  874 (912)
                      .  ......+++.|+|||++.+..++.++||||||+++|+|++|+.||.............  .....+...+.  ....
T Consensus       148 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  223 (279)
T cd06619         148 S--IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPV--LPVG  223 (279)
T ss_pred             c--cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCC--CCCC
Confidence            2  2334578999999999998889999999999999999999999986432211111000  00111111110  0111


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 039137          875 KKLMSIMQVAFSCLDQNPESRPTMKRVSQL  904 (912)
Q Consensus       875 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~  904 (912)
                      ..+..+.+++.+||+.||++||+++|+++.
T Consensus       224 ~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         224 QFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             cCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            234568899999999999999999998764

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.5e-36  Score=334.77  Aligned_cols=252  Identities=23%  Similarity=0.292  Sum_probs=200.7

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ++|++.+.||+|+||+||+|+.+ +++.||+|++....... ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv   79 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLA-QETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLV   79 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEE
Confidence            46899999999999999999876 78999999987543211 12456688999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++|+|.+++.+.  ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++.....
T Consensus        80 ~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  154 (330)
T cd05601          80 MEYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA  154 (330)
T ss_pred             ECCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence            9999999999999543  24689999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCC-ccccccccccccccccc------cCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccC--CCC
Q 039137          797 DSSN-WSELAGTHGYVAPELAY------TLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDS--RLP  867 (912)
Q Consensus       797 ~~~~-~~~~~g~~~y~aPE~~~------~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~  867 (912)
                      .... .....|++.|+|||++.      +..++.++|||||||++|||++|+.||......     .....+...  ...
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-----~~~~~i~~~~~~~~  229 (330)
T cd05601         155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA-----KTYNNIMNFQRFLK  229 (330)
T ss_pred             CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH-----HHHHHHHcCCCccC
Confidence            3322 23346899999999886      456788999999999999999999998522111     111111111  111


Q ss_pred             CCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          868 YPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       868 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ++.  ....+..+.+++.+|++ +|++|||++++++
T Consensus       230 ~~~--~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         230 FPE--DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             CCC--CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            111  11234567889999998 9999999998864

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-36  Score=313.58  Aligned_cols=250  Identities=21%  Similarity=0.365  Sum_probs=212.7

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      ..-|.+.+.||+|.|++|-.|++- +|+.||||++.+......  ....+.+|+..|+.++|||||++|++.......|+
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~--st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyL   94 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTL--STGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYL   94 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchh--hhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEE
Confidence            355888899999999999999865 899999999977654432  46678899999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEE-cCCCcEEEecccccccc
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLL-DLGYEAHVSDFGIAKFL  794 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill-~~~~~~kl~Dfgla~~~  794 (912)
                      |+|.-++|+|.+|+-...  ..+.+..+.+++.||+.|+.|+|+-   .+|||||||+||++ ..-|-||+.|||++..+
T Consensus        95 iLELGD~GDl~DyImKHe--~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf  169 (864)
T KOG4717|consen   95 ILELGDGGDLFDYIMKHE--EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF  169 (864)
T ss_pred             EEEecCCchHHHHHHhhh--ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccC
Confidence            999999999999995543  4588999999999999999999999   99999999999976 46788999999999887


Q ss_pred             CCCCCCccccccccccccccccccCCCC-cchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhh
Q 039137          795 NPDSSNWSELAGTHGYVAPELAYTLKVT-EKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHV  873 (912)
Q Consensus       795 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  873 (912)
                      .+. ......+|+..|-|||.+.|..|+ +++||||+||++|-+++|++||+..     .+.+...-++|-++..|    
T Consensus       170 ~PG-~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeA-----NDSETLTmImDCKYtvP----  239 (864)
T KOG4717|consen  170 QPG-KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEA-----NDSETLTMIMDCKYTVP----  239 (864)
T ss_pred             CCc-chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccc-----cchhhhhhhhcccccCc----
Confidence            665 456778999999999999999885 6899999999999999999998622     22233334455555554    


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          874 QKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       874 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ...+.+..++|..|+..||.+|.+.+||+.
T Consensus       240 shvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  240 SHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             hhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence            345667889999999999999999999864

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.3e-35  Score=314.13  Aligned_cols=248  Identities=24%  Similarity=0.409  Sum_probs=196.9

Q ss_pred             ceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEEeecCC
Q 039137          644 HCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLES  722 (912)
Q Consensus       644 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  722 (912)
                      +.||+|+||.||+|+.+ +++.||+|.+.....   ......+.+|+++++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   77 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLP---PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQG   77 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccC
Confidence            46899999999999875 789999998764322   22456789999999999999999999999999999999999999


Q ss_pred             CChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCCCc-
Q 039137          723 GSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNW-  801 (912)
Q Consensus       723 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~-  801 (912)
                      ++|.+++...  ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+|++|||++.......... 
T Consensus        78 ~~L~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  152 (252)
T cd05084          78 GDFLTFLRTE--GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST  152 (252)
T ss_pred             CcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCccccccccccc
Confidence            9999998542  24588999999999999999999999   99999999999999999999999999987654321111 


Q ss_pred             -cccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccCCCCCCChhhHHHHHH
Q 039137          802 -SELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMS  879 (912)
Q Consensus       802 -~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  879 (912)
                       .....+..|+|||.+.+..++.++||||+|+++|||++ |..||+.....      ............+  .....+..
T Consensus       153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~------~~~~~~~~~~~~~--~~~~~~~~  224 (252)
T cd05084         153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ------QTREAIEQGVRLP--CPELCPDA  224 (252)
T ss_pred             CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH------HHHHHHHcCCCCC--CcccCCHH
Confidence             11123457999999998889999999999999999998 88887522111      0111111111111  11223456


Q ss_pred             HHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 039137          880 IMQVAFSCLDQNPESRPTMKRVSQLLCE  907 (912)
Q Consensus       880 l~~li~~cl~~dP~~RPt~~evl~~L~~  907 (912)
                      +.+++.+|++.+|++|||+.++.++|++
T Consensus       225 ~~~li~~~l~~~p~~Rps~~~~~~~l~~  252 (252)
T cd05084         225 VYRLMERCWEYDPGQRPSFSTVHQELQS  252 (252)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence            8899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=4.8e-36  Score=329.71  Aligned_cols=244  Identities=21%  Similarity=0.316  Sum_probs=194.0

Q ss_pred             ceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEEcCCeeeEEEeecC
Q 039137          644 HCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSHPKHSFIIYEYLE  721 (912)
Q Consensus       644 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  721 (912)
                      +.||+|+||+||+|+.+ +++.||+|++....... ....+.+.+|+.++.++ +||+|+++++++...+..++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHD-DEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVN   79 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCC
Confidence            46999999999999875 67899999987543222 12456678899999888 69999999999999999999999999


Q ss_pred             CCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCCCc
Q 039137          722 SGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNW  801 (912)
Q Consensus       722 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  801 (912)
                      +|+|.+++..   .+.+++.++..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||++..........
T Consensus        80 ~~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  153 (327)
T cd05617          80 GGDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT  153 (327)
T ss_pred             CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCce
Confidence            9999988843   34689999999999999999999999   99999999999999999999999999997543333334


Q ss_pred             cccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhcccccc--ccchhhhccCCCCCCChhhHHHHHH
Q 039137          802 SELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS--SNMNIEMLDSRLPYPSLHVQKKLMS  879 (912)
Q Consensus       802 ~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  879 (912)
                      ....|++.|+|||++.+..++.++|||||||++|||++|+.||+.........  ..............+.    ..+..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~----~~~~~  229 (327)
T cd05617         154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPR----FLSVK  229 (327)
T ss_pred             ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCC----CCCHH
Confidence            45679999999999999999999999999999999999999986321111100  0111112222222222    23345


Q ss_pred             HHHHHHHcccCCCCCCCCH
Q 039137          880 IMQVAFSCLDQNPESRPTM  898 (912)
Q Consensus       880 l~~li~~cl~~dP~~RPt~  898 (912)
                      +.+++.+|++.||++||++
T Consensus       230 ~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         230 ASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             HHHHHHHHhccCHHHcCCC
Confidence            7789999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1e-35  Score=319.54  Aligned_cols=248  Identities=23%  Similarity=0.331  Sum_probs=194.8

Q ss_pred             eeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEEeecCCCC
Q 039137          646 IGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGS  724 (912)
Q Consensus       646 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  724 (912)
                      ||+|+||.||+++.+ +|+.||+|++........ ...+.+..|+++++.++||||+++++++..+...++||||+++++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~-~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~   79 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKK-SGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGD   79 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcc-hhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence            699999999999875 689999999864322111 123455679999999999999999999999999999999999999


Q ss_pred             hhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCCCcccc
Q 039137          725 LDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSEL  804 (912)
Q Consensus       725 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~  804 (912)
                      |.+++... ....+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||++...... ......
T Consensus        80 L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~-~~~~~~  154 (277)
T cd05607          80 LKYHIYNV-GERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG-KTITQR  154 (277)
T ss_pred             HHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCC-ceeecc
Confidence            99888443 234588999999999999999999999   9999999999999999999999999999866432 222345


Q ss_pred             ccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHHHHHHHHH
Q 039137          805 AGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVA  884 (912)
Q Consensus       805 ~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  884 (912)
                      .|++.|+|||++.+..++.++||||+||++|||++|+.||....+... ................   ....+.++.+++
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~---~~~~~~~~~~li  230 (277)
T cd05607         155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA-KEELKRRTLEDEVKFE---HQNFTEESKDIC  230 (277)
T ss_pred             CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh-HHHHHHHhhccccccc---cccCCHHHHHHH
Confidence            689999999999988899999999999999999999999853211100 0111111111121111   123455688999


Q ss_pred             HHcccCCCCCCCCHHHHHH
Q 039137          885 FSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       885 ~~cl~~dP~~RPt~~evl~  903 (912)
                      .+||+.||++||+++|+++
T Consensus       231 ~~~L~~~P~~R~~~~~~~~  249 (277)
T cd05607         231 RLFLAKKPEDRLGSREKND  249 (277)
T ss_pred             HHHhccCHhhCCCCccchh
Confidence            9999999999999987654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=7.2e-36  Score=343.95  Aligned_cols=257  Identities=23%  Similarity=0.314  Sum_probs=204.8

Q ss_pred             HHHhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCC-
Q 039137          634 ISATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPK-  711 (912)
Q Consensus       634 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-  711 (912)
                      ....++|++.+.||+|+||+||+|+.. +++.||||++......  ......+.+|+..+..++|+|++++++.+...+ 
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~--~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~  105 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS--EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP  105 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC--HHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence            344579999999999999999999865 7899999998654322  224567889999999999999999988775432 


Q ss_pred             -------eeeEEEeecCCCChhhHhhcc-CCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcE
Q 039137          712 -------HSFIIYEYLESGSLDKILCND-ASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEA  783 (912)
Q Consensus       712 -------~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  783 (912)
                             ..++||||+++|+|.+++... .....+++..+..++.|++.||+|+|++   +|+||||||+||+++.++.+
T Consensus       106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~v  182 (496)
T PTZ00283        106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLV  182 (496)
T ss_pred             cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCE
Confidence                   368999999999999998543 2345689999999999999999999999   99999999999999999999


Q ss_pred             EEeccccccccCCCC--CCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhh
Q 039137          784 HVSDFGIAKFLNPDS--SNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEM  861 (912)
Q Consensus       784 kl~Dfgla~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~  861 (912)
                      ||+|||+++......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....     .......
T Consensus       183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~-----~~~~~~~  257 (496)
T PTZ00283        183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM-----EEVMHKT  257 (496)
T ss_pred             EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHH
Confidence            999999998654321  223346789999999999999999999999999999999999999852110     1111111


Q ss_pred             ccCCC-CCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 039137          862 LDSRL-PYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQL  904 (912)
Q Consensus       862 ~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  904 (912)
                      ..... +.+    ...+..+.+++.+||+.||.+||++.++++.
T Consensus       258 ~~~~~~~~~----~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        258 LAGRYDPLP----PSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             hcCCCCCCC----CCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            11111 111    2234568899999999999999999998764

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.8e-35  Score=319.36  Aligned_cols=259  Identities=21%  Similarity=0.294  Sum_probs=199.8

Q ss_pred             CCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEE
Q 039137          639 DFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIY  717 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  717 (912)
                      +|++.+.||+|++|.||+|+.+ +++.||+|++.......  ...+.+.+|+.+++.++||||+++++++..++..++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEE--GVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIF   78 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccC--CchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEE
Confidence            5788899999999999999875 78999999986543222  13466788999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCC
Q 039137          718 EYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPD  797 (912)
Q Consensus       718 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  797 (912)
                      ||++ +++.+++........+++.+++.++.|++.||+|||++   +|+|+||+|+||+++.++.++|+|||++......
T Consensus        79 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  154 (285)
T cd07861          79 EFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP  154 (285)
T ss_pred             ecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCC
Confidence            9997 58988886554456789999999999999999999999   9999999999999999999999999999866544


Q ss_pred             CCCccccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCccchhcccccc----------ccc-----hhhh
Q 039137          798 SSNWSELAGTHGYVAPELAYTL-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS----------SNM-----NIEM  861 (912)
Q Consensus       798 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~----------~~~-----~~~~  861 (912)
                      ........+++.|+|||++.+. .++.++||||+|+++|+|++|+.||....+.....          ...     ....
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
T cd07861         155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD  234 (285)
T ss_pred             cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence            3333445678899999987654 47889999999999999999999985221110000          000     0000


Q ss_pred             ccCCCC-----CCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          862 LDSRLP-----YPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       862 ~~~~~~-----~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .....+     .........+.++.+++.+||+.||++|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            000000     000001113456789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2e-35  Score=314.36  Aligned_cols=253  Identities=23%  Similarity=0.414  Sum_probs=203.5

Q ss_pred             hcCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      .++|++.++||+|+||.||+|..++++.||+|.+.....     ..+.+.+|+++++.++|+||+++++++. .+..+++
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v   78 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-----SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYII   78 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-----cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEE
Confidence            467999999999999999999988899999999864322     3467889999999999999999999874 4678999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++++|.+++.... ...+++.++..++.|++.|++|||+.   +++||||||+||+++.++.++++|||++.....
T Consensus        79 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05067          79 TEYMENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIED  154 (260)
T ss_pred             EEcCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence            99999999999985432 35689999999999999999999999   999999999999999999999999999986653


Q ss_pred             CCC-CccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccCCCCCCChhhH
Q 039137          797 DSS-NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQ  874 (912)
Q Consensus       797 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  874 (912)
                      ... ......++..|+|||++.+..++.++||||||+++||+++ |+.||.....     ... ..........+  ...
T Consensus       155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~~-~~~~~~~~~~~--~~~  226 (260)
T cd05067         155 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN-----PEV-IQNLERGYRMP--RPD  226 (260)
T ss_pred             CCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh-----HHH-HHHHHcCCCCC--CCC
Confidence            221 1223345678999999988889999999999999999999 9999852111     001 11111111111  011


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 039137          875 KKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCE  907 (912)
Q Consensus       875 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  907 (912)
                      ..+.++.+++.+||+.+|++||+++++.+.|+.
T Consensus       227 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         227 NCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            234568899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2.3e-35  Score=319.33  Aligned_cols=259  Identities=25%  Similarity=0.411  Sum_probs=204.3

Q ss_pred             CCCCCceeeecCceEEEEEEeC------CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCe
Q 039137          639 DFNAEHCIGKGGHGSVYRAKVP------SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKH  712 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~  712 (912)
                      +|++.+.||+|+||.||+|...      ....+++|.+.....   ....+.+.+|+.+++.++||||+++++.+...+.
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   77 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS---SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGP   77 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC---HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCC
Confidence            4788899999999999999753      235688888764322   2245678899999999999999999999999999


Q ss_pred             eeEEEeecCCCChhhHhhccC---------------------CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCC
Q 039137          713 SFIIYEYLESGSLDKILCNDA---------------------SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDIS  771 (912)
Q Consensus       713 ~~lv~e~~~~g~L~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk  771 (912)
                      .++||||+++++|.+++....                     ....+++.+++.++.|++.|++|||++   +++|||||
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dik  154 (290)
T cd05045          78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLA  154 (290)
T ss_pred             cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhh
Confidence            999999999999999985421                     123588999999999999999999999   99999999


Q ss_pred             CCCeEEcCCCcEEEeccccccccCCCCCC--ccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchh
Q 039137          772 SKNVLLDLGYEAHVSDFGIAKFLNPDSSN--WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLF  848 (912)
Q Consensus       772 ~~Nill~~~~~~kl~Dfgla~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~  848 (912)
                      |+||++++++.+||+|||+++........  .....++..|+|||++.+..++.++||||||+++|||++ |..||....
T Consensus       155 p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~  234 (290)
T cd05045         155 ARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA  234 (290)
T ss_pred             hheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence            99999999999999999999865333221  122345678999999988889999999999999999998 999985321


Q ss_pred             ccccccccchhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 039137          849 EMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE  911 (912)
Q Consensus       849 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~~  911 (912)
                      ..      ............+.  ....+.++.+++.+||+.+|++||+++|+++.|++.+.+
T Consensus       235 ~~------~~~~~~~~~~~~~~--~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~  289 (290)
T cd05045         235 PE------RLFNLLKTGYRMER--PENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK  289 (290)
T ss_pred             HH------HHHHHHhCCCCCCC--CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence            11      11111111111110  122345688999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.6e-35  Score=313.49  Aligned_cols=253  Identities=26%  Similarity=0.455  Sum_probs=203.0

Q ss_pred             hcCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      .++|++.+.||+|+||.||+|..+++..||+|.+.....     ..+.+.+|+.++++++|++++++++++. .+..+++
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv   78 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-----SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIV   78 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-----CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEE
Confidence            357899999999999999999988888899999865332     2456889999999999999999999885 4568999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++++|.+++... ....+++.+++.++.|++.|++|||+.   +++||||||+||++++++.++++|||.+.....
T Consensus        79 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05070          79 TEYMSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIED  154 (260)
T ss_pred             EEecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence            9999999999998543 234589999999999999999999999   999999999999999999999999999986643


Q ss_pred             CCCC-ccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccCCCCCCChhhH
Q 039137          797 DSSN-WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQ  874 (912)
Q Consensus       797 ~~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  874 (912)
                      .... .....++..|+|||+..+..++.++||||||+++|||++ |..||.....     .. ....+......+  ...
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-----~~-~~~~~~~~~~~~--~~~  226 (260)
T cd05070         155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-----RE-VLEQVERGYRMP--CPQ  226 (260)
T ss_pred             cccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH-----HH-HHHHHHcCCCCC--CCC
Confidence            3221 122335668999999988889999999999999999999 8899852211     11 111111111111  112


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 039137          875 KKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCE  907 (912)
Q Consensus       875 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  907 (912)
                      ..+..+.+++.+|++.+|++|||++++.+.|++
T Consensus       227 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         227 DCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             cCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            334568899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-35  Score=305.93  Aligned_cols=254  Identities=21%  Similarity=0.287  Sum_probs=207.0

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      +.|++.+.||+|.-|+||.++.+ ++..+|+|++.+..... .....+...|-++++.++||.++.+|+.++.++..|+|
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~-rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~  155 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLAS-RKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV  155 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhh-hhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence            45677899999999999999986 46899999997654332 22456677899999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      ||||+||+|..+.++ +..+.+++..++-++.+++-||+|||..   |||+|||||+|||+.++|.+-|+||.++.....
T Consensus       156 meyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~  231 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPV  231 (459)
T ss_pred             EecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence            999999999998855 4567799999999999999999999999   999999999999999999999999998753210


Q ss_pred             ---------------------------------C-C----------------------CCccccccccccccccccccCC
Q 039137          797 ---------------------------------D-S----------------------SNWSELAGTHGYVAPELAYTLK  820 (912)
Q Consensus       797 ---------------------------------~-~----------------------~~~~~~~g~~~y~aPE~~~~~~  820 (912)
                                                       . .                      .....++||-.|+|||++.|..
T Consensus       232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G  311 (459)
T KOG0610|consen  232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG  311 (459)
T ss_pred             CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence                                             0 0                      0012357899999999999999


Q ss_pred             CCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCC---
Q 039137          821 VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPT---  897 (912)
Q Consensus       821 ~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---  897 (912)
                      .+.++|.|+|||++|||+.|..||..     .........++.+...++...  ..+..+.++|++.+.+||.+|..   
T Consensus       312 HgsAVDWWtfGIflYEmLyG~TPFKG-----~~~~~Tl~NIv~~~l~Fp~~~--~vs~~akDLIr~LLvKdP~kRlg~~r  384 (459)
T KOG0610|consen  312 HGSAVDWWTFGIFLYEMLYGTTPFKG-----SNNKETLRNIVGQPLKFPEEP--EVSSAAKDLIRKLLVKDPSKRLGSKR  384 (459)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCcCC-----CCchhhHHHHhcCCCcCCCCC--cchhHHHHHHHHHhccChhhhhcccc
Confidence            99999999999999999999999852     122233334444444444332  45667899999999999999987   


Q ss_pred             -HHHHHH
Q 039137          898 -MKRVSQ  903 (912)
Q Consensus       898 -~~evl~  903 (912)
                       +.||.+
T Consensus       385 GA~eIK~  391 (459)
T KOG0610|consen  385 GAAEIKR  391 (459)
T ss_pred             chHHhhc
Confidence             666543

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.5e-35  Score=321.92  Aligned_cols=257  Identities=17%  Similarity=0.285  Sum_probs=197.8

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ++|.+.+.||+|+||.||+|+.+ +++.||+|.+.......   ....+.+|+++++.++||||+++++++..++..++|
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   82 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG---APCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV   82 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC---cchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence            67999999999999999999876 68889999986543222   234577899999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++ ++.+++...  ...+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++.....
T Consensus        83 ~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  156 (309)
T cd07872          83 FEYLDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSV  156 (309)
T ss_pred             EeCCCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCC
Confidence            999986 888877432  34578899999999999999999999   999999999999999999999999999976544


Q ss_pred             CCCCcccccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCccchhcccc----------ccccch------h
Q 039137          797 DSSNWSELAGTHGYVAPELAYT-LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS----------SSSNMN------I  859 (912)
Q Consensus       797 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~----------~~~~~~------~  859 (912)
                      .........+++.|+|||++.+ ..++.++||||+||++|||++|+.||........          ......      .
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
T cd07872         157 PTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND  236 (309)
T ss_pred             CccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence            4333444567899999998865 4578999999999999999999999852211000          000000      0


Q ss_pred             hhccCCCC-CCC----hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          860 EMLDSRLP-YPS----LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       860 ~~~~~~~~-~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ...+...+ +..    ......+.++.+++.+|++.||.+|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            00000000 000    001123456789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2.1e-35  Score=318.47  Aligned_cols=255  Identities=22%  Similarity=0.383  Sum_probs=201.7

Q ss_pred             cCCCCCceeeecCceEEEEEEe-----CCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCe
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKV-----PSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKH  712 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~  712 (912)
                      ++|++.+.||+|+||+||+|+.     .++..||+|.+.....   ......+.+|+++++.++||||+++++++..++.
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   81 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN---PQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP   81 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC---HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc
Confidence            4688899999999999999974     2567899999864321   2245678899999999999999999999999999


Q ss_pred             eeEEEeecCCCChhhHhhccC--------------CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEc
Q 039137          713 SFIIYEYLESGSLDKILCNDA--------------SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLD  778 (912)
Q Consensus       713 ~~lv~e~~~~g~L~~~l~~~~--------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~  778 (912)
                      .++||||+++++|.+++....              ....+++.++..++.|++.|++|||++   +|+||||||+||+++
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~  158 (283)
T cd05090          82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIG  158 (283)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEc
Confidence            999999999999999985322              123478899999999999999999999   999999999999999


Q ss_pred             CCCcEEEeccccccccCCCCC--CccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccc
Q 039137          779 LGYEAHVSDFGIAKFLNPDSS--NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSS  855 (912)
Q Consensus       779 ~~~~~kl~Dfgla~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~  855 (912)
                      +++.+|++|||+++.......  ......++..|+|||++.+..++.++||||||+++|||++ |..||.....      
T Consensus       159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~------  232 (283)
T cd05090         159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN------  232 (283)
T ss_pred             CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH------
Confidence            999999999999986543321  1223345678999999988889999999999999999998 9889742111      


Q ss_pred             cchhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 039137          856 NMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLC  906 (912)
Q Consensus       856 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  906 (912)
                      ....+........+.  ....+..+.+++.+||+.||++||++.++.+.|+
T Consensus       233 ~~~~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  281 (283)
T cd05090         233 QEVIEMVRKRQLLPC--SEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR  281 (283)
T ss_pred             HHHHHHHHcCCcCCC--CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence            111111111111110  1123456888999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=3.1e-35  Score=318.86  Aligned_cols=250  Identities=26%  Similarity=0.428  Sum_probs=203.0

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      ..+|++.+.||+|++|.||+|... +++.||+|.+......    ..+.+.+|+.+++.++||||+++++++..++..++
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~----~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~l   94 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP----KKELIINEILVMRENKNPNIVNYLDSYLVGDELWV   94 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc----hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEE
Confidence            357999999999999999999864 7889999998653322    35668899999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ||||+++++|.+++..    ..+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||++....
T Consensus        95 v~e~~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~  167 (296)
T cd06654          95 VMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  167 (296)
T ss_pred             eecccCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcc
Confidence            9999999999999843    3478899999999999999999999   99999999999999999999999999988665


Q ss_pred             CCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHH
Q 039137          796 PDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQK  875 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  875 (912)
                      ..........+++.|+|||.+.+..++.++|||||||++|+|++|+.||........    ............+  ....
T Consensus       168 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~----~~~~~~~~~~~~~--~~~~  241 (296)
T cd06654         168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA----LYLIATNGTPELQ--NPEK  241 (296)
T ss_pred             ccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh----HHHHhcCCCCCCC--Cccc
Confidence            443333445788999999999888899999999999999999999999852211100    0000111111110  1123


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          876 KLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       876 ~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ....+.+++.+||..||++||++.++++
T Consensus       242 ~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         242 LSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             cCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            4456889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.5e-35  Score=319.06  Aligned_cols=257  Identities=26%  Similarity=0.459  Sum_probs=204.7

Q ss_pred             cCCCCCceeeecCceEEEEEEeC------CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCC
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP------SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPK  711 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~  711 (912)
                      .+|.+.+.||+|+||.||+|+..      ++..+++|.+....    ....+.+.+|++.+++++||||+++++++...+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT----LAARKDFQREAELLTNLQHEHIVKFYGVCGDGD   80 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc----HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence            46888899999999999999742      45568999875432    224567889999999999999999999999999


Q ss_pred             eeeEEEeecCCCChhhHhhccC-------------CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEc
Q 039137          712 HSFIIYEYLESGSLDKILCNDA-------------SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLD  778 (912)
Q Consensus       712 ~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~  778 (912)
                      ..++||||+++++|.+++....             ....+++.+++.++.|++.|++|||++   +|+||||||+||+++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~  157 (291)
T cd05094          81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVG  157 (291)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEc
Confidence            9999999999999999995432             224589999999999999999999999   999999999999999


Q ss_pred             CCCcEEEeccccccccCCCCC--CccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccc
Q 039137          779 LGYEAHVSDFGIAKFLNPDSS--NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSS  855 (912)
Q Consensus       779 ~~~~~kl~Dfgla~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~  855 (912)
                      .++.++|+|||++........  ......+++.|+|||++.+..++.++||||||+++|||++ |+.||......     
T Consensus       158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-----  232 (291)
T cd05094         158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT-----  232 (291)
T ss_pred             cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----
Confidence            999999999999976543221  1223446788999999998889999999999999999999 99997522110     


Q ss_pred             cchhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 039137          856 NMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI  909 (912)
Q Consensus       856 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l  909 (912)
                      ...........+..   ....+..+.+++.+||+.||++|||+++++++|++..
T Consensus       233 ~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~  283 (291)
T cd05094         233 EVIECITQGRVLER---PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG  283 (291)
T ss_pred             HHHHHHhCCCCCCC---CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence            11111111111111   1123456889999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.2e-35  Score=322.17  Aligned_cols=259  Identities=22%  Similarity=0.383  Sum_probs=205.8

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC------CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEE
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP------SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCS  708 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~  708 (912)
                      ..++|++.+.||+|+||.||+|...      ....+|+|.+.....   .....++.+|+++++.+ +|+||+++++++.
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   86 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT---EKDLSDLVSEMEMMKMIGKHKNIINLLGVCT   86 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC---HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence            4567899999999999999999864      236799999864322   22456688999999999 7999999999999


Q ss_pred             cCCeeeEEEeecCCCChhhHhhcc-------------CCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCe
Q 039137          709 HPKHSFIIYEYLESGSLDKILCND-------------ASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNV  775 (912)
Q Consensus       709 ~~~~~~lv~e~~~~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Ni  775 (912)
                      ..+..+++|||+++|+|.+++...             .....+++..++.++.|++.|++|||+.   +|+||||||+||
T Consensus        87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Ni  163 (293)
T cd05053          87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNV  163 (293)
T ss_pred             CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeE
Confidence            999999999999999999998543             2345689999999999999999999999   999999999999


Q ss_pred             EEcCCCcEEEeccccccccCCCCCC--ccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhcccc
Q 039137          776 LLDLGYEAHVSDFGIAKFLNPDSSN--WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSS  852 (912)
Q Consensus       776 ll~~~~~~kl~Dfgla~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~  852 (912)
                      +++.++.+|++|||.++.+......  .....++..|+|||++.+..++.++|||||||++||+++ |..||.....   
T Consensus       164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---  240 (293)
T cd05053         164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV---  240 (293)
T ss_pred             EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH---
Confidence            9999999999999999866543211  122334678999999988889999999999999999998 9998752111   


Q ss_pred             ccccchhhhccCC-CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 039137          853 SSSNMNIEMLDSR-LPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI  909 (912)
Q Consensus       853 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l  909 (912)
                        ........... ...+    ......+.+++.+||..||++|||+.|+++.|++.+
T Consensus       241 --~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         241 --EELFKLLKEGYRMEKP----QNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             --HHHHHHHHcCCcCCCC----CCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence              00111111111 1111    123456889999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=7.2e-36  Score=333.33  Aligned_cols=258  Identities=19%  Similarity=0.296  Sum_probs=200.4

Q ss_pred             HHHHHhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC
Q 039137          632 EIISATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP  710 (912)
Q Consensus       632 e~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~  710 (912)
                      ++....++|++.+.||+|+||.||+|+++ +++.||+|++....... ....+.+.+|+.+++.++||||+++++++..+
T Consensus        37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~-~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (371)
T cd05622          37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIK-RSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  115 (371)
T ss_pred             hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhh-hHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence            34445689999999999999999999876 68899999985422111 11345678899999999999999999999999


Q ss_pred             CeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccc
Q 039137          711 KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGI  790 (912)
Q Consensus       711 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl  790 (912)
                      +..++||||+++|+|.+++..    ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+
T Consensus       116 ~~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~  188 (371)
T cd05622         116 RYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT  188 (371)
T ss_pred             CEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence            999999999999999999843    3478889999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCC-CccccccccccccccccccCC----CCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCC
Q 039137          791 AKFLNPDSS-NWSELAGTHGYVAPELAYTLK----VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSR  865 (912)
Q Consensus       791 a~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~----~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  865 (912)
                      +........ ......||+.|+|||++.+..    ++.++||||+||++|||++|+.||.....     ......+....
T Consensus       189 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----~~~~~~i~~~~  263 (371)
T cd05622         189 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-----VGTYSKIMNHK  263 (371)
T ss_pred             eeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH-----HHHHHHHHcCC
Confidence            987654322 223567999999999987543    78899999999999999999999862211     11111222211


Q ss_pred             --CCCCChhhHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 039137          866 --LPYPSLHVQKKLMSIMQVAFSCLDQNPES--RPTMKRVSQL  904 (912)
Q Consensus       866 --~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~  904 (912)
                        ...+.  ....+..+.++|.+|+..++.+  ||+++|+++.
T Consensus       264 ~~~~~~~--~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         264 NSLTFPD--DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             CcccCCC--cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence              12221  1234556788999999844433  6788887763

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=5.3e-35  Score=313.35  Aligned_cols=256  Identities=23%  Similarity=0.375  Sum_probs=198.7

Q ss_pred             CCCCceeeecCceEEEEEEeCC-CC--EEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC------
Q 039137          640 FNAEHCIGKGGHGSVYRAKVPS-GE--IFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP------  710 (912)
Q Consensus       640 ~~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------  710 (912)
                      |.+.+.||+|+||.||+|+..+ ++  .||+|.+......  ....+.+.+|++.++.++||||+++++++...      
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   78 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICT--RSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGY   78 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCC
Confidence            3567899999999999998754 32  5899988654322  23467788999999999999999999987432      


Q ss_pred             CeeeEEEeecCCCChhhHhhccC---CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEec
Q 039137          711 KHSFIIYEYLESGSLDKILCNDA---SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSD  787 (912)
Q Consensus       711 ~~~~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  787 (912)
                      ...+++|||+++|+|.+++....   ....+++.++..++.|++.|++|||++   +|+||||||+||++++++.++|+|
T Consensus        79 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~D  155 (272)
T cd05075          79 PSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVAD  155 (272)
T ss_pred             CCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECC
Confidence            24689999999999998874322   234588999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCCC--ccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccC
Q 039137          788 FGIAKFLNPDSSN--WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDS  864 (912)
Q Consensus       788 fgla~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  864 (912)
                      ||+++........  .....+++.|+|||+..+..++.++||||||+++|||++ |+.||.....     ..........
T Consensus       156 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----~~~~~~~~~~  230 (272)
T cd05075         156 FGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-----SEIYDYLRQG  230 (272)
T ss_pred             CCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHHHcC
Confidence            9999876433221  122345678999999999889999999999999999999 8889753211     1111111111


Q ss_pred             C-CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 039137          865 R-LPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI  909 (912)
Q Consensus       865 ~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l  909 (912)
                      . .+.+    ...+..+.+++.+||+.||++|||+.++++.|++.+
T Consensus       231 ~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~~  272 (272)
T cd05075         231 NRLKQP----PDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL  272 (272)
T ss_pred             CCCCCC----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence            1 1111    123445789999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.6e-35  Score=318.38  Aligned_cols=260  Identities=20%  Similarity=0.342  Sum_probs=203.8

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC------CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEc
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP------SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSH  709 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~  709 (912)
                      ..++|++.+.||+|+||.||+|..+      .+..||+|.+.....   ......+.+|+..++.++||||+++++++..
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   80 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS---LRERIEFLNEASVMKGFTCHHVVRLLGVVSK   80 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC---HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            4578999999999999999999653      245799998764321   1234568899999999999999999999999


Q ss_pred             CCeeeEEEeecCCCChhhHhhccCC-------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCc
Q 039137          710 PKHSFIIYEYLESGSLDKILCNDAS-------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYE  782 (912)
Q Consensus       710 ~~~~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~  782 (912)
                      .+..++||||+++|+|.+++.....       ....++..+..++.|++.|++|||++   +|+||||||+||++++++.
T Consensus        81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~  157 (288)
T cd05061          81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFT  157 (288)
T ss_pred             CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCc
Confidence            9999999999999999999964321       23456788899999999999999999   9999999999999999999


Q ss_pred             EEEeccccccccCCCCCC--ccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchh
Q 039137          783 AHVSDFGIAKFLNPDSSN--WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNI  859 (912)
Q Consensus       783 ~kl~Dfgla~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~  859 (912)
                      ++++|||+++........  .....++..|+|||.+.+..++.++|||||||++|||++ |+.||.....     .....
T Consensus       158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~-----~~~~~  232 (288)
T cd05061         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-----EQVLK  232 (288)
T ss_pred             EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHH
Confidence            999999999865432211  122234678999999998889999999999999999998 7888752111     11111


Q ss_pred             hhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 039137          860 EMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI  909 (912)
Q Consensus       860 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l  909 (912)
                      ...+.......   ...+..+.+++.+|++.||++|||+.++++.|++.+
T Consensus       233 ~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         233 FVMDGGYLDQP---DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             HHHcCCCCCCC---CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            11111111111   122356889999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=3e-35  Score=316.67  Aligned_cols=261  Identities=21%  Similarity=0.320  Sum_probs=207.8

Q ss_pred             hcCCCCCceeeecCceEEEEEEeCC-----CCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEc-C
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVPS-----GEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSH-P  710 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-~  710 (912)
                      .++|++.+.||+|+||.||+|.+.+     +..|++|++....   .....+.+.+|+.+++.++||||+++++++.. +
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~   81 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA---SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG   81 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            4679999999999999999998765     6889999876432   22356778899999999999999999998866 4


Q ss_pred             CeeeEEEeecCCCChhhHhhccCCc-----ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEE
Q 039137          711 KHSFIIYEYLESGSLDKILCNDASA-----KELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHV  785 (912)
Q Consensus       711 ~~~~lv~e~~~~g~L~~~l~~~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  785 (912)
                      ...++++||+++++|.+++......     ..+++.+++.++.|++.|++|||+.   +++|+||||+||++++++.+|+
T Consensus        82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl  158 (280)
T cd05043          82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKI  158 (280)
T ss_pred             CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEE
Confidence            6789999999999999998654332     5689999999999999999999999   9999999999999999999999


Q ss_pred             eccccccccCCCCCC--ccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhc
Q 039137          786 SDFGIAKFLNPDSSN--WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEML  862 (912)
Q Consensus       786 ~Dfgla~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~  862 (912)
                      +|||+++.+.+....  .....++..|+|||++.+..++.++||||||+++||+++ |+.||......     . .....
T Consensus       159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----~-~~~~~  232 (280)
T cd05043         159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF-----E-MAAYL  232 (280)
T ss_pred             CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH-----H-HHHHH
Confidence            999999865433221  122345678999999988889999999999999999999 99998532111     0 11111


Q ss_pred             cCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 039137          863 DSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE  911 (912)
Q Consensus       863 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~~  911 (912)
                      ........  ....+.++.+++.+||..||++|||+.++++.|++...+
T Consensus       233 ~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         233 KDGYRLAQ--PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             HcCCCCCC--CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence            11111111  112345688999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=3.4e-35  Score=318.93  Aligned_cols=258  Identities=24%  Similarity=0.359  Sum_probs=200.9

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCC--EEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEEcCCee
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGE--IFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSHPKHS  713 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~  713 (912)
                      ++|++.+.||+|+||.||+|..+ ++.  .+++|.++...   .....+.+.+|++++.++ +||||+++++++...+..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~   78 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA---SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYL   78 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC---CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcc
Confidence            57999999999999999999875 333  46888776322   122456788999999999 799999999999999999


Q ss_pred             eEEEeecCCCChhhHhhccC-------------CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCC
Q 039137          714 FIIYEYLESGSLDKILCNDA-------------SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLG  780 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~  780 (912)
                      ++||||+++++|.++++...             ....+++.+++.++.|++.|++|||++   +|+||||||+||+++++
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~  155 (297)
T cd05089          79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGEN  155 (297)
T ss_pred             eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCC
Confidence            99999999999999995432             123588999999999999999999999   99999999999999999


Q ss_pred             CcEEEeccccccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchh
Q 039137          781 YEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNI  859 (912)
Q Consensus       781 ~~~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~  859 (912)
                      +.+||+|||++....... .......+..|+|||++.+..++.++|||||||++|||++ |..||.....     .....
T Consensus       156 ~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~-----~~~~~  229 (297)
T cd05089         156 LASKIADFGLSRGEEVYV-KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC-----AELYE  229 (297)
T ss_pred             CeEEECCcCCCcccccee-ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHH
Confidence            999999999986432111 1111223557999999988889999999999999999997 9999852211     01111


Q ss_pred             hhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          860 EMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       860 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                      .. ......+  .....+..+.+++.+||+.+|.+||+++++++.|++++.
T Consensus       230 ~~-~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~  277 (297)
T cd05089         230 KL-PQGYRME--KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE  277 (297)
T ss_pred             HH-hcCCCCC--CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            11 1111110  011234568899999999999999999999999987764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2.3e-35  Score=321.02  Aligned_cols=259  Identities=25%  Similarity=0.385  Sum_probs=201.7

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCC--EEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEEcCCe
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGE--IFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSHPKH  712 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~  712 (912)
                      .++|++.+.||+|+||.||+|.++ ++.  .+|+|.+....   .....+.+.+|++++.++ +||||+++++++...+.
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~   82 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY   82 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC---CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence            357899999999999999999875 454  35777765321   222456788999999999 89999999999999999


Q ss_pred             eeEEEeecCCCChhhHhhccC-------------CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcC
Q 039137          713 SFIIYEYLESGSLDKILCNDA-------------SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDL  779 (912)
Q Consensus       713 ~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~  779 (912)
                      .++||||+++++|.++++...             ....+++.+++.++.|++.|++|||++   +|+||||||+||+++.
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~  159 (303)
T cd05088          83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGE  159 (303)
T ss_pred             ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecC
Confidence            999999999999999996432             123588999999999999999999999   9999999999999999


Q ss_pred             CCcEEEeccccccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccch
Q 039137          780 GYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMN  858 (912)
Q Consensus       780 ~~~~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~  858 (912)
                      ++.+||+|||++...... .......++..|+|||++.+..++.++|||||||++|||+| |..||......     ...
T Consensus       160 ~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-----~~~  233 (303)
T cd05088         160 NYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----ELY  233 (303)
T ss_pred             CCcEEeCccccCcccchh-hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH-----HHH
Confidence            999999999998632211 11112234568999999988889999999999999999998 99998522110     111


Q ss_pred             hhhccC-CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 039137          859 IEMLDS-RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE  911 (912)
Q Consensus       859 ~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~~  911 (912)
                      ...... ....+    ...+..+.+++.+||+.+|++||++++++..+++++.+
T Consensus       234 ~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~  283 (303)
T cd05088         234 EKLPQGYRLEKP----LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  283 (303)
T ss_pred             HHHhcCCcCCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            111111 11111    12344678999999999999999999999999887653

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=5.2e-35  Score=311.14  Aligned_cols=252  Identities=24%  Similarity=0.417  Sum_probs=201.9

Q ss_pred             cCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIY  717 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  717 (912)
                      ++|++.+.||+|++|.||+|..+.+..+|+|.+.....     ..+.+.+|+++++.++|||++++++++. .+..++||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~   79 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVT   79 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEE
Confidence            56889999999999999999987777899998764321     3466889999999999999999999885 45689999


Q ss_pred             eecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCC
Q 039137          718 EYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPD  797 (912)
Q Consensus       718 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  797 (912)
                      ||+++++|.+++... ....+++..+..++.|++.|++|||+.   +++|+||||+||++++++.++|+|||.+......
T Consensus        80 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05069          80 EFMGKGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDN  155 (260)
T ss_pred             EcCCCCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence            999999999999543 234578999999999999999999999   9999999999999999999999999999866433


Q ss_pred             CCC-ccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccCCCCCCChhhHH
Q 039137          798 SSN-WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQK  875 (912)
Q Consensus       798 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  875 (912)
                      ... .....++..|+|||+..+..++.++||||||+++|||++ |+.||......     .... ........+  ....
T Consensus       156 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----~~~~-~~~~~~~~~--~~~~  227 (260)
T cd05069         156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR-----EVLE-QVERGYRMP--CPQG  227 (260)
T ss_pred             cccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHH-HHHcCCCCC--CCcc
Confidence            221 123345678999999988889999999999999999999 89998522111     1111 111111111  1123


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 039137          876 KLMSIMQVAFSCLDQNPESRPTMKRVSQLLCE  907 (912)
Q Consensus       876 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  907 (912)
                      .+..+.+++.+||+.||++||+++++.+.|++
T Consensus       228 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         228 CPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             cCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            45668899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3.3e-35  Score=311.85  Aligned_cols=248  Identities=23%  Similarity=0.372  Sum_probs=195.5

Q ss_pred             eeeecCceEEEEEEeC---CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEEeecC
Q 039137          645 CIGKGGHGSVYRAKVP---SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLE  721 (912)
Q Consensus       645 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  721 (912)
                      .||+|+||.||+|.+.   .+..||+|++.....   ....+.+.+|+.++++++||||+++++++. .+..++||||++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~---~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~   77 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE---KSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMAS   77 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccC---hHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCC
Confidence            3899999999999764   355799999865422   224567899999999999999999999885 457899999999


Q ss_pred             CCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCCCc
Q 039137          722 SGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNW  801 (912)
Q Consensus       722 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  801 (912)
                      +++|.+++...  ...+++.++++++.|++.|++|||++   +++||||||+||+++.++.+|++|||++..........
T Consensus        78 ~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~  152 (257)
T cd05115          78 GGPLNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY  152 (257)
T ss_pred             CCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence            99999998532  34689999999999999999999999   99999999999999999999999999998654332221


Q ss_pred             c---ccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccC-CCCCCChhhHHH
Q 039137          802 S---ELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDS-RLPYPSLHVQKK  876 (912)
Q Consensus       802 ~---~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  876 (912)
                      .   ...+++.|+|||++.+..++.++||||||+++||+++ |+.||......     ......... +...+    ...
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~----~~~  223 (257)
T cd05115         153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP-----EVMSFIEQGKRLDCP----AEC  223 (257)
T ss_pred             eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH-----HHHHHHHCCCCCCCC----CCC
Confidence            1   1223578999999988889999999999999999996 99998522111     001111111 11111    123


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          877 LMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       877 ~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                      +.++.+++.+||..||++||++.+|.+.|++..+
T Consensus       224 ~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~~  257 (257)
T cd05115         224 PPEMYALMKDCWIYKWEDRPNFAKVEERMRTYYY  257 (257)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHhhhcC
Confidence            4568899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=3e-35  Score=329.45  Aligned_cols=259  Identities=25%  Similarity=0.404  Sum_probs=205.1

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC------CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcC-CCccccEEEEEE
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP------SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR-HRNIVKFYGFCS  708 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~  708 (912)
                      ..++|.+.+.||+|+||.||+|++.      .++.||+|++......   ...+.+.+|+.++.++. ||||+++++++.
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS---SEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh---hHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            4456888999999999999999853      3467999999754322   13457889999999997 999999999999


Q ss_pred             cCCeeeEEEeecCCCChhhHhhccCC------------------------------------------------------
Q 039137          709 HPKHSFIIYEYLESGSLDKILCNDAS------------------------------------------------------  734 (912)
Q Consensus       709 ~~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------  734 (912)
                      ..+..++||||+++|+|.+++++...                                                      
T Consensus       112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence            99999999999999999999864321                                                      


Q ss_pred             -----------------------------------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCC
Q 039137          735 -----------------------------------------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSK  773 (912)
Q Consensus       735 -----------------------------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~  773 (912)
                                                               ...+++.+++.++.|++.||+|||+.   +|+||||||+
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~  268 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAAR  268 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcc
Confidence                                                     12367788999999999999999999   9999999999


Q ss_pred             CeEEcCCCcEEEeccccccccCCCCC--CccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhcc
Q 039137          774 NVLLDLGYEAHVSDFGIAKFLNPDSS--NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEM  850 (912)
Q Consensus       774 Nill~~~~~~kl~Dfgla~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~  850 (912)
                      ||++++++.+|++|||+++.......  ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... 
T Consensus       269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~-  347 (401)
T cd05107         269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM-  347 (401)
T ss_pred             eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc-
Confidence            99999999999999999986532221  1123356788999999988889999999999999999998 8899752211 


Q ss_pred             ccccccchhhhccC--CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 039137          851 SSSSSNMNIEMLDS--RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI  909 (912)
Q Consensus       851 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l  909 (912)
                          ..........  +.+.+.    ..+..+.+++.+||..+|.+||+++|+++.|++.+
T Consensus       348 ----~~~~~~~~~~~~~~~~p~----~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         348 ----NEQFYNAIKRGYRMAKPA----HASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             ----hHHHHHHHHcCCCCCCCC----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence                0001111111  111121    23456889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-35  Score=312.37  Aligned_cols=254  Identities=24%  Similarity=0.316  Sum_probs=202.3

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCc-hHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEM-SFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      +.|++.+.||+|++|.||+|... +++.||+|.+........ ....+.+.+|++++++++||||+++++++...+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            46899999999999999999865 689999999865432221 1234578899999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ||||+++++|.+++..   ...+++..+..++.|++.|++|||+.   +|+|+||+|+||++++++.++|+|||+++...
T Consensus        82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            9999999999999844   34588899999999999999999999   99999999999999999999999999997654


Q ss_pred             CCCCCc---cccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChh
Q 039137          796 PDSSNW---SELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLH  872 (912)
Q Consensus       796 ~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  872 (912)
                      ......   ....++..|+|||++.+..++.++||||+|+++|||++|+.||......     .............  ..
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~~~--~~  228 (263)
T cd06625         156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM-----AAIFKIATQPTNP--QL  228 (263)
T ss_pred             ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH-----HHHHHHhccCCCC--CC
Confidence            322111   2345778999999999988999999999999999999999998521110     0001111111110  01


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 039137          873 VQKKLMSIMQVAFSCLDQNPESRPTMKRVSQL  904 (912)
Q Consensus       873 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  904 (912)
                      ....+..+.+++.+||..+|.+|||+.|+++.
T Consensus       229 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         229 PSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             CccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            12334567899999999999999999998864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=3.3e-36  Score=335.90  Aligned_cols=256  Identities=23%  Similarity=0.311  Sum_probs=197.8

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ++|++.+.||+|+||+||+|+.+ +++.||+|++....... ......+.+|+.++..++||+|+++++++.+.+..++|
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv   79 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLE-KEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLI   79 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhh-hhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence            46889999999999999999876 68999999986432111 12456788899999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++|+|.+++.+   .+.+++..+..++.|++.||+|||++   +|+||||||+||+++.++.++|+|||++.....
T Consensus        80 ~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~  153 (360)
T cd05627          80 MEFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK  153 (360)
T ss_pred             EeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence            999999999999843   34688999999999999999999999   999999999999999999999999999875432


Q ss_pred             CCC-----------------------------------CccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCC
Q 039137          797 DSS-----------------------------------NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGK  841 (912)
Q Consensus       797 ~~~-----------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~  841 (912)
                      ...                                   ......||+.|+|||++.+..++.++||||+||++|||++|+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~  233 (360)
T cd05627         154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY  233 (360)
T ss_pred             ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence            100                                   011346899999999999999999999999999999999999


Q ss_pred             CCccchhccccccccchhhhcc--CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 039137          842 HPRDFLFEMSSSSSNMNIEMLD--SRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEK  908 (912)
Q Consensus       842 ~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  908 (912)
                      .||.....     ......+..  .....+..  ...+..+.++|.+++ .||.+|++...+.+.++..
T Consensus       234 ~Pf~~~~~-----~~~~~~i~~~~~~~~~p~~--~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp  294 (360)
T cd05627         234 PPFCSETP-----QETYRKVMNWKETLVFPPE--VPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHP  294 (360)
T ss_pred             CCCCCCCH-----HHHHHHHHcCCCceecCCC--CCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCC
Confidence            99852211     111111111  11222211  112345677888866 4999999754444444443

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=6.4e-36  Score=318.13  Aligned_cols=254  Identities=31%  Similarity=0.484  Sum_probs=200.6

Q ss_pred             CCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEEe
Q 039137          640 FNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYE  718 (912)
Q Consensus       640 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e  718 (912)
                      |++++.||+|+||+||+|+.+ +++.||+|++......  ........+|+..++.++||||+++++++...+..++|||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~--~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~   78 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIE--EEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVME   78 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHH--HHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccc--ccccchhhhhhhcccccccccccccccccccccccccccc
Confidence            567899999999999999987 5668999999755322  1123344569999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCC
Q 039137          719 YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS  798 (912)
Q Consensus       719 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  798 (912)
                      |+++++|.+++.   ....+++.++..++.|+++||++||++   +|+|+||||+||++++++.++|+|||.+.......
T Consensus        79 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~  152 (260)
T PF00069_consen   79 YCPGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN  152 (260)
T ss_dssp             EETTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT
T ss_pred             cccccccccccc---ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence            999999999995   345689999999999999999999999   99999999999999999999999999998653333


Q ss_pred             CCccccccccccccccccc-cCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHH
Q 039137          799 SNWSELAGTHGYVAPELAY-TLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKL  877 (912)
Q Consensus       799 ~~~~~~~g~~~y~aPE~~~-~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  877 (912)
                      .......+++.|+|||++. +..++.++||||+|+++|+|++|..||......  .........................
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  230 (260)
T PF00069_consen  153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD--DQLEIIEKILKRPLPSSSQQSREKS  230 (260)
T ss_dssp             SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH--HHHHHHHHHHHTHHHHHTTSHTTSH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccch--hhhhhhhhcccccccccccccchhH
Confidence            4455667899999999998 788999999999999999999999998632000  0000111111111000000001112


Q ss_pred             HHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          878 MSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       878 ~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ..+.+++.+||+.||++||++.++++
T Consensus       231 ~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  231 EELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             HHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhc
Confidence            67889999999999999999998875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=3e-35  Score=321.01  Aligned_cols=260  Identities=23%  Similarity=0.354  Sum_probs=204.3

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC--------CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP--------SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFC  707 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~  707 (912)
                      .++|.+.+.||+|+||.||+|+..        ++..||+|.+.....   .....++.+|+++++.+ +||||+++++++
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT---EKDLSDLISEMEMMKMIGKHKNIINLLGAC   93 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC---hHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            357999999999999999999752        235699999875422   22456788999999999 799999999999


Q ss_pred             EcCCeeeEEEeecCCCChhhHhhccCC-------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCC
Q 039137          708 SHPKHSFIIYEYLESGSLDKILCNDAS-------------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKN  774 (912)
Q Consensus       708 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N  774 (912)
                      ...+..++||||+++|+|.+++.....             ...+++.++++++.|++.||+|||++   +++||||||+|
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N  170 (307)
T cd05098          94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARN  170 (307)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHh
Confidence            999999999999999999999965422             23588999999999999999999999   99999999999


Q ss_pred             eEEcCCCcEEEeccccccccCCCCCCc--cccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccc
Q 039137          775 VLLDLGYEAHVSDFGIAKFLNPDSSNW--SELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMS  851 (912)
Q Consensus       775 ill~~~~~~kl~Dfgla~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~  851 (912)
                      |+++.++.+||+|||.++.........  ....+++.|+|||++.+..++.++||||+||++|||++ |..||.....  
T Consensus       171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~--  248 (307)
T cd05098         171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--  248 (307)
T ss_pred             eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH--
Confidence            999999999999999997654322111  11224568999999988889999999999999999998 8888752110  


Q ss_pred             cccccchhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          852 SSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       852 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                         . .............  .....+..+.+++.+||+.+|++|||+.++++.|++.+.
T Consensus       249 ---~-~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~  301 (307)
T cd05098         249 ---E-ELFKLLKEGHRMD--KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA  301 (307)
T ss_pred             ---H-HHHHHHHcCCCCC--CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence               0 1111111111111  111234568889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=3.3e-35  Score=313.95  Aligned_cols=255  Identities=26%  Similarity=0.461  Sum_probs=203.9

Q ss_pred             cCCCCCceeeecCceEEEEEEeC----CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCee
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP----SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHS  713 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  713 (912)
                      .+|++.+.||+|+||.||+|+..    .+..+|+|.+.....   ....+.+.+|+.+++.++||||+++++++...+..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT---EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV   80 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            56889999999999999999864    234799999865332   22456789999999999999999999999999999


Q ss_pred             eEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccc
Q 039137          714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKF  793 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  793 (912)
                      ++||||+++++|.+++....  ..+++.++..++.|++.|++|||+.   +++||||||+||+++.++.++++|||++..
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~  155 (267)
T cd05066          81 MIVTEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRV  155 (267)
T ss_pred             EEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccc
Confidence            99999999999999995432  4689999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCCc---cccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccC-CCCC
Q 039137          794 LNPDSSNW---SELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDS-RLPY  868 (912)
Q Consensus       794 ~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~  868 (912)
                      ........   ....++..|+|||++.+..++.++||||||+++||+++ |..||.....     ........+. +.+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~-----~~~~~~~~~~~~~~~  230 (267)
T cd05066         156 LEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN-----QDVIKAIEEGYRLPA  230 (267)
T ss_pred             cccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH-----HHHHHHHhCCCcCCC
Confidence            65432211   11223568999999998889999999999999999887 9999752211     0011111111 1111


Q ss_pred             CChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 039137          869 PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI  909 (912)
Q Consensus       869 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l  909 (912)
                      +    ...+..+.+++.+||+.+|.+||++.++++.|++.+
T Consensus       231 ~----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~  267 (267)
T cd05066         231 P----MDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI  267 (267)
T ss_pred             C----CCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhhC
Confidence            1    123456789999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.4e-35  Score=315.98  Aligned_cols=252  Identities=27%  Similarity=0.430  Sum_probs=198.6

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEEcC---
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSHP---  710 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~---  710 (912)
                      +.+.|++.+.||+|+||.||+|... +++.||+|++.....     ....+.+|+.+++.+ +||||+++++++...   
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   78 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP   78 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence            4567889999999999999999875 688999999864321     345678999999998 699999999998653   


Q ss_pred             ---CeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEec
Q 039137          711 ---KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSD  787 (912)
Q Consensus       711 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  787 (912)
                         ...++||||+++++|.+++... ....+++..+..++.|++.|++|||++   +|+|+||||+||++++++.++|+|
T Consensus        79 ~~~~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~D  154 (272)
T cd06637          79 GMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVD  154 (272)
T ss_pred             CCCcEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEcc
Confidence               4579999999999999998542 234688999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCCCccccccccccccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhc
Q 039137          788 FGIAKFLNPDSSNWSELAGTHGYVAPELAY-----TLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEML  862 (912)
Q Consensus       788 fgla~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~  862 (912)
                      ||++..............|++.|+|||++.     +..++.++||||+||++|||++|+.||+.......     .....
T Consensus       155 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~-----~~~~~  229 (272)
T cd06637         155 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-----LFLIP  229 (272)
T ss_pred             CCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH-----HHHHh
Confidence            999986644333444567899999999886     34578899999999999999999999852211110     00000


Q ss_pred             cCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          863 DSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       863 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                        ..+.........+..+.+++.+||..||.+|||+.|+++
T Consensus       230 --~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         230 --RNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             --cCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence              001111111123456789999999999999999998875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=7.4e-35  Score=313.25  Aligned_cols=254  Identities=23%  Similarity=0.372  Sum_probs=199.3

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCC----EEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCe
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGE----IFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKH  712 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~  712 (912)
                      ++|++.+.||+|+||+||+|.+. +++    .+++|.+....   ......++..|+..++.++||||+++++++. ...
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~   82 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS---GRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GAS   82 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc---chHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCc
Confidence            57889999999999999999864 444    47777764321   1123466788888999999999999999885 456


Q ss_pred             eeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccccc
Q 039137          713 SFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK  792 (912)
Q Consensus       713 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  792 (912)
                      .++++||+++|+|.+++...  ...+++..+..|+.|++.|++|||++   +++||||||+||++++++.+||+|||+++
T Consensus        83 ~~~i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~  157 (279)
T cd05111          83 LQLVTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVAD  157 (279)
T ss_pred             cEEEEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccce
Confidence            78999999999999999543  34689999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCC--CccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccC--CCC
Q 039137          793 FLNPDSS--NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDS--RLP  867 (912)
Q Consensus       793 ~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~--~~~  867 (912)
                      .......  ......++..|+|||++.+..++.++||||||+++||+++ |+.||......      ........  ..+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~------~~~~~~~~~~~~~  231 (279)
T cd05111         158 LLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH------EVPDLLEKGERLA  231 (279)
T ss_pred             eccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHHHCCCcCC
Confidence            6643322  1233456778999999988889999999999999999998 99998532111      00111111  111


Q ss_pred             CCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          868 YPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       868 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                      .+.    .....+.+++.+||..||++|||+.|+++.|..+..
T Consensus       232 ~~~----~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         232 QPQ----ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             CCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence            111    123456788999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.3e-35  Score=313.54  Aligned_cols=256  Identities=24%  Similarity=0.404  Sum_probs=201.8

Q ss_pred             CCCCceeeecCceEEEEEEeC----CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCe---
Q 039137          640 FNAEHCIGKGGHGSVYRAKVP----SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKH---  712 (912)
Q Consensus       640 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~---  712 (912)
                      |++.+.||+|+||.||+|...    .+..||+|+++.....  ....+.+.+|++.++.++||||+++++++...+.   
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   78 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT--YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQK   78 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC--HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCcccc
Confidence            577899999999999999864    2467999998754322  2245678999999999999999999999866554   


Q ss_pred             ---eeEEEeecCCCChhhHhhccC---CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEe
Q 039137          713 ---SFIIYEYLESGSLDKILCNDA---SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVS  786 (912)
Q Consensus       713 ---~~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  786 (912)
                         .+++|||+++|+|..++....   ....+++.++..++.|++.||+|||++   +++||||||+||++++++.+||+
T Consensus        79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~  155 (273)
T cd05035          79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVA  155 (273)
T ss_pred             CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEEC
Confidence               799999999999999884432   234689999999999999999999999   99999999999999999999999


Q ss_pred             ccccccccCCCCCCc--cccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhcc
Q 039137          787 DFGIAKFLNPDSSNW--SELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLD  863 (912)
Q Consensus       787 Dfgla~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  863 (912)
                      |||+++.........  ....++..|+|||++.+..++.++||||||+++|||++ |..||.....     .........
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~-----~~~~~~~~~  230 (273)
T cd05035         156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN-----HEIYDYLRH  230 (273)
T ss_pred             CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHc
Confidence            999998664432221  12234678999999988889999999999999999999 8888752211     111111111


Q ss_pred             CC-CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 039137          864 SR-LPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI  909 (912)
Q Consensus       864 ~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l  909 (912)
                      .. ...+    ...+..+.+++.+||+.||.+|||+.|+++.|++.+
T Consensus       231 ~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~~  273 (273)
T cd05035         231 GNRLKQP----EDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL  273 (273)
T ss_pred             CCCCCCC----cCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence            11 1111    223456889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-35  Score=315.37  Aligned_cols=256  Identities=22%  Similarity=0.355  Sum_probs=203.8

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC------CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP------SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP  710 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~  710 (912)
                      .++|++.+.||+|+||.||+|..+      ++..||+|.+....   .......+.+|+.+++.++||||+++++++...
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   81 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA---SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG   81 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence            467899999999999999999764      24689999976432   222456788999999999999999999999999


Q ss_pred             CeeeEEEeecCCCChhhHhhccCC-------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcE
Q 039137          711 KHSFIIYEYLESGSLDKILCNDAS-------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEA  783 (912)
Q Consensus       711 ~~~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  783 (912)
                      ...++||||+++|+|.+++.....       ...+++.+++.++.|++.|++|||+.   +|+||||||+||+++.++.+
T Consensus        82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~  158 (277)
T cd05032          82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTV  158 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCE
Confidence            999999999999999999854322       23478899999999999999999999   99999999999999999999


Q ss_pred             EEeccccccccCCCCC--CccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhh
Q 039137          784 HVSDFGIAKFLNPDSS--NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIE  860 (912)
Q Consensus       784 kl~Dfgla~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~  860 (912)
                      ||+|||+++.......  ......++..|+|||.+.+..++.++|||||||++||+++ |..||.....     ......
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-----~~~~~~  233 (277)
T cd05032         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN-----EEVLKF  233 (277)
T ss_pred             EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH-----HHHHHH
Confidence            9999999986543321  1223446788999999988889999999999999999998 9999742111     111111


Q ss_pred             hccC-CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 039137          861 MLDS-RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCE  907 (912)
Q Consensus       861 ~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  907 (912)
                      .... ....+.    ..+..+.+++.+||+.+|++|||+.++++.|++
T Consensus       234 ~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         234 VIDGGHLDLPE----NCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             HhcCCCCCCCC----CCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence            1111 111221    124568899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-36  Score=323.47  Aligned_cols=243  Identities=29%  Similarity=0.420  Sum_probs=200.0

Q ss_pred             eeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEEeecCCC
Q 039137          645 CIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESG  723 (912)
Q Consensus       645 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  723 (912)
                      +||+|+||+||.|++. +...+|||-+.....    ....-+.+|+.+.++++|.|||+++|.+.+.+.+-+.||-.+||
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekds----r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG  657 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS----REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG  657 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccc----hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence            7999999999999976 456789998764322    23456789999999999999999999999999999999999999


Q ss_pred             ChhhHhhccCCcccC--CHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEc-CCCcEEEeccccccccCCCCCC
Q 039137          724 SLDKILCNDASAKEL--GWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLD-LGYEAHVSDFGIAKFLNPDSSN  800 (912)
Q Consensus       724 ~L~~~l~~~~~~~~l--~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~Dfgla~~~~~~~~~  800 (912)
                      +|.++++..  -+++  .+.++-.+..||++||.|||+.   .|||||||.+||+++ -.|.+||+|||-++.+..-...
T Consensus       658 SLSsLLrsk--WGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~  732 (1226)
T KOG4279|consen  658 SLSSLLRSK--WGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC  732 (1226)
T ss_pred             cHHHHHHhc--cCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCcc
Confidence            999999543  3445  7888889999999999999999   999999999999997 5789999999999988776666


Q ss_pred             ccccccccccccccccccCC--CCcchhHHHHHHHHHHHHhCCCCccchhccccccccch-hhhccCCCCCCChhhHHHH
Q 039137          801 WSELAGTHGYVAPELAYTLK--VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMN-IEMLDSRLPYPSLHVQKKL  877 (912)
Q Consensus       801 ~~~~~g~~~y~aPE~~~~~~--~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  877 (912)
                      ..++.||..|||||++..++  |..++|||||||++.||.||++||...   ..-...+. ..+.....+.|    ...+
T Consensus       733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~El---gspqAAMFkVGmyKvHP~iP----eels  805 (1226)
T KOG4279|consen  733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVEL---GSPQAAMFKVGMYKVHPPIP----EELS  805 (1226)
T ss_pred             ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeec---CChhHhhhhhcceecCCCCc----HHHH
Confidence            77889999999999998654  889999999999999999999998522   11111111 11222222322    4456


Q ss_pred             HHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          878 MSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       878 ~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .+...+|.+|+.+||.+||++.++++
T Consensus       806 aeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  806 AEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             HHHHHHHHHHcCCCcccCccHHHhcc
Confidence            67889999999999999999998874

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=4.4e-35  Score=319.33  Aligned_cols=260  Identities=22%  Similarity=0.353  Sum_probs=204.6

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC--------CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEE
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP--------SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGF  706 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~  706 (912)
                      ..++|++.+.||+|+||.||+|+..        ++..||+|.+.....   ....+++.+|+.+++.+ +||||++++++
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   89 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT---EKDLSDLVSEMEMMKMIGKHKNIINLLGA   89 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccc---hHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence            3467899999999999999999641        345799998864321   22456788999999999 89999999999


Q ss_pred             EEcCCeeeEEEeecCCCChhhHhhccCC-------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCC
Q 039137          707 CSHPKHSFIIYEYLESGSLDKILCNDAS-------------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSK  773 (912)
Q Consensus       707 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~  773 (912)
                      +...+..++||||+++|+|.+++.....             ...+++.++..++.|++.|++|||++   +|+||||||+
T Consensus        90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~  166 (304)
T cd05101          90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAAR  166 (304)
T ss_pred             EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecccccc
Confidence            9999999999999999999999965321             23578899999999999999999999   9999999999


Q ss_pred             CeEEcCCCcEEEeccccccccCCCCCC--ccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhcc
Q 039137          774 NVLLDLGYEAHVSDFGIAKFLNPDSSN--WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEM  850 (912)
Q Consensus       774 Nill~~~~~~kl~Dfgla~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~  850 (912)
                      ||++++++.+||+|||.++........  .....+++.|+|||++.+..++.++||||||+++|||++ |..||..... 
T Consensus       167 Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-  245 (304)
T cd05101         167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-  245 (304)
T ss_pred             eEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-
Confidence            999999999999999999876443222  122345678999999988889999999999999999998 7888742111 


Q ss_pred             ccccccchhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 039137          851 SSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI  909 (912)
Q Consensus       851 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l  909 (912)
                          ...............   ....+..+.+++.+||+.+|++|||+.|+++.|++.+
T Consensus       246 ----~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~  297 (304)
T cd05101         246 ----EELFKLLKEGHRMDK---PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL  297 (304)
T ss_pred             ----HHHHHHHHcCCcCCC---CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence                011111111111100   1123456888999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-36  Score=318.83  Aligned_cols=263  Identities=24%  Similarity=0.371  Sum_probs=214.5

Q ss_pred             HHHHHHhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEc
Q 039137          631 EEIISATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSH  709 (912)
Q Consensus       631 ~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~  709 (912)
                      ++++-...+....++||.|.||.||.|.|+ -.-.||||.++.+.     ...++|++|+.+|+.++|||+|+++|+|..
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-----MeveEFLkEAAvMKeikHpNLVqLLGVCT~  334 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTH  334 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-----hhHHHHHHHHHHHHhhcCccHHHHhhhhcc
Confidence            444445567788899999999999999987 45679999987442     357899999999999999999999999999


Q ss_pred             CCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccc
Q 039137          710 PKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFG  789 (912)
Q Consensus       710 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  789 (912)
                      +..+|||+|||..|+|.+|+++. ....++.--.+.++.||+.|++||..+   +++||||.++|.|+.++..||++|||
T Consensus       335 EpPFYIiTEfM~yGNLLdYLRec-nr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFG  410 (1157)
T KOG4278|consen  335 EPPFYIITEFMCYGNLLDYLREC-NRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFG  410 (1157)
T ss_pred             CCCeEEEEecccCccHHHHHHHh-chhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccc
Confidence            99999999999999999999654 345677778899999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCCCcc-ccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccCCCC
Q 039137          790 IAKFLNPDSSNWS-ELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDSRLP  867 (912)
Q Consensus       790 la~~~~~~~~~~~-~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  867 (912)
                      +++.+..+.+... ...-.+.|+|||.+.-..++.|+|||+|||+|||+.| |-.||....-      ......+...+.
T Consensus       411 LsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl------SqVY~LLEkgyR  484 (1157)
T KOG4278|consen  411 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQVYGLLEKGYR  484 (1157)
T ss_pred             hhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH------HHHHHHHhcccc
Confidence            9999876543221 1223578999999988889999999999999999999 8888742211      111112222221


Q ss_pred             CCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          868 YPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       868 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                      ..  ....+++.+++++..||+..|.+||+++|+-+.|+.++-
T Consensus       485 M~--~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~  525 (1157)
T KOG4278|consen  485 MD--GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS  525 (1157)
T ss_pred             cc--CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence            11  124566778999999999999999999999999998764

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=4.8e-35  Score=318.29  Aligned_cols=260  Identities=25%  Similarity=0.397  Sum_probs=205.4

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC------CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEE
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP------SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCS  708 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~  708 (912)
                      ..++|.+.+.||+|+||.||+|+..      ++..||+|++.....   ....+.+.+|+++++++ +||||+++++++.
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  109 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH---SSEREALMSELKIMSHLGNHENIVNLLGACT  109 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC---hHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence            3467999999999999999999741      345799998865422   22456789999999999 7999999999999


Q ss_pred             cCCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecc
Q 039137          709 HPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDF  788 (912)
Q Consensus       709 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df  788 (912)
                      ..+..++||||+++|+|.++++... ...+++.++..++.|++.|++|||++   +|+|+||||+||+++.++.++++||
T Consensus       110 ~~~~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~df  185 (302)
T cd05055         110 IGGPILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDF  185 (302)
T ss_pred             cCCceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCC
Confidence            9999999999999999999985432 23489999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCC--CccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccCC
Q 039137          789 GIAKFLNPDSS--NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDSR  865 (912)
Q Consensus       789 gla~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  865 (912)
                      |+++.......  ......+++.|+|||++.+..++.++||||+||++|||++ |..||......     ..........
T Consensus       186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~-----~~~~~~~~~~  260 (302)
T cd05055         186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD-----SKFYKLIKEG  260 (302)
T ss_pred             cccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch-----HHHHHHHHcC
Confidence            99986543321  1122345678999999998889999999999999999998 99997522111     0011111111


Q ss_pred             CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 039137          866 LPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI  909 (912)
Q Consensus       866 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l  909 (912)
                      ....  .....+..+.+++.+||+.+|++|||+.|+++.|++.+
T Consensus       261 ~~~~--~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~~  302 (302)
T cd05055         261 YRMA--QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQL  302 (302)
T ss_pred             CcCC--CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhhC
Confidence            1111  01122456889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=4.1e-35  Score=311.33  Aligned_cols=246  Identities=27%  Similarity=0.402  Sum_probs=196.3

Q ss_pred             eeeecCceEEEEEEeC---CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEEeecC
Q 039137          645 CIGKGGHGSVYRAKVP---SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLE  721 (912)
Q Consensus       645 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  721 (912)
                      .||+|+||.||+|.++   +++.||+|++.....  .....+++.+|+.+++.++||||+++++++. .+..++||||++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~   78 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN--DPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAE   78 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCC--cHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCC
Confidence            5899999999999653   678899999864432  2224677899999999999999999999985 456789999999


Q ss_pred             CCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCCCc
Q 039137          722 SGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNW  801 (912)
Q Consensus       722 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  801 (912)
                      +|+|.+++..   ...+++..+..++.|++.|++|+|++   +|+||||||+||+++.++.+||+|||++..........
T Consensus        79 ~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~  152 (257)
T cd05116          79 LGPLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY  152 (257)
T ss_pred             CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence            9999999843   24688999999999999999999999   99999999999999999999999999998765433211


Q ss_pred             ---cccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccC--CCCCCChhhHH
Q 039137          802 ---SELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDS--RLPYPSLHVQK  875 (912)
Q Consensus       802 ---~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  875 (912)
                         ....+++.|+|||.+....++.++||||||+++|||++ |+.||......      .....+..  ..+.+    ..
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------~~~~~i~~~~~~~~~----~~  222 (257)
T cd05116         153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN------EVTQMIESGERMECP----QR  222 (257)
T ss_pred             eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHCCCCCCCC----CC
Confidence               12234578999999988889999999999999999998 99998632111      11111111  11122    12


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 039137          876 KLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI  909 (912)
Q Consensus       876 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l  909 (912)
                      .+..+.++|.+||+.||++||++++|.+.|++..
T Consensus       223 ~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~~  256 (257)
T cd05116         223 CPPEMYDLMKLCWTYGVDERPGFAVVELRLRNYY  256 (257)
T ss_pred             CCHHHHHHHHHHhccCchhCcCHHHHHHHHhccc
Confidence            3456889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=4.8e-35  Score=326.54  Aligned_cols=257  Identities=20%  Similarity=0.301  Sum_probs=196.4

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCC---
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPK---  711 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~---  711 (912)
                      ..++|++.+.||+|+||.||+|... +|+.||+|++.......  .....+.+|+.+++.++||||+++++++...+   
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   96 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQ--THAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE   96 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccch--hHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence            4578999999999999999999875 68999999987553322  24567889999999999999999999986543   


Q ss_pred             ---eeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecc
Q 039137          712 ---HSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDF  788 (912)
Q Consensus       712 ---~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df  788 (912)
                         ..++||||+++ ++.+.+.     ..+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+||
T Consensus        97 ~~~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Df  167 (359)
T cd07876          97 EFQDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF  167 (359)
T ss_pred             ccceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecC
Confidence               47999999976 5655552     2478899999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhcccccc--------------
Q 039137          789 GIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS--------------  854 (912)
Q Consensus       789 gla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~--------------  854 (912)
                      |+++..... .......+++.|+|||++.+..++.++||||+||++|+|++|+.||..........              
T Consensus       168 g~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  246 (359)
T cd07876         168 GLARTACTN-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM  246 (359)
T ss_pred             CCccccccC-ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence            999764332 22334578999999999999999999999999999999999999985321100000              


Q ss_pred             ---ccchhhhccCCCCCCC----------------hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 039137          855 ---SNMNIEMLDSRLPYPS----------------LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQL  904 (912)
Q Consensus       855 ---~~~~~~~~~~~~~~~~----------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  904 (912)
                         .............++.                .........+.+++.+||+.||++|||+.|+++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence               0000000000000000                0001123457899999999999999999998863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-35  Score=319.24  Aligned_cols=262  Identities=23%  Similarity=0.400  Sum_probs=200.3

Q ss_pred             hcCCCCCceeeecCceEEEEEEeCC---------------CCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccc
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVPS---------------GEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIV  701 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv  701 (912)
                      .++|++.+.||+|+||.||+|+...               ...||+|+++....   ......+.+|++++++++|||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~ei~~l~~l~h~~i~   80 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT---KTARNDFLKEIKIMSRLKNPNII   80 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC---HHHHHHHHHHHHHHHhCCCCCcC
Confidence            3579999999999999999987532               23589999875422   22456789999999999999999


Q ss_pred             cEEEEEEcCCeeeEEEeecCCCChhhHhhccCC---------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCC
Q 039137          702 KFYGFCSHPKHSFIIYEYLESGSLDKILCNDAS---------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISS  772 (912)
Q Consensus       702 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~  772 (912)
                      ++++++...+..++||||+++++|.+++.....         ...+++.++++++.|++.|++|||++   +++||||||
T Consensus        81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp  157 (295)
T cd05097          81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLAT  157 (295)
T ss_pred             eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccCh
Confidence            999999999999999999999999999854321         12468899999999999999999999   999999999


Q ss_pred             CCeEEcCCCcEEEeccccccccCCCCCC--ccccccccccccccccccCCCCcchhHHHHHHHHHHHHh--CCCCccchh
Q 039137          773 KNVLLDLGYEAHVSDFGIAKFLNPDSSN--WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK--GKHPRDFLF  848 (912)
Q Consensus       773 ~Nill~~~~~~kl~Dfgla~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt--g~~pf~~~~  848 (912)
                      +||++++++.+||+|||++.........  .....+++.|+|||++.+..++.++||||||+++|+|++  |..||....
T Consensus       158 ~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~  237 (295)
T cd05097         158 RNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS  237 (295)
T ss_pred             hhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence            9999999999999999999765432211  122345678999999988889999999999999999998  667765321


Q ss_pred             ccccccccchhhhccC--CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 039137          849 EMSSSSSNMNIEMLDS--RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCE  907 (912)
Q Consensus       849 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  907 (912)
                      .....  .........  ...+.. .....+..+.+++.+||+.||++||++++|++.|++
T Consensus       238 ~~~~~--~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         238 DEQVI--ENTGEFFRNQGRQIYLS-QTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             hHHHH--HHHHHhhhhccccccCC-CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence            11000  000000000  000000 011134568999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=3e-35  Score=317.27  Aligned_cols=255  Identities=20%  Similarity=0.334  Sum_probs=202.2

Q ss_pred             cCCCCCceeeecCceEEEEEEeC------CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCC
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP------SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPK  711 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~  711 (912)
                      .+|++.+.||+|+||.||+|+..      ++..||+|++.....   ....+.+.+|+.++..++||||+++++++...+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~   81 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE---GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ   81 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC---HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence            35778899999999999999753      357899999874432   224567889999999999999999999999999


Q ss_pred             eeeEEEeecCCCChhhHhhccC-------------CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEc
Q 039137          712 HSFIIYEYLESGSLDKILCNDA-------------SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLD  778 (912)
Q Consensus       712 ~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~  778 (912)
                      ..++++||+++++|.+++....             ....+++..+.+++.|++.||+|+|++   +|+||||||+||+++
T Consensus        82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~  158 (283)
T cd05091          82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVF  158 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEec
Confidence            9999999999999999984221             123578899999999999999999999   999999999999999


Q ss_pred             CCCcEEEeccccccccCCCCC--CccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccc
Q 039137          779 LGYEAHVSDFGIAKFLNPDSS--NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSS  855 (912)
Q Consensus       779 ~~~~~kl~Dfgla~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~  855 (912)
                      +++.+||+|||+++.......  ......+++.|+|||++.+..++.++||||+|+++|||++ |..||.....     .
T Consensus       159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----~  233 (283)
T cd05091         159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-----Q  233 (283)
T ss_pred             CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-----H
Confidence            999999999999886543221  1223445788999999988889999999999999999998 8888753211     1


Q ss_pred             cchhhhccCCC-CCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 039137          856 NMNIEMLDSRL-PYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCE  907 (912)
Q Consensus       856 ~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  907 (912)
                      .......+... +.+    ...+..+.+++.+||+.+|++||++++++..|+.
T Consensus       234 ~~~~~i~~~~~~~~~----~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         234 DVIEMIRNRQVLPCP----DDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHHHHHcCCcCCCC----CCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            11111222221 111    2234557899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=4.1e-35  Score=316.13  Aligned_cols=254  Identities=22%  Similarity=0.282  Sum_probs=200.0

Q ss_pred             CCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEE
Q 039137          639 DFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIY  717 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  717 (912)
                      .|+..+.||+|+||.||+|... +++.||+|.+....... ....+.+.+|+.+++.++|++++++++.+...+..++||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~   79 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL   79 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccc-hHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEE
Confidence            3677899999999999999876 78899999986543222 123456778999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCC
Q 039137          718 EYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPD  797 (912)
Q Consensus       718 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  797 (912)
                      ||+++++|.+++.... ...+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||++......
T Consensus        80 e~~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05630          80 TLMNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  155 (285)
T ss_pred             EecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence            9999999999885432 24588999999999999999999999   9999999999999999999999999999765432


Q ss_pred             CCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHH
Q 039137          798 SSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKL  877 (912)
Q Consensus       798 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  877 (912)
                       .......|++.|+|||++.+..++.++||||+|+++|+|++|+.||.........  ......... .+  ........
T Consensus       156 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~--~~~~~~~~~-~~--~~~~~~~~  229 (285)
T cd05630         156 -QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR--EEVERLVKE-VQ--EEYSEKFS  229 (285)
T ss_pred             -ccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH--HHHHhhhhh-hh--hhcCccCC
Confidence             2223457899999999999989999999999999999999999998632111000  000011000 00  00112234


Q ss_pred             HHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 039137          878 MSIMQVAFSCLDQNPESRPT-----MKRVSQ  903 (912)
Q Consensus       878 ~~l~~li~~cl~~dP~~RPt-----~~evl~  903 (912)
                      ..+.+++.+||+.||++|||     ++|+++
T Consensus       230 ~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         230 PDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             HHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            56789999999999999999     777765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=6.2e-35  Score=314.03  Aligned_cols=255  Identities=22%  Similarity=0.405  Sum_probs=202.2

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCC----EEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCC
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGE----IFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPK  711 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~  711 (912)
                      .++|++.+.||+|+||+||+|++. +++    .||+|++.....   ....+.+.+|+..++.++||||+++++++.. .
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~   81 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS---PKANKEILDEAYVMAGVGSPYVCRLLGICLT-S   81 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCC---HHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-C
Confidence            457899999999999999999854 444    489998864322   2245678899999999999999999999975 4


Q ss_pred             eeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccc
Q 039137          712 HSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIA  791 (912)
Q Consensus       712 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla  791 (912)
                      ..+++|||+++|+|.++++..  ...+++.+++.++.|++.||+|||++   +|+||||||+||++++++.+||+|||++
T Consensus        82 ~~~l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~  156 (279)
T cd05109          82 TVQLVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLA  156 (279)
T ss_pred             CcEEEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCce
Confidence            578999999999999998543  34689999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCCc--cccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccC--CC
Q 039137          792 KFLNPDSSNW--SELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDS--RL  866 (912)
Q Consensus       792 ~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~--~~  866 (912)
                      +.........  ....+++.|+|||...+..++.++|||||||++|||++ |..||+.....      ........  ..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------~~~~~~~~~~~~  230 (279)
T cd05109         157 RLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR------EIPDLLEKGERL  230 (279)
T ss_pred             eecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHHHCCCcC
Confidence            8765332221  12234678999999988889999999999999999998 89998532110      00111111  11


Q ss_pred             CCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          867 PYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       867 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                      +.+    ...+..+.+++.+||+.||++||++.++++.|+++..
T Consensus       231 ~~~----~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05109         231 PQP----PICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR  270 (279)
T ss_pred             CCC----ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            111    1234568899999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=4.5e-35  Score=318.09  Aligned_cols=263  Identities=24%  Similarity=0.397  Sum_probs=202.7

Q ss_pred             hcCCCCCceeeecCceEEEEEEeCC-----------------CCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCc
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVPS-----------------GEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRN  699 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n  699 (912)
                      ..+|++.+.||+|+||.||+|+...                 +..||+|++......   ...+.+.+|++++++++|||
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~---~~~~~~~~e~~~l~~l~~~~   80 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD---NAREDFLKEVKILSRLSDPN   80 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH---HHHHHHHHHHHHHHhcCCCC
Confidence            4579999999999999999997542                 245899988654322   25677899999999999999


Q ss_pred             cccEEEEEEcCCeeeEEEeecCCCChhhHhhccC--------CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCC
Q 039137          700 IVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDA--------SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDIS  771 (912)
Q Consensus       700 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk  771 (912)
                      |+++++++..++..++||||+++++|.+++....        ....+++..++.++.|++.|++|||++   +|+|+|||
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlk  157 (296)
T cd05051          81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLA  157 (296)
T ss_pred             EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccc
Confidence            9999999999999999999999999999985543        123689999999999999999999999   99999999


Q ss_pred             CCCeEEcCCCcEEEeccccccccCCCCC--CccccccccccccccccccCCCCcchhHHHHHHHHHHHHh--CCCCccch
Q 039137          772 SKNVLLDLGYEAHVSDFGIAKFLNPDSS--NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK--GKHPRDFL  847 (912)
Q Consensus       772 ~~Nill~~~~~~kl~Dfgla~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt--g~~pf~~~  847 (912)
                      |+||+++.++.++++|||.++.......  ......+++.|+|||++.+..++.++||||||+++|||++  |..||...
T Consensus       158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~  237 (296)
T cd05051         158 TRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL  237 (296)
T ss_pred             hhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence            9999999999999999999976543321  1223446778999999988889999999999999999998  67776422


Q ss_pred             hccccccccchhhhc-cCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 039137          848 FEMSSSSSNMNIEML-DSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCE  907 (912)
Q Consensus       848 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  907 (912)
                      ......  ....... ..............+.++.+++.+||+.||++|||+.|+++.|++
T Consensus       238 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         238 TDQQVI--ENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             ChHHHH--HHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence            110000  0000000 000000000111233568999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=4.9e-35  Score=315.61  Aligned_cols=253  Identities=23%  Similarity=0.301  Sum_probs=198.7

Q ss_pred             CCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEEe
Q 039137          640 FNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYE  718 (912)
Q Consensus       640 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e  718 (912)
                      |+..+.||+|+||+||+|.+. +++.||+|++....... ....+.+.+|+++++.++|++|+++.+++..++..++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKK-RKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhh-hhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            667789999999999999875 78899999986433221 1134557889999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCC
Q 039137          719 YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS  798 (912)
Q Consensus       719 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  798 (912)
                      |+++++|.+++.... ...+++..+..++.|++.||+|||++   +|+||||||+||++++++.++|+|||++...... 
T Consensus        81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-  155 (285)
T cd05632          81 IMNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-  155 (285)
T ss_pred             eccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCC-
Confidence            999999998885432 34689999999999999999999999   9999999999999999999999999999765332 


Q ss_pred             CCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHHH
Q 039137          799 SNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLM  878 (912)
Q Consensus       799 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  878 (912)
                      .......|++.|+|||++.+..++.++|+||+|+++|||++|..||....+... ..............++    ...+.
T Consensus       156 ~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-~~~~~~~~~~~~~~~~----~~~~~  230 (285)
T cd05632         156 ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-REEVDRRVLETEEVYS----AKFSE  230 (285)
T ss_pred             CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhhhccccccC----ccCCH
Confidence            222345789999999999888899999999999999999999999852211000 0001111111111111    22345


Q ss_pred             HHHHHHHHcccCCCCCCCC-----HHHHHH
Q 039137          879 SIMQVAFSCLDQNPESRPT-----MKRVSQ  903 (912)
Q Consensus       879 ~l~~li~~cl~~dP~~RPt-----~~evl~  903 (912)
                      .+.+++.+|++.||++||+     ++++++
T Consensus       231 ~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         231 EAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             HHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence            6789999999999999999     566654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-35  Score=310.31  Aligned_cols=253  Identities=29%  Similarity=0.436  Sum_probs=204.9

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      .++|++.+.||+|++|.||+|... +++.+++|.+......    ..+.+.+|+++++.++||||+++++++...+..++
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l   77 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD----DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWI   77 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh----hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEE
Confidence            367899999999999999999875 6788999998754322    45778899999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      +|||+++++|.+++...  ...+++.++..++.|++.|++|||++   +++|+||+|+||+++.++.++|+|||.+....
T Consensus        78 ~~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~  152 (262)
T cd06613          78 VMEYCGGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLT  152 (262)
T ss_pred             EEeCCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhh
Confidence            99999999999998443  24688999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCCccccccccccccccccccC---CCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCC-h
Q 039137          796 PDSSNWSELAGTHGYVAPELAYTL---KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPS-L  871 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~  871 (912)
                      ..........++..|+|||.+.+.   .++.++||||+|+++|||++|+.||.......     ............+. .
T Consensus       153 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~-----~~~~~~~~~~~~~~~~  227 (262)
T cd06613         153 ATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR-----ALFLISKSNFPPPKLK  227 (262)
T ss_pred             hhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhccCCCcccc
Confidence            433333455688899999998776   78999999999999999999999985221110     01111111111111 1


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          872 HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       872 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .....+.++.+++.+||..+|.+|||+.++++
T Consensus       228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         228 DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            12344567899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=4.4e-35  Score=314.80  Aligned_cols=255  Identities=25%  Similarity=0.383  Sum_probs=200.3

Q ss_pred             hcCCCCCceeeecCceEEEEEEeCC------CCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVPS------GEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP  710 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~  710 (912)
                      .++|++.+.||+|++|.||+|.+..      +..||+|.+.....   ......+.+|+.+++.++|+||+++++++.+.
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS---EQDESDFLMEALIMSKFNHQNIVRLIGVSFER   81 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence            4678999999999999999998753      56788888754321   22356789999999999999999999999998


Q ss_pred             CeeeEEEeecCCCChhhHhhccCC----cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCC---cE
Q 039137          711 KHSFIIYEYLESGSLDKILCNDAS----AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGY---EA  783 (912)
Q Consensus       711 ~~~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~---~~  783 (912)
                      +..++||||+++++|.+++.....    ...+++.++.+++.||+.|++|||++   +++||||||+||+++.++   .+
T Consensus        82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~  158 (277)
T cd05036          82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVA  158 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcce
Confidence            999999999999999999865432    23589999999999999999999999   999999999999998754   59


Q ss_pred             EEeccccccccCCCCCC--ccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhh
Q 039137          784 HVSDFGIAKFLNPDSSN--WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIE  860 (912)
Q Consensus       784 kl~Dfgla~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~  860 (912)
                      |++|||+++........  ......+..|+|||++.+..++.++|||||||++|||++ |..||+....     . ....
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~-----~-~~~~  232 (277)
T cd05036         159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN-----Q-EVME  232 (277)
T ss_pred             EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----H-HHHH
Confidence            99999999866322211  112233568999999998889999999999999999997 9999852111     0 0111


Q ss_pred             hcc--CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 039137          861 MLD--SRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCE  907 (912)
Q Consensus       861 ~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  907 (912)
                      ...  .....+    ...+..+.+++.+|++.+|++||++.+|++.|++
T Consensus       233 ~~~~~~~~~~~----~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~  277 (277)
T cd05036         233 FVTGGGRLDPP----KGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY  277 (277)
T ss_pred             HHHcCCcCCCC----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence            111  111111    1234568899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-36  Score=320.04  Aligned_cols=246  Identities=27%  Similarity=0.422  Sum_probs=200.8

Q ss_pred             CCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEEe
Q 039137          640 FNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYE  718 (912)
Q Consensus       640 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e  718 (912)
                      |.-.+.||.|+||.||-|++. +.+.||||++........ ....++++|+..+++++|||++.+-|+|-.+.+.|+|||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~-EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN-EKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccH-HHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            555688999999999999865 788999999976544333 256789999999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCC
Q 039137          719 YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS  798 (912)
Q Consensus       719 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  798 (912)
                      ||-| +-.|++.-.  .+++-+.++..|..+.+.||+|||++   +.+|||||+.|||+.+.|.||++|||.|..+.+  
T Consensus       107 YClG-SAsDlleVh--kKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P--  178 (948)
T KOG0577|consen  107 YCLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP--  178 (948)
T ss_pred             HHhc-cHHHHHHHH--hccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCc--
Confidence            9965 666666332  35688899999999999999999999   999999999999999999999999999987754  


Q ss_pred             CCccccccccccccccccc---cCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHH
Q 039137          799 SNWSELAGTHGYVAPELAY---TLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQK  875 (912)
Q Consensus       799 ~~~~~~~g~~~y~aPE~~~---~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  875 (912)
                        ...++|||.|||||++.   .+.|+-++||||+|++..|+...++|.-   .+.....   .-.+ ..-..|......
T Consensus       179 --AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlF---nMNAMSA---LYHI-AQNesPtLqs~e  249 (948)
T KOG0577|consen  179 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF---NMNAMSA---LYHI-AQNESPTLQSNE  249 (948)
T ss_pred             --hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCcc---CchHHHH---HHHH-HhcCCCCCCCch
Confidence              35679999999999875   5679999999999999999999999942   2211110   0001 111122233455


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          876 KLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       876 ~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ++..+.+++..|+++-|.+|||.+++++
T Consensus       250 WS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  250 WSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             hHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence            6777999999999999999999998875

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=4.4e-35  Score=315.25  Aligned_cols=256  Identities=24%  Similarity=0.428  Sum_probs=201.6

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC------CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP------SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP  710 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~  710 (912)
                      ..+|...+.||+|+||.||+|...      ++..+|+|.+....    ....+.+.+|++.++.++|+||+++++++...
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS----ESARQDFQREAELLTVLQHQHIVRFYGVCTEG   79 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC----HHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence            356888999999999999999632      45678999875322    22456789999999999999999999999999


Q ss_pred             CeeeEEEeecCCCChhhHhhccCC------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEc
Q 039137          711 KHSFIIYEYLESGSLDKILCNDAS------------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLD  778 (912)
Q Consensus       711 ~~~~lv~e~~~~g~L~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~  778 (912)
                      +..+++|||+++++|.+++.....            ...+++.+++.++.|++.|++|||++   +++||||||+||+++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~  156 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVG  156 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEc
Confidence            999999999999999999865432            13578999999999999999999999   999999999999999


Q ss_pred             CCCcEEEeccccccccCCCCC--CccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccc
Q 039137          779 LGYEAHVSDFGIAKFLNPDSS--NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSS  855 (912)
Q Consensus       779 ~~~~~kl~Dfgla~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~  855 (912)
                      +++.+||+|||++........  ......+++.|+|||+..+..++.++|||||||++|||++ |..||......     
T Consensus       157 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-----  231 (280)
T cd05092         157 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT-----  231 (280)
T ss_pred             CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH-----
Confidence            999999999999975533221  1122335678999999998889999999999999999998 89997421111     


Q ss_pred             cchhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 039137          856 NMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCE  907 (912)
Q Consensus       856 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  907 (912)
                      ..............   ....+..+.+++.+||+.||.+||+++|+.+.|++
T Consensus       232 ~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         232 EAIECITQGRELER---PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             HHHHHHHcCccCCC---CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence            01111111111110   11234567899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.2e-34  Score=312.48  Aligned_cols=259  Identities=26%  Similarity=0.373  Sum_probs=199.6

Q ss_pred             cCC-CCCceeeecCceEEEEEEe-----CCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC-
Q 039137          638 NDF-NAEHCIGKGGHGSVYRAKV-----PSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP-  710 (912)
Q Consensus       638 ~~~-~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-  710 (912)
                      ++| ++.+.||+|+||+||.+..     .+++.||+|.+.....   ....+.+.+|+++++.++||||+++++++... 
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   79 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG---QQNTSGWKKEINILKTLYHENIVKYKGCCSEQG   79 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            345 8889999999999988652     3678899999865422   12456788999999999999999999998653 


Q ss_pred             -CeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccc
Q 039137          711 -KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFG  789 (912)
Q Consensus       711 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  789 (912)
                       ...++||||+++++|.+++..    ..+++.+++.++.|++.|++|||++   +|+||||||+||++++++.++|+|||
T Consensus        80 ~~~~~lv~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg  152 (283)
T cd05080          80 GKGLQLIMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFG  152 (283)
T ss_pred             CceEEEEecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecc
Confidence             467899999999999999843    3489999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCCC---ccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhcccc-----cc----ccc
Q 039137          790 IAKFLNPDSSN---WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS-----SS----SNM  857 (912)
Q Consensus       790 la~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~-----~~----~~~  857 (912)
                      +++........   .....++..|+|||.+.+..++.++||||||+++|||++|..||........     ..    ...
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd05080         153 LAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVR  232 (283)
T ss_pred             cccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhh
Confidence            99866543221   1223456679999999888899999999999999999999999753211000     00    000


Q ss_pred             hhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 039137          858 NIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEK  908 (912)
Q Consensus       858 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  908 (912)
                      .....+.....+  .....+..+.+++.+||+.||++|||+++++++|++.
T Consensus       233 ~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         233 LIELLERGMRLP--CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             hhhhhhcCCCCC--CCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence            000011111000  0112345688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.1e-34  Score=307.93  Aligned_cols=252  Identities=24%  Similarity=0.362  Sum_probs=206.2

Q ss_pred             CCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEE
Q 039137          639 DFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIY  717 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  717 (912)
                      +|+..+.||.|+||.||.++.. +++.+++|.+.......  ...+++.+|++++++++|+||+++++++.+.+..+++|
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~   78 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE--KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEM   78 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch--hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEE
Confidence            5888999999999999999865 68899999986443222  24567889999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCC
Q 039137          718 EYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPD  797 (912)
Q Consensus       718 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  797 (912)
                      ||+++++|.+++.... ...+++.++..++.|++.|++|||+.   +++|+||+|+||++++++.+||+|||.+......
T Consensus        79 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~  154 (256)
T cd08221          79 EYANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE  154 (256)
T ss_pred             EecCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence            9999999999995543 35689999999999999999999999   9999999999999999999999999999876554


Q ss_pred             CCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHH
Q 039137          798 SSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKL  877 (912)
Q Consensus       798 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  877 (912)
                      ........+++.|+|||+..+..++.++||||+|+++|||++|..||+...     .............+...   ...+
T Consensus       155 ~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-----~~~~~~~~~~~~~~~~~---~~~~  226 (256)
T cd08221         155 YSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN-----PLNLVVKIVQGNYTPVV---SVYS  226 (256)
T ss_pred             cccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHcCCCCCCc---cccC
Confidence            433445678999999999988888999999999999999999999985211     11111111222221111   2344


Q ss_pred             HHHHHHHHHcccCCCCCCCCHHHHHHH
Q 039137          878 MSIMQVAFSCLDQNPESRPTMKRVSQL  904 (912)
Q Consensus       878 ~~l~~li~~cl~~dP~~RPt~~evl~~  904 (912)
                      ..+.+++.+||..+|++||++.++++.
T Consensus       227 ~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         227 SELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             HHHHHHHHHHcccCcccCCCHHHHhhC
Confidence            568899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=8.2e-35  Score=311.16  Aligned_cols=256  Identities=27%  Similarity=0.469  Sum_probs=203.3

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CC---CEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCee
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SG---EIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHS  713 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  713 (912)
                      ++|+..+.||+|+||.||+|+.+ ++   ..+|+|++.....   ....+.+..|+++++.++|||++++.+++...+..
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT---EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA   81 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC---HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence            46888899999999999999875 33   3699998864322   22456788999999999999999999999999999


Q ss_pred             eEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccc
Q 039137          714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKF  793 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  793 (912)
                      ++||||+++++|.+++...  ...+++.++..++.|++.|++|||+.   +++|+||||+||+++.++.++++|||++..
T Consensus        82 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~  156 (268)
T cd05063          82 MIITEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRV  156 (268)
T ss_pred             EEEEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCcccee
Confidence            9999999999999998543  25689999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCCCcc---ccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccCCCCCC
Q 039137          794 LNPDSSNWS---ELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDSRLPYP  869 (912)
Q Consensus       794 ~~~~~~~~~---~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  869 (912)
                      .........   ....++.|+|||++.+..++.++||||||+++|||++ |+.||.....     ......+. .....+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-----~~~~~~i~-~~~~~~  230 (268)
T cd05063         157 LEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-----HEVMKAIN-DGFRLP  230 (268)
T ss_pred             cccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-----HHHHHHHh-cCCCCC
Confidence            643322111   1123457999999988889999999999999999997 9999842111     11111111 111111


Q ss_pred             ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 039137          870 SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI  909 (912)
Q Consensus       870 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l  909 (912)
                      .  ....+.++.+++.+||+.+|++||++.++++.|++.+
T Consensus       231 ~--~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~  268 (268)
T cd05063         231 A--PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL  268 (268)
T ss_pred             C--CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence            1  1123456889999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=8.2e-35  Score=308.84  Aligned_cols=250  Identities=28%  Similarity=0.432  Sum_probs=204.4

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      .++|++.+.||+|+||.||+|... +++.|++|.+....      ..+++.+|+++++.++||||+++++++...+..++
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l   75 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE------DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWI   75 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH------HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEE
Confidence            367999999999999999999876 47899999985331      25778999999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ++||+++++|.+++...  ...+++.+++.++.|++.|++|||+.   +++|+||+|+||+++.++.++|+|||++....
T Consensus        76 ~~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~  150 (256)
T cd06612          76 VMEYCGAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLT  150 (256)
T ss_pred             EEecCCCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcc
Confidence            99999999999998432  35689999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHH
Q 039137          796 PDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQK  875 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  875 (912)
                      ..........++..|+|||++.+..++.++||||||+++|+|++|+.||........     ..... ............
T Consensus       151 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~-----~~~~~-~~~~~~~~~~~~  224 (256)
T cd06612         151 DTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA-----IFMIP-NKPPPTLSDPEK  224 (256)
T ss_pred             cCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh-----hhhhc-cCCCCCCCchhh
Confidence            543333445678899999999988899999999999999999999999863211110     00000 011101111123


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          876 KLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       876 ~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ....+.+++.+||+.||++|||+.|+++
T Consensus       225 ~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         225 WSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             cCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            4456889999999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=4.1e-35  Score=313.29  Aligned_cols=251  Identities=27%  Similarity=0.398  Sum_probs=199.5

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ++|++.+.||+|+||.||+|+.. +++.||+|.++....    .....+.+|+.+++.++||||+++++++...+..++|
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~----~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv   84 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG----EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC   84 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence            56888899999999999999865 688999999864422    1345678899999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++++|.+++..   .+.+++.+++.++.|++.|++|||+.   +++|+||||+||+++.++.++|+|||.+.....
T Consensus        85 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06645          85 MEFCGGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITA  158 (267)
T ss_pred             EeccCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence            999999999999843   34689999999999999999999999   999999999999999999999999999976654


Q ss_pred             CCCCccccccccccccccccc---cCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCC-hh
Q 039137          797 DSSNWSELAGTHGYVAPELAY---TLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPS-LH  872 (912)
Q Consensus       797 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  872 (912)
                      .........|++.|+|||++.   ...++.++||||+||++|+|++|+.||.......     ............+. ..
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~  233 (267)
T cd06645         159 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-----ALFLMTKSNFQPPKLKD  233 (267)
T ss_pred             cccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh-----hHHhhhccCCCCCcccc
Confidence            433344567899999999874   4457889999999999999999999974211100     00000111111110 00


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          873 VQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       873 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ....+..+.+++.+|++.+|++||+++++++
T Consensus       234 ~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         234 KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            1123345789999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-36  Score=322.18  Aligned_cols=248  Identities=25%  Similarity=0.414  Sum_probs=204.6

Q ss_pred             CCCCceeeecCceEEEEEEeC--CCC--EEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          640 FNAEHCIGKGGHGSVYRAKVP--SGE--IFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       640 ~~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      ..+.+.||+|.||+||+|.|+  +|+  .||||++.......   ....|++|+..|.+|+|||++++||+.-+ ....|
T Consensus       112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~---~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mM  187 (1039)
T KOG0199|consen  112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA---IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMM  187 (1039)
T ss_pred             HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch---hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhH
Confidence            455688999999999999876  343  58999998665443   56889999999999999999999999987 67889


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      |||.++.|+|.+.++. .....+-......++.|||.|+.||.++   +.||||+.++|+++-....|||+|||+.+-++
T Consensus       188 V~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg  263 (1039)
T KOG0199|consen  188 VFELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALG  263 (1039)
T ss_pred             HhhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccC
Confidence            9999999999999976 5566788899999999999999999999   99999999999999999999999999999887


Q ss_pred             CCCCCccc---cccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhcc--CCCCCC
Q 039137          796 PDSSNWSE---LAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLD--SRLPYP  869 (912)
Q Consensus       796 ~~~~~~~~---~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~  869 (912)
                      .....+..   ..-...|+|||.+....++.++|||+|||++|||+| |+.||-.....      ...+.+|  .+++-+
T Consensus       264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~------qIL~~iD~~erLpRP  337 (1039)
T KOG0199|consen  264 ENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI------QILKNIDAGERLPRP  337 (1039)
T ss_pred             CCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH------HHHHhccccccCCCC
Confidence            65544421   223567999999999999999999999999999999 89998532211      1112222  223333


Q ss_pred             ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 039137          870 SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL  905 (912)
Q Consensus       870 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  905 (912)
                          ..+++++++++..||+++|++|||+..+.+.+
T Consensus       338 ----k~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  338 ----KYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             ----CCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence                34567899999999999999999999998443

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=9.5e-35  Score=307.23  Aligned_cols=246  Identities=26%  Similarity=0.417  Sum_probs=196.6

Q ss_pred             ceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEEeecCCC
Q 039137          644 HCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESG  723 (912)
Q Consensus       644 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  723 (912)
                      +.||+|+||.||+|...+++.||+|.+.....   ......+.+|+++++.++||||+++++++...+..++||||++++
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   77 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLP---QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG   77 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCC---HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence            36899999999999988889999999875432   223456889999999999999999999999999999999999999


Q ss_pred             ChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCCCc-c
Q 039137          724 SLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNW-S  802 (912)
Q Consensus       724 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~-~  802 (912)
                      +|.+++...  ...+++.++..++.|++.|+.|+|++   +++||||||+||+++.++.++++|||++.......... .
T Consensus        78 ~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~  152 (250)
T cd05085          78 DFLSFLRKK--KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSG  152 (250)
T ss_pred             cHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCC
Confidence            999998543  24578999999999999999999999   99999999999999999999999999997543322111 1


Q ss_pred             ccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccC-CCCCCChhhHHHHHHH
Q 039137          803 ELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDS-RLPYPSLHVQKKLMSI  880 (912)
Q Consensus       803 ~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l  880 (912)
                      ...+++.|+|||++.+..++.++||||||+++|++++ |..||......     ......... +...+    ...+..+
T Consensus       153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~----~~~~~~~  223 (250)
T cd05085         153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ-----QAREQVEKGYRMSCP----QKCPDDV  223 (250)
T ss_pred             CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH-----HHHHHHHcCCCCCCC----CCCCHHH
Confidence            2234567999999988889999999999999999998 99998522111     000111111 11111    1234568


Q ss_pred             HHHHHHcccCCCCCCCCHHHHHHHHH
Q 039137          881 MQVAFSCLDQNPESRPTMKRVSQLLC  906 (912)
Q Consensus       881 ~~li~~cl~~dP~~RPt~~evl~~L~  906 (912)
                      .+++.+|++.+|++||++.|+++.|.
T Consensus       224 ~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         224 YKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             HHHHHHHcccCcccCCCHHHHHHHhc
Confidence            89999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=7.3e-35  Score=311.00  Aligned_cols=253  Identities=26%  Similarity=0.382  Sum_probs=201.7

Q ss_pred             CCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCC--chHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          639 DFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGE--MSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      +|++.+.||+|+||+||+|...+++.+|+|.+.......  .....+.+.+|++.++.++|+||+++++++.+.+..++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            588899999999999999998889999999886543221  122345688999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++++|.+++.+.   ..+++..+..++.|++.|++|||+.   +|+|+||+|+||+++.++.++|+|||.+.....
T Consensus        81 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          81 MEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            9999999999999443   4578999999999999999999999   999999999999999999999999999876532


Q ss_pred             CC------CCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCC
Q 039137          797 DS------SNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPS  870 (912)
Q Consensus       797 ~~------~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  870 (912)
                      ..      .......++..|+|||++.+..++.++||||+|+++|+|++|+.||.......     ............+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~  229 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-----AMFYIGAHRGLMPR  229 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-----HHHHhhhccCCCCC
Confidence            11      11223467889999999998889999999999999999999999985221110     00011111001110


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          871 LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       871 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                       .....+..+.+++.+||+.+|.+||++.|+++
T Consensus       230 -~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         230 -LPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             -CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence             11224456789999999999999999998875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=7.1e-35  Score=316.38  Aligned_cols=260  Identities=22%  Similarity=0.390  Sum_probs=200.3

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-----------------CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCc
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-----------------SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRN  699 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n  699 (912)
                      .++|++.+.||+|+||.||+++..                 ++..||+|++....   ......++.+|+++++.++|+|
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~~E~~~l~~l~~~~   80 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA---NKNARNDFLKEIKIMSRLKDPN   80 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCC
Confidence            357999999999999999998532                 23468999986432   1224567899999999999999


Q ss_pred             cccEEEEEEcCCeeeEEEeecCCCChhhHhhccC--------CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCC
Q 039137          700 IVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDA--------SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDIS  771 (912)
Q Consensus       700 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk  771 (912)
                      |+++++++...+..++||||+++++|.+++....        ....+++.++..++.|++.|++|||++   +++|+|||
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlk  157 (296)
T cd05095          81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLA  157 (296)
T ss_pred             cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCC
Confidence            9999999999999999999999999999985532        123477889999999999999999999   99999999


Q ss_pred             CCCeEEcCCCcEEEeccccccccCCCCCC--ccccccccccccccccccCCCCcchhHHHHHHHHHHHHh--CCCCccch
Q 039137          772 SKNVLLDLGYEAHVSDFGIAKFLNPDSSN--WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK--GKHPRDFL  847 (912)
Q Consensus       772 ~~Nill~~~~~~kl~Dfgla~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt--g~~pf~~~  847 (912)
                      |+||+++.++.++++|||+++.+......  .....+++.|+|||...+..++.++|||||||++|||++  |..||...
T Consensus       158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~  237 (296)
T cd05095         158 TRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL  237 (296)
T ss_pred             hheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence            99999999999999999999865432211  122334678999998888889999999999999999998  77887522


Q ss_pred             hccccccccchhhh----ccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 039137          848 FEMSSSSSNMNIEM----LDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCE  907 (912)
Q Consensus       848 ~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  907 (912)
                      ...... .......    .....+.+    ...+..+.+++.+||+.||++||++.++.+.|++
T Consensus       238 ~~~~~~-~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         238 SDEQVI-ENTGEFFRDQGRQVYLPKP----ALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             ChHHHH-HHHHHHHhhccccccCCCC----CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            111000 0000000    00011111    1233568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-34  Score=307.97  Aligned_cols=254  Identities=27%  Similarity=0.493  Sum_probs=205.5

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      ..++|++.+.||+|++|.||+|..+++..||+|.+.....     ..+++.+|+.+++.++|+||+++++++......++
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   78 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYI   78 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEE
Confidence            3468999999999999999999988888899999864322     35678899999999999999999999998899999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ||||+++++|.+++... ....+++.++..++.|++.|++|||+.   +++|+||||+||+++.++.++++|||.+....
T Consensus        79 v~e~~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~  154 (261)
T cd05034          79 VTEYMSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIE  154 (261)
T ss_pred             EEeccCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceecc
Confidence            99999999999999553 234689999999999999999999999   99999999999999999999999999998664


Q ss_pred             CCCCC-ccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccC-CCCCCChh
Q 039137          796 PDSSN-WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDS-RLPYPSLH  872 (912)
Q Consensus       796 ~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  872 (912)
                      ..... ......+..|+|||.+.+..++.++||||+|+++|++++ |+.||....     ........... ..+.+.  
T Consensus       155 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~-----~~~~~~~~~~~~~~~~~~--  227 (261)
T cd05034         155 DDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT-----NREVLEQVERGYRMPRPP--  227 (261)
T ss_pred             chhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHHcCCCCCCCC--
Confidence            32111 112234568999999998889999999999999999998 999974211     11111111111 111111  


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 039137          873 VQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCE  907 (912)
Q Consensus       873 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  907 (912)
                        ..+..+.+++.+|++.+|++||+++++.+.|+.
T Consensus       228 --~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         228 --NCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             --CCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence              124568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.8e-35  Score=346.13  Aligned_cols=258  Identities=23%  Similarity=0.358  Sum_probs=199.4

Q ss_pred             HHhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEc--CC
Q 039137          635 SATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSH--PK  711 (912)
Q Consensus       635 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~  711 (912)
                      ...++|++.+.||+|+||+||+|++. +++.||+|.+......  ......+..|+.+++.++||||+++++++..  ..
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~--e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~   87 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK--EREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ   87 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC--HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence            34578999999999999999999876 6778999988654322  2246778999999999999999999998854  45


Q ss_pred             eeeEEEeecCCCChhhHhhccC-CcccCCHHHHHHHHHHHHHHHHHHHhCCC----CCeeecCCCCCCeEEcCC------
Q 039137          712 HSFIIYEYLESGSLDKILCNDA-SAKELGWTQRLNVIKGVADALFYLHNNCF----PPIVHRDISSKNVLLDLG------  780 (912)
Q Consensus       712 ~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~----~~ivH~Dlk~~Nill~~~------  780 (912)
                      .+|+||||+++|+|.+++.... ....+++..++.|+.||+.||+|||+...    .+||||||||+|||++.+      
T Consensus        88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~  167 (1021)
T PTZ00266         88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK  167 (1021)
T ss_pred             EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence            6899999999999999985432 23569999999999999999999998521    259999999999999642      


Q ss_pred             -----------CcEEEeccccccccCCCCCCcccccccccccccccccc--CCCCcchhHHHHHHHHHHHHhCCCCccch
Q 039137          781 -----------YEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT--LKVTEKCDVYSFGVLALEVIKGKHPRDFL  847 (912)
Q Consensus       781 -----------~~~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~sDvwslG~vl~elltg~~pf~~~  847 (912)
                                 +.+||+|||++....... ......||+.|+|||++.+  ..++.++|||||||++|||++|+.||...
T Consensus       168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~  246 (1021)
T PTZ00266        168 ITAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA  246 (1021)
T ss_pred             ccccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence                       348999999998664332 2234578999999998854  45789999999999999999999998522


Q ss_pred             hccccccccchhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          848 FEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       848 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ...    . .....+......+   ....+..+.++|..||+.+|.+||++.|++.
T Consensus       247 ~~~----~-qli~~lk~~p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        247 NNF----S-QLISELKRGPDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             CcH----H-HHHHHHhcCCCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            111    0 1111111111111   1123456889999999999999999999884

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.8e-35  Score=312.01  Aligned_cols=249  Identities=29%  Similarity=0.433  Sum_probs=204.0

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ++|++.+.||.|++|.||+|+.. +++.||+|.+.....   ......+.+|+++++.++|+||+++++++.++...++|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   77 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA---EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWII   77 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc---chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEE
Confidence            46888999999999999999876 688999999865431   22456788999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      +||+++++|.+++...    .+++.+++.++.|++.|++|||++   +++|+||+|+||++++++.++++|||.++....
T Consensus        78 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  150 (274)
T cd06609          78 MEYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTS  150 (274)
T ss_pred             EEeeCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecc
Confidence            9999999999998432    689999999999999999999999   999999999999999999999999999987765


Q ss_pred             CCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHH
Q 039137          797 DSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKK  876 (912)
Q Consensus       797 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  876 (912)
                      .........+++.|+|||++.+..++.++||||||+++|+|++|+.||......     ...........+..  .....
T Consensus       151 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~-----~~~~~~~~~~~~~~--~~~~~  223 (274)
T cd06609         151 TMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM-----RVLFLIPKNNPPSL--EGNKF  223 (274)
T ss_pred             cccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH-----HHHHHhhhcCCCCC--ccccc
Confidence            444445567888999999999888999999999999999999999998522110     01111111111111  11114


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          877 LMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       877 ~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      +..+.+++.+||..||++|||++++++
T Consensus       224 ~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         224 SKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             CHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            556889999999999999999999865

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.3e-34  Score=309.48  Aligned_cols=251  Identities=29%  Similarity=0.433  Sum_probs=201.1

Q ss_pred             CCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCc-----hHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCe
Q 039137          639 DFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEM-----SFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKH  712 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-----~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~  712 (912)
                      +|.+.+.||+|++|.||+|... +++.||+|.+........     ....+.+.+|++++++++||||+++++++...+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            4788899999999999999865 688999998876543322     1123568899999999999999999999999999


Q ss_pred             eeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccccc
Q 039137          713 SFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK  792 (912)
Q Consensus       713 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  792 (912)
                      .++||||+++++|.+++..   .+.+++..+..++.|++.|++|||+.   +++||||+|+||++++++.++|+|||.++
T Consensus        81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCc
Confidence            9999999999999999944   34688899999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCC------CccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCC
Q 039137          793 FLNPDSS------NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRL  866 (912)
Q Consensus       793 ~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  866 (912)
                      .......      ......+++.|+|||.+.+..++.++||||+|+++|+|++|+.||......     ...........
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~  229 (267)
T cd06628         155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL-----QAIFKIGENAS  229 (267)
T ss_pred             ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH-----HHHHHHhccCC
Confidence            7653211      112345788999999999888999999999999999999999998632111     01111111111


Q ss_pred             CCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          867 PYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       867 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      +..   ....+..+.+++.+||+.||.+||++.|+++
T Consensus       230 ~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         230 PEI---PSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             CcC---CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            111   1223456889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-34  Score=307.76  Aligned_cols=250  Identities=27%  Similarity=0.417  Sum_probs=203.2

Q ss_pred             hcCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      .++|++.+.||+|+||.||+|.. .++.||+|.+.....     ..+++.+|+.+++.++|+||+++++++...+..++|
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   78 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIV   78 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEE
Confidence            35789999999999999999987 488899999865422     356788999999999999999999999988999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++++|.+++.... ...+++..+..++.|++.|++|||++   +++|+||||+||+++.++.++|+|||.++....
T Consensus        79 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~  154 (256)
T cd05039          79 TEYMAKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ  154 (256)
T ss_pred             EEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccc
Confidence            99999999999985432 23689999999999999999999999   999999999999999999999999999986632


Q ss_pred             CCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccCCCCCCChhhHH
Q 039137          797 DSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQK  875 (912)
Q Consensus       797 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  875 (912)
                      ..   .....+..|+|||++.+..++.++||||||+++||+++ |..||......      .............  ....
T Consensus       155 ~~---~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~~~~~~--~~~~  223 (256)
T cd05039         155 GQ---DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK------DVVPHVEKGYRME--APEG  223 (256)
T ss_pred             cc---ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH------HHHHHHhcCCCCC--CccC
Confidence            21   12334567999999988889999999999999999997 99997522110      0111111111100  0112


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 039137          876 KLMSIMQVAFSCLDQNPESRPTMKRVSQLLCE  907 (912)
Q Consensus       876 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  907 (912)
                      .+..+.+++.+||..+|++|||++|+++.|++
T Consensus       224 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         224 CPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             CCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence            34668899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=8.3e-35  Score=315.43  Aligned_cols=249  Identities=27%  Similarity=0.427  Sum_probs=202.1

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      .+|++.+.||.|++|.||+|... +++.||+|.+......    ..+.+.+|+..++.++|||++++++++...+..++|
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   94 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP----KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV   94 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc----hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence            46899999999999999999864 7899999998643222    356788999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      +||+++++|.+++..    ..+++.++..++.|++.|++|||++   +++||||||+||+++.++.++|+|||++.....
T Consensus        95 ~e~~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~  167 (296)
T cd06655          95 MEYLAGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP  167 (296)
T ss_pred             EEecCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence            999999999998843    3588999999999999999999999   999999999999999999999999999886654


Q ss_pred             CCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHH
Q 039137          797 DSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKK  876 (912)
Q Consensus       797 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  876 (912)
                      .........+++.|+|||.+.+..++.++|||||||++|+|++|+.||.......     ..........+. .......
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~-----~~~~~~~~~~~~-~~~~~~~  241 (296)
T cd06655         168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-----ALYLIATNGTPE-LQNPEKL  241 (296)
T ss_pred             ccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhcCCcc-cCCcccC
Confidence            4333344568899999999998889999999999999999999999985321110     000111111100 0011223


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          877 LMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       877 ~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      +..+.++|.+||..||.+||++.+++.
T Consensus       242 ~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         242 SPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             CHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            456788999999999999999998874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=9.5e-35  Score=321.70  Aligned_cols=260  Identities=23%  Similarity=0.396  Sum_probs=202.1

Q ss_pred             hcCCCCCceeeecCceEEEEEEe------CCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEEc
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKV------PSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSH  709 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~  709 (912)
                      .++|++.+.||+|+||+||+|.+      .+++.||||++.....   ......+.+|+.++.++ +||||+++++++..
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~   82 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT---HSEHRALMSELKILIHIGHHLNVVNLLGACTK   82 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC---hHHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence            46799999999999999999963      3578899999865432   12356788999999999 68999999998865


Q ss_pred             C-CeeeEEEeecCCCChhhHhhccCC------------------------------------------------------
Q 039137          710 P-KHSFIIYEYLESGSLDKILCNDAS------------------------------------------------------  734 (912)
Q Consensus       710 ~-~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------  734 (912)
                      . ...++||||+++|+|.+++.....                                                      
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (343)
T cd05103          83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE  162 (343)
T ss_pred             CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence            4 467899999999999999854210                                                      


Q ss_pred             ----------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCC--Ccc
Q 039137          735 ----------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSS--NWS  802 (912)
Q Consensus       735 ----------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~--~~~  802 (912)
                                ...+++.++..++.|++.|++|||++   +|+||||||+||+++.++.+|++|||++........  ...
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  239 (343)
T cd05103         163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG  239 (343)
T ss_pred             hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence                      12468889999999999999999999   999999999999999999999999999986533221  112


Q ss_pred             ccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccC-CCCCCChhhHHHHHHH
Q 039137          803 ELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDS-RLPYPSLHVQKKLMSI  880 (912)
Q Consensus       803 ~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l  880 (912)
                      ...+++.|+|||++.+..++.++||||||+++|||++ |..||......    .......... ....+.    ..+..+
T Consensus       240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~----~~~~~~  311 (343)
T cd05103         240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID----EEFCRRLKEGTRMRAPD----YTTPEM  311 (343)
T ss_pred             CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc----HHHHHHHhccCCCCCCC----CCCHHH
Confidence            2345678999999988889999999999999999997 89997532110    0011111111 111111    123457


Q ss_pred             HHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          881 MQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       881 ~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                      .+++.+||+.||++|||+.|+++.|++.+.
T Consensus       312 ~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         312 YQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            899999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.1e-34  Score=314.68  Aligned_cols=250  Identities=26%  Similarity=0.422  Sum_probs=203.2

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      ..+|++.+.||+|++|.||+|... +++.||+|.+......    ..+.+.+|+.+++.++||||+++++++..++..++
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l   93 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP----KKELIINEILVMRENKNPNIVNYLDSYLVGDELWV   93 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc----hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEE
Confidence            468999999999999999999864 7999999998643222    34668899999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ||||+++++|.+++.+    ..+++.++..++.|++.|++|||+.   +++||||||+||+++.++.++++|||.+....
T Consensus        94 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~  166 (297)
T cd06656          94 VMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  166 (297)
T ss_pred             eecccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEcc
Confidence            9999999999999843    3478899999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHH
Q 039137          796 PDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQK  875 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  875 (912)
                      ..........+++.|+|||.+.+..++.++||||+||++|++++|..||........    . ........+. ......
T Consensus       167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~----~-~~~~~~~~~~-~~~~~~  240 (297)
T cd06656         167 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA----L-YLIATNGTPE-LQNPER  240 (297)
T ss_pred             CCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh----e-eeeccCCCCC-CCCccc
Confidence            444334455788999999999988899999999999999999999999852211110    0 0001011110 001122


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          876 KLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       876 ~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .+..+.+++.+||+.||++||+++++++
T Consensus       241 ~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         241 LSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            3455788999999999999999999886

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.4e-34  Score=307.37  Aligned_cols=251  Identities=26%  Similarity=0.363  Sum_probs=202.6

Q ss_pred             CCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEc-CCeeeEE
Q 039137          639 DFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSH-PKHSFII  716 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-~~~~~lv  716 (912)
                      +|++.+.||+|++|.||+++.+ +++.||+|++......  ....+.+.+|++++++++|+|++++++.+.. ....++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv   78 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS--RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIV   78 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC--HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEE
Confidence            4889999999999999999876 6788999998643322  2245668899999999999999999998764 4467999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++++|.+++... ....+++.+++.++.|++.|++|||+.   +++||||+|+||+++.++.++|+|||++.....
T Consensus        79 ~e~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~  154 (257)
T cd08223          79 MGFCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN  154 (257)
T ss_pred             ecccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecc
Confidence            9999999999998543 234589999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHH
Q 039137          797 DSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKK  876 (912)
Q Consensus       797 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  876 (912)
                      .........+++.|+|||++.+..++.++||||+|+++|+|++|+.||+....     ............+..   ....
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-----~~~~~~~~~~~~~~~---~~~~  226 (257)
T cd08223         155 QCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM-----NSLVYRIIEGKLPPM---PKDY  226 (257)
T ss_pred             cCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-----HHHHHHHHhcCCCCC---cccc
Confidence            44444456788999999999998899999999999999999999999852111     111111222222111   1234


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          877 LMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       877 ~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      +..+.+++.+||+.||++|||+.++++
T Consensus       227 ~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         227 SPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             CHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            456889999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=6.3e-35  Score=325.22  Aligned_cols=258  Identities=19%  Similarity=0.280  Sum_probs=197.5

Q ss_pred             HHhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC---
Q 039137          635 SATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP---  710 (912)
Q Consensus       635 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~---  710 (912)
                      ...++|++.+.||+|+||.||+|.+. .++.||+|++.......  ...+.+.+|+.+++.++||||+++++++...   
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   91 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ--THAKRAYRELVLMKCVNHKNIISLLNVFTPQKSL   91 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccCh--HHHHHHHHHHHHHHHhCCCchhceeeeeeccccc
Confidence            34578999999999999999999865 68899999987554322  2456778999999999999999999998643   


Q ss_pred             ---CeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEec
Q 039137          711 ---KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSD  787 (912)
Q Consensus       711 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  787 (912)
                         ...++||||+++ ++.+.+.     ..+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|
T Consensus        92 ~~~~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~D  162 (355)
T cd07874          92 EEFQDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD  162 (355)
T ss_pred             cccceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEee
Confidence               357999999976 5666652     2478899999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhcccccc-------------
Q 039137          788 FGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS-------------  854 (912)
Q Consensus       788 fgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~-------------  854 (912)
                      ||+++..... .......+++.|+|||++.+..++.++|||||||++|||++|+.||..........             
T Consensus       163 fg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (355)
T cd07874         163 FGLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF  241 (355)
T ss_pred             CcccccCCCc-cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            9999865432 22344578999999999999899999999999999999999999985321100000             


Q ss_pred             ----ccchhhhccCC----------------CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 039137          855 ----SNMNIEMLDSR----------------LPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQL  904 (912)
Q Consensus       855 ----~~~~~~~~~~~----------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  904 (912)
                          ...........                .+............+.+++.+|++.||++|||+.|+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                00000000000                000000111123457899999999999999999998863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=9e-35  Score=314.33  Aligned_cols=257  Identities=24%  Similarity=0.431  Sum_probs=203.2

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC------CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP------SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP  710 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~  710 (912)
                      .++|++.+.||+|+||.||+|..+      ++..||+|++.....   ....+++.+|+.+++.++||||+++++++..+
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~   80 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS---ADMQADFQREAALMAEFDHPNIVKLLGVCAVG   80 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC---HHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence            467999999999999999999863      467899999864322   22456788999999999999999999999999


Q ss_pred             CeeeEEEeecCCCChhhHhhccC-------------------CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCC
Q 039137          711 KHSFIIYEYLESGSLDKILCNDA-------------------SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDIS  771 (912)
Q Consensus       711 ~~~~lv~e~~~~g~L~~~l~~~~-------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk  771 (912)
                      +..++||||+++|+|.+++....                   ....+++.+++.++.|++.||+|||++   +++|||||
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~  157 (288)
T cd05050          81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLA  157 (288)
T ss_pred             CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---Ceeccccc
Confidence            99999999999999999995421                   123478899999999999999999999   99999999


Q ss_pred             CCCeEEcCCCcEEEeccccccccCCCCC--CccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchh
Q 039137          772 SKNVLLDLGYEAHVSDFGIAKFLNPDSS--NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLF  848 (912)
Q Consensus       772 ~~Nill~~~~~~kl~Dfgla~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~  848 (912)
                      |+||++++++.++++|||.+........  .......++.|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus       158 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~  237 (288)
T cd05050         158 TRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA  237 (288)
T ss_pred             HhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999875533221  1122334678999999988889999999999999999998 888874211


Q ss_pred             ccccccccchhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 039137          849 EMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCE  907 (912)
Q Consensus       849 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  907 (912)
                      .     ........+.......   ...+.++.+++.+||+.||++|||+.|+++.|++
T Consensus       238 ~-----~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         238 H-----EEVIYYVRDGNVLSCP---DNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             H-----HHHHHHHhcCCCCCCC---CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            1     1111111112211111   1234568899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=6.4e-38  Score=333.90  Aligned_cols=365  Identities=29%  Similarity=0.411  Sum_probs=214.8

Q ss_pred             CCCccEEEccCCccc-ccCCccccCCCCCcEEeccccccccccccccccccccceeecccccccCCCCccccCcccccEE
Q 039137          108 FPHLVYLDLYNNELF-GIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQL  186 (912)
Q Consensus       108 l~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L  186 (912)
                      |+.++-.|+++|.++ +..|.....++.++.|-|...++. .+|++++.|.+|++|.+++|++. .+..+++.|+.|+.+
T Consensus         6 LpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv   83 (1255)
T KOG0444|consen    6 LPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSV   83 (1255)
T ss_pred             cceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHH
Confidence            344455555556555 345666666666666666666654 56666666666666666666665 555555556666666


Q ss_pred             EccCCcCCC-CCCccCCCCccceeeeeccCCCcCccccccccccccceeecccccccCccccccccccccceeeeccccC
Q 039137          187 ALDSNFLNG-SIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNEL  265 (912)
Q Consensus       187 ~l~~n~l~~-~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l  265 (912)
                      .+..|++.. -+|+.+-.|..|+.|+|+.|++. ..|..+...+++-.|+|++|+|..+.-.-|-+++.|-+||||+|++
T Consensus        84 ~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrL  162 (1255)
T KOG0444|consen   84 IVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRL  162 (1255)
T ss_pred             hhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchh
Confidence            666555542 24555555555555555555555 4555555555555555555555522223344555556666666665


Q ss_pred             cccCCcccCCccccchhhhccCccCCCCccccccccccceEeccccccc-CCCCcccCCCCCccEEEccCCcCccccccc
Q 039137          266 SGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLT-GNISETFGTYPNLTFIDLSNNSFFGEILSD  344 (912)
Q Consensus       266 ~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~  344 (912)
                      . .+|..+..+..|++|.|++|.+...--..+..+++|+.|.+++.+-+ ..+|..+..+.||..+|||.|.+. ..|..
T Consensus       163 e-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPec  240 (1255)
T KOG0444|consen  163 E-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPEC  240 (1255)
T ss_pred             h-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHH
Confidence            5 34445555555666666666554332223334455555555554422 234555555555555555555553 44555


Q ss_pred             CCCCCCCCEEeccCCcccccccccccccccccEEEccCccccCCCCccccccccccEEEccCCccc-CCCcccccccccc
Q 039137          345 WGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLS-GCIPRELGSLINL  423 (912)
Q Consensus       345 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L  423 (912)
                      +-++++|+.|+||+|+|+ .+....+.-.+|++|+||.|+++ .+|..+..+++|+.|++.+|+++ .-+|..++.+.+|
T Consensus       241 ly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~L  318 (1255)
T KOG0444|consen  241 LYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQL  318 (1255)
T ss_pred             HhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhh
Confidence            555555666666666655 33333344456777777777776 66777777777777777777765 2366677777777


Q ss_pred             ccccccCcccCccccccccccccccEEEecccccccccchhhhcccccceeecccccc
Q 039137          424 EYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFL  481 (912)
Q Consensus       424 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  481 (912)
                      +.+..++|++. ..|+.++.+.+|+.|.|++|++- .+|..+.-|+.|+.|||..|.=
T Consensus       319 evf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpn  374 (1255)
T KOG0444|consen  319 EVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPN  374 (1255)
T ss_pred             HHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcC
Confidence            77777777775 46777777777777777777764 5677777777777777776643

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=6.3e-35  Score=332.37  Aligned_cols=255  Identities=20%  Similarity=0.245  Sum_probs=189.9

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC----
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP----  710 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~----  710 (912)
                      ...+|++.+.||+|+||.||+|... +++.||||++....        ....+|+.+++.++||||+++++++...    
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~--------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~  135 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP--------QYKNRELLIMKNLNHINIIFLKDYYYTECFKK  135 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc--------chHHHHHHHHHhcCCCCCcceeeeEeeccccc
Confidence            3467999999999999999999875 68899999885321        1234799999999999999999887432    


Q ss_pred             ----CeeeEEEeecCCCChhhHhhcc-CCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCC-cEE
Q 039137          711 ----KHSFIIYEYLESGSLDKILCND-ASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGY-EAH  784 (912)
Q Consensus       711 ----~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~k  784 (912)
                          ...++||||+++ ++.+++... .....+++..++.++.||+.||+|||++   +|+||||||+||+++.++ .+|
T Consensus       136 ~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vk  211 (440)
T PTZ00036        136 NEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLK  211 (440)
T ss_pred             CCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCcee
Confidence                246799999986 676666432 3345689999999999999999999999   999999999999999665 799


Q ss_pred             EeccccccccCCCCCCccccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCccchhcccccc-------cc
Q 039137          785 VSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTL-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS-------SN  856 (912)
Q Consensus       785 l~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~-------~~  856 (912)
                      |+|||+|+...... ......|++.|+|||++.+. .++.++||||+||++|||++|.+||..........       ..
T Consensus       212 L~DFGla~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p  290 (440)
T PTZ00036        212 LCDFGSAKNLLAGQ-RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTP  290 (440)
T ss_pred             eeccccchhccCCC-CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            99999998664332 22345789999999988764 68999999999999999999999985321100000       00


Q ss_pred             ch--h-----hhccCCCCCCC-hh-----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          857 MN--I-----EMLDSRLPYPS-LH-----VQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       857 ~~--~-----~~~~~~~~~~~-~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ..  .     ...+...+... ..     ....+.++.+++.+||++||.+|||+.|+++
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence            00  0     00000011000 00     0112356889999999999999999999874

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.4e-34  Score=309.46  Aligned_cols=254  Identities=27%  Similarity=0.339  Sum_probs=197.7

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeee
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSF  714 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  714 (912)
                      +++.+.....||+|+||.||+|++. ++..||+|.+....    ....+.+.+|+.+++.++|+||+++++++..++..+
T Consensus         6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (268)
T cd06624           6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD----SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK   81 (268)
T ss_pred             ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC----HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence            4455556678999999999999865 67889999876432    224567889999999999999999999999999999


Q ss_pred             EEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcC-CCcEEEeccccccc
Q 039137          715 IIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDL-GYEAHVSDFGIAKF  793 (912)
Q Consensus       715 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~Dfgla~~  793 (912)
                      +||||+++++|.+++.........++.++..++.|++.|++|||++   +|+||||||+||+++. ++.++|+|||.+..
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~  158 (268)
T cd06624          82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKR  158 (268)
T ss_pred             EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence            9999999999999985432222237888999999999999999999   9999999999999986 67899999999986


Q ss_pred             cCCCCCCccccccccccccccccccCC--CCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhh-hccCCCCCCC
Q 039137          794 LNPDSSNWSELAGTHGYVAPELAYTLK--VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIE-MLDSRLPYPS  870 (912)
Q Consensus       794 ~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~  870 (912)
                      ............+++.|+|||++.+..  ++.++||||+|+++|+|++|+.||......   ....... ........+ 
T Consensus       159 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~-  234 (268)
T cd06624         159 LAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP---QAAMFKVGMFKIHPEIP-  234 (268)
T ss_pred             cccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh---hhhHhhhhhhccCCCCC-
Confidence            644333334456889999999986543  788999999999999999999997521110   0000000 001111111 


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          871 LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       871 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                         ......+.+++.+||+.+|.+|||+.|+++
T Consensus       235 ---~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         235 ---ESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             ---cccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence               223456889999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.3e-34  Score=313.83  Aligned_cols=252  Identities=26%  Similarity=0.394  Sum_probs=200.5

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      .+.|++.+.||+|+||.||+|+.. +++.|++|.+...    .....+.+.+|+.+++.++||||+++++++..++..++
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK----SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWI   86 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEE
Confidence            367999999999999999999876 5889999998643    22246778899999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ||||++++++..++.+.  ...+++.++..++.|++.|++|||++   +++||||||+||+++.++.++|+|||.+....
T Consensus        87 v~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  161 (292)
T cd06644          87 MIEFCPGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNV  161 (292)
T ss_pred             EEecCCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecc
Confidence            99999999998887432  24588999999999999999999999   99999999999999999999999999987644


Q ss_pred             CCCCCccccccccccccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCC
Q 039137          796 PDSSNWSELAGTHGYVAPELAY-----TLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPS  870 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  870 (912)
                      ..........+++.|+|||++.     ...++.++|||||||++|||++|+.||.....     ............+. .
T Consensus       162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~~~~~-~  235 (292)
T cd06644         162 KTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-----MRVLLKIAKSEPPT-L  235 (292)
T ss_pred             ccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH-----HHHHHHHhcCCCcc-C
Confidence            3333334556888999999884     34567899999999999999999999752211     01111111111110 0


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          871 LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       871 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ......+.++.+++.+||+.||++||+++++++
T Consensus       236 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         236 SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            011233456889999999999999999999875

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.1e-34  Score=325.32  Aligned_cols=256  Identities=22%  Similarity=0.331  Sum_probs=196.1

Q ss_pred             CCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCC-----e
Q 039137          639 DFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPK-----H  712 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-----~  712 (912)
                      +|++.+.||+|+||.||+|... +++.||+|++......  ....+++.+|+++++.++||||+++++++..++     .
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   78 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQN--LVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEE   78 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccc--hHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccce
Confidence            5788999999999999999875 7899999998644322  224567889999999999999999999998776     7


Q ss_pred             eeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccccc
Q 039137          713 SFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK  792 (912)
Q Consensus       713 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  792 (912)
                      .|+||||+. ++|.+++.   ....+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus        79 ~~lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~  151 (372)
T cd07853          79 IYVVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLAR  151 (372)
T ss_pred             EEEEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEecccccee
Confidence            899999997 47877773   335689999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCC-CccccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCccchhcccccc------c----c----
Q 039137          793 FLNPDSS-NWSELAGTHGYVAPELAYTL-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS------S----N----  856 (912)
Q Consensus       793 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~------~----~----  856 (912)
                      ....... ......+++.|+|||++.+. .++.++||||+||++|||++|+.||..........      .    .    
T Consensus       152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~  231 (372)
T cd07853         152 VEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS  231 (372)
T ss_pred             ecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence            6543322 22344678999999998774 47899999999999999999999986321110000      0    0    


Q ss_pred             ---chhhhccCCC-CCCCh-----hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          857 ---MNIEMLDSRL-PYPSL-----HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       857 ---~~~~~~~~~~-~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                         .......... ..+..     .....+..+.+++.+|++.||++|||+.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence               0000000000 00000     00112456789999999999999999999875

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.1e-34  Score=307.89  Aligned_cols=249  Identities=27%  Similarity=0.385  Sum_probs=198.6

Q ss_pred             hcCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEE-cCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCS-HPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~-~~~~~~l  715 (912)
                      .++|++.+.||+|+||.||+|.. .++.||+|.+....      ..+.+.+|+.+++.++|++++++++++. ..+..++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l   77 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI   77 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc------hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEE
Confidence            35789999999999999999987 47889999875321      3467889999999999999999999764 4567899


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ||||+++++|.+++.... ...+++..++.++.|++.|++|||++   +++||||||+||++++++.+|++|||++....
T Consensus        78 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  153 (256)
T cd05082          78 VTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  153 (256)
T ss_pred             EEECCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceecc
Confidence            999999999999985432 23588999999999999999999999   99999999999999999999999999987543


Q ss_pred             CCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccCCCCCCChhhH
Q 039137          796 PDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQ  874 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  874 (912)
                      ...   ....++..|+|||++.+..++.++||||||+++|||++ |+.||.....     . ..........+.  ....
T Consensus       154 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~-----~-~~~~~~~~~~~~--~~~~  222 (256)
T cd05082         154 STQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----K-DVVPRVEKGYKM--DAPD  222 (256)
T ss_pred             ccC---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH-----H-HHHHHHhcCCCC--CCCC
Confidence            322   22344568999999998889999999999999999998 9999752110     0 000111111110  0112


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 039137          875 KKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCE  907 (912)
Q Consensus       875 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  907 (912)
                      ..+..+.+++.+||+.+|++|||+.++++.|++
T Consensus       223 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         223 GCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence            234568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=8.6e-35  Score=313.45  Aligned_cols=249  Identities=26%  Similarity=0.386  Sum_probs=197.8

Q ss_pred             CCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEEe
Q 039137          640 FNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYE  718 (912)
Q Consensus       640 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e  718 (912)
                      |++.+.||+|+||.||+|... ++..+++|.+....    ....+.+.+|+++++.++||||+++++++...+..++|||
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e   82 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS----EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE   82 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC----HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEE
Confidence            677889999999999999876 57788998875321    2245678899999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCC
Q 039137          719 YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS  798 (912)
Q Consensus       719 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  798 (912)
                      |++++++..++.+.  ...+++.++..++.|++.||+|||+.   +++||||||+||+++.++.++++|||++.......
T Consensus        83 ~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~  157 (282)
T cd06643          83 FCAGGAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI  157 (282)
T ss_pred             ecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc
Confidence            99999999887432  34689999999999999999999999   99999999999999999999999999997654433


Q ss_pred             CCccccccccccccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhh
Q 039137          799 SNWSELAGTHGYVAPELAY-----TLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHV  873 (912)
Q Consensus       799 ~~~~~~~g~~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  873 (912)
                      .......+++.|+|||++.     +..++.++||||+||++|||++|+.||......     ...........+. ....
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-----~~~~~~~~~~~~~-~~~~  231 (282)
T cd06643         158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM-----RVLLKIAKSEPPT-LAQP  231 (282)
T ss_pred             cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH-----HHHHHHhhcCCCC-CCCc
Confidence            3334556889999999874     445778999999999999999999998532111     0111111111110 0011


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          874 QKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       874 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ...+..+.+++.+||+.||.+||++.++++
T Consensus       232 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         232 SRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            223456889999999999999999998864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=8.9e-35  Score=318.27  Aligned_cols=259  Identities=23%  Similarity=0.386  Sum_probs=203.2

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC--------CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP--------SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFC  707 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~  707 (912)
                      .++|.+.+.||+|+||.||+|+..        ....||+|++.....   .....++.+|+.+++.+ +||||+++++++
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT---DKDLADLISEMELMKLIGKHKNIINLLGVC   87 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC---hHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence            467889999999999999999742        345789998864322   22456788999999999 699999999999


Q ss_pred             EcCCeeeEEEeecCCCChhhHhhccC-------------CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCC
Q 039137          708 SHPKHSFIIYEYLESGSLDKILCNDA-------------SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKN  774 (912)
Q Consensus       708 ~~~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N  774 (912)
                      ...+..++||||+++|+|.+++....             ....+++.++.+++.|++.|++|||++   +++||||||+|
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N  164 (314)
T cd05099          88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARN  164 (314)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeecccccee
Confidence            99899999999999999999995532             124588999999999999999999999   99999999999


Q ss_pred             eEEcCCCcEEEeccccccccCCCCCCc--cccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccc
Q 039137          775 VLLDLGYEAHVSDFGIAKFLNPDSSNW--SELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMS  851 (912)
Q Consensus       775 ill~~~~~~kl~Dfgla~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~  851 (912)
                      |+++.++.+||+|||.++.........  ....+++.|+|||++.+..++.++||||||+++|||++ |..||.....  
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~--  242 (314)
T cd05099         165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV--  242 (314)
T ss_pred             EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH--
Confidence            999999999999999998664322111  12234467999999988889999999999999999999 8888752211  


Q ss_pred             cccccchhhhccCC-CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          852 SSSSNMNIEMLDSR-LPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       852 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                         ........... ...+    ...+.++.+++.+||+.||++|||+.|+++.|++...
T Consensus       243 ---~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         243 ---EELFKLLREGHRMDKP----SNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             ---HHHHHHHHcCCCCCCC----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence               00000111111 1111    1223467789999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-36  Score=327.96  Aligned_cols=255  Identities=26%  Similarity=0.456  Sum_probs=208.4

Q ss_pred             CCCCceeeecCceEEEEEEe-CCCC----EEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeee
Q 039137          640 FNAEHCIGKGGHGSVYRAKV-PSGE----IFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSF  714 (912)
Q Consensus       640 ~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  714 (912)
                      ....++||+|+||+||+|.+ ++|+    +||+|++......+   ..+++++|+..|.+++|||+++++|+|.... ..
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~---~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q  773 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPK---ASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ  773 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCch---hhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence            45568999999999999975 3444    58888876543222   4678999999999999999999999998765 88


Q ss_pred             EEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccccccc
Q 039137          715 IIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL  794 (912)
Q Consensus       715 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  794 (912)
                      +|++||+.|+|.++++.++  ..+.....+.|.+|||+||.|||.+   ++|||||.++|||+..-..+|+.|||+++..
T Consensus       774 lvtq~mP~G~LlDyvr~hr--~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll  848 (1177)
T KOG1025|consen  774 LVTQLMPLGCLLDYVREHR--DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLL  848 (1177)
T ss_pred             HHHHhcccchHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhcc
Confidence            9999999999999997644  5678899999999999999999999   9999999999999999999999999999988


Q ss_pred             CCCCCCcccccc--ccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccCCCCCCCh
Q 039137          795 NPDSSNWSELAG--THGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSL  871 (912)
Q Consensus       795 ~~~~~~~~~~~g--~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  871 (912)
                      .++...+....|  .+.|||-|.+....|+.++|||||||++||++| |..|++..   ...+.....+ ...+++.|+ 
T Consensus       849 ~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi---~~~eI~dlle-~geRLsqPp-  923 (1177)
T KOG1025|consen  849 APDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGI---PAEEIPDLLE-KGERLSQPP-  923 (1177)
T ss_pred             CcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCC---CHHHhhHHHh-ccccCCCCC-
Confidence            777655544333  568999999999999999999999999999999 99997632   1111111111 122344332 


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 039137          872 HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE  911 (912)
Q Consensus       872 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~~  911 (912)
                         ....++..++.+||..|+..||+++++...+.++..+
T Consensus       924 ---iCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard  960 (1177)
T KOG1025|consen  924 ---ICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD  960 (1177)
T ss_pred             ---CccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence               3456688899999999999999999999999988653

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.3e-34  Score=315.86  Aligned_cols=255  Identities=25%  Similarity=0.342  Sum_probs=200.1

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ++|++.+.||+|+||.||+|++. ++..||+|.+.....   .....++.+|++++++++||||+++++++..++..++|
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   77 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK---PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISIC   77 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEE
Confidence            46899999999999999999875 688899998864321   22456788999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++++|.+++...   +.+++..+..++.|++.||+|||+..  +++|+||||+||+++.++.++++|||++.....
T Consensus        78 ~ey~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  152 (308)
T cd06615          78 MEHMDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  152 (308)
T ss_pred             eeccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccc
Confidence            9999999999999543   56889999999999999999999732  899999999999999999999999999876533


Q ss_pred             CCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccc------cccch------------
Q 039137          797 DSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS------SSNMN------------  858 (912)
Q Consensus       797 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~------~~~~~------------  858 (912)
                      .  ......+++.|+|||++.+..++.++||||||+++|+|++|+.||.........      .....            
T Consensus       153 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (308)
T cd06615         153 S--MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHP  230 (308)
T ss_pred             c--ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCC
Confidence            2  223457889999999998888999999999999999999999998521100000      00000            


Q ss_pred             -------------hhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 039137          859 -------------IEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQL  904 (912)
Q Consensus       859 -------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  904 (912)
                                   ........  +.......+.++.+++.+||..||++|||+.|+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         231 PDSPRPMAIFELLDYIVNEPP--PKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CCccchhhHHHHHHHHhcCCC--ccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                         00000000  000001134568899999999999999999998764

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=9.2e-35  Score=316.28  Aligned_cols=258  Identities=17%  Similarity=0.271  Sum_probs=198.2

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      .++|++.+.||+|+||.||+|+.+ +++.||+|.+.......   ....+.+|+.+++.++||||+++++++..++..++
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l   81 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG---APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL   81 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC---chhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence            357999999999999999999876 68899999986443222   23457789999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ||||++ ++|.+++...  ...+++..+..++.|++.||+|||+.   +|+|+||||+||+++.++.++|+|||++....
T Consensus        82 v~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  155 (301)
T cd07873          82 VFEYLD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKS  155 (301)
T ss_pred             EEeccc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence            999997 4888887443  34578999999999999999999999   99999999999999999999999999997654


Q ss_pred             CCCCCccccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCccchhcccc----------ccccchhhhcc-
Q 039137          796 PDSSNWSELAGTHGYVAPELAYTL-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS----------SSSNMNIEMLD-  863 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~----------~~~~~~~~~~~-  863 (912)
                      ..........+++.|+|||++.+. .++.++|||||||++|||++|+.||........          ........... 
T Consensus       156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (301)
T cd07873         156 IPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN  235 (301)
T ss_pred             CCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcc
Confidence            433333445678999999987654 478899999999999999999999853211000          00000000000 


Q ss_pred             ---CCCCCCC-------hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          864 ---SRLPYPS-------LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       864 ---~~~~~~~-------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                         ....++.       ......+..+.++|.+|++.||.+|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence               0000010       001122446789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=8.9e-35  Score=314.11  Aligned_cols=263  Identities=24%  Similarity=0.364  Sum_probs=203.6

Q ss_pred             ccHHHHHHHhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEE
Q 039137          628 IVYEEIISATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYG  705 (912)
Q Consensus       628 ~~~~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~  705 (912)
                      +.++.+..+.++|++.+.||+|+||.||+|+.+ +++.||+|++.....     ...++.+|+.+++.+ +||||+++++
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-----~~~~~~~e~~~l~~l~~h~~i~~~~~   82 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-----IDEEIEAEYNILKALSDHPNVVKFYG   82 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-----hHHHHHHHHHHHHHHhcCCCeeeeee
Confidence            344556677899999999999999999999875 688999998753211     245677899999999 6999999999


Q ss_pred             EEE-----cCCeeeEEEeecCCCChhhHhhcc-CCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcC
Q 039137          706 FCS-----HPKHSFIIYEYLESGSLDKILCND-ASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDL  779 (912)
Q Consensus       706 ~~~-----~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~  779 (912)
                      ++.     .++..++||||+++++|.+++... .....+++..+..++.|++.|+.|||+.   +++||||||+||+++.
T Consensus        83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~  159 (286)
T cd06638          83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTT  159 (286)
T ss_pred             eeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECC
Confidence            874     345689999999999999987532 2335688999999999999999999999   9999999999999999


Q ss_pred             CCcEEEeccccccccCCCCCCcccccccccccccccccc-----CCCCcchhHHHHHHHHHHHHhCCCCccchhcccccc
Q 039137          780 GYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-----LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS  854 (912)
Q Consensus       780 ~~~~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~  854 (912)
                      ++.++++|||++..............|++.|+|||++..     ..++.++||||+||++|||++|+.||.......   
T Consensus       160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~---  236 (286)
T cd06638         160 EGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR---  236 (286)
T ss_pred             CCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH---
Confidence            999999999999876544333445578999999998753     447889999999999999999999975221110   


Q ss_pred             ccchhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 039137          855 SNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQL  904 (912)
Q Consensus       855 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  904 (912)
                        ..... ....+............+.+++.+||+.||++|||+.|+++.
T Consensus       237 --~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         237 --ALFKI-PRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             --HHhhc-cccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence              00000 000000000011123458899999999999999999999864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=9.5e-35  Score=310.83  Aligned_cols=255  Identities=28%  Similarity=0.499  Sum_probs=202.4

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CC---CEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCee
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SG---EIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHS  713 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  713 (912)
                      .+|++.+.||+|+||.||+|..+ ++   ..||+|++....   .....+++..|+..++.++||||+++++++..++..
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   80 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY---TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV   80 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence            45788999999999999999865 33   369999986532   222467899999999999999999999999999999


Q ss_pred             eEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccc
Q 039137          714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKF  793 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  793 (912)
                      ++||||+++++|.+++...  .+.+++.+++.++.|++.|++|||++   +++|+||||+||+++.++.++++|||.+..
T Consensus        81 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~  155 (269)
T cd05065          81 MIITEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRF  155 (269)
T ss_pred             EEEEecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccc
Confidence            9999999999999998543  34689999999999999999999999   999999999999999999999999999876


Q ss_pred             cCCCCCCc--c-ccc--cccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhh-ccCCC
Q 039137          794 LNPDSSNW--S-ELA--GTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEM-LDSRL  866 (912)
Q Consensus       794 ~~~~~~~~--~-~~~--g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~-~~~~~  866 (912)
                      ........  . ...  .+..|+|||++.+..++.++||||+|+++||+++ |..||......     .....+ .....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~-----~~~~~i~~~~~~  230 (269)
T cd05065         156 LEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-----DVINAIEQDYRL  230 (269)
T ss_pred             cccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH-----HHHHHHHcCCcC
Confidence            54322211  1 111  2457999999998889999999999999999887 99997522110     011111 11112


Q ss_pred             CCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 039137          867 PYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI  909 (912)
Q Consensus       867 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l  909 (912)
                      +.+    ...+..+.+++.+||..+|.+||++++++..|++.+
T Consensus       231 ~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~  269 (269)
T cd05065         231 PPP----MDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI  269 (269)
T ss_pred             CCc----ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence            222    123456789999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-34  Score=306.63  Aligned_cols=247  Identities=28%  Similarity=0.414  Sum_probs=195.3

Q ss_pred             ceeeecCceEEEEEEeC-C---CCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEEee
Q 039137          644 HCIGKGGHGSVYRAKVP-S---GEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEY  719 (912)
Q Consensus       644 ~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  719 (912)
                      +.||+|+||.||+|++. .   +..||+|.+......   ...+++.+|+++++.++||||+++++++. .+..++||||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~   76 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA---AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMEL   76 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch---HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEe
Confidence            46999999999999754 2   268999998754332   24567899999999999999999999876 4568999999


Q ss_pred             cCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCC
Q 039137          720 LESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSS  799 (912)
Q Consensus       720 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  799 (912)
                      +++|+|.+++...   ..+++..+..++.|++.|++|||+.   +++|+||||+||+++.++.+||+|||.++.......
T Consensus        77 ~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~  150 (257)
T cd05060          77 APLGPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD  150 (257)
T ss_pred             CCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence            9999999999543   3688999999999999999999999   999999999999999999999999999986654332


Q ss_pred             Ccc---ccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccCCCCCCChhhHH
Q 039137          800 NWS---ELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQK  875 (912)
Q Consensus       800 ~~~---~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  875 (912)
                      ...   ...++..|+|||...+..++.++||||||+++|||++ |..||+.....     .. ..........+  ....
T Consensus       151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~-----~~-~~~~~~~~~~~--~~~~  222 (257)
T cd05060         151 YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA-----EV-IAMLESGERLP--RPEE  222 (257)
T ss_pred             ccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH-----HH-HHHHHcCCcCC--CCCC
Confidence            221   1123467999999998889999999999999999998 99998632110     01 11111111111  1112


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 039137          876 KLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEK  908 (912)
Q Consensus       876 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  908 (912)
                      .+..+.+++.+||..+|++||++.++++.|++.
T Consensus       223 ~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         223 CPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence            345688999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-35  Score=314.24  Aligned_cols=252  Identities=27%  Similarity=0.417  Sum_probs=201.9

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      .++|++.+.||+|++|.||+|... +++.||+|.+...    .....+.+.+|++++++++||||+++++++..++..++
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE----SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWI   79 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC----CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEE
Confidence            457899999999999999999875 6889999998633    22245678899999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ||||+++++|.+++...  ...+++.+++.++.|++.|++|||++   +|+|+||+|+||+++.++.++|+|||.+....
T Consensus        80 v~e~~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~  154 (280)
T cd06611          80 LIEFCDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNK  154 (280)
T ss_pred             EeeccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhc
Confidence            99999999999998442  24689999999999999999999999   99999999999999999999999999987665


Q ss_pred             CCCCCccccccccccccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCC
Q 039137          796 PDSSNWSELAGTHGYVAPELAY-----TLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPS  870 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  870 (912)
                      ..........+++.|+|||++.     +..++.++||||+|+++|||++|+.||......     ...........+. .
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~-~  228 (280)
T cd06611         155 STLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-----RVLLKILKSEPPT-L  228 (280)
T ss_pred             ccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-----HHHHHHhcCCCCC-c
Confidence            4433444567899999999874     345678999999999999999999998522111     1111111111110 0


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          871 LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       871 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ......+..+.+++.+||+.+|.+||++.++++
T Consensus       229 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (280)
T cd06611         229 DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK  261 (280)
T ss_pred             CCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence            011223456789999999999999999998875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-34  Score=306.18  Aligned_cols=248  Identities=27%  Similarity=0.472  Sum_probs=202.3

Q ss_pred             ceeeecCceEEEEEEeCC----CCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEEee
Q 039137          644 HCIGKGGHGSVYRAKVPS----GEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEY  719 (912)
Q Consensus       644 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  719 (912)
                      +.||+|+||.||+|....    +..|++|.+.......   ..+.+.+|++.++.++|+|++++++++...+..++||||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   77 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE---ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEY   77 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh---HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEe
Confidence            468999999999998753    7889999987554322   467889999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhccCC------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccc
Q 039137          720 LESGSLDKILCNDAS------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKF  793 (912)
Q Consensus       720 ~~~g~L~~~l~~~~~------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  793 (912)
                      +++++|.+++.....      ...+++.+++.++.|++.|++|||++   +++|+||+|+||++++++.++++|||.+..
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~  154 (262)
T cd00192          78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRD  154 (262)
T ss_pred             ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccccc
Confidence            999999999955421      36789999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCC--CCccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccC-CCCCC
Q 039137          794 LNPDS--SNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDS-RLPYP  869 (912)
Q Consensus       794 ~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~  869 (912)
                      .....  .......+++.|+|||.+.+..++.++||||+|+++|||++ |..||.....     .......... ....+
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~  229 (262)
T cd00192         155 VYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-----EEVLEYLRKGYRLPKP  229 (262)
T ss_pred             cccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHHHHcCCCCCCC
Confidence            65443  22334557889999999988889999999999999999999 6999863211     1111111111 11111


Q ss_pred             ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 039137          870 SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLC  906 (912)
Q Consensus       870 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  906 (912)
                          ...+.++.+++.+||+.+|++|||+.|+++.|+
T Consensus       230 ----~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         230 ----EYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ----ccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                223567889999999999999999999998874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=2e-34  Score=308.51  Aligned_cols=250  Identities=24%  Similarity=0.393  Sum_probs=194.4

Q ss_pred             ceeeecCceEEEEEEeC-CCC--EEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEEcCCeeeEEEee
Q 039137          644 HCIGKGGHGSVYRAKVP-SGE--IFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSHPKHSFIIYEY  719 (912)
Q Consensus       644 ~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  719 (912)
                      +.||+|+||.||+|+.+ ++.  .+++|.+....   .....+.+.+|++++.++ +||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~   77 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY   77 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC---CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEe
Confidence            36899999999999875 343  46888876322   122456788999999999 799999999999999999999999


Q ss_pred             cCCCChhhHhhccC-------------CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEe
Q 039137          720 LESGSLDKILCNDA-------------SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVS  786 (912)
Q Consensus       720 ~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  786 (912)
                      +++|+|.+++....             ....+++.+++.++.|++.|++|||++   +++||||||+||++++++.+|++
T Consensus        78 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~  154 (270)
T cd05047          78 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIA  154 (270)
T ss_pred             CCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEEC
Confidence            99999999986432             123478999999999999999999999   99999999999999999999999


Q ss_pred             ccccccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccC-
Q 039137          787 DFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDS-  864 (912)
Q Consensus       787 Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~-  864 (912)
                      |||++...... ........+..|+|||++.+..++.++||||||+++|||++ |+.||.....     .......... 
T Consensus       155 dfgl~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-----~~~~~~~~~~~  228 (270)
T cd05047         155 DFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----AELYEKLPQGY  228 (270)
T ss_pred             CCCCccccchh-hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH-----HHHHHHHhCCC
Confidence            99998632211 11112233567999999988889999999999999999997 9999852111     0011111111 


Q ss_pred             CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 039137          865 RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI  909 (912)
Q Consensus       865 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l  909 (912)
                      ....+    ...+..+.+++.+||+.||.+|||+.+++..|++++
T Consensus       229 ~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         229 RLEKP----LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             CCCCC----CcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            11111    123346789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.4e-34  Score=307.31  Aligned_cols=255  Identities=27%  Similarity=0.419  Sum_probs=205.2

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ++|++.+.||.|++|+||+|... ++..+|+|++.......   ..+.+.+|++.++.++|+||+++++.+..++..++|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   77 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT---SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLV   77 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch---HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEE
Confidence            47899999999999999999865 68899999986433222   467789999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      ||++++++|.+++........+++..+..++.|++.|++|||+.   +++||||+|+||++++++.++++|||++.....
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~  154 (267)
T cd06610          78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLAD  154 (267)
T ss_pred             EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence            99999999999996544445689999999999999999999999   999999999999999999999999999986654


Q ss_pred             CCCC----ccccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCC-CCC
Q 039137          797 DSSN----WSELAGTHGYVAPELAYTL-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLP-YPS  870 (912)
Q Consensus       797 ~~~~----~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~  870 (912)
                      ....    .....++..|+|||++... .++.++||||||+++|||++|+.||.......     ..........+ .+.
T Consensus       155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~  229 (267)
T cd06610         155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-----VLMLTLQNDPPSLET  229 (267)
T ss_pred             CccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-----hHHHHhcCCCCCcCC
Confidence            3322    1334688999999998776 78999999999999999999999986321110     11111111111 111


Q ss_pred             h-hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          871 L-HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       871 ~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      . .....+..+.+++.+||+.||++||++.++++
T Consensus       230 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         230 GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             ccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            0 11234566889999999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2.5e-34  Score=308.92  Aligned_cols=249  Identities=27%  Similarity=0.413  Sum_probs=203.2

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ..|+..+.||+|+||.||+|.+. +++.||+|.+.....   ....+.+.+|+++++.++||||+++++++.++...++|
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA---EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWII   80 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            45778899999999999999875 688999998864321   22456788999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++++|.+++..    ..+++.++..++.|++.|++|+|+.   +++|+||+|+||+++.++.++++|||++.....
T Consensus        81 ~e~~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06640          81 MEYLGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD  153 (277)
T ss_pred             EecCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence            999999999999843    3578899999999999999999999   999999999999999999999999999976654


Q ss_pred             CCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHH
Q 039137          797 DSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKK  876 (912)
Q Consensus       797 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  876 (912)
                      .........++..|+|||++.+..++.++||||||+++|||++|+.||.......     . .......  .++......
T Consensus       154 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-----~-~~~~~~~--~~~~~~~~~  225 (277)
T cd06640         154 TQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR-----V-LFLIPKN--NPPTLTGEF  225 (277)
T ss_pred             CccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh-----H-hhhhhcC--CCCCCchhh
Confidence            4333344567889999999988889999999999999999999999985221110     0 0011111  111122345


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 039137          877 LMSIMQVAFSCLDQNPESRPTMKRVSQL  904 (912)
Q Consensus       877 ~~~l~~li~~cl~~dP~~RPt~~evl~~  904 (912)
                      +..+.+++.+||+.+|++||++.+++..
T Consensus       226 ~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         226 SKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             hHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            6678899999999999999999999654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=1.6e-37  Score=330.89  Aligned_cols=373  Identities=30%  Similarity=0.404  Sum_probs=272.7

Q ss_pred             cCCCCCcEEeccccccc-cccccccccccccceeecccccccCCCCccccCcccccEEEccCCcCCCCCCccCCCCccce
Q 039137          130 SNLSNLEYLDFSANKLF-GQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVV  208 (912)
Q Consensus       130 ~~l~~L~~L~Ls~n~l~-~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~  208 (912)
                      +-|+..+-.|+++|.++ +..|.....+++++.|.|...++. .+|++++.|.+|++|.+++|++. ++-..+..|+.|+
T Consensus         4 gVLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LR   81 (1255)
T KOG0444|consen    4 GVLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLR   81 (1255)
T ss_pred             cccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhH
Confidence            34556788999999998 468999999999999999999998 89999999999999999999987 6677788888888


Q ss_pred             eeeeccCCCc-CccccccccccccceeecccccccCccccccccccccceeeeccccCcccCCcccCCccccchhhhccC
Q 039137          209 ILYLYNNSFF-GSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKN  287 (912)
Q Consensus       209 ~L~L~~n~l~-~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N  287 (912)
                      .+.+..|++. ..+|..+..|..|+.|||++|++. ..|..+..-+++-.|+||+|+|..++-+.|-+++.|-.||||+|
T Consensus        82 sv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~N  160 (1255)
T KOG0444|consen   82 SVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNN  160 (1255)
T ss_pred             HHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccc
Confidence            8888888875 346777777777777777777777 66777777777777777777777544445667777777777777


Q ss_pred             ccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCcccccccCCCCCCCCEEeccCCcccccccc
Q 039137          288 HFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPL  367 (912)
Q Consensus       288 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~  367 (912)
                      ++. .+|+.++.+..|+.|+|++|.+.-.--..+-.+.+|+.|.+++.+-+                       ..-+|.
T Consensus       161 rLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRT-----------------------l~N~Pt  216 (1255)
T KOG0444|consen  161 RLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRT-----------------------LDNIPT  216 (1255)
T ss_pred             hhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccch-----------------------hhcCCC
Confidence            776 55556666777777777777655333333334444555555544322                       123566


Q ss_pred             cccccccccEEEccCccccCCCCccccccccccEEEccCCcccCCCccccccccccccccccCcccCccccccccccccc
Q 039137          368 EIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKL  447 (912)
Q Consensus       368 ~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  447 (912)
                      .+..+.+|..+|+|.|.+. .+|..+.++.+|+.|+|++|+|+ .+.-..+...+|+.|+||.|+++. .|.++..+++|
T Consensus       217 sld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt~-LP~avcKL~kL  293 (1255)
T KOG0444|consen  217 SLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLTV-LPDAVCKLTKL  293 (1255)
T ss_pred             chhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhcc-chHHHhhhHHH
Confidence            6666777777777777776 66777777777777777777777 444445556677778888888764 67777777888


Q ss_pred             cEEEecccccc-cccchhhhcccccceeeccccccCcccccccccccccccccccCccccCCCcccccccccceEEEccC
Q 039137          448 YYLNLSHNKLS-QQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISY  526 (912)
Q Consensus       448 ~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~ls~  526 (912)
                      +.|++.+|+++ .-+|..++.|.+|+++..++|.+ +..|+.++.+..|+.|.|++|+|-. .|+.+.-++.|..||+..
T Consensus       294 ~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~L-ElVPEglcRC~kL~kL~L~~NrLiT-LPeaIHlL~~l~vLDlre  371 (1255)
T KOG0444|consen  294 TKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKL-ELVPEGLCRCVKLQKLKLDHNRLIT-LPEAIHLLPDLKVLDLRE  371 (1255)
T ss_pred             HHHHhccCcccccCCccchhhhhhhHHHHhhcccc-ccCchhhhhhHHHHHhcccccceee-chhhhhhcCCcceeeccC
Confidence            88888777775 23677788888888888888877 6778888888888888888888764 477777788888888887


Q ss_pred             CccccCCC
Q 039137          527 NKLEGQIP  534 (912)
Q Consensus       527 N~l~~~~~  534 (912)
                      |+=--.+|
T Consensus       372 NpnLVMPP  379 (1255)
T KOG0444|consen  372 NPNLVMPP  379 (1255)
T ss_pred             CcCccCCC
Confidence            76544444

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.2e-34  Score=312.54  Aligned_cols=261  Identities=24%  Similarity=0.367  Sum_probs=201.4

Q ss_pred             CCCCCceeeecCceEEEEEEe-----CCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC--C
Q 039137          639 DFNAEHCIGKGGHGSVYRAKV-----PSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP--K  711 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~  711 (912)
                      -|++.+.||+|+||.||.|+.     .++..||+|.+.....   ....+.+.+|+++++.++|||++++++++...  .
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG---GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   81 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc---HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence            478899999999999999974     2578899999864432   22456789999999999999999999999775  5


Q ss_pred             eeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccc
Q 039137          712 HSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIA  791 (912)
Q Consensus       712 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla  791 (912)
                      ..++||||+++++|.+++.+.  ...+++.++..++.|++.||+|||++   +++||||||+||+++.++.++|+|||++
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~  156 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT  156 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccc
Confidence            689999999999999998443  23589999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCC---ccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhcccc-----cccc----chh
Q 039137          792 KFLNPDSSN---WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS-----SSSN----MNI  859 (912)
Q Consensus       792 ~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~-----~~~~----~~~  859 (912)
                      +........   .....++..|+|||++.+..++.++||||||+++|||+++..|+........     ....    ...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05079         157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV  236 (284)
T ss_pred             cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence            866443221   1234567789999999888899999999999999999998776421110000     0000    000


Q ss_pred             hhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 039137          860 EMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI  909 (912)
Q Consensus       860 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l  909 (912)
                      .........+.  ....+..+.+++.+||+.||++|||++++++.+++.+
T Consensus       237 ~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~  284 (284)
T cd05079         237 RVLEEGKRLPR--PPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL  284 (284)
T ss_pred             HHHHcCccCCC--CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhhC
Confidence            00000001110  1123457889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.6e-34  Score=312.49  Aligned_cols=257  Identities=24%  Similarity=0.319  Sum_probs=192.3

Q ss_pred             CCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc---CCCccccEEEEEEc-----
Q 039137          639 DFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI---RHRNIVKFYGFCSH-----  709 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l---~h~niv~l~~~~~~-----  709 (912)
                      +|++.+.||+|+||+||+|+++ +++.||+|.+........  ....+.+|+++++.+   +||||+++++++..     
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~   78 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDG--LPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDR   78 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCC--CchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCC
Confidence            5888999999999999999876 688999999875432221  223455677777665   69999999999864     


Q ss_pred             CCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccc
Q 039137          710 PKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFG  789 (912)
Q Consensus       710 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  789 (912)
                      ....++||||+++ ++.+++.... ...+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus        79 ~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg  153 (288)
T cd07863          79 ETKVTLVFEHVDQ-DLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFG  153 (288)
T ss_pred             CceEEEEEccccc-CHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccC
Confidence            2457999999985 8888885432 34589999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccc------cchhhhc-
Q 039137          790 IAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSS------NMNIEML-  862 (912)
Q Consensus       790 la~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~------~~~~~~~-  862 (912)
                      +++..... .......+++.|+|||++.+..++.++||||+||++|||++|++||...........      ....... 
T Consensus       154 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07863         154 LARIYSCQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  232 (288)
T ss_pred             ccccccCc-ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCc
Confidence            99866432 222345678999999999988899999999999999999999999852211000000      0000000 


Q ss_pred             ----------cCCCCCC-ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          863 ----------DSRLPYP-SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       863 ----------~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                                ....+.+ ..........+.+++.+|++.||++|||+.|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                      0000000 0011123456789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-35  Score=325.58  Aligned_cols=238  Identities=24%  Similarity=0.282  Sum_probs=185.3

Q ss_pred             eeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc---CCCccccEEEEEEcCCeeeEEEeecC
Q 039137          646 IGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI---RHRNIVKFYGFCSHPKHSFIIYEYLE  721 (912)
Q Consensus       646 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~  721 (912)
                      ||+|+||+||+|+.+ +++.||+|++........ .....+..|..++...   +||+|+++++++..++..|+||||++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~   79 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAK-KEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMS   79 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhh-hHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCC
Confidence            699999999999876 689999999854321111 1233445666666655   69999999999999999999999999


Q ss_pred             CCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCCCc
Q 039137          722 SGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNW  801 (912)
Q Consensus       722 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  801 (912)
                      +|+|.+++..   .+.+++.++..++.||+.||+|||++   +|+||||||+||+++.++.++|+|||++..........
T Consensus        80 ~g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~  153 (330)
T cd05586          80 GGELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTT  153 (330)
T ss_pred             CChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCc
Confidence            9999998843   35689999999999999999999999   99999999999999999999999999997644333334


Q ss_pred             cccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHHHHH
Q 039137          802 SELAGTHGYVAPELAYTL-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSI  880 (912)
Q Consensus       802 ~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  880 (912)
                      ....|++.|+|||++.+. .++.++||||+||++|||++|+.||....     ...............+..   ..+..+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~-----~~~~~~~i~~~~~~~~~~---~~~~~~  225 (330)
T cd05586         154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED-----TQQMYRNIAFGKVRFPKN---VLSDEG  225 (330)
T ss_pred             cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC-----HHHHHHHHHcCCCCCCCc---cCCHHH
Confidence            456799999999998764 47899999999999999999999985211     111111122222222221   134557


Q ss_pred             HHHHHHcccCCCCCCCCH
Q 039137          881 MQVAFSCLDQNPESRPTM  898 (912)
Q Consensus       881 ~~li~~cl~~dP~~RPt~  898 (912)
                      .+++.+||+.||.+||++
T Consensus       226 ~~li~~~L~~~P~~R~~~  243 (330)
T cd05586         226 RQFVKGLLNRNPQHRLGA  243 (330)
T ss_pred             HHHHHHHcCCCHHHCCCC
Confidence            789999999999999953

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-35  Score=321.02  Aligned_cols=255  Identities=21%  Similarity=0.274  Sum_probs=195.3

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ++|++.+.||+|+||+||+|+.+ +++.||+|++...... .....+.+.+|+.+++.++|+||+++++++.+++..|+|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   79 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEML-KRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLV   79 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEE
Confidence            47999999999999999999876 6899999998632111 111345688899999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++|+|.+++.+.  ...+++.++..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||++.....
T Consensus        80 ~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  154 (331)
T cd05597          80 MDYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA  154 (331)
T ss_pred             EecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence            9999999999998542  34588999999999999999999999   999999999999999999999999999976544


Q ss_pred             CCCC-cccccccccccccccccc-----CCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhcc--CCCCC
Q 039137          797 DSSN-WSELAGTHGYVAPELAYT-----LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLD--SRLPY  868 (912)
Q Consensus       797 ~~~~-~~~~~g~~~y~aPE~~~~-----~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~--~~~~~  868 (912)
                      .... .....|++.|+|||++..     ..++.++||||+||++|||++|+.||......     ........  .....
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~-----~~~~~i~~~~~~~~~  229 (331)
T cd05597         155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-----ETYGKIMNHKEHFQF  229 (331)
T ss_pred             CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH-----HHHHHHHcCCCcccC
Confidence            3222 223468999999999863     35788999999999999999999998521110     00111111  11111


Q ss_pred             CChhhHHHHHHHHHHHHHcccCCCC--CCCCHHHHHHH
Q 039137          869 PSLHVQKKLMSIMQVAFSCLDQNPE--SRPTMKRVSQL  904 (912)
Q Consensus       869 ~~~~~~~~~~~l~~li~~cl~~dP~--~RPt~~evl~~  904 (912)
                      +.. ....+..+.+++.+|+..+++  .||+++++++.
T Consensus       230 ~~~-~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         230 PPD-VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             CCc-cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            111 112345677888887765433  37788877653

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.5e-35  Score=312.25  Aligned_cols=253  Identities=24%  Similarity=0.411  Sum_probs=200.7

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcC-CCccccEEEEEEcCCeee
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR-HRNIVKFYGFCSHPKHSF  714 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~  714 (912)
                      ....|++.++||+||.+.||++...+.+.||+|++.....+  ......|..|+..+.+|+ |.+||++++|-..++..|
T Consensus       359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D--~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY  436 (677)
T KOG0596|consen  359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEAD--NQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY  436 (677)
T ss_pred             CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcC--HHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence            34679999999999999999999888899999988654333  235678999999999995 999999999999999999


Q ss_pred             EEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccccccc
Q 039137          715 IIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL  794 (912)
Q Consensus       715 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  794 (912)
                      |||||-+ .+|..++..... ...+| .++.+..||+.|+.++|++   ||||.||||.|+++-. |.+||+|||+|..+
T Consensus       437 mvmE~Gd-~DL~kiL~k~~~-~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI  509 (677)
T KOG0596|consen  437 MVMECGD-IDLNKILKKKKS-IDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAI  509 (677)
T ss_pred             EEeeccc-ccHHHHHHhccC-CCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhccc
Confidence            9999764 499999955432 22233 7889999999999999999   9999999999999974 58999999999988


Q ss_pred             CCCCCC--ccccccccccccccccccCC-----------CCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhh
Q 039137          795 NPDSSN--WSELAGTHGYVAPELAYTLK-----------VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEM  861 (912)
Q Consensus       795 ~~~~~~--~~~~~g~~~y~aPE~~~~~~-----------~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~  861 (912)
                      ..+...  ....+||+.||+||.+....           .+.++||||+||++|+|+.|++||+.....    ......+
T Consensus       510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~----~aKl~aI  585 (677)
T KOG0596|consen  510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ----IAKLHAI  585 (677)
T ss_pred             CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH----HHHHHhh
Confidence            776543  34678999999999886432           457899999999999999999999743211    1112223


Q ss_pred             ccC--CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 039137          862 LDS--RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQL  904 (912)
Q Consensus       862 ~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  904 (912)
                      .++  .++++.....   .++.++++.|+..||.+||++.|+++.
T Consensus       586 ~~P~~~Iefp~~~~~---~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  586 TDPNHEIEFPDIPEN---DELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             cCCCccccccCCCCc---hHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence            333  2233322211   127889999999999999999998863

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.2e-34  Score=313.08  Aligned_cols=254  Identities=24%  Similarity=0.348  Sum_probs=201.5

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ++|++.+.||+|+||.||+|..+ +++.||+|.+....   .....+.+.+|++++++++||||+++++++..++..++|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   77 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL---DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMC   77 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEE
Confidence            46889999999999999999876 78999999886432   122456788999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++++|..++........+++..+..++.|++.|++|||+..  +|+|+||||+||+++.++.++++|||.+.....
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  155 (286)
T cd06622          78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA  155 (286)
T ss_pred             EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccC
Confidence            999999999999865433457899999999999999999999632  899999999999999999999999999976533


Q ss_pred             CCCCccccccccccccccccccCC------CCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCC
Q 039137          797 DSSNWSELAGTHGYVAPELAYTLK------VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPS  870 (912)
Q Consensus       797 ~~~~~~~~~g~~~y~aPE~~~~~~------~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  870 (912)
                      .  ......+++.|+|||.+.+..      ++.++||||+||++|+|++|+.||......  ..............+.  
T Consensus       156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~--  229 (286)
T cd06622         156 S--LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA--NIFAQLSAIVDGDPPT--  229 (286)
T ss_pred             C--ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh--hHHHHHHHHhhcCCCC--
Confidence            2  223345788999999886543      478999999999999999999998522110  0000111111111111  


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          871 LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       871 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                       .....+.++.+++.+||+.+|++||+++++++
T Consensus       230 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         230 -LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             -CCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence             11235567889999999999999999999886

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.9e-34  Score=308.50  Aligned_cols=253  Identities=24%  Similarity=0.349  Sum_probs=190.0

Q ss_pred             ceeeecCceEEEEEEeC---CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEEeec
Q 039137          644 HCIGKGGHGSVYRAKVP---SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYL  720 (912)
Q Consensus       644 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  720 (912)
                      +.||+|+||.||+|+..   ++..+|+|++......   .....+.+|+.+++.++||||+++++++.+....++||||+
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   77 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV---QEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFC   77 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCCh---HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECC
Confidence            36899999999999764   3457999987654321   23457889999999999999999999999999999999999


Q ss_pred             CCCChhhHhhccCC--cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCC
Q 039137          721 ESGSLDKILCNDAS--AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS  798 (912)
Q Consensus       721 ~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  798 (912)
                      ++|+|.+++.....  ....++..+..++.|++.|++|||+.   +++|+||||+||+++.++.++++|||.+.......
T Consensus        78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~  154 (269)
T cd05087          78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED  154 (269)
T ss_pred             CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcc
Confidence            99999999964332  23467788889999999999999999   99999999999999999999999999997543322


Q ss_pred             C--CccccccccccccccccccC-------CCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccCCCCC
Q 039137          799 S--NWSELAGTHGYVAPELAYTL-------KVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDSRLPY  868 (912)
Q Consensus       799 ~--~~~~~~g~~~y~aPE~~~~~-------~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  868 (912)
                      .  ......+++.|+|||++.+.       .++.++||||||+++|||++ |+.||..........  ..........+.
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~--~~~~~~~~~~~~  232 (269)
T cd05087         155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT--YTVREQQLKLPK  232 (269)
T ss_pred             eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHH--HHhhcccCCCCC
Confidence            1  11234567889999988642       35789999999999999996 999985321111000  000000111111


Q ss_pred             CChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 039137          869 PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLC  906 (912)
Q Consensus       869 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  906 (912)
                      +. ........+.+++..|| .+|++|||++||++.|+
T Consensus       233 ~~-~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         233 PR-LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             Cc-cCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            11 01122345778889999 68999999999998875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.6e-34  Score=308.99  Aligned_cols=250  Identities=25%  Similarity=0.364  Sum_probs=188.1

Q ss_pred             ceeeecCceEEEEEEeCC---CCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEEeec
Q 039137          644 HCIGKGGHGSVYRAKVPS---GEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYL  720 (912)
Q Consensus       644 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  720 (912)
                      +.||+|+||+||+|+..+   ...+|+|.+....   .......+.+|++.++.++||||+++++++...+..++||||+
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~   77 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA---TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFC   77 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccC---ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeC
Confidence            358999999999997543   4568888765432   2224567889999999999999999999999999999999999


Q ss_pred             CCCChhhHhhccCC--cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCC
Q 039137          721 ESGSLDKILCNDAS--AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS  798 (912)
Q Consensus       721 ~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  798 (912)
                      ++|+|.+++.....  ....++..+..++.|++.|++|||++   +|+||||||+||++++++.+||+|||++.......
T Consensus        78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~  154 (269)
T cd05042          78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED  154 (269)
T ss_pred             CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccch
Confidence            99999999965432  23356788899999999999999999   99999999999999999999999999987543322


Q ss_pred             C--Ccccccccccccccccccc-------CCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhh-hccC--C
Q 039137          799 S--NWSELAGTHGYVAPELAYT-------LKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIE-MLDS--R  865 (912)
Q Consensus       799 ~--~~~~~~g~~~y~aPE~~~~-------~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~-~~~~--~  865 (912)
                      .  ......+++.|+|||++..       ..++.++||||+||++|||++ |..||......     ..... ....  .
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-----~~~~~~~~~~~~~  229 (269)
T cd05042         155 YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE-----QVLKQVVREQDIK  229 (269)
T ss_pred             heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH-----HHHHHHhhccCcc
Confidence            1  1123345678999998643       356789999999999999999 78887522111     00011 1111  1


Q ss_pred             CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 039137          866 LPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLC  906 (912)
Q Consensus       866 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  906 (912)
                      .+.+. .....+..+.+++..|| .||++|||+++|++.|.
T Consensus       230 ~~~~~-~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         230 LPKPQ-LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCCCc-ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            11111 11233455677888898 59999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.8e-34  Score=311.73  Aligned_cols=258  Identities=20%  Similarity=0.372  Sum_probs=200.6

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ++|++.+.||+|++|.||+|+.+ +++.||+|++.......  ...+.+.+|+++++.++|||++++++++..++..++|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   78 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDP--VIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLV   78 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCc--cccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEE
Confidence            46889999999999999999876 68999999986443211  1345678999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||++++++..+...   ...+++.+++.++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++.....
T Consensus        79 ~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  152 (286)
T cd07847          79 FEYCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTG  152 (286)
T ss_pred             EeccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCC
Confidence            999999988887732   34589999999999999999999999   999999999999999999999999999987755


Q ss_pred             CCCCcccccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCccchhcccccc------cc---chhhhc----
Q 039137          797 DSSNWSELAGTHGYVAPELAYT-LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS------SN---MNIEML----  862 (912)
Q Consensus       797 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~------~~---~~~~~~----  862 (912)
                      .........++..|+|||++.+ ..++.++||||+|+++|||++|+.||..........      ..   ......    
T Consensus       153 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07847         153 PGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ  232 (286)
T ss_pred             CcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence            4433344567889999998876 457899999999999999999999985221100000      00   000000    


Q ss_pred             ---cCCCCCCC------hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          863 ---DSRLPYPS------LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       863 ---~~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                         ....+.+.      ......+..+.+++.+||+.||++||++.|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence               00001000      011223466889999999999999999998875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.9e-34  Score=306.29  Aligned_cols=247  Identities=26%  Similarity=0.417  Sum_probs=198.3

Q ss_pred             ceeeecCceEEEEEEeCC--C--CEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEEee
Q 039137          644 HCIGKGGHGSVYRAKVPS--G--EIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEY  719 (912)
Q Consensus       644 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  719 (912)
                      +.||+|++|.||+|.+.+  +  ..||+|.+......   ...+.+.+|+..+++++||||+++++++.. ...++||||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~   76 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS---DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTEL   76 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH---HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEe
Confidence            468999999999998643  3  36899998765432   356788999999999999999999999988 889999999


Q ss_pred             cCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCC
Q 039137          720 LESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSS  799 (912)
Q Consensus       720 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  799 (912)
                      +++++|.+++..... ..+++..++.++.|++.||+|||++   +++|+||+|+||+++.++.+||+|||++........
T Consensus        77 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~  152 (257)
T cd05040          77 APLGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED  152 (257)
T ss_pred             cCCCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccccccccc
Confidence            999999999965433 5689999999999999999999999   999999999999999999999999999987654322


Q ss_pred             Cc---cccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhc--cCCCCCCChhh
Q 039137          800 NW---SELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEML--DSRLPYPSLHV  873 (912)
Q Consensus       800 ~~---~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  873 (912)
                      ..   ....++..|+|||++.+..++.++||||||+++|||++ |+.||+.....     .......  ....+.+    
T Consensus       153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~----  223 (257)
T cd05040         153 HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS-----QILKKIDKEGERLERP----  223 (257)
T ss_pred             ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHHhcCCcCCCC----
Confidence            21   12446788999999998889999999999999999998 99998522111     0000010  1111111    


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 039137          874 QKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCE  907 (912)
Q Consensus       874 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  907 (912)
                      ...+..+.+++.+||+.+|++||++.++++.|.+
T Consensus       224 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  257 (257)
T cd05040         224 EACPQDIYNVMLQCWAHNPADRPTFAALREFLPE  257 (257)
T ss_pred             ccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhcC
Confidence            1234568899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=9.2e-35  Score=312.35  Aligned_cols=247  Identities=28%  Similarity=0.410  Sum_probs=200.3

Q ss_pred             CCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEE
Q 039137          639 DFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIY  717 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  717 (912)
                      .|+..+.||+|+||.||+|.+. +++.||+|.+.....   ....+.+.+|+++++.++||||+++++++..++..++||
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA---EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc---hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence            4667788999999999999865 678899998764322   124567889999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCC
Q 039137          718 EYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPD  797 (912)
Q Consensus       718 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  797 (912)
                      ||+++++|.+++..    ..+++..+..++.|++.|++|||++   +++|+||+|+||++++++.++++|||++......
T Consensus        82 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06642          82 EYLGGGSALDLLKP----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT  154 (277)
T ss_pred             EccCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCc
Confidence            99999999998842    4588999999999999999999999   9999999999999999999999999999866543


Q ss_pred             CCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHH
Q 039137          798 SSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKL  877 (912)
Q Consensus       798 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  877 (912)
                      ........++..|+|||++.+..++.++||||||+++|||++|+.||.......     ..........+.   .....+
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-----~~~~~~~~~~~~---~~~~~~  226 (277)
T cd06642         155 QIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR-----VLFLIPKNSPPT---LEGQYS  226 (277)
T ss_pred             chhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh-----HHhhhhcCCCCC---CCcccC
Confidence            333334567889999999998889999999999999999999999975221110     000111111111   112234


Q ss_pred             HHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          878 MSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       878 ~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ..+.+++.+||+.+|++||++.++++
T Consensus       227 ~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         227 KPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             HHHHHHHHHHccCCcccCcCHHHHHH
Confidence            56889999999999999999999987

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.6e-34  Score=306.76  Aligned_cols=251  Identities=23%  Similarity=0.369  Sum_probs=203.9

Q ss_pred             CCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEE
Q 039137          639 DFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIY  717 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  717 (912)
                      +|++.+.||+|+||.||.++.. +++.||+|.+......  ....+++.+|+.+++.++||||+++++++...+..++||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS--PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVM   78 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC--hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEE
Confidence            5888999999999999999865 7889999998653222  124567889999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCC
Q 039137          718 EYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPD  797 (912)
Q Consensus       718 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  797 (912)
                      ||+++++|.+++.... ...+++.+++.++.|++.|++|||++   +++|+||+|+||+++.++.++++|||.+......
T Consensus        79 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~  154 (256)
T cd08218          79 DYCEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST  154 (256)
T ss_pred             ecCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence            9999999999885432 23578999999999999999999999   9999999999999999999999999999876544


Q ss_pred             CCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHH
Q 039137          798 SSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKL  877 (912)
Q Consensus       798 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  877 (912)
                      ........+++.|+|||+..+..++.++||||||+++|+|++|+.||...     ..............+..   ....+
T Consensus       155 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~-----~~~~~~~~~~~~~~~~~---~~~~~  226 (256)
T cd08218         155 VELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG-----NMKNLVLKIIRGSYPPV---SSHYS  226 (256)
T ss_pred             hhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC-----CHHHHHHHHhcCCCCCC---cccCC
Confidence            33333456788999999999888999999999999999999999997521     11111112222222111   12234


Q ss_pred             HHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          878 MSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       878 ~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .++.+++.+||+.+|++||+++++++
T Consensus       227 ~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         227 YDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             HHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            56889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.5e-34  Score=311.69  Aligned_cols=259  Identities=25%  Similarity=0.398  Sum_probs=202.6

Q ss_pred             cHHHHHHHhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEE
Q 039137          629 VYEEIISATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGF  706 (912)
Q Consensus       629 ~~~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~  706 (912)
                      ...+.....+.|++.+.||+|+||.||+|++. +++.||+|.+....     ....++..|+.+++++ +|+||++++++
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~   81 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-----DEEEEIKLEINMLKKYSHHRNIATYYGA   81 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-----HHHHHHHHHHHHHHHhcCCCcEEEEeee
Confidence            34444556688999999999999999999875 68899999875431     1345678899999998 69999999999


Q ss_pred             EEc------CCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCC
Q 039137          707 CSH------PKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLG  780 (912)
Q Consensus       707 ~~~------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~  780 (912)
                      +..      .+..+++|||+++|+|.+++.... ...+++..+..++.|++.|++|||++   +|+|+||+|+||+++++
T Consensus        82 ~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~  157 (282)
T cd06636          82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTEN  157 (282)
T ss_pred             hhcccccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCC
Confidence            853      457899999999999999985433 34578888999999999999999999   99999999999999999


Q ss_pred             CcEEEeccccccccCCCCCCccccccccccccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccc
Q 039137          781 YEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAY-----TLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSS  855 (912)
Q Consensus       781 ~~~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~  855 (912)
                      +.++|+|||++..............+++.|+|||++.     +..++.++|||||||++|||++|..||.......    
T Consensus       158 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~----  233 (282)
T cd06636         158 AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR----  233 (282)
T ss_pred             CCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh----
Confidence            9999999999886543333344567899999999875     3457889999999999999999999985221110    


Q ss_pred             cchhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          856 NMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       856 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                       .......  ...+.......+..+.+++.+||+.||.+|||+.|+++
T Consensus       234 -~~~~~~~--~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         234 -ALFLIPR--NPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             -hhhhHhh--CCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence             0001111  11111112234567889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.4e-34  Score=321.54  Aligned_cols=256  Identities=20%  Similarity=0.276  Sum_probs=196.2

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC----
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP----  710 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~----  710 (912)
                      ..++|++.+.||+|+||.||+|... .++.||||++.......  .....+.+|+.+++.++||||+++++++...    
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~   99 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ--THAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE   99 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCc--hhHHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence            4578999999999999999999865 68899999987544322  2456778999999999999999999987543    


Q ss_pred             --CeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecc
Q 039137          711 --KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDF  788 (912)
Q Consensus       711 --~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df  788 (912)
                        ...|+||||+++ ++.+++.     ..+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+||
T Consensus       100 ~~~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df  170 (364)
T cd07875         100 EFQDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF  170 (364)
T ss_pred             ccCeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeC
Confidence              357999999976 6766662     2478899999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhcccccc--------------
Q 039137          789 GIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS--------------  854 (912)
Q Consensus       789 gla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~--------------  854 (912)
                      |+++..... .......+++.|+|||++.+..++.++|||||||++|||++|+.||..........              
T Consensus       171 G~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  249 (364)
T cd07875         171 GLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM  249 (364)
T ss_pred             CCccccCCC-CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            999865432 22334578999999999999999999999999999999999999985321100000              


Q ss_pred             ---ccchhhhccCCCC--------------C--CChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          855 ---SNMNIEMLDSRLP--------------Y--PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       855 ---~~~~~~~~~~~~~--------------~--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                         ..........+..              .  ...........+.+++.+|++.||.+|||+.|+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~  317 (364)
T cd07875         250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  317 (364)
T ss_pred             HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence               0000000000000              0  00001112345789999999999999999999876

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.3e-34  Score=309.03  Aligned_cols=254  Identities=26%  Similarity=0.374  Sum_probs=203.8

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ++|+..+.||+|++|.||+|.++ +++.||+|.+......   ...+++.+|++.++.++||||+++++++...+..+++
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   77 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE---AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISIC   77 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh---HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEE
Confidence            36788899999999999999876 6899999998754322   3567788999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHN-NCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      +||+++++|.+++....  ..+++..+.+++.|++.|++|+|+ .   +++|+||+|+||++++++.++|+|||.+....
T Consensus        78 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~  152 (265)
T cd06605          78 MEYMDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV  152 (265)
T ss_pred             EEecCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence            99999999999995432  568899999999999999999999 7   99999999999999999999999999987654


Q ss_pred             CCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHH
Q 039137          796 PDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQK  875 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  875 (912)
                      ....  ....++..|+|||++.+..++.++||||+|+++|+|++|+.||......................+..  ....
T Consensus       153 ~~~~--~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  228 (265)
T cd06605         153 NSLA--KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRL--PSGK  228 (265)
T ss_pred             HHHh--hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCC--Chhh
Confidence            3221  12668889999999999899999999999999999999999985321100100111111111111111  1111


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          876 KLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       876 ~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .+..+.++|.+||..||++|||+.++++
T Consensus       229 ~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         229 FSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             cCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            4566889999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.8e-34  Score=306.47  Aligned_cols=256  Identities=25%  Similarity=0.415  Sum_probs=203.8

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCC----EEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCC
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGE----IFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPK  711 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~  711 (912)
                      ..+|++.+.||+|+||.||+|..+ +|+    .||+|.......   .....++.+|++.++.++||||+++++++.. .
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~   81 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS---PKANKEILDEAYVMASVDHPHVVRLLGICLS-S   81 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence            357899999999999999999864 333    589998764432   2245778899999999999999999999987 7


Q ss_pred             eeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccc
Q 039137          712 HSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIA  791 (912)
Q Consensus       712 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla  791 (912)
                      ..++||||+++|+|.+++...  ...+++..+..++.|++.|++|||++   +++||||||+||+++.++.+||+|||.+
T Consensus        82 ~~~~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~  156 (279)
T cd05057          82 QVQLITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLA  156 (279)
T ss_pred             ceEEEEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccc
Confidence            889999999999999998543  23589999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCCCCCCcc--ccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccC-CCC
Q 039137          792 KFLNPDSSNWS--ELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDS-RLP  867 (912)
Q Consensus       792 ~~~~~~~~~~~--~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~  867 (912)
                      +..........  ...++..|+|||.+....++.++||||||+++||+++ |+.||+....     .......... ..+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~~~~~~~~~~~~~  231 (279)
T cd05057         157 KLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA-----VEIPDLLEKGERLP  231 (279)
T ss_pred             ccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH-----HHHHHHHhCCCCCC
Confidence            87654332221  1223568999999988889999999999999999998 9999863211     1111111111 112


Q ss_pred             CCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          868 YPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       868 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                      .+.    .....+.+++.+||..||.+||++.++++.|++...
T Consensus       232 ~~~----~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         232 QPP----ICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             CCC----CCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            221    123457889999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2.3e-34  Score=305.50  Aligned_cols=250  Identities=26%  Similarity=0.445  Sum_probs=200.8

Q ss_pred             cCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIY  717 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  717 (912)
                      .+|++.+.||+|+||.||+|.+.+++.+|+|++.....     ....+.+|++++++++||+++++++++......++||
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   78 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-----SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF   78 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-----CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence            46888999999999999999887788999999864322     2456889999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCC
Q 039137          718 EYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPD  797 (912)
Q Consensus       718 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  797 (912)
                      ||+++++|.+++....  ..++++.++.++.|++.|++|||+.   +++|+||||+||+++.++.++|+|||.+......
T Consensus        79 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  153 (256)
T cd05112          79 EFMEHGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD  153 (256)
T ss_pred             EcCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccC
Confidence            9999999999985432  4578999999999999999999999   9999999999999999999999999998765432


Q ss_pred             CCC-ccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccC-CCCCCChhhH
Q 039137          798 SSN-WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDS-RLPYPSLHVQ  874 (912)
Q Consensus       798 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  874 (912)
                      ... .....++.+|+|||++.+..++.++||||+|+++|||++ |..||.....     .......... +...+.    
T Consensus       154 ~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~----  224 (256)
T cd05112         154 QYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-----SEVVETINAGFRLYKPR----  224 (256)
T ss_pred             cccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH-----HHHHHHHhCCCCCCCCC----
Confidence            211 112234678999999988889999999999999999998 9999852111     0011111111 111111    


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 039137          875 KKLMSIMQVAFSCLDQNPESRPTMKRVSQLLC  906 (912)
Q Consensus       875 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  906 (912)
                      ..+..+.+++.+||+.+|++|||+.|+++.|.
T Consensus       225 ~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         225 LASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             CCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence            12356889999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=6.1e-34  Score=307.21  Aligned_cols=260  Identities=25%  Similarity=0.400  Sum_probs=198.9

Q ss_pred             cCCCCCceeeecCceEEEEEEe-----CCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC--
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKV-----PSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP--  710 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--  710 (912)
                      .+|++.+.||+|+||.||+|..     .+++.||+|++....    ....+.+.+|+++++.++||||+++++++...  
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   79 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST----AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR   79 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC----HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence            4788999999999999999974     257899999986432    22456788999999999999999999987543  


Q ss_pred             CeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccc
Q 039137          711 KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGI  790 (912)
Q Consensus       711 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl  790 (912)
                      ...++||||+++++|.+++...  ...+++..++.++.|++.||+|||++   +|+||||||+||++++++.+||+|||+
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~  154 (284)
T cd05081          80 RNLRLVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGL  154 (284)
T ss_pred             CceEEEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcc
Confidence            4688999999999999998543  24588999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCc---cccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhcc-----ccccc--cc---
Q 039137          791 AKFLNPDSSNW---SELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEM-----SSSSS--NM---  857 (912)
Q Consensus       791 a~~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~-----~~~~~--~~---  857 (912)
                      +..........   ....++..|+|||+..+..++.++||||||+++|||++|..|+......     .....  ..   
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd05081         155 TKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYH  234 (284)
T ss_pred             cccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHH
Confidence            98764432211   1122345699999998888999999999999999999987765321110     00000  00   


Q ss_pred             hhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 039137          858 NIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEK  908 (912)
Q Consensus       858 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  908 (912)
                      ..+........+.  ....+..+.+++.+||+.+|++|||+.|+++.|+..
T Consensus       235 ~~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         235 LIELLKNNGRLPA--PPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHHHhcCCcCCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            0011111111110  112345688999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=3e-34  Score=305.22  Aligned_cols=253  Identities=23%  Similarity=0.433  Sum_probs=203.2

Q ss_pred             hcCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      .++|++.+.||+|+||.||+|...++..+|+|.+...     ....+.+.+|+++++.++|+||+++++++.. ...+++
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v   78 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYII   78 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEE
Confidence            4679999999999999999999877888999987642     1135678899999999999999999999987 778999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++++|.+++... ....+++.++..++.|++.|++|||+.   +++|+||+|+||+++.++.++++|||.+.....
T Consensus        79 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  154 (260)
T cd05073          79 TEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED  154 (260)
T ss_pred             EEeCCCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence            9999999999999553 234678899999999999999999999   999999999999999999999999999976543


Q ss_pred             CCCC-ccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccCCCCCCChhhH
Q 039137          797 DSSN-WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQ  874 (912)
Q Consensus       797 ~~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  874 (912)
                      .... .....++..|+|||++.+..++.++||||||+++|++++ |+.||.....     ... ..........+.  ..
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~-----~~~-~~~~~~~~~~~~--~~  226 (260)
T cd05073         155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-----PEV-IRALERGYRMPR--PE  226 (260)
T ss_pred             CCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH-----HHH-HHHHhCCCCCCC--cc
Confidence            2211 122345677999999988889999999999999999999 8999752111     001 111111111111  12


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 039137          875 KKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCE  907 (912)
Q Consensus       875 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  907 (912)
                      ..+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus       227 ~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         227 NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             cCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            334568899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.8e-34  Score=318.60  Aligned_cols=258  Identities=22%  Similarity=0.371  Sum_probs=202.9

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC--------CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP--------SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFC  707 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~  707 (912)
                      ..+|++.+.||+|+||.||+|+..        .+..||+|.+.....   ....+++.+|+++++++ +||||+++++++
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDAT---DKDLSDLVSEMEMMKMIGKHKNIINLLGAC   87 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccC---HHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence            357899999999999999999742        123689998764321   22456789999999999 799999999999


Q ss_pred             EcCCeeeEEEeecCCCChhhHhhccC-------------CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCC
Q 039137          708 SHPKHSFIIYEYLESGSLDKILCNDA-------------SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKN  774 (912)
Q Consensus       708 ~~~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N  774 (912)
                      ...+..+++|||+++|+|.+++....             ....+++.++..++.|++.|++|||++   +++||||||+|
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N  164 (334)
T cd05100          88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARN  164 (334)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccce
Confidence            99999999999999999999986532             223588899999999999999999999   99999999999


Q ss_pred             eEEcCCCcEEEeccccccccCCCCCCc--cccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccc
Q 039137          775 VLLDLGYEAHVSDFGIAKFLNPDSSNW--SELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMS  851 (912)
Q Consensus       775 ill~~~~~~kl~Dfgla~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~  851 (912)
                      |+++.++.+||+|||+++.........  ....++..|+|||++.+..++.++||||||+++|||++ |..||.....  
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--  242 (334)
T cd05100         165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV--  242 (334)
T ss_pred             EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH--
Confidence            999999999999999998654322111  12233567999999999889999999999999999998 8888752110  


Q ss_pred             cccccchhhhccCC-CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 039137          852 SSSSNMNIEMLDSR-LPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI  909 (912)
Q Consensus       852 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l  909 (912)
                         ........... ...+    ...+..+.+++.+||+.+|++|||+.|+++.|++.+
T Consensus       243 ---~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~  294 (334)
T cd05100         243 ---EELFKLLKEGHRMDKP----ANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL  294 (334)
T ss_pred             ---HHHHHHHHcCCCCCCC----CCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence               11111111111 1111    123346889999999999999999999999998876

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.5e-34  Score=315.48  Aligned_cols=193  Identities=23%  Similarity=0.381  Sum_probs=159.4

Q ss_pred             CceeeecCceEEEEEEeC---CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEc--CCeeeEEE
Q 039137          643 EHCIGKGGHGSVYRAKVP---SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSH--PKHSFIIY  717 (912)
Q Consensus       643 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~~lv~  717 (912)
                      +++||+|+||+||+|+.+   +++.||+|.+....      ....+.+|+.++++++||||+++++++..  ....++||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~   79 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG------ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF   79 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC------CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEE
Confidence            468999999999999864   56789999986432      12446789999999999999999999854  45689999


Q ss_pred             eecCCCChhhHhhccC------CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEE----cCCCcEEEec
Q 039137          718 EYLESGSLDKILCNDA------SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLL----DLGYEAHVSD  787 (912)
Q Consensus       718 e~~~~g~L~~~l~~~~------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill----~~~~~~kl~D  787 (912)
                      ||+++ ++.+++....      ....+++..+..++.|++.||+|||++   +|+||||||+||++    +.++.+||+|
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~D  155 (317)
T cd07868          80 DYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIAD  155 (317)
T ss_pred             eccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEee
Confidence            99865 8877764321      123588999999999999999999999   99999999999999    4567899999


Q ss_pred             cccccccCCCCC---CccccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCcc
Q 039137          788 FGIAKFLNPDSS---NWSELAGTHGYVAPELAYTL-KVTEKCDVYSFGVLALEVIKGKHPRD  845 (912)
Q Consensus       788 fgla~~~~~~~~---~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~pf~  845 (912)
                      ||+++.......   ......+|+.|+|||++.+. .++.++||||+||++|||++|++||.
T Consensus       156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~  217 (317)
T cd07868         156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH  217 (317)
T ss_pred             cCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCcc
Confidence            999987643321   22346789999999998764 58899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.7e-34  Score=314.67  Aligned_cols=260  Identities=23%  Similarity=0.288  Sum_probs=204.8

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ++|++.+.||+|+||.||+|... +++.||+|.+...... .....+.+.+|+++++.++||||+++++++..++..++|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   79 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLI-LRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMV   79 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhh-hHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEE
Confidence            46889999999999999999876 6789999988644221 112345788999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++++|.+++..   .+.+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++++|||+++....
T Consensus        80 ~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~  153 (305)
T cd05609          80 MEYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM  153 (305)
T ss_pred             EecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence            999999999999944   34688999999999999999999999   999999999999999999999999999864211


Q ss_pred             CCC---------------CccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhh
Q 039137          797 DSS---------------NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEM  861 (912)
Q Consensus       797 ~~~---------------~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~  861 (912)
                      ...               ......++..|+|||++.+..++.++||||||+++|||++|..||....     ........
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~-----~~~~~~~~  228 (305)
T cd05609         154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT-----PEELFGQV  228 (305)
T ss_pred             CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHH
Confidence            100               0112356788999999988889999999999999999999999985211     11111122


Q ss_pred             ccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          862 LDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       862 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                      .......+... ...+..+.+++.+||+.||++||++.++.+.++..++
T Consensus       229 ~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~  276 (305)
T cd05609         229 ISDDIEWPEGD-EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFF  276 (305)
T ss_pred             HhcccCCCCcc-ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccc
Confidence            22222222111 1344568899999999999999998888888777654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-36  Score=318.94  Aligned_cols=251  Identities=26%  Similarity=0.388  Sum_probs=203.9

Q ss_pred             cCCCCCceeeecCceEEEEEEeCCCCE-EEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVPSGEI-FAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~-vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      +-|.++..||.|+||.||+|..++... .|.|++..    ......+.++-||+++...+||+||++++.|...+..|+.
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet----kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwil  107 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET----KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWIL  107 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc----cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEE
Confidence            446778899999999999998775444 45565532    2233678899999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      .|||+||-.+.++-.  -...+++.++..+++|++.||.|||++   +|+|||||+.|||++-+|.++|+|||.+.....
T Consensus       108 iEFC~GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~  182 (1187)
T KOG0579|consen  108 IEFCGGGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS  182 (1187)
T ss_pred             EeecCCchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh
Confidence            999999999998844  346799999999999999999999999   999999999999999999999999999876554


Q ss_pred             CCCCcccccccccccccccc-----ccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCCh
Q 039137          797 DSSNWSELAGTHGYVAPELA-----YTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSL  871 (912)
Q Consensus       797 ~~~~~~~~~g~~~y~aPE~~-----~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  871 (912)
                      .......+.|||.|||||+.     ...+|+.++||||||+++.||..+.+|-+....+..     ... +...-|..-.
T Consensus       183 t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRV-----llK-iaKSePPTLl  256 (1187)
T KOG0579|consen  183 TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-----LLK-IAKSEPPTLL  256 (1187)
T ss_pred             HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHH-----HHH-HhhcCCCccc
Confidence            44556678999999999975     467899999999999999999999999542222111     111 1111122222


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          872 HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       872 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      +...+...+.+++.+|+.+||..||+++++++
T Consensus       257 qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  257 QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            34556677999999999999999999999875

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=3.8e-34  Score=304.92  Aligned_cols=251  Identities=25%  Similarity=0.391  Sum_probs=192.4

Q ss_pred             ceeeecCceEEEEEEeC----CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEE-cCCeeeEEEe
Q 039137          644 HCIGKGGHGSVYRAKVP----SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCS-HPKHSFIIYE  718 (912)
Q Consensus       644 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~-~~~~~~lv~e  718 (912)
                      +.||+|+||.||+|.+.    ++..||+|++....   .....+.+.+|+.+++.++||||+++++++. .++..++|||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e   77 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT---DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLP   77 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccC---CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEe
Confidence            46899999999999753    24579999875321   1224567889999999999999999999875 4556899999


Q ss_pred             ecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCC
Q 039137          719 YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS  798 (912)
Q Consensus       719 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  798 (912)
                      |+.+|+|.+++...  ....++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||+++......
T Consensus        78 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~  152 (262)
T cd05058          78 YMKHGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE  152 (262)
T ss_pred             cCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence            99999999998543  23467788899999999999999999   99999999999999999999999999997554321


Q ss_pred             C----CccccccccccccccccccCCCCcchhHHHHHHHHHHHHhC-CCCccchhccccccccchhhhccCCCCCCChhh
Q 039137          799 S----NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKG-KHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHV  873 (912)
Q Consensus       799 ~----~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  873 (912)
                      .    ......++..|+|||++.+..++.++||||||+++|||++| .+||.....     ............+...   
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~---  224 (262)
T cd05058         153 YYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS-----FDITVYLLQGRRLLQP---  224 (262)
T ss_pred             ceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHHhcCCCCCCC---
Confidence            1    11223456789999999888899999999999999999995 555531110     1111111111111111   


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          874 QKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       874 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                      ...+..+.+++.+||+.+|++||++.|+++.|++.+.
T Consensus       225 ~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         225 EYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence            1223568899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.5e-34  Score=306.02  Aligned_cols=239  Identities=21%  Similarity=0.347  Sum_probs=186.3

Q ss_pred             ceeeecCceEEEEEEeCC-------------CCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC
Q 039137          644 HCIGKGGHGSVYRAKVPS-------------GEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP  710 (912)
Q Consensus       644 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~  710 (912)
                      +.||+|+||.||+|+...             ...|++|.+....    ......+.+|+.+++.++||||+++++++...
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~   76 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH----RDISLAFFETASMMRQVSHKHIVLLYGVCVRD   76 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh----hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            368999999999997532             2258888865432    22455788899999999999999999999999


Q ss_pred             CeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCc-------E
Q 039137          711 KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYE-------A  783 (912)
Q Consensus       711 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~-------~  783 (912)
                      ...++||||+++|+|..++...  ...+++..+++++.||+.|++|||++   +|+||||||+||+++.++.       +
T Consensus        77 ~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~  151 (262)
T cd05077          77 VENIMVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFI  151 (262)
T ss_pred             CCCEEEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCcee
Confidence            9999999999999999988542  24589999999999999999999999   9999999999999987664       8


Q ss_pred             EEeccccccccCCCCCCccccccccccccccccc-cCCCCcchhHHHHHHHHHHHH-hCCCCccchhccccccccchhhh
Q 039137          784 HVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAY-TLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEM  861 (912)
Q Consensus       784 kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~sDvwslG~vl~ell-tg~~pf~~~~~~~~~~~~~~~~~  861 (912)
                      +++|||++......    ....++..|+|||.+. +..++.++|||||||++|||+ +|..||.....      ......
T Consensus       152 ~l~d~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~~~~~~  221 (262)
T cd05077         152 KLSDPGIPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL------AEKERF  221 (262)
T ss_pred             EeCCCCCCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch------hHHHHH
Confidence            99999998755322    2345788899999886 456899999999999999998 58888642110      000111


Q ss_pred             ccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 039137          862 LDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL  905 (912)
Q Consensus       862 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  905 (912)
                      .........    .....+.+++.+||+.||++||++.++++.+
T Consensus       222 ~~~~~~~~~----~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         222 YEGQCMLVT----PSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             HhcCccCCC----CChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            111111111    1234578999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3.5e-34  Score=306.66  Aligned_cols=256  Identities=26%  Similarity=0.396  Sum_probs=202.3

Q ss_pred             cCCCCCceeeecCceEEEEEEeCC----CCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCee
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVPS----GEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHS  713 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  713 (912)
                      ++|++.+.||+|+||.||+|.+.+    ...||+|.......   ....+.+.+|+.+++.++||||+++++++.. +..
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~   81 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS---PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV   81 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC---HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence            568889999999999999998643    24689998764432   2256688999999999999999999999875 567


Q ss_pred             eEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccc
Q 039137          714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKF  793 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  793 (912)
                      ++||||+++|+|.+++....  ..+++.+++.++.|++.|++|||+.   +++|+||||+||+++.++.++++|||++..
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~  156 (270)
T cd05056          82 WIVMELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRY  156 (270)
T ss_pred             EEEEEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeee
Confidence            89999999999999995432  3589999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCCC-ccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhcc-CCCCCCC
Q 039137          794 LNPDSSN-WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLD-SRLPYPS  870 (912)
Q Consensus       794 ~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~  870 (912)
                      ....... .....+++.|+|||.+.+..++.++||||||+++||+++ |..||......     ........ ...+.+ 
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~-  230 (270)
T cd05056         157 LEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN-----DVIGRIENGERLPMP-  230 (270)
T ss_pred             cccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH-----HHHHHHHcCCcCCCC-
Confidence            5443211 112234568999999988889999999999999999996 99998532211     11111111 111222 


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 039137          871 LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE  911 (912)
Q Consensus       871 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~~  911 (912)
                         ...+..+.+++.+|+..+|++|||+.++++.|++...+
T Consensus       231 ---~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         231 ---PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             ---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence               12345688999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=3.7e-34  Score=309.76  Aligned_cols=247  Identities=26%  Similarity=0.344  Sum_probs=202.0

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ++|++.+.||+|++|.||+|.+. +++.||+|++....... ....+.+.+|++++++++||||+++++++..++..++|
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   79 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVK-LKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLV   79 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEE
Confidence            46889999999999999999876 68999999986432211 12456788999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++++|.+++...   ..+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.+||+|||++.....
T Consensus        80 ~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  153 (290)
T cd05580          80 MEYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG  153 (290)
T ss_pred             EecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence            9999999999998443   5688999999999999999999999   999999999999999999999999999987644


Q ss_pred             CCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHH
Q 039137          797 DSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKK  876 (912)
Q Consensus       797 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  876 (912)
                      .   .....+++.|+|||.+.+...+.++||||||+++|+|++|+.||....     .............+.+.    ..
T Consensus       154 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~----~~  221 (290)
T cd05580         154 R---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN-----PIQIYEKILEGKVRFPS----FF  221 (290)
T ss_pred             C---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHhcCCccCCc----cC
Confidence            3   234568899999999988888999999999999999999999985221     11111222223333332    12


Q ss_pred             HHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 039137          877 LMSIMQVAFSCLDQNPESRP-----TMKRVSQ  903 (912)
Q Consensus       877 ~~~l~~li~~cl~~dP~~RP-----t~~evl~  903 (912)
                      +..+.+++.+||+.||.+||     +++|+++
T Consensus       222 ~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         222 SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             CHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence            45678999999999999999     6776653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=7.7e-34  Score=303.25  Aligned_cols=252  Identities=24%  Similarity=0.351  Sum_probs=195.8

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCC-chHHHHHHHHHHHHHhhcCCCccccEEEEEEc--CCee
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGE-MSFQQEEFLNEIQALTEIRHRNIVKFYGFCSH--PKHS  713 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~  713 (912)
                      .+|+..+.||+|+||.||+|... +++.||+|++....... .....+.+.+|+++++.++||||+++++++..  .+..
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            36889999999999999999875 68899999886543222 22245678899999999999999999999865  3678


Q ss_pred             eEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccc
Q 039137          714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKF  793 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  793 (912)
                      +++|||+++++|.+++...   ..+++..++.++.|++.|++|||+.   +|+||||+|+||+++.++.++|+|||++..
T Consensus        82 ~l~~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAY---GALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            8999999999999998432   3578899999999999999999999   999999999999999999999999999976


Q ss_pred             cCCCC---CCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCC
Q 039137          794 LNPDS---SNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPS  870 (912)
Q Consensus       794 ~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  870 (912)
                      .....   .......++..|+|||++.+..++.++||||+||++|||++|+.||......     ....... .....+ 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~-----~~~~~~~-~~~~~~-  228 (266)
T cd06651         156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM-----AAIFKIA-TQPTNP-  228 (266)
T ss_pred             cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH-----HHHHHHh-cCCCCC-
Confidence            53321   1223345788999999999888999999999999999999999998622110     0001110 000001 


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          871 LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       871 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .........+.+++ +||..+|++||+++|+++
T Consensus       229 ~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         229 QLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            11122334566666 688899999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.3e-34  Score=310.47  Aligned_cols=256  Identities=27%  Similarity=0.393  Sum_probs=202.9

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      .++|++.+.||+|+||+||+|... +++.||+|++.....   ....+.+.+|+++++.++||||+++++++...+..++
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK---SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM   80 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc---chHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence            357888999999999999999875 688999998764322   2246778999999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ||||+++++|.+++..   .+.+++..+..++.+++.|+.|||+..  +++||||+|+||++++++.++|+|||++....
T Consensus        81 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~  155 (284)
T cd06620          81 CMEFMDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELI  155 (284)
T ss_pred             EEecCCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence            9999999999998844   346899999999999999999999732  89999999999999999999999999987543


Q ss_pred             CCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhcccccc------ccchhhhccCCCCCC
Q 039137          796 PDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS------SNMNIEMLDSRLPYP  869 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~------~~~~~~~~~~~~~~~  869 (912)
                      ...  .....++..|+|||++.+..++.++|||||||++|++++|+.||+.........      ............+. 
T Consensus       156 ~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  232 (284)
T cd06620         156 NSI--ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPR-  232 (284)
T ss_pred             hhc--cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCC-
Confidence            221  224568899999999988889999999999999999999999986332210000      00111111111111 


Q ss_pred             ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 039137          870 SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQL  904 (912)
Q Consensus       870 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  904 (912)
                       ......+..+.+++.+||+.||++|||+.|+++.
T Consensus       233 -~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~  266 (284)
T cd06620         233 -LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM  266 (284)
T ss_pred             -CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence             1111244568899999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.5e-34  Score=312.70  Aligned_cols=248  Identities=27%  Similarity=0.385  Sum_probs=198.1

Q ss_pred             CCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEEe
Q 039137          640 FNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYE  718 (912)
Q Consensus       640 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e  718 (912)
                      |.....||+|+||.||++... +++.||+|++....    ....+.+.+|+..++.++||||+++++.+..++..++|||
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e   99 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK----QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME   99 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch----HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence            344567999999999999865 68899999975422    2245678899999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCC
Q 039137          719 YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS  798 (912)
Q Consensus       719 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  798 (912)
                      |+++++|.+++..    +.+++.++..++.|++.|++|||++   +|+||||||+||++++++.++|+|||++.......
T Consensus       100 ~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~  172 (292)
T cd06658         100 FLEGGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV  172 (292)
T ss_pred             CCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccc
Confidence            9999999998832    3588999999999999999999999   99999999999999999999999999997654433


Q ss_pred             CCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHHH
Q 039137          799 SNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLM  878 (912)
Q Consensus       799 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  878 (912)
                      .......+++.|+|||...+..++.++||||+|+++|||++|+.||.......     .... .....+.........+.
T Consensus       173 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-----~~~~-~~~~~~~~~~~~~~~~~  246 (292)
T cd06658         173 PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ-----AMRR-IRDNLPPRVKDSHKVSS  246 (292)
T ss_pred             ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHH-HHhcCCCccccccccCH
Confidence            33344568899999999988889999999999999999999999985211110     0001 11111111111122344


Q ss_pred             HHHHHHHHcccCCCCCCCCHHHHHHH
Q 039137          879 SIMQVAFSCLDQNPESRPTMKRVSQL  904 (912)
Q Consensus       879 ~l~~li~~cl~~dP~~RPt~~evl~~  904 (912)
                      .+.+++.+||..||.+|||++|+++.
T Consensus       247 ~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         247 VLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhhC
Confidence            67889999999999999999998863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-34  Score=307.53  Aligned_cols=254  Identities=26%  Similarity=0.411  Sum_probs=201.8

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEEcCC--
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSHPK--  711 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~--  711 (912)
                      ++++|++.+.||+|++|.||+|+.+ +++.|++|++.....     ..+.+.+|+++++++ +|+||+++++++....  
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   78 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPP   78 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCC
Confidence            5688999999999999999999875 678899999864321     356788999999999 6999999999997644  


Q ss_pred             ----eeeEEEeecCCCChhhHhhccC-CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEe
Q 039137          712 ----HSFIIYEYLESGSLDKILCNDA-SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVS  786 (912)
Q Consensus       712 ----~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  786 (912)
                          ..++||||+++++|.+++.... ....+++..+..++.|++.|++|||++   +++|+||+|+||++++++.++++
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~  155 (275)
T cd06608          79 GNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLV  155 (275)
T ss_pred             CcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEEC
Confidence                4899999999999999985432 245689999999999999999999999   99999999999999999999999


Q ss_pred             ccccccccCCCCCCcccccccccccccccccc-----CCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhh
Q 039137          787 DFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-----LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEM  861 (912)
Q Consensus       787 Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~  861 (912)
                      |||.+..............+++.|+|||++..     ..++.++||||+|+++|+|++|+.||......     ......
T Consensus       156 d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~  230 (275)
T cd06608         156 DFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-----RALFKI  230 (275)
T ss_pred             CCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-----HHHHHh
Confidence            99999876544444445678899999998753     34678999999999999999999998522111     111111


Q ss_pred             ccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          862 LDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       862 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .....+ ........+..+.+++.+||..||++|||+.|+++
T Consensus       231 ~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         231 PRNPPP-TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             hccCCC-CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            111111 11111224557889999999999999999999875

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=9.9e-35  Score=319.87  Aligned_cols=254  Identities=22%  Similarity=0.295  Sum_probs=196.7

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ++|++.+.||+|+||+||+++.+ +++.||+|++...... .......+.+|+.++..++|++|+++++++..++..|+|
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv   79 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEML-KRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLV   79 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHH-hhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence            47999999999999999999876 6888999998642111 111345578899999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++|+|.+++...  ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++.....
T Consensus        80 ~Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  154 (331)
T cd05624          80 MDYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ  154 (331)
T ss_pred             EeCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence            9999999999999542  24688999999999999999999999   999999999999999999999999999986654


Q ss_pred             CCCC-cccccccccccccccccc-----CCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhcc--CCCCC
Q 039137          797 DSSN-WSELAGTHGYVAPELAYT-----LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLD--SRLPY  868 (912)
Q Consensus       797 ~~~~-~~~~~g~~~y~aPE~~~~-----~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~--~~~~~  868 (912)
                      .... .....|++.|+|||++.+     ..++.++||||+||++|||++|+.||.....     .........  .+.+.
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-----~~~~~~i~~~~~~~~~  229 (331)
T cd05624         155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL-----VETYGKIMNHEERFQF  229 (331)
T ss_pred             CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH-----HHHHHHHHcCCCcccC
Confidence            3222 233568999999998875     4578899999999999999999999852111     011111111  11222


Q ss_pred             CChhhHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 039137          869 PSLHVQKKLMSIMQVAFSCLDQNPES--RPTMKRVSQ  903 (912)
Q Consensus       869 ~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~  903 (912)
                      +. .....+..+.+++.+|+..++++  |++++++++
T Consensus       230 p~-~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~  265 (331)
T cd05624         230 PS-HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK  265 (331)
T ss_pred             CC-ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence            21 11223566888999999866544  457776654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2e-35  Score=319.62  Aligned_cols=248  Identities=23%  Similarity=0.375  Sum_probs=194.0

Q ss_pred             CCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCe--eeEEEe
Q 039137          642 AEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKH--SFIIYE  718 (912)
Q Consensus       642 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~--~~lv~e  718 (912)
                      ...+||+|+|-+||+|.+. +|-.||=-.++.......+...++|..|+.+++.|+||||++++.+|.+...  ..+|+|
T Consensus        44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE  123 (632)
T KOG0584|consen   44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE  123 (632)
T ss_pred             hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence            3468999999999999874 4555552222111122333356889999999999999999999999987654  789999


Q ss_pred             ecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEc-CCCcEEEeccccccccCCC
Q 039137          719 YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLD-LGYEAHVSDFGIAKFLNPD  797 (912)
Q Consensus       719 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~Dfgla~~~~~~  797 (912)
                      .|..|+|..|+++   .++++...+..|++||++||.|||++ .|+|+|||||-+|||++ ..|.|||+|.|+|..... 
T Consensus       124 L~TSGtLr~Y~kk---~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~-  198 (632)
T KOG0584|consen  124 LFTSGTLREYRKK---HRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK-  198 (632)
T ss_pred             cccCCcHHHHHHH---hccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc-
Confidence            9999999999954   45688899999999999999999998 56999999999999997 568999999999998754 


Q ss_pred             CCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHH
Q 039137          798 SSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKL  877 (912)
Q Consensus       798 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  877 (912)
                       .......|||.|||||++. ..|++.+||||||+++.||+|+.+||.    .-......+..+..+..|..  ...-..
T Consensus       199 -s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs----EC~n~AQIYKKV~SGiKP~s--l~kV~d  270 (632)
T KOG0584|consen  199 -SHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS----ECTNPAQIYKKVTSGIKPAA--LSKVKD  270 (632)
T ss_pred             -cccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh----hhCCHHHHHHHHHcCCCHHH--hhccCC
Confidence             3445579999999999887 569999999999999999999999974    11111222223333322211  112224


Q ss_pred             HHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          878 MSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       878 ~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      +.+.++|.+|+.. ..+|||+.|++.
T Consensus       271 Pevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  271 PEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             HHHHHHHHHHhcC-chhccCHHHHhh
Confidence            6689999999999 999999998875

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-34  Score=305.96  Aligned_cols=248  Identities=27%  Similarity=0.430  Sum_probs=200.0

Q ss_pred             CCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcC---CCccccEEEEEEcCCeee
Q 039137          639 DFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR---HRNIVKFYGFCSHPKHSF  714 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~~~~~~  714 (912)
                      .|+..+.||+|+||.||+|.+. +++.||+|.+......   ...+++.+|+.+++.++   |||++++++++......+
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~   78 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPD---DDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLW   78 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCc---hhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEE
Confidence            4778899999999999999864 7899999998654322   14566889999999996   999999999999999999


Q ss_pred             EEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccccccc
Q 039137          715 IIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL  794 (912)
Q Consensus       715 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  794 (912)
                      +||||+++++|.+++..    ..+++..++.++.|++.|++|||+.   +|+|+||+|+||+++.++.++++|||.+...
T Consensus        79 lv~e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  151 (277)
T cd06917          79 IIMEYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALL  151 (277)
T ss_pred             EEEecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeec
Confidence            99999999999999843    2688999999999999999999999   9999999999999999999999999999877


Q ss_pred             CCCCCCccccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhh
Q 039137          795 NPDSSNWSELAGTHGYVAPELAYTL-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHV  873 (912)
Q Consensus       795 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  873 (912)
                      ...........|+..|+|||.+.+. .++.++||||||+++|+|++|+.||+......     ........  ..+....
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-----~~~~~~~~--~~~~~~~  224 (277)
T cd06917         152 NQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR-----AMMLIPKS--KPPRLED  224 (277)
T ss_pred             CCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh-----hhhccccC--CCCCCCc
Confidence            6554444556788999999988654 46889999999999999999999986321110     00000011  1111111


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          874 QKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       874 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ...+..+.+++.+||+.||++||++.|+++
T Consensus       225 ~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         225 NGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            124456889999999999999999999965

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=3.7e-34  Score=315.21  Aligned_cols=256  Identities=18%  Similarity=0.253  Sum_probs=192.7

Q ss_pred             CCceeeec--CceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEEe
Q 039137          642 AEHCIGKG--GHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYE  718 (912)
Q Consensus       642 ~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e  718 (912)
                      +.++||+|  +|++||+++.+ +|+.||+|++......  ....+.+.+|+++++.++||||+++++++..++..++|||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e   79 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT--NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS   79 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc--HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEe
Confidence            46789999  68999999865 7899999998654322  2234567789999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCC
Q 039137          719 YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS  798 (912)
Q Consensus       719 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  798 (912)
                      |+++|+|.+++.... ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.++++||+.+.......
T Consensus        80 ~~~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~  155 (327)
T cd08227          80 FMAYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG  155 (327)
T ss_pred             ccCCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence            999999999985432 23588999999999999999999999   99999999999999999999999998754332111


Q ss_pred             CC-------cccccccccccccccccc--CCCCcchhHHHHHHHHHHHHhCCCCccchhcccccc---ccchh-------
Q 039137          799 SN-------WSELAGTHGYVAPELAYT--LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS---SNMNI-------  859 (912)
Q Consensus       799 ~~-------~~~~~g~~~y~aPE~~~~--~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~---~~~~~-------  859 (912)
                      ..       .....++..|+|||++.+  ..++.++||||+||++|||++|+.||+.........   .....       
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (327)
T cd08227         156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTT  235 (327)
T ss_pred             ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccc
Confidence            10       122346778999999876  458899999999999999999999986321100000   00000       


Q ss_pred             ---hh---------ccC----------CCC-----CCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          860 ---EM---------LDS----------RLP-----YPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       860 ---~~---------~~~----------~~~-----~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                         +.         .+.          ..+     ............+.+++.+||+.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         236 IPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             hhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence               00         000          000     000011223456889999999999999999999976

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=8.3e-34  Score=302.65  Aligned_cols=252  Identities=30%  Similarity=0.439  Sum_probs=202.2

Q ss_pred             CCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEE
Q 039137          639 DFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIY  717 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  717 (912)
                      +|++.+.||+|+||.||+|... +++.|++|.+......  ....+.+.+|+++++.++|+||+++++++...+..++|+
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~   78 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND--PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFM   78 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc--hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEE
Confidence            5888999999999999999865 7889999998755432  235678999999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCC
Q 039137          718 EYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPD  797 (912)
Q Consensus       718 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  797 (912)
                      ||+++++|.+++..   ...+++..+..++.|++.|++|||+.   +|+|+||+|+||++++++.+||+|||.+......
T Consensus        79 e~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~  152 (264)
T cd06626          79 EYCSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN  152 (264)
T ss_pred             ecCCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence            99999999999844   24578899999999999999999999   9999999999999999999999999999876544


Q ss_pred             CCCc----cccccccccccccccccCC---CCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCC
Q 039137          798 SSNW----SELAGTHGYVAPELAYTLK---VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPS  870 (912)
Q Consensus       798 ~~~~----~~~~g~~~y~aPE~~~~~~---~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  870 (912)
                      ....    ....+++.|+|||++.+..   ++.++||||||+++|++++|+.||.....   ................+.
T Consensus       153 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~  229 (264)
T cd06626         153 TTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN---EFQIMFHVGAGHKPPIPD  229 (264)
T ss_pred             CCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc---hHHHHHHHhcCCCCCCCc
Confidence            3322    2356788999999988766   88999999999999999999999852211   000000000011111111


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          871 LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       871 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                        ....+..+.+++.+||+.+|.+|||+.|++.
T Consensus       230 --~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         230 --SLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             --ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence              1223456789999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-34  Score=312.05  Aligned_cols=254  Identities=22%  Similarity=0.307  Sum_probs=203.9

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ++|+..+.||+|++|+||+|... +++.||+|.+....... ....+.+.+|++.++.++||||+++++.+...+..++|
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   79 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIK-RNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLV   79 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccch-HHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEE
Confidence            36888999999999999999876 58999999987653322 12456788999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+.+++|.+++... ....+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        80 ~e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  155 (316)
T cd05574          80 MDYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDV  155 (316)
T ss_pred             EEecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence            9999999999998533 335689999999999999999999999   999999999999999999999999999875432


Q ss_pred             CCC-----------------------------CccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccch
Q 039137          797 DSS-----------------------------NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFL  847 (912)
Q Consensus       797 ~~~-----------------------------~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~  847 (912)
                      ...                             ......|+..|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~  235 (316)
T cd05574         156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS  235 (316)
T ss_pred             cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence            211                             111346788999999999888999999999999999999999998522


Q ss_pred             hccccccccchhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCC----HHHHHH
Q 039137          848 FEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPT----MKRVSQ  903 (912)
Q Consensus       848 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt----~~evl~  903 (912)
                      ..     ..............+..  ...+..+.+++.+||..||++||+    ++|+++
T Consensus       236 ~~-----~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         236 NR-----DETFSNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             ch-----HHHHHHHhcCCccCCCc--cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            11     11122222233322221  124567899999999999999999    666654

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=3.9e-34  Score=303.33  Aligned_cols=247  Identities=26%  Similarity=0.428  Sum_probs=198.6

Q ss_pred             cCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIY  717 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  717 (912)
                      ++|++.+.||+|+||.||++.. +++.||+|++....      ..+.+.+|+.+++.++|||++++++++... ..++||
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~   77 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV------TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVM   77 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc------hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEE
Confidence            5689999999999999999975 77889999985432      346788999999999999999999998754 579999


Q ss_pred             eecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCC
Q 039137          718 EYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPD  797 (912)
Q Consensus       718 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  797 (912)
                      ||+++++|.+++... ....+++.+++.++.|++.|++|||+.   +++||||||+||+++.++.++|+|||.+......
T Consensus        78 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~  153 (254)
T cd05083          78 ELMSKGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG  153 (254)
T ss_pred             ECCCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc
Confidence            999999999999543 234588999999999999999999999   9999999999999999999999999998754322


Q ss_pred             CCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccCCCCCCChhhHHH
Q 039137          798 SSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKK  876 (912)
Q Consensus       798 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  876 (912)
                         ......+..|+|||++.+..++.++||||||+++|||++ |+.||......     . .............  ....
T Consensus       154 ---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----~-~~~~~~~~~~~~~--~~~~  222 (254)
T cd05083         154 ---VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK-----E-VKECVEKGYRMEP--PEGC  222 (254)
T ss_pred             ---CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH-----H-HHHHHhCCCCCCC--CCcC
Confidence               122334578999999988889999999999999999998 99998522110     0 1111111111111  1234


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 039137          877 LMSIMQVAFSCLDQNPESRPTMKRVSQLLCE  907 (912)
Q Consensus       877 ~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  907 (912)
                      +..+.+++.+||+.+|++||+++++++.|++
T Consensus       223 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         223 PADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            4668899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-35  Score=287.68  Aligned_cols=254  Identities=23%  Similarity=0.309  Sum_probs=213.4

Q ss_pred             HHhcCCCCC-ceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEEc--
Q 039137          635 SATNDFNAE-HCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSH--  709 (912)
Q Consensus       635 ~~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~--  709 (912)
                      ..+++|.+. ++||-|-.|.|..+.++ +++.+|+|++..         .....+|++..-.. .|||||.++++|+.  
T Consensus        58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D---------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~  128 (400)
T KOG0604|consen   58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD---------SPKARREVELHWMASGHPHIVSIIDVYENSY  128 (400)
T ss_pred             cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc---------CHHHHhHhhhhhhhcCCCceEEeehhhhhhc
Confidence            456778775 57999999999999876 799999999863         23456899886665 69999999999854  


Q ss_pred             --CCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcC---CCcEE
Q 039137          710 --PKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDL---GYEAH  784 (912)
Q Consensus       710 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~k  784 (912)
                        .+...+|||.|+||.|..-+..++ ...+++.++..|+.||+.|+.|||+.   +|.||||||+|+|+..   +..+|
T Consensus       129 ~~rkcLLiVmE~meGGeLfsriq~~g-~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lK  204 (400)
T KOG0604|consen  129 QGRKCLLIVMECMEGGELFSRIQDRG-DQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLK  204 (400)
T ss_pred             cCceeeEeeeecccchHHHHHHHHcc-cccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceE
Confidence              356789999999999999885543 45699999999999999999999999   9999999999999974   45699


Q ss_pred             EeccccccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccC
Q 039137          785 VSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDS  864 (912)
Q Consensus       785 l~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  864 (912)
                      |+|||+|+.-.. .....+.+-||.|.|||++...+|+...|+||+||++|-|++|.+||..... ......+...+..+
T Consensus       205 LtDfGFAK~t~~-~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg-~aispgMk~rI~~g  282 (400)
T KOG0604|consen  205 LTDFGFAKETQE-PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-LAISPGMKRRIRTG  282 (400)
T ss_pred             ecccccccccCC-CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC-ccCChhHHhHhhcc
Confidence            999999986543 3445667889999999999999999999999999999999999999853322 22234456667777


Q ss_pred             CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          865 RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       865 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .+.+|...+...++...++|+.++..+|.+|.|+.|+++
T Consensus       283 qy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  283 QYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             CccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            888899899999999999999999999999999999875

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=4.6e-34  Score=309.32  Aligned_cols=259  Identities=27%  Similarity=0.400  Sum_probs=201.5

Q ss_pred             HHHHHHhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEE
Q 039137          631 EEIISATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCS  708 (912)
Q Consensus       631 ~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~  708 (912)
                      +++..+.++|++.+.||+|+||.||+|..+ +++.+|+|.+....     ...+.+.+|+.+++++ +|||++++++++.
T Consensus        15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   89 (291)
T cd06639          15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-----DVDEEIEAEYNILQSLPNHPNVVKFYGMFY   89 (291)
T ss_pred             ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence            444556788999999999999999999875 78899999985421     1345677899999999 7999999999986


Q ss_pred             cC-----CeeeEEEeecCCCChhhHhhccC-CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCc
Q 039137          709 HP-----KHSFIIYEYLESGSLDKILCNDA-SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYE  782 (912)
Q Consensus       709 ~~-----~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~  782 (912)
                      ..     +..++||||+++++|.++++... ....+++..++.++.|++.|++|||++   +++||||||+||+++.++.
T Consensus        90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~  166 (291)
T cd06639          90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGG  166 (291)
T ss_pred             eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCC
Confidence            54     35899999999999999885422 345689999999999999999999999   9999999999999999999


Q ss_pred             EEEeccccccccCCCCCCccccccccccccccccccC-----CCCcchhHHHHHHHHHHHHhCCCCccchhccccccccc
Q 039137          783 AHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTL-----KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNM  857 (912)
Q Consensus       783 ~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~  857 (912)
                      ++|+|||++..............++..|+|||++...     .++.++||||+||++|||++|+.||......     ..
T Consensus       167 ~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-----~~  241 (291)
T cd06639         167 VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-----KT  241 (291)
T ss_pred             EEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-----HH
Confidence            9999999998765433333445688999999987543     2678999999999999999999998522111     00


Q ss_pred             hhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          858 NIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       858 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .........+ ...........+.++|.+||+.+|++||++.|+++
T Consensus       242 ~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         242 LFKIPRNPPP-TLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             HHHHhcCCCC-CCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            1111111110 00011223456889999999999999999999875

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=6.3e-34  Score=304.28  Aligned_cols=255  Identities=23%  Similarity=0.398  Sum_probs=201.3

Q ss_pred             CCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCch--HHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          639 DFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMS--FQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      +|+..+.||+|++|.||+|+.. +++.||+|.+.........  ...+.+.+|+..++.++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            4788899999999999999864 7899999998754332221  135678999999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCC-cEEEecccccccc
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGY-EAHVSDFGIAKFL  794 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~Dfgla~~~  794 (912)
                      ||||+++++|.+++.+   .+.+++..+..++.|++.|++|||++   +++|+||+|+||+++.++ .++|+|||.+...
T Consensus        81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            9999999999999854   34688999999999999999999999   999999999999998776 5999999999876


Q ss_pred             CCCCCC----ccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCC
Q 039137          795 NPDSSN----WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPS  870 (912)
Q Consensus       795 ~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  870 (912)
                      ......    .....++..|+|||.+.+..++.++||||+|+++|+|++|+.||.......  ............  ...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~--~~~  230 (268)
T cd06630         155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN--HLALIFKIASAT--TAP  230 (268)
T ss_pred             ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc--hHHHHHHHhccC--CCC
Confidence            543211    123467889999999988889999999999999999999999985211100  000000100000  111


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          871 LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       871 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ......+..+.+++.+|+..+|++||++.++++
T Consensus       231 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         231 SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            112334567889999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=6.5e-34  Score=303.47  Aligned_cols=253  Identities=26%  Similarity=0.419  Sum_probs=204.0

Q ss_pred             CCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEc--CCeeeE
Q 039137          639 DFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSH--PKHSFI  715 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~~l  715 (912)
                      +|++.+.||.|+||.||+|... +++.||+|.+......  ....+++..|+++++.++||||+++++++..  ....++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~   78 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT--EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYI   78 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC--HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEE
Confidence            5888999999999999999865 7889999988654322  2345678899999999999999999998754  456799


Q ss_pred             EEeecCCCChhhHhhcc-CCcccCCHHHHHHHHHHHHHHHHHHH-----hCCCCCeeecCCCCCCeEEcCCCcEEEeccc
Q 039137          716 IYEYLESGSLDKILCND-ASAKELGWTQRLNVIKGVADALFYLH-----NNCFPPIVHRDISSKNVLLDLGYEAHVSDFG  789 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH-----~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  789 (912)
                      +|||+++++|.+++... .....+++.+++.++.|++.|++|||     +.   +++|+||+|+||+++.++.+|++|||
T Consensus        79 ~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g  155 (265)
T cd08217          79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFG  155 (265)
T ss_pred             EehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccc
Confidence            99999999999998553 23457899999999999999999999     77   99999999999999999999999999


Q ss_pred             cccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCC
Q 039137          790 IAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYP  869 (912)
Q Consensus       790 la~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  869 (912)
                      ++..............+++.|+|||++.+..++.++||||||+++|+|++|+.||+...     .............+. 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~-  229 (265)
T cd08217         156 LAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN-----QLQLASKIKEGKFRR-  229 (265)
T ss_pred             ccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC-----HHHHHHHHhcCCCCC-
Confidence            99877654433445678999999999998889999999999999999999999986321     111111111111111 


Q ss_pred             ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 039137          870 SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQL  904 (912)
Q Consensus       870 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  904 (912)
                        .....+..+.+++.+|++.+|++||++.+|++.
T Consensus       230 --~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         230 --IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             --CccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence              112344668899999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-34  Score=309.31  Aligned_cols=258  Identities=18%  Similarity=0.302  Sum_probs=196.2

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      .++|++.+.||+|++|.||+|+.+ +++.||+|.+.......   ....+.+|+++++.++||||+++++++...+..++
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG---APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTL   80 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC---CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEE
Confidence            367999999999999999999876 78999999986543222   23456789999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ||||+++ +|.+++....  ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus        81 v~e~~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  154 (291)
T cd07844          81 VFEYLDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKS  154 (291)
T ss_pred             EEecCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccC
Confidence            9999985 8999885432  3688999999999999999999999   99999999999999999999999999987543


Q ss_pred             CCCCCcccccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCccchhcccccc-----------ccchhh---
Q 039137          796 PDSSNWSELAGTHGYVAPELAYT-LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS-----------SNMNIE---  860 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~-----------~~~~~~---  860 (912)
                      ..........+++.|+|||++.+ ..++.++||||+|+++|+|++|+.||..........           ......   
T Consensus       155 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07844         155 VPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSS  234 (291)
T ss_pred             CCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhh
Confidence            32222233456889999998875 457899999999999999999999985221000000           000000   


Q ss_pred             ---hccCCCCC--CChh---hHHH--HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          861 ---MLDSRLPY--PSLH---VQKK--LMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       861 ---~~~~~~~~--~~~~---~~~~--~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                         ........  +...   ....  ...+.+++.+|++.+|++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence               00000000  0000   0001  145678999999999999999998874

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.4e-34  Score=316.74  Aligned_cols=195  Identities=26%  Similarity=0.383  Sum_probs=169.9

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcC-C-----CccccEEEEEEcC
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR-H-----RNIVKFYGFCSHP  710 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h-----~niv~l~~~~~~~  710 (912)
                      .+|++.+.||+|+||.|.+|.+. +++.||||+++....     -..+...|+.++..++ |     -|+|+++++|...
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-----f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr  260 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-----FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR  260 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-----HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc
Confidence            48999999999999999999765 799999999975432     3445567999999996 4     3899999999999


Q ss_pred             CeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCC--cEEEecc
Q 039137          711 KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGY--EAHVSDF  788 (912)
Q Consensus       711 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~--~~kl~Df  788 (912)
                      ++.|+|+|.+.. +|+++++.+.- ..++...++.|+.||+.||.+||+.   +|||+||||+|||+.+-+  .+||+||
T Consensus       261 ~HlciVfELL~~-NLYellK~n~f-~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDF  335 (586)
T KOG0667|consen  261 NHLCIVFELLST-NLYELLKNNKF-RGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDF  335 (586)
T ss_pred             cceeeeehhhhh-hHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEec
Confidence            999999998865 99999977654 4589999999999999999999999   999999999999997644  5999999


Q ss_pred             ccccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcc
Q 039137          789 GIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRD  845 (912)
Q Consensus       789 gla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~  845 (912)
                      |.|+.....-   .....+..|+|||++.|.+|+.+.||||||||++||++|.+-|.
T Consensus       336 GSSc~~~q~v---ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfp  389 (586)
T KOG0667|consen  336 GSSCFESQRV---YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFP  389 (586)
T ss_pred             ccccccCCcc---eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccC
Confidence            9998764332   25677889999999999999999999999999999999977663

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=4e-34  Score=306.04  Aligned_cols=248  Identities=29%  Similarity=0.465  Sum_probs=196.1

Q ss_pred             ceeeecCceEEEEEEeCC-------CCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          644 HCIGKGGHGSVYRAKVPS-------GEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       644 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      +.||+|+||.||+|+.++       ++.+|+|.+.....   ......+.+|+++++.++||||+++++++...+..++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   77 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT---DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYII   77 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccc---hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEE
Confidence            368999999999998642       25789998764321   12456788999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccC----CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCC-----cEEEec
Q 039137          717 YEYLESGSLDKILCNDA----SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGY-----EAHVSD  787 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-----~~kl~D  787 (912)
                      |||+++++|.+++....    ....+++.+++.++.|++.|++|||+.   +++|+||||+||+++.++     .++++|
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~d  154 (269)
T cd05044          78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGD  154 (269)
T ss_pred             EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECC
Confidence            99999999999985432    223478999999999999999999999   999999999999999877     899999


Q ss_pred             cccccccCCCCC--CccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhcc-
Q 039137          788 FGIAKFLNPDSS--NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLD-  863 (912)
Q Consensus       788 fgla~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~-  863 (912)
                      ||++........  ......++..|+|||++.+..++.++||||||+++|||++ |+.||......     . ...... 
T Consensus       155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~-----~-~~~~~~~  228 (269)
T cd05044         155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ-----E-VLQHVTA  228 (269)
T ss_pred             cccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH-----H-HHHHHhc
Confidence            999976543221  1122345678999999999899999999999999999998 99997522111     0 111111 


Q ss_pred             -CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 039137          864 -SRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCE  907 (912)
Q Consensus       864 -~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  907 (912)
                       .....+    ...+..+.+++.+||..+|.+||+++++++.|++
T Consensus       229 ~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         229 GGRLQKP----ENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             CCccCCc----ccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence             111111    2235668899999999999999999999999864

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=6.4e-34  Score=304.46  Aligned_cols=258  Identities=24%  Similarity=0.421  Sum_probs=203.3

Q ss_pred             CCCCCceeeecCceEEEEEEeCC--CCEEEEEEccCCCCC------CchHHHHHHHHHHHHHhh-cCCCccccEEEEEEc
Q 039137          639 DFNAEHCIGKGGHGSVYRAKVPS--GEIFAVKKFHSPLPG------EMSFQQEEFLNEIQALTE-IRHRNIVKFYGFCSH  709 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~------~~~~~~~~~~~Ei~~l~~-l~h~niv~l~~~~~~  709 (912)
                      .|++.+.||+|+||.||+|.++.  ++.+|+|.+......      .......++.+|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47888999999999999998764  688999987643221      112234567788888875 699999999999999


Q ss_pred             CCeeeEEEeecCCCChhhHhhcc-CCcccCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCCeEEcCCCcEEEec
Q 039137          710 PKHSFIIYEYLESGSLDKILCND-ASAKELGWTQRLNVIKGVADALFYLHN-NCFPPIVHRDISSKNVLLDLGYEAHVSD  787 (912)
Q Consensus       710 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~D  787 (912)
                      .+..++||||+++++|.+++... .....+++.+++.++.|++.|++|||+ .   +++|+||+|+||+++.++.++|+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEec
Confidence            99999999999999999987442 234568999999999999999999996 5   899999999999999999999999


Q ss_pred             cccccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCC
Q 039137          788 FGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLP  867 (912)
Q Consensus       788 fgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  867 (912)
                      ||.+....... ......++..|+|||+..+..++.++||||||+++|+|++|+.||.....     .............
T Consensus       158 fg~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~  231 (269)
T cd08528         158 FGLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM-----LSLATKIVEAVYE  231 (269)
T ss_pred             ccceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH-----HHHHHHHhhccCC
Confidence            99998765433 33455688999999999988899999999999999999999999752111     0111111111111


Q ss_pred             CCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 039137          868 YPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCE  907 (912)
Q Consensus       868 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  907 (912)
                      ...  ....+..+.+++.+||+.||++||++.|+.+++++
T Consensus       232 ~~~--~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~  269 (269)
T cd08528         232 PLP--EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD  269 (269)
T ss_pred             cCC--cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence            110  11234568899999999999999999999998863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.8e-34  Score=317.41  Aligned_cols=256  Identities=20%  Similarity=0.313  Sum_probs=194.7

Q ss_pred             HHhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC---
Q 039137          635 SATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP---  710 (912)
Q Consensus       635 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~---  710 (912)
                      ...++|++.+.||+|+||+||+|... +++.||||++......  ....+.+.+|+.+++.++||||+++++++...   
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQS--LIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI   89 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhh--hHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence            34678999999999999999999865 7889999998654322  12345677999999999999999999987543   


Q ss_pred             ---CeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEec
Q 039137          711 ---KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSD  787 (912)
Q Consensus       711 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  787 (912)
                         ...+++||++ +++|.+++.    ...+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|
T Consensus        90 ~~~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~D  161 (343)
T cd07878          90 ENFNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILD  161 (343)
T ss_pred             cccCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcC
Confidence               3468999987 679988873    24589999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCCCcccccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCccchhccccc------cccchhh
Q 039137          788 FGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS------SSNMNIE  860 (912)
Q Consensus       788 fgla~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~------~~~~~~~  860 (912)
                      ||+++.....   .....+++.|+|||++.+ ..++.++||||+||++|+|++|+.||.........      .......
T Consensus       162 fg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  238 (343)
T cd07878         162 FGLARQADDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPE  238 (343)
T ss_pred             CccceecCCC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            9999865432   234578999999999876 56889999999999999999999998521110000      0000000


Q ss_pred             h-----------ccCCCCC-CChh----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          861 M-----------LDSRLPY-PSLH----VQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       861 ~-----------~~~~~~~-~~~~----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .           .....+. +...    .....+.+.+++.+|++.||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         239 VLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             HHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0           0000000 0000    0112234779999999999999999999875

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.6e-34  Score=318.55  Aligned_cols=255  Identities=21%  Similarity=0.276  Sum_probs=196.0

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ++|++.+.||+|+||+||+++.+ +++.||+|++...... .......+.+|+.++..++|++|+++++++.+++..++|
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   79 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML-KRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLV   79 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHH-HhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEE
Confidence            47899999999999999999876 5788999998532111 111344578899999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++|+|.+++.+.  ...+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||++.....
T Consensus        80 ~ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~  154 (332)
T cd05623          80 MDYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME  154 (332)
T ss_pred             EeccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence            9999999999999542  24588999999999999999999999   999999999999999999999999999976543


Q ss_pred             CCCC-ccccccccccccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccC--CCCC
Q 039137          797 DSSN-WSELAGTHGYVAPELAY-----TLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDS--RLPY  868 (912)
Q Consensus       797 ~~~~-~~~~~g~~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~  868 (912)
                      .... .....||+.|+|||++.     ...++.++|||||||++|||++|+.||.....     ..........  +.+.
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~-----~~~~~~i~~~~~~~~~  229 (332)
T cd05623         155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL-----VETYGKIMNHKERFQF  229 (332)
T ss_pred             CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH-----HHHHHHHhCCCccccC
Confidence            3222 23357899999999886     34578899999999999999999999852211     0111111111  1122


Q ss_pred             CChhhHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 039137          869 PSLHVQKKLMSIMQVAFSCLDQNPES--RPTMKRVSQL  904 (912)
Q Consensus       869 ~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~  904 (912)
                      +. .....+..+.+++.+|+..+|.+  |++++|+++.
T Consensus       230 p~-~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         230 PA-QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             CC-ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            21 11233556788899988665444  6888887653

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=5.8e-34  Score=304.41  Aligned_cols=251  Identities=21%  Similarity=0.322  Sum_probs=185.9

Q ss_pred             ceeeecCceEEEEEEeCCC---CEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEEeec
Q 039137          644 HCIGKGGHGSVYRAKVPSG---EIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYL  720 (912)
Q Consensus       644 ~~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  720 (912)
                      +.||+|+||+||+|+..++   ..+++|.+.....   ....+.+.+|+..++.++||||+++++++......++||||+
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~   77 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS---SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYC   77 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC---hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecC
Confidence            3599999999999975433   3456666543321   224678999999999999999999999999999999999999


Q ss_pred             CCCChhhHhhccCC-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCC-
Q 039137          721 ESGSLDKILCNDAS-AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS-  798 (912)
Q Consensus       721 ~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~-  798 (912)
                      ++|+|.+++..... ....++..+..++.|++.||+|||++   +++||||||+||+++.++.++|+|||++....... 
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~  154 (268)
T cd05086          78 ELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY  154 (268)
T ss_pred             CCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchh
Confidence            99999999965432 24467778889999999999999999   99999999999999999999999999986432211 


Q ss_pred             -CCcccccccccccccccccc-------CCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccC-CCCC
Q 039137          799 -SNWSELAGTHGYVAPELAYT-------LKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDS-RLPY  868 (912)
Q Consensus       799 -~~~~~~~g~~~y~aPE~~~~-------~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~  868 (912)
                       .......+++.|+|||++..       ..++.++||||||+++|||++ |..||+...+.     ......... ....
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-----~~~~~~~~~~~~~~  229 (268)
T cd05086         155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR-----EVLNHVIKDQQVKL  229 (268)
T ss_pred             hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHHhhccccc
Confidence             11234567889999998753       245789999999999999997 56787522111     000011000 0000


Q ss_pred             C-ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 039137          869 P-SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLC  906 (912)
Q Consensus       869 ~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  906 (912)
                      + +.........+.+++..|| .+|++||+++++++.|.
T Consensus       230 ~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         230 FKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            0 0011123455778888999 67999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=3e-34  Score=311.25  Aligned_cols=246  Identities=26%  Similarity=0.403  Sum_probs=197.6

Q ss_pred             CCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEEee
Q 039137          641 NAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEY  719 (912)
Q Consensus       641 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  719 (912)
                      .....||+|+||.||+|... +++.||+|.+......    ..+.+.+|+..++.++||||+++++++..++..++||||
T Consensus        24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~----~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~   99 (297)
T cd06659          24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ----RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF   99 (297)
T ss_pred             HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc----hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence            33457999999999999875 7899999998543221    356688999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCC
Q 039137          720 LESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSS  799 (912)
Q Consensus       720 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  799 (912)
                      +++++|.+++..    ..+++.+++.++.|++.|++|||+.   +++||||+|+||+++.++.++|+|||++........
T Consensus       100 ~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~  172 (297)
T cd06659         100 LQGGALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP  172 (297)
T ss_pred             CCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc
Confidence            999999998733    4588999999999999999999999   999999999999999999999999999976554433


Q ss_pred             CccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHHHH
Q 039137          800 NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMS  879 (912)
Q Consensus       800 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  879 (912)
                      ......+++.|+|||++.+..++.++||||||+++|||++|+.||......      ....................+..
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~  246 (297)
T cd06659         173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV------QAMKRLRDSPPPKLKNAHKISPV  246 (297)
T ss_pred             cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhccCCCCccccCCCCHH
Confidence            344567899999999999888999999999999999999999998521110      00011111111111111223455


Q ss_pred             HHHHHHHcccCCCCCCCCHHHHHH
Q 039137          880 IMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       880 l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      +.+++.+||+.+|++||+++++++
T Consensus       247 l~~~i~~~l~~~P~~Rps~~~ll~  270 (297)
T cd06659         247 LRDFLERMLTREPQERATAQELLD  270 (297)
T ss_pred             HHHHHHHHhcCCcccCcCHHHHhh
Confidence            788999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1e-33  Score=305.83  Aligned_cols=258  Identities=26%  Similarity=0.334  Sum_probs=200.5

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC--Ceee
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP--KHSF  714 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~  714 (912)
                      ++|+..+.||.|++|.||+|..+ +++.||+|.+......   ....++.+|+++++.++||||+++++++...  +..+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   77 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP---DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIG   77 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch---HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEE
Confidence            36788899999999999999875 6889999988644221   2457789999999999999999999998643  4689


Q ss_pred             EEEeecCCCChhhHhhccC-CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccc
Q 039137          715 IIYEYLESGSLDKILCNDA-SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKF  793 (912)
Q Consensus       715 lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  793 (912)
                      +||||+++++|.+++.... ....+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.++|+|||++..
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~  154 (287)
T cd06621          78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGE  154 (287)
T ss_pred             EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccc
Confidence            9999999999998874322 345588999999999999999999999   999999999999999999999999999875


Q ss_pred             cCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCC---CC
Q 039137          794 LNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPY---PS  870 (912)
Q Consensus       794 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~  870 (912)
                      .....  .....++..|+|||.+.+..++.++||||+|+++|+|++|+.||+.....................+.   ..
T Consensus       155 ~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd06621         155 LVNSL--AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEP  232 (287)
T ss_pred             ccccc--cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCC
Confidence            53322  12345788999999999888999999999999999999999998633110001111111111111111   00


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          871 LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       871 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ......+..+.+++.+||+.+|++|||+.|+++
T Consensus       233 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         233 GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            101123566889999999999999999999886

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.2e-33  Score=301.48  Aligned_cols=252  Identities=23%  Similarity=0.322  Sum_probs=197.0

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCC-chHHHHHHHHHHHHHhhcCCCccccEEEEEEcC--Cee
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGE-MSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP--KHS  713 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~  713 (912)
                      .+|++.+.||+|+||.||+|..+ +++.||+|.+....... .....+.+.+|+++++.++||||+++++++.++  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            47889999999999999999875 68999999876432221 122456788999999999999999999998764  467


Q ss_pred             eEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccc
Q 039137          714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKF  793 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  793 (912)
                      ++||||+++++|.+++...   ..+++..+.+++.|++.||+|||++   +++|+||||+||+++.++.++|+|||++..
T Consensus        82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccc
Confidence            8999999999999998432   3578899999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCC---CCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCC
Q 039137          794 LNPDS---SNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPS  870 (912)
Q Consensus       794 ~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  870 (912)
                      .....   .......++..|+|||++.+..++.++||||||+++|||++|+.||.......    ...........+   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~~~~~---  228 (265)
T cd06652         156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA----AIFKIATQPTNP---  228 (265)
T ss_pred             cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH----HHHHHhcCCCCC---
Confidence            54221   12233468889999999988889999999999999999999999985221110    000000011111   


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          871 LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       871 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .........+.+++.+|+. +|++||+++|+++
T Consensus       229 ~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         229 VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            1122344567788999985 9999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=6.3e-34  Score=305.54  Aligned_cols=257  Identities=25%  Similarity=0.402  Sum_probs=202.7

Q ss_pred             cCCCCCceeeecCceEEEEEEeC------CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCC
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP------SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPK  711 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~  711 (912)
                      ++|++.+.||+|+||.||+|+.+      +.+.|++|.+.....   ....+.+.+|++++++++|+||+++++++...+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   81 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD---ENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE   81 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc---hHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence            57889999999999999999864      346799998754321   124567899999999999999999999999989


Q ss_pred             eeeEEEeecCCCChhhHhhccCCc------ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEE
Q 039137          712 HSFIIYEYLESGSLDKILCNDASA------KELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHV  785 (912)
Q Consensus       712 ~~~lv~e~~~~g~L~~~l~~~~~~------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  785 (912)
                      ..++||||+++|+|.+++......      ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+++
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l  158 (275)
T cd05046          82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKV  158 (275)
T ss_pred             cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEE
Confidence            999999999999999999654422      2589999999999999999999999   9999999999999999999999


Q ss_pred             eccccccccCCCC-CCccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhcc
Q 039137          786 SDFGIAKFLNPDS-SNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLD  863 (912)
Q Consensus       786 ~Dfgla~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  863 (912)
                      +|||++....... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.....     .........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~-----~~~~~~~~~  233 (275)
T cd05046         159 SLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD-----EEVLNRLQA  233 (275)
T ss_pred             cccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch-----HHHHHHHHc
Confidence            9999987543221 22234456778999999988888999999999999999999 7888742111     111111111


Q ss_pred             CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 039137          864 SRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCE  907 (912)
Q Consensus       864 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  907 (912)
                      .....+.  ....+..+.+++.+||+.+|++|||+.|+++.|.+
T Consensus       234 ~~~~~~~--~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         234 GKLELPV--PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             CCcCCCC--CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence            1111111  11234568899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.6e-34  Score=323.84  Aligned_cols=252  Identities=22%  Similarity=0.255  Sum_probs=195.0

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC---CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCee
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP---SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHS  713 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  713 (912)
                      ..+|++.+.||+|+||.||+|...   .++.||+|.+...         +...+|+++++.++||||+++++++......
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~---------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~  161 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG---------KTPGREIDILKTISHRAIINLIHAYRWKSTV  161 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc---------ccHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence            457999999999999999999753   4678999987532         2245799999999999999999999999999


Q ss_pred             eEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccc
Q 039137          714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKF  793 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  793 (912)
                      ++|||++. +++.+++   .....+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.++|+|||+++.
T Consensus       162 ~lv~e~~~-~~l~~~l---~~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~  234 (392)
T PHA03207        162 CMVMPKYK-CDLFTYV---DRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACK  234 (392)
T ss_pred             EEEehhcC-CCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccc
Confidence            99999986 5888887   2345689999999999999999999999   999999999999999999999999999976


Q ss_pred             cCCCCCC--ccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccc-----------------c
Q 039137          794 LNPDSSN--WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS-----------------S  854 (912)
Q Consensus       794 ~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~-----------------~  854 (912)
                      .......  .....||+.|+|||++.+..++.++||||+||++|||++|+.||.........                 .
T Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~  314 (392)
T PHA03207        235 LDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP  314 (392)
T ss_pred             cCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccC
Confidence            6543222  23457899999999999989999999999999999999999998421110000                 0


Q ss_pred             ccc---h----hhh---ccCCCCCCCh-hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 039137          855 SNM---N----IEM---LDSRLPYPSL-HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQL  904 (912)
Q Consensus       855 ~~~---~----~~~---~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  904 (912)
                      ...   .    ...   .......+.. .......++.++|.+|+..||++|||+.|++..
T Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence            000   0    000   0000000100 001224567889999999999999999998763

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=5e-34  Score=328.96  Aligned_cols=257  Identities=18%  Similarity=0.238  Sum_probs=189.5

Q ss_pred             HHHHHhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCC------CccccEE
Q 039137          632 EIISATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH------RNIVKFY  704 (912)
Q Consensus       632 e~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h------~niv~l~  704 (912)
                      ++....++|++.+.||+|+||+||+|.+. +++.||||++.....     ....+..|+++++.++|      .+++.++
T Consensus       123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~  197 (467)
T PTZ00284        123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK-----YTRDAKIEIQFMEKVRQADPADRFPLMKIQ  197 (467)
T ss_pred             ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh-----hHHHHHHHHHHHHHHhhcCcccCcceeeeE
Confidence            33445688999999999999999999875 678899999863211     23345567777777654      4588899


Q ss_pred             EEEEcC-CeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCCeEEcCCC-
Q 039137          705 GFCSHP-KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHN-NCFPPIVHRDISSKNVLLDLGY-  781 (912)
Q Consensus       705 ~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill~~~~-  781 (912)
                      +++..+ ++.++|||++ +++|.+++..   .+.+++.++..|+.||+.||+|||+ .   +|+||||||+||+++.++ 
T Consensus       198 ~~~~~~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~  270 (467)
T PTZ00284        198 RYFQNETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDT  270 (467)
T ss_pred             EEEEcCCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCc
Confidence            988764 5788999987 6688888743   3468999999999999999999997 5   999999999999998765 


Q ss_pred             ---------------cEEEeccccccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccc
Q 039137          782 ---------------EAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDF  846 (912)
Q Consensus       782 ---------------~~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~  846 (912)
                                     .+||+|||.+....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||+.
T Consensus       271 ~~~~~~~~~~~~~~~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~  347 (467)
T PTZ00284        271 VVDPVTNRALPPDPCRVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDT  347 (467)
T ss_pred             ccccccccccCCCCceEEECCCCccccCc---cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence                           49999999886432   223456789999999999999999999999999999999999999963


Q ss_pred             hhcccccc------ccc------------hhhhccCC---CC-CCC-----------hhhHHHHHHHHHHHHHcccCCCC
Q 039137          847 LFEMSSSS------SNM------------NIEMLDSR---LP-YPS-----------LHVQKKLMSIMQVAFSCLDQNPE  893 (912)
Q Consensus       847 ~~~~~~~~------~~~------------~~~~~~~~---~~-~~~-----------~~~~~~~~~l~~li~~cl~~dP~  893 (912)
                      ........      ...            .....+..   .+ ...           .........+.++|.+||+.||+
T Consensus       348 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~  427 (467)
T PTZ00284        348 HDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQ  427 (467)
T ss_pred             CChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChh
Confidence            21100000      000            00000000   00 000           00001134577999999999999


Q ss_pred             CCCCHHHHHH
Q 039137          894 SRPTMKRVSQ  903 (912)
Q Consensus       894 ~RPt~~evl~  903 (912)
                      +|||++|+++
T Consensus       428 ~R~ta~e~L~  437 (467)
T PTZ00284        428 KRLNARQMTT  437 (467)
T ss_pred             hCCCHHHHhc
Confidence            9999999886

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.4e-33  Score=300.87  Aligned_cols=254  Identities=26%  Similarity=0.407  Sum_probs=207.9

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ++|++.+.||+|++|.||+|+.+ +++.|++|++......   ...+.+.+|++.+..++|+|++++++++..++..++|
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE---EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIV   77 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch---HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEE
Confidence            36889999999999999999877 5999999998754322   2467789999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHN-NCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      |||+++++|.+++...   ..+++..++.++.|+++|++|||+ .   +++|+||+|+||+++.++.++|+|||.+....
T Consensus        78 ~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~  151 (264)
T cd06623          78 LEYMDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLE  151 (264)
T ss_pred             EEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecc
Confidence            9999999999999543   568999999999999999999999 8   99999999999999999999999999998775


Q ss_pred             CCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHH
Q 039137          796 PDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQK  875 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  875 (912)
                      ..........++..|+|||.+.+..++.++||||||+++|+|++|+.||.....  ...............+..  ....
T Consensus       152 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~--~~~~  227 (264)
T cd06623         152 NTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ--PSFFELMQAICDGPPPSL--PAEE  227 (264)
T ss_pred             cCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc--cCHHHHHHHHhcCCCCCC--Cccc
Confidence            544443456688999999999988899999999999999999999999853321  000111111111111111  1111


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 039137          876 KLMSIMQVAFSCLDQNPESRPTMKRVSQL  904 (912)
Q Consensus       876 ~~~~l~~li~~cl~~dP~~RPt~~evl~~  904 (912)
                      .+..+.+++.+||+.+|++||++.|+++.
T Consensus       228 ~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         228 FSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            45678899999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=9.5e-34  Score=301.04  Aligned_cols=250  Identities=26%  Similarity=0.373  Sum_probs=201.4

Q ss_pred             CCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCC-CchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          639 DFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPG-EMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      +|+..+.||+|++|.||+|..+ +++.|++|.+...... ......+.+.+|+++++.++|+||+++++++..++..++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4778899999999999999876 7899999998654322 1222456788999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++++|.+++.+.   ..+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.+||+|||.+.....
T Consensus        81 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          81 LELVPGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EEecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            9999999999998443   4588999999999999999999999   999999999999999999999999999886543


Q ss_pred             CCCCccccccccccccccccccCC-CCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhcc-CCCCCCChhhH
Q 039137          797 DSSNWSELAGTHGYVAPELAYTLK-VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLD-SRLPYPSLHVQ  874 (912)
Q Consensus       797 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  874 (912)
                      .. ......+++.|+|||.+.... ++.++|+||||+++|+|++|+.||+.....     ........ ...+.   ...
T Consensus       155 ~~-~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~---~~~  225 (258)
T cd06632         155 FS-FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV-----AAVFKIGRSKELPP---IPD  225 (258)
T ss_pred             cc-cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH-----HHHHHHHhcccCCC---cCC
Confidence            32 234456889999999987766 899999999999999999999998632211     00011101 11111   112


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          875 KKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       875 ~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .....+.+++.+||+.+|++||++.++++
T Consensus       226 ~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         226 HLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             CcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            23456788999999999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=9.5e-34  Score=305.69  Aligned_cols=261  Identities=25%  Similarity=0.373  Sum_probs=204.3

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-----CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEc--C
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-----SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSH--P  710 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~  710 (912)
                      ++|++.+.||+|+||.||+|++.     +++.||+|++......   ...+.+.+|++.++.++||||+++++++..  .
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~   80 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE---QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG   80 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch---HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence            46788899999999999999853     4688999998754332   246789999999999999999999999977  5


Q ss_pred             CeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccc
Q 039137          711 KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGI  790 (912)
Q Consensus       711 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl  790 (912)
                      ...++||||+++++|.+++....  ..+++.++..++.|++.||+|||+.   +++|+||||+||+++.++.++++|||.
T Consensus        81 ~~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~  155 (284)
T cd05038          81 RSLRLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGL  155 (284)
T ss_pred             CceEEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccc
Confidence            57899999999999999995433  3589999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCc---cccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccc---------cccch
Q 039137          791 AKFLNPDSSNW---SELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS---------SSNMN  858 (912)
Q Consensus       791 a~~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~---------~~~~~  858 (912)
                      +..........   ....++..|+|||...+..++.++||||||+++|||++|+.|+.........         .....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd05038         156 AKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRL  235 (284)
T ss_pred             ccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHH
Confidence            98765332211   1223456799999998888999999999999999999999997532111100         00000


Q ss_pred             hhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 039137          859 IEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEK  908 (912)
Q Consensus       859 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  908 (912)
                      ..........+.  ....+.++.+++.+||+.+|++|||+.|++++|++.
T Consensus       236 ~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         236 LELLKEGERLPR--PPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHHcCCcCCC--CccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            111111111111  112335688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.9e-34  Score=299.63  Aligned_cols=245  Identities=28%  Similarity=0.435  Sum_probs=197.4

Q ss_pred             ceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEEeecCCC
Q 039137          644 HCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESG  723 (912)
Q Consensus       644 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  723 (912)
                      +.||+|++|.||+|...+++.||+|.+......   ...+.+.+|++++++++|+||+++++++......++||||++++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   77 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP---DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG   77 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCH---HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence            468999999999999877999999988654332   24567899999999999999999999999999999999999999


Q ss_pred             ChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCCCc--
Q 039137          724 SLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNW--  801 (912)
Q Consensus       724 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~--  801 (912)
                      +|.+++...  ...+++..+..++.+++.|++|||++   +++||||+|+||+++.++.++|+|||.+..........  
T Consensus        78 ~l~~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~  152 (251)
T cd05041          78 SLLTFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD  152 (251)
T ss_pred             cHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence            999998543  23578999999999999999999999   99999999999999999999999999997654221111  


Q ss_pred             cccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccC--CCCCCChhhHHHHH
Q 039137          802 SELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDS--RLPYPSLHVQKKLM  878 (912)
Q Consensus       802 ~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~  878 (912)
                      .....+..|+|||.+.+..++.++||||||+++|||++ |..||......      ........  ..+.+    ...+.
T Consensus       153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~------~~~~~~~~~~~~~~~----~~~~~  222 (251)
T cd05041         153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ------QTRERIESGYRMPAP----QLCPE  222 (251)
T ss_pred             ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH------HHHHHHhcCCCCCCC----ccCCH
Confidence            11233567999999988889999999999999999999 88887522110      11111111  11111    22345


Q ss_pred             HHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 039137          879 SIMQVAFSCLDQNPESRPTMKRVSQLLC  906 (912)
Q Consensus       879 ~l~~li~~cl~~dP~~RPt~~evl~~L~  906 (912)
                      .+.+++.+||..+|.+|||+.|+++.|+
T Consensus       223 ~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         223 EIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             HHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            6889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.6e-34  Score=321.24  Aligned_cols=252  Identities=20%  Similarity=0.255  Sum_probs=192.8

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      ...|.+.+.||+|+||.||+|.++ .++.||||...          ...+.+|++++++++|+||+++++++...+..++
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~----------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~l  237 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW----------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCL  237 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc----------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence            457999999999999999999876 57889999632          2235689999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      |||++. ++|.+++...  ...+++.+++.|+.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus       238 v~e~~~-~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~  311 (461)
T PHA03211        238 VLPKYR-SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFAR  311 (461)
T ss_pred             EEEccC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecc
Confidence            999995 6888887432  24689999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCCC--ccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhcc-cccc-ccchhhhcc--------
Q 039137          796 PDSSN--WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEM-SSSS-SNMNIEMLD--------  863 (912)
Q Consensus       796 ~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~-~~~~-~~~~~~~~~--------  863 (912)
                      .....  .....||+.|+|||++.+..++.++|||||||++|||++|..|+-..... .... ......++.        
T Consensus       312 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~  391 (461)
T PHA03211        312 GSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDE  391 (461)
T ss_pred             cccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccccc
Confidence            32211  22456899999999999999999999999999999999987653111000 0000 000000000        


Q ss_pred             --------------------CCCCCCCh---hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 039137          864 --------------------SRLPYPSL---HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQL  904 (912)
Q Consensus       864 --------------------~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  904 (912)
                                          ........   ........+.++|.+||+.||.+|||+.|+++.
T Consensus       392 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        392 FPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             CCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence                                00000000   011223467889999999999999999998863

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.8e-34  Score=309.88  Aligned_cols=257  Identities=23%  Similarity=0.315  Sum_probs=196.2

Q ss_pred             CCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEE
Q 039137          639 DFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIY  717 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  717 (912)
                      +|++.+.||+|++|.||+|+.+ +|+.||+|++.......  .....+.+|+++++.++||||+++++++.+.+..++|+
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~--~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~   78 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE--GVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVF   78 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccc--cCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEE
Confidence            4888899999999999999876 78999999986543221  13356778999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCC
Q 039137          718 EYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPD  797 (912)
Q Consensus       718 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  797 (912)
                      ||+++ ++.+++...  ...+++..++.++.||++||+|||++   +|+||||||+||+++.++.++|+|||+++.....
T Consensus        79 e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  152 (284)
T cd07839          79 EYCDQ-DLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIP  152 (284)
T ss_pred             ecCCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCC
Confidence            99975 787777432  34689999999999999999999999   9999999999999999999999999999866544


Q ss_pred             CCCccccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCccchhcccccc-----------ccch---hhhc
Q 039137          798 SSNWSELAGTHGYVAPELAYTL-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS-----------SNMN---IEML  862 (912)
Q Consensus       798 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~-----------~~~~---~~~~  862 (912)
                      ........+++.|+|||++.+. .++.++||||+||++|||++|..|+..........           ....   ....
T Consensus       153 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07839         153 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP  232 (284)
T ss_pred             CCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcc
Confidence            3334445678899999988764 46899999999999999999998853111100000           0000   0000


Q ss_pred             cC-CCC-CCC-----hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          863 DS-RLP-YPS-----LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       863 ~~-~~~-~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      +. ..+ .+.     ......+..+.+++.+||+.||.+|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            00 000 000     001123456789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.8e-34  Score=316.35  Aligned_cols=192  Identities=22%  Similarity=0.329  Sum_probs=164.7

Q ss_pred             HHhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCee
Q 039137          635 SATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHS  713 (912)
Q Consensus       635 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  713 (912)
                      ....+|++.+.||+|+||.||+|+.. +++.||+|+....          ....|+.+++.++||||+++++++...+..
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~----------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  132 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG----------TTLIEAMLLQNVNHPSVIRMKDTLVSGAIT  132 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc----------ccHHHHHHHHhCCCCCCcChhheEEeCCee
Confidence            34568999999999999999999876 5778999974321          234689999999999999999999999999


Q ss_pred             eEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccc
Q 039137          714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKF  793 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  793 (912)
                      ++|||++. ++|.+++..  ....+++.+++.|+.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++.
T Consensus       133 ~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  206 (357)
T PHA03209        133 CMVLPHYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF  206 (357)
T ss_pred             EEEEEccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccc
Confidence            99999996 588888744  235689999999999999999999999   999999999999999999999999999975


Q ss_pred             cCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCC
Q 039137          794 LNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP  843 (912)
Q Consensus       794 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p  843 (912)
                      .... .......|++.|+|||++.+..++.++|||||||++|||+++..|
T Consensus       207 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~  255 (357)
T PHA03209        207 PVVA-PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPST  255 (357)
T ss_pred             cccC-cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCc
Confidence            4322 223345689999999999999999999999999999999985544

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=8.4e-34  Score=308.88  Aligned_cols=255  Identities=24%  Similarity=0.424  Sum_probs=200.0

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCC----EEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCC
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGE----IFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPK  711 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~  711 (912)
                      .++|+..+.||+|+||.||+|.+. +++    .||+|.+.....   .....++.+|+.+++.++||||+++++++..+ 
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-   81 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG---PKANVEFMDEALIMASMDHPHLVRLLGVCLSP-   81 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC---HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence            457888899999999999999864 444    478888754322   22345688999999999999999999998754 


Q ss_pred             eeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccc
Q 039137          712 HSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIA  791 (912)
Q Consensus       712 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla  791 (912)
                      ..++++||+++|+|.+++...  ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++
T Consensus        82 ~~~~v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~  156 (303)
T cd05110          82 TIQLVTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLA  156 (303)
T ss_pred             CceeeehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccc
Confidence            567999999999999998543  23578999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCC--ccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhcc--CCC
Q 039137          792 KFLNPDSSN--WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLD--SRL  866 (912)
Q Consensus       792 ~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~--~~~  866 (912)
                      +........  .....++..|+|||++.+..++.++||||||+++|||++ |+.||......      .......  ...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~------~~~~~~~~~~~~  230 (303)
T cd05110         157 RLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR------EIPDLLEKGERL  230 (303)
T ss_pred             ccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHCCCCC
Confidence            866433221  122345678999999998889999999999999999997 89998522110      0111111  112


Q ss_pred             CCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          867 PYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       867 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                      +.+.    ..+..+.+++.+||..+|++||+++++++.|++...
T Consensus       231 ~~~~----~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~  270 (303)
T cd05110         231 PQPP----ICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR  270 (303)
T ss_pred             CCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            2111    123457889999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.7e-33  Score=299.12  Aligned_cols=251  Identities=28%  Similarity=0.442  Sum_probs=199.3

Q ss_pred             CCCCceeeecCceEEEEEEeCC-----CCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeee
Q 039137          640 FNAEHCIGKGGHGSVYRAKVPS-----GEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSF  714 (912)
Q Consensus       640 ~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  714 (912)
                      +++.+.||.|+||.||+|+..+     +..||+|++......   ...+.+.+|++.++.++|+||+++++++.+.+..+
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   77 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE---QQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLM   77 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh---HHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeE
Confidence            4577899999999999998753     488999998654322   14677889999999999999999999999999999


Q ss_pred             EEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccccccc
Q 039137          715 IIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL  794 (912)
Q Consensus       715 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  794 (912)
                      ++|||+++++|.+++..... ..+++.++..++.|++.|++|||+.   +++|+||+|+||+++.++.++++|||.+...
T Consensus        78 ~i~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~  153 (258)
T smart00219       78 IVMEYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDL  153 (258)
T ss_pred             EEEeccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceec
Confidence            99999999999999854322 2289999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCCcc-ccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccCCCCCCChh
Q 039137          795 NPDSSNWS-ELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLH  872 (912)
Q Consensus       795 ~~~~~~~~-~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  872 (912)
                      ........ ...+++.|+|||.+.+..++.++||||+|+++|+|++ |..||+...     .................  
T Consensus       154 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~--  226 (258)
T smart00219      154 YDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS-----NEEVLEYLKKGYRLPKP--  226 (258)
T ss_pred             ccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHhcCCCCCCC--
Confidence            54422111 2336789999999988889999999999999999998 788875210     01111111111111111  


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 039137          873 VQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL  905 (912)
Q Consensus       873 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  905 (912)
                       ...+..+.+++.+|++.||++|||+.|+++.|
T Consensus       227 -~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      227 -ENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             -CcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence             12455688999999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.1e-33  Score=300.29  Aligned_cols=249  Identities=23%  Similarity=0.379  Sum_probs=200.7

Q ss_pred             CCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEE
Q 039137          639 DFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIY  717 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  717 (912)
                      +|+..+.||+|++|.||+|... +++.+|+|.+......  ....+.+.+|+++++.++||||+++++.+..++..++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT--KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVM   78 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc--cHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEE
Confidence            5888999999999999999865 7889999998654322  224677889999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCC-cEEEeccccccccCC
Q 039137          718 EYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGY-EAHVSDFGIAKFLNP  796 (912)
Q Consensus       718 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~Dfgla~~~~~  796 (912)
                      ||+++++|.+++.... ...+++..+.+++.|++.|++|||++   +++|+||+|+||++++++ .++++|||.+.....
T Consensus        79 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~  154 (256)
T cd08220          79 EYAPGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSS  154 (256)
T ss_pred             ecCCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence            9999999999995432 34588999999999999999999999   999999999999998654 589999999987644


Q ss_pred             CCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCC-CCCChhhHH
Q 039137          797 DSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRL-PYPSLHVQK  875 (912)
Q Consensus       797 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  875 (912)
                      .. ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||+....     ............ +.+    ..
T Consensus       155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~----~~  224 (256)
T cd08220         155 KS-KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL-----PALVLKIMSGTFAPIS----DR  224 (256)
T ss_pred             Cc-cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch-----HHHHHHHHhcCCCCCC----CC
Confidence            32 22345678899999999988899999999999999999999999852110     111111111111 111    12


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          876 KLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       876 ~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .+..+.+++.+||+.||++|||++|+++
T Consensus       225 ~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         225 YSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             cCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            3456889999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=8.7e-34  Score=308.30  Aligned_cols=260  Identities=22%  Similarity=0.290  Sum_probs=199.8

Q ss_pred             CCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCc-hHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          639 DFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEM-SFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      +|++.+.||+|++|.||+|..+ +++.||+|.+........ ......+..|+++++.++|+||+++++++...+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4788899999999999999875 689999999875543211 11345577899999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+ +++|.+++....  ..+++.+++.++.|+++||+|||++   +|+|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9999 889999995432  3689999999999999999999999   999999999999999999999999999987765


Q ss_pred             CCCCcccccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCccchhcccccc----------ccch------h
Q 039137          797 DSSNWSELAGTHGYVAPELAYT-LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS----------SNMN------I  859 (912)
Q Consensus       797 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~----------~~~~------~  859 (912)
                      .........+++.|+|||.+.+ ..++.++|||||||++|||++|.+||....+.....          ....      .
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (298)
T cd07841         155 PNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP  234 (298)
T ss_pred             CCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccc
Confidence            4444444566888999998755 457899999999999999999987764211100000          0000      0


Q ss_pred             hhcc--CCCCCC-ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 039137          860 EMLD--SRLPYP-SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQL  904 (912)
Q Consensus       860 ~~~~--~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  904 (912)
                      ....  ...+.+ .......+..+.+++.+||+.||++|||++|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            0000  000000 00112234568899999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=3.4e-34  Score=309.52  Aligned_cols=258  Identities=22%  Similarity=0.370  Sum_probs=200.3

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ++|++.+.||+|+||.||+|.++ +++.||+|++.......  ...+.+.+|+++++.++||||+++++++..++..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   78 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK--MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLV   78 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc--hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEE
Confidence            46889999999999999999986 68999999986543222  2456788999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||++++++.++...   ...+++.+++.++.|++.|++|||+.   +++|+||+|+||++++++.++++|||++.....
T Consensus        79 ~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~  152 (286)
T cd07846          79 FEFVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA  152 (286)
T ss_pred             EecCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence            999999999887733   23489999999999999999999999   999999999999999999999999999987655


Q ss_pred             CCCCcccccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCccchhcccc---------ccccchhhh-----
Q 039137          797 DSSNWSELAGTHGYVAPELAYT-LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS---------SSSNMNIEM-----  861 (912)
Q Consensus       797 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~---------~~~~~~~~~-----  861 (912)
                      .........++..|+|||++.+ ..++.++||||||+++|||++|+.||........         .........     
T Consensus       153 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07846         153 PGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP  232 (286)
T ss_pred             CccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence            4444445567899999998875 3468899999999999999999998752111000         000000000     


Q ss_pred             -----ccCCCCCCC---hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          862 -----LDSRLPYPS---LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       862 -----~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                           .........   ......+..+.+++.+||+.+|++||+++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence                 000000000   001123456889999999999999999998875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1e-33  Score=306.65  Aligned_cols=259  Identities=18%  Similarity=0.242  Sum_probs=195.6

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeee
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSF  714 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  714 (912)
                      ++++|++.+.||+|+||.||+|... +++.||+|.+.......   ....+.+|+++++.++|+||+++++++..++..+
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   79 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG---VPFTAIREASLLKGLKHANIVLLHDIIHTKETLT   79 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC---CcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEE
Confidence            3578999999999999999999865 78899999986543221   2345678999999999999999999999999999


Q ss_pred             EEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccccccc
Q 039137          715 IIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL  794 (912)
Q Consensus       715 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  794 (912)
                      +||||++ +++.+++...  ...+++.++..++.|++.||+|||+.   +|+|+||||+||+++.++.++|+|||+++..
T Consensus        80 lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~  153 (291)
T cd07870          80 FVFEYMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAK  153 (291)
T ss_pred             EEEeccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEecccccccc
Confidence            9999996 5776666332  24577888999999999999999999   9999999999999999999999999999765


Q ss_pred             CCCCCCccccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCccchhcccccccc-----------------
Q 039137          795 NPDSSNWSELAGTHGYVAPELAYTL-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSN-----------------  856 (912)
Q Consensus       795 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~-----------------  856 (912)
                      ...........+++.|+|||++.+. .++.++||||||+++|||++|+.||+...........                 
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (291)
T cd07870         154 SIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS  233 (291)
T ss_pred             CCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh
Confidence            4333333445678999999988754 4788999999999999999999998632111000000                 


Q ss_pred             ----chhhhccCCCCCCCh---hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          857 ----MNIEMLDSRLPYPSL---HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       857 ----~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                          ..........+....   ........+.+++.+|+..||++|||++|++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence                000000000000000   00011346788999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.2e-33  Score=306.10  Aligned_cols=250  Identities=26%  Similarity=0.422  Sum_probs=202.3

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ++|.+.+.||+|+||.||+|... +++.||+|.+.....    ...+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv   94 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ----PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV   94 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc----hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence            67999999999999999999864 688999999753221    1356788999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      +||+++++|.+++.+    ..+++.++..++.|++.|++|||++   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        95 ~e~~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~  167 (293)
T cd06647          95 MEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (293)
T ss_pred             EecCCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence            999999999999843    3478899999999999999999999   999999999999999999999999999876655


Q ss_pred             CCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHH
Q 039137          797 DSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKK  876 (912)
Q Consensus       797 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  876 (912)
                      .........+++.|+|||.+.+..++.++||||||+++|++++|+.||.......    ..............  .....
T Consensus       168 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~----~~~~~~~~~~~~~~--~~~~~  241 (293)
T cd06647         168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR----ALYLIATNGTPELQ--NPEKL  241 (293)
T ss_pred             cccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh----heeehhcCCCCCCC--Ccccc
Confidence            4444445568889999999988889999999999999999999999986321110    00000001111111  11223


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 039137          877 LMSIMQVAFSCLDQNPESRPTMKRVSQL  904 (912)
Q Consensus       877 ~~~l~~li~~cl~~dP~~RPt~~evl~~  904 (912)
                      +..+.+++.+||..+|++||++++++..
T Consensus       242 ~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         242 SAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            4568899999999999999999988764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=7.8e-34  Score=306.41  Aligned_cols=258  Identities=22%  Similarity=0.318  Sum_probs=197.2

Q ss_pred             CCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEE
Q 039137          639 DFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIY  717 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  717 (912)
                      +|+..+.||+|++|.||+|+.+ +++.||+|++.......  ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE--GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF   78 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccccc--ccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEe
Confidence            4788899999999999999875 78999999986543222  13457889999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCC
Q 039137          718 EYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPD  797 (912)
Q Consensus       718 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  797 (912)
                      ||+. ++|.+++... ....+++.++..++.|++.|++|||+.   +++|+||+|+||+++.++.+|++|||++......
T Consensus        79 e~~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~  153 (284)
T cd07860          79 EFLH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  153 (284)
T ss_pred             eccc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence            9996 5888888443 235689999999999999999999999   9999999999999999999999999999866544


Q ss_pred             CCCccccccccccccccccccCC-CCcchhHHHHHHHHHHHHhCCCCccchhccccccc------cch-------hhhcc
Q 039137          798 SSNWSELAGTHGYVAPELAYTLK-VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSS------NMN-------IEMLD  863 (912)
Q Consensus       798 ~~~~~~~~g~~~y~aPE~~~~~~-~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~------~~~-------~~~~~  863 (912)
                      ........+++.|+|||++.+.. ++.++||||||+++|||+||+.||....+......      ...       .....
T Consensus       154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07860         154 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD  233 (284)
T ss_pred             ccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHH
Confidence            33334445788999999887654 58899999999999999999999852211100000      000       00000


Q ss_pred             --CCCCC---CC--hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          864 --SRLPY---PS--LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       864 --~~~~~---~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                        ...+.   ..  .........+.++|.+||+.||++|||++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence              00000   00  000112345778999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.3e-33  Score=302.58  Aligned_cols=254  Identities=27%  Similarity=0.396  Sum_probs=199.3

Q ss_pred             CCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCc------hHHHHHHHHHHHHHhhcCCCccccEEEEEEcCC
Q 039137          639 DFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEM------SFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPK  711 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~------~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~  711 (912)
                      +|.+.+.||+|++|.||+|... +++.||+|.+..+.....      ....+.+.+|+.+++.++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4778899999999999999765 689999998864322111      112356788999999999999999999999999


Q ss_pred             eeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccc
Q 039137          712 HSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIA  791 (912)
Q Consensus       712 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla  791 (912)
                      ..++||||+++++|.+++.+.   ..+++..+..++.|++.|+.|||++   +++||||+|+||+++.++.++++|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccc
Confidence            999999999999999998543   5688999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCC--CccccccccccccccccccCC--CCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhh--ccCC
Q 039137          792 KFLNPDSS--NWSELAGTHGYVAPELAYTLK--VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEM--LDSR  865 (912)
Q Consensus       792 ~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~--~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~--~~~~  865 (912)
                      ........  ......++..|+|||.+....  ++.++||||+|+++||+++|..||......     ......  ....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~  230 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI-----AAMFKLGNKRSA  230 (272)
T ss_pred             ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH-----HHHHHhhccccC
Confidence            76543211  122345788999999887654  789999999999999999999998521110     000000  0111


Q ss_pred             CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          866 LPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       866 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ...+.......+..+.+++.+||+.||++||+++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         231 PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             CcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            11222222234567889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=9.9e-34  Score=303.45  Aligned_cols=239  Identities=20%  Similarity=0.329  Sum_probs=185.0

Q ss_pred             eeeecCceEEEEEEeCC-------------------------CCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCc
Q 039137          645 CIGKGGHGSVYRAKVPS-------------------------GEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRN  699 (912)
Q Consensus       645 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n  699 (912)
                      .||+|+||.||+|....                         ...|++|++....    ......+.+|+.+++.++|||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~~~~~~~~~l~h~n   77 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH----RDIALAFFETASLMSQVSHIH   77 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH----HHHHHHHHHHHHHHhcCCCCC
Confidence            58999999999996421                         1348888875321    223467889999999999999


Q ss_pred             cccEEEEEEcCCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcC
Q 039137          700 IVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDL  779 (912)
Q Consensus       700 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~  779 (912)
                      |+++++++......++||||+++|+|..++...  .+.+++..+..++.|+++||+|||++   +|+||||||+||+++.
T Consensus        78 iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~  152 (274)
T cd05076          78 LAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLAR  152 (274)
T ss_pred             eeeEEEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEec
Confidence            999999999999999999999999999998542  34688999999999999999999999   9999999999999976


Q ss_pred             CC-------cEEEeccccccccCCCCCCcccccccccccccccccc-CCCCcchhHHHHHHHHHHHH-hCCCCccchhcc
Q 039137          780 GY-------EAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEM  850 (912)
Q Consensus       780 ~~-------~~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~vl~ell-tg~~pf~~~~~~  850 (912)
                      .+       .++++|||.+......    ....++..|+|||.+.+ ..++.++||||||+++||++ +|+.||......
T Consensus       153 ~~~~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~  228 (274)
T cd05076         153 LGLAEGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS  228 (274)
T ss_pred             cCcccCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH
Confidence            43       3899999988644222    22356788999998865 55899999999999999995 699997522110


Q ss_pred             ccccccchhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 039137          851 SSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLC  906 (912)
Q Consensus       851 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  906 (912)
                            ............+..    ....+.+++.+||+.+|++|||+.++++.|+
T Consensus       229 ------~~~~~~~~~~~~~~~----~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         229 ------EKERFYEKKHRLPEP----SCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             ------HHHHHHHhccCCCCC----CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence                  011111111122211    1235788999999999999999999998773

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.8e-33  Score=302.32  Aligned_cols=249  Identities=28%  Similarity=0.415  Sum_probs=201.5

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      +-|+..+.||+|+||.||+|... +++.||+|.+.....   ....+.+.+|+..++.++||||+++++++..++..++|
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   80 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA---EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII   80 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc---hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEE
Confidence            34778899999999999999865 788999998754321   22456788999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++++|.+++..    ..+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.++++|||++.....
T Consensus        81 ~e~~~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06641          81 MEYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD  153 (277)
T ss_pred             EEeCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence            999999999999843    3588999999999999999999999   999999999999999999999999999976654


Q ss_pred             CCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHH
Q 039137          797 DSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKK  876 (912)
Q Consensus       797 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  876 (912)
                      .........++..|+|||.+.+..++.++||||+||++|+|++|..||......     ...........+.   .....
T Consensus       154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~---~~~~~  225 (277)
T cd06641         154 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM-----KVLFLIPKNNPPT---LEGNY  225 (277)
T ss_pred             chhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH-----HHHHHHhcCCCCC---CCccc
Confidence            433334456788999999998888899999999999999999999998522110     0001111111110   11223


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 039137          877 LMSIMQVAFSCLDQNPESRPTMKRVSQL  904 (912)
Q Consensus       877 ~~~l~~li~~cl~~dP~~RPt~~evl~~  904 (912)
                      +..+.+++.+||+.+|.+||++.++++.
T Consensus       226 ~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         226 SKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            4568899999999999999999999883

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.8e-33  Score=303.44  Aligned_cols=248  Identities=25%  Similarity=0.365  Sum_probs=198.4

Q ss_pred             CCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEE
Q 039137          639 DFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIY  717 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  717 (912)
                      .|...+.||+|++|.||+|... +++.+++|++....    ....+.+.+|+.+++.++||||+++++++..++..++|+
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~   95 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK----QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVM   95 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc----hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEE
Confidence            3555679999999999999864 78899999875322    123566889999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCC
Q 039137          718 EYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPD  797 (912)
Q Consensus       718 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  797 (912)
                      ||+++++|.+++..    ..+++.++..++.|++.|++|||++   +++||||+|+||+++.++.++++|||.+......
T Consensus        96 e~~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~  168 (285)
T cd06648          96 EFLEGGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE  168 (285)
T ss_pred             eccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccC
Confidence            99999999999844    4588999999999999999999999   9999999999999999999999999988765443


Q ss_pred             CCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHH
Q 039137          798 SSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKL  877 (912)
Q Consensus       798 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  877 (912)
                      ........|++.|+|||...+..++.++||||+|+++|||++|+.||.....     ............+.. ......+
T Consensus       169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~-----~~~~~~~~~~~~~~~-~~~~~~~  242 (285)
T cd06648         169 VPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP-----LQAMKRIRDNLPPKL-KNLHKVS  242 (285)
T ss_pred             CcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH-----HHHHHHHHhcCCCCC-cccccCC
Confidence            3333445688999999999888899999999999999999999999752110     000111111111111 0111234


Q ss_pred             HHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          878 MSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       878 ~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ..+.+++.+||+.+|++||++.++++
T Consensus       243 ~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         243 PRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             HHHHHHHHHHcccChhhCcCHHHHcc
Confidence            56889999999999999999998875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.3e-33  Score=309.95  Aligned_cols=193  Identities=23%  Similarity=0.387  Sum_probs=158.7

Q ss_pred             CceeeecCceEEEEEEeC---CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEc--CCeeeEEE
Q 039137          643 EHCIGKGGHGSVYRAKVP---SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSH--PKHSFIIY  717 (912)
Q Consensus       643 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~~lv~  717 (912)
                      +..||+|+||+||+|+.+   ++..||+|.+....      ....+.+|+++++.++||||+++++++..  +...++||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~   79 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG------ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLF   79 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC------CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEE
Confidence            368999999999999865   45789999886432      23456789999999999999999999853  46789999


Q ss_pred             eecCCCChhhHhhcc------CCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEE----cCCCcEEEec
Q 039137          718 EYLESGSLDKILCND------ASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLL----DLGYEAHVSD  787 (912)
Q Consensus       718 e~~~~g~L~~~l~~~------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill----~~~~~~kl~D  787 (912)
                      ||+++ ++.+++...      .....+++..++.++.|++.||+|||++   +|+||||||+||++    +.++.+||+|
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~D  155 (317)
T cd07867          80 DYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIAD  155 (317)
T ss_pred             eeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEee
Confidence            99875 777776322      1223588999999999999999999999   99999999999999    5667899999


Q ss_pred             cccccccCCCCC---CccccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCcc
Q 039137          788 FGIAKFLNPDSS---NWSELAGTHGYVAPELAYTL-KVTEKCDVYSFGVLALEVIKGKHPRD  845 (912)
Q Consensus       788 fgla~~~~~~~~---~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~pf~  845 (912)
                      ||+++.......   ......+++.|+|||++.+. .++.++||||+||++|||+||++||.
T Consensus       156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~  217 (317)
T cd07867         156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH  217 (317)
T ss_pred             ccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcc
Confidence            999987654322   22345689999999988764 57899999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2e-33  Score=298.73  Aligned_cols=238  Identities=25%  Similarity=0.428  Sum_probs=187.3

Q ss_pred             ceeeecCceEEEEEEeCCCC-----------EEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCe
Q 039137          644 HCIGKGGHGSVYRAKVPSGE-----------IFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKH  712 (912)
Q Consensus       644 ~~lg~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~  712 (912)
                      +.||+|+||.||+|.+++..           .+++|.+.....     ....+.+|+.+++.++||||+++++++.. +.
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~   74 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR-----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DE   74 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh-----hHHHHHHHHHHHHcCCCcchhheeeEEec-CC
Confidence            46899999999999876433           467776543211     25678899999999999999999999988 77


Q ss_pred             eeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCC-------cEEE
Q 039137          713 SFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGY-------EAHV  785 (912)
Q Consensus       713 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-------~~kl  785 (912)
                      .++||||+++|+|.+++....  ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++       .+|+
T Consensus        75 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl  149 (259)
T cd05037          75 NIMVEEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKL  149 (259)
T ss_pred             cEEEEEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEe
Confidence            899999999999999995433  2688999999999999999999999   999999999999999887       7999


Q ss_pred             eccccccccCCCCCCccccccccccccccccccC--CCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhc
Q 039137          786 SDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTL--KVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEML  862 (912)
Q Consensus       786 ~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~  862 (912)
                      +|||++.....    .....++..|+|||++.+.  .++.++||||||+++|||++ |..||.....   . ........
T Consensus       150 ~Dfg~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~---~-~~~~~~~~  221 (259)
T cd05037         150 SDPGIPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS---S-EKERFYQD  221 (259)
T ss_pred             CCCCccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc---h-hHHHHHhc
Confidence            99999986543    2234567789999998876  78999999999999999999 5777642211   0 00000001


Q ss_pred             cCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 039137          863 DSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLC  906 (912)
Q Consensus       863 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  906 (912)
                      ....+.+.      ...+.+++.+||+.+|.+|||+.++++.|+
T Consensus       222 ~~~~~~~~------~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         222 QHRLPMPD------CAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             CCCCCCCC------chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            11112211      156889999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-35  Score=340.93  Aligned_cols=253  Identities=28%  Similarity=0.418  Sum_probs=205.1

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      +-+++....||.|.||.||-|... +|+..|+|.+......  ....+.+.+|..++..++|||+|+++|+-.+.+..++
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~--~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD--HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc--cccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence            456778889999999999999754 7999999988654332  2245667899999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      .||||++|+|.+.+..   .+..++.....+..|++.|++|||++   |||||||||.||+++.+|.+|++|||.|..+.
T Consensus      1312 FMEyC~~GsLa~ll~~---gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEH---GRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred             HHHHhccCcHHHHHHh---cchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEec
Confidence            9999999999999943   33456677778889999999999999   99999999999999999999999999999876


Q ss_pred             CCCCC----ccccccccccccccccccCC---CCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCC
Q 039137          796 PDSSN----WSELAGTHGYVAPELAYTLK---VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPY  868 (912)
Q Consensus       796 ~~~~~----~~~~~g~~~y~aPE~~~~~~---~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  868 (912)
                      .....    .....|||.|||||++.+..   ...++||||+|||+.||+||+.||.   +.+.....+..-......+.
T Consensus      1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~---~~dne~aIMy~V~~gh~Pq~ 1462 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWA---ELDNEWAIMYHVAAGHKPQI 1462 (1509)
T ss_pred             CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchh---hccchhHHHhHHhccCCCCC
Confidence            55322    24568999999999998654   5678999999999999999999985   22222233333333333333


Q ss_pred             CChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 039137          869 PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQL  904 (912)
Q Consensus       869 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  904 (912)
                      |.    ..+.+-.+++..|+..||++|+++.|+++.
T Consensus      1463 P~----~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1463 PE----RLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             ch----hhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            32    256677899999999999999999987753

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-34  Score=307.49  Aligned_cols=258  Identities=25%  Similarity=0.378  Sum_probs=200.4

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ++|++.+.||+|++|.||+|.++ +++.||+|++.......  ...+.+.+|+++++.++|+||+++++++..++..++|
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   78 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDE--DVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLV   78 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccc--cchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEE
Confidence            36889999999999999999876 68899999986543221  2457788999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||++++.+..+...   ...+++.++..++.|++.|++|||+.   +++|+||+|+||++++++.+||+|||.+.....
T Consensus        79 ~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~  152 (288)
T cd07833          79 FEYVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRA  152 (288)
T ss_pred             EecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCC
Confidence            999998777766522   34588999999999999999999999   999999999999999999999999999987655


Q ss_pred             CCC-CccccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCccchhcccccc---------ccchhhh----
Q 039137          797 DSS-NWSELAGTHGYVAPELAYTL-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS---------SNMNIEM----  861 (912)
Q Consensus       797 ~~~-~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~---------~~~~~~~----  861 (912)
                      ... ......++..|+|||++.+. .++.++||||+|+++|+|++|+.||..........         .......    
T Consensus       153 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07833         153 RPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN  232 (288)
T ss_pred             CccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence            432 33445678899999999887 78999999999999999999999985221100000         0000000    


Q ss_pred             --ccC-CCCCCC--h-----hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          862 --LDS-RLPYPS--L-----HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       862 --~~~-~~~~~~--~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                        ... ..+...  .     .....+..+.++|.+||..+|++||+++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence              000 000000  0     00112566889999999999999999998875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.5e-33  Score=303.97  Aligned_cols=252  Identities=24%  Similarity=0.383  Sum_probs=194.3

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHH-HhhcCCCccccEEEEEEcCCeeeE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQA-LTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~-l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      ++|++.+.||+|+||.||+|+++ +|+.||+|++.......   ...++..|+.. ++..+||||+++++++..++..++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~l   77 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ---EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWI   77 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH---HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEE
Confidence            47889999999999999999876 79999999986543221   23455566665 566689999999999999999999


Q ss_pred             EEeecCCCChhhHhhcc-CCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccccccc
Q 039137          716 IYEYLESGSLDKILCND-ASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL  794 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  794 (912)
                      ||||++ |+|.+++... .....+++..++.++.|++.|++|||++.  +++||||||+||+++.++.+||+|||.+...
T Consensus        78 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~  154 (283)
T cd06617          78 CMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYL  154 (283)
T ss_pred             Ehhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence            999997 5888877442 23356899999999999999999999853  8999999999999999999999999999865


Q ss_pred             CCCCCCcccccccccccccccccc----CCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccC-CCCCC
Q 039137          795 NPDSSNWSELAGTHGYVAPELAYT----LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDS-RLPYP  869 (912)
Q Consensus       795 ~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~  869 (912)
                      ... .......++..|+|||.+.+    ..++.++|+||+|+++|+|++|+.||......    .......... ....+
T Consensus       155 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~  229 (283)
T cd06617         155 VDS-VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP----FQQLKQVVEEPSPQLP  229 (283)
T ss_pred             ccc-cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC----HHHHHHHHhcCCCCCC
Confidence            432 12233467889999998865    44688999999999999999999998521110    0001111111 11111


Q ss_pred             ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          870 SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       870 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                         ....+..+.+++.+||..+|++||++.++++
T Consensus       230 ---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         230 ---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             ---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               1224566889999999999999999999876

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.3e-34  Score=310.11  Aligned_cols=249  Identities=22%  Similarity=0.360  Sum_probs=207.9

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      ...|.+...||+|.|++|..|++. ++..||+|.+.+..-...  ....+.+|+++|+.++|||||+++++.+.+...|+
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~--~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl  132 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPS--KRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL  132 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChH--HHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence            356889999999999999999876 799999999987654433  33448899999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ||||+.+|.+.+++...   +...+..+..++.|+++|++|+|++   .|||||||++||+++.+..+||+|||++..+.
T Consensus       133 V~eya~~ge~~~yl~~~---gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~  206 (596)
T KOG0586|consen  133 VMEYASGGELFDYLVKH---GRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD  206 (596)
T ss_pred             EEEeccCchhHHHHHhc---ccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec
Confidence            99999999999999554   3455688999999999999999999   99999999999999999999999999999887


Q ss_pred             CCCCCccccccccccccccccccCCC-CcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhH
Q 039137          796 PDSSNWSELAGTHGYVAPELAYTLKV-TEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQ  874 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  874 (912)
                      . .......+|++.|.|||++.+..| .+++|+||+|+++|.|+.|..|||...-     .......+..++..+.    
T Consensus       207 ~-~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l-----k~Lr~rvl~gk~rIp~----  276 (596)
T KOG0586|consen  207 Y-GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL-----KELRPRVLRGKYRIPF----  276 (596)
T ss_pred             c-cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc-----ccccchheeeeecccc----
Confidence            3 355677899999999999999887 5799999999999999999999972111     1111222333333322    


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          875 KKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       875 ~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ..+.+..++|.+++-.+|.+|++++++.+
T Consensus       277 ~ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  277 YMSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             eeechhHHHHHHhhccCccccCCHHHhhh
Confidence            12345778999999999999999999865

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.4e-34  Score=301.50  Aligned_cols=251  Identities=22%  Similarity=0.278  Sum_probs=194.0

Q ss_pred             ceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHH-hhcCCCccccEEEEEEcCCeeeEEEeecC
Q 039137          644 HCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQAL-TEIRHRNIVKFYGFCSHPKHSFIIYEYLE  721 (912)
Q Consensus       644 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~  721 (912)
                      +.||+|+||.||+|... +++.||+|.+......... ....+..|...+ ...+|+|++++++++...+..++||||++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKN-QVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN   80 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHH-HHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccC
Confidence            56899999999999875 6889999998643221111 223344555444 44589999999999999999999999999


Q ss_pred             CCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCCCc
Q 039137          722 SGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNW  801 (912)
Q Consensus       722 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  801 (912)
                      +++|.+++...   ..+++..+..++.|++.||.|||+.   +++||||+|+||++++++.++|+|||.+.....    .
T Consensus        81 ~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~  150 (260)
T cd05611          81 GGDCASLIKTL---GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----N  150 (260)
T ss_pred             CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc----c
Confidence            99999998443   4588999999999999999999999   999999999999999999999999999875432    2


Q ss_pred             cccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHHHHHH
Q 039137          802 SELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIM  881 (912)
Q Consensus       802 ~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  881 (912)
                      ....+++.|+|||.+.+..++.++||||+|+++|+|++|..||.....     ..............+.......+..+.
T Consensus       151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (260)
T cd05611         151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP-----DAVFDNILSRRINWPEEVKEFCSPEAV  225 (260)
T ss_pred             ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHhcccCCCCcccccCCHHHH
Confidence            334678899999999888889999999999999999999999852211     111111111121122112223456688


Q ss_pred             HHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          882 QVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       882 ~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                      +++.+||+.+|++||++.++.+.+...++
T Consensus       226 ~~i~~~l~~~p~~R~~~~~~~~~l~~~~~  254 (260)
T cd05611         226 DLINRLLCMDPAKRLGANGYQEIKSHPFF  254 (260)
T ss_pred             HHHHHHccCCHHHccCCCcHHHHHcChHh
Confidence            99999999999999998877777766554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=7.2e-34  Score=301.92  Aligned_cols=240  Identities=24%  Similarity=0.413  Sum_probs=187.2

Q ss_pred             ceeeecCceEEEEEEeCC--------CCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          644 HCIGKGGHGSVYRAKVPS--------GEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       644 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      +.||+|+||.||+|..+.        ...||+|.+....    ....+.+.+|+.+++.++||||+++++++..++..++
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~l   76 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH----RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIM   76 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh----HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEE
Confidence            368999999999997642        2347777764321    2245678899999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCc--------EEEec
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYE--------AHVSD  787 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~--------~kl~D  787 (912)
                      ||||+++|+|.+++....  ..+++..+..++.||+.|++|||++   +|+||||||+||+++.++.        ++++|
T Consensus        77 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d  151 (258)
T cd05078          77 VQEYVKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD  151 (258)
T ss_pred             EEecCCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecc
Confidence            999999999999995433  3688999999999999999999999   9999999999999987765        69999


Q ss_pred             cccccccCCCCCCccccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCC-CCccchhccccccccchhhhccCC
Q 039137          788 FGIAKFLNPDSSNWSELAGTHGYVAPELAYTL-KVTEKCDVYSFGVLALEVIKGK-HPRDFLFEMSSSSSNMNIEMLDSR  865 (912)
Q Consensus       788 fgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~-~pf~~~~~~~~~~~~~~~~~~~~~  865 (912)
                      ||.+......    ....+++.|+|||++.+. .++.++||||||+++|||++|. .||.....      .........+
T Consensus       152 ~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~------~~~~~~~~~~  221 (258)
T cd05078         152 PGISITVLPK----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS------QKKLQFYEDR  221 (258)
T ss_pred             cccccccCCc----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH------HHHHHHHHcc
Confidence            9988754322    234678899999998864 4789999999999999999985 55431111      0111111222


Q ss_pred             CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 039137          866 LPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLC  906 (912)
Q Consensus       866 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  906 (912)
                      ...+.    ....++.+++.+||+.||++|||++++++.|+
T Consensus       222 ~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         222 HQLPA----PKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ccCCC----CCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            22221    12245789999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.2e-33  Score=303.22  Aligned_cols=257  Identities=23%  Similarity=0.331  Sum_probs=199.4

Q ss_pred             CCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEE
Q 039137          639 DFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIY  717 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  717 (912)
                      +|++.+.||+|++|.||+|++. +++.||+|++.......  ...+.+.+|+.+++.++||||+++++++..++..++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~   78 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG--GIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVM   78 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccc--hhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEe
Confidence            5888999999999999999875 78999999987543222  23567889999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCC
Q 039137          718 EYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPD  797 (912)
Q Consensus       718 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  797 (912)
                      ||+ +++|.+++....  ..+++.+++.++.|++.||+|||++   +++|+||||+||+++.++.++++|||.+......
T Consensus        79 e~~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~  152 (286)
T cd07832          79 EYM-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEE  152 (286)
T ss_pred             ccc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence            999 999999985433  5689999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CC-CccccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCccchhccccc----------cccchhh-----
Q 039137          798 SS-NWSELAGTHGYVAPELAYTL-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS----------SSNMNIE-----  860 (912)
Q Consensus       798 ~~-~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~----------~~~~~~~-----  860 (912)
                      .. ......++..|+|||++.+. .++.++||||+|+++|||++|.+||....+....          .......     
T Consensus       153 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07832         153 EPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP  232 (286)
T ss_pred             CCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcc
Confidence            21 23345688999999988654 4689999999999999999998887422110000          0000000     


Q ss_pred             -hccCCCCCC-----ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          861 -MLDSRLPYP-----SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       861 -~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                       ......+..     ..........+.+++.+|++.||++|||++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence             000000000     0001123467889999999999999999998875

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2.3e-33  Score=303.02  Aligned_cols=252  Identities=27%  Similarity=0.451  Sum_probs=204.8

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeee
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSF  714 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  714 (912)
                      ..+.|+..+.||+|++|.||+|.++ +++.|++|++.....     ..+.+.+|++.++.++|+|++++++++...+..+
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   91 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELW   91 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEE
Confidence            4566888899999999999999886 688999999864322     3567889999999999999999999999999999


Q ss_pred             EEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccccccc
Q 039137          715 IIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL  794 (912)
Q Consensus       715 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  794 (912)
                      +|+||+++++|.+++....  ..+++.++..++.|++.|++|||+.   +++|+||+|+||+++.++.++|+|||.+...
T Consensus        92 lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~  166 (286)
T cd06614          92 VVMEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQL  166 (286)
T ss_pred             EEEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhh
Confidence            9999999999999995533  3689999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhH
Q 039137          795 NPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQ  874 (912)
Q Consensus       795 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  874 (912)
                      ...........+++.|+|||++.+..++.++||||||+++|+|++|+.||......     ...........+ ......
T Consensus       167 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~-~~~~~~  240 (286)
T cd06614         167 TKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-----RALFLITTKGIP-PLKNPE  240 (286)
T ss_pred             ccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhcCCC-CCcchh
Confidence            54333334456788999999998888999999999999999999999997522111     001111111111 111112


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          875 KKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       875 ~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ..+..+.+++.+||+.+|.+||++.++++
T Consensus       241 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         241 KWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             hCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            24466889999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=2.4e-33  Score=302.54  Aligned_cols=258  Identities=21%  Similarity=0.314  Sum_probs=199.6

Q ss_pred             CCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEE
Q 039137          639 DFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIY  717 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  717 (912)
                      +|++.+.||+|++|.||+|+.+ +|+.||+|++.......   ..+.+.+|+++++.++||||+++++++...+..++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   77 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEG---TPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVF   77 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccccc---chHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEE
Confidence            4888999999999999999986 68899999987543221   3456778999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCC
Q 039137          718 EYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPD  797 (912)
Q Consensus       718 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  797 (912)
                      ||+++ ++.+++........+++.++..++.|++.|++|||+.   +++||||+|+||++++++.++++|||++......
T Consensus        78 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~  153 (284)
T cd07836          78 EYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIP  153 (284)
T ss_pred             ecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC
Confidence            99985 8888885554445689999999999999999999999   9999999999999999999999999999865443


Q ss_pred             CCCccccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCccchhccccc---------c-ccchh-----hh
Q 039137          798 SSNWSELAGTHGYVAPELAYTL-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS---------S-SNMNI-----EM  861 (912)
Q Consensus       798 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~---------~-~~~~~-----~~  861 (912)
                      ........+++.|+|||++.+. .++.++||||+|+++|+|++|+.||.........         . .....     ..
T Consensus       154 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07836         154 VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE  233 (284)
T ss_pred             ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence            3333445678899999987654 4688999999999999999999998522110000         0 00000     00


Q ss_pred             ccCCCCCCChh-----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          862 LDSRLPYPSLH-----VQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       862 ~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .....+.....     ....+..+.+++.+|++.||++||+++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00111110000     1122456789999999999999999999874

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1e-33  Score=300.69  Aligned_cols=251  Identities=24%  Similarity=0.341  Sum_probs=201.4

Q ss_pred             CCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEE
Q 039137          639 DFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIY  717 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  717 (912)
                      +|++.+.||+|+||.||+|..+ ++..||+|.+.......  ...+.+.+|+++++.++|+||+++++++...+..++|+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   78 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV--KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVM   78 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc--hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEE
Confidence            4788899999999999999876 68889999986532211  13567789999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCc-EEEeccccccccCC
Q 039137          718 EYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYE-AHVSDFGIAKFLNP  796 (912)
Q Consensus       718 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~-~kl~Dfgla~~~~~  796 (912)
                      ||+++++|.+++.+.. ...+++..+..++.|++.|++|||+.   +++|+||+|+||++++++. ++++|||.+.....
T Consensus        79 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~  154 (257)
T cd08225          79 EYCDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND  154 (257)
T ss_pred             ecCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence            9999999999985432 23578999999999999999999999   9999999999999998864 69999999987654


Q ss_pred             CCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHH
Q 039137          797 DSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKK  876 (912)
Q Consensus       797 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  876 (912)
                      .........|++.|+|||+..+..++.++||||||+++|||++|+.||.....     ............+..   ....
T Consensus       155 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~---~~~~  226 (257)
T cd08225         155 SMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL-----HQLVLKICQGYFAPI---SPNF  226 (257)
T ss_pred             CcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHhcccCCCC---CCCC
Confidence            43333445688999999999888899999999999999999999999852111     111111111111111   1123


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          877 LMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       877 ~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      +..+.+++.+||..+|++|||+.|+++
T Consensus       227 ~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         227 SRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            356889999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-34  Score=312.94  Aligned_cols=263  Identities=29%  Similarity=0.421  Sum_probs=208.3

Q ss_pred             CCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC------Ce
Q 039137          640 FNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP------KH  712 (912)
Q Consensus       640 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------~~  712 (912)
                      +...+.||+|+||.||+|+++ +|+.||||.+.......   ..+...+|++++++++|+|||+++++-++.      +.
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r---~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~   91 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLR---PRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL   91 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccc---hHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence            455678999999999999965 89999999997654222   467788999999999999999999987543      45


Q ss_pred             eeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEc--CCCc--EEEecc
Q 039137          713 SFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLD--LGYE--AHVSDF  788 (912)
Q Consensus       713 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~--~~~~--~kl~Df  788 (912)
                      ..+|||||.+|+|+..+.+......+++.+.+.+...++.||.|||++   +||||||||.||++-  ++|+  .||+||
T Consensus        92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDf  168 (732)
T KOG4250|consen   92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDF  168 (732)
T ss_pred             ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecc
Confidence            789999999999999998878888899999999999999999999999   999999999999984  4444  799999


Q ss_pred             ccccccCCCCCCccccccccccccccccc-cCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccch---------
Q 039137          789 GIAKFLNPDSSNWSELAGTHGYVAPELAY-TLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMN---------  858 (912)
Q Consensus       789 gla~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~---------  858 (912)
                      |+|+...++ ......+||+.|.+||.+. .+.|+..+|.|||||++|+.+||..||.+.....+..+.+.         
T Consensus       169 G~Arel~d~-s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~  247 (732)
T KOG4250|consen  169 GAARELDDN-SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG  247 (732)
T ss_pred             cccccCCCC-CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence            999988655 4678899999999999988 48899999999999999999999999974433221111110         


Q ss_pred             -----------hhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCC--CHHHHHHHHHHhh
Q 039137          859 -----------IEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRP--TMKRVSQLLCEKI  909 (912)
Q Consensus       859 -----------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP--t~~evl~~L~~~l  909 (912)
                                 .-.+...+|++..........+...+..++..+|++|.  .+.+....+..++
T Consensus       248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL  311 (732)
T KOG4250|consen  248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDIL  311 (732)
T ss_pred             eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHH
Confidence                       11112233444444455555677777888999999998  5555544444433

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-34  Score=287.25  Aligned_cols=259  Identities=22%  Similarity=0.298  Sum_probs=212.0

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeee
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSF  714 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  714 (912)
                      ..++|+..++||+|.||.|..++.+ +++.||+|++++...-... ....-+.|-.+++.-+||.+..+--.|...+..|
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakd-EVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlC  244 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKD-EVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLC  244 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehH-HhhhhhhHHHHHHhccCcHHHHhhhhhccCceEE
Confidence            4578999999999999999999876 7999999999877654332 4455678999999999999999998999999999


Q ss_pred             EEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccccccc
Q 039137          715 IIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL  794 (912)
Q Consensus       715 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  794 (912)
                      +||||..||.|.-++.+   .+.+++..++-+-..|+.||.|||++   +||.||+|.+|.++|.+|.+||+|||+++.-
T Consensus       245 FVMeyanGGeLf~HLsr---er~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~  318 (516)
T KOG0690|consen  245 FVMEYANGGELFFHLSR---ERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEE  318 (516)
T ss_pred             EEEEEccCceEeeehhh---hhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhc
Confidence            99999999999988844   45689999999999999999999999   9999999999999999999999999999865


Q ss_pred             CCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhH
Q 039137          795 NPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQ  874 (912)
Q Consensus       795 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  874 (912)
                      -.........+|||.|.|||++....|..++|.|.+||++|||++|+.||..     ........-++-..+.+|.    
T Consensus       319 I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn-----~dh~kLFeLIl~ed~kFPr----  389 (516)
T KOG0690|consen  319 IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYN-----KDHEKLFELILMEDLKFPR----  389 (516)
T ss_pred             ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccc-----cchhHHHHHHHhhhccCCc----
Confidence            5556667889999999999999999999999999999999999999999841     1111111222222333332    


Q ss_pred             HHHHHHHHHHHHcccCCCCCCC--CHHHHHHHHHHhhh
Q 039137          875 KKLMSIMQVAFSCLDQNPESRP--TMKRVSQLLCEKIF  910 (912)
Q Consensus       875 ~~~~~l~~li~~cl~~dP~~RP--t~~evl~~L~~~l~  910 (912)
                      ..+++...++...+.+||.+|.  ..+++.+..+..+|
T Consensus       390 ~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF  427 (516)
T KOG0690|consen  390 TLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFF  427 (516)
T ss_pred             cCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhh
Confidence            2334566788899999999995  44556555555544

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2.1e-33  Score=304.88  Aligned_cols=260  Identities=19%  Similarity=0.249  Sum_probs=195.9

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcC-CCccccEEEEEEcCCe---
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR-HRNIVKFYGFCSHPKH---  712 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~---  712 (912)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++.......  .....+.+|+.+++.++ ||||+++++++...+.   
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~--~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~   78 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEE--GIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGK   78 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcccc--CCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCC
Confidence            46889999999999999999876 78999999986543221  13456788999999995 6999999999977655   


Q ss_pred             --eeEEEeecCCCChhhHhhccCC--cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcC-CCcEEEec
Q 039137          713 --SFIIYEYLESGSLDKILCNDAS--AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDL-GYEAHVSD  787 (912)
Q Consensus       713 --~~lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~D  787 (912)
                        .|+||||+++ ++.+++.....  ...+++.+++.++.||+.||+|||++   +|+||||+|+||+++. ++.+||+|
T Consensus        79 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~d  154 (295)
T cd07837          79 PSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIAD  154 (295)
T ss_pred             ceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEee
Confidence              8999999986 78888754322  34689999999999999999999999   9999999999999998 88999999


Q ss_pred             cccccccCCCCCCcccccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCccchhccccccc------cchhh
Q 039137          788 FGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSS------NMNIE  860 (912)
Q Consensus       788 fgla~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~------~~~~~  860 (912)
                      ||.+..............+++.|+|||++.+ ..++.++||||||+++|+|++|..||....+......      .....
T Consensus       155 fg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (295)
T cd07837         155 LGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ  234 (295)
T ss_pred             cccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            9999866443333344467889999998765 4578999999999999999999999853211100000      00000


Q ss_pred             hc-----------cCCCC--CCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          861 ML-----------DSRLP--YPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       861 ~~-----------~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ..           .....  .........+..+.++|.+||..||++||+++|++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            00           00000  000001123456889999999999999999998864

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-33  Score=304.01  Aligned_cols=257  Identities=22%  Similarity=0.288  Sum_probs=196.7

Q ss_pred             CCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEEe
Q 039137          640 FNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYE  718 (912)
Q Consensus       640 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e  718 (912)
                      |++.+.||.|++|.||+|..+ +|+.||+|++.......  ...+.+.+|++.++.++|||++++++++..++..+++||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e   78 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDE--GVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFE   78 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccc--cchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEe
Confidence            677899999999999999875 79999999986543221  134567889999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCC
Q 039137          719 YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS  798 (912)
Q Consensus       719 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  798 (912)
                      |++ ++|.+++.... ...+++.+++.++.|++.||+|||++   +++||||+|+||+++.++.++|+|||.+.......
T Consensus        79 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~  153 (283)
T cd07835          79 FLD-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV  153 (283)
T ss_pred             ccC-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc
Confidence            996 58999885433 24689999999999999999999999   99999999999999999999999999997654433


Q ss_pred             CCccccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCccchhccccccc------cch-------------
Q 039137          799 SNWSELAGTHGYVAPELAYTL-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSS------NMN-------------  858 (912)
Q Consensus       799 ~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~------~~~-------------  858 (912)
                      .......+++.|+|||++.+. .++.++||||+|+++|+|++|+.||...........      ...             
T Consensus       154 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07835         154 RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY  233 (283)
T ss_pred             cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhh
Confidence            333344568899999987664 468899999999999999999999852211100000      000             


Q ss_pred             -hhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          859 -IEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       859 -~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                       ..................+..+.+++.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence             000000000000011122356889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.2e-33  Score=301.61  Aligned_cols=247  Identities=25%  Similarity=0.337  Sum_probs=193.2

Q ss_pred             eeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEEeecCCCC
Q 039137          646 IGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGS  724 (912)
Q Consensus       646 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  724 (912)
                      ||+|+||+||+|... +|+.||+|.+....... ....+.+..|+++++.++||||+++++++...+..|+||||+++++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKK-RKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGD   79 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhh-hhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence            689999999999865 78999999986532221 1134556789999999999999999999999999999999999999


Q ss_pred             hhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCCCcccc
Q 039137          725 LDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSEL  804 (912)
Q Consensus       725 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~  804 (912)
                      |.+++..... ..+++.++..++.|++.|+.|||+.   +++||||+|+||++++++.++|+|||.+..... .......
T Consensus        80 L~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~  154 (277)
T cd05577          80 LKYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG-GKKIKGR  154 (277)
T ss_pred             HHHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhcc-CCccccc
Confidence            9999854332 4689999999999999999999999   999999999999999999999999999876543 2223345


Q ss_pred             ccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHHHHHHHHH
Q 039137          805 AGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVA  884 (912)
Q Consensus       805 ~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  884 (912)
                      .++..|+|||++.+..++.++||||+|+++|+|++|+.||........ ...............+    ...+..+.+++
T Consensus       155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~----~~~~~~~~~li  229 (277)
T cd05577         155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE-KEELKRRTLEMAVEYP----DKFSPEAKDLC  229 (277)
T ss_pred             cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc-HHHHHhccccccccCC----ccCCHHHHHHH
Confidence            678899999999888899999999999999999999999853221100 0000011111111111    22355688999


Q ss_pred             HHcccCCCCCCC-----CHHHHHH
Q 039137          885 FSCLDQNPESRP-----TMKRVSQ  903 (912)
Q Consensus       885 ~~cl~~dP~~RP-----t~~evl~  903 (912)
                      .+||+.||++||     ++.++++
T Consensus       230 ~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         230 EALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             HHHccCChhHccCCCcccHHHHHh
Confidence            999999999999     6655653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=2.2e-34  Score=330.69  Aligned_cols=253  Identities=26%  Similarity=0.444  Sum_probs=196.0

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC----
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP----  710 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~----  710 (912)
                      -..+|+..+.||+|+||.||+++.+ ||+.||||++....   .......+.+|+..+.+|+|||||+++..|.+.    
T Consensus       477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~---s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~  553 (1351)
T KOG1035|consen  477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA---SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL  553 (1351)
T ss_pred             HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch---HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence            3457888899999999999999988 99999999997654   223567789999999999999999987532000    


Q ss_pred             --------------------------------------------------------------------------------
Q 039137          711 --------------------------------------------------------------------------------  710 (912)
Q Consensus       711 --------------------------------------------------------------------------------  710 (912)
                                                                                                      
T Consensus       554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t  633 (1351)
T KOG1035|consen  554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT  633 (1351)
T ss_pred             ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence                                                                                            


Q ss_pred             -----------------------------------CeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHH
Q 039137          711 -----------------------------------KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALF  755 (912)
Q Consensus       711 -----------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~  755 (912)
                                                         -..||-||||+..++++++.++....  ....+|+++++|+.||+
T Consensus       634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLa  711 (1351)
T KOG1035|consen  634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLA  711 (1351)
T ss_pred             cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHH
Confidence                                               12378899999988888885443221  46788999999999999


Q ss_pred             HHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC------------------CCCCCccccccccccccccccc
Q 039137          756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN------------------PDSSNWSELAGTHGYVAPELAY  817 (912)
Q Consensus       756 ~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~------------------~~~~~~~~~~g~~~y~aPE~~~  817 (912)
                      |+|++   |||||||||.||++++++.|||+|||+|....                  ......+..+||.-|+|||++.
T Consensus       712 YIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~  788 (1351)
T KOG1035|consen  712 YIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS  788 (1351)
T ss_pred             HHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence            99999   99999999999999999999999999998721                  1112345678999999999987


Q ss_pred             cCC---CCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCC
Q 039137          818 TLK---VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPES  894 (912)
Q Consensus       818 ~~~---~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~  894 (912)
                      +..   |+.|+|+||+|+|++||+.   ||+.  .+.+  ........++.+|.+.....+..+.-..+|.+|+++||.+
T Consensus       789 ~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~T--sMER--a~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~k  861 (1351)
T KOG1035|consen  789 DTSSNKYNSKIDMYSLGIVLFEMLY---PFGT--SMER--ASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSK  861 (1351)
T ss_pred             ccccccccchhhhHHHHHHHHHHhc---cCCc--hHHH--HHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCcc
Confidence            654   9999999999999999985   4541  1111  1122223355556654444445555668899999999999


Q ss_pred             CCCHHHHHH
Q 039137          895 RPTMKRVSQ  903 (912)
Q Consensus       895 RPt~~evl~  903 (912)
                      ||||.|++.
T Consensus       862 RPtA~eLL~  870 (1351)
T KOG1035|consen  862 RPTATELLN  870 (1351)
T ss_pred             CCCHHHHhh
Confidence            999999875

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=4.6e-33  Score=303.75  Aligned_cols=249  Identities=26%  Similarity=0.409  Sum_probs=196.5

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ..|+..+.||+|+||+||+|+.. +++.||+|++....... ....+++.+|+++++.++||||+++++++..++..++|
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQS-NEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCc-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            45888999999999999999875 68999999986443222 22446788999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++ ++.+++...  ...+++.++..++.|++.|+.|||+.   +|+||||+|+||+++.++.++|+|||++.....
T Consensus        94 ~e~~~g-~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          94 MEYCLG-SASDILEVH--KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             HHhhCC-CHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence            999974 777766332  24589999999999999999999999   999999999999999999999999999976543


Q ss_pred             CCCCccccccccccccccccc---cCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhh
Q 039137          797 DSSNWSELAGTHGYVAPELAY---TLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHV  873 (912)
Q Consensus       797 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  873 (912)
                      .    ....+++.|+|||++.   ...++.++||||||+++|||++|+.||.......     ..........  +....
T Consensus       168 ~----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~-----~~~~~~~~~~--~~~~~  236 (307)
T cd06607         168 A----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-----ALYHIAQNDS--PTLSS  236 (307)
T ss_pred             C----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH-----HHHHHhcCCC--CCCCc
Confidence            2    2346788999999874   3568889999999999999999999975211100     0000100111  11111


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 039137          874 QKKLMSIMQVAFSCLDQNPESRPTMKRVSQL  904 (912)
Q Consensus       874 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  904 (912)
                      ...+..+.+++.+||+.||++||++.+++..
T Consensus       237 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         237 NDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             hhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            2345568899999999999999999999763

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=8.3e-34  Score=301.56  Aligned_cols=249  Identities=27%  Similarity=0.369  Sum_probs=201.9

Q ss_pred             CCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEE
Q 039137          639 DFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIY  717 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  717 (912)
                      +|++.+.||.|+||.||+|+.+ +++.||+|.+........ ...+.+.+|++.+++++||||+++++++..++..++|+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   79 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEK-GSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVV   79 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcch-hHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEE
Confidence            4788999999999999999876 689999999875432221 24577899999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCC
Q 039137          718 EYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPD  797 (912)
Q Consensus       718 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  797 (912)
                      ||+++++|.+++...   ..+++.++..++.|+++|++|||+.   +++|+||+|+||++++++.++++|||.+......
T Consensus        80 e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  153 (258)
T cd05578          80 DLLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD  153 (258)
T ss_pred             eCCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence            999999999998443   4688999999999999999999999   9999999999999999999999999999866443


Q ss_pred             CCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhcc-CCCCCCChhhHHH
Q 039137          798 SSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLD-SRLPYPSLHVQKK  876 (912)
Q Consensus       798 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  876 (912)
                      . ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||......   .......... .....+    ...
T Consensus       154 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~----~~~  225 (258)
T cd05578         154 T-LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT---IRDQIRAKQETADVLYP----ATW  225 (258)
T ss_pred             c-cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc---HHHHHHHHhccccccCc----ccC
Confidence            2 234456788999999998888999999999999999999999998632211   0111111111 111222    223


Q ss_pred             HHHHHHHHHHcccCCCCCCCCH--HHHH
Q 039137          877 LMSIMQVAFSCLDQNPESRPTM--KRVS  902 (912)
Q Consensus       877 ~~~l~~li~~cl~~dP~~RPt~--~evl  902 (912)
                      +..+.+++.+||+.||.+||++  +|++
T Consensus       226 ~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         226 STEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             cHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            4678899999999999999999  5554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.3e-33  Score=304.13  Aligned_cols=258  Identities=23%  Similarity=0.297  Sum_probs=197.8

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC--Ceee
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP--KHSF  714 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~  714 (912)
                      ++|++.+.||+|+||.||+|+++ +++.+|+|.+......  ......+.+|++++++++||||+++++++..+  +..+
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK--EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY   82 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc--ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence            57889999999999999999986 6889999998654322  11334577899999999999999999999877  8899


Q ss_pred             EEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccccccc
Q 039137          715 IIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL  794 (912)
Q Consensus       715 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  794 (912)
                      +||||+++ +|.+++....  ..+++.+++.++.|++.||+|||++   +++|+||||+||+++.++.++|+|||++...
T Consensus        83 lv~e~~~~-~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~  156 (293)
T cd07843          83 MVMEYVEH-DLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREY  156 (293)
T ss_pred             EEehhcCc-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeec
Confidence            99999985 8988885432  3689999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCCccccccccccccccccccCC-CCcchhHHHHHHHHHHHHhCCCCccchhccccccc----------cchh---h
Q 039137          795 NPDSSNWSELAGTHGYVAPELAYTLK-VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSS----------NMNI---E  860 (912)
Q Consensus       795 ~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~----------~~~~---~  860 (912)
                      ...........+++.|+|||.+.+.. ++.++||||+|+++|+|++|..||...........          ....   .
T Consensus       157 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
T cd07843         157 GSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE  236 (293)
T ss_pred             cCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence            55433444456788999999887644 68899999999999999999999852211000000          0000   0


Q ss_pred             hc--c-CC---CCCC--ChhhHH--HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          861 ML--D-SR---LPYP--SLHVQK--KLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       861 ~~--~-~~---~~~~--~~~~~~--~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ..  . ..   ..+.  ......  ....+.+++.+||+.||++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence            00  0 00   0000  000011  2455789999999999999999999875

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-34  Score=279.18  Aligned_cols=252  Identities=22%  Similarity=0.365  Sum_probs=199.7

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEEcCCeeeE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~l  715 (912)
                      ++.+....||.|+.|.||+++.+ +|...|||.+.+..   .....++++..+.++..- .+|+||+.+|||..+...++
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~---Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~I  168 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG---NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFI  168 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC---CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHH
Confidence            45566788999999999999876 68999999987643   233667888888887766 49999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      .||.|.. -.+.++++  ..+++++.-+-++...+++||.||.+++  +|+|||+||+|||+|+.|++|+||||++.++.
T Consensus       169 cMelMs~-C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlv  243 (391)
T KOG0983|consen  169 CMELMST-CAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLV  243 (391)
T ss_pred             HHHHHHH-HHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceee
Confidence            9998854 45666643  3456888888899999999999999985  99999999999999999999999999998876


Q ss_pred             CCCCCcccccccccccccccccc---CCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChh
Q 039137          796 PDSSNWSELAGTHGYVAPELAYT---LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLH  872 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  872 (912)
                      +... .+...|-+.|||||.+.-   ..|+.++||||||+.++|+.||+.||..    ...+.++...+.+...|..+ .
T Consensus       244 dSkA-htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~----c~tdFe~ltkvln~ePP~L~-~  317 (391)
T KOG0983|consen  244 DSKA-HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKG----CKTDFEVLTKVLNEEPPLLP-G  317 (391)
T ss_pred             cccc-cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCC----CCccHHHHHHHHhcCCCCCC-c
Confidence            5433 344578889999998863   4688999999999999999999999852    11122233333343322221 1


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          873 VQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       873 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ....++.+.+++..|+++|+.+||...++++
T Consensus       318 ~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  318 HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             ccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            1226677999999999999999999998875

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=4.3e-33  Score=298.75  Aligned_cols=255  Identities=24%  Similarity=0.391  Sum_probs=198.1

Q ss_pred             CCCCceeeecCceEEEEEEeC----CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCC----
Q 039137          640 FNAEHCIGKGGHGSVYRAKVP----SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPK----  711 (912)
Q Consensus       640 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----  711 (912)
                      |.+.+.||+|+||.||+|.++    +++.||+|++......  ....+++.+|+++++.++||||+++++++...+    
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   78 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFS--SSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGR   78 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCC--hHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCc
Confidence            567889999999999999753    4688999998654322  224667889999999999999999999986532    


Q ss_pred             --eeeEEEeecCCCChhhHhhccC---CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEe
Q 039137          712 --HSFIIYEYLESGSLDKILCNDA---SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVS  786 (912)
Q Consensus       712 --~~~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  786 (912)
                        ..++++||+++|+|.+++....   ....+++..++.++.|++.|++|||+.   +|+||||||+||+++.++.+|++
T Consensus        79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~  155 (273)
T cd05074          79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVA  155 (273)
T ss_pred             ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEEC
Confidence              2478999999999988874322   223578899999999999999999999   99999999999999999999999


Q ss_pred             ccccccccCCCCC--CccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhcc
Q 039137          787 DFGIAKFLNPDSS--NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLD  863 (912)
Q Consensus       787 Dfgla~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  863 (912)
                      |||.++.......  ......+++.|++||.+.+..++.++||||||+++|||++ |+.||......     ........
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~-----~~~~~~~~  230 (273)
T cd05074         156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS-----EIYNYLIK  230 (273)
T ss_pred             cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH-----HHHHHHHc
Confidence            9999986543221  1123345678999999988889999999999999999999 88887522110     11111111


Q ss_pred             C-CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 039137          864 S-RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEK  908 (912)
Q Consensus       864 ~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  908 (912)
                      . ....+    ...+..+.+++.+||+.+|++||++.++++.|++.
T Consensus       231 ~~~~~~~----~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         231 GNRLKQP----PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CCcCCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            1 11111    12335688999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=7.8e-33  Score=292.65  Aligned_cols=249  Identities=32%  Similarity=0.483  Sum_probs=202.8

Q ss_pred             CCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEE
Q 039137          639 DFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIY  717 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  717 (912)
                      +|+..+.||+|++|.||+|..+ +++.+++|++.....    ...+.+.+|++.++.++|++++++++++..++..++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~   76 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK----EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVM   76 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence            4788899999999999999876 788999999875433    24677889999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCC
Q 039137          718 EYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPD  797 (912)
Q Consensus       718 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  797 (912)
                      ||+++++|.+++....  ..+++.++..++.|++.|++|||++   +++||||+|+||++++++.++|+|||.+......
T Consensus        77 e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  151 (253)
T cd05122          77 EFCSGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT  151 (253)
T ss_pred             ecCCCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence            9999999999985432  5689999999999999999999998   9999999999999999999999999999876554


Q ss_pred             CCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHH
Q 039137          798 SSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKL  877 (912)
Q Consensus       798 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  877 (912)
                      .. .....++..|+|||++.+..++.++||||||+++|+|++|+.||........     .........+. .......+
T Consensus       152 ~~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~~-~~~~~~~~  224 (253)
T cd05122         152 KA-RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA-----LFKIATNGPPG-LRNPEKWS  224 (253)
T ss_pred             cc-ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH-----HHHHHhcCCCC-cCcccccC
Confidence            32 3455688999999999888899999999999999999999999852211000     00000000000 00111124


Q ss_pred             HHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          878 MSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       878 ~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ..+.+++.+||+.||++|||+.|+++
T Consensus       225 ~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         225 DEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHhc
Confidence            56889999999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=3.2e-33  Score=302.21  Aligned_cols=244  Identities=27%  Similarity=0.409  Sum_probs=196.1

Q ss_pred             CceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEEeecC
Q 039137          643 EHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLE  721 (912)
Q Consensus       643 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  721 (912)
                      ...||+|+||.||+|..+ +++.||+|++....    ....+.+.+|+.+++.++|+|++++++++...+..++||||++
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  100 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK----QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE  100 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc----hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence            367999999999999875 78999999875322    1245678899999999999999999999999999999999999


Q ss_pred             CCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCCCc
Q 039137          722 SGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNW  801 (912)
Q Consensus       722 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  801 (912)
                      +++|.+++..    ..+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++++|||.+..........
T Consensus       101 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~  173 (292)
T cd06657         101 GGALTDIVTH----TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR  173 (292)
T ss_pred             CCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccccc
Confidence            9999998732    3578999999999999999999999   99999999999999999999999999987654433333


Q ss_pred             cccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHHHHHH
Q 039137          802 SELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIM  881 (912)
Q Consensus       802 ~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  881 (912)
                      ....+++.|+|||++.+..++.++||||+|+++|+|++|+.||......      ..........+.........+..+.
T Consensus       174 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~l~  247 (292)
T cd06657         174 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL------KAMKMIRDNLPPKLKNLHKVSPSLK  247 (292)
T ss_pred             cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhhCCcccCCcccCCHHHH
Confidence            4456889999999998888899999999999999999999997521111      0001111111111111122345678


Q ss_pred             HHHHHcccCCCCCCCCHHHHHH
Q 039137          882 QVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       882 ~li~~cl~~dP~~RPt~~evl~  903 (912)
                      +++.+||+.||.+||++.++++
T Consensus       248 ~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         248 GFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             HHHHHHHhCCcccCcCHHHHhc
Confidence            8999999999999999999876

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=4.6e-33  Score=299.16  Aligned_cols=244  Identities=22%  Similarity=0.251  Sum_probs=186.4

Q ss_pred             eeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhh---cCCCccccEEEEEEcCCeeeEEEeec
Q 039137          645 CIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTE---IRHRNIVKFYGFCSHPKHSFIIYEYL  720 (912)
Q Consensus       645 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~---l~h~niv~l~~~~~~~~~~~lv~e~~  720 (912)
                      .||+|+||.||+|... +++.||+|.+......... ....+.+|..+++.   .+||+|+.+++++..++..++||||+
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   79 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ-GETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLM   79 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccch-HHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecC
Confidence            4899999999999875 6889999998654332221 22334445444443   47999999999999999999999999


Q ss_pred             CCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCCC
Q 039137          721 ESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN  800 (912)
Q Consensus       721 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  800 (912)
                      ++++|.+++..   .+.+++.++..++.|++.|++|||++   +|+||||||+||++++++.++++|||++......  .
T Consensus        80 ~~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~--~  151 (279)
T cd05633          80 NGGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--K  151 (279)
T ss_pred             CCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceecccc--C
Confidence            99999998843   34689999999999999999999999   9999999999999999999999999998755332  2


Q ss_pred             ccccccccccccccccc-cCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHHHH
Q 039137          801 WSELAGTHGYVAPELAY-TLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMS  879 (912)
Q Consensus       801 ~~~~~g~~~y~aPE~~~-~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  879 (912)
                      .....|++.|+|||.+. +..++.++||||+||++|||++|..||........  . ..... .  ...........+.+
T Consensus       152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~-~~~~~-~--~~~~~~~~~~~~~~  225 (279)
T cd05633         152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--H-EIDRM-T--LTVNVELPDSFSPE  225 (279)
T ss_pred             ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH--H-HHHHH-h--hcCCcCCccccCHH
Confidence            23346899999999886 45688999999999999999999999853211100  0 00000 0  00111111234567


Q ss_pred             HHHHHHHcccCCCCCCC-----CHHHHHH
Q 039137          880 IMQVAFSCLDQNPESRP-----TMKRVSQ  903 (912)
Q Consensus       880 l~~li~~cl~~dP~~RP-----t~~evl~  903 (912)
                      +.+++.+||+.||++||     +++|+++
T Consensus       226 ~~~li~~~l~~~p~~R~~~~~~~~~~~~~  254 (279)
T cd05633         226 LKSLLEGLLQRDVSKRLGCLGRGAQEVKE  254 (279)
T ss_pred             HHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence            88999999999999999     5888766

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=4.1e-33  Score=304.57  Aligned_cols=259  Identities=26%  Similarity=0.315  Sum_probs=196.3

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC--Cee
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP--KHS  713 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~  713 (912)
                      .++|++.+.||+|+||.||+|..+ +|+.||+|++........  ....+.+|+.++++++|+||+++++++...  +..
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDG--IPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI   83 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCC--CcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence            467999999999999999999875 689999999864432211  233456899999999999999999998755  568


Q ss_pred             eEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccc
Q 039137          714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKF  793 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  793 (912)
                      ++||||+.+ +|.+++...  ...+++.++..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||.+..
T Consensus        84 ~lv~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~  157 (309)
T cd07845          84 FLVMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLART  157 (309)
T ss_pred             EEEEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeee
Confidence            999999975 888887443  25689999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCCcccccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCccchhcccccc----------ccchh---
Q 039137          794 LNPDSSNWSELAGTHGYVAPELAYT-LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS----------SNMNI---  859 (912)
Q Consensus       794 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~----------~~~~~---  859 (912)
                      ............+++.|+|||.+.+ ..++.++||||+|+++|||++|+.||..........          .....   
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07845         158 YGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS  237 (309)
T ss_pred             cCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence            6554333344456788999998865 457899999999999999999999985221100000          00000   


Q ss_pred             ------hhccCCCCCCCh--hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          860 ------EMLDSRLPYPSL--HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       860 ------~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                            .......+....  .....+..+.++|.+|++.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                  000000000000  01113456789999999999999999998875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=5.9e-33  Score=295.74  Aligned_cols=243  Identities=30%  Similarity=0.384  Sum_probs=196.3

Q ss_pred             eeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEEeecCCCC
Q 039137          646 IGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGS  724 (912)
Q Consensus       646 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  724 (912)
                      ||.|++|.||+|+.. +++.||+|++....... ....+.+.+|+.+++.++||||+++++++.+++..++||||+++++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVE-TGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGE   79 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchh-hhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence            689999999999976 58999999987543222 1245678999999999999999999999999999999999999999


Q ss_pred             hhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCCCcccc
Q 039137          725 LDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSEL  804 (912)
Q Consensus       725 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~  804 (912)
                      |.+++.+.   ..+++.++..++.|++.|++|+|++   +++|+||+|+||+++.++.++|+|||.+....... .....
T Consensus        80 L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~  152 (262)
T cd05572          80 LWTILRDR---GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTF  152 (262)
T ss_pred             HHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccc
Confidence            99999543   3588999999999999999999999   99999999999999999999999999998765432 22334


Q ss_pred             ccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhc--cCCCCCCChhhHHHHHHHHH
Q 039137          805 AGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEML--DSRLPYPSLHVQKKLMSIMQ  882 (912)
Q Consensus       805 ~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~  882 (912)
                      .+++.|+|||.+.+..++.++|+||+|+++|+|++|..||....+   ..........  .....++.    ..+..+.+
T Consensus       153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~----~~~~~~~~  225 (262)
T cd05572         153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE---DPMEIYNDILKGNGKLEFPN----YIDKAAKD  225 (262)
T ss_pred             cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC---CHHHHHHHHhccCCCCCCCc----ccCHHHHH
Confidence            678899999999888899999999999999999999999853221   0111111222  12222222    12556889


Q ss_pred             HHHHcccCCCCCCCC-----HHHHHH
Q 039137          883 VAFSCLDQNPESRPT-----MKRVSQ  903 (912)
Q Consensus       883 li~~cl~~dP~~RPt-----~~evl~  903 (912)
                      ++.+||+.+|++||+     ++|+++
T Consensus       226 ~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         226 LIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             HHHHHccCChhhCcCCcccCHHHHhc
Confidence            999999999999999     676655

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=6.1e-33  Score=300.98  Aligned_cols=259  Identities=22%  Similarity=0.296  Sum_probs=195.9

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ++|++.+.||+|++|+||+|+.+ +++.||+|++.......  ...+.+.+|+++++.++||||+++++++...+..++|
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   79 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDE--GVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV   79 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccc--cchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence            57899999999999999999876 78999999986543221  1346678999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcC-CCcEEEeccccccccC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDL-GYEAHVSDFGIAKFLN  795 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~Dfgla~~~~  795 (912)
                      |||+++ ++.+++.... ...+++..+..++.||+.||+|||++   +++|+||+|+||+++. ++.+|++|||++....
T Consensus        80 ~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~  154 (294)
T PLN00009         80 FEYLDL-DLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFG  154 (294)
T ss_pred             Eecccc-cHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence            999965 7877774332 23467889999999999999999999   9999999999999985 5679999999997654


Q ss_pred             CCCCCccccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCccchhccccccc------cchhhhc------
Q 039137          796 PDSSNWSELAGTHGYVAPELAYTL-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSS------NMNIEML------  862 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~------~~~~~~~------  862 (912)
                      ..........+++.|+|||++.+. .++.++||||+|+++|+|++|+.||....+......      ......+      
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (294)
T PLN00009        155 IPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL  234 (294)
T ss_pred             CCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccc
Confidence            433333445678899999988664 578999999999999999999999852211000000      0000000      


Q ss_pred             ------cCCCCCCC--hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          863 ------DSRLPYPS--LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       863 ------~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                            ....+...  ......+..+.+++.+|++.+|++||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence                  00000000  001123455789999999999999999999875

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.9e-33  Score=299.96  Aligned_cols=252  Identities=26%  Similarity=0.378  Sum_probs=202.0

Q ss_pred             eeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEEeecCCCC
Q 039137          646 IGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGS  724 (912)
Q Consensus       646 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  724 (912)
                      ||+|+||.||+|+.. +++.|++|.+....... ....+.+.+|++.++.++||||+++++.+..++..++||||+++++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIR-KNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGD   79 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhh-hhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCc
Confidence            689999999999986 59999999986543221 2245678899999999999999999999999999999999999999


Q ss_pred             hhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCC-----
Q 039137          725 LDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSS-----  799 (912)
Q Consensus       725 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~-----  799 (912)
                      |.+++.+.   +.+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++........     
T Consensus        80 L~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  153 (265)
T cd05579          80 LASLLENV---GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND  153 (265)
T ss_pred             HHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence            99999543   3689999999999999999999999   999999999999999999999999999876543311     


Q ss_pred             ---CccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHH
Q 039137          800 ---NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKK  876 (912)
Q Consensus       800 ---~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  876 (912)
                         ......+++.|+|||...+...+.++||||||+++|++++|+.||+....     ..............+..  ...
T Consensus       154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~--~~~  226 (265)
T cd05579         154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP-----EEIFQNILNGKIEWPED--VEV  226 (265)
T ss_pred             ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHhcCCcCCCcc--ccC
Confidence               22345678899999999888899999999999999999999999852211     11111111122222211  112


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 039137          877 LMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE  911 (912)
Q Consensus       877 ~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~~  911 (912)
                      +..+.+++.+||+.+|++|||+.++.+.|++.+|+
T Consensus       227 ~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~  261 (265)
T cd05579         227 SDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFK  261 (265)
T ss_pred             CHHHHHHHHHHhcCCHhhcCCCccHHHHhcCcccc
Confidence            56688999999999999999998888888776653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=4e-33  Score=301.92  Aligned_cols=261  Identities=20%  Similarity=0.236  Sum_probs=184.2

Q ss_pred             hcCCCCCceeeecCceEEEEEEeCC----CCEEEEEEccCCCCCCchH-------HHHHHHHHHHHHhhcCCCccccEEE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVPS----GEIFAVKKFHSPLPGEMSF-------QQEEFLNEIQALTEIRHRNIVKFYG  705 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~-------~~~~~~~Ei~~l~~l~h~niv~l~~  705 (912)
                      .++|++.+.||+|+||+||+|...+    +..+|+|+...........       .......+...+..++|++++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            3689999999999999999998754    3456666543221110000       0011223444556678999999999


Q ss_pred             EEEcCC----eeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCC
Q 039137          706 FCSHPK----HSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGY  781 (912)
Q Consensus       706 ~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~  781 (912)
                      ++....    ..++++|++.. ++.+.+...   ...++..+..++.|++.|++|||++   +|+||||||+||+++.++
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~  163 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRI---KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNN  163 (294)
T ss_pred             eeeEecCCceEEEEEEehhcc-CHHHHHHhh---ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCC
Confidence            876543    34678887654 666666332   2356788999999999999999999   999999999999999999


Q ss_pred             cEEEeccccccccCCCCC-------CccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhcccccc
Q 039137          782 EAHVSDFGIAKFLNPDSS-------NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS  854 (912)
Q Consensus       782 ~~kl~Dfgla~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~  854 (912)
                      .++|+|||+|+.......       ......||+.|+|||+..+..++.++|||||||++|||++|+.||..........
T Consensus       164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~  243 (294)
T PHA02882        164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI  243 (294)
T ss_pred             cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence            999999999986643221       1123468999999999999999999999999999999999999986331111100


Q ss_pred             ccchhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 039137          855 SNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL  905 (912)
Q Consensus       855 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  905 (912)
                      ........ .++..........+..+.+++..||+.+|++||+++++.+.|
T Consensus       244 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        244 HAAKCDFI-KRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HHhHHHHH-HHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            00000000 000101111122345688999999999999999999999876

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=3.4e-33  Score=302.04  Aligned_cols=256  Identities=25%  Similarity=0.333  Sum_probs=195.4

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcC-CCccccEEEEEEcCCeeeE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR-HRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~l  715 (912)
                      ++|+..+.||+|+||.||++... +++.||+|.+......   .....+.+|+..+.++. ||||+++++++..++..++
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~   80 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE---KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWI   80 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh---HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEE
Confidence            35667789999999999999875 6899999998654322   24567889999999996 9999999999999999999


Q ss_pred             EEeecCCCChhhHhhc--cCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccc
Q 039137          716 IYEYLESGSLDKILCN--DASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKF  793 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~--~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  793 (912)
                      +|||++. ++.++...  ......+++..+..++.|++.|++|||+..  +++||||||+||+++.++.++|+|||+++.
T Consensus        81 ~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  157 (288)
T cd06616          81 CMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQ  157 (288)
T ss_pred             EEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHH
Confidence            9999875 55544311  112356899999999999999999999742  899999999999999999999999999976


Q ss_pred             cCCCCCCccccccccccccccccccC---CCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCC-CCC
Q 039137          794 LNPDSSNWSELAGTHGYVAPELAYTL---KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRL-PYP  869 (912)
Q Consensus       794 ~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~  869 (912)
                      ..... ......+++.|+|||++.+.   .++.++||||+|+++|||++|+.||.....    ............. ..+
T Consensus       158 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~  232 (288)
T cd06616         158 LVDSI-AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS----VFDQLTQVVKGDPPILS  232 (288)
T ss_pred             hccCC-ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch----HHHHHhhhcCCCCCcCC
Confidence            54332 22334678899999998776   688999999999999999999999853211    0001111111111 111


Q ss_pred             ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 039137          870 SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQL  904 (912)
Q Consensus       870 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  904 (912)
                      .......+..+.+++.+||+.||++|||++++++.
T Consensus       233 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         233 NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            11112345678899999999999999999998763

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-34  Score=296.89  Aligned_cols=251  Identities=25%  Similarity=0.288  Sum_probs=203.2

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeee
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSF  714 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  714 (912)
                      ..+.|..-++||+|+||.||-++.+ +|+.||.|++.+...... ......+.|-.++.+++.+.||.+--+|++++..+
T Consensus       183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr-~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC  261 (591)
T KOG0986|consen  183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKR-KGETMALNEKQILEKVSSPFIVSLAYAFETKDALC  261 (591)
T ss_pred             cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHh-hhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence            3567888899999999999999765 899999998865433221 12344678999999999999999999999999999


Q ss_pred             EEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccccccc
Q 039137          715 IIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL  794 (912)
Q Consensus       715 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  794 (912)
                      +|+..|.||+|.-++.+... ..++++.++-++.+|+.||++||..   +||.||+||+|||+|+.|+++|+|.|+|..+
T Consensus       262 lVLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei  337 (591)
T KOG0986|consen  262 LVLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEI  337 (591)
T ss_pred             EEEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEec
Confidence            99999999999998855443 5699999999999999999999999   9999999999999999999999999999987


Q ss_pred             CCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCC-CCCChhh
Q 039137          795 NPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRL-PYPSLHV  873 (912)
Q Consensus       795 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  873 (912)
                      ... ......+||.+|||||++.++.|+...|.||+||++|||+.|+.||....+...      .+-++.+. ..+....
T Consensus       338 ~~g-~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk------~eEvdrr~~~~~~ey~  410 (591)
T KOG0986|consen  338 PEG-KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK------REEVDRRTLEDPEEYS  410 (591)
T ss_pred             CCC-CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh------HHHHHHHHhcchhhcc
Confidence            654 334556999999999999999999999999999999999999999964333221      11111111 1122222


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCH
Q 039137          874 QKKLMSIMQVAFSCLDQNPESRPTM  898 (912)
Q Consensus       874 ~~~~~~l~~li~~cl~~dP~~RPt~  898 (912)
                      ...+++...+....+++||++|.-.
T Consensus       411 ~kFS~eakslc~~LL~Kdp~~RLGc  435 (591)
T KOG0986|consen  411 DKFSEEAKSLCEGLLTKDPEKRLGC  435 (591)
T ss_pred             cccCHHHHHHHHHHHccCHHHhccC
Confidence            4445667777778999999999643

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-32  Score=301.62  Aligned_cols=260  Identities=23%  Similarity=0.330  Sum_probs=195.3

Q ss_pred             CCCCCceeeecCceEEEEEEeC---CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC--Cee
Q 039137          639 DFNAEHCIGKGGHGSVYRAKVP---SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP--KHS  713 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~  713 (912)
                      +|++.+.||+|++|.||+|..+   +++.||+|.+......... ..+.+.+|+++++.++||||+++++++...  +..
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTG-ISQSACREIALLRELKHENVVSLVEVFLEHADKSV   79 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccC-ccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceE
Confidence            4788899999999999999875   4789999998764321111 345677899999999999999999999888  789


Q ss_pred             eEEEeecCCCChhhHhhccC--CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcC----CCcEEEec
Q 039137          714 FIIYEYLESGSLDKILCNDA--SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDL----GYEAHVSD  787 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~----~~~~kl~D  787 (912)
                      ++||||+++ ++.+++....  ....+++..++.++.|++.|++|||++   +|+||||||+||+++.    ++.+|++|
T Consensus        80 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~D  155 (316)
T cd07842          80 YLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGD  155 (316)
T ss_pred             EEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECC
Confidence            999999976 6766663322  223689999999999999999999999   9999999999999999    89999999


Q ss_pred             cccccccCCCCC---CccccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCccchhccccccc-------c
Q 039137          788 FGIAKFLNPDSS---NWSELAGTHGYVAPELAYTL-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSS-------N  856 (912)
Q Consensus       788 fgla~~~~~~~~---~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~-------~  856 (912)
                      ||++........   ......+++.|+|||++.+. .++.++||||||+++|+|++|+.||...........       .
T Consensus       156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
T cd07842         156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE  235 (316)
T ss_pred             CccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence            999986644322   12344678899999987764 578999999999999999999999863221110000       0


Q ss_pred             chhhh-----------------------ccCCCCCCChhhH-------HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          857 MNIEM-----------------------LDSRLPYPSLHVQ-------KKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       857 ~~~~~-----------------------~~~~~~~~~~~~~-------~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .....                       ......++.....       .....+.+++.+|++.||++|||+.|+++
T Consensus       236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            00000                       0001111100000       22346889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.4e-33  Score=292.56  Aligned_cols=248  Identities=27%  Similarity=0.447  Sum_probs=204.3

Q ss_pred             CCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEE
Q 039137          639 DFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIY  717 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  717 (912)
                      +|++.+.||+|++|.||+|+.. +++.|++|.+......  ....+.+.+|++++++++|||++++++++...+..++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   78 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK--EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIIL   78 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC--HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Confidence            5788999999999999999876 6789999999765432  224578899999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCC
Q 039137          718 EYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPD  797 (912)
Q Consensus       718 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  797 (912)
                      ||+++++|.+++...   ..+++..+..++.|++.|++|||+.   +|+||||+|+||+++.++.++|+|||.+......
T Consensus        79 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  152 (254)
T cd06627          79 EYAENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDV  152 (254)
T ss_pred             ecCCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence            999999999998443   5689999999999999999999999   9999999999999999999999999999877655


Q ss_pred             CCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhc-cCCCCCCChhhHHH
Q 039137          798 SSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEML-DSRLPYPSLHVQKK  876 (912)
Q Consensus       798 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  876 (912)
                      ........++..|+|||...+..++.++||||+|+++|+|++|+.||......     ....... ......+    ...
T Consensus       153 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~----~~~  223 (254)
T cd06627         153 SKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM-----AALFRIVQDDHPPLP----EGI  223 (254)
T ss_pred             cccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH-----HHHHHHhccCCCCCC----CCC
Confidence            44344567889999999998888899999999999999999999998522110     0001111 1111111    123


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          877 LMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       877 ~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      +..+.+++.+||+.+|++|||+.+++.
T Consensus       224 ~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         224 SPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            456789999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=6.6e-33  Score=294.16  Aligned_cols=250  Identities=25%  Similarity=0.348  Sum_probs=204.2

Q ss_pred             CCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEE
Q 039137          639 DFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIY  717 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  717 (912)
                      +|++.+.||+|++|.||+++.+ +++.+|+|.+......  .....++.+|+++++.++|+||+++++++......++||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   78 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS--QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVM   78 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc--HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEe
Confidence            4788899999999999999765 7889999998654322  224567789999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhccC-CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          718 EYLESGSLDKILCNDA-SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       718 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      ||+++++|.+++.... ....+++..++.++.|++.|++|||+.   +++|+||+|+||+++.++.+|++|||++.....
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~  155 (256)
T cd08530          79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKK  155 (256)
T ss_pred             hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence            9999999999985532 235689999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHH
Q 039137          797 DSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKK  876 (912)
Q Consensus       797 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  876 (912)
                      .  ......+++.|+|||.+.+..++.++|+||+|+++|||++|+.||.....     ............+..   ....
T Consensus       156 ~--~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~---~~~~  225 (256)
T cd08530         156 N--MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM-----QDLRYKVQRGKYPPI---PPIY  225 (256)
T ss_pred             C--CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHhcCCCCCC---chhh
Confidence            4  22335678899999999998899999999999999999999999852211     111111112222211   1245


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          877 LMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       877 ~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ..++.+++.+|++.+|++||++.|+++
T Consensus       226 ~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         226 SQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             CHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            567899999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.9e-32  Score=291.05  Aligned_cols=250  Identities=28%  Similarity=0.405  Sum_probs=204.3

Q ss_pred             CCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC--CeeeE
Q 039137          639 DFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP--KHSFI  715 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~l  715 (912)
                      +|+..+.||+|++|.||+|... +++.|++|++......  ....+.+.+|++.+++++||||+++++++...  +..++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l   78 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS--EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNI   78 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc--hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEE
Confidence            4778899999999999999876 7899999998655332  23567889999999999999999999999888  88999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ||||+++++|.+++...   ..+++.+++.++.|++.|++|||+.   +++|+||+|+||+++.++.++|+|||.+....
T Consensus        79 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~  152 (260)
T cd06606          79 FLEYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLG  152 (260)
T ss_pred             EEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence            99999999999999543   2789999999999999999999998   99999999999999999999999999998775


Q ss_pred             CCCC--CccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhcc-CCCCCCChh
Q 039137          796 PDSS--NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLD-SRLPYPSLH  872 (912)
Q Consensus       796 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  872 (912)
                      ....  ......++..|+|||...+...+.++||||||+++|+|++|..||.....    .......... ...+.   .
T Consensus       153 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~---~  225 (260)
T cd06606         153 DIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN----PMAALYKIGSSGEPPE---I  225 (260)
T ss_pred             cccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----hHHHHHhccccCCCcC---C
Confidence            5432  13445688999999999888899999999999999999999999863220    0001111111 01111   1


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          873 VQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       873 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ....+..+.+++.+|++.||++||++.|+++
T Consensus       226 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         226 PEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             CcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            1222566889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.4e-32  Score=291.76  Aligned_cols=252  Identities=27%  Similarity=0.437  Sum_probs=205.5

Q ss_pred             CCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEE
Q 039137          639 DFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIY  717 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  717 (912)
                      +|++.+.||+|++|.||+|.+. +++.||+|++......  ....+.+.+|++.++.++|||++++.+.+...+..++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~   78 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS--EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVM   78 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC--hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEE
Confidence            5788899999999999999875 6899999998654332  225667889999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhccC-CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          718 EYLESGSLDKILCNDA-SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       718 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      ||+++++|.+++.... ....+++.++..++.+++.|++|||+.   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~  155 (258)
T cd08215          79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS  155 (258)
T ss_pred             EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeeccc
Confidence            9999999999985532 236789999999999999999999999   999999999999999999999999999987655


Q ss_pred             CCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHH
Q 039137          797 DSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKK  876 (912)
Q Consensus       797 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  876 (912)
                      .........+++.|+|||...+..++.++||||+|+++|+|++|+.||+....     ............+..+   ...
T Consensus       156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~---~~~  227 (258)
T cd08215         156 TVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL-----LELALKILKGQYPPIP---SQY  227 (258)
T ss_pred             CcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH-----HHHHHHHhcCCCCCCC---CCC
Confidence            43333445688999999999888899999999999999999999999852210     1111111111111111   123


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          877 LMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       877 ~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      +..+.+++.+||..+|++|||+.|+++
T Consensus       228 ~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         228 SSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            456789999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=3.3e-33  Score=302.06  Aligned_cols=261  Identities=23%  Similarity=0.332  Sum_probs=203.5

Q ss_pred             CCCCCceeeecCceEEEEEEe----CCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEEcCCee
Q 039137          639 DFNAEHCIGKGGHGSVYRAKV----PSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSHPKHS  713 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~  713 (912)
                      +|++.+.||+|++|.||+|+.    .+++.||||.+............+.+.+|++++.++ +||+|+++++++..++..
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            478889999999999999974    257889999986432222222456788999999999 599999999999999999


Q ss_pred             eEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccc
Q 039137          714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKF  793 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  793 (912)
                      ++||||+++|+|.+++..   ...+++..+..++.|+++||+|||+.   +++||||+|+||+++.++.++++|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccc
Confidence            999999999999999843   24588999999999999999999999   999999999999999999999999999876


Q ss_pred             cCCCCCC-ccccccccccccccccccCC--CCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCC
Q 039137          794 LNPDSSN-WSELAGTHGYVAPELAYTLK--VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPS  870 (912)
Q Consensus       794 ~~~~~~~-~~~~~g~~~y~aPE~~~~~~--~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  870 (912)
                      ....... .....+++.|+|||...+..  .+.++||||+|+++|||++|..||....... ..............+.+.
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~  233 (288)
T cd05583         155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN-SQSEISRRILKSKPPFPK  233 (288)
T ss_pred             cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc-hHHHHHHHHHccCCCCCc
Confidence            5443222 22345789999999987665  7889999999999999999999985211110 001111112222222221


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          871 LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       871 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                          .....+.+++.+||+.||++|||+.++.+.|+...+
T Consensus       234 ----~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~  269 (288)
T cd05583         234 ----TMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFF  269 (288)
T ss_pred             ----ccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCccc
Confidence                233567899999999999999999999888876554

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-32  Score=292.35  Aligned_cols=252  Identities=25%  Similarity=0.342  Sum_probs=197.8

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCC-CchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC--Cee
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPG-EMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP--KHS  713 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~  713 (912)
                      .+|++.+.||+|+||.||+|+.+ +++.||+|.+...... ......+.+.+|+++++.++||||+++++++.+.  +..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            46899999999999999999875 6899999987543221 1222456788999999999999999999998764  467


Q ss_pred             eEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccc
Q 039137          714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKF  793 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  793 (912)
                      ++||||+++++|.+++...   ..+++..+.+++.|++.|++|||++   +++|+||||+||+++.++.++|+|||.++.
T Consensus        82 ~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAY---GALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccc
Confidence            8999999999999998432   3578899999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCC---CCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCC
Q 039137          794 LNPDS---SNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPS  870 (912)
Q Consensus       794 ~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  870 (912)
                      .....   .......++..|+|||++.+..++.++|||||||++|++++|+.||......     .........  +...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~--~~~~  228 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM-----AAIFKIATQ--PTKP  228 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH-----HHHHHHHcC--CCCC
Confidence            53211   1123456889999999998888999999999999999999999998522111     111111111  1111


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          871 LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       871 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .........+.+++.+||+ +|.+||++.++++
T Consensus       229 ~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         229 MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             CCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            1123345668899999999 5799999998765

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.7e-32  Score=305.36  Aligned_cols=256  Identities=19%  Similarity=0.295  Sum_probs=196.4

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC----
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP----  710 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~----  710 (912)
                      ..++|+..+.||+|+||.||+|+.. +++.||+|++.......  ...+++.+|+.+++.++||||+++++++...    
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNV--THAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE   91 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccCh--hHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence            4578999999999999999999875 78999999986543222  2446678899999999999999999998643    


Q ss_pred             --CeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecc
Q 039137          711 --KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDF  788 (912)
Q Consensus       711 --~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df  788 (912)
                        ...|+||||+.+ ++.+.+..     .+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+||
T Consensus        92 ~~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Df  162 (353)
T cd07850          92 EFQDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF  162 (353)
T ss_pred             ccCcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccC
Confidence              357999999965 88887732     278899999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccc---------c-----
Q 039137          789 GIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS---------S-----  854 (912)
Q Consensus       789 gla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~---------~-----  854 (912)
                      |+++...... ......+++.|+|||.+.+..++.++||||+||++|+|++|+.||.........         .     
T Consensus       163 g~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
T cd07850         163 GLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM  241 (353)
T ss_pred             ccceeCCCCC-CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            9998664332 223446788999999999999999999999999999999999998521100000         0     


Q ss_pred             ---ccchhhhccCCC--------------CCCChh---hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          855 ---SNMNIEMLDSRL--------------PYPSLH---VQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       855 ---~~~~~~~~~~~~--------------~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                         ..........+.              .++...   ....+..+.+++.+||+.||++|||+.|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence               000000000000              000000   1123455789999999999999999999875

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.6e-32  Score=292.82  Aligned_cols=249  Identities=23%  Similarity=0.298  Sum_probs=192.0

Q ss_pred             HHHHHHhcCCCCCcee--eecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEE
Q 039137          631 EEIISATNDFNAEHCI--GKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGF  706 (912)
Q Consensus       631 ~e~~~~~~~~~~~~~l--g~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~  706 (912)
                      .+.....++|++.+.+  |+|+||.||++..+ +++.+|+|.+.......         .|+.....+ +||||++++++
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---------~e~~~~~~~~~h~~iv~~~~~   77 (267)
T PHA03390          7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---------IEPMVHQLMKDNPNFIKLYYS   77 (267)
T ss_pred             HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---------hhHHHHHHhhcCCCEEEEEEE
Confidence            3444556778887776  99999999999865 78889999976432111         122222223 69999999999


Q ss_pred             EEcCCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCC-cEEE
Q 039137          707 CSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGY-EAHV  785 (912)
Q Consensus       707 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl  785 (912)
                      +..++..++||||+++++|.+++...   ..+++.++..++.|+++|++|||+.   +++||||||+||+++.++ .+++
T Consensus        78 ~~~~~~~~iv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l  151 (267)
T PHA03390         78 VTTLKGHVLIMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYL  151 (267)
T ss_pred             EecCCeeEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEE
Confidence            99999999999999999999999543   3789999999999999999999999   999999999999999998 9999


Q ss_pred             eccccccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCC
Q 039137          786 SDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSR  865 (912)
Q Consensus       786 ~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  865 (912)
                      +|||.+......    ....+++.|+|||++.+..++.++||||+|+++|||++|+.||....+..     .........
T Consensus       152 ~dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~  222 (267)
T PHA03390        152 CDYGLCKIIGTP----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-----LDLESLLKR  222 (267)
T ss_pred             ecCccceecCCC----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-----hhHHHHHHh
Confidence            999999865432    23467899999999998889999999999999999999999986221111     000111111


Q ss_pred             CCCCChhhHHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 039137          866 LPYPSLHVQKKLMSIMQVAFSCLDQNPESRPT-MKRVSQ  903 (912)
Q Consensus       866 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~  903 (912)
                      ...........+..+.+++.+||+.+|.+||+ ++|+++
T Consensus       223 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        223 QQKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             hcccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            11111112245667889999999999999996 587763

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.9e-33  Score=277.76  Aligned_cols=204  Identities=25%  Similarity=0.385  Sum_probs=171.1

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC---C--CCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEc-
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP---S--GEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSH-  709 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~---~--~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-  709 (912)
                      ....|+....||+|+||.||+|..+   +  ...||+|+++....+..  ......||+.+++.++||||+.+..++-. 
T Consensus        22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tG--iS~SAcREiaL~REl~h~nvi~Lv~Vfl~~   99 (438)
T KOG0666|consen   22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTG--ISMSACREIALLRELKHPNVISLVKVFLSH   99 (438)
T ss_pred             HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCC--cCHHHHHHHHHHHHhcCCcchhHHHHHhcc
Confidence            3467999999999999999999533   2  34799999986544322  23456799999999999999999999866 


Q ss_pred             CCeeeEEEeecCCCChhhHhhc--cCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCC----CcE
Q 039137          710 PKHSFIIYEYLESGSLDKILCN--DASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLG----YEA  783 (912)
Q Consensus       710 ~~~~~lv~e~~~~g~L~~~l~~--~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~----~~~  783 (912)
                      +...++++||.+. +|..+++-  ....+.++...+..|..||+.|+.|||+.   -|+||||||.||++..+    |.|
T Consensus       100 d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~V  175 (438)
T KOG0666|consen  100 DKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRV  175 (438)
T ss_pred             CceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCee
Confidence            7899999999998 88888743  33446789999999999999999999999   89999999999999877    899


Q ss_pred             EEeccccccccCCCCCC---ccccccccccccccccccCC-CCcchhHHHHHHHHHHHHhCCCCcc
Q 039137          784 HVSDFGIAKFLNPDSSN---WSELAGTHGYVAPELAYTLK-VTEKCDVYSFGVLALEVIKGKHPRD  845 (912)
Q Consensus       784 kl~Dfgla~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~-~~~~sDvwslG~vl~elltg~~pf~  845 (912)
                      ||+|+|+++.+...-..   ....+-|..|+|||.+.|.. |+.+.|||+.||++.||+|-++-|.
T Consensus       176 KIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~  241 (438)
T KOG0666|consen  176 KIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFK  241 (438)
T ss_pred             EeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCcccc
Confidence            99999999987654322   24566799999999888765 8999999999999999999887664

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=3.5e-32  Score=298.07  Aligned_cols=249  Identities=25%  Similarity=0.392  Sum_probs=196.3

Q ss_pred             CCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEE
Q 039137          639 DFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIY  717 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  717 (912)
                      .|+..+.||+|+||.||+|+.. +++.||+|++....... ....+.+.+|+++++.++|||++++++++..++..++||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQS-NEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCc-hHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            3777899999999999999865 68899999986543222 224567889999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCC
Q 039137          718 EYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPD  797 (912)
Q Consensus       718 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  797 (912)
                      ||+++ ++.+.+...  ...+++.++..++.|++.|+.|||++   +|+||||+|+||+++.++.++|+|||++......
T Consensus       105 e~~~g-~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (317)
T cd06635         105 EYCLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA  178 (317)
T ss_pred             eCCCC-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence            99975 777776432  34589999999999999999999999   9999999999999999999999999998754332


Q ss_pred             CCCccccccccccccccccc---cCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhH
Q 039137          798 SSNWSELAGTHGYVAPELAY---TLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQ  874 (912)
Q Consensus       798 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  874 (912)
                          ....+++.|+|||++.   +..++.++|||||||++|||++|+.||.....     ............+..  ...
T Consensus       179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-----~~~~~~~~~~~~~~~--~~~  247 (317)
T cd06635         179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSALYHIAQNESPTL--QSN  247 (317)
T ss_pred             ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHHhccCCCC--CCc
Confidence                2346788999999874   45688999999999999999999999742110     011111111111111  112


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 039137          875 KKLMSIMQVAFSCLDQNPESRPTMKRVSQLL  905 (912)
Q Consensus       875 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  905 (912)
                      ..+..+.+++.+||+.+|.+||++.++++..
T Consensus       248 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  278 (317)
T cd06635         248 EWSDYFRNFVDSCLQKIPQDRPTSEELLKHM  278 (317)
T ss_pred             cccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence            3345688999999999999999999998753

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.4e-32  Score=297.49  Aligned_cols=254  Identities=24%  Similarity=0.329  Sum_probs=197.5

Q ss_pred             CCCCCceeeecCceEEEEEEe----CCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEEcCCee
Q 039137          639 DFNAEHCIGKGGHGSVYRAKV----PSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSHPKHS  713 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~  713 (912)
                      .|++.+.||+|+||.||.|+.    .+|+.||+|++............+.+.+|+.+++.+ +|++|+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            478889999999999999975    378899999986543322223456788999999999 599999999999999999


Q ss_pred             eEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccc
Q 039137          714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKF  793 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  793 (912)
                      ++||||+++++|.+++..   ...+++.++..++.|++.||+|||+.   +++||||+|+||+++.++.++|+|||++..
T Consensus        81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            999999999999999844   34578899999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCC-CccccccccccccccccccC--CCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCC
Q 039137          794 LNPDSS-NWSELAGTHGYVAPELAYTL--KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPS  870 (912)
Q Consensus       794 ~~~~~~-~~~~~~g~~~y~aPE~~~~~--~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  870 (912)
                      ...... ......++..|+|||.+.+.  .++.++||||||+++|+|++|+.||...... ...............+++ 
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~-  232 (290)
T cd05613         155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK-NSQAEISRRILKSEPPYP-  232 (290)
T ss_pred             cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc-ccHHHHHHHhhccCCCCC-
Confidence            543321 12235688899999988753  4678999999999999999999998521110 001111112222222222 


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 039137          871 LHVQKKLMSIMQVAFSCLDQNPESRP-----TMKRVSQ  903 (912)
Q Consensus       871 ~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~  903 (912)
                         ......+.+++.+||+.||++||     ++.++++
T Consensus       233 ---~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         233 ---QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             ---ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence               12345678999999999999997     6666654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-32  Score=294.57  Aligned_cols=256  Identities=21%  Similarity=0.320  Sum_probs=199.5

Q ss_pred             CCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEEe
Q 039137          640 FNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYE  718 (912)
Q Consensus       640 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e  718 (912)
                      |++.+.||+|++|.||+|... +++.+++|.+.......  .....+.+|+++++.++|+||+++++++..++..++|||
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   78 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESE--GIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFE   78 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccc--hhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEe
Confidence            667889999999999999875 78899999987544322  245678899999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCC
Q 039137          719 YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS  798 (912)
Q Consensus       719 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  798 (912)
                      |+++ ++.+++....  ..+++.++..++.|++.|++|||++   +|+|+||+|+||+++.++.++++|||.+.......
T Consensus        79 ~~~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~  152 (283)
T cd05118          79 FMDT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV  152 (283)
T ss_pred             ccCC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence            9976 8888774422  5789999999999999999999999   99999999999999999999999999998775543


Q ss_pred             CCccccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCccchhcccc----------ccccchhh-------
Q 039137          799 SNWSELAGTHGYVAPELAYTL-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS----------SSSNMNIE-------  860 (912)
Q Consensus       799 ~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~----------~~~~~~~~-------  860 (912)
                      .......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||........          ........       
T Consensus       153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd05118         153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARN  232 (283)
T ss_pred             ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhh
Confidence            233345678889999988776 689999999999999999999999842111000          00000000       


Q ss_pred             ----hccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          861 ----MLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       861 ----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                          ................+..+.++|.+||+.||.+||++.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                0000000001112234567899999999999999999999875

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1e-32  Score=304.92  Aligned_cols=259  Identities=23%  Similarity=0.324  Sum_probs=197.4

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC-----
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP-----  710 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----  710 (912)
                      .++|.+.+.||+|+||+||+|+.. +++.||+|++.......  .....+.+|+.+++.++||||+++++++...     
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~   81 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNR--IDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF   81 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccccc--chhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence            467999999999999999999865 78999999987543222  1345677899999999999999999988644     


Q ss_pred             CeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccc
Q 039137          711 KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGI  790 (912)
Q Consensus       711 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl  790 (912)
                      ...++||||+. ++|.+++..   .+.+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||+
T Consensus        82 ~~~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~  154 (337)
T cd07858          82 NDVYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGL  154 (337)
T ss_pred             CcEEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCcc
Confidence            34799999996 588888843   35689999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCcccccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCccchhccc---------cc-c-----
Q 039137          791 AKFLNPDSSNWSELAGTHGYVAPELAYT-LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMS---------SS-S-----  854 (912)
Q Consensus       791 a~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~---------~~-~-----  854 (912)
                      +..............++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.......         .. .     
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  234 (337)
T cd07858         155 ARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG  234 (337)
T ss_pred             ccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence            9876543333344567889999998765 458899999999999999999999985211000         00 0     


Q ss_pred             ---ccchhhhccC--CCCCC--ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 039137          855 ---SNMNIEMLDS--RLPYP--SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQL  904 (912)
Q Consensus       855 ---~~~~~~~~~~--~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  904 (912)
                         ..........  ..+.+  .......+..+.+++.+||+.||++|||++|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             hcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence               0000000000  00000  00112345668899999999999999999998864

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=8.2e-33  Score=297.70  Aligned_cols=250  Identities=25%  Similarity=0.369  Sum_probs=202.4

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcC-CCccccEEEEEEcCCeeeE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR-HRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~l  715 (912)
                      ++|++.+.||+|++|.||+|+.. +++.||+|++....... ....+.+.+|+++++.++ ||||+++++++..++..++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l   79 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIK-EKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYF   79 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccc-hHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEE
Confidence            47899999999999999999876 79999999986533222 224567889999999998 9999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ||||+++++|.+++...   +.+++.+++.++.|++.|++|||+.   +++|+||+|+||+++.++.++++|||++....
T Consensus        80 v~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~  153 (280)
T cd05581          80 VLEYAPNGELLQYIRKY---GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD  153 (280)
T ss_pred             EEcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence            99999999999999443   3689999999999999999999999   99999999999999999999999999998665


Q ss_pred             CCCC--------------------CccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccc
Q 039137          796 PDSS--------------------NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSS  855 (912)
Q Consensus       796 ~~~~--------------------~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~  855 (912)
                      ....                    ......++..|+|||+..+..++.++||||+|+++|++++|+.||.....     .
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~  228 (280)
T cd05581         154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE-----Y  228 (280)
T ss_pred             CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH-----H
Confidence            4321                    12234578899999998888899999999999999999999999862211     1


Q ss_pred             cchhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCH----HHHHH
Q 039137          856 NMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTM----KRVSQ  903 (912)
Q Consensus       856 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~----~evl~  903 (912)
                      .............+.    ..+..+.+++.+||+.+|.+||++    +++++
T Consensus       229 ~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         229 LTFQKILKLEYSFPP----NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             HHHHHHHhcCCCCCC----ccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            111112222222221    224568899999999999999999    76654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=3.1e-32  Score=293.52  Aligned_cols=253  Identities=21%  Similarity=0.287  Sum_probs=191.5

Q ss_pred             CCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcC-CCccccEEEEEEcC--CeeeE
Q 039137          640 FNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR-HRNIVKFYGFCSHP--KHSFI  715 (912)
Q Consensus       640 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~--~~~~l  715 (912)
                      |++.+.||+|+||.||+|+.. +++.||+|+++......   ......+|+..+.++. |+|++++++++.+.  +..++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l   77 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL---EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLAL   77 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc---hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEE
Confidence            677889999999999999865 78899999987543222   2234457899999885 99999999999887  88999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ||||+++ ++.+.+...  ...+++.+++.++.|++.||+|||+.   +++||||+|+||+++. +.+||+|||.++...
T Consensus        78 v~e~~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~  150 (282)
T cd07831          78 VFELMDM-NLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIY  150 (282)
T ss_pred             EEecCCc-cHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccc
Confidence            9999975 777777442  24689999999999999999999999   9999999999999999 999999999998664


Q ss_pred             CCCCCccccccccccccccccc-cCCCCcchhHHHHHHHHHHHHhCCCCccchhcccc---------ccccchhhhcc--
Q 039137          796 PDSSNWSELAGTHGYVAPELAY-TLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS---------SSSNMNIEMLD--  863 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~---------~~~~~~~~~~~--  863 (912)
                      ... ......+++.|+|||++. +..++.++||||+||++|||++|..||........         ...........  
T Consensus       151 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (282)
T cd07831         151 SKP-PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKS  229 (282)
T ss_pred             cCC-CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccc
Confidence            332 223346788999999764 45578899999999999999999999852211000         00000000000  


Q ss_pred             --CCCCCCC-------hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          864 --SRLPYPS-------LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       864 --~~~~~~~-------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                        .....+.       ......+..+.+++.+||+++|++||+++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence              0000110       011234567899999999999999999999875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-32  Score=303.55  Aligned_cols=257  Identities=22%  Similarity=0.338  Sum_probs=193.9

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC-----
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP-----  710 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----  710 (912)
                      .++|++.+.||+|+||.||+|.+. +|+.||+|++.....   ......+.+|+.+++.++||||+++++++...     
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   80 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH---QTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF   80 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc---chhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence            468999999999999999999865 789999999863211   12356678899999999999999999987544     


Q ss_pred             CeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccc
Q 039137          711 KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGI  790 (912)
Q Consensus       711 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl  790 (912)
                      ...++||||+++ ++.+++..    ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||+
T Consensus        81 ~~~~lv~e~~~~-~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~  152 (336)
T cd07849          81 NDVYIVQELMET-DLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGL  152 (336)
T ss_pred             ceEEEEehhccc-CHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccc
Confidence            357999999975 78777732    4589999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCC---cccccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCccchhccc----------ccccc
Q 039137          791 AKFLNPDSSN---WSELAGTHGYVAPELAYT-LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMS----------SSSSN  856 (912)
Q Consensus       791 a~~~~~~~~~---~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~----------~~~~~  856 (912)
                      +.........   .....+++.|+|||.+.+ ..++.++||||+||++|+|++|+.||.......          .....
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~  232 (336)
T cd07849         153 ARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQE  232 (336)
T ss_pred             eeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence            9765432211   223567899999998654 468899999999999999999999985211000          00000


Q ss_pred             chhhhcc-------CCCCCC---C--hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 039137          857 MNIEMLD-------SRLPYP---S--LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQL  904 (912)
Q Consensus       857 ~~~~~~~-------~~~~~~---~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  904 (912)
                      .......       ...+..   .  ......+..+.+++.+||+.||++|||+.|+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0000000       000000   0  0011234568899999999999999999998864

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-33  Score=296.43  Aligned_cols=245  Identities=24%  Similarity=0.375  Sum_probs=209.1

Q ss_pred             CceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEEeecC
Q 039137          643 EHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLE  721 (912)
Q Consensus       643 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  721 (912)
                      .++||.|.||+||-|+++ +|+.||||++.+..-...  +.+++..|+.+++.+.||.||.+.-.|+.++..++|||.+.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~k--qesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~  646 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTK--QESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH  646 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCc--hHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc
Confidence            478999999999999875 899999999976543322  45778899999999999999999999999999999999997


Q ss_pred             CCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCC---CcEEEeccccccccCCCC
Q 039137          722 SGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLG---YEAHVSDFGIAKFLNPDS  798 (912)
Q Consensus       722 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~Dfgla~~~~~~~  798 (912)
                      |.-|+.++.  ...+++++.....++.||+.||.|||.+   +|||+||||+|||+...   .++||||||.|+.++.. 
T Consensus       647 GDMLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-  720 (888)
T KOG4236|consen  647 GDMLEMILS--SEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-  720 (888)
T ss_pred             chHHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchh-
Confidence            755555553  3457788888899999999999999999   99999999999999754   36999999999988643 


Q ss_pred             CCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHHH
Q 039137          799 SNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLM  878 (912)
Q Consensus       799 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  878 (912)
                      .-....+|||.|.|||++..+.|...-|+||+||++|--++|..||.       .+++...++.+..+-+|...+.+.+.
T Consensus       721 sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFN-------EdEdIndQIQNAaFMyPp~PW~eis~  793 (888)
T KOG4236|consen  721 SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFN-------EDEDINDQIQNAAFMYPPNPWSEISP  793 (888)
T ss_pred             hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCC-------CccchhHHhhccccccCCCchhhcCH
Confidence            44567899999999999999999999999999999999999999985       22334445556666777777788888


Q ss_pred             HHHHHHHHcccCCCCCCCCHHHHH
Q 039137          879 SIMQVAFSCLDQNPESRPTMKRVS  902 (912)
Q Consensus       879 ~l~~li~~cl~~dP~~RPt~~evl  902 (912)
                      ...++|...++..-.+|-+.++.+
T Consensus       794 ~AidlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  794 EAIDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             HHHHHHHHHHHHHHHHhcchHhhc
Confidence            899999999999999999987654

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-33  Score=276.35  Aligned_cols=250  Identities=20%  Similarity=0.376  Sum_probs=207.1

Q ss_pred             ceeeecCceEEEEEE-eCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcC-CCccccEEEEEEcCCeeeEEEeecC
Q 039137          644 HCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR-HRNIVKFYGFCSHPKHSFIIYEYLE  721 (912)
Q Consensus       644 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  721 (912)
                      +.||+|+|+.|--+. ..+|..||||++.+. .+   -.+.++.+|++++.+.+ |+||+.++++|+++..+|+|||.|.
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-~g---HsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~  159 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-PG---HSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMR  159 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcC-Cc---hHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEeccc
Confidence            579999999998886 458999999999754 22   25788999999999995 9999999999999999999999999


Q ss_pred             CCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCc---EEEeccccccccCCC-
Q 039137          722 SGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYE---AHVSDFGIAKFLNPD-  797 (912)
Q Consensus       722 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~Dfgla~~~~~~-  797 (912)
                      ||+|...+..   ...+++.++.+++.+|+.||.|||.+   ||.|||+||+|||-.....   +|||||.++.-+... 
T Consensus       160 GGplLshI~~---~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~  233 (463)
T KOG0607|consen  160 GGPLLSHIQK---RKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNN  233 (463)
T ss_pred             CchHHHHHHH---hhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCC
Confidence            9999998844   34689999999999999999999999   9999999999999976554   899999987644321 


Q ss_pred             ------CCCccccccccccccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCccchhcc----ccc------ccc
Q 039137          798 ------SSNWSELAGTHGYVAPELAY-----TLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEM----SSS------SSN  856 (912)
Q Consensus       798 ------~~~~~~~~g~~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~----~~~------~~~  856 (912)
                            .....+.+|+..|||||+..     ...|+.+.|.||||||+|-|++|.+||...-..    .+.      ...
T Consensus       234 ~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~  313 (463)
T KOG0607|consen  234 DCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNK  313 (463)
T ss_pred             CCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHH
Confidence                  11234578899999999653     235889999999999999999999999643221    111      122


Q ss_pred             chhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          857 MNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       857 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ....+-++.+.+|...+...+.+..++|...+..|+.+|.++.+++.
T Consensus       314 LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  314 LFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             HHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            34556677888888888899999999999999999999999998875

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=7e-33  Score=281.48  Aligned_cols=264  Identities=21%  Similarity=0.287  Sum_probs=212.1

Q ss_pred             HHHHHHhcCCCCCceeeecCceEEEEEEeC------CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEE
Q 039137          631 EEIISATNDFNAEHCIGKGGHGSVYRAKVP------SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY  704 (912)
Q Consensus       631 ~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~  704 (912)
                      .++.....+++....+.+|.||.||.|.+.      +.+.|.+|.++...   ...+...++.|.-.+..+.|||+..+.
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A---S~iQv~~~L~es~lly~~sH~nll~V~  353 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA---SQIQVNLLLQESMLLYGASHPNLLSVL  353 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc---cHHHHHHHHHHHHHHhcCcCCCcccee
Confidence            455556678888899999999999999654      34557778776432   223567889999999999999999999


Q ss_pred             EEEEc-CCeeeEEEeecCCCChhhHhh-----ccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEc
Q 039137          705 GFCSH-PKHSFIIYEYLESGSLDKILC-----NDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLD  778 (912)
Q Consensus       705 ~~~~~-~~~~~lv~e~~~~g~L~~~l~-----~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~  778 (912)
                      +++.+ .+..++++.++.-|+|..++.     +....+.++..+...++.|++.|++|||.+   +|||.||.++|.++|
T Consensus       354 ~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvId  430 (563)
T KOG1024|consen  354 GVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVID  430 (563)
T ss_pred             EEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceeh
Confidence            99855 467889999999999999996     334455688889999999999999999999   999999999999999


Q ss_pred             CCCcEEEeccccccccCCCCCCc--cccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccc
Q 039137          779 LGYEAHVSDFGIAKFLNPDSSNW--SELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSS  855 (912)
Q Consensus       779 ~~~~~kl~Dfgla~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~  855 (912)
                      +.-++|++|-.+++.+-+.+...  .....+..||+||.+....|+.++|||||||++|||+| |+.|+...     +..
T Consensus       431 d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeI-----DPf  505 (563)
T KOG1024|consen  431 DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEI-----DPF  505 (563)
T ss_pred             hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcccc-----CHH
Confidence            99999999999999887765442  23345678999999999999999999999999999999 99997421     112


Q ss_pred             cchhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 039137          856 NMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEK  908 (912)
Q Consensus       856 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  908 (912)
                      ++..-..++..-..+   -+++.+++.++.-||..+|++||+++|++..|.|.
T Consensus       506 Em~~ylkdGyRlaQP---~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF  555 (563)
T KOG1024|consen  506 EMEHYLKDGYRLAQP---FNCPDELFTVMACCWALLPEERPSFSQLVICLSEF  555 (563)
T ss_pred             HHHHHHhccceecCC---CCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence            233333333322222   23456688888999999999999999999999874

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-32  Score=320.43  Aligned_cols=260  Identities=25%  Similarity=0.403  Sum_probs=207.2

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC----C----CCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP----S----GEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFC  707 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~----~----~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~  707 (912)
                      .++..+.+.+|+|+||.||+|...    .    ...||||..+.....   .+.+.+..|+++|+.+ +|+||+.++|+|
T Consensus       295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~---~~~~~~~~El~~m~~~g~H~niv~llG~~  371 (609)
T KOG0200|consen  295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS---SEKKDLMSELNVLKELGKHPNIVNLLGAC  371 (609)
T ss_pred             hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc---HHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence            344566679999999999999732    1    457999998765543   3678899999999999 599999999999


Q ss_pred             EcCCeeeEEEeecCCCChhhHhhccC-----------Cc--ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCC
Q 039137          708 SHPKHSFIIYEYLESGSLDKILCNDA-----------SA--KELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKN  774 (912)
Q Consensus       708 ~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N  774 (912)
                      ...+..++|+||+..|+|.++++..+           ..  ..++..+.+.++.|||.|++||++.   ++||||+.++|
T Consensus       372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRN  448 (609)
T KOG0200|consen  372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARN  448 (609)
T ss_pred             ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhhhh
Confidence            99999999999999999999996654           01  2388999999999999999999999   99999999999


Q ss_pred             eEEcCCCcEEEeccccccccCCCCCCc-cccc--cccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhcc
Q 039137          775 VLLDLGYEAHVSDFGIAKFLNPDSSNW-SELA--GTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEM  850 (912)
Q Consensus       775 ill~~~~~~kl~Dfgla~~~~~~~~~~-~~~~--g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~  850 (912)
                      |++.++..+||+|||+|+......... ....  -...|||||.+....|+.++|||||||++||++| |..||..... 
T Consensus       449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~-  527 (609)
T KOG0200|consen  449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP-  527 (609)
T ss_pred             EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc-
Confidence            999999999999999999665443322 2222  2456999999999999999999999999999999 8899752110 


Q ss_pred             ccccccchhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 039137          851 SSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI  909 (912)
Q Consensus       851 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l  909 (912)
                         ..+......++.....+   .....++.+++..||+.+|++||++.++.+.++.++
T Consensus       528 ---~~~l~~~l~~G~r~~~P---~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l  580 (609)
T KOG0200|consen  528 ---TEELLEFLKEGNRMEQP---EHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL  580 (609)
T ss_pred             ---HHHHHHHHhcCCCCCCC---CCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence               11111112222222222   223566889999999999999999999999999865

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-35  Score=332.40  Aligned_cols=421  Identities=30%  Similarity=0.331  Sum_probs=283.0

Q ss_pred             eEEEeeccccccccccccccCCCCCccEEEccCCcccccCCccccCCCCCcEEeccccccccccccccccccccceeecc
Q 039137           86 VVGINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHIS  165 (912)
Q Consensus        86 v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~  165 (912)
                      ++.+++..+.+-..-.++ ..+--+|+.|||++|++. ..|..+..+.+|+.|+++.|.|. ..|.+.+++.+|++|.|.
T Consensus        23 ~~~ln~~~N~~l~~pl~~-~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~   99 (1081)
T KOG0618|consen   23 LQILNLRRNSLLSRPLEF-VEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLK   99 (1081)
T ss_pred             HHhhhccccccccCchHH-hhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheec
Confidence            555565554333211111 122234899999999886 68888999999999999999997 788888999999999999


Q ss_pred             cccccCCCCccccCcccccEEEccCCcCCCCCCccCCCCccceeeeeccC-------------------CCcCccccccc
Q 039137          166 RNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNN-------------------SFFGSIPQEIG  226 (912)
Q Consensus       166 ~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n-------------------~l~~~~p~~~~  226 (912)
                      .|.+. .+|.++..+++|+.|+++.|++. .+|..+..++.+..+..++|                   .+.+.++..+.
T Consensus       100 ~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~  177 (1081)
T KOG0618|consen  100 NNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIY  177 (1081)
T ss_pred             cchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcchh
Confidence            99888 89999999999999999999987 77777776666666666666                   33334444444


Q ss_pred             cccccceeecccccccCccccccccccccceeeeccccCcccCCcccCCccccchhhhccCccCCCCccccccccccceE
Q 039137          227 NLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKL  306 (912)
Q Consensus       227 ~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  306 (912)
                      ++..  .|+|++|.+.   -..+.++.+|+.|.+..|+++...    -..++|+.|+.++|.+....+.  .--.+|+++
T Consensus       178 ~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l~----~~g~~l~~L~a~~n~l~~~~~~--p~p~nl~~~  246 (1081)
T KOG0618|consen  178 NLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSELE----ISGPSLTALYADHNPLTTLDVH--PVPLNLQYL  246 (1081)
T ss_pred             hhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceEE----ecCcchheeeeccCcceeeccc--cccccceee
Confidence            4444  4555555554   112344444444444444444211    1113444444444444421111  112456666


Q ss_pred             ecccccccCCCCcccCCCCCccEEEccCCcCcccccccCCCCCCCCEEeccCCcccccccccccccccccEEEccCcccc
Q 039137          307 RLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIV  386 (912)
Q Consensus       307 ~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~  386 (912)
                      ++++|++++.+ ++++.+++|+.++..+|+| ...|..+....+|+.|++.+|.+. .+|........|++|+|..|+|.
T Consensus       247 dis~n~l~~lp-~wi~~~~nle~l~~n~N~l-~~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~  323 (1081)
T KOG0618|consen  247 DISHNNLSNLP-EWIGACANLEALNANHNRL-VALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP  323 (1081)
T ss_pred             ecchhhhhcch-HHHHhcccceEecccchhH-HhhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhcccc
Confidence            66666666443 6666666666666666666 344444555555555566666555 45555555666666666666665


Q ss_pred             CCCCccc--------------------------cccccccEEEccCCcccCCCccccccccccccccccCcccCcccccc
Q 039137          387 GEIPTQL--------------------------GNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPES  440 (912)
Q Consensus       387 ~~~~~~l--------------------------~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~  440 (912)
                      . .|..+                          ..+..|+.|++.+|.+++..-..+.+++.|+.|+|++|+|..++...
T Consensus       324 ~-lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~  402 (1081)
T KOG0618|consen  324 S-LPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASK  402 (1081)
T ss_pred             c-cchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHH
Confidence            2 22211                          12345778888888888766667888888999999999998877778


Q ss_pred             ccccccccEEEecccccccccchhhhcccccceeeccccccCcccccccccccccccccccCccccCCCcccccccccce
Q 039137          441 LGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLL  520 (912)
Q Consensus       441 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~  520 (912)
                      +.++..|++|+||+|+|+ .+|..+.++..|++|...+|+|. ..| .+..++.|+.+|+|.|+|+...-..-...++|+
T Consensus       403 ~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~Lk  479 (1081)
T KOG0618|consen  403 LRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLK  479 (1081)
T ss_pred             HhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccc
Confidence            888899999999999997 67888888999999999999884 445 788899999999999998865333333337899


Q ss_pred             EEEccCCcc
Q 039137          521 HIDISYNKL  529 (912)
Q Consensus       521 ~l~ls~N~l  529 (912)
                      +||++||..
T Consensus       480 yLdlSGN~~  488 (1081)
T KOG0618|consen  480 YLDLSGNTR  488 (1081)
T ss_pred             eeeccCCcc
Confidence            999999874

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=3.1e-32  Score=292.65  Aligned_cols=244  Identities=21%  Similarity=0.273  Sum_probs=186.7

Q ss_pred             eeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHH---HHhhcCCCccccEEEEEEcCCeeeEEEeec
Q 039137          645 CIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQ---ALTEIRHRNIVKFYGFCSHPKHSFIIYEYL  720 (912)
Q Consensus       645 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~---~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  720 (912)
                      .||+|+||.||+|+.. +++.||+|.+......... ....+..|..   .++...||+|+++++++..++..++||||+
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   79 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ-GETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLM   79 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccch-hHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecC
Confidence            4899999999999865 6889999998754322211 1222334433   344457999999999999999999999999


Q ss_pred             CCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCCC
Q 039137          721 ESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN  800 (912)
Q Consensus       721 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  800 (912)
                      ++|+|.+++..   ...+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||++......  .
T Consensus        80 ~g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--~  151 (278)
T cd05606          80 NGGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--K  151 (278)
T ss_pred             CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCcc--C
Confidence            99999998843   34689999999999999999999999   9999999999999999999999999998755332  2


Q ss_pred             ccccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHHHH
Q 039137          801 WSELAGTHGYVAPELAYTL-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMS  879 (912)
Q Consensus       801 ~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  879 (912)
                      .....|+..|+|||++.+. .++.++||||+|+++|||++|+.||........  ..............+.    ..+..
T Consensus       152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~----~~s~~  225 (278)
T cd05606         152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLTMAVELPD----SFSPE  225 (278)
T ss_pred             CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch--HHHHHHhhccCCCCCC----cCCHH
Confidence            2345689999999998754 688999999999999999999999863211110  0011111111111111    23456


Q ss_pred             HHHHHHHcccCCCCCCC-----CHHHHHH
Q 039137          880 IMQVAFSCLDQNPESRP-----TMKRVSQ  903 (912)
Q Consensus       880 l~~li~~cl~~dP~~RP-----t~~evl~  903 (912)
                      +.+++.+|+..+|.+||     ++.++++
T Consensus       226 ~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         226 LRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             HHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            88999999999999999     8988875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=3.2e-32  Score=296.62  Aligned_cols=261  Identities=23%  Similarity=0.338  Sum_probs=196.3

Q ss_pred             HHhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCC--
Q 039137          635 SATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPK--  711 (912)
Q Consensus       635 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--  711 (912)
                      ...++|++.+.||+|+||.||+|..+ +++.||+|++........  ....+.+|+++++.++||||+++++++.+..  
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~--~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~   81 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEG--FPITAIREIKILRQLNHRNIVNLKEIVTDKQDA   81 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccC--chHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence            35678999999999999999999976 688999999865432221  3456778999999999999999999987654  


Q ss_pred             --------eeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcE
Q 039137          712 --------HSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEA  783 (912)
Q Consensus       712 --------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  783 (912)
                              ..++|+||+++ ++.+.+...  ...+++.+++.++.|++.||+|||+.   +|+|+||||+||++++++.+
T Consensus        82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~  155 (302)
T cd07864          82 LDFKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQI  155 (302)
T ss_pred             hhccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcE
Confidence                    78999999986 676666332  34689999999999999999999999   99999999999999999999


Q ss_pred             EEeccccccccCCCCC-Ccccccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCccchhccccc--------
Q 039137          784 HVSDFGIAKFLNPDSS-NWSELAGTHGYVAPELAYT-LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS--------  853 (912)
Q Consensus       784 kl~Dfgla~~~~~~~~-~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~--------  853 (912)
                      ||+|||.+........ ......+++.|+|||.+.+ ..++.++||||+||++|||++|++||+........        
T Consensus       156 kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~  235 (302)
T cd07864         156 KLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCG  235 (302)
T ss_pred             EeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            9999999987654332 2223356788999998765 35788999999999999999999998622110000        


Q ss_pred             -c-ccchhhh--------ccCCCCC---CChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          854 -S-SNMNIEM--------LDSRLPY---PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       854 -~-~~~~~~~--------~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                       . .......        .+.....   ........+..+.+++.+||+.||.+||+++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             CCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence             0 0000000        0000000   00001112456889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=3.7e-32  Score=296.57  Aligned_cols=249  Identities=26%  Similarity=0.414  Sum_probs=195.2

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      +.|+..+.||+|++|.||+|+.. +++.+|+|.+....... ....+++.+|+++++.++|+|++++++++......++|
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   93 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS-NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccC-hHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence            34777789999999999999875 67889999886432222 22456788999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+. |++.+++...  ...+++.++..++.|++.|++|||++   +++||||+|+||+++.++.++++|||++.....
T Consensus        94 ~e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  167 (308)
T cd06634          94 MEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (308)
T ss_pred             EEccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence            99997 5787776432  24588999999999999999999999   999999999999999999999999999876543


Q ss_pred             CCCCccccccccccccccccc---cCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhh
Q 039137          797 DSSNWSELAGTHGYVAPELAY---TLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHV  873 (912)
Q Consensus       797 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  873 (912)
                      .    ....+++.|+|||++.   ...++.++|||||||++|+|++|..||......     ...........+  ....
T Consensus       168 ~----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~~--~~~~  236 (308)
T cd06634         168 A----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----SALYHIAQNESP--ALQS  236 (308)
T ss_pred             c----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH-----HHHHHHhhcCCC--CcCc
Confidence            2    2346788999999874   345788999999999999999999997421110     000111111111  1111


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 039137          874 QKKLMSIMQVAFSCLDQNPESRPTMKRVSQL  904 (912)
Q Consensus       874 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  904 (912)
                      ...+..+.++|.+||+.+|++||++.++++.
T Consensus       237 ~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         237 GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             ccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence            2345568899999999999999999998764

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.7e-32  Score=291.90  Aligned_cols=253  Identities=23%  Similarity=0.300  Sum_probs=198.1

Q ss_pred             CCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCC-chHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          639 DFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGE-MSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      +|.+.+.||+|+||.||++++. .+..+++|..+...... ......++.+|+.+++.++||||+++++++.+.+..++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            5888999999999999999865 34556666654322211 111344567899999999999999999999988999999


Q ss_pred             EeecCCCChhhHhhcc-CCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          717 YEYLESGSLDKILCND-ASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      |||+++++|.+++... .....+++.+++.++.|++.|++|||+.   +++|+||+|+||+++. +.++++|||.+....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence            9999999999988543 2345689999999999999999999999   9999999999999975 569999999998765


Q ss_pred             CCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHH
Q 039137          796 PDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQK  875 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  875 (912)
                      ..........+++.|+|||...+..++.++||||+|+++|+|++|..||....     .............+.   ....
T Consensus       157 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-----~~~~~~~~~~~~~~~---~~~~  228 (260)
T cd08222         157 GSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-----FLSVVLRIVEGPTPS---LPET  228 (260)
T ss_pred             CCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHHcCCCCC---Ccch
Confidence            44444445668899999999888888999999999999999999999975211     111111111111111   1134


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          876 KLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       876 ~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .+.++.+++.+||+.+|++||++.|+++
T Consensus       229 ~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         229 YSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             hcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            4567889999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=3.4e-32  Score=297.59  Aligned_cols=258  Identities=22%  Similarity=0.342  Sum_probs=192.0

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCC----
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPK----  711 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----  711 (912)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++........  ....+.+|++++++++||||+++++++...+    
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEG--FPITALREIKILQLLKHENVVNLIEICRTKATPYN   88 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCC--chhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence            457999999999999999999876 789999999865432211  2345668999999999999999999987654    


Q ss_pred             ----eeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEec
Q 039137          712 ----HSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSD  787 (912)
Q Consensus       712 ----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  787 (912)
                          ..++||||+.+ ++.+++...  ...+++.+++.++.|++.|++|||++   +++|+||||+||+++.++.+||+|
T Consensus        89 ~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~d  162 (310)
T cd07865          89 RYKGSFYLVFEFCEH-DLAGLLSNK--NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLAD  162 (310)
T ss_pred             CCCceEEEEEcCCCc-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECc
Confidence                34999999975 788777432  23689999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCC----CccccccccccccccccccCC-CCcchhHHHHHHHHHHHHhCCCCccchhcccccc--------
Q 039137          788 FGIAKFLNPDSS----NWSELAGTHGYVAPELAYTLK-VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS--------  854 (912)
Q Consensus       788 fgla~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~-~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~--------  854 (912)
                      ||.+........    ......++..|+|||.+.+.. ++.++||||+|+++|||++|..||..........        
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~  242 (310)
T cd07865         163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGS  242 (310)
T ss_pred             CCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            999986543221    122345678899999876644 6889999999999999999999985321100000        


Q ss_pred             -------ccchhhhccCCCCCCChh---hH------HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          855 -------SNMNIEMLDSRLPYPSLH---VQ------KKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       855 -------~~~~~~~~~~~~~~~~~~---~~------~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                             ........+ ....+...   ..      .....+.++|.+||..||++|||++|+++
T Consensus       243 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         243 ITPEVWPGVDKLELFK-KMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             CChhhcccccchhhhh-hccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence                   000000000 00000000   00      01235678999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2e-32  Score=302.87  Aligned_cols=259  Identities=24%  Similarity=0.353  Sum_probs=196.1

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEEcC--C
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSHP--K  711 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~--~  711 (912)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++.......  .....+.+|+.+++++ +||||+++++++...  .
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~--~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~   82 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNA--TDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK   82 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcc--hhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence            4567999999999999999999876 68899999986533222  1345677899999999 999999999998654  3


Q ss_pred             eeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccc
Q 039137          712 HSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIA  791 (912)
Q Consensus       712 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla  791 (912)
                      ..++||||+++ +|.+++...    .+++..++.++.|++.||+|||++   +|+|+||||+||+++.++.+||+|||++
T Consensus        83 ~~~lv~e~~~~-~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~  154 (337)
T cd07852          83 DIYLVFEYMET-DLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLA  154 (337)
T ss_pred             eEEEEeccccc-CHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccch
Confidence            68999999974 898888432    678899999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCC-----Ccccccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCccchhcccccc----------c
Q 039137          792 KFLNPDSS-----NWSELAGTHGYVAPELAYT-LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS----------S  855 (912)
Q Consensus       792 ~~~~~~~~-----~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~----------~  855 (912)
                      ........     ......+++.|+|||++.+ ..++.++||||||+++|+|++|+.||..........          .
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  234 (337)
T cd07852         155 RSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSA  234 (337)
T ss_pred             hccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            86644321     2233567889999998765 457889999999999999999999985211100000          0


Q ss_pred             --------cchhhhcc----CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 039137          856 --------NMNIEMLD----SRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQL  904 (912)
Q Consensus       856 --------~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  904 (912)
                              .......+    .............+..+.+++.+||+.||++|||+.++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                    00000000    00000001111234568899999999999999999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-31  Score=290.20  Aligned_cols=256  Identities=23%  Similarity=0.320  Sum_probs=195.1

Q ss_pred             CCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc---CCCccccEEEEEEcCCe---
Q 039137          640 FNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI---RHRNIVKFYGFCSHPKH---  712 (912)
Q Consensus       640 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l---~h~niv~l~~~~~~~~~---  712 (912)
                      |++.+.||+|+||.||+|+++ +++.||+|++.......  .....+.+|+.+++++   +|||++++++++...+.   
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~   78 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE--GIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRE   78 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccc--hhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCC
Confidence            677899999999999999987 58999999997554322  1344566788877766   59999999999987776   


Q ss_pred             --eeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccc
Q 039137          713 --SFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGI  790 (912)
Q Consensus       713 --~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl  790 (912)
                        .+++|||+++ ++.+++.... ...+++.+++.++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||.
T Consensus        79 ~~~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~  153 (287)
T cd07838          79 LKLTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGL  153 (287)
T ss_pred             ceeEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCc
Confidence              8999999975 8988885433 23589999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhcccccc---------ccc--h-
Q 039137          791 AKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS---------SNM--N-  858 (912)
Q Consensus       791 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~---------~~~--~-  858 (912)
                      +....... ......+++.|+|||++.+..++.++||||||+++|||++|+.||+...+.....         ...  . 
T Consensus       154 ~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07838         154 ARIYSFEM-ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR  232 (287)
T ss_pred             ceeccCCc-ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCC
Confidence            98764332 2233457889999999999889999999999999999999999986321100000         000  0 


Q ss_pred             -----hhhccCCC-CCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          859 -----IEMLDSRL-PYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       859 -----~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                           ........ .............+.+++.+||+.||.+||+++|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence                 00000000 0011112234566789999999999999999998874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-32  Score=293.52  Aligned_cols=256  Identities=25%  Similarity=0.363  Sum_probs=196.2

Q ss_pred             CCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC--CeeeEE
Q 039137          640 FNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP--KHSFII  716 (912)
Q Consensus       640 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~lv  716 (912)
                      |++.+.||+|++|.||+|+.. +++.||+|++.....  .......+.+|+++++.++|||++++++++...  +..++|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   78 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENE--KEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMV   78 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccc--cccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEE
Confidence            677899999999999999876 588999999976541  122346688999999999999999999999888  889999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++ +|.+++....  ..+++.+++.++.|++.|++|||++   +++|+||+|+||++++++.++++|||.+.....
T Consensus        79 ~e~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~  152 (287)
T cd07840          79 FEYMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTK  152 (287)
T ss_pred             eccccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccC
Confidence            999985 8888884432  4689999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCC-Ccccccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCccchhcccccc----------ccc-------
Q 039137          797 DSS-NWSELAGTHGYVAPELAYT-LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS----------SNM-------  857 (912)
Q Consensus       797 ~~~-~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~----------~~~-------  857 (912)
                      ... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||+.........          ...       
T Consensus       153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07840         153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL  232 (287)
T ss_pred             CCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc
Confidence            432 1233456788999997765 457899999999999999999999985221100000          000       


Q ss_pred             -hhhhccCCCCCCC---hhhHH-HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          858 -NIEMLDSRLPYPS---LHVQK-KLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       858 -~~~~~~~~~~~~~---~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                       ...........+.   ..... .+..+.+++.+||+.+|++||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence             0000000000000   00111 1556889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=3.6e-32  Score=297.96  Aligned_cols=256  Identities=19%  Similarity=0.217  Sum_probs=190.3

Q ss_pred             CCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEEeec
Q 039137          641 NAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYL  720 (912)
Q Consensus       641 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  720 (912)
                      .+++.+|.|+++.||+++. +++.||+|++......  ....+.+.+|++.++.++||||+++++++...+..+++|||+
T Consensus         5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~--~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~   81 (314)
T cd08216           5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCS--KEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLM   81 (314)
T ss_pred             hhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccc--hhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEecc
Confidence            3444455555555555544 7999999998754222  225677999999999999999999999999999999999999


Q ss_pred             CCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCC-
Q 039137          721 ESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSS-  799 (912)
Q Consensus       721 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~-  799 (912)
                      ++|++.+++.... ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.++++|||.+........ 
T Consensus        82 ~~~~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~  157 (314)
T cd08216          82 AYGSCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKR  157 (314)
T ss_pred             CCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccc
Confidence            9999999996532 24588999999999999999999999   999999999999999999999999998875532211 


Q ss_pred             ------CccccccccccccccccccC--CCCcchhHHHHHHHHHHHHhCCCCccchhccccccccc--------------
Q 039137          800 ------NWSELAGTHGYVAPELAYTL--KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNM--------------  857 (912)
Q Consensus       800 ------~~~~~~g~~~y~aPE~~~~~--~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~--------------  857 (912)
                            ......++..|+|||++.+.  .++.++||||+||++|||++|+.||.............              
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (314)
T cd08216         158 QRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYP  237 (314)
T ss_pred             ccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchh
Confidence                  11234567789999998763  47889999999999999999999986321110000000              


Q ss_pred             --hhhhc-------cC--CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          858 --NIEML-------DS--RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       858 --~~~~~-------~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                        .....       ..  ...............+.+++.+||+.||++|||++++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence              00000       00  000111112233456889999999999999999999876

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=3.9e-32  Score=294.89  Aligned_cols=253  Identities=24%  Similarity=0.364  Sum_probs=194.8

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcC-CCccccEEEEEEcCCeee
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR-HRNIVKFYGFCSHPKHSF  714 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~  714 (912)
                      .++|++.+.||+|++|.||+|+++ +++.||||.+......   ....++.+|+..+.... ||||+++++++..+...+
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~   90 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK---EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVF   90 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh---HHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEE
Confidence            467899999999999999999986 4899999998654221   13456677887777774 999999999999999999


Q ss_pred             EEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCCeEEcCCCcEEEeccccccc
Q 039137          715 IIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHN-NCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKF  793 (912)
Q Consensus       715 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  793 (912)
                      +||||+++ ++.+++...  ...+++..+..++.|++.|++|||+ .   +|+||||+|+||++++++.++|+|||++..
T Consensus        91 ~v~e~~~~-~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~~  164 (296)
T cd06618          91 ICMELMST-CLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGR  164 (296)
T ss_pred             EEeeccCc-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccchh
Confidence            99999864 777776432  2468999999999999999999997 5   899999999999999999999999999976


Q ss_pred             cCCCCCCccccccccccccccccccCC----CCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCC
Q 039137          794 LNPDSSNWSELAGTHGYVAPELAYTLK----VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYP  869 (912)
Q Consensus       794 ~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  869 (912)
                      ..... ......+++.|+|||++.+..    ++.++||||||+++|+|++|+.||.....    .............+..
T Consensus       165 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~~~~~~~~~~~  239 (296)
T cd06618         165 LVDSK-AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT----EFEVLTKILQEEPPSL  239 (296)
T ss_pred             ccCCC-cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh----HHHHHHHHhcCCCCCC
Confidence            54322 223345788999999987654    78899999999999999999999852110    0111111122211111


Q ss_pred             ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 039137          870 SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQL  904 (912)
Q Consensus       870 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  904 (912)
                      + .....+.++.+++.+||+.||.+||++.++++.
T Consensus       240 ~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         240 P-PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             C-CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            1 011234568899999999999999999998764

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=8.3e-32  Score=294.42  Aligned_cols=246  Identities=26%  Similarity=0.412  Sum_probs=192.7

Q ss_pred             CCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEEe
Q 039137          640 FNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYE  718 (912)
Q Consensus       640 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e  718 (912)
                      |...+.||+|+||+||+|+.. +++.|++|++....... ....+.+.+|+++++.++|||++++++++.+.+..|+|||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  101 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQT-NEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME  101 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCc-hHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence            666788999999999999875 78899999986543322 2244678899999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCC
Q 039137          719 YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS  798 (912)
Q Consensus       719 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  798 (912)
                      |+.+ ++.+++...  ...+++.++..++.|++.|++|||++   +++|+||+|+||+++.++.++|+|||.+.....  
T Consensus       102 ~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--  173 (313)
T cd06633         102 YCLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP--  173 (313)
T ss_pred             cCCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence            9964 777776432  34688999999999999999999999   999999999999999999999999999864322  


Q ss_pred             CCccccccccccccccccc---cCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHH
Q 039137          799 SNWSELAGTHGYVAPELAY---TLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQK  875 (912)
Q Consensus       799 ~~~~~~~g~~~y~aPE~~~---~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  875 (912)
                        .....++..|+|||++.   ...++.++||||||+++|||++|..||.......     ..........+  ......
T Consensus       174 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~-----~~~~~~~~~~~--~~~~~~  244 (313)
T cd06633         174 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-----ALYHIAQNDSP--TLQSNE  244 (313)
T ss_pred             --CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHhcCCC--CCCccc
Confidence              23456788999999874   4567889999999999999999999974211100     00001111111  111122


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          876 KLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       876 ~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .+..+.+++.+||+.+|.+||++.++++
T Consensus       245 ~~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         245 WTDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            3345788999999999999999999885

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.5e-32  Score=315.69  Aligned_cols=261  Identities=19%  Similarity=0.225  Sum_probs=186.5

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC--CCCEEEEEEccCCC-------------CCCchHHHHHHHHHHHHHhhcCCCcc
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP--SGEIFAVKKFHSPL-------------PGEMSFQQEEFLNEIQALTEIRHRNI  700 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~-------------~~~~~~~~~~~~~Ei~~l~~l~h~ni  700 (912)
                      ..++|++.+.||+|+||+||+|..+  .++.+++|.+....             ..........+.+|+++++.++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            4578999999999999999998754  22222222111000             01111234568899999999999999


Q ss_pred             ccEEEEEEcCCeeeEEEeecCCCChhhHhhccCC--cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEc
Q 039137          701 VKFYGFCSHPKHSFIIYEYLESGSLDKILCNDAS--AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLD  778 (912)
Q Consensus       701 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~  778 (912)
                      +++++++...+..|+|+|++.+ ++.+++.....  .......++..++.|++.||+|||++   +|+||||||+||+++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~  301 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN  301 (501)
T ss_pred             CcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence            9999999999999999999865 67666633221  22344677889999999999999999   999999999999999


Q ss_pred             CCCcEEEeccccccccCCCCCC-ccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCC-ccchhcccccccc
Q 039137          779 LGYEAHVSDFGIAKFLNPDSSN-WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP-RDFLFEMSSSSSN  856 (912)
Q Consensus       779 ~~~~~kl~Dfgla~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p-f~~~~~~~~~~~~  856 (912)
                      .++.+||+|||+++.+...... .....|++.|+|||++.+..++.++|||||||++|||++|..+ +.....   ....
T Consensus       302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~---~~~~  378 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGG---KPGK  378 (501)
T ss_pred             CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCC---CHHH
Confidence            9999999999999876543222 2345789999999999999999999999999999999998754 321100   0000


Q ss_pred             chhhhc------cCCCCC---------------------CCh-hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          857 MNIEML------DSRLPY---------------------PSL-HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       857 ~~~~~~------~~~~~~---------------------~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ....++      ....+.                     +.. ........+.+++.+|++.||.+|||+.|+++
T Consensus       379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            000000      000000                     000 00011234677899999999999999999976

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=7.4e-32  Score=297.01  Aligned_cols=254  Identities=20%  Similarity=0.263  Sum_probs=190.0

Q ss_pred             ceeeec--CceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEEeec
Q 039137          644 HCIGKG--GHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYL  720 (912)
Q Consensus       644 ~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  720 (912)
                      ..||+|  +||+||+|++. +|+.||+|++......  ....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~   81 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT--EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFM   81 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecc
Confidence            356666  99999999875 7999999998654322  224577889999999999999999999999999999999999


Q ss_pred             CCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCCC
Q 039137          721 ESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN  800 (912)
Q Consensus       721 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  800 (912)
                      +++++.+++.... ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++++||+.+.........
T Consensus        82 ~~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~  157 (328)
T cd08226          82 AYGSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK  157 (328)
T ss_pred             cCCCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence            9999999985543 23588999999999999999999999   9999999999999999999999999865433221111


Q ss_pred             c-------cccccccccccccccccC--CCCcchhHHHHHHHHHHHHhCCCCccchhcccccccc---------------
Q 039137          801 W-------SELAGTHGYVAPELAYTL--KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSN---------------  856 (912)
Q Consensus       801 ~-------~~~~g~~~y~aPE~~~~~--~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~---------------  856 (912)
                      .       ....++..|+|||++.+.  .++.++||||+||++|||++|+.||............               
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (328)
T cd08226         158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFP  237 (328)
T ss_pred             ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccc
Confidence            1       112345679999998764  4789999999999999999999998632110000000               


Q ss_pred             -chh---------------hhccC----CC---CCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          857 -MNI---------------EMLDS----RL---PYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       857 -~~~---------------~~~~~----~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                       ...               .....    ..   .............+.+++.+||+.||++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence             000               00000    00   0001112335567899999999999999999999874

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=2.3e-32  Score=301.86  Aligned_cols=258  Identities=22%  Similarity=0.321  Sum_probs=196.2

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEc----CC
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSH----PK  711 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~----~~  711 (912)
                      .++|++.+.||+|++|.||+|..+ +++.||+|++.......  ...+.+.+|+.+++.++||||+++++++..    ..
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   81 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVP--TLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFK   81 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccc--cchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCc
Confidence            468999999999999999999865 69999999987543221  135667789999999999999999998753    34


Q ss_pred             eeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccc
Q 039137          712 HSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIA  791 (912)
Q Consensus       712 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla  791 (912)
                      ..++||||+. ++|.+++..   ...+++..++.++.|++.||+|||++   +|+||||||+||++++++.+||+|||++
T Consensus        82 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~  154 (334)
T cd07855          82 DVYVVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMA  154 (334)
T ss_pred             eEEEEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccc
Confidence            6899999996 589888833   34589999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCC----cccccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCccchhcccc------cccc----
Q 039137          792 KFLNPDSSN----WSELAGTHGYVAPELAYT-LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS------SSSN----  856 (912)
Q Consensus       792 ~~~~~~~~~----~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~------~~~~----  856 (912)
                      .........    .....++..|+|||.+.+ ..++.++||||+|+++|||++|+.||........      ....    
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~  234 (334)
T cd07855         155 RGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEE  234 (334)
T ss_pred             eeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhH
Confidence            765432211    123468889999998765 4588999999999999999999999852111000      0000    


Q ss_pred             --------chhhh---ccCCCCCCC-hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          857 --------MNIEM---LDSRLPYPS-LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       857 --------~~~~~---~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                              .....   .......+. ......+..+.+++.+||+.||++||++++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             hhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence                    00000   000111110 011223567899999999999999999998876

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-32  Score=286.93  Aligned_cols=239  Identities=26%  Similarity=0.359  Sum_probs=195.2

Q ss_pred             eeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEEeecCCCC
Q 039137          646 IGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGS  724 (912)
Q Consensus       646 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  724 (912)
                      ||+|+||.||++... +++.||+|.+........ ...+.+..|+++++.++||||+++++.+..++..++||||+++++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~   79 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKR-KEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGE   79 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcch-HHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence            689999999999876 589999999875533221 245678899999999999999999999999999999999999999


Q ss_pred             hhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCCCcccc
Q 039137          725 LDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSEL  804 (912)
Q Consensus       725 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~  804 (912)
                      |.+++...   ..+++.++..++.|++.|++|+|+.   +++|+||+|+||+++.++.++++|||.+.............
T Consensus        80 L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~  153 (250)
T cd05123          80 LFSHLSKE---GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTF  153 (250)
T ss_pred             HHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCC
Confidence            99999443   3589999999999999999999998   99999999999999999999999999998765443334455


Q ss_pred             ccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHHHHHHHHH
Q 039137          805 AGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVA  884 (912)
Q Consensus       805 ~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  884 (912)
                      .++..|+|||...+...+.++|+||||+++|++++|+.||+....     ............+.+..    .+..+.+++
T Consensus       154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~----~~~~l~~~i  224 (250)
T cd05123         154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-----KEIYEKILKDPLRFPEF----LSPEARDLI  224 (250)
T ss_pred             cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHhcCCCCCCCC----CCHHHHHHH
Confidence            678899999999888889999999999999999999999852211     11112222222232221    245678999


Q ss_pred             HHcccCCCCCCCCHHH
Q 039137          885 FSCLDQNPESRPTMKR  900 (912)
Q Consensus       885 ~~cl~~dP~~RPt~~e  900 (912)
                      .+||..||++||++.+
T Consensus       225 ~~~l~~~p~~R~~~~~  240 (250)
T cd05123         225 SGLLQKDPTKRLGSGG  240 (250)
T ss_pred             HHHhcCCHhhCCCccc
Confidence            9999999999999955

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=4.8e-32  Score=297.97  Aligned_cols=258  Identities=22%  Similarity=0.351  Sum_probs=197.0

Q ss_pred             HHHhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEc-CC
Q 039137          634 ISATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSH-PK  711 (912)
Q Consensus       634 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-~~  711 (912)
                      ...+++|++.+.||+|+||.||+|..+ +++.||+|++..+....  ...+.+.+|+++++.++||||+++++++.. ..
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   83 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTP--VLAKRTYRELKLLKHLRHENIISLSDIFISPLE   83 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccccc--chhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence            446788999999999999999999866 79999999986543221  235667899999999999999999999865 45


Q ss_pred             eeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccc
Q 039137          712 HSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIA  791 (912)
Q Consensus       712 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla  791 (912)
                      ..++||||+. ++|.+++..    ..+++..+..++.|++.|++|||+.   +|+||||+|+||++++++.++++|||.+
T Consensus        84 ~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~  155 (328)
T cd07856          84 DIYFVTELLG-TDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLA  155 (328)
T ss_pred             cEEEEeehhc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccc
Confidence            7899999984 589888742    3578888999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCccchhcccc------c----cc-----
Q 039137          792 KFLNPDSSNWSELAGTHGYVAPELAYT-LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS------S----SS-----  855 (912)
Q Consensus       792 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~------~----~~-----  855 (912)
                      .....   ......+++.|+|||.+.+ ..++.++||||+|+++|+|++|+.||........      .    ..     
T Consensus       156 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (328)
T cd07856         156 RIQDP---QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT  232 (328)
T ss_pred             cccCC---CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            75432   2233467889999998765 5689999999999999999999999852211000      0    00     


Q ss_pred             ---cchhhh---ccCCCCCCC-hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 039137          856 ---NMNIEM---LDSRLPYPS-LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQL  904 (912)
Q Consensus       856 ---~~~~~~---~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  904 (912)
                         ......   .....+.+. ......+..+.++|.+|++.+|++|||+++++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence               000000   000011111 0111234678899999999999999999988653

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-34  Score=279.95  Aligned_cols=254  Identities=25%  Similarity=0.327  Sum_probs=196.5

Q ss_pred             CCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEEcCCeeeEEE
Q 039137          640 FNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSHPKHSFIIY  717 (912)
Q Consensus       640 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~  717 (912)
                      .+-...||.|+||+|++..++ +|+..|||+++....   ...+++++.|.+...+- ++||||+++|++..++..|+.|
T Consensus        66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~---~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM  142 (361)
T KOG1006|consen   66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI---EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM  142 (361)
T ss_pred             HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc---hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence            344578999999999999876 899999999986544   23678889999876555 7999999999999999999999


Q ss_pred             eecCCCChhhHhhc--cCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          718 EYLESGSLDKILCN--DASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       718 e~~~~g~L~~~l~~--~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      |.|+- +++.+-+.  ......+++.-.-.|....+.||.||-...  .|+|||+||+|||++..|.+||||||++..+.
T Consensus       143 ELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv  219 (361)
T KOG1006|consen  143 ELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLV  219 (361)
T ss_pred             HHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHH
Confidence            99965 77655422  123456888888899999999999998874  89999999999999999999999999998765


Q ss_pred             CCCCCcccccccccccccccccc--CCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCC--CCCCh
Q 039137          796 PDSSNWSELAGTHGYVAPELAYT--LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRL--PYPSL  871 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~  871 (912)
                      .. ...+.-.|-..|||||.+..  ..|+.+|||||+|+++||+.||..|++....  ..++  ...+..+..  .....
T Consensus       220 ~S-iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeq--l~~Vv~gdpp~l~~~~  294 (361)
T KOG1006|consen  220 DS-IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQ--LCQVVIGDPPILLFDK  294 (361)
T ss_pred             HH-HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHH--HHHHHcCCCCeecCcc
Confidence            33 22233456778999998863  3489999999999999999999999752211  1111  111122222  22233


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 039137          872 HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQL  904 (912)
Q Consensus       872 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  904 (912)
                      ........+..+|..|+.+|-..||.++++.++
T Consensus       295 ~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  295 ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             cccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            344567789999999999999999999998764

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.2e-32  Score=300.52  Aligned_cols=257  Identities=24%  Similarity=0.341  Sum_probs=199.3

Q ss_pred             CCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCC-----e
Q 039137          639 DFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPK-----H  712 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-----~  712 (912)
                      +|++.+.||+|++|.||+|+.. +++.||+|++......  ....+.+.+|++.++.++||||+++++++...+     .
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~   78 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDD--LIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFND   78 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccccc--chhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccc
Confidence            5888999999999999999876 5899999998754321  224567889999999999999999999997765     7


Q ss_pred             eeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccccc
Q 039137          713 SFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK  792 (912)
Q Consensus       713 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  792 (912)
                      .|+||||+++ +|.+++.+   ...+++..++.++.|++.|++|||++   +|+||||||+||+++.++.++|+|||++.
T Consensus        79 ~~lv~e~~~~-~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~  151 (330)
T cd07834          79 VYIVTELMET-DLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLAR  151 (330)
T ss_pred             eEEEecchhh-hHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceE
Confidence            8999999984 88888843   23789999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCC---CCccccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCccchhcccc----------c-----
Q 039137          793 FLNPDS---SNWSELAGTHGYVAPELAYTL-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS----------S-----  853 (912)
Q Consensus       793 ~~~~~~---~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~----------~-----  853 (912)
                      ......   .......+++.|+|||++.+. .++.++||||+|+++|+|++|..||........          .     
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  231 (330)
T cd07834         152 GVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDL  231 (330)
T ss_pred             eecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHh
Confidence            765543   123445678899999999887 789999999999999999999999852211000          0     


Q ss_pred             ---cccchhhhccCCCCCCCh----hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 039137          854 ---SSNMNIEMLDSRLPYPSL----HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQL  904 (912)
Q Consensus       854 ---~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  904 (912)
                         ..................    .....+..+.+++.+||+.+|++||+++++++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence               000000000000000000    011134568899999999999999999998863

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.98  E-value=5.7e-32  Score=299.05  Aligned_cols=260  Identities=21%  Similarity=0.238  Sum_probs=193.7

Q ss_pred             hcCCC-CCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCch----------HHHHHHHHHHHHHhhcCCCccccEE
Q 039137          637 TNDFN-AEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMS----------FQQEEFLNEIQALTEIRHRNIVKFY  704 (912)
Q Consensus       637 ~~~~~-~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~----------~~~~~~~~Ei~~l~~l~h~niv~l~  704 (912)
                      .++|. +.+.||+|+||+||+|.++ +++.||+|++.........          .....+.+|+++++.++||||++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            45665 4577999999999999865 7899999998654322110          0112577899999999999999999


Q ss_pred             EEEEcCCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEE
Q 039137          705 GFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAH  784 (912)
Q Consensus       705 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  784 (912)
                      +++...+..++||||++ |+|.+++..   ...+++..+..++.|++.|++|||+.   +|+|+||+|+||+++.++.++
T Consensus        87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~k  159 (335)
T PTZ00024         87 DVYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICK  159 (335)
T ss_pred             EEEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEE
Confidence            99999999999999997 589888843   34588999999999999999999999   999999999999999999999


Q ss_pred             EeccccccccCC--------------CCCCccccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCccchhc
Q 039137          785 VSDFGIAKFLNP--------------DSSNWSELAGTHGYVAPELAYTL-KVTEKCDVYSFGVLALEVIKGKHPRDFLFE  849 (912)
Q Consensus       785 l~Dfgla~~~~~--------------~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~pf~~~~~  849 (912)
                      ++|||.+.....              .........+++.|+|||++.+. .++.++||||+|+++|||++|+.||.....
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~  239 (335)
T PTZ00024        160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE  239 (335)
T ss_pred             ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            999999976541              11122233467889999988764 468999999999999999999999853211


Q ss_pred             ccccc---------ccc-hhhh-----ccCCCC-CCC---hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          850 MSSSS---------SNM-NIEM-----LDSRLP-YPS---LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       850 ~~~~~---------~~~-~~~~-----~~~~~~-~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .....         ... ....     ...... .+.   ......+..+.+++.+|++.+|++|||++|++.
T Consensus       240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        240 IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            10000         000 0000     000000 000   001122456889999999999999999999875

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=3.6e-33  Score=284.81  Aligned_cols=246  Identities=23%  Similarity=0.345  Sum_probs=205.8

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEEcCCee
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSHPKHS  713 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~  713 (912)
                      ...+|....+||+|+||.|..|..+ +.+.||||+++++..-... ..+--+.|-+++... +-|.++.++.++...+..
T Consensus       347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdD-Dvectm~EKrvLAL~~kppFL~qlHScFQTmDRL  425 (683)
T KOG0696|consen  347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDD-DVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL  425 (683)
T ss_pred             eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecC-cccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence            3467999999999999999999766 6788999999877654322 233334566666665 578999999999999999


Q ss_pred             eEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccc
Q 039137          714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKF  793 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  793 (912)
                      |.||||+.||+|--.+   ..-+++.+..+.-+|..||-||-+||++   +|+.||||.+||++|.+|.+||+|||+++.
T Consensus       426 yFVMEyvnGGDLMyhi---QQ~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKE  499 (683)
T KOG0696|consen  426 YFVMEYVNGGDLMYHI---QQVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE  499 (683)
T ss_pred             eeEEEEecCchhhhHH---HHhcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccc
Confidence            9999999999998887   3456688899999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhh
Q 039137          794 LNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHV  873 (912)
Q Consensus       794 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  873 (912)
                      ---+.....+.+|||.|+|||.+...+|+.++|.||+||++|||+.|++||+..     .+.+....+++....+|..  
T Consensus       500 ni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe-----DE~elF~aI~ehnvsyPKs--  572 (683)
T KOG0696|consen  500 NIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE-----DEDELFQAIMEHNVSYPKS--  572 (683)
T ss_pred             cccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC-----CHHHHHHHHHHccCcCccc--
Confidence            555556677899999999999999999999999999999999999999999733     2344556677777777753  


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCC
Q 039137          874 QKKLMSIMQVAFSCLDQNPESRPT  897 (912)
Q Consensus       874 ~~~~~~l~~li~~cl~~dP~~RPt  897 (912)
                        .+.+.+.+....+.+.|.+|..
T Consensus       573 --lSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  573 --LSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             --ccHHHHHHHHHHhhcCCccccC
Confidence              3445667778889999999953

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.98  E-value=7e-32  Score=290.82  Aligned_cols=256  Identities=23%  Similarity=0.326  Sum_probs=198.8

Q ss_pred             CCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEEe
Q 039137          640 FNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYE  718 (912)
Q Consensus       640 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e  718 (912)
                      |+..+.||+|++|.||+|+.. +++.||+|++......  ....+.+..|+++++.++|+|++++++++...+..++|||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e   78 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE--EGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFE   78 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEecccccc--ccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEec
Confidence            566788999999999999876 5899999998765421  1134667889999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCC
Q 039137          719 YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS  798 (912)
Q Consensus       719 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  798 (912)
                      |+++ +|.+++....  ..+++.++.+++.|++.|++|||++   +|+||||+|+||++++++.++|+|||.+.......
T Consensus        79 ~~~~-~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~  152 (282)
T cd07829          79 YCDM-DLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPL  152 (282)
T ss_pred             CcCc-CHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCc
Confidence            9984 8999995432  4689999999999999999999999   99999999999999999999999999998765544


Q ss_pred             CCccccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCccchhcccc----------ccccchhh---h--c
Q 039137          799 SNWSELAGTHGYVAPELAYTL-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS----------SSSNMNIE---M--L  862 (912)
Q Consensus       799 ~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~----------~~~~~~~~---~--~  862 (912)
                      .......++..|+|||.+.+. .++.++||||||+++||+++|+.||........          ........   .  .
T Consensus       153 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
T cd07829         153 RTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY  232 (282)
T ss_pred             cccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence            334445567889999988776 789999999999999999999999853211000          00000000   0  0


Q ss_pred             cCCCCCC-----ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          863 DSRLPYP-----SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       863 ~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      +...+..     ..........+.+++.+||..||++||++.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            0001000     0111122456899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.98  E-value=1.6e-31  Score=296.06  Aligned_cols=261  Identities=18%  Similarity=0.312  Sum_probs=196.9

Q ss_pred             HHHHHHHhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEE
Q 039137          630 YEEIISATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCS  708 (912)
Q Consensus       630 ~~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~  708 (912)
                      ..++....++|++.+.||+|+||.||+|... +++.||+|++......  ....+.+.+|++++++++||||+++++++.
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~   86 (345)
T cd07877           9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLLDVFT   86 (345)
T ss_pred             HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchh--hHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence            3556677899999999999999999999864 7899999998754322  113466789999999999999999999885


Q ss_pred             cC------CeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCc
Q 039137          709 HP------KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYE  782 (912)
Q Consensus       709 ~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~  782 (912)
                      ..      ...+++++++ +++|.+++..    ..+++..++.++.|++.|++|||++   +|+||||||+||++++++.
T Consensus        87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~  158 (345)
T cd07877          87 PARSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCE  158 (345)
T ss_pred             ecccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCC
Confidence            43      3467888876 6799888732    3588999999999999999999999   9999999999999999999


Q ss_pred             EEEeccccccccCCCCCCcccccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCccchhcccccc------c
Q 039137          783 AHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS------S  855 (912)
Q Consensus       783 ~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~------~  855 (912)
                      +||+|||++.....   ......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||..........      .
T Consensus       159 ~kl~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  235 (345)
T cd07877         159 LKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG  235 (345)
T ss_pred             EEEecccccccccc---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            99999999875432   2234567889999998766 467889999999999999999999984211100000      0


Q ss_pred             ----cch--------hhhcc--CCCCCCCh--hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          856 ----NMN--------IEMLD--SRLPYPSL--HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       856 ----~~~--------~~~~~--~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                          ...        .....  ...+....  .....+..+.+++.+|++.||.+||++.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  299 (345)
T cd07877         236 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  299 (345)
T ss_pred             CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence                000        00000  00000000  00012456789999999999999999998875

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.98  E-value=1.6e-31  Score=295.81  Aligned_cols=258  Identities=21%  Similarity=0.321  Sum_probs=195.8

Q ss_pred             HHHHhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCC
Q 039137          633 IISATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPK  711 (912)
Q Consensus       633 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~  711 (912)
                      +....++|++.+.||+|+||.||+|... +++.||+|++......  ....+.+.+|+++++.++||||+++++++..+.
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   87 (343)
T cd07880          10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQS--ELFAKRAYRELRLLKHMKHENVIGLLDVFTPDL   87 (343)
T ss_pred             hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccc--hHHHHHHHHHHHHHHhcCCCCccceeeeecCCc
Confidence            3445778999999999999999999865 7899999998654322  223556889999999999999999999987553


Q ss_pred             ------eeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEE
Q 039137          712 ------HSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHV  785 (912)
Q Consensus       712 ------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  785 (912)
                            ..++||||+ +++|.+++..    ..+++.+++.++.|++.|++|||+.   +|+||||||+||+++.++.+++
T Consensus        88 ~~~~~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl  159 (343)
T cd07880          88 SLDRFHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKI  159 (343)
T ss_pred             cccccceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEE
Confidence                  358999998 6799888732    4589999999999999999999999   9999999999999999999999


Q ss_pred             eccccccccCCCCCCcccccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCccchhcccccc---------c
Q 039137          786 SDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS---------S  855 (912)
Q Consensus       786 ~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~---------~  855 (912)
                      +|||++......   .....+++.|+|||++.+ ..++.++||||+|+++|++++|+.||..........         .
T Consensus       160 ~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  236 (343)
T cd07880         160 LDFGLARQTDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPS  236 (343)
T ss_pred             eecccccccccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            999999865332   233467889999998876 457899999999999999999999985221100000         0


Q ss_pred             cchhhhcc--------CCCCCC-C----hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          856 NMNIEMLD--------SRLPYP-S----LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       856 ~~~~~~~~--------~~~~~~-~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ......+.        ...+.. .    .........+.+++.+|++.||++|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         237 KEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             HHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00000000        000000 0    001122345789999999999999999999873

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.98  E-value=8.6e-32  Score=290.30  Aligned_cols=255  Identities=22%  Similarity=0.361  Sum_probs=194.5

Q ss_pred             CCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcC-CCccccEEEEEEcCCeeeEEE
Q 039137          640 FNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR-HRNIVKFYGFCSHPKHSFIIY  717 (912)
Q Consensus       640 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~  717 (912)
                      |++.+.||+|++|+||+|+.. +++.|++|++.......   ......+|+..+++++ |||++++++++..++..++||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   77 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW---EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVF   77 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch---hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEE
Confidence            677899999999999999976 57889999986543321   2334557999999998 999999999999999999999


Q ss_pred             eecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCC
Q 039137          718 EYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPD  797 (912)
Q Consensus       718 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  797 (912)
                      ||+ +|++.+++.... ...+++.++..++.|++.|++|||++   +++|+||+|+||++++++.++|+|||.+......
T Consensus        78 e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~  152 (283)
T cd07830          78 EYM-EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR  152 (283)
T ss_pred             ecC-CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCC
Confidence            999 779988885433 34689999999999999999999999   9999999999999999999999999999866432


Q ss_pred             CCCccccccccccccccccc-cCCCCcchhHHHHHHHHHHHHhCCCCccchhccccc----------ccc------chhh
Q 039137          798 SSNWSELAGTHGYVAPELAY-TLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS----------SSN------MNIE  860 (912)
Q Consensus       798 ~~~~~~~~g~~~y~aPE~~~-~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~----------~~~------~~~~  860 (912)
                       .......++..|+|||++. +..++.++||||||+++|||++|++||.........          ...      ....
T Consensus       153 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07830         153 -PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS  231 (283)
T ss_pred             -CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence             2233456788999999875 445789999999999999999999998422110000          000      0000


Q ss_pred             hccCCCCCCC-----hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          861 MLDSRLPYPS-----LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       861 ~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ..+...+...     .........+.+++.+||+.||++|||++|++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            0000100000     000111356889999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.98  E-value=2.5e-32  Score=248.94  Aligned_cols=257  Identities=22%  Similarity=0.314  Sum_probs=198.4

Q ss_pred             CCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEE
Q 039137          639 DFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIY  717 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  717 (912)
                      +|...++||+|.||+||+|+.+ +++.||+|+++.+...+  ......++|+-+++.++|+|||+++++...++..-+|+
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrldddde--gvpssalreicllkelkhknivrl~dvlhsdkkltlvf   80 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDE--GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCC--CCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence            4666789999999999999865 78999999997654332  24567889999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCC
Q 039137          718 EYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPD  797 (912)
Q Consensus       718 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  797 (912)
                      |||.. +|..+..  .-.+.++.+.++.++.|+++|+.++|++   ++.|||+||+|.+++.+|++|++|||+++-++-.
T Consensus        81 e~cdq-dlkkyfd--slng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgip  154 (292)
T KOG0662|consen   81 EFCDQ-DLKKYFD--SLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIP  154 (292)
T ss_pred             HHhhH-HHHHHHH--hcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCc
Confidence            99976 7887773  3456799999999999999999999999   9999999999999999999999999999987766


Q ss_pred             CCCccccccccccccccccccCC-CCcchhHHHHHHHHHHHHh-CCCCccch---------hc---cccccccchhhhcc
Q 039137          798 SSNWSELAGTHGYVAPELAYTLK-VTEKCDVYSFGVLALEVIK-GKHPRDFL---------FE---MSSSSSNMNIEMLD  863 (912)
Q Consensus       798 ~~~~~~~~g~~~y~aPE~~~~~~-~~~~sDvwslG~vl~ellt-g~~pf~~~---------~~---~~~~~~~~~~~~~~  863 (912)
                      -..++..+-|..|.+|.++.+.. |++..|+||.||++.|+.. |++-|...         +.   ....+.-.....+.
T Consensus       155 vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lp  234 (292)
T KOG0662|consen  155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP  234 (292)
T ss_pred             eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCC
Confidence            55666778899999999988765 7899999999999999998 55544310         00   00000001111111


Q ss_pred             CCCCCCChh----hHH----HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          864 SRLPYPSLH----VQK----KLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       864 ~~~~~~~~~----~~~----~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ...++|...    +.+    ....-.+++.+.+.-+|.+|.++++.++
T Consensus       235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            111222111    111    1223456777888899999999997764

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.98  E-value=1.3e-31  Score=296.78  Aligned_cols=253  Identities=21%  Similarity=0.353  Sum_probs=192.0

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCC----
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPK----  711 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----  711 (912)
                      .++|.+.+.||+|+||.||+|... +++.||+|++.......  .....+.+|+++++.++||||+++++++....    
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~   91 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSE--IFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE   91 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccc--cchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence            478999999999999999999865 78999999987543222  13456789999999999999999999986543    


Q ss_pred             --eeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccc
Q 039137          712 --HSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFG  789 (912)
Q Consensus       712 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  789 (912)
                        ..++|+||+.. ++.++.     ...+++..+..++.|++.|++|||++   +|+||||||+||+++.++.++|+|||
T Consensus        92 ~~~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg  162 (342)
T cd07879          92 FQDFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFG  162 (342)
T ss_pred             CceEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCC
Confidence              45899999965 776665     13588999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCCCcccccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCccchhccccccc-------------
Q 039137          790 IAKFLNPDSSNWSELAGTHGYVAPELAYT-LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSS-------------  855 (912)
Q Consensus       790 la~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~-------------  855 (912)
                      +++....   ......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||...........             
T Consensus       163 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  239 (342)
T cd07879         163 LARHADA---EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV  239 (342)
T ss_pred             CCcCCCC---CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            9976432   2234467889999998876 4588999999999999999999999863211000000             


Q ss_pred             -----cchhhhccCCCCCCChh----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          856 -----NMNIEMLDSRLPYPSLH----VQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       856 -----~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                           .............+...    ....+..+.+++.+||+.||++||++++++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~  296 (342)
T cd07879         240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE  296 (342)
T ss_pred             HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                 00000000000000000    0123355789999999999999999999974

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.98  E-value=5.6e-32  Score=296.06  Aligned_cols=259  Identities=22%  Similarity=0.311  Sum_probs=191.5

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCC----
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPK----  711 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----  711 (912)
                      .++|++.+.||+|+||.||+|+++ +++.||+|++........  ....+.+|+++++.++||||+++++++....    
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   84 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG--FPITALREIKILKKLKHPNVVPLIDMAVERPDKSK   84 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC--cchhHHHHHHHHHhcCCCCccchhhheeccccccc
Confidence            478999999999999999999876 689999999865432221  2345678999999999999999999875433    


Q ss_pred             ----eeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEec
Q 039137          712 ----HSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSD  787 (912)
Q Consensus       712 ----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  787 (912)
                          ..++||||+.+ ++...+..  ....+++.++..++.|+++||+|||++   +|+|+||||+||++++++.++++|
T Consensus        85 ~~~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~d  158 (311)
T cd07866          85 RKRGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIAD  158 (311)
T ss_pred             ccCceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECc
Confidence                46999999976 67666633  234689999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCCC-----------ccccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCccchhcccccc-
Q 039137          788 FGIAKFLNPDSSN-----------WSELAGTHGYVAPELAYTL-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS-  854 (912)
Q Consensus       788 fgla~~~~~~~~~-----------~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~-  854 (912)
                      ||+++........           .....+++.|+|||.+.+. .++.++||||+|+++|||++|++||.......... 
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~  238 (311)
T cd07866         159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHL  238 (311)
T ss_pred             CccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9999865432211           1223567889999987654 57899999999999999999999985221110000 


Q ss_pred             --------ccch-------hh----hccCCCCCC-ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          855 --------SNMN-------IE----MLDSRLPYP-SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       855 --------~~~~-------~~----~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                              ....       ..    ......+.. ..........+.+++.+|++.||++|||+.|++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence                    0000       00    000000000 0001122356789999999999999999998864

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.98  E-value=9.1e-32  Score=300.17  Aligned_cols=254  Identities=26%  Similarity=0.420  Sum_probs=212.6

Q ss_pred             HHHhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEEc--
Q 039137          634 ISATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSH--  709 (912)
Q Consensus       634 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~--  709 (912)
                      ...++.|++.+.||.|.+|.||+++.+ +++..|+|+.......     .+++..|.++++.. .|||++.++|++..  
T Consensus        15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-----deEiE~eynil~~~~~hpnv~~fyg~~~k~~   89 (953)
T KOG0587|consen   15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-----EEEIELEYNMLKKYSHHPNVATFYGAFIKKD   89 (953)
T ss_pred             CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-----cHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence            344677899999999999999999865 7888899987655433     45667899999998 59999999999853  


Q ss_pred             ---CCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEe
Q 039137          710 ---PKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVS  786 (912)
Q Consensus       710 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  786 (912)
                         +++.|+|||||.+|+..|+++... ...+.|+.+..|++.++.|+.+||..   .++|||||-.||+++.++.||++
T Consensus        90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLv  165 (953)
T KOG0587|consen   90 PGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLV  165 (953)
T ss_pred             CCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEe
Confidence               578999999999999999997766 77899999999999999999999999   99999999999999999999999


Q ss_pred             ccccccccCCCCCCcccccccccccccccccc-----CCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhh
Q 039137          787 DFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-----LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEM  861 (912)
Q Consensus       787 Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~  861 (912)
                      |||.+..++.......+..|||.|||||++.-     ..|+.++|+||+|++..||.-|.+|+-...+       +..-+
T Consensus       166 DFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP-------mraLF  238 (953)
T KOG0587|consen  166 DFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP-------MRALF  238 (953)
T ss_pred             eeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch-------hhhhc
Confidence            99999988777777788899999999998863     3467899999999999999999999642221       11122


Q ss_pred             ccCCCCCCCh-hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          862 LDSRLPYPSL-HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       862 ~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ...+-|.|.. .......++-++|..|+.+|-++||++.++++
T Consensus       239 ~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  239 LIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             cCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            2233344433 36677888999999999999999999998775

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.97  E-value=2.2e-31  Score=317.20  Aligned_cols=148  Identities=26%  Similarity=0.369  Sum_probs=131.9

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ++|++.+.||+|+||+||+|.+. +++.||+|++....... ......+.+|+.+++.++||||+++++++...+..|+|
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~-~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMIN-KNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccC-HHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            67999999999999999999876 78999999986543222 22456788999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccccc
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK  792 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  792 (912)
                      |||+.+++|.+++...   +.+++..++.|+.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~~---~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIY---GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999998442   4578899999999999999999999   99999999999999999999999999885

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.5e-31  Score=296.18  Aligned_cols=255  Identities=19%  Similarity=0.343  Sum_probs=195.0

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCe--
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKH--  712 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~--  712 (912)
                      ..++|++.+.||+|++|.||+|+.. +++.||+|++......  ....+.+.+|+.+++.++|||++++++++...+.  
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS--AIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE   90 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccch--hhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence            4678999999999999999999876 6889999998654322  1234667789999999999999999988865554  


Q ss_pred             ----eeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecc
Q 039137          713 ----SFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDF  788 (912)
Q Consensus       713 ----~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df  788 (912)
                          .++|+||+ +++|.+++..    ..+++.+++.++.|++.|++|||+.   +|+||||+|+||+++.++.++|+||
T Consensus        91 ~~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~df  162 (343)
T cd07851          91 DFQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDF  162 (343)
T ss_pred             ccccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccc
Confidence                89999998 5699998843    4689999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCCCcccccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCccchhcccccc------ccchhhh
Q 039137          789 GIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS------SNMNIEM  861 (912)
Q Consensus       789 gla~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~------~~~~~~~  861 (912)
                      |++......   .....+++.|+|||.+.+ ..++.++||||+|+++||+++|+.||..........      .......
T Consensus       163 g~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  239 (343)
T cd07851         163 GLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL  239 (343)
T ss_pred             ccccccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence            999865432   334467889999998765 357889999999999999999999985211100000      0000000


Q ss_pred             c------------cC--CCCCCCh--hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          862 L------------DS--RLPYPSL--HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       862 ~------------~~--~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .            ..  ....+..  .....+..+.+++.+|++.||++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            0            00  0000000  01122567889999999999999999999864

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=6.5e-33  Score=316.05  Aligned_cols=256  Identities=22%  Similarity=0.281  Sum_probs=205.1

Q ss_pred             HHHHHhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC
Q 039137          632 EIISATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP  710 (912)
Q Consensus       632 e~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~  710 (912)
                      ++.-..++|.+.++||+|+||.|..++++ +++.||.|++.+..--. .....-|..|=++|..-+.+=|+.++-.|.++
T Consensus        69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlK-r~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~  147 (1317)
T KOG0612|consen   69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLK-RAETACFREERDIMVFGNSEWIVQLHYAFQDE  147 (1317)
T ss_pred             HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhh-chhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence            34445689999999999999999999987 78899999986521111 11345688899999988999999999999999


Q ss_pred             CeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccc
Q 039137          711 KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGI  790 (912)
Q Consensus       711 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl  790 (912)
                      ++.|+|||||+||+|-.++...   .++++.-++.++..|+-||+.+|+.   |+|||||||+|||+|..|++||+|||.
T Consensus       148 ~~LYlVMdY~pGGDlltLlSk~---~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGs  221 (1317)
T KOG0612|consen  148 RYLYLVMDYMPGGDLLTLLSKF---DRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGS  221 (1317)
T ss_pred             cceEEEEecccCchHHHHHhhc---CCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchh
Confidence            9999999999999999999443   3689999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCC-Cccccccccccccccccc----c-CCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccC
Q 039137          791 AKFLNPDSS-NWSELAGTHGYVAPELAY----T-LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDS  864 (912)
Q Consensus       791 a~~~~~~~~-~~~~~~g~~~y~aPE~~~----~-~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  864 (912)
                      +-.+..++. .....+|||.|++||++.    + +.|++.+|.||+||++|||+.|..||...     .....+..+++.
T Consensus       222 Clkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad-----slveTY~KIm~h  296 (1317)
T KOG0612|consen  222 CLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD-----SLVETYGKIMNH  296 (1317)
T ss_pred             HHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH-----HHHHHHHHHhch
Confidence            988875544 345678999999999875    3 56899999999999999999999998521     111222233333


Q ss_pred             --CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCC---HHHHH
Q 039137          865 --RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPT---MKRVS  902 (912)
Q Consensus       865 --~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~evl  902 (912)
                        .+.+|.  ....+....++|.+.+. +|+.|..   ++++.
T Consensus       297 k~~l~FP~--~~~VSeeakdLI~~ll~-~~e~RLgrngiedik  336 (1317)
T KOG0612|consen  297 KESLSFPD--ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIK  336 (1317)
T ss_pred             hhhcCCCc--ccccCHHHHHHHHHHhc-ChhhhcccccHHHHH
Confidence              344552  23366777888877664 6888887   55554

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.97  E-value=1.6e-31  Score=295.93  Aligned_cols=255  Identities=23%  Similarity=0.310  Sum_probs=189.9

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC-----
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP-----  710 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----  710 (912)
                      ..+|++.+.||.|+||.||+|... +++.||+|++.....    ...+.+.+|+++++.++||||+++++++...     
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~----~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP----QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLT   79 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC----chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccc
Confidence            367999999999999999999875 689999999865432    1456788999999999999999999776543     


Q ss_pred             ---------CeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEc-CC
Q 039137          711 ---------KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLD-LG  780 (912)
Q Consensus       711 ---------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~-~~  780 (912)
                               ...++||||++ ++|.+++..    ..+++..++.++.|++.|++|||+.   +|+||||||+||+++ ++
T Consensus        80 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~  151 (342)
T cd07854          80 EDVGSLTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTED  151 (342)
T ss_pred             cccccccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCC
Confidence                     35789999997 488888732    3588999999999999999999999   999999999999997 45


Q ss_pred             CcEEEeccccccccCCCCCC---cccccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCccchhcccccc--
Q 039137          781 YEAHVSDFGIAKFLNPDSSN---WSELAGTHGYVAPELAYT-LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS--  854 (912)
Q Consensus       781 ~~~kl~Dfgla~~~~~~~~~---~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~--  854 (912)
                      +.++++|||.+.........   .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||....+.....  
T Consensus       152 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~  231 (342)
T cd07854         152 LVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI  231 (342)
T ss_pred             ceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            67899999999765432111   123357888999997654 457889999999999999999999985221100000  


Q ss_pred             --------ccchh-------hhcc--CCCCCCC--hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          855 --------SNMNI-------EMLD--SRLPYPS--LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       855 --------~~~~~-------~~~~--~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                              .....       ....  ...+..+  .........+.+++.+||+.||++|||+.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         232 LESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             HHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence                    00000       0000  0000000  001123356789999999999999999999874

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.97  E-value=4.6e-31  Score=291.22  Aligned_cols=256  Identities=20%  Similarity=0.302  Sum_probs=190.1

Q ss_pred             CCCCCceeeecCceEEEEEEeC-C--CCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEEcC----
Q 039137          639 DFNAEHCIGKGGHGSVYRAKVP-S--GEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSHP----  710 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~----  710 (912)
                      +|++.+.||+|+||.||+|+.. +  +..||+|++......  ....+.+.+|+++++++ +||||+++++.+...    
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~   78 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSK--KILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNF   78 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccccc--chhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccC
Confidence            4788899999999999999875 4  778999998643322  11356678899999999 599999999875432    


Q ss_pred             CeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccc
Q 039137          711 KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGI  790 (912)
Q Consensus       711 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl  790 (912)
                      ...++++||+. ++|.+++..   ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.++|+|||.
T Consensus        79 ~~~~~~~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~  151 (332)
T cd07857          79 NELYLYEELME-ADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGL  151 (332)
T ss_pred             CcEEEEEeccc-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCC
Confidence            45788999886 589888843   35689999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCC----Ccccccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCccchhccc----------cccc
Q 039137          791 AKFLNPDSS----NWSELAGTHGYVAPELAYT-LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMS----------SSSS  855 (912)
Q Consensus       791 a~~~~~~~~----~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~----------~~~~  855 (912)
                      +........    ......|++.|+|||+..+ ..++.++||||+|+++|+|++|++||.......          ....
T Consensus       152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  231 (332)
T cd07857         152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDE  231 (332)
T ss_pred             ceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCH
Confidence            986543221    1233568899999998765 468899999999999999999999985211000          0000


Q ss_pred             cchhhh--------cc--CCCCCCC--hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          856 NMNIEM--------LD--SRLPYPS--LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       856 ~~~~~~--------~~--~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ......        ..  ...+...  .........+.+++.+|++.||++|||+.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000000        00  0000000  000112456889999999999999999998764

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=9.9e-32  Score=292.61  Aligned_cols=240  Identities=23%  Similarity=0.296  Sum_probs=192.6

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEEcCCee
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSHPKHS  713 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~  713 (912)
                      .+++|.+...+|.|+|+.|-.+.+. +++.+++|++.+....        ..+|+.++... +||||+++.+.+.+..+.
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~--------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~  391 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD--------NQDEIPISLLVRDHPNIVKSHDVYEDGKEI  391 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccccc--------cccccchhhhhcCCCcceeecceecCCcee
Confidence            3567888888999999999998765 7888999999765222        12567666665 699999999999999999


Q ss_pred             eEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEE-cCCCcEEEecccccc
Q 039137          714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLL-DLGYEAHVSDFGIAK  792 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill-~~~~~~kl~Dfgla~  792 (912)
                      |+|||++.++-+.+.+...   +... .++..|+++|+.|+.|||++   ||||||+||+|||+ +..++++|+|||.++
T Consensus       392 ~~v~e~l~g~ell~ri~~~---~~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~  464 (612)
T KOG0603|consen  392 YLVMELLDGGELLRRIRSK---PEFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWS  464 (612)
T ss_pred             eeeehhccccHHHHHHHhc---chhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhh
Confidence            9999999998777666332   2233 77888999999999999999   99999999999999 689999999999998


Q ss_pred             ccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChh
Q 039137          793 FLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLH  872 (912)
Q Consensus       793 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  872 (912)
                      ....+   ....+-|..|.|||+.....|++++|+||||++||+|++|+.||......         ..+..++..+...
T Consensus       465 ~~~~~---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---------~ei~~~i~~~~~s  532 (612)
T KOG0603|consen  465 ELERS---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---------IEIHTRIQMPKFS  532 (612)
T ss_pred             hCchh---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch---------HHHHHhhcCCccc
Confidence            76554   33445688899999999999999999999999999999999998522111         1112222222211


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          873 VQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       873 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                       ...+....+++.+|++.||.+||+++++..
T Consensus       533 -~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  533 -ECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             -cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence             456677889999999999999999999864

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-33  Score=316.67  Aligned_cols=426  Identities=29%  Similarity=0.360  Sum_probs=329.1

Q ss_pred             CCCCCccEEEccCCcccccCCccccCCCCCcEEeccccccccccccccccccccceeecccccccCCCCccccCcccccE
Q 039137          106 SSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQ  185 (912)
Q Consensus       106 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~  185 (912)
                      ..-.+++.|+++.|.+-...-+.+.+.-+|+.|||++|++. ..|..+..+.+|+.|+++.|.+. ..|.+.+++.+|++
T Consensus        18 ~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~   95 (1081)
T KOG0618|consen   18 LNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQY   95 (1081)
T ss_pred             ccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchh
Confidence            34445888999999776322233444556999999999996 89999999999999999999999 89999999999999


Q ss_pred             EEccCCcCCCCCCccCCCCccceeeeeccCCCcCccccccccccccceeecccc-------------------cccCccc
Q 039137          186 LALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCIN-------------------QLSGAIP  246 (912)
Q Consensus       186 L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n-------------------~l~~~~p  246 (912)
                      |.|.+|++. .+|.++..+++|++|+++.|.+. .+|..+..+..+..+..++|                   .+.+.++
T Consensus        96 lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~  173 (1081)
T KOG0618|consen   96 LNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFL  173 (1081)
T ss_pred             heeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchh
Confidence            999999998 89999999999999999999997 77877776666666666666                   3344444


Q ss_pred             cccccccccceeeeccccCcccCCcccCCccccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCC
Q 039137          247 LSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPN  326 (912)
Q Consensus       247 ~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~  326 (912)
                      ..+..++.  .|+|.+|.+. .  ..+.++.+|+.|....|++...    --..++|+.|+.++|.++...+.  ..-.+
T Consensus       174 ~~i~~l~~--~ldLr~N~~~-~--~dls~~~~l~~l~c~rn~ls~l----~~~g~~l~~L~a~~n~l~~~~~~--p~p~n  242 (1081)
T KOG0618|consen  174 IDIYNLTH--QLDLRYNEME-V--LDLSNLANLEVLHCERNQLSEL----EISGPSLTALYADHNPLTTLDVH--PVPLN  242 (1081)
T ss_pred             cchhhhhe--eeecccchhh-h--hhhhhccchhhhhhhhcccceE----EecCcchheeeeccCcceeeccc--ccccc
Confidence            44444444  4666666655 2  2345556666666666666522    11236778888888887732222  22358


Q ss_pred             ccEEEccCCcCcccccccCCCCCCCCEEeccCCcccccccccccccccccEEEccCccccCCCCccccccccccEEEccC
Q 039137          327 LTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSG  406 (912)
Q Consensus       327 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~  406 (912)
                      |+.++++.|++++.. .+++.+.+|+.++..+|++. .+|..+....+|+.|.+.+|.+. -+|.....++.|++|+|..
T Consensus       243 l~~~dis~n~l~~lp-~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~  319 (1081)
T KOG0618|consen  243 LQYLDISHNNLSNLP-EWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQS  319 (1081)
T ss_pred             ceeeecchhhhhcch-HHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehh
Confidence            999999999998655 88999999999999999995 88888989999999999999998 7788888899999999999


Q ss_pred             CcccCCCcccc-c-------------------------cccccccccccCcccCccccccccccccccEEEecccccccc
Q 039137          407 NKLSGCIPREL-G-------------------------SLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQ  460 (912)
Q Consensus       407 N~l~~~~p~~~-~-------------------------~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  460 (912)
                      |+|.. .|+.+ .                         .++.|+.|++.+|.+++..-..+.+.+.|+.|+|++|+|...
T Consensus       320 N~L~~-lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~f  398 (1081)
T KOG0618|consen  320 NNLPS-LPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSF  398 (1081)
T ss_pred             ccccc-cchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccC
Confidence            99983 44321 1                         234578888888988876666778889999999999999755


Q ss_pred             cchhhhcccccceeeccccccCcccccccccccccccccccCccccCCCcccccccccceEEEccCCcccc-CCCCCccC
Q 039137          461 IPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEG-QIPNSTTF  539 (912)
Q Consensus       461 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~-~~~~~~~~  539 (912)
                      ....+.++..|++|+||+|+++ .+|..+..++.|++|...+|+|... | .+..++.|+.+|+|.|+|+- .+|.....
T Consensus       399 pas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~~f-P-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~  475 (1081)
T KOG0618|consen  399 PASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLLSF-P-ELAQLPQLKVLDLSCNNLSEVTLPEALPS  475 (1081)
T ss_pred             CHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCceeec-h-hhhhcCcceEEecccchhhhhhhhhhCCC
Confidence            5667889999999999999996 4678899999999999999999864 5 88899999999999999975 33333232


Q ss_pred             CCCchhhhccCCcc
Q 039137          540 RDAPLEALQGNKGL  553 (912)
Q Consensus       540 ~~~~~~~l~~n~~~  553 (912)
                      ++....-+.||..+
T Consensus       476 p~LkyLdlSGN~~l  489 (1081)
T KOG0618|consen  476 PNLKYLDLSGNTRL  489 (1081)
T ss_pred             cccceeeccCCccc
Confidence            33334446677653

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=1.4e-30  Score=272.72  Aligned_cols=219  Identities=21%  Similarity=0.190  Sum_probs=175.2

Q ss_pred             cCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEEeecCCCChhh
Q 039137          649 GGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDK  727 (912)
Q Consensus       649 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  727 (912)
                      |.+|.||+++++ +++.||+|++....         .+.+|...+....||||+++++++...+..++||||+++|+|.+
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~---------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   74 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS---------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWS   74 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh---------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHH
Confidence            899999999876 78999999986432         12244555555679999999999999999999999999999999


Q ss_pred             HhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCCCccccccc
Q 039137          728 ILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGT  807 (912)
Q Consensus       728 ~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~g~  807 (912)
                      ++...   ..+++..+..++.|++.|++|+|++   +|+||||||+||+++.++.++++|||.+......   .....++
T Consensus        75 ~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~  145 (237)
T cd05576          75 HISKF---LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVE  145 (237)
T ss_pred             HHHHh---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcC
Confidence            98443   3589999999999999999999999   9999999999999999999999999988655432   2233457


Q ss_pred             cccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHHHHHHHHHHHc
Q 039137          808 HGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSC  887 (912)
Q Consensus       808 ~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  887 (912)
                      ..|+|||++.+..++.++||||+|+++|||++|..|++.....       ...  ......+    ...+..+.+++.+|
T Consensus       146 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-------~~~--~~~~~~~----~~~~~~~~~li~~~  212 (237)
T cd05576         146 NMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-------INT--HTTLNIP----EWVSEEARSLLQQL  212 (237)
T ss_pred             ccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-------ccc--ccccCCc----ccCCHHHHHHHHHH
Confidence            7899999998888999999999999999999999886421110       000  0011111    12345678999999


Q ss_pred             ccCCCCCCCCH
Q 039137          888 LDQNPESRPTM  898 (912)
Q Consensus       888 l~~dP~~RPt~  898 (912)
                      ++.||++||++
T Consensus       213 l~~dp~~R~~~  223 (237)
T cd05576         213 LQFNPTERLGA  223 (237)
T ss_pred             ccCCHHHhcCC
Confidence            99999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3e-31  Score=263.92  Aligned_cols=249  Identities=22%  Similarity=0.319  Sum_probs=201.7

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEEcCCeee
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSHPKHSF  714 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~  714 (912)
                      ..+|.+.++||+|+|+.|..++++ +.+.||+|++++....+.+ ..+-...|-.+..+. +||.+|.++.+|..+...+
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~ndde-didwvqtek~vfe~asn~pflvglhscfqtesrlf  327 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDE-DIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF  327 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcc-cchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence            368999999999999999999876 7889999999876655433 333344566666665 6999999999999999999


Q ss_pred             EEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccccccc
Q 039137          715 IIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL  794 (912)
Q Consensus       715 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  794 (912)
                      +|.||.+||+|--++   ...+.++++.++.+...|+-||.|||++   ||+.||+|.+|+++|..|.+|+.|+|+++.-
T Consensus       328 fvieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~  401 (593)
T KOG0695|consen  328 FVIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  401 (593)
T ss_pred             EEEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcC
Confidence            999999999997777   3446799999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhcc---ccccccchhhhccCCCCCCCh
Q 039137          795 NPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEM---SSSSSNMNIEMLDSRLPYPSL  871 (912)
Q Consensus       795 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~  871 (912)
                      -.+....++++|||.|+|||.+.+..|...+|.|++||+++||+.|+.||+.....   ...+.....-++...+..|..
T Consensus       402 l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprs  481 (593)
T KOG0695|consen  402 LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRS  481 (593)
T ss_pred             CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccce
Confidence            55666678899999999999999999999999999999999999999999843211   111122223344444444432


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCC
Q 039137          872 HVQKKLMSIMQVAFSCLDQNPESRP  896 (912)
Q Consensus       872 ~~~~~~~~l~~li~~cl~~dP~~RP  896 (912)
                      .    +.....+++.-+++||.+|.
T Consensus       482 l----svkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  482 L----SVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             e----ehhhHHHHHHhhcCCcHHhc
Confidence            2    22344567788999999985

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=2.2e-32  Score=262.51  Aligned_cols=258  Identities=22%  Similarity=0.350  Sum_probs=192.5

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEc-------
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSH-------  709 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-------  709 (912)
                      +.|+...+||+|.||+||+|+.+ +|+.||+|++......+  .-....++|+.++..++|+|++.++++|..       
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKe--GfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r   94 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKE--GFPITALREIKILQLLKHENVVNLIEICRTKATPTNR   94 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcccc--CCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence            45677789999999999999876 67788998875432211  134567899999999999999999988743       


Q ss_pred             -CCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecc
Q 039137          710 -PKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDF  788 (912)
Q Consensus       710 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df  788 (912)
                       ...+|+|+++|++ +|.-++..  ...+++..++.+++.++..||.|+|..   .|+|||+||.|++++.+|.+||+||
T Consensus        95 ~r~t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADF  168 (376)
T KOG0669|consen   95 DRATFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADF  168 (376)
T ss_pred             ccceeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecc
Confidence             2457999999988 88888833  235689999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCC----CCCccccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCccchhcc-------------
Q 039137          789 GIAKFLNPD----SSNWSELAGTHGYVAPELAYTL-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEM-------------  850 (912)
Q Consensus       789 gla~~~~~~----~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~pf~~~~~~-------------  850 (912)
                      |+++.+...    ...++..+-|..|++||.+.|. .|+++.|||..||++.||++|.+-+....+.             
T Consensus       169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~  248 (376)
T KOG0669|consen  169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI  248 (376)
T ss_pred             ccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC
Confidence            999755322    2335566779999999987764 5899999999999999999999887522111             


Q ss_pred             --ccccccchhhhccCC--CCCCChhhH---HH------HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          851 --SSSSSNMNIEMLDSR--LPYPSLHVQ---KK------LMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       851 --~~~~~~~~~~~~~~~--~~~~~~~~~---~~------~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                        ..+........+...  .|.+.....   +.      .....+++..++..||.+|+++++++.
T Consensus       249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence              111111111111100  011111111   11      225678999999999999999998764

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.6e-31  Score=273.26  Aligned_cols=259  Identities=27%  Similarity=0.370  Sum_probs=196.4

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCC--CCc-hHHHHHHHHHHHHHhhcCCCccccEEEEEEc-CC
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLP--GEM-SFQQEEFLNEIQALTEIRHRNIVKFYGFCSH-PK  711 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-~~  711 (912)
                      .++|.+...||+|+|++||+|.+- ..+.||||+-.....  .+. ..-.+...+|..+.+.|.||.||++|+|+.- .+
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            457888899999999999999754 677788887543221  111 1123457799999999999999999999975 46


Q ss_pred             eeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcC---CCcEEEecc
Q 039137          712 HSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDL---GYEAHVSDF  788 (912)
Q Consensus       712 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~Df  788 (912)
                      .+|-|+|||+|.+|+-|++.   .+.+++.+++.|+.||+.||.||.+.. |+|+|-||||.|||+-.   -|.+||.||
T Consensus       542 sFCTVLEYceGNDLDFYLKQ---hklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDF  617 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYLKQ---HKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDF  617 (775)
T ss_pred             cceeeeeecCCCchhHHHHh---hhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeec
Confidence            78999999999999999944   456899999999999999999999974 59999999999999954   467999999


Q ss_pred             ccccccCCCCCC-------ccccccccccccccccccC----CCCcchhHHHHHHHHHHHHhCCCCccchhccccccccc
Q 039137          789 GIAKFLNPDSSN-------WSELAGTHGYVAPELAYTL----KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNM  857 (912)
Q Consensus       789 gla~~~~~~~~~-------~~~~~g~~~y~aPE~~~~~----~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~  857 (912)
                      |+++.+++++..       .....||..|++||.+.-+    ..+.|+||||+||++|+.+.|+.||+.......-... 
T Consensus       618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe-  696 (775)
T KOG1151|consen  618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE-  696 (775)
T ss_pred             chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh-
Confidence            999998776543       2356799999999976532    3678999999999999999999999732211110000 


Q ss_pred             hhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 039137          858 NIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVS  902 (912)
Q Consensus       858 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl  902 (912)
                      ..........+|+.  +..+.+...+|++|+++.-++|.+..++.
T Consensus       697 NTIlkAtEVqFP~K--PvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  697 NTILKATEVQFPPK--PVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             hchhcceeccCCCC--CccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence            00111122223321  23445678899999999999998877764

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1.1e-30  Score=266.75  Aligned_cols=266  Identities=23%  Similarity=0.320  Sum_probs=199.8

Q ss_pred             CCcccHHHHHHHhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcC--CC---
Q 039137          625 EGKIVYEEIISATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR--HR---  698 (912)
Q Consensus       625 ~~~~~~~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~--h~---  698 (912)
                      +|...+......+++|.+...+|+|+||.|.++.+. .+..||+|+++.-.     ...+..+-|+++++++.  .|   
T Consensus        76 dGH~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-----kYreAa~iEi~vLqki~~~DP~g~  150 (415)
T KOG0671|consen   76 DGHYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-----KYREAALIEIEVLQKINESDPNGK  150 (415)
T ss_pred             CceEEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-----HHhhHHHHHHHHHHHHHhcCCCCc
Confidence            444555444455889999999999999999999765 57899999986321     13566778999999993  23   


Q ss_pred             -ccccEEEEEEcCCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEE
Q 039137          699 -NIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLL  777 (912)
Q Consensus       699 -niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill  777 (912)
                       -+|.+.+|+...++.++|+|.+ |-++.++++++ ...+++..+++.|++|++++++|||+.   +++|.||||+||++
T Consensus       151 ~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILf  225 (415)
T KOG0671|consen  151 FRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILF  225 (415)
T ss_pred             eEEEeeehhhhccCceEEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEE
Confidence             3788889999999999999988 44899999554 345689999999999999999999999   99999999999999


Q ss_pred             cC--------------------CCcEEEeccccccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHH
Q 039137          778 DL--------------------GYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEV  837 (912)
Q Consensus       778 ~~--------------------~~~~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~el  837 (912)
                      ..                    +..++++|||.|++....   -...+.|..|.|||++.+..++..+||||+||||+|+
T Consensus       226 vss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~---hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~El  302 (415)
T KOG0671|consen  226 VSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH---HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVEL  302 (415)
T ss_pred             eccceEEEeccCCccceeccCCCcceEEEecCCcceeccC---cceeeeccccCCchheeccCcCCccCceeeeeEEEEe
Confidence            32                    234899999999865432   2567889999999999999999999999999999999


Q ss_pred             HhCCCCccchhc------cccccccchhhhcc----------CCCCCCC----------------h-----hhHHHHHHH
Q 039137          838 IKGKHPRDFLFE------MSSSSSNMNIEMLD----------SRLPYPS----------------L-----HVQKKLMSI  880 (912)
Q Consensus       838 ltg~~pf~~~~~------~~~~~~~~~~~~~~----------~~~~~~~----------------~-----~~~~~~~~l  880 (912)
                      .+|..-|.....      +..-.......++.          .++.++.                .     ........+
T Consensus       303 ytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~L  382 (415)
T KOG0671|consen  303 YTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQL  382 (415)
T ss_pred             eccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHH
Confidence            999988752210      00000000000000          0010000                0     011233468


Q ss_pred             HHHHHHcccCCCCCCCCHHHHHH
Q 039137          881 MQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       881 ~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .+++.+|+..||.+|+|+.|++.
T Consensus       383 fDLl~~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  383 FDLLRRMLEFDPARRITLREALS  405 (415)
T ss_pred             HHHHHHHHccCccccccHHHHhc
Confidence            99999999999999999998764

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.96  E-value=3.8e-29  Score=262.58  Aligned_cols=239  Identities=28%  Similarity=0.406  Sum_probs=192.0

Q ss_pred             CceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEEeecCCCChhhH
Q 039137          650 GHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKI  728 (912)
Q Consensus       650 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~  728 (912)
                      +||.||+|... +++.+|+|++.......   ..+.+.+|++.+++++|+|++++++++......+++|||+++++|.++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~   77 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKK---KRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDL   77 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEeccccccc---HHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHH
Confidence            58999999986 58999999987543321   167889999999999999999999999999999999999999999999


Q ss_pred             hhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCCCcccccccc
Q 039137          729 LCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH  808 (912)
Q Consensus       729 l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~g~~  808 (912)
                      +....   .+++.+++.++.+++.+++|||+.   +++|+||+|+||+++.++.++++|||.+....... ......+++
T Consensus        78 ~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~  150 (244)
T smart00220       78 LKKRG---RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTP  150 (244)
T ss_pred             HHhcc---CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCc
Confidence            85432   288999999999999999999999   99999999999999999999999999998765432 334556788


Q ss_pred             ccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHHHHHHHHHHHcc
Q 039137          809 GYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCL  888 (912)
Q Consensus       809 ~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  888 (912)
                      .|+|||...+..++.++||||+|+++|++++|..||+....     ......................+..+.+++.+|+
T Consensus       151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  225 (244)
T smart00220      151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ-----LLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLL  225 (244)
T ss_pred             CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----HHHHHHHHhccCCCCccccccCCHHHHHHHHHHc
Confidence            99999999888889999999999999999999999852111     1111111111111111111114456889999999


Q ss_pred             cCCCCCCCCHHHHHH
Q 039137          889 DQNPESRPTMKRVSQ  903 (912)
Q Consensus       889 ~~dP~~RPt~~evl~  903 (912)
                      ..+|++||++.++++
T Consensus       226 ~~~p~~Rp~~~~~~~  240 (244)
T smart00220      226 VKDPEKRLTAEEALQ  240 (244)
T ss_pred             cCCchhccCHHHHhh
Confidence            999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.96  E-value=2.4e-29  Score=292.01  Aligned_cols=257  Identities=18%  Similarity=0.191  Sum_probs=167.6

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC-C----CCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEE----
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP-S----GEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGF----  706 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~----  706 (912)
                      ..++|++.+.||+|+||.||+|++. +    +..||+|++.....      .+....|  .+....+.++..+...    
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~------~e~~~~e--~l~~~~~~~~~~~~~~~~~~  201 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA------VEIWMNE--RVRRACPNSCADFVYGFLEP  201 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch------hHHHHHH--HHHhhchhhHHHHHHhhhcc
Confidence            4578999999999999999999875 4    68999998753211      1111111  1111122222222211    


Q ss_pred             --EEcCCeeeEEEeecCCCChhhHhhccCCc-----------------ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeee
Q 039137          707 --CSHPKHSFIIYEYLESGSLDKILCNDASA-----------------KELGWTQRLNVIKGVADALFYLHNNCFPPIVH  767 (912)
Q Consensus       707 --~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH  767 (912)
                        .......++||||+++++|.+++......                 .......+..++.|++.||+|||++   +|+|
T Consensus       202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiH  278 (566)
T PLN03225        202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVH  278 (566)
T ss_pred             cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence              24556789999999999999988543210                 1112345678999999999999999   9999


Q ss_pred             cCCCCCCeEEcC-CCcEEEeccccccccCCCC-CCccccccccccccccccccC----------------------CCCc
Q 039137          768 RDISSKNVLLDL-GYEAHVSDFGIAKFLNPDS-SNWSELAGTHGYVAPELAYTL----------------------KVTE  823 (912)
Q Consensus       768 ~Dlk~~Nill~~-~~~~kl~Dfgla~~~~~~~-~~~~~~~g~~~y~aPE~~~~~----------------------~~~~  823 (912)
                      |||||+|||++. ++.+||+|||+|+...... .......+++.|+|||.+...                      .++.
T Consensus       279 RDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~  358 (566)
T PLN03225        279 RDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD  358 (566)
T ss_pred             CcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCC
Confidence            999999999986 5789999999998654322 223456789999999965322                      2345


Q ss_pred             chhHHHHHHHHHHHHhCCCCccchhc-----cccccc--cchhhhccCCCCCC----ChhhHHHHHHHHHHHHHcccCCC
Q 039137          824 KCDVYSFGVLALEVIKGKHPRDFLFE-----MSSSSS--NMNIEMLDSRLPYP----SLHVQKKLMSIMQVAFSCLDQNP  892 (912)
Q Consensus       824 ~sDvwslG~vl~elltg~~pf~~~~~-----~~~~~~--~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP  892 (912)
                      ++||||+||++|||+++..|++....     ......  ..............    ............+++.+|++.||
T Consensus       359 k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP  438 (566)
T PLN03225        359 RFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG  438 (566)
T ss_pred             CcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence            67999999999999998877542100     000000  00000111110000    00000111234589999999999


Q ss_pred             CCCCCHHHHHH
Q 039137          893 ESRPTMKRVSQ  903 (912)
Q Consensus       893 ~~RPt~~evl~  903 (912)
                      ++|||++|+++
T Consensus       439 ~kR~ta~e~L~  449 (566)
T PLN03225        439 RQRISAKAALA  449 (566)
T ss_pred             ccCCCHHHHhC
Confidence            99999999876

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=1.8e-30  Score=288.55  Aligned_cols=243  Identities=26%  Similarity=0.406  Sum_probs=187.0

Q ss_pred             CCCceeeecCceE-EEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEEcCCeeeEEEe
Q 039137          641 NAEHCIGKGGHGS-VYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSHPKHSFIIYE  718 (912)
Q Consensus       641 ~~~~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  718 (912)
                      .-.+++|.|+.|+ ||+|.. +|+.||||++-..       ..+...+|++.++.- +||||||+++.-.++...|+..|
T Consensus       512 ~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e-------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE  583 (903)
T KOG1027|consen  512 SPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE-------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE  583 (903)
T ss_pred             ccHHHcccCCCCcEEEEEee-CCceehHHHHhhH-------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence            3346789999876 699988 7889999998532       234566999999998 59999999999999999999999


Q ss_pred             ecCCCChhhHhhcc-CCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcC---C--CcEEEecccccc
Q 039137          719 YLESGSLDKILCND-ASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDL---G--YEAHVSDFGIAK  792 (912)
Q Consensus       719 ~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~---~--~~~kl~Dfgla~  792 (912)
                      .|.. +|++++... .+.........+.+..|++.||++||+.   +||||||||.|||+..   +  .+++|+|||+++
T Consensus       584 LC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK  659 (903)
T KOG1027|consen  584 LCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSK  659 (903)
T ss_pred             Hhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccc
Confidence            9965 999999553 1111112245678899999999999998   9999999999999975   3  468999999999


Q ss_pred             ccCCCCCC---ccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccCCCCC
Q 039137          793 FLNPDSSN---WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDSRLPY  868 (912)
Q Consensus       793 ~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  868 (912)
                      .+..+...   .....||.+|+|||++.+..-+.++||||+||++|+.++ |.+||+...+-..       .++......
T Consensus       660 kl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~-------NIl~~~~~L  732 (903)
T KOG1027|consen  660 KLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA-------NILTGNYTL  732 (903)
T ss_pred             ccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh-------hhhcCccce
Confidence            88766443   345678999999999999888999999999999999998 5999973322111       111111111


Q ss_pred             CChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          869 PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       869 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ......... ...++|.+|+++||..||+|.+|+.
T Consensus       733 ~~L~~~~d~-eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  733 VHLEPLPDC-EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             eeeccCchH-HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            111111111 5779999999999999999999874

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=6.5e-31  Score=275.22  Aligned_cols=255  Identities=25%  Similarity=0.347  Sum_probs=206.6

Q ss_pred             hcCCCCCceeeecCceEEEEEEeCCCC-EEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVPSGE-IFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      -.+++.+..||-|+||.|-.++.++.+ .+|+|++++...-+.. +++.+..|-.+|...+.|.||++|..|.+.++.|+
T Consensus       419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtk-QqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYm  497 (732)
T KOG0614|consen  419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTK-QQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYM  497 (732)
T ss_pred             hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchh-HHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhh
Confidence            345677788999999999999875433 4888888765544433 67888999999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      .||-|-||.+...+   +..+.++..++.-++..+++|++|||++   +||+|||||+|.+++.+|-+||.|||.|+.+.
T Consensus       498 LmEaClGGElWTiL---rdRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~  571 (732)
T KOG0614|consen  498 LMEACLGGELWTIL---RDRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG  571 (732)
T ss_pred             hHHhhcCchhhhhh---hhcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhc
Confidence            99999999999999   4456788999999999999999999999   99999999999999999999999999999987


Q ss_pred             CCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccC--CCCCCChhh
Q 039137          796 PDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDS--RLPYPSLHV  873 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  873 (912)
                      ..... -+++|||.|.|||.+.+..++.++|.||+|+++||+++|.+||....++....     .++.+  .+.+|    
T Consensus       572 ~g~KT-wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn-----~ILkGid~i~~P----  641 (732)
T KOG0614|consen  572 SGRKT-WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYN-----LILKGIDKIEFP----  641 (732)
T ss_pred             cCCce-eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHH-----HHHhhhhhhhcc----
Confidence            66544 45799999999999999999999999999999999999999997443332211     11111  01122    


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCC--HHHHHHHHHHh
Q 039137          874 QKKLMSIMQVAFSCLDQNPESRPT--MKRVSQLLCEK  908 (912)
Q Consensus       874 ~~~~~~l~~li~~cl~~dP~~RPt--~~evl~~L~~~  908 (912)
                      ........++|.+....+|.+|.-  ...|-+.=++.
T Consensus       642 r~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~  678 (732)
T KOG0614|consen  642 RRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHR  678 (732)
T ss_pred             cccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhh
Confidence            233455678888999999999976  33444433333

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.96  E-value=4.6e-30  Score=239.93  Aligned_cols=205  Identities=25%  Similarity=0.390  Sum_probs=170.2

Q ss_pred             HHHhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEEcCC
Q 039137          634 ISATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSHPK  711 (912)
Q Consensus       634 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~  711 (912)
                      ....++...+..||+|++|.|-+.++. +|...|+|.+......   ..+++.++|+.+..+- .+|.+|.++|.....+
T Consensus        42 eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~---q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg  118 (282)
T KOG0984|consen   42 EVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNS---QEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG  118 (282)
T ss_pred             ccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcCh---HHHHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence            344556667788999999999998875 8999999999866543   3567788999876554 7999999999999999


Q ss_pred             eeeEEEeecCCCChhhHhhc-cCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccc
Q 039137          712 HSFIIYEYLESGSLDKILCN-DASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGI  790 (912)
Q Consensus       712 ~~~lv~e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl  790 (912)
                      ..|+.||.|+. +|+.+-+. ....+.+++.-+-+||..+++||.|||++.  .|+|||+||+|||++.+|++|+||||+
T Consensus       119 dvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGI  195 (282)
T KOG0984|consen  119 DVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGI  195 (282)
T ss_pred             cEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEccccc
Confidence            99999999976 77666533 234567889999999999999999999985  899999999999999999999999999


Q ss_pred             ccccCCCCCCcccccccccccccccccc----CCCCcchhHHHHHHHHHHHHhCCCCcc
Q 039137          791 AKFLNPDSSNWSELAGTHGYVAPELAYT----LKVTEKCDVYSFGVLALEVIKGKHPRD  845 (912)
Q Consensus       791 a~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~sDvwslG~vl~elltg~~pf~  845 (912)
                      +.++.+.- ..+...|-..|||||.+..    ..|+.++||||+|+.+.||.++++||+
T Consensus       196 sG~L~dSi-Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~  253 (282)
T KOG0984|consen  196 SGYLVDSI-AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYE  253 (282)
T ss_pred             ceeehhhh-HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccc
Confidence            98775432 2222356667999998753    368999999999999999999999975

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.96  E-value=9.2e-29  Score=279.19  Aligned_cols=263  Identities=16%  Similarity=0.217  Sum_probs=182.0

Q ss_pred             HhcCCCCCceeeecCceEEEEEEe-----------------CCCCEEEEEEccCCCCCCch----------HHHHHHHHH
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKV-----------------PSGEIFAVKKFHSPLPGEMS----------FQQEEFLNE  688 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~----------~~~~~~~~E  688 (912)
                      ..++|++.++||+|+||+||+|..                 .+++.||||++.........          ...+....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            357899999999999999999963                 24567999998643221100          011234457


Q ss_pred             HHHHhhcCCCcc-----ccEEEEEEc--------CCeeeEEEeecCCCChhhHhhccC---------------------C
Q 039137          689 IQALTEIRHRNI-----VKFYGFCSH--------PKHSFIIYEYLESGSLDKILCNDA---------------------S  734 (912)
Q Consensus       689 i~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~---------------------~  734 (912)
                      +.++.+++|.++     ++++++|..        .+..++||||+++++|.++++...                     .
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777888866544     677787753        356899999999999999885421                     1


Q ss_pred             cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCCC-ccccccccccccc
Q 039137          735 AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN-WSELAGTHGYVAP  813 (912)
Q Consensus       735 ~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~g~~~y~aP  813 (912)
                      ...+++..++.++.|++.|++|+|++   +|+||||||+||+++.++.+||+|||++......... .....+++.|+||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence            12356788999999999999999999   9999999999999999999999999999765432111 1122347899999


Q ss_pred             cccccCCC----------------------CcchhHHHHHHHHHHHHhCCC-Cccchhccccc------cccchhhhccC
Q 039137          814 ELAYTLKV----------------------TEKCDVYSFGVLALEVIKGKH-PRDFLFEMSSS------SSNMNIEMLDS  864 (912)
Q Consensus       814 E~~~~~~~----------------------~~~sDvwslG~vl~elltg~~-pf~~~~~~~~~------~~~~~~~~~~~  864 (912)
                      |.+.....                      ..+.||||+||++|+|++|.. ||.........      ...........
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~  459 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ  459 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence            98753221                      134799999999999999875 66421111000      00001111111


Q ss_pred             CCCCCChhhHHHHHHHHHHHHHcccCCC---CCCCCHHHHHH
Q 039137          865 RLPYPSLHVQKKLMSIMQVAFSCLDQNP---ESRPTMKRVSQ  903 (912)
Q Consensus       865 ~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPt~~evl~  903 (912)
                      ...++  ..........+++.+++..+|   .+|+|++|+++
T Consensus       460 ~~~~~--~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        460 KYDFS--LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             CCCcc--cccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            22222  223345667889999999876   68999998875

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.2e-30  Score=252.99  Aligned_cols=257  Identities=23%  Similarity=0.344  Sum_probs=193.1

Q ss_pred             CCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC-----Cee
Q 039137          640 FNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP-----KHS  713 (912)
Q Consensus       640 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----~~~  713 (912)
                      .+..+.||-|+||.||.++++ +|+.||.|++..-...  -...+++.+|+.++..++|.||+..+++..-+     ...
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~--L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi  132 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQN--LASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL  132 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHH--HHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence            455688999999999999876 8999999998654322  22567899999999999999999999887544     246


Q ss_pred             eEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccc
Q 039137          714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKF  793 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  793 (912)
                      |+++|.|.. +|..++   -+...++.+.+.-+.+||++||.|||+.   +|.||||||.|.+++.+..+||||||+++.
T Consensus       133 YV~TELmQS-DLHKII---VSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARv  205 (449)
T KOG0664|consen  133 YVLTELMQS-DLHKII---VSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLART  205 (449)
T ss_pred             HHHHHHHHh-hhhhee---ccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccc
Confidence            889998865 787777   4556788999999999999999999999   999999999999999999999999999997


Q ss_pred             cCCCC-CCccccccccccccccccccCC-CCcchhHHHHHHHHHHHHhCCCCccchhccccc------------------
Q 039137          794 LNPDS-SNWSELAGTHGYVAPELAYTLK-VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS------------------  853 (912)
Q Consensus       794 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~-~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~------------------  853 (912)
                      .+.+. ..++..+-|..|+|||.+.|.+ |+.+.||||+||++.|++..+.-|....++...                  
T Consensus       206 ee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~A  285 (449)
T KOG0664|consen  206 WDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYA  285 (449)
T ss_pred             cchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHH
Confidence            76543 3455667788999999988764 899999999999999999887776521111000                  


Q ss_pred             cccchhhhccCCCCCCChh-------hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 039137          854 SSNMNIEMLDSRLPYPSLH-------VQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL  905 (912)
Q Consensus       854 ~~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  905 (912)
                      -+.....+++.....|...       ......+...+...++..||++|.+..+.+..+
T Consensus       286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence            0001111111111111110       011122355677789999999999988776543

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=2.7e-29  Score=267.27  Aligned_cols=208  Identities=23%  Similarity=0.318  Sum_probs=177.3

Q ss_pred             HHHHHHHhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHH----HHHHHHHHHhhcC---CCccc
Q 039137          630 YEEIISATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQE----EFLNEIQALTEIR---HRNIV  701 (912)
Q Consensus       630 ~~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~----~~~~Ei~~l~~l~---h~niv  701 (912)
                      .+.......+|...+.+|+|+||.|+.|.++ +...|+||.+.+...-...+.++    .+-.|+++|..++   |+||+
T Consensus       553 ~e~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIl  632 (772)
T KOG1152|consen  553 CEKEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENIL  632 (772)
T ss_pred             ceeeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchh
Confidence            3333445567999999999999999999987 56789999987665433332222    3557999999997   99999


Q ss_pred             cEEEEEEcCCeeeEEEeec-CCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCC
Q 039137          702 KFYGFCSHPKHSFIIYEYL-ESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLG  780 (912)
Q Consensus       702 ~l~~~~~~~~~~~lv~e~~-~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~  780 (912)
                      +++++|++++.+|++||-. ++-+|.+++   .-...+++.++..|+.|++.|+++||++   +|||||||-+|+.++.+
T Consensus       633 KlLdfFEddd~yyl~te~hg~gIDLFd~I---E~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~  706 (772)
T KOG1152|consen  633 KLLDFFEDDDYYYLETEVHGEGIDLFDFI---EFKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSN  706 (772)
T ss_pred             hhhheeecCCeeEEEecCCCCCcchhhhh---hccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecC
Confidence            9999999999999999975 456889998   4456799999999999999999999999   99999999999999999


Q ss_pred             CcEEEeccccccccCCCCCCccccccccccccccccccCCC-CcchhHHHHHHHHHHHHhCCCCcc
Q 039137          781 YEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKV-TEKCDVYSFGVLALEVIKGKHPRD  845 (912)
Q Consensus       781 ~~~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltg~~pf~  845 (912)
                      |.+||+|||.|.+...  .....++||.+|.|||++.|.+| ...-|||++|+++|.++..+.||.
T Consensus       707 g~~klidfgsaa~~ks--gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  707 GFVKLIDFGSAAYTKS--GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             CeEEEeeccchhhhcC--CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            9999999999987654  45677899999999999999988 566899999999999999998863

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=1.7e-28  Score=262.81  Aligned_cols=200  Identities=24%  Similarity=0.360  Sum_probs=170.3

Q ss_pred             CCCCCceeeecCceEEEEEE-eCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEE
Q 039137          639 DFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIY  717 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  717 (912)
                      -|..++.||-|+||+|.+++ ..+...||.|.+++...- ...+...++.|-++|.....+=||+++-.|.+.+..|+||
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl-~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVL-MRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHH-hhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            46677899999999999995 446778999988653322 2224567888999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccccccc---
Q 039137          718 EYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL---  794 (912)
Q Consensus       718 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~---  794 (912)
                      ||++||++-.++.+   .+.+.+..++.++..+..|+++.|..   |+|||||||+|||+|.+|.+||.|||++.-+   
T Consensus       709 dYIPGGDmMSLLIr---mgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT  782 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLIR---MGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  782 (1034)
T ss_pred             eccCCccHHHHHHH---hccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceec
Confidence            99999999998843   45688899999999999999999999   9999999999999999999999999998632   


Q ss_pred             ------CCCCCC---------------------------------ccccccccccccccccccCCCCcchhHHHHHHHHH
Q 039137          795 ------NPDSSN---------------------------------WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLAL  835 (912)
Q Consensus       795 ------~~~~~~---------------------------------~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~  835 (912)
                            ...+..                                 ....+||+.|+|||++....|+..+|.||.|||||
T Consensus       783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~  862 (1034)
T KOG0608|consen  783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY  862 (1034)
T ss_pred             cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence                  110000                                 01246999999999999999999999999999999


Q ss_pred             HHHhCCCCcc
Q 039137          836 EVIKGKHPRD  845 (912)
Q Consensus       836 elltg~~pf~  845 (912)
                      ||+.|+.||.
T Consensus       863 em~~g~~pf~  872 (1034)
T KOG0608|consen  863 EMLVGQPPFL  872 (1034)
T ss_pred             HHhhCCCCcc
Confidence            9999999986

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.95  E-value=1.2e-26  Score=237.65  Aligned_cols=211  Identities=34%  Similarity=0.610  Sum_probs=183.8

Q ss_pred             eeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEEeecCCCC
Q 039137          646 IGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGS  724 (912)
Q Consensus       646 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  724 (912)
                      ||+|.+|.||++... +++.+++|++.......   ..+.+.+|++.++.++|++++++++++......+++|||+++++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~---~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~   77 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS---LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGS   77 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh---HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCc
Confidence            689999999999886 48999999987543221   34678899999999999999999999999999999999999999


Q ss_pred             hhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcC-CCcEEEeccccccccCCCCCCccc
Q 039137          725 LDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDL-GYEAHVSDFGIAKFLNPDSSNWSE  803 (912)
Q Consensus       725 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~Dfgla~~~~~~~~~~~~  803 (912)
                      |.+++....  ..+++..++.++.++++++++||++   +++|+||+|.||+++. ++.++++|||.+............
T Consensus        78 l~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~  152 (215)
T cd00180          78 LKDLLKENE--GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT  152 (215)
T ss_pred             HHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhc
Confidence            999985432  4688999999999999999999999   9999999999999999 899999999999876544322344


Q ss_pred             cccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHHHHHHH
Q 039137          804 LAGTHGYVAPELAYTL-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQ  882 (912)
Q Consensus       804 ~~g~~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  882 (912)
                      ..+...|++||..... .++.++|+|++|++++++                                        ..+.+
T Consensus       153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------~~~~~  192 (215)
T cd00180         153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------PELKD  192 (215)
T ss_pred             ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------HHHHH
Confidence            5678899999998877 788999999999999998                                        45778


Q ss_pred             HHHHcccCCCCCCCCHHHHHHH
Q 039137          883 VAFSCLDQNPESRPTMKRVSQL  904 (912)
Q Consensus       883 li~~cl~~dP~~RPt~~evl~~  904 (912)
                      ++.+|++.+|++||++.++++.
T Consensus       193 ~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         193 LIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             HHHHHhhCCcccCcCHHHHhhC
Confidence            9999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=3.2e-27  Score=247.46  Aligned_cols=132  Identities=26%  Similarity=0.427  Sum_probs=110.6

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcC-----C---CccccEEEEE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR-----H---RNIVKFYGFC  707 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-----h---~niv~l~~~~  707 (912)
                      ..+|.+.++||.|.|++||+|.+. ..+.||+|+++..     ..-.+..+.||.++++++     |   .+||++++.|
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F  151 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-----QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF  151 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-----hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence            368999999999999999999765 6788999998632     113566789999999993     2   3699999999


Q ss_pred             Ec----CCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEE
Q 039137          708 SH----PKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLL  777 (912)
Q Consensus       708 ~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill  777 (912)
                      ..    +.+++||+|++. .+|-.++... ..+.++...+.+|++||+.||.|||.+|  +|+|.||||+|||+
T Consensus       152 khsGpNG~HVCMVfEvLG-dnLLklI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  152 KHSGPNGQHVCMVFEVLG-DNLLKLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             eecCCCCcEEEEEehhhh-hHHHHHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence            65    358899999984 4888888553 3456889999999999999999999998  99999999999999

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.95  E-value=5.3e-28  Score=229.35  Aligned_cols=251  Identities=21%  Similarity=0.318  Sum_probs=191.7

Q ss_pred             HhcCCCCCceeeecCceEEEEEEe-CCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcC-CCccccEEEEEEcC--C
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKV-PSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR-HRNIVKFYGFCSHP--K  711 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~--~  711 (912)
                      ..++|++.+++|+|-+++||.|.. .+.+.++||++++-       ..+.+.+|+.+++.++ ||||+.++++..++  .
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sk  108 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESK  108 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-------HHHHHHHHHHHHHhccCCCCeeehhhhhcCcccc
Confidence            357899999999999999999974 47888999998632       4677899999999996 99999999999776  4


Q ss_pred             eeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcC-CCcEEEecccc
Q 039137          712 HSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDL-GYEAHVSDFGI  790 (912)
Q Consensus       712 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~Dfgl  790 (912)
                      .+.+|+||..+.+...+.      ..++.-+++.++.+++.||.|+|+.   ||.|||+||.|+++|. ...++++|+|+
T Consensus       109 tpaLiFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGL  179 (338)
T KOG0668|consen  109 TPSLIFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGL  179 (338)
T ss_pred             CchhHhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecch
Confidence            678999999998887766      3477788999999999999999999   9999999999999995 45699999999


Q ss_pred             ccccCCCCCCccccccccccccccccccCC-CCcchhHHHHHHHHHHHHhCCCCccchhccccc----------------
Q 039137          791 AKFLNPDSSNWSELAGTHGYVAPELAYTLK-VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS----------------  853 (912)
Q Consensus       791 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~----------------  853 (912)
                      |.++.+. ..+.-.+.+.-|-.||.+-..+ |+..-|+|||||++..|+..+.||-.-.+...+                
T Consensus       180 AEFYHp~-~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Y  258 (338)
T KOG0668|consen  180 AEFYHPG-KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAY  258 (338)
T ss_pred             HhhcCCC-ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHH
Confidence            9988765 3344456677788999887654 788999999999999999999997311000000                


Q ss_pred             -------cccchhhhccCCC--CC----CChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          854 -------SSNMNIEMLDSRL--PY----PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       854 -------~~~~~~~~~~~~~--~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                             .......++....  +.    .+....-..++..+++.+.+..|-.+|||++|.++
T Consensus       259 l~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  259 LNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence                   0000000000000  00    00001112356889999999999999999998764

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.95  E-value=6.5e-28  Score=240.74  Aligned_cols=254  Identities=19%  Similarity=0.270  Sum_probs=194.4

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC-----
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP-----  710 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----  710 (912)
                      ..+|.-.+.+|.|.- .|..|.+. .++.||+|+...+....  ...++..+|..++..++|+|+++++.++.-.     
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~--~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~   92 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQ--THAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE   92 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccC--ccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence            356777888999998 66666544 78999999998885553  3567788999999999999999999999543     


Q ss_pred             -CeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccc
Q 039137          711 -KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFG  789 (912)
Q Consensus       711 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  789 (912)
                       ...|+|||+|.. +|...+.     -+++-.++..+..|++.|++|||+.   +|+||||||+||++..++.+||.|||
T Consensus        93 ~~e~y~v~e~m~~-nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg  163 (369)
T KOG0665|consen   93 FQEVYLVMELMDA-NLCQVIL-----MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFG  163 (369)
T ss_pred             HHhHHHHHHhhhh-HHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccch
Confidence             357999999976 8888774     3467788999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhcccccc------c--------
Q 039137          790 IAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS------S--------  855 (912)
Q Consensus       790 la~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~------~--------  855 (912)
                      +|+..+.. -..+..+.+..|.|||++.+..+.+.+||||+||++.||++|+.-|..-...+.+.      .        
T Consensus       164 ~ar~e~~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~  242 (369)
T KOG0665|consen  164 LARTEDTD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMK  242 (369)
T ss_pred             hhcccCcc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHH
Confidence            99876554 35567788999999999999999999999999999999999987764111000000      0        


Q ss_pred             ----------cch---------hhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          856 ----------NMN---------IEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       856 ----------~~~---------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                                ...         ....|..++...........-..+++.+|+..||++|-+++++++
T Consensus       243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence                      000         000011111111111112234678899999999999999998875

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.95  E-value=1.3e-28  Score=266.40  Aligned_cols=253  Identities=28%  Similarity=0.407  Sum_probs=203.7

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeee
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSF  714 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  714 (912)
                      ..++|+..+.+|.|+||.||+|+++ +++..|+|+++.....    ..+-+.+|+-+++.-+|||||.++|.+-..+..|
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d----d~~~iqqei~~~~dc~h~nivay~gsylr~dklw   88 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD----DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLW   88 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCc----cccccccceeeeecCCCcChHHHHhhhhhhcCcE
Confidence            3468999999999999999999976 7899999998765433    3445568999999999999999999999999999


Q ss_pred             EEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccccccc
Q 039137          715 IIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL  794 (912)
Q Consensus       715 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  794 (912)
                      +.||||.+|+|++.-+   -.+++++.++..+.+...+|++|||++   +=+|||||-.||++++.|.+|++|||.+..+
T Consensus        89 icMEycgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqi  162 (829)
T KOG0576|consen   89 ICMEYCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQI  162 (829)
T ss_pred             EEEEecCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhh
Confidence            9999999999999873   346799999999999999999999999   8899999999999999999999999999877


Q ss_pred             CCCCCCccccccccccccccccc---cCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCCh
Q 039137          795 NPDSSNWSELAGTHGYVAPELAY---TLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSL  871 (912)
Q Consensus       795 ~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  871 (912)
                      ...-.....+.|||.|||||+..   .+.|...+|||+.|+...|+-.-++|.-   +........  -+....+..+..
T Consensus       163 tati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplf---dlhpmr~l~--LmTkS~~qpp~l  237 (829)
T KOG0576|consen  163 TATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLF---DLHPMRALF--LMTKSGFQPPTL  237 (829)
T ss_pred             hhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccc---ccchHHHHH--HhhccCCCCCcc
Confidence            66556667889999999999653   5568999999999999999988888731   111111000  011111112211


Q ss_pred             h-hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          872 H-VQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       872 ~-~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      . .....+.+.++++.|+.++|++||+++.++.
T Consensus       238 kDk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  238 KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             cCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            1 1234566889999999999999999987653

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=8.9e-28  Score=233.56  Aligned_cols=255  Identities=19%  Similarity=0.293  Sum_probs=190.9

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEE-EEcCCe
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGF-CSHPKH  712 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~-~~~~~~  712 (912)
                      ..+.|++.+.+|+|.||.+-.++++ +.+.+++|.+..+..     ..++|.+|...--.| .|.||+.-|++ |+..+.
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-----t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~   96 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-----TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDA   96 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh-----hHHHHHHHhccceeeccchhhhHHHHHHhhcCce
Confidence            4567999999999999999999987 678899999986643     467888998876666 48999987765 567788


Q ss_pred             eeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEc--CCCcEEEecccc
Q 039137          713 SFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLD--LGYEAHVSDFGI  790 (912)
Q Consensus       713 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~--~~~~~kl~Dfgl  790 (912)
                      +++++||++.|+|..-+..    ..+.+....+++.|+++|+.|+|++   ++||||||.+|||+-  +..++|+||||.
T Consensus        97 YvF~qE~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~  169 (378)
T KOG1345|consen   97 YVFVQEFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGL  169 (378)
T ss_pred             EEEeeccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeeccc
Confidence            8899999999999887722    4477888999999999999999999   999999999999994  334799999999


Q ss_pred             ccccCCCCCCccccccccccccccccccC-----CCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCC
Q 039137          791 AKFLNPDSSNWSELAGTHGYVAPELAYTL-----KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSR  865 (912)
Q Consensus       791 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  865 (912)
                      .+..+.   ......-+..|.|||.....     ...+.+|||.||+++|..+||..||+- ................+.
T Consensus       170 t~k~g~---tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk-a~~~d~~Y~~~~~w~~rk  245 (378)
T KOG1345|consen  170 TRKVGT---TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK-ASIMDKPYWEWEQWLKRK  245 (378)
T ss_pred             ccccCc---eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh-hhccCchHHHHHHHhccc
Confidence            986532   22223345678999966432     356789999999999999999999972 222222222222222233


Q ss_pred             CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 039137          866 LPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLC  906 (912)
Q Consensus       866 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  906 (912)
                      .+..+......++.+.++.++-+.++|++|=-..++.++-.
T Consensus       246 ~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk  286 (378)
T KOG1345|consen  246 NPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRK  286 (378)
T ss_pred             CccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence            33333334445566778888999999999954444444433

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.94  E-value=2.3e-27  Score=249.38  Aligned_cols=201  Identities=21%  Similarity=0.284  Sum_probs=172.6

Q ss_pred             HHHhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcC------CCccccEEEE
Q 039137          634 ISATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR------HRNIVKFYGF  706 (912)
Q Consensus       634 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~------h~niv~l~~~  706 (912)
                      +....+|.+....|+|-|++|.+|.+. .|..||||++.....     -.+.=++|+++|++|.      --|.++++..
T Consensus       428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-----M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~  502 (752)
T KOG0670|consen  428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-----MHKTGLKELEILKKLNDADPEDKFHCLRLFRH  502 (752)
T ss_pred             hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-----HhhhhhHHHHHHHHhhccCchhhhHHHHHHHH
Confidence            345678999999999999999999875 578999999975422     3455578999999994      3489999999


Q ss_pred             EEcCCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCC-cEEE
Q 039137          707 CSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGY-EAHV  785 (912)
Q Consensus       707 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl  785 (912)
                      |....+.|||+|-+.. +|.++++.....-.+....+..+++|+.-||..|-..   +|+|.||||.|||+++.. .+||
T Consensus       503 F~hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKL  578 (752)
T KOG0670|consen  503 FKHKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKL  578 (752)
T ss_pred             hhhcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeee
Confidence            9999999999998754 9999998887777788999999999999999999998   999999999999999765 4799


Q ss_pred             eccccccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcc
Q 039137          786 SDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRD  845 (912)
Q Consensus       786 ~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~  845 (912)
                      ||||.|..+...  ..+.+.-+..|.|||++.|.+|+...|+||+||+|||+.||+.-|.
T Consensus       579 CDfGSA~~~~en--eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFp  636 (752)
T KOG0670|consen  579 CDFGSASFASEN--EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFP  636 (752)
T ss_pred             ccCccccccccc--cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecC
Confidence            999999876543  2334445677999999999999999999999999999999998764

>PLN03210 Resistant to P

Probab=99.93  E-value=2.5e-25  Score=280.23  Aligned_cols=348  Identities=23%  Similarity=0.257  Sum_probs=227.3

Q ss_pred             ccccccCCCCCccEEEccCCc------ccccCCccccCCC-CCcEEeccccccccccccccccccccceeecccccccCC
Q 039137          100 LLEFSFSSFPHLVYLDLYNNE------LFGIIPPQISNLS-NLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGS  172 (912)
Q Consensus       100 ~~~~~~~~l~~L~~L~L~~n~------l~~~~p~~~~~l~-~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~  172 (912)
                      +.+.+|.++++|+.|.++++.      +...+|..|..++ +|+.|++.++.+. .+|..| .+.+|+.|+|++|++. .
T Consensus       549 i~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~  625 (1153)
T PLN03210        549 IHENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-K  625 (1153)
T ss_pred             ecHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-c
Confidence            345568889999999887653      3345777777764 5888998888885 778777 4688888999888887 7


Q ss_pred             CCccccCcccccEEEccCCcCCCCCCccCCCCccceeeeeccCCCcCccccccccccccceeecccccccCccccccccc
Q 039137          173 IPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNL  252 (912)
Q Consensus       173 ~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l  252 (912)
                      +|..+..+++|+.|+|++|...+.+|. ++.+++|+.|+|++|.....+|..++++++|+.|++++|..-..+|..+ ++
T Consensus       626 L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l  703 (1153)
T PLN03210        626 LWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NL  703 (1153)
T ss_pred             cccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CC
Confidence            788888888888888888765556764 7788888888888887767888888888888888888865444666655 67


Q ss_pred             cccceeeeccccCcccCCcccCCccccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEc
Q 039137          253 TNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDL  332 (912)
Q Consensus       253 ~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  332 (912)
                      ++|+.|++++|.....+|..   .++|++|+|++|.+. .+|..+ .+++|+.|++.++..... ...+           
T Consensus       704 ~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l-~~~~-----------  766 (1153)
T PLN03210        704 KSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKL-WERV-----------  766 (1153)
T ss_pred             CCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhc-cccc-----------
Confidence            88888888887654445533   346777777777776 445444 456677676665432110 0000           


Q ss_pred             cCCcCcccccccCCCCCCCCEEeccCCcccccccccccccccccEEEccCccccCCCCccccccccccEEEccCCcccCC
Q 039137          333 SNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGC  412 (912)
Q Consensus       333 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~  412 (912)
                           ....+..+..+++|+.|++++|...+.+|..++++++|+.|+|++|...+.+|..+ ++++|+.|++++|.....
T Consensus       767 -----~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~  840 (1153)
T PLN03210        767 -----QPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRT  840 (1153)
T ss_pred             -----cccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccc
Confidence                 00011111223455555555555555555555566666666666554333455444 456666666666544334


Q ss_pred             CccccccccccccccccCcccCccccccccccccccEEEeccc-ccccccchhhhcccccceeeccccc
Q 039137          413 IPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHN-KLSQQIPIELDNLIHLSELDLSHNF  480 (912)
Q Consensus       413 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~Ls~N~  480 (912)
                      +|..   .++|+.|+|++|.++. +|.++..+++|+.|+|++| ++. .+|..+..+++|+.|++++|.
T Consensus       841 ~p~~---~~nL~~L~Ls~n~i~~-iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~  904 (1153)
T PLN03210        841 FPDI---STNISDLNLSRTGIEE-VPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG  904 (1153)
T ss_pred             cccc---ccccCEeECCCCCCcc-ChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence            4432   2456677777777764 4666677777777777763 343 456666677777777776663

syringae 6; Provisional

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.93  E-value=4.4e-28  Score=247.66  Aligned_cols=403  Identities=24%  Similarity=0.256  Sum_probs=258.8

Q ss_pred             CccEEEccCCcccccCCccccCCCCCcEEeccccccccccccccccccccceeeccc-ccccCCCCccccCcccccEEEc
Q 039137          110 HLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISR-NWLSGSIPHEVGQLTVLNQLAL  188 (912)
Q Consensus       110 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~l  188 (912)
                      ..+.++|..|+|+.+.|.+|+.+++|++||||+|.|+.+-|++|.+|.+|..|-+.+ |+|+..--..|++|..|+.|.+
T Consensus        68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll  147 (498)
T KOG4237|consen   68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL  147 (498)
T ss_pred             cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence            356788999999977778899999999999999999988899999998888877766 8888444467888999999999


Q ss_pred             cCCcCCCCCCccCCCCccceeeeeccCCCcCccccccccccccceeeccccccc------------Cccccccccccccc
Q 039137          189 DSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLS------------GAIPLSISNLTNLR  256 (912)
Q Consensus       189 ~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~------------~~~p~~~~~l~~L~  256 (912)
                      ..|++.-.....|..|++|..|.+.+|.+...--..|..+.+++.+.+..|.+.            ...|..++...-..
T Consensus       148 Nan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~  227 (498)
T KOG4237|consen  148 NANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVS  227 (498)
T ss_pred             ChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecc
Confidence            999998777788888999999999998887433448888888888888888732            12233344444444


Q ss_pred             eeeeccccCcccCCcccCC-ccccchhhhccCccCCCCc-cccccccccceEecccccccCCCCcccCCCCCccEEEccC
Q 039137          257 FLFLYHNELSGIIPQEIGN-LKKLNSLLLAKNHFRGTVP-KSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSN  334 (912)
Q Consensus       257 ~L~L~~N~l~~~~~~~l~~-l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~  334 (912)
                      -..+.++++..+.+..|.. +.++.+=..+.+...++-| ..|..+++|++|+|++|+|+.+.+.+|.....+++|.|..
T Consensus       228 p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~  307 (498)
T KOG4237|consen  228 PYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTR  307 (498)
T ss_pred             hHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCc
Confidence            4444555554333333321 1122111122222333333 3466667777777777777766666676666777777777


Q ss_pred             CcCcccccccCCCCCCCCEEeccCCcccccccccccccccccEEEccCccccCCCC-ccccccccccEEEccCCcccCCC
Q 039137          335 NSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIP-TQLGNIIYLNRLSLSGNKLSGCI  413 (912)
Q Consensus       335 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~-~~l~~l~~L~~L~L~~N~l~~~~  413 (912)
                      |++.......|.++..|+.|+|.+|+|+...|..|..+..|.+|+|-.|.+.-.-- .+++.       .|.++...|..
T Consensus       308 N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~-------Wlr~~~~~~~~  380 (498)
T KOG4237|consen  308 NKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGE-------WLRKKSVVGNP  380 (498)
T ss_pred             chHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHH-------HHhhCCCCCCC
Confidence            76666656666666666666666666666666666666666666666665532100 00000       01112211111


Q ss_pred             ccccccccccccccccCcccCcc---ccccc---------cccccccEEEecccccccccchhhhcccccceeecccccc
Q 039137          414 PRELGSLINLEYLDLSANNLSNF---VPESL---------GSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFL  481 (912)
Q Consensus       414 p~~~~~l~~L~~L~Ls~N~l~~~---~~~~~---------~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  481 (912)
                      |-  +.-..++.++++.+.+...   .|++.         ..++-+....=-.|+....+|..+.  ..-.+|++.+|.+
T Consensus       381 ~C--q~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk~lp~~iP--~d~telyl~gn~~  456 (498)
T KOG4237|consen  381 RC--QSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLKLLPRGIP--VDVTELYLDGNAI  456 (498)
T ss_pred             CC--CCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchhhcCCCCC--chhHHHhcccchh
Confidence            11  1223455566665554321   12211         1233444333334444446665543  3567899999999


Q ss_pred             CcccccccccccccccccccCccccCCCcccccccccceEEEccCC
Q 039137          482 GEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYN  527 (912)
Q Consensus       482 ~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~ls~N  527 (912)
                      +.+ |..  .+.+| .+|+|+|+++...-..|.++.+|.+|-+|+|
T Consensus       457 ~~v-p~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn  498 (498)
T KOG4237|consen  457 TSV-PDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN  498 (498)
T ss_pred             ccc-CHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence            654 443  67778 8999999999888889999999999999987

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.93  E-value=7.1e-28  Score=246.15  Aligned_cols=390  Identities=20%  Similarity=0.195  Sum_probs=262.6

Q ss_pred             cCCccccCCCCCcEEeccccccccccccccccccccceeecccccccCCCCccccCcccccEEEccC-CcCCCCCCccCC
Q 039137          124 IIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDS-NFLNGSIPRSLG  202 (912)
Q Consensus       124 ~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~-n~l~~~~p~~~~  202 (912)
                      .+|..+..  .-..++|..|+|+...|.+|+.+++|+.||||+|+|+.+-|+.|..|.+|.+|.+.+ |+|+......|+
T Consensus        60 eVP~~LP~--~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~  137 (498)
T KOG4237|consen   60 EVPANLPP--ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFG  137 (498)
T ss_pred             cCcccCCC--cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhh
Confidence            35544432  457899999999977778899999999999999999988899999999988887777 888855556888


Q ss_pred             CCccceeeeeccCCCcCccccccccccccceeecccccccCccccccccccccceeeeccccC------------cccCC
Q 039137          203 NLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNEL------------SGIIP  270 (912)
Q Consensus       203 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l------------~~~~~  270 (912)
                      +|..|+.|.+.-|++.-...+.|..|++|..|.+..|.+...--..|..+.+++.+++..|.+            ....|
T Consensus       138 gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~  217 (498)
T KOG4237|consen  138 GLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNP  217 (498)
T ss_pred             hHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhch
Confidence            899999998888888877778888888888888888888744444788888888888888872            22334


Q ss_pred             cccCCccccchhhhccCccCCCCccccccc-cccc-eEecccccccCCCCcccCCCCCccEEEccCCcCcccccccCCCC
Q 039137          271 QEIGNLKKLNSLLLAKNHFRGTVPKSFRNL-TDLV-KLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRC  348 (912)
Q Consensus       271 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~-~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  348 (912)
                      .+++...-.....+.++++..+-+..|... .++. .+....+.....+...|..+++|+.|+|++|+++.+...+|...
T Consensus       218 ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~  297 (498)
T KOG4237|consen  218 IETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGA  297 (498)
T ss_pred             hhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcch
Confidence            455555556666666666665544444322 2221 12222223333333567788888888888888888888888888


Q ss_pred             CCCCEEeccCCcccccccccccccccccEEEccCccccCCCCccccccccccEEEccCCcccC-CCcccccccccccccc
Q 039137          349 PQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSG-CIPRELGSLINLEYLD  427 (912)
Q Consensus       349 ~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~  427 (912)
                      ..+++|.|..|+|...-...|.++..|+.|+|.+|+|+...|..|..+.+|.+|+|-.|.+.- .--.+++.       .
T Consensus       298 a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~-------W  370 (498)
T KOG4237|consen  298 AELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGE-------W  370 (498)
T ss_pred             hhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHH-------H
Confidence            888888888888876666667777788888888888887777778878888888877776541 10111111       1


Q ss_pred             ccCcccCccccccccccccccEEEeccccccc---ccchhh---------hcccccce-eeccccccCcccccccccccc
Q 039137          428 LSANNLSNFVPESLGSLVKLYYLNLSHNKLSQ---QIPIEL---------DNLIHLSE-LDLSHNFLGEKISSRICRMES  494 (912)
Q Consensus       428 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~---~~~~~~---------~~l~~L~~-L~Ls~N~l~~~~~~~~~~l~~  494 (912)
                      |..+.-.+.+|-  +.-..++.+.++.+.+..   ..|++.         ...+-+.+ ...|++.+. .+|..+  -..
T Consensus       371 lr~~~~~~~~~C--q~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk-~lp~~i--P~d  445 (498)
T KOG4237|consen  371 LRKKSVVGNPRC--QSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK-LLPRGI--PVD  445 (498)
T ss_pred             HhhCCCCCCCCC--CCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchh-hcCCCC--Cch
Confidence            223332332221  112356677777666532   122222         22333433 455555554 334322  234


Q ss_pred             cccccccCccccCCCcccccccccceEEEccCCcccc
Q 039137          495 LEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEG  531 (912)
Q Consensus       495 L~~L~ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~  531 (912)
                      -..|++.+|.++.+ |+.  .+..| .+|+++|+|..
T Consensus       446 ~telyl~gn~~~~v-p~~--~~~~l-~~dls~n~i~~  478 (498)
T KOG4237|consen  446 VTELYLDGNAITSV-PDE--LLRSL-LLDLSNNRISS  478 (498)
T ss_pred             hHHHhcccchhccc-CHH--HHhhh-hcccccCceeh
Confidence            57899999999965 554  56777 99999999964

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.93  E-value=5.4e-25  Score=228.26  Aligned_cols=198  Identities=34%  Similarity=0.567  Sum_probs=171.4

Q ss_pred             CCCCceeeecCceEEEEEEeCC-CCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEEe
Q 039137          640 FNAEHCIGKGGHGSVYRAKVPS-GEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYE  718 (912)
Q Consensus       640 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e  718 (912)
                      |.+.+.||+|++|.||+|...+ ++.+|+|.+......   ...+.+.+|++.++.++|+|++++++++...+..++++|
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   77 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE---KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVME   77 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch---HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEe
Confidence            5677899999999999998874 889999998754332   146778899999999999999999999999899999999


Q ss_pred             ecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCC
Q 039137          719 YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS  798 (912)
Q Consensus       719 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  798 (912)
                      |+++++|.+++.....  .+++..+..++.+++.++++||++   +++|+|++|.||+++.++.++++|||.+.......
T Consensus        78 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~  152 (225)
T smart00221       78 YCEGGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL  152 (225)
T ss_pred             ccCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc
Confidence            9999999999854321  178999999999999999999999   99999999999999999999999999998765432


Q ss_pred             -CCcccccccccccccccc-ccCCCCcchhHHHHHHHHHHHHhCCCCcc
Q 039137          799 -SNWSELAGTHGYVAPELA-YTLKVTEKCDVYSFGVLALEVIKGKHPRD  845 (912)
Q Consensus       799 -~~~~~~~g~~~y~aPE~~-~~~~~~~~sDvwslG~vl~elltg~~pf~  845 (912)
                       .......++..|++||.. ....++.++|||++|++++||++|+.||+
T Consensus       153 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~  201 (225)
T smart00221      153 AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS  201 (225)
T ss_pred             cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence             122345677889999998 66678889999999999999999999985

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN03210 Resistant to P

Probab=99.93  E-value=5.3e-25  Score=277.33  Aligned_cols=338  Identities=25%  Similarity=0.286  Sum_probs=218.2

Q ss_pred             ccccCCCCCcEEeccccc------cccccccccccc-cccceeecccccccCCCCccccCcccccEEEccCCcCCCCCCc
Q 039137          127 PQISNLSNLEYLDFSANK------LFGQIPSGIGLL-THLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPR  199 (912)
Q Consensus       127 ~~~~~l~~L~~L~Ls~n~------l~~~~p~~~~~l-~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~  199 (912)
                      .+|.++.+|+.|.+..+.      +...+|..|..+ .+|+.|++.+|.+. .+|..+ ...+|++|++++|++. .+|.
T Consensus       552 ~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~  628 (1153)
T PLN03210        552 NAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWD  628 (1153)
T ss_pred             HHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-cccc
Confidence            456667777777765442      223455555554 35666776666665 566655 3566666666666665 4556


Q ss_pred             cCCCCccceeeeeccCCCcCccccccccccccceeecccccccCccccccccccccceeeeccccCcccCCcccCCcccc
Q 039137          200 SLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKL  279 (912)
Q Consensus       200 ~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L  279 (912)
                      ++..+++|+.|+|++|...+.+|. ++.+++|+.|+|++|..-..+|..++++++|+.|++++|..-..+|..+ ++++|
T Consensus       629 ~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL  706 (1153)
T PLN03210        629 GVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSL  706 (1153)
T ss_pred             ccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCC
Confidence            666666666666666544444543 5556666666666555444555556666666666665543333344433 45555


Q ss_pred             chhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCcccccccCCCCCCCCEEeccCC
Q 039137          280 NSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSIN  359 (912)
Q Consensus       280 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  359 (912)
                      +.|++++|...+.+|..   .++|+.|++++|.++.                         +|..+ .+++|+.|++.++
T Consensus       707 ~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~~-------------------------lP~~~-~l~~L~~L~l~~~  757 (1153)
T PLN03210        707 YRLNLSGCSRLKSFPDI---STNISWLDLDETAIEE-------------------------FPSNL-RLENLDELILCEM  757 (1153)
T ss_pred             CEEeCCCCCCccccccc---cCCcCeeecCCCcccc-------------------------ccccc-ccccccccccccc
Confidence            55555555433333321   2344445555544432                         22222 3444444444442


Q ss_pred             cc-------cccccccccccccccEEEccCccccCCCCccccccccccEEEccCCcccCCCccccccccccccccccCcc
Q 039137          360 NI-------SGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANN  432 (912)
Q Consensus       360 ~l-------~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~  432 (912)
                      ..       ....+......++|+.|+|++|...+.+|..++++++|+.|++++|...+.+|..+ .+++|+.|++++|.
T Consensus       758 ~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~  836 (1153)
T PLN03210        758 KSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCS  836 (1153)
T ss_pred             chhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCC
Confidence            21       11222223345689999999999888999999999999999999986555788766 78999999999986


Q ss_pred             cCccccccccccccccEEEecccccccccchhhhcccccceeeccc-cccCcccccccccccccccccccCcc
Q 039137          433 LSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSH-NFLGEKISSRICRMESLEKLNLSYNN  504 (912)
Q Consensus       433 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~ls~N~  504 (912)
                      .....|..   .++|+.|+|++|.++ .+|..+..+++|+.|+|++ |++. .+|..+..+++|+.|+++++.
T Consensus       837 ~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~  904 (1153)
T PLN03210        837 RLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG  904 (1153)
T ss_pred             cccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence            55445543   368999999999997 6899999999999999999 5564 467778899999999999885

syringae 6; Provisional

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.93  E-value=5.4e-26  Score=236.01  Aligned_cols=198  Identities=27%  Similarity=0.418  Sum_probs=166.5

Q ss_pred             HHHHhcCCCCCceeeecCceEEEEEEeC----CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEE
Q 039137          633 IISATNDFNAEHCIGKGGHGSVYRAKVP----SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFC  707 (912)
Q Consensus       633 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~  707 (912)
                      +....+.|..+++||+|+|++||+|.+.    .++.||+|.+....      ...++..|++++..+ .+.||+++.+++
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts------~p~ri~~El~~L~~~gG~~ni~~~~~~~  104 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS------SPSRILNELEMLYRLGGSDNIIKLNGCF  104 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc------CchHHHHHHHHHHHhccchhhhcchhhh
Confidence            4445678999999999999999999753    46789999986543      345688999999999 599999999999


Q ss_pred             EcCCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEc-CCCcEEEe
Q 039137          708 SHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLD-LGYEAHVS  786 (912)
Q Consensus       708 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~  786 (912)
                      ...++..+|+||+++....++.      ..++..++..+++.+..||+++|..   |||||||||.|++++ ..+.-.|+
T Consensus       105 rnnd~v~ivlp~~~H~~f~~l~------~~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~Lv  175 (418)
T KOG1167|consen  105 RNNDQVAIVLPYFEHDRFRDLY------RSLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLV  175 (418)
T ss_pred             ccCCeeEEEecccCccCHHHHH------hcCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEE
Confidence            9999999999999999999988      3366889999999999999999999   999999999999998 46678999


Q ss_pred             ccccccccCCC------------------CC--------------------------CccccccccccccccccccC-CC
Q 039137          787 DFGIAKFLNPD------------------SS--------------------------NWSELAGTHGYVAPELAYTL-KV  821 (912)
Q Consensus       787 Dfgla~~~~~~------------------~~--------------------------~~~~~~g~~~y~aPE~~~~~-~~  821 (912)
                      |||+|...+..                  ..                          ......||+||.|||++... ..
T Consensus       176 DFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Q  255 (418)
T KOG1167|consen  176 DFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQ  255 (418)
T ss_pred             echhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCc
Confidence            99998721100                  00                          00134699999999988764 46


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCcc
Q 039137          822 TEKCDVYSFGVLALEVIKGKHPRD  845 (912)
Q Consensus       822 ~~~sDvwslG~vl~elltg~~pf~  845 (912)
                      ++++||||.||++..++++++||-
T Consensus       256 ttaiDiws~GVI~Lslls~~~PFf  279 (418)
T KOG1167|consen  256 TTAIDIWSAGVILLSLLSRRYPFF  279 (418)
T ss_pred             CCccceeeccceeehhhccccccc
Confidence            889999999999999999999983

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.91  E-value=5.5e-24  Score=211.76  Aligned_cols=169  Identities=21%  Similarity=0.192  Sum_probs=126.9

Q ss_pred             CChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCCCcc
Q 039137          723 GSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWS  802 (912)
Q Consensus       723 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  802 (912)
                      |+|.+++...  ...+++.+++.|+.|++.||+|||++   +      ||+||+++.++.+++  ||.+.......    
T Consensus         1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----   63 (176)
T smart00750        1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ----   63 (176)
T ss_pred             CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc----
Confidence            6899998542  34699999999999999999999998   6      999999999999999  99998764422    


Q ss_pred             ccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHHH--HH
Q 039137          803 ELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLM--SI  880 (912)
Q Consensus       803 ~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~l  880 (912)
                       ..|++.|+|||++.+..++.++|||||||++|||++|+.||.............. .......+...........  .+
T Consensus        64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  141 (176)
T smart00750       64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILL-NGMPADDPRDRSNLESVSAARSF  141 (176)
T ss_pred             -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHH-HHhccCCccccccHHHHHhhhhH
Confidence             2578999999999999999999999999999999999999853222111101000 0011111111111122222  58


Q ss_pred             HHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          881 MQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       881 ~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                      .+++.+||+.||++||++.|+++.+.....
T Consensus       142 ~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      142 ADFMRVCASRLPQRREAANHYLAHCRALFA  171 (176)
T ss_pred             HHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence            899999999999999999999998876543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.90  E-value=1.5e-24  Score=265.57  Aligned_cols=194  Identities=16%  Similarity=0.163  Sum_probs=138.4

Q ss_pred             hcCC-CccccEEEEE-------EcCCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 039137          694 EIRH-RNIVKFYGFC-------SHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI  765 (912)
Q Consensus       694 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i  765 (912)
                      .++| +||+++++++       ...+.++.++||+ +++|.+++...  ...+++.+++.+++||++||+|||++   +|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---gI  101 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQ---GI  101 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            3455 6888888887       2334677889987 45999999432  35589999999999999999999999   99


Q ss_pred             eecCCCCCCeEEcCC-------------------CcEEEeccccccccCCCC----------------CCcccccccccc
Q 039137          766 VHRDISSKNVLLDLG-------------------YEAHVSDFGIAKFLNPDS----------------SNWSELAGTHGY  810 (912)
Q Consensus       766 vH~Dlk~~Nill~~~-------------------~~~kl~Dfgla~~~~~~~----------------~~~~~~~g~~~y  810 (912)
                      +||||||+|||++..                   +.+|++|||+++......                .......||+.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            999999999999654                   445666666665321100                000113578889


Q ss_pred             ccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHHHHHHHHHHHcccC
Q 039137          811 VAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQ  890 (912)
Q Consensus       811 ~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  890 (912)
                      ||||++.+..++.++|||||||++|||++|..|+......       .........+  . ...........++.+||++
T Consensus       182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~-------~~~~~~~~~~--~-~~~~~~~~~~~~~~~~L~~  251 (793)
T PLN00181        182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT-------MSSLRHRVLP--P-QILLNWPKEASFCLWLLHP  251 (793)
T ss_pred             EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH-------HHHHHHhhcC--h-hhhhcCHHHHHHHHHhCCC
Confidence            9999999999999999999999999999999886421110       0000001111  1 1111223456788899999


Q ss_pred             CCCCCCCHHHHHH
Q 039137          891 NPESRPTMKRVSQ  903 (912)
Q Consensus       891 dP~~RPt~~evl~  903 (912)
                      +|.+||++.|+++
T Consensus       252 ~P~~Rps~~eil~  264 (793)
T PLN00181        252 EPSCRPSMSELLQ  264 (793)
T ss_pred             ChhhCcChHHHhh
Confidence            9999999999975

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.90  E-value=3.6e-24  Score=208.16  Aligned_cols=251  Identities=22%  Similarity=0.339  Sum_probs=192.0

Q ss_pred             CCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEEe
Q 039137          639 DFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYE  718 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e  718 (912)
                      +..+..+|.+...|+.|+|++ .|..+++|++....  ......+.|.+|.-.++-+.||||++++|.|..+....++..
T Consensus       191 ~lnl~tkl~e~hsgelwrgrw-qgndivakil~vr~--~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq  267 (448)
T KOG0195|consen  191 SLNLITKLAESHSGELWRGRW-QGNDIVAKILNVRE--VTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQ  267 (448)
T ss_pred             hhhhhhhhccCCCcccccccc-cCcchhhhhhhhhh--cchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeee
Confidence            345567889999999999999 45566777765322  222234678889999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCee-ecCCCCCCeEEcCCCcEEEe--ccccccccC
Q 039137          719 YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIV-HRDISSKNVLLDLGYEAHVS--DFGIAKFLN  795 (912)
Q Consensus       719 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iv-H~Dlk~~Nill~~~~~~kl~--Dfgla~~~~  795 (912)
                      ||+.|+|+..+++.. .-.++..++.+++.++|+|++|||+-.  +++ ---+....+++|++.+++|+  |--.+.   
T Consensus       268 ~mp~gslynvlhe~t-~vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltarismad~kfsf---  341 (448)
T KOG0195|consen  268 YMPFGSLYNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARISMADTKFSF---  341 (448)
T ss_pred             eccchHHHHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhheecccceeee---
Confidence            999999999997643 356788999999999999999999974  444 34688999999999988764  322221   


Q ss_pred             CCCCCccccccccccccccccccCCCC---cchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChh
Q 039137          796 PDSSNWSELAGTHGYVAPELAYTLKVT---EKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLH  872 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~~~~~~---~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  872 (912)
                          ......-.|.||+||.++..+.+   .++|+|||++++||+.|.+.||..   .+..+..+......-+...|+  
T Consensus       342 ----qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfad---lspmecgmkialeglrv~ipp--  412 (448)
T KOG0195|consen  342 ----QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFAD---LSPMECGMKIALEGLRVHIPP--  412 (448)
T ss_pred             ----eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhcccccccc---CCchhhhhhhhhccccccCCC--
Confidence                01122346889999999876643   478999999999999999999863   333333444433333333332  


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 039137          873 VQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI  909 (912)
Q Consensus       873 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l  909 (912)
                        ..+..+.+++.-|++.||.+||.++.++-.|+++.
T Consensus       413 --gis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  413 --GISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             --CccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence              34455778888999999999999999999999875

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.89  E-value=3.3e-23  Score=241.75  Aligned_cols=267  Identities=27%  Similarity=0.318  Sum_probs=153.4

Q ss_pred             CCcEEeccccccccccccccccccccceeecccccccCCCCccccCcccccEEEccCCcCCCCCCccCCCCccceeeeec
Q 039137          134 NLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLY  213 (912)
Q Consensus       134 ~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~  213 (912)
                      .-..|||++|.++ .+|..+.  .+|+.|++++|+++ .+|..   +++|++|+|++|+|+ .+|..   .++|+.|+++
T Consensus       202 ~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls  270 (788)
T PRK15387        202 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT-SLPVL---PPGLLELSIF  270 (788)
T ss_pred             CCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccC-cccCc---ccccceeecc
Confidence            3445666666665 4555553  35666666666665 45532   345566666666555 33432   2345555555


Q ss_pred             cCCCcCccccccccccccceeecccccccCccccccccccccceeeeccccCcccCCcccCCccccchhhhccCccCCCC
Q 039137          214 NNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTV  293 (912)
Q Consensus       214 ~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~  293 (912)
                      +|.++ .+|..+   ++|+.|++++|+++ .+|.   .+++|+.|+|++|++++ +|...                    
T Consensus       271 ~N~L~-~Lp~lp---~~L~~L~Ls~N~Lt-~LP~---~p~~L~~LdLS~N~L~~-Lp~lp--------------------  321 (788)
T PRK15387        271 SNPLT-HLPALP---SGLCKLWIFGNQLT-SLPV---LPPGLQELSVSDNQLAS-LPALP--------------------  321 (788)
T ss_pred             CCchh-hhhhch---hhcCEEECcCCccc-cccc---cccccceeECCCCcccc-CCCCc--------------------
Confidence            55554 233221   33444555555554 2332   12345555555555543 22211                    


Q ss_pred             ccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCcccccccCCCCCCCCEEeccCCcccccccccccccc
Q 039137          294 PKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESL  373 (912)
Q Consensus       294 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~  373 (912)
                             .+|+.|++++|.+++. |..   ..+|+.|+|++|+|++ +|..   .++|+.|++++|+|.. +|..   ..
T Consensus       322 -------~~L~~L~Ls~N~L~~L-P~l---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~-LP~l---~~  382 (788)
T PRK15387        322 -------SELCKLWAYNNQLTSL-PTL---PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL---PS  382 (788)
T ss_pred             -------ccccccccccCccccc-ccc---ccccceEecCCCccCC-CCCC---Ccccceehhhcccccc-Cccc---cc
Confidence                   2344444444444431 111   1245555555555543 2221   2345566666666653 4432   24


Q ss_pred             cccEEEccCccccCCCCccccccccccEEEccCCcccCCCccccccccccccccccCcccCccccccccccccccEEEec
Q 039137          374 QLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLS  453 (912)
Q Consensus       374 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  453 (912)
                      +|+.|+|++|+|++ +|..   ..+|+.|++++|++++ +|..   ..+|+.|++++|+|+. +|..+..+++|+.|+|+
T Consensus       383 ~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt~-LP~sl~~L~~L~~LdLs  453 (788)
T PRK15387        383 GLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLTR-LPESLIHLSSETTVNLE  453 (788)
T ss_pred             ccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcc---hhhhhhhhhccCcccc-cChHHhhccCCCeEECC
Confidence            67888888888874 4543   2568888999999884 6653   3468899999999985 68889999999999999


Q ss_pred             ccccccccchhhhcc
Q 039137          454 HNKLSQQIPIELDNL  468 (912)
Q Consensus       454 ~N~l~~~~~~~~~~l  468 (912)
                      +|+|++..+..+..+
T Consensus       454 ~N~Ls~~~~~~L~~l  468 (788)
T PRK15387        454 GNPLSERTLQALREI  468 (788)
T ss_pred             CCCCCchHHHHHHHH
Confidence            999998888777543

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.89  E-value=4.7e-23  Score=240.44  Aligned_cols=267  Identities=25%  Similarity=0.300  Sum_probs=188.7

Q ss_pred             ccceeecccccccCCCCccccCcccccEEEccCCcCCCCCCccCCCCccceeeeeccCCCcCccccccccccccceeecc
Q 039137          158 HLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELC  237 (912)
Q Consensus       158 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~  237 (912)
                      .-..|+|++|.|+ .+|+.+.  ++|+.|++++|+++ .+|..                           +++|++|+++
T Consensus       202 ~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---------------------------p~~Lk~LdLs  250 (788)
T PRK15387        202 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---------------------------PPELRTLEVS  250 (788)
T ss_pred             CCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---------------------------CCCCcEEEec
Confidence            3455666666666 5565554  25556666665555 23321                           2445555555


Q ss_pred             cccccCccccccccccccceeeeccccCcccCCcccCCccccchhhhccCccCCCCccccccccccceEecccccccCCC
Q 039137          238 INQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNI  317 (912)
Q Consensus       238 ~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~  317 (912)
                      +|+++ .+|..   .++|+.|+|++|.++. +|..+   ++|+.|++++|+++. +|..   +++|+.|+|++|++++. 
T Consensus       251 ~N~Lt-sLP~l---p~sL~~L~Ls~N~L~~-Lp~lp---~~L~~L~Ls~N~Lt~-LP~~---p~~L~~LdLS~N~L~~L-  317 (788)
T PRK15387        251 GNQLT-SLPVL---PPGLLELSIFSNPLTH-LPALP---SGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLASL-  317 (788)
T ss_pred             CCccC-cccCc---ccccceeeccCCchhh-hhhch---hhcCEEECcCCcccc-cccc---ccccceeECCCCccccC-
Confidence            55555 23322   2466677777777763 33322   456677777787773 4432   36799999999998864 


Q ss_pred             CcccCCCCCccEEEccCCcCcccccccCCCCCCCCEEeccCCcccccccccccccccccEEEccCccccCCCCccccccc
Q 039137          318 SETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNII  397 (912)
Q Consensus       318 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~  397 (912)
                      |..   ..+|+.|++++|++++ +|.   ..++|+.|+|++|+|++ +|..   ..+|+.|++++|+|++ +|..   ..
T Consensus       318 p~l---p~~L~~L~Ls~N~L~~-LP~---lp~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~-LP~l---~~  382 (788)
T PRK15387        318 PAL---PSELCKLWAYNNQLTS-LPT---LPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL---PS  382 (788)
T ss_pred             CCC---cccccccccccCcccc-ccc---cccccceEecCCCccCC-CCCC---Ccccceehhhcccccc-Cccc---cc
Confidence            332   2468899999999975 333   23589999999999984 5543   3578999999999994 6654   35


Q ss_pred             cccEEEccCCcccCCCccccccccccccccccCcccCccccccccccccccEEEecccccccccchhhhcccccceeecc
Q 039137          398 YLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLS  477 (912)
Q Consensus       398 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  477 (912)
                      +|+.|++++|+|++ +|..   .++|+.|++++|+|++ +|..+   .+|+.|+|++|+|+ .+|..+.++++|+.|+|+
T Consensus       383 ~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs  453 (788)
T PRK15387        383 GLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE  453 (788)
T ss_pred             ccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECC
Confidence            79999999999994 5653   3679999999999997 45433   57889999999998 789999999999999999


Q ss_pred             ccccCcccccccccc
Q 039137          478 HNFLGEKISSRICRM  492 (912)
Q Consensus       478 ~N~l~~~~~~~~~~l  492 (912)
                      +|+|++..+..+..+
T Consensus       454 ~N~Ls~~~~~~L~~l  468 (788)
T PRK15387        454 GNPLSERTLQALREI  468 (788)
T ss_pred             CCCCCchHHHHHHHH
Confidence            999998877766443

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.89  E-value=1.8e-22  Score=202.37  Aligned_cols=260  Identities=17%  Similarity=0.225  Sum_probs=206.5

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEEcCCeeeE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~l  715 (912)
                      -.|.++++||+|+||+++.|+.- +++.||||.-...  .    ...++..|...++.| ..++|..++-+..++.+-.+
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiL  101 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--S----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNIL  101 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEecccc--C----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhh
Confidence            35899999999999999999743 8999999974322  2    356778899999999 48999999998888889999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCC-----cEEEecccc
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGY-----EAHVSDFGI  790 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-----~~kl~Dfgl  790 (912)
                      |+|.+ |-+|+|++.  -..+.++..++..+|.|++.-++|+|++   ..|.|||||+|+|+...+     .+.++|||+
T Consensus       102 VidLL-GPSLEDLFD--~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm  175 (449)
T KOG1165|consen  102 VIDLL-GPSLEDLFD--LCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGM  175 (449)
T ss_pred             hhhhh-CcCHHHHHH--HhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccc
Confidence            99988 558988873  2456799999999999999999999999   999999999999997544     489999999


Q ss_pred             ccccCCCCCC-------ccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhcc
Q 039137          791 AKFLNPDSSN-------WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLD  863 (912)
Q Consensus       791 a~~~~~~~~~-------~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~  863 (912)
                      |+.+.+..+.       .....||.+||+--...|.+.+.+.|.=|+|-++.+.+-|..||..+................
T Consensus       176 AK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~K  255 (449)
T KOG1165|consen  176 AKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETK  255 (449)
T ss_pred             hhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccc
Confidence            9987665432       235679999999998899999999999999999999999999998765544433332222222


Q ss_pred             CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          864 SRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       864 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                      ...+ ....+...+.++..-+.-.-..+-++-|+.+-+...+...+.
T Consensus       256 r~T~-i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvld  301 (449)
T KOG1165|consen  256 RSTP-IEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLD  301 (449)
T ss_pred             ccCC-HHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence            2222 223344556666666666777888899999988888877664

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.89  E-value=4.3e-23  Score=197.77  Aligned_cols=261  Identities=19%  Similarity=0.270  Sum_probs=203.9

Q ss_pred             HhcCCCCCceeeecCceEEEEEEe-CCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcC-CCccccEEEEEEcCCee
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKV-PSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR-HRNIVKFYGFCSHPKHS  713 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~  713 (912)
                      ...+|.++++||.|+||.+|.|.. .+|+.||||.-....      ...++..|..+++.++ ...|..+..+..+..+-
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a------~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn   86 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA------KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN   86 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC------CCcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence            357899999999999999999974 589999999854332      3456788999999997 47888888888999999


Q ss_pred             eEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCC---CcEEEecccc
Q 039137          714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLG---YEAHVSDFGI  790 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~Dfgl  790 (912)
                      .+|||.. |.+|++++.  -..+.++..+++-.+-|++.-++|+|.+   +++||||||+|+|..-+   ..+.++|||+
T Consensus        87 vlVMdLL-GPsLEdLfn--fC~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGL  160 (341)
T KOG1163|consen   87 VLVMDLL-GPSLEDLFN--FCSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGL  160 (341)
T ss_pred             eeeeecc-CccHHHHHH--HHhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccc
Confidence            9999987 569999883  2345689999999999999999999999   99999999999999754   3589999999


Q ss_pred             ccccCCCCCC-------ccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhcc
Q 039137          791 AKFLNPDSSN-------WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLD  863 (912)
Q Consensus       791 a~~~~~~~~~-------~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~  863 (912)
                      |+.+.+..+.       .....||.+|.+-....+.+.+.+.|+=|+|.++.++--|..||+.............  +..
T Consensus       161 aKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEk--I~E  238 (341)
T KOG1163|consen  161 AKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEK--ISE  238 (341)
T ss_pred             hhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHH--HHH
Confidence            9977553322       2356799999998888888889999999999999999999999986554433222222  222


Q ss_pred             CCCCCC-ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          864 SRLPYP-SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       864 ~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                      .+...+ ...+...+.++.-.+..|-..--++-|+..-+.+.++-.++
T Consensus       239 kK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr  286 (341)
T KOG1163|consen  239 KKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFR  286 (341)
T ss_pred             hhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHh
Confidence            222211 12334456677788888988888999998888777665543

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=6.1e-22  Score=216.20  Aligned_cols=259  Identities=21%  Similarity=0.262  Sum_probs=192.7

Q ss_pred             CCCCCceeeecCceEEEEEEeCCC--CEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCC----CccccEEEEE-EcCC
Q 039137          639 DFNAEHCIGKGGHGSVYRAKVPSG--EIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH----RNIVKFYGFC-SHPK  711 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h----~niv~l~~~~-~~~~  711 (912)
                      +|.+.+.||+|+||.||.|...+.  ..+|+|.........    ...+..|..++..+..    +++..+++.. ..++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~----~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~   94 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK----PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTED   94 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC----CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCc
Confidence            799999999999999999987643  478888865433221    1256678888888863    6899999999 5778


Q ss_pred             eeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCC-----CcEEEe
Q 039137          712 HSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLG-----YEAHVS  786 (912)
Q Consensus       712 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~-----~~~kl~  786 (912)
                      ..++||+.+ |.+|.++..... .+.++..++.+|+.|++.+|+++|+.   |++||||||.|+++...     ..+.+.
T Consensus        95 ~~~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~ll  169 (322)
T KOG1164|consen   95 FNFIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLL  169 (322)
T ss_pred             eeEEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEE
Confidence            899999977 669999885554 67899999999999999999999999   99999999999999865     359999


Q ss_pred             ccccccccC--CCCC-------C-ccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhcccccccc
Q 039137          787 DFGIAKFLN--PDSS-------N-WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSN  856 (912)
Q Consensus       787 Dfgla~~~~--~~~~-------~-~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~  856 (912)
                      |||+++...  ....       . .....||.+|+++....+...+.+.|+||++.++.|+..|..||........ ...
T Consensus       170 DfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~~~  248 (322)
T KOG1164|consen  170 DFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-KSK  248 (322)
T ss_pred             ecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-HHH
Confidence            999998322  1111       1 2345699999999999999999999999999999999999999853322111 000


Q ss_pred             chhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          857 MNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       857 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                      ......+.....   .....+..+.++...+-..+..++|....+...++....
T Consensus       249 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~  299 (322)
T KOG1164|consen  249 FEKDPRKLLTDR---FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD  299 (322)
T ss_pred             HHHHhhhhcccc---ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence            000000011110   001112334455555556899999999999999887654

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.88  E-value=3.4e-22  Score=235.19  Aligned_cols=224  Identities=27%  Similarity=0.432  Sum_probs=145.1

Q ss_pred             CCCcEEeccccccccccccccccccccceeecccccccCCCCccccCcccccEEEccCCcCCCCCCccCCCCccceeeee
Q 039137          133 SNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYL  212 (912)
Q Consensus       133 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L  212 (912)
                      .+...|+|++++++ .+|..+.  ++|+.|+|++|+++ .+|..+.  ++|++|++++|+++ .+|..+.  .+|+.|+|
T Consensus       178 ~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~L  248 (754)
T PRK15370        178 NNKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMEL  248 (754)
T ss_pred             cCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEEC
Confidence            35677888888876 5676553  57888888888887 5676554  47888888888877 5666553  36788888


Q ss_pred             ccCCCcCccccccccccccceeecccccccCccccccccccccceeeeccccCcccCCcccCCccccchhhhccCccCCC
Q 039137          213 YNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGT  292 (912)
Q Consensus       213 ~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~  292 (912)
                      ++|.+. .+|..+.  ++|+.|++++|+++ .+|..+.  ++|+.|+|++|+|++ +|..+.  ++|+.|++++|+++. 
T Consensus       249 s~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~-  318 (754)
T PRK15370        249 SINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTA-  318 (754)
T ss_pred             cCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCcccc-
Confidence            888877 5666554  47888888888887 4666553  478888888888885 454443  468888888888874 


Q ss_pred             CccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCcccccccCCCCCCCCEEeccCCccccccccccccc
Q 039137          293 VPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGES  372 (912)
Q Consensus       293 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~  372 (912)
                      +|..+.  ++|+.|++++|.+++ +|..+.  ++|+.|+|++|+++. +|..+  .++|+.|++++|+++ .+|..+.  
T Consensus       319 LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~~-LP~~l--p~~L~~LdLs~N~Lt-~LP~~l~--  387 (754)
T PRK15370        319 LPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQITV-LPETL--PPTITTLDVSRNALT-NLPENLP--  387 (754)
T ss_pred             CCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCCc-CChhh--cCCcCEEECCCCcCC-CCCHhHH--
Confidence            444332  577777777777775 333332  566777777776652 33322  245555666665555 2333322  


Q ss_pred             ccccEEEccCcccc
Q 039137          373 LQLQYLDLSSNYIV  386 (912)
Q Consensus       373 ~~L~~L~L~~N~l~  386 (912)
                      ..|+.|++++|++.
T Consensus       388 ~sL~~LdLs~N~L~  401 (754)
T PRK15370        388 AALQIMQASRNNLV  401 (754)
T ss_pred             HHHHHHhhccCCcc
Confidence            24555555555554

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.87  E-value=9.7e-22  Score=212.99  Aligned_cols=170  Identities=20%  Similarity=0.183  Sum_probs=131.4

Q ss_pred             HHHhcCCCCCceeeecCceEEEEEEeC--CCCEEEEEEccCCCCC-CchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC
Q 039137          634 ISATNDFNAEHCIGKGGHGSVYRAKVP--SGEIFAVKKFHSPLPG-EMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP  710 (912)
Q Consensus       634 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~  710 (912)
                      ....++|++.+.||+|+||+||+|.++  +++.||||++...... ......+.+.+|+++++.++|+|+++.+..+   
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---   90 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---   90 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence            345678999999999999999999865  5777899987532110 1222456789999999999999998633322   


Q ss_pred             CeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCC-CCCCeEEcCCCcEEEeccc
Q 039137          711 KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDI-SSKNVLLDLGYEAHVSDFG  789 (912)
Q Consensus       711 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl-k~~Nill~~~~~~kl~Dfg  789 (912)
                      +..|+||||+++++|....    ...      ...++.|+++||+|||++   +|+|||| ||+||+++.++.+||+|||
T Consensus        91 ~~~~LVmE~~~G~~L~~~~----~~~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFG  157 (365)
T PRK09188         91 GKDGLVRGWTEGVPLHLAR----PHG------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQ  157 (365)
T ss_pred             CCcEEEEEccCCCCHHHhC----ccc------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECc
Confidence            4679999999999996321    101      146789999999999999   9999999 9999999999999999999


Q ss_pred             cccccCCCCCC--------ccccccccccccccccccC
Q 039137          790 IAKFLNPDSSN--------WSELAGTHGYVAPELAYTL  819 (912)
Q Consensus       790 la~~~~~~~~~--------~~~~~g~~~y~aPE~~~~~  819 (912)
                      +|+........        .....+++.|+|||++...
T Consensus       158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            99976544311        1345678889999988644

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.85  E-value=3.4e-22  Score=231.07  Aligned_cols=256  Identities=21%  Similarity=0.261  Sum_probs=187.9

Q ss_pred             CCCceeeecCceEEEEEEeC-CCCEEEEEEccCCC-CCCchH-HHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEE
Q 039137          641 NAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPL-PGEMSF-QQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIY  717 (912)
Q Consensus       641 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  717 (912)
                      ...+.+|.|++|.|+.+... ..+.++.|.+.... ...... ....+..|+.+-..++|||++..+..+.+.....-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            34678999999988877543 44445555443210 111111 1222677888888999999988877776666666669


Q ss_pred             eecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCC
Q 039137          718 EYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPD  797 (912)
Q Consensus       718 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  797 (912)
                      |||++ +|...+...   ..++..++..++.|+..|++|+|+.   ||.|||+|++|+++..+|.+||+|||.+....-+
T Consensus       401 E~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~  473 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYP  473 (601)
T ss_pred             hcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccC
Confidence            99999 999998432   4688899999999999999999999   9999999999999999999999999999876543


Q ss_pred             CC----CccccccccccccccccccCCCCc-chhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChh
Q 039137          798 SS----NWSELAGTHGYVAPELAYTLKVTE-KCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLH  872 (912)
Q Consensus       798 ~~----~~~~~~g~~~y~aPE~~~~~~~~~-~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  872 (912)
                      ..    .....+|+-.|+|||.+.+..|.+ ..||||.|+++..|.+|+.||........................+...
T Consensus       474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~  553 (601)
T KOG0590|consen  474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRL  553 (601)
T ss_pred             cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHH
Confidence            32    245678999999999999999976 5799999999999999999986433222211111111111111122223


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          873 VQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       873 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ....+.....++.+|++.||.+|.|+++|++
T Consensus       554 ~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  554 LSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             HHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            3444566778999999999999999999875

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.84  E-value=7.4e-20  Score=201.99  Aligned_cols=258  Identities=29%  Similarity=0.423  Sum_probs=197.2

Q ss_pred             CCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCC-ccccEEEEEEcCCeeeEEEe
Q 039137          640 FNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHR-NIVKFYGFCSHPKHSFIIYE  718 (912)
Q Consensus       640 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~-niv~l~~~~~~~~~~~lv~e  718 (912)
                      |.+.+.||.|+||.||++...  ..+++|.+........ .....+.+|+..++.+.|+ +++++.+++......+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKS-KEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccch-hHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            677889999999999999876  7889999876654432 2467789999999999988 79999999987778899999


Q ss_pred             ecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCC-cEEEeccccccccCCC
Q 039137          719 YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGY-EAHVSDFGIAKFLNPD  797 (912)
Q Consensus       719 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~Dfgla~~~~~~  797 (912)
                      ++.++++.+++........+.......++.|++.+++|+|+.   +++|||+||+||+++..+ .++++|||.++.....
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence            999999997774332113688899999999999999999999   999999999999999988 7999999999865544


Q ss_pred             CC------Ccccccccccccccccccc---CCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCC-
Q 039137          798 SS------NWSELAGTHGYVAPELAYT---LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLP-  867 (912)
Q Consensus       798 ~~------~~~~~~g~~~y~aPE~~~~---~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-  867 (912)
                      ..      ......|+..|+|||.+.+   ..+....|+||+|++++++++|..||...... ...............+ 
T Consensus       156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~~  234 (384)
T COG0515         156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS-SATSQTLKIILELPTPS  234 (384)
T ss_pred             CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc-ccHHHHHHHHHhcCCcc
Confidence            32      2356789999999999987   57889999999999999999999996532210 0000000001111101 


Q ss_pred             CCChhh----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 039137          868 YPSLHV----QKKLMSIMQVAFSCLDQNPESRPTMKRVSQL  904 (912)
Q Consensus       868 ~~~~~~----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  904 (912)
                      ......    ......+.+++..|+..+|..|.+..+....
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            000000    1122457788899999999999998876653

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.84  E-value=2.9e-21  Score=227.26  Aligned_cols=247  Identities=29%  Similarity=0.450  Sum_probs=122.6

Q ss_pred             cccceeecccccccCCCCccccCcccccEEEccCCcCCCCCCccCCCCccceeeeeccCCCcCccccccccccccceeec
Q 039137          157 THLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLEL  236 (912)
Q Consensus       157 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l  236 (912)
                      .+...|+++++.++ .+|..+.  ++|+.|+|++|+++ .+|..+.  ++|++|++++|.++ .+|..+.  .+|+.|+|
T Consensus       178 ~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~L  248 (754)
T PRK15370        178 NNKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMEL  248 (754)
T ss_pred             cCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEEC
Confidence            45677777777777 5666553  46777777777776 4555443  36666666666665 3444332  24555555


Q ss_pred             ccccccCccccccccccccceeeeccccCcccCCcccCCccccchhhhccCccCCCCccccccccccceEecccccccCC
Q 039137          237 CINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGN  316 (912)
Q Consensus       237 ~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~  316 (912)
                      ++|++. .+|..+.  ++|+.|+|++|+++. +|..+.  ++|+.|++++|++++ +|..+.                  
T Consensus       249 s~N~L~-~LP~~l~--s~L~~L~Ls~N~L~~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp------------------  303 (754)
T PRK15370        249 SINRIT-ELPERLP--SALQSLDLFHNKISC-LPENLP--EELRYLSVYDNSIRT-LPAHLP------------------  303 (754)
T ss_pred             cCCccC-cCChhHh--CCCCEEECcCCccCc-cccccC--CCCcEEECCCCcccc-Ccccch------------------
Confidence            555555 3444332  245555555555552 333332  234444444444442 222211                  


Q ss_pred             CCcccCCCCCccEEEccCCcCcccccccCCCCCCCCEEeccCCcccccccccccccccccEEEccCccccCCCCcccccc
Q 039137          317 ISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNI  396 (912)
Q Consensus       317 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l  396 (912)
                              ++|+.|++++|+++.. |..+  .++|+.|++++|.+++ +|..+.  ++|+.|+|++|+|+ .+|..+.  
T Consensus       304 --------~sL~~L~Ls~N~Lt~L-P~~l--~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--  366 (754)
T PRK15370        304 --------SGITHLNVQSNSLTAL-PETL--PPGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--  366 (754)
T ss_pred             --------hhHHHHHhcCCccccC-Cccc--cccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--
Confidence                    2344444444444321 1111  1344445555554442 333221  35666666666655 3444332  


Q ss_pred             ccccEEEccCCcccCCCccccccccccccccccCcccCccccccc----cccccccEEEecccccc
Q 039137          397 IYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESL----GSLVKLYYLNLSHNKLS  458 (912)
Q Consensus       397 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~----~~l~~L~~L~Ls~N~l~  458 (912)
                      ++|+.|+|++|+++ .+|..+.  ..|+.|++++|+|.. +|..+    ..++.+..|+|.+|+++
T Consensus       367 ~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~~-LP~sl~~~~~~~~~l~~L~L~~Npls  428 (754)
T PRK15370        367 PTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLVR-LPESLPHFRGEGPQPTRIIVEYNPFS  428 (754)
T ss_pred             CCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCccc-CchhHHHHhhcCCCccEEEeeCCCcc
Confidence            35666666666665 3344332  246666666666654 23322    22344555555555554

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.83  E-value=2.6e-21  Score=221.02  Aligned_cols=252  Identities=21%  Similarity=0.250  Sum_probs=186.2

Q ss_pred             CCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEEe
Q 039137          639 DFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYE  718 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e  718 (912)
                      +|...+.+|++.|=+|.+|++++|. |+||++-+......-...++-++|++ ...++|||++++..+....+..|+|-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            6788899999999999999998887 89999866543332223344445555 555689999999999888888999999


Q ss_pred             ecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccc--cCC
Q 039137          719 YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKF--LNP  796 (912)
Q Consensus       719 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~--~~~  796 (912)
                      |..+ +|+|-+   ....-+...+.+.|+.|++.|+..+|..   ||+|||||.+|||++.=.-+.|+||..-+.  +..
T Consensus       102 yvkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe  174 (1431)
T KOG1240|consen  102 YVKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE  174 (1431)
T ss_pred             HHhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCC
Confidence            9977 888887   3344577788899999999999999999   999999999999999988999999986542  221


Q ss_pred             C-CCCccc----cccccccccccccccC----------C-CCcchhHHHHHHHHHHHHh-CCCCccc--hhccccccccc
Q 039137          797 D-SSNWSE----LAGTHGYVAPELAYTL----------K-VTEKCDVYSFGVLALEVIK-GKHPRDF--LFEMSSSSSNM  857 (912)
Q Consensus       797 ~-~~~~~~----~~g~~~y~aPE~~~~~----------~-~~~~sDvwslG~vl~ellt-g~~pf~~--~~~~~~~~~~~  857 (912)
                      + ...+..    ...-..|+|||.+-..          . .+++.||||+||++.|+++ |++||..  ++...+.....
T Consensus       175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~  254 (1431)
T KOG1240|consen  175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADD  254 (1431)
T ss_pred             CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccC
Confidence            1 122222    2233469999976431          1 5678999999999999998 7899862  23333322222


Q ss_pred             hhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 039137          858 NIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI  909 (912)
Q Consensus       858 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l  909 (912)
                      ....+.. +         ....+..++..|++.||.+|.++++.++-.+-.+
T Consensus       255 ~e~~Le~-I---------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~  296 (1431)
T KOG1240|consen  255 PEQLLEK-I---------EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLV  296 (1431)
T ss_pred             HHHHHHh-C---------cCccHHHHHHHHHccCchhccCHHHHHHhhhccc
Confidence            2222211 1         1124778999999999999999999998754433

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.83  E-value=1.6e-20  Score=194.35  Aligned_cols=236  Identities=21%  Similarity=0.266  Sum_probs=152.7

Q ss_pred             CCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCC----------CccccEEEEE
Q 039137          639 DFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH----------RNIVKFYGFC  707 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h----------~niv~l~~~~  707 (912)
                      .+..++.||.|+++.||.+++. +++.+|+|++..+. .......+++++|.-....+.+          -.++-.++..
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~-~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~   91 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA-DASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL   91 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS-TTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEeccc-ccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence            3456789999999999999986 69999999987665 3333367788888877666432          1222222222


Q ss_pred             Ec---------C---C-----eeeEEEeecCCCChhhHhhc---cC-CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCee
Q 039137          708 SH---------P---K-----HSFIIYEYLESGSLDKILCN---DA-SAKELGWTQRLNVIKGVADALFYLHNNCFPPIV  766 (912)
Q Consensus       708 ~~---------~---~-----~~~lv~e~~~~g~L~~~l~~---~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iv  766 (912)
                      ..         .   .     ..+++|+.+. ++|.+++..   .. .........+..+..|+++.+++||+.   |+|
T Consensus        92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlV  167 (288)
T PF14531_consen   92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLV  167 (288)
T ss_dssp             EETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             EEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceE
Confidence            11         1   1     1267888774 488877632   11 122344455577779999999999999   999


Q ss_pred             ecCCCCCCeEEcCCCcEEEeccccccccCCCCCCcccccccccccccccccc--------CCCCcchhHHHHHHHHHHHH
Q 039137          767 HRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT--------LKVTEKCDVYSFGVLALEVI  838 (912)
Q Consensus       767 H~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~sDvwslG~vl~ell  838 (912)
                      |+||+|+|++++++|.++|+||+.....+..   ......+..|.+||....        ..++.+.|.|++|+++|.|+
T Consensus       168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~---~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW  244 (288)
T PF14531_consen  168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGTR---YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW  244 (288)
T ss_dssp             EST-SGGGEEE-TTS-EEE--GGGEEETTEE---EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred             ecccceeeEEEcCCCCEEEcChHHHeecCce---eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence            9999999999999999999999988755432   111345578999996643        24788999999999999999


Q ss_pred             hCCCCccchhccccccccchhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCC
Q 039137          839 KGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESR  895 (912)
Q Consensus       839 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  895 (912)
                      +|..||+..........             ....+.+.+..+.++|..+++.+|++|
T Consensus       245 C~~lPf~~~~~~~~~~~-------------~f~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  245 CGRLPFGLSSPEADPEW-------------DFSRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HSS-STCCCGGGSTSGG-------------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             HccCCCCCCCccccccc-------------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence            99999873222111100             011122556678899999999999988

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.82  E-value=1.2e-19  Score=181.03  Aligned_cols=144  Identities=17%  Similarity=0.195  Sum_probs=111.3

Q ss_pred             CceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCch----------------------HHHHHHHHHHHHHhhcCCCcc
Q 039137          643 EHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMS----------------------FQQEEFLNEIQALTEIRHRNI  700 (912)
Q Consensus       643 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~----------------------~~~~~~~~Ei~~l~~l~h~ni  700 (912)
                      .+.||+|++|.||+|..++|+.||||+++........                      .......+|++.+..+.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4689999999999999889999999999754321110                      001223459999999988877


Q ss_pred             ccEEEEEEcCCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHH-HhCCCCCeeecCCCCCCeEEcC
Q 039137          701 VKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYL-HNNCFPPIVHRDISSKNVLLDL  779 (912)
Q Consensus       701 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH~Dlk~~Nill~~  779 (912)
                      .....+..  ...++||||++++++.....   ....++..++..++.|++.+++|+ |+.   +|+||||||+||+++ 
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-  152 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-  152 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-
Confidence            54443332  22389999999987765431   224688999999999999999999 688   999999999999998 


Q ss_pred             CCcEEEeccccccccC
Q 039137          780 GYEAHVSDFGIAKFLN  795 (912)
Q Consensus       780 ~~~~kl~Dfgla~~~~  795 (912)
                      ++.++++|||+|....
T Consensus       153 ~~~v~LiDFG~a~~~~  168 (190)
T cd05147         153 DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             CCcEEEEEccccccCC
Confidence            4789999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.82  E-value=3.8e-20  Score=185.92  Aligned_cols=174  Identities=13%  Similarity=0.144  Sum_probs=135.9

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHH------HHHHHHHHhhcCCCccccEEEEEEc
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEE------FLNEIQALTEIRHRNIVKFYGFCSH  709 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~------~~~Ei~~l~~l~h~niv~l~~~~~~  709 (912)
                      ..++|...+++|.|+||.||.+.. ++..+|+|.+......... ....      +.+|+..+.+++|++|..+.+++..
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~-~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTER-FLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHH-HHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            468999999999999999999766 6778999999766544322 2222      6799999999999999999988653


Q ss_pred             C--------CeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCC
Q 039137          710 P--------KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGY  781 (912)
Q Consensus       710 ~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~  781 (912)
                      .        +..++||||++|.+|.++.       .++.    ....+++.+++.+|+.   |++|||+||.||+++.++
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~-------~~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g  172 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMP-------EISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG  172 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhh-------hccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC
Confidence            3        3578999999999998874       1222    2456999999999999   999999999999999988


Q ss_pred             cEEEeccccccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHH
Q 039137          782 EAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVI  838 (912)
Q Consensus       782 ~~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ell  838 (912)
                       ++++|||.......+.. .           ..+.....+..++|+|+||+.+....
T Consensus       173 -i~liDfg~~~~~~e~~a-~-----------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 -LRIIDLSGKRCTAQRKA-K-----------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             -EEEEECCCcccccchhh-H-----------HHHHHHhHhcccccccceeEeehHHH
Confidence             99999998875432211 0           11334445677999999999987653

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.81  E-value=9.8e-22  Score=178.76  Aligned_cols=166  Identities=35%  Similarity=0.579  Sum_probs=130.5

Q ss_pred             cCCCCCccEEEccCCcccccCCccccCCCCCcEEeccccccccccccccccccccceeecccccccCCCCccccCccccc
Q 039137          105 FSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLN  184 (912)
Q Consensus       105 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~  184 (912)
                      +..+.+++.|-||+|+++ .+|+.+.+|.+|+.|++++|+|. .+|.+++.+++|+.|+++-|++. .+|..||.++.|+
T Consensus        29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le  105 (264)
T KOG0617|consen   29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE  105 (264)
T ss_pred             ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence            446677888888899888 67888888888999999888887 78888888888888888888887 8888888888888


Q ss_pred             EEEccCCcCC-CCCCccCCCCccceeeeeccCCCcCccccccccccccceeecccccccCccccccccccccceeeeccc
Q 039137          185 QLALDSNFLN-GSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHN  263 (912)
Q Consensus       185 ~L~l~~n~l~-~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N  263 (912)
                      .|||..|+++ ..+|..|-.++.|+.|+|++|.+. .+|..++++++||.|.+..|.+- .+|..++.++.|+.|++.+|
T Consensus       106 vldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgn  183 (264)
T KOG0617|consen  106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGN  183 (264)
T ss_pred             hhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccc
Confidence            8888888776 456777777778888888888776 67777777777777777777766 56777777777777777777


Q ss_pred             cCcccCCcccCCc
Q 039137          264 ELSGIIPQEIGNL  276 (912)
Q Consensus       264 ~l~~~~~~~l~~l  276 (912)
                      +++ .+|.+++++
T Consensus       184 rl~-vlppel~~l  195 (264)
T KOG0617|consen  184 RLT-VLPPELANL  195 (264)
T ss_pred             eee-ecChhhhhh
Confidence            777 455555543

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.80  E-value=6.8e-19  Score=176.61  Aligned_cols=144  Identities=18%  Similarity=0.208  Sum_probs=113.4

Q ss_pred             CceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCch----------------------HHHHHHHHHHHHHhhcCCCcc
Q 039137          643 EHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMS----------------------FQQEEFLNEIQALTEIRHRNI  700 (912)
Q Consensus       643 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~----------------------~~~~~~~~Ei~~l~~l~h~ni  700 (912)
                      .+.||+|++|.||+|+..+|+.||||++.........                      .....+.+|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            5789999999999999878999999998765321100                      012234679999999999988


Q ss_pred             ccEEEEEEcCCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCCeEEcC
Q 039137          701 VKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHN-NCFPPIVHRDISSKNVLLDL  779 (912)
Q Consensus       701 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill~~  779 (912)
                      .....+...  ..++||||++++++.....   ....++..++.+++.|++.++.++|+ +   ||+||||||+||+++ 
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-  152 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-  152 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-
Confidence            655554433  2489999999885543321   12356788999999999999999999 8   999999999999999 


Q ss_pred             CCcEEEeccccccccC
Q 039137          780 GYEAHVSDFGIAKFLN  795 (912)
Q Consensus       780 ~~~~kl~Dfgla~~~~  795 (912)
                      ++.++++|||+++...
T Consensus       153 ~~~~~liDFG~a~~~~  168 (190)
T cd05145         153 DGKPYIIDVSQAVELD  168 (190)
T ss_pred             CCCEEEEEcccceecC
Confidence            8899999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.79  E-value=7.6e-21  Score=173.00  Aligned_cols=166  Identities=33%  Similarity=0.518  Sum_probs=149.0

Q ss_pred             ccCCCCCcEEeccccccccccccccccccccceeecccccccCCCCccccCcccccEEEccCCcCCCCCCccCCCCccce
Q 039137          129 ISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVV  208 (912)
Q Consensus       129 ~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~  208 (912)
                      +.++++.+.|-||+|+++ .+|..+..|.+|++|++++|+++ .+|.+++.+++|+.|+++-|++. .+|.+|+.++.|+
T Consensus        29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le  105 (264)
T KOG0617|consen   29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE  105 (264)
T ss_pred             ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence            556778899999999998 78888999999999999999999 99999999999999999999998 8899999999999


Q ss_pred             eeeeccCCCcC-ccccccccccccceeecccccccCccccccccccccceeeeccccCcccCCcccCCccccchhhhccC
Q 039137          209 ILYLYNNSFFG-SIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKN  287 (912)
Q Consensus       209 ~L~L~~n~l~~-~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N  287 (912)
                      .|||.+|++.. .+|..|..|..|+.|+|+.|.+. .+|..++++++|+.|.+.+|.+- .+|.+++.++.|++|++.+|
T Consensus       106 vldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgn  183 (264)
T KOG0617|consen  106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGN  183 (264)
T ss_pred             hhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccc
Confidence            99999988874 67888889999999999999998 88888999999999999999987 58889999999999999999


Q ss_pred             ccCCCCccccccc
Q 039137          288 HFRGTVPKSFRNL  300 (912)
Q Consensus       288 ~l~~~~~~~~~~l  300 (912)
                      +++ .+|..++++
T Consensus       184 rl~-vlppel~~l  195 (264)
T KOG0617|consen  184 RLT-VLPPELANL  195 (264)
T ss_pred             eee-ecChhhhhh
Confidence            998 666666543

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.78  E-value=3e-18  Score=168.14  Aligned_cols=186  Identities=13%  Similarity=0.086  Sum_probs=138.4

Q ss_pred             CCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcC-CCccccEEEEEEcCCeeeEEEee
Q 039137          641 NAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR-HRNIVKFYGFCSHPKHSFIIYEY  719 (912)
Q Consensus       641 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  719 (912)
                      .+...|++|+||+||.+.. .+..++.+.+.....-........+.+|++++++++ |+++++++++    +..+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            4567899999999998766 677777666643221111112335789999999995 5889999886    346999999


Q ss_pred             cCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCC-CCCCeEEcCCCcEEEeccccccccCCCC
Q 039137          720 LESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDI-SSKNVLLDLGYEAHVSDFGIAKFLNPDS  798 (912)
Q Consensus       720 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl-k~~Nill~~~~~~kl~Dfgla~~~~~~~  798 (912)
                      +.|.+|.+....          ....++.|++.+++++|++   ||+|||| ||+||+++.++.++|+|||+|.......
T Consensus        80 I~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~  146 (218)
T PRK12274         80 LAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA  146 (218)
T ss_pred             ecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence            999998654311          1135778999999999999   9999999 7999999999999999999998655433


Q ss_pred             CC-----cc--------ccccccccccccccccC-CCC-cchhHHHHHHHHHHHHhCCCCc
Q 039137          799 SN-----WS--------ELAGTHGYVAPELAYTL-KVT-EKCDVYSFGVLALEVIKGKHPR  844 (912)
Q Consensus       799 ~~-----~~--------~~~g~~~y~aPE~~~~~-~~~-~~sDvwslG~vl~elltg~~pf  844 (912)
                      ..     ..        ....++.|++|+...-. ..+ .+.+-++-|.-+|.++|+..|+
T Consensus       147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~  207 (218)
T PRK12274        147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH  207 (218)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence            21     00        12257788888854322 233 5678899999999999999884

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.78  E-value=8.1e-21  Score=208.51  Aligned_cols=277  Identities=24%  Similarity=0.247  Sum_probs=146.5

Q ss_pred             eeeccccccc-CccccccccccccceeeeccccCccc----CCcccCCccccchhhhccCccCC------CCcccccccc
Q 039137          233 DLELCINQLS-GAIPLSISNLTNLRFLFLYHNELSGI----IPQEIGNLKKLNSLLLAKNHFRG------TVPKSFRNLT  301 (912)
Q Consensus       233 ~L~l~~n~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~----~~~~l~~l~~L~~L~L~~N~l~~------~~~~~~~~l~  301 (912)
                      .|+|..+.++ ...+..+..+.+|+.|+++++.++..    ++..+...++|++|+++++.+.+      .++..+..++
T Consensus         2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~   81 (319)
T cd00116           2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC   81 (319)
T ss_pred             ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence            4566677766 34445556667788888888777432    34445555667777777666652      1223344455


Q ss_pred             ccceEecccccccCCCCcccCCCCC---ccEEEccCCcCcccccccCCCCCCCCEEeccCCccccccccccccc-ccccE
Q 039137          302 DLVKLRLNQNYLTGNISETFGTYPN---LTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGES-LQLQY  377 (912)
Q Consensus       302 ~L~~L~L~~n~l~~~~~~~~~~l~~---L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~-~~L~~  377 (912)
                      +|+.|++++|.+.+..+..+..+.+   |++|++++|++.+...                    ..+...+..+ ++|+.
T Consensus        82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~--------------------~~l~~~l~~~~~~L~~  141 (319)
T cd00116          82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGL--------------------RLLAKGLKDLPPALEK  141 (319)
T ss_pred             ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHH--------------------HHHHHHHHhCCCCceE
Confidence            5555555555555433333333322   5555555555442111                    1111222333 45555


Q ss_pred             EEccCccccCC----CCccccccccccEEEccCCcccCC----CccccccccccccccccCcccCccc----cccccccc
Q 039137          378 LDLSSNYIVGE----IPTQLGNIIYLNRLSLSGNKLSGC----IPRELGSLINLEYLDLSANNLSNFV----PESLGSLV  445 (912)
Q Consensus       378 L~L~~N~l~~~----~~~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~  445 (912)
                      |++++|.+++.    ++..+..+.+|++|++++|.+++.    ++..+..+++|++|++++|.+++..    +..+..++
T Consensus       142 L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~  221 (319)
T cd00116         142 LVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLK  221 (319)
T ss_pred             EEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccC
Confidence            55555555421    222334445566666666655532    2223334456666666666665332    23344556


Q ss_pred             cccEEEecccccccccchhhhc-----ccccceeeccccccCc----ccccccccccccccccccCccccCC----Cccc
Q 039137          446 KLYYLNLSHNKLSQQIPIELDN-----LIHLSELDLSHNFLGE----KISSRICRMESLEKLNLSYNNLSGL----IPRC  512 (912)
Q Consensus       446 ~L~~L~Ls~N~l~~~~~~~~~~-----l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~ls~N~l~~~----~p~~  512 (912)
                      +|++|++++|.+++.....+..     .+.|++|++++|.++.    .+...+..+++|+.+++++|+++..    ....
T Consensus       222 ~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~  301 (319)
T cd00116         222 SLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAES  301 (319)
T ss_pred             CCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHH
Confidence            6777777777766433333222     2567777777777752    2234445556777777777777744    2333


Q ss_pred             cccc-ccceEEEccCCcc
Q 039137          513 FEEM-HGLLHIDISYNKL  529 (912)
Q Consensus       513 ~~~l-~~L~~l~ls~N~l  529 (912)
                      +... +.|+.+++.+|+|
T Consensus       302 ~~~~~~~~~~~~~~~~~~  319 (319)
T cd00116         302 LLEPGNELESLWVKDDSF  319 (319)
T ss_pred             HhhcCCchhhcccCCCCC
Confidence            3334 5677777777764

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.77  E-value=6.6e-19  Score=180.67  Aligned_cols=198  Identities=24%  Similarity=0.323  Sum_probs=140.7

Q ss_pred             CCCccccEEEEEEc---------------------------CCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHH
Q 039137          696 RHRNIVKFYGFCSH---------------------------PKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIK  748 (912)
Q Consensus       696 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~  748 (912)
                      +|||||++.++|.+                           +...|+||...+. +|..++..+    ..+.....-++.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~----~~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR----HRSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC----CCchHHHHHHHH
Confidence            69999999887632                           2456899998766 899998443    355667788999


Q ss_pred             HHHHHHHHHHhCCCCCeeecCCCCCCeEEc--CCC--cEEEeccccccccCC------CCCCcccccccccccccccccc
Q 039137          749 GVADALFYLHNNCFPPIVHRDISSKNVLLD--LGY--EAHVSDFGIAKFLNP------DSSNWSELAGTHGYVAPELAYT  818 (912)
Q Consensus       749 ~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~--~~~--~~kl~Dfgla~~~~~------~~~~~~~~~g~~~y~aPE~~~~  818 (912)
                      |+++|+.|||.+   ||.|||+|.+||++.  +|+  .++++|||++---+.      -.+......|...-||||+...
T Consensus       349 QlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta  425 (598)
T KOG4158|consen  349 QLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA  425 (598)
T ss_pred             HHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence            999999999999   999999999999994  333  478999998742211      1122334567788999998775


Q ss_pred             CCC------CcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCC
Q 039137          819 LKV------TEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNP  892 (912)
Q Consensus       819 ~~~------~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP  892 (912)
                      .+-      -.|+|.|+.|.+.||+++...||..--++.-    ....+-...+|..+   ...++.+.+++...++.||
T Consensus       426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L----~~r~Yqe~qLPalp---~~vpp~~rqlV~~lL~r~p  498 (598)
T KOG4158|consen  426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL----DTRTYQESQLPALP---SRVPPVARQLVFDLLKRDP  498 (598)
T ss_pred             CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee----chhhhhhhhCCCCc---ccCChHHHHHHHHHhcCCc
Confidence            432      2489999999999999999999853111110    01111122222222   2344567889999999999


Q ss_pred             CCCCCHHHHHHHHHHh
Q 039137          893 ESRPTMKRVSQLLCEK  908 (912)
Q Consensus       893 ~~RPt~~evl~~L~~~  908 (912)
                      .+|++..-....|.-.
T Consensus       499 skRvsp~iAANvl~Ls  514 (598)
T KOG4158|consen  499 SKRVSPNIAANVLNLS  514 (598)
T ss_pred             cccCCccHHHhHHHHH
Confidence            9999987766666543

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.77  E-value=1.4e-20  Score=206.72  Aligned_cols=260  Identities=26%  Similarity=0.287  Sum_probs=134.0

Q ss_pred             ccccccceeecccccccC----ccccccccccccceeeeccccCcc------cCCcccCCccccchhhhccCccCCCCcc
Q 039137          226 GNLKSLFDLELCINQLSG----AIPLSISNLTNLRFLFLYHNELSG------IIPQEIGNLKKLNSLLLAKNHFRGTVPK  295 (912)
Q Consensus       226 ~~l~~L~~L~l~~n~l~~----~~p~~~~~l~~L~~L~L~~N~l~~------~~~~~l~~l~~L~~L~L~~N~l~~~~~~  295 (912)
                      ..+.+|+.|+++++.++.    .++..+...++|++|+++++.+.+      .++..+..+++|+.|++++|.+.+..+.
T Consensus        20 ~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~   99 (319)
T cd00116          20 PKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCG   99 (319)
T ss_pred             HHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHH
Confidence            333444444444444422    123334444455555555554441      1233445556666666666666655555


Q ss_pred             ccccccc---cceEecccccccC----CCCcccCCC-CCccEEEccCCcCcccc----cccCCCCCCCCEEeccCCcccc
Q 039137          296 SFRNLTD---LVKLRLNQNYLTG----NISETFGTY-PNLTFIDLSNNSFFGEI----LSDWGRCPQLSLLDVSINNISG  363 (912)
Q Consensus       296 ~~~~l~~---L~~L~L~~n~l~~----~~~~~~~~l-~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~  363 (912)
                      .+..+.+   |++|++++|++++    .+...+..+ ++|+.|++++|.+++..    ...+..+++|++|++++|.+++
T Consensus       100 ~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~  179 (319)
T cd00116         100 VLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGD  179 (319)
T ss_pred             HHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCch
Confidence            5555444   7777777777663    222334455 67777777777776322    2234445556666666665553


Q ss_pred             c----ccccccccccccEEEccCccccCCCCccccccccccEEEccCCcccCCCccccccccccccccccCcccCccccc
Q 039137          364 S----IPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPE  439 (912)
Q Consensus       364 ~----~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~  439 (912)
                      .    ++..+...++|++|+|++|.+++....                    .++..+..+++|++|++++|.+++....
T Consensus       180 ~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~--------------------~l~~~~~~~~~L~~L~ls~n~l~~~~~~  239 (319)
T cd00116         180 AGIRALAEGLKANCNLEVLDLNNNGLTDEGAS--------------------ALAETLASLKSLEVLNLGDNNLTDAGAA  239 (319)
T ss_pred             HHHHHHHHHHHhCCCCCEEeccCCccChHHHH--------------------HHHHHhcccCCCCEEecCCCcCchHHHH
Confidence            1    122223334555555555554422111                    1122333445555555555555542222


Q ss_pred             ccc-----ccccccEEEeccccccc----ccchhhhcccccceeeccccccCcc----cccccccc-cccccccccCccc
Q 039137          440 SLG-----SLVKLYYLNLSHNKLSQ----QIPIELDNLIHLSELDLSHNFLGEK----ISSRICRM-ESLEKLNLSYNNL  505 (912)
Q Consensus       440 ~~~-----~l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l-~~L~~L~ls~N~l  505 (912)
                      .+.     ..+.|++|++++|.++.    .+...+..+++|+++++++|.++..    ....+... +.|+.|++.+|.+
T Consensus       240 ~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (319)
T cd00116         240 ALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF  319 (319)
T ss_pred             HHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence            221     12567777777777652    2334455556777777777777644    23333334 5677777777754

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.77  E-value=2.5e-18  Score=201.95  Aligned_cols=251  Identities=21%  Similarity=0.241  Sum_probs=189.6

Q ss_pred             HHHhcCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcC---CCccccEEEEEEcC
Q 039137          634 ISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR---HRNIVKFYGFCSHP  710 (912)
Q Consensus       634 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~~  710 (912)
                      ....+.|.+.+.||+|+||+||+|...+|+.||+|+-+.+..-+       |.-=.+++.+|+   -+.|+.+..++.-.
T Consensus       694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE-------fYI~~q~~~RLk~~~~~~~~~~~~a~~~~  766 (974)
T KOG1166|consen  694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE-------FYICLQVMERLKPQMLPSIMHISSAHVFQ  766 (974)
T ss_pred             eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee-------eeehHHHHHhhchhhhcchHHHHHHHccC
Confidence            34456789999999999999999998889999999976543211       111223334443   34566666667777


Q ss_pred             CeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcC-------CCcE
Q 039137          711 KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDL-------GYEA  783 (912)
Q Consensus       711 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-------~~~~  783 (912)
                      +..++|+||.+.|+|.+++.   ..+.++|.-+..++.|+++.+++||..   +||||||||+|+++..       ..-+
T Consensus       767 ~~S~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l  840 (974)
T KOG1166|consen  767 NASVLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGL  840 (974)
T ss_pred             CcceeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccce
Confidence            88899999999999999993   556789999999999999999999999   9999999999999953       3348


Q ss_pred             EEeccccccccC--CCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhh
Q 039137          784 HVSDFGIAKFLN--PDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEM  861 (912)
Q Consensus       784 kl~Dfgla~~~~--~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~  861 (912)
                      +|+|||.+..+.  ++.......++|-.+-.+|+..|.++++.+|.|.++.+++-|+.|++--         ........
T Consensus       841 ~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q---------~~~g~~~~  911 (974)
T KOG1166|consen  841 YLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME---------VKNGSSWM  911 (974)
T ss_pred             EEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH---------hcCCccee
Confidence            999999998664  3344567788899999999999999999999999999999999998751         00011111


Q ss_pred             ccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 039137          862 LDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE  911 (912)
Q Consensus       862 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~~  911 (912)
                      ++.  .++.....+.   +.+++..+|+.|-..=|...++...+++.+.+
T Consensus       912 ~~~--~~~Ry~~~~~---W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~  956 (974)
T KOG1166|consen  912 VKT--NFPRYWKRDM---WNKFFDLLLNPDCDTLPNLQELRTELEEVLAE  956 (974)
T ss_pred             ccc--cchhhhhHHH---HHHHHHHHhCcCcccchhHHHHHHHHHHHHHH
Confidence            111  1223233333   34555567776666668999999999888754

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.76  E-value=2e-19  Score=196.96  Aligned_cols=239  Identities=24%  Similarity=0.311  Sum_probs=188.4

Q ss_pred             eeeecCceEEEEEE----eCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcC-CCccccEEEEEEcCCeeeEEEee
Q 039137          645 CIGKGGHGSVYRAK----VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR-HRNIVKFYGFCSHPKHSFIIYEY  719 (912)
Q Consensus       645 ~lg~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  719 (912)
                      .+|+|+||.|+.++    .+.|..||.|..++.......  ......|-.++...+ ||.++++.-.+..+...++++++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~--~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~   78 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRD--RTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDF   78 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhccccccccccc--ccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhh
Confidence            37899999999874    336778999887765443222  114556778888886 99999999999999999999999


Q ss_pred             cCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCC
Q 039137          720 LESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSS  799 (912)
Q Consensus       720 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  799 (912)
                      ..+|.+...+.   ....+++.....+...++-+++++|+.   +|+|||+|++||+++.+|.+++.|||+++..-....
T Consensus        79 ~rgg~lft~l~---~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~  152 (612)
T KOG0603|consen   79 LRGGDLFTRLS---KEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI  152 (612)
T ss_pred             cccchhhhccc---cCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhh
Confidence            99999988773   334577788888899999999999999   999999999999999999999999999986544332


Q ss_pred             CccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHHHH
Q 039137          800 NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMS  879 (912)
Q Consensus       800 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  879 (912)
                      .    +||..|||||++.  ....++|.||||++++||+||..||..         +....+.......|    ...+..
T Consensus       153 ~----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~---------~~~~~Il~~~~~~p----~~l~~~  213 (612)
T KOG0603|consen  153 A----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG---------DTMKRILKAELEMP----RELSAE  213 (612)
T ss_pred             c----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch---------HHHHHHhhhccCCc----hhhhHH
Confidence            2    8999999999988  578899999999999999999999863         23333344444544    334455


Q ss_pred             HHHHHHHcccCCCCCCCCH--HHHHHHHHHhhh
Q 039137          880 IMQVAFSCLDQNPESRPTM--KRVSQLLCEKIF  910 (912)
Q Consensus       880 l~~li~~cl~~dP~~RPt~--~evl~~L~~~l~  910 (912)
                      +..++..+...+|..|--.  ..+.+..+..++
T Consensus       214 a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~  246 (612)
T KOG0603|consen  214 ARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFF  246 (612)
T ss_pred             HHHHHHHHHhhCHHHHhccCcchhHHHhccchh
Confidence            6677888999999999755  456555555444

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.76  E-value=2.9e-18  Score=188.65  Aligned_cols=212  Identities=26%  Similarity=0.456  Sum_probs=161.2

Q ss_pred             HhhcCCCccccEEEEEEcCCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCe-eecCC
Q 039137          692 LTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI-VHRDI  770 (912)
Q Consensus       692 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i-vH~Dl  770 (912)
                      |+.+.|.|+.+++|.+.++...+.|.+||..|+|.|.+..  ....+++-....++++++.|++|+|+.   +| +|+.+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l   75 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGAL   75 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeee
Confidence            4568899999999999999999999999999999999954  345688999999999999999999998   55 99999


Q ss_pred             CCCCeEEcCCCcEEEeccccccccCC--CCCCccccccccccccccccccCC-------CCcchhHHHHHHHHHHHHhCC
Q 039137          771 SSKNVLLDLGYEAHVSDFGIAKFLNP--DSSNWSELAGTHGYVAPELAYTLK-------VTEKCDVYSFGVLALEVIKGK  841 (912)
Q Consensus       771 k~~Nill~~~~~~kl~Dfgla~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~-------~~~~sDvwslG~vl~elltg~  841 (912)
                      ++.|.++|....+|++|||+......  ............-|.|||.+.+..       .+.+.||||||++++|+++.+
T Consensus        76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~  155 (484)
T KOG1023|consen   76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS  155 (484)
T ss_pred             ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence            99999999999999999999987643  111112223456799999887642       466799999999999999999


Q ss_pred             CCccchhccccccccchhhhcc-CCC-CCCChhhH-HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 039137          842 HPRDFLFEMSSSSSNMNIEMLD-SRL-PYPSLHVQ-KKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI  909 (912)
Q Consensus       842 ~pf~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~-~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l  909 (912)
                      .||+........ .+....+.+ ... ..|..... ...+.+..++.+||..+|++||+++++...++...
T Consensus       156 ~~~~~~~~~~~~-~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~  225 (484)
T KOG1023|consen  156 GPFDLRNLVEDP-DEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN  225 (484)
T ss_pred             CccccccccCCh-HHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence            998743222211 111111222 221 11221111 33346888999999999999999999988877543

>PRK10345 hypothetical protein; Provisional

Probab=99.72  E-value=5.5e-17  Score=163.16  Aligned_cols=137  Identities=18%  Similarity=0.223  Sum_probs=105.7

Q ss_pred             CCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-----CCCccccEEEEEEcCC---
Q 039137          640 FNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-----RHRNIVKFYGFCSHPK---  711 (912)
Q Consensus       640 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-----~h~niv~l~~~~~~~~---  711 (912)
                      +.-.+.||+|+||.||.  +++....+||++......    ..+.+.+|+..++.+     .||||++++|+++++.   
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~----~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g   77 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDG----GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTG   77 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccc----hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCe
Confidence            34457899999999995  554444579988653221    356789999999999     5799999999998863   


Q ss_pred             e-eeEEEee--cCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHH-HHHHhCCCCCeeecCCCCCCeEEcC----CCcE
Q 039137          712 H-SFIIYEY--LESGSLDKILCNDASAKELGWTQRLNVIKGVADAL-FYLHNNCFPPIVHRDISSKNVLLDL----GYEA  783 (912)
Q Consensus       712 ~-~~lv~e~--~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L-~~LH~~~~~~ivH~Dlk~~Nill~~----~~~~  783 (912)
                      . ..+||||  +++++|.+++.+.    .+++.  ..++.+++.++ +|||++   +|+||||||+||+++.    ++.+
T Consensus        78 ~v~~~I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~  148 (210)
T PRK10345         78 YVYDVIADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIP  148 (210)
T ss_pred             EEEEEEecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcE
Confidence            3 3378999  5579999999442    35544  35678888777 999999   9999999999999974    3379


Q ss_pred             EEeccccc
Q 039137          784 HVSDFGIA  791 (912)
Q Consensus       784 kl~Dfgla  791 (912)
                      +|+||+-+
T Consensus       149 ~LiDg~G~  156 (210)
T PRK10345        149 VVCDNIGE  156 (210)
T ss_pred             EEEECCCC
Confidence            99995434

>smart00090 RIO RIO-like kinase

Probab=99.70  E-value=1.1e-16  Score=165.31  Aligned_cols=148  Identities=18%  Similarity=0.196  Sum_probs=114.2

Q ss_pred             hcCCCCCceeeecCceEEEEEE--eCCCCEEEEEEccCCCCCCc--------------------hHHHHHHHHHHHHHhh
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAK--VPSGEIFAVKKFHSPLPGEM--------------------SFQQEEFLNEIQALTE  694 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~~~--------------------~~~~~~~~~Ei~~l~~  694 (912)
                      ..-|.+.+.||+|++|.||+|.  ..+|+.||+|+++.......                    ......+.+|++.+++
T Consensus        27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~  106 (237)
T smart00090       27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR  106 (237)
T ss_pred             CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence            3358899999999999999998  45899999999875432100                    0012346689999999


Q ss_pred             cCCC--ccccEEEEEEcCCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCC-eeecCCC
Q 039137          695 IRHR--NIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP-IVHRDIS  771 (912)
Q Consensus       695 l~h~--niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-ivH~Dlk  771 (912)
                      +.+.  .+++++++    ...++||||++++++......   .......++..++.|++.++++||++   + |+|||||
T Consensus       107 L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dik  176 (237)
T smart00090      107 LYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLS  176 (237)
T ss_pred             HHhcCCCCCeeeEe----cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCC
Confidence            9753  34445543    235899999999888765421   23455667789999999999999999   9 9999999


Q ss_pred             CCCeEEcCCCcEEEeccccccccC
Q 039137          772 SKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       772 ~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      |+||+++ ++.++++|||.+....
T Consensus       177 p~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      177 EYNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             hhhEEEE-CCCEEEEEChhhhccC
Confidence            9999999 8899999999987543

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.68  E-value=1.5e-17  Score=179.01  Aligned_cols=174  Identities=22%  Similarity=0.347  Sum_probs=135.4

Q ss_pred             CeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccc
Q 039137          711 KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGI  790 (912)
Q Consensus       711 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl  790 (912)
                      .+.|+.|++|...+|.+|+.+.......++.....++.|++.|++|   +   +.+|+|+||.||++..+..+||+|||+
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence            3578999999999999999877777788999999999999999999   6   899999999999999999999999999


Q ss_pred             ccccCCCC------CCccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhcc
Q 039137          791 AKFLNPDS------SNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLD  863 (912)
Q Consensus       791 a~~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  863 (912)
                      ........      .......||..||+||.+.+..|+.++||||||++++|++. =..+|+.        ......+-+
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er--------~~t~~d~r~  474 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER--------IATLTDIRD  474 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH--------HHhhhhhhc
Confidence            98765543      12345689999999999999999999999999999999987 3333321        111112222


Q ss_pred             CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 039137          864 SRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRV  901 (912)
Q Consensus       864 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev  901 (912)
                      ..+|  +....+++. -..++.+++...|.+||++.++
T Consensus       475 g~ip--~~~~~d~p~-e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  475 GIIP--PEFLQDYPE-EYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             CCCC--hHHhhcCcH-HHHHHHHhcCCCcccCchHHHH
Confidence            3332  222233332 3467779999999999955443

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.67  E-value=6.7e-16  Score=158.39  Aligned_cols=138  Identities=20%  Similarity=0.353  Sum_probs=115.5

Q ss_pred             ceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCc----hHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEEee
Q 039137          644 HCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEM----SFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEY  719 (912)
Q Consensus       644 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  719 (912)
                      +.||+|++|.||+|.. .|..+++|+.........    ......+.+|++.+..++|+++.....++...+..++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 777899998654332211    11235678899999999999998888888777889999999


Q ss_pred             cCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccc
Q 039137          720 LESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKF  793 (912)
Q Consensus       720 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  793 (912)
                      ++|++|.+++....      . ++..++.+++.+++++|+.   +++|+|++|.||+++ ++.++++|||.+..
T Consensus        81 ~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNG------M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999984321      2 7889999999999999999   999999999999999 78999999998874

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.67  E-value=5.4e-16  Score=157.04  Aligned_cols=148  Identities=18%  Similarity=0.214  Sum_probs=115.1

Q ss_pred             HHHHHhcCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCch------------------HHHHHHHHHHHHHh
Q 039137          632 EIISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMS------------------FQQEEFLNEIQALT  693 (912)
Q Consensus       632 e~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~------------------~~~~~~~~Ei~~l~  693 (912)
                      ++......|.+.+.||+|+||.||+|..++|+.||||++.........                  .....+.+|+..+.
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   88 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK   88 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence            444444458889999999999999999888999999987643311100                  01223678899999


Q ss_pred             hcCCC--ccccEEEEEEcCCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCC
Q 039137          694 EIRHR--NIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDIS  771 (912)
Q Consensus       694 ~l~h~--niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk  771 (912)
                      .+.|+  .++..++.    ...++||||++++++.+...         .....+++.+++.++.++|+.   +|+||||+
T Consensus        89 ~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~  152 (198)
T cd05144          89 ALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKH---GIIHGDLS  152 (198)
T ss_pred             HHHHcCCCCCceeec----CCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHC---CCCcCCCC
Confidence            99877  45555442    34589999999999877641         134568899999999999998   99999999


Q ss_pred             CCCeEEcCCCcEEEeccccccccC
Q 039137          772 SKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       772 ~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      |+||++++++.++|+|||.+....
T Consensus       153 p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         153 EFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             cccEEEcCCCcEEEEECCccccCC
Confidence            999999999999999999997554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.65  E-value=1e-15  Score=155.36  Aligned_cols=135  Identities=21%  Similarity=0.350  Sum_probs=109.2

Q ss_pred             eeeecCceEEEEEEeCCCCEEEEEEccCCCCCC----chHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEEeec
Q 039137          645 CIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGE----MSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYL  720 (912)
Q Consensus       645 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  720 (912)
                      .||+|++|.||+|.+ ++..+++|+........    .....+++.+|++++..++|+++.....++...+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            379999999999986 67889999865432111    1122466789999999999887766666666677789999999


Q ss_pred             CCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccccccc
Q 039137          721 ESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL  794 (912)
Q Consensus       721 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  794 (912)
                      +|++|.+++....   .       .++.+++.+++++|+.   +++|||++|.||+++ ++.++++|||++...
T Consensus        80 ~g~~l~~~~~~~~---~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        80 EGKPLKDVIEEGN---D-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CCccHHHHHhhcH---H-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            9999998873311   0       7899999999999999   999999999999999 889999999998753

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PLN03150 hypothetical protein; Provisional

Probab=99.65  E-value=2.6e-16  Score=185.43  Aligned_cols=155  Identities=36%  Similarity=0.558  Sum_probs=121.6

Q ss_pred             CCCHHHHHHHHHHHHhcccCCcccCCCcccCCCCCCCCCCC-----ccceeEecCCCCeEEEeeccccccccccccccCC
Q 039137           33 SNSAEEAHALVKWKASLEVHSRSLLHSWSLSSVNATKISPC-----AWSGIFCNHAERVVGINLTSISLNGTLLEFSFSS  107 (912)
Q Consensus        33 ~~~~~~~~all~~k~~~~~~~~~~l~~w~~~~~~~~~~~~C-----~w~gv~c~~~~~v~~l~l~~~~l~~~~~~~~~~~  107 (912)
                      ++.++|..||+++|+++.. +.  ..+|.+        |+|     .|.||+|+.....                    .
T Consensus       368 ~t~~~~~~aL~~~k~~~~~-~~--~~~W~g--------~~C~p~~~~w~Gv~C~~~~~~--------------------~  416 (623)
T PLN03150        368 KTLLEEVSALQTLKSSLGL-PL--RFGWNG--------DPCVPQQHPWSGADCQFDSTK--------------------G  416 (623)
T ss_pred             ccCchHHHHHHHHHHhcCC-cc--cCCCCC--------CCCCCcccccccceeeccCCC--------------------C
Confidence            4677899999999999854 32  247953        334     7999999531100                    0


Q ss_pred             CCCccEEEccCCcccccCCccccCCCCCcEEeccccccccccccccccccccceeecccccccCCCCccccCcccccEEE
Q 039137          108 FPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLA  187 (912)
Q Consensus       108 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~  187 (912)
                      ...++.|+|++|++.|.+|+.|+.+++|++|+|++|++.|.+|..++.+++|+.|+|++|+++|.+|..++++++|+.|+
T Consensus       417 ~~~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~  496 (623)
T PLN03150        417 KWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILN  496 (623)
T ss_pred             ceEEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEE
Confidence            01245678888999999999999999999999999999888998899999999999999999988999899999999999


Q ss_pred             ccCCcCCCCCCccCCCC-ccceeeeeccCCCc
Q 039137          188 LDSNFLNGSIPRSLGNL-THVVILYLYNNSFF  218 (912)
Q Consensus       188 l~~n~l~~~~p~~~~~l-~~L~~L~L~~n~l~  218 (912)
                      |++|+++|.+|..++++ .++..+++.+|...
T Consensus       497 Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~l  528 (623)
T PLN03150        497 LNGNSLSGRVPAALGGRLLHRASFNFTDNAGL  528 (623)
T ss_pred             CcCCcccccCChHHhhccccCceEEecCCccc
Confidence            99999888888887664 35667777777643

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.65  E-value=1.2e-15  Score=178.14  Aligned_cols=143  Identities=20%  Similarity=0.334  Sum_probs=115.2

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeCCCCEEEEEEc-cCCCCC---CchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCC
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKF-HSPLPG---EMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPK  711 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~-~~~~~~---~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~  711 (912)
                      ....|...+.||+|+||+||+|.+.... +++|+. ......   ......+++.+|+++++.++|++++....++..+.
T Consensus       331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~  409 (535)
T PRK09605        331 VKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE  409 (535)
T ss_pred             cccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence            3445677899999999999999875443 444433 221111   11123467889999999999999998888888778


Q ss_pred             eeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccc
Q 039137          712 HSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIA  791 (912)
Q Consensus       712 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla  791 (912)
                      ..++||||+++++|.+++.           ....++.+++.+++|||+.   +++|||+||+||++ .++.++++|||++
T Consensus       410 ~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla  474 (535)
T PRK09605        410 EKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLG  474 (535)
T ss_pred             CCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccc
Confidence            8899999999999999883           4578999999999999999   99999999999999 6779999999999


Q ss_pred             ccc
Q 039137          792 KFL  794 (912)
Q Consensus       792 ~~~  794 (912)
                      +..
T Consensus       475 ~~~  477 (535)
T PRK09605        475 KYS  477 (535)
T ss_pred             ccC
Confidence            753

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.64  E-value=1.6e-16  Score=182.46  Aligned_cols=221  Identities=23%  Similarity=0.286  Sum_probs=149.3

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      ..+|+.++.|.-|+||.||.++++ +.+.+|.|+-+.          .-+.+-  ++.....|.+|              
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq----------~lilRn--ilt~a~npfvv--------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ----------NLILRN--ILTFAGNPFVV--------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhccccc----------chhhhc--cccccCCccee--------------
Confidence            367999999999999999999987 567788844221          111111  22222333333              


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                             |+=...+   +..+.++.        +++.+++|+|+.   +|||||+||+|.+++.-|.+|+.|||+++...
T Consensus       136 -------gDc~tll---k~~g~lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GL  194 (1205)
T KOG0606|consen  136 -------GDCATLL---KNIGPLPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGL  194 (1205)
T ss_pred             -------chhhhhc---ccCCCCcc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhh
Confidence                   3333444   22233332        338899999999   99999999999999999999999999987542


Q ss_pred             CCCC---------------CccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhh
Q 039137          796 PDSS---------------NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIE  860 (912)
Q Consensus       796 ~~~~---------------~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~  860 (912)
                      ....               .....+|||.|+|||++....|...+|.|++|+++||.+-|..||+....     ++....
T Consensus       195 ms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp-----eelfg~  269 (1205)
T KOG0606|consen  195 MSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-----EELFGQ  269 (1205)
T ss_pred             hhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH-----HHHHhh
Confidence            2111               11345899999999999999999999999999999999999999863311     111112


Q ss_pred             hccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          861 MLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       861 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                      ++...+.++.. ......+..+++.+.++.+|..|--....+++-++-+|
T Consensus       270 visd~i~wpE~-dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff  318 (1205)
T KOG0606|consen  270 VISDDIEWPEE-DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFF  318 (1205)
T ss_pred             hhhhhcccccc-CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccce
Confidence            22222222221 22334567788999999999999654455555554444

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.56  E-value=2.3e-14  Score=143.94  Aligned_cols=140  Identities=19%  Similarity=0.212  Sum_probs=100.7

Q ss_pred             CceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHH--------------------HHHHHHHHHHhhcCCC--cc
Q 039137          643 EHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQ--------------------EEFLNEIQALTEIRHR--NI  700 (912)
Q Consensus       643 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~--------------------~~~~~Ei~~l~~l~h~--ni  700 (912)
                      .+.||+|+||+||+|...+++.||||++............                    .....|.+.+..+.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4679999999999999888999999998754322111000                    0113566666666443  34


Q ss_pred             ccEEEEEEcCCeeeEEEeecCCCChhhH-hhccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCCeEEc
Q 039137          701 VKFYGFCSHPKHSFIIYEYLESGSLDKI-LCNDASAKELGWTQRLNVIKGVADALFYLHN-NCFPPIVHRDISSKNVLLD  778 (912)
Q Consensus       701 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill~  778 (912)
                      .+.+++    ...++||||++++++... +....    . ..++..++.+++.++.++|. .   +|+|+||||+||+++
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~-~~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----L-LEDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh----h-cccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE
Confidence            555543    246899999999544221 11100    0 16788999999999999999 7   999999999999999


Q ss_pred             CCCcEEEeccccccccC
Q 039137          779 LGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       779 ~~~~~kl~Dfgla~~~~  795 (912)
                       ++.++++|||.+....
T Consensus       150 -~~~~~liDfg~a~~~~  165 (187)
T cd05119         150 -DGKVYIIDVPQAVEID  165 (187)
T ss_pred             -CCcEEEEECccccccc
Confidence             8899999999997554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.55  E-value=5.9e-16  Score=179.40  Aligned_cols=256  Identities=21%  Similarity=0.304  Sum_probs=189.5

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC--CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcC-CCccccEEEEEEcCCee
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP--SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR-HRNIVKFYGFCSHPKHS  713 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~  713 (912)
                      ...|.+.+.||+|+|+.|-.+...  ....+|+|.+..+.  ......+....|..+-+.+. |+|++.+++....++..
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~--~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~   96 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP--KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSY   96 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC--CccchhhhcCccccccccccccccccccCCccCCCccc
Confidence            356888889999999999888654  33446666655443  22224555667888888886 99999999999999999


Q ss_pred             eEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHH-hCCCCCeeecCCCCCCeEEcCCC-cEEEeccccc
Q 039137          714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLH-NNCFPPIVHRDISSKNVLLDLGY-EAHVSDFGIA  791 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH-~~~~~~ivH~Dlk~~Nill~~~~-~~kl~Dfgla  791 (912)
                      ++++||..++++.+-+. .......+...+..++.|+..++.|+| ..   +++|+|+||+|.+++..+ ..+++|||+|
T Consensus        97 ~~~~~~s~g~~~f~~i~-~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~A  172 (601)
T KOG0590|consen   97 LLSLSYSDGGSLFSKIS-HPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLA  172 (601)
T ss_pred             ccccCcccccccccccc-cCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhh
Confidence            99999999999988773 122224566778899999999999999 77   999999999999999999 9999999999


Q ss_pred             cccCC-CC--CCcccccc-ccccccccccccCC-CCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCC
Q 039137          792 KFLNP-DS--SNWSELAG-THGYVAPELAYTLK-VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRL  866 (912)
Q Consensus       792 ~~~~~-~~--~~~~~~~g-~~~y~aPE~~~~~~-~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  866 (912)
                      ..+.. .+  .......| ++.|+|||...+.. ..+..|+||.|+++..+++|..||+......    ...........
T Consensus       173 t~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~----~~~~~~~~~~~  248 (601)
T KOG0590|consen  173 TAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD----GRYSSWKSNKG  248 (601)
T ss_pred             ccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc----ccceeeccccc
Confidence            87765 22  22345567 99999999988854 4678999999999999999999987332221    11111111111


Q ss_pred             CCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 039137          867 PYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVS  902 (912)
Q Consensus       867 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl  902 (912)
                      ......+........+++.+++..+|..|.+.+++.
T Consensus       249 ~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  249 RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             ccccCccccCChhhhhcccccccCCchhcccccccc
Confidence            100111223334566788899999999999988764

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.54  E-value=6.6e-14  Score=135.22  Aligned_cols=135  Identities=19%  Similarity=0.252  Sum_probs=113.7

Q ss_pred             CCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCC--CccccEEEEEEcCCeeeEEEee
Q 039137          642 AEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH--RNIVKFYGFCSHPKHSFIIYEY  719 (912)
Q Consensus       642 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~  719 (912)
                      +.+.||+|.++.||+++..+ ..+++|.......      ...+.+|+..++.++|  ..+++++++....+..+++|||
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~   74 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK------GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW   74 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence            45789999999999999844 7899999764432      3567899999999976  5899999998888899999999


Q ss_pred             cCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccc
Q 039137          720 LESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKF  793 (912)
Q Consensus       720 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  793 (912)
                      ++++.+..+          +......++.+++++++++|....++++|+|++|+||+++..+.+++.|||.++.
T Consensus        75 ~~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          75 IEGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             cCCeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            998766543          4566778899999999999996434799999999999999989999999998874

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.52  E-value=1.2e-13  Score=143.08  Aligned_cols=140  Identities=15%  Similarity=0.253  Sum_probs=107.2

Q ss_pred             Cceee-ecCceEEEEEEeCCCCEEEEEEccCCCC------C---CchHHHHHHHHHHHHHhhcCCCcc--ccEEEEEEcC
Q 039137          643 EHCIG-KGGHGSVYRAKVPSGEIFAVKKFHSPLP------G---EMSFQQEEFLNEIQALTEIRHRNI--VKFYGFCSHP  710 (912)
Q Consensus       643 ~~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~---~~~~~~~~~~~Ei~~l~~l~h~ni--v~l~~~~~~~  710 (912)
                      ...|| .|+.|+||.++. .+..+++|.+.....      .   ........+.+|++++..++|+++  ++.+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            45687 899999999987 477899998854211      0   011244678899999999998775  6777765432


Q ss_pred             C----eeeEEEeecCC-CChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEE
Q 039137          711 K----HSFIIYEYLES-GSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHV  785 (912)
Q Consensus       711 ~----~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  785 (912)
                      .    ..++|||++++ .+|.+++..    ..++..    .+.+++.++++||++   ||+||||||+||+++.++.+++
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~L  183 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWL  183 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEE
Confidence            2    23599999997 689888743    234433    367899999999999   9999999999999999999999


Q ss_pred             ecccccccc
Q 039137          786 SDFGIAKFL  794 (912)
Q Consensus       786 ~Dfgla~~~  794 (912)
                      +|||.++..
T Consensus       184 IDfg~~~~~  192 (239)
T PRK01723        184 IDFDRGELR  192 (239)
T ss_pred             EECCCcccC
Confidence            999988753

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.45  E-value=2.6e-15  Score=161.41  Aligned_cols=172  Identities=31%  Similarity=0.443  Sum_probs=83.0

Q ss_pred             CccEEEccCCcccccCCccccCCCCCcEEeccccccccccccccccccccceeecccccccCCCCccccCcccccEEEcc
Q 039137          110 HLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALD  189 (912)
Q Consensus       110 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~  189 (912)
                      .....||+.|++. .+|..+..+..|+.|.|.+|.+. .||..+..|..|++|||+.|+++ .+|..+..|+ |+.|-++
T Consensus        76 dt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~s  151 (722)
T KOG0532|consen   76 DTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVS  151 (722)
T ss_pred             chhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEe
Confidence            3344455555554 44555555555555555555553 45555555555555555555554 4455444444 4555555


Q ss_pred             CCcCCCCCCccCCCCccceeeeeccCCCcCccccccccccccceeecccccccCccccccccccccceeeeccccCcccC
Q 039137          190 SNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGII  269 (912)
Q Consensus       190 ~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  269 (912)
                      +|+++ .+|..++.+..|.+|+.+.|.+. .+|..++++.+|+.|.+..|++. .+|..+..| .|..||++.|+++ .+
T Consensus       152 NNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~i  226 (722)
T KOG0532|consen  152 NNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-YL  226 (722)
T ss_pred             cCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-ec
Confidence            55544 44444444444555555554444 34444444444444444444444 333334422 2444444444444 34


Q ss_pred             CcccCCccccchhhhccCccC
Q 039137          270 PQEIGNLKKLNSLLLAKNHFR  290 (912)
Q Consensus       270 ~~~l~~l~~L~~L~L~~N~l~  290 (912)
                      |-.|.+|+.|++|.|.+|.+.
T Consensus       227 Pv~fr~m~~Lq~l~LenNPLq  247 (722)
T KOG0532|consen  227 PVDFRKMRHLQVLQLENNPLQ  247 (722)
T ss_pred             chhhhhhhhheeeeeccCCCC
Confidence            444444444444444444444

>PLN03150 hypothetical protein; Provisional

Probab=99.44  E-value=2e-13  Score=160.98  Aligned_cols=117  Identities=29%  Similarity=0.479  Sum_probs=69.5

Q ss_pred             ccEEEecccccccccchhhhcccccceeeccccccCcccccccccccccccccccCccccCCCcccccccccceEEEccC
Q 039137          447 LYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISY  526 (912)
Q Consensus       447 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~ls~  526 (912)
                      ++.|+|++|.+++.+|..+..+++|+.|+|++|.|.+.+|..++.+++|+.|+|++|++++.+|..+..+++|+.|+|++
T Consensus       420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~  499 (623)
T PLN03150        420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG  499 (623)
T ss_pred             EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence            55666666666666666666666666666666666666666666666666666666666666666666666666666666


Q ss_pred             CccccCCCCCcc--CCCCchhhhccCCcccCCcCCCCccc
Q 039137          527 NKLEGQIPNSTT--FRDAPLEALQGNKGLYGDIRGFPSCM  564 (912)
Q Consensus       527 N~l~~~~~~~~~--~~~~~~~~l~~n~~~~~~~~~~~~c~  564 (912)
                      |++.|.+|....  +.......+.+|+.+||.+ +.+.|.
T Consensus       500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p-~l~~C~  538 (623)
T PLN03150        500 NSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP-GLRACG  538 (623)
T ss_pred             CcccccCChHHhhccccCceEEecCCccccCCC-CCCCCc
Confidence            666666664321  1111223456677777643 234564

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.42  E-value=2.4e-13  Score=153.61  Aligned_cols=175  Identities=37%  Similarity=0.474  Sum_probs=86.0

Q ss_pred             ccccEEEccCCcCCCCCCccCCCCc-cceeeeeccCCCcCccccccccccccceeecccccccCccccccccccccceee
Q 039137          181 TVLNQLALDSNFLNGSIPRSLGNLT-HVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLF  259 (912)
Q Consensus       181 ~~L~~L~l~~n~l~~~~p~~~~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~  259 (912)
                      +.++.|++.+|.++ .+|.....++ +|++|++++|++. .+|..++.+++|+.|+++.|+++ .+|...+.+++|+.|+
T Consensus       116 ~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~  192 (394)
T COG4886         116 TNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLD  192 (394)
T ss_pred             cceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhhee
Confidence            44444444444444 3444444442 4555555555544 33344555555555555555555 3343333555566666


Q ss_pred             eccccCcccCCcccCCccccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCcc
Q 039137          260 LYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFG  339 (912)
Q Consensus       260 L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  339 (912)
                      +++|+++ .+|........|++|.+++|.+. ..+..+.++.++..|.+.+|++.. .+..++.+++++.|++++|.++.
T Consensus       193 ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~-~~~~~~~l~~l~~L~~s~n~i~~  269 (394)
T COG4886         193 LSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED-LPESIGNLSNLETLDLSNNQISS  269 (394)
T ss_pred             ccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeee-ccchhccccccceeccccccccc
Confidence            6666665 34443334444666666666432 344445555555555555555542 13444455555555555555543


Q ss_pred             cccccCCCCCCCCEEeccCCcccc
Q 039137          340 EILSDWGRCPQLSLLDVSINNISG  363 (912)
Q Consensus       340 ~~~~~~~~l~~L~~L~Ls~N~l~~  363 (912)
                      ...  ++.+.+++.|++++|.+..
T Consensus       270 i~~--~~~~~~l~~L~~s~n~~~~  291 (394)
T COG4886         270 ISS--LGSLTNLRELDLSGNSLSN  291 (394)
T ss_pred             ccc--ccccCccCEEeccCccccc
Confidence            222  4444444444444444443

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.42  E-value=9.5e-15  Score=157.17  Aligned_cols=192  Identities=30%  Similarity=0.460  Sum_probs=160.0

Q ss_pred             EEccCCcccccCC--ccccCCCCCcEEeccccccccccccccccccccceeecccccccCCCCccccCcccccEEEccCC
Q 039137          114 LDLYNNELFGIIP--PQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSN  191 (912)
Q Consensus       114 L~L~~n~l~~~~p--~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n  191 (912)
                      |.|++-.+. ..|  ..=-.|+--...||+.|++. ++|..+..+-.|+.|.|..|.+. .+|..+.+|..|.+|+|+.|
T Consensus        55 l~Ls~rrlk-~fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~N  131 (722)
T KOG0532|consen   55 LLLSGRRLK-EFPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSN  131 (722)
T ss_pred             cccccchhh-cCCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccc
Confidence            445555544 222  11245666678999999997 89999999999999999999998 89999999999999999999


Q ss_pred             cCCCCCCccCCCCccceeeeeccCCCcCccccccccccccceeecccccccCccccccccccccceeeeccccCcccCCc
Q 039137          192 FLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQ  271 (912)
Q Consensus       192 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~  271 (912)
                      +++ .+|..+..|+ |+.|-+++|+++ .+|+.++-+..|..|+.+.|++. .+|..++.+.+|+.|.+..|++. .+|.
T Consensus       132 qlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~  206 (722)
T KOG0532|consen  132 QLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPE  206 (722)
T ss_pred             hhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCH
Confidence            998 7888888775 888999999997 78888888889999999999988 67888888999999999999888 4677


Q ss_pred             ccCCccccchhhhccCccCCCCccccccccccceEecccccccC
Q 039137          272 EIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTG  315 (912)
Q Consensus       272 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~  315 (912)
                      .++.| .|..||++.|++. .+|-.|.+|+.|++|.|.+|.+.+
T Consensus       207 El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqS  248 (722)
T KOG0532|consen  207 ELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQS  248 (722)
T ss_pred             HHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCC
Confidence            77755 4888899999988 788889999999999999998884

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.42  E-value=4.5e-12  Score=142.91  Aligned_cols=145  Identities=18%  Similarity=0.242  Sum_probs=101.7

Q ss_pred             CceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchH------------------------------------HHHHHH
Q 039137          643 EHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSF------------------------------------QQEEFL  686 (912)
Q Consensus       643 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~------------------------------------~~~~~~  686 (912)
                      .+.||.|++|.||+|+.++|+.||||+.+.........                                    ..-.|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            36899999999999999999999999987543211000                                    001255


Q ss_pred             HHHHHHhhcC-----CCccccEEEEEEcCCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHH-HHHHHHhC
Q 039137          687 NEIQALTEIR-----HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVAD-ALFYLHNN  760 (912)
Q Consensus       687 ~Ei~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~-~L~~LH~~  760 (912)
                      +|+..+.+++     +++|.-..-+.......++||||++|+++.++......  ..   ...+++.+++. .+..+|..
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~  276 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRD  276 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhC
Confidence            5666666652     33322111222233457999999999999887632211  11   24556677666 47889998


Q ss_pred             CCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       761 ~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                         |++|+|++|.||+++.+++++++|||++..+.
T Consensus       277 ---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       277 ---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             ---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence               99999999999999999999999999997653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.41  E-value=2.3e-13  Score=153.83  Aligned_cols=200  Identities=33%  Similarity=0.431  Sum_probs=129.1

Q ss_pred             EEeccccccccccccccccccccceeecccccccCCCCccccCcc-cccEEEccCCcCCCCCCccCCCCccceeeeeccC
Q 039137          137 YLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLT-VLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNN  215 (912)
Q Consensus       137 ~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~-~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n  215 (912)
                      .|+++.|.+. ..+..+..++.++.|++.+|.++ .+|...+.++ +|++|++++|++. .+|..++.+++|+.|++++|
T Consensus        97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N  173 (394)
T COG4886          97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN  173 (394)
T ss_pred             eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence            4566666553 22233444566666666666666 5666666663 6666666666665 55556666666777777776


Q ss_pred             CCcCccccccccccccceeecccccccCccccccccccccceeeeccccCcccCCcccCCccccchhhhccCccCCCCcc
Q 039137          216 SFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPK  295 (912)
Q Consensus       216 ~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~  295 (912)
                      +++ .+|...+.+++|+.|++++|+++ .+|.....+..|++|.+++|.+. ..+..+.++.++..|.+.+|++. ..+.
T Consensus       174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~  249 (394)
T COG4886         174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPE  249 (394)
T ss_pred             hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccc
Confidence            666 45555556667777777777776 45555455556777777777533 34566677777777777777776 3356


Q ss_pred             ccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCcccccccC
Q 039137          296 SFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDW  345 (912)
Q Consensus       296 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~  345 (912)
                      .+..+++++.|++++|.++....  ++.+.+++.|++++|.+....+...
T Consensus       250 ~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~  297 (394)
T COG4886         250 SIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLIA  297 (394)
T ss_pred             hhccccccceecccccccccccc--ccccCccCEEeccCccccccchhhh
Confidence            67777778888888887775444  7777788888888887766555443

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.38  E-value=6.3e-13  Score=146.65  Aligned_cols=249  Identities=25%  Similarity=0.283  Sum_probs=185.3

Q ss_pred             cCCCCCceeee--cCceEEEEEEe--C-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcC-CCccccEEEEEEcCC
Q 039137          638 NDFNAEHCIGK--GGHGSVYRAKV--P-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR-HRNIVKFYGFCSHPK  711 (912)
Q Consensus       638 ~~~~~~~~lg~--G~~g~Vy~~~~--~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~  711 (912)
                      ..+.+.+.+|.  |.+|.||.+..  . ++..+|+|+-+.+.....  ....=.+|+...+.++ |++.++.+..+...+
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~--~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~  191 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPL--DSKRKLREFLSHHKIDSHENPVRDSPAWEGSG  191 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCcc--ccccccchhhcccccCccccccccCcccccCC
Confidence            45677788999  99999999976  3 788899998666554322  2333357888888885 999999999999999


Q ss_pred             eeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHH----HHHHHHhCCCCCeeecCCCCCCeEEcCC-CcEEEe
Q 039137          712 HSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVAD----ALFYLHNNCFPPIVHRDISSKNVLLDLG-YEAHVS  786 (912)
Q Consensus       712 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~----~L~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~  786 (912)
                      ..++-+|++. .++.++.+..  ...++...++.+..+...    |+.++|+.   +++|-|+||.||+...+ ...+++
T Consensus       192 ~lfiqtE~~~-~sl~~~~~~~--~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~  265 (524)
T KOG0601|consen  192 ILFIQTELCG-ESLQSYCHTP--CNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLT  265 (524)
T ss_pred             cceeeecccc-chhHHhhhcc--cccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecC
Confidence            9999999986 5777776432  233667778888888888    99999999   99999999999999999 889999


Q ss_pred             ccccccccCCCCCCcc-----ccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhh
Q 039137          787 DFGIAKFLNPDSSNWS-----ELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEM  861 (912)
Q Consensus       787 Dfgla~~~~~~~~~~~-----~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~  861 (912)
                      |||+...+.+..-...     ...|...|++||...+ .++.++|+|++|.+..+..++.++...-      ....+. .
T Consensus       266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g------~~~~W~-~  337 (524)
T KOG0601|consen  266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVG------KNSSWS-Q  337 (524)
T ss_pred             CcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCC------CCCCcc-c
Confidence            9999988766542222     2267788999998665 4889999999999999999887764210      000111 1


Q ss_pred             ccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          862 LDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       862 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .+... .+.........++...+..|++.+|..|++++.+..
T Consensus       338 ~r~~~-ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  338 LRQGY-IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             ccccc-CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            11111 222233333445556888999999999999887764

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.34  E-value=1.3e-11  Score=137.24  Aligned_cols=166  Identities=17%  Similarity=0.252  Sum_probs=129.3

Q ss_pred             CCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEEeecCCCChhhHhhccCCcccCC
Q 039137          660 PSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELG  739 (912)
Q Consensus       660 ~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~  739 (912)
                      .++.+|.|..+.....    ...+...+-++.++.+|||+|+++++.++..+..|+|+|.+.  .|..++.+      ++
T Consensus        35 ~~~~~vsVF~~~~~~~----~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~  102 (690)
T KOG1243|consen   35 ADGGPVSVFVYKRSNG----EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LG  102 (690)
T ss_pred             ccCCceEEEEEeCCCc----hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hH
Confidence            3788888888765433    235566788999999999999999999999999999999874  67777733      33


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCCCccccccccccccccccccC
Q 039137          740 WTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTL  819 (912)
Q Consensus       740 ~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~  819 (912)
                      ...+...++||+.||-|||+.+  +++|+++....|++++.|..||++|.++.....-.........-..|..|+.+...
T Consensus       103 ~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s  180 (690)
T KOG1243|consen  103 KEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPS  180 (690)
T ss_pred             HHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCcc
Confidence            5667778999999999999776  99999999999999999999999999887554333222223333456777754322


Q ss_pred             CCCcchhHHHHHHHHHHHHhCC
Q 039137          820 KVTEKCDVYSFGVLALEVIKGK  841 (912)
Q Consensus       820 ~~~~~sDvwslG~vl~elltg~  841 (912)
                      .  -..|.|.||+++||++.|.
T Consensus       181 ~--~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  181 E--WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             c--cchhhhhHHHHHHHHhCcc
Confidence            2  3569999999999999993

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.31  E-value=1e-11  Score=141.30  Aligned_cols=148  Identities=15%  Similarity=0.173  Sum_probs=96.6

Q ss_pred             hcCCCCCceeeecCceEEEEEEeCC-CCEEEEEEccCCCCCC--------------------------ch----HHHH--
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVPS-GEIFAVKKFHSPLPGE--------------------------MS----FQQE--  683 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~--------------------------~~----~~~~--  683 (912)
                      -.+|+. +.||.|++|.||+|+.++ |+.||||+.++.....                          ..    ...+  
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            345776 789999999999999987 9999999997653110                          00    0111  


Q ss_pred             ----HHHHHHHHHhhcC----CCccccEEEEEE-cCCeeeEEEeecCCCChhhHh--hccC-CcccCCHHHHHHHHHHHH
Q 039137          684 ----EFLNEIQALTEIR----HRNIVKFYGFCS-HPKHSFIIYEYLESGSLDKIL--CNDA-SAKELGWTQRLNVIKGVA  751 (912)
Q Consensus       684 ----~~~~Ei~~l~~l~----h~niv~l~~~~~-~~~~~~lv~e~~~~g~L~~~l--~~~~-~~~~l~~~~~~~i~~~i~  751 (912)
                          ++.+|+..+.+++    +...+.+=.++. .....++||||++|+.+.++-  .... ....+....+..++.|+.
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif  277 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF  277 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence                2444555555542    333333323332 245678999999999998753  1111 111233333344444443


Q ss_pred             HHHHHHHhCCCCCeeecCCCCCCeEEcCCC----cEEEeccccccccC
Q 039137          752 DALFYLHNNCFPPIVHRDISSKNVLLDLGY----EAHVSDFGIAKFLN  795 (912)
Q Consensus       752 ~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~Dfgla~~~~  795 (912)
                             ..   |++|+|+||.||+++.++    ++++.|||++..+.
T Consensus       278 -------~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        278 -------RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             -------hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence                   45   999999999999999888    99999999998653

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.31  E-value=2.4e-12  Score=130.02  Aligned_cols=200  Identities=24%  Similarity=0.344  Sum_probs=138.7

Q ss_pred             HHHhhcCCCccccEEEEEEcCC-----eeeEEEeecCCCChhhHhhccC-CcccCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 039137          690 QALTEIRHRNIVKFYGFCSHPK-----HSFIIYEYLESGSLDKILCNDA-SAKELGWTQRLNVIKGVADALFYLHNNCFP  763 (912)
Q Consensus       690 ~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~  763 (912)
                      ..+-.+-|.|+|+++.||.+.+     ...++.|||..|++..++++.+ ....+......+|+-||..||.|||+. .|
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~P  197 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CC
Confidence            3455557999999999996543     4688999999999999996644 344577888899999999999999996 67


Q ss_pred             CeeecCCCCCCeEEcCCCcEEEeccccccccCCCC----CCccccccccccccccccccCCCCcchhHHHHHHHHHHHHh
Q 039137          764 PIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS----SNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK  839 (912)
Q Consensus       764 ~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt  839 (912)
                      +|+|+++..+-|++..+|-+|++----......-.    .......+-++|.|||+-.....+.++|||+||....||.-
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai  277 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI  277 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence            99999999999999999888875211111100000    00112345789999998877778889999999999999987


Q ss_pred             CCCCccchhccccccccchhh--hccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          840 GKHPRDFLFEMSSSSSNMNIE--MLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       840 g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      +..--.      ........+  .....+....       ..-..++.+|++..|..||+|++++.
T Consensus       278 lEiq~t------nseS~~~~ee~ia~~i~~len-------~lqr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  278 LEIQST------NSESKVEVEENIANVIIGLEN-------GLQRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             heeccC------CCcceeehhhhhhhheeeccC-------ccccCcCcccccCCCCCCcchhhhhc
Confidence            765411      000111000  0000111100       01135677999999999999998764

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.21  E-value=2e-13  Score=139.36  Aligned_cols=226  Identities=22%  Similarity=0.308  Sum_probs=122.4

Q ss_pred             cCCCCCccEEEccCCcccc----cCCccccCCCCCcEEecccc---cccccccccc-------ccccccceeeccccccc
Q 039137          105 FSSFPHLVYLDLYNNELFG----IIPPQISNLSNLEYLDFSAN---KLFGQIPSGI-------GLLTHLTVLHISRNWLS  170 (912)
Q Consensus       105 ~~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~Ls~n---~l~~~~p~~~-------~~l~~L~~L~L~~n~l~  170 (912)
                      ...+..+++++|++|.+..    .+.+.+.+.++|+..++|+-   ++..++|+.+       -..++|++||||+|-+.
T Consensus        26 ~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G  105 (382)
T KOG1909|consen   26 LEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFG  105 (382)
T ss_pred             hcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccC
Confidence            3455667777777777642    24455667777777777753   2333455432       22345555555555554


Q ss_pred             CCCCccccCcccccEEEccCCcCCCCCCccCCCCccceeeeeccCCCcCccccccccc-cccceeecccccccCcccccc
Q 039137          171 GSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNL-KSLFDLELCINQLSGAIPLSI  249 (912)
Q Consensus       171 ~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l-~~L~~L~l~~n~l~~~~p~~~  249 (912)
                      -.-+..|+                    .-+.+++.|++|+|.||.+.   |..=+.+ ..|..|.  .|+..       
T Consensus       106 ~~g~~~l~--------------------~ll~s~~~L~eL~L~N~Glg---~~ag~~l~~al~~l~--~~kk~-------  153 (382)
T KOG1909|consen  106 PKGIRGLE--------------------ELLSSCTDLEELYLNNCGLG---PEAGGRLGRALFELA--VNKKA-------  153 (382)
T ss_pred             ccchHHHH--------------------HHHHhccCHHHHhhhcCCCC---hhHHHHHHHHHHHHH--HHhcc-------
Confidence            32222221                    12344667777777777664   2211111 1233333  22221       


Q ss_pred             ccccccceeeeccccCcccC----CcccCCccccchhhhccCccCC----CCccccccccccceEecccccccCC----C
Q 039137          250 SNLTNLRFLFLYHNELSGII----PQEIGNLKKLNSLLLAKNHFRG----TVPKSFRNLTDLVKLRLNQNYLTGN----I  317 (912)
Q Consensus       250 ~~l~~L~~L~L~~N~l~~~~----~~~l~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~n~l~~~----~  317 (912)
                      ..-+.|+++..++|++..-.    ...|...+.|+.+.+..|.|..    .+...|..+++|+.|||.+|.++..    +
T Consensus       154 ~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~L  233 (382)
T KOG1909|consen  154 ASKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVAL  233 (382)
T ss_pred             CCCcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHH
Confidence            23356888888888876322    2335556677777777777652    1223456677777777777776632    3


Q ss_pred             CcccCCCCCccEEEccCCcCcccccccC-----CCCCCCCEEeccCCccc
Q 039137          318 SETFGTYPNLTFIDLSNNSFFGEILSDW-----GRCPQLSLLDVSINNIS  362 (912)
Q Consensus       318 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~-----~~l~~L~~L~Ls~N~l~  362 (912)
                      ..++..+++|++|++++|.+.......+     ...|+|+.|.+.+|.|+
T Consensus       234 akaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt  283 (382)
T KOG1909|consen  234 AKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEIT  283 (382)
T ss_pred             HHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhH
Confidence            3455666677777777776654433222     12455555555555554

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.21  E-value=6.7e-11  Score=116.64  Aligned_cols=131  Identities=21%  Similarity=0.188  Sum_probs=96.5

Q ss_pred             CceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCcc-ccEEEEEEcCCeeeEEEeecC
Q 039137          643 EHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNI-VKFYGFCSHPKHSFIIYEYLE  721 (912)
Q Consensus       643 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~  721 (912)
                      .+.++.|.++.||+++.. ++.|++|.......     ....+.+|+..++.+.+.++ .+++.+.  ....++||||++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-----~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~   74 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-----LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIE   74 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-----cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecC
Confidence            367899999999999874 77899998754321     12235689999999865554 4455443  334689999999


Q ss_pred             CCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--CCCeeecCCCCCCeEEcCCCcEEEeccccccc
Q 039137          722 SGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNC--FPPIVHRDISSKNVLLDLGYEAHVSDFGIAKF  793 (912)
Q Consensus       722 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  793 (912)
                      +.++.+..           .....++.+++++++.||+..  ..+++|+|++|.||+++ ++.++++|||.+..
T Consensus        75 G~~l~~~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          75 GSELLTED-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             CCcccccc-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            98775431           111345689999999999982  12259999999999999 66899999998864

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.21  E-value=4.1e-13  Score=137.20  Aligned_cols=211  Identities=22%  Similarity=0.282  Sum_probs=105.9

Q ss_pred             ccccCCCCCcEEeccccccccc----cccccccccccceeecccccccC----CCCccccCcccccEEEccCCcCCCCCC
Q 039137          127 PQISNLSNLEYLDFSANKLFGQ----IPSGIGLLTHLTVLHISRNWLSG----SIPHEVGQLTVLNQLALDSNFLNGSIP  198 (912)
Q Consensus       127 ~~~~~l~~L~~L~Ls~n~l~~~----~p~~~~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~l~~n~l~~~~p  198 (912)
                      +.+..+..+++|+||+|.+...    +-+.+.+.++|+..++|+= ++|    .+|+.+..                 +.
T Consensus        24 ~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~-ftGR~~~Ei~e~L~~-----------------l~   85 (382)
T KOG1909|consen   24 EELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDM-FTGRLKDEIPEALKM-----------------LS   85 (382)
T ss_pred             HHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhh-hcCCcHHHHHHHHHH-----------------HH
Confidence            4567788899999999998543    4455666778888877752 333    23332211                 11


Q ss_pred             ccCCCCccceeeeeccCCCcCccccccccccccceeecccccccCccccccccccccceeeeccccCcccCCcccCCccc
Q 039137          199 RSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKK  278 (912)
Q Consensus       199 ~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~  278 (912)
                      +.+...++|++|+||+|-|....+..|..                    -+.+++.|++|+|.+|.+.-.--..++  ..
T Consensus        86 ~aL~~~~~L~~ldLSDNA~G~~g~~~l~~--------------------ll~s~~~L~eL~L~N~Glg~~ag~~l~--~a  143 (382)
T KOG1909|consen   86 KALLGCPKLQKLDLSDNAFGPKGIRGLEE--------------------LLSSCTDLEELYLNNCGLGPEAGGRLG--RA  143 (382)
T ss_pred             HHHhcCCceeEeeccccccCccchHHHHH--------------------HHHhccCHHHHhhhcCCCChhHHHHHH--HH
Confidence            33445556777777777665433333321                    133455666666666655421111122  12


Q ss_pred             cchhhhccCccCCCCccccccccccceEecccccccCC----CCcccCCCCCccEEEccCCcCcccc----cccCCCCCC
Q 039137          279 LNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGN----ISETFGTYPNLTFIDLSNNSFFGEI----LSDWGRCPQ  350 (912)
Q Consensus       279 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~  350 (912)
                      |..|.  .|+..       ..-++|+++...+|++...    +...|...+.|+.+.++.|.+....    ...+..+++
T Consensus       144 l~~l~--~~kk~-------~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~  214 (382)
T KOG1909|consen  144 LFELA--VNKKA-------ASKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPH  214 (382)
T ss_pred             HHHHH--HHhcc-------CCCcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCc
Confidence            33333  22111       1224566666666665432    2234455566666666666653222    123444555


Q ss_pred             CCEEeccCCccccc----ccccccccccccEEEccCcccc
Q 039137          351 LSLLDVSINNISGS----IPLEIGESLQLQYLDLSSNYIV  386 (912)
Q Consensus       351 L~~L~Ls~N~l~~~----~~~~~~~~~~L~~L~L~~N~l~  386 (912)
                      |+.|||.+|-++..    +...+...++|++|++++|.+.
T Consensus       215 LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~  254 (382)
T KOG1909|consen  215 LEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLE  254 (382)
T ss_pred             ceeeecccchhhhHHHHHHHHHhcccchheeecccccccc
Confidence            55555555555421    1222333344555555555444

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=99.20  E-value=1.2e-11  Score=148.77  Aligned_cols=204  Identities=25%  Similarity=0.294  Sum_probs=127.8

Q ss_pred             CCCCCccEEEccCCcccccCCccccCCCCCcEEeccccc--cccccccccccccccceeecccccccCCCCccccCcccc
Q 039137          106 SSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANK--LFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVL  183 (912)
Q Consensus       106 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~--l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L  183 (912)
                      .+....+...+.+|.+. .++..... ++|+.|-+..|.  +....++.|..++.|++|||++|.=-+.+|.++++|-+|
T Consensus       520 ~~~~~~rr~s~~~~~~~-~~~~~~~~-~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~L  597 (889)
T KOG4658|consen  520 KSWNSVRRMSLMNNKIE-HIAGSSEN-PKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHL  597 (889)
T ss_pred             cchhheeEEEEeccchh-hccCCCCC-CccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhh
Confidence            34456677777777765 33433332 368888888886  442333446778888888888887667888888888888


Q ss_pred             cEEEccCCcCCCCCCccCCCCccceeeeeccCCCcCccccccccccccceeecccccc--cCccccccccccccceeeec
Q 039137          184 NQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQL--SGAIPLSISNLTNLRFLFLY  261 (912)
Q Consensus       184 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l--~~~~p~~~~~l~~L~~L~L~  261 (912)
                      ++|+|++..++ .+|.++++|+.|.+|++..+.....+|.....|++|++|.+.....  +...-..+.++.+|+.|...
T Consensus       598 ryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~  676 (889)
T KOG4658|consen  598 RYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSIT  676 (889)
T ss_pred             hcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheee
Confidence            88888888887 7888888888888888888776666677777788888888765542  22222334445555555543


Q ss_pred             cccCcccCCcccCCccccc----hhhhccCccCCCCccccccccccceEecccccccC
Q 039137          262 HNELSGIIPQEIGNLKKLN----SLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTG  315 (912)
Q Consensus       262 ~N~l~~~~~~~l~~l~~L~----~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~  315 (912)
                      ....  .+-..+..++.|.    .+.+.++... ..+..+..+.+|+.|.+.++.+..
T Consensus       677 ~~s~--~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e  731 (889)
T KOG4658|consen  677 ISSV--LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISE  731 (889)
T ss_pred             cchh--HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCch
Confidence            3222  1112223333333    2232222222 344455666667777776666653

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.19  E-value=3.9e-12  Score=126.64  Aligned_cols=132  Identities=27%  Similarity=0.286  Sum_probs=87.2

Q ss_pred             cccccEEEccCCcccCCCccccccccccccccccCcccCccccccccccccccEEEecccccccccchhhhcccccceee
Q 039137          396 IIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELD  475 (912)
Q Consensus       396 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  475 (912)
                      -..|++++|++|.|+ .+.+...-++.++.|++|+|.|..+  +.+..+++|+.||||+|.++ .+..+-..+.+++.|.
T Consensus       283 Wq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~  358 (490)
T KOG1259|consen  283 WQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLK  358 (490)
T ss_pred             Hhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeee
Confidence            345666777777666 4555555666777777777777653  33666777777777777775 4555566667777777


Q ss_pred             ccccccCcccccccccccccccccccCccccCCCc-ccccccccceEEEccCCccccCC
Q 039137          476 LSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIP-RCFEEMHGLLHIDISYNKLEGQI  533 (912)
Q Consensus       476 Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p-~~~~~l~~L~~l~ls~N~l~~~~  533 (912)
                      |++|.|...  ..+..+-+|..||+++|+|..... ..++++|.|.++.+.+|++.+.+
T Consensus       359 La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v  415 (490)
T KOG1259|consen  359 LAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV  415 (490)
T ss_pred             hhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence            777776322  345566677777777777765432 45677777777878888777644

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.18  E-value=3.9e-12  Score=133.48  Aligned_cols=88  Identities=25%  Similarity=0.201  Sum_probs=47.3

Q ss_pred             ccccccceeeeccccCcccCC--cccCCccccchhhhccCccCCCC--ccccccccccceEecccccccCCCCcc-cCCC
Q 039137          250 SNLTNLRFLFLYHNELSGIIP--QEIGNLKKLNSLLLAKNHFRGTV--PKSFRNLTDLVKLRLNQNYLTGNISET-FGTY  324 (912)
Q Consensus       250 ~~l~~L~~L~L~~N~l~~~~~--~~l~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~L~~n~l~~~~~~~-~~~l  324 (912)
                      +++.+|+...|.+.... .++  .....+++++.|||++|-+....  -.....+++|+.|+|+.|++.....+. -..+
T Consensus       118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l  196 (505)
T KOG3207|consen  118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL  196 (505)
T ss_pred             hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence            45667777777777665 233  24556677777777777665321  123345666666666666655322211 1233


Q ss_pred             CCccEEEccCCcCc
Q 039137          325 PNLTFIDLSNNSFF  338 (912)
Q Consensus       325 ~~L~~L~Ls~N~l~  338 (912)
                      +.|+.|.|+.|.++
T Consensus       197 ~~lK~L~l~~CGls  210 (505)
T KOG3207|consen  197 SHLKQLVLNSCGLS  210 (505)
T ss_pred             hhhheEEeccCCCC
Confidence            44555555555443

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.17  E-value=4.7e-10  Score=110.75  Aligned_cols=141  Identities=18%  Similarity=0.205  Sum_probs=101.9

Q ss_pred             CceeeecCceEEEEEEeCC-------CCEEEEEEccCCCCC----------Cch--------HHHHHH----HHHHHHHh
Q 039137          643 EHCIGKGGHGSVYRAKVPS-------GEIFAVKKFHSPLPG----------EMS--------FQQEEF----LNEIQALT  693 (912)
Q Consensus       643 ~~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~----------~~~--------~~~~~~----~~Ei~~l~  693 (912)
                      ...||.|--+.||.|...+       +..+|||+++.....          +..        ...+.+    .+|+..|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4679999999999997543       478999987643221          100        012223    38999999


Q ss_pred             hcCC--CccccEEEEEEcCCeeeEEEeecCCCChhh-HhhccCCcccCCHHHHHHHHHHHHHHHHHH-HhCCCCCeeecC
Q 039137          694 EIRH--RNIVKFYGFCSHPKHSFIIYEYLESGSLDK-ILCNDASAKELGWTQRLNVIKGVADALFYL-HNNCFPPIVHRD  769 (912)
Q Consensus       694 ~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH~D  769 (912)
                      ++..  -+++.++++    ...++||||+.++.+.. .++.    ..++.++...+..+++.++..+ |..   ++||||
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGD  150 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHAD  150 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence            9953  567777765    46789999998753321 2211    1244566778889999999999 788   999999


Q ss_pred             CCCCCeEEcCCCcEEEeccccccccC
Q 039137          770 ISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       770 lk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      +++.||+++ ++.+.++|||-+....
T Consensus       151 Ls~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         151 LSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             CCHHHEEEE-CCcEEEEECCCceeCC
Confidence            999999997 4689999999887654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.17  E-value=9.9e-10  Score=115.16  Aligned_cols=256  Identities=17%  Similarity=0.229  Sum_probs=165.7

Q ss_pred             CCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEE-------EcCC
Q 039137          640 FNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFC-------SHPK  711 (912)
Q Consensus       640 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~-------~~~~  711 (912)
                      ...++.||+|+.+.+|-.-  +-...+.|+++.+....    +.   +.++.|... .||-+-.-+.|=       ....
T Consensus        13 i~~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~----~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~   83 (637)
T COG4248          13 IPPGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAA----QA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGK   83 (637)
T ss_pred             cCCCccccCCccceeeecc--hhhchhheeecCCCchH----HH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccc
Confidence            3456889999999999653  22234568887664432    11   233444444 566543312211       1122


Q ss_pred             eeeEEEeecCCC-ChhhHh---hccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEec
Q 039137          712 HSFIIYEYLESG-SLDKIL---CNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSD  787 (912)
Q Consensus       712 ~~~lv~e~~~~g-~L~~~l---~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  787 (912)
                      ...+.|+.+++- .+.++.   .++.......|...++.++.+|.+.+.||++   |.+-+|+.++|+|+.+++.|++.|
T Consensus        84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVd  160 (637)
T COG4248          84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVD  160 (637)
T ss_pred             eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEc
Confidence            367788887663 233333   3344556689999999999999999999999   999999999999999999999998


Q ss_pred             cccccccCCCCCCccccccccccccccccc-----cCCCCcchhHHHHHHHHHHHHhC-CCCccchhccccccccchhhh
Q 039137          788 FGIAKFLNPDSSNWSELAGTHGYVAPELAY-----TLKVTEKCDVYSFGVLALEVIKG-KHPRDFLFEMSSSSSNMNIEM  861 (912)
Q Consensus       788 fgla~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltg-~~pf~~~~~~~~~~~~~~~~~  861 (912)
                      -..-... ..+......+|.+.|++||.-.     +..-+...|-|.+|+++++++.| ++||................+
T Consensus       161 sDsfqi~-~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~I  239 (637)
T COG4248         161 SDSFQIN-ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDI  239 (637)
T ss_pred             ccceeec-cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhh
Confidence            6543322 3345556778999999999543     34456789999999999999985 999975433222211111000


Q ss_pred             -----------ccCCCCCC-ChhhHHHHHHHHHHHHHcccC--CCCCCCCHHHHHHHHHHh
Q 039137          862 -----------LDSRLPYP-SLHVQKKLMSIMQVAFSCLDQ--NPESRPTMKRVSQLLCEK  908 (912)
Q Consensus       862 -----------~~~~~~~~-~~~~~~~~~~l~~li~~cl~~--dP~~RPt~~evl~~L~~~  908 (912)
                                 -.+..+.| .....-..+++..+..+|+..  .|.-|||++.++..|.+.
T Consensus       240 a~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al  300 (637)
T COG4248         240 AHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL  300 (637)
T ss_pred             hcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence                       11111111 112222344566667788765  356899999998887654

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.14  E-value=2.1e-11  Score=117.89  Aligned_cols=124  Identities=33%  Similarity=0.404  Sum_probs=40.3

Q ss_pred             cccccEEEccCCcccCCCccccc-cccccccccccCcccCccccccccccccccEEEecccccccccchhh-hcccccce
Q 039137          396 IIYLNRLSLSGNKLSGCIPRELG-SLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIEL-DNLIHLSE  473 (912)
Q Consensus       396 l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~  473 (912)
                      ...+++|+|.+|+|+. + +.++ .+.+|+.|||++|.|+.+  +.+..++.|+.|++++|+|+.. ...+ ..+++|++
T Consensus        18 ~~~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i-~~~l~~~lp~L~~   92 (175)
T PF14580_consen   18 PVKLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSI-SEGLDKNLPNLQE   92 (175)
T ss_dssp             --------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S--CHHHHHH-TT--E
T ss_pred             cccccccccccccccc-c-cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCcc-ccchHHhCCcCCE
Confidence            3345566666666652 2 2333 355666666777766654  2466667777777777777643 3233 35677777


Q ss_pred             eeccccccCccc-ccccccccccccccccCccccCCCc---ccccccccceEEEc
Q 039137          474 LDLSHNFLGEKI-SSRICRMESLEKLNLSYNNLSGLIP---RCFEEMHGLLHIDI  524 (912)
Q Consensus       474 L~Ls~N~l~~~~-~~~~~~l~~L~~L~ls~N~l~~~~p---~~~~~l~~L~~l~l  524 (912)
                      |+|++|+|.+.. -..+..+++|+.|+|.+|+++...-   ..+..+|+|+.||-
T Consensus        93 L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~  147 (175)
T PF14580_consen   93 LYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG  147 (175)
T ss_dssp             EE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred             EECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence            777777775432 2345566777777777777764421   23556777777653

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.14  E-value=3.5e-11  Score=133.07  Aligned_cols=248  Identities=20%  Similarity=0.222  Sum_probs=180.5

Q ss_pred             HhcCCCCCceeeecCceEEEEEEe--CCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEEcCCe
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKV--PSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSHPKH  712 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~  712 (912)
                      ...+|..+..||.|.|+.|++...  .++..|++|..........  ....-..|+.+...+ .|.+++++...|...+.
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~--~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~  340 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFA--SDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ  340 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchH--hhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence            345788899999999999999853  3688899999887665432  233345788888888 49999999988888888


Q ss_pred             eeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCC-CcEEEeccccc
Q 039137          713 SFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLG-YEAHVSDFGIA  791 (912)
Q Consensus       713 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~Dfgla  791 (912)
                      .|+--||+.+++.....   .....+++...+++..|++.++.++|+.   .++|+|++|+||++..+ +..+++|||++
T Consensus       341 ~~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~  414 (524)
T KOG0601|consen  341 GYIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCW  414 (524)
T ss_pred             ccCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccc
Confidence            89999999999887665   3345577888999999999999999999   99999999999999886 78899999998


Q ss_pred             cccCCCCCCcccccccccc-ccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCC
Q 039137          792 KFLNPDSSNWSELAGTHGY-VAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPS  870 (912)
Q Consensus       792 ~~~~~~~~~~~~~~g~~~y-~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  870 (912)
                      ..+.....  .....+..| .+|+......+..++|++|||.-+.|.++|..--.    .    ......+.....+-.+
T Consensus       415 t~~~~~~~--~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~----~----~~~~~~i~~~~~p~~~  484 (524)
T KOG0601|consen  415 TRLAFSSG--VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE----S----GVQSLTIRSGDTPNLP  484 (524)
T ss_pred             cccceecc--cccccccccccchhhccccccccccccccccccccccccCcccCc----c----cccceeeecccccCCC
Confidence            74322111  111223334 35666667778899999999999999998765311    0    1111111222222221


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 039137          871 LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL  905 (912)
Q Consensus       871 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  905 (912)
                      .    ....+..+...+...|+..||.+.++....
T Consensus       485 ~----~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~  515 (524)
T KOG0601|consen  485 G----LKLQLQVLLKVMINPDRKRRPSAVELSLHS  515 (524)
T ss_pred             c----hHHhhhhhhhhhcCCccccchhhhhhcccc
Confidence            1    113355666778999999999998876543

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.13  E-value=5.1e-12  Score=142.91  Aligned_cols=85  Identities=40%  Similarity=0.407  Sum_probs=43.5

Q ss_pred             ccEEEccCCcccCCCccccccccccccccccCcccCccccccccccccccEEEecccccccc---cchh-hhccccccee
Q 039137          399 LNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQ---IPIE-LDNLIHLSEL  474 (912)
Q Consensus       399 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~---~~~~-~~~l~~L~~L  474 (912)
                      |+.+++++|++. ..+..+..+..+..|++.+|++...  ..+...+.+..+.++.|++...   .... ....+.++.+
T Consensus       234 L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (414)
T KOG0531|consen  234 LRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTL  310 (414)
T ss_pred             HHHHhcccCccc-cccccccccccccccchhhcccccc--ccccccchHHHhccCcchhcchhhhhcccccccccccccc
Confidence            444455555444 2223444555566666666665543  2344445555566666655421   1111 3455667777


Q ss_pred             eccccccCcccc
Q 039137          475 DLSHNFLGEKIS  486 (912)
Q Consensus       475 ~Ls~N~l~~~~~  486 (912)
                      ++..|.+....+
T Consensus       311 ~~~~~~~~~~~~  322 (414)
T KOG0531|consen  311 TLELNPIRKISS  322 (414)
T ss_pred             ccccCccccccc
Confidence            777777655443

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.13  E-value=1e-11  Score=140.55  Aligned_cols=243  Identities=29%  Similarity=0.311  Sum_probs=123.2

Q ss_pred             CccccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCcccccccCCCCCCCCEE
Q 039137          275 NLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLL  354 (912)
Q Consensus       275 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  354 (912)
                      .+..++.++++.|.+.. +-..+..+++|+.|++.+|+|... ...+..+++|++|+|++|.|+...  .+..++.|+.|
T Consensus        70 ~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L  145 (414)
T KOG0531|consen   70 SLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKEL  145 (414)
T ss_pred             HhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhc-ccchhhhhcchheecccccccccc--chhhccchhhh
Confidence            34445555555555542 223344555555566666555532 111445555666666666554322  23344445555


Q ss_pred             eccCCcccccccccccccccccEEEccCccccCCCC-ccccccccccEEEccCCcccCCCccccccccccccccccCccc
Q 039137          355 DVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIP-TQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNL  433 (912)
Q Consensus       355 ~Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~-~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  433 (912)
                      ++++|.|+..  ..+..+..|+.+++++|++....+ . ...+.+++.+.+.+|.+..  ...+..+..+..+++..|.+
T Consensus       146 ~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~--i~~~~~~~~l~~~~l~~n~i  220 (414)
T KOG0531|consen  146 NLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE--IEGLDLLKKLVLLSLLDNKI  220 (414)
T ss_pred             eeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhc--ccchHHHHHHHHhhcccccc
Confidence            5555555422  223335566666666666653322 1 3555666666666666652  22334444555556666666


Q ss_pred             Ccccccccccccc--ccEEEecccccccccchhhhcccccceeeccccccCcccccccccccccccccccCccccCC---
Q 039137          434 SNFVPESLGSLVK--LYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGL---  508 (912)
Q Consensus       434 ~~~~~~~~~~l~~--L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~---  508 (912)
                      +.+-+  +..+..  |+.+++++|++. ..+..+..+..+..|++++|++...  ..+.....+..+.+..|.+...   
T Consensus       221 ~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  295 (414)
T KOG0531|consen  221 SKLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLALSEAI  295 (414)
T ss_pred             eeccC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccc--ccccccchHHHhccCcchhcchhhh
Confidence            54322  222222  666666666665 2334555566666666666666433  2234445555666666665422   


Q ss_pred             Cccc-ccccccceEEEccCCcccc
Q 039137          509 IPRC-FEEMHGLLHIDISYNKLEG  531 (912)
Q Consensus       509 ~p~~-~~~l~~L~~l~ls~N~l~~  531 (912)
                      .... ....+.+..+.+.+|+...
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~  319 (414)
T KOG0531|consen  296 SQEYITSAAPTLVTLTLELNPIRK  319 (414)
T ss_pred             hccccccccccccccccccCcccc
Confidence            1111 3344555555555555544

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.11  E-value=1.1e-11  Score=130.12  Aligned_cols=64  Identities=23%  Similarity=0.319  Sum_probs=38.0

Q ss_pred             CCccccchhhhccCccCCCCc--cccccccccceEecccccccCCCC--cccCCCCCccEEEccCCcCc
Q 039137          274 GNLKKLNSLLLAKNHFRGTVP--KSFRNLTDLVKLRLNQNYLTGNIS--ETFGTYPNLTFIDLSNNSFF  338 (912)
Q Consensus       274 ~~l~~L~~L~L~~N~l~~~~~--~~~~~l~~L~~L~L~~n~l~~~~~--~~~~~l~~L~~L~Ls~N~l~  338 (912)
                      .++++|+...|.+..+. ..+  .....+++++.|||+.|-+....+  .....+|+|+.|+|+.|++.
T Consensus       118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~  185 (505)
T KOG3207|consen  118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLS  185 (505)
T ss_pred             hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhccccccccc
Confidence            35667777777777765 222  245556677777777776654222  33455666666666666653

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.10  E-value=1.2e-11  Score=123.15  Aligned_cols=132  Identities=24%  Similarity=0.269  Sum_probs=63.1

Q ss_pred             cCCCCccceeeeeccCCCcCccccccccccccceeecccccccCccccccccccccceeeeccccCcccCCcccCCcccc
Q 039137          200 SLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKL  279 (912)
Q Consensus       200 ~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L  279 (912)
                      .+.....|++|||++|.++ .+.+++.-++.++.|++++|.+.. + ..+..+++|+.||||+|.++. +..+=..+.++
T Consensus       279 ~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~-v-~nLa~L~~L~~LDLS~N~Ls~-~~Gwh~KLGNI  354 (490)
T KOG1259|consen  279 SADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRT-V-QNLAELPQLQLLDLSGNLLAE-CVGWHLKLGNI  354 (490)
T ss_pred             ecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceee-e-hhhhhcccceEeecccchhHh-hhhhHhhhcCE
Confidence            3344445555555555554 344444444555555555555541 1 224555555555555555552 23333344455


Q ss_pred             chhhhccCccCCCCccccccccccceEecccccccCCC-CcccCCCCCccEEEccCCcC
Q 039137          280 NSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNI-SETFGTYPNLTFIDLSNNSF  337 (912)
Q Consensus       280 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~Ls~N~l  337 (912)
                      ++|.|++|.+...  ..+.++-+|..||+++|+|.... ...++++|.|+.+.|.+|.+
T Consensus       355 KtL~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl  411 (490)
T KOG1259|consen  355 KTLKLAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPL  411 (490)
T ss_pred             eeeehhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCc
Confidence            5555555555421  23444555555555555554321 13344444444444444444

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=99.09  E-value=3.9e-11  Score=144.36  Aligned_cols=267  Identities=25%  Similarity=0.279  Sum_probs=171.2

Q ss_pred             CCCccEEEccCCc--ccccCCccccCCCCCcEEeccccccccccccccccccccceeecccccccCCCCccccCcccccE
Q 039137          108 FPHLVYLDLYNNE--LFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQ  185 (912)
Q Consensus       108 l~~L~~L~L~~n~--l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~  185 (912)
                      .+.|+.|=+..|.  +....+..|..++.|++||||+|.=-+++|+.++.|-+||+|+|+++.++ .+|..+++|+.|.+
T Consensus       544 ~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~  622 (889)
T KOG4658|consen  544 NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIY  622 (889)
T ss_pred             CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhhe
Confidence            3468888888886  44333445888999999999998766799999999999999999999999 99999999999999


Q ss_pred             EEccCCcCCCCCCccCCCCccceeeeeccCC--CcCccccccccccccceeecccccccCccccccccccccc----eee
Q 039137          186 LALDSNFLNGSIPRSLGNLTHVVILYLYNNS--FFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLR----FLF  259 (912)
Q Consensus       186 L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~--l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~----~L~  259 (912)
                      |++..+.-...+|..+..|.+|++|.+..-.  .....-..+.++.+|+.+.......  .+-..+..++.|.    .+.
T Consensus       623 Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~--~~~e~l~~~~~L~~~~~~l~  700 (889)
T KOG4658|consen  623 LNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSV--LLLEDLLGMTRLRSLLQSLS  700 (889)
T ss_pred             eccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchh--HhHhhhhhhHHHHHHhHhhh
Confidence            9999988776777777889999999997654  2223334556666666666644333  1112233344443    333


Q ss_pred             eccccCcccCCcccCCccccchhhhccCccCCCCcccccc------ccccceEecccccccCCCCcccCCCCCccEEEcc
Q 039137          260 LYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRN------LTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLS  333 (912)
Q Consensus       260 L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~------l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls  333 (912)
                      +..+... ..+..+..+.+|+.|.+.++.+.......+..      ++++..+...++..- ..+......++|+.|++.
T Consensus       701 ~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~~~~-r~l~~~~f~~~L~~l~l~  778 (889)
T KOG4658|consen  701 IEGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSILNCHML-RDLTWLLFAPHLTSLSLV  778 (889)
T ss_pred             hcccccc-eeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhhccccc-cccchhhccCcccEEEEe
Confidence            3333333 45567788889999999888886433322221      122222222222211 111222344677777777


Q ss_pred             CCcCcccccccCCCCCCCCEEeccCCccccc-ccccccccccccEEE
Q 039137          334 NNSFFGEILSDWGRCPQLSLLDVSINNISGS-IPLEIGESLQLQYLD  379 (912)
Q Consensus       334 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~~~~L~~L~  379 (912)
                      .+.....+.+....+..+..+.+..+.+.+. .-...++++++..+.
T Consensus       779 ~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l~~~~~l~~l~~i~~~~  825 (889)
T KOG4658|consen  779 SCRLLEDIIPKLKALLELKELILPFNKLEGLRMLCSLGGLPQLYWLP  825 (889)
T ss_pred             cccccccCCCHHHHhhhcccEEecccccccceeeecCCCCceeEecc
Confidence            7777666666666666666555555555544 233334444444333

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.06  E-value=6.7e-11  Score=114.33  Aligned_cols=122  Identities=35%  Similarity=0.376  Sum_probs=33.7

Q ss_pred             cccEEEccCccccCCCCcccc-ccccccEEEccCCcccCCCccccccccccccccccCcccCccccccc-cccccccEEE
Q 039137          374 QLQYLDLSSNYIVGEIPTQLG-NIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESL-GSLVKLYYLN  451 (912)
Q Consensus       374 ~L~~L~L~~N~l~~~~~~~l~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~  451 (912)
                      ++++|+|++|+|+. + +.++ .+.+|+.|+|++|.|+. ++ .+..++.|+.|++++|+|+.+.+ .+ ..+++|++|+
T Consensus        20 ~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~~i~~-~l~~~lp~L~~L~   94 (175)
T PF14580_consen   20 KLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRISSISE-GLDKNLPNLQELY   94 (175)
T ss_dssp             ------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S-CH-HHHHH-TT--EEE
T ss_pred             cccccccccccccc-c-cchhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCCcccc-chHHhCCcCCEEE
Confidence            34555555555542 1 1233 34455555555555552 21 34445555555555555554322 22 2355555666


Q ss_pred             ecccccccc-cchhhhcccccceeeccccccCccc---ccccccccccccccc
Q 039137          452 LSHNKLSQQ-IPIELDNLIHLSELDLSHNFLGEKI---SSRICRMESLEKLNL  500 (912)
Q Consensus       452 Ls~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~---~~~~~~l~~L~~L~l  500 (912)
                      |++|+|... .-..+..+++|+.|+|.+|+++...   ...+..+|+|+.||-
T Consensus        95 L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~  147 (175)
T PF14580_consen   95 LSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG  147 (175)
T ss_dssp             -TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred             CcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence            666555432 1133455566666666666664321   123455666666653

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.05  E-value=2.5e-09  Score=101.28  Aligned_cols=135  Identities=24%  Similarity=0.369  Sum_probs=103.7

Q ss_pred             ceeeecCceEEEEEEeCCCCEEEEEE-ccCCCCCC---chHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEEee
Q 039137          644 HCIGKGGHGSVYRAKVPSGEIFAVKK-FHSPLPGE---MSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEY  719 (912)
Q Consensus       644 ~~lg~G~~g~Vy~~~~~~~~~vavK~-~~~~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  719 (912)
                      ..+++|+-+.+|.+.+. |..+++|. +.+.....   .....++-.+|+.++.+++--.|....=+..+++...++|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            35789999999999774 43445553 22222211   122345678899999999877777777778888899999999


Q ss_pred             cCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccc
Q 039137          720 LESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKF  793 (912)
Q Consensus       720 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  793 (912)
                      .+|..|.+.+...          ...++..+-.-+.-||..   +|+|+|+.++||.+..++ +.++|||++.+
T Consensus        81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999999888332          245677777888899999   999999999999999775 99999999974

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.02  E-value=3.7e-09  Score=99.35  Aligned_cols=147  Identities=18%  Similarity=0.253  Sum_probs=109.3

Q ss_pred             CCceeeecCceEEEEEEeCCCCEEEEEEc-cCCCCC---CchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEE
Q 039137          642 AEHCIGKGGHGSVYRAKVPSGEIFAVKKF-HSPLPG---EMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIY  717 (912)
Q Consensus       642 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~-~~~~~~---~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  717 (912)
                      ....+-+|+-+.|+++.+ .|+.+.||.- .+....   +......+.++|+..+.+++--.|.-..-++.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            567899999999999988 6777777642 221111   11223467789999999987666666666777777788999


Q ss_pred             eecCC-CChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCc---EEEeccccccc
Q 039137          718 EYLES-GSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYE---AHVSDFGIAKF  793 (912)
Q Consensus       718 e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~Dfgla~~  793 (912)
                      ||++| .++.+++...-.... ..+.....+..|-+.+.-||..   +|+||||..+||++..++.   +.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~-~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDES-EDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcc-cchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence            99987 577888754433222 2223367889999999999999   9999999999999976653   58999999864

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.02  E-value=2.8e-09  Score=110.21  Aligned_cols=143  Identities=21%  Similarity=0.275  Sum_probs=110.9

Q ss_pred             ceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCC--CccccEEEEEEcC---CeeeEEEe
Q 039137          644 HCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH--RNIVKFYGFCSHP---KHSFIIYE  718 (912)
Q Consensus       644 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h--~niv~l~~~~~~~---~~~~lv~e  718 (912)
                      +.++.|.++.||+++..+|+.+++|........   .....+.+|+++++.+++  ..+.+++.+....   +..++|||
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~---~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL---PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccC---cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence            578999999999998877789999997644321   123467789999999975  4467788877654   36789999


Q ss_pred             ecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 039137          719 YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNC-------------------------------------  761 (912)
Q Consensus       719 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-------------------------------------  761 (912)
                      |++|.++.+.+..    ..++..+...++.++++++++||+..                                     
T Consensus        81 ~i~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (223)
T cd05154          81 RVDGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA  156 (223)
T ss_pred             EeCCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence            9999888776521    34677788888899999999998531                                     


Q ss_pred             ----------------CCCeeecCCCCCCeEEcC--CCcEEEeccccccc
Q 039137          762 ----------------FPPIVHRDISSKNVLLDL--GYEAHVSDFGIAKF  793 (912)
Q Consensus       762 ----------------~~~ivH~Dlk~~Nill~~--~~~~kl~Dfgla~~  793 (912)
                                      ...++|+|+++.||+++.  ++.+.++||+.+..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                            135799999999999998  66789999998864

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []

Probab=99.00  E-value=3.5e-10  Score=82.08  Aligned_cols=42  Identities=38%  Similarity=0.847  Sum_probs=31.0

Q ss_pred             HHHHHHHHHHHHhcccCCcccCCCcccCCCCCCCCCCCccceeEec
Q 039137           36 AEEAHALVKWKASLEVHSRSLLHSWSLSSVNATKISPCAWSGIFCN   81 (912)
Q Consensus        36 ~~~~~all~~k~~~~~~~~~~l~~w~~~~~~~~~~~~C~w~gv~c~   81 (912)
                      ++|++||++||+++..+|.+.+.+|+.+.    ..+||.|.||+|+
T Consensus         2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~----~~~~C~W~GV~Cd   43 (43)
T PF08263_consen    2 NQDRQALLAFKKSLNNDPSGVLSSWNPSS----DSDPCSWSGVTCD   43 (43)
T ss_dssp             HHHHHHHHHHHHCTT-SC-CCCTT--TT------S-CCCSTTEEE-
T ss_pred             cHHHHHHHHHHHhcccccCcccccCCCcC----CCCCeeeccEEeC
Confidence            57999999999999877888999997542    3689999999996

LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.93  E-value=2.2e-10  Score=132.79  Aligned_cols=252  Identities=21%  Similarity=0.240  Sum_probs=171.8

Q ss_pred             HHhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCee
Q 039137          635 SATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHS  713 (912)
Q Consensus       635 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  713 (912)
                      ...+.+.+.+.+.+|+++.++.++-. .|...++|....... ....+.+...++-.+.-..++|-+++..--+......
T Consensus       801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~-i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~  879 (1205)
T KOG0606|consen  801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPK-IRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL  879 (1205)
T ss_pred             CCCccceecccccCCCCcccccCCccccccccchhhhccchh-hccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence            34567777888999999999988643 444444443321100 0000122222333333333456666554444455678


Q ss_pred             eEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccc
Q 039137          714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKF  793 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  793 (912)
                      +++++|..++++...++...   ..+.+-++.....+..+.+|||+.   .+.|+|++|.|.+...++..++.|||....
T Consensus       880 ~L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~  953 (1205)
T KOG0606|consen  880 PLVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSK  953 (1205)
T ss_pred             chhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccc
Confidence            99999999999998885433   455566777888899999999998   899999999999999999999999984332


Q ss_pred             cCCC----------C---------------------CCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCC
Q 039137          794 LNPD----------S---------------------SNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKH  842 (912)
Q Consensus       794 ~~~~----------~---------------------~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~  842 (912)
                      ..-.          .                     .......+|+.|.+||...+......+|.|++|++++|.++|.+
T Consensus       954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen  954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred             cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence            2100          0                     00123468999999999999999999999999999999999999


Q ss_pred             CccchhccccccccchhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHH
Q 039137          843 PRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMK  899 (912)
Q Consensus       843 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~  899 (912)
                      ||....     .+.....+.....+.+. ..........+++...+..+|.+|-.+.
T Consensus      1034 p~na~t-----pq~~f~ni~~~~~~~p~-g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1034 PFNAET-----PQQIFENILNRDIPWPE-GPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCCcc-----hhhhhhccccCCCCCCC-CccccChhhhhhhhhhhccCchhccCcc
Confidence            986322     22333444444444432 2233345577888888999999997765

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.92  E-value=3e-08  Score=107.16  Aligned_cols=223  Identities=15%  Similarity=0.245  Sum_probs=157.4

Q ss_pred             CceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEc----CCeeeEEEeecCC-C
Q 039137          650 GHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSH----PKHSFIIYEYLES-G  723 (912)
Q Consensus       650 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~-g  723 (912)
                      -..+.|++... ||..|+.|+++.......    ..-..-+++++++.|+|||++.+++..    +...++||+|.++ +
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~----nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~  363 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQST----NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSP  363 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCc----ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence            34678999765 899999999954433221    112346889999999999999999863    4568999999887 5


Q ss_pred             ChhhHhhcc------------CCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccc
Q 039137          724 SLDKILCND------------ASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIA  791 (912)
Q Consensus       724 ~L~~~l~~~------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla  791 (912)
                      +|.++....            ......++..+|.++.|+..||.++|+.   |...+-+.+.+|+++.+.+++|+..|..
T Consensus       364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~  440 (655)
T KOG3741|consen  364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIM  440 (655)
T ss_pred             hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccce
Confidence            776665322            1233477899999999999999999999   9999999999999999999999988888


Q ss_pred             cccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCCh
Q 039137          792 KFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSL  871 (912)
Q Consensus       792 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  871 (912)
                      .....+..            +|  +   .--.+-|.-.||.++..|.||..---        ......+...      ..
T Consensus       441 Dvl~~d~~------------~~--l---e~~Qq~D~~~lG~ll~aLAt~~~ns~--------~~d~~~~s~~------~~  489 (655)
T KOG3741|consen  441 DVLQEDPT------------EP--L---ESQQQNDLRDLGLLLLALATGTENSN--------RTDSTQSSHL------TR  489 (655)
T ss_pred             eeecCCCC------------cc--h---hHHhhhhHHHHHHHHHHHhhcccccc--------cccchHHHHH------HH
Confidence            76655431            00  1   12346799999999999999865410        0001111000      00


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 039137          872 HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE  911 (912)
Q Consensus       872 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~~  911 (912)
                      ....++.++.+++.......+++ -++.+++.++-+.+|.
T Consensus       490 I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~~~~ff~  528 (655)
T KOG3741|consen  490 ITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMIGSRFFT  528 (655)
T ss_pred             hhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHHHHHHHH
Confidence            12344556777777777777776 6788888777666553

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.82  E-value=4.3e-08  Score=96.61  Aligned_cols=130  Identities=27%  Similarity=0.371  Sum_probs=86.7

Q ss_pred             EEEEEEeCCCCEEEEEEccCCCCC----------------------CchHHHHHHHHHHHHHhhcCCC--ccccEEEEEE
Q 039137          653 SVYRAKVPSGEIFAVKKFHSPLPG----------------------EMSFQQEEFLNEIQALTEIRHR--NIVKFYGFCS  708 (912)
Q Consensus       653 ~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~~~~~Ei~~l~~l~h~--niv~l~~~~~  708 (912)
                      .||.|...+|..+|+|..+.....                      ..........+|.+.|.++..-  ++++++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            489999889999999987653221                      1112234577899999999755  566676553 


Q ss_pred             cCCeeeEEEeecC--CCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHH-HHhCCCCCeeecCCCCCCeEEcCCCcEEE
Q 039137          709 HPKHSFIIYEYLE--SGSLDKILCNDASAKELGWTQRLNVIKGVADALFY-LHNNCFPPIVHRDISSKNVLLDLGYEAHV  785 (912)
Q Consensus       709 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~-LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  785 (912)
                         ..++||||++  |..+..+....     ++......++.+++..+.. +|..   ||+|||+.+.||+++++ .+.+
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEE
Confidence               4579999998  65554443111     1235567788888886666 5677   99999999999999988 9999


Q ss_pred             eccccccccC
Q 039137          786 SDFGIAKFLN  795 (912)
Q Consensus       786 ~Dfgla~~~~  795 (912)
                      +|||.+....
T Consensus       148 IDf~qav~~~  157 (188)
T PF01163_consen  148 IDFGQAVDSS  157 (188)
T ss_dssp             --GTTEEETT
T ss_pred             EecCcceecC
Confidence            9999887543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.81  E-value=3.2e-09  Score=84.38  Aligned_cols=58  Identities=45%  Similarity=0.568  Sum_probs=26.5

Q ss_pred             cccccccCcccCccccccccccccccEEEecccccccccchhhhcccccceeeccccc
Q 039137          423 LEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNF  480 (912)
Q Consensus       423 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  480 (912)
                      |++|++++|+|+.+.+..|..+++|++|++++|+++...|..|.++++|++|++++|+
T Consensus         3 L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~   60 (61)
T PF13855_consen    3 LESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN   60 (61)
T ss_dssp             ESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred             CcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence            4444444444444444444444444444444444444444444444444444444443

...

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.79  E-value=4e-09  Score=83.80  Aligned_cols=59  Identities=39%  Similarity=0.461  Sum_probs=29.7

Q ss_pred             cccEEEecccccccccchhhhcccccceeeccccccCcccccccccccccccccccCcc
Q 039137          446 KLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNN  504 (912)
Q Consensus       446 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~  504 (912)
                      +|++|++++|+|+...+..|.++++|++|++++|.|+...+..|..+++|+.|++++|+
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~   60 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN   60 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence            44555555555554444455555555555555555544444444555555555554444

...

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.79  E-value=8.5e-08  Score=100.45  Aligned_cols=145  Identities=22%  Similarity=0.195  Sum_probs=102.5

Q ss_pred             ceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCc-------hHHHHHHHHHHHHHhhcCCCc--cccEEEEEEc-----
Q 039137          644 HCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEM-------SFQQEEFLNEIQALTEIRHRN--IVKFYGFCSH-----  709 (912)
Q Consensus       644 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~~~~Ei~~l~~l~h~n--iv~l~~~~~~-----  709 (912)
                      +.+-......|+++.. +|+.|.||..........       ..-...+.+|...+..+...+  ++..+++.+.     
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            4455445555777766 778899997743221000       000114779999999885433  3445666543     


Q ss_pred             CCeeeEEEeecCCC-ChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcC-------CC
Q 039137          710 PKHSFIIYEYLESG-SLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDL-------GY  781 (912)
Q Consensus       710 ~~~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-------~~  781 (912)
                      ....++|||++++. +|.+++.... ..+.+......++.+++..++-||..   ||+|+|+++.||+++.       +.
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~  182 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDL  182 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCc
Confidence            23578999999986 8999874321 23455677889999999999999999   9999999999999985       46


Q ss_pred             cEEEeccccccc
Q 039137          782 EAHVSDFGIAKF  793 (912)
Q Consensus       782 ~~kl~Dfgla~~  793 (912)
                      .+.++||+.+..
T Consensus       183 ~~~LIDl~r~~~  194 (268)
T PRK15123        183 KLSVIDLHRAQI  194 (268)
T ss_pred             eEEEEECCcccc
Confidence            799999998864

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.71  E-value=7.9e-10  Score=122.68  Aligned_cols=180  Identities=28%  Similarity=0.225  Sum_probs=105.4

Q ss_pred             cccCCCCCCCCEEeccCCccccccccccccc-ccccEEEccCcccc----------CCCCccccccccccEEEccCCccc
Q 039137          342 LSDWGRCPQLSLLDVSINNISGSIPLEIGES-LQLQYLDLSSNYIV----------GEIPTQLGNIIYLNRLSLSGNKLS  410 (912)
Q Consensus       342 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~-~~L~~L~L~~N~l~----------~~~~~~l~~l~~L~~L~L~~N~l~  410 (912)
                      |..+..+.+|+.|.+.++.|...  ..+..+ .+|+.|.. +|.+.          |.+...+. -..|...+.++|++.
T Consensus       102 pi~ifpF~sLr~LElrg~~L~~~--~GL~~lr~qLe~LIC-~~Sl~Al~~v~ascggd~~ns~~-Wn~L~~a~fsyN~L~  177 (1096)
T KOG1859|consen  102 PISIFPFRSLRVLELRGCDLSTA--KGLQELRHQLEKLIC-HNSLDALRHVFASCGGDISNSPV-WNKLATASFSYNRLV  177 (1096)
T ss_pred             CceeccccceeeEEecCcchhhh--hhhHHHHHhhhhhhh-hccHHHHHHHHHHhccccccchh-hhhHhhhhcchhhHH
Confidence            55677889999999999998631  111111 13443322 22221          11111111 124566667777776


Q ss_pred             CCCccccccccccccccccCcccCccccccccccccccEEEecccccccccchhhhcccccceeeccccccCcccccccc
Q 039137          411 GCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRIC  490 (912)
Q Consensus       411 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  490 (912)
                       .+...+.-++.|+.|||++|+++..  +.+..+++|++|||+.|.+....--...++. |..|.|++|.++..  ..+.
T Consensus       178 -~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN~l~tL--~gie  251 (1096)
T KOG1859|consen  178 -LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNNALTTL--RGIE  251 (1096)
T ss_pred             -hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhhh-heeeeecccHHHhh--hhHH
Confidence             5556666677777777777777664  3666777777777777777532222222333 77777777777543  3456


Q ss_pred             cccccccccccCccccCCCc-ccccccccceEEEccCCcccc
Q 039137          491 RMESLEKLNLSYNNLSGLIP-RCFEEMHGLLHIDISYNKLEG  531 (912)
Q Consensus       491 ~l~~L~~L~ls~N~l~~~~p-~~~~~l~~L~~l~ls~N~l~~  531 (912)
                      +|.+|+.||+++|-|++-.. .-+..|..|+.|+|.||++.|
T Consensus       252 ~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c  293 (1096)
T KOG1859|consen  252 NLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC  293 (1096)
T ss_pred             hhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence            67777777777777765322 223445667777777777766

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.61  E-value=3.3e-07  Score=92.37  Aligned_cols=139  Identities=22%  Similarity=0.209  Sum_probs=100.3

Q ss_pred             CCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCC------------------CchHHHHHHHHHHHHHhhcCCC--c
Q 039137          640 FNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPG------------------EMSFQQEEFLNEIQALTEIRHR--N  699 (912)
Q Consensus       640 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~~~~~Ei~~l~~l~h~--n  699 (912)
                      +.++..||-|--+.||.|..++|.++|||.=+.....                  .....+....+|.+.|..|.-.  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            4567899999999999999999999999963321110                  0111234567899999999644  6


Q ss_pred             cccEEEEEEcCCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcC
Q 039137          700 IVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDL  779 (912)
Q Consensus       700 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~  779 (912)
                      |.+.+++-    .-.+||||++|-.|...-        ++.+....++..|+.-+..+-..   ||||+|+.+-||++++
T Consensus       173 VP~P~~~n----RHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~  237 (304)
T COG0478         173 VPKPIAWN----RHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTE  237 (304)
T ss_pred             CCCccccc----cceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEec
Confidence            77776553    457999999986664432        12344445555555555555556   9999999999999999


Q ss_pred             CCcEEEeccccccc
Q 039137          780 GYEAHVSDFGIAKF  793 (912)
Q Consensus       780 ~~~~kl~Dfgla~~  793 (912)
                      +|.+.++||--+..
T Consensus       238 dg~~~vIDwPQ~v~  251 (304)
T COG0478         238 DGDIVVIDWPQAVP  251 (304)
T ss_pred             CCCEEEEeCccccc
Confidence            99999999986654

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.60  E-value=1.9e-09  Score=119.76  Aligned_cols=129  Identities=34%  Similarity=0.317  Sum_probs=97.9

Q ss_pred             cccEEEccCccccCCCCccccccccccEEEccCCcccCCCccccccccccccccccCcccCccccccccccccccEEEec
Q 039137          374 QLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLS  453 (912)
Q Consensus       374 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  453 (912)
                      .|.+.+.++|.+. .+-.++.-++.|+.|+|++|+++...  .+..++.|++|||++|.++.++--....+ +|..|+|+
T Consensus       165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc-~L~~L~lr  240 (1096)
T KOG1859|consen  165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGC-KLQLLNLR  240 (1096)
T ss_pred             hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhh-hheeeeec
Confidence            4777888888887 56667777888899999999988543  78888899999999999986433333333 48999999


Q ss_pred             ccccccccchhhhcccccceeeccccccCccc-ccccccccccccccccCccccCC
Q 039137          454 HNKLSQQIPIELDNLIHLSELDLSHNFLGEKI-SSRICRMESLEKLNLSYNNLSGL  508 (912)
Q Consensus       454 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~ls~N~l~~~  508 (912)
                      +|-++.  -..+.+|++|+.||+++|-|.+.- -.-+..|..|+.|+|.+|++-..
T Consensus       241 nN~l~t--L~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~  294 (1096)
T KOG1859|consen  241 NNALTT--LRGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA  294 (1096)
T ss_pred             ccHHHh--hhhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence            998863  245778888999999999886542 23356778889999999988643

>PRK09902 hypothetical protein; Provisional

Probab=98.60  E-value=9e-07  Score=87.53  Aligned_cols=142  Identities=15%  Similarity=0.171  Sum_probs=104.2

Q ss_pred             eeecCceEEEEEEeCCCCEEEEEEccCCCCCC-c-hHHHHHHHHHHHHHhhcCC--CccccEEEEEE---cC--CeeeEE
Q 039137          646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGE-M-SFQQEEFLNEIQALTEIRH--RNIVKFYGFCS---HP--KHSFII  716 (912)
Q Consensus       646 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~-~~~~~~~~~Ei~~l~~l~h--~niv~l~~~~~---~~--~~~~lv  716 (912)
                      -|+|+.+-|++... +|+.|-+|.-....... . +.-...|.+|...++.+..  -.+.+.. ++.   .+  -..++|
T Consensus        26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            36689999999876 45578888865222111 0 2246789999999999952  2255555 332   11  246899


Q ss_pred             EeecCC-CChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCc--EEEeccccccc
Q 039137          717 YEYLES-GSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYE--AHVSDFGIAKF  793 (912)
Q Consensus       717 ~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~--~kl~Dfgla~~  793 (912)
                      +|.+++ -+|.+++... ...+.+..+...++.+++..++-||+.   |+.|+|+.+.||+++.++.  ++++||.-++.
T Consensus       104 Te~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            997764 5888887442 233567788889999999999999999   9999999999999986667  99999987764

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.58  E-value=1.7e-08  Score=113.35  Aligned_cols=149  Identities=21%  Similarity=0.325  Sum_probs=100.3

Q ss_pred             HHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCC----Ccc-----ccccccccccccccc
Q 039137          747 IKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSS----NWS-----ELAGTHGYVAPELAY  817 (912)
Q Consensus       747 ~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~----~~~-----~~~g~~~y~aPE~~~  817 (912)
                      +.+++.|+.|+|...  ++||++|.|++|+++.++.+|++.|+.+....+...    .+.     -......|.|||++.
T Consensus       105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            445669999999884  999999999999999999999999999876554211    111     122356799999999


Q ss_pred             cCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccC-CCCCCChhhHHHHHHHHHHHHHcccCCCCCC
Q 039137          818 TLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDS-RLPYPSLHVQKKLMSIMQVAFSCLDQNPESR  895 (912)
Q Consensus       818 ~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  895 (912)
                      +...+.++|+||+|+++|.+.. |+.-++.......  ........+. ...+.    ...+.++.+=+.+++..++.-|
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~--~~~~~~~~~~~~~~~s----~~~p~el~~~l~k~l~~~~~~r  256 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS--YSFSRNLLNAGAFGYS----NNLPSELRESLKKLLNGDSAVR  256 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCcch--hhhhhccccccccccc----ccCcHHHHHHHHHHhcCCcccC
Confidence            9888999999999999999985 4444321100000  0000000000 01111    2234456667778999999999


Q ss_pred             CCHHHHHH
Q 039137          896 PTMKRVSQ  903 (912)
Q Consensus       896 Pt~~evl~  903 (912)
                      |++.++..
T Consensus       257 p~~~~l~~  264 (700)
T KOG2137|consen  257 PTLDLLLS  264 (700)
T ss_pred             cchhhhhc
Confidence            98776654

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.51  E-value=3.6e-08  Score=98.88  Aligned_cols=82  Identities=23%  Similarity=0.266  Sum_probs=47.3

Q ss_pred             CCccccchhhhccCccCCCCccccccccccceEecccccccCCC-CcccCCCCCccEEEccCCcCccc-ccccCCCCCCC
Q 039137          274 GNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNI-SETFGTYPNLTFIDLSNNSFFGE-ILSDWGRCPQL  351 (912)
Q Consensus       274 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L  351 (912)
                      ..++.+..+.++-|++....       +++..+.+..|.+.... .+.+..+|.+..|+|+.|++..- ....+.++++|
T Consensus       179 h~~~c~~~~w~~~~~l~r~F-------pnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l  251 (418)
T KOG2982|consen  179 HQLPCLEQLWLNKNKLSRIF-------PNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQL  251 (418)
T ss_pred             hcCCcHHHHHHHHHhHHhhc-------ccchheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchh
Confidence            33455566666666665332       45566667777665432 23455666666777777776432 23345556666


Q ss_pred             CEEeccCCccc
Q 039137          352 SLLDVSINNIS  362 (912)
Q Consensus       352 ~~L~Ls~N~l~  362 (912)
                      .-|.+++|.+.
T Consensus       252 ~dlRv~~~Pl~  262 (418)
T KOG2982|consen  252 VDLRVSENPLS  262 (418)
T ss_pred             heeeccCCccc
Confidence            66666666654

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.50  E-value=1.7e-08  Score=101.22  Aligned_cols=112  Identities=21%  Similarity=0.230  Sum_probs=62.0

Q ss_pred             cccccccceeeeccccCcccCC-cccC-CccccchhhhccCccCC--CCccccccccccceEecccccccCCCCcccCCC
Q 039137          249 ISNLTNLRFLFLYHNELSGIIP-QEIG-NLKKLNSLLLAKNHFRG--TVPKSFRNLTDLVKLRLNQNYLTGNISETFGTY  324 (912)
Q Consensus       249 ~~~l~~L~~L~L~~N~l~~~~~-~~l~-~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l  324 (912)
                      +..+..++.|.+.++.|...-. ..|+ ..+.++.|||.+|.|+.  .+...+.+++.|+.|+|+.|++...+...-...
T Consensus        41 v~s~ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~  120 (418)
T KOG2982|consen   41 VSSLRALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPL  120 (418)
T ss_pred             eccccchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccc
Confidence            3334445555555555542211 1122 34567778888887773  333445677777777777777765443332445


Q ss_pred             CCccEEEccCCcCccccc-ccCCCCCCCCEEeccCCc
Q 039137          325 PNLTFIDLSNNSFFGEIL-SDWGRCPQLSLLDVSINN  360 (912)
Q Consensus       325 ~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~  360 (912)
                      .+|+.|-|.+..+.-... ..+..+|.++.|.+|.|.
T Consensus       121 ~nl~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~  157 (418)
T KOG2982|consen  121 KNLRVLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNS  157 (418)
T ss_pred             cceEEEEEcCCCCChhhhhhhhhcchhhhhhhhccch
Confidence            577777777766643222 223445555666665554

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.49  E-value=2.1e-06  Score=97.51  Aligned_cols=144  Identities=18%  Similarity=0.210  Sum_probs=95.4

Q ss_pred             ceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCch--------------------------H----------HHHHHHH
Q 039137          644 HCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMS--------------------------F----------QQEEFLN  687 (912)
Q Consensus       644 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~--------------------------~----------~~~~~~~  687 (912)
                      ..|+.++-|.||+|++++|+.||||+.++.......                          .          ..-.+.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            689999999999999999999999998866432100                          0          0012445


Q ss_pred             HHHHHhhcC-----CCccccEEEEEEcCCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHH-HHHHHhCC
Q 039137          688 EIQALTEIR-----HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADA-LFYLHNNC  761 (912)
Q Consensus       688 Ei~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~-L~~LH~~~  761 (912)
                      |...+.+++     .+.|.-..=|++.....+++|||++|-.+.+...-..  ...+..   .++..++++ +..+=.. 
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k---~ia~~~~~~f~~q~~~d-  284 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRK---ELAELLVRAFLRQLLRD-  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHH---HHHHHHHHHHHHHHHhc-
Confidence            555555552     3443333333444567789999999998888752222  223322   333333332 2222224 


Q ss_pred             CCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          762 FPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       762 ~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                        |++|+|.+|.||+++.+|++.+.|||+...+.
T Consensus       285 --gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         285 --GFFHADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             --CccccCCCccceEEecCCcEEEEcCcceecCC
Confidence              89999999999999999999999999987654

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	912
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		3e-43
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		5e-37
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		4e-43
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		7e-37
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		5e-38
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-37
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-29
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-29
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		7e-29
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		8e-29
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-28
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		4e-27
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		4e-26
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		4e-26
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		6e-22
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-21
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		4e-21
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-20
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-20
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-20
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-20
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-20
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-20
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		4e-20
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		4e-20
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-20
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		5e-20
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-20
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		5e-20
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		6e-20
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		6e-20
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-19
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-19
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-19
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-19
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-19
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		2e-19
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		4e-18
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		8e-19
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		9e-19
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-18
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-18
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-18
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-18
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-18
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-18
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-18
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-18
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-18
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-18
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-18
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-18
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-18
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-18
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-18
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		3e-18
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-18
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-18
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-18
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-18
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		4e-18
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		5e-18
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		5e-18
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		6e-18
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-18
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		7e-18
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		7e-18
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-18
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		8e-18
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		9e-18
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		9e-18
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-17
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-17
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-17
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-17
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-17
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-17
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-17
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-17
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-17
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-17
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-17
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-17
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-17
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-17
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-17
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		3e-17
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-17
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-17
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-17
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-17
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		3e-17
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-17
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		4e-17
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		4e-17
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		4e-17
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-17
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		4e-17
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		4e-17
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-17
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-17
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-17
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-17
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-17
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-17
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		4e-17
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		4e-17
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-17
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		5e-17
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		5e-17
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		6e-17
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		6e-17
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		6e-17
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		6e-17
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		6e-17
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		6e-17
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		6e-17
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		7e-17
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		7e-17
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		7e-17
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		7e-17
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		8e-17
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		8e-17
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		9e-17
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		9e-17
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-16
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-16
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-16
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-16
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-16
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-16
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-16
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-16
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-16
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-16
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-16
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-16
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-16
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-16
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-16
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		4e-16
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		5e-16
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		5e-16
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		5e-16
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		5e-16
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		5e-16
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		5e-16
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		8e-16
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-15
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-15
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-15
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-15
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-15
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-15
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-15
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-15
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-15
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-15
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-15
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-15
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-15
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-15
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-15
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-15
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-15
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-15
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-15
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		4e-15
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-15
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		6e-15
4h58_A	275	Braf In Complex With Compound 3 Length = 275		6e-15
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		6e-15
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		6e-15
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		7e-15
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		8e-15
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		9e-15
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		9e-15
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		9e-15
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		9e-15
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-14
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-14
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-14
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-14
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-14
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-14
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-14
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-14
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-14
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-14
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-14
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-14
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-14
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		4e-14
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		4e-14
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		5e-14
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		5e-14
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		5e-14
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		5e-14
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		6e-14
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-14
3a4o_X	286	Lyn Kinase Domain Length = 286		7e-14
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		7e-14
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		7e-14
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		7e-14
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		9e-14
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-13
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-13
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-13
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-13
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-13
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-13
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-13
2omv_A	461	Crystal Structure Of Inla S192n Y369s/hec1 Complex		1e-13
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-13
2omy_A	461	Crystal Structure Of Inla S192n/hec1 Complex Length		1e-13
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-13
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-13
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-13
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-13
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-13
2omz_A	466	Crystal Structure Of Inla Y369a/hec1 Complex Length		2e-13
1o6s_A	466	Internalin (Listeria Monocytogenes) E-Cadherin (Hum		2e-13
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-13
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-13
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-13
2omx_A	462	Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX		2e-13
2omu_A	462	Crystal Structure Of Inla G194s+s Y369s/hec1 Comple		3e-13
2omt_A	462	Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt		3e-13
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-13
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-13
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-13
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-13
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-13
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-13
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-13
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-13
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		3e-13
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		3e-13
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		4e-13
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		4e-13
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		4e-13
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		4e-13
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		4e-13
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		4e-13
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		4e-13
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		4e-13
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		5e-13
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		5e-13
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-13
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		5e-13
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		5e-13
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		6e-13
2pl0_A	289	Lck Bound To Imatinib Length = 289		6e-13
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		6e-13
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		6e-13
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		6e-13
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		6e-13
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		7e-13
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		7e-13
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		8e-13
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		8e-13
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		8e-13
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		8e-13
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		9e-13
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		9e-13
4fl3_A	635	Structural And Biophysical Characterization Of The		9e-13
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-13
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-12
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-12
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-12
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-12
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-12
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-12
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-12
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-12
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-12
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-12
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-12
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-12
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-12
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-12
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-12
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-12
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-12
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-12
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-12
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-12
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-12
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-12
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-12
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-12
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-12
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-12
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-12
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-12
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-12
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-12
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-12
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-12
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		3e-12
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		3e-12
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-12
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-12
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		4e-12
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		5e-12
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		5e-12
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		5e-12
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		6e-12
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		6e-12
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		7e-12
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		7e-12
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		7e-12
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		7e-12
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		8e-12
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		8e-12
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		8e-12
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		9e-12
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-11
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-11
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-11
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-11
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-11
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-11
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-11
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-11
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-11
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-11
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-11
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-11
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-11
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-11
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-11
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-11
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-11
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-11
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-11
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		3e-11
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-11
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-11
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-11
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		3e-11
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-11
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		4e-11
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-11
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-11
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-11
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-11
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		4e-11
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		4e-11
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-11
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		5e-11
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		5e-11
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-11
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-11
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		5e-11
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		6e-11
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		6e-11
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		7e-11
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		8e-11
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		8e-11
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		8e-11
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		9e-11
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		9e-11
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		9e-11
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-10
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-10
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-10
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-10
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-10
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-10
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-10
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-10
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-10
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-10
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-10
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-10
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-10
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-10
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-10
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-10
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-10
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-10
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-10
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-10
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-10
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-10
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-10
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-10
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		3e-10
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-10
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-10
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-10
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-10
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		4e-10
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		4e-10
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		4e-10
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		4e-10
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		5e-10
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-10
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		5e-10
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		5e-10
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		5e-10
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		5e-10
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		5e-10
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		5e-10
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		5e-10
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		5e-10
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		6e-10
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-10
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		6e-10
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		7e-10
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-10
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		7e-10
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		7e-10
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		7e-10
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		7e-10
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		7e-10
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		7e-10
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		8e-10
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		8e-10
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		8e-10
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		8e-10
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		8e-10
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		8e-10
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		8e-10
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		8e-10
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		8e-10
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		8e-10
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		8e-10
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		8e-10
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		8e-10
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		8e-10
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		8e-10
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		9e-10
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		9e-10
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		9e-10
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		9e-10
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-09
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-09
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-09
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-09
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-09
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-09
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-09
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-09
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-09
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-09
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-09
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-09
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-09
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-09
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-09
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-09
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-09
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-09
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-09
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-09
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-09
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-09
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-09
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-09
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-09
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-09
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-09
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-09
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-09
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-09
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-09
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-09
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-09
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-09
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-09
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-09
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-09
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-09
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-09
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-09
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-09
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-09
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-09
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-09
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-09
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-09
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-09
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-09
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-09
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-09
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-09
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-09
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-09
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-09
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-09
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-09
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-09
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-09
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-09
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-09
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-09
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-09
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-09
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-09
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-09
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-09
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-09
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-09
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-09
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-09
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-09
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-09
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-09
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		3e-09
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-09
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		4e-09
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-09
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-09
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		4e-09
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		4e-09
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		4e-09
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		4e-09
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		4e-09
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-09
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		4e-09
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		4e-09
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-09
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		5e-09
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		5e-09
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		5e-09
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		6e-09
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-09
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-09
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		6e-09
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		6e-09
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		6e-09
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		6e-09
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		7e-09
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		7e-09
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		7e-09
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		7e-09
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		7e-09
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		7e-09
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		7e-09
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		7e-09
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		8e-09
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		8e-09
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		8e-09
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		8e-09
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		9e-09
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		9e-09
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		9e-09
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		9e-09
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		9e-09
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		9e-09
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		9e-09
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		9e-09
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-08
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-08
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-08
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-08
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-08
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-08
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-08
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-08
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-08
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-08
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-08
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-08
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-08
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-08
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-08
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-08
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-08
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-08
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-08
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-08
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-08
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-08
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-08
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-08
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-08
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-08
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-08
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-08
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-08
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-08
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-08
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-08
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-08
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-08
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-08
3soa_A	444	Full-Length Human Camkii Length = 444		2e-08
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-08
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-08
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-08
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-08
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-08
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-08
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-08
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-08
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-08
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-08
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-08
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-08
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-08
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		3e-08
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-08
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-08
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		3e-08
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-08
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-08
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-08
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		3e-08
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-08
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-08
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-08
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		3e-08
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-08
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-08
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-08
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-08
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		3e-08
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-08
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-08
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-08
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-08
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-08
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-08
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		3e-08
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-08
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-08
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-08
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-08
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-08
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-08
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		3e-08
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		4e-08
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		4e-08
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		4e-08
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-08
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		4e-08
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		4e-08
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		5e-08
3zyn_A	321	Crystal Structure Of The N-Terminal Leucine Rich Re		5e-08
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		5e-08
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-08
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		5e-08
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		5e-08
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		5e-08
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		5e-08
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		5e-08
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		6e-08
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		6e-08
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		6e-08
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		6e-08
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		6e-08
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-08
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		7e-08
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		7e-08
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		7e-08
3zyo_A	411	Crystal Structure Of The N-Terminal Leucine Rich Re		8e-08
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		8e-08
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		8e-08
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		8e-08
4exu_A	371	Mapk13, Inactive Form Length = 371		9e-08
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		9e-08
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		9e-08
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-07
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-07
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		1e-07
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-07
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-07
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-07
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-07
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-07
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-07
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-07
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-07
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-07
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-07
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-07
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-07
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-07
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-07
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-07
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-07
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-07
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-07
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-07
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-07
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-07
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-07
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-07
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-07
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-07
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-07
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-07
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-07
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-07
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-07
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-07
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-07
3zyj_A	440	Netring1 In Complex With Ngl1 Length = 440		2e-07
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-07
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-07
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-07
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-07
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		3e-07
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-07
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-07
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-07
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-07
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		3e-07
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-07
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-07
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-07
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-07
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		3e-07
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-07
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-07
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-07
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-07
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-07
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-07
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-07
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-07
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-07
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-07
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-07
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-07
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		3e-07
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		3e-07
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-07
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		3e-07
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-07
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-07
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-07
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		3e-07
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-07
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-07
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		3e-07
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-07
2oza_B	366	Structure Of P38alpha Complex Length = 366		4e-07
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		4e-07
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		4e-07
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		4e-07
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		4e-07
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-07
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		4e-07
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		5e-07
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		5e-07
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		5e-07
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		5e-07
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		5e-07
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		5e-07
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		5e-07
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		5e-07
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		5e-07
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-07
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-07
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		5e-07
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		5e-07
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		5e-07
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		5e-07
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		5e-07
3hec_A	348	P38 In Complex With Imatinib Length = 348		5e-07
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		5e-07
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		5e-07
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		6e-07
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		6e-07
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		6e-07
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		6e-07
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		6e-07
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		6e-07
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		6e-07
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		6e-07
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		6e-07
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		6e-07
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		6e-07
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		6e-07
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		6e-07
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		6e-07
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		6e-07
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		6e-07
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		6e-07
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		6e-07
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		6e-07
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		6e-07
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		6e-07
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		6e-07
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		7e-07
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		7e-07
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		7e-07
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		7e-07
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		7e-07
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		7e-07
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-07
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		7e-07
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		8e-07
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		8e-07
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		9e-07
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		9e-07
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		9e-07
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-06
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-06
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-06
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-06
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-06
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-06
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-06
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-06
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-06
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-06
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-06
3rfs_A	272	Design Of A Binding Scaffold Based On Variable Lymp		1e-06
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-06
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-06
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-06
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-06
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-06
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-06
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-06
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-06
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-06
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-06
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-06
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-06
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		2e-06
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-06
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-06
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-06
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-06
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-06
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-06
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-06
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-06
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-06
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		3e-06
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-06
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-06
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-06
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-06
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-06
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-06
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-06
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-06
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		4e-06
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		4e-06
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-06
3e6j_A	229	Crystal Structure Of Variable Lymphocyte Receptor (		4e-06
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-06
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		4e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		4e-06
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		4e-06
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		4e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		5e-06
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		5e-06
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		5e-06
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		5e-06
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		5e-06
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-06
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		6e-06
2o6q_A	270	Structural Diversity Of The Hagfish Variable Lympho		7e-06
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		7e-06
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-06
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		7e-06
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		8e-06
2z66_A	306	Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 A		8e-06
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		9e-06
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		9e-06
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		9e-06
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		9e-06
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		9e-06
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		9e-06
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-05
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-05
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-05
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-05
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-05
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-05
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		1e-05
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-05
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-05
3ulu_A	694	Structure Of Quaternary Complex Of Human Tlr3ecd Wi		2e-05
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-05
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		2e-05
2z63_A	570	Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 A		2e-05
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-05
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-05
2a0z_A	705	The Molecular Structure Of Toll-like Receptor 3 Lig		2e-05
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-05
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		2e-05
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		3e-05
3rg1_A	612	Crystal Structure Of The Rp105MD-1 Complex Length =		3e-05
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		3e-05
3j0a_A	844	Homology Model Of Human Toll-Like Receptor 5 Fitted		3e-05
1ziw_A	680	Human Toll-Like Receptor 3 Extracellular Domain Str		3e-05
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-05
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-05
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		3e-05
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		3e-05
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		3e-05
3rfj_A	279	Design Of A Binding Scaffold Based On Variable Lymp		4e-05
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		4e-05
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		4e-05
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		5e-05
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		6e-05
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		6e-05
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		6e-05
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		6e-05
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-05
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		7e-05
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		7e-05
4ae9_A	343	Structure And Function Of The Human Sperm-specific		7e-05
4ae6_A	343	Structure And Function Of The Human Sperm-specific		7e-05
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		7e-05
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		8e-05
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		8e-05
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		8e-05
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		8e-05
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		8e-05
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		8e-05
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		8e-05
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		8e-05
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-05
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		8e-05
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		8e-05
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		8e-05
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		8e-05
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		8e-05
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		8e-05
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		8e-05
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		8e-05
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		8e-05
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		8e-05
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-05
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		8e-05
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		8e-05
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		8e-05
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		8e-05
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		8e-05
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		9e-05
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		9e-05
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		9e-05
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		9e-05
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		1e-04
3b2d_A	603	Crystal Structure Of Human Rp105MD-1 Complex Length		1e-04
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-04
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-04
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-04
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-04
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-04
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-04
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-04
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-04
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-04
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-04
4b8c_D	727	Nuclease Module Of The Yeast Ccr4-Not Complex Lengt		2e-04
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-04
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-04
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-04
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-04
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-04
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-04
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-04
3m18_A	251	Crystal Structure Of Variable Lymphocyte Receptor V		2e-04
3m19_A	251	Crystal Structure Of Variable Lymphocyte Receptor V		2e-04
2o6s_A	208	Structural Diversity Of The Hagfish Variable Lympho		2e-04
2o6s_A	208	Structural Diversity Of The Hagfish Variable Lympho		6e-04
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		3e-04
2z64_A	599	Crystal Structure Of Mouse Tlr4 And Mouse Md-2 Comp		3e-04
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		3e-04
3vq1_A	606	Crystal Structure Of Mouse Tlr4MD-2LIPID IVA COMPLE		3e-04
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		3e-04
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		3e-04
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		3e-04
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		3e-04
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		4e-04
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		4e-04
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		4e-04
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		4e-04
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		4e-04
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		4e-04
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		4e-04
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		4e-04
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		4e-04
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		4e-04
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		5e-04
2oza_A	356	Structure Of P38alpha Complex Length = 356		5e-04
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		5e-04
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		6e-04
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-04
3fxi_A	605	Crystal Structure Of The Human Tlr4-Human Md-2-E.Co		7e-04
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		8e-04
3v47_A	455	Crystal Structure Of The N-Tetminal Fragment Of Zeb		8e-04

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  114 bits (284), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 156/547 (28%), Positives = 226/547 (41%), Gaps = 104/547 (19%)
Query: 67  ATKISPCAWSGIFCNHAERVVGINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIP 126
           ++  +PC + G+ C   ++V  I+L+S  LN       FS+    +        LF    
Sbjct: 31  SSNKNPCTFDGVTC-RDDKVTSIDLSSKPLN-----VGFSAVSSSLLSLTGLESLF---- 80
Query: 127 PQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSI------------- 173
                         S + + G + SG      LT L +SRN LSG +             
Sbjct: 81  -------------LSNSHINGSV-SGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLK 126
Query: 174 -----------PHEVG---QLTVLNQLALDSNFLNGS------IPRSLGNLTHVVI---- 209
                      P +V    +L  L  L L +N ++G+      +    G L H+ I    
Sbjct: 127 FLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNK 186
Query: 210 ---------------LYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTN 254
                          L + +N+F   IP  +G+  +L  L++  N+LSG    +IS  T 
Sbjct: 187 ISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTE 245
Query: 255 LRFLFLYHNELSGIIPQ------------------EI-----GXXXXXXXXXXXXXHFRG 291
           L+ L +  N+  G IP                   EI     G             HF G
Sbjct: 246 LKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYG 305
Query: 292 TVPKSFRNLTDLVKLRLNQNYLTGNIS-ETFGTYPNLTFIDLSNNSFFGEILSDWGR-CP 349
            VP  F + + L  L L+ N  +G +  +T      L  +DLS N F GE+         
Sbjct: 306 AVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSA 365
Query: 350 QLSLLDVSINNISGSIPLEIGESLQ--LQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGN 407
            L  LD+S NN SG I   + ++ +  LQ L L +N   G+IP  L N   L  L LS N
Sbjct: 366 SLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFN 425
Query: 408 KLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDN 467
            LSG IP  LGSL  L  L L  N L   +P+ L  +  L  L L  N L+ +IP  L N
Sbjct: 426 YLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSN 485
Query: 468 LIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYN 527
             +L+ + LS+N L  +I   I R+E+L  L LS N+ SG IP    +   L+ +D++ N
Sbjct: 486 CTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTN 545
Query: 528 KLEGQIP 534
              G IP
Sbjct: 546 LFNGTIP 552

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  152 bits (385), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 147/498 (29%), Positives = 229/498 (45%), Gaps = 53/498 (10%)
Query: 111 LVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLS 170
           L +LD+  N+L G     IS  + L+ L+ S+N+  G IP     L  L  L ++ N  +
Sbjct: 222 LQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFT 279
Query: 171 GSIPHEV-GQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQE-IGNL 228
           G IP  + G    L  L L  N   G++P   G+ + +  L L +N+F G +P + +  +
Sbjct: 280 GEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKM 339
Query: 229 KSLFDLELCINQLSGAIPLSISNLT-NLRFLFLYHNELSG-IIPQEIGXXXXXXXXXXXX 286
           + L  L+L  N+ SG +P S++NL+ +L  L L  N  SG I+P                
Sbjct: 340 RGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQ 399
Query: 287 XH-FRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDW 345
            + F G +P +  N ++LV L L+ NYL+G I  + G+   L  + L  N   GEI  + 
Sbjct: 400 NNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQEL 459
Query: 346 GRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLS 405
                L  L +  N+++G IP  +     L ++ LS+N + GEIP  +G +  L  L LS
Sbjct: 460 MYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLS 519
Query: 406 GNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESL------------------------ 441
            N  SG IP ELG   +L +LDL+ N  +  +P ++                        
Sbjct: 520 NNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDG 579
Query: 442 --------GSLVKLYYLNLSH-NKLSQQIPIEL-------------DNLIHLSELDLSHN 479
                   G+L++   +     N+LS + P  +             DN   +  LD+S+N
Sbjct: 580 MKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYN 639
Query: 480 FLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNSTTF 539
            L   I   I  M  L  LNL +N++SG IP    ++ GL  +D+S NKL+G+IP + + 
Sbjct: 640 MLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSA 699
Query: 540 RDAPLEALQGNKGLYGDI 557
                E    N  L G I
Sbjct: 700 LTMLTEIDLSNNNLSGPI 717

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  113 bits (283), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 156/547 (28%), Positives = 226/547 (41%), Gaps = 104/547 (19%)
Query: 67  ATKISPCAWSGIFCNHAERVVGINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIP 126
           ++  +PC + G+ C   ++V  I+L+S  LN       FS+    +        LF    
Sbjct: 34  SSNKNPCTFDGVTC-RDDKVTSIDLSSKPLN-----VGFSAVSSSLLSLTGLESLF---- 83
Query: 127 PQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSI------------- 173
                         S + + G + SG      LT L +SRN LSG +             
Sbjct: 84  -------------LSNSHINGSV-SGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLK 129
Query: 174 -----------PHEVG---QLTVLNQLALDSNFLNGS------IPRSLGNLTHVVI---- 209
                      P +V    +L  L  L L +N ++G+      +    G L H+ I    
Sbjct: 130 FLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNK 189
Query: 210 ---------------LYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTN 254
                          L + +N+F   IP  +G+  +L  L++  N+LSG    +IS  T 
Sbjct: 190 ISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTE 248
Query: 255 LRFLFLYHNELSGIIPQ------------------EI-----GXXXXXXXXXXXXXHFRG 291
           L+ L +  N+  G IP                   EI     G             HF G
Sbjct: 249 LKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYG 308
Query: 292 TVPKSFRNLTDLVKLRLNQNYLTGNIS-ETFGTYPNLTFIDLSNNSFFGEILSDWGR-CP 349
            VP  F + + L  L L+ N  +G +  +T      L  +DLS N F GE+         
Sbjct: 309 AVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSA 368
Query: 350 QLSLLDVSINNISGSIPLEIGESLQ--LQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGN 407
            L  LD+S NN SG I   + ++ +  LQ L L +N   G+IP  L N   L  L LS N
Sbjct: 369 SLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFN 428
Query: 408 KLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDN 467
            LSG IP  LGSL  L  L L  N L   +P+ L  +  L  L L  N L+ +IP  L N
Sbjct: 429 YLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSN 488
Query: 468 LIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYN 527
             +L+ + LS+N L  +I   I R+E+L  L LS N+ SG IP    +   L+ +D++ N
Sbjct: 489 CTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTN 548
Query: 528 KLEGQIP 534
              G IP
Sbjct: 549 LFNGTIP 555

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  152 bits (385), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 147/498 (29%), Positives = 229/498 (45%), Gaps = 53/498 (10%)
Query: 111 LVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLS 170
           L +LD+  N+L G     IS  + L+ L+ S+N+  G IP     L  L  L ++ N  +
Sbjct: 225 LQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFT 282
Query: 171 GSIPHEV-GQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQE-IGNL 228
           G IP  + G    L  L L  N   G++P   G+ + +  L L +N+F G +P + +  +
Sbjct: 283 GEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKM 342
Query: 229 KSLFDLELCINQLSGAIPLSISNLT-NLRFLFLYHNELSG-IIPQEIGXXXXXXXXXXXX 286
           + L  L+L  N+ SG +P S++NL+ +L  L L  N  SG I+P                
Sbjct: 343 RGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQ 402
Query: 287 XH-FRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDW 345
            + F G +P +  N ++LV L L+ NYL+G I  + G+   L  + L  N   GEI  + 
Sbjct: 403 NNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQEL 462
Query: 346 GRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLS 405
                L  L +  N+++G IP  +     L ++ LS+N + GEIP  +G +  L  L LS
Sbjct: 463 MYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLS 522
Query: 406 GNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESL------------------------ 441
            N  SG IP ELG   +L +LDL+ N  +  +P ++                        
Sbjct: 523 NNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDG 582
Query: 442 --------GSLVKLYYLNLSH-NKLSQQIPIEL-------------DNLIHLSELDLSHN 479
                   G+L++   +     N+LS + P  +             DN   +  LD+S+N
Sbjct: 583 MKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYN 642
Query: 480 FLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNSTTF 539
            L   I   I  M  L  LNL +N++SG IP    ++ GL  +D+S NKL+G+IP + + 
Sbjct: 643 MLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSA 702
Query: 540 RDAPLEALQGNKGLYGDI 557
                E    N  L G I
Sbjct: 703 LTMLTEIDLSNNNLSGPI 720

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  156 bits (394), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 90/289 (31%), Positives = 151/289 (52%), Gaps = 21/289 (7%)
Query: 632 EIISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLP--GEMSFQQEEFLNEI 689
           E+  A+++F+ ++ +G+GG G VY+ ++  G + AVK+        GE+ FQ      E+
Sbjct: 32  ELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQ-----TEV 86
Query: 690 QALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE-LGWTQRLNVIK 748
           + ++   HRN+++  GFC  P    ++Y Y+ +GS+   L     ++  L W +R  +  
Sbjct: 87  EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 146
Query: 749 GVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN-PDSSNWSELAGT 807
           G A  L YLH++C P I+HRD+ + N+LLD  +EA V DFG+AK ++  D      + GT
Sbjct: 147 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGT 206
Query: 808 HGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEXXXXXXXXXIEMLDSRLP 867
            G++APE   T K +EK DV+ +GV+ LE+I G+   D L           ++ +   L 
Sbjct: 207 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD-LARLANDDDVMLLDWVKGLLK 265
Query: 868 YPSLHV-----------QKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
              L              +++  ++QVA  C   +P  RP M  V ++L
Sbjct: 266 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 314

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  154 bits (390), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 89/289 (30%), Positives = 149/289 (51%), Gaps = 21/289 (7%)
Query: 632 EIISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLP--GEMSFQQEEFLNEI 689
           E+  A+++F  ++ +G+GG G VY+ ++  G + AVK+        GE+ FQ      E+
Sbjct: 24  ELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQ-----TEV 78
Query: 690 QALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE-LGWTQRLNVIK 748
           + ++   HRN+++  GFC  P    ++Y Y+ +GS+   L     ++  L W +R  +  
Sbjct: 79  EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 138
Query: 749 GVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN-PDSSNWSELAGT 807
           G A  L YLH++C P I+HRD+ + N+LLD  +EA V DFG+AK ++  D      + G 
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGX 198
Query: 808 HGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEXXXXXXXXXIEMLDSRLP 867
            G++APE   T K +EK DV+ +GV+ LE+I G+   D L           ++ +   L 
Sbjct: 199 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD-LARLANDDDVMLLDWVKGLLK 257
Query: 868 YPSLHV-----------QKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
              L              +++  ++QVA  C   +P  RP M  V ++L
Sbjct: 258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  127 bits (320), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 93/295 (31%), Positives = 152/295 (51%), Gaps = 29/295 (9%)
Query: 632 EIISATNDFNAE------HCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEF 685
           E+ + TN+F+        + +G+GG G VY+  V +  + AVKK  + +       +++F
Sbjct: 19  ELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTV-AVKKLAAMVDITTEELKQQF 77
Query: 686 LNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSL-DKILCNDASAKELGWTQRL 744
             EI+ + + +H N+V+  GF S      ++Y Y+ +GSL D++ C D +   L W  R 
Sbjct: 78  DQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP-LSWHMRC 136
Query: 745 NVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN--PDSSNWS 802
            + +G A+ + +LH N     +HRDI S N+LLD  + A +SDFG+A+       +   S
Sbjct: 137 KIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXS 193
Query: 803 ELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKG-------KHPRDFL--FEXXXX 853
            + GT  Y+APE A   ++T K D+YSFGV+ LE+I G       + P+  L   E    
Sbjct: 194 RIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIED 252
Query: 854 XXXXXIEMLDSRL-PYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCE 907
                 + +D ++    S  V+    ++  VA  CL +    RP +K+V QLL E
Sbjct: 253 EEKTIEDYIDKKMNDADSTSVE----AMYSVASQCLHEKKNKRPDIKKVQQLLQE 303

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  126 bits (317), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 81/225 (36%), Positives = 117/225 (52%), Gaps = 10/225 (4%)
Query: 622 LTFEGKIVYEEIISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQ 681
           L F+G +  +++     D N +  IG G  G+V+RA+   G   AVK        E  F 
Sbjct: 21  LYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILM-----EQDFH 74
Query: 682 QE---EFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKEL 738
            E   EFL E+  +  +RH NIV F G  + P +  I+ EYL  GSL ++L    + ++L
Sbjct: 75  AERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQL 134
Query: 739 GWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS 798
              +RL++   VA  + YLHN   PPIVHRD+ S N+L+D  Y   V DFG+++      
Sbjct: 135 DERRRLSMAYDVAKGMNYLHNRN-PPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXF 193
Query: 799 SNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
                 AGT  ++APE+       EK DVYSFGV+  E+   + P
Sbjct: 194 LXSKXAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 238

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  125 bits (315), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 92/295 (31%), Positives = 151/295 (51%), Gaps = 29/295 (9%)
Query: 632 EIISATNDFNAE------HCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEF 685
           E+ + TN+F+        + +G+GG G VY+  V +  + AVKK  + +       +++F
Sbjct: 19  ELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTV-AVKKLAAMVDITTEELKQQF 77
Query: 686 LNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSL-DKILCNDASAKELGWTQRL 744
             EI+ + + +H N+V+  GF S      ++Y Y+ +GSL D++ C D +   L W  R 
Sbjct: 78  DQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP-LSWHMRC 136
Query: 745 NVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN--PDSSNWS 802
            + +G A+ + +LH N     +HRDI S N+LLD  + A +SDFG+A+       +    
Sbjct: 137 KIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXX 193
Query: 803 ELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKG-------KHPRDFL--FEXXXX 853
            + GT  Y+APE A   ++T K D+YSFGV+ LE+I G       + P+  L   E    
Sbjct: 194 RIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIED 252
Query: 854 XXXXXIEMLDSRL-PYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCE 907
                 + +D ++    S  V+    ++  VA  CL +    RP +K+V QLL E
Sbjct: 253 EEKTIEDYIDKKMNDADSTSVE----AMYSVASQCLHEKKNKRPDIKKVQQLLQE 303

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  125 bits (315), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 80/225 (35%), Positives = 118/225 (52%), Gaps = 10/225 (4%)
Query: 622 LTFEGKIVYEEIISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQ 681
           L F+G +  +++     D N +  IG G  G+V+RA+   G   AVK        E  F 
Sbjct: 21  LYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILM-----EQDFH 74
Query: 682 QE---EFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKEL 738
            E   EFL E+  +  +RH NIV F G  + P +  I+ EYL  GSL ++L    + ++L
Sbjct: 75  AERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQL 134
Query: 739 GWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS 798
              +RL++   VA  + YLHN   PPIVHR++ S N+L+D  Y   V DFG+++      
Sbjct: 135 DERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF 193
Query: 799 SNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
            +    AGT  ++APE+       EK DVYSFGV+  E+   + P
Sbjct: 194 LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 238

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  125 bits (313), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 90/294 (30%), Positives = 149/294 (50%), Gaps = 27/294 (9%)
Query: 632 EIISATNDFNAE------HCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEF 685
           E+ + TN+F+        + +G+GG G VY+  V +  + AVKK  + +       +++F
Sbjct: 13  ELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTV-AVKKLAAMVDITTEELKQQF 71
Query: 686 LNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSL-DKILCNDASAKELGWTQRL 744
             EI+ + + +H N+V+  GF S      ++Y Y+ +GSL D++ C D +   L W  R 
Sbjct: 72  DQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP-LSWHMRC 130
Query: 745 NVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN--WS 802
            + +G A+ + +LH N     +HRDI S N+LLD  + A +SDFG+A+     +      
Sbjct: 131 KIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXX 187
Query: 803 ELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKG-------KHPRDFL--FEXXXX 853
            + GT  Y+APE A   ++T K D+YSFGV+ LE+I G       + P+  L   E    
Sbjct: 188 RIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIED 246
Query: 854 XXXXXIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCE 907
                 + +D ++          + ++  VA  CL +    RP +K+V QLL E
Sbjct: 247 EEKTIEDYIDKKMNDAD---STSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 297

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  120 bits (300), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 90/292 (30%), Positives = 142/292 (48%), Gaps = 23/292 (7%)
Query: 632 EIISATNDFNAE------HCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEF 685
           E+ + TN+F+        +  G+GG G VY+  V +  + AVKK  + +       +++F
Sbjct: 10  ELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTTV-AVKKLAAMVDITTEELKQQF 68
Query: 686 LNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSL-DKILCNDASAKELGWTQRL 744
             EI+   + +H N+V+  GF S      ++Y Y  +GSL D++ C D +   L W  R 
Sbjct: 69  DQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPP-LSWHXRC 127
Query: 745 NVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN--PDSSNWS 802
            + +G A+ + +LH N     +HRDI S N+LLD  + A +SDFG+A+           S
Sbjct: 128 KIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXS 184
Query: 803 ELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKG-------KHPRDFLFEXXXXXX 855
            + GT  Y APE A   ++T K D+YSFGV+ LE+I G       + P+  L +      
Sbjct: 185 RIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ-LLLDIKEEIE 242
Query: 856 XXXIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCE 907
                + D      +      + +   VA  CL +    RP +K+V QLL E
Sbjct: 243 DEEKTIEDYIDKKXNDADSTSVEAXYSVASQCLHEKKNKRPDIKKVQQLLQE 294

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  116 bits (291), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 94/285 (32%), Positives = 141/285 (49%), Gaps = 34/285 (11%)
Query: 636 ATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI 695
           ATN+F+ +  IG G  G VY+  +  G   A+K+  +P   E S   EEF  EI+ L+  
Sbjct: 37  ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR-RTP---ESSQGIEEFETEIETLSFC 92
Query: 696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKIL-CNDASAKELGWTQRLNVIKGVADAL 754
           RH ++V   GFC       +IY+Y+E+G+L + L  +D     + W QRL +  G A  L
Sbjct: 93  RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGL 152
Query: 755 FYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH------ 808
            YLH      I+HRD+ S N+LLD  +   ++DFGI+K         +EL  TH      
Sbjct: 153 HYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK-------KGTELGQTHLXXVVK 202
Query: 809 ---GYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKH------PRDFLFEXXXXXXXXXI 859
              GY+ PE     ++TEK DVYSFGV+  EV+  +       PR+ +            
Sbjct: 203 GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN 262
Query: 860 EMLDSRLPYPSLHVQKKLMSIMQ---VAFSCLDQNPESRPTMKRV 901
             L+ ++  P+L  + +  S+ +    A  CL  + E RP+M  V
Sbjct: 263 GQLE-QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDV 306

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  116 bits (291), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 93/278 (33%), Positives = 142/278 (51%), Gaps = 20/278 (7%)
Query: 636 ATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI 695
           ATN+F+ +  IG G  G VY+  +  G   A+K+  +P   E S   EEF  EI+ L+  
Sbjct: 37  ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR-RTP---ESSQGIEEFETEIETLSFC 92
Query: 696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKIL-CNDASAKELGWTQRLNVIKGVADAL 754
           RH ++V   GFC       +IY+Y+E+G+L + L  +D     + W QRL +  G A  L
Sbjct: 93  RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGL 152
Query: 755 FYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP-DSSNWSELA-GTHGYVA 812
            YLH      I+HRD+ S N+LLD  +   ++DFGI+K     D ++   +  GT GY+ 
Sbjct: 153 HYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYID 209
Query: 813 PELAYTLKVTEKCDVYSFGVLALEVIKGKH------PRDFLFEXXXXXXXXXIEMLDSRL 866
           PE     ++TEK DVYSFGV+  EV+  +       PR+ +              L+ ++
Sbjct: 210 PEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE-QI 268
Query: 867 PYPSLHVQKKLMSIMQ---VAFSCLDQNPESRPTMKRV 901
             P+L  + +  S+ +    A  CL  + E RP+M  V
Sbjct: 269 VDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDV 306

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score =  103 bits (256), Expect = 6e-22,   Method: Composition-based stats.
 Identities = 78/260 (30%), Positives = 122/260 (46%), Gaps = 24/260 (9%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           +G G  G V   K       AVK        E S  ++EF  E Q + ++ H  +VKFYG
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIK-----EGSMSEDEFFQEAQTMMKLSHPKLVKFYG 70
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
            CS     +I+ EY+ +G L   L   +  K L  +Q L +   V + + +L ++ F   
Sbjct: 71  VCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFLESHQF--- 125
Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPELAYTLKVT 822
           +HRD++++N L+D      VSDFG+ +++  D   +    GT     + APE+ +  K +
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD--QYVSSVGTKFPVKWSAPEVFHYFKYS 183
Query: 823 EKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLHVQKKLMSIM 881
            K DV++FG+L  EV   GK P D                   RL  P L       +I 
Sbjct: 184 SKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ----GHRLYRPHLASD----TIY 235
Query: 882 QVAFSCLDQNPESRPTMKRV 901
           Q+ +SC  + PE RPT +++
Sbjct: 236 QIMYSCWHELPEKRPTFQQL 255

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score =  101 bits (252), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 133/275 (48%), Gaps = 22/275 (8%)
Query: 643 EHCIGKGGHGSVYRAKVPS-GEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIV 701
           E  IG G  G V R ++ + G+  +     +   G    Q+ EFL+E   + +  H NI+
Sbjct: 21  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 80
Query: 702 KFYGFCSHPKHSFIIYEYLESGSLDKIL-CNDASAKELGWTQRLNVIKGVADALFYLHNN 760
           +  G  ++     I+ E++E+G+LD  L  ND    +    Q + +++G+A  + YL   
Sbjct: 81  RLEGVVTNSMPVMILTEFMENGALDSFLRLNDG---QFTVIQLVGMLRGIASGMRYLAEM 137
Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG-----YVAPEL 815
            +   VHRD++++N+L++      VSDFG+++FL  +SS+ +E +   G     + APE 
Sbjct: 138 SY---VHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEA 194
Query: 816 AYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLHVQ 874
               K T   D +S+G++  EV+  G+ P    ++         IE  D RLP P     
Sbjct: 195 IAFRKFTSASDAWSYGIVMWEVMSFGERP---YWDMSNQDVINAIEQ-DYRLPPPP---- 246
Query: 875 KKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI 909
               S+ Q+   C  ++  +RP   +V   L + I
Sbjct: 247 DCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMI 281

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  100 bits (249), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 77/263 (29%), Positives = 130/263 (49%), Gaps = 26/263 (9%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           IG+G  G+VY A  V +G+  A+++ +     +   ++E  +NEI  + E ++ NIV + 
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNL----QQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 705 GFCSHPKHSFIIYEYLESGSLDKIL---CNDASAKELGWTQRLNVIKGVADALFYLHNNC 761
                    +++ EYL  GSL  ++   C D         Q   V +    AL +LH+N 
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG-------QIAAVCRECLQALEFLHSN- 135
Query: 762 FPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKV 821
              ++HRDI S N+LL +     ++DFG    + P+ S  SE+ GT  ++APE+      
Sbjct: 136 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKAY 193
Query: 822 TEKCDVYSFGVLALEVIKGKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLHVQKKLMSIM 881
             K D++S G++A+E+I+G+ P  +L E            L +    P L   +KL +I 
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPP--YLNENPLRAL-----YLIATNGTPELQNPEKLSAIF 246
Query: 882 QVAFS-CLDQNPESRPTMKRVSQ 903
           +   + CLD + E R + K + Q
Sbjct: 247 RDFLNRCLDMDVEKRGSAKELLQ 269

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 88/315 (27%), Positives = 145/315 (46%), Gaps = 40/315 (12%)
Query: 615 TPGLRSVLTFEGKIVYEEIISATNDF---------NAEHCIGKGGHGSVYRA--KVPSG- 662
           TPG++    F     +E+   A  +F           E  IG G  G V     K+P   
Sbjct: 4   TPGMK---IFIDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKR 60
Query: 663 EIF-AVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLE 721
           EIF A+K   S   G    Q+ +FL+E   + +  H N++   G  +      II E++E
Sbjct: 61  EIFVAIKTLKS---GYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFME 117
Query: 722 SGSLDKIL-CNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLG 780
           +GSLD  L  ND    +    Q + +++G+A  + YL +  +   VHRD++++N+L++  
Sbjct: 118 NGSLDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLADMNY---VHRDLAARNILVNSN 171
Query: 781 YEAHVSDFGIAKFLNPDSSNWSELAGTHG-----YVAPELAYTLKVTEKCDVYSFGVLAL 835
               VSDFG+++FL  D+S+ +  +   G     + APE     K T   DV+S+G++  
Sbjct: 172 LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMW 231
Query: 836 EVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPES 894
           EV+  G+ P    ++         IE  D RLP P +     L  +M     C  ++   
Sbjct: 232 EVMSYGERP---YWDMTNQDVINAIEQ-DYRLP-PPMDCPSALHQLM---LDCWQKDRNH 283
Query: 895 RPTMKRVSQLLCEKI 909
           RP   ++   L + I
Sbjct: 284 RPKFGQIVNTLDKMI 298

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 90/321 (28%), Positives = 153/321 (47%), Gaps = 38/321 (11%)
Query: 605 SQTQQSSFGNT----PGLRSVL---TFEG--KIVYE--EIISATNDFNAEHCIGKGGHGS 653
           S  ++  FGN     PGLR+ +   TFE   + V+E  + + ATN  + +  +G G  G 
Sbjct: 2   SDEKRLHFGNGHLKLPGLRTFVDPHTFEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGE 60
Query: 654 VY--RAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPK 711
           V   R K+PS +  +V    +   G    Q+ +FL E   + +  H NI++  G  +  K
Sbjct: 61  VCSGRLKLPSKKEISVA-IKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK 119
Query: 712 HSFIIYEYLESGSLDKIL-CNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDI 770
              I+ EY+E+GSLD  L  +DA   +    Q + +++G+A  + YL +  +   VHRD+
Sbjct: 120 PVMIVTEYMENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKYLSDMGY---VHRDL 173
Query: 771 SSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPELAYTLKVTEKCDV 827
           +++N+L++      VSDFG+A+ L  D        G      + +PE     K T   DV
Sbjct: 174 AARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDV 233
Query: 828 YSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDS--RLPYPSLHVQKKLMSIMQVA 884
           +S+G++  EV+  G+ P               I+ +D   RLP P +     L  +M   
Sbjct: 234 WSYGIVLWEVMSYGERP------YWEMSNQDVIKAVDEGYRLP-PPMDCPAALYQLM--- 283
Query: 885 FSCLDQNPESRPTMKRVSQLL 905
             C  ++  +RP  +++  +L
Sbjct: 284 LDCWQKDRNNRPKFEQIVSIL 304

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 134/304 (44%), Gaps = 29/304 (9%)
Query: 609 QSSFGNTPGLRSVLTFEGKIVYEEIISATNDFNAEHCIGKGGHGSVYRA--KVPSGEIFA 666
           Q + G+ P  ++VL F  +I         +    +  IG G  G VY+   K  SG+   
Sbjct: 23  QGAMGSDPN-QAVLKFTTEI-------HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEV 74
Query: 667 VKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLD 726
                +   G    Q+ +FL E   + +  H NI++  G  S  K   II EY+E+G+LD
Sbjct: 75  PVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALD 134
Query: 727 KILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVS 786
           K L       E    Q + +++G+A  + YL N  +   VHRD++++N+L++      VS
Sbjct: 135 KFLREKDG--EFSVLQLVGMLRGIAAGMKYLANMNY---VHRDLAARNILVNSNLVCKVS 189
Query: 787 DFGIAKFLNPDSSNWSELAGTH---GYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKH 842
           DFG+++ L  D       +G      + APE     K T   DV+SFG++  EV+  G+ 
Sbjct: 190 DFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER 249
Query: 843 PRDFLFEXXXXXXXXXIEMLDS-RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
           P    +E         I   D  RLP P         +I Q+   C  Q    RP    +
Sbjct: 250 P---YWELSNHEVMKAIN--DGFRLPTP----MDCPSAIYQLMMQCWQQERARRPKFADI 300
Query: 902 SQLL 905
             +L
Sbjct: 301 VSIL 304

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 129/263 (49%), Gaps = 26/263 (9%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           IG+G  G+VY A  V +G+  A+++ +     +   ++E  +NEI  + E ++ NIV + 
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNL----QQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 705 GFCSHPKHSFIIYEYLESGSLDKIL---CNDASAKELGWTQRLNVIKGVADALFYLHNNC 761
                    +++ EYL  GSL  ++   C D         Q   V +    AL +LH+N 
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG-------QIAAVCRECLQALEFLHSN- 135
Query: 762 FPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKV 821
              ++HRDI S N+LL +     ++DFG    + P+ S  S + GT  ++APE+      
Sbjct: 136 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 193
Query: 822 TEKCDVYSFGVLALEVIKGKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLHVQKKLMSIM 881
             K D++S G++A+E+I+G+ P  +L E            L +    P L   +KL +I 
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPP--YLNENPLRAL-----YLIATNGTPELQNPEKLSAIF 246
Query: 882 QVAFS-CLDQNPESRPTMKRVSQ 903
           +   + CLD + E R + K + Q
Sbjct: 247 RDFLNRCLDMDVEKRGSAKELLQ 269

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 90/321 (28%), Positives = 153/321 (47%), Gaps = 38/321 (11%)
Query: 605 SQTQQSSFGNT----PGLRSVL---TFEG--KIVYE--EIISATNDFNAEHCIGKGGHGS 653
           S  ++  FGN     PGLR+ +   TFE   + V+E  + + ATN  + +  +G G  G 
Sbjct: 2   SDEKRLHFGNGHLKLPGLRTFVDPHTFEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGE 60
Query: 654 VY--RAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPK 711
           V   R K+PS +  +V    +   G    Q+ +FL E   + +  H NI++  G  +  K
Sbjct: 61  VCSGRLKLPSKKEISVA-IKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK 119
Query: 712 HSFIIYEYLESGSLDKIL-CNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDI 770
              I+ EY+E+GSLD  L  +DA   +    Q + +++G+A  + YL +  F   VHRD+
Sbjct: 120 PVMIVTEYMENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKYLSDMGF---VHRDL 173
Query: 771 SSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPELAYTLKVTEKCDV 827
           +++N+L++      VSDFG+++ L  D        G      + +PE     K T   DV
Sbjct: 174 AARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDV 233
Query: 828 YSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDS--RLPYPSLHVQKKLMSIMQVA 884
           +S+G++  EV+  G+ P               I+ +D   RLP P +     L  +M   
Sbjct: 234 WSYGIVLWEVMSYGERP------YWEMSNQDVIKAVDEGYRLP-PPMDCPAALYQLM--- 283
Query: 885 FSCLDQNPESRPTMKRVSQLL 905
             C  ++  +RP  +++  +L
Sbjct: 284 LDCWQKDRNNRPKFEQIVSIL 304

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Composition-based stats.
 Identities = 76/276 (27%), Positives = 131/276 (47%), Gaps = 32/276 (11%)
Query: 643 EHCIGKGGHGSVYRAKVPS-GEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIV 701
           E  IG G  G V R ++ + G+  +     +   G    Q+ EFL+E   + +  H NI+
Sbjct: 19  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 78
Query: 702 KFYGFCSHPKHSFIIYEYLESGSLDKIL-CNDASAKELGWTQRLNVIKGVADALFYLHNN 760
           +  G  ++     I+ E++E+G+LD  L  ND    +    Q + +++G+A  + YL   
Sbjct: 79  RLEGVVTNSMPVMILTEFMENGALDSFLRLNDG---QFTVIQLVGMLRGIASGMRYLAEM 135
Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG-----YVAPEL 815
            +   VHRD++++N+L++      VSDFG+++FL  +SS+ +  +   G     + APE 
Sbjct: 136 SY---VHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEA 192
Query: 816 AYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPYP----- 869
               K T   D +S+G++  EV+  G+ P    ++         IE  D RLP P     
Sbjct: 193 IAFRKFTSASDAWSYGIVMWEVMSFGERP---YWDMSNQDVINAIEQ-DYRLPPPPDCPT 248
Query: 870 SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
           SLH         Q+   C  ++  +RP   +V   L
Sbjct: 249 SLH---------QLMLDCWQKDRNARPRFPQVVSAL 275

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 105/202 (51%), Gaps = 18/202 (8%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           IG+G  G+VY A  V +G+  A+++ +     +   ++E  +NEI  + E ++ NIV + 
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNL----QQQPKKELIINEILVMRENKNPNIVNYL 84
Query: 705 GFCSHPKHSFIIYEYLESGSLDKIL---CNDASAKELGWTQRLNVIKGVADALFYLHNNC 761
                    +++ EYL  GSL  ++   C D         Q   V +    AL +LH+N 
Sbjct: 85  DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG-------QIAAVCRECLQALEFLHSN- 136
Query: 762 FPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKV 821
              ++HRDI S N+LL +     ++DFG    + P+ S  S + GT  ++APE+      
Sbjct: 137 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAY 194
Query: 822 TEKCDVYSFGVLALEVIKGKHP 843
             K D++S G++A+E+I+G+ P
Sbjct: 195 GPKVDIWSLGIMAIEMIEGEPP 216

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 129/279 (46%), Gaps = 39/279 (13%)
Query: 638 NDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH 697
            +   E  +G+G  G V +AK  + ++ A+K+  S        +++ F+ E++ L+ + H
Sbjct: 9   KEIEVEEVVGRGAFGVVCKAKWRAKDV-AIKQIES------ESERKAFIVELRQLSRVNH 61
Query: 698 RNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCND------ASAKELGWTQRLNVIKGVA 751
            NIVK YG C +P    ++ EY E GSL  +L          +A  + W   L   +GVA
Sbjct: 62  PNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWC--LQCSQGVA 117
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEA-HVSDFGIAKFLNPDSSNWSELAGTHGY 810
               YLH+     ++HRD+   N+LL  G     + DFG A  +    +N     G+  +
Sbjct: 118 ----YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTN---NKGSAAW 170
Query: 811 VAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFL----FEXXXXXXXXXIEMLDSRL 866
           +APE+      +EKCDV+S+G++  EVI  + P D +    F             L   L
Sbjct: 171 MAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNL 230
Query: 867 PYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
           P P          I  +   C  ++P  RP+M+ + +++
Sbjct: 231 PKP----------IESLMTRCWSKDPSQRPSMEEIVKIM 259

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 105/202 (51%), Gaps = 18/202 (8%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           IG+G  G+VY A  V +G+  A+++ +     +   ++E  +NEI  + E ++ NIV + 
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNL----QQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 705 GFCSHPKHSFIIYEYLESGSLDKIL---CNDASAKELGWTQRLNVIKGVADALFYLHNNC 761
                    +++ EYL  GSL  ++   C D         Q   V +    AL +LH+N 
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG-------QIAAVCRECLQALEFLHSN- 135
Query: 762 FPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKV 821
              ++HRDI S N+LL +     ++DFG    + P+ S  S + GT  ++APE+      
Sbjct: 136 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAY 193
Query: 822 TEKCDVYSFGVLALEVIKGKHP 843
             K D++S G++A+E+I+G+ P
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPP 215

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 97.1 bits (240), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 129/279 (46%), Gaps = 39/279 (13%)
Query: 638 NDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH 697
            +   E  +G+G  G V +AK  + ++ A+K+  S        +++ F+ E++ L+ + H
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKWRAKDV-AIKQIES------ESERKAFIVELRQLSRVNH 60
Query: 698 RNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCND------ASAKELGWTQRLNVIKGVA 751
            NIVK YG C +P    ++ EY E GSL  +L          +A  + W   L   +GVA
Sbjct: 61  PNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWC--LQCSQGVA 116
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEA-HVSDFGIAKFLNPDSSNWSELAGTHGY 810
               YLH+     ++HRD+   N+LL  G     + DFG A  +    +N     G+  +
Sbjct: 117 ----YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTN---NKGSAAW 169
Query: 811 VAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFL----FEXXXXXXXXXIEMLDSRL 866
           +APE+      +EKCDV+S+G++  EVI  + P D +    F             L   L
Sbjct: 170 MAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNL 229
Query: 867 PYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
           P P          I  +   C  ++P  RP+M+ + +++
Sbjct: 230 PKP----------IESLMTRCWSKDPSQRPSMEEIVKIM 258

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 89/321 (27%), Positives = 153/321 (47%), Gaps = 38/321 (11%)
Query: 605 SQTQQSSFGNT----PGLRSVL---TFEG--KIVYE--EIISATNDFNAEHCIGKGGHGS 653
           S  ++  FGN     PGLR+ +   TFE   + V+E  + + ATN  + +  +G G  G 
Sbjct: 2   SDEKRLHFGNGHLKLPGLRTFVDPHTFEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGE 60
Query: 654 VY--RAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPK 711
           V   R K+PS +  +V    +   G    Q+ +FL E   + +  H NI++  G  +  K
Sbjct: 61  VCSGRLKLPSKKEISVA-IKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK 119
Query: 712 HSFIIYEYLESGSLDKIL-CNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDI 770
              I+ EY+E+GSLD  L  +DA   +    Q + +++G+A  + YL +  +   VHRD+
Sbjct: 120 PVMIVTEYMENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKYLSDMGY---VHRDL 173
Query: 771 SSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPELAYTLKVTEKCDV 827
           +++N+L++      VSDFG+++ L  D        G      + +PE     K T   DV
Sbjct: 174 AARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDV 233
Query: 828 YSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDS--RLPYPSLHVQKKLMSIMQVA 884
           +S+G++  EV+  G+ P               I+ +D   RLP P +     L  +M   
Sbjct: 234 WSYGIVLWEVMSYGERP------YWEMSNQDVIKAVDEGYRLP-PPMDCPAALYQLM--- 283
Query: 885 FSCLDQNPESRPTMKRVSQLL 905
             C  ++  +RP  +++  +L
Sbjct: 284 LDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 89/321 (27%), Positives = 153/321 (47%), Gaps = 38/321 (11%)
Query: 605 SQTQQSSFGNT----PGLRSVL---TFEG--KIVYE--EIISATNDFNAEHCIGKGGHGS 653
           S  ++  FGN     PGLR+ +   TFE   + V+E  + + ATN  + +  +G G  G 
Sbjct: 2   SDEKRLHFGNGHLKLPGLRTYVDPHTFEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGE 60
Query: 654 VY--RAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPK 711
           V   R K+PS +  +V    +   G    Q+ +FL E   + +  H NI++  G  +  K
Sbjct: 61  VCSGRLKLPSKKEISVA-IKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK 119
Query: 712 HSFIIYEYLESGSLDKIL-CNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDI 770
              I+ EY+E+GSLD  L  +DA   +    Q + +++G+A  + YL +  +   VHRD+
Sbjct: 120 PVMIVTEYMENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKYLSDMGY---VHRDL 173
Query: 771 SSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPELAYTLKVTEKCDV 827
           +++N+L++      VSDFG+++ L  D        G      + +PE     K T   DV
Sbjct: 174 AARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDV 233
Query: 828 YSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDS--RLPYPSLHVQKKLMSIMQVA 884
           +S+G++  EV+  G+ P               I+ +D   RLP P +     L  +M   
Sbjct: 234 WSYGIVLWEVMSYGERP------YWEMSNQDVIKAVDEGYRLP-PPMDCPAALYQLM--- 283
Query: 885 FSCLDQNPESRPTMKRVSQLL 905
             C  ++  +RP  +++  +L
Sbjct: 284 LDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 96.7 bits (239), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 89/321 (27%), Positives = 152/321 (47%), Gaps = 38/321 (11%)
Query: 605 SQTQQSSFGNT----PGLRSVL---TFEG--KIVYE--EIISATNDFNAEHCIGKGGHGS 653
           S  ++  FGN     PGLR+ +   TFE   + V+E  + + ATN  + +  +G G  G 
Sbjct: 2   SDEKRLHFGNGHLKLPGLRTFVDPHTFEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGE 60
Query: 654 VY--RAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPK 711
           V   R K+PS +  +V    +   G    Q+ +FL E   + +  H NI++  G  +  K
Sbjct: 61  VCSGRLKLPSKKEISVA-IKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK 119
Query: 712 HSFIIYEYLESGSLDKIL-CNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDI 770
              I+ EY+E+GSLD  L  +DA   +    Q + +++G+A  + YL +  +   VHRD+
Sbjct: 120 PVMIVTEYMENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKYLSDMGY---VHRDL 173
Query: 771 SSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPELAYTLKVTEKCDV 827
           +++N+L++      VSDFG+ + L  D        G      + +PE     K T   DV
Sbjct: 174 AARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDV 233
Query: 828 YSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDS--RLPYPSLHVQKKLMSIMQVA 884
           +S+G++  EV+  G+ P               I+ +D   RLP P +     L  +M   
Sbjct: 234 WSYGIVLWEVMSYGERP------YWEMSNQDVIKAVDEGYRLP-PPMDCPAALYQLM--- 283
Query: 885 FSCLDQNPESRPTMKRVSQLL 905
             C  ++  +RP  +++  +L
Sbjct: 284 LDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 87/323 (26%), Positives = 146/323 (45%), Gaps = 42/323 (13%)
Query: 605 SQTQQSSFGNT----PGLRSVLTFEGKIVYEEIISATNDFNAE---------HCIGKGGH 651
           S  ++  FGN     PGLR   TF     YE+     ++F  E           +G G  
Sbjct: 2   SDEKRLHFGNGHLKLPGLR---TFVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEF 58
Query: 652 GSVY--RAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSH 709
           G V   R K+PS +  +V    +   G    Q+ +FL E   + +  H NI++  G  + 
Sbjct: 59  GEVCSGRLKLPSKKEISVA-IKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117
Query: 710 PKHSFIIYEYLESGSLDKIL-CNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHR 768
            K   I+ EY+E+GSLD  L  +DA   +    Q + +++G+A  + YL +  +   VHR
Sbjct: 118 SKPVMIVTEYMENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKYLSDMGY---VHR 171
Query: 769 DISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPELAYTLKVTEKC 825
           D++++N+L++      VSDFG+++ L  D        G      + +PE     K T   
Sbjct: 172 DLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSAS 231
Query: 826 DVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDS--RLPYPSLHVQKKLMSIMQ 882
           DV+S+G++  EV+  G+ P               I+ +D   RLP P +     L  +M 
Sbjct: 232 DVWSYGIVLWEVMSYGERP------YWEMSNQDVIKAVDEGYRLP-PPMDCPAALYQLM- 283
Query: 883 VAFSCLDQNPESRPTMKRVSQLL 905
               C  ++  +RP  +++  +L
Sbjct: 284 --LDCWQKDRNNRPKFEQIVSIL 304

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 88/321 (27%), Positives = 153/321 (47%), Gaps = 38/321 (11%)
Query: 605 SQTQQSSFGNT----PGLRSVL---TFEG--KIVYE--EIISATNDFNAEHCIGKGGHGS 653
           S  ++  FGN     PGLR+ +   T+E   + V+E  + + ATN  + +  +G G  G 
Sbjct: 2   SDEKRLHFGNGHLKLPGLRTYVDPHTYEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGE 60
Query: 654 VY--RAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPK 711
           V   R K+PS +  +V    +   G    Q+ +FL E   + +  H NI++  G  +  K
Sbjct: 61  VCSGRLKLPSKKEISVA-IKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK 119
Query: 712 HSFIIYEYLESGSLDKIL-CNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDI 770
              I+ EY+E+GSLD  L  +DA   +    Q + +++G+A  + YL +  +   VHRD+
Sbjct: 120 PVMIVTEYMENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKYLSDMGY---VHRDL 173
Query: 771 SSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPELAYTLKVTEKCDV 827
           +++N+L++      VSDFG+++ L  D        G      + +PE     K T   DV
Sbjct: 174 AARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDV 233
Query: 828 YSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDS--RLPYPSLHVQKKLMSIMQVA 884
           +S+G++  EV+  G+ P               I+ +D   RLP P +     L  +M   
Sbjct: 234 WSYGIVLWEVMSYGERP------YWEMSNQDVIKAVDEGYRLP-PPMDCPAALYQLM--- 283
Query: 885 FSCLDQNPESRPTMKRVSQLL 905
             C  ++  +RP  +++  +L
Sbjct: 284 LDCWQKDRNNRPKFEQIVSIL 304

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 95.1 bits (235), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 105/202 (51%), Gaps = 18/202 (8%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           IG+G  G+VY A  V +G+  A+++ +     +   ++E  +NEI  + E ++ NIV + 
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNL----QQQPKKELIINEILVMRENKNPNIVNYL 84
Query: 705 GFCSHPKHSFIIYEYLESGSLDKIL---CNDASAKELGWTQRLNVIKGVADALFYLHNNC 761
                    +++ EYL  GSL  ++   C D         Q   V +    AL +LH+N 
Sbjct: 85  DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG-------QIAAVCRECLQALEFLHSN- 136
Query: 762 FPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKV 821
              ++HR+I S N+LL +     ++DFG    + P+ S  S + GT  ++APE+      
Sbjct: 137 --QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 194
Query: 822 TEKCDVYSFGVLALEVIKGKHP 843
             K D++S G++A+E+I+G+ P
Sbjct: 195 GPKVDIWSLGIMAIEMIEGEPP 216

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 95.1 bits (235), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 87/314 (27%), Positives = 150/314 (47%), Gaps = 38/314 (12%)
Query: 612 FGNT----PGLRSVL---TFEG--KIVYE--EIISATNDFNAEHCIGKGGHGSVY--RAK 658
           FGN     PGLR+ +   T+E   + V+E  + + ATN  + +  +G G  G V   R K
Sbjct: 7   FGNGHLKLPGLRTYVDPHTYEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLK 65
Query: 659 VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYE 718
           +PS +  +V    +   G    Q+ +FL E   + +  H NI++  G  +  K   I+ E
Sbjct: 66  LPSKKEISVA-IKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTE 124
Query: 719 YLESGSLDKIL-CNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLL 777
           Y+E+GSLD  L  +DA   +    Q + +++G+A  + YL +  +   VHRD++++N+L+
Sbjct: 125 YMENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKYLSDMGY---VHRDLAARNILI 178
Query: 778 DLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPELAYTLKVTEKCDVYSFGVLA 834
           +      VSDFG+++ L  D        G      + +PE     K T   DV+S+G++ 
Sbjct: 179 NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVL 238
Query: 835 LEVIK-GKHPRDFLFEXXXXXXXXXIEMLDS--RLPYPSLHVQKKLMSIMQVAFSCLDQN 891
            EV+  G+ P               I+ +D   RLP P +     L  +M     C  ++
Sbjct: 239 WEVMSYGERP------YWEMSNQDVIKAVDEGYRLP-PPMDCPAALYQLM---LDCWQKD 288
Query: 892 PESRPTMKRVSQLL 905
             +RP  +++  +L
Sbjct: 289 RNNRPKFEQIVSIL 302

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Composition-based stats.
 Identities = 81/296 (27%), Positives = 139/296 (46%), Gaps = 27/296 (9%)
Query: 622 LTFEGKIVYEEIISATNDFNAEHCIGKGGHGSVYRAKVPSGEI-FAVKKFHSPLPGEMSF 680
           L F+G   Y++      D   +H +G G +G VY        +  AVK        E + 
Sbjct: 10  LYFQGSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTM 64
Query: 681 QQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGW 740
           + EEFL E   + EI+H N+V+  G C+     +II E++  G+L   L  + + +E+  
Sbjct: 65  EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNA 123
Query: 741 TQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN 800
              L +   ++ A+ YL    F   +HRD++++N L+   +   V+DFG+++ +  D+  
Sbjct: 124 VVLLYMATQISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-- 178
Query: 801 WSELAGTH---GYVAPE-LAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXX 855
           ++  AG      + APE LAY  K + K DV++FGVL  E+   G  P    +       
Sbjct: 179 YTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSP----YPGIDLSQ 233
Query: 856 XXXIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
              +   D R+  P     +K+  +M+   +C   NP  RP+   + Q   E +F+
Sbjct: 234 VYELLEKDYRMERPE-GCPEKVYELMR---ACWQWNPSDRPSFAEIHQAF-ETMFQ 284

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 132/278 (47%), Gaps = 28/278 (10%)
Query: 643 EHCIGKGGHGSVYRA--KVPSG-EIF-AVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHR 698
           E  IG G  G V     K+P   EIF A+K   S   G    Q+ +FL+E   + +  H 
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKS---GYTEKQRRDFLSEASIMGQFDHP 68
Query: 699 NIVKFYGFCSHPKHSFIIYEYLESGSLDKIL-CNDASAKELGWTQRLNVIKGVADALFYL 757
           N++   G  +      II E++E+GSLD  L  ND    +    Q + +++G+A  + YL
Sbjct: 69  NVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYL 125
Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG-----YVA 812
            +  +   VHR ++++N+L++      VSDFG+++FL  D+S+ +  +   G     + A
Sbjct: 126 ADMNY---VHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTA 182
Query: 813 PELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSL 871
           PE     K T   DV+S+G++  EV+  G+ P    ++         IE  D RLP P +
Sbjct: 183 PEAIQYRKFTSASDVWSYGIVMWEVMSYGERP---YWDMTNQDVINAIEQ-DYRLP-PPM 237
Query: 872 HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI 909
                L  +M     C  ++   RP   ++   L + I
Sbjct: 238 DCPSALHQLM---LDCWQKDRNHRPKFGQIVNTLDKMI 272

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/248 (33%), Positives = 120/248 (48%), Gaps = 11/248 (4%)
Query: 173 IPHEVGQLTVLNQLALDS-NFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSL 231
           IP  +  L  LN L +   N L G IP ++  LT +  LY+ + +  G+IP  +  +K+L
Sbjct: 68  IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTL 127
Query: 232 FDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGX-XXXXXXXXXXXXHFR 290
             L+   N LSG +P SIS+L NL  +    N +SG IP   G                 
Sbjct: 128 VTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLT 187
Query: 291 GTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQ 350
           G +P +F NL +L  + L++N L G+ S  FG+  N   I L+ NS   + L   G    
Sbjct: 188 GKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFD-LGKVGLSKN 245
Query: 351 LSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNI------IYLNRLSL 404
           L+ LD+  N I G++P  + +   L  L++S N + GEIP Q GN+       Y N   L
Sbjct: 246 LNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCL 304
Query: 405 SGNKLSGC 412
            G+ L  C
Sbjct: 305 CGSPLPAC 312

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 75/248 (30%), Positives = 115/248 (46%), Gaps = 28/248 (11%)
Query: 341 ILSDWGRCPQLSLLDVS-INNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYL 399
           I S     P L+ L +  INN+ G IP  I +  QL YL ++   + G IP  L  I  L
Sbjct: 68  IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTL 127
Query: 400 NRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYY-LNLSHNKLS 458
             L  S N LSG +P  + SL NL  +    N +S  +P+S GS  KL+  + +S N+L+
Sbjct: 128 VTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLT 187
Query: 459 QQIPIELDNLIHLSELDLSHNFLGEKIS-----------------------SRICRMESL 495
            +IP    NL +L+ +DLS N L    S                        ++   ++L
Sbjct: 188 GKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNL 246
Query: 496 EKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNSTTFRDAPLEALQGNKGLYG 555
             L+L  N + G +P+   ++  L  +++S+N L G+IP     +   + A   NK L G
Sbjct: 247 NGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCG 306
Query: 556 DIRGFPSC 563
                P+C
Sbjct: 307 S--PLPAC 312

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 92.8 bits (229), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 134/285 (47%), Gaps = 28/285 (9%)
Query: 636 ATNDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKF---HSPLPGEMSFQQEEFLNEIQA 691
           A N+   E  IGKGG G V++ + V    + A+K      S    EM  + +EF  E+  
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 692 LTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVA 751
           ++ + H NIVK YG   +P    ++ E++  G L   L + A    + W+ +L ++  +A
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDIA 132
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYE-----AHVSDFGIAKFLNPDSSNWSELAG 806
             + Y+ N   PPIVHRD+ S N+ L    E     A V+DFG+++       + S L G
Sbjct: 133 LGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ---QSVHSVSGLLG 188
Query: 807 THGYVAPEL--AYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEXXXXXXXXXIEMLDS 864
              ++APE   A     TEK D YSF ++   ++ G+ P    F+         I M+  
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP----FDEYSYGKIKFINMIRE 244
Query: 865 RLPYPSL--HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCE 907
               P++      +L +++++   C   +P+ RP    + + L E
Sbjct: 245 EGLRPTIPEDCPPRLRNVIEL---CWSGDPKKRPHFSYIVKELSE 286

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 92.4 bits (228), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 133/281 (47%), Gaps = 27/281 (9%)
Query: 634 ISATNDFNAEHCIGKGGHGSVY--RAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQA 691
           + ATN  + +  +G G  G V   R K+PS +  +V    +   G    Q+ +FL E   
Sbjct: 30  LDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVA-IKTLKVGYTEKQRRDFLGEASI 87
Query: 692 LTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKIL-CNDASAKELGWTQRLNVIKGV 750
           + +  H NI++  G  +  K   I+ EY+E+GSLD  L  +DA   +    Q + +++G+
Sbjct: 88  MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA---QFTVIQLVGMLRGI 144
Query: 751 ADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH-- 808
           A  + YL +  +   VHRD++++N+L++      VSDFG+++ L  D        G    
Sbjct: 145 ASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 201
Query: 809 -GYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDS-- 864
             + +PE     K T   DV+S+G++  EV+  G+ P               I+ +D   
Sbjct: 202 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP------YWEMSNQDVIKAVDEGY 255
Query: 865 RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
           RLP P +     L  +M     C  ++  +RP  +++  +L
Sbjct: 256 RLP-PPMDCPAALYQLM---LDCWQKDRNNRPKFEQIVSIL 292

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 87/321 (27%), Positives = 152/321 (47%), Gaps = 38/321 (11%)
Query: 605 SQTQQSSFGNT----PGLRSVL---TFEG--KIVYE--EIISATNDFNAEHCIGKGGHGS 653
           S  ++  FGN     PGLR+ +   T+E   + V+E  + + ATN  + +  +G G  G 
Sbjct: 2   SDEKRLHFGNGHLKLPGLRTYVDPHTYEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGE 60
Query: 654 VY--RAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPK 711
           V   R K+PS +  +V    +   G    Q+ +FL E   + +  H NI++  G  +  K
Sbjct: 61  VCSGRLKLPSKKEISVA-IKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK 119
Query: 712 HSFIIYEYLESGSLDKIL-CNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDI 770
              I+ E +E+GSLD  L  +DA   +    Q + +++G+A  + YL +  +   VHRD+
Sbjct: 120 PVMIVTEXMENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKYLSDMGY---VHRDL 173
Query: 771 SSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPELAYTLKVTEKCDV 827
           +++N+L++      VSDFG+++ L  D        G      + +PE     K T   DV
Sbjct: 174 AARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDV 233
Query: 828 YSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDS--RLPYPSLHVQKKLMSIMQVA 884
           +S+G++  EV+  G+ P               I+ +D   RLP P +     L  +M   
Sbjct: 234 WSYGIVLWEVMSYGERP------YWEMSNQDVIKAVDEGYRLP-PPMDCPAALYQLM--- 283
Query: 885 FSCLDQNPESRPTMKRVSQLL 905
             C  ++  +RP  +++  +L
Sbjct: 284 LDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 133/281 (47%), Gaps = 27/281 (9%)
Query: 634 ISATNDFNAEHCIGKGGHGSVY--RAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQA 691
           + ATN  + +  +G G  G V   R K+PS +  +V    +   G    Q+ +FL E   
Sbjct: 13  LDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVA-IKTLKVGYTEKQRRDFLGEASI 70
Query: 692 LTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKIL-CNDASAKELGWTQRLNVIKGV 750
           + +  H NI++  G  +  K   I+ EY+E+GSLD  L  +DA   +    Q + +++G+
Sbjct: 71  MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA---QFTVIQLVGMLRGI 127
Query: 751 ADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH-- 808
           A  + YL +  +   VHRD++++N+L++      VSDFG+++ L  D        G    
Sbjct: 128 ASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 184
Query: 809 -GYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDS-- 864
             + +PE     K T   DV+S+G++  EV+  G+ P               I+ +D   
Sbjct: 185 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP------YWEMSNQDVIKAVDEGY 238
Query: 865 RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
           RLP P +     L  +M     C  ++  +RP  +++  +L
Sbjct: 239 RLP-PPMDCPAALYQLM---LDCWQKDRNNRPKFEQIVSIL 275

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 88/321 (27%), Positives = 151/321 (47%), Gaps = 38/321 (11%)
Query: 605 SQTQQSSFGNT----PGLRSVL---TFEG--KIVYE--EIISATNDFNAEHCIGKGGHGS 653
           S  ++  FGN     PGLR+ +   TFE   + V+E  + + ATN  + +  +G G  G 
Sbjct: 2   SDEKRLHFGNGHLKLPGLRTFVDPHTFEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGE 60
Query: 654 VY--RAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPK 711
           V   R K+PS +  +V    +   G    Q+ +FL E   + +  H NI++  G  +  K
Sbjct: 61  VCSGRLKLPSKKEISVA-IKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK 119
Query: 712 HSFIIYEYLESGSLDKIL-CNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDI 770
              I+ E +E+GSLD  L  +DA   +    Q + +++G+A  + YL +      VHRD+
Sbjct: 120 PVMIVTEXMENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKYLSDMG---AVHRDL 173
Query: 771 SSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPELAYTLKVTEKCDV 827
           +++N+L++      VSDFG+++ L  D        G      + +PE     K T   DV
Sbjct: 174 AARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDV 233
Query: 828 YSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDS--RLPYPSLHVQKKLMSIMQVA 884
           +S+G++  EV+  G+ P               I+ +D   RLP P +     L  +M   
Sbjct: 234 WSYGIVLWEVMSYGERP------YWEMSNQDVIKAVDEGYRLP-PPMDCPAALYQLM--- 283
Query: 885 FSCLDQNPESRPTMKRVSQLL 905
             C  ++  +RP  +++  +L
Sbjct: 284 LDCWQKDRNNRPKFEQIVSIL 304

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 133/285 (46%), Gaps = 28/285 (9%)
Query: 636 ATNDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKF---HSPLPGEMSFQQEEFLNEIQA 691
           A N+   E  IGKGG G V++ + V    + A+K      S    EM  + +EF  E+  
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 692 LTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVA 751
           ++ + H NIVK YG   +P    ++ E++  G L   L + A    + W+ +L ++  +A
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDIA 132
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYE-----AHVSDFGIAKFLNPDSSNWSELAG 806
             + Y+ N   PPIVHRD+ S N+ L    E     A V+DFG ++       + S L G
Sbjct: 133 LGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ---QSVHSVSGLLG 188
Query: 807 THGYVAPEL--AYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEXXXXXXXXXIEMLDS 864
              ++APE   A     TEK D YSF ++   ++ G+ P    F+         I M+  
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP----FDEYSYGKIKFINMIRE 244
Query: 865 RLPYPSL--HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCE 907
               P++      +L +++++   C   +P+ RP    + + L E
Sbjct: 245 EGLRPTIPEDCPPRLRNVIEL---CWSGDPKKRPHFSYIVKELSE 286

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Composition-based stats.
 Identities = 72/264 (27%), Positives = 123/264 (46%), Gaps = 24/264 (9%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           +G G  G V+          A+K      PG MS   E FL E Q + +++H  +V+ Y 
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLK---PGTMS--PESFLEEAQIMKKLKHDKLVQLYA 71
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
             S  +  +I+ EY+  GSL   L  D   + L     +++   VA  + Y+    +   
Sbjct: 72  VVSE-EPIYIVTEYMNKGSLLDFL-KDGEGRALKLPNLVDMAAQVAAGMAYIERMNY--- 126
Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH-GYVAPELAYTLKVTEK 824
           +HRD+ S N+L+  G    ++DFG+A+ +  +     + A     + APE A   + T K
Sbjct: 127 IHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIK 186
Query: 825 CDVYSFGVLALEVI-KGKHPRDFLFEXXXXXXXXXIEMLDS--RLPYPSLHVQKKLMSIM 881
            DV+SFG+L  E++ KG+ P   +           +E ++   R+P P    Q   +S+ 
Sbjct: 187 SDVWSFGILLTELVTKGRVPYPGM------NNREVLEQVERGYRMPCP----QDCPISLH 236
Query: 882 QVAFSCLDQNPESRPTMKRVSQLL 905
           ++   C  ++PE RPT + +   L
Sbjct: 237 ELMIHCWKKDPEERPTFEYLQSFL 260

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Composition-based stats.
 Identities = 77/279 (27%), Positives = 132/279 (47%), Gaps = 27/279 (9%)
Query: 639 DFNAEHCIGKGGHGSVYRAKVPSGEI-FAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH 697
           D   +H +G G +G VY        +  AVK        E + + EEFL E   + EI+H
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKH 68
Query: 698 RNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYL 757
            N+V+  G C+     +II E++  G+L   L  + + +E+     L +   ++ A+ YL
Sbjct: 69  PNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPE 814
               F   +HRD++++N L+   +   V+DFG+++ +  D+  ++  AG      + APE
Sbjct: 128 EKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE 182
Query: 815 -LAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLH 872
            LAY  K + K DV++FGVL  E+   G  P    +          +   D R+  P   
Sbjct: 183 SLAYN-KFSIKSDVWAFGVLLWEIATYGMSP----YPGIDLSQVYELLEKDYRMERPE-G 236
Query: 873 VQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
             +K+  +M+   +C   NP  RP+   + Q   E +F+
Sbjct: 237 CPEKVYELMR---ACWQWNPSDRPSFAEIHQAF-ETMFQ 271

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Composition-based stats.
 Identities = 77/279 (27%), Positives = 132/279 (47%), Gaps = 27/279 (9%)
Query: 639 DFNAEHCIGKGGHGSVYRAKVPSGEI-FAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH 697
           D   +H +G G +G VY        +  AVK        E + + EEFL E   + EI+H
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKH 68
Query: 698 RNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYL 757
            N+V+  G C+     +II E++  G+L   L  + + +E+     L +   ++ A+ YL
Sbjct: 69  PNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPE 814
               F   +HRD++++N L+   +   V+DFG+++ +  D+  ++  AG      + APE
Sbjct: 128 EKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE 182
Query: 815 -LAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLH 872
            LAY  K + K DV++FGVL  E+   G  P    +          +   D R+  P   
Sbjct: 183 SLAYN-KFSIKSDVWAFGVLLWEIATYGMSP----YPGIDLSQVYELLEKDYRMERPE-G 236
Query: 873 VQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
             +K+  +M+   +C   NP  RP+   + Q   E +F+
Sbjct: 237 CPEKVYELMR---ACWQWNPSDRPSFAEIHQAF-ETMFQ 271

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Composition-based stats.
 Identities = 73/273 (26%), Positives = 121/273 (44%), Gaps = 26/273 (9%)
Query: 639 DFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHR 698
           +   E  IG GG G VYRA     E+      H P   ++S   E    E +    ++H 
Sbjct: 8   ELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDP-DEDISQTIENVRQEAKLFAMLKHP 66
Query: 699 NIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLH 758
           NI+   G C    +  ++ E+   G L+++L    S K +     +N    +A  + YLH
Sbjct: 67  NIIALRGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLH 122
Query: 759 NNCFPPIVHRDISSKNVLL-------DLGYEA-HVSDFGIAKFLNPDSSNWSELAGTHGY 810
           +    PI+HRD+ S N+L+       DL  +   ++DFG+A+  +  +      AG + +
Sbjct: 123 DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK--MSAAGAYAW 180
Query: 811 VAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEXXXXXXXXXIEMLDSRLPYPS 870
           +APE+      ++  DV+S+GVL  E++ G+ P               + M    LP PS
Sbjct: 181 MAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP---FRGIDGLAVAYGVAMNKLALPIPS 237
Query: 871 LHVQ--KKLMSIMQVAFSCLDQNPESRPTMKRV 901
              +   KLM        C + +P SRP+   +
Sbjct: 238 TCPEPFAKLME------DCWNPDPHSRPSFTNI 264

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Composition-based stats.
 Identities = 77/279 (27%), Positives = 132/279 (47%), Gaps = 27/279 (9%)
Query: 639 DFNAEHCIGKGGHGSVYRAKVPSGEI-FAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH 697
           D   +H +G G +G VY        +  AVK        E + + EEFL E   + EI+H
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKH 73
Query: 698 RNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYL 757
            N+V+  G C+     +II E++  G+L   L  + + +E+     L +   ++ A+ YL
Sbjct: 74  PNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYL 132
Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPE 814
               F   +HRD++++N L+   +   V+DFG+++ +  D+  ++  AG      + APE
Sbjct: 133 EKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE 187
Query: 815 -LAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLH 872
            LAY  K + K DV++FGVL  E+   G  P    +          +   D R+  P   
Sbjct: 188 SLAYN-KFSIKSDVWAFGVLLWEIATYGMSP----YPGIDLSQVYELLEKDYRMERPE-G 241
Query: 873 VQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
             +K+  +M+   +C   NP  RP+   + Q   E +F+
Sbjct: 242 CPEKVYELMR---ACWQWNPSDRPSFAEIHQAF-ETMFQ 276

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Composition-based stats.
 Identities = 77/279 (27%), Positives = 132/279 (47%), Gaps = 27/279 (9%)
Query: 639 DFNAEHCIGKGGHGSVYRAKVPSGEI-FAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH 697
           D   +H +G G +G VY        +  AVK        E + + EEFL E   + EI+H
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKH 68
Query: 698 RNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYL 757
            N+V+  G C+     +II E++  G+L   L  + + +E+     L +   ++ A+ YL
Sbjct: 69  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPE 814
               F   +HRD++++N L+   +   V+DFG+++ +  D+  ++  AG      + APE
Sbjct: 128 EKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE 182
Query: 815 -LAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLH 872
            LAY  K + K DV++FGVL  E+   G  P    +          +   D R+  P   
Sbjct: 183 SLAYN-KFSIKSDVWAFGVLLWEIATYGMSP----YPGIDLSQVYELLEKDYRMERPE-G 236
Query: 873 VQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
             +K+  +M+   +C   NP  RP+   + Q   E +F+
Sbjct: 237 CPEKVYELMR---ACWQWNPSDRPSFAEIHQAF-ETMFQ 271

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Composition-based stats.
 Identities = 77/279 (27%), Positives = 132/279 (47%), Gaps = 27/279 (9%)
Query: 639 DFNAEHCIGKGGHGSVYRAKVPSGEI-FAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH 697
           D   +H +G G +G VY        +  AVK        E + + EEFL E   + EI+H
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKH 68
Query: 698 RNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYL 757
            N+V+  G C+     +II E++  G+L   L  + + +E+     L +   ++ A+ YL
Sbjct: 69  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPE 814
               F   +HRD++++N L+   +   V+DFG+++ +  D+  ++  AG      + APE
Sbjct: 128 EKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE 182
Query: 815 -LAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLH 872
            LAY  K + K DV++FGVL  E+   G  P    +          +   D R+  P   
Sbjct: 183 SLAYN-KFSIKSDVWAFGVLLWEIATYGMSP----YPGIDLSQVYELLEKDYRMERPE-G 236
Query: 873 VQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
             +K+  +M+   +C   NP  RP+   + Q   E +F+
Sbjct: 237 CPEKVYELMR---ACWQWNPSDRPSFAEIHQAF-ETMFQ 271

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Composition-based stats.
 Identities = 77/279 (27%), Positives = 132/279 (47%), Gaps = 27/279 (9%)
Query: 639 DFNAEHCIGKGGHGSVYRAKVPSGEI-FAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH 697
           D   +H +G G +G VY        +  AVK        E + + EEFL E   + EI+H
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKH 73
Query: 698 RNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYL 757
            N+V+  G C+     +II E++  G+L   L  + + +E+     L +   ++ A+ YL
Sbjct: 74  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYL 132
Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPE 814
               F   +HRD++++N L+   +   V+DFG+++ +  D+  ++  AG      + APE
Sbjct: 133 EKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE 187
Query: 815 -LAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLH 872
            LAY  K + K DV++FGVL  E+   G  P    +          +   D R+  P   
Sbjct: 188 SLAYN-KFSIKSDVWAFGVLLWEIATYGMSP----YPGIDLSQVYELLEKDYRMERPE-G 241
Query: 873 VQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
             +K+  +M+   +C   NP  RP+   + Q   E +F+
Sbjct: 242 CPEKVYELMR---ACWQWNPSDRPSFAEIHQAF-ETMFQ 276

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Composition-based stats.
 Identities = 77/279 (27%), Positives = 132/279 (47%), Gaps = 27/279 (9%)
Query: 639 DFNAEHCIGKGGHGSVYRAKVPSGEI-FAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH 697
           D   +H +G G +G VY        +  AVK        E + + EEFL E   + EI+H
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKH 73
Query: 698 RNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYL 757
            N+V+  G C+     +II E++  G+L   L  + + +E+     L +   ++ A+ YL
Sbjct: 74  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYL 132
Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPE 814
               F   +HRD++++N L+   +   V+DFG+++ +  D+  ++  AG      + APE
Sbjct: 133 EKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE 187
Query: 815 -LAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLH 872
            LAY  K + K DV++FGVL  E+   G  P    +          +   D R+  P   
Sbjct: 188 SLAYN-KFSIKSDVWAFGVLLWEIATYGMSP----YPGIDLSQVYELLEKDYRMERPE-G 241
Query: 873 VQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
             +K+  +M+   +C   NP  RP+   + Q   E +F+
Sbjct: 242 CPEKVYELMR---ACWQWNPSDRPSFAEIHQAF-ETMFQ 276

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Composition-based stats.
 Identities = 77/279 (27%), Positives = 132/279 (47%), Gaps = 27/279 (9%)
Query: 639 DFNAEHCIGKGGHGSVYRAKVPSGEI-FAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH 697
           D   +H +G G +G VY        +  AVK        E + + EEFL E   + EI+H
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKH 73
Query: 698 RNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYL 757
            N+V+  G C+     +II E++  G+L   L  + + +E+     L +   ++ A+ YL
Sbjct: 74  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYL 132
Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPE 814
               F   +HRD++++N L+   +   V+DFG+++ +  D+  ++  AG      + APE
Sbjct: 133 EKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE 187
Query: 815 -LAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLH 872
            LAY  K + K DV++FGVL  E+   G  P    +          +   D R+  P   
Sbjct: 188 SLAYN-KFSIKSDVWAFGVLLWEIATYGMSP----YPGIDLSQVYELLEKDYRMERPE-G 241
Query: 873 VQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
             +K+  +M+   +C   NP  RP+   + Q   E +F+
Sbjct: 242 CPEKVYELMR---ACWQWNPSDRPSFAEIHQAF-ETMFQ 276

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Composition-based stats.
 Identities = 77/279 (27%), Positives = 132/279 (47%), Gaps = 27/279 (9%)
Query: 639 DFNAEHCIGKGGHGSVYRAKVPSGEI-FAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH 697
           D   +H +G G +G VY        +  AVK        E + + EEFL E   + EI+H
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKH 68
Query: 698 RNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYL 757
            N+V+  G C+     +II E++  G+L   L  + + +E+     L +   ++ A+ YL
Sbjct: 69  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYL 127
Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPE 814
               F   +HRD++++N L+   +   V+DFG+++ +  D+  ++  AG      + APE
Sbjct: 128 EKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE 182
Query: 815 -LAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLH 872
            LAY  K + K DV++FGVL  E+   G  P    +          +   D R+  P   
Sbjct: 183 SLAYN-KFSIKSDVWAFGVLLWEIATYGMSP----YPGIDLSQVYELLEKDYRMERPE-G 236
Query: 873 VQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
             +K+  +M+   +C   NP  RP+   + Q   E +F+
Sbjct: 237 CPEKVYELMR---ACWQWNPSDRPSFAEIHQAF-ETMFQ 271

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Composition-based stats.
 Identities = 77/279 (27%), Positives = 132/279 (47%), Gaps = 27/279 (9%)
Query: 639 DFNAEHCIGKGGHGSVYRAKVPSGEI-FAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH 697
           D   +H +G G +G VY        +  AVK        E + + EEFL E   + EI+H
Sbjct: 18  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKH 72
Query: 698 RNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYL 757
            N+V+  G C+     +II E++  G+L   L  + + +E+     L +   ++ A+ YL
Sbjct: 73  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYL 131
Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPE 814
               F   +HRD++++N L+   +   V+DFG+++ +  D+  ++  AG      + APE
Sbjct: 132 EKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE 186
Query: 815 -LAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLH 872
            LAY  K + K DV++FGVL  E+   G  P    +          +   D R+  P   
Sbjct: 187 SLAYN-KFSIKSDVWAFGVLLWEIATYGMSP----YPGIDLSQVYELLEKDYRMERPE-G 240
Query: 873 VQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
             +K+  +M+   +C   NP  RP+   + Q   E +F+
Sbjct: 241 CPEKVYELMR---ACWQWNPSDRPSFAEIHQAF-ETMFQ 275

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Composition-based stats.
 Identities = 77/279 (27%), Positives = 132/279 (47%), Gaps = 27/279 (9%)
Query: 639 DFNAEHCIGKGGHGSVYRAKVPSGEI-FAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH 697
           D   +H +G G +G VY        +  AVK        E + + EEFL E   + EI+H
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKH 70
Query: 698 RNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYL 757
            N+V+  G C+     +II E++  G+L   L  + + +E+     L +   ++ A+ YL
Sbjct: 71  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYL 129
Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPE 814
               F   +HRD++++N L+   +   V+DFG+++ +  D+  ++  AG      + APE
Sbjct: 130 EKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE 184
Query: 815 -LAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLH 872
            LAY  K + K DV++FGVL  E+   G  P    +          +   D R+  P   
Sbjct: 185 SLAYN-KFSIKSDVWAFGVLLWEIATYGMSP----YPGIDLSQVYELLEKDYRMERPE-G 238
Query: 873 VQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
             +K+  +M+   +C   NP  RP+   + Q   E +F+
Sbjct: 239 CPEKVYELMR---ACWQWNPSDRPSFAEIHQAF-ETMFQ 273

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Composition-based stats.
 Identities = 77/279 (27%), Positives = 132/279 (47%), Gaps = 27/279 (9%)
Query: 639 DFNAEHCIGKGGHGSVYRAKVPSGEI-FAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH 697
           D   +H +G G +G VY        +  AVK        E + + EEFL E   + EI+H
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKH 70
Query: 698 RNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYL 757
            N+V+  G C+     +II E++  G+L   L  + + +E+     L +   ++ A+ YL
Sbjct: 71  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYL 129
Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPE 814
               F   +HRD++++N L+   +   V+DFG+++ +  D+  ++  AG      + APE
Sbjct: 130 EKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE 184
Query: 815 -LAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLH 872
            LAY  K + K DV++FGVL  E+   G  P    +          +   D R+  P   
Sbjct: 185 SLAYN-KFSIKSDVWAFGVLLWEIATYGMSP----YPGIDLSQVYELLEKDYRMERPE-G 238
Query: 873 VQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
             +K+  +M+   +C   NP  RP+   + Q   E +F+
Sbjct: 239 CPEKVYELMR---ACWQWNPSDRPSFAEIHQAF-ETMFQ 273

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Composition-based stats.
 Identities = 77/279 (27%), Positives = 132/279 (47%), Gaps = 27/279 (9%)
Query: 639 DFNAEHCIGKGGHGSVYRAKVPSGEI-FAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH 697
           D   +H +G G +G VY        +  AVK        E + + EEFL E   + EI+H
Sbjct: 15  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKH 69
Query: 698 RNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYL 757
            N+V+  G C+     +II E++  G+L   L  + + +E+     L +   ++ A+ YL
Sbjct: 70  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYL 128
Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPE 814
               F   +HRD++++N L+   +   V+DFG+++ +  D+  ++  AG      + APE
Sbjct: 129 EKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAPAGAKFPIKWTAPE 183
Query: 815 -LAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLH 872
            LAY  K + K DV++FGVL  E+   G  P    +          +   D R+  P   
Sbjct: 184 SLAYN-KFSIKSDVWAFGVLLWEIATYGMSP----YPGIDLSQVYELLEKDYRMERPE-G 237
Query: 873 VQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
             +K+  +M+   +C   NP  RP+   + Q   E +F+
Sbjct: 238 CPEKVYELMR---ACWQWNPSDRPSFAEIHQAF-ETMFQ 272

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Composition-based stats.
 Identities = 77/279 (27%), Positives = 132/279 (47%), Gaps = 27/279 (9%)
Query: 639 DFNAEHCIGKGGHGSVYRAKVPSGEI-FAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH 697
           D   +H +G G +G VY        +  AVK        E + + EEFL E   + EI+H
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKH 70
Query: 698 RNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYL 757
            N+V+  G C+     +II E++  G+L   L  + + +E+     L +   ++ A+ YL
Sbjct: 71  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYL 129
Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPE 814
               F   +HRD++++N L+   +   V+DFG+++ +  D+  ++  AG      + APE
Sbjct: 130 EKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAPAGAKFPIKWTAPE 184
Query: 815 -LAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLH 872
            LAY  K + K DV++FGVL  E+   G  P    +          +   D R+  P   
Sbjct: 185 SLAYN-KFSIKSDVWAFGVLLWEIATYGMSP----YPGIDLSQVYELLEKDYRMERPE-G 238
Query: 873 VQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
             +K+  +M+   +C   NP  RP+   + Q   E +F+
Sbjct: 239 CPEKVYELMR---ACWQWNPSDRPSFAEIHQAF-ETMFQ 273

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 71/278 (25%), Positives = 122/278 (43%), Gaps = 36/278 (12%)
Query: 646 IGKGGHGSVYR-AKVPSGEIFAVKKFHSPLPGEMSFQQEE---FLNEIQALTEIRHRNIV 701
           +GKG  G   +     +GE+  +K+        + F +E    FL E++ +  + H N++
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKEL-------IRFDEETQRTFLKEVKVMRCLEHPNVL 70
Query: 702 KFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNC 761
           KF G     K    I EY++ G+L  I+   +   +  W+QR++  K +A  + YLH+  
Sbjct: 71  KFIGVLYKDKRLNFITEYIKGGTLRGII--KSMDSQYPWSQRVSFAKDIASGMAYLHSM- 127
Query: 762 FPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL--------------NPDSSNWSELAGT 807
              I+HRD++S N L+       V+DFG+A+ +               PD      + G 
Sbjct: 128 --NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185
Query: 808 HGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEXXXXXXXXXIEMLDSRLP 867
             ++APE+       EK DV+SFG++  E+I G+   D  +          +     R  
Sbjct: 186 PYWMAPEMINGRSYDEKVDVFSFGIVLCEII-GRVNADPDYLPRTMDFGLNVRGFLDRYC 244
Query: 868 YPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
            P+        S   +   C D +PE RP+  ++   L
Sbjct: 245 PPNCPP-----SFFPITVRCCDLDPEKRPSFVKLEHWL 277

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Composition-based stats.
 Identities = 75/271 (27%), Positives = 128/271 (47%), Gaps = 26/271 (9%)
Query: 639 DFNAEHCIGKGGHGSVYRAKVPSGEI-FAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH 697
           D   +H +G G +G VY        +  AVK        E + + EEFL E   + EI+H
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKH 68
Query: 698 RNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYL 757
            N+V+  G C+     +II E++  G+L   L  + + +E+     L +   ++ A+ YL
Sbjct: 69  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYL 127
Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPE 814
               F   +HRD++++N L+   +   V+DFG+++ +  D+  ++  AG      + APE
Sbjct: 128 EKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE 182
Query: 815 -LAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLH 872
            LAY  K + K DV++FGVL  E+   G  P    +          +   D R+  P   
Sbjct: 183 SLAYN-KFSIKSDVWAFGVLLWEIATYGMSP----YPGIDLSQVYELLEKDYRMERPE-G 236
Query: 873 VQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ 903
             +K+  +M+   +C   NP  RP+   + Q
Sbjct: 237 CPEKVYELMR---ACWQWNPSDRPSFAEIHQ 264

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 133/285 (46%), Gaps = 28/285 (9%)
Query: 636 ATNDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKF---HSPLPGEMSFQQEEFLNEIQA 691
           A N+   E  IGKGG G V++ + V    + A+K      S    EM  + +EF  E+  
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 692 LTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVA 751
           ++ + H NIVK YG   +P    ++ E++  G L   L + A    + W+ +L ++  +A
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDIA 132
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYE-----AHVSDFGIAKFLNPDSSNWSELAG 806
             + Y+ N   PPIVHRD+ S N+ L    E     A V+DF +++       + S L G
Sbjct: 133 LGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ---QSVHSVSGLLG 188
Query: 807 THGYVAPEL--AYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEXXXXXXXXXIEMLDS 864
              ++APE   A     TEK D YSF ++   ++ G+ P    F+         I M+  
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP----FDEYSYGKIKFINMIRE 244
Query: 865 RLPYPSL--HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCE 907
               P++      +L +++++   C   +P+ RP    + + L E
Sbjct: 245 EGLRPTIPEDCPPRLRNVIEL---CWSGDPKKRPHFSYIVKELSE 286

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 90.1 bits (222), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 73/252 (28%), Positives = 113/252 (44%), Gaps = 35/252 (13%)
Query: 619 RSVLTFEGKI----------VYEEIISATNDFNAE---------HCIGKGGHGSVY--RA 657
           R  L F+GK+           YEE   A   F  E           IG G  G V   R 
Sbjct: 11  RENLYFQGKLPEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRL 70
Query: 658 KVPSGE--IFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI 715
           +VP       A+K   +   G    Q+ +FL+E   + +  H NI++  G  +  + + I
Sbjct: 71  RVPGQRDVPVAIKALKA---GYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127
Query: 716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNV 775
           + EY+E+GSLD  L       +    Q + +++GV   + YL +  +   VHRD++++NV
Sbjct: 128 VTEYMENGSLDTFLRTHDG--QFTIMQLVGMLRGVGAGMRYLSDLGY---VHRDLAARNV 182
Query: 776 LLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPELAYTLKVTEKCDVYSFGV 832
           L+D      VSDFG+++ L  D        G      + APE       +   DV+SFGV
Sbjct: 183 LVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGV 242
Query: 833 LALEVIK-GKHP 843
           +  EV+  G+ P
Sbjct: 243 VMWEVLAYGERP 254

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Composition-based stats.
 Identities = 77/279 (27%), Positives = 132/279 (47%), Gaps = 27/279 (9%)
Query: 639 DFNAEHCIGKGGHGSVYRAKVPSGEI-FAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH 697
           D   +H +G G +G VY        +  AVK        E + + EEFL E   + EI+H
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKH 66
Query: 698 RNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYL 757
            N+V+  G C+     +II E++  G+L   L  + + +E+     L +   ++ A+ YL
Sbjct: 67  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYL 125
Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPE 814
               F   +HRD++++N L+   +   V+DFG+++ +  D+  ++  AG      + APE
Sbjct: 126 EKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--FTAHAGAKFPIKWTAPE 180
Query: 815 -LAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLH 872
            LAY  K + K DV++FGVL  E+   G  P    +          +   D R+  P   
Sbjct: 181 SLAYN-KFSIKSDVWAFGVLLWEIATYGMSP----YPGIDPSQVYELLEKDYRMERPE-G 234
Query: 873 VQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
             +K+  +M+   +C   NP  RP+   + Q   E +F+
Sbjct: 235 CPEKVYELMR---ACWQWNPSDRPSFAEIHQAF-ETMFQ 269

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 89.7 bits (221), Expect = 7e-18,   Method: Composition-based stats.
 Identities = 77/279 (27%), Positives = 131/279 (46%), Gaps = 27/279 (9%)
Query: 639 DFNAEHCIGKGGHGSVYRAKVPSGEI-FAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH 697
           D   +H +G G +G VY        +  AVK        E + + EEFL E   + EI+H
Sbjct: 15  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKH 69
Query: 698 RNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYL 757
            N+V+  G C+     +II E++  G+L   L  + + +E+     L +   ++ A+ YL
Sbjct: 70  PNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYL 128
Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPE 814
               F   +HRD++++N L+   +   V+DFG+++ +  D+   +  AG      + APE
Sbjct: 129 EKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--TAHAGAKFPIKWTAPE 183
Query: 815 -LAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLH 872
            LAY  K + K DV++FGVL  E+   G  P    +          +   D R+  P   
Sbjct: 184 SLAYN-KFSIKSDVWAFGVLLWEIATYGMSP----YPGIDLSQVYELLEKDYRMERPE-G 237
Query: 873 VQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
             +K+  +M+   +C   NP  RP+   + Q   E +F+
Sbjct: 238 CPEKVYELMR---ACWQWNPSDRPSFAEIHQAF-ETMFQ 272

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 89.7 bits (221), Expect = 7e-18,   Method: Composition-based stats.
 Identities = 77/279 (27%), Positives = 131/279 (46%), Gaps = 27/279 (9%)
Query: 639 DFNAEHCIGKGGHGSVYRAKVPSGEI-FAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH 697
           D   +H +G G +G VY        +  AVK        E + + EEFL E   + EI+H
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKH 73
Query: 698 RNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYL 757
            N+V+  G C+     +II E++  G+L   L  + + +E+     L +   ++ A+ YL
Sbjct: 74  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYL 132
Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPE 814
               F   +HRD++++N L+   +   V+DFG+++ +  D+   +  AG      + APE
Sbjct: 133 EKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--TAHAGAKFPIKWTAPE 187
Query: 815 -LAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLH 872
            LAY  K + K DV++FGVL  E+   G  P    +          +   D R+  P   
Sbjct: 188 SLAYN-KFSIKSDVWAFGVLLWEIATYGMSP----YPGIDLSQVYELLEKDYRMERPE-G 241
Query: 873 VQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
             +K+  +M+   +C   NP  RP+   + Q   E +F+
Sbjct: 242 CPEKVYELMR---ACWQWNPSDRPSFAEIHQAF-ETMFQ 276

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Composition-based stats.
 Identities = 77/279 (27%), Positives = 131/279 (46%), Gaps = 27/279 (9%)
Query: 639 DFNAEHCIGKGGHGSVYRAKVPSGEI-FAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH 697
           D   +H +G G +G VY        +  AVK        E + + EEFL E   + EI+H
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKH 66
Query: 698 RNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYL 757
            N+V+  G C+     +II E++  G+L   L  + + +E+     L +   ++ A+ YL
Sbjct: 67  PNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYL 125
Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPE 814
               F   +HRD++++N L+   +   V+DFG+++ +  D+   +  AG      + APE
Sbjct: 126 EKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--TAHAGAKFPIKWTAPE 180
Query: 815 -LAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLH 872
            LAY  K + K DV++FGVL  E+   G  P    +          +   D R+  P   
Sbjct: 181 SLAYN-KFSIKSDVWAFGVLLWEIATYGMSP----YPGIDPSQVYELLEKDYRMERPE-G 234
Query: 873 VQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
             +K+  +M+   +C   NP  RP+   + Q   E +F+
Sbjct: 235 CPEKVYELMR---ACWQWNPSDRPSFAEIHQAF-ETMFQ 269

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 132/281 (46%), Gaps = 27/281 (9%)
Query: 634 ISATNDFNAEHCIGKGGHGSVY--RAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQA 691
           + ATN  + +  +G G  G V   R K+PS +  +V    +   G    Q+ +FL E   
Sbjct: 13  LDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVA-IKTLKVGYTEKQRRDFLGEASI 70
Query: 692 LTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKIL-CNDASAKELGWTQRLNVIKGV 750
           + +  H NI++  G  +  K   I+ E +E+GSLD  L  +DA   +    Q + +++G+
Sbjct: 71  MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDA---QFTVIQLVGMLRGI 127
Query: 751 ADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH-- 808
           A  + YL +  +   VHRD++++N+L++      VSDFG+++ L  D        G    
Sbjct: 128 ASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 184
Query: 809 -GYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDS-- 864
             + +PE     K T   DV+S+G++  EV+  G+ P               I+ +D   
Sbjct: 185 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP------YWEMSNQDVIKAVDEGY 238
Query: 865 RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
           RLP P +     L  +M     C  ++  +RP  +++  +L
Sbjct: 239 RLP-PPMDCPAALYQLM---LDCWQKDRNNRPKFEQIVSIL 275

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 89.4 bits (220), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 78/269 (28%), Positives = 126/269 (46%), Gaps = 23/269 (8%)
Query: 636 ATNDFNAEHCIGKGGHGSVYRAKVPSGE-IFAVKK-FHSPLPGEMSFQQEEFLNEIQALT 693
           A  DF     +GKG  G+VY A+    + I A+K  F + L  E +  + +   E++  +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQS 63
Query: 694 EIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADA 753
            +RH NI++ YG+       ++I EY   G++ + L   +   E    +    I  +A+A
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANA 120
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAP 813
           L Y H+     ++HRDI  +N+LL    E  ++DFG +  ++  SS  +EL GT  Y+ P
Sbjct: 121 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTELCGTLDYLPP 175
Query: 814 ELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEX-XXXXXXXXIEMLDSRLPYPSLH 872
           E+       EK D++S GVL  E + GK P    FE          I  ++   P     
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFVTE 231
Query: 873 VQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
             + L+S +      L  NP  RP ++ V
Sbjct: 232 GARDLISRL------LKHNPSQRPMLREV 254

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 89.4 bits (220), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 73/252 (28%), Positives = 113/252 (44%), Gaps = 35/252 (13%)
Query: 619 RSVLTFEGKI----------VYEEIISATNDFNAE---------HCIGKGGHGSVY--RA 657
           R  L F+GK+           YEE   A   F  E           IG G  G V   R 
Sbjct: 11  RENLYFQGKLPEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRL 70
Query: 658 KVPSGE--IFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI 715
           +VP       A+K   +   G    Q+ +FL+E   + +  H NI++  G  +  + + I
Sbjct: 71  RVPGQRDVPVAIKALKA---GYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127
Query: 716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNV 775
           + EY+E+GSLD  L       +    Q + +++GV   + YL +  +   VHRD++++NV
Sbjct: 128 VTEYMENGSLDTFLRTHDG--QFTIMQLVGMLRGVGAGMRYLSDLGY---VHRDLAARNV 182
Query: 776 LLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPELAYTLKVTEKCDVYSFGV 832
           L+D      VSDFG+++ L  D        G      + APE       +   DV+SFGV
Sbjct: 183 LVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGV 242
Query: 833 LALEVIK-GKHP 843
           +  EV+  G+ P
Sbjct: 243 VMWEVLAYGERP 254

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 82/305 (26%), Positives = 132/305 (43%), Gaps = 35/305 (11%)
Query: 619 RSVLTFEGKIVYEEIISATNDF---------NAEHCIGKGGHGSVY--RAKVPSGE--IF 665
           + V TF     +E+   A  +F           E  IG G  G V   R KVP       
Sbjct: 1   QGVRTFVDPFTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICV 60
Query: 666 AVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSL 725
           A+K   +   G    Q+ +FL+E   + +  H NI+   G  +  K   II EY+E+GSL
Sbjct: 61  AIKTLKA---GYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSL 117
Query: 726 DKIL-CNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAH 784
           D  L  ND     +   Q + +++G+   + YL +      VHRD++++N+L++      
Sbjct: 118 DAFLRKNDGRFTVI---QLVGMLRGIGSGMKYLSDMS---AVHRDLAARNILVNSNLVCK 171
Query: 785 VSDFGIAKFLNPDSSNWSELAGTH---GYVAPELAYTLKVTEKCDVYSFGVLALEVIK-G 840
           VSDFG+++ L  D        G      + APE     K T   DV+S+G++  EV+  G
Sbjct: 172 VSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYG 231
Query: 841 KHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKR 900
           + P    ++         IE    RLP P        +++ Q+   C  +    RP   +
Sbjct: 232 ERP---YWDMSNQDVIKAIEE-GYRLPPP----MDCPIALHQLMLDCWQKERSDRPKFGQ 283
Query: 901 VSQLL 905
           +  +L
Sbjct: 284 IVNML 288

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 106/205 (51%), Gaps = 12/205 (5%)
Query: 640 FNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHR 698
           F+    +G+G +GSVY+A    +G+I A+K+    +P E   Q  E + EI  + +    
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQ----VPVESDLQ--EIIKEISIMQQCDSP 84
Query: 699 NIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLH 758
           ++VK+YG        +I+ EY  +GS+  I+      K L   +   +++     L YLH
Sbjct: 85  HVVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIATILQSTLKGLEYLH 142
Query: 759 NNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT 818
              F   +HRDI + N+LL+    A ++DFG+A  L    +  + + GT  ++APE+   
Sbjct: 143 ---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQE 199
Query: 819 LKVTEKCDVYSFGVLALEVIKGKHP 843
           +      D++S G+ A+E+ +GK P
Sbjct: 200 IGYNCVADIWSLGITAIEMAEGKPP 224

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Composition-based stats.
 Identities = 76/269 (28%), Positives = 123/269 (45%), Gaps = 34/269 (12%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           +G+G  G V+          A+K      PG MS   E FL E Q + ++RH  +V+ Y 
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMS--PEAFLQEAQVMKKLRHEKLVQLYA 77
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
             S  +  +I+ EY+  GSL   L  + + K L   Q +++   +A  + Y+    +   
Sbjct: 78  VVSE-EPIYIVTEYMNKGSLLDFLKGE-TGKYLRLPQLVDMSAQIASGMAYVERMNY--- 132
Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPELAYTLKVT 822
           VHRD+ + N+L+       V+DFG+A+ +  + + W+   G      + APE A   + T
Sbjct: 133 VHRDLRAANILVGENLVCKVADFGLARLI--EDNEWTARQGAKFPIKWTAPEAALYGRFT 190
Query: 823 EKCDVYSFGVLALEV-IKGKHPRDFLFEXXXXXXXXXIEMLDS-----RLPYPSLHVQKK 876
            K DV+SFG+L  E+  KG+ P   +            E+LD      R+P P     + 
Sbjct: 191 IKSDVWSFGILLTELTTKGRVPYPGMVNR---------EVLDQVERGYRMPCPP-ECPES 240
Query: 877 LMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
           L  +M     C  + PE RPT + +   L
Sbjct: 241 LHDLM---CQCWRKEPEERPTFEYLQAFL 266

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/269 (28%), Positives = 125/269 (46%), Gaps = 23/269 (8%)
Query: 636 ATNDFNAEHCIGKGGHGSVYRAKVPSGE-IFAVKK-FHSPLPGEMSFQQEEFLNEIQALT 693
           A  DF     +GKG  G+VY A+    + I A+K  F + L  E +  + +   E++  +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQS 66
Query: 694 EIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADA 753
            +RH NI++ YG+       ++I EY   G++ + L   +   E    +    I  +A+A
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANA 123
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAP 813
           L Y H+     ++HRDI  +N+LL    E  ++DFG +  ++  SS   +L GT  Y+ P
Sbjct: 124 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDDLCGTLDYLPP 178
Query: 814 ELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEX-XXXXXXXXIEMLDSRLPYPSLH 872
           E+       EK D++S GVL  E + GK P    FE          I  ++   P     
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFVTE 234
Query: 873 VQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
             + L+S +      L  NP  RP ++ V
Sbjct: 235 GARDLISRL------LKHNPSQRPMLREV 257

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 77/279 (27%), Positives = 130/279 (46%), Gaps = 27/279 (9%)
Query: 639 DFNAEHCIGKGGHGSVYRAKVPSGEI-FAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH 697
           D   +H +G G  G VY        +  AVK        E + + EEFL E   + EI+H
Sbjct: 12  DITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKH 66
Query: 698 RNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYL 757
            N+V+  G C+     +II E++  G+L   L  + + +E+     L +   ++ A+ YL
Sbjct: 67  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYL 125
Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPE 814
               F   +HRD++++N L+   +   V+DFG+++ +  D+   +  AG      + APE
Sbjct: 126 EKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--TAHAGAKFPIKWTAPE 180
Query: 815 -LAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLH 872
            LAY  K + K DV++FGVL  E+   G  P    +          +   D R+  P   
Sbjct: 181 SLAYN-KFSIKSDVWAFGVLLWEIATYGMSP----YPGIDPSQVYELLEKDYRMERPE-G 234
Query: 873 VQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
             +K+  +M+   +C   NP  RP+   + Q   E +F+
Sbjct: 235 CPEKVYELMR---ACWQWNPSDRPSFAEIHQAF-ETMFQ 269

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 120/267 (44%), Gaps = 19/267 (7%)
Query: 636 ATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI 695
           A  DF     +GKG  G+VY A+    +     K       E +  + +   E++  + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALF 755
           RH NI++ YG+       ++I EY   G++ + L   +   E    +    I  +A+AL 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 122
Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           Y H+     ++HRDI  +N+LL    E  ++DFG +  ++  SS  ++L GT  Y+ PE+
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEM 177
Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEX-XXXXXXXXIEMLDSRLPYPSLHVQ 874
                  EK D++S GVL  E + GK P    FE          I  ++   P       
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFVTEGA 233
Query: 875 KKLMSIMQVAFSCLDQNPESRPTMKRV 901
           + L+S +      L  NP  RP ++ V
Sbjct: 234 RDLISRL------LKHNPSQRPMLREV 254

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/269 (28%), Positives = 126/269 (46%), Gaps = 23/269 (8%)
Query: 636 ATNDFNAEHCIGKGGHGSVYRAKVPSGE-IFAVKK-FHSPLPGEMSFQQEEFLNEIQALT 693
           A  DF     +GKG  G+VY A+    + I A+K  F + L  E +  + +   E++  +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQS 63
Query: 694 EIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADA 753
            +RH NI++ YG+       ++I EY   G++ + L   +   E    +    I  +A+A
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANA 120
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAP 813
           L Y H+     ++HRDI  +N+LL    E  ++DFG +  ++  SS  ++L GT  Y+ P
Sbjct: 121 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPP 175
Query: 814 ELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEX-XXXXXXXXIEMLDSRLPYPSLH 872
           E+       EK D++S GVL  E + GK P    FE          I  ++   P     
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFVTE 231
Query: 873 VQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
             + L+S +      L  NP  RP ++ V
Sbjct: 232 GARDLISRL------LKHNPSQRPMLREV 254

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 74/270 (27%), Positives = 120/270 (44%), Gaps = 22/270 (8%)
Query: 643 EHCIGKGGHGSVY--RAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNI 700
           E  IG G  G V   R K+P      V    +   G    Q+ +FL E   + +  H NI
Sbjct: 27  ERVIGAGEFGEVCSGRLKLPGKRELPVA-IKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 85
Query: 701 VKFYGFCSHPKHSFIIYEYLESGSLDKIL-CNDASAKELGWTQRLNVIKGVADALFYLHN 759
           +   G  +  K   I+ EY+E+GSLD  L  ND    +    Q + +++G++  + YL +
Sbjct: 86  IHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDG---QFTVIQLVGMLRGISAGMKYLSD 142
Query: 760 NCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPELA 816
             +   VHRD++++N+L++      VSDFG+++ L  D        G      + APE  
Sbjct: 143 MGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 199
Query: 817 YTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLHVQK 875
              K T   DV+S+G++  EV+  G+ P    +E         +E    RLP P      
Sbjct: 200 AFRKFTSASDVWSYGIVMWEVVSYGERP---YWEMTNQDVIKAVEE-GYRLPSP----MD 251
Query: 876 KLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
              ++ Q+   C  +   SRP    +  +L
Sbjct: 252 CPAALYQLMLDCWQKERNSRPKFDEIVNML 281

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/269 (28%), Positives = 126/269 (46%), Gaps = 23/269 (8%)
Query: 636 ATNDFNAEHCIGKGGHGSVYRAKVPSGE-IFAVKK-FHSPLPGEMSFQQEEFLNEIQALT 693
           A  DF     +GKG  G+VY A+    + I A+K  F + L  E +  + +   E++  +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQS 64
Query: 694 EIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADA 753
            +RH NI++ YG+       ++I EY   G++ + L   +   E    +    I  +A+A
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANA 121
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAP 813
           L Y H+     ++HRDI  +N+LL    E  ++DFG +  ++  SS  ++L GT  Y+ P
Sbjct: 122 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPP 176
Query: 814 ELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEX-XXXXXXXXIEMLDSRLPYPSLH 872
           E+       EK D++S GVL  E + GK P    FE          I  ++   P     
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFVTE 232
Query: 873 VQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
             + L+S +      L  NP  RP ++ V
Sbjct: 233 GARDLISRL------LKHNPSQRPMLREV 255

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 78/269 (28%), Positives = 124/269 (46%), Gaps = 23/269 (8%)
Query: 636 ATNDFNAEHCIGKGGHGSVYRAKVPSGE-IFAVKK-FHSPLPGEMSFQQEEFLNEIQALT 693
           A  DF     +GKG  G+VY A+    + I A+K  F + L  E +  + +   E++  +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQS 68
Query: 694 EIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADA 753
            +RH NI++ YG+       ++I EY   G + K L   +   E    +    I  +A+A
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDE---QRTATYITELANA 125
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAP 813
           L Y H+     ++HRDI  +N+LL    E  ++DFG +  ++  SS  + L GT  Y+ P
Sbjct: 126 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPP 180
Query: 814 ELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEX-XXXXXXXXIEMLDSRLPYPSLH 872
           E+       EK D++S GVL  E + GK P    FE          I  ++   P     
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFVTE 236
Query: 873 VQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
             + L+S +      L  NP  RP ++ V
Sbjct: 237 GARDLISRL------LKHNPSQRPMLREV 259

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 134/288 (46%), Gaps = 27/288 (9%)
Query: 630 YEEIISATNDFNAEHCIGKGGHGSVYRAKVPSGEI-FAVKKFHSPLPGEMSFQQEEFLNE 688
           Y++      D   +H +G G +G VY        +  AVK        E + + EEFL E
Sbjct: 212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKE 266
Query: 689 IQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIK 748
              + EI+H N+V+  G C+     +II E++  G+L   L  + + +E+     L +  
Sbjct: 267 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMAT 325
Query: 749 GVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH 808
            ++ A+ YL    F   +HR+++++N L+   +   V+DFG+++ +  D+  ++  AG  
Sbjct: 326 QISSAMEYLEKKNF---IHRNLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAK 380
Query: 809 ---GYVAPE-LAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLD 863
               + APE LAY  K + K DV++FGVL  E+   G  P    +          +   D
Sbjct: 381 FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSP----YPGIDLSQVYELLEKD 435
Query: 864 SRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
            R+  P    +K    + ++  +C   NP  RP+   + Q   E +F+
Sbjct: 436 YRMERPEGCPEK----VYELMRACWQWNPSDRPSFAEIHQAF-ETMFQ 478

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/269 (28%), Positives = 126/269 (46%), Gaps = 23/269 (8%)
Query: 636 ATNDFNAEHCIGKGGHGSVYRAKVPSGE-IFAVKK-FHSPLPGEMSFQQEEFLNEIQALT 693
           A  DF     +GKG  G+VY A+    + I A+K  F + L  E +  + +   E++  +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQS 68
Query: 694 EIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADA 753
            +RH NI++ YG+       ++I EY   G++ + L   +   E    +    I  +A+A
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANA 125
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAP 813
           L Y H+     ++HRDI  +N+LL    E  ++DFG +  ++  SS  ++L GT  Y+ P
Sbjct: 126 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPP 180
Query: 814 ELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEX-XXXXXXXXIEMLDSRLPYPSLH 872
           E+       EK D++S GVL  E + GK P    FE          I  ++   P     
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFVTE 236
Query: 873 VQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
             + L+S +      L  NP  RP ++ V
Sbjct: 237 GARDLISRL------LKHNPSQRPMLREV 259

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Composition-based stats.
 Identities = 76/285 (26%), Positives = 129/285 (45%), Gaps = 43/285 (15%)
Query: 646 IGKGGHGSVYRAKV----PSGE--IFAVKKFHSP-LPGEMSFQQEEFLNEIQALTEIRHR 698
           +G+G  G V+ A+     P+ +  + AVK    P L     FQ+E  L     LT ++H 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL-----LTNLQHE 77
Query: 699 NIVKFYGFCSHPKHSFIIYEYLESGSLDKIL---CNDA----------SAKELGWTQRLN 745
           +IVKFYG C       +++EY++ G L+K L     DA          +  ELG +Q L+
Sbjct: 78  HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 746 VIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELA 805
           +   +A  + YL +  F   VHRD++++N L+       + DFG+++  +  S+++  + 
Sbjct: 138 IASQIASGMVYLASQHF---VHRDLATRNCLVGANLLVKIGDFGMSR--DVYSTDYYRVG 192
Query: 806 GTH----GYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIE 860
           G       ++ PE     K T + DV+SFGV+  E+   GK P   L             
Sbjct: 193 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGR 252
Query: 861 MLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
           +L+     P          +  V   C  + P+ R  +K + ++L
Sbjct: 253 VLERPRVCPK--------EVYDVMLGCWQREPQQRLNIKEIYKIL 289

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/269 (28%), Positives = 125/269 (46%), Gaps = 23/269 (8%)
Query: 636 ATNDFNAEHCIGKGGHGSVYRAKVPSGE-IFAVKK-FHSPLPGEMSFQQEEFLNEIQALT 693
           A  DF     +GKG  G+VY A+    + I A+K  F + L  E +  + +   E++  +
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQS 67
Query: 694 EIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADA 753
            +RH NI++ YG+       ++I EY   G++ + L   +   E    +    I  +A+A
Sbjct: 68  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANA 124
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAP 813
           L Y H+     ++HRDI  +N+LL    E  ++DFG +  ++  SS  + L GT  Y+ P
Sbjct: 125 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPP 179
Query: 814 ELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEX-XXXXXXXXIEMLDSRLPYPSLH 872
           E+       EK D++S GVL  E + GK P    FE          I  ++   P     
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFVTE 235
Query: 873 VQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
             + L+S +      L  NP  RP ++ V
Sbjct: 236 GARDLISRL------LKHNPSQRPMLREV 258

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Composition-based stats.
 Identities = 65/227 (28%), Positives = 108/227 (47%), Gaps = 19/227 (8%)
Query: 677 EMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAK 736
           E S  ++EF+ E + +  + H  +V+ YG C+  +  FII EY+ +G L   L       
Sbjct: 43  EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL--REMRH 100
Query: 737 ELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP 796
                Q L + K V +A+ YL +  F   +HRD++++N L++      VSDFG+++++  
Sbjct: 101 RFQTQQLLEMCKDVCEAMEYLESKQF---LHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 157
Query: 797 D---SSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXX 852
           D   SS  S+      +  PE+    K + K D+++FGVL  E+   GK P    +E   
Sbjct: 158 DEYTSSRGSKFPVR--WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP----YERFT 211
Query: 853 XXXXXXIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMK 899
                       RL  P L  +K    +  + +SC  +  + RPT K
Sbjct: 212 NSETAEHIAQGLRLYRPHLASEK----VYTIMYSCWHEKADERPTFK 254

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/269 (28%), Positives = 125/269 (46%), Gaps = 23/269 (8%)
Query: 636 ATNDFNAEHCIGKGGHGSVYRAKVPSGE-IFAVKK-FHSPLPGEMSFQQEEFLNEIQALT 693
           A  DF     +GKG  G+VY A+    + I A+K  F + L  E +  + +   E++  +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQS 63
Query: 694 EIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADA 753
            +RH NI++ YG+       ++I EY   G++ + L   +   E    +    I  +A+A
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANA 120
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAP 813
           L Y H+     ++HRDI  +N+LL    E  ++DFG +  ++  SS  + L GT  Y+ P
Sbjct: 121 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTXLCGTLDYLPP 175
Query: 814 ELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEX-XXXXXXXXIEMLDSRLPYPSLH 872
           E+       EK D++S GVL  E + GK P    FE          I  ++   P     
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFVTE 231
Query: 873 VQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
             + L+S +      L  NP  RP ++ V
Sbjct: 232 GARDLISRL------LKHNPSQRPMLREV 254

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Composition-based stats.
 Identities = 79/294 (26%), Positives = 133/294 (45%), Gaps = 36/294 (12%)
Query: 638 NDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
           +D+  +  IG G    V  A   P  E  A+K+ +     +     +E L EIQA+++  
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLE---KCQTSMDELLKEIQAMSQCH 66
Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE-----LGWTQRLNVIKGVA 751
           H NIV +Y         +++ + L  GS+  I+ +  +  E     L  +    +++ V 
Sbjct: 67  HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 126
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPD-----SSNWSELAG 806
           + L YLH N     +HRD+ + N+LL       ++DFG++ FL        +       G
Sbjct: 127 EGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 183
Query: 807 THGYVAPELAYTLKVTE-KCDVYSFGVLALEVIKGKHPRDFLFEXXXXXXXXXIEMLDSR 865
           T  ++APE+   ++  + K D++SFG+ A+E+  G  P               + ML  +
Sbjct: 184 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP-------YHKYPPMKVLMLTLQ 236
Query: 866 LPYPSLH--VQKKLM------SIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
              PSL   VQ K M      S  ++   CL ++PE RPT    ++LL  K F+
Sbjct: 237 NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT---AAELLRHKFFQ 287

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Composition-based stats.
 Identities = 79/294 (26%), Positives = 133/294 (45%), Gaps = 36/294 (12%)
Query: 638 NDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
           +D+  +  IG G    V  A   P  E  A+K+ +     +     +E L EIQA+++  
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLE---KCQTSMDELLKEIQAMSQCH 71
Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE-----LGWTQRLNVIKGVA 751
           H NIV +Y         +++ + L  GS+  I+ +  +  E     L  +    +++ V 
Sbjct: 72  HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPD-----SSNWSELAG 806
           + L YLH N     +HRD+ + N+LL       ++DFG++ FL        +       G
Sbjct: 132 EGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188
Query: 807 THGYVAPELAYTLKVTE-KCDVYSFGVLALEVIKGKHPRDFLFEXXXXXXXXXIEMLDSR 865
           T  ++APE+   ++  + K D++SFG+ A+E+  G  P               + ML  +
Sbjct: 189 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP-------YHKYPPMKVLMLTLQ 241
Query: 866 LPYPSLH--VQKKLM------SIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
              PSL   VQ K M      S  ++   CL ++PE RPT    ++LL  K F+
Sbjct: 242 NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT---AAELLRHKFFQ 292

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Composition-based stats.
 Identities = 63/227 (27%), Positives = 108/227 (47%), Gaps = 19/227 (8%)
Query: 677 EMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAK 736
           E S  ++EF+ E + +  + H  +V+ YG C+  +  FII EY+ +G L   L       
Sbjct: 49  EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL--REMRH 106
Query: 737 ELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP 796
                Q L + K V +A+ YL +  F   +HRD++++N L++      VSDFG+++++  
Sbjct: 107 RFQTQQLLEMCKDVCEAMEYLESKQF---LHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 163
Query: 797 DSSNWSELAGTH---GYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXX 852
           D   ++   G+     +  PE+    K + K D+++FGVL  E+   GK P    +E   
Sbjct: 164 DE--YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP----YERFT 217
Query: 853 XXXXXXIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMK 899
                       RL  P L  +K    +  + +SC  +  + RPT K
Sbjct: 218 NSETAEHIAQGLRLYRPHLASEK----VYTIMYSCWHEKADERPTFK 260

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Composition-based stats.
 Identities = 63/227 (27%), Positives = 108/227 (47%), Gaps = 19/227 (8%)
Query: 677 EMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAK 736
           E S  ++EF+ E + +  + H  +V+ YG C+  +  FII EY+ +G L   L       
Sbjct: 42  EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL--REMRH 99
Query: 737 ELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP 796
                Q L + K V +A+ YL +  F   +HRD++++N L++      VSDFG+++++  
Sbjct: 100 RFQTQQLLEMCKDVCEAMEYLESKQF---LHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 156
Query: 797 DSSNWSELAGTH---GYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXX 852
           D   ++   G+     +  PE+    K + K D+++FGVL  E+   GK P    +E   
Sbjct: 157 DE--YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP----YERFT 210
Query: 853 XXXXXXIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMK 899
                       RL  P L  +K    +  + +SC  +  + RPT K
Sbjct: 211 NSETAEHIAQGLRLYRPHLASEK----VYTIMYSCWHEKADERPTFK 253

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 119/267 (44%), Gaps = 19/267 (7%)
Query: 636 ATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI 695
           A  DF     +GKG  G+VY A+    +     K       E +  + +   E++  + +
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALF 755
           RH NI++ YG+       ++I EY   G++ + L   +   E    +    I  +A+AL 
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 119
Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           Y H+     ++HRDI  +N+LL    E  ++DFG +  ++  SS  + L GT  Y+ PE+
Sbjct: 120 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 174
Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEX-XXXXXXXXIEMLDSRLPYPSLHVQ 874
                  EK D++S GVL  E + GK P    FE          I  ++   P       
Sbjct: 175 IEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFVTEGA 230
Query: 875 KKLMSIMQVAFSCLDQNPESRPTMKRV 901
           + L+S +      L  NP  RP ++ V
Sbjct: 231 RDLISRL------LKHNPSQRPMLREV 251

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 77/269 (28%), Positives = 126/269 (46%), Gaps = 23/269 (8%)
Query: 636 ATNDFNAEHCIGKGGHGSVYRAKVPSGE-IFAVKK-FHSPLPGEMSFQQEEFLNEIQALT 693
           A  DF     +GKG  G+VY A+  + + I A+K  F + L  E +  + +   E++  +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQL--EKAGVEHQLRREVEIQS 63
Query: 694 EIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADA 753
            +RH NI++ YG+       ++I EY   G++ + L   +   E    +    I  +A+A
Sbjct: 64  HLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANA 120
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAP 813
           L Y H+     ++HRDI  +N+LL    E  ++DFG +  ++  SS  + L GT  Y+ P
Sbjct: 121 LSYCHSK---KVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRAALCGTLDYLPP 175
Query: 814 ELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEX-XXXXXXXXIEMLDSRLPYPSLH 872
           E+       EK D++S GVL  E + GK P    FE          I  ++   P     
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQDTYKRISRVEFTFPDFVTE 231
Query: 873 VQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
             + L+S +      L  NP  RP ++ V
Sbjct: 232 GARDLISRL------LKHNPSQRPMLREV 254

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 119/267 (44%), Gaps = 19/267 (7%)
Query: 636 ATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI 695
           A  DF     +GKG  G+VY A+    +     K       E +  + +   E++  + +
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALF 755
           RH NI++ YG+       ++I EY   G++ + L   +   E    +    I  +A+AL 
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 121
Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           Y H+     ++HRDI  +N+LL    E  ++DFG +  ++  SS  + L GT  Y+ PE+
Sbjct: 122 YCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 176
Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEX-XXXXXXXXIEMLDSRLPYPSLHVQ 874
                  EK D++S GVL  E + GK P    FE          I  ++   P       
Sbjct: 177 IEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFVTEGA 232
Query: 875 KKLMSIMQVAFSCLDQNPESRPTMKRV 901
           + L+S +      L  NP  RP ++ V
Sbjct: 233 RDLISRL------LKHNPSQRPMLREV 253

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 119/267 (44%), Gaps = 19/267 (7%)
Query: 636 ATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI 695
           A  DF     +GKG  G+VY A+    +     K       E +  + +   E++  + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALF 755
           RH NI++ YG+       ++I EY   G++ + L   +   E    +    I  +A+AL 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 125
Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           Y H+     ++HRDI  +N+LL    E  ++DFG +  ++  SS  + L GT  Y+ PE+
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 180
Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEX-XXXXXXXXIEMLDSRLPYPSLHVQ 874
                  EK D++S GVL  E + GK P    FE          I  ++   P       
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFVTEGA 236
Query: 875 KKLMSIMQVAFSCLDQNPESRPTMKRV 901
           + L+S +      L  NP  RP ++ V
Sbjct: 237 RDLISRL------LKHNPSQRPMLREV 257

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 77/269 (28%), Positives = 125/269 (46%), Gaps = 23/269 (8%)
Query: 636 ATNDFNAEHCIGKGGHGSVYRAKVPSGE-IFAVKK-FHSPLPGEMSFQQEEFLNEIQALT 693
           A  DF     +GKG  G+VY A+    + I A+K  F + L  E +  + +   E++  +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQS 63
Query: 694 EIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADA 753
            +RH NI++ YG+       ++I EY   G++ + L   +   E    +    I  +A+A
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANA 120
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAP 813
           L Y H+     ++HRDI  +N+LL    E  ++DFG +  ++  SS  + L GT  Y+ P
Sbjct: 121 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRAALCGTLDYLPP 175
Query: 814 ELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEX-XXXXXXXXIEMLDSRLPYPSLH 872
           E+       EK D++S GVL  E + GK P    FE          I  ++   P     
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFVTE 231
Query: 873 VQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
             + L+S +      L  NP  RP ++ V
Sbjct: 232 GARDLISRL------LKHNPSQRPMLREV 254

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Composition-based stats.
 Identities = 63/227 (27%), Positives = 108/227 (47%), Gaps = 19/227 (8%)
Query: 677 EMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAK 736
           E S  ++EF+ E + +  + H  +V+ YG C+  +  FII EY+ +G L   L       
Sbjct: 43  EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL--REMRH 100
Query: 737 ELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP 796
                Q L + K V +A+ YL +  F   +HRD++++N L++      VSDFG+++++  
Sbjct: 101 RFQTQQLLEMCKDVCEAMEYLESKQF---LHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 157
Query: 797 DSSNWSELAGTH---GYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXX 852
           D   ++   G+     +  PE+    K + K D+++FGVL  E+   GK P    +E   
Sbjct: 158 DE--YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP----YERFT 211
Query: 853 XXXXXXIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMK 899
                       RL  P L  +K    +  + +SC  +  + RPT K
Sbjct: 212 NSETAEHIAQGLRLYRPHLASEK----VYTIMYSCWHEKADERPTFK 254

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Composition-based stats.
 Identities = 63/227 (27%), Positives = 108/227 (47%), Gaps = 19/227 (8%)
Query: 677 EMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAK 736
           E S  ++EF+ E + +  + H  +V+ YG C+  +  FII EY+ +G L   L       
Sbjct: 38  EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL--REMRH 95
Query: 737 ELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP 796
                Q L + K V +A+ YL +  F   +HRD++++N L++      VSDFG+++++  
Sbjct: 96  RFQTQQLLEMCKDVCEAMEYLESKQF---LHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 152
Query: 797 DSSNWSELAGTH---GYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXX 852
           D   ++   G+     +  PE+    K + K D+++FGVL  E+   GK P    +E   
Sbjct: 153 DE--YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP----YERFT 206
Query: 853 XXXXXXIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMK 899
                       RL  P L  +K    +  + +SC  +  + RPT K
Sbjct: 207 NSETAEHIAQGLRLYRPHLASEK----VYTIMYSCWHEKADERPTFK 249

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 123/269 (45%), Gaps = 34/269 (12%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           +G+G  G V+          A+K      PG MS   E FL E Q + ++RH  +V+ Y 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMS--PEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
             S  +  +I+ EY+  GSL   L  + + K L   Q +++   +A  + Y+    +   
Sbjct: 247 VVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMNY--- 301
Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPELAYTLKVT 822
           VHRD+ + N+L+       V+DFG+A+ +  + + ++   G      + APE A   + T
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFT 359
Query: 823 EKCDVYSFGVLALEV-IKGKHPRDFLFEXXXXXXXXXIEMLDS-----RLPYPSLHVQKK 876
            K DV+SFG+L  E+  KG+ P   +            E+LD      R+P P    +  
Sbjct: 360 IKSDVWSFGILLTELTTKGRVPYPGMVNR---------EVLDQVERGYRMPCPPECPE-- 408
Query: 877 LMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
             S+  +   C  + PE RPT + +   L
Sbjct: 409 --SLHDLMCQCWRKEPEERPTFEYLQAFL 435

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 134/288 (46%), Gaps = 27/288 (9%)
Query: 630 YEEIISATNDFNAEHCIGKGGHGSVYRAKVPSGEI-FAVKKFHSPLPGEMSFQQEEFLNE 688
           Y++      D   +H +G G +G VY        +  AVK        E + + EEFL E
Sbjct: 251 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKE 305
Query: 689 IQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIK 748
              + EI+H N+V+  G C+     +II E++  G+L   L  + + +E+     L +  
Sbjct: 306 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMAT 364
Query: 749 GVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH 808
            ++ A+ YL    F   +HR+++++N L+   +   V+DFG+++ +  D+  ++  AG  
Sbjct: 365 QISSAMEYLEKKNF---IHRNLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAK 419
Query: 809 ---GYVAPE-LAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLD 863
               + APE LAY  K + K DV++FGVL  E+   G  P    +          +   D
Sbjct: 420 FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSP----YPGIDLSQVYELLEKD 474
Query: 864 SRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
            R+  P    +K    + ++  +C   NP  RP+   + Q   E +F+
Sbjct: 475 YRMERPEGCPEK----VYELMRACWQWNPSDRPSFAEIHQAF-ETMFQ 517

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 77/269 (28%), Positives = 125/269 (46%), Gaps = 23/269 (8%)
Query: 636 ATNDFNAEHCIGKGGHGSVYRAKVPSGE-IFAVKK-FHSPLPGEMSFQQEEFLNEIQALT 693
           A  DF     +GKG  G+VY A+    + I A+K  F + L  E +  + +   E++  +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQS 63
Query: 694 EIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADA 753
            +RH NI++ YG+       ++I EY   G++ + L   +   E    +    I  +A+A
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANA 120
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAP 813
           L Y H+     ++HRDI  +N+LL    E  ++DFG +  ++  SS  + L GT  Y+ P
Sbjct: 121 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPP 175
Query: 814 ELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEX-XXXXXXXXIEMLDSRLPYPSLH 872
           E+       EK D++S GVL  E + GK P    FE          I  ++   P     
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFVTE 231
Query: 873 VQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
             + L+S +      L  NP  RP ++ V
Sbjct: 232 GARDLISRL------LKHNPSQRPMLREV 254

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 123/269 (45%), Gaps = 34/269 (12%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           +G+G  G V+          A+K      PG MS   E FL E Q + ++RH  +V+ Y 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMS--PEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
             S  +  +I+ EY+  GSL   L  + + K L   Q +++   +A  + Y+    +   
Sbjct: 247 VVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMNY--- 301
Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPELAYTLKVT 822
           VHRD+ + N+L+       V+DFG+A+ +  + + ++   G      + APE A   + T
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFT 359
Query: 823 EKCDVYSFGVLALEV-IKGKHPRDFLFEXXXXXXXXXIEMLDS-----RLPYPSLHVQKK 876
            K DV+SFG+L  E+  KG+ P   +            E+LD      R+P P    +  
Sbjct: 360 IKSDVWSFGILLTELTTKGRVPYPGMVNR---------EVLDQVERGYRMPCPPECPE-- 408
Query: 877 LMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
             S+  +   C  + PE RPT + +   L
Sbjct: 409 --SLHDLMCQCWRKEPEERPTFEYLQAFL 435

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Composition-based stats.
 Identities = 78/272 (28%), Positives = 125/272 (45%), Gaps = 26/272 (9%)
Query: 643 EHCIGKGGHGSVY--RAKVPSG-EI-FAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHR 698
           E  IG G  G V   R KVP   EI  A+K   +   G    Q+ +FL+E   + +  H 
Sbjct: 13  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKA---GYTDKQRRDFLSEASIMGQFDHP 69
Query: 699 NIVKFYGFCSHPKHSFIIYEYLESGSLDKIL-CNDASAKELGWTQRLNVIKGVADALFYL 757
           NI+   G  +  K   II EY+E+GSLD  L  ND     +   Q + +++G+   + YL
Sbjct: 70  NIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVI---QLVGMLRGIGSGMKYL 126
Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPE 814
            +  +   VHRD++++N+L++      VSDFG+++ L  D        G      + APE
Sbjct: 127 SDMSY---VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPE 183
Query: 815 LAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLHV 873
                K T   DV+S+G++  EV+  G+ P    ++         IE    RLP P    
Sbjct: 184 AIAYRKFTSASDVWSYGIVMWEVMSYGERP---YWDMSNQDVIKAIEE-GYRLPPP---- 235
Query: 874 QKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
               +++ Q+   C  +    RP   ++  +L
Sbjct: 236 MDCPIALHQLMLDCWQKERSDRPKFGQIVNML 267

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Composition-based stats.
 Identities = 78/272 (28%), Positives = 125/272 (45%), Gaps = 26/272 (9%)
Query: 643 EHCIGKGGHGSVY--RAKVPSG-EI-FAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHR 698
           E  IG G  G V   R KVP   EI  A+K   +   G    Q+ +FL+E   + +  H 
Sbjct: 19  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKA---GYTDKQRRDFLSEASIMGQFDHP 75
Query: 699 NIVKFYGFCSHPKHSFIIYEYLESGSLDKIL-CNDASAKELGWTQRLNVIKGVADALFYL 757
           NI+   G  +  K   II EY+E+GSLD  L  ND     +   Q + +++G+   + YL
Sbjct: 76  NIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVI---QLVGMLRGIGSGMKYL 132
Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPE 814
            +  +   VHRD++++N+L++      VSDFG+++ L  D        G      + APE
Sbjct: 133 SDMSY---VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPE 189
Query: 815 LAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLHV 873
                K T   DV+S+G++  EV+  G+ P    ++         IE    RLP P    
Sbjct: 190 AIAYRKFTSASDVWSYGIVMWEVMSYGERP---YWDMSNQDVIKAIEE-GYRLPPP---- 241
Query: 874 QKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
               +++ Q+   C  +    RP   ++  +L
Sbjct: 242 MDCPIALHQLMLDCWQKERSDRPKFGQIVNML 273

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Composition-based stats.
 Identities = 64/227 (28%), Positives = 107/227 (47%), Gaps = 19/227 (8%)
Query: 677 EMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAK 736
           E S  ++EF+ E + +  + H  +V+ YG C+  +  FII EY+ +G L   L       
Sbjct: 58  EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL--REMRH 115
Query: 737 ELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP 796
                Q L + K V +A+ YL +  F   +HRD++++N L++      VSDFG+++++  
Sbjct: 116 RFQTQQLLEMCKDVCEAMEYLESKQF---LHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172
Query: 797 DSSNWSELAGTH---GYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXX 852
           D    S   G+     +  PE+    K + K D+++FGVL  E+   GK P    +E   
Sbjct: 173 DEETSS--VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP----YERFT 226
Query: 853 XXXXXXIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMK 899
                       RL  P L  +K    +  + +SC  +  + RPT K
Sbjct: 227 NSETAEHIAQGLRLYRPHLASEK----VYTIMYSCWHEKADERPTFK 269

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Composition-based stats.
 Identities = 63/227 (27%), Positives = 108/227 (47%), Gaps = 19/227 (8%)
Query: 677 EMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAK 736
           E S  ++EF+ E + +  + H  +V+ YG C+  +  FII EY+ +G L   L       
Sbjct: 58  EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL--REMRH 115
Query: 737 ELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP 796
                Q L + K V +A+ YL +  F   +HRD++++N L++      VSDFG+++++  
Sbjct: 116 RFQTQQLLEMCKDVCEAMEYLESKQF---LHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172
Query: 797 DSSNWSELAGTH---GYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXX 852
           D   ++   G+     +  PE+    K + K D+++FGVL  E+   GK P    +E   
Sbjct: 173 DE--YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP----YERFT 226
Query: 853 XXXXXXIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMK 899
                       RL  P L  +K    +  + +SC  +  + RPT K
Sbjct: 227 NSETAEHIAQGLRLYRPHLASEK----VYTIMYSCWHEKADERPTFK 269

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 77/269 (28%), Positives = 125/269 (46%), Gaps = 23/269 (8%)
Query: 636 ATNDFNAEHCIGKGGHGSVYRAKVPSGE-IFAVKK-FHSPLPGEMSFQQEEFLNEIQALT 693
           A  DF     +GKG  G+VY A+    + I A+K  F + L  E +  + +   E++  +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQS 66
Query: 694 EIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADA 753
            +RH NI++ YG+       ++I EY   G++ + L   +   E    +    I  +A+A
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANA 123
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAP 813
           L Y H+     ++HRDI  +N+LL    E  ++DFG +  ++  SS  + L GT  Y+ P
Sbjct: 124 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRAALCGTLDYLPP 178
Query: 814 ELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEX-XXXXXXXXIEMLDSRLPYPSLH 872
           E+       EK D++S GVL  E + GK P    FE          I  ++   P     
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFVTE 234
Query: 873 VQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
             + L+S +      L  NP  RP ++ V
Sbjct: 235 GARDLISRL------LKHNPSQRPMLREV 257

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 87.0 bits (214), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 78/269 (28%), Positives = 123/269 (45%), Gaps = 23/269 (8%)
Query: 636 ATNDFNAEHCIGKGGHGSVYRAKVPSGE-IFAVKK-FHSPLPGEMSFQQEEFLNEIQALT 693
           A  DF     +GKG  G+VY A+    + I A+K  F + L  E +  + +   E++  +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQS 68
Query: 694 EIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADA 753
            +RH NI++ YG+       ++I EY   G + K L   +   E    +    I  +A+A
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDE---QRTATYITELANA 125
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAP 813
           L Y H+     ++HRDI  +N+LL    E  ++DFG +  ++  SS    L GT  Y+ P
Sbjct: 126 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLXGTLDYLPP 180
Query: 814 ELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEX-XXXXXXXXIEMLDSRLPYPSLH 872
           E+       EK D++S GVL  E + GK P    FE          I  ++   P     
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFVTE 236
Query: 873 VQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
             + L+S +      L  NP  RP ++ V
Sbjct: 237 GARDLISRL------LKHNPSQRPMLREV 259

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 77/269 (28%), Positives = 125/269 (46%), Gaps = 23/269 (8%)
Query: 636 ATNDFNAEHCIGKGGHGSVYRAKVPSGE-IFAVKK-FHSPLPGEMSFQQEEFLNEIQALT 693
           A  DF     +GKG  G+VY A+    + I A+K  F + L  E +  + +   E++  +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQS 66
Query: 694 EIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADA 753
            +RH NI++ YG+       ++I EY   G++ + L   +   E    +    I  +A+A
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANA 123
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAP 813
           L Y H+     ++HRDI  +N+LL    E  ++DFG +  ++  SS  + L GT  Y+ P
Sbjct: 124 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPP 178
Query: 814 ELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEX-XXXXXXXXIEMLDSRLPYPSLH 872
           E+       EK D++S GVL  E + GK P    FE          I  ++   P     
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFVTE 234
Query: 873 VQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
             + L+S +      L  NP  RP ++ V
Sbjct: 235 GARDLISRL------LKHNPSQRPMLREV 257

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 77/269 (28%), Positives = 125/269 (46%), Gaps = 23/269 (8%)
Query: 636 ATNDFNAEHCIGKGGHGSVYRAKVPSGE-IFAVKK-FHSPLPGEMSFQQEEFLNEIQALT 693
           A  DF     +GKG  G+VY A+    + I A+K  F + L  E +  + +   E++  +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQS 68
Query: 694 EIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADA 753
            +RH NI++ YG+       ++I EY   G++ + L   +   E    +    I  +A+A
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANA 125
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAP 813
           L Y H+     ++HRDI  +N+LL    E  ++DFG +  ++  SS  + L GT  Y+ P
Sbjct: 126 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPP 180
Query: 814 ELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEX-XXXXXXXXIEMLDSRLPYPSLH 872
           E+       EK D++S GVL  E + GK P    FE          I  ++   P     
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFVTE 236
Query: 873 VQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
             + L+S +      L  NP  RP ++ V
Sbjct: 237 GARDLISRL------LKHNPSQRPMLREV 259

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Composition-based stats.
 Identities = 75/268 (27%), Positives = 121/268 (45%), Gaps = 28/268 (10%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           IG G  G V+     + +  A+K       G MS  +E+F+ E + + ++ H  +V+ YG
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIRE---GAMS--EEDFIEEAEVMMKLSHPKLVQLYG 69
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDAS--AKELGWTQRLNVIKGVADALFYLHNNCFP 763
            C       +++E++E G L   L       A E      L+V +G+A    YL   C  
Sbjct: 70  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA----YLEEAC-- 123
Query: 764 PIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPELAYTLK 820
            ++HRD++++N L+       VSDFG+ +F+  D   ++   GT     + +PE+    +
Sbjct: 124 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--QYTSSTGTKFPVKWASPEVFSFSR 180
Query: 821 VTEKCDVYSFGVLALEVI-KGKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLHVQKKLMS 879
            + K DV+SFGVL  EV  +GK P    +E               RL  P L        
Sbjct: 181 YSSKSDVWSFGVLMWEVFSEGKIP----YENRSNSEVVEDISTGFRLYKPRLASTH---- 232
Query: 880 IMQVAFSCLDQNPESRPTMKRVSQLLCE 907
           + Q+   C  + PE RP   R+ + L E
Sbjct: 233 VYQIMNHCWKERPEDRPAFSRLLRQLAE 260

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 123/269 (45%), Gaps = 34/269 (12%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           +G+G  G V+          A+K      PG MS   E FL E Q + ++RH  +V+ Y 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMS--PEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
             S  +  +I+ EY+  GSL   L  + + K L   Q +++   +A  + Y+    +   
Sbjct: 247 VVSE-EPIYIVGEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMNY--- 301
Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPELAYTLKVT 822
           VHRD+ + N+L+       V+DFG+A+ +  + + ++   G      + APE A   + T
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFT 359
Query: 823 EKCDVYSFGVLALEV-IKGKHPRDFLFEXXXXXXXXXIEMLDS-----RLPYPSLHVQKK 876
            K DV+SFG+L  E+  KG+ P   +            E+LD      R+P P    +  
Sbjct: 360 IKSDVWSFGILLTELTTKGRVPYPGMVNR---------EVLDQVERGYRMPCPPECPE-- 408
Query: 877 LMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
             S+  +   C  + PE RPT + +   L
Sbjct: 409 --SLHDLMCQCWRKEPEERPTFEYLQAFL 435

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Composition-based stats.
 Identities = 75/268 (27%), Positives = 121/268 (45%), Gaps = 28/268 (10%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           IG G  G V+     + +  A+K       G MS  +E+F+ E + + ++ H  +V+ YG
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIRE---GAMS--EEDFIEEAEVMMKLSHPKLVQLYG 67
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDAS--AKELGWTQRLNVIKGVADALFYLHNNCFP 763
            C       +++E++E G L   L       A E      L+V +G+A    YL   C  
Sbjct: 68  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA----YLEEAC-- 121
Query: 764 PIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPELAYTLK 820
            ++HRD++++N L+       VSDFG+ +F+  D   ++   GT     + +PE+    +
Sbjct: 122 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--QYTSSTGTKFPVKWASPEVFSFSR 178
Query: 821 VTEKCDVYSFGVLALEVI-KGKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLHVQKKLMS 879
            + K DV+SFGVL  EV  +GK P    +E               RL  P L        
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIP----YENRSNSEVVEDISTGFRLYKPRLASTH---- 230
Query: 880 IMQVAFSCLDQNPESRPTMKRVSQLLCE 907
           + Q+   C  + PE RP   R+ + L E
Sbjct: 231 VYQIMNHCWKERPEDRPAFSRLLRQLAE 258

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 77/269 (28%), Positives = 124/269 (46%), Gaps = 23/269 (8%)
Query: 636 ATNDFNAEHCIGKGGHGSVYRAKVPSGE-IFAVKK-FHSPLPGEMSFQQEEFLNEIQALT 693
           A  DF     +GKG  G+VY A+    + I A+K  F + L  E +  + +   E++  +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQS 63
Query: 694 EIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADA 753
            +RH NI++ YG+       ++I EY   G++ + L   +   E    +    I  +A+A
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANA 120
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAP 813
           L Y H+     ++HRDI  +N+LL    E  ++DFG +  ++  SS    L GT  Y+ P
Sbjct: 121 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLCGTLDYLPP 175
Query: 814 ELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEX-XXXXXXXXIEMLDSRLPYPSLH 872
           E+       EK D++S GVL  E + GK P    FE          I  ++   P     
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFVTE 231
Query: 873 VQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
             + L+S +      L  NP  RP ++ V
Sbjct: 232 GARDLISRL------LKHNPSQRPMLREV 254

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 118/267 (44%), Gaps = 19/267 (7%)
Query: 636 ATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI 695
           A  DF     +GKG  G+VY A+    +     K       E +  + +   E++  + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALF 755
           RH NI++ YG+       ++I EY   G++ + L   +   E    +    I  +A+AL 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 125
Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           Y H+     ++HRDI  +N+LL    E  ++DFG +  ++  SS    L GT  Y+ PE+
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLCGTLDYLPPEM 180
Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEX-XXXXXXXXIEMLDSRLPYPSLHVQ 874
                  EK D++S GVL  E + GK P    FE          I  ++   P       
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFVTEGA 236
Query: 875 KKLMSIMQVAFSCLDQNPESRPTMKRV 901
           + L+S +      L  NP  RP ++ V
Sbjct: 237 RDLISRL------LKHNPSQRPMLREV 257

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Composition-based stats.
 Identities = 76/269 (28%), Positives = 123/269 (45%), Gaps = 34/269 (12%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           +G+G  G V+          A+K      PG MS   E FL E Q + +IRH  +V+ Y 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMS--PEAFLQEAQVMKKIRHEKLVQLYA 80
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
             S  +  +I+ EY+  GSL   L  +   K L   Q +++   +A  + Y+    +   
Sbjct: 81  VVSE-EPIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMNY--- 135
Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPELAYTLKVT 822
           VHRD+ + N+L+       V+DFG+A+ +  + + ++   G      + APE A   + T
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 823 EKCDVYSFGVLALEV-IKGKHPRDFLFEXXXXXXXXXIEMLDS-----RLPYPSLHVQKK 876
            K DV+SFG+L  E+  KG+ P   +            E+LD      R+P P     + 
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMVNR---------EVLDQVERGYRMPCPP-ECPES 243
Query: 877 LMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
           L  +M     C  ++PE RPT + +   L
Sbjct: 244 LHDLM---CQCWRKDPEERPTFEYLQAFL 269

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 77/269 (28%), Positives = 125/269 (46%), Gaps = 23/269 (8%)
Query: 636 ATNDFNAEHCIGKGGHGSVYRAKVPSGE-IFAVKK-FHSPLPGEMSFQQEEFLNEIQALT 693
           A  DF     +GKG  G+VY A+    + I A+K  F + L  E +  + +   E++  +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQS 64
Query: 694 EIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADA 753
            +RH NI++ YG+       ++I EY   G++ + L   +   E    +    I  +A+A
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANA 121
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAP 813
           L Y H+     ++HRDI  +N+LL    E  ++DFG +   +  SS  + L+GT  Y+ P
Sbjct: 122 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS--CHAPSSRRTTLSGTLDYLPP 176
Query: 814 ELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEX-XXXXXXXXIEMLDSRLPYPSLH 872
           E+       EK D++S GVL  E + GK P    FE          I  ++   P     
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFVTE 232
Query: 873 VQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
             + L+S +      L  NP  RP ++ V
Sbjct: 233 GARDLISRL------LKHNPSQRPMLREV 255

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 122/269 (45%), Gaps = 34/269 (12%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           +G+G  G V+          A+K      PG MS   E FL E Q + ++RH  +V+ Y 
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMS--PEAFLQEAQVMKKLRHEKLVQLYA 329
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
             S  +  +I+ EY+  GSL   L  + + K L   Q +++   +A  + Y+    +   
Sbjct: 330 VVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMNY--- 384
Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPELAYTLKVT 822
           VHRD+ + N+L+       V+DFG+A+ +  + + ++   G      + APE A   + T
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFT 442
Query: 823 EKCDVYSFGVLALE-VIKGKHPRDFLFEXXXXXXXXXIEMLDS-----RLPYPSLHVQKK 876
            K DV+SFG+L  E   KG+ P   +            E+LD      R+P P    +  
Sbjct: 443 IKSDVWSFGILLTELTTKGRVPYPGMVNR---------EVLDQVERGYRMPCPPECPE-- 491
Query: 877 LMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
             S+  +   C  + PE RPT + +   L
Sbjct: 492 --SLHDLMCQCWRKEPEERPTFEYLQAFL 518

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 106/210 (50%), Gaps = 12/210 (5%)
Query: 636 ATNDFNAEHCIGKGGHGSVYRAKVPSGE-IFAVKK-FHSPLPGEMSFQQEEFLNEIQALT 693
           A  DF     +GKG  G+VY A+    + I A+K  F + L  E +  + +   E++  +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQS 89
Query: 694 EIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADA 753
            +RH NI++ YG+       ++I EY   G++ + L   +   E    +    I  +A+A
Sbjct: 90  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANA 146
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAP 813
           L Y H+     ++HRDI  +N+LL    E  ++DFG +  ++  SS   +L GT  Y+ P
Sbjct: 147 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDDLCGTLDYLPP 201
Query: 814 ELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           E+       EK D++S GVL  E + GK P
Sbjct: 202 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 77/269 (28%), Positives = 124/269 (46%), Gaps = 23/269 (8%)
Query: 636 ATNDFNAEHCIGKGGHGSVYRAKVPSGE-IFAVKK-FHSPLPGEMSFQQEEFLNEIQALT 693
           A  DF     +GKG  G+VY A+    + I A+K  F + L  E +  + +   E++  +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQS 64
Query: 694 EIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADA 753
            +RH NI++ YG+       ++I EY   G++ + L   +   E    +    I  +A+A
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANA 121
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAP 813
           L Y H+     ++HRDI  +N+LL    E  ++DFG +  ++  SS    L GT  Y+ P
Sbjct: 122 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDTLCGTLDYLPP 176
Query: 814 ELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEX-XXXXXXXXIEMLDSRLPYPSLH 872
           E+       EK D++S GVL  E + GK P    FE          I  ++   P     
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFVTE 232
Query: 873 VQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
             + L+S +      L  NP  RP ++ V
Sbjct: 233 GARDLISRL------LKHNPSQRPMLREV 255

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 86.3 bits (212), Expect = 8e-17,   Method: Composition-based stats.
 Identities = 75/268 (27%), Positives = 121/268 (45%), Gaps = 28/268 (10%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           IG G  G V+     + +  A+K       G MS  +E+F+ E + + ++ H  +V+ YG
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIRE---GAMS--EEDFIEEAEVMMKLSHPKLVQLYG 72
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDAS--AKELGWTQRLNVIKGVADALFYLHNNCFP 763
            C       +++E++E G L   L       A E      L+V +G+A    YL   C  
Sbjct: 73  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA----YLEEAC-- 126
Query: 764 PIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPELAYTLK 820
            ++HRD++++N L+       VSDFG+ +F+  D   ++   GT     + +PE+    +
Sbjct: 127 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--QYTSSTGTKFPVKWASPEVFSFSR 183
Query: 821 VTEKCDVYSFGVLALEVI-KGKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLHVQKKLMS 879
            + K DV+SFGVL  EV  +GK P    +E               RL  P L        
Sbjct: 184 YSSKSDVWSFGVLMWEVFSEGKIP----YENRSNSEVVEDISTGFRLYKPRLASTH---- 235
Query: 880 IMQVAFSCLDQNPESRPTMKRVSQLLCE 907
           + Q+   C  + PE RP   R+ + L E
Sbjct: 236 VYQIMNHCWRERPEDRPAFSRLLRQLAE 263

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 86.3 bits (212), Expect = 8e-17,   Method: Composition-based stats.
 Identities = 75/269 (27%), Positives = 124/269 (46%), Gaps = 34/269 (12%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           +G+G  G V+          A+K      PG MS   E FL E Q + ++RH  +V+ Y 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMS--PEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
             S  +  +I+ EY+  GSL   L  +   K L   Q +++   +A  + Y+    +   
Sbjct: 81  VVSE-EPIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMNY--- 135
Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPELAYTLKVT 822
           VHRD+++ N+L+       V+DFG+A+ +  + + ++   G      + APE A   + T
Sbjct: 136 VHRDLAAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 823 EKCDVYSFGVLALEV-IKGKHPRDFLFEXXXXXXXXXIEMLDS-----RLPYPSLHVQKK 876
            K DV+SFG+L  E+  KG+ P   +            E+LD      R+P P     + 
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMVNR---------EVLDQVERGYRMPCPP-ECPES 243
Query: 877 LMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
           L  +M     C  ++PE RPT + +   L
Sbjct: 244 LHDLM---CQCWRKDPEERPTFEYLQAFL 269

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 120/268 (44%), Gaps = 28/268 (10%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           IG G  G V+     + +  A+K        E S  +++F+ E + + ++ H  +V+ YG
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIK-----EGSMSEDDFIEEAEVMMKLSHPKLVQLYG 89
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDAS--AKELGWTQRLNVIKGVADALFYLHNNCFP 763
            C       +++E++E G L   L       A E      L+V +G+A    YL   C  
Sbjct: 90  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA----YLEEAC-- 143
Query: 764 PIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPELAYTLK 820
            ++HRD++++N L+       VSDFG+ +F+  D   ++   GT     + +PE+    +
Sbjct: 144 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--QYTSSTGTKFPVKWASPEVFSFSR 200
Query: 821 VTEKCDVYSFGVLALEVI-KGKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLHVQKKLMS 879
            + K DV+SFGVL  EV  +GK P    +E               RL  P L        
Sbjct: 201 YSSKSDVWSFGVLMWEVFSEGKIP----YENRSNSEVVEDISTGFRLYKPRLASTH---- 252
Query: 880 IMQVAFSCLDQNPESRPTMKRVSQLLCE 907
           + Q+   C  + PE RP   R+ + L E
Sbjct: 253 VYQIMNHCWKERPEDRPAFSRLLRQLAE 280

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 77/269 (28%), Positives = 124/269 (46%), Gaps = 23/269 (8%)
Query: 636 ATNDFNAEHCIGKGGHGSVYRAKVPSGE-IFAVKK-FHSPLPGEMSFQQEEFLNEIQALT 693
           A  DF     +GKG  G+VY A+    + I A+K  F + L  E +  + +   E++  +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQS 65
Query: 694 EIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADA 753
            +RH NI++ YG+       ++I EY   G++ + L   +   E    +    I  +A+A
Sbjct: 66  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANA 122
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAP 813
           L Y H+     ++HRDI  +N+LL    E  ++DFG +  ++  SS    L GT  Y+ P
Sbjct: 123 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLCGTLDYLPP 177
Query: 814 ELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEX-XXXXXXXXIEMLDSRLPYPSLH 872
           E+       EK D++S GVL  E + GK P    FE          I  ++   P     
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFVTE 233
Query: 873 VQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
             + L+S +      L  NP  RP ++ V
Sbjct: 234 GARDLISRL------LKHNPSQRPMLREV 256

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 106/210 (50%), Gaps = 12/210 (5%)
Query: 636 ATNDFNAEHCIGKGGHGSVYRAKVPSGE-IFAVKK-FHSPLPGEMSFQQEEFLNEIQALT 693
           A  DF     +GKG  G+VY A+    + I A+K  F + L  E +  + +   E++  +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQS 89
Query: 694 EIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADA 753
            +RH NI++ YG+       ++I EY   G++ + L   +   E    +    I  +A+A
Sbjct: 90  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANA 146
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAP 813
           L Y H+     ++HRDI  +N+LL    E  ++DFG +  ++  SS  + L GT  Y+ P
Sbjct: 147 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPP 201
Query: 814 ELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           E+       EK D++S GVL  E + GK P
Sbjct: 202 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/269 (28%), Positives = 125/269 (46%), Gaps = 23/269 (8%)
Query: 636 ATNDFNAEHCIGKGGHGSVYRAKVPSGE-IFAVKK-FHSPLPGEMSFQQEEFLNEIQALT 693
           A  DF     +GKG  G+VY A+    + I A+K  F + L  E +  + +   E++  +
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQS 80
Query: 694 EIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADA 753
            +RH NI++ YG+       ++I EY   G++ + L   +   E    +    I  +A+A
Sbjct: 81  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANA 137
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAP 813
           L Y H+     ++HRDI  +N+LL    E  ++DFG +  ++  SS  + L GT  Y+ P
Sbjct: 138 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPP 192
Query: 814 ELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEX-XXXXXXXXIEMLDSRLPYPSLH 872
           E+       EK D++S GVL  E + GK P    FE          I  ++   P     
Sbjct: 193 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFVTE 248
Query: 873 VQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
             + L+S +      L  NP  RP ++ V
Sbjct: 249 GARDLISRL------LKHNPSQRPMLREV 271

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Composition-based stats.
 Identities = 75/269 (27%), Positives = 123/269 (45%), Gaps = 34/269 (12%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           +G+G  G V+          A+K      PG MS   E FL E Q + ++RH  +V+ Y 
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMS--PEAFLQEAQVMKKLRHEKLVQLYA 73
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
             S  +  +I+ EY+  GSL   L  + + K L   Q +++   +A  + Y+    +   
Sbjct: 74  VVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMNY--- 128
Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPELAYTLKVT 822
           VHRD+ + N+L+       V+DFG+A+ +  + + ++   G      + APE A   + T
Sbjct: 129 VHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFT 186
Query: 823 EKCDVYSFGVLALEV-IKGKHPRDFLFEXXXXXXXXXIEMLDS-----RLPYPSLHVQKK 876
            K DV+SFG+L  E+  KG+ P   +            E+LD      R+P P     + 
Sbjct: 187 IKSDVWSFGILLTELTTKGRVPYPGMVNR---------EVLDQVERGYRMPCPP-ECPES 236
Query: 877 LMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
           L  +M     C  + PE RPT + +   L
Sbjct: 237 LHDLM---CQCWRKEPEERPTFEYLQAFL 262

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Composition-based stats.
 Identities = 75/269 (27%), Positives = 123/269 (45%), Gaps = 34/269 (12%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           +G+G  G V+          A+K      PG MS   E FL E Q + ++RH  +V+ Y 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMS--PEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
             S  +  +I+ EY+  GSL   L  +   K L   Q +++   +A  + Y+    +   
Sbjct: 81  VVSE-EPIYIVIEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMNY--- 135
Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPELAYTLKVT 822
           VHRD+ + N+L+       V+DFG+A+ +  + + ++   G      + APE A   + T
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 823 EKCDVYSFGVLALEV-IKGKHPRDFLFEXXXXXXXXXIEMLDS-----RLPYPSLHVQKK 876
            K DV+SFG+L  E+  KG+ P   +            E+LD      R+P P     + 
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMVNR---------EVLDQVERGYRMPCPP-ECPES 243
Query: 877 LMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
           L  +M     C  ++PE RPT + +   L
Sbjct: 244 LHDLM---CQCWRKDPEERPTFEYLQAFL 269

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/269 (28%), Positives = 124/269 (46%), Gaps = 23/269 (8%)
Query: 636 ATNDFNAEHCIGKGGHGSVYRAKVPSGE-IFAVKK-FHSPLPGEMSFQQEEFLNEIQALT 693
           A  DF     +GKG  G+VY A+    + I A+K  F + L  E +  + +   E++  +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQS 68
Query: 694 EIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADA 753
            +RH NI++ YG+       ++I EY   G++ + L   +   E    +    I  +A+A
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANA 125
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAP 813
           L Y H+     ++HRDI  +N+LL    E  ++DFG +  ++  SS  + L GT  Y+ P
Sbjct: 126 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPP 180
Query: 814 ELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEX-XXXXXXXXIEMLDSRLPYPSLH 872
           E        EK D++S GVL  E + GK P    FE          I  ++   P     
Sbjct: 181 EXIEGRXHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFVTE 236
Query: 873 VQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
             + L+S +      L  NP  RP ++ V
Sbjct: 237 GARDLISRL------LKHNPSQRPXLREV 259

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Composition-based stats.
 Identities = 75/269 (27%), Positives = 123/269 (45%), Gaps = 34/269 (12%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           +G+G  G V+          A+K      PG MS   E FL E Q + ++RH  +V+ Y 
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMS--PEAFLQEAQVMKKLRHEKLVQLYA 69
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
             S  +  +I+ EY+  GSL   L  +   K L   Q +++   +A  + Y+    +   
Sbjct: 70  VVSE-EPIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMNY--- 124
Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPELAYTLKVT 822
           VHRD+ + N+L+       V+DFG+A+ +  + + ++   G      + APE A   + T
Sbjct: 125 VHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFT 182
Query: 823 EKCDVYSFGVLALEV-IKGKHPRDFLFEXXXXXXXXXIEMLDS-----RLPYPSLHVQKK 876
            K DV+SFG+L  E+  KG+ P   +            E+LD      R+P P     + 
Sbjct: 183 IKSDVWSFGILLTELTTKGRVPYPGMVNR---------EVLDQVERGYRMPCPP-ECPES 232
Query: 877 LMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
           L  +M     C  ++PE RPT + +   L
Sbjct: 233 LHDLM---CQCWRKDPEERPTFEYLQAFL 258

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Composition-based stats.
 Identities = 75/269 (27%), Positives = 123/269 (45%), Gaps = 34/269 (12%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           +G+G  G V+          A+K      PG MS   E FL E Q + ++RH  +V+ Y 
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMS--PEAFLQEAQVMKKLRHEKLVQLYA 71
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
             S  +  +I+ EY+  GSL   L  +   K L   Q +++   +A  + Y+    +   
Sbjct: 72  VVSE-EPIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMNY--- 126
Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPELAYTLKVT 822
           VHRD+ + N+L+       V+DFG+A+ +  + + ++   G      + APE A   + T
Sbjct: 127 VHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFT 184
Query: 823 EKCDVYSFGVLALEV-IKGKHPRDFLFEXXXXXXXXXIEMLDS-----RLPYPSLHVQKK 876
            K DV+SFG+L  E+  KG+ P   +            E+LD      R+P P     + 
Sbjct: 185 IKSDVWSFGILLTELTTKGRVPYPGMVNR---------EVLDQVERGYRMPCPP-ECPES 234
Query: 877 LMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
           L  +M     C  ++PE RPT + +   L
Sbjct: 235 LHDLM---CQCWRKDPEERPTFEYLQAFL 260

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Composition-based stats.
 Identities = 75/269 (27%), Positives = 123/269 (45%), Gaps = 34/269 (12%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           +G+G  G V+          A+K      PG MS   E FL E Q + ++RH  +V+ Y 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMS--PEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
             S  +  +I+ EY+  GSL   L  +   K L   Q +++   +A  + Y+    +   
Sbjct: 81  VVSE-EPIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMNY--- 135
Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPELAYTLKVT 822
           VHRD+ + N+L+       V+DFG+A+ +  + + ++   G      + APE A   + T
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 823 EKCDVYSFGVLALEV-IKGKHPRDFLFEXXXXXXXXXIEMLDS-----RLPYPSLHVQKK 876
            K DV+SFG+L  E+  KG+ P   +            E+LD      R+P P     + 
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMVNR---------EVLDQVERGYRMPCPP-ECPES 243
Query: 877 LMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
           L  +M     C  ++PE RPT + +   L
Sbjct: 244 LHDLM---CQCWRKDPEERPTFEYLQAFL 269

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/269 (27%), Positives = 122/269 (45%), Gaps = 34/269 (12%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           +G+G  G V+          A+K      PG MS   E FL E Q + ++RH  +V+ Y 
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLK---PGNMS--PEAFLQEAQVMKKLRHEKLVQLYA 247
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
             S  +  +I+ EY+  GSL   L  +   K L   Q +++   +A  + Y+    +   
Sbjct: 248 VVSE-EPIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMNY--- 302
Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPELAYTLKVT 822
           VHRD+ + N+L+       V+DFG+ + +  + + ++   G      + APE A   + T
Sbjct: 303 VHRDLRAANILVGENLVCKVADFGLGRLI--EDNEYTARQGAKFPIKWTAPEAALYGRFT 360
Query: 823 EKCDVYSFGVLALEV-IKGKHPRDFLFEXXXXXXXXXIEMLDS-----RLPYPSLHVQKK 876
            K DV+SFG+L  E+  KG+ P   +            E+LD      R+P P    +  
Sbjct: 361 IKSDVWSFGILLTELTTKGRVPYPGMVNR---------EVLDQVERGYRMPCPPECPE-- 409
Query: 877 LMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
             S+  +   C  ++PE RPT + +   L
Sbjct: 410 --SLHDLMCQCWRKDPEERPTFEYLQAFL 436

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Composition-based stats.
 Identities = 75/267 (28%), Positives = 121/267 (45%), Gaps = 30/267 (11%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           +G+G  G V+          A+K      PG MS   E FL E Q + ++RH  +V+ Y 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMS--PEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
             S  +  +I+ EY+  GSL   L  +   K L   Q +++   +A  + Y+    +   
Sbjct: 81  VVSE-EPIYIVIEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMNY--- 135
Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH-GYVAPELAYTLKVTEK 824
           VHRD+ + N+L+       V+DFG+A+ +  +     + A     + APE A   + T K
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 825 CDVYSFGVLALEV-IKGKHPRDFLFEXXXXXXXXXIEMLDS-----RLPYPSLHVQKKLM 878
            DV+SFG+L  E+  KG+ P   +            E+LD      R+P P     + L 
Sbjct: 196 SDVWSFGILLTELTTKGRVPYPGMVNR---------EVLDQVERGYRMPCPP-ECPESLH 245
Query: 879 SIMQVAFSCLDQNPESRPTMKRVSQLL 905
            +M     C  ++PE RPT + +   L
Sbjct: 246 DLM---CQCWRKDPEERPTFEYLQAFL 269

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Composition-based stats.
 Identities = 75/269 (27%), Positives = 123/269 (45%), Gaps = 34/269 (12%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           +G+G  G V+          A+K      PG MS   E FL E Q + ++RH  +V+ Y 
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMS--PEAFLQEAQVMKKLRHEKLVQLYA 77
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
             S  +  +I+ EY+  GSL   L  + + K L   Q +++   +A  + Y+    +   
Sbjct: 78  VVSE-EPIYIVTEYMNKGSLLDFLKGE-TGKYLRLPQLVDMSAQIASGMAYVERMNY--- 132
Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPELAYTLKVT 822
           VHRD+ + N+L+       V+DFG+A+ +  + + ++   G      + APE A   + T
Sbjct: 133 VHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFT 190
Query: 823 EKCDVYSFGVLALEV-IKGKHPRDFLFEXXXXXXXXXIEMLDS-----RLPYPSLHVQKK 876
            K DV+SFG+L  E+  KG+ P   +            E+LD      R+P P     + 
Sbjct: 191 IKSDVWSFGILLTELTTKGRVPYPGMVNR---------EVLDQVERGYRMPCPP-ECPES 240
Query: 877 LMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
           L  +M     C  + PE RPT + +   L
Sbjct: 241 LHDLM---CQCWRKEPEERPTFEYLQAFL 266

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/269 (28%), Positives = 125/269 (46%), Gaps = 23/269 (8%)
Query: 636 ATNDFNAEHCIGKGGHGSVYRAKVPSGE-IFAVKK-FHSPLPGEMSFQQEEFLNEIQALT 693
           A  DF     +GKG  G+VY A+    + I A+K  F + L  E +  + +   E++  +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQS 66
Query: 694 EIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADA 753
            +RH NI++ YG+       ++I EY   G++ + L   +   E    +    I  +A+A
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANA 123
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAP 813
           L Y H+     ++HRDI  +N+LL    E  +++FG +  ++  SS  + L GT  Y+ P
Sbjct: 124 LSYCHSKR---VIHRDIKPENLLLGSAGELKIANFGWS--VHAPSSRRTTLCGTLDYLPP 178
Query: 814 ELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEX-XXXXXXXXIEMLDSRLPYPSLH 872
           E+       EK D++S GVL  E + GK P    FE          I  ++   P     
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFVTE 234
Query: 873 VQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
             + L+S +      L  NP  RP ++ V
Sbjct: 235 GARDLISRL------LKHNPSQRPMLREV 257

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Composition-based stats.
 Identities = 75/269 (27%), Positives = 123/269 (45%), Gaps = 34/269 (12%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           +G+G  G V+          A+K      PG MS   E FL E Q + ++RH  +V+ Y 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMS--PEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
             S  +  +I+ EY+  GSL   L  +   K L   Q +++   +A  + Y+    +   
Sbjct: 81  VVSE-EPIYIVCEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMNY--- 135
Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPELAYTLKVT 822
           VHRD+ + N+L+       V+DFG+A+ +  + + ++   G      + APE A   + T
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 823 EKCDVYSFGVLALEV-IKGKHPRDFLFEXXXXXXXXXIEMLDS-----RLPYPSLHVQKK 876
            K DV+SFG+L  E+  KG+ P   +            E+LD      R+P P     + 
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMVNR---------EVLDQVERGYRMPCPP-ECPES 243
Query: 877 LMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
           L  +M     C  ++PE RPT + +   L
Sbjct: 244 LHDLM---CQCWRKDPEERPTFEYLQAFL 269

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/269 (28%), Positives = 125/269 (46%), Gaps = 23/269 (8%)
Query: 636 ATNDFNAEHCIGKGGHGSVYRAKVPSGE-IFAVKK-FHSPLPGEMSFQQEEFLNEIQALT 693
           A  DF     +GKG  G+VY A+    + I A+K  F + L  E +  + +   E++  +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQS 65
Query: 694 EIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADA 753
            +RH NI++ YG+       ++I EY   G++ + L   +   E    +    I  +A+A
Sbjct: 66  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANA 122
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAP 813
           L Y H+     ++HRDI  +N+LL    E  +++FG +  ++  SS  + L GT  Y+ P
Sbjct: 123 LSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWS--VHAPSSRRTTLCGTLDYLPP 177
Query: 814 ELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEX-XXXXXXXXIEMLDSRLPYPSLH 872
           E+       EK D++S GVL  E + GK P    FE          I  ++   P     
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFVTE 233
Query: 873 VQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
             + L+S +      L  NP  RP ++ V
Sbjct: 234 GARDLISRL------LKHNPSQRPMLREV 256

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Composition-based stats.
 Identities = 75/268 (27%), Positives = 120/268 (44%), Gaps = 28/268 (10%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           IG G  G V+     + +  A+K       G MS  +E+F+ E + + ++ H  +V+ YG
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIRE---GAMS--EEDFIEEAEVMMKLSHPKLVQLYG 70
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDAS--AKELGWTQRLNVIKGVADALFYLHNNCFP 763
            C       ++ E++E G L   L       A E      L+V +G+A    YL   C  
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA----YLEEAC-- 124
Query: 764 PIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPELAYTLK 820
            ++HRD++++N L+       VSDFG+ +F+  D   ++   GT     + +PE+    +
Sbjct: 125 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--QYTSSTGTKFPVKWASPEVFSFSR 181
Query: 821 VTEKCDVYSFGVLALEVI-KGKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLHVQKKLMS 879
            + K DV+SFGVL  EV  +GK P    +E               RL  P L        
Sbjct: 182 YSSKSDVWSFGVLMWEVFSEGKIP----YENRSNSEVVEDISTGFRLYKPRLASTH---- 233
Query: 880 IMQVAFSCLDQNPESRPTMKRVSQLLCE 907
           + Q+   C  + PE RP   R+ + L E
Sbjct: 234 VYQIMNHCWRERPEDRPAFSRLLRQLAE 261

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 78/309 (25%), Positives = 133/309 (43%), Gaps = 32/309 (10%)
Query: 616 PGLRSVLTFEGKIVYEEIISATNDF---------NAEHCIGKGGHGSVY--RAKVPSGEI 664
           PG ++ +  E    YE+   A + F           E  IG G  G V   R K+P    
Sbjct: 15  PGTKTYIDPE---TYEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRD 71
Query: 665 FAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGS 724
            AV    +   G    Q+ +FL E   + +  H N+V   G  +  K   I+ E++E+G+
Sbjct: 72  VAVA-IKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGA 130
Query: 725 LDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAH 784
           LD  L       +    Q + +++G+A  + YL +  +   VHRD++++N+L++      
Sbjct: 131 LDAFLRKHDG--QFTVIQLVGMLRGIAAGMRYLADMGY---VHRDLAARNILVNSNLVCK 185
Query: 785 VSDFGIAKFLNPDSSNWSELAGTH---GYVAPELAYTLKVTEKCDVYSFGVLALEVIK-G 840
           VSDFG+++ +  D        G      + APE     K T   DV+S+G++  EV+  G
Sbjct: 186 VSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG 245
Query: 841 KHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKR 900
           + P    ++         IE    RLP P          + Q+   C  +    RP  ++
Sbjct: 246 ERP---YWDMSNQDVIKAIEE-GYRLPAP----MDCPAGLHQLMLDCWQKERAERPKFEQ 297
Query: 901 VSQLLCEKI 909
           +  +L + I
Sbjct: 298 IVGILDKMI 306

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Composition-based stats.
 Identities = 74/269 (27%), Positives = 122/269 (45%), Gaps = 34/269 (12%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           +G+G  G V+          A+K      PG MS   E FL E Q + ++RH  +V+ Y 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMS--PEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
             S  +  +I+ EY+  G L   L  +   K L   Q +++   +A  + Y+    +   
Sbjct: 81  VVSE-EPIYIVMEYMSKGCLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMNY--- 135
Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPELAYTLKVT 822
           VHRD+ + N+L+       V+DFG+A+ +  + + ++   G      + APE A   + T
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 823 EKCDVYSFGVLALEV-IKGKHPRDFLFEXXXXXXXXXIEMLDS-----RLPYPSLHVQKK 876
            K DV+SFG+L  E+  KG+ P   +            E+LD      R+P P     + 
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMVNR---------EVLDQVERGYRMPCPP-ECPES 243
Query: 877 LMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
           L  +M     C  ++PE RPT + +   L
Sbjct: 244 LHDLM---CQCWRKDPEERPTFEYLQAFL 269

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Composition-based stats.
 Identities = 75/267 (28%), Positives = 120/267 (44%), Gaps = 30/267 (11%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           +G+G  G V+          A+K      PG MS   E FL E Q + ++RH  +V+ Y 
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMS--PEAFLQEAQVMKKLRHEKLVQLYA 70
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
             S  +   I+ EY+  GSL   L  + + K L   Q +++   +A  + Y+    +   
Sbjct: 71  VVSE-EPIXIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMNY--- 125
Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH-GYVAPELAYTLKVTEK 824
           VHRD+ + N+L+       V+DFG+A+ +  +     + A     + APE A   + T K
Sbjct: 126 VHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIK 185
Query: 825 CDVYSFGVLALEV-IKGKHPRDFLFEXXXXXXXXXIEMLDS-----RLPYPSLHVQKKLM 878
            DV+SFG+L  E+  KG+ P   +            E+LD      R+P P     + L 
Sbjct: 186 SDVWSFGILLTELTTKGRVPYPGMVNR---------EVLDQVERGYRMPCPP-ECPESLH 235
Query: 879 SIMQVAFSCLDQNPESRPTMKRVSQLL 905
            +M     C  + PE RPT + +   L
Sbjct: 236 DLM---CQCWRKEPEERPTFEYLQAFL 259

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 16/201 (7%)
Query: 646 IGKGGHGSVYRAKV-PSGEIFAVKKFHSPLPGEMSFQQ--EEFLNEIQALTEIRHRNIVK 702
           IG+G  G V  A V  SG++ AVKK       ++  QQ  E   NE+  + + +H N+V+
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKM------DLRKQQRRELLFNEVVIMRDYQHENVVE 135
Query: 703 FYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
            Y         +++ E+LE G+L  I+ +    +E    Q   V   V  AL  LH    
Sbjct: 136 MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----QIAAVCLAVLQALSVLHAQG- 190
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVT 822
             ++HRDI S ++LL       +SDFG    ++ +      L GT  ++APEL   L   
Sbjct: 191 --VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYG 248
Query: 823 EKCDVYSFGVLALEVIKGKHP 843
            + D++S G++ +E++ G+ P
Sbjct: 249 PEVDIWSLGIMVIEMVDGEPP 269

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 102/202 (50%), Gaps = 18/202 (8%)
Query: 646 IGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQ--EEFLNEIQALTEIRHRNIVK 702
           IG+G  G V  A+   SG   AVK        ++  QQ  E   NE+  + + +H N+V+
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMM------DLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 703 FYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
            Y      +  +++ E+L+ G+L  I+    S   L   Q   V + V  AL YLH    
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIV----SQVRLNEEQIATVCEAVLQALAYLHAQG- 161
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPE-LAYTLKV 821
             ++HRDI S ++LL L     +SDFG    ++ D      L GT  ++APE ++ +L  
Sbjct: 162 --VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLYA 219
Query: 822 TEKCDVYSFGVLALEVIKGKHP 843
           TE  D++S G++ +E++ G+ P
Sbjct: 220 TE-VDIWSLGIMVIEMVDGEPP 240

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 8/206 (3%)
Query: 638 NDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH 697
            DF+    +GKG  G+VY A+    +     K       E +  + +   E++  + +RH
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 698 RNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYL 757
            NI++ YG+       ++I EY   G++ + L   +   E    +    I  +A+AL Y 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDE---QRTATYITELANALSYC 128
Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAY 817
           H+     ++HRDI  +N+LL    E  ++DFG +  ++  SS  + L GT  Y+ PE+  
Sbjct: 129 HSK---RVIHRDIKPENLLLGSNGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIE 183
Query: 818 TLKVTEKCDVYSFGVLALEVIKGKHP 843
                EK D++S GVL  E + G  P
Sbjct: 184 GRMHDEKVDLWSLGVLCYEFLVGMPP 209

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Composition-based stats.
 Identities = 74/269 (27%), Positives = 122/269 (45%), Gaps = 34/269 (12%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           +G+G  G V+          A+K      PG MS   E FL E Q + ++RH  +V+ Y 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMS--PEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
             S  +  +I+ EY+  G L   L  +   K L   Q +++   +A  + Y+    +   
Sbjct: 81  VVSE-EPIYIVTEYMSKGCLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMNY--- 135
Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPELAYTLKVT 822
           VHRD+ + N+L+       V+DFG+A+ +  + + ++   G      + APE A   + T
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 823 EKCDVYSFGVLALEV-IKGKHPRDFLFEXXXXXXXXXIEMLDS-----RLPYPSLHVQKK 876
            K DV+SFG+L  E+  KG+ P   +            E+LD      R+P P     + 
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMVNR---------EVLDQVERGYRMPCPP-ECPES 243
Query: 877 LMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
           L  +M     C  ++PE RPT + +   L
Sbjct: 244 LHDLM---CQCWRKDPEERPTFEYLQAFL 269

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 8/206 (3%)
Query: 638 NDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH 697
            DF+    +GKG  G+VY A+    +     K       E +  + +   E++  + +RH
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 698 RNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYL 757
            NI++ YG+       ++I EY   G++ + L   +   E    +    I  +A+AL Y 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDE---QRTATYITELANALSYC 128
Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAY 817
           H+     ++HRDI  +N+LL    E  ++DFG +  ++  SS    L GT  Y+ PE+  
Sbjct: 129 HSK---RVIHRDIKPENLLLGSNGELKIADFGWS--VHAPSSRRDTLCGTLDYLPPEMIE 183
Query: 818 TLKVTEKCDVYSFGVLALEVIKGKHP 843
                EK D++S GVL  E + G  P
Sbjct: 184 GRMHDEKVDLWSLGVLCYEFLVGMPP 209

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 124/271 (45%), Gaps = 38/271 (14%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           IG G  G+VY+ K   G++ AVK  +   P     Q   F NE+  L + RH NI+ F G
Sbjct: 32  IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQ--AFKNEVGVLRKTRHVNILLFMG 87
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
           + + P+ + I+ ++ E  SL   L   AS  +    + +++ +  A  + YLH      I
Sbjct: 88  YSTKPQLA-IVTQWCEGSSLYHHL--HASETKFEMKKLIDIARQTARGMDYLHAKS---I 141
Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWS------ELAGTHGYVAPELAYTL 819
           +HRD+ S N+ L       + DFG+A     + S WS      +L+G+  ++APE+    
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLA----TEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 820 KVTE---KCDVYSFGVLALEVIKGKHP------RDFLFEXXXXXXXXXIEMLDSRLPYPS 870
                  + DVY+FG++  E++ G+ P      RD + E            L   L    
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGS------LSPDLSKVR 251
Query: 871 LHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
            +  K++  +M     CL +  + RP+  R+
Sbjct: 252 SNCPKRMKRLMA---ECLKKKRDERPSFPRI 279

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 101/201 (50%), Gaps = 16/201 (7%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQ--EEFLNEIQALTEIRHRNIVK 702
           IG+G  G V  A +  +G+  AVKK       ++  QQ  E   NE+  + +  H N+V 
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKM------DLRKQQRRELLFNEVVIMRDYHHDNVVD 106
Query: 703 FYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
            Y         +++ E+LE G+L  I+ +    +E   T  L+V++    AL YLHN   
Sbjct: 107 MYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLR----ALSYLHNQG- 161
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVT 822
             ++HRDI S ++LL       +SDFG    ++ +      L GT  ++APE+   L   
Sbjct: 162 --VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLPYG 219
Query: 823 EKCDVYSFGVLALEVIKGKHP 843
            + D++S G++ +E+I G+ P
Sbjct: 220 TEVDIWSLGIMVIEMIDGEPP 240

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 16/201 (7%)
Query: 646 IGKGGHGSVYRAKV-PSGEIFAVKKFHSPLPGEMSFQQEEFL--NEIQALTEIRHRNIVK 702
           IG+G  G V  A V  SG++ AVKK       ++  QQ   L  NE+  + + +H N+V+
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKM------DLRKQQRRELLFNEVVIMRDYQHENVVE 212
Query: 703 FYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
            Y         +++ E+LE G+L  I+ +    +E    Q   V   V  AL  LH    
Sbjct: 213 MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----QIAAVCLAVLQALSVLHAQG- 267
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVT 822
             ++HRDI S ++LL       +SDFG    ++ +      L GT  ++APEL   L   
Sbjct: 268 --VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYG 325
Query: 823 EKCDVYSFGVLALEVIKGKHP 843
            + D++S G++ +E++ G+ P
Sbjct: 326 PEVDIWSLGIMVIEMVDGEPP 346

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 10/210 (4%)
Query: 635 SATNDFNAEHCIGKGGHGSVYRAKVPS-GEIFAVKKFHSPLPGEMSFQQEEFL-NEIQAL 692
           S   D+   + IG G +G   + +  S G+I   K+      G M+  +++ L +E+  L
Sbjct: 3   SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDY---GSMTEAEKQMLVSEVNLL 59
Query: 693 TEIRHRNIVKFYGFCSHPKHS--FIIYEYLESGSLDKILCNDASAKE-LGWTQRLNVIKG 749
            E++H NIV++Y       ++  +I+ EY E G L  ++      ++ L     L V+  
Sbjct: 60  RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 119
Query: 750 VADALFYLH--NNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGT 807
           +  AL   H  ++    ++HRD+   NV LD      + DFG+A+ LN D     E  GT
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGT 179
Query: 808 HGYVAPELAYTLKVTEKCDVYSFGVLALEV 837
             Y++PE    +   EK D++S G L  E+
Sbjct: 180 PYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 16/201 (7%)
Query: 646 IGKGGHGSVYRAKV-PSGEIFAVKKFHSPLPGEMSFQQ--EEFLNEIQALTEIRHRNIVK 702
           IG+G  G V  A V  SG++ AVKK       ++  QQ  E   NE+  + + +H N+V+
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKM------DLRKQQRRELLFNEVVIMRDYQHENVVE 90
Query: 703 FYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
            Y         +++ E+LE G+L  I+ +    +E    Q   V   V  AL  LH    
Sbjct: 91  MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----QIAAVCLAVLQALSVLHAQ-- 144
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVT 822
             ++HRDI S ++LL       +SDFG    ++ +      L GT  ++APEL   L   
Sbjct: 145 -GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYG 203
Query: 823 EKCDVYSFGVLALEVIKGKHP 843
            + D++S G++ +E++ G+ P
Sbjct: 204 PEVDIWSLGIMVIEMVDGEPP 224

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 16/201 (7%)
Query: 646 IGKGGHGSVYRAKV-PSGEIFAVKKFHSPLPGEMSFQQ--EEFLNEIQALTEIRHRNIVK 702
           IG+G  G V  A V  SG++ AVKK       ++  QQ  E   NE+  + + +H N+V+
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKM------DLRKQQRRELLFNEVVIMRDYQHENVVE 92
Query: 703 FYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
            Y         +++ E+LE G+L  I+ +    +E    Q   V   V  AL  LH    
Sbjct: 93  MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----QIAAVCLAVLQALSVLHAQ-- 146
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVT 822
             ++HRDI S ++LL       +SDFG    ++ +      L GT  ++APEL   L   
Sbjct: 147 -GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYG 205
Query: 823 EKCDVYSFGVLALEVIKGKHP 843
            + D++S G++ +E++ G+ P
Sbjct: 206 PEVDIWSLGIMVIEMVDGEPP 226

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 16/201 (7%)
Query: 646 IGKGGHGSVYRAKV-PSGEIFAVKKFHSPLPGEMSFQQ--EEFLNEIQALTEIRHRNIVK 702
           IG+G  G V  A V  SG++ AVKK       ++  QQ  E   NE+  + + +H N+V+
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKM------DLRKQQRRELLFNEVVIMRDYQHENVVE 81
Query: 703 FYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
            Y         +++ E+LE G+L  I+ +    +E    Q   V   V  AL  LH    
Sbjct: 82  MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----QIAAVCLAVLQALSVLHAQ-- 135
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVT 822
             ++HRDI S ++LL       +SDFG    ++ +      L GT  ++APEL   L   
Sbjct: 136 -GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYG 194
Query: 823 EKCDVYSFGVLALEVIKGKHP 843
            + D++S G++ +E++ G+ P
Sbjct: 195 PEVDIWSLGIMVIEMVDGEPP 215

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 16/201 (7%)
Query: 646 IGKGGHGSVYRAKV-PSGEIFAVKKFHSPLPGEMSFQQ--EEFLNEIQALTEIRHRNIVK 702
           IG+G  G V  A V  SG++ AVKK       ++  QQ  E   NE+  + + +H N+V+
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKM------DLRKQQRRELLFNEVVIMRDYQHENVVE 85
Query: 703 FYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
            Y         +++ E+LE G+L  I+ +    +E    Q   V   V  AL  LH    
Sbjct: 86  MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----QIAAVCLAVLQALSVLHAQ-- 139
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVT 822
             ++HRDI S ++LL       +SDFG    ++ +      L GT  ++APEL   L   
Sbjct: 140 -GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYG 198
Query: 823 EKCDVYSFGVLALEVIKGKHP 843
            + D++S G++ +E++ G+ P
Sbjct: 199 PEVDIWSLGIMVIEMVDGEPP 219

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 60/210 (28%), Positives = 102/210 (48%), Gaps = 10/210 (4%)
Query: 635 SATNDFNAEHCIGKGGHGSVYRAKVPS-GEIFAVKKFHSPLPGEMSFQQEEFL-NEIQAL 692
           S   D+   + IG G +G   + +  S G+I   K+      G M+  +++ L +E+  L
Sbjct: 3   SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDY---GSMTEAEKQMLVSEVNLL 59
Query: 693 TEIRHRNIVKFYGFCSHPKHS--FIIYEYLESGSLDKILCNDASAKE-LGWTQRLNVIKG 749
            E++H NIV++Y       ++  +I+ EY E G L  ++      ++ L     L V+  
Sbjct: 60  RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 119
Query: 750 VADALFYLH--NNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGT 807
           +  AL   H  ++    ++HRD+   NV LD      + DFG+A+ LN D+S      GT
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGT 179
Query: 808 HGYVAPELAYTLKVTEKCDVYSFGVLALEV 837
             Y++PE    +   EK D++S G L  E+
Sbjct: 180 PYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 60/210 (28%), Positives = 102/210 (48%), Gaps = 10/210 (4%)
Query: 635 SATNDFNAEHCIGKGGHGSVYRAKVPS-GEIFAVKKFHSPLPGEMSFQQEEFL-NEIQAL 692
           S   D+   + IG G +G   + +  S G+I   K+      G M+  +++ L +E+  L
Sbjct: 3   SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDY---GSMTEAEKQMLVSEVNLL 59
Query: 693 TEIRHRNIVKFYGFCSHPKHS--FIIYEYLESGSLDKILCNDASAKE-LGWTQRLNVIKG 749
            E++H NIV++Y       ++  +I+ EY E G L  ++      ++ L     L V+  
Sbjct: 60  RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 119
Query: 750 VADALFYLH--NNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGT 807
           +  AL   H  ++    ++HRD+   NV LD      + DFG+A+ LN D+S      GT
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGT 179
Query: 808 HGYVAPELAYTLKVTEKCDVYSFGVLALEV 837
             Y++PE    +   EK D++S G L  E+
Sbjct: 180 PYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 123/271 (45%), Gaps = 38/271 (14%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           IG G  G+VY+ K   G++ AVK  +   P     Q   F NE+  L + RH NI+ F G
Sbjct: 20  IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQ--AFKNEVGVLRKTRHVNILLFMG 75
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
           + + P+ + I+ ++ E  SL   L   AS  +    + +++ +  A  + YLH      I
Sbjct: 76  YSTKPQLA-IVTQWCEGSSLYHHL--HASETKFEMKKLIDIARQTARGMDYLHAKS---I 129
Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWS------ELAGTHGYVAPELAYTL 819
           +HRD+ S N+ L       + DFG+A       S WS      +L+G+  ++APE+    
Sbjct: 130 IHRDLKSNNIFLHEDNTVKIGDFGLATV----KSRWSGSHQFEQLSGSILWMAPEVIRMQ 185
Query: 820 KVTE---KCDVYSFGVLALEVIKGKHP------RDFLFEXXXXXXXXXIEMLDSRLPYPS 870
                  + DVY+FG++  E++ G+ P      RD + E            L   L    
Sbjct: 186 DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGS------LSPDLSKVR 239
Query: 871 LHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
            +  K++  +M     CL +  + RP+  R+
Sbjct: 240 SNCPKRMKRLMA---ECLKKKRDERPSFPRI 267

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 62/221 (28%), Positives = 109/221 (49%), Gaps = 32/221 (14%)
Query: 646 IGKGGHGSVYRAK----VPSGE--IFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRN 699
           +G+G  G V+ A+    +P  +  + AVK     L       +++F  E + LT ++H++
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKA----LKEASESARQDFQREAELLTMLQHQH 75
Query: 700 IVKFYGFCSHPKHSFIIYEYLESGSLDKIL------------CNDASAKELGWTQRLNVI 747
           IV+F+G C+  +   +++EY+  G L++ L              D +   LG  Q L V 
Sbjct: 76  IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 135
Query: 748 KGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGT 807
             VA  + YL    F   VHRD++++N L+  G    + DFG+++ +   S+++  + G 
Sbjct: 136 SQVAAGMVYLAGLHF---VHRDLATRNCLVGQGLVVKIGDFGMSRDIY--STDYYRVGGR 190
Query: 808 H----GYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHP 843
                 ++ PE     K T + DV+SFGV+  E+   GK P
Sbjct: 191 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 231

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 92/179 (51%), Gaps = 22/179 (12%)
Query: 682 QEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKIL------------ 729
           +++F  E + LT ++H++IV+F+G C+  +   +++EY+  G L++ L            
Sbjct: 87  RQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAG 146
Query: 730 CNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFG 789
             D +   LG  Q L V   VA  + YL    F   VHRD++++N L+  G    + DFG
Sbjct: 147 GEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHF---VHRDLATRNCLVGQGLVVKIGDFG 203
Query: 790 IAKFLNPDSSNWSELAGTH----GYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHP 843
           +++ +   S+++  + G       ++ PE     K T + DV+SFGV+  E+   GK P
Sbjct: 204 MSRDIY--STDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 124/271 (45%), Gaps = 38/271 (14%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           IG G  G+VY+ K   G++ AVK  +   P     Q   F NE+  L + RH NI+ F G
Sbjct: 32  IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQ--AFKNEVGVLRKTRHVNILLFMG 87
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
           + + P+ + I+ ++ E  SL   L   AS  +    + +++ +  A  + YLH      I
Sbjct: 88  YSTAPQLA-IVTQWCEGSSLYHHL--HASETKFEMKKLIDIARQTARGMDYLHAKS---I 141
Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWS------ELAGTHGYVAPELAYTL 819
           +HRD+ S N+ L       + DFG+A     + S WS      +L+G+  ++APE+    
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLA----TEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 820 KVTE---KCDVYSFGVLALEVIKGKHP------RDFLFEXXXXXXXXXIEMLDSRLPYPS 870
                  + DVY+FG++  E++ G+ P      RD + E            L   L    
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGS------LSPDLSKVR 251
Query: 871 LHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
            +  K++  +M     CL +  + RP+  R+
Sbjct: 252 SNCPKRMKRLMA---ECLKKKRDERPSFPRI 279

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 61/204 (29%), Positives = 104/204 (50%), Gaps = 17/204 (8%)
Query: 639 DFNAEHCIGKGGHGSVYRAKVPSGEI-FAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH 697
           D   +H +G G +G VY        +  AVK        E + + EEFL E   + EI+H
Sbjct: 33  DITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKH 87
Query: 698 RNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYL 757
            N+V+  G C+     +I+ EY+  G+L   L  + + +E+     L +   ++ A+ YL
Sbjct: 88  PNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYL-RECNREEVTAVVLLYMATQISSAMEYL 146
Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPE 814
               F   +HRD++++N L+   +   V+DFG+++ +  D+  ++  AG      + APE
Sbjct: 147 EKKNF---IHRDLAARNCLVGENHVVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE 201
Query: 815 -LAYTLKVTEKCDVYSFGVLALEV 837
            LAY    + K DV++FGVL  E+
Sbjct: 202 SLAYN-TFSIKSDVWAFGVLLWEI 224

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 124/269 (46%), Gaps = 26/269 (9%)
Query: 638 NDFNAEHCIGKGGHGSVYR-AKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
           +DF     +G G  G V++ +  PSG + A K  H  +   +   + + + E+Q L E  
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI---RNQIIRELQVLHECN 65
Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE--LGWTQRLNVIKGVADAL 754
              IV FYG         I  E+++ GSLD++L       E  LG    + VIKG    L
Sbjct: 66  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVS-IAVIKG----L 120
Query: 755 FYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPE 814
            YL       I+HRD+   N+L++   E  + DFG++  L  + +N  E  GT  Y++PE
Sbjct: 121 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMAN--EFVGTRSYMSPE 176
Query: 815 LAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLHVQ 874
                  + + D++S G+  +E+  G++PR  +            E+LD  +  P   + 
Sbjct: 177 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPRPPM---------AIFELLDYIVNEPPPKLP 227
Query: 875 KKLMSIMQVAF--SCLDQNPESRPTMKRV 901
             + S+    F   CL +NP  R  +K++
Sbjct: 228 SAVFSLEFQDFVNKCLIKNPAERADLKQL 256

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 92/179 (51%), Gaps = 22/179 (12%)
Query: 682 QEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKIL------------ 729
           +++F  E + LT ++H++IV+F+G C+  +   +++EY+  G L++ L            
Sbjct: 64  RQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAG 123
Query: 730 CNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFG 789
             D +   LG  Q L V   VA  + YL    F   VHRD++++N L+  G    + DFG
Sbjct: 124 GEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHF---VHRDLATRNCLVGQGLVVKIGDFG 180
Query: 790 IAKFLNPDSSNWSELAGTH----GYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHP 843
           +++ +   S+++  + G       ++ PE     K T + DV+SFGV+  E+   GK P
Sbjct: 181 MSRDIY--STDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 237

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 120/264 (45%), Gaps = 32/264 (12%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           IG G  G V+     + +  A+K       G MS  +E+F+ E + + ++ H  +V+ YG
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIRE---GAMS--EEDFIEEAEVMMKLSHPKLVQLYG 69
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDAS--AKELGWTQRLNVIKGVADALFYLHNNCFP 763
            C       +++E++E G L   L       A E      L+V +G+A    YL      
Sbjct: 70  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA----YLEE---A 122
Query: 764 PIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPELAYTLK 820
            ++HRD++++N L+       VSDFG+ +F+  D   ++   GT     + +PE+    +
Sbjct: 123 SVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--QYTSSTGTKFPVKWASPEVFSFSR 180
Query: 821 VTEKCDVYSFGVLALEVI-KGKHPRDFLFEXXXXXXXXXIEMLDS--RLPYPSLHVQKKL 877
            + K DV+SFGVL  EV  +GK P +             +E + +  RL  P L      
Sbjct: 181 YSSKSDVWSFGVLMWEVFSEGKIPYE------NRSNSEVVEDISTGFRLYKPRLASTH-- 232
Query: 878 MSIMQVAFSCLDQNPESRPTMKRV 901
             + Q+   C  + PE RP   R+
Sbjct: 233 --VYQIMNHCWKERPEDRPAFSRL 254

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 80/305 (26%), Positives = 134/305 (43%), Gaps = 62/305 (20%)
Query: 645 CIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           C+GKG +G V+R     GE  AVK F S    +  F++ E  N +     +RH NI+ F 
Sbjct: 44  CVGKGRYGEVWRGSW-QGENVAVKIF-SSRDEKSWFRETELYNTVM----LRHENILGFI 97
Query: 705 GFCSHPKHSFI-------------IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVA 751
                 +HS               +Y+YL+  +LD + C             L ++  +A
Sbjct: 98  ASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSC-------------LRIVLSIA 144
Query: 752 DALFYLHNNCF-----PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELA- 805
             L +LH   F     P I HRD+ SKN+L+    +  ++D G+A  ++  S+N  ++  
Sbjct: 145 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGN 203
Query: 806 ----GTHGYVAPE-LAYTLKVT-----EKCDVYSFGVLALEVIKG----------KHP-R 844
               GT  Y+APE L  T++V      ++ D+++FG++  EV +           K P  
Sbjct: 204 NPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 263
Query: 845 DFLFEXXXXXXXXXIEMLDSRLP-YPSLHVQK-KLMSIMQVAFSCLDQNPESRPTMKRVS 902
           D +           +  +D + P  P+       L S+ ++   C  QNP +R T  R+ 
Sbjct: 264 DVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIK 323
Query: 903 QLLCE 907
           + L +
Sbjct: 324 KTLTK 328

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 80/305 (26%), Positives = 134/305 (43%), Gaps = 62/305 (20%)
Query: 645 CIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           C+GKG +G V+R     GE  AVK F S    +  F++ E  N +     +RH NI+ F 
Sbjct: 15  CVGKGRYGEVWRGSW-QGENVAVKIF-SSRDEKSWFRETELYNTVM----LRHENILGFI 68
Query: 705 GFCSHPKHSFI-------------IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVA 751
                 +HS               +Y+YL+  +LD + C             L ++  +A
Sbjct: 69  ASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSC-------------LRIVLSIA 115
Query: 752 DALFYLHNNCF-----PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELA- 805
             L +LH   F     P I HRD+ SKN+L+    +  ++D G+A  ++  S+N  ++  
Sbjct: 116 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGN 174
Query: 806 ----GTHGYVAPE-LAYTLKVT-----EKCDVYSFGVLALEVIKG----------KHP-R 844
               GT  Y+APE L  T++V      ++ D+++FG++  EV +           K P  
Sbjct: 175 NPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234
Query: 845 DFLFEXXXXXXXXXIEMLDSRLP-YPSLHVQK-KLMSIMQVAFSCLDQNPESRPTMKRVS 902
           D +           +  +D + P  P+       L S+ ++   C  QNP +R T  R+ 
Sbjct: 235 DVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIK 294
Query: 903 QLLCE 907
           + L +
Sbjct: 295 KTLTK 299

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 126/270 (46%), Gaps = 46/270 (17%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           IG G  G+VY+ K   G++ AVK  +   P     Q   F NE+  L + RH NI+ F G
Sbjct: 16  IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQ--AFKNEVGVLRKTRHVNILLFMG 71
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
           + + P+ + I+ ++ E  SL   L    +  E+   + +++ +  A  + YLH      I
Sbjct: 72  YSTKPQLA-IVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---I 125
Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWS------ELAGTHGYVAPELAYTL 819
           +HRD+ S N+ L       + DFG+A     + S WS      +L+G+  ++APE+   +
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLAT----EKSRWSGSHQFEQLSGSILWMAPEV---I 178
Query: 820 KVTEK------CDVYSFGVLALEVIKGKHP------RD-FLFEXXXXXXXXXIEMLDSRL 866
           ++ +K       DVY+FG++  E++ G+ P      RD  +F          +  + S  
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 867 PYPSLHVQKKLMSIMQVAFSCLDQNPESRP 896
           P       K+LM+       CL +  + RP
Sbjct: 239 P----KAMKRLMA------ECLKKKRDERP 258

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 125/270 (46%), Gaps = 46/270 (17%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           IG G  G+VY+ K   G++ AVK  +   P     Q   F NE+  L + RH NI+ F G
Sbjct: 16  IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQ--AFKNEVGVLRKTRHVNILLFMG 71
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
           + + P+ + I+ ++ E  SL   L    +  E+   + +++ +  A  + YLH      I
Sbjct: 72  YSTKPQLA-IVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---I 125
Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWS------ELAGTHGYVAPELAYTL 819
           +HRD+ S N+ L       + DFG+A       S WS      +L+G+  ++APE+   +
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATV----KSRWSGSHQFEQLSGSILWMAPEV---I 178
Query: 820 KVTEK------CDVYSFGVLALEVIKGKHP------RD-FLFEXXXXXXXXXIEMLDSRL 866
           ++ +K       DVY+FG++  E++ G+ P      RD  +F          +  + S  
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 867 PYPSLHVQKKLMSIMQVAFSCLDQNPESRP 896
           P       K+LM+       CL +  + RP
Sbjct: 239 P----KAMKRLMA------ECLKKKRDERP 258

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 107/210 (50%), Gaps = 29/210 (13%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           IG G  G+VY+ K   G++ AVK  +   P     Q   F NE+  L + RH NI+ F G
Sbjct: 36  IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQ--AFKNEVGVLRKTRHVNILLFMG 91
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
           + + P+ + I+ ++ E  SL   L    +  E+   + +++ +  A  + YLH      I
Sbjct: 92  YSTKPQLA-IVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---I 145
Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWS------ELAGTHGYVAPELAYTL 819
           +HRD+ S N+ L       + DFG+A     + S WS      +L+G+  ++APE+   +
Sbjct: 146 IHRDLKSNNIFLHEDLTVKIGDFGLAT----EKSRWSGSHQFEQLSGSILWMAPEV---I 198
Query: 820 KVTEK------CDVYSFGVLALEVIKGKHP 843
           ++ +K       DVY+FG++  E++ G+ P
Sbjct: 199 RMQDKNPYSFQSDVYAFGIVLYELMTGQLP 228

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Composition-based stats.
 Identities = 62/210 (29%), Positives = 101/210 (48%), Gaps = 12/210 (5%)
Query: 638 NDFNAEHCIGKGGHGSVYRAKVPSGE-IFAVKK-FHSPLPGEMSFQQEEFLNEIQALTEI 695
           +DF+    +GKG  G+VY A+    + I A+K  F S L  E    + +   EI+  + +
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQL--EKEGVEHQLRREIEIQSHL 71
Query: 696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALF 755
           RH NI++ Y +    K  +++ E+   G L K L       E    +    ++ +ADAL 
Sbjct: 72  RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDE---QRSATFMEELADALH 128
Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           Y H      ++HRDI  +N+L+    E  ++DFG +  ++  S     + GT  Y+ PE+
Sbjct: 129 YCHER---KVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRXMCGTLDYLPPEM 183
Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHPRD 845
                  EK D++  GVL  E + G  P D
Sbjct: 184 IEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-15,   Method: Composition-based stats.
 Identities = 62/210 (29%), Positives = 101/210 (48%), Gaps = 12/210 (5%)
Query: 638 NDFNAEHCIGKGGHGSVYRAKVPSGE-IFAVKK-FHSPLPGEMSFQQEEFLNEIQALTEI 695
           +DF+    +GKG  G+VY A+    + I A+K  F S L  E    + +   EI+  + +
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQL--EKEGVEHQLRREIEIQSHL 72
Query: 696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALF 755
           RH NI++ Y +    K  +++ E+   G L K L       E    +    ++ +ADAL 
Sbjct: 73  RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDE---QRSATFMEELADALH 129
Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           Y H      ++HRDI  +N+L+    E  ++DFG +  ++  S     + GT  Y+ PE+
Sbjct: 130 YCHER---KVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRXMCGTLDYLPPEM 184
Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHPRD 845
                  EK D++  GVL  E + G  P D
Sbjct: 185 IEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 125/270 (46%), Gaps = 46/270 (17%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           IG G  G+VY+ K   G++ AVK  +   P     Q   F NE+  L + RH NI+ F G
Sbjct: 21  IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQ--AFKNEVGVLRKTRHVNILLFMG 76
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
           + + P+ + I+ ++ E  SL   L    +  E+   + +++ +  A  + YLH      I
Sbjct: 77  YSTKPQLA-IVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---I 130
Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWS------ELAGTHGYVAPELAYTL 819
           +HRD+ S N+ L       + DFG+A       S WS      +L+G+  ++APE+   +
Sbjct: 131 IHRDLKSNNIFLHEDLTVKIGDFGLATV----KSRWSGSHQFEQLSGSILWMAPEV---I 183
Query: 820 KVTEK------CDVYSFGVLALEVIKGKHP------RD-FLFEXXXXXXXXXIEMLDSRL 866
           ++ +K       DVY+FG++  E++ G+ P      RD  +F          +  + S  
Sbjct: 184 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 243
Query: 867 PYPSLHVQKKLMSIMQVAFSCLDQNPESRP 896
           P       K+LM+       CL +  + RP
Sbjct: 244 P----KAMKRLMA------ECLKKKRDERP 263

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 107/210 (50%), Gaps = 29/210 (13%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           IG G  G+VY+ K   G++ AVK  +   P     Q   F NE+  L + RH NI+ F G
Sbjct: 44  IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQ--AFKNEVGVLRKTRHVNILLFMG 99
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
           + + P+ + I+ ++ E  SL   L    +  E+   + +++ +  A  + YLH      I
Sbjct: 100 YSTKPQLA-IVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---I 153
Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWS------ELAGTHGYVAPELAYTL 819
           +HRD+ S N+ L       + DFG+A     + S WS      +L+G+  ++APE+   +
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLA----TEKSRWSGSHQFEQLSGSILWMAPEV---I 206
Query: 820 KVTEK------CDVYSFGVLALEVIKGKHP 843
           ++ +K       DVY+FG++  E++ G+ P
Sbjct: 207 RMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 125/270 (46%), Gaps = 46/270 (17%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           IG G  G+VY+ K   G++ AVK  +   P     Q   F NE+  L + RH NI+ F G
Sbjct: 18  IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQ--AFKNEVGVLRKTRHVNILLFMG 73
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
           + + P+ + I+ ++ E  SL   L    +  E+   + +++ +  A  + YLH      I
Sbjct: 74  YSTKPQLA-IVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---I 127
Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWS------ELAGTHGYVAPELAYTL 819
           +HRD+ S N+ L       + DFG+A       S WS      +L+G+  ++APE+   +
Sbjct: 128 IHRDLKSNNIFLHEDLTVKIGDFGLATV----KSRWSGSHQFEQLSGSILWMAPEV---I 180
Query: 820 KVTEK------CDVYSFGVLALEVIKGKHP------RD-FLFEXXXXXXXXXIEMLDSRL 866
           ++ +K       DVY+FG++  E++ G+ P      RD  +F          +  + S  
Sbjct: 181 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 240
Query: 867 PYPSLHVQKKLMSIMQVAFSCLDQNPESRP 896
           P       K+LM+       CL +  + RP
Sbjct: 241 P----KAMKRLMA------ECLKKKRDERP 260

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-15,   Method: Composition-based stats.
 Identities = 67/232 (28%), Positives = 111/232 (47%), Gaps = 17/232 (7%)
Query: 619 RSVLTFEGKIVYEEIISA--TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLP 675
           R  L F+G  ++ +  +A  ++ +  +  +GKG  G V   K   +G+  AVK   S   
Sbjct: 11  RENLYFQGPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVI-SKRQ 69
Query: 676 GEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSL-DKILCNDAS 734
            +    +E  L E+Q L ++ H NI+K Y F     + +++ E    G L D+I+    S
Sbjct: 70  VKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII----S 125
Query: 735 AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYE---AHVSDFGIA 791
            K         +I+ V   + Y+H N    IVHRD+  +N+LL+   +     + DFG++
Sbjct: 126 RKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS 182
Query: 792 KFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
                 S    +  GT  Y+APE+ +     EKCDV+S GV+   ++ G  P
Sbjct: 183 THFEA-SKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPP 232

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 125/270 (46%), Gaps = 46/270 (17%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           IG G  G+VY+ K   G++ AVK  +   P     Q   F NE+  L + RH NI+ F G
Sbjct: 16  IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQ--AFKNEVGVLRKTRHVNILLFMG 71
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
           + + P+ + I+ ++ E  SL   L    +  E+   + +++ +  A  + YLH      I
Sbjct: 72  YSTAPQLA-IVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---I 125
Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWS------ELAGTHGYVAPELAYTL 819
           +HRD+ S N+ L       + DFG+A       S WS      +L+G+  ++APE+   +
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATV----KSRWSGSHQFEQLSGSILWMAPEV---I 178
Query: 820 KVTEK------CDVYSFGVLALEVIKGKHP------RD-FLFEXXXXXXXXXIEMLDSRL 866
           ++ +K       DVY+FG++  E++ G+ P      RD  +F          +  + S  
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 867 PYPSLHVQKKLMSIMQVAFSCLDQNPESRP 896
           P       K+LM+       CL +  + RP
Sbjct: 239 P----KAMKRLMA------ECLKKKRDERP 258

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Composition-based stats.
 Identities = 70/267 (26%), Positives = 122/267 (45%), Gaps = 24/267 (8%)
Query: 643 EHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVK 702
           E  +G G  G V+ A        AVK      PG MS   E FL E   +  ++H  +VK
Sbjct: 20  EKKLGAGQFGEVWMATYNKHTKVAVKTMK---PGSMSV--EAFLAEANVMKTLQHDKLVK 74
Query: 703 FYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
            +   +  +  +II E++  GSL   L +D  +K+    + ++    +A+ + ++    +
Sbjct: 75  LHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQ-PLPKLIDFSAQIAEGMAFIEQRNY 132
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH-GYVAPELAYTLKV 821
              +HRD+ + N+L+       ++DFG+A+ +  +     E A     + APE       
Sbjct: 133 ---IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSF 189
Query: 822 TEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDS--RLPYPSLHVQKKLM 878
           T K DV+SFG+L +E++  G+ P   +           I  L+   R+P P  +  ++L 
Sbjct: 190 TIKSDVWSFGILLMEIVTYGRIPYPGM------SNPEVIRALERGYRMPRPE-NCPEELY 242
Query: 879 SIMQVAFSCLDQNPESRPTMKRVSQLL 905
           +IM     C    PE RPT + +  +L
Sbjct: 243 NIM---MRCWKNRPEERPTFEYIQSVL 266

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 125/270 (46%), Gaps = 46/270 (17%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           IG G  G+VY+ K   G++ AVK  +   P     Q   F NE+  L + RH NI+ F G
Sbjct: 21  IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQ--AFKNEVGVLRKTRHVNILLFMG 76
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
           + + P+ + I+ ++ E  SL   L    +  E+   + +++ +  A  + YLH      I
Sbjct: 77  YSTKPQLA-IVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---I 130
Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWS------ELAGTHGYVAPELAYTL 819
           +HRD+ S N+ L       + DFG+A       S WS      +L+G+  ++APE+   +
Sbjct: 131 IHRDLKSNNIFLHEDLTVKIGDFGLATV----KSRWSGSHQFEQLSGSILWMAPEV---I 183
Query: 820 KVTEK------CDVYSFGVLALEVIKGKHP------RD-FLFEXXXXXXXXXIEMLDSRL 866
           ++ +K       DVY+FG++  E++ G+ P      RD  +F          +  + S  
Sbjct: 184 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 243
Query: 867 PYPSLHVQKKLMSIMQVAFSCLDQNPESRP 896
           P       K+LM+       CL +  + RP
Sbjct: 244 P----KAMKRLMA------ECLKKKRDERP 263

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 106/210 (50%), Gaps = 29/210 (13%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           IG G  G+VY+ K   G++ AVK  +   P     Q   F NE+  L + RH NI+ F G
Sbjct: 43  IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQ--AFKNEVGVLRKTRHVNILLFMG 98
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
           + + P+ + I+ ++ E  SL   L    +  E+   + +++ +  A  + YLH      I
Sbjct: 99  YSTKPQLA-IVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---I 152
Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWS------ELAGTHGYVAPELAYTL 819
           +HRD+ S N+ L       + DFG+A       S WS      +L+G+  ++APE+   +
Sbjct: 153 IHRDLKSNNIFLHEDLTVKIGDFGLATV----KSRWSGSHQFEQLSGSILWMAPEV---I 205
Query: 820 KVTEK------CDVYSFGVLALEVIKGKHP 843
           ++ +K       DVY+FG++  E++ G+ P
Sbjct: 206 RMQDKNPYSFQSDVYAFGIVLYELMTGQLP 235

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Composition-based stats.
 Identities = 87/311 (27%), Positives = 134/311 (43%), Gaps = 58/311 (18%)
Query: 635 SATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMS-FQQEEFLNEIQALT 693
           +   D     C+GKG +G V+R     GE  AVK F S    E S F++ E  N +    
Sbjct: 5   TVARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR--DEKSWFRETELYNTVM--- 58
Query: 694 EIRHRNIVKFYGFCSHPKHS----FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKG 749
            +RH NI+ F       +HS    ++I  Y E GSL   L        L     L ++  
Sbjct: 59  -LRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLS 113
Query: 750 VADALFYLHNNCF-----PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSEL 804
           +A  L +LH   F     P I HRD+ SKN+L+    +  ++D G+A  ++  S+N  ++
Sbjct: 114 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDV 172
Query: 805 A-----GTHGYVAPE-LAYTLKVT-----EKCDVYSFGVLALEVIKG----------KHP 843
                 GT  Y+APE L  T++V      ++ D+++FG++  EV +           K P
Sbjct: 173 GNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP 232
Query: 844 -RDFLFEXXXXXXXXXIEMLDSRLPY--------PSLHVQKKLMSIMQVAFSCLDQNPES 894
             D +           +  +D + P         P+L    KLM        C  QNP +
Sbjct: 233 FYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMK------ECWYQNPSA 286
Query: 895 RPTMKRVSQLL 905
           R T  R+ + L
Sbjct: 287 RLTALRIKKTL 297

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 106/210 (50%), Gaps = 29/210 (13%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           IG G  G+VY+ K   G++ AVK  +   P     Q   F NE+  L + RH NI+ F G
Sbjct: 44  IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQ--AFKNEVGVLRKTRHVNILLFMG 99
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
           + + P+ + I+ ++ E  SL   L    +  E+   + +++ +  A  + YLH      I
Sbjct: 100 YSTKPQLA-IVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---I 153
Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWS------ELAGTHGYVAPELAYTL 819
           +HRD+ S N+ L       + DFG+A       S WS      +L+G+  ++APE+   +
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLATV----KSRWSGSHQFEQLSGSILWMAPEV---I 206
Query: 820 KVTEK------CDVYSFGVLALEVIKGKHP 843
           ++ +K       DVY+FG++  E++ G+ P
Sbjct: 207 RMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 48/159 (30%), Positives = 81/159 (50%), Gaps = 8/159 (5%)
Query: 688 EIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVI 747
           EIQ L   RH +I+K Y   S P   F++ EY+  G L   +C     +E+   +   + 
Sbjct: 61  EIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEM---EARRLF 117
Query: 748 KGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGT 807
           + +  A+ Y H +    +VHRD+  +NVLLD    A ++DFG++  ++ D     +  G+
Sbjct: 118 QQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRDSCGS 173
Query: 808 HGYVAPE-LAYTLKVTEKCDVYSFGVLALEVIKGKHPRD 845
             Y APE ++  L    + D++S GV+   ++ G  P D
Sbjct: 174 PNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 122/267 (45%), Gaps = 24/267 (8%)
Query: 643 EHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVK 702
           E  +G G  G V+ A        AVK      PG MS   E FL E   +  ++H  +VK
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMK---PGSMSV--EAFLAEANVMKTLQHDKLVK 247
Query: 703 FYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
            +   +  +  +II E++  GSL   L +D  +K+    + ++    +A+ + ++    +
Sbjct: 248 LHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQ-PLPKLIDFSAQIAEGMAFIEQRNY 305
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAG-THGYVAPELAYTLKV 821
              +HRD+ + N+L+       ++DFG+A+ +  +     E A     + APE       
Sbjct: 306 ---IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSF 362
Query: 822 TEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDS--RLPYPSLHVQKKLM 878
           T K DV+SFG+L +E++  G+ P   +           I  L+   R+P P  +  ++L 
Sbjct: 363 TIKSDVWSFGILLMEIVTYGRIPYPGM------SNPEVIRALERGYRMPRPE-NCPEELY 415
Query: 879 SIMQVAFSCLDQNPESRPTMKRVSQLL 905
           +IM     C    PE RPT + +  +L
Sbjct: 416 NIM---MRCWKNRPEERPTFEYIQSVL 439

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 98/198 (49%), Gaps = 13/198 (6%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           IG+G +G VY+A+   GE FA+KK    L  E        + EI  L E++H NIVK Y 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIR--LEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 706 FCSHPKHSFIIYEYLESGSLDKIL--CNDASAKELGWTQRLNVIKGVADALFYLHNNCFP 763
                K   +++E+L+   L K+L  C          +  L ++ G+A    Y H+    
Sbjct: 68  VIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIA----YCHDR--- 119
Query: 764 PIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPE-LAYTLKVT 822
            ++HRD+  +N+L++   E  ++DFG+A+        ++    T  Y AP+ L  + K +
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYS 179
Query: 823 EKCDVYSFGVLALEVIKG 840
              D++S G +  E++ G
Sbjct: 180 TTIDIWSVGCIFAEMVNG 197

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 98/198 (49%), Gaps = 13/198 (6%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           IG+G +G VY+A+   GE FA+KK    L  E        + EI  L E++H NIVK Y 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIR--LEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 706 FCSHPKHSFIIYEYLESGSLDKIL--CNDASAKELGWTQRLNVIKGVADALFYLHNNCFP 763
                K   +++E+L+   L K+L  C          +  L ++ G+A    Y H+    
Sbjct: 68  VIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIA----YCHDR--- 119
Query: 764 PIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPE-LAYTLKVT 822
            ++HRD+  +N+L++   E  ++DFG+A+        ++    T  Y AP+ L  + K +
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYS 179
Query: 823 EKCDVYSFGVLALEVIKG 840
              D++S G +  E++ G
Sbjct: 180 TTIDIWSVGCIFAEMVNG 197

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 15/212 (7%)
Query: 637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI 695
           ++ +  +  +GKG  G V   K   +G+  AVK   S    +    +E  L E+Q L ++
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVI-SKRQVKQKTDKESLLREVQLLKQL 83
Query: 696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSL-DKILCNDASAKELGWTQRLNVIKGVADAL 754
            H NI+K Y F     + +++ E    G L D+I+    S K         +I+ V   +
Sbjct: 84  DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII----SRKRFSEVDAARIIRQVLSGI 139
Query: 755 FYLHNNCFPPIVHRDISSKNVLLD-LGYEAHVS--DFGIAKFLNPDSSNWSELAGTHGYV 811
            Y+H N    IVHRD+  +N+LL+    +A++   DFG++      S    +  GT  Y+
Sbjct: 140 TYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA-SKKMKDKIGTAYYI 195
Query: 812 APELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           APE+ +     EKCDV+S GV+   ++ G  P
Sbjct: 196 APEVLHGT-YDEKCDVWSTGVILYILLSGCPP 226

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 98/198 (49%), Gaps = 13/198 (6%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           IG+G +G VY+A+   GE FA+KK    L  E        + EI  L E++H NIVK Y 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIR--LEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 706 FCSHPKHSFIIYEYLESGSLDKIL--CNDASAKELGWTQRLNVIKGVADALFYLHNNCFP 763
                K   +++E+L+   L K+L  C          +  L ++ G+A    Y H+    
Sbjct: 68  VIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIA----YCHDR--- 119
Query: 764 PIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPE-LAYTLKVT 822
            ++HRD+  +N+L++   E  ++DFG+A+        ++    T  Y AP+ L  + K +
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYS 179
Query: 823 EKCDVYSFGVLALEVIKG 840
              D++S G +  E++ G
Sbjct: 180 TTIDIWSVGCIFAEMVNG 197

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 60/219 (27%), Positives = 106/219 (48%), Gaps = 30/219 (13%)
Query: 646 IGKGGHGSVYRAKV----PSGE--IFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRN 699
           +G+G  G V+ A+     P  +  + AVK     L       +++F  E + LT ++H +
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKT----LKDASDNARKDFHREAELLTNLQHEH 76
Query: 700 IVKFYGFCSHPKHSFIIYEYLESGSLDKIL----------CNDASAKELGWTQRLNVIKG 749
           IVKFYG C       +++EY++ G L+K L                 EL  +Q L++ + 
Sbjct: 77  IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQ 136
Query: 750 VADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH- 808
           +A  + YL +  F   VHRD++++N L+       + DFG+++  +  S+++  + G   
Sbjct: 137 IAAGMVYLASQHF---VHRDLATRNCLVGENLLVKIGDFGMSR--DVYSTDYYRVGGHTM 191
Query: 809 ---GYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHP 843
               ++ PE     K T + DV+S GV+  E+   GK P
Sbjct: 192 LPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 230

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 48/159 (30%), Positives = 80/159 (50%), Gaps = 8/159 (5%)
Query: 688 EIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVI 747
           EIQ L   RH +I+K Y   S P   F++ EY+  G L   +C     +E+   +   + 
Sbjct: 61  EIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEM---EARRLF 117
Query: 748 KGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGT 807
           + +  A+ Y H +    +VHRD+  +NVLLD    A ++DFG++  ++ D        G+
Sbjct: 118 QQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRTSCGS 173
Query: 808 HGYVAPE-LAYTLKVTEKCDVYSFGVLALEVIKGKHPRD 845
             Y APE ++  L    + D++S GV+   ++ G  P D
Sbjct: 174 PNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 70/257 (27%), Positives = 119/257 (46%), Gaps = 24/257 (9%)
Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQ-EEFLNEIQALTEIRHRNIVKF 703
           IG G  G+VY A+ V + E+ A+KK      G+ S ++ ++ + E++ L ++RH N +++
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMS--YSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 704 YGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFP 763
            G       ++++ EY   GS   +L  +   K L   +   V  G    L YLH++   
Sbjct: 120 RGCYLREHTAWLVMEYC-LGSASDLL--EVHKKPLQEVEIAAVTHGALQGLAYLHSHN-- 174
Query: 764 PIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTE 823
            ++HRD+ + N+LL       + DFG A  + P +       GT  ++APE+   +   +
Sbjct: 175 -MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX----FVGTPYWMAPEVILAMDEGQ 229
Query: 824 ---KCDVYSFGVLALEVIKGKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLHVQKKLMSI 880
              K DV+S G+  +E+ + K P   LF          I   +S    P+L         
Sbjct: 230 YDGKVDVWSLGITCIELAERKPP---LFNMNAMSALYHIAQNES----PALQSGHWSEYF 282
Query: 881 MQVAFSCLDQNPESRPT 897
                SCL + P+ RPT
Sbjct: 283 RNFVDSCLQKIPQDRPT 299

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 99/208 (47%), Gaps = 7/208 (3%)
Query: 639 DFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH 697
           DF   + +GKG    VYRA+ + +G   A+K        +    Q    NE++   +++H
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR-VQNEVKIHCQLKH 70
Query: 698 RNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYL 757
            +I++ Y +     + +++ E   +G +++ L N    K     +  + +  +   + YL
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYL 128
Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAY 817
           H++    I+HRD++  N+LL       ++DFG+A  L         L GT  Y++PE+A 
Sbjct: 129 HSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIAT 185
Query: 818 TLKVTEKCDVYSFGVLALEVIKGKHPRD 845
                 + DV+S G +   ++ G+ P D
Sbjct: 186 RSAHGLESDVWSLGCMFYTLLIGRPPFD 213

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 15/212 (7%)
Query: 637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI 695
           ++ +  +  +GKG  G V   K   +G+  AVK   S    +    +E  L E+Q L ++
Sbjct: 48  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVI-SKRQVKQKTDKESLLREVQLLKQL 106
Query: 696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSL-DKILCNDASAKELGWTQRLNVIKGVADAL 754
            H NI+K Y F     + +++ E    G L D+I+    S K         +I+ V   +
Sbjct: 107 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII----SRKRFSEVDAARIIRQVLSGI 162
Query: 755 FYLHNNCFPPIVHRDISSKNVLLD-LGYEAHVS--DFGIAKFLNPDSSNWSELAGTHGYV 811
            Y+H N    IVHRD+  +N+LL+    +A++   DFG++      S    +  GT  Y+
Sbjct: 163 TYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA-SKKMKDKIGTAYYI 218
Query: 812 APELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           APE+ +     EKCDV+S GV+   ++ G  P
Sbjct: 219 APEVLHGT-YDEKCDVWSTGVILYILLSGCPP 249

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 15/212 (7%)
Query: 637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI 695
           ++ +  +  +GKG  G V   K   +G+  AVK   S    +    +E  L E+Q L ++
Sbjct: 49  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVI-SKRQVKQKTDKESLLREVQLLKQL 107
Query: 696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSL-DKILCNDASAKELGWTQRLNVIKGVADAL 754
            H NI+K Y F     + +++ E    G L D+I+    S K         +I+ V   +
Sbjct: 108 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII----SRKRFSEVDAARIIRQVLSGI 163
Query: 755 FYLHNNCFPPIVHRDISSKNVLLD-LGYEAHVS--DFGIAKFLNPDSSNWSELAGTHGYV 811
            Y+H N    IVHRD+  +N+LL+    +A++   DFG++      S    +  GT  Y+
Sbjct: 164 TYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA-SKKMKDKIGTAYYI 219
Query: 812 APELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           APE+ +     EKCDV+S GV+   ++ G  P
Sbjct: 220 APEVLHGT-YDEKCDVWSTGVILYILLSGCPP 250

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 72/271 (26%), Positives = 118/271 (43%), Gaps = 35/271 (12%)
Query: 640 FNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHR 698
           F     IGKG  G V++     + ++ A+K        +     ++   EI  L++    
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSP 85
Query: 699 NIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLH 758
            + K+YG        +II EYL  GS   +L        L  TQ   +++ +   L YLH
Sbjct: 86  YVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLH 141
Query: 759 NNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT 818
           +      +HRDI + NVLL    E  ++DFG+A  L       +   GT  ++APE+   
Sbjct: 142 SE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ 198
Query: 819 LKVTEKCDVYSFGVLALEVIKGK------HPRDFLFEXXXXXXXXXIEMLDSRLPYPSL- 871
                K D++S G+ A+E+ +G+      HP   LF            ++    P P+L 
Sbjct: 199 SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF------------LIPKNNP-PTLE 245
Query: 872 -HVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
            +  K L   ++   +CL++ P  RPT K +
Sbjct: 246 GNYSKPLKEFVE---ACLNKEPSFRPTAKEL 273

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 70/257 (27%), Positives = 119/257 (46%), Gaps = 24/257 (9%)
Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQ-EEFLNEIQALTEIRHRNIVKF 703
           IG G  G+VY A+ V + E+ A+KK      G+ S ++ ++ + E++ L ++RH N +++
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKM--SYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 704 YGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFP 763
            G       ++++ EY   GS   +L  +   K L   +   V  G    L YLH++   
Sbjct: 81  RGCYLREHTAWLVMEYC-LGSASDLL--EVHKKPLQEVEIAAVTHGALQGLAYLHSHN-- 135
Query: 764 PIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTE 823
            ++HRD+ + N+LL       + DFG A  + P +       GT  ++APE+   +   +
Sbjct: 136 -MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX----FVGTPYWMAPEVILAMDEGQ 190
Query: 824 ---KCDVYSFGVLALEVIKGKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLHVQKKLMSI 880
              K DV+S G+  +E+ + K P   LF          I   +S    P+L         
Sbjct: 191 YDGKVDVWSLGITCIELAERKPP---LFNMNAMSALYHIAQNES----PALQSGHWSEYF 243
Query: 881 MQVAFSCLDQNPESRPT 897
                SCL + P+ RPT
Sbjct: 244 RNFVDSCLQKIPQDRPT 260

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 23/207 (11%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           IG G  G+VY+ K        + K   P P +     + F NE+  L + RH NI+ F G
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQF----QAFRNEVAVLRKTRHVNILLFMG 99
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
           + +    + I+ ++ E  SL K L    +  ++   Q +++ +  A  + YLH      I
Sbjct: 100 YMTKDNLA-IVTQWCEGSSLYKHLHVQETKFQM--FQLIDIARQTAQGMDYLHAKN---I 153
Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWS------ELAGTHGYVAPELAYTL 819
           +HRD+ S N+ L  G    + DFG+A       S WS      +  G+  ++APE+    
Sbjct: 154 IHRDMKSNNIFLHEGLTVKIGDFGLATV----KSRWSGSQQVEQPTGSVLWMAPEVIRMQ 209
Query: 820 K---VTEKCDVYSFGVLALEVIKGKHP 843
                + + DVYS+G++  E++ G+ P
Sbjct: 210 DNNPFSFQSDVYSYGIVLYELMTGELP 236

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 105/233 (45%), Gaps = 22/233 (9%)
Query: 622 LTFEGKIVYEEIISATNDFNAEHC------IGKGGHGSVYRAKVPSGEIFAVKKFHSPLP 675
           L F+    YE +   T D N E        +G G  G VY+A+     + A  K    + 
Sbjct: 18  LYFQSMKQYEHV---TRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKV---ID 71
Query: 676 GEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASA 735
            +   + E+++ EI  L    H NIVK      +  + +I+ E+   G++D ++      
Sbjct: 72  TKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LE 129
Query: 736 KELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN 795
           + L  +Q   V K   DAL YLH+N    I+HRD+ + N+L  L  +  ++DFG++    
Sbjct: 130 RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNT 186
Query: 796 PDSSNWSELAGTHGYVAPELAYTLKVTE-----KCDVYSFGVLALEVIKGKHP 843
                     GT  ++APE+       +     K DV+S G+  +E+ + + P
Sbjct: 187 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Composition-based stats.
 Identities = 69/262 (26%), Positives = 114/262 (43%), Gaps = 19/262 (7%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           +G G  G V+     +    AVK      PG MS Q   FL E   +  ++H  +V+ Y 
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLK---PGTMSVQA--FLEEANLMKTLQHDKLVRLYA 75
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
             +  +  +II EY+  GSL   L +D   K L   + ++    +A+ + Y+    +   
Sbjct: 76  VVTREEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIERKNY--- 131
Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH-GYVAPELAYTLKVTEK 824
           +HRD+ + NVL+       ++DFG+A+ +  +     E A     + APE       T K
Sbjct: 132 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIK 191
Query: 825 CDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLHVQKKLMSIMQV 883
            DV+SFG+L  E++  GK P    +                R+P    +   +L  IM++
Sbjct: 192 SDVWSFGILLYEIVTYGKIP----YPGRTNADVMTALSQGYRMPRVE-NCPDELYDIMKM 246
Query: 884 AFSCLDQNPESRPTMKRVSQLL 905
              C  +  E RPT   +  +L
Sbjct: 247 ---CWKEKAEERPTFDYLQSVL 265

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 105/233 (45%), Gaps = 22/233 (9%)
Query: 622 LTFEGKIVYEEIISATNDFNAEHC------IGKGGHGSVYRAKVPSGEIFAVKKFHSPLP 675
           L F+    YE +   T D N E        +G G  G VY+A+     + A  K    + 
Sbjct: 18  LYFQSMKQYEHV---TRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKV---ID 71
Query: 676 GEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASA 735
            +   + E+++ EI  L    H NIVK      +  + +I+ E+   G++D ++      
Sbjct: 72  TKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LE 129
Query: 736 KELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN 795
           + L  +Q   V K   DAL YLH+N    I+HRD+ + N+L  L  +  ++DFG++    
Sbjct: 130 RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNT 186
Query: 796 PDSSNWSELAGTHGYVAPELAYTLKVTE-----KCDVYSFGVLALEVIKGKHP 843
                     GT  ++APE+       +     K DV+S G+  +E+ + + P
Sbjct: 187 RXIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 111/254 (43%), Gaps = 15/254 (5%)
Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           IG+G  G     K    G  + +K+ +  +    S ++EE   E+  L  ++H NIV++ 
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEIN--ISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 705 GFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP 764
                    +I+ +Y E G L K + N          Q L+    +  AL ++H+     
Sbjct: 90  ESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVHDR---K 145
Query: 765 IVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEK 824
           I+HRDI S+N+ L       + DFGIA+ LN          GT  Y++PE+        K
Sbjct: 146 ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNK 205
Query: 825 CDVYSFGVLALEVIKGKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLHVQKKLMSIMQVA 884
            D+++ G +  E+   KH     FE         ++++    P  SLH    L S++   
Sbjct: 206 SDIWALGCVLYELCTLKHA----FE-AGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQL 260
Query: 885 FSCLDQNPESRPTM 898
           F    +NP  RP++
Sbjct: 261 FK---RNPRDRPSV 271

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 105/233 (45%), Gaps = 22/233 (9%)
Query: 622 LTFEGKIVYEEIISATNDFNAEHC------IGKGGHGSVYRAKVPSGEIFAVKKFHSPLP 675
           L F+    YE +   T D N E        +G G  G VY+A+     + A  K    + 
Sbjct: 18  LYFQSMKQYEHV---TRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKV---ID 71
Query: 676 GEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASA 735
            +   + E+++ EI  L    H NIVK      +  + +I+ E+   G++D ++      
Sbjct: 72  TKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LE 129
Query: 736 KELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN 795
           + L  +Q   V K   DAL YLH+N    I+HRD+ + N+L  L  +  ++DFG++    
Sbjct: 130 RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNT 186
Query: 796 PDSSNWSELAGTHGYVAPELAYTLKVTE-----KCDVYSFGVLALEVIKGKHP 843
                     GT  ++APE+       +     K DV+S G+  +E+ + + P
Sbjct: 187 RXIQRRDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 123/281 (43%), Gaps = 31/281 (11%)
Query: 646 IGKGGHGSVYRAKVP-----SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNI 700
           +GKG  GSV   +       +GE+ AVKK        +     +F  EI+ L  ++H NI
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR----DFEREIEILKSLQHDNI 76
Query: 701 VKFYGFC--SHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLH 758
           VK+ G C  +  ++  +I EYL  GSL   L   A A+ +   + L     +   + YL 
Sbjct: 77  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QAHAERIDHIKLLQYTSQICKGMEYLG 134
Query: 759 NNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG---YVAPEL 815
              +   +HRD++++N+L++      + DFG+ K L  D               + APE 
Sbjct: 135 TKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 191
Query: 816 AYTLKVTEKCDVYSFGVLALEVI----KGKH-PRDFLF-----EXXXXXXXXXIEML--D 863
               K +   DV+SFGV+  E+     K K  P +F+      +         IE+L  +
Sbjct: 192 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 251
Query: 864 SRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQL 904
            RLP P     +  M + +   + ++Q P  R    RV Q+
Sbjct: 252 GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 292

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 106/239 (44%), Gaps = 21/239 (8%)
Query: 607 TQQSSFGNTPGLRSVLTFEGKIVYEEIISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFA 666
           + Q    N+ G   +LT    I         +DF     +GKG  G+VY A+        
Sbjct: 1   SMQKVMENSSGTPDILTRHFTI---------DDFEIGRPLGKGKFGNVYLAREKKSHFIV 51
Query: 667 VKK--FHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGS 724
             K  F S +  E    + +   EI+    + H NI++ Y +    +  ++I EY   G 
Sbjct: 52  ALKVLFKSQI--EKEGVEHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGE 109
Query: 725 LDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAH 784
           L K L    +  E    +   +++ +ADAL Y H      ++HRDI  +N+LL L  E  
Sbjct: 110 LYKELQKSCTFDE---QRTATIMEELADALMYCHGK---KVIHRDIKPENLLLGLKGELK 163
Query: 785 VSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           ++DFG +  ++  S     + GT  Y+ PE+       EK D++  GVL  E++ G  P
Sbjct: 164 IADFGWS--VHAPSLRRKTMCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPP 220

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 101/213 (47%), Gaps = 23/213 (10%)
Query: 638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
            DF     +G G  G V+  +   +G  +A+K     +   +  Q E   +E   L+ + 
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLK-QVEHTNDERLMLSIVT 64
Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLN--VIKGVAD-- 752
           H  I++ +G     +  F+I +Y+E G L  +L           +QR    V K  A   
Sbjct: 65  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK---------SQRFPNPVAKFYAAEV 115
Query: 753 --ALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGY 810
             AL YLH+     I++RD+  +N+LLD      ++DFG AK++ PD +    L GT  Y
Sbjct: 116 CLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYV-PDVT--YXLCGTPDY 169
Query: 811 VAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           +APE+  T    +  D +SFG+L  E++ G  P
Sbjct: 170 IAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 58/200 (29%), Positives = 95/200 (47%), Gaps = 9/200 (4%)
Query: 646 IGKGGHGSVYRAKVPSGEI-FAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G GG  +VY A+     I  A+K    P P E     + F  E+   +++ H+NIV   
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIP-PREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 705 GFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP 764
                    +++ EY+E  +L + +    S   L     +N    + D + + H+     
Sbjct: 78  DVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAHDM---R 131
Query: 765 IVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS-SNWSELAGTHGYVAPELAYTLKVTE 823
           IVHRDI  +N+L+D      + DFGIAK L+  S +  + + GT  Y +PE A      E
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDE 191
Query: 824 KCDVYSFGVLALEVIKGKHP 843
             D+YS G++  E++ G+ P
Sbjct: 192 CTDIYSIGIVLYEMLVGEPP 211

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/269 (27%), Positives = 120/269 (44%), Gaps = 22/269 (8%)
Query: 638 NDFNAEHCIGKGGHGSVYR-AKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
           +DF     +G G  G V++ +  PSG + A K  H  +   +   + + + E+Q L E  
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI---RNQIIRELQVLHECN 81
Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE--LGWTQRLNVIKGVADAL 754
              IV FYG         I  E+++ GSLD++L       E  LG    + VIKG    L
Sbjct: 82  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVS-IAVIKG----L 136
Query: 755 FYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPE 814
            YL       I+HRD+   N+L++   E  + DFG++  L    +N     GT  Y++PE
Sbjct: 137 TYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPE 192
Query: 815 LAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLHVQ 874
                  + + D++S G+  +E+  G++P                E+LD  +  P   + 
Sbjct: 193 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIG-----SGSGSMAIFELLDYIVNEPPPKLP 247
Query: 875 KKLMSIMQVAF--SCLDQNPESRPTMKRV 901
             + S+    F   CL +NP  R  +K++
Sbjct: 248 SGVFSLEFQDFVNKCLIKNPAERADLKQL 276

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/266 (25%), Positives = 119/266 (44%), Gaps = 32/266 (12%)
Query: 643 EHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVK 702
           E  +G G  G V+ A        AVK      PG MS   E FL E   +  ++H  +VK
Sbjct: 187 EKKLGAGQFGEVWMATYNKHTKVAVKTMK---PGSMSV--EAFLAEANVMKTLQHDKLVK 241
Query: 703 FYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
            +   +  +  +II E++  GSL   L +D  +K+    + ++    +A+ + ++    +
Sbjct: 242 LHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQ-PLPKLIDFSAQIAEGMAFIEQRNY 299
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVT 822
              +HRD+ + N+L+       ++DFG+A+        W+         APE       T
Sbjct: 300 ---IHRDLRAANILVSASLVCKIADFGLARVGAKFPIKWT---------APEAINFGSFT 347
Query: 823 EKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDS--RLPYPSLHVQKKLMS 879
            K DV+SFG+L +E++  G+ P   +           I  L+   R+P P  +  ++L +
Sbjct: 348 IKSDVWSFGILLMEIVTYGRIPYPGM------SNPEVIRALERGYRMPRPE-NCPEELYN 400
Query: 880 IMQVAFSCLDQNPESRPTMKRVSQLL 905
           IM     C    PE RPT + +  +L
Sbjct: 401 IM---MRCWKNRPEERPTFEYIQSVL 423

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/269 (26%), Positives = 116/269 (43%), Gaps = 31/269 (11%)
Query: 640 FNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHR 698
           F     IGKG  G V++     + ++ A+K        +     ++   EI  L++    
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSS 81
Query: 699 NIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLH 758
            + K+YG        +II EYL  GS   +L     A      Q   ++K +   L YLH
Sbjct: 82  YVTKYYGSYLKGSKLWIIMEYLGGGSALDLL----RAGPFDEFQIATMLKEILKGLDYLH 137
Query: 759 NNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT 818
           +      +HRDI + NVLL    +  ++DFG+A  L       +   GT  ++APE+   
Sbjct: 138 SE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQ 194
Query: 819 LKVTEKCDVYSFGVLALEVIKGK------HPRDFLFEXXXXXXXXXIEMLDSRLPYPSLH 872
                K D++S G+ A+E+ KG+      HP   LF            ++    P P+L 
Sbjct: 195 SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF------------LIPKNNP-PTL- 240
Query: 873 VQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
           V     S  +   +CL+++P  RPT K +
Sbjct: 241 VGDFTKSFKEFIDACLNKDPSFRPTAKEL 269

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 116/273 (42%), Gaps = 39/273 (14%)
Query: 640 FNAEHCIGKGGHGSVYRA-KVPSGEIFAVK--KFHSPLPGEMSFQQEEFLNEIQALTEIR 696
           F     IGKG  G V++     + ++ A+K              QQE     I  L++  
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQE-----ITVLSQCD 63
Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFY 756
              + K+YG        +II EYL  GS   +L        L  TQ   +++ +   L Y
Sbjct: 64  SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDY 119
Query: 757 LHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELA 816
           LH+      +HRDI + NVLL    E  ++DFG+A  L       +   GT  ++APE+ 
Sbjct: 120 LHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI 176
Query: 817 YTLKVTEKCDVYSFGVLALEVIKGK------HPRDFLFEXXXXXXXXXIEMLDSRLPYPS 870
                  K D++S G+ A+E+ +G+      HP   LF            ++    P P+
Sbjct: 177 KQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF------------LIPKNNP-PT 223
Query: 871 LH--VQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
           L     K L   ++   +CL++ P  RPT K +
Sbjct: 224 LEGNYSKPLKEFVE---ACLNKEPSFRPTAKEL 253

>pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 101/315 (32%), Positives = 150/315 (47%), Gaps = 60/315 (19%)
Query: 201 LGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFL 260
           L NLT +      NN      P  + NL  L D+ +  NQ++   PL+  NLTNL  L L
Sbjct: 62  LNNLTQI---NFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLA--NLTNLTGLTL 114
Query: 261 YHNELSGIIPQEIGXXXXXXXXXXXXXHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISET 320
           ++N+++ I P                           +NLT+L +L L+ N ++ +IS  
Sbjct: 115 FNNQITDIDP--------------------------LKNLTNLNRLELSSNTIS-DISAL 147
Query: 321 FGTYPNLTFIDLSNNSFFGEILSDW---GRCPQLSLLDVSINNISGSIPLEIGESLQLQY 377
            G    LT +   N   FG  ++D         L  LD+S N +S     +I    +L  
Sbjct: 148 SG----LTSLQQLN---FGNQVTDLKPLANLTTLERLDISSNKVS-----DISVLAKLTN 195
Query: 378 LD--LSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSN 435
           L+  +++N  + +I T LG +  L+ LSL+GN+L       L SL NL  LDL+ N +SN
Sbjct: 196 LESLIATNNQISDI-TPLGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISN 252
Query: 436 FVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESL 495
             P  L  L KL  L L  N++S   P  L  L  L+ L+L+ N L E IS  I  +++L
Sbjct: 253 LAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQL-EDISP-ISNLKNL 306
Query: 496 EKLNLSYNNLSGLIP 510
             L L +NN+S + P
Sbjct: 307 TYLTLYFNNISDISP 321

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 116/273 (42%), Gaps = 39/273 (14%)
Query: 640 FNAEHCIGKGGHGSVYRA-KVPSGEIFAVK--KFHSPLPGEMSFQQEEFLNEIQALTEIR 696
           F     IGKG  G V++     + ++ A+K              QQE     I  L++  
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQE-----ITVLSQCD 63
Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFY 756
              + K+YG        +II EYL  GS   +L        L  TQ   +++ +   L Y
Sbjct: 64  SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDY 119
Query: 757 LHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELA 816
           LH+      +HRDI + NVLL    E  ++DFG+A  L       +   GT  ++APE+ 
Sbjct: 120 LHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI 176
Query: 817 YTLKVTEKCDVYSFGVLALEVIKGK------HPRDFLFEXXXXXXXXXIEMLDSRLPYPS 870
                  K D++S G+ A+E+ +G+      HP   LF            ++    P P+
Sbjct: 177 KQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF------------LIPKNNP-PT 223
Query: 871 LH--VQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
           L     K L   ++   +CL++ P  RPT K +
Sbjct: 224 LEGNYSKPLKEFVE---ACLNKEPSFRPTAKEL 253

>pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 101/315 (32%), Positives = 150/315 (47%), Gaps = 60/315 (19%)
Query: 201 LGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFL 260
           L NLT +      NN      P  + NL  L D+ +  NQ++   PL+  NLTNL  L L
Sbjct: 62  LNNLTQI---NFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLA--NLTNLTGLTL 114
Query: 261 YHNELSGIIPQEIGXXXXXXXXXXXXXHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISET 320
           ++N+++ I P                           +NLT+L +L L+ N ++ +IS  
Sbjct: 115 FNNQITDIDP--------------------------LKNLTNLNRLELSSNTIS-DISAL 147
Query: 321 FGTYPNLTFIDLSNNSFFGEILSDW---GRCPQLSLLDVSINNISGSIPLEIGESLQLQY 377
            G    LT +   N   FG  ++D         L  LD+S N +S     +I    +L  
Sbjct: 148 SG----LTSLQQLN---FGNQVTDLKPLANLTTLERLDISSNKVS-----DISVLAKLTN 195
Query: 378 LD--LSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSN 435
           L+  +++N  + +I T LG +  L+ LSL+GN+L       L SL NL  LDL+ N +SN
Sbjct: 196 LESLIATNNQISDI-TPLGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISN 252
Query: 436 FVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESL 495
             P  L  L KL  L L  N++S   P  L  L  L+ L+L+ N L E IS  I  +++L
Sbjct: 253 LAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQL-EDISP-ISNLKNL 306
Query: 496 EKLNLSYNNLSGLIP 510
             L L +NN+S + P
Sbjct: 307 TYLTLYFNNISDISP 321

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 75/270 (27%), Positives = 125/270 (46%), Gaps = 32/270 (11%)
Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G  G VY+AK   +G + A K   +    E+    E+++ EI+ L    H  IVK  
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL----EDYIVEIEILATCDHPYIVKLL 74
Query: 705 GFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP 764
           G   H    +I+ E+   G++D I+      + L   Q   V + + +AL +LH+     
Sbjct: 75  GAYYHDGKLWIMIEFCPGGAVDAIMLE--LDRGLTEPQIQVVCRQMLEALNFLHSK---R 129
Query: 765 IVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAY--TLKVT 822
           I+HRD+ + NVL+ L  +  ++DFG++              GT  ++APE+    T+K T
Sbjct: 130 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDT 189
Query: 823 E---KCDVYSFGVLALEVIKGKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLHVQKK--- 876
               K D++S G+  +E+ + + P     E         I   D     P+L    K   
Sbjct: 190 PYDYKADIWSLGITLIEMAQIEPPHH---ELNPMRVLLKIAKSDP----PTLLTPSKWSV 242
Query: 877 -LMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
                +++A   LD+NPE+RP+    +QLL
Sbjct: 243 EFRDFLKIA---LDKNPETRPS---AAQLL 266

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 75/270 (27%), Positives = 125/270 (46%), Gaps = 32/270 (11%)
Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G  G VY+AK   +G + A K   +    E+    E+++ EI+ L    H  IVK  
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL----EDYIVEIEILATCDHPYIVKLL 82
Query: 705 GFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP 764
           G   H    +I+ E+   G++D I+      + L   Q   V + + +AL +LH+     
Sbjct: 83  GAYYHDGKLWIMIEFCPGGAVDAIMLE--LDRGLTEPQIQVVCRQMLEALNFLHSK---R 137
Query: 765 IVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAY--TLKVT 822
           I+HRD+ + NVL+ L  +  ++DFG++              GT  ++APE+    T+K T
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDT 197
Query: 823 E---KCDVYSFGVLALEVIKGKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLHVQKK--- 876
               K D++S G+  +E+ + + P     E         I   D     P+L    K   
Sbjct: 198 PYDYKADIWSLGITLIEMAQIEPPHH---ELNPMRVLLKIAKSDP----PTLLTPSKWSV 250
Query: 877 -LMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
                +++A   LD+NPE+RP+    +QLL
Sbjct: 251 EFRDFLKIA---LDKNPETRPS---AAQLL 274

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 116/273 (42%), Gaps = 39/273 (14%)
Query: 640 FNAEHCIGKGGHGSVYRA-KVPSGEIFAVK--KFHSPLPGEMSFQQEEFLNEIQALTEIR 696
           F     IGKG  G V++     + ++ A+K              QQE     I  L++  
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQE-----ITVLSQCD 78
Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFY 756
              + K+YG        +II EYL  GS   +L        L  TQ   +++ +   L Y
Sbjct: 79  SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDY 134
Query: 757 LHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELA 816
           LH+      +HRDI + NVLL    E  ++DFG+A  L       +   GT  ++APE+ 
Sbjct: 135 LHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI 191
Query: 817 YTLKVTEKCDVYSFGVLALEVIKGK------HPRDFLFEXXXXXXXXXIEMLDSRLPYPS 870
                  K D++S G+ A+E+ +G+      HP   LF            ++    P P+
Sbjct: 192 KQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF------------LIPKNNP-PT 238
Query: 871 LH--VQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
           L     K L   ++   +CL++ P  RPT K +
Sbjct: 239 LEGNYSKPLKEFVE---ACLNKEPSFRPTAKEL 268

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 93/202 (46%), Gaps = 13/202 (6%)
Query: 645 CIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           C  K GH S    KV     F   ++         F  EE  NEI  L  + H NI+K +
Sbjct: 55  CKEKNGH-SEKAIKVIKKSQFDKGRYSDDNKNIEKFH-EEIYNEISLLKSLDHPNIIKLF 112
Query: 705 GFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP 764
                 K+ +++ E+ E G L + + N     E       N++K +   + YLH +    
Sbjct: 113 DVFEDKKYFYLVTEFYEGGELFEQIINRHKFDE---CDAANIMKQILSGICYLHKH---N 166
Query: 765 IVHRDISSKNVLLDLG---YEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKV 821
           IVHRDI  +N+LL+         + DFG++ F + D      L GT  Y+APE+    K 
Sbjct: 167 IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL-GTAYYIAPEVL-KKKY 224
Query: 822 TEKCDVYSFGVLALEVIKGKHP 843
            EKCDV+S GV+   ++ G  P
Sbjct: 225 NEKCDVWSCGVIMYILLCGYPP 246

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 96/199 (48%), Gaps = 12/199 (6%)
Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G+G +G V + +   +G I A+KKF      +M   ++  + EI+ L ++RH N+V   
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMV--KKIAMREIKLLKQLRHENLVNLL 90
Query: 705 GFCSHPKHSFIIYEYLESGSLDKI-LCNDASAKELGWTQRLNVIKGVADALFYLHNNCFP 763
             C   K  ++++E+++   LD + L  +    ++       +I G+     + HN    
Sbjct: 91  EVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIG--FCHSHN---- 144
Query: 764 PIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAY-TLKVT 822
            I+HRDI  +N+L+       + DFG A+ L      + +   T  Y APEL    +K  
Sbjct: 145 -IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYG 203
Query: 823 EKCDVYSFGVLALEVIKGK 841
           +  DV++ G L  E+  G+
Sbjct: 204 KAVDVWAIGCLVTEMFMGE 222

>pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 99/314 (31%), Positives = 147/314 (46%), Gaps = 58/314 (18%)
Query: 201 LGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFL 260
           L NLT +      NN      P  + NL  L D+ +  NQ++   PL+  NLTNL  L L
Sbjct: 66  LNNLTQI---NFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLA--NLTNLTGLTL 118
Query: 261 YHNELSGIIPQEIGXXXXXXXXXXXXXHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISET 320
           ++N+++ I P                           +NLT+L +L L+ N ++ +IS  
Sbjct: 119 FNNQITDIDP--------------------------LKNLTNLNRLELSSNTIS-DISAL 151
Query: 321 FGTYPNLTFIDLSNNSFFGEI--LSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYL 378
            G         L   SF  ++  L        L  LD+S N +S     +I    +L  L
Sbjct: 152 SG------LTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVS-----DISVLAKLTNL 200
Query: 379 D--LSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNF 436
           +  +++N  + +I T LG +  L+ LSL+GN+L       L SL NL  LDL+ N +SN 
Sbjct: 201 ESLIATNNQISDI-TPLGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNL 257
Query: 437 VPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLE 496
            P  L  L KL  L L  N++S   P  L  L  L+ L+L+ N L E IS  I  +++L 
Sbjct: 258 AP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQL-EDISP-ISNLKNLT 311
Query: 497 KLNLSYNNLSGLIP 510
            L L +NN+S + P
Sbjct: 312 YLTLYFNNISDISP 325

>pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 99/314 (31%), Positives = 147/314 (46%), Gaps = 58/314 (18%)
Query: 201 LGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFL 260
           L NLT +      NN      P  + NL  L D+ +  NQ++   PL+  NLTNL  L L
Sbjct: 67  LNNLTQI---NFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLA--NLTNLTGLTL 119
Query: 261 YHNELSGIIPQEIGXXXXXXXXXXXXXHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISET 320
           ++N+++ I P                           +NLT+L +L L+ N ++ +IS  
Sbjct: 120 FNNQITDIDP--------------------------LKNLTNLNRLELSSNTIS-DISAL 152
Query: 321 FGTYPNLTFIDLSNNSFFGEI--LSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYL 378
            G         L   SF  ++  L        L  LD+S N +S     +I    +L  L
Sbjct: 153 SG------LTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVS-----DISVLAKLTNL 201
Query: 379 D--LSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNF 436
           +  +++N  + +I T LG +  L+ LSL+GN+L       L SL NL  LDL+ N +SN 
Sbjct: 202 ESLIATNNQISDI-TPLGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNL 258
Query: 437 VPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLE 496
            P  L  L KL  L L  N++S   P  L  L  L+ L+L+ N L E IS  I  +++L 
Sbjct: 259 AP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQL-EDISP-ISNLKNLT 312
Query: 497 KLNLSYNNLSGLIP 510
            L L +NN+S + P
Sbjct: 313 YLTLYFNNISDISP 326

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 107/213 (50%), Gaps = 24/213 (11%)
Query: 640 FNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGE-MSFQQEEFLNEIQALTEIRH 697
           F  +  +G G    V  A+   +G++FAVK     +P + +  ++    NEI  L +I+H
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVK----CIPKKALKGKESSIENEIAVLRKIKH 79
Query: 698 RNIVKFYGFCSHPKHSFIIYEYLESGSL-DKILCNDASAKELG-WTQR--LNVIKGVADA 753
            NIV        P H +++ + +  G L D+I+       E G +T++    +I+ V DA
Sbjct: 80  ENIVALEDIYESPNHLYLVMQLVSGGELFDRIV-------EKGFYTEKDASTLIRQVLDA 132
Query: 754 LFYLHNNCFPPIVHRDISSKNVLL---DLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGY 810
           ++YLH      IVHRD+  +N+L    D   +  +SDFG++K +       S   GT GY
Sbjct: 133 VYYLHRM---GIVHRDLKPENLLYYSQDEESKIMISDFGLSK-MEGKGDVMSTACGTPGY 188
Query: 811 VAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           VAPE+      ++  D +S GV+A  ++ G  P
Sbjct: 189 VAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 221

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 53/168 (31%), Positives = 86/168 (51%), Gaps = 15/168 (8%)
Query: 682 QEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWT 741
           ++E L E   + ++ +  IV+  G C   +   ++ E  E G L+K L  +   K+    
Sbjct: 56  KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---K 111
Query: 742 QRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNW 801
             + ++  V+  + YL  + F   VHRD++++NVLL   + A +SDFG++K L  D + +
Sbjct: 112 NIIELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENXY 168
Query: 802 SELAGTHG-----YVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHP 843
              A THG     + APE     K + K DV+SFGVL  E    G+ P
Sbjct: 169 K--AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/275 (25%), Positives = 123/275 (44%), Gaps = 41/275 (14%)
Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKF 703
           +G G +G VY+ + V +G++ A+K     + G+   ++EE   EI  L +   HRNI  +
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMD--VTGD---EEEEIKQEINMLKKYSHHRNIATY 86
Query: 704 YG--FCSHP----KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYL 757
           YG     +P       +++ E+  +GS+  ++ N      L       + + +   L +L
Sbjct: 87  YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN-TKGNTLKEEWIAYICREILRGLSHL 145
Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAY 817
           H +    ++HRDI  +NVLL    E  + DFG++  L+      +   GT  ++APE+  
Sbjct: 146 HQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 202
Query: 818 TLKVTE-----KCDVYSFGVLALEVIKGK------HPRDFLFEXXXXXXXXXIEMLDSRL 866
             +  +     K D++S G+ A+E+ +G       HP   LF             L  R 
Sbjct: 203 CDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-------------LIPRN 249
Query: 867 PYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
           P P L  +K          SCL +N   RP  +++
Sbjct: 250 PAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQL 284

>pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 99/312 (31%), Positives = 149/312 (47%), Gaps = 53/312 (16%)
Query: 201 LGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFL 260
           L NLT +      NN      P  + NL  L D+ +  NQ++   PL+  NLTNL  L L
Sbjct: 62  LNNLTQI---NFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLA--NLTNLTGLTL 114
Query: 261 YHNELSGIIPQEIGXXXXXXXXXXXXXHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISET 320
           ++N+++ I P                           +NLT+L +L L+ N ++ +IS  
Sbjct: 115 FNNQITDIDP--------------------------LKNLTNLNRLELSSNTIS-DISAL 147
Query: 321 FGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLD- 379
            G   +L  ++ S+N      L        L  LD+S N +S     +I    +L  L+ 
Sbjct: 148 SG-LTSLQQLNFSSNQVTD--LKPLANLTTLERLDISSNKVS-----DISVLAKLTNLES 199
Query: 380 -LSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVP 438
            +++N  + +I T LG +  L+ LSL+GN+L       L SL NL  LDL+ N +SN  P
Sbjct: 200 LIATNNQISDI-TPLGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP 256
Query: 439 ESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKL 498
             L  L KL  L L  N++S   P  L  L  L+ L+L+ N L E IS  I  +++L  L
Sbjct: 257 --LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQL-EDISP-ISNLKNLTYL 310
Query: 499 NLSYNNLSGLIP 510
            L +NN+S + P
Sbjct: 311 TLYFNNISDISP 322

>pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 99/315 (31%), Positives = 147/315 (46%), Gaps = 59/315 (18%)
Query: 201 LGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFL 260
           L NLT +      NN      P  + NL  L D+ +  NQ++   PL+  NLTNL  L L
Sbjct: 62  LNNLTQI---NFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLA--NLTNLTGLTL 114
Query: 261 YHNELSGIIPQEIGXXXXXXXXXXXXXHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISET 320
           ++N+++ I P                           +NLT+L +L L+ N ++ +IS  
Sbjct: 115 FNNQITDIDP--------------------------LKNLTNLNRLELSSNTIS-DISAL 147
Query: 321 FGTYPNLTFIDLSNNSFFGEILSDW---GRCPQLSLLDVSINNISGSIPLEIGESLQLQY 377
            G         L   SF    ++D         L  LD+S N +S     +I    +L  
Sbjct: 148 SG------LTSLQQLSFSSNQVTDLKPLANLTTLERLDISSNKVS-----DISVLAKLTN 196
Query: 378 LD--LSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSN 435
           L+  +++N  + +I T LG +  L+ LSL+GN+L       L SL NL  LDL+ N +SN
Sbjct: 197 LESLIATNNQISDI-TPLGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISN 253
Query: 436 FVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESL 495
             P  L  L KL  L L  N++S   P  L  L  L+ L+L+ N L E IS  I  +++L
Sbjct: 254 LAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQL-EDISP-ISNLKNL 307
Query: 496 EKLNLSYNNLSGLIP 510
             L L +NN+S + P
Sbjct: 308 TYLTLYFNNISDISP 322

>pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 99/315 (31%), Positives = 147/315 (46%), Gaps = 59/315 (18%)
Query: 201 LGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFL 260
           L NLT +      NN      P  + NL  L D+ +  NQ++   PL+  NLTNL  L L
Sbjct: 62  LNNLTQI---NFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLA--NLTNLTGLTL 114
Query: 261 YHNELSGIIPQEIGXXXXXXXXXXXXXHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISET 320
           ++N+++ I P                           +NLT+L +L L+ N ++ +IS  
Sbjct: 115 FNNQITDIDP--------------------------LKNLTNLNRLELSSNTIS-DISAL 147
Query: 321 FGTYPNLTFIDLSNNSFFGEILSDW---GRCPQLSLLDVSINNISGSIPLEIGESLQLQY 377
            G         L   SF    ++D         L  LD+S N +S     +I    +L  
Sbjct: 148 SG------LTSLQQLSFSSNQVTDLKPLANLTTLERLDISSNKVS-----DISVLAKLTN 196
Query: 378 LD--LSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSN 435
           L+  +++N  + +I T LG +  L+ LSL+GN+L       L SL NL  LDL+ N +SN
Sbjct: 197 LESLIATNNQISDI-TPLGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISN 253
Query: 436 FVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESL 495
             P  L  L KL  L L  N++S   P  L  L  L+ L+L+ N L E IS  I  +++L
Sbjct: 254 LAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQL-EDISP-ISNLKNL 307
Query: 496 EKLNLSYNNLSGLIP 510
             L L +NN+S + P
Sbjct: 308 TYLTLYFNNISDISP 322

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 53/168 (31%), Positives = 86/168 (51%), Gaps = 15/168 (8%)
Query: 682 QEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWT 741
           ++E L E   + ++ +  IV+  G C   +   ++ E  E G L+K L  +   K+    
Sbjct: 50  KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---K 105
Query: 742 QRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNW 801
             + ++  V+  + YL  + F   VHRD++++NVLL   + A +SDFG++K L  D + +
Sbjct: 106 NIIELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 162
Query: 802 SELAGTHG-----YVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHP 843
              A THG     + APE     K + K DV+SFGVL  E    G+ P
Sbjct: 163 K--AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 208

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 53/168 (31%), Positives = 86/168 (51%), Gaps = 15/168 (8%)
Query: 682 QEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWT 741
           ++E L E   + ++ +  IV+  G C   +   ++ E  E G L+K L  +   K+    
Sbjct: 62  KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---K 117
Query: 742 QRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNW 801
             + ++  V+  + YL  + F   VHRD++++NVLL   + A +SDFG++K L  D + +
Sbjct: 118 NIIELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 174
Query: 802 SELAGTHG-----YVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHP 843
              A THG     + APE     K + K DV+SFGVL  E    G+ P
Sbjct: 175 K--AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 53/168 (31%), Positives = 86/168 (51%), Gaps = 15/168 (8%)
Query: 682 QEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWT 741
           ++E L E   + ++ +  IV+  G C   +   ++ E  E G L+K L  +   K+    
Sbjct: 72  KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---K 127
Query: 742 QRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNW 801
             + ++  V+  + YL  + F   VHRD++++NVLL   + A +SDFG++K L  D + +
Sbjct: 128 NIIELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 184
Query: 802 SELAGTHG-----YVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHP 843
              A THG     + APE     K + K DV+SFGVL  E    G+ P
Sbjct: 185 K--AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 53/168 (31%), Positives = 86/168 (51%), Gaps = 15/168 (8%)
Query: 682 QEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWT 741
           ++E L E   + ++ +  IV+  G C   +   ++ E  E G L+K L  +   K+    
Sbjct: 72  KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---K 127
Query: 742 QRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNW 801
             + ++  V+  + YL  + F   VHRD++++NVLL   + A +SDFG++K L  D + +
Sbjct: 128 NIIELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 184
Query: 802 SELAGTHG-----YVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHP 843
              A THG     + APE     K + K DV+SFGVL  E    G+ P
Sbjct: 185 K--AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 53/168 (31%), Positives = 86/168 (51%), Gaps = 15/168 (8%)
Query: 682 QEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWT 741
           ++E L E   + ++ +  IV+  G C   +   ++ E  E G L+K L  +   K+    
Sbjct: 52  KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---K 107
Query: 742 QRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNW 801
             + ++  V+  + YL  + F   VHRD++++NVLL   + A +SDFG++K L  D + +
Sbjct: 108 NIIELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164
Query: 802 SELAGTHG-----YVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHP 843
              A THG     + APE     K + K DV+SFGVL  E    G+ P
Sbjct: 165 K--AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 210

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 53/168 (31%), Positives = 86/168 (51%), Gaps = 15/168 (8%)
Query: 682 QEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWT 741
           ++E L E   + ++ +  IV+  G C   +   ++ E  E G L+K L  +   K+    
Sbjct: 56  KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---K 111
Query: 742 QRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNW 801
             + ++  V+  + YL  + F   VHRD++++NVLL   + A +SDFG++K L  D + +
Sbjct: 112 NIIELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 168
Query: 802 SELAGTHG-----YVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHP 843
              A THG     + APE     K + K DV+SFGVL  E    G+ P
Sbjct: 169 K--AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 93/208 (44%), Gaps = 17/208 (8%)
Query: 646 IGKGGHGSVYR-AKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G GG G V R     +GE  A+K+    L  +    +E +  EIQ + ++ H N+V   
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPK---NRERWCLEIQIMKKLNHPNVVSAR 78
Query: 705 GFCSHPKH------SFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLH 758
                 +         +  EY E G L K L    +   L       ++  ++ AL YLH
Sbjct: 79  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 138
Query: 759 NNCFPPIVHRDISSKNVLLDLGYEA---HVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
            N    I+HRD+  +N++L  G +     + D G AK L+      +E  GT  Y+APEL
Sbjct: 139 EN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEFVGTLQYLAPEL 194
Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
               K T   D +SFG LA E I G  P
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 101/212 (47%), Gaps = 15/212 (7%)
Query: 637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI 695
           ++ +  +  +GKG  G V   K   +G+  AVK   S    +    +E  L E+Q L ++
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVI-SKRQVKQKTDKESLLREVQLLKQL 83
Query: 696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSL-DKILCNDASAKELGWTQRLNVIKGVADAL 754
            H NI K Y F     + +++ E    G L D+I+    S K         +I+ V   +
Sbjct: 84  DHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEII----SRKRFSEVDAARIIRQVLSGI 139
Query: 755 FYLHNNCFPPIVHRDISSKNVLLD-LGYEAHVS--DFGIAKFLNPDSSNWSELAGTHGYV 811
            Y H N    IVHRD+  +N+LL+    +A++   DFG++      S    +  GT  Y+
Sbjct: 140 TYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA-SKKXKDKIGTAYYI 195
Query: 812 APELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           APE+ +     EKCDV+S GV+   ++ G  P
Sbjct: 196 APEVLHGT-YDEKCDVWSTGVILYILLSGCPP 226

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 53/168 (31%), Positives = 86/168 (51%), Gaps = 15/168 (8%)
Query: 682 QEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWT 741
           ++E L E   + ++ +  IV+  G C   +   ++ E  E G L+K L  +   K+    
Sbjct: 70  KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---K 125
Query: 742 QRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNW 801
             + ++  V+  + YL  + F   VHRD++++NVLL   + A +SDFG++K L  D + +
Sbjct: 126 NIIELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 182
Query: 802 SELAGTHG-----YVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHP 843
              A THG     + APE     K + K DV+SFGVL  E    G+ P
Sbjct: 183 K--AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 228

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 93/208 (44%), Gaps = 17/208 (8%)
Query: 646 IGKGGHGSVYR-AKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G GG G V R     +GE  A+K+    L  +    +E +  EIQ + ++ H N+V   
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPK---NRERWCLEIQIMKKLNHPNVVSAR 79
Query: 705 GFCSHPKH------SFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLH 758
                 +         +  EY E G L K L    +   L       ++  ++ AL YLH
Sbjct: 80  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 139
Query: 759 NNCFPPIVHRDISSKNVLLDLGYEA---HVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
            N    I+HRD+  +N++L  G +     + D G AK L+      +E  GT  Y+APEL
Sbjct: 140 EN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEFVGTLQYLAPEL 195
Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
               K T   D +SFG LA E I G  P
Sbjct: 196 LEQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 67/264 (25%), Positives = 122/264 (46%), Gaps = 24/264 (9%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           +G G  G V+          AVK       G MS   + FL E   + +++H+ +V+ Y 
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLKQ---GSMS--PDAFLAEANLMKQLQHQRLVRLYA 83
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
             +  +  +II EY+E+GSL   L    S  +L   + L++   +A+ + ++    +   
Sbjct: 84  VVTQ-EPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERNY--- 138
Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH-GYVAPELAYTLKVTEK 824
           +HRD+ + N+L+       ++DFG+A+ +  +     E A     + APE       T K
Sbjct: 139 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 198
Query: 825 CDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDS--RLPYPSLHVQKKLMSIM 881
            DV+SFG+L  E++  G+ P   +           I+ L+   R+  P  +  ++L  +M
Sbjct: 199 SDVWSFGILLTEIVTHGRIPYPGM------TNPEVIQNLERGYRMVRPD-NCPEELYQLM 251
Query: 882 QVAFSCLDQNPESRPTMKRVSQLL 905
           ++   C  + PE RPT   +  +L
Sbjct: 252 RL---CWKERPEDRPTFDYLRSVL 272

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 67/264 (25%), Positives = 122/264 (46%), Gaps = 24/264 (9%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           +G G  G V+          AVK       G MS   + FL E   + +++H+ +V+ Y 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQ---GSMS--PDAFLAEANLMKQLQHQRLVRLYA 75
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
             +  +  +II EY+E+GSL   L    S  +L   + L++   +A+ + ++    +   
Sbjct: 76  VVTQ-EPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERNY--- 130
Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH-GYVAPELAYTLKVTEK 824
           +HRD+ + N+L+       ++DFG+A+ +  +     E A     + APE       T K
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 825 CDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDS--RLPYPSLHVQKKLMSIM 881
            DV+SFG+L  E++  G+ P   +           I+ L+   R+  P  +  ++L  +M
Sbjct: 191 SDVWSFGILLTEIVTHGRIPYPGM------TNPEVIQNLERGYRMVRPD-NCPEELYQLM 243
Query: 882 QVAFSCLDQNPESRPTMKRVSQLL 905
           ++   C  + PE RPT   +  +L
Sbjct: 244 RL---CWKERPEDRPTFDYLRSVL 264

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 67/264 (25%), Positives = 122/264 (46%), Gaps = 24/264 (9%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           +G G  G V+          AVK       G MS   + FL E   + +++H+ +V+ Y 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQ---GSMS--PDAFLAEANLMKQLQHQRLVRLYA 75
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
             +  +  +II EY+E+GSL   L    S  +L   + L++   +A+ + ++    +   
Sbjct: 76  VVTQ-EPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERNY--- 130
Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH-GYVAPELAYTLKVTEK 824
           +HRD+ + N+L+       ++DFG+A+ +  +     E A     + APE       T K
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 825 CDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDS--RLPYPSLHVQKKLMSIM 881
            DV+SFG+L  E++  G+ P   +           I+ L+   R+  P  +  ++L  +M
Sbjct: 191 SDVWSFGILLTEIVTHGRIPYPGM------TNPEVIQNLERGYRMVRPD-NCPEELYQLM 243
Query: 882 QVAFSCLDQNPESRPTMKRVSQLL 905
           ++   C  + PE RPT   +  +L
Sbjct: 244 RL---CWKERPEDRPTFDYLRSVL 264

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 67/264 (25%), Positives = 122/264 (46%), Gaps = 24/264 (9%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           +G G  G V+          AVK       G MS   + FL E   + +++H+ +V+ Y 
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQ---GSMS--PDAFLAEANLMKQLQHQRLVRLYA 81
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
             +  +  +II EY+E+GSL   L    S  +L   + L++   +A+ + ++    +   
Sbjct: 82  VVTQ-EPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERNY--- 136
Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH-GYVAPELAYTLKVTEK 824
           +HRD+ + N+L+       ++DFG+A+ +  +     E A     + APE       T K
Sbjct: 137 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 196
Query: 825 CDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDS--RLPYPSLHVQKKLMSIM 881
            DV+SFG+L  E++  G+ P   +           I+ L+   R+  P  +  ++L  +M
Sbjct: 197 SDVWSFGILLTEIVTHGRIPYPGM------TNPEVIQNLERGYRMVRPD-NCPEELYQLM 249
Query: 882 QVAFSCLDQNPESRPTMKRVSQLL 905
           ++   C  + PE RPT   +  +L
Sbjct: 250 RL---CWKERPEDRPTFDYLRSVL 270

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 67/264 (25%), Positives = 122/264 (46%), Gaps = 24/264 (9%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           +G G  G V+          AVK       G MS   + FL E   + +++H+ +V+ Y 
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLKQ---GSMS--PDAFLAEANLMKQLQHQRLVRLYA 76
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
             +  +  +II EY+E+GSL   L    S  +L   + L++   +A+ + ++    +   
Sbjct: 77  VVTQ-EPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERNY--- 131
Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH-GYVAPELAYTLKVTEK 824
           +HRD+ + N+L+       ++DFG+A+ +  +     E A     + APE       T K
Sbjct: 132 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 191
Query: 825 CDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDS--RLPYPSLHVQKKLMSIM 881
            DV+SFG+L  E++  G+ P   +           I+ L+   R+  P  +  ++L  +M
Sbjct: 192 SDVWSFGILLTEIVTHGRIPYPGM------TNPEVIQNLERGYRMVRPD-NCPEELYQLM 244
Query: 882 QVAFSCLDQNPESRPTMKRVSQLL 905
           ++   C  + PE RPT   +  +L
Sbjct: 245 RL---CWKERPEDRPTFDYLRSVL 265

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 67/264 (25%), Positives = 122/264 (46%), Gaps = 24/264 (9%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           +G G  G V+          AVK       G MS   + FL E   + +++H+ +V+ Y 
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLKQ---GSMS--PDAFLAEANLMKQLQHQRLVRLYA 77
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
             +  +  +II EY+E+GSL   L    S  +L   + L++   +A+ + ++    +   
Sbjct: 78  VVTQ-EPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERNY--- 132
Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH-GYVAPELAYTLKVTEK 824
           +HRD+ + N+L+       ++DFG+A+ +  +     E A     + APE       T K
Sbjct: 133 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 192
Query: 825 CDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDS--RLPYPSLHVQKKLMSIM 881
            DV+SFG+L  E++  G+ P   +           I+ L+   R+  P  +  ++L  +M
Sbjct: 193 SDVWSFGILLTEIVTHGRIPYPGM------TNPEVIQNLERGYRMVRPD-NCPEELYQLM 245
Query: 882 QVAFSCLDQNPESRPTMKRVSQLL 905
           ++   C  + PE RPT   +  +L
Sbjct: 246 RL---CWKERPEDRPTFDYLRSVL 266

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 67/264 (25%), Positives = 122/264 (46%), Gaps = 24/264 (9%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           +G G  G V+          AVK       G MS   + FL E   + +++H+ +V+ Y 
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLKQ---GSMS--PDAFLAEANLMKQLQHQRLVRLYA 84
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
             +  +  +II EY+E+GSL   L    S  +L   + L++   +A+ + ++    +   
Sbjct: 85  VVTQ-EPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERNY--- 139
Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH-GYVAPELAYTLKVTEK 824
           +HRD+ + N+L+       ++DFG+A+ +  +     E A     + APE       T K
Sbjct: 140 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 199
Query: 825 CDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDS--RLPYPSLHVQKKLMSIM 881
            DV+SFG+L  E++  G+ P   +           I+ L+   R+  P  +  ++L  +M
Sbjct: 200 SDVWSFGILLTEIVTHGRIPYPGM------TNPEVIQNLERGYRMVRPD-NCPEELYQLM 252
Query: 882 QVAFSCLDQNPESRPTMKRVSQLL 905
           ++   C  + PE RPT   +  +L
Sbjct: 253 RL---CWKERPEDRPTFDYLRSVL 273

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/266 (23%), Positives = 113/266 (42%), Gaps = 24/266 (9%)
Query: 646 IGKGGHGSVYRAKVPS-GEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           IG+G  G V+  ++ +   + AVK     LP ++   + +FL E + L +  H NIV+  
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDL---KAKFLQEARILKQYSHPNIVRLI 178
Query: 705 GFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP 764
           G C+  +  +I+ E ++ G     L  + +   L     L ++   A  + YL + C   
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGA--RLRVKTLLQMVGDAAAGMEYLESKC--- 233
Query: 765 IVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH----GYVAPELAYTLK 820
            +HRD++++N L+       +SDFG+++        ++   G       + APE     +
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSR--EEADGVYAASGGLRQVPVKWTAPEALNYGR 291
Query: 821 VTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLHVQKKLMS 879
            + + DV+SFG+L  E    G  P    +                RLP P L       +
Sbjct: 292 YSSESDVWSFGILLWETFSLGASP----YPNLSNQQTREFVEKGGRLPCPELCPD----A 343
Query: 880 IMQVAFSCLDQNPESRPTMKRVSQLL 905
           + ++   C    P  RP+   + Q L
Sbjct: 344 VFRLMEQCWAYEPGQRPSFSTIYQEL 369

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 121/270 (44%), Gaps = 18/270 (6%)
Query: 638 NDFNAEHCIGKGGHGSVYR-AKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
           +DF     +G G  G V++ +  PSG + A K  H  +   +   + + + E+Q L E  
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI---RNQIIRELQVLHECN 62
Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE--LGWTQRLNVIKGVADAL 754
              IV FYG         I  E+++ GSLD++L       E  LG    + VIKG    L
Sbjct: 63  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVS-IAVIKG----L 117
Query: 755 FYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPE 814
            YL       I+HRD+   N+L++   E  + DFG++  L    +N     GT  Y++PE
Sbjct: 118 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPE 173
Query: 815 LAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEXXXXXXXXXI-EMLDSRLPYPSLHV 873
                  + + D++S G+  +E+  G++P               I E+LD  +  P   +
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPKL 233
Query: 874 QKKLMSIMQVAF--SCLDQNPESRPTMKRV 901
              + S+    F   CL +NP  R  +K++
Sbjct: 234 PSGVFSLEFQDFVNKCLIKNPAERADLKQL 263

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Composition-based stats.
 Identities = 66/197 (33%), Positives = 91/197 (46%), Gaps = 23/197 (11%)
Query: 646 IGKGGHGSV----YRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIV 701
           IGKG  G V    YR     G   AVK   +    +       FL E   +T++RH N+V
Sbjct: 14  IGKGEFGDVMLGDYR-----GNKVAVKCIKNDATAQ------AFLAEASVMTQLRHSNLV 62
Query: 702 KFYGFCSHPKHS-FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
           +  G     K   +I+ EY+  GSL   L +   +  LG    L     V +A+ YL  N
Sbjct: 63  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGN 121
Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLK 820
            F   VHRD++++NVL+     A VSDFG+ K     SS          + APE     K
Sbjct: 122 NF---VHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWTAPEALREKK 175
Query: 821 VTEKCDVYSFGVLALEV 837
            + K DV+SFG+L  E+
Sbjct: 176 FSTKSDVWSFGILLWEI 192

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 80/296 (27%), Positives = 129/296 (43%), Gaps = 40/296 (13%)
Query: 638 NDFNAEHCIGKGGHGSVYRA------KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQA 691
           N+      +G G  G V  A      K  +    AVK   S    +   ++E  ++E++ 
Sbjct: 38  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD---EKEALMSELKI 94
Query: 692 LTEI-RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASA---KELGWTQRL--- 744
           ++ + +H NIV   G C+H     +I EY   G L   L   A A   KE G    L   
Sbjct: 95  MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDL 154
Query: 745 -----NVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSS 799
                 V +G+A   F    NC    +HRD++++NVLL  G+ A + DFG+A+ +  D S
Sbjct: 155 LHFSSQVAQGMA---FLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMND-S 206
Query: 800 NWSELAGTH---GYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXX 855
           N+           ++APE  +    T + DV+S+G+L  E+   G +P   +        
Sbjct: 207 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL---VNSK 263
Query: 856 XXXIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
              +     ++  P+    K + SIMQ   +C    P  RPT +++   L E+  E
Sbjct: 264 FYKLVKDGYQMAQPAF-APKNIYSIMQ---ACWALEPTHRPTFQQICSFLQEQAQE 315

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Composition-based stats.
 Identities = 66/197 (33%), Positives = 91/197 (46%), Gaps = 23/197 (11%)
Query: 646 IGKGGHGSV----YRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIV 701
           IGKG  G V    YR     G   AVK   +    +       FL E   +T++RH N+V
Sbjct: 29  IGKGEFGDVMLGDYR-----GNKVAVKCIKNDATAQ------AFLAEASVMTQLRHSNLV 77
Query: 702 KFYGFCSHPKHS-FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
           +  G     K   +I+ EY+  GSL   L +   +  LG    L     V +A+ YL  N
Sbjct: 78  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGN 136
Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLK 820
            F   VHRD++++NVL+     A VSDFG+ K     SS          + APE     K
Sbjct: 137 NF---VHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWTAPEALREKK 190
Query: 821 VTEKCDVYSFGVLALEV 837
            + K DV+SFG+L  E+
Sbjct: 191 FSTKSDVWSFGILLWEI 207

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Composition-based stats.
 Identities = 67/264 (25%), Positives = 122/264 (46%), Gaps = 24/264 (9%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           +G G  G V+          AVK       G MS   + FL E   + +++H+ +V+ Y 
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQ---GSMS--PDAFLAEANLMKQLQHQRLVRLYA 81
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
             +  +  +II EY+E+GSL   L    S  +L   + L++   +A+ + ++    +   
Sbjct: 82  VVTQ-EPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERNY--- 136
Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH-GYVAPELAYTLKVTEK 824
           +HRD+ + N+L+       ++DFG+A+ +  +     E A     + APE       T K
Sbjct: 137 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 196
Query: 825 CDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDS--RLPYPSLHVQKKLMSIM 881
            DV+SFG+L  E++  G+ P   +           I+ L+   R+  P  +  ++L  +M
Sbjct: 197 SDVWSFGILLTEIVTHGRIPYPGM------TNPEVIQNLERGYRMVRPD-NCPEELYQLM 249
Query: 882 QVAFSCLDQNPESRPTMKRVSQLL 905
           ++   C  + PE RPT   +  +L
Sbjct: 250 RL---CWKERPEDRPTFDYLRSVL 270

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Composition-based stats.
 Identities = 67/264 (25%), Positives = 122/264 (46%), Gaps = 24/264 (9%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           +G G  G V+          AVK       G MS   + FL E   + +++H+ +V+ Y 
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLKQ---GSMS--PDAFLAEANLMKQLQHQRLVRLYA 85
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
             +  +  +II EY+E+GSL   L    S  +L   + L++   +A+ + ++    +   
Sbjct: 86  VVTQ-EPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERNY--- 140
Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH-GYVAPELAYTLKVTEK 824
           +HRD+ + N+L+       ++DFG+A+ +  +     E A     + APE       T K
Sbjct: 141 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 200
Query: 825 CDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDS--RLPYPSLHVQKKLMSIM 881
            DV+SFG+L  E++  G+ P   +           I+ L+   R+  P  +  ++L  +M
Sbjct: 201 SDVWSFGILLTEIVTHGRIPYPGM------TNPEVIQNLERGYRMVRPD-NCPEELYQLM 253
Query: 882 QVAFSCLDQNPESRPTMKRVSQLL 905
           ++   C  + PE RPT   +  +L
Sbjct: 254 RL---CWKERPEDRPTFDYLRSVL 274

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Composition-based stats.
 Identities = 67/264 (25%), Positives = 122/264 (46%), Gaps = 24/264 (9%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           +G G  G V+          AVK       G MS   + FL E   + +++H+ +V+ Y 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQ---GSMS--PDAFLAEANLMKQLQHQRLVRLYA 75
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
             +  +  +II EY+E+GSL   L    S  +L   + L++   +A+ + ++    +   
Sbjct: 76  VVTQ-EPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERNY--- 130
Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH-GYVAPELAYTLKVTEK 824
           +HRD+ + N+L+       ++DFG+A+ +  +     E A     + APE       T K
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 825 CDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDS--RLPYPSLHVQKKLMSIM 881
            DV+SFG+L  E++  G+ P   +           I+ L+   R+  P  +  ++L  +M
Sbjct: 191 SDVWSFGILLTEIVTHGRIPYPGM------TNPEVIQNLERGYRMVRPD-NCPEELYQLM 243
Query: 882 QVAFSCLDQNPESRPTMKRVSQLL 905
           ++   C  + PE RPT   +  +L
Sbjct: 244 RL---CWKERPEDRPTFDYLRSVL 264

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Composition-based stats.
 Identities = 67/264 (25%), Positives = 122/264 (46%), Gaps = 24/264 (9%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           +G G  G V+          AVK       G MS   + FL E   + +++H+ +V+ Y 
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQ---GSMS--PDAFLAEANLMKQLQHQRLVRLYA 70
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
             +  +  +II EY+E+GSL   L    S  +L   + L++   +A+ + ++    +   
Sbjct: 71  VVTQ-EPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERNY--- 125
Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH-GYVAPELAYTLKVTEK 824
           +HRD+ + N+L+       ++DFG+A+ +  +     E A     + APE       T K
Sbjct: 126 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 185
Query: 825 CDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDS--RLPYPSLHVQKKLMSIM 881
            DV+SFG+L  E++  G+ P   +           I+ L+   R+  P  +  ++L  +M
Sbjct: 186 SDVWSFGILLTEIVTHGRIPYPGM------TNPEVIQNLERGYRMVRPD-NCPEELYQLM 238
Query: 882 QVAFSCLDQNPESRPTMKRVSQLL 905
           ++   C  + PE RPT   +  +L
Sbjct: 239 RL---CWKERPEDRPTFDYLRSVL 259

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Composition-based stats.
 Identities = 67/264 (25%), Positives = 122/264 (46%), Gaps = 24/264 (9%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           +G G  G V+          AVK       G MS   + FL E   + +++H+ +V+ Y 
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLKQ---GSMS--PDAFLAEANLMKQLQHQRLVRLYA 80
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
             +  +  +II EY+E+GSL   L    S  +L   + L++   +A+ + ++    +   
Sbjct: 81  VVTQ-EPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERNY--- 135
Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH-GYVAPELAYTLKVTEK 824
           +HRD+ + N+L+       ++DFG+A+ +  +     E A     + APE       T K
Sbjct: 136 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 195
Query: 825 CDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDS--RLPYPSLHVQKKLMSIM 881
            DV+SFG+L  E++  G+ P   +           I+ L+   R+  P  +  ++L  +M
Sbjct: 196 SDVWSFGILLTEIVTHGRIPYPGM------TNPEVIQNLERGYRMVRPD-NCPEELYQLM 248
Query: 882 QVAFSCLDQNPESRPTMKRVSQLL 905
           ++   C  + PE RPT   +  +L
Sbjct: 249 RL---CWKERPEDRPTFDYLRSVL 269

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 70/263 (26%), Positives = 114/263 (43%), Gaps = 31/263 (11%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           IGKG  G VY+     + E+ A+K        +     ++   EI  L++     I +++
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSPYITRYF 83
Query: 705 GFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP 764
           G        +II EYL  GS   +L        L  T    +++ +   L YLH+     
Sbjct: 84  GSYLKSTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDYLHSER--- 136
Query: 765 IVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEK 824
            +HRDI + NVLL    +  ++DFG+A  L       +   GT  ++APE+        K
Sbjct: 137 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDFK 196
Query: 825 CDVYSFGVLALEVIKGK------HPRDFLFEXXXXXXXXXIEMLDSRLPYPSLHVQKKLM 878
            D++S G+ A+E+ KG+      HP   LF            ++    P P+L  Q    
Sbjct: 197 ADIWSLGITAIELAKGEPPNSDLHPMRVLF------------LIPKNSP-PTLEGQHS-K 242
Query: 879 SIMQVAFSCLDQNPESRPTMKRV 901
              +   +CL+++P  RPT K +
Sbjct: 243 PFKEFVEACLNKDPRFRPTAKEL 265

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Composition-based stats.
 Identities = 67/263 (25%), Positives = 114/263 (43%), Gaps = 21/263 (7%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           +G G  G V+     +    AVK      PG MS Q   FL E   +  ++H  +V+ Y 
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLK---PGTMSVQA--FLEEANLMKTLQHDKLVRLYA 74
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
             +  +  +II E++  GSL   L +D   K L   + ++    +A+ + Y+    +   
Sbjct: 75  VVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIERKNY--- 130
Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH-GYVAPELAYTLKVTEK 824
           +HRD+ + NVL+       ++DFG+A+ +  +     E A     + APE       T K
Sbjct: 131 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIK 190
Query: 825 CDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSL-HVQKKLMSIMQ 882
            +V+SFG+L  E++  GK P               +  L      P + +   +L  IM+
Sbjct: 191 SNVWSFGILLYEIVTYGKIP------YPGRTNADVMSALSQGYRMPRMENCPDELYDIMK 244
Query: 883 VAFSCLDQNPESRPTMKRVSQLL 905
           +   C  +  E RPT   +  +L
Sbjct: 245 M---CWKEKAEERPTFDYLQSVL 264

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/197 (33%), Positives = 91/197 (46%), Gaps = 23/197 (11%)
Query: 646 IGKGGHGSV----YRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIV 701
           IGKG  G V    YR     G   AVK   +    +       FL E   +T++RH N+V
Sbjct: 201 IGKGEFGDVMLGDYR-----GNKVAVKCIKNDATAQA------FLAEASVMTQLRHSNLV 249
Query: 702 KFYGFCSHPKHS-FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
           +  G     K   +I+ EY+  GSL   L +   +  LG    L     V +A+ YL  N
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGN 308
Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLK 820
            F   VHRD++++NVL+     A VSDFG+ K     SS          + APE     K
Sbjct: 309 NF---VHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWTAPEALREKK 362
Query: 821 VTEKCDVYSFGVLALEV 837
            + K DV+SFG+L  E+
Sbjct: 363 FSTKSDVWSFGILLWEI 379

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 69/247 (27%), Positives = 114/247 (46%), Gaps = 31/247 (12%)
Query: 681 QQEEFLNEIQALTEI-RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASA---K 736
           ++E  ++E++ ++ + +H NIV   G C+H     +I EY   G L   L   A A   K
Sbjct: 92  EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDK 151
Query: 737 ELGWTQRL--------NVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDF 788
           E G    L         V +G+A   F    NC    +HRD++++NVLL  G+ A + DF
Sbjct: 152 EDGRPLELRDLLHFSSQVAQGMA---FLASKNC----IHRDVAARNVLLTNGHVAKIGDF 204
Query: 789 GIAKFLNPDSSNWSELAGTH---GYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPR 844
           G+A+ +  D SN+           ++APE  +    T + DV+S+G+L  E+   G +P 
Sbjct: 205 GLARDIMND-SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 263
Query: 845 DFLFEXXXXXXXXXIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQL 904
             +           +     ++  P+    K + SIMQ   +C    P  RPT +++   
Sbjct: 264 PGIL---VNSKFYKLVKDGYQMAQPAF-APKNIYSIMQ---ACWALEPTHRPTFQQICSF 316
Query: 905 LCEKIFE 911
           L E+  E
Sbjct: 317 LQEQAQE 323

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 63/267 (23%), Positives = 114/267 (42%), Gaps = 26/267 (9%)
Query: 646 IGKGGHGSVYRAKVPS-GEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           IG+G  G V+  ++ +   + AVK     LP ++   + +FL E + L +  H NIV+  
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDL---KAKFLQEARILKQYSHPNIVRLI 178
Query: 705 GFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP 764
           G C+  +  +I+ E ++ G     L  + +   L     L ++   A  + YL + C   
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGA--RLRVKTLLQMVGDAAAGMEYLESKC--- 233
Query: 765 IVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAG-----THGYVAPELAYTL 819
            +HRD++++N L+       +SDFG+++    ++      +G        + APE     
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSR---EEADGVXAASGGLRQVPVKWTAPEALNYG 290
Query: 820 KVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLHVQKKLM 878
           + + + DV+SFG+L  E    G  P    +                RLP P L       
Sbjct: 291 RYSSESDVWSFGILLWETFSLGASP----YPNLSNQQTREFVEKGGRLPCPELCPD---- 342
Query: 879 SIMQVAFSCLDQNPESRPTMKRVSQLL 905
           ++ ++   C    P  RP+   + Q L
Sbjct: 343 AVFRLMEQCWAYEPGQRPSFSTIYQEL 369

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 99/209 (47%), Gaps = 15/209 (7%)
Query: 638 NDFNAEHCIGKGGHGSVYR-AKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
           +DF     +G G  G V++ +  PSG + A K  H  +   +   + + + E+Q L E  
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI---RNQIIRELQVLHECN 62
Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE--LGWTQRLNVIKGVADAL 754
              IV FYG         I  E+++ GSLD++L       E  LG    + VIKG    L
Sbjct: 63  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVS-IAVIKG----L 117
Query: 755 FYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPE 814
            YL       I+HRD+   N+L++   E  + DFG++  L    +N     GT  Y++PE
Sbjct: 118 TYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPE 173
Query: 815 LAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
                  + + D++S G+  +E+  G++P
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 99/209 (47%), Gaps = 15/209 (7%)
Query: 638 NDFNAEHCIGKGGHGSVYR-AKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
           +DF     +G G  G V++ +  PSG + A K  H  +   +   + + + E+Q L E  
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI---RNQIIRELQVLHECN 62
Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE--LGWTQRLNVIKGVADAL 754
              IV FYG         I  E+++ GSLD++L       E  LG    + VIKG    L
Sbjct: 63  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVS-IAVIKG----L 117
Query: 755 FYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPE 814
            YL       I+HRD+   N+L++   E  + DFG++  L    +N     GT  Y++PE
Sbjct: 118 TYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPE 173
Query: 815 LAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
                  + + D++S G+  +E+  G++P
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 121/281 (43%), Gaps = 31/281 (11%)
Query: 646 IGKGGHGSVYRAKVP-----SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNI 700
           +GKG  GSV   +       +GE+ AVKK        +     +F  EI+ L  ++H NI
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR----DFEREIEILKSLQHDNI 91
Query: 701 VKFYGFC--SHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLH 758
           VK+ G C  +  ++  +I EYL  GSL   L      + +   + L     +   + YL 
Sbjct: 92  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLG 149
Query: 759 NNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG---YVAPEL 815
              +   +HRD++++N+L++      + DFG+ K L  D               + APE 
Sbjct: 150 TKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 206
Query: 816 AYTLKVTEKCDVYSFGVLALEVI----KGKH-PRDFLF-----EXXXXXXXXXIEML--D 863
               K +   DV+SFGV+  E+     K K  P +F+      +         IE+L  +
Sbjct: 207 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 266
Query: 864 SRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQL 904
            RLP P     +  M + +   + ++Q P  R    RV Q+
Sbjct: 267 GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 307

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 121/281 (43%), Gaps = 31/281 (11%)
Query: 646 IGKGGHGSVYRAKVP-----SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNI 700
           +GKG  GSV   +       +GE+ AVKK        +     +F  EI+ L  ++H NI
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR----DFEREIEILKSLQHDNI 91
Query: 701 VKFYGFC--SHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLH 758
           VK+ G C  +  ++  +I EYL  GSL   L      + +   + L     +   + YL 
Sbjct: 92  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLG 149
Query: 759 NNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG---YVAPEL 815
              +   +HRD++++N+L++      + DFG+ K L  D               + APE 
Sbjct: 150 TKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 206
Query: 816 AYTLKVTEKCDVYSFGVLALEVI----KGKH-PRDFLF-----EXXXXXXXXXIEML--D 863
               K +   DV+SFGV+  E+     K K  P +F+      +         IE+L  +
Sbjct: 207 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 266
Query: 864 SRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQL 904
            RLP P     +  M + +   + ++Q P  R    RV Q+
Sbjct: 267 GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 307

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 86/168 (51%), Gaps = 15/168 (8%)
Query: 682 QEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWT 741
           ++E L E   + ++ +  IV+  G C   +   ++ E  E G L+K L  +   K+    
Sbjct: 414 KDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKD---K 469
Query: 742 QRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNW 801
             + ++  V+  + YL  + F   VHRD++++NVLL   + A +SDFG++K L  D + +
Sbjct: 470 NIIELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526
Query: 802 SELAGTHG-----YVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHP 843
              A THG     + APE     K + K DV+SFGVL  E    G+ P
Sbjct: 527 K--AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 572

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 99/209 (47%), Gaps = 15/209 (7%)
Query: 638 NDFNAEHCIGKGGHGSVYR-AKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
           +DF     +G G  G V++ +  PSG + A K  H  +   +   + + + E+Q L E  
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI---RNQIIRELQVLHECN 62
Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE--LGWTQRLNVIKGVADAL 754
              IV FYG         I  E+++ GSLD++L       E  LG    + VIKG    L
Sbjct: 63  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVS-IAVIKG----L 117
Query: 755 FYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPE 814
            YL       I+HRD+   N+L++   E  + DFG++  L    +N     GT  Y++PE
Sbjct: 118 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPE 173
Query: 815 LAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
                  + + D++S G+  +E+  G++P
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 99/209 (47%), Gaps = 15/209 (7%)
Query: 638 NDFNAEHCIGKGGHGSVYR-AKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
           +DF     +G G  G V++ +  PSG + A K  H  +   +   + + + E+Q L E  
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI---RNQIIRELQVLHECN 62
Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE--LGWTQRLNVIKGVADAL 754
              IV FYG         I  E+++ GSLD++L       E  LG    + VIKG    L
Sbjct: 63  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVS-IAVIKG----L 117
Query: 755 FYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPE 814
            YL       I+HRD+   N+L++   E  + DFG++  L    +N     GT  Y++PE
Sbjct: 118 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPE 173
Query: 815 LAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
                  + + D++S G+  +E+  G++P
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 111/259 (42%), Gaps = 22/259 (8%)
Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G GG   V+ A+ +      AVK   + L  + SF    F  E Q    + H  IV  Y
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLR-FRREAQNAAALNHPAIVAVY 78
Query: 705 --GFCSHPKHS--FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
             G    P     +I+ EY++  +L  I+  +     +   + + VI     AL + H N
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQN 135
Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN----WSELAGTHGYVAPELA 816
               I+HRD+   N+L+       V DFGIA+ +  DS N     + + GT  Y++PE A
Sbjct: 136 G---IIHRDVKPANILISATNAVKVVDFGIARAIA-DSGNSVXQTAAVIGTAQYLSPEQA 191
Query: 817 YTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLHVQKK 876
               V  + DVYS G +  EV+ G+ P    F            + +  +P PS   +  
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQHVREDPIP-PSARHEGL 246
Query: 877 LMSIMQVAFSCLDQNPESR 895
              +  V    L +NPE+R
Sbjct: 247 SADLDAVVLKALAKNPENR 265

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 122/281 (43%), Gaps = 31/281 (11%)
Query: 646 IGKGGHGSVYRAKVP-----SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNI 700
           +GKG  GSV   +       +GE+ AVKK        +     +F  EI+ L  ++H NI
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR----DFEREIEILKSLQHDNI 73
Query: 701 VKFYGFC--SHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLH 758
           VK+ G C  +  ++  +I EYL  GSL   L      + +   + L     +   + YL 
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLG 131
Query: 759 NNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG---YVAPEL 815
              +   +HRD++++N+L++      + DFG+ K L  D   +           + APE 
Sbjct: 132 TKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPES 188
Query: 816 AYTLKVTEKCDVYSFGVLALEVI----KGKH-PRDFLF-----EXXXXXXXXXIEML--D 863
               K +   DV+SFGV+  E+     K K  P +F+      +         IE+L  +
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 248
Query: 864 SRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQL 904
            RLP P     +  M + +   + ++Q P  R    RV Q+
Sbjct: 249 GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 121/281 (43%), Gaps = 31/281 (11%)
Query: 646 IGKGGHGSVYRAKVP-----SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNI 700
           +GKG  GSV   +       +GE+ AVKK        +     +F  EI+ L  ++H NI
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR----DFEREIEILKSLQHDNI 73
Query: 701 VKFYGFC--SHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLH 758
           VK+ G C  +  ++  +I EYL  GSL   L      + +   + L     +   + YL 
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLG 131
Query: 759 NNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG---YVAPEL 815
              +   +HRD++++N+L++      + DFG+ K L  D               + APE 
Sbjct: 132 TKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 188
Query: 816 AYTLKVTEKCDVYSFGVLALEVI----KGKH-PRDFLF-----EXXXXXXXXXIEML--D 863
               K +   DV+SFGV+  E+     K K  P +F+      +         IE+L  +
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 248
Query: 864 SRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQL 904
            RLP P     +  M + +   + ++Q P  R    RV Q+
Sbjct: 249 GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 86/168 (51%), Gaps = 15/168 (8%)
Query: 682 QEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWT 741
           ++E L E   + ++ +  IV+  G C   +   ++ E  E G L+K L  +   K+    
Sbjct: 415 KDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKD---K 470
Query: 742 QRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNW 801
             + ++  V+  + YL  + F   VHRD++++NVLL   + A +SDFG++K L  D + +
Sbjct: 471 NIIELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 527
Query: 802 SELAGTHG-----YVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHP 843
              A THG     + APE     K + K DV+SFGVL  E    G+ P
Sbjct: 528 K--AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 573

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 67/264 (25%), Positives = 121/264 (45%), Gaps = 24/264 (9%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           +G G  G V+          AVK       G MS   + FL E   + +++H+ +V+ Y 
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQ---GSMS--PDAFLAEANLMKQLQHQRLVRLYA 75
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
             +  +  +II EY+E+GSL   L    S  +L   + L++   +A+ + ++    +   
Sbjct: 76  VVTQ-EPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERNY--- 130
Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH-GYVAPELAYTLKVTEK 824
           +HRD+ + N+L+       ++DFG+A+ +        E A     + APE       T K
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 825 CDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDS--RLPYPSLHVQKKLMSIM 881
            DV+SFG+L  E++  G+ P   +           I+ L+   R+  P  +  ++L  +M
Sbjct: 191 SDVWSFGILLTEIVTHGRIPYPGM------TNPEVIQNLERGYRMVRPD-NCPEELYQLM 243
Query: 882 QVAFSCLDQNPESRPTMKRVSQLL 905
           ++   C  + PE RPT   +  +L
Sbjct: 244 RL---CWKERPEDRPTFDYLRSVL 264

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 122/268 (45%), Gaps = 33/268 (12%)
Query: 646 IGKGGHGSVY----RAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIV 701
           +G G  G V+    R+      I  + K  S +P       E+   EI+ L  + H NI+
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP------MEQIEAEIEVLKSLDHPNII 83
Query: 702 KFYGFCSHPKHSFIIYEYLESGS-LDKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
           K +       + +I+ E  E G  L++I+   A  K L       ++K + +AL Y H+ 
Sbjct: 84  KIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ 143
Query: 761 CFPPIVHRDISSKNVLL-DLGYEAHVS--DFGIAKFLNPDSSNWSELAGTHGYVAPELAY 817
               +VH+D+  +N+L  D    + +   DFG+A+    D  + +  AGT  Y+APE+ +
Sbjct: 144 ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS-TNAAGTALYMAPEV-F 198
Query: 818 TLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEXXXXXXXXXIEMLDSRLPY--PSLHVQK 875
              VT KCD++S GV+   ++ G  P               +E +  +  Y  P+  V+ 
Sbjct: 199 KRDVTFKCDIWSAGVVMYFLLTGCLP----------FTGTSLEEVQQKATYKEPNYAVEC 248
Query: 876 KLMSIMQVAF--SCLDQNPESRPTMKRV 901
           + ++   V      L ++PE RP+  +V
Sbjct: 249 RPLTPQAVDLLKQMLTKDPERRPSAAQV 276

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 15/209 (7%)
Query: 638 NDFNAEHCIGKGGHGSVYR-AKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
           +DF     +G G  G V++ +  PSG + A K  H  +   +  Q    + E+Q L E  
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ---IIRELQVLHECN 89
Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE--LGWTQRLNVIKGVADAL 754
              IV FYG         I  E+++ GSLD++L       E  LG    + VIKG    L
Sbjct: 90  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVS-IAVIKG----L 144
Query: 755 FYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPE 814
            YL       I+HRD+   N+L++   E  + DFG++  L    +N     GT  Y++PE
Sbjct: 145 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPE 200
Query: 815 LAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
                  + + D++S G+  +E+  G++P
Sbjct: 201 RLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 121/281 (43%), Gaps = 31/281 (11%)
Query: 646 IGKGGHGSVYRAKVP-----SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNI 700
           +GKG  GSV   +       +GE+ AVKK        +     +F  EI+ L  ++H NI
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR----DFEREIEILKSLQHDNI 104
Query: 701 VKFYGFC--SHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLH 758
           VK+ G C  +  ++  +I EYL  GSL   L      + +   + L     +   + YL 
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLG 162
Query: 759 NNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG---YVAPEL 815
              +   +HRD++++N+L++      + DFG+ K L  D               + APE 
Sbjct: 163 TKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 219
Query: 816 AYTLKVTEKCDVYSFGVLALEVI----KGKH-PRDFLF-----EXXXXXXXXXIEML--D 863
               K +   DV+SFGV+  E+     K K  P +F+      +         IE+L  +
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 279
Query: 864 SRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQL 904
            RLP P     +  M + +   + ++Q P  R    RV Q+
Sbjct: 280 GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 121/281 (43%), Gaps = 31/281 (11%)
Query: 646 IGKGGHGSVYRAKVP-----SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNI 700
           +GKG  GSV   +       +GE+ AVKK        +     +F  EI+ L  ++H NI
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR----DFEREIEILKSLQHDNI 72
Query: 701 VKFYGFC--SHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLH 758
           VK+ G C  +  ++  +I EYL  GSL   L      + +   + L     +   + YL 
Sbjct: 73  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLG 130
Query: 759 NNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG---YVAPEL 815
              +   +HRD++++N+L++      + DFG+ K L  D               + APE 
Sbjct: 131 TKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 187
Query: 816 AYTLKVTEKCDVYSFGVLALEVI----KGKH-PRDFLF-----EXXXXXXXXXIEML--D 863
               K +   DV+SFGV+  E+     K K  P +F+      +         IE+L  +
Sbjct: 188 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 247
Query: 864 SRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQL 904
            RLP P     +  M + +   + ++Q P  R    RV Q+
Sbjct: 248 GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 288

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 121/281 (43%), Gaps = 31/281 (11%)
Query: 646 IGKGGHGSVYRAKVP-----SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNI 700
           +GKG  GSV   +       +GE+ AVKK        +     +F  EI+ L  ++H NI
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR----DFEREIEILKSLQHDNI 73
Query: 701 VKFYGFC--SHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLH 758
           VK+ G C  +  ++  +I EYL  GSL   L      + +   + L     +   + YL 
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLG 131
Query: 759 NNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG---YVAPEL 815
              +   +HRD++++N+L++      + DFG+ K L  D               + APE 
Sbjct: 132 TKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 188
Query: 816 AYTLKVTEKCDVYSFGVLALEVI----KGKH-PRDFLF-----EXXXXXXXXXIEML--D 863
               K +   DV+SFGV+  E+     K K  P +F+      +         IE+L  +
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 248
Query: 864 SRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQL 904
            RLP P     +  M + +   + ++Q P  R    RV Q+
Sbjct: 249 GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 121/281 (43%), Gaps = 31/281 (11%)
Query: 646 IGKGGHGSVYRAKVP-----SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNI 700
           +GKG  GSV   +       +GE+ AVKK        +     +F  EI+ L  ++H NI
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR----DFEREIEILKSLQHDNI 80
Query: 701 VKFYGFC--SHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLH 758
           VK+ G C  +  ++  +I EYL  GSL   L      + +   + L     +   + YL 
Sbjct: 81  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLG 138
Query: 759 NNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG---YVAPEL 815
              +   +HRD++++N+L++      + DFG+ K L  D               + APE 
Sbjct: 139 TKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 195
Query: 816 AYTLKVTEKCDVYSFGVLALEVI----KGKH-PRDFLF-----EXXXXXXXXXIEML--D 863
               K +   DV+SFGV+  E+     K K  P +F+      +         IE+L  +
Sbjct: 196 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 255
Query: 864 SRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQL 904
            RLP P     +  M + +   + ++Q P  R    RV Q+
Sbjct: 256 GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 296

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 17/220 (7%)
Query: 633 IISATNDFNAEH-----CIGKGGHGSV-YRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFL 686
           +     D N +H      IGKG  G V    K  + +++A+K  +     E + +     
Sbjct: 5   VFDENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERN-EVRNVF 63
Query: 687 NEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNV 746
            E+Q +  + H  +V  +      +  F++ + L  G L   L  +   KE   T +L +
Sbjct: 64  KELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE--TVKLFI 121
Query: 747 IKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAG 806
            + V  AL YL N     I+HRD+   N+LLD     H++DF IA  L P  +  + +AG
Sbjct: 122 CELVM-ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAML-PRETQITTMAG 176
Query: 807 THGYVAPELAYTLK---VTEKCDVYSFGVLALEVIKGKHP 843
           T  Y+APE+  + K    +   D +S GV A E+++G+ P
Sbjct: 177 TKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 15/209 (7%)
Query: 638 NDFNAEHCIGKGGHGSVYR-AKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
           +DF     +G G  G V++ +  PSG + A K  H  +   +  Q    + E+Q L E  
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ---IIRELQVLHECN 124
Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE--LGWTQRLNVIKGVADAL 754
              IV FYG         I  E+++ GSLD++L       E  LG    + VIKG    L
Sbjct: 125 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVS-IAVIKG----L 179
Query: 755 FYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPE 814
            YL       I+HRD+   N+L++   E  + DFG++  L    +N     GT  Y++PE
Sbjct: 180 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPE 235
Query: 815 LAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
                  + + D++S G+  +E+  G++P
Sbjct: 236 RLQGTHYSVQSDIWSMGLSLVEMAVGRYP 264

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 121/281 (43%), Gaps = 31/281 (11%)
Query: 646 IGKGGHGSVYRAKVP-----SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNI 700
           +GKG  GSV   +       +GE+ AVKK        +     +F  EI+ L  ++H NI
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR----DFEREIEILKSLQHDNI 78
Query: 701 VKFYGFC--SHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLH 758
           VK+ G C  +  ++  +I EYL  GSL   L      + +   + L     +   + YL 
Sbjct: 79  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLG 136
Query: 759 NNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG---YVAPEL 815
              +   +HRD++++N+L++      + DFG+ K L  D               + APE 
Sbjct: 137 TKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 193
Query: 816 AYTLKVTEKCDVYSFGVLALEVI----KGKH-PRDFLF-----EXXXXXXXXXIEML--D 863
               K +   DV+SFGV+  E+     K K  P +F+      +         IE+L  +
Sbjct: 194 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 253
Query: 864 SRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQL 904
            RLP P     +  M + +   + ++Q P  R    RV Q+
Sbjct: 254 GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 294

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 121/281 (43%), Gaps = 31/281 (11%)
Query: 646 IGKGGHGSVYRAKVP-----SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNI 700
           +GKG  GSV   +       +GE+ AVKK        +     +F  EI+ L  ++H NI
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR----DFEREIEILKSLQHDNI 77
Query: 701 VKFYGFC--SHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLH 758
           VK+ G C  +  ++  +I EYL  GSL   L      + +   + L     +   + YL 
Sbjct: 78  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLG 135
Query: 759 NNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG---YVAPEL 815
              +   +HRD++++N+L++      + DFG+ K L  D               + APE 
Sbjct: 136 TKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 192
Query: 816 AYTLKVTEKCDVYSFGVLALEVI----KGKH-PRDFLF-----EXXXXXXXXXIEML--D 863
               K +   DV+SFGV+  E+     K K  P +F+      +         IE+L  +
Sbjct: 193 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 252
Query: 864 SRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQL 904
            RLP P     +  M + +   + ++Q P  R    RV Q+
Sbjct: 253 GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 293

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 121/281 (43%), Gaps = 31/281 (11%)
Query: 646 IGKGGHGSVYRAKVP-----SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNI 700
           +GKG  GSV   +       +GE+ AVKK        +     +F  EI+ L  ++H NI
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR----DFEREIEILKSLQHDNI 71
Query: 701 VKFYGFC--SHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLH 758
           VK+ G C  +  ++  +I EYL  GSL   L      + +   + L     +   + YL 
Sbjct: 72  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLG 129
Query: 759 NNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG---YVAPEL 815
              +   +HRD++++N+L++      + DFG+ K L  D               + APE 
Sbjct: 130 TKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 186
Query: 816 AYTLKVTEKCDVYSFGVLALEVI----KGKH-PRDFLF-----EXXXXXXXXXIEML--D 863
               K +   DV+SFGV+  E+     K K  P +F+      +         IE+L  +
Sbjct: 187 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 246
Query: 864 SRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQL 904
            RLP P     +  M + +   + ++Q P  R    RV Q+
Sbjct: 247 GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 287

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 58/164 (35%), Positives = 86/164 (52%), Gaps = 18/164 (10%)
Query: 687 NEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSL-DKILCNDASAKELG-WTQR- 743
           NEI  L +I+H NIV          H ++I + +  G L D+I+       E G +T+R 
Sbjct: 65  NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV-------EKGFYTERD 117
Query: 744 -LNVIKGVADALFYLHNNCFPPIVHRDISSKNVL---LDLGYEAHVSDFGIAKFLNPDSS 799
              +I  V DA+ YLH+     IVHRD+  +N+L   LD   +  +SDFG++K  +P S 
Sbjct: 118 ASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV 174
Query: 800 NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
             S   GT GYVAPE+      ++  D +S GV+A  ++ G  P
Sbjct: 175 -LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 121/281 (43%), Gaps = 31/281 (11%)
Query: 646 IGKGGHGSVYRAKVP-----SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNI 700
           +GKG  GSV   +       +GE+ AVKK        +     +F  EI+ L  ++H NI
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR----DFEREIEILKSLQHDNI 79
Query: 701 VKFYGFC--SHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLH 758
           VK+ G C  +  ++  +I EYL  GSL   L      + +   + L     +   + YL 
Sbjct: 80  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLG 137
Query: 759 NNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG---YVAPEL 815
              +   +HRD++++N+L++      + DFG+ K L  D               + APE 
Sbjct: 138 TKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 194
Query: 816 AYTLKVTEKCDVYSFGVLALEVI----KGKH-PRDFLF-----EXXXXXXXXXIEML--D 863
               K +   DV+SFGV+  E+     K K  P +F+      +         IE+L  +
Sbjct: 195 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 254
Query: 864 SRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQL 904
            RLP P     +  M + +   + ++Q P  R    RV Q+
Sbjct: 255 GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 295

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 121/281 (43%), Gaps = 31/281 (11%)
Query: 646 IGKGGHGSVYRAKVP-----SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNI 700
           +GKG  GSV   +       +GE+ AVKK        +     +F  EI+ L  ++H NI
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR----DFEREIEILKSLQHDNI 76
Query: 701 VKFYGFC--SHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLH 758
           VK+ G C  +  ++  +I EYL  GSL   L      + +   + L     +   + YL 
Sbjct: 77  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLG 134
Query: 759 NNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG---YVAPEL 815
              +   +HRD++++N+L++      + DFG+ K L  D               + APE 
Sbjct: 135 TKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 191
Query: 816 AYTLKVTEKCDVYSFGVLALEVI----KGKH-PRDFLF-----EXXXXXXXXXIEML--D 863
               K +   DV+SFGV+  E+     K K  P +F+      +         IE+L  +
Sbjct: 192 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 251
Query: 864 SRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQL 904
            RLP P     +  M + +   + ++Q P  R    RV Q+
Sbjct: 252 GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 292

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/258 (26%), Positives = 111/258 (43%), Gaps = 20/258 (7%)
Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G GG   V+ A+ +      AVK   + L  + SF    F  E Q    + H  IV  Y
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLR-FRREAQNAAALNHPAIVAVY 78
Query: 705 --GFCSHPKHS--FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
             G    P     +I+ EY++  +L  I+  +     +   + + VI     AL + H N
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQN 135
Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELA---GTHGYVAPELAY 817
               I+HRD+   N+++       V DFGIA+ +    ++ ++ A   GT  Y++PE A 
Sbjct: 136 G---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 818 TLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLHVQKKL 877
              V  + DVYS G +  EV+ G+ P    F            + +  +P PS   +   
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQHVREDPIP-PSARHEGLS 247
Query: 878 MSIMQVAFSCLDQNPESR 895
             +  V    L +NPE+R
Sbjct: 248 ADLDAVVLKALAKNPENR 265

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 76/312 (24%), Positives = 124/312 (39%), Gaps = 80/312 (25%)
Query: 646 IGKGGHGSVYRA------KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHR 698
           +G G  G V  A      K  +    AVK      P     ++E  ++E++ L+ +  H 
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK---PSAHLTEREALMSELKVLSYLGNHM 87
Query: 699 NIVKFYGFCSHPKHSFIIYEYLESGSL--------DKILCNDASAKELGWTQ-------- 742
           NIV   G C+    + +I EY   G L        D  +C+  S   +   +        
Sbjct: 88  NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 743 ---RLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSS 799
                 V KG+A   F    NC    +HRD++++N+LL  G    + DFG+A+ +  D S
Sbjct: 148 LSFSYQVAKGMA---FLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIKND-S 199
Query: 800 NWSELAGTH---GYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEXXXXXXX 856
           N+           ++APE  +    T + DV+S+G+             FL+E       
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI-------------FLWELFSLGSS 246
Query: 857 XXIEMLDSRLPYPSLHVQKKLMSIMQVAF-----------------SCLDQNPESRPTMK 899
                     PYP + V  K   +++  F                 +C D +P  RPT K
Sbjct: 247 ----------PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFK 296
Query: 900 RVSQLLCEKIFE 911
           ++ QL+ ++I E
Sbjct: 297 QIVQLIEKQISE 308

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/258 (26%), Positives = 111/258 (43%), Gaps = 20/258 (7%)
Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G GG   V+ A+ +      AVK   + L  + SF    F  E Q    + H  IV  Y
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLR-FRREAQNAAALNHPAIVAVY 78
Query: 705 --GFCSHPKHS--FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
             G    P     +I+ EY++  +L  I+  +     +   + + VI     AL + H N
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQN 135
Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELA---GTHGYVAPELAY 817
               I+HRD+   N+++       V DFGIA+ +    ++ ++ A   GT  Y++PE A 
Sbjct: 136 G---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 818 TLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLHVQKKL 877
              V  + DVYS G +  EV+ G+ P    F            + +  +P PS   +   
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPDSVAYQHVREDPIP-PSARHEGLS 247
Query: 878 MSIMQVAFSCLDQNPESR 895
             +  V    L +NPE+R
Sbjct: 248 ADLDAVVLKALAKNPENR 265

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 76/312 (24%), Positives = 124/312 (39%), Gaps = 80/312 (25%)
Query: 646 IGKGGHGSVYRA------KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHR 698
           +G G  G V  A      K  +    AVK      P     ++E  ++E++ L+ +  H 
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK---PSAHLTEREALMSELKVLSYLGNHM 110
Query: 699 NIVKFYGFCSHPKHSFIIYEYLESGSL--------DKILCNDASAKELGWTQ-------- 742
           NIV   G C+    + +I EY   G L        D  +C+  S   +   +        
Sbjct: 111 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 170
Query: 743 ---RLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSS 799
                 V KG+A   F    NC    +HRD++++N+LL  G    + DFG+A+ +  D S
Sbjct: 171 LSFSYQVAKGMA---FLASKNC----IHRDLAARNILLTHGRITKICDFGLARHIKND-S 222
Query: 800 NWSELAGTH---GYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEXXXXXXX 856
           N+           ++APE  +    T + DV+S+G+             FL+E       
Sbjct: 223 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI-------------FLWELFSLGSS 269
Query: 857 XXIEMLDSRLPYPSLHVQKKLMSIMQVAF-----------------SCLDQNPESRPTMK 899
                     PYP + V  K   +++  F                 +C D +P  RPT K
Sbjct: 270 ----------PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFK 319
Query: 900 RVSQLLCEKIFE 911
           ++ QL+ ++I E
Sbjct: 320 QIVQLIEKQISE 331

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 102/238 (42%), Gaps = 19/238 (7%)
Query: 665 FAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY--GFCSHPKHS--FIIYEYL 720
            AVK   + L  + SF    F  E Q    + H  IV  Y  G    P     +I+ EY+
Sbjct: 40  VAVKVLRADLARDPSFYLR-FRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYV 98
Query: 721 ESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLG 780
           +  +L  I+  +     +   + + VI     AL + H N    I+HRD+   N+++   
Sbjct: 99  DGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISAT 152
Query: 781 YEAHVSDFGIAKFLNPDSSNWSELA---GTHGYVAPELAYTLKVTEKCDVYSFGVLALEV 837
               V DFGIA+ +    ++ ++ A   GT  Y++PE A    V  + DVYS G +  EV
Sbjct: 153 NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEV 212
Query: 838 IKGKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESR 895
           + G+ P    F            + +  +P PS   +     +  V    L +NPE+R
Sbjct: 213 LTGEPP----FTGDSPVSVAYQHVREDPIP-PSARHEGLSADLDAVVLKALAKNPENR 265

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 78/160 (48%), Gaps = 8/160 (5%)
Query: 687 NEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNV 746
            EIQ L   RH +I+K Y   S P   F++ EY+  G L   +C +    E    +   +
Sbjct: 65  REIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDE---KESRRL 121
Query: 747 IKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAG 806
            + +   + Y H +    +VHRD+  +NVLLD    A ++DFG++  ++ D        G
Sbjct: 122 FQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRXSCG 177
Query: 807 THGYVAPE-LAYTLKVTEKCDVYSFGVLALEVIKGKHPRD 845
           +  Y APE ++  L    + D++S GV+   ++ G  P D
Sbjct: 178 SPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 102/238 (42%), Gaps = 19/238 (7%)
Query: 665 FAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY--GFCSHPKHS--FIIYEYL 720
            AVK   + L  + SF    F  E Q    + H  IV  Y  G    P     +I+ EY+
Sbjct: 40  VAVKVLRADLARDPSFYLR-FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYV 98
Query: 721 ESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLG 780
           +  +L  I+  +     +   + + VI     AL + H N    I+HRD+   N+++   
Sbjct: 99  DGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISAT 152
Query: 781 YEAHVSDFGIAKFLNPDSSNWSELA---GTHGYVAPELAYTLKVTEKCDVYSFGVLALEV 837
               V DFGIA+ +    ++ ++ A   GT  Y++PE A    V  + DVYS G +  EV
Sbjct: 153 NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEV 212
Query: 838 IKGKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESR 895
           + G+ P    F            + +  +P PS   +     +  V    L +NPE+R
Sbjct: 213 LTGEPP----FTGDSPVSVAYQHVREDPIP-PSARHEGLSADLDAVVLKALAKNPENR 265

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 76/312 (24%), Positives = 124/312 (39%), Gaps = 80/312 (25%)
Query: 646 IGKGGHGSVYRA------KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHR 698
           +G G  G V  A      K  +    AVK      P     ++E  ++E++ L+ +  H 
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK---PSAHLTEREALMSELKVLSYLGNHM 103
Query: 699 NIVKFYGFCSHPKHSFIIYEYLESGSL--------DKILCNDASAKELGWTQRL------ 744
           NIV   G C+    + +I EY   G L        D  +C+  S   +   +        
Sbjct: 104 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 163
Query: 745 -----NVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSS 799
                 V KG+A   F    NC    +HRD++++N+LL  G    + DFG+A+ +  D S
Sbjct: 164 LSFSYQVAKGMA---FLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIKND-S 215
Query: 800 NWSELAGTH---GYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEXXXXXXX 856
           N+           ++APE  +    T + DV+S+G+             FL+E       
Sbjct: 216 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI-------------FLWELFSLGSS 262
Query: 857 XXIEMLDSRLPYPSLHVQKKLMSIMQVAF-----------------SCLDQNPESRPTMK 899
                     PYP + V  K   +++  F                 +C D +P  RPT K
Sbjct: 263 ----------PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFK 312
Query: 900 RVSQLLCEKIFE 911
           ++ QL+ ++I E
Sbjct: 313 QIVQLIEKQISE 324

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 65/197 (32%), Positives = 90/197 (45%), Gaps = 23/197 (11%)
Query: 646 IGKGGHGSV----YRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIV 701
           IGKG  G V    YR     G   AVK   +    +       FL E   +T++RH N+V
Sbjct: 20  IGKGEFGDVMLGDYR-----GNKVAVKCIKNDATAQ------AFLAEASVMTQLRHSNLV 68
Query: 702 KFYGFCSHPKHS-FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
           +  G     K   +I+ EY+  GSL   L +   +  LG    L     V +A+ YL  N
Sbjct: 69  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGN 127
Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLK 820
            F   VHRD++++NVL+     A VSDFG+ K     SS          + APE      
Sbjct: 128 NF---VHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWTAPEALREAA 181
Query: 821 VTEKCDVYSFGVLALEV 837
            + K DV+SFG+L  E+
Sbjct: 182 FSTKSDVWSFGILLWEI 198

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 76/312 (24%), Positives = 124/312 (39%), Gaps = 80/312 (25%)
Query: 646 IGKGGHGSVYRA------KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHR 698
           +G G  G V  A      K  +    AVK      P     ++E  ++E++ L+ +  H 
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK---PSAHLTEREALMSELKVLSYLGNHM 105
Query: 699 NIVKFYGFCSHPKHSFIIYEYLESGSL--------DKILCNDASAKELGWTQ-------- 742
           NIV   G C+    + +I EY   G L        D  +C+  S   +   +        
Sbjct: 106 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 165
Query: 743 ---RLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSS 799
                 V KG+A   F    NC    +HRD++++N+LL  G    + DFG+A+ +  D S
Sbjct: 166 LSFSYQVAKGMA---FLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIKND-S 217
Query: 800 NWSELAGTH---GYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEXXXXXXX 856
           N+           ++APE  +    T + DV+S+G+             FL+E       
Sbjct: 218 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI-------------FLWELFSLGSS 264
Query: 857 XXIEMLDSRLPYPSLHVQKKLMSIMQVAF-----------------SCLDQNPESRPTMK 899
                     PYP + V  K   +++  F                 +C D +P  RPT K
Sbjct: 265 ----------PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFK 314
Query: 900 RVSQLLCEKIFE 911
           ++ QL+ ++I E
Sbjct: 315 QIVQLIEKQISE 326

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 104/223 (46%), Gaps = 39/223 (17%)
Query: 646 IGKGGHGSVYRAKVPS------GEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRN 699
           IG+G  G V++A+ P         + AVK        +M   Q +F  E   + E  + N
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM---QADFQREAALMAEFDNPN 111
Query: 700 IVKFYGFCSHPKHSFIIYEYLESGSLDKIL--------C----NDASAKE---------L 738
           IVK  G C+  K   +++EY+  G L++ L        C    +D S +          L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 739 GWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS 798
              ++L + + VA  + YL    F   VHRD++++N L+       ++DFG+++  N  S
Sbjct: 172 SCAEQLCIARQVAAGMAYLSERKF---VHRDLATRNCLVGENMVVKIADFGLSR--NIYS 226
Query: 799 SNWSELAGTHG----YVAPELAYTLKVTEKCDVYSFGVLALEV 837
           +++ +  G       ++ PE  +  + T + DV+++GV+  E+
Sbjct: 227 ADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 269

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 66/264 (25%), Positives = 122/264 (46%), Gaps = 24/264 (9%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           +G G  G V+          AVK       G MS   + FL E   + +++H+ +V+ Y 
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQ---GSMS--PDAFLAEANLMKQLQHQRLVRLYA 71
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
             +  +  +II EY+E+GSL   L    S  +L   + L++   +A+ + ++    +   
Sbjct: 72  VVTQ-EPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERNY--- 126
Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH-GYVAPELAYTLKVTEK 824
           +HR++ + N+L+       ++DFG+A+ +  +     E A     + APE       T K
Sbjct: 127 IHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 186
Query: 825 CDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDS--RLPYPSLHVQKKLMSIM 881
            DV+SFG+L  E++  G+ P   +           I+ L+   R+  P  +  ++L  +M
Sbjct: 187 SDVWSFGILLTEIVTHGRIPYPGM------TNPEVIQNLERGYRMVRPD-NCPEELYQLM 239
Query: 882 QVAFSCLDQNPESRPTMKRVSQLL 905
           ++   C  + PE RPT   +  +L
Sbjct: 240 RL---CWKERPEDRPTFDYLRSVL 260

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/269 (26%), Positives = 108/269 (40%), Gaps = 20/269 (7%)
Query: 646 IGKGGHGSVYRAK--VPSGEIFAVK-KFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVK 702
           +G G  G V R +   PSG+  +V  K   P         ++F+ E+ A+  + HRN+++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 703 FYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
            YG    P    ++ E    GSL   L        LG   R  V   VA+ + YL +  F
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESKRF 136
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNW---SELAGTHGYVAPELAYTL 819
              +HRD++++N+LL       + DFG+ + L  +  ++           + APE   T 
Sbjct: 137 ---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 193
Query: 820 KVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLHVQKKLM 878
             +   D + FGV   E+   G+ P               I+    RLP P    Q    
Sbjct: 194 TFSHASDTWMFGVTLWEMFTYGQEP---WIGLNGSQILHKIDKEGERLPRPEDCPQ---- 246
Query: 879 SIMQVAFSCLDQNPESRPTMKRVSQLLCE 907
            I  V   C    PE RPT   +   L E
Sbjct: 247 DIYNVMVQCWAHKPEDRPTFVALRDFLLE 275

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 122/281 (43%), Gaps = 31/281 (11%)
Query: 646 IGKGGHGSVYRAKVP-----SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNI 700
           +GKG  GSV   +       +GE+ AVKK        +     +F  EI+ L  ++H NI
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR----DFEREIEILKSLQHDNI 74
Query: 701 VKFYGFC--SHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLH 758
           VK+ G C  +  ++  +I EYL  GSL   L      + +   + L     +   + YL 
Sbjct: 75  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLG 132
Query: 759 NNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG---YVAPEL 815
              +   +HR+++++N+L++      + DFG+ K L  D   +           + APE 
Sbjct: 133 TKRY---IHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPES 189
Query: 816 AYTLKVTEKCDVYSFGVLALEVI----KGKH-PRDFLF-----EXXXXXXXXXIEML--D 863
               K +   DV+SFGV+  E+     K K  P +F+      +         IE+L  +
Sbjct: 190 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 249
Query: 864 SRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQL 904
            RLP P     +  M + +   + ++Q P  R    RV Q+
Sbjct: 250 GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 290

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 76/312 (24%), Positives = 124/312 (39%), Gaps = 80/312 (25%)
Query: 646 IGKGGHGSVYRA------KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHR 698
           +G G  G V  A      K  +    AVK      P     ++E  ++E++ L+ +  H 
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK---PSAHLTEREALMSELKVLSYLGNHM 110
Query: 699 NIVKFYGFCSHPKHSFIIYEYLESGSL--------DKILCNDASAKELGWTQ-------- 742
           NIV   G C+    + +I EY   G L        D  +C+  S   +   +        
Sbjct: 111 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 170
Query: 743 ---RLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSS 799
                 V KG+A   F    NC    +HRD++++N+LL  G    + DFG+A+ +  D S
Sbjct: 171 LSFSYQVAKGMA---FLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIKND-S 222
Query: 800 NWSELAGTH---GYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEXXXXXXX 856
           N+           ++APE  +    T + DV+S+G+             FL+E       
Sbjct: 223 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI-------------FLWELFSLGSS 269
Query: 857 XXIEMLDSRLPYPSLHVQKKLMSIMQVAF-----------------SCLDQNPESRPTMK 899
                     PYP + V  K   +++  F                 +C D +P  RPT K
Sbjct: 270 ----------PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFK 319
Query: 900 RVSQLLCEKIFE 911
           ++ QL+ ++I E
Sbjct: 320 QIVQLIEKQISE 331

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 15/209 (7%)
Query: 638 NDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
           +DF     +G G  G V + +  PSG I A K  H  +   +  Q    + E+Q L E  
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQ---IIRELQVLHECN 72
Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE--LGWTQRLNVIKGVADAL 754
              IV FYG         I  E+++ GSLD++L       E  LG    + V++G+A   
Sbjct: 73  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVS-IAVLRGLA--- 128
Query: 755 FYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPE 814
            YL       I+HRD+   N+L++   E  + DFG++  L    +N     GT  Y+APE
Sbjct: 129 -YLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMAPE 183
Query: 815 LAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
                  + + D++S G+  +E+  G++P
Sbjct: 184 RLQGTHYSVQSDIWSMGLSLVELAVGRYP 212

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 122/281 (43%), Gaps = 31/281 (11%)
Query: 646 IGKGGHGSVYRAKVP-----SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNI 700
           +GKG  GSV   +       +GE+ AVKK        +     +F  EI+ L  ++H NI
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR----DFEREIEILKSLQHDNI 76
Query: 701 VKFYGFC--SHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLH 758
           VK+ G C  +  ++  +I E+L  GSL + L      + +   + L     +   + YL 
Sbjct: 77  VKYKGVCYSAGRRNLKLIMEFLPYGSLREYL--QKHKERIDHIKLLQYTSQICKGMEYLG 134
Query: 759 NNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG---YVAPEL 815
              +   +HRD++++N+L++      + DFG+ K L  D               + APE 
Sbjct: 135 TKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 191
Query: 816 AYTLKVTEKCDVYSFGVLALEVI----KGKH-PRDFLF-----EXXXXXXXXXIEML--D 863
               K +   DV+SFGV+  E+     K K  P +F+      +         IE+L  +
Sbjct: 192 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 251
Query: 864 SRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQL 904
            RLP P     +  M + +   + ++Q P  R    RV Q+
Sbjct: 252 GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 292

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 100/201 (49%), Gaps = 18/201 (8%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVK---KFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIV 701
           +G G  G+V++   +P GE   +    K      G  SFQ     + + A+  + H +IV
Sbjct: 39  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQA--VTDHMLAIGSLDHAHIV 96
Query: 702 KFYGFCSHPKHSF-IIYEYLESGSL-DKILCNDASAKELGWTQRLNVIKGVADALFYLHN 759
           +  G C  P  S  ++ +YL  GSL D +  +  +   LG    LN    +A  ++YL  
Sbjct: 97  RLLGLC--PGSSLQLVTQYLPLGSLLDHVRQHRGA---LGPQLLLNWGVQIAKGMYYLEE 151
Query: 760 NCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN--WSELAGTHGYVAPELAY 817
           +    +VHR+++++NVLL    +  V+DFG+A  L PD     +SE      ++A E  +
Sbjct: 152 HG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH 208
Query: 818 TLKVTEKCDVYSFGVLALEVI 838
             K T + DV+S+GV   E++
Sbjct: 209 FGKYTHQSDVWSYGVTVWELM 229

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 100/201 (49%), Gaps = 18/201 (8%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVK---KFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIV 701
           +G G  G+V++   +P GE   +    K      G  SFQ     + + A+  + H +IV
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQA--VTDHMLAIGSLDHAHIV 78
Query: 702 KFYGFCSHPKHSF-IIYEYLESGSL-DKILCNDASAKELGWTQRLNVIKGVADALFYLHN 759
           +  G C  P  S  ++ +YL  GSL D +  +  +   LG    LN    +A  ++YL  
Sbjct: 79  RLLGLC--PGSSLQLVTQYLPLGSLLDHVRQHRGA---LGPQLLLNWGVQIAKGMYYLEE 133
Query: 760 NCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN--WSELAGTHGYVAPELAY 817
           +    +VHR+++++NVLL    +  V+DFG+A  L PD     +SE      ++A E  +
Sbjct: 134 HG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH 190
Query: 818 TLKVTEKCDVYSFGVLALEVI 838
             K T + DV+S+GV   E++
Sbjct: 191 FGKYTHQSDVWSYGVTVWELM 211

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 118/267 (44%), Gaps = 22/267 (8%)
Query: 646 IGKGGHGSVYR-AKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +GKGG    +  +   + E+FA K     L  +   Q+E+   EI     + H+++V F+
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK-PHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 705 GFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP 764
           GF       F++ E     SL ++       K L   +    ++ +     YLH N    
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLEL---HKRRKALTEPEARYYLRQIVLGCQYLHRN---R 137
Query: 765 IVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEK 824
           ++HRD+   N+ L+   E  + DFG+A  +  D      L GT  Y+APE+      + +
Sbjct: 138 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFE 197
Query: 825 CDVYSFGVLALEVIKGKHPRDFLFEXX-XXXXXXXIEMLDSRLPYPSLHVQKKLMSIMQV 883
            DV+S G +   ++ GK P    FE          I+  +  +P    H+     S++Q 
Sbjct: 198 VDVWSIGCIMYTLLVGKPP----FETSCLKETYLRIKKNEYSIPK---HINPVAASLIQ- 249
Query: 884 AFSCLDQNPESRPTMKRVSQLLCEKIF 910
               L  +P +RPT   +++LL ++ F
Sbjct: 250 --KMLQTDPTARPT---INELLNDEFF 271

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 118/267 (44%), Gaps = 22/267 (8%)
Query: 646 IGKGGHGSVYR-AKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +GKGG    +  +   + E+FA K     L  +   Q+E+   EI     + H+++V F+
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK-PHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 705 GFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP 764
           GF       F++ E     SL ++       K L   +    ++ +     YLH N    
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLEL---HKRRKALTEPEARYYLRQIVLGCQYLHRN---R 137
Query: 765 IVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEK 824
           ++HRD+   N+ L+   E  + DFG+A  +  D      L GT  Y+APE+      + +
Sbjct: 138 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFE 197
Query: 825 CDVYSFGVLALEVIKGKHPRDFLFEXX-XXXXXXXIEMLDSRLPYPSLHVQKKLMSIMQV 883
            DV+S G +   ++ GK P    FE          I+  +  +P    H+     S++Q 
Sbjct: 198 VDVWSIGCIMYTLLVGKPP----FETSCLKETYLRIKKNEYSIPK---HINPVAASLIQ- 249
Query: 884 AFSCLDQNPESRPTMKRVSQLLCEKIF 910
               L  +P +RPT   +++LL ++ F
Sbjct: 250 --KMLQTDPTARPT---INELLNDEFF 271

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 131/300 (43%), Gaps = 44/300 (14%)
Query: 638 NDFNAEHCIGKGGHGSVYRA------KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQA 691
           N+      +G G  G V  A      K  +    AVK   S    +   ++E  ++E++ 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD---EKEALMSELKI 102
Query: 692 LTEI-RHRNIVKFYGFCSHPKHSFIIYEYLESGSL-------DKILCND---ASAKELGW 740
           ++ + +H NIV   G C+H     +I EY   G L        ++L  D   A A     
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162
Query: 741 TQRL-----NVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN 795
           T+ L      V +G+A   F    NC    +HRD++++NVLL  G+ A + DFG+A+ + 
Sbjct: 163 TRDLLHFSSQVAQGMA---FLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIM 215
Query: 796 PDSSNWSELAGTH---GYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXX 851
            D SN+           ++APE  +    T + DV+S+G+L  E+   G +P   +    
Sbjct: 216 ND-SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL--- 271
Query: 852 XXXXXXXIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
                  +     ++  P+    K + SIMQ   +C    P  RPT +++   L E+  E
Sbjct: 272 VNSKFYKLVKDGYQMAQPAF-APKNIYSIMQ---ACWALEPTHRPTFQQICSFLQEQAQE 327

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 103/209 (49%), Gaps = 28/209 (13%)
Query: 647 GKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGF 706
            +G  G V++A++ + E  AVK F  P+  + S+Q E    E+ +L  ++H NI++F G 
Sbjct: 33  ARGRFGCVWKAQLLN-EYVAVKIF--PIQDKQSWQNE---YEVYSLPGMKHENILQFIGA 86
Query: 707 ----CSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNC- 761
                S     ++I  + E GSL   L     A  + W +  ++ + +A  L YLH +  
Sbjct: 87  EKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIAETMARGLAYLHEDIP 142
Query: 762 ------FPPIVHRDISSKNVLLDLGYEAHVSDFGIA-KFLNPDSSNWSE-LAGTHGYVAP 813
                  P I HRDI SKNVLL     A ++DFG+A KF    S+  +    GT  Y+AP
Sbjct: 143 GLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAP 202
Query: 814 E-----LAYTLKVTEKCDVYSFGVLALEV 837
           E     + +      + D+Y+ G++  E+
Sbjct: 203 EVLEGAINFQRDAFLRIDMYAMGLVLWEL 231

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 120/266 (45%), Gaps = 13/266 (4%)
Query: 639 DFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQ-QEEFLNEIQALTEIR 696
           +F  E  IG+G    VYRA  +  G   A+KK    +   M  + + + + EI  L ++ 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQ--IFDLMDAKARADCIKEIDLLKQLN 90
Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRL-NVIKGVADALF 755
           H N++K+Y          I+ E  ++G L +++ +    K L   + +      +  AL 
Sbjct: 91  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150
Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           ++H+     ++HRDI   NV +       + D G+ +F +  ++    L GT  Y++PE 
Sbjct: 151 HMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 207
Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLHVQK 875
            +      K D++S G L  E+   + P  +  +         IE  D   P PS H  +
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSPF-YGDKMNLYSLCKKIEQCDYP-PLPSDHYSE 265
Query: 876 KLMSIMQVAFSCLDQNPESRPTMKRV 901
           +L  ++ +   C++ +PE RP +  V
Sbjct: 266 ELRQLVNM---CINPDPEKRPDVTYV 288

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 68/270 (25%), Positives = 119/270 (44%), Gaps = 28/270 (10%)
Query: 646 IGKGGHGSVYR-AKVPSGEIFAVKKFHSPLPGEM---SFQQEEFLNEIQALTEIRHRNIV 701
           +GKGG    +  +   + E+FA K     +P  +     Q+E+   EI     + H+++V
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKI----VPKSLLLKPHQREKMSMEISIHRSLAHQHVV 84
Query: 702 KFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNC 761
            F+GF       F++ E     SL ++       K L   +    ++ +     YLH N 
Sbjct: 85  GFHGFFEDNDFVFVVLELCRRRSLLEL---HKRRKALTEPEARYYLRQIVLGCQYLHRN- 140
Query: 762 FPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKV 821
              ++HRD+   N+ L+   E  + DFG+A  +  D      L GT  Y+APE+      
Sbjct: 141 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGH 198
Query: 822 TEKCDVYSFGVLALEVIKGKHPRDFLFEXX-XXXXXXXIEMLDSRLPYPSLHVQKKLMSI 880
           + + DV+S G +   ++ GK P    FE          I+  +  +P    H+     S+
Sbjct: 199 SFEVDVWSIGCIMYTLLVGKPP----FETSCLKETYLRIKKNEYSIPK---HINPVAASL 251
Query: 881 MQVAFSCLDQNPESRPTMKRVSQLLCEKIF 910
           +Q     L  +P +RPT   +++LL ++ F
Sbjct: 252 IQ---KMLQTDPTARPT---INELLNDEFF 275

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Composition-based stats.
 Identities = 74/269 (27%), Positives = 108/269 (40%), Gaps = 20/269 (7%)
Query: 646 IGKGGHGSVYRAK--VPSGEIFAVK-KFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVK 702
           +G G  G V R +   PSG+  +V  K   P         ++F+ E+ A+  + HRN+++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 703 FYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
            YG    P    ++ E    GSL   L        LG   R  V   VA+ + YL +  F
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESKRF 142
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL--NPDSSNWSELAGT-HGYVAPELAYTL 819
              +HRD++++N+LL       + DFG+ + L  N D     E       + APE   T 
Sbjct: 143 ---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTR 199
Query: 820 KVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLHVQKKLM 878
             +   D + FGV   E+   G+ P               I+    RLP P    Q    
Sbjct: 200 TFSHASDTWMFGVTLWEMFTYGQEP---WIGLNGSQILHKIDKEGERLPRPEDCPQ---- 252
Query: 879 SIMQVAFSCLDQNPESRPTMKRVSQLLCE 907
            I  V   C    PE RPT   +   L E
Sbjct: 253 DIYNVMVQCWAHKPEDRPTFVALRDFLLE 281

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Composition-based stats.
 Identities = 74/269 (27%), Positives = 108/269 (40%), Gaps = 20/269 (7%)
Query: 646 IGKGGHGSVYRAK--VPSGEIFAVK-KFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVK 702
           +G G  G V R +   PSG+  +V  K   P         ++F+ E+ A+  + HRN+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 703 FYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
            YG    P    ++ E    GSL   L        LG   R  V   VA+ + YL +  F
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESKRF 132
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL--NPDSSNWSELAGT-HGYVAPELAYTL 819
              +HRD++++N+LL       + DFG+ + L  N D     E       + APE   T 
Sbjct: 133 ---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTR 189
Query: 820 KVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLHVQKKLM 878
             +   D + FGV   E+   G+ P               I+    RLP P    Q    
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQEP---WIGLNGSQILHKIDKEGERLPRPEDCPQ---- 242
Query: 879 SIMQVAFSCLDQNPESRPTMKRVSQLLCE 907
            I  V   C    PE RPT   +   L E
Sbjct: 243 DIYNVMVQCWAHKPEDRPTFVALRDFLLE 271

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Composition-based stats.
 Identities = 71/269 (26%), Positives = 108/269 (40%), Gaps = 20/269 (7%)
Query: 646 IGKGGHGSVYRAK--VPSGEIFAVK-KFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVK 702
           +G G  G V R +   PSG+  +V  K   P         ++F+ E+ A+  + HRN+++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 703 FYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
            YG    P    ++ E    GSL   L        LG   R  V   VA+ + YL +  F
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESKRF 136
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNW---SELAGTHGYVAPELAYTL 819
              +HRD++++N+LL       + DFG+ + L  +  ++           + APE   T 
Sbjct: 137 ---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 193
Query: 820 KVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLHVQKKLM 878
             +   D + FGV   E+   G+ P               I+    RLP P    Q    
Sbjct: 194 TFSHASDTWMFGVTLWEMFTYGQEP---WIGLNGSQILHKIDKEGERLPRPEDCPQ---- 246
Query: 879 SIMQVAFSCLDQNPESRPTMKRVSQLLCE 907
            I  V   C    PE RPT   +   L E
Sbjct: 247 DIYNVMVQCWAHKPEDRPTFVALRDFLLE 275

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Composition-based stats.
 Identities = 71/269 (26%), Positives = 108/269 (40%), Gaps = 20/269 (7%)
Query: 646 IGKGGHGSVYRAK--VPSGEIFAVK-KFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVK 702
           +G G  G V R +   PSG+  +V  K   P         ++F+ E+ A+  + HRN+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 703 FYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
            YG    P    ++ E    GSL   L        LG   R  V   VA+ + YL +  F
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESKRF 132
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNW---SELAGTHGYVAPELAYTL 819
              +HRD++++N+LL       + DFG+ + L  +  ++           + APE   T 
Sbjct: 133 ---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 820 KVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLHVQKKLM 878
             +   D + FGV   E+   G+ P               I+    RLP P    Q    
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQEP---WIGLNGSQILHKIDKEGERLPRPEDCPQ---- 242
Query: 879 SIMQVAFSCLDQNPESRPTMKRVSQLLCE 907
            I  V   C    PE RPT   +   L E
Sbjct: 243 DIYNVMVQCWAHKPEDRPTFVALRDFLLE 271

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Composition-based stats.
 Identities = 71/269 (26%), Positives = 108/269 (40%), Gaps = 20/269 (7%)
Query: 646 IGKGGHGSVYRAK--VPSGEIFAVK-KFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVK 702
           +G G  G V R +   PSG+  +V  K   P         ++F+ E+ A+  + HRN+++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 703 FYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
            YG    P    ++ E    GSL   L        LG   R  V   VA+ + YL +  F
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESKRF 142
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNW---SELAGTHGYVAPELAYTL 819
              +HRD++++N+LL       + DFG+ + L  +  ++           + APE   T 
Sbjct: 143 ---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 199
Query: 820 KVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLHVQKKLM 878
             +   D + FGV   E+   G+ P               I+    RLP P    Q    
Sbjct: 200 TFSHASDTWMFGVTLWEMFTYGQEP---WIGLNGSQILHKIDKEGERLPRPEDCPQ---- 252
Query: 879 SIMQVAFSCLDQNPESRPTMKRVSQLLCE 907
            I  V   C    PE RPT   +   L E
Sbjct: 253 DIYNVMVQCWAHKPEDRPTFVALRDFLLE 281

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Composition-based stats.
 Identities = 71/269 (26%), Positives = 108/269 (40%), Gaps = 20/269 (7%)
Query: 646 IGKGGHGSVYRAK--VPSGEIFAVK-KFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVK 702
           +G G  G V R +   PSG+  +V  K   P         ++F+ E+ A+  + HRN+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 703 FYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
            YG    P    ++ E    GSL   L        LG   R  V   VA+ + YL +  F
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESKRF 132
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNW---SELAGTHGYVAPELAYTL 819
              +HRD++++N+LL       + DFG+ + L  +  ++           + APE   T 
Sbjct: 133 ---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 820 KVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLHVQKKLM 878
             +   D + FGV   E+   G+ P               I+    RLP P    Q    
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQEP---WIGLNGSQILHKIDKEGERLPRPEDCPQ---- 242
Query: 879 SIMQVAFSCLDQNPESRPTMKRVSQLLCE 907
            I  V   C    PE RPT   +   L E
Sbjct: 243 DIYNVMVQCWAHKPEDRPTFVALRDFLLE 271

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Composition-based stats.
 Identities = 65/284 (22%), Positives = 121/284 (42%), Gaps = 43/284 (15%)
Query: 639 DFNAEHCIGKGGHGSVYRAKVPSGEI-FAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH 697
           DF    C+G+GG G V+ AK    +  +A+K+   P        +E+ + E++AL ++ H
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLP---NRELAREKVMREVKALAKLEH 62
Query: 698 RNIVKFYGFC-----------SHPK-HSFIIYEYLESGSLDKILCNDASAKELGWTQRLN 745
             IV+++              S PK + +I  +     +L   +    + +E   +  L+
Sbjct: 63  PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122
Query: 746 VIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELA 805
           +   +A+A+ +LH+     ++HRD+   N+   +     V DFG+   ++ D    + L 
Sbjct: 123 IFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 806 ------------GTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEXXXX 853
                       GT  Y++PE  +    + K D++S G++  E++   +P     E    
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YPFSTQMERVRT 236
Query: 854 XXXXXIEMLDSR-LPYPSLHVQKKLMSIMQVAFSCLDQNPESRP 896
                  + D R L +P L  QK     + V    L  +P  RP
Sbjct: 237 -------LTDVRNLKFPPLFTQKYPCEYVMVQ-DMLSPSPMERP 272

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 118/267 (44%), Gaps = 22/267 (8%)
Query: 646 IGKGGHGSVYR-AKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +GKGG    +  +   + E+FA K     L  +   Q+E+   EI     + H+++V F+
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK-PHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 705 GFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP 764
           GF       F++ E     SL ++       K L   +    ++ +     YLH N    
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLEL---HKRRKALTEPEARYYLRQIVLGCQYLHRN---R 135
Query: 765 IVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEK 824
           ++HRD+   N+ L+   E  + DFG+A  +  D      L GT  Y+APE+      + +
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFE 195
Query: 825 CDVYSFGVLALEVIKGKHPRDFLFEXX-XXXXXXXIEMLDSRLPYPSLHVQKKLMSIMQV 883
            DV+S G +   ++ GK P    FE          I+  +  +P    H+     S++Q 
Sbjct: 196 VDVWSIGCIMYTLLVGKPP----FETSCLKETYLRIKKNEYSIPK---HINPVAASLIQ- 247
Query: 884 AFSCLDQNPESRPTMKRVSQLLCEKIF 910
               L  +P +RPT   +++LL ++ F
Sbjct: 248 --KMLQTDPTARPT---INELLNDEFF 269

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 65/264 (24%), Positives = 114/264 (43%), Gaps = 23/264 (8%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVK---KFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIV 701
           +G G  G+VY+   VP GE   +    K  +   G  +    EF++E   +  + H ++V
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKA--NVEFMDEALIMASMDHPHLV 80
Query: 702 KFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNC 761
           +  G C  P    +  + +  G L + +        +G    LN    +A  + YL    
Sbjct: 81  RLLGVCLSPTIQLVT-QLMPHGCLLEYV--HEHKDNIGSQLLLNWCVQIAKGMMYLEER- 136
Query: 762 FPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH--GYVAPELAYTL 819
              +VHRD++++NVL+       ++DFG+A+ L  D   ++   G     ++A E  +  
Sbjct: 137 --RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR 194
Query: 820 KVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLHVQKKLM 878
           K T + DV+S+GV   E++  G  P D +            E    RLP P +      +
Sbjct: 195 KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGE----RLPQPPICT----I 246
Query: 879 SIMQVAFSCLDQNPESRPTMKRVS 902
            +  V   C   + +SRP  K ++
Sbjct: 247 DVYMVMVKCWMIDADSRPKFKELA 270

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 71/224 (31%), Positives = 105/224 (46%), Gaps = 32/224 (14%)
Query: 639 DFNAEHC-----IGKGGHGSVYR-AKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQAL 692
           DF AE       IG+G +GSV +    PSG+I AVK+  S +  +   +Q++ L ++  +
Sbjct: 18  DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK---EQKQLLMDLDVV 74
Query: 693 TEIRHRN---IVKFYGFCSHPKHSFIIYEYLESGSLDKI------LCNDASAKELGWTQR 743
             +R  +   IV+FYG        +I  E L S S DK       + +D   +E+     
Sbjct: 75  --MRSSDCPYIVQFYGALFREGDCWICME-LMSTSFDKFYKYVYSVLDDVIPEEILGKIT 131
Query: 744 LNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSE 803
           L  +K    AL +L  N    I+HRDI   N+LLD      + DFGI+  L  DS   + 
Sbjct: 132 LATVK----ALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV-DSIAKTR 184
Query: 804 LAGTHGYVAPEL----AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
            AG   Y+APE     A       + DV+S G+   E+  G+ P
Sbjct: 185 DAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/270 (25%), Positives = 119/270 (44%), Gaps = 28/270 (10%)
Query: 646 IGKGGHGSVYR-AKVPSGEIFAVKKFHSPLPGEM---SFQQEEFLNEIQALTEIRHRNIV 701
           +GKGG    +  +   + E+FA K     +P  +     Q+E+   EI     + H+++V
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKI----VPKSLLLKPHQREKMSMEISIHRSLAHQHVV 102
Query: 702 KFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNC 761
            F+GF       F++ E     SL ++       K L   +    ++ +     YLH N 
Sbjct: 103 GFHGFFEDNDFVFVVLELCRRRSLLEL---HKRRKALTEPEARYYLRQIVLGCQYLHRN- 158
Query: 762 FPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKV 821
              ++HRD+   N+ L+   E  + DFG+A  +  D      L GT  Y+APE+      
Sbjct: 159 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 216
Query: 822 TEKCDVYSFGVLALEVIKGKHPRDFLFEXX-XXXXXXXIEMLDSRLPYPSLHVQKKLMSI 880
           + + DV+S G +   ++ GK P    FE          I+  +  +P    H+     S+
Sbjct: 217 SFEVDVWSIGCIMYTLLVGKPP----FETSCLKETYLRIKKNEYSIPK---HINPVAASL 269
Query: 881 MQVAFSCLDQNPESRPTMKRVSQLLCEKIF 910
           +Q     L  +P +RPT   +++LL ++ F
Sbjct: 270 IQ---KMLQTDPTARPT---INELLNDEFF 293

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/264 (24%), Positives = 114/264 (43%), Gaps = 23/264 (8%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVK---KFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIV 701
           +G G  G+VY+   VP GE   +    K  +   G  +    EF++E   +  + H ++V
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKA--NVEFMDEALIMASMDHPHLV 103
Query: 702 KFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNC 761
           +  G C  P    +  + +  G L + +        +G    LN    +A  + YL    
Sbjct: 104 RLLGVCLSPTIQLVT-QLMPHGCLLEYV--HEHKDNIGSQLLLNWCVQIAKGMMYLEER- 159
Query: 762 FPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH--GYVAPELAYTL 819
              +VHRD++++NVL+       ++DFG+A+ L  D   ++   G     ++A E  +  
Sbjct: 160 --RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR 217
Query: 820 KVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLHVQKKLM 878
           K T + DV+S+GV   E++  G  P D +            E    RLP P +      +
Sbjct: 218 KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGE----RLPQPPICT----I 269
Query: 879 SIMQVAFSCLDQNPESRPTMKRVS 902
            +  V   C   + +SRP  K ++
Sbjct: 270 DVYMVMVKCWMIDADSRPKFKELA 293

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/270 (25%), Positives = 119/270 (44%), Gaps = 28/270 (10%)
Query: 646 IGKGGHGSVYR-AKVPSGEIFAVKKFHSPLPGEM---SFQQEEFLNEIQALTEIRHRNIV 701
           +GKGG    +  +   + E+FA K     +P  +     Q+E+   EI     + H+++V
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKI----VPKSLLLKPHQREKMSMEISIHRSLAHQHVV 104
Query: 702 KFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNC 761
            F+GF       F++ E     SL ++       K L   +    ++ +     YLH N 
Sbjct: 105 GFHGFFEDNDFVFVVLELCRRRSLLEL---HKRRKALTEPEARYYLRQIVLGCQYLHRN- 160
Query: 762 FPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKV 821
              ++HRD+   N+ L+   E  + DFG+A  +  D      L GT  Y+APE+      
Sbjct: 161 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 218
Query: 822 TEKCDVYSFGVLALEVIKGKHPRDFLFEXX-XXXXXXXIEMLDSRLPYPSLHVQKKLMSI 880
           + + DV+S G +   ++ GK P    FE          I+  +  +P    H+     S+
Sbjct: 219 SFEVDVWSIGCIMYTLLVGKPP----FETSCLKETYLRIKKNEYSIPK---HINPVAASL 271
Query: 881 MQVAFSCLDQNPESRPTMKRVSQLLCEKIF 910
           +Q     L  +P +RPT   +++LL ++ F
Sbjct: 272 IQ---KMLQTDPTARPT---INELLNDEFF 295

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/260 (26%), Positives = 114/260 (43%), Gaps = 44/260 (16%)
Query: 681 QQEEFLNEIQALTEI-RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASA---- 735
           ++E  ++E++ ++ + +H NIV   G C+H     +I EY   G L   L   A A    
Sbjct: 77  EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGP 136
Query: 736 ------------KELGWTQRL--------NVIKGVADALFYLHNNCFPPIVHRDISSKNV 775
                       KE G    L         V +G+A   F    NC    +HRD++++NV
Sbjct: 137 SLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMA---FLASKNC----IHRDVAARNV 189
Query: 776 LLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPELAYTLKVTEKCDVYSFGV 832
           LL  G+ A + DFG+A+ +  D SN+           ++APE  +    T + DV+S+G+
Sbjct: 190 LLTNGHVAKIGDFGLARDIMND-SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGI 248
Query: 833 LALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQN 891
           L  E+   G +P   +           +     ++  P+    K + SIMQ   +C    
Sbjct: 249 LLWEIFSLGLNPYPGIL---VNSKFYKLVKDGYQMAQPAF-APKNIYSIMQ---ACWALE 301
Query: 892 PESRPTMKRVSQLLCEKIFE 911
           P  RPT +++   L E+  E
Sbjct: 302 PTHRPTFQQICSFLQEQAQE 321

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 71/295 (24%), Positives = 126/295 (42%), Gaps = 58/295 (19%)
Query: 637 TNDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI 695
            +DF     +G+G  G V +A+       +A+KK           +    L+E+  L  +
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-----HTEEKLSTILSEVMLLASL 59
Query: 696 RHRNIVKFYG-----------FCSHPKHS--FIIYEYLESGSLDKILCNDASAKELGWTQ 742
            H+ +V++Y              +  K S  FI  EY E+G+L  ++ ++   ++     
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW 119
Query: 743 RLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN------- 795
           RL   + + +AL Y+H+     I+HRD+   N+ +D      + DFG+AK ++       
Sbjct: 120 RL--FRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 796 ------PDSS-NWSELAGTHGYVAPE-LAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFL 847
                 P SS N +   GT  YVA E L  T    EK D+YS G++  E+I       + 
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI-------YP 227
Query: 848 FEXXXXXXXXXIEMLDSRLPYP------SLHVQKKLMSIMQVAFSCLDQNPESRP 896
           F           ++    + +P       + V+KK++ ++      +D +P  RP
Sbjct: 228 FSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLL------IDHDPNKRP 276

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 131/300 (43%), Gaps = 44/300 (14%)
Query: 638 NDFNAEHCIGKGGHGSVYRA------KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQA 691
           N+      +G G  G V  A      K  +    AVK   S    +   ++E  ++E++ 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD---EKEALMSELKI 102
Query: 692 LTEI-RHRNIVKFYGFCSHPKHSFIIYEYLESGSL-------DKILCND---ASAKELGW 740
           ++ + +H NIV   G C+H     +I EY   G L        ++L  D   A A     
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLS 162
Query: 741 TQRL-----NVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN 795
           T+ L      V +G+A   F    NC    +HRD++++NVLL  G+ A + DFG+A+ + 
Sbjct: 163 TRDLLHFSSQVAQGMA---FLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIM 215
Query: 796 PDSSNWSELAGTH---GYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXX 851
            D SN+           ++APE  +    T + DV+S+G+L  E+   G +P   +    
Sbjct: 216 ND-SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL--- 271
Query: 852 XXXXXXXIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
                  +     ++  P+    K + SIMQ   +C    P  RPT +++   L E+  E
Sbjct: 272 VNSKFYKLVKDGYQMAQPAF-APKNIYSIMQ---ACWALEPTHRPTFQQICSFLQEQAQE 327

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 101/207 (48%), Gaps = 26/207 (12%)
Query: 646 IGKGGHGSVYRAKVP-SGEIFAVKKFH-SPLPGEMSFQQEEFLNEIQALTEIRHRNIVKF 703
           +G G    V+  K   +G++FA+K    SP     +F+     NEI  L +I+H NIV  
Sbjct: 17  LGSGAFSEVFLVKQRLTGKLFALKCIKKSP-----AFRDSSLENEIAVLKKIKHENIVTL 71
Query: 704 YGFCSHPKHSFIIYEYLESGSL-DKILCNDASAKELG-WTQRLN--VIKGVADALFYLHN 759
                   H +++ + +  G L D+IL       E G +T++    VI+ V  A+ YLH 
Sbjct: 72  EDIYESTTHYYLVMQLVSGGELFDRIL-------ERGVYTEKDASLVIQQVLSAVKYLHE 124
Query: 760 NCFPPIVHRDISSKNVLL---DLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELA 816
           N    IVHRD+  +N+L    +   +  ++DFG++K     +   S   GT GYVAPE+ 
Sbjct: 125 N---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM--EQNGIMSTACGTPGYVAPEVL 179
Query: 817 YTLKVTEKCDVYSFGVLALEVIKGKHP 843
                ++  D +S GV+   ++ G  P
Sbjct: 180 AQKPYSKAVDCWSIGVITYILLCGYPP 206

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 54/212 (25%), Positives = 104/212 (49%), Gaps = 15/212 (7%)
Query: 637 TNDFNAEHCIGKGGHGSVYR-AKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI 695
           +++++ +  +GKG    V R     +G  FA K  ++       FQ+ E   E +   ++
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE--REARICRKL 61
Query: 696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKEL-GWTQRLNVIKGVADAL 754
           +H NIV+ +         +++++ +  G L      D  A+E        + I+ + +++
Sbjct: 62  QHPNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQILESI 117
Query: 755 FYLHNNCFPPIVHRDISSKNVLLDL---GYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV 811
            Y H+N    IVHR++  +N+LL     G    ++DFG+A  +N DS  W   AGT GY+
Sbjct: 118 AYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYL 173
Query: 812 APELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           +PE+      ++  D+++ GV+   ++ G  P
Sbjct: 174 SPEVLKKDPYSKPVDIWACGVILYILLVGYPP 205

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 54/212 (25%), Positives = 104/212 (49%), Gaps = 15/212 (7%)
Query: 637 TNDFNAEHCIGKGGHGSVYR-AKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI 695
           +++++ +  +GKG    V R     +G  FA K  ++       FQ+ E   E +   ++
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE--REARICRKL 62
Query: 696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKEL-GWTQRLNVIKGVADAL 754
           +H NIV+ +         +++++ +  G L      D  A+E        + I+ + +++
Sbjct: 63  QHPNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQILESI 118
Query: 755 FYLHNNCFPPIVHRDISSKNVLLDL---GYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV 811
            Y H+N    IVHR++  +N+LL     G    ++DFG+A  +N DS  W   AGT GY+
Sbjct: 119 AYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYL 174
Query: 812 APELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           +PE+      ++  D+++ GV+   ++ G  P
Sbjct: 175 SPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 55/214 (25%), Positives = 102/214 (47%), Gaps = 14/214 (6%)
Query: 635 SATNDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALT 693
           S T+++     +GKG    V R  K+P+G+ +A K  ++        Q+ E   E +   
Sbjct: 1   SMTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLE--REARICR 58
Query: 694 EIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKEL-GWTQRLNVIKGVAD 752
            ++H NIV+ +   S     +++++ +  G L      D  A+E        + I+ + +
Sbjct: 59  LLKHPNIVRLHDSISEEGFHYLVFDLVTGGEL----FEDIVAREYYSEADASHCIQQILE 114
Query: 753 ALFYLHNNCFPPIVHRDISSKNVLL---DLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG 809
           ++ + H N    IVHRD+  +N+LL     G    ++DFG+A  +  D   W   AGT G
Sbjct: 115 SVNHCHLN---GIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPG 171
Query: 810 YVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           Y++PE+       +  D+++ GV+   ++ G  P
Sbjct: 172 YLSPEVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/164 (35%), Positives = 86/164 (52%), Gaps = 18/164 (10%)
Query: 687 NEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSL-DKILCNDASAKELG-WTQR- 743
           NEI  L +I+H NIV          H ++I + +  G L D+I+       E G +T+R 
Sbjct: 65  NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV-------EKGFYTERD 117
Query: 744 -LNVIKGVADALFYLHNNCFPPIVHRDISSKNVL---LDLGYEAHVSDFGIAKFLNPDSS 799
              +I  V DA+ YLH+     IVHRD+  +N+L   LD   +  +SDFG++K  +P  S
Sbjct: 118 ASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP-GS 173
Query: 800 NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
             S   GT GYVAPE+      ++  D +S GV+A  ++ G  P
Sbjct: 174 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/164 (35%), Positives = 86/164 (52%), Gaps = 18/164 (10%)
Query: 687 NEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSL-DKILCNDASAKELG-WTQR- 743
           NEI  L +I+H NIV          H ++I + +  G L D+I+       E G +T+R 
Sbjct: 65  NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV-------EKGFYTERD 117
Query: 744 -LNVIKGVADALFYLHNNCFPPIVHRDISSKNVL---LDLGYEAHVSDFGIAKFLNPDSS 799
              +I  V DA+ YLH+     IVHRD+  +N+L   LD   +  +SDFG++K  +P  S
Sbjct: 118 ASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP-GS 173
Query: 800 NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
             S   GT GYVAPE+      ++  D +S GV+A  ++ G  P
Sbjct: 174 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 104/215 (48%), Gaps = 26/215 (12%)
Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQ--EEFLNEIQALTEIRHRNIVK 702
           +G+G   +V+R +   +G++FA+K F++     +SF +  +  + E + L ++ H+NIVK
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNN-----ISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 703 FYGFCSH--PKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
            +        +H  +I E+   GSL  +L   ++A  L  ++ L V++ V   + +L  N
Sbjct: 72  LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN 131
Query: 761 CFPPIVHRDISSKNVLLDLGYEAH----VSDFGIAKFLNPDSSNWSELAGTHGYVAPEL- 815
               IVHR+I   N++  +G +      ++DFG A+ L  D   +  L GT  Y+ P++ 
Sbjct: 132 G---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLYGTEEYLHPDMY 187
Query: 816 -------AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
                   +  K     D++S GV       G  P
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 69/258 (26%), Positives = 110/258 (42%), Gaps = 20/258 (7%)
Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G GG   V+ A+ +      AVK   + L  + SF    F  E Q    + H  IV  Y
Sbjct: 37  LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLR-FRREAQNAAALNHPAIVAVY 95
Query: 705 --GFCSHPKHS--FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
             G    P     +I+ EY++  +L  I+  +         + + VI     AL + H N
Sbjct: 96  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP---KRAIEVIADACQALNFSHQN 152
Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELA---GTHGYVAPELAY 817
               I+HRD+   N+++       V DFGIA+ +    ++ ++ A   GT  Y++PE A 
Sbjct: 153 ---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 209
Query: 818 TLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLHVQKKL 877
              V  + DVYS G +  EV+ G+ P    F            + +  +P PS   +   
Sbjct: 210 GDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQHVREDPIP-PSARHEGLS 264
Query: 878 MSIMQVAFSCLDQNPESR 895
             +  V    L +NPE+R
Sbjct: 265 ADLDAVVLKALAKNPENR 282

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 93/210 (44%), Gaps = 27/210 (12%)
Query: 646 IGKGGHGSVYRAKV------PSGEIFAVKKFHSPLPGEMSFQQE-EFLNEIQALTEIRHR 698
           +G G  G VY  +V      PS    AVK     LP   S Q E +FL E   ++++ H+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT----LPEVCSEQDELDFLMEALIISKLNHQ 94
Query: 699 NIVKFYGFCSHPKHSFIIYEYLESGSLDKIL----CNDASAKELGWTQRLNVIKGVADAL 754
           NIV+  G        FI+ E +  G L   L       +    L     L+V + +A   
Sbjct: 95  NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 154
Query: 755 FYLHNNCFPPIVHRDISSKNVLLDL---GYEAHVSDFGIAKFLNPDSSNWSELAGTH--- 808
            YL  N F   +HRDI+++N LL     G  A + DFG+A+ +    +++    G     
Sbjct: 155 QYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RASYYRKGGCAMLP 209
Query: 809 -GYVAPELAYTLKVTEKCDVYSFGVLALEV 837
             ++ PE       T K D +SFGVL  E+
Sbjct: 210 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 239

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/164 (35%), Positives = 86/164 (52%), Gaps = 18/164 (10%)
Query: 687 NEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSL-DKILCNDASAKELG-WTQR- 743
           NEI  L +I+H NIV          H ++I + +  G L D+I+       E G +T+R 
Sbjct: 65  NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV-------EKGFYTERD 117
Query: 744 -LNVIKGVADALFYLHNNCFPPIVHRDISSKNVL---LDLGYEAHVSDFGIAKFLNPDSS 799
              +I  V DA+ YLH+     IVHRD+  +N+L   LD   +  +SDFG++K  +P  S
Sbjct: 118 ASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP-GS 173
Query: 800 NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
             S   GT GYVAPE+      ++  D +S GV+A  ++ G  P
Sbjct: 174 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 51/202 (25%), Positives = 92/202 (45%), Gaps = 14/202 (6%)
Query: 646 IGKGGHGSVYR-AKVPSGEIFAVKKFHSPLPGEMSF---QQEEFLNEIQALTEIRHRNIV 701
           +GKGG    Y    + + E+FA K     +P  M     Q+E+   EI     + + ++V
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKV----VPKSMLLKPHQKEKMSTEIAIHKSLDNPHVV 89
Query: 702 KFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNC 761
            F+GF       +++ E     SL ++     +  E    +    ++     + YLHNN 
Sbjct: 90  GFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTE---PEARYFMRQTIQGVQYLHNN- 145
Query: 762 FPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKV 821
              ++HRD+   N+ L+   +  + DFG+A  +  D     +L GT  Y+APE+      
Sbjct: 146 --RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGH 203
Query: 822 TEKCDVYSFGVLALEVIKGKHP 843
           + + D++S G +   ++ GK P
Sbjct: 204 SFEVDIWSLGCILYTLLVGKPP 225

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 104/215 (48%), Gaps = 26/215 (12%)
Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQ--EEFLNEIQALTEIRHRNIVK 702
           +G+G   +V+R +   +G++FA+K F++     +SF +  +  + E + L ++ H+NIVK
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNN-----ISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 703 FYGFCSH--PKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
            +        +H  +I E+   GSL  +L   ++A  L  ++ L V++ V   + +L  N
Sbjct: 72  LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN 131
Query: 761 CFPPIVHRDISSKNVLLDLGYEAH----VSDFGIAKFLNPDSSNWSELAGTHGYVAPEL- 815
               IVHR+I   N++  +G +      ++DFG A+ L  D   +  L GT  Y+ P++ 
Sbjct: 132 G---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVXLYGTEEYLHPDMY 187
Query: 816 -------AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
                   +  K     D++S GV       G  P
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 93/210 (44%), Gaps = 27/210 (12%)
Query: 646 IGKGGHGSVYRAKV------PSGEIFAVKKFHSPLPGEMSFQQE-EFLNEIQALTEIRHR 698
           +G G  G VY  +V      PS    AVK     LP   S Q E +FL E   ++++ H+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT----LPEVCSEQDELDFLMEALIISKLNHQ 108
Query: 699 NIVKFYGFCSHPKHSFIIYEYLESGSLDKIL----CNDASAKELGWTQRLNVIKGVADAL 754
           NIV+  G        FI+ E +  G L   L       +    L     L+V + +A   
Sbjct: 109 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 168
Query: 755 FYLHNNCFPPIVHRDISSKNVLLDL---GYEAHVSDFGIAKFLNPDSSNWSELAGTH--- 808
            YL  N F   +HRDI+++N LL     G  A + DFG+A+ +    +++    G     
Sbjct: 169 QYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RASYYRKGGCAMLP 223
Query: 809 -GYVAPELAYTLKVTEKCDVYSFGVLALEV 837
             ++ PE       T K D +SFGVL  E+
Sbjct: 224 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 253

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 121/272 (44%), Gaps = 34/272 (12%)
Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQ-ALTEIRHRNIVKF 703
           +G+G +G V + + VPSG+I AVK+  + +    S +Q+  L ++  ++  +     V F
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATV---NSQEQKRLLMDLDISMRTVDCPFTVTF 115
Query: 704 YGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVA----DALFYLHN 759
           YG        +I  E +++ SLDK         + G T   +++  +A     AL +LH+
Sbjct: 116 YGALFREGDVWICMELMDT-SLDKFY---KQVIDKGQTIPEDILGKIAVSIVKALEHLHS 171
Query: 760 NCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL---- 815
                ++HRD+   NVL++   +  + DFGI+ +L  DS   +  AG   Y+APE     
Sbjct: 172 KL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV-DSVAKTIDAGCKPYMAPERINPE 228
Query: 816 ----AYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSL 871
                Y++    K D++S G+  +E+   + P D              E      P P L
Sbjct: 229 LNQKGYSV----KSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEE------PSPQL 278
Query: 872 HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ 903
              K     +     CL +N + RPT   + Q
Sbjct: 279 PADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 310

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 124/300 (41%), Gaps = 56/300 (18%)
Query: 645 CIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           C+GKG +G V+R  +  GE  AVK F S    E S+ +E    EI     +RH NI+ F 
Sbjct: 15  CVGKGRYGEVWRG-LWHGESVAVKIFSSR--DEQSWFRE---TEIYNTVLLRHDNILGFI 68
Query: 705 GFCSHPKHS----FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
                 ++S    ++I  Y E GSL   L        L     L +    A  L +LH  
Sbjct: 69  ASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLA----LRLAVSAACGLAHLHVE 124
Query: 761 CF-----PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELA-----GTHGY 810
            F     P I HRD  S+NVL+    +  ++D G+A  ++   S++ ++      GT  Y
Sbjct: 125 IFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLA-VMHSQGSDYLDIGNNPRVGTKRY 183
Query: 811 VAPELAYTLKVTEKC-------DVYSFGVLALEVIKGK----------------HPRDFL 847
           +APE+    ++   C       D+++FG++  E+ +                   P D  
Sbjct: 184 MAPEV-LDEQIRTDCFESYKWTDIWAFGLVLWEIARRTIVNGIVEDYRPPFYDVVPNDPS 242
Query: 848 FEXXXXXXXXXIEMLDSRLPY--PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
           FE         +  +D + P     L     L  + Q+   C   NP +R T  R+ + L
Sbjct: 243 FE-----DMKKVVCVDQQTPTIPNRLAADPVLSGLAQMMRECWYPNPSARLTALRIKKTL 297

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 71/276 (25%), Positives = 122/276 (44%), Gaps = 42/276 (15%)
Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNI---- 700
           +G+G +G V + + VPSG+I AVK+  + +  +   +Q+  L ++    +I  R +    
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQ---EQKRLLMDL----DISMRTVDCPF 67
Query: 701 -VKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVA----DALF 755
            V FYG        +I  E +++ SLDK         + G T   +++  +A     AL 
Sbjct: 68  TVTFYGALFREGDVWICMELMDT-SLDKFY---KQVIDKGQTIPEDILGKIAVSIVKALE 123
Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           +LH+     ++HRD+   NVL++   +  + DFGI+ +L  D +   + AG   Y+APE 
Sbjct: 124 HLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID-AGCKPYMAPER 180
Query: 816 --------AYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEXXXXXXXXXIEMLDSRLP 867
                    Y++    K D++S G+  +E+   + P D              E      P
Sbjct: 181 INPELNQKGYSV----KSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEE------P 230
Query: 868 YPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ 903
            P L   K     +     CL +N + RPT   + Q
Sbjct: 231 SPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 92/202 (45%), Gaps = 14/202 (6%)
Query: 646 IGKGGHGSVYR-AKVPSGEIFAVKKFHSPLPGEM---SFQQEEFLNEIQALTEIRHRNIV 701
           +GKGG    Y    + + E+FA K     +P  M     Q+E+   EI     + + ++V
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKV----VPKSMLLKPHQKEKMSTEIAIHKSLDNPHVV 105
Query: 702 KFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNC 761
            F+GF       +++ E     SL ++       K +   +    ++     + YLHNN 
Sbjct: 106 GFHGFFEDDDFVYVVLEICRRRSLLEL---HKRRKAVTEPEARYFMRQTIQGVQYLHNN- 161
Query: 762 FPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKV 821
              ++HRD+   N+ L+   +  + DFG+A  +  D     +L GT  Y+APE+      
Sbjct: 162 --RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGH 219
Query: 822 TEKCDVYSFGVLALEVIKGKHP 843
           + + D++S G +   ++ GK P
Sbjct: 220 SFEVDIWSLGCILYTLLVGKPP 241

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 92/210 (43%), Gaps = 27/210 (12%)
Query: 646 IGKGGHGSVYRAKV------PSGEIFAVKKFHSPLPGEMSFQQE-EFLNEIQALTEIRHR 698
           +G G  G VY  +V      PS    AVK     LP   S Q E +FL E   +++  H+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT----LPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 699 NIVKFYGFCSHPKHSFIIYEYLESGSLDKIL----CNDASAKELGWTQRLNVIKGVADAL 754
           NIV+  G        FI+ E +  G L   L       +    L     L+V + +A   
Sbjct: 94  NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 755 FYLHNNCFPPIVHRDISSKNVLLDL---GYEAHVSDFGIAKFLNPDSSNWSELAGTH--- 808
            YL  N F   +HRDI+++N LL     G  A + DFG+A+ +    +++    G     
Sbjct: 154 QYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RASYYRKGGCAMLP 208
Query: 809 -GYVAPELAYTLKVTEKCDVYSFGVLALEV 837
             ++ PE       T K D +SFGVL  E+
Sbjct: 209 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 238

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 92/210 (43%), Gaps = 27/210 (12%)
Query: 646 IGKGGHGSVYRAKV------PSGEIFAVKKFHSPLPGEMSFQQE-EFLNEIQALTEIRHR 698
           +G G  G VY  +V      PS    AVK     LP   S Q E +FL E   +++  H+
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT----LPEVCSEQDELDFLMEALIISKFNHQ 85
Query: 699 NIVKFYGFCSHPKHSFIIYEYLESGSLDKIL----CNDASAKELGWTQRLNVIKGVADAL 754
           NIV+  G        FI+ E +  G L   L       +    L     L+V + +A   
Sbjct: 86  NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 145
Query: 755 FYLHNNCFPPIVHRDISSKNVLLDL---GYEAHVSDFGIAKFLNPDSSNWSELAGTH--- 808
            YL  N F   +HRDI+++N LL     G  A + DFG+A+ +    +++    G     
Sbjct: 146 QYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RASYYRKGGCAMLP 200
Query: 809 -GYVAPELAYTLKVTEKCDVYSFGVLALEV 837
             ++ PE       T K D +SFGVL  E+
Sbjct: 201 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 230

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 92/210 (43%), Gaps = 27/210 (12%)
Query: 646 IGKGGHGSVYRAKV------PSGEIFAVKKFHSPLPGEMSFQQE-EFLNEIQALTEIRHR 698
           +G G  G VY  +V      PS    AVK     LP   S Q E +FL E   +++  H+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT----LPEVCSEQDELDFLMEALIISKFNHQ 94
Query: 699 NIVKFYGFCSHPKHSFIIYEYLESGSLDKIL----CNDASAKELGWTQRLNVIKGVADAL 754
           NIV+  G        FI+ E +  G L   L       +    L     L+V + +A   
Sbjct: 95  NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 154
Query: 755 FYLHNNCFPPIVHRDISSKNVLLDL---GYEAHVSDFGIAKFLNPDSSNWSELAGTH--- 808
            YL  N F   +HRDI+++N LL     G  A + DFG+A+ +    +++    G     
Sbjct: 155 QYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RASYYRKGGCAMLP 209
Query: 809 -GYVAPELAYTLKVTEKCDVYSFGVLALEV 837
             ++ PE       T K D +SFGVL  E+
Sbjct: 210 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 239

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 92/210 (43%), Gaps = 27/210 (12%)
Query: 646 IGKGGHGSVYRAKV------PSGEIFAVKKFHSPLPGEMSFQQE-EFLNEIQALTEIRHR 698
           +G G  G VY  +V      PS    AVK     LP   S Q E +FL E   +++  H+
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT----LPEVCSEQDELDFLMEALIISKFNHQ 110
Query: 699 NIVKFYGFCSHPKHSFIIYEYLESGSLDKIL----CNDASAKELGWTQRLNVIKGVADAL 754
           NIV+  G        FI+ E +  G L   L       +    L     L+V + +A   
Sbjct: 111 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 170
Query: 755 FYLHNNCFPPIVHRDISSKNVLLDL---GYEAHVSDFGIAKFLNPDSSNWSELAGTH--- 808
            YL  N F   +HRDI+++N LL     G  A + DFG+A+ +    +++    G     
Sbjct: 171 QYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RASYYRKGGCAMLP 225
Query: 809 -GYVAPELAYTLKVTEKCDVYSFGVLALEV 837
             ++ PE       T K D +SFGVL  E+
Sbjct: 226 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 255

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 92/210 (43%), Gaps = 27/210 (12%)
Query: 646 IGKGGHGSVYRAKV------PSGEIFAVKKFHSPLPGEMSFQQE-EFLNEIQALTEIRHR 698
           +G G  G VY  +V      PS    AVK     LP   S Q E +FL E   +++  H+
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT----LPEVCSEQDELDFLMEALIISKFNHQ 100
Query: 699 NIVKFYGFCSHPKHSFIIYEYLESGSLDKIL----CNDASAKELGWTQRLNVIKGVADAL 754
           NIV+  G        FI+ E +  G L   L       +    L     L+V + +A   
Sbjct: 101 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 160
Query: 755 FYLHNNCFPPIVHRDISSKNVLLDL---GYEAHVSDFGIAKFLNPDSSNWSELAGTH--- 808
            YL  N F   +HRDI+++N LL     G  A + DFG+A+ +    +++    G     
Sbjct: 161 QYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RASYYRKGGCAMLP 215
Query: 809 -GYVAPELAYTLKVTEKCDVYSFGVLALEV 837
             ++ PE       T K D +SFGVL  E+
Sbjct: 216 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 245

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 91/210 (43%), Gaps = 27/210 (12%)
Query: 646 IGKGGHGSVYRAKV------PSGEIFAVKKFHSPLPGEMSFQQE-EFLNEIQALTEIRHR 698
           +G G  G VY  +V      PS    AVK     LP   S Q E +FL E   +++  H+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT----LPEVCSEQDELDFLMEALIISKFNHQ 134
Query: 699 NIVKFYGFCSHPKHSFIIYEYLESGSLDKIL----CNDASAKELGWTQRLNVIKGVADAL 754
           NIV+  G        FI+ E +  G L   L       +    L     L+V + +A   
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194
Query: 755 FYLHNNCFPPIVHRDISSKNVLLDL---GYEAHVSDFGIAKFLNPDSSNWSELAGTH--- 808
            YL  N F   +HRDI+++N LL     G  A + DFG+A+ +    + +    G     
Sbjct: 195 QYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RAGYYRKGGCAMLP 249
Query: 809 -GYVAPELAYTLKVTEKCDVYSFGVLALEV 837
             ++ PE       T K D +SFGVL  E+
Sbjct: 250 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 279

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 92/210 (43%), Gaps = 27/210 (12%)
Query: 646 IGKGGHGSVYRAKV------PSGEIFAVKKFHSPLPGEMSFQQE-EFLNEIQALTEIRHR 698
           +G G  G VY  +V      PS    AVK     LP   S Q E +FL E   +++  H+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT----LPEVCSEQDELDFLMEALIISKFNHQ 108
Query: 699 NIVKFYGFCSHPKHSFIIYEYLESGSLDKIL----CNDASAKELGWTQRLNVIKGVADAL 754
           NIV+  G        FI+ E +  G L   L       +    L     L+V + +A   
Sbjct: 109 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 168
Query: 755 FYLHNNCFPPIVHRDISSKNVLLDL---GYEAHVSDFGIAKFLNPDSSNWSELAGTH--- 808
            YL  N F   +HRDI+++N LL     G  A + DFG+A+ +    +++    G     
Sbjct: 169 QYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RASYYRKGGCAMLP 223
Query: 809 -GYVAPELAYTLKVTEKCDVYSFGVLALEV 837
             ++ PE       T K D +SFGVL  E+
Sbjct: 224 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 253

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 92/210 (43%), Gaps = 27/210 (12%)
Query: 646 IGKGGHGSVYRAKV------PSGEIFAVKKFHSPLPGEMSFQQE-EFLNEIQALTEIRHR 698
           +G G  G VY  +V      PS    AVK     LP   S Q E +FL E   +++  H+
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT----LPEVCSEQDELDFLMEALIISKFNHQ 120
Query: 699 NIVKFYGFCSHPKHSFIIYEYLESGSLDKIL----CNDASAKELGWTQRLNVIKGVADAL 754
           NIV+  G        FI+ E +  G L   L       +    L     L+V + +A   
Sbjct: 121 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 180
Query: 755 FYLHNNCFPPIVHRDISSKNVLLDL---GYEAHVSDFGIAKFLNPDSSNWSELAGTH--- 808
            YL  N F   +HRDI+++N LL     G  A + DFG+A+ +    +++    G     
Sbjct: 181 QYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RASYYRKGGCAMLP 235
Query: 809 -GYVAPELAYTLKVTEKCDVYSFGVLALEV 837
             ++ PE       T K D +SFGVL  E+
Sbjct: 236 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 265

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 92/210 (43%), Gaps = 27/210 (12%)
Query: 646 IGKGGHGSVYRAKV------PSGEIFAVKKFHSPLPGEMSFQQE-EFLNEIQALTEIRHR 698
           +G G  G VY  +V      PS    AVK     LP   S Q E +FL E   +++  H+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT----LPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 699 NIVKFYGFCSHPKHSFIIYEYLESGSLDKIL----CNDASAKELGWTQRLNVIKGVADAL 754
           NIV+  G        FI+ E +  G L   L       +    L     L+V + +A   
Sbjct: 94  NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 755 FYLHNNCFPPIVHRDISSKNVLLDL---GYEAHVSDFGIAKFLNPDSSNWSELAGTH--- 808
            YL  N F   +HRDI+++N LL     G  A + DFG+A+ +    +++    G     
Sbjct: 154 QYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RASYYRKGGCAMLP 208
Query: 809 -GYVAPELAYTLKVTEKCDVYSFGVLALEV 837
             ++ PE       T K D +SFGVL  E+
Sbjct: 209 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 238

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Composition-based stats.
 Identities = 67/284 (23%), Positives = 121/284 (42%), Gaps = 43/284 (15%)
Query: 639 DFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH 697
           DF     IG GG G V++AK    G+ + +K+        + +  E+   E++AL ++ H
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKR--------VKYNNEKAEREVKALAKLDH 63
Query: 698 RNIVKFY----GFCSHPKHS------------FIIYEYLESGSLDKILCNDASAKELGWT 741
            NIV +     GF   P+ S            FI  E+ + G+L++ +      ++L   
Sbjct: 64  VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKV 122
Query: 742 QRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNW 801
             L + + +   + Y+H+     +++RD+   N+ L    +  + DFG+   L  D    
Sbjct: 123 LALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR- 178
Query: 802 SELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEXXXXXXXXXIEM 861
               GT  Y++PE   +    ++ D+Y+ G++  E++   H  D  FE            
Sbjct: 179 XRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL---HVCDTAFETSKF-------F 228
Query: 862 LDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
            D R    S    KK  +++Q     L + PE RP    + + L
Sbjct: 229 TDLRDGIISDIFDKKEKTLLQ---KLLSKKPEDRPNTSEILRTL 269

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 91/210 (43%), Gaps = 27/210 (12%)
Query: 646 IGKGGHGSVYRAKV------PSGEIFAVKKFHSPLPGEMSFQQE-EFLNEIQALTEIRHR 698
           +G G  G VY  +V      PS    AVK     LP   S Q E +FL E   +++  H+
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT----LPEVCSEQDELDFLMEALIISKFNHQ 111
Query: 699 NIVKFYGFCSHPKHSFIIYEYLESGSLDKIL----CNDASAKELGWTQRLNVIKGVADAL 754
           NIV+  G        FI+ E +  G L   L       +    L     L+V + +A   
Sbjct: 112 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 171
Query: 755 FYLHNNCFPPIVHRDISSKNVLLDL---GYEAHVSDFGIAKFLNPDSSNWSELAGTH--- 808
            YL  N F   +HRDI+++N LL     G  A + DFG+A+ +    + +    G     
Sbjct: 172 QYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RAGYYRKGGCAMLP 226
Query: 809 -GYVAPELAYTLKVTEKCDVYSFGVLALEV 837
             ++ PE       T K D +SFGVL  E+
Sbjct: 227 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 256

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 92/210 (43%), Gaps = 27/210 (12%)
Query: 646 IGKGGHGSVYRAKV------PSGEIFAVKKFHSPLPGEMSFQQE-EFLNEIQALTEIRHR 698
           +G G  G VY  +V      PS    AVK     LP   S Q E +FL E   +++  H+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT----LPEVCSEQDELDFLMEALIISKFNHQ 94
Query: 699 NIVKFYGFCSHPKHSFIIYEYLESGSLDKIL----CNDASAKELGWTQRLNVIKGVADAL 754
           NIV+  G        FI+ E +  G L   L       +    L     L+V + +A   
Sbjct: 95  NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 154
Query: 755 FYLHNNCFPPIVHRDISSKNVLLDL---GYEAHVSDFGIAKFLNPDSSNWSELAGTH--- 808
            YL  N F   +HRDI+++N LL     G  A + DFG+A+ +    +++    G     
Sbjct: 155 QYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIY--RASYYRKGGCAMLP 209
Query: 809 -GYVAPELAYTLKVTEKCDVYSFGVLALEV 837
             ++ PE       T K D +SFGVL  E+
Sbjct: 210 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 239

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 92/210 (43%), Gaps = 27/210 (12%)
Query: 646 IGKGGHGSVYRAKV------PSGEIFAVKKFHSPLPGEMSFQQE-EFLNEIQALTEIRHR 698
           +G G  G VY  +V      PS    AVK     LP   S Q E +FL E   +++  H+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT----LPEVYSEQDELDFLMEALIISKFNHQ 108
Query: 699 NIVKFYGFCSHPKHSFIIYEYLESGSLDKIL----CNDASAKELGWTQRLNVIKGVADAL 754
           NIV+  G        FI+ E +  G L   L       +    L     L+V + +A   
Sbjct: 109 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 168
Query: 755 FYLHNNCFPPIVHRDISSKNVLLDL---GYEAHVSDFGIAKFLNPDSSNWSELAGTH--- 808
            YL  N F   +HRDI+++N LL     G  A + DFG+A+ +    +++    G     
Sbjct: 169 QYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RASYYRKGGCAMLP 223
Query: 809 -GYVAPELAYTLKVTEKCDVYSFGVLALEV 837
             ++ PE       T K D +SFGVL  E+
Sbjct: 224 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 253

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           +G+G +G VY+AK   G I A+K+    L  E        + EI  L E+ H NIV    
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIR--LDAEDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQ--RLNVIKGVADALFYLHNNCFP 763
                +   +++E++E   L K+L  + +  +    +     +++GVA    + H +   
Sbjct: 87  VIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVA----HCHQH--- 138
Query: 764 PIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPE-LAYTLKVT 822
            I+HRD+  +N+L++      ++DFG+A+       +++    T  Y AP+ L  + K +
Sbjct: 139 RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYS 198
Query: 823 EKCDVYSFGVLALEVIKGK 841
              D++S G +  E+I GK
Sbjct: 199 TSVDIWSIGCIFAEMITGK 217

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           +G+G +G VY+AK   G I A+K+    L  E        + EI  L E+ H NIV    
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIR--LDAEDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQ--RLNVIKGVADALFYLHNNCFP 763
                +   +++E++E   L K+L  + +  +    +     +++GVA    + H +   
Sbjct: 87  VIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVA----HCHQH--- 138
Query: 764 PIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPE-LAYTLKVT 822
            I+HRD+  +N+L++      ++DFG+A+       +++    T  Y AP+ L  + K +
Sbjct: 139 RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYS 198
Query: 823 EKCDVYSFGVLALEVIKGK 841
              D++S G +  E+I GK
Sbjct: 199 TSVDIWSIGCIFAEMITGK 217

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 94/221 (42%), Gaps = 17/221 (7%)
Query: 633 IISATND------FNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEF 685
           I SAT++      +  +  IGKG    V  A+ V +G   AVK          S Q+   
Sbjct: 4   ITSATDEQPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQK--L 61
Query: 686 LNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLN 745
             E++ +  + H NIVK +      K  +++ EY   G +   L      KE     +  
Sbjct: 62  FREVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF- 120
Query: 746 VIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELA 805
             + +  A+ Y H      IVHRD+ ++N+LLD      ++DFG +       +      
Sbjct: 121 --RQIVSAVQYCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTV-GNKLDTFC 174
Query: 806 GTHGYVAPELAYTLKVT-EKCDVYSFGVLALEVIKGKHPRD 845
           G+  Y APEL    K    + DV+S GV+   ++ G  P D
Sbjct: 175 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 91/202 (45%), Gaps = 14/202 (6%)
Query: 646 IGKGGHGSVYR-AKVPSGEIFAVKKFHSPLPGEM---SFQQEEFLNEIQALTEIRHRNIV 701
           +GKGG    Y    + + E+FA K     +P  M     Q+E+   EI     + + ++V
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKV----VPKSMLLKPHQKEKMSTEIAIHKSLDNPHVV 105
Query: 702 KFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNC 761
            F+GF       +++ E     SL ++       K +   +    ++     + YLHNN 
Sbjct: 106 GFHGFFEDDDFVYVVLEICRRRSLLEL---HKRRKAVTEPEARYFMRQTIQGVQYLHNN- 161
Query: 762 FPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKV 821
              ++HRD+   N+ L+   +  + DFG+A  +  D      L GT  Y+APE+      
Sbjct: 162 --RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCKKGH 219
Query: 822 TEKCDVYSFGVLALEVIKGKHP 843
           + + D++S G +   ++ GK P
Sbjct: 220 SFEVDIWSLGCILYTLLVGKPP 241

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 91/202 (45%), Gaps = 14/202 (6%)
Query: 646 IGKGGHGSVYR-AKVPSGEIFAVKKFHSPLPGEM---SFQQEEFLNEIQALTEIRHRNIV 701
           +GKGG    Y    + + E+FA K     +P  M     Q+E+   EI     + + ++V
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKV----VPKSMLLKPHQKEKMSTEIAIHKSLDNPHVV 105
Query: 702 KFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNC 761
            F+GF       +++ E     SL ++       K +   +    ++     + YLHNN 
Sbjct: 106 GFHGFFEDDDFVYVVLEICRRRSLLEL---HKRRKAVTEPEARYFMRQTIQGVQYLHNN- 161
Query: 762 FPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKV 821
              ++HRD+   N+ L+   +  + DFG+A  +  D      L GT  Y+APE+      
Sbjct: 162 --RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLCKKGH 219
Query: 822 TEKCDVYSFGVLALEVIKGKHP 843
           + + D++S G +   ++ GK P
Sbjct: 220 SFEVDIWSLGCILYTLLVGKPP 241

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 113/250 (45%), Gaps = 31/250 (12%)
Query: 681 QQEEFLNEIQALTEI-RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASA---- 735
           ++E  ++E++ ++ + +H NIV   G C+H     +I EY   G L   L          
Sbjct: 92  EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEY 151
Query: 736 ---------KELGWTQRLNVIKGVADALFYLHN-NCFPPIVHRDISSKNVLLDLGYEAHV 785
                    ++L     L+    VA  + +L + NC    +HRD++++NVLL  G+ A +
Sbjct: 152 SYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKI 207
Query: 786 SDFGIAKFLNPDSSNWSELAGTH---GYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GK 841
            DFG+A+ +  D SN+           ++APE  +    T + DV+S+G+L  E+   G 
Sbjct: 208 GDFGLARDIMND-SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGL 266
Query: 842 HPRDFLFEXXXXXXXXXIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
           +P   +           +     ++  P+    K + SIMQ   +C    P  RPT +++
Sbjct: 267 NPYPGIL---VNSKFYKLVKDGYQMAQPAF-APKNIYSIMQ---ACWALEPTHRPTFQQI 319
Query: 902 SQLLCEKIFE 911
              L E+  E
Sbjct: 320 CSFLQEQAQE 329

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 113/265 (42%), Gaps = 24/265 (9%)
Query: 639 DFNAEHCI-GKGGHGSVYRAKVPSGEI-FAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
           D N +  + GKG +G VY  +  S ++  A+K+    +P   S   +    EI     ++
Sbjct: 8   DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKE----IPERDSRYSQPLHEEIALHKHLK 63
Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFY 756
           H+NIV++ G  S      I  E +  GSL  +L +     +          K + + L Y
Sbjct: 64  HKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKY 123
Query: 757 LHNNCFPPIVHRDISSKNVLLDLGYEA--HVSDFGIAKFLNPDSSNWSELAGTHGYVAPE 814
           LH+N    IVHRDI   NVL++  Y     +SDFG +K L   +       GT  Y+APE
Sbjct: 124 LHDN---QIVHRDIKGDNVLINT-YSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPE 179
Query: 815 L--AYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLH 872
           +         +  D++S G   +E+  GK P   L E         +  +   +P     
Sbjct: 180 IIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIP----- 234
Query: 873 VQKKLMSIMQVAF--SCLDQNPESR 895
              + MS    AF   C + +P+ R
Sbjct: 235 ---ESMSAEAKAFILKCFEPDPDKR 256

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 88/203 (43%), Gaps = 11/203 (5%)
Query: 645 CIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKF 703
            IGKG    V  A+ + +G+  AV+          S Q+     E++ +  + H NIVK 
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQK--LFREVRIMKVLNHPNIVKL 78
Query: 704 YGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFP 763
           +      K  +++ EY   G +   L      KE     +    + +  A+ Y H     
Sbjct: 79  FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF---RQIVSAVQYCHQKF-- 133
Query: 764 PIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVT- 822
            IVHRD+ ++N+LLD      ++DFG +       +   E  G+  Y APEL    K   
Sbjct: 134 -IVHRDLKAENLLLDADMNIKIADFGFSNEFTF-GNKLDEFCGSPPYAAPELFQGKKYDG 191
Query: 823 EKCDVYSFGVLALEVIKGKHPRD 845
            + DV+S GV+   ++ G  P D
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 125/300 (41%), Gaps = 44/300 (14%)
Query: 622 LTFEGKIVYEEIISATNDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSF 680
           L F+G    E      +D      +G+G +G V + + VPSG+I AVK+  + +    S 
Sbjct: 20  LYFQG--AXENFEVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATV---NSQ 74
Query: 681 QQEEFLNEIQALTEIRHRNI-----VKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASA 735
           +Q+  L ++    +I  R +     V FYG        +I  E L   SLDK        
Sbjct: 75  EQKRLLXDL----DISXRTVDCPFTVTFYGALFREGDVWICXE-LXDTSLDKFY---KQV 126
Query: 736 KELGWTQRLNVIKGVA----DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIA 791
            + G T   +++  +A     AL +LH+     ++HRD+   NVL++   +    DFGI+
Sbjct: 127 IDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKXCDFGIS 184
Query: 792 KFLNPDSSNWSELAGTHGYVAPEL--------AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
            +L  D +   + AG   Y APE          Y++    K D++S G+  +E+   + P
Sbjct: 185 GYLVDDVAKDID-AGCKPYXAPERINPELNQKGYSV----KSDIWSLGITXIELAILRFP 239
Query: 844 RDFLFEXXXXXXXXXIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ 903
            D              E      P P L   K     +     CL +N + RPT   + Q
Sbjct: 240 YDSWGTPFQQLKQVVEE------PSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELXQ 293

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 102/214 (47%), Gaps = 14/214 (6%)
Query: 635 SATNDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALT 693
           S T+++     +GKG    V R  K+P+G+ +A K  ++        Q+ E   E +   
Sbjct: 1   SMTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLE--REARICR 58
Query: 694 EIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKEL-GWTQRLNVIKGVAD 752
            ++H NIV+ +   S     +++++ +  G L      D  A+E        + I+ + +
Sbjct: 59  LLKHPNIVRLHDSISEEGFHYLVFDLVTGGEL----FEDIVAREYYSEADASHCIQQILE 114
Query: 753 ALFYLHNNCFPPIVHRDISSKNVLL---DLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG 809
           ++ + H N    IVHRD+  +N+LL     G    ++DFG+A  +  D   W   AGT G
Sbjct: 115 SVNHCHLN---GIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPG 171
Query: 810 YVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           Y++PE+       +  D+++ GV+   ++ G  P
Sbjct: 172 YLSPEVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 100/216 (46%), Gaps = 19/216 (8%)
Query: 640 FNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPL----PGEMSFQQEEFLNEIQALTE 694
           ++ +  IG+G    V R     +G  FAVK          P ++   +E    E   L +
Sbjct: 96  YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155
Query: 695 IR-HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADA 753
           +  H +I+            F++++ +  G L   L    +  E    +  ++++ + +A
Sbjct: 156 VAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSE---KETRSIMRSLLEA 212
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAP 813
           + +LH N    IVHRD+  +N+LLD   +  +SDFG +  L P      EL GT GY+AP
Sbjct: 213 VSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEP-GEKLRELCGTPGYLAP 268
Query: 814 E-LAYTLKVT-----EKCDVYSFGVLALEVIKGKHP 843
           E L  ++  T     ++ D+++ GV+   ++ G  P
Sbjct: 269 EILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 86/183 (46%), Gaps = 13/183 (7%)
Query: 661 SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI--IYE 718
           +GE  AVK      P        +   EI+ L  + H NIVK+ G C+    + I  I E
Sbjct: 37  TGEQVAVKSLK---PESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIME 93
Query: 719 YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLD 778
           +L SGSL + L  + +  ++   Q+L     +   + YL +  +   VHRD++++NVL++
Sbjct: 94  FLPSGSLKEYLPKNKN--KINLKQQLKYAVQICKGMDYLGSRQY---VHRDLAARNVLVE 148
Query: 779 LGYEAHVSDFGIAKFLNPDSSNWSELAGTHG---YVAPELAYTLKVTEKCDVYSFGVLAL 835
             ++  + DFG+ K +  D    +          + APE     K     DV+SFGV   
Sbjct: 149 SEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLH 208
Query: 836 EVI 838
           E++
Sbjct: 209 ELL 211

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 89/303 (29%), Positives = 129/303 (42%), Gaps = 37/303 (12%)
Query: 561 PSCMSYKKASRKIWI--VIVFPLLGMVALFIA--LTGFFFIFHQRKNDSQTQQSSFGNTP 616
           PSC+S + A  K  +   +V  L G V+   A  LT     +  R + S+       +  
Sbjct: 15  PSCLS-RGAHEKFSVEEYLVHALQGSVSSGQAHSLTSLAKTWAARGSRSREPSPKTEDNE 73
Query: 617 GLRSVLTFEGKIV----YEEIISATNDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFH 671
           G+  +LT + K V     EE+  AT+       +G+G  G V+R +   +G   AVKK  
Sbjct: 74  GV--LLTEKLKPVDYEYREEVHWATHQLR----LGRGSFGEVHRMEDKQTGFQCAVKKVR 127
Query: 672 SPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCN 731
             +     F+ EE +     LT  R   IV  YG         I  E LE GSL +++  
Sbjct: 128 LEV-----FRAEELMA-CAGLTSPR---IVPLYGAVREGPWVNIFMELLEGGSLGQLVKE 178
Query: 732 DASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDL-GYEAHVSDFGI 790
                E    + L  +    + L YLH+     I+H D+ + NVLL   G  A + DFG 
Sbjct: 179 QGCLPE---DRALYYLGQALEGLEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGH 232
Query: 791 AKFLNPDSSNWSELAG-----THGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRD 845
           A  L PD    S L G     T  ++APE+        K DV+S   + L ++ G HP  
Sbjct: 233 AVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWT 292
Query: 846 FLF 848
             F
Sbjct: 293 QFF 295

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 86/183 (46%), Gaps = 13/183 (7%)
Query: 661 SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI--IYE 718
           +GE  AVK      P        +   EI+ L  + H NIVK+ G C+    + I  I E
Sbjct: 49  TGEQVAVKSLK---PESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIME 105
Query: 719 YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLD 778
           +L SGSL + L  + +  ++   Q+L     +   + YL +  +   VHRD++++NVL++
Sbjct: 106 FLPSGSLKEYLPKNKN--KINLKQQLKYAVQICKGMDYLGSRQY---VHRDLAARNVLVE 160
Query: 779 LGYEAHVSDFGIAKFLNPDSSNWSELAGTHG---YVAPELAYTLKVTEKCDVYSFGVLAL 835
             ++  + DFG+ K +  D    +          + APE     K     DV+SFGV   
Sbjct: 161 SEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLH 220
Query: 836 EVI 838
           E++
Sbjct: 221 ELL 223

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 113/265 (42%), Gaps = 24/265 (9%)
Query: 639 DFNAEHCI-GKGGHGSVYRAKVPSGEI-FAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
           D N +  + GKG +G VY  +  S ++  A+K+    +P   S   +    EI     ++
Sbjct: 22  DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKE----IPERDSRYSQPLHEEIALHKHLK 77
Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFY 756
           H+NIV++ G  S      I  E +  GSL  +L +     +          K + + L Y
Sbjct: 78  HKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKY 137
Query: 757 LHNNCFPPIVHRDISSKNVLLDLGYEA--HVSDFGIAKFLNPDSSNWSELAGTHGYVAPE 814
           LH+N    IVHRDI   NVL++  Y     +SDFG +K L   +       GT  Y+APE
Sbjct: 138 LHDN---QIVHRDIKGDNVLINT-YSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPE 193
Query: 815 L--AYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLH 872
           +         +  D++S G   +E+  GK P   L E         +  +   +P     
Sbjct: 194 IIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIP----- 248
Query: 873 VQKKLMSIMQVAF--SCLDQNPESR 895
              + MS    AF   C + +P+ R
Sbjct: 249 ---ESMSAEAKAFILKCFEPDPDKR 270

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 54/214 (25%), Positives = 99/214 (46%), Gaps = 14/214 (6%)
Query: 635 SATNDFNAEHCIGKGGHGSVYR-AKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALT 693
           S T+++     IGKG    V R  K+ +G  +A K  ++        Q+ E   E +   
Sbjct: 1   SMTDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLE--REARICR 58
Query: 694 EIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKEL-GWTQRLNVIKGVAD 752
            ++H NIV+ +   S     +++++ +  G L      D  A+E        + I+ + +
Sbjct: 59  LLKHSNIVRLHDSISEEGFHYLVFDLVTGGEL----FEDIVAREYYSEADASHCIQQILE 114
Query: 753 ALFYLHNNCFPPIVHRDISSKNVLLDL---GYEAHVSDFGIAKFLNPDSSNWSELAGTHG 809
           A+ + H      +VHRD+  +N+LL     G    ++DFG+A  +  D   W   AGT G
Sbjct: 115 AVLHCHQM---GVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPG 171
Query: 810 YVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           Y++PE+       +  D+++ GV+   ++ G  P
Sbjct: 172 YLSPEVLRKEAYGKPVDIWACGVILYILLVGYPP 205

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 637 TNDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI 695
           +++++ +  +GKG    V R     +G  FA K  ++       FQ+ E   E +   ++
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE--REARICRKL 85
Query: 696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKEL-GWTQRLNVIKGVADAL 754
           +H NIV+ +         +++++ +  G L      D  A+E        + I+ + +++
Sbjct: 86  QHPNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQILESI 141
Query: 755 FYLHNNCFPPIVHRDISSKNVLLD---LGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV 811
            Y H+N    IVHR++  +N+LL     G    ++DFG+A  +N DS  W   AGT GY+
Sbjct: 142 AYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYL 197
Query: 812 APELAYTLKVTEKCDVYSFGVL 833
           +PE+      ++  D+++ GV+
Sbjct: 198 SPEVLKKDPYSKPVDIWACGVI 219

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 125/295 (42%), Gaps = 58/295 (19%)
Query: 637 TNDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI 695
            +DF     +G+G  G V +A+       +A+KK           +    L+E+  L  +
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-----HTEEKLSTILSEVMLLASL 59
Query: 696 RHRNIVKFYG-----------FCSHPKHS--FIIYEYLESGSLDKILCNDASAKELGWTQ 742
            H+ +V++Y              +  K S  FI  EY E+ +L  ++ ++   ++     
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYW 119
Query: 743 RLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN------- 795
           RL   + + +AL Y+H+     I+HRD+   N+ +D      + DFG+AK ++       
Sbjct: 120 RL--FRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 796 ------PDSS-NWSELAGTHGYVAPE-LAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFL 847
                 P SS N +   GT  YVA E L  T    EK D+YS G++  E+I       + 
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI-------YP 227
Query: 848 FEXXXXXXXXXIEMLDSRLPYP------SLHVQKKLMSIMQVAFSCLDQNPESRP 896
           F           ++    + +P       + V+KK++ ++      +D +P  RP
Sbjct: 228 FSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLL------IDHDPNKRP 276

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 99/215 (46%), Gaps = 33/215 (15%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLP--------GEMSFQQEEFLNEIQALTEIRH 697
           IG+G  G VY   +   +    KK H  +         GE+S    +FL E   + +  H
Sbjct: 57  IGRGHFGCVYHGTLLDND---GKKIHCAVKSLNRITDIGEVS----QFLTEGIIMKDFSH 109
Query: 698 RNIVKFYGFCSHPKHS-FIIYEYLESGSLDKILCNDA---SAKELGWTQRLNVIKGVADA 753
            N++   G C   + S  ++  Y++ G L   + N+    + K+L     +     VA  
Sbjct: 110 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKG 164
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG---- 809
           + YL +  F   VHRD++++N +LD  +   V+DFG+A+ +  D   +S    T      
Sbjct: 165 MKYLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMY-DKEYYSVHNKTGAKLPV 220
Query: 810 -YVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
            ++A E   T K T K DV+SFGVL  E++    P
Sbjct: 221 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 255

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 99/215 (46%), Gaps = 33/215 (15%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLP--------GEMSFQQEEFLNEIQALTEIRH 697
           IG+G  G VY   +   +    KK H  +         GE+S    +FL E   + +  H
Sbjct: 56  IGRGHFGCVYHGTLLDND---GKKIHCAVKSLNRITDIGEVS----QFLTEGIIMKDFSH 108
Query: 698 RNIVKFYGFCSHPKHS-FIIYEYLESGSLDKILCNDA---SAKELGWTQRLNVIKGVADA 753
            N++   G C   + S  ++  Y++ G L   + N+    + K+L     +     VA  
Sbjct: 109 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKG 163
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG---- 809
           + YL +  F   VHRD++++N +LD  +   V+DFG+A+ +  D   +S    T      
Sbjct: 164 MKYLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMY-DKEYYSVHNKTGAKLPV 219
Query: 810 -YVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
            ++A E   T K T K DV+SFGVL  E++    P
Sbjct: 220 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 254

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 86/203 (42%), Gaps = 11/203 (5%)
Query: 645 CIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKF 703
            IGKG    V  A+ + +G   A+K          S Q+     E++ +  + H NIVK 
Sbjct: 19  TIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQK--LFREVRIMKILNHPNIVKL 76
Query: 704 YGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFP 763
           +      K  ++I EY   G +   L      KE    +  +  + +  A+ Y H     
Sbjct: 77  FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKE---KEARSKFRQIVSAVQYCHQK--- 130
Query: 764 PIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVT- 822
            IVHRD+ ++N+LLD      ++DFG +              G+  Y APEL    K   
Sbjct: 131 RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV-GGKLDTFCGSPPYAAPELFQGKKYDG 189
Query: 823 EKCDVYSFGVLALEVIKGKHPRD 845
            + DV+S GV+   ++ G  P D
Sbjct: 190 PEVDVWSLGVILYTLVSGSLPFD 212

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 99/215 (46%), Gaps = 33/215 (15%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLP--------GEMSFQQEEFLNEIQALTEIRH 697
           IG+G  G VY   +   +    KK H  +         GE+S    +FL E   + +  H
Sbjct: 30  IGRGHFGCVYHGTLLDND---GKKIHCAVKSLNRITDIGEVS----QFLTEGIIMKDFSH 82
Query: 698 RNIVKFYGFCSHPKHS-FIIYEYLESGSLDKILCNDA---SAKELGWTQRLNVIKGVADA 753
            N++   G C   + S  ++  Y++ G L   + N+    + K+L     +     VA  
Sbjct: 83  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKG 137
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG---- 809
           + YL +  F   VHRD++++N +LD  +   V+DFG+A+ +  D   +S    T      
Sbjct: 138 MKYLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMY-DKEYYSVHNKTGAKLPV 193
Query: 810 -YVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
            ++A E   T K T K DV+SFGVL  E++    P
Sbjct: 194 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 228

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 97/218 (44%), Gaps = 24/218 (11%)
Query: 638 NDFNAEHCIGKGGHGSVYRAKVPSGEI---FAVKKFHSPLPGEMSFQQEEFLNEIQALTE 694
           ND   +  IG+G  G V +A++    +    A+K+       +      +F  E++ L +
Sbjct: 15  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD---DHRDFAGELEVLCK 71
Query: 695 IRHR-NIVKFYGFCSHPKHSFIIYEYLESGSL------DKILCND-------ASAKELGW 740
           + H  NI+   G C H  + ++  EY   G+L       ++L  D       ++A  L  
Sbjct: 72  LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 131
Query: 741 TQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN 800
            Q L+    VA  + YL    F   +HRD++++N+L+   Y A ++DFG+++        
Sbjct: 132 QQLLHFAADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 188
Query: 801 WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVI 838
                         L Y++  T   DV+S+GVL  E++
Sbjct: 189 TMGRLPVRWMAIESLNYSVYTTNS-DVWSYGVLLWEIV 225

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 99/215 (46%), Gaps = 33/215 (15%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLP--------GEMSFQQEEFLNEIQALTEIRH 697
           IG+G  G VY   +   +    KK H  +         GE+S    +FL E   + +  H
Sbjct: 35  IGRGHFGCVYHGTLLDND---GKKIHCAVKSLNRITDIGEVS----QFLTEGIIMKDFSH 87
Query: 698 RNIVKFYGFCSHPKHS-FIIYEYLESGSLDKILCNDA---SAKELGWTQRLNVIKGVADA 753
            N++   G C   + S  ++  Y++ G L   + N+    + K+L     +     VA  
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKG 142
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG---- 809
           + YL +  F   VHRD++++N +LD  +   V+DFG+A+ +  D   +S    T      
Sbjct: 143 MKYLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMY-DKEYYSVHNKTGAKLPV 198
Query: 810 -YVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
            ++A E   T K T K DV+SFGVL  E++    P
Sbjct: 199 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 233

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 99/215 (46%), Gaps = 33/215 (15%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLP--------GEMSFQQEEFLNEIQALTEIRH 697
           IG+G  G VY   +   +    KK H  +         GE+S    +FL E   + +  H
Sbjct: 38  IGRGHFGCVYHGTLLDND---GKKIHCAVKSLNRITDIGEVS----QFLTEGIIMKDFSH 90
Query: 698 RNIVKFYGFCSHPKHS-FIIYEYLESGSLDKILCNDA---SAKELGWTQRLNVIKGVADA 753
            N++   G C   + S  ++  Y++ G L   + N+    + K+L     +     VA  
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKG 145
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG---- 809
           + YL +  F   VHRD++++N +LD  +   V+DFG+A+ +  D   +S    T      
Sbjct: 146 MKYLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMY-DKEYYSVHNKTGAKLPV 201
Query: 810 -YVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
            ++A E   T K T K DV+SFGVL  E++    P
Sbjct: 202 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 97/218 (44%), Gaps = 24/218 (11%)
Query: 638 NDFNAEHCIGKGGHGSVYRAKVPSGEI---FAVKKFHSPLPGEMSFQQEEFLNEIQALTE 694
           ND   +  IG+G  G V +A++    +    A+K+       +      +F  E++ L +
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD---DHRDFAGELEVLCK 81
Query: 695 IRHR-NIVKFYGFCSHPKHSFIIYEYLESGSL------DKILCND-------ASAKELGW 740
           + H  NI+   G C H  + ++  EY   G+L       ++L  D       ++A  L  
Sbjct: 82  LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 141
Query: 741 TQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN 800
            Q L+    VA  + YL    F   +HRD++++N+L+   Y A ++DFG+++        
Sbjct: 142 QQLLHFAADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 198
Query: 801 WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVI 838
                         L Y++  T   DV+S+GVL  E++
Sbjct: 199 TMGRLPVRWMAIESLNYSVYTTNS-DVWSYGVLLWEIV 235

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 104/212 (49%), Gaps = 15/212 (7%)
Query: 637 TNDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI 695
           +++++ +  +GKG    V R     +G  FA K  ++       FQ+ E   E +   ++
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE--REARICRKL 62
Query: 696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKEL-GWTQRLNVIKGVADAL 754
           +H NIV+ +         +++++ +  G L      D  A+E        + I+ + +++
Sbjct: 63  QHPNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQILESI 118
Query: 755 FYLHNNCFPPIVHRDISSKNVLLD---LGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV 811
            Y H+N    IVHR++  +N+LL     G    ++DFG+A  +N DS  W   AGT GY+
Sbjct: 119 AYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYL 174
Query: 812 APELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           +PE+      ++  D+++ GV+   ++ G  P
Sbjct: 175 SPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 85/203 (41%), Gaps = 11/203 (5%)
Query: 645 CIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKF 703
            IGKG    V  A+ + +G   A+K          S Q+     E++ +  + H NIVK 
Sbjct: 22  TIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQK--LFREVRIMKILNHPNIVKL 79
Query: 704 YGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFP 763
           +      K  ++I EY   G +   L      KE    +  +  + +  A+ Y H     
Sbjct: 80  FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKE---KEARSKFRQIVSAVQYCHQK--- 133
Query: 764 PIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVT- 822
            IVHRD+ ++N+LLD      ++DFG +              G   Y APEL    K   
Sbjct: 134 RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV-GGKLDAFCGAPPYAAPELFQGKKYDG 192
Query: 823 EKCDVYSFGVLALEVIKGKHPRD 845
            + DV+S GV+   ++ G  P D
Sbjct: 193 PEVDVWSLGVILYTLVSGSLPFD 215

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 99/215 (46%), Gaps = 33/215 (15%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLP--------GEMSFQQEEFLNEIQALTEIRH 697
           IG+G  G VY   +   +    KK H  +         GE+S    +FL E   + +  H
Sbjct: 38  IGRGHFGCVYHGTLLDND---GKKIHCAVKSLNRITDIGEVS----QFLTEGIIMKDFSH 90
Query: 698 RNIVKFYGFCSHPKHS-FIIYEYLESGSLDKILCNDA---SAKELGWTQRLNVIKGVADA 753
            N++   G C   + S  ++  Y++ G L   + N+    + K+L     +     VA  
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKG 145
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG---- 809
           + YL +  F   VHRD++++N +LD  +   V+DFG+A+ +  D   +S    T      
Sbjct: 146 MKYLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMY-DKEYYSVHNKTGAKLPV 201
Query: 810 -YVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
            ++A E   T K T K DV+SFGVL  E++    P
Sbjct: 202 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 31/214 (14%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLP--------GEMSFQQEEFLNEIQALTEIRH 697
           IG+G  G VY   +   +    KK H  +         GE+S    +FL E   + +  H
Sbjct: 37  IGRGHFGCVYHGTLLDND---GKKIHCAVKSLNRITDIGEVS----QFLTEGIIMKDFSH 89
Query: 698 RNIVKFYGFCSHPKHS-FIIYEYLESGSLDKILCNDA---SAKELGWTQRLNVIKGVADA 753
            N++   G C   + S  ++  Y++ G L   + N+    + K+L     +     VA  
Sbjct: 90  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKG 144
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK-FLNPDSSNWSELAGTH---G 809
           + YL +  F   VHRD++++N +LD  +   V+DFG+A+   + +  +     G      
Sbjct: 145 MKYLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVK 201
Query: 810 YVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           ++A E   T K T K DV+SFGVL  E++    P
Sbjct: 202 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 99/215 (46%), Gaps = 33/215 (15%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLP--------GEMSFQQEEFLNEIQALTEIRH 697
           IG+G  G VY   +   +    KK H  +         GE+S    +FL E   + +  H
Sbjct: 37  IGRGHFGCVYHGTLLDND---GKKIHCAVKSLNRITDIGEVS----QFLTEGIIMKDFSH 89
Query: 698 RNIVKFYGFCSHPKHS-FIIYEYLESGSLDKILCNDA---SAKELGWTQRLNVIKGVADA 753
            N++   G C   + S  ++  Y++ G L   + N+    + K+L     +     VA  
Sbjct: 90  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKG 144
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG---- 809
           + YL +  F   VHRD++++N +LD  +   V+DFG+A+ +  D   +S    T      
Sbjct: 145 MKYLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMY-DKEYYSVHNKTGAKLPV 200
Query: 810 -YVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
            ++A E   T K T K DV+SFGVL  E++    P
Sbjct: 201 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 87/203 (42%), Gaps = 11/203 (5%)
Query: 645 CIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKF 703
            IGKG    V  A+ + +G+  AVK          S Q+     E++ +  + H NIVK 
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQK--LFREVRIMKVLNHPNIVKL 78
Query: 704 YGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFP 763
           +      K  +++ EY   G +   L      KE     +    + +  A+ Y H     
Sbjct: 79  FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF---RQIVSAVQYCHQKF-- 133
Query: 764 PIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVT- 822
            IVHRD+ ++N+LLD      ++DFG +       +      G+  Y APEL    K   
Sbjct: 134 -IVHRDLKAENLLLDADMNIKIADFGFSNEFTF-GNKLDTFCGSPPYAAPELFQGKKYDG 191
Query: 823 EKCDVYSFGVLALEVIKGKHPRD 845
            + DV+S GV+   ++ G  P D
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 99/215 (46%), Gaps = 33/215 (15%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLP--------GEMSFQQEEFLNEIQALTEIRH 697
           IG+G  G VY   +   +    KK H  +         GE+S    +FL E   + +  H
Sbjct: 36  IGRGHFGCVYHGTLLDND---GKKIHCAVKSLNRITDIGEVS----QFLTEGIIMKDFSH 88
Query: 698 RNIVKFYGFCSHPKHS-FIIYEYLESGSLDKILCNDA---SAKELGWTQRLNVIKGVADA 753
            N++   G C   + S  ++  Y++ G L   + N+    + K+L     +     VA  
Sbjct: 89  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKG 143
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG---- 809
           + YL +  F   VHRD++++N +LD  +   V+DFG+A+ +  D   +S    T      
Sbjct: 144 MKYLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMY-DKEYYSVHNKTGAKLPV 199
Query: 810 -YVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
            ++A E   T K T K DV+SFGVL  E++    P
Sbjct: 200 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 87/203 (42%), Gaps = 11/203 (5%)
Query: 645 CIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKF 703
            IGKG    V  A+ + +G+  AVK          S Q+     E++ +  + H NIVK 
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQK--LFREVRIMKVLNHPNIVKL 78
Query: 704 YGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFP 763
           +      K  +++ EY   G +   L      KE     +    + +  A+ Y H     
Sbjct: 79  FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF---RQIVSAVQYCHQKF-- 133
Query: 764 PIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVT- 822
            IVHRD+ ++N+LLD      ++DFG +       +      G+  Y APEL    K   
Sbjct: 134 -IVHRDLKAENLLLDADMNIKIADFGFSNEFTF-GNKLDTFCGSPPYAAPELFQGKKYDG 191
Query: 823 EKCDVYSFGVLALEVIKGKHPRD 845
            + DV+S GV+   ++ G  P D
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 99/215 (46%), Gaps = 33/215 (15%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLP--------GEMSFQQEEFLNEIQALTEIRH 697
           IG+G  G VY   +   +    KK H  +         GE+S    +FL E   + +  H
Sbjct: 33  IGRGHFGCVYHGTLLDND---GKKIHCAVKSLNRITDIGEVS----QFLTEGIIMKDFSH 85
Query: 698 RNIVKFYGFCSHPKHS-FIIYEYLESGSLDKILCNDA---SAKELGWTQRLNVIKGVADA 753
            N++   G C   + S  ++  Y++ G L   + N+    + K+L     +     VA  
Sbjct: 86  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKG 140
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG---- 809
           + YL +  F   VHRD++++N +LD  +   V+DFG+A+ +  D   +S    T      
Sbjct: 141 MKYLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMY-DKEYYSVHNKTGAKLPV 196
Query: 810 -YVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
            ++A E   T K T K DV+SFGVL  E++    P
Sbjct: 197 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 231

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 87/203 (42%), Gaps = 11/203 (5%)
Query: 645 CIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKF 703
            IGKG    V  A+ + +G+  AVK          S Q+     E++ +  + H NIVK 
Sbjct: 14  TIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQK--LFREVRIMKVLNHPNIVKL 71
Query: 704 YGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFP 763
           +      K  +++ EY   G +   L      KE    +     + +  A+ Y H     
Sbjct: 72  FEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKE---KEARAKFRQIVSAVQYCHQKF-- 126
Query: 764 PIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVT- 822
            IVHRD+ ++N+LLD      ++DFG +       +      G+  Y APEL    K   
Sbjct: 127 -IVHRDLKAENLLLDADMNIKIADFGFSNEFTF-GNKLDTFCGSPPYAAPELFQGKKYDG 184
Query: 823 EKCDVYSFGVLALEVIKGKHPRD 845
            + DV+S GV+   ++ G  P D
Sbjct: 185 PEVDVWSLGVILYTLVSGSLPFD 207

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 102/215 (47%), Gaps = 33/215 (15%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLP--------GEMSFQQEEFLNEIQALTEIRH 697
           IG+G  G VY   +   +    KK H  +         GE+S    +FL E   + +  H
Sbjct: 39  IGRGHFGCVYHGTLLDND---GKKIHCAVKSLNRITDIGEVS----QFLTEGIIMKDFSH 91
Query: 698 RNIVKFYGFCSHPKHS-FIIYEYLESGSLDKILCNDA---SAKEL-GWTQRLNVIKGVAD 752
            N++   G C   + S  ++  Y++ G L   + N+    + K+L G+   L V KG+  
Sbjct: 92  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG--LQVAKGMK- 148
Query: 753 ALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK-FLNPDSSNWSELAGTH--- 808
              +L +  F   VHRD++++N +LD  +   V+DFG+A+  L+ +  +     G     
Sbjct: 149 ---FLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPV 202
Query: 809 GYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
            ++A E   T K T K DV+SFGVL  E++    P
Sbjct: 203 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 18/206 (8%)
Query: 646 IGKGGHGSV----YRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIV 701
           +G G  GSV    YR +    ++ A+K       G      EE + E Q + ++ +  IV
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDV-AIKVLKQ---GTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 702 KFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNC 761
           +  G C   +   ++ E    G L K L      +E+  +    ++  V+  + YL    
Sbjct: 74  RLIGVC-QAEALMLVMEMAGGGPLHKFLV--GKREEIPVSNVAELLHQVSMGMKYLEEKN 130
Query: 762 FPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPELAYT 818
           F   VHRD++++NVLL   + A +SDFG++K L  D S ++  +       + APE    
Sbjct: 131 F---VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 187
Query: 819 LKVTEKCDVYSFGVLALEVIK-GKHP 843
            K + + DV+S+GV   E +  G+ P
Sbjct: 188 RKFSSRSDVWSYGVTMWEALSYGQKP 213

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 86/203 (42%), Gaps = 11/203 (5%)
Query: 645 CIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKF 703
            IGKG    V  A+ + +G+  AVK          S Q+     E++ +  + H NIVK 
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQK--LFREVRIMKVLNHPNIVKL 78
Query: 704 YGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFP 763
           +      K  +++ EY   G +   L      KE     +    + +  A+ Y H     
Sbjct: 79  FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF---RQIVSAVQYCHQKF-- 133
Query: 764 PIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVT- 822
            IVHRD+ ++N+LLD      ++DFG +       +      G   Y APEL    K   
Sbjct: 134 -IVHRDLKAENLLLDADMNIKIADFGFSNEFTF-GNKLDAFCGAPPYAAPELFQGKKYDG 191
Query: 823 EKCDVYSFGVLALEVIKGKHPRD 845
            + DV+S GV+   ++ G  P D
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 87/203 (42%), Gaps = 11/203 (5%)
Query: 645 CIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKF 703
            IGKG    V  A+ + +G+  AV+          S Q+     E++ +  + H NIVK 
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQK--LFREVRIMKVLNHPNIVKL 78
Query: 704 YGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFP 763
           +      K  +++ EY   G +   L      KE     +    + +  A+ Y H     
Sbjct: 79  FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF---RQIVSAVQYCHQKF-- 133
Query: 764 PIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVT- 822
            IVHRD+ ++N+LLD      ++DFG +       +      G+  Y APEL    K   
Sbjct: 134 -IVHRDLKAENLLLDADMNIKIADFGFSNEFTF-GNKLDTFCGSPPYAAPELFQGKKYDG 191
Query: 823 EKCDVYSFGVLALEVIKGKHPRD 845
            + DV+S GV+   ++ G  P D
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 80/164 (48%), Gaps = 13/164 (7%)
Query: 684 EFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSL-DKILCNDASAKELGWTQ 742
           + L E+  L  + H NI+K Y F    ++ +++ E  + G L D+I+       +     
Sbjct: 82  KLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEII----HRMKFNEVD 137
Query: 743 RLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEA---HVSDFGIAKFLNPDSS 799
              +IK V   + YLH +    IVHRD+  +N+LL+   +     + DFG++     +  
Sbjct: 138 AAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE-NQK 193
Query: 800 NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
              E  GT  Y+APE+    K  EKCDV+S GV+   ++ G  P
Sbjct: 194 KMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPP 236

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 70/270 (25%), Positives = 116/270 (42%), Gaps = 28/270 (10%)
Query: 641 NAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQ-EEFLNEIQALTEIRHRN 699
           +++  IGKG  G VY  +        ++     L      QQ E FL E   +  + H N
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83
Query: 700 IVKFYGFCSHPKH-SFIIYEYLESGSLDKILCN---DASAKELGWTQRLNVIKGVADALF 755
           ++   G    P+    ++  Y+  G L + + +   + + K+L     ++    VA  + 
Sbjct: 84  VLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL-----ISFGLQVARGME 138
Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG-----Y 810
           YL    F   VHRD++++N +LD  +   V+DFG+A+ +  D   +S     H      +
Sbjct: 139 YLAEQKF---VHRDLAARNCMLDESFTVKVADFGLARDI-LDREYYSVQQHRHARLPVKW 194
Query: 811 VAPELAYTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEXXXXXXXXXIEMLDSRLPYP 869
            A E   T + T K DV+SFGVL  E++ +G  P    +                RLP P
Sbjct: 195 TALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP----YRHIDPFDLTHFLAQGRRLPQP 250
Query: 870 SLHVQKKLMSIMQVAFSCLDQNPESRPTMK 899
             +    L  +MQ    C + +P  RPT +
Sbjct: 251 E-YCPDSLYQVMQ---QCWEADPAVRPTFR 276

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 91/202 (45%), Gaps = 15/202 (7%)
Query: 646 IGKGGHGSVYR-AKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G  G V+R  +  +G +F  K  ++P P      +    NEI  + ++ H  ++  +
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYP----LDKYTVKNEISIMNQLHHPKLINLH 114
Query: 705 GFCSHPKHSFIIYEYLESGSL-DKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFP 763
                     +I E+L  G L D+I   D    E    + +N ++   + L ++H +   
Sbjct: 115 DAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSE---AEVINYMRQACEGLKHMHEHS-- 169
Query: 764 PIVHRDISSKNVLLDLGYEAHVS--DFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKV 821
            IVH DI  +N++ +    + V   DFG+A  LNPD       A T  + APE+     V
Sbjct: 170 -IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTA-TAEFAAPEIVDREPV 227
Query: 822 TEKCDVYSFGVLALEVIKGKHP 843
               D+++ GVL   ++ G  P
Sbjct: 228 GFYTDMWAIGVLGYVLLSGLSP 249

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/297 (22%), Positives = 122/297 (41%), Gaps = 56/297 (18%)
Query: 639 DFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH 697
           DF     IG GG G V++AK    G+ + +++        + +  E+   E++AL ++ H
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRR--------VKYNNEKAEREVKALAKLDH 64
Query: 698 RNIVKFYG----FCSHPKHS-------------------------FIIYEYLESGSLDKI 728
            NIV + G    F   P+ S                         FI  E+ + G+L++ 
Sbjct: 65  VNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQW 124
Query: 729 LCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDF 788
           +      ++L     L + + +   + Y+H+     ++HRD+   N+ L    +  + DF
Sbjct: 125 I-EKRRGEKLDKVLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIGDF 180
Query: 789 GIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLF 848
           G+   L  D    +   GT  Y++PE   +    ++ D+Y+ G++  E++   H  D  F
Sbjct: 181 GLVTSLKNDGKR-TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL---HVCDTAF 236
Query: 849 EXXXXXXXXXIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
           E             D R    S    KK  +++Q     L + PE RP    + + L
Sbjct: 237 ETSKF-------FTDLRDGIISDIFDKKEKTLLQ---KLLSKKPEDRPNTSEILRTL 283

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 19/205 (9%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           IG+G +G V  A     ++    K  SP   +   Q+   L EI+ L   RH NI+    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT--LREIKILLRFRHENIIGIND 92
Query: 706 FCSHP-----KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
               P     K  +I+ + +E+     + C   S   + +      +  +   L Y+H+ 
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICY-----FLYQILRGLKYIHS- 146
Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN---WSELAGTHGYVAPELAY 817
               ++HRD+   N+LL+   +  + DFG+A+  +PD  +    +E   T  Y APE+  
Sbjct: 147 --ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 818 TLK-VTEKCDVYSFGVLALEVIKGK 841
             K  T+  D++S G +  E++  +
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 17/215 (7%)
Query: 636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSP-----LPGEMSFQQEEFLNEI 689
           AT+ +     IG G +G+VY+A+ P SG   A+K    P     LP  +S  +E  L  +
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLP--ISTVREVAL--L 57
Query: 690 QALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKIL---CNDASAKELGWTQRLNV 746
           + L    H N+V+    C+  +    I   L    +D+ L    + A    L      ++
Sbjct: 58  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL 117
Query: 747 IKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAG 806
           ++     L +LH NC   IVHRD+  +N+L+  G    ++DFG+A+  +   +  + +  
Sbjct: 118 MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-LAPVVV 173
Query: 807 THGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGK 841
           T  Y APE+          D++S G +  E+ + K
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 22/214 (10%)
Query: 638 NDFNAEHCIGKGGHGSV--YRAKVPSGEIFAVKKFHSPLPGEMSFQQEEF---LNEIQAL 692
           NDF+    +GKG  G V   R K  +G  +A+K     L  E+   ++E    + E + L
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKA-TGRYYAMK----ILRKEVIIAKDEVAHTVTESRVL 59
Query: 693 TEIRHRNIVKF-YGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKG-- 749
              RH  +    Y F +H +  F++ EY   G L   L     ++E  +T+      G  
Sbjct: 60  QNTRHPFLTALKYAFQTHDRLCFVM-EYANGGELFFHL-----SRERVFTEERARFYGAE 113
Query: 750 VADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG 809
           +  AL YLH+     +V+RDI  +N++LD      ++DFG+ K    D +      GT  
Sbjct: 114 IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 170
Query: 810 YVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           Y+APE+          D +  GV+  E++ G+ P
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 72/305 (23%), Positives = 127/305 (41%), Gaps = 47/305 (15%)
Query: 631 EEIISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQE--EFLNE 688
           E+++   N       +G+G  GSV    +   +  ++K     +  + S Q+E  EFL+E
Sbjct: 27  EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSE 86
Query: 689 IQALTEIRHRNIVKFYGFCSH------PK-------------HSFIIYEYLESGSLDKIL 729
              + +  H N+++  G C        PK             H++++Y  LE+G      
Sbjct: 87  AACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETG------ 140
Query: 730 CNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFG 789
                 K +     L  +  +A  + YL N  F   +HRD++++N +L       V+DFG
Sbjct: 141 -----PKHIPLQTLLKFMVDIALGMEYLSNRNF---LHRDLAARNCMLRDDMTVCVADFG 192
Query: 790 IAKFL-NPDSSNWSELAGTH-GYVAPELAYTLKVTEKCDVYSFGVLALEV-IKGKHPRDF 846
           ++K + + D      +A     ++A E       T K DV++FGV   E+  +G  P   
Sbjct: 193 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP--- 249
Query: 847 LFEXXXXXXXXXIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLC 906
            +            +   RL  P    +  L  + ++ +SC   +P  RPT   V +L  
Sbjct: 250 -YPGVQNHEMYDYLLHGHRLKQP----EDCLDELYEIMYSCWRTDPLDRPTFS-VLRLQL 303
Query: 907 EKIFE 911
           EK+ E
Sbjct: 304 EKLLE 308

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 22/214 (10%)
Query: 638 NDFNAEHCIGKGGHGSV--YRAKVPSGEIFAVKKFHSPLPGEMSFQQEEF---LNEIQAL 692
           NDF+    +GKG  G V   R K  +G  +A+K     L  E+   ++E    + E + L
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKA-TGRYYAMK----ILRKEVIIAKDEVAHTVTESRVL 59
Query: 693 TEIRHRNIVKF-YGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKG-- 749
              RH  +    Y F +H +  F++ EY   G L   L     ++E  +T+      G  
Sbjct: 60  QNTRHPFLTALKYAFQTHDRLCFVM-EYANGGELFFHL-----SRERVFTEERARFYGAE 113
Query: 750 VADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG 809
           +  AL YLH+     +V+RDI  +N++LD      ++DFG+ K    D +      GT  
Sbjct: 114 IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPE 170
Query: 810 YVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           Y+APE+          D +  GV+  E++ G+ P
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 22/214 (10%)
Query: 638 NDFNAEHCIGKGGHGSV--YRAKVPSGEIFAVKKFHSPLPGEMSFQQEEF---LNEIQAL 692
           NDF+    +GKG  G V   R K  +G  +A+K     L  E+   ++E    + E + L
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKA-TGRYYAMK----ILRKEVIIAKDEVAHTVTESRVL 59
Query: 693 TEIRHRNIVKF-YGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKG-- 749
              RH  +    Y F +H +  F++ EY   G L   L     ++E  +T+      G  
Sbjct: 60  QNTRHPFLTALKYAFQTHDRLCFVM-EYANGGELFFHL-----SRERVFTEERARFYGAE 113
Query: 750 VADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG 809
           +  AL YLH+     +V+RDI  +N++LD      ++DFG+ K    D +      GT  
Sbjct: 114 IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 170
Query: 810 YVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           Y+APE+          D +  GV+  E++ G+ P
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 20/211 (9%)
Query: 640 FNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHR 698
           +N    +GKG  G V + K   + + +AVK  +       +      L E++ L ++ H 
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKA--SAKNKDTSTILREVELLKKLDHP 81
Query: 699 NIVKFYGFCSHPKHSFIIYEYLESGSL-DKILCNDASAKELGWTQRLNVIKGVADALFYL 757
           NI+K +         +I+ E    G L D+I+      K         +IK V   + Y+
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEII----KRKRFSEHDAARIIKQVFSGITYM 137
Query: 758 HNNCFPPIVHRDISSKNVLLD---LGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPE 814
           H +    IVHRD+  +N+LL+      +  + DFG++     ++    +  GT  Y+APE
Sbjct: 138 HKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-KMKDRIGTAYYIAPE 193
Query: 815 LAYTLKVT--EKCDVYSFGVLALEVIKGKHP 843
           +   L+ T  EKCDV+S GV+   ++ G  P
Sbjct: 194 V---LRGTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 22/214 (10%)
Query: 638 NDFNAEHCIGKGGHGSV--YRAKVPSGEIFAVKKFHSPLPGEMSFQQEEF---LNEIQAL 692
           NDF+    +GKG  G V   R K  +G  +A+K     L  E+   ++E    + E + L
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKA-TGRYYAMK----ILRKEVIIAKDEVAHTVTESRVL 59
Query: 693 TEIRHRNIVKF-YGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKG-- 749
              RH  +    Y F +H +  F++ EY   G L   L     ++E  +T+      G  
Sbjct: 60  QNTRHPFLTALKYAFQTHDRLCFVM-EYANGGELFFHL-----SRERVFTEERARFYGAE 113
Query: 750 VADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG 809
           +  AL YLH+     +V+RDI  +N++LD      ++DFG+ K    D +      GT  
Sbjct: 114 IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPE 170
Query: 810 YVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           Y+APE+          D +  GV+  E++ G+ P
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 22/214 (10%)
Query: 638 NDFNAEHCIGKGGHGSV--YRAKVPSGEIFAVKKFHSPLPGEMSFQQEEF---LNEIQAL 692
           NDF+    +GKG  G V   R K  +G  +A+K     L  E+   ++E    + E + L
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKA-TGRYYAMK----ILRKEVIIAKDEVAHTVTESRVL 59
Query: 693 TEIRHRNIVKF-YGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKG-- 749
              RH  +    Y F +H +  F++ EY   G L   L     ++E  +T+      G  
Sbjct: 60  QNTRHPFLTALKYAFQTHDRLCFVM-EYANGGELFFHL-----SRERVFTEERARFYGAE 113
Query: 750 VADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG 809
           +  AL YLH+     +V+RDI  +N++LD      ++DFG+ K    D +      GT  
Sbjct: 114 IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPE 170
Query: 810 YVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           Y+APE+          D +  GV+  E++ G+ P
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 22/214 (10%)
Query: 638 NDFNAEHCIGKGGHGSV--YRAKVPSGEIFAVKKFHSPLPGEMSFQQEEF---LNEIQAL 692
           NDF+    +GKG  G V   R K  +G  +A+K     L  E+   ++E    + E + L
Sbjct: 8   NDFDYLKLLGKGTFGKVILVREKA-TGRYYAMK----ILRKEVIIAKDEVAHTVTESRVL 62
Query: 693 TEIRHRNIVKF-YGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKG-- 749
              RH  +    Y F +H +  F++ EY   G L   L     ++E  +T+      G  
Sbjct: 63  QNTRHPFLTALKYAFQTHDRLCFVM-EYANGGELFFHL-----SRERVFTEERARFYGAE 116
Query: 750 VADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG 809
           +  AL YLH+     +V+RDI  +N++LD      ++DFG+ K    D +      GT  
Sbjct: 117 IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 173
Query: 810 YVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           Y+APE+          D +  GV+  E++ G+ P
Sbjct: 174 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 207

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 22/214 (10%)
Query: 638 NDFNAEHCIGKGGHGSV--YRAKVPSGEIFAVKKFHSPLPGEMSFQQEEF---LNEIQAL 692
           NDF+    +GKG  G V   R K  +G  +A+K     L  E+   ++E    + E + L
Sbjct: 10  NDFDYLKLLGKGTFGKVILVREKA-TGRYYAMK----ILRKEVIIAKDEVAHTVTESRVL 64
Query: 693 TEIRHRNIVKF-YGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKG-- 749
              RH  +    Y F +H +  F++ EY   G L   L     ++E  +T+      G  
Sbjct: 65  QNTRHPFLTALKYAFQTHDRLCFVM-EYANGGELFFHL-----SRERVFTEERARFYGAE 118
Query: 750 VADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG 809
           +  AL YLH+     +V+RDI  +N++LD      ++DFG+ K    D +      GT  
Sbjct: 119 IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPE 175
Query: 810 YVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           Y+APE+          D +  GV+  E++ G+ P
Sbjct: 176 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 17/215 (7%)
Query: 636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSP-----LPGEMSFQQEEFLNEI 689
           AT+ +     IG G +G+VY+A+ P SG   A+K    P     LP  +S  +E  L  +
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLP--ISTVREVAL--L 57
Query: 690 QALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKIL---CNDASAKELGWTQRLNV 746
           + L    H N+V+    C+  +    I   L    +D+ L    + A    L      ++
Sbjct: 58  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL 117
Query: 747 IKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAG 806
           ++     L +LH NC   IVHRD+  +N+L+  G    ++DFG+A+  +   + +  +  
Sbjct: 118 MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVV- 173
Query: 807 THGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGK 841
           T  Y APE+          D++S G +  E+ + K
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Composition-based stats.
 Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 21/215 (9%)
Query: 639 DFNAEHCIGKGGHGSVYRA-KVPSGEIFAVK--KFHSPLPGEMSFQQEEFLNEIQALTEI 695
           D++    +G+G +G V  A    + E  AVK       +    + ++E  +N++     +
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKM-----L 61
Query: 696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRL--NVIKGVADA 753
            H N+VKFYG        ++  EY   G L   +  D    E    QR    ++ GV   
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMAGVV-- 118
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL--NPDSSNWSELAGTHGYV 811
             YLH      I HRDI  +N+LLD      +SDFG+A     N      +++ GT  YV
Sbjct: 119 --YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 812 APELAYTLKV-TEKCDVYSFGVLALEVIKGKHPRD 845
           APEL    +   E  DV+S G++   ++ G+ P D
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 97/218 (44%), Gaps = 24/218 (11%)
Query: 638 NDFNAEHCIGKGGHGSVYRAKVPSGEI---FAVKKFHSPLPGEMSFQQEEFLNEIQALTE 694
           ND   +  IG+G  G V +A++    +    A+K+       +      +F  E++ L +
Sbjct: 22  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD---DHRDFAGELEVLCK 78
Query: 695 IRHR-NIVKFYGFCSHPKHSFIIYEYLESGSL------DKILCND-------ASAKELGW 740
           + H  NI+   G C H  + ++  EY   G+L       ++L  D       ++A  L  
Sbjct: 79  LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 138
Query: 741 TQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN 800
            Q L+    VA  + YL    F   +HR+++++N+L+   Y A ++DFG+++        
Sbjct: 139 QQLLHFAADVARGMDYLSQKQF---IHRNLAARNILVGENYVAKIADFGLSRGQEVYVKK 195
Query: 801 WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVI 838
                         L Y++  T   DV+S+GVL  E++
Sbjct: 196 TMGRLPVRWMAIESLNYSVYTTNS-DVWSYGVLLWEIV 232

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 17/215 (7%)
Query: 636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSP-----LPGEMSFQQEEFLNEI 689
           AT+ +     IG G +G+VY+A+ P SG   A+K    P     LP  +S  +E  L  +
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLP--ISTVREVAL--L 57
Query: 690 QALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKIL---CNDASAKELGWTQRLNV 746
           + L    H N+V+    C+  +    I   L    +D+ L    + A    L      ++
Sbjct: 58  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL 117
Query: 747 IKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAG 806
           ++     L +LH NC   IVHRD+  +N+L+  G    ++DFG+A+  +   +    +  
Sbjct: 118 MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-LDPVVV 173
Query: 807 THGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGK 841
           T  Y APE+          D++S G +  E+ + K
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Composition-based stats.
 Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 21/215 (9%)
Query: 639 DFNAEHCIGKGGHGSVYRA-KVPSGEIFAVK--KFHSPLPGEMSFQQEEFLNEIQALTEI 695
           D++    +G+G +G V  A    + E  AVK       +    + ++E  +N++     +
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKM-----L 61
Query: 696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRL--NVIKGVADA 753
            H N+VKFYG        ++  EY   G L   +  D    E    QR    ++ GV   
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMAGVV-- 118
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL--NPDSSNWSELAGTHGYV 811
             YLH      I HRDI  +N+LLD      +SDFG+A     N      +++ GT  YV
Sbjct: 119 --YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 173
Query: 812 APELAYTLKV-TEKCDVYSFGVLALEVIKGKHPRD 845
           APEL    +   E  DV+S G++   ++ G+ P D
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Composition-based stats.
 Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 21/215 (9%)
Query: 639 DFNAEHCIGKGGHGSVYRA-KVPSGEIFAVK--KFHSPLPGEMSFQQEEFLNEIQALTEI 695
           D++    +G+G +G V  A    + E  AVK       +    + ++E  +N++     +
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKM-----L 62
Query: 696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRL--NVIKGVADA 753
            H N+VKFYG        ++  EY   G L   +  D    E    QR    ++ GV   
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMAGVV-- 119
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL--NPDSSNWSELAGTHGYV 811
             YLH      I HRDI  +N+LLD      +SDFG+A     N      +++ GT  YV
Sbjct: 120 --YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 174
Query: 812 APELAYTLKV-TEKCDVYSFGVLALEVIKGKHPRD 845
           APEL    +   E  DV+S G++   ++ G+ P D
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 96/225 (42%), Gaps = 26/225 (11%)
Query: 631 EEIISATNDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEI 689
           EE+  AT+       +G+G  G V+R +   +G   AVKK    +     F+ EE +   
Sbjct: 71  EEVHWATHQLR----LGRGSFGEVHRMEDKQTGFQCAVKKVRLEV-----FRAEELMA-C 120
Query: 690 QALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKG 749
             LT  R   IV  YG         I  E LE GSL +++       E    + L  +  
Sbjct: 121 AGLTSPR---IVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPE---DRALYYLGQ 174
Query: 750 VADALFYLHNNCFPPIVHRDISSKNVLLDL-GYEAHVSDFGIAKFLNPDSSNWSELAG-- 806
             + L YLH+     I+H D+ + NVLL   G  A + DFG A  L PD      L G  
Sbjct: 175 ALEGLEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDY 231
Query: 807 ---THGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLF 848
              T  ++APE+        K DV+S   + L ++ G HP    F
Sbjct: 232 IPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFF 276

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 14/203 (6%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +GKG    V R  KV +G+ +A K  ++        Q+ E   E +    ++H NIV+ +
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLE--REARICRLLKHPNIVRLH 87
Query: 705 GFCSHPKHSFIIYEYLESGSLDKILCNDASAKEL-GWTQRLNVIKGVADALFYLHNNCFP 763
              S   H ++I++ +  G L      D  A+E        + I+ + +A+ + H     
Sbjct: 88  DSISEEGHHYLIFDLVTGGEL----FEDIVAREYYSEADASHCIQQILEAVLHCHQM--- 140
Query: 764 PIVHRDISSKNVLLD---LGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLK 820
            +VHRD+  +N+LL     G    ++DFG+A  +  +   W   AGT GY++PE+     
Sbjct: 141 GVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDP 200
Query: 821 VTEKCDVYSFGVLALEVIKGKHP 843
             +  D+++ GV+   ++ G  P
Sbjct: 201 YGKPVDLWACGVILYILLVGYPP 223

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 105/229 (45%), Gaps = 34/229 (14%)
Query: 627 KIVYEEIISATNDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEF 685
           +IVY    + ++DF  +  +G+G +G V  A   P+GEI A+KK     P +        
Sbjct: 4   RIVY----NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE---PFDKPLFALRT 56
Query: 686 LNEIQALTEIRHRNIVKFYGFCSHPK------HSFIIYEYLESGSLDKILCNDASAKELG 739
           L EI+ L   +H NI+  +     P         +II E +++  L +++    S + L 
Sbjct: 57  LREIKILKHFKHENIITIFNI-QRPDSFENFNEVYIIQELMQT-DLHRVI----STQMLS 110
Query: 740 WTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSS 799
                  I     A+  LH +    ++HRD+   N+L++   +  V DFG+A+ ++  ++
Sbjct: 111 DDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167
Query: 800 NWSELAG----------THGYVAPELAYT-LKVTEKCDVYSFGVLALEV 837
           + SE  G          T  Y APE+  T  K +   DV+S G +  E+
Sbjct: 168 DNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 105/229 (45%), Gaps = 34/229 (14%)
Query: 627 KIVYEEIISATNDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEF 685
           +IVY    + ++DF  +  +G+G +G V  A   P+GEI A+KK     P +        
Sbjct: 4   RIVY----NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE---PFDKPLFALRT 56
Query: 686 LNEIQALTEIRHRNIVKFYGFCSHPK------HSFIIYEYLESGSLDKILCNDASAKELG 739
           L EI+ L   +H NI+  +     P         +II E +++  L +++    S + L 
Sbjct: 57  LREIKILKHFKHENIITIFNI-QRPDSFENFNEVYIIQELMQT-DLHRVI----STQMLS 110
Query: 740 WTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSS 799
                  I     A+  LH +    ++HRD+   N+L++   +  V DFG+A+ ++  ++
Sbjct: 111 DDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167
Query: 800 NWSELAG----------THGYVAPELAYT-LKVTEKCDVYSFGVLALEV 837
           + SE  G          T  Y APE+  T  K +   DV+S G +  E+
Sbjct: 168 DNSEPTGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 94/214 (43%), Gaps = 9/214 (4%)
Query: 632 EIISATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQ 690
           +I     DF     +GKG  G V+ A+   + + FA+K     +   M    E  + E +
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVL-MDDDVECTMVEKR 70
Query: 691 ALT-EIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKG 749
            L+    H  +   +      ++ F + EYL  G L   + +  S  +   ++       
Sbjct: 71  VLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAAE 127
Query: 750 VADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG 809
           +   L +LH+     IV+RD+   N+LLD      ++DFG+ K      +  +E  GT  
Sbjct: 128 IILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPD 184
Query: 810 YVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           Y+APE+    K     D +SFGVL  E++ G+ P
Sbjct: 185 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 218

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 99/218 (45%), Gaps = 20/218 (9%)
Query: 636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSP--------LPGEMSFQQEEFL 686
           AT+ +     IG G +G+VY+A+ P SG   A+K    P        LP  +S  +E  L
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLP--ISTVREVAL 64
Query: 687 NEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKIL---CNDASAKELGWTQR 743
             ++ L    H N+V+    C+  +    I   L    +D+ L    + A    L     
Sbjct: 65  --LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETI 122
Query: 744 LNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSE 803
            ++++     L +LH NC   IVHRD+  +N+L+  G    ++DFG+A+  +   +  + 
Sbjct: 123 KDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-LTP 178
Query: 804 LAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGK 841
           +  T  Y APE+          D++S G +  E+ + K
Sbjct: 179 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Composition-based stats.
 Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 21/215 (9%)
Query: 639 DFNAEHCIGKGGHGSVYRA-KVPSGEIFAVK--KFHSPLPGEMSFQQEEFLNEIQALTEI 695
           D++    +G+G +G V  A    + E  AVK       +    + ++E  +N++     +
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM-----L 62
Query: 696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRL--NVIKGVADA 753
            H N+VKFYG        ++  EY   G L   +  D    E    QR    ++ GV   
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMAGVV-- 119
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL--NPDSSNWSELAGTHGYV 811
             YLH      I HRDI  +N+LLD      +SDFG+A     N      +++ GT  YV
Sbjct: 120 --YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 812 APELAYTLKV-TEKCDVYSFGVLALEVIKGKHPRD 845
           APEL    +   E  DV+S G++   ++ G+ P D
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Composition-based stats.
 Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 21/215 (9%)
Query: 639 DFNAEHCIGKGGHGSVYRA-KVPSGEIFAVK--KFHSPLPGEMSFQQEEFLNEIQALTEI 695
           D++    +G+G +G V  A    + E  AVK       +    + ++E  +N++     +
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM-----L 62
Query: 696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRL--NVIKGVADA 753
            H N+VKFYG        ++  EY   G L   +  D    E    QR    ++ GV   
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMAGVV-- 119
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL--NPDSSNWSELAGTHGYV 811
             YLH      I HRDI  +N+LLD      +SDFG+A     N      +++ GT  YV
Sbjct: 120 --YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 812 APELAYTLKV-TEKCDVYSFGVLALEVIKGKHPRD 845
           APEL    +   E  DV+S G++   ++ G+ P D
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Composition-based stats.
 Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 21/215 (9%)
Query: 639 DFNAEHCIGKGGHGSVYRA-KVPSGEIFAVK--KFHSPLPGEMSFQQEEFLNEIQALTEI 695
           D++    +G+G +G V  A    + E  AVK       +    + ++E  +N++     +
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM-----L 60
Query: 696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRL--NVIKGVADA 753
            H N+VKFYG        ++  EY   G L   +  D    E    QR    ++ GV   
Sbjct: 61  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMAGVV-- 117
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL--NPDSSNWSELAGTHGYV 811
             YLH      I HRDI  +N+LLD      +SDFG+A     N      +++ GT  YV
Sbjct: 118 --YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 172
Query: 812 APELAYTLKV-TEKCDVYSFGVLALEVIKGKHPRD 845
           APEL    +   E  DV+S G++   ++ G+ P D
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 207

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Composition-based stats.
 Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 21/215 (9%)
Query: 639 DFNAEHCIGKGGHGSVYRA-KVPSGEIFAVK--KFHSPLPGEMSFQQEEFLNEIQALTEI 695
           D++    +G+G +G V  A    + E  AVK       +    + ++E  +N++     +
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM-----L 61
Query: 696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRL--NVIKGVADA 753
            H N+VKFYG        ++  EY   G L   +  D    E    QR    ++ GV   
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMAGVV-- 118
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL--NPDSSNWSELAGTHGYV 811
             YLH      I HRDI  +N+LLD      +SDFG+A     N      +++ GT  YV
Sbjct: 119 --YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 812 APELAYTLKV-TEKCDVYSFGVLALEVIKGKHPRD 845
           APEL    +   E  DV+S G++   ++ G+ P D
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Composition-based stats.
 Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 21/215 (9%)
Query: 639 DFNAEHCIGKGGHGSVYRA-KVPSGEIFAVK--KFHSPLPGEMSFQQEEFLNEIQALTEI 695
           D++    +G+G +G V  A    + E  AVK       +    + ++E  +N++     +
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM-----L 61
Query: 696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRL--NVIKGVADA 753
            H N+VKFYG        ++  EY   G L   +  D    E    QR    ++ GV   
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMAGVV-- 118
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL--NPDSSNWSELAGTHGYV 811
             YLH      I HRDI  +N+LLD      +SDFG+A     N      +++ GT  YV
Sbjct: 119 --YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 812 APELAYTLKV-TEKCDVYSFGVLALEVIKGKHPRD 845
           APEL    +   E  DV+S G++   ++ G+ P D
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Composition-based stats.
 Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 21/215 (9%)
Query: 639 DFNAEHCIGKGGHGSVYRA-KVPSGEIFAVK--KFHSPLPGEMSFQQEEFLNEIQALTEI 695
           D++    +G+G +G V  A    + E  AVK       +    + ++E  +N++     +
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM-----L 62
Query: 696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRL--NVIKGVADA 753
            H N+VKFYG        ++  EY   G L   +  D    E    QR    ++ GV   
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMAGVV-- 119
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL--NPDSSNWSELAGTHGYV 811
             YLH      I HRDI  +N+LLD      +SDFG+A     N      +++ GT  YV
Sbjct: 120 --YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 812 APELAYTLKV-TEKCDVYSFGVLALEVIKGKHPRD 845
           APEL    +   E  DV+S G++   ++ G+ P D
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Composition-based stats.
 Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 21/215 (9%)
Query: 639 DFNAEHCIGKGGHGSVYRA-KVPSGEIFAVK--KFHSPLPGEMSFQQEEFLNEIQALTEI 695
           D++    +G+G +G V  A    + E  AVK       +    + ++E  +N++     +
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM-----L 61
Query: 696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRL--NVIKGVADA 753
            H N+VKFYG        ++  EY   G L   +  D    E    QR    ++ GV   
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMAGVV-- 118
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL--NPDSSNWSELAGTHGYV 811
             YLH      I HRDI  +N+LLD      +SDFG+A     N      +++ GT  YV
Sbjct: 119 --YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 812 APELAYTLKV-TEKCDVYSFGVLALEVIKGKHPRD 845
           APEL    +   E  DV+S G++   ++ G+ P D
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Composition-based stats.
 Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 21/215 (9%)
Query: 639 DFNAEHCIGKGGHGSVYRA-KVPSGEIFAVK--KFHSPLPGEMSFQQEEFLNEIQALTEI 695
           D++    +G+G +G V  A    + E  AVK       +    + ++E  +N++     +
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM-----L 61
Query: 696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRL--NVIKGVADA 753
            H N+VKFYG        ++  EY   G L   +  D    E    QR    ++ GV   
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMAGVV-- 118
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL--NPDSSNWSELAGTHGYV 811
             YLH      I HRDI  +N+LLD      +SDFG+A     N      +++ GT  YV
Sbjct: 119 --YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 812 APELAYTLKV-TEKCDVYSFGVLALEVIKGKHPRD 845
           APEL    +   E  DV+S G++   ++ G+ P D
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Composition-based stats.
 Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 21/215 (9%)
Query: 639 DFNAEHCIGKGGHGSVYRA-KVPSGEIFAVK--KFHSPLPGEMSFQQEEFLNEIQALTEI 695
           D++    +G+G +G V  A    + E  AVK       +    + ++E  +N++     +
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM-----L 61
Query: 696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRL--NVIKGVADA 753
            H N+VKFYG        ++  EY   G L   +  D    E    QR    ++ GV   
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMAGVV-- 118
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL--NPDSSNWSELAGTHGYV 811
             YLH      I HRDI  +N+LLD      +SDFG+A     N      +++ GT  YV
Sbjct: 119 --YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 812 APELAYTLKV-TEKCDVYSFGVLALEVIKGKHPRD 845
           APEL    +   E  DV+S G++   ++ G+ P D
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Composition-based stats.
 Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 21/215 (9%)
Query: 639 DFNAEHCIGKGGHGSVYRA-KVPSGEIFAVK--KFHSPLPGEMSFQQEEFLNEIQALTEI 695
           D++    +G+G +G V  A    + E  AVK       +    + ++E  +N++     +
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM-----L 62
Query: 696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRL--NVIKGVADA 753
            H N+VKFYG        ++  EY   G L   +  D    E    QR    ++ GV   
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMAGVV-- 119
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL--NPDSSNWSELAGTHGYV 811
             YLH      I HRDI  +N+LLD      +SDFG+A     N      +++ GT  YV
Sbjct: 120 --YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 812 APELAYTLKV-TEKCDVYSFGVLALEVIKGKHPRD 845
           APEL    +   E  DV+S G++   ++ G+ P D
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Composition-based stats.
 Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 21/215 (9%)
Query: 639 DFNAEHCIGKGGHGSVYRA-KVPSGEIFAVK--KFHSPLPGEMSFQQEEFLNEIQALTEI 695
           D++    +G+G +G V  A    + E  AVK       +    + ++E  +N++     +
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM-----L 62
Query: 696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRL--NVIKGVADA 753
            H N+VKFYG        ++  EY   G L   +  D    E    QR    ++ GV   
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMAGVV-- 119
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL--NPDSSNWSELAGTHGYV 811
             YLH      I HRDI  +N+LLD      +SDFG+A     N      +++ GT  YV
Sbjct: 120 --YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 812 APELAYTLKV-TEKCDVYSFGVLALEVIKGKHPRD 845
           APEL    +   E  DV+S G++   ++ G+ P D
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 105/229 (45%), Gaps = 34/229 (14%)
Query: 627 KIVYEEIISATNDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEF 685
           +IVY    + ++DF  +  +G+G +G V  A   P+GEI A+KK     P +        
Sbjct: 4   RIVY----NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE---PFDKPLFALRT 56
Query: 686 LNEIQALTEIRHRNIVKFYGFCSHPK------HSFIIYEYLESGSLDKILCNDASAKELG 739
           L EI+ L   +H NI+  +     P         +II E +++  L +++    S + L 
Sbjct: 57  LREIKILKHFKHENIITIFNI-QRPDSFENFNEVYIIQELMQT-DLHRVI----STQMLS 110
Query: 740 WTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSS 799
                  I     A+  LH +    ++HRD+   N+L++   +  V DFG+A+ ++  ++
Sbjct: 111 DDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167
Query: 800 NWSELAG----------THGYVAPELAYT-LKVTEKCDVYSFGVLALEV 837
           + SE  G          T  Y APE+  T  K +   DV+S G +  E+
Sbjct: 168 DNSEPTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 76/329 (23%), Positives = 135/329 (41%), Gaps = 49/329 (14%)
Query: 594 FFFIFHQRKNDSQTQQSSFGNTPGLRSV--LTFEGKIVY--EEIISATNDFNAEHCIGKG 649
             ++FH+++N+S+      GN     SV    F    VY  +E   A         +G+G
Sbjct: 4   MLYVFHRKRNNSR-----LGNGVLYASVNPEYFSAADVYVPDEWEVAREKITMSRELGQG 58
Query: 650 GHGSVYRAKVPSGEI-------FAVKKFHSPLPGEMSFQQE--EFLNEIQALTEIRHRNI 700
             G VY   V  G +        A+K  +     E +  +E  EFLNE   + E    ++
Sbjct: 59  SFGMVYEG-VAKGVVKDEPETRVAIKTVN-----EAASMRERIEFLNEASVMKEFNCHHV 112
Query: 701 VKFYGFCSHPKHSFIIYEYLESGSLDKILC-------NDASAKELGWTQRLNVIKGVADA 753
           V+  G  S  + + +I E +  G L   L        N+        ++ + +   +AD 
Sbjct: 113 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 172
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH----G 809
           + YL+ N F   VHRD++++N ++   +   + DFG+ + +    +++    G       
Sbjct: 173 MAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPVR 227
Query: 810 YVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPY 868
           +++PE       T   DV+SFGV+  E+    + P   L             +LD     
Sbjct: 228 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNC 287
Query: 869 PSLHVQKKLMSIMQVAFSCLDQNPESRPT 897
           P +     L  +M++   C   NP+ RP+
Sbjct: 288 PDM-----LFELMRM---CWQYNPKMRPS 308

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Composition-based stats.
 Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 21/215 (9%)
Query: 639 DFNAEHCIGKGGHGSVYRA-KVPSGEIFAVK--KFHSPLPGEMSFQQEEFLNEIQALTEI 695
           D++    +G+G +G V  A    + E  AVK       +    + ++E  +N++     +
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM-----L 61
Query: 696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRL--NVIKGVADA 753
            H N+VKFYG        ++  EY   G L   +  D    E    QR    ++ GV   
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMAGVV-- 118
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL--NPDSSNWSELAGTHGYV 811
             YLH      I HRDI  +N+LLD      +SDFG+A     N      +++ GT  YV
Sbjct: 119 --YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 173
Query: 812 APELAYTLKV-TEKCDVYSFGVLALEVIKGKHPRD 845
           APEL    +   E  DV+S G++   ++ G+ P D
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Composition-based stats.
 Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 21/215 (9%)
Query: 639 DFNAEHCIGKGGHGSVYRA-KVPSGEIFAVK--KFHSPLPGEMSFQQEEFLNEIQALTEI 695
           D++    +G+G +G V  A    + E  AVK       +    + ++E  +N++     +
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM-----L 61
Query: 696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRL--NVIKGVADA 753
            H N+VKFYG        ++  EY   G L   +  D    E    QR    ++ GV   
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMAGVV-- 118
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL--NPDSSNWSELAGTHGYV 811
             YLH      I HRDI  +N+LLD      +SDFG+A     N      +++ GT  YV
Sbjct: 119 --YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 173
Query: 812 APELAYTLKV-TEKCDVYSFGVLALEVIKGKHPRD 845
           APEL    +   E  DV+S G++   ++ G+ P D
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Composition-based stats.
 Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 21/215 (9%)
Query: 639 DFNAEHCIGKGGHGSVYRA-KVPSGEIFAVK--KFHSPLPGEMSFQQEEFLNEIQALTEI 695
           D++    +G+G +G V  A    + E  AVK       +    + ++E  +N++     +
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM-----L 61
Query: 696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRL--NVIKGVADA 753
            H N+VKFYG        ++  EY   G L   +  D    E    QR    ++ GV   
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMAGVV-- 118
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL--NPDSSNWSELAGTHGYV 811
             YLH      I HRDI  +N+LLD      +SDFG+A     N      +++ GT  YV
Sbjct: 119 --YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 173
Query: 812 APELAYTLKV-TEKCDVYSFGVLALEVIKGKHPRD 845
           APEL    +   E  DV+S G++   ++ G+ P D
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 98/215 (45%), Gaps = 21/215 (9%)
Query: 639 DFNAEHCIGKGGHGSVYRA-KVPSGEIFAVK--KFHSPLPGEMSFQQEEFLNEIQALTEI 695
           D++    +G+G +G V  A    + E  AVK       +    + ++E  +N++     +
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM-----L 62
Query: 696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRL--NVIKGVADA 753
            H N+VKFYG        ++  EY   G L   +  D    E    QR    ++ GV   
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMAGVV-- 119
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNW--SELAGTHGYV 811
             YLH      I HRDI  +N+LLD      +SDFG+A     ++     +++ GT  YV
Sbjct: 120 --YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 812 APELAYTLKV-TEKCDVYSFGVLALEVIKGKHPRD 845
           APEL    +   E  DV+S G++   ++ G+ P D
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 74/153 (48%), Gaps = 13/153 (8%)
Query: 685 FLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSL-DKILCNDASAKELGWTQR 743
            L+E+  L ++ H NI+K Y F    ++ +++ E    G L D+I+      ++      
Sbjct: 51  LLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILR----QKFSEVDA 106
Query: 744 LNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEA---HVSDFGIAKFLNPDSSN 800
             ++K V     YLH +    IVHRD+  +N+LL+         + DFG++         
Sbjct: 107 AVIMKQVLSGTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEV-GGK 162
Query: 801 WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVL 833
             E  GT  Y+APE+    K  EKCDV+S GV+
Sbjct: 163 MKERLGTAYYIAPEVLRK-KYDEKCDVWSCGVI 194

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 90/203 (44%), Gaps = 19/203 (9%)
Query: 646 IGKGGHGSVYRAKVP-----SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNI 700
           +GKG  GSV   +       +G + AVK+     P     QQ +F  EIQ L  +    I
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPD----QQRDFQREIQILKALHSDFI 73
Query: 701 VKFYGFCSHPKHS--FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLH 758
           VK+ G    P      ++ EYL SG L   L    +   L  ++ L     +   + YL 
Sbjct: 74  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLG 131
Query: 759 NNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG---YVAPEL 815
           +      VHRD++++N+L++      ++DFG+AK L  D   +           + APE 
Sbjct: 132 SR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 188
Query: 816 AYTLKVTEKCDVYSFGVLALEVI 838
                 + + DV+SFGV+  E+ 
Sbjct: 189 LSDNIFSRQSDVWSFGVVLYELF 211

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 89/203 (43%), Gaps = 19/203 (9%)
Query: 646 IGKGGHGSVYRAKVP-----SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNI 700
           +GKG  GSV   +       +G + AVK+     P     QQ +F  EIQ L  +    I
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPD----QQRDFQREIQILKALHSDFI 86
Query: 701 VKFYGFCSHPKHS--FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLH 758
           VK+ G    P      ++ EYL SG L   L        L  ++ L     +   + YL 
Sbjct: 87  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLG 144
Query: 759 NNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG---YVAPEL 815
           +      VHRD++++N+L++      ++DFG+AK L  D   +           + APE 
Sbjct: 145 SR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 201
Query: 816 AYTLKVTEKCDVYSFGVLALEVI 838
                 + + DV+SFGV+  E+ 
Sbjct: 202 LSDNIFSRQSDVWSFGVVLYELF 224

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 101/221 (45%), Gaps = 28/221 (12%)
Query: 634 ISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEE-----FLNE 688
           +S+++ F     +G G + +VY+    +  ++   K       E+    EE      + E
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALK-------EVKLDSEEGTPSTAIRE 53
Query: 689 IQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQR---LN 745
           I  + E++H NIV+ Y          +++E++     D  L     ++ +G T R   LN
Sbjct: 54  ISLMKELKHENIVRLYDVIHTENKLTLVFEFM-----DNDLKKYMDSRTVGNTPRGLELN 108
Query: 746 VIK----GVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNW 801
           ++K     +   L + H N    I+HRD+  +N+L++   +  + DFG+A+      + +
Sbjct: 109 LVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF 165
Query: 802 SELAGTHGYVAPE-LAYTLKVTEKCDVYSFGVLALEVIKGK 841
           S    T  Y AP+ L  +   +   D++S G +  E+I GK
Sbjct: 166 SSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 97/209 (46%), Gaps = 34/209 (16%)
Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKF----HSPLPGEMSFQQEEFLNEIQALTEIRHRNI 700
           IG+G +G V++ +   +G+I A+KKF      P+  +++      L EI+ L +++H N+
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIA------LREIRMLKQLKHPNL 64
Query: 701 VKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQR---LNVIKGVA----DA 753
           V         +   +++EY          C+     EL   QR    +++K +      A
Sbjct: 65  VNLLEVFRRKRRLHLVFEY----------CDHTVLHELDRYQRGVPEHLVKSITWQTLQA 114
Query: 754 LFYLH-NNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVA 812
           + + H +NC    +HRD+  +N+L+       + DFG A+ L   S  + +   T  Y +
Sbjct: 115 VNFCHKHNC----IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRS 170
Query: 813 PELAY-TLKVTEKCDVYSFGVLALEVIKG 840
           PEL     +     DV++ G +  E++ G
Sbjct: 171 PELLVGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 54/168 (32%), Positives = 75/168 (44%), Gaps = 13/168 (7%)
Query: 683 EEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQ 742
           E    EI     + H N+VKFYG        ++  EY   G L   +  D    E    Q
Sbjct: 50  ENIKKEICINAMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQ 108
Query: 743 RL--NVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL--NPDS 798
           R    ++ GV     YLH      I HRDI  +N+LLD      +SDFG+A     N   
Sbjct: 109 RFFHQLMAGVV----YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161
Query: 799 SNWSELAGTHGYVAPELAYTLKV-TEKCDVYSFGVLALEVIKGKHPRD 845
              +++ GT  YVAPEL    +   E  DV+S G++   ++ G+ P D
Sbjct: 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 89/203 (43%), Gaps = 19/203 (9%)
Query: 646 IGKGGHGSVYRAKVP-----SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNI 700
           +GKG  GSV   +       +G + AVK+     P     QQ +F  EIQ L  +    I
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPD----QQRDFQREIQILKALHSDFI 74
Query: 701 VKFYGFCSHPKHS--FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLH 758
           VK+ G    P      ++ EYL SG L   L        L  ++ L     +   + YL 
Sbjct: 75  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLG 132
Query: 759 NNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG---YVAPEL 815
           +      VHRD++++N+L++      ++DFG+AK L  D   +           + APE 
Sbjct: 133 SR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 189
Query: 816 AYTLKVTEKCDVYSFGVLALEVI 838
                 + + DV+SFGV+  E+ 
Sbjct: 190 LSDNIFSRQSDVWSFGVVLYELF 212

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 74/153 (48%), Gaps = 13/153 (8%)
Query: 685 FLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSL-DKILCNDASAKELGWTQR 743
            L+E+  L ++ H NI+K Y F    ++ +++ E    G L D+I+      ++      
Sbjct: 68  LLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILR----QKFSEVDA 123
Query: 744 LNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEA---HVSDFGIAKFLNPDSSN 800
             ++K V     YLH +    IVHRD+  +N+LL+         + DFG++         
Sbjct: 124 AVIMKQVLSGTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEV-GGK 179
Query: 801 WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVL 833
             E  GT  Y+APE+    K  EKCDV+S GV+
Sbjct: 180 MKERLGTAYYIAPEVLRK-KYDEKCDVWSCGVI 211

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 65/262 (24%), Positives = 110/262 (41%), Gaps = 32/262 (12%)
Query: 661 SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSH--PKHSFIIYE 718
           +GE+ AVK   +    +    +  +  EI  L  + H +I+K+ G C     K   ++ E
Sbjct: 42  TGEMVAVKALKADCGPQ---HRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVME 98
Query: 719 YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLD 778
           Y+  GSL   L        +G  Q L   + + + + YLH+  +   +HR+++++NVLLD
Sbjct: 99  YVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHSQHY---IHRNLAARNVLLD 151
Query: 779 LGYEAHVSDFGIAKFLNPDSSNWSELAGTHG----YVAPELAYTLKVTEKCDVYSFGVLA 834
                 + DFG+AK + P+   +  +         + APE     K     DV+SFGV  
Sbjct: 152 NDRLVKIGDFGLAKAV-PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTL 210
Query: 835 LEVI-----KGKHPRDFL----FEXXXXXXXXXIEMLD--SRLPYPSLHVQKKLMSIMQV 883
            E++         P  FL                E+L+   RLP P     K    +  +
Sbjct: 211 YELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPD----KCPCEVYHL 266
Query: 884 AFSCLDQNPESRPTMKRVSQLL 905
             +C +     RPT + +  +L
Sbjct: 267 MKNCWETEASFRPTFENLIPIL 288

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 101/215 (46%), Gaps = 33/215 (15%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLP--------GEMSFQQEEFLNEIQALTEIRH 697
           IG+G  G VY   +   +    KK H  +         GE+S    +FL E   + +  H
Sbjct: 36  IGRGHFGCVYHGTLLDND---GKKIHCAVKSLNRITDIGEVS----QFLTEGIIMKDFSH 88
Query: 698 RNIVKFYGFCSHPKHS-FIIYEYLESGSLDKILCNDA---SAKEL-GWTQRLNVIKGVAD 752
            N++   G C   + S  ++  Y++ G L   + N+    + K+L G+   L V KG+  
Sbjct: 89  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG--LQVAKGMK- 145
Query: 753 ALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK-FLNPDSSNWSELAGTH--- 808
              +L +  F   VHRD++++N +LD  +   V+DFG+A+   + +  +     G     
Sbjct: 146 ---FLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 199
Query: 809 GYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
            ++A E   T K T K DV+SFGVL  E++    P
Sbjct: 200 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 634 ISATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQAL 692
           + +  +F     IG+G +G VY+A+   +GE+ A+KK    L  E        + EI  L
Sbjct: 2   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLL 59
Query: 693 TEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE-----LGWTQRLNVI 747
            E+ H NIVK           ++++E+L   S+D     DASA       L  +    ++
Sbjct: 60  KELNHPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLL 116
Query: 748 KGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGT 807
           +G+A    + H++    ++HRD+  +N+L++      ++DFG+A+        +     T
Sbjct: 117 QGLA----FCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVT 169
Query: 808 HGYVAPELAYTLK-VTEKCDVYSFGVLALEVIKGK 841
             Y APE+    K  +   D++S G +  E++  +
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 98/215 (45%), Gaps = 21/215 (9%)
Query: 639 DFNAEHCIGKGGHGSVYRA-KVPSGEIFAVK--KFHSPLPGEMSFQQEEFLNEIQALTEI 695
           D++    +G+G +G V  A    + E  AVK       +    + ++E  +N++     +
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM-----L 61
Query: 696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRL--NVIKGVADA 753
            H N+VKFYG        ++  EY   G L   +  D    E    QR    ++ GV   
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMAGVV-- 118
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNW--SELAGTHGYV 811
             YLH      I HRDI  +N+LLD      +SDFG+A     ++     +++ GT  YV
Sbjct: 119 --YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 812 APELAYTLKV-TEKCDVYSFGVLALEVIKGKHPRD 845
           APEL    +   E  DV+S G++   ++ G+ P D
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 54/168 (32%), Positives = 75/168 (44%), Gaps = 13/168 (7%)
Query: 683 EEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQ 742
           E    EI     + H N+VKFYG        ++  EY   G L   +  D    E    Q
Sbjct: 49  ENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQ 107
Query: 743 RL--NVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL--NPDS 798
           R    ++ GV     YLH      I HRDI  +N+LLD      +SDFG+A     N   
Sbjct: 108 RFFHQLMAGVV----YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 160
Query: 799 SNWSELAGTHGYVAPELAYTLKV-TEKCDVYSFGVLALEVIKGKHPRD 845
              +++ GT  YVAPEL    +   E  DV+S G++   ++ G+ P D
Sbjct: 161 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 98/214 (45%), Gaps = 31/214 (14%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLP--------GEMSFQQEEFLNEIQALTEIRH 697
           IG+G  G VY   +   +    KK H  +         GE+S    +FL E   + +  H
Sbjct: 39  IGRGHFGCVYHGTLLDND---GKKIHCAVKSLNRITDIGEVS----QFLTEGIIMKDFSH 91
Query: 698 RNIVKFYGFCSHPKHS-FIIYEYLESGSLDKILCNDA---SAKELGWTQRLNVIKGVADA 753
            N++   G C   + S  ++  Y++ G L   + N+    + K+L     +     VA  
Sbjct: 92  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKG 146
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK-FLNPDSSNWSELAGTH---G 809
           + +L +  F   VHRD++++N +LD  +   V+DFG+A+   + +  +     G      
Sbjct: 147 MKFLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 203
Query: 810 YVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           ++A E   T K T K DV+SFGVL  E++    P
Sbjct: 204 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 101/215 (46%), Gaps = 33/215 (15%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLP--------GEMSFQQEEFLNEIQALTEIRH 697
           IG+G  G VY   +   +    KK H  +         GE+S    +FL E   + +  H
Sbjct: 38  IGRGHFGCVYHGTLLDND---GKKIHCAVKSLNRITDIGEVS----QFLTEGIIMKDFSH 90
Query: 698 RNIVKFYGFCSHPKHS-FIIYEYLESGSLDKILCNDA---SAKEL-GWTQRLNVIKGVAD 752
            N++   G C   + S  ++  Y++ G L   + N+    + K+L G+   L V KG+  
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG--LQVAKGMK- 147
Query: 753 ALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK-FLNPDSSNWSELAGTH--- 808
              +L +  F   VHRD++++N +LD  +   V+DFG+A+   + +  +     G     
Sbjct: 148 ---FLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 201
Query: 809 GYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
            ++A E   T K T K DV+SFGVL  E++    P
Sbjct: 202 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 634 ISATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQAL 692
           + +  +F     IG+G +G VY+A+   +GE+ A+KK    L  E        + EI  L
Sbjct: 2   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLL 59
Query: 693 TEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE-----LGWTQRLNVI 747
            E+ H NIVK           ++++E+L   S+D     DASA       L  +    ++
Sbjct: 60  KELNHPNIVKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLL 116
Query: 748 KGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGT 807
           +G+A    + H++    ++HRD+  +N+L++      ++DFG+A+        +     T
Sbjct: 117 QGLA----FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVT 169
Query: 808 HGYVAPELAYTLK-VTEKCDVYSFGVLALEVIKGK 841
             Y APE+    K  +   D++S G +  E++  +
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 79/309 (25%), Positives = 135/309 (43%), Gaps = 61/309 (19%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSF-QQEEFLNE--IQALTEIRHRNIVK 702
           IG+G +G+VY+  +    + AVK F        SF  ++ F+NE  I  +  + H NI +
Sbjct: 21  IGRGRYGAVYKGSLDERPV-AVKVF--------SFANRQNFINEKNIYRVPLMEHDNIAR 71
Query: 703 FY----GFCSHPKHSFI-IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYL 757
           F        +  +  ++ + EY  +GSL K L    S     W     +   V   L YL
Sbjct: 72  FIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS----DWVSSCRLAHSVTRGLAYL 127
Query: 758 H------NNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIA------KFLNP---DSSNWS 802
           H      ++  P I HRD++S+NVL+       +SDFG++      + + P   D++  S
Sbjct: 128 HTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAIS 187
Query: 803 ELAGTHGYVAPEL---AYTLKVTE----KCDVYSFGVLALEVIKG-----------KHPR 844
           E+ GT  Y+APE+   A  L+  E    + D+Y+ G++  E+              ++  
Sbjct: 188 EV-GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQM 246
Query: 845 DFLFEXXXXXXXXXIEMLDSRL----PYPSLHVQKKLM--SIMQVAFSCLDQNPESRPTM 898
            F  E         +++L SR      +P    +  L   S+ +    C DQ+ E+R T 
Sbjct: 247 AFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTA 306
Query: 899 KRVSQLLCE 907
           +   + + E
Sbjct: 307 QXAEERMAE 315

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 94/201 (46%), Gaps = 13/201 (6%)
Query: 646 IGKGGHGSVYR-AKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G  G V+R  +  +G  FA K   +P   +    +E    EIQ ++ +RH  +V  +
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESD----KETVRKEIQTMSVLRHPTLVNLH 220
Query: 705 GFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP 764
                     +IYE++  G L + + ++ +  ++   + +  ++ V   L ++H N +  
Sbjct: 221 DAFEDDNEMVMIYEFMSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHENNY-- 276
Query: 765 IVHRDISSKNVLLDLGY--EAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVT 822
            VH D+  +N++       E  + DFG+   L+P  S      GT  + APE+A    V 
Sbjct: 277 -VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV-KVTTGTAEFAAPEVAEGKPVG 334
Query: 823 EKCDVYSFGVLALEVIKGKHP 843
              D++S GVL+  ++ G  P
Sbjct: 335 YYTDMWSVGVLSYILLSGLSP 355

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 103/224 (45%), Gaps = 40/224 (17%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR-HRNIVKF 703
           +GKG +G V+++    +GE+ AVKK           Q+     EI  LTE+  H NIV  
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRT--FREIMILTELSGHENIVNL 74
Query: 704 YGF--CSHPKHSFIIYEYLESGSLDKILCN--DASAKELGWTQRLNVIKGVADALFYLHN 759
                  + +  +++++Y+E+     I  N  +   K+    Q + VIK       YLH+
Sbjct: 75  LNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIK-------YLHS 127
Query: 760 NCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK--------------FLNPDSSNW---- 801
                ++HRD+   N+LL+      V+DFG+++               +N ++ N+    
Sbjct: 128 GG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 802 ---SELAGTHGYVAPE-LAYTLKVTEKCDVYSFGVLALEVIKGK 841
              ++   T  Y APE L  + K T+  D++S G +  E++ GK
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 634 ISATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQAL 692
           + +  +F     IG+G +G VY+A+   +GE+ A+KK    L  E        + EI  L
Sbjct: 1   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLL 58
Query: 693 TEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE-----LGWTQRLNVI 747
            E+ H NIVK           ++++E+L   S+D     DASA       L  +    ++
Sbjct: 59  KELNHPNIVKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLL 115
Query: 748 KGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGT 807
           +G+A    + H++    ++HRD+  +N+L++      ++DFG+A+        +     T
Sbjct: 116 QGLA----FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVT 168
Query: 808 HGYVAPELAYTLK-VTEKCDVYSFGVLALEVIKGK 841
             Y APE+    K  +   D++S G +  E++  +
Sbjct: 169 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 85/203 (41%), Gaps = 11/203 (5%)
Query: 645 CIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKF 703
            IGKG    V  A+ + +G+  AVK          S Q+     E++    + H NIVK 
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQK--LFREVRIXKVLNHPNIVKL 78
Query: 704 YGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFP 763
           +      K  +++ EY   G +   L      KE     +    + +  A+ Y H     
Sbjct: 79  FEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKF---RQIVSAVQYCHQKF-- 133
Query: 764 PIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVT- 822
            IVHRD+ ++N+LLD      ++DFG +       +      G   Y APEL    K   
Sbjct: 134 -IVHRDLKAENLLLDADXNIKIADFGFSNEFTF-GNKLDAFCGAPPYAAPELFQGKKYDG 191
Query: 823 EKCDVYSFGVLALEVIKGKHPRD 845
            + DV+S GV+   ++ G  P D
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPFD 214

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 88/205 (42%), Gaps = 22/205 (10%)
Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G+G  G V+R K   +G   AVKK    +     F+ EE +    A   +    IV  Y
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELV----ACAGLSSPRIVPLY 116
Query: 705 GFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP 764
           G         I  E LE GSL +++       E    + L  +    + L YLH      
Sbjct: 117 GAVREGPWVNIFMELLEGGSLGQLIKQMGCLPE---DRALYYLGQALEGLEYLHTR---R 170
Query: 765 IVHRDISSKNVLLDL-GYEAHVSDFGIAKFLNPDSSNWSELAG-----THGYVAPELAYT 818
           I+H D+ + NVLL   G  A + DFG A  L PD    S L G     T  ++APE+   
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230
Query: 819 LKVTEKCDVYSFGVLALEVIKGKHP 843
                K D++S   + L ++ G HP
Sbjct: 231 KPCDAKVDIWSSCCMMLHMLNGCHP 255

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 98/214 (45%), Gaps = 31/214 (14%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLP--------GEMSFQQEEFLNEIQALTEIRH 697
           IG+G  G VY   +   +    KK H  +         GE+S    +FL E   + +  H
Sbjct: 38  IGRGHFGCVYHGTLLDND---GKKIHCAVKSLNRITDIGEVS----QFLTEGIIMKDFSH 90
Query: 698 RNIVKFYGFCSHPKHS-FIIYEYLESGSLDKILCNDA---SAKELGWTQRLNVIKGVADA 753
            N++   G C   + S  ++  Y++ G L   + N+    + K+L     +     VA  
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKG 145
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK-FLNPDSSNWSELAGTH---G 809
           + +L +  F   VHRD++++N +LD  +   V+DFG+A+   + +  +     G      
Sbjct: 146 MKFLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 202
Query: 810 YVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           ++A E   T K T K DV+SFGVL  E++    P
Sbjct: 203 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 98/214 (45%), Gaps = 31/214 (14%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLP--------GEMSFQQEEFLNEIQALTEIRH 697
           IG+G  G VY   +   +    KK H  +         GE+S    +FL E   + +  H
Sbjct: 43  IGRGHFGCVYHGTLLDND---GKKIHCAVKSLNRITDIGEVS----QFLTEGIIMKDFSH 95
Query: 698 RNIVKFYGFCSHPKHS-FIIYEYLESGSLDKILCNDA---SAKELGWTQRLNVIKGVADA 753
            N++   G C   + S  ++  Y++ G L   + N+    + K+L     +     VA  
Sbjct: 96  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKG 150
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK-FLNPDSSNWSELAGTH---G 809
           + +L +  F   VHRD++++N +LD  +   V+DFG+A+   + +  +     G      
Sbjct: 151 MKFLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 207
Query: 810 YVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           ++A E   T K T K DV+SFGVL  E++    P
Sbjct: 208 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 241

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 101/215 (46%), Gaps = 33/215 (15%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLP--------GEMSFQQEEFLNEIQALTEIRH 697
           IG+G  G VY   +   +    KK H  +         GE+S    +FL E   + +  H
Sbjct: 97  IGRGHFGCVYHGTLLDND---GKKIHCAVKSLNRITDIGEVS----QFLTEGIIMKDFSH 149
Query: 698 RNIVKFYGFCSHPKHS-FIIYEYLESGSLDKILCNDA---SAKEL-GWTQRLNVIKGVAD 752
            N++   G C   + S  ++  Y++ G L   + N+    + K+L G+   L V KG+  
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG--LQVAKGMK- 206
Query: 753 ALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK-FLNPDSSNWSELAGTH--- 808
              +L +  F   VHRD++++N +LD  +   V+DFG+A+   + +  +     G     
Sbjct: 207 ---FLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 260
Query: 809 GYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
            ++A E   T K T K DV+SFGVL  E++    P
Sbjct: 261 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 295

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 96/207 (46%), Gaps = 13/207 (6%)
Query: 640 FNAEHCIGKGGHGSVYR-AKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHR 698
           ++    +G G  G V+R  +  +G  FA K   +P   +    +E    EIQ ++ +RH 
Sbjct: 53  YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD----KETVRKEIQTMSVLRHP 108
Query: 699 NIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLH 758
            +V  +          +IYE++  G L + + ++ +  ++   + +  ++ V   L ++H
Sbjct: 109 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMH 166
Query: 759 NNCFPPIVHRDISSKNVLLDLGY--EAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELA 816
            N +   VH D+  +N++       E  + DFG+   L+P  S      GT  + APE+A
Sbjct: 167 ENNY---VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV-KVTTGTAEFAAPEVA 222
Query: 817 YTLKVTEKCDVYSFGVLALEVIKGKHP 843
               V    D++S GVL+  ++ G  P
Sbjct: 223 EGKPVGYYTDMWSVGVLSYILLSGLSP 249

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 20/211 (9%)
Query: 640 FNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHR 698
           +N    +GKG  G V + K   + + +AVK  +       +      L E++ L ++ H 
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKA--SAKNKDTSTILREVELLKKLDHP 81
Query: 699 NIVKFYGFCSHPKHSFIIYEYLESGSL-DKILCNDASAKELGWTQRLNVIKGVADALFYL 757
           NI+K +         +I+ E    G L D+I+      K         +IK V   + Y+
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEII----KRKRFSEHDAARIIKQVFSGITYM 137
Query: 758 HNNCFPPIVHRDISSKNVLLD---LGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPE 814
           H +    IVHRD+  +N+LL+      +  + DFG++     ++    +  GT  Y+APE
Sbjct: 138 HKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-KMKDRIGTAYYIAPE 193
Query: 815 LAYTLKVT--EKCDVYSFGVLALEVIKGKHP 843
           +   L+ T  EKCDV+S GV+   ++ G  P
Sbjct: 194 V---LRGTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 19/211 (9%)
Query: 638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
            +F     IG+G +G VY+A+   +GE+ A+KK    L  E        + EI  L E+ 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKELN 67
Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE-----LGWTQRLNVIKGVA 751
           H NIVK           ++++E+L    L K +  DASA       L  +    +++G+A
Sbjct: 68  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSYLFQLLQGLA 124
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV 811
               + H++    ++HRD+  +N+L++      ++DFG+A+        ++    T  Y 
Sbjct: 125 ----FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 177
Query: 812 APELAYTLK-VTEKCDVYSFGVLALEVIKGK 841
           APE+    K  +   D++S G +  E++  +
Sbjct: 178 APEILLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 68/305 (22%), Positives = 127/305 (41%), Gaps = 55/305 (18%)
Query: 626 GKIVYEEIISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKF-HSPLPGEMSFQQEE 684
           G+  + +++ AT    A H  G+ G+ +V           AVK    +  P E+     +
Sbjct: 32  GEGEFGKVVKAT----AFHLKGRAGYTTV-----------AVKMLKENASPSEL----RD 72
Query: 685 FLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKIL--------------- 729
            L+E   L ++ H +++K YG CS      +I EY + GSL   L               
Sbjct: 73  LLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGG 132
Query: 730 ------CNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEA 783
                  +    + L     ++    ++  + YL       +VHRD++++N+L+  G + 
Sbjct: 133 SRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMS---LVHRDLAARNILVAEGRKM 189
Query: 784 HVSDFGIAKFLNPDSSNWSELAGT--HGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-G 840
            +SDFG+++ +  + S      G     ++A E  +    T + DV+SFGVL  E++  G
Sbjct: 190 KISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG 249
Query: 841 KHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKR 900
            +P    +          +     R+  P  +  +++  +M     C  Q P+ RP    
Sbjct: 250 GNP----YPGIPPERLFNLLKTGHRMERPD-NCSEEMYRLM---LQCWKQEPDKRPVFAD 301
Query: 901 VSQLL 905
           +S+ L
Sbjct: 302 ISKDL 306

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 20/211 (9%)
Query: 640 FNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHR 698
           +N    +GKG  G V + K   + + +AVK  +       +      L E++ L ++ H 
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKA--SAKNKDTSTILREVELLKKLDHP 81
Query: 699 NIVKFYGFCSHPKHSFIIYEYLESGSL-DKILCNDASAKELGWTQRLNVIKGVADALFYL 757
           NI+K +         +I+ E    G L D+I+      K         +IK V   + Y+
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEII----KRKRFSEHDAARIIKQVFSGITYM 137
Query: 758 HNNCFPPIVHRDISSKNVLLD---LGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPE 814
           H +    IVHRD+  +N+LL+      +  + DFG++     ++    +  GT  Y+APE
Sbjct: 138 HKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-KMKDRIGTAYYIAPE 193
Query: 815 LAYTLKVT--EKCDVYSFGVLALEVIKGKHP 843
           +   L+ T  EKCDV+S GV+   ++ G  P
Sbjct: 194 V---LRGTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 19/211 (9%)
Query: 638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
            +F     IG+G +G VY+A+   +GE+ A+KK    L  E        + EI  L E+ 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKELN 60
Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE-----LGWTQRLNVIKGVA 751
           H NIVK           ++++E+L    L K +  DASA       L  +    +++G+A
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSYLFQLLQGLA 117
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV 811
               + H++    ++HRD+  +N+L++      ++DFG+A+        ++    T  Y 
Sbjct: 118 ----FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 170
Query: 812 APELAYTLK-VTEKCDVYSFGVLALEVIKGK 841
           APE+    K  +   D++S G +  E++  +
Sbjct: 171 APEILLGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 88/205 (42%), Gaps = 22/205 (10%)
Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G+G  G V+R K   +G   AVKK    +     F+ EE +    A   +    IV  Y
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELV----ACAGLSSPRIVPLY 130
Query: 705 GFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP 764
           G         I  E LE GSL +++       E    + L  +    + L YLH      
Sbjct: 131 GAVREGPWVNIFMELLEGGSLGQLIKQMGCLPE---DRALYYLGQALEGLEYLHTR---R 184
Query: 765 IVHRDISSKNVLLDL-GYEAHVSDFGIAKFLNPDSSNWSELAG-----THGYVAPELAYT 818
           I+H D+ + NVLL   G  A + DFG A  L PD    S L G     T  ++APE+   
Sbjct: 185 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 244
Query: 819 LKVTEKCDVYSFGVLALEVIKGKHP 843
                K D++S   + L ++ G HP
Sbjct: 245 KPCDAKVDIWSSCCMMLHMLNGCHP 269

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 19/211 (9%)
Query: 638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
            +F     IG+G +G VY+A+   +GE+ A+KK    L  E        + EI  L E+ 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKELN 67
Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE-----LGWTQRLNVIKGVA 751
           H NIVK           ++++E+L    L K +  DASA       L  +    +++G+A
Sbjct: 68  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSYLFQLLQGLA 124
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV 811
               + H++    ++HRD+  +N+L++      ++DFG+A+        ++    T  Y 
Sbjct: 125 ----FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 177
Query: 812 APELAYTLK-VTEKCDVYSFGVLALEVIKGK 841
           APE+    K  +   D++S G +  E++  +
Sbjct: 178 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 19/213 (8%)
Query: 636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTE 694
           +  +F     IG+G +G VY+A+   +GE+ A+KK    L  E        + EI  L E
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKE 59
Query: 695 IRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE-----LGWTQRLNVIKG 749
           + H NIVK           ++++E+L   S+D     DASA       L  +    +++G
Sbjct: 60  LNHPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQG 116
Query: 750 VADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG 809
           +A    + H++    ++HRD+  +N+L++      ++DFG+A+        +     T  
Sbjct: 117 LA----FCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW 169
Query: 810 YVAPELAYTLK-VTEKCDVYSFGVLALEVIKGK 841
           Y APE+    K  +   D++S G +  E++  +
Sbjct: 170 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 19/211 (9%)
Query: 638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
            +F     IG+G +G VY+A+   +GE+ A+KK    L  E        + EI  L E+ 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKELN 60
Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE-----LGWTQRLNVIKGVA 751
           H NIVK           ++++E+L    L K +  DASA       L  +    +++G+A
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSYLFQLLQGLA 117
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV 811
               + H++    ++HRD+  +N+L++      ++DFG+A+        ++    T  Y 
Sbjct: 118 ----FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 170
Query: 812 APELAYTLK-VTEKCDVYSFGVLALEVIKGK 841
           APE+    K  +   D++S G +  E++  +
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 88/205 (42%), Gaps = 22/205 (10%)
Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G+G  G V+R K   +G   AVKK    +     F+ EE +    A   +    IV  Y
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELV----ACAGLSSPRIVPLY 132
Query: 705 GFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP 764
           G         I  E LE GSL +++       E    + L  +    + L YLH      
Sbjct: 133 GAVREGPWVNIFMELLEGGSLGQLIKQMGCLPE---DRALYYLGQALEGLEYLHTR---R 186
Query: 765 IVHRDISSKNVLLDL-GYEAHVSDFGIAKFLNPDSSNWSELAG-----THGYVAPELAYT 818
           I+H D+ + NVLL   G  A + DFG A  L PD    S L G     T  ++APE+   
Sbjct: 187 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 246
Query: 819 LKVTEKCDVYSFGVLALEVIKGKHP 843
                K D++S   + L ++ G HP
Sbjct: 247 KPCDAKVDIWSSCCMMLHMLNGCHP 271

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 19/211 (9%)
Query: 638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
            +F     IG+G +G VY+A+   +GE+ A+KK    L  E        + EI  L E+ 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKELN 59
Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE-----LGWTQRLNVIKGVA 751
           H NIVK           ++++E+L    L K +  DASA       L  +    +++G+A
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSYLFQLLQGLA 116
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV 811
               + H++    ++HRD+  +N+L++      ++DFG+A+        ++    T  Y 
Sbjct: 117 ----FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 169
Query: 812 APELAYTLK-VTEKCDVYSFGVLALEVIKGK 841
           APE+    K  +   D++S G +  E++  +
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 101/213 (47%), Gaps = 19/213 (8%)
Query: 636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTE 694
           +  +F     IG+G +G VY+A+   +GE+ A+KK    L  E        + EI  L E
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKE 59
Query: 695 IRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE-----LGWTQRLNVIKG 749
           + H NIVK           ++++E+L    L K +  DASA       L  +    +++G
Sbjct: 60  LNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSYLFQLLQG 116
Query: 750 VADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG 809
           +A    + H++    ++HRD+  +N+L++      ++DFG+A+        ++    T  
Sbjct: 117 LA----FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW 169
Query: 810 YVAPELAYTLK-VTEKCDVYSFGVLALEVIKGK 841
           Y APE+    K  +   D++S G +  E++  +
Sbjct: 170 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 19/211 (9%)
Query: 638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
            +F     IG+G +G VY+A+   +GE+ A+KK    L  E        + EI  L E+ 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKELN 59
Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE-----LGWTQRLNVIKGVA 751
           H NIVK           ++++E+L    L K +  DASA       L  +    +++G+A
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSYLFQLLQGLA 116
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV 811
               + H++    ++HRD+  +N+L++      ++DFG+A+        ++    T  Y 
Sbjct: 117 ----FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 169
Query: 812 APELAYTLK-VTEKCDVYSFGVLALEVIKGK 841
           APE+    K  +   D++S G +  E++  +
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 19/211 (9%)
Query: 638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
            +F     IG+G +G VY+A+   +GE+ A+KK    L  E        + EI  L E+ 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKELN 60
Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE-----LGWTQRLNVIKGVA 751
           H NIVK           ++++E+L    L K +  DASA       L  +    +++G+A
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSYLFQLLQGLA 117
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV 811
               + H++    ++HRD+  +N+L++      ++DFG+A+        ++    T  Y 
Sbjct: 118 ----FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 170
Query: 812 APELAYTLK-VTEKCDVYSFGVLALEVIKGK 841
           APE+    K  +   D++S G +  E++  +
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 634 ISATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQAL 692
           + +  +F     IG+G +G VY+A+   +GE+ A+KK    L  E        + EI  L
Sbjct: 3   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLL 60
Query: 693 TEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE-----LGWTQRLNVI 747
            E+ H NIVK           ++++E+L    L K +  DASA       L  +    ++
Sbjct: 61  KELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSYLFQLL 117
Query: 748 KGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGT 807
           +G+A    + H++    ++HRD+  +N+L++      ++DFG+A+        +     T
Sbjct: 118 QGLA----FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVT 170
Query: 808 HGYVAPELAYTLK-VTEKCDVYSFGVLALEVIKGK 841
             Y APE+    K  +   D++S G +  E++  +
Sbjct: 171 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 65/262 (24%), Positives = 109/262 (41%), Gaps = 32/262 (12%)
Query: 661 SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSH--PKHSFIIYE 718
           +GE+ AVK   +    +    +  +  EI  L  + H +I+K+ G C     K   ++ E
Sbjct: 42  TGEMVAVKALKADCGPQ---HRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVME 98
Query: 719 YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLD 778
           Y+  GSL   L        +G  Q L   + + + + YLH   +   +HR+++++NVLLD
Sbjct: 99  YVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHAQHY---IHRNLAARNVLLD 151
Query: 779 LGYEAHVSDFGIAKFLNPDSSNWSELAGTHG----YVAPELAYTLKVTEKCDVYSFGVLA 834
                 + DFG+AK + P+   +  +         + APE     K     DV+SFGV  
Sbjct: 152 NDRLVKIGDFGLAKAV-PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTL 210
Query: 835 LEVI-----KGKHPRDFL----FEXXXXXXXXXIEMLD--SRLPYPSLHVQKKLMSIMQV 883
            E++         P  FL                E+L+   RLP P     K    +  +
Sbjct: 211 YELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPD----KCPCEVYHL 266
Query: 884 AFSCLDQNPESRPTMKRVSQLL 905
             +C +     RPT + +  +L
Sbjct: 267 MKNCWETEASFRPTFENLIPIL 288

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 19/205 (9%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           IG+G +G V  A     ++    K  SP   +   Q+   L EI+ L   RH NI+    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRT--LREIKILLRFRHENIIGIND 88
Query: 706 FCSHP-----KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
               P     K  +I+ + +E+  L K+L      + L        +  +   L Y+H+ 
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMET-DLYKLL----KTQHLSNDHICYFLYQILRGLKYIHSA 143
Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN---WSELAGTHGYVAPELAY 817
               ++HRD+   N+LL+   +  + DFG+A+  +PD  +    +E   T  Y APE+  
Sbjct: 144 N---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 818 TLK-VTEKCDVYSFGVLALEVIKGK 841
             K  T+  D++S G +  E++  +
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 19/205 (9%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           IG+G +G V  A     ++    K  SP   +   Q+   L EI+ L   RH NI+    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRT--LREIKILLRFRHENIIGIND 88
Query: 706 FCSHP-----KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
               P     K  +I+ + +E+  L K+L      + L        +  +   L Y+H+ 
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMET-DLYKLL----KTQHLSNDHICYFLYQILRGLKYIHSA 143
Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN---WSELAGTHGYVAPELAY 817
               ++HRD+   N+LL+   +  + DFG+A+  +PD  +    +E   T  Y APE+  
Sbjct: 144 N---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 818 TLK-VTEKCDVYSFGVLALEVIKGK 841
             K  T+  D++S G +  E++  +
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 19/211 (9%)
Query: 638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
            +F     IG+G +G VY+A+   +GE+ A+KK    L  E        + EI  L E+ 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKELN 64
Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE-----LGWTQRLNVIKGVA 751
           H NIVK           ++++E+L    L K +  DASA       L  +    +++G+A
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSYLFQLLQGLA 121
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV 811
               + H++    ++HRD+  +N+L++      ++DFG+A+        ++    T  Y 
Sbjct: 122 ----FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 174
Query: 812 APELAYTLK-VTEKCDVYSFGVLALEVIKGK 841
           APE+    K  +   D++S G +  E++  +
Sbjct: 175 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/305 (22%), Positives = 127/305 (41%), Gaps = 55/305 (18%)
Query: 626 GKIVYEEIISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKF-HSPLPGEMSFQQEE 684
           G+  + +++ AT    A H  G+ G+ +V           AVK    +  P E+     +
Sbjct: 32  GEGEFGKVVKAT----AFHLKGRAGYTTV-----------AVKMLKENASPSEL----RD 72
Query: 685 FLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKIL--------------- 729
            L+E   L ++ H +++K YG CS      +I EY + GSL   L               
Sbjct: 73  LLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGG 132
Query: 730 ------CNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEA 783
                  +    + L     ++    ++  + YL       +VHRD++++N+L+  G + 
Sbjct: 133 SRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKM 189
Query: 784 HVSDFGIAKFLNPDSSNWSELAGT--HGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-G 840
            +SDFG+++ +  + S      G     ++A E  +    T + DV+SFGVL  E++  G
Sbjct: 190 KISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG 249
Query: 841 KHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKR 900
            +P    +          +     R+  P  +  +++  +M     C  Q P+ RP    
Sbjct: 250 GNP----YPGIPPERLFNLLKTGHRMERPD-NCSEEMYRLM---LQCWKQEPDKRPVFAD 301
Query: 901 VSQLL 905
           +S+ L
Sbjct: 302 ISKDL 306

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 634 ISATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQAL 692
           + +  +F     IG+G +G VY+A+   +GE+ A+KK    L  E        + EI  L
Sbjct: 2   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLL 59
Query: 693 TEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE-----LGWTQRLNVI 747
            E+ H NIVK           ++++E+L    L K +  DASA       L  +    ++
Sbjct: 60  KELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSYLFQLL 116
Query: 748 KGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGT 807
           +G+A    + H++    ++HRD+  +N+L++      ++DFG+A+        +     T
Sbjct: 117 QGLA----FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVT 169
Query: 808 HGYVAPELAYTLK-VTEKCDVYSFGVLALEVIKGK 841
             Y APE+    K  +   D++S G +  E++  +
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 19/205 (9%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           IG+G +G V  A     ++    K  SP   +   Q+   L EI+ L   RH NI+    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRT--LREIKILLRFRHENIIGIND 88
Query: 706 FCSHP-----KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
               P     K  +I+ + +E+  L K+L      + L        +  +   L Y+H+ 
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMET-DLYKLL----KTQHLSNDHICYFLYQILRGLKYIHSA 143
Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN---WSELAGTHGYVAPELAY 817
               ++HRD+   N+LL+   +  + DFG+A+  +PD  +    +E   T  Y APE+  
Sbjct: 144 N---VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 818 TLK-VTEKCDVYSFGVLALEVIKGK 841
             K  T+  D++S G +  E++  +
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 33/213 (15%)
Query: 647 GKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGF 706
            +G  G V++A++   +  AVK F  PL  + S+Q E    EI +   ++H N+++F   
Sbjct: 24  ARGRFGCVWKAQL-MNDFVAVKIF--PLQDKQSWQSE---REIFSTPGMKHENLLQF--I 75
Query: 707 CSHPKHS------FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
            +  + S      ++I  + + GSL   L  +     + W +  +V + ++  L YLH +
Sbjct: 76  AAEKRGSNLEVELWLITAFHDKGSLTDYLKGNI----ITWNELCHVAETMSRGLSYLHED 131
Query: 761 ---CF-----PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS--SNWSELAGTHGY 810
              C      P I HRD  SKNVLL     A ++DFG+A    P     +     GT  Y
Sbjct: 132 VPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRY 191
Query: 811 VAPE-----LAYTLKVTEKCDVYSFGVLALEVI 838
           +APE     + +      + D+Y+ G++  E++
Sbjct: 192 MAPEVLEGAINFQRDAFLRIDMYAMGLVLWELV 224

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 98/202 (48%), Gaps = 14/202 (6%)
Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           IG+G +G+V++AK   + EI A+K+    L  +        L EI  L E++H+NIV+ +
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVR--LDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 705 GFCSHPKHSFIIYEYLESGSLDKIL--CNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
                 K   +++E+ +   L K    CN     E+  +    ++KG+     + H+   
Sbjct: 68  DVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLG----FCHSR-- 120
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKV- 821
             ++HRD+  +N+L++   E  ++DFG+A+        +S    T  Y  P++ +  K+ 
Sbjct: 121 -NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 822 TEKCDVYSFGVLALEVIKGKHP 843
           +   D++S G +  E+     P
Sbjct: 180 STSIDMWSAGCIFAELANAARP 201

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 96/206 (46%), Gaps = 18/206 (8%)
Query: 646 IGKGGHGSV----YRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIV 701
           +G G  GSV    YR +    ++ A+K       G      EE + E Q + ++ +  IV
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDV-AIKVLKQ---GTEKADTEEMMREAQIMHQLDNPYIV 399
Query: 702 KFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNC 761
           +  G C   +   ++ E    G L K L      +E+  +    ++  V+  + YL    
Sbjct: 400 RLIGVC-QAEALMLVMEMAGGGPLHKFLV--GKREEIPVSNVAELLHQVSMGMKYLEEKN 456
Query: 762 FPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPELAYT 818
           F   VHR+++++NVLL   + A +SDFG++K L  D S ++  +       + APE    
Sbjct: 457 F---VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 513
Query: 819 LKVTEKCDVYSFGVLALEVIK-GKHP 843
            K + + DV+S+GV   E +  G+ P
Sbjct: 514 RKFSSRSDVWSYGVTMWEALSYGQKP 539

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 19/205 (9%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           IG+G +G V  A     ++    K  SP   +   Q+   L EI+ L   RH NI+    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRT--LREIKILLRFRHENIIGIND 88
Query: 706 FCSHP-----KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
               P     K  +I+ + +E+  L K+L      + L        +  +   L Y+H+ 
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMET-DLYKLL----KTQHLSNDHICYFLYQILRGLKYIHS- 142
Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN---WSELAGTHGYVAPELAY 817
               ++HRD+   N+LL+   +  + DFG+A+  +PD  +    +E   T  Y APE+  
Sbjct: 143 --ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 818 TLK-VTEKCDVYSFGVLALEVIKGK 841
             K  T+  D++S G +  E++  +
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 19/205 (9%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           IG+G +G V  A     ++    K  SP   +   Q+   L EI+ L   RH NI+    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRT--LREIKILLRFRHENIIGIND 90
Query: 706 FCSHP-----KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
               P     K  +I+ + +E+  L K+L      + L        +  +   L Y+H+ 
Sbjct: 91  IIRAPTIEQMKDVYIVQDLMET-DLYKLL----KTQHLSNDHICYFLYQILRGLKYIHS- 144
Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN---WSELAGTHGYVAPELAY 817
               ++HRD+   N+LL+   +  + DFG+A+  +PD  +    +E   T  Y APE+  
Sbjct: 145 --ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 818 TLK-VTEKCDVYSFGVLALEVIKGK 841
             K  T+  D++S G +  E++  +
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 19/205 (9%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           IG+G +G V  A     ++    K  SP   +   Q+   L EI+ L   RH NI+    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRT--LREIKILLRFRHENIIGIND 92
Query: 706 FCSHP-----KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
               P     K  +I+ + +E+  L K+L      + L        +  +   L Y+H+ 
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMET-DLYKLL----KTQHLSNDHICYFLYQILRGLKYIHSA 147
Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN---WSELAGTHGYVAPELAY 817
               ++HRD+   N+LL+   +  + DFG+A+  +PD  +    +E   T  Y APE+  
Sbjct: 148 N---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 818 TLK-VTEKCDVYSFGVLALEVIKGK 841
             K  T+  D++S G +  E++  +
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 100/222 (45%), Gaps = 20/222 (9%)
Query: 638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEF---LNEIQALT 693
           ++F     +GKG  G V  A+V  +G+++AVK     L  ++  Q ++    + E + L+
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKV----LKKDVILQDDDVECTMTEKRILS 78
Query: 694 EIR-HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVAD 752
             R H  + + +     P   F + E++  G L   + +   ++     +       +  
Sbjct: 79  LARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEIIS 135
Query: 753 ALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVA 812
           AL +LH+     I++RD+   NVLLD      ++DFG+ K    +    +   GT  Y+A
Sbjct: 136 ALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIA 192
Query: 813 PELAYTLKVTEKCDVYSFGVLALEVIKGKHP-----RDFLFE 849
           PE+   +      D ++ GVL  E++ G  P      D LFE
Sbjct: 193 PEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFE 234

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 68/305 (22%), Positives = 127/305 (41%), Gaps = 55/305 (18%)
Query: 626 GKIVYEEIISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKF-HSPLPGEMSFQQEE 684
           G+  + +++ AT    A H  G+ G+ +V           AVK    +  P E+     +
Sbjct: 32  GEGEFGKVVKAT----AFHLKGRAGYTTV-----------AVKMLKENASPSEL----RD 72
Query: 685 FLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKIL--------------- 729
            L+E   L ++ H +++K YG CS      +I EY + GSL   L               
Sbjct: 73  LLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGG 132
Query: 730 ------CNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEA 783
                  +    + L     ++    ++  + YL       +VHRD++++N+L+  G + 
Sbjct: 133 SRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKM 189
Query: 784 HVSDFGIAKFLNPDSSNWSELAGT--HGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-G 840
            +SDFG+++ +  + S      G     ++A E  +    T + DV+SFGVL  E++  G
Sbjct: 190 KISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG 249
Query: 841 KHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKR 900
            +P    +          +     R+  P  +  +++  +M     C  Q P+ RP    
Sbjct: 250 GNP----YPGIPPERLFNLLKTGHRMERPD-NCSEEMYRLM---LQCWKQEPDKRPVFAD 301
Query: 901 VSQLL 905
           +S+ L
Sbjct: 302 ISKDL 306

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 19/205 (9%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           IG+G +G V  A     ++    K  SP   +   Q+   L EI+ L   RH NI+    
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRT--LREIKILLRFRHENIIGIND 96
Query: 706 FCSHP-----KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
               P     K  +I+ + +E+  L K+L      + L        +  +   L Y+H+ 
Sbjct: 97  IIRAPTIEQMKDVYIVQDLMET-DLYKLL----KTQHLSNDHICYFLYQILRGLKYIHS- 150
Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN---WSELAGTHGYVAPELAY 817
               ++HRD+   N+LL+   +  + DFG+A+  +PD  +    +E   T  Y APE+  
Sbjct: 151 --ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 208
Query: 818 TLK-VTEKCDVYSFGVLALEVIKGK 841
             K  T+  D++S G +  E++  +
Sbjct: 209 NSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 19/205 (9%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           IG+G +G V  A     ++    K  SP   +   Q+   L EI+ L   RH NI+    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRT--LREIKILLRFRHENIIGIND 88
Query: 706 FCSHP-----KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
               P     K  +I+ + +E+  L K+L      + L        +  +   L Y+H+ 
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMET-DLYKLL----KTQHLSNDHICYFLYQILRGLKYIHS- 142
Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN---WSELAGTHGYVAPELAY 817
               ++HRD+   N+LL+   +  + DFG+A+  +PD  +    +E   T  Y APE+  
Sbjct: 143 --ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 818 TLK-VTEKCDVYSFGVLALEVIKGK 841
             K  T+  D++S G +  E++  +
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 19/213 (8%)
Query: 636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTE 694
           +  +F     IG+G +G VY+A+   +GE+ A+KK    L  E        + EI  L E
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKE 58
Query: 695 IRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE-----LGWTQRLNVIKG 749
           + H NIVK           ++++E+L    L K +  DASA       L  +    +++G
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSYLFQLLQG 115
Query: 750 VADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG 809
           +A    + H++    ++HRD+  +N+L++      ++DFG+A+        +     T  
Sbjct: 116 LA----FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW 168
Query: 810 YVAPELAYTLK-VTEKCDVYSFGVLALEVIKGK 841
           Y APE+    K  +   D++S G +  E++  +
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 19/213 (8%)
Query: 636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTE 694
           +  +F     IG+G +G VY+A+   +GE+ A+KK    L  E        + EI  L E
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKE 58
Query: 695 IRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE-----LGWTQRLNVIKG 749
           + H NIVK           ++++E+L    L K +  DASA       L  +    +++G
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSYLFQLLQG 115
Query: 750 VADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG 809
           +A    + H++    ++HRD+  +N+L++      ++DFG+A+        +     T  
Sbjct: 116 LA----FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW 168
Query: 810 YVAPELAYTLK-VTEKCDVYSFGVLALEVIKGK 841
           Y APE+    K  +   D++S G +  E++  +
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 83/183 (45%), Gaps = 15/183 (8%)
Query: 661 SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI--IYE 718
           +GE+ AVK   +    +    +  +  EI  L  + H +I+K+ G C     + +  + E
Sbjct: 59  TGEMVAVKALKADAGPQ---HRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVME 115
Query: 719 YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLD 778
           Y+  GSL   L   +    +G  Q L   + + + + YLH   +   +HRD++++NVLLD
Sbjct: 116 YVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLHAQHY---IHRDLAARNVLLD 168
Query: 779 LGYEAHVSDFGIAKFLNPDSSNWSELAGTHG---YVAPELAYTLKVTEKCDVYSFGVLAL 835
                 + DFG+AK +      +           + APE     K     DV+SFGV   
Sbjct: 169 NDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLY 228
Query: 836 EVI 838
           E++
Sbjct: 229 ELL 231

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 19/205 (9%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           IG+G +G V  A     ++    K  SP   +   Q+   L EI+ L   RH NI+    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRT--LREIKILLRFRHENIIGIND 108
Query: 706 FCSHP-----KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
               P     K  +I+ + +E+  L K+L      + L        +  +   L Y+H+ 
Sbjct: 109 IIRAPTIEQMKDVYIVQDLMET-DLYKLL----KTQHLSNDHICYFLYQILRGLKYIHSA 163
Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN---WSELAGTHGYVAPELAY 817
               ++HRD+   N+LL+   +  + DFG+A+  +PD  +    +E   T  Y APE+  
Sbjct: 164 N---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 818 TLK-VTEKCDVYSFGVLALEVIKGK 841
             K  T+  D++S G +  E++  +
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 19/213 (8%)
Query: 636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTE 694
           +  +F     IG+G +G VY+A+   +GE+ A+KK    L  E        + EI  L E
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKE 60
Query: 695 IRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE-----LGWTQRLNVIKG 749
           + H NIVK           ++++E+L    L K +  DASA       L  +    +++G
Sbjct: 61  LNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSYLFQLLQG 117
Query: 750 VADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG 809
           +A    + H++    ++HRD+  +N+L++      ++DFG+A+        +     T  
Sbjct: 118 LA----FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW 170
Query: 810 YVAPELAYTLK-VTEKCDVYSFGVLALEVIKGK 841
           Y APE+    K  +   D++S G +  E++  +
Sbjct: 171 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 19/213 (8%)
Query: 636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTE 694
           +  +F     IG+G +G VY+A+   +GE+ A+KK    L  E        + EI  L E
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKE 60
Query: 695 IRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE-----LGWTQRLNVIKG 749
           + H NIVK           ++++E+L    L K +  DASA       L  +    +++G
Sbjct: 61  LNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSYLFQLLQG 117
Query: 750 VADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG 809
           +A    + H++    ++HRD+  +N+L++      ++DFG+A+        +     T  
Sbjct: 118 LA----FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW 170
Query: 810 YVAPELAYTLK-VTEKCDVYSFGVLALEVIKGK 841
           Y APE+    K  +   D++S G +  E++  +
Sbjct: 171 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 58/203 (28%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 646 IGKGGHGSVYRAKVP-----SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNI 700
           +GKG  GSV   +       +G + AVK+     P     QQ +F  EIQ L  +    I
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPD----QQRDFQREIQILKALHSDFI 70
Query: 701 VKFYGFCSHPKHS--FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYL- 757
           VK+ G    P      ++ EYL SG L   L    +   L  ++ L     +   + YL 
Sbjct: 71  VKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLG 128
Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG---YVAPE 814
              C    VHRD++++N+L++      ++DFG+AK L  D               + APE
Sbjct: 129 SRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPE 184
Query: 815 LAYTLKVTEKCDVYSFGVLALEV 837
                  + + DV+SFGV+  E+
Sbjct: 185 SLSDNIFSRQSDVWSFGVVLYEL 207

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 19/205 (9%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           IG+G +G V  A     ++    K  SP   +   Q+   L EI+ L   RH NI+    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT--LREIKILLRFRHENIIGIND 92
Query: 706 FCSHP-----KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
               P     K  +I+ + +E+  L K+L      + L        +  +   L Y+H+ 
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMET-DLYKLL----KTQHLSNDHICYFLYQILRGLKYIHSA 147
Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN---WSELAGTHGYVAPELAY 817
               ++HRD+   N+LL+   +  + DFG+A+  +PD  +    +E   T  Y APE+  
Sbjct: 148 N---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 818 TLK-VTEKCDVYSFGVLALEVIKGK 841
             K  T+  D++S G +  E++  +
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 99/211 (46%), Gaps = 19/211 (9%)
Query: 638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
            +F     IG+G +G VY+A+   +GE+ A+KK    L  E        + EI  L E+ 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKELN 59
Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE-----LGWTQRLNVIKGVA 751
           H NIVK           ++++E+L    L K +  DASA       L  +    +++G+A
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSYLFQLLQGLA 116
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV 811
               + H++    ++HRD+  +N+L++      ++DFG+A+        +     T  Y 
Sbjct: 117 ----FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 169
Query: 812 APELAYTLK-VTEKCDVYSFGVLALEVIKGK 841
           APE+    K  +   D++S G +  E++  +
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 19/213 (8%)
Query: 636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTE 694
           +  +F     IG+G +G VY+A+   +GE+ A+KK    L  E        + EI  L E
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKE 59
Query: 695 IRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE-----LGWTQRLNVIKG 749
           + H NIVK           ++++E+L    L K +  DASA       L  +    +++G
Sbjct: 60  LNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSYLFQLLQG 116
Query: 750 VADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG 809
           +A    + H++    ++HRD+  +N+L++      ++DFG+A+        +     T  
Sbjct: 117 LA----FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW 169
Query: 810 YVAPELAYTLK-VTEKCDVYSFGVLALEVIKGK 841
           Y APE+    K  +   D++S G +  E++  +
Sbjct: 170 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 19/213 (8%)
Query: 636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTE 694
           +  +F     IG+G +G VY+A+   +GE+ A+KK    L  E        + EI  L E
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKE 58
Query: 695 IRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE-----LGWTQRLNVIKG 749
           + H NIVK           ++++E+L    L K +  DASA       L  +    +++G
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSYLFQLLQG 115
Query: 750 VADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG 809
           +A    + H++    ++HRD+  +N+L++      ++DFG+A+        +     T  
Sbjct: 116 LA----FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW 168
Query: 810 YVAPELAYTLK-VTEKCDVYSFGVLALEVIKGK 841
           Y APE+    K  +   D++S G +  E++  +
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 98/210 (46%), Gaps = 17/210 (8%)
Query: 638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
            +F     IG+G +G VY+A+   +GE+ A+KK    L  E        + EI  L E+ 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKELN 60
Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKG----VAD 752
           H NIVK           ++++E+L    L K +  DASA        L +IK     +  
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALT---GIPLPLIKSYLFQLLQ 114
Query: 753 ALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVA 812
            L + H++    ++HRD+  +N+L++      ++DFG+A+        ++    T  Y A
Sbjct: 115 GLSFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 171
Query: 813 PELAYTLK-VTEKCDVYSFGVLALEVIKGK 841
           PE+    K  +   D++S G +  E++  +
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 19/213 (8%)
Query: 636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTE 694
           +  +F     IG+G +G VY+A+   +GE+ A+KK    L  E        + EI  L E
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKE 58
Query: 695 IRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE-----LGWTQRLNVIKG 749
           + H NIVK           ++++E+L    L K +  DASA       L  +    +++G
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSYLFQLLQG 115
Query: 750 VADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG 809
           +A    + H++    ++HRD+  +N+L++      ++DFG+A+        +     T  
Sbjct: 116 LA----FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW 168
Query: 810 YVAPELAYTLK-VTEKCDVYSFGVLALEVIKGK 841
           Y APE+    K  +   D++S G +  E++  +
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 19/213 (8%)
Query: 636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTE 694
           +  +F     IG+G +G VY+A+   +GE+ A+KK    L  E        + EI  L E
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKE 61
Query: 695 IRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE-----LGWTQRLNVIKG 749
           + H NIVK           ++++E+L    L K +  DASA       L  +    +++G
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSYLFQLLQG 118
Query: 750 VADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG 809
           +A    + H++    ++HRD+  +N+L++      ++DFG+A+        +     T  
Sbjct: 119 LA----FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW 171
Query: 810 YVAPELAYTLK-VTEKCDVYSFGVLALEVIKGK 841
           Y APE+    K  +   D++S G +  E++  +
Sbjct: 172 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 99/211 (46%), Gaps = 19/211 (9%)
Query: 638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
            +F     IG+G +G VY+A+   +GE+ A+KK    L  E        + EI  L E+ 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKELN 59
Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE-----LGWTQRLNVIKGVA 751
           H NIVK           ++++E+L    L K +  DASA       L  +    +++G+A
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSYLFQLLQGLA 116
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV 811
               + H++    ++HRD+  +N+L++      ++DFG+A+        +     T  Y 
Sbjct: 117 ----FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 169
Query: 812 APELAYTLK-VTEKCDVYSFGVLALEVIKGK 841
           APE+    K  +   D++S G +  E++  +
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 100/221 (45%), Gaps = 45/221 (20%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           IGKG +G V+  K   GE  AVK F +    E S+ +E    EI     +RH NI+ F  
Sbjct: 45  IGKGRYGEVWMGKW-RGEKVAVKVFFTT--EEASWFRE---TEIYQTVLMRHENILGFIA 98
Query: 706 FCSHPKHS----FIIYEYLESGSL-DKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
                  S    ++I +Y E+GSL D +      AK +     L +       L +LH  
Sbjct: 99  ADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSM-----LKLAYSSVSGLCHLHTE 153
Query: 761 CF-----PPIVHRDISSKNVLLDLGYEAHVSDFGIA-KFLNPDSSNWSEL-----AGTHG 809
            F     P I HRD+ SKN+L+       ++D G+A KF++   +N  ++      GT  
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFIS--DTNEVDIPPNTRVGTKR 211
Query: 810 YVAPEL-----------AYTLKVTEKCDVYSFGVLALEVIK 839
           Y+ PE+           +Y +      D+YSFG++  EV +
Sbjct: 212 YMPPEVLDESLNRNHFQSYIM-----ADMYSFGLILWEVAR 247

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 70/298 (23%), Positives = 124/298 (41%), Gaps = 58/298 (19%)
Query: 637 TNDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI 695
            +DF     +G+G  G V +A+       +A+KK           +    L+E+  L  +
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-----HTEEKLSTILSEVXLLASL 59
Query: 696 RHRNIVKFYG-----------FCSHPKHS--FIIYEYLESGSLDKILCNDASAKELGWTQ 742
            H+ +V++Y              +  K S  FI  EY E+ +L  ++ ++   ++     
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYW 119
Query: 743 RLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN------- 795
           RL   + + +AL Y+H+     I+HR++   N+ +D      + DFG+AK ++       
Sbjct: 120 RL--FRQILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 796 ------PDSS-NWSELAGTHGYVAPE-LAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFL 847
                 P SS N +   GT  YVA E L  T    EK D YS G++  E I       + 
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI-------YP 227
Query: 848 FEXXXXXXXXXIEMLDSRLPYP------SLHVQKKLMSIMQVAFSCLDQNPESRPTMK 899
           F           ++    + +P         V+KK++ ++      +D +P  RP  +
Sbjct: 228 FSTGXERVNILKKLRSVSIEFPPDFDDNKXKVEKKIIRLL------IDHDPNKRPGAR 279

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 19/205 (9%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           IG+G +G V  A     ++    K  SP   +   Q+   L EI+ L   RH NI+    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT--LREIKILLRFRHENIIGIND 86
Query: 706 FCSHP-----KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
               P     K  +I+ + +E+  L K+L      + L        +  +   L Y+H+ 
Sbjct: 87  IIRAPTIEQMKDVYIVQDLMET-DLYKLL----KTQHLSNDHICYFLYQILRGLKYIHS- 140
Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN---WSELAGTHGYVAPELAY 817
               ++HRD+   N+LL+   +  + DFG+A+  +PD  +    +E   T  Y APE+  
Sbjct: 141 --ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 818 TLK-VTEKCDVYSFGVLALEVIKGK 841
             K  T+  D++S G +  E++  +
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 19/213 (8%)
Query: 636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTE 694
           +  +F     IG+G +G VY+A+   +GE+ A+KK    L  E        + EI  L E
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKE 59
Query: 695 IRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE-----LGWTQRLNVIKG 749
           + H NIVK           ++++E+L    L K +  DASA       L  +    +++G
Sbjct: 60  LNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSYLFQLLQG 116
Query: 750 VADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG 809
           +A    + H++    ++HRD+  +N+L++      ++DFG+A+        +     T  
Sbjct: 117 LA----FCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW 169
Query: 810 YVAPELAYTLK-VTEKCDVYSFGVLALEVIKGK 841
           Y APE+    K  +   D++S G +  E++  +
Sbjct: 170 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 19/205 (9%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           IG+G +G V  A     ++    K  SP   +   Q+   L EI+ L   RH NI+    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRT--LREIKILLAFRHENIIGIND 90
Query: 706 FCSHP-----KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
               P     K  +I+ + +E+  L K+L      + L        +  +   L Y+H+ 
Sbjct: 91  IIRAPTIEQMKDVYIVQDLMET-DLYKLL----KTQHLSNDHICYFLYQILRGLKYIHS- 144
Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN---WSELAGTHGYVAPELAY 817
               ++HRD+   N+LL+   +  + DFG+A+  +PD  +    +E   T  Y APE+  
Sbjct: 145 --ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 818 TLK-VTEKCDVYSFGVLALEVIKGK 841
             K  T+  D++S G +  E++  +
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 75/161 (46%), Gaps = 10/161 (6%)
Query: 687 NEIQALTEIR-HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLN 745
            EI AL     H NIVK +       H+F++ E L  G L + +      K    T+   
Sbjct: 54  KEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERI---KKKKHFSETEASY 110
Query: 746 VIKGVADALFYLHNNCFPPIVHRDISSKNVLL---DLGYEAHVSDFGIAKFLNPDSSNWS 802
           +++ +  A+ ++H+     +VHRD+  +N+L    +   E  + DFG A+   PD+    
Sbjct: 111 IMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLK 167
Query: 803 ELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
               T  Y APEL       E CD++S GV+   ++ G+ P
Sbjct: 168 TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVP 208

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 19/205 (9%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           IG+G +G V  A     ++    K  SP   +   Q+   L EI+ L   RH NI+    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT--LREIKILLRFRHENIIGIND 93
Query: 706 FCSHP-----KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
               P     K  +I+ + +E+  L K+L      + L        +  +   L Y+H+ 
Sbjct: 94  IIRAPTIEQMKDVYIVQDLMET-DLYKLL----KTQHLSNDHICYFLYQILRGLKYIHS- 147
Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN---WSELAGTHGYVAPELAY 817
               ++HRD+   N+LL+   +  + DFG+A+  +PD  +    +E   T  Y APE+  
Sbjct: 148 --ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 205
Query: 818 TLK-VTEKCDVYSFGVLALEVIKGK 841
             K  T+  D++S G +  E++  +
Sbjct: 206 NSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 19/205 (9%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           IG+G +G V  A     ++    K  SP   +   Q+   L EI+ L   RH NI+    
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT--LREIKILLRFRHENIIGIND 94
Query: 706 FCSHP-----KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
               P     K  +I+ + +E+  L K+L      + L        +  +   L Y+H+ 
Sbjct: 95  IIRAPTIEQMKDVYIVQDLMET-DLYKLL----KTQHLSNDHICYFLYQILRGLKYIHS- 148
Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN---WSELAGTHGYVAPELAY 817
               ++HRD+   N+LL+   +  + DFG+A+  +PD  +    +E   T  Y APE+  
Sbjct: 149 --ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 206
Query: 818 TLK-VTEKCDVYSFGVLALEVIKGK 841
             K  T+  D++S G +  E++  +
Sbjct: 207 NSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 19/205 (9%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           IG+G +G V  A     ++    K  SP   +   Q+   L EI+ L   RH NI+    
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT--LREIKILLRFRHENIIGIND 85
Query: 706 FCSHP-----KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
               P     K  +I+ + +E+  L K+L      + L        +  +   L Y+H+ 
Sbjct: 86  IIRAPTIEQMKDVYIVQDLMET-DLYKLL----KTQHLSNDHICYFLYQILRGLKYIHS- 139
Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN---WSELAGTHGYVAPELAY 817
               ++HRD+   N+LL+   +  + DFG+A+  +PD  +    +E   T  Y APE+  
Sbjct: 140 --ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 197
Query: 818 TLK-VTEKCDVYSFGVLALEVIKGK 841
             K  T+  D++S G +  E++  +
Sbjct: 198 NSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 19/205 (9%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           IG+G +G V  A     ++    K  SP   +   Q+   L EI+ L   RH NI+    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT--LREIKILLRFRHENIIGIND 92
Query: 706 FCSHP-----KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
               P     K  +I+ + +E+  L K+L      + L        +  +   L Y+H+ 
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMET-DLYKLL----KTQHLSNDHICYFLYQILRGLKYIHS- 146
Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN---WSELAGTHGYVAPELAY 817
               ++HRD+   N+LL+   +  + DFG+A+  +PD  +    +E   T  Y APE+  
Sbjct: 147 --ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 818 TLK-VTEKCDVYSFGVLALEVIKGK 841
             K  T+  D++S G +  E++  +
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 19/213 (8%)
Query: 636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTE 694
           +  +F     IG+G +G VY+A+   +GE+ A+KK    L  E        + EI  L E
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKE 60
Query: 695 IRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE-----LGWTQRLNVIKG 749
           + H NIVK           ++++E+L    L K +  DASA       L  +    +++G
Sbjct: 61  LNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSYLFQLLQG 117
Query: 750 VADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG 809
           +A    + H++    ++HRD+  +N+L++      ++DFG+A+        +     T  
Sbjct: 118 LA----FCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW 170
Query: 810 YVAPELAYTLK-VTEKCDVYSFGVLALEVIKGK 841
           Y APE+    K  +   D++S G +  E++  +
Sbjct: 171 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 19/205 (9%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           IG+G +G V  A     ++    K  SP   +   Q+   L EI+ L   RH NI+    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT--LREIKILLRFRHENIIGIND 86
Query: 706 FCSHP-----KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
               P     K  +I+ + +E+  L K+L      + L        +  +   L Y+H+ 
Sbjct: 87  IIRAPTIEQMKDVYIVQDLMET-DLYKLL----KTQHLSNDHICYFLYQILRGLKYIHS- 140
Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN---WSELAGTHGYVAPELAY 817
               ++HRD+   N+LL+   +  + DFG+A+  +PD  +    +E   T  Y APE+  
Sbjct: 141 --ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 818 TLK-VTEKCDVYSFGVLALEVIKGK 841
             K  T+  D++S G +  E++  +
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 99/213 (46%), Gaps = 19/213 (8%)
Query: 636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTE 694
           +  +F     IG+G +G VY+A+   +GE+ A+KK    L  E        + EI  L E
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKE 58
Query: 695 IRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE-----LGWTQRLNVIKG 749
           + H NIVK           ++++E+L     D +   DASA       L  +    +++G
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKDFM---DASALTGIPLPLIKSYLFQLLQG 115
Query: 750 VADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG 809
           +A    + H++    ++HRD+  +N+L++      ++DFG+A+        +     T  
Sbjct: 116 LA----FCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW 168
Query: 810 YVAPELAYTLK-VTEKCDVYSFGVLALEVIKGK 841
           Y APE+    K  +   D++S G +  E++  +
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 19/205 (9%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           IG+G +G V  A     ++    K  SP   +   Q+   L EI+ L   RH NI+    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRT--LREIKILLAFRHENIIGIND 90
Query: 706 FCSHP-----KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
               P     K  +I+ + +E+  L K+L      + L        +  +   L Y+H+ 
Sbjct: 91  IIRAPTIEQMKDVYIVQDLMET-DLYKLL----KTQHLSNDHICYFLYQILRGLKYIHSA 145
Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN---WSELAGTHGYVAPELAY 817
               ++HRD+   N+LL+   +  + DFG+A+  +PD  +    +E   T  Y APE+  
Sbjct: 146 N---VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 818 TLK-VTEKCDVYSFGVLALEVIKGK 841
             K  T+  D++S G +  E++  +
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 99/211 (46%), Gaps = 19/211 (9%)
Query: 638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
            +F     IG+G +G VY+A+   +GE+ A+KK    L  E        + EI  L E+ 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKELN 61
Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE-----LGWTQRLNVIKGVA 751
           H NIVK           ++++E+L    L K +  DASA       L  +    +++G+A
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSYLFQLLQGLA 118
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV 811
               + H++    ++HRD+  +N+L++      ++DFG+A+        +     T  Y 
Sbjct: 119 ----FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 171
Query: 812 APELAYTLK-VTEKCDVYSFGVLALEVIKGK 841
           APE+    K  +   D++S G +  E++  +
Sbjct: 172 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 93/215 (43%), Gaps = 24/215 (11%)
Query: 640 FNAEHCIGKGGHGSVYRAK----VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI 695
           F     +GKGG+G V++ +      +G+IFA+K     +    +        E   L E+
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 696 RHRNIVKF-YGFCSHPKHSFIIYEYLESGSL------DKILCNDASAKELGWTQRLNVIK 748
           +H  IV   Y F +  K  ++I EYL  G L      + I   D +   L          
Sbjct: 79  KHPFIVDLIYAFQTGGK-LYLILEYLSGGELFMQLEREGIFMEDTACFYLA--------- 128
Query: 749 GVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH 808
            ++ AL +LH      I++RD+  +N++L+      ++DFG+ K    D +      GT 
Sbjct: 129 EISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTI 185
Query: 809 GYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
            Y+APE+          D +S G L  +++ G  P
Sbjct: 186 EYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 93/215 (43%), Gaps = 24/215 (11%)
Query: 640 FNAEHCIGKGGHGSVYRAK----VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI 695
           F     +GKGG+G V++ +      +G+IFA+K     +    +        E   L E+
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 696 RHRNIVKF-YGFCSHPKHSFIIYEYLESGSL------DKILCNDASAKELGWTQRLNVIK 748
           +H  IV   Y F +  K  ++I EYL  G L      + I   D +   L          
Sbjct: 79  KHPFIVDLIYAFQTGGK-LYLILEYLSGGELFMQLEREGIFMEDTACFYLA--------- 128
Query: 749 GVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH 808
            ++ AL +LH      I++RD+  +N++L+      ++DFG+ K    D +      GT 
Sbjct: 129 EISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTI 185
Query: 809 GYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
            Y+APE+          D +S G L  +++ G  P
Sbjct: 186 EYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 93/202 (46%), Gaps = 11/202 (5%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G+G  G V  A    +G+  A+K  +  +  + S  Q     EI  L  +RH +I+K Y
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAK-SDMQGRIEREISYLRLLRHPHIIKLY 74
Query: 705 GFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP 764
                     ++ EY  +   D I+  D  +++    +     + +  A+ Y H +    
Sbjct: 75  DVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQ----EARRFFQQIISAVEYCHRH---K 127
Query: 765 IVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPE-LAYTLKVTE 823
           IVHRD+  +N+LLD      ++DFG++  +  D +      G+  Y APE ++  L    
Sbjct: 128 IVHRDLKPENLLLDEHLNVKIADFGLSNIMT-DGNFLKTSCGSPNYAAPEVISGKLYAGP 186
Query: 824 KCDVYSFGVLALEVIKGKHPRD 845
           + DV+S GV+   ++  + P D
Sbjct: 187 EVDVWSCGVILYVMLCRRLPFD 208

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Composition-based stats.
 Identities = 51/184 (27%), Positives = 85/184 (46%), Gaps = 17/184 (9%)
Query: 661 SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSH--PKHSFIIYE 718
           +GE+ AVK        ++   +  +  EI+ L  + H +IVK+ G C     K   ++ E
Sbjct: 36  TGEMVAVKALKEGCGPQL---RSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVME 92
Query: 719 YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLD 778
           Y+  GSL   L        +G  Q L   + + + + YLH   +   +HR ++++NVLLD
Sbjct: 93  YVPLGSLRDYLPRHC----VGLAQLLLFAQQICEGMAYLHAQHY---IHRALAARNVLLD 145
Query: 779 LGYEAHVSDFGIAKFLNPDSSNWSELAGTHG----YVAPELAYTLKVTEKCDVYSFGVLA 834
                 + DFG+AK + P+   +  +         + APE     K     DV+SFGV  
Sbjct: 146 NDRLVKIGDFGLAKAV-PEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTL 204
Query: 835 LEVI 838
            E++
Sbjct: 205 YELL 208

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Composition-based stats.
 Identities = 51/184 (27%), Positives = 85/184 (46%), Gaps = 17/184 (9%)
Query: 661 SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSH--PKHSFIIYE 718
           +GE+ AVK        ++   +  +  EI+ L  + H +IVK+ G C     K   ++ E
Sbjct: 37  TGEMVAVKALKEGCGPQL---RSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVME 93
Query: 719 YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLD 778
           Y+  GSL   L        +G  Q L   + + + + YLH   +   +HR ++++NVLLD
Sbjct: 94  YVPLGSLRDYLPRHC----VGLAQLLLFAQQICEGMAYLHAQHY---IHRALAARNVLLD 146
Query: 779 LGYEAHVSDFGIAKFLNPDSSNWSELAGTHG----YVAPELAYTLKVTEKCDVYSFGVLA 834
                 + DFG+AK + P+   +  +         + APE     K     DV+SFGV  
Sbjct: 147 NDRLVKIGDFGLAKAV-PEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTL 205
Query: 835 LEVI 838
            E++
Sbjct: 206 YELL 209

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 73/159 (45%), Gaps = 8/159 (5%)
Query: 687 NEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNV 746
            E   ++ + H   VK Y      +  +    Y ++G L K +    S  E   T     
Sbjct: 81  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDE---TCTRFY 137
Query: 747 IKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS--SNWSEL 804
              +  AL YLH      I+HRD+  +N+LL+      ++DFG AK L+P+S  +  +  
Sbjct: 138 TAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 194
Query: 805 AGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
            GT  YV+PEL      ++  D+++ G +  +++ G  P
Sbjct: 195 VGTAQYVSPELLTEKSASKSSDLWALGCIIYQLVAGLPP 233

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 100/210 (47%), Gaps = 19/210 (9%)
Query: 636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTE 694
           +  +F     IG+G +G VY+A+   +GE+ A+KK    L  E        + EI  L E
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKE 61
Query: 695 IRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE-----LGWTQRLNVIKG 749
           + H NIVK           ++++E+++   L K +  DASA       L  +    +++G
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEHVDQ-DLKKFM--DASALTGIPLPLIKSYLFQLLQG 118
Query: 750 VADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG 809
           +A    + H++    ++HRD+  +N+L++      ++DFG+A+        +     T  
Sbjct: 119 LA----FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW 171
Query: 810 YVAPELAYTLK-VTEKCDVYSFGVLALEVI 838
           Y APE+    K  +   D++S G +  E++
Sbjct: 172 YRAPEILLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 19/205 (9%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           IG+G +G V  A     ++    K  SP   +   Q+   L EI+ L   RH NI+    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT--LREIKILLRFRHENIIGIND 92
Query: 706 FCSHP-----KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
               P     K  +I+ + +E+  L K+L      + L        +  +   L Y+H+ 
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMET-DLYKLL----KTQHLSNDHICYFLYQILRGLKYIHS- 146
Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN---WSELAGTHGYVAPELAY 817
               ++HRD+   N+LL+   +  + DFG+A+  +PD  +     E   T  Y APE+  
Sbjct: 147 --ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIML 204
Query: 818 TLK-VTEKCDVYSFGVLALEVIKGK 841
             K  T+  D++S G +  E++  +
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 19/205 (9%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           IG+G +G V  A     ++    K  SP   +   Q+   L EI+ L   RH NI+    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT--LREIKILLRFRHENIIGIND 93
Query: 706 FCSHP-----KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
               P     K  +I+ + +E+  L K+L      + L        +  +   L Y+H+ 
Sbjct: 94  IIRAPTIEQMKDVYIVQDLMET-DLYKLL----KTQHLSNDHICYFLYQILRGLKYIHS- 147
Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN---WSELAGTHGYVAPELAY 817
               ++HRD+   N+LL+   +  + DFG+A+  +PD  +     E   T  Y APE+  
Sbjct: 148 --ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIML 205
Query: 818 TLK-VTEKCDVYSFGVLALEVIKGK 841
             K  T+  D++S G +  E++  +
Sbjct: 206 NSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 93/202 (46%), Gaps = 11/202 (5%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G+G  G V  A    +G+  A+K  +  +  + S  Q     EI  L  +RH +I+K Y
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAK-SDMQGRIEREISYLRLLRHPHIIKLY 79
Query: 705 GFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP 764
                     ++ EY  +   D I+  D  +++    +     + +  A+ Y H +    
Sbjct: 80  DVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQ----EARRFFQQIISAVEYCHRH---K 132
Query: 765 IVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPE-LAYTLKVTE 823
           IVHRD+  +N+LLD      ++DFG++  +  D +      G+  Y APE ++  L    
Sbjct: 133 IVHRDLKPENLLLDEHLNVKIADFGLSNIMT-DGNFLKTSCGSPNYAAPEVISGKLYAGP 191
Query: 824 KCDVYSFGVLALEVIKGKHPRD 845
           + DV+S GV+   ++  + P D
Sbjct: 192 EVDVWSCGVILYVMLCRRLPFD 213

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 93/202 (46%), Gaps = 11/202 (5%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G+G  G V  A    +G+  A+K  +  +  + S  Q     EI  L  +RH +I+K Y
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAK-SDMQGRIEREISYLRLLRHPHIIKLY 80
Query: 705 GFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP 764
                     ++ EY  +   D I+  D  +++    +     + +  A+ Y H +    
Sbjct: 81  DVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQ----EARRFFQQIISAVEYCHRH---K 133
Query: 765 IVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPE-LAYTLKVTE 823
           IVHRD+  +N+LLD      ++DFG++  +  D +      G+  Y APE ++  L    
Sbjct: 134 IVHRDLKPENLLLDEHLNVKIADFGLSNIMT-DGNFLKTSCGSPNYAAPEVISGKLYAGP 192
Query: 824 KCDVYSFGVLALEVIKGKHPRD 845
           + DV+S GV+   ++  + P D
Sbjct: 193 EVDVWSCGVILYVMLCRRLPFD 214

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 92/205 (44%), Gaps = 19/205 (9%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           IG+G +G V  A     ++    +  SP   +   Q+   L EI+ L   RH NI+    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRT--LREIKILLRFRHENIIGIND 92
Query: 706 FCSHP-----KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
               P     K  +I+ + +E+  L K+L      + L        +  +   L Y+H+ 
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMET-DLYKLL----KTQHLSNDHICYFLYQILRGLKYIHS- 146
Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN---WSELAGTHGYVAPELAY 817
               ++HRD+   N+LL+   +  + DFG+A+  +PD  +    +E   T  Y APE+  
Sbjct: 147 --ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 818 TLK-VTEKCDVYSFGVLALEVIKGK 841
             K  T+  D++S G +  E++  +
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 98/213 (46%), Gaps = 19/213 (8%)
Query: 636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTE 694
           +  +F     IG+G +G VY+A+   +GE+ A+KK    L  E        + EI  L E
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKE 61
Query: 695 IRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE-----LGWTQRLNVIKG 749
           + H NIVK           ++++E+L     D     DASA       L  +    +++G
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFLHQ---DLKTFMDASALTGIPLPLIKSYLFQLLQG 118
Query: 750 VADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG 809
           +A    + H++    ++HRD+  +N+L++      ++DFG+A+        +     T  
Sbjct: 119 LA----FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW 171
Query: 810 YVAPELAYTLK-VTEKCDVYSFGVLALEVIKGK 841
           Y APE+    K  +   D++S G +  E++  +
Sbjct: 172 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 9/214 (4%)
Query: 632 EIISATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQ 690
           +I     DF     +GKG  G V+ A+   + + FA+K     +   M    E  + E +
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVL-MDDDVECTMVEKR 69
Query: 691 ALT-EIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKG 749
            L+    H  +   +      ++ F + EYL  G L   + +  S  +   ++       
Sbjct: 70  VLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAAE 126
Query: 750 VADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG 809
           +   L +LH+     IV+RD+   N+LLD      ++DFG+ K      +  +   GT  
Sbjct: 127 IILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPD 183
Query: 810 YVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           Y+APE+    K     D +SFGVL  E++ G+ P
Sbjct: 184 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 93/202 (46%), Gaps = 11/202 (5%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G+G  G V  A    +G+  A+K  +  +  + S  Q     EI  L  +RH +I+K Y
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAK-SDMQGRIEREISYLRLLRHPHIIKLY 70
Query: 705 GFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP 764
                     ++ EY  +   D I+  D  +++    +     + +  A+ Y H +    
Sbjct: 71  DVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQ----EARRFFQQIISAVEYCHRH---K 123
Query: 765 IVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPE-LAYTLKVTE 823
           IVHRD+  +N+LLD      ++DFG++  +  D +      G+  Y APE ++  L    
Sbjct: 124 IVHRDLKPENLLLDEHLNVKIADFGLSNIMT-DGNFLKTSCGSPNYAAPEVISGKLYAGP 182
Query: 824 KCDVYSFGVLALEVIKGKHPRD 845
           + DV+S GV+   ++  + P D
Sbjct: 183 EVDVWSCGVILYVMLCRRLPFD 204

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 99/211 (46%), Gaps = 19/211 (9%)
Query: 638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
            +F     IG+G +G VY+A+   +GE+ A+ K    L  E        + EI  L E+ 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIR--LDTETEGVPSTAIREISLLKELN 60
Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE-----LGWTQRLNVIKGVA 751
           H NIVK           ++++E+L    L K +  DASA       L  +    +++G+A
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSYLFQLLQGLA 117
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV 811
               + H++    ++HRD+  +N+L++      ++DFG+A+        ++    T  Y 
Sbjct: 118 ----FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 170
Query: 812 APELAYTLK-VTEKCDVYSFGVLALEVIKGK 841
           APE+    K  +   D++S G +  E++  +
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 99/211 (46%), Gaps = 19/211 (9%)
Query: 638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
            +F     IG+G +G VY+A+   +GE+ A+ K    L  E        + EI  L E+ 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIR--LDTETEGVPSTAIREISLLKELN 59
Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE-----LGWTQRLNVIKGVA 751
           H NIVK           ++++E+L    L K +  DASA       L  +    +++G+A
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSYLFQLLQGLA 116
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV 811
               + H++    ++HRD+  +N+L++      ++DFG+A+        ++    T  Y 
Sbjct: 117 ----FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 169
Query: 812 APELAYTLK-VTEKCDVYSFGVLALEVIKGK 841
           APE+    K  +   D++S G +  E++  +
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 22/215 (10%)
Query: 638 NDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEE--FLNEIQALTE 694
           NDF+    IG+GG G VY   K  +G+++A+K         +  +Q E   LNE   L+ 
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDK---KRIKMKQGETLALNERIMLSL 245
Query: 695 IRHRN----IVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWT-QRLNVIKG 749
           +   +    +   Y F +  K SFI+ + +  G L   L       E         +I G
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 304
Query: 750 VADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG 809
               L ++HN     +V+RD+   N+LLD      +SD G+A   +    + S   GTHG
Sbjct: 305 ----LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--VGTHG 355
Query: 810 YVAPE-LAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           Y+APE L   +      D +S G +  ++++G  P
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 22/215 (10%)
Query: 638 NDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEE--FLNEIQALTE 694
           NDF+    IG+GG G VY   K  +G+++A+K         +  +Q E   LNE   L+ 
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDK---KRIKMKQGETLALNERIMLSL 245
Query: 695 IRHRN----IVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWT-QRLNVIKG 749
           +   +    +   Y F +  K SFI+ + +  G L   L       E         +I G
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 304
Query: 750 VADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG 809
               L ++HN     +V+RD+   N+LLD      +SD G+A   +    + S   GTHG
Sbjct: 305 ----LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--VGTHG 355
Query: 810 YVAPE-LAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           Y+APE L   +      D +S G +  ++++G  P
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 86/200 (43%), Gaps = 9/200 (4%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           IG+G +G V  A     ++    K  SP   +   Q+   L EI+ L   RH NI+    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRT--LREIKILLRFRHENIIGIND 108
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
               P    +   YL +  +   L      + L        +  +   L Y+H+     +
Sbjct: 109 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---V 165
Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN---WSELAGTHGYVAPELAYTLK-V 821
           +HRD+   N+LL+   +  + DFG+A+  +PD  +    +E   T  Y APE+    K  
Sbjct: 166 LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 225
Query: 822 TEKCDVYSFGVLALEVIKGK 841
           T+  D++S G +  E++  +
Sbjct: 226 TKSIDIWSVGCILAEMLSNR 245

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 22/215 (10%)
Query: 638 NDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEE--FLNEIQALTE 694
           NDF+    IG+GG G VY   K  +G+++A+K         +  +Q E   LNE   L+ 
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKK---RIKMKQGETLALNERIMLSL 245
Query: 695 IRHRN----IVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWT-QRLNVIKG 749
           +   +    +   Y F +  K SFI+ + +  G L   L       E         +I G
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 304
Query: 750 VADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG 809
               L ++HN     +V+RD+   N+LLD      +SD G+A   +    + S   GTHG
Sbjct: 305 ----LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--VGTHG 355
Query: 810 YVAPE-LAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           Y+APE L   +      D +S G +  ++++G  P
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 102/214 (47%), Gaps = 20/214 (9%)
Query: 638 NDFNAEHCIGKGGHGSVYRAKVPSG----EIFAVKKFHSPLPGEMSFQQEEFLNEIQALT 693
           + F     +G+G  G V+  K  SG    +++A+K             + +   +I  L 
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI--LV 81
Query: 694 EIRHRNIVKF-YGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNV---IKG 749
           E+ H  IVK  Y F +  K  ++I ++L  G L   L     +KE+ +T+  +V   +  
Sbjct: 82  EVNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRL-----SKEVMFTEE-DVKFYLAE 134
Query: 750 VADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG 809
           +A AL +LH+     I++RD+  +N+LLD      ++DFG++K             GT  
Sbjct: 135 LALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVE 191
Query: 810 YVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           Y+APE+      T+  D +SFGVL  E++ G  P
Sbjct: 192 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 102/214 (47%), Gaps = 20/214 (9%)
Query: 638 NDFNAEHCIGKGGHGSVYRAKVPSG----EIFAVKKFHSPLPGEMSFQQEEFLNEIQALT 693
           + F     +G+G  G V+  K  SG    +++A+K             + +   +I  L 
Sbjct: 25  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI--LV 82
Query: 694 EIRHRNIVKF-YGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNV---IKG 749
           E+ H  IVK  Y F +  K  ++I ++L  G L   L     +KE+ +T+  +V   +  
Sbjct: 83  EVNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRL-----SKEVMFTEE-DVKFYLAE 135
Query: 750 VADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG 809
           +A AL +LH+     I++RD+  +N+LLD      ++DFG++K             GT  
Sbjct: 136 LALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVE 192
Query: 810 YVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           Y+APE+      T+  D +SFGVL  E++ G  P
Sbjct: 193 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 226

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 22/215 (10%)
Query: 638 NDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEE--FLNEIQALTE 694
           NDF+    IG+GG G VY   K  +G+++A+K         +  +Q E   LNE   L+ 
Sbjct: 188 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKK---RIKMKQGETLALNERIMLSL 244
Query: 695 IRHRN----IVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWT-QRLNVIKG 749
           +   +    +   Y F +  K SFI+ + +  G L   L       E         +I G
Sbjct: 245 VSTGDCPFIVCMSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 303
Query: 750 VADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG 809
               L ++HN     +V+RD+   N+LLD      +SD G+A   +    + S   GTHG
Sbjct: 304 ----LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--VGTHG 354
Query: 810 YVAPE-LAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           Y+APE L   +      D +S G +  ++++G  P
Sbjct: 355 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 389

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 10/160 (6%)
Query: 687 NEIQALTEIRHRNIVKFYGFCSHPKHS-FIIYEYLESGSLDKILCNDASAKELGWTQRLN 745
            E   ++ + H   VK Y FC       +    Y ++G L K +    S  E   T    
Sbjct: 86  RERDVMSRLDHPFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---TCTRF 141
Query: 746 VIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS--SNWSE 803
               +  AL YLH      I+HRD+  +N+LL+      ++DFG AK L+P+S  +  + 
Sbjct: 142 YTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 198
Query: 804 LAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
             GT  YV+PEL       +  D+++ G +  +++ G  P
Sbjct: 199 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 238

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 16/212 (7%)
Query: 638 NDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVK---KFHSPLPGEMSFQQEEFLNEIQALT 693
            DF     +G+G   +V  A+ + +   +A+K   K H     ++ +       E   ++
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY----VTRERDVMS 84
Query: 694 EIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADA 753
            + H   VK Y      +  +    Y ++G L K +    S  E   T        +  A
Sbjct: 85  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---TCTRFYTAEIVSA 141
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS--SNWSELAGTHGYV 811
           L YLH      I+HRD+  +N+LL+      ++DFG AK L+P+S  +  +   GT  YV
Sbjct: 142 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 198
Query: 812 APELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           +PEL       +  D+++ G +  +++ G  P
Sbjct: 199 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 52/226 (23%), Positives = 97/226 (42%), Gaps = 25/226 (11%)
Query: 684 EFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESG-------SLDKILCNDASAK 736
           EFLNE   + E    ++V+  G  S  + + +I E +  G       SL   + N+    
Sbjct: 64  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 123
Query: 737 ELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP 796
               ++ + +   +AD + YL+ N F   VHRD++++N ++   +   + DFG+ + +  
Sbjct: 124 PPSLSKMIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY- 179
Query: 797 DSSNWSELAGTH----GYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXX 851
             +++    G       +++PE       T   DV+SFGV+  E+    + P   L    
Sbjct: 180 -ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 238
Query: 852 XXXXXXXIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPT 897
                    +LD     P +     L  +M++   C   NP+ RP+
Sbjct: 239 VLRFVMEGGLLDKPDNCPDM-----LFELMRM---CWQYNPKMRPS 276

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 72/159 (45%), Gaps = 8/159 (5%)
Query: 687 NEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNV 746
            E   ++ + H   VK Y      +  +    Y ++G L K +    S  E   T     
Sbjct: 59  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---TCTRFY 115
Query: 747 IKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS--SNWSEL 804
              +  AL YLH      I+HRD+  +N+LL+      ++DFG AK L+P+S  +  +  
Sbjct: 116 TAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 172
Query: 805 AGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
            GT  YV+PEL       +  D+++ G +  +++ G  P
Sbjct: 173 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 211

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 96/217 (44%), Gaps = 23/217 (10%)
Query: 635 SATNDFNAEH-------CIGKGGHGSVYRAKVPSGE----IFAVKKFHSPLPGEMSFQQE 683
           S+T D+  +        CIG+G  G V++    S E      A+K   +     +   +E
Sbjct: 28  SSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV---RE 84
Query: 684 EFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQR 743
           +FL E   + +  H +IVK  G  +     +II E    G L   L        L     
Sbjct: 85  KFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASL 141
Query: 744 LNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSE 803
           +     ++ AL YL +  F   VHRDI+++NVL+       + DFG+++++  DS+ +  
Sbjct: 142 ILYAYQLSTALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKA 197
Query: 804 LAGTH--GYVAPELAYTLKVTEKCDVYSFGVLALEVI 838
             G     ++APE     + T   DV+ FGV   E++
Sbjct: 198 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 234

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 88/204 (43%), Gaps = 9/204 (4%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           +G+G  G V  A     +     KF S    + S        EI  L  +RH +I+K Y 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
             + P    ++ EY      D I+      K +   +     + +  A+ Y H +    I
Sbjct: 77  VITTPTDIVMVIEYAGGELFDYIV----EKKRMTEDEGRRFFQQIICAIEYCHRH---KI 129
Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAY-TLKVTEK 824
           VHRD+  +N+LLD      ++DFG++  +  D +      G+  Y APE+    L    +
Sbjct: 130 VHRDLKPENLLLDDNLNVKIADFGLSNIMT-DGNFLKTSCGSPNYAAPEVINGKLYAGPE 188
Query: 825 CDVYSFGVLALEVIKGKHPRDFLF 848
            DV+S G++   ++ G+ P D  F
Sbjct: 189 VDVWSCGIVLYVMLVGRLPFDDEF 212

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 72/159 (45%), Gaps = 8/159 (5%)
Query: 687 NEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNV 746
            E   ++ + H   VK Y      +  +    Y ++G L K +    S  E   T     
Sbjct: 82  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---TCTRFY 138
Query: 747 IKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS--SNWSEL 804
              +  AL YLH      I+HRD+  +N+LL+      ++DFG AK L+P+S  +  +  
Sbjct: 139 TAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 195
Query: 805 AGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
            GT  YV+PEL       +  D+++ G +  +++ G  P
Sbjct: 196 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 16/212 (7%)
Query: 638 NDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVK---KFHSPLPGEMSFQQEEFLNEIQALT 693
            DF     +G+G   +V  A+ + +   +A+K   K H     ++ +       E   ++
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY----VTRERDVMS 63
Query: 694 EIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADA 753
            + H   VK Y      +  +    Y ++G L K +    S  E   T        +  A
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---TCTRFYTAEIVSA 120
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS--SNWSELAGTHGYV 811
           L YLH      I+HRD+  +N+LL+      ++DFG AK L+P+S  +  +   GT  YV
Sbjct: 121 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 177
Query: 812 APELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           +PEL       +  D+++ G +  +++ G  P
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 209

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/226 (23%), Positives = 97/226 (42%), Gaps = 25/226 (11%)
Query: 684 EFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESG-------SLDKILCNDASAK 736
           EFLNE   + E    ++V+  G  S  + + +I E +  G       SL   + N+    
Sbjct: 74  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 133
Query: 737 ELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP 796
               ++ + +   +AD + YL+ N F   VHRD++++N ++   +   + DFG+ + +  
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY- 189
Query: 797 DSSNWSELAGTH----GYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXX 851
             +++    G       +++PE       T   DV+SFGV+  E+    + P   L    
Sbjct: 190 -ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 248
Query: 852 XXXXXXXIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPT 897
                    +LD     P +     L  +M++   C   NP+ RP+
Sbjct: 249 VLRFVMEGGLLDKPDNCPDM-----LFELMRM---CWQYNPKMRPS 286

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 72/159 (45%), Gaps = 8/159 (5%)
Query: 687 NEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNV 746
            E   ++ + H   VK Y      +  +    Y ++G L K +    S  E   T     
Sbjct: 84  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---TCTRFY 140
Query: 747 IKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS--SNWSEL 804
              +  AL YLH      I+HRD+  +N+LL+      ++DFG AK L+P+S  +  +  
Sbjct: 141 TAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 197
Query: 805 AGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
            GT  YV+PEL       +  D+++ G +  +++ G  P
Sbjct: 198 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 236

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 72/159 (45%), Gaps = 8/159 (5%)
Query: 687 NEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNV 746
            E   ++ + H   VK Y      +  +    Y ++G L K +    S  E   T     
Sbjct: 82  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---TCTRFY 138
Query: 747 IKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS--SNWSEL 804
              +  AL YLH      I+HRD+  +N+LL+      ++DFG AK L+P+S  +  +  
Sbjct: 139 TAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 195
Query: 805 AGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
            GT  YV+PEL       +  D+++ G +  +++ G  P
Sbjct: 196 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 637 TNDFNAEHCIGKGGHGSVYRA--KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTE 694
           T+D+     +GKG    V R   K P+ E +A K  ++        Q+ E   E +    
Sbjct: 30  TDDYQLFEELGKGAFSVVRRCVKKTPTQE-YAAKIINTKKLSARDHQKLE--REARICRL 86
Query: 695 IRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKEL-GWTQRLNVIKGVADA 753
           ++H NIV+ +   S     +++++ +  G L      D  A+E        + I  + ++
Sbjct: 87  LKHPNIVRLHDSISEEGFHYLVFDLVTGGEL----FEDIVAREYYSEADASHCIHQILES 142
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLD---LGYEAHVSDFGIAKFLNPDSSNWSELAGTHGY 810
           + ++H +    IVHRD+  +N+LL     G    ++DFG+A  +  +   W   AGT GY
Sbjct: 143 VNHIHQH---DIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGY 199
Query: 811 VAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           ++PE+       +  D+++ GV+   ++ G  P
Sbjct: 200 LSPEVLRKDPYGKPVDIWACGVILYILLVGYPP 232

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 72/159 (45%), Gaps = 8/159 (5%)
Query: 687 NEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNV 746
            E   ++ + H   VK Y      +  +    Y ++G L K +    S  E   T     
Sbjct: 58  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---TCTRFY 114
Query: 747 IKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS--SNWSEL 804
              +  AL YLH      I+HRD+  +N+LL+      ++DFG AK L+P+S  +  +  
Sbjct: 115 TAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 171
Query: 805 AGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
            GT  YV+PEL       +  D+++ G +  +++ G  P
Sbjct: 172 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 210

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/170 (24%), Positives = 81/170 (47%), Gaps = 19/170 (11%)
Query: 684 EFLNEIQALTEI-RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKIL------------- 729
           + ++E++ +  I +H+NI+   G C+     ++I EY   G+L + L             
Sbjct: 86  DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYD 145
Query: 730 CNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFG 789
            N    +++ +   ++    +A  + YL +      +HRD++++NVL+       ++DFG
Sbjct: 146 INRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFG 202
Query: 790 IAKFLNPDSSNWSELAGT--HGYVAPELAYTLKVTEKCDVYSFGVLALEV 837
           +A+ +N          G     ++APE  +    T + DV+SFGVL  E+
Sbjct: 203 LARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 16/212 (7%)
Query: 638 NDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVK---KFHSPLPGEMSFQQEEFLNEIQALT 693
            DF     +G+G   +V  A+ + +   +A+K   K H     ++ +       E   ++
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY----VTRERDVMS 62
Query: 694 EIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADA 753
            + H   VK Y      +  +    Y ++G L K +    S  E   T        +  A
Sbjct: 63  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---TCTRFYTAEIVSA 119
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS--SNWSELAGTHGYV 811
           L YLH      I+HRD+  +N+LL+      ++DFG AK L+P+S  +  +   GT  YV
Sbjct: 120 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 176
Query: 812 APELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           +PEL       +  D+++ G +  +++ G  P
Sbjct: 177 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 208

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 72/159 (45%), Gaps = 8/159 (5%)
Query: 687 NEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNV 746
            E   ++ + H   VK Y      +  +    Y ++G L K +    S  E   T     
Sbjct: 81  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---TCTRFY 137
Query: 747 IKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS--SNWSEL 804
              +  AL YLH      I+HRD+  +N+LL+      ++DFG AK L+P+S  +  +  
Sbjct: 138 TAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 805 AGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
            GT  YV+PEL       +  D+++ G +  +++ G  P
Sbjct: 195 VGTAQYVSPELLTEKSAXKSSDLWALGCIIYQLVAGLPP 233

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 16/212 (7%)
Query: 638 NDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVK---KFHSPLPGEMSFQQEEFLNEIQALT 693
            DF     +G+G   +V  A+ + +   +A+K   K H     ++ +       E   ++
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY----VTRERDVMS 84
Query: 694 EIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADA 753
            + H   VK Y      +  +    Y ++G L K +    S  E   T        +  A
Sbjct: 85  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---TCTRFYTAEIVSA 141
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS--SNWSELAGTHGYV 811
           L YLH      I+HRD+  +N+LL+      ++DFG AK L+P+S  +  +   GT  YV
Sbjct: 142 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 198
Query: 812 APELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           +PEL       +  D+++ G +  +++ G  P
Sbjct: 199 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 72/159 (45%), Gaps = 8/159 (5%)
Query: 687 NEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNV 746
            E   ++ + H   VK Y      +  +    Y ++G L K +    S  E   T     
Sbjct: 81  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---TCTRFY 137
Query: 747 IKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS--SNWSEL 804
              +  AL YLH      I+HRD+  +N+LL+      ++DFG AK L+P+S  +  +  
Sbjct: 138 TAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 805 AGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
            GT  YV+PEL       +  D+++ G +  +++ G  P
Sbjct: 195 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 16/212 (7%)
Query: 638 NDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVK---KFHSPLPGEMSFQQEEFLNEIQALT 693
            DF     +G+G   +V  A+ + +   +A+K   K H     ++ +       E   ++
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY----VTRERDVMS 69
Query: 694 EIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADA 753
            + H   VK Y      +  +    Y ++G L K +    S  E   T        +  A
Sbjct: 70  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---TCTRFYTAEIVSA 126
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS--SNWSELAGTHGYV 811
           L YLH      I+HRD+  +N+LL+      ++DFG AK L+P+S  +  +   GT  YV
Sbjct: 127 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 183
Query: 812 APELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           +PEL       +  D+++ G +  +++ G  P
Sbjct: 184 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 215

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 72/159 (45%), Gaps = 8/159 (5%)
Query: 687 NEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNV 746
            E   ++ + H   VK Y      +  +    Y ++G L K +    S  E   T     
Sbjct: 81  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---TCTRFY 137
Query: 747 IKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS--SNWSEL 804
              +  AL YLH      I+HRD+  +N+LL+      ++DFG AK L+P+S  +  +  
Sbjct: 138 TAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 805 AGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
            GT  YV+PEL       +  D+++ G +  +++ G  P
Sbjct: 195 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/170 (24%), Positives = 81/170 (47%), Gaps = 19/170 (11%)
Query: 684 EFLNEIQALTEI-RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKIL------------- 729
           + ++E++ +  I +H+NI+   G C+     ++I EY   G+L + L             
Sbjct: 86  DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 145
Query: 730 CNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFG 789
            N    +++ +   ++    +A  + YL +      +HRD++++NVL+       ++DFG
Sbjct: 146 INRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFG 202
Query: 790 IAKFLNPDSSNWSELAGT--HGYVAPELAYTLKVTEKCDVYSFGVLALEV 837
           +A+ +N          G     ++APE  +    T + DV+SFGVL  E+
Sbjct: 203 LARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 72/159 (45%), Gaps = 8/159 (5%)
Query: 687 NEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNV 746
            E   ++ + H   VK Y      +  +    Y ++G L K +    S  E   T     
Sbjct: 79  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---TCTRFY 135
Query: 747 IKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS--SNWSEL 804
              +  AL YLH      I+HRD+  +N+LL+      ++DFG AK L+P+S  +  +  
Sbjct: 136 TAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 192
Query: 805 AGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
            GT  YV+PEL       +  D+++ G +  +++ G  P
Sbjct: 193 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 72/159 (45%), Gaps = 8/159 (5%)
Query: 687 NEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNV 746
            E   ++ + H   VK Y      +  +    Y ++G L K +    S  E   T     
Sbjct: 79  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---TCTRFY 135
Query: 747 IKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS--SNWSEL 804
              +  AL YLH      I+HRD+  +N+LL+      ++DFG AK L+P+S  +  +  
Sbjct: 136 TAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 192
Query: 805 AGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
            GT  YV+PEL       +  D+++ G +  +++ G  P
Sbjct: 193 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 72/159 (45%), Gaps = 8/159 (5%)
Query: 687 NEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNV 746
            E   ++ + H   VK Y      +  +    Y ++G L K +    S  E   T     
Sbjct: 81  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---TCTRFY 137
Query: 747 IKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS--SNWSEL 804
              +  AL YLH      I+HRD+  +N+LL+      ++DFG AK L+P+S  +  +  
Sbjct: 138 TAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 805 AGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
            GT  YV+PEL       +  D+++ G +  +++ G  P
Sbjct: 195 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 72/159 (45%), Gaps = 8/159 (5%)
Query: 687 NEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNV 746
            E   ++ + H   VK Y      +  +    Y ++G L K +    S  E   T     
Sbjct: 79  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---TCTRFY 135
Query: 747 IKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS--SNWSEL 804
              +  AL YLH      I+HRD+  +N+LL+      ++DFG AK L+P+S  +  +  
Sbjct: 136 TAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 192
Query: 805 AGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
            GT  YV+PEL       +  D+++ G +  +++ G  P
Sbjct: 193 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 72/159 (45%), Gaps = 8/159 (5%)
Query: 687 NEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNV 746
            E   ++ + H   VK Y      +  +    Y ++G L K +    S  E   T     
Sbjct: 79  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---TCTRFY 135
Query: 747 IKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS--SNWSEL 804
              +  AL YLH      I+HRD+  +N+LL+      ++DFG AK L+P+S  +  +  
Sbjct: 136 TAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAF 192
Query: 805 AGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
            GT  YV+PEL       +  D+++ G +  +++ G  P
Sbjct: 193 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 72/159 (45%), Gaps = 8/159 (5%)
Query: 687 NEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNV 746
            E   ++ + H   VK Y      +  +    Y ++G L K +    S  E   T     
Sbjct: 81  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---TCTRFY 137
Query: 747 IKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS--SNWSEL 804
              +  AL YLH      I+HRD+  +N+LL+      ++DFG AK L+P+S  +  +  
Sbjct: 138 TAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 805 AGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
            GT  YV+PEL       +  D+++ G +  +++ G  P
Sbjct: 195 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 18/206 (8%)
Query: 645 CIGKGGHGSVYRAKVPSG----EIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNI 700
            +G+G  G V+  K  SG    +++A+K             + +   +I  L E+ H  I
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI--LVEVNHPFI 88
Query: 701 VKF-YGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQR--LNVIKGVADALFYL 757
           VK  Y F +  K  ++I ++L  G L   L     +KE+ +T+      +  +A AL +L
Sbjct: 89  VKLHYAFQTEGK-LYLILDFLRGGDLFTRL-----SKEVMFTEEDVKFYLAELALALDHL 142
Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAY 817
           H+     I++RD+  +N+LLD      ++DFG++K             GT  Y+APE+  
Sbjct: 143 HSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 199
Query: 818 TLKVTEKCDVYSFGVLALEVIKGKHP 843
               T+  D +SFGVL  E++ G  P
Sbjct: 200 RRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 98/202 (48%), Gaps = 14/202 (6%)
Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           IG+G +G+V++AK   + EI A+K+    L  +        L EI  L E++H+NIV+ +
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVR--LDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 705 GFCSHPKHSFIIYEYLESGSLDKIL--CNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
                 K   +++E+ +   L K    CN     E+  +    ++KG+     + H+   
Sbjct: 68  DVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLG----FCHSR-- 120
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKV- 821
             ++HRD+  +N+L++   E  +++FG+A+        +S    T  Y  P++ +  K+ 
Sbjct: 121 -NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 822 TEKCDVYSFGVLALEVIKGKHP 843
           +   D++S G +  E+     P
Sbjct: 180 STSIDMWSAGCIFAELANAGRP 201

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 25/212 (11%)
Query: 640 FNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHR 698
           F  E  +G+G    VYR K   + + +A+K          +  ++    EI  L  + H 
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVLKK------TVDKKIVRTEIGVLLRLSHP 108
Query: 699 NIVKFYGFCSHPKHSFIIYEYLESGSL-DKILCNDASAKELGW-TQR--LNVIKGVADAL 754
           NI+K       P    ++ E +  G L D+I+       E G+ ++R   + +K + +A+
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIV-------EKGYYSERDAADAVKQILEAV 161
Query: 755 FYLHNNCFPPIVHRDISSKNVLLDL---GYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV 811
            YLH N    IVHRD+  +N+L           ++DFG++K +         + GT GY 
Sbjct: 162 AYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE-HQVLMKTVCGTPGYC 217
Query: 812 APELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           APE+        + D++S G++   ++ G  P
Sbjct: 218 APEILRGCAYGPEVDMWSVGIITYILLCGFEP 249

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/273 (22%), Positives = 109/273 (39%), Gaps = 19/273 (6%)
Query: 634 ISATNDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQ-EEFLNEIQA 691
           I    +F     +G G  G+VY+   +P GE   +      L    S +  +E L+E   
Sbjct: 8   ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 67
Query: 692 LTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVA 751
           +  + + ++ +  G C       I         LD +         +G    LN    +A
Sbjct: 68  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIA 124
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH--G 809
           + + YL +     +VHRD++++NVL+       ++DFG+AK L  +   +    G     
Sbjct: 125 EGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 181
Query: 810 YVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPY 868
           ++A E       T + DV+S+GV   E++  G  P D +            E    RLP 
Sbjct: 182 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE----RLPQ 237
Query: 869 PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
           P +      + +  +   C   + +SRP  + +
Sbjct: 238 PPICT----IDVYMIMVKCWMIDADSRPKFREL 266

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/273 (22%), Positives = 109/273 (39%), Gaps = 19/273 (6%)
Query: 634 ISATNDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQ-EEFLNEIQA 691
           I    +F     +G G  G+VY+   +P GE   +      L    S +  +E L+E   
Sbjct: 12  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 71
Query: 692 LTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVA 751
           +  + + ++ +  G C       I+        LD +         +G    LN    +A
Sbjct: 72  MASVDNPHVCRLLGICLTSTVQLIMQLMPFGXLLDYV---REHKDNIGSQYLLNWCVQIA 128
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH--G 809
             + YL +     +VHRD++++NVL+       ++DFG+AK L  +   +    G     
Sbjct: 129 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 185
Query: 810 YVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPY 868
           ++A E       T + DV+S+GV   E++  G  P D +            E    RLP 
Sbjct: 186 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE----RLPQ 241
Query: 869 PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
           P +      + +  +   C   + +SRP  + +
Sbjct: 242 PPICT----IDVYMIMVKCWMIDADSRPKFREL 270

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 96/217 (44%), Gaps = 23/217 (10%)
Query: 635 SATNDFNAEH-------CIGKGGHGSVYRAKVPSGE----IFAVKKFHSPLPGEMSFQQE 683
           S+T D+  +        CIG+G  G V++    S E      A+K   +     +   +E
Sbjct: 5   SSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV---RE 61
Query: 684 EFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQR 743
           +FL E   + +  H +IVK  G  +     +II E    G L   L        L     
Sbjct: 62  KFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASL 118
Query: 744 LNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSE 803
           +     ++ AL YL +  F   VHRDI+++NVL+       + DFG+++++  DS+ +  
Sbjct: 119 ILYAYQLSTALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKA 174
Query: 804 LAGTH--GYVAPELAYTLKVTEKCDVYSFGVLALEVI 838
             G     ++APE     + T   DV+ FGV   E++
Sbjct: 175 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 211

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 98/211 (46%), Gaps = 19/211 (9%)
Query: 638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
            +F     IG+G +G VY+A+   +GE+ A+KK    L  E        + EI  L E+ 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKELN 59
Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE-----LGWTQRLNVIKGVA 751
           H NIVK           ++++E++     D     DASA       L  +    +++G+A
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEHVHQ---DLKTFMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV 811
               + H++    ++HRD+  +N+L++      ++DFG+A+        ++    T  Y 
Sbjct: 117 ----FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 169
Query: 812 APELAYTLK-VTEKCDVYSFGVLALEVIKGK 841
           APE+    K  +   D++S G +  E++  +
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 87/183 (47%), Gaps = 28/183 (15%)
Query: 679 SFQQEEFLNEIQALTEI-RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCND----- 732
           S ++E  ++E++ +T++  H NIV   G C+     ++I+EY   G L   L +      
Sbjct: 89  SSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFS 148
Query: 733 ------ASAKELGWTQRLNVIK---------GVADALFYLHNNCFPPIVHRDISSKNVLL 777
                  + K L   + LNV+           VA  + +L    F   VHRD++++NVL+
Sbjct: 149 EDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLV 205
Query: 778 DLGYEAHVSDFGIAKFLNPDSSNWSELAGTH---GYVAPELAYTLKVTEKCDVYSFGVLA 834
             G    + DFG+A+ +  D SN+           ++APE  +    T K DV+S+G+L 
Sbjct: 206 THGKVVKICDFGLARDIMSD-SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILL 264
Query: 835 LEV 837
            E+
Sbjct: 265 WEI 267

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 96/217 (44%), Gaps = 21/217 (9%)
Query: 638 NDFNAEHCIGKGGHGSVYRAKVPSGE-IFAVKKFHSPLPGEMSFQQEE--FLNEIQALTE 694
            DF     IG+G  G V   K+ + E I+A+K  +     EM  + E   F  E   L  
Sbjct: 74  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNK---WEMLKRAETACFREERDVLVN 130
Query: 695 IRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCN--DASAKELGWTQRLNVIKGVAD 752
              + I   +       H +++ +Y   G L  +L    D   +++       ++  + D
Sbjct: 131 GDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAI-D 189
Query: 753 ALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELA-GTHGYV 811
           ++  LH       VHRDI   NVLLD+     ++DFG    +N D +  S +A GT  Y+
Sbjct: 190 SIHQLH------YVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYI 243
Query: 812 APELAYTL-----KVTEKCDVYSFGVLALEVIKGKHP 843
           +PE+   +     K   +CD +S GV   E++ G+ P
Sbjct: 244 SPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 280

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/273 (22%), Positives = 109/273 (39%), Gaps = 19/273 (6%)
Query: 634 ISATNDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQ-EEFLNEIQA 691
           I    +F     +G G  G+VY+   +P GE   +      L    S +  +E L+E   
Sbjct: 13  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 72
Query: 692 LTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVA 751
           +  + + ++ +  G C       I+        LD +         +G    LN    +A
Sbjct: 73  MASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIA 129
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH--G 809
             + YL +     +VHRD++++NVL+       ++DFG+AK L  +   +    G     
Sbjct: 130 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 186
Query: 810 YVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPY 868
           ++A E       T + DV+S+GV   E++  G  P D +            E    RLP 
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE----RLPQ 242
Query: 869 PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
           P +      + +  +   C   + +SRP  + +
Sbjct: 243 PPICT----IDVYMIMVKCWMIDADSRPKFREL 271

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 96/217 (44%), Gaps = 21/217 (9%)
Query: 638 NDFNAEHCIGKGGHGSVYRAKVPSGE-IFAVKKFHSPLPGEMSFQQEE--FLNEIQALTE 694
            DF     IG+G  G V   K+ + E I+A+K  +     EM  + E   F  E   L  
Sbjct: 90  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNK---WEMLKRAETACFREERDVLVN 146
Query: 695 IRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCN--DASAKELGWTQRLNVIKGVAD 752
              + I   +       H +++ +Y   G L  +L    D   +++       ++  + D
Sbjct: 147 GDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAI-D 205
Query: 753 ALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELA-GTHGYV 811
           ++  LH       VHRDI   NVLLD+     ++DFG    +N D +  S +A GT  Y+
Sbjct: 206 SIHQLH------YVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYI 259
Query: 812 APELAYTL-----KVTEKCDVYSFGVLALEVIKGKHP 843
           +PE+   +     K   +CD +S GV   E++ G+ P
Sbjct: 260 SPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 296

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/273 (22%), Positives = 109/273 (39%), Gaps = 19/273 (6%)
Query: 634 ISATNDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQ-EEFLNEIQA 691
           I    +F     +G G  G+VY+   +P GE   +      L    S +  +E L+E   
Sbjct: 12  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 71
Query: 692 LTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVA 751
           +  + + ++ +  G C       I+        LD +         +G    LN    +A
Sbjct: 72  MASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIA 128
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH--G 809
             + YL +     +VHRD++++NVL+       ++DFG+AK L  +   +    G     
Sbjct: 129 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 185
Query: 810 YVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPY 868
           ++A E       T + DV+S+GV   E++  G  P D +            E    RLP 
Sbjct: 186 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE----RLPQ 241
Query: 869 PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
           P +      + +  +   C   + +SRP  + +
Sbjct: 242 PPICT----IDVYMIMVKCWMIDADSRPKFREL 270

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/273 (22%), Positives = 109/273 (39%), Gaps = 19/273 (6%)
Query: 634 ISATNDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQ-EEFLNEIQA 691
           I    +F     +G G  G+VY+   +P GE   +      L    S +  +E L+E   
Sbjct: 15  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 74
Query: 692 LTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVA 751
           +  + + ++ +  G C       I+        LD +         +G    LN    +A
Sbjct: 75  MASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIA 131
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH--G 809
             + YL +     +VHRD++++NVL+       ++DFG+AK L  +   +    G     
Sbjct: 132 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 188
Query: 810 YVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPY 868
           ++A E       T + DV+S+GV   E++  G  P D +            E    RLP 
Sbjct: 189 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE----RLPQ 244
Query: 869 PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
           P +      + +  +   C   + +SRP  + +
Sbjct: 245 PPICT----IDVYMIMVKCWMIDADSRPKFREL 273

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 95/203 (46%), Gaps = 14/203 (6%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +GKG    V R  KV +G+ +A    ++        Q+ E   E +    ++H NIV+ +
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLE--REARICRLLKHPNIVRLH 76
Query: 705 GFCSHPKHSFIIYEYLESGSLDKILCNDASAKEL-GWTQRLNVIKGVADALFYLHNNCFP 763
              S   H ++I++ +  G L      D  A+E        + I+ + +A+ + H     
Sbjct: 77  DSISEEGHHYLIFDLVTGGEL----FEDIVAREYYSEADASHCIQQILEAVLHCHQM--- 129
Query: 764 PIVHRDISSKNVLLD---LGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLK 820
            +VHR++  +N+LL     G    ++DFG+A  +  +   W   AGT GY++PE+     
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDP 189
Query: 821 VTEKCDVYSFGVLALEVIKGKHP 843
             +  D+++ GV+   ++ G  P
Sbjct: 190 YGKPVDLWACGVILYILLVGYPP 212

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/273 (22%), Positives = 109/273 (39%), Gaps = 19/273 (6%)
Query: 634 ISATNDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQ-EEFLNEIQA 691
           I    +F     +G G  G+VY+   +P GE   +      L    S +  +E L+E   
Sbjct: 14  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 73
Query: 692 LTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVA 751
           +  + + ++ +  G C       I+        LD +         +G    LN    +A
Sbjct: 74  MASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIA 130
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH--G 809
             + YL +     +VHRD++++NVL+       ++DFG+AK L  +   +    G     
Sbjct: 131 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 810 YVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPY 868
           ++A E       T + DV+S+GV   E++  G  P D +            E    RLP 
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE----RLPQ 243
Query: 869 PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
           P +      + +  +   C   + +SRP  + +
Sbjct: 244 PPICT----IDVYMIMVKCWMIDADSRPKFREL 272

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 100/221 (45%), Gaps = 25/221 (11%)
Query: 683 EEFLNEIQALTEIRHRNIVKFYGFCSHP--KHSFIIYEYLESGSLDKILCNDASAKELGW 740
           E+   EI  L ++ H N+VK       P   H ++++E +  G + ++      +++   
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQAR 140
Query: 741 TQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN 800
               ++IKG+     YLH   +  I+HRDI   N+L+       ++DFG++       + 
Sbjct: 141 FYFQDLIKGIE----YLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL 193
Query: 801 WSELAGTHGYVAPE-LAYTLKV--TEKCDVYSFGVLALEVIKGKHPRDFLFEXXXXXXXX 857
            S   GT  ++APE L+ T K+   +  DV++ GV     + G+ P  F+ E        
Sbjct: 194 LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP--FMDE-------- 243
Query: 858 XIEMLDSRLPYPSLHVQKK---LMSIMQVAFSCLDQNPESR 895
            I  L S++   +L    +      +  +    LD+NPESR
Sbjct: 244 RIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESR 284

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/273 (22%), Positives = 109/273 (39%), Gaps = 19/273 (6%)
Query: 634 ISATNDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQ-EEFLNEIQA 691
           I    +F     +G G  G+VY+   +P GE   +      L    S +  +E L+E   
Sbjct: 11  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 70
Query: 692 LTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVA 751
           +  + + ++ +  G C       I+        LD +         +G    LN    +A
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIA 127
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH--G 809
             + YL +     +VHRD++++NVL+       ++DFG+AK L  +   +    G     
Sbjct: 128 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 810 YVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPY 868
           ++A E       T + DV+S+GV   E++  G  P D +            E    RLP 
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE----RLPQ 240
Query: 869 PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
           P +      + +  +   C   + +SRP  + +
Sbjct: 241 PPICT----IDVYMIMVKCWMIDADSRPKFREL 269

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 90/201 (44%), Gaps = 16/201 (7%)
Query: 644 HCIGKGGHGSVYRAKVPSGE----IFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRN 699
            CIG+G  G V++    S E      A+K   +     +   +E+FL E   + +  H +
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSV---REKFLQEALTMRQFDHPH 72
Query: 700 IVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHN 759
           IVK  G  +     +II E    G L   L        L     +     ++ AL YL +
Sbjct: 73  IVKLIGVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLES 129
Query: 760 NCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH--GYVAPELAY 817
             F   VHRDI+++NVL+       + DFG+++++  DS+ +    G     ++APE   
Sbjct: 130 KRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESIN 185
Query: 818 TLKVTEKCDVYSFGVLALEVI 838
             + T   DV+ FGV   E++
Sbjct: 186 FRRFTSASDVWMFGVCMWEIL 206

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 90/201 (44%), Gaps = 16/201 (7%)
Query: 644 HCIGKGGHGSVYRAKVPSGE----IFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRN 699
            CIG+G  G V++    S E      A+K   +     +   +E+FL E   + +  H +
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV---REKFLQEALTMRQFDHPH 72
Query: 700 IVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHN 759
           IVK  G  +     +II E    G L   L        L     +     ++ AL YL +
Sbjct: 73  IVKLIGVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLES 129
Query: 760 NCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH--GYVAPELAY 817
             F   VHRDI+++NVL+       + DFG+++++  DS+ +    G     ++APE   
Sbjct: 130 KRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESIN 185
Query: 818 TLKVTEKCDVYSFGVLALEVI 838
             + T   DV+ FGV   E++
Sbjct: 186 FRRFTSASDVWMFGVCMWEIL 206

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/279 (22%), Positives = 110/279 (39%), Gaps = 31/279 (11%)
Query: 634 ISATNDFNAEHCIGKGGHGSVYRA-KVPSGE-------IFAVKKFHSPLPGEMSFQQEEF 685
           I    +F     +G G  G+VY+   +P GE       I  +++  SP         +E 
Sbjct: 45  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPK------ANKEI 98
Query: 686 LNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLN 745
           L+E   +  + + ++ +  G C       I         LD +         +G    LN
Sbjct: 99  LDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV---REHKDNIGSQYLLN 155
Query: 746 VIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELA 805
               +A  + YL +     +VHRD++++NVL+       ++DFG+AK L  +   +    
Sbjct: 156 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 212
Query: 806 GTH--GYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEML 862
           G     ++A E       T + DV+S+GV   E++  G  P D +            E  
Sbjct: 213 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-- 270
Query: 863 DSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
             RLP P +      + +  +   C   + +SRP  + +
Sbjct: 271 --RLPQPPICT----IDVYMIMVKCWMIDADSRPKFREL 303

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/227 (23%), Positives = 94/227 (41%), Gaps = 27/227 (11%)
Query: 684 EFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILC-------NDASAK 736
           EFLNE   + E    ++V+  G  S  + + +I E +  G L   L        N+    
Sbjct: 68  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 127
Query: 737 ELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP 796
               ++ + +   +AD + YL+ N F   VHRD++++N ++   +   + DFG+ + +  
Sbjct: 128 PPSLSKMIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIXE 184
Query: 797 DSSNWSELAGTHG-----YVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEX 850
                    G  G     +++PE       T   DV+SFGV+  E+    + P   L   
Sbjct: 185 TDXX---RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 241
Query: 851 XXXXXXXXIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPT 897
                     +LD     P +     L  +M++   C   NP+ RP+
Sbjct: 242 QVLRFVMEGGLLDKPDNCPDM-----LFELMRM---CWQYNPKMRPS 280

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 90/201 (44%), Gaps = 16/201 (7%)
Query: 644 HCIGKGGHGSVYRAKVPSGE----IFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRN 699
            CIG+G  G V++    S E      A+K   +     +   +E+FL E   + +  H +
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSV---REKFLQEALTMRQFDHPH 72
Query: 700 IVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHN 759
           IVK  G  +     +II E    G L   L        L     +     ++ AL YL +
Sbjct: 73  IVKLIGVITE-NPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLES 129
Query: 760 NCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH--GYVAPELAY 817
             F   VHRDI+++NVL+       + DFG+++++  DS+ +    G     ++APE   
Sbjct: 130 KRF---VHRDIAARNVLVSATDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESIN 185
Query: 818 TLKVTEKCDVYSFGVLALEVI 838
             + T   DV+ FGV   E++
Sbjct: 186 FRRFTSASDVWMFGVCMWEIL 206

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/170 (24%), Positives = 81/170 (47%), Gaps = 19/170 (11%)
Query: 684 EFLNEIQALTEI-RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKIL------------- 729
           + ++E++ +  I +H+NI+   G C+     ++I EY   G+L + L             
Sbjct: 132 DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 191
Query: 730 CNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFG 789
            N    +++ +   ++    +A  + YL +      +HRD++++NVL+       ++DFG
Sbjct: 192 INRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFG 248
Query: 790 IAKFLNPDSSNWSELAGT--HGYVAPELAYTLKVTEKCDVYSFGVLALEV 837
           +A+ +N          G     ++APE  +    T + DV+SFGVL  E+
Sbjct: 249 LARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 298

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/170 (24%), Positives = 81/170 (47%), Gaps = 19/170 (11%)
Query: 684 EFLNEIQALTEI-RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKIL------------- 729
           + ++E++ +  I +H+NI+   G C+     ++I EY   G+L + L             
Sbjct: 86  DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 145
Query: 730 CNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFG 789
            N    +++ +   ++    +A  + YL +      +HRD++++NVL+       ++DFG
Sbjct: 146 INRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMRIADFG 202
Query: 790 IAKFLNPDSSNWSELAGT--HGYVAPELAYTLKVTEKCDVYSFGVLALEV 837
           +A+ +N          G     ++APE  +    T + DV+SFGVL  E+
Sbjct: 203 LARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 54/239 (22%), Positives = 100/239 (41%), Gaps = 27/239 (11%)
Query: 684 EFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILC-------NDASAK 736
           EFLNE   + E    ++V+  G  S  + + +I E +  G L   L        N+    
Sbjct: 59  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 118
Query: 737 ELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP 796
               ++ + +   +AD + YL+ N F   VHRD++++N ++   +   + DFG+ + +  
Sbjct: 119 PPSLSKMIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIXE 175
Query: 797 DSSNWSELAGTHG-----YVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEX 850
                    G  G     +++PE       T   DV+SFGV+  E+    + P   L   
Sbjct: 176 TD---XXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 232
Query: 851 XXXXXXXXIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI 909
                     +LD     P +     L+ +M++   C   NP+ RP+   +   + E++
Sbjct: 233 QVLRFVMEGGLLDKPDNCPDM-----LLELMRM---CWQYNPKMRPSFLEIISSIKEEM 283

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/170 (24%), Positives = 81/170 (47%), Gaps = 19/170 (11%)
Query: 684 EFLNEIQALTEI-RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKIL------------- 729
           + ++E++ +  I +H+NI+   G C+     ++I EY   G+L + L             
Sbjct: 73  DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 132
Query: 730 CNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFG 789
            N    +++ +   ++    +A  + YL +      +HRD++++NVL+       ++DFG
Sbjct: 133 INRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLTARNVLVTENNVMKIADFG 189
Query: 790 IAKFLNPDSSNWSELAGT--HGYVAPELAYTLKVTEKCDVYSFGVLALEV 837
           +A+ +N          G     ++APE  +    T + DV+SFGVL  E+
Sbjct: 190 LARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 239

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 90/201 (44%), Gaps = 16/201 (7%)
Query: 644 HCIGKGGHGSVYRAKVPSGE----IFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRN 699
            CIG+G  G V++    S E      A+K   +     +   +E+FL E   + +  H +
Sbjct: 13  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV---REKFLQEALTMRQFDHPH 69
Query: 700 IVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHN 759
           IVK  G  +     +II E    G L   L        L     +     ++ AL YL +
Sbjct: 70  IVKLIGVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLES 126
Query: 760 NCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH--GYVAPELAY 817
             F   VHRDI+++NVL+       + DFG+++++  DS+ +    G     ++APE   
Sbjct: 127 KRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESIN 182
Query: 818 TLKVTEKCDVYSFGVLALEVI 838
             + T   DV+ FGV   E++
Sbjct: 183 FRRFTSASDVWMFGVCMWEIL 203

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/265 (23%), Positives = 107/265 (40%), Gaps = 31/265 (11%)
Query: 646 IGKGGHGSVYRA-KVPSGE-------IFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH 697
           +G G  G+VY+   +P GE       I  +++  SP         +E L+E   +  +  
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPK------ANKEILDEAYVMAGVGS 78
Query: 698 RNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYL 757
             + +  G C       +         LD +  N      LG    LN    +A  + YL
Sbjct: 79  PYVSRLLGICLTSTVQLVTQLMPYGCLLDHVRENRG---RLGSQDLLNWCMQIAKGMSYL 135
Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH--GYVAPEL 815
            +     +VHRD++++NVL+       ++DFG+A+ L+ D + +    G     ++A E 
Sbjct: 136 EDV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 192
Query: 816 AYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLHVQ 874
               + T + DV+S+GV   E++  G  P D +            E    RLP P +   
Sbjct: 193 ILRRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGE----RLPQPPICT- 247
Query: 875 KKLMSIMQVAFSCLDQNPESRPTMK 899
              + +  +   C   + E RP  +
Sbjct: 248 ---IDVYMIMVKCWMIDSECRPRFR 269

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/273 (22%), Positives = 108/273 (39%), Gaps = 19/273 (6%)
Query: 634 ISATNDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQ-EEFLNEIQA 691
           I    +F     +G G  G+VY+   +P GE   +      L    S +  +E L+E   
Sbjct: 11  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 70
Query: 692 LTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVA 751
           +  + + ++ +  G C       I         LD +         +G    LN    +A
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQLITQLMPFGXLLDYV---REHKDNIGSQYLLNWCVQIA 127
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH--G 809
             + YL +     +VHRD++++NVL+       ++DFG+AK L  +   +    G     
Sbjct: 128 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 810 YVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPY 868
           ++A E       T + DV+S+GV   E++  G  P D +            E    RLP 
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE----RLPQ 240
Query: 869 PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
           P +      + +  +   C   + +SRP  + +
Sbjct: 241 PPICT----IDVYMIMVKCWMIDADSRPKFREL 269

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/170 (24%), Positives = 81/170 (47%), Gaps = 19/170 (11%)
Query: 684 EFLNEIQALTEI-RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKIL------------- 729
           + ++E++ +  I +H+NI+   G C+     ++I EY   G+L + L             
Sbjct: 75  DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 134
Query: 730 CNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFG 789
            N    +++ +   ++    +A  + YL +      +HRD++++NVL+       ++DFG
Sbjct: 135 INRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFG 191
Query: 790 IAKFLNPDSSNWSELAGT--HGYVAPELAYTLKVTEKCDVYSFGVLALEV 837
           +A+ +N          G     ++APE  +    T + DV+SFGVL  E+
Sbjct: 192 LARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 241

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/132 (28%), Positives = 62/132 (46%), Gaps = 6/132 (4%)
Query: 714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSK 773
           + + EY+  G L   +      KE    Q +     ++  LF+LH      I++RD+   
Sbjct: 96  YFVMEYVNGGDLMYHIQQVGKFKE---PQAVFYAAEISIGLFFLHKRG---IIYRDLKLD 149
Query: 774 NVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVL 833
           NV+LD      ++DFG+ K    D     E  GT  Y+APE+       +  D +++GVL
Sbjct: 150 NVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVL 209
Query: 834 ALEVIKGKHPRD 845
             E++ G+ P D
Sbjct: 210 LYEMLAGQPPFD 221

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 99/218 (45%), Gaps = 31/218 (14%)
Query: 638 NDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFH-SPLPGEMSFQQ------------EE 684
           ND+     + +G    +   +    + +A+KK+  S L  +  F +            ++
Sbjct: 31  NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 685 FLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDK----ILCNDASAKELGW 740
           F NE+Q +T+I++   +   G  ++    +IIYEY+E+ S+ K        D +      
Sbjct: 90  FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 741 TQRLN-VIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSS 799
            Q +  +IK V ++  Y+HN     I HRD+   N+L+D      +SDFG ++++     
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI 207
Query: 800 NWSELAGTHGYVAPEL-----AYTLKVTEKCDVYSFGV 832
             S   GT+ ++ PE      +Y      K D++S G+
Sbjct: 208 KGSR--GTYEFMPPEFFSNESSYN---GAKVDIWSLGI 240

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 76/166 (45%), Gaps = 11/166 (6%)
Query: 682 QEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWT 741
           +EE   E+  L EIRH NI+  +    +     +I E +  G L   L    S  E   T
Sbjct: 73  REEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT 132
Query: 742 QRLNVIKGVADALFYLHNNCFPPIVHRDISSKNV-LLDLGY---EAHVSDFGIAKFLNPD 797
           Q    +K + D + YLH+     I H D+  +N+ LLD         + DFGIA  +   
Sbjct: 133 Q---FLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA- 185
Query: 798 SSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
            + +  + GT  +VAPE+     +  + D++S GV+   ++ G  P
Sbjct: 186 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 231

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/273 (22%), Positives = 108/273 (39%), Gaps = 19/273 (6%)
Query: 634 ISATNDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQ-EEFLNEIQA 691
           I    +F     +G G  G+VY+   +P GE   +      L    S +  +E L+E   
Sbjct: 14  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 73
Query: 692 LTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVA 751
           +  + + ++ +  G C       I         LD +         +G    LN    +A
Sbjct: 74  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIA 130
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH--G 809
             + YL +     +VHRD++++NVL+       ++DFG+AK L  +   +    G     
Sbjct: 131 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 810 YVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPY 868
           ++A E       T + DV+S+GV   E++  G  P D +            E    RLP 
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE----RLPQ 243
Query: 869 PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
           P +      + +  +   C   + +SRP  + +
Sbjct: 244 PPICT----IDVYMIMVKCWMIDADSRPKFREL 272

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/226 (23%), Positives = 96/226 (42%), Gaps = 25/226 (11%)
Query: 684 EFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILC-------NDASAK 736
           EFLNE   + E    ++V+  G  S  + + +I E +  G L   L        N+    
Sbjct: 67  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 126
Query: 737 ELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP 796
               ++ + +   +AD + YL+ N F   VHRD++++N ++   +   + DFG+ + +  
Sbjct: 127 PPSLSKMIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY- 182
Query: 797 DSSNWSELAGTH----GYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXX 851
             +++    G       +++PE       T   DV+SFGV+  E+    + P   L    
Sbjct: 183 -ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 241
Query: 852 XXXXXXXIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPT 897
                    +LD     P +     L  +M++   C   NP+ RP+
Sbjct: 242 VLRFVMEGGLLDKPDNCPDM-----LFELMRM---CWQYNPKMRPS 279

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 76/166 (45%), Gaps = 11/166 (6%)
Query: 682 QEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWT 741
           +EE   E+  L EIRH NI+  +    +     +I E +  G L   L    S  E   T
Sbjct: 59  REEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT 118
Query: 742 QRLNVIKGVADALFYLHNNCFPPIVHRDISSKNV-LLDLGY---EAHVSDFGIAKFLNPD 797
           Q    +K + D + YLH+     I H D+  +N+ LLD         + DFGIA  +   
Sbjct: 119 Q---FLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA- 171
Query: 798 SSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
            + +  + GT  +VAPE+     +  + D++S GV+   ++ G  P
Sbjct: 172 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 23/229 (10%)
Query: 682 QEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKIL-CNDASAKELGW 740
           +E+F++E   +  + H +IVK  G     + ++II E    G L   L  N  S K L  
Sbjct: 53  KEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVL-- 109
Query: 741 TQRLNVIKGVADALFYLHN-NCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL-NPDS 798
           T  L  ++ +  A+ YL + NC    VHRDI+ +N+L+       + DFG+++++ + D 
Sbjct: 110 TLVLYSLQ-ICKAMAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY 164
Query: 799 SNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXX 857
              S       +++PE     + T   DV+ F V   E++  GK P    F         
Sbjct: 165 YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP---FFWLENKDVIG 221
Query: 858 XIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLC 906
            +E  D RLP P L     L ++M     C D +P  RP   R ++L+C
Sbjct: 222 VLEKGD-RLPKPDL-CPPVLYTLMT---RCWDYDPSDRP---RFTELVC 262

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 103/218 (47%), Gaps = 35/218 (16%)
Query: 640 FNAEHCIGKGGHGSVYRAKV-PSGEIFAVKKFHSPLPGEMSFQQEEFLN-EIQALTEIRH 697
           +     IG G  G VY+AK+  SGE+ A+KK           Q + F N E+Q + ++ H
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQDKRFKNRELQIMRKLDH 72
Query: 698 RNIVKF-YGFCSHPKHSFIIY-----EYLESGSLDKILCNDASAKELGWTQRLNVIK--- 748
            NIV+  Y F S  +   ++Y     +Y+   ++ ++  + + AK     Q L VI    
Sbjct: 73  CNIVRLRYFFYSSGEKKDVVYLNLVLDYVPE-TVYRVARHYSRAK-----QTLPVIYVKL 126
Query: 749 ---GVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEA-HVSDFGIAKFLNPDSSNWSEL 804
               +  +L Y+H+     I HRDI  +N+LLD       + DFG AK L     N S +
Sbjct: 127 YMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI 183
Query: 805 AGTHGYVAPELAY-TLKVTEKCDVYSFGVLALEVIKGK 841
              + Y APEL +     T   DV+S G +  E++ G+
Sbjct: 184 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 23/229 (10%)
Query: 682 QEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKIL-CNDASAKELGW 740
           +E+F++E   +  + H +IVK  G     + ++II E    G L   L  N  S K L  
Sbjct: 57  KEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVL-- 113
Query: 741 TQRLNVIKGVADALFYLHN-NCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL-NPDS 798
           T  L  ++ +  A+ YL + NC    VHRDI+ +N+L+       + DFG+++++ + D 
Sbjct: 114 TLVLYSLQ-ICKAMAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY 168
Query: 799 SNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXX 857
              S       +++PE     + T   DV+ F V   E++  GK P    F         
Sbjct: 169 YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP---FFWLENKDVIG 225
Query: 858 XIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLC 906
            +E  D RLP P L     L ++M     C D +P  RP   R ++L+C
Sbjct: 226 VLEKGD-RLPKPDL-CPPVLYTLMT---RCWDYDPSDRP---RFTELVC 266

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/170 (24%), Positives = 81/170 (47%), Gaps = 19/170 (11%)
Query: 684 EFLNEIQALTEI-RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKIL------------- 729
           + ++E++ +  I +H+NI+   G C+     ++I EY   G+L + L             
Sbjct: 86  DLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 145
Query: 730 CNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFG 789
            N    +++ +   ++    +A  + YL +      +HRD++++NVL+       ++DFG
Sbjct: 146 INRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFG 202
Query: 790 IAKFLNPDSSNWSELAGT--HGYVAPELAYTLKVTEKCDVYSFGVLALEV 837
           +A+ +N          G     ++APE  +    T + DV+SFGVL  E+
Sbjct: 203 LARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/170 (24%), Positives = 82/170 (48%), Gaps = 19/170 (11%)
Query: 684 EFLNEIQALTEI-RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKIL------------- 729
           + ++E++ +  I +H+NI+   G C+     ++I EY   G+L + L             
Sbjct: 86  DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 145
Query: 730 CNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFG 789
            N    +++ +   ++    +A  + YL +      +HRD++++NVL+       ++DFG
Sbjct: 146 INRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFG 202
Query: 790 IAKFLNPDSSNWSELAGT--HGYVAPELAYTLKVTEKCDVYSFGVLALEV 837
           +A+ +N      +   G     ++APE  +    T + DV+SFGVL  E+
Sbjct: 203 LARDINNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/273 (22%), Positives = 108/273 (39%), Gaps = 19/273 (6%)
Query: 634 ISATNDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQ-EEFLNEIQA 691
           I    +F     +G G  G+VY+   +P GE   +      L    S +  +E L+E   
Sbjct: 13  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 72
Query: 692 LTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVA 751
           +  + + ++ +  G C       I         LD +         +G    LN    +A
Sbjct: 73  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIA 129
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH--G 809
             + YL +     +VHRD++++NVL+       ++DFG+AK L  +   +    G     
Sbjct: 130 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 186
Query: 810 YVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPY 868
           ++A E       T + DV+S+GV   E++  G  P D +            E    RLP 
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE----RLPQ 242
Query: 869 PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
           P +      + +  +   C   + +SRP  + +
Sbjct: 243 PPICT----IDVYMIMVKCWMIDADSRPKFREL 271

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/273 (22%), Positives = 108/273 (39%), Gaps = 19/273 (6%)
Query: 634 ISATNDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQ-EEFLNEIQA 691
           I    +F     +G G  G+VY+   +P GE   +      L    S +  +E L+E   
Sbjct: 18  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 77
Query: 692 LTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVA 751
           +  + + ++ +  G C       I         LD +         +G    LN    +A
Sbjct: 78  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIA 134
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH--G 809
             + YL +     +VHRD++++NVL+       ++DFG+AK L  +   +    G     
Sbjct: 135 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 191
Query: 810 YVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPY 868
           ++A E       T + DV+S+GV   E++  G  P D +            E    RLP 
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE----RLPQ 247
Query: 869 PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
           P +      + +  +   C   + +SRP  + +
Sbjct: 248 PPICT----IDVYMIMVKCWMIDADSRPKFREL 276

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 124/292 (42%), Gaps = 49/292 (16%)
Query: 642 AEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR-HRNI 700
           +E  +G G  G+V       G   AVK+        + F     + EI+ LTE   H N+
Sbjct: 19  SEKILGYGSSGTVVFQGSFQGRPVAVKRML------IDFCDIALM-EIKLLTESDDHPNV 71
Query: 701 VKFYGFCSHPKHSFIIYEYLESGSL---DKILCNDASAKELGWTQRLN---VIKGVADAL 754
           +++Y  CS     F+ Y  LE  +L   D +   + S + L   +  N   +++ +A  +
Sbjct: 72  IRYY--CSETTDRFL-YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128
Query: 755 FYLHNNCFPPIVHRDISSKNVLLDLG--YEAH-----------VSDFGIAKFLNPDSS-- 799
            +LH+     I+HRD+  +N+L+     + A            +SDFG+ K L+   S  
Sbjct: 129 AHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185
Query: 800 --NWSELAGTHGYVAPE-------LAYTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFE 849
             N +  +GT G+ APE       L    ++T   D++S G +   ++ KGKHP    F 
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP----FG 241
Query: 850 XXXXXXXXXIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
                    I  + S      LH +  +     +    +D +P  RPT  +V
Sbjct: 242 DKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 293

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/170 (24%), Positives = 81/170 (47%), Gaps = 19/170 (11%)
Query: 684 EFLNEIQALTEI-RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKIL------------- 729
           + ++E++ +  I +H+NI+   G C+     ++I EY   G+L + L             
Sbjct: 86  DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 145
Query: 730 CNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFG 789
            N    +++ +   ++    +A  + YL +      +HRD++++NVL+       ++DFG
Sbjct: 146 INRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFG 202
Query: 790 IAKFLNPDSSNWSELAGT--HGYVAPELAYTLKVTEKCDVYSFGVLALEV 837
           +A+ +N          G     ++APE  +    T + DV+SFGVL  E+
Sbjct: 203 LARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 76/166 (45%), Gaps = 11/166 (6%)
Query: 682 QEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWT 741
           +EE   E+  L EIRH NI+  +    +     +I E +  G L   L    S  E   T
Sbjct: 52  REEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT 111
Query: 742 QRLNVIKGVADALFYLHNNCFPPIVHRDISSKNV-LLDLGY---EAHVSDFGIAKFLNPD 797
           Q    +K + D + YLH+     I H D+  +N+ LLD         + DFGIA  +   
Sbjct: 112 Q---FLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA- 164
Query: 798 SSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
            + +  + GT  +VAPE+     +  + D++S GV+   ++ G  P
Sbjct: 165 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/273 (22%), Positives = 108/273 (39%), Gaps = 19/273 (6%)
Query: 634 ISATNDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQ-EEFLNEIQA 691
           I    +F     +G G  G+VY+   +P GE   +      L    S +  +E L+E   
Sbjct: 11  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 70
Query: 692 LTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVA 751
           +  + + ++ +  G C       I         LD +         +G    LN    +A
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIA 127
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH--G 809
             + YL +     +VHRD++++NVL+       ++DFG+AK L  +   +    G     
Sbjct: 128 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 810 YVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPY 868
           ++A E       T + DV+S+GV   E++  G  P D +            E    RLP 
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE----RLPQ 240
Query: 869 PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
           P +      + +  +   C   + +SRP  + +
Sbjct: 241 PPICT----IDVYMIMVKCWMIDADSRPKFREL 269

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 90/201 (44%), Gaps = 16/201 (7%)
Query: 644 HCIGKGGHGSVYRAKVPSGE----IFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRN 699
            CIG+G  G V++    S E      A+K   +     +   +E+FL E   + +  H +
Sbjct: 18  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV---REKFLQEALTMRQFDHPH 74
Query: 700 IVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHN 759
           IVK  G  +     +II E    G L   L        L     +     ++ AL YL +
Sbjct: 75  IVKLIGVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLES 131
Query: 760 NCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH--GYVAPELAY 817
             F   VHRDI+++NVL+       + DFG+++++  DS+ +    G     ++APE   
Sbjct: 132 KRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESIN 187
Query: 818 TLKVTEKCDVYSFGVLALEVI 838
             + T   DV+ FGV   E++
Sbjct: 188 FRRFTSASDVWMFGVCMWEIL 208

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/170 (24%), Positives = 81/170 (47%), Gaps = 19/170 (11%)
Query: 684 EFLNEIQALTEI-RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKIL------------- 729
           + ++E++ +  I +H+NI+   G C+     ++I EY   G+L + L             
Sbjct: 78  DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 137
Query: 730 CNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFG 789
            N    +++ +   ++    +A  + YL +      +HRD++++NVL+       ++DFG
Sbjct: 138 INRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFG 194
Query: 790 IAKFLNPDSSNWSELAGT--HGYVAPELAYTLKVTEKCDVYSFGVLALEV 837
           +A+ +N          G     ++APE  +    T + DV+SFGVL  E+
Sbjct: 195 LARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 244

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/273 (22%), Positives = 108/273 (39%), Gaps = 19/273 (6%)
Query: 634 ISATNDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQ-EEFLNEIQA 691
           I    +F     +G G  G+VY+   +P GE   +      L    S +  +E L+E   
Sbjct: 14  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 73
Query: 692 LTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVA 751
           +  + + ++ +  G C       I         LD +         +G    LN    +A
Sbjct: 74  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIA 130
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH--G 809
             + YL +     +VHRD++++NVL+       ++DFG+AK L  +   +    G     
Sbjct: 131 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 810 YVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPY 868
           ++A E       T + DV+S+GV   E++  G  P D +            E    RLP 
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE----RLPQ 243
Query: 869 PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
           P +      + +  +   C   + +SRP  + +
Sbjct: 244 PPICT----IDVYMIMVKCWMIDADSRPKFREL 272

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/273 (22%), Positives = 108/273 (39%), Gaps = 19/273 (6%)
Query: 634 ISATNDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQ-EEFLNEIQA 691
           I    +F     +G G  G+VY+   +P GE   +      L    S +  +E L+E   
Sbjct: 5   ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 64
Query: 692 LTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVA 751
           +  + + ++ +  G C       I         LD +         +G    LN    +A
Sbjct: 65  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIA 121
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH--G 809
             + YL +     +VHRD++++NVL+       ++DFG+AK L  +   +    G     
Sbjct: 122 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 178
Query: 810 YVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPY 868
           ++A E       T + DV+S+GV   E++  G  P D +            E    RLP 
Sbjct: 179 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE----RLPQ 234
Query: 869 PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
           P +      + +  +   C   + +SRP  + +
Sbjct: 235 PPICT----IDVYMIMVKCWMIDADSRPKFREL 263

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 23/229 (10%)
Query: 682 QEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKIL-CNDASAKELGW 740
           +E+F++E   +  + H +IVK  G     + ++II E    G L   L  N  S K L  
Sbjct: 69  KEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVL-- 125
Query: 741 TQRLNVIKGVADALFYLHN-NCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL-NPDS 798
           T  L  ++ +  A+ YL + NC    VHRDI+ +N+L+       + DFG+++++ + D 
Sbjct: 126 TLVLYSLQ-ICKAMAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY 180
Query: 799 SNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXX 857
              S       +++PE     + T   DV+ F V   E++  GK P    F         
Sbjct: 181 YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP---FFWLENKDVIG 237
Query: 858 XIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLC 906
            +E  D RLP P L     L ++M     C D +P  RP   R ++L+C
Sbjct: 238 VLEKGD-RLPKPDL-CPPVLYTLMT---RCWDYDPSDRP---RFTELVC 278

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/273 (22%), Positives = 108/273 (39%), Gaps = 19/273 (6%)
Query: 634 ISATNDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQ-EEFLNEIQA 691
           I    +F     +G G  G+VY+   +P GE   +      L    S +  +E L+E   
Sbjct: 36  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 95
Query: 692 LTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVA 751
           +  + + ++ +  G C       I         LD +         +G    LN    +A
Sbjct: 96  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIA 152
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH--G 809
             + YL +     +VHRD++++NVL+       ++DFG+AK L  +   +    G     
Sbjct: 153 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 209
Query: 810 YVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPY 868
           ++A E       T + DV+S+GV   E++  G  P D +            E    RLP 
Sbjct: 210 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE----RLPQ 265
Query: 869 PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
           P +      + +  +   C   + +SRP  + +
Sbjct: 266 PPICT----IDVYMIMVKCWMIDADSRPKFREL 294

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/226 (23%), Positives = 96/226 (42%), Gaps = 25/226 (11%)
Query: 684 EFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILC-------NDASAK 736
           EFLNE   + E    ++V+  G  S  + + +I E +  G L   L        N+    
Sbjct: 65  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 124
Query: 737 ELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP 796
               ++ + +   +AD + YL+ N F   VHRD++++N ++   +   + DFG+ + +  
Sbjct: 125 PPSLSKMIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY- 180
Query: 797 DSSNWSELAGTH----GYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXX 851
             +++    G       +++PE       T   DV+SFGV+  E+    + P   L    
Sbjct: 181 -ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 239
Query: 852 XXXXXXXIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPT 897
                    +LD     P +     L  +M++   C   NP+ RP+
Sbjct: 240 VLRFVMEGGLLDKPDNCPDM-----LFELMRM---CWQYNPKMRPS 277

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/226 (23%), Positives = 96/226 (42%), Gaps = 25/226 (11%)
Query: 684 EFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILC-------NDASAK 736
           EFLNE   + E    ++V+  G  S  + + +I E +  G L   L        N+    
Sbjct: 68  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 127
Query: 737 ELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP 796
               ++ + +   +AD + YL+ N F   VHRD++++N ++   +   + DFG+ + +  
Sbjct: 128 PPSLSKMIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY- 183
Query: 797 DSSNWSELAGTH----GYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXX 851
             +++    G       +++PE       T   DV+SFGV+  E+    + P   L    
Sbjct: 184 -ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 242
Query: 852 XXXXXXXIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPT 897
                    +LD     P +     L  +M++   C   NP+ RP+
Sbjct: 243 VLRFVMEGGLLDKPDNCPDM-----LFELMRM---CWQYNPKMRPS 280

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 90/201 (44%), Gaps = 16/201 (7%)
Query: 644 HCIGKGGHGSVYRAKVPSGE----IFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRN 699
            CIG+G  G V++    S E      A+K   +     +   +E+FL E   + +  H +
Sbjct: 19  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV---REKFLQEALTMRQFDHPH 75
Query: 700 IVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHN 759
           IVK  G  +     +II E    G L   L        L     +     ++ AL YL +
Sbjct: 76  IVKLIGVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLES 132
Query: 760 NCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH--GYVAPELAY 817
             F   VHRDI+++NVL+       + DFG+++++  DS+ +    G     ++APE   
Sbjct: 133 KRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESIN 188
Query: 818 TLKVTEKCDVYSFGVLALEVI 838
             + T   DV+ FGV   E++
Sbjct: 189 FRRFTSASDVWMFGVCMWEIL 209

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/273 (22%), Positives = 108/273 (39%), Gaps = 19/273 (6%)
Query: 634 ISATNDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQ-EEFLNEIQA 691
           I    +F     +G G  G+VY+   +P GE   +      L    S +  +E L+E   
Sbjct: 17  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 76
Query: 692 LTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVA 751
           +  + + ++ +  G C       I         LD +         +G    LN    +A
Sbjct: 77  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIA 133
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH--G 809
             + YL +     +VHRD++++NVL+       ++DFG+AK L  +   +    G     
Sbjct: 134 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 190
Query: 810 YVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPY 868
           ++A E       T + DV+S+GV   E++  G  P D +            E    RLP 
Sbjct: 191 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE----RLPQ 246
Query: 869 PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
           P +      + +  +   C   + +SRP  + +
Sbjct: 247 PPICT----IDVYMIMVKCWMIDADSRPKFREL 275

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/226 (23%), Positives = 96/226 (42%), Gaps = 25/226 (11%)
Query: 684 EFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILC-------NDASAK 736
           EFLNE   + E    ++V+  G  S  + + +I E +  G L   L        N+    
Sbjct: 67  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 126
Query: 737 ELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP 796
               ++ + +   +AD + YL+ N F   VHRD++++N ++   +   + DFG+ + +  
Sbjct: 127 PPSLSKMIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY- 182
Query: 797 DSSNWSELAGTH----GYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXX 851
             +++    G       +++PE       T   DV+SFGV+  E+    + P   L    
Sbjct: 183 -ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 241
Query: 852 XXXXXXXIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPT 897
                    +LD     P +     L  +M++   C   NP+ RP+
Sbjct: 242 VLRFVMEGGLLDKPDNCPDM-----LFELMRM---CWQYNPKMRPS 279

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 34/221 (15%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           IGKG  G VY  +   GE+ A++        E   Q + F  E+ A  + RH N+V F G
Sbjct: 41  IGKGRFGQVYHGRW-HGEV-AIRLIDIERDNED--QLKAFKREVMAYRQTRHENVVLFMG 96
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRL--NVIKGVADALFYLHNNCFP 763
            C  P H  II    +  +L  ++ +     ++  T+++   ++KG+     YLH     
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMG----YLHAKG-- 150
Query: 764 PIVHRDISSKNVLLDLGYEAHVSDFG---IAKFLNPDSSNWSELAGTHGY---VAPELAY 817
            I+H+D+ SKNV  D G +  ++DFG   I+  L        +L   +G+   +APE+  
Sbjct: 151 -ILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRRE-DKLRIQNGWLCHLAPEIIR 207
Query: 818 TLK---------VTEKCDVYSFGVLALEVIKGKHPRDFLFE 849
            L           ++  DV++ G +  E+    H R++ F+
Sbjct: 208 QLSPDTEEDKLPFSKHSDVFALGTIWYEL----HAREWPFK 244

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/273 (22%), Positives = 108/273 (39%), Gaps = 19/273 (6%)
Query: 634 ISATNDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQ-EEFLNEIQA 691
           I    +F     +G G  G+VY+   +P GE   +      L    S +  +E L+E   
Sbjct: 11  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 70
Query: 692 LTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVA 751
           +  + + ++ +  G C       I         LD +         +G    LN    +A
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIA 127
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH--G 809
             + YL +     +VHRD++++NVL+       ++DFG+AK L  +   +    G     
Sbjct: 128 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 810 YVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPY 868
           ++A E       T + DV+S+GV   E++  G  P D +           I     RLP 
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI----PASEISSILEKGERLPQ 240
Query: 869 PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
           P +      + +  +   C   + +SRP  + +
Sbjct: 241 PPICT----IDVYMIMRKCWMIDADSRPKFREL 269

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/226 (23%), Positives = 96/226 (42%), Gaps = 25/226 (11%)
Query: 684 EFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILC-------NDASAK 736
           EFLNE   + E    ++V+  G  S  + + +I E +  G L   L        N+    
Sbjct: 74  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 133
Query: 737 ELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP 796
               ++ + +   +AD + YL+ N F   VHRD++++N ++   +   + DFG+ + +  
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY- 189
Query: 797 DSSNWSELAGTH----GYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXX 851
             +++    G       +++PE       T   DV+SFGV+  E+    + P   L    
Sbjct: 190 -ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 248
Query: 852 XXXXXXXIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPT 897
                    +LD     P +     L  +M++   C   NP+ RP+
Sbjct: 249 VLRFVMEGGLLDKPDNCPDM-----LFELMRM---CWQYNPKMRPS 286

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/170 (24%), Positives = 81/170 (47%), Gaps = 19/170 (11%)
Query: 684 EFLNEIQALTEI-RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKIL------------- 729
           + ++E++ +  I +H+NI+   G C+     ++I EY   G+L + L             
Sbjct: 86  DLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 145
Query: 730 CNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFG 789
            N    +++ +   ++    +A  + YL +      +HRD++++NVL+       ++DFG
Sbjct: 146 INRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFG 202
Query: 790 IAKFLNPDSSNWSELAGT--HGYVAPELAYTLKVTEKCDVYSFGVLALEV 837
           +A+ +N          G     ++APE  +    T + DV+SFGVL  E+
Sbjct: 203 LARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 124/288 (43%), Gaps = 45/288 (15%)
Query: 642 AEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR-HRNI 700
           +E  +G G  G+V       G   AVK+        + F     + EI+ LTE   H N+
Sbjct: 37  SEKILGYGSSGTVVFQGSFQGRPVAVKRML------IDFCDIALM-EIKLLTESDDHPNV 89
Query: 701 VKFYGFCSHPKHSFIIYEYLESGSL---DKILCNDASAKELGWTQRLN---VIKGVADAL 754
           +++Y  CS     F+ Y  LE  +L   D +   + S + L   +  N   +++ +A  +
Sbjct: 90  IRYY--CSETTDRFL-YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 146
Query: 755 FYLHNNCFPPIVHRDISSKNVLL--------DLGYEAH-----VSDFGIAKFLNPDS--- 798
            +LH+     I+HRD+  +N+L+        D    A      +SDFG+ K L+      
Sbjct: 147 AHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 203
Query: 799 -SNWSELAGTHGYVAPEL---AYTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEXXXX 853
             N +  +GT G+ APEL   +   ++T   D++S G +   ++ KGKHP    F     
Sbjct: 204 RXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHP----FGDKYS 259
Query: 854 XXXXXIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
                I  + S      LH +  +     +    +D +P  RPT  +V
Sbjct: 260 RESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 307

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 104/235 (44%), Gaps = 34/235 (14%)
Query: 620 SVLTFEGKIVYEEIISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMS 679
            VL  +GK   +  I+ TN       IG G  G V++AK+   +  A+KK          
Sbjct: 26  KVLASDGKTGEQREIAYTNC----KVIGNGSFGVVFQAKLVESDEVAIKKV--------- 72
Query: 680 FQQEEFLN-EIQALTEIRHRNIVK----FYGFCSHPKHSFI--IYEYLESGSLDKILCND 732
            Q + F N E+Q +  ++H N+V     FY         F+  + EY+     + +    
Sbjct: 73  LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP----ETVYRAS 128
Query: 733 ASAKELGWTQRLNVIK----GVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEA-HVSD 787
               +L  T  + +IK     +  +L Y+H+     I HRDI  +N+LLD       + D
Sbjct: 129 RHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLID 185
Query: 788 FGIAKFLNPDSSNWSELAGTHGYVAPELAY-TLKVTEKCDVYSFGVLALEVIKGK 841
           FG AK L     N S +   + Y APEL +     T   D++S G +  E+++G+
Sbjct: 186 FGSAKILIAGEPNVSXICSRY-YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 95/217 (43%), Gaps = 27/217 (12%)
Query: 638 NDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEF---LNEIQALT 693
           N+F     +GKG  G V   K   +G  +A+K     L  E+   ++E    L E + L 
Sbjct: 8   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMK----ILKKEVIVAKDEVAHTLTENRVLQ 63
Query: 694 EIRHRNIVKF-YGFCSHPKHSFIIYEYLESGSL------DKILCNDASAKELGWTQRLNV 746
             RH  +    Y F +H +  F++ EY   G L      +++   D  A+  G       
Sbjct: 64  NSRHPFLTALKYSFQTHDRLCFVM-EYANGGELFFHLSRERVFSED-RARFYGAE----- 116
Query: 747 IKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAG 806
              +  AL YLH+     +V+RD+  +N++LD      ++DFG+ K    D +      G
Sbjct: 117 ---IVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCG 171
Query: 807 THGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           T  Y+APE+          D +  GV+  E++ G+ P
Sbjct: 172 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 208

>pdb|3ZYN|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats Of Netrin-G Ligand-3 Length = 321

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 120/264 (45%), Gaps = 19/264 (7%)
Query: 306 LRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSI 365
           L L +N +    ++TF    +L  + LS N      +  +   P L+ L++  N ++ ++
Sbjct: 40  LNLQENSIQVIRTDTFKHLRHLEILQLSKNLVRKIEVGAFNGLPSLNTLELFDNRLT-TV 98
Query: 366 PLEIGESL-QLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSG-NKLSGCIPRELGSLINL 423
           P +  E L +L+ L L +N I          +  L RL L    +L          L+NL
Sbjct: 99  PTQAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLRRLDLGELKRLEYISEAAFEGLVNL 158
Query: 424 EYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGE 483
            YL+L   NL + +P +L +LV+L  L LS N+L    P     L  L +L L H  +  
Sbjct: 159 RYLNLGMCNLKD-IP-NLTALVRLEELELSGNRLDLIRPGSFQGLTSLRKLWLMHAQVAT 216
Query: 484 KISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNK-------------LE 530
              +    ++SLE+LNLS+NNL  L    F  +H L  + +++N              L+
Sbjct: 217 IERNAFDDLKSLEELNLSHNNLMSLPHDLFTPLHRLERVHLNHNPWHCNCDVLWLSWWLK 276
Query: 531 GQIPNSTTFRDAPLEALQGNKGLY 554
             +P++TT   A   A  G KG Y
Sbjct: 277 ETVPSNTTC-CARCHAPAGLKGRY 299

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/273 (22%), Positives = 108/273 (39%), Gaps = 19/273 (6%)
Query: 634 ISATNDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQ-EEFLNEIQA 691
           I    +F     +G G  G+VY+   +P GE   +      L    S +  +E L+E   
Sbjct: 14  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 73
Query: 692 LTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVA 751
           +  + + ++ +  G C       I         LD +         +G    LN    +A
Sbjct: 74  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIA 130
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH--G 809
             + YL +     +VHRD++++NVL+       ++DFG+AK L  +   +    G     
Sbjct: 131 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 810 YVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPY 868
           ++A E       T + DV+S+GV   E++  G  P D +            E    RLP 
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE----RLPQ 243
Query: 869 PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
           P +      + +  +   C   + +SRP  + +
Sbjct: 244 PPICT----IDVYMIMRKCWMIDADSRPKFREL 272

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 90/201 (44%), Gaps = 16/201 (7%)
Query: 644 HCIGKGGHGSVYRAKVPSGE----IFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRN 699
            CIG+G  G V++    S E      A+K   +     +   +E+FL E   + +  H +
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSV---REKFLQEALTMRQFDHPH 452
Query: 700 IVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHN 759
           IVK  G  +     +II E    G L   L        L     +     ++ AL YL +
Sbjct: 453 IVKLIGVITE-NPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLES 509
Query: 760 NCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH--GYVAPELAY 817
             F   VHRDI+++NVL+       + DFG+++++  DS+ +    G     ++APE   
Sbjct: 510 KRF---VHRDIAARNVLVSATDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESIN 565
Query: 818 TLKVTEKCDVYSFGVLALEVI 838
             + T   DV+ FGV   E++
Sbjct: 566 FRRFTSASDVWMFGVCMWEIL 586

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Composition-based stats.
 Identities = 53/238 (22%), Positives = 101/238 (42%), Gaps = 25/238 (10%)
Query: 684 EFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILC-------NDASAK 736
           EFLNE   + E    ++V+  G  S  + + +I E +  G L   L        N+    
Sbjct: 61  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 120
Query: 737 ELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP 796
               ++ + +   +AD + YL+ N F   VHRD++++N ++   +   + DFG+ + +  
Sbjct: 121 PPSLSKMIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY- 176
Query: 797 DSSNWSELAGTH----GYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXX 851
             +++    G       +++PE       T   DV+SFGV+  E+    + P   L    
Sbjct: 177 -ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 235
Query: 852 XXXXXXXIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI 909
                    +LD     P +     L  +M++   C   NP+ RP+   +   + E++
Sbjct: 236 VLRFVMEGGLLDKPDNCPDM-----LFELMRM---CWQYNPKMRPSFLEIISSIKEEM 285

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 124/288 (43%), Gaps = 45/288 (15%)
Query: 642 AEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR-HRNI 700
           +E  +G G  G+V       G   AVK+        + F     + EI+ LTE   H N+
Sbjct: 37  SEKILGYGSSGTVVFQGSFQGRPVAVKRML------IDFCDIALM-EIKLLTESDDHPNV 89
Query: 701 VKFYGFCSHPKHSFIIYEYLESGSL---DKILCNDASAKELGWTQRLN---VIKGVADAL 754
           +++Y  CS     F+ Y  LE  +L   D +   + S + L   +  N   +++ +A  +
Sbjct: 90  IRYY--CSETTDRFL-YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 146
Query: 755 FYLHNNCFPPIVHRDISSKNVLL--------DLGYEAH-----VSDFGIAKFLNPDS--- 798
            +LH+     I+HRD+  +N+L+        D    A      +SDFG+ K L+      
Sbjct: 147 AHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 203
Query: 799 -SNWSELAGTHGYVAPEL---AYTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEXXXX 853
             N +  +GT G+ APEL   +   ++T   D++S G +   ++ KGKHP    F     
Sbjct: 204 RXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHP----FGDKYS 259
Query: 854 XXXXXIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
                I  + S      LH +  +     +    +D +P  RPT  +V
Sbjct: 260 RESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 307

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/273 (22%), Positives = 108/273 (39%), Gaps = 19/273 (6%)
Query: 634 ISATNDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQ-EEFLNEIQA 691
           I    +F     +G G  G+VY+   +P GE   +      L    S +  +E L+E   
Sbjct: 13  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 72
Query: 692 LTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVA 751
           +  + + ++ +  G C       I+        LD +         +G    LN    +A
Sbjct: 73  MASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIA 129
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH--G 809
             + YL +     +VHRD++++NVL+       ++DFG AK L  +   +    G     
Sbjct: 130 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 186
Query: 810 YVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPY 868
           ++A E       T + DV+S+GV   E++  G  P D +            E    RLP 
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE----RLPQ 242
Query: 869 PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
           P +      + +  +   C   + +SRP  + +
Sbjct: 243 PPICT----IDVYMIMVKCWMIDADSRPKFREL 271

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 89/201 (44%), Gaps = 16/201 (7%)
Query: 644 HCIGKGGHGSVYRAKVPSGE----IFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRN 699
            CIG+G  G V++    S E      A+K   +     +   +E+FL E   + +  H +
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSV---REKFLQEALTMRQFDHPH 72
Query: 700 IVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHN 759
           IVK  G  +     +II E    G L   L        L     +     ++ AL YL +
Sbjct: 73  IVKLIGVITE-NPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLES 129
Query: 760 NCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH--GYVAPELAY 817
             F   VHRDI+++NVL+       + DFG+++++  DS+      G     ++APE   
Sbjct: 130 KRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTXXKASKGKLPIKWMAPESIN 185
Query: 818 TLKVTEKCDVYSFGVLALEVI 838
             + T   DV+ FGV   E++
Sbjct: 186 FRRFTSASDVWMFGVCMWEIL 206

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/273 (22%), Positives = 108/273 (39%), Gaps = 19/273 (6%)
Query: 634 ISATNDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQ-EEFLNEIQA 691
           I    +F     +G G  G+VY+   +P GE   +      L    S +  +E L+E   
Sbjct: 15  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 74
Query: 692 LTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVA 751
           +  + + ++ +  G C       I+        LD +         +G    LN    +A
Sbjct: 75  MASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIA 131
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH--G 809
             + YL +     +VHRD++++NVL+       ++DFG AK L  +   +    G     
Sbjct: 132 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 188
Query: 810 YVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPY 868
           ++A E       T + DV+S+GV   E++  G  P D +            E    RLP 
Sbjct: 189 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE----RLPQ 244
Query: 869 PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
           P +      + +  +   C   + +SRP  + +
Sbjct: 245 PPICT----IDVYMIMVKCWMIDADSRPKFREL 273

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 75/165 (45%), Gaps = 15/165 (9%)
Query: 687 NEIQALTEIRHRNIVKFYG--FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRL 744
            EIQ L  +RH+N+++     +    +  +++ EY   G  +  + +    K     Q  
Sbjct: 55  KEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAH 112
Query: 745 NVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP----DSSN 800
                + D L YLH+     IVH+DI   N+LL  G    +S  G+A+ L+P    D+  
Sbjct: 113 GYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCR 169
Query: 801 WSELAGTHGYVAPELAYTLKVTE--KCDVYSFGVLALEVIKGKHP 843
            S+  G+  +  PE+A  L      K D++S GV    +  G +P
Sbjct: 170 TSQ--GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 95/217 (43%), Gaps = 27/217 (12%)
Query: 638 NDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEF---LNEIQALT 693
           N+F     +GKG  G V   K   +G  +A+K     L  E+   ++E    L E + L 
Sbjct: 9   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMK----ILKKEVIVAKDEVAHTLTENRVLQ 64
Query: 694 EIRHRNIVKF-YGFCSHPKHSFIIYEYLESGSL------DKILCNDASAKELGWTQRLNV 746
             RH  +    Y F +H +  F++ EY   G L      +++   D  A+  G       
Sbjct: 65  NSRHPFLTALKYSFQTHDRLCFVM-EYANGGELFFHLSRERVFSED-RARFYGAE----- 117
Query: 747 IKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAG 806
              +  AL YLH+     +V+RD+  +N++LD      ++DFG+ K    D +      G
Sbjct: 118 ---IVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCG 172
Query: 807 THGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           T  Y+APE+          D +  GV+  E++ G+ P
Sbjct: 173 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/273 (22%), Positives = 108/273 (39%), Gaps = 19/273 (6%)
Query: 634 ISATNDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQ-EEFLNEIQA 691
           I    +F     +G G  G+VY+   +P GE   +      L    S +  +E L+E   
Sbjct: 21  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 80
Query: 692 LTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVA 751
           +  + + ++ +  G C       I         LD +         +G    LN    +A
Sbjct: 81  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIA 137
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH--G 809
             + YL +     +VHRD++++NVL+       ++DFG+AK L  +   +    G     
Sbjct: 138 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 194
Query: 810 YVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPY 868
           ++A E       T + DV+S+GV   E++  G  P D +            E    RLP 
Sbjct: 195 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE----RLPQ 250
Query: 869 PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
           P +      + +  +   C   + +SRP  + +
Sbjct: 251 PPICT----IDVYMIMRKCWMIDADSRPKFREL 279

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 95/217 (43%), Gaps = 27/217 (12%)
Query: 638 NDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEF---LNEIQALT 693
           N+F     +GKG  G V   K   +G  +A+K     L  E+   ++E    L E + L 
Sbjct: 10  NEFEYLKLLGKGTFGKVILVKEKATGRYYAMK----ILKKEVIVAKDEVAHTLTENRVLQ 65
Query: 694 EIRHRNIVKF-YGFCSHPKHSFIIYEYLESGSL------DKILCNDASAKELGWTQRLNV 746
             RH  +    Y F +H +  F++ EY   G L      +++   D  A+  G       
Sbjct: 66  NSRHPFLTALKYSFQTHDRLCFVM-EYANGGELFFHLSRERVFSED-RARFYGAE----- 118
Query: 747 IKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAG 806
              +  AL YLH+     +V+RD+  +N++LD      ++DFG+ K    D +      G
Sbjct: 119 ---IVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCG 173
Query: 807 THGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           T  Y+APE+          D +  GV+  E++ G+ P
Sbjct: 174 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 210

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 95/217 (43%), Gaps = 27/217 (12%)
Query: 638 NDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEF---LNEIQALT 693
           N+F     +GKG  G V   K   +G  +A+K     L  E+   ++E    L E + L 
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMK----ILKKEVIVAKDEVAHTLTENRVLQ 203
Query: 694 EIRHRNIVKF-YGFCSHPKHSFIIYEYLESGSL------DKILCNDASAKELGWTQRLNV 746
             RH  +    Y F +H +  F++ EY   G L      +++   D  A+  G       
Sbjct: 204 NSRHPFLTALKYSFQTHDRLCFVM-EYANGGELFFHLSRERVFSED-RARFYG------- 254
Query: 747 IKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAG 806
              +  AL YLH+     +V+RD+  +N++LD      ++DFG+ K    D +      G
Sbjct: 255 -AEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCG 311
Query: 807 THGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           T  Y+APE+          D +  GV+  E++ G+ P
Sbjct: 312 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 90/201 (44%), Gaps = 16/201 (7%)
Query: 644 HCIGKGGHGSVYRAKVPSGE----IFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRN 699
            CIG+G  G V++    S E      A+K   +     +   +E+FL E   + +  H +
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSV---REKFLQEALTMRQFDHPH 452
Query: 700 IVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHN 759
           IVK  G  +     +II E    G L   L        L     +     ++ AL YL +
Sbjct: 453 IVKLIGVITE-NPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLES 509
Query: 760 NCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH--GYVAPELAY 817
             F   VHRDI+++NVL+       + DFG+++++  DS+ +    G     ++APE   
Sbjct: 510 KRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESIN 565
Query: 818 TLKVTEKCDVYSFGVLALEVI 838
             + T   DV+ FGV   E++
Sbjct: 566 FRRFTSASDVWMFGVCMWEIL 586

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 95/217 (43%), Gaps = 27/217 (12%)
Query: 638 NDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEF---LNEIQALT 693
           N+F     +GKG  G V   K   +G  +A+K     L  E+   ++E    L E + L 
Sbjct: 151 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMK----ILKKEVIVAKDEVAHTLTENRVLQ 206
Query: 694 EIRHRNIVKF-YGFCSHPKHSFIIYEYLESGSL------DKILCNDASAKELGWTQRLNV 746
             RH  +    Y F +H +  F++ EY   G L      +++   D  A+  G       
Sbjct: 207 NSRHPFLTALKYSFQTHDRLCFVM-EYANGGELFFHLSRERVFSED-RARFYG------- 257
Query: 747 IKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAG 806
              +  AL YLH+     +V+RD+  +N++LD      ++DFG+ K    D +      G
Sbjct: 258 -AEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCG 314
Query: 807 THGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           T  Y+APE+          D +  GV+  E++ G+ P
Sbjct: 315 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 351

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Composition-based stats.
 Identities = 53/238 (22%), Positives = 101/238 (42%), Gaps = 25/238 (10%)
Query: 684 EFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILC-------NDASAK 736
           EFLNE   + E    ++V+  G  S  + + +I E +  G L   L        N+    
Sbjct: 61  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 120
Query: 737 ELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP 796
               ++ + +   +AD + YL+ N F   VHRD++++N  +   +   + DFG+ + +  
Sbjct: 121 PPSLSKMIQMAGEIADGMAYLNANKF---VHRDLAARNCXVAEDFTVKIGDFGMTRDIY- 176
Query: 797 DSSNWSELAGTH----GYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXX 851
             +++    G       +++PE       T   DV+SFGV+  E+    + P   L    
Sbjct: 177 -ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 235
Query: 852 XXXXXXXIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI 909
                    +LD     P +     L+ +M++   C   NP+ RP+   +   + E++
Sbjct: 236 VLRFVMEGGLLDKPDNCPDM-----LLELMRM---CWQYNPKMRPSFLEIISSIKEEM 285

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 31/217 (14%)
Query: 643 EHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVK 702
           +  IGKG  G V+R K   GE  AVK F S    E S+ +E    EI     +RH NI+ 
Sbjct: 47  QESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFREA---EIYQTVMLRHENILG 100
Query: 703 FYGFCSHPKHSF----IIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLH 758
           F    +    ++    ++ +Y E GSL   L N  +    G    + +    A  L +LH
Sbjct: 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEG---MIKLALSTASGLAHLH 156
Query: 759 NNCF-----PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELA-----GTH 808
                    P I HRD+ SKN+L+       ++D G+A   +  +++  ++A     GT 
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVGTK 215
Query: 809 GYVAPEL---AYTLKVTE---KCDVYSFGVLALEVIK 839
            Y+APE+   +  +K  E   + D+Y+ G++  E+ +
Sbjct: 216 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR 252

>pdb|3ZYO|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats And Immunoglobulin Domain Of Netrin-G Ligand-3 Length = 411

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 120/264 (45%), Gaps = 19/264 (7%)
Query: 306 LRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSI 365
           L L +N +    ++TF    +L  + LS N      +  +   P L+ L++  N ++ ++
Sbjct: 40  LNLQENSIQVIRTDTFKHLRHLEILQLSKNLVRKIEVGAFNGLPSLNTLELFDNRLT-TV 98
Query: 366 PLEIGESL-QLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSG-NKLSGCIPRELGSLINL 423
           P +  E L +L+ L L +N I          +  L RL L    +L          L+NL
Sbjct: 99  PTQAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLRRLDLGELKRLEYISEAAFEGLVNL 158
Query: 424 EYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGE 483
            YL+L   NL + +P +L +LV+L  L LS N+L    P     L  L +L L H  +  
Sbjct: 159 RYLNLGMCNLKD-IP-NLTALVRLEELELSGNRLDLIRPGSFQGLTSLRKLWLMHAQVAT 216
Query: 484 KISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNK-------------LE 530
              +    ++SLE+LNLS+NNL  L    F  +H L  + +++N              L+
Sbjct: 217 IERNAFDDLKSLEELNLSHNNLMSLPHDLFTPLHRLERVHLNHNPWHCNCDVLWLSWWLK 276
Query: 531 GQIPNSTTFRDAPLEALQGNKGLY 554
             +P++TT   A   A  G KG Y
Sbjct: 277 ETVPSNTTC-CARCHAPAGLKGRY 299

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Composition-based stats.
 Identities = 57/239 (23%), Positives = 106/239 (44%), Gaps = 28/239 (11%)
Query: 684 EFLNEIQALTEI-RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKIL----------CND 732
           + ++E++ +  I +H+NI+   G C+     ++I EY   G+L + L          C +
Sbjct: 64  DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYN 123
Query: 733 AS---AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFG 789
            S    ++L     ++    VA  + YL +      +HRD++++NVL+       ++DFG
Sbjct: 124 PSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFG 180
Query: 790 IAKFLNPDSSNWSELAGTH--GYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDF 846
           +A+ ++          G     ++APE  +    T + DV+SFGVL  E+   G  P   
Sbjct: 181 LARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--- 237
Query: 847 LFEXXXXXXXXXIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
            +          +     R+  PS +   +L  +M+    C    P  RPT K++ + L
Sbjct: 238 -YPGVPVEELFKLLKEGHRMDKPS-NCTNELYMMMR---DCWHAVPSQRPTFKQLVEDL 291

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 31/217 (14%)
Query: 643 EHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVK 702
           +  IGKG  G V+R K   GE  AVK F S    E S+ +E    EI     +RH NI+ 
Sbjct: 34  QESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFREA---EIYQTVMLRHENILG 87
Query: 703 FYGFCSHPKHSF----IIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLH 758
           F    +    ++    ++ +Y E GSL   L N  +    G    + +    A  L +LH
Sbjct: 88  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEG---MIKLALSTASGLAHLH 143
Query: 759 NNCF-----PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELA-----GTH 808
                    P I HRD+ SKN+L+       ++D G+A   +  +++  ++A     GT 
Sbjct: 144 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVGTK 202
Query: 809 GYVAPEL---AYTLKVTE---KCDVYSFGVLALEVIK 839
            Y+APE+   +  +K  E   + D+Y+ G++  E+ +
Sbjct: 203 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR 239

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 100/213 (46%), Gaps = 15/213 (7%)
Query: 632 EIISATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEF----L 686
           ++ S    +     +G+G   +VY+A+   + +I A+KK      G  S  ++      L
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKL---GHRSEAKDGINRTAL 60
Query: 687 NEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNV 746
            EI+ L E+ H NI+       H  +  ++++++E+  L+ I+ +++        +   +
Sbjct: 61  REIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYML 119
Query: 747 IKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAG 806
           +      L YLH +    I+HRD+   N+LLD      ++DFG+AK     +  +     
Sbjct: 120 M--TLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV 174
Query: 807 THGYVAPELAYTLKVTE-KCDVYSFGVLALEVI 838
           T  Y APEL +  ++     D+++ G +  E++
Sbjct: 175 TRWYRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 100/211 (47%), Gaps = 36/211 (17%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIV--- 701
           +G G +GSV  A    SGE  A+KK   P   E+ F +  +  E+  L  ++H N++   
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEI-FAKRAY-RELLLLKHMQHENVIGLL 107
Query: 702 ----------KFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVA 751
                      FY F       +++  ++++  L KI+  + S +++ +     ++  + 
Sbjct: 108 DVFTPASSLRNFYDF-------YLVMPFMQT-DLQKIMGMEFSEEKIQY-----LVYQML 154
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV 811
             L Y+H+     +VHRD+   N+ ++   E  + DFG+A+  + + + +     T  Y 
Sbjct: 155 KGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGY---VVTRWYR 208
Query: 812 APELAYT-LKVTEKCDVYSFGVLALEVIKGK 841
           APE+  + +   +  D++S G +  E++ GK
Sbjct: 209 APEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 61/273 (22%), Positives = 108/273 (39%), Gaps = 19/273 (6%)
Query: 634 ISATNDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQ-EEFLNEIQA 691
           I    +F     +G G  G+VY+   +P GE   +      L    S +  +E L+E   
Sbjct: 13  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 72
Query: 692 LTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVA 751
           +  + + ++ +  G C       I+        LD +         +G    LN    +A
Sbjct: 73  MASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIA 129
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH--G 809
             + YL +     +VHRD++++NVL+       ++DFG AK L  +   +    G     
Sbjct: 130 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 186
Query: 810 YVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPY 868
           ++A E       T + DV+S+GV   E++  G  P D +            E    RLP 
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE----RLPQ 242
Query: 869 PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
           P +      + +  +   C   + +SRP  + +
Sbjct: 243 PPICT----IDVYMIMRKCWMIDADSRPKFREL 271

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 60/273 (21%), Positives = 108/273 (39%), Gaps = 19/273 (6%)
Query: 634 ISATNDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQ-EEFLNEIQA 691
           I    +F     +  G  G+VY+   +P GE   +      L    S +  +E L+E   
Sbjct: 18  ILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 77
Query: 692 LTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVA 751
           +  + + ++ +  G C       I+        LD +         +G    LN    +A
Sbjct: 78  MASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIA 134
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH--G 809
             + YL +     +VHRD++++NVL+       ++DFG+AK L  +   +    G     
Sbjct: 135 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 191
Query: 810 YVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPY 868
           ++A E       T + DV+S+GV   E++  G  P D +            E    RLP 
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE----RLPQ 247
Query: 869 PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
           P +      + +  +   C   + +SRP  + +
Sbjct: 248 PPICT----IDVYMIMVKCWMIDADSRPKFREL 276

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/273 (22%), Positives = 107/273 (39%), Gaps = 19/273 (6%)
Query: 634 ISATNDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQ-EEFLNEIQA 691
           I    +F     +G G  G+VY+   +P GE   +      L    S +  +E L+E   
Sbjct: 11  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 70
Query: 692 LTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVA 751
           +  + + ++ +  G C       I         LD +         +G    LN    +A
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIA 127
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH--G 809
             + YL +     +VHRD++++NVL+       ++DFG AK L  +   +    G     
Sbjct: 128 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 184
Query: 810 YVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPY 868
           ++A E       T + DV+S+GV   E++  G  P D +            E    RLP 
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE----RLPQ 240
Query: 869 PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
           P +      + +  +   C   + +SRP  + +
Sbjct: 241 PPICT----IDVYMIMVKCWMIDADSRPKFREL 269

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/273 (22%), Positives = 107/273 (39%), Gaps = 19/273 (6%)
Query: 634 ISATNDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQ-EEFLNEIQA 691
           I    +F     +G G  G+VY+   +P GE   +      L    S +  +E L+E   
Sbjct: 18  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 77
Query: 692 LTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVA 751
           +  + + ++ +  G C       I         LD +         +G    LN    +A
Sbjct: 78  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIA 134
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH--G 809
             + YL +     +VHRD++++NVL+       ++DFG AK L  +   +    G     
Sbjct: 135 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 191
Query: 810 YVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPY 868
           ++A E       T + DV+S+GV   E++  G  P D +            E    RLP 
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE----RLPQ 247
Query: 869 PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
           P +      + +  +   C   + +SRP  + +
Sbjct: 248 PPICT----IDVYMIMVKCWMIDADSRPKFREL 276

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 123/292 (42%), Gaps = 49/292 (16%)
Query: 642 AEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR-HRNI 700
           +E  +G G  G+V       G   AVK+        + F     + EI+ LTE   H N+
Sbjct: 19  SEKILGYGSSGTVVFQGSFQGRPVAVKRML------IDFCDIALM-EIKLLTESDDHPNV 71
Query: 701 VKFYGFCSHPKHSFIIYEYLESGSL---DKILCNDASAKELGWTQRLN---VIKGVADAL 754
           +++Y  CS     F+ Y  LE  +L   D +   + S + L   +  N   +++ +A  +
Sbjct: 72  IRYY--CSETTDRFL-YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128
Query: 755 FYLHNNCFPPIVHRDISSKNVLLDLG--YEAH-----------VSDFGIAKFLNPDS--- 798
            +LH+     I+HRD+  +N+L+     + A            +SDFG+ K L+      
Sbjct: 129 AHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 185
Query: 799 -SNWSELAGTHGYVAPE-------LAYTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFE 849
             N +  +GT G+ APE       L    ++T   D++S G +   ++ KGKHP    F 
Sbjct: 186 RXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP----FG 241
Query: 850 XXXXXXXXXIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
                    I  + S      LH +  +     +    +D +P  RPT  +V
Sbjct: 242 DKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 293

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 49/171 (28%), Positives = 76/171 (44%), Gaps = 18/171 (10%)
Query: 681 QQEEFLNEIQALTEIRHRNIVKFY----GFCSHPKHSFIIYEYLESGSLDKILCNDASAK 736
           +++ F  E + L  ++H NIV+FY          K   ++ E   SG+L   L      K
Sbjct: 68  ERQRFKEEAEXLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXK 127
Query: 737 ---ELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGY-EAHVSDFGIAK 792
                 W ++  ++KG    L +LH    PPI+HRD+   N+ +        + D G+A 
Sbjct: 128 IKVLRSWCRQ--ILKG----LQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180
Query: 793 FLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
                +S    + GT  + APE  Y  K  E  DVY+FG   LE    ++P
Sbjct: 181 L--KRASFAKAVIGTPEFXAPE-XYEEKYDESVDVYAFGXCXLEXATSEYP 228

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 90/215 (41%), Gaps = 29/215 (13%)
Query: 646 IGKGGHGSVYRA------KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHR- 698
           +G+G  G V  A      K  +    AVK       G    +    ++E++ L  I H  
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE---GATHSEHRALMSELKILIHIGHHL 91
Query: 699 NIVKFYGFCSHPKHSF-IIYEYLESGSLD-------------KILCNDASAKELGWTQRL 744
           N+V   G C+ P     +I E+ + G+L              K+   D     L     +
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 745 NVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK--FLNPDSSNWS 802
                VA  + +L +      +HRD++++N+LL       + DFG+A+  + +PD     
Sbjct: 152 CYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKG 208
Query: 803 ELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEV 837
           +      ++APE  +    T + DV+SFGVL  E+
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 92/209 (44%), Gaps = 18/209 (8%)
Query: 639 DFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHR 698
           DF  +   G  G   + R K+ + E+ AVK        + + Q+E  +N       +RH 
Sbjct: 23  DFVKDIGSGNFGVARLMRDKL-TKELVAVKYIERGAAIDENVQRE-IINH----RSLRHP 76
Query: 699 NIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLH 758
           NIV+F      P H  II EY   G L + +CN   A      +     + +   + Y H
Sbjct: 77  NIVRFKEVILTPTHLAIIMEYASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCH 133
Query: 759 NNCFPPIVHRDISSKNVLLDLGYEA---HVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           +     I HRD+  +N LLD G  A    + DFG +K     S   S + GT  Y+APE+
Sbjct: 134 SM---QICHRDLKLENTLLD-GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEV 188
Query: 816 AYTLKVTEK-CDVYSFGVLALEVIKGKHP 843
               +   K  DV+S GV    ++ G +P
Sbjct: 189 LLRQEYDGKIADVWSCGVTLYVMLVGAYP 217

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 98/223 (43%), Gaps = 28/223 (12%)
Query: 638 NDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQ-----EEFLNEIQA 691
            ++  +  +G+G    V R    P+ + +AVK       G  S ++     E  L E+  
Sbjct: 4   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 63
Query: 692 LTEIR-HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGV 750
           L ++  H NI++           F++++ ++ G L   L    +  E    +   +++ +
Sbjct: 64  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE---KETRKIMRAL 120
Query: 751 ADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGY 810
            + +  LH      IVHRD+  +N+LLD      ++DFG +  L+P      E+ GT  Y
Sbjct: 121 LEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP-GEKLREVCGTPSY 176
Query: 811 VAPEL----------AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           +APE+           Y  +V    D++S GV+   ++ G  P
Sbjct: 177 LAPEIIECSMNDNHPGYGKEV----DMWSTGVIMYTLLAGSPP 215

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/269 (23%), Positives = 120/269 (44%), Gaps = 37/269 (13%)
Query: 646 IGKGGHGSVYRAKVPS-GEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH-RNIVKF 703
           +G+G    V +    S G+ +A K       G+    + E L+EI  L   +    ++  
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDC--RAEILHEIAVLELAKSCPRVINL 94
Query: 704 YGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFP 763
           +    +     +I EY   G +   LC    A+ +     + +IK + + ++YLH N   
Sbjct: 95  HEVYENTSEIILILEYAAGGEIFS-LCLPELAEMVSENDVIRLIKQILEGVYYLHQN--- 150
Query: 764 PIVHRDISSKNVLLDLGY---EAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLK 820
            IVH D+  +N+LL   Y   +  + DFG+++ +   +    E+ GT  Y+APE+     
Sbjct: 151 NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG-HACELREIMGTPEYLAPEILNYDP 209
Query: 821 VTEKCDVYSFGVLALEVIKGKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSL------HVQ 874
           +T   D+++ G++A  ++    P  F+ E             D++  Y ++      + +
Sbjct: 210 ITTATDMWNIGIIAYMLLTHTSP--FVGE-------------DNQETYLNISQVNVDYSE 254
Query: 875 KKLMSIMQVAF----SCLDQNPESRPTMK 899
           +   S+ Q+A     S L +NPE RPT +
Sbjct: 255 ETFSSVSQLATDFIQSLLVKNPEKRPTAE 283

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 31/217 (14%)
Query: 643 EHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVK 702
           +  IGKG  G V+R K   GE  AVK F S    E S+ +E    EI     +RH NI+ 
Sbjct: 14  QESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFREA---EIYQTVMLRHENILG 67
Query: 703 FYGFCSHPKHSF----IIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLH 758
           F    +    ++    ++ +Y E GSL   L N  +    G    + +    A  L +LH
Sbjct: 68  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEG---MIKLALSTASGLAHLH 123
Query: 759 NNCF-----PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELA-----GTH 808
                    P I HRD+ SKN+L+       ++D G+A   +  +++  ++A     GT 
Sbjct: 124 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVGTK 182
Query: 809 GYVAPEL---AYTLKVTE---KCDVYSFGVLALEVIK 839
            Y+APE+   +  +K  E   + D+Y+ G++  E+ +
Sbjct: 183 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR 219

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 65/282 (23%), Positives = 107/282 (37%), Gaps = 37/282 (13%)
Query: 646 IGKGGHGSVYRA------KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHR- 698
           +G+G  G V  A      K  +    AVK       G    +    ++E++ L  I H  
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKE---GATHSEHRALMSELKILIHIGHHL 91
Query: 699 NIVKFYGFCSHPKHSF-IIYEYLESGSLDKIL---------CNDASAKELGWTQRLNVIK 748
           N+V   G C+ P     +I E+ + G+L   L           D     L     +    
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSF 151
Query: 749 GVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK--FLNPDSSNWSELAG 806
            VA  + +L +      +HRD++++N+LL       + DFG+A+  + +PD     +   
Sbjct: 152 QVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARL 208
Query: 807 THGYVAPELAYTLKVTEKCDVYSFGVLALEVI---KGKHPRDFLFEXXXXXXXXXIEMLD 863
              ++APE  +    T + DV+SFGVL  E+       +P   + E           M  
Sbjct: 209 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFXRRLKEGTRMRA 268
Query: 864 SRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
                P ++         Q    C    P  RPT   + + L
Sbjct: 269 PDYTTPEMY---------QTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 31/217 (14%)
Query: 643 EHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVK 702
           +  IGKG  G V+R K   GE  AVK F S    E S+ +E    EI     +RH NI+ 
Sbjct: 11  QESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFREA---EIYQTVMLRHENILG 64
Query: 703 FYGFCSHPKHSF----IIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLH 758
           F    +    ++    ++ +Y E GSL   L N  +    G    + +    A  L +LH
Sbjct: 65  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEG---MIKLALSTASGLAHLH 120
Query: 759 NNCF-----PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELA-----GTH 808
                    P I HRD+ SKN+L+       ++D G+A   +  +++  ++A     GT 
Sbjct: 121 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVGTK 179
Query: 809 GYVAPEL---AYTLKVTE---KCDVYSFGVLALEVIK 839
            Y+APE+   +  +K  E   + D+Y+ G++  E+ +
Sbjct: 180 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR 216

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 95/203 (46%), Gaps = 19/203 (9%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +G+V  A    +G   A+KK + P   E+ F +  +  E++ L  +RH N++   
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL-FAKRAY-RELRLLKHMRHENVIGLL 90
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  +   +   YL    +   L      ++LG  +   ++  +   L Y+H    
Sbjct: 91  DVFT-PDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG- 148
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAG---THGYVAPELAYT- 818
             I+HRD+   N+ ++   E  + DFG+A+  +      SE+ G   T  Y APE+    
Sbjct: 149 --IIHRDLKPGNLAVNEDCELKILDFGLARQAD------SEMXGXVVTRWYRAPEVILNW 200
Query: 819 LKVTEKCDVYSFGVLALEVIKGK 841
           ++ T+  D++S G +  E+I GK
Sbjct: 201 MRYTQTVDIWSVGCIMAEMITGK 223

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 102/218 (46%), Gaps = 35/218 (16%)
Query: 640 FNAEHCIGKGGHGSVYRAKV-PSGEIFAVKKFHSPLPGEMSFQQEEFLN-EIQALTEIRH 697
           +     IG G  G VY+AK+  SGE+ A+KK           Q + F N E+Q + ++ H
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQDKRFKNRELQIMRKLDH 73
Query: 698 RNIVKF-YGFCSHPKHSFIIY-----EYLESGSLDKILCNDASAKELGWTQRLNVIK--- 748
            NIV+  Y F S  +    +Y     +Y+   ++ ++  + + AK     Q L VI    
Sbjct: 74  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAK-----QTLPVIYVKL 127
Query: 749 ---GVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEA-HVSDFGIAKFLNPDSSNWSEL 804
               +  +L Y+H+     I HRDI  +N+LLD       + DFG AK L     N S +
Sbjct: 128 YMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI 184
Query: 805 AGTHGYVAPELAY-TLKVTEKCDVYSFGVLALEVIKGK 841
              + Y APEL +     T   DV+S G +  E++ G+
Sbjct: 185 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 102/218 (46%), Gaps = 35/218 (16%)
Query: 640 FNAEHCIGKGGHGSVYRAKV-PSGEIFAVKKFHSPLPGEMSFQQEEFLN-EIQALTEIRH 697
           +     IG G  G VY+AK+  SGE+ A+KK           Q + F N E+Q + ++ H
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQDKRFKNRELQIMRKLDH 72
Query: 698 RNIVKF-YGFCSHPKHSFIIY-----EYLESGSLDKILCNDASAKELGWTQRLNVIK--- 748
            NIV+  Y F S  +    +Y     +Y+   ++ ++  + + AK     Q L VI    
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAK-----QTLPVIYVKL 126
Query: 749 ---GVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEA-HVSDFGIAKFLNPDSSNWSEL 804
               +  +L Y+H+     I HRDI  +N+LLD       + DFG AK L     N S +
Sbjct: 127 YMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI 183
Query: 805 AGTHGYVAPELAY-TLKVTEKCDVYSFGVLALEVIKGK 841
              + Y APEL +     T   DV+S G +  E++ G+
Sbjct: 184 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 90/215 (41%), Gaps = 29/215 (13%)
Query: 646 IGKGGHGSVYRA------KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHR- 698
           +G+G  G V  A      K  +    AVK       G    +    ++E++ L  I H  
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE---GATHSEHRALMSELKILIHIGHHL 128
Query: 699 NIVKFYGFCSHPKHSF-IIYEYLESGSLD-------------KILCNDASAKELGWTQRL 744
           N+V   G C+ P     +I E+ + G+L              K+   D     L     +
Sbjct: 129 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 188
Query: 745 NVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK--FLNPDSSNWS 802
                VA  + +L +      +HRD++++N+LL       + DFG+A+  + +PD     
Sbjct: 189 CYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 245
Query: 803 ELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEV 837
           +      ++APE  +    T + DV+SFGVL  E+
Sbjct: 246 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 280

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/273 (21%), Positives = 107/273 (39%), Gaps = 19/273 (6%)
Query: 634 ISATNDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQ-EEFLNEIQA 691
           I    +F     +  G  G+VY+   +P GE   +      L    S +  +E L+E   
Sbjct: 18  ILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 77
Query: 692 LTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVA 751
           +  + + ++ +  G C       I         LD +         +G    LN    +A
Sbjct: 78  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIA 134
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH--G 809
             + YL +     +VHRD++++NVL+       ++DFG+AK L  +   +    G     
Sbjct: 135 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 191
Query: 810 YVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPY 868
           ++A E       T + DV+S+GV   E++  G  P D +            E    RLP 
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE----RLPQ 247
Query: 869 PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
           P +      + +  +   C   + +SRP  + +
Sbjct: 248 PPICT----IDVYMIMVKCWMIDADSRPKFREL 276

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 102/218 (46%), Gaps = 35/218 (16%)
Query: 640 FNAEHCIGKGGHGSVYRAKV-PSGEIFAVKKFHSPLPGEMSFQQEEFLN-EIQALTEIRH 697
           +     IG G  G VY+AK+  SGE+ A+KK           Q + F N E+Q + ++ H
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQDKRFKNRELQIMRKLDH 76
Query: 698 RNIVKF-YGFCSHPKHSFIIY-----EYLESGSLDKILCNDASAKELGWTQRLNVIK--- 748
            NIV+  Y F S  +    +Y     +Y+   ++ ++  + + AK     Q L VI    
Sbjct: 77  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAK-----QTLPVIYVKL 130
Query: 749 ---GVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEA-HVSDFGIAKFLNPDSSNWSEL 804
               +  +L Y+H+     I HRDI  +N+LLD       + DFG AK L     N S +
Sbjct: 131 YMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI 187
Query: 805 AGTHGYVAPELAY-TLKVTEKCDVYSFGVLALEVIKGK 841
              + Y APEL +     T   DV+S G +  E++ G+
Sbjct: 188 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/170 (23%), Positives = 80/170 (47%), Gaps = 19/170 (11%)
Query: 684 EFLNEIQALTEI-RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKIL------------- 729
           + ++E++ +  I +H+NI+   G C+     ++I  Y   G+L + L             
Sbjct: 86  DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYD 145
Query: 730 CNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFG 789
            N    +++ +   ++    +A  + YL +      +HRD++++NVL+       ++DFG
Sbjct: 146 INRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFG 202
Query: 790 IAKFLNPDSSNWSELAGT--HGYVAPELAYTLKVTEKCDVYSFGVLALEV 837
           +A+ +N          G     ++APE  +    T + DV+SFGVL  E+
Sbjct: 203 LARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/170 (25%), Positives = 82/170 (48%), Gaps = 19/170 (11%)
Query: 684 EFLNEIQALTEI-RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKIL----------CND 732
           + ++E++ +  I +H+NI+   G C+     ++I EY   G+L + L          C +
Sbjct: 79  DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYN 138
Query: 733 AS---AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFG 789
            S    ++L     ++    VA  + YL +      +HRD++++NVL+       ++DFG
Sbjct: 139 PSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFG 195
Query: 790 IAKFLNPDSSNWSELAGT--HGYVAPELAYTLKVTEKCDVYSFGVLALEV 837
           +A+ ++          G     ++APE  +    T + DV+SFGVL  E+
Sbjct: 196 LARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 95/216 (43%), Gaps = 21/216 (9%)
Query: 639 DFNAEHCIGKGGHGSVYRAKVPSGE-IFAVKKFHSPLPGEMSFQQEE--FLNEIQALTEI 695
           DF     IG+G  G V   K+ + + +FA+K  +     EM  + E   F  E   L   
Sbjct: 75  DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNK---WEMLKRAETACFREERDVLVNG 131
Query: 696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCN--DASAKELGWTQRLNVIKGVADA 753
             + I   +       + +++ +Y   G L  +L    D   +E+       ++  + D+
Sbjct: 132 DSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAI-DS 190
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELA-GTHGYVA 812
           +  LH       VHRDI   N+L+D+     ++DFG    L  D +  S +A GT  Y++
Sbjct: 191 VHQLH------YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 244
Query: 813 PELAYTL-----KVTEKCDVYSFGVLALEVIKGKHP 843
           PE+   +     +   +CD +S GV   E++ G+ P
Sbjct: 245 PEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 102/218 (46%), Gaps = 35/218 (16%)
Query: 640 FNAEHCIGKGGHGSVYRAKV-PSGEIFAVKKFHSPLPGEMSFQQEEFLN-EIQALTEIRH 697
           +     IG G  G VY+AK+  SGE+ A+KK           Q + F N E+Q + ++ H
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQDKRFKNRELQIMRKLDH 84
Query: 698 RNIVKF-YGFCSHPKHSFIIY-----EYLESGSLDKILCNDASAKELGWTQRLNVIK--- 748
            NIV+  Y F S  +    +Y     +Y+   ++ ++  + + AK     Q L VI    
Sbjct: 85  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAK-----QTLPVIYVKL 138
Query: 749 ---GVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEA-HVSDFGIAKFLNPDSSNWSEL 804
               +  +L Y+H+     I HRDI  +N+LLD       + DFG AK L     N S +
Sbjct: 139 YMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI 195
Query: 805 AGTHGYVAPELAY-TLKVTEKCDVYSFGVLALEVIKGK 841
              + Y APEL +     T   DV+S G +  E++ G+
Sbjct: 196 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 102/218 (46%), Gaps = 35/218 (16%)
Query: 640 FNAEHCIGKGGHGSVYRAKV-PSGEIFAVKKFHSPLPGEMSFQQEEFLN-EIQALTEIRH 697
           +     IG G  G VY+AK+  SGE+ A+KK           Q + F N E+Q + ++ H
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQDKRFKNRELQIMRKLDH 72
Query: 698 RNIVKF-YGFCSHPKHSFIIY-----EYLESGSLDKILCNDASAKELGWTQRLNVIK--- 748
            NIV+  Y F S  +    +Y     +Y+   ++ ++  + + AK     Q L VI    
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAK-----QTLPVIYVKL 126
Query: 749 ---GVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEA-HVSDFGIAKFLNPDSSNWSEL 804
               +  +L Y+H+     I HRDI  +N+LLD       + DFG AK L     N S +
Sbjct: 127 YMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI 183
Query: 805 AGTHGYVAPELAY-TLKVTEKCDVYSFGVLALEVIKGK 841
              + Y APEL +     T   DV+S G +  E++ G+
Sbjct: 184 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/273 (22%), Positives = 107/273 (39%), Gaps = 19/273 (6%)
Query: 634 ISATNDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQ-EEFLNEIQA 691
           I    +F     +G G  G+VY+   +P GE   +      L    S +  +E L+E   
Sbjct: 13  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 72
Query: 692 LTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVA 751
           +  + + ++ +  G C       I         LD +         +G    LN    +A
Sbjct: 73  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIA 129
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH--G 809
             + YL +     +VHRD++++NVL+       ++DFG AK L  +   +    G     
Sbjct: 130 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 186
Query: 810 YVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPY 868
           ++A E       T + DV+S+GV   E++  G  P D +            E    RLP 
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE----RLPQ 242
Query: 869 PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
           P +      + +  +   C   + +SRP  + +
Sbjct: 243 PPICT----IDVYMIMRKCWMIDADSRPKFREL 271

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/273 (21%), Positives = 107/273 (39%), Gaps = 19/273 (6%)
Query: 634 ISATNDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQ-EEFLNEIQA 691
           I    +F     +  G  G+VY+   +P GE   +      L    S +  +E L+E   
Sbjct: 11  ILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 70
Query: 692 LTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVA 751
           +  + + ++ +  G C       I         LD +         +G    LN    +A
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIA 127
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH--G 809
             + YL +     +VHRD++++NVL+       ++DFG+AK L  +   +    G     
Sbjct: 128 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 810 YVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRLPY 868
           ++A E       T + DV+S+GV   E++  G  P D +            E    RLP 
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE----RLPQ 240
Query: 869 PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
           P +      + +  +   C   + +SRP  + +
Sbjct: 241 PPICT----IDVYMIMVKCWMIDADSRPKFREL 269

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 90/215 (41%), Gaps = 29/215 (13%)
Query: 646 IGKGGHGSVYRA------KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHR- 698
           +G+G  G V  A      K  +    AVK       G    +    ++E++ L  I H  
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE---GATHSEHRALMSELKILIHIGHHL 91
Query: 699 NIVKFYGFCSHPKHSF-IIYEYLESGSLD-------------KILCNDASAKELGWTQRL 744
           N+V   G C+ P     +I E+ + G+L              K+   D     L     +
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 745 NVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK--FLNPDSSNWS 802
                VA  + +L +      +HRD++++N+LL       + DFG+A+  + +PD     
Sbjct: 152 CYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 208
Query: 803 ELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEV 837
           +      ++APE  +    T + DV+SFGVL  E+
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 102/218 (46%), Gaps = 35/218 (16%)
Query: 640 FNAEHCIGKGGHGSVYRAKV-PSGEIFAVKKFHSPLPGEMSFQQEEFLN-EIQALTEIRH 697
           +     IG G  G VY+AK+  SGE+ A+KK           Q + F N E+Q + ++ H
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQDKRFKNRELQIMRKLDH 91
Query: 698 RNIVKF-YGFCSHPKHSFIIY-----EYLESGSLDKILCNDASAKELGWTQRLNVIK--- 748
            NIV+  Y F S  +    +Y     +Y+   ++ ++  + + AK     Q L VI    
Sbjct: 92  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAK-----QTLPVIYVKL 145
Query: 749 ---GVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEA-HVSDFGIAKFLNPDSSNWSEL 804
               +  +L Y+H+     I HRDI  +N+LLD       + DFG AK L     N S +
Sbjct: 146 YMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI 202
Query: 805 AGTHGYVAPELAY-TLKVTEKCDVYSFGVLALEVIKGK 841
              + Y APEL +     T   DV+S G +  E++ G+
Sbjct: 203 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 102/218 (46%), Gaps = 35/218 (16%)
Query: 640 FNAEHCIGKGGHGSVYRAKV-PSGEIFAVKKFHSPLPGEMSFQQEEFLN-EIQALTEIRH 697
           +     IG G  G VY+AK+  SGE+ A+KK           Q + F N E+Q + ++ H
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQDKRFKNRELQIMRKLDH 80
Query: 698 RNIVKF-YGFCSHPKHSFIIY-----EYLESGSLDKILCNDASAKELGWTQRLNVIK--- 748
            NIV+  Y F S  +    +Y     +Y+   ++ ++  + + AK     Q L VI    
Sbjct: 81  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAK-----QTLPVIYVKL 134
Query: 749 ---GVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEA-HVSDFGIAKFLNPDSSNWSEL 804
               +  +L Y+H+     I HRDI  +N+LLD       + DFG AK L     N S +
Sbjct: 135 YMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI 191
Query: 805 AGTHGYVAPELAY-TLKVTEKCDVYSFGVLALEVIKGK 841
              + Y APEL +     T   DV+S G +  E++ G+
Sbjct: 192 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 102/218 (46%), Gaps = 35/218 (16%)
Query: 640 FNAEHCIGKGGHGSVYRAKV-PSGEIFAVKKFHSPLPGEMSFQQEEFLN-EIQALTEIRH 697
           +     IG G  G VY+AK+  SGE+ A+KK           Q + F N E+Q + ++ H
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQDKRFKNRELQIMRKLDH 84
Query: 698 RNIVKF-YGFCSHPKHSFIIY-----EYLESGSLDKILCNDASAKELGWTQRLNVIK--- 748
            NIV+  Y F S  +    +Y     +Y+   ++ ++  + + AK     Q L VI    
Sbjct: 85  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAK-----QTLPVIYVKL 138
Query: 749 ---GVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEA-HVSDFGIAKFLNPDSSNWSEL 804
               +  +L Y+H+     I HRDI  +N+LLD       + DFG AK L     N S +
Sbjct: 139 YMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI 195
Query: 805 AGTHGYVAPELAY-TLKVTEKCDVYSFGVLALEVIKGK 841
              + Y APEL +     T   DV+S G +  E++ G+
Sbjct: 196 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 102/218 (46%), Gaps = 35/218 (16%)
Query: 640 FNAEHCIGKGGHGSVYRAKV-PSGEIFAVKKFHSPLPGEMSFQQEEFLN-EIQALTEIRH 697
           +     IG G  G VY+AK+  SGE+ A+KK           Q + F N E+Q + ++ H
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQDKRFKNRELQIMRKLDH 72
Query: 698 RNIVKF-YGFCSHPKHSFIIY-----EYLESGSLDKILCNDASAKELGWTQRLNVIK--- 748
            NIV+  Y F S  +    +Y     +Y+   ++ ++  + + AK     Q L VI    
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAK-----QTLPVIYVKL 126
Query: 749 ---GVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEA-HVSDFGIAKFLNPDSSNWSEL 804
               +  +L Y+H+     I HRDI  +N+LLD       + DFG AK L     N S +
Sbjct: 127 YMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 183
Query: 805 AGTHGYVAPELAY-TLKVTEKCDVYSFGVLALEVIKGK 841
              + Y APEL +     T   DV+S G +  E++ G+
Sbjct: 184 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 89/211 (42%), Gaps = 25/211 (11%)
Query: 646 IGKGGHGSVYRA------KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHR- 698
           +G+G  G V  A      K  +    AVK       G    +    ++E++ L  I H  
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKE---GATHSEHRALMSELKILIHIGHHL 91
Query: 699 NIVKFYGFCSHPKHSF-IIYEYLESGSLDKIL---------CNDASAKELGWTQRLNVIK 748
           N+V   G C+ P     +I E+ + G+L   L           D     L     +    
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSF 151
Query: 749 GVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK--FLNPDSSNWSELAG 806
            VA  + +L +      +HRD++++N+LL       + DFG+A+  + +PD     +   
Sbjct: 152 QVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 208
Query: 807 THGYVAPELAYTLKVTEKCDVYSFGVLALEV 837
              ++APE  +    T + DV+SFGVL  E+
Sbjct: 209 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 239

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 98/223 (43%), Gaps = 28/223 (12%)
Query: 638 NDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQ-----EEFLNEIQA 691
            ++  +  +G+G    V R    P+ + +AVK       G  S ++     E  L E+  
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 692 LTEIR-HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGV 750
           L ++  H NI++           F++++ ++ G L   L    +  E    +   +++ +
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE---KETRKIMRAL 133
Query: 751 ADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGY 810
            + +  LH      IVHRD+  +N+LLD      ++DFG +  L+P      E+ GT  Y
Sbjct: 134 LEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP-GEKLREVCGTPSY 189
Query: 811 VAPEL----------AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           +APE+           Y  +V    D++S GV+   ++ G  P
Sbjct: 190 LAPEIIECSMNDNHPGYGKEV----DMWSTGVIMYTLLAGSPP 228

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 102/218 (46%), Gaps = 35/218 (16%)
Query: 640 FNAEHCIGKGGHGSVYRAKV-PSGEIFAVKKFHSPLPGEMSFQQEEFLN-EIQALTEIRH 697
           +     IG G  G VY+AK+  SGE+ A+KK           Q + F N E+Q + ++ H
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQDKRFKNRELQIMRKLDH 106
Query: 698 RNIVKF-YGFCSHPKHSFIIY-----EYLESGSLDKILCNDASAKELGWTQRLNVIK--- 748
            NIV+  Y F S  +    +Y     +Y+   ++ ++  + + AK     Q L VI    
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAK-----QTLPVIYVKL 160
Query: 749 ---GVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEA-HVSDFGIAKFLNPDSSNWSEL 804
               +  +L Y+H+     I HRDI  +N+LLD       + DFG AK L     N S +
Sbjct: 161 YMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI 217
Query: 805 AGTHGYVAPELAY-TLKVTEKCDVYSFGVLALEVIKGK 841
              + Y APEL +     T   DV+S G +  E++ G+
Sbjct: 218 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 103/218 (47%), Gaps = 35/218 (16%)
Query: 640 FNAEHCIGKGGHGSVYRAKV-PSGEIFAVKKFHSPLPGEMSFQQEEFLN-EIQALTEIRH 697
           +     IG G  G VY+AK+  SGE+ A+KK           Q + F N E+Q + ++ H
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQGKAFKNRELQIMRKLDH 72
Query: 698 RNIVKF-YGFCSHPKHSFIIY-----EYLESGSLDKILCNDASAKELGWTQRLNVIK--- 748
            NIV+  Y F S  +    +Y     +Y+ + ++ ++  + + AK     Q L VI    
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPA-TVYRVARHYSRAK-----QTLPVIYVKL 126
Query: 749 ---GVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEA-HVSDFGIAKFLNPDSSNWSEL 804
               +  +L Y+H+     I HRDI  +N+LLD       + DFG AK L     N S +
Sbjct: 127 YMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI 183
Query: 805 AGTHGYVAPELAY-TLKVTEKCDVYSFGVLALEVIKGK 841
              + Y APEL +     T   DV+S G +  E++ G+
Sbjct: 184 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/170 (23%), Positives = 80/170 (47%), Gaps = 19/170 (11%)
Query: 684 EFLNEIQALTEI-RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKIL------------- 729
           + ++E++ +  I +H+NI+   G C+     ++I  Y   G+L + L             
Sbjct: 86  DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYD 145
Query: 730 CNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFG 789
            N    +++ +   ++    +A  + YL +      +HRD++++NVL+       ++DFG
Sbjct: 146 INRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFG 202
Query: 790 IAKFLNPDSSNWSELAGT--HGYVAPELAYTLKVTEKCDVYSFGVLALEV 837
           +A+ +N          G     ++APE  +    T + DV+SFGVL  E+
Sbjct: 203 LARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 102/218 (46%), Gaps = 35/218 (16%)
Query: 640 FNAEHCIGKGGHGSVYRAKV-PSGEIFAVKKFHSPLPGEMSFQQEEFLN-EIQALTEIRH 697
           +     IG G  G VY+AK+  SGE+ A+KK           Q + F N E+Q + ++ H
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQDKRFKNRELQIMRKLDH 85
Query: 698 RNIVKF-YGFCSHPKHSFIIY-----EYLESGSLDKILCNDASAKELGWTQRLNVIK--- 748
            NIV+  Y F S  +    +Y     +Y+   ++ ++  + + AK     Q L VI    
Sbjct: 86  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAK-----QTLPVIYVKL 139
Query: 749 ---GVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEA-HVSDFGIAKFLNPDSSNWSEL 804
               +  +L Y+H+     I HRDI  +N+LLD       + DFG AK L     N S +
Sbjct: 140 YMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 196
Query: 805 AGTHGYVAPELAY-TLKVTEKCDVYSFGVLALEVIKGK 841
              + Y APEL +     T   DV+S G +  E++ G+
Sbjct: 197 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 102/218 (46%), Gaps = 35/218 (16%)
Query: 640 FNAEHCIGKGGHGSVYRAKV-PSGEIFAVKKFHSPLPGEMSFQQEEFLN-EIQALTEIRH 697
           +     IG G  G VY+AK+  SGE+ A+KK           Q + F N E+Q + ++ H
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQDKRFKNRELQIMRKLDH 77
Query: 698 RNIVKF-YGFCSHPKHSFIIY-----EYLESGSLDKILCNDASAKELGWTQRLNVIK--- 748
            NIV+  Y F S  +    +Y     +Y+   ++ ++  + + AK     Q L VI    
Sbjct: 78  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAK-----QTLPVIYVKL 131
Query: 749 ---GVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEA-HVSDFGIAKFLNPDSSNWSEL 804
               +  +L Y+H+     I HRDI  +N+LLD       + DFG AK L     N S +
Sbjct: 132 YMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 188
Query: 805 AGTHGYVAPELAY-TLKVTEKCDVYSFGVLALEVIKGK 841
              + Y APEL +     T   DV+S G +  E++ G+
Sbjct: 189 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|3ZYJ|A Chain A, Netring1 In Complex With Ngl1 Length = 440

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 79/276 (28%), Positives = 114/276 (41%), Gaps = 35/276 (12%)
Query: 232 FDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGXXXXXXXXXXXXXHFRG 291
           F   +C+ +    +P  IS  TN R L L+ N++  I                   H R 
Sbjct: 45  FSKVICVRKNLREVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRT 102
Query: 292 TVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRC-PQ 350
               +F  L +L  L L  N LT        T PN  F+ LS      ++   W R  P 
Sbjct: 103 IEIGAFNGLANLNTLELFDNRLT--------TIPNGAFVYLS------KLKELWLRNNPI 148
Query: 351 LSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLS 410
            S+   + N I     L++GE  +L Y+  S     G     L N+ YLN        L+
Sbjct: 149 ESIPSYAFNRIPSLRRLDLGELKRLSYI--SEGAFEG-----LSNLRYLN--------LA 193
Query: 411 GCIPRE---LGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDN 467
            C  RE   L  LI L+ LDLS N+LS   P S   L+ L  L +  +++        DN
Sbjct: 194 MCNLREIPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDN 253
Query: 468 LIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYN 503
           L  L E++L+HN L          +  LE+++L +N
Sbjct: 254 LQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 90/215 (41%), Gaps = 29/215 (13%)
Query: 646 IGKGGHGSVYRA------KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHR- 698
           +G+G  G V  A      K  +    AVK       G    +    ++E++ L  I H  
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE---GATHSEHRALMSELKILIHIGHHL 91
Query: 699 NIVKFYGFCSHPKHS-FIIYEYLESGSLD-------------KILCNDASAKELGWTQRL 744
           N+V   G C+ P     +I E+ + G+L              K+   D     L     +
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 745 NVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL--NPDSSNWS 802
                VA  + +L +      +HRD++++N+LL       + DFG+A+ +  +PD     
Sbjct: 152 CYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 208
Query: 803 ELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEV 837
           +      ++APE  +    T + DV+SFGVL  E+
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 92/217 (42%), Gaps = 19/217 (8%)
Query: 638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI- 695
            DF+    IG+G +  V   ++  +  I+A+K     L        +E ++ +Q    + 
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKEL-----VNDDEDIDWVQTEKHVF 63
Query: 696 ----RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVA 751
                H  +V  +         F + EY+  G L   + +    ++L           ++
Sbjct: 64  EQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEIS 120
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK-FLNPDSSNWSELAGTHGY 810
            AL YLH      I++RD+   NVLLD      ++D+G+ K  L P  +  S   GT  Y
Sbjct: 121 LALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT-SXFCGTPNY 176
Query: 811 VAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFL 847
           +APE+          D ++ GVL  E++ G+ P D +
Sbjct: 177 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 213

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 93/217 (42%), Gaps = 19/217 (8%)
Query: 638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI- 695
            DF+    IG+G +  V   ++  +  I+A+K     L  +     +E ++ +Q    + 
Sbjct: 5   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVND-----DEDIDWVQTEKHVF 59
Query: 696 ----RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVA 751
                H  +V  +         F + EY+  G L   + +    ++L           ++
Sbjct: 60  EQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEIS 116
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK-FLNPDSSNWSELAGTHGY 810
            AL YLH      I++RD+   NVLLD      ++D+G+ K  L P  +  S   GT  Y
Sbjct: 117 LALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT-SXFCGTPNY 172
Query: 811 VAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFL 847
           +APE+          D ++ GVL  E++ G+ P D +
Sbjct: 173 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 209

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 100/219 (45%), Gaps = 29/219 (13%)
Query: 646 IGKGGHGSVYRA--KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKF 703
           IG+G +G V  A   V    + A+KK  SP   +   Q+   L EIQ L   RH N++  
Sbjct: 51  IGEGAYGMVSSAYDHVRKTRV-AIKKI-SPFEHQTYCQRT--LREIQILLRFRHENVIGI 106
Query: 704 YGFCSHP-----KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLH 758
                       +  +I+ + +E+  L K+L     +++L        +  +   L Y+H
Sbjct: 107 RDILRASTLEAMRDVYIVQDLMET-DLYKLL----KSQQLSNDHICYFLYQILRGLKYIH 161
Query: 759 NNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN---WSELAGTHGYVAPEL 815
           +     ++HRD+   N+L++   +  + DFG+A+  +P+  +    +E   T  Y APE+
Sbjct: 162 SAN---VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEI 218
Query: 816 AYTLK-VTEKCDVYSFGVLALEVIK------GKHPRDFL 847
               K  T+  D++S G +  E++       GKH  D L
Sbjct: 219 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 257

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 70/154 (45%), Gaps = 14/154 (9%)
Query: 696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSL-DKILCNDA-SAKELGWTQRLNVIKGVADA 753
           +H NI+         KH +++ E +  G L DKIL     S +E  +     V+  +   
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASF-----VLHTIGKT 133
Query: 754 LFYLHNNCFPPIVHRDISSKNVL-LDLGYEA---HVSDFGIAKFLNPDSSNWSELAGTHG 809
           + YLH+     +VHRD+   N+L +D         + DFG AK L  ++        T  
Sbjct: 134 VEYLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTAN 190
Query: 810 YVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           +VAPE+       E CD++S G+L   ++ G  P
Sbjct: 191 FVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 102/218 (46%), Gaps = 35/218 (16%)
Query: 640 FNAEHCIGKGGHGSVYRAKV-PSGEIFAVKKFHSPLPGEMSFQQEEFLN-EIQALTEIRH 697
           +     IG G  G VY+AK+  SGE+ A+KK           Q + F N E+Q + ++ H
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQDKRFKNRELQIMRKLDH 151
Query: 698 RNIVKF-YGFCSHPKHSFIIY-----EYLESGSLDKILCNDASAKELGWTQRLNVIK--- 748
            NIV+  Y F S  +    +Y     +Y+   ++ ++  + + AK     Q L VI    
Sbjct: 152 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAK-----QTLPVIYVKL 205
Query: 749 ---GVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEA-HVSDFGIAKFLNPDSSNWSEL 804
               +  +L Y+H+     I HRDI  +N+LLD       + DFG AK L     N S +
Sbjct: 206 YMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 262
Query: 805 AGTHGYVAPELAY-TLKVTEKCDVYSFGVLALEVIKGK 841
              + Y APEL +     T   DV+S G +  E++ G+
Sbjct: 263 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 88  DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 143
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKV 821
             I+HRD+   N+ ++   E  + DFG+A+  + + + +     T  Y APE+    +  
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHY 200
Query: 822 TEKCDVYSFGVLALEVIKGK 841
            +  D++S G +  E++ G+
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 82/168 (48%), Gaps = 24/168 (14%)
Query: 687 NEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSL-DKILCN----DASAKELGWT 741
            EI+ L ++ H  I+K   F     + +I+ E +E G L DK++ N    +A+ K L + 
Sbjct: 64  TEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCK-LYFY 121
Query: 742 QRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEA---HVSDFGIAKFLNPDS 798
           Q L  ++       YLH N    I+HRD+  +NVLL    E     ++DFG +K L  ++
Sbjct: 122 QMLLAVQ-------YLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ET 170
Query: 799 SNWSELAGTHGYVAPELAYTLKVT---EKCDVYSFGVLALEVIKGKHP 843
           S    L GT  Y+APE+  ++         D +S GV+    + G  P
Sbjct: 171 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 90/215 (41%), Gaps = 29/215 (13%)
Query: 646 IGKGGHGSVYRA------KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHR- 698
           +G+G  G V  A      K  +    AVK       G    +    ++E++ L  I H  
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE---GATHSEHRALMSELKILIHIGHHL 82
Query: 699 NIVKFYGFCSHPKHS-FIIYEYLESGSLD-------------KILCNDASAKELGWTQRL 744
           N+V   G C+ P     +I E+ + G+L              K+   D     L     +
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 142
Query: 745 NVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK--FLNPDSSNWS 802
                VA  + +L +      +HRD++++N+LL       + DFG+A+  + +PD     
Sbjct: 143 CYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 199
Query: 803 ELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEV 837
           +      ++APE  +    T + DV+SFGVL  E+
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 234

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 82/168 (48%), Gaps = 24/168 (14%)
Query: 687 NEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSL-DKILCN----DASAKELGWT 741
            EI+ L ++ H  I+K   F     + +I+ E +E G L DK++ N    +A+ K L + 
Sbjct: 64  TEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCK-LYFY 121
Query: 742 QRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEA---HVSDFGIAKFLNPDS 798
           Q L  ++       YLH N    I+HRD+  +NVLL    E     ++DFG +K L  ++
Sbjct: 122 QMLLAVQ-------YLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ET 170
Query: 799 SNWSELAGTHGYVAPELAYTLKVT---EKCDVYSFGVLALEVIKGKHP 843
           S    L GT  Y+APE+  ++         D +S GV+    + G  P
Sbjct: 171 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 99/211 (46%), Gaps = 36/211 (17%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIV--- 701
           +G G +GSV  A    SGE  A+KK   P   E+ F +  +  E+  L  ++H N++   
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEI-FAKRAY-RELLLLKHMQHENVIGLL 89
Query: 702 ----------KFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVA 751
                      FY F       +++  ++++  L KI+    S +++ +     ++  + 
Sbjct: 90  DVFTPASSLRNFYDF-------YLVMPFMQT-DLQKIMGLKFSEEKIQY-----LVYQML 136
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV 811
             L Y+H+     +VHRD+   N+ ++   E  + DFG+A+  + + + +     T  Y 
Sbjct: 137 KGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGY---VVTRWYR 190
Query: 812 APELAYT-LKVTEKCDVYSFGVLALEVIKGK 841
           APE+  + +   +  D++S G +  E++ GK
Sbjct: 191 APEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 84  DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 139
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKV 821
             I+HRD+   N+ ++   E  + DFG+A+  + + + +     T  Y APE+    +  
Sbjct: 140 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHY 196
Query: 822 TEKCDVYSFGVLALEVIKGK 841
            +  D++S G +  E++ G+
Sbjct: 197 NQTVDIWSVGCIMAELLTGR 216

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 82/168 (48%), Gaps = 24/168 (14%)
Query: 687 NEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSL-DKILCN----DASAKELGWT 741
            EI+ L ++ H  I+K   F     + +I+ E +E G L DK++ N    +A+ K L + 
Sbjct: 70  TEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCK-LYFY 127
Query: 742 QRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEA---HVSDFGIAKFLNPDS 798
           Q L  ++       YLH N    I+HRD+  +NVLL    E     ++DFG +K L  ++
Sbjct: 128 QMLLAVQ-------YLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ET 176
Query: 799 SNWSELAGTHGYVAPELAYTLKVT---EKCDVYSFGVLALEVIKGKHP 843
           S    L GT  Y+APE+  ++         D +S GV+    + G  P
Sbjct: 177 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 224

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 107
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 108 DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 163
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKV 821
             I+HRD+   N+ ++   E  + DFG+A+  + + + +     T  Y APE+    +  
Sbjct: 164 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHY 220
Query: 822 TEKCDVYSFGVLALEVIKGK 841
            +  D++S G +  E++ G+
Sbjct: 221 NQTVDIWSVGCIMAELLTGR 240

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 90/203 (44%), Gaps = 19/203 (9%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 88  DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 143
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAG---THGYVAPELAYT- 818
             I+HRD+   N+ ++   E  + DFG+A+  +       E+AG   T  Y APE+    
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD------DEMAGFVATRWYRAPEIMLNW 197
Query: 819 LKVTEKCDVYSFGVLALEVIKGK 841
           +   +  D++S G +  E++ G+
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 91/219 (41%), Gaps = 37/219 (16%)
Query: 646 IGKGGHGSVYRA------KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHR- 698
           +G+G  G V  A      K  +    AVK       G    +    ++E++ L  I H  
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE---GATHSEHRALMSELKILIHIGHHL 93
Query: 699 NIVKFYGFCSHPKHSF-IIYEYLESGSLDKILCND-------ASAKELGWTQRL------ 744
           N+V   G C+ P     +I E+ + G+L   L +          A E  +   L      
Sbjct: 94  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLI 153
Query: 745 ----NVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK--FLNPDS 798
                V KG+    F     C    +HRD++++N+LL       + DFG+A+  + +PD 
Sbjct: 154 CYSFQVAKGME---FLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 206
Query: 799 SNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEV 837
               +      ++APE  +    T + DV+SFGVL  E+
Sbjct: 207 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 245

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 90/215 (41%), Gaps = 29/215 (13%)
Query: 646 IGKGGHGSVYRA------KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHR- 698
           +G+G  G V  A      K  +    AVK       G    +    ++E++ L  I H  
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE---GATHSEHRALMSELKILIHIGHHL 82
Query: 699 NIVKFYGFCSHPKHS-FIIYEYLESGSLD-------------KILCNDASAKELGWTQRL 744
           N+V   G C+ P     +I E+ + G+L              K+   D     L     +
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 142
Query: 745 NVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK--FLNPDSSNWS 802
                VA  + +L +      +HRD++++N+LL       + DFG+A+  + +PD     
Sbjct: 143 CYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 199
Query: 803 ELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEV 837
           +      ++APE  +    T + DV+SFGVL  E+
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 234

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 102/218 (46%), Gaps = 35/218 (16%)
Query: 640 FNAEHCIGKGGHGSVYRAKV-PSGEIFAVKKFHSPLPGEMSFQQEEFLN-EIQALTEIRH 697
           +     IG G  G VY+AK+  SGE+ A+KK           Q + F N E+Q + ++ H
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQDKRFKNRELQIMRKLDH 106
Query: 698 RNIVKF-YGFCSHPKHSFIIY-----EYLESGSLDKILCNDASAKELGWTQRLNVIK--- 748
            NIV+  Y F S  +    +Y     +Y+   ++ ++  + + AK     Q L VI    
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAK-----QTLPVIYVKL 160
Query: 749 ---GVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEA-HVSDFGIAKFLNPDSSNWSEL 804
               +  +L Y+H+     I HRDI  +N+LLD       + DFG AK L     N S +
Sbjct: 161 YMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 217
Query: 805 AGTHGYVAPELAY-TLKVTEKCDVYSFGVLALEVIKGK 841
              + Y APEL +     T   DV+S G +  E++ G+
Sbjct: 218 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/273 (20%), Positives = 105/273 (38%), Gaps = 80/273 (29%)
Query: 638 NDFNAEHCIGKGGHGSVYRAKVPSGEI-FAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
            DF    C+G+GG G V+ AK    +  +A+K+   P        +E+ + E++AL ++ 
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLP---NRELAREKVMREVKALAKLE 62
Query: 697 HRNIVK-FYGFCSHPKHSF---IIYEYLESGSLD--------------KI---------- 728
           H  IV+ F  +   P   +   +   +L+  S D              KI          
Sbjct: 63  HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKN 122
Query: 729 -------------------LCNDASAKELGWTQR------------LNVIKGVADALFYL 757
                              LC   + K+  W  R            L++   +A+A+ +L
Sbjct: 123 TVGQLQPSSPKVYLYIQMQLCRKENLKD--WMNRRCSLEDREHGVCLHIFIQIAEAVEFL 180
Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELA------------ 805
           H+     ++HRD+   N+   +     V DFG+   ++ D    + L             
Sbjct: 181 HSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQV 237
Query: 806 GTHGYVAPELAYTLKVTEKCDVYSFGVLALEVI 838
           GT  Y++PE  +    + K D++S G++  E++
Sbjct: 238 GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 90/203 (44%), Gaps = 19/203 (9%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 88  DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 143
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAG---THGYVAPELAYT- 818
             I+HRD+   N+ ++   E  + DFG+A+  +       E+AG   T  Y APE+    
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD------DEMAGFVATRWYRAPEIMLNW 197
Query: 819 LKVTEKCDVYSFGVLALEVIKGK 841
           +   +  D++S G +  E++ G+
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 102/218 (46%), Gaps = 35/218 (16%)
Query: 640 FNAEHCIGKGGHGSVYRAKV-PSGEIFAVKKFHSPLPGEMSFQQEEFLN-EIQALTEIRH 697
           +     IG G  G VY+AK+  SGE+ A+KK           Q + F N E+Q + ++ H
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQDKRFKNRELQIMRKLDH 110
Query: 698 RNIVKF-YGFCSHPKHSFIIY-----EYLESGSLDKILCNDASAKELGWTQRLNVIK--- 748
            NIV+  Y F S  +    +Y     +Y+   ++ ++  + + AK     Q L VI    
Sbjct: 111 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAK-----QTLPVIYVKL 164
Query: 749 ---GVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEA-HVSDFGIAKFLNPDSSNWSEL 804
               +  +L Y+H+     I HRDI  +N+LLD       + DFG AK L     N S +
Sbjct: 165 YMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 221
Query: 805 AGTHGYVAPELAY-TLKVTEKCDVYSFGVLALEVIKGK 841
              + Y APEL +     T   DV+S G +  E++ G+
Sbjct: 222 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 102/218 (46%), Gaps = 35/218 (16%)
Query: 640 FNAEHCIGKGGHGSVYRAKV-PSGEIFAVKKFHSPLPGEMSFQQEEFLN-EIQALTEIRH 697
           +     IG G  G VY+AK+  SGE+ A+KK           Q + F N E+Q + ++ H
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQDKRFKNRELQIMRKLDH 108
Query: 698 RNIVKF-YGFCSHPKHSFIIY-----EYLESGSLDKILCNDASAKELGWTQRLNVIK--- 748
            NIV+  Y F S  +    +Y     +Y+   ++ ++  + + AK     Q L VI    
Sbjct: 109 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAK-----QTLPVIYVKL 162
Query: 749 ---GVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEA-HVSDFGIAKFLNPDSSNWSEL 804
               +  +L Y+H+     I HRDI  +N+LLD       + DFG AK L     N S +
Sbjct: 163 YMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 219
Query: 805 AGTHGYVAPELAY-TLKVTEKCDVYSFGVLALEVIKGK 841
              + Y APEL +     T   DV+S G +  E++ G+
Sbjct: 220 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 97
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 98  DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 153
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKV 821
             I+HRD+   N+ ++   E  + DFG+A+  + + + +     T  Y APE+    +  
Sbjct: 154 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHY 210
Query: 822 TEKCDVYSFGVLALEVIKGK 841
            +  D++S G +  E++ G+
Sbjct: 211 NQTVDIWSVGCIMAELLTGR 230

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/170 (24%), Positives = 80/170 (47%), Gaps = 19/170 (11%)
Query: 684 EFLNEIQALTEI-RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKIL------------- 729
           + ++E++ +  I +H+NI+   G C+     ++I EY   G+L + L             
Sbjct: 79  DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFN 138
Query: 730 CNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFG 789
            +    ++L     ++    VA  + YL +      +HRD++++NVL+       ++DFG
Sbjct: 139 PSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFG 195
Query: 790 IAKFLNPDSSNWSELAGT--HGYVAPELAYTLKVTEKCDVYSFGVLALEV 837
           +A+ ++          G     ++APE  +    T + DV+SFGVL  E+
Sbjct: 196 LARDIHHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 90/215 (41%), Gaps = 29/215 (13%)
Query: 646 IGKGGHGSVYRA------KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHR- 698
           +G+G  G V  A      K  +    AVK       G    +    ++E++ L  I H  
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE---GATHSEHRALMSELKILIHIGHHL 82
Query: 699 NIVKFYGFCSHPKHSF-IIYEYLESGSLD-------------KILCNDASAKELGWTQRL 744
           N+V   G C+ P     +I E+ + G+L              K+   D     L     +
Sbjct: 83  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 142
Query: 745 NVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL--NPDSSNWS 802
                VA  + +L +      +HRD++++N+LL       + DFG+A+ +  +PD     
Sbjct: 143 CYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 199
Query: 803 ELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEV 837
           +      ++APE  +    T + DV+SFGVL  E+
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 234

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 62/284 (21%), Positives = 115/284 (40%), Gaps = 38/284 (13%)
Query: 646 IGKGGHGSVYRA---KVPSGEI---FAVKKFHSPLPGEMSFQQE-EFLNEIQALTEIRHR 698
           +G+G  G VY      +  GE     AVK  +       S ++  EFLNE   +      
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNE----SASLRERIEFLNEASVMKGFTCH 80
Query: 699 NIVKFYGFCSHPKHSFIIYEYLESGSLDKILC-------NDASAKELGWTQRLNVIKGVA 751
           ++V+  G  S  + + ++ E +  G L   L        N+         + + +   +A
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG-- 809
           D + YL+   F   VHRD++++N ++   +   + DFG+ + +           G  G  
Sbjct: 141 DGMAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXX---RKGGKGLL 194
Query: 810 ---YVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSR 865
              ++APE       T   D++SFGV+  E+    + P    ++           M    
Sbjct: 195 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP----YQGLSNEQVLKFVMDGGY 250
Query: 866 LPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI 909
           L  P  +  +++  +M++   C   NP+ RPT   +  LL + +
Sbjct: 251 LDQPD-NCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLKDDL 290

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           IG G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 92
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 93  DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 148
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKV 821
             I+HRD+   N+ ++   E  + DFG+A+  + + + +     T  Y APE+    +  
Sbjct: 149 ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHY 205
Query: 822 TEKCDVYSFGVLALEVIKGK 841
            +  D++S G +  E++ G+
Sbjct: 206 NQTVDIWSVGCIMAELLTGR 225

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 33/218 (15%)
Query: 643 EHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVK 702
           +  IGKG  G V+R K   GE  AVK F S    E S+ +E    EI     +RH NI+ 
Sbjct: 9   QESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFREA---EIYQTVMLRHENILG 62
Query: 703 FYGFCSHPKHSF----IIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLH 758
           F    +    ++    ++ +Y E GSL   L N  +    G    + +    A  L +LH
Sbjct: 63  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEG---MIKLALSTASGLAHLH 118
Query: 759 NNCF-----PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWS------ELAGT 807
                    P I HRD+ SKN+L+       ++D G+A  +  DS+  +         GT
Sbjct: 119 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGT 176
Query: 808 HGYVAPEL---AYTLKVTE---KCDVYSFGVLALEVIK 839
             Y+APE+   +  +K  E   + D+Y+ G++  E+ +
Sbjct: 177 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR 214

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 33/218 (15%)
Query: 643 EHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVK 702
           +  IGKG  G V+R K   GE  AVK F S    E S+ +E    EI     +RH NI+ 
Sbjct: 8   QESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFREA---EIYQTVMLRHENILG 61
Query: 703 FYGFCSHPKHSF----IIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLH 758
           F    +    ++    ++ +Y E GSL   L N  +    G    + +    A  L +LH
Sbjct: 62  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEG---MIKLALSTASGLAHLH 117
Query: 759 NNCF-----PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWS------ELAGT 807
                    P I HRD+ SKN+L+       ++D G+A  +  DS+  +         GT
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGT 175
Query: 808 HGYVAPEL---AYTLKVTE---KCDVYSFGVLALEVIK 839
             Y+APE+   +  +K  E   + D+Y+ G++  E+ +
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR 213

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 82/168 (48%), Gaps = 24/168 (14%)
Query: 687 NEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSL-DKILCN----DASAKELGWT 741
            EI+ L ++ H  I+K   F     + +I+ E +E G L DK++ N    +A+ K L + 
Sbjct: 63  TEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCK-LYFY 120
Query: 742 QRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEA---HVSDFGIAKFLNPDS 798
           Q L  ++       YLH N    I+HRD+  +NVLL    E     ++DFG +K L  ++
Sbjct: 121 QMLLAVQ-------YLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ET 169
Query: 799 SNWSELAGTHGYVAPELAYTLKVT---EKCDVYSFGVLALEVIKGKHP 843
           S    L GT  Y+APE+  ++         D +S GV+    + G  P
Sbjct: 170 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 217

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 106
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 107 DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 162
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKV 821
             I+HRD+   N+ ++   E  + DFG+A+  + + + +     T  Y APE+    +  
Sbjct: 163 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHY 219
Query: 822 TEKCDVYSFGVLALEVIKGK 841
            +  D++S G +  E++ G+
Sbjct: 220 NQTVDIWSVGCIMAELLTGR 239

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 92/218 (42%), Gaps = 36/218 (16%)
Query: 646 IGKGGHGSVYRA------KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHR- 698
           +G+G  G V  A      K  +    AVK       G    +    ++E++ L  I H  
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE---GATHSEHRALMSELKILIHIGHHL 92
Query: 699 NIVKFYGFCSHPKHSF-IIYEYLESGSLDKILCNDASA-----------KELGWTQRL-- 744
           N+V   G C+ P     +I E+ + G+L   L +  +            K+    + L  
Sbjct: 93  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLIC 152
Query: 745 ---NVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL--NPDSS 799
               V KG+    F     C    +HRD++++N+LL       + DFG+A+ +  +PD  
Sbjct: 153 YSFQVAKGME---FLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXV 205
Query: 800 NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEV 837
              +      ++APE  +    T + DV+SFGVL  E+
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 82/168 (48%), Gaps = 24/168 (14%)
Query: 687 NEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSL-DKILCN----DASAKELGWT 741
            EI+ L ++ H  I+K   F     + +I+ E +E G L DK++ N    +A+ K L + 
Sbjct: 64  TEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCK-LYFY 121
Query: 742 QRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEA---HVSDFGIAKFLNPDS 798
           Q L  ++       YLH N    I+HRD+  +NVLL    E     ++DFG +K L  ++
Sbjct: 122 QMLLAVQ-------YLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ET 170
Query: 799 SNWSELAGTHGYVAPELAYTLKVT---EKCDVYSFGVLALEVIKGKHP 843
           S    L GT  Y+APE+  ++         D +S GV+    + G  P
Sbjct: 171 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 63/286 (22%), Positives = 118/286 (41%), Gaps = 44/286 (15%)
Query: 646 IGKGGHGSVYRAKV------PSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRN 699
           +G+   G VY+  +         +  A+K       G +   +EEF +E      ++H N
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPL---REEFRHEAMLRARLQHPN 73
Query: 700 IVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKG---------- 749
           +V   G  +  +   +I+ Y   G L + L   +   ++G T     +K           
Sbjct: 74  VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 750 ---VADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAG 806
              +A  + YL ++    +VH+D++++NVL+       +SD G+  F    ++++ +L G
Sbjct: 134 VAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGL--FREVYAADYYKLLG 188
Query: 807 TH----GYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEM 861
                  ++APE     K +   D++S+GV+  EV   G  P               +EM
Sbjct: 189 NSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP------YCGYSNQDVVEM 242
Query: 862 LDSR--LPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
           + +R  LP P       + ++M     C ++ P  RP  K +   L
Sbjct: 243 IRNRQVLPCPD-DCPAWVYALM---IECWNEFPSRRPRFKDIHSRL 284

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 90/203 (44%), Gaps = 19/203 (9%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 84  DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 139
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAG---THGYVAPELAYT- 818
             I+HRD+   N+ ++   E  + DFG+A+  +       E+AG   T  Y APE+    
Sbjct: 140 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD------DEMAGFVATRWYRAPEIMLNW 193
Query: 819 LKVTEKCDVYSFGVLALEVIKGK 841
           +   +  D++S G +  E++ G+
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 70/154 (45%), Gaps = 14/154 (9%)
Query: 696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSL-DKILCNDA-SAKELGWTQRLNVIKGVADA 753
           +H NI+         KH +++ E +  G L DKIL     S +E  +     V+  +   
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASF-----VLHTIGKT 133
Query: 754 LFYLHNNCFPPIVHRDISSKNVL-LDLGYEA---HVSDFGIAKFLNPDSSNWSELAGTHG 809
           + YLH+     +VHRD+   N+L +D         + DFG AK L  ++        T  
Sbjct: 134 VEYLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTAN 190
Query: 810 YVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           +VAPE+       E CD++S G+L   ++ G  P
Sbjct: 191 FVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 102/218 (46%), Gaps = 35/218 (16%)
Query: 640 FNAEHCIGKGGHGSVYRAKV-PSGEIFAVKKFHSPLPGEMSFQQEEFLN-EIQALTEIRH 697
           +     IG G  G VY+AK+  SGE+ A+KK           Q + F N E+Q + ++ H
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQDKRFKNRELQIMRKLDH 100
Query: 698 RNIVKF-YGFCSHPKHSFIIY-----EYLESGSLDKILCNDASAKELGWTQRLNVIK--- 748
            NIV+  Y F S  +    +Y     +Y+   ++ ++  + + AK     Q L VI    
Sbjct: 101 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAK-----QTLPVIYVKL 154
Query: 749 ---GVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEA-HVSDFGIAKFLNPDSSNWSEL 804
               +  +L Y+H+     I HRDI  +N+LLD       + DFG AK L     N S +
Sbjct: 155 YMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 211
Query: 805 AGTHGYVAPELAY-TLKVTEKCDVYSFGVLALEVIKGK 841
              + Y APEL +     T   DV+S G +  E++ G+
Sbjct: 212 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 93/217 (42%), Gaps = 19/217 (8%)
Query: 638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI- 695
            DF+    IG+G +  V   ++  +  I+A+K     L  +     +E ++ +Q    + 
Sbjct: 20  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVND-----DEDIDWVQTEKHVF 74
Query: 696 ----RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVA 751
                H  +V  +         F + EY+  G L   + +    ++L           ++
Sbjct: 75  EQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEIS 131
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKF-LNPDSSNWSELAGTHGY 810
            AL YLH      I++RD+   NVLLD      ++D+G+ K  L P  +  S   GT  Y
Sbjct: 132 LALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT-SXFCGTPNY 187
Query: 811 VAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFL 847
           +APE+          D ++ GVL  E++ G+ P D +
Sbjct: 188 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 224

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 115/272 (42%), Gaps = 54/272 (19%)
Query: 619 RSVLTFEGKIVYEEIISATNDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGE 677
           R  L F+G      ++     ++ +  IG+G +G V  A +  +  I A+K  +     +
Sbjct: 11  RENLYFQGG----SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQ 66
Query: 678 MSFQQ-EEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSL-DK--ILCNDA 733
           ++ +  E    E++ + ++ H NI + Y      ++  ++ E    G L DK  +  +D+
Sbjct: 67  INPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDS 126
Query: 734 SAK------------------------------ELGWTQR----LNVIKGVADALFYLHN 759
           + K                               L + QR     N+++ +  AL YLHN
Sbjct: 127 TGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN 186
Query: 760 NCFPPIVHRDISSKNVLL--DLGYEAHVSDFGIAKFL----NPDSSNWSELAGTHGYVAP 813
                I HRDI  +N L   +  +E  + DFG++K      N +    +  AGT  +VAP
Sbjct: 187 Q---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP 243
Query: 814 ELAYTLKVT--EKCDVYSFGVLALEVIKGKHP 843
           E+  T   +   KCD +S GVL   ++ G  P
Sbjct: 244 EVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP 275

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 90/215 (41%), Gaps = 29/215 (13%)
Query: 646 IGKGGHGSVYRA------KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHR- 698
           +G+G  G V  A      K  +    AVK       G    +    ++E++ L  I H  
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE---GATHSEHRALMSELKILIHIGHHL 82
Query: 699 NIVKFYGFCSHPKHSF-IIYEYLESGSLD-------------KILCNDASAKELGWTQRL 744
           N+V   G C+ P     +I E+ + G+L              K+   D     L     +
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 142
Query: 745 NVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL--NPDSSNWS 802
                VA  + +L +      +HRD++++N+LL       + DFG+A+ +  +PD     
Sbjct: 143 CYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 199
Query: 803 ELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEV 837
           +      ++APE  +    T + DV+SFGVL  E+
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 234

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 93
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 94  DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 149
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKV 821
             I+HRD+   N+ ++   E  + DFG+A+  + + + +     T  Y APE+    +  
Sbjct: 150 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHY 206
Query: 822 TEKCDVYSFGVLALEVIKGK 841
            +  D++S G +  E++ G+
Sbjct: 207 NQTVDIWSVGCIMAELLTGR 226

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 63/286 (22%), Positives = 116/286 (40%), Gaps = 44/286 (15%)
Query: 646 IGKGGHGSVYR------AKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRN 699
           +G+   G VY+      A     +  A+K       G +   +EEF +E      ++H N
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPL---REEFRHEAMLRARLQHPN 90
Query: 700 IVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKG---------- 749
           +V   G  +  +   +I+ Y   G L + L   +   ++G T     +K           
Sbjct: 91  VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 150
Query: 750 ---VADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAG 806
              +A  + YL ++    +VH+D++++NVL+       +SD G+  F    ++++ +L G
Sbjct: 151 VAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGL--FREVYAADYYKLLG 205
Query: 807 TH----GYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEM 861
                  ++APE     K +   D++S+GV+  EV   G  P               +EM
Sbjct: 206 NSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP------YCGYSNQDVVEM 259
Query: 862 LDSR--LPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
           + +R  LP P          +  +   C ++ P  RP  K +   L
Sbjct: 260 IRNRQVLPCPD----DCPAWVYALMIECWNEFPSRRPRFKDIHSRL 301

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 96/221 (43%), Gaps = 29/221 (13%)
Query: 635 SATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTE 694
           +  +DF+    IGKG  G V  A+  + E+F   K           Q++  L + +    
Sbjct: 35  AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKV---------LQKKAILKKKEEKHI 85
Query: 695 IRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKI--LCNDASAKELGWT-QRLNVI---- 747
           +  RN++       + KH F++  +    + DK+  + +  +  EL +  QR        
Sbjct: 86  MSERNVL-----LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPR 140
Query: 748 -----KGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWS 802
                  +A AL YLH+     IV+RD+  +N+LLD      ++DFG+ K     +S  S
Sbjct: 141 ARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTS 197
Query: 803 ELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
              GT  Y+APE+ +        D +  G +  E++ G  P
Sbjct: 198 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 90/213 (42%), Gaps = 27/213 (12%)
Query: 646 IGKGGHGSVYRA------KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHR- 698
           +G+G  G V  A      K  +    AVK       G    +    ++E++ L  I H  
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKE---GATHSEHRALMSELKILIHIGHHL 93
Query: 699 NIVKFYGFCSHPKHSF-IIYEYLESGSLDKILCN-----------DASAKELGWTQRLNV 746
           N+V   G C+ P     +I E+ + G+L   L +           D     L     +  
Sbjct: 94  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXY 153
Query: 747 IKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL--NPDSSNWSEL 804
              VA  + +L +      +HRD++++N+LL       + DFG+A+ +  +PD     + 
Sbjct: 154 SFQVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 805 AGTHGYVAPELAYTLKVTEKCDVYSFGVLALEV 837
                ++APE  +    T + DV+SFGVL  E+
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 62/284 (21%), Positives = 114/284 (40%), Gaps = 38/284 (13%)
Query: 646 IGKGGHGSVYRA---KVPSGEI---FAVKKFHSPLPGEMSFQQE-EFLNEIQALTEIRHR 698
           +G+G  G VY      +  GE     AVK  +       S ++  EFLNE   +      
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNE----SASLRERIEFLNEASVMKGFTCH 80
Query: 699 NIVKFYGFCSHPKHSFIIYEYLESGSLDKILC-------NDASAKELGWTQRLNVIKGVA 751
           ++V+  G  S  + + ++ E +  G L   L        N+         + + +   +A
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG-- 809
           D + YL+   F   VHRD++++N ++   +   + DFG+ + +           G  G  
Sbjct: 141 DGMAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXX---RKGGKGLL 194
Query: 810 ---YVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSR 865
              ++APE       T   D++SFGV+  E+    + P    ++           M    
Sbjct: 195 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP----YQGLSNEQVLKFVMDGGY 250
Query: 866 LPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI 909
           L  P  +  +++  +M++   C   NP  RPT   +  LL + +
Sbjct: 251 LDQPD-NCPERVTDLMRM---CWQFNPNMRPTFLEIVNLLKDDL 290

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/238 (21%), Positives = 100/238 (42%), Gaps = 25/238 (10%)
Query: 684 EFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILC-------NDASAK 736
           EFLNE   +      ++V+  G  S  + + ++ E +  G L   L        N+    
Sbjct: 66  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 125
Query: 737 ELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP 796
                + + +   +AD + YL+   F   VHRD++++N ++   +   + DFG+ + +  
Sbjct: 126 PPTLQEMIQMAAEIADGMAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIY- 181
Query: 797 DSSNWSELAGTH----GYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXX 851
             +++    G       ++APE       T   D++SFGV+  E+    + P    ++  
Sbjct: 182 -ETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP----YQGL 236
Query: 852 XXXXXXXIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI 909
                    M    L  P  +  +++  +M++   C   NP+ RPT   +  LL + +
Sbjct: 237 SNEQVLKFVMDGGYLDQPD-NCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLKDDL 290

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 92/221 (41%), Gaps = 35/221 (15%)
Query: 638 NDFNAEHCIGKGGHGSVYRAKV-PSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
           N F     +GKGG G V   +V  +G+++A KK       +    +   LNE Q L ++ 
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR-IKKRKGEAMALNEKQILEKVN 242
Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAK-------ELGWTQRLNVIKG 749
            R +V               YE  ++  L   L N    K       + G+ +       
Sbjct: 243 SRFVVSLA----------YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPE------- 285
Query: 750 VADALFYLHNNCF-------PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWS 802
            A A+FY    C          IV+RD+  +N+LLD      +SD G+A  + P+     
Sbjct: 286 -ARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHV-PEGQTIK 343
Query: 803 ELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
              GT GY+APE+    + T   D ++ G L  E+I G+ P
Sbjct: 344 GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 110/241 (45%), Gaps = 37/241 (15%)
Query: 622 LTFEGKIVYEEIISATNDFNAEHCIGKGGHGSVYRA------KVPSGEIFAVKKFH--SP 673
           LT + + VY + +   +++     +G G  G V  A      K  +  I + +KF   S 
Sbjct: 135 LTVDDQSVYPKALR--DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSA 192
Query: 674 LPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSL-DKILCN- 731
              + +   E    EI+ L ++ H  I+K   F     + +I+ E +E G L DK++ N 
Sbjct: 193 READPALNVE---TEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNK 248
Query: 732 ---DASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEA---HV 785
              +A+ K L + Q L  ++       YLH N    I+HRD+  +NVLL    E     +
Sbjct: 249 RLKEATCK-LYFYQMLLAVQ-------YLHEN---GIIHRDLKPENVLLSSQEEDCLIKI 297
Query: 786 SDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVT---EKCDVYSFGVLALEVIKGKH 842
           +DFG +K L  ++S    L GT  Y+APE+  ++         D +S GV+    + G  
Sbjct: 298 TDFGHSKILG-ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 356
Query: 843 P 843
           P
Sbjct: 357 P 357

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 110
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 111 DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 166
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKV 821
             I+HRD+   N+ ++   E  + DFG+A+  + + + +     T  Y APE+    +  
Sbjct: 167 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHY 223
Query: 822 TEKCDVYSFGVLALEVIKGK 841
            +  D++S G +  E++ G+
Sbjct: 224 NQTVDIWSVGCIMAELLTGR 243

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 102/218 (46%), Gaps = 35/218 (16%)
Query: 640 FNAEHCIGKGGHGSVYRAKV-PSGEIFAVKKFHSPLPGEMSFQQEEFLN-EIQALTEIRH 697
           +     IG G  G VY+AK+  SGE+ A+KK           Q + F N E+Q + ++ H
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQGKAFKNRELQIMRKLDH 72
Query: 698 RNIVKF-YGFCSHPKHSFIIY-----EYLESGSLDKILCNDASAKELGWTQRLNVIK--- 748
            NIV+  Y F S  +    +Y     +Y+   ++ ++  + + AK     Q L VI    
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAK-----QTLPVIYVKL 126
Query: 749 ---GVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEA-HVSDFGIAKFLNPDSSNWSEL 804
               +  +L Y+H+     I HRDI  +N+LLD       + DFG AK L     N S +
Sbjct: 127 YMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 183
Query: 805 AGTHGYVAPELAY-TLKVTEKCDVYSFGVLALEVIKGK 841
              + Y APEL +     T   DV+S G +  E++ G+
Sbjct: 184 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 88  DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 143
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAY-TLKV 821
             I+HRD+   N+ ++   E  + DFG+A+  + + + +     T  Y APE+    +  
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNAMHY 200
Query: 822 TEKCDVYSFGVLALEVIKGK 841
            +  D++S G +  E++ G+
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 102/218 (46%), Gaps = 35/218 (16%)
Query: 640 FNAEHCIGKGGHGSVYRAKV-PSGEIFAVKKFHSPLPGEMSFQQEEFLN-EIQALTEIRH 697
           +     IG G  G VY+AK+  SGE+ A+KK           Q + F N E+Q + ++ H
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQGKAFKNRELQIMRKLDH 72
Query: 698 RNIVKF-YGFCSHPKHSFIIY-----EYLESGSLDKILCNDASAKELGWTQRLNVIK--- 748
            NIV+  Y F S  +    +Y     +Y+   ++ ++  + + AK     Q L VI    
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAK-----QTLPVIYVKL 126
Query: 749 ---GVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEA-HVSDFGIAKFLNPDSSNWSEL 804
               +  +L Y+H+     I HRDI  +N+LLD       + DFG AK L     N S +
Sbjct: 127 YMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 183
Query: 805 AGTHGYVAPELAY-TLKVTEKCDVYSFGVLALEVIKGK 841
              + Y APEL +     T   DV+S G +  E++ G+
Sbjct: 184 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 92
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 93  DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 148
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKV 821
             I+HRD+   N+ ++   E  + DFG+A+  + + + +     T  Y APE+    +  
Sbjct: 149 ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHY 205
Query: 822 TEKCDVYSFGVLALEVIKGK 841
            +  D++S G +  E++ G+
Sbjct: 206 NQTVDIWSVGCIMAELLTGR 225

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 92
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 93  DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 148
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKV 821
             I+HRD+   N+ ++   E  + DFG+A+  + + + +     T  Y APE+    +  
Sbjct: 149 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHY 205
Query: 822 TEKCDVYSFGVLALEVIKGK 841
            +  D++S G +  E++ G+
Sbjct: 206 NQTVDIWSVGCIMAELLTGR 225

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 98
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 99  DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 154
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKV 821
             I+HRD+   N+ ++   E  + DFG+A+  + + + +     T  Y APE+    +  
Sbjct: 155 ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHY 211
Query: 822 TEKCDVYSFGVLALEVIKGK 841
            +  D++S G +  E++ G+
Sbjct: 212 NQTVDIWSVGCIMAELLTGR 231

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/238 (21%), Positives = 100/238 (42%), Gaps = 25/238 (10%)
Query: 684 EFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILC-------NDASAK 736
           EFLNE   +      ++V+  G  S  + + ++ E +  G L   L        N+    
Sbjct: 65  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 124
Query: 737 ELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP 796
                + + +   +AD + YL+   F   VHRD++++N ++   +   + DFG+ + +  
Sbjct: 125 PPTLQEMIQMAAEIADGMAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIY- 180
Query: 797 DSSNWSELAGTH----GYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXX 851
             +++    G       ++APE       T   D++SFGV+  E+    + P    ++  
Sbjct: 181 -ETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP----YQGL 235
Query: 852 XXXXXXXIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI 909
                    M    L  P  +  +++  +M++   C   NP+ RPT   +  LL + +
Sbjct: 236 SNEQVLKFVMDGGYLDQPD-NCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLKDDL 289

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 88  DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHS--- 143
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKV 821
             I+HRD+   N+ ++   E  + DFG+A+  + + + +     T  Y APE+    +  
Sbjct: 144 ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHY 200
Query: 822 TEKCDVYSFGVLALEVIKGK 841
            +  D++S G +  E++ G+
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 88  DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 143
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKV 821
             I+HRD+   N+ ++   E  + DFG+A+  + + + +     T  Y APE+    +  
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHY 200
Query: 822 TEKCDVYSFGVLALEVIKGK 841
            +  D++S G +  E++ G+
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 85
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 86  DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 141
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKV 821
             I+HRD+   N+ ++   E  + DFG+A+  + + + +     T  Y APE+    +  
Sbjct: 142 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHY 198
Query: 822 TEKCDVYSFGVLALEVIKGK 841
            +  D++S G +  E++ G+
Sbjct: 199 NQTVDIWSVGCIMAELLTGR 218

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 93
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 94  DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 149
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKV 821
             I+HRD+   N+ ++   E  + DFG+A+  + + + +     T  Y APE+    +  
Sbjct: 150 ADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHY 206
Query: 822 TEKCDVYSFGVLALEVIKGK 841
            +  D++S G +  E++ G+
Sbjct: 207 NQTVDIWSVGCIMAELLTGR 226

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 93
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 94  DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 149
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKV 821
             I+HRD+   N+ ++   E  + DFG+A+  + + + +     T  Y APE+    +  
Sbjct: 150 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHY 206
Query: 822 TEKCDVYSFGVLALEVIKGK 841
            +  D++S G +  E++ G+
Sbjct: 207 NQTVDIWSVGCIMAELLTGR 226

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 88  DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 143
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKV 821
             I+HRD+   N+ ++   E  + DFG+A+  + + + +     T  Y APE+    +  
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHY 200
Query: 822 TEKCDVYSFGVLALEVIKGK 841
            +  D++S G +  E++ G+
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 88/200 (44%), Gaps = 13/200 (6%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N     +L       +I  +   L Y+H+   
Sbjct: 84  DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGLKYIHS--- 139
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKV 821
             I+HRD+   N+ ++   E  + DFG+A+  + + + +     T  Y APE+    +  
Sbjct: 140 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHY 196
Query: 822 TEKCDVYSFGVLALEVIKGK 841
            +  D++S G +  E++ G+
Sbjct: 197 NQTVDIWSVGCIMAELLTGR 216

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 84  DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 139
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKV 821
             I+HRD+   N+ ++   E  + DFG+A+  + + + +     T  Y APE+    +  
Sbjct: 140 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHY 196
Query: 822 TEKCDVYSFGVLALEVIKGK 841
            +  D++S G +  E++ G+
Sbjct: 197 NQTVDIWSVGCIMAELLTGR 216

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 88  DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 143
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKV 821
             I+HRD+   N+ ++   E  + DFG+A+  + + + +     T  Y APE+    +  
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHY 200
Query: 822 TEKCDVYSFGVLALEVIKGK 841
            +  D++S G +  E++ G+
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 92/221 (41%), Gaps = 35/221 (15%)
Query: 638 NDFNAEHCIGKGGHGSVYRAKV-PSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
           N F     +GKGG G V   +V  +G+++A KK       +    +   LNE Q L ++ 
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR-IKKRKGEAMALNEKQILEKVN 242
Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAK-------ELGWTQRLNVIKG 749
            R +V               YE  ++  L   L N    K       + G+ +       
Sbjct: 243 SRFVVSLA----------YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPE------- 285
Query: 750 VADALFYLHNNCF-------PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWS 802
            A A+FY    C          IV+RD+  +N+LLD      +SD G+A  + P+     
Sbjct: 286 -ARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHV-PEGQTIK 343
Query: 803 ELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
              GT GY+APE+    + T   D ++ G L  E+I G+ P
Sbjct: 344 GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 99
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 100 DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 155
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKV 821
             I+HRD+   N+ ++   E  + DFG+A+  + + + +     T  Y APE+    +  
Sbjct: 156 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHY 212
Query: 822 TEKCDVYSFGVLALEVIKGK 841
            +  D++S G +  E++ G+
Sbjct: 213 NQTVDIWSVGCIMAELLTGR 232

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 82/168 (48%), Gaps = 24/168 (14%)
Query: 687 NEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSL-DKILCN----DASAKELGWT 741
            EI+ L ++ H  I+K   F     + +I+ E +E G L DK++ N    +A+ K L + 
Sbjct: 189 TEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCK-LYFY 246
Query: 742 QRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEA---HVSDFGIAKFLNPDS 798
           Q L  ++       YLH N    I+HRD+  +NVLL    E     ++DFG +K L  ++
Sbjct: 247 QMLLAVQ-------YLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ET 295
Query: 799 SNWSELAGTHGYVAPELAYTLKVT---EKCDVYSFGVLALEVIKGKHP 843
           S    L GT  Y+APE+  ++         D +S GV+    + G  P
Sbjct: 296 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 88  DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 143
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKV 821
             I+HRD+   N+ ++   E  + DFG+A+  + + + +     T  Y APE+    +  
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHY 200
Query: 822 TEKCDVYSFGVLALEVIKGK 841
            +  D++S G +  E++ G+
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 107
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 108 DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 163
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKV 821
             I+HRD+   N+ ++   E  + DFG+A+  + + + +     T  Y APE+    +  
Sbjct: 164 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHY 220
Query: 822 TEKCDVYSFGVLALEVIKGK 841
            +  D++S G +  E++ G+
Sbjct: 221 NQTVDIWSVGCIMAELLTGR 240

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 84
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 85  DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 140
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKV 821
             I+HRD+   N+ ++   E  + DFG+A+  + + + +     T  Y APE+    +  
Sbjct: 141 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHY 197
Query: 822 TEKCDVYSFGVLALEVIKGK 841
            +  D++S G +  E++ G+
Sbjct: 198 NQTVDIWSVGCIMAELLTGR 217

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 97/218 (44%), Gaps = 24/218 (11%)
Query: 637 TNDFNAEHCIGKGGHGSVYRAKVPSG-EIFAVK---KFHSPLPGEMSFQQEEFLNEIQAL 692
             D+     IG+G  G V   +  S  +++A+K   KF      + +F  EE   +I A 
Sbjct: 73  AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE--RDIMAF 130
Query: 693 TEIRHRNIVK-FYGFCSHPKHSFIIYEYLESGSLDKILCN-DASAKELGWTQRLNVIKGV 750
                  +V+ FY F    ++ +++ EY+  G L  ++ N D   K   W +       V
Sbjct: 131 ANSPW--VVQLFYAF-QDDRYLYMVMEYMPGGDLVNLMSNYDVPEK---WARFYTA--EV 182
Query: 751 ADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELA-GTHG 809
             AL  +H+  F   +HRD+   N+LLD      ++DFG    +N +     + A GT  
Sbjct: 183 VLALDAIHSMGF---IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 239
Query: 810 YVAPELAYTLK----VTEKCDVYSFGVLALEVIKGKHP 843
           Y++PE+  +         +CD +S GV   E++ G  P
Sbjct: 240 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 88  DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 143
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKV 821
             I+HRD+   N+ ++   E  + DFG+A+  + + + +     T  Y APE+    +  
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHY 200
Query: 822 TEKCDVYSFGVLALEVIKGK 841
            +  D++S G +  E++ G+
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 89
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 90  DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 145
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKV 821
             I+HRD+   N+ ++   E  + DFG+A+  + + + +     T  Y APE+    +  
Sbjct: 146 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHY 202
Query: 822 TEKCDVYSFGVLALEVIKGK 841
            +  D++S G +  E++ G+
Sbjct: 203 NQTVDIWSVGCIMAELLTGR 222

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 96/225 (42%), Gaps = 21/225 (9%)
Query: 631 EEIISATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVK---KFHSPLPGEMSFQQEEFL 686
           +E+    +DF     IG+G    V   K+  +G+++A+K   K+     GE+S     F 
Sbjct: 54  KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSC----FR 109
Query: 687 NEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNV 746
            E   L     R I + +       + +++ EY   G L  +L      + +        
Sbjct: 110 EERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSK--FGERIPAEMARFY 167
Query: 747 IKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELA- 805
           +  +  A+  +H   +   VHRDI   N+LLD      ++DFG    L  D +  S +A 
Sbjct: 168 LAEIVMAIDSVHRLGY---VHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV 224
Query: 806 GTHGYVAPELAYTLKVTE-------KCDVYSFGVLALEVIKGKHP 843
           GT  Y++PE+   +           +CD ++ GV A E+  G+ P
Sbjct: 225 GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 88  DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 143
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKV 821
             I+HRD+   N+ ++   E  + DFG+A+  + + + +     T  Y APE+    +  
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHY 200
Query: 822 TEKCDVYSFGVLALEVIKGK 841
            +  D++S G +  E++ G+
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 92
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 93  DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 148
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKV 821
             I+HRD+   N+ ++   E  + DFG+A+  + + + +     T  Y APE+    +  
Sbjct: 149 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHY 205
Query: 822 TEKCDVYSFGVLALEVIKGK 841
            +  D++S G +  E++ G+
Sbjct: 206 NQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 86
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 87  DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 142
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKV 821
             I+HRD+   N+ ++   E  + DFG+A+  + + + +     T  Y APE+    +  
Sbjct: 143 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHY 199
Query: 822 TEKCDVYSFGVLALEVIKGK 841
            +  D++S G +  E++ G+
Sbjct: 200 NQTVDIWSVGCIMAELLTGR 219

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 106
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 107 DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 162
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKV 821
             I+HRD+   N+ ++   E  + DFG+A+  + + + +     T  Y APE+    +  
Sbjct: 163 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHY 219
Query: 822 TEKCDVYSFGVLALEVIKGK 841
            +  D++S G +  E++ G+
Sbjct: 220 NQTVDIWSVGCIMAELLTGR 239

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 84
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 85  DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 140
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKV 821
             I+HRD+   N+ ++   E  + DFG+A+  + + + +     T  Y APE+    +  
Sbjct: 141 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHY 197
Query: 822 TEKCDVYSFGVLALEVIKGK 841
            +  D++S G +  E++ G+
Sbjct: 198 NQTVDIWSVGCIMAELLTGR 217

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 89
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 90  DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 145
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKV 821
             I+HRD+   N+ ++   E  + DFG+A+  + + + +     T  Y APE+    +  
Sbjct: 146 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHY 202
Query: 822 TEKCDVYSFGVLALEVIKGK 841
            +  D++S G +  E++ G+
Sbjct: 203 NQTVDIWSVGCIMAELLTGR 222

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 99
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 100 DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 155
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKV 821
             I+HRD+   N+ ++   E  + DFG+A+  + + + +     T  Y APE+    +  
Sbjct: 156 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHY 212
Query: 822 TEKCDVYSFGVLALEVIKGK 841
            +  D++S G +  E++ G+
Sbjct: 213 NQTVDIWSVGCIMAELLTGR 232

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 89
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 90  DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 145
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKV 821
             I+HRD+   N+ ++   E  + DFG+A+  + + + +     T  Y APE+    +  
Sbjct: 146 ADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHY 202
Query: 822 TEKCDVYSFGVLALEVIKGK 841
            +  D++S G +  E++ G+
Sbjct: 203 NQTVDIWSVGCIMAELLTGR 222

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 95  DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 150
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKV 821
             I+HRD+   N+ ++   E  + DFG+A+  + + + +     T  Y APE+    +  
Sbjct: 151 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHY 207
Query: 822 TEKCDVYSFGVLALEVIKGK 841
            +  D++S G +  E++ G+
Sbjct: 208 NQTVDIWSVGCIMAELLTGR 227

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 99
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 100 DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 155
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKV 821
             I+HRD+   N+ ++   E  + DFG+A+  + + + +     T  Y APE+    +  
Sbjct: 156 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHY 212
Query: 822 TEKCDVYSFGVLALEVIKGK 841
            +  D++S G +  E++ G+
Sbjct: 213 NQTVDIWSVGCIMAELLTGR 232

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/239 (21%), Positives = 103/239 (43%), Gaps = 27/239 (11%)
Query: 684 EFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILC-------NDASAK 736
           EFLNE   +      ++V+  G  S  + + ++ E +  G L   L        N+    
Sbjct: 66  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 125
Query: 737 ELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP 796
                + + +   +AD + YL+   F   VHRD++++N ++   +   + DFG+ + +  
Sbjct: 126 PPTLQEMIQMAAEIADGMAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIY- 181
Query: 797 DSSNWSELAGTHG-----YVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEX 850
           +++ + +  G  G     ++APE       T   D++SFGV+  E+    + P    ++ 
Sbjct: 182 ETAYYRK--GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP----YQG 235
Query: 851 XXXXXXXXIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI 909
                     M    L  P  +  +++  +M++   C   NP+ RPT   +  LL + +
Sbjct: 236 LSNEQVLKFVMDGGYLDQPD-NCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLKDDL 290

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 88  DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 143
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKV 821
             I+HRD+   N+ ++   E  + DFG+A+  + + + +     T  Y APE+    +  
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHY 200
Query: 822 TEKCDVYSFGVLALEVIKGK 841
            +  D++S G +  E++ G+
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 41/170 (24%), Positives = 80/170 (47%), Gaps = 19/170 (11%)
Query: 684 EFLNEIQALTEI-RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKIL------------- 729
           + ++E++ +  I +H+NI+   G C+     ++I EY   G+L + L             
Sbjct: 120 DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYN 179
Query: 730 CNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFG 789
            +    ++L     ++    VA  + YL +      +HRD++++NVL+       ++DFG
Sbjct: 180 PSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFG 236
Query: 790 IAKFLNPDSSNWSELAGT--HGYVAPELAYTLKVTEKCDVYSFGVLALEV 837
           +A+ ++          G     ++APE  +    T + DV+SFGVL  E+
Sbjct: 237 LARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 286

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 92/217 (42%), Gaps = 19/217 (8%)
Query: 638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI- 695
            DF+    IG+G +  V   ++  +  I+A++     L        +E ++ +Q    + 
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKEL-----VNDDEDIDWVQTEKHVF 106
Query: 696 ----RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVA 751
                H  +V  +         F + EY+  G L   + +    ++L           ++
Sbjct: 107 EQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEIS 163
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK-FLNPDSSNWSELAGTHGY 810
            AL YLH      I++RD+   NVLLD      ++D+G+ K  L P  +  S   GT  Y
Sbjct: 164 LALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT-STFCGTPNY 219
Query: 811 VAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFL 847
           +APE+          D ++ GVL  E++ G+ P D +
Sbjct: 220 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 256

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 89
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 90  DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 145
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKV 821
             I+HRD+   N+ ++   E  + DFG+A+  + + + +     T  Y APE+    +  
Sbjct: 146 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHY 202
Query: 822 TEKCDVYSFGVLALEVIKGK 841
            +  D++S G +  E++ G+
Sbjct: 203 NQTVDIWSVGCIMAELLTGR 222

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 24/216 (11%)
Query: 639 DFNAEHCIGKGGHGSVYRAKVPSG-EIFAVK---KFHSPLPGEMSFQQEEFLNEIQALTE 694
           D+     IG+G  G V   +  S  +++A+K   KF      + +F  EE   +I A   
Sbjct: 70  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE--RDIMAFAN 127
Query: 695 IRHRNIVK-FYGFCSHPKHSFIIYEYLESGSLDKILCN-DASAKELGWTQRLNVIKGVAD 752
                +V+ FY F    ++ +++ EY+  G L  ++ N D   K   W +       V  
Sbjct: 128 SPW--VVQLFYAF-QDDRYLYMVMEYMPGGDLVNLMSNYDVPEK---WARFYTA--EVVL 179
Query: 753 ALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELA-GTHGYV 811
           AL  +H+  F   +HRD+   N+LLD      ++DFG    +N +     + A GT  Y+
Sbjct: 180 ALDAIHSMGF---IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI 236
Query: 812 APELAYTLK----VTEKCDVYSFGVLALEVIKGKHP 843
           +PE+  +         +CD +S GV   E++ G  P
Sbjct: 237 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 114/243 (46%), Gaps = 38/243 (15%)
Query: 620 SVLTFEGKIVYEEIISATNDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEM 678
           S  +F G+  +E++     D      +G+G H  V     + + + +AVK      PG +
Sbjct: 2   STDSFSGR--FEDVYQLQEDV-----LGEGAHARVQTCINLITSQEYAVKIIEKQ-PGHI 53
Query: 679 S---FQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASA 735
               F++ E L + Q      HRN+++   F       ++++E +  GS   IL +    
Sbjct: 54  RSRVFREVEMLYQCQG-----HRNVLELIEFFEEEDRFYLVFEKMRGGS---ILSHIHKR 105
Query: 736 KELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYE---AHVSDFGIAK 792
           +     +   V++ VA AL +LHN     I HRD+  +N+L +   +     + DFG+  
Sbjct: 106 RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFGLGS 162
Query: 793 --FLNPDSSNWS--EL---AGTHGYVAPEL--AYTLKVT---EKCDVYSFGVLALEVIKG 840
              LN D S  S  EL    G+  Y+APE+  A++ + +   ++CD++S GV+   ++ G
Sbjct: 163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222
Query: 841 KHP 843
             P
Sbjct: 223 YPP 225

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 98
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 99  DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 154
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKV 821
             I+HRD+   N+ ++   E  + DFG+A+  + + + +     T  Y APE+    +  
Sbjct: 155 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHY 211
Query: 822 TEKCDVYSFGVLALEVIKGK 841
            +  D++S G +  E++ G+
Sbjct: 212 NQTVDIWSVGCIMAELLTGR 231

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 24/216 (11%)
Query: 639 DFNAEHCIGKGGHGSVYRAKVPSG-EIFAVK---KFHSPLPGEMSFQQEEFLNEIQALTE 694
           D+     IG+G  G V   +  S  +++A+K   KF      + +F  EE   +I A   
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE--RDIMAFAN 132
Query: 695 IRHRNIVK-FYGFCSHPKHSFIIYEYLESGSLDKILCN-DASAKELGWTQRLNVIKGVAD 752
                +V+ FY F    ++ +++ EY+  G L  ++ N D   K   W +       V  
Sbjct: 133 SPW--VVQLFYAF-QDDRYLYMVMEYMPGGDLVNLMSNYDVPEK---WARFYTA--EVVL 184
Query: 753 ALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELA-GTHGYV 811
           AL  +H+  F   +HRD+   N+LLD      ++DFG    +N +     + A GT  Y+
Sbjct: 185 ALDAIHSMGF---IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI 241
Query: 812 APELAYTLK----VTEKCDVYSFGVLALEVIKGKHP 843
           +PE+  +         +CD +S GV   E++ G  P
Sbjct: 242 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 88  DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHS--- 143
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKV 821
             I+HRD+   N+ ++   E  + DFG+A+  + + + +     T  Y APE+    +  
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHY 200
Query: 822 TEKCDVYSFGVLALEVIKGK 841
            +  D++S G +  E++ G+
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 93
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 94  DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 149
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKV 821
             I+HRD+   N+ ++   E  + DFG+A+  + + + +     T  Y APE+    +  
Sbjct: 150 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHY 206
Query: 822 TEKCDVYSFGVLALEVIKGK 841
            +  D++S G +  E++ G+
Sbjct: 207 NQTVDIWSVGCIMAELLTGR 226

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/168 (32%), Positives = 77/168 (45%), Gaps = 18/168 (10%)
Query: 683 EEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELG--- 739
           E    EI     +RH NIV+F      P H  I+ EY   G L + +CN     E     
Sbjct: 60  ENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 119
Query: 740 WTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEA---HVSDFGIAKFLNP 796
           + Q+L  I GV+    Y H      + HRD+  +N LLD G  A    ++DFG +K    
Sbjct: 120 FFQQL--ISGVS----YAHAMQ---VAHRDLKLENTLLD-GSPAPRLKIADFGYSKASVL 169
Query: 797 DSSNWSELAGTHGYVAPELAYTLKVTEK-CDVYSFGVLALEVIKGKHP 843
            S   S + GT  Y+APE+    +   K  DV+S GV    ++ G +P
Sbjct: 170 HSQPKSAV-GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP 216

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 91/207 (43%), Gaps = 26/207 (12%)
Query: 646 IGKGGHG--SVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKF 703
           IG G  G   + R K  S E+ AVK       GE     E    EI     +RH NIV+F
Sbjct: 26  IGSGNFGVARLMRDK-QSNELVAVKYIER---GEKI--DENVKREIINHRSLRHPNIVRF 79
Query: 704 YGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELG---WTQRLNVIKGVADALFYLHNN 760
                 P H  I+ EY   G L + +CN     E     + Q+L  I GV+    Y H  
Sbjct: 80  KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL--ISGVS----YCHAM 133
Query: 761 CFPPIVHRDISSKNVLLDLGYEA---HVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAY 817
               + HRD+  +N LLD G  A    + DFG +K     S   S + GT  Y+APE+  
Sbjct: 134 ---QVCHRDLKLENTLLD-GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLL 188
Query: 818 TLKVTEK-CDVYSFGVLALEVIKGKHP 843
             +   K  DV+S GV    ++ G +P
Sbjct: 189 KKEYDGKVADVWSCGVTLYVMLVGAYP 215

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 96/227 (42%), Gaps = 25/227 (11%)
Query: 683 EEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQ 742
           E F      ++++ H+++V  YG C     + ++ E+++ GSLD  L  + +   + W  
Sbjct: 57  ESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW-- 114
Query: 743 RLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSS--- 799
           +L V K +A A+ +L  N    ++H ++ +KN+LL    +    +    K  +P  S   
Sbjct: 115 KLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV 171
Query: 800 -NWSELAGTHGYVAPELAYTLK-VTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXX 856
                L     +V PE     K +    D +SFG    E+   G  P   L         
Sbjct: 172 LPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL------DSQ 225
Query: 857 XXIEMLDSR--LPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
             ++  + R  LP P      K   +  +  +C+D  P+ RP+ + +
Sbjct: 226 RKLQFYEDRHQLPAP------KAAELANLINNCMDYEPDHRPSFRAI 266

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 41/170 (24%), Positives = 80/170 (47%), Gaps = 19/170 (11%)
Query: 684 EFLNEIQALTEI-RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKIL------------- 729
           + ++E++ +  I +H+NI+   G C+     ++I EY   G+L + L             
Sbjct: 79  DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYN 138
Query: 730 CNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFG 789
            +    ++L     ++    VA  + YL +      +HRD++++NVL+       ++DFG
Sbjct: 139 PSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFG 195
Query: 790 IAKFLNPDSSNWSELAGT--HGYVAPELAYTLKVTEKCDVYSFGVLALEV 837
           +A+ ++          G     ++APE  +    T + DV+SFGVL  E+
Sbjct: 196 LARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 97/223 (43%), Gaps = 28/223 (12%)
Query: 638 NDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQ-----EEFLNEIQA 691
            ++  +  +G+G    V R    P+ + +AVK       G  S ++     E  L E+  
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 692 LTEIR-HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGV 750
           L ++  H NI++           F++++ ++ G L   L    +  E    +   +++ +
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE---KETRKIMRAL 133
Query: 751 ADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGY 810
            + +  LH      IVHRD+  +N+LLD      ++DFG +  L+P       + GT  Y
Sbjct: 134 LEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP-GEKLRSVCGTPSY 189
Query: 811 VAPEL----------AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           +APE+           Y  +V    D++S GV+   ++ G  P
Sbjct: 190 LAPEIIECSMNDNHPGYGKEV----DMWSTGVIMYTLLAGSPP 228

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 62/280 (22%), Positives = 113/280 (40%), Gaps = 38/280 (13%)
Query: 646 IGKGGHGSVYRAK---VPSGEI---FAVKKFHSPLPGEMSFQQE-EFLNEIQALTEIRHR 698
           +G+G  G VY      +  GE     AVK  +       S ++  EFLNE   +      
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNE----SASLRERIEFLNEASVMKGFTCH 77
Query: 699 NIVKFYGFCSHPKHSFIIYEYLESGSLDKILC-------NDASAKELGWTQRLNVIKGVA 751
           ++V+  G  S  + + ++ E +  G L   L        N+         + + +   +A
Sbjct: 78  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 137
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG-- 809
           D + YL+   F   VHRD++++N ++   +   + DFG+ + +           G  G  
Sbjct: 138 DGMAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIXETD---XXRKGGKGLL 191
Query: 810 ---YVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSR 865
              ++APE       T   D++SFGV+  E+    + P    ++           M    
Sbjct: 192 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP----YQGLSNEQVLKFVMDGGY 247
Query: 866 LPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
           L  P  +  +++  +M++   C   NP+ RPT   +  LL
Sbjct: 248 LDQPD-NCPERVTDLMRM---CWQFNPKMRPTFLEIVNLL 283

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/170 (24%), Positives = 80/170 (47%), Gaps = 19/170 (11%)
Query: 684 EFLNEIQALTEI-RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKIL------------- 729
           + ++E++ +  I +H+NI+   G C+     ++I EY   G+L + L             
Sbjct: 79  DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYN 138
Query: 730 CNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFG 789
            +    ++L     ++    VA  + YL +      +HRD++++NVL+       ++DFG
Sbjct: 139 PSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFG 195
Query: 790 IAKFLNPDSSNWSELAGT--HGYVAPELAYTLKVTEKCDVYSFGVLALEV 837
           +A+ ++          G     ++APE  +    T + DV+SFGVL  E+
Sbjct: 196 LARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 89/207 (42%), Gaps = 14/207 (6%)
Query: 640 FNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRN 699
           +  E+ IG+G  G V   K+   +   +++    +P       + F  EI+ +  + H N
Sbjct: 28  YTLENTIGRGSWGEV---KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 84
Query: 700 IVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHN 759
           I++ Y         +++ E    G L + + +    +E   +    ++K V  A+ Y H 
Sbjct: 85  IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRE---SDAARIMKDVLSAVAYCHK 141
Query: 760 NCFPPIVHRDISSKNVLL---DLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELA 816
                + HRD+  +N L           + DFG+A    P     +++ GT  YV+P++ 
Sbjct: 142 LN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV-GTPYYVSPQVL 197
Query: 817 YTLKVTEKCDVYSFGVLALEVIKGKHP 843
             L   E CD +S GV+   ++ G  P
Sbjct: 198 EGLYGPE-CDEWSAGVMMYVLLCGYPP 223

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/170 (24%), Positives = 80/170 (47%), Gaps = 19/170 (11%)
Query: 684 EFLNEIQALTEI-RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKIL------------- 729
           + ++E++ +  I +H+NI+   G C+     ++I EY   G+L + L             
Sbjct: 72  DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYN 131
Query: 730 CNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFG 789
            +    ++L     ++    VA  + YL +      +HRD++++NVL+       ++DFG
Sbjct: 132 PSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFG 188
Query: 790 IAKFLNPDSSNWSELAGT--HGYVAPELAYTLKVTEKCDVYSFGVLALEV 837
           +A+ ++          G     ++APE  +    T + DV+SFGVL  E+
Sbjct: 189 LARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 238

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 88/200 (44%), Gaps = 13/200 (6%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 110
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 111 DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 166
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKV 821
             I+HRD+   N+ ++   E  + DFG+A+  + +   +     T  Y APE+    +  
Sbjct: 167 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGY---VATRWYRAPEIMLNWMHY 223
Query: 822 TEKCDVYSFGVLALEVIKGK 841
            +  D++S G +  E++ G+
Sbjct: 224 NQTVDIWSVGCIMAELLTGR 243

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 87/200 (43%), Gaps = 13/200 (6%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 107
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 108 DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 163
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKV 821
             I+HRD+   N+ ++   E  + DFG+A+  + +         T  Y APE+    +  
Sbjct: 164 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXG---XVATRWYRAPEIMLNWMHY 220
Query: 822 TEKCDVYSFGVLALEVIKGK 841
            +  D++S G +  E++ G+
Sbjct: 221 NQTVDIWSVGCIMAELLTGR 240

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 89/207 (42%), Gaps = 14/207 (6%)
Query: 640 FNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRN 699
           +  E+ IG+G  G V   K+   +   +++    +P       + F  EI+ +  + H N
Sbjct: 11  YTLENTIGRGSWGEV---KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 700 IVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHN 759
           I++ Y         +++ E    G L + + +    +E   +    ++K V  A+ Y H 
Sbjct: 68  IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRE---SDAARIMKDVLSAVAYCHK 124
Query: 760 NCFPPIVHRDISSKNVLL---DLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELA 816
                + HRD+  +N L           + DFG+A    P     +++ GT  YV+P++ 
Sbjct: 125 LN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV-GTPYYVSPQVL 180
Query: 817 YTLKVTEKCDVYSFGVLALEVIKGKHP 843
             L   E CD +S GV+   ++ G  P
Sbjct: 181 EGLYGPE-CDEWSAGVMMYVLLCGYPP 206

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/170 (24%), Positives = 80/170 (47%), Gaps = 19/170 (11%)
Query: 684 EFLNEIQALTEI-RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKIL------------- 729
           + ++E++ +  I +H+NI+   G C+     ++I EY   G+L + L             
Sbjct: 71  DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYN 130
Query: 730 CNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFG 789
            +    ++L     ++    VA  + YL +      +HRD++++NVL+       ++DFG
Sbjct: 131 PSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFG 187
Query: 790 IAKFLNPDSSNWSELAGT--HGYVAPELAYTLKVTEKCDVYSFGVLALEV 837
           +A+ ++          G     ++APE  +    T + DV+SFGVL  E+
Sbjct: 188 LARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 237

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/170 (24%), Positives = 80/170 (47%), Gaps = 19/170 (11%)
Query: 684 EFLNEIQALTEI-RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKIL------------- 729
           + ++E++ +  I +H+NI+   G C+     ++I EY   G+L + L             
Sbjct: 68  DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYN 127
Query: 730 CNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFG 789
            +    ++L     ++    VA  + YL +      +HRD++++NVL+       ++DFG
Sbjct: 128 PSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFG 184
Query: 790 IAKFLNPDSSNWSELAGT--HGYVAPELAYTLKVTEKCDVYSFGVLALEV 837
           +A+ ++          G     ++APE  +    T + DV+SFGVL  E+
Sbjct: 185 LARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 234

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 88/200 (44%), Gaps = 13/200 (6%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 88  DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 143
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKV 821
             I+HRD+   N+ ++   E  + DFG+A+  + + +       T  Y APE+    +  
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG---XVATRWYRAPEIMLNWMHY 200
Query: 822 TEKCDVYSFGVLALEVIKGK 841
            +  D++S G +  E++ G+
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 3/94 (3%)
Query: 750 VADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG 809
           +A  LF+L +     I++RD+   NV+LD      ++DFG+ K    D        GT  
Sbjct: 130 IAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPD 186
Query: 810 YVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           Y+APE+       +  D ++FGVL  E++ G+ P
Sbjct: 187 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220

>pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 68/144 (47%), Gaps = 5/144 (3%)
Query: 392 QLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLN 451
           +L N+ YL    L+GN+L          L NL+ L L  N L +        L  L YLN
Sbjct: 83  ELTNLTYL---ILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLN 139
Query: 452 LSHNKLSQQIPIEL-DNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIP 510
           L+HN+L Q +P  + D L +L+ELDLS+N L         ++  L+ L L  N L  +  
Sbjct: 140 LAHNQL-QSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPD 198
Query: 511 RCFEEMHGLLHIDISYNKLEGQIP 534
             F+ +  L +I +  N  +   P
Sbjct: 199 GVFDRLTSLQYIWLHDNPWDCTCP 222

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 100/236 (42%), Gaps = 19/236 (8%)
Query: 645 CIGKGGHGSVYRAKVPSG----EIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRN- 699
            +G G +G V+  +  SG    +++A+K        + +   E    E Q L  IR    
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 700 -IVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKG-VADALFYL 757
            +   Y F +  K   I+ +Y+  G L        S +E      + +  G +  AL +L
Sbjct: 121 LVTLHYAFQTETKLHLIL-DYINGGEL----FTHLSQRERFTEHEVQIYVGEIVLALEHL 175
Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK-FLNPDSSNWSELAGTHGYVAPELA 816
           H      I++RDI  +N+LLD      ++DFG++K F+  ++    +  GT  Y+AP++ 
Sbjct: 176 HKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 232
Query: 817 YTLKV--TEKCDVYSFGVLALEVIKGKHPRDFLFEXXXXXXXXXIEMLDSRLPYPS 870
                   +  D +S GVL  E++ G  P     E           +L S  PYP 
Sbjct: 233 RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR-RILKSEPPYPQ 287

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 87/205 (42%), Gaps = 14/205 (6%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQ---QEEFLNEIQALTEIRHRNIVK 702
           +G G    V + +  S  +    KF        S +   +EE   E+  L ++ H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 703 FYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
            +    +     +I E +  G L   L    S  E   T   + IK + D + YLH    
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT---SFIKQILDGVNYLHTK-- 134
Query: 763 PPIVHRDISSKNV-LLDLGYE-AHVS--DFGIAKFLNPDSSNWSELAGTHGYVAPELAYT 818
             I H D+  +N+ LLD      H+   DFG+A  +  D   +  + GT  +VAPE+   
Sbjct: 135 -KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKNIFGTPEFVAPEIVNY 192
Query: 819 LKVTEKCDVYSFGVLALEVIKGKHP 843
             +  + D++S GV+   ++ G  P
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASP 217

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/200 (23%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 88  DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 143
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKV 821
             I+HRD+   N+ ++   E  + D+G+A+  + + + +     T  Y APE+    +  
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGY---VATRWYRAPEIMLNWMHY 200
Query: 822 TEKCDVYSFGVLALEVIKGK 841
            +  D++S G +  E++ G+
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 88/200 (44%), Gaps = 13/200 (6%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 95  DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 150
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKV 821
             I+HRD+   N+ ++   E  + DFG+A+    + + +     T  Y APE+    +  
Sbjct: 151 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY---VATRWYRAPEIMLNWMHY 207
Query: 822 TEKCDVYSFGVLALEVIKGK 841
            +  D++S G +  E++ G+
Sbjct: 208 NQTVDIWSVGCIMAELLTGR 227

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/200 (23%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N   +++L       +I  +   L Y+H+   
Sbjct: 88  DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHS--- 143
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKV 821
             I+HRD+   N+ ++   E  + DFG+ +  + + + +     T  Y APE+    +  
Sbjct: 144 ADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGY---VATRWYRAPEIMLNWMHY 200
Query: 822 TEKCDVYSFGVLALEVIKGK 841
            +  D++S G +  E++ G+
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 75/166 (45%), Gaps = 11/166 (6%)
Query: 682 QEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWT 741
           +EE   E+  L ++ H N++  +    +     +I E +  G L   L    S  E   T
Sbjct: 59  REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT 118
Query: 742 QRLNVIKGVADALFYLHNNCFPPIVHRDISSKNV-LLDLGYE-AHVS--DFGIAKFLNPD 797
              + IK + D + YLH      I H D+  +N+ LLD      H+   DFG+A  +  D
Sbjct: 119 ---SFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-D 171
Query: 798 SSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
              +  + GT  +VAPE+     +  + D++S GV+   ++ G  P
Sbjct: 172 GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 87/205 (42%), Gaps = 14/205 (6%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQ---QEEFLNEIQALTEIRHRNIVK 702
           +G G    V + +  S  +    KF        S +   +EE   E+  L ++ H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 703 FYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
            +    +     +I E +  G L   L    S  E   T   + IK + D + YLH    
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT---SFIKQILDGVNYLHTK-- 134
Query: 763 PPIVHRDISSKNV-LLDLGYE-AHVS--DFGIAKFLNPDSSNWSELAGTHGYVAPELAYT 818
             I H D+  +N+ LLD      H+   DFG+A  +  D   +  + GT  +VAPE+   
Sbjct: 135 -KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKNIFGTPEFVAPEIVNY 192
Query: 819 LKVTEKCDVYSFGVLALEVIKGKHP 843
             +  + D++S GV+   ++ G  P
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASP 217

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 88/200 (44%), Gaps = 13/200 (6%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 95  DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 150
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKV 821
             I+HRD+   N+ ++   E  + DFG+A+    + + +     T  Y APE+    +  
Sbjct: 151 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY---VATRWYRAPEIMLNWMHY 207
Query: 822 TEKCDVYSFGVLALEVIKGK 841
            +  D++S G +  E++ G+
Sbjct: 208 NQTVDIWSVGCIMAELLTGR 227

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 87/205 (42%), Gaps = 14/205 (6%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQ---QEEFLNEIQALTEIRHRNIVK 702
           +G G    V + +  S  +    KF        S +   +EE   E+  L ++ H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 703 FYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
            +    +     +I E +  G L   L    S  E   T   + IK + D + YLH    
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT---SFIKQILDGVNYLHTK-- 134
Query: 763 PPIVHRDISSKNV-LLDLGYE-AHVS--DFGIAKFLNPDSSNWSELAGTHGYVAPELAYT 818
             I H D+  +N+ LLD      H+   DFG+A  +  D   +  + GT  +VAPE+   
Sbjct: 135 -KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKNIFGTPEFVAPEIVNY 192
Query: 819 LKVTEKCDVYSFGVLALEVIKGKHP 843
             +  + D++S GV+   ++ G  P
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASP 217

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 88/200 (44%), Gaps = 13/200 (6%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 95  DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 150
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKV 821
             I+HRD+   N+ ++   E  + DFG+A+    + + +     T  Y APE+    +  
Sbjct: 151 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY---VATRWYRAPEIMLNWMHY 207
Query: 822 TEKCDVYSFGVLALEVIKGK 841
            +  D++S G +  E++ G+
Sbjct: 208 NQTVDIWSVGCIMAELLTGR 227

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 75/166 (45%), Gaps = 11/166 (6%)
Query: 682 QEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWT 741
           +EE   E+  L ++ H N++  +    +     +I E +  G L   L    S  E   T
Sbjct: 59  REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT 118
Query: 742 QRLNVIKGVADALFYLHNNCFPPIVHRDISSKNV-LLDLGYE-AHVS--DFGIAKFLNPD 797
              + IK + D + YLH      I H D+  +N+ LLD      H+   DFG+A  +  D
Sbjct: 119 ---SFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-D 171
Query: 798 SSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
              +  + GT  +VAPE+     +  + D++S GV+   ++ G  P
Sbjct: 172 GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 108/231 (46%), Gaps = 40/231 (17%)
Query: 633 IISATNDFNAEHCIGKGGHGS-VYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQA 691
           +I     F  +  +G G  G+ VYR    + ++ AVK+    LP   SF       E+Q 
Sbjct: 19  VIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDV-AVKRI---LPECFSFAD----REVQL 70
Query: 692 LTEI-RHRNIVKFYGFCSHPKHSF-IIYEYLESGSLDKILCNDASAKELGWTQRLNVIKG 749
           L E   H N++++  FC+     F  I   L + +L + +     A  LG  + + +++ 
Sbjct: 71  LRESDEHPNVIRY--FCTEKDRQFQYIAIELCAATLQEYVEQKDFA-HLGL-EPITLLQQ 126
Query: 750 VADALFYLHNNCFPPIVHRDISSKNVLLDL-----GYEAHVSDFGIAKFLNPDSSNWSE- 803
               L +LH+     IVHRD+   N+L+ +       +A +SDFG+ K L     ++S  
Sbjct: 127 TTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRR 183
Query: 804 --LAGTHGYVAPELAYTLKVTEKC--------DVYSFGVLALEVI-KGKHP 843
             + GT G++APE+     ++E C        D++S G +   VI +G HP
Sbjct: 184 SGVPGTEGWIAPEM-----LSEDCKENPTYTVDIFSAGCVFYYVISEGSHP 229

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/231 (23%), Positives = 99/231 (42%), Gaps = 33/231 (14%)
Query: 683 EEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQ 742
           E F      ++++ H+++V  YG C     + ++ E+++ GSLD  L  + +   + W  
Sbjct: 57  ESFFEAASMMSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILW-- 114
Query: 743 RLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEA--------HVSDFGIAKFL 794
           +L V K +A A+ +L  N    ++H ++ +KN+LL    +          +SD GI+  +
Sbjct: 115 KLEVAKQLAWAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV 171
Query: 795 NPDSSNWSELAGTHGYVAPELAYTLK-VTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXX 852
            P       L     +V PE     K +    D +SFG    E+   G  P   L     
Sbjct: 172 LPKDI----LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL----- 222
Query: 853 XXXXXXIEMLDSR--LPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
                 ++  + R  LP P      K   +  +  +C+D  P+ RP+ + +
Sbjct: 223 -DSQRKLQFYEDRHQLPAP------KAAELANLINNCMDYEPDHRPSFRAI 266

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 3/94 (3%)
Query: 750 VADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG 809
           +A  LF+L +     I++RD+   NV+LD      ++DFG+ K    D        GT  
Sbjct: 451 IAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPD 507
Query: 810 YVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           Y+APE+       +  D ++FGVL  E++ G+ P
Sbjct: 508 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 65/245 (26%), Positives = 113/245 (46%), Gaps = 42/245 (17%)
Query: 620 SVLTFEGKIVYEEIISATNDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEM 678
           S  +F G+  +E++     D      +G+G H  V     + + + +AVK      PG +
Sbjct: 2   STDSFSGR--FEDVYQLQEDV-----LGEGAHARVQTCINLITSQEYAVKIIEKQ-PGHI 53
Query: 679 S---FQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASA 735
               F++ E L + Q      HRN+++   F       ++++E +  GS   IL +    
Sbjct: 54  RSRVFREVEMLYQCQG-----HRNVLELIEFFEEEDRFYLVFEKMRGGS---ILSHIHKR 105
Query: 736 KELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKF-- 793
           +     +   V++ VA AL +LHN     I HRD+  +N+L +  +   VS   I  F  
Sbjct: 106 RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCE--HPNQVSPVKICDFDL 160
Query: 794 -----LNPDSSNWS--EL---AGTHGYVAPEL--AYTLKVT---EKCDVYSFGVLALEVI 838
                LN D S  S  EL    G+  Y+APE+  A++ + +   ++CD++S GV+   ++
Sbjct: 161 GSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILL 220
Query: 839 KGKHP 843
            G  P
Sbjct: 221 SGYPP 225

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 87/205 (42%), Gaps = 14/205 (6%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQ---QEEFLNEIQALTEIRHRNIVK 702
           +G G    V + +  S  +    KF        S +   +EE   E+  L ++ H NI+ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 703 FYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
            +    +     +I E +  G L   L    S  E   T   + IK + D + YLH    
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT---SFIKQILDGVNYLHTK-- 134
Query: 763 PPIVHRDISSKNV-LLDLGYE-AHVS--DFGIAKFLNPDSSNWSELAGTHGYVAPELAYT 818
             I H D+  +N+ LLD      H+   DFG+A  +  D   +  + GT  +VAPE+   
Sbjct: 135 -KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKNIFGTPEFVAPEIVNY 192
Query: 819 LKVTEKCDVYSFGVLALEVIKGKHP 843
             +  + D++S GV+   ++ G  P
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASP 217

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 73/156 (46%), Gaps = 18/156 (11%)
Query: 695 IRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELG---WTQRLNVIKGVA 751
           +RH NIV+F      P H  I+ EY   G L + +CN     E     + Q+L  I GV+
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL--ISGVS 129
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEA---HVSDFGIAKFLNPDSSNWSELAGTH 808
               Y H      + HRD+  +N LLD G  A    + DFG +K     S   S + GT 
Sbjct: 130 ----YCHAM---QVCHRDLKLENTLLD-GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTP 180
Query: 809 GYVAPELAYTLKVTEK-CDVYSFGVLALEVIKGKHP 843
            Y+APE+    +   K  DV+S GV    ++ G +P
Sbjct: 181 AYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP 216

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/283 (21%), Positives = 116/283 (40%), Gaps = 36/283 (12%)
Query: 646 IGKGGHGSVYRA---KVPSGEI---FAVKKFHSPLPGEMSFQQE-EFLNEIQALTEIRHR 698
           +G+G  G VY      +  GE     AVK  +       S ++  EFLNE   +      
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNE----SASLRERIEFLNEASVMKGFTCH 80
Query: 699 NIVKFYGFCSHPKHSFIIYEYLESGSLDKILC-------NDASAKELGWTQRLNVIKGVA 751
           ++V+  G  S  + + ++ E +  G L   L        N+         + + +   +A
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH--- 808
           D + YL+   F   VHR+++++N ++   +   + DFG+ + +    +++    G     
Sbjct: 141 DGMAYLNAKKF---VHRNLAARNCMVAHDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLP 195
Query: 809 -GYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRL 866
             ++APE       T   D++SFGV+  E+    + P    ++           M    L
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP----YQGLSNEQVLKFVMDGGYL 251
Query: 867 PYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI 909
             P  +  +++  +M++   C   NP  RPT   +  LL + +
Sbjct: 252 DQPD-NCPERVTDLMRM---CWQFNPNMRPTFLEIVNLLKDDL 290

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/283 (21%), Positives = 116/283 (40%), Gaps = 36/283 (12%)
Query: 646 IGKGGHGSVYRA---KVPSGEI---FAVKKFHSPLPGEMSFQQE-EFLNEIQALTEIRHR 698
           +G+G  G VY      +  GE     AVK  +       S ++  EFLNE   +      
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNE----SASLRERIEFLNEASVMKGFTCH 81
Query: 699 NIVKFYGFCSHPKHSFIIYEYLESGSLDKILC-------NDASAKELGWTQRLNVIKGVA 751
           ++V+  G  S  + + ++ E +  G L   L        N+         + + +   +A
Sbjct: 82  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 141
Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH--- 808
           D + YL+   F   VHR+++++N ++   +   + DFG+ + +    +++    G     
Sbjct: 142 DGMAYLNAKKF---VHRNLAARNCMVAHDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLP 196
Query: 809 -GYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEXXXXXXXXXIEMLDSRL 866
             ++APE       T   D++SFGV+  E+    + P    ++           M    L
Sbjct: 197 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP----YQGLSNEQVLKFVMDGGYL 252
Query: 867 PYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI 909
             P  +  +++  +M++   C   NP  RPT   +  LL + +
Sbjct: 253 DQPD-NCPERVTDLMRM---CWQFNPNMRPTFLEIVNLLKDDL 291

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 97/221 (43%), Gaps = 27/221 (12%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVK-----KFHSPLPGEMSFQQEEFLNEIQALTEIRHRN 699
           IGKG    V R     +G+ FAVK     KF S  PG      E+   E      ++H +
Sbjct: 32  IGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSS-PG---LSTEDLKREASICHMLKHPH 87
Query: 700 IVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNV----IKGVADALF 755
           IV+     S     ++++E+++   L   +   A A   G+     V    ++ + +AL 
Sbjct: 88  IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADA---GFVYSEAVASHYMRQILEALR 144
Query: 756 YLHNNCFPPIVHRDISSKNVLL---DLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVA 812
           Y H+N    I+HRD+  +NVLL   +      + DFG+A  L           GT  ++A
Sbjct: 145 YCHDN---NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMA 201
Query: 813 PELAYTLKVTEKCDVYSFGVLALEVIKGKHP----RDFLFE 849
           PE+       +  DV+  GV+   ++ G  P    ++ LFE
Sbjct: 202 PEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFE 242

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  +  V SG   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 116
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 117 DVFT-PATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 172
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKV 821
             I+HRD+   N+ ++   E  + DFG+A+  + + + +     T  Y APE+    +  
Sbjct: 173 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHY 229
Query: 822 TEKCDVYSFGVLALEVIKGK 841
               D++S G +  E++ G+
Sbjct: 230 NMTVDIWSVGCIMAELLTGR 249

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/202 (23%), Positives = 91/202 (45%), Gaps = 17/202 (8%)
Query: 646 IGKGGHGSV---YRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVK 702
           +G G +GSV   Y A++   +  AVKK   P   +          E++ L  ++H N++ 
Sbjct: 36  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPF--QSLIHARRTYRELRLLKHLKHENVIG 91
Query: 703 FYGFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
                + P  S   +   YL +  +   L N   ++ L       ++  +   L Y+H+ 
Sbjct: 92  LLDVFT-PATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHSA 150
Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-L 819
               I+HRD+   NV ++   E  + DFG+A+  + + + +     T  Y APE+    +
Sbjct: 151 G---IIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGY---VATRWYRAPEIMLNWM 204
Query: 820 KVTEKCDVYSFGVLALEVIKGK 841
              +  D++S G +  E+++GK
Sbjct: 205 HYNQTVDIWSVGCIMAELLQGK 226

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 89/187 (47%), Gaps = 29/187 (15%)
Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEF----LNEIQALTEIRHRNI 700
           IG+G  G V++A+   +G+  A+KK        M  ++E F    L EI+ L  ++H N+
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVL------MENEKEGFPITALREIKILQLLKHENV 78
Query: 701 VKFYGFC---SHPKHS-----FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVAD 752
           V     C   + P +      ++++++ E   L  +L N      L   +R  V++ + +
Sbjct: 79  VNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--VMQMLLN 135
Query: 753 ALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL----NPDSSNWSELAGTH 808
            L+Y+H N    I+HRD+ + NVL+       ++DFG+A+      N   + +     T 
Sbjct: 136 GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTL 192
Query: 809 GYVAPEL 815
            Y  PEL
Sbjct: 193 WYRPPEL 199

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 95/206 (46%), Gaps = 18/206 (8%)
Query: 645 CIGKGGHGSVYRAKV----PSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNI 700
            +G+G  G V+  +      SG ++A+K             + +   +I  L ++ H  +
Sbjct: 35  VLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDI--LADVNHPFV 92
Query: 701 VKF-YGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQR--LNVIKGVADALFYL 757
           VK  Y F +  K  ++I ++L  G L   L     +KE+ +T+      +  +A  L +L
Sbjct: 93  VKLHYAFQTEGK-LYLILDFLRGGDLFTRL-----SKEVMFTEEDVKFYLAELALGLDHL 146
Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAY 817
           H+     I++RD+  +N+LLD      ++DFG++K             GT  Y+APE+  
Sbjct: 147 HSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVN 203
Query: 818 TLKVTEKCDVYSFGVLALEVIKGKHP 843
               +   D +S+GVL  E++ G  P
Sbjct: 204 RQGHSHSADWWSYGVLMFEMLTGSLP 229

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 92/211 (43%), Gaps = 14/211 (6%)
Query: 640 FNAEHCIGKGGHGSVYRAKVPS-GEIFAVK--KFHSPLPGEMSFQQEEFLNEIQALTEIR 696
           ++    +G G    V + +  S G  +A K  K            +E+   E+  L EI+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFY 756
           H N++  +    +     +I E +  G L   L    S  E   T+    +K + + ++Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE---FLKQILNGVYY 129
Query: 757 LHNNCFPPIVHRDISSKNV-LLDLGY---EAHVSDFGIAKFLNPDSSNWSELAGTHGYVA 812
           LH+     I H D+  +N+ LLD         + DFG+A  ++   + +  + GT  +VA
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF-GNEFKNIFGTPAFVA 185
Query: 813 PELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           PE+     +  + D++S GV+   ++ G  P
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 89/187 (47%), Gaps = 29/187 (15%)
Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEF----LNEIQALTEIRHRNI 700
           IG+G  G V++A+   +G+  A+KK        M  ++E F    L EI+ L  ++H N+
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVL------MENEKEGFPITALREIKILQLLKHENV 79
Query: 701 VKFYGFC---SHPKHS-----FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVAD 752
           V     C   + P +      ++++++ E   L  +L N      L   +R  V++ + +
Sbjct: 80  VNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--VMQMLLN 136
Query: 753 ALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL----NPDSSNWSELAGTH 808
            L+Y+H N    I+HRD+ + NVL+       ++DFG+A+      N   + +     T 
Sbjct: 137 GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTL 193
Query: 809 GYVAPEL 815
            Y  PEL
Sbjct: 194 WYRPPEL 200

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 89/187 (47%), Gaps = 29/187 (15%)
Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEF----LNEIQALTEIRHRNI 700
           IG+G  G V++A+   +G+  A+KK        M  ++E F    L EI+ L  ++H N+
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVL------MENEKEGFPITALREIKILQLLKHENV 79
Query: 701 VKFYGFC---SHPKHS-----FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVAD 752
           V     C   + P +      ++++++ E   L  +L N      L   +R  V++ + +
Sbjct: 80  VNLIEICRTKASPYNRCKASIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--VMQMLLN 136
Query: 753 ALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL----NPDSSNWSELAGTH 808
            L+Y+H N    I+HRD+ + NVL+       ++DFG+A+      N   + +     T 
Sbjct: 137 GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTL 193
Query: 809 GYVAPEL 815
            Y  PEL
Sbjct: 194 WYRPPEL 200

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 89/187 (47%), Gaps = 29/187 (15%)
Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEF----LNEIQALTEIRHRNI 700
           IG+G  G V++A+   +G+  A+KK        M  ++E F    L EI+ L  ++H N+
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVL------MENEKEGFPITALREIKILQLLKHENV 79
Query: 701 VKFYGFC---SHPKHS-----FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVAD 752
           V     C   + P +      ++++++ E   L  +L N      L   +R  V++ + +
Sbjct: 80  VNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--VMQMLLN 136
Query: 753 ALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL----NPDSSNWSELAGTH 808
            L+Y+H N    I+HRD+ + NVL+       ++DFG+A+      N   + +     T 
Sbjct: 137 GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTL 193
Query: 809 GYVAPEL 815
            Y  PEL
Sbjct: 194 WYRPPEL 200

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 100/231 (43%), Gaps = 29/231 (12%)
Query: 630 YEEIISA-------TNDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVK---KFHSPLPGEM 678
           YE+I+           D++    IG+G  G V   +   S +++A+K   KF      + 
Sbjct: 60  YEKIVKKIRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDS 119
Query: 679 SFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCN-DASAKE 737
           +F  EE   +I A        +V+ +      K+ +++ EY+  G L  ++ N D   K 
Sbjct: 120 AFFWEE--RDIMAFANSPW--VVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK- 174
Query: 738 LGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPD 797
             W +       V  AL  +H+     ++HRD+   N+LLD      ++DFG    ++  
Sbjct: 175 --WAKFYTA--EVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET 227
Query: 798 SSNWSELA-GTHGYVAPELAYTLK----VTEKCDVYSFGVLALEVIKGKHP 843
                + A GT  Y++PE+  +         +CD +S GV   E++ G  P
Sbjct: 228 GMVHCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 278

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/200 (23%), Positives = 88/200 (44%), Gaps = 13/200 (6%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 88  DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 143
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKV 821
             I+HRD+   N+ ++   E  + DF +A+  + + + +     T  Y APE+    +  
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGY---VATRWYRAPEIMLNWMHY 200
Query: 822 TEKCDVYSFGVLALEVIKGK 841
            +  D++S G +  E++ G+
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 79/165 (47%), Gaps = 10/165 (6%)
Query: 682 QEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSL-DKILCNDASAKELGW 740
           +EE  NEI  + ++ H N+++ Y          ++ EY++ G L D+I+    +  EL  
Sbjct: 130 KEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTEL-- 187
Query: 741 TQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLL--DLGYEAHVSDFGIAKFLNPDS 798
              +  +K + + + ++H      I+H D+  +N+L       +  + DFG+A+   P  
Sbjct: 188 -DTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243
Query: 799 SNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
                  GT  ++APE+     V+   D++S GV+A  ++ G  P
Sbjct: 244 KLKVNF-GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 100/215 (46%), Gaps = 27/215 (12%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR-HRNIVKF 703
           +G+G +  V  A  + +G+ +AVK        +    +     E++ L + + ++NI++ 
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYAVKIIEK----QAGHSRSRVFREVETLYQCQGNKNILEL 76
Query: 704 YGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFP 763
             F       ++++E L+ GS   IL +    K     +   V++ VA AL +LH     
Sbjct: 77  IEFFEDDTRFYLVFEKLQGGS---ILAHIQKQKHFNEREASRVVRDVAAALDFLHTK--- 130
Query: 764 PIVHRDISSKNVLLDLGYE---AHVSDFGIAKFLNPDSS-------NWSELAGTHGYVAP 813
            I HRD+  +N+L +   +     + DF +   +  ++S         +   G+  Y+AP
Sbjct: 131 GIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAP 190
Query: 814 EL--AYTLKVT---EKCDVYSFGVLALEVIKGKHP 843
           E+   +T + T   ++CD++S GV+   ++ G  P
Sbjct: 191 EVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPP 225

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/202 (23%), Positives = 90/202 (44%), Gaps = 17/202 (8%)
Query: 646 IGKGGHGSV---YRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVK 702
           +G G +GSV   Y A++   +  AVKK   P   +          E++ L  ++H N++ 
Sbjct: 36  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPF--QSLIHARRTYRELRLLKHLKHENVIG 91
Query: 703 FYGFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
                + P  S   +   YL +  +   L N    + L       ++  +   L Y+H+ 
Sbjct: 92  LLDVFT-PATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSA 150
Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-L 819
               I+HRD+   NV ++   E  + DFG+A+  + + + +     T  Y APE+    +
Sbjct: 151 G---IIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGY---VATRWYRAPEIMLNWM 204
Query: 820 KVTEKCDVYSFGVLALEVIKGK 841
              +  D++S G +  E+++GK
Sbjct: 205 HYNQTVDIWSVGCIMAELLQGK 226

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 41/79 (51%)
Query: 765 IVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEK 824
           I++RD+  +NVLLD      +SD G+A  L    +     AGT G++APEL    +    
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFS 369
Query: 825 CDVYSFGVLALEVIKGKHP 843
            D ++ GV   E+I  + P
Sbjct: 370 VDYFALGVTLYEMIAARGP 388

>pdb|3E6J|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor (Vlr) Rbc36 In Complex With H-Trisaccharide Length = 229

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Composition-based stats.
 Identities = 43/133 (32%), Positives = 61/133 (45%), Gaps = 7/133 (5%)
Query: 389 IPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLY 448
           IPT    I+YL+      N+++   P    SLINL+ L L +N L         SL +L 
Sbjct: 38  IPTN-AQILYLH-----DNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLT 91
Query: 449 YLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGL 508
            L+L  N+L+       D L+HL EL +  N L E +   I R+  L  L L  N L  +
Sbjct: 92  VLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKSI 150
Query: 509 IPRCFEEMHGLLH 521
               F+ +  L H
Sbjct: 151 PHGAFDRLSSLTH 163

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 41/79 (51%)
Query: 765 IVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEK 824
           I++RD+  +NVLLD      +SD G+A  L    +     AGT G++APEL    +    
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFS 369
Query: 825 CDVYSFGVLALEVIKGKHP 843
            D ++ GV   E+I  + P
Sbjct: 370 VDYFALGVTLYEMIAARGP 388

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 41/79 (51%)
Query: 765 IVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEK 824
           I++RD+  +NVLLD      +SD G+A  L    +     AGT G++APEL    +    
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFS 369
Query: 825 CDVYSFGVLALEVIKGKHP 843
            D ++ GV   E+I  + P
Sbjct: 370 VDYFALGVTLYEMIAARGP 388

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 101/217 (46%), Gaps = 21/217 (9%)
Query: 638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
           +++     IG G +G V  A+   +G+  A+KK   P   ++    +  L E++ L   +
Sbjct: 54  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKI--PNAFDVVTNAKRTLRELKILKHFK 111
Query: 697 HRNIVKFYGFCSHP------KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGV 750
           H NI+               K  +++ + +ES  L +I+    S++ L        +  +
Sbjct: 112 HDNIIAIKDILRPTVPYGEFKSVYVVLDLMES-DLHQII---HSSQPLTLEHVRYFLYQL 167
Query: 751 ADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL--NPDSSNW--SELAG 806
              L Y+H+     ++HRD+   N+L++   E  + DFG+A+ L  +P    +  +E   
Sbjct: 168 LRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVA 224
Query: 807 THGYVAPELAYTL-KVTEKCDVYSFGVLALEVIKGKH 842
           T  Y APEL  +L + T+  D++S G +  E++  + 
Sbjct: 225 TRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 41/79 (51%)
Query: 765 IVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEK 824
           I++RD+  +NVLLD      +SD G+A  L    +     AGT G++APEL    +    
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFS 369
Query: 825 CDVYSFGVLALEVIKGKHP 843
            D ++ GV   E+I  + P
Sbjct: 370 VDYFALGVTLYEMIAARGP 388

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/202 (23%), Positives = 90/202 (44%), Gaps = 17/202 (8%)
Query: 646 IGKGGHGSV---YRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVK 702
           +G G +GSV   Y A++   +  AVKK   P   +          E++ L  ++H N++ 
Sbjct: 28  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPF--QSLIHARRTYRELRLLKHLKHENVIG 83
Query: 703 FYGFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
                + P  S   +   YL +  +   L N    + L       ++  +   L Y+H+ 
Sbjct: 84  LLDVFT-PATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSA 142
Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-L 819
               I+HRD+   NV ++   E  + DFG+A+  + + + +     T  Y APE+    +
Sbjct: 143 G---IIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGY---VATRWYRAPEIMLNWM 196
Query: 820 KVTEKCDVYSFGVLALEVIKGK 841
              +  D++S G +  E+++GK
Sbjct: 197 HYNQTVDIWSVGCIMAELLQGK 218

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 101/217 (46%), Gaps = 21/217 (9%)
Query: 638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
           +++     IG G +G V  A+   +G+  A+KK   P   ++    +  L E++ L   +
Sbjct: 55  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKI--PNAFDVVTNAKRTLRELKILKHFK 112
Query: 697 HRNIVKFYGFCSHP------KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGV 750
           H NI+               K  +++ + +ES  L +I+    S++ L        +  +
Sbjct: 113 HDNIIAIKDILRPTVPYGEFKSVYVVLDLMES-DLHQII---HSSQPLTLEHVRYFLYQL 168
Query: 751 ADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL--NPDSSNW--SELAG 806
              L Y+H+     ++HRD+   N+L++   E  + DFG+A+ L  +P    +  +E   
Sbjct: 169 LRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVA 225
Query: 807 THGYVAPELAYTL-KVTEKCDVYSFGVLALEVIKGKH 842
           T  Y APEL  +L + T+  D++S G +  E++  + 
Sbjct: 226 TRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/200 (23%), Positives = 88/200 (44%), Gaps = 13/200 (6%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 88  DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 143
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKV 821
             I+HRD+   N+ ++   E  +  FG+A+  + + + +     T  Y APE+    +  
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHY 200
Query: 822 TEKCDVYSFGVLALEVIKGK 841
            +  D++S G +  E++ G+
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 92/211 (43%), Gaps = 14/211 (6%)
Query: 640 FNAEHCIGKGGHGSVYRAKVPS-GEIFAVK--KFHSPLPGEMSFQQEEFLNEIQALTEIR 696
           ++    +G G    V + +  S G  +A K  K            +E+   E+  L EI+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFY 756
           H N++  +    +     +I E +  G L   L    S  E   T+    +K + + ++Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE---FLKQILNGVYY 129
Query: 757 LHNNCFPPIVHRDISSKNV-LLDLGY---EAHVSDFGIAKFLNPDSSNWSELAGTHGYVA 812
           LH+     I H D+  +N+ LLD         + DFG+A  ++   + +  + GT  +VA
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF-GNEFKNIFGTPEFVA 185
Query: 813 PELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           PE+     +  + D++S GV+   ++ G  P
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 91/209 (43%), Gaps = 30/209 (14%)
Query: 646 IGKGGHG--SVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKF 703
           IG G  G   + R K  S E+ AVK       GE     E    EI     +RH NIV+F
Sbjct: 27  IGSGNFGVARLMRDK-QSNELVAVKYIER---GEKI--DENVKREIINHRSLRHPNIVRF 80
Query: 704 YGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELG---WTQRLNVIKGVADALFYLHNN 760
                 P H  I+ EY   G L + +CN     E     + Q+L  I GV+    Y H  
Sbjct: 81  KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL--ISGVS----YCHAM 134
Query: 761 CFPPIVHRDISSKNVLLDLGYEA---HVSDFGIAK--FLNPDSSNWSELAGTHGYVAPEL 815
               + HRD+  +N LLD G  A    +  FG +K   L+   S   +  GT  Y+APE+
Sbjct: 135 ---QVCHRDLKLENTLLD-GSPAPRLKICAFGYSKSSVLH---SQPKDTVGTPAYIAPEV 187
Query: 816 AYTLKVTEK-CDVYSFGVLALEVIKGKHP 843
               +   K  DV+S GV    ++ G +P
Sbjct: 188 LLKKEYDGKVADVWSCGVTLYVMLVGAYP 216

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/200 (23%), Positives = 88/200 (44%), Gaps = 13/200 (6%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 88  DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 143
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKV 821
             I+HRD+   N+ ++   E  + D G+A+  + + + +     T  Y APE+    +  
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGY---VATRWYRAPEIMLNWMHY 200
Query: 822 TEKCDVYSFGVLALEVIKGK 841
            +  D++S G +  E++ G+
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/200 (23%), Positives = 88/200 (44%), Gaps = 13/200 (6%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 88  DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 143
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKV 821
             I+HRD+   N+ ++   E  + D G+A+  + + + +     T  Y APE+    +  
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGY---VATRWYRAPEIMLNWMHY 200
Query: 822 TEKCDVYSFGVLALEVIKGK 841
            +  D++S G +  E++ G+
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 78/166 (46%), Gaps = 11/166 (6%)
Query: 682 QEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWT 741
           +E+   E+  L EI+H N++  +    +     +I E +  G L   L    S  E   T
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 742 QRLNVIKGVADALFYLHNNCFPPIVHRDISSKNV-LLDLGY---EAHVSDFGIAKFLNPD 797
           + L   K + + ++YLH+     I H D+  +N+ LLD         + DFG+A  ++  
Sbjct: 118 EFL---KQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF- 170
Query: 798 SSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
            + +  + GT  +VAPE+     +  + D++S GV+   ++ G  P
Sbjct: 171 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Composition-based stats.
 Identities = 49/175 (28%), Positives = 74/175 (42%), Gaps = 2/175 (1%)
Query: 354 LDVSINNISGSIPLEIGESL-QLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGC 412
           LD+  N +S S+P +    L +L+ L L+ N +          +  L  L ++ NKL   
Sbjct: 42  LDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQAL 100
Query: 413 IPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLS 472
                  L+NL  L L  N L +  P    SL KL YL+L +N+L        D L  L 
Sbjct: 101 PIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLK 160
Query: 473 ELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYN 527
           EL L +N L         ++  L+ L L  N L  +    F+ +  L  + +  N
Sbjct: 161 ELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 78/166 (46%), Gaps = 11/166 (6%)
Query: 682 QEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWT 741
           +E+   E+  L EI+H N++  +    +     +I E +  G L   L    S  E   T
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 742 QRLNVIKGVADALFYLHNNCFPPIVHRDISSKNV-LLDLGY---EAHVSDFGIAKFLNPD 797
           + L   K + + ++YLH+     I H D+  +N+ LLD         + DFG+A  ++  
Sbjct: 118 EFL---KQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF- 170
Query: 798 SSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
            + +  + GT  +VAPE+     +  + D++S GV+   ++ G  P
Sbjct: 171 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 46/200 (23%), Positives = 88/200 (44%), Gaps = 13/200 (6%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +GSV  A    +G   AVKK   P   +     +    E++ L  ++H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P  S   +   YL +  +   L N    ++L       +I  +   L Y+H+   
Sbjct: 88  DVFT-PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 143
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKV 821
             I+HRD+   N+ ++   E  + D G+A+  + + + +     T  Y APE+    +  
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGY---VATRWYRAPEIMLNWMHY 200
Query: 822 TEKCDVYSFGVLALEVIKGK 841
            +  D++S G +  E++ G+
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 78/166 (46%), Gaps = 11/166 (6%)
Query: 682 QEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWT 741
           +E+   E+  L EI+H N++  +    +     +I E +  G L   L    S  E   T
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 742 QRLNVIKGVADALFYLHNNCFPPIVHRDISSKNV-LLDLGY---EAHVSDFGIAKFLNPD 797
           +    +K + + ++YLH+     I H D+  +N+ LLD         + DFG+A  ++  
Sbjct: 118 E---FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF- 170
Query: 798 SSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
            + +  + GT  +VAPE+     +  + D++S GV+   ++ G  P
Sbjct: 171 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 90/207 (43%), Gaps = 26/207 (12%)
Query: 646 IGKGGHG--SVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKF 703
           IG G  G   + R K  S E+ AVK       GE     E    EI     +RH NIV+F
Sbjct: 27  IGSGNFGVARLMRDK-QSNELVAVKYIER---GEKI--DENVKREIINHRSLRHPNIVRF 80
Query: 704 YGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELG---WTQRLNVIKGVADALFYLHNN 760
                 P H  I+ EY   G L + +CN     E     + Q+L  I GV+    Y H  
Sbjct: 81  KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL--ISGVS----YCHAM 134
Query: 761 CFPPIVHRDISSKNVLLDLGYEA---HVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAY 817
               + HRD+  +N LLD G  A    +  FG +K     S   S + GT  Y+APE+  
Sbjct: 135 ---QVCHRDLKLENTLLD-GSPAPRLKICAFGYSKSSVLHSQPKSTV-GTPAYIAPEVLL 189
Query: 818 TLKVTEK-CDVYSFGVLALEVIKGKHP 843
             +   K  DV+S GV    ++ G +P
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVGAYP 216

>pdb|2Z66|A Chain A, Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 306

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 54/164 (32%), Positives = 77/164 (46%), Gaps = 7/164 (4%)
Query: 297 FRNLTDLVKLRLNQNYLT--GNISET-FGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSL 353
           F  LT L KL L+ N L+  G  S++ FGT  +L ++DLS N     + S++    QL  
Sbjct: 48  FDKLTQLTKLSLSSNGLSFKGCCSQSDFGT-TSLKYLDLSFNGVI-TMSSNFLGLEQLEH 105
Query: 354 LDVSINNISGSIPLEIGESLQ-LQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLS-G 411
           LD   +N+       +  SL+ L YLD+S  +           +  L  L ++GN     
Sbjct: 106 LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN 165
Query: 412 CIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHN 455
            +P     L NL +LDLS   L    P +  SL  L  LN+SHN
Sbjct: 166 FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHN 209

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 34/145 (23%), Positives = 63/145 (43%), Gaps = 14/145 (9%)
Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAK--FLNPDSSNWSELAGTHGYVAPELAYTLKVTE 823
           +HRD++++N+LL       + DFG+A+  + NPD     +      ++APE  +    + 
Sbjct: 221 IHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLPLKWMAPESIFDKIYST 280
Query: 824 KCDVYSFGVLALEVIK---GKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLHVQKKLMSI 880
           K DV+S+GVL  E+       +P   + E         + M       P ++        
Sbjct: 281 KSDVWSYGVLLWEIFSLGGSPYPGVQMDEDFCSRLREGMRMRAPEYSTPEIY-------- 332
Query: 881 MQVAFSCLDQNPESRPTMKRVSQLL 905
            Q+   C  ++P+ RP    + + L
Sbjct: 333 -QIMLDCWHRDPKERPRFAELVEKL 356

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 67/153 (43%), Gaps = 12/153 (7%)
Query: 696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSL-DKILCNDASAKELGWTQRLNVIKGVADAL 754
           +H NI+         K+ +++ E ++ G L DKIL      K     +   V+  +   +
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL----RQKFFSEREASAVLFTITKTV 129
Query: 755 FYLHNNCFPPIVHRDISSKNVL-LDLG---YEAHVSDFGIAKFLNPDSSNWSELAGTHGY 810
            YLH      +VHRD+   N+L +D         + DFG AK L  ++        T  +
Sbjct: 130 EYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANF 186
Query: 811 VAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           VAPE+         CD++S GVL   ++ G  P
Sbjct: 187 VAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 69/143 (48%), Gaps = 27/143 (18%)
Query: 765 IVHRDISSKNVLLDLGYE-AHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELA-----YT 818
           +VHRDI  +N+L+DL    A + DFG    L+     +++  GT  Y  PE       + 
Sbjct: 160 VVHRDIKDENILIDLRRGCAKLIDFGSGALLH--DEPYTDFDGTRVYSPPEWISRHQYHA 217
Query: 819 LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEXXXXXXXXXIEMLDSRLPYPSLHVQKKLM 878
           L  T    V+S G+L  +++ G    D  FE          E+L++ L +P+ HV     
Sbjct: 218 LPAT----VWSLGILLYDMVCG----DIPFERDQ-------EILEAELHFPA-HVSPDCC 261
Query: 879 SIMQVAFSCLDQNPESRPTMKRV 901
           ++++    CL   P SRP+++ +
Sbjct: 262 ALIR---RCLAPKPSSRPSLEEI 281

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 78/166 (46%), Gaps = 11/166 (6%)
Query: 682 QEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWT 741
           +E+   E+  L EI+H N++  +    +     +I E +  G L   L    S  E   T
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 742 QRLNVIKGVADALFYLHNNCFPPIVHRDISSKNV-LLDLGY---EAHVSDFGIAKFLNPD 797
           +    +K + + ++YLH+     I H D+  +N+ LLD         + DFG+A  ++  
Sbjct: 118 E---FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF- 170
Query: 798 SSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
            + +  + GT  +VAPE+     +  + D++S GV+   ++ G  P
Sbjct: 171 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 78/166 (46%), Gaps = 11/166 (6%)
Query: 682 QEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWT 741
           +E+   E+  L EI+H N++  +    +     +I E +  G L   L    S  E   T
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 742 QRLNVIKGVADALFYLHNNCFPPIVHRDISSKNV-LLDLGY---EAHVSDFGIAKFLNPD 797
           +    +K + + ++YLH+     I H D+  +N+ LLD         + DFG+A  ++  
Sbjct: 118 E---FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF- 170
Query: 798 SSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
            + +  + GT  +VAPE+     +  + D++S GV+   ++ G  P
Sbjct: 171 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 78/166 (46%), Gaps = 11/166 (6%)
Query: 682 QEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWT 741
           +E+   E+  L EI+H N++  +    +     +I E +  G L   L    S  E   T
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 742 QRLNVIKGVADALFYLHNNCFPPIVHRDISSKNV-LLDLGY---EAHVSDFGIAKFLNPD 797
           + L   K + + ++YLH+     I H D+  +N+ LLD         + DFG+A  ++  
Sbjct: 118 EFL---KQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF- 170
Query: 798 SSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
            + +  + GT  +VAPE+     +  + D++S GV+   ++ G  P
Sbjct: 171 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 78/166 (46%), Gaps = 11/166 (6%)
Query: 682 QEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWT 741
           +E+   E+  L EI+H N++  +    +     +I E +  G L   L    S  E   T
Sbjct: 57  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 116
Query: 742 QRLNVIKGVADALFYLHNNCFPPIVHRDISSKNV-LLDLGY---EAHVSDFGIAKFLNPD 797
           +    +K + + ++YLH+     I H D+  +N+ LLD         + DFG+A  ++  
Sbjct: 117 E---FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF- 169
Query: 798 SSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
            + +  + GT  +VAPE+     +  + D++S GV+   ++ G  P
Sbjct: 170 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 78/166 (46%), Gaps = 11/166 (6%)
Query: 682 QEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWT 741
           +E+   E+  L EI+H N++  +    +     +I E +  G L   L    S  E   T
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 742 QRLNVIKGVADALFYLHNNCFPPIVHRDISSKNV-LLDLGY---EAHVSDFGIAKFLNPD 797
           +    +K + + ++YLH+     I H D+  +N+ LLD         + DFG+A  ++  
Sbjct: 118 E---FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF- 170
Query: 798 SSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
            + +  + GT  +VAPE+     +  + D++S GV+   ++ G  P
Sbjct: 171 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 78/166 (46%), Gaps = 11/166 (6%)
Query: 682 QEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWT 741
           +E+   E+  L EI+H N++  +    +     +I E +  G L   L    S  E   T
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 742 QRLNVIKGVADALFYLHNNCFPPIVHRDISSKNV-LLDLGY---EAHVSDFGIAKFLNPD 797
           +    +K + + ++YLH+     I H D+  +N+ LLD         + DFG+A  ++  
Sbjct: 118 E---FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF- 170
Query: 798 SSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
            + +  + GT  +VAPE+     +  + D++S GV+   ++ G  P
Sbjct: 171 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 78/166 (46%), Gaps = 11/166 (6%)
Query: 682 QEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWT 741
           +E+   E+  L EI+H N++  +    +     +I E +  G L   L    S  E   T
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 742 QRLNVIKGVADALFYLHNNCFPPIVHRDISSKNV-LLDLGY---EAHVSDFGIAKFLNPD 797
           +    +K + + ++YLH+     I H D+  +N+ LLD         + DFG+A  ++  
Sbjct: 118 E---FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF- 170
Query: 798 SSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
            + +  + GT  +VAPE+     +  + D++S GV+   ++ G  P
Sbjct: 171 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 78/166 (46%), Gaps = 11/166 (6%)
Query: 682 QEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWT 741
           +E+   E+  L EI+H N++  +    +     +I E +  G L   L    S  E   T
Sbjct: 57  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 116
Query: 742 QRLNVIKGVADALFYLHNNCFPPIVHRDISSKNV-LLDLGY---EAHVSDFGIAKFLNPD 797
           +    +K + + ++YLH+     I H D+  +N+ LLD         + DFG+A  ++  
Sbjct: 117 E---FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF- 169
Query: 798 SSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
            + +  + GT  +VAPE+     +  + D++S GV+   ++ G  P
Sbjct: 170 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 49/100 (49%), Gaps = 8/100 (8%)
Query: 749 GVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH 808
            +  AL+YL       ++HRD+   N+LLD   +  + DFGI+  L  D +     AG  
Sbjct: 132 AIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK-DRSAGCA 188
Query: 809 GYVAPELAYTLKVTE-----KCDVYSFGVLALEVIKGKHP 843
            Y+APE       T+     + DV+S G+  +E+  G+ P
Sbjct: 189 AYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 14/206 (6%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           +G+G  G V+R    S +   + KF   + G     Q     EI  L   RHRNI+  + 
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKF-VKVKGT---DQVLVKKEISILNIARHRNILHLHE 68
Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
                +   +I+E++ SG LD     + SA EL   + ++ +  V +AL +LH++    I
Sbjct: 69  SFESMEELVMIFEFI-SG-LDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NI 123
Query: 766 VHRDISSKNVLLDLGYEAHVS--DFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTE 823
            H DI  +N++      + +   +FG A+ L P   N+  L     Y APE+     V+ 
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-GDNFRLLFTAPEYYAPEVHQHDVVST 182
Query: 824 KCDVYSFGVLALEVIKGKHPRDFLFE 849
             D++S G L   ++ G +P  FL E
Sbjct: 183 ATDMWSLGTLVYVLLSGINP--FLAE 206

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/281 (20%), Positives = 113/281 (40%), Gaps = 25/281 (8%)
Query: 631 EEIISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEM--SFQQEEFLNE 688
           E+++     F     +GKG  GSV  A++   +   VK     L  ++  S   EEFL E
Sbjct: 16  EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLRE 75
Query: 689 IQALTEIRHRNIVKFYGFCSHPKHS------FIIYEYLESGSLDKILCNDASAKE---LG 739
              + E  H ++ K  G     +         +I  +++ G L   L      +    L 
Sbjct: 76  AACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLP 135
Query: 740 WTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSS 799
               +  +  +A  + YL +  F   +HRD++++N +L       V+DFG+++ +     
Sbjct: 136 LQTLVRFMVDIACGMEYLSSRNF---IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDY 192
Query: 800 NWSELAGT--HGYVAPELAYTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEXXXXXXX 856
                A      ++A E       T   DV++FGV   E++ +G+ P    +        
Sbjct: 193 YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP----YAGIENAEI 248
Query: 857 XXIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPT 897
               +  +RL  P   +++    +  + + C   +P+ RP+
Sbjct: 249 YNYLIGGNRLKQPPECMEE----VYDLMYQCWSADPKQRPS 285

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 78/166 (46%), Gaps = 11/166 (6%)
Query: 682 QEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWT 741
           +E+   E+  L EI+H N++  +    +     +I E +  G L   L    S  E   T
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEAT 117
Query: 742 QRLNVIKGVADALFYLHNNCFPPIVHRDISSKNV-LLDLGY---EAHVSDFGIAKFLNPD 797
           +    +K + + ++YLH+     I H D+  +N+ LLD         + DFG+A  ++  
Sbjct: 118 E---FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF- 170
Query: 798 SSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
            + +  + GT  +VAPE+     +  + D++S GV+   ++ G  P
Sbjct: 171 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3ULU|A Chain A, Structure Of Quaternary Complex Of Human Tlr3ecd With Three Fabs (Form1) Length = 694

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 105/426 (24%), Positives = 174/426 (40%), Gaps = 35/426 (8%)
Query: 104 SFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLH 163
           +F+ +  L  LD+  N +  + P     L  L+ L+   N+L           T+LT LH
Sbjct: 54  NFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELH 113
Query: 164 ISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQ 223
           +  N +     +   +   L  L L  N L+ +   +   L ++  L L NN       +
Sbjct: 114 LMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSE 173
Query: 224 EIGNL--KSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGXXXXXXX 281
           E+      SL  LEL  NQ+    P     +  L  LFL + +L   + +++        
Sbjct: 174 ELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANT- 232
Query: 282 XXXXXXHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEI 341
                         S RNL+    L  +Q   T N +     + NLT +DLS N+     
Sbjct: 233 --------------SIRNLS----LSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVG 274
Query: 342 LSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIP----TQLGNII 397
              +   PQL    +  NNI       +     ++YL+L  ++    I      ++ +  
Sbjct: 275 NDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFS 334
Query: 398 Y-----LNRLSLSGNKLSGCIPRELGSLINLEYLDLSAN--NLSNFVPESLGSLVK--LY 448
           +     L  L++  N + G        LINL+YL LS +  +L     E+  SL    L+
Sbjct: 335 FQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLH 394
Query: 449 YLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICR-MESLEKLNLSYNNLSG 507
            LNL+ NK+S+        L HL  LDL  N +G++++ +  R +E++ ++ LSYN    
Sbjct: 395 ILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQ 454
Query: 508 LIPRCF 513
           L    F
Sbjct: 455 LTRNSF 460

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 47/88 (53%), Gaps = 6/88 (6%)
Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           YLH+     +++RD+  +N+L+D      V+DFG AK +      W  LAGT  Y+APE+
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LAGTPEYLAPEI 209
Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
             +    +  D ++ GVL  E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 68/144 (47%), Gaps = 8/144 (5%)
Query: 637 TNDFNAEHCIGKGGHGSVYR-AKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI 695
           T +F+    IG G  GSV++  K   G I+A+K+   PL G  S  ++  L E+ A   +
Sbjct: 6   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAG--SVDEQNALREVYAHAVL 63
Query: 696 -RHRNIVKFYGFCSHPKHSFIIYEYLESGSL-DKILCNDASAKELGWTQRLNVIKGVADA 753
            +H ++V+++   +   H  I  EY   GSL D I  N          +  +++  V   
Sbjct: 64  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 123
Query: 754 LFYLHNNCFPPIVHRDISSKNVLL 777
           L Y+H+     +VH DI   N+ +
Sbjct: 124 LRYIHSMS---LVHMDIKPSNIFI 144

>pdb|2Z63|A Chain A, Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 570

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 90/197 (45%), Gaps = 17/197 (8%)
Query: 325 PNLTFIDLSNN--SFFGEI-LSDWGRCPQLSLLDVSINNI----SGSIPLEIGESLQLQY 377
           P+L F+DLS N  SF G    SD+G    L  LD+S N +    S  + LE  E L  Q+
Sbjct: 347 PSLEFLDLSRNGLSFKGCCSQSDFGT-TSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQH 405
Query: 378 LDLSSNYIVGEIPT--QLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLS- 434
            +L     + E      L N+IYL+   +S              L +LE L ++ N+   
Sbjct: 406 SNLKQ---MSEFSVFLSLRNLIYLD---ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQE 459
Query: 435 NFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMES 494
           NF+P+    L  L +L+LS  +L Q  P   ++L  L  L+++ N L         R+ S
Sbjct: 460 NFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTS 519
Query: 495 LEKLNLSYNNLSGLIPR 511
           L+K+ L  N      PR
Sbjct: 520 LQKIWLHTNPWDCSCPR 536

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/267 (22%), Positives = 116/267 (43%), Gaps = 35/267 (13%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRN--IVKF 703
           IG GG   V++      +I+A+K  +       +   + + NEI  L +++  +  I++ 
Sbjct: 20  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL--DSYRNEIAYLNKLQQHSDKIIRL 77
Query: 704 YGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFP 763
           Y +    ++   IY  +E G++D +       K +   +R +  K + +A+  +H +   
Sbjct: 78  YDYEITDQY---IYMVMECGNID-LNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG-- 131
Query: 764 PIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN--WSELAGTHGYVAPELAYTLKV 821
            IVH D+   N L+  G    + DFGIA  + PD+++       GT  Y+ PE    +  
Sbjct: 132 -IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 189
Query: 822 TEK-----------CDVYSFGVLALEVIKGKHPRDFLFEXXXXXXXXXIEMLDS--RLPY 868
           + +            DV+S G +   +  GK P    F+           ++D    + +
Sbjct: 190 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTP----FQQIINQISKLHAIIDPNHEIEF 245
Query: 869 PSLHVQKKLMSIMQVAFSCLDQNPESR 895
           P +  +K L  +++    CL ++P+ R
Sbjct: 246 PDI-PEKDLQDVLKC---CLKRDPKQR 268

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 95/226 (42%), Gaps = 37/226 (16%)
Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR----HRNI 700
           + +GG   VY A+ V SG  +A+K+        +S ++E+    IQ +  ++    H NI
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRL-------LSNEEEKNRAIIQEVCFMKKLSGHPNI 88
Query: 701 VKFYGFCSHPKHS-------FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADA 753
           V+F    S  K         F++   L  G L + L    S   L     L +      A
Sbjct: 89  VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN--PDSSNWSELA------ 805
           + ++H    PPI+HRD+  +N+LL       + DFG A  ++  PD S WS         
Sbjct: 149 VQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYS-WSAQRRALVEE 206
Query: 806 -----GTHGYVAPE---LAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
                 T  Y  PE   L     + EK D+++ G +   +   +HP
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252

>pdb|2A0Z|A Chain A, The Molecular Structure Of Toll-like Receptor 3 Ligand Binding Domain Length = 705

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 105/426 (24%), Positives = 174/426 (40%), Gaps = 35/426 (8%)
Query: 104 SFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLH 163
           +F+ +  L  LD+  N +  + P     L  L+ L+   N+L           T+LT LH
Sbjct: 49  NFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELH 108
Query: 164 ISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQ 223
           +  N +     +   +   L  L L  N L+ +   +   L ++  L L NN       +
Sbjct: 109 LMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSE 168
Query: 224 EIGNL--KSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGXXXXXXX 281
           E+      SL  LEL  NQ+    P     +  L  LFL + +L   + +++        
Sbjct: 169 ELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANT- 227
Query: 282 XXXXXXHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEI 341
                         S RNL+    L  +Q   T N +     + NLT +DLS N+     
Sbjct: 228 --------------SIRNLS----LSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVG 269
Query: 342 LSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIP----TQLGNII 397
              +   PQL    +  NNI       +     ++YL+L  ++    I      ++ +  
Sbjct: 270 NDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFS 329
Query: 398 Y-----LNRLSLSGNKLSGCIPRELGSLINLEYLDLSAN--NLSNFVPESLGSLVK--LY 448
           +     L  L++  N + G        LINL+YL LS +  +L     E+  SL    L+
Sbjct: 330 FQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLH 389
Query: 449 YLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICR-MESLEKLNLSYNNLSG 507
            LNL+ NK+S+        L HL  LDL  N +G++++ +  R +E++ ++ LSYN    
Sbjct: 390 ILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQ 449
Query: 508 LIPRCF 513
           L    F
Sbjct: 450 LTRNSF 455

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/267 (22%), Positives = 116/267 (43%), Gaps = 35/267 (13%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRN--IVKF 703
           IG GG   V++      +I+A+K  +       +   + + NEI  L +++  +  I++ 
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL--DSYRNEIAYLNKLQQHSDKIIRL 93
Query: 704 YGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFP 763
           Y +    ++   IY  +E G++D +       K +   +R +  K + +A+  +H +   
Sbjct: 94  YDYEITDQY---IYMVMECGNID-LNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG-- 147
Query: 764 PIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN--WSELAGTHGYVAPELAYTLKV 821
            IVH D+   N L+  G    + DFGIA  + PD+++       GT  Y+ PE    +  
Sbjct: 148 -IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 822 TEK-----------CDVYSFGVLALEVIKGKHPRDFLFEXXXXXXXXXIEMLDS--RLPY 868
           + +            DV+S G +   +  GK P    F+           ++D    + +
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTP----FQQIINQISKLHAIIDPNHEIEF 261
Query: 869 PSLHVQKKLMSIMQVAFSCLDQNPESR 895
           P +  +K L  +++    CL ++P+ R
Sbjct: 262 PDI-PEKDLQDVLKC---CLKRDPKQR 284

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 68/144 (47%), Gaps = 8/144 (5%)
Query: 637 TNDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI 695
           T +F+    IG G  GSV++  K   G I+A+K+   PL G  S  ++  L E+ A   +
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAG--SVDEQNALREVYAHAVL 67
Query: 696 -RHRNIVKFYGFCSHPKHSFIIYEYLESGSL-DKILCNDASAKELGWTQRLNVIKGVADA 753
            +H ++V+++   +   H  I  EY   GSL D I  N          +  +++  V   
Sbjct: 68  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 754 LFYLHNNCFPPIVHRDISSKNVLL 777
           L Y+H+     +VH DI   N+ +
Sbjct: 128 LRYIHSMS---LVHMDIKPSNIFI 148

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 68/144 (47%), Gaps = 8/144 (5%)
Query: 637 TNDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI 695
           T +F+    IG G  GSV++  K   G I+A+K+   PL G  S  ++  L E+ A   +
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAG--SVDEQNALREVYAHAVL 65
Query: 696 -RHRNIVKFYGFCSHPKHSFIIYEYLESGSL-DKILCNDASAKELGWTQRLNVIKGVADA 753
            +H ++V+++   +   H  I  EY   GSL D I  N          +  +++  V   
Sbjct: 66  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 125
Query: 754 LFYLHNNCFPPIVHRDISSKNVLL 777
           L Y+H+     +VH DI   N+ +
Sbjct: 126 LRYIHSMS---LVHMDIKPSNIFI 146

>pdb|3RG1|A Chain A, Crystal Structure Of The Rp105MD-1 Complex Length = 612

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 93/345 (26%), Positives = 144/345 (41%), Gaps = 26/345 (7%)
Query: 289 FRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRC 348
           F      +FR  T + +L L   +L G  S   G   +L  + L+ NSF      +    
Sbjct: 265 FSDLSSSTFRCFTRVQELDLTAAHLNGLPSGIEG-MNSLKKLVLNANSFDQLCQINAASF 323
Query: 349 PQLSLLDVSINNISGSIPLEIGESLQ-LQYLDLSSNYIVGE--IPTQLGNIIYLNRLSLS 405
           P L  L +  N     +     E L+ LQ LDLS + I        QL N+ +L  L+LS
Sbjct: 324 PSLRDLYIKGNMRKLDLGTRCLEKLENLQKLDLSHSDIEASDCCNLQLKNLRHLQYLNLS 383
Query: 406 GNKLSGCIPRELGSLINLEYLDLSANNLSNFVPES-LGSLVKLYYLNLSHNKLSQQIPIE 464
            N+  G   +       LE LD++  +L    P S   +L  L  LNLSH  L       
Sbjct: 384 YNEPLGLEDQAFKECPQLELLDVAFTHLHVKAPHSPFQNLHLLRVLNLSHCLLDTSNQHL 443
Query: 465 LDNLIHLSELDLSHNFLGEKISSRICRME---SLEKLNLSYNNLSGLIPRCFEEMHGLLH 521
           L  L  L  L+L  N   +   S+   ++   SLE L LS  NL  +  + F  +  + H
Sbjct: 444 LAGLQDLRHLNLQGNSFQDGSISKTNLLQMVGSLEILILSSCNLLSIDQQAFHGLRNVNH 503
Query: 522 IDISYNKLEGQIPNSTTFRDAPLEALQGNKGLY-----GDIRGFPSCMSYKKASRKIWIV 576
           +D+S+N L G            ++AL   KGLY      +IR  P  +    + + I  +
Sbjct: 504 LDLSHNSLTGD----------SMDALSHLKGLYLNMASNNIRIIPPHLLPALSQQSIINL 553
Query: 577 IVFPLLGMVALFIALTGFFFIFHQRKNDSQTQQSSFGNTPGLRSV 621
              PL    +    +T +    H+ ++   +++++  N P LR V
Sbjct: 554 SHNPLDCTCSNIHFITWYKENLHKLED---SEETTCANPPSLRGV 595

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 68/144 (47%), Gaps = 8/144 (5%)
Query: 637 TNDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI 695
           T +F+    IG G  GSV++  K   G I+A+K+   PL G  S  ++  L E+ A   +
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAG--SVDEQNALREVYAHAVL 65
Query: 696 -RHRNIVKFYGFCSHPKHSFIIYEYLESGSL-DKILCNDASAKELGWTQRLNVIKGVADA 753
            +H ++V+++   +   H  I  EY   GSL D I  N          +  +++  V   
Sbjct: 66  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 125
Query: 754 LFYLHNNCFPPIVHRDISSKNVLL 777
           L Y+H+     +VH DI   N+ +
Sbjct: 126 LRYIHSMS---LVHMDIKPSNIFI 146

>pdb|3J0A|A Chain A, Homology Model Of Human Toll-Like Receptor 5 Fitted Into An Electron Microscopy Single Particle Reconstruction Length = 844

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 99/213 (46%), Gaps = 24/213 (11%)
Query: 327 LTFIDLSNNSFFGEILSDWGRCPQ------LSLLDVSIN----NISGSIPLEIGESLQLQ 376
           L+F  L+ NS +  +  DWG+C        L +LDVS N    +I+G+    I +S    
Sbjct: 176 LSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFS 235
Query: 377 YLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNF 436
            +   +++I+G          + N      N  +G + R      ++ +LDLS   + + 
Sbjct: 236 LI--LAHHIMG------AGFGFHNIKDPDQNTFAG-LARS-----SVRHLDLSHGFVFSL 281
Query: 437 VPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLE 496
                 +L  L  LNL++NK+++        L +L  L+LS+N LGE  SS    +  + 
Sbjct: 282 NSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVA 341
Query: 497 KLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKL 529
            ++L  N+++ +  + F+ +  L  +D+  N L
Sbjct: 342 YIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL 374

>pdb|1ZIW|A Chain A, Human Toll-Like Receptor 3 Extracellular Domain Structure Length = 680

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 105/426 (24%), Positives = 174/426 (40%), Gaps = 35/426 (8%)
Query: 104 SFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLH 163
           +F+ +  L  LD+  N +  + P     L  L+ L+   N+L           T+LT LH
Sbjct: 44  NFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELH 103
Query: 164 ISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQ 223
           +  N +     +   +   L  L L  N L+ +   +   L ++  L L NN       +
Sbjct: 104 LMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSE 163
Query: 224 EIGNL--KSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGXXXXXXX 281
           E+      SL  LEL  NQ+    P     +  L  LFL + +L   + +++        
Sbjct: 164 ELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANT- 222
Query: 282 XXXXXXHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEI 341
                         S RNL+    L  +Q   T N +     + NLT +DLS N+     
Sbjct: 223 --------------SIRNLS----LSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVG 264
Query: 342 LSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIP----TQLGNII 397
              +   PQL    +  NNI       +     ++YL+L  ++    I      ++ +  
Sbjct: 265 NDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFS 324
Query: 398 Y-----LNRLSLSGNKLSGCIPRELGSLINLEYLDLSAN--NLSNFVPESLGSLVK--LY 448
           +     L  L++  N + G        LINL+YL LS +  +L     E+  SL    L+
Sbjct: 325 FQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLH 384
Query: 449 YLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICR-MESLEKLNLSYNNLSG 507
            LNL+ NK+S+        L HL  LDL  N +G++++ +  R +E++ ++ LSYN    
Sbjct: 385 ILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQ 444
Query: 508 LIPRCF 513
           L    F
Sbjct: 445 LTRNSF 450

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 48/88 (54%), Gaps = 6/88 (6%)
Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           YLH+     +++RD+  +N+L+D      V+DFG AK +    + W+ L GT  Y+APE+
Sbjct: 177 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GATWT-LCGTPEYLAPEI 230
Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
             +    +  D ++ GVL  E+  G  P
Sbjct: 231 ILSKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/267 (22%), Positives = 116/267 (43%), Gaps = 35/267 (13%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRN--IVKF 703
           IG GG   V++      +I+A+K  +       +   + + NEI  L +++  +  I++ 
Sbjct: 16  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL--DSYRNEIAYLNKLQQHSDKIIRL 73
Query: 704 YGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFP 763
           Y +    ++   IY  +E G++D +       K +   +R +  K + +A+  +H +   
Sbjct: 74  YDYEITDQY---IYMVMECGNID-LNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG-- 127
Query: 764 PIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN--WSELAGTHGYVAPELAYTLKV 821
            IVH D+   N L+  G    + DFGIA  + PD+++       GT  Y+ PE    +  
Sbjct: 128 -IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 185
Query: 822 TEK-----------CDVYSFGVLALEVIKGKHPRDFLFEXXXXXXXXXIEMLDS--RLPY 868
           + +            DV+S G +   +  GK P    F+           ++D    + +
Sbjct: 186 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTP----FQQIINQISKLHAIIDPNHEIEF 241
Query: 869 PSLHVQKKLMSIMQVAFSCLDQNPESR 895
           P +  +K L  +++    CL ++P+ R
Sbjct: 242 PDI-PEKDLQDVLKC---CLKRDPKQR 264

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 86/201 (42%), Gaps = 18/201 (8%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G+G +G VY+A    + E  A+K+    L  E        + E+  L E++HRNI++  
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIR--LEHEEEGVPGTAIREVSLLKELQHRNIIELK 99
Query: 705 GFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFP- 763
               H     +I+EY E+  L K +  +           + VIK     L    N C   
Sbjct: 100 SVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVS-------MRVIKSFLYQLINGVNFCHSR 151
Query: 764 PIVHRDISSKNVLLDLGYEAH-----VSDFGIAKFLNPDSSNWSELAGTHGYVAPE-LAY 817
             +HRD+  +N+LL +   +      + DFG+A+        ++    T  Y  PE L  
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLG 211
Query: 818 TLKVTEKCDVYSFGVLALEVI 838
           +   +   D++S   +  E++
Sbjct: 212 SRHYSTSVDIWSIACIWAEML 232

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/205 (21%), Positives = 96/205 (46%), Gaps = 25/205 (12%)
Query: 646 IGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEE-----FLNEIQALTEIRHRN 699
           +G+G + +VY+ K   +  + A+K        E+  + EE      + E+  L +++H N
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALK--------EIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 700 IVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRL--NVIKGVADALFYL 757
           IV  +      K   +++EYL+   L + L +  +   +   +     +++G+A    Y 
Sbjct: 62  IVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLA----YC 116
Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPE-LA 816
           H      ++HRD+  +N+L++   E  ++DFG+A+  +  +  +     T  Y  P+ L 
Sbjct: 117 HRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILL 173
Query: 817 YTLKVTEKCDVYSFGVLALEVIKGK 841
            +   + + D++  G +  E+  G+
Sbjct: 174 GSTDYSTQIDMWGVGCIFYEMATGR 198

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 65/153 (42%), Gaps = 12/153 (7%)
Query: 696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSL-DKILCNDASAKELGWTQRLNVIKGVADAL 754
           +H NI+         K+ +++ E  + G L DKIL      K     +   V+  +   +
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELXKGGELLDKIL----RQKFFSEREASAVLFTITKTV 129
Query: 755 FYLHNNCFPPIVHRDISSKNVL-LDLG---YEAHVSDFGIAKFLNPDSSNWSELAGTHGY 810
            YLH      +VHRD+   N+L +D         + DFG AK L  ++        T  +
Sbjct: 130 EYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANF 186
Query: 811 VAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           VAPE+         CD++S GVL    + G  P
Sbjct: 187 VAPEVLERQGYDAACDIWSLGVLLYTXLTGYTP 219

>pdb|3RFJ|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 279

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 63/132 (47%), Gaps = 5/132 (3%)
Query: 392 QLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLN 451
           +L N+ YL    L+GN+L          L NL+ L L  N L +        L  L YL 
Sbjct: 83  ELTNLTYL---ILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLY 139
Query: 452 LSHNKLSQQIPIEL-DNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIP 510
           L HN+L Q +P  + D L +L+ LDL +N L         ++  L++L+L+ N L  +  
Sbjct: 140 LYHNQL-QSLPKGVFDKLTNLTRLDLDNNQLQSLPEGVFDKLTQLKQLSLNDNQLKSVPD 198
Query: 511 RCFEEMHGLLHI 522
             F+ +  L HI
Sbjct: 199 GVFDRLTSLTHI 210

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 26/79 (32%), Positives = 43/79 (54%), Gaps = 3/79 (3%)
Query: 765 IVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEK 824
           +++RD+  +N+L+D      V+DFG AK +      W+ L GT  Y+APE+  +    + 
Sbjct: 148 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWT-LCGTPEYLAPEIILSKGYNKA 204
Query: 825 CDVYSFGVLALEVIKGKHP 843
            D ++ GVL  E+  G  P
Sbjct: 205 VDWWALGVLIYEMAAGYPP 223

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 47/88 (53%), Gaps = 6/88 (6%)
Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           YLH+     +++RD+  +N+L+D      V+DFG AK +      W+ L GT  Y+APE+
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWT-LCGTPEYLAPEI 210
Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
             +    +  D ++ GVL  E+  G  P
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 59/267 (22%), Positives = 116/267 (43%), Gaps = 35/267 (13%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRN--IVKF 703
           IG GG   V++      +I+A+K  +       +   + + NEI  L +++  +  I++ 
Sbjct: 17  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL--DSYRNEIAYLNKLQQHSDKIIRL 74
Query: 704 YGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFP 763
           Y +    ++   IY  +E G++D +       K +   +R +  K + +A+  +H +   
Sbjct: 75  YDYEITDQY---IYMVMECGNID-LNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG-- 128
Query: 764 PIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN--WSELAGTHGYVAPELAYTLKV 821
            IVH D+   N L+  G    + DFGIA  + PD+++       GT  Y+ PE    +  
Sbjct: 129 -IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 822 TEK-----------CDVYSFGVLALEVIKGKHPRDFLFEXXXXXXXXXIEMLD--SRLPY 868
           + +            DV+S G +   +  GK P    F+           ++D    + +
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTP----FQQIINQISKLHAIIDPNHEIEF 242
Query: 869 PSLHVQKKLMSIMQVAFSCLDQNPESR 895
           P +  +K L  +++    CL ++P+ R
Sbjct: 243 PDI-PEKDLQDVLKC---CLKRDPKQR 265

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 24/74 (32%), Positives = 42/74 (56%), Gaps = 2/74 (2%)
Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAK--FLNPDSSNWSELAGTHGYVAPELAYTLKVTE 823
           +HRD++++N+LL       + DFG+A+  + +PD     +      ++APE  +    T 
Sbjct: 215 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 274
Query: 824 KCDVYSFGVLALEV 837
           + DV+SFGVL  E+
Sbjct: 275 QSDVWSFGVLLWEI 288

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 24/74 (32%), Positives = 42/74 (56%), Gaps = 2/74 (2%)
Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAK--FLNPDSSNWSELAGTHGYVAPELAYTLKVTE 823
           +HRD++++N+LL       + DFG+A+  + +PD     +      ++APE  +    T 
Sbjct: 220 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 279
Query: 824 KCDVYSFGVLALEV 837
           + DV+SFGVL  E+
Sbjct: 280 QSDVWSFGVLLWEI 293

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 24/74 (32%), Positives = 42/74 (56%), Gaps = 2/74 (2%)
Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAK--FLNPDSSNWSELAGTHGYVAPELAYTLKVTE 823
           +HRD++++N+LL       + DFG+A+  + +PD     +      ++APE  +    T 
Sbjct: 213 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 272
Query: 824 KCDVYSFGVLALEV 837
           + DV+SFGVL  E+
Sbjct: 273 QSDVWSFGVLLWEI 286

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 59/267 (22%), Positives = 116/267 (43%), Gaps = 35/267 (13%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRN--IVKF 703
           IG GG   V++      +I+A+K  +       +   + + NEI  L +++  +  I++ 
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL--DSYRNEIAYLNKLQQHSDKIIRL 121
Query: 704 YGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFP 763
           Y +    ++   IY  +E G++D +       K +   +R +  K + +A+  +H +   
Sbjct: 122 YDYEITDQY---IYMVMECGNID-LNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG-- 175
Query: 764 PIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN--WSELAGTHGYVAPELAYTLKV 821
            IVH D+   N L+  G    + DFGIA  + PD+++       GT  Y+ PE    +  
Sbjct: 176 -IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 233
Query: 822 TEK-----------CDVYSFGVLALEVIKGKHPRDFLFEXXXXXXXXXIEMLDS--RLPY 868
           + +            DV+S G +   +  GK P    F+           ++D    + +
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTP----FQQIINQISKLHAIIDPNHEIEF 289
Query: 869 PSLHVQKKLMSIMQVAFSCLDQNPESR 895
           P +  +K L  +++    CL ++P+ R
Sbjct: 290 PDI-PEKDLQDVLKC---CLKRDPKQR 312

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 24/74 (32%), Positives = 42/74 (56%), Gaps = 2/74 (2%)
Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAK--FLNPDSSNWSELAGTHGYVAPELAYTLKVTE 823
           +HRD++++N+LL       + DFG+A+  + +PD     +      ++APE  +    T 
Sbjct: 222 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 281
Query: 824 KCDVYSFGVLALEV 837
           + DV+SFGVL  E+
Sbjct: 282 QSDVWSFGVLLWEI 295

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           YLH+     +++RD+  +N+L+D      V+DFG AK +      W  L GT  Y+APE+
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEI 209
Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
             +    +  D ++ GVL  E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           YLH+     +++RD+  +N+L+D      V+DFG AK +      W  L GT  Y+APE+
Sbjct: 151 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEI 204
Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
             +    +  D ++ GVL  E+  G  P
Sbjct: 205 ILSKGYNKAVDWWALGVLIYEMAAGYPP 232

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 26/79 (32%), Positives = 42/79 (53%), Gaps = 3/79 (3%)
Query: 765 IVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEK 824
           +++RD+  +N+L+D      V+DFG AK +      W  L GT  Y+APE+  +    + 
Sbjct: 155 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 211
Query: 825 CDVYSFGVLALEVIKGKHP 843
            D ++ GVL  E+  G  P
Sbjct: 212 VDWWALGVLIYEMAAGYPP 230

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 26/79 (32%), Positives = 42/79 (53%), Gaps = 3/79 (3%)
Query: 765 IVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEK 824
           +++RD+  +N+L+D      V+DFG AK +      W  L GT  Y+APE+  +    + 
Sbjct: 155 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 211
Query: 825 CDVYSFGVLALEVIKGKHP 843
            D ++ GVL  E+  G  P
Sbjct: 212 VDWWALGVLIYEMAAGYPP 230

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           YLH+     +++RD+  +N+L+D      V+DFG AK +      W  L GT  Y+APE+
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LXGTPEYLAPEI 209
Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
             +    +  D ++ GVL  E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           YLH+     +++RD+  +N+L+D      V+DFG AK +      W  L GT  Y+APE+
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEI 210
Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
             +    +  D ++ GVL  E+  G  P
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           YLH+     +++RD+  +N+L+D      V+DFG AK +      W  L GT  Y+APE+
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEI 209
Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
             +    +  D ++ GVL  E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           YLH+     +++RD+  +N+L+D      V+DFG AK +      W  L GT  Y+APE+
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEI 210
Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
             +    +  D ++ GVL  E+  G  P
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           YLH+     +++RD+  +N+L+D      V+DFG AK +      W  L GT  Y+APE+
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEI 209
Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
             +    +  D ++ GVL  E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           YLH+     +++RD+  +N+L+D      V+DFG AK +      W  L GT  Y+APE+
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEI 210
Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
             +    +  D ++ GVL  E+  G  P
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           YLH+     +++RD+  +N+L+D      V+DFG AK +      W  L GT  Y+APE+
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEI 209
Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
             +    +  D ++ GVL  E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           YLH+     +++RD+  +N+L+D      V+DFG AK +      W  L GT  Y+APE+
Sbjct: 177 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEI 230
Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
             +    +  D ++ GVL  E+  G  P
Sbjct: 231 ILSKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           YLH+     +++RD+  +N+L+D      V+DFG AK +      W  L GT  Y+APE+
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEI 209
Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
             +    +  D ++ GVL  E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           YLH+     +++RD+  +N+L+D      V+DFG AK +      W  L GT  Y+APE+
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEI 210
Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
             +    +  D ++ GVL  E+  G  P
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           YLH+     +++RD+  +N+L+D      V+DFG AK +      W  L GT  Y+APE+
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEI 209
Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
             +    +  D ++ GVL  E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 47/88 (53%), Gaps = 6/88 (6%)
Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           YLH+     +++RD+  +N+++D      V+DFG+AK +      W  L GT  Y+APE+
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVK--GRTWX-LCGTPEYLAPEI 209
Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
             +    +  D ++ GVL  E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           YLH+     +++RD+  +N+L+D      V+DFG AK +      W  L GT  Y+APE+
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEI 209
Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
             +    +  D ++ GVL  E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           YLH+     +++RD+  +N+L+D      V+DFG AK +      W  L GT  Y+APE+
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEI 209
Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
             +    +  D ++ GVL  E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           YLH+     +++RD+  +N+L+D      V+DFG AK +      W  L GT  Y+APE+
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEI 209
Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
             +    +  D ++ GVL  E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 63/133 (47%), Gaps = 8/133 (6%)
Query: 714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSK 773
            I+ E L+ G L   +  D   +     +   ++K + +A+ YLH+     I HRD+  +
Sbjct: 89  LIVMECLDGGELFSRI-QDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPE 144
Query: 774 NVLLDLGYEAHV---SDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSF 830
           N+L        +   +DFG AK     +S  +E   T  YVAPE+    K  + CD++S 
Sbjct: 145 NLLYTSKRPNAILKLTDFGFAKETTSHNS-LTEPCYTPYYVAPEVLGPEKYDKSCDMWSL 203
Query: 831 GVLALEVIKGKHP 843
           GV+   ++ G  P
Sbjct: 204 GVIMYILLCGYPP 216

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           YLH+     +++RD+  +N+L+D      V+DFG AK +      W  L GT  Y+APE+
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEI 209
Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
             +    +  D ++ GVL  E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           YLH+     +++RD+  +N+L+D      V+DFG AK +      W  L GT  Y+APE+
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEI 209
Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
             +    +  D ++ GVL  E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           YLH+     +++RD+  +N+L+D      V+DFG AK +      W  L GT  Y+APE+
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEI 210
Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
             +    +  D ++ GVL  E+  G  P
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           YLH+     +++RD+  +N+L+D      V+DFG AK +      W  L GT  Y+APE+
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEI 209
Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
             +    +  D ++ GVL  E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           YLH+     +++RD+  +N+L+D      V+DFG AK +      W  L GT  Y+APE+
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEI 210
Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
             +    +  D ++ GVL  E+  G  P
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           YLH+     +++RD+  +N+L+D      V+DFG AK +      W  L GT  Y+APE+
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEI 209
Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
             +    +  D ++ GVL  E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           YLH+     +++RD+  +N+L+D      V+DFG AK +      W  L GT  Y+APE+
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEI 209
Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
             +    +  D ++ GVL  E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           YLH+     +++RD+  +N+L+D      V+DFG AK +      W  L GT  Y+APE+
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEI 209
Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
             +    +  D ++ GVL  E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 26/79 (32%), Positives = 42/79 (53%), Gaps = 3/79 (3%)
Query: 765 IVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEK 824
           +++RD+  +N+L+D      V+DFG AK +      W  L GT  Y+APE+  +    + 
Sbjct: 183 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 239
Query: 825 CDVYSFGVLALEVIKGKHP 843
            D ++ GVL  E+  G  P
Sbjct: 240 VDWWALGVLIYEMAAGYPP 258

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           YLH+     +++RD+  +N+L+D      V+DFG AK +      W  L GT  Y+APE+
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEI 209
Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
             +    +  D ++ GVL  E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           YLH+     +++RD+  +N+L+D      V+DFG AK +      W  L GT  Y+APE+
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEI 209
Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
             +    +  D ++ GVL  E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           YLH+     +++RD+  +N+L+D      V+DFG AK +      W  L GT  Y+APE+
Sbjct: 143 YLHS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEI 196
Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
             +    +  D ++ GVL  E+  G  P
Sbjct: 197 ILSKGYNKAVDWWALGVLIYEMAAGYPP 224

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           YLH+     +++RD+  +N+L+D      V+DFG AK +      W  L GT  Y+APE+
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEI 209
Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
             +    +  D ++ GVL  E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 45/207 (21%), Positives = 94/207 (45%), Gaps = 20/207 (9%)
Query: 646 IGKGGHGSVYRAK--VPSGEIFAVKKFHSPLPGE-MSFQQEEFLNEIQALTEIRHRNIVK 702
           IG+G +G V++A+     G   A+K+       E M       +  ++ L    H N+V+
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 703 FYGFCSHPKHS-----FIIYEYLE---SGSLDKILCNDASAKELGWTQRLNVIKGVADAL 754
            +  C+  +        +++E+++   +  LDK+        E        +++G    L
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV-PEPGVPTETIKDMMFQLLRG----L 133
Query: 755 FYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPE 814
            +LH++    +VHRD+  +N+L+    +  ++DFG+A+  +   +  + +  T  Y APE
Sbjct: 134 DFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA-LTSVVVTLWYRAPE 189
Query: 815 LAYTLKVTEKCDVYSFGVLALEVIKGK 841
           +          D++S G +  E+ + K
Sbjct: 190 VLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 59/267 (22%), Positives = 116/267 (43%), Gaps = 35/267 (13%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRN--IVKF 703
           IG GG   V++      +I+A+K  +       +   + + NEI  L +++  +  I++ 
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL--DSYRNEIAYLNKLQQHSDKIIRL 121
Query: 704 YGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFP 763
           Y +    ++   IY  +E G++D +       K +   +R +  K + +A+  +H +   
Sbjct: 122 YDYEITDQY---IYMVMECGNID-LNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG-- 175
Query: 764 PIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN--WSELAGTHGYVAPELAYTLKV 821
            IVH D+   N L+  G    + DFGIA  + PD+++       GT  Y+ PE    +  
Sbjct: 176 -IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 233
Query: 822 TEK-----------CDVYSFGVLALEVIKGKHPRDFLFEXXXXXXXXXIEMLDS--RLPY 868
           + +            DV+S G +   +  GK P    F+           ++D    + +
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTP----FQQIINQISKLHAIIDPNHEIEF 289
Query: 869 PSLHVQKKLMSIMQVAFSCLDQNPESR 895
           P +  +K L  +++    CL ++P+ R
Sbjct: 290 PDI-PEKDLQDVLKC---CLKRDPKQR 312

>pdb|3B2D|A Chain A, Crystal Structure Of Human Rp105MD-1 Complex Length = 603

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 120/451 (26%), Positives = 184/451 (40%), Gaps = 79/451 (17%)
Query: 117 YNNELFGI--IPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISR---NWLSG 171
           YN E  G+  IP  + N +  E+L+FS N L          L +LT L ++R   NW+  
Sbjct: 14  YNCENLGLSEIPDTLPNTT--EFLEFSFNFLPTIHNRTFSRLMNLTFLDLTRCQINWIHE 71
Query: 172 SIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSL 231
                  QL+ L                    LT   ++++   S  G  P+   +LK L
Sbjct: 72  DTFQSHHQLSTLV-------------------LTGNPLIFMAETSLNG--PK---SLKHL 107
Query: 232 FDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGI-IPQEI-GXXXXXXXXXXXXXHF 289
           F ++  I+ L   IP  + NL NL  L+L  N +S I  P++                H+
Sbjct: 108 FLIQTGISNLE-FIP--VHNLENLESLYLGSNHISSIKFPKDFPARNLKVLDFQNNAIHY 164
Query: 290 RGTVPKSFRNLTDLVKLRLNQNYLTGN---------------ISETFGTYPNLTFI--DL 332
                +  R+L   + L LN N   GN                S  FG  PNL+ I   L
Sbjct: 165 ISR--EDMRSLEQAINLSLNFN---GNNVKGIELGAFDSTIFQSLNFGGTPNLSVIFNGL 219
Query: 333 SNNSFFGEILSDW-GRCPQLSLLDVSINNISGSIPLEIGESLQLQ---YLDLSSNYIVGE 388
            N++      S W G    +   D+S   + G   + + ESL LQ   + D+SS      
Sbjct: 220 QNST----TQSLWLGTFEDIDDEDISSAMLKGLCEMSV-ESLNLQEHRFSDISS------ 268
Query: 389 IPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLY 448
             T       L  L L+   L G +P  +  L  L+ L LS N+       S  +   L 
Sbjct: 269 --TTFQCFTQLQELDLTATHLKG-LPSGMKGLNLLKKLVLSVNHFDQLCQISAANFPSLT 325
Query: 449 YLNLSHNKLSQQIPIE-LDNLIHLSELDLSHNFL--GEKISSRICRMESLEKLNLSYNNL 505
           +L +  N     + +  L+ L +L  LDLSHN +   +  S ++  +  L+ LNLS+N  
Sbjct: 326 HLYIRGNVKKLHLGVGCLEKLGNLQTLDLSHNDIEASDCCSLQLKNLSHLQTLNLSHNEP 385
Query: 506 SGLIPRCFEEMHGLLHIDISYNKLEGQIPNS 536
            GL  + F+E   L  +D+++ +L    P S
Sbjct: 386 LGLQSQAFKECPQLELLDLAFTRLHINAPQS 416

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/220 (20%), Positives = 97/220 (44%), Gaps = 20/220 (9%)
Query: 633 IISATNDFNAEHCIGKGGHGSVYRAK--VPSGEIFAVKKFHSPLPGE-MSFQQEEFLNEI 689
           +  A   +     IG+G +G V++A+     G   A+K+       E M       +  +
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 690 QALTEIRHRNIVKFYGFCSHPKHS-----FIIYEYLE---SGSLDKILCNDASAKELGWT 741
           + L    H N+V+ +  C+  +        +++E+++   +  LDK+        E    
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV-PEPGVPTETIKD 124
Query: 742 QRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNW 801
               +++G    L +LH++    +VHRD+  +N+L+    +  ++DFG+A+  +   +  
Sbjct: 125 MMFQLLRG----LDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA-L 176
Query: 802 SELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGK 841
           + +  T  Y APE+          D++S G +  E+ + K
Sbjct: 177 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           YLH+     +++RD+  +N+L+D      V+DFG AK +      W  L GT  Y+APE+
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK--GRTWX-LCGTPEYLAPEI 209
Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
             +    +  D ++ GVL  E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 47/88 (53%), Gaps = 6/88 (6%)
Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           YLH+     +++RD+  +N+++D      V+DFG+AK +      W  L GT  Y+APE+
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVK--GRTWX-LCGTPEYLAPEI 209
Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
             +    +  D ++ GVL  E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           YLH+     +++RD+  +N+L+D      V+DFG AK +      W  L GT  Y+APE+
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK--GRTWX-LCGTPEYLAPEI 209
Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
             +    +  D ++ GVL  E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 59/267 (22%), Positives = 113/267 (42%), Gaps = 35/267 (13%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRN--IVKF 703
           IG GG   V++      +I+A+K  +       +   + + NEI  L +++  +  I++ 
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL--DSYRNEIAYLNKLQQHSDKIIRL 93
Query: 704 YGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFP 763
           Y +    ++   IY  +E G++D +       K +   +R +  K + +A+  +H +   
Sbjct: 94  YDYEITDQY---IYMVMECGNID-LNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG-- 147
Query: 764 PIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN--WSELAGTHGYVAPELAYTLKV 821
            IVH D+   N L+  G    + DFGIA  + PD          GT  Y+ PE    +  
Sbjct: 148 -IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 822 TEK-----------CDVYSFGVLALEVIKGKHPRDFLFEXXXXXXXXXIEMLDS--RLPY 868
           + +            DV+S G +   +  GK P    F+           ++D    + +
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTP----FQQIINQISKLHAIIDPNHEIEF 261
Query: 869 PSLHVQKKLMSIMQVAFSCLDQNPESR 895
           P +  +K L  +++    CL ++P+ R
Sbjct: 262 PDI-PEKDLQDVLKC---CLKRDPKQR 284

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           YLH+     +++RD+  +N+L+D      V+DFG AK +      W  L GT  Y+APE+
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK--GRTWX-LCGTPEYLAPEI 210
Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
             +    +  D ++ GVL  E+  G  P
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           YLH+     +++RD+  +N+L+D      V+DFG AK +      W  L GT  Y+APE+
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK--GRTWX-LCGTPEYLAPEI 209
Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
             +    +  D ++ GVL  E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/220 (20%), Positives = 97/220 (44%), Gaps = 20/220 (9%)
Query: 633 IISATNDFNAEHCIGKGGHGSVYRAK--VPSGEIFAVKKFHSPLPGE-MSFQQEEFLNEI 689
           +  A   +     IG+G +G V++A+     G   A+K+       E M       +  +
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 690 QALTEIRHRNIVKFYGFCSHPKHS-----FIIYEYLE---SGSLDKILCNDASAKELGWT 741
           + L    H N+V+ +  C+  +        +++E+++   +  LDK+        E    
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV-PEPGVPTETIKD 124
Query: 742 QRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNW 801
               +++G    L +LH++    +VHRD+  +N+L+    +  ++DFG+A+  +   +  
Sbjct: 125 MMFQLLRG----LDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA-L 176
Query: 802 SELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGK 841
           + +  T  Y APE+          D++S G +  E+ + K
Sbjct: 177 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           YLH+     +++RD+  +N+++D      V+DFG AK +      W  L GT  Y+APE+
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEI 209
Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
             +    +  D ++ GVL  E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           YLH+     +++RD+  +N+++D      V+DFG AK +      W  L GT  Y+APE+
Sbjct: 156 YLHS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEI 209
Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
             +    +  D ++ GVL  E+  G  P
Sbjct: 210 IISKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4B8C|D Chain D, Nuclease Module Of The Yeast Ccr4-Not Complex Length = 727

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/107 (36%), Positives = 58/107 (54%), Gaps = 4/107 (3%)
Query: 378 LDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFV 437
           LDLS N  +  I   +    +L RL L+GN L+  +P E+ +L NL  LDLS N L++ +
Sbjct: 229 LDLS-NLQIFNISANIFKYDFLTRLYLNGNSLTE-LPAEIKNLSNLRVLDLSHNRLTS-L 285
Query: 438 PESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEK 484
           P  LGS  +L Y     N ++  +P E  NL +L  L +  N L ++
Sbjct: 286 PAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQ 331

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           YLH+     +++RD+  +N+++D      V+DFG AK +      W  L GT  Y+APE+
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRTWX-LCGTPEYLAPEI 210
Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
             +    +  D ++ GVL  E+  G  P
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           YLH+     +++RD+  +N+++D      V+DFG AK +      W  L GT  Y+APE+
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRTWX-LCGTPEYLAPEI 210
Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
             +    +  D ++ GVL  E+  G  P
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           YLH+     +++RD+  +N+++D      V+DFG AK +      W  L GT  Y+APE+
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRTWX-LCGTPEYLAPEI 210
Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
             +    +  D ++ GVL  E+  G  P
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           YLH+     +++RD+  +N+++D      V+DFG AK +      W  L GT  Y+APE+
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRTWX-LCGTPEYLAPEI 210
Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
             +    +  D ++ GVL  E+  G  P
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/79 (31%), Positives = 42/79 (53%), Gaps = 3/79 (3%)
Query: 765 IVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEK 824
           +++RD+  +N+++D      V+DFG AK +      W  L GT  Y+APE+  +    + 
Sbjct: 162 LIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 825 CDVYSFGVLALEVIKGKHP 843
            D ++ GVL  E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           YLH+     +++RD+  +N+++D      V+DFG AK +      W  L GT  Y+APE+
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRTWX-LCGTPEYLAPEI 209
Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
             +    +  D ++ GVL  E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           YLH+     +++RD+  +N+L+D      V+DFG AK +      W  L GT  Y+APE+
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEI 209
Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
             +    +  D ++ GVL  ++  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYQMAAGYPP 237

>pdb|3M18|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor Vlra.R2.1 In Complex With Hen Egg Lysozyme Length = 251

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Composition-based stats.
 Identities = 38/148 (25%), Positives = 68/148 (45%), Gaps = 3/148 (2%)
Query: 401 RLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQ 460
           +L L    L+         L  L +L+L  N L          L +L  L L++N+L+  
Sbjct: 39  KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS- 97
Query: 461 IPIEL-DNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGL 519
           +P+ + D+L  L +L L  N L    S    R+  L++L L+ N L  +    F+++  L
Sbjct: 98  LPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNL 157
Query: 520 LHIDISYNKLEGQIPNSTTFRDAPLEAL 547
             + +S N+L+  +P+    R   L+ +
Sbjct: 158 QTLSLSTNQLQ-SVPHGAFDRLGKLQTI 184

>pdb|3M19|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor Vlra.R5.1 Length = 251

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Composition-based stats.
 Identities = 38/148 (25%), Positives = 68/148 (45%), Gaps = 3/148 (2%)
Query: 401 RLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQ 460
           +L L    L+         L  L +L+L  N L          L +L  L L++N+L+  
Sbjct: 39  KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS- 97
Query: 461 IPIEL-DNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGL 519
           +P+ + D+L  L +L L  N L    S    R+  L++L L+ N L  +    F+++  L
Sbjct: 98  LPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNL 157
Query: 520 LHIDISYNKLEGQIPNSTTFRDAPLEAL 547
             + +S N+L+  +P+    R   L+ +
Sbjct: 158 QTLSLSTNQLQ-SVPHGAFDRLGKLQTI 184

>pdb|2O6S|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors B59 Length = 208

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 81/169 (47%), Gaps = 15/169 (8%)
Query: 110 HLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGI-GLLTHLTVLHISRNW 168
              YLDL  N L  +       L++L  L    NKL   +P+G+   LT LT L++S N 
Sbjct: 29  QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKL-QSLPNGVFNKLTSLTYLNLSTNQ 87
Query: 169 LSGSIPHEV-GQLTVLNQLALDSNFLNGSIPRSL-GNLTHVVILYLYNNSFFGSIPQEI- 225
           L  S+P+ V  +LT L +LAL++N L  S+P  +   LT +  L LY N    S+P  + 
Sbjct: 88  LQ-SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQ-LKSVPDGVF 144
Query: 226 GNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIG 274
             L SL  + L  N      P        +R+L  + N+ SG++    G
Sbjct: 145 DRLTSLQYIWLHDNPWDCTCP-------GIRYLSEWINKHSGVVRNSAG 186

>pdb|2O6S|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors B59 Length = 208

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 71/175 (40%), Gaps = 9/175 (5%)
Query: 363 GSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLIN 422
           G   +  G   Q  YLDL +N +          +  L +L L GNKL          L +
Sbjct: 18  GRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTS 77
Query: 423 LEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIEL-DNLIHLSELDLSHNFL 481
           L YL+LS N L +        L +L  L L+ N+L Q +P  + D L  L +L L  N L
Sbjct: 78  LTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQL-QSLPDGVFDKLTQLKDLRLYQNQL 136
Query: 482 GEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNS 536
                    R+ SL+ + L  N      P       G+ ++    NK  G + NS
Sbjct: 137 KSVPDGVFDRLTSLQYIWLHDNPWDCTCP-------GIRYLSEWINKHSGVVRNS 184

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 69/250 (27%), Positives = 103/250 (41%), Gaps = 50/250 (20%)
Query: 629 VYEEIISATNDFNAEHCIGKGGHGSVYRA----KVPSGEIFAVKKFHSPLPGEMSFQQEE 684
           +YE +   +N F  E  IG+G   SVY A    +V   E  A+K     +P     +   
Sbjct: 12  LYEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHL---IPTSHPIR--- 65
Query: 685 FLNEIQALTEIRHRNIVKFYGFC-SHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQR 743
              E+Q LT    ++ V    +C     H  I   YLE  S   IL N  S +E+     
Sbjct: 66  IAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDIL-NSLSFQEV-REYM 123
Query: 744 LNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAH-VSDFGIA----------- 791
           LN+ K    AL  +H      IVHRD+   N L +   + + + DFG+A           
Sbjct: 124 LNLFK----ALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELL 176
Query: 792 KFLNPDSSNW-----------------SELAGTHGYVAPE-LAYTLKVTEKCDVYSFGVL 833
           KF+  ++                    +  AGT G+ APE L      T   D++S GV+
Sbjct: 177 KFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVI 236
Query: 834 ALEVIKGKHP 843
            L ++ G++P
Sbjct: 237 FLSLLSGRYP 246

>pdb|2Z64|A Chain A, Crystal Structure Of Mouse Tlr4 And Mouse Md-2 Complex Length = 599

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/133 (31%), Positives = 66/133 (49%), Gaps = 8/133 (6%)
Query: 357 SINNISGSI-PLEIGESL------QLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKL 409
           S  NI  S  PL+I +S       +LQ+LDLS   I          + +L+ L L+GN +
Sbjct: 28  STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPI 87
Query: 410 SGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKL-SQQIPIELDNL 468
               P     L +LE L      L++     +G L+ L  LN++HN + S ++P    NL
Sbjct: 88  QSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNL 147
Query: 469 IHLSELDLSHNFL 481
            +L  +DLS+N++
Sbjct: 148 TNLVHVDLSYNYI 160

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 62/133 (46%), Gaps = 8/133 (6%)
Query: 714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSK 773
            I+ E L+ G L   +  D   +     +   ++K + +A+ YLH+     I HRD+  +
Sbjct: 97  LIVMECLDGGELFSRI-QDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPE 152
Query: 774 NVLLDLGYEAHV---SDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSF 830
           N+L        +   +DFG AK     +S  +    T  YVAPE+    K  + CD++S 
Sbjct: 153 NLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 211
Query: 831 GVLALEVIKGKHP 843
           GV+   ++ G  P
Sbjct: 212 GVIMYILLCGYPP 224

>pdb|3VQ1|A Chain A, Crystal Structure Of Mouse Tlr4MD-2LIPID IVA COMPLEX Length = 606

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/133 (31%), Positives = 66/133 (49%), Gaps = 8/133 (6%)
Query: 357 SINNISGSI-PLEIGESL------QLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKL 409
           S  NI  S  PL+I +S       +LQ+LDLS   I          + +L+ L L+GN +
Sbjct: 33  STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPI 92
Query: 410 SGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKL-SQQIPIELDNL 468
               P     L +LE L      L++     +G L+ L  LN++HN + S ++P    NL
Sbjct: 93  QSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNL 152
Query: 469 IHLSELDLSHNFL 481
            +L  +DLS+N++
Sbjct: 153 TNLVHVDLSYNYI 165

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 62/133 (46%), Gaps = 8/133 (6%)
Query: 714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSK 773
            I+ E L+ G L   +  D   +     +   ++K + +A+ YLH+     I HRD+  +
Sbjct: 96  LIVMECLDGGELFSRI-QDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPE 151
Query: 774 NVLLDLGYEAHV---SDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSF 830
           N+L        +   +DFG AK     +S  +    T  YVAPE+    K  + CD++S 
Sbjct: 152 NLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 210
Query: 831 GVLALEVIKGKHP 843
           GV+   ++ G  P
Sbjct: 211 GVIMYILLCGYPP 223

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 84/191 (43%), Gaps = 25/191 (13%)
Query: 619 RSVLTFEGKIVYEEIISATNDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGE 677
           R  L F+G I+    +   +++  +H IG+G +G VY A    + +  A+KK +      
Sbjct: 11  RENLYFQGAIIKN--VKVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDL 68
Query: 678 MSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYE-YLESGSLDKIL-CNDASA 735
           +  ++   L EI  L  ++   I++         H  II E  L+   L  +L   D+  
Sbjct: 69  IDCKR--ILREITILNRLKSDYIIRL--------HDLIIPEDLLKFDELYIVLEIADSDL 118
Query: 736 KELGWTQRLNVIKGVADALF-------YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDF 788
           K+L  T      + V   L+       ++H +    I+HRD+   N LL+      + DF
Sbjct: 119 KKLFKTPIFLTEQHVKTILYNLLLGEKFIHESG---IIHRDLKPANCLLNQDCSVKICDF 175
Query: 789 GIAKFLNPDSS 799
           G+A+ +N D  
Sbjct: 176 GLARTINSDKD 186

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 62/133 (46%), Gaps = 8/133 (6%)
Query: 714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSK 773
            I+ E L+ G L   +  D   +     +   ++K + +A+ YLH+     I HRD+  +
Sbjct: 105 LIVMECLDGGELFSRI-QDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPE 160
Query: 774 NVLLDLGYEAHV---SDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSF 830
           N+L        +   +DFG AK     +S  +    T  YVAPE+    K  + CD++S 
Sbjct: 161 NLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 219
Query: 831 GVLALEVIKGKHP 843
           GV+   ++ G  P
Sbjct: 220 GVIMYILLCGYPP 232

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 62/133 (46%), Gaps = 8/133 (6%)
Query: 714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSK 773
            I+ E L+ G L   +  D   +     +   ++K + +A+ YLH+     I HRD+  +
Sbjct: 95  LIVMECLDGGELFSRI-QDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPE 150
Query: 774 NVLLDLGYEAHV---SDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSF 830
           N+L        +   +DFG AK     +S  +    T  YVAPE+    K  + CD++S 
Sbjct: 151 NLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 209
Query: 831 GVLALEVIKGKHP 843
           GV+   ++ G  P
Sbjct: 210 GVIMYILLCGYPP 222

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 94/221 (42%), Gaps = 27/221 (12%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVK-----KFHSPLPGEMSFQQEEFLNEIQALTEIRHRN 699
           IGKG    V R     +G+ FAVK     KF S  PG      E+   E      ++H +
Sbjct: 34  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSS-PG---LSTEDLKREASICHMLKHPH 89
Query: 700 IVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNV----IKGVADALF 755
           IV+     S     ++++E+++   L   +   A A   G+     V    ++ + +AL 
Sbjct: 90  IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADA---GFVYSEAVASHYMRQILEALR 146
Query: 756 YLHNNCFPPIVHRDISSKNVLL---DLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVA 812
           Y H+N    I+HRD+    VLL   +      +  FG+A  L           GT  ++A
Sbjct: 147 YCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMA 203
Query: 813 PELAYTLKVTEKCDVYSFGVLALEVIKGKHP----RDFLFE 849
           PE+       +  DV+  GV+   ++ G  P    ++ LFE
Sbjct: 204 PEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFE 244

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 62/133 (46%), Gaps = 8/133 (6%)
Query: 714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSK 773
            I+ E L+ G L   +  D   +     +   ++K + +A+ YLH+     I HRD+  +
Sbjct: 90  LIVMECLDGGELFSRI-QDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPE 145
Query: 774 NVLLDLGYEAHV---SDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSF 830
           N+L        +   +DFG AK     +S  +    T  YVAPE+    K  + CD++S 
Sbjct: 146 NLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 204
Query: 831 GVLALEVIKGKHP 843
           GV+   ++ G  P
Sbjct: 205 GVIMYILLCGYPP 217

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 62/133 (46%), Gaps = 8/133 (6%)
Query: 714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSK 773
            I+ E L+ G L   +  D   +     +   ++K + +A+ YLH+     I HRD+  +
Sbjct: 89  LIVMECLDGGELFSRI-QDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPE 144
Query: 774 NVLLDLGYEAHV---SDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSF 830
           N+L        +   +DFG AK     +S  +    T  YVAPE+    K  + CD++S 
Sbjct: 145 NLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 203
Query: 831 GVLALEVIKGKHP 843
           GV+   ++ G  P
Sbjct: 204 GVIMYILLCGYPP 216

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 58/267 (21%), Positives = 115/267 (43%), Gaps = 35/267 (13%)
Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRN--IVKF 703
           IG GG   V++      +I+A+K  +       +   + + NEI  L +++  +  I++ 
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL--DSYRNEIAYLNKLQQHSDKIIRL 121
Query: 704 YGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFP 763
           Y +    ++   IY  +E G++D +       K +   +R +  K + +A+  +H +   
Sbjct: 122 YDYEITDQY---IYMVMECGNID-LNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG-- 175
Query: 764 PIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN--WSELAGTHGYVAPELAYTLKV 821
            IVH D+   N L+  G    + DFGIA  + PD+++       G   Y+ PE    +  
Sbjct: 176 -IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233
Query: 822 TEK-----------CDVYSFGVLALEVIKGKHPRDFLFEXXXXXXXXXIEMLDS--RLPY 868
           + +            DV+S G +   +  GK P    F+           ++D    + +
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTP----FQQIINQISKLHAIIDPNHEIEF 289
Query: 869 PSLHVQKKLMSIMQVAFSCLDQNPESR 895
           P +  +K L  +++    CL ++P+ R
Sbjct: 290 PDI-PEKDLQDVLKC---CLKRDPKQR 312

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 88/200 (44%), Gaps = 15/200 (7%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           IG G  G V  A     G   AVKK   P   +   ++     E+  L  + H+NI+   
Sbjct: 30  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRA--YRELVLLKCVNHKNIISLL 87
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P+ +   ++  YL    +D  LC      EL   +   ++  +   + +LH+   
Sbjct: 88  NVFT-PQKTLEEFQDVYLVMELMDANLCQ-VIHMELDHERMSYLLYQMLCGIKHLHSAG- 144
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNW--SELAGTHGYVAPELAYTLK 820
             I+HRD+   N+++       + DFG+A+     S+N+  +    T  Y APE+   + 
Sbjct: 145 --IIHRDLKPSNIVVKSDCTLKILDFGLARTA---STNFMMTPYVVTRYYRAPEVILGMG 199
Query: 821 VTEKCDVYSFGVLALEVIKG 840
             E  D++S G +  E++KG
Sbjct: 200 YKENVDIWSVGCIMGELVKG 219

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 6/88 (6%)
Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           YLH+     +++RD+  +N+L+D      V+DFG AK +      W  L GT  Y+AP +
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPAI 209
Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
             +    +  D ++ GVL  E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 62/133 (46%), Gaps = 8/133 (6%)
Query: 714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSK 773
            I+ E L+ G L   +  D   +     +   ++K + +A+ YLH+     I HRD+  +
Sbjct: 91  LIVMECLDGGELFSRI-QDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPE 146
Query: 774 NVLLDLGYEAHV---SDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSF 830
           N+L        +   +DFG AK     +S  +    T  YVAPE+    K  + CD++S 
Sbjct: 147 NLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 205
Query: 831 GVLALEVIKGKHP 843
           GV+   ++ G  P
Sbjct: 206 GVIMYILLCGYPP 218

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 62/133 (46%), Gaps = 8/133 (6%)
Query: 714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSK 773
            I+ E L+ G L   +  D   +     +   ++K + +A+ YLH+     I HRD+  +
Sbjct: 141 LIVMECLDGGELFSRI-QDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPE 196
Query: 774 NVLLDLGYEAHV---SDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSF 830
           N+L        +   +DFG AK     +S  +    T  YVAPE+    K  + CD++S 
Sbjct: 197 NLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 255
Query: 831 GVLALEVIKGKHP 843
           GV+   ++ G  P
Sbjct: 256 GVIMYILLCGYPP 268

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 62/133 (46%), Gaps = 8/133 (6%)
Query: 714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSK 773
            I+ E L+ G L   +  D   +     +   ++K + +A+ YLH+     I HRD+  +
Sbjct: 135 LIVMECLDGGELFSRI-QDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPE 190
Query: 774 NVLLDLGYEAHV---SDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSF 830
           N+L        +   +DFG AK     +S  +    T  YVAPE+    K  + CD++S 
Sbjct: 191 NLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 249
Query: 831 GVLALEVIKGKHP 843
           GV+   ++ G  P
Sbjct: 250 GVIMYILLCGYPP 262

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 91/205 (44%), Gaps = 25/205 (12%)
Query: 646 IGKGGHGSVYRAKVPSGEI-FAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           IG G  G V  A     E   A+KK   P   +   ++     E+  +  + H+NI+   
Sbjct: 32  IGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRA--YRELVLMKVVNHKNIIGLL 89
Query: 705 GFCSHPKHS-------FIIYEYLESGSLDKILCNDASAKELGWT--QRLNVIKGVADALF 755
              + P+ S       +I+ E +++ +L +++  +   + + +   Q L  IK       
Sbjct: 90  NVFT-PQKSLEEFQDVYIVMELMDA-NLSQVIQMELDHERMSYLLYQMLVGIK------- 140
Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           +LH+     I+HRD+   N+++       + DFG+A+     S   +    T  Y APE+
Sbjct: 141 HLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEV 196
Query: 816 AYTLKVTEKCDVYSFGVLALEVIKG 840
              +   E  D++S GV+  E+IKG
Sbjct: 197 ILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 94/221 (42%), Gaps = 27/221 (12%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVK-----KFHSPLPGEMSFQQEEFLNEIQALTEIRHRN 699
           IGKG    V R     +G+ FAVK     KF S  PG      E+   E      ++H +
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSS-PG---LSTEDLKREASICHMLKHPH 87
Query: 700 IVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNV----IKGVADALF 755
           IV+     S     ++++E+++   L   +   A A   G+     V    ++ + +AL 
Sbjct: 88  IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADA---GFVYSEAVASHYMRQILEALR 144
Query: 756 YLHNNCFPPIVHRDISSKNVLL---DLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVA 812
           Y H+N    I+HRD+    VLL   +      +  FG+A  L           GT  ++A
Sbjct: 145 YCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMA 201
Query: 813 PELAYTLKVTEKCDVYSFGVLALEVIKGKHP----RDFLFE 849
           PE+       +  DV+  GV+   ++ G  P    ++ LFE
Sbjct: 202 PEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFE 242

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 62/133 (46%), Gaps = 8/133 (6%)
Query: 714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSK 773
            I+ E L+ G L   +  D   +     +   ++K + +A+ YLH+     I HRD+  +
Sbjct: 91  LIVMECLDGGELFSRI-QDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPE 146
Query: 774 NVLLDLGYEAHV---SDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSF 830
           N+L        +   +DFG AK     +S  +    T  YVAPE+    K  + CD++S 
Sbjct: 147 NLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 205
Query: 831 GVLALEVIKGKHP 843
           GV+   ++ G  P
Sbjct: 206 GVIMYILLCGYPP 218

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 96/216 (44%), Gaps = 32/216 (14%)
Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G GG+G V+ A      +  A+KK     P  +    +  L EI+ +  + H NIVK +
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSV----KHALREIKIIRRLDHDNIVKVF 74
Query: 705 --------------GFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGV 750
                         G  +     +I+ EY+E+  L  +L      +E        +++G 
Sbjct: 75  EILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEEHARLFMYQLLRG- 132
Query: 751 ADALFYLHNNCFPPIVHRDISSKNVLLDL-GYEAHVSDFGIAKFLNPDSSNWSELAG--- 806
              L Y+H+     ++HRD+   N+ ++       + DFG+A+ ++P  S+   L+    
Sbjct: 133 ---LKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV 186
Query: 807 THGYVAPELAYTL-KVTEKCDVYSFGVLALEVIKGK 841
           T  Y +P L  +    T+  D+++ G +  E++ GK
Sbjct: 187 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 85/198 (42%), Gaps = 11/198 (5%)
Query: 646 IGKGGHGSVYRAKVPSGEI-FAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           IG G  G V  A     E   A+KK   P   +   ++     E+  +  + H+NI+   
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRA--YRELVLMKCVNHKNIIGLL 89
Query: 705 GFCSHPKHSFIIYE--YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
              + P+ S   ++  Y+    +D  LC      EL   +   ++  +   + +LH+   
Sbjct: 90  NVFT-PQKSLEEFQDVYIVMELMDANLCQ-VIQMELDHERMSYLLYQMLCGIKHLHSAG- 146
Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVT 822
             I+HRD+   N+++       + DFG+A+          E+  T  Y APE+   +   
Sbjct: 147 --IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVV-TRYYRAPEVILGMGYK 203
Query: 823 EKCDVYSFGVLALEVIKG 840
           E  D++S G +  E+IKG
Sbjct: 204 ENVDIWSVGCIMGEMIKG 221

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 92/207 (44%), Gaps = 29/207 (14%)
Query: 646 IGKGGHG---SVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVK 702
           IG G  G   + Y A +      A+KK   P   +   ++     E+  +  + H+NI+ 
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRA--YRELVLMKVVNHKNIIG 87
Query: 703 FYGFCSHPKHS-------FIIYEYLESGSLDKILCNDASAKELGWT--QRLNVIKGVADA 753
                + P+ S       +I+ E +++ +L +++  +   + + +   Q L  IK     
Sbjct: 88  LLNVFT-PQKSLEEFQDVYIVMELMDA-NLSQVIQMELDHERMSYLLYQMLVGIK----- 140
Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAP 813
             +LH+     I+HRD+   N+++       + DFG+A+     S   +    T  Y AP
Sbjct: 141 --HLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG-TSFMMTPYVVTRYYRAP 194
Query: 814 ELAYTLKVTEKCDVYSFGVLALEVIKG 840
           E+   +   E  D++S GV+  E+IKG
Sbjct: 195 EVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3FXI|A Chain A, Crystal Structure Of The Human Tlr4-Human Md-2-E.Coli Lps Ra Complex Length = 605

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 82/211 (38%), Gaps = 30/211 (14%)
Query: 325 PNLTFIDLSNN--SFFGEI-LSDWGRCPQLSLLDVSINNI----SGSIPLEIGESLQLQ- 376
           P+L F+DLS N  SF G    SD+G    L  LD+S N +    S  + LE  E L  Q 
Sbjct: 347 PSLEFLDLSRNGLSFKGCCSQSDFGT-TSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQH 405
Query: 377 -------------------YLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLS-GCIPRE 416
                              YLD+S  +           +  L  L ++GN      +P  
Sbjct: 406 SNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDI 465
Query: 417 LGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDL 476
              L NL +LDLS   L    P +  SL  L  LN+SHN            L  L  LD 
Sbjct: 466 FTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDY 525
Query: 477 SHNFLGEKISSRICRM-ESLEKLNLSYNNLS 506
           S N +       +     SL  LNL+ N+ +
Sbjct: 526 SLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 556

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 6/88 (6%)
Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           YLH+     +++RD+  +N+L+D      V+DFG AK +      W  L GT   +APE+
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEALAPEI 209
Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
             +    +  D ++ GVL  E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3V47|A Chain A, Crystal Structure Of The N-Tetminal Fragment Of Zebrafish Tlr5 In Complex With Salmonella Flagellin Length = 455

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 26/214 (12%)
Query: 345 WGRC------PQLSLLDVSINNISGSIPLEIGESL---QLQYLDLSSNYIVGEIPTQLG- 394
           W +C        ++ LD+S N    S+     +++   ++Q L LS++Y +G   +  G 
Sbjct: 202 WEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMG---SSFGH 258
Query: 395 -NIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLS 453
            N    +  +  G + SG           ++  DLS + +   +         L  L L+
Sbjct: 259 TNFKDPDNFTFKGLEASG-----------VKTCDLSKSKIFALLKSVFSHFTDLEQLTLA 307
Query: 454 HNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCF 513
            N++++        L HL +L+LS NFLG   S     ++ LE L+LSYN++  L  + F
Sbjct: 308 QNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSF 367
Query: 514 EEMHGLLHIDISYNKLEGQIPNSTTFRDAPLEAL 547
             +  L  + +  N+L+  +P+    R   L+ +
Sbjct: 368 LGLPNLKELALDTNQLKS-VPDGIFDRLTSLQKI 400

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	912
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-144
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-135
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-129
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-94
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-84
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	7e-90
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	8e-89
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-33
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	9e-31
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	7e-85
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	5e-84
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-80
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-60
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-24
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	8e-80
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-78
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	6e-53
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-43
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	9e-17
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-79
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	9e-76
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-67
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-47
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	6e-23
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-78
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	5e-76
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-74
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-40
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-29
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	7e-76
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-69
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	8e-68
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-67
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-46
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-65
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-62
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-57
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-48
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-61
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-57
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	6e-55
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-20
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	6e-61
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	6e-61
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	6e-61
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-59
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	7e-55
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-50
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-41
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-39
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-35
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-26
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	4e-58
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	8e-55
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-52
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-52
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-51
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	9e-51
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	9e-35
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-24
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	6e-19
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-51
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-51
3q4u_A	301	Activin receptor type-1; structural genomics conso	5e-51
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	5e-50
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	5e-50
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-49
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-46
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-42
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-26
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-49
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	6e-49
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-48
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	6e-49
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-48
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-47
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-41
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-28
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-13
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-48
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	5e-48
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	6e-43
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	5e-41
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	8e-39
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-47
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-47
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-42
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	5e-44
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	7e-43
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-40
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-38
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-38
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	5e-30
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-17
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-43
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	4e-42
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-33
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-32
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-42
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-38
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-27
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-41
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	4e-40
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-36
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-14
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	5e-41
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-39
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	5e-34
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-16
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-40
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-40
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	8e-39
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	5e-37
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-36
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-32
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-31
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	5e-23
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-39
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-39
2a19_B	284	Interferon-induced, double-stranded RNA-activated	8e-39
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-38
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-38
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-38
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-38
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	9e-14
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-13
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-38
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-34
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-29
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	8e-24
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-20
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-18
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-12
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-36
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-36
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	5e-36
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-35
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-35
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	4e-35
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-28
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-26
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	5e-25
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	8e-35
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-31
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-30
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	7e-27
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	9e-35
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-34
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-34
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	5e-34
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	5e-34
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	5e-34
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	9e-34
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-33
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-33
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-33
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-33
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-33
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-33
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-33
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	7e-33
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-30
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	4e-30
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-20
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-18
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-11
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-33
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-33
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	4e-33
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	5e-33
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	5e-33
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	6e-33
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-31
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	3e-20
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	7e-33
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	8e-33
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	4e-32
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-25
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-25
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-23
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-15
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-32
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-32
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-32
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-32
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-32
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-32
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-32
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	4e-32
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-32
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	5e-32
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	5e-32
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	7e-32
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	9e-32
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-31
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-31
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-31
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-31
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-31
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-31
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-31
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	4e-31
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	4e-31
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	4e-31
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	5e-31
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	7e-31
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	8e-31
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	6e-30
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	4e-28
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	8e-28
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	6e-06
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	9e-31
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-30
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-30
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-30
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-30
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-29
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	7e-29
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	8e-29
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-29
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-29
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	3e-29
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-29
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	4e-29
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	7e-29
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-28
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-28
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-28
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	7e-28
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	7e-27
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	4e-26
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-18
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-28
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-28
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-19
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-19
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-14
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	4e-09
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-28
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-28
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-28
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-28
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-28
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-28
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-28
3fme_A	290	Dual specificity mitogen-activated protein kinase;	4e-28
3an0_A	340	Dual specificity mitogen-activated protein kinase;	6e-28
3pls_A	298	Macrophage-stimulating protein receptor; protein k	8e-28
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	8e-28
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-27
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-27
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-27
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-27
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	9e-27
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	4e-25
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	7e-24
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-23
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	5e-23
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	4e-21
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-27
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-27
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-27
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	4e-27
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	3e-23
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	4e-23
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	4e-20
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-06
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-27
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-27
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	4e-27
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	4e-27
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	3e-26
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-24
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	7e-23
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-19
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	5e-27
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	7e-27
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	7e-27
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-26
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-26
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-26
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-26
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-26
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-26
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-26
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-26
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	5e-26
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	7e-26
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	1e-19
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-17
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	1e-15
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-14
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-12
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	7e-26
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	8e-26
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-25
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-25
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-25
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-25
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-25
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-25
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-25
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-25
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-25
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-25
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-25
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	5e-25
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	5e-25
3bhy_A	283	Death-associated protein kinase 3; death associate	6e-25
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	9e-25
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-24
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-24
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-24
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-24
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	4e-24
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	4e-24
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	4e-24
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	4e-24
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	5e-24
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	6e-24
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	6e-24
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	8e-24
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	9e-24
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-23
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	6e-22
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	9e-22
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	4e-21
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	7e-19
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-13
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-23
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-23
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-23
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	5e-22
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-21
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-20
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-19
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-18
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-07
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-23
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-23
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	5e-22
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-21
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	4e-19
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-17
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-10
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	7e-22
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	2e-21
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	4e-13
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-21
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	4e-21
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-18
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-16
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	9e-16
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-13
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	4e-13
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-20
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-15
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-14
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-14
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	6e-14
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-12
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-20
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-20
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-20
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-17
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-16
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	4e-13
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-07
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	7e-20
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-19
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-18
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	3e-18
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-16
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-16
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	3e-16
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-15
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	4e-19
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	5e-18
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-12
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-11
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-10
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-18
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-18
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	5e-18
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	1e-15
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	4e-15
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	4e-09
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-17
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-17
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	5e-17
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	5e-17
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	6e-17
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	8e-17
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	9e-17
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-16
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-16
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-16
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	5e-16
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	8e-16
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-15
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-15
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-15
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-15
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-15
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-15
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	5e-15
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	5e-15
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	3e-14
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	2e-11
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	2e-08
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	3e-08
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	3e-06
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	6e-15
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-14
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-14
3m19_A	251	Variable lymphocyte receptor A diversity region; a	8e-13
3m19_A	251	Variable lymphocyte receptor A diversity region; a	9e-12
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-10
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-09
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-08
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-08
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-07
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-06
3m19_A	251	Variable lymphocyte receptor A diversity region; a	5e-06
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-14
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	4e-14
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	4e-14
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	4e-13
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	3e-12
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-11
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	3e-10
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	5e-14
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	8e-14
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-13
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	4e-13
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	7e-13
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-12
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	3e-12
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	9e-12
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-13
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-13
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-13
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	9e-09
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-06
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-13
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	2e-13
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	1e-12
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	4e-08
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-13
3o0g_A	292	Cell division protein kinase 5; kinase activator c	4e-13
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-13
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	5e-13
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-09
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-09
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	7e-09
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	4e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-04
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	5e-13
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	5e-13
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	6e-13
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	6e-13
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	8e-13
3e6j_A	229	Variable lymphocyte receptor diversity region; var	8e-13
3e6j_A	229	Variable lymphocyte receptor diversity region; var	1e-11
3e6j_A	229	Variable lymphocyte receptor diversity region; var	1e-09
3e6j_A	229	Variable lymphocyte receptor diversity region; var	7e-08
3e6j_A	229	Variable lymphocyte receptor diversity region; var	3e-07
3e6j_A	229	Variable lymphocyte receptor diversity region; var	7e-06
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	1e-12
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	4e-09
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	5e-09
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-12
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-12
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-12
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-12
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-12
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-12
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-10
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	7e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	5e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	6e-05
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	5e-04
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	4e-12
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	4e-12
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	7e-10
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	3e-08
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	5e-07
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	1e-06
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	3e-06
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	2e-04
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	8e-12
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	8e-12
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	1e-11
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-09
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-08
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	3e-08
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-07
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	5e-06
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	3e-05
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-11
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-11
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-11
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	3e-11
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	7e-07
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	7e-07
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	2e-04
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	4e-11
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-11
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	8e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	9e-06
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-11
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-06
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-11
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	6e-11
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	8e-11
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	8e-11
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	9e-09
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-08
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-07
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	8e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-04
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-10
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-08
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-08
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-07
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-05
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-10
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	2e-10
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	8e-09
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	6e-04
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-10
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	3e-10
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-10
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	6e-10
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	6e-10
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-09
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-09
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-09
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-09
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-09
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-09
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-09
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-09
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	4e-09
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	1e-07
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	4e-09
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	1e-08
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	3e-04
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-08
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-08
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	3e-08
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	4e-08
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	2e-07
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	4e-06
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	1e-05
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	2e-04
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	2e-04
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-08
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	6e-08
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	3e-05
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-07
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	6e-07
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-05
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	2e-05
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-05
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	9e-05
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-04
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-04
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-04
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	4e-04
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	8e-04

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  446 bits (1149), Expect = e-144
 Identities = 152/473 (32%), Positives = 227/473 (47%), Gaps = 10/473 (2%)

Query: 89  INLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQ 148
           ++L      G + +F   +   L  LDL  N  +G +PP   + S LE L  S+N   G+
Sbjct: 274 LSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGE 333

Query: 149 IP-SGIGLLTHLTVLHISRNWLSGSIPHEVGQLTV-LNQLALDSNFLNGSIPRSLGN--L 204
           +P   +  +  L VL +S N  SG +P  +  L+  L  L L SN  +G I  +L     
Sbjct: 334 LPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPK 393

Query: 205 THVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNE 264
             +  LYL NN F G IP  + N   L  L L  N LSG IP S+ +L+ LR L L+ N 
Sbjct: 394 NTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNM 453

Query: 265 LSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTY 324
           L G IPQE+  +K L +L+L  N   G +P    N T+L  + L+ N LTG I +  G  
Sbjct: 454 LEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRL 513

Query: 325 PNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNY 384
            NL  + LSNNSF G I ++ G C  L  LD++ N  +G+IP  + +    Q   +++N+
Sbjct: 514 ENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFK----QSGKIAANF 569

Query: 385 IVGEIPTQLGNIIYLNRLSLSGN--KLSGCIPRELGSLINLEYLDLSANNLSNFVPESLG 442
           I G+    + N         +GN  +  G    +L  L      ++++         +  
Sbjct: 570 IAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFD 629

Query: 443 SLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSY 502
           +   + +L++S+N LS  IP E+ ++ +L  L+L HN +   I   +  +  L  L+LS 
Sbjct: 630 NNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSS 689

Query: 503 NNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNSTTFRDAPLEALQGNKGLYG 555
           N L G IP+    +  L  ID+S N L G IP    F   P      N GL G
Sbjct: 690 NKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCG 742

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  422 bits (1087), Expect = e-135
 Identities = 171/570 (30%), Positives = 245/570 (42%), Gaps = 74/570 (12%)

Query: 27  FSLAISSNSAEEAHALVKWKASLEVHSRSLLHSWSLSSVNATKISPCAWSGIFCNHAERV 86
           F  + S +   E H L+ +K  L    ++LL  WS +       +PC + G+ C    +V
Sbjct: 2   FQASPSQSLYREIHQLISFKDVL--PDKNLLPDWSSNK------NPCTFDGVTCRDD-KV 52

Query: 87  VGINLTSI---------------------------SLNGTLLEF---------------- 103
             I+L+S                             +NG++  F                
Sbjct: 53  TSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSL 112

Query: 104 --------SFSSFPHLVYLDLYNNELFGIIP-PQISNLSNLEYLDFSANKLFGQIPSGI- 153
                   S  S   L +L++ +N L           L++LE LD SAN + G    G  
Sbjct: 113 SGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWV 172

Query: 154 --GLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILY 211
                  L  L IS N +SG +   V +   L  L + SN  +  IP  LG+ + +  L 
Sbjct: 173 LSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLD 229

Query: 212 LYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQ 271
           +  N   G   + I     L  L +  NQ  G IP     L +L++L L  N+ +G IP 
Sbjct: 230 ISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPD 287

Query: 272 EI-GNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNI-SETFGTYPNLTF 329
            + G    L  L L+ NHF G VP  F + + L  L L+ N  +G +  +T      L  
Sbjct: 288 FLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKV 347

Query: 330 IDLSNNSFFGEILSDWGRC-PQLSLLDVSINNISGSIPLEIGESL--QLQYLDLSSNYIV 386
           +DLS N F GE+          L  LD+S NN SG I   + ++    LQ L L +N   
Sbjct: 348 LDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFT 407

Query: 387 GEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVK 446
           G+IP  L N   L  L LS N LSG IP  LGSL  L  L L  N L   +P+ L  +  
Sbjct: 408 GKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKT 467

Query: 447 LYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLS 506
           L  L L  N L+ +IP  L N  +L+ + LS+N L  +I   I R+E+L  L LS N+ S
Sbjct: 468 LETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFS 527

Query: 507 GLIPRCFEEMHGLLHIDISYNKLEGQIPNS 536
           G IP    +   L+ +D++ N   G IP +
Sbjct: 528 GNIPAELGDCRSLIWLDLNTNLFNGTIPAA 557

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  405 bits (1043), Expect = e-129
 Identities = 143/476 (30%), Positives = 215/476 (45%), Gaps = 32/476 (6%)

Query: 90  NLTSISLNGTLL--EFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFG 147
            L  ++++G  +  +   S   +L +LD+ +N     IP  + + S L++LD S NKL G
Sbjct: 179 ELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSG 237

Query: 148 QIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSL-GNLTH 206
                I   T L +L+IS N   G IP     L  L  L+L  N   G IP  L G    
Sbjct: 238 DFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDT 295

Query: 207 VVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPL-SISNLTNLRFLFLYHNEL 265
           +  L L  N F+G++P   G+   L  L L  N  SG +P+ ++  +  L+ L L  NE 
Sbjct: 296 LTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEF 355

Query: 266 SGIIPQEIGNLK-KLNSLLLAKNHFRGTVPKSFRN--LTDLVKLRLNQNYLTGNISETFG 322
           SG +P+ + NL   L +L L+ N+F G +  +        L +L L  N  TG I  T  
Sbjct: 356 SGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLS 415

Query: 323 TYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSS 382
               L  + LS N   G I S  G   +L  L + +N + G IP E+     L+ L L  
Sbjct: 416 NCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDF 475

Query: 383 NYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLG 442
           N + GEIP+ L N   LN +SLS N+L+G IP+ +G L NL  L LS N+ S  +P  LG
Sbjct: 476 NDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELG 535

Query: 443 SLVKLYYLNLSHNKLS--------------------QQIPIELDNLIHLSELDLSHNF-- 480
               L +L+L+ N  +                     +  + + N     E   + N   
Sbjct: 536 DCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLE 595

Query: 481 LGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNS 536
                S ++ R+ +    N++     G     F+    ++ +D+SYN L G IP  
Sbjct: 596 FQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKE 651

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  310 bits (795), Expect = 2e-94
 Identities = 92/580 (15%), Positives = 185/580 (31%), Gaps = 79/580 (13%)

Query: 25  LDFSLAISSNSAEEAHALVKWKASLEVHSRSLLHSWSLSSVNATKIS-------PCAWS- 76
           +   L+ ++   ++  AL +   +L         +WS         +          W  
Sbjct: 18  VPIKLSRTAEYIKDYLALKEIWDALN------GKNWSQQGFGTQPGANWNFNKELDMWGA 71

Query: 77  --GIFCNHAERVVGINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFG----IIPPQIS 130
             G+  N   RV G++L     +G + + +      L  L L ++          P  IS
Sbjct: 72  QPGVSLNSNGRVTGLSLEGFGASGRVPD-AIGQLTELEVLALGSHGEKVNERLFGPKGIS 130

Query: 131 NLSNLEYLDFSANKLFGQIPSGIGLL--THLTVLHISRNWLSGSIPHEVGQLTVLNQLAL 188
              + E                      + L    I+ +    SI           Q+  
Sbjct: 131 ANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQ 190

Query: 189 DSNFLNGSIPRSLGNLTHVVILYLYNNSF-------------------FGSIPQEIGNLK 229
            SN +   + +++  LT +   Y+ N+ F                   + +   +  NLK
Sbjct: 191 LSNNI-TFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLK 249

Query: 230 SLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGI--------IPQEIGNLKKLNS 281
            L D+E+        +P  +  L  ++ + +  N                +    +K+  
Sbjct: 250 DLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQI 309

Query: 282 LLLAKNHFR-GTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGE 340
           + +  N+ +   V  S + +  L  L    N L G +   FG+   L  ++L+ N     
Sbjct: 310 IYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITEI 368

Query: 341 ILSDWGRCPQLSLLDVSINNISG-SIPLEIGESLQLQYLDLSSNYIVG-------EIPTQ 392
             +  G   Q+  L  + N +       +      +  +D S N I          +   
Sbjct: 369 PANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPT 428

Query: 393 LGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNF-------VPESLGSLV 445
               I ++ ++LS N++S        +   L  ++L  N L+           E+  +  
Sbjct: 429 PFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTY 488

Query: 446 KLYYLNLSHNKLSQQIP--IELDNLIHLSELDLSHNFLGEKISSRICRMESLEKL----- 498
            L  ++L  NKL+ ++        L +L  +DLS+N    K  ++     +L+       
Sbjct: 489 LLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSF-SKFPTQPLNSSTLKGFGIRNQ 546

Query: 499 -NLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNST 537
            +   N      P        L  + I  N +   +    
Sbjct: 547 RDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI 585

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  283 bits (727), Expect = 1e-84
 Identities = 75/452 (16%), Positives = 149/452 (32%), Gaps = 46/452 (10%)

Query: 90  NLTSISLNGTLLEF---SFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLF 146
             T I      + F   +      L    + N+        +     N EY      + +
Sbjct: 184 KDTQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEY-----AQQY 238

Query: 147 GQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFL--------NGSIP 198
                    L  LT + +        +P  +  L  +  + +  N          +    
Sbjct: 239 KTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQAL 298

Query: 199 RSLGNLTHVVILYLYNNSFF-GSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRF 257
                   + I+Y+  N+     +   +  +K L  LE   NQL G +P +  +   L  
Sbjct: 299 ADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLAS 357

Query: 258 LFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSF--RNLTDLVKLRLNQNYLTG 315
           L L +N+++ I     G  +++ +L  A N  +  +P  F  ++++ +  +  + N +  
Sbjct: 358 LNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGS 416

Query: 316 NISETFGTYP-------NLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISG----- 363
              + F           N++ I+LSNN         +     LS +++  N ++      
Sbjct: 417 VDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNS 476

Query: 364 --SIPLEIGESLQLQYLDLSSNYIVGEIPT-QLGNIIYLNRLSLSGNKLSGCIPRELGSL 420
                     +  L  +DL  N +       +   + YL  + LS N  S   P +  + 
Sbjct: 477 LKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNS 535

Query: 421 INLEYL------DLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSEL 474
             L+        D   N      PE +     L  L +  N + + +  ++    ++S L
Sbjct: 536 STLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVL 592

Query: 475 DLSHNFLGEKISSRICRMESLEKLNLSYNNLS 506
           D+  N       S +C         L Y+   
Sbjct: 593 DIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  299 bits (767), Expect = 7e-90
 Identities = 107/505 (21%), Positives = 174/505 (34%), Gaps = 36/505 (7%)

Query: 90  NLTSISLNGTLL------EFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSAN 143
           NL  + L+   +      E    +   L  L+L +N++    P     +  L  L  +  
Sbjct: 146 NLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNV 205

Query: 144 KLFGQIPSGIGL---LTHLTVLHISRNWLSGSIPHEVGQL--TVLNQLALDSNFLNGSIP 198
           +L   +   + L    T +  L +S + LS +       L  T L  L L  N LN    
Sbjct: 206 QLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGN 265

Query: 199 RSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSL---------FDLELCINQLSGAIPLSI 249
            S   L  +   +L  N+        +  L ++             + +  L      S 
Sbjct: 266 DSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSF 325

Query: 250 SNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTV--PKSFRNL--TDLVK 305
             L  L  L +  N++ GI       L  L  L L+ +         ++F +L  + L  
Sbjct: 326 QWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHI 385

Query: 306 LRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEI-LSDWGRCPQLSLLDVSINNISGS 364
           L L +N ++   S+ F    +L  +DL  N    E+   +W     +  + +S N     
Sbjct: 386 LNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQL 445

Query: 365 IPLEIGESLQLQYLDLSSNYI--VGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLIN 422
                     LQ L L    +  V   P+    +  L  L LS N ++      L  L  
Sbjct: 446 TRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEK 505

Query: 423 LEYLDLSANNLSNF--------VPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSEL 474
           LE LDL  NNL+              L  L  L+ LNL  N   +       +L  L  +
Sbjct: 506 LEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKII 565

Query: 475 DLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEE-MHGLLHIDISYNKLEGQI 533
           DL  N L    +S      SL+ LNL  N ++ +  + F      L  +D+ +N  +   
Sbjct: 566 DLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTC 625

Query: 534 PNSTTFRDAPLEALQGNKGLYGDIR 558
            +   F +   E       L     
Sbjct: 626 ESIAWFVNWINETHTNIPELSSHYL 650

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  296 bits (759), Expect = 8e-89
 Identities = 108/482 (22%), Positives = 190/482 (39%), Gaps = 24/482 (4%)

Query: 89  INLTSISLNG-TLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFG 147
           ++      +   L +       ++  L+L +N+L  +     +  S L  LD   N +  
Sbjct: 4   VSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISK 63

Query: 148 QIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHV 207
             P     L  L VL++  N LS          T L +L L SN +            ++
Sbjct: 64  LEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNL 123

Query: 208 VILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIP--LSISNLTNLRFLFLYHNEL 265
           + L L +N    +       L++L +L L  N++       L I   ++L+ L L  N++
Sbjct: 124 ITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQI 183

Query: 266 SGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFR---NLTDLVKLRLNQNYLTGNISETFG 322
               P     + +L  L L       ++ +        T +  L L+ + L+   + TF 
Sbjct: 184 KEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFL 243

Query: 323 --TYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDL 380
              + NLT +DLS N+        +   PQL    +  NNI       +     ++YL+L
Sbjct: 244 GLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNL 303

Query: 381 SSNY---------IVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSAN 431
             ++         +          +  L  L++  N + G        LINL+YL LS +
Sbjct: 304 KRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNS 363

Query: 432 NLS--NFVPESLGSLV--KLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISS 487
             S      E+  SL    L+ LNL+ NK+S+        L HL  LDL  N +G++++ 
Sbjct: 364 FTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTG 423

Query: 488 R-ICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNSTTFRDAPLEA 546
           +    +E++ ++ LSYN    L    F  +  L  + +    L+    + + F+  PL  
Sbjct: 424 QEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQ--PLRN 481

Query: 547 LQ 548
           L 
Sbjct: 482 LT 483

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  136 bits (345), Expect = 2e-33
 Identities = 49/249 (19%), Positives = 90/249 (36%), Gaps = 16/249 (6%)

Query: 89  INLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKL--F 146
           ++L    +   L    +    ++  + L  N+   +     + + +L+ L      L   
Sbjct: 410 LDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNV 469

Query: 147 GQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLN--------GSIP 198
              PS    L +LT+L +S N ++      +  L  L  L L  N L         G   
Sbjct: 470 DSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPI 529

Query: 199 RSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFL 258
             L  L+H+ IL L +N F     +   +L  L  ++L +N L+       +N  +L+ L
Sbjct: 530 YFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSL 589

Query: 259 FLYHNELSGIIPQEIG-NLKKLNSLLLAKNHFRGTVPKSFRNLTDLVK-LRLNQNYLTGN 316
            L  N ++ +  +  G   + L  L +  N F  T      ++   V  +      +   
Sbjct: 590 NLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE----SIAWFVNWINETHTNIPEL 645

Query: 317 ISETFGTYP 325
            S      P
Sbjct: 646 SSHYLCNTP 654

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  128 bits (324), Expect = 9e-31
 Identities = 41/168 (24%), Positives = 71/168 (42%), Gaps = 3/168 (1%)

Query: 372 SLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSAN 431
           ++  +  D S   +  ++P  L     +  L+L+ N+L             L  LD+  N
Sbjct: 3   TVSHEVADCSHLKLT-QVPDDLPT--NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFN 59

Query: 432 NLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICR 491
            +S   PE    L  L  LNL HN+LSQ          +L+EL L  N + +  ++   +
Sbjct: 60  TISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVK 119

Query: 492 MESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNSTTF 539
            ++L  L+LS+N LS        ++  L  + +S NK++         
Sbjct: 120 QKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDI 167

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  274 bits (703), Expect = 7e-85
 Identities = 87/294 (29%), Positives = 153/294 (52%), Gaps = 27/294 (9%)

Query: 630 YEEIISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQ--QEEFLN 687
             E+  A+++F+ ++ +G+GG G VY+ ++  G + AVK+           Q  + +F  
Sbjct: 22  LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKE-----ERTQGGELQFQT 76

Query: 688 EIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE-LGWTQRLNV 746
           E++ ++   HRN+++  GFC  P    ++Y Y+ +GS+   L     ++  L W +R  +
Sbjct: 77  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136

Query: 747 IKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWS-ELA 805
             G A  L YLH++C P I+HRD+ + N+LLD  +EA V DFG+AK ++   ++ +  + 
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 196

Query: 806 GTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMN------- 858
           GT G++APE   T K +EK DV+ +GV+ LE+I G+   D     +     +        
Sbjct: 197 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256

Query: 859 -----IEMLDSRLP--YPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
                  ++D  L   Y      +++  ++QVA  C   +P  RP M  V ++L
Sbjct: 257 KEKKLEALVDVDLQGNYK----DEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  271 bits (696), Expect = 5e-84
 Identities = 85/308 (27%), Positives = 140/308 (45%), Gaps = 15/308 (4%)

Query: 35  SAEEAHALVKWKASLEVHSRSLLHSWSLSSVNATKISPCAWSGIFCN---HAERVVGINL 91
           + ++  AL++ K  L   + + L SW  +    T      W G+ C+      RV  ++L
Sbjct: 4   NPQDKQALLQIKKDL--GNPTTLSSWLPT----TDCCNRTWLGVLCDTDTQTYRVNNLDL 57

Query: 92  TSISLNGTL-LEFSFSSFPHLVYLDLYN-NELFGIIPPQISNLSNLEYLDFSANKLFGQI 149
           + ++L     +  S ++ P+L +L +   N L G IPP I+ L+ L YL  +   + G I
Sbjct: 58  SGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAI 117

Query: 150 PSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTH-VV 208
           P  +  +  L  L  S N LSG++P  +  L  L  +  D N ++G+IP S G+ +    
Sbjct: 118 PDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFT 177

Query: 209 ILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGI 268
            + +  N   G IP    NL +L  ++L  N L G   +   +  N + + L  N L+  
Sbjct: 178 SMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFD 236

Query: 269 IPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLT 328
           +  ++G  K LN L L  N   GT+P+    L  L  L ++ N L G I +  G      
Sbjct: 237 LG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFD 294

Query: 329 FIDLSNNS 336
               +NN 
Sbjct: 295 VSAYANNK 302

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  262 bits (672), Expect = 1e-80
 Identities = 87/316 (27%), Positives = 139/316 (43%), Gaps = 35/316 (11%)

Query: 125 IPPQISNLSNL----EYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGS--IPHEVG 178
           I   + N + L       D       G +         +  L +S   L     IP  + 
Sbjct: 14  IKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLA 73

Query: 179 QLTVLNQLAL-DSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELC 237
            L  LN L +   N L G IP ++  LT +  LY+ + +  G+IP  +  +K+L  L+  
Sbjct: 74  NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFS 133

Query: 238 INQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKL-NSLLLAKNHFRGTVPKS 296
            N LSG +P SIS+L NL  +    N +SG IP   G+  KL  S+ +++N   G +P +
Sbjct: 134 YNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPT 193

Query: 297 FRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDV 356
           F NL                         NL F+DLS N   G+    +G       + +
Sbjct: 194 FANL-------------------------NLAFVDLSRNMLEGDASVLFGSDKNTQKIHL 228

Query: 357 SINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRE 416
           + N+++  +  ++G S  L  LDL +N I G +P  L  + +L+ L++S N L G IP +
Sbjct: 229 AKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-Q 286

Query: 417 LGSLINLEYLDLSANN 432
            G+L   +    + N 
Sbjct: 287 GGNLQRFDVSAYANNK 302

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  207 bits (529), Expect = 2e-60
 Identities = 78/282 (27%), Positives = 122/282 (43%), Gaps = 32/282 (11%)

Query: 310 QNYLTGNISETFGTYPNLTFIDLSNNSFFGE--ILSDWGRCPQLSLLDVS-INNISGSIP 366
                G + +T      +  +DLS  +      I S     P L+ L +  INN+ G IP
Sbjct: 35  NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP 94

Query: 367 LEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYL 426
             I +  QL YL ++   + G IP  L  I  L  L  S N LSG +P  + SL NL  +
Sbjct: 95  PAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI 154

Query: 427 DLSANNLSNFVPESLGSLVKLY-YLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKI 485
               N +S  +P+S GS  KL+  + +S N+L+ +IP    NL +L+ +DLS N L    
Sbjct: 155 TFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDA 213

Query: 486 SSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNK----------------- 528
           S      ++ +K++L+ N+L+  + +       L  +D+  N+                 
Sbjct: 214 SVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHS 272

Query: 529 -------LEGQIPNSTTFRDAPLEALQGNKGLYGDIRGFPSC 563
                  L G+IP     +   + A   NK L G     P+C
Sbjct: 273 LNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCG--SPLPAC 312

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  104 bits (263), Expect = 1e-24
 Identities = 31/113 (27%), Positives = 49/113 (43%), Gaps = 2/113 (1%)

Query: 110 HLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWL 169
           +L ++DL  N L G       +  N + +  + N L   +   +GL  +L  L +  N +
Sbjct: 198 NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRI 256

Query: 170 SGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIP 222
            G++P  + QL  L+ L +  N L G IP   GNL    +    NN      P
Sbjct: 257 YGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  269 bits (691), Expect = 8e-80
 Identities = 100/471 (21%), Positives = 181/471 (38%), Gaps = 33/471 (7%)

Query: 90  NLTSISLNGTLL----EFSFSSFPHLVYLDLYNNELFGI-IPPQISNLSNLEYLDFSANK 144
           +L  +    T L     F       L  L++ +N +    +P   SNL+NLE+LD S+NK
Sbjct: 101 SLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNK 160

Query: 145 LFGQIPSGIGLLTHLTV----LHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPR- 199
           +     + + +L  + +    L +S N ++  I     +   L++L L +NF + ++ + 
Sbjct: 161 IQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKT 219

Query: 200 SLGNLTHVVILYLYNNSFFGSIPQE---IGNLKSLFDLELCINQLS------GAIPLSIS 250
            +  L  + +  L    F      E      L+ L +L +   +L+        I    +
Sbjct: 220 CIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFN 279

Query: 251 NLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQ 310
            LTN+    L    +  +             L L    F        ++L      RL  
Sbjct: 280 CLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLK-----RLTF 332

Query: 311 NYLTGNISETFGTYPNLTFIDLSNN--SFFGEILSDWGRCPQLSLLDVSINNISGSIPLE 368
               G  + +    P+L F+DLS N  SF G           L  LD+S N +   +   
Sbjct: 333 TSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSN 391

Query: 369 IGESLQLQYLDLSSNYIVGEIPTQ-LGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLD 427
                QL++LD   + +          ++  L  L +S              L +LE L 
Sbjct: 392 FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLK 451

Query: 428 LSANNLS-NFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKIS 486
           ++ N+   NF+P+    L  L +L+LS  +L Q  P   ++L  L  L++SHN      +
Sbjct: 452 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDT 511

Query: 487 SRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLL-HIDISYNKLEGQIPNS 536
                + SL+ L+ S N++     +  +     L  ++++ N       + 
Sbjct: 512 FPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQ 562

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  266 bits (681), Expect = 2e-78
 Identities = 91/466 (19%), Positives = 162/466 (34%), Gaps = 27/466 (5%)

Query: 90  NLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQI 149
           N+T   +     +   +       LDL  N L  +      +   L+ LD S  ++    
Sbjct: 9   NITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIE 68

Query: 150 PSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVI 209
                 L+HL+ L ++ N +          L+ L +L      L       +G+L  +  
Sbjct: 69  DGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKE 128

Query: 210 LYLYNNSF-FGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRF----LFLYHNE 264
           L + +N      +P+   NL +L  L+L  N++       +  L  +      L L  N 
Sbjct: 129 LNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188

Query: 265 LSGIIPQEIGNLKKLNSLLLAKNHFRGTVPK-SFRNLTDLVKLRL------NQNYLTGNI 317
           ++ I P     ++ L+ L L  N     V K   + L  L   RL      N+  L    
Sbjct: 189 MNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFD 247

Query: 318 SETFGTYPNLTFIDLS---NNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQ 374
                   NLT  +      + +  +I+  +     +S   +    I          +  
Sbjct: 248 KSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDF--SYNFG 305

Query: 375 LQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLS 434
            Q+L+L +         +L ++  L   S  G             L +LE+LDLS N LS
Sbjct: 306 WQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFS-----EVDLPSLEFLDLSRNGLS 360

Query: 435 --NFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRI-CR 491
                 +S      L YL+LS N +   +      L  L  LD  H+ L +     +   
Sbjct: 361 FKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS 419

Query: 492 MESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNST 537
           + +L  L++S+ +        F  +  L  + ++ N  +       
Sbjct: 420 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDI 465

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  194 bits (495), Expect = 6e-53
 Identities = 61/359 (16%), Positives = 122/359 (33%), Gaps = 25/359 (6%)

Query: 196 SIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNL 255
            IP +L        L L  N           +   L  L+L   ++      +  +L++L
Sbjct: 21  KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78

Query: 256 RFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTG 315
             L L  N +  +       L  L  L+  + +          +L  L +L +  N +  
Sbjct: 79  STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138

Query: 316 -NISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSL----LDVSINNISGSIPLEIG 370
             + E F    NL  +DLS+N       +D     Q+ L    LD+S+N ++  I     
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAF 197

Query: 371 ESLQLQYLDLSSNYIVGEIP-TQLGNIIYLNRLSLSGNKLSGCIPRE---LGSLINLEYL 426
           + ++L  L L +N+    +  T +  +  L    L   +       E     +L  L  L
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257

Query: 427 DLSANNLS------NFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNF 480
            +    L+      + + +    L  +   +L    + +    +         L+L +  
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCK 315

Query: 481 LGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNSTTF 539
                  +   ++      L++ +  G       ++  L  +D+S N L  +   S + 
Sbjct: 316 F-----GQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSD 369

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  165 bits (420), Expect = 4e-43
 Identities = 59/300 (19%), Positives = 107/300 (35%), Gaps = 12/300 (4%)

Query: 90  NLTSISLNG-TLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKL--F 146
               + L      +F       L  L   +N+          +L +LE+LD S N L   
Sbjct: 305 GWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFS--EVDLPSLEFLDLSRNGLSFK 362

Query: 147 GQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRS-LGNLT 205
           G         T L  L +S N +   +      L  L  L    + L      S   +L 
Sbjct: 363 GCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 421

Query: 206 HVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAI-PLSISNLTNLRFLFLYHNE 264
           +++ L + +     +       L SL  L++  N       P   + L NL FL L   +
Sbjct: 422 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 481

Query: 265 LSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTY 324
           L  + P    +L  L  L ++ N+F       ++ L  L  L  + N++  +  +    +
Sbjct: 482 LEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHF 541

Query: 325 P-NLTFIDLSNNSFFGEILSDWGR--CPQLSLLDVSINNISGSIPLEIGESLQLQYLDLS 381
           P +L F++L+ N F                  L V +  +  + P +    + +  L+++
Sbjct: 542 PSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQ-GMPVLSLNIT 600

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 83.9 bits (208), Expect = 9e-17
 Identities = 32/151 (21%), Positives = 54/151 (35%), Gaps = 4/151 (2%)

Query: 89  INLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQ 148
           + +   S     L   F+   +L +LDL   +L  + P   ++LS+L+ L+ S N  F  
Sbjct: 450 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSL 509

Query: 149 IPSGIGLLTHLTVLHISRNWLSGSIPHEVGQL-TVLNQLALDSNFLNGSIPRS--LGNLT 205
                  L  L VL  S N +  S   E+    + L  L L  N    +      L  + 
Sbjct: 510 DTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIK 569

Query: 206 HVVILYLYNNSFFGSIPQEIGNLKSLFDLEL 236
               L +       + P +      +  L +
Sbjct: 570 DQRQLLVEVERMECATPSDKQG-MPVLSLNI 599

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  275 bits (705), Expect = 1e-79
 Identities = 92/535 (17%), Positives = 166/535 (31%), Gaps = 76/535 (14%)

Query: 66  NATKISPCAWSGIFCNHAERVVGINL-TSISLNGTLLEFSFSSFPHLVYLDLYNNELFGI 124
            A       +     N+    +  N    + + G        +   +  L L      G 
Sbjct: 279 EALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGR 338

Query: 125 IPPQISNLSNLEYLDFSANKLFGQIPSG-------------------------IGLLTHL 159
           +P  I  L+ L+ L F  +                                  +     L
Sbjct: 339 VPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRL 398

Query: 160 TVLHISRNWLS-----GSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYN 214
            +  + ++ ++       I  +        Q+   +N +   I +++  LT + I+Y  N
Sbjct: 399 NLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRI-TFISKAIQRLTKLQIIYFAN 457

Query: 215 NSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIG 274
           + F               D      +      LS SNL +L  + LY+      +P  + 
Sbjct: 458 SPFTYDNIAV-----DWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLY 512

Query: 275 NLKKLNSLLLAKNHFRG---------TVPKSFRNLTDLVKLRLNQNYLTG-NISETFGTY 324
           +L +L SL +A N              +         +    +  N L     S +    
Sbjct: 513 DLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKM 572

Query: 325 PNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESL-QLQYLDLSSN 383
             L  +D  +N      L  +G   +L+ L +  N I   IP +      Q++ L  S N
Sbjct: 573 VKLGLLDCVHNKV--RHLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHN 629

Query: 384 YIVGEIP--TQLGNIIYLNRLSLSGNKLSGCIPRELGS------LINLEYLDLSANNLSN 435
            +   IP      ++  +  +  S NK+     R +         IN   + LS N +  
Sbjct: 630 KL-KYIPNIFNAKSVYVMGSVDFSYNKIGS-EGRNISCSMDDYKGINASTVTLSYNEIQK 687

Query: 436 FVPESLGSLVKLYYLNLSHNKLSQ-------QIPIELDNLIHLSELDLSHNFLGEKISS- 487
           F  E   +   +  + LS+N ++               N   L+ +DL  N L       
Sbjct: 688 FPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDF 747

Query: 488 RICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISY------NKLEGQIPNS 536
           R   +  L  +++SYN  S   P        L    I +      N++  Q P  
Sbjct: 748 RATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTG 801

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  264 bits (677), Expect = 9e-76
 Identities = 69/513 (13%), Positives = 145/513 (28%), Gaps = 72/513 (14%)

Query: 89  INLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKL--- 145
                  +     +        L   DL  + +     P++  +     +     ++   
Sbjct: 376 SEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRN--PEMKPIKKDSRISLKDTQIGNL 433

Query: 146 ---FGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLG 202
                 I   I  LT L +++ + +  +                  D      +   S  
Sbjct: 434 TNRITFISKAIQRLTKLQIIYFANSPFTYDNI-----AVDWEDANSDYAKQYENEELSWS 488

Query: 203 NLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSG---------AIPLSISNLT 253
           NL  +  + LYN      +P  + +L  L  L +  N+             +        
Sbjct: 489 NLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGP 548

Query: 254 NLRFLFLYHNELSGI-IPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNY 312
            ++  ++ +N L        +  + KL  L    N       ++F     L  L+L+ N 
Sbjct: 549 KIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKV--RHLEAFGTNVKLTDLKLDYNQ 606

Query: 313 LTGNISETFGTYPNLTFIDLSNNSFFGEILSDW--GRCPQLSLLDVSINNISG-----SI 365
           +     +       +  +  S+N     I + +       +  +D S N I       S 
Sbjct: 607 IEEIPEDFCAFTDQVEGLGFSHNKL-KYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISC 665

Query: 366 PLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLS-------GCIPRELG 418
            ++  + +    + LS N I             ++ + LS N ++               
Sbjct: 666 SMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYK 725

Query: 419 SLINLEYLDLSANNLSNFVPE-SLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLS 477
           +   L  +DL  N L++   +    +L  L  +++S+N  S   P +  N   L    + 
Sbjct: 726 NTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIR 784

Query: 478 HNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNST 537
           H                    +   N +    P        L+ + I  N +   +    
Sbjct: 785 HQ------------------RDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKL 825

Query: 538 TFRDAPLEALQ-----GNKGLYGDIRGFPSCMS 565
                    L       N  +  D+      + 
Sbjct: 826 ------TPQLYILDIADNPNISIDVTSVCPYIE 852

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  240 bits (615), Expect = 2e-67
 Identities = 76/440 (17%), Positives = 146/440 (33%), Gaps = 44/440 (10%)

Query: 90  NLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQI 149
            L  I    +      +        +    + +       SNL +L  ++        Q+
Sbjct: 449 KLQIIYFANSPFT-YDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQL 507

Query: 150 PSGIGLLTHLTVLHISRNWLSG---------SIPHEVGQLTVLNQLALDSNFLNG-SIPR 199
           P  +  L  L  L+I+ N              +  +      +    +  N L       
Sbjct: 508 PDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASA 567

Query: 200 SLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSI-SNLTNLRFL 258
           SL  +  + +L   +N       +  G    L DL+L  NQ+   IP    +    +  L
Sbjct: 568 SLQKMVKLGLLDCVHNKV--RHLEAFGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGL 624

Query: 259 FLYHNELSGIIPQ-EIGNLKKLNSLLLAKNHFRGTVPKSFR-----NLTDLVKLRLNQNY 312
              HN+L  I       ++  + S+  + N                   +   + L+ N 
Sbjct: 625 GFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNE 684

Query: 313 LTGNISETFGTYPNLTFIDLSNNSF-------FGEILSDWGRCPQLSLLDVSINNISGSI 365
           +    +E F T   ++ I LSNN               ++     L+ +D+  N ++ S+
Sbjct: 685 IQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SL 743

Query: 366 PLEIGES--LQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSL------SGNKLSGCIPREL 417
             +   +    L  +D+S N      PTQ  N   L    +       GN++    P  +
Sbjct: 744 SDDFRATTLPYLSNMDVSYNCF-SSFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGI 802

Query: 418 GSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLS 477
            +  +L  L + +N++   V E L    +LY L+++ N         +   I      L 
Sbjct: 803 TTCPSLIQLQIGSNDIRK-VDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLL 859

Query: 478 HNFLGEKISSRICRMESLEK 497
           ++   + I    C    +E+
Sbjct: 860 YDKT-QDIRG--CDALGIER 876

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  181 bits (460), Expect = 3e-47
 Identities = 63/450 (14%), Positives = 134/450 (29%), Gaps = 35/450 (7%)

Query: 113 YLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGS 172
            + +   E         +       +  +       +P+G   +   T    S    S  
Sbjct: 175 GMKVTYKEDSKEHQNPDNANDKYMDIGVATCDSAVWLPAGTYQVVAYTTYSQSGIKRSEL 234

Query: 173 IPHEV---------GQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQ 223
               V          +LT    + +        I            L   N  ++     
Sbjct: 235 ETQSVRGESFTVIDNKLTKDANVPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTIN 294

Query: 224 EIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLL 283
              +  +  +    ++       + + N   +  L L      G +P  IG L +L  L 
Sbjct: 295 NTIHSLNW-NFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLS 353

Query: 284 LAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYP-NLTFIDLSNNSF----- 337
              +    +                 ++ +  +  + F  Y   L   DL  ++      
Sbjct: 354 FGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPE 413

Query: 338 FGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNII 397
              I  D     + + +    N I+  I   I    +LQ +  +++    +        +
Sbjct: 414 MKPIKKDSRISLKDTQIGNLTNRIT-FISKAIQRLTKLQIIYFANSPFTYDNIA-----V 467

Query: 398 YLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKL 457
                +    K          +L +L  ++L        +P+ L  L +L  LN++ N+ 
Sbjct: 468 DWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRG 527

Query: 458 S---------QQIPIELDNLIHLSELDLSHNFLGE-KISSRICRMESLEKLNLSYNNLSG 507
                      ++  + D    +    + +N L E   S+ + +M  L  L+  +N +  
Sbjct: 528 ISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRH 587

Query: 508 LIPRCFEEMHGLLHIDISYNKLEGQIPNST 537
           L    F     L  + + YN++E +IP   
Sbjct: 588 LEA--FGTNVKLTDLKLDYNQIE-EIPEDF 614

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  104 bits (261), Expect = 6e-23
 Identities = 32/210 (15%), Positives = 73/210 (34%), Gaps = 24/210 (11%)

Query: 88  GINLTSISLNG----TLLEFSFSSFPHLVYLDLYNNEL-------FGIIPPQISNLSNLE 136
           GIN ++++L+           F++   +  + L NN +                N   L 
Sbjct: 672 GINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLT 731

Query: 137 YLDFSANKLFGQIPSGIGL--LTHLTVLHISRNWLSGSIPHEVGQLTVLNQLAL------ 188
            +D   NKL   +        L +L+ + +S N  S S P +    + L    +      
Sbjct: 732 TIDLRFNKL-TSLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDA 789

Query: 189 DSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLS 248
           + N +    P  +     ++ L + +N     + +++     L+ L++  N        S
Sbjct: 790 EGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKL--TPQLYILDIADNPNISIDVTS 846

Query: 249 ISNLTNLRFLFLYHNELSGIIPQEIGNLKK 278
           +          L +++   I   +   +++
Sbjct: 847 VCPYIEAGMYVLLYDKTQDIRGCDALGIER 876

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  265 bits (679), Expect = 4e-78
 Identities = 88/463 (19%), Positives = 159/463 (34%), Gaps = 18/463 (3%)

Query: 90  NLTSISLNG----TLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKL 145
            L ++ L       + E + S    L +L      +  I    + N   LE L   +N +
Sbjct: 82  RLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHI 141

Query: 146 FGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLN-GSIPRSLGNL 204
                        L VL    N +      ++  L     L+L+ N  +   I     + 
Sbjct: 142 SSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDS 201

Query: 205 THVVILYLYNNSFFGSIPQEIGN--LKSLFDLELCINQLSGAIPLSISNL--TNLRFLFL 260
                L          I + + N  ++SL+             P     L   ++  + L
Sbjct: 202 AVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINL 261

Query: 261 YHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISET 320
             +    I          L  L L   H    +P     L+ L KL L+ N        +
Sbjct: 262 QKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQIS 320

Query: 321 FGTYPNLTFIDLSNNSFFGEILSDW-GRCPQLSLLDVSINNI--SGSIPLEIGESLQLQY 377
              +P+LT + +  N+   E+ +        L  LD+S ++I  S    L++     LQ 
Sbjct: 321 ASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQS 380

Query: 378 LDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRE-LGSLINLEYLDLSANNLSNF 436
           L+LS N  +            L  L L+  +L     +    +L  L+ L+LS + L   
Sbjct: 381 LNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDIS 440

Query: 437 VPESLGSLVKLYYLNLSHNKLSQQIPIE---LDNLIHLSELDLSHNFLGEKISSRICRME 493
             +    L  L +LNL  N   +    +   L  L  L  L LS   L          ++
Sbjct: 441 SEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLK 500

Query: 494 SLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNS 536
            +  ++LS+N L+         +   ++++++ N +   +P+ 
Sbjct: 501 MMNHVDLSHNRLTSSSIEALSHLK-GIYLNLASNHISIILPSL 542

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  259 bits (663), Expect = 5e-76
 Identities = 91/437 (20%), Positives = 151/437 (34%), Gaps = 12/437 (2%)

Query: 108 FPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRN 167
                 L+   N L  I     S L NL +LD +  +++            L  L ++ N
Sbjct: 32  PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN 91

Query: 168 WLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGN 227
            L       +     L  L      ++      L N   +  LYL +N        +   
Sbjct: 92  PLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFP 151

Query: 228 LKSLFDLELCINQLSGAIPLSISNLTNLRFLFLY--HNELSGIIPQEIGNLKKLNSLLLA 285
            + L  L+   N +       +S+L     L L    N+++GI P    +     SL   
Sbjct: 152 TEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEP-GAFDSAVFQSLNFG 210

Query: 286 KNHFRGTVPK--SFRNLTDLVKLRLNQNYLTGNISETFG--TYPNLTFIDLSNNSFFGEI 341
                  + K      +  L                 F      ++  I+L  + FF   
Sbjct: 211 GTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNIS 270

Query: 342 LSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNR 401
            + +     L  LD++  ++S  +P  +     L+ L LS+N           N   L  
Sbjct: 271 SNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTH 329

Query: 402 LSLSGNKLSGCIPRE-LGSLINLEYLDLSANNLSN--FVPESLGSLVKLYYLNLSHNKLS 458
           LS+ GN     +    L +L NL  LDLS +++         L +L  L  LNLS+N+  
Sbjct: 330 LSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPL 389

Query: 459 QQIPIELDNLIHLSELDLSHNFLGEKIS-SRICRMESLEKLNLSYNNLSGLIPRCFEEMH 517
                       L  LDL+   L  K + S    +  L+ LNLS++ L     + F+ + 
Sbjct: 390 SLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLP 449

Query: 518 GLLHIDISYNKLEGQIP 534
            L H+++  N       
Sbjct: 450 ALQHLNLQGNHFPKGNI 466

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  255 bits (653), Expect = 1e-74
 Identities = 95/459 (20%), Positives = 164/459 (35%), Gaps = 20/459 (4%)

Query: 90  NLTSISLNGTLL----EFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKL 145
            L  +    T +         +   L  L L +N +  I  P+      L+ LDF  N +
Sbjct: 106 ALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAI 165

Query: 146 FGQIPSGIGLLTHLTV--LHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGN 203
                  +  L   T   L+++ N ++  I        V   L          I + L N
Sbjct: 166 HYLSKEDMSSLQQATNLSLNLNGNDIA-GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKN 224

Query: 204 --LTHVVILYLYNNSFFGSIPQEIGNLK--SLFDLELCINQLSGAIPLSISNLTNLRFLF 259
             +  + +    +       P     L   S+  + L  +        +    + L+ L 
Sbjct: 225 STIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELD 284

Query: 260 LYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNI-S 318
           L    LS + P  +  L  L  L+L+ N F      S  N   L  L +  N     + +
Sbjct: 285 LTATHLSEL-PSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGT 343

Query: 319 ETFGTYPNLTFIDLSNN--SFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQ 376
                  NL  +DLS++                 L  L++S N           E  QL+
Sbjct: 344 GCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLE 403

Query: 377 YLDLSSNYIVG-EIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSN 435
            LDL+   +   +  +   N+  L  L+LS + L     +    L  L++L+L  N+   
Sbjct: 404 LLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPK 463

Query: 436 FV---PESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRM 492
                  SL +L +L  L LS   LS        +L  ++ +DLSHN L       +  +
Sbjct: 464 GNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHL 523

Query: 493 ESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEG 531
           + +  LNL+ N++S ++P     +     I++  N L+ 
Sbjct: 524 KGIY-LNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  158 bits (401), Expect = 1e-40
 Identities = 62/331 (18%), Positives = 111/331 (33%), Gaps = 15/331 (4%)

Query: 90  NLTSISLNG---TLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLF 146
            L  + L     + L         L  L L  N+   +     SN  +L +L    N   
Sbjct: 279 GLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKR 338

Query: 147 GQIPSG-IGLLTHLTVLHISRNWL--SGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGN 203
            ++ +G +  L +L  L +S + +  S     ++  L+ L  L L  N        +   
Sbjct: 339 LELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKE 398

Query: 204 LTHVVILYLYNNSFFGSIPQEI-GNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYH 262
              + +L L          Q    NL  L  L L  + L  +       L  L+ L L  
Sbjct: 399 CPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQG 458

Query: 263 NELSGIIPQEIG---NLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISE 319
           N       Q+      L +L  L+L+          +F +L  +  + L+ N LT +  E
Sbjct: 459 NHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIE 518

Query: 320 TFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLD 379
                  +  ++L++N     + S      Q   +++  N +  +          L++  
Sbjct: 519 ALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNI----YFLEWYK 573

Query: 380 LSSNYIVGEIPTQLGNIIYLNRLSLSGNKLS 410
            +   +     T   N   L  + LS   LS
Sbjct: 574 ENMQKLEDTEDTLCENPPLLRGVRLSDVTLS 604

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  124 bits (314), Expect = 1e-29
 Identities = 41/212 (19%), Positives = 72/212 (33%), Gaps = 5/212 (2%)

Query: 354 LDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCI 413
            +     ++  IP  +  S +   L+ S N +     T    +I L  L L+  ++    
Sbjct: 17  YNCENLGLN-EIPGTLPNSTE--CLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH 73

Query: 414 PRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSE 473
                S   L+ L L+AN L      +L     L +L      +S    I L N   L  
Sbjct: 74  EDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLES 133

Query: 474 LDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGL--LHIDISYNKLEG 531
           L L  N +      +    E L+ L+   N +  L       +     L ++++ N + G
Sbjct: 134 LYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG 193

Query: 532 QIPNSTTFRDAPLEALQGNKGLYGDIRGFPSC 563
             P +            G + L    +G  + 
Sbjct: 194 IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNS 225

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  249 bits (639), Expect = 7e-76
 Identities = 95/320 (29%), Positives = 145/320 (45%), Gaps = 36/320 (11%)

Query: 602 KNDSQTQQSSFGNTPGLRSVLTFEGKIVYEEIISATNDFNAEHCIGKGGHGSVYRAKVPS 661
              S+   S          V     ++   ++  ATN+F+ +  IG G  G VY+  +  
Sbjct: 3   SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62

Query: 662 GEIFAVKKFHSPLPGEMSFQ-QEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYL 720
           G   A+K+         S Q  EEF  EI+ L+  RH ++V   GFC       +IY+Y+
Sbjct: 63  GAKVALKRRTP-----ESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYM 117

Query: 721 ESGSLDKIL-CNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDL 779
           E+G+L + L  +D     + W QRL +  G A  L YLH      I+HRD+ S N+LLD 
Sbjct: 118 ENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDE 174

Query: 780 GYEAHVSDFGIAK-FLNPDSSNWS-ELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEV 837
            +   ++DFGI+K     D ++ S  + GT GY+ PE     ++TEK DVYSFGV+  EV
Sbjct: 175 NFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEV 234

Query: 838 IKGKHPRDFLFEMSSSSSNMNI--------------EMLDSRLP--YPSLHVQKKLMSIM 881
           +  +         S     +N+              +++D  L        ++K      
Sbjct: 235 LCARSAIV----QSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRK----FG 286

Query: 882 QVAFSCLDQNPESRPTMKRV 901
             A  CL  + E RP+M  V
Sbjct: 287 DTAVKCLALSSEDRPSMGDV 306

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  232 bits (595), Expect = 1e-69
 Identities = 89/296 (30%), Positives = 145/296 (48%), Gaps = 31/296 (10%)

Query: 630 YEEIISATNDFNAEHC------IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQ-Q 682
           + E+ + TN+F+          +G+GG G VY+  V +  + AVKK  + +    + + +
Sbjct: 17  FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTV-AVKKLAAMVDIT-TEELK 74

Query: 683 EEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQ 742
           ++F  EI+ + + +H N+V+  GF S      ++Y Y+ +GSL   L        L W  
Sbjct: 75  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 134

Query: 743 RLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNW- 801
           R  + +G A+ + +LH N     +HRDI S N+LLD  + A +SDFG+A+  +   +   
Sbjct: 135 RCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLAR-ASEKFAQTV 190

Query: 802 --SELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS------- 852
             S + GT  Y+APE A   ++T K D+YSFGV+ LE+I G    D   E          
Sbjct: 191 MTSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEE 249

Query: 853 --SSSNMNIEMLDSRL-PYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
                    + +D ++    S  V+     +  VA  CL +    RP +K+V QLL
Sbjct: 250 IEDEEKTIEDYIDKKMNDADSTSVEA----MYSVASQCLHEKKNKRPDIKKVQQLL 301

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  236 bits (605), Expect = 8e-68
 Identities = 97/462 (20%), Positives = 170/462 (36%), Gaps = 31/462 (6%)

Query: 90  NLTSISLNGTLL----EFSFSSFPHLVYLDLYNNELFGI-IPPQISNLSNLEYLDFSANK 144
           +L ++    T L     F       L  L++ +N +    +P   SNL+NL ++D S N 
Sbjct: 105 SLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNY 164

Query: 145 LFGQIPSGIGLLTHLT----VLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPR- 199
           +     + +  L         L +S N +   I  +  Q   L++L L  NF + +I + 
Sbjct: 165 IQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKT 223

Query: 200 SLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLF--------DLELCINQLSGAIPLSISN 251
            L NL  + +  L    F      EI     +         +  L          +    
Sbjct: 224 CLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHC 283

Query: 252 LTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQN 311
           L N+  + L    +  +  +++    K  SL + +   +        +L  L  L L  N
Sbjct: 284 LANVSAMSLAGVSIKYL--EDVPKHFKWQSLSIIRCQLKQF---PTLDLPFLKSLTLTMN 338

Query: 312 YLTGNISETFGTYPNLTFIDLSNN--SFFGEILSDWGRCPQLSLLDVSINNISGSIPLEI 369
             +  IS      P+L+++DLS N  SF G           L  LD+S N     +    
Sbjct: 339 KGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANF 395

Query: 370 GESLQLQYLDLSSNYIVGEIPTQ-LGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDL 428
               +LQ+LD   + +          ++  L  L +S              L +L  L +
Sbjct: 396 MGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKM 455

Query: 429 SANNLSNFVPES-LGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISS 487
           + N+  +    +   +   L +L+LS  +L Q      D L  L  L++SHN L    SS
Sbjct: 456 AGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSS 515

Query: 488 RICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKL 529
              ++ SL  L+ S+N +             L   +++ N +
Sbjct: 516 HYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  236 bits (604), Expect = 1e-67
 Identities = 104/469 (22%), Positives = 171/469 (36%), Gaps = 31/469 (6%)

Query: 90  NLTSISLNG----TLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKL 145
           +  +I L+      L  +SFS+F  L +LDL   E+  I       L +L  L  + N +
Sbjct: 33  STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPI 92

Query: 146 FGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNG-SIPRSLGNL 204
               P     LT L  L      L+      +GQL  L +L +  NF++   +P    NL
Sbjct: 93  QSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNL 152

Query: 205 THVVILYLYNNSFFGSIPQEIGNLK----SLFDLELCINQLSGAIPLSISNLTNLRFLFL 260
           T++V + L  N        ++  L+        L++ +N +   I         L  L L
Sbjct: 153 TNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTL 211

Query: 261 YHNELSGIIPQE-IGNLKKLNSLLLAKNHFRGTV------PKSFRNLTDLVK--LRLNQN 311
             N  S  I +  + NL  L+   L    F+         P     L D+     RL   
Sbjct: 212 RGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYT 271

Query: 312 YLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGE 371
               +    F    N++ + L+  S   + L D  +  +   L +    +         +
Sbjct: 272 NDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQLKQ---FPTLD 326

Query: 372 SLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLS--GCIPRELGSLINLEYLDLS 429
              L+ L L+ N     I  +   +  L+ L LS N LS  GC         +L +LDLS
Sbjct: 327 LPFLKSLTLTMNKG--SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLS 384

Query: 430 ANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIE-LDNLIHLSELDLSHNFLGEKISSR 488
            N     +  +   L +L +L+  H+ L +        +L  L  LD+S+          
Sbjct: 385 FNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGI 443

Query: 489 ICRMESLEKLNLSYNNLSGLIPRC-FEEMHGLLHIDISYNKLEGQIPNS 536
              + SL  L ++ N+         F     L  +D+S  +LE      
Sbjct: 444 FLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGV 492

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  174 bits (442), Expect = 6e-46
 Identities = 77/368 (20%), Positives = 138/368 (37%), Gaps = 30/368 (8%)

Query: 195 GSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTN 254
           GS+   +  + ++    +        +P +I +  S  +++L  N L      S SN + 
Sbjct: 2   GSLNPCIEVVPNITYQCMDQK--LSKVPDDIPS--STKNIDLSFNPLKILKSYSFSNFSE 57

Query: 255 LRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLT 314
           L++L L   E+  I  +    L  L++L+L  N  +   P SF  LT L  L   +  L 
Sbjct: 58  LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117

Query: 315 GNISETFGTYPNLTFIDLSNNSFFGEILSDW-GRCPQLSLLDVSINNISGSIPLEI---- 369
              S   G    L  +++++N      L  +      L  +D+S N I      ++    
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLR 177

Query: 370 GESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRE-LGSLINLEYLDL 428
                   LD+S N I   I  Q    I L+ L+L GN  S  I +  L +L  L    L
Sbjct: 178 ENPQVNLSLDMSLNPI-DFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRL 236

Query: 429 SAN------NLSNFVPESLGSLVKLYY--LNLSHNKLSQQIPIELDNLIHLSELDLSHNF 480
                    NL  F P  +  L  +      L++        ++   L ++S + L+   
Sbjct: 237 ILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVS 296

Query: 481 LGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNSTTFR 540
           +  K    + +    + L++    L         ++  L  + ++ NK       S +F+
Sbjct: 297 I--KYLEDVPKHFKWQSLSIIRCQLKQFP---TLDLPFLKSLTLTMNKG------SISFK 345

Query: 541 DAPLEALQ 548
              L +L 
Sbjct: 346 KVALPSLS 353

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  220 bits (563), Expect = 3e-65
 Identities = 67/308 (21%), Positives = 114/308 (37%), Gaps = 42/308 (13%)

Query: 630 YEEIISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEI 689
            E +   +          +G  G V++A     E  AVK F          Q  +   E+
Sbjct: 16  TENLYFQSMPLQLLEVKARGRFGCVWKA-QLLNEYVAVKIFPI-----QDKQSWQNEYEV 69

Query: 690 QALTEIRHRNIVKFYGFCSHPKHS----FIIYEYLESGSLDKILCNDASAKELGWTQRLN 745
            +L  ++H NI++F G            ++I  + E GSL   L     A  + W +  +
Sbjct: 70  YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCH 125

Query: 746 VIKGVADALFYLHNNCF-------PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS 798
           + + +A  L YLH +         P I HRDI SKNVLL     A ++DFG+A       
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185

Query: 799 SNWS--ELAGTHGYVAPELA-----YTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFE-- 849
           S        GT  Y+APE+      +      + D+Y+ G++  E+       D   +  
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245

Query: 850 ----MSSSSSNMNIEMLDS-------RLPYP-SLHVQKKLMSIMQVAFSCLDQNPESRPT 897
                     + ++E +         R            +  + +    C D + E+R +
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305

Query: 898 MKRVSQLL 905
              V + +
Sbjct: 306 AGCVGERI 313

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  218 bits (557), Expect = 2e-62
 Identities = 107/435 (24%), Positives = 181/435 (41%), Gaps = 36/435 (8%)

Query: 103 FSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVL 162
           F+ ++    +   L    +   +    ++L  +  L      +  +   G+  L +LT +
Sbjct: 18  FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQI 73

Query: 163 HISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIP 222
           + S N L+   P  +  LT L  + +++N +    P  L NLT++  L L+NN      P
Sbjct: 74  NFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP 129

Query: 223 QEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSL 282
             + NL +L  LEL  N +S    L  S LT+L+ L    N+++ + P  + NL  L  L
Sbjct: 130 --LKNLTNLNRLELSSNTISDISAL--SGLTSLQQLSF-GNQVTDLKP--LANLTTLERL 182

Query: 283 LLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEIL 342
            ++ N    +       LT+L  L    N ++       G   NL  + L+ N    + +
Sbjct: 183 DISSNKV--SDISVLAKLTNLESLIATNNQISD--ITPLGILTNLDELSLNGNQL--KDI 236

Query: 343 SDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRL 402
                   L+ LD++ N IS   PL      +L  L L +N I    P  L  +  L  L
Sbjct: 237 GTLASLTNLTDLDLANNQISNLAPL--SGLTKLTELKLGANQISNISP--LAGLTALTNL 292

Query: 403 SLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIP 462
            L+ N+L    P  + +L NL YL L  NN+S+  P  + SL KL  L   +NK+S    
Sbjct: 293 ELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--V 346

Query: 463 IELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHI 522
             L NL +++ L   HN + +     +  +  + +L L+    +            +   
Sbjct: 347 SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKAN---VSIP 401

Query: 523 DISYNKLEGQIPNST 537
           +   N     I  +T
Sbjct: 402 NTVKNVTGALIAPAT 416

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  204 bits (521), Expect = 1e-57
 Identities = 104/424 (24%), Positives = 168/424 (39%), Gaps = 34/424 (8%)

Query: 90  NLTSISLNGTLLE--FSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFG 147
           NLT I+ +   L       +   LV + + NN++  I P  ++NL+NL  L    N++  
Sbjct: 69  NLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITD 126

Query: 148 QIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHV 207
             P  +  LT+L  L +S N +S      +  LT L QL+  +   +    + L NLT +
Sbjct: 127 IDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQVTD---LKPLANLTTL 179

Query: 208 VILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSG 267
             L + +N    S    +  L +L  L    NQ+S   PL    LTNL  L L  N+L  
Sbjct: 180 ERLDISSNKV--SDISVLAKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKD 235

Query: 268 IIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNL 327
           I    + +L  L  L LA N    +       LT L +L+L  N ++            L
Sbjct: 236 IGT--LASLTNLTDLDLANNQI--SNLAPLSGLTKLTELKLGANQISN--ISPLAGLTAL 289

Query: 328 TFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVG 387
           T ++L+ N      +S       L+ L +  NNIS   P+      +LQ L   +N +  
Sbjct: 290 TNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISPV--SSLTKLQRLFFYNNKV-- 343

Query: 388 EIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKL 447
              + L N+  +N LS   N++S   P  L +L  +  L L+    +N       ++   
Sbjct: 344 SDVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVS-- 399

Query: 448 YYLNLSHNKLSQQI-PIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLS 506
              N   N     I P  + +    +E D++ N      +           +       S
Sbjct: 400 -IPNTVKNVTGALIAPATISDGGSYTEPDITWNLP-SYTNEVSYTFSQPVTIGKGTTTFS 457

Query: 507 GLIP 510
           G + 
Sbjct: 458 GTVT 461

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  177 bits (452), Expect = 3e-48
 Identities = 85/354 (24%), Positives = 145/354 (40%), Gaps = 29/354 (8%)

Query: 181 TVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQ 240
            + +        +N         L   +   L   +   ++ Q   +L  +  L+     
Sbjct: 2   PLGSATITQDTPINQIFT--DTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLG 57

Query: 241 LSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNL 300
           +       +  L NL  +   +N+L+ I P  + NL KL  +L+  N           NL
Sbjct: 58  IK--SIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQI--ADITPLANL 111

Query: 301 TDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINN 360
           T+L  L L  N +T    +      NL  ++LS+N+     +S       L  L    N 
Sbjct: 112 TNLTGLTLFNNQITD--IDPLKNLTNLNRLELSSNTI--SDISALSGLTSLQQLSFG-NQ 166

Query: 361 ISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSL 420
           ++   PL       L+ LD+SSN +     + L  +  L  L  + N++S   P  LG L
Sbjct: 167 VTDLKPL--ANLTTLERLDISSNKV--SDISVLAKLTNLESLIATNNQISDITP--LGIL 220

Query: 421 INLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNF 480
            NL+ L L+ N L +    +L SL  L  L+L++N++S   P+    L  L+EL L  N 
Sbjct: 221 TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLS--GLTKLTELKLGANQ 276

Query: 481 LGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIP 534
           +   IS  +  + +L  L L+ N L  + P     +  L ++ + +N +    P
Sbjct: 277 I-SNISP-LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP 326

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  212 bits (541), Expect = 1e-61
 Identities = 86/371 (23%), Positives = 155/371 (41%), Gaps = 27/371 (7%)

Query: 91  LTSISLNGTLLE--FSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQ 148
             +++     +   F  +     +   L    +  ++      L ++  L  +  K+   
Sbjct: 2   AATLATLPAPINQIFPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKV--A 57

Query: 149 IPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVV 208
              GI  LT+L  L+++ N ++   P  +  L  L  L + +N +  +   +L NLT++ 
Sbjct: 58  SIQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTNLR 113

Query: 209 ILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGI 268
            LYL  ++     P  + NL  ++ L L  N     +   +SN+T L +L +  +++  +
Sbjct: 114 ELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDV 170

Query: 269 IPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLT 328
            P  I NL  L SL L  N           +LT L       N +T            L 
Sbjct: 171 TP--IANLTDLYSLSLNYNQIED--ISPLASLTSLHYFTAYVNQITDITP--VANMTRLN 224

Query: 329 FIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGE 388
            + + NN      LS      QL+ L++  N IS  I   + +  +L+ L++ SN I   
Sbjct: 225 SLKIGNNKI--TDLSPLANLSQLTWLEIGTNQIS-DIN-AVKDLTKLKMLNVGSNQISD- 279

Query: 389 IPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLY 448
             + L N+  LN L L+ N+L       +G L NL  L LS N++++     L SL K+ 
Sbjct: 280 -ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDI--RPLASLSKMD 336

Query: 449 YLNLSHNKLSQ 459
             + ++  + +
Sbjct: 337 SADFANQVIKK 347

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  200 bits (510), Expect = 2e-57
 Identities = 84/372 (22%), Positives = 151/372 (40%), Gaps = 27/372 (7%)

Query: 159 LTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFF 218
              L      ++   P     L    +  L    +   +      L  +  L +      
Sbjct: 2   AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKV- 56

Query: 219 GSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKK 278
            +  Q I  L +L  L L  NQ++   PLS  NL  L  L++  N+++ I    + NL  
Sbjct: 57  -ASIQGIEYLTNLEYLNLNGNQITDISPLS--NLVKLTNLYIGTNKITDISA--LQNLTN 111

Query: 279 LNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFF 338
           L  L L +++   +      NLT +  L L  N+   ++S        L ++ ++ +   
Sbjct: 112 LRELYLNEDNI--SDISPLANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKV- 167

Query: 339 GEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIY 398
            + ++       L  L ++ N I    PL       L Y     N I    P  + N+  
Sbjct: 168 -KDVTPIANLTDLYSLSLNYNQIEDISPL--ASLTSLHYFTAYVNQITDITP--VANMTR 222

Query: 399 LNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLS 458
           LN L +  NK++   P  L +L  L +L++  N +S+    ++  L KL  LN+  N++S
Sbjct: 223 LNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQIS 278

Query: 459 QQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHG 518
                 L+NL  L+ L L++N LG +    I  + +L  L LS N+++ + P     +  
Sbjct: 279 D--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSK 334

Query: 519 LLHIDISYNKLE 530
           +   D +   ++
Sbjct: 335 MDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  193 bits (492), Expect = 6e-55
 Identities = 77/352 (21%), Positives = 144/352 (40%), Gaps = 25/352 (7%)

Query: 183 LNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLS 242
              LA     +N   P    +L   +   L   S    +      L+S+  L +   +++
Sbjct: 2   AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57

Query: 243 GAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTD 302
             I   I  LTNL +L L  N+++ I P  + NL KL +L +  N    T   + +NLT+
Sbjct: 58  S-IQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTN 111

Query: 303 LVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNIS 362
           L +L LN++ ++            +  ++L  N    ++ S       L+ L V+ + + 
Sbjct: 112 LRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSDL-SPLSNMTGLNYLTVTESKVK 168

Query: 363 GSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLIN 422
              P  I     L  L L+ N I    P  L ++  L+  +   N+++   P  + ++  
Sbjct: 169 DVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTR 222

Query: 423 LEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLG 482
           L  L +  N +++     L +L +L +L +  N++S      + +L  L  L++  N + 
Sbjct: 223 LNSLKIGNNKITDL--SPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQI- 277

Query: 483 EKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIP 534
             IS  +  +  L  L L+ N L          +  L  + +S N +    P
Sbjct: 278 SDISV-LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 93.0 bits (232), Expect = 2e-20
 Identities = 29/161 (18%), Positives = 68/161 (42%), Gaps = 12/161 (7%)

Query: 375 LQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLS 434
              L      I  +I     ++    R  L    ++  +      L ++  L ++   ++
Sbjct: 2   AATLATLPAPI-NQI-FPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57

Query: 435 NFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMES 494
           +   + +  L  L YLNL+ N+++   P+   NL+ L+ L +  N +   IS+ +  + +
Sbjct: 58  SI--QGIEYLTNLEYLNLNGNQITDISPLS--NLVKLTNLYIGTNKI-TDISA-LQNLTN 111

Query: 495 LEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPN 535
           L +L L+ +N+S + P     +  +  +++  N     +  
Sbjct: 112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSP 150

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  208 bits (532), Expect = 6e-61
 Identities = 84/274 (30%), Positives = 132/274 (48%), Gaps = 12/274 (4%)

Query: 638 NDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH 697
            D N +  IG G  G+V+RA+   G   AVK               EFL E+  +  +RH
Sbjct: 37  CDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERV--NEFLREVAIMKRLRH 93

Query: 698 RNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYL 757
            NIV F G  + P +  I+ EYL  GSL ++L    + ++L   +RL++   VA  + YL
Sbjct: 94  PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYL 153

Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAY 817
           HN   PPIVHR++ S N+L+D  Y   V DFG+++       +    AGT  ++APE+  
Sbjct: 154 HNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLR 212

Query: 818 TLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKL 877
                EK DVYSFGV+  E+   + P      ++ +     +     RL  P  ++  ++
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQPWG---NLNPAQVVAAVGFKCKRLEIPR-NLNPQV 268

Query: 878 MSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
            +I++    C    P  RP+   +  LL   + +
Sbjct: 269 AAIIE---GCWTNEPWKRPSFATIMDLL-RPLIK 298

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  207 bits (529), Expect = 6e-61
 Identities = 72/280 (25%), Positives = 123/280 (43%), Gaps = 23/280 (8%)

Query: 638 NDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH 697
            +   E  IG GG G VYRA    G+  AVK        ++S   E    E +    ++H
Sbjct: 7   AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65

Query: 698 RNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYL 757
            NI+   G C    +  ++ E+   G L+++L      K +     +N    +A  + YL
Sbjct: 66  PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYL 121

Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAH--------VSDFGIAKFLNPDSSNWSELAGTHG 809
           H+    PI+HRD+ S N+L+    E          ++DFG+A+  +  +      AG + 
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK--MSAAGAYA 179

Query: 810 YVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYP 869
           ++APE+      ++  DV+S+GVL  E++ G+ P      +   +    + M    LP P
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFR---GIDGLAVAYGVAMNKLALPIP 236

Query: 870 SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI 909
           S    +    +M+    C + +P SRP+   +   L   I
Sbjct: 237 S-TCPEPFAKLME---DCWNPDPHSRPSFTNILDQL-TTI 271

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  208 bits (532), Expect = 6e-61
 Identities = 72/272 (26%), Positives = 128/272 (47%), Gaps = 25/272 (9%)

Query: 638 NDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH 697
            +   E  +G+G  G V +AK    +  A+K+  S        +++ F+ E++ L+ + H
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE------SERKAFIVELRQLSRVNH 60

Query: 698 RNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYL 757
            NIVK YG C +P    ++ EY E GSL  +L              ++     +  + YL
Sbjct: 61  PNIVKLYGACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118

Query: 758 HNNCFPPIVHRDISSKNVLLDLGYE-AHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELA 816
           H+     ++HRD+   N+LL  G     + DFG A  +    +N     G+  ++APE+ 
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTN---NKGSAAWMAPEVF 175

Query: 817 YTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEML---DSRLPYPSLHV 873
                +EKCDV+S+G++  EVI  + P D   E+   +    I       +R P    ++
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVITRRKPFD---EIGGPA--FRIMWAVHNGTRPPLIK-NL 229

Query: 874 QKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
            K + S+M     C  ++P  RP+M+ + +++
Sbjct: 230 PKPIESLMT---RCWSKDPSQRPSMEEIVKIM 258

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  213 bits (543), Expect = 1e-59
 Identities = 108/489 (22%), Positives = 177/489 (36%), Gaps = 45/489 (9%)

Query: 90  NLTSISLNG----TLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKL 145
           +  ++ L+      L  +SF SFP L  LDL   E+  I      +LS+L  L  + N +
Sbjct: 29  STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88

Query: 146 FGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLN-GSIPRSLGNL 204
                     L+ L  L      L+      +G L  L +L +  N +    +P    NL
Sbjct: 89  QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL 148

Query: 205 THVVILYLYNNSFFGSIPQEIGNLKSL----FDLELCINQLSGAIPLSISNLTNLRFLFL 260
           T++  L L +N        ++  L  +      L+L +N ++  I         L  L L
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTL 207

Query: 261 YHNELSGIIPQE-IGNLKKLNSLLLAKNHFRGTV------PKSFRNLTDLVKLRLNQNYL 313
            +N  S  + +  I  L  L    L    FR           +   L +L        YL
Sbjct: 208 RNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 267

Query: 314 TG---NISETFGTYPNLTFIDLSNNSFFG-EILSDWGRCPQLSLLDVSINNISGSIPLEI 369
                +I + F    N++   L + +    +  S       L L++        ++ L+ 
Sbjct: 268 DYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFP-TLKLKS 326

Query: 370 GESL-----------------QLQYLDLSSNYI--VGEIPTQLGNIIYLNRLSLSGNKLS 410
            + L                  L++LDLS N +   G           L  L LS N + 
Sbjct: 327 LKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI 386

Query: 411 GCIPRELGSLINLEYLDLSANNLSNFVPES-LGSLVKLYYLNLSHNKLSQQIPIELDNLI 469
             +      L  LE+LD   +NL      S   SL  L YL++SH           + L 
Sbjct: 387 T-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLS 445

Query: 470 HLSELDLSHNFLGEKISSRI-CRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNK 528
            L  L ++ N   E     I   + +L  L+LS   L  L P  F  +  L  ++++ N+
Sbjct: 446 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQ 505

Query: 529 LEGQIPNST 537
           L+  +P+  
Sbjct: 506 LK-SVPDGI 513

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  199 bits (507), Expect = 7e-55
 Identities = 102/482 (21%), Positives = 161/482 (33%), Gaps = 46/482 (9%)

Query: 90  NLTSISLNG----TLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKL 145
            L  + L+     T+ + ++ S  HL  L L  N +  +     S LS+L+ L      L
Sbjct: 53  ELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNL 112

Query: 146 FGQIPSGIGLLTHLTVLHISRNWL-SGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNL 204
                  IG L  L  L+++ N + S  +P     LT L  L L SN +       L  L
Sbjct: 113 ASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVL 172

Query: 205 TH----VVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIP-LSISNLTNLRFL- 258
                  + L L  N     I         L  L L  N  S  +    I  L  L    
Sbjct: 173 HQMPLLNLSLDLSLN-PMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHR 231

Query: 259 -----FLYHNELSGIIPQEIGNLKKLNSLLLAKNH---FRGTVPKSFRNLTDLVKLRLNQ 310
                F     L       +  L  L        +   +   +   F  LT++    L  
Sbjct: 232 LVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVS 291

Query: 311 NYLTGNISETFGTY-------------------PNLTFIDLSNNSFFGEILSDWGRCPQL 351
             +      ++                       +L  +  ++N   G         P L
Sbjct: 292 VTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNK--GGNAFSEVDLPSL 349

Query: 352 SLLDVSINNIS--GSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKL 409
             LD+S N +S  G        +  L+YLDLS N ++  + +    +  L  L    + L
Sbjct: 350 EFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNL 408

Query: 410 SGCIPRE-LGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIE-LDN 467
                     SL NL YLD+S  +           L  L  L ++ N   +    +    
Sbjct: 409 KQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 468

Query: 468 LIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYN 527
           L +L+ LDLS   L +   +    + SL+ LN++ N L  +    F+ +  L  I +  N
Sbjct: 469 LRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTN 528

Query: 528 KL 529
             
Sbjct: 529 PW 530

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  187 bits (476), Expect = 1e-50
 Identities = 103/447 (23%), Positives = 165/447 (36%), Gaps = 32/447 (7%)

Query: 109 PHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNW 168
           P++ Y        + I P  +    + + LD S N L             L VL +SR  
Sbjct: 8   PNITY-QCMELNFYKI-PDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCE 63

Query: 169 LSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNL 228
           +          L+ L+ L L  N +      +   L+ +  L     +        IG+L
Sbjct: 64  IQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHL 123

Query: 229 KSLFDLELCINQL-SGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKL----NSLL 283
           K+L +L +  N + S  +P   SNLTNL  L L  N++  I   ++  L ++     SL 
Sbjct: 124 KTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLD 183

Query: 284 LAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISET-FGTYPNLTFIDLSNNSFFGEI- 341
           L+ N      P +F+ +  L KL L  N+ + N+ +T       L    L    F  E  
Sbjct: 184 LSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGN 242

Query: 342 -----LSDWGRCPQLSLLDVSINNISGSIPLEIG---ESLQLQYLDLSSNYIVGEIPTQL 393
                 S       L++ +  +  +   +   I        +    L S  I   +    
Sbjct: 243 LEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFS 301

Query: 394 GNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLS 453
            N      L L   K     P     L +L+ L  ++N   N    S   L  L +L+LS
Sbjct: 302 YN-FGWQHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLS 355

Query: 454 HNKLSQQ--IPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPR 511
            N LS +            L  LDLS N +   +SS    +E LE L+  ++NL  +   
Sbjct: 356 RNGLSFKGCCSQSDFGTTSLKYLDLSFNGV-ITMSSNFLGLEQLEHLDFQHSNLKQMSEF 414

Query: 512 C-FEEMHGLLHIDISYNKLEGQIPNST 537
             F  +  L+++DIS+        N  
Sbjct: 415 SVFLSLRNLIYLDISHTHTRV-AFNGI 440

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  159 bits (404), Expect = 3e-41
 Identities = 80/392 (20%), Positives = 130/392 (33%), Gaps = 37/392 (9%)

Query: 183 LNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLS 242
              L L  N L      S  +   + +L L              +L  L  L L  N + 
Sbjct: 30  TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89

Query: 243 GAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFR-GTVPKSFRNLT 301
                + S L++L+ L      L+ +    IG+LK L  L +A N  +   +P+ F NLT
Sbjct: 90  SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149

Query: 302 DLVKLRLNQNYLTGNISETFGTYPNLTF----IDLSNNSFFGEILSDWGRCPQLSLLDVS 357
           +L  L L+ N +             +      +DLS N     I     +  +L  L + 
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN-PMNFIQPGAFKEIRLHKLTLR 208

Query: 358 INNISGSIPLEIGESLQ-LQYLDL------SSNYIVGEIPTQLGNIIYLNRLSLSGNKLS 410
            N  S ++     + L  L+   L      +   +     + L  +  L         L 
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD 268

Query: 411 G---CIPRELGSLINLEYLDLSANNLSNFVPES-LGSLVKLYYLNLSHNKLSQQIPIELD 466
                I      L N+    L +  +      S       L  +N    +        L 
Sbjct: 269 YYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLK 328

Query: 467 ----------------NLIHLSELDLSHNFLGEK--ISSRICRMESLEKLNLSYNNLSGL 508
                           +L  L  LDLS N L  K   S       SL+ L+LS+N +   
Sbjct: 329 RLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT- 387

Query: 509 IPRCFEEMHGLLHIDISYNKLEGQIPNSTTFR 540
           +   F  +  L H+D  ++ L+ Q+   + F 
Sbjct: 388 MSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFL 418

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  154 bits (391), Expect = 1e-39
 Identities = 79/414 (19%), Positives = 139/414 (33%), Gaps = 52/414 (12%)

Query: 90  NLTSISLNGTLLEF-----SFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEY----LDF 140
            L  +++   L++       FS+  +L +LDL +N++  I    +  L  +      LD 
Sbjct: 125 TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDL 184

Query: 141 SANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEV-GQLTVLNQLALDSNFLNG---- 195
           S N +   I  G      L  L +  N+ S ++       L  L    L           
Sbjct: 185 SLNPM-NFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNL 243

Query: 196 -SIPRS-LGNLTHVVILYL---YNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSI- 249
               +S L  L ++ I      Y + +   I      L ++    L    +      S  
Sbjct: 244 EKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYN 303

Query: 250 ------------------SNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFR- 290
                               L +L+ L    N+      +   +L  L  L L++N    
Sbjct: 304 FGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEV--DLPSLEFLDLSRNGLSF 361

Query: 291 -GTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWG--- 346
            G   +S    T L  L L+ N +   +S  F     L  +D  +++   + +S++    
Sbjct: 362 KGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNL--KQMSEFSVFL 418

Query: 347 RCPQLSLLDVSINNISGSIPLEIGESL-QLQYLDLSSNYIVGEIPTQ-LGNIIYLNRLSL 404
               L  LD+S  +        I   L  L+ L ++ N             +  L  L L
Sbjct: 419 SLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 477

Query: 405 SGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLS 458
           S  +L    P    SL +L+ L++++N L +        L  L  + L  N   
Sbjct: 478 SQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  140 bits (355), Expect = 4e-35
 Identities = 75/382 (19%), Positives = 130/382 (34%), Gaps = 44/382 (11%)

Query: 220 SIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKL 279
            IP  +    S  +L+L  N L      S  +   L+ L L   E+  I      +L  L
Sbjct: 21  KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78

Query: 280 NSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSF-F 338
           ++L+L  N  +     +F  L+ L KL   +  L    +   G    L  +++++N    
Sbjct: 79  STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138

Query: 339 GEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQY----LDLSSNYIVGEIPTQLG 394
            ++   +     L  LD+S N I      ++    Q+      LDLS N +   I     
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM-NFIQPGAF 197

Query: 395 NIIYLNRLSLSGNKLSGCIPRE-LGSLINLEYLDL------SANNLSNFVPESLGSLVKL 447
             I L++L+L  N  S  + +  +  L  LE   L      +  NL  F   +L  L  L
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257

Query: 448 YYLNLSHNKLSQ---QIPIELDNLIHLSELDLSHNFLGE-------------------KI 485
                    L      I    + L ++S   L    +                       
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFG 317

Query: 486 SSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNSTTFRDAP-L 544
                +++SL++L  + N           ++  L  +D+S N L  +   S +      L
Sbjct: 318 QFPTLKLKSLKRLTFTSNKGGNAFS--EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSL 375

Query: 545 EAL--QGNK--GLYGDIRGFPS 562
           + L    N    +  +  G   
Sbjct: 376 KYLDLSFNGVITMSSNFLGLEQ 397

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  113 bits (284), Expect = 4e-26
 Identities = 48/209 (22%), Positives = 81/209 (38%), Gaps = 7/209 (3%)

Query: 90  NLTSISLNGTLLE--FSFSSFPHLVYLDLYNNEL--FGIIPPQISNLSNLEYLDFSANKL 145
           +L  ++         FS    P L +LDL  N L   G         ++L+YLD S N +
Sbjct: 326 SLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGV 385

Query: 146 FGQIPSGIGLLTHLTVLHISRNWLSGSIPHEV-GQLTVLNQLALDSNFLNGSIPRSLGNL 204
              + S    L  L  L    + L       V   L  L  L +       +       L
Sbjct: 386 I-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGL 444

Query: 205 THVVILYLYNNSFFGSIPQEI-GNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHN 263
           + + +L +  NSF  +   +I   L++L  L+L   QL    P + ++L++L+ L +  N
Sbjct: 445 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASN 504

Query: 264 ELSGIIPQEIGNLKKLNSLLLAKNHFRGT 292
           +L  +       L  L  + L  N +  +
Sbjct: 505 QLKSVPDGIFDRLTSLQKIWLHTNPWDCS 533

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  200 bits (510), Expect = 4e-58
 Identities = 79/281 (28%), Positives = 127/281 (45%), Gaps = 28/281 (9%)

Query: 638 NDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPL---PGEMSFQQEEFLNEIQALT 693
           N+   E  IGKGG G V++ + V    + A+K           EM  + +EF  E+  ++
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78

Query: 694 EIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADA 753
            + H NIVK YG   +P    ++ E++  G L   L +   A  + W+ +L ++  +A  
Sbjct: 79  NLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALG 134

Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYE-----AHVSDFGIAKFLNPDSSNWSELAGTH 808
           + Y+ N   PPIVHRD+ S N+ L    E     A V+DFG+++      S    L G  
Sbjct: 135 IEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSG---LLGNF 190

Query: 809 GYVAPEL--AYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS--SSNMNIEMLDS 864
            ++APE   A     TEK D YSF ++   ++ G+ P D   E S         I     
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD---EYSYGKIKFINMIREEGL 247

Query: 865 RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
           R   P      +L ++++    C   +P+ RP    + + L
Sbjct: 248 RPTIPE-DCPPRLRNVIE---LCWSGDPKKRPHFSYIVKEL 284

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  190 bits (484), Expect = 8e-55
 Identities = 53/277 (19%), Positives = 106/277 (38%), Gaps = 23/277 (8%)

Query: 638 NDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH 697
              N    + +   G +++ +   G    VK            +  +F  E   L    H
Sbjct: 10  KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSR--DFNEECPRLRIFSH 66

Query: 698 RNIVKFYGFCSHP--KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALF 755
            N++   G C  P   H  +I  ++  GSL  +L ++ +   +  +Q +     +A  + 
Sbjct: 67  PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVL-HEGTNFVVDQSQAVKFALDMARGMA 125

Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           +LH    P I    ++S++V++D    A +S   +                   +VAPE 
Sbjct: 126 FLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR-----MYAPAWVAPEA 179

Query: 816 ---AYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLH 872
                        D++SF VL  E++  + P     ++S+    M + +   R   P   
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWELVTREVPFA---DLSNMEIGMKVALEGLRPTIPP-G 235

Query: 873 VQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI 909
           +   +  +M+    C++++P  RP    +  +L EK+
Sbjct: 236 ISPHVSKLMK---ICMNEDPAKRPKFDMIVPIL-EKM 268

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  184 bits (470), Expect = 2e-52
 Identities = 70/289 (24%), Positives = 122/289 (42%), Gaps = 31/289 (10%)

Query: 638 NDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
           +D      +GKG  G   +     +GE+  +K+       E    Q  FL E++ +  + 
Sbjct: 10  SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEE--TQRTFLKEVKVMRCLE 65

Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFY 756
           H N++KF G     K    I EY++ G+L  I+ +     +  W+QR++  K +A  + Y
Sbjct: 66  HPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAY 123

Query: 757 LHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSEL------------ 804
           LH+     I+HRD++S N L+       V+DFG+A+ +  + +    L            
Sbjct: 124 LHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRY 180

Query: 805 --AGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEML 862
              G   ++APE+       EK DV+SFG++  E+I   +         +    +N+   
Sbjct: 181 TVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY-LPRTMDFGLNVRG- 238

Query: 863 DSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
                 P  +       I      C D +PE RP+  ++   L E +  
Sbjct: 239 FLDRYCPP-NCPPSFFPIT---VRCCDLDPEKRPSFVKLEHWL-ETLRM 282

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  191 bits (487), Expect = 2e-52
 Identities = 84/448 (18%), Positives = 162/448 (36%), Gaps = 34/448 (7%)

Query: 109 PHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNW 168
                 D  +     I P  ++  + ++ LD S NK+       +    +L VL +  + 
Sbjct: 5   DASGVCDGRSRSFTSI-PSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSR 61

Query: 169 LSGSIPHEV-GQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFG-SIPQEIG 226
           ++ +I  +    L  L  L L  N L+       G L+ +  L L  N +    +     
Sbjct: 62  IN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFP 120

Query: 227 NLKSLFDLELCINQLSGAIP-LSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLA 285
           NL +L  L +   +    I  +  + LT+L  L +    L     Q + +++ ++ L L 
Sbjct: 121 NLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLH 180

Query: 286 KNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNS--------- 336
            +     +      L+ +  L L    L              + +               
Sbjct: 181 LSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESF 240

Query: 337 -FFGEILSDWGRCPQLSLLDVSINNISGSIPLEIG--------ESLQLQYLDLSSNYIVG 387
               ++L       ++   D ++N +    P E          E++ ++ L +   Y+  
Sbjct: 241 NELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFY 300

Query: 388 EIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPES---LGSL 444
           ++ T    +  + R+++  +K+          L +LE+LDLS N +     ++    G+ 
Sbjct: 301 DLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAW 360

Query: 445 VKLYYLNLSHNKLS--QQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSY 502
             L  L LS N L   Q+    L  L +L+ LD+S N     +       E +  LNLS 
Sbjct: 361 PSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTF-HPMPDSCQWPEKMRFLNLSS 419

Query: 503 NNLSGLIPRCFEEMHGLLHIDISYNKLE 530
             +  +          L  +D+S N L+
Sbjct: 420 TGIRVVKTCIP---QTLEVLDVSNNNLD 444

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  189 bits (481), Expect = 2e-51
 Identities = 87/462 (18%), Positives = 176/462 (38%), Gaps = 26/462 (5%)

Query: 90  NLTSISLNG----TLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKL 145
            + S+ L+      +      +  +L  L L ++ +  I      +L +LE+LD S N L
Sbjct: 27  AMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHL 86

Query: 146 FGQIPSGIGLLTHLTVLHISRNWLSG-SIPHEVGQLTVLNQLALDSNFLNGSIPR-SLGN 203
                S  G L+ L  L++  N      +      LT L  L + +      I R     
Sbjct: 87  SSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAG 146

Query: 204 LTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHN 263
           LT +  L +   S      Q + +++ +  L L +++ +  + +    L+++R+L L   
Sbjct: 147 LTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDT 206

Query: 264 ELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGT 323
            L+      +   +  + +            +SF  L  L++  L  + +         T
Sbjct: 207 NLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEV----EFDDCT 262

Query: 324 YPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSN 383
              L   + S +    E+         +  L +    +   +        +++ + + ++
Sbjct: 263 LNGLGDFNPSESDVVSELGKV--ETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENS 320

Query: 384 YIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRE---LGSLINLEYLDLSANNLSNF--VP 438
            +     +   ++  L  L LS N +     +     G+  +L+ L LS N+L +     
Sbjct: 321 KVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTG 380

Query: 439 ESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKL 498
           E L +L  L  L++S N     +P        +  L+LS   +      + C  ++LE L
Sbjct: 381 EILLTLKNLTSLDISRNTF-HPMPDSCQWPEKMRFLNLSSTGIR---VVKTCIPQTLEVL 436

Query: 499 NLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNSTTFR 540
           ++S NNL          +  L  + IS NKL+  +P+++ F 
Sbjct: 437 DVSNNNLDSF----SLFLPRLQELYISRNKLK-TLPDASLFP 473

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  187 bits (476), Expect = 9e-51
 Identities = 84/451 (18%), Positives = 149/451 (33%), Gaps = 27/451 (5%)

Query: 90  NLTSISLNG----TLLEFSFSSFPHLVYLDLYNNELFGIIPPQ-ISNLSNLEYLDFSANK 144
           +L  + L+     +L    F     L YL+L  N    +       NL+NL+ L     +
Sbjct: 75  SLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVE 134

Query: 145 LFGQIPSG-IGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGN 203
            F +I       LT L  L I    L       +  +  ++ L L  +     +      
Sbjct: 135 TFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADI 194

Query: 204 LTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHN 263
           L+ V  L L + +        +   +    ++    + S     S + L  L    L  +
Sbjct: 195 LSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELS 254

Query: 264 ELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGT 323
           E+         +           +               + +L + Q YL  ++S  +  
Sbjct: 255 EVE------FDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSL 308

Query: 324 YPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSI---PLEIGESLQLQYLDL 380
              +  I + N+  F    S       L  LD+S N +           G    LQ L L
Sbjct: 309 LEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVL 368

Query: 381 SSNYI--VGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVP 438
           S N++  + +    L  +  L  L +S N     +P        + +L+LS+  +     
Sbjct: 369 SQNHLRSMQKTGEILLTLKNLTSLDISRNTFHP-MPDSCQWPEKMRFLNLSSTGIRVV-- 425

Query: 439 ESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKL 498
                   L  L++S+N L     + L  L    EL +S N L + +         L  +
Sbjct: 426 -KTCIPQTLEVLDVSNNNLDS-FSLFLPRL---QELYISRNKL-KTLPD-ASLFPVLLVM 478

Query: 499 NLSYNNLSGLIPRCFEEMHGLLHIDISYNKL 529
            +S N L  +    F+ +  L  I +  N  
Sbjct: 479 KISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  139 bits (352), Expect = 9e-35
 Identities = 60/344 (17%), Positives = 125/344 (36%), Gaps = 24/344 (6%)

Query: 220 SIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKL 279
           SIP  +    ++  L+L  N+++      +    NL+ L L  + ++ I      +L  L
Sbjct: 19  SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSL 76

Query: 280 NSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTG-NISETFGTYPNLTFIDLSNNSFF 338
             L L+ NH        F  L+ L  L L  N      ++  F    NL  + + N   F
Sbjct: 77  EHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETF 136

Query: 339 GEILSDW-GRCPQLSLLDVSINNISGSIPLEIGESLQ-LQYLDLSSNYIVGEIPTQLGNI 396
            EI          L+ L++   ++  +   +  +S++ + +L L  +     +      +
Sbjct: 137 SEIRRIDFAGLTSLNELEIKALSLR-NYQSQSLKSIRDIHHLTLHLSESAFLLEIFADIL 195

Query: 397 IYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKL--------- 447
             +  L L    L+      L        +   A   S    ES   L+KL         
Sbjct: 196 SSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSE 255

Query: 448 -YYLNLSHNKLSQQIPIELD--------NLIHLSELDLSHNFLGEKISSRICRMESLEKL 498
             + + + N L    P E D          + +  L +   +L   +S+    +E ++++
Sbjct: 256 VEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRI 315

Query: 499 NLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNSTTFRDA 542
            +  + +  +     + +  L  +D+S N +  +   ++  + A
Sbjct: 316 TVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGA 359

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  107 bits (269), Expect = 3e-24
 Identities = 48/256 (18%), Positives = 91/256 (35%), Gaps = 17/256 (6%)

Query: 88  GINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFG 147
           G+   + S +  + E        +  L +    LF  +    S L  ++ +    +K+F 
Sbjct: 265 GLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF- 323

Query: 148 QIPSGIG-LLTHLTVLHISRNWLSGSIPHE---VGQLTVLNQLALDSNFLN--GSIPRSL 201
            +P      L  L  L +S N +           G    L  L L  N L         L
Sbjct: 324 LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEIL 383

Query: 202 GNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLY 261
             L ++  L +  N+ F  +P      + +  L L    +   +   I     L  L + 
Sbjct: 384 LTLKNLTSLDISRNT-FHPMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVS 439

Query: 262 HNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETF 321
           +N L       +  L++L    +++N  + T+P +      L+ +++++N L       F
Sbjct: 440 NNNLDS-FSLFLPRLQELY---ISRNKLK-TLPDAS-LFPVLLVMKISRNQLKSVPDGIF 493

Query: 322 GTYPNLTFIDLSNNSF 337
               +L  I L  N +
Sbjct: 494 DRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 90.6 bits (225), Expect = 6e-19
 Identities = 40/185 (21%), Positives = 68/185 (36%), Gaps = 29/185 (15%)

Query: 348 CPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGN 407
           C    + D    + + SIP  +  +  ++ LDLS N I   I                  
Sbjct: 4   CDASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKIT-YIG----------------- 42

Query: 408 KLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDN 467
                   +L +  NL+ L L ++ ++    ++  SL  L +L+LS N LS         
Sbjct: 43  ------HGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGP 96

Query: 468 LIHLSELDLSHNFLGE-KISSRICRMESLEKLNLSYNNLSGLIPR-CFEEMHGLLHIDIS 525
           L  L  L+L  N      ++S    + +L+ L +        I R  F  +  L  ++I 
Sbjct: 97  LSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIK 156

Query: 526 YNKLE 530
              L 
Sbjct: 157 ALSLR 161

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  183 bits (466), Expect = 1e-51
 Identities = 68/319 (21%), Positives = 113/319 (35%), Gaps = 53/319 (16%)

Query: 630 YEEIISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEI 689
             E     ++      IG+G +G+VY+  +      AVK F        +F  E+    I
Sbjct: 5   ASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF--SFANRQNFINEK---NI 58

Query: 690 QALTEIRHRNIVKFYGFCSHPKHS-----FIIYEYLESGSLDKILCNDASAKELGWTQRL 744
             +  + H NI +F                ++ EY  +GSL K L    S     W    
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSC 114

Query: 745 NVIKGVADALFYLHN------NCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS 798
            +   V   L YLH       +  P I HRD++S+NVL+       +SDFG++  L  + 
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174

Query: 799 SNWSE--------LAGTHGYVAPE-------LAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
                          GT  Y+APE       L       ++ D+Y+ G++  E+      
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234

Query: 844 RDFL---------FEMSSSSSNMNIEMLDS------RLPYPS--LHVQKKLMSIMQVAFS 886
                        F+    +     +M         R  +P         + S+ +    
Sbjct: 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294

Query: 887 CLDQNPESRPTMKRVSQLL 905
           C DQ+ E+R T +   + +
Sbjct: 295 CWDQDAEARLTAQXAEERM 313

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  182 bits (464), Expect = 2e-51
 Identities = 71/324 (21%), Positives = 121/324 (37%), Gaps = 50/324 (15%)

Query: 602 KNDSQTQQSSFGNTPGLRSVLTFEGKIVYEEIISATNDFNAEHCIGKGGHGSVYRAKVPS 661
            N S     SF       S+   E  I +E++            IGKG  G VY  +   
Sbjct: 4   MNLSLLSARSFPRKASQTSIFLQEWDIPFEQL-------EIGELIGKGRFGQVYHGRW-H 55

Query: 662 GEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLE 721
           GE+ A++        E   Q + F  E+ A  + RH N+V F G C  P H  II    +
Sbjct: 56  GEV-AIRLIDIERDNED--QLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCK 112

Query: 722 SGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGY 781
             +L  ++ +      L   +   + + +   + YLH      I+H+D+ SKNV  D G 
Sbjct: 113 GRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYDNG- 166

Query: 782 EAHVSDFGIAK-----FLNPDSSNWSELAGTHGYVAPEL---------AYTLKVTEKCDV 827
           +  ++DFG+                    G   ++APE+            L  ++  DV
Sbjct: 167 KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDV 226

Query: 828 YSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEML------DSRLPYPSLHVQKKLMSIM 881
           ++ G +  E+   + P    F+          E +        +     + + K++  I+
Sbjct: 227 FALGTIWYELHAREWP----FK------TQPAEAIIWQMGTGMKPNLSQIGMGKEISDIL 276

Query: 882 QVAFSCLDQNPESRPTMKRVSQLL 905
                C     E RPT  ++  +L
Sbjct: 277 L---FCWAFEQEERPTFTKLMDML 297

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  180 bits (459), Expect = 5e-51
 Identities = 76/298 (25%), Positives = 121/298 (40%), Gaps = 48/298 (16%)

Query: 643 EHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVK 702
             C+GKG +G V+R     GE  AVK F S    E S+ +E    E+     +RH NI+ 
Sbjct: 13  LECVGKGRYGEVWRGSW-QGENVAVKIFSSRD--EKSWFRE---TELYNTVMLRHENILG 66

Query: 703 FYGFCSHPKHS----FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLH 758
           F       +HS    ++I  Y E GSL   L        L     L ++  +A  L +LH
Sbjct: 67  FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLH 122

Query: 759 NNCF-----PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSEL----AGTHG 809
              F     P I HRD+ SKN+L+    +  ++D G+A   +  ++          GT  
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182

Query: 810 YVAPEL------AYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMN----- 858
           Y+APE+             ++ D+++FG++  EV +       + +      ++      
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS 242

Query: 859 -IEMLD------SRLPYP----SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
             +M         R   P    S      L  +M+    C  QNP +R T  R+ + L
Sbjct: 243 FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMK---ECWYQNPSARLTALRIKKTL 297

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  178 bits (454), Expect = 5e-50
 Identities = 76/298 (25%), Positives = 117/298 (39%), Gaps = 48/298 (16%)

Query: 643 EHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVK 702
              IGKG +G V+  K   GE  AVK F +    E S+ +E    EI     +RH NI+ 
Sbjct: 42  VKQIGKGRYGEVWMGKW-RGEKVAVKVFFTT--EEASWFRE---TEIYQTVLMRHENILG 95

Query: 703 FYGFCSHPKHS----FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLH 758
           F         S    ++I +Y E+GSL   L +      L     L +       L +LH
Sbjct: 96  FIAADIKGTGSWTQLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLH 151

Query: 759 NNCF-----PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSEL----AGTHG 809
              F     P I HRD+ SKN+L+       ++D G+A     D++          GT  
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR 211

Query: 810 YVAPEL------AYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMN----- 858
           Y+ PE+          +     D+YSFG++  EV +       + E      ++      
Sbjct: 212 YMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPS 271

Query: 859 -IEMLDS------RLPYPSL----HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
             +M +       R  +P+        +++  +M     C   NP SR T  RV + L
Sbjct: 272 YEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMT---ECWAHNPASRLTALRVKKTL 326

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  181 bits (461), Expect = 2e-49
 Identities = 68/452 (15%), Positives = 138/452 (30%), Gaps = 28/452 (6%)

Query: 90  NLTSISLNG----TLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKL 145
                 +        L     S  ++  LDL  N L  I    ++  + LE L+ S+N L
Sbjct: 11  RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70

Query: 146 FGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLT 205
           + +    +  L+ L  L ++ N++      E+     +  L   +N ++           
Sbjct: 71  Y-ETLD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRVSCSRGQGKK 123

Query: 206 HVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSG-AIPLSISNLTNLRFLFLYHNE 264
           +   +YL NN        + G    +  L+L +N++         ++   L  L L +N 
Sbjct: 124 N---IYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF 180

Query: 265 LSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTY 324
           +   +  ++    KL +L L+ N     +   F++   +  + L  N L   I +     
Sbjct: 181 IY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFS 236

Query: 325 PNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNY 384
            NL   DL  N F    L D+       +  V+   +         E          +  
Sbjct: 237 QNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYC 295

Query: 385 IVGEIPTQLGNIIYLNRLSLSGNKLSG----CIPRELGSLINLEYLDLSANNLSNFVPES 440
                      +I L R   +     G     +  E  +      +D         + + 
Sbjct: 296 CEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQV 355

Query: 441 LGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGE--KISSRICRMESLEKL 498
                    L      L +Q+         L           E    +     ++ L  +
Sbjct: 356 TLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAI 415

Query: 499 NLSYNNLSGLIPRCFEEMHGLLHIDISYNKLE 530
              Y  +   + +   + + +   D+  +K  
Sbjct: 416 VKRYEEM--YVEQQSVQNNAIRDWDMYQHKET 445

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  172 bits (438), Expect = 2e-46
 Identities = 64/437 (14%), Positives = 131/437 (29%), Gaps = 68/437 (15%)

Query: 105 FSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHI 164
             +        + ++ L   +     +  N++ LD S N L     + +   T L +L++
Sbjct: 6   KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65

Query: 165 SRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQE 224
           S N L                               L +L+ +  L L NN       QE
Sbjct: 66  SSNVLYE--------------------------TLDLESLSTLRTLDLNNNYV-----QE 94

Query: 225 IGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLL 284
           +    S+  L    N +S    +S S     + ++L +N+++ +   + G   ++  L L
Sbjct: 95  LLVGPSIETLHAANNNISR---VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDL 151

Query: 285 AKNHFRG-TVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILS 343
             N        +   +   L  L L  N++                 D+           
Sbjct: 152 KLNEIDTVNFAELAASSDTLEHLNLQYNFIY----------------DVKGQVV------ 189

Query: 344 DWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLS 403
                 +L  LD+S N ++  +  E   +  + ++ L +N +V  I   L     L    
Sbjct: 190 ----FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFD 243

Query: 404 LSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPI 463
           L GN    C         N     ++   +     ++          +            
Sbjct: 244 LRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAP 302

Query: 464 ELDNLIHLSELDLSHNFLG----EKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGL 519
             D LI L   + +         E++           +++        +I +        
Sbjct: 303 FADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAK 362

Query: 520 LHIDISYNKLEGQIPNS 536
           + ++     L+ Q+ N 
Sbjct: 363 ITLEQKKKALDEQVSNG 379

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  161 bits (408), Expect = 2e-42
 Identities = 65/312 (20%), Positives = 116/312 (37%), Gaps = 16/312 (5%)

Query: 220 SIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKL 279
           +I +   N       ++  + L  A+     +  N++ L L  N LS I   ++    KL
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 280 NSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFG 339
             L L+ N           +L+ L  L LN NY+           P++  +  +NN+   
Sbjct: 61  ELLNLSSNVL--YETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNN-IS 112

Query: 340 EILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVG-EIPTQLGNIIY 398
            +     R      + ++ N I+    L+ G   ++QYLDL  N I          +   
Sbjct: 113 RV--SCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170

Query: 399 LNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLS 458
           L  L+L  N +   +  ++     L+ LDLS+N L+  +     S   + +++L +NKL 
Sbjct: 171 LEHLNLQYNFIYD-VKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV 227

Query: 459 QQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHG 518
             I   L    +L   DL  N      + R    ++     ++   +  L  +  EE   
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGF-HCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTV 285

Query: 519 LLHIDISYNKLE 530
                      E
Sbjct: 286 PTLGHYGAYCCE 297

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  113 bits (283), Expect = 2e-26
 Identities = 34/185 (18%), Positives = 75/185 (40%), Gaps = 13/185 (7%)

Query: 364 SIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINL 423
           +I        + +   ++ + +   + +   +   +  L LSGN LS     +L     L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 424 EYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGE 483
           E L+LS+N L       L SL  L  L+L++N +      EL     +  L  ++N +  
Sbjct: 61  ELLNLSSNVLYET--LDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-S 112

Query: 484 KISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNSTTFRDAP 543
           ++S      +  + + L+ N ++ L          + ++D+  N+++  +  +       
Sbjct: 113 RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAAS-- 167

Query: 544 LEALQ 548
            + L+
Sbjct: 168 SDTLE 172

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  180 bits (459), Expect = 2e-49
 Identities = 85/454 (18%), Positives = 160/454 (35%), Gaps = 84/454 (18%)

Query: 125 IPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLN 184
           I P+  + + L+     ++ L  ++P     +   T  + + +    + P   G+   + 
Sbjct: 3   INPRNVSNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61

Query: 185 QLALDSNFLNG------------SIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLF 232
              L                   S+P    +L     L    NS    +P+   +LKSL 
Sbjct: 62  VSRLRDCLDRQAHELELNNLGLSSLPELPPHLES---LVASCNS-LTELPELPQSLKSLL 117

Query: 233 DLELCINQLSGAIPL---------------SISNLTNLRFLFLYHNELSGIIPQEIGNLK 277
                +  LS   PL                + N + L+ + + +N L   +P    +L+
Sbjct: 118 VDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK-KLPDLPPSLE 176

Query: 278 KLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSF 337
            +       N          +NL  L  +  + N L     +      +L  I   NN  
Sbjct: 177 FIA---AGNNQL--EELPELQNLPFLTAIYADNNSLK----KLPDLPLSLESIVAGNNIL 227

Query: 338 FGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNII 397
             E L +    P L+ +    N +  ++P        L+ L++  NY+  ++P    ++ 
Sbjct: 228 --EELPELQNLPFLTTIYADNNLLK-TLPDLPP---SLEALNVRDNYLT-DLPELPQSLT 280

Query: 398 YLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKL 457
           +L+      + LS   P       NL YL+ S+N + +   +   SL +   LN+S+NKL
Sbjct: 281 FLDVSENIFSGLSELPP-------NLYYLNASSNEIRSL-CDLPPSLEE---LNVSNNKL 329

Query: 458 SQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGL--------- 508
             ++P        L  L  S N L  ++        +L++L++ YN L            
Sbjct: 330 I-ELPALPPR---LERLIASFNHL-AEVPELPQ---NLKQLHVEYNPLREFPDIPESVED 381

Query: 509 ------IPRCFEEMHGLLHIDISYNKLEGQIPNS 536
                 +    E    L  + +  N L  + P+ 
Sbjct: 382 LRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDI 414

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  179 bits (456), Expect = 6e-49
 Identities = 79/469 (16%), Positives = 153/469 (32%), Gaps = 91/469 (19%)

Query: 90  NLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQI 149
           NLT + +          +           +E     PP       +              
Sbjct: 22  NLTEMPV-------EAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDC------ 68

Query: 150 PSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVI 209
                L      L ++   LS S+P     L  L       N L   +P    +L  +++
Sbjct: 69  -----LDRQAHELELNNLGLS-SLPELPPHLESLV---ASCNSLT-ELPELPQSLKSLLV 118

Query: 210 LYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGII 269
                     ++      L+ L    +  NQL   +P  + N + L+ + + +N L   +
Sbjct: 119 DNNNLK----ALSDLPPLLEYLG---VSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK-KL 168

Query: 270 PQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTF 329
           P    +L+ +       N          +NL  L  +  + N L     +      +L  
Sbjct: 169 PDLPPSLEFIA---AGNNQL--EELPELQNLPFLTAIYADNNSLK----KLPDLPLSLES 219

Query: 330 IDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEI 389
           I   NN    E L +    P L+ +    N +  ++P        L+ L++  NY+  ++
Sbjct: 220 IVAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPDLPP---SLEALNVRDNYLT-DL 272

Query: 390 PTQLGNIIYLNRLSLSGNKLSGCIP--REL-----------GSLINLEYLDLSANNLSNF 436
           P    ++ +L+      + LS   P    L               +LE L++S N L   
Sbjct: 273 PELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIEL 332

Query: 437 VPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRME--- 493
            P     L +L     S N L+ ++P    N   L +L + +N L  +       +E   
Sbjct: 333 -PALPPRLERLI---ASFNHLA-EVPELPQN---LKQLHVEYNPL-REFPDIPESVEDLR 383

Query: 494 -------------SLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKL 529
                        +L++L++  N L        +    +  + ++  ++
Sbjct: 384 MNSHLAEVPELPQNLKQLHVETNPLREF----PDIPESVEDLRMNSERV 428

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  177 bits (451), Expect = 3e-48
 Identities = 90/432 (20%), Positives = 160/432 (37%), Gaps = 65/432 (15%)

Query: 90  NLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQI 149
               + LN   L       PHL  L    N L   +P    +L +L   + +   L    
Sbjct: 72  QAHELELNNLGLSSLPELPPHLESLVASCNSL-TELPELPQSLKSLLVDNNNLKALSDLP 130

Query: 150 PS---------------GIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLN 194
           P                 +   + L ++ +  N L   +P     L  +      +N L 
Sbjct: 131 PLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK-KLPDLPPSLEFIA---AGNNQLE 186

Query: 195 GSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTN 254
             +P  L NL  +  +Y  NNS    +P    +L+S+       N L       + NL  
Sbjct: 187 -ELP-ELQNLPFLTAIYADNNSL-KKLPDLPLSLESI---VAGNNILE--ELPELQNLPF 238

Query: 255 LRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLT 314
           L  ++  +N L   +P    +L+ LN   +  N+    +P+  ++LT L       + L+
Sbjct: 239 LTTIYADNNLLK-TLPDLPPSLEALN---VRDNYLT-DLPELPQSLTFLDVSENIFSGLS 293

Query: 315 GNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQ 374
                     PNL +++ S+N    EI S     P L  L+VS N +   +P       +
Sbjct: 294 ELP-------PNLYYLNASSN----EIRSLCDLPPSLEELNVSNNKLI-ELPALPP---R 338

Query: 375 LQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLS 434
           L+ L  S N++  E+P    N   L +L +  N L    P    S+ +L       N+  
Sbjct: 339 LERLIASFNHLA-EVPELPQN---LKQLHVEYNPLR-EFPDIPESVEDLR-----MNSHL 388

Query: 435 NFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMES 494
             VPE   +L +L   ++  N L +  P   +++    +L ++   + +         + 
Sbjct: 389 AEVPELPQNLKQL---HVETNPLRE-FPDIPESV---EDLRMNSERVVDPYEFAHETTDK 441

Query: 495 LEKLNLSYNNLS 506
           LE     +++  
Sbjct: 442 LEDDVFEHHHHH 453

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  174 bits (443), Expect = 6e-49
 Identities = 68/265 (25%), Positives = 124/265 (46%), Gaps = 18/265 (6%)

Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG 705
           IG G  G+VY+ K   G++ AVK  +   P     Q + F NE+  L + RH NI+ F G
Sbjct: 32  IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQ--QLQAFKNEVGVLRKTRHVNILLFMG 87

Query: 706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 765
           + + P+ + I+ ++ E  SL   L    S  +    + +++ +  A  + YLH      I
Sbjct: 88  YSTAPQLA-IVTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAK---SI 141

Query: 766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLN--PDSSNWSELAGTHGYVAPEL---AYTLK 820
           +HRD+ S N+ L       + DFG+A   +    S  + +L+G+  ++APE+     +  
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201

Query: 821 VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSI 880
            + + DVY+FG++  E++ G+ P   +         +    L   L     +  K++  +
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRL 261

Query: 881 MQVAFSCLDQNPESRPTMKRVSQLL 905
           M     CL +  + RP+  R+   +
Sbjct: 262 MA---ECLKKKRDERPSFPRILAEI 283

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  174 bits (444), Expect = 1e-48
 Identities = 52/329 (15%), Positives = 101/329 (30%), Gaps = 23/329 (6%)

Query: 195 GSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTN 254
           GS      + +    LY   ++        +   +  ++ +              +N  N
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNN 57

Query: 255 LRFLFLYHNELSGIIPQEIGNLK--KLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNY 312
            +        L       + +       +L L         P     L+ L  + ++   
Sbjct: 58  PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115

Query: 313 LTGNISETFGTYPNLTFIDLSNNSFFGEILSDW-GRCPQLSLLDVSINNISGSIPLEIGE 371
           L   + +T   +  L  + L+ N      L        +L  L +        +P  +  
Sbjct: 116 LM-ELPDTMQQFAGLETLTLARNPL--RALPASIASLNRLRELSIRACPELTELPEPLAS 172

Query: 372 SL---------QLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLIN 422
           +           LQ L L    I   +P  + N+  L  L +  + LS  +   +  L  
Sbjct: 173 TDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPK 230

Query: 423 LEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLG 482
           LE LDL         P   G    L  L L        +P+++  L  L +LDL      
Sbjct: 231 LEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNL 290

Query: 483 EKISSRICRMESLEKLNLSYNNLSGLIPR 511
            ++ S I ++ +   + +  +  + L   
Sbjct: 291 SRLPSLIAQLPANCIILVPPHLQAQLDQH 319

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  170 bits (433), Expect = 3e-47
 Identities = 53/362 (14%), Positives = 99/362 (27%), Gaps = 51/362 (14%)

Query: 129 ISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLAL 188
             + S  E L F  +         +           +R   +    +             
Sbjct: 8   HHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQAN----SNNPQIETR 63

Query: 189 DSNFLNGSIPRSLGNLTHV--VILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIP 246
               L  +    L + T    V L L +       P +   L  L  + +    L   +P
Sbjct: 64  TGRALK-ATADLLEDATQPGRVALELRSVP-LPQFPDQAFRLSHLQHMTIDAAGLM-ELP 120

Query: 247 LSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKL 306
            ++     L  L L  N L   +P  I +L +L  L +        +P+   +       
Sbjct: 121 DTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTD----- 174

Query: 307 RLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIP 366
                      S       NL  + L                               S+P
Sbjct: 175 ----------ASGEHQGLVNLQSLRLEWTGI-------------------------RSLP 199

Query: 367 LEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYL 426
             I     L+ L + ++ +   +   + ++  L  L L G       P   G    L+ L
Sbjct: 200 ASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRL 258

Query: 427 DLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKIS 486
            L   +    +P  +  L +L  L+L       ++P  +  L     + +  +   +   
Sbjct: 259 ILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQ 318

Query: 487 SR 488
            R
Sbjct: 319 HR 320

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  153 bits (390), Expect = 2e-41
 Identities = 60/260 (23%), Positives = 99/260 (38%), Gaps = 19/260 (7%)

Query: 90  NLTSISLNGTLL-----EFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANK 144
           N    +  G  L         ++ P  V L+L +  L    P Q   LS+L+++   A  
Sbjct: 57  NPQIETRTGRALKATADLLEDATQPGRVALELRSVPL-PQFPDQAFRLSHLQHMTIDAAG 115

Query: 145 LFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGN- 203
           L  ++P  +     L  L ++RN L  ++P  +  L  L +L++ +      +P  L + 
Sbjct: 116 L-MELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST 173

Query: 204 --------LTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNL 255
                   L ++  L L       S+P  I NL++L  L++  + LS A+  +I +L  L
Sbjct: 174 DASGEHQGLVNLQSLRLEWTG-IRSLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKL 231

Query: 256 RFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTG 315
             L L         P   G    L  L+L       T+P     LT L KL L       
Sbjct: 232 EELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLS 291

Query: 316 NISETFGTYPNLTFIDLSNN 335
            +       P    I +  +
Sbjct: 292 RLPSLIAQLPANCIILVPPH 311

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  115 bits (291), Expect = 3e-28
 Identities = 38/199 (19%), Positives = 71/199 (35%), Gaps = 14/199 (7%)

Query: 90  NLTSISLNGTLLEF---SFSSFPHLVYLDLYNNELFGIIPPQISN---------LSNLEY 137
            L +++L    L     S +S   L  L +        +P  +++         L NL+ 
Sbjct: 128 GLETLTLARNPLRALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQS 187

Query: 138 LDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSI 197
           L      +   +P+ I  L +L  L I  + LS ++   +  L  L +L L       + 
Sbjct: 188 LRLEWTGI-RSLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNY 245

Query: 198 PRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRF 257
           P   G    +  L L + S   ++P +I  L  L  L+L        +P  I+ L     
Sbjct: 246 PPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCI 305

Query: 258 LFLYHNELSGIIPQEIGNL 276
           + +  +  + +        
Sbjct: 306 ILVPPHLQAQLDQHRPVAR 324

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 71.9 bits (177), Expect = 1e-13
 Identities = 22/119 (18%), Positives = 35/119 (29%), Gaps = 3/119 (2%)

Query: 90  NLTSISLNGTLLEF---SFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLF 146
           NL S+ +  + L     +    P L  LDL         PP     + L+ L        
Sbjct: 207 NLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNL 266

Query: 147 GQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLT 205
             +P  I  LT L  L +        +P  + QL     + +  +              
Sbjct: 267 LTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARP 325

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  174 bits (443), Expect = 2e-48
 Identities = 69/298 (23%), Positives = 116/298 (38%), Gaps = 48/298 (16%)

Query: 643 EHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVK 702
           +  IGKG  G V+R K   GE  AVK F S    E S+ +E    EI     +RH NI+ 
Sbjct: 47  QESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE--ERSWFRE---AEIYQTVMLRHENILG 100

Query: 703 FYGFCSHPKHS----FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLH 758
           F    +    +    +++ +Y E GSL   L        +     + +    A  L +LH
Sbjct: 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLH 156

Query: 759 NNCF-----PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSEL----AGTHG 809
                    P I HRD+ SKN+L+       ++D G+A   +  +           GT  
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216

Query: 810 YVAPEL------AYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEM-----SSSSSNMN 858
           Y+APE+          +  ++ D+Y+ G++  E+ +         +          S+ +
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 276

Query: 859 IEML-------DSRLPYPSLH----VQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
           +E +         R   P+        + +  IM+    C   N  +R T  R+ + L
Sbjct: 277 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR---ECWYANGAARLTALRIKKTL 331

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  174 bits (444), Expect = 5e-48
 Identities = 77/360 (21%), Positives = 141/360 (39%), Gaps = 20/360 (5%)

Query: 172 SIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEI-GNLKS 230
            I   +    V   + +D    +         L +  I+   N++    +P  +  + + 
Sbjct: 12  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNST-MRKLPAALLDSFRQ 70

Query: 231 LFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFR 290
           +  L L   Q+      + +    ++ L++  N +  + P    N+  L  L+L +N   
Sbjct: 71  VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 130

Query: 291 GTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQ 350
                 F N   L  L ++ N L     +TF    +L  + LS+N     +  D    P 
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNR-LTHV--DLSLIPS 187

Query: 351 LSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLS 410
           L   +VS N +S      +   + ++ LD S N I   +   +   + L  L L  N L+
Sbjct: 188 LFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT 239

Query: 411 GCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIH 470
                 L +   L  +DLS N L   +      + +L  L +S+N+L   + +    +  
Sbjct: 240 D--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPT 296

Query: 471 LSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLE 530
           L  LDLSHN L   +     + + LE L L +N++  L        H L ++ +S+N  +
Sbjct: 297 LKVLDLSHNHL-LHVERNQPQFDRLENLYLDHNSIVTLKLSTH---HTLKNLTLSHNDWD 352

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  160 bits (406), Expect = 6e-43
 Identities = 68/351 (19%), Positives = 134/351 (38%), Gaps = 28/351 (7%)

Query: 112 VYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGI-GLLTHLTVLHISRNWLS 170
           V++D+   +++     +   L+N + + F  + +  ++P+ +      + +L+++   + 
Sbjct: 26  VHIDMQTQDVYF--GFEDITLNNQKIVTFKNSTM-RKLPAALLDSFRQVELLNLNDLQIE 82

Query: 171 GSIPHEV-GQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEI-GNL 228
             I          + +L +  N +    P    N+  + +L L  N    S+P+ I  N 
Sbjct: 83  -EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERND-LSSLPRGIFHNT 140

Query: 229 KSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNH 288
             L  L +  N L      +    T+L+ L L  N L+ +   ++  +  L    ++ N 
Sbjct: 141 PKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNL 197

Query: 289 FRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRC 348
                  +      + +L  + N +   +         LT + L +N+      +     
Sbjct: 198 L-----STLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNL--TDTAWLLNY 247

Query: 349 PQLSLLDVSINNISGSIPLEIGESL-QLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGN 407
           P L  +D+S N +   I       + +L+ L +S+N +V  +      I  L  L LS N
Sbjct: 248 PGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHN 305

Query: 408 KLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLS 458
            L   + R       LE L L  N++       L +   L  L LSHN   
Sbjct: 306 HLLH-VERNQPQFDRLENLYLDHNSIVTL---KLSTHHTLKNLTLSHNDWD 352

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  154 bits (392), Expect = 5e-41
 Identities = 76/337 (22%), Positives = 133/337 (39%), Gaps = 22/337 (6%)

Query: 214 NNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEI 273
               +  I   +      +D+ + +             L N + +   ++ +  +    +
Sbjct: 6   RQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALL 65

Query: 274 GNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLS 333
            + +++  L L           +F     + KL +  N +       F   P LT + L 
Sbjct: 66  DSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE 125

Query: 334 NNSFFGEILSD--WGRCPQLSLLDVSINNISGSIPLEIGESL-QLQYLDLSSNYIVGEIP 390
            N      L    +   P+L+ L +S NN+   I  +  ++   LQ L LSSN +   + 
Sbjct: 126 RNDL--SSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD 181

Query: 391 TQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYL 450
             L  I  L   ++S N LS      L   I +E LD S N+++          V+L  L
Sbjct: 182 --LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINVV---RGPVNVELTIL 231

Query: 451 NLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIP 510
            L HN L+      L N   L E+DLS+N L + +     +M+ LE+L +S N L   + 
Sbjct: 232 KLQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LN 288

Query: 511 RCFEEMHGLLHIDISYNKLEGQIPNSTTFRDAPLEAL 547
              + +  L  +D+S+N L   +  +   +   LE L
Sbjct: 289 LYGQPIPTLKVLDLSHNHLL-HVERN-QPQFDRLENL 323

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  148 bits (375), Expect = 8e-39
 Identities = 73/351 (20%), Positives = 129/351 (36%), Gaps = 28/351 (7%)

Query: 90  NLTSISLNG----TLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKL 145
           N   ++        L      SF  +  L+L + ++  I     +    ++ L    N +
Sbjct: 46  NQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAI 105

Query: 146 FGQIPSGIGL-LTHLTVLHISRNWLSGSIPHEV-GQLTVLNQLALDSNFLNGSIPRSLGN 203
              +P  +   +  LTVL + RN LS S+P  +      L  L++ +N L      +   
Sbjct: 106 -RYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQA 163

Query: 204 LTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHN 263
            T +  L L +N     +   +  + SLF   +  N LS     +++    +  L   HN
Sbjct: 164 TTSLQNLQLSSNR-LTHVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHN 215

Query: 264 ELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGT 323
            ++ +         +L  L L  N+   T      N   LV++ L+ N L   +   F  
Sbjct: 216 SINVV---RGPVNVELTILKLQHNNL--TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVK 270

Query: 324 YPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSN 383
              L  + +SNN     +       P L +LD+S N++   +     +  +L+ L L  N
Sbjct: 271 MQRLERLYISNNR-LVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHN 328

Query: 384 YIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLS 434
            IV  +   L     L  L+LS N    C         N+    +   +  
Sbjct: 329 SIV-TLK--LSTHHTLKNLTLSHNDWD-CNSL-RALFRNVARPAVDDADQH 374

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  181 bits (462), Expect = 2e-47
 Identities = 89/476 (18%), Positives = 155/476 (32%), Gaps = 63/476 (13%)

Query: 80  CNHAERVV---GINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLE 136
           C+   R+      NLT +                   L L  N +  +       L  L+
Sbjct: 2   CSFDGRIAFYRFCNLTQV----------PQVLNTTERLLLSFNYIRTVTASSFPFLEQLQ 51

Query: 137 YLDFSANKLFGQIPSGI-GLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNG 195
            L+  +      I       L +L +L +  + +    P     L  L +L L    L+ 
Sbjct: 52  LLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSD 111

Query: 196 SI--PRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLT 253
           ++       NL  +  L L  N            ++SL+            +  S   L 
Sbjct: 112 AVLKDGYFRNLKALTRLDLSKN-----------QIRSLY------------LHPSFGKLN 148

Query: 254 NLRFLFLYHNELSGIIPQEIGNL--KKLNSLLLAKNHFRGTVPKSFRNLTDLVK-LRLNQ 310
           +L+ +    N++  +   E+  L  K L+   LA N     V   +    +  + + L  
Sbjct: 149 SLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEI 208

Query: 311 NYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIG 370
             ++GN          +      +N+              +       +NI         
Sbjct: 209 LDVSGN-------GWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK-DPDQNTF 260

Query: 371 ESL---QLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLD 427
             L    +++LDLS  ++          +  L  L+L+ NK++         L NL+ L+
Sbjct: 261 AGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLN 320

Query: 428 LSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISS 487
           LS N L      +   L K+ Y++L  N ++         L  L  LDL  N L     +
Sbjct: 321 LSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL-----T 375

Query: 488 RICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNSTTFRDAP 543
            I  + S+  + LS N L  L             I +S N+LE  +         P
Sbjct: 376 TIHFIPSIPDIFLSGNKLVTLPKINLT----ANLIHLSENRLE-NLDILYFLLRVP 426

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  165 bits (420), Expect = 2e-42
 Identities = 110/541 (20%), Positives = 186/541 (34%), Gaps = 59/541 (10%)

Query: 90  NLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLS--NLEYLDFSANKLFG 147
            + S+ L+      SF     L  +D  +N++F +   ++  L    L +   +AN L+ 
Sbjct: 134 QIRSLYLHP-----SFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYS 188

Query: 148 QIPSGIGLL------THLTVLHISRN------------WLSGSIPHEVGQLTVLNQLALD 189
           ++    G          L +L +S N             +S S    +     +      
Sbjct: 189 RVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFG 248

Query: 190 SNFLNGSIPRSLGNL--THVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPL 247
            + +      +   L  + V  L L +   F    +    LK L  L L  N+++     
Sbjct: 249 FHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADE 308

Query: 248 SISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLR 307
           +   L NL+ L L +N L  +       L K+  + L KNH      ++F+ L  L  L 
Sbjct: 309 AFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLD 368

Query: 308 LNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPL 367
           L  N LT     T    P++  I LS N     +++        +L+ +S N +     L
Sbjct: 369 LRDNALT-----TIHFIPSIPDIFLSGNK----LVTLPKINLTANLIHLSENRLENLDIL 419

Query: 368 EIGESL-QLQYLDLSSNYIVGEIPTQL-GNIIYLNRLSLSGNKLSGCIPREL-----GSL 420
                +  LQ L L+ N        Q       L +L L  N L      EL       L
Sbjct: 420 YFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGL 479

Query: 421 INLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNF 480
            +L+ L L+ N L++  P     L  L  L+L+ N+L+  +        +L  LD+S N 
Sbjct: 480 SHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHND-LPANLEILDISRNQ 537

Query: 481 LGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNSTTFR 540
           L    +  +    SL  L++++N        C  E+   ++     N             
Sbjct: 538 L-LAPNPDV--FVSLSVLDITHNKFI-----CECELSTFINWLNHTNVT--IAGPPADIY 587

Query: 541 DAPLEALQGNKGLYGDIRGFPSCMSYKKASRKIWIVIVFPLLGMVALFIALTGFFFIFHQ 600
               ++  G         G       K     ++IV    L     LF+        F  
Sbjct: 588 CVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCTVTLT----LFLMTILTVTKFRG 643

Query: 601 R 601
            
Sbjct: 644 F 644

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  168 bits (426), Expect = 5e-44
 Identities = 76/360 (21%), Positives = 139/360 (38%), Gaps = 20/360 (5%)

Query: 172 SIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEI-GNLKS 230
            I   +    V   + +D    +         L +  I+   N++    +P  +  + + 
Sbjct: 18  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNST-MRKLPAALLDSFRQ 76

Query: 231 LFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFR 290
           +  L L   Q+      + +    ++ L++  N +  + P    N+  L  L+L +N   
Sbjct: 77  VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 136

Query: 291 GTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQ 350
                 F N   L  L ++ N L     +TF    +L  + LS+N      +      P 
Sbjct: 137 SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRL--THVDL-SLIPS 193

Query: 351 LSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLS 410
           L   +VS N +S      +   + ++ LD S N I   +       + L  L L  N L+
Sbjct: 194 LFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNLT 245

Query: 411 GCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIH 470
                 L +   L  +DLS N L   +      + +L  L +S+N+L   + +    +  
Sbjct: 246 D--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPT 302

Query: 471 LSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLE 530
           L  LDLSHN L   +     + + LE L L +N++  L        H L ++ +S+N  +
Sbjct: 303 LKVLDLSHNHL-LHVERNQPQFDRLENLYLDHNSIVTLKLSTH---HTLKNLTLSHNDWD 358

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  164 bits (417), Expect = 7e-43
 Identities = 79/359 (22%), Positives = 131/359 (36%), Gaps = 20/359 (5%)

Query: 149 IPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVV 208
           I S +        +HI           E   L     +   ++ +       L +   V 
Sbjct: 19  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 78

Query: 209 ILYLYNNSFFGSIPQEI-GNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSG 267
           +L L +      I         ++  L +  N +    P    N+  L  L L  N+LS 
Sbjct: 79  LLNLNDLQ-IEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS 137

Query: 268 IIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNL 327
           +      N  KL +L ++ N+       +F+  T L  L+L+ N LT          P+L
Sbjct: 138 LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT---HVDLSLIPSL 194

Query: 328 TFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVG 387
              ++S N      LS       +  LD S N+I+  +   +  +++L  L L  N +  
Sbjct: 195 FHANVSYNL-----LSTLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT- 245

Query: 388 EIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKL 447
           +    L N   L  + LS N+L   +      +  LE L +S N L   +      +  L
Sbjct: 246 DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTL 303

Query: 448 YYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLS 506
             L+LSHN L   +         L  L L HN +   +        +L+ L LS+N+  
Sbjct: 304 KVLDLSHNHL-LHVERNQPQFDRLENLYLDHNSI-VTLKLST--HHTLKNLTLSHNDWD 358

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  157 bits (397), Expect = 3e-40
 Identities = 74/430 (17%), Positives = 149/430 (34%), Gaps = 54/430 (12%)

Query: 88  GINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFG 147
            +++   + +     F   +  +   +   N+ +  +    + +   +E L+ +  ++  
Sbjct: 31  DVHIDMQTQDVYFG-FEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQI-E 88

Query: 148 QIPSGI-GLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTH 206
           +I +        +  L++  N +   +P                       P    N+  
Sbjct: 89  EIDTYAFAYAHTIQKLYMGFNAIR-YLP-----------------------PHVFQNVPL 124

Query: 207 VVILYLYNNSFFGSIPQEI-GNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNEL 265
           + +L L  N    S+P+ I  N   L  L +  N L      +    T+L+ L L  N L
Sbjct: 125 LTVLVLERND-LSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRL 183

Query: 266 SGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYP 325
           + +   ++  +  L    ++ N        +      + +L  + N +            
Sbjct: 184 THV---DLSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSINVVRGPVN---V 232

Query: 326 NLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESL-QLQYLDLSSNY 384
            LT + L +N+      +     P L  +D+S N +   I       + +L+ L +S+N 
Sbjct: 233 ELTILKLQHNNL--TDTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNR 289

Query: 385 IVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSL 444
           +V  +      I  L  L LS N L   + R       LE L L  N++       L + 
Sbjct: 290 LV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL---KLSTH 344

Query: 445 VKLYYLNLSHNKLS-QQIPIELDNLIHLSELDLSHNF-LGEKISSRICRMES---LEKLN 499
             L  L LSHN      +     N+   +  D   +  +  ++   +C  ES        
Sbjct: 345 HTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRL 404

Query: 500 LSYNNLSGLI 509
           L Y  L+ ++
Sbjct: 405 LQYIALTSVV 414

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  152 bits (384), Expect = 1e-38
 Identities = 73/316 (23%), Positives = 127/316 (40%), Gaps = 20/316 (6%)

Query: 218 FGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLK 277
           +  I   +      +D+ + +             L N + +   ++ +  +    + + +
Sbjct: 16  YKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFR 75

Query: 278 KLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSF 337
           ++  L L           +F     + KL +  N +       F   P LT + L  N  
Sbjct: 76  QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDL 135

Query: 338 FGEILSD--WGRCPQLSLLDVSINNISGSIPLEIGESL-QLQYLDLSSNYIVGEIPTQLG 394
               L    +   P+L+ L +S NN+   I  +  ++   LQ L LSSN +   +   L 
Sbjct: 136 --SSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD--LS 189

Query: 395 NIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSH 454
            I  L   ++S N LS      L   I +E LD S N+++          V+L  L L H
Sbjct: 190 LIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINVV---RGPVNVELTILKLQH 241

Query: 455 NKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFE 514
           N L+      L N   L E+DLS+N L + +     +M+ LE+L +S N L   +    +
Sbjct: 242 NNLT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQ 298

Query: 515 EMHGLLHIDISYNKLE 530
            +  L  +D+S+N L 
Sbjct: 299 PIPTLKVLDLSHNHLL 314

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  151 bits (383), Expect = 2e-38
 Identities = 84/462 (18%), Positives = 162/462 (35%), Gaps = 62/462 (13%)

Query: 90  NLTSISLNG----TLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKL 145
           N   ++        L      SF  +  L+L + ++  I     +    ++ L    N +
Sbjct: 52  NQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAI 111

Query: 146 FGQIPSGIGL-LTHLTVLHISRNWLSGSIPHEV-GQLTVLNQLALDSNFLNGSIPRSLGN 203
              +P  +   +  LTVL + RN LS S+P  +      L  L++ +N L      +   
Sbjct: 112 -RYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQA 169

Query: 204 LTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHN 263
            T +  L L +N     +   +  + SLF   +  N LS     +++    +  L   HN
Sbjct: 170 TTSLQNLQLSSNR-LTHVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHN 221

Query: 264 ELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGT 323
            ++ +         +L  L L  N+   T      N   LV++ L+ N L   +   F  
Sbjct: 222 SINVV---RGPVNVELTILKLQHNNL--TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVK 276

Query: 324 YPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSN 383
              L  + +SNN              +L  L++    I             L+ LDLS N
Sbjct: 277 MQRLERLYISNN--------------RLVALNLYGQPIP-----------TLKVLDLSHN 311

Query: 384 YIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGS 443
           +++  +         L  L L  N +   +   L +   L+ L LS N+       +L  
Sbjct: 312 HLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNSLRAL-- 365

Query: 444 LVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNF----------LGEKISSRICRME 493
              +    +       +I  +L++ +   E D  +            + EK+     R  
Sbjct: 366 FRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCS 425

Query: 494 SLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPN 535
           + + +N   +    +  +    + G   ++   N+L  ++  
Sbjct: 426 ATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQ 467

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  125 bits (315), Expect = 5e-30
 Identities = 58/299 (19%), Positives = 112/299 (37%), Gaps = 19/299 (6%)

Query: 235 ELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVP 294
                     I  ++        + +           E   L     +    +  R    
Sbjct: 9   VKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPA 68

Query: 295 KSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDW--GRCPQLS 352
               +   +  L LN   +    +  F     +  + +  N+     L        P L+
Sbjct: 69  ALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAI--RYLPPHVFQNVPLLT 126

Query: 353 LLDVSINNISGSIPLEIGESL-QLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSG 411
           +L +  N++S S+P  I  +  +L  L +S+N +             L  L LS N+L+ 
Sbjct: 127 VLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT- 184

Query: 412 CIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHL 471
            +   L  + +L + ++S N LS     +L   + +  L+ SHN ++    +     + L
Sbjct: 185 HVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINV---VRGPVNVEL 234

Query: 472 SELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLE 530
           + L L HN L +  ++ +     L +++LSYN L  ++   F +M  L  + IS N+L 
Sbjct: 235 TILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 291

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 86.5 bits (214), Expect = 1e-17
 Identities = 27/150 (18%), Positives = 51/150 (34%), Gaps = 1/150 (0%)

Query: 388 EIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKL 447
            I + L        + +           E  +L N + +    + +       L S  ++
Sbjct: 18  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77

Query: 448 YYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSG 507
             LNL+  ++ +           + +L +  N +          +  L  L L  N+LS 
Sbjct: 78  ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS 137

Query: 508 LIPRCFEEMHGLLHIDISYNKLEGQIPNST 537
           L    F     L  + +S N LE +I + T
Sbjct: 138 LPRGIFHNTPKLTTLSMSNNNLE-RIEDDT 166

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  167 bits (424), Expect = 1e-43
 Identities = 76/371 (20%), Positives = 132/371 (35%), Gaps = 49/371 (13%)

Query: 132 LSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSN 191
            +    L+   + L   +P  +    H+T L I  N L+ S+P    +L  L    +  N
Sbjct: 39  NNGNAVLNVGESGL-TTLPDCLP--AHITTLVIPDNNLT-SLPALPPELRTLE---VSGN 91

Query: 192 FLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISN 251
            L  S+P     L  + I           +P     L  L    +  NQL+ ++P+    
Sbjct: 92  QLT-SLPVLPPGLLELSIFSNPLTH----LPALPSGLCKL---WIFGNQLT-SLPVLPPG 142

Query: 252 LTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQN 311
           L  L    +  N+L+ + P     L KL       N    ++P     L    +L ++ N
Sbjct: 143 LQELS---VSDNQLASL-PALPSELCKLW---AYNNQLT-SLPMLPSGLQ---ELSVSDN 191

Query: 312 YLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGE 371
            L  ++         L  +   NN      L        L  L VS N ++ S+P+    
Sbjct: 192 QLA-SLPTLPS---ELYKLWAYNNRL--TSLPAL--PSGLKELIVSGNRLT-SLPVLPS- 241

Query: 372 SLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSAN 431
             +L+ L +S N +   +P        L  LS+  N+L+  +P  L  L +   ++L  N
Sbjct: 242 --ELKELMVSGNRLT-SLPMLPSG---LLSLSVYRNQLT-RLPESLIHLSSETTVNLEGN 294

Query: 432 NLSNFVPESLGSLVKLYYLN---LSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSR 488
            LS    ++L  +      +   +  +      P E   L   +   L     GE   + 
Sbjct: 295 PLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGE--PAP 352

Query: 489 ICRMESLEKLN 499
             R     + +
Sbjct: 353 ADRWHMFGQED 363

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  162 bits (412), Expect = 4e-42
 Identities = 74/417 (17%), Positives = 144/417 (34%), Gaps = 70/417 (16%)

Query: 155 LLTHLTVLHISRNWLSGSIPHEVGQ-LTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLY 213
           L     VL++  + L+ ++P  +   +T L    +  N L  S+P     L     L + 
Sbjct: 38  LNNGNAVLNVGESGLT-TLPDCLPAHITTLV---IPDNNLT-SLPALPPELRT---LEVS 89

Query: 214 NNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEI 273
            N    S+P     L  L      +  L        +  + L  L+++ N+L+ + P   
Sbjct: 90  GNQL-TSLPVLPPGLLELSIFSNPLTHLP-------ALPSGLCKLWIFGNQLTSL-PVLP 140

Query: 274 GNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLS 333
             L++L+   ++ N    ++P     L    KL    N LT ++         L  + +S
Sbjct: 141 PGLQELS---VSDNQLA-SLPALPSELC---KLWAYNNQLT-SLPMLPS---GLQELSVS 189

Query: 334 NNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQL 393
           +N              QL+           S+P       +L  L   +N +   +P   
Sbjct: 190 DN--------------QLA-----------SLPTLPS---ELYKLWAYNNRLT-SLPALP 220

Query: 394 GNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLS 453
                L  L +SGN+L+  +P        L+ L +S N L++ +P     L+ L   ++ 
Sbjct: 221 SG---LKELIVSGNRLT-SLPVLPS---ELKELMVSGNRLTS-LPMLPSGLLSL---SVY 269

Query: 454 HNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCF 513
            N+L++ +P  L +L   + ++L  N L E+    +  + S    +              
Sbjct: 270 RNQLTR-LPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAP 328

Query: 514 EEMHGLLHIDISYNKLEGQIPNSTTFRDAPLEALQGNKGLYGDIRGFPSCMSYKKAS 570
            E   L      +     +   +   R                +       ++ K +
Sbjct: 329 RETRALHLAAADWLVPAREGEPAPADRWHMFGQEDNADAFSLFLDRLSETENFIKDA 385

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  136 bits (343), Expect = 2e-33
 Identities = 68/357 (19%), Positives = 123/357 (34%), Gaps = 46/357 (12%)

Query: 87  VGINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLF 146
           +  ++T++ +    L    +  P L  L++  N+L   +P     L  L         L 
Sbjct: 59  LPAHITTLVIPDNNLTSLPALPPELRTLEVSGNQL-TSLPVLPPGLLELSIFSNPLTHL- 116

Query: 147 GQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTH 206
                   L + L  L I  N L+ S+P     L  L+   +  N L  S+P     L  
Sbjct: 117 ------PALPSGLCKLWIFGNQLT-SLPVLPPGLQELS---VSDNQLA-SLPALPSELCK 165

Query: 207 VVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELS 266
              L+ YNN    S+P     L+    L +  NQL+ ++P   S L  L     Y+N L+
Sbjct: 166 ---LWAYNNQ-LTSLPMLPSGLQE---LSVSDNQLA-SLPTLPSELYKLW---AYNNRLT 214

Query: 267 GIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPN 326
             +P     LK+L    ++ N    ++P     L    +L ++ N LT ++         
Sbjct: 215 S-LPALPSGLKELI---VSGNRLT-SLPVLPSELK---ELMVSGNRLT-SLPMLPS---G 262

Query: 327 LTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLD----LSS 382
           L  + +  N     +          + +++  N +S    L+    +          +  
Sbjct: 263 LLSLSVYRNQ-LTRLPESLIHLSSETTVNLEGNPLS-ERTLQALREITSAPGYSGPIIRF 320

Query: 383 NYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRE----LGSLINLEYLDLSANNLSN 435
           +      P +   +       L   +     P +     G   N +   L  + LS 
Sbjct: 321 DMAGASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQEDNADAFSLFLDRLSE 377

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  133 bits (336), Expect = 2e-32
 Identities = 60/290 (20%), Positives = 110/290 (37%), Gaps = 44/290 (15%)

Query: 247 LSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKL 306
           +          L +  + L+  +P  +     + +L++  N+   ++P     L     L
Sbjct: 34  MRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPALPPELR---TL 86

Query: 307 RLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIP 366
            ++ N LT ++         L+                      L  L +  N ++ S+P
Sbjct: 87  EVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALP-------SGLCKLWIFGNQLT-SLP 137

Query: 367 LEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYL 426
           +       LQ L +S N +   +P        L +L    N+L+  +P        L+ L
Sbjct: 138 VLPP---GLQELSVSDNQL-ASLPALPSE---LCKLWAYNNQLT-SLPMLPS---GLQEL 186

Query: 427 DLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKIS 486
            +S N L++  P     L KL+     +N+L+  +P        L EL +S N L   + 
Sbjct: 187 SVSDNQLASL-PTLPSELYKLW---AYNNRLT-SLPALPSG---LKELIVSGNRLTS-LP 237

Query: 487 SRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNS 536
                   L++L +S N L+ L P       GLL + +  N+L  ++P S
Sbjct: 238 VLPS---ELKELMVSGNRLTSL-P---MLPSGLLSLSVYRNQLT-RLPES 279

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  157 bits (398), Expect = 1e-42
 Identities = 62/290 (21%), Positives = 113/290 (38%), Gaps = 16/290 (5%)

Query: 220 SIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKL 279
           +I +   N       ++  + L  A+     +  N++ L L  N LS I   ++    KL
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 280 NSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFG 339
             L L+ N           +L+ L  L LN NY+           P++  +  +NN+   
Sbjct: 61  ELLNLSSNVL--YETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNN-IS 112

Query: 340 EILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVG-EIPTQLGNIIY 398
            +    G+      + ++ N I+    L+ G   ++QYLDL  N I          +   
Sbjct: 113 RVSCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170

Query: 399 LNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLS 458
           L  L+L  N +   +  ++     L+ LDLS+N L+  +     S   + +++L +NKL 
Sbjct: 171 LEHLNLQYNFIYD-VKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV 227

Query: 459 QQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGL 508
             I   L    +L   DL  N      + R    ++     ++   +  L
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGF-HCGTLRDFFSKNQRVQTVAKQTVKKL 275

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  144 bits (365), Expect = 4e-38
 Identities = 62/376 (16%), Positives = 116/376 (30%), Gaps = 66/376 (17%)

Query: 105 FSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHI 164
             +        + ++ L   +     +  N++ LD S N L     + +   T L +L++
Sbjct: 6   KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65

Query: 165 SRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQE 224
           S N L                               L +L+ +  L L NN       QE
Sbjct: 66  SSNVLY-ETL-------------------------DLESLSTLRTLDLNNNYV-----QE 94

Query: 225 IGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLL 284
           +    S+  L    N +S    +S S     + ++L +N+++ +   + G   ++  L L
Sbjct: 95  LLVGPSIETLHAANNNISR---VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDL 151

Query: 285 AKNHFRG-TVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILS 343
             N        +   +   L  L L  N++                 D+           
Sbjct: 152 KLNEIDTVNFAELAASSDTLEHLNLQYNFIY----------------DVKGQVV------ 189

Query: 344 DWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLS 403
                 +L  LD+S N ++  +  E   +  + ++ L +N +V  I   L     L    
Sbjct: 190 ----FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFD 243

Query: 404 LSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPI 463
           L GN    C         N     ++   +   +         +  L        + +P 
Sbjct: 244 LRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKK-LTGQNEEECTVPTLGHYGAYCCEDLPA 301

Query: 464 -ELDNLIHLSELDLSH 478
              D LI L      H
Sbjct: 302 PFADRLIALGHHHHHH 317

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  113 bits (285), Expect = 1e-27
 Identities = 35/185 (18%), Positives = 76/185 (41%), Gaps = 13/185 (7%)

Query: 364 SIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINL 423
           +I        + +   ++ + +   + +   +   +  L LSGN LS     +L     L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 424 EYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGE 483
           E L+LS+N L       L SL  L  L+L++N +      EL     +  L  ++N +  
Sbjct: 61  ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-S 112

Query: 484 KISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNSTTFRDAP 543
           ++S      +  + + L+ N ++ L          + ++D+  N+++  +  +     A 
Sbjct: 113 RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELA--AS 167

Query: 544 LEALQ 548
            + L+
Sbjct: 168 SDTLE 172

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  156 bits (397), Expect = 3e-41
 Identities = 75/414 (18%), Positives = 140/414 (33%), Gaps = 52/414 (12%)

Query: 97  NGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLL 156
                  S      L  LD +N+ +  +    I  L+ L  L  ++N +   +   +   
Sbjct: 30  MQATDTISEEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNNI-TTLD--LSQN 84

Query: 157 THLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNS 216
           T+LT L    N L+ ++   V  LT L  L  D+N L          LT+   L    N+
Sbjct: 85  TNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLTKLDVSQNPLLTY---LNCARNT 138

Query: 217 FFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNL 276
               I   + +   L +L+  +N+      L ++  T L  L    N+++ +   ++   
Sbjct: 139 -LTEID--VSHNTQLTELDCHLNKKIT--KLDVTPQTQLTTLDCSFNKITEL---DVSQN 190

Query: 277 KKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNS 336
           K LN L    N+              L  L  + N LT            LT+ D S N 
Sbjct: 191 KLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLT---EIDVTPLTQLTYFDCSVNP 244

Query: 337 FFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNI 396
                  D     +L+ L     ++     +++  + QL Y        + E+   + + 
Sbjct: 245 L---TELDVSTLSKLTTLHCIQTDLLE---IDLTHNTQLIYFQAEGCRKIKELD--VTHN 296

Query: 397 IYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNK 456
             L  L      ++     +L     L YL L+   L+      +    KL  L+  +  
Sbjct: 297 TQLYLLDCQAAGITEL---DLSQNPKLVYLYLNNTELTEL---DVSHNTKLKSLSCVNAH 350

Query: 457 LSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIP 510
           +       +  +  L+    +                ++ K  L+ N+L+  + 
Sbjct: 351 IQ-DFS-SVGKIPALNNNFEAEGQT-----------ITMPKETLTNNSLTIAVS 391

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  153 bits (389), Expect = 4e-40
 Identities = 85/425 (20%), Positives = 155/425 (36%), Gaps = 50/425 (11%)

Query: 108 FPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRN 167
           F   V           I       L+ L  LD   + +     +GI  LT LT L  + N
Sbjct: 20  FASEVAAAFEMQATDTI---SEEQLATLTSLDCHNSSI--TDMTGIEKLTGLTKLICTSN 74

Query: 168 WLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGN 227
            ++ ++   + Q T L  LA DSN L  ++   +  LT +  L    N     +   +  
Sbjct: 75  NIT-TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNK-LTKLD--VSQ 125

Query: 228 LKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKN 287
              L  L    N L+    + +S+ T L  L  + N+    +   +    +L +L  + N
Sbjct: 126 NPLLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFN 180

Query: 288 HFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILS--DW 345
                          L +L  + N +T            LTF+D S+N      L+  D 
Sbjct: 181 KITEL---DVSQNKLLNRLNCDTNNIT---KLDLNQNIQLTFLDCSSNK-----LTEIDV 229

Query: 346 GRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLS 405
               QL+  D S+N ++    L++    +L  L      ++ EI   L +   L      
Sbjct: 230 TPLTQLTYFDCSVNPLT---ELDVSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAE 283

Query: 406 GNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIEL 465
           G +    +  ++     L  LD  A  ++      L    KL YL L++ +L++   +++
Sbjct: 284 GCRKIKEL--DVTHNTQLYLLDCQAAGITEL---DLSQNPKLVYLYLNNTELTE---LDV 335

Query: 466 DNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDIS 525
            +   L  L   +  + +  SS + ++ +L     +      +           L I +S
Sbjct: 336 SHNTKLKSLSCVNAHI-QDFSS-VGKIPALNNNFEAEGQTITMPKETLTN--NSLTIAVS 391

Query: 526 YNKLE 530
            + L+
Sbjct: 392 PDLLD 396

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  142 bits (359), Expect = 3e-36
 Identities = 77/404 (19%), Positives = 137/404 (33%), Gaps = 44/404 (10%)

Query: 90  NLTSISLNGTLL-EFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQ 148
            LT +      +     S   +L YL   +N+L  +    ++ L+ L YL+   NKL   
Sbjct: 65  GLTKLICTSNNITTLDLSQNTNLTYLACDSNKLTNL---DVTPLTKLTYLNCDTNKL--- 118

Query: 149 IPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVV 208
               +     LT L+ +RN L+  I   V   T L +L    N     +   +   T + 
Sbjct: 119 TKLDVSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLT 173

Query: 209 ILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGI 268
            L    N     +   +   K L  L    N ++    L ++    L FL    N+L+ I
Sbjct: 174 TLDCSFNKI-TELD--VSQNKLLNRLNCDTNNITK---LDLNQNIQLTFLDCSSNKLTEI 227

Query: 269 IPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLT 328
              ++  L +L     + N     +  S   L+ L  L   Q  L             L 
Sbjct: 228 ---DVTPLTQLTYFDCSVNPLT-ELDVS--TLSKLTTLHCIQTDLL---EIDLTHNTQLI 278

Query: 329 FIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGE 388
           +          E+  D     QL LLD     I+    L++ ++ +L YL L++  +  E
Sbjct: 279 YFQAEGCRKIKEL--DVTHNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTELT-E 332

Query: 389 IPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSL---- 444
           +   + +   L  LS     +       +G +  L     +         E+L +     
Sbjct: 333 LD--VSHNTKLKSLSCVNAHIQDFSS--VGKIPALNNNFEAEGQTITMPKETLTNNSLTI 388

Query: 445 -VKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISS 487
            V    L+   N ++  I      +   +   ++   L     +
Sbjct: 389 AVSPDLLDQFGNPMN--IEPGDGGVYDQATNTITWENLSTDNPA 430

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 75.1 bits (185), Expect = 3e-14
 Identities = 40/242 (16%), Positives = 73/242 (30%), Gaps = 20/242 (8%)

Query: 89  INLTSISLNGTLL-EFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFG 147
           I LT +  +   L E   +    L Y D   N L  +    +S LS L  L      L  
Sbjct: 212 IQLTFLDCSSNKLTEIDVTPLTQLTYFDCSVNPLTELD---VSTLSKLTTLHCIQTDL-L 267

Query: 148 QIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHV 207
           +I   +   T L             +  +V   T L  L   +  +   +   L     +
Sbjct: 268 EID--LTHNTQLIYFQAEGCRKIKEL--DVTHNTQLYLLDCQAAGIT-ELD--LSQNPKL 320

Query: 208 VILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSG 267
           V LYL N      +   + +   L  L      +      S+  +  L   F    +   
Sbjct: 321 VYLYLNNTEL-TELD--VSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTIT 375

Query: 268 IIPQEIGNLKKLNSL---LLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTY 324
           +  + + N     ++   LL +      +      + D     +    L+ +      T+
Sbjct: 376 MPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTDNPAVTYTF 435

Query: 325 PN 326
            +
Sbjct: 436 TS 437

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  156 bits (397), Expect = 5e-41
 Identities = 73/370 (19%), Positives = 135/370 (36%), Gaps = 55/370 (14%)

Query: 114 LDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSI 173
           +  +      + P  I   +    LD   N++            HL  L ++ N +S ++
Sbjct: 16  VLCHRKRFVAV-PEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AV 71

Query: 174 PHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEI-GNLKSLF 232
                                   P +  NL ++  L L +N     IP  +   L +L 
Sbjct: 72  E-----------------------PGAFNNLFNLRTLGLRSNRL-KLIPLGVFTGLSNLT 107

Query: 233 DLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGT 292
            L++  N++   +     +L NL+ L +  N+L  I  +    L  L  L L K +    
Sbjct: 108 KLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSI 167

Query: 293 VPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLS 352
             ++  +L  L+ LRL    +                  + + SF            +L 
Sbjct: 168 PTEALSHLHGLIVLRLRHLNIN----------------AIRDYSFKR--------LYRLK 203

Query: 353 LLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQ-LGNIIYLNRLSLSGNKLSG 411
           +L++S      ++       L L  L ++   +   +P   + +++YL  L+LS N +S 
Sbjct: 204 VLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIST 262

Query: 412 CIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHL 471
                L  L+ L+ + L    L+   P +   L  L  LN+S N+L+        ++ +L
Sbjct: 263 IEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNL 322

Query: 472 SELDLSHNFL 481
             L L  N L
Sbjct: 323 ETLILDSNPL 332

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  151 bits (384), Expect = 2e-39
 Identities = 71/355 (20%), Positives = 127/355 (35%), Gaps = 56/355 (15%)

Query: 108 FPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGI-GLLTHLTVLHISR 166
                 LDL  N +  +   + ++  +LE L+ + N +   +  G    L +L  L +  
Sbjct: 31  PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIV-SAVEPGAFNNLFNLRTLGLRS 89

Query: 167 NWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEI- 225
           N           +L ++                 L NLT    L +  N     +   + 
Sbjct: 90  N-----------RLKLIPLGVF----------TGLSNLTK---LDISENK-IVILLDYMF 124

Query: 226 GNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLA 285
            +L +L  LE+  N L      + S L +L  L L    L+ I  + + +L  L  L L 
Sbjct: 125 QDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLR 184

Query: 286 KNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDW 345
             +       SF+ L  L  L ++       ++       NLT + +++           
Sbjct: 185 HLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITH----------- 233

Query: 346 GRCPQLSLLDVSINNISGSIPLEIGESL-QLQYLDLSSNYIVGEIPTQLGNIIYLNRLSL 404
                         N++ ++P      L  L++L+LS N I     + L  ++ L  + L
Sbjct: 234 -------------CNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQL 279

Query: 405 SGNKLSGCIPRE-LGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLS 458
            G +L+  +       L  L  L++S N L+        S+  L  L L  N L+
Sbjct: 280 VGGQLA-VVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  136 bits (343), Expect = 5e-34
 Identities = 70/312 (22%), Positives = 109/312 (34%), Gaps = 57/312 (18%)

Query: 244 AIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDL 303
           A+P  I   T  R L L  N +  +   E  +   L  L L +N      P +F NL +L
Sbjct: 25  AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNL 82

Query: 304 VKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISG 363
             L L  N L           P   F  LSN                             
Sbjct: 83  RTLGLRSNRLK--------LIPLGVFTGLSN----------------------------- 105

Query: 364 SIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRE-LGSLIN 422
                      L  LD+S N IV  +     ++  L  L +  N L   I       L +
Sbjct: 106 -----------LTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNS 153

Query: 423 LEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLG 482
           LE L L   NL++   E+L  L  L  L L H  ++         L  L  L++SH    
Sbjct: 154 LEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYL 213

Query: 483 EKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNSTTFRDA 542
           + ++       +L  L++++ NL+ +       +  L  +++SYN +   I  S    + 
Sbjct: 214 DTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIS-TIEGS-MLHEL 271

Query: 543 P-LEAL--QGNK 551
             L+ +   G +
Sbjct: 272 LRLQEIQLVGGQ 283

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 82.8 bits (205), Expect = 1e-16
 Identities = 37/206 (17%), Positives = 69/206 (33%), Gaps = 30/206 (14%)

Query: 90  NLTSISLNG----TLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKL 145
           +L  ++L      ++   + S    L+ L L +  +  I       L  L+ L+ S    
Sbjct: 153 SLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPY 212

Query: 146 FGQIPSGIGLLTHLTVLHISRNWLSGSIPHEV-GQLTVLNQLALDSNFLNGSIPRSLGNL 204
              +        +LT L I+   L+ ++P+     L  L  L L  N ++      L  L
Sbjct: 213 LDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHEL 271

Query: 205 THVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNE 264
             +  + L               L  +              P +   L  LR L +  N+
Sbjct: 272 LRLQEIQLVGG-----------QLAVVE-------------PYAFRGLNYLRVLNVSGNQ 307

Query: 265 LSGIIPQEIGNLKKLNSLLLAKNHFR 290
           L+ +      ++  L +L+L  N   
Sbjct: 308 LTTLEESVFHSVGNLETLILDSNPLA 333

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  149 bits (378), Expect = 3e-40
 Identities = 59/267 (22%), Positives = 108/267 (40%), Gaps = 24/267 (8%)

Query: 645 CIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKF 703
            IG+G   +VY+     +    A  +           +++ F  E + L  ++H NIV+F
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQ--DRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90

Query: 704 YG----FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHN 759
           Y          K   ++ E + SG+L   L      K +      +  + +   L +LH 
Sbjct: 91  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHT 147

Query: 760 NCFPPIVHRDISSKNVLLDLGY-EAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT 818
              PPI+HRD+   N+ +        + D G+A       +    + GT  ++APE+ Y 
Sbjct: 148 -RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA--KAVIGTPEFMAPEM-YE 203

Query: 819 LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLM 878
            K  E  DVY+FG+  LE+   ++P     E  +++          +          ++ 
Sbjct: 204 EKYDESVDVYAFGMCMLEMATSEYP---YSECQNAAQIYRRVTSGVKPASFDKVAIPEVK 260

Query: 879 SIMQVAFSCLDQNPESRPTMKRVSQLL 905
            I++    C+ QN + R +   +  LL
Sbjct: 261 EIIE---GCIRQNKDERYS---IKDLL 281

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  147 bits (374), Expect = 2e-39
 Identities = 69/305 (22%), Positives = 126/305 (41%), Gaps = 20/305 (6%)

Query: 604 DSQTQQSSFGNTPGLRSVLTFEGKIVYEEIISATNDFNAEHCIGKGGHGSVYRAK-VPSG 662
           D Q+Q       P  +        + Y  +     +F  E  IG+G    VYRA  +  G
Sbjct: 2   DEQSQGMQGPPVPQFQPQKALRPDMGYNTL----ANFRIEKKIGRGQFSEVYRAACLLDG 57

Query: 663 EIFAVKKFHSPLPGEMSFQ-QEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLE 721
              A+KK    +   M  + + + + EI  L ++ H N++K+Y          I+ E  +
Sbjct: 58  VPVALKKV--QIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELAD 115

Query: 722 SGSLDKILCNDASAKE-LGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLG 780
           +G L +++ +    K  +           +  AL ++H+     ++HRDI   NV +   
Sbjct: 116 AGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITAT 172

Query: 781 YEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKG 840
               + D G+ +F +  ++    L GT  Y++PE  +      K D++S G L  E+   
Sbjct: 173 GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAAL 232

Query: 841 KHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKR 900
           + P  F  +  +  S           P PS H  ++L  ++     C++ +PE RP    
Sbjct: 233 QSP--FYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVN---MCINPDPEKRPD--- 284

Query: 901 VSQLL 905
           V+ + 
Sbjct: 285 VTYVY 289

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  148 bits (377), Expect = 4e-39
 Identities = 66/287 (22%), Positives = 112/287 (39%), Gaps = 39/287 (13%)

Query: 638 NDFNAEHCIGKGGHGSVYRAKVPSGEIF-AVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
            D      IG+G  G V+  ++ +     AVK             + +FL E + L +  
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR---ETLPPDLKAKFLQEARILKQYS 170

Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFY 756
           H NIV+  G C+  +  +I+ E ++ G     L  +     L     L ++   A  + Y
Sbjct: 171 HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEY 228

Query: 757 LHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAG------THGY 810
           L + C    +HRD++++N L+       +SDFG+++         S          T   
Sbjct: 229 LESKCC---IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT--- 282

Query: 811 VAPELAYTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEMLDS----- 864
            APE     + + + DV+SFG+L  E    G  P      +S      N +  +      
Sbjct: 283 -APEALNYGRYSSESDVWSFGILLWETFSLGASPYP---NLS------NQQTREFVEKGG 332

Query: 865 RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
           RLP P       +  +M+    C    P  RP+   + Q L + I +
Sbjct: 333 RLPCPE-LCPDAVFRLME---QCWAYEPGQRPSFSTIYQEL-QSIRK 374

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  145 bits (367), Expect = 8e-39
 Identities = 63/285 (22%), Positives = 119/285 (41%), Gaps = 46/285 (16%)

Query: 638 NDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
            DF     IG GG G V++AK    G+ + +K         + +  E+   E++AL ++ 
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIK--------RVKYNNEKAEREVKALAKLD 62

Query: 697 HRNIVKFYGF----------------CSHPKHSFIIYEYLESGSLDKILCNDASAKELGW 740
           H NIV + G                  S  K  FI  E+ + G+L++ +      ++L  
Sbjct: 63  HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDK 121

Query: 741 TQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN 800
              L + + +   + Y+H+     +++RD+   N+ L    +  + DFG+   L  D   
Sbjct: 122 VLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR 178

Query: 801 WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIE 860
            +   GT  Y++PE   +    ++ D+Y+ G++  E++         FE S   +++   
Sbjct: 179 -TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT---AFETSKFFTDLR-- 232

Query: 861 MLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
                         KK  +++Q     L + PE RP     S++L
Sbjct: 233 ----DGIISD-IFDKKEKTLLQ---KLLSKKPEDRPN---TSEIL 266

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  145 bits (367), Expect = 1e-38
 Identities = 58/299 (19%), Positives = 120/299 (40%), Gaps = 44/299 (14%)

Query: 638 NDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
            DF    C+G+GG G V+ AK       +A+K+   P        +E+ + E++AL ++ 
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLP---NRELAREKVMREVKALAKLE 61

Query: 697 HRNIVKFYGFC------------SHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRL 744
           H  IV+++               S   + +I  +     +L   +    + +E   +  L
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121

Query: 745 NVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN--------- 795
           ++   +A+A+ +LH+     ++HRD+   N+   +     V DFG+   ++         
Sbjct: 122 HIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178

Query: 796 ---PDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS 852
              P  +  +   GT  Y++PE  +    + K D++S G++  E++   +P    F    
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YP----FSTQM 231

Query: 853 SSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
                  ++ + + P            ++Q     L  +P  RP       ++   +FE
Sbjct: 232 ERVRTLTDVRNLKFPPLFTQKYPCEYVMVQ---DMLSPSPMERPE---AINIIENAVFE 284

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  149 bits (377), Expect = 1e-38
 Identities = 80/409 (19%), Positives = 145/409 (35%), Gaps = 43/409 (10%)

Query: 109 PHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGI-GLLTHLTVLHISRN 167
            H+ Y+DL  N +  +     S L +L++L          I +     L+ L +L +  N
Sbjct: 30  AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89

Query: 168 WLSGSIPHEV-GQLTVLNQLALDSNFLNGSI--PRSLGNLTHVVILYLYNNSFFGSIPQE 224
                +       L  L  L L    L+G++        LT + +L L +N+     P  
Sbjct: 90  QFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS 148

Query: 225 I-GNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLL 283
              N++    L+L  N++       + N     F  L               L  +    
Sbjct: 149 FFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLL--------------RLSSITLQD 194

Query: 284 LAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILS 343
           + +         +    T +  L L+ N    ++++ F      T           +I S
Sbjct: 195 MNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGT-----------KIQS 243

Query: 344 DWGRCPQLSLLDVSINNISGSIPLEIG--ESLQLQYLDLSSNYIV---GEIPTQLGNIIY 398
                           N            E+  ++  DLS + I      + +   +   
Sbjct: 244 LILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTD--- 300

Query: 399 LNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLS 458
           L +L+L+ N+++         L +L  L+LS N L +       +L KL  L+LS+N + 
Sbjct: 301 LEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHI- 359

Query: 459 QQIPIEL-DNLIHLSELDLSHNFLGEKISSRI-CRMESLEKLNLSYNNL 505
           + +  +    L +L EL L  N L + +   I  R+ SL+K+ L  N  
Sbjct: 360 RALGDQSFLGLPNLKELALDTNQL-KSVPDGIFDRLTSLQKIWLHTNPW 407

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  148 bits (376), Expect = 2e-38
 Identities = 92/408 (22%), Positives = 149/408 (36%), Gaps = 51/408 (12%)

Query: 90  NLTSISLNGTLL----EFSFSSFPHLVYLDLYNNELFGIIPPQI-SNLSNLEYLDFSANK 144
           ++  + L+   +    E SFS    L +L +       +I       LS+L  L    N+
Sbjct: 31  HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90

Query: 145 LFGQIPSGI-GLLTHLTVLHISRNWL-SGSIPHEV-GQLTVLNQLALDSNFLNGSIPRSL 201
              Q+ +G    L +L VL +++  L    +       LT L  L L  N +    P S 
Sbjct: 91  F-LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASF 149

Query: 202 -GNLTHVVILYLYNNSFFGSIPQEI---GNLKSLFDLELCINQLSGAIPLSISNLTNLRF 257
             N+    +L L  N    SI +E       K    L L    L                
Sbjct: 150 FLNMRRFHVLDLTFNK-VKSICEEDLLNFQGKHFTLLRLSSITL---------------- 192

Query: 258 LFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNI 317
             +    L             + +L L+ N F+ ++ K F +     K++      + N+
Sbjct: 193 QDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNM 252

Query: 318 SETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESL-QLQ 376
             +F    +  F D  N +F G           +   D+S + I  ++   +      L+
Sbjct: 253 GSSF---GHTNFKDPDNFTFKGL------EASGVKTCDLSKSKIF-ALLKSVFSHFTDLE 302

Query: 377 YLDLSSNYIVGEIP----TQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANN 432
            L L+ N I  +I       L +   L +L+LS N L     R   +L  LE LDLS N+
Sbjct: 303 QLTLAQNEIN-KIDDNAFWGLTH---LLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNH 358

Query: 433 LSNFVPESLGSLVKLYYLNLSHNKLSQQIPIE-LDNLIHLSELDLSHN 479
           +     +S   L  L  L L  N+L + +P    D L  L ++ L  N
Sbjct: 359 IRALGDQSFLGLPNLKELALDTNQL-KSVPDGIFDRLTSLQKIWLHTN 405

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  148 bits (375), Expect = 2e-38
 Identities = 87/396 (21%), Positives = 154/396 (38%), Gaps = 48/396 (12%)

Query: 148 QIPSGIGLLTHLTVLHISRNWLSGSIPHEV-GQLTVLNQLALDSNFLNGSIPR-SLGNLT 205
           Q+P    L  H+  + +S N ++  +      +L  L  L ++       I   +   L+
Sbjct: 24  QVPE---LPAHVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLS 79

Query: 206 HVVILYLYNNSFFGSIPQEI-GNLKSLFDLELCINQL-SGAIPLSI-SNLTNLRFLFLYH 262
            ++IL L  N F   +       L +L  L L    L    +  +    LT+L  L L  
Sbjct: 80  SLIILKLDYNQF-LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRD 138

Query: 263 NELSGIIPQEI-GNLKKLNSLLLAKNHFRGTVPKSFRNLT--DLVKLRLNQNYLTGNISE 319
           N +  I P     N+++ + L L  N  +    +   N        LRL+   L      
Sbjct: 139 NNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQ----- 193

Query: 320 TFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIP---LEIGESLQLQ 376
                      D++      E   +  +   ++ LD+S N    S+     +     ++Q
Sbjct: 194 -----------DMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQ 242

Query: 377 YLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNF 436
            L LS++Y +G       N    +  +  G + S            ++  DLS + +   
Sbjct: 243 SLILSNSYNMGS-SFGHTNFKDPDNFTFKGLEAS-----------GVKTCDLSKSKIFAL 290

Query: 437 VPESLGSLVKLYYLNLSHNKLSQQIPIE-LDNLIHLSELDLSHNFLGEKISSRICR-MES 494
           +         L  L L+ N++  +I       L HL +L+LS NFLG  I SR+   ++ 
Sbjct: 291 LKSVFSHFTDLEQLTLAQNEI-NKIDDNAFWGLTHLLKLNLSQNFLGS-IDSRMFENLDK 348

Query: 495 LEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLE 530
           LE L+LSYN++  L  + F  +  L  + +  N+L+
Sbjct: 349 LEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLK 384

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 73.6 bits (181), Expect = 9e-14
 Identities = 46/222 (20%), Positives = 76/222 (34%), Gaps = 23/222 (10%)

Query: 89  INLTSISLN--GTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLF 146
           I L  ++    G     +      +  LDL  N     +  +  +      +        
Sbjct: 190 ITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNS 249

Query: 147 GQIPSGIGL---------------LTHLTVLHISRNWLSGSIPHEV-GQLTVLNQLALDS 190
             + S  G                 + +    +S++ +  ++   V    T L QL L  
Sbjct: 250 YNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQ 308

Query: 191 NFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEI-GNLKSLFDLELCINQLSGAIPLSI 249
           N +N     +   LTH++ L L  N F GSI   +  NL  L  L+L  N +  A+    
Sbjct: 309 NEINKIDDNAFWGLTHLLKLNLSQN-FLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQS 366

Query: 250 -SNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFR 290
              L NL+ L L  N+L  +       L  L  + L  N + 
Sbjct: 367 FLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 408

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 72.9 bits (179), Expect = 2e-13
 Identities = 26/131 (19%), Positives = 53/131 (40%), Gaps = 8/131 (6%)

Query: 422 NLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIEL-DNLIHLSELDLSHNF 480
           ++ Y+DLS N+++     S   L  L +L +        I       L  L  L L +N 
Sbjct: 31  HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90

Query: 481 LGEKISSRI-CRMESLEKLNLSYNNL-SGLIPR-CFEEMHGLLHIDISYNKLEGQIPNST 537
              ++ +     + +LE L L+  NL   ++    F+ +  L  + +  N ++ +I  ++
Sbjct: 91  F-LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK-KIQPAS 148

Query: 538 TFRDAPLEALQ 548
            F    +    
Sbjct: 149 FF--LNMRRFH 157

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  150 bits (380), Expect = 2e-38
 Identities = 78/467 (16%), Positives = 160/467 (34%), Gaps = 57/467 (12%)

Query: 109 PHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGI-GLLTHLTVLHISRN 167
                L++  N +  +    I +LS L  L  S N++   +   +      L  L +S N
Sbjct: 21  QKTTILNISQNYISELWTSDILSLSKLRILIISHNRI-QYLDISVFKFNQELEYLDLSHN 79

Query: 168 WLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRS--LGNLTHVVILYLYNNSF----FGSI 221
            L     H    L  L+   L  N  + ++P     GN++ +  L L            I
Sbjct: 80  KLVKISCHPTVNLKHLD---LSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPI 135

Query: 222 ------------------PQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHN 263
                              ++   L+      L I   +      I +++      L  +
Sbjct: 136 AHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELS 195

Query: 264 ELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTD--------------LVKLRLN 309
            +  ++     +        L  N     +  +    T               +    ++
Sbjct: 196 NIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSIS 255

Query: 310 QNYLTGNISETFGTYPN-----LTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGS 364
              L G +      Y       L+   + ++ F       +     +++ + +++     
Sbjct: 256 NVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMV 315

Query: 365 IPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELG---SLI 421
             L   +     +LD S+N +   +    G++  L  L L  N+L   + +       + 
Sbjct: 316 HMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKE-LSKIAEMTTQMK 374

Query: 422 NLEYLDLSANNLSNFVPESL-GSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNF 480
           +L+ LD+S N++S    +        L  LN+S N L+  I   L     +  LDL  N 
Sbjct: 375 SLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPR--IKVLDLHSNK 432

Query: 481 LGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYN 527
           + + I  ++ ++E+L++LN++ N L  +    F+ +  L  I +  N
Sbjct: 433 I-KSIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  138 bits (348), Expect = 2e-34
 Identities = 81/427 (18%), Positives = 151/427 (35%), Gaps = 31/427 (7%)

Query: 114 LDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSI 173
           +D   N L  + P  +S       L+ S N +     S I  L+ L +L IS N +   +
Sbjct: 5   VDRSKNGLIHV-PKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YL 60

Query: 174 PHEV-GQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQ--EIGNLKS 230
              V      L  L L  N L         NL H   L L  N+F  ++P   E GN+  
Sbjct: 61  DISVFKFNQELEYLDLSHNKLVKISCHPTVNLKH---LDLSFNAF-DALPICKEFGNMSQ 116

Query: 231 LFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFR 290
           L  L L    L  +  L I++L   + L +          ++   L+  N+  L      
Sbjct: 117 LKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETY--GEKEDPEGLQDFNTESLHIVFPT 174

Query: 291 GTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQ 350
                   +++      L  + +   + +   +Y       L  N               
Sbjct: 175 NKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPK----------LSN 224

Query: 351 LSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNII-----YLNRLSLS 405
           L+L ++     S    L++     + Y  +S+  + G++  +  +        L+   + 
Sbjct: 225 LTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVV 284

Query: 406 GNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIEL 465
            +              N+   + + +            +    +L+ S+N L+  +    
Sbjct: 285 SDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENC 344

Query: 466 DNLIHLSELDLSHNFLG--EKISSRICRMESLEKLNLSYNNLSGLIPRC-FEEMHGLLHI 522
            +L  L  L L  N L    KI+    +M+SL++L++S N++S    +        LL +
Sbjct: 345 GHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSL 404

Query: 523 DISYNKL 529
           ++S N L
Sbjct: 405 NMSSNIL 411

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  121 bits (306), Expect = 3e-29
 Identities = 74/414 (17%), Positives = 128/414 (30%), Gaps = 53/414 (12%)

Query: 90  NLTSISLNGTLL-EFSFSSFPHLVYLDLYNNELFGI-IPPQISNLSNLEYLDFSANKLFG 147
            L  + L+   L + S     +L +LDL  N    + I  +  N+S L++L  S   L  
Sbjct: 70  ELEYLDLSHNKLVKISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK 129

Query: 148 QIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGN---- 203
                I  L    VL +           +   L   N  +L   F        + +    
Sbjct: 130 SSVLPIAHLNISKVLLVLGETYGEKE--DPEGLQDFNTESLHIVFPTNKEFHFILDVSVK 187

Query: 204 -------------------------------LTHVVILYLYNNSFFGSIPQEIGNL---K 229
                                             +  L L N     +    I  L    
Sbjct: 188 TVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHT 247

Query: 230 SLFDLELCINQLSG-----AIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLL 284
           +++   +   +L G         S ++L  L    +  +               +N    
Sbjct: 248 TVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNF 307

Query: 285 AKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSF--FGEIL 342
             +  R         ++  + L  + N LT  + E  G    L  + L  N      +I 
Sbjct: 308 TVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIA 367

Query: 343 SDWGRCPQLSLLDVSINNISGSIPLEIGESL-QLQYLDLSSNYIVGEIPTQLGNIIYLNR 401
               +   L  LD+S N++S             L  L++SSN +   I   L     +  
Sbjct: 368 EMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPP--RIKV 425

Query: 402 LSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHN 455
           L L  NK+   IP+++  L  L+ L++++N L +        L  L  + L  N
Sbjct: 426 LDLHSNKIKS-IPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  105 bits (264), Expect = 8e-24
 Identities = 68/389 (17%), Positives = 127/389 (32%), Gaps = 54/389 (13%)

Query: 90  NLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQI 149
              ++ +        F +   L +L L    L       I++L+  + L         + 
Sbjct: 101 AFDALPICKE-----FGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKE 155

Query: 150 PSGIGLLTHLTVLHISRNW---------------------------------LSGSIPHE 176
                   +   LHI                                        SI  +
Sbjct: 156 DPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAK 215

Query: 177 VGQLTVLNQLALDSNFLNGSIPRSLGNL---THVVILYLYNNSFFGSIPQEIG-----NL 228
           +     L+ L L++     +    +  L   T V    + N    G +          +L
Sbjct: 216 LQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSL 275

Query: 229 KSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNH 288
           K+L   ++  +             +N+       +    +       +     L  + N 
Sbjct: 276 KALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNL 335

Query: 289 FRGTVPKSFRNLTDLVKLRLNQNYLT--GNISETFGTYPNLTFIDLSNNSF-FGEILSDW 345
              TV ++  +LT+L  L L  N L     I+E      +L  +D+S NS  + E   D 
Sbjct: 336 LTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDC 395

Query: 346 GRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLS 405
                L  L++S N ++ +I   +    +++ LDL SN I   IP Q+  +  L  L+++
Sbjct: 396 SWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVA 452

Query: 406 GNKLSGCIPRE-LGSLINLEYLDLSANNL 433
            N+L   +P      L +L+ + L  N  
Sbjct: 453 SNQLKS-VPDGIFDRLTSLQKIWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 94.5 bits (235), Expect = 3e-20
 Identities = 53/319 (16%), Positives = 112/319 (35%), Gaps = 14/319 (4%)

Query: 28  SLAISSNSAEEAHALVKWKASLEVHSRSLLHSWSLSSVNATKISPCAWSGIFCNHAERVV 87
           SL I   + +E H ++   +   V +  L +   +   N         + +  N     +
Sbjct: 167 SLHIVFPTNKEFHFILDV-SVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNL 225

Query: 88  GINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSN-----LEYLDFSA 142
            +N    + N  +          + Y  + N +L G +  +  + S      L      +
Sbjct: 226 TLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVS 285

Query: 143 NKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLG 202
           +           + +++ + + + +           +++    L   +N L  ++  + G
Sbjct: 286 DVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCG 345

Query: 203 NLTHVVILYLYNNSFFGSIPQEIG---NLKSLFDLELCINQLSGAIPLSI-SNLTNLRFL 258
           +LT +  L L  N     + +       +KSL  L++  N +S        S   +L  L
Sbjct: 346 HLTELETLILQMNQL-KELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSL 404

Query: 259 FLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNIS 318
            +  N L+  I + +    ++  L L  N  + ++PK    L  L +L +  N L     
Sbjct: 405 NMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPD 461

Query: 319 ETFGTYPNLTFIDLSNNSF 337
             F    +L  I L  N +
Sbjct: 462 GIFDRLTSLQKIWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 88.8 bits (220), Expect = 2e-18
 Identities = 60/347 (17%), Positives = 116/347 (33%), Gaps = 40/347 (11%)

Query: 45  WKASLEVHSRSLLHSWSLSSVNATKISPCAWSGIFCNHAERVVGINLTSISLNGTLLEFS 104
              SL +   +      +  V+   ++    S I C   +      L+ ++   T  + S
Sbjct: 164 NTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLS 223

Query: 105 FSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIG-----LLTHL 159
             +  ++   +   N    I   Q+   + + Y   S  KL GQ+           L  L
Sbjct: 224 NLTLNNI---ETTWNSFIRI--LQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKAL 278

Query: 160 TVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFG 219
           ++  +  +       +     + +N      +            ++  + L   NN    
Sbjct: 279 SIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTD 338

Query: 220 SIPQEIGNLKSLFDLELCINQLS--GAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLK 277
           ++ +  G+L  L  L L +NQL     I    + + +L+ L +  N +S    +      
Sbjct: 339 TVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGD---- 394

Query: 278 KLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSF 337
                                    L+ L ++ N LT  I       P +  +DL +N  
Sbjct: 395 -------------------CSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKI 433

Query: 338 FGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQ-LQYLDLSSN 383
              I     +   L  L+V+ N +  S+P  I + L  LQ + L +N
Sbjct: 434 K-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTN 478

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 68.7 bits (168), Expect = 3e-12
 Identities = 42/190 (22%), Positives = 74/190 (38%), Gaps = 7/190 (3%)

Query: 354 LDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCI 413
           L++S N IS     +I    +L+ L +S N I     +       L  L LS NKL   I
Sbjct: 26  LNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVK-I 84

Query: 414 PRELGSLINLEYLDLSANNLSNF-VPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLS 472
                  +NL++LDLS N      + +  G++ +L +L LS   L +   + + +L    
Sbjct: 85  S--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISK 142

Query: 473 ELDLSHNFLGEKISS---RICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKL 529
            L +     GEK      +    ESL  +  +      ++    + +  L   +I     
Sbjct: 143 VLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLE 202

Query: 530 EGQIPNSTTF 539
           + +     + 
Sbjct: 203 DNKCSYFLSI 212

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  140 bits (355), Expect = 1e-36
 Identities = 69/270 (25%), Positives = 113/270 (41%), Gaps = 20/270 (7%)

Query: 638 NDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQ-EEFLNEIQALTEI 695
             +     IG+G  G     K    G  + +K+ +      MS ++ EE   E+  L  +
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINI---SRMSSKEREESRREVAVLANM 80

Query: 696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALF 755
           +H NIV++          +I+ +Y E G L K + N          Q L+    +  AL 
Sbjct: 81  KHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALK 139

Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           ++H+     I+HRDI S+N+ L       + DFGIA+ LN          GT  Y++PE+
Sbjct: 140 HVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEI 196

Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQK 875
                   K D+++ G +  E+   KH     FE  S  + +   +  S  P    H   
Sbjct: 197 CENKPYNNKSDIWALGCVLYELCTLKHA----FEAGSMKNLVLKIISGSFPPVSL-HYSY 251

Query: 876 KLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
            L S++        +NP  RP+   V+ +L
Sbjct: 252 DLRSLVS---QLFKRNPRDRPS---VNSIL 275

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  141 bits (357), Expect = 4e-36
 Identities = 60/279 (21%), Positives = 110/279 (39%), Gaps = 38/279 (13%)

Query: 639 DFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFL-NEIQALTEI-R 696
            F  +  +G G  G++    +      AVK+        +  +   F   E+Q L E   
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKR--------ILPECFSFADREVQLLRESDE 76

Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFY 756
           H N+++++      +  +I  E   +   + +   D +   L   + + +++     L +
Sbjct: 77  HPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGL---EPITLLQQTTSGLAH 133

Query: 757 LHNNCFPPIVHRDISSKNVLL-----DLGYEAHVSDFGIAKFLNPDSS---NWSELAGTH 808
           LH+     IVHRD+   N+L+         +A +SDFG+ K L          S + GT 
Sbjct: 134 LHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTE 190

Query: 809 GYVAPEL---AYTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEMLDS 864
           G++APE+         T   D++S G +   VI +G HP     +        NI +   
Sbjct: 191 GWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR-----QANILLGAC 245

Query: 865 RLPYPSLHVQKKLMSIMQVAF--SCLDQNPESRPTMKRV 901
            L        +K   ++        +  +P+ RP+ K V
Sbjct: 246 SLDCLH---PEKHEDVIARELIEKMIAMDPQKRPSAKHV 281

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  138 bits (350), Expect = 5e-36
 Identities = 65/278 (23%), Positives = 105/278 (37%), Gaps = 35/278 (12%)

Query: 637 TNDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI 695
            +    +  +G+G  G V+R K   +G   AVK        ++  +    + E+ A   +
Sbjct: 57  VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVK--------KVRLEVFR-VEELVACAGL 107

Query: 696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALF 755
               IV  YG         I  E LE GSL +++       E    + L  +    + L 
Sbjct: 108 SSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPE---DRALYYLGQALEGLE 164

Query: 756 YLHNNCFPPIVHRDISSKNVLLDL-GYEAHVSDFGIAKFLNPDSSNWSE-----LAGTHG 809
           YLH      I+H D+ + NVLL   G  A + DFG A  L PD    S      + GT  
Sbjct: 165 YLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTET 221

Query: 810 YVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYP 869
           ++APE+        K D++S   + L ++ G HP    F          + +  +  P P
Sbjct: 222 HMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP-------LCLKIASEPPP 274

Query: 870 SLHVQKKLMSIMQVAF--SCLDQNPESRPTMKRVSQLL 905
              +     + +        L + P  R +     +L 
Sbjct: 275 IREIPPSC-APLTAQAIQEGLRKEPVHRAS---AMELR 308

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  135 bits (342), Expect = 1e-35
 Identities = 69/278 (24%), Positives = 115/278 (41%), Gaps = 21/278 (7%)

Query: 635 SATNDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQ-QEEFLNEIQAL 692
           S   D+   + IG G +G   + +    G+I   K+      G M+   ++  ++E+  L
Sbjct: 3   SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDY---GSMTEAEKQMLVSEVNLL 59

Query: 693 TEIRHRNIVKFYG--FCSHPKHSFIIYEYLESGSLDKILCNDASAKE-LGWTQRLNVIKG 749
            E++H NIV++Y           +I+ EY E G L  ++      ++ L     L V+  
Sbjct: 60  RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 119

Query: 750 VADALFYLH--NNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGT 807
           +  AL   H  ++    ++HRD+   NV LD      + DFG+A+ LN D+S      GT
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGT 179

Query: 808 HGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLP 867
             Y++PE    +   EK D++S G L  E+     P    F   S               
Sbjct: 180 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP----FTAFSQKELAGKIREGKFRR 235

Query: 868 YPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
            P      +L  I+      L+     RP+   V ++L
Sbjct: 236 IPY-RYSDELNEIIT---RMLNLKDYHRPS---VEEIL 266

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  135 bits (342), Expect = 2e-35
 Identities = 69/276 (25%), Positives = 114/276 (41%), Gaps = 42/276 (15%)

Query: 645 CIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFL----NEIQALTEIRHRN 699
            +GKG +G VY  + + +    A+K        E+  +   +      EI     ++H+N
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIK--------EIPERDSRYSQPLHEEIALHKHLKHKN 80

Query: 700 IVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHN 759
           IV++ G  S      I  E +  GSL  +L +     +          K + + L YLH+
Sbjct: 81  IVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD 140

Query: 760 NCFPPIVHRDISSKNVLLDLGYEAHV--SDFGIAKFLNPDSSNWSELAGTHGYVAPEL-- 815
           N    IVHRDI   NVL++  Y   +  SDFG +K L   +       GT  Y+APE+  
Sbjct: 141 NQ---IVHRDIKGDNVLIN-TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIID 196

Query: 816 ----AYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNM-NIEMLDSRLPYPS 870
                Y        D++S G   +E+  GK P    +E+    + M  + M       P 
Sbjct: 197 KGPRGYGKAA----DIWSLGCTIIEMATGKPP---FYELGEPQAAMFKVGMFKVHPEIPE 249

Query: 871 LHVQKKLMS-IMQVAFSCLDQNPESRPTMKRVSQLL 905
             +  +  + I++    C + +P+ R      + LL
Sbjct: 250 -SMSAEAKAFILK----CFEPDPDKRAC---ANDLL 277

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  135 bits (342), Expect = 4e-35
 Identities = 76/318 (23%), Positives = 119/318 (37%), Gaps = 42/318 (13%)

Query: 220 SIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKL 279
           ++P+EI        L+L  N +S         L +L  L L +N++S I  +    L+KL
Sbjct: 47  AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKL 104

Query: 280 NSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFG 339
             L ++KNH     P    +L    +LR++ N +       F    N+  I++  N    
Sbjct: 105 QKLYISKNHLVEIPPNLPSSLV---ELRIHDNRIRKVPKGVFSGLRNMNCIEMGGN---- 157

Query: 340 EILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYL 399
                      L          +        + L+L YL +S   +   IP  L     L
Sbjct: 158 ----------PLE---------NSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETL 195

Query: 400 NRLSLSGNKLSGCIPRE-LGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLS 458
           N L L  NK+   I  E L     L  L L  N +      SL  L  L  L+L +NKLS
Sbjct: 196 NELHLDHNKIQA-IELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS 254

Query: 459 QQIPIELDNLIHLSELDLSHNFLGEKISSRICRME------SLEKLNLSYNNLS--GLIP 510
            ++P  L +L  L  + L  N + +   +  C +           ++L  N +    + P
Sbjct: 255 -RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQP 313

Query: 511 RCFEEMHGLLHIDISYNK 528
             F  +   L I     K
Sbjct: 314 ATFRCVTDRLAIQFGNYK 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  117 bits (294), Expect = 1e-28
 Identities = 55/288 (19%), Positives = 96/288 (33%), Gaps = 22/288 (7%)

Query: 108 FPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGI-GLLTHLTVLHISR 166
            P    LDL NN++  +       L +L  L    NK+  +I       L  L  L+IS+
Sbjct: 53  SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI-SKIHEKAFSPLRKLQKLYISK 111

Query: 167 NWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSF-FGSIPQEI 225
           N L   IP      + L +L +  N +          L ++  + +  N           
Sbjct: 112 NHLV-EIP--PNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGA 168

Query: 226 GNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLA 285
            +   L  L +   +L+  IP  +     L  L L HN++  I  +++    KL  L L 
Sbjct: 169 FDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLG 225

Query: 286 KNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNN--------SF 337
            N  R     S   L  L +L L+ N L+  +         L  + L  N         F
Sbjct: 226 HNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDF 284

Query: 338 FGEILSDWGRCPQLSLLDVSINNIS-GSIPLEIGESL-QLQYLDLSSN 383
               +    +    + + +  N +    +       +     +   + 
Sbjct: 285 CP--VGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  110 bits (277), Expect = 2e-26
 Identities = 60/287 (20%), Positives = 101/287 (35%), Gaps = 40/287 (13%)

Query: 254 NLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYL 313
           +LR +      L  + P+EI        L L  N         F+ L  L  L L  N +
Sbjct: 34  HLRVVQCSDLGLKAV-PKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90

Query: 314 TGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESL 373
           +    + F     L  + +S N               L             IP  +  SL
Sbjct: 91  SKIHEKAFSPLRKLQKLYISKN--------------HLV-----------EIPPNLPSSL 125

Query: 374 QLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKL-SGCIPRELGSLINLEYLDLSANN 432
               L +  N I          +  +N + + GN L +          + L YL +S   
Sbjct: 126 V--ELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAK 183

Query: 433 LSNFVPESLGSLVKLYYLNLSHNKLSQQIPIE-LDNLIHLSELDLSHNFLGEKISSRICR 491
           L+    +   +L +L+   L HNK+   I +E L     L  L L HN +   I +    
Sbjct: 184 LTGIPKDLPETLNELH---LDHNKIQA-IELEDLLRYSKLYRLGLGHNQI-RMIENGSLS 238

Query: 492 -MESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNST 537
            + +L +L+L  N LS  +P    ++  L  + +  N +  ++  + 
Sbjct: 239 FLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVND 283

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  106 bits (266), Expect = 5e-25
 Identities = 60/261 (22%), Positives = 98/261 (37%), Gaps = 24/261 (9%)

Query: 90  NLTSISLNGTLLEF----SFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKL 145
           +L ++ L    +      +FS    L  L +  N L   IPP +   S+L  L    N++
Sbjct: 79  HLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHL-VEIPPNL--PSSLVELRIHDNRI 135

Query: 146 FGQIPSGI-GLLTHLTVLHISRNWL-SGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGN 203
             ++P G+   L ++  + +  N L +            LN L +    L   IP+ L  
Sbjct: 136 R-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL-- 191

Query: 204 LTHVVILYLYNNSFFGSIPQEI-GNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYH 262
              +  L+L +N    +I  E       L+ L L  NQ+      S+S L  LR L L +
Sbjct: 192 PETLNELHLDHNK-IQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDN 250

Query: 263 NELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFR------NLTDLVKLRLNQNYLT-G 315
           N+LS  +P  + +LK L  + L  N+        F              + L  N +   
Sbjct: 251 NKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYW 309

Query: 316 NISE-TFGTYPNLTFIDLSNN 335
            +   TF    +   I   N 
Sbjct: 310 EVQPATFRCVTDRLAIQFGNY 330

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  134 bits (340), Expect = 8e-35
 Identities = 67/299 (22%), Positives = 127/299 (42%), Gaps = 27/299 (9%)

Query: 244 AIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDL 303
            +P  +    +   L L +N+++ I   +  NLK L++L+L  N      P +F  L  L
Sbjct: 45  KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 102

Query: 304 VKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSD-WGRCPQLSLLDVSINNI- 361
            +L L++N L     +       L  + +  N    ++    +    Q+ ++++  N + 
Sbjct: 103 ERLYLSKNQLKELPEKMP---KTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLK 158

Query: 362 SGSIPLEIGESL-QLQYLDLSSNYIVGEIPTQL-GNIIYLNRLSLSGNKLSGCIPRE-LG 418
           S  I     + + +L Y+ ++   I   IP  L  +   L  L L GNK++  +    L 
Sbjct: 159 SSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPS---LTELHLDGNKIT-KVDAASLK 213

Query: 419 SLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSH 478
            L NL  L LS N++S     SL +   L  L+L++NKL  ++P  L +  ++  + L +
Sbjct: 214 GLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL-VKVPGGLADHKYIQVVYLHN 272

Query: 479 NFLGEKISSR-------ICRMESLEKLNLSYNNL--SGLIPRCFEEMHGLLHIDISYNK 528
           N +   I S          +  S   ++L  N +    + P  F  ++    + +   K
Sbjct: 273 NNI-SAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  124 bits (313), Expect = 3e-31
 Identities = 64/307 (20%), Positives = 107/307 (34%), Gaps = 33/307 (10%)

Query: 108 FPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGL-LTHLTVLHISR 166
            P    LDL NN++  I      NL NL  L    NK+  +I  G    L  L  L++S+
Sbjct: 51  PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI-SKISPGAFAPLVKLERLYLSK 109

Query: 167 NWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPR-SLGNLTHVVILYLYNNSF-FGSIPQE 224
           N L   +P        L +L +  N +   + +     L  ++++ L  N      I   
Sbjct: 110 NQLK-ELP--EKMPKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENG 165

Query: 225 I-GNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLL 283
               +K L  + +    ++  IP  +    +L  L L  N+++ +    +  L  L  L 
Sbjct: 166 AFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLG 222

Query: 284 LAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILS 343
           L+ N        S  N   L +L LN N L   +      +  +  + L NN        
Sbjct: 223 LSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNN-------- 273

Query: 344 DWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYI-VGEIPTQL-GNIIYLNR 401
                  +S    +I +     P    +      + L SN +   EI       +     
Sbjct: 274 ------NIS----AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAA 323

Query: 402 LSLSGNK 408
           + L   K
Sbjct: 324 VQLGNYK 330

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  122 bits (308), Expect = 1e-30
 Identities = 56/259 (21%), Positives = 102/259 (39%), Gaps = 21/259 (8%)

Query: 90  NLTSISLNGTLL----EFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKL 145
           +   + L    +    +  F +  +L  L L NN++  I P   + L  LE L  S N+L
Sbjct: 53  DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 112

Query: 146 FGQIPSGIGLLTHLTVLHISRNWLSGSIPHEV-GQLTVLNQLALDSNFLNGSI--PRSLG 202
             ++P    +   L  L +  N ++  +   V   L  +  + L +N L  S     +  
Sbjct: 113 -KELPE--KMPKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 168

Query: 203 NLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYH 262
            +  +  + + + +   +IPQ  G   SL +L L  N+++     S+  L NL  L L  
Sbjct: 169 GMKKLSYIRIADTN-ITTIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSF 225

Query: 263 NELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFG 322
           N +S +    + N   L  L L  N     VP    +   +  + L+ N ++   S  F 
Sbjct: 226 NSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFC 284

Query: 323 T------YPNLTFIDLSNN 335
                    + + + L +N
Sbjct: 285 PPGYNTKKASYSGVSLFSN 303

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  111 bits (280), Expect = 7e-27
 Identities = 57/305 (18%), Positives = 108/305 (35%), Gaps = 41/305 (13%)

Query: 254 NLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYL 313
           +LR +      L  + P+++        L L  N         F+NL +L  L L  N +
Sbjct: 32  HLRVVQCSDLGLEKV-PKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88

Query: 314 TGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESL 373
           +      F     L  + LS N              QL             +P ++ ++L
Sbjct: 89  SKISPGAFAPLVKLERLYLSKN--------------QLK-----------ELPEKMPKTL 123

Query: 374 QLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKL-SGCIPRE-LGSLINLEYLDLSAN 431
           Q   L +  N I     +    +  +  + L  N L S  I       +  L Y+ ++  
Sbjct: 124 Q--ELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADT 181

Query: 432 NLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIE-LDNLIHLSELDLSHNFLGEKISSRIC 490
           N++        SL +L+   L  NK+++ +    L  L +L++L LS N +   + +   
Sbjct: 182 NITTIPQGLPPSLTELH---LDGNKITK-VDAASLKGLNNLAKLGLSFNSI-SAVDNGSL 236

Query: 491 R-MESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNSTTFRDAPLEALQG 549
                L +L+L+ N L   +P    +   +  + +  N +   I ++             
Sbjct: 237 ANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKAS 294

Query: 550 NKGLY 554
             G+ 
Sbjct: 295 YSGVS 299

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  134 bits (339), Expect = 9e-35
 Identities = 60/320 (18%), Positives = 115/320 (35%), Gaps = 41/320 (12%)

Query: 609 QSSFGNTPGLRSVLTFEGKIVYEEIISATNDFNAEHCIGKGGHGSVYRAK-VPSGEIFAV 667
                +    R  L F+G +V    I     +     +G+GG   V   + +  G  +A+
Sbjct: 4   SHHHHHHSSGRENLYFQGHMV----IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYAL 59

Query: 668 KKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHS----FIIYEYLESG 723
           K+       E    +EE   E        H NI++   +C   + +    +++  + + G
Sbjct: 60  KRILCH---EQQ-DREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRG 115

Query: 724 SLDKILCNDASAKELGWTQR--LNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGY 781
           +L   +      K    T+   L ++ G+   L  +H        HRD+   N+LL    
Sbjct: 116 TLWNEI-ERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEG 171

Query: 782 EAHVSDFGIAKFLNPDSSNWSELA---------GTHGYVAPEL----AYTLKVTEKCDVY 828
           +  + D G             +            T  Y APEL    ++   + E+ DV+
Sbjct: 172 QPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHC-VIDERTDVW 230

Query: 829 SFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYP-SLHVQKKLMSIMQVAFSC 887
           S G +   ++ G+ P    ++M     +     + ++L  P S      L  ++    S 
Sbjct: 231 SLGCVLYAMMFGEGP----YDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLN---SM 283

Query: 888 LDQNPESRPTMKRVSQLLCE 907
           +  +P  RP +  +   L  
Sbjct: 284 MTVDPHQRPHIPLLLSQLEA 303

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  134 bits (338), Expect = 1e-34
 Identities = 71/282 (25%), Positives = 126/282 (44%), Gaps = 28/282 (9%)

Query: 630 YEEIISATN---DFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEF 685
            +E          F+    +G+G +GSVY+A    +G+I A+K+        +    +E 
Sbjct: 18  LDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV------PVESDLQEI 71

Query: 686 LNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLN 745
           + EI  + +    ++VK+YG        +I+ EY  +GS+  I+      K L   +   
Sbjct: 72  IKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIAT 129

Query: 746 VIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELA 805
           +++     L YLH       +HRDI + N+LL+    A ++DFG+A  L    +  + + 
Sbjct: 130 ILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI 186

Query: 806 GTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSR 865
           GT  ++APE+   +      D++S G+ A+E+ +GK P     ++      M    +   
Sbjct: 187 GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP---YADIHP----MRAIFMIPT 239

Query: 866 LPYPSLHVQKKLMSIMQ--VAFSCLDQNPESRPTMKRVSQLL 905
            P P+    +         V   CL ++PE R T    +QLL
Sbjct: 240 NPPPTFRKPELWSDNFTDFVK-QCLVKSPEQRAT---ATQLL 277

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  132 bits (335), Expect = 3e-34
 Identities = 76/321 (23%), Positives = 132/321 (41%), Gaps = 41/321 (12%)

Query: 598 FHQRKNDSQTQQSSFGNTPGLRSVLTFEGKIV-YEEIISATN---DFNAEHCIGKGGHGS 653
            H   + S        N      V+T E        ++   +     ++   IG+G  G 
Sbjct: 1   MHHHHHHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGI 60

Query: 654 VYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKH 712
           V  A+   SG   AVK     +      ++E   NE+  + + +H N+V+ Y      + 
Sbjct: 61  VCLAREKHSGRQVAVKM----MDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEE 116

Query: 713 SFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISS 772
            +++ E+L+ G+L  I+    S   L   Q   V + V  AL YLH      ++HRDI S
Sbjct: 117 LWVLMEFLQGGALTDIV----SQVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKS 169

Query: 773 KNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGV 832
            ++LL L     +SDFG    ++ D      L GT  ++APE+        + D++S G+
Sbjct: 170 DSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGI 229

Query: 833 LALEVIKGK------HPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAF- 885
           + +E++ G+       P   +  +  S             P P L    K+  +++  F 
Sbjct: 230 MVIEMVDGEPPYFSDSPVQAMKRLRDS-------------PPPKLKNSHKVSPVLR-DFL 275

Query: 886 -SCLDQNPESRPTMKRVSQLL 905
              L ++P+ R T     +LL
Sbjct: 276 ERMLVRDPQERAT---AQELL 293

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  131 bits (331), Expect = 5e-34
 Identities = 69/285 (24%), Positives = 118/285 (41%), Gaps = 43/285 (15%)

Query: 643 EHCIGKGGHGSVYRA--KVPSGEIF-AVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRN 699
           +  +G G  GSV +   ++   +I  A+K       G      EE + E Q + ++ +  
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLK---QGTEKADTEEMMREAQIMHQLDNPY 71

Query: 700 IVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHN 759
           IV+  G C       ++ E    G L K L      +E+  +    ++  V+  + YL  
Sbjct: 72  IVRLIGVCQAEAL-MLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEE 128

Query: 760 NCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV-----APE 814
             F   VHRD++++NVLL   + A +SDFG++K L  D S ++  A + G       APE
Sbjct: 129 KNF---VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT--ARSAGKWPLKWYAPE 183

Query: 815 LAYTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEMLDS--RLPYP-- 869
                K + + DV+S+GV   E +  G+ P     +M        +  ++   R+  P  
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALSYGQKPYK---KMKGPEV---MAFIEQGKRMECPPE 237

Query: 870 ---SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
               L+      ++M     C     E RP    V Q +    + 
Sbjct: 238 CPPELY------ALMS---DCWIYKWEDRPDFLTVEQRM-RACYY 272

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  131 bits (332), Expect = 5e-34
 Identities = 74/287 (25%), Positives = 136/287 (47%), Gaps = 40/287 (13%)

Query: 631 EEIISATN---DFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFL 686
             I+S  +    +     IG+G  G+VY A  V +G+  A+++    +  +   ++E  +
Sbjct: 10  RSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQ----MNLQQQPKKELII 65

Query: 687 NEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNV 746
           NEI  + E ++ NIV +          +++ EYL  GSL  ++    +   +   Q   V
Sbjct: 66  NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAV 121

Query: 747 IKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAG 806
            +    AL +LH+N    ++HRDI S N+LL +     ++DFG    + P+ S  S + G
Sbjct: 122 CRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG 178

Query: 807 THGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGK------HPRDFLFEMSSSSSNMNIE 860
           T  ++APE+        K D++S G++A+E+I+G+      +P   L+ ++++       
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN------- 231

Query: 861 MLDSRLPYPSLHVQKKLMSIMQVAF--SCLDQNPESRPTMKRVSQLL 905
                   P L   +KL +I +  F   CL+ + E R +     +LL
Sbjct: 232 ------GTPELQNPEKLSAIFR-DFLNRCLEMDVEKRGS---AKELL 268

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  132 bits (334), Expect = 5e-34
 Identities = 75/283 (26%), Positives = 123/283 (43%), Gaps = 37/283 (13%)

Query: 643 EHCIGKGGHGSVYRA--KVPSGEIF--AVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHR 698
           E  IG G  G V     +VP       A+K       G    Q+ +FL+E   + +  H 
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALK---AGYTERQRRDFLSEASIMGQFDHP 110

Query: 699 NIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLH 758
           NI++  G  +  + + I+ EY+E+GSLD  L       +    Q + +++GV   + YL 
Sbjct: 111 NIIRLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYLS 168

Query: 759 NNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV---APEL 815
           +  +   VHRD++++NVL+D      VSDFG+++ L  D        G    +   APE 
Sbjct: 169 DLGY---VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEA 225

Query: 816 AYTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMN----IEMLDS--RLPY 868
                 +   DV+SFGV+  EV+  G+ P    +       NM     I  ++   RLP 
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLAYGERP----YW------NMTNRDVISSVEEGYRLPA 275

Query: 869 PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
           P       L  +M     C  ++   RP   ++  +L + +  
Sbjct: 276 PM-GCPHALHQLML---DCWHKDRAQRPRFSQIVSVL-DALIR 313

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  130 bits (329), Expect = 9e-34
 Identities = 71/281 (25%), Positives = 123/281 (43%), Gaps = 39/281 (13%)

Query: 643 EHCIGKGGHGSVYRAKVPSGEIF-AVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIV 701
           +H +G G +G VY        +  AVK         M    EEFL E   + EI+H N+V
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTME--VEEFLKEAAVMKEIKHPNLV 72

Query: 702 KFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNC 761
           +  G C+     +II E++  G+L   L  + + +E+     L +   ++ A+ YL    
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYLEKKN 131

Query: 762 FPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV-----APELA 816
           F   +HRD++++N L+   +   V+DFG+++ +  D    +  A           APE  
Sbjct: 132 F---IHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TYTAHAGAKFPIKWTAPESL 184

Query: 817 YTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEMLDS-----RLPYPS 870
              K + K DV++FGVL  E+   G  P      +         ++ +      R+  P 
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIATYGMSP---YPGID------LSQVYELLEKDYRMERPE 235

Query: 871 LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
               +K+  +M+   +C   NP  RP+   + Q   E +F+
Sbjct: 236 -GCPEKVYELMR---ACWQWNPSDRPSFAEIHQAF-ETMFQ 271

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  129 bits (327), Expect = 1e-33
 Identities = 74/285 (25%), Positives = 119/285 (41%), Gaps = 49/285 (17%)

Query: 643 EHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVK 702
              IG G  G V+     + +  A+K       G MS  +E+F+ E + + ++ H  +V+
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMS--EEDFIEEAEVMMKLSHPKLVQ 67

Query: 703 FYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
            YG C       ++ E++E G L   L              L +   V + + YL   C 
Sbjct: 68  LYGVCLEQAPICLVTEFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEACV 125

Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPD----SSN------WSELAGTHGYVA 812
              +HRD++++N L+       VSDFG+ +F+  D    S+       W+         +
Sbjct: 126 ---IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA---------S 173

Query: 813 PELAYTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEMLDS-----RL 866
           PE+    + + K DV+SFGVL  EV  +GK P       S      N E+++      RL
Sbjct: 174 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP---YENRS------NSEVVEDISTGFRL 224

Query: 867 PYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
             P       +  IM     C  + PE RP   R+ + L  +I E
Sbjct: 225 YKPR-LASTHVYQIMN---HCWRERPEDRPAFSRLLRQL-AEIAE 264

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  134 bits (340), Expect = 1e-33
 Identities = 73/285 (25%), Positives = 124/285 (43%), Gaps = 37/285 (12%)

Query: 638 NDFNAEHCIGKGGHGSVYRAKVPSGEIF-AVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
            D   +H +G G +G VY        +  AVK         M    EEFL E   + EI+
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTME--VEEFLKEAAVMKEIK 274

Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFY 756
           H N+V+  G C+     +II E++  G+L   L  + + +E+     L +   ++ A+ Y
Sbjct: 275 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEY 333

Query: 757 LHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV----- 811
           L    F   +HR+++++N L+   +   V+DFG+++ +  D           G       
Sbjct: 334 LEKKNF---IHRNLAARNCLVGENHLVKVADFGLSRLMTGD-----TYTAHAGAKFPIKW 385

Query: 812 -APELAYTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMN-IEMLDS--RL 866
            APE     K + K DV++FGVL  E+   G  P   +             E+L+   R+
Sbjct: 386 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-------DLSQVYELLEKDYRM 438

Query: 867 PYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
             P     +K+  +M+   +C   NP  RP+   + Q   E +F+
Sbjct: 439 ERPE-GCPEKVYELMR---ACWQWNPSDRPSFAEIHQAF-ETMFQ 478

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  131 bits (331), Expect = 2e-33
 Identities = 79/285 (27%), Positives = 131/285 (45%), Gaps = 40/285 (14%)

Query: 643 EHCIGKGGHGSVYRA--KVPSGEIF---AVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH 697
           +  IG G  G VY+   K  SG+     A+K       G    Q+ +FL E   + +  H
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK---AGYTEKQRVDFLGEAGIMGQFSH 105

Query: 698 RNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYL 757
            NI++  G  S  K   II EY+E+G+LDK L       E    Q + +++G+A  + YL
Sbjct: 106 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYL 163

Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV---APE 814
            N  +   VHRD++++N+L++      VSDFG+++ L  D       +G    +   APE
Sbjct: 164 ANMNY---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 220

Query: 815 -LAYTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMN----IEMLDS--RL 866
            ++Y  K T   DV+SFG++  EV+  G+ P    +        ++    ++ ++   RL
Sbjct: 221 AISYR-KFTSASDVWSFGIVMWEVMTYGERP----YW------ELSNHEVMKAINDGFRL 269

Query: 867 PYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
           P P       +  +M     C  Q    RP    +  +L +K+  
Sbjct: 270 PTPM-DCPSAIYQLMM---QCWQQERARRPKFADIVSIL-DKLIR 309

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  129 bits (327), Expect = 2e-33
 Identities = 71/282 (25%), Positives = 117/282 (41%), Gaps = 43/282 (15%)

Query: 646 IGKGGHGSVYRA--KVPSGEIF-AVKKFHSPLPGEMSFQ-QEEFLNEIQALTEIRHRNIV 701
           +G G  G+V +   ++       AVK              ++E L E   + ++ +  IV
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILK---NEANDPALKDELLAEANVMQQLDNPYIV 81

Query: 702 KFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNC 761
           +  G C       ++ E  E G L+K L      + +     + ++  V+  + YL  + 
Sbjct: 82  RMIGICEAESW-MLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN 137

Query: 762 FPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV-----APELA 816
           F   VHRD++++NVLL   + A +SDFG++K L  D + +   A THG       APE  
Sbjct: 138 F---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK--AQTHGKWPVKWYAPECI 192

Query: 817 YTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMN----IEMLDS--RLPYP 869
              K + K DV+SFGVL  E    G+ P             M       ML+   R+  P
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYR----------GMKGSEVTAMLEKGERMGCP 242

Query: 870 SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
           +    +++  +M     C   + E+RP    V   L    + 
Sbjct: 243 A-GCPREMYDLMN---LCWTYDVENRPGFAAVELRL-RNYYY 279

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  130 bits (330), Expect = 2e-33
 Identities = 64/283 (22%), Positives = 110/283 (38%), Gaps = 44/283 (15%)

Query: 646 IGKGGHGSVYRAK-VPSGEIF----AVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNI 700
           +G G  G+VY+   +P GE      A+K+             +E L+E   +  + + ++
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDEAYVMASVDNPHV 79

Query: 701 VKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
            +  G C       +I + +  G L   +        +G    LN    +A  + YL + 
Sbjct: 80  CRLLGICLTSTV-QLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDR 136

Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV-----APEL 815
                VHRD++++NVL+       ++DFG+AK L  +     E     G V     A E 
Sbjct: 137 RL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE---KEYHAEGGKVPIKWMALES 190

Query: 816 AYTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMN----IEMLDS--RLPY 868
                 T + DV+S+GV   E++  G  P D           +       +L+   RLP 
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD----------GIPASEISSILEKGERLPQ 240

Query: 869 PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
           P       +  IM+    C   + +SRP  + +      K+  
Sbjct: 241 PP-ICTIDVYMIMR---KCWMIDADSRPKFRELIIEF-SKMAR 278

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  130 bits (328), Expect = 2e-33
 Identities = 66/292 (22%), Positives = 118/292 (40%), Gaps = 38/292 (13%)

Query: 643 EHCIGKGGHGSVYRAKVP-----SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH 697
              +G+G  G V   +       +GE  AVK      P        +   EI+ L  + H
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK---PESGGNHIADLKKEIEILRNLYH 82

Query: 698 RNIVKFYGFCSHPKHS--FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALF 755
            NIVK+ G C+    +   +I E+L SGSL + L  +    ++   Q+L     +   + 
Sbjct: 83  ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMD 140

Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV---- 811
           YL +  +   VHRD++++NVL++  ++  + DFG+ K +  D   ++             
Sbjct: 141 YLGSRQY---VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT--VKDDRDSPVFW 195

Query: 812 -APELAYTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSS----NMN----IEM 861
            APE     K     DV+SFGV   E++         +             M     +  
Sbjct: 196 YAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255

Query: 862 LDS--RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
           L    RLP P  +   ++  +M+    C +  P +R + + + +   E + +
Sbjct: 256 LKEGKRLPCPP-NCPDEVYQLMR---KCWEFQPSNRTSFQNLIEGF-EALLK 302

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  135 bits (341), Expect = 3e-33
 Identities = 86/442 (19%), Positives = 158/442 (35%), Gaps = 25/442 (5%)

Query: 105 FSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHI 164
            S    L  L L +N +  +         +LEYLD S N+L   I      +  L  L +
Sbjct: 72  ISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRL-QNISCC--PMASLRHLDL 128

Query: 165 SRN-WLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNL-THVVILYLYNNSFFGSIP 222
           S N +    +  E G LT L  L L +          + +L    ++L L +    G   
Sbjct: 129 SFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGET 188

Query: 223 QEIGNLKSLF-DLELCINQLSGAI------PLSISNLTNLRFLFLYHNELSGIIPQEIGN 275
           + +    +    L    N L           L    L+N++        L   + +    
Sbjct: 189 ESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRG 248

Query: 276 LKKLNSLLLAKNHFRGTVPKSFRNL--TDLVKLRLNQNYLTGNISETFGTY-----PNLT 328
              LN  L           K F+      +  L +    +T  I     TY      +L 
Sbjct: 249 PTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLM 308

Query: 329 FIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGE 388
              + N  F     + +    ++++  +SI++      +         +L+ + N     
Sbjct: 309 IEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDS 368

Query: 389 IPTQLGNIIYLNRLSLSGNKLS--GCIPRELGSLINLEYLDLSANNLSNFVPESL-GSLV 445
           +      +  L  L L  N L     +     ++ +LE LD+S N+L++   +       
Sbjct: 369 VFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAE 428

Query: 446 KLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNL 505
            +  LNLS N L+  +   L     +  LDL +N +   I   +  +++L++LN++ N L
Sbjct: 429 SILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRI-MSIPKDVTHLQALQELNVASNQL 485

Query: 506 SGLIPRCFEEMHGLLHIDISYN 527
             +    F+ +  L +I +  N
Sbjct: 486 KSVPDGVFDRLTSLQYIWLHDN 507

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  133 bits (337), Expect = 7e-33
 Identities = 88/428 (20%), Positives = 148/428 (34%), Gaps = 30/428 (7%)

Query: 113 YLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGI-GLLTHLTVLHISRNWLSG 171
            L L  N +  +  P IS LS L  L  S N++   +   +      L  L +S N L  
Sbjct: 56  ALSLSQNSISELRMPDISFLSELRVLRLSHNRI-RSLDFHVFLFNQDLEYLDVSHNRLQ- 113

Query: 172 SIPHEVGQLTVLNQLALDSNFLNGSIPRS--LGNLTHVVILYLYNNSFFGSIPQEIGNLK 229
           +I      +  L  L L  N  +  +P     GNLT +  L L    F       + +L 
Sbjct: 114 NIS--CCPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLH 170

Query: 230 -SLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNH 288
            S   L+L    + G    S+    N   L L  +  S    Q   ++  L  L L+   
Sbjct: 171 LSCILLDLVSYHIKGGETESLQIP-NTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIK 229

Query: 289 FRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRC 348
                 +        +        +T            L  I+ +           W R 
Sbjct: 230 LNDENCQRLMTFLSELTRGPTLLNVT------------LQHIETTWKCSVKLFQFFWPRP 277

Query: 349 PQ-LSLLDVSINNISGSIPLEIGESL--QLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLS 405
            + L++ +++I            E+    L    + +   +            +N   LS
Sbjct: 278 VEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLS 337

Query: 406 GNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQ--QIPI 463
            +           S  +  +L+ + N  ++ V +   +L +L  L L  N L    ++ +
Sbjct: 338 ISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVAL 397

Query: 464 ELDNLIHLSELDLSHNFLGEKISSRICR-MESLEKLNLSYNNLSGLIPRCFEEMHGLLHI 522
              N+  L  LD+S N L      R C   ES+  LNLS N L+G + RC      +  +
Sbjct: 398 MTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPP--KVKVL 455

Query: 523 DISYNKLE 530
           D+  N++ 
Sbjct: 456 DLHNNRIM 463

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  126 bits (319), Expect = 1e-30
 Identities = 75/432 (17%), Positives = 152/432 (35%), Gaps = 41/432 (9%)

Query: 90  NLTSISLNG-TLLEFSFSSFPHLVYLDLYNNELFGI-IPPQISNLSNLEYLDFSANKLFG 147
           +L  + ++   L   S      L +LDL  N+   + +  +  NL+ L +L  SA K   
Sbjct: 101 DLEYLDVSHNRLQNISCCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ 160

Query: 148 QIPSGIGLLTHLTV-LHISRNWLSGSIPHEVGQL-TVLNQLALDSNFLNGSIPR-SLGNL 204
                +  L    + L +    + G     +    T +  L    N L       S+  L
Sbjct: 161 LDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNAL 220

Query: 205 THVVILYLYNNSF----FGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNL---TNLRF 257
            H+ +  +  N        +   E+    +L ++ L   + +    + +        + +
Sbjct: 221 GHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEY 280

Query: 258 LFLYHNELSGIIPQEIGN-----LKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNY 312
           L +Y+  ++  I +E        LK L    +    F  +    +    ++    L+ + 
Sbjct: 281 LNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISD 340

Query: 313 LTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGES 372
                     +  + TF++ + N F   +        +L  L +  N +  +       +
Sbjct: 341 TPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMT 399

Query: 373 LQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANN 432
             +  L+                   LN L+      S    R      ++  L+LS+N 
Sbjct: 400 KNMSSLETLDVS--------------LNSLN------SHAYDRTCAWAESILVLNLSSNM 439

Query: 433 LSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRM 492
           L+  V   L    K+  L+L +N++   IP ++ +L  L EL+++ N L         R+
Sbjct: 440 LTGSVFRCLPP--KVKVLDLHNNRI-MSIPKDVTHLQALQELNVASNQLKSVPDGVFDRL 496

Query: 493 ESLEKLNLSYNN 504
            SL+ + L  N 
Sbjct: 497 TSLQYIWLHDNP 508

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  125 bits (316), Expect = 4e-30
 Identities = 86/436 (19%), Positives = 156/436 (35%), Gaps = 39/436 (8%)

Query: 121 LFGIIPPQISNLSN--LEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEV- 177
              +I   ++  SN     +D+S   L   +P  +        L +S+N +S  +     
Sbjct: 17  ALALIVGSMTPFSNELESMVDYSNRNLT-HVPKDL--PPRTKALSLSQNSIS-ELRMPDI 72

Query: 178 GQLTVLNQLALDSNFLNGSIP----RSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFD 233
             L+ L  L L  N +  S+         +L +   L + +N    +I      + SL  
Sbjct: 73  SFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEY---LDVSHNRL-QNIS--CCPMASLRH 125

Query: 234 LELCINQLSGAIPLS--ISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLL-LAKNHFR 290
           L+L  N     +P+     NLT L FL L   +   +    + +L     LL L   H +
Sbjct: 126 LDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIK 184

Query: 291 GTVPKSFRNL-TDLVKLRLNQNYLTG---NISETFGTYPNLTFIDLSNNSFFGEILSDWG 346
           G   +S +   T ++ L  + N L     N+S     +  L+ I L++ +    +     
Sbjct: 185 GGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSE 244

Query: 347 RCPQLSLLDVSINNISGSIP-----LEIGESLQLQYLDLSSNYIVGEIPTQLGNII---- 397
                +LL+V++ +I  +        +      ++YL++ +  I   I  +         
Sbjct: 245 LTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETAL 304

Query: 398 -YLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNK 456
             L    +                  +    LS ++          S     +LN + N 
Sbjct: 305 KSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNV 364

Query: 457 LSQQIPIELDNLIHLSELDLSHNFLG--EKISSRICRMESLEKLNLSYNNL-SGLIPRCF 513
            +  +      L  L  L L  N L    K++     M SLE L++S N+L S    R  
Sbjct: 365 FTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTC 424

Query: 514 EEMHGLLHIDISYNKL 529
                +L +++S N L
Sbjct: 425 AWAESILVLNLSSNML 440

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 94.9 bits (236), Expect = 2e-20
 Identities = 43/249 (17%), Positives = 89/249 (35%), Gaps = 17/249 (6%)

Query: 49  LEVHSRSLLHSWSLSSVNATKISPCAWSGIFCNHAERVVGINLTSISLNGTLLEFSFSSF 108
            +      +   ++ ++  T+         +   A + + I      +     E  +S F
Sbjct: 270 FQFFWPRPVEYLNIYNLTITERIDRE-EFTYSETALKSLMIEHVKNQVFLFSKEALYSVF 328

Query: 109 PHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNW 168
             +    L  ++   I      + S+  +L+F+ N     +  G   L  L  L + RN 
Sbjct: 329 AEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNG 388

Query: 169 LSGSIPHEVGQLTVLNQLALDSNFLN----GSIPRSLGNLTHVVILYLYNN----SFFGS 220
           L  +          ++ L      LN     +  R+      +++L L +N    S F  
Sbjct: 389 LK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRC 447

Query: 221 IPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLN 280
           +P        +  L+L  N++  +IP  +++L  L+ L +  N+L  +       L  L 
Sbjct: 448 LPP------KVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQ 500

Query: 281 SLLLAKNHF 289
            + L  N +
Sbjct: 501 YIWLHDNPW 509

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 88.0 bits (218), Expect = 3e-18
 Identities = 47/258 (18%), Positives = 92/258 (35%), Gaps = 13/258 (5%)

Query: 89  INLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQI-----SNLSNLEYLDFSAN 143
           +     +   ++  F F     + YL++YN  +   I  +      + L +L        
Sbjct: 256 LQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQ 315

Query: 144 KLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGN 203
                  +   +   + +  +S +             +    L    N    S+ +    
Sbjct: 316 VFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCST 375

Query: 204 LTHVVILYLYNNSF--FGSIPQEIGNLKSLFDLELCINQL-SGAIPLSISNLTNLRFLFL 260
           L  +  L L  N    F  +     N+ SL  L++ +N L S A   + +   ++  L L
Sbjct: 376 LKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNL 435

Query: 261 YHNELSGIIPQEI-GNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISE 319
             N L+G + + +   +K L+   L  N    ++PK   +L  L +L +  N L      
Sbjct: 436 SSNMLTGSVFRCLPPKVKVLD---LHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDG 491

Query: 320 TFGTYPNLTFIDLSNNSF 337
            F    +L +I L +N +
Sbjct: 492 VFDRLTSLQYIWLHDNPW 509

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 66.8 bits (163), Expect = 2e-11
 Identities = 47/217 (21%), Positives = 75/217 (34%), Gaps = 10/217 (4%)

Query: 325 PNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESL-QLQYLDLSSN 383
           P    + LS NS     + D     +L +L +S N I  S+   +      L+YLD+S N
Sbjct: 52  PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHN 110

Query: 384 YIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPR--ELGSLINLEYLDLSANNLSNFVPESL 441
            +   I      +  L  L LS N     +P   E G+L  L +L LSA          +
Sbjct: 111 RLQ-NISC--CPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPV 166

Query: 442 GSL-VKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNL 500
             L +    L+L    +       L    + + L L  +            + +L  L L
Sbjct: 167 AHLHLSCILLDLVSYHIKGGETESLQIP-NTTVLHLVFHPNSLFSVQVNMSVNALGHLQL 225

Query: 501 SYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNST 537
           S   L+    +        L    +   +  Q   +T
Sbjct: 226 SNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETT 262

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  131 bits (332), Expect = 3e-33
 Identities = 85/328 (25%), Positives = 144/328 (43%), Gaps = 43/328 (13%)

Query: 604 DSQTQQSSFGNTPGLRSVLTFEGKIVYEEIISATNDFNAE---------HCIGKGGHGSV 654
                 +     PGLR   TF     +E+     ++F  E           +G G  G V
Sbjct: 5   KRLHFGNGHLKLPGLR---TFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEV 61

Query: 655 YRA--KVPSGEIF--AVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP 710
                K+PS +    A+K       G    Q+ +FL E   + +  H NI++  G  +  
Sbjct: 62  CSGRLKLPSKKEISVAIKTLK---VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS 118

Query: 711 KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDI 770
           K   I+ EY+E+GSLD  L       +    Q + +++G+A  + YL +  +   VHRD+
Sbjct: 119 KPVMIVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMGY---VHRDL 173

Query: 771 SSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV---APELAYTLKVTEKCDV 827
           +++N+L++      VSDFG+ + L  D        G    +   +PE     K T   DV
Sbjct: 174 AARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDV 233

Query: 828 YSFGVLALEVI-KGKHPRDFLFEMSSSSSNMN-IEMLDS--RLPYPSLHVQKKLMSIMQV 883
           +S+G++  EV+  G+ P    +EM    SN + I+ +D   RLP P       L  +M  
Sbjct: 234 WSYGIVLWEVMSYGERP---YWEM----SNQDVIKAVDEGYRLPPPM-DCPAALYQLML- 284

Query: 884 AFSCLDQNPESRPTMKRVSQLLCEKIFE 911
              C  ++  +RP  +++  +L +K+  
Sbjct: 285 --DCWQKDRNNRPKFEQIVSIL-DKLIR 309

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  129 bits (326), Expect = 4e-33
 Identities = 63/294 (21%), Positives = 127/294 (43%), Gaps = 34/294 (11%)

Query: 627 KIVYEEIISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFL 686
            + ++ +      ++    IG GG   V++      +I+A+K     L    +   + + 
Sbjct: 17  NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYV--NLEEADNQTLDSYR 74

Query: 687 NEIQALTEIRHRN--IVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRL 744
           NEI  L +++  +  I++ Y +    ++ +++ E   +  L+  L    S       +R 
Sbjct: 75  NEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDP---WERK 130

Query: 745 NVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSE- 803
           +  K + +A+  +H +    IVH D+   N L+  G    + DFGIA  + PD+++  + 
Sbjct: 131 SYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKD 186

Query: 804 -LAGTHGYVAPEL-----------AYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMS 851
              GT  Y+ PE                K++ K DV+S G +   +  GK P  F   ++
Sbjct: 187 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--FQQIIN 244

Query: 852 SSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
             S    I   +  + +P    +K L  +++    CL ++P+ R ++    +LL
Sbjct: 245 QISKLHAIIDPNHEIEFPD-IPEKDLQDVLK---CCLKRDPKQRISIP---ELL 291

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  128 bits (325), Expect = 4e-33
 Identities = 72/275 (26%), Positives = 120/275 (43%), Gaps = 36/275 (13%)

Query: 639 DFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQ-----EEFLNEIQAL 692
            F     IGKG  G V++     + ++ A+K         +  ++     E+   EI  L
Sbjct: 23  LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKI--------IDLEEAEDEIEDIQQEITVL 74

Query: 693 TEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVAD 752
           ++     + K+YG        +II EYL  GS   +L        L  TQ   +++ +  
Sbjct: 75  SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILK 130

Query: 753 ALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVA 812
            L YLH+      +HRDI + NVLL    E  ++DFG+A  L       +   GT  ++A
Sbjct: 131 GLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMA 187

Query: 813 PELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLH 872
           PE+        K D++S G+ A+E+ +G+ P     E+      M +  L  +   P+L 
Sbjct: 188 PEVIKQSAYDSKADIWSLGITAIELARGEPP---HSELHP----MKVLFLIPKNNPPTL- 239

Query: 873 VQKKLMSIMQ--VAFSCLDQNPESRPTMKRVSQLL 905
            +      ++  V  +CL++ P  RPT     +LL
Sbjct: 240 -EGNYSKPLKEFVE-ACLNKEPSFRPT---AKELL 269

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  128 bits (325), Expect = 5e-33
 Identities = 71/287 (24%), Positives = 131/287 (45%), Gaps = 31/287 (10%)

Query: 630 YEEIISATN---DFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEF 685
           YE +    +    +     +G G  G VY+AK   +G + A K     +  +   + E++
Sbjct: 8   YEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKV----IETKSEEELEDY 63

Query: 686 LNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLN 745
           + EI+ L    H  IVK  G   H    +I+ E+   G++D I+      + L   Q   
Sbjct: 64  IVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIM--LELDRGLTEPQIQV 121

Query: 746 VIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELA 805
           V + + +AL +LH+     I+HRD+ + NVL+ L  +  ++DFG++              
Sbjct: 122 VCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI 178

Query: 806 GTHGYVAPELAYTLKVTE-----KCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIE 860
           GT  ++APE+     + +     K D++S G+  +E+ + + P     E++     M + 
Sbjct: 179 GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP---HHELNP----MRVL 231

Query: 861 MLDSRLPYPSLHVQKKLMSIMQ--VAFSCLDQNPESRPTMKRVSQLL 905
           +  ++   P+L    K     +  +    LD+NPE+RP+    +QLL
Sbjct: 232 LKIAKSDPPTLLTPSKWSVEFRDFLK-IALDKNPETRPS---AAQLL 274

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  127 bits (322), Expect = 5e-33
 Identities = 81/283 (28%), Positives = 128/283 (45%), Gaps = 45/283 (15%)

Query: 643 EHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVK 702
              +G G  G V   K       AVK       G MS  ++EF  E Q + ++ H  +VK
Sbjct: 13  LKELGSGQFGVVKLGKWKGQYDVAVKMIK---EGSMS--EDEFFQEAQTMMKLSHPKLVK 67

Query: 703 FYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
           FYG CS     +I+ EY+ +G L   L +    K L  +Q L +   V + + +L ++ F
Sbjct: 68  FYGVCSKEYPIYIVTEYISNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQF 125

Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPD----SSN------WSELAGTHGYVA 812
              +HRD++++N L+D      VSDFG+ +++  D    S        WS         A
Sbjct: 126 ---IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS---------A 173

Query: 813 PELAYTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMN-IEMLDS--RLPY 868
           PE+ +  K + K DV++FG+L  EV   GK P    ++     +N   +  +    RL  
Sbjct: 174 PEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP----YD---LYTNSEVVLKVSQGHRLYR 226

Query: 869 PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
           P       +  IM    SC  + PE RPT +++   + E + E
Sbjct: 227 PH-LASDTIYQIMY---SCWHELPEKRPTFQQLLSSI-EPLRE 264

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  132 bits (333), Expect = 6e-33
 Identities = 73/243 (30%), Positives = 99/243 (40%), Gaps = 8/243 (3%)

Query: 239 NQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFR 298
             LS  +P  I   +N R+L L  N +  I      +L  L  L L +N  R     +F 
Sbjct: 64  RGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFN 120

Query: 299 NLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSD-WGRCPQLSLLDVS 357
            L  L  L L  N+LT   S  F     L  + L NN     I S  + R P L  LD+ 
Sbjct: 121 GLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPI-ESIPSYAFNRVPSLMRLDLG 179

Query: 358 INNISGSIPLEIGESL-QLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRE 416
                  I     E L  L+YL+L    I  ++P  L  ++ L  L +SGN      P  
Sbjct: 180 ELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGS 237

Query: 417 LGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDL 476
              L +L+ L +  + +S     +   L  L  LNL+HN LS         L +L EL L
Sbjct: 238 FHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHL 297

Query: 477 SHN 479
            HN
Sbjct: 298 HHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  127 bits (322), Expect = 2e-31
 Identities = 55/233 (23%), Positives = 89/233 (38%), Gaps = 7/233 (3%)

Query: 108 FPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGI-GLLTHLTVLHISR 166
             +  YL+L  N +  I      +L +LE L    N +  QI  G    L  L  L +  
Sbjct: 74  PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI-RQIEVGAFNGLASLNTLELFD 132

Query: 167 NWLSGSIPHEV-GQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEI 225
           NWL+  IP      L+ L +L L +N +      +   +  ++ L L        I +  
Sbjct: 133 NWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGA 191

Query: 226 -GNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLL 284
              L +L  L L +  +   +P +++ L  L  L +  N    I P     L  L  L +
Sbjct: 192 FEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWV 249

Query: 285 AKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSF 337
             +        +F  L  LV+L L  N L+    + F     L  + L +N +
Sbjct: 250 MNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 93.7 bits (233), Expect = 3e-20
 Identities = 46/187 (24%), Positives = 73/187 (39%), Gaps = 9/187 (4%)

Query: 347 RC-PQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLS 405
            C  Q S +  +   +S  +P  I      +YL+L  N I         ++ +L  L L 
Sbjct: 51  SCSNQFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLG 107

Query: 406 GNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIE- 464
            N +          L +L  L+L  N L+     +   L KL  L L +N +   IP   
Sbjct: 108 RNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYA 166

Query: 465 LDNLIHLSELDLSHNFLGEKISSRI-CRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHID 523
            + +  L  LDL      E IS      + +L+ LNL   N+   +P     + GL  ++
Sbjct: 167 FNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MPN-LTPLVGLEELE 224

Query: 524 ISYNKLE 530
           +S N   
Sbjct: 225 MSGNHFP 231

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  129 bits (325), Expect = 7e-33
 Identities = 73/292 (25%), Positives = 119/292 (40%), Gaps = 39/292 (13%)

Query: 643 EHCIGKGGHGSVYRA-----KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH 697
              +GKG  GSV           +G + AVK+    L      QQ +F  EIQ L  +  
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQ----LQHSGPDQQRDFQREIQILKALHS 83

Query: 698 RNIVKFYGFCSHPKHS--FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALF 755
             IVK+ G    P      ++ EYL SG L   L    +   L  ++ L     +   + 
Sbjct: 84  DFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGME 141

Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV---- 811
           YL +      VHRD++++N+L++      ++DFG+AK L  D   +       G      
Sbjct: 142 YLGSRRC---VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYV--VREPGQSPIFW 196

Query: 812 -APELAYTLKVTEKCDVYSFGVLALEVI-KGKHP----RDFLFEMSSSSSNMN----IEM 861
            APE       + + DV+SFGV+  E+            +FL  M            +E+
Sbjct: 197 YAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256

Query: 862 LDS--RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
           L+   RLP P      ++  +M+    C   +P+ RP+   +   L + ++ 
Sbjct: 257 LEEGQRLPAPP-ACPAEVHELMK---LCWAPSPQDRPSFSALGPQL-DMLWS 303

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  131 bits (332), Expect = 8e-33
 Identities = 74/238 (31%), Positives = 106/238 (44%), Gaps = 7/238 (2%)

Query: 244 AIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDL 303
            +P  IS  TN R L L+ N++  I      +L+ L  L L++NH R     +F  L +L
Sbjct: 57  EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANL 114

Query: 304 VKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSD-WGRCPQLSLLDVSINNIS 362
             L L  N LT   +  F     L  + L NN     I S  + R P L  LD+      
Sbjct: 115 NTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPI-ESIPSYAFNRIPSLRRLDLGELKRL 173

Query: 363 GSIPLEIGESL-QLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLI 421
             I     E L  L+YL+L+   +  EIP  L  +I L+ L LSGN LS   P     L+
Sbjct: 174 SYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLM 231

Query: 422 NLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHN 479
           +L+ L +  + +      +  +L  L  +NL+HN L+         L HL  + L HN
Sbjct: 232 HLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  129 bits (327), Expect = 4e-32
 Identities = 60/233 (25%), Positives = 97/233 (41%), Gaps = 7/233 (3%)

Query: 108 FPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGI-GLLTHLTVLHISR 166
             +   L+L+ N++  I      +L +LE L  S N +   I  G    L +L  L +  
Sbjct: 63  STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI-RTIEIGAFNGLANLNTLELFD 121

Query: 167 NWLSGSIPHEV-GQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEI 225
           N L+ +IP+     L+ L +L L +N +      +   +  +  L L        I +  
Sbjct: 122 NRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGA 180

Query: 226 -GNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLL 284
              L +L  L L +  L   IP +++ L  L  L L  N LS I P     L  L  L +
Sbjct: 181 FEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWM 238

Query: 285 AKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSF 337
            ++  +     +F NL  LV++ L  N LT    + F    +L  I L +N +
Sbjct: 239 IQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  109 bits (273), Expect = 3e-25
 Identities = 62/245 (25%), Positives = 96/245 (39%), Gaps = 20/245 (8%)

Query: 294 PKSFRNLTDLVKLRLNQNYLT---GNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQ 350
           P          K+   +  L      IS       N   ++L  N      ++ +     
Sbjct: 36  PSVCSCSNQFSKVICVRKNLREVPDGIS------TNTRLLNLHENQIQIIKVNSFKHLRH 89

Query: 351 LSLLDVSINNISGSIPLEIGESL-QLQYLDLSSNYIVGEIPTQ-LGNIIYLNRLSLSGNK 408
           L +L +S N+I  +I +     L  L  L+L  N +   IP      +  L  L L  N 
Sbjct: 90  LEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNP 147

Query: 409 LSGCIPREL-GSLINLEYLDLSANN-LSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELD 466
           +   IP      + +L  LDL     LS     +   L  L YLNL+   L + IP  L 
Sbjct: 148 IE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IP-NLT 204

Query: 467 NLIHLSELDLSHNFLGEKISSRI-CRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDIS 525
            LI L ELDLS N L   I       +  L+KL +  + +  +    F+ +  L+ I+++
Sbjct: 205 PLIKLDELDLSGNHL-SAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLA 263

Query: 526 YNKLE 530
           +N L 
Sbjct: 264 HNNLT 268

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  108 bits (272), Expect = 3e-25
 Identities = 56/241 (23%), Positives = 95/241 (39%), Gaps = 9/241 (3%)

Query: 196 SIPRSLGNLTHVVILYLYNNSFFGSIPQEI-GNLKSLFDLELCINQLSGAIPLSISNLTN 254
            +P  +   T+  +L L+ N     I      +L+ L  L+L  N +      + + L N
Sbjct: 57  EVPDGI--STNTRLLNLHEN-QIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLAN 113

Query: 255 LRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRL-NQNYL 313
           L  L L+ N L+ I       L KL  L L  N        +F  +  L +L L     L
Sbjct: 114 LNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRL 173

Query: 314 TGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESL 373
           +      F    NL +++L+  +     + +     +L  LD+S N++S +I     + L
Sbjct: 174 SYISEGAFEGLSNLRYLNLAMCNL--REIPNLTPLIKLDELDLSGNHLS-AIRPGSFQGL 230

Query: 374 -QLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANN 432
             LQ L +  + I         N+  L  ++L+ N L+         L +LE + L  N 
Sbjct: 231 MHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNP 290

Query: 433 L 433
            
Sbjct: 291 W 291

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  102 bits (257), Expect = 3e-23
 Identities = 51/204 (25%), Positives = 91/204 (44%), Gaps = 13/204 (6%)

Query: 349 PQLSLLDVSINNISGSIPLEIGESL-QLQYLDLSSNYIVGEIPTQ-LGNIIYLNRLSLSG 406
               LL++  N I   I +   + L  L+ L LS N+I   I       +  LN L L  
Sbjct: 64  TNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHI-RTIEIGAFNGLANLNTLELFD 121

Query: 407 NKLSGCIPRE-LGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIE- 464
           N+L+  IP      L  L+ L L  N + +    +   +  L  L+L   K    I    
Sbjct: 122 NRLTT-IPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGA 180

Query: 465 LDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDI 524
            + L +L  L+L+   L  +I + +  +  L++L+LS N+LS + P  F+ +  L  + +
Sbjct: 181 FEGLSNLRYLNLAMCNL-REIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWM 238

Query: 525 SYNKLEGQIPNSTTFRDAPLEALQ 548
             ++++  I  +  F +  L++L 
Sbjct: 239 IQSQIQ-VIERN-AFDN--LQSLV 258

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 79.4 bits (196), Expect = 1e-15
 Identities = 47/180 (26%), Positives = 76/180 (42%), Gaps = 9/180 (5%)

Query: 90  NLTSISLNGTLLEF----SFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKL 145
           NL ++ L    L      +F     L  L L NN +  I     + + +L  LD    K 
Sbjct: 113 NLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKR 172

Query: 146 FGQIPSGI-GLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNL 204
              I  G    L++L  L+++   L   IP+    L  L++L L  N L+   P S   L
Sbjct: 173 LSYISEGAFEGLSNLRYLNLAMCNLR-EIPNLTP-LIKLDELDLSGNHLSAIRPGSFQGL 230

Query: 205 THVVILYLYNNSFFGSIPQE-IGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHN 263
            H+  L++  +     I +    NL+SL ++ L  N L+       + L +L  + L+HN
Sbjct: 231 MHLQKLWMIQSQ-IQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  127 bits (321), Expect = 1e-32
 Identities = 75/285 (26%), Positives = 122/285 (42%), Gaps = 49/285 (17%)

Query: 643 EHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVK 702
              +G G  G V   K       A+K       G MS  ++EF+ E + +  + H  +V+
Sbjct: 29  LKELGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMS--EDEFIEEAKVMMNLSHEKLVQ 83

Query: 703 FYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
            YG C+  +  FII EY+ +G L   L            Q L + K V +A+ YL +  F
Sbjct: 84  LYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESKQF 141

Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPD----SSN------WSELAGTHGYVA 812
              +HRD++++N L++      VSDFG+++++  D    S        WS          
Sbjct: 142 ---LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS---------P 189

Query: 813 PELAYTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEMLDS-----RL 866
           PE+    K + K D+++FGVL  E+   GK P       +      N E  +      RL
Sbjct: 190 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP---YERFT------NSETAEHIAQGLRL 240

Query: 867 PYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
             P     +K+ +IM    SC  +  + RPT K +   +   + +
Sbjct: 241 YRPH-LASEKVYTIMY---SCWHEKADERPTFKILLSNI-LDVMD 280

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  128 bits (324), Expect = 1e-32
 Identities = 63/283 (22%), Positives = 122/283 (43%), Gaps = 34/283 (12%)

Query: 638 NDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH 697
             ++    IG GG   V++      +I+A+K     L    +   + + NEI  L +++ 
Sbjct: 9   RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYV--NLEEADNQTLDSYRNEIAYLNKLQQ 66

Query: 698 --RNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALF 755
               I++ Y +    ++ +++ E   +  L+  L    S       +R +  K + +A+ 
Sbjct: 67  HSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDP---WERKSYWKNMLEAVH 122

Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSE--LAGTHGYVAP 813
            +H +    IVH D+   N L+  G    + DFGIA  + PD+++  +    GT  Y+ P
Sbjct: 123 TIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178

Query: 814 EL-----------AYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEML 862
           E                K++ K DV+S G +   +  GK P  F   ++  S    I   
Sbjct: 179 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--FQQIINQISKLHAIIDP 236

Query: 863 DSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
           +  + +P    +K L  +++    CL ++P+ R ++    +LL
Sbjct: 237 NHEIEFPD-IPEKDLQDVLK---CCLKRDPKQRISIP---ELL 272

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  127 bits (321), Expect = 2e-32
 Identities = 68/289 (23%), Positives = 115/289 (39%), Gaps = 40/289 (13%)

Query: 646 IGKGGHGSVYRA-----KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNI 700
           +G+G  G V           +GE+ AVK             +  +  EI  L  + H +I
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALK---ADAGPQHRSGWKQEIDILRTLYHEHI 95

Query: 701 VKFYGFCSHPKHS--FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLH 758
           +K+ G C     +   ++ EY+  GSL   L        +G  Q L   + + + + YLH
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLH 151

Query: 759 NNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV-----AP 813
              +   +HRD++++NVLLD      + DFG+AK +      +       G       AP
Sbjct: 152 AQHY---IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR--VREDGDSPVFWYAP 206

Query: 814 ELAYTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSS----SNMN----IEMLDS 864
           E     K     DV+SFGV   E++      +    +           M      E+L+ 
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER 266

Query: 865 --RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
             RLP P      ++  +M+   +C +     RPT + +  +L + + E
Sbjct: 267 GERLPRPD-KCPAEVYHLMK---NCWETEASFRPTFENLIPIL-KTVHE 310

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  126 bits (319), Expect = 3e-32
 Identities = 68/297 (22%), Positives = 113/297 (38%), Gaps = 54/297 (18%)

Query: 646 IGKGGHGSVYRAKVP-----SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNI 700
           +GKG  GSV   +       +GE+ AVKK              +F  EI+ L  ++H NI
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ---HSTEE-HLRDFEREIEILKSLQHDNI 73

Query: 701 VKFYGFCSHPKHS--FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLH 758
           VK+ G C         +I EYL  GSL   L      + +   + L     +   + YL 
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLG 131

Query: 759 NNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV-----AP 813
              +   +HRD++++N+L++      + DFG+ K L  D   +       G       AP
Sbjct: 132 TKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFK--VKEPGESPIFWYAP 186

Query: 814 ELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHV 873
           E     K +   DV+SFGV+  E+        F +   S S       +        + V
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYEL--------FTYIEKSKSPPAEFMRMIGNDKQGQMIV 238

Query: 874 Q-------------------KKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
                                ++  IM     C + N   RP+ + ++  + ++I +
Sbjct: 239 FHLIELLKNNGRLPRPDGCPDEIYMIMT---ECWNNNVNQRPSFRDLALRV-DQIRD 291

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  126 bits (318), Expect = 3e-32
 Identities = 72/280 (25%), Positives = 115/280 (41%), Gaps = 43/280 (15%)

Query: 643 EHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVK 702
              IGKG  G V        ++ AVK          +   + FL E   +T++RH N+V+
Sbjct: 26  LQTIGKGEFGDVMLGDYRGNKV-AVKCIK---NDATA---QAFLAEASVMTQLRHSNLVQ 78

Query: 703 FYGFCSHPKHS-FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNC 761
             G     K   +I+ EY+  GSL   L        LG    L     V +A+ YL  N 
Sbjct: 79  LLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 137

Query: 762 FPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN------WSELAGTHGYVAPEL 815
           F   VHRD++++NVL+     A VSDFG+ K  +           W+         APE 
Sbjct: 138 F---VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT---------APEA 185

Query: 816 AYTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMN-IEMLDS--RLPYPSL 871
               K + K DV+SFG+L  E+   G+ P   +          + +  ++   ++  P  
Sbjct: 186 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-------PLKDVVPRVEKGYKMDAPD- 237

Query: 872 HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
                +  +M+   +C   +   RP+  ++ + L E I  
Sbjct: 238 GCPPAVYEVMK---NCWHLDAAMRPSFLQLREQL-EHIKT 273

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  130 bits (328), Expect = 3e-32
 Identities = 76/276 (27%), Positives = 125/276 (45%), Gaps = 31/276 (11%)

Query: 643 EHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVK 702
           E  +G+G  G V+          A+K      PG MS   E FL E Q + ++RH  +V+
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMS--PEAFLQEAQVMKKLRHEKLVQ 243

Query: 703 FYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
            Y   S  +  +I+ EY+  GSL   L    + K L   Q +++   +A  + Y+    +
Sbjct: 244 LYAVVSE-EPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVERMNY 301

Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV---APELAYTL 819
              VHRD+ + N+L+       V+DFG+A+ +  +   ++   G    +   APE A   
Sbjct: 302 ---VHRDLRAANILVGENLVCKVADFGLARLIEDNE--YTARQGAKFPIKWTAPEAALYG 356

Query: 820 KVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMN-IEMLDS--RLPYPSLHVQK 875
           + T K DV+SFG+L  E+  KG+ P   +        N   ++ ++   R+P P     +
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGRVPYPGM-------VNREVLDQVERGYRMPCPP-ECPE 408

Query: 876 KLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
            L  +M     C  + PE RPT + +   L E  F 
Sbjct: 409 SLHDLMC---QCWRKEPEERPTFEYLQAFL-EDYFT 440

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  128 bits (324), Expect = 3e-32
 Identities = 67/321 (20%), Positives = 134/321 (41%), Gaps = 35/321 (10%)

Query: 601 RKNDSQTQQSSFGNTPGLRSVLTFEGKIVYEEIISATN-DFNAEHCIGKGGHGSVYRAKV 659
           ++  +   +    ++P L +    +      E IS     ++    IG GG   V++   
Sbjct: 18  KETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLN 77

Query: 660 PSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH--RNIVKFYGFCSHPKHSFIIY 717
              +I+A+K     L    +   + + NEI  L +++     I++ Y +    ++ +++ 
Sbjct: 78  EKKQIYAIKYV--NLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135

Query: 718 EYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLL 777
           E   +  L+  L    S       +R +  K + +A+  +H +    IVH D+   N L+
Sbjct: 136 EC-GNIDLNSWLKKKKSIDP---WERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLI 188

Query: 778 DLGYEAHVSDFGIAKFLNPDSSNWSE--LAGTHGYVAPEL-----------AYTLKVTEK 824
             G    + DFGIA  + PD+++  +    G   Y+ PE                K++ K
Sbjct: 189 VDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPK 247

Query: 825 CDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVA 884
            DV+S G +   +  GK P  F   ++  S    I   +  + +P    +K L  +++  
Sbjct: 248 SDVWSLGCILYYMTYGKTP--FQQIINQISKLHAIIDPNHEIEFPD-IPEKDLQDVLK-- 302

Query: 885 FSCLDQNPESRPTMKRVSQLL 905
             CL ++P+ R ++    +LL
Sbjct: 303 -CCLKRDPKQRISIP---ELL 319

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  127 bits (320), Expect = 4e-32
 Identities = 68/300 (22%), Positives = 113/300 (37%), Gaps = 54/300 (18%)

Query: 643 EHCIGKGGHGSVYRAKVP-----SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH 697
              +GKG  GSV   +       +GE+ AVKK              +F  EI+ L  ++H
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ---HSTEE-HLRDFEREIEILKSLQH 101

Query: 698 RNIVKFYGFCSHPKHS--FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALF 755
            NIVK+ G C         +I EYL  GSL   L      + +   + L     +   + 
Sbjct: 102 DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGME 159

Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV---- 811
           YL    +   +HRD++++N+L++      + DFG+ K L  D   +       G      
Sbjct: 160 YLGTKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYK--VKEPGESPIFW 214

Query: 812 -APELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPS 870
            APE     K +   DV+SFGV+  E+        F +   S S       +        
Sbjct: 215 YAPESLTESKFSVASDVWSFGVVLYEL--------FTYIEKSKSPPAEFMRMIGNDKQGQ 266

Query: 871 LHVQ-------------------KKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
           + V                     ++  IM     C + N   RP+ + ++  + ++I +
Sbjct: 267 MIVFHLIELLKNNGRLPRPDGCPDEIYMIMT---ECWNNNVNQRPSFRDLALRV-DQIRD 322

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  125 bits (317), Expect = 4e-32
 Identities = 57/297 (19%), Positives = 114/297 (38%), Gaps = 62/297 (20%)

Query: 643 EHCIGKGGHGSVYRA--KVPSGEIF------AVKKFHSPLPGEMSFQQEEFLNEIQALTE 694
              +G+G    +++   +              +K          +   E F      +++
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD---KAHRN-YSESFFEAASMMSK 68

Query: 695 IRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADAL 754
           + H+++V  YG C     + ++ E+++ GSLD  L  + +   +    +L V K +A A+
Sbjct: 69  LSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN--CINILWKLEVAKQLAAAM 126

Query: 755 FYLHNNCFPPIVHRDISSKNVLLDLGYEAH--------VSDFGIAKFLNPDSS-----NW 801
            +L  N     +H ++ +KN+LL    +          +SD GI+  + P         W
Sbjct: 127 HFLEENTL---IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPW 183

Query: 802 SELAGTHGYVAPE-LAYTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNI 859
                    V PE +     +    D +SFG    E+   G  P   L  + S      +
Sbjct: 184 ---------VPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP---LSALDSQRK---L 228

Query: 860 EMLDS--RLPYP---SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
           +  +   +LP P    L       +++    +C+D  P+ RP+ + + + L   +F 
Sbjct: 229 QFYEDRHQLPAPKAAELA------NLIN---NCMDYEPDHRPSFRAIIRDL-NSLFT 275

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  132 bits (334), Expect = 5e-32
 Identities = 51/210 (24%), Positives = 87/210 (41%), Gaps = 24/210 (11%)

Query: 643 EHCIGKGGHGSVYRAK--VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNI 700
           + CI  GG G +Y A     +G    +K       G+   Q    + E Q L E+ H +I
Sbjct: 85  KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS--GDAEAQ-AMAMAERQFLAEVVHPSI 141

Query: 701 VKFYGFCSHPKHS-----FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALF 755
           V+ + F  H         +I+ EY+   SL +        ++L   + +  +  +  AL 
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK-----GQKLPVAEAIAYLLEILPALS 196

Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           YLH+     +V+ D+  +N++L    +  + D G    +N        L GT G+ APE+
Sbjct: 197 YLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGY----LYGTPGFQAPEI 248

Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHPRD 845
             T   T   D+Y+ G     +      R+
Sbjct: 249 VRT-GPTVATDIYTVGRTLAALTLDLPTRN 277

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  130 bits (329), Expect = 5e-32
 Identities = 76/278 (27%), Positives = 122/278 (43%), Gaps = 35/278 (12%)

Query: 643 EHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVK 702
           E  +G+G  G V+          A+K      PG MS   E FL E Q + ++RH  +V+
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMS--PEAFLQEAQVMKKLRHEKLVQ 326

Query: 703 FYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
            Y   S  +  +I+ EY+  GSL   L    + K L   Q +++   +A  + Y+    +
Sbjct: 327 LYAVVSE-EPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVERMNY 384

Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV-----APELAY 817
              VHRD+ + N+L+       V+DFG+A+ +  +       A           APE A 
Sbjct: 385 ---VHRDLRAANILVGENLVCKVADFGLARLIEDNEYT----ARQGAKFPIKWTAPEAAL 437

Query: 818 TLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMN-IEMLDS--RLPYPSLHV 873
             + T K DV+SFG+L  E+  KG+ P   +        N   ++ ++   R+P P    
Sbjct: 438 YGRFTIKSDVWSFGILLTELTTKGRVPYPGM-------VNREVLDQVERGYRMPCPP-EC 489

Query: 874 QKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
            + L  +M     C  + PE RPT + +   L E  F 
Sbjct: 490 PESLHDLMC---QCWRKEPEERPTFEYLQAFL-EDYFT 523

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  129 bits (325), Expect = 7e-32
 Identities = 70/278 (25%), Positives = 126/278 (45%), Gaps = 35/278 (12%)

Query: 643 EHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVK 702
           E  +G G  G V+ A        AVK      PG MS   E FL E   +  ++H  +VK
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMK---PGSMS--VEAFLAEANVMKTLQHDKLVK 247

Query: 703 FYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
            +   +  +  +II E++  GSL   L +D    +    + ++    +A+ + ++    +
Sbjct: 248 LHAVVTK-EPIYIITEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQRNY 305

Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV---APELAYTL 819
              +HRD+ + N+L+       ++DFG+A+ +  +   ++   G    +   APE     
Sbjct: 306 ---IHRDLRAANILVSASLVCKIADFGLARVIEDNE--YTAREGAKFPIKWTAPEAINFG 360

Query: 820 KVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEMLDS-----RLPYPSLHV 873
             T K DV+SFG+L +E++  G+ P      MS      N E++ +     R+P P  + 
Sbjct: 361 SFTIKSDVWSFGILLMEIVTYGRIPYP---GMS------NPEVIRALERGYRMPRPE-NC 410

Query: 874 QKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
            ++L +IM     C    PE RPT + +  +L +  + 
Sbjct: 411 PEELYNIMM---RCWKNRPEERPTFEYIQSVL-DDFYT 444

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  131 bits (330), Expect = 9e-32
 Identities = 70/286 (24%), Positives = 116/286 (40%), Gaps = 51/286 (17%)

Query: 646 IGKGGHGSVYRA--KVPSGEIF-AVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVK 702
           +G G  GSV +   ++   +I  A+K       G      EE + E Q + ++ +  IV+
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLK---QGTEKADTEEMMREAQIMHQLDNPYIVR 400

Query: 703 FYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
             G C       ++ E    G L K L      +E+  +    ++  V+  + YL    F
Sbjct: 401 LIGVCQAEAL-MLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEEKNF 457

Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV-----APELAY 817
              VHR+++++NVLL   + A +SDFG++K L  D S ++  A + G       APE   
Sbjct: 458 ---VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYT--ARSAGKWPLKWYAPECIN 512

Query: 818 TLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMN----IEMLDS--RLPYP- 869
             K + + DV+S+GV   E +  G+ P             M     +  ++   R+  P 
Sbjct: 513 FRKFSSRSDVWSYGVTMWEALSYGQKPYK----------KMKGPEVMAFIEQGKRMECPP 562

Query: 870 ----SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
                L+    LMS       C     E RP    V Q +    + 
Sbjct: 563 ECPPELY---ALMS------DCWIYKWEDRPDFLTVEQRM-RACYY 598

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  124 bits (314), Expect = 1e-31
 Identities = 66/283 (23%), Positives = 110/283 (38%), Gaps = 40/283 (14%)

Query: 643 EHCIGKGGHGSVYRA--KVPSGEIF--AVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHR 698
              +G+G  G VY        GE    AVK             +E+F++E   +  + H 
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK---KDCTLDNKEKFMSEAVIMKNLDHP 73

Query: 699 NIVKFYGFCS-HPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYL 757
           +IVK  G     P   +II E    G L   L  +     L     +     +  A+ YL
Sbjct: 74  HIVKLIGIIEEEPT--WIIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYL 129

Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV-----A 812
            +      VHRDI+ +N+L+       + DFG+++++  +         +   +     +
Sbjct: 130 ESINC---VHRDIAVRNILVASPECVKLGDFGLSRYIEDE----DYYKASVTRLPIKWMS 182

Query: 813 PELAYTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMN-IEMLDS--RLPY 868
           PE     + T   DV+ F V   E++  GK P    F +     N + I +L+   RLP 
Sbjct: 183 PESINFRRFTTASDVWMFAVCMWEILSFGKQP---FFWL----ENKDVIGVLEKGDRLPK 235

Query: 869 PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
           P       L ++M     C D +P  RP    +   L   +++
Sbjct: 236 PD-LCPPVLYTLMT---RCWDYDPSDRPRFTELVCSL-SDVYQ 273

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  125 bits (315), Expect = 1e-31
 Identities = 67/300 (22%), Positives = 118/300 (39%), Gaps = 53/300 (17%)

Query: 637 TNDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMS-FQQEEFLNEIQALTE 694
            +DF     +G+G  G V +A+       +A+KK         +  +    L+E+  L  
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI------RHTEEKLSTILSEVMLLAS 58

Query: 695 IRHRNIVKFYGF-------------CSHPKHSFIIYEYLESGSL-DKILCNDASAKELGW 740
           + H+ +V++Y                      FI  EY E+G+L D I   + + +    
Sbjct: 59  LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQR--- 115

Query: 741 TQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN 800
            +   + + + +AL Y+H+     I+HRD+   N+ +D      + DFG+AK ++     
Sbjct: 116 DEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172

Query: 801 WSELA--------------GTHGYVAPE-LAYTLKVTEKCDVYSFGVLALEVIKGKHPRD 845
               +              GT  YVA E L  T    EK D+YS G++  E+I       
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGM 232

Query: 846 FLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
               +     +++IE          + V+KK++         +D +P  RP       LL
Sbjct: 233 ERVNILKKLRSVSIE-FPPDFDDNKMKVEKKIIR------LLIDHDPNKRPG---ARTLL 282

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  128 bits (323), Expect = 1e-31
 Identities = 74/282 (26%), Positives = 112/282 (39%), Gaps = 47/282 (16%)

Query: 643 EHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVK 702
              IGKG  G V       G   AVK              + FL E   +T++RH N+V+
Sbjct: 198 LQTIGKGEFGDVMLGDY-RGNKVAVKCIK---NDAT---AQAFLAEASVMTQLRHSNLVQ 250

Query: 703 FYGFCSHPKHSF-IIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNC 761
             G     K    I+ EY+  GSL   L        LG    L     V +A+ YL  N 
Sbjct: 251 LLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 309

Query: 762 FPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN------WSELAGTHGYVAPEL 815
           F   VHRD++++NVL+     A VSDFG+ K  +           W+         APE 
Sbjct: 310 F---VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT---------APEA 357

Query: 816 AYTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEMLDS-----RLPYP 869
               K + K DV+SFG+L  E+   G+ P      +         +++       ++  P
Sbjct: 358 LREKKFSTKSDVWSFGILLWEIYSFGRVPYP---RIP------LKDVVPRVEKGYKMDAP 408

Query: 870 SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
                  +  +M+   +C   +  +RPT  ++ + L E I  
Sbjct: 409 D-GCPPAVYDVMK---NCWHLDAATRPTFLQLREQL-EHIRT 445

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  124 bits (313), Expect = 2e-31
 Identities = 70/279 (25%), Positives = 111/279 (39%), Gaps = 40/279 (14%)

Query: 646 IGKGGHGSVYRA--KVPSGEIF--AVKKFHSPLPGEMS--FQQEEFLNEIQALTEIRHRN 699
           +G G  G V R     PSG+    AVK      P  +S     ++F+ E+ A+  + HRN
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLK---PDVLSQPEAMDDFIREVNAMHSLDHRN 82

Query: 700 IVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHN 759
           +++ YG    P    ++ E    GSL   L                    VA+ + YL +
Sbjct: 83  LIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLES 139

Query: 760 NCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV-----APE 814
             F   +HRD++++N+LL       + DFG+ + L  +  ++      H  V     APE
Sbjct: 140 KRF---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYV--MQEHRKVPFAWCAPE 194

Query: 815 LAYTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEMLDSRLPYP---- 869
              T   +   D + FGV   E+   G+ P      ++ S     I+    RLP P    
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI---GLNGSQILHKIDKEGERLPRPEDCP 251

Query: 870 -SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCE 907
             ++      ++M     C    PE RPT   +   L E
Sbjct: 252 QDIY------NVMV---QCWAHKPEDRPTFVALRDFLLE 281

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  123 bits (312), Expect = 2e-31
 Identities = 69/283 (24%), Positives = 124/283 (43%), Gaps = 45/283 (15%)

Query: 643 EHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVK 702
              +G G  G V+          AVK       G MS   + FL E   + +++H+ +V+
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMS--PDAFLAEANLMKQLQHQRLVR 72

Query: 703 FYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
            Y   +  +  +II EY+E+GSL   L    S  +L   + L++   +A+ + ++    +
Sbjct: 73  LYAVVTQ-EPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 130

Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPD----SSN------WSELAGTHGYVA 812
              +HRD+ + N+L+       ++DFG+A+ +  +             W+         A
Sbjct: 131 ---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT---------A 178

Query: 813 PELAYTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMN-IEMLDS--RLPY 868
           PE       T K DV+SFG+L  E++  G+ P   +       +N   I+ L+   R+  
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-------TNPEVIQNLERGYRMVR 231

Query: 869 PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
           P  +  ++L  +M+    C  + PE RPT   +  +L E  F 
Sbjct: 232 PD-NCPEELYQLMR---LCWKERPEDRPTFDYLRSVL-EDFFT 269

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  125 bits (316), Expect = 2e-31
 Identities = 69/279 (24%), Positives = 125/279 (44%), Gaps = 43/279 (15%)

Query: 640 FNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQ-EEFLNEIQALTEIRH 697
           F+    IG G  G+VY A+ V + E+ A+KK      G+ S ++ ++ + E++ L ++RH
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKM--SYSGKQSNEKWQDIIKEVRFLQKLRH 113

Query: 698 RNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYL 757
            N +++ G       ++++ EY    + D +  +    +E    +   V  G    L YL
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQE---VEIAAVTHGALQGLAYL 170

Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAY 817
           H++    ++HRD+ + N+LL       + DFG A  + P +S      GT  ++APE+  
Sbjct: 171 HSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS----FVGTPYWMAPEVIL 223

Query: 818 TLKVTE---KCDVYSFGVLALEVIKGK------HPRDFLFEMSSSSSNMNIEMLDSRLPY 868
            +   +   K DV+S G+  +E+ + K      +    L+ ++ +               
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-------------ES 270

Query: 869 PSLHVQKKLMSIMQVAF--SCLDQNPESRPTMKRVSQLL 905
           P+L       S     F  SCL + P+ RPT      LL
Sbjct: 271 PALQSGH--WSEYFRNFVDSCLQKIPQDRPT---SEVLL 304

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  124 bits (313), Expect = 3e-31
 Identities = 64/282 (22%), Positives = 108/282 (38%), Gaps = 42/282 (14%)

Query: 646 IGKGGHGSVYRAK-VPSGEIF----AVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNI 700
           +G G  G+VY+   +P GE      A+K+             +E L+E   +  + + ++
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDEAYVMASVDNPHV 79

Query: 701 VKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
            +  G C       +I + +  G L   +        +G    LN    +A  + YL + 
Sbjct: 80  CRLLGICLTST-VQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLEDR 136

Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV-----APEL 815
                VHRD++++NVL+       ++DFG+AK L  +     E     G V     A E 
Sbjct: 137 RL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE---KEYHAEGGKVPIKWMALES 190

Query: 816 AYTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEMLDS-----RLPYP 869
                 T + DV+S+GV   E++  G  P D    +         E+        RLP P
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD---GIP------ASEISSILEKGERLPQP 241

Query: 870 SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
                  +  IM     C   + +SRP  + +      K+  
Sbjct: 242 P-ICTIDVYMIMV---KCWMIDADSRPKFRELIIEF-SKMAR 278

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  124 bits (314), Expect = 4e-31
 Identities = 69/306 (22%), Positives = 114/306 (37%), Gaps = 53/306 (17%)

Query: 638 NDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
           +DF     +G G  G V++    PSG + A K  H  +   +   + + + E+Q L E  
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI---RNQIIRELQVLHECN 89

Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE--LGWTQRLNVIKGVADAL 754
              IV FYG         I  E+++ GSLD++L       E  LG      V   V   L
Sbjct: 90  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGL 144

Query: 755 FYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPE 814
            YL       I+HRD+   N+L++   E  + DFG++  L    S  +   GT  Y++PE
Sbjct: 145 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFVGTRSYMSPE 200

Query: 815 LAYTLKVTEKCDVYSFGVLALEVIKGKHP--------------RDFLFEMSSSSSNMNIE 860
                  + + D++S G+  +E+  G++P                   + + +       
Sbjct: 201 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260

Query: 861 MLDSRLPYPSLHVQKKLMSIMQV------------AFS---------CLDQNPESRPTMK 899
                           +  ++               FS         CL +NP  R  +K
Sbjct: 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 320

Query: 900 RVSQLL 905
              QL+
Sbjct: 321 ---QLM 323

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  123 bits (310), Expect = 4e-31
 Identities = 57/292 (19%), Positives = 109/292 (37%), Gaps = 46/292 (15%)

Query: 637 TNDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI 695
           T +F+    IG G  GSV++  K   G I+A+K+  S  P   S  ++  L E+ A   +
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR--SKKPLAGSVDEQNALREVYAHAVL 67

Query: 696 -RHRNIVKFYGFCSHPKHSFIIYEYLESGSL-DKILCNDASAKELGWTQRLNVIKGVADA 753
            +H ++V+++   +   H  I  EY   GSL D I  N          +  +++  V   
Sbjct: 68  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127

Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVS-------------------DFGIAKFL 794
           L Y+H+     +VH DI   N+ +      + +                   D G    +
Sbjct: 128 LRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184

Query: 795 NPDSSNWSELAGTHGYVAPE-LAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS 853
           +          G   ++A E L        K D+++  +  +     +            
Sbjct: 185 SSPQV----EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL--------PR 232

Query: 854 SSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
           + +   E+   RLP     + ++   +++     +  +PE RP+      L+
Sbjct: 233 NGDQWHEIRQGRLPRIPQVLSQEFTELLK---VMIHPDPERRPS---AMALV 278

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  123 bits (311), Expect = 4e-31
 Identities = 56/272 (20%), Positives = 99/272 (36%), Gaps = 31/272 (11%)

Query: 639 DFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-R 696
            F     +G G +G V++      G ++AVK+  S  P      +   L E+ +  ++ +
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKR--SMSPFRGPKDRARKLAEVGSHEKVGQ 115

Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFY 756
           H   V+           ++  E     SL +    +A    L   Q    ++    AL +
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTELCG-PSLQQHC--EAWGASLPEAQVWGYLRDTLLALAH 172

Query: 757 LHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL- 815
           LH+     +VH D+   N+ L       + DFG+   L    +   +  G   Y+APEL 
Sbjct: 173 LHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE-GDPRYMAPELL 228

Query: 816 --AYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHV 873
             +Y        DV+S G+  LEV                     +        + +  +
Sbjct: 229 QGSYG----TAADVFSLGLTILEVACNMELPHGGEGWQ------QLRQGYLPPEFTA-GL 277

Query: 874 QKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
             +L S++      L+ +P+ R T      LL
Sbjct: 278 SSELRSVLV---MMLEPDPKLRAT---AEALL 303

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  123 bits (310), Expect = 5e-31
 Identities = 77/296 (26%), Positives = 126/296 (42%), Gaps = 52/296 (17%)

Query: 638 NDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQ-EEFLNEIQALTEI 695
           +D+  +  IG G    V  A   P  E  A+K+    +  E      +E L EIQA+++ 
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKR----INLEKCQTSMDELLKEIQAMSQC 70

Query: 696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLN------VIKG 749
            H NIV +Y         +++ + L  GS+  I+     AK    +  L+      +++ 
Sbjct: 71  HHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDII-KHIVAKGEHKSGVLDESTIATILRE 129

Query: 750 VADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELA---- 805
           V + L YLH N     +HRD+ + N+LL       ++DFG++ FL     + +       
Sbjct: 130 VLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLA-TGGDITRNKVRKT 185

Query: 806 --GTHGYVAPEL-----AYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMN 858
             GT  ++APE+      Y      K D++SFG+ A+E+  G  P     +       M 
Sbjct: 186 FVGTPCWMAPEVMEQVRGY----DFKADIWSFGITAIELATGAAP---YHKYPP----MK 234

Query: 859 IEMLDSRLPYPSLHVQKKLMSIMQVAFS---------CLDQNPESRPTMKRVSQLL 905
           + ML  +   PSL         M   +          CL ++PE RPT    ++LL
Sbjct: 235 VLMLTLQNDPPSLE-TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT---AAELL 286

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  125 bits (316), Expect = 7e-31
 Identities = 65/296 (21%), Positives = 125/296 (42%), Gaps = 49/296 (16%)

Query: 638 NDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-R 696
           N   +E  +G G  G+V       G   AVK+        +    +  L EI+ LTE   
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRM-------LIDFCDIALMEIKLLTESDD 67

Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQR----LNVIKGVAD 752
           H N++++Y   +  +  +I  E     +L  ++ +   + E    Q+    +++++ +A 
Sbjct: 68  HPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126

Query: 753 ALFYLHNNCFPPIVHRDISSKNVLLDLGYEAH-------------VSDFGIAKFLNPDSS 799
            + +LH+     I+HRD+  +N+L+                    +SDFG+ K L+   S
Sbjct: 127 GVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183

Query: 800 NW----SELAGTHGYVAPEL-------AYTLKVTEKCDVYSFGVLALEVI-KGKHP--RD 845
           ++    +  +GT G+ APEL           ++T   D++S G +   ++ KGKHP    
Sbjct: 184 SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243

Query: 846 FLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
           +  E +      +++ +        +     L+S        +D +P  RPT  +V
Sbjct: 244 YSRESNIIRGIFSLDEMKCLHDRSLIAEATDLIS------QMIDHDPLKRPTAMKV 293

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  127 bits (321), Expect = 8e-31
 Identities = 49/292 (16%), Positives = 99/292 (33%), Gaps = 33/292 (11%)

Query: 196 SIPRSLGNLTHVVILYLYNN--SFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLT 253
           SI   + N   +     YN     +          +         N+    +   +  + 
Sbjct: 2   SIMLPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--IN 59

Query: 254 NLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYL 313
               L L    LS  +P  +    ++  L + +N    ++P+   +L     L    N L
Sbjct: 60  QFSELQLNRLNLS-SLPDNLP--PQITVLEITQNALI-SLPELPASLE---YLDACDNRL 112

Query: 314 TGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESL 373
           +  + E      +L  +D+ NN     +L +      L  ++   N ++  +P       
Sbjct: 113 S-TLPELPA---SLKHLDVDNNQL--TMLPEL--PALLEYINADNNQLT-MLPELPT--- 160

Query: 374 QLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLE----YLDLS 429
            L+ L + +N +   +P    +   L  L +S N L   +P       + E    +    
Sbjct: 161 SLEVLSVRNNQL-TFLPELPES---LEALDVSTNLLES-LPAVPVRNHHSEETEIFFRCR 215

Query: 430 ANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFL 481
            N +++ +PE++ SL     + L  N LS +I   L       +      + 
Sbjct: 216 ENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYF 266

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  125 bits (314), Expect = 6e-30
 Identities = 55/345 (15%), Positives = 114/345 (33%), Gaps = 35/345 (10%)

Query: 220 SIPQEIGNLKSLFDLEL--CINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLK 277
           SI   I N  SL        I+        +              NE   ++ +    + 
Sbjct: 2   SIMLPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKE--CLIN 59

Query: 278 KLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSF 337
           + + L L + +   ++P +      +  L + QN L  ++ E      +L ++D  +N  
Sbjct: 60  QFSELQLNRLNLS-SLPDNL--PPQITVLEITQNALI-SLPELPA---SLEYLDACDNRL 112

Query: 338 FGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNII 397
               L +      L  LDV  N ++  +P        L+Y++  +N +   +P    +  
Sbjct: 113 --STLPE--LPASLKHLDVDNNQLT-MLPELPA---LLEYINADNNQLT-MLPELPTS-- 161

Query: 398 YLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKL----YYLNLS 453
            L  LS+  N+L+  +P       +LE LD+S N L + +P              +    
Sbjct: 162 -LEVLSVRNNQLT-FLPELPE---SLEALDVSTNLLES-LPAVPVRNHHSEETEIFFRCR 215

Query: 454 HNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCF 513
            N+++  IP  + +L     + L  N L  +I   + +  +    +     +   +    
Sbjct: 216 ENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHG--PRIYFSMSDGQ 272

Query: 514 EEMHGLLHIDISYNKLEGQIPNSTTFRDAPLEALQGNKGLYGDIR 558
           +        D           +  +      E  +        + 
Sbjct: 273 QNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAFLD 317

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  119 bits (300), Expect = 4e-28
 Identities = 65/370 (17%), Positives = 126/370 (34%), Gaps = 43/370 (11%)

Query: 90  NLTSISLNGTLL-EFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQ 148
             + + LN   L     +  P +  L++  N L   +P   ++L   EYLD   N+L   
Sbjct: 60  QFSELQLNRLNLSSLPDNLPPQITVLEITQNAL-ISLPELPASL---EYLDACDNRL-ST 114

Query: 149 IPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVV 208
           +P    L   L  L +  N L+  +P     L  +N    D+N L   +P    +L    
Sbjct: 115 LPE---LPASLKHLDVDNNQLT-MLPELPALLEYIN---ADNNQLT-MLPELPTSLEV-- 164

Query: 209 ILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLR----FLFLYHNE 264
            L + NN     +P+   +L++L    +  N L  ++P       +      F     N 
Sbjct: 165 -LSVRNNQL-TFLPELPESLEALD---VSTNLLE-SLPAVPVRNHHSEETEIFFRCRENR 218

Query: 265 LSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTY 324
           ++ I P+ I +L    +++L  N     + +S    T        + Y + +  +    +
Sbjct: 219 ITHI-PENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLH 277

Query: 325 PNL-----TFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLD 379
             L      +   +  S   +I   +      +     ++ +S ++        + Q   
Sbjct: 278 RPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAFLDRLSDTVSARNTSGFREQ--- 334

Query: 380 LSSNYIVGEIPTQLGNIIYL--NRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFV 437
                 V     +L     L     +++ +    C  R   +  NL    L         
Sbjct: 335 ------VAAWLEKLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLLVHQASEGLF 388

Query: 438 PESLGSLVKL 447
               G+L+ L
Sbjct: 389 DNDTGALLSL 398

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  118 bits (297), Expect = 8e-28
 Identities = 60/342 (17%), Positives = 118/342 (34%), Gaps = 35/342 (10%)

Query: 110 HLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWL 169
                    NE   ++      ++    L  +   L   +P  +     +TVL I++N L
Sbjct: 38  KQALPGENRNEAVSLLK--ECLINQFSELQLNRLNL-SSLPDNLP--PQITVLEITQNAL 92

Query: 170 SGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLK 229
             S+P     L  L+      N L+ ++P    +L H   L + NN     +P+    L+
Sbjct: 93  I-SLPELPASLEYLD---ACDNRLS-TLPELPASLKH---LDVDNNQ-LTMLPELPALLE 143

Query: 230 SLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHF 289
               +    NQL+  +P      T+L  L + +N+L+  +P+   +L+ L+   ++ N  
Sbjct: 144 Y---INADNNQLT-MLP---ELPTSLEVLSVRNNQLTF-LPELPESLEALD---VSTNLL 192

Query: 290 RGTVPKSFRNLTDL----VKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDW 345
             ++P             +  R  +N +T +I E   +      I L +N          
Sbjct: 193 E-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPL--SSRIRE 248

Query: 346 GRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLS 405
               Q +  D     I  S+      +L     D  + +      + +  I +       
Sbjct: 249 SLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEH 308

Query: 406 GNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKL 447
            N  S  +   L   ++          ++    E L +  +L
Sbjct: 309 ANTFSAFL-DRLSDTVSARNTSGFREQVAA-WLEKLSASAEL 348

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 48.8 bits (116), Expect = 6e-06
 Identities = 36/232 (15%), Positives = 68/232 (29%), Gaps = 16/232 (6%)

Query: 90  NLTSISLNGTLLE---FSFSSFPHL----VYLDLYNNELFGIIPPQISNLSNLEYLDFSA 142
           +L ++ ++  LLE          H     ++     N +   IP  I +L     +    
Sbjct: 181 SLEALDVSTNLLESLPAVPVRNHHSEETEIFFRCRENRI-THIPENILSLDPTCTIILED 239

Query: 143 NKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLG 202
           N L  +I   +   T     H  R + S S   +             + +   +    + 
Sbjct: 240 NPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ--NTLHRPLADAVTAWFPENKQSDVS 297

Query: 203 NLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRF-LFLY 261
            + H      + N+F  +    + +  S  +      Q++ A    +S    LR   F  
Sbjct: 298 QIWHAFEHEEHANTFS-AFLDRLSDTVSARNTSGFREQVA-AWLEKLSASAELRQQSFAV 355

Query: 262 HNELSGIIPQEIG-NLKKLNSLLLAKNHFRGTVPKSFRNLTDLVK--LRLNQ 310
             + +      +      L   LL      G        L  L +   RL  
Sbjct: 356 AADATESCEDRVALTWNNLRKTLLVHQASEGLFDNDTGALLSLGREMFRLEI 407

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  121 bits (306), Expect = 9e-31
 Identities = 71/283 (25%), Positives = 113/283 (39%), Gaps = 40/283 (14%)

Query: 643 EHCIGKGGHGSVYRA--KVPSGEIF--AVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHR 698
             CIG+G  G V++     P       A+K             +E+FL E   + +  H 
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK---NCTSDSVREKFLQEALTMRQFDHP 76

Query: 699 NIVKFYGFCS-HPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYL 757
           +IVK  G  + +P   +II E    G L   L        L     +     ++ AL YL
Sbjct: 77  HIVKLIGVITENPV--WIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYL 132

Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV-----A 812
            +  F   VHRDI+++NVL+       + DFG+++++       +    + G +     A
Sbjct: 133 ESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS----TYYKASKGKLPIKWMA 185

Query: 813 PELAYTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMN-IEMLDS--RLPY 868
           PE     + T   DV+ FGV   E++  G  P      +     N + I  +++  RLP 
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEILMHGVKP---FQGV----KNNDVIGRIENGERLPM 238

Query: 869 PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
           P  +    L S+M     C   +P  RP    +   L   I E
Sbjct: 239 PP-NCPPTLYSLMT---KCWAYDPSRRPRFTELKAQL-STILE 276

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  123 bits (311), Expect = 1e-30
 Identities = 56/318 (17%), Positives = 100/318 (31%), Gaps = 58/318 (18%)

Query: 637 TNDFNAEHCIGKGGH--GSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALT 693
              +     IGKG     +V  A+  P+GE   V++    L    +        E+    
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRI--NLEACSNEMVTFLQGELHVSK 81

Query: 694 EIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADA 753
              H NIV +          +++  ++  GS   ++C       +       +++GV  A
Sbjct: 82  LFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICT-HFMDGMNELAIAYILQGVLKA 140

Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL-------NPDSSNWSELAG 806
           L Y+H+      VHR + + ++L+ +  + ++S       +                   
Sbjct: 141 LDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197

Query: 807 THGYVAPELAYTLKV--TEKCDVYSFGVLALEVIKGK------HPRDFLFEM-------- 850
              +++PE+          K D+YS G+ A E+  G            L E         
Sbjct: 198 VLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257

Query: 851 --------------SSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFS---------C 887
                          S S   +          P               FS         C
Sbjct: 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQC 317

Query: 888 LDQNPESRPTMKRVSQLL 905
           L +NP++RP+    S LL
Sbjct: 318 LQRNPDARPS---ASTLL 332

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  121 bits (306), Expect = 1e-30
 Identities = 63/256 (24%), Positives = 115/256 (44%), Gaps = 19/256 (7%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G GG  +VY A+        A+K    P   +     + F  E+   +++ H+NIV   
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETL-KRFEREVHNSSQLSHQNIVSMI 77

Query: 705 GFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP 764
                    +++ EY+E  +L + +    S   L     +N    + D + + H+     
Sbjct: 78  DVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAHDM---R 131

Query: 765 IVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS-SNWSELAGTHGYVAPELAYTLKVTE 823
           IVHRDI  +N+L+D      + DFGIAK L+  S +  + + GT  Y +PE A      E
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDE 191

Query: 824 KCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEM--LDSRLPYPSLHVQKKL-MSI 880
             D+YS G++  E++ G+ P    F      + ++I +  +   +P  +  V+K +  S+
Sbjct: 192 CTDIYSIGIVLYEMLVGEPP----FN---GETAVSIAIKHIQDSVPNVTTDVRKDIPQSL 244

Query: 881 MQVAFSCLDQNPESRP 896
             V     +++  +R 
Sbjct: 245 SNVILRATEKDKANRY 260

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  121 bits (306), Expect = 2e-30
 Identities = 74/284 (26%), Positives = 126/284 (44%), Gaps = 36/284 (12%)

Query: 637 TNDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI 695
              F     +G G +G VY+ + V +G++ A+K     + G+   ++EE   EI  L + 
Sbjct: 23  AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM--DVTGD---EEEEIKQEINMLKKY 77

Query: 696 -RHRNIVKFYG------FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIK 748
             HRNI  +YG              +++ E+  +GS+  ++  +     L       + +
Sbjct: 78  SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI-KNTKGNTLKEEWIAYICR 136

Query: 749 GVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH 808
            +   L +LH +    ++HRDI  +NVLL    E  + DFG++  L+      +   GT 
Sbjct: 137 EILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTP 193

Query: 809 GYVAPELAYTLKVTE-----KCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLD 863
            ++APE+    +  +     K D++S G+ A+E+ +G  P   L +M      M    L 
Sbjct: 194 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP---LCDMHP----MRALFLI 246

Query: 864 SRLPYPSLHVQKKLMSIMQ--VAFSCLDQNPESRPTMKRVSQLL 905
            R P P L   KK     Q  +  SCL +N   RP  +   QL+
Sbjct: 247 PRNPAPRLK-SKKWSKKFQSFIE-SCLVKNHSQRPATE---QLM 285

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  121 bits (305), Expect = 3e-30
 Identities = 68/285 (23%), Positives = 114/285 (40%), Gaps = 42/285 (14%)

Query: 643 EHCIGKGGHGSVYRAK-VPSGEIF----AVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH 697
              +G G  G+V++   +P GE       +K       G  SF  +   + + A+  + H
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK-SGRQSF--QAVTDHMLAIGSLDH 74

Query: 698 RNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYL 757
            +IV+  G C       ++ +YL  GSL   +        LG    LN    +A  ++YL
Sbjct: 75  AHIVRLLGLCPGSSL-QLVTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYL 131

Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV-----A 812
             +     VHR+++++NVLL    +  V+DFG+A  L PD     +L  +         A
Sbjct: 132 EEHGM---VHRNLAARNVLLKSPSQVQVADFGVADLLPPDD---KQLLYSEAKTPIKWMA 185

Query: 813 PELAYTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEMLDS-----RL 866
            E  +  K T + DV+S+GV   E++  G  P      +         E+ D      RL
Sbjct: 186 LESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYA---GLR------LAEVPDLLEKGERL 236

Query: 867 PYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
             P       +  +M     C   +   RPT K ++     ++  
Sbjct: 237 AQPQ-ICTIDVYMVMV---KCWMIDENIRPTFKELANEF-TRMAR 276

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  118 bits (299), Expect = 1e-29
 Identities = 53/236 (22%), Positives = 91/236 (38%), Gaps = 8/236 (3%)

Query: 108 FPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKL-FGQIPSGIGL-LTHLTVLHIS 165
                 L+L +N+L  +       L+ L  L  S+N L F    S      T L  L +S
Sbjct: 27  PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS 86

Query: 166 RNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSL-GNLTHVVILYLYNNSFFGSIPQE 224
            N +  ++      L  L  L    + L      S+  +L +++ L + +          
Sbjct: 87  FNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT-RVAFNG 144

Query: 225 I-GNLKSLFDLELCINQLSGAIPLSI-SNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSL 282
           I   L SL  L++  N         I + L NL FL L   +L  + P    +L  L  L
Sbjct: 145 IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 204

Query: 283 LLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETF-GTYPNLTFIDLSNNSF 337
            ++ N+F       ++ L  L  L  + N++  +  +       +L F++L+ N F
Sbjct: 205 NMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 260

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  117 bits (294), Expect = 7e-29
 Identities = 58/242 (23%), Positives = 93/242 (38%), Gaps = 29/242 (11%)

Query: 292 TVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQL 351
           +VP      +   +L L  N L       F     LT + LS+N               L
Sbjct: 21  SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSN--------------GL 64

Query: 352 SLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSG 411
           S       +  G+          L+YLDLS N ++  + +    +  L  L    + L  
Sbjct: 65  SFKGCCSQSDFGTT--------SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQ 115

Query: 412 CIPREL-GSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIE-LDNLI 469
                +  SL NL YLD+S  +           L  L  L ++ N   +    +    L 
Sbjct: 116 MSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELR 175

Query: 470 HLSELDLSHNFLGEKISSRI-CRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNK 528
           +L+ LDLS   L E++S      + SL+ LN+S+NN   L    ++ ++ L  +D S N 
Sbjct: 176 NLTFLDLSQCQL-EQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH 234

Query: 529 LE 530
           + 
Sbjct: 235 IM 236

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  116 bits (293), Expect = 8e-29
 Identities = 63/269 (23%), Positives = 99/269 (36%), Gaps = 34/269 (12%)

Query: 244 AIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNH--FRGTVPKSFRNLT 301
           ++P  I   ++   L L  N+L  +       L +L  L L+ N   F+G   +S    T
Sbjct: 21  SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78

Query: 302 DLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNI 361
            L  L L+ N +   +S  F     L  +D  +++   + +S++     L          
Sbjct: 79  SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNL--KQMSEFSVFLSLR--------- 126

Query: 362 SGSIPLEIGESLQLQYLDLSSNYIVGEIPTQ-LGNIIYLNRLSLSGNKLSGCIPRE-LGS 419
                        L YLD+S  +            +  L  L ++GN        +    
Sbjct: 127 ------------NLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 173

Query: 420 LINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHN 479
           L NL +LDLS   L    P +  SL  L  LN+SHN            L  L  LD S N
Sbjct: 174 LRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN 233

Query: 480 FLGEKISSRICR--MESLEKLNLSYNNLS 506
            +      +  +    SL  LNL+ N+ +
Sbjct: 234 HI-MTSKKQELQHFPSSLAFLNLTQNDFA 261

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  119 bits (301), Expect = 2e-29
 Identities = 68/268 (25%), Positives = 113/268 (42%), Gaps = 35/268 (13%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVK---KFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIV 701
           +GKGG    +      + E+FA K   K     P     Q+E+   EI     + H+++V
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPH----QREKMSMEISIHRSLAHQHVV 104

Query: 702 KFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNC 761
            F+GF       F++ E     SL ++     +  E     R   ++ +     YLH N 
Sbjct: 105 GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTE--PEAR-YYLRQIVLGCQYLHRNR 161

Query: 762 FPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL----AY 817
              ++HRD+   N+ L+   E  + DFG+A  +  D      L GT  Y+APE+     +
Sbjct: 162 ---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 218

Query: 818 TLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNM--NIEMLDSRLPYPSLHVQK 875
           + +V    DV+S G +   ++ GK P    FE +S        I+  +  +P     V  
Sbjct: 219 SFEV----DVWSIGCIMYTLLVGKPP----FE-TSCLKETYLRIKKNEYSIPKHINPVAA 269

Query: 876 KLMSIMQVAFSCLDQNPESRPTMKRVSQ 903
            L+  M      L  +P +RPT+  +  
Sbjct: 270 SLIQKM------LQTDPTARPTINELLN 291

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  118 bits (298), Expect = 2e-29
 Identities = 45/201 (22%), Positives = 79/201 (39%), Gaps = 11/201 (5%)

Query: 646 IGKGGHGSVYRAKVPS-GEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G+GG G VY A+      I A+K     L  +  F+      E +    ++  ++V  +
Sbjct: 42  VGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFR-TRMQREARTAGRLQEPHVVPIH 100

Query: 705 GFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP 764
            F       ++    +    L  +L        L   + + +++ +  AL   H      
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAHAA---G 154

Query: 765 IVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSS--NWSELAGTHGYVAPELAYTLKVT 822
             HRD+  +N+L+     A++ DFGIA     D          GT  Y+APE       T
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATT-DEKLTQLGNTVGTLYYMAPERFSESHAT 213

Query: 823 EKCDVYSFGVLALEVIKGKHP 843
            + D+Y+   +  E + G  P
Sbjct: 214 YRADIYALTCVLYECLTGSPP 234

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  117 bits (296), Expect = 3e-29
 Identities = 68/266 (25%), Positives = 113/266 (42%), Gaps = 31/266 (11%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVK-KFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKF 703
           +GKGG    +      + E+FA K    S L      Q+E+   EI     + H+++V F
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLL--LKPHQREKMSMEISIHRSLAHQHVVGF 80

Query: 704 YGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFP 763
           +GF       F++ E     SL ++     +  E     R   ++ +     YLH N   
Sbjct: 81  HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTE--PEAR-YYLRQIVLGCQYLHRNR-- 135

Query: 764 PIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL----AYTL 819
            ++HRD+   N+ L+   E  + DFG+A  +  D      L GT  Y+APE+     ++ 
Sbjct: 136 -VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSF 194

Query: 820 KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNM--NIEMLDSRLPYPSLHVQKKL 877
           +V    DV+S G +   ++ GK P    FE +S        I+  +  +P     V   L
Sbjct: 195 EV----DVWSIGCIMYTLLVGKPP----FE-TSCLKETYLRIKKNEYSIPKHINPVAASL 245

Query: 878 MSIMQVAFSCLDQNPESRPTMKRVSQ 903
           +  M      L  +P +RPT+  +  
Sbjct: 246 IQKM------LQTDPTARPTINELLN 265

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  119 bits (300), Expect = 3e-29
 Identities = 33/292 (11%), Positives = 65/292 (22%), Gaps = 47/292 (16%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +  G    V+  + V   E FA+K F        S   E       A   +   +  +  
Sbjct: 70  LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSEL-ERLHEATFAAARLLGESPEEAR 128

Query: 705 GFC------------SHPK--------------HSFIIYEYLESGSLDKILCNDASAKE- 737
                          S P               +  ++               D      
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188

Query: 738 --LGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN 795
              G      +   +      L +     +VH   +  N+ +       + D        
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALW--- 242

Query: 796 PDSSNWSELAGTHGYVAPEL--AYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS 853
              +     +    Y   E   A T   T   + +  G+    V     P    F + + 
Sbjct: 243 KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP----FGLVTP 298

Query: 854 SSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFS----CLDQNPESRPTMKRV 901
               + +    R+P            +     +     L+ +   R      
Sbjct: 299 GIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEA 350

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  118 bits (297), Expect = 4e-29
 Identities = 75/328 (22%), Positives = 120/328 (36%), Gaps = 53/328 (16%)

Query: 608 QQSSFGNTPGLRSVLTFEGKIVYEEIISATNDFNAEHCIGKGGHGSVYRAK-VPSGEIFA 666
              S G   G R    F G+ V  E+            + +GG   VY A+ V SG  +A
Sbjct: 3   GPGSLGGASG-RDQSDFVGQTV--EL--GELRLRVRRVLAEGGFAFVYEAQDVGSGREYA 57

Query: 667 VKKFHSPLPGEMSFQQEEFLNEIQALTEIR-HRNIVKFYGFCSHPKHS-------FIIYE 718
           +K+    L      +    + E+  + ++  H NIV+F    S  K         F++  
Sbjct: 58  LKR----LLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLT 113

Query: 719 YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLD 778
            L  G L + L    S   L     L +      A+ ++H    PPI+HRD+  +N+LL 
Sbjct: 114 ELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLS 172

Query: 779 LGYEAHVSDFGIAKFLNPDSSNWSELA------------GTHGYVAPELAYTLK---VTE 823
                 + DFG A  ++                       T  Y  PE+        + E
Sbjct: 173 NQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGE 232

Query: 824 KCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQ----KKLMS 879
           K D+++ G +   +   +HP    FE     + + I  ++ +   P    Q      L+ 
Sbjct: 233 KQDIWALGCILYLLCFRQHP----FE---DGAKLRI--VNGKYSIPPHDTQYTVFHSLIR 283

Query: 880 IMQVAFSCLDQNPESRPTMKRVSQLLCE 907
            M      L  NPE R ++  V   L E
Sbjct: 284 AM------LQVNPEERLSIAEVVHQLQE 305

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  116 bits (292), Expect = 7e-29
 Identities = 74/268 (27%), Positives = 122/268 (45%), Gaps = 25/268 (9%)

Query: 638 NDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
            DF     +GKG  G+VY A+   S  I A+K        +    + +   E++  + +R
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLR 67

Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFY 756
           H NI++ YG+       ++I EY   G++ + L   +   E         I  +A+AL Y
Sbjct: 68  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE--QRTA-TYITELANALSY 124

Query: 757 LHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELA 816
            H+     ++HRDI  +N+LL    E  ++DFG +      SS  ++L GT  Y+ PE+ 
Sbjct: 125 CHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA--PSSRRTDLCGTLDYLPPEMI 179

Query: 817 YTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNM--NIEMLDSRLPYPSLHVQ 874
                 EK D++S GVL  E + GK P    FE +++       I  ++   P   +   
Sbjct: 180 EGRMHDEKVDLWSLGVLCYEFLVGKPP----FE-ANTYQETYKRISRVEFTFP-DFVTEG 233

Query: 875 -KKLMSIMQVAFSCLDQNPESRPTMKRV 901
            + L+S +      L  NP  RP ++ V
Sbjct: 234 ARDLISRL------LKHNPSQRPMLREV 255

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  115 bits (291), Expect = 1e-28
 Identities = 62/275 (22%), Positives = 125/275 (45%), Gaps = 32/275 (11%)

Query: 638 NDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKK-FHSPLPGEMSFQQEEFLNEIQALTEI 695
            DF   + +GKG    VYRA+ + +G   A+K      +    +   +   NE++   ++
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAM--YKAGMVQRVQNEVKIHCQL 68

Query: 696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALF 755
           +H +I++ Y +     + +++ E   +G +++ L      K     +  + +  +   + 
Sbjct: 69  KHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLK--NRVKPFSENEARHFMHQIITGML 126

Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           YLH++    I+HRD++  N+LL       ++DFG+A  L         L GT  Y++PE+
Sbjct: 127 YLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEI 183

Query: 816 ----AYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNM--NIEMLDSRLPYP 869
               A+ L+     DV+S G +   ++ G+ P    F+ + +  N    + + D  +P  
Sbjct: 184 ATRSAHGLES----DVWSLGCMFYTLLIGRPP----FD-TDTVKNTLNKVVLADYEMP-S 233

Query: 870 SLHVQ-KKLMSIMQVAFSCLDQNPESRPTMKRVSQ 903
            L ++ K L+  +      L +NP  R ++  V  
Sbjct: 234 FLSIEAKDLIHQL------LRRNPADRLSLSSVLD 262

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  116 bits (293), Expect = 1e-28
 Identities = 62/294 (21%), Positives = 125/294 (42%), Gaps = 48/294 (16%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G+G   +V+R +   +G++FA+K F++          +  + E + L ++ H+NIVK +
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP---VDVQMREFEVLKKLNHKNIVKLF 73

Query: 705 GF--CSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
                +  +H  +I E+   GSL  +L   ++A  L  ++ L V++ V   + +L  N  
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG- 132

Query: 763 PPIVHRDISSKNVLLDLGYEAH----VSDFGIAKFLNPDSSNWSELAGTHGYVAPEL--- 815
             IVHR+I   N++  +G +      ++DFG A+ L  D   +  L GT  Y+ P++   
Sbjct: 133 --IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTEEYLHPDMYER 189

Query: 816 -----AYTLKVTEKCDVYSFGVLALEVIKGKHP----------RDFLFEMSSSSSNMNIE 860
                 +  K     D++S GV       G  P          ++ ++++ +   +  I 
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAIS 249

Query: 861 ML----------DSRLPYP---SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
            +             +P     S  +Q  L  ++    + L+ + E      + 
Sbjct: 250 GVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLA---NILEADQEKCWGFDQF 300

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  117 bits (295), Expect = 1e-28
 Identities = 50/269 (18%), Positives = 96/269 (35%), Gaps = 29/269 (10%)

Query: 90  NLTSISLNG----TLLEFSFSSFPHLVYLDLYNNELFGIIPPQI-SNLSNLEYLDFSANK 144
            + S+ L+      +         +L  L L +N +   I     S+L +LE+LD S N 
Sbjct: 53  AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGI-NTIEEDSFSSLGSLEHLDLSYNY 111

Query: 145 LFGQIPSGI-GLLTHLTVLHISRNWLSGSIPHEV--GQLTVLNQLALDSNFLNGSIPR-- 199
           L   + S     L+ LT L++  N    ++        LT L  L + +      I R  
Sbjct: 112 L-SNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKD 169

Query: 200 --SLGNLTHVVILYLYNNSFFGSIPQEI-GNLKSLFDLELCINQLSGAIPLSISNLTNLR 256
              L  L     L +  +    S   +   +++++  L L + Q    + + +   +++ 
Sbjct: 170 FAGLTFLEE---LEIDASD-LQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVE 225

Query: 257 FLFLYHNELSGIIPQEI--------GNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRL 308
            L L   +L      E+               ++ +        V K    ++ L++L  
Sbjct: 226 CLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEF 284

Query: 309 NQNYLTGNISETFGTYPNLTFIDLSNNSF 337
           ++N L       F    +L  I L  N +
Sbjct: 285 SRNQLKSVPDGIFDRLTSLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  115 bits (289), Expect = 7e-28
 Identities = 55/295 (18%), Positives = 109/295 (36%), Gaps = 35/295 (11%)

Query: 244 AIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDL 303
           +IP  ++    ++ L L +N ++ I   ++     L +L+L  N        SF +L  L
Sbjct: 45  SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSL 102

Query: 304 VKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISG 363
             L L+ NYL+   S  F    +LTF++L  N +              +L + S+ +   
Sbjct: 103 EHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPY-------------KTLGETSLFS--- 146

Query: 364 SIPLEIGESLQLQYLDLSSNYIVGEIPTQ-LGNIIYLNRLSLSGNKLSGCIPRELGSLIN 422
                     +LQ L + +     +I  +    + +L  L +  + L    P+ L S+ N
Sbjct: 147 -------HLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQN 199

Query: 423 LEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLS----QQIPI----ELDNLIHLSEL 474
           + +L L        +   +     +  L L    L      ++       L        +
Sbjct: 200 VSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNV 259

Query: 475 DLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKL 529
            ++   L + +   + ++  L +L  S N L  +    F+ +  L  I +  N  
Sbjct: 260 KITDESLFQ-VMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  112 bits (281), Expect = 7e-27
 Identities = 55/289 (19%), Positives = 106/289 (36%), Gaps = 41/289 (14%)

Query: 108 FPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGI-GLLTHLTVLHISR 166
              +  LDL NN +  I    +    NL+ L  ++N +   I       L  L  L +S 
Sbjct: 51  TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGI-NTIEEDSFSSLGSLEHLDLSY 109

Query: 167 NWLSGSIPHEV-GQLTVLNQLALDSNFLNGSIPRS--LGNLTHVVILYLYNNSFFGSIPQ 223
           N+LS ++       L+ L  L L  N    ++  +    +LT + IL + N   F  I +
Sbjct: 110 NYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQR 167

Query: 224 EIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLL 283
           +                         + LT L  L +  ++L    P+ + +++ ++ L+
Sbjct: 168 KD-----------------------FAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLI 204

Query: 284 LAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGN--------ISETFGTYPNLTFIDLSNN 335
           L        +       + +  L L    L            + +         + +++ 
Sbjct: 205 LHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDE 264

Query: 336 SFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESL-QLQYLDLSSN 383
           S F +++    +   L  L+ S N +  S+P  I + L  LQ + L +N
Sbjct: 265 SLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTN 311

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  109 bits (275), Expect = 4e-26
 Identities = 55/296 (18%), Positives = 108/296 (36%), Gaps = 27/296 (9%)

Query: 143 NKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEV-GQLTVLNQLALDSNFLNGSIPRSL 201
           +     IPSG+     +  L +S N ++  I +    +   L  L L SN +N     S 
Sbjct: 40  SGSLNSIPSGL--TEAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGINTIEEDSF 96

Query: 202 GNLTHVVILYLYNNSFFGSIPQEI-GNLKSLFDLELCINQLSGAIPLSI-SNLTNLRFLF 259
            +L  +  L L  N    ++       L SL  L L  N        S+ S+LT L+ L 
Sbjct: 97  SSLGSLEHLDLSYNY-LSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILR 155

Query: 260 LYHNE-LSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNIS 318
           + + +  + I  ++   L  L  L +  +  +   PKS +++ ++  L L+       + 
Sbjct: 156 VGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLE 215

Query: 319 ETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYL 378
                  ++  ++L +                  L     + +S      + +    + +
Sbjct: 216 IFVDVTSSVECLELRDT----------------DLDTFHFSELSTGETNSLIKKFTFRNV 259

Query: 379 DLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRE-LGSLINLEYLDLSANNL 433
            ++   +  ++   L  I  L  L  S N+L   +P      L +L+ + L  N  
Sbjct: 260 KITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 87.9 bits (218), Expect = 1e-18
 Identities = 36/217 (16%), Positives = 71/217 (32%), Gaps = 19/217 (8%)

Query: 90  NLTSISLNGTLLEF----SFSSFPHLVYLDLYNNELFGIIPPQI-SNLSNLEYLDFSANK 144
           +L  + L+   L       F     L +L+L  N    +    + S+L+ L+ L      
Sbjct: 101 SLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMD 160

Query: 145 LFGQIPSGI-GLLTHLTVLHISRNWLSGSIPHEV-GQLTVLNQLALDSNFLNGSIPR-SL 201
            F +I       LT L  L I  + L  S   +    +  ++ L L        +    +
Sbjct: 161 TFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHI-LLLEIFV 218

Query: 202 GNLTHVVILYLYNNSFFGSIPQEI--------GNLKSLFDLELCINQLSGAIPLSISNLT 253
              + V  L L +         E+            +  ++++    L   +   ++ ++
Sbjct: 219 DVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQIS 277

Query: 254 NLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFR 290
            L  L    N+L  +       L  L  + L  N + 
Sbjct: 278 GLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 314

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  116 bits (292), Expect = 1e-28
 Identities = 67/261 (25%), Positives = 110/261 (42%), Gaps = 24/261 (9%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G GG   V+ A+ +      AVK   + L  + SF    F  E Q    + H  IV  Y
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFY-LRFRREAQNAAALNHPAIVAVY 78

Query: 705 --GF--CSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
             G          +I+ EY++  +L  I+  +     +   + + VI     AL + H N
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQN 135

Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNW---SELAGTHGYVAPELAY 817
               I+HRD+   N+++       V DFGIA+ +    ++    + + GT  Y++PE A 
Sbjct: 136 ---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192

Query: 818 TLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEM--LDSRLPYPSLHVQK 875
              V  + DVYS G +  EV+ G+ P    F      S +++    +      PS   + 
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPP----FT---GDSPVSVAYQHVREDPIPPSARHEG 245

Query: 876 KLMSIMQVAFSCLDQNPESRP 896
               +  V    L +NPE+R 
Sbjct: 246 LSADLDAVVLKALAKNPENRY 266

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score =  116 bits (291), Expect = 2e-28
 Identities = 63/293 (21%), Positives = 99/293 (33%), Gaps = 24/293 (8%)

Query: 232 FDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRG 291
                C+      +     +L     L     E       +I     L  L +       
Sbjct: 25  SSAFNCLGAADVELYGGGRSLE--YLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPS 82

Query: 292 TVPKS---FRNLTDLVKLRLNQNYLTGNI--SETFGTYPNLTFIDLSNNSF--FGEILSD 344
            +         ++ L +L L    +TG         T P+L  ++L N S+      L++
Sbjct: 83  RILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAE 142

Query: 345 WGRCPQLSLLDVSI-NNISGSIPLEIGESLQ-LQYLDLSSNYIVGEI-------PTQLGN 395
             +  +  L  +SI    S +   E       L  LDLS N  +GE        P +   
Sbjct: 143 LQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPT 202

Query: 396 IIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGS-LVKLYYLNLSH 454
           +  L   +      SG       + + L+ LDLS N+L +           +L  LNLS 
Sbjct: 203 LQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSF 262

Query: 455 NKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSG 507
             L  Q+P  L     LS LDLS+N L    +     +  +  L+L  N    
Sbjct: 263 TGLK-QVPKGLPA--KLSVLDLSYNRLDR--NPSPDELPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 90.0 bits (223), Expect = 1e-19
 Identities = 41/219 (18%), Positives = 73/219 (33%), Gaps = 16/219 (7%)

Query: 327 LTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIV 386
           L  +D   +      +       +L++    I +      L +     LQ L L +  + 
Sbjct: 49  LKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT 108

Query: 387 GEIPTQLGNIIY--LNRLSLSGNKLSGCIPRELGSLIN-----LEYLDLSANNLSNFVPE 439
           G  P  L       LN L+L     +      L  L       L+ L ++  +  NF  E
Sbjct: 109 GTAPPPLLEATGPDLNILNLRNVSWAT-RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCE 167

Query: 440 SLGSLVKLYYLNLSHNKLSQQIPIE----LDNLIHLSELDLSHNF---LGEKISSRICRM 492
            +     L  L+LS N    +  +           L  L L +          S+     
Sbjct: 168 QVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAAR 227

Query: 493 ESLEKLNLSYNNLSGLIPR-CFEEMHGLLHIDISYNKLE 530
             L+ L+LS+N+L         +    L  +++S+  L+
Sbjct: 228 VQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK 266

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 89.6 bits (222), Expect = 1e-19
 Identities = 61/326 (18%), Positives = 92/326 (28%), Gaps = 46/326 (14%)

Query: 79  FCNHAERVVGINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYL 138
            CN ++     +     L    +E           L   + E        I    +L+ L
Sbjct: 14  SCNFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRL 73

Query: 139 DFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIP 198
              A ++         L   L VL IS                 L +L L++  + G+ P
Sbjct: 74  TVRAARI-----PSRILFGALRVLGISG----------------LQELTLENLEVTGTAP 112

Query: 199 RSLGNLTH--VVILYLYNNSF--FGSIPQEIGNL--KSLFDLELCINQLSGAIPLSISNL 252
             L   T   + IL L N S+    +   E+       L  L +            +   
Sbjct: 113 PPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVF 172

Query: 253 TNLRFLFLYHNELSGIIPQEI----GNLKKLNSLLLAKNHFR---GTVPKSFRNLTDLVK 305
             L  L L  N   G               L  L L         G           L  
Sbjct: 173 PALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQG 232

Query: 306 LRLNQNYLTGNISETFGTYP-NLTFIDLSNN---SFFGEILSDWGRCPQLSLLDVSINNI 361
           L L+ N L          +P  L  ++LS          +        +LS+LD+S N +
Sbjct: 233 LDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLP------AKLSVLDLSYNRL 286

Query: 362 SGSIPLEIGESLQLQYLDLSSNYIVG 387
               P    E  Q+  L L  N  + 
Sbjct: 287 D-RNPS-PDELPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 73.8 bits (181), Expect = 2e-14
 Identities = 44/249 (17%), Positives = 69/249 (27%), Gaps = 31/249 (12%)

Query: 48  SLEVHSRSLLHSWSLSSVNATKISPCAWSGIFCNHAERVVGINLTSISLNGTLLEFSFSS 107
           +L V   S L   +L ++  T  +P             +   N++  + +  L E     
Sbjct: 88  ALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWL 147

Query: 108 FPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGL----LTHLTVLH 163
            P L  L +           Q+     L  LD S N   G+      L       L VL 
Sbjct: 148 KPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLA 207

Query: 164 ISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQ 223
           +    +                        +G           +  L L +NS   +   
Sbjct: 208 LRNAGM---------------------ETPSGVCSALAAARVQLQGLDLSHNSLRDAAGA 246

Query: 224 EI-GNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSL 282
                   L  L L    L   +P  +     L  L L +N L          L ++ +L
Sbjct: 247 PSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRNPS--PDELPQVGNL 301

Query: 283 LLAKNHFRG 291
            L  N F  
Sbjct: 302 SLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 58.0 bits (140), Expect = 4e-09
 Identities = 21/156 (13%), Positives = 52/156 (33%), Gaps = 9/156 (5%)

Query: 402 LSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPES---LGSLVKLYYLNLSHNKLS 458
           L     +       ++   ++L+ L + A  + + +      +  +  L  L L + +++
Sbjct: 49  LKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT 108

Query: 459 QQIPIELDNLIH--LSELDLSHNFLGEKISS----RICRMESLEKLNLSYNNLSGLIPRC 512
              P  L       L+ L+L +     + +     +      L+ L+++  +        
Sbjct: 109 GTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQ 168

Query: 513 FEEMHGLLHIDISYNKLEGQIPNSTTFRDAPLEALQ 548
                 L  +D+S N   G+    +         LQ
Sbjct: 169 VRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQ 204

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  117 bits (295), Expect = 2e-28
 Identities = 67/285 (23%), Positives = 111/285 (38%), Gaps = 39/285 (13%)

Query: 643 EHCIGKGGHGSVYRA--KVPSGEIF--AVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHR 698
              IG+G  G VY        G+    AVK  +         +  +FL E   + +  H 
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN---RITDIGEVSQFLTEGIIMKDFSHP 150

Query: 699 NIVKFYGFCSHPKHS-FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYL 757
           N++   G C   + S  ++  Y++ G L   +              +     VA  + +L
Sbjct: 151 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKFL 208

Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV-----A 812
            +  F   VHRD++++N +LD  +   V+DFG+A+ +  D    S    T   +     A
Sbjct: 209 ASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMY-DKEFDSVHNKTGAKLPVKWMA 264

Query: 813 PELAYTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEMLDS-----RL 866
            E   T K T K DV+SFGVL  E++ +G  P     +++        ++        RL
Sbjct: 265 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPP---YPDVN------TFDITVYLLQGRRL 315

Query: 867 PYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
             P  +    L  +M     C     E RP+   +   +   IF 
Sbjct: 316 LQPE-YCPDPLYEVML---KCWHPKAEMRPSFSELVSRI-SAIFS 355

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  115 bits (291), Expect = 2e-28
 Identities = 72/283 (25%), Positives = 105/283 (37%), Gaps = 44/283 (15%)

Query: 646 IGKGGHGSVYRAKVPSGEIF------AVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRN 699
           +G G  G VY  +V            AVK             + +FL E   +++  H+N
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALIISKFNHQN 94

Query: 700 IVKFYGFCSHPKHSFIIYEYLESGSLDKILCN----DASAKELGWTQRLNVIKGVADALF 755
           IV+  G        FI+ E +  G L   L       +    L     L+V + +A    
Sbjct: 95  IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154

Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHV---SDFGIAKFLNPDSSNWSELAGTHGYV- 811
           YL  N F   +HRDI+++N LL       V    DFG+A+ +   S       G    + 
Sbjct: 155 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS---YYRKGGCAMLP 208

Query: 812 ----APE-LAYTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMN-IEMLDS 864
                PE        T K D +SFGVL  E+   G  P         S SN   +E + S
Sbjct: 209 VKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMP-------YPSKSNQEVLEFVTS 260

Query: 865 --RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
             R+  P  +    +  IM     C    PE RP    + + +
Sbjct: 261 GGRMDPPK-NCPGPVYRIMT---QCWQHQPEDRPNFAIILERI 299

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  117 bits (294), Expect = 2e-28
 Identities = 65/309 (21%), Positives = 130/309 (42%), Gaps = 52/309 (16%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G+G   +V+R +   +G++FA+K F++          +  + E + L ++ H+NIVK +
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP---VDVQMREFEVLKKLNHKNIVKLF 73

Query: 705 GF--CSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
                +  +H  +I E+   GSL  +L   ++A  L  ++ L V++ V   + +L  N  
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG- 132

Query: 763 PPIVHRDISSKNVLLDLGYEAH----VSDFGIAKFLNPDSSNWSELAGTHGYVAPEL--- 815
             IVHR+I   N++  +G +      ++DFG A+ L  D   +  L GT  Y+ P++   
Sbjct: 133 --IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTEEYLHPDMYER 189

Query: 816 -----AYTLKVTEKCDVYSFGVLALEVIKGKHP----------RDFLFEMSSSSSNMNIE 860
                 +  K     D++S GV       G  P          ++ ++++ +   +  I 
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAIS 249

Query: 861 ML----------DSRLPYP---SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRV----SQ 903
            +             +P     S  +Q  L  ++    + L+ + E      +     S 
Sbjct: 250 GVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLA---NILEADQEKCWGFDQFFAETSD 306

Query: 904 LLCEKIFEV 912
           +L   +  V
Sbjct: 307 ILHRMVIHV 315

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  115 bits (289), Expect = 3e-28
 Identities = 68/285 (23%), Positives = 112/285 (39%), Gaps = 39/285 (13%)

Query: 643 EHCIGKGGHGSVYRA--KVPSGEIF--AVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHR 698
              IG+G  G VY        G+    AVK  +         +  +FL E   + +  H 
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN---RITDIGEVSQFLTEGIIMKDFSHP 86

Query: 699 NIVKFYGFCSHPKHS-FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYL 757
           N++   G C   + S  ++  Y++ G L   +              +     VA  + YL
Sbjct: 87  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYL 144

Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV-----A 812
            +  F   VHRD++++N +LD  +   V+DFG+A+ +  D   +S    T   +     A
Sbjct: 145 ASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMY-DKEYYSVHNKTGAKLPVKWMA 200

Query: 813 PELAYTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEMLDS-----RL 866
            E   T K T K DV+SFGVL  E++ +G  P     +++        ++        RL
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPP---YPDVN------TFDITVYLLQGRRL 251

Query: 867 PYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
             P  +    L  +M     C     E RP+   +   +   IF 
Sbjct: 252 LQPE-YCPDPLYEVML---KCWHPKAEMRPSFSELVSRI-SAIFS 291

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  116 bits (292), Expect = 3e-28
 Identities = 47/302 (15%), Positives = 94/302 (31%), Gaps = 41/302 (13%)

Query: 631 EEIISATNDFNAEHCIGKGGHGSVYRAK------VPSGEIFAVKKFHSPLPGEMSFQQEE 684
            E    +      H +G+G    VY A         + + F +K      P E       
Sbjct: 58  TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEF----YI 113

Query: 685 FLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRL 744
               ++ L        +KFY        S ++ E    G+L   +    +  E    Q L
Sbjct: 114 GTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGL 173

Query: 745 --NVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAH-----------VSDFGIA 791
             +    +   +  +H+     I+H DI   N +L  G+              + D G +
Sbjct: 174 VISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQS 230

Query: 792 KFLN--PDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFE 849
             +   P  + ++    T G+   E+        + D +        ++ G +      +
Sbjct: 231 IDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM-----K 285

Query: 850 MSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI 909
           + +       E L  R   P L +  +   +M      L+           + +   +K+
Sbjct: 286 VKNEGGECKPEGLFRR--LPHLDMWNEFFHVM------LNIPDCHHLPSLDLLRQKLKKV 337

Query: 910 FE 911
           F+
Sbjct: 338 FQ 339

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  115 bits (290), Expect = 3e-28
 Identities = 74/281 (26%), Positives = 116/281 (41%), Gaps = 31/281 (11%)

Query: 638 NDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQ-ALTEI 695
            D      IG+G +GSV +    PSG+I AVK+  S +  +    Q++ L ++   +   
Sbjct: 22  EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKE---QKQLLMDLDVVMRSS 78

Query: 696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRL--NVIKGVADA 753
               IV+FYG        +I  E +   S DK      S  +    + +   +      A
Sbjct: 79  DCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKA 137

Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAP 813
           L +L  N    I+HRDI   N+LLD      + DFGI+  L  DS   +  AG   Y+AP
Sbjct: 138 LNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV-DSIAKTRDAGCRPYMAP 194

Query: 814 E----LAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLD--SRLP 867
           E     A       + DV+S G+   E+  G+ P           +++  + L    +  
Sbjct: 195 ERIDPSASRQGYDVRSDVWSLGITLYELATGRFPY-------PKWNSV-FDQLTQVVKGD 246

Query: 868 YPSLHVQKKLM-SIMQVAF--SCLDQNPESRPTMKRVSQLL 905
            P L   ++   S   + F   CL ++   RP  K   +LL
Sbjct: 247 PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYK---ELL 284

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  115 bits (289), Expect = 3e-28
 Identities = 62/279 (22%), Positives = 105/279 (37%), Gaps = 32/279 (11%)

Query: 638 NDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQAL-TEI 695
           ND      +G G  G V++ +   +G + AVK+       E     +  L ++  +    
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEE---NKRILMDLDVVLKSH 81

Query: 696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKE--LGWTQRLNVIKGVADA 753
               IV+ +G        FI  E + + +            E  LG      +   +  A
Sbjct: 82  DCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG-----KMTVAIVKA 136

Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAP 813
           L+YL       ++HRD+   N+LLD   +  + DFGI+  L  D       AG   Y+AP
Sbjct: 137 LYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLV-DDKAKDRSAGCAAYMAP 193

Query: 814 ELAYTLKVTE-----KCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPY 868
           E       T+     + DV+S G+  +E+  G+ P        +  ++  +     +   
Sbjct: 194 ERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP------YKNCKTDFEVLTKVLQEEP 247

Query: 869 PSLHVQKKLMSIMQVAF--SCLDQNPESRPTMKRVSQLL 905
           P L       S    +F   CL ++   RP      +LL
Sbjct: 248 PLLPGHMG-FSGDFQSFVKDCLTKDHRKRPKYN---KLL 282

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  114 bits (287), Expect = 4e-28
 Identities = 70/286 (24%), Positives = 120/286 (41%), Gaps = 45/286 (15%)

Query: 638 NDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQ-ALTEI 695
           +D      +G+G +G V + + VPSG+I AVK+  + +  +    Q+  L ++  ++  +
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQE---QKRLLMDLDISMRTV 63

Query: 696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLN------VIKG 749
                V FYG        +I  E ++  SLDK        + +   Q +       +   
Sbjct: 64  DCPFTVTFYGALFREGDVWICMELMD-TSLDKFY-----KQVIDKGQTIPEDILGKIAVS 117

Query: 750 VADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG 809
           +  AL +LH+     ++HRD+   NVL++   +  + DFGI+ +L  D       AG   
Sbjct: 118 IVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV-DDVAKDIDAGCKP 174

Query: 810 YVAPE--------LAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEM 861
           Y+APE          Y++    K D++S G+  +E+   + P        S  +      
Sbjct: 175 YMAPERINPELNQKGYSV----KSDIWSLGITMIELAILRFP------YDSWGTPFQQLK 224

Query: 862 LDSRLPYPSLHVQKKLMSIMQVAF--SCLDQNPESRPTMKRVSQLL 905
                P P L   K   S   V F   CL +N + RPT     +L+
Sbjct: 225 QVVEEPSPQLPADK--FSAEFVDFTSQCLKKNSKERPTYP---ELM 265

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  113 bits (285), Expect = 8e-28
 Identities = 71/285 (24%), Positives = 117/285 (41%), Gaps = 39/285 (13%)

Query: 643 EHCIGKGGHGSVYRAKV---PSGEIF-AVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHR 698
           +  IGKG  G VY  +        I  A+K            Q E FL E   +  + H 
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLS---RITEMQQVEAFLREGLLMRGLNHP 82

Query: 699 NIVKFYGFCSHPK-HSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYL 757
           N++   G    P+    ++  Y+  G L + +   +  +       ++    VA  + YL
Sbjct: 83  NVLALIGIMLPPEGLPHVLLPYMCHGDLLQFI--RSPQRNPTVKDLISFGLQVARGMEYL 140

Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV-----A 812
               F   VHRD++++N +LD  +   V+DFG+A+ +  D   +S     H  +     A
Sbjct: 141 AEQKF---VHRDLAARNCMLDESFTVKVADFGLARDIL-DREYYSVQQHRHARLPVKWTA 196

Query: 813 PELAYTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEMLDS-----RL 866
            E   T + T K DV+SFGVL  E++ +G  P      +         ++        RL
Sbjct: 197 LESLQTYRFTTKSDVWSFGVLLWELLTRGAPP---YRHID------PFDLTHFLAQGRRL 247

Query: 867 PYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
           P P  +    L  +MQ    C + +P  RPT + +   + E+I  
Sbjct: 248 PQPE-YCPDSLYQVMQ---QCWEADPAVRPTFRVLVGEV-EQIVS 287

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  113 bits (286), Expect = 8e-28
 Identities = 61/288 (21%), Positives = 111/288 (38%), Gaps = 43/288 (14%)

Query: 646 IGKGGHGSVYRAKVPSGEIF------AVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRN 699
           +G+G  G VY                A+K  +         ++ EFLNE   + E    +
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLNEASVMKEFNCHH 89

Query: 700 IVKFYGFCSHPKHSFIIYEYLESGSLDKIL-------CNDASAKELGWTQRLNVIKGVAD 752
           +V+  G  S  + + +I E +  G L   L        N+        ++ + +   +AD
Sbjct: 90  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149

Query: 753 ALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV- 811
            + YL+ N F   VHRD++++N ++   +   + DFG+ + +           G  G + 
Sbjct: 150 GMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD---YYRKGGKGLLP 203

Query: 812 ----APELAYTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMN-IEMLDS- 864
               +PE       T   DV+SFGV+  E+    + P           SN   +  +   
Sbjct: 204 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-------YQGLSNEQVLRFVMEG 256

Query: 865 -RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
             L  P  +    L  +M+    C   NP+ RP+   +   + ++  E
Sbjct: 257 GLLDKPD-NCPDMLFELMR---MCWQYNPKMRPSFLEIISSI-KEEME 299

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  114 bits (288), Expect = 1e-27
 Identities = 71/283 (25%), Positives = 105/283 (37%), Gaps = 44/283 (15%)

Query: 646 IGKGGHGSVYRAKVP-----SGEIF-AVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRN 699
           +G G  G VY  +V         +  AVK             + +FL E   +++  H+N
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALIISKFNHQN 135

Query: 700 IVKFYGFCSHPKHSFIIYEYLESGSLDKILCN----DASAKELGWTQRLNVIKGVADALF 755
           IV+  G        FI+ E +  G L   L       +    L     L+V + +A    
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195

Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHV---SDFGIAKFLNPDSSNWSELAGTHGYV- 811
           YL  N F   +HRDI+++N LL       V    DFG+A+ +           G    + 
Sbjct: 196 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG---YYRKGGCAMLP 249

Query: 812 ----APE-LAYTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMN-IEMLDS 864
                PE        T K D +SFGVL  E+   G  P         S SN   +E + S
Sbjct: 250 VKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMP-------YPSKSNQEVLEFVTS 301

Query: 865 --RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
             R+  P  +    +  IM     C    PE RP    + + +
Sbjct: 302 GGRMDPPK-NCPGPVYRIMT---QCWQHQPEDRPNFAIILERI 340

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  112 bits (283), Expect = 1e-27
 Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 36/202 (17%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFH-SPLPGEMSFQQEEFLNEIQALTEIRHRNIVKF 703
           +GKG  G V + K   + + +AVK  + +    +        L E++ L ++ H NI+K 
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK---DTSTILREVELLKKLDHPNIMKL 86

Query: 704 YGFCSHPKHSFIIYEYLESGSL-DKILCN------DASAKELGWTQRLNVIKGVADALFY 756
           +         +I+ E    G L D+I+        DA+           +IK V   + Y
Sbjct: 87  FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA----------RIIKQVFSGITY 136

Query: 757 LHNNCFPPIVHRDISSKNVLL---DLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAP 813
           +H +    IVHRD+  +N+LL   +   +  + DFG++     ++    +  GT  Y+AP
Sbjct: 137 MHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRIGTAYYIAP 192

Query: 814 EL---AYTLKVTEKCDVYSFGV 832
           E+    Y     EKCDV+S GV
Sbjct: 193 EVLRGTY----DEKCDVWSAGV 210

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  118 bits (297), Expect = 1e-27
 Identities = 68/292 (23%), Positives = 110/292 (37%), Gaps = 44/292 (15%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G GG G V R     +GE  A+K+    L  +    +E +  EIQ + ++ H N+V   
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKN---RERWCLEIQIMKKLNHPNVVSAR 78

Query: 705 ------GFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLH 758
                    +      +  EY E G L K L    +   L       ++  ++ AL YLH
Sbjct: 79  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 138

Query: 759 NNCFPPIVHRDISSKNVLLDLGYEAH---VSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
            N    I+HRD+  +N++L  G +     + D G AK L+      +E  GT  Y+APEL
Sbjct: 139 ENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE-LCTEFVGTLQYLAPEL 194

Query: 816 AYTLKVTEKCDVYSFGVLA-------------------LEVIKGKHPRDFLFEMSSSSSN 856
               K T   D +SFG LA                      ++ K     +     + + 
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAV 254

Query: 857 MNIEML--DSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLC 906
               +L   + L        ++ +  M      L  +   R T  +   + C
Sbjct: 255 KFSSVLPTPNHLSGILAGKLERWLQCM------LMWHQRQRGTDPQNPNVGC 300

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  112 bits (281), Expect = 2e-27
 Identities = 51/232 (21%), Positives = 84/232 (36%), Gaps = 27/232 (11%)

Query: 108 FPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGI-GLLTHLTVLHISR 166
                 + L+ N +  +         NL  L   +N L  +I +     L  L  L +S 
Sbjct: 31  PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVL-ARIDAAAFTGLALLEQLDLSD 89

Query: 167 NWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEI- 225
           N    S+                        P +   L  +  L+L        +   + 
Sbjct: 90  NAQLRSVD-----------------------PATFHGLGRLHTLHLDRCGLQ-ELGPGLF 125

Query: 226 GNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLA 285
             L +L  L L  N L      +  +L NL  LFL+ N +S +  +    L  L+ LLL 
Sbjct: 126 RGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLH 185

Query: 286 KNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSF 337
           +N      P +FR+L  L+ L L  N L+   +E       L ++ L++N +
Sbjct: 186 QNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  110 bits (276), Expect = 9e-27
 Identities = 56/215 (26%), Positives = 86/215 (40%), Gaps = 9/215 (4%)

Query: 269 IPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLT 328
           +P  I        + L  N        SFR   +L  L L+ N L    +  F     L 
Sbjct: 26  VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83

Query: 329 FIDLSNNSFFGEILSD-WGRCPQLSLLDVSINNISGSIPLEIGESL-QLQYLDLSSNYIV 386
            +DLS+N+    +    +    +L  L +    +   +   +   L  LQYL L  N + 
Sbjct: 84  QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ 142

Query: 387 GEIPTQ-LGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLV 445
             +P     ++  L  L L GN++S    R    L +L+ L L  N +++  P +   L 
Sbjct: 143 -ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLG 201

Query: 446 KLYYLNLSHNKLSQQIPIE-LDNLIHLSELDLSHN 479
           +L  L L  N LS  +P E L  L  L  L L+ N
Sbjct: 202 RLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  105 bits (264), Expect = 4e-25
 Identities = 51/240 (21%), Positives = 82/240 (34%), Gaps = 33/240 (13%)

Query: 292 TVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQL 351
            VP          ++ L+ N ++   + +F    NLT + L +N                
Sbjct: 25  AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSN---------------- 66

Query: 352 SLLDVSINNISGSIPLEIGESL-QLQYLDLSSNYIVGEIPTQ-LGNIIYLNRLSLSGNKL 409
                    ++  I       L  L+ LDLS N  +  +       +  L+ L L    L
Sbjct: 67  --------VLA-RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL 117

Query: 410 SGCIPRE-LGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNL 468
              +       L  L+YL L  N L     ++   L  L +L L  N++S         L
Sbjct: 118 Q-ELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGL 176

Query: 469 IHLSELDLSHNFLGEKISSRICR-MESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYN 527
             L  L L  N +   +     R +  L  L L  NNLS L       +  L ++ ++ N
Sbjct: 177 HSLDRLLLHQNRV-AHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  101 bits (254), Expect = 7e-24
 Identities = 46/187 (24%), Positives = 72/187 (38%), Gaps = 9/187 (4%)

Query: 349 PQLSLLDVSINNISGSIPLEIGESL-QLQYLDLSSNYIVGEIPTQ-LGNIIYLNRLSLSG 406
                + +  N IS  +P     +   L  L L SN +   I       +  L +L LS 
Sbjct: 32  AASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVL-ARIDAAAFTGLALLEQLDLSD 89

Query: 407 NKLSGCIPRE-LGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIE- 464
           N     +       L  L  L L    L    P     L  L YL L  N L Q +P + 
Sbjct: 90  NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNAL-QALPDDT 148

Query: 465 LDNLIHLSELDLSHNFLGEKISSRI-CRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHID 523
             +L +L+ L L  N +   +  R    + SL++L L  N ++ + P  F ++  L+ + 
Sbjct: 149 FRDLGNLTHLFLHGNRI-SSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLY 207

Query: 524 ISYNKLE 530
           +  N L 
Sbjct: 208 LFANNLS 214

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  100 bits (252), Expect = 2e-23
 Identities = 57/244 (23%), Positives = 85/244 (34%), Gaps = 31/244 (12%)

Query: 143 NKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLG 202
            +    +P GI        + +  N +S            L  L L SN L      +  
Sbjct: 20  QQGLQAVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFT 77

Query: 203 NLTHVVILYLYNNSFFGSIPQEI-GNLKSLFDLELCINQLSGAIPLSI-SNLTNLRFLFL 260
            L  +  L L +N+   S+       L  L  L L    L   +   +   L  L++L+L
Sbjct: 78  GLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYL 136

Query: 261 YHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISET 320
             N L  +      +L  L  L L  N       ++FR L  L +L L+QN +       
Sbjct: 137 QDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA------ 190

Query: 321 FGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESL-QLQYLD 379
                   F DL                 +L  L +  NN+S ++P E    L  LQYL 
Sbjct: 191 --HVHPHAFRDL----------------GRLMTLYLFANNLS-ALPTEALAPLRALQYLR 231

Query: 380 LSSN 383
           L+ N
Sbjct: 232 LNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 99.3 bits (248), Expect = 5e-23
 Identities = 56/209 (26%), Positives = 90/209 (43%), Gaps = 11/209 (5%)

Query: 90  NLTSISLNG----TLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKL 145
               I L+G     +   SF +  +L  L L++N L  I     + L+ LE LD S N  
Sbjct: 33  ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92

Query: 146 FGQIPSGI-GLLTHLTVLHISRNWLSGSIPHEV-GQLTVLNQLALDSNFLNGSIP-RSLG 202
              +       L  L  LH+ R  L   +   +   L  L  L L  N L  ++P  +  
Sbjct: 93  LRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFR 150

Query: 203 NLTHVVILYLYNNSFFGSIPQEI-GNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLY 261
           +L ++  L+L+ N    S+P+     L SL  L L  N+++   P +  +L  L  L+L+
Sbjct: 151 DLGNLTHLFLHGNRI-SSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLF 209

Query: 262 HNELSGIIPQEIGNLKKLNSLLLAKNHFR 290
            N LS +  + +  L+ L  L L  N + 
Sbjct: 210 ANNLSALPTEALAPLRALQYLRLNDNPWV 238

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 93.9 bits (234), Expect = 4e-21
 Identities = 58/220 (26%), Positives = 87/220 (39%), Gaps = 13/220 (5%)

Query: 220 SIPQEI-GNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKK 278
           ++P  I    + +F   L  N++S     S     NL  L+L+ N L+ I       L  
Sbjct: 25  AVPVGIPAASQRIF---LHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLAL 81

Query: 279 LNSLLLAKNHFRGTVPKS-FRNLTDLVKLRLNQNYLTGNISE-TFGTYPNLTFIDLSNNS 336
           L  L L+ N    +V  + F  L  L  L L++  L   +    F     L ++ L +N+
Sbjct: 82  LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNA 140

Query: 337 FFGEILSD--WGRCPQLSLLDVSINNISGSIPLEIGESL-QLQYLDLSSNYIVGEIPTQL 393
              + L D  +     L+ L +  N IS S+P      L  L  L L  N +    P   
Sbjct: 141 L--QALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAF 197

Query: 394 GNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNL 433
            ++  L  L L  N LS      L  L  L+YL L+ N  
Sbjct: 198 RDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  112 bits (283), Expect = 2e-27
 Identities = 58/198 (29%), Positives = 87/198 (43%), Gaps = 30/198 (15%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G    V+  K   +G++FA+K            +     NEI  L +I+H NIV   
Sbjct: 17  LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF----RDSSLENEIAVLKKIKHENIVTLE 72

Query: 705 GFCSHPKHSFIIYEYLESGSL-DKILC------NDASAKELGWTQRLNVIKGVADALFYL 757
                  H +++ + +  G L D+IL        DAS           VI+ V  A+ YL
Sbjct: 73  DIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDAS----------LVIQQVLSAVKYL 122

Query: 758 HNNCFPPIVHRDISSKNVLL-DLGYEAHV--SDFGIAKFLNPDSSNWSELAGTHGYVAPE 814
           H N    IVHRD+  +N+L       + +  +DFG++K         S   GT GYVAPE
Sbjct: 123 HENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN--GIMSTACGTPGYVAPE 177

Query: 815 LAYTLKVTEKCDVYSFGV 832
           +      ++  D +S GV
Sbjct: 178 VLAQKPYSKAVDCWSIGV 195

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  117 bits (295), Expect = 2e-27
 Identities = 70/287 (24%), Positives = 112/287 (39%), Gaps = 48/287 (16%)

Query: 643 EHCIGKGGHGSVYRA--KVPSGEIF--AVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHR 698
             CIG+G  G V++     P       A+K             +E+FL E   + +  H 
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK---NCTSDSVREKFLQEALTMRQFDHP 451

Query: 699 NIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLH 758
           +IVK  G  +     +II E    G L   L        L     +     ++ AL YL 
Sbjct: 452 HIVKLIGVITENPV-WIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLE 508

Query: 759 NNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV-----AP 813
           +  F   VHRDI+++NVL+       + DFG+++++       +    + G +     AP
Sbjct: 509 SKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS----TYYKASKGKLPIKWMAP 561

Query: 814 ELAYTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMN-IEMLDS--RLPYP 869
           E     + T   DV+ FGV   E++  G  P   +        N + I  +++  RLP P
Sbjct: 562 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV-------KNNDVIGRIENGERLPMP 614

Query: 870 -----SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
                +L+      S+M     C   +P  RP    +   L   I E
Sbjct: 615 PNCPPTLY------SLMT---KCWAYDPSRRPRFTELKAQL-STILE 651

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score =  112 bits (282), Expect = 2e-27
 Identities = 47/231 (20%), Positives = 96/231 (41%), Gaps = 18/231 (7%)

Query: 299 NLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSI 358
            L + +K+   ++ +T   + T      +T +           +        L  L++  
Sbjct: 17  ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGV--TTIEGVQYLNNLIGLELKD 72

Query: 359 NNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELG 418
           N I+   PL+     ++  L+LS N +  +  + +  +  +  L L+  +++   P  L 
Sbjct: 73  NQITDLAPLK--NLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITDVTP--LA 126

Query: 419 SLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSH 478
            L NL+ L L  N ++N     L  L  L YL++ + ++S   P  L NL  L+ L    
Sbjct: 127 GLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADD 182

Query: 479 NFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKL 529
           N +   IS  +  + +L +++L  N +S + P        L  + ++   +
Sbjct: 183 NKI-SDISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTI 229

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score =  111 bits (280), Expect = 4e-27
 Identities = 52/281 (18%), Positives = 96/281 (34%), Gaps = 20/281 (7%)

Query: 201 LGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFL 260
              L + + +    ++   ++ Q   +L  +  L      ++    +    L NL  L L
Sbjct: 15  DPALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTIEGVQ--YLNNLIGLEL 70

Query: 261 YHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISET 320
             N+++ + P  + NL K+  L L+ N        +   L  +  L L    +T      
Sbjct: 71  KDNQITDLAP--LKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITD--VTP 124

Query: 321 FGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDL 380
                NL  + L  N      +S       L  L +    +S   PL      +L  L  
Sbjct: 125 LAGLSNLQVLYLDLNQI--TNISPLAGLTNLQYLSIGNAQVSDLTPLA--NLSKLTTLKA 180

Query: 381 SSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPES 440
             N I    P  L ++  L  + L  N++S   P  L +  NL  + L+   ++N     
Sbjct: 181 DDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFY 236

Query: 441 LGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFL 481
             +LV    +           P  + +    +  +L+ N  
Sbjct: 237 NNNLVVPNVVKGPSGAPIA--PATISDNGTYASPNLTWNLT 275

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score =  100 bits (250), Expect = 3e-23
 Identities = 66/317 (20%), Positives = 116/317 (36%), Gaps = 46/317 (14%)

Query: 118 NNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEV 177
              +  I P     L+N   +    + +          L  +T L      ++ +I   V
Sbjct: 6   PTAINVIFP--DPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIE-GV 59

Query: 178 GQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELC 237
             L  L  L L  N +   +   L NLT +  L L  N         I  L+S+  L+L 
Sbjct: 60  QYLNNLIGLELKDNQIT-DLA-PLKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLT 115

Query: 238 INQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSF 297
             Q++   PL  + L+NL+ L+L  N+++ I P  +  L  L  L +         P   
Sbjct: 116 STQITDVTPL--AGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--L 169

Query: 298 RNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVS 357
            NL+ L  L+ + N ++ +IS    + PNL  + L NN                      
Sbjct: 170 ANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNN---------------------Q 206

Query: 358 INNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPREL 417
           I+++S      +  +  L  + L++  I  +      N++  N   + G   +   P  +
Sbjct: 207 ISDVSP-----LANTSNLFIVTLTNQTITNQPVFYNNNLVVPN--VVKGPSGAPIAPATI 259

Query: 418 GSLINLEYLDLSANNLS 434
                    +L+ N  S
Sbjct: 260 SDNGTYASPNLTWNLTS 276

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score =  100 bits (250), Expect = 4e-23
 Identities = 57/298 (19%), Positives = 108/298 (36%), Gaps = 44/298 (14%)

Query: 90  NLTSISLNGTLLE--FSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFG 147
           N   I+   + +    + +    +  L  +   +  I    +  L+NL  L+   N++  
Sbjct: 20  NAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVTTIEG--VQYLNNLIGLELKDNQI-- 75

Query: 148 QIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHV 207
              + +  LT +T L +S N L  ++   +  L  +  L L S  +    P  L  L+++
Sbjct: 76  TDLAPLKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDVTP--LAGLSNL 131

Query: 208 VILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSG 267
            +LYL  N    +    +  L +L  L +   Q+S   PL  +NL+ L  L    N++S 
Sbjct: 132 QVLYLDLNQI--TNISPLAGLTNLQYLSIGNAQVSDLTPL--ANLSKLTTLKADDNKISD 187

Query: 268 IIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNL 327
           I P  + +L  L  + L  N    +      N ++L  + L    +T           N 
Sbjct: 188 ISP--LASLPNLIEVHLKNNQI--SDVSPLANTSNLFIVTLTNQTIT-----------NQ 232

Query: 328 TFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYI 385
                +N                +    V   + +   P  I ++      +L+ N  
Sbjct: 233 PVFYNNNL---------------VVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLT 275

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 91.3 bits (227), Expect = 4e-20
 Identities = 35/182 (19%), Positives = 72/182 (39%), Gaps = 14/182 (7%)

Query: 349 PQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNK 408
                +    +N++ ++     +   +  L      +       +  +  L  L L  N+
Sbjct: 19  ANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGV--TTIEGVQYLNNLIGLELKDNQ 74

Query: 409 LSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNL 468
           ++   P  L +L  +  L+LS N L N    ++  L  +  L+L+  +++   P  L  L
Sbjct: 75  ITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITDVTP--LAGL 128

Query: 469 IHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNK 528
            +L  L L  N +   IS  +  + +L+ L++    +S L P     +  L  +    NK
Sbjct: 129 SNLQVLYLDLNQI-TNISP-LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNK 184

Query: 529 LE 530
           + 
Sbjct: 185 IS 186

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 50.5 bits (121), Expect = 1e-06
 Identities = 13/92 (14%), Positives = 35/92 (38%), Gaps = 6/92 (6%)

Query: 439 ESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKL 498
               +L     +    + ++    +   +L  ++ L      +   I   +  + +L  L
Sbjct: 13  FPDPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGV-TTIEG-VQYLNNLIGL 68

Query: 499 NLSYNNLSGLIPRCFEEMHGLLHIDISYNKLE 530
            L  N ++ L P   + +  +  +++S N L+
Sbjct: 69  ELKDNQITDLAP--LKNLTKITELELSGNPLK 98

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  113 bits (284), Expect = 3e-27
 Identities = 45/194 (23%), Positives = 80/194 (41%), Gaps = 9/194 (4%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFH-SPLPGEMSFQQEEFLNEIQALTEIRHRNIVKF 703
           IGKG    V R     +G+ FAVK    +          E+   E      ++H +IV+ 
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91

Query: 704 YGFCSHPKHSFIIYEYLESGSL-DKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
               S     ++++E+++   L  +I+    +          + ++ + +AL Y H+N  
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN- 150

Query: 763 PPIVHRDISSKNVLLDLGYEAH---VSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTL 819
             I+HRD+    VLL     +    +  FG+A  L           GT  ++APE+    
Sbjct: 151 --IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKRE 208

Query: 820 KVTEKCDVYSFGVL 833
              +  DV+  GV+
Sbjct: 209 PYGKPVDVWGCGVI 222

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  112 bits (283), Expect = 3e-27
 Identities = 74/294 (25%), Positives = 132/294 (44%), Gaps = 51/294 (17%)

Query: 646 IGKGGHGSVYRAKVP-----SGEIF-AVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRN 699
           +G+G  G V+ A+         ++  AVK     L       +++F  E + LT ++H++
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKA----LKEASESARQDFQREAELLTMLQHQH 104

Query: 700 IVKFYGFCSHPKHSFIIYEYLESGSLDKIL------------CNDASAKELGWTQRLNVI 747
           IV+F+G C+  +   +++EY+  G L++ L              D +   LG  Q L V 
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164

Query: 748 KGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGT 807
             VA  + YL    F   VHRD++++N L+  G    + DFG+++ +           G 
Sbjct: 165 SQVAAGMVYLAGLHF---VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD---YYRVGG 218

Query: 808 HGYV-----APE-LAYTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMN-I 859
              +      PE + Y  K T + DV+SFGV+  E+   GK P    +++    SN   I
Sbjct: 219 RTMLPIRWMPPESILYR-KFTTESDVWSFGVVLWEIFTYGKQP---WYQL----SNTEAI 270

Query: 860 EMLDS--RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
           + +     L  P      ++ +IM+    C  + P+ R ++K V   L + + +
Sbjct: 271 DCITQGRELERPR-ACPPEVYAIMR---GCWQREPQQRHSIKDVHARL-QALAQ 319

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  112 bits (282), Expect = 4e-27
 Identities = 69/295 (23%), Positives = 124/295 (42%), Gaps = 56/295 (18%)

Query: 646 IGKGGHGSVYRAKVPSGEIF---AVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIV 701
           IG+G  G V +A++    +    A+K+              +F  E++ L ++  H NI+
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMK---EYASKDDHRDFAGELEVLCKLGHHPNII 89

Query: 702 KFYGFCSHPKHSFIIYEYLESGSLDKIL-------------CNDASAKELGWTQRLNVIK 748
              G C H  + ++  EY   G+L   L               +++A  L   Q L+   
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149

Query: 749 GVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH 808
            VA  + YL    F   +HRD++++N+L+   Y A ++DFG+++        +     T 
Sbjct: 150 DVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSR----GQEVYV--KKTM 200

Query: 809 GYV-----APE-LAYTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEM 861
           G +     A E L Y+   T   DV+S+GVL  E++  G  P      M+        E+
Sbjct: 201 GRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTP---YCGMT------CAEL 250

Query: 862 LDS-----RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
            +      RL  P  +   ++  +M+    C  + P  RP+  ++   L  ++ E
Sbjct: 251 YEKLPQGYRLEKPL-NCDDEVYDLMR---QCWREKPYERPSFAQILVSL-NRMLE 300

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score =  116 bits (291), Expect = 4e-27
 Identities = 57/283 (20%), Positives = 99/283 (34%), Gaps = 22/283 (7%)

Query: 258 LFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNI 317
                  +  I P +     +     L K      V ++   L  + ++  N + +  ++
Sbjct: 4   TITVSTPIKQIFPDD--AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SV 58

Query: 318 SETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESL-QLQ 376
                  PN+T + L+ N      +        L  L +  N I     L+    L +L+
Sbjct: 59  QG-IQYLPNVTKLFLNGNKL--TDIKPLTNLKNLGWLFLDENKIKDLSSLK---DLKKLK 112

Query: 377 YLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNF 436
            L L  N I  +I   L ++  L  L L  NK++      L  L  L+ L L  N +S+ 
Sbjct: 113 SLSLEHNGIS-DING-LVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQISDI 168

Query: 437 VPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLE 496
               L  L KL  L LS N +S  +   L  L +L  L+L       K  +    +    
Sbjct: 169 --VPLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECLNKPINHQSNLVVPN 224

Query: 497 KLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNSTTF 539
            +  +  +L    P    +       ++ ++  E     S  F
Sbjct: 225 TVKNTDGSLV--TPEIISDDGDYEKPNVKWHLPEFTNEVSFIF 265

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score =  113 bits (284), Expect = 3e-26
 Identities = 57/280 (20%), Positives = 104/280 (37%), Gaps = 42/280 (15%)

Query: 227 NLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAK 286
                    L    ++ A+  +   L ++  +   ++++  +  Q I  L  +  L L  
Sbjct: 19  AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNG 74

Query: 287 NHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWG 346
           N      P    NL +L  L L++N +  ++  +      L  + L +N           
Sbjct: 75  NKLTDIKP--LTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEHNG---------- 120

Query: 347 RCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSG 406
                      I++I+G     +    QL+ L L +N I     T L  +  L+ LSL  
Sbjct: 121 -----------ISDING-----LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLED 162

Query: 407 NKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELD 466
           N++S  +P  L  L  L+ L LS N++S+    +L  L  L  L L   +   +      
Sbjct: 163 NQISDIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQS 218

Query: 467 NLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLS 506
           NL+  + +  +   L       I      EK N+ ++   
Sbjct: 219 NLVVPNTVKNTDGSLVTPEI--ISDDGDYEKPNVKWHLPE 256

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score =  108 bits (271), Expect = 1e-24
 Identities = 59/281 (20%), Positives = 97/281 (34%), Gaps = 42/281 (14%)

Query: 201 LGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFL 260
                  +   L   S   ++ Q    L S+  +    + +     +    L N+  LFL
Sbjct: 17  DDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGIQ--YLPNVTKLFL 72

Query: 261 YHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISET 320
             N+L+ I P  + NLK L  L L +N  +       ++L  L  L L  N ++ +I   
Sbjct: 73  NGNKLTDIKP--LTNLKNLGWLFLDENKIKDLSS--LKDLKKLKSLSLEHNGIS-DI-NG 126

Query: 321 FGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDL 380
               P L  + L NN                      I +I+      +    +L  L L
Sbjct: 127 LVHLPQLESLYLGNNK---------------------ITDITV-----LSRLTKLDTLSL 160

Query: 381 SSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPES 440
             N I  +I   L  +  L  L LS N +S    R L  L NL+ L+L +    N     
Sbjct: 161 EDNQIS-DIV-PLAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINH 216

Query: 441 LGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFL 481
             +LV    +  +   L     I   +     + ++  +  
Sbjct: 217 QSNLVVPNTVKNTDGSLVTPEIIS--DDGDYEKPNVKWHLP 255

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score =  103 bits (257), Expect = 7e-23
 Identities = 60/353 (16%), Positives = 115/353 (32%), Gaps = 92/353 (26%)

Query: 91  LTSISLNGTLLE--FSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQ 148
           +       T ++  F   +F   +  +L    +   +    + L++++ +  + + +   
Sbjct: 1   MGETITVSTPIKQIFPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI-KS 57

Query: 149 IPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVV 208
           +  GI  L ++T L ++ N           +LT +  L                NL ++ 
Sbjct: 58  V-QGIQYLPNVTKLFLNGN-----------KLTDIKPLT---------------NLKNLG 90

Query: 209 ILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGI 268
            L+L  N                      I  LS      + +L  L+ L L HN +S I
Sbjct: 91  WLFLDENK---------------------IKDLSS-----LKDLKKLKSLSLEHNGISDI 124

Query: 269 IPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLT 328
               + +L +L SL L  N  + T       LT L  L L  N ++ +I         L 
Sbjct: 125 NG--LVHLPQLESLYLGNN--KITDITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQ 178

Query: 329 FIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGE 388
            + LS N                      I+++     L+      L  L+L S   + +
Sbjct: 179 NLYLSKN---------------------HISDLRALAGLK-----NLDVLELFSQECLNK 212

Query: 389 IPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESL 441
                 N++  N +  +   L    P  +    + E  ++  +        S 
Sbjct: 213 PINHQSNLVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWHLPEFTNEVSF 263

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 92.9 bits (230), Expect = 1e-19
 Identities = 56/258 (21%), Positives = 94/258 (36%), Gaps = 14/258 (5%)

Query: 90  NLTSISLNGTLLE--FSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFG 147
           ++  I  N + ++        P++  L L  N+L  I P  ++NL NL +L    NK+  
Sbjct: 44  SIDQIIANNSDIKSVQGIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKI-K 100

Query: 148 QIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHV 207
            + S +  L  L  L +  N +S  I   +  L  L  L L +N +  +    L  LT +
Sbjct: 101 DL-SSLKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKI--TDITVLSRLTKL 155

Query: 208 VILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSG 267
             L L +N     I   +  L  L +L L  N +S    L+   L NL  L L+  E   
Sbjct: 156 DTLSLEDNQI-SDIV-PLAGLTKLQNLYLSKNHISDLRALA--GLKNLDVLELFSQECLN 211

Query: 268 IIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNL 327
                  NL   N++             S     +   ++ +    T  +S  F     +
Sbjct: 212 KPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTI 271

Query: 328 TFIDLSNNSFFGEILSDW 345
                  +    + L + 
Sbjct: 272 GKAKARFHGRVTQPLKEV 289

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  111 bits (279), Expect = 5e-27
 Identities = 48/207 (23%), Positives = 90/207 (43%), Gaps = 34/207 (16%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVK-----KFHSPLPGEMSFQQEEFLNEIQALTEI-RHR 698
           +G+G    V R    P+ + +AVK        S    E+   +E  L E+  L ++  H 
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84

Query: 699 NIVKFYGFCSHPKHSFIIYEYLESGSL-DKILCN------DASAKELGWTQRLNVIKGVA 751
           NI++           F++++ ++ G L D +         +             +++ + 
Sbjct: 85  NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR----------KIMRALL 134

Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV 811
           + +  LH      IVHRD+  +N+LLD      ++DFG +  L+P      E+ GT  Y+
Sbjct: 135 EVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-LREVCGTPSYL 190

Query: 812 APE-LAYTLKV-----TEKCDVYSFGV 832
           APE +  ++        ++ D++S GV
Sbjct: 191 APEIIECSMNDNHPGYGKEVDMWSTGV 217

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  114 bits (288), Expect = 7e-27
 Identities = 61/257 (23%), Positives = 103/257 (40%), Gaps = 35/257 (13%)

Query: 599 HQRKNDSQTQQSSFGNTPGLRSVLTFEGKIVYEEIISATNDFNAEHCIGKGGHGSVYRAK 658
           H   + S  +   F             G  +  +    +  +     +G G +G V   +
Sbjct: 3   HHHHHSSGRENLYFQGDLQATP-----GMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCR 57

Query: 659 -VPSGEIFAVKKFH-SPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII 716
              +    A+K    + +         + L E+  L  + H NI+K Y F    ++ +++
Sbjct: 58  DKVTHVERAIKIIRKTSVSTS---SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114

Query: 717 YEYLESGSL-DKILC------NDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRD 769
            E  + G L D+I+        DA+           +IK V   + YLH +    IVHRD
Sbjct: 115 MECYKGGELFDEIIHRMKFNEVDAA----------VIIKQVLSGVTYLHKHN---IVHRD 161

Query: 770 ISSKNVLL---DLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCD 826
           +  +N+LL   +      + DFG++           E  GT  Y+APE+    K  EKCD
Sbjct: 162 LKPENLLLESKEKDALIKIVDFGLSAVFENQKK-MKERLGTAYYIAPEV-LRKKYDEKCD 219

Query: 827 VYSFGVLALEVIKGKHP 843
           V+S GV+   ++ G  P
Sbjct: 220 VWSIGVILFILLAGYPP 236

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  111 bits (279), Expect = 7e-27
 Identities = 71/292 (24%), Positives = 112/292 (38%), Gaps = 45/292 (15%)

Query: 643 EHCIGKGGHGSVYRAKVPSGEIF----AVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHR 698
              +G+G  GSV    +   +      AVK        +   + EEFL+E   + +  H 
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQR--EIEEFLSEAACMKDFSHP 96

Query: 699 NIVKFYGFCS-----HPKHSFIIYEYLESGSLDKILCN---DASAKELGWTQRLNVIKGV 750
           N+++  G C            +I  +++ G L   L     +   K +     L  +  +
Sbjct: 97  NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI 156

Query: 751 ADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGY 810
           A  + YL N  F   +HRD++++N +L       V+DFG++K +           G    
Sbjct: 157 ALGMEYLSNRNF---LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD---YYRQGRIAK 210

Query: 811 V-----APELAYTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEMLDS 864
           +     A E       T K DV++FGV   E+  +G  P      +       N EM D 
Sbjct: 211 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP---YPGVQ------NHEMYDY 261

Query: 865 -----RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
                RL  P      +L  IM    SC   +P  RPT   +   L EK+ E
Sbjct: 262 LLHGHRLKQPE-DCLDELYEIMY---SCWRTDPLDRPTFSVLRLQL-EKLLE 308

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  112 bits (283), Expect = 2e-26
 Identities = 50/203 (24%), Positives = 91/203 (44%), Gaps = 36/203 (17%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFH-SPLPGEMSFQQEEFLNEIQALTEIRHRNIVKF 703
           +GKG    V R   V +G+ +A    +   L        ++   E +    ++H NIV+ 
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSA---RDHQKLEREARICRLLKHPNIVRL 75

Query: 704 YGFCSHPKHSFIIYEYLESGSL-DKILC------NDASAKELGWTQRLNVIKGVADALFY 756
           +   S   H ++I++ +  G L + I+        DAS          + I+ + +A+ +
Sbjct: 76  HDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS----------HCIQQILEAVLH 125

Query: 757 LHNNCFPPIVHRDISSKNVLL-DLGYEAHV--SDFGIAKFLNPDSSNWSELAGTHGYVAP 813
            H      +VHR++  +N+LL      A V  +DFG+A  +  +   W   AGT GY++P
Sbjct: 126 CHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSP 182

Query: 814 EL----AYTLKVTEKCDVYSFGV 832
           E+     Y     +  D+++ GV
Sbjct: 183 EVLRKDPY----GKPVDLWACGV 201

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  113 bits (285), Expect = 2e-26
 Identities = 68/256 (26%), Positives = 103/256 (40%), Gaps = 44/256 (17%)

Query: 599 HQRKNDSQTQQSSFGNTPGLRSVLTFEGKIVYEEIISATNDFNAEHCIGKGGHGSVYRAK 658
           H                PG+  V   EGKI           +     +G G +G V   K
Sbjct: 6   HHSSGRENLYFQGIAINPGM-YVRKKEGKI--------GESYFKVRKLGSGAYGEVLLCK 56

Query: 659 -VPSGEIFAVK---------KFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCS 708
                   A+K           +S     +    EE  NEI  L  + H NI+K +    
Sbjct: 57  EKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFE 116

Query: 709 HPKHSFIIYEYLESGSL-DKILC------NDASAKELGWTQRLNVIKGVADALFYLHNNC 761
             K+ +++ E+ E G L ++I+        DA+          N++K +   + YLH + 
Sbjct: 117 DKKYFYLVTEFYEGGELFEQIINRHKFDECDAA----------NIMKQILSGICYLHKHN 166

Query: 762 FPPIVHRDISSKNVLL---DLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT 818
              IVHRDI  +N+LL   +      + DFG++ F + D     +  GT  Y+APE    
Sbjct: 167 ---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK-LRDRLGTAYYIAPE-VLK 221

Query: 819 LKVTEKCDVYSFGVLA 834
            K  EKCDV+S GV+ 
Sbjct: 222 KKYNEKCDVWSCGVIM 237

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  108 bits (273), Expect = 2e-26
 Identities = 54/193 (27%), Positives = 87/193 (45%), Gaps = 15/193 (7%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G  G V+  +   SG    +K  +           E+   EI+ L  + H NI+K +
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDR---SQVPMEQIEAEIEVLKSLDHPNIIKIF 86

Query: 705 GFCSHPKHSFIIYEYLESGSL-DKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFP 763
                  + +I+ E  E G L ++I+   A  K L       ++K + +AL Y H+    
Sbjct: 87  EVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ--- 143

Query: 764 PIVHRDISSKNVLLDLGYEAH---VSDFGIAKFLNPDSSNWSELAGTHGYVAPE-LAYTL 819
            +VH+D+  +N+L           + DFG+A+    D    +  AGT  Y+APE      
Sbjct: 144 HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH-STNAAGTALYMAPEVFKR-- 200

Query: 820 KVTEKCDVYSFGV 832
            VT KCD++S GV
Sbjct: 201 DVTFKCDIWSAGV 213

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  108 bits (273), Expect = 3e-26
 Identities = 51/203 (25%), Positives = 93/203 (45%), Gaps = 37/203 (18%)

Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFH-SPLPGEMSFQQEEFLNEIQALTEIRHRNIVKF 703
           +GKG    V R     +G  FA K  +   L        ++   E +   +++H NIV+ 
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR---DFQKLEREARICRKLQHPNIVRL 70

Query: 704 YGFCSHPKHSFIIYEYLESGSL-DKILCN------DASAKELGWTQRLNVIKGVADALFY 756
           +         +++++ +  G L + I+        DAS          + I+ + +++ Y
Sbjct: 71  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS----------HCIQQILESIAY 120

Query: 757 LHNNCFPPIVHRDISSKNVLL-DLGYEAHV--SDFGIAKFLNPDSSNWSELAGTHGYVAP 813
            H+N    IVHR++  +N+LL      A V  +DFG+A  +N   + W   AGT GY++P
Sbjct: 121 CHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WHGFAGTPGYLSP 176

Query: 814 EL----AYTLKVTEKCDVYSFGV 832
           E+     Y    ++  D+++ GV
Sbjct: 177 EVLKKDPY----SKPVDIWACGV 195

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  108 bits (272), Expect = 3e-26
 Identities = 75/279 (26%), Positives = 123/279 (44%), Gaps = 47/279 (16%)

Query: 638 NDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFH-SPLPGEMSFQQEEFLNEIQALTEI 695
           +DF+    +GKG  G+VY A+   +  I A+K    S L  E    + +   EI+  + +
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQL--EKEGVEHQLRREIEIQSHL 71

Query: 696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSL-DKI-----LCNDASAKELGWTQRLNVIKG 749
           RH NI++ Y +    K  +++ E+   G L  ++          SA           ++ 
Sbjct: 72  RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSAT---------FMEE 122

Query: 750 VADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG 809
           +ADAL Y H      ++HRDI  +N+L+    E  ++DFG +    P     + + GT  
Sbjct: 123 LADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSV-HAPSLRRRT-MCGTLD 177

Query: 810 YVAPEL----AYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNM--NIEMLD 863
           Y+ PE+     +  KV    D++  GVL  E + G  P    F+ S S +     I  +D
Sbjct: 178 YLPPEMIEGKTHDEKV----DLWCAGVLCYEFLVGMPP----FD-SPSHTETHRRIVNVD 228

Query: 864 SRLPYPSLHVQ-KKLMSIMQVAFSCLDQNPESRPTMKRV 901
            + P P L    K L+S +      L  +P  R  +K V
Sbjct: 229 LKFP-PFLSDGSKDLISKL------LRYHPPQRLPLKGV 260

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  109 bits (274), Expect = 3e-26
 Identities = 54/205 (26%), Positives = 80/205 (39%), Gaps = 33/205 (16%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFH----SPLPGEMSFQQEEFLNEIQALTEIRHRNI 700
           +G G  G V  A    + +  A+K       +      +        EI+ L ++ H  I
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77

Query: 701 VKFYGFCSHPKHSFIIYEYLESGSL-DKILCN------DASAKELGWTQRLNVIKGVADA 753
           +K   F     + +I+ E +E G L DK++ N                        +  A
Sbjct: 78  IKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCK----------LYFYQMLLA 126

Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAH---VSDFGIAKFLNPDSSNWSELAGTHGY 810
           + YLH N    I+HRD+  +NVLL    E     ++DFG +K L   S     L GT  Y
Sbjct: 127 VQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLCGTPTY 182

Query: 811 VAPE-LAYTLKV--TEKCDVYSFGV 832
           +APE L            D +S GV
Sbjct: 183 LAPEVLVSVGTAGYNRAVDCWSLGV 207

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  109 bits (274), Expect = 3e-26
 Identities = 62/290 (21%), Positives = 110/290 (37%), Gaps = 46/290 (15%)

Query: 646 IGKGGHGSVYRAKVPSGEIF----AVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIV 701
           +GKG  GSV  A++   +      AVK   + +        EEFL E   + E  H ++ 
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASS--DIEEFLREAACMKEFDHPHVA 88

Query: 702 KFYGFCS------HPKHSFIIYEYLESGSLDKILCN---DASAKELGWTQRLNVIKGVAD 752
           K  G               +I  +++ G L   L       +   L     +  +  +A 
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148

Query: 753 ALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV- 811
            + YL +  F   +HRD++++N +L       V+DFG+++ +           G    + 
Sbjct: 149 GMEYLSSRNF---IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD---YYRQGCASKLP 202

Query: 812 ----APELAYTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEMLDS-- 864
               A E       T   DV++FGV   E++ +G+ P      +       N E+ +   
Sbjct: 203 VKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP---YAGIE------NAEIYNYLI 253

Query: 865 ---RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
              RL  P     +++  +M     C   +P+ RP+   +   L E I  
Sbjct: 254 GGNRLKQPP-ECMEEVYDLMY---QCWSADPKQRPSFTCLRMEL-ENILG 298

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  110 bits (278), Expect = 3e-26
 Identities = 49/196 (25%), Positives = 88/196 (44%), Gaps = 21/196 (10%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G  G V+R     +G +F  K  ++P P +    +    NEI  + ++ H  ++  +
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD----KYTVKNEISIMNQLHHPKLINLH 114

Query: 705 GFCSHPKHSFIIYEYLESGSL-DKILCNDASAKELGWTQR--LNVIKGVADALFYLHNNC 761
                     +I E+L  G L D+I      A++   ++   +N ++   + L ++H + 
Sbjct: 115 DAFEDKYEMVLILEFLSGGELFDRIA-----AEDYKMSEAEVINYMRQACEGLKHMHEH- 168

Query: 762 FPPIVHRDISSKNVLLDLGYEAHV--SDFGIAKFLNPDSSNWSELAGTHGYVAPE-LAYT 818
              IVH DI  +N++ +    + V   DFG+A  LNPD         T  + APE +   
Sbjct: 169 --SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-EIVKVTTATAEFAAPEIVDRE 225

Query: 819 LKVTEKCDVYSFGVLA 834
             V    D+++ GVL 
Sbjct: 226 -PVGFYTDMWAIGVLG 240

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  111 bits (280), Expect = 5e-26
 Identities = 68/275 (24%), Positives = 109/275 (39%), Gaps = 41/275 (14%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFH-SPLPGEMSFQQEEFLNEIQALTEIRHRNIVKF 703
           +GKG  G V   K   +G+  AVK      +  +    +E  L E+Q L ++ H NI+K 
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD--KESLLREVQLLKQLDHPNIMKL 91

Query: 704 YGFCSHPKHSFIIYEYLESGSL-DKILC------NDASAKELGWTQRLNVIKGVADALFY 756
           Y F     + +++ E    G L D+I+        DA+           +I+ V   + Y
Sbjct: 92  YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA----------RIIRQVLSGITY 141

Query: 757 LHNNCFPPIVHRDISSKNVLL---DLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAP 813
           +H N    IVHRD+  +N+LL          + DFG++           +  GT  Y+AP
Sbjct: 142 MHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK-MKDKIGTAYYIAP 197

Query: 814 ELAYTLKVTEKCDVYSFGVLALEVIKGKHP--RDFLFEMSSSSSNMNIEMLDSRLPYPSL 871
           E+       EKCDV+S GV+   ++ G  P      +++              +    S 
Sbjct: 198 EV-LHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSE 256

Query: 872 HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLC 906
              K L+  M      L   P  R + +     L 
Sbjct: 257 SA-KDLIRKM------LTYVPSMRISAR---DALD 281

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score =  109 bits (273), Expect = 7e-26
 Identities = 62/279 (22%), Positives = 101/279 (36%), Gaps = 23/279 (8%)

Query: 244 AIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKS-FRNLTD 302
            IP  +    N   L     +L  I          L  + +++N     +    F NL  
Sbjct: 23  EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80

Query: 303 LVKLRL-NQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRC--PQLSLLDVSIN 359
           L ++R+   N L     E F   PNL ++ +SN     + L D  +    Q  LLD+  N
Sbjct: 81  LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGI--KHLPDVHKIHSLQKVLLDIQDN 138

Query: 360 NISGSIPLEI--GESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRE- 416
               +I      G S +   L L+ N I  EI     N   L+ L+LS N     +P + 
Sbjct: 139 INIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDV 197

Query: 417 LGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDL 476
                    LD+S   + +     L +L KL   +  + K   ++P  L+ L+ L E  L
Sbjct: 198 FHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT-LEKLVALMEASL 253

Query: 477 SHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEE 515
           ++        S  C   +  +     + +        E 
Sbjct: 254 TYP-------SHCCAFANWRRQISELHPICNKSILRQEV 285

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 90.7 bits (225), Expect = 1e-19
 Identities = 47/233 (20%), Positives = 75/233 (32%), Gaps = 16/233 (6%)

Query: 90  NLTSISLNGTLLEF----SFSSFPHLVYLDLYNNELFGIIPPQI-SNLSNLEYLDFSANK 144
           N   +    T L      +FS F  L  +++  N++  +I   + SNL  L  +      
Sbjct: 31  NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN 90

Query: 145 LFGQIPSGI-GLLTHLTVLHISRNWLSGSIPHEVGQ-LTVLNQLALDSNFLNGSIP-RSL 201
               I       L +L  L IS   +   +P            L +  N    +I   S 
Sbjct: 91  NLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSF 149

Query: 202 GNLTH-VVILYLYNNSFFGSIPQEIGNLKSLFDLELCI-NQLSGAIPLSISNLTNLRFLF 259
             L+   VIL+L  N     I     N   L +L L   N L           +    L 
Sbjct: 150 VGLSFESVILWLNKNG-IQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILD 208

Query: 260 LYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNY 312
           +    +  +    + NLKKL +           +P +   L  L++  L    
Sbjct: 209 ISRTRIHSLPSYGLENLKKLRARSTYNLK---KLP-TLEKLVALMEASLTYPS 257

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 84.1 bits (208), Expect = 2e-17
 Identities = 38/234 (16%), Positives = 68/234 (29%), Gaps = 30/234 (12%)

Query: 108 FPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGI-GLLTHLTVLHISR 166
             + + L     +L  I     S   +LE ++ S N +   I + +   L  L  + I +
Sbjct: 29  PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88

Query: 167 -NWLSGSIPHEV-GQLTVLNQLALDSNFLNGSIPR-SLGNLTHVVILYLYNNSFFGSIPQ 223
            N L   I  E    L  L  L + +  +   +P     +    V+L + +N    +I  
Sbjct: 89  ANNLL-YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIE- 145

Query: 224 EIGNLKSLFDLELCINQLSGAIPLSISNLT-NLRFLFLYHNELSGIIPQEIGNLKKLNSL 282
                                   S   L+     L+L  N +  I        +     
Sbjct: 146 ----------------------RNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELN 183

Query: 283 LLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNS 336
           L   N+        F   +  V L +++  +    S        L      N  
Sbjct: 184 LSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 237

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 78.3 bits (193), Expect = 1e-15
 Identities = 39/186 (20%), Positives = 71/186 (38%), Gaps = 8/186 (4%)

Query: 351 LSLLDVSINNISGSIPLEIGESL-QLQYLDLSSNYIVGEIPTQ-LGNIIYLNRLSLS-GN 407
              L   +  +   I          L+ +++S N ++  I      N+  L+ + +   N
Sbjct: 32  AIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN 90

Query: 408 KLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIE-LD 466
            L    P    +L NL+YL +S   + +         ++   L++  N     I      
Sbjct: 91  NLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFV 150

Query: 467 NL-IHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNN-LSGLIPRCFEEMHGLLHIDI 524
            L      L L+ N + ++I +       L++LNLS NN L  L    F    G + +DI
Sbjct: 151 GLSFESVILWLNKNGI-QEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDI 209

Query: 525 SYNKLE 530
           S  ++ 
Sbjct: 210 SRTRIH 215

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 74.5 bits (183), Expect = 2e-14
 Identities = 42/243 (17%), Positives = 83/243 (34%), Gaps = 34/243 (13%)

Query: 292 TVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQL 351
            +P       + ++LR     L       F  + +L  I++S N                
Sbjct: 23  EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQN---------------- 64

Query: 352 SLLDVSINNISGSIPLEIGESL-QLQYLDLS-SNYIVGEIPTQLGNIIYLNRLSLSGNKL 409
                   ++   I  ++  +L +L  + +  +N ++   P    N+  L  L +S   +
Sbjct: 65  --------DVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGI 116

Query: 410 SGCIPREL-GSLINLEYLDLSANNLSNFVPESL--GSLVKLYYLNLSHNKLSQQIPIELD 466
              +P       +    LD+  N   + +  +   G   +   L L+ N + Q+I     
Sbjct: 117 K-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGI-QEIHNSAF 174

Query: 467 NLIHLSELDLSHNFLGEKISSRICR-MESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDIS 525
           N   L EL+LS N   E++ + +         L++S   +  L     E +  L      
Sbjct: 175 NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 234

Query: 526 YNK 528
             K
Sbjct: 235 NLK 237

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 68.3 bits (167), Expect = 2e-12
 Identities = 23/128 (17%), Positives = 44/128 (34%), Gaps = 5/128 (3%)

Query: 402 LSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQI 461
                +K++  IP +L    N   L      L      +      L  + +S N + + I
Sbjct: 14  FLCQESKVTE-IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 70

Query: 462 PIE-LDNLIHLSELDLSHNFLGEKISSRICR-MESLEKLNLSYNNLSGLIPRCFEEMHGL 519
             +   NL  L E+ +        I+    + + +L+ L +S   +  L           
Sbjct: 71  EADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQK 130

Query: 520 LHIDISYN 527
           + +DI  N
Sbjct: 131 VLLDIQDN 138

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  109 bits (274), Expect = 7e-26
 Identities = 53/206 (25%), Positives = 89/206 (43%), Gaps = 33/206 (16%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVK----KFHSPLPGEMSFQQEEFLNEIQALTEIR-HRN 699
           IG+G    V R     +G  FAVK          P ++   +E    E   L ++  H +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161

Query: 700 IVKFYGFCSHPKHSFIIYEYLESGSL-DKILCN------DASAKELGWTQRLNVIKGVAD 752
           I+            F++++ +  G L D +         +            ++++ + +
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETR----------SIMRSLLE 211

Query: 753 ALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVA 812
           A+ +LH N    IVHRD+  +N+LLD   +  +SDFG +  L P      EL GT GY+A
Sbjct: 212 AVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK-LRELCGTPGYLA 267

Query: 813 PE-LAYTLKVTEK-----CDVYSFGV 832
           PE L  ++  T        D+++ GV
Sbjct: 268 PEILKCSMDETHPGYGKEVDLWACGV 293

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  109 bits (274), Expect = 8e-26
 Identities = 47/201 (23%), Positives = 90/201 (44%), Gaps = 17/201 (8%)

Query: 639 DFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH 697
             +    +G G  G V++ +   +G   A K   +    +    +EE  NEI  + ++ H
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD----KEEVKNEISVMNQLDH 145

Query: 698 RNIVKFYGFCSHPKHSFIIYEYLESGSL-DKILCNDASAKELGWTQRLNVIKGVADALFY 756
            N+++ Y          ++ EY++ G L D+I+    +  EL     +  +K + + + +
Sbjct: 146 ANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTEL---DTILFMKQICEGIRH 202

Query: 757 LHNNCFPPIVHRDISSKNVLLDLGYEAHV--SDFGIAKFLNPDSSNWSELAGTHGYVAPE 814
           +H      I+H D+  +N+L        +   DFG+A+   P         GT  ++APE
Sbjct: 203 MHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR-EKLKVNFGTPEFLAPE 258

Query: 815 -LAYTLKVTEKCDVYSFGVLA 834
            + Y   V+   D++S GV+A
Sbjct: 259 VVNYD-FVSFPTDMWSVGVIA 278

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  110 bits (276), Expect = 1e-25
 Identities = 53/206 (25%), Positives = 81/206 (39%), Gaps = 33/206 (16%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFH----SPLPGEMSFQQEEFLNEIQALTEIRHRNI 700
           +G G  G V  A    + +  A++       +      +        EI+ L ++ H  I
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202

Query: 701 VKFYGFCSHPKHSFIIYEYLESGSL-DKILCN------DASAKELGWTQRLNVIKGVADA 753
           +K   F     + +I+ E +E G L DK++ N                        +  A
Sbjct: 203 IKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCK----------LYFYQMLLA 251

Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAH---VSDFGIAKFLNPDSSNWSELAGTHGY 810
           + YLH N    I+HRD+  +NVLL    E     ++DFG +K L   S     L GT  Y
Sbjct: 252 VQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLCGTPTY 307

Query: 811 VAPE-LAYTLKV--TEKCDVYSFGVL 833
           +APE L            D +S GV+
Sbjct: 308 LAPEVLVSVGTAGYNRAVDCWSLGVI 333

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  107 bits (268), Expect = 1e-25
 Identities = 28/263 (10%), Positives = 60/263 (22%), Gaps = 55/263 (20%)

Query: 643 EHCIGKGGHGSVYRAK-------VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI 695
               G       ++A        V      A+               +E L+    L+ I
Sbjct: 36  LIFHGGVPPLQFWQALDTALDRQV------ALTFVDPQGVLPDDVL-QETLSRTLRLSRI 88

Query: 696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALF 755
               + +            ++ E++  GSL ++               +  ++ +A A  
Sbjct: 89  DKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAAD 143

Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
             H      +         V         VS  G                     +    
Sbjct: 144 AAHRA---GVALSIDHPSRVR--------VSIDGDVV------------LAYPATMPD-- 178

Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEM--LDSRLPYPSLHV 873
                   + D+   G     ++  + P       +   S +         +   P+   
Sbjct: 179 -----ANPQDDIRGIGASLYALLVNRWP----LPEAGVRSGLAPAERDTAGQPIEPADID 229

Query: 874 QKKLMSIMQVAFSCLDQNPESRP 896
           +     I  VA   +  +   R 
Sbjct: 230 RDIPFQISAVAARSVQGDGGIRS 252

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  108 bits (272), Expect = 1e-25
 Identities = 57/244 (23%), Positives = 101/244 (41%), Gaps = 31/244 (12%)

Query: 600 QRKNDSQTQQSSFGNTPGLRSVLTFEGKIVYEEIISATNDFNAEHCIGKGGHGSVYRAK- 658
                 Q+  S   +     + L  +  I      + ++ F  E  +G+G    VYR K 
Sbjct: 15  TENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQ 74

Query: 659 VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYE 718
             + + +A+K          +  ++    EI  L  + H NI+K       P    ++ E
Sbjct: 75  KGTQKPYALKVLKK------TVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128

Query: 719 YLESGSL-DKILC------NDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDIS 771
            +  G L D+I+        DA+          + +K + +A+ YLH N    IVHRD+ 
Sbjct: 129 LVTGGELFDRIVEKGYYSERDAA----------DAVKQILEAVAYLHENG---IVHRDLK 175

Query: 772 SKNVLL-DLGYEAHV--SDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVY 828
            +N+L      +A +  +DFG++K +         + GT GY APE+        + D++
Sbjct: 176 PENLLYATPAPDAPLKIADFGLSKIVEHQVL-MKTVCGTPGYCAPEILRGCAYGPEVDMW 234

Query: 829 SFGV 832
           S G+
Sbjct: 235 SVGI 238

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  106 bits (268), Expect = 1e-25
 Identities = 75/295 (25%), Positives = 130/295 (44%), Gaps = 52/295 (17%)

Query: 646 IGKGGHGSVYRAKVPSGEIF------AVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRN 699
           +G+G  G V+ A+  +          AVK     L       +++F  E + LT ++H +
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKA----LKDPTLAARKDFQREAELLTNLQHEH 78

Query: 700 IVKFYGFCSHPKHSFIIYEYLESGSLDKIL-------------CNDASAKELGWTQRLNV 746
           IVKFYG C       +++EY++ G L+K L                 +  ELG +Q L++
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138

Query: 747 IKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAG 806
              +A  + YL +  F   VHRD++++N L+       + DFG+++ +   +  +    G
Sbjct: 139 ASQIASGMVYLASQHF---VHRDLATRNCLVGANLLVKIGDFGMSRDVY-STDYYR--VG 192

Query: 807 THGYV-----APE-LAYTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMN- 858
            H  +      PE + Y  K T + DV+SFGV+  E+   GK P           SN   
Sbjct: 193 GHTMLPIRWMPPESIMYR-KFTTESDVWSFGVILWEIFTYGKQP-------WFQLSNTEV 244

Query: 859 IEMLDS--RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
           IE +     L  P     K++  +M     C  + P+ R  +K + ++L   + +
Sbjct: 245 IECITQGRVLERPR-VCPKEVYDVML---GCWQREPQQRLNIKEIYKIL-HALGK 294

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  108 bits (271), Expect = 2e-25
 Identities = 51/203 (25%), Positives = 93/203 (45%), Gaps = 37/203 (18%)

Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFH-SPLPGEMSFQQEEFLNEIQALTEIRHRNIVKF 703
           +GKG    V R     +G  FA K  +   L        ++   E +   +++H NIV+ 
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR---DFQKLEREARICRKLQHPNIVRL 93

Query: 704 YGFCSHPKHSFIIYEYLESGSL-DKILC------NDASAKELGWTQRLNVIKGVADALFY 756
           +         +++++ +  G L + I+        DAS          + I+ + +++ Y
Sbjct: 94  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS----------HCIQQILESIAY 143

Query: 757 LHNNCFPPIVHRDISSKNVLL-DLGYEAHV--SDFGIAKFLNPDSSNWSELAGTHGYVAP 813
            H+N    IVHR++  +N+LL      A V  +DFG+A  +N   + W   AGT GY++P
Sbjct: 144 CHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WHGFAGTPGYLSP 199

Query: 814 EL----AYTLKVTEKCDVYSFGV 832
           E+     Y    ++  D+++ GV
Sbjct: 200 EVLKKDPY----SKPVDIWACGV 218

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  106 bits (267), Expect = 2e-25
 Identities = 58/291 (19%), Positives = 114/291 (39%), Gaps = 48/291 (16%)

Query: 643 EHCIGKGGHGSVYRAKVPSGEIF------AVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
              +G+   G VY+  +            A+K             +EEF +E      ++
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK---DKAEGPLREEFRHEAMLRARLQ 70

Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKIL-------------CNDASAKELGWTQR 743
           H N+V   G  +  +   +I+ Y   G L + L              +      L     
Sbjct: 71  HPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDF 130

Query: 744 LNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSE 803
           ++++  +A  + YL ++     VH+D++++NVL+       +SD G+ + +   ++++ +
Sbjct: 131 VHLVAQIAAGMEYLSSHHV---VHKDLATRNVLVYDKLNVKISDLGLFREV--YAADYYK 185

Query: 804 LAGTHGYV-----APELAYTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNM 857
               +  +     APE     K +   D++S+GV+  EV   G  P           SN 
Sbjct: 186 -LLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP---YCGY----SNQ 237

Query: 858 N-IEMLDS--RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
           + +EM+ +   LP P       + ++M     C ++ P  RP  K +   L
Sbjct: 238 DVVEMIRNRQVLPCPD-DCPAWVYALMI---ECWNEFPSRRPRFKDIHSRL 284

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  110 bits (276), Expect = 2e-25
 Identities = 59/231 (25%), Positives = 99/231 (42%), Gaps = 38/231 (16%)

Query: 614 NTPGLRSVLTFEGKIVYEEIISATNDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFH- 671
           +    R  L F+G             +N    +GKG  G V + K   + + +AVK  + 
Sbjct: 6   HHSSGRENLYFQGTF--------AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINK 57

Query: 672 SPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSL-DKILC 730
           +    +        L E++ L ++ H NI+K +         +I+ E    G L D+I+ 
Sbjct: 58  ASAKNK---DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK 114

Query: 731 ------NDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLL-DLGYEA 783
                 +DA+           +IK V   + Y+H +    IVHRD+  +N+LL     + 
Sbjct: 115 RKRFSEHDAA----------RIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDC 161

Query: 784 H--VSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGV 832
              + DFG++     ++    +  GT  Y+APE+       EKCDV+S GV
Sbjct: 162 DIKIIDFGLSTCFQQNTK-MKDRIGTAYYIAPEV-LRGTYDEKCDVWSAGV 210

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  107 bits (269), Expect = 2e-25
 Identities = 66/293 (22%), Positives = 122/293 (41%), Gaps = 47/293 (16%)

Query: 646 IGKGGHGSVYRAKVP-----SGEIF-AVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHR 698
           +G G  G V  A           +  AVK          + ++E  ++E++ ++ + +H 
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK---STAHADEKEALMSELKIMSHLGQHE 110

Query: 699 NIVKFYGFCSHPKHSFIIYEYLESGSL-----------DKILCNDASAKELGWTQRLNVI 747
           NIV   G C+H     +I EY   G L           +       +         L+  
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170

Query: 748 KGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGT 807
             VA  + +L +      +HRD++++NVLL  G+ A + DFG+A+ +  DS+    +   
Sbjct: 171 SQVAQGMAFLASKNC---IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY---IVKG 224

Query: 808 HGYV-----APELAYTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMN-IE 860
           +  +     APE  +    T + DV+S+G+L  E+   G +P            N    +
Sbjct: 225 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP------YPGILVNSKFYK 278

Query: 861 MLDS--RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
           ++    ++  P+    K + SIMQ   +C    P  RPT +++   L ++  +
Sbjct: 279 LVKDGYQMAQPA-FAPKNIYSIMQ---ACWALEPTHRPTFQQICSFL-QEQAQ 326

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  111 bits (278), Expect = 2e-25
 Identities = 49/193 (25%), Positives = 84/193 (43%), Gaps = 15/193 (7%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G  G V+R     +G  FA K   +P   +    +E    EIQ ++ +RH  +V  +
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESD----KETVRKEIQTMSVLRHPTLVNLH 220

Query: 705 GFCSHPKHSFIIYEYLESGSL-DKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFP 763
                     +IYE++  G L +K+        E    + +  ++ V   L ++H N   
Sbjct: 221 DAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSED---EAVEYMRQVCKGLCHMHEN--- 274

Query: 764 PIVHRDISSKNVLLDLGYEAHV--SDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKV 821
             VH D+  +N++        +   DFG+   L+P   +     GT  + APE+A    V
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-QSVKVTTGTAEFAAPEVAEGKPV 333

Query: 822 TEKCDVYSFGVLA 834
               D++S GVL+
Sbjct: 334 GYYTDMWSVGVLS 346

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  107 bits (268), Expect = 3e-25
 Identities = 59/302 (19%), Positives = 114/302 (37%), Gaps = 46/302 (15%)

Query: 638 NDFNAEHCIGKGGHGSVYRAKVPSGEIFAVK-------------KFHSPLPGEMSFQQEE 684
           ND+     + +G    +   +    + +A+K                +     +  + ++
Sbjct: 31  NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89

Query: 685 FLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRL 744
           F NE+Q +T+I++   +   G  ++    +IIYEY+E+ S+ K         +  +T  +
Sbjct: 90  FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFI 148

Query: 745 ------NVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS 798
                  +IK V ++  Y+HN     I HRD+   N+L+D      +SDFG ++++    
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYM--VD 204

Query: 799 SNWSELAGTHGYVAPELAYTLKVT--EKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSN 856
                  GT+ ++ PE           K D++S G+    +     P    F +  S   
Sbjct: 205 KKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP----FSLKISLVE 260

Query: 857 M--NIEMLDSRLPYPSLHVQKKLMSIMQVAFSC-------------LDQNPESRPTMKRV 901
           +  NI   +   P    H    L +      +              L +NP  R T +  
Sbjct: 261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDA 320

Query: 902 SQ 903
            +
Sbjct: 321 LK 322

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  108 bits (270), Expect = 4e-25
 Identities = 36/294 (12%), Positives = 78/294 (26%), Gaps = 56/294 (19%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR-------- 696
           +G+    +   A    +GE F V   +       +   ++   E+  L  +R        
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAI-KQMKEEVLRLRLLRGIKNQKQA 144

Query: 697 --------------HRNIVKFYGFCSHPKHSFIIYEYL-------ESGSLDKILCNDASA 735
                              K        +  +++  +           +  ++L + +S 
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 736 KE-LGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL 794
            + L    RL +   V   L  LH+     +VH  +   +++LD      ++ F      
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261

Query: 795 N-PDSSNWSELAGTHGYVAPELAY-----TLKVTEKCDVYSFGVLALEVIKGKHPRDFLF 848
                S            A  +          +T   D ++ G+    +     P     
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP----N 317

Query: 849 EMSSSSSNMN-IEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
              ++      I      +P P   +      +       L    E R    + 
Sbjct: 318 TDDAALGGSEWIFRSCKNIPQPVRAL------LEG----FLRYPKEDRLLPLQA 361

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  106 bits (266), Expect = 5e-25
 Identities = 52/236 (22%), Positives = 85/236 (36%), Gaps = 50/236 (21%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFH-SPLPGEMSFQQEEFLNEIQALTEIRHRNIVKF 703
           IG+G +G V  A    +  I A+K  + + +        E    E++ + ++ H NI + 
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93

Query: 704 YGFCSHPKHSFIIYEYLESGSL-DKILCNDASAKELGWTQRL------------------ 744
           Y      ++  ++ E    G L DK+      +        +                  
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153

Query: 745 ------------------NVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHV- 785
                             N+++ +  AL YLHN     I HRDI  +N L        + 
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIK 210

Query: 786 -SDFGIAKFLNP----DSSNWSELAGTHGYVAPEL--AYTLKVTEKCDVYSFGVLA 834
             DFG++K        +    +  AGT  +VAPE+          KCD +S GVL 
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  104 bits (263), Expect = 5e-25
 Identities = 48/201 (23%), Positives = 79/201 (39%), Gaps = 36/201 (17%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           IG+G  G V  A    +    A KK    +P       + F  EI+ +  + H NI++ Y
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKK----IPKYFVEDVDRFKQEIEIMKSLDHPNIIRLY 72

Query: 705 GFCSHPKHSFIIYEYLESGSL-DKILC------NDASAKELGWTQRLNVIKGVADALFYL 757
                    +++ E    G L ++++       +DA+           ++K V  A+ Y 
Sbjct: 73  ETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA----------RIMKDVLSAVAYC 122

Query: 758 HNNCFPPIVHRDISSKNVLL---DLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPE 814
           H      + HRD+  +N L           + DFG+A    P         GT  YV+P+
Sbjct: 123 HKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-KMMRTKVGTPYYVSPQ 178

Query: 815 L---AYTLKVTEKCDVYSFGV 832
           +    Y      +CD +S GV
Sbjct: 179 VLEGLY----GPECDEWSAGV 195

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  104 bits (263), Expect = 6e-25
 Identities = 50/204 (24%), Positives = 86/204 (42%), Gaps = 30/204 (14%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVK--KFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVK 702
           +G G    V + +   +G+ +A K  K            +EE   E+  L EIRH NI+ 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 703 FYGFCSHPKHSFIIYEYLESGSL-DKILCN------DASAKELGWTQRLNVIKGVADALF 755
            +    +     +I E +  G L D +         +A+            +K + D + 
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT----------QFLKQILDGVH 122

Query: 756 YLHNNCFPPIVHRDISSKNVLL-DLGYEAH---VSDFGIAKFLNPDSSNWSELAGTHGYV 811
           YLH+     I H D+  +N++L D         + DFGIA  +   +  +  + GT  +V
Sbjct: 123 YLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIFGTPEFV 178

Query: 812 APE-LAYTLKVTEKCDVYSFGVLA 834
           APE + Y   +  + D++S GV+ 
Sbjct: 179 APEIVNYE-PLGLEADMWSIGVIT 201

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  105 bits (263), Expect = 9e-25
 Identities = 46/196 (23%), Positives = 81/196 (41%), Gaps = 22/196 (11%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G+G  G V+R     S + +  K             Q     EI  L   RHRNI+  +
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKV-----KGTDQVLVKKEISILNIARHRNILHLH 67

Query: 705 GFCSHPKHSFIIYEYLESGSL-DKILCNDASAKELGWTQR--LNVIKGVADALFYLHNNC 761
                 +   +I+E++    + ++I             +R  ++ +  V +AL +LH++ 
Sbjct: 68  ESFESMEELVMIFEFISGLDIFERIN-----TSAFELNEREIVSYVHQVCEALQFLHSH- 121

Query: 762 FPPIVHRDISSKNVLLDLGYEAHV--SDFGIAKFLNPDSSNWSELAGTHGYVAPE-LAYT 818
              I H DI  +N++      + +   +FG A+ L P   N+  L     Y APE   + 
Sbjct: 122 --NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DNFRLLFTAPEYYAPEVHQHD 178

Query: 819 LKVTEKCDVYSFGVLA 834
             V+   D++S G L 
Sbjct: 179 -VVSTATDMWSLGTLV 193

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  105 bits (264), Expect = 1e-24
 Identities = 65/300 (21%), Positives = 123/300 (41%), Gaps = 56/300 (18%)

Query: 646 IGKGGHGSVYRAKVPSGEIF--------AVKKFHSPLPGEMSFQQEEFLNEIQALTEI-R 696
           +G+G  G V  A+    +          AVK               + ++E++ +  I +
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEMEMMKMIGK 99

Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKIL-------------CNDASAKELGWTQR 743
           H+NI+   G C+     ++I EY   G+L + L              N    +++ +   
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159

Query: 744 LNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSE 803
           ++    +A  + YL +      +HRD++++NVL+       ++DFG+A+ +N        
Sbjct: 160 VSCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNVMKIADFGLARDINNID---YY 213

Query: 804 LAGTHGYV-----APELAYTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNM 857
              T+G +     APE  +    T + DV+SFGVL  E+   G  P      +       
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP---YPGIP------ 264

Query: 858 NIEMLDS-----RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFEV 912
             E+        R+  P+ +   +L  +M+    C    P  RPT K++ + L ++I  +
Sbjct: 265 VEELFKLLKEGHRMDKPA-NCTNELYMMMR---DCWHAVPSQRPTFKQLVEDL-DRILTL 319

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  104 bits (262), Expect = 1e-24
 Identities = 44/204 (21%), Positives = 81/204 (39%), Gaps = 30/204 (14%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFH--SPLPGEMSFQQEEFLNEIQALTEIRHRNIVK 702
           +G G    V + +   +G  +A K               +EE   E+  L ++ H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79

Query: 703 FYGFCSHPKHSFIIYEYLESGSL-DKILC------NDASAKELGWTQRLNVIKGVADALF 755
            +    +     +I E +  G L D +         +A+          + IK + D + 
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT----------SFIKQILDGVN 129

Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAH----VSDFGIAKFLNPDSSNWSELAGTHGYV 811
           YLH      I H D+  +N++L           + DFG+A  +      +  + GT  +V
Sbjct: 130 YLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPEFV 185

Query: 812 APE-LAYTLKVTEKCDVYSFGVLA 834
           APE + Y   +  + D++S GV+ 
Sbjct: 186 APEIVNYE-PLGLEADMWSIGVIT 208

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  104 bits (262), Expect = 2e-24
 Identities = 44/204 (21%), Positives = 86/204 (42%), Gaps = 30/204 (14%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFH--SPLPGEMSFQQEEFLNEIQALTEIRHRNIVK 702
           +G G    V + +   +G  +A K               +E+   E+  L EI+H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78

Query: 703 FYGFCSHPKHSFIIYEYLESGSL-DKILCN------DASAKELGWTQRLNVIKGVADALF 755
            +    +     +I E +  G L D +         +A+            +K + + ++
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT----------EFLKQILNGVY 128

Query: 756 YLHNNCFPPIVHRDISSKNVLL-DLGYEAH---VSDFGIAKFLNPDSSNWSELAGTHGYV 811
           YLH+     I H D+  +N++L D         + DFG+A  ++  +  +  + GT  +V
Sbjct: 129 YLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFV 184

Query: 812 APE-LAYTLKVTEKCDVYSFGVLA 834
           APE + Y   +  + D++S GV+ 
Sbjct: 185 APEIVNYE-PLGLEADMWSIGVIT 207

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  105 bits (263), Expect = 2e-24
 Identities = 45/204 (22%), Positives = 81/204 (39%), Gaps = 30/204 (14%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFH--SPLPGEMSFQQEEFLNEIQALTEIRHRNIVK 702
           +G G    V + +   +G  +A K               +EE   E+  L ++ H NI+ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79

Query: 703 FYGFCSHPKHSFIIYEYLESGSL-DKILC------NDASAKELGWTQRLNVIKGVADALF 755
            +    +     +I E +  G L D +         +A+          + IK + D + 
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT----------SFIKQILDGVN 129

Query: 756 YLHNNCFPPIVHRDISSKNVLL----DLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV 811
           YLH      I H D+  +N++L           + DFG+A  +      +  + GT  +V
Sbjct: 130 YLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPEFV 185

Query: 812 APE-LAYTLKVTEKCDVYSFGVLA 834
           APE + Y   +  + D++S GV+ 
Sbjct: 186 APEIVNYE-PLGLEADMWSIGVIT 208

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  103 bits (258), Expect = 4e-24
 Identities = 66/309 (21%), Positives = 121/309 (39%), Gaps = 71/309 (22%)

Query: 646 IGKGGHGSVYRAKVP-----SGEIF-AVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRN 699
           +G+G  G V +A        +G    AVK            +  + L+E   L ++ H +
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK---ENASPSELRDLLSEFNVLKQVNHPH 87

Query: 700 IVKFYGFCSHPKHSFIIYEYLESGSL---------------------DKILCNDASAKEL 738
           ++K YG CS      +I EY + GSL                     +    +    + L
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147

Query: 739 GWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS 798
                ++    ++  + YL        VHRD++++N+L+  G +  +SDFG+++ +  + 
Sbjct: 148 TMGDLISFAWQISQGMQYLAEMKL---VHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204

Query: 799 SNWSELAGTHGYV-----APE-LAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS 852
           S    +  + G +     A E L      T + DV+SFGVL             L+E+ +
Sbjct: 205 SY---VKRSQGRIPVKWMAIESLFDH-IYTTQSDVWSFGVL-------------LWEIVT 247

Query: 853 -------SSSNMN-IEMLDS--RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVS 902
                           +L +  R+  P  +  +++  +M     C  Q P+ RP    +S
Sbjct: 248 LGGNPYPGIPPERLFNLLKTGHRMERPD-NCSEEMYRLML---QCWKQEPDKRPVFADIS 303

Query: 903 QLLCEKIFE 911
           + L EK+  
Sbjct: 304 KDL-EKMMV 311

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  103 bits (258), Expect = 4e-24
 Identities = 69/297 (23%), Positives = 119/297 (40%), Gaps = 51/297 (17%)

Query: 646 IGKGGHGSVYRAKVPSGEIF------AVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHR 698
           +G G  G V  A              AVK      P     ++E  ++E++ L+ +  H 
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK---PSAHLTEREALMSELKVLSYLGNHM 87

Query: 699 NIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKG--------- 749
           NIV   G C+    + +I EY   G L   L     +     T    +            
Sbjct: 88  NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147

Query: 750 ------VADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSE 803
                 VA  + +L +      +HRD++++N+LL  G    + DFG+A+ +  DS+    
Sbjct: 148 LSFSYQVAKGMAFLASKNC---IHRDLAARNILLTHGRITKICDFGLARDIKNDSNY--- 201

Query: 804 LAGTHGYV-----APELAYTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNM 857
           +   +  +     APE  +    T + DV+S+G+   E+   G  P   +        + 
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM------PVDS 255

Query: 858 N-IEMLDS--RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
              +M+    R+  P  H   ++  IM+   +C D +P  RPT K++ QL+ EK   
Sbjct: 256 KFYKMIKEGFRMLSPE-HAPAEMYDIMK---TCWDADPLKRPTFKQIVQLI-EKQIS 307

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  103 bits (259), Expect = 4e-24
 Identities = 47/298 (15%), Positives = 107/298 (35%), Gaps = 30/298 (10%)

Query: 627 KIVYE-EIISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEF 685
           K++ E + ++                    + +    EI+   +     P       +  
Sbjct: 50  KVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDW-PLSSPSPMDAP 108

Query: 686 LNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLN 745
             +I+ +     +N V      S   + +I  +     +L   +    S ++      L+
Sbjct: 109 SVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLH 168

Query: 746 VIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELA 805
           +   +A+A+ +LH+     ++HRD+   N+   +     V DFG+   ++ D    + L 
Sbjct: 169 IFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 225

Query: 806 ------------GTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS 853
                       GT  Y++PE  +    + K D++S G++  E++   +      E    
Sbjct: 226 PMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL---YSFSTQMERVRI 282

Query: 854 SSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
            +++     + + P        +   ++Q     L  +P  RP     + ++   IFE
Sbjct: 283 ITDVR----NLKFPLLFTQKYPQEHMMVQ---DMLSPSPTERPE---ATDIIENAIFE 330

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  103 bits (258), Expect = 4e-24
 Identities = 63/298 (21%), Positives = 108/298 (36%), Gaps = 54/298 (18%)

Query: 646 IGKGGHGSVYRAKV------PSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHR 698
           +G+G  G V  A         +    AVK       G    +    ++E++ L  I  H 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKILIHIGHHL 91

Query: 699 NIVKFYGFCSHP-KHSFIIYEYLESGSL-------------DKILCNDASAKELGWTQRL 744
           N+V   G C+ P     +I E+ + G+L              K+   D     L     +
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151

Query: 745 NVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSEL 804
                VA  + +L +      +HRD++++N+LL       + DFG+A+ +  D      +
Sbjct: 152 CYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY---V 205

Query: 805 AGTHGYV-----APELAYTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMN 858
                 +     APE  +    T + DV+SFGVL  E+   G  P      +       +
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP---YPGVKI-----D 257

Query: 859 IEMLDS-----RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
            E         R+  P  +   ++   M     C    P  RPT   + + L   + +
Sbjct: 258 EEFCRRLKEGTRMRAPD-YTTPEMYQTML---DCWHGEPSQRPTFSELVEHL-GNLLQ 310

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  103 bits (258), Expect = 5e-24
 Identities = 52/200 (26%), Positives = 82/200 (41%), Gaps = 32/200 (16%)

Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR-HRNIVKF 703
           +G+G      +     S + FAVK             +     EI AL     H NIVK 
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKR-------MEANTQKEITALKLCEGHPNIVKL 71

Query: 704 YGFCSHPKHSFIIYEYLESGSL-DKILC------NDASAKELGWTQRLNVIKGVADALFY 756
           +       H+F++ E L  G L ++I         +AS           +++ +  A+ +
Sbjct: 72  HEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEAS----------YIMRKLVSAVSH 121

Query: 757 LHNNCFPPIVHRDISSKNVLL-DLGYEAHV--SDFGIAKFLNPDSSNWSELAGTHGYVAP 813
           +H+     +VHRD+  +N+L  D      +   DFG A+   PD+        T  Y AP
Sbjct: 122 MHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAP 178

Query: 814 ELAYTLKVTEKCDVYSFGVL 833
           EL       E CD++S GV+
Sbjct: 179 ELLNQNGYDESCDLWSLGVI 198

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  103 bits (258), Expect = 6e-24
 Identities = 52/201 (25%), Positives = 80/201 (39%), Gaps = 34/201 (16%)

Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQAL-TEIRHRNIVKF 703
           IG G +    R     +   FAVK         +   + +   EI+ L    +H NI+  
Sbjct: 30  IGVGSYSVCKRCIHKATNMEFAVKI--------IDKSKRDPTEEIEILLRYGQHPNIITL 81

Query: 704 YGFCSHPKHSFIIYEYLESGSL-DKILC------NDASAKELGWTQRLNVIKGVADALFY 756
                  K+ +++ E ++ G L DKIL        +ASA          V+  +   + Y
Sbjct: 82  KDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASA----------VLFTITKTVEY 131

Query: 757 LHNNCFPPIVHRDISSKNVLLDLGYEAH----VSDFGIAKFLNPDSSNWSELAGTHGYVA 812
           LH      +VHRD+   N+L            + DFG AK L  ++        T  +VA
Sbjct: 132 LHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVA 188

Query: 813 PELAYTLKVTEKCDVYSFGVL 833
           PE+         CD++S GVL
Sbjct: 189 PEVLERQGYDAACDIWSLGVL 209

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  103 bits (259), Expect = 6e-24
 Identities = 63/303 (20%), Positives = 123/303 (40%), Gaps = 64/303 (21%)

Query: 646 IGKGGHGSVYRAKVPSGEIF--------AVKKFHSPLPGEMSFQQEEFLNEIQALTEI-R 696
           +G+G  G V  A+    +          AVK               + ++E++ +  I +
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEMEMMKMIGK 145

Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKIL-------------CNDASAKELGWTQR 743
           H+NI+   G C+     ++I EY   G+L + L              N    +++ +   
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205

Query: 744 LNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSE 803
           ++    +A  + YL +      +HRD++++NVL+       ++DFG+A+ +N        
Sbjct: 206 VSCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNVMKIADFGLARDINNIDYY--- 259

Query: 804 LAGTHGYV-----APELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS------ 852
              T+G +     APE  +    T + DV+SFGVL             ++E+ +      
Sbjct: 260 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVL-------------MWEIFTLGGSPY 306

Query: 853 -SSSNMN-IEMLDS--RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEK 908
                    ++L    R+  P+ +   +L  +M+    C    P  RPT K++ + L ++
Sbjct: 307 PGIPVEELFKLLKEGHRMDKPA-NCTNELYMMMR---DCWHAVPSQRPTFKQLVEDL-DR 361

Query: 909 IFE 911
           I  
Sbjct: 362 ILT 364

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  103 bits (259), Expect = 8e-24
 Identities = 66/300 (22%), Positives = 119/300 (39%), Gaps = 58/300 (19%)

Query: 646 IGKGGHGSVYRAKVPSGEIF--------AVKKFHSPLPGEMSFQQEEFLNEIQALTEI-R 696
           +G+G  G V  A+    +          AVK               + ++E++ +  I +
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK---SDATEKDLSDLISEMEMMKMIGK 133

Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSL-------------DKILCNDASAKELGWTQR 743
           H+NI+   G C+     ++I EY   G+L                  +    ++L     
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193

Query: 744 LNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSE 803
           ++    VA  + YL +      +HRD++++NVL+       ++DFG+A+ ++        
Sbjct: 194 VSCAYQVARGMEYLASKKC---IHRDLAARNVLVTEDNVMKIADFGLARDIHHID---YY 247

Query: 804 LAGTHGYV-----APE-LAYTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSN 856
              T+G +     APE L      T + DV+SFGVL  E+   G  P      +      
Sbjct: 248 KKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSP---YPGVP----- 298

Query: 857 MNIEMLDS-----RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
              E+        R+  PS +   +L  +M+    C    P  RPT K++ + L ++I  
Sbjct: 299 -VEELFKLLKEGHRMDKPS-NCTNELYMMMR---DCWHAVPSQRPTFKQLVEDL-DRIVA 352

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  102 bits (257), Expect = 9e-24
 Identities = 65/309 (21%), Positives = 125/309 (40%), Gaps = 71/309 (22%)

Query: 646 IGKGGHGSVYRAKVPSGEIF------AVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRN 699
           IG+G  G V++A+ P    +      AVK          +  Q +F  E   + E  + N
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQADFQREAALMAEFDNPN 111

Query: 700 IVKFYGFCSHPKHSFIIYEYLESGSLDKIL---------------------CNDASAKEL 738
           IVK  G C+  K   +++EY+  G L++ L                      +      L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171

Query: 739 GWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS 798
              ++L + + VA  + YL    F   VHRD++++N L+       ++DFG+++ +    
Sbjct: 172 SCAEQLCIARQVAAGMAYLSERKF---VHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228

Query: 799 SNWSELAGTHGYV-----APE-LAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS 852
                 A  +  +      PE + Y  + T + DV+++GV+             L+E+ S
Sbjct: 229 ---YYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVV-------------LWEIFS 271

Query: 853 -------SSSNMN-IEMLDS--RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVS 902
                    ++   I  +     L  P  +   +L ++M+    C  + P  RP+   + 
Sbjct: 272 YGLQPYYGMAHEEVIYYVRDGNILACPE-NCPLELYNLMR---LCWSKLPADRPSFCSIH 327

Query: 903 QLLCEKIFE 911
           ++L +++ E
Sbjct: 328 RIL-QRMCE 335

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score =  101 bits (253), Expect = 1e-23
 Identities = 50/248 (20%), Positives = 88/248 (35%), Gaps = 18/248 (7%)

Query: 258 LFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNI 317
                  +  I         +     L K      V ++   L  + ++  N + +  ++
Sbjct: 7   TITVPTPIKQIFS--DDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SV 61

Query: 318 SETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQY 377
                  PN+T + L+ N      +        L  L +  N +     L+  +  +L+ 
Sbjct: 62  QG-IQYLPNVTKLFLNGNKL--TDIKPLANLKNLGWLFLDENKVKDLSSLK--DLKKLKS 116

Query: 378 LDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFV 437
           L L  N I  +I   L ++  L  L L  NK++      L  L  L+ L L  N +S+  
Sbjct: 117 LSLEHNGIS-DING-LVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQISDI- 171

Query: 438 PESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEK 497
              L  L KL  L LS N +S  +   L  L +L  L+L       K  +    +     
Sbjct: 172 -VPLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNT 228

Query: 498 LNLSYNNL 505
           +  +  +L
Sbjct: 229 VKNTDGSL 236

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 96.3 bits (240), Expect = 6e-22
 Identities = 54/260 (20%), Positives = 90/260 (34%), Gaps = 46/260 (17%)

Query: 299 NLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSI 358
              + +K  L +  +T     T     ++  I  +N+                      I
Sbjct: 22  AFAETIKDNLKKKSVTDA--VTQNELNSIDQIIANNSD---------------------I 58

Query: 359 NNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELG 418
            ++ G     I     +  L L+ N +  +I   L N+  L  L L  NK+       L 
Sbjct: 59  KSVQG-----IQYLPNVTKLFLNGNKLT-DI-KPLANLKNLGWLFLDENKVKDLSS--LK 109

Query: 419 SLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIE-LDNLIHLSELDLS 477
            L  L+ L L  N +S+     L  L +L  L L +NK++    I  L  L  L  L L 
Sbjct: 110 DLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITD---ITVLSRLTKLDTLSLE 164

Query: 478 HNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNST 537
            N +   I   +  +  L+ L LS N++S L       +  L  +++       +  N  
Sbjct: 165 DNQI-SDIVP-LAGLTKLQNLYLSKNHISDLRA--LAGLKNLDVLELFSQ----ECLNKP 216

Query: 538 TFRDAPLEALQGNKGLYGDI 557
               + L      K   G +
Sbjct: 217 INHQSNLVVPNTVKNTDGSL 236

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 95.5 bits (238), Expect = 9e-22
 Identities = 59/284 (20%), Positives = 98/284 (34%), Gaps = 42/284 (14%)

Query: 201 LGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFL 260
                  +   L   S   ++ Q    L S+  +    + +     +    L N+  LFL
Sbjct: 20  DDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGIQ--YLPNVTKLFL 75

Query: 261 YHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISET 320
             N+L+ I P  + NLK L  L L +N  +       ++L  L  L L  N ++ +I   
Sbjct: 76  NGNKLTDIKP--LANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGIS-DI-NG 129

Query: 321 FGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDL 380
               P L  + L NN                      I +I+      +    +L  L L
Sbjct: 130 LVHLPQLESLYLGNNK---------------------ITDITV-----LSRLTKLDTLSL 163

Query: 381 SSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPES 440
             N I  +I   L  +  L  L LS N +S    R L  L NL+ L+L +    N     
Sbjct: 164 EDNQIS-DIV-PLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFSQECLNKPINH 219

Query: 441 LGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEK 484
             +LV    +  +   L    P  + +     + ++  +     
Sbjct: 220 QSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKPNVKWHLPEFT 261

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 93.6 bits (233), Expect = 4e-21
 Identities = 55/235 (23%), Positives = 99/235 (42%), Gaps = 16/235 (6%)

Query: 103 FSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVL 162
           FS  +F   +  +L    +   +    + L++++ +  + + +  +   GI  L ++T L
Sbjct: 18  FSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI--KSVQGIQYLPNVTKL 73

Query: 163 HISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIP 222
            ++ N L+  I   +  L  L  L LD N +   +  SL +L  +  L L +N    S  
Sbjct: 74  FLNGNKLT-DIK-PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGI--SDI 127

Query: 223 QEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSL 282
             + +L  L  L L  N+++    L  S LT L  L L  N++S I+P  +  L KL +L
Sbjct: 128 NGLVHLPQLESLYLGNNKITDITVL--SRLTKLDTLSLEDNQISDIVP--LAGLTKLQNL 183

Query: 283 LLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSF 337
            L+KNH   +  ++   L +L  L L                     +  ++ S 
Sbjct: 184 YLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 87.0 bits (216), Expect = 7e-19
 Identities = 57/256 (22%), Positives = 98/256 (38%), Gaps = 20/256 (7%)

Query: 90  NLTSISLNGTLLE--FSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFG 147
                +L    +    + +    +  +   N+++  +    I  L N+  L  + NKL  
Sbjct: 25  ETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKL-T 81

Query: 148 QIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHV 207
            I   +  L +L  L +  N +   +   +  L  L  L+L+ N ++  I   L +L  +
Sbjct: 82  DI-KPLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGIS-DIN-GLVHLPQL 136

Query: 208 VILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSG 267
             LYL NN    +    +  L  L  L L  NQ+S  +PL  + LT L+ L+L  N +S 
Sbjct: 137 ESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISDIVPL--AGLTKLQNLYLSKNHISD 192

Query: 268 IIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTG--NISETFGTYP 325
           +  + +  LK L+ L L              NL     ++     L     IS+  G Y 
Sbjct: 193 L--RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISD-DGDYE 249

Query: 326 NLTFIDLSNNSFFGEI 341
               +      F  E+
Sbjct: 250 KPN-VKWHLPEFTNEV 264

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 51/234 (21%), Positives = 89/234 (38%), Gaps = 23/234 (9%)

Query: 90  NLTSISLNGTLLE--FSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFG 147
           N+T + LNG  L      ++  +L +L L  N++  +    + +L  L+ L    N +  
Sbjct: 69  NVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGI-- 124

Query: 148 QIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHV 207
              +G+  L  L  L++  N ++      + +LT L+ L+L+ N ++  I   L  LT +
Sbjct: 125 SDINGLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQIS-DIV-PLAGLTKL 180

Query: 208 VILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSG 267
             LYL  N    S  + +  LK+L  LEL   +         SNL     +      L  
Sbjct: 181 QNLYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL-- 236

Query: 268 IIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETF 321
           + P+ I +        +  +             T+ V     Q    G     F
Sbjct: 237 VTPEIISDDGDYEKPNVKWH---------LPEFTNEVSFIFYQPVTIGKAKARF 281

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  101 bits (255), Expect = 1e-23
 Identities = 47/199 (23%), Positives = 88/199 (44%), Gaps = 22/199 (11%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHR-NIVKF 703
           +G+G    V +     +G+ +A K       G+    + E L+EI  L   +    ++  
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQD--CRAEILHEIAVLELAKSCPRVINL 94

Query: 704 YGFCSHPKHSFIIYEYLESGSL-DKILCNDASAKELGW-TQR--LNVIKGVADALFYLHN 759
           +    +     +I EY   G +    L      +     ++   + +IK + + ++YLH 
Sbjct: 95  HEVYENTSEIILILEYAAGGEIFSLCL-----PELAEMVSENDVIRLIKQILEGVYYLHQ 149

Query: 760 NCFPPIVHRDISSKNVLLDLGYEAH---VSDFGIAKFLNPDSSNWSELAGTHGYVAPE-L 815
           N    IVH D+  +N+LL   Y      + DFG+++ +        E+ GT  Y+APE L
Sbjct: 150 NN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-LREIMGTPEYLAPEIL 205

Query: 816 AYTLKVTEKCDVYSFGVLA 834
            Y   +T   D+++ G++A
Sbjct: 206 NYD-PITTATDMWNIGIIA 223

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 98.1 bits (245), Expect = 1e-23
 Identities = 33/184 (17%), Positives = 73/184 (39%), Gaps = 13/184 (7%)

Query: 349 PQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIY---LNRLSLS 405
                    +   S +  +   +   L Y+ L++  +     T L  I Y   +  L+++
Sbjct: 20  STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINV-----TDLTGIEYAHNIKDLTIN 74

Query: 406 GNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIEL 465
               +   P  +  L NLE L +   ++++    +L  L  L  L++SH+     I  ++
Sbjct: 75  NIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI 132

Query: 466 DNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDIS 525
           + L  ++ +DLS+N     I   +  +  L+ LN+ ++ +        E+   L  +   
Sbjct: 133 NTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAF 189

Query: 526 YNKL 529
              +
Sbjct: 190 SQTI 193

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 97.3 bits (243), Expect = 3e-23
 Identities = 39/210 (18%), Positives = 78/210 (37%), Gaps = 34/210 (16%)

Query: 299 NLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSI 358
                +   L Q+  T NI  T     +LT+I L+N +                     +
Sbjct: 21  TFKAYLNGLLGQS-STANI--TEAQMNSLTYITLANIN---------------------V 56

Query: 359 NNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELG 418
            +++G     I  +  ++ L +++ +     P  +  +  L RL + G  ++      L 
Sbjct: 57  TDLTG-----IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLS 109

Query: 419 SLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSH 478
            L +L  LD+S +   + +   + +L K+  ++LS+N     I   L  L  L  L++  
Sbjct: 110 GLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQF 168

Query: 479 NFLGEKISSRICRMESLEKLNLSYNNLSGL 508
           + +       I     L +L      + G 
Sbjct: 169 DGV-HDYRG-IEDFPKLNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 93.9 bits (234), Expect = 5e-22
 Identities = 29/165 (17%), Positives = 57/165 (34%), Gaps = 7/165 (4%)

Query: 104 SFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLH 163
           + +    L Y+ L N  +  +    I    N++ L  +         + I  L++L  L 
Sbjct: 39  TEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHA--TNYNPISGLSNLERLR 94

Query: 164 ISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQ 223
           I    ++      +  LT L  L +  +  + SI   +  L  V  + L  N     I  
Sbjct: 95  IMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-M 153

Query: 224 EIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGI 268
            +  L  L  L +  + +     +   +   L  L+ +   + G 
Sbjct: 154 PLKTLPELKSLNIQFDGVHDYRGI--EDFPKLNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 93.1 bits (232), Expect = 1e-21
 Identities = 29/184 (15%), Positives = 66/184 (35%), Gaps = 10/184 (5%)

Query: 275 NLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSN 334
             K   + LL ++    T   +   +  L  + L    +T +++       N+  + ++N
Sbjct: 21  TFKAYLNGLLGQSS---TANITEAQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINN 75

Query: 335 NSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLG 394
                   +       L  L +   +++      +     L  LD+S +     I T++ 
Sbjct: 76  IHA--TNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133

Query: 395 NIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSH 454
            +  +N + LS N     I   L +L  L+ L++  + + ++    +    KL  L    
Sbjct: 134 TLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDY--RGIEDFPKLNQLYAFS 190

Query: 455 NKLS 458
             + 
Sbjct: 191 QTIG 194

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 88.5 bits (220), Expect = 4e-20
 Identities = 30/209 (14%), Positives = 72/209 (34%), Gaps = 34/209 (16%)

Query: 227 NLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAK 286
             K+  +  L  +  +    ++ + + +L ++ L +  ++ +    I     +  L +  
Sbjct: 21  TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINN 75

Query: 287 NHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWG 346
            H   T       L++L +LR+    +T +         +LT +D+S++           
Sbjct: 76  IHA--TNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHS----------- 122

Query: 347 RCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSG 406
                            SI  +I    ++  +DLS N  + +I   L  +  L  L++  
Sbjct: 123 -------------AHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQF 168

Query: 407 NKLSGCIPRELGSLINLEYLDLSANNLSN 435
           + +       +     L  L   +  +  
Sbjct: 169 DGVHDYRG--IEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 86.9 bits (216), Expect = 1e-19
 Identities = 33/197 (16%), Positives = 73/197 (37%), Gaps = 10/197 (5%)

Query: 92  TSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPS 151
           T +  +   +    S+F   +   L  +          + +++L Y+  +   +     +
Sbjct: 6   TGLKASQDNVNIPDSTFKAYLNGLLGQSS---TANITEAQMNSLTYITLANINV--TDLT 60

Query: 152 GIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILY 211
           GI    ++  L I+    +   P  +  L+ L +L +    +      +L  LT + +L 
Sbjct: 61  GIEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLD 118

Query: 212 LYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQ 271
           + +++   SI  +I  L  +  ++L  N     I   +  L  L+ L +  + +      
Sbjct: 119 ISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRG- 176

Query: 272 EIGNLKKLNSLLLAKNH 288
            I +  KLN L      
Sbjct: 177 -IEDFPKLNQLYAFSQT 192

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 82.7 bits (205), Expect = 4e-18
 Identities = 26/164 (15%), Positives = 58/164 (35%), Gaps = 7/164 (4%)

Query: 200 SLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLF 259
           +   +  +  + L N +    +   I    ++ DL +     +   P+S   L+NL  L 
Sbjct: 39  TEAQMNSLTYITLANINV-TDL-TGIEYAHNIKDLTINNIHATNYNPIS--GLSNLERLR 94

Query: 260 LYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISE 319
           +   +++      +  L  L  L ++ +    ++      L  +  + L+ N    +I  
Sbjct: 95  IMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP 154

Query: 320 TFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISG 363
              T P L  +++  +             P+L+ L      I G
Sbjct: 155 -LKTLPELKSLNIQFDGV--HDYRGIEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 51.5 bits (124), Expect = 2e-07
 Identities = 16/115 (13%), Positives = 44/115 (38%), Gaps = 4/115 (3%)

Query: 422 NLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFL 481
             +         S+    +   +  L Y+ L++  ++    IE     ++ +L +++   
Sbjct: 21  TFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTGIE--YAHNIKDLTINNIHA 78

Query: 482 GEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNS 536
               +  I  + +LE+L +   +++         +  L  +DIS++  +  I   
Sbjct: 79  -TNYNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  102 bits (254), Expect = 3e-23
 Identities = 41/298 (13%), Positives = 85/298 (28%), Gaps = 63/298 (21%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVK---KFHSPLPGEMSFQQEE----------------- 684
           +G+    +   A    +GE F V        P    +   +EE                 
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 685 ----FLNEIQALTEIRHRNIVKFYGFCSHPKH-SFIIYEYLESGSL----DKILCNDASA 735
               F+     + + + + +++           S          +L    + +L + ++ 
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200

Query: 736 KELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN 795
           K L    RL +   V   L  LH+     +VH  +   +++LD      ++ F       
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257

Query: 796 PDSSNWSELAGTHGYVAPEL-----------AYTLKVTEKCDVYSFGVLALEVIKGKHPR 844
                    + + G+  PEL                +T   D ++ G++   +     P 
Sbjct: 258 ARVV----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP- 312

Query: 845 DFLFEMSSSSSNMN-IEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
                  ++      I      +P P     + L  +       L    E R    + 
Sbjct: 313 ---ITKDAALGGSEWIFRSCKNIPQPV----RAL--LEG----FLRYPKEDRLLPLQA 357

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  101 bits (253), Expect = 3e-23
 Identities = 67/309 (21%), Positives = 119/309 (38%), Gaps = 70/309 (22%)

Query: 646 IGKGGHGSVYRAKVPSGEIF------AVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHR 698
           +G G  G V  A              AVK          S ++E  ++E++ +T++  H 
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLK---EKADSSEREALMSELKMMTQLGSHE 109

Query: 699 NIVKFYGFCSHPKHSFIIYEYLESGSL--------------------DKILCNDASAKEL 738
           NIV   G C+     ++I+EY   G L                     K L  +     L
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169

Query: 739 GWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS 798
            +   L     VA  + +L        VHRD++++NVL+  G    + DFG+A+ +  DS
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFKSC---VHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226

Query: 799 SNWSELAGTHGYV-----APELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS- 852
              + +   +  +     APE  +    T K DV+S+G+L             L+E+ S 
Sbjct: 227 ---NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGIL-------------LWEIFSL 270

Query: 853 -------SSSNMN-IEMLDS--RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVS 902
                     + N  +++ +  ++  P  +  +++  IMQ   SC   +   RP+   ++
Sbjct: 271 GVNPYPGIPVDANFYKLIQNGFKMDQPF-YATEEIYIIMQ---SCWAFDSRKRPSFPNLT 326

Query: 903 QLLCEKIFE 911
             L      
Sbjct: 327 SFL-GCQLA 334

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 96.2 bits (240), Expect = 5e-22
 Identities = 54/230 (23%), Positives = 86/230 (37%), Gaps = 34/230 (14%)

Query: 113 YLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGI-GLLTHLTVLHISRNWLSG 171
            LDL  N L  +      +   L+ LD S  ++   I  G    L+HL+ L ++ N +  
Sbjct: 32  NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEI-QTIEDGAYQSLSHLSTLILTGNPIQ- 89

Query: 172 SIPHEV-GQLTVLNQLALDSNFLNGSIP-RSLGNLTHVVILYLYNNSFFGSIPQEIGNLK 229
           S+       L+ L +L      L  S+    +G+L  +  L + +N    S         
Sbjct: 90  SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNL-IQSFKLP----- 142

Query: 230 SLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKL----NSLLLA 285
             F                  NLTNL  L L  N++  I   ++  L ++     SL L+
Sbjct: 143 EYFS-----------------NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLS 185

Query: 286 KNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNN 335
            N      P +F+ +  L +L L+ N L       F    +L  I L  N
Sbjct: 186 LNPMNFIQPGAFKEIR-LKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 93.5 bits (233), Expect = 3e-21
 Identities = 56/237 (23%), Positives = 92/237 (38%), Gaps = 40/237 (16%)

Query: 301 TDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINN 360
                L L+ N L    S +F ++P L  +DLS                ++         
Sbjct: 28  FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRC--------------EIQ-------- 65

Query: 361 ISGSIPLEIGESL-QLQYLDLSSN---YIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRE 416
              +I     +SL  L  L L+ N    +     + L +   L +L      L+      
Sbjct: 66  ---TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSS---LQKLVAVETNLASLENFP 119

Query: 417 LGSLINLEYLDLSANNLSNF-VPESLGSLVKLYYLNLSHNKLSQQIPIE-LDNLIHL--- 471
           +G L  L+ L+++ N + +F +PE   +L  L +L+LS NK+ Q I    L  L  +   
Sbjct: 120 IGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI-QSIYCTDLRVLHQMPLL 178

Query: 472 -SELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYN 527
              LDLS N +   I     +   L++L L  N L  +    F+ +  L  I +  N
Sbjct: 179 NLSLDLSLNPM-NFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 87.3 bits (217), Expect = 4e-19
 Identities = 48/251 (19%), Positives = 76/251 (30%), Gaps = 52/251 (20%)

Query: 209 ILYLYNNSFFGSIPQEI-GNLKSLFDLELCINQLSGAIPLSI-SNLTNLRFLFLYHNELS 266
            L L  N     +      +   L  L+L   ++   I      +L++L  L L  N + 
Sbjct: 32  NLDLSFNPL-RHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ 89

Query: 267 GIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNIS-ETFGTYP 325
            +       L  L  L+  + +          +L  L +L +  N +      E F    
Sbjct: 90  SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149

Query: 326 NLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESL-QLQYLDLSSNY 384
           NL  +DLS+N              ++            SI       L Q+  L+L    
Sbjct: 150 NLEHLDLSSN--------------KIQ-----------SIYCTDLRVLHQMPLLNL---- 180

Query: 385 IVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSL 444
                            L LS N ++  I       I L+ L L  N L +        L
Sbjct: 181 ----------------SLDLSLNPMNF-IQPGAFKEIRLKELALDTNQLKSVPDGIFDRL 223

Query: 445 VKLYYLNLSHN 455
             L  + L  N
Sbjct: 224 TSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 82.3 bits (204), Expect = 2e-17
 Identities = 42/190 (22%), Positives = 73/190 (38%), Gaps = 9/190 (4%)

Query: 364 SIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINL 423
            IP  +      + LDLS N +         +   L  L LS  ++         SL +L
Sbjct: 21  KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78

Query: 424 EYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGE 483
             L L+ N + +    +   L  L  L      L+      + +L  L EL+++HN +  
Sbjct: 79  STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138

Query: 484 KISSRIC-RMESLEKLNLSYNNLSGLIPRCFEEMHGL----LHIDISYNKLEGQIPNSTT 538
                    + +LE L+LS N +  +       +H +    L +D+S N +   I     
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPG-A 196

Query: 539 FRDAPLEALQ 548
           F++  L+ L 
Sbjct: 197 FKEIRLKELA 206

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 61.1 bits (149), Expect = 3e-10
 Identities = 38/181 (20%), Positives = 67/181 (37%), Gaps = 30/181 (16%)

Query: 90  NLTSISLNGTLLEF----SFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKL 145
           +L+++ L G  ++     +FS    L  L      L  +    I +L  L+ L+ + N +
Sbjct: 77  HLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI 136

Query: 146 FGQIPSGI-GLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNL 204
                      LT+L  L +S N           ++  +    L            L  +
Sbjct: 137 QSFKLPEYFSNLTNLEHLDLSSN-----------KIQSIYCTDLR----------VLHQM 175

Query: 205 THVVI-LYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSI-SNLTNLRFLFLYH 262
             + + L L  N     I         L +L L  NQL  ++P  I   LT+L+ ++L+ 
Sbjct: 176 PLLNLSLDLSLNP-MNFIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHT 233

Query: 263 N 263
           N
Sbjct: 234 N 234

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 98.9 bits (247), Expect = 7e-22
 Identities = 81/438 (18%), Positives = 137/438 (31%), Gaps = 64/438 (14%)

Query: 133 SNLEYLDFSANKL-FGQIPSGIGLLTHLTVLHISRNWLS----GSIPHEVGQLTVLNQLA 187
            +++ LD    +L   +    + LL    V+ +    L+      I   +     L +L 
Sbjct: 3   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62

Query: 188 LDSNFLNGSIPRSLGNL-----THVVILYLYNNSF----FGSIPQEIGNLKSLFDLELCI 238
           L SN L       +          +  L L N        G +   +  L +L +L L  
Sbjct: 63  LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122

Query: 239 NQL--SGAIPLS---ISNLTNLRFLFLYHNELSGIIPQEIG----NLKKLNSLLLAKNHF 289
           N L  +G   L    +     L  L L +  LS    + +            L ++ N  
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 182

Query: 290 RGTVPKSF-----RNLTDLVKLRLNQNYLT----GNISETFGTYPNLTFIDLSNNSFFGE 340
                +        +   L  L+L    +T     ++     +  +L  + L +N     
Sbjct: 183 NEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 242

Query: 341 ---ILSDWGRCPQLSL--LDVSINNISGSIPLEIGESLQ----LQYLDLSSNYIVGEIPT 391
               L      P   L  L +    I+     ++   L+    L+ L L+ N +  E   
Sbjct: 243 GMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGAR 302

Query: 392 QLGNIIY-----LNRLSLSGNKLS--GC--IPRELGSLINLEYLDLSANNLSNFVPESLG 442
            L   +      L  L +     +   C      L     L  L +S N L +     L 
Sbjct: 303 LLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELC 362

Query: 443 SLVK-----LYYLNLSHNKLS----QQIPIELDNLIHLSELDLSHNFLGEKISSRICRM- 492
             +      L  L L+   +S      +   L     L ELDLS+N LG+    ++    
Sbjct: 363 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 422

Query: 493 ----ESLEKLNLSYNNLS 506
                 LE+L L     S
Sbjct: 423 RQPGCLLEQLVLYDIYWS 440

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 97.7 bits (244), Expect = 2e-21
 Identities = 72/373 (19%), Positives = 128/373 (34%), Gaps = 67/373 (17%)

Query: 203 NLTHVVILYLYNNSF-FGSIPQEIGNLKSLFDLELCINQLS--GAIPLS--ISNLTNLRF 257
           ++     L +           + +  L+    + L    L+      +S  +     L  
Sbjct: 4   DIQS---LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 60

Query: 258 LFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLT--- 314
           L L  NEL      ++G +  +   L   +               + KL L    LT   
Sbjct: 61  LNLRSNEL-----GDVG-VHCVLQGLQTPS-------------CKIQKLSLQNCCLTGAG 101

Query: 315 -GNISETFGTYPNLTFIDLSNNSF---FGEILSDWGRCPQLSL--LDVSINNISGSIPLE 368
            G +S T  T P L  + LS+N       ++L +    PQ  L  L +   ++S +    
Sbjct: 102 CGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEP 161

Query: 369 IGESLQ----LQYLDLSSNYI----VGEIPTQLG-NIIYLNRLSLSGNKLS--GC--IPR 415
           +   L+     + L +S+N I    V  +   L  +   L  L L    ++   C  +  
Sbjct: 162 LASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCG 221

Query: 416 ELGSLINLEYLDLSANNLSNFVPESLGSLVK-----LYYLNLSHNKLS----QQIPIELD 466
            + S  +L  L L +N L +     L   +      L  L +    ++      +   L 
Sbjct: 222 IVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLR 281

Query: 467 NLIHLSELDLSHNFLGEKISSRICRM-----ESLEKLNLSYNNLSGL----IPRCFEEMH 517
               L EL L+ N LG++ +  +C         LE L +   + +            +  
Sbjct: 282 AKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNR 341

Query: 518 GLLHIDISYNKLE 530
            LL + IS N+LE
Sbjct: 342 FLLELQISNNRLE 354

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 71.5 bits (176), Expect = 4e-13
 Identities = 40/181 (22%), Positives = 66/181 (36%), Gaps = 23/181 (12%)

Query: 372 SLQLQYLDLSSNYIVGEIPTQLGNII-YLNRLSLSGNKLS--GC--IPRELGSLINLEYL 426
           SL +Q LD+    +      +L  ++     + L    L+   C  I   L     L  L
Sbjct: 2   SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 61

Query: 427 DLSANNLSNFVPESLGSLVK-----LYYLNLSHNKLS----QQIPIELDNLIHLSELDLS 477
           +L +N L +     +   ++     +  L+L +  L+      +   L  L  L EL LS
Sbjct: 62  NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLS 121

Query: 478 HNFLGEKISSRICRME-----SLEKLNLSYNNLS----GLIPRCFEEMHGLLHIDISYNK 528
            N LG+     +C         LEKL L Y +LS      +            + +S N 
Sbjct: 122 DNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNND 181

Query: 529 L 529
           +
Sbjct: 182 I 182

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 95.8 bits (239), Expect = 1e-21
 Identities = 50/220 (22%), Positives = 88/220 (40%), Gaps = 51/220 (23%)

Query: 643 EHCIGKGGHGSVYRAK-VPSGEIFAVK---KFHSPLPGEMSFQQEEFLNEIQALTEIR-H 697
           E  +G+G H  V     + + + +AVK   K   P              E++ L + + H
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEK--QPGHIR-----SRVFREVEMLYQCQGH 70

Query: 698 RNIVKFYGFCSHPKHSFIIYEYLESGSL-DKILCN------DASAKELGWTQRLNVIKGV 750
           RN+++   F       ++++E +  GS+   I         +AS           V++ V
Sbjct: 71  RNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS----------VVVQDV 120

Query: 751 ADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVS-----DFGIAKFLNPDSS------ 799
           A AL +LHN     I HRD+  +N+L +  +   VS     DF +   +  +        
Sbjct: 121 ASALDFLHNKG---IAHRDLKPENILCE--HPNQVSPVKICDFDLGSGIKLNGDCSPIST 175

Query: 800 -NWSELAGTHGYVAPE-----LAYTLKVTEKCDVYSFGVL 833
                  G+  Y+APE             ++CD++S GV+
Sbjct: 176 PELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVI 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 93.1 bits (232), Expect = 4e-21
 Identities = 62/183 (33%), Positives = 89/183 (48%), Gaps = 16/183 (8%)

Query: 113 YLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGI-GLLTHLTVLHISRNWLSG 171
            LDL +N+L  +       L+ L  L  + NKL   +P+GI   L +L  L ++ N L  
Sbjct: 41  KLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKL-QTLPAGIFKELKNLETLWVTDNKLQ- 98

Query: 172 SIPHEV-GQLTVLNQLALDSNFLNGSIP----RSLGNLTHVVILYLYNNSFFGSIPQEI- 225
           ++P  V  QL  L +L LD N L  S+P     SL  LT+   L L  N    S+P+ + 
Sbjct: 99  ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTY---LSLGYNE-LQSLPKGVF 153

Query: 226 GNLKSLFDLELCINQLSGAIPLSI-SNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLL 284
             L SL +L L  NQL   +P      LT L+ L L +N+L  +      +L+KL  L L
Sbjct: 154 DKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQL 212

Query: 285 AKN 287
            +N
Sbjct: 213 QEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 84.6 bits (210), Expect = 3e-18
 Identities = 58/182 (31%), Positives = 79/182 (43%), Gaps = 22/182 (12%)

Query: 90  NLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQI-SNLSNLEYLDFSANKLFGQ 148
            L+S+         +F     L  L L +N+L   +P  I   L NLE L  + NKL   
Sbjct: 48  KLSSLPSK------AFHRLTKLRLLYLNDNKL-QTLPAGIFKELKNLETLWVTDNKL-QA 99

Query: 149 IPSGI-GLLTHLTVLHISRNWLSGSIPHEV-GQLTVLNQLALDSNFLNGSIP----RSLG 202
           +P G+   L +L  L + RN L  S+P  V   LT L  L+L  N L  S+P      L 
Sbjct: 100 LPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLT 157

Query: 203 NLTHVVILYLYNNSFFGSIPQEI-GNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLY 261
           +L     L LYNN     +P+     L  L  L+L  NQL      +  +L  L+ L L 
Sbjct: 158 SLKE---LRLYNNQ-LKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQ 213

Query: 262 HN 263
            N
Sbjct: 214 EN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 79.3 bits (196), Expect = 2e-16
 Identities = 55/180 (30%), Positives = 82/180 (45%), Gaps = 12/180 (6%)

Query: 354 LDVSINNISGSIPLEIGESL-QLQYLDLSSNYI----VGEIPTQLGNIIYLNRLSLSGNK 408
           LD+  N +S S+P +    L +L+ L L+ N +     G I  +L N   L  L ++ NK
Sbjct: 42  LDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQTLPAG-IFKELKN---LETLWVTDNK 96

Query: 409 LSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIEL-DN 467
           L          L+NL  L L  N L +  P    SL KL YL+L +N+L Q +P  + D 
Sbjct: 97  LQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNEL-QSLPKGVFDK 155

Query: 468 LIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYN 527
           L  L EL L +N L         ++  L+ L L  N L  +    F+ +  L  + +  N
Sbjct: 156 LTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 77.3 bits (191), Expect = 9e-16
 Identities = 56/218 (25%), Positives = 84/218 (38%), Gaps = 40/218 (18%)

Query: 269 IPQEI-GNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNL 327
           IP  I  + KKL+   L  N       K+F  LT L  L LN N L    +  F    NL
Sbjct: 31  IPSNIPADTKKLD---LQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNL 87

Query: 328 TFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESL-QLQYLDLSSNYIV 386
             + +++N              +L            ++P+ + + L  L  L L  N + 
Sbjct: 88  ETLWVTDN--------------KLQ-----------ALPIGVFDQLVNLAELRLDRNQLK 122

Query: 387 GEIP----TQLGNIIYLNRLSLSGNKLSGCIPREL-GSLINLEYLDLSANNLSNFVPESL 441
             +P      L     L  LSL  N+L   +P+ +   L +L+ L L  N L      + 
Sbjct: 123 -SLPPRVFDSLTK---LTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAF 177

Query: 442 GSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHN 479
             L +L  L L +N+L +      D+L  L  L L  N
Sbjct: 178 DKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 70.8 bits (174), Expect = 2e-13
 Identities = 47/169 (27%), Positives = 77/169 (45%), Gaps = 8/169 (4%)

Query: 364 SIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPREL-GSLIN 422
           +IP  I      + LDL SN +          +  L  L L+ NKL   +P  +   L N
Sbjct: 30  AIPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT-LPAGIFKELKN 86

Query: 423 LEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIEL-DNLIHLSELDLSHNFL 481
           LE L ++ N L          LV L  L L  N+L + +P  + D+L  L+ L L +N L
Sbjct: 87  LETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQL-KSLPPRVFDSLTKLTYLSLGYNEL 145

Query: 482 GEKISSRIC-RMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKL 529
            + +   +  ++ SL++L L  N L  +    F+++  L  + +  N+L
Sbjct: 146 -QSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQL 193

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 69.6 bits (171), Expect = 4e-13
 Identities = 48/179 (26%), Positives = 75/179 (41%), Gaps = 8/179 (4%)

Query: 209 ILYLYNNSFFGSIPQEI-GNLKSLFDLELCINQLSGAIPLSI-SNLTNLRFLFLYHNELS 266
            L L +N    S+P +    L  L  L L  N+L   +P  I   L NL  L++  N+L 
Sbjct: 41  KLDLQSNKL-SSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ 98

Query: 267 GIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISE-TFGTYP 325
            +       L  L  L L +N  +   P+ F +LT L  L L  N L  ++ +  F    
Sbjct: 99  ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLT 157

Query: 326 NLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESL-QLQYLDLSSN 383
           +L  + L NN         + +  +L  L +  N +   +P    +SL +L+ L L  N
Sbjct: 158 SLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQEN 215

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 93.8 bits (233), Expect = 1e-20
 Identities = 40/169 (23%), Positives = 69/169 (40%), Gaps = 12/169 (7%)

Query: 364 SIPLEIGESLQLQYLDLSSNYIVGEIPTQ--LGNIIYLNRLSLSGNKLSGCIPRE-LGSL 420
           ++P  +        LDLS N +   +  +     +  L+ L LS N L+  I  E    +
Sbjct: 32  NVPQSL--PSYTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLNF-ISSEAFVPV 87

Query: 421 INLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIE-LDNLIHLSELDLSHN 479
            NL YLDLS+N+L          L  L  L L +N +   +     +++  L +L LS N
Sbjct: 88  PNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHI-VVVDRNAFEDMAQLQKLYLSQN 146

Query: 480 ---FLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDIS 525
                  ++     ++  L  L+LS N L  L     +++   +   + 
Sbjct: 147 QISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY 195

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 78.7 bits (194), Expect = 1e-15
 Identities = 43/159 (27%), Positives = 70/159 (44%), Gaps = 12/159 (7%)

Query: 354 LDVSINNISGSIPLEIGES--LQLQYLDLSSNYIVGEIPTQ-LGNIIYLNRLSLSGNKLS 410
           LD+S NN+S  +  E   +    L  L LS N++   I ++    +  L  L LS N L 
Sbjct: 44  LDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHL-NFISSEAFVPVPNLRYLDLSSNHLH 101

Query: 411 GCIPRE-LGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIE----L 465
             +       L  LE L L  N++      +   + +L  L LS N++  + P+E     
Sbjct: 102 -TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQI-SRFPVELIKDG 159

Query: 466 DNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNN 504
           + L  L  LDLS N L +   + + ++ +  K  L  +N
Sbjct: 160 NKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 74.9 bits (184), Expect = 2e-14
 Identities = 48/152 (31%), Positives = 69/152 (45%), Gaps = 9/152 (5%)

Query: 400 NRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPE-SLGSLVKLYYLNLSHNKLS 458
           N LS S  +L   +P+ L S      LDLS NNLS    E +   L  L+ L LSHN L 
Sbjct: 21  NILSCSKQQLPN-VPQSLPS--YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHL- 76

Query: 459 QQIPIE-LDNLIHLSELDLSHNFLGEKISSRICR-MESLEKLNLSYNNLSGLIPRCFEEM 516
             I  E    + +L  LDLS N L   +   +   +++LE L L  N++  +    FE+M
Sbjct: 77  NFISSEAFVPVPNLRYLDLSSNHL-HTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDM 135

Query: 517 HGLLHIDISYNKLEGQIPNSTTFRDAPLEALQ 548
             L  + +S N++  + P         L  L 
Sbjct: 136 AQLQKLYLSQNQIS-RFPVELIKDGNKLPKLM 166

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 74.9 bits (184), Expect = 2e-14
 Identities = 45/170 (26%), Positives = 75/170 (44%), Gaps = 8/170 (4%)

Query: 196 SIPRSLGNLTHVVILYLYNNSFFGSIPQEI--GNLKSLFDLELCINQLSGAIPLSISNLT 253
           ++P+SL   ++  +L L +N+    +  E     L +L  L L  N L+     +   + 
Sbjct: 32  NVPQSL--PSYTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVP 88

Query: 254 NLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYL 313
           NLR+L L  N L  +      +L+ L  LLL  NH       +F ++  L KL L+QN +
Sbjct: 89  NLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQI 148

Query: 314 TGNISETFGTY---PNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINN 360
           +    E        P L  +DLS+N      L+D  + P      + ++N
Sbjct: 149 SRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 73.3 bits (180), Expect = 6e-14
 Identities = 33/157 (21%), Positives = 62/157 (39%), Gaps = 16/157 (10%)

Query: 90  NLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQI-SNLSNLEYLDFSANKLFGQ 148
           NL+ +       E++ +   +L  L L +N L   I  +    + NL YLD S+N L   
Sbjct: 50  NLSRLRA-----EWTPTRLTNLHSLLLSHNHL-NFISSEAFVPVPNLRYLDLSSNHL-HT 102

Query: 149 IPSGI-GLLTHLTVLHISRNWLSGSIPHEV-GQLTVLNQLALDSNFLNGSIP----RSLG 202
           +   +   L  L VL +  N +   +       +  L +L L  N ++   P    +   
Sbjct: 103 LDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGN 160

Query: 203 NLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCIN 239
            L  +++L L +N        ++  L +     L ++
Sbjct: 161 KLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLH 197

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 68.7 bits (168), Expect = 2e-12
 Identities = 40/140 (28%), Positives = 59/140 (42%), Gaps = 15/140 (10%)

Query: 90  NLTSISLNG----TLLEFSFSSFPHLVYLDLYNNELFGIIPPQI-SNLSNLEYLDFSANK 144
           NL S+ L+      +   +F   P+L YLDL +N L   +   + S+L  LE L    N 
Sbjct: 65  NLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHL-HTLDEFLFSDLQALEVLLLYNNH 123

Query: 145 LFGQIPSGI-GLLTHLTVLHISRNWLSGSIPHEV----GQLTVLNQLALDSNFLNGSIPR 199
           +   +       +  L  L++S+N +S   P E+     +L  L  L L SN L      
Sbjct: 124 I-VVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLT 181

Query: 200 SLGNLT--HVVILYLYNNSF 217
            L  L       LYL+NN  
Sbjct: 182 DLQKLPAWVKNGLYLHNNPL 201

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 93.2 bits (232), Expect = 1e-20
 Identities = 46/206 (22%), Positives = 82/206 (39%), Gaps = 42/206 (20%)

Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKF 703
           +G G +G V       +G+  A+K  +            +   E+    +     +IV  
Sbjct: 37  LGLGVNGKVLECFHRRTGQKCALKLLY---------DSPKARQEVDHHWQASGGPHIVCI 87

Query: 704 YGFCSHPKHS----FIIYEYLESGSL-DKILC--------NDASAKELGWTQRLNVIKGV 750
                +  H      II E +E G L  +I           +A+           +++ +
Sbjct: 88  LDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAA----------EIMRDI 137

Query: 751 ADALFYLHNNCFPPIVHRDISSKNVLL-DLGYEAHV--SDFGIAKFLNPDSSNWSELAGT 807
             A+ +LH++    I HRD+  +N+L      +A +  +DFG AK    ++        T
Sbjct: 138 GTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYT 192

Query: 808 HGYVAPELAYTLKVTEKCDVYSFGVL 833
             YVAPE+    K  + CD++S GV+
Sbjct: 193 PYYVAPEVLGPEKYDKSCDMWSLGVI 218

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 94.0 bits (234), Expect = 1e-20
 Identities = 50/206 (24%), Positives = 84/206 (40%), Gaps = 41/206 (19%)

Query: 646 IGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKF 703
           +G G +G V +     + E FA+K               +   E++      +  +IV+ 
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKMLQ---------DCPKARREVELHWRASQCPHIVRI 120

Query: 704 YGFC----SHPKHSFIIYEYLESGSL-DKILC--------NDASAKELGWTQRLNVIKGV 750
                   +  K   I+ E L+ G L  +I           +AS           ++K +
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS----------EIMKSI 170

Query: 751 ADALFYLHNNCFPPIVHRDISSKNVLL-DLGYEAHV--SDFGIAKFLNPDSSNWSELAGT 807
            +A+ YLH+     I HRD+  +N+L       A +  +DFG AK     +S  +    T
Sbjct: 171 GEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPCYT 226

Query: 808 HGYVAPELAYTLKVTEKCDVYSFGVL 833
             YVAPE+    K  + CD++S GV+
Sbjct: 227 PYYVAPEVLGPEKYDKSCDMWSLGVI 252

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 91.2 bits (227), Expect = 2e-20
 Identities = 52/247 (21%), Positives = 88/247 (35%), Gaps = 21/247 (8%)

Query: 263 NELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFG 322
             ++ + P     L       L K     T   S + L+ +     + + +  ++     
Sbjct: 7   TPINQVFP--DPGLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQ-SL-AGMQ 60

Query: 323 TYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSS 382
            + NL  + LS+N      LS      +L  L V+ N +     L    S  L  L L +
Sbjct: 61  FFTNLKELHLSHNQI--SDLSPLKDLTKLEELSVNRNRLKN---LNGIPSACLSRLFLDN 115

Query: 383 NYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLG 442
           N +       L ++  L  LS+  NKL   +   LG L  LE LDL  N ++N     L 
Sbjct: 116 NEL--RDTDSLIHLKNLEILSIRNNKLKSIVM--LGFLSKLEVLDLHGNEITNT--GGLT 169

Query: 443 SLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKIS-SRICRMESLEKLNLS 501
            L K+ +++L+  K   +       L   + +    +  G  IS   I    S     + 
Sbjct: 170 RLKKVNWIDLTGQKCVNEPVKYQPELYITNTV---KDPDGRWISPYYISNGGSYVDGCVL 226

Query: 502 YNNLSGL 508
           +      
Sbjct: 227 WELPVYT 233

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 82.0 bits (203), Expect = 3e-17
 Identities = 49/230 (21%), Positives = 90/230 (39%), Gaps = 18/230 (7%)

Query: 103 FSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVL 162
           F      + V  +L    +  ++      LS ++  +   + +  Q  +G+   T+L  L
Sbjct: 13  FPDPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNI--QSLAGMQFFTNLKEL 68

Query: 163 HISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIP 222
           H+S N +S  +   +  LT L +L+++ N L          L+    L+L NN       
Sbjct: 69  HLSHNQIS-DLSP-LKDLTKLEELSVNRNRLKNLNGIPSACLSR---LFLDNNEL--RDT 121

Query: 223 QEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSL 282
             + +LK+L  L +  N+L   + L    L+ L  L L+ NE++      +  LKK+N +
Sbjct: 122 DSLIHLKNLEILSIRNNKLKSIVML--GFLSKLEVLDLHGNEITNTGG--LTRLKKVNWI 177

Query: 283 LLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTG--NISETFGTYPNLTFI 330
            L          K    L     ++           IS   G+Y +   +
Sbjct: 178 DLTGQKCVNEPVKYQPELYITNTVKDPDGRWISPYYISNG-GSYVDGCVL 226

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 80.1 bits (198), Expect = 1e-16
 Identities = 38/182 (20%), Positives = 72/182 (39%), Gaps = 15/182 (8%)

Query: 348 CPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGN 407
                  ++   +++  +  +  E   +Q  +  ++ I  +    +     L  L LS N
Sbjct: 18  LANAVKQNLGKQSVTDLVSQK--ELSGVQNFNGDNSNI--QSLAGMQFFTNLKELHLSHN 73

Query: 408 KLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDN 467
           ++S   P  L  L  LE L ++ N L N    +      L  L L +N+L       L +
Sbjct: 74  QISDLSP--LKDLTKLEELSVNRNRLKNL---NGIPSACLSRLFLDNNELRDTDS--LIH 126

Query: 468 LIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYN 527
           L +L  L + +N L + I   +  +  LE L+L  N ++         +  +  ID++  
Sbjct: 127 LKNLEILSIRNNKL-KSIVM-LGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQ 182

Query: 528 KL 529
           K 
Sbjct: 183 KC 184

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 69.7 bits (171), Expect = 4e-13
 Identities = 46/258 (17%), Positives = 78/258 (30%), Gaps = 43/258 (16%)

Query: 179 QLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCI 238
            L    +  L    +   +      L+ V      N++        +    +L +L L  
Sbjct: 17  GLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNI--QSLAGMQFFTNLKELHLSH 72

Query: 239 NQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFR 298
           NQ+S   PL   +LT L  L +  N L  +          L+ L L  N        S  
Sbjct: 73  NQISDLSPLK--DLTKLEELSVNRNRLKNL---NGIPSACLSRLFLDNNEL--RDTDSLI 125

Query: 299 NLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSI 358
           +L +L  L +  N L  +I    G    L  +DL  N                      I
Sbjct: 126 HLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGN---------------------EI 162

Query: 359 NNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLS-LSGNKLSGCIPREL 417
            N  G     +    ++ ++DL+    V E       +   N +    G  +S   P  +
Sbjct: 163 TNTGG-----LTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWIS---PYYI 214

Query: 418 GSLINLEYLDLSANNLSN 435
            +  +     +       
Sbjct: 215 SNGGSYVDGCVLWELPVY 232

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 52.3 bits (126), Expect = 2e-07
 Identities = 34/154 (22%), Positives = 55/154 (35%), Gaps = 9/154 (5%)

Query: 90  NLTSISLNGTLL-EFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQ 148
            L  +S+N   L   +      L  L L NNEL       + +L NLE L    NKL  +
Sbjct: 86  KLEELSVNRNRLKNLNGIPSACLSRLFLDNNELRDTDS--LIHLKNLEILSIRNNKL--K 141

Query: 149 IPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVV 208
               +G L+ L VL +  N ++ +    + +L  +N + L          +    L    
Sbjct: 142 SIVMLGFLSKLEVLDLHGNEIT-NTG-GLTRLKKVNWIDLTGQKCVNEPVKYQPELYITN 199

Query: 209 ILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLS 242
            +   +  +    P  I N  S  D  +      
Sbjct: 200 TVKDPDGRWIS--PYYISNGGSYVDGCVLWELPV 231

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 91.6 bits (228), Expect = 7e-20
 Identities = 71/277 (25%), Positives = 123/277 (44%), Gaps = 48/277 (17%)

Query: 638 NDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
           + F     IGKG  G V    K  + +++A+K  +     E + +      E+Q +  + 
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERN-EVRNVFKELQIMQGLE 73

Query: 697 HRNIVK-FYGFCSHPKHSFIIYEYLESGSL------DKILCNDAS---AKELGWTQRLNV 746
           H  +V  +Y F    +  F++ + L  G L      +     +       EL        
Sbjct: 74  HPFLVNLWYSFQD-EEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICEL-------- 124

Query: 747 IKGVADALFYLHNNCFPPIVHRDISSKNVLLDL-GYEAHVSDFGIAKFLNPDSSNWSELA 805
                 AL YL N     I+HRD+   N+LLD  G+  H++DF IA  L  ++   + +A
Sbjct: 125 ----VMALDYLQNQ---RIIHRDMKPDNILLDEHGH-VHITDFNIAAMLPRETQITT-MA 175

Query: 806 GTHGYVAPEL-------AYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMN 858
           GT  Y+APE+        Y+  V    D +S GV A E+++G+ P  +    S+SS  + 
Sbjct: 176 GTKPYMAPEMFSSRKGAGYSFAV----DWWSLGVTAYELLRGRRP--YHIRSSTSSKEIV 229

Query: 859 IEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESR 895
                + + YPS    ++++S+++     L+ NP+ R
Sbjct: 230 HTFETTVVTYPS-AWSQEMVSLLK---KLLEPNPDQR 262

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 88.6 bits (220), Expect = 2e-19
 Identities = 52/184 (28%), Positives = 73/184 (39%), Gaps = 20/184 (10%)

Query: 90  NLTSISLNG----TLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKL 145
           + T + L+     T    +   +  L  L+L   EL  +       L  L  LD S N+L
Sbjct: 32  DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL--QVDGTLPVLGTLDLSHNQL 89

Query: 146 FGQIPSGIGLLTHLTVLHISRNWLSGSIPHEV-GQLTVLNQLALDSNFLNGSIP----RS 200
              +P     L  LTVL +S N L+ S+P      L  L +L L  N L  ++P      
Sbjct: 90  -QSLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTP 146

Query: 201 LGNLTHVVILYLYNNSFFGSIPQEI-GNLKSLFDLELCINQLSGAIPLSISNLTNLRFLF 259
              L     L L NN+    +P  +   L++L  L L  N L   IP        L F F
Sbjct: 147 TPKLEK---LSLANNN-LTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAF 201

Query: 260 LYHN 263
           L+ N
Sbjct: 202 LHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 86.3 bits (214), Expect = 1e-18
 Identities = 49/186 (26%), Positives = 68/186 (36%), Gaps = 16/186 (8%)

Query: 108 FPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRN 167
                 L L  N L+      +   + L  L+    +L  ++      L  L  L +S N
Sbjct: 30  PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL-TKLQVDGT-LPVLGTLDLSHN 87

Query: 168 WLSGSIPHEVGQLTVLNQLALDSNFLNGSIP----RSLGNLTHVVILYLYNNSFFGSIPQ 223
            L  S+P     L  L  L +  N L  S+P    R LG L     LYL  N    ++P 
Sbjct: 88  QLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQE---LYLKGNE-LKTLPP 141

Query: 224 EI-GNLKSLFDLELCINQLSGAIPLSI-SNLTNLRFLFLYHNELSGIIPQEIGNLKKLNS 281
            +      L  L L  N L+  +P  + + L NL  L L  N L   IP+       L  
Sbjct: 142 GLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPF 199

Query: 282 LLLAKN 287
             L  N
Sbjct: 200 AFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 85.2 bits (211), Expect = 3e-18
 Identities = 53/204 (25%), Positives = 73/204 (35%), Gaps = 30/204 (14%)

Query: 301 TDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINN 360
            D   L L++N L      T   Y  LT ++L                 +L+ L V    
Sbjct: 31  KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA--------------ELTKLQVD--- 73

Query: 361 ISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSL 420
                    G    L  LDLS N +   +P     +  L  L +S N+L+      L  L
Sbjct: 74  ---------GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGL 123

Query: 421 INLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIEL-DNLIHLSELDLSHN 479
             L+ L L  N L    P  L    KL  L+L++N L  ++P  L + L +L  L L  N
Sbjct: 124 GELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL-TELPAGLLNGLENLDTLLLQEN 182

Query: 480 FLGEKISSRICRMESLEKLNLSYN 503
            L   I         L    L  N
Sbjct: 183 SL-YTIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 79.8 bits (197), Expect = 2e-16
 Identities = 46/169 (27%), Positives = 75/169 (44%), Gaps = 9/169 (5%)

Query: 364 SIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINL 423
           ++P ++ +      L LS N +       L     L +L+L   +L+  +    G+L  L
Sbjct: 24  ALPPDLPKDTT--ILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVL 79

Query: 424 EYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIEL-DNLIHLSELDLSHNFLG 482
             LDLS N L + +P    +L  L  L++S N+L   +P+     L  L EL L  N L 
Sbjct: 80  GTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRL-TSLPLGALRGLGELQELYLKGNEL- 136

Query: 483 EKISSRIC-RMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLE 530
           + +   +      LEKL+L+ NNL+ L       +  L  + +  N L 
Sbjct: 137 KTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY 185

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 79.4 bits (196), Expect = 2e-16
 Identities = 46/206 (22%), Positives = 73/206 (35%), Gaps = 11/206 (5%)

Query: 180 LTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCIN 239
           +    ++  D   L  ++P  L       IL+L  N  +      +     L  L L   
Sbjct: 9   VASHLEVNCDKRNL-TALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65

Query: 240 QLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRN 299
           +L+  + +    L  L  L L HN+L  + P     L  L  L ++ N        + R 
Sbjct: 66  ELT-KLQVD-GTLPVLGTLDLSHNQLQSL-PLLGQTLPALTVLDVSFNRLTSLPLGALRG 122

Query: 300 LTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSD--WGRCPQLSLLDVS 357
           L +L +L L  N L           P L  + L+NN+     L          L  L + 
Sbjct: 123 LGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL--TELPAGLLNGLENLDTLLLQ 180

Query: 358 INNISGSIPLEIGESLQLQYLDLSSN 383
            N++  +IP     S  L +  L  N
Sbjct: 181 ENSLY-TIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 79.4 bits (196), Expect = 3e-16
 Identities = 48/177 (27%), Positives = 81/177 (45%), Gaps = 10/177 (5%)

Query: 354 LDVSINNISGSIPLEIGESL-QLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGC 412
           L +S N +  +  L       +L  L+L    +  ++    G +  L  L LS N+L   
Sbjct: 36  LHLSENLLY-TFSLATLMPYTRLTQLNLDRAEL-TKLQV-DGTLPVLGTLDLSHNQLQ-S 91

Query: 413 IPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIEL-DNLIHL 471
           +P    +L  L  LD+S N L++    +L  L +L  L L  N+L + +P  L      L
Sbjct: 92  LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNEL-KTLPPGLLTPTPKL 150

Query: 472 SELDLSHNFLGEKISSRIC-RMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYN 527
            +L L++N L  ++ + +   +E+L+ L L  N+L   IP+ F   H L    +  N
Sbjct: 151 EKLSLANNNL-TELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 77.5 bits (191), Expect = 1e-15
 Identities = 39/157 (24%), Positives = 62/157 (39%), Gaps = 10/157 (6%)

Query: 375 LQYLDLSSNYIVGEIPTQLGNI-IYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNL 433
              ++     +   +P    ++      L LS N L       L     L  L+L    L
Sbjct: 12  HLEVNCDKRNL-TALPP---DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL 67

Query: 434 SNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRI-CRM 492
           +    +  G+L  L  L+LSHN+L Q +P+    L  L+ LD+S N L   +       +
Sbjct: 68  TKL--QVDGTLPVLGTLDLSHNQL-QSLPLLGQTLPALTVLDVSFNRL-TSLPLGALRGL 123

Query: 493 ESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKL 529
             L++L L  N L  L P        L  + ++ N L
Sbjct: 124 GELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL 160

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 91.4 bits (226), Expect = 4e-19
 Identities = 58/300 (19%), Positives = 97/300 (32%), Gaps = 11/300 (3%)

Query: 208 VILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSG 267
           + +        GS    +  +     L +      G    S   L +L    L       
Sbjct: 257 LSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQH 316

Query: 268 IIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNL 327
                          +L K+       +       L +  L+    T   SE   +   L
Sbjct: 317 TFRVIWTGSDSQKECVLLKDRPE-CWCRDSATDEQLFRCELSVEKSTVLQSE-LESCKEL 374

Query: 328 TFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVG 387
             ++  N      +L+       L  L      +     L+  + ++  YLD   +  + 
Sbjct: 375 QELEPENKWC---LLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLL 431

Query: 388 EIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKL 447
           E          +  L L+   L+  +   L  L+ + +LDLS N L   +P +L +L  L
Sbjct: 432 ENSVLKMEYADVRVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLRA-LPPALAALRCL 488

Query: 448 YYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGE-KISSRICRMESLEKLNLSYNNLS 506
             L  S N L   +   + NL  L EL L +N L +      +     L  LNL  N+L 
Sbjct: 489 EVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 87.5 bits (216), Expect = 5e-18
 Identities = 47/244 (19%), Positives = 87/244 (35%), Gaps = 34/244 (13%)

Query: 246 PLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVK 305
               +    L    L   + + ++  E+ + K+L  L         T+    R L  L+ 
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY 400

Query: 306 LRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSI 365
                        ET   +  L  +D    ++  ++ S +                    
Sbjct: 401 E-----------KETLQYFSTLKAVDPMRAAYLDDLRSKFLLEN---------------- 433

Query: 366 PLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEY 425
            +   E   ++ L L+   +   +   L  ++ +  L LS N+L   +P  L +L  LE 
Sbjct: 434 SVLKMEYADVRVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEV 490

Query: 426 LDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQ-QIPIELDNLIHLSELDLSHNFLGEK 484
           L  S N L N   + + +L +L  L L +N+L Q      L +   L  L+L  N L ++
Sbjct: 491 LQASDNALENV--DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 548

Query: 485 ISSR 488
              +
Sbjct: 549 EGIQ 552

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 69.8 bits (170), Expect = 2e-12
 Identities = 48/286 (16%), Positives = 92/286 (32%), Gaps = 14/286 (4%)

Query: 247 LSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKL 306
           + +S       +        G     +  +     L +      G    S   L DL   
Sbjct: 248 VHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAA 307

Query: 307 RLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIP 366
            LN           +    +     L  +        D     QL   ++S+   +  + 
Sbjct: 308 SLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWC-RDSATDEQLFRCELSVEKST-VLQ 365

Query: 367 LEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLE-- 424
            E+    +LQ L+  + + +  I   +  +  L     +    S      L ++  +   
Sbjct: 366 SELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFS-----TLKAVDPMRAA 420

Query: 425 YLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEK 484
           YLD   +               +  L+L+H  L+      L+ L+ ++ LDLSHN L   
Sbjct: 421 YLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRL-RA 477

Query: 485 ISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLE 530
           +   +  +  LE L  S N L  +       +  L  + +  N+L+
Sbjct: 478 LPPALAALRCLEVLQASDNALENVDG--VANLPRLQELLLCNNRLQ 521

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 67.5 bits (164), Expect = 1e-11
 Identities = 40/197 (20%), Positives = 76/197 (38%), Gaps = 17/197 (8%)

Query: 94  ISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQ--ISNLSNLEYLDF--------SAN 143
           +     L E    +   L+ + L    L  ++  +  +   S L+ +D           +
Sbjct: 368 LESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRS 427

Query: 144 KLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGN 203
           K   +          + VLH++   L+  + H + QL ++  L L  N L  ++P +L  
Sbjct: 428 KFLLENSVLKMEYADVRVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAA 484

Query: 204 LTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSG-AIPLSISNLTNLRFLFLYH 262
           L  + +L   +N+   ++   + NL  L +L LC N+L   A    + +   L  L L  
Sbjct: 485 LRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQG 542

Query: 263 NELSGIIPQEIGNLKKL 279
           N L          L ++
Sbjct: 543 NSLC-QEEGIQERLAEM 558

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 64.0 bits (155), Expect = 1e-10
 Identities = 41/264 (15%), Positives = 74/264 (28%), Gaps = 49/264 (18%)

Query: 126 PPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQ 185
               +    L   + S  K    + S +     L  L     W   +I   +  L  L  
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY 400

Query: 186 LALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAI 245
                 + +         L  V  +                            ++     
Sbjct: 401 EKETLQYFS--------TLKAVDPMRAAYLDD-------------------LRSKFLLEN 433

Query: 246 PLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVK 305
            +      ++R L L H +L+ +    +  L  +  L L+ N  R  +P +   L  L  
Sbjct: 434 SVLKMEYADVRVLHLAHKDLTVLC--HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEV 490

Query: 306 LRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDW------GRCPQLSLLDVSIN 359
           L+ + N L  N+       P L  + L NN      L           CP+L LL++  N
Sbjct: 491 LQASDNALE-NVDG-VANLPRLQELLLCNNR-----LQQSAAIQPLVSCPRLVLLNLQGN 543

Query: 360 NISGSIPLEIGESL----QLQYLD 379
           ++                 +  + 
Sbjct: 544 SLC-QEEGIQERLAEMLPSVSSIL 566

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 85.8 bits (213), Expect = 3e-18
 Identities = 61/273 (22%), Positives = 108/273 (39%), Gaps = 43/273 (15%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVK---KFHSPLPGEMSFQQEEFLNEIQALTEIR----H 697
           +GKGG G+V+    +      A+K   +        +S      L E+  L ++     H
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL-EVALLWKVGAGGGH 97

Query: 698 RNIVKFYGFCSHPKHSFIIYEYLESGS--LDKILCNDASAKELGWTQRLNVIKGVADALF 755
             +++   +    +   ++ E         D I         LG          V  A+ 
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYI----TEKGPLGEGPSRCFFGQVVAAIQ 153

Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGY-EAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPE 814
           + H+     +VHRDI  +N+L+DL    A + DFG    L+     +++  GT  Y  PE
Sbjct: 154 HCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLH--DEPYTDFDGTRVYSPPE 208

Query: 815 L----AYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPS 870
                 Y         V+S G+L  +++ G  P    FE          E+L++ L +P+
Sbjct: 209 WISRHQYHAL---PATVWSLGILLYDMVCGDIP----FERDQ-------EILEAELHFPA 254

Query: 871 LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ 903
            HV     ++++    CL   P SRP+++ +  
Sbjct: 255 -HVSPDCCALIR---RCLAPKPSSRPSLEEILL 283

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 85.8 bits (213), Expect = 3e-18
 Identities = 62/277 (22%), Positives = 107/277 (38%), Gaps = 54/277 (19%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           IGKG    V  A+ + +G   A+K          S Q+     E++ +  + H NIVK +
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF--REVRIMKILNHPNIVKLF 80

Query: 705 GFCSHPKHSFIIYEYLESGSL-DKILCNDASAKELGWTQRLN----------VIKGVADA 753
                 K  ++I EY   G + D ++ +           R+           ++  V   
Sbjct: 81  EVIETEKTLYLIMEYASGGEVFDYLVAH----------GRMKEKEARSKFRQIVSAVQ-- 128

Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAP 813
             Y H      IVHRD+ ++N+LLD      ++DFG +              G   Y AP
Sbjct: 129 --YCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKLDAFCGAPPYAAP 182

Query: 814 EL----AYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYP 869
           EL     Y      + DV+S GV+   ++ G  P    F+   +   +   +L  +   P
Sbjct: 183 ELFQGKKYDGP---EVDVWSLGVILYTLVSGSLP----FD-GQNLKELRERVLRGKYRIP 234

Query: 870 SLHV---QKKLMSIMQVAFSCLDQNPESRPTMKRVSQ 903
             ++    + L+         L  NP  R T++++ +
Sbjct: 235 F-YMSTDCENLLKRF------LVLNPIKRGTLEQIMK 264

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 83.5 bits (207), Expect = 5e-18
 Identities = 42/219 (19%), Positives = 79/219 (36%), Gaps = 13/219 (5%)

Query: 244 AIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVP-KSFRNLTD 302
            IP   S   + + L L    L  I      NL  ++ + ++ +     +   SF NL+ 
Sbjct: 25  RIP---SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSK 81

Query: 303 LVKLRLNQNYLTGNIS-ETFGTYPNLTFIDLSNNSFFGEI--LSDWGRCPQLSLLDVSIN 359
           +  + +        I  +     P L F+ + N         L+         +L+++ N
Sbjct: 82  VTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGL-KMFPDLTKVYSTDIFFILEITDN 140

Query: 360 NISGSIPLEIGESL--QLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPREL 417
               SIP+   + L  +   L L +N     +     N   L+ + L+ NK    I ++ 
Sbjct: 141 PYMTSIPVNAFQGLCNETLTLKLYNNGF-TSVQGYAFNGTKLDAVYLNKNKYLTVIDKDA 199

Query: 418 --GSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSH 454
             G       LD+S  +++    + L  L +L   N   
Sbjct: 200 FGGVYSGPSLLDVSQTSVTALPSKGLEHLKELIARNTWT 238

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 76.6 bits (189), Expect = 1e-15
 Identities = 34/229 (14%), Positives = 73/229 (31%), Gaps = 34/229 (14%)

Query: 300 LTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSIN 359
                 L+L + +L    S  F   PN++ I +S +                        
Sbjct: 30  PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSID-----------------------V 66

Query: 360 NISGSIPLEIGESL-QLQYLDLSSNYIVGEIPTQ-LGNIIYLNRLSLSGNKLSGCIP--R 415
            +   +      +L ++ ++++ +   +  I    L  +  L  L +    L    P   
Sbjct: 67  TLQ-QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLT 124

Query: 416 ELGSLINLEYLDLSANNLSNFVPE-SLGSLVK-LYYLNLSHNKLSQQIPIELDNLIHLSE 473
           ++ S      L+++ N     +P  +   L      L L +N     +     N   L  
Sbjct: 125 KVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGF-TSVQGYAFNGTKLDA 183

Query: 474 LDLSHNFLGEKISSRICR--MESLEKLNLSYNNLSGLIPRCFEEMHGLL 520
           + L+ N     I              L++S  +++ L  +  E +  L+
Sbjct: 184 VYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKELI 232

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 75.0 bits (185), Expect = 4e-15
 Identities = 47/233 (20%), Positives = 80/233 (34%), Gaps = 32/233 (13%)

Query: 109 PHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGI-GLLTHLTVLHISRN 167
           P    L L    L  I     SNL N+  +  S +    Q+ S     L+ +T + I   
Sbjct: 31  PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNT 90

Query: 168 WLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQE--I 225
                I                        P +L  L  +  L ++N       P    +
Sbjct: 91  RNLTYID-----------------------PDALKELPLLKFLGIFNTG-LKMFPDLTKV 126

Query: 226 GNLKSLFDLELCINQLSGAIPL-SISNLTN-LRFLFLYHNELSGIIPQEIGNLKKLNSLL 283
            +    F LE+  N    +IP+ +   L N    L LY+N  +  +     N  KL+++ 
Sbjct: 127 YSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVY 185

Query: 284 LAKNHFRGTVPK-SFRNL-TDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSN 334
           L KN +   + K +F  + +    L ++Q  +T   S+       L   +   
Sbjct: 186 LNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKELIARNTWT 238

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 57.3 bits (139), Expect = 4e-09
 Identities = 17/119 (14%), Positives = 41/119 (34%), Gaps = 3/119 (2%)

Query: 422 NLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIEL-DNLIHLSELDLSHNF 480
           + + L L   +L      +  +L  +  + +S +   QQ+      NL  ++ +++ +  
Sbjct: 32  STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91

Query: 481 LGEKISSRICR-MESLEKLNLSYNNLSGLIPRCF-EEMHGLLHIDISYNKLEGQIPNST 537
               I     + +  L+ L +    L                 ++I+ N     IP + 
Sbjct: 92  NLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNA 150

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 83.2 bits (206), Expect = 3e-17
 Identities = 59/276 (21%), Positives = 100/276 (36%), Gaps = 51/276 (18%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVK-----KFHSPLPGEMSFQQEEFLNEIQALTEIRHRN 699
           +G G  G V+ A      +   VK     K       E     +  L EI  L+ + H N
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTL-EIAILSRVEHAN 90

Query: 700 IVKFYGFCSHPKHSFIIYEYLESGS--LDKILCNDASAKELGWTQRLN------VIKGVA 751
           I+K      +     ++ E   SG      I  +           RL+      + + + 
Sbjct: 91  IIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRH----------PRLDEPLASYIFRQLV 140

Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV 811
            A+ YL       I+HRDI  +N+++   +   + DFG A +L      +    GT  Y 
Sbjct: 141 SAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG-KLFYTFCGTIEYC 196

Query: 812 APEL----AYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLP 867
           APE+     Y      + +++S GV    ++  ++P   L E   +             P
Sbjct: 197 APEVLMGNPYRGP---ELEMWSLGVTLYTLVFEENPFCELEETVEA---------AIHPP 244

Query: 868 YPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ 903
           Y        L+S +      L   PE R T++++  
Sbjct: 245 YLVSKELMSLVSGL------LQPVPERRTTLEKLVT 274

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 82.3 bits (204), Expect = 4e-17
 Identities = 50/221 (22%), Positives = 89/221 (40%), Gaps = 34/221 (15%)

Query: 638 NDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
            DF     +G+G   +V  A+ + +   +A+K        + + +      E   ++ + 
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN-KVPYVTRERDVMSRLD 88

Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSL------DKILCNDAS---AKELGWTQRLNVI 747
           H   VK Y      +  +    Y ++G L              +     E          
Sbjct: 89  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE---------- 138

Query: 748 KGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHV--SDFGIAKFLNPDSSN---WS 802
             +  AL YLH      I+HRD+  +N+LL+   + H+  +DFG AK L+P+S      S
Sbjct: 139 --IVSALEYLHGK---GIIHRDLKPENILLN--EDMHIQITDFGTAKVLSPESKQARANS 191

Query: 803 ELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP 843
              GT  YV+PEL       +  D+++ G +  +++ G  P
Sbjct: 192 -FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 84.5 bits (209), Expect = 5e-17
 Identities = 65/275 (23%), Positives = 109/275 (39%), Gaps = 44/275 (16%)

Query: 638 NDFNAEHCIGKGGHGSVYRAKV-PSGEIFAVKKFHSPLPGEMSFQQEEF---LNEIQALT 693
           N F     +GKGG G V   +V  +G+++A KK    L  +   +++     LNE Q L 
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKK----LEKKRIKKRKGEAMALNEKQILE 239

Query: 694 EIRHRNIVK-FYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKG--V 750
           ++  R +V   Y + +      ++   +  G L   + +     + G+ +   V     +
Sbjct: 240 KVNSRFVVSLAYAYET-KDALCLVLTLMNGGDLKFHIYH---MGQAGFPEARAVFYAAEI 295

Query: 751 ADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHV--SDFGIAKFLNPDSSNWSELAGTH 808
              L  LH      IV+RD+  +N+LLD     H+  SD G+A  +    +      GT 
Sbjct: 296 CCGLEDLHRER---IVYRDLKPENILLD--DHGHIRISDLGLAVHVPEGQTIKG-RVGTV 349

Query: 809 GYVAPEL----AYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDS 864
           GY+APE+     YT       D ++ G L  E+I G+ P    F+          E+   
Sbjct: 350 GYMAPEVVKNERYTFSP----DWWALGCLLYEMIAGQSP----FQ-QRKKKIKREEVERL 400

Query: 865 RL----PYPSLHVQKKLMSIMQVAFSCLDQNPESR 895
                  Y       +  S+       L ++P  R
Sbjct: 401 VKEVPEEYSE-RFSPQARSLCS---QLLCKDPAER 431

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 82.4 bits (204), Expect = 5e-17
 Identities = 62/277 (22%), Positives = 104/277 (37%), Gaps = 53/277 (19%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVK---KFHSPLPGEMSFQQEEFLNEIQALTEIRHR--N 699
           +G GG GSVY    V      A+K   K      GE+       + E+  L ++      
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKVSSGFSG 109

Query: 700 IVKFYGFCSHPKHSFIIYEYLE-SGSL-DKILCNDASAKELGWTQRLN------VIKGVA 751
           +++   +   P    +I E  E    L D I               L           V 
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITER----------GALQEELARSFFWQVL 159

Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGY-EAHVSDFGIAKFLNPDSSNWSELAGTHGY 810
           +A+ + HN     ++HRDI  +N+L+DL   E  + DFG    L    + +++  GT  Y
Sbjct: 160 EAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVY 214

Query: 811 VAPEL----AYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRL 866
             PE      Y  +      V+S G+L  +++ G  P    FE          E++  ++
Sbjct: 215 SPPEWIRYHRYHGR---SAAVWSLGILLYDMVCGDIP----FEHDE-------EIIRGQV 260

Query: 867 PYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ 903
            +    V  +   +++    CL   P  RPT + +  
Sbjct: 261 FFRQ-RVSSECQHLIR---WCLALRPSDRPTFEEIQN 293

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 84.1 bits (208), Expect = 6e-17
 Identities = 62/280 (22%), Positives = 114/280 (40%), Gaps = 51/280 (18%)

Query: 638 NDFNAEHCIGKGGHGSVYRAKV-PSGEIFAVKKFHSPLPGEMSFQQEEF---LNEIQALT 693
           + F     +G+GG G V+  ++  +G+++A KK    L  +   +++ +   + E + L 
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKK----LNKKRLKKRKGYQGAMVEKKILA 240

Query: 694 EIRHRNIVK-FYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKG--V 750
           ++  R IV   Y F +      ++   +  G +   + N       G+ +   +     +
Sbjct: 241 KVHSRFIVSLAYAFET-KTDLCLVMTIMNGGDIRYHIYNVDE-DNPGFQEPRAIFYTAQI 298

Query: 751 ADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHV--SDFGIAKFLNPDSSNWSELAGTH 808
              L +LH      I++RD+  +NVLLD   + +V  SD G+A  L    +     AGT 
Sbjct: 299 VSGLEHLHQRN---IIYRDLKPENVLLD--DDGNVRISDLGLAVELKAGQTKTKGYAGTP 353

Query: 809 GYVAPEL----AYTLKVTEKCDVYSFGVLALEVIKGKHP---------RDFLFEMSSSSS 855
           G++APEL     Y   V    D ++ GV   E+I  + P            L +      
Sbjct: 354 GFMAPELLLGEEYDFSV----DYFALGVTLYEMIAARGPFRARGEKVENKELKQR----- 404

Query: 856 NMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESR 895
                +L+  + YP            +   + L ++PE R
Sbjct: 405 -----VLEQAVTYPD-KFSPASKDFCE---ALLQKDPEKR 435

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 81.2 bits (201), Expect = 8e-17
 Identities = 65/300 (21%), Positives = 108/300 (36%), Gaps = 70/300 (23%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVK------------KFHSPLPGEMSFQQEEFLN----- 687
           IGKG +G V  A        +A+K                P P          +      
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 688 -----EIQALTEIRHRNIVKFYGFCSHP--KHSFIIYEYLESGSLDKILCNDASAKELGW 740
                EI  L ++ H N+VK       P   H ++++E +  G + ++            
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--------- 131

Query: 741 TQRLN----------VIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGI 790
            + L+          +IKG+     YLH      I+HRDI   N+L+       ++DFG+
Sbjct: 132 -KPLSEDQARFYFQDLIKGIE----YLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGV 183

Query: 791 AKFLNPDSSNWSELAGTHGYVAPELAYTLKVT---EKCDVYSFGVLALEVIKGKHPRDFL 847
           +       +  S   GT  ++APE     +     +  DV++ GV     + G+ P    
Sbjct: 184 SNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP---- 239

Query: 848 FEMSSSSSNM--NIEMLDSRLP-YPSLHVQ-KKLMSIMQVAFSCLDQNPESRPTMKRVSQ 903
           F        +   I+      P  P +    K L++ M      LD+NPESR  +  +  
Sbjct: 240 FM-DERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRM------LDKNPESRIVVPEIKL 292

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 82.0 bits (203), Expect = 9e-17
 Identities = 58/248 (23%), Positives = 90/248 (36%), Gaps = 55/248 (22%)

Query: 623 TFEGKIVYEEIISATNDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQ 681
                   E      + F  E   G+G  G+V   K   +G   A+KK           Q
Sbjct: 8   LNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV---------IQ 58

Query: 682 QEEF----LNEIQALTEIRHRNIVK-FYGFCSHPKHSF------IIYEYLESGSLDKILC 730
              F    L  +Q L  + H NIV+    F +  +         ++ EY+   +L +   
Sbjct: 59  DPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCR 117

Query: 731 NDASAKELGWTQRLNVI----------KGVADALFYLHNNCFPPIVHRDISSKNVLLDLG 780
           N    +          I          + +      LH      + HRDI   NVL++  
Sbjct: 118 NYYRRQ-----VAPPPILIKVFLFQLIRSIG----CLHLPSVN-VCHRDIKPHNVLVNEA 167

Query: 781 -YEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL-----AYTLKVTEKCDVYSFG-VL 833
                + DFG AK L+P   N + +  +  Y APEL      YT  V    D++S G + 
Sbjct: 168 DGTLKLCDFGSAKKLSPSEPNVAYIC-SRYYRAPELIFGNQHYTTAV----DIWSVGCIF 222

Query: 834 ALEVIKGK 841
           A E++ G+
Sbjct: 223 A-EMMLGE 229

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 79.9 bits (198), Expect = 1e-16
 Identities = 68/279 (24%), Positives = 108/279 (38%), Gaps = 57/279 (20%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G+G +G V  A    + E  AVK        +     +    EI     + H N+VKFY
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK---KEICINKMLNHENVVKFY 71

Query: 705 GFCSHPKHSFIIYEYLESGSL-DKILCNDASAKELGWTQRLN----------VIKGVADA 753
           G        ++  EY   G L D+I  +            +           ++ GV   
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRIEPD----------IGMPEPDAQRFFHQLMAGVV-- 119

Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELA---GTHGY 810
             YLH      I HRDI  +N+LLD      +SDFG+A     ++     L    GT  Y
Sbjct: 120 --YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE-RLLNKMCGTLPY 173

Query: 811 VAPEL----AYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLD--- 863
           VAPEL     +     E  DV+S G++   ++ G+ P    ++  S S     +  +   
Sbjct: 174 VAPELLKRREFH---AEPVDVWSCGIVLTAMLAGELP----WDQPSDSCQEYSDWKEKKT 226

Query: 864 SRLPYPSLHVQ-KKLMSIMQVAFSCLDQNPESRPTMKRV 901
              P+  +      L+  +      L +NP +R T+  +
Sbjct: 227 YLNPWKKIDSAPLALLHKI------LVENPSARITIPDI 259

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 81.7 bits (202), Expect = 2e-16
 Identities = 67/219 (30%), Positives = 101/219 (46%), Gaps = 49/219 (22%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLN-EIQALTEIRHRNIVKF 703
           IG G  G VY+AK   SGE+ A+KK           Q + F N E+Q + ++ H NIV+ 
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKV---------LQDKRFKNRELQIMRKLDHCNIVRL 112

Query: 704 YGFCSHPKHSF------IIYEYLESGSLDKILCNDASAKELGWTQRL--NVIKG----VA 751
             F              ++ +Y+   ++ ++  + + AK     Q L    +K     + 
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAK-----QTLPVIYVKLYMYQLF 166

Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHV---SDFGIAKFLNPDSSNWSELAGTH 808
            +L Y+H+     I HRDI  +N+LLD   +  V    DFG AK L     N S +  + 
Sbjct: 167 RSLAYIHSFG---ICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPNVSYIC-SR 220

Query: 809 GYVAPEL-----AYTLKVTEKCDVYSFG-VLALEVIKGK 841
            Y APEL      YT  +    DV+S G VLA E++ G+
Sbjct: 221 YYRAPELIFGATDYTSSI----DVWSAGCVLA-ELLLGQ 254

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 83.0 bits (205), Expect = 2e-16
 Identities = 64/267 (23%), Positives = 107/267 (40%), Gaps = 28/267 (10%)

Query: 638 NDFNAEHCIGKGGHGSVYRAKV-PSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI- 695
           NDF+    IG+GG G VY  +   +G+++A+K             +   LNE   L+ + 
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ-GETLALNERIMLSLVS 247

Query: 696 --RHRNIVK-FYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNV-IKGVA 751
                 IV   Y F + P     I + +  G L   L       E      +      + 
Sbjct: 248 TGDCPFIVCMSYAFHT-PDKLSFILDLMNGGDLHYHLSQHGVFSE----ADMRFYAAEII 302

Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHV--SDFGIAKFLNPDSSNWSELAGTHG 809
             L ++HN     +V+RD+   N+LLD     HV  SD G+A   +    +     GTHG
Sbjct: 303 LGLEHMHNRF---VVYRDLKPANILLD--EHGHVRISDLGLACDFSKKKPH--ASVGTHG 355

Query: 810 YVAPE-LAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPY 868
           Y+APE L   +      D +S G +  ++++G  P  F    +     ++   L   +  
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP--FRQHKTKDKHEIDRMTLTMAVEL 413

Query: 869 PSLHVQKKLMSIMQVAFSCLDQNPESR 895
           P      +L S+++     L ++   R
Sbjct: 414 PD-SFSPELRSLLE---GLLQRDVNRR 436

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 78.8 bits (195), Expect = 5e-16
 Identities = 64/274 (23%), Positives = 108/274 (39%), Gaps = 39/274 (14%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G+G +G V       +    AVK         +   +     EIQ L  +RH+N+++  
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 705 GFCSH--PKHSFIIYEYLESGS---LDKILCNDASAKELGWTQRLNVIKGVADALFYLHN 759
               +   +  +++ EY   G    LD +       K     Q       + D L YLH+
Sbjct: 73  DVLYNEEKQKMYMVMEYCVCGMQEMLDSV-----PEKRFPVCQAHGYFCQLIDGLEYLHS 127

Query: 760 NCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELA---GTHGYVAPELA 816
                IVH+DI   N+LL  G    +S  G+A+ L+P +++        G+  +  PE+A
Sbjct: 128 QG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAAD-DTCRTSQGSPAFQPPEIA 183

Query: 817 YTLKVTE--KCDVYSFGVLALEVIKGKHPRD-----FLFEMSSSSSNMNIEMLDSRLPYP 869
             L      K D++S GV    +  G +P +      LFE        NI      +P  
Sbjct: 184 NGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFE--------NIGKGSYAIPGD 235

Query: 870 SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ 903
                  L+  M      L+  P  R +++++ Q
Sbjct: 236 CGPPLSDLLKGM------LEYEPAKRFSIRQIRQ 263

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 78.5 bits (194), Expect = 8e-16
 Identities = 68/279 (24%), Positives = 108/279 (38%), Gaps = 57/279 (20%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G+G +G V  A    + E  AVK        +     +    EI     + H N+VKFY
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK---KEICINKMLNHENVVKFY 71

Query: 705 GFCSHPKHSFIIYEYLESGSL-DKILCNDASAKELGWTQRLN----------VIKGVADA 753
           G        ++  EY   G L D+I  +            +           ++ GV   
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRIEPD----------IGMPEPDAQRFFHQLMAGVV-- 119

Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELA---GTHGY 810
             YLH      I HRDI  +N+LLD      +SDFG+A     ++     L    GT  Y
Sbjct: 120 --YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE-RLLNKMCGTLPY 173

Query: 811 VAPEL----AYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDS-- 864
           VAPEL     +     E  DV+S G++   ++ G+ P    ++  S S     +  +   
Sbjct: 174 VAPELLKRREFH---AEPVDVWSCGIVLTAMLAGELP----WDQPSDSCQEYSDWKEKKT 226

Query: 865 -RLPYPSLHVQ-KKLMSIMQVAFSCLDQNPESRPTMKRV 901
              P+  +      L+  +      L +NP +R T+  +
Sbjct: 227 YLNPWKKIDSAPLALLHKI------LVENPSARITIPDI 259

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 79.4 bits (196), Expect = 1e-15
 Identities = 57/255 (22%), Positives = 97/255 (38%), Gaps = 46/255 (18%)

Query: 638 NDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
            DF     IG+G  G V       + ++FA+K  +     + + +   F  E   L    
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRA-ETACFREERDVLVNGD 132

Query: 697 HRNIVK-FYGFCSHPKHSFIIYEYLESGSL-------DKILCNDAS---AKELGWTQRLN 745
            + I    Y F     + +++ +Y   G L       +  L  + +     E+       
Sbjct: 133 SKWITTLHYAFQD-DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEM------- 184

Query: 746 VIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHV--SDFGIAKFLNPDSSNWSE 803
                  A+  +H       VHRDI   N+L+D     H+  +DFG    L  D +  S 
Sbjct: 185 -----VIAIDSVHQLH---YVHRDIKPDNILMD--MNGHIRLADFGSCLKLMEDGTVQSS 234

Query: 804 LA-GTHGYVAPELAYTLKVTEK-----CDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNM 857
           +A GT  Y++PE+   ++  +      CD +S GV   E++ G+ P    F  + S    
Sbjct: 235 VAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP----FY-AESLVET 289

Query: 858 --NIEMLDSRLPYPS 870
              I     R  +P+
Sbjct: 290 YGKIMNHKERFQFPT 304

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 78.4 bits (194), Expect = 1e-15
 Identities = 50/206 (24%), Positives = 93/206 (45%), Gaps = 26/206 (12%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEF----LNEIQALTEIRHRNI 700
           +G+G +G V + +   +G I A+KKF        S   +      + EI+ L ++RH N+
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFL------ESDDDKMVKKIAMREIKLLKQLRHENL 86

Query: 701 VKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
           V     C   K  ++++E+++  ++   L  +     L +      +  + + + + H++
Sbjct: 87  VNLLEVCKKKKRWYLVFEFVDH-TILDDL--ELFPNGLDYQVVQKYLFQIINGIGFCHSH 143

Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL----- 815
               I+HRDI  +N+L+       + DFG A+ L      + +   T  Y APEL     
Sbjct: 144 N---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDV 200

Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGK 841
            Y   V    DV++ G L  E+  G+
Sbjct: 201 KYGKAV----DVWAIGCLVTEMFMGE 222

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 78.6 bits (194), Expect = 2e-15
 Identities = 59/231 (25%), Positives = 89/231 (38%), Gaps = 47/231 (20%)

Query: 638 NDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVK---KFHSPLPGEMSFQQEEFLNEIQALT 693
           +DF     IG+G    V       +G+++A+K   K+     GE+S     F  E   L 
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSC----FREERDVLV 116

Query: 694 EIRHRNIVK-FYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVAD 752
               R I +  + F     + +++ EY   G L            L    +         
Sbjct: 117 NGDRRWITQLHFAFQD-ENYLYLVMEYYVGGDL------------LTLLSKFGERIPAEM 163

Query: 753 ALFY----------LHNNCFPPIVHRDISSKNVLLDLGYEAHV--SDFGIAKFLNPDSSN 800
           A FY          +H       VHRDI   N+LLD     H+  +DFG    L  D + 
Sbjct: 164 ARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLD--RCGHIRLADFGSCLKLRADGTV 218

Query: 801 WSELA-GTHGYVAPEL-------AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
            S +A GT  Y++PE+         T     +CD ++ GV A E+  G+ P
Sbjct: 219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 78.1 bits (193), Expect = 2e-15
 Identities = 66/259 (25%), Positives = 112/259 (43%), Gaps = 52/259 (20%)

Query: 605 SQTQQSSFGNTPGLRSVLTFEGKIVYEEIISATNDFNAEHCIGKGGHGSVYRAKVPSGEI 664
           +  + +   +   +  VL  +GK   +  I+    +     IG G  G V++AK+   + 
Sbjct: 11  NGVKLNPLDDPNKVIKVLASDGKTGEQREIA----YTNCKVIGNGSFGVVFQAKLVESDE 66

Query: 665 FAVKKFHSPLPGEMSFQQEEFLN-EIQALTEIRHRNIVKFYGFCSHPKHS------FIIY 717
            A+KK           Q + F N E+Q +  ++H N+V    F              ++ 
Sbjct: 67  VAIKKV---------LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL 117

Query: 718 EYLESGSLDKILCNDASAKELGWTQRL--NVIKG----VADALFYLHNNCFPPIVHRDIS 771
           EY+   ++ +   + A  K     Q +   +IK     +  +L Y+H+     I HRDI 
Sbjct: 118 EYVPE-TVYRASRHYAKLK-----QTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIK 168

Query: 772 SKNVLLDLGYEAHV---SDFGIAKFLNPDSSNWSELAGTHGYVAPEL-----AYTLKVTE 823
            +N+LLD    + V    DFG AK L     N S +  +  Y APEL      YT  +  
Sbjct: 169 PQNLLLDP--PSGVLKLIDFGSAKILIAGEPNVSYIC-SRYYRAPELIFGATNYTTNI-- 223

Query: 824 KCDVYSFG-VLALEVIKGK 841
             D++S G V+A E+++G+
Sbjct: 224 --DIWSTGCVMA-ELMQGQ 239

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 78.2 bits (193), Expect = 3e-15
 Identities = 55/250 (22%), Positives = 96/250 (38%), Gaps = 39/250 (15%)

Query: 638 NDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
            D+     IG+G  G V   +   + +++A+K        + S     F  E   +    
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRS-DSAFFWEERDIMAFAN 127

Query: 697 HRNIVK-FYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKG------ 749
              +V+ FY F    ++ +++ EY+  G L  ++ N            +           
Sbjct: 128 SPWVVQLFYAFQD-DRYLYMVMEYMPGGDLVNLMSN----------YDVPEKWARFYTAE 176

Query: 750 VADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHV--SDFGIAKFLNPDSSNWSELA-G 806
           V  AL  +H+      +HRD+   N+LLD     H+  +DFG    +N +     + A G
Sbjct: 177 VVLALDAIHSMG---FIHRDVKPDNMLLD--KSGHLKLADFGTCMKMNKEGMVRCDTAVG 231

Query: 807 THGYVAPEL----AYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNM--NIE 860
           T  Y++PE+            +CD +S GV   E++ G  P    F  + S       I 
Sbjct: 232 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP----FY-ADSLVGTYSKIM 286

Query: 861 MLDSRLPYPS 870
              + L +P 
Sbjct: 287 NHKNSLTFPD 296

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 76.4 bits (189), Expect = 3e-15
 Identities = 41/175 (23%), Positives = 78/175 (44%), Gaps = 17/175 (9%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEF----LNEIQALTEIRHRNI 700
           IG+G +G V++ +   +G+I A+KKF        S          L EI+ L +++H N+
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFL------ESEDDPVIKKIALREIRMLKQLKHPNL 64

Query: 701 VKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
           V         +   +++EY +  ++   L  D   + +      ++      A+ + H +
Sbjct: 65  VNLLEVFRRKRRLHLVFEYCDH-TVLHEL--DRYQRGVPEHLVKSITWQTLQAVNFCHKH 121

Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
                +HRD+  +N+L+       + DFG A+ L   S  + +   T  Y +PEL
Sbjct: 122 N---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPEL 173

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 77.1 bits (190), Expect = 5e-15
 Identities = 48/288 (16%), Positives = 101/288 (35%), Gaps = 57/288 (19%)

Query: 298 RNLTDLVKLRLNQNYLTGN----ISETFGTYPNLTFIDLSNNSFFGEILSDWG------- 346
                + ++ L+ N +       +SE   +  +L   + S+  F G +  +         
Sbjct: 29  LEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDI-FTGRVKDEIPEALRLLL 87

Query: 347 ----RCPQLSLLDVSINNISGSIPLEIGESLQ----LQYLDLSSNYI------------- 385
               +CP+L  + +S N    +    + + L     L++L L +N +             
Sbjct: 88  QALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQ 147

Query: 386 VGEIPTQLGNIIYLNRLSLSGNKLS--GC--IPRELGSLINLEYLDLSANNL-----SNF 436
              +  +  N   L  +    N+L         +   S   L  + +  N +      + 
Sbjct: 148 ELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHL 207

Query: 437 VPESLGSLVKLYYLNLSHNKLS----QQIPIELDNLIHLSELDLSHNFLGEKISSRICRM 492
           + E L    +L  L+L  N  +      + I L +  +L EL L+   L  + ++ +   
Sbjct: 208 LLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDA 267

Query: 493 ------ESLEKLNLSYNNLSG----LIPRCFEE-MHGLLHIDISYNKL 529
                   L+ L L YN +       +    +E M  LL ++++ N+ 
Sbjct: 268 FSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 77.1 bits (190), Expect = 5e-15
 Identities = 51/329 (15%), Positives = 102/329 (31%), Gaps = 67/329 (20%)

Query: 229 KSLFDLELCINQLS--GAIPLS--ISNLTNLRFLFLYHNELSGIIPQEIGN-LKKLNSLL 283
            S+    L ++ ++      +   +    +++ + L  N +     + +   +     L 
Sbjct: 4   FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 63

Query: 284 LAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTG--NISETFGTYPNLTFIDLSNNSF---- 337
           +A               +D+   R+          + +     P L  + LS+N+F    
Sbjct: 64  IA-------------EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTA 110

Query: 338 ---FGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQ-------------LQYLDLS 381
                + LS       L  L +  N +      +I  +LQ             L+ +   
Sbjct: 111 QEPLIDFLSK---HTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICG 167

Query: 382 SNYI----VGEIPTQLGNIIYLNRLSLSGNKL-----SGCIPRELGSLINLEYLDLSANN 432
            N +    + E      +   L+ + +  N +        +   L     L+ LDL  N 
Sbjct: 168 RNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNT 227

Query: 433 LSN----FVPESLGSLVKLYYLNLSHNKLS----QQIPIELDNLIH--LSELDLSHNFLG 482
            ++     +  +L S   L  L L+   LS      +      L +  L  L L +N + 
Sbjct: 228 FTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIE 287

Query: 483 EKISSRICR-----MESLEKLNLSYNNLS 506
                 +       M  L  L L+ N  S
Sbjct: 288 LDAVRTLKTVIDEKMPDLLFLELNGNRFS 316

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 74.4 bits (183), Expect = 3e-14
 Identities = 44/285 (15%), Positives = 89/285 (31%), Gaps = 55/285 (19%)

Query: 299 NLTDLVKLRLNQNYLTG----NISETFGTYPNLTFIDLSNNSF-------FGEILSDWGR 347
             + +    L  + +T     ++        ++  I LS N+          E ++    
Sbjct: 3   RFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKD 61

Query: 348 CPQLSLLDVSINNISGSIP---LEIGESL----QLQYLDLSSNYI----VGEIPTQLGNI 396
                  D+    +   IP     + ++L    +L  + LS N         +   L   
Sbjct: 62  LEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKH 121

Query: 397 IYLNRLSLSGNKLS-------------GCIPRELGSLINLEYLDLSANNLSN----FVPE 439
             L  L L  N L                + ++  +   L  +    N L N       +
Sbjct: 122 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAK 181

Query: 440 SLGSLVKLYYLNLSHNKLSQQ-----IPIELDNLIHLSELDLSHNFLGEK----ISSRIC 490
           +  S   L+ + +  N +  +     +   L     L  LDL  N         ++  + 
Sbjct: 182 TFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALK 241

Query: 491 RMESLEKLNLSYNNLSG----LIPRCFEEMH--GLLHIDISYNKL 529
              +L +L L+   LS      +   F ++   GL  + + YN++
Sbjct: 242 SWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEI 286

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 65.9 bits (161), Expect = 2e-11
 Identities = 58/347 (16%), Positives = 111/347 (31%), Gaps = 70/347 (20%)

Query: 129 ISNLSNLEYLDFSANKL----FGQIPSGIGLLTHLTVLHISRNWLSG----SIPHEVGQL 180
           ++  S +E      + +       + + +     +  + +S N +       +   +   
Sbjct: 1   MARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASK 59

Query: 181 TVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQ 240
             L        F           L                + Q +     L  + L  N 
Sbjct: 60  KDLEIAEFSDIFTGRVKDEIPEALRL--------------LLQALLKCPKLHTVRLSDNA 105

Query: 241 LS--GAIPLS--ISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKS 296
                  PL   +S  T L  L+L++N L      +I          L +        K 
Sbjct: 106 FGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARA-------LQELAVN----KK 154

Query: 297 FRNLTDLVKLRLNQNYLTGN----ISETFGTYPNLTFIDLSNNSF--------FGEILSD 344
            +N   L  +   +N L        ++TF ++  L  + +  N            E L+ 
Sbjct: 155 AKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAY 214

Query: 345 WGRCPQLSLLDVSINNISGSIPLEIGESL----QLQYLDLSSNYI-------VGEIPTQL 393
              C +L +LD+  N  +      +  +L     L+ L L+   +       V +  ++L
Sbjct: 215 ---CQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKL 271

Query: 394 GNIIYLNRLSLSGNKLSGCIPRELGSLI-----NLEYLDLSANNLSN 435
            NI  L  L L  N++     R L ++I     +L +L+L+ N  S 
Sbjct: 272 ENI-GLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 317

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 56.6 bits (137), Expect = 2e-08
 Identities = 51/330 (15%), Positives = 96/330 (29%), Gaps = 93/330 (28%)

Query: 106 SSFPHLVYLDLYNNELFGI-----IPPQISNLSNLEYLDFSAN---KLFGQIPSGIGLL- 156
                +  + L  N + G      +   I++  +LE  +FS     ++  +IP  + LL 
Sbjct: 29  LEDDSVKEIVLSGNTI-GTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLL 87

Query: 157 ------THLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVIL 210
                   L  + +S N    +    +          L  +            L H   L
Sbjct: 88  QALLKCPKLHTVRLSDNAFGPTAQEPLID-------FLSKHT----------PLEH---L 127

Query: 211 YLYNNSF-------------FGSIPQEIGNLKSLFDLELCINQLS--GAIPLS--ISNLT 253
           YL+NN                 ++ ++  N   L  +    N+L        +    +  
Sbjct: 128 YLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR 187

Query: 254 NLRFLFLYHNELS--GIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQN 311
            L  + +  N +   GI              LL          +      +L  L L  N
Sbjct: 188 LLHTVKMVQNGIRPEGI------------EHLLL---------EGLAYCQELKVLDLQDN 226

Query: 312 YLTGN----ISETFGTYPNLTFIDLSNNSF-------FGEILSDWGRCPQLSLLDVSINN 360
             T      ++    ++PNL  + L++            +  S       L  L +  N 
Sbjct: 227 TFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSK-LENIGLQTLRLQYNE 285

Query: 361 ISGSIPLEIGESLQ-----LQYLDLSSNYI 385
           I       +   +      L +L+L+ N  
Sbjct: 286 IELDAVRTLKTVIDEKMPDLLFLELNGNRF 315

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 55.9 bits (135), Expect = 3e-08
 Identities = 27/167 (16%), Positives = 52/167 (31%), Gaps = 35/167 (20%)

Query: 399 LNRLSLSGNKLSG----CIPRELGSLINLEYLDLSANNLSN----FVPESLGSLVKLYYL 450
           +   SL  + ++      +   L    +++ + LS N +      ++ E++ S   L   
Sbjct: 6   IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65

Query: 451 NLSHNKLSQQIPIELDNLIHLSE----------LDLSHNFLGEK----ISSRICRMESLE 496
             S     +      + L  L +          + LS N  G      +   + +   LE
Sbjct: 66  EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 125

Query: 497 KLNLSYNNLS-------------GLIPRCFEEMHGLLHIDISYNKLE 530
            L L  N L                + +  +    L  I    N+LE
Sbjct: 126 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLE 172

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 49.3 bits (118), Expect = 3e-06
 Identities = 50/307 (16%), Positives = 95/307 (30%), Gaps = 52/307 (16%)

Query: 68  TKISPCAWSGIFCNHAERVVGINLTSISLNGTLLEFSFSSFPHLVYLDLYNNEL--FGII 125
             +    +S IF    +  +   L  +         +    P L  + L +N        
Sbjct: 60  KDLEIAEFSDIFTGRVKDEIPEALRLLL-------QALLKCPKLHTVRLSDNAFGPTAQE 112

Query: 126 P--PQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVL 183
           P    +S  + LE+L    N L     +G  +   L  L +++   +         L  +
Sbjct: 113 PLIDFLSKHTPLEHLYLHNNGL--GPQAGAKIARALQELAVNKKAKNAP------PLRSI 164

Query: 184 NQLALDSNFLNG----SIPRSLGNLTHVVILYLYNNSFF-----GSIPQEIGNLKSLFDL 234
                  N L         ++  +   +  + +  N          + + +   + L  L
Sbjct: 165 I---CGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVL 221

Query: 235 ELCINQLS--GAIPLS--ISNLTNLRFLFLYHNELSGIIPQEIGNL------KKLNSLLL 284
           +L  N  +  G+  L+  + +  NLR L L    LS      + +         L +L L
Sbjct: 222 DLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRL 281

Query: 285 AKNHFRGTVPKSF-----RNLTDLVKLRLNQNYLT------GNISETFGTYPNLTFIDLS 333
             N       ++        + DL+ L LN N  +        I E F T       +L 
Sbjct: 282 QYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDELD 341

Query: 334 NNSFFGE 340
           +     +
Sbjct: 342 DMEELTD 348

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 76.2 bits (188), Expect = 6e-15
 Identities = 67/290 (23%), Positives = 104/290 (35%), Gaps = 75/290 (25%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVK---KFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIV 701
           IG G  G     +   + E+ AVK   +         +   E    EI     +RH NIV
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIER--------GAAIDENVQREIINHRSLRHPNIV 79

Query: 702 KFYGFCSHPKHSFIIYEYLESGSL-DKILCNDASAKELGWTQRLN----------VIKGV 750
           +F      P H  II EY   G L ++I              R +          ++ GV
Sbjct: 80  RFKEVILTPTHLAIIMEYASGGELYERICNA----------GRFSEDEARFFFQQLLSGV 129

Query: 751 ADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAH--VSDFGIAKFLNPDSSNWSELA--- 805
           +    Y H+     I HRD+  +N LLD        + DFG +K         S+     
Sbjct: 130 S----YCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH----SQPKSTV 178

Query: 806 GTHGYVAPEL----AYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNM---- 857
           GT  Y+APE+     Y  K     DV+S GV    ++ G +P    FE      +     
Sbjct: 179 GTPAYIAPEVLLRQEYDGK---IADVWSCGVTLYVMLVGAYP----FEDPEEPRDYRKTI 231

Query: 858 -NIEMLDSRLPYPSLHV---QKKLMSIMQVAFSCLDQNPESRPTMKRVSQ 903
             I  +   +P   + +      L+S +         +P +R ++  +  
Sbjct: 232 QRILSVKYSIP-DDIRISPECCHLISRI------FVADPATRISIPEIKT 274

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 73.8 bits (182), Expect = 2e-14
 Identities = 68/287 (23%), Positives = 109/287 (37%), Gaps = 73/287 (25%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVK-----KFHSPLPGEMSFQQEEFLNEIQALTEIRHRN 699
           +G G  G V   +   +G   AVK     K  S    ++  + +    EIQ L   RH +
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSL---DVVGKIK---REIQNLKLFRHPH 72

Query: 700 IVKFYGFCSHPKHSFIIYEYLESGSL-DKILCNDASAKELGWTQRLNVIKGVADALFYLH 758
           I+K Y   S P   F++ EY+  G L D I         +   +   + + +  A+ Y H
Sbjct: 73  IIKLYQVISTPTDFFMVMEYVSGGELFDYI----CKHGRVEEMEARRLFQQILSAVDYCH 128

Query: 759 NNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELA---GTHGYVAPEL 815
            +    +VHRD+  +NVLLD    A ++DFG++  ++        L    G+  Y APE+
Sbjct: 129 RHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG----EFLRTSCGSPNYAAPEV 181

Query: 816 ----AYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSL 871
                Y      + D++S GV+             L+            +L   LP+   
Sbjct: 182 ISGRLYA---GPEVDIWSCGVI-------------LY-----------ALLCGTLPFDDE 214

Query: 872 HVQKKLMSIMQVAFSC---------------LDQNPESRPTMKRVSQ 903
           HV      I    F                 L  +P  R T+K + +
Sbjct: 215 HVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 52/182 (28%), Positives = 73/182 (40%), Gaps = 36/182 (19%)

Query: 114 LDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGI-GLLTHLTVLHISRNWLSGS 172
           LDL +  L  +       L+ L +L+   N+L   + +G+   LT L  L ++ N L+ S
Sbjct: 40  LDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANNQLA-S 97

Query: 173 IPHEV-GQLTVLNQLALDSNFLNGSIPR----SLGNLTHVVILYLYNNSFFGSIPQEIGN 227
           +P  V   LT L++L L  N L  S+P      L  L     L L  N    SIP     
Sbjct: 98  LPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKE---LRLNTNQL-QSIPAGA-- 150

Query: 228 LKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKN 287
               FD                  LTNL+ L L  N+L  +       L KL ++ L  N
Sbjct: 151 ----FD-----------------KLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189

Query: 288 HF 289
            F
Sbjct: 190 QF 191

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 68.6 bits (168), Expect = 8e-13
 Identities = 51/169 (30%), Positives = 71/169 (42%), Gaps = 11/169 (6%)

Query: 185 QLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEI-GNLKSLFDLELCINQLSG 243
           +L L S  L      +   LT +  L L  N    ++   +  +L  L  L L  NQL+ 
Sbjct: 39  KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQ-LQTLSAGVFDDLTELGTLGLANNQLA- 96

Query: 244 AIPLSI-SNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKS-FRNLT 301
           ++PL +  +LT L  L+L  N+L  +       L KL  L L  N  + ++P   F  LT
Sbjct: 97  SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLT 155

Query: 302 DLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFF---GEI--LSDW 345
           +L  L L+ N L       F     L  I L  N F     EI  LS W
Sbjct: 156 NLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCSRCEILYLSQW 204

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 65.5 bits (160), Expect = 9e-12
 Identities = 45/144 (31%), Positives = 65/144 (45%), Gaps = 16/144 (11%)

Query: 105 FSSFPHLVYLDLYNNELFGIIPPQI-SNLSNLEYLDFSANKLFGQIPSGI-GLLTHLTVL 162
           F     L +L+L  N+L   +   +  +L+ L  L  + N+L   +P G+   LT L  L
Sbjct: 55  FRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANNQL-ASLPLGVFDHLTQLDKL 112

Query: 163 HISRNWLSGSIPHEV-GQLTVLNQLALDSNFLNGSIP----RSLGNLTHVVILYLYNNSF 217
           ++  N L  S+P  V  +LT L +L L++N L  SIP      L NL     L L  N  
Sbjct: 113 YLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQT---LSLSTNQ- 166

Query: 218 FGSIPQEI-GNLKSLFDLELCINQ 240
             S+P      L  L  + L  NQ
Sbjct: 167 LQSVPHGAFDRLGKLQTITLFGNQ 190

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 61.6 bits (150), Expect = 2e-10
 Identities = 40/153 (26%), Positives = 64/153 (41%), Gaps = 2/153 (1%)

Query: 376 QYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSN 435
           + LDL S  +          +  L  L+L  N+L          L  L  L L+ N L++
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS 97

Query: 436 FVPESLGSLVKLYYLNLSHNKLSQQIPIEL-DNLIHLSELDLSHNFLGEKISSRICRMES 494
                   L +L  L L  N+L + +P  + D L  L EL L+ N L    +    ++ +
Sbjct: 98  LPLGVFDHLTQLDKLYLGGNQL-KSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTN 156

Query: 495 LEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYN 527
           L+ L+LS N L  +    F+ +  L  I +  N
Sbjct: 157 LQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 35/131 (26%), Positives = 62/131 (47%), Gaps = 4/131 (3%)

Query: 401 RLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQ 460
           +L L    L+         L  L +L+L  N L          L +L  L L++N+L   
Sbjct: 39  KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQL-AS 97

Query: 461 IPIEL-DNLIHLSELDLSHNFLGEKISSRIC-RMESLEKLNLSYNNLSGLIPRCFEEMHG 518
           +P+ + D+L  L +L L  N L + + S +  R+  L++L L+ N L  +    F+++  
Sbjct: 98  LPLGVFDHLTQLDKLYLGGNQL-KSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTN 156

Query: 519 LLHIDISYNKL 529
           L  + +S N+L
Sbjct: 157 LQTLSLSTNQL 167

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 56.2 bits (136), Expect = 1e-08
 Identities = 45/185 (24%), Positives = 68/185 (36%), Gaps = 36/185 (19%)

Query: 301 TDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINN 360
            D  KL L    L      TF     LT+++L  N              QL         
Sbjct: 35  ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYN--------------QLQ-------- 72

Query: 361 ISGSIPLEIGESL-QLQYLDLSSNYI----VGEIPTQLGNIIYLNRLSLSGNKLSGCIPR 415
              ++   + + L +L  L L++N +    +G +   L     L++L L GN+L      
Sbjct: 73  ---TLSAGVFDDLTELGTLGLANNQLASLPLG-VFDHLTQ---LDKLYLGGNQLKSLPSG 125

Query: 416 ELGSLINLEYLDLSANNLSNFVPESL-GSLVKLYYLNLSHNKLSQQIPIELDNLIHLSEL 474
               L  L+ L L+ N L + +P      L  L  L+LS N+L        D L  L  +
Sbjct: 126 VFDRLTKLKELRLNTNQLQS-IPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTI 184

Query: 475 DLSHN 479
            L  N
Sbjct: 185 TLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 49/181 (27%), Positives = 67/181 (37%), Gaps = 36/181 (19%)

Query: 281 SLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGE 340
            L L           +FR LT L  L L+ N L    +  F     L  + L+NN     
Sbjct: 39  KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANN----- 93

Query: 341 ILSDWGRCPQLSLLDVSINNISGSIPLEIGESL-QLQYLDLSSNYIVGEIP----TQLGN 395
                    QL+           S+PL + + L QL  L L  N +   +P     +L  
Sbjct: 94  ---------QLA-----------SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTK 132

Query: 396 IIYLNRLSLSGNKLSGCIPREL-GSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSH 454
              L  L L+ N+L   IP      L NL+ L LS N L +    +   L KL  + L  
Sbjct: 133 ---LKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFG 188

Query: 455 N 455
           N
Sbjct: 189 N 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 52.8 bits (127), Expect = 1e-07
 Identities = 48/194 (24%), Positives = 70/194 (36%), Gaps = 38/194 (19%)

Query: 244 AIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDL 303
           ++P  I    +   L L    L+ +       L KL  L L  N  +      F +LT+L
Sbjct: 28  SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTEL 85

Query: 304 VKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISG 363
             L L  N L       F     L  + L  N              QL            
Sbjct: 86  GTLGLANNQLASLPLGVFDHLTQLDKLYLGGN--------------QLK----------- 120

Query: 364 SIPLEIGESL-QLQYLDLSSNYIVGEIPT----QLGNIIYLNRLSLSGNKLSGCIPRE-L 417
           S+P  + + L +L+ L L++N +   IP     +L N   L  LSLS N+L   +P    
Sbjct: 121 SLPSGVFDRLTKLKELRLNTNQL-QSIPAGAFDKLTN---LQTLSLSTNQLQS-VPHGAF 175

Query: 418 GSLINLEYLDLSAN 431
             L  L+ + L  N
Sbjct: 176 DRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 49.3 bits (118), Expect = 2e-06
 Identities = 32/108 (29%), Positives = 53/108 (49%), Gaps = 4/108 (3%)

Query: 424 EYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIEL-DNLIHLSELDLSHNFLG 482
           E LDL +  L+     +   L KL +LNL +N+L Q +   + D+L  L  L L++N L 
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANNQL- 95

Query: 483 EKISSRI-CRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKL 529
             +   +   +  L+KL L  N L  L    F+ +  L  + ++ N+L
Sbjct: 96  ASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQL 143

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 48.2 bits (115), Expect = 5e-06
 Identities = 36/136 (26%), Positives = 50/136 (36%), Gaps = 40/136 (29%)

Query: 90  NLTSISLNG----TLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKL 145
            L ++ L      +L    F     L  L L  N        Q+ +L             
Sbjct: 84  ELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGN--------QLKSL------------- 122

Query: 146 FGQIPSGI-GLLTHLTVLHISRNWLSGSIPHEV-GQLTVLNQLALDSNFLNGSIPR---- 199
               PSG+   LT L  L ++ N L  SIP     +LT L  L+L +N L  S+P     
Sbjct: 123 ----PSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFD 176

Query: 200 SLGNLTHVVILYLYNN 215
            LG L     + L+ N
Sbjct: 177 RLGKLQT---ITLFGN 189

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 74.1 bits (183), Expect = 2e-14
 Identities = 55/209 (26%), Positives = 96/209 (45%), Gaps = 33/209 (15%)

Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEF----LNEIQALTEIRHRNIV 701
           IG+G +G VY+A+   GE FA+KK        +  + E      + EI  L E++H NIV
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILKELKHSNIV 63

Query: 702 KFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVA----DALFYL 757
           K Y      K   +++E+L+   L K+L  D     L         K       + + Y 
Sbjct: 64  KLYDVIHTKKRLVLVFEHLDQ-DLKKLL--DVCEGGLE----SVTAKSFLLQLLNGIAYC 116

Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL-- 815
           H+     ++HRD+  +N+L++   E  ++DFG+A+        ++    T  Y AP++  
Sbjct: 117 HDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLM 173

Query: 816 ---AYTLKVTEKCDVYSFGVLALEVIKGK 841
               Y+  +    D++S G +  E++ G 
Sbjct: 174 GSKKYSTTI----DIWSVGCIFAEMVNGT 198

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 73.4 bits (181), Expect = 4e-14
 Identities = 49/211 (23%), Positives = 94/211 (44%), Gaps = 32/211 (15%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEE-----FLNEIQALTEIRHRN 699
           +G G + +VY+     +G   A+K+             EE      + EI  + E++H N
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVK--------LDSEEGTPSTAIREISLMKELKHEN 64

Query: 700 IVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVA----DALF 755
           IV+ Y          +++E++++  L K + +  +         LN++K         L 
Sbjct: 65  IVRLYDVIHTENKLTLVFEFMDN-DLKKYM-DSRTVGNTPRGLELNLVKYFQWQLLQGLA 122

Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
           + H N    I+HRD+  +N+L++   +  + DFG+A+      + +S    T  Y AP++
Sbjct: 123 FCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDV 179

Query: 816 -----AYTLKVTEKCDVYSFGVLALEVIKGK 841
                 Y+  +    D++S G +  E+I GK
Sbjct: 180 LMGSRTYSTSI----DIWSCGCILAEMITGK 206

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 71.6 bits (176), Expect = 4e-14
 Identities = 25/134 (18%), Positives = 52/134 (38%), Gaps = 17/134 (12%)

Query: 90  NLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQI 149
             T +   G      F   P L  ++  NN++  I        S +  +  ++N+L   +
Sbjct: 43  EFTVLEATGI-----FKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRL-ENV 96

Query: 150 PSGI-GLLTHLTVLHISRNWLSGSIPHEV-GQLTVLNQLALDSNFLNGSIPR----SLGN 203
              +   L  L  L +  N ++  + ++    L+ +  L+L  N +  ++      +L +
Sbjct: 97  QHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHS 154

Query: 204 LTHVVILYLYNNSF 217
           L+    L L  N F
Sbjct: 155 LST---LNLLANPF 165

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 68.5 bits (168), Expect = 4e-13
 Identities = 30/134 (22%), Positives = 51/134 (38%), Gaps = 1/134 (0%)

Query: 205 THVVILYLYNNSFFGSIPQEI-GNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHN 263
            +   L L NN F       I   L  L  +    N+++     +    + +  + L  N
Sbjct: 32  QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91

Query: 264 ELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGT 323
            L  +  +    L+ L +L+L  N        SF  L+ +  L L  N +T      F T
Sbjct: 92  RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDT 151

Query: 324 YPNLTFIDLSNNSF 337
             +L+ ++L  N F
Sbjct: 152 LHSLSTLNLLANPF 165

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 65.8 bits (161), Expect = 3e-12
 Identities = 31/132 (23%), Positives = 57/132 (43%), Gaps = 11/132 (8%)

Query: 354 LDVSINNISGSIPLEIGESL-QLQYLDLSSNYIVGEIP----TQLGNIIYLNRLSLSGNK 408
           L ++ N  +      I + L QL+ ++ S+N I  +I             +N + L+ N+
Sbjct: 37  LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASG---VNEILLTSNR 92

Query: 409 LSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIE-LDN 467
           L     +    L +L+ L L +N ++    +S   L  +  L+L  N++   +     D 
Sbjct: 93  LENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQI-TTVAPGAFDT 151

Query: 468 LIHLSELDLSHN 479
           L  LS L+L  N
Sbjct: 152 LHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 24/130 (18%), Positives = 55/130 (42%), Gaps = 5/130 (3%)

Query: 401 RLSLSGNKLSGCIPR-ELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQ 459
            L L+ N+ +          L  L  ++ S N +++    +      +  + L+ N+L +
Sbjct: 36  ELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRL-E 94

Query: 460 QIPIEL-DNLIHLSELDLSHNFLGEKISSRI-CRMESLEKLNLSYNNLSGLIPRCFEEMH 517
            +  ++   L  L  L L  N +   + +     + S+  L+L  N ++ + P  F+ +H
Sbjct: 95  NVQHKMFKGLESLKTLMLRSNRI-TCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLH 153

Query: 518 GLLHIDISYN 527
            L  +++  N
Sbjct: 154 SLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 60.1 bits (146), Expect = 3e-10
 Identities = 26/130 (20%), Positives = 54/130 (41%), Gaps = 9/130 (6%)

Query: 422 NLEYLDLSANNLSNFVPESL-GSLVKLYYLNLSHNKLSQQIPIE-LDNLIHLSELDLSHN 479
               L L+ N  +      +   L +L  +N S+NK+   I     +    ++E+ L+ N
Sbjct: 33  YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKI-TDIEEGAFEGASGVNEILLTSN 91

Query: 480 FLGEKISSRIC-RMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNSTT 538
            L E +  ++   +ESL+ L L  N ++ +    F  +  +  + +  N++   +     
Sbjct: 92  RL-ENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPG-A 148

Query: 539 FRDAPLEALQ 548
           F    L +L 
Sbjct: 149 F--DTLHSLS 156

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 73.5 bits (181), Expect = 5e-14
 Identities = 52/222 (23%), Positives = 92/222 (41%), Gaps = 41/222 (18%)

Query: 638 NDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
           + F+    +G G  G V   K   SG  +A+K        ++  Q E  LNE + L  + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK-QIEHTLNEKRILQAVN 99

Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILC-----NDASAK----ELGWTQRLNVI 747
              +VK         + +++ EY+  G +   L      ++  A+    +          
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ---------- 149

Query: 748 KGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHV--SDFGIAKFLNPDSSNWSELA 805
             +     YLH+     +++RD+  +N+L+D   + ++  +DFG AK +      W+ L 
Sbjct: 150 --IVLTFEYLHSLD---LIYRDLKPENLLID--QQGYIQVTDFGFAKRV--KGRTWT-LC 199

Query: 806 GTHGYVAPEL----AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           GT   +APE+     Y   V    D ++ GVL  E+  G  P
Sbjct: 200 GTPEALAPEIILSKGYNKAV----DWWALGVLIYEMAAGYPP 237

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 72.7 bits (179), Expect = 8e-14
 Identities = 44/211 (20%), Positives = 91/211 (43%), Gaps = 32/211 (15%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEF----LNEIQALTEIRHRNI 700
           +G+G +G VY+A    + E  A+K+        +  ++E      + E+  L E++HRNI
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLLKELQHRNI 95

Query: 701 VKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
           ++      H     +I+EY E+  L K +       ++      + +  + + + + H+ 
Sbjct: 96  IELKSVIHHNHRLHLIFEYAEN-DLKKYM---DKNPDVSMRVIKSFLYQLINGVNFCHSR 151

Query: 761 CFPPIVHRDISSKNVLLDLGYEAH-----VSDFGIAKFLNPDSSNWSELAGTHGYVAPEL 815
                +HRD+  +N+LL +   +      + DFG+A+        ++    T  Y  PE+
Sbjct: 152 R---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEI 208

Query: 816 -----AYTLKVTEKCDVYSFGVLALEVIKGK 841
                 Y+  V    D++S   +  E++   
Sbjct: 209 LLGSRHYSTSV----DIWSIACIWAEMLMKT 235

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 70.4 bits (173), Expect = 1e-13
 Identities = 34/135 (25%), Positives = 53/135 (39%), Gaps = 4/135 (2%)

Query: 205 THVVILYLYNNSFFGSIPQEI-GNLKSLFDLELCINQLSGAIPLSI-SNLTNLRFLFLYH 262
             +  + L  N+    IP       K L  ++L  NQ+S  +       L +L  L LY 
Sbjct: 32  ETITEIRLEQNTI-KVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYG 89

Query: 263 NELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFG 322
           N+++ +       L  L  LLL  N        +F++L +L  L L  N L      TF 
Sbjct: 90  NKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFS 149

Query: 323 TYPNLTFIDLSNNSF 337
               +  + L+ N F
Sbjct: 150 PLRAIQTMHLAQNPF 164

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 68.5 bits (168), Expect = 4e-13
 Identities = 30/129 (23%), Positives = 52/129 (40%), Gaps = 4/129 (3%)

Query: 401 RLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQ 460
            + L  N +    P        L  +DLS N +S   P++   L  L  L L  NK+  +
Sbjct: 36  EIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKI-TE 94

Query: 461 IPIEL-DNLIHLSELDLSHNFLGEKISSRI-CRMESLEKLNLSYNNLSGLIPRCFEEMHG 518
           +P  L + L  L  L L+ N +   +       + +L  L+L  N L  +    F  +  
Sbjct: 95  LPKSLFEGLFSLQLLLLNANKI-NCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRA 153

Query: 519 LLHIDISYN 527
           +  + ++ N
Sbjct: 154 IQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 67.8 bits (166), Expect = 7e-13
 Identities = 35/131 (26%), Positives = 56/131 (42%), Gaps = 10/131 (7%)

Query: 354 LDVSINNISGSIPLEIGESL-QLQYLDLSSNYIVGEIPT----QLGNIIYLNRLSLSGNK 408
           + +  N I   IP        +L+ +DLS+N I  E+       L +   LN L L GNK
Sbjct: 37  IRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRS---LNSLVLYGNK 91

Query: 409 LSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNL 468
           ++         L +L+ L L+AN ++    ++   L  L  L+L  NKL          L
Sbjct: 92  ITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPL 151

Query: 469 IHLSELDLSHN 479
             +  + L+ N
Sbjct: 152 RAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 67.0 bits (164), Expect = 1e-12
 Identities = 31/121 (25%), Positives = 55/121 (45%), Gaps = 14/121 (11%)

Query: 104 SFSSFPHLVYLDLYNNELFGIIPPQI-SNLSNLEYLDFSANKLFGQIPSGI-GLLTHLTV 161
           +FS +  L  +DL NN++   + P     L +L  L    NK+  ++P  +   L  L +
Sbjct: 51  AFSPYKKLRRIDLSNNQI-SELAPDAFQGLRSLNSLVLYGNKI-TELPKSLFEGLFSLQL 108

Query: 162 LHISRNWLSGSIPHEVGQ-LTVLNQLALDSNFLNGSIPR----SLGNLTHVVILYLYNNS 216
           L ++ N ++  +  +  Q L  LN L+L  N L  +I +     L  +     ++L  N 
Sbjct: 109 LLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQT---MHLAQNP 163

Query: 217 F 217
           F
Sbjct: 164 F 164

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 65.8 bits (161), Expect = 3e-12
 Identities = 29/130 (22%), Positives = 57/130 (43%), Gaps = 8/130 (6%)

Query: 114 LDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGI-GLLTHLTVLHISRNWLSGS 172
           + L  N +  I P   S    L  +D S N++  ++       L  L  L +  N ++  
Sbjct: 37  IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQI-SELAPDAFQGLRSLNSLVLYGNKIT-E 94

Query: 173 IPHEV-GQLTVLNQLALDSNFLNGSIPR-SLGNLTHVVILYLYNNSFFGSIPQEI-GNLK 229
           +P  +   L  L  L L++N +N  +   +  +L ++ +L LY+N    +I +     L+
Sbjct: 95  LPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNK-LQTIAKGTFSPLR 152

Query: 230 SLFDLELCIN 239
           ++  + L  N
Sbjct: 153 AIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 64.7 bits (158), Expect = 9e-12
 Identities = 27/129 (20%), Positives = 58/129 (44%), Gaps = 5/129 (3%)

Query: 422 NLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIEL-DNLIHLSELDLSHNF 480
            +  + L  N +    P +     KL  ++LS+N++  ++  +    L  L+ L L  N 
Sbjct: 33  TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQI-SELAPDAFQGLRSLNSLVLYGNK 91

Query: 481 LGEKISSRI-CRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNSTTF 539
           +  ++   +   + SL+ L L+ N ++ L    F+++H L  + +  NKL+  I   T  
Sbjct: 92  I-TELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFS 149

Query: 540 RDAPLEALQ 548
               ++ + 
Sbjct: 150 PLRAIQTMH 158

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 72.5 bits (178), Expect = 1e-13
 Identities = 48/214 (22%), Positives = 88/214 (41%), Gaps = 47/214 (21%)

Query: 646 IGKGGHGSVYRAK---VPSGEIFAVKKFHSPLPGEMSFQQEEF----LNEIQALTEIRHR 698
           +G+G +G VY+AK       + +A+K+                      EI  L E++H 
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEG----------TGISMSACREIALLRELKHP 78

Query: 699 NIVKFYG-FCSHPKHS-FIIYEYLES---GSLDKILCNDASAKELGWTQRLNVIKGVA-- 751
           N++     F SH     +++++Y E      +     + A+ K +   +   ++K +   
Sbjct: 79  NVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR--GMVKSLLYQ 136

Query: 752 --DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAH----VSDFGIAKFLNPDSSNWSELA 805
             D + YLH N    ++HRD+   N+L+           ++D G A+  N      ++L 
Sbjct: 137 ILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 193

Query: 806 G---THGYVAPEL-----AYTLKVTEKCDVYSFG 831
               T  Y APEL      YT  +    D+++ G
Sbjct: 194 PVVVTFWYRAPELLLGARHYTKAI----DIWAIG 223

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 71.4 bits (176), Expect = 2e-13
 Identities = 52/205 (25%), Positives = 96/205 (46%), Gaps = 25/205 (12%)

Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEF----LNEIQALTEIRHRNIV 701
           +G+G +G VY+AK   G I A+K+        +  + E      + EI  L E+ H NIV
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLKELHHPNIV 82

Query: 702 KFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNC 761
                    +   +++E++E   L K+L  D +   L  +Q    +  +   + + H + 
Sbjct: 83  SLIDVIHSERCLTLVFEFMEK-DLKKVL--DENKTGLQDSQIKIYLYQLLRGVAHCHQHR 139

Query: 762 FPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL-----A 816
              I+HRD+  +N+L++      ++DFG+A+       +++    T  Y AP++      
Sbjct: 140 ---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKK 196

Query: 817 YTLKVTEKCDVYSFGVLALEVIKGK 841
           Y+  V    D++S G +  E+I GK
Sbjct: 197 YSTSV----DIWSIGCIFAEMITGK 217

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 68.9 bits (169), Expect = 2e-13
 Identities = 32/144 (22%), Positives = 59/144 (40%), Gaps = 11/144 (7%)

Query: 401 RLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQ 460
            L      +   +   L +L   ++L LS NN+      SL  +  L  L+L  N + + 
Sbjct: 29  ELHGMIPPIEK-MDATLSTLKACKHLALSTNNIEKI--SSLSGMENLRILSLGRNLIKK- 84

Query: 461 IPIE-LDNLI-HLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIP-RCFEEMH 517
             IE LD +   L EL +S+N +   +S  I ++ +L  L +S N ++          + 
Sbjct: 85  --IENLDAVADTLEELWISYNQI-ASLSG-IEKLVNLRVLYMSNNKITNWGEIDKLAALD 140

Query: 518 GLLHIDISYNKLEGQIPNSTTFRD 541
            L  + ++ N L      +    +
Sbjct: 141 KLEDLLLAGNPLYNDYKENNATSE 164

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 55.5 bits (134), Expect = 9e-09
 Identities = 35/206 (16%), Positives = 67/206 (32%), Gaps = 46/206 (22%)

Query: 223 QEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSL 282
                 + + +L   I  +   +  ++S L   + L L  N +      +I +L      
Sbjct: 20  VVATEAEKV-ELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-----KISSLS----- 67

Query: 283 LLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEIL 342
                            + +L  L L +N +   I         L  + +S N      L
Sbjct: 68  ----------------GMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQI--ASL 108

Query: 343 SDWGRCPQLSLLDVSINNISGSIPLEIGESL-QLQYLDLSSNYIVGEIPTQLGNIIYLNR 401
           S   +   L +L +S N I+    ++   +L +L+ L L+ N +  +         Y   
Sbjct: 109 SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIE 168

Query: 402 LSLSGNKLSGCIPRELGSLINLEYLD 427
           +              +  L NL+ LD
Sbjct: 169 V--------------VKRLPNLKKLD 180

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 48.1 bits (115), Expect = 2e-06
 Identities = 35/182 (19%), Positives = 63/182 (34%), Gaps = 39/182 (21%)

Query: 111 LVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLS 170
            V L      +  +    +S L   ++L  S N +  +I S +  + +L +L + RN + 
Sbjct: 27  KVELHGMIPPIEKM-DATLSTLKACKHLALSTNNI-EKI-SSLSGMENLRILSLGRNLIK 83

Query: 171 GSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKS 230
             I +       L +L +  N +  S+   +  L ++ +LY+ NN        +I N   
Sbjct: 84  -KIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNN--------KITNWGE 132

Query: 231 LFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQE----------IGNLKKLN 280
           +  L               + L  L  L L  N L     +           +  L  L 
Sbjct: 133 IDKL---------------AALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLK 177

Query: 281 SL 282
            L
Sbjct: 178 KL 179

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 71.5 bits (176), Expect = 2e-13
 Identities = 52/221 (23%), Positives = 97/221 (43%), Gaps = 44/221 (19%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEF----LNEIQALTEIRHRNI 700
           IG+G  G V++A+   +G+  A+KK        M  ++E F    L EI+ L  ++H N+
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVL------MENEKEGFPITALREIKILQLLKHENV 78

Query: 701 VKFYGFCSHPKHS--------FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVAD 752
           V     C              ++++++ E   L  +L       +   ++   V++ + +
Sbjct: 79  VNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLL--SNVLVKFTLSEIKRVMQMLLN 135

Query: 753 ALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIA-KFLNPDSSNWSELAGTHG-- 809
            L+Y+H N    I+HRD+ + NVL+       ++DFG+A  F    +S  +    T+   
Sbjct: 136 GLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY--TNRVV 190

Query: 810 ---YVAPEL-----AYTLKVTEKCDVYSFG-VLALEVIKGK 841
              Y  PEL      Y   +    D++  G ++A E+    
Sbjct: 191 TLWYRPPELLLGERDYGPPI----DLWGAGCIMA-EMWTRS 226

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 71.7 bits (176), Expect = 2e-13
 Identities = 58/330 (17%), Positives = 109/330 (33%), Gaps = 61/330 (18%)

Query: 234 LELCINQLSGAIPLS--ISNLTNLRFLFLYHNELSGIIPQEIG-----NLKKLNSLLLAK 286
           +   +    G+ P+    S    +  L L  N L  I   E+          + SL L+ 
Sbjct: 1   MNYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSG 60

Query: 287 NHFRGTVPKSF-----RNLTDLVKLRLNQNYLTGN----ISETFGTYP-NLTFIDLSNNS 336
           N                   ++  L L+ N+L+      + +T    P  +T +DL  N 
Sbjct: 61  NSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWND 120

Query: 337 F-------FGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQ-----LQYLDLSSNY 384
           F       F +  S+      ++ L++  N++      E+ + L      +  L+L  N 
Sbjct: 121 FSSKSSSEFKQAFSNLPA--SITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNN 178

Query: 385 I----VGEIPTQLGNI-IYLNRLSLSGNKL--SGCIPRELGSLI-----NLEYLDLSANN 432
           +      E+   L +I   +  L LS N L        EL  +      ++  L+L  N 
Sbjct: 179 LASKNCAELAKFLASIPASVTSLDLSANLLGLKSY--AELAYIFSSIPNHVVSLNLCLNC 236

Query: 433 LSNFVPESLGSLVK----LYYLNLSHNKLSQQIPIE-------LDNLIHLSELDLSHNFL 481
           L     E+L  L      L  + L ++ +      +         N+  +  +D +   +
Sbjct: 237 LHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEI 296

Query: 482 GEKISSRICRM-----ESLEKLNLSYNNLS 506
               S  I  +        +  +L    L 
Sbjct: 297 HPSHSIPISNLIRELSGKADVPSLLNQCLI 326

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 69.4 bits (170), Expect = 1e-12
 Identities = 54/341 (15%), Positives = 98/341 (28%), Gaps = 60/341 (17%)

Query: 201 LGNLTHVVILYLYNNSFFGSIPQEIG-----NLKSLFDLELCINQLS--GAIPLS---IS 250
                 V  L L  N+ +     E+         S+  L L  N L    +  L     +
Sbjct: 18  TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77

Query: 251 NLTNLRFLFLYHNELSGIIPQEIGNL-----KKLNSLLLAKNHFRGTVPKSF-----RNL 300
              N+  L L  N LS     E+          +  L L  N F       F        
Sbjct: 78  IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLP 137

Query: 301 TDLVKLRLNQNYLTGN----ISETFGTYP-NLTFIDLSNNSF-------FGEILSDWGRC 348
             +  L L  N L       + +     P N+  ++L  N+          + L+     
Sbjct: 138 ASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLAS--IP 195

Query: 349 PQLSLLDVSINNISGSIPLEIGESLQ-----LQYLDLSSNYIVGEIPTQLGNIIYLNR-- 401
             ++ LD+S N +      E+          +  L+L  N + G     L  +    +  
Sbjct: 196 ASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHL 255

Query: 402 --LSLSGNKLS-----GC--IPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNL 452
             + L  + +       C  +     ++  +  +D +   +       + +L++      
Sbjct: 256 QTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKA 315

Query: 453 SHNKLSQQIPIE----------LDNLIHLSELDLSHNFLGE 483
               L  Q  I           L+    L E   +   L E
Sbjct: 316 DVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPLLE 356

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 55.5 bits (134), Expect = 4e-08
 Identities = 54/358 (15%), Positives = 101/358 (28%), Gaps = 82/358 (22%)

Query: 109 PHLVYLDLYNNEL-----FGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLL------- 156
             +  LDL  N L       +I    +  +++  L+ S N L          L       
Sbjct: 22  HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSL---GFKNSDELVQILAAI 78

Query: 157 -THLTVLHISRN--------WLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNL--- 204
             ++T L++S N         L  ++      +TVL+   L  N  +             
Sbjct: 79  PANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLD---LGWNDFSSKSSSEFKQAFSN 135

Query: 205 --THVVILYLYNNSFFGSIPQEIGNL-----KSLFDLELCINQLS--GAIPLS---ISNL 252
               +  L L  N        E+  +      ++  L L  N L+      L+    S  
Sbjct: 136 LPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIP 195

Query: 253 TNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNY 312
            ++  L L  N L            +L  +  +                 +V L L  N 
Sbjct: 196 ASVTSLDLSANLLG-----LKS-YAELAYIFSSIP-------------NHVVSLNLCLNC 236

Query: 313 LTG----NISETFGTYPNLTFIDLSNNSF-------FGEILSDWGRCPQLSLLDVSINNI 361
           L G    N+     +  +L  + L  +            + + +    ++ L+D +   I
Sbjct: 237 LHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEI 296

Query: 362 SGSIPLEIGESLQ-----LQYLDLSSNYI-----VGEIPTQLGNIIYLNRLSLSGNKL 409
             S  + I   ++          L +  +            L     L     +   L
Sbjct: 297 HPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPL 354

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 69.9 bits (172), Expect = 4e-13
 Identities = 50/213 (23%), Positives = 97/213 (45%), Gaps = 29/213 (13%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEF----LNEIQALTEIRHRNI 700
           IG+G +G+V++AK   + EI A+K+        +    E      L EI  L E++H+NI
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLLKELKHKNI 63

Query: 701 VKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
           V+ +      K   +++E+ +   L K    D+   +L      + +  +   L + H+ 
Sbjct: 64  VRLHDVLHSDKKLTLVFEFCDQ-DLKKYF--DSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120

Query: 761 CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL----- 815
               ++HRD+  +N+L++   E  +++FG+A+        +S    T  Y  P++     
Sbjct: 121 N---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 177

Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLF 848
            Y+  +    D++S G +  E+     P   LF
Sbjct: 178 LYSTSI----DMWSAGCIFAELANAGRP---LF 203

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 71.7 bits (176), Expect = 4e-13
 Identities = 60/212 (28%), Positives = 89/212 (41%), Gaps = 54/212 (25%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVK-----KFHSPLPGEMSFQQEEFLNEIQALTEIRHRN 699
           +G G  G V   K   +G   AVK     K  S    ++  +      EIQ L   RH +
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSL---DVVGKIR---REIQNLKLFRHPH 77

Query: 700 IVKFYGFCSHPKHSFIIYEYLESGSL-DKILCNDASAKELGWTQRLN----------VIK 748
           I+K Y   S P   F++ EY+  G L D I  N           RL+          ++ 
Sbjct: 78  IIKLYQVISTPSDIFMVMEYVSGGELFDYICKN----------GRLDEKESRRLFQQILS 127

Query: 749 GVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELA--- 805
           GV     Y H +    +VHRD+  +NVLLD    A ++DFG++  ++        L    
Sbjct: 128 GVD----YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF----LRTSC 176

Query: 806 GTHGYVAPEL----AYTLKVTEKCDVYSFGVL 833
           G+  Y APE+     Y      + D++S GV+
Sbjct: 177 GSPNYAAPEVISGRLYA---GPEVDIWSSGVI 205

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 67.4 bits (165), Expect = 5e-13
 Identities = 30/127 (23%), Positives = 54/127 (42%), Gaps = 6/127 (4%)

Query: 378 LDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFV 437
           + L++  I  E   Q  N +    L L G K+   I     +L   + +D S N +    
Sbjct: 2   VKLTAELI--EQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL- 57

Query: 438 PESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGE-KISSRICRMESLE 496
            +    L +L  L +++N++ +        L  L+EL L++N L E      +  ++SL 
Sbjct: 58  -DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLT 116

Query: 497 KLNLSYN 503
            L +  N
Sbjct: 117 YLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 57.0 bits (138), Expect = 2e-09
 Identities = 18/105 (17%), Positives = 39/105 (37%), Gaps = 5/105 (4%)

Query: 426 LDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKI 485
           + L+A  +         + V+   L+L   K+   I      L     +D S N +  K+
Sbjct: 2   VKLTAELIEQ--AAQYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEI-RKL 57

Query: 486 SSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLE 530
                 +  L+ L ++ N +  +     + +  L  + ++ N L 
Sbjct: 58  DG-FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 57.0 bits (138), Expect = 2e-09
 Identities = 28/138 (20%), Positives = 50/138 (36%), Gaps = 11/138 (7%)

Query: 296 SFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLD 355
            + N     +L L    +   I     T      ID S+N      L  +    +L  L 
Sbjct: 14  QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLL 70

Query: 356 VSINNISGSIPLEIGESL-QLQYLDLSSNYI--VGEIPTQLGNIIYLNRLSLSGN---KL 409
           V+ N I   I   + ++L  L  L L++N +  +G++   L ++  L  L +  N     
Sbjct: 71  VNNNRIC-RIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRNPVTNK 128

Query: 410 SGCIPRELGSLINLEYLD 427
                  +  +  +  LD
Sbjct: 129 KHYRLYVIYKVPQVRVLD 146

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 55.4 bits (134), Expect = 7e-09
 Identities = 19/95 (20%), Positives = 41/95 (43%), Gaps = 7/95 (7%)

Query: 416 ELGSLINLEYLDLSANNLSNFVPESLGS-LVKLYYLNLSHNKLSQQIPIE-LDNLIHLSE 473
           +  + +    LDL    +     E+LG+ L +   ++ S N++ +   ++    L  L  
Sbjct: 14  QYTNAVRDRELDLRGYKIPVI--ENLGATLDQFDAIDFSDNEIRK---LDGFPLLRRLKT 68

Query: 474 LDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGL 508
           L +++N +          +  L +L L+ N+L  L
Sbjct: 69  LLVNNNRICRIGEGLDQALPDLTELILTNNSLVEL 103

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 44.3 bits (105), Expect = 4e-05
 Identities = 27/149 (18%), Positives = 42/149 (28%), Gaps = 33/149 (22%)

Query: 200 SLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFD----LELCINQLSGAIPLS-ISNLTN 254
              N      L L            I NL +  D    ++   N++     L     L  
Sbjct: 14  QYTNAVRDRELDLRGYKI-----PVIENLGATLDQFDAIDFSDNEIR---KLDGFPLLRR 65

Query: 255 LRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQN--- 311
           L+ L + +N +  I       L  L  L+L  N            L DL  L   ++   
Sbjct: 66  LKTLLVNNNRICRIGEGLDQALPDLTELILTNNS--------LVELGDLDPLASLKSLTY 117

Query: 312 -YLTGNISETFGTY--------PNLTFID 331
             +  N       Y        P +  +D
Sbjct: 118 LCILRNPVTNKKHYRLYVIYKVPQVRVLD 146

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 19/101 (18%), Positives = 37/101 (36%), Gaps = 7/101 (6%)

Query: 89  INLTSISLNG---TLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKL 145
           +    + L G    ++E   ++      +D  +NE+  +       L  L+ L  + N++
Sbjct: 19  VRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRI 76

Query: 146 FGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQL 186
                     L  LT L ++ N L      ++  L  L  L
Sbjct: 77  CRIGEGLDQALPDLTELILTNNSLVE--LGDLDPLASLKSL 115

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 71.9 bits (176), Expect = 5e-13
 Identities = 72/480 (15%), Positives = 149/480 (31%), Gaps = 51/480 (10%)

Query: 48  SLEVHSRSLLHSWSLSSVNATKISPCAWSGIFCNHAERVVGINLTSISLNGTLLEFSFSS 107
           S+E+  +     ++L            W     +    +  I L  + +    LE    S
Sbjct: 70  SVELKGKPHFADFNLVPDGWGGYV-YPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKS 128

Query: 108 FPHLVYLDLYNNELF---GIIPPQISNLSNLEYLDFSANKL-------FGQIPSGIGLLT 157
           F +   L L + E F   G+     +   NL+ LD   + +           P     L 
Sbjct: 129 FKNFKVLVLSSCEGFSTDGLAAI-AATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLV 187

Query: 158 HLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLY---- 213
            L +  ++      ++   V +   L  L L+       +   L     +  L       
Sbjct: 188 SLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTA 247

Query: 214 --NNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGI-IP 270
                 +  +   +   K L  L    + +   +P   S  + L  L L +  +    + 
Sbjct: 248 EVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLV 307

Query: 271 QEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFI 330
           + +    KL  L +        +        DL +LR+  +           T      +
Sbjct: 308 KLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALT--EQGLV 365

Query: 331 DLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESL-QLQYLDLSSNYIVGEI 389
            +S              CP+L  +      ++ +  + I  +   +    L         
Sbjct: 366 SVSMG------------CPKLESVLYFCRQMTNAALITIARNRPNMTRFRLC-------- 405

Query: 390 PTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGS-LVKLY 448
                 I       L+   L       +    +L  L LS   L++ V E +G+   K+ 
Sbjct: 406 -----IIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLS-GLLTDKVFEYIGTYAKKME 459

Query: 449 YLNLSHNKLSQQ-IPIELDNLIHLSELDLSH-NFLGEKISSRICRMESLEKLNLSYNNLS 506
            L+++    S   +   L     L +L++    F  + + +   ++E++  L +S  ++S
Sbjct: 460 MLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVS 519

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 70.0 bits (172), Expect = 5e-13
 Identities = 41/206 (19%), Positives = 73/206 (35%), Gaps = 62/206 (30%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKF 703
           +G G +G V +     + E FA+K               +   E++      +  +IV+ 
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQ---------DCPKARREVELHWRASQCPHIVRI 76

Query: 704 YGFC----SHPKHSFIIYEYLESGSL-DKILC--------NDASAKELGWTQRLNVIKGV 750
                   +  K   I+ E L+ G L  +I           +AS           ++K +
Sbjct: 77  VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE----------IMKSI 126

Query: 751 ADALFYLHNNCFPPIVHRDISSKNVLL---DLGYEAHVSDFGIAKFLNPDSSNWSELAGT 807
            +A+ YLH+     I HRD+  +N+L           ++DFG AK               
Sbjct: 127 GEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET---------TGEK 174

Query: 808 HGYVAPELAYTLKVTEKCDVYSFGVL 833
           +              + CD++S GV+
Sbjct: 175 YD-------------KSCDMWSLGVI 187

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 69.9 bits (172), Expect = 6e-13
 Identities = 43/207 (20%), Positives = 91/207 (43%), Gaps = 29/207 (14%)

Query: 646 IGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEE-----FLNEIQALTEIRHRN 699
           +G+G + +VY+ K   +  + A+K+           + EE      + E+  L +++H N
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIR--------LEHEEGAPCTAIREVSLLKDLKHAN 61

Query: 700 IVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHN 759
           IV  +      K   +++EYL+   L + L  D     +        +  +   L Y H 
Sbjct: 62  IVTLHDIIHTEKSLTLVFEYLDK-DLKQYL--DDCGNIINMHNVKLFLFQLLRGLAYCHR 118

Query: 760 NCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL---- 815
                ++HRD+  +N+L++   E  ++DFG+A+  +  +  +     T  Y  P++    
Sbjct: 119 QK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGS 175

Query: 816 -AYTLKVTEKCDVYSFGVLALEVIKGK 841
             Y+ ++    D++  G +  E+  G+
Sbjct: 176 TDYSTQI----DMWGVGCIFYEMATGR 198

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 70.9 bits (174), Expect = 6e-13
 Identities = 67/279 (24%), Positives = 116/279 (41%), Gaps = 56/279 (20%)

Query: 638 NDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEF---LNEIQALT 693
           N+F     +GKG  G V    +  +G  +A+K     L  E+   ++E    L E + L 
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKI----LKKEVIVAKDEVAHTLTENRVLQ 203

Query: 694 EIRHRNIVK-FYGFCSHPKHSFIIYEYLESGSL------DKILCNDAS---AKELGWTQR 743
             RH  +    Y F +H +  F++ EY   G L      +++   D +     E      
Sbjct: 204 NSRHPFLTALKYSFQTHDRLCFVM-EYANGGELFFHLSRERVFSEDRARFYGAE------ 256

Query: 744 LNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHV--SDFGIAKFLNPDSSNW 801
                 +  AL YLH+     +V+RD+  +N++LD   + H+  +DFG+ K    D +  
Sbjct: 257 ------IVSALDYLHSEK--NVVYRDLKLENLMLD--KDGHIKITDFGLCKEGIKDGATM 306

Query: 802 SELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP-----RDFLFEMSSSSSN 856
               GT  Y+APE+          D +  GV+  E++ G+ P      + LFE       
Sbjct: 307 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE------- 359

Query: 857 MNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESR 895
             I  L   + +P   +  +  S++      L ++P+ R
Sbjct: 360 -LI--LMEEIRFPR-TLGPEAKSLLS---GLLKKDPKQR 391

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 69.9 bits (172), Expect = 8e-13
 Identities = 55/217 (25%), Positives = 103/217 (47%), Gaps = 45/217 (20%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEF-------LNEIQALTEIRH 697
           +G+G   +VY+A+   + +I A+KK        +  + E         L EI+ L E+ H
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIK------LGHRSEAKDGINRTALREIKLLQELSH 71

Query: 698 RNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELG------WTQRLNVIKGVA 751
            NI+       H  +  ++++++E+  L+ I+    ++  L       +      ++G+ 
Sbjct: 72  PNIIGLLDAFGHKSNISLVFDFMET-DLEVII--KDNSLVLTPSHIKAYMLMT--LQGLE 126

Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK-FLNPDSSNWSELAGTHGY 810
               YLH +    I+HRD+   N+LLD      ++DFG+AK F +P+ +   ++  T  Y
Sbjct: 127 ----YLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-TRWY 178

Query: 811 VAPEL-----AYTLKVTEKCDVYSFG-VLALEVIKGK 841
            APEL      Y + V    D+++ G +LA E++   
Sbjct: 179 RAPELLFGARMYGVGV----DMWAVGCILA-ELLLRV 210

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 67.8 bits (166), Expect = 8e-13
 Identities = 43/117 (36%), Positives = 60/117 (51%), Gaps = 13/117 (11%)

Query: 105 FSSFPHLVYLDLYNNELFGIIPPQI-SNLSNLEYLDFSANKLFGQIPSGI-GLLTHLTVL 162
           F S  +L  L L +N+L G +P  +  +L+ L  LD   N+L   +PS +   L HL  L
Sbjct: 60  FDSLINLKELYLGSNQL-GALPVGVFDSLTQLTVLDLGTNQL-TVLPSAVFDRLVHLKEL 117

Query: 163 HISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPR----SLGNLTHVVILYLYNN 215
            +  N L+  +P  + +LT L  LALD N L  SIP      L +LTH    YL+ N
Sbjct: 118 FMCCNKLT-ELPRGIERLTHLTHLALDQNQLK-SIPHGAFDRLSSLTH---AYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 64.3 bits (157), Expect = 1e-11
 Identities = 44/131 (33%), Positives = 64/131 (48%), Gaps = 7/131 (5%)

Query: 113 YLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGI-GLLTHLTVLHISRNWLSG 171
            L L++N++  + P    +L NL+ L   +N+L G +P G+   LT LTVL +  N L+ 
Sbjct: 44  ILYLHDNQITKLEPGVFDSLINLKELYLGSNQL-GALPVGVFDSLTQLTVLDLGTNQLT- 101

Query: 172 SIPHEV-GQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEI-GNLK 229
            +P  V  +L  L +L +  N L   +PR +  LTH+  L L  N    SIP      L 
Sbjct: 102 VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQ-LKSIPHGAFDRLS 159

Query: 230 SLFDLELCINQ 240
           SL    L  N 
Sbjct: 160 SLTHAYLFGNP 170

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 58.6 bits (142), Expect = 1e-09
 Identities = 40/128 (31%), Positives = 57/128 (44%), Gaps = 3/128 (2%)

Query: 209 ILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSI-SNLTNLRFLFLYHNELSG 267
           ILYL++N      P    +L +L +L L  NQL  A+P+ +  +LT L  L L  N+L+ 
Sbjct: 44  ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLTV 102

Query: 268 IIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNL 327
           +       L  L  L +  N     +P+    LT L  L L+QN L       F    +L
Sbjct: 103 LPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSL 161

Query: 328 TFIDLSNN 335
           T   L  N
Sbjct: 162 THAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 53.2 bits (128), Expect = 7e-08
 Identities = 40/128 (31%), Positives = 59/128 (46%), Gaps = 3/128 (2%)

Query: 401 RLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQ 460
            L L  N+++   P    SLINL+ L L +N L         SL +L  L+L  N+L   
Sbjct: 44  ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQL-TV 102

Query: 461 IPIEL-DNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGL 519
           +P  + D L+HL EL +  N L  ++   I R+  L  L L  N L  +    F+ +  L
Sbjct: 103 LPSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSL 161

Query: 520 LHIDISYN 527
            H  +  N
Sbjct: 162 THAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 51.6 bits (124), Expect = 3e-07
 Identities = 33/108 (30%), Positives = 55/108 (50%), Gaps = 5/108 (4%)

Query: 424 EYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIEL-DNLIHLSELDLSHNFLG 482
           + L L  N ++   P    SL+ L  L L  N+L   +P+ + D+L  L+ LDL  N L 
Sbjct: 43  QILYLHDNQITKLEPGVFDSLINLKELYLGSNQL-GALPVGVFDSLTQLTVLDLGTNQL- 100

Query: 483 EKISSRIC-RMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKL 529
             + S +  R+  L++L +  N L+  +PR  E +  L H+ +  N+L
Sbjct: 101 TVLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQL 147

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 47.4 bits (113), Expect = 7e-06
 Identities = 40/180 (22%), Positives = 60/180 (33%), Gaps = 51/180 (28%)

Query: 301 TDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINN 360
           T+   L L+ N +T      F +  NL  + L +N                         
Sbjct: 40  TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSN------------------------- 74

Query: 361 ISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSL 420
                        QL  L       VG +   L     L  L L  N+L+         L
Sbjct: 75  -------------QLGALP------VG-VFDSLTQ---LTVLDLGTNQLTVLPSAVFDRL 111

Query: 421 INLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIE-LDNLIHLSELDLSHN 479
           ++L+ L +  N L+  +P  +  L  L +L L  N+L + IP    D L  L+   L  N
Sbjct: 112 VHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQL-KSIPHGAFDRLSSLTHAYLFGN 169

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 68.5 bits (168), Expect = 1e-12
 Identities = 60/185 (32%), Positives = 92/185 (49%), Gaps = 22/185 (11%)

Query: 90  NLTSISLNGTLLEFSFSSFPHLV---YLDLYNNELFGIIPPQISNLSNLEYLDFSANKLF 146
           ++  I  N + ++ S     +L    YL L  N+L  I    +  L+NL YL  + N+L 
Sbjct: 42  SIDQIIANNSDIK-SVQGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQL- 97

Query: 147 GQIPSGI-GLLTHLTVLHISRNWLSGSIPHEV-GQLTVLNQLALDSNFLNGSIPR----S 200
             +P+G+   LT+L  L +  N L  S+P  V  +LT L  L L  N L  S+P+     
Sbjct: 98  QSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDK 155

Query: 201 LGNLTHVVILYLYNNSFFGSIPQEI-GNLKSLFDLELCINQLSGAIPLSI-SNLTNLRFL 258
           L NLT    L L  N    S+P+ +   L  L DL L  NQL  ++P  +   LT+L+++
Sbjct: 156 LTNLTE---LDLSYNQ-LQSLPEGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYI 210

Query: 259 FLYHN 263
           +L+ N
Sbjct: 211 WLHDN 215

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 57.7 bits (140), Expect = 4e-09
 Identities = 45/191 (23%), Positives = 86/191 (45%), Gaps = 21/191 (10%)

Query: 347 RCP-QLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYI--VGEIPTQLGNIIYLNRLS 403
               +    ++   +++     +   +  +  +  +++ I  V  I      +  +  L+
Sbjct: 16  DAFAETIKANLKKKSVT-DAVTQNELN-SIDQIIANNSDIKSVQGIQY----LPNVRYLA 69

Query: 404 LSGNKLSGCIPRELG---SLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQ 460
           L GNKL      ++     L NL YL L+ N L +        L  L  L L  N+L Q 
Sbjct: 70  LGGNKLH-----DISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQL-QS 123

Query: 461 IPIEL-DNLIHLSELDLSHNFLGEKISSRIC-RMESLEKLNLSYNNLSGLIPRCFEEMHG 518
           +P  + D L +L+ L+L+HN L + +   +  ++ +L +L+LSYN L  L    F+++  
Sbjct: 124 LPDGVFDKLTNLTYLNLAHNQL-QSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQ 182

Query: 519 LLHIDISYNKL 529
           L  + +  N+L
Sbjct: 183 LKDLRLYQNQL 193

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 57.3 bits (139), Expect = 5e-09
 Identities = 56/231 (24%), Positives = 88/231 (38%), Gaps = 48/231 (20%)

Query: 210 LYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGII 269
             L   S       +   L S+  +    + +  ++   I  L N+R+L L  N+L    
Sbjct: 24  ANLKKKSV-TDAVTQNE-LNSIDQIIANNSDIK-SVQ-GIQYLPNVRYLALGGNKL---- 75

Query: 270 PQEIG---NLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPN 326
             +I     L  L  L+L  N  +      F  LT+L +L L +N L       F    N
Sbjct: 76  -HDISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTN 134

Query: 327 LTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESL-QLQYLDLSSNYI 385
           LT+++L++N              QL            S+P  + + L  L  LDLS N +
Sbjct: 135 LTYLNLAHN--------------QLQ-----------SLPKGVFDKLTNLTELDLSYNQL 169

Query: 386 VGEIPT----QLGNIIYLNRLSLSGNKLSGCIPRE-LGSLINLEYLDLSAN 431
              +P     +L     L  L L  N+L   +P      L +L+Y+ L  N
Sbjct: 170 -QSLPEGVFDKLTQ---LKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 215

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 69.3 bits (170), Expect = 1e-12
 Identities = 48/209 (22%), Positives = 85/209 (40%), Gaps = 31/209 (14%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEF----LNEIQALTEIRHRNI 700
           IG G  G V  A         A+KK   P      FQ +        E+  +  + H+NI
Sbjct: 33  IGSGAQGIVCAAYDAILERNVAIKKLSRP------FQNQTHAKRAYRELVLMKCVNHKNI 86

Query: 701 VKFYG-FCSHPKHS-----FIIYEYLESGSLDKILCNDASAKELGWT--QRLNVIKGVAD 752
           +     F            +I+ E +++ +L +++  +   + + +   Q L  IK    
Sbjct: 87  IGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIK---- 141

Query: 753 ALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVA 812
              +LH+     I+HRD+   N+++       + DFG+A+         +    T  Y A
Sbjct: 142 ---HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRA 194

Query: 813 PELAYTLKVTEKCDVYSFGVLALEVIKGK 841
           PE+   +   E  D++S G +  E+IKG 
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 69.9 bits (171), Expect = 1e-12
 Identities = 45/209 (21%), Positives = 85/209 (40%), Gaps = 31/209 (14%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEF----LNEIQALTEIRHRNI 700
           IG G  G V  A         A+KK   P      FQ +        E+  +  + H+NI
Sbjct: 70  IGSGAQGIVCAAYDAVLDRNVAIKKLSRP------FQNQTHAKRAYRELVLMKCVNHKNI 123

Query: 701 VKFYG-FCSHPKHS-----FIIYEYLESGSLDKILCNDASAKELGWT--QRLNVIKGVAD 752
           +     F            +++ E +++ +L +++  +   + + +   Q L  IK    
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIK---- 178

Query: 753 ALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVA 812
              +LH+     I+HRD+   N+++       + DFG+A+         +    T  Y A
Sbjct: 179 ---HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRA 231

Query: 813 PELAYTLKVTEKCDVYSFGVLALEVIKGK 841
           PE+   +   E  D++S G +  E+++ K
Sbjct: 232 PEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 68.3 bits (168), Expect = 2e-12
 Identities = 66/279 (23%), Positives = 115/279 (41%), Gaps = 60/279 (21%)

Query: 638 NDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
            DF     +G G  G V+      +G  +A+K     +   +  Q E   +E   L+ + 
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLK-QVEHTNDERLMLSIVT 64

Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSL------DKILCNDAS---AKELGWTQRLNVI 747
           H  I++ +G     +  F+I +Y+E G L       +   N  +   A E          
Sbjct: 65  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAE---------- 114

Query: 748 KGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHV--SDFGIAKFLNPDSSNWSELA 805
             V  AL YLH+     I++RD+  +N+LLD     H+  +DFG AK++      ++ L 
Sbjct: 115 --VCLALEYLHSK---DIIYRDLKPENILLD--KNGHIKITDFGFAKYV--PDVTYT-LC 164

Query: 806 GTHGYVAPEL----AYTLKVTEKCDVYSFGVLALEVIKGKHP-----RDFLFEMSSSSSN 856
           GT  Y+APE+     Y   +    D +SFG+L  E++ G  P         +E       
Sbjct: 165 GTPDYIAPEVVSTKPYNKSI----DWWSFGILIYEMLAGYTPFYDSNTMKTYE------- 213

Query: 857 MNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESR 895
             I  L++ L +P     + +  ++      + ++   R
Sbjct: 214 -KI--LNAELRFPP-FFNEDVKDLLS---RLITRDLSQR 245

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 68.1 bits (167), Expect = 3e-12
 Identities = 51/202 (25%), Positives = 85/202 (42%), Gaps = 35/202 (17%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVK-----KFHSPLPGEMSFQQEEFLNEIQALTEIRHRN 699
           +G+G  G V  A    + +  A+K             +M  + E    EI  L  +RH +
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKS---DMHMRVE---REISYLKLLRHPH 70

Query: 700 IVKFYGFCSHPKHSFIIYEYLESGSL-DKILCNDASAKELGWTQRLNVIKGVADALFYLH 758
           I+K Y   + P    ++ EY   G L D I       K +   +     + +  A+ Y H
Sbjct: 71  IIKLYDVITTPTDIVMVIEYA-GGELFDYI----VEKKRMTEDEGRRFFQQIICAIEYCH 125

Query: 759 NNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELA---GTHGYVAPEL 815
            +    IVHRD+  +N+LLD      ++DFG++  +       + L    G+  Y APE+
Sbjct: 126 RHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG----NFLKTSCGSPNYAAPEV 178

Query: 816 ----AYTLKVTEKCDVYSFGVL 833
                Y      + DV+S G++
Sbjct: 179 INGKLYA---GPEVDVWSCGIV 197

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 67.8 bits (165), Expect = 3e-12
 Identities = 21/102 (20%), Positives = 39/102 (38%), Gaps = 2/102 (1%)

Query: 237 CINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQE-IGNLKKLNSLLLAKNHFRGTVPK 295
           C    +      +    NL  L++ + +    +    +  L +L +L + K+  R   P 
Sbjct: 15  CTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD 74

Query: 296 SFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSF 337
           +F     L +L L+ N L     +T     +L  + LS N  
Sbjct: 75  AFHFTPRLSRLNLSFNALESLSWKTV-QGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 62.4 bits (151), Expect = 2e-10
 Identities = 24/95 (25%), Positives = 34/95 (35%), Gaps = 2/95 (2%)

Query: 388 EIPTQLGNIIYLNRLSLSGNKLSGCIPRE-LGSLINLEYLDLSANNLSNFVPESLGSLVK 446
           +    L     L  L +   +    +    L  L  L  L +  + L    P++     +
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81

Query: 447 LYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFL 481
           L  LNLS N L       +  L  L EL LS N L
Sbjct: 82  LSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 59.8 bits (144), Expect = 2e-09
 Identities = 21/101 (20%), Positives = 39/101 (38%), Gaps = 4/101 (3%)

Query: 431 NNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIE-LDNLIHLSELDLSHNFLGEKISSRI 489
            + +      L     L  L + + +  Q + +  L  L  L  L +  + L   ++   
Sbjct: 17  RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL-RFVAPDA 75

Query: 490 -CRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKL 529
                 L +LNLS+N L  L  +  + +  L  + +S N L
Sbjct: 76  FHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 59.4 bits (143), Expect = 2e-09
 Identities = 23/148 (15%), Positives = 46/148 (31%), Gaps = 11/148 (7%)

Query: 347 RCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQ-LGNIIYLNRLSLS 405
                S L  + +         +  +  L  L + +   +  +  + L  +  L  L++ 
Sbjct: 6   CPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIV 64

Query: 406 GNKLSGCIPRE-LGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIE 464
            + L   +  +       L  L+LS N L +   +++  L  L  L LS N      P+ 
Sbjct: 65  KSGLR-FVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGL-SLQELVLSGN------PLH 116

Query: 465 LDNLIHLSELDLSHNFLGEKISSRICRM 492
               +   +        G       C  
Sbjct: 117 CSCALRWLQRWEEEGLGGVPEQKLQCHG 144

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 57.8 bits (139), Expect = 7e-09
 Identities = 19/96 (19%), Positives = 33/96 (34%), Gaps = 2/96 (2%)

Query: 196 SIPRSLGNLTHVVILYLYNNSFFGSIPQE-IGNLKSLFDLELCINQLSGAIPLSISNLTN 254
                L    ++  LY+ N      +    +  L  L +L +  + L    P +      
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81

Query: 255 LRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFR 290
           L  L L  N L  +  + +  L  L  L+L+ N   
Sbjct: 82  LSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 55.1 bits (132), Expect = 5e-08
 Identities = 19/93 (20%), Positives = 34/93 (36%), Gaps = 4/93 (4%)

Query: 104 SFSSFPHLVYLDLYNNELFGIIPPQ-ISNLSNLEYLDFSANKLFGQIPSGI-GLLTHLTV 161
                 +L  L + N +    +  + +  L  L  L    + L   +          L+ 
Sbjct: 26  HLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL-RFVAPDAFHFTPRLSR 84

Query: 162 LHISRNWLSGSIPHEVGQLTVLNQLALDSNFLN 194
           L++S N L  S+  +  Q   L +L L  N L+
Sbjct: 85  LNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 53.6 bits (128), Expect = 1e-07
 Identities = 20/100 (20%), Positives = 38/100 (38%), Gaps = 5/100 (5%)

Query: 454 HNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSR-ICRMESLEKLNLSYNNLSGLIPRC 512
               +      L    +L+EL + +    + +  R +  +  L  L +  + L  + P  
Sbjct: 16  TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75

Query: 513 FEEMHGLLHIDISYNKLEGQIPNSTTFRDAPLE--ALQGN 550
           F     L  +++S+N LE       T +   L+   L GN
Sbjct: 76  FHFTPRLSRLNLSFNALESLSWK--TVQGLSLQELVLSGN 113

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 50.5 bits (120), Expect = 1e-06
 Identities = 17/95 (17%), Positives = 29/95 (30%), Gaps = 4/95 (4%)

Query: 125 IPPQISNLSNLEYLDFSANKLFGQIPSG-IGLLTHLTVLHISRNWLSGSIPHEVGQ-LTV 182
               +    NL  L     +    +    +  L  L  L I ++ L   +  +       
Sbjct: 23  SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPR 81

Query: 183 LNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSF 217
           L++L L  N L  S+         +  L L  N  
Sbjct: 82  LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 45.1 bits (106), Expect = 6e-05
 Identities = 18/85 (21%), Positives = 26/85 (30%), Gaps = 6/85 (7%)

Query: 90  NLTSISLNG-----TLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANK 144
           NLT + +        L          L  L +  + L  + P        L  L+ S N 
Sbjct: 32  NLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA 91

Query: 145 LFGQIPSGIGLLTHLTVLHISRNWL 169
           L   +         L  L +S N L
Sbjct: 92  L-ESLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 42.4 bits (99), Expect = 5e-04
 Identities = 17/95 (17%), Positives = 29/95 (30%), Gaps = 2/95 (2%)

Query: 143 NKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEV-GQLTVLNQLALDSNFLNGSIPRSL 201
                     +    +LT L+I        +       L  L  L +  + L    P + 
Sbjct: 17  RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76

Query: 202 GNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLEL 236
                +  L L  N+   S+  +     SL +L L
Sbjct: 77  HFTPRLSRLNLSFNA-LESLSWKTVQGLSLQELVL 110

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 68.2 bits (167), Expect = 4e-12
 Identities = 51/245 (20%), Positives = 85/245 (34%), Gaps = 69/245 (28%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLN-EIQALTEIRHRNIV-- 701
           +G G  G V     + SG+ FA+KK           Q   + N E+  +  + H NI+  
Sbjct: 15  LGTGSFGIVCEVFDIESGKRFALKKV---------LQDPRYKNRELDIMKVLDHVNIIKL 65

Query: 702 KFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLN---------------- 745
             Y + +  +         +   L        +  +                        
Sbjct: 66  VDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLH 125

Query: 746 -VIKGVAD-------------------ALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHV 785
            V+K                       A+ ++H+     I HRDI  +N+L++   + + 
Sbjct: 126 KVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNS--KDNT 180

Query: 786 ---SDFGIAKFLNPDSSNWSELAGTHGYVAPEL-----AYTLKVTEKCDVYSFG-VLALE 836
               DFG AK L P   + + +  +  Y APEL      YT  +    D++S G V   E
Sbjct: 181 LKLCDFGSAKKLIPSEPSVAYIC-SRFYRAPELMLGATEYTPSI----DLWSIGCVFG-E 234

Query: 837 VIKGK 841
           +I GK
Sbjct: 235 LILGK 239

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 65.5 bits (160), Expect = 4e-12
 Identities = 40/124 (32%), Positives = 62/124 (50%), Gaps = 14/124 (11%)

Query: 99  TLLEFSFSSFPHLVYLDLYNNELFGIIPPQISN-LSNLEYLDFSANKLFGQIPSGI-GLL 156
           +L    F     L  L L  N+L   +P  + N L++L YL+ S N+L   +P+G+   L
Sbjct: 42  SLPNGVFDELTSLTQLYLGGNKL-QSLPNGVFNKLTSLTYLNLSTNQL-QSLPNGVFDKL 99

Query: 157 THLTVLHISRNWLSGSIPHEV-GQLTVLNQLALDSNFLNGSIPR----SLGNLTHVVILY 211
           T L  L ++ N L  S+P  V  +LT L  L L  N L  S+P      L +L +   ++
Sbjct: 100 TQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQY---IW 154

Query: 212 LYNN 215
           L++N
Sbjct: 155 LHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 58.9 bits (143), Expect = 7e-10
 Identities = 48/135 (35%), Positives = 66/135 (48%), Gaps = 14/135 (10%)

Query: 113 YLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGI-GLLTHLTVLHISRNWLSG 171
           YLDL  N L  +       L++L  L    NKL   +P+G+   LT LT L++S N L  
Sbjct: 32  YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKL-QSLPNGVFNKLTSLTYLNLSTNQLQ- 89

Query: 172 SIPHEV-GQLTVLNQLALDSNFLNGSIPR----SLGNLTHVVILYLYNNSFFGSIPQEI- 225
           S+P+ V  +LT L +LAL++N L  S+P      L  L     L LY N    S+P  + 
Sbjct: 90  SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKD---LRLYQNQ-LKSVPDGVF 144

Query: 226 GNLKSLFDLELCINQ 240
             L SL  + L  N 
Sbjct: 145 DRLTSLQYIWLHDNP 159

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 53.9 bits (130), Expect = 3e-08
 Identities = 46/148 (31%), Positives = 65/148 (43%), Gaps = 8/148 (5%)

Query: 143 NKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLG 202
           ++    +P+GI   T  T L +  N L         +LT L QL L  N L  S+P  + 
Sbjct: 16  SQGRTSVPTGIPAQT--TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVF 72

Query: 203 N-LTHVVILYLYNNSFFGSIPQEI-GNLKSLFDLELCINQLSGAIPLSI-SNLTNLRFLF 259
           N LT +  L L  N    S+P  +   L  L +L L  NQL  ++P  +   LT L+ L 
Sbjct: 73  NKLTSLTYLNLSTNQL-QSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLR 130

Query: 260 LYHNELSGIIPQEIGNLKKLNSLLLAKN 287
           LY N+L  +       L  L  + L  N
Sbjct: 131 LYQNQLKSVPDGVFDRLTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 50.4 bits (121), Expect = 5e-07
 Identities = 40/127 (31%), Positives = 53/127 (41%), Gaps = 2/127 (1%)

Query: 210 LYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISN-LTNLRFLFLYHNELSGI 268
           L L  NS           L SL  L L  N+L  ++P  + N LT+L +L L  N+L  +
Sbjct: 33  LDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQSL 91

Query: 269 IPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLT 328
                  L +L  L L  N  +      F  LT L  LRL QN L       F    +L 
Sbjct: 92  PNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQ 151

Query: 329 FIDLSNN 335
           +I L +N
Sbjct: 152 YIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 32/108 (29%), Positives = 54/108 (50%), Gaps = 4/108 (3%)

Query: 424 EYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIEL-DNLIHLSELDLSHNFLG 482
            YLDL  N+L +        L  L  L L  NKL Q +P  + + L  L+ L+LS N L 
Sbjct: 31  TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKL-QSLPNGVFNKLTSLTYLNLSTNQL- 88

Query: 483 EKISSRIC-RMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKL 529
           + + + +  ++  L++L L+ N L  L    F+++  L  + +  N+L
Sbjct: 89  QSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQL 136

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 48.1 bits (115), Expect = 3e-06
 Identities = 39/130 (30%), Positives = 56/130 (43%), Gaps = 6/130 (4%)

Query: 401 RLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQ 460
            L L  N L          L +L  L L  N L +        L  L YLNLS N+L Q 
Sbjct: 32  YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQL-QS 90

Query: 461 IPIEL-DNLIHLSELDLSHNFLGEKISSRIC-RMESLEKLNLSYNNLSGLIPR-CFEEMH 517
           +P  + D L  L EL L+ N L + +   +  ++  L+ L L  N L   +P   F+ + 
Sbjct: 91  LPNGVFDKLTQLKELALNTNQL-QSLPDGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLT 148

Query: 518 GLLHIDISYN 527
            L +I +  N
Sbjct: 149 SLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 42.7 bits (101), Expect = 2e-04
 Identities = 38/180 (21%), Positives = 55/180 (30%), Gaps = 50/180 (27%)

Query: 301 TDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINN 360
                L L  N L    +  F    +LT + L  N                         
Sbjct: 28  AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGN------------------------- 62

Query: 361 ISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSL 420
                        +LQ L        G +  +L +   L  L+LS N+L          L
Sbjct: 63  -------------KLQSLP------NG-VFNKLTS---LTYLNLSTNQLQSLPNGVFDKL 99

Query: 421 INLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIE-LDNLIHLSELDLSHN 479
             L+ L L+ N L +        L +L  L L  N+L + +P    D L  L  + L  N
Sbjct: 100 TQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQL-KSVPDGVFDRLTSLQYIWLHDN 158

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 66.4 bits (163), Expect = 8e-12
 Identities = 68/283 (24%), Positives = 117/283 (41%), Gaps = 63/283 (22%)

Query: 638 NDFNAEHCIGKGGHGSVYRAK----VPSGEIFAVK---KFHSPLPGEMSFQQEEFLNEIQ 690
           + F     +G+G  G V+  K      + +++A+K   K            +     E  
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATL-----KVRDRVRTKMERD 78

Query: 691 ALTEIRHRNIVK-FYGFCSHPKHSFIIYEYLESGSL------DKILCNDAS---AKELGW 740
            L E+ H  IVK  Y F +     ++I ++L  G L      + +   +       EL  
Sbjct: 79  ILVEVNHPFIVKLHYAFQT-EGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAEL-- 135

Query: 741 TQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHV--SDFGIAK-FLNPD 797
                     A AL +LH+     I++RD+  +N+LLD   E H+  +DFG++K  ++ +
Sbjct: 136 ----------ALALDHLHSLG---IIYRDLKPENILLD--EEGHIKLTDFGLSKESIDHE 180

Query: 798 SSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP-----RDFLFEMSS 852
              +S   GT  Y+APE+      T+  D +SFGVL  E++ G  P     R        
Sbjct: 181 KKAYS-FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMT--- 236

Query: 853 SSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESR 895
                 I  L ++L  P   +  +  S+++       +NP +R
Sbjct: 237 -----MI--LKAKLGMPQ-FLSPEAQSLLR---MLFKRNPANR 268

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 66.5 bits (163), Expect = 8e-12
 Identities = 67/283 (23%), Positives = 115/283 (40%), Gaps = 65/283 (22%)

Query: 638 NDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEF---LNEIQALT 693
           NDF+    +GKG  G V    +  +G  +A+K     L  E+   ++E    + E + L 
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKI----LRKEVIIAKDEVAHTVTESRVLQ 60

Query: 694 EIRHRNIVK-FYGFCSHPKHSFIIYEYLESGSL------DKILCNDAS---AKELGWTQR 743
             RH  +    Y F +       + EY   G L      +++   + +     E      
Sbjct: 61  NTRHPFLTALKYAFQT-HDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE------ 113

Query: 744 LNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHV--SDFGIAKFLNPDSSNW 801
                 +  AL YLH+     +V+RDI  +N++LD   + H+  +DFG+ K    D +  
Sbjct: 114 ------IVSALEYLHSR---DVVYRDIKLENLMLD--KDGHIKITDFGLCKEGISDGATM 162

Query: 802 SELAGTHGYVAPEL----AYTLKVTEKCDVYSFGVLALEVIKGKHP-----RDFLFEMSS 852
               GT  Y+APE+     Y   V    D +  GV+  E++ G+ P      + LFE   
Sbjct: 163 KTFCGTPEYLAPEVLEDNDYGRAV----DWWGLGVVMYEMMCGRLPFYNQDHERLFE--- 215

Query: 853 SSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESR 895
                 I  L   + +P   +  +  S++      L ++P+ R
Sbjct: 216 -----LI--LMEEIRFPR-TLSPEAKSLLA---GLLKKDPKQR 247

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 63.9 bits (156), Expect = 1e-11
 Identities = 29/108 (26%), Positives = 48/108 (44%), Gaps = 13/108 (12%)

Query: 114 LDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGI-GLLTHLTVLHISRNWLSGS 172
           L L  N+   ++P ++SN  +L  +D S N++   + +     +T L  L +S N L   
Sbjct: 36  LYLDGNQF-TLVPKELSNYKHLTLIDLSNNRI-STLSNQSFSNMTQLLTLILSYNRLR-C 92

Query: 173 IPHEV-GQLTVLNQLALDSNFLNGSIPR----SLGNLTHVVILYLYNN 215
           IP      L  L  L+L  N ++  +P      L  L+H   L +  N
Sbjct: 93  IPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSH---LAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 56.9 bits (138), Expect = 2e-09
 Identities = 38/108 (35%), Positives = 53/108 (49%), Gaps = 3/108 (2%)

Query: 205 THVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNE 264
             V  LYL  N F   +P+E+ N K L  ++L  N++S     S SN+T L  L L +N 
Sbjct: 31  RDVTELYLDGNQF-TLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89

Query: 265 LSGIIPQEIGNLKKLNSLLLAKNHFRGTVPK-SFRNLTDLVKLRLNQN 311
           L  I P+    LK L  L L  N     VP+ +F +L+ L  L +  N
Sbjct: 90  LRCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 54.2 bits (131), Expect = 2e-08
 Identities = 28/80 (35%), Positives = 43/80 (53%), Gaps = 3/80 (3%)

Query: 401 RLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQ 460
            L L GN+ +  +P+EL +  +L  +DLS N +S    +S  ++ +L  L LS+N+L + 
Sbjct: 35  ELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL-RC 92

Query: 461 IPIEL-DNLIHLSELDLSHN 479
           IP    D L  L  L L  N
Sbjct: 93  IPPRTFDGLKSLRLLSLHGN 112

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 53.8 bits (130), Expect = 3e-08
 Identities = 29/105 (27%), Positives = 45/105 (42%), Gaps = 3/105 (2%)

Query: 376 QYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSN 435
             L L  N     +P +L N  +L  + LS N++S    +   ++  L  L LS N L  
Sbjct: 34  TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRC 92

Query: 436 FVPESLGSLVKLYYLNLSHNKLSQQIPIEL-DNLIHLSELDLSHN 479
             P +   L  L  L+L  N +   +P    ++L  LS L +  N
Sbjct: 93  IPPRTFDGLKSLRLLSLHGNDI-SVVPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 51.1 bits (123), Expect = 2e-07
 Identities = 28/102 (27%), Positives = 49/102 (48%), Gaps = 1/102 (0%)

Query: 234 LELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTV 293
           L L  NQ +  +P  +SN  +L  + L +N +S +  Q   N+ +L +L+L+ N  R   
Sbjct: 36  LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIP 94

Query: 294 PKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNN 335
           P++F  L  L  L L+ N ++      F     L+ + +  N
Sbjct: 95  PRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 47.3 bits (113), Expect = 5e-06
 Identities = 27/81 (33%), Positives = 42/81 (51%), Gaps = 3/81 (3%)

Query: 450 LNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRIC-RMESLEKLNLSYNNLSGL 508
           L L  N+    +P EL N  HL+ +DLS+N +   +S++    M  L  L LSYN L  +
Sbjct: 36  LYLDGNQF-TLVPKELSNYKHLTLIDLSNNRI-STLSNQSFSNMTQLLTLILSYNRLRCI 93

Query: 509 IPRCFEEMHGLLHIDISYNKL 529
            PR F+ +  L  + +  N +
Sbjct: 94  PPRTFDGLKSLRLLSLHGNDI 114

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 45.0 bits (107), Expect = 3e-05
 Identities = 31/104 (29%), Positives = 44/104 (42%), Gaps = 16/104 (15%)

Query: 354 LDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPT----QLGNIIYLNRLSLSGNKL 409
           L +  N  +  +P E+     L  +DLS+N I   +       +     L  L LS N+L
Sbjct: 36  LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQ---LLTLILSYNRL 90

Query: 410 SGCIPREL-GSLINLEYLDLSANNLSNFVPE----SLGSLVKLY 448
             CIP      L +L  L L  N++S  VPE     L +L  L 
Sbjct: 91  R-CIPPRTFDGLKSLRLLSLHGNDISV-VPEGAFNDLSALSHLA 132

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 66.2 bits (162), Expect = 1e-11
 Identities = 47/251 (18%), Positives = 92/251 (36%), Gaps = 46/251 (18%)

Query: 617 GLRSVLTFEGKIVYEEIISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPG 676
           G+++      + +  E+ +  + +  +  I  G +G+V       G   A+K+  + +  
Sbjct: 1   GMQAKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSD 60

Query: 677 EMS---FQQEEF----LNEIQALTEIRHRNIVKFYG-FCSHPKHSF----IIYEYLESGS 724
             +             L EI+ L    H NI+     F    + +     ++ E + +  
Sbjct: 61  GRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-D 119

Query: 725 LDKILCNDASAKELGWT---------QRLNVIKGVADALFYLHNNCFPPIVHRDISSKNV 775
           L +++      + +  +           L         L  LH      +VHRD+   N+
Sbjct: 120 LAQVI----HDQRIVISPQHIQYFMYHILL-------GLHVLHEAG---VVHRDLHPGNI 165

Query: 776 LLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPEL-----AYTLKVTEKCDVYSF 830
           LL    +  + DF +A+    D +N +       Y APEL      +T  V    D++S 
Sbjct: 166 LLADNNDITICDFNLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLV----DMWSA 220

Query: 831 GVLALEVIKGK 841
           G +  E+   K
Sbjct: 221 GCVMAEMFNRK 231

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 65.4 bits (160), Expect = 2e-11
 Identities = 43/215 (20%), Positives = 86/215 (40%), Gaps = 45/215 (20%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR-HRNIVKF 703
           +G+G +  V+ A  + + E   VK            ++++   EI+ L  +R   NI+  
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILKP-------VKKKKIKREIKILENLRGGPNIITL 96

Query: 704 YGFCSHPKHSFI---IYEYLESGSLDKILCNDASAKELGWTQRLNV------IKGVADAL 754
                    S     ++E++ +    ++             Q L        +  +  AL
Sbjct: 97  AD-IVKDPVSRTPALVFEHVNNTDFKQLY------------QTLTDYDIRFYMYEILKAL 143

Query: 755 FYLHNNCFPPIVHRDISSKNVLLDLGY-EAHVSDFGIAKFLNPDSSNWSELAGTHGYVAP 813
            Y H+     I+HRD+   NV++D  + +  + D+G+A+F +P    ++    +  +  P
Sbjct: 144 DYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGP 199

Query: 814 EL-----AYTLKVTEKCDVYSFGVLALEVIKGKHP 843
           EL      Y   +    D++S G +   +I  K P
Sbjct: 200 ELLVDYQMYDYSL----DMWSLGCMLASMIFRKEP 230

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 65.3 bits (160), Expect = 2e-11
 Identities = 66/279 (23%), Positives = 114/279 (40%), Gaps = 53/279 (18%)

Query: 638 NDFNAEHCIGKGGHGSVYRAKVP----SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALT 693
             F     +GKGG+G V++ +      +G+IFA+K     +    +        E   L 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76

Query: 694 EIRHRNIVK-FYGFCSHPKHSFIIYEYLESGSL------DKILCNDAS---AKELGWTQR 743
           E++H  IV   Y F +     ++I EYL  G L      + I   D +     E      
Sbjct: 77  EVKHPFIVDLIYAFQT-GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAE------ 129

Query: 744 LNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHV--SDFGIAKFLNPDSSNW 801
                 ++ AL +LH      I++RD+  +N++L+  ++ HV  +DFG+ K    D +  
Sbjct: 130 ------ISMALGHLHQK---GIIYRDLKPENIMLN--HQGHVKLTDFGLCKESIHDGTVT 178

Query: 802 SELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP-----RDFLFEMSSSSSN 856
               GT  Y+APE+          D +S G L  +++ G  P     R    +       
Sbjct: 179 HTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTID------- 231

Query: 857 MNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESR 895
             I  L  +L  P  ++ ++   +++     L +N  SR
Sbjct: 232 -KI--LKCKLNLPP-YLTQEARDLLK---KLLKRNAASR 263

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 62.3 bits (152), Expect = 3e-11
 Identities = 36/109 (33%), Positives = 58/109 (53%), Gaps = 12/109 (11%)

Query: 113 YLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGI-GLLTHLTVLHISRNWLSG 171
            L+L +N+L  +       L+ L  L  S N++   +P G+   LT LT+L++  N L  
Sbjct: 32  RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQI-QSLPDGVFDKLTKLTILYLHENKLQ- 89

Query: 172 SIPHEV-GQLTVLNQLALDSNFLNGSIPR----SLGNLTHVVILYLYNN 215
           S+P+ V  +LT L +LALD+N L  S+P      L +L     ++L+ N
Sbjct: 90  SLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQK---IWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 49.6 bits (119), Expect = 7e-07
 Identities = 30/102 (29%), Positives = 39/102 (38%)

Query: 234 LELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTV 293
           LEL  N+L          LT L  L L  N++  +       L KL  L L +N  +   
Sbjct: 33  LELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLP 92

Query: 294 PKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNN 335
              F  LT L +L L+ N L       F    +L  I L  N
Sbjct: 93  NGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 49.2 bits (118), Expect = 7e-07
 Identities = 40/121 (33%), Positives = 58/121 (47%), Gaps = 14/121 (11%)

Query: 149 IPSGIGLLTHLTVLHISRNWLSGSIPHEV-GQLTVLNQLALDSNFLNGSIPR----SLGN 203
           +P+GI      T L +  N L  S+PH V  +LT L +L+L  N +  S+P      L  
Sbjct: 22  VPTGIPSSA--TRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTK 77

Query: 204 LTHVVILYLYNNSFFGSIPQEI-GNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYH 262
           LT    LYL+ N    S+P  +   L  L +L L  NQL          LT+L+ ++L+ 
Sbjct: 78  LTI---LYLHENKL-QSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHT 133

Query: 263 N 263
           N
Sbjct: 134 N 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 42.6 bits (101), Expect = 2e-04
 Identities = 35/135 (25%), Positives = 63/135 (46%), Gaps = 10/135 (7%)

Query: 400 NRLSLSGNKLSGCIPRELGSL-----INLEYLDLSANNLSNFVPESLGSLVKLYYLNLSH 454
           +R S SG ++  C  + L S+      +   L+L +N L +        L +L  L+LS 
Sbjct: 3   SRCSCSGTEIR-CNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQ 61

Query: 455 NKLSQQIPIEL-DNLIHLSELDLSHNFLGEKISSRIC-RMESLEKLNLSYNNLSGLIPRC 512
           N++ Q +P  + D L  L+ L L  N L + + + +  ++  L++L L  N L  +    
Sbjct: 62  NQI-QSLPDGVFDKLTKLTILYLHENKL-QSLPNGVFDKLTQLKELALDTNQLKSVPDGI 119

Query: 513 FEEMHGLLHIDISYN 527
           F+ +  L  I +  N
Sbjct: 120 FDRLTSLQKIWLHTN 134

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 65.8 bits (160), Expect = 4e-11
 Identities = 66/284 (23%), Positives = 118/284 (41%), Gaps = 66/284 (23%)

Query: 638 NDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEF---LNEIQALT 693
            DFN    +GKG  G V  + +  + E++AVK     L  ++  Q ++    + E + L 
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKI----LKKDVVIQDDDVECTMVEKRVLA 396

Query: 694 EI-RHRNIVK-FYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIK--- 748
              +   + +    F +     + + EY+  G L            +   Q++   K   
Sbjct: 397 LPGKPPFLTQLHSCFQT-MDRLYFVMEYVNGGDL------------MYHIQQVGRFKEPH 443

Query: 749 ------GVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHV--SDFGIAKFLNPDSSN 800
                  +A  LF+L +     I++RD+   NV+LD   E H+  +DFG+ K    D   
Sbjct: 444 AVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLD--SEGHIKIADFGMCKENIWDGVT 498

Query: 801 WSELAGTHGYVAPEL----AYTLKVTEKCDVYSFGVLALEVIKGKHP-----RDFLFEMS 851
                GT  Y+APE+     Y   V    D ++FGVL  E++ G+ P      D LF+  
Sbjct: 499 TKTFCGTPDYIAPEIIAYQPYGKSV----DWWAFGVLLYEMLAGQAPFEGEDEDELFQS- 553

Query: 852 SSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESR 895
                    +++  + YP   + K+ ++I +     + ++P  R
Sbjct: 554 ---------IMEHNVAYPK-SMSKEAVAICK---GLMTKHPGKR 584

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 66.0 bits (160), Expect = 4e-11
 Identities = 92/578 (15%), Positives = 189/578 (32%), Gaps = 146/578 (25%)

Query: 168 WLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILY------LYNNS----- 216
           W   S   E+ Q  V   L ++  FL   I       + +  +Y      LYN++     
Sbjct: 69  WTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAK 128

Query: 217 FFGSIPQEIGNLKS-LFDLE----LCINQLSGA--IPLSISNLTNLRFLFLYHNE---LS 266
           +  S  Q    L+  L +L     + I+ + G+    +++    + +       +   L+
Sbjct: 129 YNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLN 188

Query: 267 GIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTD-LVKLRLNQNYLTGNISETFGT-- 323
                 + N     ++L         +  ++ + +D    ++L  + +   +     +  
Sbjct: 189 ------LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKP 242

Query: 324 YPNLTFI--DLSN----NSFFGEILSDWGRCPQL------SLLDVSINNISGSIPLEI-- 369
           Y N   +  ++ N    N+F      +   C  L       + D      +  I L+   
Sbjct: 243 YENCLLVLLNVQNAKAWNAF------N-LSCKILLTTRFKQVTDFLSAATTTHISLDHHS 295

Query: 370 -----GESLQL--QYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLIN 422
                 E   L  +YLD        ++P ++          L+ N      PR L S+I 
Sbjct: 296 MTLTPDEVKSLLLKYLDCR----PQDLPREV----------LTTN------PRRL-SII- 333

Query: 423 LEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFL- 481
                  A ++ +    +        + +++ +KL+  I   L+    L   +    F  
Sbjct: 334 -------AESIRDG-LATWD-----NWKHVNCDKLTTIIESSLNV---LEPAEYRKMFDR 377

Query: 482 ------GEKISSRI-----------CRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDI 524
                    I + +             M  + KL    +  S L+ +  +E    +   I
Sbjct: 378 LSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKL----HKYS-LVEKQPKESTISIP-SI 431

Query: 525 SYNKLEGQIPNSTTFRDAPLEALQGNKGLYGDIRGFPSCMSYKKASRKIWIVIVFPLLGM 584
            Y +L+ ++ N      + ++     K    D    P    Y       +  I   L  +
Sbjct: 432 -YLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQY------FYSHIGHHLKNI 484

Query: 585 -----VALFIALTGFF-FIFHQRK--NDSQTQQSSFGNTPGLRSVLTFEGKIV-----YE 631
                + LF  +  F  F F ++K  +DS    +S      L+ +  ++  I      YE
Sbjct: 485 EHPERMTLFRMV--FLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYE 542

Query: 632 EIISATNDF--NAEHCIGKGGHGSVYRAKV--PSGEIF 665
            +++A  DF    E  +    +  + R  +      IF
Sbjct: 543 RLVNAILDFLPKIEENLICSKYTDLLRIALMAEDEAIF 580

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 54.5 bits (130), Expect = 1e-07
 Identities = 102/732 (13%), Positives = 195/732 (26%), Gaps = 271/732 (37%)

Query: 222 PQEIGNLKSLFDLELCINQLSGAIPLSISNL-TNLRFLF-LYHNELSGIIPQEIGNLKKL 279
              +     LF   L   Q           L  N +FL      E           +++ 
Sbjct: 58  KDAVSGTLRLFWT-LLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQR 116

Query: 280 NSL-----LLAKNHF-RGTVPKSFRNLTD-LVKLRLNQN------------YLTGNISET 320
           + L     + AK +  R    + +  L   L++LR  +N            ++  ++  +
Sbjct: 117 DRLYNDNQVFAKYNVSR---LQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLS 173

Query: 321 FGTYPNLTF----IDLSNNSFFGEILSD-WGRCPQLSLLDVSINNISGSIPLEIGESLQ- 374
           +     + F    ++L N +    +L        Q+     S ++ S +I L I  S+Q 
Sbjct: 174 YKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRI-HSIQA 232

Query: 375 -LQYLDLSSNYIVGEIPTQLGNII--------YLNRLSLSGNKLSGC----IPRELG--- 418
            L+ L  S  Y        L  ++          N  +L       C      R      
Sbjct: 233 ELRRLLKSKPY-----ENCL--LVLLNVQNAKAWNAFNL------SCKILLTTRFKQVTD 279

Query: 419 SLINLEYLDLSANNLS-NFVP-ESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDL 476
            L       +S ++ S    P E    L+K  YL+     L +++        +      
Sbjct: 280 FLSAATTTHISLDHHSMTLTPDEVKSLLLK--YLDCRPQDLPREV-----LTTNP----R 328

Query: 477 SHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNS 536
             + + E I   +   ++ + +N   + L+ +I             + S N LE      
Sbjct: 329 RLSIIAESIRDGLATWDNWKHVN--CDKLTTII-------------ESSLNVLE------ 367

Query: 537 TTFRDAPLEALQGNKGLYGDIRGFPSCMSYKKASRKIWIVIVFPLLGMVALFIALTGFFF 596
                 P E     + ++                                          
Sbjct: 368 ------PAE----YRKMFDR--------------------------------------LS 379

Query: 597 IFHQRKNDSQTQQSSFGNTPGLRSVL-TFEGKIVYEEIISATNDFNAEHCIGKGGHGSVY 655
           +F    +          + P    +L      ++  +++   N  +    + K    S  
Sbjct: 380 VF--PPS---------AHIP--TILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTI 426

Query: 656 RAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI 715
                           S           E   +++    + HR+IV  Y           
Sbjct: 427 S-------------IPS--------IYLELKVKLENEYAL-HRSIVDHY----------- 453

Query: 716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVH-------- 767
                   ++ K   +D            ++I    D  FY H      I H        
Sbjct: 454 --------NIPKTFDSD------------DLIPPYLDQYFYSH------IGHHLKNIEHP 487

Query: 768 -RDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELA----YTLKVT 822
            R    + V LD         F   K +  DS+ W       G +   L     Y   + 
Sbjct: 488 ERMTLFRMVFLDF-------RFLEQK-IRHDSTAW----NASGSILNTLQQLKFYKPYIC 535

Query: 823 EKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQ 882
           +    Y   V A+         DFL ++  +                   +  K   +++
Sbjct: 536 DNDPKYERLVNAIL--------DFLPKIEENL------------------ICSKYTDLLR 569

Query: 883 VAFSCLDQNPES 894
           +A        + 
Sbjct: 570 IAL----MAEDE 577

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 52.2 bits (124), Expect = 8e-07
 Identities = 64/392 (16%), Positives = 121/392 (30%), Gaps = 108/392 (27%)

Query: 20  ILFVVLDFSLAISSNSAEEAH-ALVKWKASL-EVHSRSLLHSWSLSSVN-----ATKISP 72
           IL       +    ++A   H +L     +L     +SLL  +               +P
Sbjct: 268 ILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNP 327

Query: 73  CAWSGI------FCNHAERVVGINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIP 126
              S I           +    +N   ++   T++E S +      Y  ++  +   + P
Sbjct: 328 RRLSIIAESIRDGLATWDNWKHVNCDKLT---TIIESSLNVLEPAEYRKMF--DRLSVFP 382

Query: 127 PQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQL 186
           P             SA+     IP+ +     L+++     W    I  +V    V+N+L
Sbjct: 383 P-------------SAH-----IPTIL-----LSLI-----W-FDVIKSDVMV--VVNKL 411

Query: 187 A----LDSNFLNG--SIP-------RSLGNLT--HVVILYLYNNSFFGSIPQEIGNLKSL 231
                ++        SIP         L N    H  I+  YN      IP+        
Sbjct: 412 HKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYN------IPKT------- 458

Query: 232 FDLE-LCINQLSGAIPLSISNLTNLRFLFL-YHNELSGIIPQEIGNLKKLNSLLL----- 284
           FD + L    L               +  + +H  L  I   E   L     + L     
Sbjct: 459 FDSDDLIPPYLDQYF-----------YSHIGHH--LKNIEHPERMTL--FRMVFLDFRFL 503

Query: 285 -AKNHFRGTVPKSFRNLTDLVK-LRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEIL 342
             K     T   +  ++ + ++ L+  + Y+  N    +    N     + +  F  +I 
Sbjct: 504 EQKIRHDSTAWNASGSILNTLQQLKFYKPYICDN-DPKYERLVN----AILD--FLPKIE 556

Query: 343 SDWGRCPQLSLLDVSINNISGSIPLEIGESLQ 374
            +        LL +++     +I  E  + +Q
Sbjct: 557 ENLICSKYTDLLRIALMAEDEAIFEEAHKQVQ 588

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 48.7 bits (115), Expect = 9e-06
 Identities = 51/364 (14%), Positives = 108/364 (29%), Gaps = 93/364 (25%)

Query: 618 LRSVLTFEGKIVYEEIISATNDFNAEH----CIGKGGHGSVYRA---------------- 657
            +S+L+ E     + II + +  +        +       V +                 
Sbjct: 42  PKSILSKE---EIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPI 98

Query: 658 ----KVPSGEIFAVKKFHSPLPGE------MSFQQEEFLNEIQ-ALTEIRHRNIVKFYGF 706
               + PS       +    L  +       +  + +   +++ AL E+R    V   G 
Sbjct: 99  KTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGV 158

Query: 707 ------------CS----HPKHSFIIYEYLESGSLDKI---------LC-----NDASAK 736
                       C       K  F I+ +L   + +           L      N  S  
Sbjct: 159 LGSGKTWVALDVCLSYKVQCKMDFKIF-WLNLKNCNSPETVLEMLQKLLYQIDPNWTSRS 217

Query: 737 ELGWT--QRLNVIKGVADALFYL--HNNCFPPIVHRDISSKNVL--LDLGYEAHV--SDF 788
           +       R++ I+     L     + NC   +V  ++ +       +L  +  +     
Sbjct: 218 DHSSNIKLRIHSIQAELRRLLKSKPYENCL--LVLLNVQNAKAWNAFNLSCKILLTTRFK 275

Query: 789 GIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLF 848
            +  FL+  ++  + ++  H  +         +  K        L  EV+   +P     
Sbjct: 276 QVTDFLSAATT--THISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTT-NP--RRL 330

Query: 849 EMSSSSSNMNIEMLDSRLPYPSLHVQ-KKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCE 907
            + + S    +   D        HV   KL +I++ + + L+   E R    R+S     
Sbjct: 331 SIIAESIRDGLATWD-----NWKHVNCDKLTTIIESSLNVLEPA-EYRKMFDRLS----- 379

Query: 908 KIFE 911
            +F 
Sbjct: 380 -VFP 382

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 64.6 bits (157), Expect = 4e-11
 Identities = 39/171 (22%), Positives = 66/171 (38%), Gaps = 26/171 (15%)

Query: 750 VADALFYL-HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH 808
           VA  + +L    C    +HRD++++N+LL       + DFG+A+ +  D      +    
Sbjct: 202 VAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY---VRKGD 254

Query: 809 GYV-----APELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEML 862
             +     APE  +    T + DV+SFGVL  E+   G  P    +             L
Sbjct: 255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP----YPGVKIDEEF-CRRL 309

Query: 863 DS--RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
               R+  P  +   ++   M     C    P  RPT   + + L   + +
Sbjct: 310 KEGTRMRAPD-YTTPEMYQTML---DCWHGEPSQRPTFSELVEHL-GNLLQ 355

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 49.5 bits (118), Expect = 3e-06
 Identities = 25/140 (17%), Positives = 48/140 (34%), Gaps = 21/140 (15%)

Query: 646 IGKGGHGSVYRAKV------PSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHR 698
           +G+G  G V  A         +    AVK       G    +    ++E++ L  I  H 
Sbjct: 30  LGRGAFGQVIEADAFGIDKTATCRTVAVK---MLKEGATHSEHRALMSELKILIHIGHHL 86

Query: 699 NIVKFYGFCSHPKHS-FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYL 757
           N+V   G C+ P     +I E+ + G+L   L           ++R   +        + 
Sbjct: 87  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTKGARFR 136

Query: 758 HNNCFPPIVHRDISSKNVLL 777
               +   +  D+  +   +
Sbjct: 137 QGKDYVGAIPVDLKRRLDSI 156

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 64.6 bits (158), Expect = 4e-11
 Identities = 52/222 (23%), Positives = 92/222 (41%), Gaps = 58/222 (26%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEF----LNEIQALTEIRHRNI 700
           +G G +GSV  A    SGE  A+KK   P      FQ E F      E+  L  ++H N+
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRP------FQSEIFAKRAYRELLLLKHMQHENV 85

Query: 701 VKFYGFCSHPKHS------FIIYEYLESGSLDKILCNDASAKELGWTQRLN--------- 745
           +      +           +++  ++++  L KI+             + +         
Sbjct: 86  IGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIM-----------GLKFSEEKIQYLVY 133

Query: 746 -VIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSEL 804
            ++KG    L Y+H+     +VHRD+   N+ ++   E  + DFG+A+  + +    +  
Sbjct: 134 QMLKG----LKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE---MTGY 183

Query: 805 AGTHGYVAPEL-----AYTLKVTEKCDVYSFGVLALEVIKGK 841
             T  Y APE+      Y   V    D++S G +  E++ GK
Sbjct: 184 VVTRWYRAPEVILSWMHYNQTV----DIWSVGCIMAEMLTGK 221

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 64.3 bits (157), Expect = 6e-11
 Identities = 50/224 (22%), Positives = 88/224 (39%), Gaps = 59/224 (26%)

Query: 645 CIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEF----LNEIQALTEIRHRN 699
            +G G +GSV  A    +G   AVKK   P      FQ          E++ L  ++H N
Sbjct: 36  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRP------FQSIIHAKRTYRELRLLKHMKHEN 89

Query: 700 IVKFYGFCSHPKHSF-------IIYEYLESGSLDKILCNDASAKELGWTQRLN------- 745
           ++        P  S        ++   + +  L+ I+            Q+L        
Sbjct: 90  VIGLLD-VFTPARSLEEFNDVYLVTHLMGA-DLNNIV----------KCQKLTDDHVQFL 137

Query: 746 ---VIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWS 802
              +++G    L Y+H+     I+HRD+   N+ ++   E  + DFG+A+     +   +
Sbjct: 138 IYQILRG----LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTADEMT 187

Query: 803 ELAGTHGYVAPEL-----AYTLKVTEKCDVYSFGVLALEVIKGK 841
               T  Y APE+      Y   V    D++S G +  E++ G+
Sbjct: 188 GYVATRWYRAPEIMLNWMHYNQTV----DIWSVGCIMAELLTGR 227

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 63.9 bits (156), Expect = 8e-11
 Identities = 52/222 (23%), Positives = 95/222 (42%), Gaps = 39/222 (17%)

Query: 637 TNDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEF----LNEIQA 691
              +     +G G +G+V  A    +G   A+KK + P      FQ E F      E++ 
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP------FQSELFAKRAYRELRL 77

Query: 692 LTEIRHRNIVKFYGFCSHPKHSF-------IIYEYLESGSLDKILCNDASAKELGWTQRL 744
           L  +RH N++        P  +        ++  ++ +  L K++      ++LG  +  
Sbjct: 78  LKHMRHENVIGLLD-VFTPDETLDDFTDFYLVMPFMGT-DLGKLM----KHEKLGEDRIQ 131

Query: 745 NVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSEL 804
            ++  +   L Y+H      I+HRD+   N+ ++   E  + DFG+A+  + +    +  
Sbjct: 132 FLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE---MTGY 185

Query: 805 AGTHGYVAPEL-----AYTLKVTEKCDVYSFGVLALEVIKGK 841
             T  Y APE+      YT  V    D++S G +  E+I GK
Sbjct: 186 VVTRWYRAPEVILNWMRYTQTV----DIWSVGCIMAEMITGK 223

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 60.1 bits (146), Expect = 8e-11
 Identities = 25/107 (23%), Positives = 50/107 (46%), Gaps = 4/107 (3%)

Query: 399 LNRLSLSGNKLS-GCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKL 457
           +  L L  ++ + G +         LE+L      L++    +L  L KL  L LS N++
Sbjct: 19  VKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRV 76

Query: 458 SQQIPIELDNLIHLSELDLSHNFLGE-KISSRICRMESLEKLNLSYN 503
           S  + +  +   +L+ L+LS N + +      + ++E+L+ L+L   
Sbjct: 77  SGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 54.3 bits (131), Expect = 9e-09
 Identities = 27/111 (24%), Positives = 48/111 (43%), Gaps = 13/111 (11%)

Query: 350 QLSLLDVSINNISGSIPLEIGESL-QLQYLDLSSNYIVGEIPTQLGNIIYLNRL---SLS 405
           +L L +   N         + +   +L++L   +  +     T + N+  LN+L    LS
Sbjct: 21  ELVLDNSRSNEGKL---EGLTDEFEELEFLSTINVGL-----TSIANLPKLNKLKKLELS 72

Query: 406 GNKLSGCIPRELGSLINLEYLDLSANNLSNF-VPESLGSLVKLYYLNLSHN 455
            N++SG +        NL +L+LS N + +    E L  L  L  L+L + 
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 52.4 bits (126), Expect = 3e-08
 Identities = 30/135 (22%), Positives = 53/135 (39%), Gaps = 7/135 (5%)

Query: 298 RNLTDLVKLRLNQNYLT-GNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDV 356
           R  +D+ +L L+ +    G +      +  L F+   N       +++  +  +L  L++
Sbjct: 14  RTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGL--TSIANLPKLNKLKKLEL 71

Query: 357 SINNISGSIPLEIGESLQLQYLDLSSNYIVG-EIPTQLGNIIYLNRLSLSGN---KLSGC 412
           S N +SG + +   +   L +L+LS N I        L  +  L  L L       L+  
Sbjct: 72  SDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDY 131

Query: 413 IPRELGSLINLEYLD 427
                  L  L YLD
Sbjct: 132 RENVFKLLPQLTYLD 146

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 50.4 bits (121), Expect = 2e-07
 Identities = 23/86 (26%), Positives = 42/86 (48%), Gaps = 3/86 (3%)

Query: 445 VKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNN 504
           VK   L+ S +   +   +  D    L  L   +  L   I++ + ++  L+KL LS N 
Sbjct: 19  VKELVLDNSRSNEGKLEGL-TDEFEELEFLSTINVGL-TSIAN-LPKLNKLKKLELSDNR 75

Query: 505 LSGLIPRCFEEMHGLLHIDISYNKLE 530
           +SG +    E+   L H+++S NK++
Sbjct: 76  VSGGLEVLAEKCPNLTHLNLSGNKIK 101

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 45.8 bits (109), Expect = 8e-06
 Identities = 28/154 (18%), Positives = 50/154 (32%), Gaps = 31/154 (20%)

Query: 183 LNQLALDSNFLN-GSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQL 241
           + +L LD++  N G +         +  L   N                       +  +
Sbjct: 19  VKELVLDNSRSNEGKLEGLTDEFEELEFLSTINV---------------------GLTSI 57

Query: 242 SGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRG-TVPKSFRNL 300
           +      +  L  L+ L L  N +SG +         L  L L+ N  +  +  +  + L
Sbjct: 58  AN-----LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKL 112

Query: 301 TDLVKLRLNQNYLTGNI---SETFGTYPNLTFID 331
            +L  L L    +T         F   P LT++D
Sbjct: 113 ENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLD 146

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 18/82 (21%), Positives = 30/82 (36%), Gaps = 5/82 (6%)

Query: 90  NLTSISLNGTLLEF--SFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKL-- 145
            L  +S     L    +      L  L+L +N + G +        NL +L+ S NK+  
Sbjct: 43  ELEFLSTINVGLTSIANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKD 102

Query: 146 FGQIPSGIGLLTHLTVLHISRN 167
              I   +  L +L  L +   
Sbjct: 103 LSTI-EPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 40.8 bits (96), Expect = 3e-04
 Identities = 27/127 (21%), Positives = 47/127 (37%), Gaps = 25/127 (19%)

Query: 89  INLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQ 148
           + L +   N   LE     F  L +L   N  L  I    +  L+ L+ L+ S N++ G 
Sbjct: 22  LVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGG 79

Query: 149 IPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVV 208
           +        +LT L++S N           ++  L+ +              L  L ++ 
Sbjct: 80  LEVLAEKCPNLTHLNLSGN-----------KIKDLSTIE------------PLKKLENLK 116

Query: 209 ILYLYNN 215
            L L+N 
Sbjct: 117 SLDLFNC 123

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 60.1 bits (146), Expect = 1e-10
 Identities = 30/107 (28%), Positives = 50/107 (46%), Gaps = 4/107 (3%)

Query: 399 LNRLSLSGNKLS-GCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKL 457
           +  L L   K + G I       +NLE+L L    L +    +L  L KL  L LS N++
Sbjct: 26  VRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRI 83

Query: 458 SQQIPIELDNLIHLSELDLSHNFLGE-KISSRICRMESLEKLNLSYN 503
              + +  + L +L+ L+LS N L +      + ++E L+ L+L   
Sbjct: 84  FGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 54.4 bits (131), Expect = 1e-08
 Identities = 33/136 (24%), Positives = 54/136 (39%), Gaps = 9/136 (6%)

Query: 298 RNLTDLVKLRLNQNYLT-GNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDV 356
           R    + +L L+      G I      + NL F+ L N       +S+  + P+L  L++
Sbjct: 21  RTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGL--ISVSNLPKLPKLKKLEL 78

Query: 357 SINNISGSIPLEIGESLQLQYLDLSSNYI--VGEIPTQLGNIIYLNRLSLSGN---KLSG 411
           S N I G + +   +   L +L+LS N +  +  +   L  +  L  L L       L+ 
Sbjct: 79  SENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNCEVTNLND 137

Query: 412 CIPRELGSLINLEYLD 427
                   L  L YLD
Sbjct: 138 YRESVFKLLPQLTYLD 153

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 52.4 bits (126), Expect = 5e-08
 Identities = 30/108 (27%), Positives = 52/108 (48%), Gaps = 4/108 (3%)

Query: 354 LDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCI 413
           LD   +N  G I     E + L++L L +  ++  + + L  +  L +L LS N++ G +
Sbjct: 31  LDNCKSND-GKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGGL 87

Query: 414 PRELGSLINLEYLDLSANNLSNFVP-ESLGSLVKLYYLNLSHNKLSQQ 460
                 L NL +L+LS N L +    E L  L  L  L+L + +++  
Sbjct: 88  DMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNL 135

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 49.7 bits (119), Expect = 5e-07
 Identities = 21/86 (24%), Positives = 43/86 (50%), Gaps = 3/86 (3%)

Query: 445 VKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNN 504
           V+   L+   +   +   +     ++L  L L +  L   +S+ + ++  L+KL LS N 
Sbjct: 26  VRELVLDNCKSNDGKIEGL-TAEFVNLEFLSLINVGL-ISVSN-LPKLPKLKKLELSENR 82

Query: 505 LSGLIPRCFEEMHGLLHIDISYNKLE 530
           + G +    E++  L H+++S NKL+
Sbjct: 83  IFGGLDMLAEKLPNLTHLNLSGNKLK 108

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 45.5 bits (108), Expect = 1e-05
 Identities = 32/160 (20%), Positives = 52/160 (32%), Gaps = 33/160 (20%)

Query: 183 LNQLALDSNFLN-GSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQL 241
           + +L LD+   N G I        ++  L L N                       +  +
Sbjct: 26  VRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINV---------------------GLISV 64

Query: 242 SGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFR--GTVPKSFRN 299
           S      +  L  L+ L L  N + G +      L  L  L L+ N  +   T+ +  + 
Sbjct: 65  SN-----LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKK 118

Query: 300 LTDLVKLRLNQNYLT---GNISETFGTYPNLTFIDLSNNS 336
           L  L  L L    +T         F   P LT++D  +  
Sbjct: 119 LECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDRE 158

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 43.6 bits (103), Expect = 5e-05
 Identities = 29/127 (22%), Positives = 50/127 (39%), Gaps = 25/127 (19%)

Query: 89  INLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQ 148
           + L +   N   +E   + F +L +L L N  L  +    +  L  L+ L+ S N++FG 
Sbjct: 29  LVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGG 86

Query: 149 IPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVV 208
           +      L +LT L++S N           +L  ++ L              L  L  + 
Sbjct: 87  LDMLAEKLPNLTHLNLSGN-----------KLKDISTLE------------PLKKLECLK 123

Query: 209 ILYLYNN 215
            L L+N 
Sbjct: 124 SLDLFNC 130

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 62.7 bits (153), Expect = 2e-10
 Identities = 65/285 (22%), Positives = 115/285 (40%), Gaps = 57/285 (20%)

Query: 638 NDFNAEHCIGKGGHGSVYRAKVP----SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALT 693
            +F     +G G +G V+  +      +G+++A+K        + +   E    E Q L 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113

Query: 694 EIRHRN-IVK-FYGFCSHPKHSFIIYEYLESGSL------DKILCNDAS---AKELGWTQ 742
            IR    +V   Y F +      +I +Y+  G L       +            E+    
Sbjct: 114 HIRQSPFLVTLHYAFQT-ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI---- 168

Query: 743 RLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHV--SDFGIAK-FLNPDSS 799
                     AL +LH      I++RDI  +N+LLD     HV  +DFG++K F+  ++ 
Sbjct: 169 --------VLALEHLHKL---GIIYRDIKLENILLD--SNGHVVLTDFGLSKEFVADETE 215

Query: 800 NWSELAGTHGYVAPELAYTLKVTEK-----CDVYSFGVLALEVIKGKHPRDFLFEMSSSS 854
              +  GT  Y+AP++   ++  +       D +S GVL  E++ G  P    F +    
Sbjct: 216 RAYDFCGTIEYMAPDI---VRGGDSGHDKAVDWWSLGVLMYELLTGASP----FTVDGEK 268

Query: 855 SNMNIEM----LDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESR 895
           ++   E+    L S  PYP   +      ++Q     L ++P+ R
Sbjct: 269 NSQA-EISRRILKSEPPYPQ-EMSALAKDLIQ---RLLMKDPKKR 308

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 62.7 bits (151), Expect = 2e-10
 Identities = 33/216 (15%), Positives = 66/216 (30%), Gaps = 36/216 (16%)

Query: 309 NQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLE 368
           + + +   I E    + +   +   +  F  + +S W     LS +              
Sbjct: 123 DCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEIS-WIEQVDLSPV-------------- 167

Query: 369 IGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGS--LINLEYL 426
           +     L  L +     +        N   L  L +    L   +  ++    L NLE L
Sbjct: 168 LDAMPLLNNLKIKGTNNLSIGKKPRPN---LKSLEIISGGLPDSVVEDILGSDLPNLEKL 224

Query: 427 DL---SANNLSNFVPESL------GSLVKLYYLNLSHNKLSQQIPIEL---DNLIHLSEL 474
            L     +   +                 L +L +   +    +       D L  L  +
Sbjct: 225 VLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETM 284

Query: 475 DLSHNFLG----EKISSRICRMESLEKLNLSYNNLS 506
           D+S   L       +   + +++ L+ +N+ YN LS
Sbjct: 285 DISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 57.7 bits (138), Expect = 8e-09
 Identities = 29/200 (14%), Positives = 70/200 (35%), Gaps = 23/200 (11%)

Query: 298 RNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSD--WGRCPQLSLLD 355
             L  +  L   +   T N+S      PNL  +++ +      ++ D      P L  L 
Sbjct: 166 PVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLV 225

Query: 356 VSI--NNISGSIPLEIGESL-------QLQYLDLSSNYIVGEIPTQLGNIIYLNRL---S 403
           + +   +      + +   L        L++L +        +         L +L    
Sbjct: 226 LYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMD 285

Query: 404 LSGNKLSG----CIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQ 459
           +S   L+      +   +  + +L+++++  N LS+ + + L        L +  +    
Sbjct: 286 ISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKS-----LPMKIDVSDS 340

Query: 460 QIPIELDNLIHLSELDLSHN 479
           Q   +  +   ++EL+  H+
Sbjct: 341 QEYDDDYSYPMITELEHHHH 360

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 42.2 bits (98), Expect = 6e-04
 Identities = 23/160 (14%), Positives = 50/160 (31%), Gaps = 21/160 (13%)

Query: 125 IPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVG-----Q 179
           + P +  +  L  L          +  G     +L  L I    L  S+  ++       
Sbjct: 164 LSPVLDAMPLLNNLKIKGT---NNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPN 220

Query: 180 LTVLNQLALDSNFLNGSIPRSL------GNLTHVVILYLYNNSFFGSIPQEIGN---LKS 230
           L  L       ++                   ++  L + +      + +       L  
Sbjct: 221 LEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQ 280

Query: 231 LFDLELCINQLS--GAIPL--SISNLTNLRFLFLYHNELS 266
           L  +++    L+  GA  L   +  + +L+F+ + +N LS
Sbjct: 281 LETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 62.2 bits (152), Expect = 2e-10
 Identities = 69/281 (24%), Positives = 114/281 (40%), Gaps = 60/281 (21%)

Query: 638 NDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEF---LNEIQAL- 692
            DF     +GKG  G V+ A    + + FA+K     L  ++    ++    + E + L 
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKA----LKKDVVLMDDDVECTMVEKRVLS 72

Query: 693 TEIRHRNIVK-FYGFCSHPKHSFIIYEYLESGSL-------DKILCNDAS--AKELGWTQ 742
               H  +   F  F +  ++ F + EYL  G L        K   + A+  A E     
Sbjct: 73  LAWEHPFLTHMFCTFQT-KENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAE----- 126

Query: 743 RLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHV--SDFGIAK-FLNPDSS 799
                  +   L +LH+     IV+RD+   N+LLD   + H+  +DFG+ K  +  D+ 
Sbjct: 127 -------IILGLQFLHSK---GIVYRDLKLDNILLD--KDGHIKIADFGMCKENMLGDAK 174

Query: 800 NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP-----RDFLFEMSSSS 854
             +   GT  Y+APE+    K     D +SFGVL  E++ G+ P      + LF      
Sbjct: 175 TNT-FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH----- 228

Query: 855 SNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESR 895
              +I        YP   ++K+   ++        + PE R
Sbjct: 229 ---SI--RMDNPFYPR-WLEKEAKDLLV---KLFVREPEKR 260

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 62.3 bits (152), Expect = 3e-10
 Identities = 54/231 (23%), Positives = 98/231 (42%), Gaps = 64/231 (27%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEF----LNEIQALTEIRHRNI 700
           +G+G +G V  A   P+GEI A+KK          F +  F    L EI+ L   +H NI
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEP-------FDKPLFALRTLREIKILKHFKHENI 71

Query: 701 VKFYG-FCSHPKHSF----IIYEYLESGSLDKILCNDASAKELGWTQRLN---------- 745
           +  +         +F    II E +++  L +++           TQ L+          
Sbjct: 72  ITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVIS----------TQMLSDDHIQYFIYQ 120

Query: 746 VIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELA 805
            ++     +  LH +    ++HRD+   N+L++   +  V DFG+A+ ++  +++ SE  
Sbjct: 121 TLRA----VKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173

Query: 806 GTHG----YV------APEL-----AYTLKVTEKCDVYSFGVLALEVIKGK 841
           G       +V      APE+      Y+  +    DV+S G +  E+   +
Sbjct: 174 GQQSGMVEFVATRWYRAPEVMLTSAKYSRAM----DVWSCGCILAELFLRR 220

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 61.9 bits (151), Expect = 3e-10
 Identities = 56/225 (24%), Positives = 96/225 (42%), Gaps = 59/225 (26%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEF----LNEIQALTEIRHRNI 700
           IG+G +G V  A    +    A+KK          F+ + +    L EI+ L   RH NI
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISP-------FEHQTYCQRTLREIKILLRFRHENI 87

Query: 701 VKFYG-FCSHPKHSF----IIYEYLESGSLDKILCNDASAKELGWTQRLN---------- 745
           +       +          I+ + +E+  L K+L           TQ L+          
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL----------KTQHLSNDHICYFLYQ 136

Query: 746 VIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELA 805
           +++G    L Y+H+     ++HRD+   N+LL+   +  + DFG+A+  +PD  +   L 
Sbjct: 137 ILRG----LKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189

Query: 806 G---THGYVAPEL-----AYTLKVTEKCDVYSFG-VLALEVIKGK 841
               T  Y APE+      YT  +    D++S G +LA E++  +
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSI----DIWSVGCILA-EMLSNR 229

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 61.1 bits (147), Expect = 6e-10
 Identities = 49/309 (15%), Positives = 91/309 (29%), Gaps = 69/309 (22%)

Query: 646 IGKGGHGSVYRAKVPSGEIFAVKK--FHSPLPGEMSFQQ--EEFLNEIQALTEI------ 695
           IG+G  G V++         A+K      P     S Q+  EE L EI    E+      
Sbjct: 28  IGEGVFGEVFQTIAD-HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGE 86

Query: 696 ---RHRNIVKFYGFC----SHPKH--------------------------SFIIYEYLES 722
              R    +          S+P                             FI+ E+   
Sbjct: 87  VCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146

Query: 723 GSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYE 782
           G   + +      K        +++  +  +L     +      HRD+   NVLL     
Sbjct: 147 GIDLEQMRT----KLSSLATAKSILHQLTASLAVAEASL--RFEHRDLHWGNVLLKKTSL 200

Query: 783 AHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEK--CDVYSFGVLALEVIKG 840
             +      K              + G     + YTL   E+    V+    +  ++  G
Sbjct: 201 KKLHYTLNGKSSTI---------PSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTG 251

Query: 841 KHPRDFLFEMSSSSSNMNIEMLDSRLPYPSL----HVQKKLMSIMQVAFSCLDQNPESRP 896
               D+ F++       N        PY ++    ++  K+  + Q+ F      P  + 
Sbjct: 252 DG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKM--LKQMTFKTKCNTPAMKQ 307

Query: 897 TMKRVSQLL 905
             +++ +  
Sbjct: 308 IKRKIQEFH 316

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 60.7 bits (148), Expect = 6e-10
 Identities = 50/234 (21%), Positives = 91/234 (38%), Gaps = 68/234 (29%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEF----LNEIQALTEIRHRNI 700
           +G GG+G V+ A      +  A+KK        +     +     L EI+ +  + H NI
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKK--------IVLTDPQSVKHALREIKIIRRLDHDNI 70

Query: 701 VKFY----------GFCSHPKHSF----IIYEYLESGSLDKILCNDASAKELGWTQRLN- 745
           VK +                        I+ EY+E+  L  +L              L  
Sbjct: 71  VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLE----------QGPLLE 119

Query: 746 ---------VIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLG-YEAHVSDFGIAKFLN 795
                    +++G    L Y+H+     ++HRD+   N+ ++       + DFG+A+ ++
Sbjct: 120 EHARLFMYQLLRG----LKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMD 172

Query: 796 PDSSNWSELAG---THGYVAPEL-----AYTLKVTEKCDVYSFGVLALEVIKGK 841
           P  S+   L+    T  Y +P L      YT  +    D+++ G +  E++ GK
Sbjct: 173 PHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAI----DMWAAGCIFAEMLTGK 222

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 60.3 bits (147), Expect = 1e-09
 Identities = 67/284 (23%), Positives = 119/284 (41%), Gaps = 66/284 (23%)

Query: 638 NDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEF---LNEIQALT 693
            DFN    +GKG  G V  + +  + E++AVK     L  ++  Q ++    + E + L 
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKI----LKKDVVIQDDDVECTMVEKRVLA 75

Query: 694 EI-RHRNIVK-FYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIK--- 748
              +   + +    F +     + + EY+  G L            +   Q++   K   
Sbjct: 76  LPGKPPFLTQLHSCFQT-MDRLYFVMEYVNGGDL------------MYHIQQVGRFKEPH 122

Query: 749 ------GVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHV--SDFGIAKFLNPDSSN 800
                  +A  LF+L +     I++RD+   NV+LD   E H+  +DFG+ K    D   
Sbjct: 123 AVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLD--SEGHIKIADFGMCKENIWDGVT 177

Query: 801 WSELAGTHGYVAPEL----AYTLKVTEKCDVYSFGVLALEVIKGKHP-----RDFLFEMS 851
                GT  Y+APE+     Y   V    D ++FGVL  E++ G+ P      D LF+  
Sbjct: 178 TKTFCGTPDYIAPEIIAYQPYGKSV----DWWAFGVLLYEMLAGQAPFEGEDEDELFQ-- 231

Query: 852 SSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESR 895
                 +I  ++  + YP   + K+ ++I +     + ++P  R
Sbjct: 232 ------SI--MEHNVAYPK-SMSKEAVAICK---GLMTKHPGKR 263

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 59.9 bits (146), Expect = 1e-09
 Identities = 52/221 (23%), Positives = 94/221 (42%), Gaps = 46/221 (20%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEF-------LNEIQALTEIR- 696
           IG G +G+VY+A+   SG   A+K         +              + E+  L  +  
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVR------VPNGGGGGGGLPISTVREVALLRRLEA 70

Query: 697 --HRNIVKFYGFCSHPKHS-----FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKG 749
             H N+V+    C+  +        +++E+++   L   L + A    L      ++++ 
Sbjct: 71  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL-DKAPPPGLPAETIKDLMRQ 128

Query: 750 VADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG 809
               L +LH NC   IVHRD+  +N+L+  G    ++DFG+A+  +       ++A T  
Sbjct: 129 FLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS------YQMALTPV 179

Query: 810 -----YVAPEL----AYTLKVTEKCDVYSFGVLALEVIKGK 841
                Y APE+     Y   V    D++S G +  E+ + K
Sbjct: 180 VVTLWYRAPEVLLQSTYATPV----DMWSVGCIFAEMFRRK 216

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 60.4 bits (147), Expect = 1e-09
 Identities = 61/281 (21%), Positives = 115/281 (40%), Gaps = 60/281 (21%)

Query: 638 NDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEF---LNEIQALT 693
           +DF+    IGKG  G V  A        +AVK     L  +   +++E    ++E   L 
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKV----LQKKAILKKKEEKHIMSERNVLL 93

Query: 694 E-IRHRNIVK-FYGFCSHPKHSFIIYEYLESGSL------DKILCNDAS---AKELGWTQ 742
           + ++H  +V   + F +     + + +Y+  G L      ++      +   A E     
Sbjct: 94  KNVKHPFLVGLHFSFQT-ADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAE----- 147

Query: 743 RLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHV--SDFGIAK-FLNPDSS 799
                  +A AL YLH+     IV+RD+  +N+LLD   + H+  +DFG+ K  +  +S+
Sbjct: 148 -------IASALGYLHSL---NIVYRDLKPENILLD--SQGHIVLTDFGLCKENIEHNST 195

Query: 800 NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP-----RDFLFEMSSSS 854
             +   GT  Y+APE+ +        D +  G +  E++ G  P        +++     
Sbjct: 196 TST-FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD----- 249

Query: 855 SNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESR 895
              NI  L+  L     ++      +++     L ++   R
Sbjct: 250 ---NI--LNKPLQLKP-NITNSARHLLE---GLLQKDRTKR 281

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 59.9 bits (146), Expect = 1e-09
 Identities = 66/284 (23%), Positives = 115/284 (40%), Gaps = 57/284 (20%)

Query: 638 NDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEF---LNEIQALT 693
            DF+    IG+G +  V       +  I+A+K     +  E+    E+      E     
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKV----VKKELVNDDEDIDWVQTEKHVFE 64

Query: 694 EI-RHRNIVK-FYGFCSHPKHSFIIYEYLESGSL------DKILCNDAS---AKELGWTQ 742
           +   H  +V     F +     F + EY+  G L       + L  + +   + E     
Sbjct: 65  QASNHPFLVGLHSCFQT-ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE----- 118

Query: 743 RLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHV--SDFGIAK-FLNPDSS 799
                  ++ AL YLH      I++RD+   NVLLD   E H+  +D+G+ K  L P  +
Sbjct: 119 -------ISLALNYLHER---GIIYRDLKLDNVLLD--SEGHIKLTDYGMCKEGLRPGDT 166

Query: 800 NWSELAGTHGYVAPEL----AYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSS 855
             +   GT  Y+APE+     Y   V    D ++ GVL  E++ G+ P D +    +   
Sbjct: 167 TST-FCGTPNYIAPEILRGEDYGFSV----DWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 221

Query: 856 NMNIEMLDS----RLPYPSLHVQKKLMSIMQVAFSCLDQNPESR 895
           N    +       ++  P   +  K  S+++   S L+++P+ R
Sbjct: 222 NTEDYLFQVILEKQIRIPR-SLSVKAASVLK---SFLNKDPKER 261

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 60.4 bits (147), Expect = 1e-09
 Identities = 65/284 (22%), Positives = 115/284 (40%), Gaps = 57/284 (20%)

Query: 638 NDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEF---LNEIQALT 693
            DF+    IG+G +  V       +  I+A++     +  E+    E+      E     
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRV----VKKELVNDDEDIDWVQTEKHVFE 107

Query: 694 EI-RHRNIVK-FYGFCSHPKHSFIIYEYLESGSL------DKILCNDAS---AKELGWTQ 742
           +   H  +V     F +     F + EY+  G L       + L  + +   + E     
Sbjct: 108 QASNHPFLVGLHSCFQT-ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE----- 161

Query: 743 RLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHV--SDFGIAK-FLNPDSS 799
                  ++ AL YLH      I++RD+   NVLLD   E H+  +D+G+ K  L P  +
Sbjct: 162 -------ISLALNYLHER---GIIYRDLKLDNVLLD--SEGHIKLTDYGMCKEGLRPGDT 209

Query: 800 NWSELAGTHGYVAPEL----AYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSS 855
             +   GT  Y+APE+     Y   V    D ++ GVL  E++ G+ P D +    +   
Sbjct: 210 TST-FCGTPNYIAPEILRGEDYGFSV----DWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 264

Query: 856 NMNIEMLDS----RLPYPSLHVQKKLMSIMQVAFSCLDQNPESR 895
           N    +       ++  P   +  K  S+++   S L+++P+ R
Sbjct: 265 NTEDYLFQVILEKQIRIPR-SLSVKAASVLK---SFLNKDPKER 304

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 59.9 bits (146), Expect = 1e-09
 Identities = 70/285 (24%), Positives = 119/285 (41%), Gaps = 68/285 (23%)

Query: 638 NDFNAEHCIGKGGHGSVYRA-KVPSGEIFAVKKFHSPLPGEMSFQQEEF---LNEIQALT 693
           ++F     +GKG  G V  A    +G+++AVK     L  ++  Q ++    + E + L+
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKV----LKKDVILQDDDVECTMTEKRILS 78

Query: 694 EI-RHRNIVK-FYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKG-- 749
               H  + + F  F + P   F + E++  G L            +   Q+        
Sbjct: 79  LARNHPFLTQLFCCFQT-PDRLFFVMEFVNGGDL------------MFHIQKSRRFDEAR 125

Query: 750 -------VADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHV--SDFGIAK-FLNPDSS 799
                  +  AL +LH+     I++RD+   NVLLD  +E H   +DFG+ K  +    +
Sbjct: 126 ARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLD--HEGHCKLADFGMCKEGICNGVT 180

Query: 800 NWSELAGTHGYVAPEL----AYTLKVTEKCDVYSFGVLALEVIKGKHP-----RDFLFEM 850
             +   GT  Y+APE+     Y   V    D ++ GVL  E++ G  P      D LFE 
Sbjct: 181 TAT-FCGTPDYIAPEILQEMLYGPAV----DWWAMGVLLYEMLCGHAPFEAENEDDLFE- 234

Query: 851 SSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESR 895
                   I  L+  + YP+  + +    I++   S + +NP  R
Sbjct: 235 -------AI--LNDEVVYPT-WLHEDATGILK---SFMTKNPTMR 266

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 59.8 bits (145), Expect = 2e-09
 Identities = 38/165 (23%), Positives = 66/165 (40%), Gaps = 23/165 (13%)

Query: 646 IGKGGHGSVYRAK---------VPSGEIFAVK--KFHSPLPGEMSFQQ----EEFLNEIQ 690
             +   G +Y A           P  + F++K       L  E +F Q       +N+ +
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 691 ALTEIRHRNIVKFYGFCSH-PKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKG 749
            L       I    GF  H  K+ F++   L   SL   L + +    L     L V   
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSAL-DVSPKHVLSERSVLQVACR 167

Query: 750 VADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHV--SDFGIAK 792
           + DAL +LH N +   VH +++++N+ +D   ++ V  + +G A 
Sbjct: 168 LLDALEFLHENEY---VHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 58.8 bits (143), Expect = 2e-09
 Identities = 44/219 (20%), Positives = 95/219 (43%), Gaps = 44/219 (20%)

Query: 646 IGKGGHGSVYRAK--VPSGEIFAVKKFHSPLPGEMSFQQEEF----LNEIQALTEIR--- 696
           IG+G +G V++A+     G   A+K+        +   +E      + E+  L  +    
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVR------VQTGEEGMPLSTIREVAVLRHLETFE 72

Query: 697 HRNIVK----FYGFCSHPKHS-FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVA 751
           H N+V+         +  +    +++E+++   L   L +      +      +++  + 
Sbjct: 73  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL-DKVPEPGVPTETIKDMMFQLL 130

Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHG-- 809
             L +LH++    +VHRD+  +N+L+    +  ++DFG+A+  +       ++A T    
Sbjct: 131 RGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYS------FQMALTSVVV 181

Query: 810 ---YVAPEL----AYTLKVTEKCDVYSFGVLALEVIKGK 841
              Y APE+    +Y   V    D++S G +  E+ + K
Sbjct: 182 TLWYRAPEVLLQSSYATPV----DLWSVGCIFAEMFRRK 216

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 59.2 bits (143), Expect = 4e-09
 Identities = 69/540 (12%), Positives = 158/540 (29%), Gaps = 78/540 (14%)

Query: 17  FPLILFVVLDFSLAISSNSAEEAHALVKWKASLEVHSRSL--LHSWSLSSVNATKISPCA 74
           FP +  + L      +  +    +        +   S +L  L S     +  + +    
Sbjct: 72  FPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDR 131

Query: 75  WSGIFCNHAERVVGINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQIS---- 130
            +    +  E +     +  + +G  L    +    +  L +  +         +     
Sbjct: 132 LAKARADDLETLKLDKCSGFTTDG--LLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQ 189

Query: 131 NLSNLEYLDFSANKLFGQIPSGIGLL----THLTVLHISRNWLS--GSIPHEVGQLTVLN 184
           + ++LE L+F   +     P  +  +      L  + +    +            L    
Sbjct: 190 HNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFC 249

Query: 185 QLALDSNFLNGSIPRSLGNLTHVVILYLYN--NSFFGSIPQEIGNLKSLFDLELCINQLS 242
             +L+ +        +L     +  L L     +    +      ++ L DL   + +  
Sbjct: 250 GGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKL-DLLYALLETE 308

Query: 243 GAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTD 302
               L I    NL  L   +      +       K+L  L + +      +      ++ 
Sbjct: 309 DHCTL-IQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQ 367

Query: 303 ------------LVKLRLNQNYLTGNISETFGTY-PNLT---FIDLSNNSFFGEILSDWG 346
                       L  + +  + +T    E+ GTY  NL     + L       ++  D G
Sbjct: 368 RGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNG 427

Query: 347 ------RCPQLSLLDVSIN--NISGSIPLEIGESL-QLQYLDLSSNYIVGEIPTQLGNII 397
                  C +L      +    ++      IG+    ++++ L          +  G ++
Sbjct: 428 VRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGE-----SDEG-LM 481

Query: 398 YLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNF-VPESLGSLVKLYYLNLSHNK 456
                        GC         NL+ L++     S   +  ++  L  L YL +   +
Sbjct: 482 EF---------SRGCP--------NLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYR 524

Query: 457 LSQQIPIEL---DNLIHLSELDLSHNFLGEKIS--SRICRMESLEKLNLSYNNLSGLIPR 511
            S      +       ++  +         +++    I  ME    + L+Y +L+G   R
Sbjct: 525 ASMTGQDLMQMARPYWNIELIPSRRV---PEVNQQGEIREMEHPAHI-LAYYSLAG--QR 578

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 54.6 bits (131), Expect = 1e-07
 Identities = 66/477 (13%), Positives = 144/477 (30%), Gaps = 54/477 (11%)

Query: 85  RVVGINLTSISLN---GTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFS 141
           ++       +++        +     FP+L  L L       +      N         +
Sbjct: 46  KIDSETREHVTMALCYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVT 105

Query: 142 ANKLFGQIPSGIGLLTHLTV--LHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPR 199
                  I + +  L  +    + +S   L          L  L  L   S F    +  
Sbjct: 106 E------ISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLK-LDKCSGFTTDGLLS 158

Query: 200 SLGNLTHVVILYLYNNSF-------FGSIPQEIGNLKSL-FDLELCINQLSGAIPLSISN 251
            + +   +  L +  +SF          + Q   +L+ L F +          +     N
Sbjct: 159 IVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARN 218

Query: 252 LTNLRFLFLYHNELSGI--IPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLN 309
             +L  + +   E+  +    +   NL++     L ++        +      L +L L+
Sbjct: 219 CRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLS 278

Query: 310 QNYLTGNISETFGTY-PNLTFIDLSNNSFFGE-ILSDWGRCPQLSLLDVSINNISGSIPL 367
             Y+  N       +   +  +DL       E   +   +CP L +L+   N I      
Sbjct: 279 --YMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLE 335

Query: 368 EIGESL-QLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYL 426
            + +   QL+ L +        +  + G +     ++L+     GC          LEY+
Sbjct: 336 VLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALA----QGCQ--------ELEYM 383

Query: 427 DLSANNLSNF----VPESLGSLVKLYYLNLSHNKLSQQIPIE------LDNLIHLSELDL 476
            +  ++++N     +   L +L     + L   +    +P++      L     L     
Sbjct: 384 AVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAF 443

Query: 477 SHN--FLGEKISSRICRM-ESLEKLNLSYNNLSGL-IPRCFEEMHGLLHIDISYNKL 529
                 L +   S I +   ++  + L Y   S   +         L  +++     
Sbjct: 444 YLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCF 500

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 58.2 bits (141), Expect = 4e-09
 Identities = 41/176 (23%), Positives = 69/176 (39%), Gaps = 45/176 (25%)

Query: 646 IGKGGHGSVYRAKVPSGEIFAVK---------KFHSPLPGEMSF----QQEEFLNEIQAL 692
           IG+GG G +Y A + S E                + PL  E+ F     + E + +    
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102

Query: 693 TEIRHRNIVKFYGFCSH----PKHSFIIYEYLESG-SLDKIL--CNDASAKELGWTQRLN 745
            ++++  + K++G   H      + F+I +    G  L KI               +R +
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANA----------KRFS 150

Query: 746 VIKGVA-------DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHV--SDFGIAK 792
             K V        D L Y+H + +   VH DI + N+LL+      V   D+G+A 
Sbjct: 151 -RKTVLQLSLRILDILEYIHEHEY---VHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 57.0 bits (138), Expect = 1e-08
 Identities = 47/328 (14%), Positives = 90/328 (27%), Gaps = 63/328 (19%)

Query: 228 LKSLFDLELCINQLS--GAIPLS---ISNLTNLRFLFLYHNELSGIIPQEIGN-LKKLNS 281
           L SL  L L   +++      ++    S    L  + L   +L     + +     +   
Sbjct: 71  LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARK 130

Query: 282 LLLAKNHFRGTVPKSF-----RNLTDLVKLRLNQNYLTGN----ISETFGTYPNLTFIDL 332
           L L  N       K        +   +  LRL+ N LT      + E      ++T + L
Sbjct: 131 LGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSL 190

Query: 333 SNNS-------FFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQ----LQYLDLS 381
            +              L       QL  L+V+ N    +  L +  + +    L+ L L 
Sbjct: 191 LHTGLGDEGLELLAAQLDR---NRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLY 247

Query: 382 SNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESL 441
            N                  LS  G ++   +         +         +S +    L
Sbjct: 248 FN-----------------ELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVSEYWSVIL 290

Query: 442 GSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLG----EKISSRICRMESLEK 497
             + +          L+      +   + L   DL  +        + +  +     +  
Sbjct: 291 SEVQR---------NLNSWDRARVQRHLELLLRDLEDSRGATLNPWRKAQLLRVEGEVRA 341

Query: 498 LNLSYNNLSG----LIPRCFEEMHGLLH 521
           L     +            FE+  G  H
Sbjct: 342 LLEQLGSSGSPSGSWSHPQFEKGAGHHH 369

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 42.8 bits (101), Expect = 3e-04
 Identities = 45/342 (13%), Positives = 89/342 (26%), Gaps = 51/342 (14%)

Query: 118 NNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEV 177
           N  +   +   I NL  LE       KL       +     L  L     + +     EV
Sbjct: 11  NRAVLAQLGCPIKNLDALENAQAIKKKLGKLGRQVLPPSELLDHLFFHYEFQNQRFSAEV 70

Query: 178 GQLTVLNQLALDSNFLNGSIPRSLG-----NLTHVVILYLYNNSFFGSIPQEIGN-LKSL 231
             L+ L QL L    +       +          +  + L +     +  + +       
Sbjct: 71  --LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRA 128

Query: 232 FDLELCINQLS--GAIPLS---ISNLTNLRFLFLYHNELSGIIPQEIGNL----KKLNSL 282
             L L +N L       L    + +   +  L L +N L+      +         +  L
Sbjct: 129 RKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHL 188

Query: 283 LLAKNHFRGTVPKSF----RNLTDLVKLRLNQNYLTGN----ISETFGTYPNLTFIDLSN 334
            L          +           L +L +  N         ++     +P+L  + L  
Sbjct: 189 SLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYF 248

Query: 335 NSF-------FGEILSDWGRCPQLSLLDVSINNIS--GSIPL-------------EIGES 372
           N           ++        ++ +       +S   S+ L              +   
Sbjct: 249 NELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVSEYWSVILSEVQRNLNSWDRARVQRH 308

Query: 373 LQLQYLDLSSNYIVGEIPTQLGNIIYLN----RLSLSGNKLS 410
           L+L   DL  +      P +   ++ +      L        
Sbjct: 309 LELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSSG 350

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 57.5 bits (139), Expect = 1e-08
 Identities = 51/238 (21%), Positives = 81/238 (34%), Gaps = 79/238 (33%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEF----LNEIQALTEIRHRNI 700
           IG G +G V  A       + A+KK          F+        L EI  L  + H ++
Sbjct: 61  IGTGSYGHVCEAYDKLEKRVVAIKKILRV------FEDLIDCKRILREIAILNRLNHDHV 114

Query: 701 VKFYG-FCSHPKHSF----IIYEYLESGSLDKILCNDASAKELGWTQRL----------N 745
           VK            F    ++ E  +S    K+               L          N
Sbjct: 115 VKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTP---------VYLTELHIKTLLYN 164

Query: 746 VIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELA 805
           ++ G    + Y+H+     I+HRD+   N L++      V DFG+A+ ++   +  S+L 
Sbjct: 165 LLVG----VKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLP 217

Query: 806 GTH---------------------GYV------APEL-----AYTLKVTEKCDVYSFG 831
            +                      G+V      APEL      YT  +    DV+S G
Sbjct: 218 ISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAI----DVWSIG 271

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 56.3 bits (136), Expect = 2e-08
 Identities = 53/248 (21%), Positives = 86/248 (34%), Gaps = 76/248 (30%)

Query: 644 HCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEF----LNEIQALTEIRHR 698
           H IG+G +G VY A    + +  A+KK +        F+        L EI  L  ++  
Sbjct: 32  HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM------FEDLIDCKRILREITILNRLKSD 85

Query: 699 NIVKFYG-FCSHPKHSF----IIYEYLESGSLDKILCNDASAKELGWTQRL--------- 744
            I++ Y          F    I+ E  +S  L K+               L         
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTP---------IFLTEEHIKTIL 135

Query: 745 -NVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSE 803
            N++ G      ++H +    I+HRD+   N LL+      V DFG+A+ +N +      
Sbjct: 136 YNLLLG----ENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIV 188

Query: 804 LAGTH----------------GYV------APEL-----AYTLKVTEKCDVYSFG-VLAL 835
                                 +V      APEL      YT  +    D++S G + A 
Sbjct: 189 NDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSI----DIWSTGCIFA- 243

Query: 836 EVIKGKHP 843
           E++     
Sbjct: 244 ELLNMLQS 251

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 53.9 bits (130), Expect = 3e-08
 Identities = 29/133 (21%), Positives = 46/133 (34%), Gaps = 41/133 (30%)

Query: 91  LTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIP 150
           L  IS +G      F   PHLV L+L  N        Q++ +                  
Sbjct: 41  LGRISSDGL-----FGRLPHLVKLELKRN--------QLTGI-----------------E 70

Query: 151 SGI-GLLTHLTVLHISRNWLSGSIPHEV-GQLTVLNQLALDSNFLNGSIPR----SLGNL 204
                  +H+  L +  N +   I +++   L  L  L L  N ++  +       L +L
Sbjct: 71  PNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSL 128

Query: 205 THVVILYLYNNSF 217
           T    L L +N F
Sbjct: 129 TS---LNLASNPF 138

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 53.1 bits (128), Expect = 4e-08
 Identities = 29/105 (27%), Positives = 46/105 (43%), Gaps = 1/105 (0%)

Query: 234 LELCINQLSGAIPLSI-SNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGT 292
           L L  N+L       +   L +L  L L  N+L+GI P        +  L L +N  +  
Sbjct: 34  LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEI 93

Query: 293 VPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSF 337
             K F  L  L  L L  N ++  +  +F    +LT ++L++N F
Sbjct: 94  SNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPF 138

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 51.5 bits (124), Expect = 2e-07
 Identities = 32/123 (26%), Positives = 50/123 (40%), Gaps = 20/123 (16%)

Query: 389 IPTQLGNIIYLNRLSLSGNKLSGCIPREL-GSLINLEYLDLSANNLSNFVPESLGSLVKL 447
           IP       +   L L+ N+L       L G L +L  L+L  N L+   P +      +
Sbjct: 27  IPL------HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI 80

Query: 448 YYLNLSHNKLSQQIPIEL-DNLIHLSELDLSHNFLGEKISSRICR-----MESLEKLNLS 501
             L L  NK+ ++I  ++   L  L  L+L  N +     S +       + SL  LNL 
Sbjct: 81  QELQLGENKI-KEISNKMFLGLHQLKTLNLYDNQI-----SCVMPGSFEHLNSLTSLNL- 133

Query: 502 YNN 504
            +N
Sbjct: 134 ASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 47.3 bits (113), Expect = 4e-06
 Identities = 33/107 (30%), Positives = 47/107 (43%), Gaps = 5/107 (4%)

Query: 186 LALDSNFLNGSIPRSL-GNLTHVVILYLYNNSFFGSIPQEI-GNLKSLFDLELCINQLSG 243
           L L+ N L       L G L H+V L L  N     I          + +L+L  N++  
Sbjct: 34  LLLNDNELGRISSDGLFGRLPHLVKLELKRNQL-TGIEPNAFEGASHIQELQLGENKIK- 91

Query: 244 AIPLSI-SNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHF 289
            I   +   L  L+ L LY N++S ++P    +L  L SL LA N F
Sbjct: 92  EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPF 138

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 46.1 bits (110), Expect = 1e-05
 Identities = 32/107 (29%), Positives = 52/107 (48%), Gaps = 5/107 (4%)

Query: 424 EYLDLSANNLSNFVPESL-GSLVKLYYLNLSHNKLSQQIPIEL-DNLIHLSELDLSHNFL 481
             L L+ N L     + L G L  L  L L  N+L   I     +   H+ EL L  N +
Sbjct: 32  TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQL-TGIEPNAFEGASHIQELQLGENKI 90

Query: 482 GEKISSRIC-RMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYN 527
            E IS+++   +  L+ LNL  N +S ++P  FE ++ L  ++++ N
Sbjct: 91  KE-ISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 42.7 bits (101), Expect = 2e-04
 Identities = 36/140 (25%), Positives = 51/140 (36%), Gaps = 41/140 (29%)

Query: 301 TDLVKLRLNQNYLTGNISE-TFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSIN 359
               +L LN N L    S+  FG  P+L  ++L  N              QL+       
Sbjct: 29  LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRN--------------QLT------- 67

Query: 360 NISGSIPLEIGESL-QLQYLDLSSNYIVGEIP----TQLGNIIYLNRLSLSGNKLSGCIP 414
                I     E    +Q L L  N I  EI       L     L  L+L  N++S C+ 
Sbjct: 68  ----GIEPNAFEGASHIQELQLGENKI-KEISNKMFLGLHQ---LKTLNLYDNQIS-CVM 118

Query: 415 RELG---SLINLEYLDLSAN 431
              G    L +L  L+L++N
Sbjct: 119 P--GSFEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 20/83 (24%), Positives = 37/83 (44%), Gaps = 3/83 (3%)

Query: 449 YLNLSHNKLSQQIPIEL-DNLIHLSELDLSHNFLGEKISSRIC-RMESLEKLNLSYNNLS 506
            L L+ N+L +     L   L HL +L+L  N L   I          +++L L  N + 
Sbjct: 33  ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQL-TGIEPNAFEGASHIQELQLGENKIK 91

Query: 507 GLIPRCFEEMHGLLHIDISYNKL 529
            +  + F  +H L  +++  N++
Sbjct: 92  EISNKMFLGLHQLKTLNLYDNQI 114

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 55.5 bits (134), Expect = 3e-08
 Identities = 39/169 (23%), Positives = 69/169 (40%), Gaps = 34/169 (20%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVK------KFHSPLPGEMSF----QQEEFLNEIQALTE 694
           IG GG G +Y A      E  A        + + PL  E+ F     +++ + +     +
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104

Query: 695 IRHRNIVKFYGFCSHP----KHSFIIYEYLESGSLDKIL--CNDASAK---ELGWTQRLN 745
           + +  I  FYG          + F++ E L    L KI             +LG  + L+
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKISGQNGTFKKSTVLQLG-IRMLD 162

Query: 746 VIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYE--AHVSDFGIAK 792
           V++       Y+H N +   VH DI + N+LL        +++D+G++ 
Sbjct: 163 VLE-------YIHENEY---VHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 54.5 bits (131), Expect = 6e-08
 Identities = 33/164 (20%), Positives = 58/164 (35%), Gaps = 10/164 (6%)

Query: 325 PNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSI-NNISGSIPLEIGESL-QLQYLDLSS 382
             L  + L        I++   +   L  L++S  +  S      +  S  +L  L+LS 
Sbjct: 118 SKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSW 177

Query: 383 NY------IVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLS-ANNLSN 435
            +      +   +      I  LN      N     +   +    NL +LDLS +  L N
Sbjct: 178 CFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKN 237

Query: 436 FVPESLGSLVKLYYLNLSH-NKLSQQIPIELDNLIHLSELDLSH 478
              +    L  L +L+LS    +  +  +EL  +  L  L +  
Sbjct: 238 DCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFG 281

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 46.4 bits (110), Expect = 3e-05
 Identities = 50/210 (23%), Positives = 86/210 (40%), Gaps = 18/210 (8%)

Query: 330 IDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPL-EIGESLQLQYLDLSSNYI-VG 387
           +DL+  +   ++    GR     ++           PL E     ++Q++DLS++ I V 
Sbjct: 52  LDLTGKNLHPDVT---GRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVS 108

Query: 388 EIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLV-- 445
            +   L     L  LSL G +LS  I   L    NL  L+LS    S F   +L +L+  
Sbjct: 109 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLS--GCSGFSEFALQTLLSS 166

Query: 446 --KLYYLNLSHNK------LSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEK 497
             +L  LNLS         +   +    + +  L+      N     +S+ + R  +L  
Sbjct: 167 CSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVH 226

Query: 498 LNLSY-NNLSGLIPRCFEEMHGLLHIDISY 526
           L+LS    L     + F +++ L H+ +S 
Sbjct: 227 LDLSDSVMLKNDCFQEFFQLNYLQHLSLSR 256

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 52.8 bits (127), Expect = 2e-07
 Identities = 50/240 (20%), Positives = 92/240 (38%), Gaps = 39/240 (16%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR-------- 696
           +G G   +V+ AK + +    A+K        ++  +  E   EI+ L  +         
Sbjct: 27  LGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAED--EIKLLQRVNDADNTKED 81

Query: 697 ---HRNIVKFYGFCSH----PKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKG 749
                +I+K     +H      H  +++E L    L  I   +     L + ++  + K 
Sbjct: 82  SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ--ISKQ 139

Query: 750 VADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAH------VSDFGIAKFLNPDSSNWSE 803
           +   L Y+H  C   I+H DI  +NVL+++           ++D G A + +   +N   
Sbjct: 140 LLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS-- 195

Query: 804 LAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFE-MSSSSSNMNIEML 862
              T  Y +PE+          D++S   L  E+I G      LFE     S   + + +
Sbjct: 196 -IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF----LFEPDEGHSYTKDDDHI 250

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 51.6 bits (124), Expect = 6e-07
 Identities = 55/241 (22%), Positives = 95/241 (39%), Gaps = 74/241 (30%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEF----LNEIQALTEIR-HRN 699
           +GKG +G V+++    +GE+ AVKK          FQ          EI  LTE+  H N
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDA------FQNSTDAQRTFREIMILTELSGHEN 70

Query: 700 IVKFYGFCSHP--KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLN----------VI 747
           IV           +  +++++Y+E+  L  ++              L           +I
Sbjct: 71  IVNLLNVLRADNDRDVYLVFDYMET-DLHAVI----------RANILEPVHKQYVVYQLI 119

Query: 748 KGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGT 807
           K     + YLH+     ++HRD+   N+LL+      V+DFG+++         + +  +
Sbjct: 120 KV----IKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLS 172

Query: 808 H---------------GYV------APEL-----AYTLKVTEKCDVYSFG-VLALEVIKG 840
                            YV      APE+      YT  +    D++S G +L  E++ G
Sbjct: 173 INENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGI----DMWSLGCILG-EILCG 227

Query: 841 K 841
           K
Sbjct: 228 K 228

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 48.2 bits (115), Expect = 1e-05
 Identities = 48/215 (22%), Positives = 89/215 (41%), Gaps = 42/215 (19%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVK------KFHSPLPGEMSFQQEEFLNEIQALTEIRHR 698
           IGKG  G V +A      +  A+K      +FH            +   EI+ L  +R +
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFH-----------RQAAEEIRILEHLRKQ 153

Query: 699 ------NIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVA- 751
                 N++      +   H  + +E L S +L +++  +   K  G++  L +++  A 
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKN---KFQGFS--LPLVRKFAH 207

Query: 752 ---DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAH--VSDFGIAKFLNPDSSNWSELAG 806
                L  LH N    I+H D+  +N+LL     +   V DFG + + +     + +   
Sbjct: 208 SILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQ--- 261

Query: 807 THGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGK 841
           +  Y APE+    +     D++S G +  E++ G 
Sbjct: 262 SRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 45.3 bits (108), Expect = 2e-05
 Identities = 37/108 (34%), Positives = 50/108 (46%), Gaps = 34/108 (31%)

Query: 113 YLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGS 172
            L L NN++  + P    +L NL+ L F++NKL                          +
Sbjct: 37  RLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKL-------------------------TA 71

Query: 173 IPHEV-GQLTVLNQLALDSNFLNGSIPR----SLGNLTHVVILYLYNN 215
           IP  V  +LT L QL L+ N L  SIPR    +L +LTH   +YLYNN
Sbjct: 72  IPTGVFDKLTQLTQLDLNDNHLK-SIPRGAFDNLKSLTH---IYLYNN 115

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 46.2 bits (110), Expect = 2e-05
 Identities = 34/161 (21%), Positives = 66/161 (40%), Gaps = 19/161 (11%)

Query: 638 NDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
           N +     IG G  G +Y    + +GE  A+K        +    Q     E +    ++
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL----ECVKTKHPQ--LHIESKIYKMMQ 62

Query: 697 H-RNIVKFYGFCSHPKHSFIIYEYLESG-SLDKILCNDASAKELGWTQRLNVIKGVADAL 754
               I       +   ++ ++ E L  G SL+ +   +  +++      L +   +   +
Sbjct: 63  GGVGIPTIRWCGAEGDYNVMVMELL--GPSLEDLF--NFCSRKFSLKTVLLLADQMISRI 118

Query: 755 FYLHNNCFPPIVHRDISSKNVLLDLGYEAH---VSDFGIAK 792
            Y+H+  F   +HRD+   N L+ LG + +   + DFG+AK
Sbjct: 119 EYIHSKNF---IHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 44.7 bits (106), Expect = 9e-05
 Identities = 48/215 (22%), Positives = 81/215 (37%), Gaps = 40/215 (18%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVK------KFHSPLPGEMSFQQEEFLNEIQALTEIRHR 698
           IGKG  G V +A      E  A+K       F           Q     E++ L  +   
Sbjct: 62  IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFL---------NQA--QIEVRLLELMNKH 110

Query: 699 ------NIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVA- 751
                  IV          H  +++E L S +L  +L N       G +  LN+ +  A 
Sbjct: 111 DTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNT---NFRGVS--LNLTRKFAQ 164

Query: 752 ---DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAH--VSDFGIAKFLNPDSSNWSELAG 806
               AL +L       I+H D+  +N+LL     +   + DFG +  L      + +   
Sbjct: 165 QMCTALLFLATPELS-IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQ--- 220

Query: 807 THGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGK 841
           +  Y +PE+   +      D++S G + +E+  G+
Sbjct: 221 SRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 43.9 bits (104), Expect = 2e-04
 Identities = 38/175 (21%), Positives = 72/175 (41%), Gaps = 32/175 (18%)

Query: 638 NDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVK--KFHSPLPGEMSFQQEEFLNEIQALTE 694
            +F     IG G  G +   K + + E  A+K     S  P            E +   +
Sbjct: 9   PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLH--------LEYRFYKQ 60

Query: 695 IRH-RNIVKFYGFCSHPKHSFIIYEYLESG-SLDKI--LCNDA-SAKELGWTQRLNVIKG 749
           +     I + Y F    K++ ++ E L  G SL+ +  LC+   S K +     L +   
Sbjct: 61  LGSGDGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTV-----LMIAIQ 113

Query: 750 VADALFYLHNNCFPPIVHRDISSKNVLLDLGYEA-----HVSDFGIAK-FLNPDS 798
           +   + Y+H+      ++RD+  +N L+           H+ DF +AK +++P++
Sbjct: 114 LISRMEYVHSKNL---IYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPET 165

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 43.5 bits (103), Expect = 2e-04
 Identities = 35/169 (20%), Positives = 61/169 (36%), Gaps = 36/169 (21%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH-RNIVKF 703
           IG+G  G ++    + + +  A+K      P      Q    +E +    +     I   
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKF----EPRRSDAPQ--LRDEYRTYKLLAGCTGIPNV 71

Query: 704 YGFCSHPKHSFIIYEYLESG-SLDKILCNDASAKELGWTQRLNVIKGVA-------DALF 755
           Y F     H+ ++ + L  G SL+ +L             R   +K VA         + 
Sbjct: 72  YYFGQEGLHNVLVIDLL--GPSLEDLLD---------LCGRKFSVKTVAMAAKQMLARVQ 120

Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEA-----HVSDFGIAK-FLNPDS 798
            +H       V+RDI   N L+           +V DFG+ K + +P +
Sbjct: 121 SIHEKSL---VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 166

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 43.1 bits (101), Expect = 3e-04
 Identities = 37/161 (22%), Positives = 68/161 (42%), Gaps = 19/161 (11%)

Query: 638 NDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
           N F     IG G  G +Y    + + E  A+K        +    Q   L E +    ++
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKHPQ--LLYESKIYRILQ 60

Query: 697 -HRNIVKFYGFCSHPKHSFIIYEYLESG-SLDKILCNDASAKELGWTQRLNVIKGVADAL 754
               I     F     ++ ++ + L  G SL+ +   +  +++L     L +   + + +
Sbjct: 61  GGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLF--NFCSRKLSLKTVLMLADQMINRV 116

Query: 755 FYLHNNCFPPIVHRDISSKNVLLDLGYEAH---VSDFGIAK 792
            ++H+  F   +HRDI   N L+ LG  A+   + DFG+AK
Sbjct: 117 EFVHSKSF---LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185

 Score = 41.5 bits (98), Expect = 4e-04
 Identities = 18/99 (18%), Positives = 35/99 (35%), Gaps = 14/99 (14%)

Query: 423 LEYLDLSANNLSNFVPESLGSLVK----LYYLNLSHNKLS----QQIPIELDNLIHLSEL 474
           ++   +     ++ V  +L  ++K    L  LN+  N +S      +   L +   L EL
Sbjct: 67  VKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIEL 126

Query: 475 DLSHNF--LGEKISSRICRM----ESLEKLNLSYNNLSG 507
            + +    LG  +   I  M     +L K    +     
Sbjct: 127 RIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQGP 165

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 40.3 bits (95), Expect = 8e-04
 Identities = 24/88 (27%), Positives = 41/88 (46%), Gaps = 8/88 (9%)

Query: 400 NRLSLSGNKLSGCIPRELGSL-----INLEYLDLSANNLSNFVPESLGSLVKLYYLNLSH 454
           ++ S SG  +  C  + L S+        + L L  N ++   P     L +L  L+L +
Sbjct: 5   SQCSCSGTTVD-CSGKSLASVPTGIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDN 63

Query: 455 NKLSQQIPIEL-DNLIHLSELDLSHNFL 481
           N+L   +P  + D L  L++L L+ N L
Sbjct: 64  NQL-TVLPAGVFDKLTQLTQLSLNDNQL 90

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	912
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.98
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.97
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.97
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.97
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.97
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.96
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.96
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.96
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.96
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.96
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.96
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.96
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.96
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.96
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.96
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.96
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.96
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.95
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.95
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.95
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.95
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.94
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.94
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.94
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.93
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.93
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.93
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.92
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.92
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.92
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.91
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.91
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.91
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.91
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.91
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.9
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.9
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.9
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.9
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.89
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.89
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.89
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.89
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.89
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.88
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.88
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.88
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.88
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.86
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.86
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.86
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.86
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.85
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.84
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.83
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.82
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.81
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.81
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.81
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.81
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.81
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.81
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.8
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.79
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.79
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.78
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.78
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.78
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.78
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.77
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.76
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.75
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.75
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.74
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.74
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.74
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.74
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.71
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.7
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.65
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.65
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.64
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.63
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.63
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.62
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.62
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.62
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.62
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.62
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.59
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.59
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.57
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.56
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.56
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.54
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.53
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.47
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.44
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.44
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.41
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.33
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.33
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.29
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.26
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.25
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.24
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.22
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.04
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	99.01
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.98
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	98.96
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.93
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.93
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.91
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.83
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.57
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.47
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.4
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.4
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.37
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.31
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.29
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.2
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.99
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.82
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.77
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.76
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.73
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.67
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.49
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.44
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.25
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.23
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.2
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.11
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.07
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.94
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.93
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.91
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.88
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.83
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.55
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.55
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.49
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.12
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.72
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.16
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	93.38
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	91.53
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	90.65

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=7.7e-73  Score=692.18  Aligned_cols=528  Identities=32%  Similarity=0.494  Sum_probs=398.4

Q ss_pred             hhccCCCCHHHHHHHHHHHHhcccCCcccCCCcccCCCCCCCCCCCccceeEecCCCCeEEEeecccccccc---ccc--
Q 039137           28 SLAISSNSAEEAHALVKWKASLEVHSRSLLHSWSLSSVNATKISPCAWSGIFCNHAERVVGINLTSISLNGT---LLE--  102 (912)
Q Consensus        28 ~~~~~~~~~~~~~all~~k~~~~~~~~~~l~~w~~~~~~~~~~~~C~w~gv~c~~~~~v~~l~l~~~~l~~~---~~~--  102 (912)
                      ..+.+++.++|++||++||+++. ||. .+++|+.      +.|||+|.||+|+ ++||++++|++.++.|.   +++  
T Consensus         3 ~~~~~~~~~~~~~all~~k~~~~-~~~-~l~~W~~------~~~~C~w~gv~C~-~~~v~~L~L~~~~l~g~~~~l~~~l   73 (768)
T 3rgz_A            3 QASPSQSLYREIHQLISFKDVLP-DKN-LLPDWSS------NKNPCTFDGVTCR-DDKVTSIDLSSKPLNVGFSAVSSSL   73 (768)
T ss_dssp             -----CCHHHHHHHHHHHHTTCS-CTT-SSTTCCT------TSCGGGSTTEEEE-TTEEEEEECTTSCCCEEHHHHHHHT
T ss_pred             cCccccCCHHHHHHHHHHHhhCC-Ccc-cccCCCC------CCCCcCCcceEEC-CCcEEEEECCCCCcCCccCccChhH
Confidence            33445567889999999999997 666 8999963      3589999999999 79999999999988887   432  


Q ss_pred             --------------------cccCCCCCccEEEccCCcccccCCc--cccCCCCCcEEecccccccccccccc-c-----
Q 039137          103 --------------------FSFSSFPHLVYLDLYNNELFGIIPP--QISNLSNLEYLDFSANKLFGQIPSGI-G-----  154 (912)
Q Consensus       103 --------------------~~~~~l~~L~~L~L~~n~l~~~~p~--~~~~l~~L~~L~Ls~n~l~~~~p~~~-~-----  154 (912)
                                          ..|+.+++|++|||++|.++|.+|.  .++++++|++|||++|.+.+.+|..+ +     
T Consensus        74 ~~L~~L~~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L  153 (768)
T 3rgz_A           74 LSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSL  153 (768)
T ss_dssp             TTCTTCCEEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTC
T ss_pred             hccCcccccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCC
Confidence                                4688889999999999999998888  88888888888888887776665433 2     


Q ss_pred             --------------------------------------------cccccceeecccccccCCCCccccCcccccEEEccC
Q 039137          155 --------------------------------------------LLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDS  190 (912)
Q Consensus       155 --------------------------------------------~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~  190 (912)
                                                                  .+++|++|+|++|.+++.+|. ++++++|++|++++
T Consensus       154 ~~L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~  232 (768)
T 3rgz_A          154 EVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISG  232 (768)
T ss_dssp             SEEECCSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCS
T ss_pred             CEEECCCCccCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcC
Confidence                                                        233444444444444444444 66666666666666


Q ss_pred             CcCCCCCCccCCCCccceeeeeccCCCcC----------------------ccccccccc-cccceeecccccccCcccc
Q 039137          191 NFLNGSIPRSLGNLTHVVILYLYNNSFFG----------------------SIPQEIGNL-KSLFDLELCINQLSGAIPL  247 (912)
Q Consensus       191 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~----------------------~~p~~~~~l-~~L~~L~l~~n~l~~~~p~  247 (912)
                      |++++.+|..++++++|++|+|++|.+.+                      .+|..+.++ ++|++|++++|++++.+|.
T Consensus       233 n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~  312 (768)
T 3rgz_A          233 NKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPP  312 (768)
T ss_dssp             SCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCCCCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCG
T ss_pred             CcCCCcccHHHhcCCCCCEEECCCCcccCccCccccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccch
Confidence            66665555555555444444444444332                      333333332 5555555555555544444


Q ss_pred             ccccccccceeeeccccC-------------------------cccCCcccCCc--------------------------
Q 039137          248 SISNLTNLRFLFLYHNEL-------------------------SGIIPQEIGNL--------------------------  276 (912)
Q Consensus       248 ~~~~l~~L~~L~L~~N~l-------------------------~~~~~~~l~~l--------------------------  276 (912)
                      .|+++++|++|+|++|++                         ++.+|..+.++                          
T Consensus       313 ~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~  392 (768)
T 3rgz_A          313 FFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNP  392 (768)
T ss_dssp             GGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCST
T ss_pred             HHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcc
Confidence            444444444444444444                         43344333322                          


Q ss_pred             -cccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCcccccccCCCCCCCCEEe
Q 039137          277 -KKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLD  355 (912)
Q Consensus       277 -~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  355 (912)
                       ++|++|++++|++++.+|..|.++++|++|+|++|.+++.+|..|+.+++|+.|+|++|.+.+..|..+..+++|+.|+
T Consensus       393 ~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~  472 (768)
T 3rgz_A          393 KNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLI  472 (768)
T ss_dssp             TCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEE
T ss_pred             cCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEE
Confidence             2344444444444445666667777777777777777777777788888888888888888878888888888888888


Q ss_pred             ccCCcccccccccccccccccEEEccCccccCCCCccccccccccEEEccCCcccCCCccccccccccccccccCcccCc
Q 039137          356 VSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSN  435 (912)
Q Consensus       356 Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  435 (912)
                      +++|++++.+|..++.+++|++|+|++|++++.+|..++.+++|++|+|++|++++.+|..+..+++|++|+|++|++++
T Consensus       473 L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g  552 (768)
T 3rgz_A          473 LDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNG  552 (768)
T ss_dssp             CCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEES
T ss_pred             ecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCC
Confidence            88888888888888888888888888888888888888888888888888888888888888888889999998888876


Q ss_pred             ccccc----------------------------------------------------------------------ccccc
Q 039137          436 FVPES----------------------------------------------------------------------LGSLV  445 (912)
Q Consensus       436 ~~~~~----------------------------------------------------------------------~~~l~  445 (912)
                      .+|..                                                                      +..++
T Consensus       553 ~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~  632 (768)
T 3rgz_A          553 TIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNG  632 (768)
T ss_dssp             BCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSB
T ss_pred             cCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccc
Confidence            66643                                                                      33356


Q ss_pred             cccEEEecccccccccchhhhcccccceeeccccccCcccccccccccccccccccCccccCCCcccccccccceEEEcc
Q 039137          446 KLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDIS  525 (912)
Q Consensus       446 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~ls  525 (912)
                      +|+.|+|++|+++|.+|..++++++|+.|+|++|+++|.+|..++++++|+.|||++|+++|.+|..+..++.|++||++
T Consensus       633 ~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls  712 (768)
T 3rgz_A          633 SMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLS  712 (768)
T ss_dssp             CCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECC
T ss_pred             cccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECc
Confidence            78999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCccccCCCCCccCCCCchhhhccCCcccCCcCCCCcccccc
Q 039137          526 YNKLEGQIPNSTTFRDAPLEALQGNKGLYGDIRGFPSCMSYK  567 (912)
Q Consensus       526 ~N~l~~~~~~~~~~~~~~~~~l~~n~~~~~~~~~~~~c~~~~  567 (912)
                      +|+++|.+|....|...+...+.||+++||.+..  +|....
T Consensus       713 ~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~--~C~~~~  752 (768)
T 3rgz_A          713 NNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLP--RCDPSN  752 (768)
T ss_dssp             SSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSC--CCCSCC
T ss_pred             CCcccccCCCchhhccCCHHHhcCCchhcCCCCc--CCCCCc
Confidence            9999999999999999999999999999998754  675433

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=6.5e-60  Score=564.64  Aligned_cols=480  Identities=20%  Similarity=0.256  Sum_probs=412.1

Q ss_pred             CCCHHHHHHHHHHHHhcccCCcccC-------CCcccCCCCCCCCCCCcc---ceeEecCCCCeEEEeeccccccccccc
Q 039137           33 SNSAEEAHALVKWKASLEVHSRSLL-------HSWSLSSVNATKISPCAW---SGIFCNHAERVVGINLTSISLNGTLLE  102 (912)
Q Consensus        33 ~~~~~~~~all~~k~~~~~~~~~~l-------~~w~~~~~~~~~~~~C~w---~gv~c~~~~~v~~l~l~~~~l~~~~~~  102 (912)
                      +....|+.||.+||+++..+.+..-       ++|+.      ..+||.|   .||+|+..+||++++|.+.++.|+++ 
T Consensus        26 ~~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~------~~~~c~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp-   98 (636)
T 4eco_A           26 AEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNF------NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVP-   98 (636)
T ss_dssp             CHHHHHHHHHHHHHHHTTGGGCCCCC------CCCCC------SSCGGGTTCCTTEEECTTCCEEEEECTTSCCEEEEC-
T ss_pred             hhHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCC------CCCcccccCCCCeEEcCCCCEEEEEecCcccCCcCC-
Confidence            3445799999999999976544322       36753      3689999   99999888999999999999999987 


Q ss_pred             cccCCCCCccEEEccCCcc------cc------cCCccccCCCCCcEEecccccccccccccccc-ccccceeecc----
Q 039137          103 FSFSSFPHLVYLDLYNNEL------FG------IIPPQISNLSNLEYLDFSANKLFGQIPSGIGL-LTHLTVLHIS----  165 (912)
Q Consensus       103 ~~~~~l~~L~~L~L~~n~l------~~------~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~-l~~L~~L~L~----  165 (912)
                      .+|+++++|++|+|++|.+      .|      .+|+..  +..|+ +++++|.+.+.+|..++. +.++..+++.    
T Consensus        99 ~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~  175 (636)
T 4eco_A           99 DAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSI  175 (636)
T ss_dssp             GGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCC
T ss_pred             hHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHHHHHHhhcCcccccc
Confidence            5799999999999999987      33      455444  56777 899999998888887763 2333333333    


Q ss_pred             ----------------cccccCCCCccccCcccccEEEccCCcCCCC-----------------CCccCC--CCccceee
Q 039137          166 ----------------RNWLSGSIPHEVGQLTVLNQLALDSNFLNGS-----------------IPRSLG--NLTHVVIL  210 (912)
Q Consensus       166 ----------------~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~-----------------~p~~~~--~l~~L~~L  210 (912)
                                      .|+++| +|..++++++|++|+|++|+++|.                 +|..++  ++++|++|
T Consensus       176 ~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L  254 (636)
T 4eco_A          176 KKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDV  254 (636)
T ss_dssp             CCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEE
T ss_pred             ccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEE
Confidence                            688998 999999999999999999999986                 999999  99999999


Q ss_pred             eeccCCCcCccccccccccccceeeccccc-ccC-ccccccccc------cccceeeeccccCcccCCc--ccCCccccc
Q 039137          211 YLYNNSFFGSIPQEIGNLKSLFDLELCINQ-LSG-AIPLSISNL------TNLRFLFLYHNELSGIIPQ--EIGNLKKLN  280 (912)
Q Consensus       211 ~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~-l~~-~~p~~~~~l------~~L~~L~L~~N~l~~~~~~--~l~~l~~L~  280 (912)
                      +|++|.+.+.+|..++++++|++|++++|+ ++| .+|..++.+      ++|++|+|++|+++ .+|.  .++++++|+
T Consensus       255 ~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~  333 (636)
T 4eco_A          255 EVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLG  333 (636)
T ss_dssp             EEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCC
T ss_pred             EecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCC
Confidence            999999999999999999999999999998 998 899988887      99999999999999 6888  899999999


Q ss_pred             hhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCC-ccEEEccCCcCcccccccCCCCC--CCCEEecc
Q 039137          281 SLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPN-LTFIDLSNNSFFGEILSDWGRCP--QLSLLDVS  357 (912)
Q Consensus       281 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~-L~~L~Ls~N~l~~~~~~~~~~l~--~L~~L~Ls  357 (912)
                      +|++++|+++|.+| .|..+++|++|++++|.++ .+|..+..+++ |++|++++|+++ .+|..+..++  +|+.|+++
T Consensus       334 ~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls  410 (636)
T 4eco_A          334 MLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFS  410 (636)
T ss_dssp             EEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECC
T ss_pred             EEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECc
Confidence            99999999998888 8999999999999999999 67778999999 999999999998 6777777655  89999999


Q ss_pred             CCccccccccccc-------ccccccEEEccCccccCCCCccccccccccEEEccCCcccCCCccc-cccc-------cc
Q 039137          358 INNISGSIPLEIG-------ESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRE-LGSL-------IN  422 (912)
Q Consensus       358 ~N~l~~~~~~~~~-------~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~-~~~l-------~~  422 (912)
                      +|++.+.+|..+.       .+.+|++|+|++|++++..+..+..+++|+.|+|++|+++ .+|.. +...       ++
T Consensus       411 ~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~  489 (636)
T 4eco_A          411 YNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYL  489 (636)
T ss_dssp             SSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGG
T ss_pred             CCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCC
Confidence            9999999998888       7889999999999999544445567899999999999999 55544 3332       38


Q ss_pred             cccccccCcccCcccccccc--ccccccEEEecccccccccchhhhcccccceeec------cccccCcccccccccccc
Q 039137          423 LEYLDLSANNLSNFVPESLG--SLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDL------SHNFLGEKISSRICRMES  494 (912)
Q Consensus       423 L~~L~Ls~N~l~~~~~~~~~--~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L------s~N~l~~~~~~~~~~l~~  494 (912)
                      |++|+|++|+++. +|..+.  .+++|+.|+|++|++++ +|..+..+++|++|+|      ++|++.+.+|..+..+++
T Consensus       490 L~~L~Ls~N~l~~-lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~  567 (636)
T 4eco_A          490 LTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPS  567 (636)
T ss_dssp             CCEEECCSSCCCB-CCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSS
T ss_pred             ccEEECcCCcCCc-cChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCC
Confidence            9999999999995 677776  89999999999999997 8999999999999999      568888999999999999


Q ss_pred             cccccccCccccCCCcccccccccceEEEccCCccccCC
Q 039137          495 LEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQI  533 (912)
Q Consensus       495 L~~L~ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~  533 (912)
                      |+.|+|++|+| +.+|..+.  ++|+.|++++|++.+..
T Consensus       568 L~~L~Ls~N~l-~~ip~~~~--~~L~~L~Ls~N~l~~~~  603 (636)
T 4eco_A          568 LTQLQIGSNDI-RKVNEKIT--PNISVLDIKDNPNISID  603 (636)
T ss_dssp             CCEEECCSSCC-CBCCSCCC--TTCCEEECCSCTTCEEE
T ss_pred             CCEEECCCCcC-CccCHhHh--CcCCEEECcCCCCcccc
Confidence            99999999999 45676665  79999999999998643

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=1.2e-57  Score=552.90  Aligned_cols=476  Identities=20%  Similarity=0.245  Sum_probs=308.4

Q ss_pred             CCCHHHHHHHHHHHHhcccCCcccCCCcccCCCCCCCCCC--Ccc------------ceeEecCCCCeEEEeeccccccc
Q 039137           33 SNSAEEAHALVKWKASLEVHSRSLLHSWSLSSVNATKISP--CAW------------SGIFCNHAERVVGINLTSISLNG   98 (912)
Q Consensus        33 ~~~~~~~~all~~k~~~~~~~~~~l~~w~~~~~~~~~~~~--C~w------------~gv~c~~~~~v~~l~l~~~~l~~   98 (912)
                      ++..+|++||++||+++. +|     +|+.+.++. ..+|  |.|            .||+|+..+||++++|.++++.|
T Consensus       265 ~~~~~d~~ALl~~k~~l~-~~-----~W~~~~~~~-~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G  337 (876)
T 4ecn_A          265 AEYIKDYKALKAIWEALD-GK-----NWRYYSGTI-NNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKG  337 (876)
T ss_dssp             CHHHHHHHHHHHHHHHTT-GG-----GCCCCCSSC-SSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEE
T ss_pred             ccchHHHHHHHHHHHHcC-CC-----CCCcCCCcc-cccCCccccccccccccccCcCceEecCCCCEEEEECccCCCCC
Confidence            455689999999999995 44     797654221 1355  999            99999988999999999999999


Q ss_pred             cccccccCCCCCccEEEc-cCCcccccCCccc------------------------------------------------
Q 039137           99 TLLEFSFSSFPHLVYLDL-YNNELFGIIPPQI------------------------------------------------  129 (912)
Q Consensus        99 ~~~~~~~~~l~~L~~L~L-~~n~l~~~~p~~~------------------------------------------------  129 (912)
                      .++ .+|++|++|++|+| ++|.+.|..|-..                                                
T Consensus       338 ~ip-~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~  416 (876)
T 4ecn_A          338 RVP-DAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKP  416 (876)
T ss_dssp             EEC-GGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCC
T ss_pred             cCc-hHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccc
Confidence            986 57999999999999 8898888744221                                                


Q ss_pred             ---cCCCCCcEEeccc--cccccccccccccccccceeecccccccC-----------------CCCcccc--CcccccE
Q 039137          130 ---SNLSNLEYLDFSA--NKLFGQIPSGIGLLTHLTVLHISRNWLSG-----------------SIPHEVG--QLTVLNQ  185 (912)
Q Consensus       130 ---~~l~~L~~L~Ls~--n~l~~~~p~~~~~l~~L~~L~L~~n~l~~-----------------~~p~~~~--~l~~L~~  185 (912)
                         .....++.+.+..  |++++ +|..|+++++|++|+|++|.++|                 .+|..++  ++++|++
T Consensus       417 i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~  495 (876)
T 4ecn_A          417 IKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTD  495 (876)
T ss_dssp             CCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCE
T ss_pred             cccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCE
Confidence               1112233333333  66766 77777777777777777777776                 2677766  7777777


Q ss_pred             EEccCCcCCCCCCccCCCCccceeeeeccCC-CcC-cccccccccc-------ccceeecccccccCcccc--ccccccc
Q 039137          186 LALDSNFLNGSIPRSLGNLTHVVILYLYNNS-FFG-SIPQEIGNLK-------SLFDLELCINQLSGAIPL--SISNLTN  254 (912)
Q Consensus       186 L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~-l~~-~~p~~~~~l~-------~L~~L~l~~n~l~~~~p~--~~~~l~~  254 (912)
                      |+|++|.+.+.+|..|+++++|++|+|++|+ ++| .+|..+++++       +|+.|++++|+++ .+|.  .++++++
T Consensus       496 L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~  574 (876)
T 4ecn_A          496 VELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVK  574 (876)
T ss_dssp             EEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTT
T ss_pred             EECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCC
Confidence            7777777777777777777777777777776 666 6666666555       7777777777776 6666  6777777


Q ss_pred             cceeeeccccCcccCCcccCCccccchhhhccCccCCCCccccccccc-cceEecccccccCCCCcccCCCCC--ccEEE
Q 039137          255 LRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTD-LVKLRLNQNYLTGNISETFGTYPN--LTFID  331 (912)
Q Consensus       255 L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~L~~n~l~~~~~~~~~~l~~--L~~L~  331 (912)
                      |+.|+|++|+++ .+| .|+++++|+.|+|++|+++ .+|..+..+++ |+.|+|++|.++ .+|..+..++.  |+.|+
T Consensus       575 L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~  650 (876)
T 4ecn_A          575 LGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVD  650 (876)
T ss_dssp             CCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEE
T ss_pred             CCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEE
Confidence            777777777776 455 6667777777777777776 66666666666 777777777766 45555555543  77777


Q ss_pred             ccCCcCccccccc---CC--CCCCCCEEeccCCcccccccccc-cccccccEEEccCccccCCCCccccc--------cc
Q 039137          332 LSNNSFFGEILSD---WG--RCPQLSLLDVSINNISGSIPLEI-GESLQLQYLDLSSNYIVGEIPTQLGN--------II  397 (912)
Q Consensus       332 Ls~N~l~~~~~~~---~~--~l~~L~~L~Ls~N~l~~~~~~~~-~~~~~L~~L~L~~N~l~~~~~~~l~~--------l~  397 (912)
                      |++|++.+.+|..   +.  .+++|+.|++++|++. .+|..+ ..+++|+.|+|++|+++ .+|..+..        ++
T Consensus       651 Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~  728 (876)
T 4ecn_A          651 FSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTY  728 (876)
T ss_dssp             CCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGG
T ss_pred             CcCCcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccC
Confidence            7777766554422   12  2346666666666666 334333 35666666666666666 44443322        22


Q ss_pred             cccEEEccCCcccCCCccccc--cccccccccccCcccCccccccccccccccEEEecc------cccccccchhhhccc
Q 039137          398 YLNRLSLSGNKLSGCIPRELG--SLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSH------NKLSQQIPIELDNLI  469 (912)
Q Consensus       398 ~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~------N~l~~~~~~~~~~l~  469 (912)
                      +|+.|+|++|+++ .+|..+.  .+++|+.|+|++|++++ +|..+..+++|+.|+|++      |++.+.+|..+.+++
T Consensus       729 ~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~  806 (876)
T 4ecn_A          729 LLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCP  806 (876)
T ss_dssp             GCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCS
T ss_pred             CccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCC
Confidence            6666666666666 4555554  66666666666666665 455566666666666654      445555555555555


Q ss_pred             ccceeeccccccCcccccccccccccccccccCccccCCCcccccccccceEEEccCCcc
Q 039137          470 HLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKL  529 (912)
Q Consensus       470 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l  529 (912)
                      +|+.|+|++|+| +.+|..+.  ++|+.|+|++|++..+.+..|.....+..+.+.+|++
T Consensus       807 ~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~  863 (876)
T 4ecn_A          807 SLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKT  863 (876)
T ss_dssp             SCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHHHHTTCCEEECCTT
T ss_pred             CCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHHccccccchheeecCCCc
Confidence            566666666655 44444443  3555555555555555545554444444455555544

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=7.8e-57  Score=550.61  Aligned_cols=444  Identities=33%  Similarity=0.480  Sum_probs=355.3

Q ss_pred             CeEEEeeccccccccccccccCCCCCccEEEccCCcccccCCccccCCCCCcEEecccccccc-----------------
Q 039137           85 RVVGINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFG-----------------  147 (912)
Q Consensus        85 ~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~-----------------  147 (912)
                      ....+++..+.+.+.++.  ++++++|++|+|++|++++.+|..|+++++|++|+|++|++++                 
T Consensus       201 ~L~~L~Ls~n~l~~~~~~--l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~L~~  278 (768)
T 3rgz_A          201 NLEFLDVSSNNFSTGIPF--LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAE  278 (768)
T ss_dssp             TCCEEECCSSCCCSCCCB--CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCCCCTTCCEEECCS
T ss_pred             cCCEEECcCCcCCCCCcc--cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCccccCCCCEEECcC
Confidence            344555555555554332  5566666666666666666566556555555555555555544                 


Q ss_pred             -----ccccccccc-cccceeecccccccCCCCccccCcccccEEEccCCcCCCCCCcc-CCCCccceeeeeccCCCcCc
Q 039137          148 -----QIPSGIGLL-THLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRS-LGNLTHVVILYLYNNSFFGS  220 (912)
Q Consensus       148 -----~~p~~~~~l-~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~-~~~l~~L~~L~L~~n~l~~~  220 (912)
                           .+|..++.+ ++|++|+|++|.+++.+|..|+++++|++|++++|+++|.+|.. +.++++|++|++++|.+++.
T Consensus       279 n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~  358 (768)
T 3rgz_A          279 NKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGE  358 (768)
T ss_dssp             SEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEEC
T ss_pred             CccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCcc
Confidence                 455555443 55666666666666566666666666666666666666555544 56666666666666666666


Q ss_pred             ccccccccc-ccceeecccccccCcccccccc--ccccceeeeccccCcccCCcccCCccccchhhhccCccCCCCcccc
Q 039137          221 IPQEIGNLK-SLFDLELCINQLSGAIPLSISN--LTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSF  297 (912)
Q Consensus       221 ~p~~~~~l~-~L~~L~l~~n~l~~~~p~~~~~--l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~  297 (912)
                      +|..+.+++ +|+.|++++|++++.+|..+..  +++|++|++++|++++.+|..+.++++|++|+|++|++++.+|..|
T Consensus       359 ~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l  438 (768)
T 3rgz_A          359 LPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSL  438 (768)
T ss_dssp             CCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGG
T ss_pred             ccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHH
Confidence            666666665 6666666666666666666655  6778888888888888899999999999999999999999999999


Q ss_pred             ccccccceEecccccccCCCCcccCCCCCccEEEccCCcCcccccccCCCCCCCCEEeccCCcccccccccccccccccE
Q 039137          298 RNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQY  377 (912)
Q Consensus       298 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~  377 (912)
                      ..+++|+.|++++|.+++.+|..+..+++|++|+|++|++++..|..++.+++|+.|++++|++++.+|..++.+++|++
T Consensus       439 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  518 (768)
T 3rgz_A          439 GSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAI  518 (768)
T ss_dssp             GGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCE
T ss_pred             hcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCE
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             EEccCccccCCCCccccccccccEEEccCCcccCCCcccc----------------------------------------
Q 039137          378 LDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPREL----------------------------------------  417 (912)
Q Consensus       378 L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~----------------------------------------  417 (912)
                      |+|++|++++.+|..+.++++|+.|++++|+++|.+|..+                                        
T Consensus       519 L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  598 (768)
T 3rgz_A          519 LKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQG  598 (768)
T ss_dssp             EECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTT
T ss_pred             EECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcccccccccccccccccccccccccccccc
Confidence            9999999999999999999999999999999998777544                                        


Q ss_pred             ------------------------------ccccccccccccCcccCccccccccccccccEEEecccccccccchhhhc
Q 039137          418 ------------------------------GSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDN  467 (912)
Q Consensus       418 ------------------------------~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  467 (912)
                                                    ..+++|++|||++|++++.+|..|+.++.|+.|+|++|+++|.+|..+++
T Consensus       599 ~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~  678 (768)
T 3rgz_A          599 IRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGD  678 (768)
T ss_dssp             CCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGG
T ss_pred             ccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhC
Confidence                                          33567899999999999999999999999999999999999999999999


Q ss_pred             ccccceeeccccccCcccccccccccccccccccCccccCCCcccccccccceEEEccCCcccc
Q 039137          468 LIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEG  531 (912)
Q Consensus       468 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~  531 (912)
                      +++|+.|||++|+++|.+|..++.+++|+.||+++|+|+|.+|.. ..+..+....+.+|+--|
T Consensus       679 L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~-~~~~~~~~~~~~gN~~Lc  741 (768)
T 3rgz_A          679 LRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM-GQFETFPPAKFLNNPGLC  741 (768)
T ss_dssp             CTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSS-SSGGGSCGGGGCSCTEEE
T ss_pred             CCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCc-hhhccCCHHHhcCCchhc
Confidence            999999999999999999999999999999999999999999964 233444455677887444

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=1.2e-53  Score=510.50  Aligned_cols=468  Identities=20%  Similarity=0.188  Sum_probs=381.5

Q ss_pred             CCeEEEeeccccccccccccccCCCCCccEEEccCCcccccCCccccCCCCCcEEeccccccccccccccccccccceee
Q 039137           84 ERVVGINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLH  163 (912)
Q Consensus        84 ~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~  163 (912)
                      ..++.++++.+.+.+ +.+.+|+++++|++|+|++|++++..|..|+++++|++|+|++|++++..|..|+++++|++|+
T Consensus        33 ~~l~~L~Ls~n~i~~-~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~  111 (606)
T 3t6q_A           33 NSTECLEFSFNVLPT-IQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLF  111 (606)
T ss_dssp             TTCCEEECTTCCCSE-ECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEE
T ss_pred             CcCcEEEccCCccCc-CChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEee
Confidence            357888999888875 4466899999999999999999999999999999999999999999988899999999999999


Q ss_pred             cccccccCCCCccccCcccccEEEccCCcCCCCCCccCCCCccceeeeeccCCCcCccccccccccccc--eeecccccc
Q 039137          164 ISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLF--DLELCINQL  241 (912)
Q Consensus       164 L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~--~L~l~~n~l  241 (912)
                      |++|.+++..|..++++++|++|++++|++.+..++.+..+++|++|++++|.+++..|..++.+++|+  .|++++|++
T Consensus       112 L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l  191 (606)
T 3t6q_A          112 FIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI  191 (606)
T ss_dssp             CTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCC
T ss_pred             ccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCcc
Confidence            999999977688999999999999999999975545566699999999999999988888999999999  889999998


Q ss_pred             cCccccccccc---------------------------------------------------cccceeeeccccCcccCC
Q 039137          242 SGAIPLSISNL---------------------------------------------------TNLRFLFLYHNELSGIIP  270 (912)
Q Consensus       242 ~~~~p~~~~~l---------------------------------------------------~~L~~L~L~~N~l~~~~~  270 (912)
                      ++..|..+...                                                   .+|+.|++++|++++..+
T Consensus       192 ~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~  271 (606)
T 3t6q_A          192 AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISS  271 (606)
T ss_dssp             CEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCT
T ss_pred             CccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCH
Confidence            87666554321                                                   167778888888887777


Q ss_pred             cccCCccccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCcccccc-cCCCCC
Q 039137          271 QEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILS-DWGRCP  349 (912)
Q Consensus       271 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~  349 (912)
                      ..|.++++|++|++++|+++ .+|..+..+++|++|++++|.+++..+..+..+++|++|++++|.+.+..+. .+..++
T Consensus       272 ~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~  350 (606)
T 3t6q_A          272 NTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLE  350 (606)
T ss_dssp             TTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCT
T ss_pred             HHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccC
Confidence            77888888888888888887 6777788888888888888888877778888888888888888888765544 477888


Q ss_pred             CCCEEeccCCcccccc--cccccccccccEEEccCccccCCCCccccccccccEEEccCCcccCCCcc-ccccccccccc
Q 039137          350 QLSLLDVSINNISGSI--PLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPR-ELGSLINLEYL  426 (912)
Q Consensus       350 ~L~~L~Ls~N~l~~~~--~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L  426 (912)
                      +|+.|++++|++.+..  +..++.+++|++|++++|++.+..|..+..+++|+.|++++|++++..|. .+..+++|++|
T Consensus       351 ~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L  430 (606)
T 3t6q_A          351 NLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVL  430 (606)
T ss_dssp             TCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEE
T ss_pred             cCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEE
Confidence            8888888888887665  66778888888888888888877777888888888888888888766554 37788888888


Q ss_pred             cccCcccCccccccccccccccEEEecccccccc---cchhhhcccccceeeccccccCcccccccccccccccccccCc
Q 039137          427 DLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQ---IPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYN  503 (912)
Q Consensus       427 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~---~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N  503 (912)
                      ++++|.+++..|..+..+++|++|+|++|++++.   .+..+..+++|++|++++|++++..|..|..+++|+.|+|++|
T Consensus       431 ~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N  510 (606)
T 3t6q_A          431 NLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHN  510 (606)
T ss_dssp             ECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             ECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCC
Confidence            8888888887788888888888888888888762   2356778888888888888888877888888888888888888


Q ss_pred             cccCCCcccccccccceEEEccCCccccCCCCC-ccCCCCchhhhccCCccc
Q 039137          504 NLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNS-TTFRDAPLEALQGNKGLY  554 (912)
Q Consensus       504 ~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~~~~-~~~~~~~~~~l~~n~~~~  554 (912)
                      ++++..|..|..++.| .|++++|++++.+|.. ..+.......+.+|+-.|
T Consensus       511 ~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c  561 (606)
T 3t6q_A          511 RLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDC  561 (606)
T ss_dssp             CCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEEC
T ss_pred             ccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccc
Confidence            8888888888888888 8888888888766543 122333334455665544

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=1.3e-52  Score=508.53  Aligned_cols=471  Identities=25%  Similarity=0.253  Sum_probs=326.4

Q ss_pred             CCeEEEeeccccccccccccccCCCCCccEEEccCCcccccCCccccCCCCCcEEeccccccccccccccccccccceee
Q 039137           84 ERVVGINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLH  163 (912)
Q Consensus        84 ~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~  163 (912)
                      .+++.+++.++.+.+ +.+..|.++++|++|+|++|.+++..|..|+++++|++|+|++|++++..+..|+++++|++|+
T Consensus        25 ~~l~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~  103 (680)
T 1ziw_A           25 TNITVLNLTHNQLRR-LPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELH  103 (680)
T ss_dssp             TTCSEEECCSSCCCC-CCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEE
T ss_pred             CCCcEEECCCCCCCC-cCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEE
Confidence            468888998888775 4455688999999999999999988899999999999999999999855555799999999999


Q ss_pred             cccccccCCCCccccCcccccEEEccCCcCCCCCCccCCCCccceeeeeccCCCcCccccccc--cccccceeecccccc
Q 039137          164 ISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIG--NLKSLFDLELCINQL  241 (912)
Q Consensus       164 L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~--~l~~L~~L~l~~n~l  241 (912)
                      |++|.+++..|..|+++++|++|++++|.+++..|..++++++|++|++++|.+++..+..++  .+++|+.|++++|++
T Consensus       104 L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l  183 (680)
T 1ziw_A          104 LMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQI  183 (680)
T ss_dssp             CCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCC
T ss_pred             CCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcc
Confidence            999999877778899999999999999999988888899999999999999988876666544  346777777777766


Q ss_pred             cCcccccc---------------------------------------------------ccccc--cceeeeccccCccc
Q 039137          242 SGAIPLSI---------------------------------------------------SNLTN--LRFLFLYHNELSGI  268 (912)
Q Consensus       242 ~~~~p~~~---------------------------------------------------~~l~~--L~~L~L~~N~l~~~  268 (912)
                      ++..|..+                                                   ..++.  |++|+|++|++++.
T Consensus       184 ~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~  263 (680)
T 1ziw_A          184 KEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVV  263 (680)
T ss_dssp             CCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEE
T ss_pred             cccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCcc
Confidence            65554433                                                   33322  66666666666666


Q ss_pred             CCcccCCccccchhhhccCccCCCCcccccc---------------------------------ccccceEecccccccC
Q 039137          269 IPQEIGNLKKLNSLLLAKNHFRGTVPKSFRN---------------------------------LTDLVKLRLNQNYLTG  315 (912)
Q Consensus       269 ~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~---------------------------------l~~L~~L~L~~n~l~~  315 (912)
                      .|..|+.+++|++|++++|++++..|..|..                                 +++|++|++++|.+++
T Consensus       264 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~  343 (680)
T 1ziw_A          264 GNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPG  343 (680)
T ss_dssp             CTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCC
T ss_pred             CcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCC
Confidence            6666666666666666666666554443333                                 3444444444444444


Q ss_pred             CCCcccCCCCCccEEEccCC----------------------------cCcccccccCCCCCCCCEEeccCCccccccc-
Q 039137          316 NISETFGTYPNLTFIDLSNN----------------------------SFFGEILSDWGRCPQLSLLDVSINNISGSIP-  366 (912)
Q Consensus       316 ~~~~~~~~l~~L~~L~Ls~N----------------------------~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-  366 (912)
                      ..+..|..+++|++|++++|                            ++++..+..+..+++|+.|++++|++.+.+| 
T Consensus       344 ~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  423 (680)
T 1ziw_A          344 IKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTG  423 (680)
T ss_dssp             CCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCS
T ss_pred             CChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCc
Confidence            44444444444444444333                            2223333344444444444444444444333 


Q ss_pred             ccccccccccEEEccCccccCCCCccccccccccEEEccCCccc--CCCccccccccccccccccCcccCcccccccccc
Q 039137          367 LEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLS--GCIPRELGSLINLEYLDLSANNLSNFVPESLGSL  444 (912)
Q Consensus       367 ~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  444 (912)
                      ..+.++++|++|++++|++.+..+..+..+++|+.|++++|.++  +..|..+..+++|++|+|++|+++++.+..|..+
T Consensus       424 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l  503 (680)
T 1ziw_A          424 QEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGL  503 (680)
T ss_dssp             GGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred             ccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccc
Confidence            34444444555555555544444444555555555555555554  4567777788888888888888888777778888


Q ss_pred             ccccEEEecccccccccc--------hhhhcccccceeeccccccCcccccccccccccccccccCccccCCCccccccc
Q 039137          445 VKLYYLNLSHNKLSQQIP--------IELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEM  516 (912)
Q Consensus       445 ~~L~~L~Ls~N~l~~~~~--------~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l  516 (912)
                      ++|++|+|++|++++..+        ..|.++++|++|+|++|+|+...+..|.++++|+.|+|++|+|+++.+..|..+
T Consensus       504 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l  583 (680)
T 1ziw_A          504 EKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQ  583 (680)
T ss_dssp             TTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred             cccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCC
Confidence            888888888888875422        236778888888888888876666678888888888888888888877788888


Q ss_pred             ccceEEEccCCccccCCCCCc--cCCCCchhhhccCCcccC
Q 039137          517 HGLLHIDISYNKLEGQIPNST--TFRDAPLEALQGNKGLYG  555 (912)
Q Consensus       517 ~~L~~l~ls~N~l~~~~~~~~--~~~~~~~~~l~~n~~~~~  555 (912)
                      ++|+.|++++|++++.+|...  .+.......+.+|+-.|.
T Consensus       584 ~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~  624 (680)
T 1ziw_A          584 VSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCT  624 (680)
T ss_dssp             TTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBC
T ss_pred             CCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccC
Confidence            888888888888887665432  344455555677777664

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=8.6e-53  Score=520.13  Aligned_cols=470  Identities=24%  Similarity=0.246  Sum_probs=355.3

Q ss_pred             CccceeEecCCCCeEEEeeccccccccccccccCCCCCccEEEccCCcccccC-CccccCCCCCcEEecccccccccccc
Q 039137           73 CAWSGIFCNHAERVVGINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGII-PPQISNLSNLEYLDFSANKLFGQIPS  151 (912)
Q Consensus        73 C~w~gv~c~~~~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~Ls~n~l~~~~p~  151 (912)
                      |.|..|.+ -..++..++++.+.+.+ +.+.+|.++++|++|+|++|.+.+.+ |..|+++++|++|+|++|++.+..|+
T Consensus        14 ~~L~~vP~-lp~~l~~LdLs~N~i~~-i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~   91 (844)
T 3j0a_A           14 CNLTQVPQ-VLNTTERLLLSFNYIRT-VTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPD   91 (844)
T ss_dssp             CCSSCCCS-SCTTCCEEEEESCCCCE-ECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTT
T ss_pred             CCCCCCCC-CCCCcCEEECCCCcCCc-cChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHh
Confidence            67888877 56788999999888764 44567999999999999999776666 77899999999999999999988899


Q ss_pred             ccccccccceeecccccccCCCCcc--ccCcccccEEEccCCcCCCCCC-ccCCCCccceeeeeccCCCcCccccccccc
Q 039137          152 GIGLLTHLTVLHISRNWLSGSIPHE--VGQLTVLNQLALDSNFLNGSIP-RSLGNLTHVVILYLYNNSFFGSIPQEIGNL  228 (912)
Q Consensus       152 ~~~~l~~L~~L~L~~n~l~~~~p~~--~~~l~~L~~L~l~~n~l~~~~p-~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l  228 (912)
                      .|+++++|++|+|++|.+++.+|..  ++++++|++|+|++|.+++..| ..|+++++|++|+|++|.+++..|..+..+
T Consensus        92 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l  171 (844)
T 3j0a_A           92 AFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPL  171 (844)
T ss_dssp             SSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHH
T ss_pred             HccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccc
Confidence            9999999999999999999877776  9999999999999999987765 579999999999999999999999999888


Q ss_pred             --cccceeecccccccCccccccccccc------cceeeeccccCcccCCcccCC-------------------------
Q 039137          229 --KSLFDLELCINQLSGAIPLSISNLTN------LRFLFLYHNELSGIIPQEIGN-------------------------  275 (912)
Q Consensus       229 --~~L~~L~l~~n~l~~~~p~~~~~l~~------L~~L~L~~N~l~~~~~~~l~~-------------------------  275 (912)
                        ++|+.|+++.|.+.+..|..++.+++      |+.|++++|.+++..+..+..                         
T Consensus       172 ~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~  251 (844)
T 3j0a_A          172 QGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHN  251 (844)
T ss_dssp             HHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSS
T ss_pred             cCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccc
Confidence              88999999999998888877777665      888888888777655544332                         


Q ss_pred             -------------ccccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCccccc
Q 039137          276 -------------LKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEIL  342 (912)
Q Consensus       276 -------------l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  342 (912)
                                   .++|+.|+|++|.+.+..|..|..+++|+.|+|++|.+++..+..|..+++|++|+|++|.+.+..+
T Consensus       252 l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  331 (844)
T 3j0a_A          252 IKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYS  331 (844)
T ss_dssp             STTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCS
T ss_pred             cCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCH
Confidence                         1568888888888888778888888888888888888888888888888888888888888888778


Q ss_pred             ccCCCCCCCCEEeccCCcccccccccccccccccEEEccCccccCCCCccccccccccEEEccCCcccCCCcc-------
Q 039137          343 SDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPR-------  415 (912)
Q Consensus       343 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~-------  415 (912)
                      ..+..+++|+.|++++|++.+..+..+..+++|++|+|++|.+++. +.    +++|+.|++++|+++ .+|.       
T Consensus       332 ~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i-~~----~~~L~~L~l~~N~l~-~l~~~~~~l~~  405 (844)
T 3j0a_A          332 SNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI-HF----IPSIPDIFLSGNKLV-TLPKINLTANL  405 (844)
T ss_dssp             CSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC-SS----CCSCSEEEEESCCCC-CCCCCCTTCCE
T ss_pred             HHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcc-cC----CCCcchhccCCCCcc-cccccccccce
Confidence            8888888888888888888877777788888888888888887742 11    334444444444443 1111       


Q ss_pred             ---------------ccccccccccccccCcccCccccc-cccccccccEEEecccccc-----cccchhhhccccccee
Q 039137          416 ---------------ELGSLINLEYLDLSANNLSNFVPE-SLGSLVKLYYLNLSHNKLS-----QQIPIELDNLIHLSEL  474 (912)
Q Consensus       416 ---------------~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~-----~~~~~~~~~l~~L~~L  474 (912)
                                     .+..+++|++|+|++|++++..+. .+..+++|+.|+|++|.++     +..+..|.++++|++|
T Consensus       406 L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L  485 (844)
T 3j0a_A          406 IHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVL  485 (844)
T ss_dssp             EECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECC
T ss_pred             eecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEE
Confidence                           133566666666666666654332 3444566666666666665     2334456666667777


Q ss_pred             eccccccCcccccccccccccccccccCccccCCCcccccccccceEEEccCCccccCCCCCccCCCCchhhhccCCccc
Q 039137          475 DLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNSTTFRDAPLEALQGNKGLY  554 (912)
Q Consensus       475 ~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~~~~~~~~~~~~~~l~~n~~~~  554 (912)
                      +|++|+|++.+|..|..+++|+.|+|++|+|+++.|..+.  ++|+.|++++|++++.+|..  |.......+.+|+-.|
T Consensus       486 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~--~~~L~~l~l~~Np~~C  561 (844)
T 3j0a_A          486 YLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDV--FVSLSVLDITHNKFIC  561 (844)
T ss_dssp             CCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCC--CSSCCEEEEEEECCCC
T ss_pred             ECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhH--hCCcCEEEecCCCccc
Confidence            7777777666666666677777777777777666665554  56666666666666666543  3333333445555544

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=7.8e-53  Score=503.56  Aligned_cols=426  Identities=23%  Similarity=0.203  Sum_probs=392.7

Q ss_pred             CCccEEEccCCcccccCCccccCCCCCcEEeccccccccccccccccccccceeecccccccCCCCccccCcccccEEEc
Q 039137          109 PHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLAL  188 (912)
Q Consensus       109 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l  188 (912)
                      +++++|+|++|++++..|..|+++++|++|+|++|++.+..|..|+++++|++|+|++|.+++..|..|+.+++|++|++
T Consensus        33 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L  112 (606)
T 3t6q_A           33 NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFF  112 (606)
T ss_dssp             TTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEEC
T ss_pred             CcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeec
Confidence            36899999999999988999999999999999999999888999999999999999999999888999999999999999


Q ss_pred             cCCcCCCCCCccCCCCccceeeeeccCCCcCccccccccccccceeecccccccCccccccccccccc--eeeeccccCc
Q 039137          189 DSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLR--FLFLYHNELS  266 (912)
Q Consensus       189 ~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~--~L~L~~N~l~  266 (912)
                      ++|++++..|..++++++|++|++++|.+++..+..+..+++|+.|++++|++++..|..++.+++|+  .|++++|+++
T Consensus       113 ~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~  192 (606)
T 3t6q_A          113 IQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA  192 (606)
T ss_dssp             TTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCC
T ss_pred             cccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccC
Confidence            99999987788999999999999999999975544555599999999999999988899999999999  8999999999


Q ss_pred             ccCCcccCCc---------------------------------------------------cccchhhhccCccCCCCcc
Q 039137          267 GIIPQEIGNL---------------------------------------------------KKLNSLLLAKNHFRGTVPK  295 (912)
Q Consensus       267 ~~~~~~l~~l---------------------------------------------------~~L~~L~L~~N~l~~~~~~  295 (912)
                      +..|..+...                                                   .+|+.|++++|.+++..+.
T Consensus       193 ~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~  272 (606)
T 3t6q_A          193 GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSN  272 (606)
T ss_dssp             EECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTT
T ss_pred             ccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHH
Confidence            8877665431                                                   1688899999999988888


Q ss_pred             ccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCcccccccCCCCCCCCEEeccCCccccccccc-cccccc
Q 039137          296 SFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLE-IGESLQ  374 (912)
Q Consensus       296 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~-~~~~~~  374 (912)
                      .|..+++|++|++++|.++ .+|..+..+++|++|++++|++.+..+..+..+++|+.|++++|.+.+.+|.. +..+++
T Consensus       273 ~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~  351 (606)
T 3t6q_A          273 TFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLEN  351 (606)
T ss_dssp             TTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTT
T ss_pred             HhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCc
Confidence            8999999999999999999 56778999999999999999999988999999999999999999999777654 889999


Q ss_pred             ccEEEccCccccCCC--CccccccccccEEEccCCcccCCCccccccccccccccccCcccCccccc-cccccccccEEE
Q 039137          375 LQYLDLSSNYIVGEI--PTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPE-SLGSLVKLYYLN  451 (912)
Q Consensus       375 L~~L~L~~N~l~~~~--~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~  451 (912)
                      |++|++++|++++..  +..+.++++|++|++++|++++..|..+..+++|++|++++|++++..+. .+..+++|++|+
T Consensus       352 L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~  431 (606)
T 3t6q_A          352 LRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLN  431 (606)
T ss_dssp             CCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEE
T ss_pred             CCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEE
Confidence            999999999999765  77899999999999999999988999999999999999999999987654 489999999999


Q ss_pred             ecccccccccchhhhcccccceeeccccccCcc---cccccccccccccccccCccccCCCcccccccccceEEEccCCc
Q 039137          452 LSHNKLSQQIPIELDNLIHLSELDLSHNFLGEK---ISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNK  528 (912)
Q Consensus       452 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~---~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~ls~N~  528 (912)
                      +++|++++..|..+..+++|++|++++|++++.   .+..+..+++|+.|++++|++++..|..|..+++|+.|++++|+
T Consensus       432 l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~  511 (606)
T 3t6q_A          432 LSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNR  511 (606)
T ss_dssp             CTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred             CCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCc
Confidence            999999999999999999999999999999873   33678999999999999999999999999999999999999999


Q ss_pred             cccCCCC
Q 039137          529 LEGQIPN  535 (912)
Q Consensus       529 l~~~~~~  535 (912)
                      +++.+|.
T Consensus       512 l~~~~~~  518 (606)
T 3t6q_A          512 LTSSSIE  518 (606)
T ss_dssp             CCGGGGG
T ss_pred             cCcCChh
Confidence            9987764

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=3e-52  Score=498.51  Aligned_cols=461  Identities=24%  Similarity=0.223  Sum_probs=381.8

Q ss_pred             CCeEEEeeccccccccccccccCCCCCccEEEccCCcccccCCccccCCCCCcEEeccccccccccccccccccccceee
Q 039137           84 ERVVGINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLH  163 (912)
Q Consensus        84 ~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~  163 (912)
                      .+++.++++++.+.+ +.+.+|+++++|++|+|++|++++..|..|+++++|++|+|++|++++..|..|+++++|++|+
T Consensus        32 ~~l~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~  110 (606)
T 3vq2_A           32 SSTKNIDLSFNPLKI-LKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLV  110 (606)
T ss_dssp             TTCCEEECTTSCCCE-ECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEE
T ss_pred             CCcCEEECCCCCcCE-eChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEE
Confidence            467888888887764 3455789999999999999999988888999999999999999999988899999999999999


Q ss_pred             cccccccCCCCccccCcccccEEEccCCcCCC-CCCccCCCCccceeeeeccCCCcCccccccccccccc----eeeccc
Q 039137          164 ISRNWLSGSIPHEVGQLTVLNQLALDSNFLNG-SIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLF----DLELCI  238 (912)
Q Consensus       164 L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~-~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~----~L~l~~  238 (912)
                      |++|.+++..|..++++++|++|++++|++.+ .+|..++++++|++|++++|.+++..|..++.+++|+    .|++++
T Consensus       111 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~  190 (606)
T 3vq2_A          111 AVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSL  190 (606)
T ss_dssp             CTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTT
T ss_pred             ccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccC
Confidence            99999997777889999999999999999986 6799999999999999999999988888888888776    789999


Q ss_pred             ccccCccccccccccccceeeeccccCc----------------------------------------------------
Q 039137          239 NQLSGAIPLSISNLTNLRFLFLYHNELS----------------------------------------------------  266 (912)
Q Consensus       239 n~l~~~~p~~~~~l~~L~~L~L~~N~l~----------------------------------------------------  266 (912)
                      |++++..+..+... +|+.|++++|.++                                                    
T Consensus       191 n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~  269 (606)
T 3vq2_A          191 NPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLT  269 (606)
T ss_dssp             CCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEEC
T ss_pred             CCcceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheecc
Confidence            99886555555444 7888888877653                                                    


Q ss_pred             ------ccCCcccCCccccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCccc
Q 039137          267 ------GIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGE  340 (912)
Q Consensus       267 ------~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  340 (912)
                            +.+|. +..+++|+.|++++|.+. .+| .+..+++|++|++++|.+ +.+| .+ .+++|+.|++++|+..+.
T Consensus       270 ~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~-~l~-~l~~~~~L~~L~l~~n~l-~~lp-~~-~l~~L~~L~l~~n~~~~~  343 (606)
T 3vq2_A          270 YTNDFSDDIVK-FHCLANVSAMSLAGVSIK-YLE-DVPKHFKWQSLSIIRCQL-KQFP-TL-DLPFLKSLTLTMNKGSIS  343 (606)
T ss_dssp             CCTTCCGGGGS-CGGGTTCSEEEEESCCCC-CCC-CCCTTCCCSEEEEESCCC-SSCC-CC-CCSSCCEEEEESCSSCEE
T ss_pred             ccccccccccc-cccCCCCCEEEecCccch-hhh-hccccccCCEEEcccccC-cccc-cC-CCCccceeeccCCcCccc
Confidence                  22333 566778888888888886 445 788888888999999888 4556 44 888888899888866543


Q ss_pred             ccccCCCCCCCCEEeccCCccccc--ccccccccccccEEEccCccccCCCCccccccccccEEEccCCcccCCCc-ccc
Q 039137          341 ILSDWGRCPQLSLLDVSINNISGS--IPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIP-REL  417 (912)
Q Consensus       341 ~~~~~~~l~~L~~L~Ls~N~l~~~--~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~~  417 (912)
                      .  .+..+++|+.|++++|++++.  .|..+..+++|++|++++|.+++ +|..+..+++|+.|++++|++++..| ..+
T Consensus       344 ~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~  420 (606)
T 3vq2_A          344 F--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAF  420 (606)
T ss_dssp             C--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTT
T ss_pred             h--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhh
Confidence            3  677889999999999999866  37788888999999999999884 66888889999999999999988777 678


Q ss_pred             ccccccccccccCcccCccccccccccccccEEEeccccccc-ccchhhhcccccceeeccccccCcccccccccccccc
Q 039137          418 GSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQ-QIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLE  496 (912)
Q Consensus       418 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  496 (912)
                      ..+++|++|++++|.+.+..|..+..+++|++|+|++|++++ .+|..+..+++|++|+|++|++++..|..|..+++|+
T Consensus       421 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~  500 (606)
T 3vq2_A          421 LSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQ  500 (606)
T ss_dssp             TTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred             hccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCC
Confidence            889999999999999998888889999999999999999987 4788899999999999999999988888899999999


Q ss_pred             cccccCccccCCCcccccccccceEEEccCCccccCCCCCccCC-CCchhhhccCCcccC
Q 039137          497 KLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNSTTFR-DAPLEALQGNKGLYG  555 (912)
Q Consensus       497 ~L~ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~~~~~~~~-~~~~~~l~~n~~~~~  555 (912)
                      .|++++|++++..|..|..+++|++|++++|+++..++....+. ......+.+|+-.|.
T Consensus       501 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~  560 (606)
T 3vq2_A          501 LLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACI  560 (606)
T ss_dssp             EEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCCCCS
T ss_pred             EEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCcccC
Confidence            99999999999889999999999999999999985333322222 133345667766553

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=2.6e-50  Score=488.44  Aligned_cols=432  Identities=25%  Similarity=0.265  Sum_probs=309.6

Q ss_pred             ccCCCCCccEEEccCCcccccCCccccCCCCCcEEeccccccccccccccccccccceeecccccccCCCCcccc--Ccc
Q 039137          104 SFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVG--QLT  181 (912)
Q Consensus       104 ~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~--~l~  181 (912)
                      +|+++++|++|+|++|++++..|..|+++++|++|+|++|.+++..|..++.+++|++|++++|.+++..|..++  .++
T Consensus        92 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~  171 (680)
T 1ziw_A           92 TFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANS  171 (680)
T ss_dssp             TTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTC
T ss_pred             hhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccc
Confidence            344455555555555555444444455555555555555554444444444444455555544444433333322  224


Q ss_pred             cccEEEccCCcCCCCCCccCCCC---------------------------ccceeeeeccCCCcCccccccccccc--cc
Q 039137          182 VLNQLALDSNFLNGSIPRSLGNL---------------------------THVVILYLYNNSFFGSIPQEIGNLKS--LF  232 (912)
Q Consensus       182 ~L~~L~l~~n~l~~~~p~~~~~l---------------------------~~L~~L~L~~n~l~~~~p~~~~~l~~--L~  232 (912)
                      +|++|++++|++++..|..+..+                           ++|++|++++|.+++..|..+.+++.  |+
T Consensus       172 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~  251 (680)
T 1ziw_A          172 SLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLT  251 (680)
T ss_dssp             EESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCC
T ss_pred             cccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCC
Confidence            44444444444444333332222                           12233333333333333334444433  66


Q ss_pred             eeecccccccCccccccccccccceeeeccccCcccCCc---------------------------------ccCCcccc
Q 039137          233 DLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQ---------------------------------EIGNLKKL  279 (912)
Q Consensus       233 ~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~---------------------------------~l~~l~~L  279 (912)
                      .|++++|++++..|..|+.+++|++|++++|++++..|.                                 .|..+++|
T Consensus       252 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L  331 (680)
T 1ziw_A          252 MLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCL  331 (680)
T ss_dssp             EEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTC
T ss_pred             EEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCC
Confidence            666666666555555556666666666666655544433                                 34456667


Q ss_pred             chhhhccCccCCCCccccccccccceEecc----------------------------cccccCCCCcccCCCCCccEEE
Q 039137          280 NSLLLAKNHFRGTVPKSFRNLTDLVKLRLN----------------------------QNYLTGNISETFGTYPNLTFID  331 (912)
Q Consensus       280 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~----------------------------~n~l~~~~~~~~~~l~~L~~L~  331 (912)
                      ++|++++|++++..+..|.++++|++|+++                            +|++++..+..|..+++|+.|+
T Consensus       332 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  411 (680)
T 1ziw_A          332 EHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLD  411 (680)
T ss_dssp             CEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred             CEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEe
Confidence            777777777777777777776666666554                            4556666778899999999999


Q ss_pred             ccCCcCccccc-ccCCCCCCCCEEeccCCcccccccccccccccccEEEccCcccc--CCCCccccccccccEEEccCCc
Q 039137          332 LSNNSFFGEIL-SDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIV--GEIPTQLGNIIYLNRLSLSGNK  408 (912)
Q Consensus       332 Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~--~~~~~~l~~l~~L~~L~L~~N~  408 (912)
                      |++|.+.+.++ ..+..+++|+.|++++|++.+..+..+..+++|++|++++|.+.  +.+|..+.++++|+.|++++|+
T Consensus       412 L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~  491 (680)
T 1ziw_A          412 LGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNN  491 (680)
T ss_dssp             CCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSC
T ss_pred             CCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCC
Confidence            99999987665 68899999999999999999989999999999999999999997  5788999999999999999999


Q ss_pred             ccCCCccccccccccccccccCcccCcccc--------ccccccccccEEEecccccccccchhhhcccccceeeccccc
Q 039137          409 LSGCIPRELGSLINLEYLDLSANNLSNFVP--------ESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNF  480 (912)
Q Consensus       409 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~--------~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  480 (912)
                      +++..+..|..+++|++|+|++|+++++.+        ..|..+++|++|+|++|+++...+..|.++++|++|+|++|+
T Consensus       492 l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~  571 (680)
T 1ziw_A          492 IANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNN  571 (680)
T ss_dssp             CCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCC
Confidence            998888889999999999999999987533        247889999999999999996666679999999999999999


Q ss_pred             cCcccccccccccccccccccCccccCCCccccc-ccccceEEEccCCccccCCCC
Q 039137          481 LGEKISSRICRMESLEKLNLSYNNLSGLIPRCFE-EMHGLLHIDISYNKLEGQIPN  535 (912)
Q Consensus       481 l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~-~l~~L~~l~ls~N~l~~~~~~  535 (912)
                      |++..+..|..+++|+.|+|++|+|++..|..|. .+++|+.+++++|+|.|..+.
T Consensus       572 l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~  627 (680)
T 1ziw_A          572 LNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES  627 (680)
T ss_dssp             CCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred             CCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence            9998888899999999999999999999998888 899999999999999997653

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.4e-50  Score=477.25  Aligned_cols=443  Identities=23%  Similarity=0.239  Sum_probs=384.8

Q ss_pred             CCeEEEeeccccccccccccccCCCCCccEEEccCCcccccCCccccCCCCCcEEeccccccccccccccccccccceee
Q 039137           84 ERVVGINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLH  163 (912)
Q Consensus        84 ~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~  163 (912)
                      .++..++++++.+.+ +.+.+|.++++|++|+|++|++++..|..|+++++|++|+|++|++++..|..|+++++|++|+
T Consensus        28 ~~l~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  106 (570)
T 2z63_A           28 FSTKNLDLSFNPLRH-LGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV  106 (570)
T ss_dssp             SSCCEEECCSCCCCE-ECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEE
T ss_pred             ccccEEEccCCccCc-cChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccc
Confidence            357788888877764 3455788999999999999999988888899999999999999999877778899999999999


Q ss_pred             cccccccCCCCccccCcccccEEEccCCcCCC-CCCccCCCCccceeeeeccCCCcCcccccccccccc----ceeeccc
Q 039137          164 ISRNWLSGSIPHEVGQLTVLNQLALDSNFLNG-SIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSL----FDLELCI  238 (912)
Q Consensus       164 L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~-~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L----~~L~l~~  238 (912)
                      +++|.+++..+..++++++|++|++++|.+++ .+|..|+++++|++|++++|.+++..|..++.+++|    +.|++++
T Consensus       107 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~  186 (570)
T 2z63_A          107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL  186 (570)
T ss_dssp             CTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTT
T ss_pred             ccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCC
Confidence            99999986555579999999999999999986 578999999999999999999998888889988888    8899999


Q ss_pred             ccccCccccccccccccceeeeccc-------------------------------------------------------
Q 039137          239 NQLSGAIPLSISNLTNLRFLFLYHN-------------------------------------------------------  263 (912)
Q Consensus       239 n~l~~~~p~~~~~l~~L~~L~L~~N-------------------------------------------------------  263 (912)
                      |.+++..|..+..+ +|+.|++++|                                                       
T Consensus       187 n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~  265 (570)
T 2z63_A          187 NPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA  265 (570)
T ss_dssp             CCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEE
T ss_pred             CCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhh
Confidence            99988777777665 7888888776                                                       


Q ss_pred             ---cCcccCCcccCCccccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCccc
Q 039137          264 ---ELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGE  340 (912)
Q Consensus       264 ---~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  340 (912)
                         .+.+..|..+..+++|++|++++|.++ .+|..+..+ +|++|++++|.++.. |.  ..+++|+.|++++|.+.+.
T Consensus       266 ~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~~l-~~--~~l~~L~~L~l~~n~~~~~  340 (570)
T 2z63_A          266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFGQF-PT--LKLKSLKRLTFTSNKGGNA  340 (570)
T ss_dssp             ETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCSSC-CB--CBCSSCCEEEEESCBSCCB
T ss_pred             cchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCccccc-Cc--ccccccCEEeCcCCccccc
Confidence               334456677778888889999988888 577778777 899999999988843 33  4678899999999988766


Q ss_pred             ccccCCCCCCCCEEeccCCcccccc--cccccccccccEEEccCccccCCCCccccccccccEEEccCCcccCCCc-ccc
Q 039137          341 ILSDWGRCPQLSLLDVSINNISGSI--PLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIP-REL  417 (912)
Q Consensus       341 ~~~~~~~l~~L~~L~Ls~N~l~~~~--~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~~  417 (912)
                      .+.  ..+++|+.|++++|++++..  +..+..+++|++|++++|.+.+..+ .+..+++|++|++++|++++..| ..+
T Consensus       341 ~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~  417 (570)
T 2z63_A          341 FSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSS-NFLGLEQLEHLDFQHSNLKQMSEFSVF  417 (570)
T ss_dssp             CCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEE-EEETCTTCCEEECTTSEEESCTTSCTT
T ss_pred             ccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCccccccc-cccccCCCCEEEccCCccccccchhhh
Confidence            554  78899999999999998654  6788899999999999999996544 49999999999999999997766 578


Q ss_pred             ccccccccccccCcccCccccccccccccccEEEecccccc-cccchhhhcccccceeeccccccCcccccccccccccc
Q 039137          418 GSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLS-QQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLE  496 (912)
Q Consensus       418 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  496 (912)
                      ..+++|++|++++|.+.+..|..|..+++|++|+|++|+++ +.+|..+..+++|++|+|++|++++..|..|..+++|+
T Consensus       418 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~  497 (570)
T 2z63_A          418 LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ  497 (570)
T ss_dssp             TTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred             hcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCC
Confidence            89999999999999999999999999999999999999997 57899999999999999999999999899999999999


Q ss_pred             cccccCccccCCCcccccccccceEEEccCCccccCCCCC
Q 039137          497 KLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNS  536 (912)
Q Consensus       497 ~L~ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~~~~  536 (912)
                      .|++++|++++.+|..|..+++|+.|++++|+++|.+|..
T Consensus       498 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~  537 (570)
T 2z63_A          498 VLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI  537 (570)
T ss_dssp             EEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred             EEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcch
Confidence            9999999999998899999999999999999999988754

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=2e-50  Score=498.98  Aligned_cols=441  Identities=25%  Similarity=0.243  Sum_probs=378.1

Q ss_pred             CCeEEEeeccccccccccccccCCCCCccEEEccCCcccccCCccccCCCCCcEEeccccccccccccc--cccccccce
Q 039137           84 ERVVGINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSG--IGLLTHLTV  161 (912)
Q Consensus        84 ~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~--~~~l~~L~~  161 (912)
                      .....++++.+...+.+.+.+|.++++|++|+|++|++++..|..|+++++|++|+|++|++++.+|..  |+.+++|++
T Consensus        48 ~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~  127 (844)
T 3j0a_A           48 EQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTR  127 (844)
T ss_dssp             CSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCE
T ss_pred             ccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCE
Confidence            456778888887788888889999999999999999999999999999999999999999999877765  999999999


Q ss_pred             eecccccccCCCC-ccccCcccccEEEccCCcCCCCCCccCCCC--ccceeeeeccCCCcCccccccccccc------cc
Q 039137          162 LHISRNWLSGSIP-HEVGQLTVLNQLALDSNFLNGSIPRSLGNL--THVVILYLYNNSFFGSIPQEIGNLKS------LF  232 (912)
Q Consensus       162 L~L~~n~l~~~~p-~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l--~~L~~L~L~~n~l~~~~p~~~~~l~~------L~  232 (912)
                      |+|++|.+++..| ..|+++++|++|+|++|.+++..|..+..+  ++|+.|++++|.+.+..|..++.+.+      |+
T Consensus       128 L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~  207 (844)
T 3j0a_A          128 LDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLE  207 (844)
T ss_dssp             EEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBS
T ss_pred             EECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCccccccccchhhcCCccccCcee
Confidence            9999999997755 579999999999999999999999999888  88999999999999888887777765      89


Q ss_pred             eeecccccccCcccccccc--------------------------------------ccccceeeeccccCcccCCcccC
Q 039137          233 DLELCINQLSGAIPLSISN--------------------------------------LTNLRFLFLYHNELSGIIPQEIG  274 (912)
Q Consensus       233 ~L~l~~n~l~~~~p~~~~~--------------------------------------l~~L~~L~L~~N~l~~~~~~~l~  274 (912)
                      .|++++|++++..|..+..                                      .++|+.|+|++|.+++..|..|.
T Consensus       208 ~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~  287 (844)
T 3j0a_A          208 ILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFE  287 (844)
T ss_dssp             EEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSS
T ss_pred             EEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhh
Confidence            9999999877665544432                                      26788999999999888888899


Q ss_pred             CccccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCcccccccCCCCCCCCEE
Q 039137          275 NLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLL  354 (912)
Q Consensus       275 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  354 (912)
                      .+++|+.|+|++|++++..|..|..+++|++|+|++|.+++..+..|..+++|+.|+|++|++.+..+..|..+++|+.|
T Consensus       288 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L  367 (844)
T 3j0a_A          288 TLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTL  367 (844)
T ss_dssp             SCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEE
T ss_pred             cCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEE
Confidence            99999999999999998888889999999999999999988888889999999999999999988888888889999999


Q ss_pred             eccCCcccccccccccccccccEEEc--------------------cCccccCC-CCccccccccccEEEccCCcccCCC
Q 039137          355 DVSINNISGSIPLEIGESLQLQYLDL--------------------SSNYIVGE-IPTQLGNIIYLNRLSLSGNKLSGCI  413 (912)
Q Consensus       355 ~Ls~N~l~~~~~~~~~~~~~L~~L~L--------------------~~N~l~~~-~~~~l~~l~~L~~L~L~~N~l~~~~  413 (912)
                      ++++|.+++..     .+++|+.|++                    ++|++++. .+..+.++++|+.|+|++|++++..
T Consensus       368 ~Ls~N~l~~i~-----~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~  442 (844)
T 3j0a_A          368 DLRDNALTTIH-----FIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCS  442 (844)
T ss_dssp             EEETCCSCCCS-----SCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCC
T ss_pred             ECCCCCCCccc-----CCCCcchhccCCCCcccccccccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccc
Confidence            99999887421     2444555554                    45544432 1123457899999999999999655


Q ss_pred             cc-ccccccccccccccCcccC-----ccccccccccccccEEEecccccccccchhhhcccccceeeccccccCccccc
Q 039137          414 PR-ELGSLINLEYLDLSANNLS-----NFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISS  487 (912)
Q Consensus       414 p~-~~~~l~~L~~L~Ls~N~l~-----~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~  487 (912)
                      +. .+..+++|+.|+|++|.++     +..+..|..+++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+.
T Consensus       443 ~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~  522 (844)
T 3j0a_A          443 GDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHN  522 (844)
T ss_dssp             SSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCC
T ss_pred             cccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChh
Confidence            43 4566899999999999997     44456789999999999999999999999999999999999999999998887


Q ss_pred             ccccccccccccccCccccCCCcccccccccceEEEccCCccccCCC
Q 039137          488 RICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIP  534 (912)
Q Consensus       488 ~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~~  534 (912)
                      .+.  ++|+.|+|++|+|++.+|..|.   +|+.+++++|++.|..+
T Consensus       523 ~~~--~~L~~L~Ls~N~l~~~~~~~~~---~L~~l~l~~Np~~C~c~  564 (844)
T 3j0a_A          523 DLP--ANLEILDISRNQLLAPNPDVFV---SLSVLDITHNKFICECE  564 (844)
T ss_dssp             CCC--SCCCEEEEEEECCCCCCSCCCS---SCCEEEEEEECCCCSSS
T ss_pred             hhh--ccccEEECCCCcCCCCChhHhC---CcCEEEecCCCcccccc
Confidence            776  8999999999999999998764   78899999999999665

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=8.8e-50  Score=477.17  Aligned_cols=440  Identities=21%  Similarity=0.200  Sum_probs=391.8

Q ss_pred             CCeEEEeeccccccccccccccCCCCCccEEEccCCcccccCCccccCCCCCcEEeccccccccccccccccccccceee
Q 039137           84 ERVVGINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLH  163 (912)
Q Consensus        84 ~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~  163 (912)
                      .++..++++++.+.+ +.+.+|.++++|++|+|++|++++..|..|+++++|++|+|++|++++..|..|+.+++|++|+
T Consensus        56 ~~L~~L~Ls~n~l~~-i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  134 (606)
T 3vq2_A           56 SELQWLDLSRCEIET-IEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLN  134 (606)
T ss_dssp             TTCCEEECTTCCCCE-ECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEE
T ss_pred             ccCcEEeCCCCcccc-cCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEe
Confidence            467788888887764 4456799999999999999999998899999999999999999999977778899999999999


Q ss_pred             cccccccC-CCCccccCcccccEEEccCCcCCCCCCccCCCCccce----eeeeccCCCcCccccccccccccceeeccc
Q 039137          164 ISRNWLSG-SIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVV----ILYLYNNSFFGSIPQEIGNLKSLFDLELCI  238 (912)
Q Consensus       164 L~~n~l~~-~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~----~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~  238 (912)
                      |++|.+++ .+|..++++++|++|++++|++++..|..++++++|+    +|++++|.+++..+..+... +|+.|++++
T Consensus       135 L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~  213 (606)
T 3vq2_A          135 VAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRG  213 (606)
T ss_dssp             CCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEES
T ss_pred             CCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccC
Confidence            99999986 6799999999999999999999988888888888765    79999999886555555444 788888887


Q ss_pred             cccc----------------------------------------------------------Cccccccccccccceeee
Q 039137          239 NQLS----------------------------------------------------------GAIPLSISNLTNLRFLFL  260 (912)
Q Consensus       239 n~l~----------------------------------------------------------~~~p~~~~~l~~L~~L~L  260 (912)
                      |.++                                                          +.+|. +..+++|+.|++
T Consensus       214 n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l  292 (606)
T 3vq2_A          214 NFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSL  292 (606)
T ss_dssp             CCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEE
T ss_pred             CccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccc-cccCCCCCEEEe
Confidence            7653                                                          33444 777899999999


Q ss_pred             ccccCcccCCcccCCccccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCccc
Q 039137          261 YHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGE  340 (912)
Q Consensus       261 ~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  340 (912)
                      ++|.+.. +| .+..+++|++|++++|.+ +.+| .+ .+++|++|++++|...+..  .+..+++|++|++++|.+++.
T Consensus       293 ~~~~~~~-l~-~l~~~~~L~~L~l~~n~l-~~lp-~~-~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~  365 (606)
T 3vq2_A          293 AGVSIKY-LE-DVPKHFKWQSLSIIRCQL-KQFP-TL-DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFS  365 (606)
T ss_dssp             ESCCCCC-CC-CCCTTCCCSEEEEESCCC-SSCC-CC-CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEE
T ss_pred             cCccchh-hh-hccccccCCEEEcccccC-cccc-cC-CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCC
Confidence            9999985 55 899999999999999999 5777 45 9999999999999655433  678999999999999999876


Q ss_pred             c--cccCCCCCCCCEEeccCCcccccccccccccccccEEEccCccccCCCC-ccccccccccEEEccCCcccCCCcccc
Q 039137          341 I--LSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIP-TQLGNIIYLNRLSLSGNKLSGCIPREL  417 (912)
Q Consensus       341 ~--~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~-~~l~~l~~L~~L~L~~N~l~~~~p~~~  417 (912)
                      .  +..+..+++|+.|++++|.+.+ +|..+..+++|++|++++|++.+..| ..+.++++|+.|++++|++++..|..+
T Consensus       366 ~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~  444 (606)
T 3vq2_A          366 GCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIF  444 (606)
T ss_dssp             EECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTT
T ss_pred             cchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhh
Confidence            4  7788999999999999999985 66889999999999999999998877 689999999999999999999999999


Q ss_pred             ccccccccccccCcccCc-cccccccccccccEEEecccccccccchhhhcccccceeeccccccCcccccccccccccc
Q 039137          418 GSLINLEYLDLSANNLSN-FVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLE  496 (912)
Q Consensus       418 ~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  496 (912)
                      ..+++|++|++++|++++ .+|..|..+++|++|+|++|++++..|..|.++++|++|+|++|++++.+|..|+.+++|+
T Consensus       445 ~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  524 (606)
T 3vq2_A          445 LGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLS  524 (606)
T ss_dssp             TTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCC
T ss_pred             cCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCC
Confidence            999999999999999998 5789999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccccCccccCCCcccccccc-cceEEEccCCccccCCCC
Q 039137          497 KLNLSYNNLSGLIPRCFEEMH-GLLHIDISYNKLEGQIPN  535 (912)
Q Consensus       497 ~L~ls~N~l~~~~p~~~~~l~-~L~~l~ls~N~l~~~~~~  535 (912)
                      .|++++|+|+. +|..+..++ +|+.|++++|++.|..+.
T Consensus       525 ~L~l~~N~l~~-~p~~~~~l~~~L~~l~l~~N~~~c~c~~  563 (606)
T 3vq2_A          525 TLDCSFNRIET-SKGILQHFPKSLAFFNLTNNSVACICEH  563 (606)
T ss_dssp             EEECTTSCCCC-EESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred             EEECCCCcCcc-cCHhHhhhcccCcEEEccCCCcccCCcc
Confidence            99999999995 566699997 599999999999986653

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.4e-50  Score=437.80  Aligned_cols=249  Identities=27%  Similarity=0.392  Sum_probs=210.1

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      +.|++.+.||+|+||+||+|+++ +|+.||||++......    ..+.+.+|+++++.++|||||++++++.+++..|+|
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~----~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iv  149 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ----RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV  149 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS----SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh----HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            56999999999999999999976 7999999998644322    245678999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      ||||++|+|.+++.+    ..+++.++..|+.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+.+..
T Consensus       150 mEy~~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  222 (346)
T 4fih_A          150 MEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK  222 (346)
T ss_dssp             ECCCTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCC
Confidence            999999999999953    4589999999999999999999999   999999999999999999999999999998876


Q ss_pred             CCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHH
Q 039137          797 DSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKK  876 (912)
Q Consensus       797 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  876 (912)
                      ........+||+.|||||++.+..|+.++||||+||++|||++|+.||......     .....+... .+.........
T Consensus       223 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-----~~~~~i~~~-~~~~~~~~~~~  296 (346)
T 4fih_A          223 EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-----KAMKMIRDN-LPPRLKNLHKV  296 (346)
T ss_dssp             SSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHHHHHS-SCCCCSCGGGS
T ss_pred             CCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-----HHHHHHHcC-CCCCCCccccC
Confidence            656667789999999999999999999999999999999999999998522111     111111111 11111122344


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          877 LMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       877 ~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      +.++.++|.+||++||++|||++|+++
T Consensus       297 s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          297 SPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            567889999999999999999999875

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3.3e-50  Score=429.83  Aligned_cols=256  Identities=26%  Similarity=0.396  Sum_probs=201.7

Q ss_pred             hcCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      .+++++.+.||+|+||+||+|+++  ..||||+++....  .....++|.+|++++++++|||||+++|++.+ +..++|
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV  109 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDP--TPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV  109 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence            467888999999999999999874  3599999865432  23356789999999999999999999999864 568999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      ||||++|+|.++++..  ...+++.++..|+.|||.||+|||++   +||||||||+|||+++++.+||+|||+|+....
T Consensus       110 mEy~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~  184 (307)
T 3omv_A          110 TQWCEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR  184 (307)
T ss_dssp             EECCSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred             EEcCCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence            9999999999999543  35699999999999999999999999   999999999999999999999999999987653


Q ss_pred             CC--CCcccccccccccccccccc---CCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCC--CCCC
Q 039137          797 DS--SNWSELAGTHGYVAPELAYT---LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSR--LPYP  869 (912)
Q Consensus       797 ~~--~~~~~~~g~~~y~aPE~~~~---~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~  869 (912)
                      ..  .......||+.|||||++.+   .+|+.++|||||||++|||+||+.||......     ..........  .+..
T Consensus       185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~-----~~~~~~~~~~~~~p~~  259 (307)
T 3omv_A          185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR-----DQIIFMVGRGYASPDL  259 (307)
T ss_dssp             ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----HHHHHHHHTTCCCCCS
T ss_pred             CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH-----HHHHHHHhcCCCCCCc
Confidence            32  22345689999999999864   45899999999999999999999998632111     0111111111  1111


Q ss_pred             ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 039137          870 SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCE  907 (912)
Q Consensus       870 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  907 (912)
                      .......+..+.+++.+||+.||++|||++||++.|+.
T Consensus       260 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~  297 (307)
T 3omv_A          260 SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIEL  297 (307)
T ss_dssp             TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHH
T ss_pred             ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            11223345678899999999999999999999988764

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=6.9e-51  Score=440.94  Aligned_cols=253  Identities=24%  Similarity=0.366  Sum_probs=206.6

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      .++|++.+.||+|+||+||+|+++ +|+.||||++......  ....+.+.+|++++++++|||||++++++.+++..|+
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yi  100 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS--SKEREESRREVAVLANMKHPNIVQYRESFEENGSLYI  100 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCC--HHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence            368999999999999999999876 7999999999765432  2356789999999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      |||||+||+|.+++... ....+++.+++.|+.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+...
T Consensus       101 VmEy~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  176 (350)
T 4b9d_A          101 VMDYCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLN  176 (350)
T ss_dssp             EEECCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCC
T ss_pred             EEeCCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeec
Confidence            99999999999999543 234578999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHH
Q 039137          796 PDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQK  875 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  875 (912)
                      .........+||+.|||||++.+..|+.++||||+||++|||++|+.||....     .......+.....+...   ..
T Consensus       177 ~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~-----~~~~~~~i~~~~~~~~~---~~  248 (350)
T 4b9d_A          177 STVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS-----MKNLVLKIISGSFPPVS---LH  248 (350)
T ss_dssp             HHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHTCCCCCC---TT
T ss_pred             CCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-----HHHHHHHHHcCCCCCCC---cc
Confidence            43333345689999999999999999999999999999999999999986321     11122223333332221   22


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          876 KLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       876 ~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .+.++.++|.+||++||++|||++|+++
T Consensus       249 ~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          249 YSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            3456889999999999999999999975

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=8.1e-51  Score=434.86  Aligned_cols=256  Identities=25%  Similarity=0.457  Sum_probs=210.5

Q ss_pred             cCCCCCceeeecCceEEEEEEeC------CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCC
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP------SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPK  711 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~  711 (912)
                      ++|.+.+.||+|+||+||+|++.      ++..||||+++..    .....++|.+|++++++++|||||+++|+|.+++
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~----~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~   88 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA----SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD   88 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC----ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence            56888999999999999999863      4778999998643    2335678999999999999999999999999999


Q ss_pred             eeeEEEeecCCCChhhHhhccC----------CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCC
Q 039137          712 HSFIIYEYLESGSLDKILCNDA----------SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGY  781 (912)
Q Consensus       712 ~~~lv~e~~~~g~L~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~  781 (912)
                      ..++|||||++|+|.++++...          ....+++.++++|+.|||+||+|||++   +|+||||||+|||+++++
T Consensus        89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~  165 (299)
T 4asz_A           89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENL  165 (299)
T ss_dssp             SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCC
Confidence            9999999999999999996532          245699999999999999999999999   999999999999999999


Q ss_pred             cEEEeccccccccCCCCCC--ccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccch
Q 039137          782 EAHVSDFGIAKFLNPDSSN--WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMN  858 (912)
Q Consensus       782 ~~kl~Dfgla~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~  858 (912)
                      .+||+|||+|+........  .....||+.|||||++.+..|+.++|||||||++|||+| |+.||.....     ....
T Consensus       166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~-----~~~~  240 (299)
T 4asz_A          166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-----NEVI  240 (299)
T ss_dssp             CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-----HHHH
T ss_pred             cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-----HHHH
Confidence            9999999999866443222  223468999999999999999999999999999999999 8999863211     1122


Q ss_pred             hhhccCC-CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 039137          859 IEMLDSR-LPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI  909 (912)
Q Consensus       859 ~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l  909 (912)
                      ..+.... .+.|.    ..+.++.+++.+||+.||++|||++||.+.|++..
T Consensus       241 ~~i~~~~~~~~p~----~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~  288 (299)
T 4asz_A          241 ECITQGRVLQRPR----TCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA  288 (299)
T ss_dssp             HHHHHTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHcCCCCCCCc----cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            2222222 22222    23456889999999999999999999999998754

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.5e-50  Score=433.02  Aligned_cols=255  Identities=21%  Similarity=0.360  Sum_probs=209.6

Q ss_pred             cCCCCCceeeecCceEEEEEEeC------CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCC
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP------SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPK  711 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~  711 (912)
                      .++++.+.||+|+||+||+|++.      +++.||||+++......   ..++|.+|+.++++++|||||+++|+|.+++
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~---~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~  102 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGP---LREEFRHEAMLRARLQHPNVVCLLGVVTKDQ  102 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChH---HHHHHHHHHHHHHhCCCCCCCCcceEEEECC
Confidence            35677889999999999999862      56789999997543322   4678999999999999999999999999999


Q ss_pred             eeeEEEeecCCCChhhHhhccC-------------CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEc
Q 039137          712 HSFIIYEYLESGSLDKILCNDA-------------SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLD  778 (912)
Q Consensus       712 ~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~  778 (912)
                      ..++|||||++|+|.+++....             ....+++.++.+|+.|||+||+|||++   +||||||||+|||++
T Consensus       103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~  179 (308)
T 4gt4_A          103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVY  179 (308)
T ss_dssp             SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred             EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEEC
Confidence            9999999999999999996532             134689999999999999999999999   999999999999999


Q ss_pred             CCCcEEEeccccccccCCCC--CCccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccc
Q 039137          779 LGYEAHVSDFGIAKFLNPDS--SNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSS  855 (912)
Q Consensus       779 ~~~~~kl~Dfgla~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~  855 (912)
                      +++.+||+|||+|+......  .......||++|||||++.+..|+.++|||||||++|||+| |+.||.....     .
T Consensus       180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~-----~  254 (308)
T 4gt4_A          180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-----Q  254 (308)
T ss_dssp             GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH-----H
T ss_pred             CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH-----H
Confidence            99999999999998764332  22345679999999999999999999999999999999999 8999863211     1


Q ss_pred             cchhhhccCC-CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 039137          856 NMNIEMLDSR-LPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCE  907 (912)
Q Consensus       856 ~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  907 (912)
                      .....+.... .+.|.    ..+..+.+++.+||+.||++||||+||++.|+.
T Consensus       255 ~~~~~i~~~~~~~~p~----~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a  303 (308)
T 4gt4_A          255 DVVEMIRNRQVLPCPD----DCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA  303 (308)
T ss_dssp             HHHHHHHTTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             HHHHHHHcCCCCCCcc----cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence            1112222222 23332    344568899999999999999999999999974

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=6.6e-51  Score=486.72  Aligned_cols=488  Identities=19%  Similarity=0.252  Sum_probs=403.2

Q ss_pred             CCCHHHHHHHHHHHHhcccCCcccCCCcccCCCCCCCCCCCccce-eEecCC---CCeEEEeeccccccccccccccCCC
Q 039137           33 SNSAEEAHALVKWKASLEVHSRSLLHSWSLSSVNATKISPCAWSG-IFCNHA---ERVVGINLTSISLNGTLLEFSFSSF  108 (912)
Q Consensus        33 ~~~~~~~~all~~k~~~~~~~~~~l~~w~~~~~~~~~~~~C~w~g-v~c~~~---~~v~~l~l~~~~l~~~~~~~~~~~l  108 (912)
                      ...+++.+.-.++++-...- .  -..|.....  .....|.|.. ..|...   ..|+.-   .              -
T Consensus        23 ~~~~~~~~d~~aL~~~~~~~-~--~~~w~~~~~--~~~~~~~W~~~~~~c~w~~~~GV~C~---~--------------~   80 (636)
T 4eco_A           23 SRTAEYIKDYLALKEIWDAL-N--GKNWSQQGF--GTQPGANWNFNKELDMWGAQPGVSLN---S--------------N   80 (636)
T ss_dssp             CCCCHHHHHHHHHHHHHHHT-T--GGGCCCCC--------CCCCCSSCGGGTTCCTTEEEC---T--------------T
T ss_pred             hhhhhHHHHHHHHHHHHHHc-C--CCCcccCCc--CCccCCCCCCCCCcccccCCCCeEEc---C--------------C
Confidence            35555666666666654322 2  236764321  1112358963 334333   345431   0              1


Q ss_pred             CCccEEEccCCcccccCCccccCCCCCcEEecccccc------cc------ccccccccccccceeecccccccCCCCcc
Q 039137          109 PHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKL------FG------QIPSGIGLLTHLTVLHISRNWLSGSIPHE  176 (912)
Q Consensus       109 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l------~~------~~p~~~~~l~~L~~L~L~~n~l~~~~p~~  176 (912)
                      .+++.|+|++|++.|.+|++|++|++|++|||++|.+      .|      .+|...  +.+|+ +++++|.+.+.+|..
T Consensus        81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~  157 (636)
T 4eco_A           81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPRED  157 (636)
T ss_dssp             CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGG
T ss_pred             CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhh
Confidence            4688999999999999999999999999999999986      33      456554  77888 999999999999888


Q ss_pred             ccCc-ccccEEEcc--------------------CCcCCCCCCccCCCCccceeeeeccCCCcCc---------------
Q 039137          177 VGQL-TVLNQLALD--------------------SNFLNGSIPRSLGNLTHVVILYLYNNSFFGS---------------  220 (912)
Q Consensus       177 ~~~l-~~L~~L~l~--------------------~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~---------------  220 (912)
                      ++.+ ..+..+++.                    +|+++| +|..++++++|++|+|++|.+++.               
T Consensus       158 ~~~~~~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~  236 (636)
T 4eco_A          158 FSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQ  236 (636)
T ss_dssp             SCHHHHHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHH
T ss_pred             HHHHHHHHhhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhc
Confidence            7732 222222222                    688998 999999999999999999999986               


Q ss_pred             --cccccc--cccccceeecccccccCccccccccccccceeeecccc-Ccc-cCCcccCCc------cccchhhhccCc
Q 039137          221 --IPQEIG--NLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNE-LSG-IIPQEIGNL------KKLNSLLLAKNH  288 (912)
Q Consensus       221 --~p~~~~--~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~-l~~-~~~~~l~~l------~~L~~L~L~~N~  288 (912)
                        +|..++  ++++|++|++++|++.+.+|..|+++++|++|+|++|+ +++ .+|..++++      ++|++|++++|+
T Consensus       237 ~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~  316 (636)
T 4eco_A          237 QYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNN  316 (636)
T ss_dssp             HHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSC
T ss_pred             ccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCc
Confidence              999999  99999999999999999999999999999999999998 998 889988887      999999999999


Q ss_pred             cCCCCcc--ccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCcccccccCCCCCC-CCEEeccCCcccccc
Q 039137          289 FRGTVPK--SFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQ-LSLLDVSINNISGSI  365 (912)
Q Consensus       289 l~~~~~~--~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~-L~~L~Ls~N~l~~~~  365 (912)
                      ++ .+|.  .|.++++|++|++++|.++|.+| .|+.+++|++|+|++|++. .+|..+..+++ |+.|++++|+++ .+
T Consensus       317 l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~l  392 (636)
T 4eco_A          317 LK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YI  392 (636)
T ss_dssp             CS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SC
T ss_pred             CC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-cc
Confidence            99 7888  89999999999999999998888 9999999999999999998 78888999999 999999999999 78


Q ss_pred             cccccccc--cccEEEccCccccCCCCcccc-------ccccccEEEccCCcccCCCccccccccccccccccCcccCcc
Q 039137          366 PLEIGESL--QLQYLDLSSNYIVGEIPTQLG-------NIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNF  436 (912)
Q Consensus       366 ~~~~~~~~--~L~~L~L~~N~l~~~~~~~l~-------~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  436 (912)
                      |..+....  +|++|++++|++++.+|..+.       .+.+|++|+|++|+++...+..+..+++|++|+|++|+++.+
T Consensus       393 p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i  472 (636)
T 4eco_A          393 PNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEI  472 (636)
T ss_dssp             CSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBC
T ss_pred             chhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCc
Confidence            88887765  899999999999999999888       888999999999999954444556699999999999999965


Q ss_pred             ccccccccc-------cccEEEecccccccccchhhh--cccccceeeccccccCcccccccccccccccccc------c
Q 039137          437 VPESLGSLV-------KLYYLNLSHNKLSQQIPIELD--NLIHLSELDLSHNFLGEKISSRICRMESLEKLNL------S  501 (912)
Q Consensus       437 ~~~~~~~l~-------~L~~L~Ls~N~l~~~~~~~~~--~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l------s  501 (912)
                      .+..+....       +|++|+|++|+++ .+|..+.  .+++|++|+|++|+|++ +|..+..+++|+.|+|      +
T Consensus       473 ~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls  550 (636)
T 4eco_A          473 PKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQ  550 (636)
T ss_dssp             CSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTT
T ss_pred             CHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccc
Confidence            555554433       9999999999998 6888887  99999999999999998 8999999999999999      5


Q ss_pred             CccccCCCcccccccccceEEEccCCccccCCCCCccCCCCchhhhccCCccc
Q 039137          502 YNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNSTTFRDAPLEALQGNKGLY  554 (912)
Q Consensus       502 ~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~~~~~~~~~~~~~~l~~n~~~~  554 (912)
                      +|++.+.+|..+..+++|+.|++++|++ +.+|... +.......+.+|+-.|
T Consensus       551 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~-~~~L~~L~Ls~N~l~~  601 (636)
T 4eco_A          551 GNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKI-TPNISVLDIKDNPNIS  601 (636)
T ss_dssp             CCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCC-CTTCCEEECCSCTTCE
T ss_pred             cCcccccChHHHhcCCCCCEEECCCCcC-CccCHhH-hCcCCEEECcCCCCcc
Confidence            6889999999999999999999999999 6777642 2333334455665443

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=4.5e-50  Score=435.22  Aligned_cols=256  Identities=26%  Similarity=0.450  Sum_probs=204.9

Q ss_pred             cCCCCCceeeecCceEEEEEEeC------CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCC
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP------SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPK  711 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~  711 (912)
                      ++|.+.+.||+|+||+||+|+++      +++.||||+++..    .....++|.+|++++++++|||||+++|+|.+++
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~----~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~  116 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQREAELLTMLQHQHIVRFFGVCTEGR  116 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC----SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            46778899999999999999864      4788999998643    2335678999999999999999999999999999


Q ss_pred             eeeEEEeecCCCChhhHhhccC------------CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcC
Q 039137          712 HSFIIYEYLESGSLDKILCNDA------------SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDL  779 (912)
Q Consensus       712 ~~~lv~e~~~~g~L~~~l~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~  779 (912)
                      ..++|||||++|+|.++++...            ...++++.++++|+.|||.||+|||++   +|+||||||+|||+++
T Consensus       117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~  193 (329)
T 4aoj_A          117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQ  193 (329)
T ss_dssp             SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEET
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECC
Confidence            9999999999999999996543            234699999999999999999999999   9999999999999999


Q ss_pred             CCcEEEeccccccccCCCCC--CccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhcccccccc
Q 039137          780 GYEAHVSDFGIAKFLNPDSS--NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSN  856 (912)
Q Consensus       780 ~~~~kl~Dfgla~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~  856 (912)
                      ++.+||+|||+|+.......  ......||+.|||||++.+..++.++|||||||++|||+| |+.||.....     ..
T Consensus       194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~-----~~  268 (329)
T 4aoj_A          194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-----TE  268 (329)
T ss_dssp             TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH-----HH
T ss_pred             CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH-----HH
Confidence            99999999999987644322  2234679999999999999999999999999999999999 8999863211     11


Q ss_pred             chhhhccC-CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 039137          857 MNIEMLDS-RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI  909 (912)
Q Consensus       857 ~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l  909 (912)
                      ....+... +.+.|.    ..+.++.+++.+||+.||++|||++||++.|+...
T Consensus       269 ~~~~i~~g~~~~~p~----~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~  318 (329)
T 4aoj_A          269 AIDCITQGRELERPR----ACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA  318 (329)
T ss_dssp             HHHHHHHTCCCCCCT----TCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred             HHHHHHcCCCCCCcc----cccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence            11122222 223332    23456889999999999999999999999998764

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=7.3e-50  Score=472.07  Aligned_cols=450  Identities=20%  Similarity=0.216  Sum_probs=329.3

Q ss_pred             CCccceeEecCC------------CCeEEEeeccccccccccccccCCCCCccEEEccCCcccccCCccccCCCCCcEEe
Q 039137           72 PCAWSGIFCNHA------------ERVVGINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLD  139 (912)
Q Consensus        72 ~C~w~gv~c~~~------------~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~  139 (912)
                      .|.|.|+ |+..            ..++.+++.++.+.+. .+.+|.++++|++|+|++|++++..|..|+++++|++||
T Consensus         3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~-~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~   80 (549)
T 2z81_A            3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYI-GHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLD   80 (549)
T ss_dssp             EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEE-CSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred             cCCCCce-EECCCCccccccccCCCCccEEECcCCccCcc-ChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEE
Confidence            4999998 8632            2466677776666543 344677778888888888888777777778888888888


Q ss_pred             ccccccccccccccccccccceeecccccccC-CCCccccCcccccEEEccCCcCCCCCC-ccCCCCccceeeeeccCCC
Q 039137          140 FSANKLFGQIPSGIGLLTHLTVLHISRNWLSG-SIPHEVGQLTVLNQLALDSNFLNGSIP-RSLGNLTHVVILYLYNNSF  217 (912)
Q Consensus       140 Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~l~~n~l~~~~p-~~~~~l~~L~~L~L~~n~l  217 (912)
                      |++|++++..|..|+.+++|++|+|++|.+++ .+|..++++++|++|++++|.+.+.+| ..+.++++|++|++++|.+
T Consensus        81 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l  160 (549)
T 2z81_A           81 LSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSL  160 (549)
T ss_dssp             CTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTC
T ss_pred             CCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcc
Confidence            88888776666667778888888888887775 356677778888888888777544554 5677788888888888888


Q ss_pred             cCccccccccccccceeecccccccCccccccccccccceeeeccccCcccC--C-cccCCccccchhhhccCccCCCCc
Q 039137          218 FGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGII--P-QEIGNLKKLNSLLLAKNHFRGTVP  294 (912)
Q Consensus       218 ~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~--~-~~l~~l~~L~~L~L~~N~l~~~~~  294 (912)
                      ++..|..++++++|+.|+++.|.+....+..+..+++|++|++++|++++..  | .....+++|+.|++++|.+++..+
T Consensus       161 ~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~  240 (549)
T 2z81_A          161 RNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESF  240 (549)
T ss_dssp             CEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHH
T ss_pred             cccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHH
Confidence            7777777777788888888777776332233355778888888888877642  1 122345667777777776664333


Q ss_pred             c----ccccccccceEecccccccCCCC------ccc-----------------------------CCCCCccEEEccCC
Q 039137          295 K----SFRNLTDLVKLRLNQNYLTGNIS------ETF-----------------------------GTYPNLTFIDLSNN  335 (912)
Q Consensus       295 ~----~~~~l~~L~~L~L~~n~l~~~~~------~~~-----------------------------~~l~~L~~L~Ls~N  335 (912)
                      .    .+..+++|+.|++++|.+.+...      ..+                             ...++|+.|++++|
T Consensus       241 ~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n  320 (549)
T 2z81_A          241 NELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENS  320 (549)
T ss_dssp             HHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESS
T ss_pred             HHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccC
Confidence            2    23455677777777776654211      111                             12346777777777


Q ss_pred             cCcccccccC-CCCCCCCEEeccCCccccccc---ccccccccccEEEccCccccCCCC--ccccccccccEEEccCCcc
Q 039137          336 SFFGEILSDW-GRCPQLSLLDVSINNISGSIP---LEIGESLQLQYLDLSSNYIVGEIP--TQLGNIIYLNRLSLSGNKL  409 (912)
Q Consensus       336 ~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~~---~~~~~~~~L~~L~L~~N~l~~~~~--~~l~~l~~L~~L~L~~N~l  409 (912)
                      .+. .+|..+ ..+++|+.|++++|++.+.+|   ..++.+++|++|+|++|++++..+  ..+..+++|++|++++|++
T Consensus       321 ~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l  399 (549)
T 2z81_A          321 KVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTF  399 (549)
T ss_dssp             CCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCC
T ss_pred             ccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCC
Confidence            775 344443 578899999999999987664   346778889999999999885432  4578888999999999998


Q ss_pred             cCCCccccccccccccccccCcccCccccccccccccccEEEecccccccccchhhhcccccceeeccccccCccccccc
Q 039137          410 SGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRI  489 (912)
Q Consensus       410 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~  489 (912)
                      + .+|..+..+++|++|++++|+++++ |..+.  ++|++|+|++|+|++.+    ..+++|++|+|++|+|+. +|. .
T Consensus       400 ~-~lp~~~~~~~~L~~L~Ls~N~l~~l-~~~~~--~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~~-ip~-~  469 (549)
T 2z81_A          400 H-PMPDSCQWPEKMRFLNLSSTGIRVV-KTCIP--QTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLKT-LPD-A  469 (549)
T ss_dssp             C-CCCSCCCCCTTCCEEECTTSCCSCC-CTTSC--TTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCSS-CCC-G
T ss_pred             c-cCChhhcccccccEEECCCCCcccc-cchhc--CCceEEECCCCChhhhc----ccCChhcEEECCCCccCc-CCC-c
Confidence            8 6788888888999999999998764 43332  58899999999988643    578899999999999974 554 4


Q ss_pred             ccccccccccccCccccCCCcccccccccceEEEccCCccccCCC
Q 039137          490 CRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIP  534 (912)
Q Consensus       490 ~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~~  534 (912)
                      ..+++|+.|+|++|+|++.+|..|..+++|+.|++++|++.|..|
T Consensus       470 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  514 (549)
T 2z81_A          470 SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  514 (549)
T ss_dssp             GGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred             ccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence            678999999999999999888889999999999999999988665

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=7e-50  Score=431.21  Aligned_cols=253  Identities=25%  Similarity=0.327  Sum_probs=207.3

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      +.|++.++||+|+||+||+|+++ +|+.||||+++....         ..+|+.+++.++|||||++++++.+++..|+|
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~---------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv  128 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF---------RVEELVACAGLSSPRIVPLYGAVREGPWVNIF  128 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh---------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            46788899999999999999976 799999999975422         13699999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCC-cEEEeccccccccC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGY-EAHVSDFGIAKFLN  795 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~Dfgla~~~~  795 (912)
                      ||||+||+|.+++++   .+.+++.++..|+.||+.||+|||++   +|+||||||+|||++.++ .+||+|||+|+.+.
T Consensus       129 mEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~  202 (336)
T 4g3f_A          129 MELLEGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQ  202 (336)
T ss_dssp             ECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred             EeccCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence            999999999999954   35699999999999999999999999   999999999999999987 69999999999775


Q ss_pred             CCCCC-----ccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCC
Q 039137          796 PDSSN-----WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPS  870 (912)
Q Consensus       796 ~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  870 (912)
                      .....     ....+||+.|||||++.+..|+.++||||+||++|||++|++||.....     ......+.....+. .
T Consensus       203 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~-----~~~~~~i~~~~~~~-~  276 (336)
T 4g3f_A          203 PDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFR-----GPLCLKIASEPPPI-R  276 (336)
T ss_dssp             -----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCC-----SCCHHHHHHSCCGG-G
T ss_pred             CCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH-----HHHHHHHHcCCCCc-h
Confidence            43221     2345799999999999999999999999999999999999999863211     11122222222111 1


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 039137          871 LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE  911 (912)
Q Consensus       871 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~~  911 (912)
                      ......+..+.++|.+||++||++|||+.|+++.+.+.+.+
T Consensus       277 ~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~  317 (336)
T 4g3f_A          277 EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE  317 (336)
T ss_dssp             GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence            11123456688999999999999999999999999887754

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.7e-50  Score=430.54  Aligned_cols=249  Identities=21%  Similarity=0.329  Sum_probs=210.1

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ++|++.+.||+|+||+||+|+++ +++.||||++.+..... ....+.+.+|+++++.++|||||++++++.+++..|+|
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv  110 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK-ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG  110 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            57999999999999999999876 79999999986422111 11356789999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      ||||+||+|.+++.+   .+.+++.+++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+.+..
T Consensus       111 mEy~~gG~L~~~i~~---~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~  184 (311)
T 4aw0_A          111 LSYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  184 (311)
T ss_dssp             ECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence            999999999999954   35699999999999999999999999   999999999999999999999999999998754


Q ss_pred             CC--CCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhH
Q 039137          797 DS--SNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQ  874 (912)
Q Consensus       797 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  874 (912)
                      ..  ......+||+.|||||++.+..|+.++||||+||++|||++|+.||...     ........+......++.    
T Consensus       185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~-----~~~~~~~~i~~~~~~~p~----  255 (311)
T 4aw0_A          185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG-----NEGLIFAKIIKLEYDFPE----  255 (311)
T ss_dssp             TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHTCCCCCT----
T ss_pred             CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHcCCCCCCc----
Confidence            33  2345678999999999999999999999999999999999999998621     112222333344444443    


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 039137          875 KKLMSIMQVAFSCLDQNPESRPTMKRVS  902 (912)
Q Consensus       875 ~~~~~l~~li~~cl~~dP~~RPt~~evl  902 (912)
                      ..+.++.++|.+||++||++|||++|+.
T Consensus       256 ~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          256 KFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             TCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             ccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence            2345688999999999999999999864

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.4e-49  Score=416.24  Aligned_cols=248  Identities=22%  Similarity=0.324  Sum_probs=193.5

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++........ ...+.+.+|+++++.++|||||++++++.+++..|+|
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKS-DMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCH-HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            68999999999999999999875 799999999976543322 2456799999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+ +|+|.+++..   .+.+++.+++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+|+....
T Consensus        92 mEy~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  164 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD  164 (275)
T ss_dssp             EECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred             EeCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence            9999 6799998854   35699999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCCccccccccccccccccccCCC-CcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHH
Q 039137          797 DSSNWSELAGTHGYVAPELAYTLKV-TEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQK  875 (912)
Q Consensus       797 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  875 (912)
                      . ......+||+.|||||++.+..+ +.++||||+||++|||++|+.||+..     ........+.....+.+.    .
T Consensus       165 ~-~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~-----~~~~~~~~i~~~~~~~p~----~  234 (275)
T 3hyh_A          165 G-NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE-----SIPVLFKNISNGVYTLPK----F  234 (275)
T ss_dssp             -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHTCCCCCT----T
T ss_pred             C-CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC-----CHHHHHHHHHcCCCCCCC----C
Confidence            3 33456789999999999998886 57999999999999999999998621     111122233334444432    2


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          876 KLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       876 ~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .+.++.++|.+||+.||++|||++|+++
T Consensus       235 ~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          235 LSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            3456789999999999999999999876

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=6.8e-49  Score=476.19  Aligned_cols=412  Identities=22%  Similarity=0.271  Sum_probs=360.5

Q ss_pred             CCccEEEccCCcccccCCccccCCCCCcEEec-ccccccccccccc----------------------------------
Q 039137          109 PHLVYLDLYNNELFGIIPPQISNLSNLEYLDF-SANKLFGQIPSGI----------------------------------  153 (912)
Q Consensus       109 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L-s~n~l~~~~p~~~----------------------------------  153 (912)
                      .+++.|+|++|++.|.+|++|++|++|++||| ++|.++|..|-..                                  
T Consensus       323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~  402 (876)
T 4ecn_A          323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD  402 (876)
T ss_dssp             SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred             CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence            57899999999999999999999999999999 8998887744221                                  


Q ss_pred             -----------------ccccccceeeccc--ccccCCCCccccCcccccEEEccCCcCCC-----------------CC
Q 039137          154 -----------------GLLTHLTVLHISR--NWLSGSIPHEVGQLTVLNQLALDSNFLNG-----------------SI  197 (912)
Q Consensus       154 -----------------~~l~~L~~L~L~~--n~l~~~~p~~~~~l~~L~~L~l~~n~l~~-----------------~~  197 (912)
                                       .....++.+.+..  |.+++ +|..|+++++|++|+|++|++++                 .+
T Consensus       403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~i  481 (876)
T 4ecn_A          403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYE  481 (876)
T ss_dssp             HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHT
T ss_pred             HHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccC
Confidence                             1122344444544  89997 99999999999999999999998                 49


Q ss_pred             CccCC--CCccceeeeeccCCCcCccccccccccccceeeccccc-ccC-cccccccccc-------ccceeeeccccCc
Q 039137          198 PRSLG--NLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQ-LSG-AIPLSISNLT-------NLRFLFLYHNELS  266 (912)
Q Consensus       198 p~~~~--~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~-l~~-~~p~~~~~l~-------~L~~L~L~~N~l~  266 (912)
                      |..++  ++++|++|+|++|.+.+.+|..|+++++|+.|+|++|+ +++ .+|..+++++       +|++|+|++|+++
T Consensus       482 P~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~  561 (876)
T 4ecn_A          482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE  561 (876)
T ss_dssp             TSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC
T ss_pred             ChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC
Confidence            99988  99999999999999999999999999999999999998 998 8998888776       9999999999999


Q ss_pred             ccCCc--ccCCccccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCC-ccEEEccCCcCcccccc
Q 039137          267 GIIPQ--EIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPN-LTFIDLSNNSFFGEILS  343 (912)
Q Consensus       267 ~~~~~--~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~-L~~L~Ls~N~l~~~~~~  343 (912)
                       .+|.  .++++++|++|+|++|+++ .+| .|..+++|+.|+|++|.++ .+|..+..+++ |+.|+|++|++. .+|.
T Consensus       562 -~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~  636 (876)
T 4ecn_A          562 -EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPN  636 (876)
T ss_dssp             -BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCS
T ss_pred             -ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCch
Confidence             7888  8999999999999999999 778 8999999999999999999 78888999999 999999999998 6778


Q ss_pred             cCCCCCC--CCEEeccCCccccccccc---cc--ccccccEEEccCccccCCCCccc-cccccccEEEccCCcccCCCcc
Q 039137          344 DWGRCPQ--LSLLDVSINNISGSIPLE---IG--ESLQLQYLDLSSNYIVGEIPTQL-GNIIYLNRLSLSGNKLSGCIPR  415 (912)
Q Consensus       344 ~~~~l~~--L~~L~Ls~N~l~~~~~~~---~~--~~~~L~~L~L~~N~l~~~~~~~l-~~l~~L~~L~L~~N~l~~~~p~  415 (912)
                      .+..++.  |+.|++++|++.+.+|..   +.  .+++|+.|+|++|+++ .+|..+ ..+++|+.|+|++|+++ .+|.
T Consensus       637 ~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~  714 (876)
T 4ecn_A          637 IFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMT-SIPE  714 (876)
T ss_dssp             CCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCS-CCCT
T ss_pred             hhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCC-ccCh
Confidence            7877654  999999999999876643   22  3458999999999999 556554 58899999999999999 5665


Q ss_pred             cccc--------ccccccccccCcccCcccccccc--ccccccEEEecccccccccchhhhcccccceeeccc------c
Q 039137          416 ELGS--------LINLEYLDLSANNLSNFVPESLG--SLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSH------N  479 (912)
Q Consensus       416 ~~~~--------l~~L~~L~Ls~N~l~~~~~~~~~--~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~------N  479 (912)
                      .+..        +++|+.|+|++|+|+. +|..+.  .+++|+.|+|++|+|++ +|..+..+++|+.|+|++      |
T Consensus       715 ~~~~~~~~~l~nl~~L~~L~Ls~N~L~~-lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N  792 (876)
T 4ecn_A          715 NSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGN  792 (876)
T ss_dssp             TSSSCTTSCCTTGGGCCEEECCSSCCCC-CCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCC
T ss_pred             HHhccccccccccCCccEEECCCCCCcc-chHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccc
Confidence            4433        3499999999999995 677776  99999999999999997 798999999999999977      8


Q ss_pred             ccCcccccccccccccccccccCccccCCCcccccccccceEEEccCCccccCC
Q 039137          480 FLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQI  533 (912)
Q Consensus       480 ~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~  533 (912)
                      ++.+.+|..+..+++|+.|+|++|+| +.+|..+.  ++|+.|||++|++....
T Consensus       793 ~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~  843 (876)
T 4ecn_A          793 RILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISID  843 (876)
T ss_dssp             BCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEE
T ss_pred             cccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccC
Confidence            88899999999999999999999999 56777665  69999999999987543

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.8e-49  Score=438.21  Aligned_cols=250  Identities=27%  Similarity=0.390  Sum_probs=210.3

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      .+.|++.+.||+|+||+||+|+++ +|+.||||++......    ..+.+.+|+.+|+.++|||||++++++.+++..|+
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~----~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~i  225 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ----RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV  225 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS----SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh----HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEE
Confidence            357999999999999999999976 7999999999754332    34568899999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      |||||+||+|.+++..    ..+++.++..|+.||+.||+|||++   +|+||||||+|||++.+|.+||+|||+|+.+.
T Consensus       226 VmEy~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~  298 (423)
T 4fie_A          226 VMEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS  298 (423)
T ss_dssp             EEECCTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECC
T ss_pred             EEeCCCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECC
Confidence            9999999999999943    3589999999999999999999999   99999999999999999999999999999887


Q ss_pred             CCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHH
Q 039137          796 PDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQK  875 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  875 (912)
                      .........+||+.|||||++.+..|+.++||||+||++|||++|+.||......     .....+... .+........
T Consensus       299 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-----~~~~~i~~~-~~~~~~~~~~  372 (423)
T 4fie_A          299 KEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-----KAMKMIRDN-LPPRLKNLHK  372 (423)
T ss_dssp             SSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHHHHHS-CCCCCSCTTS
T ss_pred             CCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-----HHHHHHHcC-CCCCCccccc
Confidence            6666667789999999999999999999999999999999999999998522111     111111111 1111111123


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          876 KLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       876 ~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .+..+.++|.+||+.||++|||++|+++
T Consensus       373 ~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          373 VSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            4566889999999999999999999875

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.8e-48  Score=460.81  Aligned_cols=437  Identities=21%  Similarity=0.202  Sum_probs=387.9

Q ss_pred             CCccEEEccCCcccccCCccccCCCCCcEEeccccccccccccccccccccceeecccccccCCCCccccCcccccEEEc
Q 039137          109 PHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLAL  188 (912)
Q Consensus       109 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l  188 (912)
                      +++++|+|++|++++..+..|.++++|++|||++|++++..|..|+++++|++|+|++|.+++..|..|+.+++|++|++
T Consensus        28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  107 (570)
T 2z63_A           28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA  107 (570)
T ss_dssp             SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred             ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence            57999999999999988889999999999999999999877889999999999999999999888899999999999999


Q ss_pred             cCCcCCCCCCccCCCCccceeeeeccCCCcC-ccccccccccccceeecccccccCcccccccccccc----ceeeeccc
Q 039137          189 DSNFLNGSIPRSLGNLTHVVILYLYNNSFFG-SIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNL----RFLFLYHN  263 (912)
Q Consensus       189 ~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L----~~L~L~~N  263 (912)
                      ++|++++..+..++++++|++|++++|.+++ .+|..++++++|+.|++++|++++..|..++.+++|    +.|++++|
T Consensus       108 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n  187 (570)
T 2z63_A          108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN  187 (570)
T ss_dssp             TTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTC
T ss_pred             cccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCC
Confidence            9999997666689999999999999999987 579999999999999999999998888899999999    89999999


Q ss_pred             cCcccCCcccCCccccchhhhccC--------------------------------------------------------
Q 039137          264 ELSGIIPQEIGNLKKLNSLLLAKN--------------------------------------------------------  287 (912)
Q Consensus       264 ~l~~~~~~~l~~l~~L~~L~L~~N--------------------------------------------------------  287 (912)
                      .+++..|..+..+ +|+.|++++|                                                        
T Consensus       188 ~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~  266 (570)
T 2z63_A          188 PMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY  266 (570)
T ss_dssp             CCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEE
T ss_pred             CceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhc
Confidence            9998888887765 7888888776                                                        


Q ss_pred             --ccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCcccccccCCCCCCCCEEeccCCcccccc
Q 039137          288 --HFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSI  365 (912)
Q Consensus       288 --~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  365 (912)
                        .+.+..|..|..+++|+.|++++|.+++ +|..+..+ +|+.|++++|.+. .+|.  ..+++|+.|++++|.+.+..
T Consensus       267 ~~~~~~~~~~~~~~l~~L~~L~l~~~~l~~-l~~~~~~~-~L~~L~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~~~~  341 (570)
T 2z63_A          267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNF-GWQHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGNAF  341 (570)
T ss_dssp             TTEEESCSTTTTGGGTTCSEEEEESCEECS-CCBCCSCC-CCSEEEEESCBCS-SCCB--CBCSSCCEEEEESCBSCCBC
T ss_pred             chhhhhhchhhhcCcCcccEEEecCccchh-hhhhhccC-CccEEeeccCccc-ccCc--ccccccCEEeCcCCcccccc
Confidence              4445667788889999999999999984 67777888 9999999999997 3343  57899999999999998766


Q ss_pred             cccccccccccEEEccCccccCCC--CccccccccccEEEccCCcccCCCccccccccccccccccCcccCcccc-cccc
Q 039137          366 PLEIGESLQLQYLDLSSNYIVGEI--PTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVP-ESLG  442 (912)
Q Consensus       366 ~~~~~~~~~L~~L~L~~N~l~~~~--~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~  442 (912)
                      +.  ..+++|++|++++|++++..  +..+.++++|++|++++|++++..+. +..+++|++|++++|.+.+..| ..+.
T Consensus       342 ~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~  418 (570)
T 2z63_A          342 SE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFL  418 (570)
T ss_dssp             CC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTT
T ss_pred             cc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhh
Confidence            65  78899999999999998654  77889999999999999999965444 9999999999999999998766 5789


Q ss_pred             ccccccEEEecccccccccchhhhcccccceeeccccccC-cccccccccccccccccccCccccCCCcccccccccceE
Q 039137          443 SLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLG-EKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLH  521 (912)
Q Consensus       443 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~  521 (912)
                      .+++|++|++++|++++..|..+.++++|++|+|++|.++ +.+|..+..+++|+.|++++|++++..|..|..+++|++
T Consensus       419 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~  498 (570)
T 2z63_A          419 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV  498 (570)
T ss_dssp             TCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred             cCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCE
Confidence            9999999999999999999999999999999999999998 578999999999999999999999999999999999999


Q ss_pred             EEccCCccccCCCCC-ccCCCCchhhhccCCccc
Q 039137          522 IDISYNKLEGQIPNS-TTFRDAPLEALQGNKGLY  554 (912)
Q Consensus       522 l~ls~N~l~~~~~~~-~~~~~~~~~~l~~n~~~~  554 (912)
                      |++++|++++.+|.. ..+.......+.+|+-.|
T Consensus       499 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~  532 (570)
T 2z63_A          499 LNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDC  532 (570)
T ss_dssp             EECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred             EeCCCCcCCCCCHHHhhcccCCcEEEecCCcccC
Confidence            999999999877653 233444444566665544

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.1e-48  Score=415.12  Aligned_cols=246  Identities=22%  Similarity=0.354  Sum_probs=197.9

Q ss_pred             CCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEc----CCeeeE
Q 039137          641 NAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSH----PKHSFI  715 (912)
Q Consensus       641 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~----~~~~~l  715 (912)
                      ++.+.||+|+||+||+|.++ +++.||+|++......  ....+.|.+|++++++++|||||++++++.+    ++..|+
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~l  106 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT--KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC--HHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEE
Confidence            56678999999999999876 6899999998654322  2356789999999999999999999999865    356899


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCC--eeecCCCCCCeEEc-CCCcEEEecccccc
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP--IVHRDISSKNVLLD-LGYEAHVSDFGIAK  792 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlk~~Nill~-~~~~~kl~Dfgla~  792 (912)
                      |||||++|+|.+++.+   .+.+++.++..|+.||+.||+|||++   +  |+||||||+|||++ .++.+||+|||+|+
T Consensus       107 vmEy~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~  180 (290)
T 3fpq_A          107 VTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence            9999999999999954   35689999999999999999999998   6  99999999999998 47899999999998


Q ss_pred             ccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChh
Q 039137          793 FLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLH  872 (912)
Q Consensus       793 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  872 (912)
                      ....  ......+||+.|||||++.+ .|+.++|||||||++|||+||+.||.....    .......+.....  +...
T Consensus       181 ~~~~--~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~----~~~~~~~i~~~~~--~~~~  251 (290)
T 3fpq_A          181 LKRA--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN----AAQIYRRVTSGVK--PASF  251 (290)
T ss_dssp             GCCT--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS----HHHHHHHHTTTCC--CGGG
T ss_pred             eCCC--CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc----HHHHHHHHHcCCC--CCCC
Confidence            6432  34456789999999998865 599999999999999999999999852111    0111111111111  1111


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          873 VQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       873 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ....++++.++|.+||++||++|||++|+++
T Consensus       252 ~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          252 DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            2223456889999999999999999998865

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.1e-49  Score=424.70  Aligned_cols=244  Identities=24%  Similarity=0.293  Sum_probs=198.0

Q ss_pred             cCCCCCceeeecCceEEEEEEeC----CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCee
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP----SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHS  713 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  713 (912)
                      ++|++.+.||+|+||+||+|+..    +++.||||++........  ...++.+|++++++++|||||++++++.+++..
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  101 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR--DRVRTKMERDILVEVNHPFIVKLHYAFQTEGKL  101 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE--ECC------CCCCCCCCTTEECEEEEEEETTEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH--HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence            57999999999999999999863    578899999875432211  234578899999999999999999999999999


Q ss_pred             eEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccc
Q 039137          714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKF  793 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  793 (912)
                      |+|||||+||+|.+++.+   .+.+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+.
T Consensus       102 ~ivmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~  175 (304)
T 3ubd_A          102 YLILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKE  175 (304)
T ss_dssp             EEEECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred             EEEEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEeccccccee
Confidence            999999999999999954   35699999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhh
Q 039137          794 LNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHV  873 (912)
Q Consensus       794 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  873 (912)
                      ...........+||+.|||||++.+..|+.++||||+||++|||+||+.||....     .......+.....+.|.   
T Consensus       176 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~-----~~~~~~~i~~~~~~~p~---  247 (304)
T 3ubd_A          176 SIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD-----RKETMTMILKAKLGMPQ---  247 (304)
T ss_dssp             -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHCCCCCCT---
T ss_pred             ccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC-----HHHHHHHHHcCCCCCCC---
Confidence            6555555667789999999999999999999999999999999999999986221     11222233334444443   


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCH
Q 039137          874 QKKLMSIMQVAFSCLDQNPESRPTM  898 (912)
Q Consensus       874 ~~~~~~l~~li~~cl~~dP~~RPt~  898 (912)
                       ..+.++.++|.+||++||++|||+
T Consensus       248 -~~s~~~~~li~~~L~~dP~~R~ta  271 (304)
T 3ubd_A          248 -FLSPEAQSLLRMLFKRNPANRLGA  271 (304)
T ss_dssp             -TSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred             -cCCHHHHHHHHHHcccCHHHCCCC
Confidence             234568899999999999999995

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.4e-48  Score=426.78  Aligned_cols=267  Identities=22%  Similarity=0.364  Sum_probs=215.6

Q ss_pred             HHHHHHHhcCCCCCceeeecCceEEEEEEeC------CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCC-Ccccc
Q 039137          630 YEEIISATNDFNAEHCIGKGGHGSVYRAKVP------SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH-RNIVK  702 (912)
Q Consensus       630 ~~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h-~niv~  702 (912)
                      ..+++...++|++.+.||+|+||+||+|++.      .++.||||++....   .....++|.+|++++++++| ||||+
T Consensus        56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~---~~~~~~~~~~E~~il~~l~hhpnIV~  132 (353)
T 4ase_A           56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVN  132 (353)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc---ChHHHHHHHHHHHHHHHcCCCCcEEE
Confidence            3455556789999999999999999999854      23679999987543   22356789999999999965 89999


Q ss_pred             EEEEEEcC-CeeeEEEeecCCCChhhHhhccCC-------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeec
Q 039137          703 FYGFCSHP-KHSFIIYEYLESGSLDKILCNDAS-------------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHR  768 (912)
Q Consensus       703 l~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~  768 (912)
                      ++|+|.++ +..++|||||++|+|.++++....             ...+++.++..|+.|||+||+|||++   +||||
T Consensus       133 l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHR  209 (353)
T 4ase_A          133 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR  209 (353)
T ss_dssp             EEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred             EEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecC
Confidence            99999765 568999999999999999965332             34589999999999999999999999   99999


Q ss_pred             CCCCCCeEEcCCCcEEEeccccccccCCCCCC--ccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcc
Q 039137          769 DISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN--WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRD  845 (912)
Q Consensus       769 Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~  845 (912)
                      ||||+|||+++++.+||+|||+|+........  .....||+.|||||++.+..|+.++|||||||++|||+| |+.||.
T Consensus       210 DLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~  289 (353)
T 4ase_A          210 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  289 (353)
T ss_dssp             CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             ccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCC
Confidence            99999999999999999999999876544332  234678999999999999999999999999999999998 999985


Q ss_pred             chhccccccccchhhhcc-CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          846 FLFEMSSSSSNMNIEMLD-SRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       846 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                      ....    .......+.+ .+.+.|.    ..+.++.+++.+||+.||++|||++|+++.|++.+.
T Consensus       290 ~~~~----~~~~~~~i~~g~~~~~p~----~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq  347 (353)
T 4ase_A          290 GVKI----DEEFCRRLKEGTRMRAPD----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  347 (353)
T ss_dssp             TCCC----SHHHHHHHHHTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCH----HHHHHHHHHcCCCCCCCc----cCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence            3211    1111111112 2233332    234568899999999999999999999999998764

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=3.6e-48  Score=454.21  Aligned_cols=412  Identities=20%  Similarity=0.205  Sum_probs=291.4

Q ss_pred             CCccEEEccCCcccccCCccccCCCCCcEEeccccccccccccccccccccceeecccccccCCCCccccCcccccEEEc
Q 039137          109 PHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLAL  188 (912)
Q Consensus       109 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l  188 (912)
                      ++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|+.+++|++|+|++|+++ .+|..  .+++|++|+|
T Consensus        21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L   97 (520)
T 2z7x_B           21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDL   97 (520)
T ss_dssp             TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEEC
T ss_pred             ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEec
Confidence            56666777777666665566666667777777777666656666666677777777777666 45555  5666777777


Q ss_pred             cCCcCCC-CCCccCCCCccceeeeeccCCCcCcccccccccccc--ceeecccccc--cCcccccccc------------
Q 039137          189 DSNFLNG-SIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSL--FDLELCINQL--SGAIPLSISN------------  251 (912)
Q Consensus       189 ~~n~l~~-~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L--~~L~l~~n~l--~~~~p~~~~~------------  251 (912)
                      ++|++++ .+|..|+++++|++|++++|.+++   ..+..+++|  +.|++++|++  .+..|..+..            
T Consensus        98 ~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~  174 (520)
T 2z7x_B           98 SFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPT  174 (520)
T ss_dssp             CSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCS
T ss_pred             cCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccccccceEEEEecc
Confidence            7776665 356666666677777776666654   345555555  6666666666  5555555554            


Q ss_pred             --------------ccccceeeecccc-------CcccCCcccCCccccchhhhccCccCCCCccccc---cccccceEe
Q 039137          252 --------------LTNLRFLFLYHNE-------LSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFR---NLTDLVKLR  307 (912)
Q Consensus       252 --------------l~~L~~L~L~~N~-------l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~---~l~~L~~L~  307 (912)
                                    +++|+.|++++|.       +.+.+| .+..+++|+.|++++|.+++..+..+.   ..++|++|+
T Consensus       175 n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~  253 (520)
T 2z7x_B          175 NKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFS  253 (520)
T ss_dssp             SSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEE
T ss_pred             Ccchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhccccccccCHHHHHHHHHHhhhCcccEEE
Confidence                          4455555555554       333333 445555555555555555432221111   124677777


Q ss_pred             cccccccCCCCccc-----CCCCCccEEEccCCcCccccc-ccCCCC---CCCCEEeccCCcccccccccccccccccEE
Q 039137          308 LNQNYLTGNISETF-----GTYPNLTFIDLSNNSFFGEIL-SDWGRC---PQLSLLDVSINNISGSIPLEIGESLQLQYL  378 (912)
Q Consensus       308 L~~n~l~~~~~~~~-----~~l~~L~~L~Ls~N~l~~~~~-~~~~~l---~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L  378 (912)
                      +++|.+++.+|..+     +.+++|+.+++++|.+  .+| ..+..+   .+|+.|++++|.+....  ....+++|++|
T Consensus       254 l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L  329 (520)
T 2z7x_B          254 ISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHL  329 (520)
T ss_dssp             EEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEE
T ss_pred             eecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEE
Confidence            77777777777766     7777888888888777  333 233332   56888888888876322  12577889999


Q ss_pred             EccCccccCCCCccccccccccEEEccCCcccC--CCccccccccccccccccCcccCc-cccccccccccccEEEeccc
Q 039137          379 DLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSG--CIPRELGSLINLEYLDLSANNLSN-FVPESLGSLVKLYYLNLSHN  455 (912)
Q Consensus       379 ~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N  455 (912)
                      ++++|++++.+|..+.++++|++|++++|++++  .+|..+..+++|++|+|++|++++ +++..+..+++|++|+|++|
T Consensus       330 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N  409 (520)
T 2z7x_B          330 DFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSN  409 (520)
T ss_dssp             ECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSS
T ss_pred             EeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCC
Confidence            999999998888889999999999999999986  556778889999999999999988 44445888899999999999


Q ss_pred             ccccccchhhhcccccceeeccccccCcccccccccccccccccccCccccCCCcccccccccceEEEccCCccccCCC
Q 039137          456 KLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIP  534 (912)
Q Consensus       456 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~~  534 (912)
                      ++++..|..+.  ++|++|+|++|+|+ .+|..+..+++|+.|++++|+|+++.+..|..+++|++|++++|++.|..+
T Consensus       410 ~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~  485 (520)
T 2z7x_B          410 ILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  485 (520)
T ss_dssp             CCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             CCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcccCC
Confidence            99887777664  78999999999997 567777799999999999999997655558889999999999999988543

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.6e-47  Score=410.96  Aligned_cols=263  Identities=25%  Similarity=0.327  Sum_probs=199.7

Q ss_pred             cCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCC----ee
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPK----HS  713 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----~~  713 (912)
                      .+|.+.+.||+|+||+||+|++ +|+.||||++...     ......+.+|+..+..++|||||+++|++.+++    ..
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~-----~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~   76 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc-----chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence            4688889999999999999998 6899999998532     112223345666677889999999999997654    57


Q ss_pred             eEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeeecCCCCCCeEEcCCCcEEEecc
Q 039137          714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNC-----FPPIVHRDISSKNVLLDLGYEAHVSDF  788 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~Dlk~~Nill~~~~~~kl~Df  788 (912)
                      |+|||||++|+|.++++.    ..++++++.+++.|++.||+|||+++     .++|+||||||+|||++.++++||+||
T Consensus        77 ~lV~Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DF  152 (303)
T 3hmm_A           77 WLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  152 (303)
T ss_dssp             EEEEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred             EEEecCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeC
Confidence            999999999999999954    35899999999999999999999762     348999999999999999999999999


Q ss_pred             ccccccCCCCCC----ccccccccccccccccccC------CCCcchhHHHHHHHHHHHHhCCCCccchhcccc------
Q 039137          789 GIAKFLNPDSSN----WSELAGTHGYVAPELAYTL------KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS------  852 (912)
Q Consensus       789 gla~~~~~~~~~----~~~~~g~~~y~aPE~~~~~------~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~------  852 (912)
                      |+|+........    .....||+.|||||++.+.      .++.++|||||||++|||+||..||........      
T Consensus       153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~  232 (303)
T 3hmm_A          153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV  232 (303)
T ss_dssp             TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred             CCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcc
Confidence            999876544322    2345799999999998764      367899999999999999999887642211100      


Q ss_pred             ----ccccchhhhccCCC--CCCC-hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          853 ----SSSNMNIEMLDSRL--PYPS-LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       853 ----~~~~~~~~~~~~~~--~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                          ..............  ..|. .........+.+++.+||+.||++||||.||++.|++...
T Consensus       233 ~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~  297 (303)
T 3hmm_A          233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence                00011111112211  1221 1223455678899999999999999999999999988654

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.7e-47  Score=409.92  Aligned_cols=250  Identities=22%  Similarity=0.433  Sum_probs=194.0

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCC-----
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPK-----  711 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-----  711 (912)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++....   .....+.+.+|++++++++|||||++++++.+.+     
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~   81 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL   81 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence            46999999999999999999876 79999999986542   2335678999999999999999999999986543     


Q ss_pred             -------eeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEE
Q 039137          712 -------HSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAH  784 (912)
Q Consensus       712 -------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  784 (912)
                             ..|+|||||++|+|.+++.........++..++.|+.||+.||+|||++   +|+||||||+|||++.++.+|
T Consensus        82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vK  158 (299)
T 4g31_A           82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVK  158 (299)
T ss_dssp             -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred             cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEE
Confidence                   3699999999999999997665556677788999999999999999999   999999999999999999999


Q ss_pred             EeccccccccCCCCC------------CccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhcccc
Q 039137          785 VSDFGIAKFLNPDSS------------NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS  852 (912)
Q Consensus       785 l~Dfgla~~~~~~~~------------~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~  852 (912)
                      |+|||+|+.......            .....+||+.|||||++.+..|+.++||||+||++|||++   ||....+.  
T Consensus       159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~--  233 (299)
T 4g31_A          159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER--  233 (299)
T ss_dssp             ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHH--
T ss_pred             EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHH--
Confidence            999999987654322            1234579999999999999999999999999999999996   76421110  


Q ss_pred             ccccchhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          853 SSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       853 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                        ..........  ..++ ......+...++|.+||++||++|||+.|+++
T Consensus       234 --~~~~~~~~~~--~~p~-~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          234 --VRTLTDVRNL--KFPP-LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             --HHHHHHHHTT--CCCH-HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --HHHHHHHhcC--CCCC-CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence              0111111122  2222 23344556778999999999999999999875

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=8.3e-47  Score=445.92  Aligned_cols=459  Identities=23%  Similarity=0.208  Sum_probs=369.6

Q ss_pred             eEecCCCCeEEEeeccccccccccccccCCCCCccEEEccCCcccccCCccccCCCCCcEEecccccccccccccccccc
Q 039137           78 IFCNHAERVVGINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLT  157 (912)
Q Consensus        78 v~c~~~~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~  157 (912)
                      ..|...+ |  .+..+.++. .+++ .+  .++|++|+|++|++++..|..|+++++|++|+|++|++++..|..|+.++
T Consensus         2 ~~C~~~~-~--c~~~~~~l~-~ip~-~~--~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~   74 (549)
T 2z81_A            2 LSCDASG-V--CDGRSRSFT-SIPS-GL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLG   74 (549)
T ss_dssp             CEECTTS-E--EECTTSCCS-SCCS-CC--CTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCT
T ss_pred             ccCCCCc-e--EECCCCccc-cccc-cC--CCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccc
Confidence            3587544 3  455555544 2222 22  37899999999999999899999999999999999999988889999999


Q ss_pred             ccceeecccccccCCCCccccCcccccEEEccCCcCCC-CCCccCCCCccceeeeeccCCCcCccc-cccccccccceee
Q 039137          158 HLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNG-SIPRSLGNLTHVVILYLYNNSFFGSIP-QEIGNLKSLFDLE  235 (912)
Q Consensus       158 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~-~~p~~~~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~  235 (912)
                      +|++|+|++|.+++..|..|+.+++|++|++++|++++ .+|..++++++|++|++++|.+.+.+| ..++++++|++|+
T Consensus        75 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~  154 (549)
T 2z81_A           75 SLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELE  154 (549)
T ss_dssp             TCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEE
T ss_pred             cCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeee
Confidence            99999999999998777789999999999999999987 467899999999999999999655665 6899999999999


Q ss_pred             cccccccCccccccccccccceeeeccccCcccCCcccCCccccchhhhccCccCCCC--c-cccccccccceEeccccc
Q 039137          236 LCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTV--P-KSFRNLTDLVKLRLNQNY  312 (912)
Q Consensus       236 l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~--~-~~~~~l~~L~~L~L~~n~  312 (912)
                      +++|++++..|..++.+++|++|+++.|.+.......+..+++|++|++++|++++..  | .....+++|+.|++++|.
T Consensus       155 L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~  234 (549)
T 2z81_A          155 IKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSV  234 (549)
T ss_dssp             EEETTCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCE
T ss_pred             ccCCcccccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccc
Confidence            9999999999999999999999999999987543333467899999999999999752  2 234567899999999999


Q ss_pred             ccCCCC----cccCCCCCccEEEccCCcCccccc------ccCC-----------------------------CCCCCCE
Q 039137          313 LTGNIS----ETFGTYPNLTFIDLSNNSFFGEIL------SDWG-----------------------------RCPQLSL  353 (912)
Q Consensus       313 l~~~~~----~~~~~l~~L~~L~Ls~N~l~~~~~------~~~~-----------------------------~l~~L~~  353 (912)
                      +++..+    ..+..+++|+.+++++|.+.+...      ..+.                             .+++|+.
T Consensus       235 l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~  314 (549)
T 2z81_A          235 LTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKR  314 (549)
T ss_dssp             EEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCE
T ss_pred             cchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceE
Confidence            886443    345678899999999998765311      0111                             1356788


Q ss_pred             EeccCCcccccccccc-cccccccEEEccCccccCCCCc---cccccccccEEEccCCcccCCCc--ccccccccccccc
Q 039137          354 LDVSINNISGSIPLEI-GESLQLQYLDLSSNYIVGEIPT---QLGNIIYLNRLSLSGNKLSGCIP--RELGSLINLEYLD  427 (912)
Q Consensus       354 L~Ls~N~l~~~~~~~~-~~~~~L~~L~L~~N~l~~~~~~---~l~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~  427 (912)
                      |++++|++. .+|..+ ..+++|++|+|++|++++.+|.   .++.+++|++|++++|++++..+  ..+..+++|++|+
T Consensus       315 L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~  393 (549)
T 2z81_A          315 ITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLD  393 (549)
T ss_dssp             EEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEE
T ss_pred             EEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEE
Confidence            888888876 566555 5788999999999999876643   47788999999999999986533  5688899999999


Q ss_pred             ccCcccCccccccccccccccEEEecccccccccchhhhcccccceeeccccccCcccccccccccccccccccCccccC
Q 039137          428 LSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSG  507 (912)
Q Consensus       428 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~  507 (912)
                      +++|+++. +|..+..+++|++|+|++|++++ +|..+.  ++|++|+|++|+|++.+    ..+++|+.|+|++|+|+.
T Consensus       394 Ls~N~l~~-lp~~~~~~~~L~~L~Ls~N~l~~-l~~~~~--~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~~  465 (549)
T 2z81_A          394 ISRNTFHP-MPDSCQWPEKMRFLNLSSTGIRV-VKTCIP--QTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLKT  465 (549)
T ss_dssp             CTTCCCCC-CCSCCCCCTTCCEEECTTSCCSC-CCTTSC--TTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCSS
T ss_pred             CCCCCCcc-CChhhcccccccEEECCCCCccc-ccchhc--CCceEEECCCCChhhhc----ccCChhcEEECCCCccCc
Confidence            99999985 67788889999999999999974 444432  68999999999998753    578999999999999995


Q ss_pred             CCcccccccccceEEEccCCccccCCCCC-ccCCCCchhhhccCCccc
Q 039137          508 LIPRCFEEMHGLLHIDISYNKLEGQIPNS-TTFRDAPLEALQGNKGLY  554 (912)
Q Consensus       508 ~~p~~~~~l~~L~~l~ls~N~l~~~~~~~-~~~~~~~~~~l~~n~~~~  554 (912)
                      + |. ...+++|+.|++++|++++.+|.. ..+.......+.+|+-.|
T Consensus       466 i-p~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~  511 (549)
T 2z81_A          466 L-PD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDC  511 (549)
T ss_dssp             C-CC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCC
T ss_pred             C-CC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccC
Confidence            4 54 467899999999999999877753 344444444566665433

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.8e-46  Score=439.73  Aligned_cols=425  Identities=22%  Similarity=0.212  Sum_probs=335.5

Q ss_pred             cEEEccCCcccccCCccccCCCCCcEEeccccccccccccccccccccceeecccccccCCCCccccCcccccEEEccCC
Q 039137          112 VYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSN  191 (912)
Q Consensus       112 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n  191 (912)
                      ++||+++|+++ .+|..+.  ++|++|||++|++++..|..|..+++|++|+|++|++++..|..|+++++|++|+|++|
T Consensus         3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N   79 (520)
T 2z7x_B            3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN   79 (520)
T ss_dssp             CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred             ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence            47999999999 5888776  89999999999999888889999999999999999999888999999999999999999


Q ss_pred             cCCCCCCccCCCCccceeeeeccCCCcC-ccccccccccccceeecccccccCcccccccccccc--ceeeeccccC--c
Q 039137          192 FLNGSIPRSLGNLTHVVILYLYNNSFFG-SIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNL--RFLFLYHNEL--S  266 (912)
Q Consensus       192 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L--~~L~L~~N~l--~  266 (912)
                      +++ .+|..  .+++|++|+|++|.+++ .+|..++++++|++|++++|++++   ..+..+++|  ++|++++|++  .
T Consensus        80 ~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~  153 (520)
T 2z7x_B           80 KLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGE  153 (520)
T ss_dssp             CCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTS
T ss_pred             cee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeeccccccc
Confidence            999 67777  89999999999999997 578999999999999999999986   457778888  9999999999  7


Q ss_pred             ccCCcccCC--------------------------ccccchhhhccCc-------cCCCCccccccccccceEecccccc
Q 039137          267 GIIPQEIGN--------------------------LKKLNSLLLAKNH-------FRGTVPKSFRNLTDLVKLRLNQNYL  313 (912)
Q Consensus       267 ~~~~~~l~~--------------------------l~~L~~L~L~~N~-------l~~~~~~~~~~l~~L~~L~L~~n~l  313 (912)
                      +..|..+..                          +++|+.|++++|.       +.+.+| .+..+++|+.|++++|.+
T Consensus       154 ~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l  232 (520)
T 2z7x_B          154 KEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIET  232 (520)
T ss_dssp             SCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEE
T ss_pred             ccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhcccccccc
Confidence            777777766                          4455555555554       443333 455556666666666555


Q ss_pred             cCCCCccc---CCCCCccEEEccCCcCcccccccC-----CCCCCCCEEeccCCccccccc-cccccc---ccccEEEcc
Q 039137          314 TGNISETF---GTYPNLTFIDLSNNSFFGEILSDW-----GRCPQLSLLDVSINNISGSIP-LEIGES---LQLQYLDLS  381 (912)
Q Consensus       314 ~~~~~~~~---~~l~~L~~L~Ls~N~l~~~~~~~~-----~~l~~L~~L~Ls~N~l~~~~~-~~~~~~---~~L~~L~L~  381 (912)
                      ++..+..+   ...++|++|++++|++.+.+|..+     +.+++|+.+++++|.+  .+| ..+..+   .+|+.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~  310 (520)
T 2z7x_B          233 TWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVS  310 (520)
T ss_dssp             EHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEE
T ss_pred             CHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcC
Confidence            43221111   013467777777777776667666     6777777777777777  344 333333   467888888


Q ss_pred             CccccCCCCccccccccccEEEccCCcccCCCccccccccccccccccCcccCc--cccccccccccccEEEeccccccc
Q 039137          382 SNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSN--FVPESLGSLVKLYYLNLSHNKLSQ  459 (912)
Q Consensus       382 ~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~  459 (912)
                      +|.+.+..  .+..+++|++|++++|++++..|..+..+++|++|+|++|++++  ..|..+..+++|++|+|++|++++
T Consensus       311 ~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~  388 (520)
T 2z7x_B          311 GTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSY  388 (520)
T ss_dssp             SSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBC
T ss_pred             CCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCc
Confidence            88776432  12678899999999999999899999999999999999999997  456789999999999999999998


Q ss_pred             ccch-hhhcccccceeeccccccCcccccccccccccccccccCccccCCCcccccccccceEEEccCCccccCCCCC--
Q 039137          460 QIPI-ELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNS--  536 (912)
Q Consensus       460 ~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~~~~--  536 (912)
                      .+|. .+..+++|++|++++|++++..|..+.  ++|+.|++++|+|+ .+|..+..+++|++|++++|+++. +|..  
T Consensus       389 ~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~-l~~~~~  464 (520)
T 2z7x_B          389 DEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKS-VPDGIF  464 (520)
T ss_dssp             CGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CCTTTT
T ss_pred             ccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCc-cCHHHh
Confidence            5665 488899999999999999988777664  79999999999999 457667799999999999999995 4432  


Q ss_pred             ccCCCCchhhhccCCccc
Q 039137          537 TTFRDAPLEALQGNKGLY  554 (912)
Q Consensus       537 ~~~~~~~~~~l~~n~~~~  554 (912)
                      ..+.......+.+|+-.|
T Consensus       465 ~~l~~L~~L~l~~N~~~c  482 (520)
T 2z7x_B          465 DRLTSLQKIWLHTNPWDC  482 (520)
T ss_dssp             TTCTTCCEEECCSSCBCC
T ss_pred             ccCCcccEEECcCCCCcc
Confidence            233333334455665433

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=3.1e-44  Score=431.80  Aligned_cols=419  Identities=21%  Similarity=0.224  Sum_probs=218.4

Q ss_pred             CccEEEccCCcccccCCccccCCCCCcEEeccccccccccccccccccccceeecccccccCCCCccccCcccccEEEcc
Q 039137          110 HLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALD  189 (912)
Q Consensus       110 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~  189 (912)
                      ++++|||++|+|++..|.+|.++++|++|||++|+|++..|.+|++|++|++|+|++|++++..|..|+++++|++|+|+
T Consensus        53 ~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls  132 (635)
T 4g8a_A           53 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV  132 (635)
T ss_dssp             TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECT
T ss_pred             CCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECC
Confidence            45566666666655555556666666666666666654444555566666666666666654444455566666666666


Q ss_pred             CCcCCCCCCccCCCCccceeeeeccCCCcC-ccccccccccccceeecccccccCccccccccccccc----eeeecccc
Q 039137          190 SNFLNGSIPRSLGNLTHVVILYLYNNSFFG-SIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLR----FLFLYHNE  264 (912)
Q Consensus       190 ~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~----~L~L~~N~  264 (912)
                      +|++++..+..|+++++|++|+|++|.+++ .+|..++++++|++|++++|++++..|..+..+.+++    .++++.|.
T Consensus       133 ~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~  212 (635)
T 4g8a_A          133 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP  212 (635)
T ss_dssp             TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCC
T ss_pred             CCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCc
Confidence            666654444455666666666666665543 2455555566666666666666555555554444332    34444554


Q ss_pred             CcccCCcccCCc--------------------------------------------------------------------
Q 039137          265 LSGIIPQEIGNL--------------------------------------------------------------------  276 (912)
Q Consensus       265 l~~~~~~~l~~l--------------------------------------------------------------------  276 (912)
                      ++.+.+..+..+                                                                    
T Consensus       213 l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~  292 (635)
T 4g8a_A          213 MNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD  292 (635)
T ss_dssp             CCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCC
T ss_pred             ccccCcccccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhc
Confidence            443322222111                                                                    


Q ss_pred             -------------cccchhhhccCccCCCCccccccccccceEecccccccCCCCccc-------------------CCC
Q 039137          277 -------------KKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETF-------------------GTY  324 (912)
Q Consensus       277 -------------~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~-------------------~~l  324 (912)
                                   .+++.+++.+|.+...  ..+....+|+.|++.+|.+.+..+..+                   ..+
T Consensus       293 ~~~~~~~~~~~~~~~l~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l  370 (635)
T 4g8a_A          293 YYLDGIIDLFNCLTNVSSFSLVSVTIERV--KDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDL  370 (635)
T ss_dssp             SCEEECTTTTGGGTTCSEEEEESCEEEEC--GGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCBC
T ss_pred             ccccchhhhhhhhcccccccccccccccc--cccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCcccccc
Confidence                         1111122222221111  112233445555555555543332211                   123


Q ss_pred             CCccEEEccCCcCccc--ccccCCCCCCCCEEeccCCcccccccccccccccccEEEccCccccCCCC-ccccccccccE
Q 039137          325 PNLTFIDLSNNSFFGE--ILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIP-TQLGNIIYLNR  401 (912)
Q Consensus       325 ~~L~~L~Ls~N~l~~~--~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~-~~l~~l~~L~~  401 (912)
                      ++|+.|++++|.+...  .+..+..+.+|+.++++.|.+. ..+..+..+++|+.+++++|......+ ..+..+.+++.
T Consensus       371 ~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~-~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~  449 (635)
T 4g8a_A          371 PSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY  449 (635)
T ss_dssp             TTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEE-EECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCE
T ss_pred             cccccchhhccccccccccccchhhhhhhhhhhccccccc-cccccccccccccchhhhhcccccccccccccccccccc
Confidence            3444444444443221  1222233344444444444443 223344455555555555555443322 34455556666


Q ss_pred             EEccCCcccCCCccccccccccccccccCccc-CccccccccccccccEEEecccccccccchhhhcccccceeeccccc
Q 039137          402 LSLSGNKLSGCIPRELGSLINLEYLDLSANNL-SNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNF  480 (912)
Q Consensus       402 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l-~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  480 (912)
                      ++++.|++.+..+..+..++.|+.|+|++|++ .+..|..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+
T Consensus       450 l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~  529 (635)
T 4g8a_A          450 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNN  529 (635)
T ss_dssp             EECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSC
T ss_pred             ccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCc
Confidence            66666666655555666666666666666653 33455556666666666666666666566666666666666666666


Q ss_pred             cCcccccccccccccccccccCccccCCCccccccc-ccceEEEccCCcccc
Q 039137          481 LGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEM-HGLLHIDISYNKLEG  531 (912)
Q Consensus       481 l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l-~~L~~l~ls~N~l~~  531 (912)
                      |++..+..|..+++|+.|+|++|+|++..|..|..+ ++|++|++++|+|.|
T Consensus       530 l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C  581 (635)
T 4g8a_A          530 FFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC  581 (635)
T ss_dssp             CCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCC
T ss_pred             CCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcc
Confidence            666666666666666666666666666666666655 456666666666665

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=1.2e-44  Score=428.00  Aligned_cols=429  Identities=20%  Similarity=0.198  Sum_probs=334.1

Q ss_pred             EEEeeccccccccccccccCCCCCccEEEccCCcccccCCccccCCCCCcEEeccccccccccccccccccccceeeccc
Q 039137           87 VGINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISR  166 (912)
Q Consensus        87 ~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~  166 (912)
                      ..++++++++.+ ++. .+  .++|++|+|++|++++..|..|.++++|++|+|++|++++..|+.|+++++|++|+|++
T Consensus        34 ~~l~ls~~~L~~-ip~-~~--~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  109 (562)
T 3a79_B           34 SMVDYSNRNLTH-VPK-DL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSH  109 (562)
T ss_dssp             CEEECTTSCCCS-CCT-TS--CTTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTT
T ss_pred             cEEEcCCCCCcc-CCC-CC--CCCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCC
Confidence            456777777664 332 22  27899999999999988888999999999999999999988889999999999999999


Q ss_pred             ccccCCCCccccCcccccEEEccCCcCCC-CCCccCCCCccceeeeeccCCCcCcccccccccccc--ceeecccccc--
Q 039137          167 NWLSGSIPHEVGQLTVLNQLALDSNFLNG-SIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSL--FDLELCINQL--  241 (912)
Q Consensus       167 n~l~~~~p~~~~~l~~L~~L~l~~n~l~~-~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L--~~L~l~~n~l--  241 (912)
                      |+++ .+|..  .+++|++|+|++|++++ .+|..|+++++|++|++++|.+++.   .+..+++|  +.|++++|++  
T Consensus       110 N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~  183 (562)
T 3a79_B          110 NRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHI  183 (562)
T ss_dssp             SCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCC
T ss_pred             CcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccc
Confidence            9998 77877  89999999999999986 4568999999999999999999863   45555666  9999999999  


Q ss_pred             cCcccccccccc--ccceeeeccccCcccCCc-ccCCccccchhhhccCcc-----CCCCccccccc-------------
Q 039137          242 SGAIPLSISNLT--NLRFLFLYHNELSGIIPQ-EIGNLKKLNSLLLAKNHF-----RGTVPKSFRNL-------------  300 (912)
Q Consensus       242 ~~~~p~~~~~l~--~L~~L~L~~N~l~~~~~~-~l~~l~~L~~L~L~~N~l-----~~~~~~~~~~l-------------  300 (912)
                      ++..|..+..+.  .| .++++.|.+.+.++. .+.++++|+.|++++|+.     .+. ...|..+             
T Consensus       184 ~~~~~~~l~~l~~~~l-~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~-~~~l~~l~~L~~L~L~~~~l  261 (562)
T 3a79_B          184 KGGETESLQIPNTTVL-HLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTF-LSELTRGPTLLNVTLQHIET  261 (562)
T ss_dssp             CSSSCCEEEECCEEEE-EEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHH-HHHHHSCSSCEEEEEEEEEE
T ss_pred             cccCcccccccCcceE-EEEecCccchhhhhhhcccccceEEEecccccccccchHHHH-HHHHhccCcceEEEecCCcC
Confidence            888888877754  33 456677777664443 355677777777777641     110 1112222             


Q ss_pred             --------------cccceEecccccccCCCCccc-----CCCCCccEEEccCCcCccccc-ccCC---CCCCCCEEecc
Q 039137          301 --------------TDLVKLRLNQNYLTGNISETF-----GTYPNLTFIDLSNNSFFGEIL-SDWG---RCPQLSLLDVS  357 (912)
Q Consensus       301 --------------~~L~~L~L~~n~l~~~~~~~~-----~~l~~L~~L~Ls~N~l~~~~~-~~~~---~l~~L~~L~Ls  357 (912)
                                    ++|++|++++|.+++.+|..+     ..++.|+.++++.|.+  .+| ..+.   ...+|+.|+++
T Consensus       262 ~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~L~l~  339 (562)
T 3a79_B          262 TWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSKEALYSVFAEMNIKMLSIS  339 (562)
T ss_dssp             CHHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCCCSEEEEE
T ss_pred             cHHHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhccccee--ecChhhhhhhhccCcceEEEcc
Confidence                          367777777777776666655     5566666666666655  222 1111   12568888888


Q ss_pred             CCcccccccccccccccccEEEccCccccCCCCccccccccccEEEccCCcccCC--CccccccccccccccccCcccCc
Q 039137          358 INNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGC--IPRELGSLINLEYLDLSANNLSN  435 (912)
Q Consensus       358 ~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~  435 (912)
                      +|.+....  ....+++|++|++++|++++.+|..+.++++|++|++++|++++.  +|..+..+++|++|++++|++++
T Consensus       340 ~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~  417 (562)
T 3a79_B          340 DTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNS  417 (562)
T ss_dssp             SSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBS
T ss_pred             CCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCC
Confidence            88875322  126788999999999999998999999999999999999999963  35678999999999999999998


Q ss_pred             -cccccccccccccEEEecccccccccchhhhcccccceeeccccccCcccccccccccccccccccCccccCCCccccc
Q 039137          436 -FVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFE  514 (912)
Q Consensus       436 -~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~  514 (912)
                       +.+..+..+++|++|+|++|++++..|..+.  ++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|+++.+..|.
T Consensus       418 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~  494 (562)
T 3a79_B          418 HAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFD  494 (562)
T ss_dssp             CCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTT
T ss_pred             ccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHh
Confidence             5555688999999999999999887776654  78999999999997 4666666999999999999999976555599


Q ss_pred             ccccceEEEccCCccccCCC
Q 039137          515 EMHGLLHIDISYNKLEGQIP  534 (912)
Q Consensus       515 ~l~~L~~l~ls~N~l~~~~~  534 (912)
                      .+++|+.|++++|+|.|..+
T Consensus       495 ~l~~L~~L~l~~N~~~c~c~  514 (562)
T 3a79_B          495 RLTSLQYIWLHDNPWDCTCP  514 (562)
T ss_dssp             TCTTCCCEECCSCCBCCCHH
T ss_pred             cCCCCCEEEecCCCcCCCcc
Confidence            99999999999999998655

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-44  Score=402.85  Aligned_cols=257  Identities=22%  Similarity=0.326  Sum_probs=200.0

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC------
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP------  710 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------  710 (912)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++......  ....+.+.+|+++|+.++|||||++++++...      
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~  131 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDV--VTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF  131 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSS--HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccc--hHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence            57999999999999999999876 7999999999754332  23567789999999999999999999998643      


Q ss_pred             CeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccc
Q 039137          711 KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGI  790 (912)
Q Consensus       711 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl  790 (912)
                      +..|+|||||+ |+|.+++.   ..+.+++.++..+++||+.||+|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       132 ~~~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGl  204 (398)
T 4b99_A          132 KSVYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGM  204 (398)
T ss_dssp             CCEEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred             CEEEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecce
Confidence            57899999996 57999984   345799999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCC----CCCccccccccccccccccccCC-CCcchhHHHHHHHHHHHHhCCCCccchhcccccc---------c-
Q 039137          791 AKFLNPD----SSNWSELAGTHGYVAPELAYTLK-VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS---------S-  855 (912)
Q Consensus       791 a~~~~~~----~~~~~~~~g~~~y~aPE~~~~~~-~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~---------~-  855 (912)
                      |+.+...    .......+||+.|||||++.+.. ++.++||||+||++|||++|++||..........         . 
T Consensus       205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~  284 (398)
T 4b99_A          205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP  284 (398)
T ss_dssp             CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG
T ss_pred             eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            9876432    22345678999999999988754 6999999999999999999999996321100000         0 


Q ss_pred             --------cchhhhcc---CCCCCCC-hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          856 --------NMNIEMLD---SRLPYPS-LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       856 --------~~~~~~~~---~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                              ........   ...+.+. ......+..+.++|.+||+.||++|||++|+++
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                    00000000   0111110 001122456889999999999999999998764

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=7.1e-44  Score=410.51  Aligned_cols=391  Identities=21%  Similarity=0.207  Sum_probs=286.6

Q ss_pred             cEEEccCCcccccCCccccCCCCCcEEeccccccccccccccccccccceeecccccccCCC-CccccCcccccEEEccC
Q 039137          112 VYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSI-PHEVGQLTVLNQLALDS  190 (912)
Q Consensus       112 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~l~~  190 (912)
                      +.++.++++++ .+|. +.  ++|++|||++|++++..|..|+.+++|++|+|++|.+.+.+ |..|+++++|++|+|++
T Consensus        13 ~~~~c~~~~l~-~lp~-l~--~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~   88 (455)
T 3v47_A           13 YNAICINRGLH-QVPE-LP--AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY   88 (455)
T ss_dssp             TEEECCSSCCS-SCCC-CC--TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTT
T ss_pred             cccCcCCCCcc-cCCC-CC--CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCC
Confidence            46788888887 5665 33  78999999999998878888999999999999999887665 56788888888998888


Q ss_pred             CcCCCCCCccCCCCccceeeeeccCCCcCccccc--cccccccceeecccccccCccccc-cccccccceeeeccccCcc
Q 039137          191 NFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQE--IGNLKSLFDLELCINQLSGAIPLS-ISNLTNLRFLFLYHNELSG  267 (912)
Q Consensus       191 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~--~~~l~~L~~L~l~~n~l~~~~p~~-~~~l~~L~~L~L~~N~l~~  267 (912)
                      |++++..|..|+++++|++|+|++|.+++.+|..  ++++++|++|++++|++++..|.. +.++++|++|++++|++++
T Consensus        89 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~  168 (455)
T 3v47_A           89 NQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKS  168 (455)
T ss_dssp             CTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSC
T ss_pred             CccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccc
Confidence            8888777888888888888888888888755554  777777888888777777666655 6777777777777777777


Q ss_pred             cCCcccCCc--cccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCcccccccC
Q 039137          268 IIPQEIGNL--KKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDW  345 (912)
Q Consensus       268 ~~~~~l~~l--~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~  345 (912)
                      ..+..+..+  .+|+.|++++|.+.+..+..+..                .....+..+++|++|++++|++.+..+..+
T Consensus       169 ~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~----------------~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~  232 (455)
T 3v47_A          169 ICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGW----------------EKCGNPFKNTSITTLDLSGNGFKESMAKRF  232 (455)
T ss_dssp             CCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTH----------------HHHCCTTTTCEEEEEECTTSCCCHHHHHHH
T ss_pred             cChhhhhccccccccccccccCcccccchhhccc----------------cccccccccceeeeEecCCCcccccchhhh
Confidence            666666655  45666666666665443332210                000112234455555555555554444433


Q ss_pred             CC---CCCCCEEeccCCcccccccccccccccccEEEccCccccCCCCccccc--cccccEEEccCCcccCCCccccccc
Q 039137          346 GR---CPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGN--IIYLNRLSLSGNKLSGCIPRELGSL  420 (912)
Q Consensus       346 ~~---l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~--l~~L~~L~L~~N~l~~~~p~~~~~l  420 (912)
                      ..   .++|+.|++++|.+.+..              +..+.+.+..+..+..  .++|+.|++++|++++..|..+..+
T Consensus       233 ~~~~~~~~L~~L~l~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l  298 (455)
T 3v47_A          233 FDAIAGTKIQSLILSNSYNMGSS--------------FGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHF  298 (455)
T ss_dssp             HHHTTTCCEEEEECTTCTTTSCC--------------TTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTC
T ss_pred             hccccccceeeEeeccccccccc--------------cchhhhccCcccccccccccCceEEEecCccccccchhhcccC
Confidence            22   245555555555443221              1112222222222332  2578888888888888788888888


Q ss_pred             cccccccccCcccCccccccccccccccEEEecccccccccchhhhcccccceeeccccccCcccccccccccccccccc
Q 039137          421 INLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNL  500 (912)
Q Consensus       421 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l  500 (912)
                      ++|++|+|++|++++..|..|..+++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|..+++|+.|++
T Consensus       299 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  378 (455)
T 3v47_A          299 TDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELAL  378 (455)
T ss_dssp             TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred             CCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEEC
Confidence            88888888888888888888888899999999999998888888888999999999999998888888999999999999


Q ss_pred             cCccccCCCcccccccccceEEEccCCccccCCCCC
Q 039137          501 SYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNS  536 (912)
Q Consensus       501 s~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~~~~  536 (912)
                      ++|+|++..+..|..+++|+.|++++|+++|.+|..
T Consensus       379 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~  414 (455)
T 3v47_A          379 DTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI  414 (455)
T ss_dssp             CSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred             CCCccccCCHhHhccCCcccEEEccCCCcccCCCcc
Confidence            999999888888889999999999999999988754

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=8.8e-44  Score=409.73  Aligned_cols=364  Identities=23%  Similarity=0.261  Sum_probs=284.4

Q ss_pred             CCccEEEccCCcccccCCccccCCCCCcEEecccccccccc-ccccccccccceeecccccccCCCCccccCcccccEEE
Q 039137          109 PHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQI-PSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLA  187 (912)
Q Consensus       109 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~-p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~  187 (912)
                      ++|++|+|++|++++..|..|+++++|++|+|++|.+.+.+ |..|+++++|++|+|++|.+++..|..|+++++|++|+
T Consensus        30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~  109 (455)
T 3v47_A           30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT  109 (455)
T ss_dssp             TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred             CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence            78999999999999988999999999999999999998666 56799999999999999999988899999999999999


Q ss_pred             ccCCcCCCCCCcc--CCCCccceeeeeccCCCcCccccc-cccccccceeecccccccCccccccccc--cccceeeecc
Q 039137          188 LDSNFLNGSIPRS--LGNLTHVVILYLYNNSFFGSIPQE-IGNLKSLFDLELCINQLSGAIPLSISNL--TNLRFLFLYH  262 (912)
Q Consensus       188 l~~n~l~~~~p~~--~~~l~~L~~L~L~~n~l~~~~p~~-~~~l~~L~~L~l~~n~l~~~~p~~~~~l--~~L~~L~L~~  262 (912)
                      |++|++++.+|..  ++++++|++|+|++|.+++..|.. ++++++|++|++++|++++..|..+..+  .+|+.|++++
T Consensus       110 L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~  189 (455)
T 3v47_A          110 LTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSS  189 (455)
T ss_dssp             CTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTT
T ss_pred             CCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhcccccccccccccc
Confidence            9999999866665  999999999999999999888876 8999999999999999999999888877  7999999999


Q ss_pred             ccCcccCCcccC--------CccccchhhhccCccCCCCccccccc---cccceEecccccccCCCCcccCCCCCccEEE
Q 039137          263 NELSGIIPQEIG--------NLKKLNSLLLAKNHFRGTVPKSFRNL---TDLVKLRLNQNYLTGNISETFGTYPNLTFID  331 (912)
Q Consensus       263 N~l~~~~~~~l~--------~l~~L~~L~L~~N~l~~~~~~~~~~l---~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  331 (912)
                      |.+.+..+..+.        .+++|++|++++|++++..|..+...   ++|+.|++++|.+.+                
T Consensus       190 n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~----------------  253 (455)
T 3v47_A          190 ITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMG----------------  253 (455)
T ss_dssp             CBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTS----------------
T ss_pred             CcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccc----------------
Confidence            999976554432        44566666666666665555555443   445555555544332                


Q ss_pred             ccCCcCcccccccCCCCCCCCEEeccCCcccccccccccc--cccccEEEccCccccCCCCccccccccccEEEccCCcc
Q 039137          332 LSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGE--SLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKL  409 (912)
Q Consensus       332 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~--~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l  409 (912)
                              ...              ..+.+....+..+..  .++|++|++++|++++..|..+..+++|++|++++|++
T Consensus       254 --------~~~--------------~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l  311 (455)
T 3v47_A          254 --------SSF--------------GHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEI  311 (455)
T ss_dssp             --------CCT--------------TCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCC
T ss_pred             --------ccc--------------chhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcc
Confidence                    111              111111111122222  24677777777777766677777777777777777777


Q ss_pred             cCCCccccccccccccccccCcccCccccccccccccccEEEecccccccccchhhhcccccceeeccccccCccccccc
Q 039137          410 SGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRI  489 (912)
Q Consensus       410 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~  489 (912)
                      ++..|..|..+++|++|+|++|++++..|..|..+++|++|+|++|++++..|..|.++++|++|+|++|+|++..+..|
T Consensus       312 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  391 (455)
T 3v47_A          312 NKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIF  391 (455)
T ss_dssp             CEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTT
T ss_pred             cccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHh
Confidence            77667777777778888888888877777777778888888888888877777778888888888888888877777777


Q ss_pred             ccccccccccccCccccCCCc
Q 039137          490 CRMESLEKLNLSYNNLSGLIP  510 (912)
Q Consensus       490 ~~l~~L~~L~ls~N~l~~~~p  510 (912)
                      ..+++|+.|++++|++++..|
T Consensus       392 ~~l~~L~~L~l~~N~l~~~~~  412 (455)
T 3v47_A          392 DRLTSLQKIWLHTNPWDCSCP  412 (455)
T ss_dssp             TTCTTCCEEECCSSCBCCCTT
T ss_pred             ccCCcccEEEccCCCcccCCC
Confidence            788888888888888887766

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=9.4e-44  Score=391.58  Aligned_cols=198  Identities=28%  Similarity=0.369  Sum_probs=171.0

Q ss_pred             HHHHhcCCCCCceeeecCceEEEEEEeC----CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEE
Q 039137          633 IISATNDFNAEHCIGKGGHGSVYRAKVP----SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFC  707 (912)
Q Consensus       633 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~  707 (912)
                      +....++|++.+.||+|+||+||+|+++    +++.||+|++....      ...++.+|+++++.+ +||||+++++++
T Consensus        16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~------~~~~~~~E~~~l~~~~~h~nIv~l~~~~   89 (361)
T 4f9c_A           16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS------HPIRIAAELQCLTVAGGQDNVMGVKYCF   89 (361)
T ss_dssp             SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS------CHHHHHHHHHHHHHTCSBTTBCCCSEEE
T ss_pred             cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc------CHHHHHHHHHHHHHhcCCCCCceEEEEE
Confidence            3345688999999999999999999753    46789999986432      245678999999998 699999999999


Q ss_pred             EcCCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCC-CcEEEe
Q 039137          708 SHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLG-YEAHVS  786 (912)
Q Consensus       708 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~  786 (912)
                      .+.++.|+||||+++|+|.+++      +.+++.+++.+++|++.||+|||++   +|+||||||+|||++.+ +.+||+
T Consensus        90 ~~~~~~~lvmE~~~g~~L~~~~------~~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~  160 (361)
T 4f9c_A           90 RKNDHVVIAMPYLEHESFLDIL------NSLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALV  160 (361)
T ss_dssp             EETTEEEEEEECCCCCCHHHHH------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEEC
T ss_pred             EECCEEEEEEeCCCcccHHHHH------cCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEEC
Confidence            9999999999999999999998      2488999999999999999999999   99999999999999876 799999


Q ss_pred             ccccccccCCCCC----------------------------CccccccccccccccccccC-CCCcchhHHHHHHHHHHH
Q 039137          787 DFGIAKFLNPDSS----------------------------NWSELAGTHGYVAPELAYTL-KVTEKCDVYSFGVLALEV  837 (912)
Q Consensus       787 Dfgla~~~~~~~~----------------------------~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~vl~el  837 (912)
                      |||+|+.......                            .....+||+.|+|||++.+. .++.++||||+||++|||
T Consensus       161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~el  240 (361)
T 4f9c_A          161 DFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSL  240 (361)
T ss_dssp             CCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHH
T ss_pred             cCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHH
Confidence            9999986543211                            12345799999999998875 489999999999999999


Q ss_pred             HhCCCCcc
Q 039137          838 IKGKHPRD  845 (912)
Q Consensus       838 ltg~~pf~  845 (912)
                      ++|+.||.
T Consensus       241 l~G~~Pf~  248 (361)
T 4f9c_A          241 LSGRYPFY  248 (361)
T ss_dssp             HHTCSSSS
T ss_pred             HHCCCCCC
Confidence            99999984

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2e-43  Score=412.77  Aligned_cols=252  Identities=21%  Similarity=0.334  Sum_probs=212.4

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      .++|++.+.||+|+||+||+|+++ +|+.||+|++....    ....+.+.+|+++|+.++|||||++++++.+++..|+
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~----~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i  231 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH----ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM  231 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc----hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence            368999999999999999999876 79999999986532    2246778899999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCC--CcEEEeccccccc
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLG--YEAHVSDFGIAKF  793 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~--~~~kl~Dfgla~~  793 (912)
                      |||||+||+|.+++..  ....+++.++..+++||+.||+|||++   +|+||||||+||+++.+  +.+||+|||+|+.
T Consensus       232 v~E~~~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~  306 (573)
T 3uto_A          232 IYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH  306 (573)
T ss_dssp             EEECCCCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred             EEeecCCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeE
Confidence            9999999999999843  235689999999999999999999999   99999999999999854  8999999999998


Q ss_pred             cCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhh
Q 039137          794 LNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHV  873 (912)
Q Consensus       794 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  873 (912)
                      +... ......+||+.|||||++.+..|+.++||||+||++|||++|+.||.....     ......+......++....
T Consensus       307 ~~~~-~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~-----~~~~~~i~~~~~~~~~~~~  380 (573)
T 3uto_A          307 LDPK-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-----DETLRNVKSCDWNMDDSAF  380 (573)
T ss_dssp             CCTT-SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-----HHHHHHHHTTCCCCCSGGG
T ss_pred             ccCC-CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----HHHHHHHHhCCCCCCcccc
Confidence            7543 334566899999999999999999999999999999999999999862211     1122223333333444344


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          874 QKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       874 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ...+..+.++|.+||+.||.+|||+.|+++
T Consensus       381 ~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          381 SGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            455667889999999999999999999875

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=2.6e-42  Score=415.02  Aligned_cols=430  Identities=24%  Similarity=0.251  Sum_probs=341.1

Q ss_pred             CCcccccCCccccCCCCCcEEeccccccccccccccccccccceeecccccccCCCCccccCcccccEEEccCCcCCCCC
Q 039137          118 NNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSI  197 (912)
Q Consensus       118 ~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~  197 (912)
                      +.+++ .+|..+.  +++++|||++|+|++..|..|.++++|++|+|++|++++..|..|++|++|++|+|++|+|++..
T Consensus        40 ~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~  116 (635)
T 4g8a_A           40 ELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLA  116 (635)
T ss_dssp             TSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEEC
T ss_pred             CCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCC
Confidence            33454 4666553  47999999999999777789999999999999999999777888999999999999999999777


Q ss_pred             CccCCCCccceeeeeccCCCcCccccccccccccceeecccccccC-ccccccccccccceeeeccccCcccCCcccCCc
Q 039137          198 PRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSG-AIPLSISNLTNLRFLFLYHNELSGIIPQEIGNL  276 (912)
Q Consensus       198 p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l  276 (912)
                      +..|.++++|++|+|++|++++..+..|+++++|++|++++|++++ ..|..++.+++|++|+|++|++++..+..|..+
T Consensus       117 ~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L  196 (635)
T 4g8a_A          117 LGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVL  196 (635)
T ss_dssp             GGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHH
T ss_pred             HHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccch
Confidence            7889999999999999999998777889999999999999999975 468889999999999999999999888888777


Q ss_pred             cccc----hhhhccCccCCCCccccccccccceEecccc-----------------------------------------
Q 039137          277 KKLN----SLLLAKNHFRGTVPKSFRNLTDLVKLRLNQN-----------------------------------------  311 (912)
Q Consensus       277 ~~L~----~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n-----------------------------------------  311 (912)
                      ++++    .++++.|.++...+..+.. ..++.+++.+|                                         
T Consensus       197 ~~l~~~~~~~~ls~n~l~~i~~~~~~~-~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~  275 (635)
T 4g8a_A          197 HQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSAL  275 (635)
T ss_dssp             HTCTTCCCEEECTTCCCCEECTTTTTT-CEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTT
T ss_pred             hhhhhhhhhhhcccCcccccCcccccc-hhhhhhhhhcccccccccchhhcCCccccccccccccccccccccccccccc
Confidence            6654    4667777776443333322 12233333322                                         


Q ss_pred             -----------------------------------------cccCCCCcccCCCCCccEEEccCCcCcccccc-------
Q 039137          312 -----------------------------------------YLTGNISETFGTYPNLTFIDLSNNSFFGEILS-------  343 (912)
Q Consensus       312 -----------------------------------------~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-------  343 (912)
                                                               .+...  ..+....+|+.|++++|.+......       
T Consensus       276 ~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~  353 (635)
T 4g8a_A          276 EGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERV--KDFSYNFGWQHLELVNCKFGQFPTLKLKSLKR  353 (635)
T ss_dssp             GGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEEC--GGGGSCCCCSEEEEESCEESSCCCCBCTTCCE
T ss_pred             ccccchhhhhhhhhhhcccccchhhhhhhhcccccccccccccccc--cccccchhhhhhhcccccccCcCcccchhhhh
Confidence                                                     22211  1233345667777777765443222       


Q ss_pred             ------------cCCCCCCCCEEeccCCcccc--cccccccccccccEEEccCccccCCCCccccccccccEEEccCCcc
Q 039137          344 ------------DWGRCPQLSLLDVSINNISG--SIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKL  409 (912)
Q Consensus       344 ------------~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l  409 (912)
                                  ....+++|+.|++++|.+..  ..+..+..+.+|++|+++.|.+.. .+..+..+++|+.+++.+|+.
T Consensus       354 l~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~-~~~~~~~l~~L~~l~l~~~~~  432 (635)
T 4g8a_A          354 LTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNL  432 (635)
T ss_dssp             EEEESCCSCCBCCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEE-ECSCCTTCTTCCEEECTTSEE
T ss_pred             cccccccCCCCcccccccccccchhhccccccccccccchhhhhhhhhhhcccccccc-ccccccccccccchhhhhccc
Confidence                        22346677777777777753  334455566778888888777763 456677888999999998887


Q ss_pred             cCCCc-cccccccccccccccCcccCccccccccccccccEEEeccccc-ccccchhhhcccccceeeccccccCccccc
Q 039137          410 SGCIP-RELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKL-SQQIPIELDNLIHLSELDLSHNFLGEKISS  487 (912)
Q Consensus       410 ~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l-~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~  487 (912)
                      ....+ ..+..+++++.++++.|.+.+..+..+..++.|+.|+|++|++ .+..|..|..+++|++|+|++|+|++.+|.
T Consensus       433 ~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~  512 (635)
T 4g8a_A          433 KQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPT  512 (635)
T ss_dssp             ESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTT
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChH
Confidence            75544 5678899999999999999999999999999999999999985 456788999999999999999999999999


Q ss_pred             ccccccccccccccCccccCCCcccccccccceEEEccCCccccCCCCCc-cC-CCCchhhhccCCccc
Q 039137          488 RICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNST-TF-RDAPLEALQGNKGLY  554 (912)
Q Consensus       488 ~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~~~~~-~~-~~~~~~~l~~n~~~~  554 (912)
                      .|.++++|+.|+|++|+|+++.|..|..+++|++||+++|++++.+|... .+ .......+.+||-.|
T Consensus       513 ~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C  581 (635)
T 4g8a_A          513 AFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC  581 (635)
T ss_dssp             TTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCC
T ss_pred             HHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcc
Confidence            99999999999999999999999999999999999999999999888643 22 233344567777666

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=1.6e-43  Score=385.17  Aligned_cols=292  Identities=27%  Similarity=0.446  Sum_probs=170.3

Q ss_pred             CCCHHHHHHHHHHHHhcccCCcccCCCcccCCCCCCCCCCCc--cceeEecCC---CCeEEEeeccccccc--ccccccc
Q 039137           33 SNSAEEAHALVKWKASLEVHSRSLLHSWSLSSVNATKISPCA--WSGIFCNHA---ERVVGINLTSISLNG--TLLEFSF  105 (912)
Q Consensus        33 ~~~~~~~~all~~k~~~~~~~~~~l~~w~~~~~~~~~~~~C~--w~gv~c~~~---~~v~~l~l~~~~l~~--~~~~~~~  105 (912)
                      .|.++|++||++||+++. +|. .+++|..      +.+||.  |.||+|+..   ++|+.+++.++.+.|  .++ .+|
T Consensus         2 ~c~~~~~~aL~~~k~~~~-~~~-~l~~W~~------~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~-~~l   72 (313)
T 1ogq_A            2 LCNPQDKQALLQIKKDLG-NPT-TLSSWLP------TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIP-SSL   72 (313)
T ss_dssp             CSCHHHHHHHHHHHHHTT-CCG-GGTTCCT------TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECC-GGG
T ss_pred             CCCHHHHHHHHHHHHhcC-Ccc-cccCCCC------CCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccC-hhH
Confidence            589999999999999995 454 7899964      258998  999999753   567766666555555  332 345


Q ss_pred             CCCCCccEEEccC-CcccccCCccccCCCCCcEEeccccccccccccccccccccceeecccccccCCCCccccCccccc
Q 039137          106 SSFPHLVYLDLYN-NELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLN  184 (912)
Q Consensus       106 ~~l~~L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~  184 (912)
                      +++++|++|+|++ |++.+.+|..|+++++|++|+|++|++++.+|..|+.+++|++|+|++|.+++.+|..++.+++|+
T Consensus        73 ~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  152 (313)
T 1ogq_A           73 ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLV  152 (313)
T ss_dssp             GGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCC
T ss_pred             hCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCC
Confidence            5555555555553 555555555555555555555555555555555555555555555555555555555555555555


Q ss_pred             EEEccCCcCCCCCCccCCCCc-cceeeeeccCCCcCccccccccccccceeecccccccCccccccccccccceeeeccc
Q 039137          185 QLALDSNFLNGSIPRSLGNLT-HVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHN  263 (912)
Q Consensus       185 ~L~l~~n~l~~~~p~~~~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N  263 (912)
                      +|++++|++++.+|..+.+++ +|++|++++|.+++.+|..++.++ |+.|++++|++++..|..+..+++|++|+|++|
T Consensus       153 ~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  231 (313)
T 1ogq_A          153 GITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKN  231 (313)
T ss_dssp             EEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSS
T ss_pred             eEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCC
Confidence            555555555555555555554 555555555555555555555444 555555555554444444445555555555555


Q ss_pred             cCcccCCcccCCccccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCcccccc
Q 039137          264 ELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILS  343 (912)
Q Consensus       264 ~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~  343 (912)
                      ++++                        .+|. +..+++|++|+|++|.+++.+|..|..+++|++|+|++|++++.+|.
T Consensus       232 ~l~~------------------------~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~  286 (313)
T 1ogq_A          232 SLAF------------------------DLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ  286 (313)
T ss_dssp             EECC------------------------BGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC
T ss_pred             ceee------------------------ecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCC
Confidence            4443                        3333 44445555555555555555555555555555555555555555544


Q ss_pred             cCCCCCCCCEEeccCCc
Q 039137          344 DWGRCPQLSLLDVSINN  360 (912)
Q Consensus       344 ~~~~l~~L~~L~Ls~N~  360 (912)
                      . +.+++|+.+++++|.
T Consensus       287 ~-~~l~~L~~l~l~~N~  302 (313)
T 1ogq_A          287 G-GNLQRFDVSAYANNK  302 (313)
T ss_dssp             S-TTGGGSCGGGTCSSS
T ss_pred             C-ccccccChHHhcCCC
Confidence            3 455555555555555

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2.5e-43  Score=407.26  Aligned_cols=252  Identities=21%  Similarity=0.271  Sum_probs=200.9

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCC--CchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCee
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPG--EMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHS  713 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  713 (912)
                      .++|++.+.||+|+||+||+|+++ +|+.||+|++.+....  ...........++.+++.++|||||++++++.+++..
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            367999999999999999999876 7999999998542111  1111112223446677788999999999999999999


Q ss_pred             eEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccc
Q 039137          714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKF  793 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  793 (912)
                      |+|||||+||+|.+++.+   .+.+++.+++.++.||+.||+|||++   +||||||||+|||++.+|.+||+|||+|+.
T Consensus       268 ylVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~  341 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD  341 (689)
T ss_dssp             EEEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeee
Confidence            999999999999999954   35699999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCCccccccccccccccccc-cCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChh
Q 039137          794 LNPDSSNWSELAGTHGYVAPELAY-TLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLH  872 (912)
Q Consensus       794 ~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  872 (912)
                      ....  .....+||+.|||||++. +..|+.++||||+||++|||++|++||.......  ..............++.  
T Consensus       342 ~~~~--~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~--~~~i~~~i~~~~~~~p~--  415 (689)
T 3v5w_A          342 FSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDRMTLTMAVELPD--  415 (689)
T ss_dssp             CSSC--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC--HHHHHHHHHHCCCCCCT--
T ss_pred             cCCC--CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHhhcCCCCCCCc--
Confidence            6543  334578999999999996 4579999999999999999999999996321111  11112223333334432  


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCC-----HHHHH
Q 039137          873 VQKKLMSIMQVAFSCLDQNPESRPT-----MKRVS  902 (912)
Q Consensus       873 ~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl  902 (912)
                        ..+.++.++|.+||++||.+|++     ++|++
T Consensus       416 --~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~  448 (689)
T 3v5w_A          416 --SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK  448 (689)
T ss_dssp             --TSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred             --cCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHh
Confidence              23456889999999999999998     56554

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=1.5e-42  Score=409.95  Aligned_cols=426  Identities=18%  Similarity=0.175  Sum_probs=335.1

Q ss_pred             ccEEEccCCcccccCCccccCCCCCcEEeccccccccccccccccccccceeecccccccCCCCccccCcccccEEEccC
Q 039137          111 LVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDS  190 (912)
Q Consensus       111 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~  190 (912)
                      .+++|+++|++++ +|..+.  ++|++|||++|++++..|..|+.+++|++|+|++|++++..|..|+++++|++|+|++
T Consensus        33 ~~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  109 (562)
T 3a79_B           33 ESMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSH  109 (562)
T ss_dssp             CCEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTT
T ss_pred             CcEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCC
Confidence            4789999999995 787665  8999999999999988888999999999999999999988899999999999999999


Q ss_pred             CcCCCCCCccCCCCccceeeeeccCCCcC-ccccccccccccceeecccccccCcccccccccccc--ceeeeccccC--
Q 039137          191 NFLNGSIPRSLGNLTHVVILYLYNNSFFG-SIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNL--RFLFLYHNEL--  265 (912)
Q Consensus       191 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L--~~L~L~~N~l--  265 (912)
                      |+++ .+|..  .+++|++|+|++|.+++ .+|..|+++++|++|++++|++++.   .+..+++|  ++|++++|++  
T Consensus       110 N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~  183 (562)
T 3a79_B          110 NRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHI  183 (562)
T ss_dssp             SCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCC
T ss_pred             CcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccc
Confidence            9999 78877  89999999999999997 4578999999999999999999863   45555666  9999999999  


Q ss_pred             cccCCcccCCcc--ccchhhhccCccCCCCcc-ccccccccceEeccccc-----ccCCCCcccCCCC------------
Q 039137          266 SGIIPQEIGNLK--KLNSLLLAKNHFRGTVPK-SFRNLTDLVKLRLNQNY-----LTGNISETFGTYP------------  325 (912)
Q Consensus       266 ~~~~~~~l~~l~--~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~n~-----l~~~~~~~~~~l~------------  325 (912)
                      ++..|..+..+.  .+ .+++++|.+.+.++. .+..+++|+.|++++|.     +.+. ...+..++            
T Consensus       184 ~~~~~~~l~~l~~~~l-~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~-~~~l~~l~~L~~L~L~~~~l  261 (562)
T 3a79_B          184 KGGETESLQIPNTTVL-HLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTF-LSELTRGPTLLNVTLQHIET  261 (562)
T ss_dssp             CSSSCCEEEECCEEEE-EEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHH-HHHHHSCSSCEEEEEEEEEE
T ss_pred             cccCcccccccCcceE-EEEecCccchhhhhhhcccccceEEEecccccccccchHHHH-HHHHhccCcceEEEecCCcC
Confidence            888888887765  33 568899998876665 46789999999999984     1111 11233333            


Q ss_pred             ---------------CccEEEccCCcCcccccccC-----CCCCCCCEEeccCCccccccc-ccccc---cccccEEEcc
Q 039137          326 ---------------NLTFIDLSNNSFFGEILSDW-----GRCPQLSLLDVSINNISGSIP-LEIGE---SLQLQYLDLS  381 (912)
Q Consensus       326 ---------------~L~~L~Ls~N~l~~~~~~~~-----~~l~~L~~L~Ls~N~l~~~~~-~~~~~---~~~L~~L~L~  381 (912)
                                     +|++|++++|.+.+.+|..+     ..++.|+.++++.|.+  .+| ..+..   ..+|++|+++
T Consensus       262 ~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~L~l~  339 (562)
T 3a79_B          262 TWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSKEALYSVFAEMNIKMLSIS  339 (562)
T ss_dssp             CHHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCCCSEEEEE
T ss_pred             cHHHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhccccee--ecChhhhhhhhccCcceEEEcc
Confidence                           55556666665555555544     4444444444444444  222 11111   2458888888


Q ss_pred             CccccCCCCccccccccccEEEccCCcccCCCccccccccccccccccCcccCccc--cccccccccccEEEeccccccc
Q 039137          382 SNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFV--PESLGSLVKLYYLNLSHNKLSQ  459 (912)
Q Consensus       382 ~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~  459 (912)
                      +|.+....  ....+++|++|++++|++++..|..+..+++|++|+|++|+++++.  |..|..+++|++|+|++|++++
T Consensus       340 ~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~  417 (562)
T 3a79_B          340 DTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNS  417 (562)
T ss_dssp             SSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBS
T ss_pred             CCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCC
Confidence            88876322  1267899999999999999989999999999999999999999743  5678999999999999999998


Q ss_pred             ccc-hhhhcccccceeeccccccCcccccccccccccccccccCccccCCCcccccccccceEEEccCCccccCCCC-Cc
Q 039137          460 QIP-IELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPN-ST  537 (912)
Q Consensus       460 ~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~~~-~~  537 (912)
                      .+| ..+..+++|++|++++|++++..|..+.  ++|+.|+|++|+|+.+ |..+..+++|++|++++|+++..++. -.
T Consensus       418 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~~i-p~~~~~l~~L~~L~L~~N~l~~l~~~~~~  494 (562)
T 3a79_B          418 HAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMSI-PKDVTHLQALQELNVASNQLKSVPDGVFD  494 (562)
T ss_dssp             CCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCCCC-CTTTTSSCCCSEEECCSSCCCCCCTTSTT
T ss_pred             ccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCccc-ChhhcCCCCCCEEECCCCCCCCCCHHHHh
Confidence            455 4588999999999999999987776554  7999999999999965 55555999999999999999954333 22


Q ss_pred             cCCCCchhhhccCCccc
Q 039137          538 TFRDAPLEALQGNKGLY  554 (912)
Q Consensus       538 ~~~~~~~~~l~~n~~~~  554 (912)
                      .+.......+.+|+-.|
T Consensus       495 ~l~~L~~L~l~~N~~~c  511 (562)
T 3a79_B          495 RLTSLQYIWLHDNPWDC  511 (562)
T ss_dssp             TCTTCCCEECCSCCBCC
T ss_pred             cCCCCCEEEecCCCcCC
Confidence            33334444456665443

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=2.6e-42  Score=394.38  Aligned_cols=377  Identities=25%  Similarity=0.295  Sum_probs=271.9

Q ss_pred             CCCCccEEEccCCcccccCCccccCCCCCcEEecccccccccccccccccccc-------------ceeecccccccCCC
Q 039137          107 SFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHL-------------TVLHISRNWLSGSI  173 (912)
Q Consensus       107 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L-------------~~L~L~~n~l~~~~  173 (912)
                      +.++|++|++++|++ |.+|++|+++++|++|+|++|++.|.+|.+++.+++|             ++|++++|.+++ +
T Consensus         9 ~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-l   86 (454)
T 1jl5_A            9 SNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-L   86 (454)
T ss_dssp             --------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-C
T ss_pred             ccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-C
Confidence            457889999999999 7899999999999999999999999999999988875             999999999984 5


Q ss_pred             CccccCcccccEEEccCCcCCCCCCccCCCCccceeeeeccCCCcCccccccccccccceeecccccccCcccccccccc
Q 039137          174 PHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLT  253 (912)
Q Consensus       174 p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~  253 (912)
                      |..   .++|++|++++|++++ +|..   +++|++|++++|.+++ +|..   .++|++|++++|++++ +| .+++++
T Consensus        87 p~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~  153 (454)
T 1jl5_A           87 PEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSS  153 (454)
T ss_dssp             CSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCT
T ss_pred             CCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCC
Confidence            553   3789999999999996 7754   3789999999999985 3332   2689999999999996 67 599999


Q ss_pred             ccceeeeccccCcccCCcccCCccccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEcc
Q 039137          254 NLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLS  333 (912)
Q Consensus       254 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls  333 (912)
                      +|++|++++|++++ +|..+   ++|++|++++|++++ +| .+.++++|++|++++|.+++. |..   .++|++|+++
T Consensus       154 ~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~l-~~~---~~~L~~L~l~  223 (454)
T 1jl5_A          154 FLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKKL-PDL---PLSLESIVAG  223 (454)
T ss_dssp             TCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSSC-CCC---CTTCCEEECC
T ss_pred             CCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCcC-CCC---cCcccEEECc
Confidence            99999999999986 55544   589999999999996 55 689999999999999999863 332   2589999999


Q ss_pred             CCcCcccccccCCCCCCCCEEeccCCcccccccccccccccccEEEccCccccCCCCccccccccccEEEccCCcccCCC
Q 039137          334 NNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCI  413 (912)
Q Consensus       334 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~  413 (912)
                      +|.+. .+| .++.+++|+.|++++|++++ +|..   .++|++|++++|++++ +|..   .++|+.|++++|++++ +
T Consensus       224 ~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~-l  292 (454)
T 1jl5_A          224 NNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSG-L  292 (454)
T ss_dssp             SSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSE-E
T ss_pred             CCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCc-c
Confidence            99998 455 48899999999999999985 4432   4789999999999986 5543   3789999999999986 2


Q ss_pred             ccccccccccccccccCcccCcccccccccc-ccccEEEecccccccccchhhhcccccceeeccccccCcccccccccc
Q 039137          414 PRELGSLINLEYLDLSANNLSNFVPESLGSL-VKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRM  492 (912)
Q Consensus       414 p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  492 (912)
                      |..   .++|++|++++|+++++ +    .+ ++|++|++++|++++ +|..   +++|++|++++|++++ +|.   .+
T Consensus       293 ~~~---~~~L~~L~l~~N~l~~i-~----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~-lp~---~l  356 (454)
T 1jl5_A          293 SEL---PPNLYYLNASSNEIRSL-C----DLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAE-VPE---LP  356 (454)
T ss_dssp             SCC---CTTCCEEECCSSCCSEE-C----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CC
T ss_pred             cCc---CCcCCEEECcCCcCCcc-c----CCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCcccc-ccc---hh
Confidence            221   26899999999999873 2    23 589999999999986 5554   5789999999999985 454   47


Q ss_pred             cccccccccCccccC--CCccccccc-------------ccceEEEccCCcccc--CCCC
Q 039137          493 ESLEKLNLSYNNLSG--LIPRCFEEM-------------HGLLHIDISYNKLEG--QIPN  535 (912)
Q Consensus       493 ~~L~~L~ls~N~l~~--~~p~~~~~l-------------~~L~~l~ls~N~l~~--~~~~  535 (912)
                      ++|+.|++++|++++  .+|..+..+             ++|+.|++++|++++  .+|.
T Consensus       357 ~~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~~~~i~~~~~~L~~L~ls~N~l~~~~~iP~  416 (454)
T 1jl5_A          357 QNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLREFPDIPE  416 (454)
T ss_dssp             TTCCEEECCSSCCSSCCCCCTTCCEEECCC------------------------------
T ss_pred             hhccEEECCCCCCCcCCCChHHHHhhhhcccccccccccCcCCEEECCCCcCCccccchh
Confidence            899999999999999  678888888             889999999999998  5654

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=7.3e-42  Score=371.54  Aligned_cols=265  Identities=31%  Similarity=0.445  Sum_probs=207.4

Q ss_pred             HHHhcCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCee
Q 039137          634 ISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHS  713 (912)
Q Consensus       634 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  713 (912)
                      ....++|++.+.||+|+||+||+|++ +++.||||++.....  .....+++.+|++++++++||||+++++++...+..
T Consensus        33 ~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  109 (309)
T 3p86_A           33 DIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDF--HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL  109 (309)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCC--SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred             cCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence            33457899999999999999999987 688999999875432  233467789999999999999999999999999999


Q ss_pred             eEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCC--eeecCCCCCCeEEcCCCcEEEeccccc
Q 039137          714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP--IVHRDISSKNVLLDLGYEAHVSDFGIA  791 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlk~~Nill~~~~~~kl~Dfgla  791 (912)
                      ++||||+++|+|.+++........+++.+++.++.|++.||+|||++   +  |+||||||+||+++.++.+||+|||++
T Consensus       110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a  186 (309)
T 3p86_A          110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLS  186 (309)
T ss_dssp             EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred             EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence            99999999999999996654445699999999999999999999999   8  999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCCh
Q 039137          792 KFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSL  871 (912)
Q Consensus       792 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  871 (912)
                      +.............||+.|+|||++.+..++.++||||||+++|||++|+.||.......   ..............+. 
T Consensus       187 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~---~~~~~~~~~~~~~~~~-  262 (309)
T 3p86_A          187 RLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ---VVAAVGFKCKRLEIPR-  262 (309)
T ss_dssp             ---------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH---HHHHHHHSCCCCCCCT-
T ss_pred             ccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhcCCCCCCCc-
Confidence            866544444456689999999999999999999999999999999999999986321110   0000111112222221 


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 039137          872 HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE  911 (912)
Q Consensus       872 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~~  911 (912)
                         ..+..+.+++.+||+.||++|||++|+++.|++.+..
T Consensus       263 ---~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          263 ---NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             ---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             ---cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence               2345688999999999999999999999999987653

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.7e-41  Score=365.10  Aligned_cols=250  Identities=26%  Similarity=0.425  Sum_probs=208.0

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      .++|++.+.||+|+||+||+|.+. +++.||+|++......    ..+.+.+|+.+++.++||||+++++++..++..++
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   94 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP----KKELIINEILVMRENKNPNIVNYLDSYLVGDELWV   94 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS----CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc----HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEE
Confidence            468999999999999999999864 7899999998644322    35678899999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ||||+++|+|.+++..    ..+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++....
T Consensus        95 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (297)
T 3fxz_A           95 VMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  167 (297)
T ss_dssp             EEECCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEECCCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecC
Confidence            9999999999999954    3588999999999999999999999   99999999999999999999999999998877


Q ss_pred             CCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHH
Q 039137          796 PDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQK  875 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  875 (912)
                      ..........||+.|+|||++.+..++.++||||+|+++|||++|+.||........    .............  ....
T Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~----~~~~~~~~~~~~~--~~~~  241 (297)
T 3fxz_A          168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA----LYLIATNGTPELQ--NPEK  241 (297)
T ss_dssp             STTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH----HHHHHHHCSCCCS--CGGG
T ss_pred             CcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhCCCCCCC--Cccc
Confidence            665556667899999999999999999999999999999999999999852211100    0000011111111  1123


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          876 KLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       876 ~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .+..+.+++.+||+.||++|||++|+++
T Consensus       242 ~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          242 LSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            3456889999999999999999999875

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=4.4e-41  Score=369.10  Aligned_cols=278  Identities=31%  Similarity=0.599  Sum_probs=225.4

Q ss_pred             CcccHHHHHHHhcCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEE
Q 039137          626 GKIVYEEIISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG  705 (912)
Q Consensus       626 ~~~~~~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~  705 (912)
                      ..+...++....++|++.+.||+|+||.||+|+.++++.||||++.......   ....+.+|+++++.++||||+++++
T Consensus        18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~   94 (326)
T 3uim_A           18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQG---GELQFQTEVEMISMAVHRNLLRLRG   94 (326)
T ss_dssp             EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC--------CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred             ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCch---HHHHHHHHHHHHHhccCCCccceEE
Confidence            3567788999999999999999999999999998889999999987543322   2235889999999999999999999


Q ss_pred             EEEcCCeeeEEEeecCCCChhhHhhccC-CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEE
Q 039137          706 FCSHPKHSFIIYEYLESGSLDKILCNDA-SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAH  784 (912)
Q Consensus       706 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  784 (912)
                      ++..++..++||||+++|+|.+++.... ....+++.+++.++.|++.||+|||+++.++|+||||||+||+++.++.+|
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k  174 (326)
T 3uim_A           95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV  174 (326)
T ss_dssp             EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred             EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence            9999999999999999999999996644 334599999999999999999999998666899999999999999999999


Q ss_pred             EeccccccccCCCCCC-ccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhcccccc---------
Q 039137          785 VSDFGIAKFLNPDSSN-WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS---------  854 (912)
Q Consensus       785 l~Dfgla~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~---------  854 (912)
                      |+|||+++........ .....||+.|+|||++.+..++.++||||+|+++|||++|+.||+.........         
T Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  254 (326)
T 3uim_A          175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG  254 (326)
T ss_dssp             ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred             eccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence            9999999876543332 334568999999999988889999999999999999999999996322111100         


Q ss_pred             ---ccchhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 039137          855 ---SNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEK  908 (912)
Q Consensus       855 ---~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  908 (912)
                         ........+....  .......+..+.+++.+||+.||.+|||++|+++.|++.
T Consensus       255 ~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          255 LLKEKKLEALVDVDLQ--GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             TTSSCCSTTSSCTTCT--TSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             HhhchhhhhhcChhhc--cccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence               0011111111111  112355677899999999999999999999999999853

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=4.4e-41  Score=368.16  Aligned_cols=271  Identities=32%  Similarity=0.503  Sum_probs=220.0

Q ss_pred             HHHHHHhcCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC
Q 039137          631 EEIISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP  710 (912)
Q Consensus       631 ~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~  710 (912)
                      .++...+++|++.+.||+|+||+||+|++++++.||||++.....    ...+.+.+|+++++.++||||+++++++...
T Consensus        32 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  107 (321)
T 2qkw_B           32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS----QGIEEFETEIETLSFCRHPHLVSLIGFCDER  107 (321)
T ss_dssp             SCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCS----SHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred             HHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccCh----HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence            344456789999999999999999999988899999999865422    1467789999999999999999999999999


Q ss_pred             CeeeEEEeecCCCChhhHhhccCC-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccc
Q 039137          711 KHSFIIYEYLESGSLDKILCNDAS-AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFG  789 (912)
Q Consensus       711 ~~~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  789 (912)
                      +..++||||+++|+|.+++..... ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg  184 (321)
T 2qkw_B          108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFG  184 (321)
T ss_dssp             TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCT
T ss_pred             CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecc
Confidence            999999999999999999954432 23589999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCC--CCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccc----------cc
Q 039137          790 IAKFLNPDS--SNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSS----------NM  857 (912)
Q Consensus       790 la~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~----------~~  857 (912)
                      +++......  .......|++.|+|||++.+..++.++||||||+++|||++|+.||...........          ..
T Consensus       185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  264 (321)
T 2qkw_B          185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ  264 (321)
T ss_dssp             TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred             cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence            998654322  122345689999999999988999999999999999999999999863221111000          00


Q ss_pred             hhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          858 NIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       858 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                      .....+...  ........+..+.+++.+||+.||++|||++|+++.|++.+.
T Consensus       265 ~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~  315 (321)
T 2qkw_B          265 LEQIVDPNL--ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR  315 (321)
T ss_dssp             CCSSSSSSC--TTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHhcChhh--ccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence            001111111  111234567789999999999999999999999999998764

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=5.5e-41  Score=383.43  Aligned_cols=393  Identities=23%  Similarity=0.246  Sum_probs=282.0

Q ss_pred             CCeEEEeeccccccccccccccCCCCCccEEEccCCcccccCCccccCCCCC-------------cEEeccccccccccc
Q 039137           84 ERVVGINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNL-------------EYLDFSANKLFGQIP  150 (912)
Q Consensus        84 ~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L-------------~~L~Ls~n~l~~~~p  150 (912)
                      .++..+++.++.+ |.++ .+++++++|++|++++|+++|.+|..++++++|             ++|++++|++++ +|
T Consensus        11 ~~L~~L~l~~n~l-~~iP-~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp   87 (454)
T 1jl5_A           11 TFLQEPLRHSSNL-TEMP-VEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LP   87 (454)
T ss_dssp             -------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CC
T ss_pred             ccchhhhcccCch-hhCC-hhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CC
Confidence            3566778888888 6664 469999999999999999999999999999875             999999999985 56


Q ss_pred             cccccccccceeecccccccCCCCccccCcccccEEEccCCcCCCCCCccCCCCccceeeeeccCCCcCccccccccccc
Q 039137          151 SGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKS  230 (912)
Q Consensus       151 ~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~  230 (912)
                      ..   .++|++|++++|.+++ +|..   +++|++|++++|++++ +|..   .++|++|++++|.+++ +| .++++++
T Consensus        88 ~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~  154 (454)
T 1jl5_A           88 EL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSF  154 (454)
T ss_dssp             SC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTT
T ss_pred             CC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCC
Confidence            52   4799999999999996 7764   4889999999999984 4432   1689999999999996 77 6999999


Q ss_pred             cceeecccccccCccccccccccccceeeeccccCcccCCcccCCccccchhhhccCccCCCCccccccccccceEeccc
Q 039137          231 LFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQ  310 (912)
Q Consensus       231 L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  310 (912)
                      |++|++++|++++ +|..+   ++|++|++++|++++ +| .++++++|++|++++|++++ +|...   ++|++|++++
T Consensus       155 L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l~~  224 (454)
T 1jl5_A          155 LKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP---LSLESIVAGN  224 (454)
T ss_dssp             CCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC---TTCCEEECCS
T ss_pred             CCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc---CcccEEECcC
Confidence            9999999999995 66543   589999999999997 55 69999999999999999996 45433   5899999999


Q ss_pred             ccccCCCCcccCCCCCccEEEccCCcCcccccccCCCCCCCCEEeccCCcccccccccccccccccEEEccCccccCCCC
Q 039137          311 NYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIP  390 (912)
Q Consensus       311 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~  390 (912)
                      |.++ .+| .++.+++|++|++++|++++. |.   .+++|+.|++++|++.+ +|..   .++|++|++++|++++. |
T Consensus       225 n~l~-~lp-~~~~l~~L~~L~l~~N~l~~l-~~---~~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l-~  293 (454)
T 1jl5_A          225 NILE-ELP-ELQNLPFLTTIYADNNLLKTL-PD---LPPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGL-S  293 (454)
T ss_dssp             SCCS-SCC-CCTTCTTCCEEECCSSCCSSC-CS---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEE-S
T ss_pred             CcCC-ccc-ccCCCCCCCEEECCCCcCCcc-cc---cccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCcc-c
Confidence            9999 455 489999999999999999863 33   35899999999999986 5543   37899999999999862 2


Q ss_pred             ccccccccccEEEccCCcccCCCccccccccccccccccCcccCccccccccccccccEEEecccccccccchhhhcccc
Q 039137          391 TQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIH  470 (912)
Q Consensus       391 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  470 (912)
                      ..   .++|+.|++++|++++ ++..   .++|++|++++|++++ +|..   +++|++|++++|++++ +|.   .+++
T Consensus       294 ~~---~~~L~~L~l~~N~l~~-i~~~---~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~-lp~---~l~~  358 (454)
T 1jl5_A          294 EL---PPNLYYLNASSNEIRS-LCDL---PPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAE-VPE---LPQN  358 (454)
T ss_dssp             CC---CTTCCEEECCSSCCSE-ECCC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTT
T ss_pred             Cc---CCcCCEEECcCCcCCc-ccCC---cCcCCEEECCCCcccc-cccc---CCcCCEEECCCCcccc-ccc---hhhh
Confidence            21   2689999999999985 3321   2589999999999998 4544   5899999999999984 665   4789


Q ss_pred             cceeeccccccCc--ccccccccc-------------cccccccccCccccC--CCcccccccccceEEEccCCccccCC
Q 039137          471 LSELDLSHNFLGE--KISSRICRM-------------ESLEKLNLSYNNLSG--LIPRCFEEMHGLLHIDISYNKLEGQI  533 (912)
Q Consensus       471 L~~L~Ls~N~l~~--~~~~~~~~l-------------~~L~~L~ls~N~l~~--~~p~~~~~l~~L~~l~ls~N~l~~~~  533 (912)
                      |++|++++|++++  .+|..+..+             ++|+.|++++|++++  .+|.      .++.|.+.+|.+.+.+
T Consensus       359 L~~L~L~~N~l~~l~~ip~~l~~L~~n~~~~~i~~~~~~L~~L~ls~N~l~~~~~iP~------sl~~L~~~~~~~~~~~  432 (454)
T 1jl5_A          359 LKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLREFPDIPE------SVEDLRMNSERVVDPY  432 (454)
T ss_dssp             CCEEECCSSCCSSCCCCCTTCCEEECCC----------------------------------------------------
T ss_pred             ccEEECCCCCCCcCCCChHHHHhhhhcccccccccccCcCCEEECCCCcCCccccchh------hHhheeCcCcccCCcc
Confidence            9999999999999  788888888             889999999999998  5564      4567788899888866


Q ss_pred             C
Q 039137          534 P  534 (912)
Q Consensus       534 ~  534 (912)
                      |
T Consensus       433 ~  433 (454)
T 1jl5_A          433 E  433 (454)
T ss_dssp             -
T ss_pred             c
Confidence            5

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=5.9e-41  Score=365.28  Aligned_cols=258  Identities=26%  Similarity=0.441  Sum_probs=210.0

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      .++|++.+.||+|+||+||+|++. +++.||+|++...    .....+.+.+|+++++.++||||+++++++.+++..++
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   84 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF----DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNF   84 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEE
Confidence            367899999999999999999876 6899999988532    23356789999999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ||||+++|+|.+++...  ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus        85 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  159 (310)
T 3s95_A           85 ITEYIKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMV  159 (310)
T ss_dssp             EEECCTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC
T ss_pred             EEEecCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecc
Confidence            99999999999999553  35689999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCCCc--------------cccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhh
Q 039137          796 PDSSNW--------------SELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEM  861 (912)
Q Consensus       796 ~~~~~~--------------~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~  861 (912)
                      ......              ....||+.|+|||++.+..++.++||||||+++|||++|..||.................
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~  239 (310)
T 3s95_A          160 DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF  239 (310)
T ss_dssp             --------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHH
T ss_pred             cccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcc
Confidence            432211              145789999999999999999999999999999999999999763322211111111111


Q ss_pred             ccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 039137          862 LDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI  909 (912)
Q Consensus       862 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l  909 (912)
                      .....+      ...+..+.+++.+||+.||++|||++|+++.|++..
T Consensus       240 ~~~~~~------~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~  281 (310)
T 3s95_A          240 LDRYCP------PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR  281 (310)
T ss_dssp             HHHTCC------TTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccccCC------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            111111      112245788999999999999999999999998754

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.1e-40  Score=369.22  Aligned_cols=255  Identities=19%  Similarity=0.283  Sum_probs=212.5

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCc--hHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCee
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEM--SFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHS  713 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  713 (912)
                      .++|++.+.||+|+||+||+|+.+ +|+.||+|++........  ....+.+.+|+.+++.++||||+++++++.+++..
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            467999999999999999999876 789999999876543221  11357789999999999999999999999999999


Q ss_pred             eEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCC----cEEEeccc
Q 039137          714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGY----EAHVSDFG  789 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~Dfg  789 (912)
                      ++||||+++|+|.+++..   ...+++.++..++.||+.||+|||++   +|+||||||+||+++.++    .+||+|||
T Consensus        91 ~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG  164 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (361)
T ss_dssp             EEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred             EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence            999999999999999943   45689999999999999999999999   999999999999998877    79999999


Q ss_pred             cccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCC
Q 039137          790 IAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYP  869 (912)
Q Consensus       790 la~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  869 (912)
                      ++...... .......||+.|+|||++.+..++.++||||+||++|+|++|..||....     .......+......++
T Consensus       165 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~-----~~~~~~~i~~~~~~~~  238 (361)
T 2yab_A          165 LAHEIEDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT-----KQETLANITAVSYDFD  238 (361)
T ss_dssp             SCEECCTT-CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS-----HHHHHHHHHTTCCCCC
T ss_pred             CceEcCCC-CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhcCCCCC
Confidence            99876543 33455679999999999999899999999999999999999999985221     1112223333344444


Q ss_pred             ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          870 SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       870 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .......+..+.++|.+||..||++|||+.|+++
T Consensus       239 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          239 EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             chhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            3333445667889999999999999999998874

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=6.6e-41  Score=366.52  Aligned_cols=249  Identities=23%  Similarity=0.375  Sum_probs=208.3

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      .++|++.+.||+|+||.||+|++. +|+.||||++......  ....+.+.+|+++++.++||||+++++++...+..++
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l   91 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN--PTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL   91 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence            467999999999999999999974 8999999998654322  2356778899999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ||||+++|+|.+++...   +.+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++....
T Consensus        92 v~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  165 (328)
T 3fe3_A           92 IMEYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFT  165 (328)
T ss_dssp             EECCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred             EEECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence            99999999999998443   4689999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCCccccccccccccccccccCCCC-cchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhH
Q 039137          796 PDSSNWSELAGTHGYVAPELAYTLKVT-EKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQ  874 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  874 (912)
                      .. .......||+.|+|||++.+..+. .++||||+||++|||++|+.||+...     .......+.......+..   
T Consensus       166 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~~i~~~~~~~p~~---  236 (328)
T 3fe3_A          166 VG-GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-----LKELRERVLRGKYRIPFY---  236 (328)
T ss_dssp             SS-CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHCCCCCCTT---
T ss_pred             CC-CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhCCCCCCCC---
Confidence            43 334566899999999999888775 79999999999999999999986321     111222233333333321   


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          875 KKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       875 ~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                       .+..+.+++.+||+.||.+|||++|+++
T Consensus       237 -~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          237 -MSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             -SCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             -CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence             3455789999999999999999999875

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.4e-39  Score=353.93  Aligned_cols=276  Identities=32%  Similarity=0.515  Sum_probs=224.9

Q ss_pred             CcccHHHHHHHhcCCCCC------ceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCc
Q 039137          626 GKIVYEEIISATNDFNAE------HCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRN  699 (912)
Q Consensus       626 ~~~~~~e~~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n  699 (912)
                      ..+.+.++..+++.|...      +.||+|+||.||+|+. +++.||+|++............+.+.+|+.+++.++|||
T Consensus        13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   91 (307)
T 2nru_A           13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN   91 (307)
T ss_dssp             EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred             CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence            356788899999888877      8999999999999987 688999999976543333335678999999999999999


Q ss_pred             cccEEEEEEcCCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcC
Q 039137          700 IVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDL  779 (912)
Q Consensus       700 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~  779 (912)
                      |+++++++...+..++||||+++++|.+++........+++..++.++.|++.||+|||++   +|+||||||+||+++.
T Consensus        92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~  168 (307)
T 2nru_A           92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDE  168 (307)
T ss_dssp             BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECT
T ss_pred             eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcC
Confidence            9999999999999999999999999999996655556799999999999999999999999   9999999999999999


Q ss_pred             CCcEEEeccccccccCCCCCC--ccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhcccccc---
Q 039137          780 GYEAHVSDFGIAKFLNPDSSN--WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS---  854 (912)
Q Consensus       780 ~~~~kl~Dfgla~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~---  854 (912)
                      ++.+||+|||++.........  .....|++.|+|||.+.+ .++.++||||||+++|+|++|+.||+.........   
T Consensus       169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~  247 (307)
T 2nru_A          169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK  247 (307)
T ss_dssp             TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHH
T ss_pred             CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHH
Confidence            999999999999876543222  234578999999998875 48899999999999999999999986332211000   


Q ss_pred             ------ccchhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 039137          855 ------SNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI  909 (912)
Q Consensus       855 ------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l  909 (912)
                            ........+.....   .....+..+.+++.+||+.||.+|||++++++.|++..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          248 EEIEDEEKTIEDYIDKKMND---ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             HHHHTTSCCHHHHSCSSCSC---CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             HHhhhhhhhhhhhccccccc---cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence                  00111122222221   22455677899999999999999999999999998763

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=6e-41  Score=361.99  Aligned_cols=262  Identities=23%  Similarity=0.360  Sum_probs=208.9

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      .++|++.+.||+|+||.||+|++. +++.||+|++....... ....+.+.+|+.+++.++||||+++++++..++..++
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l   88 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREK-EETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL   88 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCC-HHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCcccc-HHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence            467999999999999999999875 78999999986654333 3356789999999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ||||+++++|.+++...   +.+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus        89 v~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  162 (294)
T 4eqm_A           89 VMEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS  162 (294)
T ss_dssp             EEECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred             EEeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence            99999999999999443   4689999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCC-CccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCC-Chhh
Q 039137          796 PDSS-NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYP-SLHV  873 (912)
Q Consensus       796 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  873 (912)
                      .... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||+.....     ...........+.. ....
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~  237 (294)
T 4eqm_A          163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV-----SIAIKHIQDSVPNVTTDVR  237 (294)
T ss_dssp             ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH-----HHHHHHHSSCCCCHHHHSC
T ss_pred             cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHhhccCCCcchhcc
Confidence            4322 233457899999999999999999999999999999999999998632111     11111111111111 1111


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHHhhh
Q 039137          874 QKKLMSIMQVAFSCLDQNPESRP-TMKRVSQLLCEKIF  910 (912)
Q Consensus       874 ~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~l~  910 (912)
                      ...+..+.+++.+||+.||++|| +++++.+.|++.+.
T Consensus       238 ~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          238 KDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             TTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             cCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence            22345688999999999999998 99999999987654

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.7e-40  Score=361.36  Aligned_cols=261  Identities=26%  Similarity=0.383  Sum_probs=213.0

Q ss_pred             CcccHHHHHHHhcC----------CCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhh
Q 039137          626 GKIVYEEIISATND----------FNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTE  694 (912)
Q Consensus       626 ~~~~~~e~~~~~~~----------~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~  694 (912)
                      +.+.++++..+.+.          |+..+.||+|+||.||+|+.+ +|+.||||++......    ..+.+.+|+.+++.
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~----~~~~~~~E~~~l~~   98 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ----RRELLFNEVVIMRD   98 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC----SHHHHHHHHHHHTT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh----HHHHHHHHHHHHHh
Confidence            34566777766654          667789999999999999986 7999999998754322    35678899999999


Q ss_pred             cCCCccccEEEEEEcCCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCC
Q 039137          695 IRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKN  774 (912)
Q Consensus       695 l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N  774 (912)
                      ++||||+++++++...+..++||||+++++|.+++..    ..+++.++..++.|++.||+|||++   +|+||||||+|
T Consensus        99 l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~N  171 (321)
T 2c30_A           99 YQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDS  171 (321)
T ss_dssp             CCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGG
T ss_pred             CCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHH
Confidence            9999999999999999999999999999999999843    4589999999999999999999999   99999999999


Q ss_pred             eEEcCCCcEEEeccccccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhcccccc
Q 039137          775 VLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS  854 (912)
Q Consensus       775 ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~  854 (912)
                      |+++.++.+||+|||++..............||+.|+|||++.+..++.++||||||+++|||++|+.||......    
T Consensus       172 Ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~----  247 (321)
T 2c30_A          172 ILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV----  247 (321)
T ss_dssp             EEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----
T ss_pred             EEECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----
Confidence            9999999999999999987765544455678999999999999999999999999999999999999998522111    


Q ss_pred             ccchhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          855 SNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       855 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                       ...........+.. ......+..+.+++.+||+.||++|||++|+++
T Consensus       248 -~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          248 -QAMKRLRDSPPPKL-KNSHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             -HHHHHHHHSSCCCC-TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -HHHHHHhcCCCCCc-CccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             11111111111111 111233456889999999999999999999876

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=1.7e-40  Score=379.60  Aligned_cols=357  Identities=21%  Similarity=0.211  Sum_probs=297.9

Q ss_pred             ccCCCCCccEEEccCCcccccCCccccCCCCCcEEeccccccccccccccccccccceeecccccccCCCCccccCcccc
Q 039137          104 SFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVL  183 (912)
Q Consensus       104 ~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L  183 (912)
                      +++++++|++|+|++|++++. | .++.+++|++|+|++|++++ +|  ++.+++|++|++++|.+++. |  ++.+++|
T Consensus        37 ~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L  108 (457)
T 3bz5_A           37 SEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTNL-D--VTPLTKL  108 (457)
T ss_dssp             EHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCC-C--CTTCTTC
T ss_pred             ChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCcee-e--cCCCCcC
Confidence            567789999999999999974 5 79999999999999999986 45  88999999999999999964 4  8899999


Q ss_pred             cEEEccCCcCCCCCCccCCCCccceeeeeccCCCcCccccccccccccceeecccccccCccccccccccccceeeeccc
Q 039137          184 NQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHN  263 (912)
Q Consensus       184 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N  263 (912)
                      ++|++++|++++ +|  ++++++|++|++++|.+++. +  ++++++|++|++++|+..+.+  .++.+++|++|++++|
T Consensus       109 ~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n  180 (457)
T 3bz5_A          109 TYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFN  180 (457)
T ss_dssp             CEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSS
T ss_pred             CEEECCCCcCCe-ec--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCC
Confidence            999999999986 44  88999999999999999874 3  888999999999999665555  4788999999999999


Q ss_pred             cCcccCCcccCCccccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCcccccc
Q 039137          264 ELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILS  343 (912)
Q Consensus       264 ~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~  343 (912)
                      ++++. |  +..+++|+.|++++|++++.   .+..+++|+.|++++|++++. |  ++.+++|+.|++++|++++..  
T Consensus       181 ~l~~l-~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~i-p--~~~l~~L~~L~l~~N~l~~~~--  249 (457)
T 3bz5_A          181 KITEL-D--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTEI-D--VTPLTQLTYFDCSVNPLTELD--  249 (457)
T ss_dssp             CCCCC-C--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCCC--
T ss_pred             cccee-c--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCccccc-C--ccccCCCCEEEeeCCcCCCcC--
Confidence            99974 4  88889999999999999875   488889999999999999974 4  788899999999999998754  


Q ss_pred             cCCCCCCCCEEeccCCcccccccccccccccccEEEccCccccCCCCccccccccccEEEccCCcccCCCcccccccccc
Q 039137          344 DWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINL  423 (912)
Q Consensus       344 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  423 (912)
                       ++.+++|+.|+++.|+              |+.|++++|.+.+.+|  ++.+++|+.|++++|...+.+|.   ...+|
T Consensus       250 -~~~l~~L~~L~l~~n~--------------L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~---~~~~L  309 (457)
T 3bz5_A          250 -VSTLSKLTTLHCIQTD--------------LLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDC---QAAGI  309 (457)
T ss_dssp             -CTTCTTCCEEECTTCC--------------CSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEEC---TTCCC
T ss_pred             -HHHCCCCCEEeccCCC--------------CCEEECCCCccCCccc--ccccccCCEEECCCCcccceecc---CCCcc
Confidence             4567888888887763              5677888888887776  56788899999999988777774   34566


Q ss_pred             ccccccCcccCccccccccccccccEEEecccccccccchhhhcccccceeeccccccCcccccccccccccccccccCc
Q 039137          424 EYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYN  503 (912)
Q Consensus       424 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N  503 (912)
                      +.|++++|             ++|++|+|++|++++. +  +.++++|+.|++++|+|++        ++.|..|++++|
T Consensus       310 ~~L~l~~~-------------~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n  365 (457)
T 3bz5_A          310 TELDLSQN-------------PKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNN  365 (457)
T ss_dssp             SCCCCTTC-------------TTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGT
T ss_pred             eEechhhc-------------ccCCEEECCCCccccc-c--cccCCcCcEEECCCCCCCC--------ccccccccccCC
Confidence            77766655             6889999999999874 3  8889999999999999976        367788899999


Q ss_pred             cccCCCcccccccccceEEEccCCccccCCCCC
Q 039137          504 NLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNS  536 (912)
Q Consensus       504 ~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~~~~  536 (912)
                      +++|.     ..+..|..+++++|+++|.+|..
T Consensus       366 ~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~  393 (457)
T 3bz5_A          366 NFEAE-----GQTITMPKETLTNNSLTIAVSPD  393 (457)
T ss_dssp             SEEEE-----EEEEECCCBCCBTTBEEEECCTT
T ss_pred             cEEec-----ceeeecCccccccCcEEEEcChh
Confidence            99886     24566778899999999988854

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.1e-40  Score=378.81  Aligned_cols=255  Identities=20%  Similarity=0.313  Sum_probs=212.0

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeee
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSF  714 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  714 (912)
                      ..++|++.+.||+|+||+||+|.+. +|+.||+|++.....  .....+.+.+|+++++.++||||+++++++.+++..+
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   86 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL--SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHY   86 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC--HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence            4578999999999999999999875 789999999875432  2234567899999999999999999999999999999


Q ss_pred             EEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEc---CCCcEEEeccccc
Q 039137          715 IIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLD---LGYEAHVSDFGIA  791 (912)
Q Consensus       715 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~---~~~~~kl~Dfgla  791 (912)
                      +||||+++|+|.+.+...   ..+++.++..++.||+.||+|||++   +|+||||||+||+++   .++.+||+|||++
T Consensus        87 lv~E~~~gg~L~~~i~~~---~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a  160 (444)
T 3soa_A           87 LIFDLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLA  160 (444)
T ss_dssp             EEECCCBCCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSC
T ss_pred             EEEEeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCcee
Confidence            999999999999988543   4689999999999999999999999   999999999999998   5678999999999


Q ss_pred             cccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCCh
Q 039137          792 KFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSL  871 (912)
Q Consensus       792 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  871 (912)
                      ..............||+.|+|||++.+..++.++||||+||++|+|++|..||....     .......+.......+..
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~-----~~~~~~~i~~~~~~~~~~  235 (444)
T 3soa_A          161 IEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED-----QHRLYQQIKAGAYDFPSP  235 (444)
T ss_dssp             BCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHTCCCCCTT
T ss_pred             EEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHHhCCCCCCcc
Confidence            877665555566789999999999999899999999999999999999999985211     111222233333333333


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          872 HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       872 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .....+..+.+++.+||+.||++|||+.|+++
T Consensus       236 ~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          236 EWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            33445567889999999999999999999876

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-40  Score=363.03  Aligned_cols=251  Identities=22%  Similarity=0.302  Sum_probs=211.3

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      .++|++.+.||+|+||+||+|+++ +++.||+|.+...     ....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l   78 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-----GTDQVLVKKEISILNIARHRNILHLHESFESMEELVM   78 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-----cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEE
Confidence            468999999999999999999876 6889999998633     1245678899999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcC--CCcEEEeccccccc
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDL--GYEAHVSDFGIAKF  793 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~--~~~~kl~Dfgla~~  793 (912)
                      ||||+++|+|.+++..  ....+++.+++.++.|++.||+|||++   +|+||||||+||+++.  ++.+||+|||+++.
T Consensus        79 v~e~~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~  153 (321)
T 1tki_A           79 IFEFISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ  153 (321)
T ss_dssp             EECCCCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred             EEEeCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeE
Confidence            9999999999999943  234689999999999999999999999   9999999999999997  78999999999987


Q ss_pred             cCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhh
Q 039137          794 LNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHV  873 (912)
Q Consensus       794 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  873 (912)
                      .... .......||+.|+|||++.+..++.++||||+||++|+|++|..||....     .......+.......+....
T Consensus       154 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-----~~~~~~~i~~~~~~~~~~~~  227 (321)
T 1tki_A          154 LKPG-DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET-----NQQIIENIMNAEYTFDEEAF  227 (321)
T ss_dssp             CCTT-CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHHHHTCCCCCHHHH
T ss_pred             CCCC-CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC-----HHHHHHHHHcCCCCCChhhh
Confidence            7543 33455678999999999998889999999999999999999999985221     11222333344444443333


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          874 QKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       874 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ...+..+.+++.+||+.||++|||+.|+++
T Consensus       228 ~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          228 KEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            445677899999999999999999999876

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=3.1e-40  Score=367.99  Aligned_cols=259  Identities=22%  Similarity=0.376  Sum_probs=211.2

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC--------CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP--------SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFC  707 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~  707 (912)
                      .++|++.+.||+|+||.||+|++.        ++..||||++....   .....+.+.+|+++++.+ +||||+++++++
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  156 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC  156 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC---BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc---CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            467999999999999999999752        45679999987542   233567899999999999 899999999999


Q ss_pred             EcCCeeeEEEeecCCCChhhHhhccCC-------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCC
Q 039137          708 SHPKHSFIIYEYLESGSLDKILCNDAS-------------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKN  774 (912)
Q Consensus       708 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N  774 (912)
                      ...+..|+||||+++|+|.+++.....             ...+++.+++.++.||+.||+|||++   +|+||||||+|
T Consensus       157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~N  233 (370)
T 2psq_A          157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARN  233 (370)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGG
T ss_pred             ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccchhh
Confidence            999999999999999999999965432             24589999999999999999999999   99999999999


Q ss_pred             eEEcCCCcEEEeccccccccCCCCC--CccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccc
Q 039137          775 VLLDLGYEAHVSDFGIAKFLNPDSS--NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMS  851 (912)
Q Consensus       775 ill~~~~~~kl~Dfgla~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~  851 (912)
                      |+++.++.+||+|||+++.......  ......+++.|+|||++.+..++.++|||||||++|||++ |+.||.....  
T Consensus       234 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~--  311 (370)
T 2psq_A          234 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--  311 (370)
T ss_dssp             EEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG--
T ss_pred             EEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH--
Confidence            9999999999999999987654332  2233456889999999999999999999999999999999 9999863211  


Q ss_pred             cccccchhhhccCC-CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          852 SSSSNMNIEMLDSR-LPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       852 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                         ........... ...+    ...+..+.+++.+||+.||++|||+.|+++.|++.+.
T Consensus       312 ---~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~  364 (370)
T 2psq_A          312 ---EELFKLLKEGHRMDKP----ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  364 (370)
T ss_dssp             ---GGHHHHHHTTCCCCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---HHHHHHHhcCCCCCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence               11111111111 1111    1234568899999999999999999999999998763

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1e-40  Score=365.95  Aligned_cols=251  Identities=22%  Similarity=0.289  Sum_probs=208.1

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      .++|++.+.||+|+||+||+|+.+ +|+.||+|++...... .....+.+.+|+.+++.++||||+++++++...+..++
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l   82 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII-AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF   82 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhh-hhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence            367999999999999999999876 7999999998643110 11135678899999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ||||+++|+|.+++..   .+.+++.+++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus        83 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  156 (337)
T 1o6l_A           83 VMEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             EEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence            9999999999999844   34689999999999999999999999   99999999999999999999999999998655


Q ss_pred             CCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHH
Q 039137          796 PDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQK  875 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  875 (912)
                      ..........||+.|+|||++.+..++.++||||+||++|||++|+.||....     .......+......++.    .
T Consensus       157 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-----~~~~~~~i~~~~~~~p~----~  227 (337)
T 1o6l_A          157 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HERLFELILMEEIRFPR----T  227 (337)
T ss_dssp             CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHCCCCCCT----T
T ss_pred             cCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC-----HHHHHHHHHcCCCCCCC----C
Confidence            44455566789999999999999999999999999999999999999985211     11112222233333332    2


Q ss_pred             HHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 039137          876 KLMSIMQVAFSCLDQNPESRP-----TMKRVSQ  903 (912)
Q Consensus       876 ~~~~l~~li~~cl~~dP~~RP-----t~~evl~  903 (912)
                      .+..+.++|.+||+.||++||     +++|+++
T Consensus       228 ~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          228 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence            345688999999999999999     8888764

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=5.3e-41  Score=374.82  Aligned_cols=263  Identities=22%  Similarity=0.319  Sum_probs=210.9

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEEcCCeee
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSHPKHSF  714 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~  714 (912)
                      .++|++.+.||+|+||+||+|+.+ +++.||+|++........ ...+.+.+|..++.++ +||||+++++++.+++..+
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~-~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  129 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDD-EDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF  129 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC-----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCH-HHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence            468999999999999999999976 688999999875433221 1335577899999887 8999999999999999999


Q ss_pred             EEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccccccc
Q 039137          715 IIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL  794 (912)
Q Consensus       715 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  794 (912)
                      +||||+++|+|.+++.+   .+.+++.+++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus       130 lV~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~  203 (396)
T 4dc2_A          130 FVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  203 (396)
T ss_dssp             EEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence            99999999999999854   34689999999999999999999999   9999999999999999999999999999865


Q ss_pred             CCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhcccc----ccccchhhhccCCCCCCC
Q 039137          795 NPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS----SSSNMNIEMLDSRLPYPS  870 (912)
Q Consensus       795 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~  870 (912)
                      ..........+||+.|+|||++.+..++.++||||+||++|||++|+.||+.......    ................+.
T Consensus       204 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~  283 (396)
T 4dc2_A          204 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR  283 (396)
T ss_dssp             CCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCT
T ss_pred             ccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCC
Confidence            4444556677899999999999999999999999999999999999999963211111    011122223334444443


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHH---HHHHHHHHhhh
Q 039137          871 LHVQKKLMSIMQVAFSCLDQNPESRPTMK---RVSQLLCEKIF  910 (912)
Q Consensus       871 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~---evl~~L~~~l~  910 (912)
                      .    .+..+.++|.+||+.||++||++.   .+.+.++..+|
T Consensus       284 ~----~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff  322 (396)
T 4dc2_A          284 S----LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF  322 (396)
T ss_dssp             T----SCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTT
T ss_pred             c----CCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccc
Confidence            2    345678999999999999999962   44555555444

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2.6e-40  Score=367.19  Aligned_cols=254  Identities=21%  Similarity=0.343  Sum_probs=211.0

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeee
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSF  714 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  714 (912)
                      ..++|++.+.||+|+||.||+|.++ +++.||+|++......  ....+.+.+|+++++.++||||+++++++.+.+..+
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  104 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS--ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY  104 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence            3567999999999999999999876 7899999999754332  224577899999999999999999999999999999


Q ss_pred             EEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCC---cEEEeccccc
Q 039137          715 IIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGY---EAHVSDFGIA  791 (912)
Q Consensus       715 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~---~~kl~Dfgla  791 (912)
                      +||||+++|+|.+++..   ...+++.+++.++.||+.||+|||++   +|+||||||+||+++.++   .+||+|||++
T Consensus       105 lv~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a  178 (362)
T 2bdw_A          105 LVFDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA  178 (362)
T ss_dssp             EEECCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence            99999999999998843   35689999999999999999999999   999999999999998654   5999999999


Q ss_pred             cccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCCh
Q 039137          792 KFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSL  871 (912)
Q Consensus       792 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  871 (912)
                      ...... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||....     .......+......++..
T Consensus       179 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~-----~~~~~~~i~~~~~~~~~~  252 (362)
T 2bdw_A          179 IEVNDS-EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED-----QHRLYAQIKAGAYDYPSP  252 (362)
T ss_dssp             BCCTTC-CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHTCCCCCTT
T ss_pred             eEecCC-cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHhCCCCCCcc
Confidence            876533 33445689999999999999899999999999999999999999985211     111222233333334433


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          872 HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       872 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .....+..+.++|.+||+.||++|||+.|+++
T Consensus       253 ~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          253 EWDTVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            33445667889999999999999999999875

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=7e-40  Score=358.29  Aligned_cols=265  Identities=22%  Similarity=0.333  Sum_probs=213.1

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCC--ee
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPK--HS  713 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--~~  713 (912)
                      .++|++.+.||+|+||+||+|++. +++.||||++......   ...+.+.+|+++++.++||||+++++++...+  ..
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   84 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL---RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK   84 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG---SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc---chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence            367999999999999999999876 5899999998643221   13567789999999999999999999998765  77


Q ss_pred             eEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEE----cCCCcEEEeccc
Q 039137          714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLL----DLGYEAHVSDFG  789 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill----~~~~~~kl~Dfg  789 (912)
                      ++||||+++++|.+++........+++.+++.++.|++.||+|||++   +|+||||||+||++    +.++.+||+|||
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg  161 (319)
T 4euu_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFG  161 (319)
T ss_dssp             EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred             EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCC
Confidence            99999999999999997655555599999999999999999999999   99999999999999    778889999999


Q ss_pred             cccccCCCCCCccccccccccccccccc--------cCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhh
Q 039137          790 IAKFLNPDSSNWSELAGTHGYVAPELAY--------TLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEM  861 (912)
Q Consensus       790 la~~~~~~~~~~~~~~g~~~y~aPE~~~--------~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~  861 (912)
                      +++...... ......||+.|+|||++.        +..++.++|||||||++|||++|+.||.......... ......
T Consensus       162 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~-~~~~~~  239 (319)
T 4euu_A          162 AARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK-EVMYKI  239 (319)
T ss_dssp             TCEECCTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCH-HHHHHH
T ss_pred             CceecCCCC-ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhH-HHHHHH
Confidence            998765443 334567999999999886        5678999999999999999999999986322111100 000000


Q ss_pred             ---------------------ccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 039137          862 ---------------------LDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI  909 (912)
Q Consensus       862 ---------------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l  909 (912)
                                           +....+............+.+++.+||+.||++|||++|+++...+..
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~  308 (319)
T 4euu_A          240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (319)
T ss_dssp             HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred             hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence                                 111222222334566777899999999999999999999999887653

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=4e-40  Score=360.89  Aligned_cols=255  Identities=19%  Similarity=0.311  Sum_probs=209.9

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCc--hHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCee
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEM--SFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHS  713 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  713 (912)
                      .++|++.+.||+|+||.||+|+++ +++.||+|++........  ....+.+.+|+.+++.++||||+++++++..++..
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            356999999999999999999876 689999999875433221  11357789999999999999999999999999999


Q ss_pred             eEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCC----cEEEeccc
Q 039137          714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGY----EAHVSDFG  789 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~Dfg  789 (912)
                      ++||||+++|+|.+++..   ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++    .+||+|||
T Consensus        90 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  163 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG  163 (326)
T ss_dssp             EEEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence            999999999999999943   35689999999999999999999999   999999999999999887    79999999


Q ss_pred             cccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCC
Q 039137          790 IAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYP  869 (912)
Q Consensus       790 la~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  869 (912)
                      +++..... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||.....     ..............+
T Consensus       164 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~~~~~~~~~~~  237 (326)
T 2y0a_A          164 LAHKIDFG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-----QETLANVSAVNYEFE  237 (326)
T ss_dssp             TCEECCTT-SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-----HHHHHHHHHTCCCCC
T ss_pred             CCeECCCC-CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH-----HHHHHHHHhcCCCcC
Confidence            99876543 233456799999999999988999999999999999999999999852211     111112222233333


Q ss_pred             ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          870 SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       870 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .......+..+.+++.+||+.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          238 DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            3233344567889999999999999999999876

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.4e-40  Score=364.22  Aligned_cols=257  Identities=26%  Similarity=0.450  Sum_probs=207.8

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC----CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCe
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP----SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKH  712 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~  712 (912)
                      .++|++.+.||+|+||+||+|++.    .+..||||++....   .....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  124 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY---TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL  124 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc
Confidence            467889999999999999999875    34469999997542   23356789999999999999999999999999999


Q ss_pred             eeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccccc
Q 039137          713 SFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK  792 (912)
Q Consensus       713 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  792 (912)
                      .++||||+++|+|.+++...  ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus       125 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  199 (325)
T 3kul_A          125 AMIVTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSR  199 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred             cEEEeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccc
Confidence            99999999999999999543  34689999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCCCc---cccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccC-CCC
Q 039137          793 FLNPDSSNW---SELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDS-RLP  867 (912)
Q Consensus       793 ~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~  867 (912)
                      .........   ....+|+.|+|||++.+..++.++||||||+++|||++ |+.||.....     ......+... ..+
T Consensus       200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-----~~~~~~~~~~~~~~  274 (325)
T 3kul_A          200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN-----RDVISSVEEGYRLP  274 (325)
T ss_dssp             ECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH-----HHHHHHHHTTCCCC
T ss_pred             ccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH-----HHHHHHHHcCCCCC
Confidence            765433221   23345778999999998899999999999999999999 9999852211     1111111111 122


Q ss_pred             CCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          868 YPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       868 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                      .+    ...+..+.+++.+||+.||++|||+.|+++.|++.+.
T Consensus       275 ~~----~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~  313 (325)
T 3kul_A          275 AP----MGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR  313 (325)
T ss_dssp             CC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CC----CCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            22    1234568899999999999999999999999998764

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.5e-40  Score=368.18  Aligned_cols=258  Identities=20%  Similarity=0.260  Sum_probs=210.4

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCC-CCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeee
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLP-GEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSF  714 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  714 (912)
                      .++|++.+.||+|+||+||+|+++ +++.||||++..... .......+.+.+|+.+++.++||||+++++++...+..|
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            457999999999999999999876 789999999853210 011113567899999999999999999999999999999


Q ss_pred             EEEeecCCCChhhHhhccC-CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCc---EEEecccc
Q 039137          715 IIYEYLESGSLDKILCNDA-SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYE---AHVSDFGI  790 (912)
Q Consensus       715 lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~Dfgl  790 (912)
                      +||||+++++|.+++.... ....+++..++.++.||+.||+|||++   +|+||||||+||+++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            9999999999988875432 334589999999999999999999999   9999999999999986654   99999999


Q ss_pred             ccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCC
Q 039137          791 AKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPS  870 (912)
Q Consensus       791 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  870 (912)
                      +..............||+.|+|||++.+..++.++||||+||++|+|++|+.||....      ..............+.
T Consensus       180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~~~~i~~~~~~~~~  253 (351)
T 3c0i_A          180 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK------ERLFEGIIKGKYKMNP  253 (351)
T ss_dssp             CEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH------HHHHHHHHHTCCCCCH
T ss_pred             eeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH------HHHHHHHHcCCCCCCc
Confidence            9887655444556789999999999999999999999999999999999999986321      1122223333333333


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          871 LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       871 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ......+..+.+++.+||+.||++|||+.|+++
T Consensus       254 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          254 RQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            333344567889999999999999999999875

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=2.6e-39  Score=372.94  Aligned_cols=346  Identities=30%  Similarity=0.391  Sum_probs=207.7

Q ss_pred             CCCCccEEEccCCcccccCCccccCCCCCcEEeccccccccccccccccccccceeecccccccCCCCccccCcccccEE
Q 039137          107 SFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQL  186 (912)
Q Consensus       107 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L  186 (912)
                      .+++++.|+++++++.. +| .+..+++|++|||++|.+++. |. ++.+++|++|++++|.+++..|  ++++++|++|
T Consensus        44 ~l~~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L  117 (466)
T 1o6v_A           44 DLDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQIADITP--LANLTNLTGL  117 (466)
T ss_dssp             HHHTCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred             HhccccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCccCCc-hh-hhccccCCEEECCCCccccChh--hcCCCCCCEE
Confidence            34567778888887764 44 377788888888888887744 33 7778888888888888775443  7777788888


Q ss_pred             EccCCcCCCCCCccCCCCccceeeeeccCCCcCccccccccccccceeecccccccCccccccccccccceeeeccccCc
Q 039137          187 ALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELS  266 (912)
Q Consensus       187 ~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~  266 (912)
                      ++++|.+++..+  +.++++|++|++++|.+.+ ++ .++++++|+.|+++ |.+.+..+  +.++++|++|++++|.++
T Consensus       118 ~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~-~~~~~~~~--~~~l~~L~~L~l~~n~l~  190 (466)
T 1o6v_A          118 TLFNNQITDIDP--LKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKVS  190 (466)
T ss_dssp             ECCSSCCCCCGG--GTTCTTCSEEEEEEEEECC-CG-GGTTCTTCSEEEEE-ESCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred             ECCCCCCCCChH--HcCCCCCCEEECCCCccCC-Ch-hhccCCcccEeecC-CcccCchh--hccCCCCCEEECcCCcCC
Confidence            888777774432  7777777777777777764 33 36677777777775 44443322  666777777777777766


Q ss_pred             ccCCcccCCccccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCcccccccCC
Q 039137          267 GIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWG  346 (912)
Q Consensus       267 ~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  346 (912)
                      +.  ..+..+++|++|++++|.+.+..|  +..+++|+.|++++|.+++.  ..+..+++|+.|++++|.+.+..+  +.
T Consensus       191 ~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~  262 (466)
T 1o6v_A          191 DI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LS  262 (466)
T ss_dssp             CC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GT
T ss_pred             CC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hh
Confidence            43  235666666666666666665443  55566666666666666543  245555666666666666554433  55


Q ss_pred             CCCCCCEEeccCCcccccccccccccccccEEEccCccccCCCCccccccccccEEEccCCcccCCCccccccccccccc
Q 039137          347 RCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYL  426 (912)
Q Consensus       347 ~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  426 (912)
                      .+++|+.|++++|++.+..+  +..+++|++|+|++|++.+..+  +..+++|+.|++++|++++..|  +..+++|++|
T Consensus       263 ~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L  336 (466)
T 1o6v_A          263 GLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRL  336 (466)
T ss_dssp             TCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEE
T ss_pred             cCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEe
Confidence            55555555555555554333  4455555555555555554322  4455555555555555554433  4445555555


Q ss_pred             cccCcccCccccccccccccccEEEecccccccccchhhhcccccceeeccccccCc
Q 039137          427 DLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGE  483 (912)
Q Consensus       427 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  483 (912)
                      ++++|++++.  ..+..+++|+.|++++|++++..|  +..+++|+.|++++|++++
T Consensus       337 ~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~  389 (466)
T 1o6v_A          337 FFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN  389 (466)
T ss_dssp             ECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEEC
T ss_pred             ECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccC
Confidence            5555555443  234455555555555555544443  4445555555555555544

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=1.9e-39  Score=373.97  Aligned_cols=347  Identities=29%  Similarity=0.393  Sum_probs=235.0

Q ss_pred             cCCCCCcEEeccccccccccccccccccccceeecccccccCCCCccccCcccccEEEccCCcCCCCCCccCCCCcccee
Q 039137          130 SNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVI  209 (912)
Q Consensus       130 ~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~  209 (912)
                      ..+++|++|+++++.+. .+|. +..+++|++|+|++|.+++. |. ++++++|++|++++|.+++..|  ++++++|++
T Consensus        43 ~~l~~l~~L~l~~~~i~-~l~~-~~~l~~L~~L~Ls~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~  116 (466)
T 1o6v_A           43 TDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQIADITP--LANLTNLTG  116 (466)
T ss_dssp             HHHHTCCEEECCSSCCC-CCTT-GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCE
T ss_pred             hHhccccEEecCCCCCc-cCcc-hhhhcCCCEEECCCCccCCc-hh-hhccccCCEEECCCCccccChh--hcCCCCCCE
Confidence            45678899999999887 4664 88899999999999999854 44 8889999999999999886544  888889999


Q ss_pred             eeeccCCCcCccccccccccccceeecccccccCccccccccccccceeeeccccCcccCCcccCCccccchhhhccCcc
Q 039137          210 LYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHF  289 (912)
Q Consensus       210 L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l  289 (912)
                      |++++|.+++..+  +.++++|++|++++|++++ ++ .++.+++|++|+++ |.+.+..  .+.++++|++|++++|.+
T Consensus       117 L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~l  189 (466)
T 1o6v_A          117 LTLFNNQITDIDP--LKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISSNKV  189 (466)
T ss_dssp             EECCSSCCCCCGG--GTTCTTCSEEEEEEEEECC-CG-GGTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSCC
T ss_pred             EECCCCCCCCChH--HcCCCCCCEEECCCCccCC-Ch-hhccCCcccEeecC-CcccCch--hhccCCCCCEEECcCCcC
Confidence            9999988886543  7888888888888888875 33 47888888888886 5555433  277788888888888887


Q ss_pred             CCCCccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCcccccccCCCCCCCCEEeccCCcccccccccc
Q 039137          290 RGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEI  369 (912)
Q Consensus       290 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~  369 (912)
                      ++.  ..+..+++|++|++++|.+++..+  ++.+++|++|++++|++.+.  ..+..+++|+.|++++|++.+..+  +
T Consensus       190 ~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~  261 (466)
T 1o6v_A          190 SDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--L  261 (466)
T ss_dssp             CCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--G
T ss_pred             CCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--h
Confidence            753  346777777777777777776544  56677777777777777543  345566666666666666665443  5


Q ss_pred             cccccccEEEccCccccCCCCccccccccccEEEccCCcccCCCccccccccccccccccCcccCccccccccccccccE
Q 039137          370 GESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYY  449 (912)
Q Consensus       370 ~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  449 (912)
                      ..+++|++|++++|++++..+  +..+++|+.|++++|++++..+  +..+++|+.|+|++|++++..|  +..+++|+.
T Consensus       262 ~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~  335 (466)
T 1o6v_A          262 SGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQR  335 (466)
T ss_dssp             TTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCE
T ss_pred             hcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCE
Confidence            556666666666666664332  5555666666666666654333  4555566666666666555443  455555566


Q ss_pred             EEecccccccccchhhhcccccceeeccccccCcccccccccccccccccccCccccC
Q 039137          450 LNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSG  507 (912)
Q Consensus       450 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~  507 (912)
                      |++++|++++.  ..+..+++|+.|++++|++++..|  +..+++|+.|++++|++++
T Consensus       336 L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~  389 (466)
T 1o6v_A          336 LFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN  389 (466)
T ss_dssp             EECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEEC
T ss_pred             eECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccC
Confidence            66665555543  245555555555555555555444  4555555555555555554

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.1e-40  Score=365.15  Aligned_cols=262  Identities=22%  Similarity=0.330  Sum_probs=210.5

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEEcCCeeeE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~l  715 (912)
                      ++|++.+.||+|+||.||+|+++ +++.||+|++....... ....+.+.+|..+++.+ +||||+++++++.+.+..|+
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVND-DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCS-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcc-hHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            57999999999999999999976 68899999997654332 22456788999999988 89999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ||||+++|+|.+++..   .+.+++.+++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus        88 v~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~  161 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  161 (345)
T ss_dssp             EECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred             EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEecccccccc
Confidence            9999999999999954   34689999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhcccc----ccccchhhhccCCCCCCCh
Q 039137          796 PDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS----SSSNMNIEMLDSRLPYPSL  871 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~  871 (912)
                      ..........||+.|+|||++.+..++.++||||+||++|||++|+.||+.......    ................+. 
T Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~-  240 (345)
T 3a8x_A          162 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR-  240 (345)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCT-
T ss_pred             CCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCC-
Confidence            444455667899999999999999999999999999999999999999863211110    011111222333333332 


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCHH---HHHHHHHHhhh
Q 039137          872 HVQKKLMSIMQVAFSCLDQNPESRPTMK---RVSQLLCEKIF  910 (912)
Q Consensus       872 ~~~~~~~~l~~li~~cl~~dP~~RPt~~---evl~~L~~~l~  910 (912)
                         ..+..+.+++.+||+.||++||++.   .+.+.++..+|
T Consensus       241 ---~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f  279 (345)
T 3a8x_A          241 ---SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF  279 (345)
T ss_dssp             ---TSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGG
T ss_pred             ---CCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCcc
Confidence               2345688999999999999999962   33444444443

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=9.6e-41  Score=368.66  Aligned_cols=247  Identities=23%  Similarity=0.366  Sum_probs=200.0

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEEcCCee
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSHPKHS  713 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~  713 (912)
                      ..++|++.+.||+|+||+||+|+++ +++.||+|++...... .....+.+.+|..+++.+ +||||+++++++.+++..
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~-~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~   99 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVIL-QDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL   99 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-HHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhc-chhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence            3578999999999999999999876 6899999998643111 111346678999999988 699999999999999999


Q ss_pred             eEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccc
Q 039137          714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKF  793 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  793 (912)
                      |+||||+++|+|.+++...   +.+++.+++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++.
T Consensus       100 ~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~  173 (353)
T 3txo_A          100 FFVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKE  173 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceee
Confidence            9999999999999999543   4689999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhh
Q 039137          794 LNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHV  873 (912)
Q Consensus       794 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  873 (912)
                      ...........+||+.|+|||++.+..++.++||||+||++|||++|+.||....     .......+......++..  
T Consensus       174 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~-----~~~~~~~i~~~~~~~p~~--  246 (353)
T 3txo_A          174 GICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN-----EDDLFEAILNDEVVYPTW--  246 (353)
T ss_dssp             SCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHCCCCCCTT--
T ss_pred             cccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC-----HHHHHHHHHcCCCCCCCC--
Confidence            5544445566789999999999999899999999999999999999999986221     122233334444444432  


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCH
Q 039137          874 QKKLMSIMQVAFSCLDQNPESRPTM  898 (912)
Q Consensus       874 ~~~~~~l~~li~~cl~~dP~~RPt~  898 (912)
                        .+..+.+++.+||+.||++||++
T Consensus       247 --~~~~~~~li~~lL~~dP~~R~~~  269 (353)
T 3txo_A          247 --LHEDATGILKSFMTKNPTMRLGS  269 (353)
T ss_dssp             --SCHHHHHHHHHHTCSSGGGSTTS
T ss_pred             --CCHHHHHHHHHHhhhCHHHccCC
Confidence              33457889999999999999998

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.6e-40  Score=352.36  Aligned_cols=256  Identities=24%  Similarity=0.411  Sum_probs=210.4

Q ss_pred             hcCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      .++|++.+.||+|+||+||+|++.+++.||+|++.....     ..+++.+|++++++++||||+++++++.+++..++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV   83 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-----CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEE
Confidence            367899999999999999999998899999999975432     246788999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++++|.+++...  ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++.....
T Consensus        84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  158 (269)
T 4hcu_A           84 FEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  158 (269)
T ss_dssp             EECCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             EEeCCCCcHHHHHHhc--CcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccc
Confidence            9999999999999543  34689999999999999999999999   999999999999999999999999999986543


Q ss_pred             CC-CCccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccCCCCCCChhhH
Q 039137          797 DS-SNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQ  874 (912)
Q Consensus       797 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  874 (912)
                      .. .......+++.|+|||++.+..++.++||||+|+++|+|++ |+.||.....     ...............+   .
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~---~  230 (269)
T 4hcu_A          159 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-----SEVVEDISTGFRLYKP---R  230 (269)
T ss_dssp             HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHHHHTTCCCCCC---T
T ss_pred             cccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH-----HHHHHHHhcCccCCCC---C
Confidence            21 11233456788999999998999999999999999999999 9999863211     1111111111111111   1


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          875 KKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       875 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                      ..+..+.+++.+||+.||++|||++|+++.|++...
T Consensus       231 ~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          231 LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence            124558899999999999999999999999998764

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.1e-39  Score=358.78  Aligned_cols=251  Identities=21%  Similarity=0.412  Sum_probs=205.0

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCC----
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPK----  711 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----  711 (912)
                      .++|++.+.||+|+||.||+|+++ +++.||||++.....   ....+.+.+|++++++++||||+++++++.+.+    
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   81 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR---ELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKW   81 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCST---TTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCc---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchh
Confidence            467999999999999999999987 899999999975432   225678999999999999999999999986543    


Q ss_pred             -----------------------------------------------------eeeEEEeecCCCChhhHhhccCCcccC
Q 039137          712 -----------------------------------------------------HSFIIYEYLESGSLDKILCNDASAKEL  738 (912)
Q Consensus       712 -----------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~l  738 (912)
                                                                           ..++||||+++|+|.+++.........
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~  161 (332)
T 3qd2_B           82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR  161 (332)
T ss_dssp             HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGS
T ss_pred             hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccch
Confidence                                                                 379999999999999999777666677


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCC------------Ccccccc
Q 039137          739 GWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSS------------NWSELAG  806 (912)
Q Consensus       739 ~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~------------~~~~~~g  806 (912)
                      ++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.......            ......|
T Consensus       162 ~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g  238 (332)
T 3qd2_B          162 EHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG  238 (332)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred             hhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence            8888999999999999999999   999999999999999999999999999987765421            2234579


Q ss_pred             ccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHHHHHHHHHHH
Q 039137          807 THGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFS  886 (912)
Q Consensus       807 ~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  886 (912)
                      |+.|+|||++.+..++.++||||+|+++|||++|..|+.....       ........  .. +.........+.+++.+
T Consensus       239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~-------~~~~~~~~--~~-~~~~~~~~~~~~~li~~  308 (332)
T 3qd2_B          239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR-------IITDVRNL--KF-PLLFTQKYPQEHMMVQD  308 (332)
T ss_dssp             CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHH-------HHHHHHTT--CC-CHHHHHHCHHHHHHHHH
T ss_pred             CcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHH-------HHHHhhcc--CC-CcccccCChhHHHHHHH
Confidence            9999999999999999999999999999999999888531111       11111111  11 22334455677899999


Q ss_pred             cccCCCCCCCCHHHHHH
Q 039137          887 CLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       887 cl~~dP~~RPt~~evl~  903 (912)
                      ||+.||++|||++|+++
T Consensus       309 ~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          309 MLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHCSSGGGSCCHHHHHH
T ss_pred             HccCCCCcCCCHHHHhh
Confidence            99999999999998875

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=9.4e-40  Score=355.54  Aligned_cols=257  Identities=21%  Similarity=0.294  Sum_probs=201.4

Q ss_pred             hcCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      .++|++.+.||+|+||+||+|++++++.||+|++......  ....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   97 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAED--EGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV   97 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC--------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEeccccc--chhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence            4789999999999999999999988999999998754322  22456788999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++ ++.+++...  ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        98 ~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  171 (311)
T 3niz_A           98 FEFMEK-DLKKVLDEN--KTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGI  171 (311)
T ss_dssp             EECCSE-EHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred             EcCCCC-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence            999985 787777442  34589999999999999999999999   999999999999999999999999999988765


Q ss_pred             CCCCcccccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhc-------------
Q 039137          797 DSSNWSELAGTHGYVAPELAYT-LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEML-------------  862 (912)
Q Consensus       797 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~-------------  862 (912)
                      .........+|+.|+|||++.+ ..++.++||||+||++|+|++|+.||..........  ......             
T Consensus       172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~--~i~~~~~~~~~~~~~~~~~  249 (311)
T 3niz_A          172 PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLP--KIFSILGTPNPREWPQVQE  249 (311)
T ss_dssp             CCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHH--HHHHHHCCCCTTTSGGGTT
T ss_pred             CcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHH--HHHHHHCCCChHHhhhhhc
Confidence            5555566688999999999876 568999999999999999999999986322111000  000000             


Q ss_pred             -----cCCCC---CCC--hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          863 -----DSRLP---YPS--LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       863 -----~~~~~---~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                           .....   ...  ......+.++.+++.+||+.||++|||++|+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          250 LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             SHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             cchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                 00000   000  001112356789999999999999999999875

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.3e-39  Score=353.21  Aligned_cols=257  Identities=28%  Similarity=0.436  Sum_probs=200.9

Q ss_pred             hcCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhh--cCCCccccEEEEEEcC----
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTE--IRHRNIVKFYGFCSHP----  710 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~--l~h~niv~l~~~~~~~----  710 (912)
                      .++|++.+.||+|+||+||+|++ +++.||||++...       ..+.+.+|.+++..  ++||||+++++++...    
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~   78 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR-------DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSS   78 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG-------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc-------cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCC
Confidence            46899999999999999999988 7899999998532       34556667777766  7899999999997543    


Q ss_pred             CeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeeecCCCCCCeEEcCCCc
Q 039137          711 KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLH--------NNCFPPIVHRDISSKNVLLDLGYE  782 (912)
Q Consensus       711 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--------~~~~~~ivH~Dlk~~Nill~~~~~  782 (912)
                      ...++||||+++|+|.+++..    ..+++.++++++.|++.||+|||        ++   +|+||||||+||+++.++.
T Consensus        79 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~  151 (301)
T 3q4u_A           79 TQLWLITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQ  151 (301)
T ss_dssp             EEEEEEECCCTTCBHHHHHTT----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSC
T ss_pred             ceeEEehhhccCCCHHHHHhh----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCC
Confidence            458999999999999999932    46899999999999999999999        77   9999999999999999999


Q ss_pred             EEEeccccccccCCCCCC----ccccccccccccccccccC------CCCcchhHHHHHHHHHHHHhC----------CC
Q 039137          783 AHVSDFGIAKFLNPDSSN----WSELAGTHGYVAPELAYTL------KVTEKCDVYSFGVLALEVIKG----------KH  842 (912)
Q Consensus       783 ~kl~Dfgla~~~~~~~~~----~~~~~g~~~y~aPE~~~~~------~~~~~sDvwslG~vl~elltg----------~~  842 (912)
                      +||+|||+++........    .....||+.|+|||++.+.      .++.++||||||+++|||++|          +.
T Consensus       152 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~  231 (301)
T 3q4u_A          152 CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP  231 (301)
T ss_dssp             EEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred             EEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccc
Confidence            999999999866543322    2334789999999998876      455799999999999999999          77


Q ss_pred             Cccchhccccccccchhh-hccC-CCCCCC-hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 039137          843 PRDFLFEMSSSSSNMNIE-MLDS-RLPYPS-LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEK  908 (912)
Q Consensus       843 pf~~~~~~~~~~~~~~~~-~~~~-~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  908 (912)
                      ||................ .... ....+. ......+..+.+++.+||+.||++|||++|+++.|++.
T Consensus       232 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          232 PFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            764222111111111111 1111 111111 12334667899999999999999999999999999874

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=5.3e-40  Score=349.80  Aligned_cols=256  Identities=27%  Similarity=0.439  Sum_probs=209.9

Q ss_pred             hcCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      .++|++.+.||+|+||.||+|+++++..||+|++.....     ..+++.+|+++++.++||||+++++++..++..++|
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   81 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-----SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIV   81 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-----cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEE
Confidence            467999999999999999999998888999999865432     346788999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++++|.+++...  ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++.....
T Consensus        82 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  156 (268)
T 3sxs_A           82 TEYISNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD  156 (268)
T ss_dssp             EECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred             EEccCCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecch
Confidence            9999999999999543  34589999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCC-ccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccCCCCCCChhhH
Q 039137          797 DSSN-WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQ  874 (912)
Q Consensus       797 ~~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  874 (912)
                      .... .....+++.|+|||.+.+..++.++||||+|+++|||++ |+.||+.....     ..............+   .
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~---~  228 (268)
T 3sxs_A          157 DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS-----EVVLKVSQGHRLYRP---H  228 (268)
T ss_dssp             TCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH-----HHHHHHHTTCCCCCC---T
T ss_pred             hhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH-----HHHHHHHcCCCCCCC---C
Confidence            3221 223445678999999998889999999999999999999 99998632111     111111111111111   1


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          875 KKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       875 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                      ..+..+.+++.+||+.||++|||++|+++.|+....
T Consensus       229 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          229 LASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             TSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             cChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence            123458899999999999999999999999987654

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=8.3e-40  Score=358.52  Aligned_cols=252  Identities=23%  Similarity=0.301  Sum_probs=195.1

Q ss_pred             hcCCCCCceeeecCceEEEEEEe----CCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCe
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKV----PSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKH  712 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~  712 (912)
                      .++|++.+.||+|+||.||+|+.    .+++.||+|++..............+.+|+.+++.++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            46799999999999999999986    47899999999765432222245667899999999999999999999999999


Q ss_pred             eeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccccc
Q 039137          713 SFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK  792 (912)
Q Consensus       713 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  792 (912)
                      .++||||+++|+|.+++..   .+.+++.+++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus        96 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             EEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence            9999999999999999954   34688999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChh
Q 039137          793 FLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLH  872 (912)
Q Consensus       793 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  872 (912)
                      .............||+.|+|||++.+..++.++||||||+++|||++|+.||.....     ......+.......+.  
T Consensus       170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~i~~~~~~~p~--  242 (327)
T 3a62_A          170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR-----KKTIDKILKCKLNLPP--  242 (327)
T ss_dssp             ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHTCCCCCT--
T ss_pred             ccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHhCCCCCCC--
Confidence            654444444566799999999999998999999999999999999999999863211     1112222233333332  


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 039137          873 VQKKLMSIMQVAFSCLDQNPESRP-----TMKRVSQ  903 (912)
Q Consensus       873 ~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~  903 (912)
                        ..+..+.+++.+||+.||++||     ++.|+++
T Consensus       243 --~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          243 --YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             --TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             --CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence              2345678999999999999999     5666543

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.7e-40  Score=362.21  Aligned_cols=248  Identities=23%  Similarity=0.338  Sum_probs=201.2

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ++|.+.+.||+|+||+||+|++. +++.||+|++....... ....+.+.+|+.+++.++||||+++++++..++..++|
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKK-SDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccc-hhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            67999999999999999999974 78999999985321110 01235688999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+ +|+|.+++..   .+.+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++.....
T Consensus        88 ~E~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~  160 (336)
T 3h4j_B           88 IEYA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD  160 (336)
T ss_dssp             ECCC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred             EECC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence            9999 6788888844   34689999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCCccccccccccccccccccCCC-CcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHH
Q 039137          797 DSSNWSELAGTHGYVAPELAYTLKV-TEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQK  875 (912)
Q Consensus       797 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  875 (912)
                      . .......||+.|+|||++.+..+ +.++||||+||++|+|++|+.||+.....     .............+.    .
T Consensus       161 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-----~~~~~i~~~~~~~p~----~  230 (336)
T 3h4j_B          161 G-NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP-----NLFKKVNSCVYVMPD----F  230 (336)
T ss_dssp             S-BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSST-----TCBCCCCSSCCCCCT----T
T ss_pred             C-cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHH-----HHHHHHHcCCCCCcc----c
Confidence            3 23345679999999999988776 78999999999999999999998632111     111111111222221    2


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          876 KLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       876 ~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .+..+.+++.+||+.||.+|||++|+++
T Consensus       231 ~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          231 LSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            3456789999999999999999999875

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=7.8e-40  Score=364.94  Aligned_cols=257  Identities=25%  Similarity=0.456  Sum_probs=198.4

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC----CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCe
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP----SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKH  712 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~  712 (912)
                      .++|++.+.||+|+||.||+|+++    ++..||||++....   .....+.+.+|+.++++++||||+++++++...+.
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  120 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY---TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP  120 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCc
Confidence            357999999999999999999865    57789999987542   23356789999999999999999999999999999


Q ss_pred             eeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccccc
Q 039137          713 SFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK  792 (912)
Q Consensus       713 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  792 (912)
                      .++||||+++|+|.+++...  ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus       121 ~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  195 (373)
T 2qol_A          121 VMIVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGR  195 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred             eEEEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcccc
Confidence            99999999999999999543  34689999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCCCc---cccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccC-CCC
Q 039137          793 FLNPDSSNW---SELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDS-RLP  867 (912)
Q Consensus       793 ~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~  867 (912)
                      .........   ....+++.|+|||++.+..++.++||||||+++|||++ |+.||.....     ......+... +.+
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~-----~~~~~~i~~~~~~~  270 (373)
T 2qol_A          196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-----QDVIKAVDEGYRLP  270 (373)
T ss_dssp             ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH-----HHHHHHHHTTEECC
T ss_pred             ccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHcCCCCC
Confidence            765432211   22335678999999999999999999999999999998 9999852211     1111111111 112


Q ss_pred             CCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          868 YPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       868 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                      .+    ...+..+.+++.+||+.||++||+++|+++.|++.+.
T Consensus       271 ~~----~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  309 (373)
T 2qol_A          271 PP----MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR  309 (373)
T ss_dssp             CC----TTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CC----ccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence            11    1234568899999999999999999999999998764

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=6.8e-40  Score=352.82  Aligned_cols=258  Identities=24%  Similarity=0.353  Sum_probs=198.4

Q ss_pred             cCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIY  717 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  717 (912)
                      ++|++.+.||+|+||+||+|+..+++.||+|++......  ....+.+.+|+++++.++||||+++++++..++..++||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED--EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF   79 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGG--GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccc--cccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence            578999999999999999999988999999998654322  113467889999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCC
Q 039137          718 EYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPD  797 (912)
Q Consensus       718 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  797 (912)
                      ||+++ +|.+++...  .+.+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        80 e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  153 (288)
T 1ob3_A           80 EHLDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIP  153 (288)
T ss_dssp             ECCSE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred             EecCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence            99986 898888442  35689999999999999999999999   9999999999999999999999999999876544


Q ss_pred             CCCccccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCccchhcccccc----------ccc-----hhhh
Q 039137          798 SSNWSELAGTHGYVAPELAYTL-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS----------SNM-----NIEM  861 (912)
Q Consensus       798 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~----------~~~-----~~~~  861 (912)
                      ........+|+.|+|||++.+. .++.++||||+||++|||++|+.||..........          ...     ....
T Consensus       154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T 1ob3_A          154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK  233 (288)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccc
Confidence            4444556789999999998764 58999999999999999999999986321110000          000     0000


Q ss_pred             ccCCCC----CC-ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          862 LDSRLP----YP-SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       862 ~~~~~~----~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .+....    .+ .......+..+.+++.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            000000    00 0001123456789999999999999999998865

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=9.7e-40  Score=357.19  Aligned_cols=252  Identities=25%  Similarity=0.353  Sum_probs=202.3

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      .++|++.+.||+|+||+||+|++. +++.||+|++.......   ..+.+.+|+.+++.++||||+++++++.+++..++
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l   82 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD---CPENIKKEICINKMLNHENVVKFYGHRREGNIQYL   82 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccc---hHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence            468999999999999999999876 78999999986543221   34668899999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ||||+++|+|.+++.   ....+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus        83 v~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  156 (323)
T 3tki_A           83 FLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR  156 (323)
T ss_dssp             EEECCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred             EEEcCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceec
Confidence            999999999999983   334689999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCC--CCccccccccccccccccccCCC-CcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChh
Q 039137          796 PDS--SNWSELAGTHGYVAPELAYTLKV-TEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLH  872 (912)
Q Consensus       796 ~~~--~~~~~~~g~~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  872 (912)
                      ...  .......||+.|+|||++.+..+ +.++||||+||++|+|++|+.||+.....    ..............+  .
T Consensus       157 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~~~~~~~~~~~--~  230 (323)
T 3tki_A          157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS----CQEYSDWKEKKTYLN--P  230 (323)
T ss_dssp             ETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT----SHHHHHHHTTCTTST--T
T ss_pred             cCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH----HHHHHHHhcccccCC--c
Confidence            322  22345679999999999987775 77899999999999999999998632111    011111111111111  1


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          873 VQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       873 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ....+..+.+++.+||+.||++|||++|+++
T Consensus       231 ~~~~~~~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          231 WKKIDSAPLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            1234456789999999999999999998865

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.5e-39  Score=351.03  Aligned_cols=258  Identities=22%  Similarity=0.292  Sum_probs=201.5

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ++|++.+.||+|+||+||+|+++ +++.||+|++.......  ...+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   79 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE--GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSST--THHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcC--CcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence            57999999999999999999876 68999999997654322  2457788999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++ ++.+.+..  ..+.+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        80 ~e~~~~-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  153 (292)
T 3o0g_A           80 FEFCDQ-DLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGI  153 (292)
T ss_dssp             EECCSE-EHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred             EecCCC-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence            999986 55555533  235689999999999999999999999   999999999999999999999999999988765


Q ss_pred             CCCCccccccccccccccccccCC-CCcchhHHHHHHHHHHHHhCCCCccchhcccccc-----------ccch--hhhc
Q 039137          797 DSSNWSELAGTHGYVAPELAYTLK-VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS-----------SNMN--IEML  862 (912)
Q Consensus       797 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~-----------~~~~--~~~~  862 (912)
                      .........||+.|+|||++.+.. ++.++||||+||++|||++|..||..........           ....  ....
T Consensus       154 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  233 (292)
T 3o0g_A          154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL  233 (292)
T ss_dssp             CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred             ccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccc
Confidence            555556678899999999988766 7999999999999999999888852110000000           0000  0000


Q ss_pred             cCCCCC--------CChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          863 DSRLPY--------PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       863 ~~~~~~--------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ....+.        ........+..+.+++.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            000000        00011123456789999999999999999998875

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1e-39  Score=353.29  Aligned_cols=253  Identities=23%  Similarity=0.332  Sum_probs=199.0

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCc----------------------hHHHHHHHHHHHHHh
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEM----------------------SFQQEEFLNEIQALT  693 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~----------------------~~~~~~~~~Ei~~l~  693 (912)
                      .++|++.+.||+|+||.||+|++. +++.||||++........                      ....+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            468999999999999999999875 788999999865432110                      112356889999999


Q ss_pred             hcCCCccccEEEEEEc--CCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCC
Q 039137          694 EIRHRNIVKFYGFCSH--PKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDIS  771 (912)
Q Consensus       694 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk  771 (912)
                      .++||||+++++++.+  .+..++||||+++++|.++.    ....+++.+++.++.|++.||+|||++   +|+|||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlk  164 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIK  164 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCC
Confidence            9999999999999987  56889999999999998875    234689999999999999999999999   99999999


Q ss_pred             CCCeEEcCCCcEEEeccccccccCCCCCCccccccccccccccccccCC---CCcchhHHHHHHHHHHHHhCCCCccchh
Q 039137          772 SKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLK---VTEKCDVYSFGVLALEVIKGKHPRDFLF  848 (912)
Q Consensus       772 ~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~sDvwslG~vl~elltg~~pf~~~~  848 (912)
                      |+||+++.++.+||+|||+++.............||+.|+|||++.+..   ++.++||||||+++|||++|+.||....
T Consensus       165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  244 (298)
T 2zv2_A          165 PSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER  244 (298)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             HHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence            9999999999999999999987765544445668999999999988765   3778999999999999999999985221


Q ss_pred             ccccccccchhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          849 EMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       849 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .     ..............+.  ....+..+.+++.+||+.||++|||++|+++
T Consensus       245 ~-----~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          245 I-----MCLHSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             H-----HHHHHHHHHCCCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             H-----HHHHHHHhcccCCCCC--ccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            1     0111111112222211  1123456889999999999999999999864

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=6.6e-40  Score=349.63  Aligned_cols=255  Identities=26%  Similarity=0.450  Sum_probs=194.8

Q ss_pred             hcCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      .++|++.+.||+|+||.||+|++ .++.||||++............+.+.+|+++++.++||||+++++++..++..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            35789999999999999999998 48899999987654443333457789999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcC--------CCcEEEecc
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDL--------GYEAHVSDF  788 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~--------~~~~kl~Df  788 (912)
                      |||+++++|.+++.    ...+++.+++.++.|++.|++|||++...+|+||||||+||+++.        ++.+||+||
T Consensus        85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            99999999999983    346899999999999999999999992112999999999999986        678999999


Q ss_pred             ccccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCC--C
Q 039137          789 GIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSR--L  866 (912)
Q Consensus       789 gla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~  866 (912)
                      |++.......  .....|++.|+|||.+.+..++.++||||+|+++|+|++|+.||......     ..........  .
T Consensus       161 g~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~  233 (271)
T 3dtc_A          161 GLAREWHRTT--KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL-----AVAYGVAMNKLAL  233 (271)
T ss_dssp             CC---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH-----HHHHHHHTSCCCC
T ss_pred             Cccccccccc--ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHhhhcCCCCC
Confidence            9998664332  23457899999999999999999999999999999999999998632111     1111111111  1


Q ss_pred             CCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 039137          867 PYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCE  907 (912)
Q Consensus       867 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  907 (912)
                      +.+    ...+..+.+++.+||+.||++|||+.|+++.|++
T Consensus       234 ~~~----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          234 PIP----STCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             CCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             CCC----cccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence            111    1234568899999999999999999999999975

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=5.1e-40  Score=361.12  Aligned_cols=260  Identities=17%  Similarity=0.200  Sum_probs=208.4

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEEcCCeee
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSHPKHSF  714 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~  714 (912)
                      .++|++.+.||+|+||+||+|+.. +++.||||++.....      .+.+.+|+++++.+ +||||+++++++...+..+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~   81 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR------APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA   81 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS------SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc------hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence            367999999999999999999864 789999999865422      23477899999999 8999999999999999999


Q ss_pred             EEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCc-----EEEeccc
Q 039137          715 IIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYE-----AHVSDFG  789 (912)
Q Consensus       715 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~-----~kl~Dfg  789 (912)
                      +||||+ +++|.+++...  ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.     +||+|||
T Consensus        82 lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg  155 (330)
T 2izr_A           82 MVLELL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFA  155 (330)
T ss_dssp             EEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCT
T ss_pred             EEEEeC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcc
Confidence            999999 89999999543  35799999999999999999999999   9999999999999998887     9999999


Q ss_pred             cccccCCCCCC-------ccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhc
Q 039137          790 IAKFLNPDSSN-------WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEML  862 (912)
Q Consensus       790 la~~~~~~~~~-------~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~  862 (912)
                      +++........       .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......  .........
T Consensus       156 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~--~~~~~~~i~  233 (330)
T 2izr_A          156 LAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADT--LKERYQKIG  233 (330)
T ss_dssp             TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSS--HHHHHHHHH
T ss_pred             cceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccccc--HHHHHHHHH
Confidence            99876543321       245679999999999999999999999999999999999999986321110  000011111


Q ss_pred             cCCCCCCChhh-HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 039137          863 DSRLPYPSLHV-QKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE  911 (912)
Q Consensus       863 ~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~~  911 (912)
                      ....+.+.... ...+ .+.+++..||+.||.+||+++++.+.|++.+.+
T Consensus       234 ~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~  282 (330)
T 2izr_A          234 DTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR  282 (330)
T ss_dssp             HHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             hhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence            11111111111 1122 788999999999999999999999999977643

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.8e-40  Score=363.41  Aligned_cols=252  Identities=23%  Similarity=0.330  Sum_probs=205.8

Q ss_pred             HHhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEEcCCe
Q 039137          635 SATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSHPKH  712 (912)
Q Consensus       635 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~  712 (912)
                      ...++|++.+.||+|+||.||+|+++ +++.||+|++....... ....+.+..|..++..+ +||||+++++++.+.+.
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM-DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhh-hhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            45678999999999999999999986 68999999986431100 11345677899999887 89999999999999999


Q ss_pred             eeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccccc
Q 039137          713 SFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK  792 (912)
Q Consensus       713 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  792 (912)
                      .|+||||+++|+|.+++..   .+.+++.+++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus        93 ~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~  166 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK  166 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhh
Confidence            9999999999999999954   34689999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChh
Q 039137          793 FLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLH  872 (912)
Q Consensus       793 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  872 (912)
                      .............||+.|+|||++.+..++.++||||+||++|||++|+.||.....     ......+......++.  
T Consensus       167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~~i~~~~~~~p~--  239 (345)
T 1xjd_A          167 ENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-----EELFHSIRMDNPFYPR--  239 (345)
T ss_dssp             CCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCCCCCCT--
T ss_pred             hcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH-----HHHHHHHHhCCCCCCc--
Confidence            654444455667899999999999999999999999999999999999999852211     1111222222333332  


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 039137          873 VQKKLMSIMQVAFSCLDQNPESRPTMK-RVS  902 (912)
Q Consensus       873 ~~~~~~~l~~li~~cl~~dP~~RPt~~-evl  902 (912)
                        ..+..+.+++.+||+.||++||++. |++
T Consensus       240 --~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          240 --WLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             --TSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             --ccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence              1345678999999999999999987 543

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.7e-39  Score=348.78  Aligned_cols=257  Identities=25%  Similarity=0.417  Sum_probs=208.2

Q ss_pred             hcCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      .++|++.+.||+|+||+||+|++.++..||+|++.....     ..+++.+|+++++.++||||+++++++.+.+..++|
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   97 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII   97 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-----CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEE
Confidence            467999999999999999999998888999999975432     246788999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++++|.+++...  ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        98 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  172 (283)
T 3gen_A           98 TEYMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  172 (283)
T ss_dssp             ECCCTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred             EeccCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccc
Confidence            9999999999999542  34689999999999999999999999   999999999999999999999999999986643


Q ss_pred             CC-CCccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccCCCCCCChhhH
Q 039137          797 DS-SNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQ  874 (912)
Q Consensus       797 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  874 (912)
                      .. .......+++.|+|||++.+..++.++||||+|+++|||++ |+.||......     ..............+   .
T Consensus       173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~-----~~~~~~~~~~~~~~~---~  244 (283)
T 3gen_A          173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-----ETAEHIAQGLRLYRP---H  244 (283)
T ss_dssp             HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-----HHHHHHHTTCCCCCC---T
T ss_pred             cccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh-----HHHHHHhcccCCCCC---C
Confidence            21 11223456788999999998899999999999999999998 99998632111     111111111111111   1


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 039137          875 KKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE  911 (912)
Q Consensus       875 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~~  911 (912)
                      ..+..+.+++.+||+.||++|||++|+++.|++.+.+
T Consensus       245 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          245 LASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence            1234688999999999999999999999999988754

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=6.6e-40  Score=358.85  Aligned_cols=247  Identities=23%  Similarity=0.348  Sum_probs=186.0

Q ss_pred             CceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcC-CCccccEEEEEEcCCeeeEEEeec
Q 039137          643 EHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR-HRNIVKFYGFCSHPKHSFIIYEYL  720 (912)
Q Consensus       643 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  720 (912)
                      .+.||+|+||+||+|.++ +++.||||++...       ....+.+|+.+++.++ ||||+++++++.+++..++||||+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~   88 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELL   88 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh-------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEcc
Confidence            478999999999999876 6899999998532       3566789999999997 999999999999999999999999


Q ss_pred             CCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCC---cEEEeccccccccCCC
Q 039137          721 ESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGY---EAHVSDFGIAKFLNPD  797 (912)
Q Consensus       721 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~---~~kl~Dfgla~~~~~~  797 (912)
                      ++|+|.+++...   +.+++.+++.++.|++.||+|||++   +|+||||||+||+++.++   .+||+|||+++.....
T Consensus        89 ~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  162 (325)
T 3kn6_A           89 NGGELFERIKKK---KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD  162 (325)
T ss_dssp             CSCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred             CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence            999999999543   5689999999999999999999999   999999999999998766   7999999999877665


Q ss_pred             CCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhcccc--ccccchhhhccCCCCCCChhhHH
Q 039137          798 SSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS--SSSNMNIEMLDSRLPYPSLHVQK  875 (912)
Q Consensus       798 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  875 (912)
                      ........||+.|+|||++.+..++.++||||+|+++|+|++|+.||........  ................+......
T Consensus       163 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  242 (325)
T 3kn6_A          163 NQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKN  242 (325)
T ss_dssp             ---------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHT
T ss_pred             CCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccC
Confidence            5555667789999999999999999999999999999999999999863222110  11112223334444555545555


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHH
Q 039137          876 KLMSIMQVAFSCLDQNPESRPTMKRVS  902 (912)
Q Consensus       876 ~~~~l~~li~~cl~~dP~~RPt~~evl  902 (912)
                      .+..+.+++.+||+.||++|||++|++
T Consensus       243 ~s~~~~~li~~~L~~dP~~Rpt~~ell  269 (325)
T 3kn6_A          243 VSQEAKDLIQGLLTVDPNKRLKMSGLR  269 (325)
T ss_dssp             SCHHHHHHHHHHHCCCTTTCCCTTTST
T ss_pred             CCHHHHHHHHHHCCCChhHCCCHHHHh
Confidence            677899999999999999999999876

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=4.6e-40  Score=367.94  Aligned_cols=257  Identities=24%  Similarity=0.377  Sum_probs=209.1

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      .++|++.+.||+|+||+||+|+++ +++.||||++....   .....+++.+|+++++.++||||+++++++...+..++
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  189 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL---PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI  189 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS---CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC---CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence            467899999999999999999986 78999999987432   22245678899999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ||||+++|+|.+++...  ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus       190 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~  264 (377)
T 3cbl_A          190 VMELVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEA  264 (377)
T ss_dssp             EEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred             EEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence            99999999999999542  34589999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCCC--ccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhc-cCCCCCCCh
Q 039137          796 PDSSN--WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEML-DSRLPYPSL  871 (912)
Q Consensus       796 ~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~  871 (912)
                      .....  .....+++.|+|||++.+..++.++|||||||++|||++ |..||......     ....... ..+.+.+. 
T Consensus       265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~-  338 (377)
T 3cbl_A          265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ-----QTREFVEKGGRLPCPE-  338 (377)
T ss_dssp             TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH-----HHHHHHHTTCCCCCCT-
T ss_pred             CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHHcCCCCCCCC-
Confidence            32111  112235778999999998889999999999999999998 99998632111     0111111 11222222 


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          872 HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       872 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                         ..+..+.+++.+||+.||++|||++++++.|++...
T Consensus       339 ---~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~  374 (377)
T 3cbl_A          339 ---LCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK  374 (377)
T ss_dssp             ---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence               234568899999999999999999999999998754

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=7.4e-40  Score=358.33  Aligned_cols=264  Identities=25%  Similarity=0.365  Sum_probs=205.2

Q ss_pred             hcCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCC----e
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPK----H  712 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----~  712 (912)
                      .++|++.+.||+|+||+||+|++. ++.||||++...     ........+|+.++++++||||+++++++....    .
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   96 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ-----DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD   96 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecC-----chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCce
Confidence            468999999999999999999884 889999998532     223455667999999999999999999998754    3


Q ss_pred             eeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC-------CCCeeecCCCCCCeEEcCCCcEEE
Q 039137          713 SFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNC-------FPPIVHRDISSKNVLLDLGYEAHV  785 (912)
Q Consensus       713 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-------~~~ivH~Dlk~~Nill~~~~~~kl  785 (912)
                      .++||||+++|+|.+++..    ..+++.+++.++.|++.||+|||+..       .++|+||||||+||+++.++.+||
T Consensus        97 ~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL  172 (322)
T 3soc_A           97 LWLITAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI  172 (322)
T ss_dssp             EEEEEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred             EEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence            6999999999999999954    34899999999999999999999861       238999999999999999999999


Q ss_pred             eccccccccCCCCC--CccccccccccccccccccC-----CCCcchhHHHHHHHHHHHHhCCCCccchhcccccc----
Q 039137          786 SDFGIAKFLNPDSS--NWSELAGTHGYVAPELAYTL-----KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS----  854 (912)
Q Consensus       786 ~Dfgla~~~~~~~~--~~~~~~g~~~y~aPE~~~~~-----~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~----  854 (912)
                      +|||+++.......  ......||+.|+|||++.+.     .++.++|||||||++|||++|+.||+...+.....    
T Consensus       173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~  252 (322)
T 3soc_A          173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE  252 (322)
T ss_dssp             CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred             ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence            99999987654332  23346789999999998863     45678999999999999999999986322111000    


Q ss_pred             -------ccchhhhccC-CCCCCC--hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          855 -------SNMNIEMLDS-RLPYPS--LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       855 -------~~~~~~~~~~-~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                             .......... ..+...  ......+..+.+++.+||+.||++|||++|+++.|++.-.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~  318 (322)
T 3soc_A          253 IGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR  318 (322)
T ss_dssp             HCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                   0000001111 111111  1122345668999999999999999999999999998643

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.5e-39  Score=359.70  Aligned_cols=251  Identities=23%  Similarity=0.347  Sum_probs=191.6

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeee
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSF  714 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  714 (912)
                      ..++|++.+.||+|+||+||+|+++ +++.||||++....      ..+.+.+|+++++.++||||+++++++..++..+
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  124 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV------DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS  124 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------------CHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch------hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEE
Confidence            3567999999999999999999986 68899999987532      3456788999999999999999999999999999


Q ss_pred             EEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcC---CCcEEEeccccc
Q 039137          715 IIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDL---GYEAHVSDFGIA  791 (912)
Q Consensus       715 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~Dfgla  791 (912)
                      +||||+++|+|.+++..   .+.+++.+++.++.|++.||+|||++   +|+||||||+||+++.   ++.+||+|||++
T Consensus       125 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a  198 (349)
T 2w4o_A          125 LVLELVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLS  198 (349)
T ss_dssp             EEECCCCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC--
T ss_pred             EEEEeCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccc
Confidence            99999999999999843   35689999999999999999999999   9999999999999975   889999999999


Q ss_pred             cccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCCh
Q 039137          792 KFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSL  871 (912)
Q Consensus       792 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  871 (912)
                      +..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....    .......+.......+..
T Consensus       199 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~~~~i~~~~~~~~~~  273 (349)
T 2w4o_A          199 KIVEHQ-VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG----DQFMFRRILNCEYYFISP  273 (349)
T ss_dssp             ---------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC----HHHHHHHHHTTCCCCCTT
T ss_pred             cccCcc-cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc----cHHHHHHHHhCCCccCCc
Confidence            866433 223456789999999999999999999999999999999999999852211    111122222233222222


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          872 HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       872 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .....+..+.+++.+||+.||++|||+.|+++
T Consensus       274 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          274 WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            22334567889999999999999999999875

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2e-39  Score=362.24  Aligned_cols=252  Identities=20%  Similarity=0.322  Sum_probs=207.0

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      .++|++.+.||+|+||+||+|..+ +++.||+|++....    ......+.+|+++++.++||||+++++++.+.+..++
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  125 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY----PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL  125 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc----hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEE
Confidence            467999999999999999999876 78999999986432    2245678899999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcC--CCcEEEeccccccc
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDL--GYEAHVSDFGIAKF  793 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~--~~~~kl~Dfgla~~  793 (912)
                      ||||+++|+|.+++...  ...+++.+++.++.||+.||+|||++   +|+||||||+||+++.  ++.+||+|||+++.
T Consensus       126 v~E~~~gg~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~  200 (387)
T 1kob_A          126 ILEFLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATK  200 (387)
T ss_dssp             EEECCCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred             EEEcCCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEeccccee
Confidence            99999999999998432  34689999999999999999999999   9999999999999974  56799999999987


Q ss_pred             cCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhh
Q 039137          794 LNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHV  873 (912)
Q Consensus       794 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  873 (912)
                      .... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......     .....+.......+....
T Consensus       201 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-----~~~~~i~~~~~~~~~~~~  274 (387)
T 1kob_A          201 LNPD-EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-----ETLQNVKRCDWEFDEDAF  274 (387)
T ss_dssp             CCTT-SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-----HHHHHHHHCCCCCCSSTT
T ss_pred             cCCC-cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH-----HHHHHHHhCCCCCCcccc
Confidence            6543 2334557999999999999999999999999999999999999998632111     111112222222222222


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          874 QKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       874 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ...+..+.++|.+||+.||++|||+.|+++
T Consensus       275 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          275 SSVSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence            334567889999999999999999999875

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1e-39  Score=361.05  Aligned_cols=263  Identities=22%  Similarity=0.394  Sum_probs=212.2

Q ss_pred             HHhcCCCCCceeeecCceEEEEEEeC------CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEE
Q 039137          635 SATNDFNAEHCIGKGGHGSVYRAKVP------SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCS  708 (912)
Q Consensus       635 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~  708 (912)
                      ...++|++.+.||+|+||.||+|++.      +++.||+|++....   .....+.+.+|+.+++.++||||+++++++.
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  120 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDNPNIVKLLGVCA  120 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            34678999999999999999999874      34789999987542   2235678999999999999999999999999


Q ss_pred             cCCeeeEEEeecCCCChhhHhhccCC---------------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeee
Q 039137          709 HPKHSFIIYEYLESGSLDKILCNDAS---------------------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVH  767 (912)
Q Consensus       709 ~~~~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH  767 (912)
                      ..+..++||||+++|+|.+++.....                     ...+++.+++.++.||+.||+|||++   +|+|
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH  197 (343)
T 1luf_A          121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVH  197 (343)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence            99999999999999999999965321                     25689999999999999999999999   9999


Q ss_pred             cCCCCCCeEEcCCCcEEEeccccccccCCCC--CCccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCc
Q 039137          768 RDISSKNVLLDLGYEAHVSDFGIAKFLNPDS--SNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPR  844 (912)
Q Consensus       768 ~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf  844 (912)
                      |||||+||+++.++.+||+|||+++......  .......+++.|+|||++.+..++.++||||||+++|||++ |..||
T Consensus       198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  277 (343)
T 1luf_A          198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY  277 (343)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence            9999999999999999999999998654322  12234567899999999998899999999999999999999 99998


Q ss_pred             cchhccccccccchhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 039137          845 DFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE  911 (912)
Q Consensus       845 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~~  911 (912)
                      .....     ......+.+...+..+   ...+..+.+++.+||+.||++|||+.++++.|++...+
T Consensus       278 ~~~~~-----~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~  336 (343)
T 1luf_A          278 YGMAH-----EEVIYYVRDGNILACP---ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER  336 (343)
T ss_dssp             TTSCH-----HHHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred             CCCCh-----HHHHHHHhCCCcCCCC---CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence            52211     1111112222221111   12345688999999999999999999999999987653

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2.1e-39  Score=353.78  Aligned_cols=260  Identities=23%  Similarity=0.410  Sum_probs=212.4

Q ss_pred             hcCCCCCceeeecCceEEEEEEe------CCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKV------PSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP  710 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~  710 (912)
                      .++|.+.+.||+|+||.||+|++      .+++.||+|++....   .....+.+.+|+++++.++||||+++++++...
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   98 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA---SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD   98 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC---CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence            46799999999999999999985      245789999987432   233567889999999999999999999999999


Q ss_pred             CeeeEEEeecCCCChhhHhhccCC---------------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecC
Q 039137          711 KHSFIIYEYLESGSLDKILCNDAS---------------------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRD  769 (912)
Q Consensus       711 ~~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~D  769 (912)
                      +..++||||+++|+|.+++.....                     ...+++.+++.++.|++.||+|||++   +|+|||
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~d  175 (314)
T 2ivs_A           99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRD  175 (314)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred             CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccc
Confidence            999999999999999999965432                     23489999999999999999999999   999999


Q ss_pred             CCCCCeEEcCCCcEEEeccccccccCCCCCC--ccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccc
Q 039137          770 ISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN--WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDF  846 (912)
Q Consensus       770 lk~~Nill~~~~~~kl~Dfgla~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~  846 (912)
                      |||+||+++.++.+||+|||+++........  .....+++.|+|||.+.+..++.++||||+|+++|||++ |+.||..
T Consensus       176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  255 (314)
T 2ivs_A          176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG  255 (314)
T ss_dssp             CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999999999999999876543322  233456789999999999889999999999999999999 9999853


Q ss_pred             hhccccccccchhhhccCC-CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 039137          847 LFEMSSSSSNMNIEMLDSR-LPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE  911 (912)
Q Consensus       847 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~~  911 (912)
                      ...     ........... ...+    ...+..+.+++.+||+.||++|||+.|+++.|++.+.+
T Consensus       256 ~~~-----~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          256 IPP-----ERLFNLLKTGHRMERP----DNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             CCG-----GGHHHHHHTTCCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCH-----HHHHHHhhcCCcCCCC----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence            211     11111111111 1111    12345688999999999999999999999999998765

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=7.2e-40  Score=361.40  Aligned_cols=247  Identities=21%  Similarity=0.314  Sum_probs=204.4

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEEcCCee
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSHPKHS  713 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~  713 (912)
                      ..++|++.+.||+|+||+||+|+.+ +++.||+|++....... ....+.+.+|..++..+ +||+|+++++++.+.+..
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~-~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~   96 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ-DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL   96 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhc-chHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence            3578999999999999999999986 58899999986432110 11346678999999988 799999999999999999


Q ss_pred             eEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccc
Q 039137          714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKF  793 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  793 (912)
                      |+||||+++|+|.+++...   +.+++.+++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++.
T Consensus        97 ~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~  170 (353)
T 2i0e_A           97 YFVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE  170 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence            9999999999999999543   4689999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhh
Q 039137          794 LNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHV  873 (912)
Q Consensus       794 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  873 (912)
                      ............||+.|+|||++.+..++.++|||||||++|||++|+.||....     .......+......++.   
T Consensus       171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~-----~~~~~~~i~~~~~~~p~---  242 (353)
T 2i0e_A          171 NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED-----EDELFQSIMEHNVAYPK---  242 (353)
T ss_dssp             CCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHCCCCCCT---
T ss_pred             cccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC-----HHHHHHHHHhCCCCCCC---
Confidence            5444445566789999999999999999999999999999999999999986221     11222233334444442   


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCH
Q 039137          874 QKKLMSIMQVAFSCLDQNPESRPTM  898 (912)
Q Consensus       874 ~~~~~~l~~li~~cl~~dP~~RPt~  898 (912)
                       ..+..+.++|.+||+.||++||++
T Consensus       243 -~~s~~~~~li~~lL~~dP~~R~~~  266 (353)
T 2i0e_A          243 -SMSKEAVAICKGLMTKHPGKRLGC  266 (353)
T ss_dssp             -TSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred             -CCCHHHHHHHHHHhhcCHHHcCCC
Confidence             234568899999999999999964

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=4e-39  Score=352.53  Aligned_cols=255  Identities=19%  Similarity=0.288  Sum_probs=209.8

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCc--hHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCee
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEM--SFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHS  713 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  713 (912)
                      .++|++.+.||+|+||.||+|+++ +++.||+|++........  ....+.+.+|+.+++.++||||+++++++...+..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            457999999999999999999976 689999999875443221  11367789999999999999999999999999999


Q ss_pred             eEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCC----cEEEeccc
Q 039137          714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGY----EAHVSDFG  789 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~Dfg  789 (912)
                      ++||||+++++|.+++..   ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++    .+||+|||
T Consensus        91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg  164 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (321)
T ss_dssp             EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred             EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence            999999999999999943   34689999999999999999999999   999999999999999888    79999999


Q ss_pred             cccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCC
Q 039137          790 IAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYP  869 (912)
Q Consensus       790 la~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  869 (912)
                      ++...... .......|++.|+|||++.+..++.++||||||+++|+|++|+.||.....     ..............+
T Consensus       165 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~i~~~~~~~~  238 (321)
T 2a2a_A          165 LAHEIEDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-----QETLANITSVSYDFD  238 (321)
T ss_dssp             TCEECCTT-CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-----HHHHHHHHTTCCCCC
T ss_pred             cceecCcc-ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHhcccccC
Confidence            99876543 233456789999999999999999999999999999999999999852211     111122222222333


Q ss_pred             ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          870 SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       870 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .......+..+.+++.+||+.||++|||++|+++
T Consensus       239 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          239 EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             hhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            2222334566889999999999999999999876

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.8e-39  Score=362.40  Aligned_cols=259  Identities=23%  Similarity=0.368  Sum_probs=211.4

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC--------CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP--------SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFC  707 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~  707 (912)
                      .++|++.+.||+|+||+||+|++.        ++..||||++....   .....+++.+|+++++.+ +||||+++++++
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  144 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA---TEKDLSDLISEMEMMKMIGKHKNIINLLGAC  144 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc---CHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence            468999999999999999999852        34579999987542   233567889999999999 899999999999


Q ss_pred             EcCCeeeEEEeecCCCChhhHhhccCC-------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCC
Q 039137          708 SHPKHSFIIYEYLESGSLDKILCNDAS-------------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKN  774 (912)
Q Consensus       708 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N  774 (912)
                      ..++..++||||+++|+|.+++.....             ...+++.+++.++.|++.||+|||++   +|+||||||+|
T Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N  221 (382)
T 3tt0_A          145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARN  221 (382)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGG
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcce
Confidence            999999999999999999999965432             24589999999999999999999999   99999999999


Q ss_pred             eEEcCCCcEEEeccccccccCCCCC--CccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccc
Q 039137          775 VLLDLGYEAHVSDFGIAKFLNPDSS--NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMS  851 (912)
Q Consensus       775 ill~~~~~~kl~Dfgla~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~  851 (912)
                      |+++.++.+||+|||+++.......  ......+++.|+|||++.+..++.++|||||||++|||++ |..||.....  
T Consensus       222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~--  299 (382)
T 3tt0_A          222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--  299 (382)
T ss_dssp             EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--
T ss_pred             EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence            9999999999999999987654322  2334567889999999999999999999999999999999 9999852211  


Q ss_pred             cccccchhhhccC-CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          852 SSSSNMNIEMLDS-RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       852 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                         ......+... ....+    ...+..+.+++.+||+.||++|||++|+++.|++.+.
T Consensus       300 ---~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  352 (382)
T 3tt0_A          300 ---EELFKLLKEGHRMDKP----SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  352 (382)
T ss_dssp             ---HHHHHHHHTTCCCCCC----SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---HHHHHHHHcCCCCCCC----ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence               1111111111 11111    1234568899999999999999999999999998764

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-39  Score=354.72  Aligned_cols=248  Identities=25%  Similarity=0.371  Sum_probs=205.3

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      .++|++.+.||+|+||+||+|+.+ +|+.||+|++....... ....+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l   83 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR-LKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM   83 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence            367999999999999999999876 79999999986421110 1134667899999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ||||+++|+|.+++..   ...+++..++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus        84 v~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~  157 (318)
T 1fot_A           84 IMDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP  157 (318)
T ss_dssp             EECCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred             EEeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecC
Confidence            9999999999999954   34689999999999999999999999   99999999999999999999999999998754


Q ss_pred             CCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHH
Q 039137          796 PDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQK  875 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  875 (912)
                      ..   .....||+.|+|||++.+..++.++||||+||++|||++|+.||....     .......+......++.    .
T Consensus       158 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~~i~~~~~~~p~----~  225 (318)
T 1fot_A          158 DV---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN-----TMKTYEKILNAELRFPP----F  225 (318)
T ss_dssp             SC---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHHHHCCCCCCT----T
T ss_pred             Cc---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhCCCCCCC----C
Confidence            32   345679999999999999999999999999999999999999985211     11122233333333332    2


Q ss_pred             HHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 039137          876 KLMSIMQVAFSCLDQNPESRP-----TMKRVSQ  903 (912)
Q Consensus       876 ~~~~l~~li~~cl~~dP~~RP-----t~~evl~  903 (912)
                      .+..+.+++.+|++.||++||     +++|+++
T Consensus       226 ~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          226 FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence            345678999999999999999     7887763

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=5.5e-40  Score=354.95  Aligned_cols=262  Identities=26%  Similarity=0.401  Sum_probs=205.6

Q ss_pred             hcCCCCCceeeecCceEEEEEEe-----CCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC-
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKV-----PSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP-  710 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-  710 (912)
                      .++|++.+.||+|+||+||+|++     .+++.||||++...    .....+.+.+|+++++.++||||+++++++... 
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   84 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG   84 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC----CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            46799999999999999999984     36889999998643    223567889999999999999999999999654 


Q ss_pred             -CeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccc
Q 039137          711 -KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFG  789 (912)
Q Consensus       711 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  789 (912)
                       ...++||||+++|+|.+++...  ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus        85 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg  159 (295)
T 3ugc_A           85 RRNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFG  159 (295)
T ss_dssp             HTSCEEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred             CCceEEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCc
Confidence             5689999999999999999553  24589999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCCC---ccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhcc-----cccccc-----
Q 039137          790 IAKFLNPDSSN---WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEM-----SSSSSN-----  856 (912)
Q Consensus       790 la~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~-----~~~~~~-----  856 (912)
                      +++........   .....+++.|+|||++.+..++.++||||||+++|||++|..||......     ......     
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (295)
T 3ugc_A          160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF  239 (295)
T ss_dssp             SCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHH
T ss_pred             ccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHH
Confidence            99876543221   22345677899999999999999999999999999999999997632211     000000     


Q ss_pred             chhhhc--cCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 039137          857 MNIEML--DSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE  911 (912)
Q Consensus       857 ~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~~  911 (912)
                      ......  ..+.+.+    ...+..+.+++.+||+.||++|||++|+++.|++...+
T Consensus       240 ~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~  292 (295)
T 3ugc_A          240 HLIELLKNNGRLPRP----DGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN  292 (295)
T ss_dssp             HHHHHHHTTCCCCCC----TTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHHhccCcCCCC----cCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            000111  1122222    22345688999999999999999999999999988754

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=6.9e-40  Score=364.83  Aligned_cols=267  Identities=22%  Similarity=0.367  Sum_probs=212.5

Q ss_pred             HHHHHHHhcCCCCCceeeecCceEEEEEEe------CCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCcccc
Q 039137          630 YEEIISATNDFNAEHCIGKGGHGSVYRAKV------PSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVK  702 (912)
Q Consensus       630 ~~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~  702 (912)
                      ..++....++|++.+.||+|+||.||+|++      .+++.||||++....   .....+.+.+|+++++++ +||||++
T Consensus        14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hpniv~   90 (359)
T 3vhe_A           14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVN   90 (359)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC---CHHHHHHHHHHHHHHHhhcCCcceee
Confidence            445555678999999999999999999973      256889999997532   222457799999999999 7999999


Q ss_pred             EEEEEEcCCe-eeEEEeecCCCChhhHhhccCC-----------------------------------------------
Q 039137          703 FYGFCSHPKH-SFIIYEYLESGSLDKILCNDAS-----------------------------------------------  734 (912)
Q Consensus       703 l~~~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~-----------------------------------------------  734 (912)
                      +++++..++. .++||||+++|+|.+++.....                                               
T Consensus        91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (359)
T 3vhe_A           91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE  170 (359)
T ss_dssp             EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred             eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence            9999987654 8999999999999999965432                                               


Q ss_pred             ----------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCC
Q 039137          735 ----------------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS  798 (912)
Q Consensus       735 ----------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  798 (912)
                                      ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++......
T Consensus       171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  247 (359)
T 3vhe_A          171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP  247 (359)
T ss_dssp             -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred             cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence                            12289999999999999999999999   99999999999999999999999999998664432


Q ss_pred             C--CccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccC-CCCCCChhhH
Q 039137          799 S--NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDS-RLPYPSLHVQ  874 (912)
Q Consensus       799 ~--~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  874 (912)
                      .  ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......    .......... ....+.    
T Consensus       248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~----  319 (359)
T 3vhe_A          248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID----EEFCRRLKEGTRMRAPD----  319 (359)
T ss_dssp             TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS----HHHHHHHHHTCCCCCCT----
T ss_pred             cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh----HHHHHHHHcCCCCCCCC----
Confidence            2  2234567899999999999999999999999999999998 99998522110    1111111111 112221    


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          875 KKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       875 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                      ..+..+.+++.+||+.||++|||++|+++.|++.+.
T Consensus       320 ~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  355 (359)
T 3vhe_A          320 YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  355 (359)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            233568899999999999999999999999998764

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=5.5e-40  Score=357.69  Aligned_cols=259  Identities=24%  Similarity=0.343  Sum_probs=198.8

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCe---
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKH---  712 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~---  712 (912)
                      .++|++.+.||+|+||.||+|++. +++.||||++....... ....+.+.+|+.+++.++||||+++++++.....   
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~   89 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARD-PSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   89 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTS-HHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCC-HHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence            468999999999999999999974 78999999997654433 2345678999999999999999999999876543   


Q ss_pred             -eeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccc
Q 039137          713 -SFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIA  791 (912)
Q Consensus       713 -~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla  791 (912)
                       .++||||+++++|.+++..   .+.+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a  163 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA  163 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred             ccEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence             4999999999999999954   34689999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCC---CccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCC
Q 039137          792 KFLNPDSS---NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPY  868 (912)
Q Consensus       792 ~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  868 (912)
                      +.......   ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....     ..............
T Consensus       164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~-----~~~~~~~~~~~~~~  238 (311)
T 3ork_A          164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP-----VSVAYQHVREDPIP  238 (311)
T ss_dssp             ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHCCCCC
T ss_pred             ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHhcCCCCC
Confidence            87654322   22345689999999999999999999999999999999999999863211     11111122222222


Q ss_pred             CChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHH-HHHHH
Q 039137          869 PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVS-QLLCE  907 (912)
Q Consensus       869 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl-~~L~~  907 (912)
                      +.......+..+.+++.+||+.||++||++.+++ ..+.+
T Consensus       239 ~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  278 (311)
T 3ork_A          239 PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  278 (311)
T ss_dssp             HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence            2112223456688999999999999999665544 44443

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.4e-39  Score=358.17  Aligned_cols=252  Identities=21%  Similarity=0.283  Sum_probs=204.8

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEEcCCee
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSHPKHS  713 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~  713 (912)
                      ..++|++.+.||+|+||+||+|.++ +++.||+|++......        ..+|++++.++ +||||+++++++.+++..
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~   91 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD--------PTEEIEILLRYGQHPNIITLKDVYDDGKYV   91 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC--------CHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC--------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEE
Confidence            3567999999999999999999876 6889999999754322        23688888888 799999999999999999


Q ss_pred             eEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCC----CcEEEeccc
Q 039137          714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLG----YEAHVSDFG  789 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~----~~~kl~Dfg  789 (912)
                      |+||||+++|+|.+++..   .+.+++.++..++.||+.||+|||++   +|+||||||+||++.++    +.+||+|||
T Consensus        92 ~lv~E~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg  165 (342)
T 2qr7_A           92 YVVTELMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFG  165 (342)
T ss_dssp             EEEECCCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCT
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECC
Confidence            999999999999999844   34689999999999999999999999   99999999999998543    359999999


Q ss_pred             cccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCC
Q 039137          790 IAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYP  869 (912)
Q Consensus       790 la~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  869 (912)
                      +++.............||+.|+|||++.+..++.++||||+||++|||++|+.||.....  .........+.......+
T Consensus       166 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~~~~i~~~~~~~~  243 (342)
T 2qr7_A          166 FAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD--DTPEEILARIGSGKFSLS  243 (342)
T ss_dssp             TCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT--SCHHHHHHHHHHCCCCCC
T ss_pred             CcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc--CCHHHHHHHHccCCcccC
Confidence            999776655555667899999999999888899999999999999999999999863211  111111222223333333


Q ss_pred             ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          870 SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       870 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .......+..+.+++.+||+.||++|||+.|+++
T Consensus       244 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          244 GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            2223344567889999999999999999998875

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=3.1e-39  Score=353.96  Aligned_cols=262  Identities=21%  Similarity=0.361  Sum_probs=196.0

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeCCC----CEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCC
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVPSG----EIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPK  711 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~  711 (912)
                      ..++|++.+.||+|+||+||+|++...    ..||||++.......  ...+.+.+|+++++.++||||+++++++...+
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   98 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS--SDIEEFLREAACMKEFDHPHVAKLVGVSLRSR   98 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C--HHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH--HHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence            346899999999999999999987633    279999987543322  24678999999999999999999999998776


Q ss_pred             ee------eEEEeecCCCChhhHhhccCC---cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCc
Q 039137          712 HS------FIIYEYLESGSLDKILCNDAS---AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYE  782 (912)
Q Consensus       712 ~~------~lv~e~~~~g~L~~~l~~~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~  782 (912)
                      ..      ++||||+++|+|.+++.....   ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.
T Consensus        99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~  175 (323)
T 3qup_A           99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMT  175 (323)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSC
T ss_pred             cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCC
Confidence            55      999999999999999854322   22589999999999999999999999   9999999999999999999


Q ss_pred             EEEeccccccccCCCCC--CccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchh
Q 039137          783 AHVSDFGIAKFLNPDSS--NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNI  859 (912)
Q Consensus       783 ~kl~Dfgla~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~  859 (912)
                      +||+|||+++.......  ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....     .....
T Consensus       176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-----~~~~~  250 (323)
T 3qup_A          176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN-----AEIYN  250 (323)
T ss_dssp             EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GGHHH
T ss_pred             EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh-----HHHHH
Confidence            99999999987644322  1223456789999999999999999999999999999999 9999863211     11111


Q ss_pred             hhccCC-CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 039137          860 EMLDSR-LPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE  911 (912)
Q Consensus       860 ~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~~  911 (912)
                      ...... ...+    ...+..+.+++.+||+.||++|||+.++++.|++.+..
T Consensus       251 ~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~  299 (323)
T 3qup_A          251 YLIGGNRLKQP----PECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH  299 (323)
T ss_dssp             HHHTTCCCCCC----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHhcCCCCCCC----CccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            111111 1222    12345688999999999999999999999999988753

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.3e-39  Score=364.73  Aligned_cols=267  Identities=22%  Similarity=0.331  Sum_probs=213.6

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCC--ee
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPK--HS  713 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--~~  713 (912)
                      .++|++.+.||+|+||+||+|++. +++.||||++......   ...+.+.+|+++++.++||||+++++++...+  ..
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~   84 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL---RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK   84 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG---SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc---chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence            367999999999999999999886 5899999998643221   13567789999999999999999999998765  67


Q ss_pred             eEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEE----cCCCcEEEeccc
Q 039137          714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLL----DLGYEAHVSDFG  789 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill----~~~~~~kl~Dfg  789 (912)
                      ++||||+++|+|.+++........+++.+++.++.|++.||+|||++   +|+||||||+||++    +.++.+||+|||
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG  161 (396)
T 4eut_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFG  161 (396)
T ss_dssp             EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred             EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCC
Confidence            99999999999999996655445599999999999999999999999   99999999999999    777889999999


Q ss_pred             cccccCCCCCCcccccccccccccccccc--------CCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhh
Q 039137          790 IAKFLNPDSSNWSELAGTHGYVAPELAYT--------LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEM  861 (912)
Q Consensus       790 la~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~  861 (912)
                      +++..... .......||+.|+|||++.+        ..++.++|||||||++|||++|+.||......... .......
T Consensus       162 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~-~~~~~~~  239 (396)
T 4eut_A          162 AARELEDD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN-KEVMYKI  239 (396)
T ss_dssp             GCEECCCG-GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC-HHHHHHH
T ss_pred             CceEccCC-CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch-HHHHHHH
Confidence            99876543 23345679999999998865        45788999999999999999999998632211110 0001111


Q ss_pred             ---------------------ccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 039137          862 ---------------------LDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE  911 (912)
Q Consensus       862 ---------------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~~  911 (912)
                                           +....+............+.+++.+||+.||++||+++|+++.+++.+.+
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence                                 11122222223356677788999999999999999999999999887653

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=4.3e-39  Score=344.57  Aligned_cols=251  Identities=22%  Similarity=0.334  Sum_probs=208.9

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeee
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSF  714 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  714 (912)
                      ..++|++.+.||+|+||.||+|.++ ++..||+|++......    ..+.+.+|+++++.++||||+++++++.+.+..+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE----DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIY   82 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS----CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc----hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEE
Confidence            3567999999999999999999876 5778999998754332    3567889999999999999999999999999999


Q ss_pred             EEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEE---cCCCcEEEeccccc
Q 039137          715 IIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLL---DLGYEAHVSDFGIA  791 (912)
Q Consensus       715 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~Dfgla  791 (912)
                      +||||+++++|.+++..   ...+++.+++.++.|++.||+|||++   +|+||||||+||++   +.++.+||+|||++
T Consensus        83 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~  156 (277)
T 3f3z_A           83 LVMELCTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLA  156 (277)
T ss_dssp             EEEECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEeccCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccc
Confidence            99999999999998844   34589999999999999999999999   99999999999999   78889999999999


Q ss_pred             cccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCCh
Q 039137          792 KFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSL  871 (912)
Q Consensus       792 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  871 (912)
                      ...... .......|++.|+|||++.+. ++.++||||+|+++|||++|+.||....     ...............+..
T Consensus       157 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~~  229 (277)
T 3f3z_A          157 ARFKPG-KMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPT-----DSEVMLKIREGTFTFPEK  229 (277)
T ss_dssp             EECCTT-SCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHCCCCCCHH
T ss_pred             eeccCc-cchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHhCCCCCCch
Confidence            876543 233456799999999988765 8999999999999999999999986321     112222333344444433


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          872 HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       872 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .....+..+.+++.+||+.||++|||+.|+++
T Consensus       230 ~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          230 DWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             hhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            33345667889999999999999999999875

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-39  Score=360.80  Aligned_cols=263  Identities=23%  Similarity=0.368  Sum_probs=208.1

Q ss_pred             HhcCCCCCceeeecCceEEEEEEe------CCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEE
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKV------PSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCS  708 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~  708 (912)
                      ..++|++.+.||+|+||.||+|++      .++..||+|++......   ...+.+.+|+.+++++ +||||+++++++.
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  119 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS---SEREALMSELKMMTQLGSHENIVNLLGACT  119 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCH---HHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            457899999999999999999985      24568999999754322   2456789999999999 8999999999999


Q ss_pred             cCCeeeEEEeecCCCChhhHhhccCC--------------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeec
Q 039137          709 HPKHSFIIYEYLESGSLDKILCNDAS--------------------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHR  768 (912)
Q Consensus       709 ~~~~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~  768 (912)
                      ..+..++||||+++|+|.+++.....                    ...+++.+++.++.|++.||+|||++   +|+||
T Consensus       120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~  196 (344)
T 1rjb_A          120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHR  196 (344)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred             eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccC
Confidence            99999999999999999999965432                    13479999999999999999999999   99999


Q ss_pred             CCCCCCeEEcCCCcEEEeccccccccCCCCCC--ccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcc
Q 039137          769 DISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN--WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRD  845 (912)
Q Consensus       769 Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~  845 (912)
                      ||||+||+++.++.+||+|||++.........  .....+|+.|+|||++.+..++.++||||||+++|||++ |..||.
T Consensus       197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  276 (344)
T 1rjb_A          197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  276 (344)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence            99999999999999999999999876543322  234557889999999999899999999999999999998 999985


Q ss_pred             chhccccccccchhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 039137          846 FLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE  911 (912)
Q Consensus       846 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~~  911 (912)
                      .....     .............+.  ....+..+.+++.+||+.||.+|||+.|+++.|+..+.+
T Consensus       277 ~~~~~-----~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  335 (344)
T 1rjb_A          277 GIPVD-----ANFYKLIQNGFKMDQ--PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD  335 (344)
T ss_dssp             TCCCS-----HHHHHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             cCCcH-----HHHHHHHhcCCCCCC--CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence            32111     111111111111110  012345688999999999999999999999999987653

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.6e-39  Score=361.16  Aligned_cols=257  Identities=23%  Similarity=0.278  Sum_probs=200.6

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHH-HhhcCCCccccEEEEEEcCCeee
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQA-LTEIRHRNIVKFYGFCSHPKHSF  714 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~-l~~l~h~niv~l~~~~~~~~~~~  714 (912)
                      .++|++.+.||+|+||.||+|+.+ +++.||+|++......... ..+.+.+|..+ ++.++||||+++++++.+.+..|
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~-~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~  115 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKK-EEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY  115 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC--------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhH-HHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence            467999999999999999999986 6889999998654322211 34556677776 57789999999999999999999


Q ss_pred             EEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccccccc
Q 039137          715 IIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL  794 (912)
Q Consensus       715 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  794 (912)
                      +||||+++|+|.+++.+   .+.+++.+++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus       116 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~  189 (373)
T 2r5t_A          116 FVLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN  189 (373)
T ss_dssp             EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred             EEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence            99999999999999954   34688999999999999999999999   9999999999999999999999999999875


Q ss_pred             CCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhH
Q 039137          795 NPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQ  874 (912)
Q Consensus       795 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  874 (912)
                      ...........||+.|+|||++.+..++.++|||||||++|||++|+.||....     .......+......++.    
T Consensus       190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~-----~~~~~~~i~~~~~~~~~----  260 (373)
T 2r5t_A          190 IEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-----TAEMYDNILNKPLQLKP----  260 (373)
T ss_dssp             BCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB-----HHHHHHHHHHSCCCCCS----
T ss_pred             ccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-----HHHHHHHHHhcccCCCC----
Confidence            544445566789999999999999999999999999999999999999985211     11222233333333332    


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHH-HHHHHHhh
Q 039137          875 KKLMSIMQVAFSCLDQNPESRPTMKRV-SQLLCEKI  909 (912)
Q Consensus       875 ~~~~~l~~li~~cl~~dP~~RPt~~ev-l~~L~~~l  909 (912)
                      ..+..+.++|.+||+.||++||++.+. .+.+++.+
T Consensus       261 ~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~  296 (373)
T 2r5t_A          261 NITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVF  296 (373)
T ss_dssp             SSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGG
T ss_pred             CCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCcc
Confidence            233557899999999999999998643 33344333

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=4.2e-39  Score=346.01  Aligned_cols=253  Identities=21%  Similarity=0.351  Sum_probs=208.0

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      .++|++.+.||+|+||.||+|.++ +++.||+|++......  ....+.+.+|+.+++.++||||+++++++..++..++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   82 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS--ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL   82 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCC--HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEE
Confidence            478999999999999999999876 6899999998654322  2245778899999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCc---EEEecccccc
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYE---AHVSDFGIAK  792 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~Dfgla~  792 (912)
                      ||||+++++|.+.+...   ..+++.++..++.|++.||+|||++   +|+||||||+||+++.++.   +||+|||.+.
T Consensus        83 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~  156 (284)
T 3kk8_A           83 VFDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI  156 (284)
T ss_dssp             EECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence            99999999998888443   4689999999999999999999999   9999999999999986655   9999999998


Q ss_pred             ccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChh
Q 039137          793 FLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLH  872 (912)
Q Consensus       793 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  872 (912)
                      ..... .......|++.|+|||++.+..++.++||||+|+++|+|++|+.||.....     ..............+...
T Consensus       157 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~  230 (284)
T 3kk8_A          157 EVNDS-EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-----HRLYAQIKAGAYDYPSPE  230 (284)
T ss_dssp             ECCSS-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHTCCCCCTTT
T ss_pred             EcccC-ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch-----hHHHHHHHhccccCCchh
Confidence            76543 333456789999999999999999999999999999999999999852111     111222222222233222


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          873 VQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       873 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ....+..+.+++.+||+.||++|||++|+++
T Consensus       231 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          231 WDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            2334566889999999999999999999876

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.5e-39  Score=361.84  Aligned_cols=252  Identities=25%  Similarity=0.382  Sum_probs=203.8

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++...... .....+.+.+|+++++.++||||+++++++.+.+..|+|
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCV-ERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcc-cHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            67999999999999999999876 6889999998542111 111346788999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+.+|+|.+++..   ...+++.+++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||++.....
T Consensus        94 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  167 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR  167 (384)
T ss_dssp             ECCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence            999999999999944   35689999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCCcccccccccccccccccc---CCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhh
Q 039137          797 DSSNWSELAGTHGYVAPELAYT---LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHV  873 (912)
Q Consensus       797 ~~~~~~~~~g~~~y~aPE~~~~---~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  873 (912)
                      . .......||+.|+|||++.+   ..++.++|||||||++|||++|+.||.......  ..............++.   
T Consensus       168 ~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~--~~~~~~~~~~~~~~~p~---  241 (384)
T 4fr4_A          168 E-TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS--SKEIVHTFETTVVTYPS---  241 (384)
T ss_dssp             T-CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC--HHHHHHHHHHCCCCCCT---
T ss_pred             C-CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc--HHHHHHHHhhcccCCCC---
Confidence            3 34456789999999999864   458999999999999999999999985221111  11111122222233332   


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 039137          874 QKKLMSIMQVAFSCLDQNPESRPT-MKRVSQ  903 (912)
Q Consensus       874 ~~~~~~l~~li~~cl~~dP~~RPt-~~evl~  903 (912)
                       ..+..+.++|.+||+.||++||+ ++++.+
T Consensus       242 -~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          242 -AWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             -TSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             -cCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence             23456889999999999999998 666553

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=6.5e-40  Score=360.93  Aligned_cols=262  Identities=26%  Similarity=0.418  Sum_probs=210.3

Q ss_pred             HHhcCCCCCceeeecCceEEEEEEeC-CC-----CEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEE
Q 039137          635 SATNDFNAEHCIGKGGHGSVYRAKVP-SG-----EIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFC  707 (912)
Q Consensus       635 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~-----~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~  707 (912)
                      ...++|++.+.||+|+||.||+|++. ++     ..||+|++....   .....+.+.+|+.+++.+ +||||+++++++
T Consensus        43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  119 (333)
T 2i1m_A           43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA---HADEKEALMSELKIMSHLGQHENIVNLLGAC  119 (333)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc---ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            34578999999999999999999864 22     479999987543   222567789999999999 899999999999


Q ss_pred             EcCCeeeEEEeecCCCChhhHhhccCC-----------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeE
Q 039137          708 SHPKHSFIIYEYLESGSLDKILCNDAS-----------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVL  776 (912)
Q Consensus       708 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nil  776 (912)
                      ..++..++||||+++|+|.+++.....           ...+++.+++.++.|++.||+|||++   +|+||||||+||+
T Consensus       120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl  196 (333)
T 2i1m_A          120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVL  196 (333)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCE
T ss_pred             ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEE
Confidence            999999999999999999999954321           34579999999999999999999999   9999999999999


Q ss_pred             EcCCCcEEEeccccccccCCCCCC--ccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccc
Q 039137          777 LDLGYEAHVSDFGIAKFLNPDSSN--WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSS  853 (912)
Q Consensus       777 l~~~~~~kl~Dfgla~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~  853 (912)
                      ++.++.+||+|||+++........  .....+++.|+|||++.+..++.++||||||+++|||++ |..||......   
T Consensus       197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---  273 (333)
T 2i1m_A          197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN---  273 (333)
T ss_dssp             EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS---
T ss_pred             ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh---
Confidence            999999999999999866443222  233456789999999998899999999999999999998 99998532111   


Q ss_pred             cccchhhhccC--CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 039137          854 SSNMNIEMLDS--RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE  911 (912)
Q Consensus       854 ~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~~  911 (912)
                        .........  ....+.    ..+..+.+++.+||+.||.+|||+.|+++.|++...+
T Consensus       274 --~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  327 (333)
T 2i1m_A          274 --SKFYKLVKDGYQMAQPA----FAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE  327 (333)
T ss_dssp             --HHHHHHHHHTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --HHHHHHHhcCCCCCCCC----CCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence              111111111  111111    1235678999999999999999999999999987653

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3e-39  Score=352.65  Aligned_cols=261  Identities=20%  Similarity=0.326  Sum_probs=190.0

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeee
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSF  714 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  714 (912)
                      ..++|++.+.||+|+||+||+|.++ +++.||+|++.......   ..+.+.+|+++++.++||||+++++++..++..+
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   79 (317)
T 2pmi_A            3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG---TPSTAIREISLMKELKHENIVRLYDVIHTENKLT   79 (317)
T ss_dssp             ----------------CEEEEEECSSSCCEEEEEEEECCSTTC---SCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEE
T ss_pred             cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccc---cHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEE
Confidence            3468999999999999999999876 68999999987543222   3456789999999999999999999999999999


Q ss_pred             EEEeecCCCChhhHhhccC---CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccc
Q 039137          715 IIYEYLESGSLDKILCNDA---SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIA  791 (912)
Q Consensus       715 lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla  791 (912)
                      +||||++ |+|.+++....   ....+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++
T Consensus        80 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~  155 (317)
T 2pmi_A           80 LVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLA  155 (317)
T ss_dssp             EEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSC
T ss_pred             EEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccc
Confidence            9999998 59999885432   224589999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCccchhccccc----------cccchhh
Q 039137          792 KFLNPDSSNWSELAGTHGYVAPELAYTL-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS----------SSNMNIE  860 (912)
Q Consensus       792 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~----------~~~~~~~  860 (912)
                      +.............+|+.|+|||++.+. .++.++||||+||++|||++|+.||.........          .......
T Consensus       156 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  235 (317)
T 2pmi_A          156 RAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPS  235 (317)
T ss_dssp             EETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGG
T ss_pred             eecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhh
Confidence            8776554445566889999999998764 5899999999999999999999998632110000          0000000


Q ss_pred             -----hccCCCCC--CC-h-------hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          861 -----MLDSRLPY--PS-L-------HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       861 -----~~~~~~~~--~~-~-------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                           ......+.  +. .       .....+..+.+++.+||+.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence                 00000000  00 0       00012356889999999999999999998875

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.7e-39  Score=358.50  Aligned_cols=247  Identities=21%  Similarity=0.274  Sum_probs=205.2

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ++|++.+.||+|+||.||+|+++ +|+.||+|++....... ....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhcc-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            67999999999999999999976 79999999985421110 11346788999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++|+|.+++.+.   +.+++.+++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus       120 ~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~  193 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             EECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC
Confidence            9999999999999543   4589999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHH
Q 039137          797 DSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKK  876 (912)
Q Consensus       797 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  876 (912)
                      .   .....||+.|+|||++.+..++.++|||||||++|||++|+.||....     .......+......++.    ..
T Consensus       194 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-----~~~~~~~i~~~~~~~p~----~~  261 (350)
T 1rdq_E          194 R---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PIQIYEKIVSGKVRFPS----HF  261 (350)
T ss_dssp             C---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHCCCCCCT----TC
T ss_pred             C---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC-----HHHHHHHHHcCCCCCCC----CC
Confidence            2   335679999999999999999999999999999999999999985221     11122223333333332    23


Q ss_pred             HHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 039137          877 LMSIMQVAFSCLDQNPESRPT-----MKRVSQ  903 (912)
Q Consensus       877 ~~~l~~li~~cl~~dP~~RPt-----~~evl~  903 (912)
                      +..+.++|.+||+.||++||+     ++|+++
T Consensus       262 ~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          262 SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             CHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence            456889999999999999998     776653

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.1e-39  Score=350.84  Aligned_cols=261  Identities=16%  Similarity=0.217  Sum_probs=209.3

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEEcCCeee
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSHPKHSF  714 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~  714 (912)
                      .++|++.+.||+|+||.||+|++. +++.||+|++.....      .+.+.+|+..++.+ +|++++++++++......+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~   82 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD------APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV   82 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT------SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc------cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeE
Confidence            467999999999999999999864 789999999864422      23467899999999 7999999999999999999


Q ss_pred             EEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCc-----EEEeccc
Q 039137          715 IIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYE-----AHVSDFG  789 (912)
Q Consensus       715 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~-----~kl~Dfg  789 (912)
                      +||||+ +++|.+++...  ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.     +||+|||
T Consensus        83 lv~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg  156 (298)
T 1csn_A           83 LVIDLL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFG  156 (298)
T ss_dssp             EEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred             EEEEec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECc
Confidence            999999 89999999543  34589999999999999999999999   9999999999999987776     9999999


Q ss_pred             cccccCCCCC-------CccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhc
Q 039137          790 IAKFLNPDSS-------NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEML  862 (912)
Q Consensus       790 la~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~  862 (912)
                      +++.......       ......||+.|+|||++.+..++.++||||||+++|||++|+.||.........  .......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~--~~~~~~~  234 (298)
T 1csn_A          157 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK--QKYERIG  234 (298)
T ss_dssp             TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH--HHHHHHH
T ss_pred             cccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccH--HHHHHHH
Confidence            9987654432       134567999999999999999999999999999999999999998632111110  0001110


Q ss_pred             cCCCCCC-ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 039137          863 DSRLPYP-SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE  911 (912)
Q Consensus       863 ~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~~  911 (912)
                      ......+ .......+..+.+++.+||+.||++|||++++++.|++.+.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~  284 (298)
T 1csn_A          235 EKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER  284 (298)
T ss_dssp             HHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             hhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence            0000000 111112345788999999999999999999999999988754

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.7e-39  Score=352.69  Aligned_cols=263  Identities=25%  Similarity=0.400  Sum_probs=212.5

Q ss_pred             HhcCCCCCceeeecCceEEEEEEe------CCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEE
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKV------PSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCS  708 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~  708 (912)
                      ..++|++.+.||+|+||.||+|++      .+++.||+|++....   .....+.+.+|+.+++++ +||||+++++++.
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   97 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch---hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence            346799999999999999999974      256789999987542   222567899999999999 8999999999999


Q ss_pred             cCCeeeEEEeecCCCChhhHhhccCC---------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCC
Q 039137          709 HPKHSFIIYEYLESGSLDKILCNDAS---------------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSK  773 (912)
Q Consensus       709 ~~~~~~lv~e~~~~g~L~~~l~~~~~---------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~  773 (912)
                      .++..++||||+++|+|.+++.....               ...+++.+++.++.|++.||+|||++   +|+||||||+
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~  174 (313)
T 1t46_A           98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAAR  174 (313)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred             cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccc
Confidence            99999999999999999999965432               22589999999999999999999999   9999999999


Q ss_pred             CeEEcCCCcEEEeccccccccCCCCCC--ccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhcc
Q 039137          774 NVLLDLGYEAHVSDFGIAKFLNPDSSN--WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEM  850 (912)
Q Consensus       774 Nill~~~~~~kl~Dfgla~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~  850 (912)
                      ||+++.++.+||+|||++.........  .....+++.|+|||++.+..++.++||||||+++|||++ |+.||......
T Consensus       175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  254 (313)
T 1t46_A          175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (313)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence            999999999999999999876544322  223456789999999999899999999999999999999 99998532111


Q ss_pred             ccccccchhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 039137          851 SSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE  911 (912)
Q Consensus       851 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~~  911 (912)
                           ...............  ....+..+.+++.+||+.||.+|||+.|+++.|++.+.+
T Consensus       255 -----~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  308 (313)
T 1t46_A          255 -----SKFYKMIKEGFRMLS--PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (313)
T ss_dssp             -----HHHHHHHHHTCCCCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----hHHHHHhccCCCCCC--cccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence                 011111111111100  112345688999999999999999999999999998765

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.3e-39  Score=358.54  Aligned_cols=263  Identities=24%  Similarity=0.291  Sum_probs=206.8

Q ss_pred             HHHHhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCC-CCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC
Q 039137          633 IISATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLP-GEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP  710 (912)
Q Consensus       633 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~  710 (912)
                      +....++|++.+.||+|+||+||+|++. +++.||+|++..... .......+.+.+|+++++.++||||+++++++.+.
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            3456788999999999999999999875 788999999854311 01112467899999999999999999999999999


Q ss_pred             CeeeEEEeecCCCChhhHhhccC-------------------------------------CcccCCHHHHHHHHHHHHHH
Q 039137          711 KHSFIIYEYLESGSLDKILCNDA-------------------------------------SAKELGWTQRLNVIKGVADA  753 (912)
Q Consensus       711 ~~~~lv~e~~~~g~L~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~i~~~  753 (912)
                      +..++||||+++|+|.+++....                                     ....+++..++.++.|++.|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            99999999999999999984211                                     12234678889999999999


Q ss_pred             HHHHHhCCCCCeeecCCCCCCeEEcCCC--cEEEeccccccccCCCCC----Ccccccccccccccccccc--CCCCcch
Q 039137          754 LFYLHNNCFPPIVHRDISSKNVLLDLGY--EAHVSDFGIAKFLNPDSS----NWSELAGTHGYVAPELAYT--LKVTEKC  825 (912)
Q Consensus       754 L~~LH~~~~~~ivH~Dlk~~Nill~~~~--~~kl~Dfgla~~~~~~~~----~~~~~~g~~~y~aPE~~~~--~~~~~~s  825 (912)
                      |+|||++   +|+||||||+||+++.++  .+||+|||+++.......    ......||+.|+|||++.+  ..++.++
T Consensus       181 l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  257 (345)
T 3hko_A          181 LHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC  257 (345)
T ss_dssp             HHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred             HHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence            9999999   999999999999998776  899999999986543221    2345678999999999875  6789999


Q ss_pred             hHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          826 DVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       826 DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ||||||+++|||++|+.||.....     ..............+.......+..+.+++.+||+.||++|||+.|+++
T Consensus       258 DiwslG~il~el~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  330 (345)
T 3hko_A          258 DAWSAGVLLHLLLMGAVPFPGVND-----ADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ  330 (345)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHCCCCCCCCCh-----HHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            999999999999999999853211     1222233334443333333445567889999999999999999999876

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=4.9e-39  Score=346.02  Aligned_cols=256  Identities=27%  Similarity=0.422  Sum_probs=202.9

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHH---HHHHHHHHHHhhcCCCccccEEEEEEcCCe
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQ---EEFLNEIQALTEIRHRNIVKFYGFCSHPKH  712 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~---~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~  712 (912)
                      .++|++.+.||+|+||+||+|++. +++.||+|++............   +.+.+|+++++.++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            367999999999999999999875 7899999998765443322111   67899999999999999999999996554 


Q ss_pred             eeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCC--eeecCCCCCCeEEcCCCc-----EEE
Q 039137          713 SFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP--IVHRDISSKNVLLDLGYE-----AHV  785 (912)
Q Consensus       713 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlk~~Nill~~~~~-----~kl  785 (912)
                       ++||||+++|+|.+++...  ...+++.+++.++.|++.|++|||++   +  |+||||||+||+++.++.     +||
T Consensus        97 -~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl  170 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKV  170 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred             -eEEEEecCCCCHHHHHhcc--cCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEe
Confidence             7999999999998888543  35689999999999999999999999   8  999999999999988776     999


Q ss_pred             eccccccccCCCCCCccccccccccccccccc--cCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhcc
Q 039137          786 SDFGIAKFLNPDSSNWSELAGTHGYVAPELAY--TLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLD  863 (912)
Q Consensus       786 ~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~  863 (912)
                      +|||+++....   ......|++.|+|||++.  ...++.++||||+|+++|||++|+.||+......   .........
T Consensus       171 ~Dfg~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---~~~~~~~~~  244 (287)
T 4f0f_A          171 ADFGLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK---IKFINMIRE  244 (287)
T ss_dssp             CCCTTCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH---HHHHHHHHH
T ss_pred             CCCCccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH---HHHHHHHhc
Confidence            99999975432   344567899999999984  4557899999999999999999999986221110   000111111


Q ss_pred             CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 039137          864 SRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCE  907 (912)
Q Consensus       864 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  907 (912)
                      ......  .....+..+.+++.+||+.||++|||++|+++.|++
T Consensus       245 ~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          245 EGLRPT--IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             SCCCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             cCCCCC--CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence            111110  112234568899999999999999999999999986

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=3.8e-39  Score=347.20  Aligned_cols=261  Identities=25%  Similarity=0.394  Sum_probs=197.1

Q ss_pred             hcCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      .++|++.+.||+|+||+||+|++.  ..||+|++......  ....+.+.+|+++++.++||||+++++++ ..+..++|
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv   97 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPT--PQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV   97 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCC--HHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence            468999999999999999999864  35999998755332  33567899999999999999999999965 55678999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++++|.+++...  ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++.....
T Consensus        98 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  172 (289)
T 3og7_A           98 TQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR  172 (289)
T ss_dssp             EECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred             EEecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccccc
Confidence            9999999999998433  35689999999999999999999999   999999999999999999999999999986543


Q ss_pred             C--CCCccccccccccccccccc---cCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCC-CCC
Q 039137          797 D--SSNWSELAGTHGYVAPELAY---TLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLP-YPS  870 (912)
Q Consensus       797 ~--~~~~~~~~g~~~y~aPE~~~---~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~  870 (912)
                      .  ........|++.|+|||++.   +..++.++||||+|+++|||++|+.||.......    ............ ...
T Consensus       173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~  248 (289)
T 3og7_A          173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD----QIIEMVGRGSLSPDLS  248 (289)
T ss_dssp             -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH----HHHHHHHHTSCCCCTT
T ss_pred             ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH----HHHHHhcccccCcchh
Confidence            2  22234567899999999886   5678889999999999999999999986321111    011111111111 111


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 039137          871 LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE  911 (912)
Q Consensus       871 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~~  911 (912)
                      ......+..+.+++.+||+.||++|||++|+++.|++...|
T Consensus       249 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~e  289 (289)
T 3og7_A          249 KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELARE  289 (289)
T ss_dssp             SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTCC
T ss_pred             hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhhC
Confidence            11123345688999999999999999999999999988654

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3e-39  Score=351.45  Aligned_cols=264  Identities=20%  Similarity=0.287  Sum_probs=203.2

Q ss_pred             HHhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCee
Q 039137          635 SATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHS  713 (912)
Q Consensus       635 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  713 (912)
                      ...++|++.+.||+|+||.||+|++. +++.||+|++....... ....+.+.+|+.+++.++||||+++++++..++..
T Consensus        31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~  109 (309)
T 2h34_A           31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSD-PVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQL  109 (309)
T ss_dssp             ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred             cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccC-HHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeE
Confidence            34578999999999999999999976 78899999987543222 22457789999999999999999999999999999


Q ss_pred             eEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccc
Q 039137          714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKF  793 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  793 (912)
                      ++||||+++++|.+++...   ..+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++..
T Consensus       110 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~  183 (309)
T 2h34_A          110 YVDMRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASA  183 (309)
T ss_dssp             EEEEECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC---
T ss_pred             EEEEEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcc
Confidence            9999999999999999543   4689999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCC-CCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChh
Q 039137          794 LNPDS-SNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLH  872 (912)
Q Consensus       794 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  872 (912)
                      ..... .......+++.|+|||++.+..++.++||||||+++|||++|+.||......      ..........+.+...
T Consensus       184 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~~~  257 (309)
T 2h34_A          184 TTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS------VMGAHINQAIPRPSTV  257 (309)
T ss_dssp             -------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH------HHHHHHHSCCCCGGGT
T ss_pred             ccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH------HHHHHhccCCCCcccc
Confidence            65432 2233557899999999999989999999999999999999999998632111      1111122222222122


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHHhhhc
Q 039137          873 VQKKLMSIMQVAFSCLDQNPESRP-TMKRVSQLLCEKIFE  911 (912)
Q Consensus       873 ~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~l~~  911 (912)
                      ....+..+.+++.+||+.||++|| +++++++.|++.+.+
T Consensus       258 ~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~  297 (309)
T 2h34_A          258 RPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT  297 (309)
T ss_dssp             STTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred             CCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence            223345688999999999999999 999999999987643

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-39  Score=361.02  Aligned_cols=260  Identities=24%  Similarity=0.335  Sum_probs=207.8

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC------CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP------SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP  710 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~  710 (912)
                      .++|++.+.||+|+||+||+|++.      +++.||||++....   ......++.+|+.+++.++||||+++++++...
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  146 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC---SEQDELDFLMEALIISKFNHQNIVRCIGVSLQS  146 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc---ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            367899999999999999999843      56789999986432   223556788999999999999999999999999


Q ss_pred             CeeeEEEeecCCCChhhHhhccC----CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCC---cE
Q 039137          711 KHSFIIYEYLESGSLDKILCNDA----SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGY---EA  783 (912)
Q Consensus       711 ~~~~lv~e~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~---~~  783 (912)
                      +..++||||+++|+|.+++....    ....+++.+++.++.||+.||+|||++   +|+||||||+||+++.++   .+
T Consensus       147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~  223 (367)
T 3l9p_A          147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVA  223 (367)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCE
T ss_pred             CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceE
Confidence            99999999999999999996543    224589999999999999999999999   999999999999999555   59


Q ss_pred             EEeccccccccCCCC--CCccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhh
Q 039137          784 HVSDFGIAKFLNPDS--SNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIE  860 (912)
Q Consensus       784 kl~Dfgla~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~  860 (912)
                      ||+|||+++......  .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.....     ......
T Consensus       224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~-----~~~~~~  298 (367)
T 3l9p_A          224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-----QEVLEF  298 (367)
T ss_dssp             EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----HHHHHH
T ss_pred             EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHH
Confidence            999999997543221  22334567899999999999999999999999999999998 9999852211     111111


Q ss_pred             hccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          861 MLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       861 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                      ..........   ...+..+.+++.+||+.||++|||++|+++.|+....
T Consensus       299 i~~~~~~~~~---~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~  345 (367)
T 3l9p_A          299 VTSGGRMDPP---KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  345 (367)
T ss_dssp             HHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHcCCCCCCC---ccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence            1111111111   1233458899999999999999999999999987643

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.1e-39  Score=349.94  Aligned_cols=254  Identities=26%  Similarity=0.453  Sum_probs=199.1

Q ss_pred             cCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIY  717 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  717 (912)
                      ++|++.+.||+|+||+||+|++ .++.||+|++...      ...+.+.+|++++++++||||+++++++.  +..++||
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~   78 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE------SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVM   78 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST------THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEE
T ss_pred             hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh------hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEE
Confidence            5788999999999999999988 4788999998532      14678899999999999999999999886  4589999


Q ss_pred             eecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCc-EEEeccccccccCC
Q 039137          718 EYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYE-AHVSDFGIAKFLNP  796 (912)
Q Consensus       718 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~-~kl~Dfgla~~~~~  796 (912)
                      ||+++|+|.+++........+++.+++.++.|+++||+|||+....+|+||||||+||+++.++. +||+|||++.....
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~  158 (307)
T 2eva_A           79 EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT  158 (307)
T ss_dssp             ECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred             EcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence            99999999999976655556889999999999999999999932129999999999999998886 79999999976543


Q ss_pred             CCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCC-CCCCChhhHH
Q 039137          797 DSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSR-LPYPSLHVQK  875 (912)
Q Consensus       797 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  875 (912)
                      .   .....|++.|+|||++.+..++.++||||||+++|||++|+.||+......   ........... .+.+    ..
T Consensus       159 ~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~----~~  228 (307)
T 2eva_A          159 H---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA---FRIMWAVHNGTRPPLI----KN  228 (307)
T ss_dssp             ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH---HHHHHHHHTTCCCCCB----TT
T ss_pred             c---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH---HHHHHHHhcCCCCCcc----cc
Confidence            2   234468999999999999999999999999999999999999986321100   00111111111 1111    12


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          876 KLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       876 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                      .+..+.+++.+||+.||++|||++|+++.|++...
T Consensus       229 ~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  263 (307)
T 2eva_A          229 LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR  263 (307)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred             cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence            34568899999999999999999999999988654

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=1.9e-38  Score=362.71  Aligned_cols=355  Identities=20%  Similarity=0.218  Sum_probs=307.4

Q ss_pred             CCeEEEeeccccccccccccccCCCCCccEEEccCCcccccCCccccCCCCCcEEeccccccccccccccccccccceee
Q 039137           84 ERVVGINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLH  163 (912)
Q Consensus        84 ~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~  163 (912)
                      .++..+++.++.+.+.  + +|+.+++|++|+|++|++++. |  ++.+++|++|+|++|++++ +|  ++.+++|++|+
T Consensus        42 ~~L~~L~Ls~n~l~~~--~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~-~~--~~~l~~L~~L~  112 (457)
T 3bz5_A           42 ATLTSLDCHNSSITDM--T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLN  112 (457)
T ss_dssp             TTCCEEECCSSCCCCC--T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSC-CC--CTTCTTCCEEE
T ss_pred             CCCCEEEccCCCcccC--h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCce-ee--cCCCCcCCEEE
Confidence            4678889998888864  2 689999999999999999974 4  9999999999999999986 44  89999999999


Q ss_pred             cccccccCCCCccccCcccccEEEccCCcCCCCCCccCCCCccceeeeeccCCCcCccccccccccccceeecccccccC
Q 039137          164 ISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSG  243 (912)
Q Consensus       164 L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~  243 (912)
                      +++|++++ +|  ++.+++|++|++++|++++ ++  ++++++|++|++++|...+.+  .++.+++|+.|++++|++++
T Consensus       113 L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~-l~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~  184 (457)
T 3bz5_A          113 CDTNKLTK-LD--VSQNPLLTYLNCARNTLTE-ID--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE  184 (457)
T ss_dssp             CCSSCCSC-CC--CTTCTTCCEEECTTSCCSC-CC--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC
T ss_pred             CCCCcCCe-ec--CCCCCcCCEEECCCCccce-ec--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce
Confidence            99999996 55  8999999999999999997 43  899999999999999776666  58899999999999999996


Q ss_pred             ccccccccccccceeeeccccCcccCCcccCCccccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCC
Q 039137          244 AIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGT  323 (912)
Q Consensus       244 ~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~  323 (912)
                       +|  ++.+++|+.|++++|++++.   .++.+++|++|++++|++++ +|  +..+++|+.|++++|++++.+   ++.
T Consensus       185 -l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~---~~~  252 (457)
T 3bz5_A          185 -LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELD---VST  252 (457)
T ss_dssp             -CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCC---CTT
T ss_pred             -ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcC---HHH
Confidence             45  88999999999999999975   48899999999999999997 55  889999999999999999864   567


Q ss_pred             CCCccEEEccCCcCcccccccCCCCCCCCEEeccCCcccccccccccccccccEEEccCccccCCCCccccccccccEEE
Q 039137          324 YPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLS  403 (912)
Q Consensus       324 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~  403 (912)
                      +++|+.|++++|+              |+.|++++|.+.+.+|  ++.+++|+.|++++|.+.+.+|..   ..+|+.|+
T Consensus       253 l~~L~~L~l~~n~--------------L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~---~~~L~~L~  313 (457)
T 3bz5_A          253 LSKLTTLHCIQTD--------------LLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQ---AAGITELD  313 (457)
T ss_dssp             CTTCCEEECTTCC--------------CSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECT---TCCCSCCC
T ss_pred             CCCCCEEeccCCC--------------CCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccC---CCcceEec
Confidence            7899999998764              5678899999888887  467899999999999988877753   34566665


Q ss_pred             ccCCcccCCCccccccccccccccccCcccCccccccccccccccEEEecccccccccchhhhcccccceeeccccccCc
Q 039137          404 LSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGE  483 (912)
Q Consensus       404 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  483 (912)
                      +++|             ++|++|++++|+++++   .+..+++|+.|++++|++++        ++.|..|++++|.+.|
T Consensus       314 l~~~-------------~~L~~L~L~~N~l~~l---~l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g  369 (457)
T 3bz5_A          314 LSQN-------------PKLVYLYLNNTELTEL---DVSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEA  369 (457)
T ss_dssp             CTTC-------------TTCCEEECTTCCCSCC---CCTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEE
T ss_pred             hhhc-------------ccCCEEECCCCccccc---ccccCCcCcEEECCCCCCCC--------ccccccccccCCcEEe
Confidence            5554             6899999999999985   38899999999999999986        3577888999999987


Q ss_pred             ccccccccccccccccccCccccCCCcccccc
Q 039137          484 KISSRICRMESLEKLNLSYNNLSGLIPRCFEE  515 (912)
Q Consensus       484 ~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~  515 (912)
                      .     ..+..|..+++++|+++|.+|..+..
T Consensus       370 ~-----~~~~~l~~l~l~~N~l~g~ip~~~~~  396 (457)
T 3bz5_A          370 E-----GQTITMPKETLTNNSLTIAVSPDLLD  396 (457)
T ss_dssp             E-----EEEEECCCBCCBTTBEEEECCTTCBC
T ss_pred             c-----ceeeecCccccccCcEEEEcChhHhc
Confidence            5     46778999999999999999876543

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=6.1e-39  Score=349.37  Aligned_cols=264  Identities=22%  Similarity=0.311  Sum_probs=200.6

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++....... ....+.+.+|+.+++.++||||+++++++...+..++
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l  109 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMD-AKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI  109 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence            467999999999999999999874 78999999987543222 3356788999999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccC-CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccccccc
Q 039137          716 IYEYLESGSLDKILCNDA-SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL  794 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  794 (912)
                      ||||+++++|.+++.... ....+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++...
T Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~  186 (310)
T 2wqm_A          110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF  186 (310)
T ss_dssp             EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred             EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence            999999999999985432 345689999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhH
Q 039137          795 NPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQ  874 (912)
Q Consensus       795 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  874 (912)
                      ...........+++.|+|||++.+..++.++||||||+++|+|++|+.||.....   ..............+..  ...
T Consensus       187 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~--~~~  261 (310)
T 2wqm_A          187 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLYSLCKKIEQCDYPPL--PSD  261 (310)
T ss_dssp             ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C---CHHHHHHHHHTTCSCCC--CTT
T ss_pred             cCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch---hHHHHHHHhhcccCCCC--ccc
Confidence            5544444556789999999999998999999999999999999999999852110   00011111111111111  112


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 039137          875 KKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI  909 (912)
Q Consensus       875 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l  909 (912)
                      ..+..+.+++.+||+.||++|||++++++.|++..
T Consensus       262 ~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~  296 (310)
T 2wqm_A          262 HYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH  296 (310)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            23456889999999999999999999999998764

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=4.6e-39  Score=345.05  Aligned_cols=257  Identities=25%  Similarity=0.375  Sum_probs=197.5

Q ss_pred             hcCCCCCceeeecCceEEEEEEeCC----CCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCe
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVPS----GEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKH  712 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~  712 (912)
                      .++|++.+.||+|+||.||+|.+..    +..||+|++....   .....+.+.+|+..++.++||||+++++++. .+.
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~   89 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT---SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCc
Confidence            4678999999999999999998742    4569999986432   2335678999999999999999999999984 567


Q ss_pred             eeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccccc
Q 039137          713 SFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK  792 (912)
Q Consensus       713 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  792 (912)
                      .++||||+++++|.+++...  ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  164 (281)
T 1mp8_A           90 VWIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR  164 (281)
T ss_dssp             CEEEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             cEEEEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccccc
Confidence            89999999999999999543  24689999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCC-CccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccC-CCCCC
Q 039137          793 FLNPDSS-NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDS-RLPYP  869 (912)
Q Consensus       793 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~  869 (912)
                      ....... ......+++.|+|||++.+..++.++||||||+++|||++ |..||.....     ......+... ..+.+
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~-----~~~~~~i~~~~~~~~~  239 (281)
T 1mp8_A          165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-----NDVIGRIENGERLPMP  239 (281)
T ss_dssp             --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GGHHHHHHTTCCCCCC
T ss_pred             ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH-----HHHHHHHHcCCCCCCC
Confidence            7654322 1233456789999999998899999999999999999997 9999863211     1111111111 11222


Q ss_pred             ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 039137          870 SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE  911 (912)
Q Consensus       870 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~~  911 (912)
                          ...+..+.+++.+||+.||++|||+.|+++.|++.+.+
T Consensus       240 ----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  277 (281)
T 1mp8_A          240 ----PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  277 (281)
T ss_dssp             ----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence                12345688999999999999999999999999988653

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=4.4e-39  Score=358.65  Aligned_cols=247  Identities=20%  Similarity=0.284  Sum_probs=199.3

Q ss_pred             CCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEEeec
Q 039137          642 AEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYL  720 (912)
Q Consensus       642 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  720 (912)
                      ..+.||+|+||.||+|+.. +|+.||+|++....    ....+.+.+|+++++.++||||+++++++...+..++||||+
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~  168 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG----MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYV  168 (373)
T ss_dssp             EEEECC-----CEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc----cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence            3578999999999999875 78999999987532    225678999999999999999999999999999999999999


Q ss_pred             CCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEE--cCCCcEEEeccccccccCCCC
Q 039137          721 ESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLL--DLGYEAHVSDFGIAKFLNPDS  798 (912)
Q Consensus       721 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill--~~~~~~kl~Dfgla~~~~~~~  798 (912)
                      ++++|.+++...  ...+++.+++.++.||+.||+|||++   +|+||||||+||++  +.++.+||+|||+++......
T Consensus       169 ~~~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~  243 (373)
T 2x4f_A          169 DGGELFDRIIDE--SYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE  243 (373)
T ss_dssp             TTCEEHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred             CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence            999999988542  34689999999999999999999999   99999999999999  567899999999998765432


Q ss_pred             CCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHHH
Q 039137          799 SNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLM  878 (912)
Q Consensus       799 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  878 (912)
                       ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ......+.......+.......+.
T Consensus       244 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-----~~~~~~i~~~~~~~~~~~~~~~~~  317 (373)
T 2x4f_A          244 -KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND-----AETLNNILACRWDLEDEEFQDISE  317 (373)
T ss_dssp             -BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHHHTCCCSCSGGGTTSCH
T ss_pred             -ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhccCCCChhhhccCCH
Confidence             33445799999999999988899999999999999999999999853211     111222223333333333334556


Q ss_pred             HHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          879 SIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       879 ~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .+.++|.+||+.||.+|||+.|+++
T Consensus       318 ~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          318 EAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHhc
Confidence            7889999999999999999999986

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.2e-39  Score=346.93  Aligned_cols=252  Identities=23%  Similarity=0.398  Sum_probs=183.3

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++...... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMY-KAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL   88 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhh-hhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence            467999999999999999999874 7999999998532110 01124678899999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ||||+++++|.+++...  ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++....
T Consensus        89 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~  163 (278)
T 3cok_A           89 VLEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLK  163 (278)
T ss_dssp             EEECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence            99999999999999543  35689999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHH
Q 039137          796 PDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQK  875 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  875 (912)
                      ..........|++.|+|||.+.+..++.++||||+|+++|||++|+.||......     .............+.    .
T Consensus       164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~----~  234 (278)
T 3cok_A          164 MPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK-----NTLNKVVLADYEMPS----F  234 (278)
T ss_dssp             ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------CCSSCCCCCT----T
T ss_pred             CCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHH-----HHHHHHhhcccCCcc----c
Confidence            4444444567899999999999888999999999999999999999998632111     111111111112221    1


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          876 KLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       876 ~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .+..+.+++.+||+.||++|||++++++
T Consensus       235 ~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          235 LSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            3356789999999999999999999875

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.8e-39  Score=371.75  Aligned_cols=251  Identities=22%  Similarity=0.284  Sum_probs=197.5

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++....... ......+.+|+.+++.++||||+++++++...+..++
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l  225 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVA-KDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF  225 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC--------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhh-hHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence            467999999999999999999875 78999999986432111 1134567889999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCCeEEcCCCcEEEecccccccc
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHN-NCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL  794 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  794 (912)
                      ||||+++|+|.+++..   ...+++.++..++.|++.||+|||+ +   +|+||||||+||+++.++.+||+|||+++..
T Consensus       226 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~  299 (446)
T 4ejn_A          226 VMEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEG  299 (446)
T ss_dssp             EECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred             EEeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence            9999999999999844   3468999999999999999999998 8   9999999999999999999999999999875


Q ss_pred             CCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhH
Q 039137          795 NPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQ  874 (912)
Q Consensus       795 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  874 (912)
                      ...........||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ......+......++.    
T Consensus       300 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~~i~~~~~~~p~----  370 (446)
T 4ejn_A          300 IKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELILMEEIRFPR----  370 (446)
T ss_dssp             CC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCCCCCCT----
T ss_pred             cCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-----HHHHHHHHhCCCCCCc----
Confidence            5554555667899999999999999999999999999999999999999852211     1111222223333332    


Q ss_pred             HHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 039137          875 KKLMSIMQVAFSCLDQNPESRP-----TMKRVSQ  903 (912)
Q Consensus       875 ~~~~~l~~li~~cl~~dP~~RP-----t~~evl~  903 (912)
                      ..+..+.++|.+||+.||++||     +++|+++
T Consensus       371 ~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          371 TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             cCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence            2345688999999999999999     9998874

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4e-39  Score=342.79  Aligned_cols=256  Identities=24%  Similarity=0.402  Sum_probs=209.8

Q ss_pred             hcCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      .++|++.+.||+|+||.||+|++.+++.||+|++.....     ..+.+.+|+++++.++||||+++++++..++..++|
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   81 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV   81 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-----CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEE
Confidence            357899999999999999999998889999999975432     246788999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++++|.+++...  ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++.....
T Consensus        82 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  156 (267)
T 3t9t_A           82 TEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  156 (267)
T ss_dssp             ECCCTTCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             EeCCCCCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccc
Confidence            9999999999999543  34688999999999999999999999   999999999999999999999999999986543


Q ss_pred             CC-CCccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccCCCCCCChhhH
Q 039137          797 DS-SNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQ  874 (912)
Q Consensus       797 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  874 (912)
                      .. .......+++.|+|||++.+..++.++||||+|+++|+|++ |+.||.....     ...............+   .
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~~~~i~~~~~~~~~---~  228 (267)
T 3t9t_A          157 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-----SEVVEDISTGFRLYKP---R  228 (267)
T ss_dssp             HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHHHHTTCCCCCC---T
T ss_pred             ccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH-----HHHHHHHhcCCcCCCC---c
Confidence            21 11223456788999999998889999999999999999999 8999852211     1111111111111111   1


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          875 KKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       875 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                      ..+..+.+++.+||+.||++|||++|+++.|++...
T Consensus       229 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          229 LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            224568899999999999999999999999998764

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=4.9e-39  Score=348.78  Aligned_cols=260  Identities=25%  Similarity=0.396  Sum_probs=206.5

Q ss_pred             cCCCCCceeeecCceEEEEEEe-----CCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC--
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKV-----PSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP--  710 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--  710 (912)
                      ++|++.+.||+|+||.||+|++     .+++.||+|++.......   ..+.+.+|+++++.++||||+++++++...  
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   97 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN---HIADLKKEIEILRNLYHENIVKYKGICTEDGG   97 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----C---CHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccch---hHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence            4588999999999999999983     378899999997543222   457788999999999999999999999876  


Q ss_pred             CeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccc
Q 039137          711 KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGI  790 (912)
Q Consensus       711 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl  790 (912)
                      ...++||||+++|+|.+++...  ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+
T Consensus        98 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~  172 (302)
T 4e5w_A           98 NGIKLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGL  172 (302)
T ss_dssp             CCEEEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred             ceEEEEEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccc
Confidence            6689999999999999999543  24589999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCC---CccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccc-----cc----cccch
Q 039137          791 AKFLNPDSS---NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMS-----SS----SSNMN  858 (912)
Q Consensus       791 a~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~-----~~----~~~~~  858 (912)
                      +........   ......+|+.|+|||++.+..++.++||||+|+++|||++|..|+.......     ..    .....
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  252 (302)
T 4e5w_A          173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL  252 (302)
T ss_dssp             CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred             cccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH
Confidence            987765432   2234567888999999999889999999999999999999999875321100     00    00000


Q ss_pred             hhhcc--CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 039137          859 IEMLD--SRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI  909 (912)
Q Consensus       859 ~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l  909 (912)
                      .....  ...+.+    ...+..+.+++.+||+.||.+|||+.|+++.|++.+
T Consensus       253 ~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          253 VNTLKEGKRLPCP----PNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHHHHTTCCCCCC----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHhccCCCCCC----CCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            11111  111111    123456889999999999999999999999999875

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=4.8e-39  Score=367.53  Aligned_cols=249  Identities=25%  Similarity=0.386  Sum_probs=206.0

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ++|.+.+.||+|+||.||+|++. +|+.||||++....... ....+.+.+|+.+++.++||||+++++++..++..++|
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRS-LDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHH-TTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            67999999999999999999976 79999999986421110 11346788999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++|+|.+++..   .+.+++.+++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||++.....
T Consensus        95 ~E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~  168 (476)
T 2y94_A           95 MEYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  168 (476)
T ss_dssp             EECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred             EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence            999999999999943   45699999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCCccccccccccccccccccCCC-CcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHH
Q 039137          797 DSSNWSELAGTHGYVAPELAYTLKV-TEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQK  875 (912)
Q Consensus       797 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  875 (912)
                      . .......||+.|+|||++.+..+ +.++||||+||++|||++|+.||+...     .......+.+.....+.    .
T Consensus       169 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~-----~~~~~~~i~~~~~~~p~----~  238 (476)
T 2y94_A          169 G-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH-----VPTLFKKICDGIFYTPQ----Y  238 (476)
T ss_dssp             T-CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS-----SHHHHHHHHTTCCCCCT----T
T ss_pred             c-ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC-----HHHHHHHHhcCCcCCCc----c
Confidence            3 33445679999999999988766 689999999999999999999986211     11122222333333222    1


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          876 KLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       876 ~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .+..+.+++.+||+.||++|||++|+++
T Consensus       239 ~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          239 LNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             CCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence            2345789999999999999999999986

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=5.1e-39  Score=342.66  Aligned_cols=253  Identities=19%  Similarity=0.299  Sum_probs=205.5

Q ss_pred             hcCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC--Ceee
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP--KHSF  714 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~  714 (912)
                      .++|++.+.||+|+||+||+|++ +++.||+|++.....  .....+.+.+|+.+++.++||||+++++++..+  +..+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   85 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDW--STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPT   85 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTC--CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeE
Confidence            35799999999999999999998 488999999976432  233567799999999999999999999999887  7889


Q ss_pred             EEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCC--eeecCCCCCCeEEcCCCcEEEecccccc
Q 039137          715 IIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP--IVHRDISSKNVLLDLGYEAHVSDFGIAK  792 (912)
Q Consensus       715 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlk~~Nill~~~~~~kl~Dfgla~  792 (912)
                      +||||+++|+|.+++... ....+++.+++.++.|++.||+|||++   +  |+||||||+||+++.++.++++|||++.
T Consensus        86 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~  161 (271)
T 3kmu_A           86 LITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKF  161 (271)
T ss_dssp             EEEECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred             eeecccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEecccee
Confidence            999999999999999543 233589999999999999999999998   7  9999999999999999999999999876


Q ss_pred             ccCCCCCCccccccccccccccccccCCCCc---chhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccC--CCC
Q 039137          793 FLNPDSSNWSELAGTHGYVAPELAYTLKVTE---KCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDS--RLP  867 (912)
Q Consensus       793 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~---~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~  867 (912)
                      ....     ....+|+.|+|||.+.+..++.   ++||||||+++|||++|+.||......     .........  ...
T Consensus       162 ~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~~~~  231 (271)
T 3kmu_A          162 SFQS-----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM-----EIGMKVALEGLRPT  231 (271)
T ss_dssp             TTSC-----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH-----HHHHHHHHSCCCCC
T ss_pred             eecc-----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH-----HHHHHHHhcCCCCC
Confidence            4322     2346899999999988765544   799999999999999999998632111     111111111  111


Q ss_pred             CCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          868 YPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       868 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                      .+    ...+..+.+++.+||+.||++|||++|+++.|++...
T Consensus       232 ~~----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          232 IP----PGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             CC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             CC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            11    1234568899999999999999999999999998753

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=3.5e-40  Score=370.31  Aligned_cols=257  Identities=19%  Similarity=0.294  Sum_probs=204.3

Q ss_pred             HHHHHhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC
Q 039137          632 EIISATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP  710 (912)
Q Consensus       632 e~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~  710 (912)
                      ++....++|++.+.||+|+||+||+|+++ +++.||+|++....... ....+.+.+|+.+++.++||||+++++++.++
T Consensus        63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~  141 (410)
T 3v8s_A           63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIK-RSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  141 (410)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhh-hHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            33445688999999999999999999986 68899999985311000 00123477899999999999999999999999


Q ss_pred             CeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccc
Q 039137          711 KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGI  790 (912)
Q Consensus       711 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl  790 (912)
                      +..|+||||+++|+|.+++..    ..+++..++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~  214 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT  214 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccce
Confidence            999999999999999999854    3589999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCC-CccccccccccccccccccCC----CCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccC-
Q 039137          791 AKFLNPDSS-NWSELAGTHGYVAPELAYTLK----VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDS-  864 (912)
Q Consensus       791 a~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~----~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~-  864 (912)
                      ++....... ......||+.|+|||++.+..    ++.++|||||||++|||++|+.||.....     ......+... 
T Consensus       215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----~~~~~~i~~~~  289 (410)
T 3v8s_A          215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-----VGTYSKIMNHK  289 (410)
T ss_dssp             CEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHHTHH
T ss_pred             eEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh-----hhHHHHHHhcc
Confidence            987654322 233568999999999988765    78899999999999999999999852211     1111111111 


Q ss_pred             -CCCCCChhhHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 039137          865 -RLPYPSLHVQKKLMSIMQVAFSCLDQNPES--RPTMKRVSQ  903 (912)
Q Consensus       865 -~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~  903 (912)
                       ...++..  ...+..+.++|.+|++.+|.+  ||+++|+++
T Consensus       290 ~~~~~p~~--~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          290 NSLTFPDD--NDISKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             HHCCCCTT--CCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             ccccCCCc--ccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence             1122211  123456889999999999988  999998875

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=8.4e-39  Score=345.48  Aligned_cols=251  Identities=24%  Similarity=0.375  Sum_probs=209.2

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      .++|++.+.||+|+||.||+|+++ +++.||+|++....... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   92 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK-PHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV   92 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccC-HHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence            467999999999999999999976 68899999986543332 2356778999999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ||||+++++|.+++..   ...+++.+++.++.|++.|++|||++   +|+||||||+||+++.++.+||+|||.+....
T Consensus        93 v~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  166 (294)
T 2rku_A           93 VLELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  166 (294)
T ss_dssp             EEECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence            9999999999998843   34689999999999999999999999   99999999999999999999999999998776


Q ss_pred             CCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHH
Q 039137          796 PDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQK  875 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  875 (912)
                      ..........|++.|+|||.+.+..++.++||||+|+++|+|++|+.||+....     ..............+.    .
T Consensus       167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~----~  237 (294)
T 2rku_A          167 YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-----KETYLRIKKNEYSIPK----H  237 (294)
T ss_dssp             STTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHHTTCCCCCT----T
T ss_pred             cCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHhhccCCCcc----c
Confidence            554455566799999999999998899999999999999999999999863211     1111112222222222    2


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          876 KLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       876 ~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .+..+.+++.+||+.||++|||++|+++
T Consensus       238 ~~~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          238 INPVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             cCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence            2345788999999999999999999876

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.3e-38  Score=352.41  Aligned_cols=262  Identities=23%  Similarity=0.386  Sum_probs=211.6

Q ss_pred             HHHHHHHhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCch----HHHHHHHHHHHHHhhc-CCCccccE
Q 039137          630 YEEIISATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMS----FQQEEFLNEIQALTEI-RHRNIVKF  703 (912)
Q Consensus       630 ~~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~----~~~~~~~~Ei~~l~~l-~h~niv~l  703 (912)
                      ........++|++.+.||+|+||.||+|+++ +|+.||||++.........    ...+.+.+|+.+++.+ +||||+++
T Consensus        86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~  165 (365)
T 2y7j_A           86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL  165 (365)
T ss_dssp             HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred             chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            3444556678999999999999999999986 7999999998765432221    1245688999999999 79999999


Q ss_pred             EEEEEcCCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcE
Q 039137          704 YGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEA  783 (912)
Q Consensus       704 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  783 (912)
                      ++++...+..++||||+++++|.+++..   ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+
T Consensus       166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~i  239 (365)
T 2y7j_A          166 IDSYESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQI  239 (365)
T ss_dssp             EEEEEBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred             EEEEeeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCE
Confidence            9999999999999999999999999953   34689999999999999999999999   99999999999999999999


Q ss_pred             EEeccccccccCCCCCCcccccccccccccccccc------CCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccc
Q 039137          784 HVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT------LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNM  857 (912)
Q Consensus       784 kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~  857 (912)
                      ||+|||++...... .......||+.|+|||++.+      ..++.++|||||||++|||++|+.||.....     ...
T Consensus       240 kl~DfG~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-----~~~  313 (365)
T 2y7j_A          240 RLSDFGFSCHLEPG-EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ-----ILM  313 (365)
T ss_dssp             EECCCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----HHH
T ss_pred             EEEecCcccccCCC-cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH-----HHH
Confidence            99999999876543 33445679999999998863      3578899999999999999999999852111     111


Q ss_pred             hhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          858 NIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       858 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ...+.......+.......+..+.+++.+||+.||++|||++|+++
T Consensus       314 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          314 LRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            1122223333332222234566889999999999999999998875

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.4e-38  Score=341.74  Aligned_cols=255  Identities=21%  Similarity=0.325  Sum_probs=205.5

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCc--hHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCee
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEM--SFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHS  713 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  713 (912)
                      .++|++.+.||+|+||.||+|++. +++.||+|++........  ....+.+.+|+++++.++||||+++++++...+..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            356999999999999999999986 789999999875433221  11367789999999999999999999999999999


Q ss_pred             eEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCC----cEEEeccc
Q 039137          714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGY----EAHVSDFG  789 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~Dfg  789 (912)
                      ++||||+++++|.+++..   ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++    .+||+|||
T Consensus        84 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg  157 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFG  157 (283)
T ss_dssp             EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecc
Confidence            999999999999999944   34689999999999999999999999   999999999999999877    79999999


Q ss_pred             cccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCC
Q 039137          790 IAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYP  869 (912)
Q Consensus       790 la~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  869 (912)
                      .+....... ......+++.|+|||++.+..++.++||||||+++|+|++|+.||.....     ..............+
T Consensus       158 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~  231 (283)
T 3bhy_A          158 IAHKIEAGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK-----QETLTNISAVNYDFD  231 (283)
T ss_dssp             TCEECC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHHTTCCCCC
T ss_pred             cceeccCCC-cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch-----HHHHHHhHhcccCCc
Confidence            998765432 23455789999999999988999999999999999999999999853211     111111222222222


Q ss_pred             ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          870 SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       870 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .......+..+.+++.+||+.||++|||+.|+++
T Consensus       232 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          232 EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence            2222334566889999999999999999999986

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.1e-38  Score=351.13  Aligned_cols=259  Identities=22%  Similarity=0.385  Sum_probs=208.9

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC--------CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP--------SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFC  707 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~  707 (912)
                      .++|++.+.||+|+||.||+|++.        ++..||+|++....   .....+.+.+|+++++.+ +||||+++++++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  110 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC  110 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC---cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence            468999999999999999999863        56789999987542   223567789999999999 899999999999


Q ss_pred             EcCCeeeEEEeecCCCChhhHhhccCC-------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCC
Q 039137          708 SHPKHSFIIYEYLESGSLDKILCNDAS-------------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKN  774 (912)
Q Consensus       708 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N  774 (912)
                      ...+..++||||+++|+|.+++.....             ...+++.+++.++.|++.||+|||++   +|+||||||+|
T Consensus       111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N  187 (334)
T 2pvf_A          111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARN  187 (334)
T ss_dssp             CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGG
T ss_pred             ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccce
Confidence            999999999999999999999965432             23489999999999999999999999   99999999999


Q ss_pred             eEEcCCCcEEEeccccccccCCCCC--CccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccc
Q 039137          775 VLLDLGYEAHVSDFGIAKFLNPDSS--NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMS  851 (912)
Q Consensus       775 ill~~~~~~kl~Dfgla~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~  851 (912)
                      |+++.++.+||+|||+++.......  ......+++.|+|||++.+..++.++||||||+++|||++ |+.||.....  
T Consensus       188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--  265 (334)
T 2pvf_A          188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--  265 (334)
T ss_dssp             EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH--
T ss_pred             EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH--
Confidence            9999999999999999987654322  1223456789999999988889999999999999999999 9999853211  


Q ss_pred             cccccchhhhccC-CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          852 SSSSNMNIEMLDS-RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       852 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                         .......... ....+    ...+..+.+++.+||+.||++|||+.|+++.|++.+.
T Consensus       266 ---~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~  318 (334)
T 2pvf_A          266 ---EELFKLLKEGHRMDKP----ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  318 (334)
T ss_dssp             ---HHHHHHHHHTCCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---HHHHHHHhcCCCCCCC----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence               0111111111 11111    1234568899999999999999999999999998763

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=7.8e-39  Score=348.74  Aligned_cols=258  Identities=21%  Similarity=0.345  Sum_probs=198.3

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ++|++.+.||+|+||+||+|++. +++.||+|++.....  .....+.+.+|+++++.++||||+++++++...+..++|
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED--DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV   80 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC---HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc--chHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence            67999999999999999999986 689999999865432  233467788999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++++|.+++..   ...+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++.....
T Consensus        81 ~e~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  154 (311)
T 4agu_A           81 FEYCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTG  154 (311)
T ss_dssp             EECCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EEeCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence            999999999998843   34589999999999999999999999   999999999999999999999999999987765


Q ss_pred             CCCCcccccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCccchhccccccc------c----------chh
Q 039137          797 DSSNWSELAGTHGYVAPELAYT-LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSS------N----------MNI  859 (912)
Q Consensus       797 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~------~----------~~~  859 (912)
                      .........|++.|+|||++.+ ..++.++||||+|+++|+|++|+.||...........      .          ...
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (311)
T 4agu_A          155 PSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ  234 (311)
T ss_dssp             -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred             cccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence            5445556688999999999876 5689999999999999999999999863211100000      0          000


Q ss_pred             hhccCCCCCCC------hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          860 EMLDSRLPYPS------LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       860 ~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .......+.+.      ......+..+.+++.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            00000111110      011223456889999999999999999999875

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.7e-39  Score=355.87  Aligned_cols=265  Identities=21%  Similarity=0.332  Sum_probs=212.2

Q ss_pred             HHHHHhcCCCCCceeeecCceEEEEEEeC------CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEE
Q 039137          632 EIISATNDFNAEHCIGKGGHGSVYRAKVP------SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYG  705 (912)
Q Consensus       632 e~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~  705 (912)
                      ++....++|++.+.||+|+||.||+|++.      +++.||+|++....   .......+.+|+.+++.++||||+++++
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~   95 (322)
T 1p4o_A           19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFNCHHVVRLLG   95 (322)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS---CHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred             hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc---CHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence            33445678999999999999999999764      36789999987432   2224567899999999999999999999


Q ss_pred             EEEcCCeeeEEEeecCCCChhhHhhccCC-------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEc
Q 039137          706 FCSHPKHSFIIYEYLESGSLDKILCNDAS-------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLD  778 (912)
Q Consensus       706 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~  778 (912)
                      ++...+..++||||+++|+|.+++.....       ...+++.+++.++.|++.||+|||++   +|+||||||+||+++
T Consensus        96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~  172 (322)
T 1p4o_A           96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVA  172 (322)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEEC
T ss_pred             EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEc
Confidence            99999999999999999999999854321       24578999999999999999999999   999999999999999


Q ss_pred             CCCcEEEeccccccccCCCCCC--ccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccc
Q 039137          779 LGYEAHVSDFGIAKFLNPDSSN--WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSS  855 (912)
Q Consensus       779 ~~~~~kl~Dfgla~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~  855 (912)
                      .++.+||+|||+++........  .....+++.|+|||++.+..++.++||||+|+++|||++ |+.||.....     .
T Consensus       173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----~  247 (322)
T 1p4o_A          173 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-----E  247 (322)
T ss_dssp             TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-----H
T ss_pred             CCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH-----H
Confidence            9999999999999865433211  223456889999999999899999999999999999999 8999853211     1


Q ss_pred             cchhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          856 NMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       856 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                      ...............   ...+..+.+++.+||+.||++|||+.|+++.|++.+.
T Consensus       248 ~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          248 QVLRFVMEGGLLDKP---DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             HHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHHHHHHcCCcCCCC---CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            111111122211111   1234568899999999999999999999999998754

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.6e-38  Score=363.65  Aligned_cols=250  Identities=28%  Similarity=0.409  Sum_probs=204.7

Q ss_pred             hcCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCC-eeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPK-HSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-~~~l  715 (912)
                      .++|++.+.||+|+||.||+|++ .++.||||+++...      ..+.+.+|++++++++||||+++++++...+ ..++
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~i  264 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI  264 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT------TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEE
T ss_pred             hHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch------HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEE
Confidence            46788999999999999999988 47899999997542      3467899999999999999999999987765 7899


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ||||+++|+|.+++.... ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus       265 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  340 (450)
T 1k9a_A          265 VTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  340 (450)
T ss_dssp             EEECCTTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence            999999999999996532 23478999999999999999999999   99999999999999999999999999998543


Q ss_pred             CCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccC-CCCCCChhh
Q 039137          796 PDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDS-RLPYPSLHV  873 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  873 (912)
                      ..   .....+++.|+|||++.+..++.++||||||+++|||++ |+.||.....     ......+... +.+.+    
T Consensus       341 ~~---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~-----~~~~~~i~~~~~~~~p----  408 (450)
T 1k9a_A          341 ST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----KDVVPRVEKGYKMDAP----  408 (450)
T ss_dssp             ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT-----TTHHHHHHTTCCCCCC----
T ss_pred             cc---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHcCCCCCCC----
Confidence            22   223367889999999999999999999999999999998 9999863211     1111111111 22222    


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 039137          874 QKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI  909 (912)
Q Consensus       874 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l  909 (912)
                      ...+..+.+++.+||+.||++|||+.++++.|++..
T Consensus       409 ~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~  444 (450)
T 1k9a_A          409 DGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR  444 (450)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            223456889999999999999999999999998764

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=6.8e-39  Score=355.91  Aligned_cols=252  Identities=25%  Similarity=0.324  Sum_probs=194.2

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      .++|++.+.||+|+||+||+|+.+ +++.||+|++......     .+.+.+|+.+++.++||||+++++++..++..++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   93 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI-----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   93 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS-----CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc-----cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEE
Confidence            468999999999999999999986 7899999999754322     3557899999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCc--EEEeccccccc
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYE--AHVSDFGIAKF  793 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~--~kl~Dfgla~~  793 (912)
                      ||||+++|+|.+++..   .+.+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.  +||+|||+++.
T Consensus        94 v~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~  167 (361)
T 3uc3_A           94 IMEYASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKS  167 (361)
T ss_dssp             EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred             EEEeCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence            9999999999999854   34689999999999999999999999   9999999999999987765  99999999975


Q ss_pred             cCCCCCCccccccccccccccccccCCCCcc-hhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChh
Q 039137          794 LNPDSSNWSELAGTHGYVAPELAYTLKVTEK-CDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLH  872 (912)
Q Consensus       794 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~-sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  872 (912)
                      .... .......||+.|+|||++.+..++.+ +||||+||++|+|++|+.||......... ..............+.. 
T Consensus       168 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~-  244 (361)
T 3uc3_A          168 SVLH-SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY-RKTIQRILSVKYSIPDD-  244 (361)
T ss_dssp             --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH-HHHHHHHHTTCCCCCTT-
T ss_pred             cccc-CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH-HHHHHHHhcCCCCCCCc-
Confidence            4322 22345579999999999988887655 89999999999999999998632211110 11111122222222211 


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          873 VQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       873 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                       ...+..+.++|.+||+.||++|||+.|+++
T Consensus       245 -~~~s~~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          245 -IRISPECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             -SCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             -CCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence             123456789999999999999999999875

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.8e-38  Score=365.97  Aligned_cols=320  Identities=22%  Similarity=0.255  Sum_probs=188.5

Q ss_pred             cEEEccCCcccccCCccccCCCCCcEEeccccccccccccccccccccceeecccccccCCCCccccCcccccEEEccCC
Q 039137          112 VYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSN  191 (912)
Q Consensus       112 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n  191 (912)
                      +.++.++++++ .+|..+.  ++|++|||++|++++..|..|..+++|++|+|++|.+++..|..|+++++|++|+|++|
T Consensus        14 ~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n   90 (477)
T 2id5_A           14 RAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN   90 (477)
T ss_dssp             TEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             CEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence            45777777777 4665553  47778888888877666677777777777777777777666666777777777777666


Q ss_pred             cCCCCCCccCCCCccceeeeeccCCCcCccccccccccccceeecccccccCccccccccccccceeeeccccCcccCCc
Q 039137          192 FLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQ  271 (912)
Q Consensus       192 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~  271 (912)
                      ++++..+..|.++++|++|+|++|.+.+..|..                        |..+++|++|+|++|++++..+.
T Consensus        91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~------------------------~~~l~~L~~L~l~~n~l~~~~~~  146 (477)
T 2id5_A           91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYM------------------------FQDLYNLKSLEVGDNDLVYISHR  146 (477)
T ss_dssp             CCCSCCTTSSTTCTTCCEEECTTSCCCEECTTT------------------------TTTCTTCCEEEECCTTCCEECTT
T ss_pred             cCCccCcccccCCCCCCEEECCCCccccCChhH------------------------ccccccCCEEECCCCccceeChh
Confidence            666444444555555555555555555444444                        44444555555555555444444


Q ss_pred             ccCCccccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCcccccccCCCCCCC
Q 039137          272 EIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQL  351 (912)
Q Consensus       272 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  351 (912)
                      .|.++++|++|+|++|++++..+..|.++++|+.|+|++|.+++..+..|..+++|+.|++++|.+.+..+.......+|
T Consensus       147 ~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L  226 (477)
T 2id5_A          147 AFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNL  226 (477)
T ss_dssp             SSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCC
T ss_pred             hccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccc
Confidence            55555555555555555554444455555566666666666555555556666666666666665555555444444455


Q ss_pred             CEEeccCCcccccccccccccccccEEEccCccccCCCCccccccccccEEEccCCcccCCCccccccccccccccccCc
Q 039137          352 SLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSAN  431 (912)
Q Consensus       352 ~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N  431 (912)
                      +.|++++|++++..+..+..+++|++|+|++|++++..+..+.++++|+.|+|++|++++..|..|..+++|++|+|++|
T Consensus       227 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N  306 (477)
T 2id5_A          227 TSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGN  306 (477)
T ss_dssp             SEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSS
T ss_pred             cEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCC
Confidence            55555555555333344555555555555555555544455555555555555555555555555555555555555555


Q ss_pred             ccCccccccccccccccEEEecccccc
Q 039137          432 NLSNFVPESLGSLVKLYYLNLSHNKLS  458 (912)
Q Consensus       432 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~  458 (912)
                      +|+++.+..|..+++|+.|+|++|++.
T Consensus       307 ~l~~~~~~~~~~l~~L~~L~l~~N~l~  333 (477)
T 2id5_A          307 QLTTLEESVFHSVGNLETLILDSNPLA  333 (477)
T ss_dssp             CCSCCCGGGBSCGGGCCEEECCSSCEE
T ss_pred             cCceeCHhHcCCCcccCEEEccCCCcc
Confidence            555555555555555555555555554

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=4.6e-39  Score=368.78  Aligned_cols=255  Identities=23%  Similarity=0.407  Sum_probs=208.5

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      ..++|++.+.||+|+||+||+|+++++..||||++.....     ..+.+.+|+.+++.++||||+++++++. .+..++
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~l  259 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM-----SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYI  259 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB-----CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc-----cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEE
Confidence            3567899999999999999999998889999999875321     3678999999999999999999999986 667899


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ||||+++|+|.+++... ....+++.+++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus       260 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  335 (454)
T 1qcf_A          260 ITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIE  335 (454)
T ss_dssp             EECCCTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred             EEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence            99999999999999543 223578999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCC-CccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhcc-CCCCCCChh
Q 039137          796 PDSS-NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLD-SRLPYPSLH  872 (912)
Q Consensus       796 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  872 (912)
                      .... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||......     .....+.. .+.+.+   
T Consensus       336 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~-----~~~~~i~~~~~~~~~---  407 (454)
T 1qcf_A          336 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-----EVIRALERGYRMPRP---  407 (454)
T ss_dssp             CHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-----HHHHHHHHTCCCCCC---
T ss_pred             CCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHHcCCCCCCC---
Confidence            3211 1223346788999999998899999999999999999999 99998532111     11111111 122222   


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 039137          873 VQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI  909 (912)
Q Consensus       873 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l  909 (912)
                       ...+..+.+++.+||+.||++|||++++++.|++.+
T Consensus       408 -~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~  443 (454)
T 1qcf_A          408 -ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY  443 (454)
T ss_dssp             -TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             -CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence             123456889999999999999999999999998765

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.5e-38  Score=357.94  Aligned_cols=252  Identities=22%  Similarity=0.325  Sum_probs=193.6

Q ss_pred             hcCCCCC-ceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEEc----
Q 039137          637 TNDFNAE-HCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSH----  709 (912)
Q Consensus       637 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~----  709 (912)
                      .++|.+. +.||+|+||+||+|.++ +++.||||++..         ...+.+|++++.++ +||||+++++++..    
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~---------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~  130 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD---------CPKARREVELHWRASQCPHIVRIVDVYENLYAG  130 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC---------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc---------chhHHHHHHHHHHhcCCCCcceEeEEEeecccC
Confidence            3567766 68999999999999876 789999999852         23466888887554 89999999999875    


Q ss_pred             CCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcC---CCcEEEe
Q 039137          710 PKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDL---GYEAHVS  786 (912)
Q Consensus       710 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~  786 (912)
                      .+..|+||||+++|+|.+++... ....+++.+++.|+.||+.||+|||++   +|+||||||+||+++.   ++.+||+
T Consensus       131 ~~~~~lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~  206 (400)
T 1nxk_A          131 RKCLLIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT  206 (400)
T ss_dssp             EEEEEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEEC
T ss_pred             CcEEEEEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEE
Confidence            56789999999999999999543 234689999999999999999999999   9999999999999997   7889999


Q ss_pred             ccccccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCC
Q 039137          787 DFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRL  866 (912)
Q Consensus       787 Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  866 (912)
                      |||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ......+.....
T Consensus       207 DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~i~~~~~  284 (400)
T 1nxk_A          207 DFGFAKETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-PGMKTRIRMGQY  284 (400)
T ss_dssp             CCTTCEECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC-CSHHHHHHHTCC
T ss_pred             ecccccccCCC-CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc-HHHHHHHHcCcc
Confidence            99999866433 2334567899999999999999999999999999999999999998632221110 111122222233


Q ss_pred             CCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          867 PYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       867 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ..+.......+..+.++|.+||+.||++|||+.|+++
T Consensus       285 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  321 (400)
T 1nxk_A          285 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  321 (400)
T ss_dssp             CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            3332222344567889999999999999999999986

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=8.7e-39  Score=350.66  Aligned_cols=255  Identities=23%  Similarity=0.404  Sum_probs=200.4

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCE----EEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCC
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEI----FAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPK  711 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~  711 (912)
                      .++|++.+.||+|+||+||+|++. +++.    ||+|.+.....   ....+++.+|+.++++++||||+++++++..+.
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   90 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS---PKANKEILDEAYVMASVDNPHVCRLLGICLTST   90 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC----------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccC---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC
Confidence            367999999999999999999865 4443    58888754322   124577899999999999999999999998754


Q ss_pred             eeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccc
Q 039137          712 HSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIA  791 (912)
Q Consensus       712 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla  791 (912)
                       .++||||+++|+|.+++...  ...+++.+++.|+.|++.||+|||++   +|+||||||+||+++.++.+||+|||++
T Consensus        91 -~~~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a  164 (327)
T 3poz_A           91 -VQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA  164 (327)
T ss_dssp             -EEEEEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHH
T ss_pred             -eEEEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcce
Confidence             78999999999999999553  35689999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCC--ccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccC--CC
Q 039137          792 KFLNPDSSN--WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDS--RL  866 (912)
Q Consensus       792 ~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~--~~  866 (912)
                      +........  .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||+....      .........  ..
T Consensus       165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~------~~~~~~~~~~~~~  238 (327)
T 3poz_A          165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA------SEISSILEKGERL  238 (327)
T ss_dssp             HHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG------GGHHHHHHTTCCC
T ss_pred             eEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH------HHHHHHHHcCCCC
Confidence            876544332  223456889999999999999999999999999999999 9999863211      111111111  12


Q ss_pred             CCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          867 PYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       867 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                      +.+.    ..+..+.+++.+||+.||++|||+.|+++.|++...
T Consensus       239 ~~~~----~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          239 PQPP----ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             CCCT----TBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             CCCc----cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            2221    234568899999999999999999999999988653

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.8e-39  Score=361.83  Aligned_cols=265  Identities=19%  Similarity=0.257  Sum_probs=202.6

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeCC------CCEEEEEEccCCCCCCch-------HHHHHHHHHHHHHhhcCCCcccc
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVPS------GEIFAVKKFHSPLPGEMS-------FQQEEFLNEIQALTEIRHRNIVK  702 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~-------~~~~~~~~Ei~~l~~l~h~niv~  702 (912)
                      ..++|++.+.||+|+||+||+|.++.      ++.||||++.........       .....+.+|+..++.++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            34689999999999999999998764      478999998654211000       01123445666778889999999


Q ss_pred             EEEEEEcC----CeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEc
Q 039137          703 FYGFCSHP----KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLD  778 (912)
Q Consensus       703 l~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~  778 (912)
                      +++++...    ...++||||+ +++|.+++...  ...+++.+++.|+.||+.||+|||++   +|+||||||+||+++
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~  186 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLN  186 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEE
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEe
Confidence            99998764    4589999999 99999999543  35699999999999999999999999   999999999999999


Q ss_pred             --CCCcEEEeccccccccCCCCCC-------ccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhc
Q 039137          779 --LGYEAHVSDFGIAKFLNPDSSN-------WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFE  849 (912)
Q Consensus       779 --~~~~~kl~Dfgla~~~~~~~~~-------~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~  849 (912)
                        .++.+||+|||+++.+......       .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~  266 (364)
T 3op5_A          187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK  266 (364)
T ss_dssp             SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence              8899999999999876433211       1344599999999999999999999999999999999999999863211


Q ss_pred             ccccccc-------chhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 039137          850 MSSSSSN-------MNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE  911 (912)
Q Consensus       850 ~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~~  911 (912)
                      .......       ......+...+.     ...+..+.+++..||+.||++||+++++++.|++.+.+
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  330 (364)
T 3op5_A          267 DPKYVRDSKIRYRENIASLMDKCFPA-----ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA  330 (364)
T ss_dssp             CHHHHHHHHHHHHHCHHHHHHHHSCT-----TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHhhhhHHHHHHHhccc-----ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence            1100000       000011100000     11245688999999999999999999999999988764

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2e-38  Score=356.81  Aligned_cols=256  Identities=19%  Similarity=0.277  Sum_probs=203.0

Q ss_pred             hcCCCCCceeeec--CceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCee
Q 039137          637 TNDFNAEHCIGKG--GHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHS  713 (912)
Q Consensus       637 ~~~~~~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  713 (912)
                      .++|++.+.||+|  +||+||+|+++ +++.||||++......  ....+.+.+|+.+++.++||||+++++++..++..
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  101 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS--NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL  101 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccC--hHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence            4679999999999  99999999986 7999999999754322  23567788999999999999999999999999999


Q ss_pred             eEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccc
Q 039137          714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKF  793 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  793 (912)
                      ++||||+++|+|.+++.... ...+++.+++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||.+..
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~  177 (389)
T 3gni_B          102 WVVTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLS  177 (389)
T ss_dssp             EEEEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             EEEEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEccccccee
Confidence            99999999999999996532 34589999999999999999999999   999999999999999999999999998865


Q ss_pred             cCCCC-------CCcccccccccccccccccc--CCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccC
Q 039137          794 LNPDS-------SNWSELAGTHGYVAPELAYT--LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDS  864 (912)
Q Consensus       794 ~~~~~-------~~~~~~~g~~~y~aPE~~~~--~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  864 (912)
                      .....       .......||+.|+|||++.+  ..++.++||||+||++|||++|+.||........     .......
T Consensus       178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-----~~~~~~~  252 (389)
T 3gni_B          178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM-----LLEKLNG  252 (389)
T ss_dssp             CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH-----HHHC---
T ss_pred             eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH-----HHHHhcC
Confidence            43211       11233478999999999987  5789999999999999999999999863211100     0000000


Q ss_pred             CCC------------------------------------------CCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 039137          865 RLP------------------------------------------YPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVS  902 (912)
Q Consensus       865 ~~~------------------------------------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl  902 (912)
                      ..+                                          .........+..+.+++.+||+.||++|||++|++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell  332 (389)
T 3gni_B          253 TVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLL  332 (389)
T ss_dssp             -----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred             CCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHh
Confidence            000                                          00001122345688999999999999999999987


Q ss_pred             H
Q 039137          903 Q  903 (912)
Q Consensus       903 ~  903 (912)
                      +
T Consensus       333 ~  333 (389)
T 3gni_B          333 N  333 (389)
T ss_dssp             T
T ss_pred             c
Confidence            4

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.7e-39  Score=349.81  Aligned_cols=257  Identities=26%  Similarity=0.422  Sum_probs=212.3

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeee
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSF  714 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  714 (912)
                      ..++|++.+.||+|+||+||+|.++ +++.||+|++....     ...+.+.+|+++++.++||||+++++++..++..+
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   85 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   85 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-----THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-----HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence            4567999999999999999999986 58889999986432     14677899999999999999999999999999999


Q ss_pred             EEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccccccc
Q 039137          715 IIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL  794 (912)
Q Consensus       715 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  794 (912)
                      +||||+++++|.+++... ....+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++...
T Consensus        86 ~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~  161 (288)
T 3kfa_A           86 IITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM  161 (288)
T ss_dssp             EEEECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred             EEEEcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceec
Confidence            999999999999999553 335689999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCC-CccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccCC--CCCCC
Q 039137          795 NPDSS-NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDSR--LPYPS  870 (912)
Q Consensus       795 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~  870 (912)
                      ..... ......+++.|+|||++.+..++.++||||+|+++|+|++ |..||.....      ..........  ...+ 
T Consensus       162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~------~~~~~~~~~~~~~~~~-  234 (288)
T 3kfa_A          162 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQVYELLEKDYRMERP-  234 (288)
T ss_dssp             CSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG------GGHHHHHHTTCCCCCC-
T ss_pred             cCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHhccCCCCCC-
Confidence            54332 2233456788999999998899999999999999999999 9999853211      1111111111  1111 


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 039137          871 LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE  911 (912)
Q Consensus       871 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~~  911 (912)
                         ...+..+.+++.+||+.||.+|||++|+++.|++.+.+
T Consensus       235 ---~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~  272 (288)
T 3kfa_A          235 ---EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  272 (288)
T ss_dssp             ---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---CCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence               12345688999999999999999999999999987653

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.2e-38  Score=344.77  Aligned_cols=246  Identities=22%  Similarity=0.262  Sum_probs=195.6

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEEcCCeeeE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~l  715 (912)
                      ++|++.+.||+|+||+||+|++. +++.||||++.......  .......+|+..+..+ +||||+++++++.+++..++
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l  134 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGP--KDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL  134 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccCh--HHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence            57999999999999999999987 79999999987554332  2344556666666666 89999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ||||+ +++|.+++...  ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++....
T Consensus       135 v~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~  208 (311)
T 3p1a_A          135 QTELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELG  208 (311)
T ss_dssp             EEECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred             EEecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence            99999 56898888543  34699999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHH
Q 039137          796 PDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQK  875 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  875 (912)
                      .. .......||+.|+|||++.+ .++.++|||||||++|||++|..|+.....        ........  .+......
T Consensus       209 ~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~--------~~~~~~~~--~~~~~~~~  276 (311)
T 3p1a_A          209 TA-GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG--------WQQLRQGY--LPPEFTAG  276 (311)
T ss_dssp             -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH--------HHHHTTTC--CCHHHHTT
T ss_pred             cC-CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH--------HHHHhccC--CCcccccC
Confidence            43 23344568999999998876 689999999999999999999766431111        11111111  11112223


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          876 KLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       876 ~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .+..+.+++.+||+.||++|||++|+++
T Consensus       277 ~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          277 LSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            4567889999999999999999999875

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=5.5e-39  Score=344.07  Aligned_cols=249  Identities=27%  Similarity=0.432  Sum_probs=200.5

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      .++|++.+.||+|+||+||+|++. +++.||+|++...... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLE-KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccc-hhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            467999999999999999999876 6779999998532111 11124668899999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ||||+++|+|.+++...   ..+++.+++.++.|++.|++|||++   +|+||||||+||+++.++.++|+|||++....
T Consensus        87 v~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~  160 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP  160 (279)
T ss_dssp             EECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred             EEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence            99999999999998443   4589999999999999999999999   99999999999999999999999999986543


Q ss_pred             CCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHH
Q 039137          796 PDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQK  875 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  875 (912)
                      ..  ......|++.|+|||.+.+..++.++||||+|+++|+|++|+.||.....     ..............+.    .
T Consensus       161 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~----~  229 (279)
T 3fdn_A          161 SS--RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-----QETYKRISRVEFTFPD----F  229 (279)
T ss_dssp             ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHHHTCCCCCT----T
T ss_pred             cc--cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH-----HHHHHHHHhCCCCCCC----c
Confidence            32  23456789999999999999999999999999999999999999862211     1111112222222222    1


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          876 KLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       876 ~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .+..+.+++.+||+.||++|||++|+++
T Consensus       230 ~~~~~~~li~~~l~~~p~~Rps~~e~l~  257 (279)
T 3fdn_A          230 VTEGARDLISRLLKHNPSQRPMLREVLE  257 (279)
T ss_dssp             SCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            3345789999999999999999999986

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.1e-38  Score=351.23  Aligned_cols=251  Identities=24%  Similarity=0.375  Sum_probs=209.1

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      .++|.+.+.||+|+||.||+|++. +++.||+|++....... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  118 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK-PHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV  118 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence            467999999999999999999876 68899999986543322 2356778999999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ||||+++++|.+++..   ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++....
T Consensus       119 v~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  192 (335)
T 2owb_A          119 VLELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  192 (335)
T ss_dssp             EECCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence            9999999999999844   34689999999999999999999999   99999999999999999999999999998776


Q ss_pred             CCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHH
Q 039137          796 PDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQK  875 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  875 (912)
                      ..........|++.|+|||++.+..++.++||||||+++|||++|+.||.....     ..............+.    .
T Consensus       193 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~----~  263 (335)
T 2owb_A          193 YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-----KETYLRIKKNEYSIPK----H  263 (335)
T ss_dssp             STTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHHHTCCCCCT----T
T ss_pred             cCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH-----HHHHHHHhcCCCCCCc----c
Confidence            554455567799999999999998899999999999999999999999863211     1111112222222222    1


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          876 KLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       876 ~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .+..+.+++.+||+.||++|||++|+++
T Consensus       264 ~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          264 INPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            2345788999999999999999999875

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.4e-38  Score=365.24  Aligned_cols=319  Identities=22%  Similarity=0.210  Sum_probs=216.0

Q ss_pred             eeecccccccCCCCccccCcccccEEEccCCcCCCCCCccCCCCccceeeeeccCCCcCccccccccccccceeeccccc
Q 039137          161 VLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQ  240 (912)
Q Consensus       161 ~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~  240 (912)
                      .++.+++.++ .+|..+.  ++++.|+|++|++++..|..|.++++|++|+|++|.+++..|..|+++++|++|+|++|+
T Consensus        15 ~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~   91 (477)
T 2id5_A           15 AVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR   91 (477)
T ss_dssp             EEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred             EEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCc
Confidence            3444444444 3443332  345555555555554445555666666666666666665556666666666666666666


Q ss_pred             ccCccccccccccccceeeeccccCcccCCcccCCccccchhhhccCccCCCCccccccccccceEecccccccCCCCcc
Q 039137          241 LSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISET  320 (912)
Q Consensus       241 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~  320 (912)
                      +++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|.+++..+..|..+++|++|+|++|.+++..+..
T Consensus        92 l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~  171 (477)
T 2id5_A           92 LKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEA  171 (477)
T ss_dssp             CCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHH
T ss_pred             CCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhH
Confidence            66555556777888888888888888777888888888888888888888777788888888888888888888777777


Q ss_pred             cCCCCCccEEEccCCcCcccccccCCCCCCCCEEeccCCcccccccccccccccccEEEccCccccCCCCcccccccccc
Q 039137          321 FGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLN  400 (912)
Q Consensus       321 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~  400 (912)
                      |..+++|+.|+|++|.+.+..+..|..+++|+.|++++|.+.+.+|.......+|++|+|++|++++..+..+.++++|+
T Consensus       172 l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~  251 (477)
T 2id5_A          172 LSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLR  251 (477)
T ss_dssp             HTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCC
T ss_pred             hcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccC
Confidence            88888888888888888777777777777888888877777666666655555677777777766644334566666666


Q ss_pred             EEEccCCcccCCCccccccccccccccccCcccCccccccccccccccEEEecccccccccchhhhcccccceeeccccc
Q 039137          401 RLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNF  480 (912)
Q Consensus       401 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  480 (912)
                      .|+|++|++++..+..|..+++|+.|+|++|+++++.|..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|+
T Consensus       252 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~  331 (477)
T 2id5_A          252 FLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNP  331 (477)
T ss_dssp             EEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSC
T ss_pred             eeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCC
Confidence            66666666665555556666666666666666666556666666666666666666665555555566666666666666


Q ss_pred             cC
Q 039137          481 LG  482 (912)
Q Consensus       481 l~  482 (912)
                      +.
T Consensus       332 l~  333 (477)
T 2id5_A          332 LA  333 (477)
T ss_dssp             EE
T ss_pred             cc
Confidence            54

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=5.2e-39  Score=352.76  Aligned_cols=260  Identities=18%  Similarity=0.260  Sum_probs=192.3

Q ss_pred             HHhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCee
Q 039137          635 SATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHS  713 (912)
Q Consensus       635 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  713 (912)
                      ...++|++.+.||+|+||+||+|++. +++.||||++......  ....+.+.+|+++++.++||||+++++++...+..
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEE--EGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRL  108 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC----------CHHHHHHGGGCCCTTBCCEEEEEEETTEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccc--cccchhHHHHHHHHHHcCCCCcceEEEEEecCCEE
Confidence            45678999999999999999999865 7899999999754322  22356678999999999999999999999999999


Q ss_pred             eEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEc-----CCCcEEEecc
Q 039137          714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLD-----LGYEAHVSDF  788 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~-----~~~~~kl~Df  788 (912)
                      ++||||+++ +|.+++...   ..+++.+++.++.|++.||+|||++   +|+||||||+||+++     .++.+||+||
T Consensus       109 ~lv~e~~~~-~L~~~~~~~---~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Df  181 (329)
T 3gbz_A          109 HLIFEYAEN-DLKKYMDKN---PDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDF  181 (329)
T ss_dssp             EEEEECCSE-EHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred             EEEEecCCC-CHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcC
Confidence            999999985 999998543   4589999999999999999999999   999999999999994     4556999999


Q ss_pred             ccccccCCCCCCccccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCccchhcccccccc-----------
Q 039137          789 GIAKFLNPDSSNWSELAGTHGYVAPELAYTL-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSN-----------  856 (912)
Q Consensus       789 gla~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~-----------  856 (912)
                      |+++.............+|+.|+|||++.+. .++.++||||+||++|||++|+.||............           
T Consensus       182 g~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  261 (329)
T 3gbz_A          182 GLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT  261 (329)
T ss_dssp             THHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             CCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhh
Confidence            9998776554555566789999999998875 4899999999999999999999998632111000000           


Q ss_pred             ----chhhhccCCCC---CCCh---hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          857 ----MNIEMLDSRLP---YPSL---HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       857 ----~~~~~~~~~~~---~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                          ..........+   ....   .....+..+.+++.+||+.||++|||++|+++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             STTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence                00000000000   0000   00112356889999999999999999998875

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=8.1e-39  Score=350.70  Aligned_cols=255  Identities=25%  Similarity=0.383  Sum_probs=201.4

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCE----EEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCe
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEI----FAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKH  712 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~  712 (912)
                      ++|++.+.||+|+||+||+|++. +++.    ||+|.+.......   ..+.+.+|+.+++.++||||+++++++. .+.
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~   88 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQ---SFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSS   88 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCS---CBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSS
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHH---HHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCc
Confidence            57899999999999999999865 4544    7888875433221   2345678999999999999999999986 567


Q ss_pred             eeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccccc
Q 039137          713 SFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK  792 (912)
Q Consensus       713 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  792 (912)
                      .++||||+++|+|.+++...  ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus        89 ~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~  163 (325)
T 3kex_A           89 LQLVTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVAD  163 (325)
T ss_dssp             EEEEEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred             cEEEEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCccc
Confidence            89999999999999999543  35689999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCC--CccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccC-CCCC
Q 039137          793 FLNPDSS--NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDS-RLPY  868 (912)
Q Consensus       793 ~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~  868 (912)
                      .......  ......+++.|+|||++.+..++.++||||||+++|||++ |+.||.....     .......... ....
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~~~~~~~~~~~~~~  238 (325)
T 3kex_A          164 LLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL-----AEVPDLLEKGERLAQ  238 (325)
T ss_dssp             GSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT-----THHHHHHHTTCBCCC
T ss_pred             ccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH-----HHHHHHHHcCCCCCC
Confidence            7754432  2345567889999999998999999999999999999999 9999863211     1111111111 1111


Q ss_pred             CChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          869 PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       869 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                      +.    ..+..+.+++.+||+.||++|||++|+++.|++...
T Consensus       239 ~~----~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          239 PQ----ICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             CT----TBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             CC----cCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            11    123357789999999999999999999999988753

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.4e-38  Score=341.02  Aligned_cols=255  Identities=23%  Similarity=0.407  Sum_probs=207.7

Q ss_pred             hcCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      .++|++.+.||+|+||.||+|+..+++.||+|++.....     ..+.+.+|+++++.++||||+++++++. .+..++|
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v   85 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-----SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYII   85 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-----cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEE
Confidence            467999999999999999999988888999999865422     3567889999999999999999999986 4568999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++++|.+++... ....+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||.+.....
T Consensus        86 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  161 (279)
T 1qpc_A           86 TEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIED  161 (279)
T ss_dssp             EECCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EecCCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence            9999999999999432 223689999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCC-CccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccC-CCCCCChhh
Q 039137          797 DSS-NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDS-RLPYPSLHV  873 (912)
Q Consensus       797 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  873 (912)
                      ... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....     .......... ....+    
T Consensus       162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~----  232 (279)
T 1qpc_A          162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-----PEVIQNLERGYRMVRP----  232 (279)
T ss_dssp             SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HHHHHHHHTTCCCCCC----
T ss_pred             cccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH-----HHHHHHHhcccCCCCc----
Confidence            321 1233456788999999988889999999999999999999 9999853211     0111111111 11111    


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          874 QKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       874 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                      ...+..+.+++.+||+.||++|||++++++.|++.+.
T Consensus       233 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  269 (279)
T 1qpc_A          233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (279)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence            1234568899999999999999999999999998764

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.4e-38  Score=345.66  Aligned_cols=265  Identities=27%  Similarity=0.390  Sum_probs=202.5

Q ss_pred             HHHhcCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc--CCCccccEEEEEEcC-
Q 039137          634 ISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI--RHRNIVKFYGFCSHP-  710 (912)
Q Consensus       634 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l--~h~niv~l~~~~~~~-  710 (912)
                      ....++|++.+.||+|+||.||+|++. ++.||||++...       ....+.+|.+++...  +||||+++++++... 
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~  104 (337)
T 3mdy_A           33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT-------EEASWFRETEIYQTVLMRHENILGFIAADIKGT  104 (337)
T ss_dssp             TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG-------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred             cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc-------ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence            345678999999999999999999984 899999998532       234455566666555  899999999999877 


Q ss_pred             ---CeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeeecCCCCCCeEEcCCCc
Q 039137          711 ---KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNC-----FPPIVHRDISSKNVLLDLGYE  782 (912)
Q Consensus       711 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~Dlk~~Nill~~~~~  782 (912)
                         ...++||||+++|+|.+++..    ..+++.+++.++.|++.||+|||++.     .++|+||||||+||+++.++.
T Consensus       105 ~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~  180 (337)
T 3mdy_A          105 GSWTQLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT  180 (337)
T ss_dssp             GGGCEEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred             CCCCceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC
Confidence               678999999999999999944    35899999999999999999999762     238999999999999999999


Q ss_pred             EEEeccccccccCCCCCC----ccccccccccccccccccCCCCcc------hhHHHHHHHHHHHHhC----------CC
Q 039137          783 AHVSDFGIAKFLNPDSSN----WSELAGTHGYVAPELAYTLKVTEK------CDVYSFGVLALEVIKG----------KH  842 (912)
Q Consensus       783 ~kl~Dfgla~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~------sDvwslG~vl~elltg----------~~  842 (912)
                      +||+|||+++........    .....||+.|+|||++.+.....+      +|||||||++|||++|          +.
T Consensus       181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~  260 (337)
T 3mdy_A          181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL  260 (337)
T ss_dssp             EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred             EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccc
Confidence            999999999866543322    124579999999999987766655      9999999999999999          55


Q ss_pred             CccchhccccccccchhhhccC--CCCCCC-hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          843 PRDFLFEMSSSSSNMNIEMLDS--RLPYPS-LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       843 pf~~~~~~~~~~~~~~~~~~~~--~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                      ||....................  +...+. ......+..+.+++.+||+.||++|||+.|+++.|++...
T Consensus       261 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~  331 (337)
T 3mdy_A          261 PYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE  331 (337)
T ss_dssp             TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence            5532211111111111111111  111121 1123566779999999999999999999999999998764

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=6.4e-39  Score=370.40  Aligned_cols=254  Identities=22%  Similarity=0.327  Sum_probs=207.3

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      .++|++.+.||+|+||.||+|+++ +|+.||+|++....... ....+.+.+|+.+++.++||||+++++++...+..|+
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l  262 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKK-RKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL  262 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhh-hHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence            367899999999999999999986 79999999985422111 1134678899999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCC-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccccccc
Q 039137          716 IYEYLESGSLDKILCNDAS-AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL  794 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  794 (912)
                      ||||+++|+|.+++..... ...+++..++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus       263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~  339 (543)
T 3c4z_A          263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVEL  339 (543)
T ss_dssp             EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence            9999999999999865432 44699999999999999999999999   9999999999999999999999999999887


Q ss_pred             CCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhH
Q 039137          795 NPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQ  874 (912)
Q Consensus       795 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  874 (912)
                      ...........||+.|+|||++.+..++.++||||+||++|||++|+.||....... ...............++.    
T Consensus       340 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~-~~~~~~~~i~~~~~~~p~----  414 (543)
T 3c4z_A          340 KAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQRVLEQAVTYPD----  414 (543)
T ss_dssp             CTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC-CHHHHHHHHHHCCCCCCT----
T ss_pred             cCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch-hHHHHHHHHhhcccCCCc----
Confidence            655444455689999999999999999999999999999999999999986321110 011122222333333332    


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHH
Q 039137          875 KKLMSIMQVAFSCLDQNPESRPTMK  899 (912)
Q Consensus       875 ~~~~~l~~li~~cl~~dP~~RPt~~  899 (912)
                      ..+..+.++|.+||+.||++||++.
T Consensus       415 ~~s~~~~~li~~lL~~dP~~R~~~~  439 (543)
T 3c4z_A          415 KFSPASKDFCEALLQKDPEKRLGFR  439 (543)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCCB
T ss_pred             ccCHHHHHHHHHhccCCHhHCCCCc
Confidence            2345678999999999999999763

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.5e-38  Score=360.43  Aligned_cols=257  Identities=22%  Similarity=0.288  Sum_probs=196.5

Q ss_pred             HHhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCC----chHHHHHHHHHHHHHhhcCCCccccEEEEEEc
Q 039137          635 SATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGE----MSFQQEEFLNEIQALTEIRHRNIVKFYGFCSH  709 (912)
Q Consensus       635 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~  709 (912)
                      ...++|.+.+.||+|+||+||+|.++ +++.||||++.......    .......+.+|++++++++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            34678999999999999999999876 68999999986432111    11122357899999999999999999999864


Q ss_pred             CCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCC---cEEEe
Q 039137          710 PKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGY---EAHVS  786 (912)
Q Consensus       710 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~---~~kl~  786 (912)
                       +..++||||+++|+|.+++.   ....+++.+++.++.|++.||+|||++   +|+||||||+||+++.++   .+||+
T Consensus       212 -~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~  284 (419)
T 3i6u_A          212 -EDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT  284 (419)
T ss_dssp             -SEEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred             -CceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEe
Confidence             55799999999999999884   345689999999999999999999999   999999999999997544   59999


Q ss_pred             ccccccccCCCCCCcccccccccccccccccc---CCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhcc
Q 039137          787 DFGIAKFLNPDSSNWSELAGTHGYVAPELAYT---LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLD  863 (912)
Q Consensus       787 Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~  863 (912)
                      |||+++..... .......||+.|+|||++.+   ..++.++||||+||++|+|++|+.||....    ...........
T Consensus       285 DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~----~~~~~~~~i~~  359 (419)
T 3i6u_A          285 DFGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR----TQVSLKDQITS  359 (419)
T ss_dssp             CSSTTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCS----SSCCHHHHHHT
T ss_pred             ecccceecCCC-ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCc----chHHHHHHHhc
Confidence            99999876533 33345679999999998853   567889999999999999999999985211    11112222233


Q ss_pred             CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          864 SRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       864 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ......+......+..+.+++.+||+.||++|||++|+++
T Consensus       360 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          360 GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             TCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            3333333333345667899999999999999999998875

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.6e-38  Score=347.20  Aligned_cols=257  Identities=19%  Similarity=0.339  Sum_probs=199.9

Q ss_pred             hcCCCCC-ceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEEcCCee
Q 039137          637 TNDFNAE-HCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSHPKHS  713 (912)
Q Consensus       637 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~  713 (912)
                      .++|++. +.||+|+||+||+|++. +++.||||++......    ..+.+.+|+++++++ +||||+++++++.+++..
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~   86 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH----IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRF   86 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSC----CHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcch----hHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence            3568874 78999999999999865 7899999999754322    456788999999985 799999999999999999


Q ss_pred             eEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCc---EEEecccc
Q 039137          714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYE---AHVSDFGI  790 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~Dfgl  790 (912)
                      ++||||+++|+|.+++...   ..+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.   +||+|||+
T Consensus        87 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~  160 (316)
T 2ac3_A           87 YLVFEKMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDL  160 (316)
T ss_dssp             EEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTC
T ss_pred             EEEEEcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccC
Confidence            9999999999999999543   4689999999999999999999999   9999999999999998776   99999999


Q ss_pred             ccccCCCC-------CCcccccccccccccccccc-----CCCCcchhHHHHHHHHHHHHhCCCCccchhccccc-----
Q 039137          791 AKFLNPDS-------SNWSELAGTHGYVAPELAYT-----LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS-----  853 (912)
Q Consensus       791 a~~~~~~~-------~~~~~~~g~~~y~aPE~~~~-----~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~-----  853 (912)
                      +.......       .......||+.|+|||++.+     ..++.++||||+||++|||++|+.||.........     
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~  240 (316)
T 2ac3_A          161 GSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE  240 (316)
T ss_dssp             CC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----
T ss_pred             ccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccc
Confidence            98654221       11224468999999999875     45889999999999999999999998632211100     


Q ss_pred             -----cccchhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          854 -----SSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       854 -----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                           .......+.......+.......+..+.+++.+||+.||++|||++|+++
T Consensus       241 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          241 ACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             cchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence                 00111222233333333222334567889999999999999999999876

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=7e-39  Score=370.74  Aligned_cols=255  Identities=25%  Similarity=0.412  Sum_probs=210.2

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      .++|++.+.||+|+||.||+|+++ ++..||||++.....     ..+++.+|+.++++++||||+++++++...+..++
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  293 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI  293 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-----chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence            457889999999999999999987 488999999875322     35779999999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ||||+++|+|.+++... ....+++..++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus       294 v~E~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  369 (495)
T 1opk_A          294 ITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMT  369 (495)
T ss_dssp             EEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred             EEEccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceecc
Confidence            99999999999999653 235689999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCC-CccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccCC--CCCCCh
Q 039137          796 PDSS-NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDSR--LPYPSL  871 (912)
Q Consensus       796 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~  871 (912)
                      .... ......+++.|+|||++.+..++.++|||||||++|||++ |..||.....      ......+...  .+.+  
T Consensus       370 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~------~~~~~~~~~~~~~~~~--  441 (495)
T 1opk_A          370 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQVYELLEKDYRMERP--  441 (495)
T ss_dssp             TCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG------GGHHHHHHTTCCCCCC--
T ss_pred             CCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHcCCCCCCC--
Confidence            3321 1223445788999999998889999999999999999999 9999853211      1111111111  1222  


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          872 HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       872 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                        ...+..+.+++.+||+.||++|||+.++++.|+..+.
T Consensus       442 --~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          442 --EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             --TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             --CCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence              1234568899999999999999999999999987653

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=9.1e-39  Score=351.19  Aligned_cols=247  Identities=21%  Similarity=0.293  Sum_probs=204.0

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCc----hHHHHHHHHHHHHHhhcCCCccccEEEEEEcC
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEM----SFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP  710 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~----~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~  710 (912)
                      ..++|++.+.||+|+||+||+|++. +++.||||++........    ....+.+.+|+.+++.++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            4578999999999999999999865 788999999876543221    11234567899999999999999999999999


Q ss_pred             CeeeEEEeecCCC-ChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccc
Q 039137          711 KHSFIIYEYLESG-SLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFG  789 (912)
Q Consensus       711 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  789 (912)
                      +..++||||+.+| +|.+++..   ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             CEEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecc
Confidence            9999999999777 99999843   34689999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCCCccccccccccccccccccCCC-CcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCC
Q 039137          790 IAKFLNPDSSNWSELAGTHGYVAPELAYTLKV-TEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPY  868 (912)
Q Consensus       790 la~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  868 (912)
                      +++..... .......||+.|+|||++.+..+ +.++||||||+++|||++|+.||....+.           .......
T Consensus       176 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----------~~~~~~~  243 (335)
T 3dls_A          176 SAAYLERG-KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-----------VEAAIHP  243 (335)
T ss_dssp             TCEECCTT-CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----------TTTCCCC
T ss_pred             cceECCCC-CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----------HhhccCC
Confidence            99876543 23345679999999999988876 78999999999999999999998632111           1111111


Q ss_pred             CChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 039137          869 PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQL  904 (912)
Q Consensus       869 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  904 (912)
                      +.    ..+..+.+++.+||+.||++|||++|+++.
T Consensus       244 ~~----~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          244 PY----LVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             SS----CCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             Cc----ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            11    123458899999999999999999998863

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.4e-38  Score=341.86  Aligned_cols=253  Identities=25%  Similarity=0.361  Sum_probs=197.2

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      .++|.+.+.||+|+||+||+|+.. +++.||+|++.......   ..+.+.+|+++++.++||||+++++++.+.+..++
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   97 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV---PMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYI   97 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCS---CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccch---hHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEE
Confidence            357999999999999999999875 68899999987543222   35778899999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccC-CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEE---cCCCcEEEeccccc
Q 039137          716 IYEYLESGSLDKILCNDA-SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLL---DLGYEAHVSDFGIA  791 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~Dfgla  791 (912)
                      ||||+++|+|.+++.... ....+++.+++.++.|++.||+|||++   +|+||||||+||++   +.++.+||+|||++
T Consensus        98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a  174 (285)
T 3is5_A           98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLA  174 (285)
T ss_dssp             EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred             EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence            999999999999885432 235689999999999999999999999   99999999999999   45678999999999


Q ss_pred             cccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCCh
Q 039137          792 KFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSL  871 (912)
Q Consensus       792 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  871 (912)
                      ...... .......|++.|+|||++. ..++.++||||+|+++|||++|+.||......     ............... 
T Consensus       175 ~~~~~~-~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~-----~~~~~~~~~~~~~~~-  246 (285)
T 3is5_A          175 ELFKSD-EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE-----EVQQKATYKEPNYAV-  246 (285)
T ss_dssp             CC-----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHHCCCCCCC-
T ss_pred             eecCCc-ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH-----HHHhhhccCCccccc-
Confidence            866443 2334567899999999876 46899999999999999999999998632110     000011111111110 


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          872 HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       872 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .....+..+.+++.+||+.||++|||++|+++
T Consensus       247 ~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          247 ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             --CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            11112356789999999999999999999875

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.3e-38  Score=368.85  Aligned_cols=253  Identities=25%  Similarity=0.393  Sum_probs=210.5

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      .++|++.+.||+|+||+||+|+.+ +++.||||++........ ...+.+.+|+++++.++||||+++++++...+..++
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  103 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQK-TDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL  103 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBS-SCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccc-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            457999999999999999999986 799999999865543222 246778999999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEE---cCCCcEEEecccccc
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLL---DLGYEAHVSDFGIAK  792 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~Dfgla~  792 (912)
                      ||||+.+|+|.+++..   ...+++.+++.++.|++.||+|||++   +|+||||||+||++   +.++.+||+|||+++
T Consensus       104 v~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  177 (484)
T 3nyv_A          104 VGEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLST  177 (484)
T ss_dssp             EECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred             EEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence            9999999999998844   34689999999999999999999999   99999999999999   567899999999998


Q ss_pred             ccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChh
Q 039137          793 FLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLH  872 (912)
Q Consensus       793 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  872 (912)
                      ..... .......||+.|+|||++.+ .++.++||||+||++|+|++|++||.....     ......+.......+...
T Consensus       178 ~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~~i~~~~~~~~~~~  250 (484)
T 3nyv_A          178 HFEAS-KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE-----YDILKKVEKGKYTFELPQ  250 (484)
T ss_dssp             HBCCC-CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCCCCCCSGG
T ss_pred             Ecccc-cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHcCCCCCCCcc
Confidence            76543 33455679999999999876 699999999999999999999999863211     112222333333333334


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          873 VQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       873 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ....+..+.++|.+||+.||.+|||+.|+++
T Consensus       251 ~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          251 WKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence            4455677899999999999999999999875

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-38  Score=339.00  Aligned_cols=256  Identities=24%  Similarity=0.355  Sum_probs=207.4

Q ss_pred             cCCCCCc-eeeecCceEEEEEEeC---CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCee
Q 039137          638 NDFNAEH-CIGKGGHGSVYRAKVP---SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHS  713 (912)
Q Consensus       638 ~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  713 (912)
                      ++|.+.+ .||+|+||.||+|.+.   ++..||+|++....   .....+.+.+|+++++.++||||+++++++ ..+..
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~   84 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT---EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEAL   84 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc---chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCc
Confidence            4566666 9999999999999854   67789999997542   233567899999999999999999999999 45678


Q ss_pred             eEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccc
Q 039137          714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKF  793 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  793 (912)
                      ++||||+++++|.+++..  ....+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++..
T Consensus        85 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~  159 (287)
T 1u59_A           85 MLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKA  159 (287)
T ss_dssp             EEEEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceee
Confidence            999999999999999843  235689999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCC---ccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccC-CCCC
Q 039137          794 LNPDSSN---WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDS-RLPY  868 (912)
Q Consensus       794 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~  868 (912)
                      .......   .....+++.|+|||++.+..++.++||||||+++|||++ |+.||.....     .......... ....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----~~~~~~i~~~~~~~~  234 (287)
T 1u59_A          160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-----PEVMAFIEQGKRMEC  234 (287)
T ss_dssp             CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-----HHHHHHHHTTCCCCC
T ss_pred             eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-----HHHHHHHhcCCcCCC
Confidence            7543322   223456889999999988889999999999999999998 9999853211     1111111111 1122


Q ss_pred             CChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 039137          869 PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE  911 (912)
Q Consensus       869 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~~  911 (912)
                      +    ...+..+.+++.+||+.||++||++.++++.|++.+.+
T Consensus       235 ~----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  273 (287)
T 1u59_A          235 P----PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  273 (287)
T ss_dssp             C----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             C----CCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            2    12345688999999999999999999999999998764

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.1e-38  Score=349.74  Aligned_cols=264  Identities=21%  Similarity=0.337  Sum_probs=208.2

Q ss_pred             ccHHHHHHHhcCCCCC-ceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcC-CCccccEE
Q 039137          628 IVYEEIISATNDFNAE-HCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR-HRNIVKFY  704 (912)
Q Consensus       628 ~~~~e~~~~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~  704 (912)
                      +.+.......++|.+. +.||+|+||.||+|..+ +++.||+|++........  ....+.+|+.+++.++ ||||++++
T Consensus        18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~e~~~l~~l~~~~~iv~~~   95 (327)
T 3lm5_A           18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQD--CRAEILHEIAVLELAKSCPRVINLH   95 (327)
T ss_dssp             CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEE--CHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred             hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchH--HHHHHHHHHHHHHhccCCCCEEEEE
Confidence            3334445566778887 89999999999999876 689999999876443322  4577889999999995 79999999


Q ss_pred             EEEEcCCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcC---CC
Q 039137          705 GFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDL---GY  781 (912)
Q Consensus       705 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~---~~  781 (912)
                      +++...+..++||||+++|+|.+++... ....+++.+++.++.|++.||+|||++   +|+||||||+||+++.   ++
T Consensus        96 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~  171 (327)
T 3lm5_A           96 EVYENTSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLG  171 (327)
T ss_dssp             EEEECSSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBC
T ss_pred             EEEEeCCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCC
Confidence            9999999999999999999999998432 345689999999999999999999999   9999999999999998   78


Q ss_pred             cEEEeccccccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhh
Q 039137          782 EAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEM  861 (912)
Q Consensus       782 ~~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~  861 (912)
                      .+||+|||+++..... .......|++.|+|||++.+..++.++||||||+++|||++|+.||.....     .......
T Consensus       172 ~~kL~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~~i  245 (327)
T 3lm5_A          172 DIKIVDFGMSRKIGHA-CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN-----QETYLNI  245 (327)
T ss_dssp             CEEECCGGGCEEC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHH
T ss_pred             cEEEeeCccccccCCc-cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----hHHHHHH
Confidence            9999999999876543 223456799999999999999999999999999999999999999852211     1111112


Q ss_pred             ccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          862 LDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       862 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .......+.......+..+.+++.+||+.||++|||++|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          246 SQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             HHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence            222222222222334566889999999999999999999864

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.3e-38  Score=347.92  Aligned_cols=260  Identities=24%  Similarity=0.340  Sum_probs=206.3

Q ss_pred             CCCCceeeecCceEEEEEEeC-----CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC--Ce
Q 039137          640 FNAEHCIGKGGHGSVYRAKVP-----SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP--KH  712 (912)
Q Consensus       640 ~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~  712 (912)
                      |++.+.||+|+||+||+|.++     +++.||||++....   .....+.+.+|+++++.++||||+++++++.+.  ..
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA---GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS  109 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc---ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence            489999999999999988642     68899999997542   223567799999999999999999999999874  67


Q ss_pred             eeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccccc
Q 039137          713 SFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK  792 (912)
Q Consensus       713 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  792 (912)
                      .++||||+++|+|.+++..    ..+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++.
T Consensus       110 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~  182 (318)
T 3lxp_A          110 LQLVMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK  182 (318)
T ss_dssp             EEEEECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             EEEEEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccc
Confidence            8999999999999999944    2489999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCCC---ccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhcccc----c-----cccchhh
Q 039137          793 FLNPDSSN---WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS----S-----SSNMNIE  860 (912)
Q Consensus       793 ~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~----~-----~~~~~~~  860 (912)
                      ........   .....+++.|+|||++.+..++.++||||+|+++|||++|..||........    .     .......
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (318)
T 3lxp_A          183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE  262 (318)
T ss_dssp             ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHH
T ss_pred             cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHH
Confidence            77544321   2345678889999999998899999999999999999999999863221100    0     0000111


Q ss_pred             hccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 039137          861 MLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE  911 (912)
Q Consensus       861 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~~  911 (912)
                      ........+.  ....+..+.+++.+||+.||++|||++|+++.|++...+
T Consensus       263 ~~~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~  311 (318)
T 3lxp_A          263 LLERGERLPR--PDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK  311 (318)
T ss_dssp             HHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHhcccCCCC--CccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHh
Confidence            1111111110  122345688999999999999999999999999987643

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.9e-38  Score=344.38  Aligned_cols=251  Identities=25%  Similarity=0.364  Sum_probs=204.2

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeee
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSF  714 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  714 (912)
                      ..++|.+.+.||+|+||.||+|+.. +|+.||+|++......    ..+.+.+|+++++.++||||+++++++...+..+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF----RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYY   82 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC----------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc----chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEE
Confidence            3467999999999999999999876 7999999998754322    3456889999999999999999999999999999


Q ss_pred             EEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEE---cCCCcEEEeccccc
Q 039137          715 IIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLL---DLGYEAHVSDFGIA  791 (912)
Q Consensus       715 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~Dfgla  791 (912)
                      +||||+++++|.+++..   .+.+++.+++.++.|++.||+|||++   +|+||||||+||++   +.++.+||+|||++
T Consensus        83 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~  156 (304)
T 2jam_A           83 LVMQLVSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLS  156 (304)
T ss_dssp             EEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTT
T ss_pred             EEEEcCCCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcc
Confidence            99999999999999844   34689999999999999999999999   99999999999999   78889999999999


Q ss_pred             cccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCCh
Q 039137          792 KFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSL  871 (912)
Q Consensus       792 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  871 (912)
                      .....  .......|++.|+|||++.+..++.++||||+|+++|||++|+.||.....     ......+.......+..
T Consensus       157 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~i~~~~~~~~~~  229 (304)
T 2jam_A          157 KMEQN--GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE-----SKLFEKIKEGYYEFESP  229 (304)
T ss_dssp             CCCCC--BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHHCCCCCCTT
T ss_pred             eecCC--CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHcCCCCCCcc
Confidence            75432  223445689999999999999999999999999999999999999852211     11111222222222222


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          872 HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       872 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .....+..+.+++.+||+.||++|||++|+++
T Consensus       230 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          230 FWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             TTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            22334566889999999999999999999875

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=3.9e-38  Score=340.38  Aligned_cols=253  Identities=25%  Similarity=0.341  Sum_probs=199.5

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ++|.....||+|+||.||+|++. +++.||+|++.....    ...+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   97 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS----RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIF   97 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC-------HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch----HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEE
Confidence            34555669999999999999875 788999999875422    2456788999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcC-CCcEEEeccccccccC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDL-GYEAHVSDFGIAKFLN  795 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~Dfgla~~~~  795 (912)
                      |||+++++|.+++........+++..+..++.|++.||+|||++   +|+||||||+||+++. ++.+||+|||.+....
T Consensus        98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~  174 (295)
T 2clq_A           98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA  174 (295)
T ss_dssp             EECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred             EEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccC
Confidence            99999999999997654455678999999999999999999999   9999999999999987 8999999999998765


Q ss_pred             CCCCCccccccccccccccccccCC--CCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhh
Q 039137          796 PDSSNWSELAGTHGYVAPELAYTLK--VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHV  873 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  873 (912)
                      ..........|++.|+|||++.+..  ++.++||||||+++|+|++|+.||.........  .............+    
T Consensus       175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~----  248 (295)
T 2clq_A          175 GINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA--MFKVGMFKVHPEIP----  248 (295)
T ss_dssp             C-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH--HHHHHHHCCCCCCC----
T ss_pred             CCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH--HHhhcccccccccc----
Confidence            5444445567899999999987653  789999999999999999999998532111000  00000111111111    


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          874 QKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       874 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ...+..+.+++.+||+.||++|||++|+++
T Consensus       249 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          249 ESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             TTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            123456789999999999999999998864

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2.4e-38  Score=345.17  Aligned_cols=263  Identities=24%  Similarity=0.373  Sum_probs=201.0

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC----CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCC
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP----SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPK  711 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~  711 (912)
                      ..++|.+.+.||+|+||.||+|+..    +++.||+|++......  ....+.+.+|+.+++.++||||+++++++...+
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  109 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSS--QREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS  109 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCC--HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccc--hhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence            4567899999999999999999764    3457999998754322  234577899999999999999999999997755


Q ss_pred             -----eeeEEEeecCCCChhhHhhcc---CCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcE
Q 039137          712 -----HSFIIYEYLESGSLDKILCND---ASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEA  783 (912)
Q Consensus       712 -----~~~lv~e~~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  783 (912)
                           ..++||||+++|+|.+++...   .....+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+
T Consensus       110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~  186 (313)
T 3brb_A          110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTV  186 (313)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCE
T ss_pred             ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcE
Confidence                 359999999999999998433   2345699999999999999999999999   99999999999999999999


Q ss_pred             EEeccccccccCCCCC--CccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhh
Q 039137          784 HVSDFGIAKFLNPDSS--NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIE  860 (912)
Q Consensus       784 kl~Dfgla~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~  860 (912)
                      ||+|||++........  ......+++.|+|||.+.+..++.++||||||+++|||++ |..||.....     ......
T Consensus       187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----~~~~~~  261 (313)
T 3brb_A          187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN-----HEMYDY  261 (313)
T ss_dssp             EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----GGHHHH
T ss_pred             EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH-----HHHHHH
Confidence            9999999986644321  1233457889999999999999999999999999999999 8899853211     111111


Q ss_pred             hccCC-CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 039137          861 MLDSR-LPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFEV  912 (912)
Q Consensus       861 ~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~~~  912 (912)
                      ..... ...+    ...+..+.+++.+||+.||++|||++++++.|++.+.++
T Consensus       262 ~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l  310 (313)
T 3brb_A          262 LLHGHRLKQP----EDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL  310 (313)
T ss_dssp             HHTTCCCCCB----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             HHcCCCCCCC----ccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence            11111 1111    223456889999999999999999999999999987653

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.1e-38  Score=365.10  Aligned_cols=256  Identities=26%  Similarity=0.435  Sum_probs=204.0

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      ..++|++.+.||+|+||+||+|+++.+..||||++.....     ..+++.+|++++++++||||+++++++.. +..++
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~i  255 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI  255 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-----CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEE
Confidence            3467889999999999999999998888899999875432     35678999999999999999999999876 77899


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ||||+++|+|.+++... ....+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus       256 v~e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  331 (452)
T 1fmk_A          256 VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIE  331 (452)
T ss_dssp             EECCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred             EehhhcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence            99999999999999532 234589999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCC-CccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccC-CCCCCChh
Q 039137          796 PDSS-NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDS-RLPYPSLH  872 (912)
Q Consensus       796 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  872 (912)
                      .... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||......     .....+... +.+.+.  
T Consensus       332 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~-----~~~~~i~~~~~~~~~~--  404 (452)
T 1fmk_A          332 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----EVLDQVERGYRMPCPP--  404 (452)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----HHHHHHHTTCCCCCCT--
T ss_pred             CCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHHcCCCCCCCC--
Confidence            4322 1233456789999999998899999999999999999999 99998532110     111111111 222221  


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          873 VQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       873 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                        ..+..+.+++.+||+.||++|||++++++.|++.+.
T Consensus       405 --~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~  440 (452)
T 1fmk_A          405 --ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  440 (452)
T ss_dssp             --TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             --CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence              234568899999999999999999999999988653

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=5.7e-38  Score=346.81  Aligned_cols=265  Identities=25%  Similarity=0.364  Sum_probs=209.0

Q ss_pred             HHHHHhcCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhh--cCCCccccEEEEEEc
Q 039137          632 EIISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTE--IRHRNIVKFYGFCSH  709 (912)
Q Consensus       632 e~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~--l~h~niv~l~~~~~~  709 (912)
                      ......++|++.+.||+|+||.||+|++ +++.||||++...       ..+.+.+|+++++.  ++||||+++++++..
T Consensus        36 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~-------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~  107 (342)
T 1b6c_B           36 VQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR-------EERSWFREAEIYQTVMLRHENILGFIAADNK  107 (342)
T ss_dssp             HHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG-------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred             ecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch-------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence            3345567899999999999999999998 6899999998532       34567789998887  689999999999988


Q ss_pred             CC----eeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeeecCCCCCCeEE
Q 039137          710 PK----HSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLH--------NNCFPPIVHRDISSKNVLL  777 (912)
Q Consensus       710 ~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--------~~~~~~ivH~Dlk~~Nill  777 (912)
                      .+    ..++||||+++|+|.+++..    ..+++.+++.++.|++.||+|||        ++   +|+||||||+||++
T Consensus       108 ~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll  180 (342)
T 1b6c_B          108 DNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILV  180 (342)
T ss_dssp             CCSSCCCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEE
T ss_pred             cCCccceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEE
Confidence            76    78999999999999999954    35899999999999999999999        77   99999999999999


Q ss_pred             cCCCcEEEeccccccccCCCCCC----ccccccccccccccccccCC------CCcchhHHHHHHHHHHHHhC-------
Q 039137          778 DLGYEAHVSDFGIAKFLNPDSSN----WSELAGTHGYVAPELAYTLK------VTEKCDVYSFGVLALEVIKG-------  840 (912)
Q Consensus       778 ~~~~~~kl~Dfgla~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~------~~~~sDvwslG~vl~elltg-------  840 (912)
                      +.++.+||+|||++.........    .....|++.|+|||++.+..      ++.++||||||+++|||++|       
T Consensus       181 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~  260 (342)
T 1b6c_B          181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH  260 (342)
T ss_dssp             CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred             CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcc
Confidence            99999999999999876544321    24457899999999987652      34689999999999999999       


Q ss_pred             ---CCCccchhccccccccchhhhccCCC--CCCC-hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 039137          841 ---KHPRDFLFEMSSSSSNMNIEMLDSRL--PYPS-LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE  911 (912)
Q Consensus       841 ---~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~~  911 (912)
                         +.||......................  ..+. .........+.+++.+||+.||++|||+.|+++.|++...+
T Consensus       261 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~  337 (342)
T 1b6c_B          261 EDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  337 (342)
T ss_dssp             CCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             cccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence               67765322111111111111111111  1111 11234566789999999999999999999999999987654

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.4e-38  Score=344.08  Aligned_cols=263  Identities=17%  Similarity=0.261  Sum_probs=202.5

Q ss_pred             HHhcCCCCCceeeecCceEEEEEEe-CCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEE-EcCCe
Q 039137          635 SATNDFNAEHCIGKGGHGSVYRAKV-PSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFC-SHPKH  712 (912)
Q Consensus       635 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~-~~~~~  712 (912)
                      ...++|++.+.||+|+||+||+|++ .+++.||+|++.....      .+.+.+|+++++.++|++++..++++ ...+.
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~   79 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK------HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDY   79 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTE
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc------chHHHHHHHHHHHhcCCCCCCeeeeecCCCCc
Confidence            3457899999999999999999987 4789999998754332      23467899999999988777666655 66778


Q ss_pred             eeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEE---cCCCcEEEeccc
Q 039137          713 SFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLL---DLGYEAHVSDFG  789 (912)
Q Consensus       713 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~Dfg  789 (912)
                      .++||||+ +++|.+++...  ...+++.+++.++.|++.||+|||++   +|+||||||+||++   +.++.+||+|||
T Consensus        80 ~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg  153 (296)
T 4hgt_A           80 NVMVMELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFG  153 (296)
T ss_dssp             EEEEEECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCT
T ss_pred             eEEEEEcc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCc
Confidence            89999999 88999998532  34689999999999999999999999   99999999999999   788999999999


Q ss_pred             cccccCCCCC-------CccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhc
Q 039137          790 IAKFLNPDSS-------NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEML  862 (912)
Q Consensus       790 la~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~  862 (912)
                      +++.......       ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.........  .......
T Consensus       154 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~  231 (296)
T 4hgt_A          154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR--QKYERIS  231 (296)
T ss_dssp             TCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS--SHHHHHH
T ss_pred             cceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhh--hhhhhhh
Confidence            9987654432       223567899999999999999999999999999999999999998632221111  1111111


Q ss_pred             cCCCCCCC-hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 039137          863 DSRLPYPS-LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE  911 (912)
Q Consensus       863 ~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~~  911 (912)
                      ......+. ......+..+.+++.+||+.||++|||++++++.|++.+.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~  281 (296)
T 4hgt_A          232 EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  281 (296)
T ss_dssp             HHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             cccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHH
Confidence            11111110 00112245688999999999999999999999999987653

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2.3e-38  Score=352.59  Aligned_cols=199  Identities=26%  Similarity=0.322  Sum_probs=175.2

Q ss_pred             HHHhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcC-----CCccccEEEEE
Q 039137          634 ISATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR-----HRNIVKFYGFC  707 (912)
Q Consensus       634 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-----h~niv~l~~~~  707 (912)
                      ....++|++.+.||+|+||+||+|++. +++.||||++...     ....+.+.+|+++++.++     ||||+++++++
T Consensus        31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~  105 (360)
T 3llt_A           31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-----KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKF  105 (360)
T ss_dssp             CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEE
T ss_pred             eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-----hhhhhhhHHHHHHHHHhcccCCCCCCeeccccee
Confidence            344678999999999999999999875 7899999998632     224566788999999996     99999999999


Q ss_pred             EcCCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcC--------
Q 039137          708 SHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDL--------  779 (912)
Q Consensus       708 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~--------  779 (912)
                      ...+..++||||+ +++|.+++.... ...+++.+++.++.||+.||+|||++   +|+||||||+||+++.        
T Consensus       106 ~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~  180 (360)
T 3llt_A          106 MYYDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLI  180 (360)
T ss_dssp             EETTEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEE
T ss_pred             eECCeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEcccccccccc
Confidence            9999999999999 889999995533 34589999999999999999999999   9999999999999975        


Q ss_pred             -----------------CCcEEEeccccccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCC
Q 039137          780 -----------------GYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKH  842 (912)
Q Consensus       780 -----------------~~~~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~  842 (912)
                                       ++.+||+|||+++.....   .....||+.|+|||++.+..++.++||||+||++|||++|+.
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~  257 (360)
T 3llt_A          181 TVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSL  257 (360)
T ss_dssp             EEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred             chhcccccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCC
Confidence                             788999999999865432   235678999999999999999999999999999999999999


Q ss_pred             Ccc
Q 039137          843 PRD  845 (912)
Q Consensus       843 pf~  845 (912)
                      ||.
T Consensus       258 pf~  260 (360)
T 3llt_A          258 LFR  260 (360)
T ss_dssp             SCC
T ss_pred             CCC
Confidence            985

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=3.1e-39  Score=357.08  Aligned_cols=264  Identities=20%  Similarity=0.259  Sum_probs=199.4

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC----CCCEEEEEEccCCCCCCch-------HHHHHHHHHHHHHhhcCCCccccEEE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP----SGEIFAVKKFHSPLPGEMS-------FQQEEFLNEIQALTEIRHRNIVKFYG  705 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~-------~~~~~~~~Ei~~l~~l~h~niv~l~~  705 (912)
                      .++|++.+.||+|+||+||+|++.    +++.||+|++.........       ...+.+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            367999999999999999999875    5788999998754321100       01234678889999999999999999


Q ss_pred             EEEc----CCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCC
Q 039137          706 FCSH----PKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGY  781 (912)
Q Consensus       706 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~  781 (912)
                      ++..    ....++||||+ +++|.+++...   +.+++.+++.++.||+.||+|||++   +|+||||||+||+++.++
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~  188 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN---GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKN  188 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGG---GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCC
Confidence            9987    67899999999 99999999443   3799999999999999999999999   999999999999999887


Q ss_pred             --cEEEeccccccccCCCC-------CCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhcccc
Q 039137          782 --EAHVSDFGIAKFLNPDS-------SNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS  852 (912)
Q Consensus       782 --~~kl~Dfgla~~~~~~~-------~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~  852 (912)
                        .+||+|||+++.+....       .......||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus       189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~  268 (345)
T 2v62_A          189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV  268 (345)
T ss_dssp             TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred             CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence              99999999998764321       112455789999999999999999999999999999999999999852111100


Q ss_pred             ccccchhhhccCCCCCCChhhH-----HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          853 SSSNMNIEMLDSRLPYPSLHVQ-----KKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       853 ~~~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                      ........ .....  +.....     ..+..+.+++.+||+.||++|||++++++.|++.-+
T Consensus       269 ~~~~~~~~-~~~~~--~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          269 AVQTAKTN-LLDEL--PQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             HHHHHHHH-HHHTT--THHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             HHHHHHHh-hcccc--cHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            00000000 00111  100000     234568899999999999999999999999987543

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.8e-38  Score=350.66  Aligned_cols=250  Identities=22%  Similarity=0.382  Sum_probs=196.3

Q ss_pred             hcCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCC--CccccEEEEEEcCCeee
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH--RNIVKFYGFCSHPKHSF  714 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h--~niv~l~~~~~~~~~~~  714 (912)
                      .++|++.+.||+|+||.||+|...+++.||||++.....  .....+.+.+|+.+++.++|  |||+++++++..++..+
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~   85 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY   85 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeecccc--chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence            457999999999999999999998999999999875432  23345778999999999976  99999999999999999


Q ss_pred             EEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccccccc
Q 039137          715 IIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL  794 (912)
Q Consensus       715 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  794 (912)
                      +||| +.+++|.+++..   ...+++.++..++.|++.||+|||++   +|+||||||+||+++ ++.+||+|||+++..
T Consensus        86 lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~  157 (343)
T 3dbq_A           86 MVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQM  157 (343)
T ss_dssp             EEEC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred             EEEe-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence            9999 567899999954   34689999999999999999999999   999999999999997 578999999999876


Q ss_pred             CCCCC--Ccccccccccccccccccc-----------CCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhh
Q 039137          795 NPDSS--NWSELAGTHGYVAPELAYT-----------LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEM  861 (912)
Q Consensus       795 ~~~~~--~~~~~~g~~~y~aPE~~~~-----------~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~  861 (912)
                      .....  ......||+.|+|||++.+           ..++.++|||||||++|||++|+.||......    .......
T Consensus       158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----~~~~~~~  233 (343)
T 3dbq_A          158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ----ISKLHAI  233 (343)
T ss_dssp             ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH----HHHHHHH
T ss_pred             CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH----HHHHHHH
Confidence            54332  2335679999999999865           66889999999999999999999998632111    0111111


Q ss_pred             ccCC--CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 039137          862 LDSR--LPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQL  904 (912)
Q Consensus       862 ~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  904 (912)
                      .+..  ...+..    .+..+.+++.+||+.||.+|||+.|+++.
T Consensus       234 ~~~~~~~~~~~~----~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          234 IDPNHEIEFPDI----PEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             HCTTSCCCCCCC----SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hcCCcccCCccc----CCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            1111  112211    12457899999999999999999998753

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.6e-39  Score=367.83  Aligned_cols=261  Identities=20%  Similarity=0.274  Sum_probs=205.1

Q ss_pred             HHHHHHhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEc
Q 039137          631 EEIISATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSH  709 (912)
Q Consensus       631 ~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~  709 (912)
                      .++....++|++.+.||+|+||+||+|+++ +++.||+|++....... ....+.+.+|..++..++||||+++++++.+
T Consensus        67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  145 (437)
T 4aw2_A           67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLK-RAETACFREERDVLVNGDSKWITTLHYAFQD  145 (437)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH-TTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhh-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            344445689999999999999999999987 57899999985321000 0012337889999999999999999999999


Q ss_pred             CCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccc
Q 039137          710 PKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFG  789 (912)
Q Consensus       710 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  789 (912)
                      ++..|+||||+++|+|.+++...  ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus       146 ~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFG  220 (437)
T 4aw2_A          146 DNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFG  220 (437)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchh
Confidence            99999999999999999999542  35689999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCCC-ccccccccccccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhcc
Q 039137          790 IAKFLNPDSSN-WSELAGTHGYVAPELAY-----TLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLD  863 (912)
Q Consensus       790 la~~~~~~~~~-~~~~~g~~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~  863 (912)
                      +|+........ .....||+.|+|||++.     ...++.++||||+||++|||++|+.||......     .....+..
T Consensus       221 la~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~-----~~~~~i~~  295 (437)
T 4aw2_A          221 SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-----ETYGKIMN  295 (437)
T ss_dssp             TCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHHHT
T ss_pred             hhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh-----HHHHhhhh
Confidence            99876544332 23467999999999987     456899999999999999999999998622111     11111111


Q ss_pred             --CCCCCCChhhHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 039137          864 --SRLPYPSLHVQKKLMSIMQVAFSCLDQNPES--RPTMKRVSQ  903 (912)
Q Consensus       864 --~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~  903 (912)
                        ....++.. ....+..+.++|.+|+..+|++  ||+++|+++
T Consensus       296 ~~~~~~~p~~-~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          296 HKERFQFPTQ-VTDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             HHHHCCCCSS-CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             ccccccCCcc-cccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence              11222211 1123456789999999988888  999998764

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-38  Score=353.97  Aligned_cols=258  Identities=23%  Similarity=0.360  Sum_probs=195.3

Q ss_pred             cCCCCCceeeecCceEEEEEEeC--C--CCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEc-CCe
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP--S--GEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSH-PKH  712 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~--~--~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-~~~  712 (912)
                      ..|++.+.||+|+||+||+|++.  +  +..||+|.+....   .....+++.+|+.++++++||||+++++++.. .+.
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~  165 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT---DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS  165 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS---CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSC
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCC
Confidence            34677889999999999999864  2  2368999886432   22356789999999999999999999999754 567


Q ss_pred             eeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccccc
Q 039137          713 SFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK  792 (912)
Q Consensus       713 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  792 (912)
                      .++||||+++|+|.+++...  ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus       166 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~  240 (373)
T 3c1x_A          166 PLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLAR  240 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred             eEEEEECCCCCCHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccc
Confidence            89999999999999999542  34578999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCC----CccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccCCCC
Q 039137          793 FLNPDSS----NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDSRLP  867 (912)
Q Consensus       793 ~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  867 (912)
                      .......    ......+++.|+|||++.+..++.++||||||+++|||++ |.+||.....     .............
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~-----~~~~~~~~~~~~~  315 (373)
T 3c1x_A          241 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-----FDITVYLLQGRRL  315 (373)
T ss_dssp             -----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS-----SCHHHHHHTTCCC
T ss_pred             cccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH-----HHHHHHHHcCCCC
Confidence            6643321    1233456789999999999999999999999999999999 6777652211     1111112222211


Q ss_pred             CCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 039137          868 YPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE  911 (912)
Q Consensus       868 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~~  911 (912)
                      ..+   ...+..+.+++.+||+.||++|||++|+++.|++.+..
T Consensus       316 ~~p---~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~  356 (373)
T 3c1x_A          316 LQP---EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  356 (373)
T ss_dssp             CCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            111   12345688999999999999999999999999987653

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.9e-38  Score=367.35  Aligned_cols=253  Identities=23%  Similarity=0.373  Sum_probs=206.6

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeee
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSF  714 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  714 (912)
                      ..++|++.+.||+|+||+||+|+++ +++.||||++.......  ...+.+.+|+++++.++||||+++++++...+..+
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   97 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN--KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc--hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEE
Confidence            3467999999999999999999876 78999999985432111  13567889999999999999999999999999999


Q ss_pred             EEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEc---CCCcEEEeccccc
Q 039137          715 IIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLD---LGYEAHVSDFGIA  791 (912)
Q Consensus       715 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~---~~~~~kl~Dfgla  791 (912)
                      +||||+++|+|.+.+...   ..+++.+++.++.|++.||+|||++   +|+||||||+||+++   .++.+||+|||++
T Consensus        98 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a  171 (486)
T 3mwu_A           98 IVGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS  171 (486)
T ss_dssp             EEECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCT
T ss_pred             EEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcC
Confidence            999999999999988443   4689999999999999999999999   999999999999995   4567999999999


Q ss_pred             cccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCCh
Q 039137          792 KFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSL  871 (912)
Q Consensus       792 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  871 (912)
                      +..... .......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.....     ......+.......+..
T Consensus       172 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~~i~~~~~~~~~~  244 (486)
T 3mwu_A          172 TCFQQN-TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-----YDILKRVETGKYAFDLP  244 (486)
T ss_dssp             TTBCCC-----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHTCCCSCSG
T ss_pred             eECCCC-CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCCCCCCc
Confidence            876543 33445679999999999876 599999999999999999999999852211     11222233333333333


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          872 HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       872 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .....+..+.++|.+||+.||.+|||+.|+++
T Consensus       245 ~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          245 QWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (486)
T ss_dssp             GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            44455677889999999999999999999886

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-38  Score=350.06  Aligned_cols=264  Identities=21%  Similarity=0.276  Sum_probs=197.6

Q ss_pred             HHHhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCch-HHHHHHHHHHHHHhhcCCCccccEEEEEEcCC
Q 039137          634 ISATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMS-FQQEEFLNEIQALTEIRHRNIVKFYGFCSHPK  711 (912)
Q Consensus       634 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~  711 (912)
                      ....++|++.+.||+|+||.||+|++. +|+.||+|++......... ...+.+.+|+++++.++||||+++++++...+
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS   85 (346)
T ss_dssp             -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence            344678999999999999999999976 6899999998754322211 12346789999999999999999999999999


Q ss_pred             eeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccc
Q 039137          712 HSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIA  791 (912)
Q Consensus       712 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla  791 (912)
                      ..++||||+++ +|.+++..  ....+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++
T Consensus        86 ~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  159 (346)
T 1ua2_A           86 NISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLA  159 (346)
T ss_dssp             CCEEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred             ceEEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccc
Confidence            99999999986 88888843  234688999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCccchhccccccc------cchhhhc--
Q 039137          792 KFLNPDSSNWSELAGTHGYVAPELAYTL-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSS------NMNIEML--  862 (912)
Q Consensus       792 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~------~~~~~~~--  862 (912)
                      +.............+|+.|+|||++.+. .++.++|||||||++|||++|.+||...........      ......+  
T Consensus       160 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  239 (346)
T 1ua2_A          160 KSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD  239 (346)
T ss_dssp             STTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSS
T ss_pred             eeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhh
Confidence            8776555555667899999999998764 488999999999999999999999853211100000      0000000  


Q ss_pred             ---------cCCCCCCC--hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          863 ---------DSRLPYPS--LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       863 ---------~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                               ....+..+  ......+..+.++|.+||+.||++|||++|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  291 (346)
T 1ua2_A          240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  291 (346)
T ss_dssp             TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence                     00000000  001223456889999999999999999999875

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.1e-38  Score=344.84  Aligned_cols=262  Identities=25%  Similarity=0.335  Sum_probs=197.9

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCC-chHHHHHHHHHHHHHhhcC---CCccccEEEEEEcC
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGE-MSFQQEEFLNEIQALTEIR---HRNIVKFYGFCSHP  710 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~~  710 (912)
                      ..++|++.+.||+|+||+||+|++. +++.||+|++....... .......+.+|+++++.++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            4678999999999999999999974 78999999986433211 1112345667888777774   99999999999775


Q ss_pred             C-----eeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEE
Q 039137          711 K-----HSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHV  785 (912)
Q Consensus       711 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  785 (912)
                      .     ..++||||++ ++|.+++.... ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl  161 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKL  161 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEE
Confidence            5     5799999997 59999985433 34489999999999999999999999   9999999999999999999999


Q ss_pred             eccccccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccc--------
Q 039137          786 SDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNM--------  857 (912)
Q Consensus       786 ~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~--------  857 (912)
                      +|||+++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.............        
T Consensus       162 ~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  240 (308)
T 3g33_A          162 ADFGLARIYSYQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE  240 (308)
T ss_dssp             CSCSCTTTSTTC-CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             eeCccccccCCC-cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            999999876433 33455678999999999999999999999999999999999999985321110000000        


Q ss_pred             ---------hhhhccCCCCCC-ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          858 ---------NIEMLDSRLPYP-SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       858 ---------~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                               .........+.+ .......+..+.+++.+||+.||++|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence                     000000000000 0011123456889999999999999999998875

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=3.8e-38  Score=361.01  Aligned_cols=255  Identities=19%  Similarity=0.273  Sum_probs=195.6

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC-----
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP-----  710 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----  710 (912)
                      .++|++.+.||+|+||+||+|.+. +++.||||++.....  .....+++.+|+.+++.++||||+++++++...     
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~  138 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ--NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE  138 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGG--SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcccc--ChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence            468999999999999999999875 789999999975422  233567788999999999999999999999655     


Q ss_pred             -CeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccc
Q 039137          711 -KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFG  789 (912)
Q Consensus       711 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  789 (912)
                       ...|+||||++++ +.+.+.     ..+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus       139 ~~~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG  209 (464)
T 3ttj_A          139 FQDVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  209 (464)
T ss_dssp             CCEEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred             CCeEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEE
Confidence             3569999999874 655552     2488999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccc----------------
Q 039137          790 IAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS----------------  853 (912)
Q Consensus       790 la~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~----------------  853 (912)
                      +++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.........                
T Consensus       210 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~  288 (464)
T 3ttj_A          210 LARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  288 (464)
T ss_dssp             CC-----C-CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred             eeeecCCC-cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            99876543 3345578999999999999999999999999999999999999999632110000                


Q ss_pred             -cccchhhhccCC----------------CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          854 -SSNMNIEMLDSR----------------LPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       854 -~~~~~~~~~~~~----------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                       ............                .+.........+..+.+++.+||+.||++|||++|+++
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence             000000001111                11112222333667899999999999999999998875

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.2e-38  Score=342.59  Aligned_cols=261  Identities=17%  Similarity=0.263  Sum_probs=205.8

Q ss_pred             hcCCCCCceeeecCceEEEEEEe-CCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEE-EcCCeee
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKV-PSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFC-SHPKHSF  714 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~-~~~~~~~  714 (912)
                      .++|++.+.||+|+||.||+|++ .+++.||+|++.....      .+++.+|+.+++.++|++++..++++ ...+..+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK------HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV   81 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS------CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc------hhHHHHHHHHHHHhhcCCCCCccccccCCCCceE
Confidence            46899999999999999999997 4899999999865432      23577999999999988766666555 6677889


Q ss_pred             EEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEE---cCCCcEEEeccccc
Q 039137          715 IIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLL---DLGYEAHVSDFGIA  791 (912)
Q Consensus       715 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~Dfgla  791 (912)
                      +||||+ +++|.+++...  ...+++.+++.++.|++.||+|||++   +|+||||||+||++   +.++.+||+|||++
T Consensus        82 lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~  155 (296)
T 3uzp_A           82 MVMELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA  155 (296)
T ss_dssp             EEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred             EEEEec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCc
Confidence            999999 88999999532  34689999999999999999999999   99999999999999   48889999999999


Q ss_pred             cccCCCCC-------CccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccC
Q 039137          792 KFLNPDSS-------NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDS  864 (912)
Q Consensus       792 ~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  864 (912)
                      ........       ......|++.|+|||++.+..++.++||||||+++|||++|+.||.........  .........
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~  233 (296)
T 3uzp_A          156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR--QKYERISEK  233 (296)
T ss_dssp             EECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS--SHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhh--hhhhhhccc
Confidence            87655432       124567899999999999999999999999999999999999998632211111  111111111


Q ss_pred             CCCCCC-hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 039137          865 RLPYPS-LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE  911 (912)
Q Consensus       865 ~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~~  911 (912)
                      ....+. ......+..+.+++.+||+.||++|||++++++.|++.+.+
T Consensus       234 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  281 (296)
T 3uzp_A          234 KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  281 (296)
T ss_dssp             HHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             ccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHh
Confidence            111110 01112345688999999999999999999999999988754

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=4.2e-38  Score=350.96  Aligned_cols=251  Identities=15%  Similarity=0.149  Sum_probs=203.3

Q ss_pred             hcCCCCCceeeecCceEEEEEE------eCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcC---CCccccEEEEE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAK------VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR---HRNIVKFYGFC  707 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~  707 (912)
                      .++|.+.+.||+|+||+||+|.      ..+++.||+|++...       ...++.+|+++++.++   |+||+++++++
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~  136 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-------NPWEFYIGTQLMERLKPSMQHMFMKFYSAH  136 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-------CHHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-------ChhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence            4679999999999999999994      347889999998643       2456778888888886   99999999999


Q ss_pred             EcCCeeeEEEeecCCCChhhHhhccC--CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcC------
Q 039137          708 SHPKHSFIIYEYLESGSLDKILCNDA--SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDL------  779 (912)
Q Consensus       708 ~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~------  779 (912)
                      ...+..++||||+++|+|.+++....  ....+++.+++.|+.||+.||+|||++   +|+||||||+||+++.      
T Consensus       137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~  213 (365)
T 3e7e_A          137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQD  213 (365)
T ss_dssp             ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC-
T ss_pred             ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcc
Confidence            99999999999999999999995432  345699999999999999999999999   9999999999999998      


Q ss_pred             -----CCcEEEeccccccccCC--CCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhcccc
Q 039137          780 -----GYEAHVSDFGIAKFLNP--DSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS  852 (912)
Q Consensus       780 -----~~~~kl~Dfgla~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~  852 (912)
                           ++.+||+|||+|+.+..  .........||+.|+|||++.+..++.++|||||||++|||++|+.||....... 
T Consensus       214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-  292 (365)
T 3e7e_A          214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE-  292 (365)
T ss_dssp             -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-
T ss_pred             ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-
Confidence                 89999999999976542  2233455679999999999999999999999999999999999999985221100 


Q ss_pred             ccccchhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCC-CCHHHHHHHHHHhhh
Q 039137          853 SSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESR-PTMKRVSQLLCEKIF  910 (912)
Q Consensus       853 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Pt~~evl~~L~~~l~  910 (912)
                          .   .........     .....+.+++..|++.+|.+| |+++++.+.|++.+.
T Consensus       293 ----~---~~~~~~~~~-----~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~  339 (365)
T 3e7e_A          293 ----C---KPEGLFRRL-----PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ  339 (365)
T ss_dssp             ----E---EECSCCTTC-----SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred             ----e---eechhcccc-----CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence                0   011111111     113346688889999999998 688888888887664

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.3e-38  Score=347.05  Aligned_cols=255  Identities=23%  Similarity=0.394  Sum_probs=199.4

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCE----EEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCC
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEI----FAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPK  711 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~  711 (912)
                      .++|++.+.||+|+||+||+|++. +++.    ||+|.+......   ...+.+.+|+.+++.++||||+++++++..+.
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   90 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP---KANKEILDEAYVMASVDNPHVCRLLGICLTST   90 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSC---CCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCH---HHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC
Confidence            367999999999999999999865 4544    577777543322   24677899999999999999999999998754


Q ss_pred             eeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccc
Q 039137          712 HSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIA  791 (912)
Q Consensus       712 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla  791 (912)
                       .++|+||+++|+|.+++...  ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++
T Consensus        91 -~~~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a  164 (327)
T 3lzb_A           91 -VQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA  164 (327)
T ss_dssp             -EEEEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred             -ceEEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcce
Confidence             78999999999999999553  34689999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCC--ccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccC--CC
Q 039137          792 KFLNPDSSN--WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDS--RL  866 (912)
Q Consensus       792 ~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~--~~  866 (912)
                      +........  .....+++.|+|||++.+..++.++||||||+++|||++ |+.||+.....      ........  ..
T Consensus       165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~------~~~~~~~~~~~~  238 (327)
T 3lzb_A          165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS------EISSILEKGERL  238 (327)
T ss_dssp             ---------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG------GHHHHHHTTCCC
T ss_pred             eEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH------HHHHHHHcCCCC
Confidence            876543222  233456788999999999999999999999999999999 99998632111      11111111  12


Q ss_pred             CCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          867 PYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       867 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                      +.+.    ..+..+.+++.+||+.||.+|||+.|+++.|++...
T Consensus       239 ~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  278 (327)
T 3lzb_A          239 PQPP----ICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             CCCT----TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred             CCCc----cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            2221    234468899999999999999999999999998763

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=5.1e-38  Score=335.95  Aligned_cols=252  Identities=25%  Similarity=0.344  Sum_probs=204.3

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      .++|++.+.||+|+||.||+|+.+ +++.||+|++......   ...+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV---DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL   82 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT---THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch---hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEE
Confidence            467999999999999999999876 7899999998643322   245778999999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ||||+++++|.+++.   ....+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||.+....
T Consensus        83 v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  156 (276)
T 2yex_A           83 FLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR  156 (276)
T ss_dssp             EEECCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred             EEEecCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccC
Confidence            999999999999983   335689999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCC--CCccccccccccccccccccCCC-CcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChh
Q 039137          796 PDS--SNWSELAGTHGYVAPELAYTLKV-TEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLH  872 (912)
Q Consensus       796 ~~~--~~~~~~~g~~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  872 (912)
                      ...  .......|++.|+|||++.+..+ +.++||||||+++|||++|+.||+.....    ..............+  .
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~--~  230 (276)
T 2yex_A          157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS----CQEYSDWKEKKTYLN--P  230 (276)
T ss_dssp             ETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT----SHHHHHHHTTCTTST--T
T ss_pred             CCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH----HHHHHHhhhcccccC--c
Confidence            322  22345678999999999987765 77999999999999999999998632111    001111111111111  1


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          873 VQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       873 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ....+..+.+++.+||+.||++|||++|+++
T Consensus       231 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          231 WKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence            1234456889999999999999999999875

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=3.5e-38  Score=341.33  Aligned_cols=259  Identities=23%  Similarity=0.366  Sum_probs=203.4

Q ss_pred             hcCCCCCceeeecCceEEEEEEeCC----CCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEE-cCC
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVPS----GEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCS-HPK  711 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~-~~~  711 (912)
                      ..+|++.+.||+|+||+||+|++.+    ...||+|.+....   .....+.+.+|+.++++++||||+++++++. .++
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  100 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT---DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG  100 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC---CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC
Confidence            3568889999999999999998642    2358999886532   2235677899999999999999999999964 456


Q ss_pred             eeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccc
Q 039137          712 HSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIA  791 (912)
Q Consensus       712 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla  791 (912)
                      ..++||||+++|+|.+++..  ....+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++
T Consensus       101 ~~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a  175 (298)
T 3f66_A          101 SPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLA  175 (298)
T ss_dssp             CCEEEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGG
T ss_pred             ceEEEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccc
Confidence            78999999999999999954  235688999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCC----CCccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccCCC
Q 039137          792 KFLNPDS----SNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDSRL  866 (912)
Q Consensus       792 ~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  866 (912)
                      +......    .......+++.|+|||.+.+..++.++||||+|+++|||++ |.+||....     .............
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-----~~~~~~~~~~~~~  250 (298)
T 3f66_A          176 RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-----TFDITVYLLQGRR  250 (298)
T ss_dssp             CCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSC-----TTTHHHHHHTTCC
T ss_pred             ccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCC-----HHHHHHHHhcCCC
Confidence            8664332    12234567789999999999999999999999999999999 555654211     1111111122221


Q ss_pred             CCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 039137          867 PYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE  911 (912)
Q Consensus       867 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~~  911 (912)
                      ...+   ...+..+.+++.+||+.||++|||++|+++.|++.+.+
T Consensus       251 ~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  292 (298)
T 3f66_A          251 LLQP---EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  292 (298)
T ss_dssp             CCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCCC---ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            1111   11234588999999999999999999999999998764

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1e-38  Score=343.92  Aligned_cols=250  Identities=22%  Similarity=0.405  Sum_probs=201.0

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CC-------CEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SG-------EIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCS  708 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~  708 (912)
                      .++|++.+.||+|+||+||+|++. ++       ..||+|++....    ....+.+.+|+++++.++||||+++++++.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   82 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH----RNYSESFFEAASMMSKLSHKHLVLNYGVCV   82 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG----GGGHHHHHHHHHHHHTSCCTTBCCEEEEEC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc----HHHHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence            367899999999999999999865 33       469999985422    225678999999999999999999999999


Q ss_pred             cCCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCc------
Q 039137          709 HPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYE------  782 (912)
Q Consensus       709 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~------  782 (912)
                      .++..++||||+++|+|.+++...  ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.      
T Consensus        83 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~  157 (289)
T 4fvq_A           83 CGDENILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNP  157 (289)
T ss_dssp             CTTCCEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBC
T ss_pred             eCCCCEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCccccccc
Confidence            999999999999999999999543  24489999999999999999999999   9999999999999998887      


Q ss_pred             --EEEeccccccccCCCCCCcccccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCC-Cccchhccccccccch
Q 039137          783 --AHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKVTEKCDVYSFGVLALEVIKGKH-PRDFLFEMSSSSSNMN  858 (912)
Q Consensus       783 --~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~-pf~~~~~~~~~~~~~~  858 (912)
                        +||+|||++.....    .....+++.|+|||++.+ ..++.++||||+|+++|||++|.. ||.....      ...
T Consensus       158 ~~~kl~Dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~------~~~  227 (289)
T 4fvq_A          158 PFIKLSDPGISITVLP----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS------QRK  227 (289)
T ss_dssp             CEEEECCCCSCTTTSC----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH------HHH
T ss_pred             ceeeeccCcccccccC----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch------HHH
Confidence              99999999975432    234567899999999887 678999999999999999999554 4431110      111


Q ss_pred             hhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 039137          859 IEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI  909 (912)
Q Consensus       859 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l  909 (912)
                      ..........+..    .+..+.+++.+||+.||++|||++|+++.|++.+
T Consensus       228 ~~~~~~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~  274 (289)
T 4fvq_A          228 LQFYEDRHQLPAP----KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLF  274 (289)
T ss_dssp             HHHHHTTCCCCCC----SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC
T ss_pred             HHHhhccCCCCCC----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            1111111111111    1234778999999999999999999999998754

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=3.2e-38  Score=342.48  Aligned_cols=250  Identities=27%  Similarity=0.419  Sum_probs=207.4

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      .+.|++.+.||+|+||.||+|+.. +++.||+|++.......   ..+.+.+|+.+++.++||||+++++++...+..++
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   97 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED---EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI   97 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCST---THHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHH---HHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence            456999999999999999999865 78999999987553322   46778999999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ||||+++++|.+++..    ..+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++....
T Consensus        98 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~  170 (303)
T 3a7i_A           98 IMEYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT  170 (303)
T ss_dssp             EEECCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECB
T ss_pred             EEEeCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecC
Confidence            9999999999999843    4689999999999999999999999   99999999999999999999999999998776


Q ss_pred             CCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHH
Q 039137          796 PDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQK  875 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  875 (912)
                      ..........|++.|+|||++.+..++.++||||||+++|+|++|+.||.......     ..........+..   ...
T Consensus       171 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~---~~~  242 (303)
T 3a7i_A          171 DTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK-----VLFLIPKNNPPTL---EGN  242 (303)
T ss_dssp             TTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHHHHHHSCCCCC---CSS
T ss_pred             ccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH-----HHHHhhcCCCCCC---ccc
Confidence            55444556678999999999999999999999999999999999999986321110     0011111111111   012


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 039137          876 KLMSIMQVAFSCLDQNPESRPTMKRVSQL  904 (912)
Q Consensus       876 ~~~~l~~li~~cl~~dP~~RPt~~evl~~  904 (912)
                      .+..+.+++.+||+.||++|||+.|+++.
T Consensus       243 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          243 YSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             CCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             cCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            23458899999999999999999999763

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=3.6e-38  Score=365.61  Aligned_cols=252  Identities=22%  Similarity=0.362  Sum_probs=203.3

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      .++|++.+.||+|+||+||+|+++ +++.||+|++........  ..+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  113 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS--SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL  113 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----C--TTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCch--HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            457999999999999999999976 788999999876543222  35678899999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCC---CcEEEecccccc
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLG---YEAHVSDFGIAK  792 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~Dfgla~  792 (912)
                      ||||+++|+|.+.+...   ..+++.+++.++.||+.||+|||++   +|+||||||+||+++..   +.+||+|||+++
T Consensus       114 v~e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~  187 (494)
T 3lij_A          114 VMECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSA  187 (494)
T ss_dssp             EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence            99999999999988443   4689999999999999999999999   99999999999999764   459999999998


Q ss_pred             ccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChh
Q 039137          793 FLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLH  872 (912)
Q Consensus       793 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  872 (912)
                      ..... .......||+.|+|||++.+ .++.++||||+||++|+|++|..||.....     ......+......++...
T Consensus       188 ~~~~~-~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~~i~~~~~~~~~~~  260 (494)
T 3lij_A          188 VFENQ-KKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTD-----QEILRKVEKGKYTFDSPE  260 (494)
T ss_dssp             ECBTT-BCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHTCCCCCSGG
T ss_pred             ECCCC-ccccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCCCCCchh
Confidence            76543 23445679999999998864 699999999999999999999999863211     112222333344444334


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          873 VQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       873 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ....+..+.++|.+||+.||.+|||+.|+++
T Consensus       261 ~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          261 WKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence            4455667889999999999999999999875

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=3.1e-38  Score=354.20  Aligned_cols=248  Identities=22%  Similarity=0.380  Sum_probs=197.1

Q ss_pred             cCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcC--CCccccEEEEEEcCCeeeE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR--HRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~--h~niv~l~~~~~~~~~~~l  715 (912)
                      .+|++.+.||+|+||+||+|...+++.||||++.....  .....+.+.+|+++++.++  ||||+++++++..++..++
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l  133 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  133 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccc--cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence            46999999999999999999988899999999875433  2335678999999999996  5999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ||| +.+++|.+++...   ..+++.+++.++.||+.||+|||++   +|+||||||+||+++ ++.+||+|||+++...
T Consensus       134 v~E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~  205 (390)
T 2zmd_A          134 VME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  205 (390)
T ss_dssp             EEE-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred             EEe-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence            999 5678999999543   3688999999999999999999999   999999999999996 5799999999998765


Q ss_pred             CCCC--Ccccccccccccccccccc-----------CCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhc
Q 039137          796 PDSS--NWSELAGTHGYVAPELAYT-----------LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEML  862 (912)
Q Consensus       796 ~~~~--~~~~~~g~~~y~aPE~~~~-----------~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~  862 (912)
                      ....  ......||+.|+|||++.+           ..++.++|||||||++|||++|+.||......    ........
T Consensus       206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~----~~~~~~~~  281 (390)
T 2zmd_A          206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ----ISKLHAII  281 (390)
T ss_dssp             --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH----HHHHHHHH
T ss_pred             CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH----HHHHHHHh
Confidence            4322  2345679999999999865           36889999999999999999999998532111    01111222


Q ss_pred             cCCC--CCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          863 DSRL--PYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       863 ~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      +...  ..+..    .+..+.+++.+||+.||++|||+.|+++
T Consensus       282 ~~~~~~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          282 DPNHEIEFPDI----PEKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             CTTSCCCCCCC----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CccccCCCCcc----chHHHHHHHHHHcccChhhCCCHHHHhh
Confidence            2221  22211    1345789999999999999999999975

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-38  Score=346.63  Aligned_cols=256  Identities=30%  Similarity=0.470  Sum_probs=201.6

Q ss_pred             cCCCCCceeeecCceEEEEEEeCC-----CCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCe
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVPS-----GEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKH  712 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~  712 (912)
                      ++|++.+.||+|+||+||+|++..     +..||+|++....   .......+.+|+.+++.++||||+++++++...+.
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  120 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY---TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP  120 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC
Confidence            567788999999999999998642     2359999987543   22356678999999999999999999999999999


Q ss_pred             eeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccccc
Q 039137          713 SFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK  792 (912)
Q Consensus       713 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  792 (912)
                      .++||||+++|+|.+++...  ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus       121 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  195 (333)
T 1mqb_A          121 MMIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSR  195 (333)
T ss_dssp             EEEEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             cEEEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcch
Confidence            99999999999999999543  35689999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCCC---ccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccC-CCC
Q 039137          793 FLNPDSSN---WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDS-RLP  867 (912)
Q Consensus       793 ~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~  867 (912)
                      ........   .....+++.|+|||++.+..++.++||||||+++|||++ |+.||.....     ......+... +.+
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-----~~~~~~~~~~~~~~  270 (333)
T 1mqb_A          196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-----HEVMKAINDGFRLP  270 (333)
T ss_dssp             ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHHHHTTCCCC
T ss_pred             hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH-----HHHHHHHHCCCcCC
Confidence            76543221   123345788999999998899999999999999999999 9999852211     1111111111 122


Q ss_pred             CCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          868 YPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       868 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                      .+    ...+..+.+++.+||+.||++||++.++++.|++.+.
T Consensus       271 ~~----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~  309 (333)
T 1mqb_A          271 TP----MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  309 (333)
T ss_dssp             CC----TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             Cc----ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            22    1234568899999999999999999999999998764

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=8.6e-39  Score=350.20  Aligned_cols=257  Identities=17%  Similarity=0.248  Sum_probs=192.0

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ++|++.+.||+|+||+||+|+.. +++.||+|++.......   ....+.+|+++++.++||||+++++++..++..++|
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG---APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV   78 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC---------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccc---cchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence            57999999999999999999976 78999999986543221   122345799999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++ +|.+++...  ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        79 ~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  152 (324)
T 3mtl_A           79 FEYLDK-DLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSI  152 (324)
T ss_dssp             EECCSE-EHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC--
T ss_pred             eccccc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccC
Confidence            999985 888888543  34689999999999999999999999   999999999999999999999999999987655


Q ss_pred             CCCCcccccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCccchhcccccc----------ccch------h
Q 039137          797 DSSNWSELAGTHGYVAPELAYT-LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS----------SNMN------I  859 (912)
Q Consensus       797 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~----------~~~~------~  859 (912)
                      .........+|+.|+|||++.+ ..++.++||||+||++|||++|+.||..........          ....      .
T Consensus       153 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  232 (324)
T 3mtl_A          153 PTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE  232 (324)
T ss_dssp             ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCH
T ss_pred             CccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcch
Confidence            5445556678999999999876 568999999999999999999999986321100000          0000      0


Q ss_pred             hhccCCCC---CC--ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          860 EMLDSRLP---YP--SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       860 ~~~~~~~~---~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .......+   ..  .......+..+.+++.+||+.||++|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            00000000   00  0011123456789999999999999999999875

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.8e-38  Score=340.20  Aligned_cols=257  Identities=25%  Similarity=0.361  Sum_probs=203.3

Q ss_pred             CCCCCceeeecCceEEEEEEeC-C---CCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCee-
Q 039137          639 DFNAEHCIGKGGHGSVYRAKVP-S---GEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHS-  713 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~-  713 (912)
                      .|+..+.||+|+||+||+|++. +   +..||+|++....   .....+.+.+|+.+++.++||||+++++++..++.. 
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   98 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT---EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLP   98 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc---cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCc
Confidence            4666789999999999999853 2   2369999986432   223567889999999999999999999999776655 


Q ss_pred             eEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccc
Q 039137          714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKF  793 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  793 (912)
                      ++||||+.+|+|.+++..  ....+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.
T Consensus        99 ~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~  173 (298)
T 3pls_A           99 HVLLPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARD  173 (298)
T ss_dssp             EEEECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCT
T ss_pred             EEEEecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccc
Confidence            999999999999999954  235688999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCC----CCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccC-CCCC
Q 039137          794 LNPDS----SNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDS-RLPY  868 (912)
Q Consensus       794 ~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~  868 (912)
                      .....    .......+++.|+|||.+.+..++.++||||||+++|+|++|..|+.....    ........... ..+.
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~----~~~~~~~~~~~~~~~~  249 (298)
T 3pls_A          174 ILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID----PFDLTHFLAQGRRLPQ  249 (298)
T ss_dssp             TTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC----GGGHHHHHHTTCCCCC
T ss_pred             ccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC----HHHHHHHhhcCCCCCC
Confidence            54321    223345678999999999999999999999999999999996655321111    11111111111 1111


Q ss_pred             CChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 039137          869 PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE  911 (912)
Q Consensus       869 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~~  911 (912)
                      +    ...+..+.+++.+||+.||.+|||++++++.|++.+.+
T Consensus       250 ~----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  288 (298)
T 3pls_A          250 P----EYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA  288 (298)
T ss_dssp             C----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             C----ccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            1    12335688999999999999999999999999998764

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.4e-38  Score=343.25  Aligned_cols=257  Identities=25%  Similarity=0.375  Sum_probs=204.7

Q ss_pred             hcCCCCCc-eeeecCceEEEEEEe--C-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCe
Q 039137          637 TNDFNAEH-CIGKGGHGSVYRAKV--P-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKH  712 (912)
Q Consensus       637 ~~~~~~~~-~lg~G~~g~Vy~~~~--~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~  712 (912)
                      .++|++.+ .||+|+||+||+|.+  + +++.||||++......  ....+++.+|+++++.++||||+++++++ ..+.
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~   91 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND--PALKDELLAEANVMQQLDNPYIVRMIGIC-EAES   91 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSS
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccC--HHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCC
Confidence            46788888 999999999999954  2 5688999999755322  22467899999999999999999999999 5677


Q ss_pred             eeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccccc
Q 039137          713 SFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK  792 (912)
Q Consensus       713 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  792 (912)
                      .++||||+++++|.+++..   ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++.
T Consensus        92 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  165 (291)
T 1xbb_A           92 WMLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSK  165 (291)
T ss_dssp             EEEEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             cEEEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence            8999999999999999954   34589999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCCC---ccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccC-CCC
Q 039137          793 FLNPDSSN---WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDS-RLP  867 (912)
Q Consensus       793 ~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~  867 (912)
                      ........   .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......     ......... ...
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~~~~~~~~~~  240 (291)
T 1xbb_A          166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-----EVTAMLEKGERMG  240 (291)
T ss_dssp             ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----HHHHHHHTTCCCC
T ss_pred             eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH-----HHHHHHHcCCCCC
Confidence            76544322   122345788999999988889999999999999999999 99998632111     111111111 111


Q ss_pred             CCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 039137          868 YPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE  911 (912)
Q Consensus       868 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~~  911 (912)
                      .+    ...+..+.+++.+||+.||++||++.++++.|++.+.+
T Consensus       241 ~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  280 (291)
T 1xbb_A          241 CP----AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  280 (291)
T ss_dssp             CC----TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             CC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            11    12345688999999999999999999999999987653

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=7.6e-39  Score=370.32  Aligned_cols=256  Identities=22%  Similarity=0.295  Sum_probs=205.7

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      .++|++.+.||+|+||.||+|+++ +|+.||+|++...... .....+.+.+|+++++.++||||+++++++.+.+..|+
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~-~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l  261 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL  261 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhh-hhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence            467999999999999999999876 7999999998542111 01134568899999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ||||+++|+|.+++.... ...+++.+++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus       262 VmEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~  337 (576)
T 2acx_A          262 VLTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP  337 (576)
T ss_dssp             EECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecc
Confidence            999999999999985432 34589999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHH
Q 039137          796 PDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQK  875 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  875 (912)
                      .. .......||+.|+|||++.+..++.++||||+||++|||++|+.||........ ..............++    ..
T Consensus       338 ~~-~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~-~~~i~~~i~~~~~~~p----~~  411 (576)
T 2acx_A          338 EG-QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-REEVERLVKEVPEEYS----ER  411 (576)
T ss_dssp             TT-CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC-HHHHHHHHHHCCCCCC----TT
T ss_pred             cC-ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh-HHHHHHHhhcccccCC----cc
Confidence            43 233456899999999999998999999999999999999999999863211100 0111111112222222    22


Q ss_pred             HHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 039137          876 KLMSIMQVAFSCLDQNPESRP-----TMKRVSQ  903 (912)
Q Consensus       876 ~~~~l~~li~~cl~~dP~~RP-----t~~evl~  903 (912)
                      .+..+.++|.+||+.||++||     +++|+++
T Consensus       412 ~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          412 FSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             CCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence            345688999999999999999     6676653

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.5e-38  Score=345.61  Aligned_cols=267  Identities=22%  Similarity=0.365  Sum_probs=212.6

Q ss_pred             HHHHHHHhcCCCCCceeeecCceEEEEEEe------CCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCcccc
Q 039137          630 YEEIISATNDFNAEHCIGKGGHGSVYRAKV------PSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVK  702 (912)
Q Consensus       630 ~~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~  702 (912)
                      ..++....++|++.+.||+|+||+||+|++      .+++.||||++....   .....+.+.+|+.+++.+ +||||++
T Consensus        19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~   95 (316)
T 2xir_A           19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVN   95 (316)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC---CcHHHHHHHHHHHHHHhcccCCCeee
Confidence            344455578999999999999999999974      356889999987543   222456789999999999 6999999


Q ss_pred             EEEEEEcCC-eeeEEEeecCCCChhhHhhccCC-------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeec
Q 039137          703 FYGFCSHPK-HSFIIYEYLESGSLDKILCNDAS-------------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHR  768 (912)
Q Consensus       703 l~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~  768 (912)
                      +++++..++ ..++||||+++|+|.+++.....             ...+++.+++.++.|++.||+|||++   +|+||
T Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~  172 (316)
T 2xir_A           96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR  172 (316)
T ss_dssp             EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred             EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Ccccc
Confidence            999997654 58999999999999999965432             12388999999999999999999999   99999


Q ss_pred             CCCCCCeEEcCCCcEEEeccccccccCCCCCC--ccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcc
Q 039137          769 DISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN--WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRD  845 (912)
Q Consensus       769 Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~  845 (912)
                      ||||+||+++.++.+||+|||+++........  .....+++.|+|||++.+..++.++||||||+++|||++ |..||.
T Consensus       173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~  252 (316)
T 2xir_A          173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  252 (316)
T ss_dssp             CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence            99999999999999999999999876543322  234567889999999999999999999999999999998 999985


Q ss_pred             chhccccccccchhhhccC-CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          846 FLFEMSSSSSNMNIEMLDS-RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       846 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                      .....    .......... ....+.    ..+..+.+++.+||+.||.+|||+.|+++.|++.+.
T Consensus       253 ~~~~~----~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  310 (316)
T 2xir_A          253 GVKID----EEFCRRLKEGTRMRAPD----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  310 (316)
T ss_dssp             TCCCS----HHHHHHHHHTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccchh----HHHHHHhccCccCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            32110    1111111111 111111    134568899999999999999999999999998764

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=5.4e-38  Score=365.14  Aligned_cols=255  Identities=24%  Similarity=0.353  Sum_probs=206.4

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCc---------hHHHHHHHHHHHHHhhcCCCccccEEE
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEM---------SFQQEEFLNEIQALTEIRHRNIVKFYG  705 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~---------~~~~~~~~~Ei~~l~~l~h~niv~l~~  705 (912)
                      ..++|++.+.||+|+||+||+|+++ +++.||+|++........         ....+.+.+|+.+++.++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            4578999999999999999999976 688999999875432211         123567899999999999999999999


Q ss_pred             EEEcCCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCC---c
Q 039137          706 FCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGY---E  782 (912)
Q Consensus       706 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~---~  782 (912)
                      ++.+++..++||||+++|+|.+++..   ...+++.+++.++.||+.||+|||++   +|+||||||+||+++.++   .
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSS
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCcc
Confidence            99999999999999999999998844   34689999999999999999999999   999999999999999776   6


Q ss_pred             EEEeccccccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhc
Q 039137          783 AHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEML  862 (912)
Q Consensus       783 ~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~  862 (912)
                      +||+|||++...... .......||+.|+|||++.+ .++.++||||+||++|+|++|..||.....     ......+.
T Consensus       188 ~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~~i~  260 (504)
T 3q5i_A          188 IKIVDFGLSSFFSKD-YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQND-----QDIIKKVE  260 (504)
T ss_dssp             EEECCCTTCEECCTT-SCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHH
T ss_pred             EEEEECCCCEEcCCC-CccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHH
Confidence            999999999876543 33455679999999999874 589999999999999999999999863211     12222333


Q ss_pred             cCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          863 DSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       863 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .....++.......+..+.+++.+||+.||.+|||++|+++
T Consensus       261 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          261 KGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             HCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            33444443333445677899999999999999999999875

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.1e-38  Score=347.80  Aligned_cols=258  Identities=25%  Similarity=0.394  Sum_probs=204.7

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCE--EEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEEcCCee
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEI--FAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSHPKHS  713 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~--vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~  713 (912)
                      ++|++.+.||+|+||.||+|++. ++..  +|+|.+......   ...+.+.+|+++++++ +||||+++++++...+..
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  101 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK---DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL  101 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccch---HHHHHHHHHHHHHHhccCCCchhhhceeeeeCCce
Confidence            67999999999999999999875 5654  499988643222   2456788999999999 899999999999999999


Q ss_pred             eEEEeecCCCChhhHhhccC-------------CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCC
Q 039137          714 FIIYEYLESGSLDKILCNDA-------------SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLG  780 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~  780 (912)
                      ++||||+++|+|.+++....             ....+++.+++.++.|++.||+|||++   +|+||||||+||+++.+
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~  178 (327)
T 1fvr_A          102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN  178 (327)
T ss_dssp             EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGG
T ss_pred             EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCC
Confidence            99999999999999996542             234689999999999999999999999   99999999999999999


Q ss_pred             CcEEEeccccccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchh
Q 039137          781 YEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNI  859 (912)
Q Consensus       781 ~~~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~  859 (912)
                      +.+||+|||+++..... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||......     ....
T Consensus       179 ~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-----~~~~  252 (327)
T 1fvr_A          179 YVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----ELYE  252 (327)
T ss_dssp             GCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHH
T ss_pred             CeEEEcccCcCcccccc-ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH-----HHHH
Confidence            99999999999743321 12233456889999999998889999999999999999998 99998532110     1111


Q ss_pred             hhccC-CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 039137          860 EMLDS-RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE  911 (912)
Q Consensus       860 ~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~~  911 (912)
                      ..... ....+    ...+..+.+++.+||+.||++|||++|+++.|++.+.+
T Consensus       253 ~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  301 (327)
T 1fvr_A          253 KLPQGYRLEKP----LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  301 (327)
T ss_dssp             HGGGTCCCCCC----TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HhhcCCCCCCC----CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            11111 11111    12345688999999999999999999999999988754

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.7e-38  Score=350.65  Aligned_cols=248  Identities=26%  Similarity=0.405  Sum_probs=199.9

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      +.|+..+.||+|+||+||+|+.. +++.||||++...... .....+.+.+|+++++.++||||+++++++..++..++|
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  132 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ-SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV  132 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEcccccc-chHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence            45889999999999999999864 7899999998754332 222456789999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+. |++.+++...  ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus       133 ~e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          133 MEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             EECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             EecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence            99998 5788877432  35689999999999999999999999   999999999999999999999999999986643


Q ss_pred             CCCCccccccccccccccccc---cCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhh
Q 039137          797 DSSNWSELAGTHGYVAPELAY---TLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHV  873 (912)
Q Consensus       797 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  873 (912)
                      .    ....||+.|+|||++.   +..++.++|||||||++|||++|+.||.......     ..........+..  ..
T Consensus       207 ~----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-----~~~~~~~~~~~~~--~~  275 (348)
T 1u5q_A          207 A----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-----ALYHIAQNESPAL--QS  275 (348)
T ss_dssp             B----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHHHHHHSCCCCC--CC
T ss_pred             C----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHhcCCCCC--CC
Confidence            2    3457899999999884   5678999999999999999999999985221110     0111111111111  01


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          874 QKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       874 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ...+..+.+++.+||+.||++|||++++++
T Consensus       276 ~~~~~~l~~li~~~l~~dP~~Rps~~~ll~  305 (348)
T 1u5q_A          276 GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  305 (348)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence            123455789999999999999999999875

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=9.6e-39  Score=342.21  Aligned_cols=256  Identities=23%  Similarity=0.371  Sum_probs=204.9

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEc--CCee
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSH--PKHS  713 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~  713 (912)
                      .++|++.+.||+|+||.||+|+.+ +++.||+|++......  ....+.+.+|+++++.++||||+++++++..  .+..
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   82 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT--EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL   82 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC--HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence            468999999999999999999876 7899999999754332  2356789999999999999999999998853  5688


Q ss_pred             eEEEeecCCCChhhHhhccC-CcccCCHHHHHHHHHHHHHHHHHHHhCCCCC-----eeecCCCCCCeEEcCCCcEEEec
Q 039137          714 FIIYEYLESGSLDKILCNDA-SAKELGWTQRLNVIKGVADALFYLHNNCFPP-----IVHRDISSKNVLLDLGYEAHVSD  787 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-----ivH~Dlk~~Nill~~~~~~kl~D  787 (912)
                      ++||||+++++|.+++.... ....+++.+++.++.|++.||+|||++   +     |+||||||+||+++.++.+||+|
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~d  159 (279)
T 2w5a_A           83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGD  159 (279)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECC
T ss_pred             EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEec
Confidence            99999999999999995532 234589999999999999999999998   7     99999999999999999999999


Q ss_pred             cccccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCC
Q 039137          788 FGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLP  867 (912)
Q Consensus       788 fgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  867 (912)
                      ||.++.............|++.|+|||++.+..++.++||||||+++|+|++|+.||.....     ......+.....+
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~i~~~~~~  234 (279)
T 2w5a_A          160 FGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-----KELAGKIREGKFR  234 (279)
T ss_dssp             CCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHTCCC
T ss_pred             CchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH-----HHHHHHHhhcccc
Confidence            99998765443333455789999999999998899999999999999999999999863211     1111112222221


Q ss_pred             CCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 039137          868 YPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL  905 (912)
Q Consensus       868 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  905 (912)
                      ...   ...+..+.+++.+||+.||++|||++|+++.+
T Consensus       235 ~~~---~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~  269 (279)
T 2w5a_A          235 RIP---YRYSDELNEIITRMLNLKDYHRPSVEEILENP  269 (279)
T ss_dssp             CCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred             cCC---cccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence            111   12345688999999999999999999998754

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.5e-38  Score=349.08  Aligned_cols=263  Identities=24%  Similarity=0.319  Sum_probs=207.8

Q ss_pred             hcCCCCCceeeecCceEEEEEEe-----CCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEE--c
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKV-----PSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCS--H  709 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~--~  709 (912)
                      .++|++.+.||+|+||.||+|++     .+++.||||++...    .....+.+.+|+++++.++||||+++++++.  .
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   97 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS----GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG   97 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC----CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence            36799999999999999999983     36889999998743    2235677899999999999999999999987  4


Q ss_pred             CCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccc
Q 039137          710 PKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFG  789 (912)
Q Consensus       710 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  789 (912)
                      .+..++||||+++++|.+++...  ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg  172 (327)
T 3lxl_A           98 RQSLRLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFG  172 (327)
T ss_dssp             SCEEEEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGG
T ss_pred             CceEEEEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccc
Confidence            45689999999999999999543  24589999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCC---CccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhcccc------ccc---cc
Q 039137          790 IAKFLNPDSS---NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS------SSS---NM  857 (912)
Q Consensus       790 la~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~------~~~---~~  857 (912)
                      ++........   ......+++.|+|||++.+..++.++||||||+++|+|++|+.||........      ...   ..
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  252 (327)
T 3lxl_A          173 LAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR  252 (327)
T ss_dssp             GCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHH
T ss_pred             cceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHH
Confidence            9987654332   12334578889999999998899999999999999999999999853211100      000   00


Q ss_pred             hhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          858 NIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       858 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                      ...........+.  ....+..+.+++.+||+.||++|||++|+++.|++.+.
T Consensus       253 ~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  303 (327)
T 3lxl_A          253 LLELLEEGQRLPA--PPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS  303 (327)
T ss_dssp             HHHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred             HHHHhhcccCCCC--CCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            0111111111110  12234568899999999999999999999999998764

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.2e-38  Score=356.17  Aligned_cols=201  Identities=26%  Similarity=0.446  Sum_probs=164.0

Q ss_pred             HHhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcC-CCccccEEEEEEcCC-
Q 039137          635 SATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR-HRNIVKFYGFCSHPK-  711 (912)
Q Consensus       635 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~-  711 (912)
                      ...++|++.+.||+|+||.||+|.+. +++.||||++......  ....+.+.+|+.+++.+. ||||+++++++..++ 
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~   83 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQN--STDAQRTFREIMILTELSGHENIVNLLNVLRADND   83 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CC--HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccC--hHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCC
Confidence            34578999999999999999999875 7899999998754332  335677889999999997 999999999997654 


Q ss_pred             -eeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccc
Q 039137          712 -HSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGI  790 (912)
Q Consensus       712 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl  790 (912)
                       ..|+||||++ ++|.+++..    ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+
T Consensus        84 ~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~  155 (388)
T 3oz6_A           84 RDVYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGL  155 (388)
T ss_dssp             SCEEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             CEEEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcc
Confidence             6899999998 589988843    4688999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCC---------------------CCCcccccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcc
Q 039137          791 AKFLNPD---------------------SSNWSELAGTHGYVAPELAYT-LKVTEKCDVYSFGVLALEVIKGKHPRD  845 (912)
Q Consensus       791 a~~~~~~---------------------~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~pf~  845 (912)
                      |+.....                     ........||+.|+|||++.+ ..++.++||||+||++|||++|++||.
T Consensus       156 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~  232 (388)
T 3oz6_A          156 SRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFP  232 (388)
T ss_dssp             CEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             cccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCC
Confidence            9865321                     112334679999999999876 678999999999999999999999985

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.7e-39  Score=360.72  Aligned_cols=260  Identities=22%  Similarity=0.250  Sum_probs=203.6

Q ss_pred             HHHHHHhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEc
Q 039137          631 EEIISATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSH  709 (912)
Q Consensus       631 ~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~  709 (912)
                      .+.....++|++.+.||+|+||+||+|+.+ +++.||+|++.+.... .....+.+.+|..++..++||||+++++++.+
T Consensus        54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~-~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  132 (412)
T 2vd5_A           54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDML-KRGEVSCFREERDVLVNGDRRWITQLHFAFQD  132 (412)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhh-hHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence            344445689999999999999999999986 7999999998532110 01123447889999999999999999999999


Q ss_pred             CCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccc
Q 039137          710 PKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFG  789 (912)
Q Consensus       710 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  789 (912)
                      .+..|+||||+++|+|.+++.+..  ..+++..++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus       133 ~~~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFG  207 (412)
T 2vd5_A          133 ENYLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFG  207 (412)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeech
Confidence            999999999999999999995432  3689999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCCC-ccccccccccccccccc-------cCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhh
Q 039137          790 IAKFLNPDSSN-WSELAGTHGYVAPELAY-------TLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEM  861 (912)
Q Consensus       790 la~~~~~~~~~-~~~~~g~~~y~aPE~~~-------~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~  861 (912)
                      +++........ ....+||+.|+|||++.       +..++.++|||||||++|||++|+.||.....     ......+
T Consensus       208 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----~~~~~~i  282 (412)
T 2vd5_A          208 SCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST-----AETYGKI  282 (412)
T ss_dssp             TCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHH
T ss_pred             hheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH-----HHHHHHH
Confidence            99876544332 23468999999999987       35689999999999999999999999852211     1111111


Q ss_pred             cc--CCCCCCChhhHHHHHHHHHHHHHcccCCCCCC---CCHHHHHH
Q 039137          862 LD--SRLPYPSLHVQKKLMSIMQVAFSCLDQNPESR---PTMKRVSQ  903 (912)
Q Consensus       862 ~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Pt~~evl~  903 (912)
                      ..  .....+. .....+..+.++|.+||. +|++|   |+++|+++
T Consensus       283 ~~~~~~~~~p~-~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          283 VHYKEHLSLPL-VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             HTHHHHCCCC-----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             HhcccCcCCCc-cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            11  1111111 112234568899999999 99998   58887753

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=5.1e-38  Score=336.91  Aligned_cols=256  Identities=23%  Similarity=0.345  Sum_probs=203.4

Q ss_pred             hcCCCCCceeeecCceEEEEEEeCC----CCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCe
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVPS----GEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKH  712 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~  712 (912)
                      .++|++.+.||+|+||+||+|++..    +..||+|++....   .....+.+.+|+.+++.++||||+++++++.+ +.
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~   86 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC---TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EP   86 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS---CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SS
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc---CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CC
Confidence            4679999999999999999998542    3459999987542   22356789999999999999999999999865 56


Q ss_pred             eeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccccc
Q 039137          713 SFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK  792 (912)
Q Consensus       713 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  792 (912)
                      .++||||+++++|.+++...  ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++.
T Consensus        87 ~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  161 (281)
T 3cc6_A           87 TWIIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSR  161 (281)
T ss_dssp             CEEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred             CEEEEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCc
Confidence            78999999999999999543  24589999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCC-CccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhcc-CCCCCC
Q 039137          793 FLNPDSS-NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLD-SRLPYP  869 (912)
Q Consensus       793 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~  869 (912)
                      ....... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||......     ........ ...+.+
T Consensus       162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~-----~~~~~~~~~~~~~~~  236 (281)
T 3cc6_A          162 YIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK-----DVIGVLEKGDRLPKP  236 (281)
T ss_dssp             CC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG-----GHHHHHHHTCCCCCC
T ss_pred             ccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH-----HHHHHHhcCCCCCCC
Confidence            7654322 2234456889999999998899999999999999999998 99998522111     11111111 112222


Q ss_pred             ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          870 SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       870 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                      .    ..+..+.+++.+||+.||++|||+.|+++.|++.+.
T Consensus       237 ~----~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  273 (281)
T 3cc6_A          237 D----LCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ  273 (281)
T ss_dssp             T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             C----CCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence            1    234568899999999999999999999999988653

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.6e-38  Score=349.42  Aligned_cols=259  Identities=24%  Similarity=0.389  Sum_probs=198.7

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      .++|++.+.||+|+||.||+|++. +++.||+|++.....  .....+.+.+|+.+++.++||||+++++++...+..++
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  101 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD--DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL  101 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC--chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence            467999999999999999999876 589999999865432  23346678899999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ||||++++++.++...   ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus       102 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  175 (331)
T 4aaa_A          102 VFEFVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLA  175 (331)
T ss_dssp             EEECCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred             EEecCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence            9999999999888733   34589999999999999999999999   99999999999999999999999999998766


Q ss_pred             CCCCCccccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCccchhccccccccc----------------h
Q 039137          796 PDSSNWSELAGTHGYVAPELAYTL-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNM----------------N  858 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~----------------~  858 (912)
                      ..........|++.|+|||++.+. .++.++||||+|+++|+|++|+.||.............                .
T Consensus       176 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (331)
T 4aaa_A          176 APGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN  255 (331)
T ss_dssp             --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred             CCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence            554555566799999999998875 68999999999999999999999986321110000000                0


Q ss_pred             hhhccCCCCC---C---ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          859 IEMLDSRLPY---P---SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       859 ~~~~~~~~~~---~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ........+.   .   .......+..+.+++.+||+.||++|||++|+++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0000000000   0   0011123566889999999999999999998875

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.7e-38  Score=339.60  Aligned_cols=249  Identities=25%  Similarity=0.408  Sum_probs=204.5

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++....... ....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   91 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEK-EGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYL   91 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccch-HHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEE
Confidence            367999999999999999999876 67889999985321110 1124678899999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ||||+++|+|.+++...   +.+++.+++.++.|++.|++|||++   +|+||||||+||+++.++.+||+|||++....
T Consensus        92 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~  165 (284)
T 2vgo_A           92 MLEFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAP  165 (284)
T ss_dssp             EECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred             EEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence            99999999999998543   4589999999999999999999999   99999999999999999999999999997654


Q ss_pred             CCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHH
Q 039137          796 PDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQK  875 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  875 (912)
                      ..  ......|++.|+|||++.+..++.++||||||+++|+|++|+.||+....     ..............+.    .
T Consensus       166 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~----~  234 (284)
T 2vgo_A          166 SL--RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH-----TETHRRIVNVDLKFPP----F  234 (284)
T ss_dssp             SS--CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHHTTCCCCCT----T
T ss_pred             cc--ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH-----hHHHHHHhccccCCCC----c
Confidence            32  23456789999999999999999999999999999999999999863211     1111122222233322    2


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          876 KLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       876 ~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .+..+.+++.+||+.||.+|||++|+++
T Consensus       235 ~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          235 LSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence            3356789999999999999999999875

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=6.5e-38  Score=343.13  Aligned_cols=256  Identities=23%  Similarity=0.296  Sum_probs=199.6

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCC----CchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPG----EMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP  710 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~  710 (912)
                      ..++|++.+.||+|+||.||+|++. +++.||||++......    ........+.+|+++++.++||||+++++++..+
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            3467999999999999999999876 6889999998654321    1111234588999999999999999999999765


Q ss_pred             CeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCc---EEEec
Q 039137          711 KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYE---AHVSD  787 (912)
Q Consensus       711 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~D  787 (912)
                      + .++||||+++++|.+++.   ....+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.   +||+|
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             c-eEEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEcc
Confidence            5 899999999999999984   345689999999999999999999999   9999999999999987664   99999


Q ss_pred             cccccccCCCCCCccccccccccccccccc---cCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccC
Q 039137          788 FGIAKFLNPDSSNWSELAGTHGYVAPELAY---TLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDS  864 (912)
Q Consensus       788 fgla~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  864 (912)
                      ||+++..... .......|++.|+|||++.   ...++.++||||||+++|+|++|+.||......    ..........
T Consensus       161 fg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~  235 (322)
T 2ycf_A          161 FGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ----VSLKDQITSG  235 (322)
T ss_dssp             CTTCEECCCC-HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS----SCHHHHHHHT
T ss_pred             Cccceecccc-cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH----HHHHHHHHhC
Confidence            9999876432 2223456899999999874   466889999999999999999999998622111    1111222223


Q ss_pred             CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          865 RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       865 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .....+......+..+.+++.+||+.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          236 KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            333322222334567889999999999999999999874

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.4e-38  Score=353.02  Aligned_cols=261  Identities=19%  Similarity=0.245  Sum_probs=204.5

Q ss_pred             hcCCCCCceeeecCceEEEEEEeCC---------CCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCcccc-----
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVPS---------GEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVK-----  702 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~-----  702 (912)
                      .++|++.+.||+|+||.||+|++..         ++.||+|++...         +.+.+|++++++++||||++     
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---------~~~~~E~~~l~~l~h~niv~~~~~~  111 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---------GRLFNEQNFFQRAAKPLQVNKWKKL  111 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT---------STHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---------chHHHHHHHHHHhcccchhhhhhhh
Confidence            3679999999999999999998763         789999998643         34678999999999999987     


Q ss_pred             ----------EEEEEEc-CCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCC
Q 039137          703 ----------FYGFCSH-PKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDIS  771 (912)
Q Consensus       703 ----------l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk  771 (912)
                                +++++.. .+..++||||+ +++|.+++... ....+++.+++.++.|++.||+|||++   +|+|||||
T Consensus       112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dik  186 (352)
T 2jii_A          112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVT  186 (352)
T ss_dssp             TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCC
T ss_pred             ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCC
Confidence                      6777765 67899999999 99999999643 235799999999999999999999999   99999999


Q ss_pred             CCCeEEcCCC--cEEEeccccccccCCCCC-------CccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCC
Q 039137          772 SKNVLLDLGY--EAHVSDFGIAKFLNPDSS-------NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKH  842 (912)
Q Consensus       772 ~~Nill~~~~--~~kl~Dfgla~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~  842 (912)
                      |+||+++.++  .+||+|||+++.......       ......||+.|+|||++.+..++.++||||||+++|||++|+.
T Consensus       187 p~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~  266 (352)
T 2jii_A          187 AENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFL  266 (352)
T ss_dssp             GGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCC
T ss_pred             HHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCC
Confidence            9999999998  899999999986653321       1234578999999999999899999999999999999999999


Q ss_pred             CccchhccccccccchhhhccCCCCCCC--hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 039137          843 PRDFLFEMSSSSSNMNIEMLDSRLPYPS--LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE  911 (912)
Q Consensus       843 pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~~  911 (912)
                      ||..........................  ......+..+.+++.+||+.||++|||++++++.|++.+.+
T Consensus       267 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  337 (352)
T 2jii_A          267 PWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD  337 (352)
T ss_dssp             TTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             CcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence            9864321111001111111111111000  00011245688999999999999999999999999998754

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=8e-38  Score=336.64  Aligned_cols=248  Identities=21%  Similarity=0.341  Sum_probs=200.7

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEEcCCee
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSHPKHS  713 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~  713 (912)
                      ..++|++.+.||+|+||+||+|++. +++.||+|++........  ...++.+|+..+..+ +||||+++++++.+++..
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~   86 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSV--DEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM   86 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSH--HHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccH--HHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence            3467999999999999999999986 799999999976543332  467788999999999 899999999999999999


Q ss_pred             eEEEeecCCCChhhHhhccCC-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCC------------
Q 039137          714 FIIYEYLESGSLDKILCNDAS-AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLG------------  780 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~------------  780 (912)
                      ++||||+++++|.+++..... ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.+            
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~  163 (289)
T 1x8b_A           87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDE  163 (289)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC--------------
T ss_pred             EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccc
Confidence            999999999999999955322 25689999999999999999999999   99999999999999844            


Q ss_pred             -------CcEEEeccccccccCCCCCCccccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCccchhcccc
Q 039137          781 -------YEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTL-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS  852 (912)
Q Consensus       781 -------~~~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~  852 (912)
                             ..+||+|||.+.......    ...|++.|+|||++.+. .++.++||||||+++|+|++|.+|+....    
T Consensus       164 ~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----  235 (289)
T 1x8b_A          164 DDWASNKVMFKIGDLGHVTRISSPQ----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD----  235 (289)
T ss_dssp             ------CCCEEECCCTTCEETTCSC----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH----
T ss_pred             ccccCCceEEEEcccccccccCCcc----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh----
Confidence                   479999999998765432    34589999999998765 56689999999999999999998753111    


Q ss_pred             ccccchhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          853 SSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       853 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                          ..........+..+   ...+..+.+++.+||+.||++|||+.|+++
T Consensus       236 ----~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          236 ----QWHEIRQGRLPRIP---QVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             ----HHHHHHTTCCCCCS---SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----HHHHHHcCCCCCCC---cccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence                11111222221111   123356889999999999999999999875

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.8e-38  Score=354.70  Aligned_cols=254  Identities=10%  Similarity=0.011  Sum_probs=184.3

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc--CCCccccEE-------EEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI--RHRNIVKFY-------GFC  707 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l--~h~niv~l~-------~~~  707 (912)
                      .+|++.+.||+|+||+||+|++. +++.||||++...... .....+.+.+|+.+++.+  +||||++++       +++
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAEN-SRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTT-HHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccc-cccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            45889999999999999999976 7899999999875432 223556778886655555  699988755       555


Q ss_pred             EcCC-----------------eeeEEEeecCCCChhhHhhccCCcccCCHHHH------HHHHHHHHHHHHHHHhCCCCC
Q 039137          708 SHPK-----------------HSFIIYEYLESGSLDKILCNDASAKELGWTQR------LNVIKGVADALFYLHNNCFPP  764 (912)
Q Consensus       708 ~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~------~~i~~~i~~~L~~LH~~~~~~  764 (912)
                      ..++                 ..++||||++ |+|.+++....  ..+.+..+      ..++.||+.||+|||++   +
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~  214 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAANLQSK---G  214 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH--HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc--cccchhhhhhhhhHHHHHHHHHHHHHHHHHC---C
Confidence            4432                 3799999999 89999996532  23455555      68889999999999999   9


Q ss_pred             eeecCCCCCCeEEcCCCcEEEeccccccccCCCCCCcccccccccccccccccc--CCCCcchhHHHHHHHHHHHHhCCC
Q 039137          765 IVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT--LKVTEKCDVYSFGVLALEVIKGKH  842 (912)
Q Consensus       765 ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~sDvwslG~vl~elltg~~  842 (912)
                      |+||||||+||+++.++.+||+|||+++.....   .....+++.|+|||++.+  ..++.++|||||||++|||++|+.
T Consensus       215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~  291 (371)
T 3q60_A          215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR---GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL  291 (371)
T ss_dssp             EEETTCSGGGEEECTTSCEEECCGGGEEETTCE---EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred             CccCcCCHHHEEECCCCCEEEEecceeeecCCC---ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence            999999999999999999999999999866422   224567799999999987  679999999999999999999999


Q ss_pred             Cccchhcccccccc--chhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          843 PRDFLFEMSSSSSN--MNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       843 pf~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ||............  ............+  .....+..+.+++.+||+.||++|||+.|+++
T Consensus       292 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          292 PFGLVTPGIKGSWKRPSLRVPGTDSLAFG--SCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             STTBCCTTCTTCCCBCCTTSCCCCSCCCT--TSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCcCcccccchhhhhhhhccccccchh--hccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            98643221111000  0011111111111  11234566889999999999999999999864

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=3.1e-38  Score=338.09  Aligned_cols=250  Identities=27%  Similarity=0.399  Sum_probs=197.4

Q ss_pred             hcCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC-CeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP-KHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-~~~~l  715 (912)
                      .++|++.+.||+|+||+||+|++ +++.||+|++....      ..+.+.+|+++++.++||||+++++++... +..++
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~l   92 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI   92 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC--------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred             hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh------HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEE
Confidence            46799999999999999999988 58899999986432      356788999999999999999999997554 57899


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ||||+++++|.+++.... ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++....
T Consensus        93 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~  168 (278)
T 1byg_A           93 VTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  168 (278)
T ss_dssp             EECCCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred             EEecCCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccc
Confidence            999999999999995432 23478999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccC-CCCCCChhh
Q 039137          796 PDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDS-RLPYPSLHV  873 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  873 (912)
                      ..   .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....     .......... ....+    
T Consensus       169 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-----~~~~~~~~~~~~~~~~----  236 (278)
T 1byg_A          169 ST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----KDVVPRVEKGYKMDAP----  236 (278)
T ss_dssp             ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-----GGHHHHHTTTCCCCCC----
T ss_pred             cc---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHhcCCCCCCc----
Confidence            32   223457889999999998899999999999999999998 9999863211     1111111111 11111    


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 039137          874 QKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI  909 (912)
Q Consensus       874 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l  909 (912)
                      ...+..+.+++.+||+.||++|||+.|+++.|++..
T Consensus       237 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~  272 (278)
T 1byg_A          237 DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  272 (278)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence            223456889999999999999999999999998864

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.6e-37  Score=336.24  Aligned_cols=256  Identities=21%  Similarity=0.341  Sum_probs=208.0

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCc-----hHHHHHHHHHHHHHhhcC-CCccccEEEEEE
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEM-----SFQQEEFLNEIQALTEIR-HRNIVKFYGFCS  708 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-----~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~  708 (912)
                      ..++|++.+.||+|+||.||+|+++ +++.||+|++........     ....+.+.+|++++++++ ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            4578999999999999999999986 789999999875532211     123467889999999995 999999999999


Q ss_pred             cCCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecc
Q 039137          709 HPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDF  788 (912)
Q Consensus       709 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df  788 (912)
                      ..+..++||||+++++|.+++..   ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+||
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df  168 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF  168 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred             cCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecc
Confidence            99999999999999999999954   34689999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCCCccccccccccccccccc------cCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhc
Q 039137          789 GIAKFLNPDSSNWSELAGTHGYVAPELAY------TLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEML  862 (912)
Q Consensus       789 gla~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~  862 (912)
                      |.+...... .......+++.|+|||++.      ...++.++||||||+++|+|++|+.||.....     ........
T Consensus       169 g~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~~  242 (298)
T 1phk_A          169 GFSCQLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-----MLMLRMIM  242 (298)
T ss_dssp             TTCEECCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHH
T ss_pred             cchhhcCCC-cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH-----HHHHHHHh
Confidence            999876543 2334567899999999875      45688999999999999999999999852211     11111222


Q ss_pred             cCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          863 DSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       863 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ......+.......+..+.+++.+||+.||++|||+.|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          243 SGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             HTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             cCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            22222222222344567889999999999999999999875

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=8e-38  Score=341.25  Aligned_cols=251  Identities=26%  Similarity=0.407  Sum_probs=201.0

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeee
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSF  714 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  714 (912)
                      ..++|++.+.||+|+||.||+|.+. +|+.||+|++....      ..+.+.+|+.+++.++||||+++++++...+..+
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  100 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES------DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLW  100 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS------CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH------HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence            4578999999999999999999876 68999999987532      2456889999999999999999999999999999


Q ss_pred             EEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccccccc
Q 039137          715 IIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL  794 (912)
Q Consensus       715 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  794 (912)
                      +||||+++++|.+++..  ....+++.+++.++.|++.||+|||++   +|+|+||||+||+++.++.+||+|||.+...
T Consensus       101 lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  175 (314)
T 3com_A          101 IVMEYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQL  175 (314)
T ss_dssp             EEEECCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEeecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhh
Confidence            99999999999999853  235689999999999999999999999   9999999999999999999999999999877


Q ss_pred             CCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhH
Q 039137          795 NPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQ  874 (912)
Q Consensus       795 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  874 (912)
                      ...........|++.|+|||.+.+..++.++||||||+++|+|++|+.||.......     ..........+ ......
T Consensus       176 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~-~~~~~~  249 (314)
T 3com_A          176 TDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR-----AIFMIPTNPPP-TFRKPE  249 (314)
T ss_dssp             BTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHHHHHHSCCC-CCSSGG
T ss_pred             hhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHhcCCCc-ccCCcc
Confidence            655444556678999999999999899999999999999999999999986321110     00000011100 000112


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          875 KKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       875 ~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ..+..+.+++.+||+.||.+|||+.++++
T Consensus       250 ~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          250 LWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             GSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            23456889999999999999999999875

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-37  Score=368.96  Aligned_cols=254  Identities=24%  Similarity=0.356  Sum_probs=201.3

Q ss_pred             CCCCc-eeeecCceEEEEEEeC---CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          640 FNAEH-CIGKGGHGSVYRAKVP---SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       640 ~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      +.+.+ .||+|+||.||+|.++   ++..||||+++.....   ...+++.+|+++++.++||||+++++++.. +..++
T Consensus       337 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~l  412 (613)
T 2ozo_A          337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK---ADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML  412 (613)
T ss_dssp             EEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSS---TTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEE
T ss_pred             eeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCCh---HHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEE
Confidence            34444 7999999999999764   4667999999754322   246789999999999999999999999976 56899


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ||||+++|+|.+++...  ...+++.+++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus       413 v~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~  487 (613)
T 2ozo_A          413 VMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALG  487 (613)
T ss_dssp             EEECCTTCBHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred             EEEeCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence            99999999999999442  45689999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCCc---cccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccC-CCCCCC
Q 039137          796 PDSSNW---SELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDS-RLPYPS  870 (912)
Q Consensus       796 ~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~  870 (912)
                      ......   ....+++.|+|||++.+..++.++|||||||++|||++ |+.||.....     ......+... +.+.+.
T Consensus       488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-----~~~~~~i~~~~~~~~p~  562 (613)
T 2ozo_A          488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-----PEVMAFIEQGKRMECPP  562 (613)
T ss_dssp             --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS-----HHHHHHHHTTCCCCCCT
T ss_pred             CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH-----HHHHHHHHcCCCCCCCC
Confidence            432221   22345689999999998999999999999999999998 9999863211     1111111111 222221


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 039137          871 LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE  911 (912)
Q Consensus       871 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~~  911 (912)
                          ..+..+.+++.+||+.||++||++.++++.|+..+..
T Consensus       563 ----~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  599 (613)
T 2ozo_A          563 ----ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  599 (613)
T ss_dssp             ----TCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             ----cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence                2345688999999999999999999999999987653

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=5.4e-38  Score=346.11  Aligned_cols=262  Identities=24%  Similarity=0.363  Sum_probs=196.4

Q ss_pred             hcCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHH--HhhcCCCccccEEEEEEc-----
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQA--LTEIRHRNIVKFYGFCSH-----  709 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~--l~~l~h~niv~l~~~~~~-----  709 (912)
                      .++|++.+.||+|+||+||+|+. +++.||||++...       ....+..|.++  +..++||||+++++++..     
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~-------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~   83 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA-------NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADG   83 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG-------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTS
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc-------chhhHHHHHHHHHHHhccCcchhhheecccccccCC
Confidence            46899999999999999999987 7899999998532       23334444444  555899999999986643     


Q ss_pred             CCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC------CCCeeecCCCCCCeEEcCCCcE
Q 039137          710 PKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNC------FPPIVHRDISSKNVLLDLGYEA  783 (912)
Q Consensus       710 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------~~~ivH~Dlk~~Nill~~~~~~  783 (912)
                      ....++||||+++|+|.+++...    ..++.+++.++.|++.||+|||++.      .++|+||||||+||+++.++.+
T Consensus        84 ~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~  159 (336)
T 3g2f_A           84 RMEYLLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC  159 (336)
T ss_dssp             CEEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCE
T ss_pred             CceEEEEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcE
Confidence            23568999999999999999443    3588999999999999999999873      2389999999999999999999


Q ss_pred             EEeccccccccCCCC--------CCcccccccccccccccccc-------CCCCcchhHHHHHHHHHHHHhCCCCccchh
Q 039137          784 HVSDFGIAKFLNPDS--------SNWSELAGTHGYVAPELAYT-------LKVTEKCDVYSFGVLALEVIKGKHPRDFLF  848 (912)
Q Consensus       784 kl~Dfgla~~~~~~~--------~~~~~~~g~~~y~aPE~~~~-------~~~~~~sDvwslG~vl~elltg~~pf~~~~  848 (912)
                      ||+|||+++......        .......||+.|+|||++.+       ..++.++|||||||++|||++|..||....
T Consensus       160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~  239 (336)
T 3g2f_A          160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE  239 (336)
T ss_dssp             EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred             EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence            999999998765321        11234569999999999876       456679999999999999999987763211


Q ss_pred             ccccccccc-----------------hhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          849 EMSSSSSNM-----------------NIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       849 ~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                      .........                 .........+.........+..+.++|.+||+.||++|||++|+++.|++.+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~  318 (336)
T 3g2f_A          240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM  318 (336)
T ss_dssp             CCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             chhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence            111000000                 00000111111111223355679999999999999999999999999998774

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=4.1e-38  Score=344.04  Aligned_cols=259  Identities=21%  Similarity=0.341  Sum_probs=203.6

Q ss_pred             hcCCCCCceeeecCceEEEEEEe-CCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEE----cCC
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKV-PSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCS----HPK  711 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~----~~~  711 (912)
                      .++|++.+.||+|+||.||+|+. .+++.||+|++...    .....+.+.+|+++++.++||||+++++++.    ...
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH----EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKH  103 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES----SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC----CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCc
Confidence            46799999999999999999987 47999999988542    2235678899999999999999999999986    335


Q ss_pred             eeeEEEeecCCCChhhHhhccC-CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccc
Q 039137          712 HSFIIYEYLESGSLDKILCNDA-SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGI  790 (912)
Q Consensus       712 ~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl  790 (912)
                      ..++||||+++|+|.+++.... ....+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||.
T Consensus       104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~  180 (317)
T 2buj_A          104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGS  180 (317)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred             eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCc
Confidence            7899999999999999985532 345689999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCC---------ccccccccccccccccccCC---CCcchhHHHHHHHHHHHHhCCCCccchhccccccccch
Q 039137          791 AKFLNPDSSN---------WSELAGTHGYVAPELAYTLK---VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMN  858 (912)
Q Consensus       791 a~~~~~~~~~---------~~~~~g~~~y~aPE~~~~~~---~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~  858 (912)
                      +.........         .....|++.|+|||++.+..   ++.++||||||+++|||++|+.||+........   ..
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---~~  257 (317)
T 2buj_A          181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS---VA  257 (317)
T ss_dssp             CEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC---HH
T ss_pred             chhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch---hh
Confidence            8765321111         12345799999999987654   688999999999999999999998643221111   11


Q ss_pred             hhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 039137          859 IEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEK  908 (912)
Q Consensus       859 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  908 (912)
                       .........+.  ....+..+.+++.+||+.||.+|||++++++.|+..
T Consensus       258 -~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~  304 (317)
T 2buj_A          258 -LAVQNQLSIPQ--SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL  304 (317)
T ss_dssp             -HHHHCC--CCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             -HHhhccCCCCc--cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhc
Confidence             11111111111  112345688999999999999999999999999864

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.3e-37  Score=354.40  Aligned_cols=200  Identities=24%  Similarity=0.376  Sum_probs=169.3

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC-----
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP-----  710 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----  710 (912)
                      .++|++.+.||+|+||.||+|+++ +++.||||++.....  .....+++.+|+.+++.++||||+++++++...     
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  102 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFE--DLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF  102 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTT--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhc--ChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence            468999999999999999999876 688999999975432  233567899999999999999999999999766     


Q ss_pred             CeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccc
Q 039137          711 KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGI  790 (912)
Q Consensus       711 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl  790 (912)
                      +..|+||||++ |+|.+++..   ...+++.+++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+
T Consensus       103 ~~~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGl  175 (432)
T 3n9x_A          103 DELYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGL  175 (432)
T ss_dssp             CCEEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             CeEEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCC
Confidence            57899999987 499999843   35689999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCC----------------------Ccccccccccccccccc-ccCCCCcchhHHHHHHHHHHHHhCCCCcc
Q 039137          791 AKFLNPDSS----------------------NWSELAGTHGYVAPELA-YTLKVTEKCDVYSFGVLALEVIKGKHPRD  845 (912)
Q Consensus       791 a~~~~~~~~----------------------~~~~~~g~~~y~aPE~~-~~~~~~~~sDvwslG~vl~elltg~~pf~  845 (912)
                      ++.......                      .....+||+.|+|||++ .+..++.++||||+||++|||++|..||.
T Consensus       176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             CEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            987654321                      23566889999999986 56679999999999999999999766653

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=7.2e-38  Score=343.61  Aligned_cols=259  Identities=25%  Similarity=0.362  Sum_probs=203.7

Q ss_pred             hcCCCCCceeeecCceEEEEEEe------CCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKV------PSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP  710 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~  710 (912)
                      .++|++.+.||+|+||.||+|++      .+++.||||++....   ......++.+|+.+++.++||||+++++++...
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  105 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC---SEQDELDFLMEALIISKFNHQNIVRCIGVSLQS  105 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc---chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence            46799999999999999999984      257789999986432   223566789999999999999999999999999


Q ss_pred             CeeeEEEeecCCCChhhHhhccCC----cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcC---CCcE
Q 039137          711 KHSFIIYEYLESGSLDKILCNDAS----AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDL---GYEA  783 (912)
Q Consensus       711 ~~~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~  783 (912)
                      +..++||||+++++|.+++.....    ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.   +..+
T Consensus       106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~  182 (327)
T 2yfx_A          106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVA  182 (327)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCE
T ss_pred             CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceE
Confidence            999999999999999999965432    24589999999999999999999999   9999999999999994   4469


Q ss_pred             EEeccccccccCCCCC--CccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhh
Q 039137          784 HVSDFGIAKFLNPDSS--NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIE  860 (912)
Q Consensus       784 kl~Dfgla~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~  860 (912)
                      ||+|||++........  ......+++.|+|||++.+..++.++||||||+++|||++ |..||.....     ......
T Consensus       183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----~~~~~~  257 (327)
T 2yfx_A          183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-----QEVLEF  257 (327)
T ss_dssp             EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----HHHHHH
T ss_pred             EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH-----HHHHHH
Confidence            9999999976543321  2234567899999999998899999999999999999998 9999852211     111111


Q ss_pred             hccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 039137          861 MLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI  909 (912)
Q Consensus       861 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l  909 (912)
                      ..........   ...+..+.+++.+||+.||++|||+.++++.|+...
T Consensus       258 ~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          258 VTSGGRMDPP---KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             HHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HhcCCCCCCC---CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence            1111111111   123456889999999999999999999999998764

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.8e-37  Score=334.36  Aligned_cols=249  Identities=22%  Similarity=0.345  Sum_probs=198.2

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEc----CCe
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSH----PKH  712 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~----~~~  712 (912)
                      ..|.+.+.||+|+||+||+|.+. ++..||+|++......  ....+.+.+|+.+++.++||||+++++++..    ...
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  103 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT--KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC  103 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC--HHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence            34788889999999999999875 6889999998654322  2356788999999999999999999999865    356


Q ss_pred             eeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCC--eeecCCCCCCeEEc-CCCcEEEeccc
Q 039137          713 SFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP--IVHRDISSKNVLLD-LGYEAHVSDFG  789 (912)
Q Consensus       713 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlk~~Nill~-~~~~~kl~Dfg  789 (912)
                      .++||||+++++|.+++..   ...+++..++.++.|++.||+|||++   +  |+||||||+||+++ .++.+||+|||
T Consensus       104 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg  177 (290)
T 1t4h_A          104 IVLVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLG  177 (290)
T ss_dssp             EEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred             EEEEEEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCC
Confidence            8999999999999999954   24689999999999999999999999   7  99999999999998 78999999999


Q ss_pred             cccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCC
Q 039137          790 IAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYP  869 (912)
Q Consensus       790 la~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  869 (912)
                      ++.....  .......|++.|+|||++.+ .++.++||||+|+++|+|++|+.||......    ............  +
T Consensus       178 ~~~~~~~--~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----~~~~~~~~~~~~--~  248 (290)
T 1t4h_A          178 LATLKRA--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA----AQIYRRVTSGVK--P  248 (290)
T ss_dssp             GGGGCCT--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH----HHHHHHHTTTCC--C
T ss_pred             Ccccccc--cccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH----HHHHHHHhccCC--c
Confidence            9975433  23345678999999998765 5899999999999999999999998521111    111111111111  1


Q ss_pred             ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          870 SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       870 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .......+..+.+++.+||+.||++|||++|+++
T Consensus       249 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          249 ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            1111222356889999999999999999998875

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=9.2e-38  Score=346.37  Aligned_cols=259  Identities=20%  Similarity=0.303  Sum_probs=197.5

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEc------
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSH------  709 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~------  709 (912)
                      .++|++.+.||+|+||+||+|++. +++.||+|++........  ....+.+|+++++.++||||+++++++..      
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG--FPITALREIKILQLLKHENVVNLIEICRTKASPYN   93 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSS--SCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccccc--chHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence            367999999999999999999975 789999999866543322  34567899999999999999999999976      


Q ss_pred             --CCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEec
Q 039137          710 --PKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSD  787 (912)
Q Consensus       710 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  787 (912)
                        .+..++||||+++ ++.+.+...  ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|
T Consensus        94 ~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~D  167 (351)
T 3mi9_A           94 RCKGSIYLVFDFCEH-DLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLAD  167 (351)
T ss_dssp             ---CEEEEEEECCSE-EHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred             cCCceEEEEEeccCC-CHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEcc
Confidence              3468999999986 777766332  34589999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCC----CCCcccccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCccchhccccc---------
Q 039137          788 FGIAKFLNPD----SSNWSELAGTHGYVAPELAYT-LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS---------  853 (912)
Q Consensus       788 fgla~~~~~~----~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~---------  853 (912)
                      ||+++.....    ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.........         
T Consensus       168 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  247 (351)
T 3mi9_A          168 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS  247 (351)
T ss_dssp             CTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             chhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            9999876532    222345678999999998876 45799999999999999999999998632110000         


Q ss_pred             ------cccchhhhcc---C-CCCCCChh--h--HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          854 ------SSNMNIEMLD---S-RLPYPSLH--V--QKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       854 ------~~~~~~~~~~---~-~~~~~~~~--~--~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                            ..........   . ........  .  ...+..+.+++.+||+.||++|||++|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          248 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             CCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence                  0000000000   0 00000000  0  011345889999999999999999998875

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=4.2e-38  Score=376.16  Aligned_cols=247  Identities=21%  Similarity=0.321  Sum_probs=206.8

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEEcCCee
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSHPKHS  713 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~  713 (912)
                      ..++|++.+.||+|+||.||+|+++ +++.||||++....... ....+.+..|..++..+ +||+|+++++++.+.+..
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~-~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~  417 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ-DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL  417 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHH-TTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEecccccc-HHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence            4578999999999999999999876 68899999986421110 11345678899999988 799999999999999999


Q ss_pred             eEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccc
Q 039137          714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKF  793 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  793 (912)
                      |+||||+++|+|.+++...   +.+++.+++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus       418 ~lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~  491 (674)
T 3pfq_A          418 YFVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE  491 (674)
T ss_dssp             EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred             EEEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeec
Confidence            9999999999999999543   4689999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhh
Q 039137          794 LNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHV  873 (912)
Q Consensus       794 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  873 (912)
                      ............||+.|+|||++.+..++.++|||||||++|||++|+.||...     ........+......++.   
T Consensus       492 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~-----~~~~~~~~i~~~~~~~p~---  563 (674)
T 3pfq_A          492 NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE-----DEDELFQSIMEHNVAYPK---  563 (674)
T ss_dssp             CCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHSSCCCCCT---
T ss_pred             cccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC-----CHHHHHHHHHhCCCCCCc---
Confidence            555555566778999999999999999999999999999999999999998632     112233344444444443   


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCH
Q 039137          874 QKKLMSIMQVAFSCLDQNPESRPTM  898 (912)
Q Consensus       874 ~~~~~~l~~li~~cl~~dP~~RPt~  898 (912)
                       ..+.++.++|.+||+.||++||++
T Consensus       564 -~~s~~~~~li~~lL~~dP~~R~~~  587 (674)
T 3pfq_A          564 -SMSKEAVAICKGLMTKHPGKRLGC  587 (674)
T ss_dssp             -TSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred             -cCCHHHHHHHHHHccCCHHHCCCC
Confidence             234568899999999999999997

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=5.8e-38  Score=335.56  Aligned_cols=250  Identities=24%  Similarity=0.377  Sum_probs=195.4

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      .++|++.+.||+|+||.||+|+++ +++.||+|++...... .....+.+.+|+..++.++||||+++++++..++..++
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIR-SLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM   88 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEecccccc-chhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence            367999999999999999999986 7999999998532110 01134578899999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ||||+++++|.+++...   ..+++.+++.++.|++.||+|||++   +|+|+||||+||+++.++.+||+|||++....
T Consensus        89 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~  162 (276)
T 2h6d_A           89 VMEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS  162 (276)
T ss_dssp             EEECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred             EEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccC
Confidence            99999999999999543   4589999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCCccccccccccccccccccCCC-CcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhH
Q 039137          796 PDSSNWSELAGTHGYVAPELAYTLKV-TEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQ  874 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  874 (912)
                      .. .......+++.|+|||.+.+..+ +.++||||||+++|+|++|+.||+....     ..............+.    
T Consensus       163 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~----  232 (276)
T 2h6d_A          163 DG-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV-----PTLFKKIRGGVFYIPE----  232 (276)
T ss_dssp             C--------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCCCCCCT----
T ss_pred             CC-cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH-----HHHHHHhhcCcccCch----
Confidence            43 22344578999999999988765 6899999999999999999999862111     1111111122222221    


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          875 KKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       875 ~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ..+..+.+++.+||+.||++|||++|+++
T Consensus       233 ~~~~~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          233 YLNRSVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            12345789999999999999999999986

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-37  Score=347.12  Aligned_cols=254  Identities=20%  Similarity=0.316  Sum_probs=194.3

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCC----
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPK----  711 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----  711 (912)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++.....  .....+++.+|+++++.++||||+++++++...+    
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~  101 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ--SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD  101 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS--SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCcccc--CHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcccc
Confidence            467999999999999999999875 799999999976532  2335677899999999999999999999997653    


Q ss_pred             --eeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccc
Q 039137          712 --HSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFG  789 (912)
Q Consensus       712 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  789 (912)
                        ..|+||||+ +++|.+++..    ..+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus       102 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg  173 (367)
T 1cm8_A          102 FTDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG  173 (367)
T ss_dssp             CCCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             CceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeee
Confidence              459999999 7799999854    4589999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCCCcccccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCccchhcccccc------ccchh---
Q 039137          790 IAKFLNPDSSNWSELAGTHGYVAPELAYT-LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS------SNMNI---  859 (912)
Q Consensus       790 la~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~------~~~~~---  859 (912)
                      +++.....   .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||..........      .....   
T Consensus       174 ~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~  250 (367)
T 1cm8_A          174 LARQADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV  250 (367)
T ss_dssp             TCEECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             cccccccc---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            99875432   345678999999999877 679999999999999999999999986321110000      00000   


Q ss_pred             ---------hhcc--CCCCCC--ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          860 ---------EMLD--SRLPYP--SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       860 ---------~~~~--~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                               ....  ......  .......+..+.+++.+||+.||++|||++|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence                     0000  000000  0001123456889999999999999999998876

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1e-37  Score=358.77  Aligned_cols=195  Identities=24%  Similarity=0.368  Sum_probs=155.8

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC-----
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP-----  710 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----  710 (912)
                      .++|++.+.||+|+||+||+|+++ +++.||||++.....  .....+++.+|+++++.++||||+++++++...     
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  129 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFE--DLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF  129 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhc--CHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccC
Confidence            368999999999999999999876 789999999865432  233567899999999999999999999999443     


Q ss_pred             CeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccc
Q 039137          711 KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGI  790 (912)
Q Consensus       711 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl  790 (912)
                      ...|+||||+. ++|.+++..   ...+++.+++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       130 ~~~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGl  202 (458)
T 3rp9_A          130 DELYVVLEIAD-SDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGL  202 (458)
T ss_dssp             CCEEEEECCCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred             ceEEEEEeccc-cchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeeccccc
Confidence            56899999985 689998843   35699999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCC---------------------------CCcccccccccccccccc-ccCCCCcchhHHHHHHHHHHHHhC
Q 039137          791 AKFLNPDS---------------------------SNWSELAGTHGYVAPELA-YTLKVTEKCDVYSFGVLALEVIKG  840 (912)
Q Consensus       791 a~~~~~~~---------------------------~~~~~~~g~~~y~aPE~~-~~~~~~~~sDvwslG~vl~elltg  840 (912)
                      ++......                           ......+||+.|+|||++ .+..++.++|||||||++|||++|
T Consensus       203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            98764321                           123445789999999976 566799999999999999999994

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=4.1e-38  Score=367.69  Aligned_cols=256  Identities=26%  Similarity=0.437  Sum_probs=208.2

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      ..++|++.+.||+|+||+||+|+++.+..||||++.....     ..++|.+|+++++.++||||+++++++.+ +..++
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~l  338 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI  338 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-----CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceE
Confidence            3467889999999999999999998888899999975432     35678999999999999999999999876 67899


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ||||+++|+|.+++... ....+++.+++.|+.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus       339 v~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  414 (535)
T 2h8h_A          339 VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIE  414 (535)
T ss_dssp             EECCCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred             eeehhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence            99999999999999532 224589999999999999999999999   99999999999999999999999999998664


Q ss_pred             CCCC-CccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccC-CCCCCChh
Q 039137          796 PDSS-NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDS-RLPYPSLH  872 (912)
Q Consensus       796 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  872 (912)
                      .... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||.....     ......+... +.+.+.  
T Consensus       415 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~-----~~~~~~i~~~~~~~~~~--  487 (535)
T 2h8h_A          415 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-----REVLDQVERGYRMPCPP--  487 (535)
T ss_dssp             CHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH-----HHHHHHHHTTCCCCCCT--
T ss_pred             CCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHcCCCCCCCC--
Confidence            3211 1123456788999999998899999999999999999999 9999853211     0111111111 222221  


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          873 VQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       873 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                        ..+..+.++|.+||+.||++|||++++++.|++.+.
T Consensus       488 --~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  523 (535)
T 2h8h_A          488 --ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  523 (535)
T ss_dssp             --TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred             --CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence              234568899999999999999999999999988653

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=4.3e-38  Score=341.36  Aligned_cols=253  Identities=26%  Similarity=0.406  Sum_probs=198.1

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeee
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSF  714 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  714 (912)
                      ..++|++.+.||+|+||.||+|+++ +++.||+|++......    ..+.+.+|+++++.++||||+++++++..++..+
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   92 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE----ELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLW   92 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----C----CHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHH----HHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEE
Confidence            3468999999999999999999986 6899999998654322    4577889999999999999999999999999999


Q ss_pred             EEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccccccc
Q 039137          715 IIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL  794 (912)
Q Consensus       715 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  794 (912)
                      +||||+++++|.+++...  ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++...
T Consensus        93 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  167 (302)
T 2j7t_A           93 IMIEFCPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKN  167 (302)
T ss_dssp             EEEECCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHH
T ss_pred             EEEEeCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccc
Confidence            999999999999988542  34589999999999999999999999   9999999999999999999999999987643


Q ss_pred             CCCCCCcccccccccccccccc-----ccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCC
Q 039137          795 NPDSSNWSELAGTHGYVAPELA-----YTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYP  869 (912)
Q Consensus       795 ~~~~~~~~~~~g~~~y~aPE~~-----~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  869 (912)
                      ...........|++.|+|||++     .+..++.++||||||+++|+|++|+.||.......     ..........+..
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~  242 (302)
T 2j7t_A          168 LKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-----VLLKIAKSDPPTL  242 (302)
T ss_dssp             HHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHHHHHHSCCCCC
T ss_pred             cccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH-----HHHHHhccCCccc
Confidence            2221222345789999999988     46678999999999999999999999986321110     1111111111110


Q ss_pred             ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          870 SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       870 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                       ......+..+.+++.+||+.||++|||+.|+++
T Consensus       243 -~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          243 -LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             -SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             -CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence             011223456889999999999999999999875

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=3.6e-38  Score=352.84  Aligned_cols=245  Identities=16%  Similarity=0.145  Sum_probs=190.6

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHH---HHhhcCCCccccEE-------E
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQ---ALTEIRHRNIVKFY-------G  705 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~---~l~~l~h~niv~l~-------~  705 (912)
                      .++|++.+.||+|+||+||+|++. +|+.||||++......... ..+.+.+|+.   .++.++||||++++       +
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~-~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~  150 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSN-AIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  150 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTT-HHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchH-HHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence            467889999999999999999974 7999999999754332222 5678899995   55555799999998       7


Q ss_pred             EEEcCCe-----------------eeEEEeecCCCChhhHhhccCC----cccCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 039137          706 FCSHPKH-----------------SFIIYEYLESGSLDKILCNDAS----AKELGWTQRLNVIKGVADALFYLHNNCFPP  764 (912)
Q Consensus       706 ~~~~~~~-----------------~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~  764 (912)
                      ++..++.                 .++||||+ +|+|.+++.....    ...+++..++.|+.||+.||+|||++   +
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~  226 (377)
T 3byv_A          151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---G  226 (377)
T ss_dssp             EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence            7766543                 78999999 5799999954321    12344688899999999999999999   9


Q ss_pred             eeecCCCCCCeEEcCCCcEEEeccccccccCCCCCCccccccccccccccccccC-----------CCCcchhHHHHHHH
Q 039137          765 IVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTL-----------KVTEKCDVYSFGVL  833 (912)
Q Consensus       765 ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----------~~~~~sDvwslG~v  833 (912)
                      |+||||||+||+++.++.+||+|||+++....   ......| +.|+|||++.+.           .++.++|||||||+
T Consensus       227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i  302 (377)
T 3byv_A          227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV  302 (377)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred             eecCCCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence            99999999999999999999999999986432   3345567 999999999887           89999999999999


Q ss_pred             HHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          834 ALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       834 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      +|||++|+.||.......     ....... ..       ...+..+.+++.+||+.||++|||+.|+++
T Consensus       303 l~elltg~~Pf~~~~~~~-----~~~~~~~-~~-------~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          303 IYWIWCADLPITKDAALG-----GSEWIFR-SC-------KNIPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHHHSSCCC------C-----CSGGGGS-SC-------CCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHHHCCCCCccccccc-----chhhhhh-hc-------cCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            999999999985322111     1111111 11       112345789999999999999999999875

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.2e-37  Score=334.55  Aligned_cols=248  Identities=23%  Similarity=0.377  Sum_probs=204.4

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEc-----
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSH-----  709 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-----  709 (912)
                      ...+|++.+.||+|+||.||+|++. +++.||+|++....        +.+.+|+++++.++||||+++++++..     
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   80 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDP   80 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS--------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc--------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCc
Confidence            3467999999999999999999986 79999999986432        245689999999999999999999854     


Q ss_pred             -----------CCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEc
Q 039137          710 -----------PKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLD  778 (912)
Q Consensus       710 -----------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~  778 (912)
                                 ....++||||+++++|.+++.... ...+++..++.++.|++.||+|||++   +|+||||||+||+++
T Consensus        81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~  156 (284)
T 2a19_B           81 ETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLV  156 (284)
T ss_dssp             --------CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEE
T ss_pred             ccccccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEc
Confidence                       345799999999999999995432 35689999999999999999999999   999999999999999


Q ss_pred             CCCcEEEeccccccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccch
Q 039137          779 LGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMN  858 (912)
Q Consensus       779 ~~~~~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~  858 (912)
                      .++.+||+|||++....... ......+++.|+|||++.+..++.++||||||+++|||++|..|+.....       ..
T Consensus       157 ~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-------~~  228 (284)
T 2a19_B          157 DTKQVKIGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK-------FF  228 (284)
T ss_dssp             ETTEEEECCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH-------HH
T ss_pred             CCCCEEECcchhheeccccc-cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH-------HH
Confidence            99999999999998765442 23445789999999999999999999999999999999999999642111       11


Q ss_pred             hhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 039137          859 IEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI  909 (912)
Q Consensus       859 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l  909 (912)
                      ........+.      ..+..+.+++.+||+.||++|||+.|+++.|+..-
T Consensus       229 ~~~~~~~~~~------~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          229 TDLRDGIISD------IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             HHHHTTCCCT------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             HHhhcccccc------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            1111111111      12345778999999999999999999999988653

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=4.8e-37  Score=342.80  Aligned_cols=255  Identities=20%  Similarity=0.270  Sum_probs=193.1

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCC----
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPK----  711 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----  711 (912)
                      .++|++.+.||+|+||.||+|.+. +++.||||++.....  .....+.+.+|+.+++.++||||+++++++...+    
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  101 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ--NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  101 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC--ChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence            368999999999999999999875 788999999975432  2335677889999999999999999999997654    


Q ss_pred             --eeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccc
Q 039137          712 --HSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFG  789 (912)
Q Consensus       712 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  789 (912)
                        ..++||||+++ +|.+++.     ..+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus       102 ~~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg  172 (371)
T 2xrw_A          102 FQDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  172 (371)
T ss_dssp             CCEEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred             ccceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEee
Confidence              67999999985 7877773     3488999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhcccccc------c--------
Q 039137          790 IAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS------S--------  855 (912)
Q Consensus       790 la~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~------~--------  855 (912)
                      +++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..........      .        
T Consensus       173 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  251 (371)
T 2xrw_A          173 LARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK  251 (371)
T ss_dssp             C-----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHT
T ss_pred             cccccccc-cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            99866432 22345678999999999999999999999999999999999999986321110000      0        


Q ss_pred             ---cchhhhcc----------------CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          856 ---NMNIEMLD----------------SRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       856 ---~~~~~~~~----------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                         ........                ...+.........+..+.+++.+||+.||++|||++|+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence               00000000                0011112223334667899999999999999999999876

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=5.6e-38  Score=346.03  Aligned_cols=255  Identities=22%  Similarity=0.320  Sum_probs=189.2

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcC-CCccccEEEEEE------
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR-HRNIVKFYGFCS------  708 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~------  708 (912)
                      ..+|++.+.||+|+||.||+|++. +++.||+|++...    .....+.+.+|+.+++++. ||||+++++++.      
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~  102 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN----EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES  102 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES----SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC----chHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence            357999999999999999999975 7899999998533    2235677899999999996 999999999994      


Q ss_pred             --cCCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCC--eeecCCCCCCeEEcCCCcEE
Q 039137          709 --HPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP--IVHRDISSKNVLLDLGYEAH  784 (912)
Q Consensus       709 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlk~~Nill~~~~~~k  784 (912)
                        .....++||||+. |+|.+++........+++.+++.++.|++.||+|||++   +  |+||||||+||+++.++.+|
T Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~k  178 (337)
T 3ll6_A          103 DTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIK  178 (337)
T ss_dssp             TTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEE
T ss_pred             ccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEE
Confidence              2345799999996 69999886655556799999999999999999999999   8  99999999999999999999


Q ss_pred             EeccccccccCCCCCC------------cccccccccccccccc---ccCCCCcchhHHHHHHHHHHHHhCCCCccchhc
Q 039137          785 VSDFGIAKFLNPDSSN------------WSELAGTHGYVAPELA---YTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFE  849 (912)
Q Consensus       785 l~Dfgla~~~~~~~~~------------~~~~~g~~~y~aPE~~---~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~  849 (912)
                      |+|||+++........            .....|++.|+|||++   .+..++.++||||||+++|||++|+.||+....
T Consensus       179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~  258 (337)
T 3ll6_A          179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK  258 (337)
T ss_dssp             BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred             EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence            9999999876543221            1134589999999988   566789999999999999999999999863211


Q ss_pred             cccccccchhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          850 MSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       850 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                      .         .........+..  ......+.+++.+||+.||++|||+.|+++.|++...
T Consensus       259 ~---------~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~  308 (337)
T 3ll6_A          259 L---------RIVNGKYSIPPH--DTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA  308 (337)
T ss_dssp             ----------------CCCCTT--CCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             H---------HhhcCcccCCcc--cccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            1         111111111110  1112346789999999999999999999999988653

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.8e-37  Score=333.71  Aligned_cols=255  Identities=23%  Similarity=0.363  Sum_probs=206.7

Q ss_pred             HHHhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCe
Q 039137          634 ISATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKH  712 (912)
Q Consensus       634 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~  712 (912)
                      ....++|++.+.||+|+||.||+|+.+ +++.||+|++.......  ...+.+.+|++++++++||||+++++++...+.
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   95 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN--KDTSTILREVELLKKLDHPNIMKLFEILEDSSS   95 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSS--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccch--HHHHHHHHHHHHHHhccCCCccEEEEEEeCCCe
Confidence            345678999999999999999999986 78999999986543222  145778899999999999999999999999999


Q ss_pred             eeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCC---CcEEEeccc
Q 039137          713 SFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLG---YEAHVSDFG  789 (912)
Q Consensus       713 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~Dfg  789 (912)
                      .++||||+++++|.+++...   ..+++.+++.++.|++.||+|||++   +|+||||||+||+++.+   +.+||+|||
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg  169 (287)
T 2wei_A           96 FYIVGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFG  169 (287)
T ss_dssp             EEEEECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTT
T ss_pred             EEEEEEccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccC
Confidence            99999999999999988443   4689999999999999999999999   99999999999999754   469999999


Q ss_pred             cccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCC
Q 039137          790 IAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYP  869 (912)
Q Consensus       790 la~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  869 (912)
                      ++....... ......+++.|+|||.+.+. ++.++||||||+++|+|++|+.||.....     ..............+
T Consensus       170 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~  242 (287)
T 2wei_A          170 LSTCFQQNT-KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNE-----YDILKRVETGKYAFD  242 (287)
T ss_dssp             GGGTBCCCS-SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCCCCCC
T ss_pred             cceeecCCC-ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHcCCCCCC
Confidence            998765432 23345689999999988764 89999999999999999999999853211     111112222222222


Q ss_pred             ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          870 SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       870 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .......+..+.+++.+||+.||++|||+.|+++
T Consensus       243 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          243 LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            2223344567889999999999999999999987

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=7.2e-38  Score=337.58  Aligned_cols=259  Identities=24%  Similarity=0.373  Sum_probs=197.0

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC--CCC--EEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCe
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP--SGE--IFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKH  712 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~  712 (912)
                      .++|++.+.||+|+||+||+|++.  +++  .||+|++....... ....+.+.+|+++++.++||||+++++++..+. 
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   94 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ-PEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-   94 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCC-HHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence            367999999999999999999853  333  68999987543322 225678999999999999999999999998755 


Q ss_pred             eeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccccc
Q 039137          713 SFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK  792 (912)
Q Consensus       713 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  792 (912)
                      .++||||+++++|.+++...  ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++.
T Consensus        95 ~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~  169 (291)
T 1u46_A           95 MKMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR  169 (291)
T ss_dssp             CEEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             ceeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccc
Confidence            88999999999999999543  35689999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCCC---ccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccCCCCC
Q 039137          793 FLNPDSSN---WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDSRLPY  868 (912)
Q Consensus       793 ~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  868 (912)
                      ........   .....+++.|+|||++.+..++.++||||||+++|+|++ |+.||.....     ..............
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~~~~~~~~~~~~  244 (291)
T 1u46_A          170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-----SQILHKIDKEGERL  244 (291)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHHHHTSCCCC
T ss_pred             cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH-----HHHHHHHHccCCCC
Confidence            76544322   223457788999999998889999999999999999999 9999853211     11111111111111


Q ss_pred             CChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 039137          869 PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI  909 (912)
Q Consensus       869 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l  909 (912)
                      +.  ....+..+.+++.+||+.||++|||+.++++.|++..
T Consensus       245 ~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  283 (291)
T 1u46_A          245 PR--PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ  283 (291)
T ss_dssp             CC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             CC--CcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence            11  1123456889999999999999999999999998764

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-37  Score=341.57  Aligned_cols=253  Identities=25%  Similarity=0.410  Sum_probs=195.6

Q ss_pred             HHhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEEc---
Q 039137          635 SATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSH---  709 (912)
Q Consensus       635 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~---  709 (912)
                      ...++|++.+.||+|+||.||+|++. +++.||+|++.....     ..+.+.+|+.+++++ +||||+++++++..   
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   95 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP   95 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-----cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence            35678999999999999999999875 789999999865422     346688999999999 79999999999976   


Q ss_pred             ---CCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEe
Q 039137          710 ---PKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVS  786 (912)
Q Consensus       710 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  786 (912)
                         .+..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~  171 (326)
T 2x7f_A           96 PGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLV  171 (326)
T ss_dssp             -CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEEC
T ss_pred             ccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEe
Confidence               467899999999999999996532 35689999999999999999999999   99999999999999999999999


Q ss_pred             ccccccccCCCCCCccccccccccccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhh
Q 039137          787 DFGIAKFLNPDSSNWSELAGTHGYVAPELAY-----TLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEM  861 (912)
Q Consensus       787 Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~  861 (912)
                      |||++..............|++.|+|||++.     +..++.++||||||+++|+|++|+.||.......     .....
T Consensus       172 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~  246 (326)
T 2x7f_A          172 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-----ALFLI  246 (326)
T ss_dssp             CCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHHHH
T ss_pred             eCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH-----HHHHh
Confidence            9999987654433445567899999999987     5668999999999999999999999985321110     00111


Q ss_pred             ccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          862 LDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       862 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .....+.  ......+..+.+++.+||+.||++|||++|+++
T Consensus       247 ~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          247 PRNPAPR--LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             HHSCCCC--CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             hcCcccc--CCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            1111110  011122456889999999999999999999876

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-38  Score=353.13  Aligned_cols=256  Identities=23%  Similarity=0.332  Sum_probs=200.6

Q ss_pred             cCCCCCceeeecCceEEEEEEe----CCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEEcCCe
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKV----PSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSHPKH  712 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~  712 (912)
                      ++|++.+.||+|+||.||+|+.    .+++.||||++............+.+.+|+++++.+ +||||+++++++...+.
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            6799999999999999999987    378999999986432111111234566899999999 69999999999999999


Q ss_pred             eeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccccc
Q 039137          713 SFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK  792 (912)
Q Consensus       713 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  792 (912)
                      .++||||+++|+|.+++...   ..+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  207 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK  207 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             EEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence            99999999999999999543   4689999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCC-CCcccccccccccccccccc--CCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCC
Q 039137          793 FLNPDS-SNWSELAGTHGYVAPELAYT--LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYP  869 (912)
Q Consensus       793 ~~~~~~-~~~~~~~g~~~y~aPE~~~~--~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  869 (912)
                      ...... .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||........ .............+.+
T Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~  286 (355)
T 1vzo_A          208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAEISRRILKSEPPYP  286 (355)
T ss_dssp             ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHHHHHHHHHCCCCCC
T ss_pred             ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch-HHHHHHHHhccCCCCC
Confidence            654322 22334679999999999885  3478999999999999999999999863211110 0111112222222332


Q ss_pred             ChhhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 039137          870 SLHVQKKLMSIMQVAFSCLDQNPESRP-----TMKRVSQL  904 (912)
Q Consensus       870 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~  904 (912)
                      .    ..+..+.++|.+||+.||++||     +++|+++.
T Consensus       287 ~----~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          287 Q----EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             T----TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             c----ccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence            2    2334578899999999999999     88888753

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.3e-37  Score=369.27  Aligned_cols=250  Identities=25%  Similarity=0.383  Sum_probs=199.6

Q ss_pred             ceeeecCceEEEEEEeC---CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEEeec
Q 039137          644 HCIGKGGHGSVYRAKVP---SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYL  720 (912)
Q Consensus       644 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  720 (912)
                      +.||+|+||+||+|.+.   .++.||||+++.....  ....+++.+|+++++.++||||+++++++.. +..++||||+
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~  451 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND--PALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMA  451 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGC--GGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEcc
Confidence            47999999999999653   5678999998754322  2246789999999999999999999999975 5688999999


Q ss_pred             CCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCCC
Q 039137          721 ESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN  800 (912)
Q Consensus       721 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  800 (912)
                      ++|+|.+++..   ...+++.+++.|+.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++........
T Consensus       452 ~~g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~  525 (635)
T 4fl3_A          452 ELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY  525 (635)
T ss_dssp             TTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred             CCCCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence            99999999953   34689999999999999999999999   9999999999999999999999999999876544321


Q ss_pred             ---ccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccC-CCCCCChhhHH
Q 039137          801 ---WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDS-RLPYPSLHVQK  875 (912)
Q Consensus       801 ---~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  875 (912)
                         .....+++.|+|||++.+..++.++|||||||++|||++ |+.||......     .....+... +...+    ..
T Consensus       526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-----~~~~~i~~~~~~~~p----~~  596 (635)
T 4fl3_A          526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-----EVTAMLEKGERMGCP----AG  596 (635)
T ss_dssp             ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----HHHHHHHTTCCCCCC----TT
T ss_pred             cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHHcCCCCCCC----CC
Confidence               223456788999999999999999999999999999998 99998632111     111111111 11222    12


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 039137          876 KLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE  911 (912)
Q Consensus       876 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~~  911 (912)
                      .+..+.+++.+||+.||++||+++++++.|++.+.+
T Consensus       597 ~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  632 (635)
T 4fl3_A          597 CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  632 (635)
T ss_dssp             CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            345688999999999999999999999999998765

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=6.6e-38  Score=348.80  Aligned_cols=255  Identities=24%  Similarity=0.348  Sum_probs=201.9

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      .++|++.+.||+|+||+||+|++. +++.||+|++....   .....+.+.+|+.+++.++||||+++++++..++..++
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  108 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI  108 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC---CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc---CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEE
Confidence            467999999999999999999876 78999999987543   23356788999999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ||||+++++|.+++...   +.+++..+..++.|++.||+|||++.  +|+||||||+||+++.++.+||+|||++....
T Consensus       109 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  183 (360)
T 3eqc_A          109 CMEHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  183 (360)
T ss_dssp             EECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred             EEECCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence            99999999999999543   46899999999999999999999831  89999999999999999999999999997553


Q ss_pred             CCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhcccccc---------------------
Q 039137          796 PDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS---------------------  854 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~---------------------  854 (912)
                      ..  ......|++.|+|||++.+..++.++||||||+++|+|++|+.||..........                     
T Consensus       184 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (360)
T 3eqc_A          184 DS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  261 (360)
T ss_dssp             HH--C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred             cc--cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence            22  2234578999999999999999999999999999999999999986321100000                     


Q ss_pred             ------------c----cchhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          855 ------------S----NMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       855 ------------~----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                                  .    ...........+.  ......+..+.+++.+||+.||++|||++|+++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPK--LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             ------------CCCHHHHHHHHHHSCCCC--CCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CcccccccCCCCcccchhhhhHHhccCCCC--CCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                        0    0000000000000  001112456889999999999999999999875

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.9e-38  Score=342.62  Aligned_cols=262  Identities=26%  Similarity=0.397  Sum_probs=208.0

Q ss_pred             hcCCCCCceeeecCceEEEEEEe-----CCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCC
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKV-----PSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPK  711 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~  711 (912)
                      .++|++.+.||+|+||.||+|++     .+++.||+|++....    ....+.+.+|+++++.++||||+++++++...+
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  115 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST----EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG  115 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC----SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC----HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC
Confidence            45689999999999999999983     368899999987532    225678999999999999999999999986544


Q ss_pred             --eeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccc
Q 039137          712 --HSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFG  789 (912)
Q Consensus       712 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  789 (912)
                        ..++||||+++++|.+++...  ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus       116 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg  190 (326)
T 2w1i_A          116 RRNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFG  190 (326)
T ss_dssp             --CCEEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCT
T ss_pred             CCceEEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCc
Confidence              789999999999999999553  24589999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCCC---ccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhcc-----ccccc-c----
Q 039137          790 IAKFLNPDSSN---WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEM-----SSSSS-N----  856 (912)
Q Consensus       790 la~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~-----~~~~~-~----  856 (912)
                      ++.........   .....+++.|+|||.+.+..++.++||||||+++|||++|..||......     ..... .    
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (326)
T 2w1i_A          191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF  270 (326)
T ss_dssp             TCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHH
T ss_pred             chhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHH
Confidence            99876544321   12345677899999999888999999999999999999999997532110     00000 0    


Q ss_pred             chhhhccC--CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 039137          857 MNIEMLDS--RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE  911 (912)
Q Consensus       857 ~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~~  911 (912)
                      ........  +.+.+    ...+..+.+++.+||+.||++|||+.|+++.|++...+
T Consensus       271 ~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~  323 (326)
T 2w1i_A          271 HLIELLKNNGRLPRP----DGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ  323 (326)
T ss_dssp             HHHHHHHTTCCCCCC----TTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHhhcCCCCCCC----CcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            00111111  12222    22345688999999999999999999999999987654

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=5.1e-37  Score=333.37  Aligned_cols=253  Identities=22%  Similarity=0.309  Sum_probs=198.5

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEE--cCCee
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCS--HPKHS  713 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~--~~~~~  713 (912)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++............+.+.+|+++++.++||||+++++++.  +.+..
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            478999999999999999999975 788999999864321111124577899999999999999999999984  44578


Q ss_pred             eEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccc
Q 039137          714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKF  793 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  793 (912)
                      ++||||++++ +.+++... ....+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||.+..
T Consensus        84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccc
Confidence            9999999986 77776443 345689999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCC--CCccccccccccccccccccCC--CCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCC
Q 039137          794 LNPDS--SNWSELAGTHGYVAPELAYTLK--VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYP  869 (912)
Q Consensus       794 ~~~~~--~~~~~~~g~~~y~aPE~~~~~~--~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  869 (912)
                      .....  .......|++.|+|||++.+..  ++.++||||||+++|||++|+.||+....     ..............+
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~i~~~~~~~~  233 (305)
T 2wtk_C          159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI-----YKLFENIGKGSYAIP  233 (305)
T ss_dssp             CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHCCCCCC
T ss_pred             cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH-----HHHHHHHhcCCCCCC
Confidence            65322  2233556899999999987654  37799999999999999999999863211     111111222222222


Q ss_pred             ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          870 SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       870 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .    ..+..+.+++.+||+.||++|||++|+++
T Consensus       234 ~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~  263 (305)
T 2wtk_C          234 G----DCGPPLSDLLKGMLEYEPAKRFSIRQIRQ  263 (305)
T ss_dssp             S----SSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             C----ccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            2    22345789999999999999999999986

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.5e-37  Score=337.22  Aligned_cols=258  Identities=26%  Similarity=0.407  Sum_probs=185.7

Q ss_pred             HHhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCee
Q 039137          635 SATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHS  713 (912)
Q Consensus       635 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  713 (912)
                      ...++|++.+.||+|+||.||+|.+. +++.||||++......   ...+++.+|+.+++.++||||+++++++...+..
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   88 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ---TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL   88 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-------------------CCCCCCCTTBCCEEEEEESSSCE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc---hhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCc
Confidence            34578999999999999999999865 7899999998644321   2456788999999999999999999999999999


Q ss_pred             eEEEeecCCCChhhHhhcc-----CCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecc
Q 039137          714 FIIYEYLESGSLDKILCND-----ASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDF  788 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~-----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df  788 (912)
                      ++||||+++++|.+++...     .....+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+||
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df  165 (303)
T 2vwi_A           89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADF  165 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCC
T ss_pred             EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEec
Confidence            9999999999999998531     1245689999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCC-----Ccccccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhc
Q 039137          789 GIAKFLNPDSS-----NWSELAGTHGYVAPELAYT-LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEML  862 (912)
Q Consensus       789 gla~~~~~~~~-----~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~  862 (912)
                      |.+........     ......|++.|+|||++.+ ..++.++||||||+++|||++|+.||.......     ......
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~  240 (303)
T 2vwi_A          166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK-----VLMLTL  240 (303)
T ss_dssp             HHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-----HHHHHH
T ss_pred             cchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh-----HHHHHh
Confidence            99986643321     1234578999999998875 568999999999999999999999986322111     000011


Q ss_pred             cCCCCCCC------hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          863 DSRLPYPS------LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       863 ~~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ....+...      ......+..+.+++.+||+.||++|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          241 QNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             TSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            11110000      000122346889999999999999999999875

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=1e-36  Score=342.98  Aligned_cols=311  Identities=21%  Similarity=0.180  Sum_probs=168.4

Q ss_pred             CCCCccEEEccCCcccccCCccccCCCCCcEEeccccccccccccccccccccceeecccccccCCCCccccCcccccEE
Q 039137          107 SFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQL  186 (912)
Q Consensus       107 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L  186 (912)
                      .++++++|++++|.++...+..|..+++|++|+|++|++++..|..|+.+++|++|+|++|.+++..|..++.+++|++|
T Consensus        43 ~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  122 (390)
T 3o6n_A           43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL  122 (390)
T ss_dssp             GGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred             ccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEE
Confidence            35667777777777765444446677777777777777765555667777777777777777776656666666666666


Q ss_pred             EccCCcCCCCCCccCCCCccceeeeeccCCCcCccccccccccccceeecccccccCccccccccccccceeeeccccCc
Q 039137          187 ALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELS  266 (912)
Q Consensus       187 ~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~  266 (912)
                      ++++|+++...+..|.++++|++|++++|.+++..|..++++++|++|++++|++++.   .+..+++|+.|++++|.++
T Consensus       123 ~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~  199 (390)
T 3o6n_A          123 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLS  199 (390)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCS
T ss_pred             ECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeeccccccc
Confidence            6666666633333345666666666666666555555555555555555555555432   1333444444444444443


Q ss_pred             ccCCcccCCccccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCcccccccCC
Q 039137          267 GIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWG  346 (912)
Q Consensus       267 ~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  346 (912)
                      +.                             ...++|+.|++++|.++.....   ..++|+.|++++|.+++.  ..+ 
T Consensus       200 ~~-----------------------------~~~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~n~l~~~--~~l-  244 (390)
T 3o6n_A          200 TL-----------------------------AIPIAVEELDASHNSINVVRGP---VNVELTILKLQHNNLTDT--AWL-  244 (390)
T ss_dssp             EE-----------------------------ECCSSCSEEECCSSCCCEEECC---CCSSCCEEECCSSCCCCC--GGG-
T ss_pred             cc-----------------------------CCCCcceEEECCCCeeeecccc---ccccccEEECCCCCCccc--HHH-
Confidence            21                             1123444445554444432111   123444455554444332  233 


Q ss_pred             CCCCCCEEeccCCcccccccccccccccccEEEccCccccCCCCccccccccccEEEccCCcccCCCccccccccccccc
Q 039137          347 RCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYL  426 (912)
Q Consensus       347 ~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  426 (912)
                                             ..+++|++|+|++|.+++..|..+..+++|+.|+|++|++++ +|..+..+++|++|
T Consensus       245 -----------------------~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L  300 (390)
T 3o6n_A          245 -----------------------LNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVL  300 (390)
T ss_dssp             -----------------------GGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEE
T ss_pred             -----------------------cCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEE
Confidence                                   334444444444444444444444444445555555554442 33334445556666


Q ss_pred             cccCcccCccccccccccccccEEEecccccccccchhhhcccccceeeccccccCc
Q 039137          427 DLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGE  483 (912)
Q Consensus       427 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  483 (912)
                      +|++|++++ +|..+..+++|++|+|++|+++.. +  +..+++|++|++++|+++.
T Consensus       301 ~L~~n~l~~-~~~~~~~l~~L~~L~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~  353 (390)
T 3o6n_A          301 DLSHNHLLH-VERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDC  353 (390)
T ss_dssp             ECCSSCCCC-CGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEH
T ss_pred             ECCCCccee-cCccccccCcCCEEECCCCcccee-C--chhhccCCEEEcCCCCccc
Confidence            666665554 344455556666666666666533 2  4555666666666666654

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.1e-37  Score=354.60  Aligned_cols=261  Identities=17%  Similarity=0.269  Sum_probs=205.7

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCC-CccccEEEEEEcCCeee
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH-RNIVKFYGFCSHPKHSF  714 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h-~niv~l~~~~~~~~~~~  714 (912)
                      .++|++.+.||+|+||.||+|++. +++.||||++.....      .+++.+|+++++.++| +++..+..++...+..+
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~------~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~   79 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK------HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNV   79 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS------SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc------cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence            468999999999999999999874 799999998765432      2346789999999976 66666777778888999


Q ss_pred             EEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEE---cCCCcEEEeccccc
Q 039137          715 IIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLL---DLGYEAHVSDFGIA  791 (912)
Q Consensus       715 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~Dfgla  791 (912)
                      +||||+ +++|.+++...  ...+++.+++.|+.||+.||+|||++   +|+||||||+|||+   +.++.+||+|||++
T Consensus        80 lvme~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla  153 (483)
T 3sv0_A           80 LVMDLL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLA  153 (483)
T ss_dssp             EEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred             EEEECC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcc
Confidence            999999 88999999532  34699999999999999999999999   99999999999999   68899999999999


Q ss_pred             cccCCCCCC-------ccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccC
Q 039137          792 KFLNPDSSN-------WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDS  864 (912)
Q Consensus       792 ~~~~~~~~~-------~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  864 (912)
                      +........       .....||+.|+|||++.+..++.++|||||||++|||++|+.||.........  .....+...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~--~~~~~i~~~  231 (483)
T 3sv0_A          154 KKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK--QKYEKISEK  231 (483)
T ss_dssp             EECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHH--HHHHHHHHH
T ss_pred             eeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHH--HHHHHHhhc
Confidence            876554321       22567999999999999999999999999999999999999998632211100  000000000


Q ss_pred             CCCCC-ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 039137          865 RLPYP-SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE  911 (912)
Q Consensus       865 ~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~~  911 (912)
                      ..... .......+.++.+++..||+.||++||++++|++.|++.+.+
T Consensus       232 ~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~  279 (483)
T 3sv0_A          232 KVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR  279 (483)
T ss_dssp             HHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             cccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence            00000 001122345688999999999999999999999999988653

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=8.4e-37  Score=335.63  Aligned_cols=250  Identities=18%  Similarity=0.265  Sum_probs=197.6

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcC-CCccccEEEEEEc--CCe
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR-HRNIVKFYGFCSH--PKH  712 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~--~~~  712 (912)
                      .++|++.+.||+|+||+||+|++. +++.||+|++...       ..+.+.+|+++++.++ ||||+++++++..  ...
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~  107 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRT  107 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence            367999999999999999999864 7899999998632       3567889999999997 9999999999988  567


Q ss_pred             eeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCC-cEEEeccccc
Q 039137          713 SFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGY-EAHVSDFGIA  791 (912)
Q Consensus       713 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~Dfgla  791 (912)
                      .++||||+++++|.+++.      .+++.+++.++.|++.||+|||++   +|+||||||+||+++.++ .+||+|||++
T Consensus       108 ~~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a  178 (330)
T 3nsz_A          108 PALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLA  178 (330)
T ss_dssp             EEEEEECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             eEEEEeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCc
Confidence            899999999999999882      388899999999999999999999   999999999999999776 8999999999


Q ss_pred             cccCCCCCCcccccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCccchhcccccc--------ccchhh-h
Q 039137          792 KFLNPDSSNWSELAGTHGYVAPELAYT-LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS--------SNMNIE-M  861 (912)
Q Consensus       792 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~--------~~~~~~-~  861 (912)
                      +...... ......+++.|+|||++.+ ..++.++||||+||++|||++|+.||..........        ...... .
T Consensus       179 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~  257 (330)
T 3nsz_A          179 EFYHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI  257 (330)
T ss_dssp             EECCTTC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHH
T ss_pred             eEcCCCC-ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHH
Confidence            8765432 3445678999999999877 668999999999999999999999983111000000        000000 0


Q ss_pred             ccCCCCC--------------------CChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          862 LDSRLPY--------------------PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       862 ~~~~~~~--------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .......                    ........+..+.+++.+||+.||++|||++|+++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0000000                    00011123567889999999999999999999876

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.9e-37  Score=347.04  Aligned_cols=255  Identities=21%  Similarity=0.270  Sum_probs=194.1

Q ss_pred             hcCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCe----
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKH----  712 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----  712 (912)
                      ..+|++.+.||+|+||+||+|++..+..||+|++.......        .+|+++++.++||||+++++++...+.    
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~~--------~~E~~il~~l~h~niv~l~~~~~~~~~~~~~  110 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFK--------NRELQIMRIVKHPNVVDLKAFFYSNGDKKDE  110 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTSC--------CHHHHHHHTCCCTTBCCEEEEEEEESSSSSC
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcchH--------HHHHHHHHhCCCCCcceEEEEEEecCCCCCc
Confidence            35799999999999999999999877779999986543221        269999999999999999999965433    


Q ss_pred             --eeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEc-CCCcEEEeccc
Q 039137          713 --SFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLD-LGYEAHVSDFG  789 (912)
Q Consensus       713 --~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~Dfg  789 (912)
                        .++||||++++.+............+++..++.++.|++.||+|||++   +|+||||||+||+++ .++.+||+|||
T Consensus       111 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG  187 (394)
T 4e7w_A          111 VFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFG  187 (394)
T ss_dssp             EEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             eEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence              789999998855544443333456799999999999999999999999   999999999999999 79999999999


Q ss_pred             cccccCCCCCCccccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCccchhccccccc-------------
Q 039137          790 IAKFLNPDSSNWSELAGTHGYVAPELAYTL-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSS-------------  855 (912)
Q Consensus       790 la~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~-------------  855 (912)
                      +++...... ......+|+.|+|||++.+. .++.++||||+||++|||++|+.||...........             
T Consensus       188 ~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~  266 (394)
T 4e7w_A          188 SAKILIAGE-PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI  266 (394)
T ss_dssp             TCEECCTTC-CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             CcccccCCC-CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            998764432 33456789999999998765 589999999999999999999999863211100000             


Q ss_pred             -cchhhhccCCCCC---CCh---hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          856 -NMNIEMLDSRLPY---PSL---HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       856 -~~~~~~~~~~~~~---~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                       ...........+.   ...   .....+..+.+++.+||+.||++|||+.|+++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence             0000001111110   000   01113457889999999999999999998875

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.4e-37  Score=346.42  Aligned_cols=269  Identities=20%  Similarity=0.264  Sum_probs=199.6

Q ss_pred             ccHHHHHHHhcCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCc-------hHHHHHHHHHHHHHhhcCCCcc
Q 039137          628 IVYEEIISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEM-------SFQQEEFLNEIQALTEIRHRNI  700 (912)
Q Consensus       628 ~~~~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~~~~Ei~~l~~l~h~ni  700 (912)
                      ...+++....++|++.+.||+|+||.||+|.+.+++.||||++........       ....+.+.+|+++++.++||||
T Consensus        12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   91 (362)
T 3pg1_A           12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI   91 (362)
T ss_dssp             HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence            345678888999999999999999999999988899999999865433221       1234788999999999999999


Q ss_pred             ccEEEEEEcC-----CeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCe
Q 039137          701 VKFYGFCSHP-----KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNV  775 (912)
Q Consensus       701 v~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Ni  775 (912)
                      +++++++...     ...++||||++ |++.+++..  ....+++.+++.++.|++.||+|||++   +|+||||||+||
T Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NI  165 (362)
T 3pg1_A           92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNI  165 (362)
T ss_dssp             CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred             cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHE
Confidence            9999998542     36799999998 588887743  334689999999999999999999999   999999999999


Q ss_pred             EEcCCCcEEEeccccccccCCCCCCcccccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCccchhcccccc
Q 039137          776 LLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYT-LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS  854 (912)
Q Consensus       776 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~  854 (912)
                      +++.++.+||+|||+++..... .......+++.|+|||++.+ ..++.++||||+||++|+|++|+.||..........
T Consensus       166 l~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~  244 (362)
T 3pg1_A          166 LLADNNDITICDFNLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN  244 (362)
T ss_dssp             EECTTCCEEECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             EEcCCCCEEEEecCcccccccc-cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            9999999999999999754433 23345678999999998877 678999999999999999999999986321100000


Q ss_pred             c------------------cchhhhccC---CCCCCC--hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          855 S------------------NMNIEMLDS---RLPYPS--LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       855 ~------------------~~~~~~~~~---~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .                  .........   ..+...  ......+..+.+++.+||+.||++|||+.|+++
T Consensus       245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          245 KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            0                  000000000   001000  011122456889999999999999999999875

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=1.2e-36  Score=361.52  Aligned_cols=311  Identities=21%  Similarity=0.177  Sum_probs=173.1

Q ss_pred             CCCccEEEccCCcccccCCccccCCCCCcEEeccccccccccccccccccccceeecccccccCCCCccccCcccccEEE
Q 039137          108 FPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLA  187 (912)
Q Consensus       108 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~  187 (912)
                      +++++.|++++|.+.+..+..|..+++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..|..|+++++|++|+
T Consensus        50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  129 (597)
T 3oja_B           50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV  129 (597)
T ss_dssp             GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEE
Confidence            45667777777777655445566677777777777777666666667777777777777776665566666666666666


Q ss_pred             ccCCcCCCCCCccCCCCccceeeeeccCCCcCccccccccccccceeecccccccCccccccccccccceeeeccccCcc
Q 039137          188 LDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSG  267 (912)
Q Consensus       188 l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~  267 (912)
                      |++|.+++..+..|+++++|++|+|++|.+++..|..|+++++|+.|++++|++++..   ++.+++|+.|++++|.+++
T Consensus       130 L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~~  206 (597)
T 3oja_B          130 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLST  206 (597)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCSE
T ss_pred             eeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCcccc
Confidence            6666666433344456666666666666655555555555555555555555554321   2334444444444444432


Q ss_pred             cCCcccCCccccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCcccccccCCC
Q 039137          268 IIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGR  347 (912)
Q Consensus       268 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  347 (912)
                      .                             ...++|+.|++++|.++...+..   .++|+.|+|++|.+++        
T Consensus       207 l-----------------------------~~~~~L~~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~l~~--------  246 (597)
T 3oja_B          207 L-----------------------------AIPIAVEELDASHNSINVVRGPV---NVELTILKLQHNNLTD--------  246 (597)
T ss_dssp             E-----------------------------ECCTTCSEEECCSSCCCEEECSC---CSCCCEEECCSSCCCC--------
T ss_pred             c-----------------------------cCCchhheeeccCCccccccccc---CCCCCEEECCCCCCCC--------
Confidence            1                             11223444444444444322211   1344444444444432        


Q ss_pred             CCCCCEEeccCCcccccccccccccccccEEEccCccccCCCCccccccccccEEEccCCcccCCCcccccccccccccc
Q 039137          348 CPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLD  427 (912)
Q Consensus       348 l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  427 (912)
                                        +..++.+++|++|+|++|.+.+..|..++++++|+.|+|++|++++ +|..+..+++|+.|+
T Consensus       247 ------------------~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~  307 (597)
T 3oja_B          247 ------------------TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLD  307 (597)
T ss_dssp             ------------------CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEE
T ss_pred             ------------------ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEE
Confidence                              1334444445555555555554445555555555555555555553 344445556666666


Q ss_pred             ccCcccCccccccccccccccEEEecccccccccchhhhcccccceeeccccccCcc
Q 039137          428 LSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEK  484 (912)
Q Consensus       428 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  484 (912)
                      |++|.+++ +|..+..+++|++|+|++|++++. +  +..+++|+.|+|++|++++.
T Consensus       308 Ls~N~l~~-i~~~~~~l~~L~~L~L~~N~l~~~-~--~~~~~~L~~L~l~~N~~~~~  360 (597)
T 3oja_B          308 LSHNHLLH-VERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCN  360 (597)
T ss_dssp             CCSSCCCC-CGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHH
T ss_pred             CCCCCCCc-cCcccccCCCCCEEECCCCCCCCc-C--hhhcCCCCEEEeeCCCCCCh
Confidence            66666664 445556666666666666666543 2  45566777777777777543

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.7e-37  Score=343.98  Aligned_cols=256  Identities=22%  Similarity=0.355  Sum_probs=204.0

Q ss_pred             hcCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCch-------------HHHHHHHHHHHHHhhcCCCccccE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMS-------------FQQEEFLNEIQALTEIRHRNIVKF  703 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~-------------~~~~~~~~Ei~~l~~l~h~niv~l  703 (912)
                      .++|++.+.||+|+||.||+|+. +++.||+|++.........             ...+.+.+|+++++.++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            36899999999999999999999 9999999998643221110             112778999999999999999999


Q ss_pred             EEEEEcCCeeeEEEeecCCCChhhH------hhccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCCeE
Q 039137          704 YGFCSHPKHSFIIYEYLESGSLDKI------LCNDASAKELGWTQRLNVIKGVADALFYLHN-NCFPPIVHRDISSKNVL  776 (912)
Q Consensus       704 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nil  776 (912)
                      ++++.+.+..++||||+++|+|.++      +.. .....+++.+++.++.|++.||+|||+ +   +|+||||||+||+
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil  184 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNIL  184 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEE
Confidence            9999999999999999999999998      522 224679999999999999999999999 8   9999999999999


Q ss_pred             EcCCCcEEEeccccccccCCCCCCccccccccccccccccccC-CCCc-chhHHHHHHHHHHHHhCCCCccchhcccccc
Q 039137          777 LDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTL-KVTE-KCDVYSFGVLALEVIKGKHPRDFLFEMSSSS  854 (912)
Q Consensus       777 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~-~sDvwslG~vl~elltg~~pf~~~~~~~~~~  854 (912)
                      ++.++.+||+|||.+......  ......|++.|+|||++.+. .++. ++||||||+++|||++|+.||......    
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----  258 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL----  258 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS----
T ss_pred             EcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH----
Confidence            999999999999999876433  34456789999999999877 5666 999999999999999999998632110    


Q ss_pred             ccchhhhccCCCCCCC---------------hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          855 SNMNIEMLDSRLPYPS---------------LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       855 ~~~~~~~~~~~~~~~~---------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ..............+.               ......+..+.+++.+||+.||++|||++|+++
T Consensus       259 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          259 VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1111111111111110               001233456889999999999999999999876

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.8e-37  Score=344.91  Aligned_cols=254  Identities=19%  Similarity=0.315  Sum_probs=182.6

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC-----
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP-----  710 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----  710 (912)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++.....  .....+.+.+|+.+++.++||||+++++++...     
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~  105 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ--SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE  105 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTS--SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCcccc--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence            468999999999999999999865 789999999876432  233567888999999999999999999999654     


Q ss_pred             -CeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccc
Q 039137          711 -KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFG  789 (912)
Q Consensus       711 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  789 (912)
                       ...++|||++ +++|.+++..    ..+++.+++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus       106 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG  177 (367)
T 2fst_X          106 FNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG  177 (367)
T ss_dssp             CCCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC--
T ss_pred             CCeEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecc
Confidence             5679999999 6799988843    4689999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCCCcccccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCccchhcccccc--------------
Q 039137          790 IAKFLNPDSSNWSELAGTHGYVAPELAYT-LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS--------------  854 (912)
Q Consensus       790 la~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~--------------  854 (912)
                      +++.....   .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||..........              
T Consensus       178 ~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~  254 (367)
T 2fst_X          178 LARHTADE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL  254 (367)
T ss_dssp             ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             cccccccc---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            99865432   345678999999999877 678999999999999999999999986321110000              


Q ss_pred             ----ccchhhhccC--CCCCCCh--hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          855 ----SNMNIEMLDS--RLPYPSL--HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       855 ----~~~~~~~~~~--~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                          ..........  ..+....  .....+..+.+++.+||+.||++|||++|+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence                0000000000  0010000  01122456889999999999999999998875

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.2e-36  Score=345.70  Aligned_cols=196  Identities=20%  Similarity=0.288  Sum_probs=171.3

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc------CCCccccEEEEEEc
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI------RHRNIVKFYGFCSH  709 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l------~h~niv~l~~~~~~  709 (912)
                      ..+|++.+.||+|+||+||+|.+. +++.||||++...     ....+.+.+|+.+++.+      +|+||+++++++..
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~  170 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF  170 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence            467999999999999999999876 6899999998642     22456677888888887      57799999999999


Q ss_pred             CCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCc--EEEec
Q 039137          710 PKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYE--AHVSD  787 (912)
Q Consensus       710 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~--~kl~D  787 (912)
                      .+..++||||+. ++|.+++.... ...+++..++.++.||+.||+|||++   +|+||||||+||+++.++.  +||+|
T Consensus       171 ~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~D  245 (429)
T 3kvw_A          171 RNHICMTFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVID  245 (429)
T ss_dssp             TTEEEEEECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECC
T ss_pred             CCeEEEEEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEee
Confidence            999999999996 58999885533 34589999999999999999999999   9999999999999999887  99999


Q ss_pred             cccccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcc
Q 039137          788 FGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRD  845 (912)
Q Consensus       788 fgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~  845 (912)
                      ||+++.....   .....||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       246 FG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~  300 (429)
T 3kvw_A          246 FGSSCYEHQR---VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLP  300 (429)
T ss_dssp             CTTCEETTCC---CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             cccceecCCc---ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCC
Confidence            9999765432   334678999999999999999999999999999999999999986

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=8.2e-37  Score=331.26  Aligned_cols=251  Identities=25%  Similarity=0.441  Sum_probs=193.5

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEc-----
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSH-----  709 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-----  709 (912)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|++..     .....+.+.+|+.+++.++||||+++++++.+     
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-----TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFV   78 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-----EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCC
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-----cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchh
Confidence            3467999999999999999999975 799999999853     22356778999999999999999999998854     


Q ss_pred             --------CCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCC
Q 039137          710 --------PKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGY  781 (912)
Q Consensus       710 --------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~  781 (912)
                              .+..++||||+++|+|.+++...  ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++
T Consensus        79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~  153 (303)
T 1zy4_A           79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESR  153 (303)
T ss_dssp             C------CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTS
T ss_pred             hhhcccccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCC
Confidence                    35679999999999999999543  34578899999999999999999999   999999999999999999


Q ss_pred             cEEEeccccccccCCCC--------------CCccccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCccc
Q 039137          782 EAHVSDFGIAKFLNPDS--------------SNWSELAGTHGYVAPELAYTL-KVTEKCDVYSFGVLALEVIKGKHPRDF  846 (912)
Q Consensus       782 ~~kl~Dfgla~~~~~~~--------------~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~pf~~  846 (912)
                      .+||+|||++.......              .......|++.|+|||++.+. .++.++||||+|+++|||++   ||..
T Consensus       154 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~  230 (303)
T 1zy4_A          154 NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST  230 (303)
T ss_dssp             CEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred             CEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCC
Confidence            99999999998664321              122345689999999998764 68999999999999999998   4431


Q ss_pred             hhccccccccchhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          847 LFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       847 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ....    ..............+.......+..+.+++.+||+.||.+|||++|+++
T Consensus       231 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          231 GMER----VNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             HHHH----HHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             chhH----HHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            1110    0111111112222222222333456789999999999999999999985

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.1e-37  Score=342.68  Aligned_cols=257  Identities=23%  Similarity=0.249  Sum_probs=193.5

Q ss_pred             HHHhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC--
Q 039137          634 ISATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP--  710 (912)
Q Consensus       634 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--  710 (912)
                      ....++|++.+.||+|+||+||+|++. +|+.||||++......        ..+|+++++.++||||+++++++...  
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~--------~~~E~~il~~l~hpnIv~l~~~~~~~~~   74 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY--------KNRELDIMKVLDHVNIIKLVDYFYTTGD   74 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS--------CCHHHHHHTTCCCTTBCCEEEEEEEC--
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch--------HHHHHHHHHHcCCCCccchhheeeecCc
Confidence            345678999999999999999999874 7999999998654322        22699999999999999999998442  


Q ss_pred             ------------------------------------CeeeEEEeecCCCChhhHhhcc-CCcccCCHHHHHHHHHHHHHH
Q 039137          711 ------------------------------------KHSFIIYEYLESGSLDKILCND-ASAKELGWTQRLNVIKGVADA  753 (912)
Q Consensus       711 ------------------------------------~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~  753 (912)
                                                          ...++||||+++ +|.+.+... .....+++..++.++.|++.|
T Consensus        75 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~a  153 (383)
T 3eb0_A           75 EEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRA  153 (383)
T ss_dssp             -----------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHH
Confidence                                                348899999985 887777432 234579999999999999999


Q ss_pred             HHHHHhCCCCCeeecCCCCCCeEEc-CCCcEEEeccccccccCCCCCCccccccccccccccccccC-CCCcchhHHHHH
Q 039137          754 LFYLHNNCFPPIVHRDISSKNVLLD-LGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTL-KVTEKCDVYSFG  831 (912)
Q Consensus       754 L~~LH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG  831 (912)
                      |+|||++   +|+||||||+||+++ .++.+||+|||+++...... ......+|+.|+|||++.+. .++.++||||+|
T Consensus       154 L~~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG  229 (383)
T 3eb0_A          154 VGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYICSRFYRAPELMLGATEYTPSIDLWSIG  229 (383)
T ss_dssp             HHHHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHH
T ss_pred             HHHHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-CCcCcccCCCccCHHHhcCCCCCCcchhhhhHH
Confidence            9999999   999999999999998 68899999999998765432 33455789999999988775 489999999999


Q ss_pred             HHHHHHHhCCCCccchhcccccccc-------chh-------hhccCCCCC---CCh---hhHHHHHHHHHHHHHcccCC
Q 039137          832 VLALEVIKGKHPRDFLFEMSSSSSN-------MNI-------EMLDSRLPY---PSL---HVQKKLMSIMQVAFSCLDQN  891 (912)
Q Consensus       832 ~vl~elltg~~pf~~~~~~~~~~~~-------~~~-------~~~~~~~~~---~~~---~~~~~~~~l~~li~~cl~~d  891 (912)
                      |++|||++|+.||............       ...       .......+.   ...   .....+..+.+++.+||+.|
T Consensus       230 ~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  309 (383)
T 3eb0_A          230 CVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE  309 (383)
T ss_dssp             HHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred             HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence            9999999999998632111000000       000       000000000   000   00113456889999999999


Q ss_pred             CCCCCCHHHHHH
Q 039137          892 PESRPTMKRVSQ  903 (912)
Q Consensus       892 P~~RPt~~evl~  903 (912)
                      |++|||+.|+++
T Consensus       310 P~~R~t~~e~l~  321 (383)
T 3eb0_A          310 PDLRINPYEAMA  321 (383)
T ss_dssp             GGGSCCHHHHHT
T ss_pred             hhhCCCHHHHhc
Confidence            999999999874

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=9.8e-37  Score=339.48  Aligned_cols=263  Identities=22%  Similarity=0.211  Sum_probs=187.6

Q ss_pred             HHHHHHhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEc
Q 039137          631 EEIISATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSH  709 (912)
Q Consensus       631 ~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~  709 (912)
                      ++.....++|++.+.||+|+||+||+|++. +++.||||++......     .....+|++.++.++||||+++++++..
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~l~~l~h~niv~~~~~~~~   90 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF-----RNRELQIMQDLAVLHHPNIVQLQSYFYT   90 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC-----CCHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc-----cHHHHHHHHHHHhcCCCCcccHHHhhhc
Confidence            445667789999999999999999999975 7899999998654322     2345678888899999999999999965


Q ss_pred             CCe-------eeEEEeecCCCChhhHh-hccCCcccCCHHHHHHHHHHHHHHHHHHH--hCCCCCeeecCCCCCCeEEcC
Q 039137          710 PKH-------SFIIYEYLESGSLDKIL-CNDASAKELGWTQRLNVIKGVADALFYLH--NNCFPPIVHRDISSKNVLLDL  779 (912)
Q Consensus       710 ~~~-------~~lv~e~~~~g~L~~~l-~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--~~~~~~ivH~Dlk~~Nill~~  779 (912)
                      .+.       .++||||+++ ++.+.+ ........+++..++.++.|++.|++|||  ++   +|+||||||+||+++.
T Consensus        91 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~  166 (360)
T 3e3p_A           91 LGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNE  166 (360)
T ss_dssp             ECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEET
T ss_pred             cccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeC
Confidence            433       7899999987 444433 22244567899999999999999999999  87   9999999999999996


Q ss_pred             -CCcEEEeccccccccCCCCCCccccccccccccccccccCC-CCcchhHHHHHHHHHHHHhCCCCccchhcccccccc-
Q 039137          780 -GYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLK-VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSN-  856 (912)
Q Consensus       780 -~~~~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~-  856 (912)
                       ++.+||+|||+++...... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||............ 
T Consensus       167 ~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~  245 (360)
T 3e3p_A          167 ADGTLKLCDFGSAKKLSPSE-PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIV  245 (360)
T ss_dssp             TTTEEEECCCTTCBCCCTTS-CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             CCCcEEEeeCCCceecCCCC-CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHH
Confidence             8999999999998765432 334557899999999986654 899999999999999999999998632110000000 


Q ss_pred             --------chhhhccCCC---------CCCC-----hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          857 --------MNIEMLDSRL---------PYPS-----LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       857 --------~~~~~~~~~~---------~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                              ..........         ..+.     ......+..+.+++.+||+.||.+|||+.|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          246 RVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             HHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence                    0000000000         0000     000113467889999999999999999998875

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=3.2e-37  Score=332.30  Aligned_cols=255  Identities=24%  Similarity=0.340  Sum_probs=187.7

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      .++|++.+.||+|+||+||+|++. +++.||+|++.....  .....+.+.++...++.++||||+++++++..++..++
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l   83 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN--SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI   83 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C--HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC--cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence            467999999999999999999875 789999999875432  22233445556666888899999999999999999999


Q ss_pred             EEeecCCCChhhHhhcc-CCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccccccc
Q 039137          716 IYEYLESGSLDKILCND-ASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL  794 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  794 (912)
                      ||||+++ +|.+++... .....+++.+++.++.|++.||+|||++.  +|+||||||+||+++.++.+||+|||++...
T Consensus        84 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           84 CMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             EEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            9999985 887777432 23457999999999999999999999852  8999999999999999999999999999876


Q ss_pred             CCCCCCcccccccccccccccc----ccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCC
Q 039137          795 NPDSSNWSELAGTHGYVAPELA----YTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPS  870 (912)
Q Consensus       795 ~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  870 (912)
                      .... ......|++.|+|||++    .+..++.++||||+|+++|||++|+.||+....    .............+...
T Consensus       161 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~  235 (290)
T 3fme_A          161 VDDV-AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT----PFQQLKQVVEEPSPQLP  235 (290)
T ss_dssp             ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC----HHHHHHHHHHSCCCCCC
T ss_pred             cccc-cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc----hHHHHHHHhccCCCCcc
Confidence            5432 23345789999999996    566789999999999999999999999862111    01111111111111111


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          871 LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       871 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                        ....+..+.+++.+||+.||++|||++|+++
T Consensus       236 --~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          236 --ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             --TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             --cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence              1123456889999999999999999999876

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.3e-36  Score=343.41  Aligned_cols=255  Identities=21%  Similarity=0.305  Sum_probs=197.2

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcC--------CCccccEEEEE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR--------HRNIVKFYGFC  707 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~--------h~niv~l~~~~  707 (912)
                      .++|++.+.||+|+||+||+|++. +++.||||++...     ....+.+.+|+++++.++        |+||+++++++
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~  110 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF  110 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence            468999999999999999999865 6889999998632     224677889999999995        78899999999


Q ss_pred             E----cCCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCC--
Q 039137          708 S----HPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGY--  781 (912)
Q Consensus       708 ~----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~--  781 (912)
                      .    .....++||||+. +++.+++... ....+++.+++.++.||+.||+|||+++  +|+||||||+||+++.++  
T Consensus       111 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~  186 (397)
T 1wak_A          111 KISGVNGTHICMVFEVLG-HHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQY  186 (397)
T ss_dssp             EEEETTEEEEEEEECCCC-CBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHH
T ss_pred             eecCCCCceEEEEEeccC-ccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchh
Confidence            7    5568899999995 4665555332 2356899999999999999999999963  899999999999999775  


Q ss_pred             -----------------------------------------------cEEEeccccccccCCCCCCcccccccccccccc
Q 039137          782 -----------------------------------------------EAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPE  814 (912)
Q Consensus       782 -----------------------------------------------~~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE  814 (912)
                                                                     .+||+|||+++.....   .....||+.|+|||
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE  263 (397)
T 1wak_A          187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLE  263 (397)
T ss_dssp             HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHH
T ss_pred             hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCCh
Confidence                                                           7999999999876432   34457899999999


Q ss_pred             ccccCCCCcchhHHHHHHHHHHHHhCCCCccchhcccccccc----chhhh------------------ccC--------
Q 039137          815 LAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSN----MNIEM------------------LDS--------  864 (912)
Q Consensus       815 ~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~----~~~~~------------------~~~--------  864 (912)
                      ++.+..++.++|||||||++|||++|+.||+...........    .....                  ...        
T Consensus       264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  343 (397)
T 1wak_A          264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT  343 (397)
T ss_dssp             HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred             hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence            999999999999999999999999999998632111000000    00000                  000        


Q ss_pred             -CCCCC--------ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          865 -RLPYP--------SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       865 -~~~~~--------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                       ..+..        .......+..+.+++.+||+.||++|||++|+++
T Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence             00000        0012445667899999999999999999999875

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=7.7e-37  Score=340.49  Aligned_cols=256  Identities=22%  Similarity=0.310  Sum_probs=198.3

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC-----
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP-----  710 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----  710 (912)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++....   .....+.+.+|+++++.++||||+++++++..+     
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  102 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM  102 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT---CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc---CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcccc
Confidence            468999999999999999999876 78899999986422   233457789999999999999999999999765     


Q ss_pred             CeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccc
Q 039137          711 KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGI  790 (912)
Q Consensus       711 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl  790 (912)
                      ...++||||+++ +|.+++..    ..+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+
T Consensus       103 ~~~~iv~e~~~~-~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~  174 (364)
T 3qyz_A          103 KDVYIVQDLMET-DLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGL  174 (364)
T ss_dssp             CCEEEEEECCSE-EHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             ceEEEEEcccCc-CHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcc
Confidence            368999999985 89998843    3589999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCC---Ccccccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCccchhcccccccc------chh-
Q 039137          791 AKFLNPDSS---NWSELAGTHGYVAPELAYT-LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSN------MNI-  859 (912)
Q Consensus       791 a~~~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~------~~~-  859 (912)
                      ++.......   ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||............      ... 
T Consensus       175 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  254 (364)
T 3qyz_A          175 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE  254 (364)
T ss_dssp             CEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHH
T ss_pred             eEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            987653322   1244579999999998654 45899999999999999999999998532111100000      000 


Q ss_pred             -----------hhcc---CCCCCC-ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          860 -----------EMLD---SRLPYP-SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       860 -----------~~~~---~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                                 ....   .....+ .......+..+.+++.+||+.||++|||++|+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                       0000   000000 0001122456889999999999999999999875

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.3e-36  Score=331.36  Aligned_cols=250  Identities=22%  Similarity=0.382  Sum_probs=195.6

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcC--CCccccEEEEEEcCCee
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR--HRNIVKFYGFCSHPKHS  713 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~--h~niv~l~~~~~~~~~~  713 (912)
                      ..++|++.+.||+|+||.||+|++.+++.||+|++......  ....+.+.+|++++++++  ||||+++++++..++..
T Consensus        26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~  103 (313)
T 3cek_A           26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD--NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI  103 (313)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCC--HHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred             ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEecccccc--ccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence            45679999999999999999999988999999998754322  335678899999999997  59999999999999999


Q ss_pred             eEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccc
Q 039137          714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKF  793 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  793 (912)
                      ++||| +.+++|.+++...   ..+++.+++.++.|++.||+|||++   +|+||||||+||++++ +.+||+|||++..
T Consensus       104 ~lv~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~  175 (313)
T 3cek_A          104 YMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQ  175 (313)
T ss_dssp             EEEEC-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC
T ss_pred             EEEEe-cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeecccccc
Confidence            99999 5678999999543   4689999999999999999999999   9999999999999975 8999999999987


Q ss_pred             cCCCCC--Ccccccccccccccccccc-----------CCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhh
Q 039137          794 LNPDSS--NWSELAGTHGYVAPELAYT-----------LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIE  860 (912)
Q Consensus       794 ~~~~~~--~~~~~~g~~~y~aPE~~~~-----------~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~  860 (912)
                      ......  ......|++.|+|||.+.+           ..++.++||||||+++|||++|+.||......    ......
T Consensus       176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~----~~~~~~  251 (313)
T 3cek_A          176 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ----ISKLHA  251 (313)
T ss_dssp             --------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH----HHHHHH
T ss_pred             ccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH----HHHHHH
Confidence            654322  1234578999999999875           46888999999999999999999998532111    011111


Q ss_pred             hccCC--CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          861 MLDSR--LPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       861 ~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ..+..  ...+..    .+..+.+++.+||+.||++|||++|+++
T Consensus       252 ~~~~~~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          252 IIDPNHEIEFPDI----PEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             HHCTTSCCCCCCC----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHhcccccCCccc----chHHHHHHHHHHccCCcccCcCHHHHhc
Confidence            11211  112211    1345789999999999999999999875

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.3e-36  Score=344.65  Aligned_cols=253  Identities=23%  Similarity=0.288  Sum_probs=190.9

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC------
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP------  710 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------  710 (912)
                      .+|++.+.||+|+||+||+|++. +++.||||++......        ..+|+++++.++||||+++++++...      
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~--------~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~  125 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF--------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE  125 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS--------CCHHHHHHHTCCCTTBCCEEEEEEEEETTTTE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh--------HHHHHHHHHHcCCCCccceeeEEeccCCCCcc
Confidence            46889999999999999999986 6999999998654321        23699999999999999999998542      


Q ss_pred             CeeeEEEeecCCCChhhHhhc-cCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCC-CcEEEecc
Q 039137          711 KHSFIIYEYLESGSLDKILCN-DASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLG-YEAHVSDF  788 (912)
Q Consensus       711 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~Df  788 (912)
                      ...++||||+++ ++.+.+.. ......+++..++.++.||+.||+|||++   +|+||||||+||+++.+ +.+||+||
T Consensus       126 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DF  201 (420)
T 1j1b_A          126 VYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDF  201 (420)
T ss_dssp             EEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             eeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccc
Confidence            236799999986 66655532 23346799999999999999999999999   99999999999999965 57899999


Q ss_pred             ccccccCCCCCCccccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCccchhcccccccc---------ch
Q 039137          789 GIAKFLNPDSSNWSELAGTHGYVAPELAYTL-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSN---------MN  858 (912)
Q Consensus       789 gla~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~---------~~  858 (912)
                      |+++...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||............         ..
T Consensus       202 G~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~  280 (420)
T 1j1b_A          202 GSAKQLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ  280 (420)
T ss_dssp             TTCEECCTTC-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             hhhhhcccCC-CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            9998764432 23456789999999998764 6899999999999999999999998632111000000         00


Q ss_pred             hhhccC-----CCCC---CCh---hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          859 IEMLDS-----RLPY---PSL---HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       859 ~~~~~~-----~~~~---~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ......     ..+.   ...   .....+..+.+++.+||+.||++|||+.|+++
T Consensus       281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence            000000     1110   000   00122456889999999999999999998874

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.8e-37  Score=339.25  Aligned_cols=258  Identities=23%  Similarity=0.324  Sum_probs=198.9

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      ..++|++.+.||+|+||.||+|++..  .||+|++........  ..+.+.+|+.+++.++||||+++++++..++..++
T Consensus        31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i  106 (319)
T 2y4i_B           31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNED--QLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAI  106 (319)
T ss_dssp             CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCC--CCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEE
T ss_pred             CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHH--HHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEE
Confidence            45789999999999999999998743  499999875433221  23456789999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ||||+++++|.+++...  ...+++.+++.++.|++.||+|||++   +|+||||||+||+++ ++.+||+|||+++...
T Consensus       107 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~  180 (319)
T 2y4i_B          107 ITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISG  180 (319)
T ss_dssp             ECBCCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred             EeecccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence            99999999999999442  34689999999999999999999999   999999999999998 6799999999987653


Q ss_pred             CC-----CCCcccccccccccccccccc---------CCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhh
Q 039137          796 PD-----SSNWSELAGTHGYVAPELAYT---------LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEM  861 (912)
Q Consensus       796 ~~-----~~~~~~~~g~~~y~aPE~~~~---------~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~  861 (912)
                      ..     ........|++.|+|||++.+         ..++.++||||||+++|||++|+.||......     ......
T Consensus       181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~  255 (319)
T 2y4i_B          181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE-----AIIWQM  255 (319)
T ss_dssp             -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH-----HHHHHH
T ss_pred             cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHh
Confidence            21     122334568999999998874         34788999999999999999999998632111     111111


Q ss_pred             ccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          862 LDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       862 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                      .....+...  ....+..+.+++.+||+.||++|||++++++.|++...
T Consensus       256 ~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~  302 (319)
T 2y4i_B          256 GTGMKPNLS--QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK  302 (319)
T ss_dssp             HTTCCCCCC--CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred             ccCCCCCCC--cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence            111111110  01123457899999999999999999999999987654

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.5e-36  Score=332.95  Aligned_cols=260  Identities=19%  Similarity=0.286  Sum_probs=198.0

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC--CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc---CCCccccEEEEEE--
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP--SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI---RHRNIVKFYGFCS--  708 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l---~h~niv~l~~~~~--  708 (912)
                      +.++|++.+.||+|+||.||+|++.  +++.||+|++........  ....+.+|+.+++.+   +||||+++++++.  
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~   86 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG--MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS   86 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS--CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccccc--CCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence            4578999999999999999999873  688999999864332211  123455777777766   8999999999987  


Q ss_pred             ---cCCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEE
Q 039137          709 ---HPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHV  785 (912)
Q Consensus       709 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  785 (912)
                         .....++||||++ |+|.+++.... ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl  161 (326)
T 1blx_A           87 RTDRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKL  161 (326)
T ss_dssp             ECSSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred             ccCCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEE
Confidence               5567899999998 59999985533 34589999999999999999999999   9999999999999999999999


Q ss_pred             eccccccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccc----------
Q 039137          786 SDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSS----------  855 (912)
Q Consensus       786 ~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~----------  855 (912)
                      +|||+++..... .......+++.|+|||++.+..++.++||||||+++|||++|+.||...........          
T Consensus       162 ~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  240 (326)
T 1blx_A          162 ADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE  240 (326)
T ss_dssp             CSCCSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred             ecCcccccccCC-CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCc
Confidence            999999865432 223456789999999999998999999999999999999999999863211100000          


Q ss_pred             cc-------hhhhcc-CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          856 NM-------NIEMLD-SRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       856 ~~-------~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ..       ...... .............+..+.+++.+||+.||++|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            00       000000 0000000111223456789999999999999999999874

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.1e-36  Score=334.97  Aligned_cols=253  Identities=21%  Similarity=0.282  Sum_probs=173.9

Q ss_pred             HhcCCCCCc-eeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEc----
Q 039137          636 ATNDFNAEH-CIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSH----  709 (912)
Q Consensus       636 ~~~~~~~~~-~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~----  709 (912)
                      ..++|++.+ .||+|+||+||+|+++ +++.||+|++...        .....+....++.++||||+++++++..    
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~   97 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS--------PKARQEVDHHWQASGGPHIVCILDVYENMHHG   97 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc--------HHHHHHHHHHHHhcCCCChHHHHHHHhhccCC
Confidence            356888854 6999999999999886 7999999998532        1111223334566789999999999976    


Q ss_pred             CCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcC---CCcEEEe
Q 039137          710 PKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDL---GYEAHVS  786 (912)
Q Consensus       710 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~  786 (912)
                      ....++||||+++|+|.+++.... ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.   ++.+||+
T Consensus        98 ~~~~~lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~  173 (336)
T 3fhr_A           98 KRCLLIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLT  173 (336)
T ss_dssp             EEEEEEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred             CceEEEEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEe
Confidence            455899999999999999995532 34689999999999999999999999   9999999999999986   4559999


Q ss_pred             ccccccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCC
Q 039137          787 DFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRL  866 (912)
Q Consensus       787 Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  866 (912)
                      |||+++.....  ......+|+.|+|||++.+..++.++||||+|+++|+|++|+.||......... ............
T Consensus       174 Dfg~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~  250 (336)
T 3fhr_A          174 DFGFAKETTQN--ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS-PGMKRRIRLGQY  250 (336)
T ss_dssp             CCTTCEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------
T ss_pred             ccccceecccc--ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh-hhHHHhhhcccc
Confidence            99999865432  234557899999999998888999999999999999999999998632221110 000111111111


Q ss_pred             CCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          867 PYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       867 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ..+.......+..+.+++.+||+.||++|||++|+++
T Consensus       251 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          251 GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            2222222334566889999999999999999999987

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.2e-36  Score=339.67  Aligned_cols=253  Identities=20%  Similarity=0.333  Sum_probs=195.0

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCee--
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHS--  713 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~--  713 (912)
                      .++|.+.+.||+|+||+||+|.+. +|+.||+|++......  ....+.+.+|+.+++.++||||+++++++...+..  
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  118 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS--EIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN  118 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSS--HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTT
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccc--hhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccc
Confidence            468999999999999999999876 7899999999765322  33467889999999999999999999999877654  


Q ss_pred             ----eEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccc
Q 039137          714 ----FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFG  789 (912)
Q Consensus       714 ----~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  789 (912)
                          ++||||+. ++|.+++.     ..+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus       119 ~~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg  189 (371)
T 4exu_A          119 FYDFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFG  189 (371)
T ss_dssp             CCCCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTT
T ss_pred             ceeEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecC
Confidence                99999998 58888772     3489999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCCCcccccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCccchhccccccc-------------
Q 039137          790 IAKFLNPDSSNWSELAGTHGYVAPELAYT-LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSS-------------  855 (912)
Q Consensus       790 la~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~-------------  855 (912)
                      +++.....   .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||...........             
T Consensus       190 ~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  266 (371)
T 4exu_A          190 LARHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV  266 (371)
T ss_dssp             CC-----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             cccccccC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHH
Confidence            99865432   344578999999999887 6789999999999999999999999863211000000             


Q ss_pred             -----cchhhhccC--CCCCCC--hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          856 -----NMNIEMLDS--RLPYPS--LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       856 -----~~~~~~~~~--~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                           .........  ..+...  ......+..+.+++.+||+.||++|||++|+++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence                 000000000  000000  001123467889999999999999999998875

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=1.7e-36  Score=341.27  Aligned_cols=334  Identities=22%  Similarity=0.227  Sum_probs=201.1

Q ss_pred             cccccEEEccCCcCCCCCCccCCCCccceeeeeccCCCcCccccccccccccceeecccccccCccccccccccccceee
Q 039137          180 LTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLF  259 (912)
Q Consensus       180 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~  259 (912)
                      +++++.|++++|.++...+..+.++++|++|+|++|.+++..+..|+++++|++|++++|++++..|..|+++++|++|+
T Consensus        44 l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  123 (390)
T 3o6n_A           44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV  123 (390)
T ss_dssp             GCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             cCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEE
Confidence            46677888888877743333456677777777777777665556666666666666666666666566666666666666


Q ss_pred             eccccCcccCCcccCCccccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCcc
Q 039137          260 LYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFG  339 (912)
Q Consensus       260 L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  339 (912)
                      |++|+++...+..|.++++|++|++++|++++..|..|..+++|++|++++|.+++.   .+..+++|+.|++++|.+.+
T Consensus       124 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~  200 (390)
T 3o6n_A          124 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLST  200 (390)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCSE
T ss_pred             CCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeecccccccc
Confidence            666666644444456666666666666666655555566666666666666655543   13334555555555554432


Q ss_pred             cccccCCCCCCCCEEeccCCcccccccccccccccccEEEccCccccCCCCccccccccccEEEccCCcccCCCcccccc
Q 039137          340 EILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGS  419 (912)
Q Consensus       340 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~  419 (912)
                      .                             ....+|++|++++|.+... |..  ..++|+.|++++|++++.  ..+..
T Consensus       201 ~-----------------------------~~~~~L~~L~l~~n~l~~~-~~~--~~~~L~~L~l~~n~l~~~--~~l~~  246 (390)
T 3o6n_A          201 L-----------------------------AIPIAVEELDASHNSINVV-RGP--VNVELTILKLQHNNLTDT--AWLLN  246 (390)
T ss_dssp             E-----------------------------ECCSSCSEEECCSSCCCEE-ECC--CCSSCCEEECCSSCCCCC--GGGGG
T ss_pred             c-----------------------------CCCCcceEEECCCCeeeec-ccc--ccccccEEECCCCCCccc--HHHcC
Confidence            1                             1223455555555555432 221  134566666666666542  35666


Q ss_pred             ccccccccccCcccCccccccccccccccEEEecccccccccchhhhcccccceeeccccccCccccccccccccccccc
Q 039137          420 LINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLN  499 (912)
Q Consensus       420 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  499 (912)
                      +++|++|+|++|.+++..|..|..+++|++|+|++|++++ +|..+..+++|++|+|++|++++ +|..+..+++|+.|+
T Consensus       247 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~  324 (390)
T 3o6n_A          247 YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLY  324 (390)
T ss_dssp             CTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCCC-CGGGHHHHTTCSEEE
T ss_pred             CCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCccee-cCccccccCcCCEEE
Confidence            6667777777777766666666667777777777777753 45555666777777777777753 445566677777777


Q ss_pred             ccCccccCCCcccccccccceEEEccCCccccCCCCCccCCCCchhhhccCCcccCC
Q 039137          500 LSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNSTTFRDAPLEALQGNKGLYGD  556 (912)
Q Consensus       500 ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~~~~~~~~~~~~~~l~~n~~~~~~  556 (912)
                      +++|++++..   +..+++|+.|++++|++.|.... ..+.......+.+++..|..
T Consensus       325 L~~N~i~~~~---~~~~~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~c~~  377 (390)
T 3o6n_A          325 LDHNSIVTLK---LSTHHTLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKI  377 (390)
T ss_dssp             CCSSCCCCCC---CCTTCCCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCSCCCT
T ss_pred             CCCCccceeC---chhhccCCEEEcCCCCccchhHH-HHHHHHHhhcccccCceecc
Confidence            7777776652   55667777788888877763221 12223333334455555543

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.6e-36  Score=331.81  Aligned_cols=255  Identities=22%  Similarity=0.308  Sum_probs=190.7

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEE-------
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCS-------  708 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~-------  708 (912)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++...    .....+++.+|+++++.++||||+++++++.       
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   85 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT----DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT   85 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC----SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCC
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC----ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccc
Confidence            468999999999999999999986 5899999998643    2235678899999999999999999999984       


Q ss_pred             -------cCCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEc-CC
Q 039137          709 -------HPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLD-LG  780 (912)
Q Consensus       709 -------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~-~~  780 (912)
                             ..+..++||||++ |+|.+++..    +.+++.+++.++.|++.||+|||++   +|+||||||+||+++ ++
T Consensus        86 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~  157 (320)
T 2i6l_A           86 DDVGSLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTED  157 (320)
T ss_dssp             C----CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTT
T ss_pred             cccccccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCC
Confidence                   3467899999998 599999832    4689999999999999999999999   999999999999997 56


Q ss_pred             CcEEEeccccccccCCCC---CCcccccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCccchhccccccc-
Q 039137          781 YEAHVSDFGIAKFLNPDS---SNWSELAGTHGYVAPELAYT-LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSS-  855 (912)
Q Consensus       781 ~~~kl~Dfgla~~~~~~~---~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~-  855 (912)
                      +.+||+|||+++......   .......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||........... 
T Consensus       158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  237 (320)
T 2i6l_A          158 LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI  237 (320)
T ss_dssp             TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            799999999998764321   22334567899999998765 6789999999999999999999999863221100000 


Q ss_pred             ---------cchhhhc---------cCCCCCCC--hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          856 ---------NMNIEML---------DSRLPYPS--LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       856 ---------~~~~~~~---------~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                               ....+..         +...+...  ......+..+.+++.+||+.||++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             HHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence                     0000000         00000000  001123466889999999999999999999875

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=6e-36  Score=330.04  Aligned_cols=254  Identities=22%  Similarity=0.327  Sum_probs=199.0

Q ss_pred             hcCCCCCceeeecCceEEEEEEe-C-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCc------cccEEEEEE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKV-P-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRN------IVKFYGFCS  708 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n------iv~l~~~~~  708 (912)
                      .++|++.+.||+|+||+||+|.+ + +++.||+|++...     ....+.+.+|+++++.++|++      ++++++++.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~   87 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE   87 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence            46899999999999999999986 3 6889999998632     224577889999999997654      999999999


Q ss_pred             cCCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcC---------
Q 039137          709 HPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDL---------  779 (912)
Q Consensus       709 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~---------  779 (912)
                      ..+..++||||+ +++|.+++.... ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.         
T Consensus        88 ~~~~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~  162 (339)
T 1z57_A           88 HHGHICIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNP  162 (339)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC-
T ss_pred             cCCcEEEEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCC
Confidence            999999999999 789999985532 24688999999999999999999999   9999999999999987         


Q ss_pred             ----------CCcEEEeccccccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhc
Q 039137          780 ----------GYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFE  849 (912)
Q Consensus       780 ----------~~~~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~  849 (912)
                                ++.+||+|||+++.....   .....||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus       163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  239 (339)
T 1z57_A          163 KIKRDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS  239 (339)
T ss_dssp             ---CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred             ccccccccccCCCceEeeCcccccCccc---cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence                      668999999999865432   3445789999999999999999999999999999999999999863211


Q ss_pred             ccccc------ccchhhhc----------cCCCCCC-------------------ChhhHHHHHHHHHHHHHcccCCCCC
Q 039137          850 MSSSS------SNMNIEML----------DSRLPYP-------------------SLHVQKKLMSIMQVAFSCLDQNPES  894 (912)
Q Consensus       850 ~~~~~------~~~~~~~~----------~~~~~~~-------------------~~~~~~~~~~l~~li~~cl~~dP~~  894 (912)
                      .....      ........          .......                   .......+..+.+++.+||+.||++
T Consensus       240 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  319 (339)
T 1z57_A          240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK  319 (339)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence            10000      00000000          0000000                   0001234567889999999999999


Q ss_pred             CCCHHHHHH
Q 039137          895 RPTMKRVSQ  903 (912)
Q Consensus       895 RPt~~evl~  903 (912)
                      |||++|+++
T Consensus       320 Rpt~~ell~  328 (339)
T 1z57_A          320 RITLREALK  328 (339)
T ss_dssp             SCCHHHHTT
T ss_pred             ccCHHHHhc
Confidence            999999875

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.7e-36  Score=361.16  Aligned_cols=257  Identities=24%  Similarity=0.369  Sum_probs=204.6

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC----CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCe
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP----SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKH  712 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~  712 (912)
                      .++|++.+.||+|+||+||+|.+.    .+..||+|++....   .....+.+.+|+.+++.++||||+++++++. ++.
T Consensus       389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~  464 (656)
T 2j0j_A          389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT---SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP  464 (656)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred             cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCc
Confidence            467899999999999999999874    24579999986432   2235678999999999999999999999984 567


Q ss_pred             eeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccccc
Q 039137          713 SFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK  792 (912)
Q Consensus       713 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  792 (912)
                      .++||||+++|+|.+++...  ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus       465 ~~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~  539 (656)
T 2j0j_A          465 VWIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR  539 (656)
T ss_dssp             CEEEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred             eEEEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCe
Confidence            89999999999999999543  24589999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCC-CccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhcc-CCCCCC
Q 039137          793 FLNPDSS-NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLD-SRLPYP  869 (912)
Q Consensus       793 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~  869 (912)
                      ....... ......+++.|+|||++.+..++.++||||||+++|||++ |..||......     .....+.. ...+.+
T Consensus       540 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~-----~~~~~i~~~~~~~~~  614 (656)
T 2j0j_A          540 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-----DVIGRIENGERLPMP  614 (656)
T ss_dssp             SCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHHHHHHTCCCCCC
T ss_pred             ecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH-----HHHHHHHcCCCCCCC
Confidence            7654322 1223456789999999998899999999999999999997 99998632111     11111111 112222


Q ss_pred             ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 039137          870 SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE  911 (912)
Q Consensus       870 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~~  911 (912)
                      .    ..+..+.+++.+||+.||++|||+.|+++.|++.+.+
T Consensus       615 ~----~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~  652 (656)
T 2j0j_A          615 P----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  652 (656)
T ss_dssp             T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             c----cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence            1    2345688999999999999999999999999988753

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=7.3e-37  Score=345.78  Aligned_cols=199  Identities=23%  Similarity=0.378  Sum_probs=154.4

Q ss_pred             hcCCCC-CceeeecCceEEEEEEeC---CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEc--C
Q 039137          637 TNDFNA-EHCIGKGGHGSVYRAKVP---SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSH--P  710 (912)
Q Consensus       637 ~~~~~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~  710 (912)
                      .+.|++ +++||+|+||+||+|+++   +++.||+|++....      ..+.+.+|+.+++.++||||+++++++..  .
T Consensus        19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   92 (405)
T 3rgf_A           19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG------ISMSACREIALLRELKHPNVISLQKVFLSHAD   92 (405)
T ss_dssp             HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS------CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTT
T ss_pred             hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC------CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCC
Confidence            345666 558999999999999865   57889999986432      13457799999999999999999999954  6


Q ss_pred             CeeeEEEeecCCCChhhHhhccC------CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEE----cCC
Q 039137          711 KHSFIIYEYLESGSLDKILCNDA------SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLL----DLG  780 (912)
Q Consensus       711 ~~~~lv~e~~~~g~L~~~l~~~~------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill----~~~  780 (912)
                      ...++||||+++ +|.+++....      ....+++.+++.++.||+.||+|||++   +|+||||||+||++    +.+
T Consensus        93 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~  168 (405)
T 3rgf_A           93 RKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPER  168 (405)
T ss_dssp             TEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTT
T ss_pred             CeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCC
Confidence            789999999975 7877774321      223489999999999999999999999   99999999999999    678


Q ss_pred             CcEEEeccccccccCCCC---CCccccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCcc
Q 039137          781 YEAHVSDFGIAKFLNPDS---SNWSELAGTHGYVAPELAYTL-KVTEKCDVYSFGVLALEVIKGKHPRD  845 (912)
Q Consensus       781 ~~~kl~Dfgla~~~~~~~---~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~pf~  845 (912)
                      +.+||+|||+++......   .......||+.|+|||++.+. .++.++||||+||++|||++|+.||.
T Consensus       169 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~  237 (405)
T 3rgf_A          169 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH  237 (405)
T ss_dssp             TCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             CcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCC
Confidence            899999999998765432   223456789999999998874 48999999999999999999999985

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2.9e-36  Score=334.67  Aligned_cols=256  Identities=24%  Similarity=0.338  Sum_probs=197.2

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC-----
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP-----  710 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----  710 (912)
                      .++|++.+.||+|+||.||+|++. +|+.||||++...   ........+.+|+++++.++||||+++++++..+     
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   86 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF---DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF   86 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc---ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence            468999999999999999999876 7899999998642   2233466788999999999999999999998654     


Q ss_pred             CeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccc
Q 039137          711 KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGI  790 (912)
Q Consensus       711 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl  790 (912)
                      ...++||||++ ++|.+++..    ..+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+
T Consensus        87 ~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~  158 (353)
T 2b9h_A           87 NEVYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGL  158 (353)
T ss_dssp             CCEEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred             ceEEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccc
Confidence            67899999997 589998844    4689999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCC----------cccccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCccchhccccc------
Q 039137          791 AKFLNPDSSN----------WSELAGTHGYVAPELAYT-LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS------  853 (912)
Q Consensus       791 a~~~~~~~~~----------~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~------  853 (912)
                      ++........          .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........      
T Consensus       159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  238 (353)
T 2b9h_A          159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGI  238 (353)
T ss_dssp             CEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             ccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Confidence            9876532211          223568999999998754 67899999999999999999999998632110000      


Q ss_pred             -------------cccchhhhccCC--CCCCC--hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          854 -------------SSNMNIEMLDSR--LPYPS--LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       854 -------------~~~~~~~~~~~~--~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                                   ......+.....  .+...  ......+..+.+++.+||+.||++|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                         000000000000  00000  011123456889999999999999999999875

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.4e-36  Score=333.47  Aligned_cols=256  Identities=25%  Similarity=0.333  Sum_probs=179.2

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHH-HHhhcCCCccccEEEEEEcCCeee
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQ-ALTEIRHRNIVKFYGFCSHPKHSF  714 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~-~l~~l~h~niv~l~~~~~~~~~~~  714 (912)
                      .++|++.+.||+|+||.||+|..+ +++.||||++.....   .....++.+|+. +++.++||||+++++++..++..+
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~   97 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD---EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCW   97 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC---HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC---chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceE
Confidence            367999999999999999999985 789999999975432   223455666666 677789999999999999999999


Q ss_pred             EEEeecCCCChhhHhhcc--CCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccccc
Q 039137          715 IIYEYLESGSLDKILCND--ASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK  792 (912)
Q Consensus       715 lv~e~~~~g~L~~~l~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  792 (912)
                      +||||+++ +|.+++...  .....+++..+..++.|++.||+|||++.  +|+||||||+||+++.++.+||+|||+++
T Consensus        98 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~  174 (327)
T 3aln_A           98 ICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISG  174 (327)
T ss_dssp             EEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred             EEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence            99999986 887777431  12456899999999999999999999952  89999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccccccccccc----ccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCC-C
Q 039137          793 FLNPDSSNWSELAGTHGYVAPELA----YTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRL-P  867 (912)
Q Consensus       793 ~~~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~  867 (912)
                      ...... ......|++.|+|||++    .+..++.++||||||+++|||++|+.||........    .......... .
T Consensus       175 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~~~~~~~~~  249 (327)
T 3aln_A          175 QLVDSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD----QLTQVVKGDPPQ  249 (327)
T ss_dssp             C-------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------CCCCCSCCCC
T ss_pred             eccccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH----HHHHHhcCCCCC
Confidence            764332 22344789999999998    456789999999999999999999999863211100    0011111111 1


Q ss_pred             CCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          868 YPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       868 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .+.......+..+.+++.+||+.||++|||+.|+++
T Consensus       250 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          250 LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            111111123456889999999999999999999875

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=3.5e-36  Score=342.58  Aligned_cols=248  Identities=25%  Similarity=0.388  Sum_probs=187.4

Q ss_pred             cCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv  716 (912)
                      +.|...+.||+|+||+||.+...+|+.||||++...       ..+.+.+|+++++++ +||||+++++++.+++..++|
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~-------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv   87 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID-------FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA   87 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG-------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH-------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence            345567889999999998776678999999998532       245678999999987 899999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcc----cCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCC------------
Q 039137          717 YEYLESGSLDKILCNDASAK----ELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLG------------  780 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~------------  780 (912)
                      |||++ |+|.+++.......    ..++.+++.++.||+.||+|||++   +|+||||||+||+++.+            
T Consensus        88 ~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~  163 (434)
T 2rio_A           88 LELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAE  163 (434)
T ss_dssp             ECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCC
T ss_pred             EecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCC
Confidence            99996 59999996543221    124456788999999999999999   99999999999999754            


Q ss_pred             -CcEEEeccccccccCCCCCC----cccccccccccccccccc-------CCCCcchhHHHHHHHHHHHHh-CCCCccch
Q 039137          781 -YEAHVSDFGIAKFLNPDSSN----WSELAGTHGYVAPELAYT-------LKVTEKCDVYSFGVLALEVIK-GKHPRDFL  847 (912)
Q Consensus       781 -~~~kl~Dfgla~~~~~~~~~----~~~~~g~~~y~aPE~~~~-------~~~~~~sDvwslG~vl~ellt-g~~pf~~~  847 (912)
                       +.+||+|||+++........    .....||+.|+|||++.+       ..++.++|||||||++|||++ |+.||+..
T Consensus       164 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~  243 (434)
T 2rio_A          164 NLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK  243 (434)
T ss_dssp             SCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred             ceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence             47999999999877554322    234579999999999875       568999999999999999999 99998632


Q ss_pred             hccccccccchhhhccCCCC---CCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          848 FEMSSSSSNMNIEMLDSRLP---YPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       848 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ....       .........   .........+..+.+++.+||+.||++|||+.|+++
T Consensus       244 ~~~~-------~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          244 YSRE-------SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             TTHH-------HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhH-------HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            1110       111111111   111122455677899999999999999999999875

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=3.3e-36  Score=334.10  Aligned_cols=252  Identities=19%  Similarity=0.327  Sum_probs=194.5

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCe---
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKH---  712 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~---  712 (912)
                      .++|.+.+.||+|+||.||+|.++ +|+.||||++.....  .....+.+.+|+.+++.++||||+++++++...+.   
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  100 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ--SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN  100 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTS--SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEeccccc--chHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccc
Confidence            357999999999999999999875 789999999976432  23346778999999999999999999999987654   


Q ss_pred             ---eeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccc
Q 039137          713 ---SFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFG  789 (912)
Q Consensus       713 ---~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  789 (912)
                         .++||||++ ++|.+++.     ..+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus       101 ~~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg  171 (353)
T 3coi_A          101 FYDFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFG  171 (353)
T ss_dssp             CCCCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTT
T ss_pred             ceeEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecc
Confidence               499999998 58888772     2489999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCCCcccccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCccchhccccccc-------------
Q 039137          790 IAKFLNPDSSNWSELAGTHGYVAPELAYT-LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSS-------------  855 (912)
Q Consensus       790 la~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~-------------  855 (912)
                      +++.....   .....+++.|+|||++.+ ..++.++||||+|+++|||++|+.||...........             
T Consensus       172 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  248 (353)
T 3coi_A          172 LARHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV  248 (353)
T ss_dssp             CTTC-----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHH
T ss_pred             cccCCCCC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            99865432   344578999999998877 6789999999999999999999999863211000000             


Q ss_pred             -----cchhhhcc-----CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          856 -----NMNIEMLD-----SRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       856 -----~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                           ........     ...... ......+..+.+++.+||+.||++|||++|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          249 QKLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             TTCSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                 00000000     000000 011233566889999999999999999998874

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.6e-36  Score=353.89  Aligned_cols=257  Identities=28%  Similarity=0.348  Sum_probs=200.8

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEc------
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSH------  709 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~------  709 (912)
                      .++|++.+.||+|+||+||+|.+. +|+.||||++....   .....+.+.+|+++++.++||||+++++++..      
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~---~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~   89 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL---SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP   89 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC---CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC---CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence            378999999999999999999875 68999999986542   23356779999999999999999999999755      


Q ss_pred             CCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCc---EEEe
Q 039137          710 PKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYE---AHVS  786 (912)
Q Consensus       710 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~  786 (912)
                      .+..++||||+++|+|.+++........+++..++.++.|++.||+|||++   +|+||||||+||+++.++.   +||+
T Consensus        90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~  166 (676)
T 3qa8_A           90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKII  166 (676)
T ss_dssp             TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred             CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEc
Confidence            677899999999999999997665555799999999999999999999999   9999999999999997765   9999


Q ss_pred             ccccccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccc---------cccc
Q 039137          787 DFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS---------SSNM  857 (912)
Q Consensus       787 Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~---------~~~~  857 (912)
                      |||.+....... ......|++.|+|||++.+..++.++||||+|+++|+|++|..||.........         ....
T Consensus       167 DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~  245 (676)
T 3qa8_A          167 DLGYAKELDQGE-LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV  245 (676)
T ss_dssp             SCCCCCBTTSCC-CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CC
T ss_pred             cccccccccccc-ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhh
Confidence            999998765432 334567899999999999999999999999999999999999998532110000         0000


Q ss_pred             hhh------hccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 039137          858 NIE------MLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKR  900 (912)
Q Consensus       858 ~~~------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e  900 (912)
                      ...      ......+.+.......+..+.+++.+||+.||++|||++|
T Consensus       246 ~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e  294 (676)
T 3qa8_A          246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ  294 (676)
T ss_dssp             SCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred             hhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence            000      0111222222233345677899999999999999999977

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-36  Score=329.98  Aligned_cols=248  Identities=22%  Similarity=0.338  Sum_probs=192.8

Q ss_pred             HHHHhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCch--HHHHHHHHHHHHHhhc----CCCccccEEE
Q 039137          633 IISATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMS--FQQEEFLNEIQALTEI----RHRNIVKFYG  705 (912)
Q Consensus       633 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~--~~~~~~~~Ei~~l~~l----~h~niv~l~~  705 (912)
                      .....++|++.+.||+|+||.||+|++. +++.||+|++.........  .....+.+|+.+++++    +||||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            3455688999999999999999999875 7889999999754332111  1233456799999998    8999999999


Q ss_pred             EEEcCCeeeEEEee-cCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEc-CCCcE
Q 039137          706 FCSHPKHSFIIYEY-LESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLD-LGYEA  783 (912)
Q Consensus       706 ~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~-~~~~~  783 (912)
                      ++...+..++|||| +.+++|.+++..   ...+++.+++.++.|++.||+|||++   +|+||||||+||+++ .++.+
T Consensus       106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~  179 (312)
T 2iwi_A          106 WFETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCA  179 (312)
T ss_dssp             EC-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEE
T ss_pred             EEecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeE
Confidence            99999999999999 789999999954   34689999999999999999999999   999999999999999 88999


Q ss_pred             EEeccccccccCCCCCCccccccccccccccccccCCCC-cchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhc
Q 039137          784 HVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVT-EKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEML  862 (912)
Q Consensus       784 kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~  862 (912)
                      ||+|||+++.....  ......|++.|+|||++.+..+. .++||||||+++|||++|+.||+....           ..
T Consensus       180 kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----------~~  246 (312)
T 2iwi_A          180 KLIDFGSGALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-----------IL  246 (312)
T ss_dssp             EECCCSSCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----------HH
T ss_pred             EEEEcchhhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-----------Hh
Confidence            99999999876543  33456789999999998877664 589999999999999999999863211           11


Q ss_pred             cCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          863 DSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       863 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ......+.    ..+..+.+++.+||+.||++|||++|+++
T Consensus       247 ~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          247 EAELHFPA----HVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             HTCCCCCT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             hhccCCcc----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            12222221    22345789999999999999999999976

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=2.8e-36  Score=358.19  Aligned_cols=335  Identities=22%  Similarity=0.215  Sum_probs=210.6

Q ss_pred             cccccEEEccCCcCCCCCCccCCCCccceeeeeccCCCcCccccccccccccceeecccccccCccccccccccccceee
Q 039137          180 LTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLF  259 (912)
Q Consensus       180 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~  259 (912)
                      +++++.|++++|.+....+..+.++++|++|+|++|.+++..|..|+++++|++|+|++|.+++..|..|+++++|++|+
T Consensus        50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  129 (597)
T 3oja_B           50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV  129 (597)
T ss_dssp             GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEE
Confidence            45677888888887754444566777777777777777766666777777777777777777766666666777777777


Q ss_pred             eccccCcccCCcccCCccccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCcc
Q 039137          260 LYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFG  339 (912)
Q Consensus       260 L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  339 (912)
                      |++|.+++..+..|+++++|++|+|++|.+++..|..|..+++|++|+|++|.+++..   ++.+++|+.|++++|.+.+
T Consensus       130 L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~~  206 (597)
T 3oja_B          130 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLST  206 (597)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCSE
T ss_pred             eeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCcccc
Confidence            7777776555555566666666666666666666666666666666666666665432   3334555555555555543


Q ss_pred             cccccCCCCCCCCEEeccCCcccccccccccccccccEEEccCccccCCCCccccccccccEEEccCCcccCCCcccccc
Q 039137          340 EILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGS  419 (912)
Q Consensus       340 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~  419 (912)
                      .     ...+                        +|+.|++++|.+... +..+  .++|+.|+|++|.+++  +..+..
T Consensus       207 l-----~~~~------------------------~L~~L~ls~n~l~~~-~~~~--~~~L~~L~L~~n~l~~--~~~l~~  252 (597)
T 3oja_B          207 L-----AIPI------------------------AVEELDASHNSINVV-RGPV--NVELTILKLQHNNLTD--TAWLLN  252 (597)
T ss_dssp             E-----ECCT------------------------TCSEEECCSSCCCEE-ECSC--CSCCCEEECCSSCCCC--CGGGGG
T ss_pred             c-----cCCc------------------------hhheeeccCCccccc-cccc--CCCCCEEECCCCCCCC--Chhhcc
Confidence            2     1223                        455555555555422 1111  1356666666666654  245666


Q ss_pred             ccccccccccCcccCccccccccccccccEEEecccccccccchhhhcccccceeeccccccCccccccccccccccccc
Q 039137          420 LINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLN  499 (912)
Q Consensus       420 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  499 (912)
                      +++|+.|+|++|.+++.+|..|..+++|+.|+|++|++++ +|..+..+++|+.|+|++|.++ .+|..+..+++|+.|+
T Consensus       253 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~  330 (597)
T 3oja_B          253 YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLY  330 (597)
T ss_dssp             CTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEE
T ss_pred             CCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEE
Confidence            6667777777777766666666667777777777777764 4555566677777777777775 3455566777777777


Q ss_pred             ccCccccCCCcccccccccceEEEccCCccccCCCCCccCCCCchhhhccCCcccCCc
Q 039137          500 LSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNSTTFRDAPLEALQGNKGLYGDI  557 (912)
Q Consensus       500 ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~~~~~~~~~~~~~~l~~n~~~~~~~  557 (912)
                      |++|+|++..   +..++.|+.|++++|+|.|.... ..+.......+.+++..|+..
T Consensus       331 L~~N~l~~~~---~~~~~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~C~~~  384 (597)
T 3oja_B          331 LDHNSIVTLK---LSTHHTLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKID  384 (597)
T ss_dssp             CCSSCCCCCC---CCTTCCCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCCCCCTT
T ss_pred             CCCCCCCCcC---hhhcCCCCEEEeeCCCCCChhHH-HHHHHHhhhccccccccCCcc
Confidence            7777776653   55567778888888888774321 223444444556677777653

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=7.4e-37  Score=334.20  Aligned_cols=247  Identities=21%  Similarity=0.334  Sum_probs=200.5

Q ss_pred             HHHhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCch--HHHHHHHHHHHHHhhcC--CCccccEEEEEE
Q 039137          634 ISATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMS--FQQEEFLNEIQALTEIR--HRNIVKFYGFCS  708 (912)
Q Consensus       634 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~--~~~~~~~~Ei~~l~~l~--h~niv~l~~~~~  708 (912)
                      ....++|++.+.||+|+||.||+|++. +++.||||++.........  ...+.+.+|+.+++.++  ||||+++++++.
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~  118 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE  118 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence            345678999999999999999999865 7899999998654322210  01244668999999996  599999999999


Q ss_pred             cCCeeeEEEeecCC-CChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEc-CCCcEEEe
Q 039137          709 HPKHSFIIYEYLES-GSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLD-LGYEAHVS  786 (912)
Q Consensus       709 ~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~  786 (912)
                      .++..++|||++.+ ++|.+++..   ...+++.+++.++.|++.||+|||++   +|+||||||+||+++ +++.+||+
T Consensus       119 ~~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~  192 (320)
T 3a99_A          119 RPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLI  192 (320)
T ss_dssp             CSSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEEC
T ss_pred             cCCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEe
Confidence            99999999999976 899999854   35689999999999999999999999   999999999999999 78899999


Q ss_pred             ccccccccCCCCCCccccccccccccccccccCCC-CcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCC
Q 039137          787 DFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKV-TEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSR  865 (912)
Q Consensus       787 Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  865 (912)
                      |||+++.....  ......|++.|+|||++.+..+ +.++||||||+++|||++|+.||......           ....
T Consensus       193 Dfg~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----------~~~~  259 (320)
T 3a99_A          193 DFGSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI-----------IRGQ  259 (320)
T ss_dssp             CCTTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH-----------HHCC
T ss_pred             eCccccccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh-----------hccc
Confidence            99999876532  3345678999999999887766 67899999999999999999998632211           1111


Q ss_pred             CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          866 LPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       866 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ...+.    ..+..+.+++.+||+.||++|||++|+++
T Consensus       260 ~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          260 VFFRQ----RVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             CCCSS----CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ccccc----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            11111    12345789999999999999999999876

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.7e-35  Score=331.80  Aligned_cols=199  Identities=21%  Similarity=0.295  Sum_probs=170.1

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcC-CC-----ccccEEEEEE
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR-HR-----NIVKFYGFCS  708 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~-----niv~l~~~~~  708 (912)
                      ..++|++.+.||+|+||+||+|++. +++.||||++...     ....+++.+|+.+++.++ |+     +|+++++++.
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~  126 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM  126 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence            3578999999999999999999876 6889999998632     224566778999988885 55     4999999999


Q ss_pred             cCCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEc--CCCcEEEe
Q 039137          709 HPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLD--LGYEAHVS  786 (912)
Q Consensus       709 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~--~~~~~kl~  786 (912)
                      ..+..++||||+++ +|.+++.... ...+++..++.++.|++.||+|||++. .+|+||||||+||+++  .++.+||+
T Consensus       127 ~~~~~~lv~e~~~~-~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~  203 (382)
T 2vx3_A          127 FRNHLCLVFEMLSY-NLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIV  203 (382)
T ss_dssp             ETTEEEEEEECCCC-BHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred             cCCceEEEEecCCC-CHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEE
Confidence            99999999999965 9999985533 345899999999999999999999531 1899999999999995  47789999


Q ss_pred             ccccccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcc
Q 039137          787 DFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRD  845 (912)
Q Consensus       787 Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~  845 (912)
                      |||+++.....   .....||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       204 DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~  259 (382)
T 2vx3_A          204 DFGSSCQLGQR---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFS  259 (382)
T ss_dssp             CCTTCEETTCC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             eccCceecccc---cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            99999876432   345678999999999999999999999999999999999999996

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=100.00  E-value=7.1e-37  Score=334.71  Aligned_cols=291  Identities=21%  Similarity=0.247  Sum_probs=188.2

Q ss_pred             CCCHHHHHHHHHHHHhcccCCcccCCCcccCCCCCCCCCCCccceeEecCCCCeEEEeeccccccccccccccCCCCCcc
Q 039137           33 SNSAEEAHALVKWKASLEVHSRSLLHSWSLSSVNATKISPCAWSGIFCNHAERVVGINLTSISLNGTLLEFSFSSFPHLV  112 (912)
Q Consensus        33 ~~~~~~~~all~~k~~~~~~~~~~l~~w~~~~~~~~~~~~C~w~gv~c~~~~~v~~l~l~~~~l~~~~~~~~~~~l~~L~  112 (912)
                      ++..+|++||++||+++..++.+++.+|....  ....++|.|.|++|+.....                ......++++
T Consensus        23 ~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~--~~~~~~~~~~g~~~~~~~~~----------------l~~~~~~~l~   84 (328)
T 4fcg_A           23 TALRPYHDVLSQWQRHYNADRNRWHSAWRQAN--SNNPQIETRTGRALKATADL----------------LEDATQPGRV   84 (328)
T ss_dssp             CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHT--TTCTTSCCSHHHHHHHHHHH----------------HHHHTSTTCC
T ss_pred             ccCchHHHHHHHHHHhccCCchhhhhhhcccc--cccccccccCCcchhhhHHH----------------Hhccccccee
Confidence            34567999999999999888888899995321  12458999999999631100                0012356788


Q ss_pred             EEEccCCcccccCCccccCCCCCcEEeccccccccccccccccccccceeecccccccCCCCccccCcccccEEEccCCc
Q 039137          113 YLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNF  192 (912)
Q Consensus       113 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~  192 (912)
                      .|+|++|+++ .+|+.++++++|++|+|++|.++ .+|..++.+++|++|+|++|.++ .+|..++.+++|++|++++|+
T Consensus        85 ~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~  161 (328)
T 4fcg_A           85 ALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACP  161 (328)
T ss_dssp             EEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEET
T ss_pred             EEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCC
Confidence            8999999998 78888999999999999999998 88999999999999999999998 889889999999999999988


Q ss_pred             CCCCCCccCCCCccceeeeeccCCCcCccccccccccccceeecccccccCccccccccccccceeeeccccCcccCCcc
Q 039137          193 LNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQE  272 (912)
Q Consensus       193 l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~  272 (912)
                      +.+.+|..+...               .++..+.++++|++|++++|+++ .+|..++++++|++|+|++|++++ +|..
T Consensus       162 ~~~~~p~~~~~~---------------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~  224 (328)
T 4fcg_A          162 ELTELPEPLAST---------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPA  224 (328)
T ss_dssp             TCCCCCSCSEEE---------------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGG
T ss_pred             CccccChhHhhc---------------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-Cchh
Confidence            888888876540               11122333444444444444444 344444444444444444444443 2333


Q ss_pred             cCCccccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCcccccccCCCCCCCC
Q 039137          273 IGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLS  352 (912)
Q Consensus       273 l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  352 (912)
                      +..+++|++|+|++|++.+.+|..|..+++|++|+|++|.+.+.+|..+..+++|++|+|++|++.+.+|..++.+++|+
T Consensus       225 l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~  304 (328)
T 4fcg_A          225 IHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANC  304 (328)
T ss_dssp             GGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTC
T ss_pred             hccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCce
Confidence            44444444455554444444444455555555555555554444554555555555555555555555555555555555


Q ss_pred             EEeccCCcc
Q 039137          353 LLDVSINNI  361 (912)
Q Consensus       353 ~L~Ls~N~l  361 (912)
                      .+++..+.+
T Consensus       305 ~l~l~~~~~  313 (328)
T 4fcg_A          305 IILVPPHLQ  313 (328)
T ss_dssp             EEECCGGGS
T ss_pred             EEeCCHHHH
Confidence            555554443

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-35  Score=336.65  Aligned_cols=248  Identities=23%  Similarity=0.313  Sum_probs=185.9

Q ss_pred             hcCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~l  715 (912)
                      ..+|++.+.||+|+||+||.....+++.||||++.....       +.+.+|+++++.+ +||||+++++++.+.+..|+
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~-------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l   95 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF-------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYI   95 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE-------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEE
T ss_pred             cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH-------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEE
Confidence            356888999999999997665556899999999864321       2245799999999 79999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcC-----CCcEEEecccc
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDL-----GYEAHVSDFGI  790 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-----~~~~kl~Dfgl  790 (912)
                      ||||++ |+|.+++....  ....+.+++.++.||+.||+|||++   +|+||||||+||+++.     ...+||+|||+
T Consensus        96 v~E~~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~  169 (432)
T 3p23_A           96 AIELCA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGL  169 (432)
T ss_dssp             EEECCS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred             EEECCC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence            999997 59999985433  3355567789999999999999999   9999999999999953     23588999999


Q ss_pred             ccccCCCC---CCccccccccccccccccc---cCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhcc
Q 039137          791 AKFLNPDS---SNWSELAGTHGYVAPELAY---TLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLD  863 (912)
Q Consensus       791 a~~~~~~~---~~~~~~~g~~~y~aPE~~~---~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  863 (912)
                      ++......   .......||+.|+|||++.   ...++.++||||+||++|||++ |..||+.....      .......
T Consensus       170 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~------~~~~~~~  243 (432)
T 3p23_A          170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR------QANILLG  243 (432)
T ss_dssp             EECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH------HHHHHTT
T ss_pred             eeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH------HHHHHhc
Confidence            98765432   2234567999999999987   4567889999999999999999 99998522110      0000111


Q ss_pred             CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          864 SRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       864 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ................+.++|.+||+.||++|||++|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          244 ACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             CCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            1000000011233455789999999999999999999984

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.4e-35  Score=327.50  Aligned_cols=254  Identities=20%  Similarity=0.298  Sum_probs=196.0

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CC-CEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCc------cccEEEEEE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SG-EIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRN------IVKFYGFCS  708 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n------iv~l~~~~~  708 (912)
                      .++|++.+.||+|+||+||+|.+. ++ +.||+|++...     ....+.+.+|+.+++.++|++      ++.+++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~   92 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-----GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN   92 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee
Confidence            468999999999999999999875 44 68999998632     224667889999999997765      999999999


Q ss_pred             cCCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEE-----------
Q 039137          709 HPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLL-----------  777 (912)
Q Consensus       709 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill-----------  777 (912)
                      ..+..++||||+ ++++.+++... ....+++.+++.++.||+.||+|||++   +|+||||||+||++           
T Consensus        93 ~~~~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~  167 (355)
T 2eu9_A           93 FHGHMCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNE  167 (355)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECC
T ss_pred             eCCeEEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccc
Confidence            999999999999 55676666442 234689999999999999999999999   99999999999999           


Q ss_pred             --------cCCCcEEEeccccccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhc
Q 039137          778 --------DLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFE  849 (912)
Q Consensus       778 --------~~~~~~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~  849 (912)
                              +.++.+||+|||+++.....   .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  244 (355)
T 2eu9_A          168 HKSCEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN  244 (355)
T ss_dssp             C-CCCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             cccccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence                    56789999999999865432   3445789999999999999999999999999999999999999863211


Q ss_pred             ccccc------ccchhhh----------ccCCCCCC-------------------ChhhHHHHHHHHHHHHHcccCCCCC
Q 039137          850 MSSSS------SNMNIEM----------LDSRLPYP-------------------SLHVQKKLMSIMQVAFSCLDQNPES  894 (912)
Q Consensus       850 ~~~~~------~~~~~~~----------~~~~~~~~-------------------~~~~~~~~~~l~~li~~cl~~dP~~  894 (912)
                      .....      .......          .......+                   ..........+.+++.+||+.||++
T Consensus       245 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  324 (355)
T 2eu9_A          245 REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ  324 (355)
T ss_dssp             HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence            00000      0000000          00000000                   0001123457889999999999999


Q ss_pred             CCCHHHHHH
Q 039137          895 RPTMKRVSQ  903 (912)
Q Consensus       895 RPt~~evl~  903 (912)
                      |||++|+++
T Consensus       325 Rpt~~e~l~  333 (355)
T 2eu9_A          325 RITLAEALL  333 (355)
T ss_dssp             SCCHHHHTT
T ss_pred             CcCHHHHhc
Confidence            999999874

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.2e-35  Score=332.42  Aligned_cols=251  Identities=20%  Similarity=0.276  Sum_probs=196.4

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcC-----------CCccccEE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR-----------HRNIVKFY  704 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-----------h~niv~l~  704 (912)
                      .++|++.+.||+|+||+||+|++. +++.||||++...     ....+.+.+|+.++++++           ||||++++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~   92 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL   92 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-----ccchhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence            367999999999999999999875 7899999998632     224567889999999886           89999999


Q ss_pred             EEEEcCC----eeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEc--
Q 039137          705 GFCSHPK----HSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLD--  778 (912)
Q Consensus       705 ~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~--  778 (912)
                      +++...+    ..++||||+ +++|.+++.... ...+++.+++.++.||+.||+|||+++  +|+||||||+||+++  
T Consensus        93 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~  168 (373)
T 1q8y_A           93 DHFNHKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIV  168 (373)
T ss_dssp             EEEEEEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEE
T ss_pred             HHhhccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEecc
Confidence            9997654    789999999 889999985533 345899999999999999999999953  899999999999994  


Q ss_pred             ----CCCcEEEeccccccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhcccccc
Q 039137          779 ----LGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS  854 (912)
Q Consensus       779 ----~~~~~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~  854 (912)
                          ..+.+||+|||++......   .....||+.|+|||++.+..++.++|||||||++|||++|+.||+.........
T Consensus       169 ~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  245 (373)
T 1q8y_A          169 DSPENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK  245 (373)
T ss_dssp             ETTTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred             CCCcCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence                4447999999999876432   334578999999999999999999999999999999999999986322110000


Q ss_pred             -ccchhh------------------------------------------hccCCCCCCChhhHHHHHHHHHHHHHcccCC
Q 039137          855 -SNMNIE------------------------------------------MLDSRLPYPSLHVQKKLMSIMQVAFSCLDQN  891 (912)
Q Consensus       855 -~~~~~~------------------------------------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d  891 (912)
                       ......                                          .......    .....+..+.++|.+||+.|
T Consensus       246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~L~~d  321 (373)
T 1q8y_A          246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYK----FSKDEAKEISDFLSPMLQLD  321 (373)
T ss_dssp             HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTC----CCHHHHHHHHHHHGGGGCSS
T ss_pred             hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhccc----CCcchHHHHHHHHHHHhccC
Confidence             000000                                          0000001    11345677899999999999


Q ss_pred             CCCCCCHHHHHH
Q 039137          892 PESRPTMKRVSQ  903 (912)
Q Consensus       892 P~~RPt~~evl~  903 (912)
                      |++|||++|+++
T Consensus       322 P~~Rpt~~ell~  333 (373)
T 1q8y_A          322 PRKRADAGGLVN  333 (373)
T ss_dssp             TTTCBCHHHHHT
T ss_pred             ccccCCHHHHhh
Confidence            999999999875

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.2e-35  Score=316.45  Aligned_cols=234  Identities=11%  Similarity=0.041  Sum_probs=186.8

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      .++|++.+.||+|+||.||+|++. +++.||+|++....... ....+.+.+|+..++.++||||+++++++...+..|+
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  108 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLP-DDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV  108 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccC-HHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence            367999999999999999999986 58999999998654432 2355789999999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ||||+++++|.+++...     ....++.+|+.|++.||+|||++   +|+||||||+||+++.++.+||+++|      
T Consensus       109 v~e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~------  174 (286)
T 3uqc_A          109 VAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA------  174 (286)
T ss_dssp             EEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred             EEEecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc------
Confidence            99999999999999331     35567899999999999999999   99999999999999999999998543      


Q ss_pred             CCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHH
Q 039137          796 PDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQK  875 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  875 (912)
                                    |++       .++.++|||||||++|||++|+.||.........  ...........+.+......
T Consensus       175 --------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  231 (286)
T 3uqc_A          175 --------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL--APAERDTAGQPIEPADIDRD  231 (286)
T ss_dssp             --------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS--EECCBCTTSCBCCHHHHCTT
T ss_pred             --------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh--HHHHHHhccCCCChhhcccC
Confidence                          333       2688999999999999999999998632221100  00001111111111112223


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 039137          876 KLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI  909 (912)
Q Consensus       876 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l  909 (912)
                      .+..+.+++.+||+.||++| |+.|+++.|++..
T Consensus       232 ~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~  264 (286)
T 3uqc_A          232 IPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT  264 (286)
T ss_dssp             SCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence            45668899999999999999 9999999998864

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=7e-35  Score=322.72  Aligned_cols=306  Identities=28%  Similarity=0.391  Sum_probs=185.4

Q ss_pred             CCCCCccEEEccCCcccccCCccccCCCCCcEEeccccccccccccccccccccceeecccccccCCCCccccCcccccE
Q 039137          106 SSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQ  185 (912)
Q Consensus       106 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~  185 (912)
                      ..+++|++|++++|.+.. +| .+..+++|++|+|++|++++ +|. +..+++|++|++++|.+++ +| .++.+++|++
T Consensus        41 ~~l~~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~~-~~~-~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~L~~  114 (347)
T 4fmz_A           41 EELESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQITD-ISP-LSNLVKLTNLYIGTNKITD-IS-ALQNLTNLRE  114 (347)
T ss_dssp             HHHTTCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSE
T ss_pred             hhcccccEEEEeCCcccc-ch-hhhhcCCccEEEccCCcccc-chh-hhcCCcCCEEEccCCcccC-ch-HHcCCCcCCE
Confidence            456777888888887764 33 37778888888888888764 444 7777888888888887773 33 5777777777


Q ss_pred             EEccCCcCCCCCCccCCCCccceeeeeccCCCcCccccccccccccceeecccccccCccccccccccccceeeeccccC
Q 039137          186 LALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNEL  265 (912)
Q Consensus       186 L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l  265 (912)
                      |++++|.+++. |. +.++++|++|++++|.....++ .+..+++|++|++++|++.+..+  +..+++|+.|++++|.+
T Consensus       115 L~l~~n~i~~~-~~-~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l  189 (347)
T 4fmz_A          115 LYLNEDNISDI-SP-LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQI  189 (347)
T ss_dssp             EECTTSCCCCC-GG-GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCC
T ss_pred             EECcCCcccCc-hh-hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCcc
Confidence            77777777643 33 6677777777777775543333 36666666666666666654333  55666666666666666


Q ss_pred             cccCCcccCCccccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCcccccccC
Q 039137          266 SGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDW  345 (912)
Q Consensus       266 ~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~  345 (912)
                      ++..+  +..+++|+.|++++|.+.+..+  +..+++|++|++++|.+++..+  +..+++|++|               
T Consensus       190 ~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L---------------  248 (347)
T 4fmz_A          190 EDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWL---------------  248 (347)
T ss_dssp             CCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEE---------------
T ss_pred             ccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEE---------------
Confidence            54322  5555555555555555553322  4455555555555555544332  4444444444               


Q ss_pred             CCCCCCCEEeccCCcccccccccccccccccEEEccCccccCCCCccccccccccEEEccCCcccCCCcccccccccccc
Q 039137          346 GRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEY  425 (912)
Q Consensus       346 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  425 (912)
                               ++++|.+++.  ..+..+++|++|++++|++++.  ..+..+++|+.|++++|++++..|..+..+++|++
T Consensus       249 ---------~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~  315 (347)
T 4fmz_A          249 ---------EIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTT  315 (347)
T ss_dssp             ---------ECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSE
T ss_pred             ---------ECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCE
Confidence                     4444444432  2344555566666666655542  34556666666666666666666666666666666


Q ss_pred             ccccCcccCccccccccccccccEEEecccccc
Q 039137          426 LDLSANNLSNFVPESLGSLVKLYYLNLSHNKLS  458 (912)
Q Consensus       426 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  458 (912)
                      |++++|++++..|  +..+++|++|++++|+|+
T Consensus       316 L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          316 LFLSQNHITDIRP--LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             EECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred             EEccCCccccccC--hhhhhccceeehhhhccc
Confidence            7777766666544  666667777777777664

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=6.1e-36  Score=326.95  Aligned_cols=253  Identities=21%  Similarity=0.317  Sum_probs=180.0

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      .++|++.+.||+|+||.||+|+++ +++.||||++.....  .....+.+.++..+++.++||||+++++++..++..++
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~l  101 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN--KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFI  101 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC--HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc--chHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Confidence            367899999999999999999986 789999999875432  22233444555567888899999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCCeEEcCCCcEEEecccccccc
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHN-NCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL  794 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  794 (912)
                      ||||+ ++.+..+...  ....+++..++.++.|++.||+|||+ +   +|+||||||+||+++.++.+||+|||++...
T Consensus       102 v~e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  175 (318)
T 2dyl_A          102 AMELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRL  175 (318)
T ss_dssp             EECCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred             EEecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence            99999 4456555532  23568999999999999999999998 6   8999999999999999999999999999766


Q ss_pred             CCCCCCccccccccccccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCC
Q 039137          795 NPDSSNWSELAGTHGYVAPELAY-----TLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYP  869 (912)
Q Consensus       795 ~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  869 (912)
                      .... ......+++.|+|||++.     +..++.++||||||+++|||++|+.||.....    .............+..
T Consensus       176 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~  250 (318)
T 2dyl_A          176 VDDK-AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT----DFEVLTKVLQEEPPLL  250 (318)
T ss_dssp             ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS----HHHHHHHHHHSCCCCC
T ss_pred             cCCc-cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc----cHHHHHHHhccCCCCC
Confidence            4432 233457899999999984     45688999999999999999999999863111    0111111111111111


Q ss_pred             ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          870 SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       870 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      + .....+..+.+++.+||+.||.+|||++|+++
T Consensus       251 ~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          251 P-GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             C-SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             C-ccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            0 00123456889999999999999999999876

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=1.3e-34  Score=320.67  Aligned_cols=306  Identities=25%  Similarity=0.344  Sum_probs=139.1

Q ss_pred             cccccccceeecccccccCCCCccccCcccccEEEccCCcCCCCCCccCCCCccceeeeeccCCCcCccccccccccccc
Q 039137          153 IGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLF  232 (912)
Q Consensus       153 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~  232 (912)
                      +..+++|++|++++|.+. .+|. ++.+++|++|++++|++++ +|. +.++++|++|++++|.+++ +| .+.++++|+
T Consensus        40 ~~~l~~L~~L~l~~~~i~-~~~~-~~~~~~L~~L~l~~n~i~~-~~~-~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~L~  113 (347)
T 4fmz_A           40 QEELESITKLVVAGEKVA-SIQG-IEYLTNLEYLNLNGNQITD-ISP-LSNLVKLTNLYIGTNKITD-IS-ALQNLTNLR  113 (347)
T ss_dssp             HHHHTTCSEEECCSSCCC-CCTT-GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCS
T ss_pred             chhcccccEEEEeCCccc-cchh-hhhcCCccEEEccCCcccc-chh-hhcCCcCCEEEccCCcccC-ch-HHcCCCcCC
Confidence            345666666666666665 3432 5556666666666666553 222 5555555555555555542 11 344444444


Q ss_pred             eeecccccccCccccccccccccceeeeccccCcccCCcccCCccccchhhhccCccCCCCccccccccccceEeccccc
Q 039137          233 DLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNY  312 (912)
Q Consensus       233 ~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~  312 (912)
                      +|++++|++                        ++..+  +..+++|++|++++|.....++ .+..+++|++|++++|.
T Consensus       114 ~L~l~~n~i------------------------~~~~~--~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~  166 (347)
T 4fmz_A          114 ELYLNEDNI------------------------SDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESK  166 (347)
T ss_dssp             EEECTTSCC------------------------CCCGG--GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSC
T ss_pred             EEECcCCcc------------------------cCchh--hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCC
Confidence            444444444                        43211  3344444444444443222221 24444444444444444


Q ss_pred             ccCCCCcccCCCCCccEEEccCCcCcccccccCCCCCCCCEEeccCCcccccccccccccccccEEEccCccccCCCCcc
Q 039137          313 LTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQ  392 (912)
Q Consensus       313 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~  392 (912)
                      +++..+  +..+++|++|++++|.+.+..+  +..+++|+.|++++|.+.+..+  +..+++|++|++++|++++..+  
T Consensus       167 ~~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--  238 (347)
T 4fmz_A          167 VKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--  238 (347)
T ss_dssp             CCCCGG--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--
T ss_pred             cCCchh--hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--
Confidence            443222  3444444444444444433222  3344444444444444443222  3444445555555554443222  


Q ss_pred             ccccccccEEEccCCcccCCCccccccccccccccccCcccCccccccccccccccEEEecccccccccchhhhcccccc
Q 039137          393 LGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLS  472 (912)
Q Consensus       393 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  472 (912)
                      +..+++|++|++++|++++.  ..+..+++|++|++++|++++.  ..+..+++|+.|+|++|++++..|..+..+++|+
T Consensus       239 ~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~  314 (347)
T 4fmz_A          239 LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLT  314 (347)
T ss_dssp             GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCS
T ss_pred             hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCC
Confidence            44444444444444444432  2344444444444444444442  2344444444444444444444444444444444


Q ss_pred             eeeccccccCcccccccccccccccccccCccc
Q 039137          473 ELDLSHNFLGEKISSRICRMESLEKLNLSYNNL  505 (912)
Q Consensus       473 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l  505 (912)
                      +|++++|++++..|  +..+++|+.|++++|+|
T Consensus       315 ~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i  345 (347)
T 4fmz_A          315 TLFLSQNHITDIRP--LASLSKMDSADFANQVI  345 (347)
T ss_dssp             EEECCSSSCCCCGG--GGGCTTCSEESSSCC--
T ss_pred             EEEccCCccccccC--hhhhhccceeehhhhcc
Confidence            44444444444333  44444444444444444

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=9e-35  Score=350.03  Aligned_cols=242  Identities=25%  Similarity=0.352  Sum_probs=196.7

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC--CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCe--
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP--SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKH--  712 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~--  712 (912)
                      .++|++.+.||+|+||+||+|.+.  +++.||||++....   .....+.+.+|+++++.++||||+++++++...+.  
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  155 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG---DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG  155 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC---CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC---CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence            368999999999999999999875  68999999986432   22356678999999999999999999999987665  


Q ss_pred             ---eeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccc
Q 039137          713 ---SFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFG  789 (912)
Q Consensus       713 ---~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  789 (912)
                         .|+||||+++++|.+++..     .+++.+++.|+.||+.||+|||++   +|+||||||+||+++.+ .+||+|||
T Consensus       156 ~~~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG  226 (681)
T 2pzi_A          156 DPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLG  226 (681)
T ss_dssp             CEEEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCT
T ss_pred             CceeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecc
Confidence               6999999999999987732     689999999999999999999999   99999999999999986 89999999


Q ss_pred             cccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCC
Q 039137          790 IAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYP  869 (912)
Q Consensus       790 la~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  869 (912)
                      +++.....    ....||+.|+|||++.+. ++.++|||||||++|+|++|..||.....              ...+ .
T Consensus       227 ~a~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~--------------~~~~-~  286 (681)
T 2pzi_A          227 AVSRINSF----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYV--------------DGLP-E  286 (681)
T ss_dssp             TCEETTCC----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEEC--------------SSCC-T
T ss_pred             cchhcccC----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccc--------------cccc-c
Confidence            99876543    445799999999998765 48899999999999999999988752110              0011 1


Q ss_pred             ChhhHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHHhhh
Q 039137          870 SLHVQKKLMSIMQVAFSCLDQNPESRP-TMKRVSQLLCEKIF  910 (912)
Q Consensus       870 ~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~l~  910 (912)
                      ..........+.++|.+||+.||++|| +++++.+.|...+.
T Consensus       287 ~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  328 (681)
T 2pzi_A          287 DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR  328 (681)
T ss_dssp             TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred             cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence            112223446788999999999999999 56777777766553

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2.1e-34  Score=311.74  Aligned_cols=231  Identities=21%  Similarity=0.332  Sum_probs=181.0

Q ss_pred             hcCCCCC-ceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHH-hhcCCCccccEEEEEEc----
Q 039137          637 TNDFNAE-HCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQAL-TEIRHRNIVKFYGFCSH----  709 (912)
Q Consensus       637 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l-~~l~h~niv~l~~~~~~----  709 (912)
                      .++|.+. +.||+|+||.||+|.+. +++.||+|++..         ...+.+|++++ +..+||||+++++++..    
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~   86 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD---------CPKARREVELHWRASQCPHIVRIVDVYENLYAG   86 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC---------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc---------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCC
Confidence            3567776 78999999999999875 789999999852         23466888888 55589999999999976    


Q ss_pred             CCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcC---CCcEEEe
Q 039137          710 PKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDL---GYEAHVS  786 (912)
Q Consensus       710 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~  786 (912)
                      ....++||||+++|+|.+++.... ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.   ++.+||+
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~  162 (299)
T 3m2w_A           87 RKCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT  162 (299)
T ss_dssp             EEEEEEEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred             CceEEEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEe
Confidence            677899999999999999996532 34689999999999999999999999   9999999999999998   7889999


Q ss_pred             ccccccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCC
Q 039137          787 DFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRL  866 (912)
Q Consensus       787 Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  866 (912)
                      |||++....                      +..++.++||||+||++|||++|+.||......... ............
T Consensus       163 Dfg~a~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-~~~~~~~~~~~~  219 (299)
T 3m2w_A          163 DFGFAKETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-PGMKTRIRMGQY  219 (299)
T ss_dssp             CCTTCEECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------CCSCCSSCTTCC
T ss_pred             ccccccccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-HHHHHHHhhccc
Confidence            999987542                      134678999999999999999999998532221110 001111111222


Q ss_pred             CCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          867 PYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       867 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ..+.......+..+.+++.+||+.||++|||++|+++
T Consensus       220 ~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          220 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            2232222334567899999999999999999999986

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=4.8e-35  Score=318.32  Aligned_cols=252  Identities=30%  Similarity=0.455  Sum_probs=202.2

Q ss_pred             CCccEEEccCCcccc--cCCccccCCCCCcEEeccc-cccccccccccccccccceeecccccccCCCCccccCcccccE
Q 039137          109 PHLVYLDLYNNELFG--IIPPQISNLSNLEYLDFSA-NKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQ  185 (912)
Q Consensus       109 ~~L~~L~L~~n~l~~--~~p~~~~~l~~L~~L~Ls~-n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~  185 (912)
                      .+++.|+|++|+++|  .+|+.|+++++|++|+|++ |.+.+.+|..|+.+++|++|+|++|.+++.+|..|+.+++|++
T Consensus        50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~  129 (313)
T 1ogq_A           50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT  129 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred             ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence            467888888888888  7888888888888888885 8888888888888888888888888888777877777777777


Q ss_pred             EEccCCcCCCCCCccCCCCccceeeeeccCCCcCccccccccccccceeecccccccCcccccccccc-ccceeeecccc
Q 039137          186 LALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLT-NLRFLFLYHNE  264 (912)
Q Consensus       186 L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~-~L~~L~L~~N~  264 (912)
                      |+|++|.+++.+|..+.++++|++|+|++|.+++.+|.                        .+..++ +|++|++++|+
T Consensus       130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~------------------------~l~~l~~~L~~L~L~~N~  185 (313)
T 1ogq_A          130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD------------------------SYGSFSKLFTSMTISRNR  185 (313)
T ss_dssp             EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCG------------------------GGGCCCTTCCEEECCSSE
T ss_pred             EeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCH------------------------HHhhhhhcCcEEECcCCe
Confidence            77777777766666666666666666666655554554                        444444 56666666666


Q ss_pred             CcccCCcccCCccccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCccccccc
Q 039137          265 LSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSD  344 (912)
Q Consensus       265 l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~  344 (912)
                      +++.+|..+..++ |++|++++|++++.+|..|..+++|+.|+|++|.+++.++. +..+++|++|+|++|++++..|..
T Consensus       186 l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~  263 (313)
T 1ogq_A          186 LTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQG  263 (313)
T ss_dssp             EEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGG
T ss_pred             eeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChH
Confidence            6666666666665 77777777777777778888889999999999999977766 888999999999999999999999


Q ss_pred             CCCCCCCCEEeccCCcccccccccccccccccEEEccCcc-ccC
Q 039137          345 WGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNY-IVG  387 (912)
Q Consensus       345 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~-l~~  387 (912)
                      +..+++|+.|++++|++++.+|.. +.+++|+.|++++|. +.|
T Consensus       264 l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~~lc~  306 (313)
T 1ogq_A          264 LTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCG  306 (313)
T ss_dssp             GGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSSEEES
T ss_pred             HhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCCCccC
Confidence            999999999999999999999987 889999999999998 554

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=100.00  E-value=3e-37  Score=355.81  Aligned_cols=383  Identities=20%  Similarity=0.128  Sum_probs=231.4

Q ss_pred             CCccEEEccCCcccccCCcc-ccCCCCCcEEecccccccc----ccccccccccccceeecccccccCCCCcccc-Ccc-
Q 039137          109 PHLVYLDLYNNELFGIIPPQ-ISNLSNLEYLDFSANKLFG----QIPSGIGLLTHLTVLHISRNWLSGSIPHEVG-QLT-  181 (912)
Q Consensus       109 ~~L~~L~L~~n~l~~~~p~~-~~~l~~L~~L~Ls~n~l~~----~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~-~l~-  181 (912)
                      ++|++|||++|+++...... +..+++|++|+|++|++++    .+|..+..+++|++|+|++|.+++..+..+. .++ 
T Consensus         3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~   82 (461)
T 1z7x_W            3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT   82 (461)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred             ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence            46788889888887544333 7788889999999888874    3567777788888888888888754443332 344 


Q ss_pred             ---cccEEEccCCcCCC----CCCccCCCCccceeeeeccCCCcCcccccccc-----ccccceeecccccccCc----c
Q 039137          182 ---VLNQLALDSNFLNG----SIPRSLGNLTHVVILYLYNNSFFGSIPQEIGN-----LKSLFDLELCINQLSGA----I  245 (912)
Q Consensus       182 ---~L~~L~l~~n~l~~----~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~-----l~~L~~L~l~~n~l~~~----~  245 (912)
                         +|++|+|++|+++.    .+|..+.++++|++|+|++|.+++..+..+..     .++|++|++++|++++.    +
T Consensus        83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l  162 (461)
T 1z7x_W           83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL  162 (461)
T ss_dssp             TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred             CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHH
Confidence               58888888888773    45677777777777777777776544443322     34577777777766643    2


Q ss_pred             ccccccccccceeeeccccCcccCCcccCC-----ccccchhhhccCccCCCCccccccccccceEecccccccCCCCcc
Q 039137          246 PLSISNLTNLRFLFLYHNELSGIIPQEIGN-----LKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISET  320 (912)
Q Consensus       246 p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~-----l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~  320 (912)
                      +..+..+++|++|++++|.+++..+..+..     .++|++|++++|.+++....                    .++..
T Consensus       163 ~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~--------------------~l~~~  222 (461)
T 1z7x_W          163 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCR--------------------DLCGI  222 (461)
T ss_dssp             HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHH--------------------HHHHH
T ss_pred             HHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHH--------------------HHHHH
Confidence            444555666666666666665433222221     23445555555544432100                    02333


Q ss_pred             cCCCCCccEEEccCCcCcccc-----cccCCCCCCCCEEeccCCccccc----ccccccccccccEEEccCccccCCCCc
Q 039137          321 FGTYPNLTFIDLSNNSFFGEI-----LSDWGRCPQLSLLDVSINNISGS----IPLEIGESLQLQYLDLSSNYIVGEIPT  391 (912)
Q Consensus       321 ~~~l~~L~~L~Ls~N~l~~~~-----~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~~~~L~~L~L~~N~l~~~~~~  391 (912)
                      +..+++|++|+|++|.+.+..     +..+..+++|++|++++|+++..    ++..+..+++|++|+|++|.+.+..+.
T Consensus       223 l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~  302 (461)
T 1z7x_W          223 VASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGAR  302 (461)
T ss_dssp             HHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHH
T ss_pred             HHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHH
Confidence            344445555555555443322     11222455555555555555532    344455556666666666666543333


Q ss_pred             ccccc-----ccccEEEccCCcccCC----CccccccccccccccccCcccCccccccccc-----cccccEEEeccccc
Q 039137          392 QLGNI-----IYLNRLSLSGNKLSGC----IPRELGSLINLEYLDLSANNLSNFVPESLGS-----LVKLYYLNLSHNKL  457 (912)
Q Consensus       392 ~l~~l-----~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-----l~~L~~L~Ls~N~l  457 (912)
                      .+...     ++|++|++++|.+++.    ++..+..+++|++|+|++|.+++..+..+..     .++|++|+|++|++
T Consensus       303 ~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i  382 (461)
T 1z7x_W          303 LLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDV  382 (461)
T ss_dssp             HHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCC
T ss_pred             HHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCC
Confidence            33322     4677777777777654    4555666677888888888777655544432     56888888888888


Q ss_pred             cc----ccchhhhcccccceeeccccccCcccccccc-----cccccccccccCccccCCCcc
Q 039137          458 SQ----QIPIELDNLIHLSELDLSHNFLGEKISSRIC-----RMESLEKLNLSYNNLSGLIPR  511 (912)
Q Consensus       458 ~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-----~l~~L~~L~ls~N~l~~~~p~  511 (912)
                      ++    .+|..+..+++|++|+|++|+|++.....+.     ...+|+.|++.++.+....++
T Consensus       383 ~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~~~~~~  445 (461)
T 1z7x_W          383 SDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMED  445 (461)
T ss_dssp             CHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHHH
T ss_pred             ChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccCHHHHH
Confidence            75    6777788888888888888888754322222     122455566655555544333

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=6.3e-34  Score=321.78  Aligned_cols=244  Identities=16%  Similarity=0.117  Sum_probs=179.8

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCC-Ccc---------cc----
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH-RNI---------VK----  702 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h-~ni---------v~----  702 (912)
                      .+|...+.||+|+||+||+|++. +|+.||||++........ ...+.+.+|+.+++.++| ++.         +.    
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPS-NAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC-----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccH-HHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            45777899999999999999965 799999999874432221 235678899999999977 221         11    


Q ss_pred             --------EEEEEEc-----CCeeeEEEeecCCCChhhHhhc----cCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 039137          703 --------FYGFCSH-----PKHSFIIYEYLESGSLDKILCN----DASAKELGWTQRLNVIKGVADALFYLHNNCFPPI  765 (912)
Q Consensus       703 --------l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~----~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i  765 (912)
                              +..++..     ....+++|+++ +++|.+++..    ......+++..++.++.|++.||+|||++   +|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i  232 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL  232 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence                    1111111     12356777765 5799988842    22345688899999999999999999999   99


Q ss_pred             eecCCCCCCeEEcCCCcEEEeccccccccCCCCCCcccccccccccccccc----------ccCCCCcchhHHHHHHHHH
Q 039137          766 VHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELA----------YTLKVTEKCDVYSFGVLAL  835 (912)
Q Consensus       766 vH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~----------~~~~~~~~sDvwslG~vl~  835 (912)
                      +||||||+||+++.++.+||+|||+++.....   .....| +.|+|||++          .+..++.++|||||||++|
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~  308 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY  308 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence            99999999999999999999999999865432   344567 999999998          5556889999999999999


Q ss_pred             HHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          836 EVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       836 elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ||++|+.||.......     ...........        .+..+.+++.+||+.||++||++.|+++
T Consensus       309 elltg~~Pf~~~~~~~-----~~~~~~~~~~~--------~~~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          309 WIWCADLPNTDDAALG-----GSEWIFRSCKN--------IPQPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             HHHHSSCCCCTTGGGS-----CSGGGGSSCCC--------CCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHCCCCCCCcchhh-----hHHHHHhhccc--------CCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            9999999986322111     11111111111        1255889999999999999999877743

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=3e-33  Score=307.41  Aligned_cols=288  Identities=23%  Similarity=0.280  Sum_probs=135.6

Q ss_pred             CCcEEeccccccccccccccccccccceeecccccccCCCCccccCcccccEEEccCCcCCCCCCccCCCCccceeeeec
Q 039137          134 NLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLY  213 (912)
Q Consensus       134 ~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~  213 (912)
                      +|++++++++.++ .+|..+.  ++|++|+|++|.+++..|..|+++++|++|++++|++++..|..|+++++|++|+|+
T Consensus        34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  110 (332)
T 2ft3_A           34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS  110 (332)
T ss_dssp             ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred             cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence            4666666666665 5555442  456666666666664445556666666666666666655555555555555555555


Q ss_pred             cCCCcCccccccccccccceeecccccccCccccccccccccceeeeccccCc--ccCCcccCCccccchhhhccCccCC
Q 039137          214 NNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELS--GIIPQEIGNLKKLNSLLLAKNHFRG  291 (912)
Q Consensus       214 ~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~~~~l~~l~~L~~L~L~~N~l~~  291 (912)
                      +|.++ .+|..+.  ++|++|++++|++++..+..|.++++|++|++++|.++  +..+..+..+ +|++|++++|++++
T Consensus       111 ~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~  186 (332)
T 2ft3_A          111 KNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG  186 (332)
T ss_dssp             SSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS
T ss_pred             CCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc
Confidence            55555 3333332  44555555555554433344444555555555555443  1333333333 44444444444432


Q ss_pred             CCccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCcccccccCCCCCCCCEEeccCCcccccccccccc
Q 039137          292 TVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGE  371 (912)
Q Consensus       292 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  371 (912)
                       +|..+.                          ++|++|++++|.+.+..+..+..+++|+.|++++|++.         
T Consensus       187 -l~~~~~--------------------------~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~---------  230 (332)
T 2ft3_A          187 -IPKDLP--------------------------ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIR---------  230 (332)
T ss_dssp             -CCSSSC--------------------------SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCC---------
T ss_pred             -cCcccc--------------------------CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCC---------
Confidence             222111                          23333333333333333333333333333333333333         


Q ss_pred             cccccEEEccCccccCCCCccccccccccEEEccCCcccCCCccccccccccccccccCcccCccccccccc------cc
Q 039137          372 SLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGS------LV  445 (912)
Q Consensus       372 ~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~------l~  445 (912)
                                     +..+..+..+++|+.|++++|+++ .+|..+..+++|++|++++|+++++.+..|..      .+
T Consensus       231 ---------------~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~  294 (332)
T 2ft3_A          231 ---------------MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRA  294 (332)
T ss_dssp             ---------------CCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSC
T ss_pred             ---------------cCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccc
Confidence                           333333333334444444444443 33333444444444444444444443333332      24


Q ss_pred             cccEEEecccccc--cccchhhhcccccceeeccccc
Q 039137          446 KLYYLNLSHNKLS--QQIPIELDNLIHLSELDLSHNF  480 (912)
Q Consensus       446 ~L~~L~Ls~N~l~--~~~~~~~~~l~~L~~L~Ls~N~  480 (912)
                      .|+.|++++|++.  +..|..|..+++|+.|++++|+
T Consensus       295 ~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~  331 (332)
T 2ft3_A          295 YYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK  331 (332)
T ss_dssp             CBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred             cccceEeecCcccccccCcccccccchhhhhhccccc
Confidence            5666666666665  4555666666666666666653

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=100.00  E-value=3.7e-37  Score=355.08  Aligned_cols=379  Identities=20%  Similarity=0.137  Sum_probs=263.5

Q ss_pred             CCCcEEeccccccccccccc-cccccccceeecccccccC----CCCccccCcccccEEEccCCcCCCCCCccC-CCCc-
Q 039137          133 SNLEYLDFSANKLFGQIPSG-IGLLTHLTVLHISRNWLSG----SIPHEVGQLTVLNQLALDSNFLNGSIPRSL-GNLT-  205 (912)
Q Consensus       133 ~~L~~L~Ls~n~l~~~~p~~-~~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~-~~l~-  205 (912)
                      ++|++|||++|+++...... +..+++|++|+|++|.+++    .+|..+..+++|++|+|++|.++...+..+ ..++ 
T Consensus         3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~   82 (461)
T 1z7x_W            3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT   82 (461)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred             ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence            46788888888876543333 6777888888888888764    345556666677777777766654322222 1122 


Q ss_pred             ---cceeeeeccCCCcCccccccccccccceeecccccccCccccccccccccceeeeccccCcccCCcccC-----Ccc
Q 039137          206 ---HVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIG-----NLK  277 (912)
Q Consensus       206 ---~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~-----~l~  277 (912)
                         +|++|+|++|.++..-.                    ..+|..+..+++|++|+|++|.+++..+..+.     ..+
T Consensus        83 ~~~~L~~L~L~~n~i~~~~~--------------------~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~  142 (461)
T 1z7x_W           83 PSCKIQKLSLQNCCLTGAGC--------------------GVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQC  142 (461)
T ss_dssp             TTCCCCEEECTTSCCBGGGH--------------------HHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTC
T ss_pred             CCCceeEEEccCCCCCHHHH--------------------HHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCC
Confidence               35555555555542100                    12344445555555555555554432222211     133


Q ss_pred             ccchhhhccCccCCC----CccccccccccceEecccccccCCCCcccC-----CCCCccEEEccCCcCccc----cccc
Q 039137          278 KLNSLLLAKNHFRGT----VPKSFRNLTDLVKLRLNQNYLTGNISETFG-----TYPNLTFIDLSNNSFFGE----ILSD  344 (912)
Q Consensus       278 ~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-----~l~~L~~L~Ls~N~l~~~----~~~~  344 (912)
                      +|++|+|++|++++.    ++..+..+++|++|++++|.++...+..+.     ..++|++|+|++|.+++.    ++..
T Consensus       143 ~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~  222 (461)
T 1z7x_W          143 RLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGI  222 (461)
T ss_dssp             CCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHH
T ss_pred             cceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHH
Confidence            466666666665542    244566677888888888877654444332     356899999999998774    4666


Q ss_pred             CCCCCCCCEEeccCCcccccc-----cccccccccccEEEccCccccCC----CCccccccccccEEEccCCcccCCCcc
Q 039137          345 WGRCPQLSLLDVSINNISGSI-----PLEIGESLQLQYLDLSSNYIVGE----IPTQLGNIIYLNRLSLSGNKLSGCIPR  415 (912)
Q Consensus       345 ~~~l~~L~~L~Ls~N~l~~~~-----~~~~~~~~~L~~L~L~~N~l~~~----~~~~l~~l~~L~~L~L~~N~l~~~~p~  415 (912)
                      +..+++|++|++++|++.+..     +..+..+++|++|+|++|++++.    ++..+..+++|++|++++|++++..+.
T Consensus       223 l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~  302 (461)
T 1z7x_W          223 VASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGAR  302 (461)
T ss_dssp             HHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHH
T ss_pred             HHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHH
Confidence            778999999999999998543     22334578999999999999864    677788899999999999999866555


Q ss_pred             ccccc-----cccccccccCcccCcc----ccccccccccccEEEecccccccccchhhhc-----ccccceeecccccc
Q 039137          416 ELGSL-----INLEYLDLSANNLSNF----VPESLGSLVKLYYLNLSHNKLSQQIPIELDN-----LIHLSELDLSHNFL  481 (912)
Q Consensus       416 ~~~~l-----~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-----l~~L~~L~Ls~N~l  481 (912)
                      .+...     ++|++|+|++|.+++.    ++..+..+++|++|+|++|++++..+..+..     .++|++|+|++|.+
T Consensus       303 ~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i  382 (461)
T 1z7x_W          303 LLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDV  382 (461)
T ss_dssp             HHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCC
T ss_pred             HHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCC
Confidence            55543     6999999999999875    4566777899999999999998776666654     67999999999999


Q ss_pred             Cc----ccccccccccccccccccCccccCCCccccc-----ccccceEEEccCCcccc
Q 039137          482 GE----KISSRICRMESLEKLNLSYNNLSGLIPRCFE-----EMHGLLHIDISYNKLEG  531 (912)
Q Consensus       482 ~~----~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~-----~l~~L~~l~ls~N~l~~  531 (912)
                      ++    .++..+..+++|+.|++++|++++.....+.     ....|+.|++.++.+..
T Consensus       383 ~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~~  441 (461)
T 1z7x_W          383 SDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSE  441 (461)
T ss_dssp             CHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCH
T ss_pred             ChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccCH
Confidence            86    7888899999999999999999865332222     23468888888887764

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=3.2e-33  Score=307.09  Aligned_cols=267  Identities=24%  Similarity=0.297  Sum_probs=170.9

Q ss_pred             ccceeeeccccCcccCCcccCCccccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEcc
Q 039137          254 NLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLS  333 (912)
Q Consensus       254 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls  333 (912)
                      +|++|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|++++|.++...+..+   ++|++|+++
T Consensus        55 ~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~---~~L~~L~l~  131 (332)
T 2ft3_A           55 DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLVEIPPNLP---SSLVELRIH  131 (332)
T ss_dssp             TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCCSCCSSCC---TTCCEEECC
T ss_pred             CCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCCccCcccc---ccCCEEECC
Confidence            44445555555444444444555555555555555554444455555555555555555543222222   455555555


Q ss_pred             CCcCcccccccCCCCCCCCEEeccCCccc--ccccccccccccccEEEccCccccCCCCccccccccccEEEccCCcccC
Q 039137          334 NNSFFGEILSDWGRCPQLSLLDVSINNIS--GSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSG  411 (912)
Q Consensus       334 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~--~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~  411 (912)
                      +|++.+..+..+..+++|+.|++++|.++  +..+..+..+ +|++|++++|++++ +|..+.  ++|++|++++|++++
T Consensus       132 ~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~  207 (332)
T 2ft3_A          132 DNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQA  207 (332)
T ss_dssp             SSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCC
T ss_pred             CCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCCc
Confidence            55555444444555555555555555553  2445555555 66777777777664 444433  577777788888877


Q ss_pred             CCccccccccccccccccCcccCccccccccccccccEEEecccccccccchhhhcccccceeeccccccCccccccccc
Q 039137          412 CIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICR  491 (912)
Q Consensus       412 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  491 (912)
                      ..+..+..+++|++|+|++|++++..+..|..+++|++|+|++|+++ .+|..+..+++|++|++++|+|++..+..|+.
T Consensus       208 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~  286 (332)
T 2ft3_A          208 IELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCP  286 (332)
T ss_dssp             CCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSC
T ss_pred             cCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccc
Confidence            77777788888888888888888877777888888888888888887 67777888888888888888887777766665


Q ss_pred             c------cccccccccCcccc--CCCcccccccccceEEEccCCc
Q 039137          492 M------ESLEKLNLSYNNLS--GLIPRCFEEMHGLLHIDISYNK  528 (912)
Q Consensus       492 l------~~L~~L~ls~N~l~--~~~p~~~~~l~~L~~l~ls~N~  528 (912)
                      .      .+|+.|++++|+++  +..|..|..++.|+.+++++|+
T Consensus       287 ~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~  331 (332)
T 2ft3_A          287 VGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK  331 (332)
T ss_dssp             SSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred             cccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence            3      56788888888887  6677788888888888888774

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.3e-34  Score=318.97  Aligned_cols=246  Identities=15%  Similarity=0.142  Sum_probs=189.3

Q ss_pred             hcCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCC----CchHHHHHHHHHHHHHhhcC---------CCccccE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPG----EMSFQQEEFLNEIQALTEIR---------HRNIVKF  703 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~~Ei~~l~~l~---------h~niv~l  703 (912)
                      .++|++.+.||+|+||+||+|++ +|+.||||++......    ......+.+.+|+.+++.++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            46799999999999999999998 7899999999765422    11223467889999988885         8888888


Q ss_pred             EEEEE------------------------------cCCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHH
Q 039137          704 YGFCS------------------------------HPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADA  753 (912)
Q Consensus       704 ~~~~~------------------------------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~  753 (912)
                      .+++.                              ..+..|+||||+++|++.+.+.+    ..+++.+++.++.||+.|
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence            77753                              26789999999999976666522    458999999999999999


Q ss_pred             HHHHH-hCCCCCeeecCCCCCCeEEcCCC--------------------cEEEeccccccccCCCCCCcccccccccccc
Q 039137          754 LFYLH-NNCFPPIVHRDISSKNVLLDLGY--------------------EAHVSDFGIAKFLNPDSSNWSELAGTHGYVA  812 (912)
Q Consensus       754 L~~LH-~~~~~~ivH~Dlk~~Nill~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~~g~~~y~a  812 (912)
                      |+||| ++   +|+||||||+|||++.++                    .+||+|||+|+.....     ...||+.|+|
T Consensus       174 L~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~a  245 (336)
T 2vuw_A          174 LAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMD  245 (336)
T ss_dssp             HHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTC
T ss_pred             HHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccC
Confidence            99999 88   999999999999999887                    8999999999876532     3479999999


Q ss_pred             ccccccCCCCcchhHHHHHHH-HHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHHHHHHHHHHHHcccCC
Q 039137          813 PELAYTLKVTEKCDVYSFGVL-ALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQN  891 (912)
Q Consensus       813 PE~~~~~~~~~~sDvwslG~v-l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d  891 (912)
                      ||++.+.. +.++||||+|++ .+++++|..||........... ....................+.++.++|.+||+.|
T Consensus       246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d  323 (336)
T 2vuw_A          246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTD-KMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS  323 (336)
T ss_dssp             SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHH-HHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS
T ss_pred             hhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHH-hhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC
Confidence            99998776 889999998777 7788899999853211000000 00001111122233345567888999999999976


Q ss_pred             CCCCCCHHHHH
Q 039137          892 PESRPTMKRVS  902 (912)
Q Consensus       892 P~~RPt~~evl  902 (912)
                           |++|++
T Consensus       324 -----sa~e~l  329 (336)
T 2vuw_A          324 -----SATDLL  329 (336)
T ss_dssp             -----SHHHHH
T ss_pred             -----CHHHHH
Confidence                 888776

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=1.1e-32  Score=302.74  Aligned_cols=291  Identities=20%  Similarity=0.242  Sum_probs=149.5

Q ss_pred             CCcEEeccccccccccccccccccccceeecccccccCCCCccccCcccccEEEccCCcCCCCCCccCCCCccceeeeec
Q 039137          134 NLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLY  213 (912)
Q Consensus       134 ~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~  213 (912)
                      +|++++++++.++ .+|..+.  ++|++|+|++|.+++..+..|+++++|++|+|++|++++..|..|+++++|++|+|+
T Consensus        32 ~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls  108 (330)
T 1xku_A           32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS  108 (330)
T ss_dssp             ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             CCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECC
Confidence            5677777777775 5665443  466777777777765555566666666666666666665556666666666666666


Q ss_pred             cCCCcCccccccccccccceeecccccccCccccccccccccceeeeccccCcccCCcccCCccccchhhhccCccCCCC
Q 039137          214 NNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTV  293 (912)
Q Consensus       214 ~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~  293 (912)
                      +|.++ .+|..+.  ++|++|++++|++++..+..+.++++|++|++++|.++.                      .+..
T Consensus       109 ~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~----------------------~~~~  163 (330)
T 1xku_A          109 KNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKS----------------------SGIE  163 (330)
T ss_dssp             SSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCG----------------------GGBC
T ss_pred             CCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCc----------------------cCcC
Confidence            66665 3343332  344444444444444444444444444444444444431                      0133


Q ss_pred             ccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCcccccccCCCCCCCCEEeccCCcccccccccccccc
Q 039137          294 PKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESL  373 (912)
Q Consensus       294 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~  373 (912)
                      +..|..+++|++|++++|.++......+   ++|++|++++|++.+..+..+..+++|+.|++++|++++..+..+..++
T Consensus       164 ~~~~~~l~~L~~L~l~~n~l~~l~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~  240 (330)
T 1xku_A          164 NGAFQGMKKLSYIRIADTNITTIPQGLP---PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTP  240 (330)
T ss_dssp             TTGGGGCTTCCEEECCSSCCCSCCSSCC---TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGST
T ss_pred             hhhccCCCCcCEEECCCCccccCCcccc---ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCC
Confidence            4444555555555555555543222111   4455555555555444444444444444444444444443333444444


Q ss_pred             cccEEEccCccccCCCCccccccccccEEEccCCcccCCCccccccccccccccccCcccCccccccccc------cccc
Q 039137          374 QLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGS------LVKL  447 (912)
Q Consensus       374 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~------l~~L  447 (912)
                      +|++|+|++|+++ .+|..+..                        +++|++|++++|+|+++.+..|..      .+.|
T Consensus       241 ~L~~L~L~~N~l~-~lp~~l~~------------------------l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l  295 (330)
T 1xku_A          241 HLRELHLNNNKLV-KVPGGLAD------------------------HKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASY  295 (330)
T ss_dssp             TCCEEECCSSCCS-SCCTTTTT------------------------CSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCC
T ss_pred             CCCEEECCCCcCc-cCChhhcc------------------------CCCcCEEECCCCcCCccChhhcCCcccccccccc
Confidence            4444444444444 33333444                        444444444444444433333322      2556


Q ss_pred             cEEEeccccccc--ccchhhhcccccceeeccccc
Q 039137          448 YYLNLSHNKLSQ--QIPIELDNLIHLSELDLSHNF  480 (912)
Q Consensus       448 ~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~Ls~N~  480 (912)
                      +.|++++|++..  ..|..|..+.+++.++|++|+
T Consensus       296 ~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~  330 (330)
T 1xku_A          296 SGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK  330 (330)
T ss_dssp             SEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred             cceEeecCcccccccCccccccccceeEEEecccC
Confidence            666677766642  455666667777777777664

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=1.7e-32  Score=301.11  Aligned_cols=270  Identities=24%  Similarity=0.256  Sum_probs=177.4

Q ss_pred             cceeeeeccCCCcCccccccccccccceeecccccccCccccccccccccceeeeccccCcccCCcccCCccccchhhhc
Q 039137          206 HVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLA  285 (912)
Q Consensus       206 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~  285 (912)
                      +|++|+|++|.+++..+..|+++++|++|++++|++++..|..|+++++|++|+|++|+++. +|..+.  ++|++|+++
T Consensus        53 ~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~-l~~~~~--~~L~~L~l~  129 (330)
T 1xku_A           53 DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE-LPEKMP--KTLQELRVH  129 (330)
T ss_dssp             TCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSB-CCSSCC--TTCCEEECC
T ss_pred             CCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCCc-cChhhc--ccccEEECC
Confidence            34444444444443333344444444444444444444445555555555555555555552 333222  345555555


Q ss_pred             cCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCcccccccCCCCCCCCEEeccCCcccccc
Q 039137          286 KNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSI  365 (912)
Q Consensus       286 ~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  365 (912)
                      +|++++..+..|.++++|+.|++++|.++.                      .+..+..+..+++|+.|++++|+++. +
T Consensus       130 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~----------------------~~~~~~~~~~l~~L~~L~l~~n~l~~-l  186 (330)
T 1xku_A          130 ENEITKVRKSVFNGLNQMIVVELGTNPLKS----------------------SGIENGAFQGMKKLSYIRIADTNITT-I  186 (330)
T ss_dssp             SSCCCBBCHHHHTTCTTCCEEECCSSCCCG----------------------GGBCTTGGGGCTTCCEEECCSSCCCS-C
T ss_pred             CCcccccCHhHhcCCccccEEECCCCcCCc----------------------cCcChhhccCCCCcCEEECCCCcccc-C
Confidence            555554444445555555555555555432                      11334444555555555555555552 3


Q ss_pred             cccccccccccEEEccCccccCCCCccccccccccEEEccCCcccCCCccccccccccccccccCcccCccccccccccc
Q 039137          366 PLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLV  445 (912)
Q Consensus       366 ~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  445 (912)
                      |..+.  ++|++|++++|++++..|..+..+++|+.|++++|++++..+..+..+++|++|+|++|+++. +|..+..++
T Consensus       187 ~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~-lp~~l~~l~  263 (330)
T 1xku_A          187 PQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHK  263 (330)
T ss_dssp             CSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSS-CCTTTTTCS
T ss_pred             Ccccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCcc-CChhhccCC
Confidence            33332  578888888888887777888888899999999999988777789999999999999999985 678899999


Q ss_pred             cccEEEecccccccccchhhhc------ccccceeeccccccCc--ccccccccccccccccccCcc
Q 039137          446 KLYYLNLSHNKLSQQIPIELDN------LIHLSELDLSHNFLGE--KISSRICRMESLEKLNLSYNN  504 (912)
Q Consensus       446 ~L~~L~Ls~N~l~~~~~~~~~~------l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~ls~N~  504 (912)
                      +|++|+|++|+|++..+..|..      .+.|+.|++++|.+..  ..|..|..+.+|+.++|++|+
T Consensus       264 ~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~  330 (330)
T 1xku_A          264 YIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK  330 (330)
T ss_dssp             SCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred             CcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence            9999999999999877777754      3789999999999974  667889999999999999995

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.98  E-value=5.6e-35  Score=348.10  Aligned_cols=448  Identities=15%  Similarity=0.100  Sum_probs=329.1

Q ss_pred             CCccceeEecCCCCeEEEeeccccccccccccccCCCCCccEEEccCCcc---cccCCcccc------------CCCCCc
Q 039137           72 PCAWSGIFCNHAERVVGINLTSISLNGTLLEFSFSSFPHLVYLDLYNNEL---FGIIPPQIS------------NLSNLE  136 (912)
Q Consensus        72 ~C~w~gv~c~~~~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l---~~~~p~~~~------------~l~~L~  136 (912)
                      |++|.++.+... +.+.+  ...  .+...+..+..+++|++|+|+++..   .+.+|..++            .+++|+
T Consensus        41 ck~W~~~~~~~~-~~l~~--~~~--~~~~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~  115 (592)
T 3ogk_B           41 CRRWFKIDSETR-EHVTM--ALC--YTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLK  115 (592)
T ss_dssp             CHHHHHHHHHHC-CEEEE--SCG--GGSCHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCC
T ss_pred             hHHHHHhhhccc-cEEEE--eec--cccChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCC
Confidence            558998865422 22222  111  1112233456788999999988642   245555444            789999


Q ss_pred             EEeccccccccccccccccc--cccceeeccccc-ccC-CCCccccCcccccEEEccCCcCCCC----CCccCCCCccce
Q 039137          137 YLDFSANKLFGQIPSGIGLL--THLTVLHISRNW-LSG-SIPHEVGQLTVLNQLALDSNFLNGS----IPRSLGNLTHVV  208 (912)
Q Consensus       137 ~L~Ls~n~l~~~~p~~~~~l--~~L~~L~L~~n~-l~~-~~p~~~~~l~~L~~L~l~~n~l~~~----~p~~~~~l~~L~  208 (912)
                      +|+|++|.+++..+..++.+  .+|++|+|++|. ++. .++..+..+++|++|+|++|.+++.    ++..+.++++|+
T Consensus       116 ~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~  195 (592)
T 3ogk_B          116 SVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLE  195 (592)
T ss_dssp             EEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCC
T ss_pred             eEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCcc
Confidence            99999999988777777774  459999999986 221 1333345789999999999998766    444556788999


Q ss_pred             eeeeccCCCc----CccccccccccccceeecccccccCccccccccccccceeeeccccCc---ccCCcccCCccccch
Q 039137          209 ILYLYNNSFF----GSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELS---GIIPQEIGNLKKLNS  281 (912)
Q Consensus       209 ~L~L~~n~l~----~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~---~~~~~~l~~l~~L~~  281 (912)
                      +|++++|.++    +.++..+.++++|+.|++++|.+.+ +|..+..+++|+.|+++.+...   +..+..+..+++|+.
T Consensus       196 ~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~  274 (592)
T 3ogk_B          196 VLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCR  274 (592)
T ss_dssp             EEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCE
T ss_pred             EEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccc
Confidence            9999999997    3455567789999999999999985 7788999999999999864433   334456788889999


Q ss_pred             hhhccCccCCCCccccccccccceEecccccccCCCC-cccCCCCCccEEEccCCcCccc-ccccCCCCCCCCEEecc--
Q 039137          282 LLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNIS-ETFGTYPNLTFIDLSNNSFFGE-ILSDWGRCPQLSLLDVS--  357 (912)
Q Consensus       282 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~Ls--  357 (912)
                      |+++++.. +.+|..+..+++|++|+|++|.+++... ..+..+++|+.|+++ +.+... .+..+..+++|++|+++  
T Consensus       275 L~l~~~~~-~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g  352 (592)
T 3ogk_B          275 LGLSYMGP-NEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERG  352 (592)
T ss_dssp             EEETTCCT-TTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECC
T ss_pred             cCccccch-hHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecC
Confidence            99988644 4678888899999999999999765433 446889999999999 444433 33344678999999999  


Q ss_pred             ---------CCcccccc-cccccccccccEEEccCccccCCCCccccc-cccccEEEcc----CCcccCC-----Ccccc
Q 039137          358 ---------INNISGSI-PLEIGESLQLQYLDLSSNYIVGEIPTQLGN-IIYLNRLSLS----GNKLSGC-----IPREL  417 (912)
Q Consensus       358 ---------~N~l~~~~-~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~-l~~L~~L~L~----~N~l~~~-----~p~~~  417 (912)
                               .|.+++.. +.....+++|++|+++.|++++..+..+.. +++|+.|+++    .|++++.     ++..+
T Consensus       353 ~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~  432 (592)
T 3ogk_B          353 ADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLL  432 (592)
T ss_dssp             CCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHH
T ss_pred             ccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHH
Confidence                     36666432 223455789999999999998877766665 8889999996    7788764     34446


Q ss_pred             ccccccccccccCc--ccCccccccccc-cccccEEEeccccccc-ccchhhhcccccceeeccccccCcc-cccccccc
Q 039137          418 GSLINLEYLDLSAN--NLSNFVPESLGS-LVKLYYLNLSHNKLSQ-QIPIELDNLIHLSELDLSHNFLGEK-ISSRICRM  492 (912)
Q Consensus       418 ~~l~~L~~L~Ls~N--~l~~~~~~~~~~-l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l  492 (912)
                      ..+++|++|++++|  .+++..+..+.. +++|++|+|++|++++ .++..+.++++|++|+|++|.|++. ++..+..+
T Consensus       433 ~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l  512 (592)
T 3ogk_B          433 IGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKL  512 (592)
T ss_dssp             HHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHC
T ss_pred             HhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhc
Confidence            77899999999754  366655555543 7889999999999976 3455668889999999999998755 34445678


Q ss_pred             cccccccccCccccCCCccc-ccccccceEEEccCC
Q 039137          493 ESLEKLNLSYNNLSGLIPRC-FEEMHGLLHIDISYN  527 (912)
Q Consensus       493 ~~L~~L~ls~N~l~~~~p~~-~~~l~~L~~l~ls~N  527 (912)
                      ++|+.|++++|++++..... ...++.+....+..+
T Consensus       513 ~~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~~~~~  548 (592)
T 3ogk_B          513 PSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSR  548 (592)
T ss_dssp             SSCCEEEEESCBCCTTCTTGGGGCCTTEEEEEECCC
T ss_pred             CccCeeECcCCcCCHHHHHHHHHhCCCcEEEEecCc
Confidence            99999999999988663333 345677776666554

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.97  E-value=2.3e-31  Score=294.93  Aligned_cols=260  Identities=18%  Similarity=0.159  Sum_probs=142.1

Q ss_pred             CCccEEEccCCcccccCCccccCCCCCcEEeccccccccccccccccccccceeecccccccCCCCccccCcccccEEEc
Q 039137          109 PHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLAL  188 (912)
Q Consensus       109 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l  188 (912)
                      ++|++|+|++|++++..+..|.++++|++|+|++|++++..|..|+.+++|++|+|++|++++..+..++.+++|++|++
T Consensus        52 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L  131 (353)
T 2z80_A           52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNL  131 (353)
T ss_dssp             TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEEC
T ss_pred             ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEEC
Confidence            35666677666666555556666666666666666666555566666666666666666666433333556666666666


Q ss_pred             cCCcCCCCCC-ccCCCCccceeeeeccCCCcCccccccccccccceeecccccccCccccccccccccceeeeccccCcc
Q 039137          189 DSNFLNGSIP-RSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSG  267 (912)
Q Consensus       189 ~~n~l~~~~p-~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~  267 (912)
                      ++|++++..+ ..+.++++|++|++++|.                       .+++..|..|..+++|++|++++|++++
T Consensus       132 ~~n~l~~l~~~~~~~~l~~L~~L~l~~n~-----------------------~~~~~~~~~~~~l~~L~~L~l~~n~l~~  188 (353)
T 2z80_A          132 LGNPYKTLGETSLFSHLTKLQILRVGNMD-----------------------TFTKIQRKDFAGLTFLEELEIDASDLQS  188 (353)
T ss_dssp             TTCCCSSSCSSCSCTTCTTCCEEEEEESS-----------------------SCCEECTTTTTTCCEEEEEEEEETTCCE
T ss_pred             CCCCCcccCchhhhccCCCCcEEECCCCc-----------------------cccccCHHHccCCCCCCEEECCCCCcCc
Confidence            6666552222 245555555555555542                       2332333444555555555555555555


Q ss_pred             cCCcccCCccccchhhhccCccCCCCccccccccccceEecccccccCCCCcccC---CCCCccEEEccCCcCccccccc
Q 039137          268 IIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFG---TYPNLTFIDLSNNSFFGEILSD  344 (912)
Q Consensus       268 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~---~l~~L~~L~Ls~N~l~~~~~~~  344 (912)
                      ..|..+.++++|++|++++|++....+..+..+++|+.|++++|.+++..+..+.   ..+.++.++|+++.+.+     
T Consensus       189 ~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~-----  263 (353)
T 2z80_A          189 YEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITD-----  263 (353)
T ss_dssp             ECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCH-----
T ss_pred             cCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccC-----
Confidence            5555555555555555555555432222334456666666666666554333221   22334444444443322     


Q ss_pred             CCCCCCCCEEeccCCcccccccccccccccccEEEccCccccCCCCcc-ccccccccEEEccCCcccCC
Q 039137          345 WGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQ-LGNIIYLNRLSLSGNKLSGC  412 (912)
Q Consensus       345 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~-l~~l~~L~~L~L~~N~l~~~  412 (912)
                                    |.+. .+|..+..+++|++|+|++|+++ .+|.. +.++++|++|++++|.+.+.
T Consensus       264 --------------~~l~-~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~~~~~  316 (353)
T 2z80_A          264 --------------ESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCS  316 (353)
T ss_dssp             --------------HHHH-HHHHHHHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred             --------------cchh-hhHHHHhcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEEeeCCCccCc
Confidence                          1111 34555666667777777777776 34443 46677777777777777643

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.97  E-value=3.9e-31  Score=287.05  Aligned_cols=250  Identities=22%  Similarity=0.255  Sum_probs=181.1

Q ss_pred             CccceeEecCCCCeEEEeeccccccccccccccCCCCCccEEEccCCcccccCCccccCCCCCcEEecccccccc--ccc
Q 039137           73 CAWSGIFCNHAERVVGINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFG--QIP  150 (912)
Q Consensus        73 C~w~gv~c~~~~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~--~~p  150 (912)
                      |.|.+|.|+..+ ++.+            +.  .-.++|++|+|++|+++...+..|.++++|++|+|++|+++.  .+|
T Consensus         7 C~~~~l~c~~~~-l~~i------------p~--~~~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~   71 (306)
T 2z66_A            7 CSGTEIRCNSKG-LTSV------------PT--GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCS   71 (306)
T ss_dssp             EETTEEECCSSC-CSSC------------CS--CCCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEE
T ss_pred             eCCCEEEcCCCC-cccC------------CC--CCCCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcc
Confidence            899999997532 1111            11  123689999999999986555568999999999999999873  346


Q ss_pred             cccccccccceeecccccccCCCCccccCcccccEEEccCCcCCCCCC-ccCCCCccceeeeeccCCCcCcccccccccc
Q 039137          151 SGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIP-RSLGNLTHVVILYLYNNSFFGSIPQEIGNLK  229 (912)
Q Consensus       151 ~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p-~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~  229 (912)
                      ..+..+++|++|+|++|.++ .+|..+..+++|++|++++|++++..+ ..+.++++|++|++++|.+.+..|..+.+++
T Consensus        72 ~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~  150 (306)
T 2z66_A           72 QSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLS  150 (306)
T ss_dssp             HHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCT
T ss_pred             cccccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCc
Confidence            77788999999999999998 678888889999999999998886554 5778888888888888888777777777777


Q ss_pred             ccceeecccccccC-ccccccccccccceeeeccccCcccCCcccCCccccchhhhccCccCCCCccccccccccceEec
Q 039137          230 SLFDLELCINQLSG-AIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRL  308 (912)
Q Consensus       230 ~L~~L~l~~n~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  308 (912)
                      +|++|++++|++++ ..|..+..+++|++|+|++|++++..|..+.++++|++|+|++|++++..+..|..+++|++|++
T Consensus       151 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  230 (306)
T 2z66_A          151 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDY  230 (306)
T ss_dssp             TCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEEC
T ss_pred             CCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeEC
Confidence            77777777777765 46666777777777777777777666666666666666666666666555555555666666666


Q ss_pred             ccccccCCCCcccCCCC-CccEEEccCCcCc
Q 039137          309 NQNYLTGNISETFGTYP-NLTFIDLSNNSFF  338 (912)
Q Consensus       309 ~~n~l~~~~~~~~~~l~-~L~~L~Ls~N~l~  338 (912)
                      ++|.+++..+..+..++ +|++|+|++|.+.
T Consensus       231 ~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~  261 (306)
T 2z66_A          231 SLNHIMTSKKQELQHFPSSLAFLNLTQNDFA  261 (306)
T ss_dssp             TTSCCCBCSSSSCCCCCTTCCEEECTTCCEE
T ss_pred             CCCCCcccCHHHHHhhhccCCEEEccCCCee
Confidence            66666555555555553 5555555555554

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.97  E-value=5.7e-33  Score=330.70  Aligned_cols=407  Identities=14%  Similarity=0.083  Sum_probs=317.8

Q ss_pred             cCCccccCCCCCcEEecccccc---ccccccccc------------cccccceeecccccccCCCCccccCc--ccccEE
Q 039137          124 IIPPQISNLSNLEYLDFSANKL---FGQIPSGIG------------LLTHLTVLHISRNWLSGSIPHEVGQL--TVLNQL  186 (912)
Q Consensus       124 ~~p~~~~~l~~L~~L~Ls~n~l---~~~~p~~~~------------~l~~L~~L~L~~n~l~~~~p~~~~~l--~~L~~L  186 (912)
                      .++..+..+++|++|+|+++..   .+.+|..++            .+++|++|+|++|.+++..+..++.+  .+|++|
T Consensus        64 ~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L  143 (592)
T 3ogk_B           64 TPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETL  143 (592)
T ss_dssp             CHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEE
T ss_pred             ChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcEE
Confidence            4455677899999999988542   234554444            78999999999999887777777764  459999


Q ss_pred             EccCCc-CCC-CCCccCCCCccceeeeeccCCCcCc----cccccccccccceeeccccccc----Cccccccccccccc
Q 039137          187 ALDSNF-LNG-SIPRSLGNLTHVVILYLYNNSFFGS----IPQEIGNLKSLFDLELCINQLS----GAIPLSISNLTNLR  256 (912)
Q Consensus       187 ~l~~n~-l~~-~~p~~~~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~l~~n~l~----~~~p~~~~~l~~L~  256 (912)
                      +|++|. ++. .++....++++|++|+|++|.+++.    ++..+.++++|+.|+++.|+++    +.++..+.++++|+
T Consensus       144 ~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~  223 (592)
T 3ogk_B          144 KLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLV  223 (592)
T ss_dssp             EEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCC
T ss_pred             ECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCc
Confidence            999987 221 1223334789999999999998766    4456678899999999999997    34566677899999


Q ss_pred             eeeeccccCcccCCcccCCccccchhhhccCccC---CCCccccccccccceEecccccccCCCCcccCCCCCccEEEcc
Q 039137          257 FLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFR---GTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLS  333 (912)
Q Consensus       257 ~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~---~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls  333 (912)
                      .|++++|.+.+ +|..+.++++|++|+++.+...   +..+..+..+++|+.|+++++.. +.++..+..+++|++|+|+
T Consensus       224 ~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~-~~l~~~~~~~~~L~~L~Ls  301 (592)
T 3ogk_B          224 SVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGP-NEMPILFPFAAQIRKLDLL  301 (592)
T ss_dssp             EEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCT-TTGGGGGGGGGGCCEEEET
T ss_pred             EEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccch-hHHHHHHhhcCCCcEEecC
Confidence            99999999986 6788899999999999864433   34456678889999999998643 4567788889999999999


Q ss_pred             CCcCccccc-ccCCCCCCCCEEeccCCcccccccccccccccccEEEcc-----------CccccCC-CCcccccccccc
Q 039137          334 NNSFFGEIL-SDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLS-----------SNYIVGE-IPTQLGNIIYLN  400 (912)
Q Consensus       334 ~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L~-----------~N~l~~~-~~~~l~~l~~L~  400 (912)
                      +|.+++... ..+..+++|+.|+++++...+.++..+..+++|++|+|+           .|.+++. ++.....+++|+
T Consensus       302 ~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  381 (592)
T 3ogk_B          302 YALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELE  381 (592)
T ss_dssp             TCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCS
T ss_pred             CCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCe
Confidence            999876555 346889999999999443333445555678899999999           3666643 223345689999


Q ss_pred             EEEccCCcccCCCcccccc-cccccccccc----CcccCcc-----ccccccccccccEEEeccc--ccccccchhhhc-
Q 039137          401 RLSLSGNKLSGCIPRELGS-LINLEYLDLS----ANNLSNF-----VPESLGSLVKLYYLNLSHN--KLSQQIPIELDN-  467 (912)
Q Consensus       401 ~L~L~~N~l~~~~p~~~~~-l~~L~~L~Ls----~N~l~~~-----~~~~~~~l~~L~~L~Ls~N--~l~~~~~~~~~~-  467 (912)
                      +|+++.|++++..+..+.. +++|+.|+++    .|.+++.     ++..+..+++|++|+|++|  .+++..+..+.. 
T Consensus       382 ~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~  461 (592)
T 3ogk_B          382 YMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQY  461 (592)
T ss_dssp             EEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHS
T ss_pred             EEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHh
Confidence            9999999999877777766 8999999996    7788874     3334677899999999854  477666666654 


Q ss_pred             ccccceeeccccccCcc-cccccccccccccccccCccccCC-CcccccccccceEEEccCCccccC
Q 039137          468 LIHLSELDLSHNFLGEK-ISSRICRMESLEKLNLSYNNLSGL-IPRCFEEMHGLLHIDISYNKLEGQ  532 (912)
Q Consensus       468 l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~ls~N~l~~~-~p~~~~~l~~L~~l~ls~N~l~~~  532 (912)
                      +++|++|+|++|++++. ++..+..+++|++|++++|++++. ++.....+++|+.|++++|+++..
T Consensus       462 ~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~  528 (592)
T 3ogk_B          462 SPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMT  528 (592)
T ss_dssp             CTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred             CccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHH
Confidence            89999999999999874 455567899999999999999765 445567899999999999998753

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.97  E-value=1.9e-30  Score=287.51  Aligned_cols=261  Identities=20%  Similarity=0.240  Sum_probs=116.7

Q ss_pred             ccceeeeccccCcccCCcccCCccccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEcc
Q 039137          254 NLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLS  333 (912)
Q Consensus       254 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls  333 (912)
                      +|++|++++|++++..+..|.++++|++|++++|++++..|..|.++++|++|++++|.+++..+..|+.+++|++|+|+
T Consensus        53 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~  132 (353)
T 2z80_A           53 AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLL  132 (353)
T ss_dssp             TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECT
T ss_pred             cCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECC
Confidence            34444444444443333344444444444444444443333444444444444444444443333334444444444444


Q ss_pred             CCcCccccc-ccCCCCCCCCEEeccCC-cccccccccccccccccEEEccCccccCCCCccccccccccEEEccCCcccC
Q 039137          334 NNSFFGEIL-SDWGRCPQLSLLDVSIN-NISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSG  411 (912)
Q Consensus       334 ~N~l~~~~~-~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~  411 (912)
                      +|++.+... ..+..+++|+.|++++| .+.+..+..++.+++|++|++++|++++..|..+..+++|++|++++|+++.
T Consensus       133 ~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~  212 (353)
T 2z80_A          133 GNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHIL  212 (353)
T ss_dssp             TCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTT
T ss_pred             CCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCcccc
Confidence            444443222 23444444444444444 2333333444445555555555555554444555555555555555555542


Q ss_pred             CCccccccccccccccccCcccCcccccccc---ccccccEEEecccccccccchhhhcccccceeeccccccCcccccc
Q 039137          412 CIPRELGSLINLEYLDLSANNLSNFVPESLG---SLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSR  488 (912)
Q Consensus       412 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~---~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~  488 (912)
                      ..+..+..+++|++|++++|.+++..+..+.   ....++.++|++|.+++.                   .+ ..+|..
T Consensus       213 ~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~-------------------~l-~~l~~~  272 (353)
T 2z80_A          213 LLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDE-------------------SL-FQVMKL  272 (353)
T ss_dssp             HHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHH-------------------HH-HHHHHH
T ss_pred             chhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCc-------------------ch-hhhHHH
Confidence            2222233345555555555555544333222   123344444444444321                   11 023444


Q ss_pred             cccccccccccccCccccCCCcccccccccceEEEccCCccccCCC
Q 039137          489 ICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIP  534 (912)
Q Consensus       489 ~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~~  534 (912)
                      +..+++|+.|++++|+++.+.+..|..+++|++|++++|++.|..|
T Consensus       273 l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~  318 (353)
T 2z80_A          273 LNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  318 (353)
T ss_dssp             HHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             HhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence            5555555555555555554433334555566666666666655443

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.96  E-value=1.5e-29  Score=274.64  Aligned_cols=241  Identities=22%  Similarity=0.211  Sum_probs=135.5

Q ss_pred             CCCCccceeeeeccCCCcC--ccccccccccccceeecccccccCccccccccccccceeeeccccCcccCC-cccCCcc
Q 039137          201 LGNLTHVVILYLYNNSFFG--SIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIP-QEIGNLK  277 (912)
Q Consensus       201 ~~~l~~L~~L~L~~n~l~~--~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~l~~l~  277 (912)
                      |.++++|++|+|++|.++.  ..|..+..+++|++|++++|+++ .+|..+..+++|++|++++|++++..+ ..+.+++
T Consensus        48 ~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~  126 (306)
T 2z66_A           48 FDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR  126 (306)
T ss_dssp             TTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCT
T ss_pred             hhccccCCEEECCCCccCcccCcccccccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhcc
Confidence            3444444444444444431  12344445555666666666555 345556666666666666666665443 4556666


Q ss_pred             ccchhhhccCccCCCCccccccccccceEecccccccC-CCCcccCCCCCccEEEccCCcCcccccccCCCCCCCCEEec
Q 039137          278 KLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTG-NISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDV  356 (912)
Q Consensus       278 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  356 (912)
                      +|++|++++|.+.+..+..|..+++|++|++++|.+++ ..|..+..+++|++|+|++|++++..+..+..+++|+.|++
T Consensus       127 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L  206 (306)
T 2z66_A          127 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNM  206 (306)
T ss_dssp             TCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred             CCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEEC
Confidence            66666666666665555666666666666666666654 45556666666666666666666655666666666666666


Q ss_pred             cCCcccccccccccccccccEEEccCccccCCCCccccccc-cccEEEccCCcccCCCc--cccccccccccccccCccc
Q 039137          357 SINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNII-YLNRLSLSGNKLSGCIP--RELGSLINLEYLDLSANNL  433 (912)
Q Consensus       357 s~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~-~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l  433 (912)
                      ++|++++..+..+..+++|++|+|++|++++..|..+..++ +|++|+|++|.+++..+  .....+...+.+.+..+.+
T Consensus       207 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~  286 (306)
T 2z66_A          207 SHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERM  286 (306)
T ss_dssp             TTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGC
T ss_pred             CCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhcccccc
Confidence            66666655555555666666666666666665565565553 56666666666653211  1112233344444444454


Q ss_pred             Ccccccccc
Q 039137          434 SNFVPESLG  442 (912)
Q Consensus       434 ~~~~~~~~~  442 (912)
                      ....|..+.
T Consensus       287 ~C~~p~~~~  295 (306)
T 2z66_A          287 ECATPSDKQ  295 (306)
T ss_dssp             BEEESGGGT
T ss_pred             ccCCchhhC
Confidence            444444443

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.96  E-value=2.6e-29  Score=274.75  Aligned_cols=298  Identities=19%  Similarity=0.211  Sum_probs=241.0

Q ss_pred             HHHHHHHHHHhcccCCcccCCCcccCCCCCCCCCCCccceeEecCC---CCeEEEeeccccccccccccccCCCCCccEE
Q 039137           38 EAHALVKWKASLEVHSRSLLHSWSLSSVNATKISPCAWSGIFCNHA---ERVVGINLTSISLNGTLLEFSFSSFPHLVYL  114 (912)
Q Consensus        38 ~~~all~~k~~~~~~~~~~l~~w~~~~~~~~~~~~C~w~gv~c~~~---~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L  114 (912)
                      .+++..+..++-..++...|..|..+-    ..|+|.|.++-|...   ..+.       ...|                
T Consensus        13 ~~~~~~~~~~~~~~~~~~aLl~~k~~~----~~~~~~~~~~w~~~~~~~~~~~-------~~~g----------------   65 (328)
T 4fcg_A           13 GRENLYFQGSTALRPYHDVLSQWQRHY----NADRNRWHSAWRQANSNNPQIE-------TRTG----------------   65 (328)
T ss_dssp             ----CCCC--CCCCCHHHHHHHHHHHH----HHCCTTHHHHHHHHTTTCTTSC-------CSHH----------------
T ss_pred             cccceeeeccccCchHHHHHHHHHHhc----cCCchhhhhhhccccccccccc-------ccCC----------------
Confidence            444444444433345667788897431    247899998888321   1111       0001                


Q ss_pred             EccCCcccccCCccc--cCCCCCcEEeccccccccccccccccccccceeecccccccCCCCccccCcccccEEEccCCc
Q 039137          115 DLYNNELFGIIPPQI--SNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNF  192 (912)
Q Consensus       115 ~L~~n~l~~~~p~~~--~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~  192 (912)
                          .... .++..+  ...+++++|+|++|+++ .+|..++.+++|++|+|++|.++ .+|..++.+++|++|+|++|+
T Consensus        66 ----~~~~-~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~  138 (328)
T 4fcg_A           66 ----RALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNP  138 (328)
T ss_dssp             ----HHHH-HHHHHHHHHTSTTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCC
T ss_pred             ----cchh-hhHHHHhcccccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCc
Confidence                0011 122222  23578999999999997 88999999999999999999999 899999999999999999999


Q ss_pred             CCCCCCccCCCCccceeeeeccCCCcCccccccccccccceeecccccccCccccccccccccceeeeccccCcccCCcc
Q 039137          193 LNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQE  272 (912)
Q Consensus       193 l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~  272 (912)
                      ++ .+|..++++++|++|+|++|.+.+.+|..++..               ..+..+.++++|++|+|++|+++ .+|..
T Consensus       139 l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~---------------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~  201 (328)
T 4fcg_A          139 LR-ALPASIASLNRLRELSIRACPELTELPEPLAST---------------DASGEHQGLVNLQSLRLEWTGIR-SLPAS  201 (328)
T ss_dssp             CC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEE---------------C-CCCEEESTTCCEEEEEEECCC-CCCGG
T ss_pred             cc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhc---------------cchhhhccCCCCCEEECcCCCcC-cchHh
Confidence            98 888889999999999999988888888766541               12345778999999999999999 68889


Q ss_pred             cCCccccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCcccccccCCCCCCCC
Q 039137          273 IGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLS  352 (912)
Q Consensus       273 l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  352 (912)
                      ++++++|++|+|++|++++ +|..+..+++|++|+|++|.+.+.+|..|+.+++|++|+|++|.+.+.+|..++.+++|+
T Consensus       202 l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~  280 (328)
T 4fcg_A          202 IANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLE  280 (328)
T ss_dssp             GGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCC
T ss_pred             hcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCC
Confidence            9999999999999999995 666899999999999999999999999999999999999999999999999999999999


Q ss_pred             EEeccCCcccccccccccccccccEEEccCccccC
Q 039137          353 LLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVG  387 (912)
Q Consensus       353 ~L~Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~  387 (912)
                      .|++++|++.+.+|..++.+++|+.+++..|.+..
T Consensus       281 ~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~~  315 (328)
T 4fcg_A          281 KLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQ  315 (328)
T ss_dssp             EEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSCC
T ss_pred             EEeCCCCCchhhccHHHhhccCceEEeCCHHHHHH
Confidence            99999999999999999999999999999887753

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.96  E-value=1.7e-30  Score=282.48  Aligned_cols=250  Identities=21%  Similarity=0.210  Sum_probs=126.7

Q ss_pred             ccCCCCCcEEeccccccccccccccccccccceeecccccc-cCCCCcccc-------CcccccEEEccCCcCCCCCCcc
Q 039137          129 ISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWL-SGSIPHEVG-------QLTVLNQLALDSNFLNGSIPRS  200 (912)
Q Consensus       129 ~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l-~~~~p~~~~-------~l~~L~~L~l~~n~l~~~~p~~  200 (912)
                      ++..++|++|++++|.+  .+|..+...  |+.|+|++|.+ .+.+|..+.       ++++|++|+|++|++++.+|..
T Consensus        39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~  114 (312)
T 1wwl_A           39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP  114 (312)
T ss_dssp             EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCC
T ss_pred             EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHH
Confidence            34445556666666666  455544433  66666666665 334444444       4555666666666655555555


Q ss_pred             C--CCCccceeeeeccCCCcCccccccccc-----cccceeecccccccCccccccccccccceeeeccccCccc--CCc
Q 039137          201 L--GNLTHVVILYLYNNSFFGSIPQEIGNL-----KSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGI--IPQ  271 (912)
Q Consensus       201 ~--~~l~~L~~L~L~~n~l~~~~p~~~~~l-----~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~~~  271 (912)
                      +  .++++|++|+|++|++++. |..++++     ++|++|++++|++++..|..|+++++|++|+|++|++.+.  .+.
T Consensus       115 ~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~  193 (312)
T 1wwl_A          115 LLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS  193 (312)
T ss_dssp             SSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHH
T ss_pred             HHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHH
Confidence            4  5566666666666666544 5555544     5555555555555544445555555555555555554432  111


Q ss_pred             cc--CCccccchhhhccCccCCC---CccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCcccccccCC
Q 039137          272 EI--GNLKKLNSLLLAKNHFRGT---VPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWG  346 (912)
Q Consensus       272 ~l--~~l~~L~~L~L~~N~l~~~---~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  346 (912)
                      .+  .++++|++|+|++|++++.   ....+..+++|++|+|++|.+++.++                       ...+.
T Consensus       194 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-----------------------~~~~~  250 (312)
T 1wwl_A          194 ALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAG-----------------------APSCD  250 (312)
T ss_dssp             HSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCC-----------------------CSCCC
T ss_pred             HHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccc-----------------------hhhhh
Confidence            22  3444444444444444411   11122333444444444444443332                       12233


Q ss_pred             CCCCCCEEeccCCcccccccccccccccccEEEccCccccCCCCccccccccccEEEccCCcccC
Q 039137          347 RCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSG  411 (912)
Q Consensus       347 ~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~  411 (912)
                      .+++|+.|++++|+|+ .+|..+.  ++|++|+|++|+|++. |. +..+++|++|++++|++++
T Consensus       251 ~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~  310 (312)
T 1wwl_A          251 WPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD  310 (312)
T ss_dssp             CCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred             hcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence            3444555555555554 4444443  5566666666666644 43 5566666666666666653

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.96  E-value=3.8e-29  Score=293.87  Aligned_cols=268  Identities=26%  Similarity=0.317  Sum_probs=165.3

Q ss_pred             CccEEEccCCcccccCCccccCCCCCcEEeccccccccccccccccccccceeecccccccCCCCccccCcccccEEEcc
Q 039137          110 HLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALD  189 (912)
Q Consensus       110 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~  189 (912)
                      .++.|++++|+++ .+|..+.  ++|++|+|++|+|+ .+|.   .+++|++|+|++|+++ .+|.   .+++|++|+|+
T Consensus        41 ~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls  109 (622)
T 3g06_A           41 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIF  109 (622)
T ss_dssp             CCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEEC
T ss_pred             CCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECc
Confidence            3677888888888 6777665  78888899888887 5666   5678888888888887 5665   56778888888


Q ss_pred             CCcCCCCCCccCCCCccceeeeeccCCCcCccccccccccccceeecccccccCccccccccccccceeeeccccCcccC
Q 039137          190 SNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGII  269 (912)
Q Consensus       190 ~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  269 (912)
                      +|++++ +|.   .+++|+.|++++|++++ +|..   +++|++|++++|++++ +|.   .+++|+.|++++|++++ +
T Consensus       110 ~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~~-l  176 (622)
T 3g06_A          110 SNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPA---LPSELCKLWAYNNQLTS-L  176 (622)
T ss_dssp             SCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-C
T ss_pred             CCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCC-cCC---ccCCCCEEECCCCCCCC-C
Confidence            888774 444   45667777777777763 4432   3566666666666653 232   23455566666666554 2


Q ss_pred             CcccCCccccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCcccccccCCCCC
Q 039137          270 PQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCP  349 (912)
Q Consensus       270 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  349 (912)
                      |   ..+++|+.|++++|++++ +|..   +++|+.|++++|.++..                         +.   .++
T Consensus       177 ~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~~l-------------------------~~---~~~  221 (622)
T 3g06_A          177 P---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTSL-------------------------PA---LPS  221 (622)
T ss_dssp             C---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSSC-------------------------CC---CCT
T ss_pred             c---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCccccc-------------------------CC---CCC
Confidence            3   223445555555555543 2221   23444444444444422                         11   134


Q ss_pred             CCCEEeccCCcccccccccccccccccEEEccCccccCCCCccccccccccEEEccCCcccCCCcccccccccccccccc
Q 039137          350 QLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLS  429 (912)
Q Consensus       350 ~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls  429 (912)
                      +|+.|++++|+|++ +|   ..+++|++|+|++|+|+ .+|.   .+++|+.|+|++|+|+ .+|..+..+++|+.|+|+
T Consensus       222 ~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~  292 (622)
T 3g06_A          222 GLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE  292 (622)
T ss_dssp             TCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECC
T ss_pred             CCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEec
Confidence            55555555555553 33   23456666666666666 3443   4556777777777777 556667777777777777


Q ss_pred             CcccCccccccccccc
Q 039137          430 ANNLSNFVPESLGSLV  445 (912)
Q Consensus       430 ~N~l~~~~~~~~~~l~  445 (912)
                      +|.+++..|..+..++
T Consensus       293 ~N~l~~~~~~~l~~L~  308 (622)
T 3g06_A          293 GNPLSERTLQALREIT  308 (622)
T ss_dssp             SCCCCHHHHHHHHHHH
T ss_pred             CCCCCCcCHHHHHhcc
Confidence            7777776666655544

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.96  E-value=1.1e-28  Score=283.05  Aligned_cols=249  Identities=24%  Similarity=0.258  Sum_probs=147.5

Q ss_pred             cceeeeccccCcccCCcccCCccccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEccC
Q 039137          255 LRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSN  334 (912)
Q Consensus       255 L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~  334 (912)
                      ...++++++.++. +|..+.  ++|++|+|++|++++..|..|.++++|++|+|++|.+++..+..|..+++|++|+|++
T Consensus        56 ~~~v~c~~~~l~~-iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~  132 (452)
T 3zyi_A           56 FSKVVCTRRGLSE-VPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFD  132 (452)
T ss_dssp             SCEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CcEEEECCCCcCc-cCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCC
Confidence            4567777777773 555443  4677777777777766666777777777777777777766666666677777777777


Q ss_pred             CcCcccccccCCCCCCCCEEeccCCcccccccccccccccccEEEccCccccCCCCccccccccccEEEccCCcccCCCc
Q 039137          335 NSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIP  414 (912)
Q Consensus       335 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p  414 (912)
                      |+++...+..|..+++|++|++++|++....+..+..+++|++|+|++|...+.+                       .+
T Consensus       133 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i-----------------------~~  189 (452)
T 3zyi_A          133 NWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYI-----------------------SE  189 (452)
T ss_dssp             SCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEE-----------------------CT
T ss_pred             CcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCcccc-----------------------Ch
Confidence            7666655555666666666666666666444445555556666666553222222                       22


Q ss_pred             cccccccccccccccCcccCccccccccccccccEEEecccccccccchhhhcccccceeeccccccCcccccccccccc
Q 039137          415 RELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMES  494 (912)
Q Consensus       415 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  494 (912)
                      ..|..+++|++|+|++|+++++ | .+..+++|+.|+|++|++++..|..|.++++|+.|+|++|+|++..+..|..+++
T Consensus       190 ~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~  267 (452)
T 3zyi_A          190 GAFEGLFNLKYLNLGMCNIKDM-P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLAS  267 (452)
T ss_dssp             TTTTTCTTCCEEECTTSCCSSC-C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred             hhccCCCCCCEEECCCCccccc-c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCC
Confidence            2344444455555555555442 2 2445555555555555555555555555555555555555555555555555555


Q ss_pred             cccccccCccccCCCcccccccccceEEEccCCcccc
Q 039137          495 LEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEG  531 (912)
Q Consensus       495 L~~L~ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~  531 (912)
                      |+.|+|++|+|++..+..|..+++|+.|++++|+|.|
T Consensus       268 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C  304 (452)
T 3zyi_A          268 LVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNC  304 (452)
T ss_dssp             CCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEEC
T ss_pred             CCEEECCCCcCCccChHHhccccCCCEEEccCCCcCC
Confidence            5555666665555555555556666666666666555

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.96  E-value=1.1e-29  Score=275.95  Aligned_cols=250  Identities=25%  Similarity=0.288  Sum_probs=155.9

Q ss_pred             CCCCccceeeeeccCCCcCccccccccccccceeecccccc-cCccccccc-------cccccceeeeccccCcccCCcc
Q 039137          201 LGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQL-SGAIPLSIS-------NLTNLRFLFLYHNELSGIIPQE  272 (912)
Q Consensus       201 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l-~~~~p~~~~-------~l~~L~~L~L~~N~l~~~~~~~  272 (912)
                      +++.++|++|++++|.+  .+|..+...  |+.|++++|++ .+.+|..+.       ++++|++|+|++|++++.+|..
T Consensus        39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~  114 (312)
T 1wwl_A           39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP  114 (312)
T ss_dssp             EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCC
T ss_pred             EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHH
Confidence            45566788888888888  567666554  78888888888 345565554       6788888888888888777776


Q ss_pred             c--CCccccchhhhccCccCCCCccccccc-----cccceEecccccccCCCCcccCCCCCccEEEccCCcCccc--ccc
Q 039137          273 I--GNLKKLNSLLLAKNHFRGTVPKSFRNL-----TDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGE--ILS  343 (912)
Q Consensus       273 l--~~l~~L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~--~~~  343 (912)
                      +  ..+++|++|+|++|++++. |..+..+     ++|++|+|++|++++..+..|+.+++|++|+|++|++.+.  .+.
T Consensus       115 ~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~  193 (312)
T 1wwl_A          115 LLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS  193 (312)
T ss_dssp             SSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHH
T ss_pred             HHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHH
Confidence            5  7788888888888888866 7777776     7777777777777777777777777777777777776554  222


Q ss_pred             cC--CCCCCCCEEeccCCccccc--cc-ccccccccccEEEccCccccCCCCccccccccccEEEccCCcccCCCccccc
Q 039137          344 DW--GRCPQLSLLDVSINNISGS--IP-LEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELG  418 (912)
Q Consensus       344 ~~--~~l~~L~~L~Ls~N~l~~~--~~-~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~  418 (912)
                      .+  +.+++|++|++++|++++.  ++ ..+..+++|++|+|++|++++..|.                       ..+.
T Consensus       194 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-----------------------~~~~  250 (312)
T 1wwl_A          194 ALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGA-----------------------PSCD  250 (312)
T ss_dssp             HSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCC-----------------------SCCC
T ss_pred             HHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccch-----------------------hhhh
Confidence            22  5566666666666666521  11 1223344555555555555543321                       2233


Q ss_pred             cccccccccccCcccCccccccccccccccEEEecccccccccchhhhcccccceeeccccccCc
Q 039137          419 SLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGE  483 (912)
Q Consensus       419 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  483 (912)
                      .+++|++|+|++|+|+. +|..+.  ++|++|+|++|+|++. |. +..+++|++|+|++|+|++
T Consensus       251 ~l~~L~~L~Ls~N~l~~-ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~  310 (312)
T 1wwl_A          251 WPSQLNSLNLSFTGLKQ-VPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD  310 (312)
T ss_dssp             CCTTCCEEECTTSCCSS-CCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred             hcCCCCEEECCCCccCh-hhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence            34455555555555542 333333  4555555555555543 33 5555555555555555543

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.96  E-value=1.1e-28  Score=281.86  Aligned_cols=249  Identities=26%  Similarity=0.281  Sum_probs=149.7

Q ss_pred             cceeeeccccCcccCCcccCCccccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEccC
Q 039137          255 LRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSN  334 (912)
Q Consensus       255 L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~  334 (912)
                      .+.++++++.++ .+|..+.  ++++.|+|++|++++..+..|.++++|++|+|++|.+++..+..|..+++|++|+|++
T Consensus        45 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~  121 (440)
T 3zyj_A           45 FSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFD  121 (440)
T ss_dssp             SCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCS
T ss_pred             CCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCC
Confidence            456777777777 3555544  4666677777777666666666666777777776666666666666666666666666


Q ss_pred             CcCcccccccCCCCCCCCEEeccCCcccccccccccccccccEEEccCccccCCCCccccccccccEEEccCCcccCCCc
Q 039137          335 NSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIP  414 (912)
Q Consensus       335 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p  414 (912)
                      |+++...+..|..+++|+.|++++|++....+..+..+++|++|+|++|+.                       +....+
T Consensus       122 n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~-----------------------l~~i~~  178 (440)
T 3zyj_A          122 NRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKR-----------------------LSYISE  178 (440)
T ss_dssp             SCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTT-----------------------CCEECT
T ss_pred             CcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCC-----------------------cceeCc
Confidence            666655555566666666666666666544444555555555555555322                       222222


Q ss_pred             cccccccccccccccCcccCccccccccccccccEEEecccccccccchhhhcccccceeeccccccCcccccccccccc
Q 039137          415 RELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMES  494 (912)
Q Consensus       415 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  494 (912)
                      ..|..+++|++|+|++|+++.+ | .+..+++|+.|+|++|++++..|..|.++++|+.|+|++|+|++..+..|..+++
T Consensus       179 ~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~  256 (440)
T 3zyj_A          179 GAFEGLSNLRYLNLAMCNLREI-P-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQS  256 (440)
T ss_dssp             TTTTTCSSCCEEECTTSCCSSC-C-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTT
T ss_pred             chhhcccccCeecCCCCcCccc-c-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCC
Confidence            3444455555555555555442 2 2455556666666666666555566666666666666666666666666666666


Q ss_pred             cccccccCccccCCCcccccccccceEEEccCCcccc
Q 039137          495 LEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEG  531 (912)
Q Consensus       495 L~~L~ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~  531 (912)
                      |+.|+|++|+|++..+..|..+++|+.|++++|+|.|
T Consensus       257 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C  293 (440)
T 3zyj_A          257 LVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNC  293 (440)
T ss_dssp             CCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEEC
T ss_pred             CCEEECCCCCCCccChhHhccccCCCEEEcCCCCccC
Confidence            6666666666666666666666666666666666665

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.96  E-value=7.8e-29  Score=265.88  Aligned_cols=224  Identities=23%  Similarity=0.204  Sum_probs=104.5

Q ss_pred             cEEeccccccccccccccccccccceeecccccccCCCCccccCcccccEEEccCCcCCCCCCccCCCCccceeeeeccC
Q 039137          136 EYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNN  215 (912)
Q Consensus       136 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n  215 (912)
                      ++++.+++.++ .+|..+  .++|++|+|++|.+++..+..|+.+++|++|++++|.+++..|..|.++++|++|++++|
T Consensus        14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n   90 (285)
T 1ozn_A           14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN   90 (285)
T ss_dssp             CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred             eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence            45666666665 455433  346666666666666444455555555555555555555444555555555555555555


Q ss_pred             C-CcCccccccccccccceeecccccccCccccccccccccceeeeccccCcccCCcccCCccccchhhhccCccCCCCc
Q 039137          216 S-FFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVP  294 (912)
Q Consensus       216 ~-l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~  294 (912)
                      . +.+..|..+.++++|++|++++|++++..|..+.++++|++                        |++++|++++..+
T Consensus        91 ~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~------------------------L~l~~n~l~~~~~  146 (285)
T 1ozn_A           91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQY------------------------LYLQDNALQALPD  146 (285)
T ss_dssp             TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCE------------------------EECCSSCCCCCCT
T ss_pred             CCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCE------------------------EECCCCcccccCH
Confidence            4 43333444444444444444444444333333333344444                        4444444433333


Q ss_pred             cccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCcccccccCCCCCCCCEEeccCCccccccccccccccc
Q 039137          295 KSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQ  374 (912)
Q Consensus       295 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~  374 (912)
                      ..|..+++|++|+|++|.+++..+..|..+++|+.|+|++|.+.+..+..+..+++|+.|++++|++++..+..+..+++
T Consensus       147 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~  226 (285)
T 1ozn_A          147 DTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRA  226 (285)
T ss_dssp             TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTT
T ss_pred             hHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcc
Confidence            33444444444444444444333334444444444444444444444444444444444444444444333333444444


Q ss_pred             ccEEEccCcccc
Q 039137          375 LQYLDLSSNYIV  386 (912)
Q Consensus       375 L~~L~L~~N~l~  386 (912)
                      |++|+|++|.+.
T Consensus       227 L~~L~l~~N~~~  238 (285)
T 1ozn_A          227 LQYLRLNDNPWV  238 (285)
T ss_dssp             CCEEECCSSCEE
T ss_pred             cCEEeccCCCcc
Confidence            444444444443

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.96  E-value=1.8e-28  Score=281.18  Aligned_cols=228  Identities=22%  Similarity=0.250  Sum_probs=119.2

Q ss_pred             CCccEEEccCCcccccCCccccCCCCCcEEeccccccccccccccccccccceeecccccccCCCCccccCcccccEEEc
Q 039137          109 PHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLAL  188 (912)
Q Consensus       109 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l  188 (912)
                      +++++|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++..+..|+.+++|++|+|
T Consensus        75 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  154 (452)
T 3zyi_A           75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWL  154 (452)
T ss_dssp             TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEEC
T ss_pred             CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEEC
Confidence            45666666666666666666666666666666666666555566666666666666666666444445555666666666


Q ss_pred             cCCcCCCCCCccCCCCccceeeeeccCCCcCccccccccccccceeecccccccCccccccccccccceeeeccccCccc
Q 039137          189 DSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGI  268 (912)
Q Consensus       189 ~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  268 (912)
                      ++|+++...+..|.++++|++|++++|...+.++                       +..|..+++|++|+|++|++++.
T Consensus       155 ~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~-----------------------~~~~~~l~~L~~L~L~~n~l~~~  211 (452)
T 3zyi_A          155 RNNPIESIPSYAFNRVPSLMRLDLGELKKLEYIS-----------------------EGAFEGLFNLKYLNLGMCNIKDM  211 (452)
T ss_dssp             CSCCCCEECTTTTTTCTTCCEEECCCCTTCCEEC-----------------------TTTTTTCTTCCEEECTTSCCSSC
T ss_pred             CCCCcceeCHhHHhcCCcccEEeCCCCCCccccC-----------------------hhhccCCCCCCEEECCCCccccc
Confidence            6665554334445555555555555432222222                       22344455555555555555532


Q ss_pred             CCcccCCccccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCcccccccCCCC
Q 039137          269 IPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRC  348 (912)
Q Consensus       269 ~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  348 (912)
                       | .+..+++|++|+|++|++++..|..|.++++|+.|+|++|++++..+..|..+++|+.|+|++|++++..+..+..+
T Consensus       212 -~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  289 (452)
T 3zyi_A          212 -P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPL  289 (452)
T ss_dssp             -C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTC
T ss_pred             -c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccc
Confidence             2 24444444444444444444444444444444555554444444444444444444444444444444333334444


Q ss_pred             CCCCEEeccCCcc
Q 039137          349 PQLSLLDVSINNI  361 (912)
Q Consensus       349 ~~L~~L~Ls~N~l  361 (912)
                      ++|+.|++++|.+
T Consensus       290 ~~L~~L~L~~Np~  302 (452)
T 3zyi_A          290 RYLVELHLHHNPW  302 (452)
T ss_dssp             TTCCEEECCSSCE
T ss_pred             cCCCEEEccCCCc
Confidence            4444444444433

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.96  E-value=1.3e-28  Score=264.20  Aligned_cols=205  Identities=24%  Similarity=0.216  Sum_probs=93.3

Q ss_pred             ccceeeeccccCcccCCcccCCccccchhhhccCccCCCCccccccccccceEeccccc-ccCCCCcccCCCCCccEEEc
Q 039137          254 NLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNY-LTGNISETFGTYPNLTFIDL  332 (912)
Q Consensus       254 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L  332 (912)
                      +|++|+|++|++++..+..|.++++|++|+|++|.+++..|..|..+++|++|++++|. ++...+..|..+++|++|+|
T Consensus        33 ~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l  112 (285)
T 1ozn_A           33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL  112 (285)
T ss_dssp             TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEEC
T ss_pred             CceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEEC
Confidence            44444444444444433444444444444444444444444444444444444444443 44333444444444444444


Q ss_pred             cCCcCcccccccCCCCCCCCEEeccCCcccccccccccccccccEEEccCccccCCCCccccccccccEEEccCCcccCC
Q 039137          333 SNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGC  412 (912)
Q Consensus       333 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~  412 (912)
                      ++|.+.+..+..+..+++|++|++++|++++..+..++.+++|++|+|++|++++..+..+..+++|+.|++++|++++.
T Consensus       113 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~  192 (285)
T 1ozn_A          113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV  192 (285)
T ss_dssp             TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEE
T ss_pred             CCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCccccc
Confidence            44444444444444444444444444444433333344444444444444444433333344444444444444444444


Q ss_pred             CccccccccccccccccCcccCccccccccccccccEEEecccccc
Q 039137          413 IPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLS  458 (912)
Q Consensus       413 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  458 (912)
                      .|..+..+++|+.|++++|+++++.+..+..+++|++|+|++|++.
T Consensus       193 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~  238 (285)
T 1ozn_A          193 HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV  238 (285)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEE
T ss_pred             CHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCcc
Confidence            4444444444444444444444443344444444444444444443

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.96  E-value=1.1e-31  Score=319.77  Aligned_cols=447  Identities=16%  Similarity=0.104  Sum_probs=304.2

Q ss_pred             CCccceeEecCCCCeEEEeeccccccccccccccCCCCCccEEEccCCcccc---cCCc------------cccCCCCCc
Q 039137           72 PCAWSGIFCNHAERVVGINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFG---IIPP------------QISNLSNLE  136 (912)
Q Consensus        72 ~C~w~gv~c~~~~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~---~~p~------------~~~~l~~L~  136 (912)
                      |++|.++... .  ...+++...  .+..+...+..+++|++|+|+++....   ..|.            ....+++|+
T Consensus        34 ck~W~~~~~~-~--~~~l~~~~~--~~~~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~  108 (594)
T 2p1m_B           34 CKSWYEIERW-C--RRKVFIGNC--YAVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLE  108 (594)
T ss_dssp             CHHHHHHHHH-H--CCEEEESST--TSSCHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCC
T ss_pred             HHHHHHhhhh-h--ceEEeeccc--cccCHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCC
Confidence            5578877221 1  223333221  122223346678999999999976321   1222            234678999


Q ss_pred             EEeccccccccccccccc-cccccceeecccc-cccCC-CCccccCcccccEEEccCCcCCCCCCccC----CCCcccee
Q 039137          137 YLDFSANKLFGQIPSGIG-LLTHLTVLHISRN-WLSGS-IPHEVGQLTVLNQLALDSNFLNGSIPRSL----GNLTHVVI  209 (912)
Q Consensus       137 ~L~Ls~n~l~~~~p~~~~-~l~~L~~L~L~~n-~l~~~-~p~~~~~l~~L~~L~l~~n~l~~~~p~~~----~~l~~L~~  209 (912)
                      +|+|++|.+++..+..+. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+    ..+++|++
T Consensus       109 ~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~  188 (594)
T 2p1m_B          109 EIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVS  188 (594)
T ss_dssp             EEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCE
T ss_pred             eEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcE
Confidence            999999999887777776 6899999999999 55532 45555689999999999999876554444    36779999


Q ss_pred             eeeccCC--CcC-ccccccccccccceeecccc-cccCccccccccccccceeeeccc-------cCcccCCcccCCccc
Q 039137          210 LYLYNNS--FFG-SIPQEIGNLKSLFDLELCIN-QLSGAIPLSISNLTNLRFLFLYHN-------ELSGIIPQEIGNLKK  278 (912)
Q Consensus       210 L~L~~n~--l~~-~~p~~~~~l~~L~~L~l~~n-~l~~~~p~~~~~l~~L~~L~L~~N-------~l~~~~~~~l~~l~~  278 (912)
                      |++++|.  +.. .++..+.++++|+.|++++| .+++ +|..+..+++|+.|+++.+       .+.+ ++..+.++++
T Consensus       189 L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~-l~~~l~~~~~  266 (594)
T 2p1m_B          189 LNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSG-LSVALSGCKE  266 (594)
T ss_dssp             EECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHH-HHHHHHTCTT
T ss_pred             EEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHH-HHHHHhcCCC
Confidence            9999987  221 12223355799999999998 4554 7888889999999995544       4444 3446778888


Q ss_pred             cchh-hhccCccCCCCccccccccccceEecccccccCCC-CcccCCCCCccEEEccCCcCccccccc-CCCCCCCCEEe
Q 039137          279 LNSL-LLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNI-SETFGTYPNLTFIDLSNNSFFGEILSD-WGRCPQLSLLD  355 (912)
Q Consensus       279 L~~L-~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~~-~~~l~~L~~L~  355 (912)
                      |+.| .+.+... +.++..+..+++|++|+|++|.+++.. ...+..+++|+.|++++| +....... ...+++|+.|+
T Consensus       267 L~~Ls~~~~~~~-~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~  344 (594)
T 2p1m_B          267 LRCLSGFWDAVP-AYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELR  344 (594)
T ss_dssp             CCEEECCBTCCG-GGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEE
T ss_pred             cccccCCcccch-hhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEE
Confidence            8887 4443332 245555667889999999999876432 233568899999999988 44332222 23578899998


Q ss_pred             cc---------CCccccccccccc-ccccccEEEccCccccCCCCcccc-ccccccEEEcc--C----CcccCCC-----
Q 039137          356 VS---------INNISGSIPLEIG-ESLQLQYLDLSSNYIVGEIPTQLG-NIIYLNRLSLS--G----NKLSGCI-----  413 (912)
Q Consensus       356 Ls---------~N~l~~~~~~~~~-~~~~L~~L~L~~N~l~~~~~~~l~-~l~~L~~L~L~--~----N~l~~~~-----  413 (912)
                      ++         .+.+++.....+. .+++|++|+++.|.+++..+..+. .+++|+.|+++  +    |.+++..     
T Consensus       345 L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~  424 (594)
T 2p1m_B          345 VFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGF  424 (594)
T ss_dssp             EECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHH
T ss_pred             EecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHH
Confidence            83         3455543333333 477888888888888765555554 57888999988  4    5555221     


Q ss_pred             ccccccccccccccccCcccCccccccccc-cccccEEEecccccccccchhh-hcccccceeeccccccCccccc-ccc
Q 039137          414 PRELGSLINLEYLDLSANNLSNFVPESLGS-LVKLYYLNLSHNKLSQQIPIEL-DNLIHLSELDLSHNFLGEKISS-RIC  490 (912)
Q Consensus       414 p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~~~-~~~  490 (912)
                      +..+..+++|+.|+|++ .+++..+..+.. +++|++|+|++|.+++..+..+ ..+++|++|+|++|.+++.... ...
T Consensus       425 ~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~  503 (594)
T 2p1m_B          425 GAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANAS  503 (594)
T ss_dssp             HHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGG
T ss_pred             HHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHH
Confidence            22256678888898877 666655555554 7888999999888876655555 6688889999999888655443 344


Q ss_pred             cccccccccccCccccCCCcccc-cccccceEEEccCCc
Q 039137          491 RMESLEKLNLSYNNLSGLIPRCF-EEMHGLLHIDISYNK  528 (912)
Q Consensus       491 ~l~~L~~L~ls~N~l~~~~p~~~-~~l~~L~~l~ls~N~  528 (912)
                      .+++|+.|++++|+++......+ ..++.++...+..+.
T Consensus       504 ~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~~  542 (594)
T 2p1m_B          504 KLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERG  542 (594)
T ss_dssp             GGGGSSEEEEESSCCBHHHHHHHHHHCTTEEEEEECSSS
T ss_pred             hCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEEecCCC
Confidence            58888888898888854433334 456777666665543

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.96  E-value=3e-28  Score=278.28  Aligned_cols=227  Identities=24%  Similarity=0.235  Sum_probs=112.5

Q ss_pred             CCccEEEccCCcccccCCccccCCCCCcEEeccccccccccccccccccccceeecccccccCCCCccccCcccccEEEc
Q 039137          109 PHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLAL  188 (912)
Q Consensus       109 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l  188 (912)
                      ++++.|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++..+..|..+++|++|+|
T Consensus        64 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  143 (440)
T 3zyj_A           64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWL  143 (440)
T ss_dssp             TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEEC
T ss_pred             CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeC
Confidence            45666666666666666666666666666666666666555566666666666666666666444445556666666666


Q ss_pred             cCCcCCCCCCccCCCCccceeeeeccCCCcCccccccccccccceeecccccccCccccccccccccceeeeccccCccc
Q 039137          189 DSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGI  268 (912)
Q Consensus       189 ~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  268 (912)
                      ++|+++...+..|.++++|++|+|++|...+.++                       +..|.++++|++|+|++|+++. 
T Consensus       144 ~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~-----------------------~~~~~~l~~L~~L~L~~n~l~~-  199 (440)
T 3zyj_A          144 RNNPIESIPSYAFNRIPSLRRLDLGELKRLSYIS-----------------------EGAFEGLSNLRYLNLAMCNLRE-  199 (440)
T ss_dssp             CSCCCCEECTTTTTTCTTCCEEECCCCTTCCEEC-----------------------TTTTTTCSSCCEEECTTSCCSS-
T ss_pred             CCCcccccCHHHhhhCcccCEeCCCCCCCcceeC-----------------------cchhhcccccCeecCCCCcCcc-
Confidence            6665554444455555555555555432222222                       2234444445555555544442 


Q ss_pred             CCcccCCccccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCcccccccCCCC
Q 039137          269 IPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRC  348 (912)
Q Consensus       269 ~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  348 (912)
                      +| .+..+++|++|+|++|++++..|..|.++++|+.|+|++|++++..+..|..+++|+.|+|++|++++..+..+..+
T Consensus       200 ~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  278 (440)
T 3zyj_A          200 IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPL  278 (440)
T ss_dssp             CC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSC
T ss_pred             cc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccc
Confidence            12 23333444444444444443333444444444444444444444334444444444444444444433333333333


Q ss_pred             CCCCEEeccCCc
Q 039137          349 PQLSLLDVSINN  360 (912)
Q Consensus       349 ~~L~~L~Ls~N~  360 (912)
                      ++|+.|+|++|.
T Consensus       279 ~~L~~L~L~~Np  290 (440)
T 3zyj_A          279 HHLERIHLHHNP  290 (440)
T ss_dssp             TTCCEEECCSSC
T ss_pred             cCCCEEEcCCCC
Confidence            333333333333

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.95  E-value=1.3e-29  Score=276.14  Aligned_cols=237  Identities=25%  Similarity=0.249  Sum_probs=125.1

Q ss_pred             cccccceeeeccccCcccCCcccCCccccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEE
Q 039137          251 NLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFI  330 (912)
Q Consensus       251 ~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  330 (912)
                      .+++|++|+|++|++++..|..|.++++|++|+|++|++++..+  |..+++|++|++++|.+++..     ..++|++|
T Consensus        32 ~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~-----~~~~L~~L  104 (317)
T 3o53_A           32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPSIETL  104 (317)
T ss_dssp             TGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEEE-----ECTTCCEE
T ss_pred             cCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcccccc-----CCCCcCEE
Confidence            33444444444444444444444444444444444444443322  444455555555555544322     12455555


Q ss_pred             EccCCcCcccccccCCCCCCCCEEeccCCcccccccccccccccccEEEccCccccCCCCccc-cccccccEEEccCCcc
Q 039137          331 DLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQL-GNIIYLNRLSLSGNKL  409 (912)
Q Consensus       331 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~l-~~l~~L~~L~L~~N~l  409 (912)
                      ++++|++++..+..   +++|+.|++++|++++..+..++.+++|++|+|++|++++..+..+ ..+++|++|+|++|++
T Consensus       105 ~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l  181 (317)
T 3o53_A          105 HAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI  181 (317)
T ss_dssp             ECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCC
T ss_pred             ECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcC
Confidence            55555555443332   3455555555555555555555555566666666666655444444 2455666666666665


Q ss_pred             cCCCccccccccccccccccCcccCccccccccccccccEEEecccccccccchhhhcccccceeeccccccC-cccccc
Q 039137          410 SGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLG-EKISSR  488 (912)
Q Consensus       410 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~  488 (912)
                      ++. +. ...+++|++|+|++|+++++++ .+..+++|++|+|++|+++ .+|..+..+++|+.|++++|++. +.++..
T Consensus       182 ~~~-~~-~~~l~~L~~L~Ls~N~l~~l~~-~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~  257 (317)
T 3o53_A          182 YDV-KG-QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF  257 (317)
T ss_dssp             CEE-EC-CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHH
T ss_pred             ccc-cc-ccccccCCEEECCCCcCCcchh-hhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHH
Confidence            533 22 2235566666666666665333 3556666666666666665 34555666666666666666665 445555


Q ss_pred             ccccccccccccc
Q 039137          489 ICRMESLEKLNLS  501 (912)
Q Consensus       489 ~~~l~~L~~L~ls  501 (912)
                      +..+++|+.|+++
T Consensus       258 ~~~~~~L~~l~l~  270 (317)
T 3o53_A          258 FSKNQRVQTVAKQ  270 (317)
T ss_dssp             HHTCHHHHHHHHH
T ss_pred             HhccccceEEECC
Confidence            5666666666665

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.95  E-value=2.3e-29  Score=274.28  Aligned_cols=264  Identities=20%  Similarity=0.160  Sum_probs=178.6

Q ss_pred             eeeeccCCCcCccccccccccccceeecccccccCccccccccccccceeeeccccCcccCCcccCCccccchhhhccCc
Q 039137          209 ILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNH  288 (912)
Q Consensus       209 ~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~  288 (912)
                      .++++++.+...++..+..+++|++|++++|++++..|..|..+++|++|+|++|++++..+  +..+++|++|++++|+
T Consensus        14 i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~   91 (317)
T 3o53_A           14 IEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNY   91 (317)
T ss_dssp             EESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSE
T ss_pred             EeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCc
Confidence            33444444433333334444555555555555555555555555555555555555554433  5555556666666665


Q ss_pred             cCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCcccccccCCCCCCCCEEeccCCccccccccc
Q 039137          289 FRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLE  368 (912)
Q Consensus       289 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~  368 (912)
                      +++..     ..++|++|++++|.+++..+..   +++|++|++++|++++..+..++.+++|+.|++++|++.+..+..
T Consensus        92 l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~  163 (317)
T 3o53_A           92 VQELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAE  163 (317)
T ss_dssp             EEEEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGG
T ss_pred             ccccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHH
Confidence            55321     2356666666666666544433   456777777777777766667777777777777777777666665


Q ss_pred             cc-ccccccEEEccCccccCCCCccccccccccEEEccCCcccCCCccccccccccccccccCcccCccccccccccccc
Q 039137          369 IG-ESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKL  447 (912)
Q Consensus       369 ~~-~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  447 (912)
                      +. .+++|++|+|++|++++. + ....+++|++|+|++|++++ +|..+..+++|++|+|++|++++ +|..+..+++|
T Consensus       164 ~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~~-l~~~~~~l~~L  239 (317)
T 3o53_A          164 LAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNL  239 (317)
T ss_dssp             GGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTC
T ss_pred             HhhccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCCc-chhhhcccCcccEEECcCCcccc-hhhHhhcCCCC
Confidence            53 577888888888888754 2 23347889999999999985 44558889999999999999986 57778899999


Q ss_pred             cEEEecccccc-cccchhhhcccccceeecccc-ccCcccc
Q 039137          448 YYLNLSHNKLS-QQIPIELDNLIHLSELDLSHN-FLGEKIS  486 (912)
Q Consensus       448 ~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~N-~l~~~~~  486 (912)
                      +.|+|++|+++ +.+|..+..+++|+.|++++| .+++..+
T Consensus       240 ~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~  280 (317)
T 3o53_A          240 EHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNE  280 (317)
T ss_dssp             CEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSS
T ss_pred             CEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCch
Confidence            99999999998 788889999999999999844 4555444

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.95  E-value=4.8e-27  Score=276.06  Aligned_cols=269  Identities=24%  Similarity=0.300  Sum_probs=152.8

Q ss_pred             cccceeecccccccCCCCccccCcccccEEEccCCcCCCCCCccCCCCccceeeeeccCCCcCccccccccccccceeec
Q 039137          157 THLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLEL  236 (912)
Q Consensus       157 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l  236 (912)
                      .++++|++++|.++ .+|..+.  ++|++|+|++|.++ .+|.   .+++|++|+|++|.++ .+|.   .+++|++|++
T Consensus        40 ~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~L  108 (622)
T 3g06_A           40 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSI  108 (622)
T ss_dssp             HCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEE
T ss_pred             CCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEEC
Confidence            35899999999998 8888776  78899999999888 5665   4677778888887776 3444   4566666666


Q ss_pred             ccccccCccccccccccccceeeeccccCcccCCcccCCccccchhhhccCccCCCCccccccccccceEecccccccCC
Q 039137          237 CINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGN  316 (912)
Q Consensus       237 ~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~  316 (912)
                      ++|++++ +|.   .+++|+.|++++|++++ +|..   +++|++|+|++|++++ +|.                     
T Consensus       109 s~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~-l~~---------------------  158 (622)
T 3g06_A          109 FSNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPA---------------------  158 (622)
T ss_dssp             CSCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---------------------
T ss_pred             cCCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCC-cCC---------------------
Confidence            6666653 332   34555666666665553 2322   2344444444444442 121                     


Q ss_pred             CCcccCCCCCccEEEccCCcCcccccccCCCCCCCCEEeccCCcccccccccccccccccEEEccCccccCCCCcccccc
Q 039137          317 ISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNI  396 (912)
Q Consensus       317 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l  396 (912)
                            .+++|+.|++++|.+++. +   ..+++|+.|++++|++++ +|..   +++|+.|++++|.++ .+|..   +
T Consensus       159 ------~~~~L~~L~L~~N~l~~l-~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~-~l~~~---~  220 (622)
T 3g06_A          159 ------LPSELCKLWAYNNQLTSL-P---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT-SLPAL---P  220 (622)
T ss_dssp             ------CCTTCCEEECCSSCCSCC-C---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-SCCCC---C
T ss_pred             ------ccCCCCEEECCCCCCCCC-c---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCccc-ccCCC---C
Confidence                  123444445555444431 1   233445555555555542 2221   245555666666555 23322   2


Q ss_pred             ccccEEEccCCcccCCCccccccccccccccccCcccCccccccccccccccEEEecccccccccchhhhcccccceeec
Q 039137          397 IYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDL  476 (912)
Q Consensus       397 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  476 (912)
                      ++|+.|++++|++++ +|   ..+++|++|+|++|+|+.+ |.   .+++|+.|+|++|+|+ .+|..+.++++|+.|+|
T Consensus       221 ~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~l-p~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L  291 (622)
T 3g06_A          221 SGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTSL-PM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNL  291 (622)
T ss_dssp             TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEEC
T ss_pred             CCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCcC-Cc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEe
Confidence            456666666666653 33   2345566666666666543 32   3456666666666665 45555666666666666


Q ss_pred             cccccCccccccccccc
Q 039137          477 SHNFLGEKISSRICRME  493 (912)
Q Consensus       477 s~N~l~~~~~~~~~~l~  493 (912)
                      ++|++++.+|..+..++
T Consensus       292 ~~N~l~~~~~~~l~~L~  308 (622)
T 3g06_A          292 EGNPLSERTLQALREIT  308 (622)
T ss_dssp             CSCCCCHHHHHHHHHHH
T ss_pred             cCCCCCCcCHHHHHhcc
Confidence            66666665555554443

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.95  E-value=2.9e-28  Score=280.97  Aligned_cols=234  Identities=25%  Similarity=0.233  Sum_probs=111.2

Q ss_pred             ccceeeeccccCcccCCcccCCccccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEcc
Q 039137          254 NLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLS  333 (912)
Q Consensus       254 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls  333 (912)
                      +|++|+|++|.+++..|..|..+++|++|+|++|.+++..|  |..+++|++|+|++|.+++..+     .++|+.|+|+
T Consensus        35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~L~  107 (487)
T 3oja_A           35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLHAA  107 (487)
T ss_dssp             GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEECC
T ss_pred             CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEECc
Confidence            55555555555555555555555555555555555554333  4555555555555555543221     1344444444


Q ss_pred             CCcCcccccccCCCCCCCCEEeccCCcccccccccccccccccEEEccCccccCCCCccccccccccEEEccCCcccCCC
Q 039137          334 NNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCI  413 (912)
Q Consensus       334 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~  413 (912)
                      +|.+++..+.                        .   +++|++|+|++|.+++..|..++++++|+.|+|++|.+++..
T Consensus       108 ~N~l~~~~~~------------------------~---l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  160 (487)
T 3oja_A          108 NNNISRVSCS------------------------R---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVN  160 (487)
T ss_dssp             SSCCCCEEEC------------------------C---CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEE
T ss_pred             CCcCCCCCcc------------------------c---cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcC
Confidence            4444433322                        1   234444444444444444444444444444444444444444


Q ss_pred             ccccc-cccccccccccCcccCccccccccccccccEEEecccccccccchhhhcccccceeeccccccCcccccccccc
Q 039137          414 PRELG-SLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRM  492 (912)
Q Consensus       414 p~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  492 (912)
                      |..+. .+++|++|+|++|.|++..+  +..+++|+.|+|++|+|++. |..+..+++|+.|+|++|.|++ +|..+..+
T Consensus       161 ~~~l~~~l~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l  236 (487)
T 3oja_A          161 FAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLVL-IEKALRFS  236 (487)
T ss_dssp             GGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCCE-ECTTCCCC
T ss_pred             hHHHhhhCCcccEEecCCCccccccc--cccCCCCCEEECCCCCCCCC-CHhHcCCCCccEEEecCCcCcc-cchhhccC
Confidence            44443 34455555555555544321  22345555555555555432 2234455555555555555543 33344455


Q ss_pred             cccccccccCcccc-CCCcccccccccceEEEcc
Q 039137          493 ESLEKLNLSYNNLS-GLIPRCFEEMHGLLHIDIS  525 (912)
Q Consensus       493 ~~L~~L~ls~N~l~-~~~p~~~~~l~~L~~l~ls  525 (912)
                      ++|+.|++++|+++ +.+|..+..++.|+.++++
T Consensus       237 ~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~  270 (487)
T 3oja_A          237 QNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ  270 (487)
T ss_dssp             TTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred             CCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence            55555555555554 3344444444444444443

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.94  E-value=6.7e-27  Score=248.54  Aligned_cols=216  Identities=24%  Similarity=0.295  Sum_probs=124.4

Q ss_pred             CCCccceeEecCCCCeEEEeeccccccccccccccCCCCCccEEEccCCcccccCCccccCCCCCcEEeccccccccccc
Q 039137           71 SPCAWSGIFCNHAERVVGINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIP  150 (912)
Q Consensus        71 ~~C~w~gv~c~~~~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p  150 (912)
                      ++|.|.|+.|+..+.                         .+.+++++++++ .+|..+.  ++|++|+|++|++++..+
T Consensus         3 ~~C~~~~~~C~c~~~-------------------------~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~   54 (270)
T 2o6q_A            3 ALCKKDGGVCSCNNN-------------------------KNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPS   54 (270)
T ss_dssp             CCBGGGTCSBEEETT-------------------------TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCT
T ss_pred             ccCCCCCCCCEeCCC-------------------------CCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCH
Confidence            789999999964322                         245666777776 3565544  567777777777775555


Q ss_pred             cccccccccceeecccccccCCCCccccCcccccEEEccCCcCCCCCCccCCCCccceeeeeccCCCcCccccccccccc
Q 039137          151 SGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKS  230 (912)
Q Consensus       151 ~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~  230 (912)
                      ..|+.+++|++|+|++|.+++..+..|..+++|++|++++|++++..+..|.++++|++|+|++|.+++..+..|+++++
T Consensus        55 ~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~  134 (270)
T 2o6q_A           55 KAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTK  134 (270)
T ss_dssp             TSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTT
T ss_pred             HHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcC
Confidence            56777777777777777776444444566666666666666666544445555555555555555555444444444444


Q ss_pred             cceeecccccccCccccccccccccceeeeccccCcccCCcccCCccccchhhhccCccCCCCccccccccccceEeccc
Q 039137          231 LFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQ  310 (912)
Q Consensus       231 L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  310 (912)
                      |++|++++|+++                        +..+..|..+++|++|+|++|++++..+..|..+++|++|+|++
T Consensus       135 L~~L~Ls~n~l~------------------------~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~  190 (270)
T 2o6q_A          135 LTYLSLGYNELQ------------------------SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDN  190 (270)
T ss_dssp             CCEEECCSSCCC------------------------CCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEECCCCcCC------------------------ccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCC
Confidence            444444444444                        33333344444444444444444444444445555555555555


Q ss_pred             ccccCCCCcccCCCCCccEEEccCCcCc
Q 039137          311 NYLTGNISETFGTYPNLTFIDLSNNSFF  338 (912)
Q Consensus       311 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~  338 (912)
                      |.+++..+..|..+++|+.|+|++|.+.
T Consensus       191 N~l~~~~~~~~~~l~~L~~L~l~~N~~~  218 (270)
T 2o6q_A          191 NQLKRVPEGAFDSLEKLKMLQLQENPWD  218 (270)
T ss_dssp             SCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred             CcCCcCCHHHhccccCCCEEEecCCCee
Confidence            5555544555555555666666666554

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.94  E-value=1.4e-28  Score=287.35  Aligned_cols=188  Identities=19%  Similarity=0.144  Sum_probs=133.2

Q ss_pred             eeecCceEEEEEEe-CCCCEEEEEEccCCCCCC------chHHHHHHHHHHHHHhhc-CCCccccEEEEEEcCCeeeEEE
Q 039137          646 IGKGGHGSVYRAKV-PSGEIFAVKKFHSPLPGE------MSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSHPKHSFIIY  717 (912)
Q Consensus       646 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~------~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~  717 (912)
                      .+.|+.|.+..++. -.|+.||+|.+.......      .....++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            45566666555432 268999999997643221      122346799999999999 6999999999999999999999


Q ss_pred             eecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCC
Q 039137          718 EYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPD  797 (912)
Q Consensus       718 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  797 (912)
                      ||++|++|.+++.+.   ++++..   +|+.||+.||+|+|++   |||||||||+|||++.+|.+||+|||+|+.....
T Consensus       322 Eyv~G~~L~d~i~~~---~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          322 EKLPGRLLSDMLAAG---EEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             ECCCSEEHHHHHHTT---CCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred             ecCCCCcHHHHHHhC---CCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence            999999999999543   445543   5899999999999999   9999999999999999999999999999987666


Q ss_pred             CCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCC
Q 039137          798 SSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP  843 (912)
Q Consensus       798 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p  843 (912)
                      .......+||+.|||||++.+. +..++|+||+|++.+++.++..+
T Consensus       393 ~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          393 CSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             -CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             CccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence            5666678899999999998764 67789999999998887665444

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.94  E-value=6.9e-28  Score=277.82  Aligned_cols=239  Identities=23%  Similarity=0.214  Sum_probs=173.0

Q ss_pred             cccccccceeecccccccCccccccccccccceeeeccccCcccCCcccCCccccchhhhccCccCCCCccccccccccc
Q 039137          225 IGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLV  304 (912)
Q Consensus       225 ~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  304 (912)
                      ...+++|+.|+|++|.+++..|..|+.+++|++|+|++|.+++.+|  +..+++|++|+|++|.+++..     ..++|+
T Consensus        30 ~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~-----~~~~L~  102 (487)
T 3oja_A           30 RQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPSIE  102 (487)
T ss_dssp             STTGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEE-----ECTTCC
T ss_pred             cccCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCC-----CCCCcC
Confidence            3345599999999999999888999999999999999999998766  999999999999999998543     238999


Q ss_pred             eEecccccccCCCCcccCCCCCccEEEccCCcCcccccccCCCCCCCCEEeccCCccccccccccc-ccccccEEEccCc
Q 039137          305 KLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIG-ESLQLQYLDLSSN  383 (912)
Q Consensus       305 ~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-~~~~L~~L~L~~N  383 (912)
                      .|++++|.+++..+..   +++|+.|+|++|.+++..+..++.+++|+.|++++|.+++..|..+. .+++|++|+|++|
T Consensus       103 ~L~L~~N~l~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N  179 (487)
T 3oja_A          103 TLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN  179 (487)
T ss_dssp             EEECCSSCCCCEEECC---CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTS
T ss_pred             EEECcCCcCCCCCccc---cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCC
Confidence            9999999999876654   57899999999988877777776677777777777666665555554 4555666666666


Q ss_pred             cccCCCCccccccccccEEEccCCcccCCCccccccccccccccccCcccCccccccccccccccEEEecccccccccch
Q 039137          384 YIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPI  463 (912)
Q Consensus       384 ~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~  463 (912)
                      .|++.                         |. +..+++|++|+|++|.|++++| .+..+++|+.|+|++|+|++ +|.
T Consensus       180 ~l~~~-------------------------~~-~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~  231 (487)
T 3oja_A          180 FIYDV-------------------------KG-QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEK  231 (487)
T ss_dssp             CCCEE-------------------------EC-CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECT
T ss_pred             ccccc-------------------------cc-cccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cch
Confidence            55533                         11 1234555566666666655333 35566666666666666653 455


Q ss_pred             hhhcccccceeeccccccC-ccccccccccccccccccc
Q 039137          464 ELDNLIHLSELDLSHNFLG-EKISSRICRMESLEKLNLS  501 (912)
Q Consensus       464 ~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~ls  501 (912)
                      .+..+++|+.|++++|.+. +.+|..+..++.|+.|+++
T Consensus       232 ~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~  270 (487)
T 3oja_A          232 ALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ  270 (487)
T ss_dssp             TCCCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred             hhccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence            5666666666666666665 4556666667777777665

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.93  E-value=3.1e-29  Score=298.61  Aligned_cols=396  Identities=16%  Similarity=0.146  Sum_probs=295.2

Q ss_pred             CCCCCccEEEccCCcccccCCcccc-CCCCCcEEecccc-ccccc-cccccccccccceeecccccccCCCCcccc----
Q 039137          106 SSFPHLVYLDLYNNELFGIIPPQIS-NLSNLEYLDFSAN-KLFGQ-IPSGIGLLTHLTVLHISRNWLSGSIPHEVG----  178 (912)
Q Consensus       106 ~~l~~L~~L~L~~n~l~~~~p~~~~-~l~~L~~L~Ls~n-~l~~~-~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~----  178 (912)
                      ..+++|++|+|++|.+++..+..+. .+++|++|+|++| .++.. ++..+..+++|++|+|++|.+++..+..+.    
T Consensus       102 ~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~  181 (594)
T 2p1m_B          102 SSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPD  181 (594)
T ss_dssp             HHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCT
T ss_pred             HhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhh
Confidence            4678999999999999887777776 7899999999999 56543 555566899999999999998876554444    


Q ss_pred             CcccccEEEccCCc--CCCC-CCccCCCCccceeeeeccCCCcCccccccccccccceeecc-------cccccCccccc
Q 039137          179 QLTVLNQLALDSNF--LNGS-IPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELC-------INQLSGAIPLS  248 (912)
Q Consensus       179 ~l~~L~~L~l~~n~--l~~~-~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~-------~n~l~~~~p~~  248 (912)
                      .+++|++|++++|.  ++.. ++..+.++++|++|++++|...+.+|..+.++++|++|+++       .|.+.+ ++..
T Consensus       182 ~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~-l~~~  260 (594)
T 2p1m_B          182 TYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSG-LSVA  260 (594)
T ss_dssp             TCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHHHHHHHHHCTTCSEEECSBCCCCCCHHHHHH-HHHH
T ss_pred             cCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHHHHHHHhcCCcceEcccccccCccchhhHHH-HHHH
Confidence            67799999999997  2211 11223456999999999994334488889999999999954       444553 4557


Q ss_pred             ccccccccee-eeccccCcccCCcccCCccccchhhhccCccCCCCc-cccccccccceEecccccccCC-CCcccCCCC
Q 039137          249 ISNLTNLRFL-FLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVP-KSFRNLTDLVKLRLNQNYLTGN-ISETFGTYP  325 (912)
Q Consensus       249 ~~~l~~L~~L-~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~  325 (912)
                      +.++++|+.| .+.+... +.++..+..+++|++|+|++|.+++... ..+..+++|++|++++| ++.. .+.....++
T Consensus       261 l~~~~~L~~Ls~~~~~~~-~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~  338 (594)
T 2p1m_B          261 LSGCKELRCLSGFWDAVP-AYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCK  338 (594)
T ss_dssp             HHTCTTCCEEECCBTCCG-GGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCT
T ss_pred             HhcCCCcccccCCcccch-hhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCC
Confidence            8899999999 4544333 2455555678999999999999774432 23568899999999998 4422 223334589


Q ss_pred             CccEEEccC---------CcCcccccccCC-CCCCCCEEeccCCccccccccccc-ccccccEEEcc--C----ccccCC
Q 039137          326 NLTFIDLSN---------NSFFGEILSDWG-RCPQLSLLDVSINNISGSIPLEIG-ESLQLQYLDLS--S----NYIVGE  388 (912)
Q Consensus       326 ~L~~L~Ls~---------N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~-~~~~L~~L~L~--~----N~l~~~  388 (912)
                      +|++|++++         +.+++.....+. .+++|+.|+++.|++++.....+. .+++|++|+|+  +    |.+++.
T Consensus       339 ~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~  418 (594)
T 2p1m_B          339 DLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLE  418 (594)
T ss_dssp             TCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCC
T ss_pred             CCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCC
Confidence            999999943         566554444443 489999999999999876666665 58899999999  4    566522


Q ss_pred             -----CCccccccccccEEEccCCcccCCCcccccc-ccccccccccCcccCccccccc-cccccccEEEeccccccccc
Q 039137          389 -----IPTQLGNIIYLNRLSLSGNKLSGCIPRELGS-LINLEYLDLSANNLSNFVPESL-GSLVKLYYLNLSHNKLSQQI  461 (912)
Q Consensus       389 -----~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~  461 (912)
                           ++..+.++++|+.|++++ .+++..+..+.. +++|++|+|++|.+++..+..+ ..+++|+.|+|++|++++..
T Consensus       419 ~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~  497 (594)
T 2p1m_B          419 PLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKA  497 (594)
T ss_dssp             CTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHH
T ss_pred             chhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHH
Confidence                 222366788999999987 777666666665 8899999999999987655555 67899999999999997554


Q ss_pred             ch-hhhcccccceeeccccccCccccccc-ccccccccccccCccc
Q 039137          462 PI-ELDNLIHLSELDLSHNFLGEKISSRI-CRMESLEKLNLSYNNL  505 (912)
Q Consensus       462 ~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~ls~N~l  505 (912)
                      .. ....+++|++|++++|+++......+ ..+++|+...+..+.-
T Consensus       498 ~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~~~  543 (594)
T 2p1m_B          498 LLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERGA  543 (594)
T ss_dssp             HHHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEEEEEECSSSC
T ss_pred             HHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEEecCCCc
Confidence            44 44568999999999999965444444 4567777666665543

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.93  E-value=1.2e-25  Score=239.91  Aligned_cols=210  Identities=24%  Similarity=0.234  Sum_probs=148.2

Q ss_pred             CccEEEccCCcCcccccccCCCCCCCCEEeccCCcccccccccccccccccEEEccCccccCCCCccccccccccEEEcc
Q 039137          326 NLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLS  405 (912)
Q Consensus       326 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~  405 (912)
                      +|++|+|++|.+++..+..+..+++|++|++++|++.+..+..+..+++|++|+|++|++++..+..+.++++|++|+++
T Consensus        29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~  108 (276)
T 2z62_A           29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV  108 (276)
T ss_dssp             TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred             CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence            45555555555555555555555666666666666655555556666666666666666665555666666667777777


Q ss_pred             CCcccCCCccccccccccccccccCcccCcc-ccccccccccccEEEecccccccccchhhhcccccc----eeeccccc
Q 039137          406 GNKLSGCIPRELGSLINLEYLDLSANNLSNF-VPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLS----ELDLSHNF  480 (912)
Q Consensus       406 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~----~L~Ls~N~  480 (912)
                      +|++++..+..+..+++|++|++++|++++. +|..|..+++|++|+|++|++++..+..+..+++|+    +|++++|.
T Consensus       109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~  188 (276)
T 2z62_A          109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP  188 (276)
T ss_dssp             TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSC
T ss_pred             CCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCc
Confidence            7776665555677777777777777777664 367777777888888888888776667777777776    78888888


Q ss_pred             cCcccccccccccccccccccCccccCCCcccccccccceEEEccCCccccCCCCC
Q 039137          481 LGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNS  536 (912)
Q Consensus       481 l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~~~~  536 (912)
                      +++..+..+.. .+|+.|++++|++++..+..|..+++|+.|++++|++.|..|..
T Consensus       189 l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~l  243 (276)
T 2z62_A          189 MNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI  243 (276)
T ss_dssp             CCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTTT
T ss_pred             ccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCCch
Confidence            87766655544 47899999999999887788888999999999999999876543

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.93  E-value=6.2e-26  Score=242.03  Aligned_cols=205  Identities=24%  Similarity=0.231  Sum_probs=105.9

Q ss_pred             CccEEEccCCcccccCCccccCCCCCcEEeccccccccccccccccccccceeecccccccCCCCccccCcccccEEEcc
Q 039137          110 HLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALD  189 (912)
Q Consensus       110 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~  189 (912)
                      +|++|+|++|++++..+..|.++++|++|+|++|++++..+..|+.+++|++|+|++|.+++..|..++.+++|++|+++
T Consensus        29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~  108 (276)
T 2z62_A           29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV  108 (276)
T ss_dssp             TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred             CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence            46666666666665555566666666666666666655444556666666666666666655545555555555555555


Q ss_pred             CCcCCCCCCccCCCCccceeeeeccCCCcCccccccccccccceeecccccccCccccccccccccceeeeccccCcccC
Q 039137          190 SNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGII  269 (912)
Q Consensus       190 ~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  269 (912)
                      +|.+.+..+..++++++|++|++++|.+++.                       .+|..++++++|++|+|++|++++..
T Consensus       109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-----------------------~l~~~~~~l~~L~~L~Ls~N~l~~~~  165 (276)
T 2z62_A          109 ETNLASLENFPIGHLKTLKELNVAHNLIQSF-----------------------KLPEYFSNLTNLEHLDLSSNKIQSIY  165 (276)
T ss_dssp             TSCCCCSTTCCCTTCTTCCEEECCSSCCCCC-----------------------CCCGGGGGCTTCCEEECCSSCCCEEC
T ss_pred             CCCccccCchhcccCCCCCEEECcCCcccee-----------------------cCchhhccCCCCCEEECCCCCCCcCC
Confidence            5555544444455555555555555554431                       12444444444455555555444444


Q ss_pred             CcccCCccccc----hhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCc
Q 039137          270 PQEIGNLKKLN----SLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFF  338 (912)
Q Consensus       270 ~~~l~~l~~L~----~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~  338 (912)
                      +..+..+++|+    +|++++|.+++..+..+.. .+|+.|+|++|.+++.++..|..+++|+.|+|++|++.
T Consensus       166 ~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~  237 (276)
T 2z62_A          166 CTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD  237 (276)
T ss_dssp             GGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBC
T ss_pred             HHHhhhhhhccccceeeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCccc
Confidence            44444333333    3444444444333332222 24555555555555444444445555555555555443

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.92  E-value=3.6e-25  Score=235.37  Aligned_cols=229  Identities=20%  Similarity=0.180  Sum_probs=176.4

Q ss_pred             ccccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCcccccccCCCCCCCCEEe
Q 039137          276 LKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLD  355 (912)
Q Consensus       276 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  355 (912)
                      +.++..+++..+.+...  ..+..+++|+.|++++|.++..  ..+..+++|++|+|++|.+.+.  ..+..+++|++|+
T Consensus        18 ~~~l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~   91 (272)
T 3rfs_A           18 FAETIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLI   91 (272)
T ss_dssp             HHHHHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEE
T ss_pred             HHHHHHHHhcCcccccc--cccccccceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEE
Confidence            45666777777776644  3456678888888888887742  3467788888888888888653  4677788888888


Q ss_pred             ccCCcccccccccccccccccEEEccCccccCCCCccccccccccEEEccCCcccCCCccccccccccccccccCcccCc
Q 039137          356 VSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSN  435 (912)
Q Consensus       356 Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  435 (912)
                      +++|++++..+..++.+++|++|+|++|++++..+..+.++++|++|++++|++++..+..+..+++|++|++++|++++
T Consensus        92 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  171 (272)
T 3rfs_A           92 LTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQS  171 (272)
T ss_dssp             CTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred             CCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCc
Confidence            88888887777777788888888888888887766677888888888888888887777777888888888888888888


Q ss_pred             cccccccccccccEEEecccccccccchhhhcccccceeeccccccCcccccccccccccccccccCccccCCCcccccc
Q 039137          436 FVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEE  515 (912)
Q Consensus       436 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~  515 (912)
                      ..+..|..+++|++|+|++|++++..+..+..+++|++|+|++|.+.+       .+++|+.|+++.|+++|.+|..+..
T Consensus       172 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~l~~~~n~~~g~ip~~~~~  244 (272)
T 3rfs_A          172 LPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGS  244 (272)
T ss_dssp             CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC-------CTTTTHHHHHHHHHTGGGBBCTTSC
T ss_pred             cCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccc-------cCcHHHHHHHHHHhCCCcccCcccc
Confidence            777777888888888888888887777778888888888888887754       3557888888888888888876655


Q ss_pred             cc
Q 039137          516 MH  517 (912)
Q Consensus       516 l~  517 (912)
                      +.
T Consensus       245 ~~  246 (272)
T 3rfs_A          245 VA  246 (272)
T ss_dssp             BC
T ss_pred             cC
Confidence            43

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.92  E-value=1.5e-25  Score=238.30  Aligned_cols=186  Identities=31%  Similarity=0.366  Sum_probs=87.1

Q ss_pred             ccCcccccEEEccCCcCCCCCCccCCCCccceeeeeccCCCcCccccccccccccceeecccccccCccccccccccccc
Q 039137          177 VGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLR  256 (912)
Q Consensus       177 ~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~  256 (912)
                      ++.+++|++|++++|.+++ + +.+.++++|++|+|++|.+++..+..++++++|++|++++|++++..+..|+.+++|+
T Consensus        59 l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  136 (272)
T 3rfs_A           59 IQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLT  136 (272)
T ss_dssp             GGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC
T ss_pred             cccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCC
Confidence            3334444444444444332 1 2334444444444444444433333344444444444444444444444444455555


Q ss_pred             eeeeccccCcccCCcccCCccccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEccCCc
Q 039137          257 FLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNS  336 (912)
Q Consensus       257 ~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~  336 (912)
                      +|+|++|++++..+..+..+++|++|++++|++++..+..|..+++|++|++++|.+++.++..|..+++|+.|+|++|.
T Consensus       137 ~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~  216 (272)
T 3rfs_A          137 YLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNP  216 (272)
T ss_dssp             EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCC
Confidence            55555555554444444445555555555555554444444555555555555555555444445555555555555554


Q ss_pred             CcccccccCCCCCCCCEEeccCCcccccccccccc
Q 039137          337 FFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGE  371 (912)
Q Consensus       337 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  371 (912)
                      +.+       .+++|+.|+++.|.++|.+|..++.
T Consensus       217 ~~~-------~~~~l~~l~~~~n~~~g~ip~~~~~  244 (272)
T 3rfs_A          217 WDC-------TCPGIRYLSEWINKHSGVVRNSAGS  244 (272)
T ss_dssp             BCC-------CTTTTHHHHHHHHHTGGGBBCTTSC
T ss_pred             ccc-------cCcHHHHHHHHHHhCCCcccCcccc
Confidence            432       2334444445555555444444443

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.92  E-value=2.5e-24  Score=228.60  Aligned_cols=203  Identities=26%  Similarity=0.278  Sum_probs=155.6

Q ss_pred             cceeecccccccCCCCccccCcccccEEEccCCcCCCCCCccCCCCccceeeeeccCCCcCccccccccccccceeeccc
Q 039137          159 LTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCI  238 (912)
Q Consensus       159 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~  238 (912)
                      .+.++++++.++ .+|..+.  ++|++|++++|++++..+..|.++++|++|+|++|.+++..+..|.++++|++|++++
T Consensus        18 ~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~   94 (270)
T 2o6q_A           18 KNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTD   94 (270)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCS
T ss_pred             CCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCC
Confidence            334444444444 3343332  3445555555555544444555566666666666666544444556677777777777


Q ss_pred             ccccCccccccccccccceeeeccccCcccCCcccCCccccchhhhccCccCCCCccccccccccceEecccccccCCCC
Q 039137          239 NQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNIS  318 (912)
Q Consensus       239 n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~  318 (912)
                      |++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|.+++..+
T Consensus        95 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~  174 (270)
T 2o6q_A           95 NKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPE  174 (270)
T ss_dssp             SCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred             CcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeCh
Confidence            77776666677888899999999999998888889999999999999999998877789999999999999999999888


Q ss_pred             cccCCCCCccEEEccCCcCcccccccCCCCCCCCEEeccCCccccc
Q 039137          319 ETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGS  364 (912)
Q Consensus       319 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  364 (912)
                      ..|..+++|++|+|++|++++..+..+..+++|+.|++++|.+...
T Consensus       175 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  220 (270)
T 2o6q_A          175 GAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCT  220 (270)
T ss_dssp             TTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCS
T ss_pred             hHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCC
Confidence            8999999999999999999988888899999999999999998754

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.91  E-value=2.8e-24  Score=230.27  Aligned_cols=203  Identities=25%  Similarity=0.268  Sum_probs=123.5

Q ss_pred             cCCCCCccEEEccCCcccccCCccccCCCCCcEEeccccccccccccccccccccceeecccccccCCCCccccCccccc
Q 039137          105 FSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLN  184 (912)
Q Consensus       105 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~  184 (912)
                      ++++++++.+++++|+++ .+|..+.  ++|++|+|++|++++..|..|..+++|++|+|++|.+++ +|.. +.+++|+
T Consensus         6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~-~~l~~L~   80 (290)
T 1p9a_G            6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVD-GTLPVLG   80 (290)
T ss_dssp             EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EECC-SCCTTCC
T ss_pred             ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCc-ccCC-CCCCcCC
Confidence            456777888888888887 4565554  578888888888877777778888888888888888774 3332 5667777


Q ss_pred             EEEccCCcCCCCCCccCCCCccceeeeeccCCCcCccccccccccccceeecccccccCccccccccccccceeeecccc
Q 039137          185 QLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNE  264 (912)
Q Consensus       185 ~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~  264 (912)
                      +|++++|+++ .+|..+.++++|++|+|++|++++..|..|.++++|++|++++|++++..+..|..+++|+.|+|++|+
T Consensus        81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  159 (290)
T 1p9a_G           81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN  159 (290)
T ss_dssp             EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred             EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCc
Confidence            7777777766 556666666666666666666655444455555555555555555554444444444445555554444


Q ss_pred             CcccCCcccCCccccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCc
Q 039137          265 LSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFF  338 (912)
Q Consensus       265 l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~  338 (912)
                      ++                        +..+..|..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|.+.
T Consensus       160 l~------------------------~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~  208 (290)
T 1p9a_G          160 LT------------------------ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL  208 (290)
T ss_dssp             CS------------------------CCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred             CC------------------------ccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCcc
Confidence            44                        433344444555555555555555 23333444455666666666554

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.91  E-value=4.8e-24  Score=228.50  Aligned_cols=205  Identities=25%  Similarity=0.239  Sum_probs=128.3

Q ss_pred             cccccccceEecccccccCCCCcccCCCCCccEEEccCCcCcccccccCCCCCCCCEEeccCCccccccccccccccccc
Q 039137          297 FRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQ  376 (912)
Q Consensus       297 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~  376 (912)
                      +.++++|+.+++++|.++..++...   ++++.|+|++|.+++..+..|..+++|+.|++++|+|++..+          
T Consensus         6 ~~~l~~l~~l~~~~~~l~~ip~~~~---~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~----------   72 (290)
T 1p9a_G            6 VSKVASHLEVNCDKRNLTALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV----------   72 (290)
T ss_dssp             EECSTTCCEEECTTSCCSSCCSCCC---TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC----------
T ss_pred             ccccCCccEEECCCCCCCcCCCCCC---CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC----------
Confidence            4555666666666666664332221   355555555555555555555555555555555555543221          


Q ss_pred             EEEccCccccCCCCccccccccccEEEccCCcccCCCccccccccccccccccCcccCccccccccccccccEEEecccc
Q 039137          377 YLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNK  456 (912)
Q Consensus       377 ~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  456 (912)
                                      .+.+++|++|++++|+++ .+|..+..+++|++|+|++|+|+++.+..|..+++|++|+|++|+
T Consensus        73 ----------------~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~  135 (290)
T 1p9a_G           73 ----------------DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNE  135 (290)
T ss_dssp             ----------------CSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSC
T ss_pred             ----------------CCCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCC
Confidence                            144555555556655555 455556666666666666666666666667777777777777777


Q ss_pred             cccccchhhhcccccceeeccccccCcccccccccccccccccccCccccCCCcccccccccceEEEccCCccccC
Q 039137          457 LSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQ  532 (912)
Q Consensus       457 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~  532 (912)
                      |++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+. +|..+..+..|+.+++++|+|.|.
T Consensus       136 l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~-ip~~~~~~~~L~~l~L~~Np~~C~  210 (290)
T 1p9a_G          136 LKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGNPWLCN  210 (290)
T ss_dssp             CCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCCCSEEECCSCCBCCS
T ss_pred             CCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCCc-cChhhcccccCCeEEeCCCCccCc
Confidence            766666666677777777777777776666666777777777777777774 355566667888888888888764

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.91  E-value=1.6e-24  Score=235.05  Aligned_cols=199  Identities=18%  Similarity=0.135  Sum_probs=93.5

Q ss_pred             ccceeecccccccCCCCccc--cCcccccEEEccCCcCCCCCC----ccCCCCccceeeeeccCCCcCcccccccccccc
Q 039137          158 HLTVLHISRNWLSGSIPHEV--GQLTVLNQLALDSNFLNGSIP----RSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSL  231 (912)
Q Consensus       158 ~L~~L~L~~n~l~~~~p~~~--~~l~~L~~L~l~~n~l~~~~p----~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L  231 (912)
                      +|++|+|++|.+++..|..+  +.+++|++|+|++|.+++..|    ..+..+++|++|+|++|.+.+..|..++++++|
T Consensus        92 ~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L  171 (310)
T 4glp_A           92 RLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPAL  171 (310)
T ss_dssp             CCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTC
T ss_pred             ceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCC
Confidence            34444444444444444444  444444444444444443332    223344444444444444444444444444455


Q ss_pred             ceeecccccccCc--c--ccccccccccceeeeccccCcccCCc----ccCCccccchhhhccCccCCCCccccccc---
Q 039137          232 FDLELCINQLSGA--I--PLSISNLTNLRFLFLYHNELSGIIPQ----EIGNLKKLNSLLLAKNHFRGTVPKSFRNL---  300 (912)
Q Consensus       232 ~~L~l~~n~l~~~--~--p~~~~~l~~L~~L~L~~N~l~~~~~~----~l~~l~~L~~L~L~~N~l~~~~~~~~~~l---  300 (912)
                      ++|++++|++.+.  +  +..++.+++|++|+|++|+++.. +.    .+.++++|++|+|++|++++..|..+..+   
T Consensus       172 ~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~  250 (310)
T 4glp_A          172 TSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETP-TGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWS  250 (310)
T ss_dssp             CEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCH-HHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCC
T ss_pred             CEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCch-HHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCc
Confidence            5555555444321  1  11123445555555555555421 11    12344555555555555554444444443   


Q ss_pred             cccceEecccccccCCCCcccCCCCCccEEEccCCcCcccccccCCCCCCCCEEeccCCccc
Q 039137          301 TDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNIS  362 (912)
Q Consensus       301 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  362 (912)
                      ++|++|+|++|+++. +|..+.  ++|++|+|++|++++. | .+..+++|+.|++++|+++
T Consensus       251 ~~L~~L~Ls~N~l~~-lp~~~~--~~L~~L~Ls~N~l~~~-~-~~~~l~~L~~L~L~~N~l~  307 (310)
T 4glp_A          251 SALNSLNLSFAGLEQ-VPKGLP--AKLRVLDLSSNRLNRA-P-QPDELPEVDNLTLDGNPFL  307 (310)
T ss_dssp             TTCCCEECCSSCCCS-CCSCCC--SCCSCEECCSCCCCSC-C-CTTSCCCCSCEECSSTTTS
T ss_pred             CcCCEEECCCCCCCc-hhhhhc--CCCCEEECCCCcCCCC-c-hhhhCCCccEEECcCCCCC
Confidence            355555555555552 233332  4566666666666543 1 1455566666666666654

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.91  E-value=2.7e-24  Score=225.75  Aligned_cols=191  Identities=27%  Similarity=0.271  Sum_probs=111.5

Q ss_pred             CCCccceeEecCCCCeEEEeeccccccccccccccCCCCCccEEEccCCcccccCCccccCCCCCcEEeccccccccccc
Q 039137           71 SPCAWSGIFCNHAERVVGINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIP  150 (912)
Q Consensus        71 ~~C~w~gv~c~~~~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p  150 (912)
                      +||.|.|.+|....                           +++++++++++ .+|..+.  ++|++|+|++|++++..|
T Consensus         3 ~Cp~~~gC~C~~~~---------------------------~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~   52 (251)
T 3m19_A            3 TCETVTGCTCNEGK---------------------------KEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSD   52 (251)
T ss_dssp             -CHHHHSSEEEGGG---------------------------TEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCT
T ss_pred             cCCCCCceEcCCCC---------------------------eEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCH
Confidence            68999999995322                           23455555555 3444443  356666666666665555


Q ss_pred             cccccccccceeecccccccCCCCccccCcccccEEEccCCcCCCCCCccCCCCccceeeeeccCCCcCccccccccccc
Q 039137          151 SGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKS  230 (912)
Q Consensus       151 ~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~  230 (912)
                      ..|+.+++|++|+|++|.+++..|..|..+++|++|+|++|++++..+..|.++++|++|+|++|++++..+..+.++++
T Consensus        53 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  132 (251)
T 3m19_A           53 ATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTK  132 (251)
T ss_dssp             TTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTT
T ss_pred             hHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCc
Confidence            55666666666666666666555555666666666666666666555555556666666666666665444444555555


Q ss_pred             cceeecccccccCccccccccccccceeeeccccCcccCCcccCCccccchhhhccCccCC
Q 039137          231 LFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRG  291 (912)
Q Consensus       231 L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~  291 (912)
                      |++|+|++|++++..+..|+.+++|++|+|++|++++..+..|..+++|++|+|++|.+.+
T Consensus       133 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c  193 (251)
T 3m19_A          133 LKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDC  193 (251)
T ss_dssp             CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCT
T ss_pred             ccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeC
Confidence            5555555555554444455555555555555555555555555555555555555555553

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.91  E-value=6.5e-25  Score=255.00  Aligned_cols=187  Identities=18%  Similarity=0.227  Sum_probs=147.1

Q ss_pred             CCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCch----HHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          641 NAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMS----FQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       641 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ...+.||+|+||+||+|+. .++.+++|+..........    ...+++.+|++++++++||||+++..++...+..++|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            4467899999999999955 6788999987543322211    1245689999999999999999766666677888999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++++|.+++..           +..++.|+++||+|||++   +|+||||||+||+++.  .+||+|||+++....
T Consensus       418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            999999999999843           568999999999999999   9999999999999999  999999999997754


Q ss_pred             CCCC-------cccccccccccccccccc--CCCCcchhHHHHHHHHHHHHhCCCCc
Q 039137          797 DSSN-------WSELAGTHGYVAPELAYT--LKVTEKCDVYSFGVLALEVIKGKHPR  844 (912)
Q Consensus       797 ~~~~-------~~~~~g~~~y~aPE~~~~--~~~~~~sDvwslG~vl~elltg~~pf  844 (912)
                      ....       .....||+.|||||++.+  ..|+...|+|+..+-..+.+.++.+|
T Consensus       482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            3221       135679999999999987  56788899999999888888777765

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.90  E-value=1.7e-25  Score=248.52  Aligned_cols=260  Identities=18%  Similarity=0.143  Sum_probs=146.6

Q ss_pred             eeeccCCCcCccccccccccccceeecccccccCccc----ccccccc-ccceeeeccccCcccCCcccCCc-----ccc
Q 039137          210 LYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIP----LSISNLT-NLRFLFLYHNELSGIIPQEIGNL-----KKL  279 (912)
Q Consensus       210 L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p----~~~~~l~-~L~~L~L~~N~l~~~~~~~l~~l-----~~L  279 (912)
                      +.++.|.++|.+|..+...++|++|++++|++++..+    ..+..++ +|++|+|++|++++..+..+..+     ++|
T Consensus         3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L   82 (362)
T 3goz_A            3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV   82 (362)
T ss_dssp             EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred             cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence            4566666666666666555566666666666665544    4555555 56666666666665544444443     555


Q ss_pred             chhhhccCccCCCCccccccccccceEecccccccCCCCcccCCC-CCccEEEccCCcCcccccccC----CC-CCCCCE
Q 039137          280 NSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTY-PNLTFIDLSNNSFFGEILSDW----GR-CPQLSL  353 (912)
Q Consensus       280 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~~~~~----~~-l~~L~~  353 (912)
                      ++|+|++|++++..+..+...                    +..+ ++|++|+|++|++++..+..+    .. .++|++
T Consensus        83 ~~L~Ls~n~l~~~~~~~l~~~--------------------l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~  142 (362)
T 3goz_A           83 TSLNLSGNFLSYKSSDELVKT--------------------LAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITS  142 (362)
T ss_dssp             CEEECCSSCGGGSCHHHHHHH--------------------HHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCE
T ss_pred             cEEECcCCcCChHHHHHHHHH--------------------HHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeE
Confidence            555555555554444433222                    1122 344444444444443333222    22 235555


Q ss_pred             EeccCCccccc----ccccccccc-cccEEEccCccccCCCCccccc----c-ccccEEEccCCcccCC----Ccccccc
Q 039137          354 LDVSINNISGS----IPLEIGESL-QLQYLDLSSNYIVGEIPTQLGN----I-IYLNRLSLSGNKLSGC----IPRELGS  419 (912)
Q Consensus       354 L~Ls~N~l~~~----~~~~~~~~~-~L~~L~L~~N~l~~~~~~~l~~----l-~~L~~L~L~~N~l~~~----~p~~~~~  419 (912)
                      |++++|++++.    ++..+...+ +|++|+|++|++++..+..+..    . ++|++|+|++|++++.    ++..+..
T Consensus       143 L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~  222 (362)
T 3goz_A          143 LNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSS  222 (362)
T ss_dssp             EECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHH
T ss_pred             EEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhc
Confidence            55555555532    222233333 6666667666666555443332    3 4677777777777642    3444444


Q ss_pred             -ccccccccccCcccCcccc----ccccccccccEEEecccccccc-------cchhhhcccccceeeccccccCccccc
Q 039137          420 -LINLEYLDLSANNLSNFVP----ESLGSLVKLYYLNLSHNKLSQQ-------IPIELDNLIHLSELDLSHNFLGEKISS  487 (912)
Q Consensus       420 -l~~L~~L~Ls~N~l~~~~~----~~~~~l~~L~~L~Ls~N~l~~~-------~~~~~~~l~~L~~L~Ls~N~l~~~~~~  487 (912)
                       .++|++|+|++|.+++..+    ..+..+++|+.|+|++|.+.+.       ++..+..+++|++||+++|++.+..+.
T Consensus       223 ~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~~  302 (362)
T 3goz_A          223 IPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSI  302 (362)
T ss_dssp             SCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGCH
T ss_pred             CCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcchH
Confidence             3477888888887776544    3345667888888888885433       233566777888888888888765444


Q ss_pred             cc
Q 039137          488 RI  489 (912)
Q Consensus       488 ~~  489 (912)
                      .+
T Consensus       303 ~~  304 (362)
T 3goz_A          303 PI  304 (362)
T ss_dssp             HH
T ss_pred             HH
Confidence            33

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.90  E-value=2.6e-26  Score=252.60  Aligned_cols=270  Identities=14%  Similarity=0.127  Sum_probs=135.5

Q ss_pred             CCCccceeEecCCCCeEEEeeccccccccccccccCCC--CCccEEEccCCcccccCCccccCCCCCcEEeccccccccc
Q 039137           71 SPCAWSGIFCNHAERVVGINLTSISLNGTLLEFSFSSF--PHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQ  148 (912)
Q Consensus        71 ~~C~w~gv~c~~~~~v~~l~l~~~~l~~~~~~~~~~~l--~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~  148 (912)
                      -|.+|.++.|+. ..+..+++....+.+    ..+..+  ++++.|++++|.+.+..+. +..+++|++|+|++|.+++.
T Consensus        35 vc~~W~~~~~~~-~~~~~l~l~~~~~~~----~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~  108 (336)
T 2ast_B           35 VCKRWYRLASDE-SLWQTLDLTGKNLHP----DVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVS  108 (336)
T ss_dssp             SCHHHHHHHTCS-TTSSEEECTTCBCCH----HHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHH
T ss_pred             HHHHHHHHhcCc-hhheeeccccccCCH----HHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHH
Confidence            466899998863 334555555444331    223333  5566666666666654433 44566666666666666544


Q ss_pred             -cccccccccccceeecccccccCCCCccccCcccccEEEccCC-cCCCC-CCccCCCCccceeeeeccC-CCcCc-ccc
Q 039137          149 -IPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSN-FLNGS-IPRSLGNLTHVVILYLYNN-SFFGS-IPQ  223 (912)
Q Consensus       149 -~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n-~l~~~-~p~~~~~l~~L~~L~L~~n-~l~~~-~p~  223 (912)
                       +|..+..+++|++|+|++|.+++..|..++.+++|++|++++| .+++. ++..+.++++|++|++++| .+++. ++.
T Consensus       109 ~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~  188 (336)
T 2ast_B          109 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQV  188 (336)
T ss_dssp             HHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHH
T ss_pred             HHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHH
Confidence             5555566666666666666655555555555555555555555 34431 3444444555555555555 44432 344


Q ss_pred             cccccc-ccceeecccccccCccccccccccccceeeeccccCc-ccCCcccCCccccchhhhccCc-cCCCCccccccc
Q 039137          224 EIGNLK-SLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELS-GIIPQEIGNLKKLNSLLLAKNH-FRGTVPKSFRNL  300 (912)
Q Consensus       224 ~~~~l~-~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~~~~l~~l~~L~~L~L~~N~-l~~~~~~~~~~l  300 (912)
                      .+..++ +|++|++++|.+                      .++ +.++..+.++++|++|++++|. +++..+..+..+
T Consensus       189 ~~~~l~~~L~~L~l~~~~~----------------------~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l  246 (336)
T 2ast_B          189 AVAHVSETITQLNLSGYRK----------------------NLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQL  246 (336)
T ss_dssp             HHHHSCTTCCEEECCSCGG----------------------GSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGC
T ss_pred             HHHhcccCCCEEEeCCCcc----------------------cCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCC
Confidence            444444 455555544421                      222 2233334444455555555554 443444445555


Q ss_pred             cccceEeccccc-ccCCCCcccCCCCCccEEEccCCcCcccccccCCCCCCCCEEeccCCcccccccccccc
Q 039137          301 TDLVKLRLNQNY-LTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGE  371 (912)
Q Consensus       301 ~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  371 (912)
                      ++|++|++++|. ++......++.+++|+.|++++| +.......+.  ..+..|+++.|++++..|..++.
T Consensus       247 ~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~~~~~~~l~--~~l~~L~l~~n~l~~~~~~~~~~  315 (336)
T 2ast_B          247 NYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPDGTLQLLK--EALPHLQINCSHFTTIARPTIGN  315 (336)
T ss_dssp             TTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCTTCHHHHH--HHSTTSEESCCCSCCTTCSSCSS
T ss_pred             CCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cCHHHHHHHH--hhCcceEEecccCccccCCcccc
Confidence            555555555553 22111123455556666666655 3222111111  12444446666666666655543

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.90  E-value=2e-25  Score=247.88  Aligned_cols=255  Identities=20%  Similarity=0.221  Sum_probs=132.4

Q ss_pred             eeeccccCcccCCcccCCccccchhhhccCccCCCCc----ccccccc-ccceEecccccccCCCCcccCCC-----CCc
Q 039137          258 LFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVP----KSFRNLT-DLVKLRLNQNYLTGNISETFGTY-----PNL  327 (912)
Q Consensus       258 L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~----~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l-----~~L  327 (912)
                      ++++.|.+++.+|..+...++|++|+|++|.+++..+    ..|..++ +|++|+|++|.+++..+..+..+     ++|
T Consensus         3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L   82 (362)
T 3goz_A            3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV   82 (362)
T ss_dssp             EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred             cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence            4555666665555555554556666666666554444    4444454 55555555555554444444332     455


Q ss_pred             cEEEccCCcCcccccccCCCCCCCCEEeccCCccccccccccccc-ccccEEEccCccccCCCCccccc-----cccccE
Q 039137          328 TFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGES-LQLQYLDLSSNYIVGEIPTQLGN-----IIYLNR  401 (912)
Q Consensus       328 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~-~~L~~L~L~~N~l~~~~~~~l~~-----l~~L~~  401 (912)
                      ++|+|++|.+++..+..+...                    +..+ ++|++|+|++|++++..+..+..     .++|++
T Consensus        83 ~~L~Ls~n~l~~~~~~~l~~~--------------------l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~  142 (362)
T 3goz_A           83 TSLNLSGNFLSYKSSDELVKT--------------------LAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITS  142 (362)
T ss_dssp             CEEECCSSCGGGSCHHHHHHH--------------------HHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCE
T ss_pred             cEEECcCCcCChHHHHHHHHH--------------------HHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeE
Confidence            555555555443333321111                    1111 45555555555555443333222     135555


Q ss_pred             EEccCCcccCCCcc----cccccc-ccccccccCcccCccccccccc----c-ccccEEEecccccccc----cchhhhc
Q 039137          402 LSLSGNKLSGCIPR----ELGSLI-NLEYLDLSANNLSNFVPESLGS----L-VKLYYLNLSHNKLSQQ----IPIELDN  467 (912)
Q Consensus       402 L~L~~N~l~~~~p~----~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~----l-~~L~~L~Ls~N~l~~~----~~~~~~~  467 (912)
                      |+|++|++++..+.    .+..++ +|++|+|++|++++..+..+..    + ++|++|+|++|+|++.    ++..+..
T Consensus       143 L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~  222 (362)
T 3goz_A          143 LNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSS  222 (362)
T ss_dssp             EECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHH
T ss_pred             EEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhc
Confidence            55555555533222    223333 5666666666665554433332    2 4666666666666542    3444444


Q ss_pred             c-cccceeeccccccCcccc----cccccccccccccccCccccCCCc-------ccccccccceEEEccCCccccC
Q 039137          468 L-IHLSELDLSHNFLGEKIS----SRICRMESLEKLNLSYNNLSGLIP-------RCFEEMHGLLHIDISYNKLEGQ  532 (912)
Q Consensus       468 l-~~L~~L~Ls~N~l~~~~~----~~~~~l~~L~~L~ls~N~l~~~~p-------~~~~~l~~L~~l~ls~N~l~~~  532 (912)
                      + ++|++|+|++|.|++..+    ..+..+++|+.|+|++|+++++.+       ..+..++.|+.||+++|++.+.
T Consensus       223 ~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~  299 (362)
T 3goz_A          223 IPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPS  299 (362)
T ss_dssp             SCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGG
T ss_pred             CCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCc
Confidence            2 366666666666665433    233455667777777776554433       2455667777888888877654

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.90  E-value=2.9e-25  Score=249.05  Aligned_cols=241  Identities=20%  Similarity=0.279  Sum_probs=169.7

Q ss_pred             CccccccccccceEecccccccCCCC----cccCCCCCccEEEccCC---cCcccccccC-------CCCCCCCEEeccC
Q 039137          293 VPKSFRNLTDLVKLRLNQNYLTGNIS----ETFGTYPNLTFIDLSNN---SFFGEILSDW-------GRCPQLSLLDVSI  358 (912)
Q Consensus       293 ~~~~~~~l~~L~~L~L~~n~l~~~~~----~~~~~l~~L~~L~Ls~N---~l~~~~~~~~-------~~l~~L~~L~Ls~  358 (912)
                      ++..+..+++|++|+|++|.++...+    ..+..+++|++|+|++|   ++.+.+|..+       ..+++|++|+|++
T Consensus        24 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~  103 (386)
T 2ca6_A           24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD  103 (386)
T ss_dssp             TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred             HHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCC
Confidence            34445555566666666666554322    33556666666666664   3333334333       5667777777777


Q ss_pred             Ccccc----cccccccccccccEEEccCccccCCCCcccc----cc---------ccccEEEccCCccc-CCCc---ccc
Q 039137          359 NNISG----SIPLEIGESLQLQYLDLSSNYIVGEIPTQLG----NI---------IYLNRLSLSGNKLS-GCIP---REL  417 (912)
Q Consensus       359 N~l~~----~~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~----~l---------~~L~~L~L~~N~l~-~~~p---~~~  417 (912)
                      |++.+    .+|..+..+++|++|+|++|.+++..+..+.    .+         ++|++|+|++|+++ +.+|   ..+
T Consensus       104 n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l  183 (386)
T 2ca6_A          104 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF  183 (386)
T ss_dssp             CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHH
T ss_pred             CcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHH
Confidence            77765    3566667777777777777777643333333    33         78888888888887 3344   466


Q ss_pred             ccccccccccccCcccCc-----cccccccccccccEEEecccccc----cccchhhhcccccceeeccccccCcc----
Q 039137          418 GSLINLEYLDLSANNLSN-----FVPESLGSLVKLYYLNLSHNKLS----QQIPIELDNLIHLSELDLSHNFLGEK----  484 (912)
Q Consensus       418 ~~l~~L~~L~Ls~N~l~~-----~~~~~~~~l~~L~~L~Ls~N~l~----~~~~~~~~~l~~L~~L~Ls~N~l~~~----  484 (912)
                      ..+++|++|+|++|+++.     ..+..+..+++|++|+|++|.++    +.+|..+..+++|++|+|++|.|++.    
T Consensus       184 ~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~  263 (386)
T 2ca6_A          184 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAA  263 (386)
T ss_dssp             HHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHH
T ss_pred             HhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHH
Confidence            678888899999988873     34457788889999999999986    56788888889999999999998876    


Q ss_pred             cccccc--cccccccccccCccccC----CCcccc-cccccceEEEccCCccccCC
Q 039137          485 ISSRIC--RMESLEKLNLSYNNLSG----LIPRCF-EEMHGLLHIDISYNKLEGQI  533 (912)
Q Consensus       485 ~~~~~~--~l~~L~~L~ls~N~l~~----~~p~~~-~~l~~L~~l~ls~N~l~~~~  533 (912)
                      ++..+.  .+++|+.|+|++|++++    .+|..+ .++++|+.|++++|++++..
T Consensus       264 l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~  319 (386)
T 2ca6_A          264 VVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED  319 (386)
T ss_dssp             HHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred             HHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcch
Confidence            455663  38899999999999988    466666 66899999999999987643

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.89  E-value=2.5e-23  Score=216.71  Aligned_cols=178  Identities=21%  Similarity=0.171  Sum_probs=112.9

Q ss_pred             CccEEEccCCcccccCCccccCCCCCcEEeccccc-cccccccccccccccceeeccc-ccccCCCCccccCcccccEEE
Q 039137          110 HLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANK-LFGQIPSGIGLLTHLTVLHISR-NWLSGSIPHEVGQLTVLNQLA  187 (912)
Q Consensus       110 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~-l~~~~p~~~~~l~~L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~  187 (912)
                      +|++|+|++|++++..+..|.++++|++|+|++|+ +++..+..|+.+++|++|+|++ |.+++..+..|..+++|++|+
T Consensus        32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~  111 (239)
T 2xwt_C           32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG  111 (239)
T ss_dssp             TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred             cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence            68888888888887777788888888888888886 7655555788888888888887 888755556777777777777


Q ss_pred             ccCCcCCCCCCccCCCCccce---eeeeccC-CCcCccccccccccccc-eeecccccccCccccccccccccceeeecc
Q 039137          188 LDSNFLNGSIPRSLGNLTHVV---ILYLYNN-SFFGSIPQEIGNLKSLF-DLELCINQLSGAIPLSISNLTNLRFLFLYH  262 (912)
Q Consensus       188 l~~n~l~~~~p~~~~~l~~L~---~L~L~~n-~l~~~~p~~~~~l~~L~-~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~  262 (912)
                      +++|++++ +|. +.++++|+   +|++++| .+++..+..|.++++|+ .|++++|+++ .+|......++|+.|+|++
T Consensus       112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~  188 (239)
T 2xwt_C          112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNK  188 (239)
T ss_dssp             EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECTT
T ss_pred             CCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCC
Confidence            77777774 554 66666665   6666666 66544444455555555 5555555555 2322222224455555555


Q ss_pred             cc-CcccCCcccCCc-cccchhhhccCccC
Q 039137          263 NE-LSGIIPQEIGNL-KKLNSLLLAKNHFR  290 (912)
Q Consensus       263 N~-l~~~~~~~l~~l-~~L~~L~L~~N~l~  290 (912)
                      |+ ++++.+..|.++ ++|+.|++++|+++
T Consensus       189 n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~  218 (239)
T 2xwt_C          189 NKYLTVIDKDAFGGVYSGPSLLDVSQTSVT  218 (239)
T ss_dssp             CTTCCEECTTTTTTCSBCCSEEECTTCCCC
T ss_pred             CCCcccCCHHHhhccccCCcEEECCCCccc
Confidence            52 444334444444 44444444444444

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.89  E-value=1.5e-25  Score=251.53  Aligned_cols=273  Identities=18%  Similarity=0.223  Sum_probs=130.2

Q ss_pred             cEEeccccccccccccccccccccceeecccccccCCC----CccccCcccccEEEccCCc---CCCCCCccCCCCccce
Q 039137          136 EYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSI----PHEVGQLTVLNQLALDSNF---LNGSIPRSLGNLTHVV  208 (912)
Q Consensus       136 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~----p~~~~~l~~L~~L~l~~n~---l~~~~p~~~~~l~~L~  208 (912)
                      +...++...+. .++..+..+++|++|+|++|.+++..    +..+..+++|++|+|++|.   +++.+|..+.      
T Consensus        12 ~~~~l~~~~~~-~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~------   84 (386)
T 2ca6_A           12 KLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALR------   84 (386)
T ss_dssp             EESSCCSHHHH-TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHH------
T ss_pred             ccCCCCHHHHH-HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHH------
Confidence            33344444443 46666777777777777777776542    2335566666666666643   2333333321      


Q ss_pred             eeeeccCCCcCccccccccccccceeecccccccC----ccccccccccccceeeeccccCcccCCcccCCccccchhhh
Q 039137          209 ILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSG----AIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLL  284 (912)
Q Consensus       209 ~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L  284 (912)
                                 .+...+..+++|++|+|++|++++    .+|..+..+++|++|+|++|.+++..+..+...  |..+  
T Consensus        85 -----------~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~--l~~l--  149 (386)
T 2ca6_A           85 -----------LLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARA--LQEL--  149 (386)
T ss_dssp             -----------HHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHH--HHHH--
T ss_pred             -----------HHHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHH--HHHH--
Confidence                       000112445555555555555554    344555555666666666665543322222211  0000  


Q ss_pred             ccCccCCCCccccccccccceEeccccccc-CCCC---cccCCCCCccEEEccCCcCcc-----cccccCCCCCCCCEEe
Q 039137          285 AKNHFRGTVPKSFRNLTDLVKLRLNQNYLT-GNIS---ETFGTYPNLTFIDLSNNSFFG-----EILSDWGRCPQLSLLD  355 (912)
Q Consensus       285 ~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~---~~~~~l~~L~~L~Ls~N~l~~-----~~~~~~~~l~~L~~L~  355 (912)
                      ..|.+.+.       .++|++|+|++|+++ +..+   ..+..+++|+.|+|++|++..     ..+..+..+++|+.|+
T Consensus       150 ~~~~~~~~-------~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~  222 (386)
T 2ca6_A          150 AVNKKAKN-------APPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLD  222 (386)
T ss_dssp             HHHHHHHT-------CCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEE
T ss_pred             hhhhhccc-------CCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEE
Confidence            00001000       034444444444443 1111   233344444445555544431     1222444455555555


Q ss_pred             ccCCccc----ccccccccccccccEEEccCccccCC----CCcccc--ccccccEEEccCCcccC----CCcccc-ccc
Q 039137          356 VSINNIS----GSIPLEIGESLQLQYLDLSSNYIVGE----IPTQLG--NIIYLNRLSLSGNKLSG----CIPREL-GSL  420 (912)
Q Consensus       356 Ls~N~l~----~~~~~~~~~~~~L~~L~L~~N~l~~~----~~~~l~--~l~~L~~L~L~~N~l~~----~~p~~~-~~l  420 (912)
                      |++|.++    +.+|..+..+++|++|+|++|++++.    ++..+.  .+++|+.|+|++|++++    .+|..+ .++
T Consensus       223 Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l  302 (386)
T 2ca6_A          223 LQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKM  302 (386)
T ss_dssp             CCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHC
T ss_pred             CcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcC
Confidence            5555553    34444555555555555555555543    333442  25566666666666654    255544 445


Q ss_pred             cccccccccCcccCccc
Q 039137          421 INLEYLDLSANNLSNFV  437 (912)
Q Consensus       421 ~~L~~L~Ls~N~l~~~~  437 (912)
                      ++|++|+|++|.+++..
T Consensus       303 ~~L~~L~l~~N~l~~~~  319 (386)
T 2ca6_A          303 PDLLFLELNGNRFSEED  319 (386)
T ss_dssp             TTCCEEECTTSBSCTTS
T ss_pred             CCceEEEccCCcCCcch
Confidence            66666666666666543

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.89  E-value=4.7e-25  Score=242.49  Aligned_cols=252  Identities=18%  Similarity=0.232  Sum_probs=137.0

Q ss_pred             CcEEeccccccccccccccccc--cccceeecccccccCCCCccccCcccccEEEccCCcCCCC-CCccCCCCccceeee
Q 039137          135 LEYLDFSANKLFGQIPSGIGLL--THLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGS-IPRSLGNLTHVVILY  211 (912)
Q Consensus       135 L~~L~Ls~n~l~~~~p~~~~~l--~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~-~p~~~~~l~~L~~L~  211 (912)
                      ++.||+++|.+.   |..+..+  ++++.|++++|.+.+..|. +..+++|++|++++|.+++. +|..+.++++|++|+
T Consensus        49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~  124 (336)
T 2ast_B           49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLS  124 (336)
T ss_dssp             SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEE
T ss_pred             heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEe
Confidence            455566555554   3344444  5666666666666544333 44556666666666665543 555556666666666


Q ss_pred             eccCCCcCccccccccccccceeecccc-cccC-ccccccccccccceeeeccc-cCccc-CCcccCCcc-ccchhhhcc
Q 039137          212 LYNNSFFGSIPQEIGNLKSLFDLELCIN-QLSG-AIPLSISNLTNLRFLFLYHN-ELSGI-IPQEIGNLK-KLNSLLLAK  286 (912)
Q Consensus       212 L~~n~l~~~~p~~~~~l~~L~~L~l~~n-~l~~-~~p~~~~~l~~L~~L~L~~N-~l~~~-~~~~l~~l~-~L~~L~L~~  286 (912)
                      |++|.+++..|..++++++|++|++++| .+++ .++..+.++++|++|++++| .+++. ++..+..++ +|++|++++
T Consensus       125 L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~  204 (336)
T 2ast_B          125 LEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSG  204 (336)
T ss_dssp             CTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCS
T ss_pred             CcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCC
Confidence            6666666556666666666666666666 4554 25555666777777777777 66643 344455555 666666666


Q ss_pred             C--ccC-CCCccccccccccceEeccccc-ccCCCCcccCCCCCccEEEccCCc-CcccccccCCCCCCCCEEeccCCcc
Q 039137          287 N--HFR-GTVPKSFRNLTDLVKLRLNQNY-LTGNISETFGTYPNLTFIDLSNNS-FFGEILSDWGRCPQLSLLDVSINNI  361 (912)
Q Consensus       287 N--~l~-~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~Ls~N~l  361 (912)
                      |  .++ +.+|..+..+++|++|++++|. +++..+..+..+++|++|++++|. +......                  
T Consensus       205 ~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~------------------  266 (336)
T 2ast_B          205 YRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLL------------------  266 (336)
T ss_dssp             CGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGG------------------
T ss_pred             CcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHH------------------
Confidence            6  333 2334444555555555555555 444444444555555555555552 2222122                  


Q ss_pred             cccccccccccccccEEEccCccccCCCCcccccc-ccccEEEccCCcccCCCccccc
Q 039137          362 SGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNI-IYLNRLSLSGNKLSGCIPRELG  418 (912)
Q Consensus       362 ~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l-~~L~~L~L~~N~l~~~~p~~~~  418 (912)
                            .++.+++|++|++++| ++.   ..+..+ ..+..|++++|++++..|..++
T Consensus       267 ------~l~~~~~L~~L~l~~~-i~~---~~~~~l~~~l~~L~l~~n~l~~~~~~~~~  314 (336)
T 2ast_B          267 ------ELGEIPTLKTLQVFGI-VPD---GTLQLLKEALPHLQINCSHFTTIARPTIG  314 (336)
T ss_dssp             ------GGGGCTTCCEEECTTS-SCT---TCHHHHHHHSTTSEESCCCSCCTTCSSCS
T ss_pred             ------HHhcCCCCCEEeccCc-cCH---HHHHHHHhhCcceEEecccCccccCCccc
Confidence                  3444555555555555 321   122222 2355555666666666665544

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.89  E-value=2.8e-23  Score=216.24  Aligned_cols=198  Identities=15%  Similarity=0.166  Sum_probs=89.5

Q ss_pred             ccceEecccccccCCCCcccCCCCCccEEEccCCc-CcccccccCCCCCCCCEEeccC-CcccccccccccccccccEEE
Q 039137          302 DLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNS-FFGEILSDWGRCPQLSLLDVSI-NNISGSIPLEIGESLQLQYLD  379 (912)
Q Consensus       302 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~~~~L~~L~  379 (912)
                      +|++|++++|++++..+..|..+++|++|++++|+ ++...+..|..+++|++|++++ |++++..+..|.++++|++|+
T Consensus        32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~  111 (239)
T 2xwt_C           32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG  111 (239)
T ss_dssp             TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred             cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence            44555555555554444445555555555555553 4433333444444444444444 444433333444444444444


Q ss_pred             ccCccccCCCCccccccccccEEEccCCcccCCCccccccccccccccccCc-ccCcccccccccccccc-EEEeccccc
Q 039137          380 LSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSAN-NLSNFVPESLGSLVKLY-YLNLSHNKL  457 (912)
Q Consensus       380 L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~-~L~Ls~N~l  457 (912)
                      +++|++++ +|. +..+++|+                     .|++|++++| +++++.+..|..+++|+ +|++++|++
T Consensus       112 l~~n~l~~-lp~-~~~l~~L~---------------------~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l  168 (239)
T 2xwt_C          112 IFNTGLKM-FPD-LTKVYSTD---------------------IFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGF  168 (239)
T ss_dssp             EEEECCCS-CCC-CTTCCBCC---------------------SEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCC
T ss_pred             CCCCCCcc-ccc-cccccccc---------------------cccEEECCCCcchhhcCcccccchhcceeEEEcCCCCC
Confidence            44444442 232 33333333                     0014444444 44444444444444555 555555554


Q ss_pred             ccccchhhhcccccceeeccccc-cCcccccccccc-cccccccccCccccCCCcccccccccceEEEccC
Q 039137          458 SQQIPIELDNLIHLSELDLSHNF-LGEKISSRICRM-ESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISY  526 (912)
Q Consensus       458 ~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l-~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~ls~  526 (912)
                      +...+..|.. ++|++|+|++|+ +++..+..|..+ ++|+.|++++|+|++..+.   .+++|+.|++++
T Consensus       169 ~~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~  235 (239)
T 2xwt_C          169 TSVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARN  235 (239)
T ss_dssp             CEECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTT
T ss_pred             cccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccC
Confidence            4222222222 455555555552 544444445555 5555555555555544332   334445555544

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.89  E-value=1.6e-23  Score=227.17  Aligned_cols=226  Identities=17%  Similarity=0.131  Sum_probs=189.7

Q ss_pred             CCCccEEEccCCcccccC-C--ccccCCCCCcEEecccccccccccccc--ccccccceeecccccccCCCC----cccc
Q 039137          108 FPHLVYLDLYNNELFGII-P--PQISNLSNLEYLDFSANKLFGQIPSGI--GLLTHLTVLHISRNWLSGSIP----HEVG  178 (912)
Q Consensus       108 l~~L~~L~L~~n~l~~~~-p--~~~~~l~~L~~L~Ls~n~l~~~~p~~~--~~l~~L~~L~L~~n~l~~~~p----~~~~  178 (912)
                      -..++.|.+.++.++... .  ..+..+++|++|+|++|++++.+|..+  +.+++|++|+|++|.+++..|    ..+.
T Consensus        63 ~~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~  142 (310)
T 4glp_A           63 ALRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQW  142 (310)
T ss_dssp             SCCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTT
T ss_pred             hcceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhh
Confidence            345788899888775321 1  123345779999999999999999988  899999999999999998666    4456


Q ss_pred             CcccccEEEccCCcCCCCCCccCCCCccceeeeeccCCCcCc--c--ccccccccccceeecccccccCcccc----ccc
Q 039137          179 QLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGS--I--PQEIGNLKSLFDLELCINQLSGAIPL----SIS  250 (912)
Q Consensus       179 ~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~--~--p~~~~~l~~L~~L~l~~n~l~~~~p~----~~~  250 (912)
                      .+++|++|+|++|++.+..|..++++++|++|+|++|++.+.  +  +..++++++|++|++++|+++ .++.    .++
T Consensus       143 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~  221 (310)
T 4glp_A          143 LKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAA  221 (310)
T ss_dssp             BCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHH
T ss_pred             hccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHh
Confidence            799999999999999988889999999999999999998753  2  234578999999999999997 3333    357


Q ss_pred             cccccceeeeccccCcccCCcccCCc---cccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCc
Q 039137          251 NLTNLRFLFLYHNELSGIIPQEIGNL---KKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNL  327 (912)
Q Consensus       251 ~l~~L~~L~L~~N~l~~~~~~~l~~l---~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L  327 (912)
                      .+++|++|+|++|++++..|..+..+   ++|++|+|++|+++ .+|..+.  ++|++|+|++|++++. |. +..+++|
T Consensus       222 ~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L  296 (310)
T 4glp_A          222 AGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEV  296 (310)
T ss_dssp             HTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCC
T ss_pred             cCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCc
Confidence            88999999999999998888888777   69999999999999 6677664  8999999999999975 32 6889999


Q ss_pred             cEEEccCCcCcc
Q 039137          328 TFIDLSNNSFFG  339 (912)
Q Consensus       328 ~~L~Ls~N~l~~  339 (912)
                      +.|+|++|+++.
T Consensus       297 ~~L~L~~N~l~~  308 (310)
T 4glp_A          297 DNLTLDGNPFLV  308 (310)
T ss_dssp             SCEECSSTTTSC
T ss_pred             cEEECcCCCCCC
Confidence            999999999864

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.88  E-value=1.1e-22  Score=220.13  Aligned_cols=214  Identities=23%  Similarity=0.302  Sum_probs=139.5

Q ss_pred             cccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCcccccccCCCCCCCCEEec
Q 039137          277 KKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDV  356 (912)
Q Consensus       277 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  356 (912)
                      .++..+.+..+.+...+  .+..+++|++|++++|.++.. + .+..+++|+.|+|++|.+.+..+  +..+++|+.|++
T Consensus        19 ~~~~~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~l-~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L   92 (308)
T 1h6u_A           19 ANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELEL   92 (308)
T ss_dssp             HHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEEC
T ss_pred             HHHHHHHhCCCCcCcee--cHHHcCCcCEEEeeCCCccCc-h-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEc
Confidence            44455556666655432  244566777777777776643 2 46667777777777777765444  666777777777


Q ss_pred             cCCcccccccccccccccccEEEccCccccCCCCccccccccccEEEccCCcccCCCccccccccccccccccCcccCcc
Q 039137          357 SINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNF  436 (912)
Q Consensus       357 s~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  436 (912)
                      ++|++++. + .+..+++|++|+|++|++++. + .+..+++|++|++++|++++..+  +..+++|++|+|++|++++.
T Consensus        93 ~~n~l~~~-~-~~~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~  166 (308)
T 1h6u_A           93 SGNPLKNV-S-AIAGLQSIKTLDLTSTQITDV-T-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDL  166 (308)
T ss_dssp             CSCCCSCC-G-GGTTCTTCCEEECTTSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC
T ss_pred             cCCcCCCc-h-hhcCCCCCCEEECCCCCCCCc-h-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCC
Confidence            77776643 2 466667777777777777643 2 26677777777777777765433  66677777777777777764


Q ss_pred             ccccccccccccEEEecccccccccchhhhcccccceeeccccccCcccccccccccccccccccCccccCC
Q 039137          437 VPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGL  508 (912)
Q Consensus       437 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~  508 (912)
                      .+  +..+++|+.|+|++|++++..+  +..+++|++|+|++|++++..+  +..+++|+.|++++|++++.
T Consensus       167 ~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~~  232 (308)
T 1h6u_A          167 TP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQ  232 (308)
T ss_dssp             GG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEECC
T ss_pred             hh--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeecC
Confidence            33  6677777777777777765433  6677777777777777765543  66677777777777777654

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.88  E-value=1.1e-22  Score=213.30  Aligned_cols=181  Identities=24%  Similarity=0.255  Sum_probs=126.7

Q ss_pred             CCEEeccCCcccccccccccccccccEEEccCccccCCCCccccccccccEEEccCCcccCCCccccccccccccccccC
Q 039137          351 LSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSA  430 (912)
Q Consensus       351 L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~  430 (912)
                      .+.++++++.++ .+|..+.  ++++.|+|++|++++..+..+.++++|++|+|++|++++..+..|..+++|++|+|++
T Consensus        16 ~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~   92 (251)
T 3m19_A           16 KKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLAN   92 (251)
T ss_dssp             GTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred             CeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCC
Confidence            344555555554 3343332  3566666666666666666666677777777777777766666677777777777777


Q ss_pred             cccCccccccccccccccEEEecccccccccchhhhcccccceeeccccccCcccccccccccccccccccCccccCCCc
Q 039137          431 NNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIP  510 (912)
Q Consensus       431 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p  510 (912)
                      |+++++.+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..+
T Consensus        93 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  172 (251)
T 3m19_A           93 NQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPH  172 (251)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred             CcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCH
Confidence            77777666677777777777777777776666667777777777777777777666677777777777777777777777


Q ss_pred             ccccccccceEEEccCCccccCCC
Q 039137          511 RCFEEMHGLLHIDISYNKLEGQIP  534 (912)
Q Consensus       511 ~~~~~l~~L~~l~ls~N~l~~~~~  534 (912)
                      ..|..+++|+.|++++|+++|...
T Consensus       173 ~~~~~l~~L~~L~l~~N~~~c~~~  196 (251)
T 3m19_A          173 GAFDRLGKLQTITLFGNQFDCSRC  196 (251)
T ss_dssp             TTTTTCTTCCEEECCSCCBCTTST
T ss_pred             HHHhCCCCCCEEEeeCCceeCCcc
Confidence            777777888888888888877543

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.88  E-value=2.3e-22  Score=204.47  Aligned_cols=182  Identities=26%  Similarity=0.294  Sum_probs=117.7

Q ss_pred             CccceeEecCCCCeEEEeeccccccccccccccCCCCCccEEEccCCcccccCCccccCCCCCcEEeccccccccccccc
Q 039137           73 CAWSGIFCNHAERVVGINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSG  152 (912)
Q Consensus        73 C~w~gv~c~~~~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~  152 (912)
                      |.|.+|.|+..+- +.+              ...-.++|++|+|++|++++..+..|.++++|++|+|++|++++..+..
T Consensus         7 C~~~~v~c~~~~l-~~~--------------p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~   71 (208)
T 2o6s_A            7 CSGTTVECYSQGR-TSV--------------PTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGV   71 (208)
T ss_dssp             EETTEEECCSSCC-SSC--------------CSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTT
T ss_pred             ECCCEEEecCCCc-cCC--------------CCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhh
Confidence            7999999975321 111              1122457788888888888666666778888888888888887555555


Q ss_pred             cccccccceeecccccccCCCCccccCcccccEEEccCCcCCCCCCccCCCCccceeeeeccCCCcCccccccccccccc
Q 039137          153 IGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLF  232 (912)
Q Consensus       153 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~  232 (912)
                      |..+++|++|+|++|.+++..+..++.+++|++|++++|++++..+..+.++++|++|+|++|.+++..+..+.++++|+
T Consensus        72 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~  151 (208)
T 2o6s_A           72 FNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQ  151 (208)
T ss_dssp             TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCC
T ss_pred             cCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCcc
Confidence            67778888888888877755555567777777777777777755555566666666666666666654444555555666


Q ss_pred             eeecccccccCccccccccccccceeeeccccCcccCCcccCCc
Q 039137          233 DLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNL  276 (912)
Q Consensus       233 ~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l  276 (912)
                      .|++++|.+.+       .+++|++|+++.|+++|.+|..++.+
T Consensus       152 ~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~~l  188 (208)
T 2o6s_A          152 YIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSV  188 (208)
T ss_dssp             EEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTSSB
T ss_pred             EEEecCCCeec-------CCCCHHHHHHHHHhCCceeeccCccc
Confidence            66665555442       23345555555555555555544443

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.88  E-value=1.1e-22  Score=220.23  Aligned_cols=192  Identities=24%  Similarity=0.366  Sum_probs=99.0

Q ss_pred             CCCCccEEEccCCcccccCCccccCCCCCcEEeccccccccccccccccccccceeecccccccCCCCccccCcccccEE
Q 039137          107 SFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQL  186 (912)
Q Consensus       107 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L  186 (912)
                      .+++|++|++++|+++. +| .+..+++|++|+|++|++++ +|. +..+++|++|+|++|.+++ +| .++.+++|++|
T Consensus        39 ~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~-~~~-~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L  112 (308)
T 1h6u_A           39 DLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITD-LAP-LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTL  112 (308)
T ss_dssp             HHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEE
T ss_pred             HcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCC-Chh-HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEE
Confidence            45566666666666653 33 46666666666666666653 333 6666666666666666653 32 45566666666


Q ss_pred             EccCCcCCCCCCccCCCCccceeeeeccCCCcCccccccccccccceeecccccccCccccccccccccceeeeccccCc
Q 039137          187 ALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELS  266 (912)
Q Consensus       187 ~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~  266 (912)
                      ++++|++++ +|. +.++++|++|++++|.+++..+  ++++++|+.|++++|++++..+  +..+++|+.|++++|+++
T Consensus       113 ~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~  186 (308)
T 1h6u_A          113 DLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKIS  186 (308)
T ss_dssp             ECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred             ECCCCCCCC-chh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccC
Confidence            666666653 222 5555555555555555553322  4455555555555555543222  444455555555555544


Q ss_pred             ccCCcccCCccccchhhhccCccCCCCccccccccccceEeccccccc
Q 039137          267 GIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLT  314 (912)
Q Consensus       267 ~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~  314 (912)
                      +..+  +..+++|++|+|++|++++..  .+..+++|+.|++++|.++
T Consensus       187 ~~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~  230 (308)
T 1h6u_A          187 DISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTIT  230 (308)
T ss_dssp             CCGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEE
T ss_pred             cChh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeee
Confidence            3322  344444444444444444322  1334444444444444443

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.86  E-value=6.7e-22  Score=218.25  Aligned_cols=98  Identities=21%  Similarity=0.207  Sum_probs=38.5

Q ss_pred             cccccccCcccCccccccccccccccEEEecc-cccccccchhhhcccccceeeccccccCccccccccccccccccccc
Q 039137          423 LEYLDLSANNLSNFVPESLGSLVKLYYLNLSH-NKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLS  501 (912)
Q Consensus       423 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls  501 (912)
                      ++.|+|++|+|+.+.+..| ...+|+.|++++ |.++.+.+..|.++++|++|||++|+|+...+..|.++++|+.+++ 
T Consensus       156 l~~L~L~~N~i~~i~~~~f-~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~-  233 (350)
T 4ay9_X          156 SVILWLNKNGIQEIHNSAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST-  233 (350)
T ss_dssp             CEEEECCSSCCCEECTTSS-TTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTTC-
T ss_pred             hhhhccccccccCCChhhc-cccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhccC-
Confidence            3344444444443322222 223444444432 3333222233444444444444444444433333333333333332 


Q ss_pred             CccccCCCcccccccccceEEEcc
Q 039137          502 YNNLSGLIPRCFEEMHGLLHIDIS  525 (912)
Q Consensus       502 ~N~l~~~~p~~~~~l~~L~~l~ls  525 (912)
                       ++++.. | .+..+++|+.++++
T Consensus       234 -~~l~~l-P-~l~~l~~L~~l~l~  254 (350)
T 4ay9_X          234 -YNLKKL-P-TLEKLVALMEASLT  254 (350)
T ss_dssp             -TTCCCC-C-CTTTCCSCCEEECS
T ss_pred             -CCcCcC-C-CchhCcChhhCcCC
Confidence             122222 2 24445555555554

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.86  E-value=2.4e-22  Score=233.17  Aligned_cols=193  Identities=23%  Similarity=0.284  Sum_probs=128.1

Q ss_pred             CccEEEccCCcccccCCccccCCCCCcEEeccccccccccccccccccccceeecccccccCCCCccccCcccccEEEcc
Q 039137          110 HLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALD  189 (912)
Q Consensus       110 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~  189 (912)
                      +|+.|+|++|++++ +|..+.  ++|++|+|++|+|+ .+|   +.+++|++|+|++|.+++ +|. ++.  +|++|+|+
T Consensus        60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls  128 (571)
T 3cvr_A           60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD  128 (571)
T ss_dssp             TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred             CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence            35678888888886 676663  78889999988887 677   457888888888888885 776 655  78888888


Q ss_pred             CCcCCCCCCccCCCCccceeeeeccCCCcCccccccccccccceeecccccccCccccccccccccceeeeccccCcccC
Q 039137          190 SNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGII  269 (912)
Q Consensus       190 ~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  269 (912)
                      +|++++ +|.   .+++|++|+|++|.+++ +|.   .+++|+.|+|++|++++ +|. |.  ++|++|+|++|+|+ .+
T Consensus       129 ~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~l  195 (571)
T 3cvr_A          129 NNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SL  195 (571)
T ss_dssp             SSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SC
T ss_pred             CCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-ch
Confidence            888875 565   56777777777777775 444   45666666666666664 444 44  66666666666666 33


Q ss_pred             CcccCCccccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCcccccccCCC
Q 039137          270 PQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGR  347 (912)
Q Consensus       270 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  347 (912)
                      |. +..  +|                 +...+.|+.|+|++|.|+. +|..+..+++|+.|+|++|++++..|..+..
T Consensus       196 p~-~~~--~L-----------------~~~~~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~  252 (571)
T 3cvr_A          196 PA-VPV--RN-----------------HHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQ  252 (571)
T ss_dssp             CC-CC---------------------------CCEEEECCSSCCCC-CCGGGGGSCTTEEEECCSSSCCHHHHHHHHH
T ss_pred             hh-HHH--hh-----------------hcccccceEEecCCCccee-cCHHHhcCCCCCEEEeeCCcCCCcCHHHHHH
Confidence            33 332  22                 0111233667777777764 4444455777777777777777776666544

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.86  E-value=2.6e-21  Score=213.56  Aligned_cols=221  Identities=19%  Similarity=0.163  Sum_probs=103.8

Q ss_pred             ccceeecccccccCccccccccccccceeeeccccCcccCC-cccCCccccch-hhhccCccCCCCccccccccccceEe
Q 039137          230 SLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIP-QEIGNLKKLNS-LLLAKNHFRGTVPKSFRNLTDLVKLR  307 (912)
Q Consensus       230 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~l~~l~~L~~-L~L~~N~l~~~~~~~~~~l~~L~~L~  307 (912)
                      ++++|+|++|+|+...+..|.++++|++|+|++|++.+.+| .+|.++++|.+ +.++.|+++...|..|..+++|++|+
T Consensus        31 ~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~  110 (350)
T 4ay9_X           31 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL  110 (350)
T ss_dssp             TCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEE
T ss_pred             CCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhcccccccc
Confidence            34444444444443223344455555555555555433222 23444444432 33444555544455555555555555


Q ss_pred             cccccccCCCCcccCCCCCccEEEccC-CcCcccccccCCCCC-CCCEEeccCCcccccccccccccccccEEEccC-cc
Q 039137          308 LNQNYLTGNISETFGTYPNLTFIDLSN-NSFFGEILSDWGRCP-QLSLLDVSINNISGSIPLEIGESLQLQYLDLSS-NY  384 (912)
Q Consensus       308 L~~n~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L~~-N~  384 (912)
                      +++|+++...+..+....++..|++.+ |++....+..|..+. .++.|++++|+|+ .+|.......+|++|++++ |.
T Consensus       111 l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~-~i~~~~f~~~~L~~l~l~~~n~  189 (350)
T 4ay9_X          111 ISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNN  189 (350)
T ss_dssp             EEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-EECTTSSTTEEEEEEECTTCTT
T ss_pred             ccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc-CCChhhccccchhHHhhccCCc
Confidence            555555554444444445555555543 334333333444332 3455555555555 2333333344556666653 44


Q ss_pred             ccCCCCccccccccccEEEccCCcccCCCccccccccccccccccCcccCccccccccccccccEEEeccc
Q 039137          385 IVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHN  455 (912)
Q Consensus       385 l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  455 (912)
                      ++...+..|.++++|+.|+|++|+|+...+..+.++++|+.+++  +.++. .| .+..+++|+.++++++
T Consensus       190 l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~--~~l~~-lP-~l~~l~~L~~l~l~~~  256 (350)
T 4ay9_X          190 LEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLKK-LP-TLEKLVALMEASLTYP  256 (350)
T ss_dssp             CCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTTC--TTCCC-CC-CTTTCCSCCEEECSCH
T ss_pred             ccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhccC--CCcCc-CC-CchhCcChhhCcCCCC
Confidence            44322334555556666666666655443344444444444433  22332 23 2455555555555543

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.86  E-value=6.9e-22  Score=210.23  Aligned_cols=155  Identities=15%  Similarity=0.126  Sum_probs=122.2

Q ss_pred             HHHHHhcCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCc-----h---------HHHHHHHHHHHHHhhcCC
Q 039137          632 EIISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEM-----S---------FQQEEFLNEIQALTEIRH  697 (912)
Q Consensus       632 e~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-----~---------~~~~~~~~Ei~~l~~l~h  697 (912)
                      ........|.+.+.||+|+||.||+|++.+|+.||+|+++.......     .         .....+.+|+++++.++|
T Consensus        84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~  163 (282)
T 1zar_A           84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG  163 (282)
T ss_dssp             HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT
T ss_pred             HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC
Confidence            44445566778899999999999999997899999999864322110     0         135678999999999994


Q ss_pred             CccccEEEEEEcCCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEE
Q 039137          698 RNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLL  777 (912)
Q Consensus       698 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill  777 (912)
                         +++.+++.. +..++||||+++++|.+ +..         .+...++.|++.|++|||++   +|+||||||+||++
T Consensus       164 ---~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl  226 (282)
T 1zar_A          164 ---LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLV  226 (282)
T ss_dssp             ---SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEE
T ss_pred             ---CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEE
Confidence               555555433 56799999999999988 411         23557999999999999999   99999999999999


Q ss_pred             cCCCcEEEeccccccccCCCCCCccccccccccccccccc
Q 039137          778 DLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAY  817 (912)
Q Consensus       778 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~  817 (912)
                      + ++.+||+|||+|+.             +..|+|||++.
T Consensus       227 ~-~~~vkl~DFG~a~~-------------~~~~~a~e~l~  252 (282)
T 1zar_A          227 S-EEGIWIIDFPQSVE-------------VGEEGWREILE  252 (282)
T ss_dssp             E-TTEEEECCCTTCEE-------------TTSTTHHHHHH
T ss_pred             E-CCcEEEEECCCCeE-------------CCCCCHHHHHH
Confidence            9 99999999999963             33478899764

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.85  E-value=8.4e-21  Score=192.94  Aligned_cols=180  Identities=25%  Similarity=0.234  Sum_probs=153.0

Q ss_pred             EEEccCCcccccCCccccCCCCCcEEeccccccccccccccccccccceeecccccccCCCCccccCcccccEEEccCCc
Q 039137          113 YLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNF  192 (912)
Q Consensus       113 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~  192 (912)
                      .+++++++++ .+|..+  .++|++|+|++|++++..+..|+.+++|++|+|++|++++..+..|+.+++|++|++++|+
T Consensus        11 ~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~   87 (208)
T 2o6s_A           11 TVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQ   87 (208)
T ss_dssp             EEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCc
Confidence            4667778877 456544  4589999999999987666778999999999999999996666678999999999999999


Q ss_pred             CCCCCCccCCCCccceeeeeccCCCcCccccccccccccceeecccccccCccccccccccccceeeeccccCcccCCcc
Q 039137          193 LNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQE  272 (912)
Q Consensus       193 l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~  272 (912)
                      +++..+..|.++++|++|+|++|.+++..+..+.++++|+.|++++|++++..+..+..+++|++|++++|.+.+     
T Consensus        88 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~-----  162 (208)
T 2o6s_A           88 LQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC-----  162 (208)
T ss_dssp             CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC-----
T ss_pred             CCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec-----
Confidence            997767778999999999999999997777778999999999999999997777778899999999999997764     


Q ss_pred             cCCccccchhhhccCccCCCCccccccccc
Q 039137          273 IGNLKKLNSLLLAKNHFRGTVPKSFRNLTD  302 (912)
Q Consensus       273 l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  302 (912)
                        .+++|+.|+++.|+++|.+|..++.++.
T Consensus       163 --~~~~l~~L~~~~n~~~g~ip~~~~~l~~  190 (208)
T 2o6s_A          163 --TCPGIRYLSEWINKHSGVVRNSAGSVAP  190 (208)
T ss_dssp             --CTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred             --CCCCHHHHHHHHHhCCceeeccCccccC
Confidence              3467899999999999999988877654

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.84  E-value=2.8e-21  Score=224.17  Aligned_cols=188  Identities=23%  Similarity=0.346  Sum_probs=99.3

Q ss_pred             ccceEecccccccCCCCcccCCCCCccEEEccCCcCcccccccCCCCCCCCEEeccCCcccccccccccccccccEEEcc
Q 039137          302 DLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLS  381 (912)
Q Consensus       302 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L~  381 (912)
                      +|+.|+|++|.+++ +|..+  .++|+.|+|++|+|+ .+|   ..+++|+.|++++|+|++ +|. +..  +|++|+|+
T Consensus        60 ~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls  128 (571)
T 3cvr_A           60 QFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD  128 (571)
T ss_dssp             TCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred             CccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence            45555555555554 22222  144555555555554 222   334555555555555554 343 333  55666666


Q ss_pred             CccccCCCCccccccccccEEEccCCcccCCCccccccccccccccccCcccCccccccccccccccEEEeccccccccc
Q 039137          382 SNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQI  461 (912)
Q Consensus       382 ~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  461 (912)
                      +|+|++ +|.   .+++|+.|+|++|++++ +|.   .+++|++|+|++|+|++ +|. |.  ++|+.|+|++|+|+ .+
T Consensus       129 ~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~l  195 (571)
T 3cvr_A          129 NNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SL  195 (571)
T ss_dssp             SSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SC
T ss_pred             CCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-ch
Confidence            666554 333   34556666666666654 333   34556666666666655 333 44  56666666666665 34


Q ss_pred             chhhhccccc-------ceeeccccccCcccccccccccccccccccCccccCCCcccccccc
Q 039137          462 PIELDNLIHL-------SELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMH  517 (912)
Q Consensus       462 ~~~~~~l~~L-------~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~  517 (912)
                      |. +..  +|       +.|+|++|+|+. +|..+..+++|+.|+|++|+|++.+|..+..+.
T Consensus       196 p~-~~~--~L~~~~~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~  254 (571)
T 3cvr_A          196 PA-VPV--RNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQT  254 (571)
T ss_dssp             CC-CC----------CCEEEECCSSCCCC-CCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHH
T ss_pred             hh-HHH--hhhcccccceEEecCCCccee-cCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhh
Confidence            44 333  45       666666666653 455555566666666666666666666555543

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.83  E-value=6.2e-22  Score=238.49  Aligned_cols=259  Identities=20%  Similarity=0.169  Sum_probs=91.2

Q ss_pred             CCHHHHHHHHHHHHhcccCCcccCCCcccCCCCCCCCCCCccceeEecCCCCeEEEeeccccccccccccccCCCCCccE
Q 039137           34 NSAEEAHALVKWKASLEVHSRSLLHSWSLSSVNATKISPCAWSGIFCNHAERVVGINLTSISLNGTLLEFSFSSFPHLVY  113 (912)
Q Consensus        34 ~~~~~~~all~~k~~~~~~~~~~l~~w~~~~~~~~~~~~C~w~gv~c~~~~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~  113 (912)
                      ....+++||+++..+.....+..-++|..     +...++.|.+++++. .+++.+++..+++...       ....++.
T Consensus       129 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~s~-~~~~~l~L~~n~~~~~-------~~~~l~~  195 (727)
T 4b8c_D          129 LVDCTKQALMEMADTLTDSKTAKKQQPTG-----DSTPSGTATNSAVST-PLTPKIELFANGKDEA-------NQALLQH  195 (727)
T ss_dssp             ---CCCHHHHHHHHHHHHHHTTC---------------------------------------------------------
T ss_pred             ccccchhhhhhhhhhcccccCcccCCCcC-----CCCccccCCCceecC-CccceEEeeCCCCCcc-------hhhHhhc
Confidence            34567899999998876544444555642     234567899999874 6788887766555442       1123444


Q ss_pred             EEccCCcccc---------cCCccccCCCCCcEEeccccccccccccccccccccceeecccccccCCCCccccCccccc
Q 039137          114 LDLYNNELFG---------IIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLN  184 (912)
Q Consensus       114 L~L~~n~l~~---------~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~  184 (912)
                      ++|+.|.|.+         ..|..|..++.|++|+|++|++. .+|..+..+++|++|+|++|.|+ .+|..|++|++|+
T Consensus       196 l~Ls~~~i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~  273 (727)
T 4b8c_D          196 KKLSQYSIDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLR  273 (727)
T ss_dssp             --------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCC
T ss_pred             CccCcccccCccccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCC
Confidence            5555554432         23455566666666666666665 55555556666666666666665 5555566666666


Q ss_pred             EEEccCCcCCCCCCccCCCCccceeeeeccCCCcCccccccccccccceeecccccccCccccccccccccceeeecccc
Q 039137          185 QLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNE  264 (912)
Q Consensus       185 ~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~  264 (912)
                      +|+|++|+|+ .+|..|++|++|++|+|++|.++ .+|..|++|++|+.|+|++|++++.+|..+..+..          
T Consensus       274 ~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~----------  341 (727)
T 4b8c_D          274 VLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSV----------  341 (727)
T ss_dssp             EEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHH----------
T ss_pred             EEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcch----------
Confidence            6666666655 45555555555555555555554 44444555555555555555555444444433211          


Q ss_pred             CcccCCcccCCccccchhhhccCccCCCCccccccccccceEecccc--------cccCCCCcccCCCCCccEEEccCCc
Q 039137          265 LSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQN--------YLTGNISETFGTYPNLTFIDLSNNS  336 (912)
Q Consensus       265 l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n--------~l~~~~~~~~~~l~~L~~L~Ls~N~  336 (912)
                                   .+..|+|++|.+++.+|..      |+.|+++.|        .+.+..+..+..+..+....+++|-
T Consensus       342 -------------~~~~l~l~~N~l~~~~p~~------l~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Ni  402 (727)
T 4b8c_D          342 -------------TGLIFYLRDNRPEIPLPHE------RRFIEINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNT  402 (727)
T ss_dssp             -------------HHHHHHHHHCCCCCCCCCC-----------------------------------------------C
T ss_pred             -------------hhhHHhhccCcccCcCccc------cceeEeecccccccccCCccccccchhhcccccceeeeeccc
Confidence                         1122445555555444432      223333333        3333344445566666777778887


Q ss_pred             Cc
Q 039137          337 FF  338 (912)
Q Consensus       337 l~  338 (912)
                      +.
T Consensus       403 l~  404 (727)
T 4b8c_D          403 LC  404 (727)
T ss_dssp             CC
T ss_pred             cc
Confidence            64

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.82  E-value=1.2e-20  Score=221.51  Aligned_cols=193  Identities=26%  Similarity=0.338  Sum_probs=125.7

Q ss_pred             ccEEEccCCcccccCCccccCCCCCcEEeccccccccccccccccccccceeecccccccCCCCccccCcccccEEEccC
Q 039137          111 LVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDS  190 (912)
Q Consensus       111 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~  190 (912)
                      +..++|..+.+...++  +..|++|++|+|++|.+. .+| .++.+++|+.|+|++|.+++..|  +..+++|+.|+|++
T Consensus        23 l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~   96 (605)
T 1m9s_A           23 TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDE   96 (605)
T ss_dssp             HHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCC-CCT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCS
T ss_pred             HHHHhccCCCcccccc--hhcCCCCCEEECcCCCCC-CCh-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcC
Confidence            4445555566554432  566677777777777775 344 46777777777777777774433  67777777777777


Q ss_pred             CcCCCCCCccCCCCccceeeeeccCCCcCccccccccccccceeecccccccCccccccccccccceeeeccccCcccCC
Q 039137          191 NFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIP  270 (912)
Q Consensus       191 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~  270 (912)
                      |.+++ +| .+.++++|++|+|++|.+.+ + ..+..+++|+.|+|++|++++.  ..++.+++|+.|+|++|++++..|
T Consensus        97 N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~  170 (605)
T 1m9s_A           97 NKIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP  170 (605)
T ss_dssp             SCCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG
T ss_pred             CCCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh
Confidence            77763 33 56777777777777777764 2 3466677777777777777654  456677777777777777776544


Q ss_pred             cccCCccccchhhhccCccCCCCccccccccccceEecccccccCCCCc
Q 039137          271 QEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISE  319 (912)
Q Consensus       271 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~  319 (912)
                        +..+++|+.|+|++|++++.  ..+..+++|+.|+|++|.+++.+..
T Consensus       171 --l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p~~  215 (605)
T 1m9s_A          171 --LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPIN  215 (605)
T ss_dssp             --GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECCCCC
T ss_pred             --hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCCccc
Confidence              66667777777777777643  3466666777777777766654333

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.81  E-value=7.9e-20  Score=195.84  Aligned_cols=191  Identities=25%  Similarity=0.271  Sum_probs=102.5

Q ss_pred             ccccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCcccccccCCCCCCCCEEe
Q 039137          276 LKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLD  355 (912)
Q Consensus       276 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  355 (912)
                      +.++..+.+..+.+++..  .+..+++|+.|++++|.++..  ..+..+++|+.|+|++|++++..+  +..+++|+.|+
T Consensus        23 l~~~~~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~~--~~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~   96 (291)
T 1h6t_A           23 FAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLF   96 (291)
T ss_dssp             HHHHHHHHTTCSCTTSEE--CHHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred             HHHHHHHHhcCCCccccc--chhhcCcccEEEccCCCcccC--hhHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEE
Confidence            344555666666665432  345667777777777777654  235666777777777777665443  56666666666


Q ss_pred             ccCCcccccccccccccccccEEEccCccccCCCCccccccccccEEEccCCcccCCCccccccccccccccccCcccCc
Q 039137          356 VSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSN  435 (912)
Q Consensus       356 Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  435 (912)
                      +++|++++ ++ .+..+++|++|+|++|++++.  ..+..+++|+.|++++|++++.  ..+..+++|++|++++|++++
T Consensus        97 l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~  170 (291)
T 1h6t_A           97 LDENKVKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISD  170 (291)
T ss_dssp             CCSSCCCC-GG-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCC
T ss_pred             CCCCcCCC-Ch-hhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCcccc
Confidence            66666653 22 255555566666666655532  2344555555555555555532  334444555555555555544


Q ss_pred             cccccccccccccEEEecccccccccchhhhcccccceeeccccccC
Q 039137          436 FVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLG  482 (912)
Q Consensus       436 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  482 (912)
                      ..+  +..+++|++|+|++|++++. + .+..+++|+.|++++|+++
T Consensus       171 ~~~--l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~  213 (291)
T 1h6t_A          171 IVP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECL  213 (291)
T ss_dssp             CGG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEE
T ss_pred             chh--hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCccc
Confidence            333  44444555555555544432 2 2444444444444444443

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.81  E-value=3.2e-20  Score=205.68  Aligned_cols=157  Identities=26%  Similarity=0.234  Sum_probs=85.9

Q ss_pred             ccEEEccCccccCCCCcccc-ccccccEEEccCCcccCCCccccccccccccccccCcccCccccccccccccccEEEec
Q 039137          375 LQYLDLSSNYIVGEIPTQLG-NIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLS  453 (912)
Q Consensus       375 L~~L~L~~N~l~~~~~~~l~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  453 (912)
                      ++.|+|++|+|++..+..+. ++++|+.|+|++|+|++..+..|..+++|++|+|++|+|+++.+..|..+++|++|+|+
T Consensus        41 l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  120 (361)
T 2xot_A           41 TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLY  120 (361)
T ss_dssp             CSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECC
Confidence            44555555555544444444 45555555555555554444555555555555555555555555555555555555555


Q ss_pred             ccccccccchhhhcccccceeeccccccCccccccc---ccccccccccccCccccCCCccccccccc--ceEEEccCCc
Q 039137          454 HNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRI---CRMESLEKLNLSYNNLSGLIPRCFEEMHG--LLHIDISYNK  528 (912)
Q Consensus       454 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~---~~l~~L~~L~ls~N~l~~~~p~~~~~l~~--L~~l~ls~N~  528 (912)
                      +|+|++..|..|.++++|++|+|++|+|++..+..|   ..+++|+.|+|++|+|+++.+..|..++.  ++.|++++|+
T Consensus       121 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~  200 (361)
T 2xot_A          121 NNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNP  200 (361)
T ss_dssp             SSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSC
T ss_pred             CCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCC
Confidence            555555555555555555555555555555444444   34556666666666666555555555554  2556666666


Q ss_pred             ccc
Q 039137          529 LEG  531 (912)
Q Consensus       529 l~~  531 (912)
                      |.|
T Consensus       201 ~~C  203 (361)
T 2xot_A          201 LEC  203 (361)
T ss_dssp             EEC
T ss_pred             ccC
Confidence            655

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.81  E-value=1.4e-19  Score=186.74  Aligned_cols=158  Identities=24%  Similarity=0.234  Sum_probs=89.1

Q ss_pred             CCCCCccceeEecCCCCeEEEeeccccccccccccccCCCCCccEEEccCCcccccCCccccCCCCCcEEeccccccccc
Q 039137           69 KISPCAWSGIFCNHAERVVGINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQ  148 (912)
Q Consensus        69 ~~~~C~w~gv~c~~~~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~  148 (912)
                      +...|+|.+|.|+..+ +..           ++.   .-.++|++|+|++|++++..|..|..+++|++|+|++|+|++.
T Consensus        15 ~~~~Cs~~~v~c~~~~-l~~-----------ip~---~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i   79 (229)
T 3e6j_A           15 SQCSCSGTTVDCRSKR-HAS-----------VPA---GIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGAL   79 (229)
T ss_dssp             TTCEEETTEEECTTSC-CSS-----------CCS---CCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred             CCCEEeCCEeEccCCC-cCc-----------cCC---CCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCc
Confidence            4578999999997421 111           110   1125666777777777666666666666677777776666543


Q ss_pred             cccccccccccceeecccccccCCCCccccCcccccEEEccCCcCCCCCCccCCCCccceeeeeccCCCcCccccccccc
Q 039137          149 IPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNL  228 (912)
Q Consensus       149 ~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l  228 (912)
                      .+..|..+++|++|+|++|++++..+..|..+++|++|+|++|+++ .+|..+.++++|++|+|++|++++..+..+..+
T Consensus        80 ~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  158 (229)
T 3e6j_A           80 PVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRL  158 (229)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTC
T ss_pred             ChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCC
Confidence            3444566666666666666666444444555566666666555555 445555555555555555555544333344444


Q ss_pred             cccceeeccccccc
Q 039137          229 KSLFDLELCINQLS  242 (912)
Q Consensus       229 ~~L~~L~l~~n~l~  242 (912)
                      ++|+.|++++|.+.
T Consensus       159 ~~L~~L~l~~N~~~  172 (229)
T 3e6j_A          159 SSLTHAYLFGNPWD  172 (229)
T ss_dssp             TTCCEEECTTSCBC
T ss_pred             CCCCEEEeeCCCcc
Confidence            44444444444443

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.81  E-value=1.8e-20  Score=220.08  Aligned_cols=193  Identities=23%  Similarity=0.333  Sum_probs=128.5

Q ss_pred             CCCCcEEeccccccccccccccccccccceeecccccccCCCCccccCcccccEEEccCCcCCCCCCccCCCCccceeee
Q 039137          132 LSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILY  211 (912)
Q Consensus       132 l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~  211 (912)
                      +..+..++|+.+.+...++  +..|++|+.|++++|.+. .+| .++.+++|+.|+|++|++++..|  +.++++|++|+
T Consensus        20 l~~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~   93 (605)
T 1m9s_A           20 FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLF   93 (605)
T ss_dssp             HHHHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCC-CCT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEE
T ss_pred             HHHHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCC-CCh-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEE
Confidence            3446667777777764433  567888888888888887 444 57788888888888888875444  77777888888


Q ss_pred             eccCCCcCccccccccccccceeecccccccCccccccccccccceeeeccccCcccCCcccCCccccchhhhccCccCC
Q 039137          212 LYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRG  291 (912)
Q Consensus       212 L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~  291 (912)
                      |++|.+.+ +| .+..+++|+.|+|++|++++.  ..+..+++|+.|+|++|++++.  ..+..+++|+.|+|++|++++
T Consensus        94 Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~  167 (605)
T 1m9s_A           94 LDENKIKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISD  167 (605)
T ss_dssp             CCSSCCCC-CT-TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCC
T ss_pred             CcCCCCCC-Ch-hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCC
Confidence            88887764 33 567777777777777777642  3466677777777777777654  456666666666666666665


Q ss_pred             CCccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCccc
Q 039137          292 TVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGE  340 (912)
Q Consensus       292 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  340 (912)
                      ..|  +..+++|+.|+|++|.|++.  ..+..+++|+.|+|++|++.+.
T Consensus       168 ~~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~  212 (605)
T 1m9s_A          168 IVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNK  212 (605)
T ss_dssp             CGG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECC
T ss_pred             chh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCC
Confidence            444  56666666666666666543  2355556666666666655443

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.81  E-value=7.6e-20  Score=187.27  Aligned_cols=156  Identities=19%  Similarity=0.249  Sum_probs=121.4

Q ss_pred             cEEEccCccccCCCCccccccccccEEEccCCcccCCCc-cccccccccccccccCcccCccccccccccccccEEEecc
Q 039137          376 QYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIP-RELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSH  454 (912)
Q Consensus       376 ~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  454 (912)
                      +.+++++|.++ .+|..+.  ..++.|+|++|++++..| ..|..+++|++|+|++|+|+++.+..|..+++|++|+|++
T Consensus        14 ~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~   90 (220)
T 2v70_A           14 TTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS   90 (220)
T ss_dssp             TEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence            46677777776 3555443  245677777777776544 4577788888888888888887777888888888888888


Q ss_pred             cccccccchhhhcccccceeeccccccCcccccccccccccccccccCccccCCCcccccccccceEEEccCCccccCCC
Q 039137          455 NKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIP  534 (912)
Q Consensus       455 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~~  534 (912)
                      |+|++..+..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..|..|..+++|+.|++++|+|.|..+
T Consensus        91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~  170 (220)
T 2v70_A           91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY  170 (220)
T ss_dssp             SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred             CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence            88887777778888888888888888888888888888888888888888888888888888888888888888887543

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.81  E-value=7.4e-20  Score=187.36  Aligned_cols=153  Identities=22%  Similarity=0.292  Sum_probs=115.7

Q ss_pred             cEEEccCccccCCCCccccccccccEEEccCCcccCCCccccccccccccccccCcccCccccccccccccccEEEeccc
Q 039137          376 QYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHN  455 (912)
Q Consensus       376 ~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  455 (912)
                      +.+++++|.++ .+|..+.  ++|+.|++++|++++..+..|..+++|++|+|++|+|+++.|..|..+++|++|+|++|
T Consensus        14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N   90 (220)
T 2v9t_B           14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN   90 (220)
T ss_dssp             TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence            45666666666 4454443  46777777777777666667777777777777777777777777777888888888888


Q ss_pred             ccccccchhhhcccccceeeccccccCcccccccccccccccccccCccccCCCcccccccccceEEEccCCcccc
Q 039137          456 KLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEG  531 (912)
Q Consensus       456 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~  531 (912)
                      +|+...+..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|++++|+|.|
T Consensus        91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c  166 (220)
T 2v9t_B           91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC  166 (220)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred             cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence            8876666667778888888888888877777778888888888888888888777778888888888888888876

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.80  E-value=7.5e-20  Score=196.01  Aligned_cols=192  Identities=24%  Similarity=0.304  Sum_probs=116.5

Q ss_pred             cccceeecccccccCccccccccccccceeeeccccCcccCCcccCCccccchhhhccCccCCCCccccccccccceEec
Q 039137          229 KSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRL  308 (912)
Q Consensus       229 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  308 (912)
                      ..+..+.+..+.+++..  .+..+++|+.|++++|.++..  ..+..+++|++|+|++|+++                  
T Consensus        24 ~~~~~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~~--~~~~~l~~L~~L~L~~n~l~------------------   81 (291)
T 1h6t_A           24 AETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLT------------------   81 (291)
T ss_dssp             HHHHHHHTTCSCTTSEE--CHHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCC------------------
T ss_pred             HHHHHHHhcCCCccccc--chhhcCcccEEEccCCCcccC--hhHhcCCCCCEEEccCCccC------------------
Confidence            33444445555544322  233455555666655555532  12444455555555555554                  


Q ss_pred             ccccccCCCCcccCCCCCccEEEccCCcCcccccccCCCCCCCCEEeccCCcccccccccccccccccEEEccCccccCC
Q 039137          309 NQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGE  388 (912)
Q Consensus       309 ~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~  388 (912)
                            +..+  +..+++|+.|+|++|.+.+.  ..+..+++|+.|++++|++++.  ..+..+++|++|++++|++++.
T Consensus        82 ------~~~~--l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~  149 (291)
T 1h6t_A           82 ------DIKP--LANLKNLGWLFLDENKVKDL--SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI  149 (291)
T ss_dssp             ------CCGG--GTTCTTCCEEECCSSCCCCG--GGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC
T ss_pred             ------CCcc--cccCCCCCEEECCCCcCCCC--hhhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc
Confidence                  3332  44455555555555555431  2255556666666666666542  3456667777777777777654


Q ss_pred             CCccccccccccEEEccCCcccCCCccccccccccccccccCcccCccccccccccccccEEEecccccccc
Q 039137          389 IPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQ  460 (912)
Q Consensus       389 ~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  460 (912)
                        ..+..+++|+.|++++|++++..|  +..+++|++|+|++|.++++ + .+..+++|+.|++++|+++..
T Consensus       150 --~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~~  215 (291)
T 1h6t_A          150 --TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLNK  215 (291)
T ss_dssp             --GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEECC
T ss_pred             --hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCcccCC
Confidence              567777788888888888876544  77788888888888888774 3 478888888888888888753

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.79  E-value=2.5e-21  Score=225.94  Aligned_cols=201  Identities=22%  Similarity=0.252  Sum_probs=101.7

Q ss_pred             ccccccceeecccccccCccccccccccccceeeeccccCcccCCcccCCccccchhhhccCccCCCCccccccccccce
Q 039137          226 GNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVK  305 (912)
Q Consensus       226 ~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  305 (912)
                      ..+++|+.|+|+.|+++ .+|..++++++|+.|++++|...          ..+..+ +..+.+.+.+|..+..+++|+.
T Consensus       346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l----------~~l~~l-l~~~~~~~~~~~~l~~l~~L~~  413 (567)
T 1dce_A          346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCL----------LTIILL-MRALDPLLYEKETLQYFSTLKA  413 (567)
T ss_dssp             STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHH----------HHHHHH-HHHHCTGGGHHHHHHHHHHHHH
T ss_pred             ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhh----------hhHHHH-HHhcccccCCHHHHHHHHhccc
Confidence            45667777777777776 66777777777777777555321          011111 1122244566667777777777


Q ss_pred             Ee-cccccccCCCCcccCCCCCccEEEccCCcCcccccccCCCCCCCCEEeccCCcccccccccccccccccEEEccCcc
Q 039137          306 LR-LNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNY  384 (912)
Q Consensus       306 L~-L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~  384 (912)
                      |+ ++.|.+.           +|+.+.+++|.+....+.      .|+.|++++|+|++                     
T Consensus       414 L~~l~~n~~~-----------~L~~l~l~~n~i~~l~~~------~L~~L~Ls~n~l~~---------------------  455 (567)
T 1dce_A          414 VDPMRAAYLD-----------DLRSKFLLENSVLKMEYA------DVRVLHLAHKDLTV---------------------  455 (567)
T ss_dssp             HCGGGHHHHH-----------HHHHHHHHHHHHHHHHHT------TCSEEECTTSCCSS---------------------
T ss_pred             Ccchhhcccc-----------hhhhhhhhcccccccCcc------CceEEEecCCCCCC---------------------
Confidence            77 5655443           344455555554332221      24444444444442                     


Q ss_pred             ccCCCCccccccccccEEEccCCcccCCCccccccccccccccccCcccCccccccccccccccEEEeccccccccc-ch
Q 039137          385 IVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQI-PI  463 (912)
Q Consensus       385 l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-~~  463 (912)
                          +|. ++.+++|+.|+|++|+|+ .+|..++.+++|+.|+|++|+|++ +| .|..+++|+.|+|++|+|++.. |.
T Consensus       456 ----lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~  527 (567)
T 1dce_A          456 ----LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQ  527 (567)
T ss_dssp             ----CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTG
T ss_pred             ----CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcH
Confidence                232 444444444444444444 344444444445555555555444 23 4444555555555555554443 44


Q ss_pred             hhhcccccceeeccccccCcc
Q 039137          464 ELDNLIHLSELDLSHNFLGEK  484 (912)
Q Consensus       464 ~~~~l~~L~~L~Ls~N~l~~~  484 (912)
                      .+..+++|+.|+|++|+|++.
T Consensus       528 ~l~~l~~L~~L~L~~N~l~~~  548 (567)
T 1dce_A          528 PLVSCPRLVLLNLQGNSLCQE  548 (567)
T ss_dssp             GGGGCTTCCEEECTTSGGGGS
T ss_pred             HHhcCCCCCEEEecCCcCCCC
Confidence            555555555555555555443

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.79  E-value=4.2e-19  Score=183.07  Aligned_cols=156  Identities=27%  Similarity=0.329  Sum_probs=111.9

Q ss_pred             ccEEEccCccccCCCCccccccccccEEEccCCcccCCCccccccccccccccccCcccCccccccccccccccEEEecc
Q 039137          375 LQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSH  454 (912)
Q Consensus       375 L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  454 (912)
                      .+.++.++++++ .+|..+.  ++|++|+|++|++++..|..|..+++|++|+|++|+|+.+.+..|..+++|++|+|++
T Consensus        21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~   97 (229)
T 3e6j_A           21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT   97 (229)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence            455666666665 4454433  5677777777777766677777777777777777777766666677777777777777


Q ss_pred             cccccccchhhhcccccceeeccccccCcccccccccccccccccccCccccCCCcccccccccceEEEccCCccccCCC
Q 039137          455 NKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIP  534 (912)
Q Consensus       455 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~~  534 (912)
                      |+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+..|..+++|+.|++++|++.|..+
T Consensus        98 N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  176 (229)
T 3e6j_A           98 NQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR  176 (229)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred             CcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence            7777666666777777777777777776 456667777777777777777777766777777888888888888777544

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.78  E-value=5.3e-21  Score=223.24  Aligned_cols=202  Identities=18%  Similarity=0.137  Sum_probs=132.3

Q ss_pred             CCCccceeeeeccCCCcCccccccccccccceeecccccccCccccccccccccceeeeccccCcccCCcccCCccccch
Q 039137          202 GNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNS  281 (912)
Q Consensus       202 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~  281 (912)
                      ..+++|+.|+|++|+++ .+|..++++++|+.|++++|......|.           .+..+.+.+.+|..++++++|+.
T Consensus       346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~-----------ll~~~~~~~~~~~~l~~l~~L~~  413 (567)
T 1dce_A          346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIIL-----------LMRALDPLLYEKETLQYFSTLKA  413 (567)
T ss_dssp             STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHH-----------HHHHHCTGGGHHHHHHHHHHHHH
T ss_pred             ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHH-----------HHHhcccccCCHHHHHHHHhccc
Confidence            67889999999999997 8999999999999999977652111111           01122334456666777777777


Q ss_pred             hh-hccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCcccccccCCCCCCCCEEeccCCc
Q 039137          282 LL-LAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINN  360 (912)
Q Consensus       282 L~-L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  360 (912)
                      |+ ++.|.+           .+|..+.+++|.++...+.      .|+.|+|++|.+++ +|. ++.+++|+.|+|++|+
T Consensus       414 L~~l~~n~~-----------~~L~~l~l~~n~i~~l~~~------~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~  474 (567)
T 1dce_A          414 VDPMRAAYL-----------DDLRSKFLLENSVLKMEYA------DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNR  474 (567)
T ss_dssp             HCGGGHHHH-----------HHHHHHHHHHHHHHHHHHT------TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSC
T ss_pred             Ccchhhccc-----------chhhhhhhhcccccccCcc------CceEEEecCCCCCC-CcC-ccccccCcEeecCccc
Confidence            77 555543           3455566666666643322      36777777777765 343 6677777777777777


Q ss_pred             ccccccccccccccccEEEccCccccCCCCccccccccccEEEccCCcccCCC-ccccccccccccccccCcccCccc
Q 039137          361 ISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCI-PRELGSLINLEYLDLSANNLSNFV  437 (912)
Q Consensus       361 l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~  437 (912)
                      |+ .+|..++.+++|++|+|++|+|++ +| .++++++|+.|+|++|++++.. |..+..+++|+.|+|++|.+++.+
T Consensus       475 l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~  549 (567)
T 1dce_A          475 LR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEE  549 (567)
T ss_dssp             CC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSS
T ss_pred             cc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCc
Confidence            76 556666666677777777776664 44 5666666666666666666554 566666666666666666665543

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.78  E-value=1.9e-19  Score=199.35  Aligned_cols=108  Identities=24%  Similarity=0.206  Sum_probs=48.2

Q ss_pred             ccEEEccCCcccccCCcccc-CCCCCcEEeccccccccccccccccccccceeecccccccCCCCccccCcccccEEEcc
Q 039137          111 LVYLDLYNNELFGIIPPQIS-NLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALD  189 (912)
Q Consensus       111 L~~L~L~~n~l~~~~p~~~~-~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~  189 (912)
                      ++.|+|++|+|++..+..|. ++++|++|+|++|+|++..|..|..+++|++|+|++|++++..+..|..+++|++|+|+
T Consensus        41 l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  120 (361)
T 2xot_A           41 TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLY  120 (361)
T ss_dssp             CSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECC
Confidence            44445555544444444443 44444444444444443333444444444444444444443333334444444444444


Q ss_pred             CCcCCCCCCccCCCCccceeeeeccCCCc
Q 039137          190 SNFLNGSIPRSLGNLTHVVILYLYNNSFF  218 (912)
Q Consensus       190 ~n~l~~~~p~~~~~l~~L~~L~L~~n~l~  218 (912)
                      +|+|++..|..|.++++|++|+|++|.++
T Consensus       121 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~  149 (361)
T 2xot_A          121 NNHIVVVDRNAFEDMAQLQKLYLSQNQIS  149 (361)
T ss_dssp             SSCCCEECTTTTTTCTTCCEEECCSSCCC
T ss_pred             CCcccEECHHHhCCcccCCEEECCCCcCC
Confidence            44444333344444444444444444443

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.78  E-value=5.9e-19  Score=180.65  Aligned_cols=131  Identities=21%  Similarity=0.159  Sum_probs=61.1

Q ss_pred             cEEeccccccccccc-cccccccccceeecccccccCCCCccccCcccccEEEccCCcCCCCCCccCCCCccceeeeecc
Q 039137          136 EYLDFSANKLFGQIP-SGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYN  214 (912)
Q Consensus       136 ~~L~Ls~n~l~~~~p-~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~  214 (912)
                      ++|+|++|++++..| ..|+.+++|++|+|++|++++..|..|+.+++|++|+|++|++++..|..|.++++|++|+|++
T Consensus        35 ~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  114 (220)
T 2v70_A           35 AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRS  114 (220)
T ss_dssp             SEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTT
T ss_pred             CEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCC
Confidence            444444444443322 2244444444444444444433333444444444444444444444444444444444444444


Q ss_pred             CCCcCccccccccccccceeecccccccCccccccccccccceeeeccccCc
Q 039137          215 NSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELS  266 (912)
Q Consensus       215 n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~  266 (912)
                      |++++..|..|.++++|+.|+|++|++++..|..|..+++|++|+|++|.+.
T Consensus       115 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  166 (220)
T 2v70_A          115 NRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFN  166 (220)
T ss_dssp             SCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEE
T ss_pred             CcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCc
Confidence            4444444444444444444444444444444444444555555555555444

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.78  E-value=6.3e-19  Score=180.41  Aligned_cols=134  Identities=21%  Similarity=0.234  Sum_probs=82.6

Q ss_pred             CCccEEEccCCcccccCCccccCCCCCcEEeccccccccccccccccccccceeecccccccCCCCccccCcccccEEEc
Q 039137          109 PHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLAL  188 (912)
Q Consensus       109 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l  188 (912)
                      ++|+.|+|++|+|++..+..|..+++|++|+|++|++++..|..|.++++|++|+|++|.+++..+..|..+++|++|+|
T Consensus        32 ~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L  111 (220)
T 2v9t_B           32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLL  111 (220)
T ss_dssp             TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEEC
Confidence            45677777777777655556777777777777777776666666666777777777777666433344556666666666


Q ss_pred             cCCcCCCCCCccCCCCccceeeeeccCCCcCccccccccccccceeeccccccc
Q 039137          189 DSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLS  242 (912)
Q Consensus       189 ~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~  242 (912)
                      ++|++++..|..|.++++|++|+|++|.+++..+..|..+++|+.|++++|.+.
T Consensus       112 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~  165 (220)
T 2v9t_B          112 NANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI  165 (220)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred             CCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence            666666555555655666666666655555544444555555555555555443

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.77  E-value=1.3e-18  Score=183.26  Aligned_cols=171  Identities=24%  Similarity=0.240  Sum_probs=121.4

Q ss_pred             CccccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCcccccccCCCCCCCCEE
Q 039137          275 NLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLL  354 (912)
Q Consensus       275 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  354 (912)
                      ++.+++.+++++|.+++..  .+..+++|+.|++++|.++.. + .+..+++|+.|+|++|++++..+  +..+++|+.|
T Consensus        17 ~l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L   90 (263)
T 1xeu_A           17 GLANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQSL-A-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL   90 (263)
T ss_dssp             HHHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred             HHHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcccc-h-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence            4566777777777777432  567777888888888877753 2 56777778888888887776554  7777777777


Q ss_pred             eccCCcccccccccccccccccEEEccCccccCCCCccccccccccEEEccCCcccCCCccccccccccccccccCcccC
Q 039137          355 DVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLS  434 (912)
Q Consensus       355 ~Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  434 (912)
                      ++++|++++. |... . ++|++|+|++|++++.  ..+..+++|+.|++++|++++. + .+..+++|++|+|++|+++
T Consensus        91 ~L~~N~l~~l-~~~~-~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~  163 (263)
T 1xeu_A           91 SVNRNRLKNL-NGIP-S-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEIT  163 (263)
T ss_dssp             ECCSSCCSCC-TTCC-C-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCC
T ss_pred             ECCCCccCCc-Cccc-c-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCc
Confidence            7777777743 3222 2 6788888888877753  3477777788888888877754 3 5777777888888888777


Q ss_pred             ccccccccccccccEEEecccccccc
Q 039137          435 NFVPESLGSLVKLYYLNLSHNKLSQQ  460 (912)
Q Consensus       435 ~~~~~~~~~l~~L~~L~Ls~N~l~~~  460 (912)
                      +.  ..+..+++|+.|++++|++++.
T Consensus       164 ~~--~~l~~l~~L~~L~l~~N~~~~~  187 (263)
T 1xeu_A          164 NT--GGLTRLKKVNWIDLTGQKCVNE  187 (263)
T ss_dssp             BC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred             ch--HHhccCCCCCEEeCCCCcccCC
Confidence            65  5677777778888888777654

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.76  E-value=1.6e-19  Score=217.46  Aligned_cols=224  Identities=19%  Similarity=0.219  Sum_probs=119.3

Q ss_pred             CCccEEEccCCcccccCCccccCCCCCcEEeccccccccccccccccccccceeecccccccCCCCccccCcccccEEEc
Q 039137          109 PHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLAL  188 (912)
Q Consensus       109 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l  188 (912)
                      ++++.|+|++|.+.. +|.     ..|+.++|+.|.|.+              ++++.|.+. ..|..+..++.|+.|+|
T Consensus       173 ~~~~~l~L~~n~~~~-~~~-----~~l~~l~Ls~~~i~~--------------~~~~~n~~~-~~~~~~~~l~~L~~L~L  231 (727)
T 4b8c_D          173 PLTPKIELFANGKDE-ANQ-----ALLQHKKLSQYSIDE--------------DDDIENRMV-MPKDSKYDDQLWHALDL  231 (727)
T ss_dssp             ----------------------------------------------------------------------CCCCCCEEEC
T ss_pred             CccceEEeeCCCCCc-chh-----hHhhcCccCcccccC--------------cccccccee-cChhhhccCCCCcEEEC
Confidence            567788888888775 232     235566666666542              244455555 56777778888888888


Q ss_pred             cCCcCCCCCCccCCCCccceeeeeccCCCcCccccccccccccceeecccccccCccccccccccccceeeeccccCccc
Q 039137          189 DSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGI  268 (912)
Q Consensus       189 ~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  268 (912)
                      ++|.+. .+|..+.++++|++|+|++|.++ .+|..|++|++|+.|+|++|+|+ .+|..|++|++|++|+|++|.|+ .
T Consensus       232 s~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~  307 (727)
T 4b8c_D          232 SNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-T  307 (727)
T ss_dssp             TTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-C
T ss_pred             CCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-c
Confidence            888877 67777778888888888888888 78888888999999999999988 77888999999999999999998 5


Q ss_pred             CCcccCCccccchhhhccCccCCCCccccccccc-cceEecccccccCCCCcccCCCCCccEEEccCC--------cCcc
Q 039137          269 IPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTD-LVKLRLNQNYLTGNISETFGTYPNLTFIDLSNN--------SFFG  339 (912)
Q Consensus       269 ~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N--------~l~~  339 (912)
                      +|..|+++++|++|+|++|.+++.+|..+..+.. +..|+|++|.+++.+|..      |+.|+++.|        .+.+
T Consensus       308 lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~l~~n~~~~~~~~~l~~  381 (727)
T 4b8c_D          308 LPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE------RRFIEINTDGEPQREYDSLQQ  381 (727)
T ss_dssp             CCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC---------------------------
T ss_pred             cChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc------cceeEeecccccccccCCccc
Confidence            6878999999999999999999998888876532 345889999999887764      556677776        3444


Q ss_pred             cccccCCCCCCCCEEeccCCcccc
Q 039137          340 EILSDWGRCPQLSLLDVSINNISG  363 (912)
Q Consensus       340 ~~~~~~~~l~~L~~L~Ls~N~l~~  363 (912)
                      ..+..+..+..+....+++|-+.+
T Consensus       382 ~~~~~~~~l~~~~~~~ls~Nil~~  405 (727)
T 4b8c_D          382 STEHLATDLAKRTFTVLSYNTLCQ  405 (727)
T ss_dssp             --------------------CCCG
T ss_pred             cccchhhcccccceeeeecccccc
Confidence            444445566677777888887753

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.75  E-value=6.1e-19  Score=192.78  Aligned_cols=217  Identities=14%  Similarity=0.082  Sum_probs=141.6

Q ss_pred             ccccceEecccccccCCCCcccCCCCCccEEEccCCcCcccccccCCCCCCCCEEeccCCcc----cccccccccccccc
Q 039137          300 LTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNI----SGSIPLEIGESLQL  375 (912)
Q Consensus       300 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l----~~~~~~~~~~~~~L  375 (912)
                      +++|+.|+|.+ .++.+...+|.++++|+.|++++|.+....+.+|..+.++..+.+..+..    .......|.++..|
T Consensus       100 ~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L  178 (329)
T 3sb4_A          100 KQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPL  178 (329)
T ss_dssp             CTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCC
T ss_pred             cCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccccccccccc
Confidence            66666666666 66656666666666677777766666666666666666666555554322    11223334444445


Q ss_pred             c-EEEccCccccCCCCccc----cccccccEEEccCCcccCCCcccc-ccccccccccccCcccCccccccccccccccE
Q 039137          376 Q-YLDLSSNYIVGEIPTQL----GNIIYLNRLSLSGNKLSGCIPREL-GSLINLEYLDLSANNLSNFVPESLGSLVKLYY  449 (912)
Q Consensus       376 ~-~L~L~~N~l~~~~~~~l----~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  449 (912)
                      + .+.+....   .++..+    ....++..+.+.++-.. .....+ ..+++|+.|+|++|+++.+.+..|.++++|+.
T Consensus       179 ~~~i~~~~~~---~l~~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~  254 (329)
T 3sb4_A          179 ETTIQVGAMG---KLEDEIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLK  254 (329)
T ss_dssp             EEEEEECTTC---CHHHHHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCE
T ss_pred             ceeEEecCCC---cHHHHHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCE
Confidence            4 34333221   111111    12345556666554222 111112 23678888888888888877788888888888


Q ss_pred             EEecccccccccchhhhcccccc-eeeccccccCcccccccccccccccccccCccccCCCcccccccccceEEE
Q 039137          450 LNLSHNKLSQQIPIELDNLIHLS-ELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHID  523 (912)
Q Consensus       450 L~Ls~N~l~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~  523 (912)
                      |+|++| ++.+.+.+|.++.+|+ .|++.+ .++.+.+.+|.++++|+.|++++|+++.+.+.+|.++++|+.++
T Consensus       255 l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly  327 (329)
T 3sb4_A          255 IKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIY  327 (329)
T ss_dssp             EECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred             EECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhc
Confidence            888887 7767777888888888 888887 77777778888888888888888888888888888888888876

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.75  E-value=1.3e-18  Score=174.84  Aligned_cols=153  Identities=19%  Similarity=0.221  Sum_probs=76.0

Q ss_pred             CCCCCccEEEccCCcccccCCccccCCCCCcEEeccccccccccccccccccccceeecccccccCCCCccccCcccccE
Q 039137          106 SSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQ  185 (912)
Q Consensus       106 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~  185 (912)
                      +.+++|++|++++|+++ .+| .+..+++|++|++++|.++  .+..+..+++|++|++++|.+++..|..++.+++|++
T Consensus        41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~  116 (197)
T 4ezg_A           41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL  116 (197)
T ss_dssp             HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred             hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence            34455556666666555 334 4555556666666655443  2234555555555555555555545555555555555


Q ss_pred             EEccCCcCCCCCCccCCCCccceeeeeccCCCcCccccccccccccceeecccccccCccccccccccccceeeeccccC
Q 039137          186 LALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNEL  265 (912)
Q Consensus       186 L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l  265 (912)
                      |++++|++++..|..++++++|++|++++|.+.+.+| .+..+++|+.|++++|++++ ++ .+..+++|++|++++|++
T Consensus       117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~i  193 (197)
T 4ezg_A          117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQTI  193 (197)
T ss_dssp             EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC--
T ss_pred             EEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCccc
Confidence            5555555554445555555555555555554222233 34444444444444444442 12 344444444444444444

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.74  E-value=1.7e-18  Score=182.34  Aligned_cols=149  Identities=21%  Similarity=0.276  Sum_probs=68.3

Q ss_pred             cccccccceeeeccccCcccCCcccCCccccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCcc
Q 039137          249 ISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLT  328 (912)
Q Consensus       249 ~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  328 (912)
                      +..+++|++|++++|+++. ++ .+..+++|++|+|++|++++..+  +..+++|++|+|++|++++..+.  .. ++|+
T Consensus        37 ~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~l~~~--~~-~~L~  109 (263)
T 1xeu_A           37 QKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKNLNGI--PS-ACLS  109 (263)
T ss_dssp             HHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSCCTTC--CC-SSCC
T ss_pred             hhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCCcCcc--cc-Cccc
Confidence            3444444444444444442 22 34444444444444444443322  44444555555555554432211  11 4455


Q ss_pred             EEEccCCcCcccccccCCCCCCCCEEeccCCcccccccccccccccccEEEccCccccCCCCccccccccccEEEccCCc
Q 039137          329 FIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNK  408 (912)
Q Consensus       329 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~  408 (912)
                      .|+|++|++++.  ..+..+++|+.|++++|++++. + .+..+++|++|+|++|++++.  ..+..+++|+.|++++|+
T Consensus       110 ~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~  183 (263)
T 1xeu_A          110 RLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQK  183 (263)
T ss_dssp             EEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEE
T ss_pred             EEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCc
Confidence            555555555432  2344455555555555555432 2 344455555555555555433  334445555555555555


Q ss_pred             cc
Q 039137          409 LS  410 (912)
Q Consensus       409 l~  410 (912)
                      ++
T Consensus       184 ~~  185 (263)
T 1xeu_A          184 CV  185 (263)
T ss_dssp             EE
T ss_pred             cc
Confidence            54

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.74  E-value=5.6e-18  Score=177.91  Aligned_cols=141  Identities=18%  Similarity=0.173  Sum_probs=109.6

Q ss_pred             CCCCCceeeecCceEEEEEEe-CCCCE--EEEEEccCCCCCC--------------------chHHHHHHHHHHHHHhhc
Q 039137          639 DFNAEHCIGKGGHGSVYRAKV-PSGEI--FAVKKFHSPLPGE--------------------MSFQQEEFLNEIQALTEI  695 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~~--------------------~~~~~~~~~~Ei~~l~~l  695 (912)
                      -|++.+.||+|+||.||+|.+ .+|+.  ||||+++......                    .......+.+|+..++.+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            467889999999999999988 68988  9999875432110                    011234678999999999


Q ss_pred             CCCcc--ccEEEEEEcCCeeeEEEeecCC-C----ChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHH-hCCCCCeee
Q 039137          696 RHRNI--VKFYGFCSHPKHSFIIYEYLES-G----SLDKILCNDASAKELGWTQRLNVIKGVADALFYLH-NNCFPPIVH  767 (912)
Q Consensus       696 ~h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH-~~~~~~ivH  767 (912)
                      +|+++  +.++++    +..++||||+.+ |    +|.++...      .++.++..++.|++.|++||| ++   +|+|
T Consensus       128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~---givH  194 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEA---ELVH  194 (258)
T ss_dssp             HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred             HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence            88754  444443    367899999942 4    66665421      235678899999999999999 88   9999


Q ss_pred             cCCCCCCeEEcCCCcEEEecccccccc
Q 039137          768 RDISSKNVLLDLGYEAHVSDFGIAKFL  794 (912)
Q Consensus       768 ~Dlk~~Nill~~~~~~kl~Dfgla~~~  794 (912)
                      |||||+||+++.  .++|+|||+|...
T Consensus       195 rDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          195 ADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCCHHHEEEcC--cEEEEECcccccC
Confidence            999999999998  9999999999764

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.74  E-value=1e-18  Score=190.94  Aligned_cols=265  Identities=11%  Similarity=0.043  Sum_probs=179.7

Q ss_pred             ccccceeecccccccCccccccccccccceeeeccccCcccCCcccCC--------ccccchhhhccCccCCCCcccccc
Q 039137          228 LKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGN--------LKKLNSLLLAKNHFRGTVPKSFRN  299 (912)
Q Consensus       228 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~--------l~~L~~L~L~~N~l~~~~~~~~~~  299 (912)
                      +++|+.|+|++|++.. ....-+.++.++.+.+..|.   +.+.+|.+        +++|+.|+|.+ .++.+.+.+|.+
T Consensus        48 l~~L~~LdLs~n~i~~-~~~~~~~~~~~~~~~~~~~~---I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~  122 (329)
T 3sb4_A           48 FPSLKVLDISNAEIKM-YSGKAGTYPNGKFYIYMANF---VPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKG  122 (329)
T ss_dssp             CTTCCEEEEEEEEECC-EEESSSSSGGGCCEEECTTE---ECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTT
T ss_pred             hccCeEEecCcceeEE-ecCccccccccccccccccc---cCHHHhcccccccccccCCCcEEECCc-cccchhHHHhhc
Confidence            5566666666666651 11111122234455555553   33355666        78888888877 777666677888


Q ss_pred             ccccceEecccccccCCCCcccCCCCCccEEEccCCc----CcccccccCCCCCCCC-EEeccCCcc-cccccccccccc
Q 039137          300 LTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNS----FFGEILSDWGRCPQLS-LLDVSINNI-SGSIPLEIGESL  373 (912)
Q Consensus       300 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~----l~~~~~~~~~~l~~L~-~L~Ls~N~l-~~~~~~~~~~~~  373 (912)
                      +++|+.|++++|.++...+.+|..+.++..+.+..+.    ........|..+..|+ .+.+....- ...+...-....
T Consensus       123 ~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~~~  202 (329)
T 3sb4_A          123 CDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGLQPR  202 (329)
T ss_dssp             CTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTCCGG
T ss_pred             CcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCCcHHHHHhhcccCcc
Confidence            8888888888888777777788777777777666532    2222334455566666 444443221 111111112345


Q ss_pred             cccEEEccCccccCCCCccc-cccccccEEEccCCcccCCCccccccccccccccccCcccCcccccccccccccc-EEE
Q 039137          374 QLQYLDLSSNYIVGEIPTQL-GNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLY-YLN  451 (912)
Q Consensus       374 ~L~~L~L~~N~l~~~~~~~l-~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~-~L~  451 (912)
                      +++.+.+.++-.. .....+ ..+++|+.|+|++|+++.+.+.+|.++++|+.|+|.+| ++.+.+.+|.++++|+ .++
T Consensus       203 ~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~  280 (329)
T 3sb4_A          203 DINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLE  280 (329)
T ss_dssp             GCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEE
T ss_pred             ccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEE
Confidence            6677777665322 111122 23678999999999998777778999999999999988 8888888999999999 999


Q ss_pred             ecccccccccchhhhcccccceeeccccccCcccccccccccccccccc
Q 039137          452 LSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNL  500 (912)
Q Consensus       452 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l  500 (912)
                      +.+ .++.+.+.+|.++++|+.|++++|+++.+.+..|.++++|+.++.
T Consensus       281 l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~  328 (329)
T 3sb4_A          281 LPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK  328 (329)
T ss_dssp             ECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred             Ecc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence            988 787777889999999999999999998888889999999988864

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.74  E-value=4.3e-18  Score=171.19  Aligned_cols=154  Identities=18%  Similarity=0.304  Sum_probs=104.4

Q ss_pred             cccccccEEEccCccccCCCCccccccccccEEEccCCcccCCCccccccccccccccccCcccCccccccccccccccE
Q 039137          370 GESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYY  449 (912)
Q Consensus       370 ~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  449 (912)
                      +.+++|++|++++|.++ .+| .+..+++|++|++++|.++.  +..+..+++|++|++++|++++..+..+..+++|++
T Consensus        41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~  116 (197)
T 4ezg_A           41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL  116 (197)
T ss_dssp             HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred             hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence            34556666666666666 344 46666667777777775542  235666777777777777777666677777777777


Q ss_pred             EEecccccccccchhhhcccccceeeccccc-cCcccccccccccccccccccCccccCCCcccccccccceEEEccCCc
Q 039137          450 LNLSHNKLSQQIPIELDNLIHLSELDLSHNF-LGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNK  528 (912)
Q Consensus       450 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~ls~N~  528 (912)
                      |+|++|++++..|..+..+++|++|++++|. ++. ++ .+..+++|+.|++++|++++..  .+..+++|+.|++++|+
T Consensus       117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~-~~-~l~~l~~L~~L~l~~n~i~~~~--~l~~l~~L~~L~l~~N~  192 (197)
T 4ezg_A          117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD-IM-PLKTLPELKSLNIQFDGVHDYR--GIEDFPKLNQLYAFSQT  192 (197)
T ss_dssp             EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCC-CG-GGGGCSSCCEEECTTBCCCCCT--TGGGCSSCCEEEECBC-
T ss_pred             EEecCCccCcHhHHHHhhCCCCCEEEccCCCCccc-cH-hhcCCCCCCEEECCCCCCcChH--HhccCCCCCEEEeeCcc
Confidence            7777777776667777777777777777776 543 34 5777777888888888777643  67777888888888887


Q ss_pred             ccc
Q 039137          529 LEG  531 (912)
Q Consensus       529 l~~  531 (912)
                      +.+
T Consensus       193 i~~  195 (197)
T 4ezg_A          193 IGG  195 (197)
T ss_dssp             ---
T ss_pred             cCC
Confidence            653

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.71  E-value=3.9e-17  Score=163.25  Aligned_cols=110  Identities=25%  Similarity=0.311  Sum_probs=56.9

Q ss_pred             cccEEEccCccccCCCCc-cccccccccEEEccCCcccCCCccccccccccccccccCcccCccccccccccccccEEEe
Q 039137          374 QLQYLDLSSNYIVGEIPT-QLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNL  452 (912)
Q Consensus       374 ~L~~L~L~~N~l~~~~~~-~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  452 (912)
                      +|++|+|++|+|++..+. .+..+++|++|+|++|++++..|..|..+++|++|+|++|+|+++.+..|..+++|++|+|
T Consensus        30 ~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  109 (192)
T 1w8a_A           30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL  109 (192)
T ss_dssp             TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred             CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEEC
Confidence            455555555555433332 2445555555555555555444555555555555555555555554444555555555555


Q ss_pred             cccccccccchhhhcccccceeeccccccCc
Q 039137          453 SHNKLSQQIPIELDNLIHLSELDLSHNFLGE  483 (912)
Q Consensus       453 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  483 (912)
                      ++|+|++..|..|..+++|++|+|++|.+++
T Consensus       110 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c  140 (192)
T 1w8a_A          110 YDNQISCVMPGSFEHLNSLTSLNLASNPFNC  140 (192)
T ss_dssp             CSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred             CCCcCCeeCHHHhhcCCCCCEEEeCCCCccC
Confidence            5555555555555555555555555555543

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.70  E-value=2.3e-17  Score=164.94  Aligned_cols=172  Identities=22%  Similarity=0.245  Sum_probs=123.2

Q ss_pred             cEEEccCccccCCCCccccccccccEEEccCCcccCCCcc-ccccccccccccccCcccCccccccccccccccEEEecc
Q 039137          376 QYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPR-ELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSH  454 (912)
Q Consensus       376 ~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  454 (912)
                      +++++++|+++ .+|..+..  +|++|++++|++++..+. .|..+++|++|+|++|+|+++.|..|..+++|++|+|++
T Consensus        11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~   87 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence            67888888886 56665543  788888888888866654 478888888888888888888888888888888888888


Q ss_pred             cccccccchhhhcccccceeeccccccCcccccccccccccccccccCccccCCCccc-ccccccceEEEccCCccccCC
Q 039137          455 NKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRC-FEEMHGLLHIDISYNKLEGQI  533 (912)
Q Consensus       455 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~l~~L~~l~ls~N~l~~~~  533 (912)
                      |+|++..+..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|++++..+-. +.  ..++...+.++...|..
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~--~~l~~~~~~~~~~~C~~  165 (192)
T 1w8a_A           88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFA--EWLRKKSLNGGAARCGA  165 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHH--HHHHHHCCSGGGCBBCS
T ss_pred             CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHH--HHHHHcCCCCCCCCCCC
Confidence            8888877777888888888888888888888888888888888888888888764421 11  11222244555555555


Q ss_pred             CCCccCCCCchhhhccCCccc
Q 039137          534 PNSTTFRDAPLEALQGNKGLY  554 (912)
Q Consensus       534 ~~~~~~~~~~~~~l~~n~~~~  554 (912)
                      |.  .++......+..+.-.|
T Consensus       166 P~--~l~~~~l~~l~~~~~~C  184 (192)
T 1w8a_A          166 PS--KVRDVQIKDLPHSEFKC  184 (192)
T ss_dssp             ST--TTTTSBGGGSCTTTCCC
T ss_pred             Ch--HHcCCChhhCcHhhcCc
Confidence            53  23334444444443334

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.65  E-value=1.8e-16  Score=154.80  Aligned_cols=132  Identities=20%  Similarity=0.182  Sum_probs=54.8

Q ss_pred             CCCcEEeccccccc-cccccccccccccceeecccccccCCCCccccCcccccEEEccCCcCCCCCCccCCCCccceeee
Q 039137          133 SNLEYLDFSANKLF-GQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILY  211 (912)
Q Consensus       133 ~~L~~L~Ls~n~l~-~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~  211 (912)
                      ++|++|+|++|+++ +.+|..+..+++|++|+|++|.+++.  ..++.+++|++|++++|++++.+|..+.++++|++|+
T Consensus        24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  101 (168)
T 2ell_A           24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN  101 (168)
T ss_dssp             TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred             ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence            34444444444443 34444444444444444444444422  3334444444444444444433333333344444444


Q ss_pred             eccCCCcCcc-ccccccccccceeecccccccCccc---cccccccccceeeeccccCc
Q 039137          212 LYNNSFFGSI-PQEIGNLKSLFDLELCINQLSGAIP---LSISNLTNLRFLFLYHNELS  266 (912)
Q Consensus       212 L~~n~l~~~~-p~~~~~l~~L~~L~l~~n~l~~~~p---~~~~~l~~L~~L~L~~N~l~  266 (912)
                      |++|.+++.. +..+..+++|+.|++++|++++..+   ..+..+++|++|++++|.+.
T Consensus       102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~  160 (168)
T 2ell_A          102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ  160 (168)
T ss_dssp             CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred             ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence            4444443211 1333444444444444444442222   23444444444444444444

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.65  E-value=2.4e-16  Score=153.99  Aligned_cols=133  Identities=26%  Similarity=0.289  Sum_probs=84.8

Q ss_pred             ccccEEEccCCccc-CCCccccccccccccccccCcccCccccccccccccccEEEecccccccccchhhhcccccceee
Q 039137          397 IYLNRLSLSGNKLS-GCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELD  475 (912)
Q Consensus       397 ~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  475 (912)
                      ++|+.|++++|+++ +.+|..+..+++|++|++++|.+++.  ..+..+++|++|+|++|++++.+|..+..+++|++|+
T Consensus        24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  101 (168)
T 2ell_A           24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN  101 (168)
T ss_dssp             TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred             ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence            34555555555555 44555556666666666666666654  5566666666666666666655666666666777777


Q ss_pred             ccccccCccc-ccccccccccccccccCccccCCCc---ccccccccceEEEccCCcccc
Q 039137          476 LSHNFLGEKI-SSRICRMESLEKLNLSYNNLSGLIP---RCFEEMHGLLHIDISYNKLEG  531 (912)
Q Consensus       476 Ls~N~l~~~~-~~~~~~l~~L~~L~ls~N~l~~~~p---~~~~~l~~L~~l~ls~N~l~~  531 (912)
                      |++|+|++.. +..+..+++|+.|++++|++++..+   ..+..+++|+.|++++|.+..
T Consensus       102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~  161 (168)
T 2ell_A          102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQE  161 (168)
T ss_dssp             CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCB
T ss_pred             ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhh
Confidence            7777766542 2566667777777777777776654   466677777777777776653

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.64  E-value=3.5e-16  Score=156.28  Aligned_cols=109  Identities=28%  Similarity=0.323  Sum_probs=65.9

Q ss_pred             ccccccccCcccCccccccccccccccEEEecccccccccchhhhcccccceeeccccccCccccccccccccccccccc
Q 039137          422 NLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLS  501 (912)
Q Consensus       422 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls  501 (912)
                      +|++|+|++|+|+. +|..|..+++|+.|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|+.|+|+
T Consensus        32 ~l~~L~L~~n~i~~-ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~  110 (193)
T 2wfh_A           32 DVTELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLH  110 (193)
T ss_dssp             TCCEEECCSSCCCS-CCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEECCCCcCch-hHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECC
Confidence            45555555555553 33455555555555555555555555555566666666666666655555566666666666666


Q ss_pred             CccccCCCcccccccccceEEEccCCcccc
Q 039137          502 YNNLSGLIPRCFEEMHGLLHIDISYNKLEG  531 (912)
Q Consensus       502 ~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~  531 (912)
                      +|+|+++.+..|..+++|+.|++++|+|.|
T Consensus       111 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C  140 (193)
T 2wfh_A          111 GNDISVVPEGAFNDLSALSHLAIGANPLYC  140 (193)
T ss_dssp             SSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred             CCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence            666666555566666677777777777765

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.63  E-value=3.4e-16  Score=149.50  Aligned_cols=127  Identities=23%  Similarity=0.288  Sum_probs=74.8

Q ss_pred             ccccEEEccCCccc-CCCccccccccccccccccCcccCccccccccccccccEEEecccccccccchhhhcccccceee
Q 039137          397 IYLNRLSLSGNKLS-GCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELD  475 (912)
Q Consensus       397 ~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  475 (912)
                      ++|+.|++++|.++ +.+|..+..+++|++|++++|.+++.  ..+..+++|++|+|++|++++.+|..+..+++|++|+
T Consensus        17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~   94 (149)
T 2je0_A           17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN   94 (149)
T ss_dssp             GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred             ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence            34455555555554 44455555555555555555555554  4555566666666666666655565555666666666


Q ss_pred             ccccccCcc-cccccccccccccccccCccccCCCc---ccccccccceEEEcc
Q 039137          476 LSHNFLGEK-ISSRICRMESLEKLNLSYNNLSGLIP---RCFEEMHGLLHIDIS  525 (912)
Q Consensus       476 Ls~N~l~~~-~~~~~~~l~~L~~L~ls~N~l~~~~p---~~~~~l~~L~~l~ls  525 (912)
                      +++|++++. .+..+..+++|+.|++++|++++..+   ..+..+++|+.||++
T Consensus        95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~  148 (149)
T 2je0_A           95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY  148 (149)
T ss_dssp             CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred             CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence            666666553 23556666666666666666666554   456666666666665

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.63  E-value=1.3e-15  Score=169.85  Aligned_cols=264  Identities=13%  Similarity=0.100  Sum_probs=146.6

Q ss_pred             cccceeecccccccCccccccccccccceeeeccccCcccCCcccCCccccchhhhccCccCCCCccccccccccceEec
Q 039137          229 KSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRL  308 (912)
Q Consensus       229 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  308 (912)
                      ..++.+.+.+ .++..-..+|.++ +|+.+.+..| ++.+...+|.+. +|+.+.+.. .++.+.+.+|.++++|+.+++
T Consensus       113 ~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l  187 (401)
T 4fdw_A          113 KGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADL  187 (401)
T ss_dssp             SSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEEC
T ss_pred             CCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeec
Confidence            3444444433 2333334455553 5666666555 554555555553 466666654 454455555666666666666


Q ss_pred             ccccccCCCCcccCCCCCccEEEccCCcCcccccccCCCCCCCCEEeccCCcccccccccccccccccEEEccCccccCC
Q 039137          309 NQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGE  388 (912)
Q Consensus       309 ~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~  388 (912)
                      ++|.++.....+|. ..+|+.+.|..+ +......+|.+|++|+.+++..| ++.....                     
T Consensus       188 ~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~---------------------  243 (401)
T 4fdw_A          188 SKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQE---------------------  243 (401)
T ss_dssp             TTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTT---------------------
T ss_pred             CCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccc---------------------
Confidence            66666655555555 355666666533 44445555555555555555543 3322223                     


Q ss_pred             CCccccccccccEEEccCCcccCCCccccccccccccccccCcccC-----ccccccccccccccEEEecccccccccch
Q 039137          389 IPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLS-----NFVPESLGSLVKLYYLNLSHNKLSQQIPI  463 (912)
Q Consensus       389 ~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-----~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~  463 (912)
                         .|.+ .+|+.+.+. +.++.....+|.++++|+.+++.+|.+.     .+.+..|.++++|+.++|. |.++.+...
T Consensus       244 ---aF~~-~~L~~i~lp-~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~  317 (401)
T 4fdw_A          244 ---AFRE-SGITTVKLP-NGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQG  317 (401)
T ss_dssp             ---TTTT-CCCSEEEEE-TTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTT
T ss_pred             ---cccc-CCccEEEeC-CCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhh
Confidence               3333 344444442 2333333445555555555555554443     3455666666777777776 346555566


Q ss_pred             hhhcccccceeeccccccCcccccccccccccccccccCccccCCCcccccccc-cceEEEccCCcc
Q 039137          464 ELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMH-GLLHIDISYNKL  529 (912)
Q Consensus       464 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~-~L~~l~ls~N~l  529 (912)
                      .|.++.+|+.++|..| ++.+...+|.++ +|+.+++++|.+..+.+..|..++ .++.|++..|.+
T Consensus       318 aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~  382 (401)
T 4fdw_A          318 LLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESV  382 (401)
T ss_dssp             TTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGH
T ss_pred             hhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHH
Confidence            6667777777777443 555566667777 777777777777666666676664 566776666544

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.62  E-value=6.4e-16  Score=152.29  Aligned_cols=132  Identities=22%  Similarity=0.294  Sum_probs=79.7

Q ss_pred             cEEEccCCcccCCCccccccccccccccccCcccCccccccccccccccEEEecccccccccchhhhcccccceeecccc
Q 039137          400 NRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHN  479 (912)
Q Consensus       400 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  479 (912)
                      +.+++++|+++ .+|..+  .++|+.|++++|+++++.+..|..+++|++|+|++|++++..+..|..+++|++|+|++|
T Consensus        10 ~~l~~~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   86 (177)
T 2o6r_A           10 TEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN   86 (177)
T ss_dssp             TEEECCSSCCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEecCCCCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence            34444555444 233222  145566666666666555555566666666666666666555555566666666666666


Q ss_pred             ccCcccccccccccccccccccCccccCCCcccccccccceEEEccCCccccCCC
Q 039137          480 FLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIP  534 (912)
Q Consensus       480 ~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~~  534 (912)
                      +|++..+..|..+++|+.|++++|++++..+..|..+++|++|++++|++.|..|
T Consensus        87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  141 (177)
T 2o6r_A           87 KLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  141 (177)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             CccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence            6666555556666666666666666666655566667777777777777766544

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.62  E-value=1.5e-15  Score=149.75  Aligned_cols=134  Identities=25%  Similarity=0.281  Sum_probs=89.4

Q ss_pred             CccceeEecCCCCeEEEeeccccccccccccccCCCCCccEEEccCCcccccCCccccCCCCCcEEeccccccccccccc
Q 039137           73 CAWSGIFCNHAERVVGINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSG  152 (912)
Q Consensus        73 C~w~gv~c~~~~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~  152 (912)
                      |.|+++.|+..+ ++.+              ...-.++|++|+|++|++++..+..|+.+++|++|+|++|++++..+..
T Consensus         7 C~~~~l~~~~~~-l~~~--------------p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~   71 (177)
T 2o6r_A            7 CSGTEIRCNSKG-LTSV--------------PTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGV   71 (177)
T ss_dssp             EETTEEECCSSC-CSSC--------------CTTCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTT
T ss_pred             eCCCEEEecCCC-CccC--------------CCCCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhH
Confidence            789999997532 1111              1112356778888888877666666777778888888888777555555


Q ss_pred             cccccccceeecccccccCCCCccccCcccccEEEccCCcCCCCCCccCCCCccceeeeeccCCCcCcc
Q 039137          153 IGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSI  221 (912)
Q Consensus       153 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~  221 (912)
                      |+.+++|++|+|++|.+++..+..++.+++|++|++++|++++..+..+.++++|++|+|++|.+.+..
T Consensus        72 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~  140 (177)
T 2o6r_A           72 FDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC  140 (177)
T ss_dssp             TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred             ccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccC
Confidence            677777777777777777555555677777777777777776544444566666666666666665433

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.62  E-value=4.2e-16  Score=148.86  Aligned_cols=127  Identities=24%  Similarity=0.150  Sum_probs=74.6

Q ss_pred             ccccEEEccCcccc-CCCCccccccccccEEEccCCcccCCCccccccccccccccccCcccCccccccccccccccEEE
Q 039137          373 LQLQYLDLSSNYIV-GEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLN  451 (912)
Q Consensus       373 ~~L~~L~L~~N~l~-~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  451 (912)
                      ++|++|++++|.++ +.+|..+..+++|+.|++++|++++.  ..+..+++|++|++++|.+++.+|..+..+++|++|+
T Consensus        17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~   94 (149)
T 2je0_A           17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN   94 (149)
T ss_dssp             GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred             ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence            34555555555555 44555555555555666666555543  4455566666666666666655555555566666666


Q ss_pred             ecccccccc-cchhhhcccccceeeccccccCcccc---ccccccccccccccc
Q 039137          452 LSHNKLSQQ-IPIELDNLIHLSELDLSHNFLGEKIS---SRICRMESLEKLNLS  501 (912)
Q Consensus       452 Ls~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~---~~~~~l~~L~~L~ls  501 (912)
                      +++|++++. .+..+..+++|++|++++|++++..+   ..+..+++|+.|+++
T Consensus        95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~  148 (149)
T 2je0_A           95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY  148 (149)
T ss_dssp             CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred             CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence            666666542 23556666666666666666655544   456666666666665

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.62  E-value=2.6e-15  Score=167.44  Aligned_cols=270  Identities=12%  Similarity=0.069  Sum_probs=190.0

Q ss_pred             ccceeeeeccCCCcCccccccccccccceeecccccccCccccccccccccceeeeccccCcccCCcccCCccccchhhh
Q 039137          205 THVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLL  284 (912)
Q Consensus       205 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L  284 (912)
                      ..++.+.+.+ .++......|.++ +|+.+.+..+ ++..-..+|.++ +|+.+.+.. .++.+.+.+|.++++|+.+++
T Consensus       113 ~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l  187 (401)
T 4fdw_A          113 KGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADL  187 (401)
T ss_dssp             SSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEEC
T ss_pred             CCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeec
Confidence            3445555543 3443445677775 7999999877 765666778874 799999986 777777889999999999999


Q ss_pred             ccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCcccccccCCCCCCCCEEeccCCccccc
Q 039137          285 AKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGS  364 (912)
Q Consensus       285 ~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  364 (912)
                      +.|+++.+....|. .++|+.+.|.++ ++.....+|.++++|+.+++..| +......+|.+ .+|+.+.+ .+.++..
T Consensus       188 ~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I  262 (401)
T 4fdw_A          188 SKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNI  262 (401)
T ss_dssp             TTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEE
T ss_pred             CCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEE
Confidence            99999977777787 589999999855 77788899999999999999975 66677777877 68888888 4556545


Q ss_pred             ccccccccccccEEEccCccccCCCCccccccccccEEEccCCcccCCCccccccccccccccccCcccCcccccccccc
Q 039137          365 IPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSL  444 (912)
Q Consensus       365 ~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  444 (912)
                      ....|.++.+|+.+++.+|.+..                   +.+....+..|.++++|+.++|. +.++.+....|.++
T Consensus       263 ~~~aF~~c~~L~~l~l~~~~~~~-------------------~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c  322 (401)
T 4fdw_A          263 ASRAFYYCPELAEVTTYGSTFND-------------------DPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGN  322 (401)
T ss_dssp             CTTTTTTCTTCCEEEEESSCCCC-------------------CTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTC
T ss_pred             ChhHhhCCCCCCEEEeCCccccC-------------------CcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCC
Confidence            56677777777777777766541                   11112334456666666666666 34655556666666


Q ss_pred             ccccEEEecccccccccchhhhcccccceeeccccccCccccccccccc-ccccccccCcccc
Q 039137          445 VKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRME-SLEKLNLSYNNLS  506 (912)
Q Consensus       445 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~ls~N~l~  506 (912)
                      ++|+.++|..| ++.+...+|.++ +|+.|++++|.+....+..|.+++ +++.|++..|.+.
T Consensus       323 ~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~  383 (401)
T 4fdw_A          323 RKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE  383 (401)
T ss_dssp             CSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred             CCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence            66666666444 555556666666 677777776666665556666663 5666666655543

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.62  E-value=1.6e-15  Score=151.37  Aligned_cols=125  Identities=24%  Similarity=0.308  Sum_probs=77.7

Q ss_pred             EEccCCcccccCCccccCCCCCcEEeccccccccccccccccccccceeecccccccCCCCccccCcccccEEEccCCcC
Q 039137          114 LDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFL  193 (912)
Q Consensus       114 L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l  193 (912)
                      +++++|+++ .+|..+.  ++|++|+|++|+|+ .+|..|..+++|++|+|++|.+++..|..|.++++|++|+|++|++
T Consensus        15 l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l   90 (193)
T 2wfh_A           15 VRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL   90 (193)
T ss_dssp             EECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred             EEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCcc
Confidence            445555555 3454443  46777777777775 5666677777777777777777765556666666666666666666


Q ss_pred             CCCCCccCCCCccceeeeeccCCCcCccccccccccccceeeccccccc
Q 039137          194 NGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLS  242 (912)
Q Consensus       194 ~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~  242 (912)
                      ++..|..|.++++|++|+|++|.+++..+..|..+++|+.|++++|.+.
T Consensus        91 ~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~  139 (193)
T 2wfh_A           91 RCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY  139 (193)
T ss_dssp             CBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred             CEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence            6555556666666666666666666444444555555555555555554

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.59  E-value=1e-17  Score=168.45  Aligned_cols=136  Identities=24%  Similarity=0.336  Sum_probs=85.2

Q ss_pred             CCCCCccEEEccCCcccccCCc------cccCCCCCcEEeccccccccccccccccccccceeecccccccCCCCccccC
Q 039137          106 SSFPHLVYLDLYNNELFGIIPP------QISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQ  179 (912)
Q Consensus       106 ~~l~~L~~L~L~~n~l~~~~p~------~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~  179 (912)
                      .....++.++++.+.++|.+|+      .|+.+++|++|+|++|++++ +| .++.+++|++|++++|.++ .+|..++.
T Consensus        15 ~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~   91 (198)
T 1ds9_A           15 EERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAV   91 (198)
T ss_dssp             HHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHH
T ss_pred             HhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhc
Confidence            3445556666666666666665      67777777777777777764 66 6777777777777777776 56666666


Q ss_pred             cccccEEEccCCcCCCCCCccCCCCccceeeeeccCCCcCccc-cccccccccceeecccccccCccc
Q 039137          180 LTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIP-QEIGNLKSLFDLELCINQLSGAIP  246 (912)
Q Consensus       180 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~l~~n~l~~~~p  246 (912)
                      +++|++|++++|++++ +| .+.++++|++|++++|.+++..+ ..+..+++|++|++++|.+++..|
T Consensus        92 ~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~  157 (198)
T 1ds9_A           92 ADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYK  157 (198)
T ss_dssp             HHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHH
T ss_pred             CCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccc
Confidence            6667777777766664 33 45555666666666666553222 345555555555555555554433

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.59  E-value=1.8e-15  Score=164.38  Aligned_cols=143  Identities=9%  Similarity=0.109  Sum_probs=104.0

Q ss_pred             CCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCC-------------CchH-----HHHHHHHHHHHHhhcCCCcc
Q 039137          639 DFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPG-------------EMSF-----QQEEFLNEIQALTEIRHRNI  700 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------~~~~-----~~~~~~~Ei~~l~~l~h~ni  700 (912)
                      =|.+.+.||+|++|.||+|..++|+.||||+++.....             ....     .+....+|...+.++.+.++
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            48999999999999999999999999999987643111             0000     01112457777777755544


Q ss_pred             ccEEEEEEcCCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCC
Q 039137          701 VKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLG  780 (912)
Q Consensus       701 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~  780 (912)
                      ....-+..  ...++||||++|+++.++..         .+....++.|++.++.|||++   |||||||||.|||++++
T Consensus       176 ~vp~p~~~--~~~~LVME~i~G~~L~~l~~---------~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~d  241 (397)
T 4gyi_A          176 PVPEPIAQ--SRHTIVMSLVDALPMRQVSS---------VPDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREE  241 (397)
T ss_dssp             SCCCEEEE--ETTEEEEECCSCEEGGGCCC---------CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEE
T ss_pred             CCCeeeec--cCceEEEEecCCccHhhhcc---------cHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCC
Confidence            22222211  23479999999988866541         134567889999999999999   99999999999999887


Q ss_pred             C----------cEEEeccccccccC
Q 039137          781 Y----------EAHVSDFGIAKFLN  795 (912)
Q Consensus       781 ~----------~~kl~Dfgla~~~~  795 (912)
                      +          .+.|+||+-+....
T Consensus       242 gd~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          242 KDAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             ECSSCTTSEEEEEEECCCTTCEETT
T ss_pred             CCcccccccccceEEEEeCCcccCC
Confidence            6          38999999776543

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.57  E-value=7.7e-17  Score=162.10  Aligned_cols=151  Identities=21%  Similarity=0.262  Sum_probs=97.6

Q ss_pred             ccccEEEccCccccCCCCc------cccccccccEEEccCCcccCCCccccccccccccccccCcccCcccccccccccc
Q 039137          373 LQLQYLDLSSNYIVGEIPT------QLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVK  446 (912)
Q Consensus       373 ~~L~~L~L~~N~l~~~~~~------~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  446 (912)
                      ..++.++++.|.+.+.+|.      .+..+++|++|++++|++++ +| .+..+++|++|++++|.++. +|..+..+++
T Consensus        18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~~-l~~~~~~~~~   94 (198)
T 1ds9_A           18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKK-IENLDAVADT   94 (198)
T ss_dssp             TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEECS-CSSHHHHHHH
T ss_pred             ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCccc-ccchhhcCCc
Confidence            3444445555555544444      66666667777777776664 45 66667777777777777764 4555666677


Q ss_pred             ccEEEecccccccccchhhhcccccceeeccccccCcccc-cccccccccccccccCccccCCCcc----------cccc
Q 039137          447 LYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKIS-SRICRMESLEKLNLSYNNLSGLIPR----------CFEE  515 (912)
Q Consensus       447 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~ls~N~l~~~~p~----------~~~~  515 (912)
                      |++|+|++|++++ +| .+..+++|++|++++|+|++..+ ..+..+++|+.|++++|++++.+|.          .+..
T Consensus        95 L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~  172 (198)
T 1ds9_A           95 LEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKR  172 (198)
T ss_dssp             CSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHH
T ss_pred             CCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHh
Confidence            7777777777764 34 56677777777777777765433 4566777777777777777666554          2677


Q ss_pred             cccceEEEccCCccc
Q 039137          516 MHGLLHIDISYNKLE  530 (912)
Q Consensus       516 l~~L~~l~ls~N~l~  530 (912)
                      +++|+.||  +|+++
T Consensus       173 l~~L~~Ld--~~~i~  185 (198)
T 1ds9_A          173 LPNLKKLD--GMPVD  185 (198)
T ss_dssp             CSSCSEEC--CGGGT
T ss_pred             CCCcEEEC--CcccC
Confidence            77888776  55554

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.56  E-value=7.4e-14  Score=156.40  Aligned_cols=316  Identities=12%  Similarity=0.050  Sum_probs=134.5

Q ss_pred             ccccCCccccCCCCCcEEeccccccccccccccccccccceeecccccccCCCCccccCcccccEEEccCCcCCCCCCcc
Q 039137          121 LFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRS  200 (912)
Q Consensus       121 l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~  200 (912)
                      ++.+-..+|.++++|+.+.|..+ ++..-..+|.++++|+.++|..+ ++..-...|.++++|+.+.+..+ +...-...
T Consensus        59 VtsIg~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~a  135 (394)
T 4fs7_A           59 VVSIGYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEA  135 (394)
T ss_dssp             EEEECTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTT
T ss_pred             EeEhHHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeeccee
Confidence            34333455666666666666533 44333445666666666666543 33223344555555554444322 11122223


Q ss_pred             CCCCccceeeeeccCCCcCccccccccccccceeecccccccCccccccccccccceeeeccccCcccCCcccCCccccc
Q 039137          201 LGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLN  280 (912)
Q Consensus       201 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~  280 (912)
                      |.++..+........                          ...-...|.++++|+.+.+.++. ..+...+|.++.+|+
T Consensus       136 F~~~~~~~~~~~~~~--------------------------~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~  188 (394)
T 4fs7_A          136 FKGCDFKEITIPEGV--------------------------TVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLK  188 (394)
T ss_dssp             TTTCCCSEEECCTTC--------------------------CEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCC
T ss_pred             eecccccccccCccc--------------------------cccchhhhcccCCCcEEecCCcc-ceeccccccCCCCce
Confidence            333322221111111                          11112344555555555554332 223344455555555


Q ss_pred             hhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCcccccccCCCCCCCCEEeccCCc
Q 039137          281 SLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINN  360 (912)
Q Consensus       281 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  360 (912)
                      .+++..| ++.+...+|.++..|+.+.+..+...  +.+.+....+|+.+.+..+ +.......+..+..|+.+.+..+.
T Consensus       189 ~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~  264 (394)
T 4fs7_A          189 SIKLPRN-LKIIRDYCFAECILLENMEFPNSLYY--LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNK  264 (394)
T ss_dssp             BCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE--ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTT
T ss_pred             EEEcCCC-ceEeCchhhccccccceeecCCCceE--eehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCc
Confidence            5555444 33333445555555555555444322  1222223344555554322 222333444455555555554443


Q ss_pred             ccccccccccccccccEEEccCccccCCCCccccccccccEEEccCCcccCCCccccccccccccccccCcccCcccccc
Q 039137          361 ISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPES  440 (912)
Q Consensus       361 l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~  440 (912)
                      .. .....+..+..++.+....+.+.   ...+....+|+.+.+.++ ++.+...+|.++.+|+.++|.++ ++.+...+
T Consensus       265 ~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~a  338 (394)
T 4fs7_A          265 LR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRS  338 (394)
T ss_dssp             CE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTT
T ss_pred             ce-eeccccccccccceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHh
Confidence            22 23333444444444444433221   123334444444444332 33233334444444444444322 33333444


Q ss_pred             ccccccccEEEecccccccccchhhhcccccceeecc
Q 039137          441 LGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLS  477 (912)
Q Consensus       441 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  477 (912)
                      |.++.+|+.+++..| ++.+...+|.++.+|+.+++.
T Consensus       339 F~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp  374 (394)
T 4fs7_A          339 FRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELP  374 (394)
T ss_dssp             TTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEE
T ss_pred             ccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEEC
Confidence            444444444444433 333333444444444444443

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.56  E-value=9.7e-14  Score=155.42  Aligned_cols=331  Identities=11%  Similarity=0.016  Sum_probs=209.4

Q ss_pred             cccccCCCCCccEEEccCCcccccCCccccCCCCCcEEeccccccccccccccccccccceeecccccccCCCCccccCc
Q 039137          101 LEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQL  180 (912)
Q Consensus       101 ~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l  180 (912)
                      .+.+|.+..+|+.+.|.. +++.+-..+|.++++|+.++|..+ ++..-...|.++++|+.+.+..+ +...-...|.+.
T Consensus        63 g~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~  139 (394)
T 4fs7_A           63 GYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGC  139 (394)
T ss_dssp             CTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTC
T ss_pred             HHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeecc
Confidence            456799999999999975 477666678999999999999865 55344567899999999888765 443445666666


Q ss_pred             ccccEEEccCCcCCCCCCccCCCCccceeeeeccCCCcCccccccccccccceeecccccccCccccccccccccceeee
Q 039137          181 TVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFL  260 (912)
Q Consensus       181 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L  260 (912)
                      ..++.........  .....|.++++|+.+.+.++... .....|.++.+|+.+.+..|                     
T Consensus       140 ~~~~~~~~~~~~~--i~~~aF~~c~~L~~i~l~~~~~~-I~~~~F~~c~~L~~i~l~~~---------------------  195 (394)
T 4fs7_A          140 DFKEITIPEGVTV--IGDEAFATCESLEYVSLPDSMET-LHNGLFSGCGKLKSIKLPRN---------------------  195 (394)
T ss_dssp             CCSEEECCTTCCE--ECTTTTTTCTTCCEEECCTTCCE-ECTTTTTTCTTCCBCCCCTT---------------------
T ss_pred             cccccccCccccc--cchhhhcccCCCcEEecCCccce-eccccccCCCCceEEEcCCC---------------------
Confidence            5444443333221  22346777777777776544321 23334555555555554433                     


Q ss_pred             ccccCcccCCcccCCccccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCccc
Q 039137          261 YHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGE  340 (912)
Q Consensus       261 ~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  340 (912)
                          ++.+...+|.++..|+.+.+..+...  +.+.+....+|+.+.+..+ ++......|..+..|+.+.+..+.. ..
T Consensus       196 ----~~~I~~~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~-~i  267 (394)
T 4fs7_A          196 ----LKIIRDYCFAECILLENMEFPNSLYY--LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKL-RI  267 (394)
T ss_dssp             ----CCEECTTTTTTCTTCCBCCCCTTCCE--ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTC-EE
T ss_pred             ----ceEeCchhhccccccceeecCCCceE--eehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcc-ee
Confidence                22233344444445554444433322  1122223345555555432 2333445566666666666665533 34


Q ss_pred             ccccCCCCCCCCEEeccCCcccccccccccccccccEEEccCccccCCCCccccccccccEEEccCCcccCCCccccccc
Q 039137          341 ILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSL  420 (912)
Q Consensus       341 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l  420 (912)
                      ....|..+..++.+....+.+.   ...+..+.+|+.+.+.++ ++......|.++.+|+.+++.++ ++.+...+|.++
T Consensus       268 ~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c  342 (394)
T 4fs7_A          268 GGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGC  342 (394)
T ss_dssp             CSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTC
T ss_pred             eccccccccccceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCC
Confidence            4556666777777666655432   235566777777777654 54445567788888888888654 665566788899


Q ss_pred             cccccccccCcccCccccccccccccccEEEecccccccccchhhhccccccee
Q 039137          421 INLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSEL  474 (912)
Q Consensus       421 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  474 (912)
                      .+|+.+++..| ++.+...+|.++++|+.+++..+ ++ .+..+|.++++|+.+
T Consensus       343 ~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~I  393 (394)
T 4fs7_A          343 TSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKWI  393 (394)
T ss_dssp             TTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEEE
T ss_pred             CCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcEE
Confidence            99999999877 77777889999999999999765 33 345677777777654

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.54  E-value=7.6e-15  Score=144.37  Aligned_cols=132  Identities=23%  Similarity=0.257  Sum_probs=66.0

Q ss_pred             ccccccEEEccCCcccCCCcccccccc-ccccccccCcccCccccccccccccccEEEecccccccccchhhhcccccce
Q 039137          395 NIIYLNRLSLSGNKLSGCIPRELGSLI-NLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSE  473 (912)
Q Consensus       395 ~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  473 (912)
                      +..+|+.|++++|+++. +|. +..+. +|++|++++|.++++  ..|..+++|++|+|++|+|++..+..+..+++|++
T Consensus        17 ~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~   92 (176)
T 1a9n_A           17 NAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE   92 (176)
T ss_dssp             CTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCE
T ss_pred             CcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCE
Confidence            33444444444444442 222 22222 555555555555543  34555555555555555555443344455555555


Q ss_pred             eeccccccCcccc-cccccccccccccccCccccCCCcc---cccccccceEEEccCCccc
Q 039137          474 LDLSHNFLGEKIS-SRICRMESLEKLNLSYNNLSGLIPR---CFEEMHGLLHIDISYNKLE  530 (912)
Q Consensus       474 L~Ls~N~l~~~~~-~~~~~l~~L~~L~ls~N~l~~~~p~---~~~~l~~L~~l~ls~N~l~  530 (912)
                      |+|++|+|+...+ ..+..+++|+.|++++|+++...+.   .+..+++|+.||+++|...
T Consensus        93 L~L~~N~i~~~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~Ld~~~n~~~  153 (176)
T 1a9n_A           93 LILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVKLK  153 (176)
T ss_dssp             EECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred             EECCCCcCCcchhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCccceeCCCcCCHH
Confidence            5555555533221 2455555666666666665543221   3556666666666666554

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.53  E-value=7.5e-15  Score=144.44  Aligned_cols=132  Identities=21%  Similarity=0.220  Sum_probs=78.3

Q ss_pred             cccccccEEEccCccccCCCCccccccc-cccEEEccCCcccCCCccccccccccccccccCcccCcccccccccccccc
Q 039137          370 GESLQLQYLDLSSNYIVGEIPTQLGNII-YLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLY  448 (912)
Q Consensus       370 ~~~~~L~~L~L~~N~l~~~~~~~l~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  448 (912)
                      .++.+|++|++++|+++. ++. +..+. +|+.|++++|++++.  ..+..+++|++|+|++|+|+++++..|..+++|+
T Consensus        16 ~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~   91 (176)
T 1a9n_A           16 TNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT   91 (176)
T ss_dssp             ECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred             CCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCC
Confidence            344455555555555552 332 33333 566666666666543  4556666666666666666665444456666666


Q ss_pred             EEEecccccccccch--hhhcccccceeeccccccCccccc----ccccccccccccccCccccC
Q 039137          449 YLNLSHNKLSQQIPI--ELDNLIHLSELDLSHNFLGEKISS----RICRMESLEKLNLSYNNLSG  507 (912)
Q Consensus       449 ~L~Ls~N~l~~~~~~--~~~~l~~L~~L~Ls~N~l~~~~~~----~~~~l~~L~~L~ls~N~l~~  507 (912)
                      +|+|++|+|+ .+|.  .+..+++|+.|++++|.++.. |.    .+..+++|+.||+++|.+..
T Consensus        92 ~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~~-~~~~~~~~~~l~~L~~Ld~~~n~~~~  154 (176)
T 1a9n_A           92 ELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNK-KHYRLYVIYKVPQVRVLDFQKVKLKE  154 (176)
T ss_dssp             EEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGS-TTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred             EEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCCc-HhHHHHHHHHCCccceeCCCcCCHHH
Confidence            6666666664 3443  566666777777777776533 33    36667777777777776653

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.47  E-value=5.5e-14  Score=137.20  Aligned_cols=109  Identities=25%  Similarity=0.327  Sum_probs=69.3

Q ss_pred             cccccccCcccCccccccccccccccEEEecccccccccchhhhcccccceeeccccccCcccccccccccccccccccC
Q 039137          423 LEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSY  502 (912)
Q Consensus       423 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~  502 (912)
                      .+.+++++|.++. +|..+.  ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++
T Consensus        11 ~~~l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~   87 (170)
T 3g39_A           11 GTTVDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND   87 (170)
T ss_dssp             TTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence            3455666666654 333332  5566666666666665566666666666666666666666666666666667777777


Q ss_pred             ccccCCCcccccccccceEEEccCCccccCCC
Q 039137          503 NNLSGLIPRCFEEMHGLLHIDISYNKLEGQIP  534 (912)
Q Consensus       503 N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~~  534 (912)
                      |+|+++.+..|..+++|+.|++++|+|+|..+
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~  119 (170)
T 3g39_A           88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS  119 (170)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred             CccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence            77766666667777777777777777766544

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.44  E-value=1.7e-13  Score=133.66  Aligned_cols=105  Identities=26%  Similarity=0.283  Sum_probs=52.3

Q ss_pred             ccEEEccCccccCCCCccccccccccEEEccCCcccCCCccccccccccccccccCcccCccccccccccccccEEEecc
Q 039137          375 LQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSH  454 (912)
Q Consensus       375 L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  454 (912)
                      .+.|++++|.++ .+|..+.  ++|+.|+|++|+|++..|..|..+++|++|+|++|+|+++.+..|..+++|++|+|++
T Consensus        11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~   87 (170)
T 3g39_A           11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND   87 (170)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence            345566666555 2443332  4455555555555544444555555555555555555544444444555555555555


Q ss_pred             cccccccchhhhcccccceeeccccccC
Q 039137          455 NKLSQQIPIELDNLIHLSELDLSHNFLG  482 (912)
Q Consensus       455 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  482 (912)
                      |+|++..+..|..+++|++|+|++|.++
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~  115 (170)
T 3g39_A           88 NQLKSIPRGAFDNLKSLTHIWLLNNPWD  115 (170)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred             CccCEeCHHHhcCCCCCCEEEeCCCCCC
Confidence            5554444444444455555555555443

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.44  E-value=1.4e-13  Score=134.65  Aligned_cols=107  Identities=21%  Similarity=0.330  Sum_probs=58.9

Q ss_pred             ccccccCcccCccccccccccccccEEEecccccccccchhhhcccccceeeccccccCcccccccccccccccccccCc
Q 039137          424 EYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYN  503 (912)
Q Consensus       424 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N  503 (912)
                      +.+++++|+++. +|..+.  ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|
T Consensus        15 ~~l~~~~n~l~~-iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N   91 (174)
T 2r9u_A           15 TLVNCQNIRLAS-VPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN   91 (174)
T ss_dssp             SEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             cEEEeCCCCCCc-cCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence            344555555543 233332  45555555555555555555555555555555555555554444555566666666666


Q ss_pred             cccCCCcccccccccceEEEccCCccccCC
Q 039137          504 NLSGLIPRCFEEMHGLLHIDISYNKLEGQI  533 (912)
Q Consensus       504 ~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~  533 (912)
                      +|+++.+..|..+++|++|++++|+|.|..
T Consensus        92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~  121 (174)
T 2r9u_A           92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCEC  121 (174)
T ss_dssp             CCCCCCTTTTTTCTTCSEEECCSSCBCTTB
T ss_pred             ccceeCHHHhccccCCCEEEeCCCCccccc
Confidence            666555555666666666666666665543

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.41  E-value=4.2e-13  Score=131.30  Aligned_cols=103  Identities=26%  Similarity=0.327  Sum_probs=73.5

Q ss_pred             EEEccCCcccccCCccccCCCCCcEEeccccccccccccccccccccceeecccccccCCCCccccCcccccEEEccCCc
Q 039137          113 YLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNF  192 (912)
Q Consensus       113 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~  192 (912)
                      .+++++|+++ .+|..+.  ++|++|+|++|+|++..|..|+.+++|++|+|++|+|++..+..|+.+++|++|+|++|+
T Consensus        16 ~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~   92 (174)
T 2r9u_A           16 LVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNH   92 (174)
T ss_dssp             EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCc
Confidence            4667777775 5666554  678888888888877667777778888888888888775444556777777777777777


Q ss_pred             CCCCCCccCCCCccceeeeeccCCCc
Q 039137          193 LNGSIPRSLGNLTHVVILYLYNNSFF  218 (912)
Q Consensus       193 l~~~~p~~~~~l~~L~~L~L~~n~l~  218 (912)
                      |++..+..|.++++|++|+|++|.+.
T Consensus        93 l~~l~~~~~~~l~~L~~L~L~~N~~~  118 (174)
T 2r9u_A           93 LKSIPRGAFDNLKSLTHIYLYNNPWD  118 (174)
T ss_dssp             CCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred             cceeCHHHhccccCCCEEEeCCCCcc
Confidence            77544445777777777777777765

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.33  E-value=6e-14  Score=154.88  Aligned_cols=169  Identities=21%  Similarity=0.197  Sum_probs=80.7

Q ss_pred             CCccEEEccCCcCcccccccCC-----CCCCCCEEeccCCcccccccccc-cccccccEEEccCccccCCCCcccccccc
Q 039137          325 PNLTFIDLSNNSFFGEILSDWG-----RCPQLSLLDVSINNISGSIPLEI-GESLQLQYLDLSSNYIVGEIPTQLGNIIY  398 (912)
Q Consensus       325 ~~L~~L~Ls~N~l~~~~~~~~~-----~l~~L~~L~Ls~N~l~~~~~~~~-~~~~~L~~L~L~~N~l~~~~~~~l~~l~~  398 (912)
                      +.|+.|+|++|.++......+.     ..++|+.|+|++|.++......+ ..+.+|++|+|++|.++......+..   
T Consensus        72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~---  148 (372)
T 3un9_A           72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRD---  148 (372)
T ss_dssp             TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHH---
T ss_pred             hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHH---
Confidence            4577777777777654333222     12455555555555543222221 12334445555555444322222210   


Q ss_pred             ccEEEccCCcccCCCcccc-ccccccccccccCcccCcc----ccccccccccccEEEecccccccc----cchhhhccc
Q 039137          399 LNRLSLSGNKLSGCIPREL-GSLINLEYLDLSANNLSNF----VPESLGSLVKLYYLNLSHNKLSQQ----IPIELDNLI  469 (912)
Q Consensus       399 L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~  469 (912)
                                       .+ ...++|++|+|++|.|+..    ++..+..+++|++|+|++|.|++.    ++..+...+
T Consensus       149 -----------------~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~  211 (372)
T 3un9_A          149 -----------------LLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNR  211 (372)
T ss_dssp             -----------------HHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCS
T ss_pred             -----------------HHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCC
Confidence                             01 1234455555555555432    122234455566666666665432    234445555


Q ss_pred             ccceeeccccccCcc----cccccccccccccccccCccccCCCcccc
Q 039137          470 HLSELDLSHNFLGEK----ISSRICRMESLEKLNLSYNNLSGLIPRCF  513 (912)
Q Consensus       470 ~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~ls~N~l~~~~p~~~  513 (912)
                      +|++|+|++|.|++.    +...+...++|+.|+|++|+|++.....+
T Consensus       212 ~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L  259 (372)
T 3un9_A          212 QLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVL  259 (372)
T ss_dssp             CCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHH
T ss_pred             CcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHH
Confidence            666666666666543    22333345666666666666665433333

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.33  E-value=4.8e-14  Score=155.65  Aligned_cols=171  Identities=18%  Similarity=0.112  Sum_probs=106.5

Q ss_pred             ccccceEecccccccCCCCcccC-----CCCCccEEEccCCcCcccccccCC-CCCCCCEEeccCCccccccccccc---
Q 039137          300 LTDLVKLRLNQNYLTGNISETFG-----TYPNLTFIDLSNNSFFGEILSDWG-RCPQLSLLDVSINNISGSIPLEIG---  370 (912)
Q Consensus       300 l~~L~~L~L~~n~l~~~~~~~~~-----~l~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~---  370 (912)
                      +++|+.|+|++|.++......+.     ..++|++|+|++|.++......+. .+++|+.|+|++|+|+......+.   
T Consensus        71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L  150 (372)
T 3un9_A           71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL  150 (372)
T ss_dssp             HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred             HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence            47899999999999864444432     237999999999999765544443 467899999999999855444442   


Q ss_pred             --ccccccEEEccCccccCC----CCccccccccccEEEccCCcccCCCccccccccccccccccCcccCcccccccccc
Q 039137          371 --ESLQLQYLDLSSNYIVGE----IPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSL  444 (912)
Q Consensus       371 --~~~~L~~L~L~~N~l~~~----~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  444 (912)
                        ..++|++|+|++|.|+..    ++..+...++|++|+|++|.+++....                    .++..+...
T Consensus       151 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~--------------------~L~~~L~~~  210 (372)
T 3un9_A          151 LHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLE--------------------LLAAQLDRN  210 (372)
T ss_dssp             HSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHH--------------------HHHHHGGGC
T ss_pred             HhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHH--------------------HHHHHHhcC
Confidence              345677777777777642    222234444555555555554421100                    112334445


Q ss_pred             ccccEEEecccccccc----cchhhhcccccceeeccccccCcccccccc
Q 039137          445 VKLYYLNLSHNKLSQQ----IPIELDNLIHLSELDLSHNFLGEKISSRIC  490 (912)
Q Consensus       445 ~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  490 (912)
                      ++|+.|+|++|.|+..    ++..+...++|++|+|++|.|++.....+.
T Consensus       211 ~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~  260 (372)
T 3un9_A          211 RQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLR  260 (372)
T ss_dssp             SCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHHH
T ss_pred             CCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHHH
Confidence            5666666666666542    333444557777777777777655444443

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.29  E-value=6.5e-11  Score=132.39  Aligned_cols=130  Identities=10%  Similarity=0.181  Sum_probs=62.7

Q ss_pred             ccccccccccEEEccCCcccCCCccccccccccccccccCcccCccccccccccccccEEEecccccccccchhhhcccc
Q 039137          391 TQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIH  470 (912)
Q Consensus       391 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  470 (912)
                      ..|.++..|+.+.+.++..+ ....+|.++++|+.+.+. +.++.+....|.++.+|+.++|..+ ++.+...+|.++.+
T Consensus       259 ~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~  335 (394)
T 4gt6_A          259 HAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQ  335 (394)
T ss_dssp             TTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTT
T ss_pred             ceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCC
Confidence            34445555555555444332 334455555555555553 3344444555555566666666543 44444555555666


Q ss_pred             cceeeccccccCcccccccccccccccccccCccccCCCcccccccccceEEEccCC
Q 039137          471 LSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYN  527 (912)
Q Consensus       471 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~ls~N  527 (912)
                      |+.+.|..+ ++.+...+|.++++|+.+++.+|....   ..|.....|+.+.+..|
T Consensus       336 L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~  388 (394)
T 4gt6_A          336 LERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPG  388 (394)
T ss_dssp             CCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC--------
T ss_pred             CCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCC
Confidence            666665433 444445556666666666665554321   23444455555555444

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.26  E-value=2.9e-12  Score=140.85  Aligned_cols=104  Identities=26%  Similarity=0.218  Sum_probs=67.6

Q ss_pred             EEEccCc-cccCCCCccccccccccEEEccC-CcccCCCccccccccccccccccCcccCccccccccccccccEEEecc
Q 039137          377 YLDLSSN-YIVGEIPTQLGNIIYLNRLSLSG-NKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSH  454 (912)
Q Consensus       377 ~L~L~~N-~l~~~~~~~l~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  454 (912)
                      .++++++ +++ .+|. +..+++|+.|+|++ |+|++..+..|..+++|++|+|++|+|++++|..|.++++|++|+|++
T Consensus        12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~   89 (347)
T 2ifg_A           12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF   89 (347)
T ss_dssp             CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred             EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence            4566666 666 3555 66666677777764 677666666666677777777777777666666666667777777777


Q ss_pred             cccccccchhhhcccccceeeccccccCc
Q 039137          455 NKLSQQIPIELDNLIHLSELDLSHNFLGE  483 (912)
Q Consensus       455 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  483 (912)
                      |+|++..+..|..++ |+.|+|++|.|..
T Consensus        90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~c  117 (347)
T 2ifg_A           90 NALESLSWKTVQGLS-LQELVLSGNPLHC  117 (347)
T ss_dssp             SCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred             CccceeCHHHcccCC-ceEEEeeCCCccC
Confidence            776655555555444 6666666666653

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.25  E-value=9.5e-11  Score=131.03  Aligned_cols=133  Identities=11%  Similarity=0.165  Sum_probs=81.5

Q ss_pred             cccccccccccEEEccCccccCCCCccccccccccEEEccCCcccCCCccccccccccccccccCcccCccccccccccc
Q 039137          366 PLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLV  445 (912)
Q Consensus       366 ~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  445 (912)
                      ...|.++..|+.+.+.++... .....|.++..|+.+.+. +.++.....+|.++.+|+.++|..+ ++.+...+|.++.
T Consensus       258 ~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~  334 (394)
T 4gt6_A          258 THAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCE  334 (394)
T ss_dssp             TTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCT
T ss_pred             cceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCC
Confidence            345555666666666554332 344566666777777775 3444455567777778888877654 6666667788888


Q ss_pred             cccEEEecccccccccchhhhcccccceeeccccccCcccccccccccccccccccCccc
Q 039137          446 KLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNL  505 (912)
Q Consensus       446 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l  505 (912)
                      +|+.+.|..+ ++.+...+|.++.+|+.+++.+|...   -..+....+|+.+.+..|.+
T Consensus       335 ~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~---~~~~~~~~~L~~i~i~~~~~  390 (394)
T 4gt6_A          335 QLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQ---WNAISTDSGLQNLPVAPGSI  390 (394)
T ss_dssp             TCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHH---HHTCBCCCCC----------
T ss_pred             CCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceee---hhhhhccCCCCEEEeCCCCE
Confidence            8888888654 66566777888888888888877542   24566677788877776654

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.24  E-value=8.6e-12  Score=137.05  Aligned_cols=132  Identities=22%  Similarity=0.168  Sum_probs=86.2

Q ss_pred             EEEccCC-cccCCCccccccccccccccccC-cccCccccccccccccccEEEecccccccccchhhhcccccceeeccc
Q 039137          401 RLSLSGN-KLSGCIPRELGSLINLEYLDLSA-NNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSH  478 (912)
Q Consensus       401 ~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  478 (912)
                      .++++++ +++ .+|. +..+++|++|+|++ |+|+++.+..|..+++|+.|+|++|+|++..|..|.++++|++|+|++
T Consensus        12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~   89 (347)
T 2ifg_A           12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF   89 (347)
T ss_dssp             CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred             EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence            4567776 677 4666 77777777777775 777777667777777777777777777777777777777777777777


Q ss_pred             cccCcccccccccccccccccccCccccCCCc-ccccccccceEEEccCCccccCCCC
Q 039137          479 NFLGEKISSRICRMESLEKLNLSYNNLSGLIP-RCFEEMHGLLHIDISYNKLEGQIPN  535 (912)
Q Consensus       479 N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p-~~~~~l~~L~~l~ls~N~l~~~~~~  535 (912)
                      |+|++..+..|..++ |+.|+|++|+|...-. ..|..+.......+..+++.|..|.
T Consensus        90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~~  146 (347)
T 2ifg_A           90 NALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQG  146 (347)
T ss_dssp             SCCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSS
T ss_pred             CccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCCCCCh
Confidence            777766666666555 7777777777765422 2222222222233344555555544

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.22  E-value=3.4e-11  Score=126.58  Aligned_cols=146  Identities=14%  Similarity=0.093  Sum_probs=114.9

Q ss_pred             HHHhcCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcC-CCccccEEEEEEcCCe
Q 039137          634 ISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR-HRNIVKFYGFCSHPKH  712 (912)
Q Consensus       634 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~  712 (912)
                      ......|++....+.|+.+.||++.. .++.+++|+.......    ....+.+|+++++.+. +..+.++++++...+.
T Consensus        10 ~~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~----~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~   84 (263)
T 3tm0_A           10 KKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKG----TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW   84 (263)
T ss_dssp             HHHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTT----STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred             HHHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCC----CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCc
Confidence            34456788888899999999999976 4688999998642211    1234778999999994 7788899999998899


Q ss_pred             eeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------
Q 039137          713 SFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNC-------------------------------  761 (912)
Q Consensus       713 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-------------------------------  761 (912)
                      .|+||||++|.++.+...        +..+...++.+++++++.||+..                               
T Consensus        85 ~~lv~e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (263)
T 3tm0_A           85 SNLLMSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE  156 (263)
T ss_dssp             EEEEEECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGG
T ss_pred             eEEEEEecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccc
Confidence            999999999999877641        12334578899999999999811                               


Q ss_pred             -------------------------CCCeeecCCCCCCeEEcCCCcEEEecccccc
Q 039137          762 -------------------------FPPIVHRDISSKNVLLDLGYEAHVSDFGIAK  792 (912)
Q Consensus       762 -------------------------~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  792 (912)
                                               .+.++|+|++|.||+++++..+.|+||+.+.
T Consensus       157 ~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                     0358999999999999876566799999775

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.04  E-value=3.2e-10  Score=118.94  Aligned_cols=137  Identities=15%  Similarity=0.138  Sum_probs=101.4

Q ss_pred             CCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCc--cccEEEEEEcCCeeeEE
Q 039137          639 DFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRN--IVKFYGFCSHPKHSFII  716 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~~~~~~~~~~~lv  716 (912)
                      .|.+....+.|..+.||++...+|+.+++|......       ...+.+|+++++.+++.+  +.+++++...++..++|
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~-------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v   93 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL   93 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT-------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred             CCceEecccCCCCceEEEEecCCCCeEEEEeCCccc-------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEE
Confidence            444433334666799999987778889999975431       134668999999986444  56689998888889999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNC-----------------------------------  761 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----------------------------------  761 (912)
                      |||++|.++.  ..  .    .   ....++.++++.++.||+..                                   
T Consensus        94 ~e~i~G~~l~--~~--~----~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (264)
T 1nd4_A           94 LGEVPGQDLL--SS--H----L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH  162 (264)
T ss_dssp             EECCSSEETT--TS--C----C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred             EEecCCcccC--cC--c----C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence            9999998884  21  1    1   12367788888888888752                                   


Q ss_pred             --------------------CCCeeecCCCCCCeEEcCCCcEEEeccccccc
Q 039137          762 --------------------FPPIVHRDISSKNVLLDLGYEAHVSDFGIAKF  793 (912)
Q Consensus       762 --------------------~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  793 (912)
                                          .+.++|+|++|.||++++++.+.++||+.+..
T Consensus       163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                01299999999999998776677999998863

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=99.01  E-value=6.7e-09  Score=115.32  Aligned_cols=142  Identities=12%  Similarity=0.114  Sum_probs=69.0

Q ss_pred             cccccccccEEEccCccccCCCCccccccccccEEEccCCcccCCCccccccccccccccccCcccCccccccccccccc
Q 039137          368 EIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKL  447 (912)
Q Consensus       368 ~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  447 (912)
                      .+....+|+.+.+..+ +.......+.+...|+.+.+..+ ++.....+|..+.+|+.+.+..+ +..+....|.++.+|
T Consensus       212 ~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L  288 (379)
T 4h09_A          212 GFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNL  288 (379)
T ss_dssp             TTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTC
T ss_pred             ccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceecccccccccccc
Confidence            3334444555554433 22223334445555555555443 33233444555555555555332 444444455555555


Q ss_pred             cEEEecccccccccchhhhcccccceeeccccccCcccccccccccccccccccCccccCCCccccc
Q 039137          448 YYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFE  514 (912)
Q Consensus       448 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~  514 (912)
                      +.+.+.++.++.+....|.++.+|+.++|..+ ++.+...+|.++.+|+.+.+..+ ++.+-..+|.
T Consensus       289 ~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~  353 (379)
T 4h09_A          289 TKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFE  353 (379)
T ss_dssp             CEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTT
T ss_pred             ccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhh
Confidence            55555555555444555555555555555433 44444455555555555555433 4433334443

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.98  E-value=2.4e-10  Score=124.88  Aligned_cols=83  Identities=20%  Similarity=0.375  Sum_probs=45.5

Q ss_pred             ccccccccccCcccCccccccc---cccccccEEEecccccccc----cchhhhcccccceeeccccccCccccccccc-
Q 039137          420 LINLEYLDLSANNLSNFVPESL---GSLVKLYYLNLSHNKLSQQ----IPIELDNLIHLSELDLSHNFLGEKISSRICR-  491 (912)
Q Consensus       420 l~~L~~L~Ls~N~l~~~~~~~~---~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-  491 (912)
                      +++|++|+|++|.+.+..+..+   ..+++|++|+|+.|.|++.    ++..+..+++|+.|+|++|.|++..-..+.. 
T Consensus       251 ~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~a  330 (362)
T 2ra8_A          251 FPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKS  330 (362)
T ss_dssp             CTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHH
T ss_pred             CCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHH
Confidence            4555555555555543222222   2356777777777776543    2333455677777777777776543333332 


Q ss_pred             ccccccccccCcc
Q 039137          492 MESLEKLNLSYNN  504 (912)
Q Consensus       492 l~~L~~L~ls~N~  504 (912)
                      +  ...+++++|+
T Consensus       331 l--g~~~~~~~~~  341 (362)
T 2ra8_A          331 L--PMKIDVSDSQ  341 (362)
T ss_dssp             C--CSEEECCSBC
T ss_pred             c--CCEEEecCCc
Confidence            2  2456777766

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=98.96  E-value=9.5e-09  Score=114.11  Aligned_cols=153  Identities=10%  Similarity=0.065  Sum_probs=118.9

Q ss_pred             cccccccEEEccCccccCCCCccccccccccEEEccCCcccCCCccccccccccccccccCcccCccccccccccccccE
Q 039137          370 GESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYY  449 (912)
Q Consensus       370 ~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  449 (912)
                      .....+..+.+....-. .....+.....|+.+.+..+ +.......+..+..|+.+.+..+ ++.+....|.++.+|+.
T Consensus       191 ~~~~~~~~~~~~~~~~~-i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~  267 (379)
T 4h09_A          191 PAAKTGTEFTIPSTVKT-VTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKT  267 (379)
T ss_dssp             CTTCCCSEEECCTTCCE-ECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCE
T ss_pred             cccccccccccccceeE-Eeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcc
Confidence            34445555555443322 34456667778888888765 44355677888899999999776 77777788999999999


Q ss_pred             EEecccccccccchhhhcccccceeeccccccCcccccccccccccccccccCccccCCCcccccccccceEEEccCC
Q 039137          450 LNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYN  527 (912)
Q Consensus       450 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~ls~N  527 (912)
                      +.+..+ ++.+....|.++.+|+.+++.++.++.+....|.++.+|+.++|..+ ++.+...+|.++.+|+.+.+..+
T Consensus       268 i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~  343 (379)
T 4h09_A          268 LNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS  343 (379)
T ss_dssp             EEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT
T ss_pred             cccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc
Confidence            999765 65566778999999999999999998888899999999999999755 77777889999999999988654

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.93  E-value=3.2e-09  Score=116.93  Aligned_cols=144  Identities=14%  Similarity=0.238  Sum_probs=108.2

Q ss_pred             CCceeeecCceEEEEEEeCCCCEEEEEEcc--CCCCCCchHHHHHHHHHHHHHhhcC--CCccccEEEEEEcC---Ceee
Q 039137          642 AEHCIGKGGHGSVYRAKVPSGEIFAVKKFH--SPLPGEMSFQQEEFLNEIQALTEIR--HRNIVKFYGFCSHP---KHSF  714 (912)
Q Consensus       642 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~~Ei~~l~~l~--h~niv~l~~~~~~~---~~~~  714 (912)
                      ..+.++.|.++.||+++.. +..+++|+..  .....   .....+.+|+.+++.+.  +..+++++.++.+.   +..+
T Consensus        42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~---~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~  117 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLL---PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF  117 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS-SCEEEEECCCC-------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred             eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCC---CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence            4578999999999999875 4678888875  22111   12346778999999996  45688999998776   4589


Q ss_pred             EEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------
Q 039137          715 IIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNC---------------------------------  761 (912)
Q Consensus       715 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~---------------------------------  761 (912)
                      +||||++|..+.+..     ...++..+...++.+++++|+.||+..                                 
T Consensus       118 ~vme~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (359)
T 3dxp_A          118 YIMEFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE  192 (359)
T ss_dssp             EEEECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred             EEEEecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence            999999998774421     124678888999999999999999831                                 


Q ss_pred             ----------------------CCCeeecCCCCCCeEEcCCCc--EEEecccccccc
Q 039137          762 ----------------------FPPIVHRDISSKNVLLDLGYE--AHVSDFGIAKFL  794 (912)
Q Consensus       762 ----------------------~~~ivH~Dlk~~Nill~~~~~--~kl~Dfgla~~~  794 (912)
                                            .+.++|||+++.||+++.++.  +.++||+.+...
T Consensus       193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                                  137999999999999997753  689999988753

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.93  E-value=7.5e-12  Score=129.57  Aligned_cols=146  Identities=17%  Similarity=0.117  Sum_probs=68.0

Q ss_pred             CCCccceeEecCCC-CeEEEeecc---ccccccccccccCCCCCccEEEccCCcccccCCc-cccCCCCCcE--Eecccc
Q 039137           71 SPCAWSGIFCNHAE-RVVGINLTS---ISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPP-QISNLSNLEY--LDFSAN  143 (912)
Q Consensus        71 ~~C~w~gv~c~~~~-~v~~l~l~~---~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~-~~~~l~~L~~--L~Ls~n  143 (912)
                      ..|+|.|+.|+..+ +|+.+...+   ..+.|.+.+..+..++.  .|...+|.-++.++- .|...+.|+.  ++++.|
T Consensus        76 ~l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N  153 (267)
T 3rw6_A           76 ALKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLN  153 (267)
T ss_dssp             HHHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTT
T ss_pred             HHHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCC
Confidence            46899999998654 554333322   23334443322222211  111222222222211 1333334444  555666


Q ss_pred             ccc---cccccccccccccceeecccccccC--CCCccccCcccccEEEccCCcCCCCCCccCCCCc--cceeeeeccCC
Q 039137          144 KLF---GQIPSGIGLLTHLTVLHISRNWLSG--SIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLT--HVVILYLYNNS  216 (912)
Q Consensus       144 ~l~---~~~p~~~~~l~~L~~L~L~~n~l~~--~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~--~L~~L~L~~n~  216 (912)
                      +..   +.++-....+++|+.|+|++|+|++  .+|..++.+++|+.|+|++|+|++.  ..+..++  +|++|+|++|.
T Consensus       154 ~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Np  231 (267)
T 3rw6_A          154 RRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNS  231 (267)
T ss_dssp             SHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTST
T ss_pred             HHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCc
Confidence            332   2222222345667777777776665  3345555666666666666666533  2222222  45555555555


Q ss_pred             CcCc
Q 039137          217 FFGS  220 (912)
Q Consensus       217 l~~~  220 (912)
                      +.+.
T Consensus       232 l~~~  235 (267)
T 3rw6_A          232 LCDT  235 (267)
T ss_dssp             TGGG
T ss_pred             Cccc
Confidence            5443

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.91  E-value=3e-10  Score=124.12  Aligned_cols=83  Identities=23%  Similarity=0.289  Sum_probs=53.1

Q ss_pred             cccccEEEccCCcccCCCccccc---cccccccccccCcccCccc----cccccccccccEEEecccccccccchhhhc-
Q 039137          396 IIYLNRLSLSGNKLSGCIPRELG---SLINLEYLDLSANNLSNFV----PESLGSLVKLYYLNLSHNKLSQQIPIELDN-  467 (912)
Q Consensus       396 l~~L~~L~L~~N~l~~~~p~~~~---~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-  467 (912)
                      +++|+.|+|.+|.+.+..+..+.   .+++|++|+|+.|.+.+..    +..+..+++|+.|+|++|.|+...-..+.. 
T Consensus       251 ~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~a  330 (362)
T 2ra8_A          251 FPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKS  330 (362)
T ss_dssp             CTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHH
T ss_pred             CCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHH
Confidence            45666666666666543332222   4677888888888877632    334456788888888888887544444443 


Q ss_pred             ccccceeeccccc
Q 039137          468 LIHLSELDLSHNF  480 (912)
Q Consensus       468 l~~L~~L~Ls~N~  480 (912)
                      +  ...++++.|+
T Consensus       331 l--g~~~~~~~~~  341 (362)
T 2ra8_A          331 L--PMKIDVSDSQ  341 (362)
T ss_dssp             C--CSEEECCSBC
T ss_pred             c--CCEEEecCCc
Confidence            2  3668888887

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.83  E-value=2.5e-09  Score=114.78  Aligned_cols=183  Identities=21%  Similarity=0.234  Sum_probs=124.5

Q ss_pred             CceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcC-CCc--cccEEEEEEcCC---eeeEE
Q 039137          643 EHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR-HRN--IVKFYGFCSHPK---HSFII  716 (912)
Q Consensus       643 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv  716 (912)
                      .+.++.|....||++.    ..+++|+....      .....+.+|++.++.+. +..  +.+++......+   ..|+|
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~------~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v   94 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS------RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG   94 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH------HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc------chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence            4679999999999863    56889985421      24567889999999883 433  455555543333   35899


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNC-----------------------------------  761 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----------------------------------  761 (912)
                      ||+++|.++.+...     ..++.+++..++.++++.++.||+..                                   
T Consensus        95 m~~i~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (304)
T 3sg8_A           95 FTKIKGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQ  169 (304)
T ss_dssp             EECCCCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHH
T ss_pred             EcccCCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCccc
Confidence            99999988865331     34677788889999999999998621                                   


Q ss_pred             --------------------CCCeeecCCCCCCeEEcC--CCcEEEeccccccccCCCCCCcccccccccc---cccccc
Q 039137          762 --------------------FPPIVHRDISSKNVLLDL--GYEAHVSDFGIAKFLNPDSSNWSELAGTHGY---VAPELA  816 (912)
Q Consensus       762 --------------------~~~ivH~Dlk~~Nill~~--~~~~kl~Dfgla~~~~~~~~~~~~~~g~~~y---~aPE~~  816 (912)
                                          .+.++|+|++|.||++++  +..+.++||+.+....+.. ..   .....+   ..|+..
T Consensus       170 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~-Dl---~~~~~~~~~~~~~~~  245 (304)
T 3sg8_A          170 MKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN-DF---ISLMEDDEEYGMEFV  245 (304)
T ss_dssp             HHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH-HH---HTTCCTTTSCCHHHH
T ss_pred             HHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH-HH---HHHHhhccccCHHHH
Confidence                                135899999999999998  4567899999987643311 00   000001   122211


Q ss_pred             c----cC----------CCCcchhHHHHHHHHHHHHhCCCCc
Q 039137          817 Y----TL----------KVTEKCDVYSFGVLALEVIKGKHPR  844 (912)
Q Consensus       817 ~----~~----------~~~~~sDvwslG~vl~elltg~~pf  844 (912)
                      .    ..          +.....+.|++|.++|++.+|+.+|
T Consensus       246 ~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          246 SKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            1    00          0122368999999999999999885

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.47  E-value=3.8e-08  Score=101.77  Aligned_cols=105  Identities=28%  Similarity=0.276  Sum_probs=58.5

Q ss_pred             ccccccccc--ccccCcccCc---cccccccccccccEEEeccccccc--ccchhhhcccccceeeccccccCccccccc
Q 039137          417 LGSLINLEY--LDLSANNLSN---FVPESLGSLVKLYYLNLSHNKLSQ--QIPIELDNLIHLSELDLSHNFLGEKISSRI  489 (912)
Q Consensus       417 ~~~l~~L~~--L~Ls~N~l~~---~~~~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~  489 (912)
                      +...+.|..  ++++.|+...   ..+....++++|+.|+|++|+|++  .+|..+..+++|+.|+|++|+|++.  ..+
T Consensus       137 l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l  214 (267)
T 3rw6_A          137 LRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--REL  214 (267)
T ss_dssp             GGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGG
T ss_pred             cCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhh
Confidence            333444544  5556664322   111122345667777777777765  3345566677777777777777654  223


Q ss_pred             cccc--ccccccccCccccCCCc-------ccccccccceEEE
Q 039137          490 CRME--SLEKLNLSYNNLSGLIP-------RCFEEMHGLLHID  523 (912)
Q Consensus       490 ~~l~--~L~~L~ls~N~l~~~~p-------~~~~~l~~L~~l~  523 (912)
                      ..+.  +|+.|+|++|++++..|       ..+..+++|+.||
T Consensus       215 ~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD  257 (267)
T 3rw6_A          215 DKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD  257 (267)
T ss_dssp             GGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred             hhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence            3333  66677777777665443       2355666666664

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.40  E-value=1.6e-06  Score=91.05  Aligned_cols=136  Identities=17%  Similarity=0.189  Sum_probs=101.8

Q ss_pred             ceeeecCce-EEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcC-CCccccEEEEEEcCCeeeEEEeec
Q 039137          644 HCIGKGGHG-SVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR-HRNIVKFYGFCSHPKHSFIIYEYL  720 (912)
Q Consensus       644 ~~lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  720 (912)
                      +.+..|..+ .||+.... ++..+++|+-...       ....+.+|...++.+. +--|.++++++.+++..++|||++
T Consensus        30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l  102 (272)
T 4gkh_A           30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS-------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAI  102 (272)
T ss_dssp             EEEECSSSSCEEEEEECCTTCCCEEEEEEETH-------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred             EEccCCCcCCeEEEEEecCCCeEEEEEECCCC-------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEee
Confidence            345666665 68988765 4667899985421       3566889999999884 444788999999999999999999


Q ss_pred             CCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCC--------------------------------------
Q 039137          721 ESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF--------------------------------------  762 (912)
Q Consensus       721 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~--------------------------------------  762 (912)
                      +|.++.+....       ...+...++.+++..++.||+...                                      
T Consensus       103 ~G~~~~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (272)
T 4gkh_A          103 PGKTAFQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWP  175 (272)
T ss_dssp             CSEEHHHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCC
T ss_pred             CCccccccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchH
Confidence            99888776522       123445677777888888876420                                      


Q ss_pred             -----------------CCeeecCCCCCCeEEcCCCcEEEeccccccc
Q 039137          763 -----------------PPIVHRDISSKNVLLDLGYEAHVSDFGIAKF  793 (912)
Q Consensus       763 -----------------~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  793 (912)
                                       +.++|+|+.+.||+++.++.+-|+||+.+..
T Consensus       176 ~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          176 VEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                             1379999999999999877777999998864

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.40  E-value=4.1e-08  Score=96.64  Aligned_cols=18  Identities=17%  Similarity=0.174  Sum_probs=9.5

Q ss_pred             ccccccccEEEccCc-ccc
Q 039137          369 IGESLQLQYLDLSSN-YIV  386 (912)
Q Consensus       369 ~~~~~~L~~L~L~~N-~l~  386 (912)
                      +...++|++|+|++| .+.
T Consensus        32 l~~~~~L~~L~L~~n~~i~   50 (185)
T 1io0_A           32 QNNDPDLEEVNLNNIMNIP   50 (185)
T ss_dssp             HTTCTTCCEEECTTCTTCC
T ss_pred             HhcCCCCCEEEecCCCCCC
Confidence            344455555555555 554

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.37  E-value=7e-08  Score=94.99  Aligned_cols=43  Identities=9%  Similarity=0.032  Sum_probs=23.4

Q ss_pred             cCCCCCCCCEEeccCC-ccccc----ccccccccccccEEEccCcccc
Q 039137          344 DWGRCPQLSLLDVSIN-NISGS----IPLEIGESLQLQYLDLSSNYIV  386 (912)
Q Consensus       344 ~~~~l~~L~~L~Ls~N-~l~~~----~~~~~~~~~~L~~L~L~~N~l~  386 (912)
                      .+...+.|++|+|++| .|...    +...+...++|++|+|++|+|.
T Consensus        31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~   78 (185)
T 1io0_A           31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSN   78 (185)
T ss_dssp             HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCC
T ss_pred             HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCC
Confidence            4455677777777777 66532    2223333445555555555554

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.29  E-value=6.9e-06  Score=87.79  Aligned_cols=137  Identities=19%  Similarity=0.171  Sum_probs=97.7

Q ss_pred             CceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCC---ccccEEEEEE-cCCeeeEEEe
Q 039137          643 EHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHR---NIVKFYGFCS-HPKHSFIIYE  718 (912)
Q Consensus       643 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e  718 (912)
                      .+.++.|....||+.    ++.+++|+...      ......+.+|+++++.+.+.   .|.+++.++. ..+..++|||
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~------~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e   93 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKS------QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR   93 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESS------HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCC------chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence            467889999999988    56788888421      12456788999999999642   3677777775 4566789999


Q ss_pred             ecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 039137          719 YLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNC-------------------------------------  761 (912)
Q Consensus       719 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-------------------------------------  761 (912)
                      |++|.++.+...     ..++..+...++.++++.++.||+..                                     
T Consensus        94 ~i~G~~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~  168 (306)
T 3tdw_A           94 KVQGQILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL  168 (306)
T ss_dssp             CCCSEECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred             ccCCeECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence            999988866321     12344555556666666666665431                                     


Q ss_pred             --------------------CCCeeecCCCCCCeEEcC---CCc-EEEecccccccc
Q 039137          762 --------------------FPPIVHRDISSKNVLLDL---GYE-AHVSDFGIAKFL  794 (912)
Q Consensus       762 --------------------~~~ivH~Dlk~~Nill~~---~~~-~kl~Dfgla~~~  794 (912)
                                          .+.++|+|+++.||+++.   ++. +.|+||+.+...
T Consensus       169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                                235699999999999997   455 489999988753

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.99  E-value=1.1e-05  Score=88.30  Aligned_cols=84  Identities=7%  Similarity=0.066  Sum_probs=56.5

Q ss_pred             Ccee-eecCceEEEEEEeC-------CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcC-C--CccccEEEEEEcC-
Q 039137          643 EHCI-GKGGHGSVYRAKVP-------SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR-H--RNIVKFYGFCSHP-  710 (912)
Q Consensus       643 ~~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h--~niv~l~~~~~~~-  710 (912)
                      .+.| +.|....+|+....       +++.+++|+......... .....+.+|+.+++.+. +  -.+.+++.++.+. 
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~-~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~  103 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPV-FPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD  103 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCS-SSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCcccc-CchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence            3567 88999999998764       267889998643210000 00134567888888884 3  3577888887655 


Q ss_pred             --CeeeEEEeecCCCChhh
Q 039137          711 --KHSFIIYEYLESGSLDK  727 (912)
Q Consensus       711 --~~~~lv~e~~~~g~L~~  727 (912)
                        +..++||||++|.++.+
T Consensus       104 ~~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          104 VLGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             TTSSCEEEEECCCCBCCCB
T ss_pred             ccCCceEEEEecCCCChhh
Confidence              45789999999877653

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.82  E-value=6.4e-05  Score=83.56  Aligned_cols=79  Identities=14%  Similarity=0.100  Sum_probs=50.5

Q ss_pred             CceeeecCceEEEEEEeC-CCCEEEEEEccCCCC--C-CchHHHHHHHHHHHHHhhcCC--C-ccccEEEEEEcCCeeeE
Q 039137          643 EHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLP--G-EMSFQQEEFLNEIQALTEIRH--R-NIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       643 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~-~~~~~~~~~~~Ei~~l~~l~h--~-niv~l~~~~~~~~~~~l  715 (912)
                      .+.+|.|..+.||+++.. +++.|++|.......  . ......+++..|.+.++.+..  + .+.+++.+  +++..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            467999999999999764 568899998653221  0 000123456778999888742  3 34456644  3456789


Q ss_pred             EEeecCCC
Q 039137          716 IYEYLESG  723 (912)
Q Consensus       716 v~e~~~~g  723 (912)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999763

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.77  E-value=9.4e-06  Score=77.64  Aligned_cols=83  Identities=13%  Similarity=0.118  Sum_probs=39.7

Q ss_pred             ccccccccCcccCccccccccccccccEEEecccc-cccccchhhhcc----cccceeeccccc-cCccccccccccccc
Q 039137          422 NLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNK-LSQQIPIELDNL----IHLSELDLSHNF-LGEKISSRICRMESL  495 (912)
Q Consensus       422 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l----~~L~~L~Ls~N~-l~~~~~~~~~~l~~L  495 (912)
                      .|+.||++++.++...-..+..+++|++|+|++|. |++.--..+..+    ++|++|+|++|. |++.--..+..+++|
T Consensus        62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L  141 (176)
T 3e4g_A           62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL  141 (176)
T ss_dssp             CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred             eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence            34555555555444333444455555555555553 443333333332    245555555543 544433344455555


Q ss_pred             ccccccCcc
Q 039137          496 EKLNLSYNN  504 (912)
Q Consensus       496 ~~L~ls~N~  504 (912)
                      +.|+++++.
T Consensus       142 ~~L~L~~c~  150 (176)
T 3e4g_A          142 KYLFLSDLP  150 (176)
T ss_dssp             CEEEEESCT
T ss_pred             CEEECCCCC
Confidence            555555543

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.76  E-value=9.4e-05  Score=80.32  Aligned_cols=141  Identities=20%  Similarity=0.302  Sum_probs=80.3

Q ss_pred             ceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCC--CccccEEE------EEEcCCeeeE
Q 039137          644 HCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH--RNIVKFYG------FCSHPKHSFI  715 (912)
Q Consensus       644 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h--~niv~l~~------~~~~~~~~~l  715 (912)
                      +.|+.|..+.||++...+| .+++|+....        .+++..|+.+++.+..  -.+++++.      +....+..++
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~--------~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~  108 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP--------EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFV  108 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC--------HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEE
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC--------HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEE
Confidence            4566678899999987554 5899998641        1233455666665531  12333332      1234667899


Q ss_pred             EEeecCCCChh-----h------H---hhccCC----c-------ccCCHHH----------------------------
Q 039137          716 IYEYLESGSLD-----K------I---LCNDAS----A-------KELGWTQ----------------------------  742 (912)
Q Consensus       716 v~e~~~~g~L~-----~------~---l~~~~~----~-------~~l~~~~----------------------------  742 (912)
                      +|||++|.++.     .      .   ++....    .       ..-.|..                            
T Consensus       109 l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  188 (346)
T 2q83_A          109 VYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLY  188 (346)
T ss_dssp             EEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHH
T ss_pred             EEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHH
Confidence            99999986542     0      1   111100    0       0011211                            


Q ss_pred             ---HHHHHHHHHHHHHHHHh----------CCCCCeeecCCCCCCeEEcCCCcEEEeccccccc
Q 039137          743 ---RLNVIKGVADALFYLHN----------NCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKF  793 (912)
Q Consensus       743 ---~~~i~~~i~~~L~~LH~----------~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  793 (912)
                         ...+..++..++++|++          ...+.++|+|+++.||+++.++.+.++||+.+..
T Consensus       189 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          189 LQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence               11112234446666663          0124899999999999998888999999998753

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.73  E-value=0.00018  Score=76.51  Aligned_cols=139  Identities=17%  Similarity=0.186  Sum_probs=93.1

Q ss_pred             CCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcC---CCccccEEEEEEcCCeeeEEEe
Q 039137          642 AEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR---HRNIVKFYGFCSHPKHSFIIYE  718 (912)
Q Consensus       642 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~~~~~~lv~e  718 (912)
                      -.+.|+.|....+|+... ++..+++|+....       ....+.+|.+.++.+.   ...+++++.+....+..++|||
T Consensus        40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~-------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme  111 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS-------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE  111 (312)
T ss_dssp             EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG-------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred             eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc-------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence            346799999999999986 5678899986421       3566889999999984   3678899999988889999999


Q ss_pred             ecCCCChhh-----------HhhccCCcc-------------------cCCHHHHH---HHH----------------HH
Q 039137          719 YLESGSLDK-----------ILCNDASAK-------------------ELGWTQRL---NVI----------------KG  749 (912)
Q Consensus       719 ~~~~g~L~~-----------~l~~~~~~~-------------------~l~~~~~~---~i~----------------~~  749 (912)
                      |+++..+..           -++......                   .-+|.+..   ++.                ..
T Consensus       112 ~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~  191 (312)
T 3jr1_A          112 ALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDL  191 (312)
T ss_dssp             CCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHH
T ss_pred             eccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHH
Confidence            999976521           112211100                   01343321   111                11


Q ss_pred             HHHH-HHHHHh-CCCCCeeecCCCCCCeEEcCCCcEEEeccc
Q 039137          750 VADA-LFYLHN-NCFPPIVHRDISSKNVLLDLGYEAHVSDFG  789 (912)
Q Consensus       750 i~~~-L~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  789 (912)
                      ++.. .+.|.. ...+.++|+|+.+.|++++.++ +.+.|+.
T Consensus       192 l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          192 IVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            1111 223432 2235899999999999999887 8899974

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.67  E-value=2.2e-05  Score=75.07  Aligned_cols=82  Identities=11%  Similarity=0.058  Sum_probs=45.3

Q ss_pred             CccEEEccCCcCcccccccCCCCCCCCEEeccCCc-cccccccccccc----ccccEEEccCcc-ccCCCCccccccccc
Q 039137          326 NLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINN-ISGSIPLEIGES----LQLQYLDLSSNY-IVGEIPTQLGNIIYL  399 (912)
Q Consensus       326 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~~----~~L~~L~L~~N~-l~~~~~~~l~~l~~L  399 (912)
                      .|+.|||+++.++......+..+++|++|+|++|. |+..--..++.+    ++|++|+|++|. |+..--..+..+++|
T Consensus        62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L  141 (176)
T 3e4g_A           62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL  141 (176)
T ss_dssp             CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred             eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence            56667777666666555556666666666666664 443322333332    246666666653 544333344455555


Q ss_pred             cEEEccCC
Q 039137          400 NRLSLSGN  407 (912)
Q Consensus       400 ~~L~L~~N  407 (912)
                      ++|+++++
T Consensus       142 ~~L~L~~c  149 (176)
T 3e4g_A          142 KYLFLSDL  149 (176)
T ss_dssp             CEEEEESC
T ss_pred             CEEECCCC
Confidence            55555554

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.49  E-value=0.00055  Score=72.20  Aligned_cols=79  Identities=16%  Similarity=0.230  Sum_probs=57.6

Q ss_pred             CCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcC-C--CccccEEEEEEcCCeeeE
Q 039137          639 DFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR-H--RNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h--~niv~l~~~~~~~~~~~l  715 (912)
                      +..-.+.+|.|..+.||+.+..+|+.|++|+.......    ....|.+|+..|+.+. .  --+++++++.    ..++
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~----~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~l   87 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPA----LDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTL   87 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCC----CTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEE
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcc----hhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceE
Confidence            45556889999999999999999999999986543222    2345678999999884 2  2355566542    3578


Q ss_pred             EEeecCCCCh
Q 039137          716 IYEYLESGSL  725 (912)
Q Consensus       716 v~e~~~~g~L  725 (912)
                      ||||++++..
T Consensus        88 v~e~l~~~~~   97 (288)
T 3f7w_A           88 AMEWVDERPP   97 (288)
T ss_dssp             EEECCCCCCC
T ss_pred             EEEeecccCC
Confidence            9999987654

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.44  E-value=0.00089  Score=74.81  Aligned_cols=76  Identities=12%  Similarity=0.085  Sum_probs=47.1

Q ss_pred             CCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCCCcccccc--ccccccccccccC---CCCcchhHHHHHHHHHHH
Q 039137          763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAG--THGYVAPELAYTL---KVTEKCDVYSFGVLALEV  837 (912)
Q Consensus       763 ~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~g--~~~y~aPE~~~~~---~~~~~sDvwslG~vl~el  837 (912)
                      +.++|||+++.||+++.++ ++++||+.+....+.. .......  ...|.+|+.....   ......++......+|+.
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~-Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF-DIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL  309 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH-HHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH-HHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence            3899999999999999876 9999999987543211 1111111  1345666654311   112234556777777777


Q ss_pred             HhC
Q 039137          838 IKG  840 (912)
Q Consensus       838 ltg  840 (912)
                      +++
T Consensus       310 y~~  312 (420)
T 2pyw_A          310 FNK  312 (420)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            654

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.25  E-value=9.8e-05  Score=71.98  Aligned_cols=89  Identities=13%  Similarity=0.149  Sum_probs=39.8

Q ss_pred             ccccccccEEEccCCcccCC----CccccccccccccccccCcccCcccc----ccccccccccEEEeccc---cccc--
Q 039137          393 LGNIIYLNRLSLSGNKLSGC----IPRELGSLINLEYLDLSANNLSNFVP----ESLGSLVKLYYLNLSHN---KLSQ--  459 (912)
Q Consensus       393 l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~~----~~~~~l~~L~~L~Ls~N---~l~~--  459 (912)
                      +...+.|+.|+|++|+|.+.    +.+.+...+.|++|+|++|.|.....    +.+..-+.|++|+|++|   .+..  
T Consensus        66 L~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g  145 (197)
T 1pgv_A           66 ACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQV  145 (197)
T ss_dssp             HTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHH
T ss_pred             HhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHH
Confidence            33344555555555555422    22233344555555555555543211    22333345556666543   2221  


Q ss_pred             --ccchhhhcccccceeecccccc
Q 039137          460 --QIPIELDNLIHLSELDLSHNFL  481 (912)
Q Consensus       460 --~~~~~~~~l~~L~~L~Ls~N~l  481 (912)
                        .+...+..-+.|+.|+++.|.+
T Consensus       146 ~~~ia~aL~~N~tL~~L~l~~~~~  169 (197)
T 1pgv_A          146 EMDMMMAIEENESLLRVGISFASM  169 (197)
T ss_dssp             HHHHHHHHHHCSSCCEEECCCCCH
T ss_pred             HHHHHHHHHhCCCcCeEeccCCCc
Confidence              1223344445555555555544

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.23  E-value=7.2e-05  Score=72.94  Aligned_cols=85  Identities=13%  Similarity=0.130  Sum_probs=43.6

Q ss_pred             ccccccEEEccCC-cccCC----CccccccccccccccccCcccCcccccc----ccccccccEEEecccccccc----c
Q 039137          395 NIIYLNRLSLSGN-KLSGC----IPRELGSLINLEYLDLSANNLSNFVPES----LGSLVKLYYLNLSHNKLSQQ----I  461 (912)
Q Consensus       395 ~l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~~~~----~~~l~~L~~L~Ls~N~l~~~----~  461 (912)
                      +-+.|+.|+|++| +|...    +.+.+...+.|+.|+|++|+|.......    +..-+.|++|+|++|.|+..    +
T Consensus        39 ~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~al  118 (197)
T 1pgv_A           39 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL  118 (197)
T ss_dssp             TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred             cCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHH
Confidence            3445566666553 44421    2334455566777777777776433222    23345666666666666532    2


Q ss_pred             chhhhcccccceeecccc
Q 039137          462 PIELDNLIHLSELDLSHN  479 (912)
Q Consensus       462 ~~~~~~l~~L~~L~Ls~N  479 (912)
                      -..+..-+.|++|+|++|
T Consensus       119 a~aL~~N~tL~~L~L~n~  136 (197)
T 1pgv_A          119 LRSTLVTQSIVEFKADNQ  136 (197)
T ss_dssp             HHHTTTTCCCSEEECCCC
T ss_pred             HHHHhhCCceeEEECCCC
Confidence            223333345555655543

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.20  E-value=0.0021  Score=68.21  Aligned_cols=71  Identities=14%  Similarity=0.099  Sum_probs=46.0

Q ss_pred             CceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCcc-ccEEEEEEcCCeeeEEEeec-
Q 039137          643 EHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNI-VKFYGFCSHPKHSFIIYEYL-  720 (912)
Q Consensus       643 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-  720 (912)
                      .+.|+.|....+|+.     +.+++|+........     ....+|+..++.+...++ .+++++  .++..++++||+ 
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-----~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~   90 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-----INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIA   90 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC----C-----CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCT
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccce-----eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecC
Confidence            688999999999998     568889876432111     112368888887743233 456554  344568999999 


Q ss_pred             CCCCh
Q 039137          721 ESGSL  725 (912)
Q Consensus       721 ~~g~L  725 (912)
                      ++.++
T Consensus        91 ~g~~l   95 (301)
T 3dxq_A           91 GAQTM   95 (301)
T ss_dssp             TCEEC
T ss_pred             CCccC
Confidence            66444

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.11  E-value=0.0028  Score=68.26  Aligned_cols=143  Identities=15%  Similarity=0.117  Sum_probs=75.0

Q ss_pred             ceeeecCceE-EEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcC-C-CccccEEEEEEcCCeeeEEEeec
Q 039137          644 HCIGKGGHGS-VYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR-H-RNIVKFYGFCSHPKHSFIIYEYL  720 (912)
Q Consensus       644 ~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h-~niv~l~~~~~~~~~~~lv~e~~  720 (912)
                      +.|+.|.... +|+....+++.+++|.......       +.+..|+.+++.+. + -.+.+++.+....  .+++||++
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~-------~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l   94 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG-------GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDL   94 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTT-------CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCC
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC-------ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeC
Confidence            4566665554 6777654477788876543211       12345777777774 2 2356677764332  37899999


Q ss_pred             CCCChhhHhhccC---------------------C--cccCCHHHHH-------HH-------------HHHHHHHHHHH
Q 039137          721 ESGSLDKILCNDA---------------------S--AKELGWTQRL-------NV-------------IKGVADALFYL  757 (912)
Q Consensus       721 ~~g~L~~~l~~~~---------------------~--~~~l~~~~~~-------~i-------------~~~i~~~L~~L  757 (912)
                      ++..+.+++....                     .  ...++.....       .+             ...+...++.+
T Consensus        95 ~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l  174 (333)
T 3csv_A           95 GDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQI  174 (333)
T ss_dssp             CSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHH
T ss_pred             CCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHH
Confidence            8766654432110                     0  0111111100       00             01111222222


Q ss_pred             H---hCCCCCeeecCCCCCCeEEcCC----CcEEEeccccccccC
Q 039137          758 H---NNCFPPIVHRDISSKNVLLDLG----YEAHVSDFGIAKFLN  795 (912)
Q Consensus       758 H---~~~~~~ivH~Dlk~~Nill~~~----~~~kl~Dfgla~~~~  795 (912)
                      .   ....+.++|||+.+.||+++.+    +.+.++||+.+....
T Consensus       175 ~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~  219 (333)
T 3csv_A          175 LSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH  219 (333)
T ss_dssp             HHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred             HHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence            1   1123479999999999999875    679999999887543

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.07  E-value=0.0018  Score=69.45  Aligned_cols=159  Identities=13%  Similarity=0.145  Sum_probs=88.4

Q ss_pred             ccHHHHHHHhcCCCCC-----ceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCc--c
Q 039137          628 IVYEEIISATNDFNAE-----HCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRN--I  700 (912)
Q Consensus       628 ~~~~e~~~~~~~~~~~-----~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n--i  700 (912)
                      +..+++.....+|.+.     +.|+.|....+|+....+| .+++|......      ..+.+..|+.+++.+...+  +
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~------~~~~l~~e~~~l~~L~~~g~~v   79 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV------EKNDLPFFLGLMQHLAAKGLSC   79 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---------CCHHHHHHHHHHHHHHTTCCC
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC------CHHHHHHHHHHHHHHHHCCCCC
Confidence            4455666666667652     3466788899999987555 68899876421      1233456777777774212  3


Q ss_pred             ccEEEE------EEcCCeeeEEEeecCCCChhh-----------H---hhccC-C---c-----ccCCHHHHHH------
Q 039137          701 VKFYGF------CSHPKHSFIIYEYLESGSLDK-----------I---LCNDA-S---A-----KELGWTQRLN------  745 (912)
Q Consensus       701 v~l~~~------~~~~~~~~lv~e~~~~g~L~~-----------~---l~~~~-~---~-----~~l~~~~~~~------  745 (912)
                      .+++..      ....+..+++|+|++|..+..           .   ++... .   .     ....|.....      
T Consensus        80 P~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~  159 (322)
T 2ppq_A           80 PLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERA  159 (322)
T ss_dssp             CCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGG
T ss_pred             CcccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHH
Confidence            333321      123456789999999865421           0   11110 0   0     0001211100      


Q ss_pred             ------HHHHHHHHHHHHHhC----CCCCeeecCCCCCCeEEcCCCcEEEeccccccc
Q 039137          746 ------VIKGVADALFYLHNN----CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKF  793 (912)
Q Consensus       746 ------i~~~i~~~L~~LH~~----~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  793 (912)
                            +...+...++++++.    ..+.++|+|+++.||+++.++.+.++||+.+..
T Consensus       160 ~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          160 DEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             GGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence                  001234455555532    124799999999999999876668999997753

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.94  E-value=0.0084  Score=64.22  Aligned_cols=159  Identities=13%  Similarity=0.176  Sum_probs=88.9

Q ss_pred             ccHHHHHHHhcCCCC-----CceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCC--cc
Q 039137          628 IVYEEIISATNDFNA-----EHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHR--NI  700 (912)
Q Consensus       628 ~~~~e~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~--ni  700 (912)
                      ...+++......|.+     ...++ |....||+....+|+.+++|.......     ..+.+..|..+++.+...  .+
T Consensus        11 l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-----~~~~~~~E~~~~~~L~~~g~~v   84 (328)
T 1zyl_A           11 LHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERW-----TADQILEEHQFALQLVNDEVPV   84 (328)
T ss_dssp             CCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTS-----CHHHHHHHHHHHHHHHHTTCSB
T ss_pred             CCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCC-----CHHHHHHHHHHHHHHHHcCCee
Confidence            344444444444432     24566 888899998877787899999863311     234566788888887422  24


Q ss_pred             ccEEEE-----EEcCCeeeEEEeecCCCChh-----hH---------hhccC------CcccCCHHHH----HH------
Q 039137          701 VKFYGF-----CSHPKHSFIIYEYLESGSLD-----KI---------LCNDA------SAKELGWTQR----LN------  745 (912)
Q Consensus       701 v~l~~~-----~~~~~~~~lv~e~~~~g~L~-----~~---------l~~~~------~~~~l~~~~~----~~------  745 (912)
                      ++++..     ....+..+++|||++|..+.     .+         ++...      .....++...    ..      
T Consensus        85 p~~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  164 (328)
T 1zyl_A           85 AAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDAT  164 (328)
T ss_dssp             CCCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCS
T ss_pred             cceeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcC
Confidence            444432     12245668899999885432     11         11100      0011121111    00      


Q ss_pred             ---------HHHHHHHHHHHHHhC----CCCCeeecCCCCCCeEEcCCCcEEEecccccccc
Q 039137          746 ---------VIKGVADALFYLHNN----CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL  794 (912)
Q Consensus       746 ---------i~~~i~~~L~~LH~~----~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  794 (912)
                               +...+...++.+.+.    ..+.++|+|+++.||+++ + .+.++||+.+...
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g  224 (328)
T 1zyl_A          165 LIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG  224 (328)
T ss_dssp             SSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence                     111111222333221    123689999999999999 4 8999999987643

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.93  E-value=0.0033  Score=61.38  Aligned_cols=103  Identities=18%  Similarity=0.101  Sum_probs=67.0

Q ss_pred             CChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCCCcc
Q 039137          723 GSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWS  802 (912)
Q Consensus       723 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  802 (912)
                      -+|.+++...  ..+++++++|.++.|.+.+|.-.-.+.  .-..+=+.|..|++..+|.|...+ +.+.          
T Consensus        33 vSL~eIL~~~--~~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------   97 (229)
T 2yle_A           33 LSLEEILRLY--NQPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD----------   97 (229)
T ss_dssp             EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred             ccHHHHHHHc--CCCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc----------
Confidence            3788998543  367999999999999999988873211  112333457899999999988764 1111          


Q ss_pred             ccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCC
Q 039137          803 ELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP  843 (912)
Q Consensus       803 ~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p  843 (912)
                        .....+.|||... ...+.+.=|||+|+++|.-+--..|
T Consensus        98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence              1123466888653 3457888999999999998864444

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.91  E-value=0.00078  Score=61.33  Aligned_cols=57  Identities=19%  Similarity=0.211  Sum_probs=37.6

Q ss_pred             eeeccccccC-cccccccccccccccccccCccccCCCcccccccccceEEEccCCcccc
Q 039137          473 ELDLSHNFLG-EKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEG  531 (912)
Q Consensus       473 ~L~Ls~N~l~-~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~  531 (912)
                      .++.+++.|+ ..+|..+  -++|+.|+|++|+|+.+.+..|..+++|+.|+|++|+|.|
T Consensus        12 ~v~Cs~~~L~~~~vP~~l--p~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~C   69 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAF--PVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRC   69 (130)
T ss_dssp             EEECCSSCCCTTTSCSCC--CTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBC
T ss_pred             EEEeCCCCCccccCCCCC--CcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeec
Confidence            5566666664 1333322  1356777777777777777777777778888888887776

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.88  E-value=0.0029  Score=69.02  Aligned_cols=142  Identities=16%  Similarity=0.190  Sum_probs=85.1

Q ss_pred             CceeeecCceEEEEEEeC--------CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcC-CCccccEEEEEEcCCee
Q 039137          643 EHCIGKGGHGSVYRAKVP--------SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR-HRNIVKFYGFCSHPKHS  713 (912)
Q Consensus       643 ~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~  713 (912)
                      .+.+..|....+|++...        +++.|++|+..... .    ....+.+|..+++.+. +.-..++++++..    
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~----~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----  125 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-Q----GVDSLVLESVMFAILAERSLGPQLYGVFPE----  125 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----C----CHHHHHHHHHHHHHHHHTTSSCCEEEEETT----
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-c----hHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----
Confidence            356878889999999864        35789999863211 1    2455668999999884 4444667766643    


Q ss_pred             eEEEeecCCCChhhH--------------h---hccC--CcccCC--HHHHHHHHHHHHH-------------------H
Q 039137          714 FIIYEYLESGSLDKI--------------L---CNDA--SAKELG--WTQRLNVIKGVAD-------------------A  753 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~--------------l---~~~~--~~~~l~--~~~~~~i~~~i~~-------------------~  753 (912)
                      .+||||++|.++..-              +   +...  ..+...  +.++.++..++..                   .
T Consensus       126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~  205 (379)
T 3feg_A          126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE  205 (379)
T ss_dssp             EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred             ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence            399999998655311              0   1111  011122  4555555544422                   1


Q ss_pred             HHHH----HhC-CCCCeeecCCCCCCeEEcCC----CcEEEeccccccc
Q 039137          754 LFYL----HNN-CFPPIVHRDISSKNVLLDLG----YEAHVSDFGIAKF  793 (912)
Q Consensus       754 L~~L----H~~-~~~~ivH~Dlk~~Nill~~~----~~~kl~Dfgla~~  793 (912)
                      ++.|    ... ....++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            2332    221 12368999999999999876    7899999998864

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.83  E-value=0.002  Score=71.93  Aligned_cols=73  Identities=18%  Similarity=0.250  Sum_probs=50.6

Q ss_pred             CceeeecCceEEEEEEeCC--------CCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcC-CCccccEEEEEEcCCee
Q 039137          643 EHCIGKGGHGSVYRAKVPS--------GEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR-HRNIVKFYGFCSHPKHS  713 (912)
Q Consensus       643 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~  713 (912)
                      .+.|+.|....||++...+        ++.|++|+...+  .    ..+.+.+|..+++.+. +.-.+++++.+..    
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~----~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----  147 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--E----TESHLVAESVIFTLLSERHLGPKLYGIFSG----  147 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--C----CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--C----cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----
Confidence            3678889999999998653        578999987432  1    1244557999999885 3334667776532    


Q ss_pred             eEEEeecCCCCh
Q 039137          714 FIIYEYLESGSL  725 (912)
Q Consensus       714 ~lv~e~~~~g~L  725 (912)
                      .+||||++|.++
T Consensus       148 g~v~e~l~G~~l  159 (429)
T 1nw1_A          148 GRLEEYIPSRPL  159 (429)
T ss_dssp             EEEECCCCEEEC
T ss_pred             CEEEEEeCCccc
Confidence            389999987443

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.55  E-value=0.012  Score=65.82  Aligned_cols=74  Identities=16%  Similarity=0.153  Sum_probs=48.0

Q ss_pred             CceeeecCceEEEEEEeCC-CCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCc-cccEEEEEEcCCeeeEEEeec
Q 039137          643 EHCIGKGGHGSVYRAKVPS-GEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRN-IVKFYGFCSHPKHSFIIYEYL  720 (912)
Q Consensus       643 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~  720 (912)
                      .+.|+.|-...+|++...+ ++.|++|+.........  .   ..+|..+++.+...+ ..++++++.  +  .+||||+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i--d---R~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I  183 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII--N---REREKKISCILYNKNIAKKIYVFFT--N--GRIEEFM  183 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS--C---HHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECC
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc--C---HHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEee
Confidence            3678889999999998764 47888998753221111  1   147899999886433 466777762  2  3599999


Q ss_pred             CCCCh
Q 039137          721 ESGSL  725 (912)
Q Consensus       721 ~~g~L  725 (912)
                      +|.++
T Consensus       184 ~G~~l  188 (458)
T 2qg7_A          184 DGYAL  188 (458)
T ss_dssp             CSEEC
T ss_pred             CCccC
Confidence            88544

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.55  E-value=0.0021  Score=58.39  Aligned_cols=56  Identities=27%  Similarity=0.254  Sum_probs=30.9

Q ss_pred             cccccCcccC-ccccccccccccccEEEecccccccccchhhhcccccceeeccccccC
Q 039137          425 YLDLSANNLS-NFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLG  482 (912)
Q Consensus       425 ~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  482 (912)
                      .++.+++.++ ..+|..+.  ++|+.|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus        12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            4555555554 12343333  35666666666666555555566666666666666553

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.49  E-value=0.011  Score=63.83  Aligned_cols=32  Identities=22%  Similarity=0.238  Sum_probs=28.4

Q ss_pred             CCeeecCCCCCCeEEcCCCcEEEecccccccc
Q 039137          763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL  794 (912)
Q Consensus       763 ~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  794 (912)
                      ..++|+|+.+.||+++.++.+.++||+.+...
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            47999999999999998888999999887654

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.12  E-value=0.0088  Score=65.34  Aligned_cols=74  Identities=9%  Similarity=0.090  Sum_probs=44.7

Q ss_pred             CceeeecCceEEEEEEeCC---------CCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCc-cccEEEEEEcCCe
Q 039137          643 EHCIGKGGHGSVYRAKVPS---------GEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRN-IVKFYGFCSHPKH  712 (912)
Q Consensus       643 ~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n-iv~l~~~~~~~~~  712 (912)
                      .+.++.|....+|+....+         ++.+++|+......     .......|...++.+...+ +.++++..  +  
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-----~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--  108 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-----ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--  108 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-----GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-----ceecHHHHHHHHHHHHhcCCCCceEEec--C--
Confidence            3567888889999998653         26888888653211     1112347888888885333 45677554  2  


Q ss_pred             eeEEEeecCCCCh
Q 039137          713 SFIIYEYLESGSL  725 (912)
Q Consensus       713 ~~lv~e~~~~g~L  725 (912)
                      -++||||++|.++
T Consensus       109 ~~~v~e~i~G~~l  121 (369)
T 3c5i_A          109 GGRIEEWLYGDPL  121 (369)
T ss_dssp             TEEEEECCCSEEC
T ss_pred             CcEEEEEecCCcC
Confidence            3789999988543

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.16  E-value=0.06  Score=59.46  Aligned_cols=141  Identities=9%  Similarity=0.075  Sum_probs=85.3

Q ss_pred             CceeeecCceEEEEEEeCC--------CCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcC-CCccccEEEEEEcCCee
Q 039137          643 EHCIGKGGHGSVYRAKVPS--------GEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR-HRNIVKFYGFCSHPKHS  713 (912)
Q Consensus       643 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~  713 (912)
                      .+.+..|....+|+....+        ++.|++|+........     -...+|..+++.+. +.-..++++.+  .  -
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~-----idR~~E~~~l~~L~~~gi~P~l~~~~--~--~  145 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF-----YDSKVELDVFRYLSNINIAPNIIADF--P--E  145 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC-----CCHHHHHHHHHHHHHTTSSCCEEEEE--T--T
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh-----cCHHHHHHHHHHHHhcCCCCCEEEEc--C--C
Confidence            3567788899999998753        5789999864322111     11247888888884 43356666543  2  3


Q ss_pred             eEEEeecCCCChhh--H------------h---hccC----------CcccCCHHHHHHHHHHH----------------
Q 039137          714 FIIYEYLESGSLDK--I------------L---CNDA----------SAKELGWTQRLNVIKGV----------------  750 (912)
Q Consensus       714 ~lv~e~~~~g~L~~--~------------l---~~~~----------~~~~l~~~~~~~i~~~i----------------  750 (912)
                      +.||||++|.++..  +            +   +...          ...+--+.++.++..++                
T Consensus       146 ~~I~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~  225 (424)
T 3mes_A          146 GRIEEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELY  225 (424)
T ss_dssp             EEEEECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHH
T ss_pred             CEEEEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccH
Confidence            78999999865421  0            0   1100          11111244444444332                


Q ss_pred             ---HHHHHHHHh---------------------CCCCCeeecCCCCCCeEEcCCCcEEEeccccccc
Q 039137          751 ---ADALFYLHN---------------------NCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKF  793 (912)
Q Consensus       751 ---~~~L~~LH~---------------------~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  793 (912)
                         ...+++|.+                     .....++|+|+.+.||+ +.++.+.++||..|..
T Consensus       226 ~~l~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          226 SKILEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence               122333321                     11236899999999999 8888999999998864

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=93.38  E-value=0.28  Score=47.96  Aligned_cols=117  Identities=9%  Similarity=0.077  Sum_probs=85.1

Q ss_pred             CCCccccEEEEEEcCCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCe
Q 039137          696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNV  775 (912)
Q Consensus       696 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Ni  775 (912)
                      .||++++. .+-.+.+.+.+.++.-+.  ...+-    .-...+....++++.+|+....+++.+     +|--++|+|+
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~--~~~f~----~ik~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~NL  110 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDN--HTPFD----NIKSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDEL  110 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTT--SEEGG----GGGGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGGE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcc--cCCHH----HHHhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecceE
Confidence            58888877 577777777666665432  22221    234577899999999999999887777     9999999999


Q ss_pred             EEcCCCcEEEeccccccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccc
Q 039137          776 LLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDF  846 (912)
Q Consensus       776 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~  846 (912)
                      +++.++.+++.-.|+-..+.                 |.     ..+...=.-.+=+++..++++++.|+.
T Consensus       111 ~f~~~~~p~i~~RGik~~l~-----------------P~-----~~~ee~fL~qyKAliiall~~K~~Fe~  159 (215)
T 4ann_A          111 FFTRDGLPIAKTRGLQNVVD-----------------PL-----PVSEAEFLTRYKALVICAFNEKQSFDA  159 (215)
T ss_dssp             EECTTSCEEESCCEETTTBS-----------------CC-----CCCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred             EEcCCCCEEEEEccCccCCC-----------------CC-----CCCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence            99999999998877654332                 22     123334445677888999999999863

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=91.53  E-value=0.8  Score=44.88  Aligned_cols=116  Identities=9%  Similarity=0.043  Sum_probs=83.2

Q ss_pred             CCCccccEEEEEEcCCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHH-HHHhCCCCCeeecCCCCCC
Q 039137          696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALF-YLHNNCFPPIVHRDISSKN  774 (912)
Q Consensus       696 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~-~LH~~~~~~ivH~Dlk~~N  774 (912)
                      .||++  -..+-.+++.+.+.++.-+++.=...+      ...+...+++++.+|+...+ +++.+     +|--++|+|
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i------~~~~~~eKlrll~nl~~L~~~~~~~r-----~tf~l~P~N  114 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI------RKTTLLSRIRAAIHLVSKVKHHSARR-----LIFIVCPEN  114 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH------HTSCHHHHHHHHHHHHHHHSSCCSSS-----EECCCCGGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH------HhcCHHHHHHHHHHHHHHHHHhhhCc-----eeEEEeCce
Confidence            57888  555667778887777765343222223      34778999999999999888 77766     899999999


Q ss_pred             eEEcCCCcEEEeccccccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccc
Q 039137          775 VLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDF  846 (912)
Q Consensus       775 ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~  846 (912)
                      ++++.++.+++.-.|+-..+                 +|..     .++..=.-++=+++..++.+++.|+.
T Consensus       115 L~f~~~~~p~i~hRGi~~~l-----------------pP~e-----~~ee~fl~qyKali~all~~K~~Fe~  164 (219)
T 4ano_A          115 LMFNRALEPFFLHVGVKESL-----------------PPDE-----WDDERLLREVKATVLALTEGEYRFDE  164 (219)
T ss_dssp             EEECTTCCEEESCCEETTTB-----------------SSCS-----CCHHHHHHHHHHHHHHHTTCSSCHHH
T ss_pred             EEEeCCCcEEEEEcCCcccC-----------------CCCC-----CCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence            99999999999877765433                 3321     22233344667888889999998863

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=90.65  E-value=1  Score=49.36  Aligned_cols=29  Identities=24%  Similarity=0.406  Sum_probs=24.9

Q ss_pred             eeecCCCCCCeEE------cCCCcEEEeccccccc
Q 039137          765 IVHRDISSKNVLL------DLGYEAHVSDFGIAKF  793 (912)
Q Consensus       765 ivH~Dlk~~Nill------~~~~~~kl~Dfgla~~  793 (912)
                      ++|+|+.+.||++      +++..++++||..|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            5799999999999      4566799999998864

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	912
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-59
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	6e-59
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	7e-57
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-56
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	7e-56
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	4e-55
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	6e-55
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	6e-55
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	7e-55
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-53
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-53
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	4e-53
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	5e-53
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-52
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-51
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-51
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	5e-51
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	6e-51
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-50
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-50
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	5e-50
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-49
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-49
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	5e-49
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	6e-49
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-48
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-48
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-48
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-48
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-46
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-46
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	5e-46
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-45
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-45
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-45
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	5e-45
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-44
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-43
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	4e-43
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	4e-43
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	9e-43
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-42
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-40
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	4e-40
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	7e-40
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-39
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-39
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-39
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-38
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	4e-38
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	5e-38
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	6e-37
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	5e-36
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	5e-35
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	5e-35
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	7e-35
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	4e-34
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	5e-32
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	6e-32
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-30
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-29
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	4e-27
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-25
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	6e-20
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-17
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	7e-15
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	8e-08
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-04
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-26
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-23
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	5e-16
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	3e-15
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-09
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-23
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	3e-23
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	1e-17
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	8e-14
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-20
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	3e-17
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	4e-10
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-07
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-04
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	8e-18
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	1e-11
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	1e-08
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-08
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	6e-08
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	5e-11
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-09
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-08
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	4e-04
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	6e-11
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	3e-10
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-08
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	6e-06
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-10
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-08
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.001
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.002
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.003
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.003
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.003
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.004
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	3e-09
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	8e-08
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	1e-07
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	4e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	5e-09
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-08
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	9e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	6e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	1e-08
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	7e-06
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	4e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	7e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.001
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.003
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	2e-08
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	3e-05
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	4e-05
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	1e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	0.002
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	0.002
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	2e-08
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	7e-06
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	4e-05
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	6e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	2e-07
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	7e-06
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	2e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	3e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	4e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	5e-04
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	5e-06
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	1e-04
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	1e-04
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	9e-06
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	2e-05
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	0.003
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	3e-05
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	3e-05
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	2e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	2e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	0.002
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	6e-05
d1m9la_	198	c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree	0.003

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (512), Expect = 3e-59
 Identities = 62/274 (22%), Positives = 115/274 (41%), Gaps = 19/274 (6%)

Query: 638 NDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH 697
                   +G G  G V+          AVK        + S   + FL E   + +++H
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-----QGSMSPDAFLAEANLMKQLQH 67

Query: 698 RNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYL 757
           + +V+ Y   +     +II EY+E+GSL   L    S  +L   + L++   +A+ + ++
Sbjct: 68  QRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFI 125

Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSE-LAGTHGYVAPELA 816
                   +HRD+ + N+L+       ++DFG+A+ +  +     E       + APE  
Sbjct: 126 EERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 182

Query: 817 YTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKK 876
                T K DV+SFG+L  E++         +   ++   +       R+  P  +  ++
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIP---YPGMTNPEVIQNLERGYRMVRPD-NCPEE 238

Query: 877 LMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF 910
           L  +M+    C  + PE RPT   +  +L E  F
Sbjct: 239 LYQLMR---LCWKERPEDRPTFDYLRSVL-EDFF 268

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (511), Expect = 6e-59
 Identities = 65/273 (23%), Positives = 117/273 (42%), Gaps = 18/273 (6%)

Query: 638 NDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH 697
                   IG G  G+VY+ K       AVK  +   P     Q + F NE+  L + RH
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQ--QLQAFKNEVGVLRKTRH 63

Query: 698 RNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYL 757
            NI+ F G+ + P+   I+ ++ E  SL   L       +    + +++ +  A  + YL
Sbjct: 64  VNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYL 120

Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN--WSELAGTHGYVAPEL 815
           H      I+HRD+ S N+ L       + DFG+A   +  S +  + +L+G+  ++APE+
Sbjct: 121 HAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177

Query: 816 AYTLK---VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLH 872
                    + + DVY+FG++  E++ G+ P   +         +    L   L     +
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN 237

Query: 873 VQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
             K +  +M     CL +  + RP   ++   +
Sbjct: 238 CPKAMKRLMA---ECLKKKRDERPLFPQILASI 267

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (495), Expect = 7e-57
 Identities = 64/273 (23%), Positives = 119/273 (43%), Gaps = 16/273 (5%)

Query: 635 SATNDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALT 693
           S   D+   + IG G +G   + +    G+I   K+       E   +++  ++E+  L 
Sbjct: 1   SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA--EKQMLVSEVNLLR 58

Query: 694 EIRHRNIVKFYGFCSHPKHS--FIIYEYLESGSLDKILCNDASAKE-LGWTQRLNVIKGV 750
           E++H NIV++Y       ++  +I+ EY E G L  ++      ++ L     L V+  +
Sbjct: 59  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 118

Query: 751 ADALFYLH--NNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTH 808
             AL   H  ++    ++HRD+   NV LD      + DFG+A+ LN D+S      GT 
Sbjct: 119 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTP 178

Query: 809 GYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPY 868
            Y++PE    +   EK D++S G L  E+     P       + S   +  ++ + +   
Sbjct: 179 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT-----AFSQKELAGKIREGKFRR 233

Query: 869 PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
                  +L  I+      L+     RP+++ +
Sbjct: 234 IPYRYSDELNEIIT---RMLNLKDYHRPSVEEI 263

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 1e-56
 Identities = 68/275 (24%), Positives = 117/275 (42%), Gaps = 19/275 (6%)

Query: 638 NDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH 697
           ++      IG G  G V+     + +  A+K        E +  +E+F+ E + + ++ H
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-----EGAMSEEDFIEEAEVMMKLSH 59

Query: 698 RNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYL 757
             +V+ YG C       +++E++E G L   L              L +   V + + YL
Sbjct: 60  PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFA--AETLLGMCLDVCEGMAYL 117

Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSE-LAGTHGYVAPELA 816
              C   ++HRD++++N L+       VSDFG+ +F+  D    S        + +PE+ 
Sbjct: 118 EEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 174

Query: 817 YTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKK 876
              + + K DV+SFGVL  EV          +E  S+S  +       RL  P L     
Sbjct: 175 SFSRYSSKSDVWSFGVLMWEVFSEGKI---PYENRSNSEVVEDISTGFRLYKPRLASTH- 230

Query: 877 LMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
              + Q+   C  + PE RP   R+ + L  +I E
Sbjct: 231 ---VYQIMNHCWKERPEDRPAFSRLLRQL-AEIAE 261

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 7e-56
 Identities = 71/272 (26%), Positives = 120/272 (44%), Gaps = 20/272 (7%)

Query: 638 NDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH 697
            D      +G G  G V   K       A+K        E S  ++EF+ E + +  + H
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-----EGSMSEDEFIEEAKVMMNLSH 58

Query: 698 RNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYL 757
             +V+ YG C+  +  FII EY+ +G L   L            Q L + K V +A+ YL
Sbjct: 59  EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYL 116

Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSE-LAGTHGYVAPELA 816
            +      +HRD++++N L++      VSDFG+++++  D    S        +  PE+ 
Sbjct: 117 ESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL 173

Query: 817 YTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQK 875
              K + K D+++FGVL  E+   GK P    +E  ++S          RL  P L  +K
Sbjct: 174 MYSKFSSKSDIWAFGVLMWEIYSLGKMP----YERFTNSETAEHIAQGLRLYRPHLASEK 229

Query: 876 KLMSIMQVAFSCLDQNPESRPTMKRVSQLLCE 907
               +  + +SC  +  + RPT K +   + +
Sbjct: 230 ----VYTIMYSCWHEKADERPTFKILLSNILD 257

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 4e-55
 Identities = 64/269 (23%), Positives = 109/269 (40%), Gaps = 18/269 (6%)

Query: 638 NDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH 697
                E  +G+G  G V+          A+K          +   E FL E Q + ++RH
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-----PGTMSPEAFLQEAQVMKKLRH 71

Query: 698 RNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYL 757
             +V+ Y   S     +I+ EY+  GSL        + K L   Q +++   +A  + Y+
Sbjct: 72  EKLVQLYAVVSEEPI-YIVTEYMSKGSLLD-FLKGETGKYLRLPQLVDMAAQIASGMAYV 129

Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSE-LAGTHGYVAPELA 816
                   VHRD+ + N+L+       V+DFG+A+ +  +     +       + APE A
Sbjct: 130 ERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 186

Query: 817 YTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKK 876
              + T K DV+SFG+L  E+          +    +   ++      R+P P     + 
Sbjct: 187 LYGRFTIKSDVWSFGILLTELTTKGRV---PYPGMVNREVLDQVERGYRMPCPP-ECPES 242

Query: 877 LMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
           L  +M     C  + PE RPT + +   L
Sbjct: 243 LHDLMC---QCWRKEPEERPTFEYLQAFL 268

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 6e-55
 Identities = 71/302 (23%), Positives = 118/302 (39%), Gaps = 46/302 (15%)

Query: 636 ATNDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTE 694
             +DF     +G G  G V++    PSG + A K  H  +   +   + + + E+Q L E
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI---RNQIIRELQVLHE 60

Query: 695 IRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADAL 754
                IV FYG         I  E+++ GSLD++L     A  +       V   V   L
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGL 117

Query: 755 FYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPE 814
            YL       I+HRD+   N+L++   E  + DFG++  L    +N     GT  Y++PE
Sbjct: 118 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPE 173

Query: 815 LAYTLKVTEKCDVYSFGVLALEVIKGKHP------------------------------- 843
                  + + D++S G+  +E+  G++P                               
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233

Query: 844 --RDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAF--SCLDQNPESRPTMK 899
                 + M S       E+LD  +  P   +   + S+    F   CL +NP  R  +K
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 293

Query: 900 RV 901
           ++
Sbjct: 294 QL 295

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  190 bits (483), Expect = 6e-55
 Identities = 75/301 (24%), Positives = 133/301 (44%), Gaps = 36/301 (11%)

Query: 630 YEEIISATNDFNAE---------HCIGKGGHGSVYRAKVPS----GEIFAVKKFHSPLPG 676
           +E+   A  +F  E           IG G  G V    +          A+K   S   G
Sbjct: 9   FEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKS---G 65

Query: 677 EMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAK 736
               Q+ +FL+E   + +  H N++   G  +      II E++E+GSLD  L  +    
Sbjct: 66  YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN--DG 123

Query: 737 ELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP 796
           +    Q + +++G+A  + YL +      VHRD++++N+L++      VSDFG+++FL  
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180

Query: 797 DSSNWSELA-----GTHGYVAPELAYTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEM 850
           D+S+ +  +         + APE     K T   DV+S+G++  EV+  G+ P    +  
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP----YWD 236

Query: 851 SSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF 910
            ++   +N    D RLP P +     L  +M     C  ++   RP   ++   L +K+ 
Sbjct: 237 MTNQDVINAIEQDYRLPPP-MDCPSALHQLML---DCWQKDRNHRPKFGQIVNTL-DKMI 291

Query: 911 E 911
            
Sbjct: 292 R 292

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  189 bits (482), Expect = 7e-55
 Identities = 70/276 (25%), Positives = 123/276 (44%), Gaps = 19/276 (6%)

Query: 638 NDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
            D   +H +G G +G VY           AVK        E + + EEFL E   + EI+
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIK 71

Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFY 756
           H N+V+  G C+     +II E++  G+L   L  + + +E+     L +   ++ A+ Y
Sbjct: 72  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISSAMEY 130

Query: 757 LHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN-WSELAGTHGYVAPEL 815
           L        +HRD++++N L+   +   V+DFG+++ +  D+    +       + APE 
Sbjct: 131 LEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 187

Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQK 875
               K + K DV++FGVL  E+          +     S    +   D R+  P     +
Sbjct: 188 LAYNKFSIKSDVWAFGVLLWEIATYGMS---PYPGIDLSQVYELLEKDYRMERPE-GCPE 243

Query: 876 KLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
           K+  +M+   +C   NP  RP+   + Q   E +F+
Sbjct: 244 KVYELMR---ACWQWNPSDRPSFAEIHQAF-ETMFQ 275

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (469), Expect = 2e-53
 Identities = 71/265 (26%), Positives = 117/265 (44%), Gaps = 19/265 (7%)

Query: 638 NDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
            DF     +GKG  G+VY A+   S  I A+K        +    + +   E++  + +R
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV-EHQLRREVEIQSHLR 64

Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFY 756
           H NI++ YG+       ++I EY   G++ + L       +    +    I  +A+AL Y
Sbjct: 65  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSY 121

Query: 757 LHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELA 816
            H+     ++HRDI  +N+LL    E  ++DFG +      SS  + L GT  Y+ PE+ 
Sbjct: 122 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA--PSSRRTTLCGTLDYLPPEMI 176

Query: 817 YTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKK 876
                 EK D++S GVL  E + GK P    FE ++        +      +P   V + 
Sbjct: 177 EGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYK-RISRVEFTFPD-FVTEG 230

Query: 877 LMSIMQVAFSCLDQNPESRPTMKRV 901
              ++      L  NP  RP ++ V
Sbjct: 231 ARDLIS---RLLKHNPSQRPMLREV 252

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 4e-53
 Identities = 65/274 (23%), Positives = 115/274 (41%), Gaps = 24/274 (8%)

Query: 646 IGKGGHGSVYRAKVP---SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVK 702
           +G G  G+V +         +  AVK   +         ++E L E   + ++ +  IV+
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA--LKDELLAEANVMQQLDNPYIVR 72

Query: 703 FYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF 762
             G C       ++ E  E G L+K L  +   + +     + ++  V+  + YL  +  
Sbjct: 73  MIGICEAESW-MLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN- 127

Query: 763 PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWS---ELAGTHGYVAPELAYTL 819
              VHRD++++NVLL   + A +SDFG++K L  D + +           + APE     
Sbjct: 128 --FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185

Query: 820 KVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLM 878
           K + K DV+SFGVL  E    G+ P    +     S    +     R+  P+    +++ 
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKP----YRGMKGSEVTAMLEKGERMGCPA-GCPREMY 240

Query: 879 SIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFEV 912
            +M     C   + E+RP    V   L    ++V
Sbjct: 241 DLMN---LCWTYDVENRPGFAAVELRLRNYYYDV 271

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 4e-53
 Identities = 71/273 (26%), Positives = 108/273 (39%), Gaps = 23/273 (8%)

Query: 638 NDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH 697
            +      IGKG  G V       G   AVK   +          + FL E   +T++RH
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN------DATAQAFLAEASVMTQLRH 59

Query: 698 RNIVKFYGFCSHPKHS-FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFY 756
            N+V+  G     K   +I+ EY+  GSL   L        LG    L     V +A+ Y
Sbjct: 60  SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEY 118

Query: 757 LHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELA 816
           L  N     VHRD++++NVL+     A VSDFG+ K     SS          + APE  
Sbjct: 119 LEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEAL 172

Query: 817 YTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKK 876
              K + K DV+SFG+L  E+          +        +       ++  P       
Sbjct: 173 REKKFSTKSDVWSFGILLWEIYSFGRV---PYPRIPLKDVVPRVEKGYKMDAPD-GCPPA 228

Query: 877 LMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI 909
           +  +M+   +C   +   RP+  ++ + L E I
Sbjct: 229 VYEVMK---NCWHLDAAMRPSFLQLREQL-EHI 257

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (469), Expect = 5e-53
 Identities = 69/257 (26%), Positives = 122/257 (47%), Gaps = 18/257 (7%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           IG+G  G+VY A  V +G+  A+++ +     +   ++E  +NEI  + E ++ NIV + 
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNL----QQQPKKELIINEILVMRENKNPNIVNYL 83

Query: 705 GFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP 764
                    +++ EYL  GSL  ++        +   Q   V +    AL +LH+N    
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ--- 136

Query: 765 IVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEK 824
           ++HRDI S N+LL +     ++DFG    + P+ S  S + GT  ++APE+        K
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196

Query: 825 CDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVA 884
            D++S G++A+E+I+G+ P  +L E    +  +        L  P   +       +   
Sbjct: 197 VDIWSLGIMAIEMIEGEPP--YLNENPLRALYLIATNGTPELQNPE-KLSAIFRDFLN-- 251

Query: 885 FSCLDQNPESRPTMKRV 901
             CLD + E R + K +
Sbjct: 252 -RCLDMDVEKRGSAKEL 267

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 2e-52
 Identities = 68/281 (24%), Positives = 121/281 (43%), Gaps = 24/281 (8%)

Query: 630 YEEI---ISATNDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEF 685
           YE +   ++  + +     +G G  G VY+A+   +  + A K   +    E+    E++
Sbjct: 1   YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEEL----EDY 56

Query: 686 LNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLN 745
           + EI  L    H NIVK      +  + +I+ E+   G++D ++      + L  +Q   
Sbjct: 57  MVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQV 114

Query: 746 VIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELA 805
           V K   DAL YLH+N    I+HRD+ + N+L  L  +  ++DFG++              
Sbjct: 115 VCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI 171

Query: 806 GTHGYVAPELAYTL-----KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIE 860
           GT  ++APE+             K DV+S G+  +E+ + + P   L  M         E
Sbjct: 172 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE 231

Query: 861 MLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
                L  PS          ++    CL++N ++R T  ++
Sbjct: 232 --PPTLAQPS-RWSSNFKDFLK---KCLEKNVDARWTTSQL 266

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (456), Expect = 2e-51
 Identities = 66/289 (22%), Positives = 115/289 (39%), Gaps = 26/289 (8%)

Query: 631 EEIISATNDFN-AEHCIGKGGHGSVYRAKV---PSGEIFAVKKFHSPLPGEMSFQQEEFL 686
           +++    ++   A+  +G G  GSV +            A+K       G      EE +
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLK---QGTEKADTEEMM 57

Query: 687 NEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNV 746
            E Q + ++ +  IV+  G C       ++ E    G L K L      +E+  +    +
Sbjct: 58  REAQIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKR--EEIPVSNVAEL 114

Query: 747 IKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSE--- 803
           +  V+  + YL        VHRD++++NVLL   + A +SDFG++K L  D S ++    
Sbjct: 115 LHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 171

Query: 804 LAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEML 862
                 + APE     K + + DV+S+GV   E +  G+ P    ++       M     
Sbjct: 172 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP----YKKMKGPEVMAFIEQ 227

Query: 863 DSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
             R+  P      +L ++M     C     E RP    V Q +    + 
Sbjct: 228 GKRMECPP-ECPPELYALMS---DCWIYKWEDRPDFLTVEQRM-RACYY 271

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  179 bits (455), Expect = 4e-51
 Identities = 61/303 (20%), Positives = 124/303 (40%), Gaps = 43/303 (14%)

Query: 638 NDFNAEHCIGKGGHGSVYRAKVP------SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQA 691
           N+      IG+G  G V++A+ P         + AVK          +  Q +F  E   
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQADFQREAAL 69

Query: 692 LTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKIL---------------------C 730
           + E  + NIVK  G C+  K   +++EY+  G L++ L                      
Sbjct: 70  MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 129

Query: 731 NDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGI 790
           +      L   ++L + + VA  + YL        VHRD++++N L+       ++DFG+
Sbjct: 130 SSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGL 186

Query: 791 AKFLNPDSSNWSE--LAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLF 848
           ++ +       ++   A    ++ PE  +  + T + DV+++GV+  E+          +
Sbjct: 187 SRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP---Y 243

Query: 849 EMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEK 908
              +    +      + L  P  +   +L ++M+    C  + P  RP+   + ++L ++
Sbjct: 244 YGMAHEEVIYYVRDGNILACPE-NCPLELYNLMR---LCWSKLPADRPSFCSIHRIL-QR 298

Query: 909 IFE 911
           + E
Sbjct: 299 MCE 301

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  179 bits (455), Expect = 5e-51
 Identities = 68/262 (25%), Positives = 125/262 (47%), Gaps = 22/262 (8%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           IG G  G+VY A+ V + E+ A+KK           + ++ + E++ L ++RH N +++ 
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE-KWQDIIKEVRFLQKLRHPNTIQYR 81

Query: 705 GFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP 764
           G       ++++ EY    + D +  +    K L   +   V  G    L YLH++    
Sbjct: 82  GCYLREHTAWLVMEYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---N 135

Query: 765 IVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTL---KV 821
           ++HRD+ + N+LL       + DFG A  + P +S      GT  ++APE+   +   + 
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS----FVGTPYWMAPEVILAMDEGQY 191

Query: 822 TEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIM 881
             K DV+S G+  +E+ + K P   LF M++ S+  +I   +      S H  +   + +
Sbjct: 192 DGKVDVWSLGITCIELAERKPP---LFNMNAMSALYHI-AQNESPALQSGHWSEYFRNFV 247

Query: 882 QVAFSCLDQNPESRPTMKRVSQ 903
               SCL + P+ RPT + + +
Sbjct: 248 D---SCLQKIPQDRPTSEVLLK 266

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  180 bits (458), Expect = 6e-51
 Identities = 57/279 (20%), Positives = 118/279 (42%), Gaps = 23/279 (8%)

Query: 627 KIVYEEIISATNDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEF 685
           +I ++ ++   + ++    +G G  G V+R     +G  FA K   +P   +    +E  
Sbjct: 18  EIKHDHVL---DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD----KETV 70

Query: 686 LNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLN 745
             EIQ ++ +RH  +V  +          +IYE++  G L + + +     ++   + + 
Sbjct: 71  RKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVE 128

Query: 746 VIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHV--SDFGIAKFLNPDSSNWSE 803
            ++ V   L ++H N     VH D+  +N++        +   DFG+   L+P  S    
Sbjct: 129 YMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT 185

Query: 804 LAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLD 863
             GT  + APE+A    V    D++S GVL+  ++ G  P       +   +  N++  D
Sbjct: 186 -TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP---FGGENDDETLRNVKSCD 241

Query: 864 SRLPYPSL-HVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
             +   +   + +     ++     L  +P +R T+ + 
Sbjct: 242 WNMDDSAFSGISEDGKDFIR---KLLLADPNTRMTIHQA 277

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 1e-50
 Identities = 57/262 (21%), Positives = 109/262 (41%), Gaps = 21/262 (8%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           IG+G   +VY+     +    A  +       +   +++ F  E + L  ++H NIV+FY
Sbjct: 17  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS--ERQRFKEEAEMLKGLQHPNIVRFY 74

Query: 705 GFC----SHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNN 760
                     K   ++ E + SG+L   L      K +      +  + +   L +LH  
Sbjct: 75  DSWESTVKGKKCIVLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTR 131

Query: 761 CFPPIVHRDISSKNVLL-DLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTL 819
             PPI+HRD+   N+ +        + D G+A       +    + GT  ++APE+ Y  
Sbjct: 132 T-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK--AVIGTPEFMAPEM-YEE 187

Query: 820 KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMS 879
           K  E  DVY+FG+  LE+   ++P       +     +   +  +     ++   K+++ 
Sbjct: 188 KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIE 247

Query: 880 IMQVAFSCLDQNPESRPTMKRV 901
                  C+ QN + R ++K +
Sbjct: 248 ------GCIRQNKDERYSIKDL 263

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 2e-50
 Identities = 67/301 (22%), Positives = 119/301 (39%), Gaps = 44/301 (14%)

Query: 638 NDFNAEHCIGKGGHGSVYRA------KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQA 691
            +      +G G  G V  A      K       AVK          S ++E  ++E++ 
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK---EKADSSEREALMSELKM 93

Query: 692 LTEI-RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKIL--------------------C 730
           +T++  H NIV   G C+     ++I+EY   G L   L                     
Sbjct: 94  MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153

Query: 731 NDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGI 790
            +     L +   L     VA  + +L        VHRD++++NVL+  G    + DFG+
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGL 210

Query: 791 AKFLNPDSSN--WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVI-KGKHPRDFL 847
           A+ +  DS+            ++APE  +    T K DV+S+G+L  E+   G +P    
Sbjct: 211 ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP-- 268

Query: 848 FEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL-C 906
             +   ++   +     ++  P  +  +++  IMQ   SC   +   RP+   ++  L C
Sbjct: 269 -GIPVDANFYKLIQNGFKMDQPF-YATEEIYIIMQ---SCWAFDSRKRPSFPNLTSFLGC 323

Query: 907 E 907
           +
Sbjct: 324 Q 324

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 5e-50
 Identities = 66/268 (24%), Positives = 107/268 (39%), Gaps = 19/268 (7%)

Query: 638 NDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
            D++    +G+G +G V  A    + E  AVK              E    EI     + 
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD---MKRAVDCPENIKKEICINKMLN 61

Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFY 756
           H N+VKFYG        ++  EY   G L   +  D     +           +   + Y
Sbjct: 62  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVY 118

Query: 757 LHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN--WSELAGTHGYVAPE 814
           LH      I HRDI  +N+LLD      +SDFG+A     ++     +++ GT  YVAPE
Sbjct: 119 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175

Query: 815 LAYTLKV-TEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHV 873
           L    +   E  DV+S G++   ++ G+ P D   + S S    +          P   +
Sbjct: 176 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD---QPSDSCQEYSDWKEKKTYLNPWKKI 232

Query: 874 QKKLMSIMQVAFSCLDQNPESRPTMKRV 901
               ++++      L +NP +R T+  +
Sbjct: 233 DSAPLALLH---KILVENPSARITIPDI 257

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 1e-49
 Identities = 65/304 (21%), Positives = 114/304 (37%), Gaps = 49/304 (16%)

Query: 643 EHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVK 702
           +  IGKG  G V+R K   GE  AVK F S        +      EI     +RH NI+ 
Sbjct: 8   QESIGKGRFGEVWRGKW-RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILG 61

Query: 703 FYGFCSHPKHS----FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLH 758
           F    +    +    +++ +Y E GSL   L        +     + +    A  L +LH
Sbjct: 62  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLH 117

Query: 759 NNCF-----PPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWS----ELAGTHG 809
                    P I HRD+ SKN+L+       ++D G+A   +  +           GT  
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177

Query: 810 YVAPELAYT------LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNI---- 859
           Y+APE+          +  ++ D+Y+ G++  E+ +         +      ++      
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237

Query: 860 ----------EMLDSRLP--YPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCE 907
                     + L   +P  + S    + +  IM+    C   N  +R T  R+ + L  
Sbjct: 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR---ECWYANGAARLTALRIKKTL-S 293

Query: 908 KIFE 911
           ++ +
Sbjct: 294 QLSQ 297

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (442), Expect = 2e-49
 Identities = 75/283 (26%), Positives = 119/283 (42%), Gaps = 24/283 (8%)

Query: 638 NDFNAEHCIGKGGHGSVYRAKVPSGE-----IFAVKKFHSPLPGEMSFQQEEFLNEIQAL 692
           +    +  IG G  G VY+  + +         A+K       G    Q+ +FL E   +
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK---AGYTEKQRVDFLGEAGIM 63

Query: 693 TEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVAD 752
            +  H NI++  G  S  K   II EY+E+G+LDK L       E    Q + +++G+A 
Sbjct: 64  GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAA 121

Query: 753 ALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNW---SELAGTHG 809
            + YL N      VHRD++++N+L++      VSDFG+++ L  D       S       
Sbjct: 122 GMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178

Query: 810 YVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYP 869
           + APE     K T   DV+SFG++  EV+         +   S+   M       RLP P
Sbjct: 179 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP---YWELSNHEVMKAINDGFRLPTP 235

Query: 870 SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFEV 912
                  +  +M     C  Q    RP    +  +L +K+   
Sbjct: 236 M-DCPSAIYQLMM---QCWQQERARRPKFADIVSIL-DKLIRA 273

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 5e-49
 Identities = 70/296 (23%), Positives = 120/296 (40%), Gaps = 36/296 (12%)

Query: 638 NDFNAEHCIGKGGHGSVYRA------KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQA 691
           N  +    +G G  G V  A      K  +    AVK      P     ++E  ++E++ 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK---PSAHLTEREALMSELKV 79

Query: 692 LTEI-RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCN---------------DASA 735
           L+ +  H NIV   G C+    + +I EY   G L   L                 +   
Sbjct: 80  LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139

Query: 736 KELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN 795
             L     L+    VA  + +L +      +HRD++++N+LL  G    + DFG+A+ + 
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIK 196

Query: 796 PDSSNW--SELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS 853
            DS+            ++APE  +    T + DV+S+G+   E+            M   
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY--PGMPVD 254

Query: 854 SSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI 909
           S    +     R+  P  H   ++  IM+   +C D +P  RPT K++ QL+ ++I
Sbjct: 255 SKFYKMIKEGFRMLSPE-HAPAEMYDIMK---TCWDADPLKRPTFKQIVQLIEKQI 306

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 6e-49
 Identities = 63/278 (22%), Positives = 107/278 (38%), Gaps = 22/278 (7%)

Query: 638 NDFNAEHCIGKGGHGSVYRAKVPS----GEIFAVKKFHSPLPGEMSFQQEEFLNEIQALT 693
            D      +G G  G V R +  +        AVK     +  +     ++F+ E+ A+ 
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAM-DDFIREVNAMH 66

Query: 694 EIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADA 753
            + HRN+++ YG    P    ++ E    GSL   L                    VA+ 
Sbjct: 67  SLDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEG 123

Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNW---SELAGTHGY 810
           + YL +      +HRD++++N+LL       + DFG+ + L  +  ++           +
Sbjct: 124 MGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180

Query: 811 VAPELAYTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEMLDSRLPYP 869
            APE   T   +   D + FGV   E+   G+ P      ++ S     I+    RLP P
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP---WIGLNGSQILHKIDKEGERLPRP 237

Query: 870 SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCE 907
                + + ++M     C    PE RPT   +   L E
Sbjct: 238 E-DCPQDIYNVMV---QCWAHKPEDRPTFVALRDFLLE 271

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (438), Expect = 1e-48
 Identities = 62/291 (21%), Positives = 117/291 (40%), Gaps = 32/291 (10%)

Query: 638 NDFNAEHCIGKGGHGSVYRAKVPSG---EIFAVKKFHSPLPGEMSFQQEEFLNEIQALTE 694
           ND   +  IG+G  G V +A++         A+K+       +      +F  E++ L +
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD---DHRDFAGELEVLCK 66

Query: 695 I-RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKIL-------------CNDASAKELGW 740
           +  H NI+   G C H  + ++  EY   G+L   L               +++A  L  
Sbjct: 67  LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 126

Query: 741 TQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN 800
            Q L+    VA  + YL        +HRD++++N+L+   Y A ++DFG+++        
Sbjct: 127 QQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 183

Query: 801 WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIE 860
                    ++A E       T   DV+S+GVL  E++         +   + +      
Sbjct: 184 TM-GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP---YCGMTCAELYEKL 239

Query: 861 MLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
               RL  P  +   ++  +M+    C  + P  RP+  ++   L  ++ E
Sbjct: 240 PQGYRLEKPL-NCDDEVYDLMR---QCWREKPYERPSFAQILVSL-NRMLE 285

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  174 bits (441), Expect = 1e-48
 Identities = 55/268 (20%), Positives = 108/268 (40%), Gaps = 20/268 (7%)

Query: 638 NDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
           + ++    +G G  G V+R     +G +F  K  ++P P +    +    NEI  + ++ 
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD----KYTVKNEISIMNQLH 84

Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFY 756
           H  ++  +          +I E+L  G L   +       ++   + +N ++   + L +
Sbjct: 85  HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKH 142

Query: 757 LHNNCFPPIVHRDISSKNVLLDLGYEAHV--SDFGIAKFLNPDSSNWSELAGTHGYVAPE 814
           +H +    IVH DI  +N++ +    + V   DFG+A  LNPD         T  + APE
Sbjct: 143 MHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT-TATAEFAAPE 198

Query: 815 LAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSL-HV 873
           +     V    D+++ GVL   ++ G  P           +  N++  D      +   V
Sbjct: 199 IVDREPVGFYTDMWAIGVLGYVLLSGLSP---FAGEDDLETLQNVKRCDWEFDEDAFSSV 255

Query: 874 QKKLMSIMQVAFSCLDQNPESRPTMKRV 901
             +    ++   + L + P  R T+   
Sbjct: 256 SPEAKDFIK---NLLQKEPRKRLTVHDA 280

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 1e-48
 Identities = 53/266 (19%), Positives = 105/266 (39%), Gaps = 19/266 (7%)

Query: 639 DFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH 697
           DF     +G+G   +V  A+ + +   +A+K        + + +      E   ++ + H
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN-KVPYVTRERDVMSRLDH 67

Query: 698 RNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYL 757
              VK Y      +  +    Y ++G L K +           T        +  AL YL
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYL 124

Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNW--SELAGTHGYVAPEL 815
           H      I+HRD+  +N+LL+      ++DFG AK L+P+S     +   GT  YV+PEL
Sbjct: 125 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181

Query: 816 AYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQK 875
                  +  D+++ G +  +++ G  P       + +   +  +++     +P      
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGLPPFR-----AGNEYLIFQKIIKLEYDFPE-KFFP 235

Query: 876 KLMSIMQVAFSCLDQNPESRPTMKRV 901
           K   +++     L  +   R   + +
Sbjct: 236 KARDLVE---KLLVLDATKRLGCEEM 258

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 3e-48
 Identities = 59/280 (21%), Positives = 106/280 (37%), Gaps = 25/280 (8%)

Query: 641 NAEHCIGKGGHGSVYRAKVP----SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
           +    IG+G  G VY   +          AVK  +         +  +FL E   + +  
Sbjct: 30  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN---RITDIGEVSQFLTEGIIMKDFS 86

Query: 697 HRNIVKFYGFCSHPKHS-FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALF 755
           H N++   G C   + S  ++  Y++ G L   + N+     +       +         
Sbjct: 87  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG---- 142

Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDS----SNWSELAGTHGYV 811
            +        VHRD++++N +LD  +   V+DFG+A+ +         N +       ++
Sbjct: 143 -MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 201

Query: 812 APELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSL 871
           A E   T K T K DV+SFGVL  E++    P         ++ ++ + +L  R      
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDITVYLLQGRRLLQPE 257

Query: 872 HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
           +    L  +M     C     E RP+   +   +   IF 
Sbjct: 258 YCPDPLYEVML---KCWHPKAEMRPSFSELVSRI-SAIFS 293

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (420), Expect = 1e-46
 Identities = 69/280 (24%), Positives = 107/280 (38%), Gaps = 24/280 (8%)

Query: 638 NDFNAEHCIGKGGHGSVYRAKVPS----GEIFAVKKFHSPLPGEMSFQQEEFLNEIQALT 693
                  CIG+G  G V++    S        A+K             +E+FL E   + 
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK---NCTSDSVREKFLQEALTMR 63

Query: 694 EIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADA 753
           +  H +IVK  G  +     +II E    G L   L        L     +     ++ A
Sbjct: 64  QFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTA 120

Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSS-NWSELAGTHGYVA 812
           L YL +      VHRDI+++NVL+       + DFG+++++   +    S+      ++A
Sbjct: 121 LAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 177

Query: 813 PELAYTLKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSL 871
           PE     + T   DV+ FGV   E++  G  P   +          N E    RLP P  
Sbjct: 178 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE----RLPMPP- 232

Query: 872 HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
           +    L S+M     C   +P  RP    +   L   I E
Sbjct: 233 NCPPTLYSLMT---KCWAYDPSRRPRFTELKAQL-STILE 268

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 2e-46
 Identities = 61/278 (21%), Positives = 111/278 (39%), Gaps = 18/278 (6%)

Query: 632 EIISATNDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQ-QEEFLNEI 689
            I+  T +F     +G G  G+VY+   +P GE   +      L    S +  +E L+E 
Sbjct: 4   RILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 62

Query: 690 QALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKG 749
             +  + + ++ +  G C       +I + +  G L            +G    LN    
Sbjct: 63  YVMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLD--YVREHKDNIGSQYLLNWCVQ 119

Query: 750 VADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNW--SELAGT 807
           +A  + YL +     +VHRD++++NVL+       ++DFG+AK L  +   +        
Sbjct: 120 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176

Query: 808 HGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLP 867
             ++A E       T + DV+S+GV   E++         ++   +S   +I     RLP
Sbjct: 177 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK---PYDGIPASEISSILEKGERLP 233

Query: 868 YPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLL 905
            P       +  IM     C   + +SRP  + +    
Sbjct: 234 QPP-ICTIDVYMIMV---KCWMIDADSRPKFRELIIEF 267

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  165 bits (419), Expect = 5e-46
 Identities = 62/270 (22%), Positives = 113/270 (41%), Gaps = 21/270 (7%)

Query: 637 TNDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI 695
            + ++    +G G    V  A+   + ++ A+K         +  ++    NEI  L +I
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIA---KKALEGKEGSMENEIAVLHKI 64

Query: 696 RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALF 755
           +H NIV          H ++I + +  G L   +                +I  V DA+ 
Sbjct: 65  KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVK 121

Query: 756 YLHNNCFPPIVHRDISSKNVLLDLGYE---AHVSDFGIAKFLNPDSSNWSELAGTHGYVA 812
           YLH+     IVHRD+  +N+L     E     +SDFG++K  +P S   +   GT GYVA
Sbjct: 122 YLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST-ACGTPGYVA 177

Query: 813 PELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSL- 871
           PE+      ++  D +S GV+A  ++ G  P    ++ + +     I   +     P   
Sbjct: 178 PEVLAQKPYSKAVDCWSIGVIAYILLCGYPP---FYDENDAKLFEQILKAEYEFDSPYWD 234

Query: 872 HVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
            +       ++     ++++PE R T ++ 
Sbjct: 235 DISDSAKDFIR---HLMEKDPEKRFTCEQA 261

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 1e-45
 Identities = 58/287 (20%), Positives = 111/287 (38%), Gaps = 28/287 (9%)

Query: 638 NDFNAEHCIGKGGHGSVYRA------KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQA 691
                   +G+G  G VY        K       A+K  +         ++ EFLNE   
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLNEASV 76

Query: 692 LTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILC-------NDASAKELGWTQRL 744
           + E    ++V+  G  S  + + +I E +  G L   L        N+        ++ +
Sbjct: 77  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136

Query: 745 NVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSS--NWS 802
            +   +AD + YL+ N     VHRD++++N ++   +   + DFG+ + +          
Sbjct: 137 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 193

Query: 803 ELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEML 862
           +      +++PE       T   DV+SFGV+  E+          ++  S+   +   M 
Sbjct: 194 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ---PYQGLSNEQVLRFVME 250

Query: 863 DSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI 909
              L  P  +    L  +M+    C   NP+ RP+   +   + E++
Sbjct: 251 GGLLDKPD-NCPDMLFELMR---MCWQYNPKMRPSFLEIISSIKEEM 293

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 2e-45
 Identities = 56/263 (21%), Positives = 102/263 (38%), Gaps = 16/263 (6%)

Query: 638 NDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
            DF     +GKG  G V+ A+   + + FA+K     +       +   + +        
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFY 756
           H  +   +      ++ F + EYL  G L   +    S  +   ++       +   L +
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI---QSCHKFDLSRATFYAAEIILGLQF 118

Query: 757 LHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELA 816
           LH+     IV+RD+   N+LLD      ++DFG+ K      +  +   GT  Y+APE+ 
Sbjct: 119 LHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEIL 175

Query: 817 YTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKK 876
              K     D +SFGVL  E++ G+ P             +   +      YP   ++K+
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQSPFH-----GQDEEELFHSIRMDNPFYPR-WLEKE 229

Query: 877 LMSIMQVAFSCLDQNPESRPTMK 899
              ++        + PE R  ++
Sbjct: 230 AKDLLV---KLFVREPEKRLGVR 249

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 2e-45
 Identities = 57/259 (22%), Positives = 103/259 (39%), Gaps = 19/259 (7%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G+G  G V+R     S + +  K             Q     EI  L   RHRNI+  +
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVK-----GTDQVLVKKEISILNIARHRNILHLH 67

Query: 705 GFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP 764
                 +   +I+E++    + + +  + SA EL   + ++ +  V +AL +LH++    
Sbjct: 68  ESFESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHSH---N 122

Query: 765 IVHRDISSKNVLLDLGYEAHV--SDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVT 822
           I H DI  +N++      + +   +FG A+ L P  +    L     Y APE+     V+
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL-LFTAPEYYAPEVHQHDVVS 181

Query: 823 EKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQ 882
              D++S G L   ++ G +P           + MN E       +    +  + M  + 
Sbjct: 182 TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFK--EISIEAMDFVD 239

Query: 883 VAFSCLDQNPESRPTMKRV 901
                L +  +SR T    
Sbjct: 240 ---RLLVKERKSRMTASEA 255

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  161 bits (408), Expect = 5e-45
 Identities = 67/271 (24%), Positives = 117/271 (43%), Gaps = 24/271 (8%)

Query: 637 TNDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI 695
           ++ +     +G GG   V+ A+ +      AVK   + L  + SF    F  E Q    +
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFY-LRFRREAQNAAAL 64

Query: 696 RHRNIVKFYGFCSHPKHS----FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVA 751
            H  IV  Y        +    +I+ EY++  +L  I+  +     +   + + VI    
Sbjct: 65  NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADAC 121

Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSE---LAGTH 808
            AL + H N    I+HRD+   N+++       V DFGIA+ +    ++ ++   + GT 
Sbjct: 122 QALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178

Query: 809 GYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPY 868
            Y++PE A    V  + DVYS G +  EV+ G+ P    F   S  S     + +  +P 
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQHVREDPIPP 234

Query: 869 PSLH--VQKKLMSIMQVAFSCLDQNPESRPT 897
            + H  +   L +++      L +NPE+R  
Sbjct: 235 SARHEGLSADLDAVVL---KALAKNPENRYQ 262

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (407), Expect = 1e-44
 Identities = 62/299 (20%), Positives = 117/299 (39%), Gaps = 38/299 (12%)

Query: 638 NDFNAEHCIGKGGHGSVYRA--------KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEI 689
           +       +G+G  G V  A        K       AVK               + ++E+
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK---SDATEKDLSDLISEM 69

Query: 690 QALTEI-RHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKIL-------------CNDASA 735
           + +  I +H+NI+   G C+     ++I EY   G+L + L              +    
Sbjct: 70  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129

Query: 736 KELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN 795
           ++L     ++    VA  + YL +      +HRD++++NVL+       ++DFG+A+ ++
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 186

Query: 796 PDSSNWS--ELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS 853
                           ++APE  +    T + DV+SFGVL  E+          +     
Sbjct: 187 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS---PYPGVPV 243

Query: 854 SSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFEV 912
                +     R+  PS +   +L  +M+    C    P  RPT K++ + L ++I  +
Sbjct: 244 EELFKLLKEGHRMDKPS-NCTNELYMMMR---DCWHAVPSQRPTFKQLVEDL-DRIVAL 297

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  157 bits (398), Expect = 2e-43
 Identities = 47/287 (16%), Positives = 95/287 (33%), Gaps = 28/287 (9%)

Query: 638 NDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
           N +     IG G  G +Y    + +GE  A+K         +  +  +   E +    ++
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLEC------VKTKHPQLHIESKIYKMMQ 60

Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFY 756
               +    +C       ++   L   SL+     +  +++      L +   +   + Y
Sbjct: 61  GGVGIPTIRWCGAEGDYNVMVMELLGPSLED--LFNFCSRKFSLKTVLLLADQMISRIEY 118

Query: 757 LHNNCFPPIVHRDISSKNVL---LDLGYEAHVSDFGIAKFLNPDSSN-------WSELAG 806
           +H+      +HRD+   N L      G   ++ DFG+AK      ++          L G
Sbjct: 119 IHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG 175

Query: 807 THGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRL 866
           T  Y +      ++ + + D+ S G + +    G  P   L   +       I       
Sbjct: 176 TARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 235

Query: 867 PYPSL--HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
           P   L      +  + +     C     + +P    + QL    +F 
Sbjct: 236 PIEVLCKGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLF-RNLFH 278

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  157 bits (397), Expect = 4e-43
 Identities = 62/266 (23%), Positives = 113/266 (42%), Gaps = 20/266 (7%)

Query: 638 NDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
            DF     +G G  G V+  +   +G  +A+K     +   +  Q E   +E   L+ + 
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLK-QVEHTNDERLMLSIVT 62

Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFY 756
           H  I++ +G     +  F+I +Y+E G L  +L                    V  AL Y
Sbjct: 63  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPN---PVAKFYAAEVCLALEY 119

Query: 757 LHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELA 816
           LH+     I++RD+  +N+LLD      ++DFG AK++         L GT  Y+APE+ 
Sbjct: 120 LHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP---DVTYTLCGTPDYIAPEVV 173

Query: 817 YTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKK 876
            T    +  D +SFG+L  E++ G  P        S++     ++L++ L +P     + 
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYTPFY-----DSNTMKTYEKILNAELRFPP-FFNED 227

Query: 877 LMSIMQVAFSCLDQNPESRPTMKRVS 902
           +  ++      + ++   R    +  
Sbjct: 228 VKDLLS---RLITRDLSQRLGNLQNG 250

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  155 bits (394), Expect = 4e-43
 Identities = 56/277 (20%), Positives = 109/277 (39%), Gaps = 27/277 (9%)

Query: 639 DFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQ-----EEFLNEIQAL 692
           ++  +  +G+G    V R    P+ + +AVK       G  S ++     E  L E+  L
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 693 TEIR-HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVA 751
            ++  H NI++           F++++ ++ G L   L        L   +   +++ + 
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALL 120

Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV 811
           + +  LH      IVHRD+  +N+LLD      ++DFG +  L+P       + GT  Y+
Sbjct: 121 EVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE-VCGTPSYL 176

Query: 812 APELAYT------LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSR 865
           APE+             ++ D++S GV+   ++ G  P    +          I   + +
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP---FWHRKQMLMLRMIMSGNYQ 233

Query: 866 LPYPSL-HVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
              P        +  ++      L   P+ R T +  
Sbjct: 234 FGSPEWDDYSDTVKDLVS---RFLVVQPQKRYTAEEA 267

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  157 bits (399), Expect = 9e-43
 Identities = 57/265 (21%), Positives = 100/265 (37%), Gaps = 18/265 (6%)

Query: 638 NDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQE--EFLNEIQALTE 694
           NDF+    IG+GG G VY  +   +G+++A+K            +         +  ++ 
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 695 IRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADAL 754
                IV        P     I + +  G L   L       E            +   L
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE---ADMRFYAAEIILGL 120

Query: 755 FYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPE 814
            ++HN     +V+RD+   N+LLD      +SD G+A   +    + S   GTHGY+APE
Sbjct: 121 EHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--GTHGYMAPE 175

Query: 815 -LAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHV 873
            L   +      D +S G +  ++++G  P  F    +     ++   L   +  P    
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSP--FRQHKTKDKHEIDRMTLTMAVELPD-SF 232

Query: 874 QKKLMSIMQVAFSCLDQNPESRPTM 898
             +L S+++     L ++   R   
Sbjct: 233 SPELRSLLE---GLLQRDVNRRLGC 254

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 1e-42
 Identities = 49/272 (18%), Positives = 107/272 (39%), Gaps = 21/272 (7%)

Query: 638 NDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFH--SPLPGEMSFQQEEFLNEIQALTE 694
           + ++    +G G    V + +   +G  +A K               +E+   E+  L E
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 695 IRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADAL 754
           I+H N++  +    +     +I E +  G L   L      + L   +    +K + + +
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGV 126

Query: 755 FYLHNNCFPPIVHRDISSKNVLLD----LGYEAHVSDFGIAKFLNPDSSNWSELAGTHGY 810
           +YLH+     I H D+  +N++L           + DFG+A  ++  +     + GT  +
Sbjct: 127 YYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK-NIFGTPEF 182

Query: 811 VAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPS 870
           VAPE+     +  + D++S GV+   ++ G  P       +   +  N+  ++       
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP---FLGDTKQETLANVSAVNYEFEDEY 239

Query: 871 L-HVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
             +        ++     L ++P+ R T++  
Sbjct: 240 FSNTSALAKDFIR---RLLVKDPKKRMTIQDS 268

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (373), Expect = 2e-40
 Identities = 56/271 (20%), Positives = 101/271 (37%), Gaps = 29/271 (10%)

Query: 638 NDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQ--EEFLNEIQALTE 694
           + +     +G GG GSVY    V      A+K        +            E+  L +
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 695 IR--HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVAD 752
           +      +++   +   P    +I E  E          +     L      +    V +
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLE 121

Query: 753 ALFYLHNNCFPPIVHRDISSKNVLLDL-GYEAHVSDFGIAKFLNPDSSNWSELAGTHGYV 811
           A+ + HN     ++HRDI  +N+L+DL   E  + DFG    L    + +++  GT  Y 
Sbjct: 122 AVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKD--TVYTDFDGTRVYS 176

Query: 812 APE-LAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPS 870
            PE + Y         V+S G+L  +++ G  P    FE          E++  ++ +  
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP----FEHDE-------EIIRGQVFFRQ 225

Query: 871 LHVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
             V  +   +++    CL   P  RPT + +
Sbjct: 226 -RVSSECQHLIR---WCLALRPSDRPTFEEI 252

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (373), Expect = 4e-40
 Identities = 61/297 (20%), Positives = 108/297 (36%), Gaps = 36/297 (12%)

Query: 638 NDFNAEHCIGKGGHGSVYRA------KVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQA 691
           +       +G+G  G V  A      K  +    AVK       G    +    ++E++ 
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKI 69

Query: 692 LTEIRHR-NIVKFYGFCSHPKHS-FIIYEYLESGSLDKILCN-------------DASAK 736
           L  I H  N+V   G C+ P     +I E+ + G+L   L +             D    
Sbjct: 70  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129

Query: 737 ELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP 796
            L     +     VA  + +L +      +HRD++++N+LL       + DFG+A+ +  
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186

Query: 797 DSSNW--SELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS 854
           D       +      ++APE  +    T + DV+SFGVL  E+            +    
Sbjct: 187 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS--PYPGVKIDE 244

Query: 855 SNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
                    +R+  P  +   ++   M     C    P  RPT   + + L   + +
Sbjct: 245 EFCRRLKEGTRMRAPD-YTTPEMYQTML---DCWHGEPSQRPTFSELVEHL-GNLLQ 296

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  146 bits (370), Expect = 7e-40
 Identities = 61/285 (21%), Positives = 112/285 (39%), Gaps = 29/285 (10%)

Query: 638 NDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH 697
             ++    IG+G +G VY+A+   GE FA+KK       E        + EI  L E++H
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEG--IPSTTIREISILKELKH 59

Query: 698 RNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYL 757
            NIVK Y      K   +++E+L+      +   +     L      + +  + + + Y 
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYC 116

Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPE-LA 816
           H+     ++HRD+  +N+L++   E  ++DFG+A+        ++    T  Y AP+ L 
Sbjct: 117 HDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLM 173

Query: 817 YTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKK 876
            + K +   D++S G +  E++ G      + E         I    +   +P++    K
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233

Query: 877 LMSIMQVAF--------------------SCLDQNPESRPTMKRV 901
                 V                        L  +P  R T K+ 
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 2e-39
 Identities = 56/278 (20%), Positives = 102/278 (36%), Gaps = 28/278 (10%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFH-SPLPGEMSFQQEEFLNEIQALTEIRHRNIVKF 703
           +G+G   +VY+A+   + +I A+KK                 L EI+ L E+ H NI+  
Sbjct: 6   LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65

Query: 704 YGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFP 763
                H  +  ++++++E+     I  N      L  +     +      L YLH +   
Sbjct: 66  LDAFGHKSNISLVFDFMETDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQHW-- 120

Query: 764 PIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKV-T 822
            I+HRD+   N+LLD      ++DFG+AK     +  ++    T  Y APEL +  ++  
Sbjct: 121 -ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 179

Query: 823 EKCDVYSFGVLALEVIKGKHP-----------------RDFLFEMSSSSSNMNIEMLDSR 865
              D+++ G +  E++                           E      ++   +    
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239

Query: 866 LPYPSLHVQKKLMSIMQVAF--SCLDQNPESRPTMKRV 901
            P   LH          +         NP +R T  + 
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 2e-39
 Identities = 59/270 (21%), Positives = 106/270 (39%), Gaps = 28/270 (10%)

Query: 643 EHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNI 700
              +G G +G V +     + E FA+K               +   E++      +  +I
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD---------CPKARREVELHWRASQCPHI 67

Query: 701 VKFYGFCSHP----KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFY 756
           V+      +     K   I+ E L+ G L   +  D   +     +   ++K + +A+ Y
Sbjct: 68  VRIVDVYENLYAGRKCLLIVMECLDGGELFSRI-QDRGDQAFTEREASEIMKSIGEAIQY 126

Query: 757 LHNNCFPPIVHRDISSKNVLLDLGYE---AHVSDFGIAKFLNPDSSNWSELAGTHGYVAP 813
           LH+     I HRD+  +N+L           ++DFG AK     +S  +    T  YVAP
Sbjct: 127 LHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT-PCYTPYYVAP 182

Query: 814 ELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNM-NIEMLDSRLPYPSL- 871
           E+    K  + CD++S GV+   ++ G  P      ++ S      I M     P P   
Sbjct: 183 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 242

Query: 872 HVQKKLMSIMQVAFSCLDQNPESRPTMKRV 901
            V +++  +++   + L   P  R T+   
Sbjct: 243 EVSEEVKMLIR---NLLKTEPTQRMTITEF 269

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  145 bits (366), Expect = 3e-39
 Identities = 45/282 (15%), Positives = 93/282 (32%), Gaps = 32/282 (11%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRN-IVKF 703
           IG+G  G ++    + + +  A+K               +  +E +    +     I   
Sbjct: 13  IGEGSFGVIFEGTNLLNNQQVAIKFEPR------RSDAPQLRDEYRTYKLLAGCTGIPNV 66

Query: 704 YGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFP 763
           Y F     H+ ++ + L     D +   D   ++          K +   +  +H     
Sbjct: 67  YYFGQEGLHNVLVIDLLGPSLEDLL---DLCGRKFSVKTVAMAAKQMLARVQSIHEKS-- 121

Query: 764 PIVHRDISSKNVLLDLGYEAH-----VSDFGIAKFLNPDSSN-------WSELAGTHGYV 811
            +V+RDI   N L+      +     V DFG+ KF     +           L+GT  Y+
Sbjct: 122 -LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180

Query: 812 APELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSL 871
           +       + + + D+ + G + +  ++G  P   L   ++      I       P   L
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 240

Query: 872 --HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE 911
                ++    M       +   ++ P    +  L   K+ E
Sbjct: 241 CAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLF-SKVLE 278

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 3e-38
 Identities = 58/289 (20%), Positives = 100/289 (34%), Gaps = 39/289 (13%)

Query: 639 DFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH 697
            +     IG G  G VY+AK   SGE+ A+KK        +   +     E+Q + ++ H
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--------VLQDKRFKNRELQIMRKLDH 72

Query: 698 RNIVKFYGFCSHP------KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVA 751
            NIV+   F           +  ++ +Y+             + + L        +  + 
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132

Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDL-GYEAHVSDFGIAKFLNPDSSNWSELAGTHGY 810
            +L Y+H+     I HRDI  +N+LLD       + DFG AK L     N S +   +  
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 189

Query: 811 VAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP------------------RDFLFEMSS 852
               +      T   DV+S G +  E++ G+                         ++  
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249

Query: 853 SSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAF--SCLDQNPESRPTMK 899
            + N           +P   V +       +A     L+  P +R T  
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 298

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 4e-38
 Identities = 55/285 (19%), Positives = 110/285 (38%), Gaps = 29/285 (10%)

Query: 639 DFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH 697
           +F     IG+G +G VY+A+   +GE+ A+KK       E        + EI  L E+ H
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG--VPSTAIREISLLKELNH 60

Query: 698 RNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYL 757
            NIVK           ++++E+L       +  +      +      + +  +   L + 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFC 118

Query: 758 HNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAY 817
           H++    ++HRD+  +N+L++      ++DFG+A+        ++    T  Y APE+  
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175

Query: 818 TLK-VTEKCDVYSFGVLALEVIKGKHP------RDFLFEMSSS---------SSNMNIEM 861
             K  +   D++S G +  E++  +         D LF +  +             ++  
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235

Query: 862 LDSRLPYPSLHVQKKLMSIMQVAF-----SCLDQNPESRPTMKRV 901
                P  +     K++  +           L  +P  R + K  
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (360), Expect = 5e-38
 Identities = 53/264 (20%), Positives = 95/264 (35%), Gaps = 17/264 (6%)

Query: 638 NDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
           NDF+    +GKG  G V   +   +G  +A+K     +      +    + E + L   R
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKD-EVAHTVTESRVLQNTR 63

Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFY 756
           H  +               + EY   G L   L  +         +       +  AL  
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV---FTEERARFYGAEIVSAL-- 118

Query: 757 LHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELA 816
                   +V+RDI  +N++LD      ++DFG+ K    D +      GT  Y+APE+ 
Sbjct: 119 -EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL 177

Query: 817 YTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKK 876
                    D +  GV+  E++ G+ P    F          + +L   + +P   +  +
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLP----FYNQDHERLFEL-ILMEEIRFPR-TLSPE 231

Query: 877 LMSIMQVAFSCLDQNPESRPTMKR 900
             S++      L ++P+ R     
Sbjct: 232 AKSLLA---GLLKKDPKQRLGGGP 252

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 6e-37
 Identities = 59/297 (19%), Positives = 105/297 (35%), Gaps = 33/297 (11%)

Query: 632 EIISATNDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQ 690
           ++      +     IG+G +G V  A    +    A+KK     P E     +  L EI+
Sbjct: 2   QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS---PFEHQTYCQRTLREIK 58

Query: 691 ALTEIRHRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGV 750
            L   RH NI+        P    +   YL +  +   L      + L        +  +
Sbjct: 59  ILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQI 118

Query: 751 ADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN---WSELAGT 807
              L Y+H+     ++HRD+   N+LL+   +  + DFG+A+  +PD  +    +E   T
Sbjct: 119 LRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 175

Query: 808 HGYVAPELAYT-LKVTEKCDVYSFGVLALEVIKGKHP-----------------RDFLFE 849
             Y APE+       T+  D++S G +  E++  +                        E
Sbjct: 176 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 235

Query: 850 MSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAF-----SCLDQNPESRPTMKRV 901
             +   N+        LP+ +     +L               L  NP  R  +++ 
Sbjct: 236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  137 bits (346), Expect = 5e-36
 Identities = 55/266 (20%), Positives = 96/266 (36%), Gaps = 20/266 (7%)

Query: 638 NDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
           + F+    +G G  G V   K   SG  +A+K        ++  Q E  LNE + L  + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK-QIEHTLNEKRILQAVN 99

Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFY 756
              +VK         + +++ EY+  G +   L                    +     Y
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEY 156

Query: 757 LHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELA 816
           LH+     +++RD+  +N+L+D      V+DFG AK           L GT   +APE+ 
Sbjct: 157 LHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR---VKGRTWTLCGTPEALAPEII 210

Query: 817 YTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKK 876
            +    +  D ++ GVL  E+  G  P        +       E + S       H    
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPP------FFADQPIQIYEKIVSGKVRFPSHFSSD 264

Query: 877 LMSIMQVAFSCLDQNPESRPTMKRVS 902
           L  +++   + L  +   R    +  
Sbjct: 265 LKDLLR---NLLQVDLTKRFGNLKNG 287

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 5e-35
 Identities = 51/292 (17%), Positives = 108/292 (36%), Gaps = 32/292 (10%)

Query: 636 ATNDFNAEHCIGKGGHGSVYRAK--VPSGEIFAVKKFH-SPLPGEMSFQQEEFLNEIQAL 692
           A   +     IG+G +G V++A+     G   A+K+         M       +  ++ L
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 693 TEIRHRNIVKFYGFCSHPK-----HSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVI 747
               H N+V+ +  C+  +        +++E+++      +         +      +++
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMM 122

Query: 748 KGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGT 807
             +   L +LH++    +VHRD+  +N+L+    +  ++DFG+A+  +   +  S +  T
Sbjct: 123 FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS-VVVT 178

Query: 808 HGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP------RDFLFEMSSSSSNMNIEM 861
             Y APE+          D++S G +  E+ + K         D L ++         E 
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238

Query: 862 LDSRLPYPSLHVQKKLMSIMQVAFS------------CLDQNPESRPTMKRV 901
               +  P      K    ++   +            CL  NP  R +    
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (334), Expect = 5e-35
 Identities = 55/287 (19%), Positives = 105/287 (36%), Gaps = 31/287 (10%)

Query: 638 NDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
             +     IG+G +G+V++AK   + EI A+K+    L  +        L EI  L E++
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR--LDDDDEGVPSSALREICLLKELK 59

Query: 697 HRNIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFY 756
           H+NIV+ +      K   +++E+ +          +      G      V   +   L  
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKG 113

Query: 757 LHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELA 816
           L       ++HRD+  +N+L++   E  +++FG+A+        +S    T  Y  P++ 
Sbjct: 114 LGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173

Query: 817 YTLKV-TEKCDVYSFGVLALEVIKGKHP-------RDFLFEMSSSSSNMNIEMLDSRLPY 868
           +  K+ +   D++S G +  E+     P        D L  +         E   S    
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233

Query: 869 PSLHVQKKLMSIMQVAF--------------SCLDQNPESRPTMKRV 901
           P         +   +                + L  NP  R + +  
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 7e-35
 Identities = 63/284 (22%), Positives = 113/284 (39%), Gaps = 21/284 (7%)

Query: 638 NDFNAEHCIGKGGHGSVYRAK----VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALT 693
            +F     +G G +G V+  +      +G+++A+K        + +   E    E Q L 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 694 EIRHR-NIVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVAD 752
            IR    +V  +          +I +Y+  G L   L       E         +  +  
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY---VGEIVL 140

Query: 753 ALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWS-ELAGTHGYV 811
           AL +LH      I++RDI  +N+LLD      ++DFG++K    D +  + +  GT  Y+
Sbjct: 141 ALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197

Query: 812 APELAYTLK--VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYP 869
           AP++         +  D +S GVL  E++ G  P     E +S +      +L S  PYP
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR-RILKSEPPYP 256

Query: 870 SLHVQKKLMSIMQVAFSCLDQNPESRPTMKR--VSQLLCEKIFE 911
              +      ++Q     L ++P+ R         ++     F+
Sbjct: 257 Q-EMSALAKDLIQ---RLLMKDPKKRLGCGPRDADEIKEHLFFQ 296

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (329), Expect = 4e-34
 Identities = 48/301 (15%), Positives = 107/301 (35%), Gaps = 45/301 (14%)

Query: 638 NDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
           + +     IG+G  G V++A+   +G+  A+KK    +  E        L EI+ L  ++
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL--MENEKEGFPITALREIKILQLLK 67

Query: 697 HRNIVKFYGFCSHPK--------HSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIK 748
           H N+V     C              ++++++ E      +        +   ++   V++
Sbjct: 68  HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL---VKFTLSEIKRVMQ 124

Query: 749 GVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSS----NWSEL 804
            + + L+Y+H N    I+HRD+ + NVL+       ++DFG+A+  +   +     ++  
Sbjct: 125 MLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 181

Query: 805 AGTHGYVAPELAYTLK-VTEKCDVYSFGVLALEVIKGKHP-------------------- 843
             T  Y  PEL    +      D++  G +  E+                          
Sbjct: 182 VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241

Query: 844 -RDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAF--SCLDQNPESRPTMKR 900
             +    + +      +E++  +       ++  +     +      L  +P  R     
Sbjct: 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 301

Query: 901 V 901
            
Sbjct: 302 A 302

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  125 bits (314), Expect = 5e-32
 Identities = 49/297 (16%), Positives = 106/297 (35%), Gaps = 52/297 (17%)

Query: 638 NDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR 696
           +D+     +G+G +  V+ A  + + E   VK            ++++   EI+ L  +R
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-------VKKKKIKREIKILENLR 87

Query: 697 -HRNIVKFYGFCSHPKHS--FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADA 753
              NI+        P      +++E++ +    ++       + L        +  +  A
Sbjct: 88  GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKA 141

Query: 754 LFYLHNNCFPPIVHRDISSKNVLLDL-GYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVA 812
           L Y H+     I+HRD+   NV++D    +  + D+G+A+F +P    ++    +  +  
Sbjct: 142 LDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKG 197

Query: 813 PELAYTLK-VTEKCDVYSFGVLALEVIKGKHP-------------------RDFLFEMSS 852
           PEL    +      D++S G +   +I  K P                    + L++   
Sbjct: 198 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 257

Query: 853 SSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAF----------SCLDQNPESRPTMK 899
             +       +  L   S    ++ +                   L  + +SR T +
Sbjct: 258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 314

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 6e-32
 Identities = 52/284 (18%), Positives = 109/284 (38%), Gaps = 43/284 (15%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G +G+V  A    +G   A+KK + P   E+    +    E++ L  +RH N++   
Sbjct: 26  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL--FAKRAYRELRLLKHMRHENVIGLL 83

Query: 705 GFCSHPKHS------FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLH 758
              +  +        +++  ++ +     +       ++LG  +   ++  +   L Y+H
Sbjct: 84  DVFTPDETLDDFTDFYLVMPFMGTDLGKLM-----KHEKLGEDRIQFLVYQMLKGLRYIH 138

Query: 759 NNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAY- 817
                   HRD+   N+ ++   E  + DFG+A+  + + + +     T  Y APE+   
Sbjct: 139 AAGII---HRDLKPGNLAVNEDCELKILDFGLARQADSEMTGY---VVTRWYRAPEVILN 192

Query: 818 TLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNI------EMLDSRLPYPSL 871
            ++ T+  D++S G +  E+I GK        +      M +      E +       + 
Sbjct: 193 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 252

Query: 872 HVQKKLMSIMQVAFS----------------CLDQNPESRPTMK 899
           +  K L  + +  F+                 L  + E R T  
Sbjct: 253 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAG 296

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 1e-30
 Identities = 47/291 (16%), Positives = 103/291 (35%), Gaps = 39/291 (13%)

Query: 637 TNDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI 695
              +     +G G +GSV  A    +G   AVKK   P    +    +    E++ L  +
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII--HAKRTYRELRLLKHM 74

Query: 696 RHRNIVKFYGFCSHPK-----HSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGV 750
           +H N++      +  +     +   +  +L    L+ I+      ++L       +I  +
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQI 130

Query: 751 ADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNWSELAGTHGY 810
              L Y+H+       HRD+   N+ ++   E  + DFG+A+  + + + +         
Sbjct: 131 LRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA--TRWYR 185

Query: 811 VAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP------RDFLFEMSSSSSNMNIEMLDS 864
               +   +   +  D++S G +  E++ G+         D L  +         E+L  
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 245

Query: 865 RLPYPSLHVQKKLMSIMQVAFS----------------CLDQNPESRPTMK 899
                + +  + L  + ++ F+                 L  + + R T  
Sbjct: 246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 296

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (294), Expect = 3e-29
 Identities = 51/313 (16%), Positives = 100/313 (31%), Gaps = 52/313 (16%)

Query: 629 VYEEIISATNDFNAEHCIGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLN 687
           V +   +    +     IG G  G V  A         A+KK   P   +     +    
Sbjct: 8   VGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQT--HAKRAYR 65

Query: 688 EIQALTEIRHRNIVKFYGFCSHPKHS------FIIYEYLESGSLDKILCNDASAKELGWT 741
           E+  +  + H+NI+      +  K        +++ E +++     I        EL   
Sbjct: 66  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ------MELDHE 119

Query: 742 QRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNW 801
           +   ++  +   + +LH+      +HRD+   N+++       + DFG+A+         
Sbjct: 120 RMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM-M 175

Query: 802 SELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHP-----------------R 844
           +    T  Y APE+   +   E  D++S G +  E+++ K                    
Sbjct: 176 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 235

Query: 845 DFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFS----------------CL 888
               E            +++R  Y  L   K     +  A S                 L
Sbjct: 236 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKML 295

Query: 889 DQNPESRPTMKRV 901
             +P  R ++   
Sbjct: 296 VIDPAKRISVDDA 308

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score =  112 bits (280), Expect = 4e-27
 Identities = 83/390 (21%), Positives = 149/390 (38%), Gaps = 35/390 (8%)

Query: 103 FSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVL 162
           F+ ++    +   L    +   +    ++L  +  L      +  +   G+  L +LT +
Sbjct: 16  FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQI 71

Query: 163 HISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIP 222
           + S N L+   P  +  LT L  + +++N +    P +       + L+    +    + 
Sbjct: 72  NFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLK 129

Query: 223 Q------------EIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIP 270
                         I ++ +L  L        G     +  L NL  L       + +  
Sbjct: 130 NLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSD 189

Query: 271 QEI-GNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTF 329
             +   L  L SL+   N      P      T+L +L LN N L      T  +  NLT 
Sbjct: 190 ISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTD 245

Query: 330 IDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEI 389
           +DL+NN      L+      +L+ L +  N IS   PL    +L         N    E 
Sbjct: 246 LDLANNQISN--LAPLSGLTKLTELKLGANQISNISPLAGLTALTNLE----LNENQLED 299

Query: 390 PTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYY 449
            + + N+  L  L+L  N +S   P  + SL  L+ L  + N +S+    SL +L  + +
Sbjct: 300 ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINW 355

Query: 450 LNLSHNKLSQQIPIELDNLIHLSELDLSHN 479
           L+  HN++S   P+   NL  +++L L+  
Sbjct: 356 LSAGHNQISDLTPLA--NLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score =  106 bits (265), Expect = 3e-25
 Identities = 72/383 (18%), Positives = 132/383 (34%), Gaps = 77/383 (20%)

Query: 203 NLTHVVILYLYNNSFFGSIPQ-EIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLY 261
            L   +   L   +   ++ Q ++  + +L    L I  + G     +  L NL  +   
Sbjct: 20  ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFS 74

Query: 262 HNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLR-------------- 307
           +N+L+ I P  + NL KL  +L+  N      P +       + L               
Sbjct: 75  NNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132

Query: 308 --------------LNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDW-------- 345
                         ++      ++ +            L+N +    +            
Sbjct: 133 NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISV 192

Query: 346 -GRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSL 404
             +   L  L  + N IS   PL I  +L    L L+ N +       L ++  L  L L
Sbjct: 193 LAKLTNLESLIATNNQISDITPLGILTNLD--ELSLNGNQLKD--IGTLASLTNLTDLDL 248

Query: 405 SGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGS--------------------L 444
           + N++S   P  L  L  L  L L AN +SN  P +  +                    L
Sbjct: 249 ANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNL 306

Query: 445 VKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNN 504
             L YL L  N +S   P+   +L  L  L  ++N + + +SS +  + ++  L+  +N 
Sbjct: 307 KNLTYLTLYFNNISDISPVS--SLTKLQRLFFANNKVSD-VSS-LANLTNINWLSAGHNQ 362

Query: 505 LSGLIPRCFEEMHGLLHIDISYN 527
           +S L P     +  +  + ++  
Sbjct: 363 ISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 90.8 bits (224), Expect = 6e-20
 Identities = 64/215 (29%), Positives = 95/215 (44%), Gaps = 16/215 (7%)

Query: 97  NGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLL 156
           N        +   +L  L   NN++  I P  I   +NL+ L  + N+L       +  L
Sbjct: 185 NKVSDISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASL 240

Query: 157 THLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNS 216
           T+LT L ++ N +S   P  +  LT L +L L +N ++   P  L  LT +  L L  N 
Sbjct: 241 TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQ 296

Query: 217 FFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNL 276
                   I NLK+L  L L  N +S   P  +S+LT L+ LF  +N++S      + NL
Sbjct: 297 LE--DISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANL 350

Query: 277 KKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQN 311
             +N L    N      P    NLT + +L LN  
Sbjct: 351 TNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 83.1 bits (204), Expect = 2e-17
 Identities = 53/176 (30%), Positives = 81/176 (46%), Gaps = 14/176 (7%)

Query: 90  NLTSISLNGTLLEF--SFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFG 147
           NL  +SLNG  L+   + +S  +L  LDL NN++  + P  +S L+ L  L   AN++  
Sbjct: 220 NLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN 277

Query: 148 QIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHV 207
             P  +  LT LT L ++ N         +  L  L  L L  N ++   P  + +LT +
Sbjct: 278 ISP--LAGLTALTNLELNENQ--LEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKL 331

Query: 208 VILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHN 263
             L+  NN    S    + NL ++  L    NQ+S   PL  +NLT +  L L   
Sbjct: 332 QRLFFANNKV--SDVSSLANLTNINWLSAGHNQISDLTPL--ANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 75.4 bits (184), Expect = 7e-15
 Identities = 61/338 (18%), Positives = 114/338 (33%), Gaps = 47/338 (13%)

Query: 227 NLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAK 286
            L       L    ++  +  S ++L  +  L      +  I    +  L  L  +  + 
Sbjct: 20  ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSN 75

Query: 287 NHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWG 346
           N      P   +NLT LV + +N N +         T      +  +  +    + +   
Sbjct: 76  NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133

Query: 347 RCP------QLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIV-------GEIPTQL 393
                     +S +       S        +   L+ L   +               + L
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193

Query: 394 GNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLS 453
             +  L  L  + N++S   P  + +  NL+ L L+ N L +    +L SL  L  L+L+
Sbjct: 194 AKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249

Query: 454 HNKLSQQIPIELDNLIHLSELDLSHNFLGEKIS--------------------SRICRME 493
           +N++S   P+    L  L+EL L  N +                         S I  ++
Sbjct: 250 NNQISNLAPLS--GLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLK 307

Query: 494 SLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEG 531
           +L  L L +NN+S + P     +  L  +  + NK+  
Sbjct: 308 NLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD 343

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 53.1 bits (126), Expect = 8e-08
 Identities = 18/100 (18%), Positives = 37/100 (37%), Gaps = 4/100 (4%)

Query: 68  TKISPCAWSGIFCNHAERVVGINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPP 127
           T +          +    +  +   ++  N        SS   L  L   NN++      
Sbjct: 288 TNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFANNKVSD--VS 345

Query: 128 QISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRN 167
            ++NL+N+ +L    N++    P  +  LT +T L ++  
Sbjct: 346 SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.5 bits (101), Expect = 1e-04
 Identities = 41/249 (16%), Positives = 88/249 (35%), Gaps = 23/249 (9%)

Query: 299 NLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSI 358
            L + +K  L +  +T  +S+T      +T +         + +        L+ ++ S 
Sbjct: 20  ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSN 75

Query: 359 NNISGSIPLEIGESLQL-------------QYLDLSSNYIVGEIPTQLGNIIYLNRLSLS 405
           N ++   PL+    L                    +   +              N  +L+
Sbjct: 76  NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 135

Query: 406 GNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIEL 465
             +LS     ++ +L  L  L   +        + L +L  L  L++S NK        L
Sbjct: 136 RLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNK--VSDISVL 193

Query: 466 DNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDIS 525
             L +L  L  ++N + +     +  + +L++L+L+ N L          +  L  +D++
Sbjct: 194 AKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249

Query: 526 YNKLEGQIP 534
            N++    P
Sbjct: 250 NNQISNLAP 258

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  108 bits (270), Expect = 2e-26
 Identities = 63/296 (21%), Positives = 116/296 (39%), Gaps = 15/296 (5%)

Query: 237 CINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKS 296
           C +     +P  +    +   L L +N+++ I   +  NLK L++L+L  N      P +
Sbjct: 17  CSDLGLEKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA 74

Query: 297 FRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDV 356
           F  L  L +L L++N L     +   T   L   +         + +   +   + L   
Sbjct: 75  FAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTN 134

Query: 357 SINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRE 416
                SG          +L Y+ ++   I         +   L  L L GNK++      
Sbjct: 135 P-LKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPS---LTELHLDGNKITKVDAAS 190

Query: 417 LGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDL 476
           L  L NL  L LS N++S     SL +   L  L+L++NKL  ++P  L +  ++  + L
Sbjct: 191 LKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL-VKVPGGLADHKYIQVVYL 249

Query: 477 SHNFLGEKISSRIC------RMESLEKLNLSYNNLS--GLIPRCFEEMHGLLHIDI 524
            +N +    S+  C      +  S   ++L  N +    + P  F  ++    + +
Sbjct: 250 HNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 99.7 bits (247), Expect = 2e-23
 Identities = 58/319 (18%), Positives = 98/319 (30%), Gaps = 50/319 (15%)

Query: 73  CAWSGIFCNHAERVVGINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNL 132
           C    + C+         L  +  +           P    LDL NN++  I      NL
Sbjct: 10  CHLRVVQCSDL------GLEKVPKD---------LPPDTALLDLQNNKITEIKDGDFKNL 54

Query: 133 SNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNF 192
            NL  L    NK+    P     L  L  L++S+N L          L  L       N 
Sbjct: 55  KNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVH---ENE 111

Query: 193 LNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNL 252
           +          L  ++++ L                           + SG    +   +
Sbjct: 112 ITKVRKSVFNGLNQMIVVELGT----------------------NPLKSSGIENGAFQGM 149

Query: 253 TNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNY 312
             L ++ +    ++ I     G    L  L L  N        S + L +L KL L+ N 
Sbjct: 150 KKLSYIRIADTNITTIPQ---GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNS 206

Query: 313 LTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISG------SIP 366
           ++   + +    P+L  + L+NN               + ++ +  NNIS         P
Sbjct: 207 ISAVDNGSLANTPHLRELHLNNNKLVKVPGGLAD-HKYIQVVYLHNNNISAIGSNDFCPP 265

Query: 367 LEIGESLQLQYLDLSSNYI 385
               +      + L SN +
Sbjct: 266 GYNTKKASYSGVSLFSNPV 284

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 77.8 bits (190), Expect = 5e-16
 Identities = 43/205 (20%), Positives = 79/205 (38%), Gaps = 4/205 (1%)

Query: 325 PNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNY 384
           P+   +DL NN        D+     L  L +  N IS   P      ++L+ L LS N 
Sbjct: 31  PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90

Query: 385 IVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSL 444
           +          +  L        K+   +   L  +I +  L  +    S     +   +
Sbjct: 91  LKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV-ELGTNPLKSSGIENGAFQGM 149

Query: 445 VKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNN 504
            KL Y+ ++   ++    I       L+EL L  N + +  ++ +  + +L KL LS+N+
Sbjct: 150 KKLSYIRIADTNITT---IPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNS 206

Query: 505 LSGLIPRCFEEMHGLLHIDISYNKL 529
           +S +          L  + ++ NKL
Sbjct: 207 ISAVDNGSLANTPHLRELHLNNNKL 231

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 75.5 bits (184), Expect = 3e-15
 Identities = 42/219 (19%), Positives = 77/219 (35%), Gaps = 4/219 (1%)

Query: 349 PQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNK 408
           P  +LLD+  N I+     +      L  L L +N I    P     ++ L RL LS N+
Sbjct: 31  PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90

Query: 409 LSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNL 468
           L     +   +L  L   +     +   V   L  ++ +  L  +  K S         +
Sbjct: 91  LKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSGIENGAFQGM 149

Query: 469 IHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNK 528
             LS + ++   +   I   +    SL +L+L  N ++ +     + ++ L  + +S+N 
Sbjct: 150 KKLSYIRIADTNI-TTIPQGLPP--SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNS 206

Query: 529 LEGQIPNSTTFRDAPLEALQGNKGLYGDIRGFPSCMSYK 567
           +      S        E    N  L     G       +
Sbjct: 207 ISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQ 245

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 58.5 bits (140), Expect = 1e-09
 Identities = 26/124 (20%), Positives = 48/124 (38%), Gaps = 3/124 (2%)

Query: 413 IPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLS 472
           +P++L    +   LDL  N ++        +L  L+ L L +NK+S+  P     L+ L 
Sbjct: 25  VPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82

Query: 473 ELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQ 532
            L LS N L E        ++ L         +   +     +M  ++ +  +  K  G 
Sbjct: 83  RLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI-VVELGTNPLKSSGI 141

Query: 533 IPNS 536
              +
Sbjct: 142 ENGA 145

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  100 bits (249), Expect = 3e-23
 Identities = 43/248 (17%), Positives = 85/248 (34%), Gaps = 24/248 (9%)

Query: 646 IGKGGHGSVYRAK-VPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFY 704
           +G G   +V+ AK + +    A+K              E   +EI+ L  +   +  K  
Sbjct: 21  LGWGHFSTVWLAKDMVNNTHVAMKIVRGD-----KVYTEAAEDEIKLLQRVNDADNTKED 75

Query: 705 GFCS-------------HPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVA 751
              +              P    ++  +   G     L      + +       + K + 
Sbjct: 76  SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 135

Query: 752 DALFYLHNNCFPPIVHRDISSKNVLLDL-GYEAHVSDFGIAKFLNPDSS--NWSELAGTH 808
             L Y+H  C   I+H DI  +NVL+++     ++    IA   N      +++    T 
Sbjct: 136 LGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193

Query: 809 GYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPY 868
            Y +PE+          D++S   L  E+I G    +     S +  + +I  +   L  
Sbjct: 194 EYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGE 253

Query: 869 PSLHVQKK 876
              ++ + 
Sbjct: 254 LPSYLLRN 261

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.3 bits (243), Expect = 3e-23
 Identities = 66/289 (22%), Positives = 108/289 (37%), Gaps = 31/289 (10%)

Query: 125 IPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLN 184
           +P  I   +  + +    N++     +      +LT+L +  N L+         L +L 
Sbjct: 26  VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83

Query: 185 QLALDSNFLNGSI-PRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSG 243
           QL L  N    S+ P +   L  +  L+L         P     L +L  L L  N L  
Sbjct: 84  QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143

Query: 244 AIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDL 303
               +  +L NL  LFL+ N +S +  +    L  L+ LLL +N      P +FR+L  L
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203

Query: 304 VKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISG 363
           + L L  N L+   +E       L ++ L++N +  +       C    L          
Sbjct: 204 MTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD-------CRARPLWA-------- 248

Query: 364 SIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGC 412
                      LQ    SS+ +   +P +L      +   L+ N L GC
Sbjct: 249 ----------WLQKFRGSSSEVPCSLPQRLAG---RDLKRLAANDLQGC 284

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 82.2 bits (201), Expect = 1e-17
 Identities = 54/257 (21%), Positives = 89/257 (34%), Gaps = 13/257 (5%)

Query: 301 TDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINN 360
               ++ L+ N ++   + +F    NLT + L +N       + +     L  LD+S N 
Sbjct: 32  AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91

Query: 361 ISGSI-PLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGS 419
              S+ P       +L  L L    +    P     +  L  L L  N L          
Sbjct: 92  QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151

Query: 420 LINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHN 479
           L NL +L L  N +S+    +   L  L  L L  N+++   P    +L  L  L L  N
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211

Query: 480 FLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLL----HIDISYNKLEGQIPN 535
            L    +  +  + +L+ L L+ N        C      L         S +++   +P 
Sbjct: 212 NLSALPTEALAPLRALQYLRLNDNPW-----VCDCRARPLWAWLQKFRGSSSEVPCSLPQ 266

Query: 536 S---TTFRDAPLEALQG 549
                  +      LQG
Sbjct: 267 RLAGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 70.6 bits (171), Expect = 8e-14
 Identities = 46/242 (19%), Positives = 83/242 (34%), Gaps = 4/242 (1%)

Query: 50  EVHSRSLLHSWSLSSVNATKISPCAWSGIFCNHAERVVGINLTSISLNGTLLEFSFSSFP 109
            V + S     +L+ +                    +  ++L+  +   ++   +F    
Sbjct: 46  HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLG 105

Query: 110 HLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWL 169
            L  L L    L  + P     L+ L+YL    N L          L +LT L +  N +
Sbjct: 106 RLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRI 165

Query: 170 SGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLK 229
           S         L  L++L L  N +    P +  +L  ++ LYL+ N+      + +  L+
Sbjct: 166 SSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLR 225

Query: 230 SLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHF 289
           +L  L L  N               L+      +E+   +PQ +          LA N  
Sbjct: 226 ALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRLAGRDLKR---LAANDL 281

Query: 290 RG 291
           +G
Sbjct: 282 QG 283

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 91.0 bits (224), Expect = 2e-20
 Identities = 70/308 (22%), Positives = 120/308 (38%), Gaps = 17/308 (5%)

Query: 37  EEAHALVKWKASLEVHSRSLLHSWSLSSVNATKISPC--AWSGIFCN---HAERVVGINL 91
           ++  AL++ K  L   + + L SW  ++        C   W G+ C+      RV  ++L
Sbjct: 6   QDKQALLQIKKDL--GNPTTLSSWLPTT------DCCNRTWLGVLCDTDTQTYRVNNLDL 57

Query: 92  TSISLNGTL-LEFSFSSFPHLVYLDLYNNE-LFGIIPPQISNLSNLEYLDFSANKLFGQI 149
           + ++L     +  S ++ P+L +L +     L G IPP I+ L+ L YL  +   + G I
Sbjct: 58  SGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAI 117

Query: 150 PSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVI 209
           P  +  +  L  L  S N LSG++P  +  L  L  +  D N ++G+IP S G+ + +  
Sbjct: 118 PDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFT 177

Query: 210 LYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGII 269
               + +             +L         +       +                    
Sbjct: 178 SMTISRNRLTGKIPPTFANLNLAF-VDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFD 236

Query: 270 PQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTF 329
             ++G  K LN L L  N   GT+P+    L  L  L ++ N L G I +  G       
Sbjct: 237 LGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDV 295

Query: 330 IDLSNNSF 337
              +NN  
Sbjct: 296 SAYANNKC 303

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 81.3 bits (199), Expect = 3e-17
 Identities = 60/264 (22%), Positives = 109/264 (41%), Gaps = 6/264 (2%)

Query: 303 LVKLRLNQNYLTGN--ISETFGTYPNLTFIDLSNN-SFFGEILSDWGRCPQLSLLDVSIN 359
           +  L L+   L     I  +    P L F+ +    +  G I     +  QL  L ++  
Sbjct: 52  VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHT 111

Query: 360 NISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGS 419
           N+SG+IP  + +   L  LD S N + G +P  + ++  L  ++  GN++SG IP   GS
Sbjct: 112 NVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGS 171

Query: 420 LINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHN 479
              L      + N          + + L +++LS N   +     L      ++      
Sbjct: 172 FSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNM-LEGDASVLFGSDKNTQKIHLAK 230

Query: 480 FLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNSTTF 539
                   ++   ++L  L+L  N + G +P+   ++  L  +++S+N L G+IP     
Sbjct: 231 NSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNL 290

Query: 540 RDAPLEALQGNKGLYGDIRGFPSC 563
           +   + A   NK L G     P+C
Sbjct: 291 QRFDVSAYANNKCLCG--SPLPAC 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 59.8 bits (143), Expect = 4e-10
 Identities = 25/66 (37%), Positives = 34/66 (51%), Gaps = 2/66 (3%)

Query: 108 FPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRN 167
             +L  LDL NN ++G +P  ++ L  L  L+ S N L G+IP G G L    V   + N
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANN 301

Query: 168 -WLSGS 172
             L GS
Sbjct: 302 KCLCGS 307

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 52.4 bits (124), Expect = 1e-07
 Identities = 17/61 (27%), Positives = 28/61 (45%), Gaps = 1/61 (1%)

Query: 188 LDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPL 247
           L +N + G++P+ L  L  +  L +  N+  G IP + GNL+         N+     PL
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSPL 309

Query: 248 S 248
            
Sbjct: 310 P 310

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 42.4 bits (98), Expect = 2e-04
 Identities = 46/198 (23%), Positives = 75/198 (37%), Gaps = 23/198 (11%)

Query: 331 DLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIP 390
           D  N ++ G +     +  +++ LD+S  N+    P                      IP
Sbjct: 32  DCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYP----------------------IP 69

Query: 391 TQLGNIIYLNRLSLSGN-KLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYY 449
           + L N+ YLN L + G   L G IP  +  L  L YL ++  N+S  +P+ L  +  L  
Sbjct: 70  SSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129

Query: 450 LNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLI 509
           L+ S+N LS  +P  + +L +L  +    N +   I         L        N     
Sbjct: 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGK 189

Query: 510 PRCFEEMHGLLHIDISYN 527
                    L  +D+S N
Sbjct: 190 IPPTFANLNLAFVDLSRN 207

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 80.2 bits (197), Expect = 8e-18
 Identities = 22/162 (13%), Positives = 47/162 (29%), Gaps = 16/162 (9%)

Query: 646 IGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQ------QEEFLNEIQALTEIRHRN 699
           +G+G   +V+           VK            +         F            R 
Sbjct: 8   MGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 67

Query: 700 IVKFYGFCSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHN 759
           + K  G      +++      E  ++   L +      +       V+  + + +   ++
Sbjct: 68  LQKLQGLAVPKVYAW------EGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYH 121

Query: 760 NCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSNW 801
                IVH D+S  NVL+       + DF  +  +  +    
Sbjct: 122 RG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWRE 159

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 62.7 bits (151), Expect = 1e-11
 Identities = 44/228 (19%), Positives = 72/228 (31%), Gaps = 18/228 (7%)

Query: 227 NLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAK 286
            L +   +    + ++  +  +  +L  +  L  +   ++ I  + +  L  L  L L  
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72

Query: 287 NHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWG 346
           N        +       +           N+S   G     T    S        L+   
Sbjct: 73  NQIT---DLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLS 129

Query: 347 RCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSG 406
               L L    I NIS                 LS         T L N+  L  L    
Sbjct: 130 NLQVLYLDLNQITNISPLAG-------LTNLQYLSIGNAQVSDLTPLANLSKLTTLKADD 182

Query: 407 NKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSH 454
           NK+S   P  L SL NL  + L  N +S+  P  L +   L+ + L++
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 53.9 bits (128), Expect = 1e-08
 Identities = 37/228 (16%), Positives = 71/228 (31%), Gaps = 18/228 (7%)

Query: 251 NLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQ 310
            L N   +    + ++  + Q   +L  + +L            +  + L +L+ L L  
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72

Query: 311 NYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIG 370
           N +                 +L+  +      +       ++ L         S  +   
Sbjct: 73  NQI----------TDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDV 122

Query: 371 ESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSA 430
             L            + +I          N   LS           L +L  L  L    
Sbjct: 123 TPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADD 182

Query: 431 NNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSH 478
           N +S+  P  L SL  L  ++L +N++S   P  L N  +L  + L++
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 53.9 bits (128), Expect = 2e-08
 Identities = 40/233 (17%), Positives = 79/233 (33%), Gaps = 24/233 (10%)

Query: 67  ATKISPCAWSGIFCNHA-ERVVGINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGII 125
            +   P A + IF + A    + I     ++  T+   + +    +  L  +   +  I 
Sbjct: 1   GSITQPTAINVIFPDPALANAIKIAAGKSNVTDTV---TQADLDGITTLSAFGTGVTTI- 56

Query: 126 PPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQ 185
              +  L+NL  L+   N++    P           L  +      +I       T+   
Sbjct: 57  -EGVQYLNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLT 115

Query: 186 LALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFG--------------SIPQEIGNLKSL 231
               ++    +   +L  L   +      +   G              S    + NL  L
Sbjct: 116 STQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKL 175

Query: 232 FDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLL 284
             L+   N++S   PL+  +L NL  + L +N++S + P  + N   L  + L
Sbjct: 176 TTLKADDNKISDISPLA--SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 52.3 bits (124), Expect = 6e-08
 Identities = 33/223 (14%), Positives = 72/223 (32%), Gaps = 23/223 (10%)

Query: 103 FSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVL 162
           F   +  + + +    + +   +    ++L  +  L      +      G+  L +L  L
Sbjct: 13  FPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGL 68

Query: 163 HISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIP 222
            +  N ++   P +        +L+ +      +I       T  +      +    +  
Sbjct: 69  ELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGL 128

Query: 223 QEIGNLKSLFDLELCINQL--------------SGAIPLSISNLTNLRFLFLYHNELSGI 268
             +  L    +    I+ L                +    ++NL+ L  L    N++S I
Sbjct: 129 SNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDI 188

Query: 269 IPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRL-NQ 310
            P  + +L  L  + L  N      P    N ++L  + L NQ
Sbjct: 189 SP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQ 227

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 47.3 bits (111), Expect = 2e-06
 Identities = 30/227 (13%), Positives = 67/227 (29%), Gaps = 18/227 (7%)

Query: 299 NLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSI 358
            L + +K+   ++ +T  +++       +T +           +        L  L++  
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGV--TTIEGVQYLNNLIGLELKD 72

Query: 359 NNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELG 418
           N I+   PL+    +    L  +    V  I             +   +         L 
Sbjct: 73  NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132

Query: 419 SLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSH 478
            L        + + L+                 LS           L NL  L+ L    
Sbjct: 133 VLYLDLNQITNISPLAGLT----------NLQYLSIGNAQVSDLTPLANLSKLTTLKADD 182

Query: 479 NFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDIS 525
           N + +     +  + +L +++L  N +S + P        L  + ++
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 62.9 bits (151), Expect = 5e-11
 Identities = 52/347 (14%), Positives = 91/347 (26%), Gaps = 30/347 (8%)

Query: 155 LLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYN 214
           L      L ++   LS S+P     L  L       N L   +P    +L  +++     
Sbjct: 36  LDRQAHELELNNLGLS-SLPELPPHLESLV---ASCNSLT-ELPELPQSLKSLLVDNNNL 90

Query: 215 NSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIG 274
            +     P             L    +S      +  L N  FL +   + + +      
Sbjct: 91  KALSDLPPL------------LEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDL 138

Query: 275 NLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSN 334
                               ++   LT +     +   L                ++   
Sbjct: 139 PPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELP 198

Query: 335 NSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLG 394
                  L+         L  +     S          L        S   +        
Sbjct: 199 ELQNLPFLTTI-YADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFS 257

Query: 395 NIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSH 454
            +  L       N  S  I        +LE L++S N L    P     L +   L  S 
Sbjct: 258 GLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIEL-PALPPRLER---LIASF 313

Query: 455 NKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLS 501
           N L+ ++P    N   L +L + +N     +       ES+E L ++
Sbjct: 314 NHLA-EVPELPQN---LKQLHVEYN----PLREFPDIPESVEDLRMN 352

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 57.9 bits (138), Expect = 2e-09
 Identities = 54/327 (16%), Positives = 94/327 (28%), Gaps = 25/327 (7%)

Query: 133 SNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNF 192
                L+ +   L   +P    L  HL  L  S N L+  +P     L  L     +   
Sbjct: 38  RQAHELELNNLGL-SSLPE---LPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKA 92

Query: 193 LNGSIP---------RSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSG 243
           L+   P           L  L  +            +   +           +       
Sbjct: 93  LSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQL 152

Query: 244 AIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDL 303
                + NL  L  ++  +N L  +    +     +    + +             +   
Sbjct: 153 EELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYAD 212

Query: 304 VKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDV--SINNI 361
             L      L  ++         LT +     S     +S+        L      +N  
Sbjct: 213 NNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNAS 272

Query: 362 SGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLI 421
           S  I         L+ L++S+N ++ E+P        L RL  S N L+  +P       
Sbjct: 273 SNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLAE-VPELPQ--- 324

Query: 422 NLEYLDLSANNLSNFVPESLGSLVKLY 448
           NL+ L +  N L  F P+   S+  L 
Sbjct: 325 NLKQLHVEYNPLREF-PDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 54.8 bits (130), Expect = 2e-08
 Identities = 55/341 (16%), Positives = 97/341 (28%), Gaps = 30/341 (8%)

Query: 179 QLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCI 238
           Q   L    L++  L+ S+P    +L     L    NS    +P+   +LKSL      +
Sbjct: 39  QAHELE---LNNLGLS-SLPELPPHLES---LVASCNSL-TELPELPQSLKSLLVDNNNL 90

Query: 239 NQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFR 298
             LS   PL      +   L       +    + I             +    ++ K   
Sbjct: 91  KALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKII-------------DVDNNSLKKLPD 137

Query: 299 NLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSI 358
               L  +    N L          +    + D ++     ++          + +   +
Sbjct: 138 LPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEEL 197

Query: 359 NNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELG 418
             +     L    +       L       E      N +                     
Sbjct: 198 PELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFS 257

Query: 419 SLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSH 478
            L  L       N  SN +         L  LN+S+NKL + +P     L     L  S 
Sbjct: 258 GLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRL---ERLIASF 313

Query: 479 NFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGL 519
           N     ++      ++L++L++ YN L    P   E +  L
Sbjct: 314 N----HLAEVPELPQNLKQLHVEYNPLREF-PDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 51.7 bits (122), Expect = 2e-07
 Identities = 60/325 (18%), Positives = 98/325 (30%), Gaps = 25/325 (7%)

Query: 110 HLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLH---ISR 166
               L+L N  L   +P       +LE L  S N L  ++P     L  L V +    + 
Sbjct: 39  QAHELELNNLGL-SSLPE---LPPHLESLVASCNSL-TELPELPQSLKSLLVDNNNLKAL 93

Query: 167 NWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIG 226
           + L   + +       L +L    N     I     N    +     +  F  +   ++ 
Sbjct: 94  SDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLE 153

Query: 227 NLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAK 286
            L  L +L       +    L       L    +           E+ NL  L ++    
Sbjct: 154 ELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADN 213

Query: 287 NHFRGTVPKSFRNLTDLVKLRLNQNYL--------TGNISETFGTYPNLTFIDLSNNSFF 338
           N  +             V+     +                 F     L       N+  
Sbjct: 214 NLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASS 273

Query: 339 GEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIY 398
            EI S     P L  L+VS N +   +P       +L+ L  S N++  E+P    N   
Sbjct: 274 NEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHL-AEVPELPQN--- 325

Query: 399 LNRLSLSGNKLSGCIPRELGSLINL 423
           L +L +  N L    P    S+ +L
Sbjct: 326 LKQLHVEYNPLR-EFPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 49.1 bits (115), Expect = 2e-06
 Identities = 28/104 (26%), Positives = 40/104 (38%), Gaps = 10/104 (9%)

Query: 103 FSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVL 162
             FS    L     Y N     I        +LE L+ S NKL  ++P+       L  L
Sbjct: 254 NIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKL-IELPALPP---RLERL 309

Query: 163 HISRNWLSGSIPHEVGQLTVLNQLALDSNFLNG--SIPRSLGNL 204
             S N L+  +P     L  L+   ++ N L     IP S+ +L
Sbjct: 310 IASFNHLA-EVPELPQNLKQLH---VEYNPLREFPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 46.0 bits (107), Expect = 1e-05
 Identities = 22/86 (25%), Positives = 36/86 (41%), Gaps = 9/86 (10%)

Query: 451 NLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIP 510
               N  S +I    D    L EL++S+N    K+         LE+L  S+N+L+ +  
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNN----KLIELPALPPRLERLIASFNHLAEVP- 320

Query: 511 RCFEEMHGLLHIDISYNKLEGQIPNS 536
              E    L  + + YN L  + P+ 
Sbjct: 321 ---ELPQNLKQLHVEYNPLR-EFPDI 342

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 41.3 bits (95), Expect = 4e-04
 Identities = 14/70 (20%), Positives = 24/70 (34%), Gaps = 5/70 (7%)

Query: 90  NLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQI 149
           +L  ++++   L    +  P L  L    N L  +         NL+ L    N L  + 
Sbjct: 285 SLEELNVSNNKLIELPALPPRLERLIASFNHLAEV----PELPQNLKQLHVEYNPL-REF 339

Query: 150 PSGIGLLTHL 159
           P     +  L
Sbjct: 340 PDIPESVEDL 349

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 62.0 bits (149), Expect = 6e-11
 Identities = 42/183 (22%), Positives = 57/183 (31%), Gaps = 4/183 (2%)

Query: 108 FPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRN 167
                 L L  N L+      +   + L  L+    +L      G   L  L  L +S N
Sbjct: 30  PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGT--LPVLGTLDLSHN 87

Query: 168 WLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGN 227
            L             L  L +  N L      +L  L  +  LYL  N      P  +  
Sbjct: 88  QLQSLPLLGQTL-PALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTP 146

Query: 228 LKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKN 287
              L  L L  N L+      ++ L NL  L L  N L   IP+       L    L  N
Sbjct: 147 TPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205

Query: 288 HFR 290
            + 
Sbjct: 206 PWL 208

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.7 bits (143), Expect = 3e-10
 Identities = 43/210 (20%), Positives = 74/210 (35%), Gaps = 7/210 (3%)

Query: 248 SISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLR 307
            +S + +   +      L+ + P ++   K    L L++N        +    T L +L 
Sbjct: 5   EVSKVASHLEVNCDKRNLTAL-PPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 308 LNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPL 367
           L++  LT    +          +  +       +         L   DVS N ++     
Sbjct: 62  LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVL---DVSFNRLTSLPLG 118

Query: 368 EIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLD 427
            +    +LQ L L  N +    P  L     L +LSL+ N L+      L  L NL+ L 
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178

Query: 428 LSANNLSNFVPESLGSLVKLYYLNLSHNKL 457
           L  N+L   +P+       L +  L  N  
Sbjct: 179 LQENSLYT-IPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.7 bits (130), Expect = 1e-08
 Identities = 47/179 (26%), Positives = 60/179 (33%), Gaps = 4/179 (2%)

Query: 301 TDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINN 360
            D   L L++N L      T   Y  LT ++L                  +       +N
Sbjct: 31  KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL---QVDGTLPVLGTLDLSHN 87

Query: 361 ISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSL 420
              S+PL       L  LD+S N +       L  +  L  L L GN+L    P  L   
Sbjct: 88  QLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPT 147

Query: 421 INLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHN 479
             LE L L+ NNL+      L  L  L  L L  N L   IP        L    L  N
Sbjct: 148 PKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.6 bits (109), Expect = 6e-06
 Identities = 45/200 (22%), Positives = 78/200 (39%), Gaps = 25/200 (12%)

Query: 352 SLLDVSINNIS-GSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLS 410
           S L+V+ +  +  ++P ++ +      L LS N +       L     L +L+L   +L+
Sbjct: 11  SHLEVNCDKRNLTALPPDLPKDTT--ILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT 68

Query: 411 GCIPRELGSLINL---------------------EYLDLSANNLSNFVPESLGSLVKLYY 449
                    ++                         LD+S N L++    +L  L +L  
Sbjct: 69  KLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQE 128

Query: 450 LNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLI 509
           L L  N+L    P  L     L +L L++N L E  +  +  +E+L+ L L  N+L   I
Sbjct: 129 LYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYT-I 187

Query: 510 PRCFEEMHGLLHIDISYNKL 529
           P+ F   H L    +  N  
Sbjct: 188 PKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.4 bits (98), Expect = 2e-04
 Identities = 14/65 (21%), Positives = 25/65 (38%), Gaps = 3/65 (4%)

Query: 416 ELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELD 475
           E+  + +   ++    NL+  +P  L        L+LS N L       L     L++L+
Sbjct: 5   EVSKVASHLEVNCDKRNLTA-LPPDLPKDTT--ILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 476 LSHNF 480
           L    
Sbjct: 62  LDRAE 66

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 61.5 bits (147), Expect = 3e-10
 Identities = 24/118 (20%), Positives = 44/118 (37%), Gaps = 10/118 (8%)

Query: 421 INLEYLDLSANNLSNF-VPESLGSLVKLYYLNLSHNKLS----QQIPIELDNLIHLSELD 475
           ++++ LD+    LS+    E L  L +   + L    L+    + I   L     L+EL+
Sbjct: 2   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61

Query: 476 LSHNFLGEKISSRICRM-----ESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNK 528
           L  N LG+     + +        ++KL+L    L+G            L      + 
Sbjct: 62  LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHL 119

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.8 bits (132), Expect = 2e-08
 Identities = 16/94 (17%), Positives = 30/94 (31%), Gaps = 5/94 (5%)

Query: 372 SLQLQYLDLSSNYIVGEIPTQL-GNIIYLNRLSLSGNKLSG----CIPRELGSLINLEYL 426
           SL +Q LD+    +      +L   +     + L    L+      I   L     L  L
Sbjct: 1   SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60

Query: 427 DLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQ 460
           +L +N L +     +   ++     +    L   
Sbjct: 61  NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.6 bits (116), Expect = 1e-06
 Identities = 19/94 (20%), Positives = 37/94 (39%), Gaps = 15/94 (15%)

Query: 422 NLEYLDLSANNLSN----FVPESLGSLVKLYYLNLSHNKLSQQIPIEL-----DNLIHLS 472
            L  L L+  ++S+     +  +L +   L  L+LS+N L     ++L          L 
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429

Query: 473 ELDLSHNFLGEKISSRICRMESLEKLNLSYNNLS 506
           +L L   +  E++       + L+ L     +L 
Sbjct: 430 QLVLYDIYWSEEM------EDRLQALEKDKPSLR 457

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.8 bits (114), Expect = 2e-06
 Identities = 17/89 (19%), Positives = 31/89 (34%), Gaps = 9/89 (10%)

Query: 321 FGTYPNLTFIDLSNNSFFGEILSDWG----RCPQLSLLDVSINNISGSIPLEIGESLQ-- 374
                 L  + L++        S           L  LD+S N +  +  L++ ES++  
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424

Query: 375 ---LQYLDLSSNYIVGEIPTQLGNIIYLN 400
              L+ L L   Y   E+  +L  +    
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDRLQALEKDK 453

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.4 bits (113), Expect = 3e-06
 Identities = 20/83 (24%), Positives = 30/83 (36%), Gaps = 9/83 (10%)

Query: 395 NIIYLNRLSLSGNKLSG----CIPRELGSLINLEYLDLSANNLSNFVPESLGSLVK---- 446
               L  L L+   +S      +   L +  +L  LDLS N L +     L   V+    
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 447 -LYYLNLSHNKLSQQIPIELDNL 468
            L  L L     S+++   L  L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.0 bits (112), Expect = 4e-06
 Identities = 19/80 (23%), Positives = 30/80 (37%), Gaps = 9/80 (11%)

Query: 446 KLYYLNLSHNKLS----QQIPIELDNLIHLSELDLSHNFLGEKISSRICR-----MESLE 496
            L  L L+   +S      +   L     L ELDLS+N LG+    ++          LE
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429

Query: 497 KLNLSYNNLSGLIPRCFEEM 516
           +L L     S  +    + +
Sbjct: 430 QLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.5 bits (108), Expect = 1e-05
 Identities = 19/84 (22%), Positives = 28/84 (33%), Gaps = 9/84 (10%)

Query: 374 QLQYLDLSSNYIVGE----IPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLI-----NLE 424
            L+ L L+   +       +   L     L  L LS N L      +L   +      LE
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429

Query: 425 YLDLSANNLSNFVPESLGSLVKLY 448
            L L     S  + + L +L K  
Sbjct: 430 QLVLYDIYWSEEMEDRLQALEKDK 453

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.7 bits (106), Expect = 2e-05
 Identities = 19/87 (21%), Positives = 33/87 (37%), Gaps = 9/87 (10%)

Query: 343 SDWGRCPQLSLLDVSINNISGSIPLEIGESLQ----LQYLDLSSNYIVGEIPTQLGNII- 397
                   L +L ++  ++S S    +  +L     L+ LDLS+N +      QL   + 
Sbjct: 363 GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVR 422

Query: 398 ----YLNRLSLSGNKLSGCIPRELGSL 420
                L +L L     S  +   L +L
Sbjct: 423 QPGCLLEQLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.0 bits (104), Expect = 3e-05
 Identities = 15/93 (16%), Positives = 29/93 (31%), Gaps = 10/93 (10%)

Query: 302 DLVKLRLNQNYLTGN-ISETFGTYPNLTFIDLSNNSFFGEILSDWGR----CPQLSLLDV 356
           D+  L +    L+    +E          + L +         D        P L+ L++
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 357 SINNISGSIPLEIGESLQ-----LQYLDLSSNY 384
             N +       + + LQ     +Q L L +  
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.0 bits (104), Expect = 4e-05
 Identities = 9/73 (12%), Positives = 25/73 (34%), Gaps = 5/73 (6%)

Query: 469 IHLSELDLSHNFLGEKISSRIC-RMESLEKLNLSYNNLSG----LIPRCFEEMHGLLHID 523
           + +  LD+    L +   + +   ++  + + L    L+      I         L  ++
Sbjct: 2   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61

Query: 524 ISYNKLEGQIPNS 536
           +  N+L     + 
Sbjct: 62  LRSNELGDVGVHC 74

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.0 bits (99), Expect = 1e-04
 Identities = 16/90 (17%), Positives = 27/90 (30%), Gaps = 5/90 (5%)

Query: 111 LVYLDLYNNELFGIIPPQI-SNLSNLEYLDFSANKL----FGQIPSGIGLLTHLTVLHIS 165
           +  LD+   EL      ++   L   + +      L       I S + +   L  L++ 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 166 RNWLSGSIPHEVGQLTVLNQLALDSNFLNG 195
            N L     H V Q        +    L  
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.0 bits (91), Expect = 0.001
 Identities = 16/96 (16%), Positives = 33/96 (34%), Gaps = 16/96 (16%)

Query: 465 LDNLIHLSELDLSHNFLGEK----ISSRICRMESLEKLNLSYNNLSGLIPRCFEE----- 515
                 L  L L+   + +     +++ +    SL +L+LS N L         E     
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424

Query: 516 MHGLLHIDISYNKLEGQIPNSTTFRDAPLEALQGNK 551
              L  + +       ++ +        L+AL+ +K
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDR-------LQALEKDK 453

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.2 bits (89), Expect = 0.002
 Identities = 16/121 (13%), Positives = 33/121 (27%), Gaps = 8/121 (6%)

Query: 203 NLTHVVILYLYNNSF-FGSIPQEIGNLKSLFDLELCINQLSG----AIPLSISNLTNLRF 257
           ++     L +           + +  L+    + L    L+      I  ++     L  
Sbjct: 3   DIQS---LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 59

Query: 258 LFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNI 317
           L L  NEL  +    +    +  S  + K   +               LR        ++
Sbjct: 60  LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHL 119

Query: 318 S 318
           S
Sbjct: 120 S 120

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.8 bits (88), Expect = 0.003
 Identities = 15/107 (14%), Positives = 30/107 (28%), Gaps = 10/107 (9%)

Query: 254 NLRFLFLYHNELSGI-IPQEIGNLKKLNSLLLAKNHFRG----TVPKSFRNLTDLVKLRL 308
           +++ L +   ELS     + +  L++   + L            +  + R    L +L L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 309 NQNYLTGNISETFG-----TYPNLTFIDLSNNSFFGEILSDWGRCPQ 350
             N L                  +  + L N    G          +
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLR 109

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.4 bits (87), Expect = 0.003
 Identities = 13/92 (14%), Positives = 25/92 (27%), Gaps = 9/92 (9%)

Query: 102 EFSFSSFPHLVYLDLYNNEL----FGIIPPQISNLSNLEYLDFSANKLFGQIPSGIG--- 154
           +        L  L L + ++       +   +    +L  LD S N L       +    
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421

Query: 155 --LLTHLTVLHISRNWLSGSIPHEVGQLTVLN 184
                 L  L +   + S  +   +  L    
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALEKDK 453

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.4 bits (87), Expect = 0.003
 Identities = 10/91 (10%), Positives = 22/91 (24%), Gaps = 4/91 (4%)

Query: 89  INLTSISLNGTLLEFSFSSFPHLVYLDLYNNEL----FGIIPPQISNLSNLEYLDFSANK 144
           +++    L+                + L +  L       I   +     L  L+  +N+
Sbjct: 7   LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66

Query: 145 LFGQIPSGIGLLTHLTVLHISRNWLSGSIPH 175
           L       +          I +  L      
Sbjct: 67  LGDVGVHCVLQGLQTPSCKIQKLSLQNCCLT 97

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.4 bits (87), Expect = 0.004
 Identities = 14/83 (16%), Positives = 28/83 (33%), Gaps = 9/83 (10%)

Query: 227 NLKSLFDLELCINQLSG----AIPLSISNLTNLRFLFLYHNELSGIIPQEIG-----NLK 277
               L  L L    +S     ++  ++    +LR L L +N L      ++         
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 278 KLNSLLLAKNHFRGTVPKSFRNL 300
            L  L+L   ++   +    + L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQAL 449

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.7 bits (135), Expect = 3e-09
 Identities = 41/271 (15%), Positives = 88/271 (32%), Gaps = 16/271 (5%)

Query: 281 SLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGE 340
           +L L   +    V     +   ++  R  ++++   ++E F     +  +DLSN+     
Sbjct: 4   TLDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLAEHFSP-FRVQHMDLSNSVIEVS 61

Query: 341 ILSD-WGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYL 399
            L     +C +L  L +    +S  I   + ++  L  L+LS      E   Q       
Sbjct: 62  TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 121

Query: 400 NRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLV---------KLYYL 450
               L+ +       + +   +      ++  NLS +      S +          ++  
Sbjct: 122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 181

Query: 451 NLSHNKLSQQIPIELDNLIHLSELDLSH-NFLGEKISSRICRMESLEKLNLSYNNLSGLI 509
                 L      E   L +L  L LS    +  +    +  + +L+ L +      G +
Sbjct: 182 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTL 241

Query: 510 PRCFEEMHGLLHIDISYNKLEGQIPNSTTFR 540
               E    L H+ I+ +        +   +
Sbjct: 242 QLLKE---ALPHLQINCSHFTTIARPTIGNK 269

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.4 bits (124), Expect = 8e-08
 Identities = 23/118 (19%), Positives = 48/118 (40%), Gaps = 3/118 (2%)

Query: 376 QYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLS- 434
           Q LDL+   +  ++  +L +   +       + +   +  E  S   ++++DLS + +  
Sbjct: 3   QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEV 60

Query: 435 NFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRM 492
           + +   L    KL  L+L   +LS  I   L    +L  L+LS      + + +    
Sbjct: 61  STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLS 118

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.0 bits (123), Expect = 1e-07
 Identities = 40/265 (15%), Positives = 78/265 (29%), Gaps = 21/265 (7%)

Query: 186 LALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSG-A 244
           L L    L+  +   L +   V+      +     + +     + +  ++L  + +    
Sbjct: 5   LDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVST 62

Query: 245 IPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLV 304
           +   +S  + L+ L L    LS  I   +     L  L                NL+   
Sbjct: 63  LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRL----------------NLSGCS 106

Query: 305 KLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGS 364
                      +              D +       +        QL+L     N     
Sbjct: 107 GFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSD 166

Query: 365 IPLEIGESLQLQYLDLSSNYIV-GEIPTQLGNIIYLNRLSLSG-NKLSGCIPRELGSLIN 422
           +   +     L +LDLS + ++  +   +   + YL  LSLS    +      ELG +  
Sbjct: 167 LSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPT 226

Query: 423 LEYLDLSANNLSNFVPESLGSLVKL 447
           L+ L +        +     +L  L
Sbjct: 227 LKTLQVFGIVPDGTLQLLKEALPHL 251

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.0 bits (110), Expect = 4e-06
 Identities = 34/284 (11%), Positives = 83/284 (29%), Gaps = 23/284 (8%)

Query: 89  INLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKL-FG 147
           ++LT  +L+  +     S    ++      + +   +    S    ++++D S + +   
Sbjct: 5   LDLTGKNLHPDVTGRLLSQ--GVIAFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIEVS 61

Query: 148 QIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHV 207
            +   +   + L  L +    LS  I + + + + L +L L                +  
Sbjct: 62  TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 121

Query: 208 VILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSG 267
            +  L  +  F    + +    +     +    LSG       +  +       +     
Sbjct: 122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLV--- 178

Query: 268 IIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQ-NYLTGNISETFGTYPN 326
                       +  L      +    + F  L  L  L L++   +        G  P 
Sbjct: 179 ------------HLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPT 226

Query: 327 LTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIG 370
           L  + +      G +       P    L ++ ++ +      IG
Sbjct: 227 LKTLQVFGIVPDGTLQLLKEALPH---LQINCSHFTTIARPTIG 267

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 52.8 bits (126), Expect = 5e-09
 Identities = 32/108 (29%), Positives = 46/108 (42%), Gaps = 6/108 (5%)

Query: 402 LSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQI 461
           L L+   L+  +   L  L+ + +LDLS N L    P +L +L  L  L  S N    + 
Sbjct: 3   LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNA--LEN 57

Query: 462 PIELDNLIHLSELDLSHNFLGE-KISSRICRMESLEKLNLSYNNLSGL 508
              + NL  L EL L +N L +      +     L  LNL  N+L   
Sbjct: 58  VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 51.3 bits (122), Expect = 2e-08
 Identities = 32/125 (25%), Positives = 55/125 (44%), Gaps = 6/125 (4%)

Query: 376 QYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSN 435
           + L L+   +   +   L  ++ +  L LS N+L    P  L +L  LE L  S N    
Sbjct: 1   RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNA--L 55

Query: 436 FVPESLGSLVKLYYLNLSHNKLSQQIPIE-LDNLIHLSELDLSHNFLGEKISSRICRMES 494
              + + +L +L  L L +N+L Q   I+ L +   L  L+L  N L ++   +    E 
Sbjct: 56  ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115

Query: 495 LEKLN 499
           L  ++
Sbjct: 116 LPSVS 120

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 45.9 bits (108), Expect = 2e-06
 Identities = 28/121 (23%), Positives = 45/121 (37%), Gaps = 7/121 (5%)

Query: 113 YLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGS 172
            L L + +L   +   +  L  + +LD S N+L    P+ +  L  L VL  S N L   
Sbjct: 2   VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENV 58

Query: 173 IPHEVGQLTVLNQLALDSNFLNG-SIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSL 231
                       +L L +N L   +  + L +   +V+L L  NS           L  +
Sbjct: 59  DGVANLPRL--QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115

Query: 232 F 232
            
Sbjct: 116 L 116

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 45.9 bits (108), Expect = 2e-06
 Identities = 25/119 (21%), Positives = 44/119 (36%), Gaps = 7/119 (5%)

Query: 330 IDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEI 389
           + L++      +L    +   ++ LD+S N +    P  +     L+ L  S N +    
Sbjct: 3   LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVD 59

Query: 390 PTQLGNIIYLNRLSLSGNKL-SGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKL 447
                N+  L  L L  N+L      + L S   L  L+L  N+L          L ++
Sbjct: 60  GVA--NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 43.6 bits (102), Expect = 9e-06
 Identities = 32/127 (25%), Positives = 53/127 (41%), Gaps = 9/127 (7%)

Query: 161 VLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGS 220
           VLH++   L+  +   + QL ++  L L  N L    P +L  L  + +L   +N+    
Sbjct: 2   VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALE-- 56

Query: 221 IPQEIGNLKSLFDLELCINQL-SGAIPLSISNLTNLRFLFLYHNELSGI---IPQEIGNL 276
               + NL  L +L LC N+L   A    + +   L  L L  N L        +    L
Sbjct: 57  NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116

Query: 277 KKLNSLL 283
             ++S+L
Sbjct: 117 PSVSSIL 123

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 43.2 bits (101), Expect = 1e-05
 Identities = 21/105 (20%), Positives = 39/105 (37%), Gaps = 24/105 (22%)

Query: 449 YLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISS--------------------- 487
            L+L+H  L+  +   L+ L+ ++ LDLSHN L     +                     
Sbjct: 2   VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVD 59

Query: 488 RICRMESLEKLNLSYNNLSGL-IPRCFEEMHGLLHIDISYNKLEG 531
            +  +  L++L L  N L      +       L+ +++  N L  
Sbjct: 60  GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 41.2 bits (96), Expect = 6e-05
 Identities = 23/108 (21%), Positives = 36/108 (33%), Gaps = 6/108 (5%)

Query: 282 LLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEI 341
           L LA      TV      L  +  L L+ N L             L  +    +    E 
Sbjct: 3   LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQ--ASDNALEN 57

Query: 342 LSDWGRCPQLSLLDVSINNISGSIPLEIGESL-QLQYLDLSSNYIVGE 388
           +      P+L  L +  N +  S  ++   S  +L  L+L  N +  E
Sbjct: 58  VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 40.9 bits (95), Expect = 1e-04
 Identities = 26/126 (20%), Positives = 47/126 (37%), Gaps = 12/126 (9%)

Query: 186 LALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAI 245
           L L    L  ++   L  L  V  L L +N      P  +  L+ L  L+   N      
Sbjct: 3   LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNA--LEN 57

Query: 246 PLSISNLTNLRFLFLYHNELSGI-IPQEIGNLKKLNSLLLAKNHF------RGTVPKSFR 298
              ++NL  L+ L L +N L      Q + +  +L  L L  N        +  + +   
Sbjct: 58  VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117

Query: 299 NLTDLV 304
           +++ ++
Sbjct: 118 SVSSIL 123

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.1 bits (128), Expect = 1e-08
 Identities = 29/224 (12%), Positives = 55/224 (24%), Gaps = 6/224 (2%)

Query: 237 CINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKS 296
           C       IP  +    N   L     +L  I          L  + +++N     +   
Sbjct: 15  CQESKVTEIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEAD 72

Query: 297 FRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFF----GEILSDWGRCPQLS 352
             +    +     +                     L  ++       ++         L 
Sbjct: 73  VFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLL 132

Query: 353 LLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGC 412
            +  +IN  +      +G S +   L L+ N I                     N L   
Sbjct: 133 DIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEEL 192

Query: 413 IPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNK 456
                        LD+S   + +     L +L KL   +  + K
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.1 bits (107), Expect = 7e-06
 Identities = 30/243 (12%), Positives = 60/243 (24%), Gaps = 19/243 (7%)

Query: 73  CAWSGIFCNHAERVVGINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNL 132
           C+     C  +       +T I  +            + + L     +L  I     S  
Sbjct: 8   CSNRVFLCQES------KVTEIPSD---------LPRNAIELRFVLTKLRVIQKGAFSGF 52

Query: 133 SNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSI--PHEVGQLTVLNQLALDS 190
            +LE ++ S N +   I + +                +     P     L  L  L + +
Sbjct: 53  GDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISN 112

Query: 191 NFLNGSIPRSLGNLTHVVILYLYN--NSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLS 248
             +         +    V+L + +  N         +G       L L  N +      +
Sbjct: 113 TGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCA 172

Query: 249 ISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRL 308
            +           +N L  +             L +++            NL  L     
Sbjct: 173 FNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232

Query: 309 NQN 311
              
Sbjct: 233 YNL 235

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (93), Expect = 4e-04
 Identities = 36/221 (16%), Positives = 63/221 (28%), Gaps = 8/221 (3%)

Query: 292 TVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQL 351
            +P       + ++LR     L       F  + +L  I++S N     I +D       
Sbjct: 22  EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 79

Query: 352 SL--LDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPT--QLGNIIYLNRLSLSGN 407
                    NN+    P        LQYL +S+  I               L  +  + N
Sbjct: 80  LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 139

Query: 408 KLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDN 467
             +      +G       L L+ N +      +             +N L +        
Sbjct: 140 IHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHG 199

Query: 468 LIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGL 508
                 LD+S   +    S  +  ++ L   +    NL  L
Sbjct: 200 ASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLKKL 238

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.9 bits (91), Expect = 7e-04
 Identities = 12/80 (15%), Positives = 25/80 (31%), Gaps = 3/80 (3%)

Query: 72  PCAWSGIFCNHAERVVGINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISN 131
                     +  ++  +NL+  +    L    F      V LD+    +  +    + N
Sbjct: 164 GIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLEN 223

Query: 132 LSNLEYLDFSANKLFGQIPS 151
           L  L        K   ++P+
Sbjct: 224 LKKLRARSTYNLK---KLPT 240

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.1 bits (89), Expect = 0.001
 Identities = 33/216 (15%), Positives = 56/216 (25%), Gaps = 6/216 (2%)

Query: 125 IPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLN 184
           IP  +    N   L F   KL             L  + IS+N +   I  +V       
Sbjct: 23  IPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 80

Query: 185 QLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFF----GSIPQEIGNLKSLFDLELCINQ 240
                    N              + YL  ++        + +     K L D++  IN 
Sbjct: 81  HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINI 140

Query: 241 LSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNL 300
            +      +        L+L  N +  I        +     L   N+        F   
Sbjct: 141 HTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGA 200

Query: 301 TDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNS 336
           +  V L +++  +    S        L      N  
Sbjct: 201 SGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.4 bits (87), Expect = 0.003
 Identities = 12/81 (14%), Positives = 22/81 (27%)

Query: 448 YYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSG 507
             L L+ N + +      +           +N L E  +           L++S   +  
Sbjct: 156 VILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHS 215

Query: 508 LIPRCFEEMHGLLHIDISYNK 528
           L     E +  L        K
Sbjct: 216 LPSYGLENLKKLRARSTYNLK 236

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.5 bits (125), Expect = 2e-08
 Identities = 29/146 (19%), Positives = 56/146 (38%), Gaps = 6/146 (4%)

Query: 404 LSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPI 463
           L   ++   +   +    +     L    L +     L +      LN   + ++  + I
Sbjct: 4   LKPEQVE-QLKLIMSKRYDGSQQALDLKGLRS--DPDLVAQNIDVVLNRRSS-MAATLRI 59

Query: 464 ELDNLIHLSELDLSHNFL--GEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLH 521
             +N+  L  L+LS+N L   + +SS + +  +L+ LNLS N L         +   L  
Sbjct: 60  IEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEE 119

Query: 522 IDISYNKLEGQIPNSTTFRDAPLEAL 547
           + +  N L     + +T+  A  E  
Sbjct: 120 LWLDGNSLSDTFRDQSTYISAIRERF 145

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.3 bits (101), Expect = 3e-05
 Identities = 20/145 (13%), Positives = 42/145 (28%), Gaps = 12/145 (8%)

Query: 196 SIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNL 255
            +   +          L           ++        L    + ++  + +   N+  L
Sbjct: 11  QLKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNR-RSSMAATLRIIEENIPEL 67

Query: 256 RFLFLYHNELSGI--IPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYL 313
             L L +N L  +  +   +     L  L L+ N  +            L +L L+ N L
Sbjct: 68  LSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127

Query: 314 TGNISETFG-------TYPNLTFID 331
           +    +           +P L  +D
Sbjct: 128 SDTFRDQSTYISAIRERFPKLLRLD 152

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.9 bits (100), Expect = 4e-05
 Identities = 27/156 (17%), Positives = 60/156 (38%), Gaps = 6/156 (3%)

Query: 379 DLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVP 438
           +L    +  ++   +      ++ +L    L      +L +      L+   ++++  + 
Sbjct: 3   ELKPEQV-EQLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRR-SSMAATLR 58

Query: 439 ESLGSLVKLYYLNLSHNKLS--QQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLE 496
               ++ +L  LNLS+N+L     +   +    +L  L+LS N L  +      +   LE
Sbjct: 59  IIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLE 118

Query: 497 KLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEGQ 532
           +L L  N+LS         +  +        +L+G 
Sbjct: 119 ELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLDGH 154

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.3 bits (96), Expect = 1e-04
 Identities = 24/133 (18%), Positives = 46/133 (34%), Gaps = 5/133 (3%)

Query: 269 IPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLT 328
           +   +      +   L     R             V L   ++ +   +       P L 
Sbjct: 12  LKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNR-RSSMAATLRIIEENIPELL 68

Query: 329 FIDLSNN--SFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIV 386
            ++LSNN      ++ S   + P L +L++S N +     L+  + L+L+ L L  N + 
Sbjct: 69  SLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS 128

Query: 387 GEIPTQLGNIIYL 399
                Q   I  +
Sbjct: 129 DTFRDQSTYISAI 141

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.9 bits (87), Expect = 0.002
 Identities = 21/90 (23%), Positives = 36/90 (40%), Gaps = 2/90 (2%)

Query: 89  INLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGI--IPPQISNLSNLEYLDFSANKLF 146
           + L   S     L     + P L+ L+L NN L+ +  +   +    NL+ L+ S N+L 
Sbjct: 45  VVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK 104

Query: 147 GQIPSGIGLLTHLTVLHISRNWLSGSIPHE 176
            +          L  L +  N LS +   +
Sbjct: 105 SERELDKIKGLKLEELWLDGNSLSDTFRDQ 134

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.5 bits (86), Expect = 0.002
 Identities = 25/124 (20%), Positives = 44/124 (35%), Gaps = 5/124 (4%)

Query: 350 QLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKL 409
             S   + +  +      ++        L+  S+     +     NI  L  L+LS N+L
Sbjct: 21  DGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRL 77

Query: 410 SGC--IPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDN 467
                +   +    NL+ L+LS N L +         +KL  L L  N LS     +   
Sbjct: 78  YRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTY 137

Query: 468 LIHL 471
           +  +
Sbjct: 138 ISAI 141

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 54.9 bits (130), Expect = 2e-08
 Identities = 44/334 (13%), Positives = 93/334 (27%), Gaps = 31/334 (9%)

Query: 114 LDLYNNELFGIIPPQISNLSNLEYLDFSANKL----FGQIPSGIGLLTHLTVLHISRNW- 168
           LD    E    +   +    +++ +  S N +       +   I     L +   S  + 
Sbjct: 12  LDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFT 71

Query: 169 --LSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIG 226
             +   IP  +  L          + +  S           +I +L  ++    +     
Sbjct: 72  GRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNN 131

Query: 227 NLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAK 286
            L      ++       A+     N   LR +    N L     +E     + + LL   
Sbjct: 132 GLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTV 191

Query: 287 NHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWG 346
              +  +                ++ L   ++            +   +     +     
Sbjct: 192 KMVQNGIRPEG-----------IEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALK 240

Query: 347 RCPQLSLLDVSINNISGSIPLEIGESL------QLQYLDLSSNYIVGEIPTQLGNIIY-- 398
             P L  L ++   +S      + ++        LQ L L  N I  +    L  +I   
Sbjct: 241 SWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEK 300

Query: 399 ---LNRLSLSGNKLS--GCIPRELGSLINLEYLD 427
              L  L L+GN+ S    +  E+  + +     
Sbjct: 301 MPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRG 334

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 46.8 bits (109), Expect = 7e-06
 Identities = 45/319 (14%), Positives = 89/319 (27%), Gaps = 39/319 (12%)

Query: 196 SIPRSLGNLTHVVILYLYNNSF----FGSIPQEIGNLKSLFDLEL---CINQLSGAIPLS 248
           S+   L     V  + L  N+        + + I + K L   E       ++   IP +
Sbjct: 22  SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEA 81

Query: 249 ISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRL 308
           +  L          + +           ++     L+K+     +      L      ++
Sbjct: 82  LRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKI 141

Query: 309 NQNYLTGNISETFGTYPNLTFIDLSNNSF----FGEILSDWGRCPQLSLLDVSINNISGS 364
            +      +++     P L  I    N        E    +     L  + +  N I   
Sbjct: 142 ARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE 201

Query: 365 IPLEIGESLQLQYLDLSSNYIV---------GEIPTQLGNIIYLNRLSLSGNKLSGCIPR 415
               +         +L    +            +   L +   L  L L+   LS     
Sbjct: 202 GIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAA 261

Query: 416 ELG------SLINLEYLDLSANNLSNFVPESLGS-----LVKLYYLNLSHNKLSQQIPI- 463
            +         I L+ L L  N +      +L +     +  L +L L+ N+ S++  + 
Sbjct: 262 AVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVV 321

Query: 464 -------ELDNLIHLSELD 475
                         L ELD
Sbjct: 322 DEIREVFSTRGRGELDELD 340

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 44.5 bits (103), Expect = 4e-05
 Identities = 43/323 (13%), Positives = 98/323 (30%), Gaps = 33/323 (10%)

Query: 229 KSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSG----IIPQEIGNLKKLNSLLL 284
           KSL    +       ++   +    +++ + L  N +       + + I + K L     
Sbjct: 8   KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66

Query: 285 AKNH---FRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEI 341
           +       +  +P++ R L   +      + +  + +    T        LS ++    +
Sbjct: 67  SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHL 126

Query: 342 LSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNR 401
                     +   ++      ++  +   +  L+ +    N +      +       +R
Sbjct: 127 YLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR 186

Query: 402 LSLSGNKLSGCIPRELGSLINLEYLD-------------LSANNLSNFVPESLGSLVKLY 448
           L  +   +   I  E    + LE L                 +  S+ +  +L S   L 
Sbjct: 187 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLR 246

Query: 449 YLNLSHNKLSQQIPIEL------DNLIHLSELDLSHNFLGEKISSRIC-----RMESLEK 497
            L L+   LS +    +         I L  L L +N +       +      +M  L  
Sbjct: 247 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLF 306

Query: 498 LNLSYNNLSGLIPRCFEEMHGLL 520
           L L+ N  S       +E+  + 
Sbjct: 307 LELNGNRFSEE-DDVVDEIREVF 328

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 40.6 bits (93), Expect = 6e-04
 Identities = 18/100 (18%), Positives = 31/100 (31%), Gaps = 5/100 (5%)

Query: 446 KLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLG----EKISSRICRMESLEKLNLS 501
            L    ++     + +   L     + E+ LS N +G      +S  I   + LE    S
Sbjct: 9   SLKLDAITTEDE-KSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67

Query: 502 YNNLSGLIPRCFEEMHGLLHIDISYNKLEGQIPNSTTFRD 541
                 +     E +  LL   +   KL     +   F  
Sbjct: 68  DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGP 107

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 50.4 bits (119), Expect = 2e-07
 Identities = 38/204 (18%), Positives = 67/204 (32%), Gaps = 16/204 (7%)

Query: 250 SNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLN 309
                     L    ++  + Q    L  ++ ++   +  +       + L ++ KL LN
Sbjct: 21  DAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLN 76

Query: 310 QNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEI 369
            N LT              F+D +       +               S+ +   S    +
Sbjct: 77  GNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSL------SLEHNGISDINGL 130

Query: 370 GESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLS 429
               QL+ L L +N I           +    L    N++S  +P  L  L  L+ L LS
Sbjct: 131 VHLPQLESLYLGNNKITDITVLSRLTKLDTLSLE--DNQISDIVP--LAGLTKLQNLYLS 186

Query: 430 ANNLSNFVPESLGSLVKLYYLNLS 453
            N++S+    +L  L  L  L L 
Sbjct: 187 KNHISDL--RALAGLKNLDVLELF 208

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.8 bits (107), Expect = 7e-06
 Identities = 32/201 (15%), Positives = 69/201 (34%), Gaps = 17/201 (8%)

Query: 84  ERVVGINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSAN 143
              +  NL   S+   +   + +    +  +   N+++  +    I  L N+  L  + N
Sbjct: 24  AETIKDNLKKKSVTDAV---TQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGN 78

Query: 144 KLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGN 203
           KL     + I  L +L  L       +        +     +     +     I   +  
Sbjct: 79  KL-----TDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHL 133

Query: 204 LTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHN 263
                +    N     ++   +  L +L   +  I+ +       ++ LT L+ L+L  N
Sbjct: 134 PQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIV-----PLAGLTKLQNLYLSKN 188

Query: 264 ELSGIIPQEIGNLKKLNSLLL 284
            +S +  + +  LK L+ L L
Sbjct: 189 HISDL--RALAGLKNLDVLEL 207

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.6 bits (104), Expect = 2e-05
 Identities = 33/196 (16%), Positives = 58/196 (29%), Gaps = 24/196 (12%)

Query: 203 NLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYH 262
                +   L   S   ++ Q    L S+  +    + +       I  L N+  LFL  
Sbjct: 22  AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77

Query: 263 NELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFG 322
           N+L+    + + NLK L  L L +N  +             + L  N       +     
Sbjct: 78  NKLTD--IKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQ 135

Query: 323 TYPNLTFIDLSNNSFFGEILSDW----------------GRCPQLSLLDVSINNISGSIP 366
                   +   +      L+                      +L  L +S N+IS  + 
Sbjct: 136 LESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHIS-DLR 194

Query: 367 LEIGESLQLQYLDLSS 382
             +     L  L+L S
Sbjct: 195 -ALAGLKNLDVLELFS 209

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.8 bits (94), Expect = 3e-04
 Identities = 36/215 (16%), Positives = 67/215 (31%), Gaps = 22/215 (10%)

Query: 269 IPQEIG------NLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFG 322
           +P  I          +     L K      V ++   L  + ++  N + +         
Sbjct: 10  VPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQ 65

Query: 323 TYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSS 382
             PN+T + L+ N      L+D      L  L     + +    L   + L+        
Sbjct: 66  YLPNVTKLFLNGNK-----LTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLE 120

Query: 383 NYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLG 442
           +  + +I   +      +    +       +   L  L  L   D   +++         
Sbjct: 121 HNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPL-----A 175

Query: 443 SLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLS 477
            L KL  L LS N +S  +   L  L +L  L+L 
Sbjct: 176 GLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELF 208

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.4 bits (93), Expect = 4e-04
 Identities = 27/203 (13%), Positives = 62/203 (30%), Gaps = 16/203 (7%)

Query: 299 NLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSI 358
              + +K  L +  +T  +++      ++  I  +N+      +      P ++ L ++ 
Sbjct: 22  AFAETIKDNLKKKSVTDAVTQNE--LNSIDQIIANNSDIKS--VQGIQYLPNVTKLFLNG 77

Query: 359 NNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELG 418
           N ++   PL       L+ L                  +   +     +     I     
Sbjct: 78  NKLTDIKPLA-----NLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDING--- 129

Query: 419 SLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSH 478
             +       S    +N + +            LS         + L  L  L  L LS 
Sbjct: 130 --LVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSK 187

Query: 479 NFLGEKISSRICRMESLEKLNLS 501
           N +   + + +  +++L+ L L 
Sbjct: 188 NHI-SDLRA-LAGLKNLDVLELF 208

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.4 bits (93), Expect = 5e-04
 Identities = 40/232 (17%), Positives = 77/232 (33%), Gaps = 40/232 (17%)

Query: 103 FSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVL 162
           FS  +F   +  +L    +   +    + L++++ +  + + +      GI  L ++T L
Sbjct: 18  FSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQ--GIQYLPNVTKL 73

Query: 163 HISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIP 222
            ++ N L+   P        L  L                +    +      +     I 
Sbjct: 74  FLNGNKLTDIKP--------LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGIS 125

Query: 223 QEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSL 282
              G +       L +          +S LT L  L L  N++S I+P  +  L KL +L
Sbjct: 126 DINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNL 183

Query: 283 LLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSN 334
            L+KNH   +  ++   L                         NL  ++L +
Sbjct: 184 YLSKNHI--SDLRALAGL------------------------KNLDVLELFS 209

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 46.2 bits (108), Expect = 5e-06
 Identities = 33/199 (16%), Positives = 65/199 (32%), Gaps = 17/199 (8%)

Query: 84  ERVVGINLTSISLNGTLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSAN 143
              +   L   ++  T+   S +    +  L      +  I    +  L+NL  ++FS N
Sbjct: 18  AEKMKTVLGKTNVTDTV---SQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNN 72

Query: 144 KLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGN 203
           +L    P          +++ ++      + +      +       ++        +L  
Sbjct: 73  QLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR 132

Query: 204 LTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHN 263
           L          ++  G              L    NQ++   PL  +NLT L  L +  N
Sbjct: 133 LELSSNTISDISALSGLTSL--------QQLNFSSNQVTDLKPL--ANLTTLERLDISSN 182

Query: 264 ELSGIIPQEIGNLKKLNSL 282
           ++S I    +  L  L SL
Sbjct: 183 KVSDI--SVLAKLTNLESL 199

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 42.0 bits (97), Expect = 1e-04
 Identities = 29/190 (15%), Positives = 59/190 (31%), Gaps = 20/190 (10%)

Query: 299 NLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSI 358
            L + +K  L +  +T  +S+T      +T +         + +        L+ ++ S 
Sbjct: 16  ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSN 71

Query: 359 NNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELG 418
           N ++   PL+    L    ++ +    +  +             +   +         L 
Sbjct: 72  NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 131

Query: 419 SLINLEYLDLSANNLSNFV--------------PESLGSLVKLYYLNLSHNKLSQQIPIE 464
            L          + LS                  + L +L  L  L++S NK+S      
Sbjct: 132 RLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD--ISV 189

Query: 465 LDNLIHLSEL 474
           L  L +L  L
Sbjct: 190 LAKLTNLESL 199

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.6 bits (96), Expect = 1e-04
 Identities = 36/201 (17%), Positives = 69/201 (34%), Gaps = 16/201 (7%)

Query: 250 SNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLN 309
           + L       L    ++  + Q   +L ++ +L   +             L +L ++  +
Sbjct: 15  TALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFS 70

Query: 310 QNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEI 369
            N LT        T      ++ +  +    + +           +   +          
Sbjct: 71  NNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT-- 128

Query: 370 GESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLS 429
                L  L+LSSN I          +  L +L+ S N+++   P  L +L  LE LD+S
Sbjct: 129 ----NLNRLELSSNTISDISALS--GLTSLQQLNFSSNQVTDLKP--LANLTTLERLDIS 180

Query: 430 ANNLSNFVPESLGSLVKLYYL 450
           +N +S+     L  L  L  L
Sbjct: 181 SNKVSD--ISVLAKLTNLESL 199

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 45.2 bits (105), Expect = 9e-06
 Identities = 39/167 (23%), Positives = 64/167 (38%), Gaps = 7/167 (4%)

Query: 125 IPPQISNLSNLEYLDFSANKLFGQIPSGI-GLLTHLTVLHISRNWLSGSIPHEVGQLTVL 183
           IP  I    +   L  + N+L      G+ G L HL  L + RN L+G  P+     + +
Sbjct: 23  IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI 80

Query: 184 NQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSG 243
            +L L  N +     +    L  +  L LY+N     +P    +L SL  L L  N  + 
Sbjct: 81  QELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140

Query: 244 AIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFR 290
              L       LR   L         P ++ +++  +   L  + F+
Sbjct: 141 NCHL-AWFAEWLRKKSLNGGAARCGAPSKVRDVQIKD---LPHSEFK 183

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 44.0 bits (102), Expect = 2e-05
 Identities = 37/165 (22%), Positives = 64/165 (38%), Gaps = 7/165 (4%)

Query: 220 SIPQEIGNLKSLFDLELCINQLSGAIPLSI-SNLTNLRFLFLYHNELSGIIPQEIGNLKK 278
            IP++I       +L L  N+L       +   L +L  L L  N+L+GI P        
Sbjct: 22  EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASH 79

Query: 279 LNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFF 338
           +  L L +N  +    K F  L  L  L L  N ++  +  +F    +LT ++L++N F 
Sbjct: 80  IQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139

Query: 339 GEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSN 383
                 W          ++        P ++ +   +Q  DL  +
Sbjct: 140 CNCHLAWFAEWLRK-KSLNGGAARCGAPSKVRD---VQIKDLPHS 180

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 37.9 bits (86), Expect = 0.003
 Identities = 18/104 (17%), Positives = 38/104 (36%), Gaps = 4/104 (3%)

Query: 99  TLLEFSFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTH 158
            +    F     L  L+LY+N++  ++P    +L++L  L+ + +  F            
Sbjct: 92  EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLA-SNPFNCNCHLAWFAEW 150

Query: 159 LTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLG 202
           L    ++        P +V  + + +   L  +    S   S G
Sbjct: 151 LRKKSLNGGAARCGAPSKVRDVQIKD---LPHSEFKCSSENSEG 191

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.0 bits (100), Expect = 3e-05
 Identities = 25/102 (24%), Positives = 44/102 (43%), Gaps = 5/102 (4%)

Query: 380 LSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPE 439
           L++  I  E   Q  N +    L L G K+   I     +L   + +D S N +     +
Sbjct: 3   LTAELI--EQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--D 57

Query: 440 SLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFL 481
               L +L  L +++N++ +        L  L+EL L++N L
Sbjct: 58  GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSL 99

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.0 bits (100), Expect = 3e-05
 Identities = 27/136 (19%), Positives = 43/136 (31%), Gaps = 7/136 (5%)

Query: 127 PQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQL 186
            Q +N      LD    K+   I +    L     +  S N +          L  L  L
Sbjct: 12  AQYTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIRKLDGFP--LLRRLKTL 68

Query: 187 ALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFG-SIPQEIGNLKSLFDLEL---CINQLS 242
            +++N +          L  +  L L NNS         + +LKSL  L +    +    
Sbjct: 69  LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 128

Query: 243 GAIPLSISNLTNLRFL 258
                 I  +  +R L
Sbjct: 129 HYRLYVIYKVPQVRVL 144

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.1 bits (95), Expect = 2e-04
 Identities = 28/139 (20%), Positives = 49/139 (35%), Gaps = 7/139 (5%)

Query: 247 LSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKL 306
              +N    R L L   ++  +I      L + +++  + N  R         L  L  L
Sbjct: 12  AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP--LLRRLKTL 68

Query: 307 RLNQNYLTGNISETFGTYPNLTFIDLSNNSF----FGEILSDWGRCPQLSLLDVSINNIS 362
            +N N +           P+LT + L+NNS       + L+       L +L   + N  
Sbjct: 69  LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 128

Query: 363 GSIPLEIGESLQLQYLDLS 381
                 I +  Q++ LD  
Sbjct: 129 HYRLYVIYKVPQVRVLDFQ 147

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.1 bits (95), Expect = 2e-04
 Identities = 26/132 (19%), Positives = 47/132 (35%), Gaps = 7/132 (5%)

Query: 104 SFSSFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLH 163
            +++      LDL   ++  +I    + L   + +DFS N++      G  LL  L  L 
Sbjct: 13  QYTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIR--KLDGFPLLRRLKTLL 69

Query: 164 ISRNWLSGSIPHEVGQLTVLNQLALDSNFLNG-SIPRSLGNLTHVVILYLYNNSFF---G 219
           ++ N +          L  L +L L +N L        L +L  +  L +  N       
Sbjct: 70  VNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKH 129

Query: 220 SIPQEIGNLKSL 231
                I  +  +
Sbjct: 130 YRLYVIYKVPQV 141

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.6 bits (86), Expect = 0.002
 Identities = 27/133 (20%), Positives = 51/133 (38%), Gaps = 7/133 (5%)

Query: 227 NLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAK 286
           N     +L+L   ++   I    + L     +    NE+  +       L++L +LL+  
Sbjct: 16  NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP--LLRRLKTLLVNN 72

Query: 287 NHFRGTVPKSFRNLTDLVKLRLNQNYLTG-NISETFGTYPNLTFIDLSNNSFFGEI---L 342
           N          + L DL +L L  N L      +   +  +LT++ +  N    +    L
Sbjct: 73  NRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRL 132

Query: 343 SDWGRCPQLSLLD 355
               + PQ+ +LD
Sbjct: 133 YVIYKVPQVRVLD 145

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.1 bits (97), Expect = 6e-05
 Identities = 20/109 (18%), Positives = 37/109 (33%), Gaps = 3/109 (2%)

Query: 422 NLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELD-NLIHLSELDLSHNF 480
               L  + +   +     L     L  L + + +  Q + +     L  L  L +  + 
Sbjct: 9   GSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG 67

Query: 481 LGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKL 529
           L             L +LNLS+N L  L  +  + +     + +S N L
Sbjct: 68  LRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSL-QELVLSGNPL 115

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

 Score = 37.7 bits (86), Expect = 0.003
 Identities = 24/160 (15%), Positives = 48/160 (30%), Gaps = 5/160 (3%)

Query: 395 NIIYLNRLSLSGNKLS-GCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLS 453
                 ++ L G       +   L +L   ++L LS NN+      SL  +  L  L+L 
Sbjct: 21  VATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKI--SSLSGMENLRILSLG 78

Query: 454 HNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCF 513
            N    +    LD +    E           +S     +        +    +       
Sbjct: 79  RNL--IKKIENLDAVADTLEELWISYNQIASLSGIEKLVNLRVLYMSNNKITNWGEIDKL 136

Query: 514 EEMHGLLHIDISYNKLEGQIPNSTTFRDAPLEALQGNKGL 553
             +  L  + ++ N L      +    +  +E ++    L
Sbjct: 137 AALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNL 176

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	912
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.97
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.97
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.97
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.94
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.94
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.93
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.92
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.89
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.89
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.86
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.84
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.83
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.8
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.79
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.78
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.77
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.77
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.76
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.76
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.73
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.73
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.72
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.72
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.7
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.54
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.53
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.53
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.52
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.51
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.5
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.5
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.5
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.37
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.36
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.28
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.25
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.54
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.52
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.45
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.01
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.59
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.57
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.47
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.92
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.87
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.78
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.45
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.25

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-48  Score=414.80  Aligned_cols=248  Identities=27%  Similarity=0.423  Sum_probs=208.7

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++......    ..+.+.+|+++++.++|||||++++++.+++..|+|
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   95 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP----KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS----CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh----HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEE
Confidence            47999999999999999999875 7999999998643222    356789999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++|+|.+++.+    ..+++.+++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+|+....
T Consensus        96 mEy~~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~  168 (293)
T d1yhwa1          96 MEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (293)
T ss_dssp             EECCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEecCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence            999999999998843    3589999999999999999999999   999999999999999999999999999998766


Q ss_pred             CCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhc-cCCCCCCChhhHH
Q 039137          797 DSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEML-DSRLPYPSLHVQK  875 (912)
Q Consensus       797 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  875 (912)
                      .........||+.|+|||++.+..++.++||||+||++|||++|+.||......     ....... ......+  ....
T Consensus       169 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-----~~~~~~~~~~~~~~~--~~~~  241 (293)
T d1yhwa1         169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-----RALYLIATNGTPELQ--NPEK  241 (293)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHHHHHHCSCCCS--SGGG
T ss_pred             ccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH-----HHHHHHHhCCCCCCC--Cccc
Confidence            655666778999999999999999999999999999999999999998522111     1111111 1111111  1123


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          876 KLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       876 ~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .+..+.++|.+||+.||++|||++|+++
T Consensus       242 ~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         242 LSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            4566889999999999999999999864

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-49  Score=412.20  Aligned_cols=251  Identities=25%  Similarity=0.355  Sum_probs=203.3

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++.......   ..+++.+|++++++++||||+++++++.+++..|+|
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~---~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv   81 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD---CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   81 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch---HHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence            57999999999999999999986 79999999987543221   345688999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++|+|.+++.   ....+++.+++.++.||+.||+|||++   +|+||||||+||++++++.+||+|||+|+....
T Consensus        82 mEy~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~  155 (271)
T d1nvra_          82 LEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRY  155 (271)
T ss_dssp             EECCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             EeccCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeecc
Confidence            99999999999984   345799999999999999999999999   999999999999999999999999999987643


Q ss_pred             CC--CCccccccccccccccccccCCC-CcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhh
Q 039137          797 DS--SNWSELAGTHGYVAPELAYTLKV-TEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHV  873 (912)
Q Consensus       797 ~~--~~~~~~~g~~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  873 (912)
                      ..  ......+||+.|||||++.+..+ +.++||||+||++|||++|+.||+.....    ..............+  ..
T Consensus       156 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~----~~~~~~~~~~~~~~~--~~  229 (271)
T d1nvra_         156 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS----CQEYSDWKEKKTYLN--PW  229 (271)
T ss_dssp             TTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTT----SHHHHHHHTTCTTST--TG
T ss_pred             CCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChH----HHHHHHHhcCCCCCC--cc
Confidence            32  23445689999999999988876 57899999999999999999998632111    111111111111111  12


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          874 QKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       874 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ...+.++.+++.+||+.||++|||++|+++
T Consensus       230 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         230 KKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            234566789999999999999999999865

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-48  Score=410.50  Aligned_cols=260  Identities=24%  Similarity=0.377  Sum_probs=203.4

Q ss_pred             hcCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      .++|++.+.||+|+||+||+|+++  ..||||+++......  ...+.|.+|++++++++|||||++++++.+ +..++|
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv   81 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTP--QQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIV   81 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCT--THHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCH--HHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEE
Confidence            468999999999999999999864  359999987553332  256789999999999999999999998754 568999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++|+|.+++...  ...+++.++..|+.|||+||+|||++   +||||||||+|||++.++.+||+|||+|+....
T Consensus        82 ~Ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~  156 (276)
T d1uwha_          82 TQWCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR  156 (276)
T ss_dssp             EECCCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred             EecCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence            9999999999999543  34689999999999999999999999   999999999999999999999999999987654


Q ss_pred             CC--CCcccccccccccccccccc---CCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCC-CCCCC
Q 039137          797 DS--SNWSELAGTHGYVAPELAYT---LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSR-LPYPS  870 (912)
Q Consensus       797 ~~--~~~~~~~g~~~y~aPE~~~~---~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~  870 (912)
                      ..  .......||+.|||||++.+   ..++.++|||||||++|||+||+.||.......    .......... .+...
T Consensus       157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~----~~~~~~~~~~~~p~~~  232 (276)
T d1uwha_         157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD----QIIFMVGRGYLSPDLS  232 (276)
T ss_dssp             ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH----HHHHHHHHTSCCCCGG
T ss_pred             cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH----HHHHHHhcCCCCCcch
Confidence            32  23345679999999999864   357899999999999999999999986321110    0111111111 11111


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          871 LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       871 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                      ......+..+.+++.+||+.||++|||++|+++.|+....
T Consensus       233 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~  272 (276)
T d1uwha_         233 KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR  272 (276)
T ss_dssp             GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            1122344678899999999999999999999999987643

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-49  Score=411.01  Aligned_cols=248  Identities=27%  Similarity=0.440  Sum_probs=207.9

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ++|++.+.||+|+||+||+|+++ +++.||+|++....... ....+.+.+|+++++.++|||||++++++.+++..|+|
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv   84 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK-AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   84 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccC-hHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence            57999999999999999999986 78999999985322111 11356788999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++|+|.+++..   .+.+++.+++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+|.....
T Consensus        85 mEy~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~  158 (263)
T d2j4za1          85 LEYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  158 (263)
T ss_dssp             EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred             EeecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence            999999999999954   34689999999999999999999999   999999999999999999999999999986643


Q ss_pred             CCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHH
Q 039137          797 DSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKK  876 (912)
Q Consensus       797 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  876 (912)
                      .  ......||+.|+|||++.+..++.++||||+||++|||++|+.||....     .......+.......+.    ..
T Consensus       159 ~--~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-----~~~~~~~i~~~~~~~p~----~~  227 (263)
T d2j4za1         159 S--RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-----YQETYKRISRVEFTFPD----FV  227 (263)
T ss_dssp             C--CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHHHTTCCCCCT----TS
T ss_pred             C--cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC-----HHHHHHHHHcCCCCCCc----cC
Confidence            2  3455689999999999999999999999999999999999999986221     11122223333333332    23


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          877 LMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       877 ~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      +.++.+++.+||+.||++|||++|+++
T Consensus       228 s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         228 TEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence            456889999999999999999999976

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-49  Score=412.67  Aligned_cols=257  Identities=23%  Similarity=0.369  Sum_probs=197.2

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEc--CCee
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSH--PKHS  713 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~  713 (912)
                      .++|++.+.||+|+||+||+|+++ +|+.||||++......  +...+.+.+|++++++++|||||++++++.+  .+..
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~   80 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT--EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL   80 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC--HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC--HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEE
Confidence            367999999999999999999876 7899999998765332  3356779999999999999999999999864  4568


Q ss_pred             eEEEeecCCCChhhHhhccC-CcccCCHHHHHHHHHHHHHHHHHHHhCCC--CCeeecCCCCCCeEEcCCCcEEEecccc
Q 039137          714 FIIYEYLESGSLDKILCNDA-SAKELGWTQRLNVIKGVADALFYLHNNCF--PPIVHRDISSKNVLLDLGYEAHVSDFGI  790 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~--~~ivH~Dlk~~Nill~~~~~~kl~Dfgl  790 (912)
                      |+||||+++|+|.+++.+.. ....+++.+++.++.|++.||+|||++..  .+|+||||||+|||++.++.+||+|||+
T Consensus        81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~  160 (269)
T d2java1          81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL  160 (269)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred             EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence            99999999999999985432 34579999999999999999999998710  1399999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCC
Q 039137          791 AKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPS  870 (912)
Q Consensus       791 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  870 (912)
                      |+.............||+.|+|||++.+..++.++|||||||++|||+||+.||.....     ......+.....+..+
T Consensus       161 a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~-----~~~~~~i~~~~~~~~~  235 (269)
T d2java1         161 ARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-----KELAGKIREGKFRRIP  235 (269)
T ss_dssp             HHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHTCCCCCC
T ss_pred             eeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH-----HHHHHHHHcCCCCCCC
Confidence            99876655555667899999999999999999999999999999999999999863211     1112222222222111


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          871 LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       871 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                         ...+.++.+++.+||+.||++|||++|+++
T Consensus       236 ---~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         236 ---YRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             ---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---cccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence               123456889999999999999999999874

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-48  Score=406.39  Aligned_cols=253  Identities=25%  Similarity=0.420  Sum_probs=199.6

Q ss_pred             cCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIY  717 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  717 (912)
                      ++|++.+.||+|+||+||+|++++++.||||++.....     ..++|.+|++++++++|||||+++|++..++..++||
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~   79 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF   79 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC-----cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEE
Confidence            57889999999999999999998889999999864322     3567999999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCC
Q 039137          718 EYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPD  797 (912)
Q Consensus       718 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  797 (912)
                      ||+++|+|.+++...  ...+++.+++.|+.|+|.||+|||++   +|+||||||+||++++++.+||+|||+++.....
T Consensus        80 E~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  154 (263)
T d1sm2a_          80 EFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  154 (263)
T ss_dssp             ECCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC--------
T ss_pred             EecCCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCC
Confidence            999999999998543  35688999999999999999999999   9999999999999999999999999999876544


Q ss_pred             CCC-ccccccccccccccccccCCCCcchhHHHHHHHHHHHHhC-CCCccchhccccccccchhhhccC-CCCCCChhhH
Q 039137          798 SSN-WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKG-KHPRDFLFEMSSSSSNMNIEMLDS-RLPYPSLHVQ  874 (912)
Q Consensus       798 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg-~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  874 (912)
                      ... .....||+.|+|||++.+..++.++|||||||++|||+|+ ++||....     .......+... +...+.    
T Consensus       155 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~-----~~~~~~~i~~~~~~~~p~----  225 (263)
T d1sm2a_         155 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-----NSEVVEDISTGFRLYKPR----  225 (263)
T ss_dssp             ----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC-----HHHHHHHHHHTCCCCCCT----
T ss_pred             CceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC-----HHHHHHHHHhcCCCCCcc----
Confidence            322 2346789999999999999999999999999999999995 55543111     11111111111 122221    


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 039137          875 KKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI  909 (912)
Q Consensus       875 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l  909 (912)
                      ..+.++.+++.+||+.||++|||++|+++.|++..
T Consensus       226 ~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~  260 (263)
T d1sm2a_         226 LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA  260 (263)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence            22456889999999999999999999999999865

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-48  Score=411.12  Aligned_cols=251  Identities=25%  Similarity=0.378  Sum_probs=205.8

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      +.|++.+.||+|+||+||+|+++ +++.||||++......    ..+.+.+|++++++++|||||++++++.+++..++|
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~----~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE----ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWIL   87 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSG----GGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHH----HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEE
Confidence            46899999999999999999976 7899999998754221    456788999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++|+|.+++.+.  .+.+++.++..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+|+....
T Consensus        88 mEy~~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~  162 (288)
T d2jfla1          88 IEFCAGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR  162 (288)
T ss_dssp             EECCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred             EecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCC
Confidence            9999999999987442  34699999999999999999999999   999999999999999999999999999976543


Q ss_pred             CCCCccccccccccccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCCh
Q 039137          797 DSSNWSELAGTHGYVAPELAY-----TLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSL  871 (912)
Q Consensus       797 ~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  871 (912)
                      .........||+.|+|||++.     +..|+.++||||+||++|||++|+.||.....     ......+.....+... 
T Consensus       163 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~-----~~~~~~i~~~~~~~~~-  236 (288)
T d2jfla1         163 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP-----MRVLLKIAKSEPPTLA-  236 (288)
T ss_dssp             HHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG-----GGHHHHHHHSCCCCCS-
T ss_pred             CcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH-----HHHHHHHHcCCCCCCC-
Confidence            323334568999999999884     45689999999999999999999999863211     1112222222221111 


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          872 HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       872 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .....+.++.++|.+||+.||++|||++|+++
T Consensus       237 ~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         237 QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            12234567889999999999999999999875

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.2e-48  Score=413.26  Aligned_cols=257  Identities=25%  Similarity=0.398  Sum_probs=211.8

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeee
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSF  714 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  714 (912)
                      ..++|++.+.||+|+||+||+|+++ +++.||||+++....     ..++|.+|++++++++|||||+++|++.+++..+
T Consensus        15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (287)
T d1opja_          15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   89 (287)
T ss_dssp             CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-----hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeE
Confidence            3467899999999999999999886 688999999865432     3567999999999999999999999999999999


Q ss_pred             EEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccccccc
Q 039137          715 IIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL  794 (912)
Q Consensus       715 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  794 (912)
                      +||||+++|+|.+++... ....+++..++.|+.|||.||+|||++   +|+||||||+|||+++++.+||+|||+|+..
T Consensus        90 iv~E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~  165 (287)
T d1opja_          90 IITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM  165 (287)
T ss_dssp             EEEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred             EEeecccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeec
Confidence            999999999999998543 345789999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCC-ccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccC--CCCCCCh
Q 039137          795 NPDSSN-WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDS--RLPYPSL  871 (912)
Q Consensus       795 ~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~  871 (912)
                      ...... .....|++.|+|||++.+..++.++|||||||++|||++|..||.....     .......+..  +.+.+  
T Consensus       166 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-----~~~~~~~i~~~~~~~~~--  238 (287)
T d1opja_         166 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVYELLEKDYRMERP--  238 (287)
T ss_dssp             CSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-----HHHHHHHHHTTCCCCCC--
T ss_pred             CCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-----HHHHHHHHhcCCCCCCC--
Confidence            544322 2344578999999999999999999999999999999997776531111     1111111222  22222  


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          872 HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       872 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                        ...+..+.+++.+||+.||++|||++|+++.|+..+.
T Consensus       239 --~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         239 --EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             --TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             --ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence              2234568899999999999999999999999987654

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-47  Score=403.88  Aligned_cols=255  Identities=22%  Similarity=0.382  Sum_probs=207.2

Q ss_pred             hcCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      .++|++.+.||+|+||+||+|++++++.||||++.....     ..++|.+|++++++++|||||+++|++.+ +..++|
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv   85 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII   85 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC-----CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEE
Confidence            467889999999999999999998888999999865322     35679999999999999999999998854 567999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++|+|.+++... ....+++.++++|+.||++||+|||++   +|+||||||+||++++++.+||+|||+|+....
T Consensus        86 ~Ey~~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~  161 (272)
T d1qpca_          86 TEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIED  161 (272)
T ss_dssp             EECCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EEeCCCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccC
Confidence            9999999999987443 234589999999999999999999999   999999999999999999999999999997754


Q ss_pred             CCC-CccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccC-CCCCCChhhH
Q 039137          797 DSS-NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDS-RLPYPSLHVQ  874 (912)
Q Consensus       797 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  874 (912)
                      ... ......||+.|+|||++.+..++.++|||||||++|||+||..|+.....    .......+... +.+.+    .
T Consensus       162 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~----~~~~~~~i~~~~~~~~p----~  233 (272)
T d1qpca_         162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT----NPEVIQNLERGYRMVRP----D  233 (272)
T ss_dssp             SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC----HHHHHHHHHTTCCCCCC----T
T ss_pred             CccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC----HHHHHHHHHhcCCCCCc----c
Confidence            432 23446789999999999988999999999999999999996555421110    01111111121 22222    1


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 039137          875 KKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI  909 (912)
Q Consensus       875 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l  909 (912)
                      ..+.++.+++.+||+.||++|||++||++.|++.+
T Consensus       234 ~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f  268 (272)
T d1qpca_         234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF  268 (272)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence            23456889999999999999999999999998754

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-47  Score=397.01  Aligned_cols=251  Identities=26%  Similarity=0.442  Sum_probs=210.7

Q ss_pred             cCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIY  717 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  717 (912)
                      ++|++.+.||+|+||+||+|++++++.||||+++....     ..++|.+|+.++++++||||++++|++.+++..++||
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-----~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~   78 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT   78 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-----CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-----CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Confidence            68999999999999999999998888999999875432     3567999999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCC
Q 039137          718 EYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPD  797 (912)
Q Consensus       718 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  797 (912)
                      ||+++|++.+++..  ....+++..+++++.|+++||+|||++   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        79 Ey~~~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  153 (258)
T d1k2pa_          79 EYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD  153 (258)
T ss_dssp             ECCTTEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS
T ss_pred             EccCCCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCC
Confidence            99999999999743  335688999999999999999999999   9999999999999999999999999999876544


Q ss_pred             CC-CccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccC-CCCCCChhhH
Q 039137          798 SS-NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDS-RLPYPSLHVQ  874 (912)
Q Consensus       798 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  874 (912)
                      .. ......+|+.|+|||.+.+..++.++|||||||++|||+| |+.||+....     ......+... +.+.|.    
T Consensus       154 ~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~-----~~~~~~i~~~~~~~~p~----  224 (258)
T d1k2pa_         154 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-----SETAEHIAQGLRLYRPH----  224 (258)
T ss_dssp             SCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH-----HHHHHHHHTTCCCCCCT----
T ss_pred             CceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH-----HHHHHHHHhCCCCCCcc----
Confidence            32 2334678999999999999999999999999999999998 8999863211     1111112222 222222    


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 039137          875 KKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCE  907 (912)
Q Consensus       875 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  907 (912)
                      ..+..+.+++.+||+.||++|||++|+++.|.+
T Consensus       225 ~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         225 LASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             cccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence            234568899999999999999999999998854

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-47  Score=411.41  Aligned_cols=252  Identities=25%  Similarity=0.338  Sum_probs=194.2

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      .++|++.+.||+|+||+||+|+++ +++.||||++.......   ..+.+.+|+.+++.++|||||++++++.+++..|+
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l   84 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG---KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYL   84 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            467999999999999999999976 78999999997544322   34568899999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEc---CCCcEEEecccccc
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLD---LGYEAHVSDFGIAK  792 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~---~~~~~kl~Dfgla~  792 (912)
                      ||||+++|+|.+++..   .+.+++.++..++.||+.||+|||++   +|+||||||+||++.   +++.+||+|||+|+
T Consensus        85 vmE~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~  158 (307)
T d1a06a_          85 IMQLVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSK  158 (307)
T ss_dssp             EECCCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred             EEeccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeE
Confidence            9999999999999944   35699999999999999999999999   999999999999995   57899999999998


Q ss_pred             ccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChh
Q 039137          793 FLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLH  872 (912)
Q Consensus       793 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  872 (912)
                      ..... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||....     .......+.......+...
T Consensus       159 ~~~~~-~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~~~~~~~i~~~~~~~~~~~  232 (307)
T d1a06a_         159 MEDPG-SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN-----DAKLFEQILKAEYEFDSPY  232 (307)
T ss_dssp             ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHTTCCCCCTTT
T ss_pred             EccCC-CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC-----HHHHHHHHhccCCCCCCcc
Confidence            76543 33445689999999999999999999999999999999999999985221     1112222333333333333


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          873 VQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       873 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ....++.+.+++.+||++||++|||++|+++
T Consensus       233 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         233 WDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             TTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            3345567889999999999999999999876

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.7e-47  Score=408.87  Aligned_cols=256  Identities=27%  Similarity=0.465  Sum_probs=198.7

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CC---CEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCee
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SG---EIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHS  713 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  713 (912)
                      ++|++.+.||+|+||+||+|+++ ++   ..||||++....   .....++|.+|++++++++|||||+++|++..++..
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~  102 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY---TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV  102 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc---CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence            56778899999999999999875 33   258889876432   233567899999999999999999999999999999


Q ss_pred             eEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccc
Q 039137          714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKF  793 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  793 (912)
                      ++|||||++|+|.+++...  .+.+++.++..|+.|||+||+|||++   +|+||||||+|||++.++.+||+|||+|+.
T Consensus       103 ~iv~Ey~~~g~L~~~~~~~--~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~  177 (299)
T d1jpaa_         103 MIITEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRF  177 (299)
T ss_dssp             EEEEECCTTEEHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred             EEEEEecCCCcceeeeccc--cCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceE
Confidence            9999999999999988542  34689999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCC-----ccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhc-cCCC
Q 039137          794 LNPDSSN-----WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEML-DSRL  866 (912)
Q Consensus       794 ~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~-~~~~  866 (912)
                      .......     .....||+.|+|||++.+..++.++|||||||++|||+| |+.||.....     ......+. ..+.
T Consensus       178 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~-----~~~~~~i~~~~~~  252 (299)
T d1jpaa_         178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-----QDVINAIEQDYRL  252 (299)
T ss_dssp             ------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHHHHTTCCC
T ss_pred             ccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH-----HHHHHHHHcCCCC
Confidence            6543222     123457899999999999999999999999999999998 8999853211     11111111 1222


Q ss_pred             CCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          867 PYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       867 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                      +.+.    ..+..+.+++.+||+.||++|||++||++.|++.+.
T Consensus       253 ~~~~----~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~  292 (299)
T d1jpaa_         253 PPPM----DCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR  292 (299)
T ss_dssp             CCCT----TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCCc----cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence            3222    234568899999999999999999999999998764

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-47  Score=402.51  Aligned_cols=256  Identities=24%  Similarity=0.356  Sum_probs=207.7

Q ss_pred             cCCCCCce-eeecCceEEEEEEeC---CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCee
Q 039137          638 NDFNAEHC-IGKGGHGSVYRAKVP---SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHS  713 (912)
Q Consensus       638 ~~~~~~~~-lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  713 (912)
                      ++|.+.+. ||+|+||+||+|.++   ++..||||++....   .....++|.+|++++++++|||||+++|++.. +..
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~   83 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT---EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL   83 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc---CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeE
Confidence            45666664 999999999999764   35579999987542   23356789999999999999999999999975 468


Q ss_pred             eEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccc
Q 039137          714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKF  793 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  793 (912)
                      |+||||+++|+|.+++..  ....+++.++.+++.|||.||+|||++   +|+||||||+||+++.++.+||+|||+|+.
T Consensus        84 ~lvmE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~  158 (285)
T d1u59a_          84 MLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKA  158 (285)
T ss_dssp             EEEEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhc
Confidence            999999999999999843  235689999999999999999999999   999999999999999999999999999997


Q ss_pred             cCCCCCC---ccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccC-CCCC
Q 039137          794 LNPDSSN---WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDS-RLPY  868 (912)
Q Consensus       794 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~  868 (912)
                      .......   .....||+.|+|||++.+..++.++|||||||++|||+| |+.||.....     ......+... +.+.
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~-----~~~~~~i~~~~~~~~  233 (285)
T d1u59a_         159 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-----PEVMAFIEQGKRMEC  233 (285)
T ss_dssp             CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-----HHHHHHHHTTCCCCC
T ss_pred             ccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH-----HHHHHHHHcCCCCCC
Confidence            7554322   234568899999999999999999999999999999998 9999863211     1111122222 2222


Q ss_pred             CChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 039137          869 PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE  911 (912)
Q Consensus       869 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~~  911 (912)
                      +.    ..+.++.+++.+||+.||++|||+.+|.+.|++..+.
T Consensus       234 p~----~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         234 PP----ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             CT----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CC----cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            22    2345688999999999999999999999999887653

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-48  Score=408.34  Aligned_cols=250  Identities=21%  Similarity=0.313  Sum_probs=205.0

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ++|++.+.||+|+||+||+|+++ +++.||||++...... .....+.+.+|++++++++||||+++++++.+++..|+|
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv   86 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII-KENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG   86 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHcc-CHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence            56999999999999999999975 7999999998642211 111356789999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++|+|.+++..   .+.+++.+++.++.|++.||+|||++   +|+||||||+||++++++.+||+|||+|+.+..
T Consensus        87 mEy~~gg~L~~~~~~---~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~  160 (288)
T d1uu3a_          87 LSYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  160 (288)
T ss_dssp             ECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EEccCCCCHHHhhhc---cCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence            999999999999843   35699999999999999999999999   999999999999999999999999999987754


Q ss_pred             CC--CCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhH
Q 039137          797 DS--SNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQ  874 (912)
Q Consensus       797 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  874 (912)
                      ..  .......||+.|+|||++.+..++.++||||+||++|||++|+.||....     .......+......++.    
T Consensus       161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~~~~~~~i~~~~~~~p~----  231 (288)
T d1uu3a_         161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN-----EYLIFQKIIKLEYDFPE----  231 (288)
T ss_dssp             ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHTTCCCCCT----
T ss_pred             CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC-----HHHHHHHHHcCCCCCCc----
Confidence            32  22345679999999999999999999999999999999999999986221     11122223333333332    


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          875 KKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       875 ~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ..+..+.++|.+||+.||++|||++|+++
T Consensus       232 ~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         232 KFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             TCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             cCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence            23456889999999999999999998743

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-47  Score=400.75  Aligned_cols=250  Identities=25%  Similarity=0.389  Sum_probs=200.9

Q ss_pred             ceeeecCceEEEEEEeC---CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEEeec
Q 039137          644 HCIGKGGHGSVYRAKVP---SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEYL  720 (912)
Q Consensus       644 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  720 (912)
                      +.||+|+||+||+|.++   .++.||||+++.....  ....++|.+|++++++++|||||+++|++.. +..++||||+
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~   89 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND--PALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMA   89 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCC--HHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcC
Confidence            47999999999999764   3568999998754322  2356789999999999999999999999965 4578999999


Q ss_pred             CCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCCC
Q 039137          721 ESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN  800 (912)
Q Consensus       721 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  800 (912)
                      ++|+|.+++..   ...+++.+++.|+.||+.||+|||++   +|+||||||+||+++.++.+|++|||+|+........
T Consensus        90 ~~g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~  163 (277)
T d1xbba_          90 ELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY  163 (277)
T ss_dssp             TTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred             CCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence            99999999854   34689999999999999999999999   9999999999999999999999999999876544322


Q ss_pred             ---ccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhcc-CCCCCCChhhHH
Q 039137          801 ---WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLD-SRLPYPSLHVQK  875 (912)
Q Consensus       801 ---~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  875 (912)
                         .....||+.|+|||.+.+..++.++|||||||++|||+| |+.||.....     ......+.. .+.+.+.    .
T Consensus       164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~-----~~~~~~i~~~~~~~~p~----~  234 (277)
T d1xbba_         164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-----SEVTAMLEKGERMGCPA----G  234 (277)
T ss_dssp             EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HHHHHHHHTTCCCCCCT----T
T ss_pred             cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH-----HHHHHHHHcCCCCCCCc----c
Confidence               224568999999999999999999999999999999998 8999863211     111111212 2222222    2


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 039137          876 KLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE  911 (912)
Q Consensus       876 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~~  911 (912)
                      .+.++.+++.+||+.||++|||+++|.+.|++.+++
T Consensus       235 ~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         235 CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             cCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence            345688999999999999999999999999987764

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-46  Score=402.17  Aligned_cols=255  Identities=19%  Similarity=0.311  Sum_probs=212.1

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCC--chHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCee
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGE--MSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHS  713 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  713 (912)
                      .++|++.+.||+|+||+||+|+++ +|+.||||++.......  .....+.+.+|++++++++|||||++++++.+++..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            467999999999999999999975 79999999986543322  122467899999999999999999999999999999


Q ss_pred             eEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCC----cEEEeccc
Q 039137          714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGY----EAHVSDFG  789 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~Dfg  789 (912)
                      |+|||||++|+|.+++...   +.+++.+++.++.|++.||+|||++   +|+||||||+||+++.++    .+|++|||
T Consensus        89 ~iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCccccchhccc---cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchh
Confidence            9999999999999999543   4699999999999999999999999   999999999999998776    49999999


Q ss_pred             cccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCC
Q 039137          790 IAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYP  869 (912)
Q Consensus       790 la~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  869 (912)
                      +|...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||....     .......+.......+
T Consensus       163 ~a~~~~~~-~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~~~~~~~i~~~~~~~~  236 (293)
T d1jksa_         163 LAHKIDFG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT-----KQETLANVSAVNYEFE  236 (293)
T ss_dssp             TCEECTTS-CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHTTCCCCC
T ss_pred             hhhhcCCC-ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC-----HHHHHHHHHhcCCCCC
Confidence            99877543 33445678999999999999999999999999999999999999986221     1112222333333334


Q ss_pred             ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          870 SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       870 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .......+..+.++|.+||+.||++|||++|+++
T Consensus       237 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         237 DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            3333445667889999999999999999999875

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1e-46  Score=410.79  Aligned_cols=252  Identities=21%  Similarity=0.332  Sum_probs=211.3

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      .++|++.+.||+|+||+||+|+++ +|+.||||++....    ....+.+.+|+.++++++|||||++++++.+++..|+
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~----~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i  100 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH----ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM  100 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS----HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEE
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc----hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            368999999999999999999875 79999999986432    2246778999999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEc--CCCcEEEeccccccc
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLD--LGYEAHVSDFGIAKF  793 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~--~~~~~kl~Dfgla~~  793 (912)
                      |||||++|+|.+++..  ..+.+++.+++.|+.||+.||+|||++   +|+||||||+||+++  .++.+||+|||+|+.
T Consensus       101 vmE~~~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~  175 (350)
T d1koaa2         101 IYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH  175 (350)
T ss_dssp             EECCCCSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEE
T ss_pred             EEEcCCCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchhee
Confidence            9999999999999843  235699999999999999999999999   999999999999996  467899999999987


Q ss_pred             cCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhh
Q 039137          794 LNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHV  873 (912)
Q Consensus       794 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  873 (912)
                      .... .......||+.|||||++.+..++.++||||+||++|||++|+.||....     .......+.......+....
T Consensus       176 ~~~~-~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-----~~~~~~~i~~~~~~~~~~~~  249 (350)
T d1koaa2         176 LDPK-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN-----DDETLRNVKSCDWNMDDSAF  249 (350)
T ss_dssp             CCTT-SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHTCCCSCCGGG
T ss_pred             cccc-cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC-----HHHHHHHHHhCCCCCCcccc
Confidence            7543 33456789999999999999999999999999999999999999985221     11122223333333333333


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          874 QKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       874 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ...+..+.++|.+||+.||++|||++|+++
T Consensus       250 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         250 SGISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             GGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            445667889999999999999999999876

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-46  Score=395.73  Aligned_cols=246  Identities=22%  Similarity=0.354  Sum_probs=197.0

Q ss_pred             CCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEc----CCeeeE
Q 039137          641 NAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSH----PKHSFI  715 (912)
Q Consensus       641 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~----~~~~~l  715 (912)
                      ++.+.||+|+||+||+|+++ +++.||+|++......  ....+.+.+|++++++++|||||++++++.+    ....|+
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i   89 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT--KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL   89 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence            56678999999999999876 6889999998654322  2346779999999999999999999999865    346799


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCC--eeecCCCCCCeEEc-CCCcEEEecccccc
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP--IVHRDISSKNVLLD-LGYEAHVSDFGIAK  792 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlk~~Nill~-~~~~~kl~Dfgla~  792 (912)
                      ||||+++|+|.+++.+   ...+++.+++.++.||+.||+|||++   +  |+||||||+|||++ +++.+||+|||+|+
T Consensus        90 vmE~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~  163 (270)
T d1t4ha_          90 VTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  163 (270)
T ss_dssp             EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEeCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence            9999999999999954   34689999999999999999999998   6  99999999999996 57899999999998


Q ss_pred             ccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChh
Q 039137          793 FLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLH  872 (912)
Q Consensus       793 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  872 (912)
                      ....  .......||+.|+|||++.+ .++.++||||+||++|||++|+.||.....    .......+.....  +...
T Consensus       164 ~~~~--~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~----~~~~~~~i~~~~~--~~~~  234 (270)
T d1t4ha_         164 LKRA--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN----AAQIYRRVTSGVK--PASF  234 (270)
T ss_dssp             GCCT--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS----HHHHHHHHTTTCC--CGGG
T ss_pred             eccC--CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc----HHHHHHHHHcCCC--Cccc
Confidence            6433  33456789999999998876 599999999999999999999999852111    0111111111111  1112


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          873 VQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       873 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ....++++.+++.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         235 DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            2233456889999999999999999998865

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-47  Score=412.05  Aligned_cols=256  Identities=26%  Similarity=0.375  Sum_probs=203.3

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      .++|++.+.||+|+||+||+|+++ +|+.||+|+++.....   ...+++.+|+.++++++|||||++++++.+++..|+
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i   81 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP---AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   81 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCT---THHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCH---HHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            578999999999999999999975 7899999999765322   245778999999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCCeEEcCCCcEEEecccccccc
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHN-NCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFL  794 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  794 (912)
                      ||||+++|+|.+++.+.   +.+++.+++.++.|++.||+|||+ +   +|+||||||+|||++.++.+||+|||+|+..
T Consensus        82 VmEy~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~  155 (322)
T d1s9ja_          82 CMEHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  155 (322)
T ss_dssp             EEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred             EEEcCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence            99999999999999543   468999999999999999999997 5   8999999999999999999999999999876


Q ss_pred             CCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccc----------ccc--------
Q 039137          795 NPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS----------SSN--------  856 (912)
Q Consensus       795 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~----------~~~--------  856 (912)
                      ...  .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||.........          ...        
T Consensus       156 ~~~--~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (322)
T d1s9ja_         156 IDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP  233 (322)
T ss_dssp             HHH--TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred             CCC--ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence            432  234568999999999999999999999999999999999999998531110000          000        


Q ss_pred             ---chhhhccCCCC--------------CCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          857 ---MNIEMLDSRLP--------------YPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       857 ---~~~~~~~~~~~--------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                         ......+...+              .+.......+.++.+++.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             ------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence               00000000000              000000112356889999999999999999999986

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.2e-47  Score=405.47  Aligned_cols=248  Identities=25%  Similarity=0.383  Sum_probs=203.2

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      +.|+..+.||+|+||+||+|++. +++.||||++....... ....+.+.+|++++++++|||||++++++.+++..|+|
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   93 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS-NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCH-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccC-HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence            35899999999999999999875 78899999987544322 23456799999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      ||||++|++..++..   .+.+++.+++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+....
T Consensus        94 ~E~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (309)
T d1u5ra_          94 MEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (309)
T ss_dssp             EECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             EEecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence            999999999877633   35689999999999999999999999   999999999999999999999999999986543


Q ss_pred             CCCCcccccccccccccccccc---CCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhh
Q 039137          797 DSSNWSELAGTHGYVAPELAYT---LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHV  873 (912)
Q Consensus       797 ~~~~~~~~~g~~~y~aPE~~~~---~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  873 (912)
                          .....||+.|||||++.+   ..|+.++|||||||++|||++|+.||.....     ............+...  .
T Consensus       168 ----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~-----~~~~~~i~~~~~~~~~--~  236 (309)
T d1u5ra_         168 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSALYHIAQNESPALQ--S  236 (309)
T ss_dssp             ----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHHSCCCCCS--C
T ss_pred             ----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHhCCCCCCC--C
Confidence                234679999999999864   4589999999999999999999999852211     1111112222222111  1


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          874 QKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       874 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ...+..+.++|.+||+.||++|||++|+++
T Consensus       237 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         237 GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            223456889999999999999999999875

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-47  Score=408.67  Aligned_cols=257  Identities=24%  Similarity=0.393  Sum_probs=206.3

Q ss_pred             hcCCCCCceeeecCceEEEEEEeCC-C-----CEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEEc
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVPS-G-----EIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSH  709 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~  709 (912)
                      .++|++.+.||+|+||+||+|++.. +     ..||+|++......   .....+.+|+.++.++ +|||||++++++.+
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~  112 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS---SEREALMSELKMMTQLGSHENIVNLLGACTL  112 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCH---HHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence            3679999999999999999998642 2     36999998654322   2456788999999998 89999999999999


Q ss_pred             CCeeeEEEeecCCCChhhHhhccCC--------------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecC
Q 039137          710 PKHSFIIYEYLESGSLDKILCNDAS--------------------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRD  769 (912)
Q Consensus       710 ~~~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~D  769 (912)
                      ++..++||||+++|+|.++++....                    ...+++.+++.++.||+.||+|||++   +|+|||
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRD  189 (325)
T d1rjba_         113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRD  189 (325)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred             CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecc
Confidence            9999999999999999999965431                    24589999999999999999999999   999999


Q ss_pred             CCCCCeEEcCCCcEEEeccccccccCCCCCC--ccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccc
Q 039137          770 ISSKNVLLDLGYEAHVSDFGIAKFLNPDSSN--WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDF  846 (912)
Q Consensus       770 lk~~Nill~~~~~~kl~Dfgla~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~  846 (912)
                      |||+||+++.++.+||+|||+|+........  .....||+.|||||++.+..++.++|||||||++|||+| |+.||..
T Consensus       190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~  269 (325)
T d1rjba_         190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG  269 (325)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence            9999999999999999999999876544332  234568999999999999999999999999999999998 8999852


Q ss_pred             hhccccccccchhhhccC--CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 039137          847 LFEMSSSSSNMNIEMLDS--RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEK  908 (912)
Q Consensus       847 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  908 (912)
                      ...     .......+..  +.+.+.    ..+.++.++|.+||+.||++|||++||++.|...
T Consensus       270 ~~~-----~~~~~~~~~~~~~~~~p~----~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~~  324 (325)
T d1rjba_         270 IPV-----DANFYKLIQNGFKMDQPF----YATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ  324 (325)
T ss_dssp             CCC-----SHHHHHHHHTTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCH-----HHHHHHHHhcCCCCCCCC----cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhCC
Confidence            211     1111122222  222222    2345688999999999999999999999999754

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.9e-46  Score=408.89  Aligned_cols=252  Identities=20%  Similarity=0.312  Sum_probs=210.9

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      .++|++.+.||+|+||+||+|++. +|+.||||++....    ....+.+.+|++++++++|||||++++++.+++..|+
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i  103 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY----PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL  103 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc----hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            357999999999999999999875 79999999987542    2245678899999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEc--CCCcEEEeccccccc
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLD--LGYEAHVSDFGIAKF  793 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~--~~~~~kl~Dfgla~~  793 (912)
                      |||||++|+|.+++..  ....+++.+++.|+.||+.||+|||++   +|+||||||+|||++  .++.+||+|||+|+.
T Consensus       104 vmE~~~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~  178 (352)
T d1koba_         104 ILEFLSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATK  178 (352)
T ss_dssp             EEECCCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred             EEEcCCCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeeccccee
Confidence            9999999999988733  234699999999999999999999999   999999999999998  678999999999998


Q ss_pred             cCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhh
Q 039137          794 LNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHV  873 (912)
Q Consensus       794 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  873 (912)
                      .... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.....     ......+.......+....
T Consensus       179 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----~~~~~~i~~~~~~~~~~~~  252 (352)
T d1koba_         179 LNPD-EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-----LETLQNVKRCDWEFDEDAF  252 (352)
T ss_dssp             CCTT-SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-----HHHHHHHHHCCCCCCSSTT
T ss_pred             cCCC-CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCCCCCcccc
Confidence            7654 334556899999999999999999999999999999999999999852211     1112223333333333333


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          874 QKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       874 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ...+.++.++|.+||+.||++|||++|+++
T Consensus       253 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         253 SSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            445667889999999999999999999875

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-46  Score=397.16  Aligned_cols=257  Identities=29%  Similarity=0.458  Sum_probs=200.6

Q ss_pred             cCCCCCceeeecCceEEEEEEeCCC-----CEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCe
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVPSG-----EIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKH  712 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~  712 (912)
                      ++|++.+.||+|+||+||+|.++..     ..||||++.....   ....++|.+|++++++++|||||+++|++.+.+.
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~   83 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT---EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP   83 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC---hHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCc
Confidence            4688899999999999999987532     3699999864332   2245679999999999999999999999999999


Q ss_pred             eeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccccc
Q 039137          713 SFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK  792 (912)
Q Consensus       713 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  792 (912)
                      .++||||+.+|++.+++...  ...+++.++.+++.|++.|++|||++   +|+||||||+|||++.++.+||+|||+|+
T Consensus        84 ~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~  158 (283)
T d1mqba_          84 MMIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSR  158 (283)
T ss_dssp             EEEEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             eEEEEEecccCcchhhhhcc--cccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhh
Confidence            99999999999999987443  35689999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCC---CccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccC-CCCC
Q 039137          793 FLNPDSS---NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDS-RLPY  868 (912)
Q Consensus       793 ~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~  868 (912)
                      .......   ......||+.|+|||++.+..++.++|||||||++|||++|..|+....    ........+.+. +.+.
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~----~~~~~~~~i~~~~~~~~  234 (283)
T d1mqba_         159 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL----SNHEVMKAINDGFRLPT  234 (283)
T ss_dssp             ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC----CHHHHHHHHHTTCCCCC
T ss_pred             cccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC----CHHHHHHHHhccCCCCC
Confidence            7654322   2234568999999999999999999999999999999999766642110    111111122222 2222


Q ss_pred             CChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          869 PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       869 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                      +.    ..+..+.+++.+||+.||++|||++||++.|++.+.
T Consensus       235 ~~----~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~  272 (283)
T d1mqba_         235 PM----DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  272 (283)
T ss_dssp             CT----TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ch----hhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence            22    234568899999999999999999999999987653

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-46  Score=404.53  Aligned_cols=251  Identities=22%  Similarity=0.288  Sum_probs=210.6

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      .++|++++.||+|+||+||+|+.+ +|+.||+|++.+..... ....+.+.+|+.+++.++||||+++++++.+++..|+
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~i   82 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA-KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF   82 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccC-HHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccc
Confidence            367999999999999999999975 79999999986432111 1135678899999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ||||+++|+|.+++..   .+.+++.+++.++.||+.||+|||++   +|+||||||+||+++.+|.+||+|||+|+...
T Consensus        83 v~ey~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~  156 (337)
T d1o6la_          83 VMEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             EEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             ceeccCCCchhhhhhc---ccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccc
Confidence            9999999999999854   35689999999999999999999999   99999999999999999999999999999776


Q ss_pred             CCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHH
Q 039137          796 PDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQK  875 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  875 (912)
                      .........+||+.|+|||++.+..|+.++||||+||++|||++|++||....     ..............+|.    .
T Consensus       157 ~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~-----~~~~~~~i~~~~~~~p~----~  227 (337)
T d1o6la_         157 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HERLFELILMEEIRFPR----T  227 (337)
T ss_dssp             CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHCCCCCCT----T
T ss_pred             cCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC-----HHHHHHHHhcCCCCCCc----c
Confidence            65556667889999999999999999999999999999999999999985221     11122233333444443    2


Q ss_pred             HHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 039137          876 KLMSIMQVAFSCLDQNPESRPT-----MKRVSQ  903 (912)
Q Consensus       876 ~~~~l~~li~~cl~~dP~~RPt-----~~evl~  903 (912)
                      .+.++.++|.+||++||++||+     ++|+++
T Consensus       228 ~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         228 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence            3456789999999999999995     676654

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=5e-46  Score=394.50  Aligned_cols=260  Identities=25%  Similarity=0.346  Sum_probs=205.5

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCC----
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPK----  711 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----  711 (912)
                      .++|++.+.||+|+||+||+|++. +|+.||||++....... ....+.+.+|+++++.++||||+++++++...+    
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~   84 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARD-PSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   84 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccC-HHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence            467999999999999999999875 79999999997655443 235567999999999999999999999997654    


Q ss_pred             eeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccc
Q 039137          712 HSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIA  791 (912)
Q Consensus       712 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla  791 (912)
                      ..|+||||+++++|.+++..   .+.+++.+++.++.||+.||+|||++   +|+||||||+||+++.++..+++|||.+
T Consensus        85 ~~~lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~  158 (277)
T d1o6ya_          85 LPYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA  158 (277)
T ss_dssp             EEEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred             eEEEEEECCCCCEehhhhcc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhh
Confidence            37899999999999998843   34689999999999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCC---CCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCC
Q 039137          792 KFLNPDS---SNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPY  868 (912)
Q Consensus       792 ~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  868 (912)
                      .......   .......||+.|+|||++.+..++.++||||+||++|||+||++||.....     ..............
T Consensus       159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----~~~~~~~~~~~~~~  233 (277)
T d1o6ya_         159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP-----VSVAYQHVREDPIP  233 (277)
T ss_dssp             EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHCCCCC
T ss_pred             hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH-----HHHHHHHHhcCCCC
Confidence            7654332   223456799999999999999999999999999999999999999863211     11111222222222


Q ss_pred             CChhhHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHHh
Q 039137          869 PSLHVQKKLMSIMQVAFSCLDQNPESRP-TMKRVSQLLCEK  908 (912)
Q Consensus       869 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~  908 (912)
                      +.......+..+.++|.+||++||++|| |++++++.|.+.
T Consensus       234 ~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~  274 (277)
T d1o6ya_         234 PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  274 (277)
T ss_dssp             GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence            2222233456788999999999999999 899999988765

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-46  Score=394.30  Aligned_cols=255  Identities=25%  Similarity=0.409  Sum_probs=202.2

Q ss_pred             hcCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      .++|++.+.||+|+||+||+|++++++.||||++.....     ..+.|.+|+.++++++|||||+++|++. .+..++|
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~-----~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv   89 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIV   89 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC-----CHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEE
Confidence            367999999999999999999998888999999864432     3567999999999999999999999985 4668999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++|++.+++... ....+++.+++.++.||+.||+|||++   +|+||||||+||+++.++++||+|||+|+....
T Consensus        90 ~Ey~~~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~  165 (285)
T d1fmka3          90 TEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED  165 (285)
T ss_dssp             ECCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred             EEecCCCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccC
Confidence            9999999999988543 234689999999999999999999999   999999999999999999999999999987654


Q ss_pred             CC-CCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhc-cCCCCCCChhhH
Q 039137          797 DS-SNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEML-DSRLPYPSLHVQ  874 (912)
Q Consensus       797 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  874 (912)
                      .. .......||+.|+|||++.+..++.++|||||||++|||++|..|+.....    .......+. ..+.+.+.    
T Consensus       166 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~----~~~~~~~i~~~~~~~~~~----  237 (285)
T d1fmka3         166 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV----NREVLDQVERGYRMPCPP----  237 (285)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC----HHHHHHHHHTTCCCCCCT----
T ss_pred             CCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC----HHHHHHHHHhcCCCCCCc----
Confidence            32 223446789999999999999999999999999999999997666431111    111111111 11222222    


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 039137          875 KKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI  909 (912)
Q Consensus       875 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l  909 (912)
                      ..+.++.++|.+||+.||++|||+++|+++|++.+
T Consensus       238 ~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~  272 (285)
T d1fmka3         238 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  272 (285)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             ccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence            23456889999999999999999999999998765

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.5e-45  Score=388.67  Aligned_cols=254  Identities=22%  Similarity=0.352  Sum_probs=210.4

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCch-----HHHHHHHHHHHHHhhcC-CCccccEEEEEEcC
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMS-----FQQEEFLNEIQALTEIR-HRNIVKFYGFCSHP  710 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~-----~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~  710 (912)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++.........     ...+.+.+|+.++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            68999999999999999999875 7899999998765433221     13456889999999997 99999999999999


Q ss_pred             CeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccc
Q 039137          711 KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGI  790 (912)
Q Consensus       711 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl  790 (912)
                      +..|+||||+++|+|.++++.   .+.+++.+++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchh
Confidence            999999999999999999954   35699999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCcccccccccccccccccc------CCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccC
Q 039137          791 AKFLNPDSSNWSELAGTHGYVAPELAYT------LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDS  864 (912)
Q Consensus       791 a~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  864 (912)
                      ++..... .......||+.|+|||++.+      ..++.++||||+||++|||++|+.||.....     ......+...
T Consensus       157 a~~~~~~-~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~-----~~~~~~i~~~  230 (277)
T d1phka_         157 SCQLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-----MLMLRMIMSG  230 (277)
T ss_dssp             CEECCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHT
T ss_pred             eeEccCC-CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH-----HHHHHHHHhC
Confidence            9987653 33455789999999998863      3468899999999999999999999863211     1122223333


Q ss_pred             CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          865 RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       865 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ....+.......++++.+++.+||+.||++|||++|+++
T Consensus       231 ~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         231 NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            333333333456677899999999999999999998865

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.4e-45  Score=396.68  Aligned_cols=247  Identities=25%  Similarity=0.374  Sum_probs=205.8

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++....... ....+.+.+|+.+++.++|||||++++++.+++..|+|
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   82 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR-LKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   82 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccC-HHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence            57999999999999999999975 79999999986432111 11356788999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+++|++..++..   ...+++.+++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+....
T Consensus        83 mE~~~gg~l~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~  156 (316)
T d1fota_          83 MDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD  156 (316)
T ss_dssp             ECCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             eeecCCccccccccc---cccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence            999999999998844   34578899999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHH
Q 039137          797 DSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKK  876 (912)
Q Consensus       797 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  876 (912)
                      .   .....||+.|+|||++.+..++.++||||+||++|||++|+.||....     .......+.......+.    ..
T Consensus       157 ~---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~-----~~~~~~~i~~~~~~~p~----~~  224 (316)
T d1fota_         157 V---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN-----TMKTYEKILNAELRFPP----FF  224 (316)
T ss_dssp             C---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHHHHCCCCCCT----TS
T ss_pred             c---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC-----HHHHHHHHHcCCCCCCC----CC
Confidence            3   345689999999999999999999999999999999999999985211     11122233333444332    23


Q ss_pred             HHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 039137          877 LMSIMQVAFSCLDQNPESRP-----TMKRVSQ  903 (912)
Q Consensus       877 ~~~l~~li~~cl~~dP~~RP-----t~~evl~  903 (912)
                      +.++.+++.+||+.||.+||     |++|+++
T Consensus       225 s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         225 NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence            35578999999999999996     8888864

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-45  Score=394.34  Aligned_cols=251  Identities=22%  Similarity=0.292  Sum_probs=211.1

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      .++|++.+.||+|+||+||+|.++ +++.||||++....     .....+.+|+++++.++|||||++++++.+++..|+
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   78 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-----TDQVLVKKEISILNIARHRNILHLHESFESMEELVM   78 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence            367999999999999999999876 78899999996532     235568899999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCC--CcEEEeccccccc
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLG--YEAHVSDFGIAKF  793 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~--~~~kl~Dfgla~~  793 (912)
                      |||||++|+|.+++...  ...+++.+++.|+.||+.||+|||++   +|+||||||+||+++.+  ..+|++|||+++.
T Consensus        79 vmE~~~gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~  153 (321)
T d1tkia_          79 IFEFISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ  153 (321)
T ss_dssp             EECCCCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred             EEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhc
Confidence            99999999999999432  34689999999999999999999999   99999999999999854  4799999999987


Q ss_pred             cCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhh
Q 039137          794 LNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHV  873 (912)
Q Consensus       794 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  873 (912)
                      .... .......+++.|+|||...+..++.++||||+||++|+|++|+.||....     .......+......++....
T Consensus       154 ~~~~-~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~-----~~~~~~~i~~~~~~~~~~~~  227 (321)
T d1tkia_         154 LKPG-DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET-----NQQIIENIMNAEYTFDEEAF  227 (321)
T ss_dssp             CCTT-CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHHHHTCCCCCHHHH
T ss_pred             cccC-CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhCCCCCChhhc
Confidence            6433 33455678999999999999999999999999999999999999986221     11223334444444444444


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          874 QKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       874 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ...+.++.++|.+||+.||++|||++|+++
T Consensus       228 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         228 KEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            445677899999999999999999999986

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-45  Score=388.58  Aligned_cols=257  Identities=24%  Similarity=0.370  Sum_probs=198.7

Q ss_pred             hcCCCCCceeeecCceEEEEEEeCC----CCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCe
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVPS----GEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKH  712 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~  712 (912)
                      .++|++.+.||+|+||+||+|++..    +..||||++....   .....+.+.+|++++++++||||++++|++. ++.
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~   81 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT---SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP   81 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCe
Confidence            3679999999999999999998652    3468899875432   2335678999999999999999999999995 567


Q ss_pred             eeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccccc
Q 039137          713 SFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK  792 (912)
Q Consensus       713 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  792 (912)
                      .++||||+++|++.+++...  ...+++.+++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+|+
T Consensus        82 ~~iv~E~~~~g~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~  156 (273)
T d1mp8a_          82 VWIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR  156 (273)
T ss_dssp             CEEEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             EEEEEEeccCCcHHhhhhcc--CCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhhe
Confidence            89999999999999987443  35689999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCC-CccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccCC-CCCC
Q 039137          793 FLNPDSS-NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDSR-LPYP  869 (912)
Q Consensus       793 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~  869 (912)
                      ....... ......||+.|+|||++.+..++.++|||||||++|||++ |.+||.....     ......+.... .+.+
T Consensus       157 ~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~-----~~~~~~i~~~~~~~~~  231 (273)
T d1mp8a_         157 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-----NDVIGRIENGERLPMP  231 (273)
T ss_dssp             --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GGHHHHHHTTCCCCCC
T ss_pred             eccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH-----HHHHHHHHcCCCCCCC
Confidence            7654322 2344568899999999999999999999999999999998 8999863221     11122222222 2222


Q ss_pred             ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 039137          870 SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE  911 (912)
Q Consensus       870 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~~  911 (912)
                          ...+..+.++|.+||+.||++|||++||++.|++++.+
T Consensus       232 ----~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         232 ----PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             ----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence                23345688999999999999999999999999987653

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-45  Score=384.05  Aligned_cols=249  Identities=27%  Similarity=0.400  Sum_probs=197.2

Q ss_pred             hcCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEc-CCeeeE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSH-PKHSFI  715 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-~~~~~l  715 (912)
                      .++|++.+.||+|+||.||+|++ +|+.||||+++.+.      ..+++.+|++++++++||||++++|++.+ .+..++
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~------~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~l   78 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI   78 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC--------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred             HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH------HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEE
Confidence            35788999999999999999998 57889999986432      35678999999999999999999999854 466899


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ||||+++|+|.+++... ....+++..+++|+.||+.||+|||+.   +|+||||||+||+++.++.+|++|||+++...
T Consensus        79 v~ey~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~  154 (262)
T d1byga_          79 VTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  154 (262)
T ss_dssp             EECCCTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred             EEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecC
Confidence            99999999999999543 234589999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhcc-CCCCCCChhh
Q 039137          796 PDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLD-SRLPYPSLHV  873 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  873 (912)
                      ..   .....+++.|+|||++.+..++.++|||||||++|||+| |++||.....     ......+.. .+.+.+.   
T Consensus       155 ~~---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~-----~~~~~~i~~~~~~~~~~---  223 (262)
T d1byga_         155 ST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----KDVVPRVEKGYKMDAPD---  223 (262)
T ss_dssp             ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-----GGHHHHHTTTCCCCCCT---
T ss_pred             CC---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH-----HHHHHHHHcCCCCCCCc---
Confidence            32   334567899999999999999999999999999999998 7888752211     111111211 2222222   


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 039137          874 QKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEK  908 (912)
Q Consensus       874 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  908 (912)
                       ..+.++.+++.+||+.||++|||+.|+++.|++.
T Consensus       224 -~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i  257 (262)
T d1byga_         224 -GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  257 (262)
T ss_dssp             -TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -cCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence             2345688999999999999999999999999875

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.6e-45  Score=395.12  Aligned_cols=261  Identities=22%  Similarity=0.387  Sum_probs=210.7

Q ss_pred             HHhcCCCCCceeeecCceEEEEEEeC------CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEE
Q 039137          635 SATNDFNAEHCIGKGGHGSVYRAKVP------SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCS  708 (912)
Q Consensus       635 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~  708 (912)
                      ...++|++.+.||+|+||+||+|+++      +++.||||++....   .....++|.+|++++++++||||+++++++.
T Consensus        10 ~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~E~~il~~l~h~niv~~~~~~~   86 (301)
T d1lufa_          10 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDNPNIVKLLGVCA   86 (301)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             CCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc---ChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence            34578999999999999999999863      45789999986432   2235678999999999999999999999999


Q ss_pred             cCCeeeEEEeecCCCChhhHhhccC---------------------CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeee
Q 039137          709 HPKHSFIIYEYLESGSLDKILCNDA---------------------SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVH  767 (912)
Q Consensus       709 ~~~~~~lv~e~~~~g~L~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH  767 (912)
                      ..+..++||||+++|+|.+++....                     ....+++.+++.|+.|++.||+|||++   +|||
T Consensus        87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivH  163 (301)
T d1lufa_          87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVH  163 (301)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEe
Confidence            9999999999999999999985422                     123488999999999999999999999   9999


Q ss_pred             cCCCCCCeEEcCCCcEEEeccccccccCCCCC--CccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCC-CCc
Q 039137          768 RDISSKNVLLDLGYEAHVSDFGIAKFLNPDSS--NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGK-HPR  844 (912)
Q Consensus       768 ~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~-~pf  844 (912)
                      |||||+||+++.++.+||+|||+|+.......  ......+++.|+|||.+.+..++.++|||||||++|||++|. +||
T Consensus       164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~  243 (301)
T d1lufa_         164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY  243 (301)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence            99999999999999999999999986644322  223467889999999999999999999999999999999986 566


Q ss_pred             cchhccccccccchhhhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 039137          845 DFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI  909 (912)
Q Consensus       845 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l  909 (912)
                      .....     ......+.+...+..+   ...+.++.+++.+||+.||++||||.||+++|+++.
T Consensus       244 ~~~~~-----~e~~~~v~~~~~~~~p---~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         244 YGMAH-----EEVIYYVRDGNILACP---ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             TTSCH-----HHHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCCH-----HHHHHHHHcCCCCCCC---ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            42211     1122222233222111   123456889999999999999999999999999874

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-45  Score=388.43  Aligned_cols=257  Identities=24%  Similarity=0.355  Sum_probs=196.3

Q ss_pred             cCCCCCceeeecCceEEEEEEeC--CC--CEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCee
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP--SG--EIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHS  713 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  713 (912)
                      ++|++.+.||+|+||+||+|++.  ++  ..||||++........ ...++|.+|+.++++++||||++++|++.+ +..
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~   85 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQP-EAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM   85 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------C-HHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCH-HHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence            57999999999999999999853  22  3689999876544332 256789999999999999999999999965 467


Q ss_pred             eEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccc
Q 039137          714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKF  793 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  793 (912)
                      ++||||+++|++.+++...  ...+++..+++++.|||.||+|||++   +|+||||||+||+++.++.+||+|||+++.
T Consensus        86 ~lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~  160 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA  160 (273)
T ss_dssp             EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             heeeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhh
Confidence            8999999999999887443  35699999999999999999999999   999999999999999999999999999998


Q ss_pred             cCCCCCC---ccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhccCCCCCC
Q 039137          794 LNPDSSN---WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLDSRLPYP  869 (912)
Q Consensus       794 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  869 (912)
                      .......   .....+++.|+|||++.+..++.++|||||||++|||+| |+.||......     .....+.......+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~-----~~~~~i~~~~~~~~  235 (273)
T d1u46a_         161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-----QILHKIDKEGERLP  235 (273)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHHHHHTSCCCCC
T ss_pred             cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH-----HHHHHHHhCCCCCC
Confidence            7554332   234467889999999999999999999999999999998 89998522111     11111212211111


Q ss_pred             ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 039137          870 SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEK  908 (912)
Q Consensus       870 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  908 (912)
                      .  ....+..+.+++.+||+.||++|||++||.+.|+++
T Consensus       236 ~--~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         236 R--PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             C--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             C--cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            1  122345688999999999999999999999999874

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-44  Score=392.43  Aligned_cols=252  Identities=22%  Similarity=0.323  Sum_probs=203.3

Q ss_pred             hcCCCCCc-eeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEEc----
Q 039137          637 TNDFNAEH-CIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSH----  709 (912)
Q Consensus       637 ~~~~~~~~-~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~----  709 (912)
                      .++|.+.+ .||+|+||+||+|++. +++.||||++..         .+.+.+|++++.++ +|||||++++++.+    
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~---------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~   80 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD---------CPKARREVELHWRASQCPHIVRIVDVYENLYAG   80 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC---------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC---------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccC
Confidence            36788765 6999999999999875 799999999852         24567899987655 89999999999865    


Q ss_pred             CCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcC---CCcEEEe
Q 039137          710 PKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDL---GYEAHVS  786 (912)
Q Consensus       710 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~  786 (912)
                      ....|+|||||+||+|.+++... ....+++.+++.|+.||+.||+|||++   +|+||||||+||+++.   ++.+||+
T Consensus        81 ~~~~~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~  156 (335)
T d2ozaa1          81 RKCLLIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT  156 (335)
T ss_dssp             EEEEEEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred             CCEEEEEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccc
Confidence            45689999999999999999543 235699999999999999999999999   9999999999999985   5579999


Q ss_pred             ccccccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCC
Q 039137          787 DFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRL  866 (912)
Q Consensus       787 Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  866 (912)
                      |||+|+..... .......||+.|+|||++.+..|+.++||||+||++|+|+||+.||......... ............
T Consensus       157 DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~-~~~~~~i~~~~~  234 (335)
T d2ozaa1         157 DFGFAKETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-PGMKTRIRMGQY  234 (335)
T ss_dssp             CCTTCEECCCC-CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------CCCSCSS
T ss_pred             ccceeeeccCC-CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH-HHHHHHHhcCCC
Confidence            99999876544 3345668999999999999999999999999999999999999998632211110 111112222333


Q ss_pred             CCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          867 PYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       867 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .++.......+.++.++|.+||+.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         235 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            4444445566778999999999999999999999976

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-45  Score=396.48  Aligned_cols=249  Identities=23%  Similarity=0.331  Sum_probs=205.6

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHh-hcCCCccccEEEEEEcCCeeeE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALT-EIRHRNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~-~l~h~niv~l~~~~~~~~~~~l  715 (912)
                      ++|++.+.||+|+||+||+|+++ +++.||||++.+...... ...+.+.+|..++. .++|||||++++++.+++..|+
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~-~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi   80 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMD-DDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   80 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHT-TCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccCh-HHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence            57999999999999999999986 799999999864221111 13455667777655 6899999999999999999999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccC
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLN  795 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  795 (912)
                      ||||+++|+|.+++..   ...+++.+++.++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+++...
T Consensus        81 vmEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~  154 (320)
T d1xjda_          81 VMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM  154 (320)
T ss_dssp             EEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEeecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence            9999999999999954   34689999999999999999999999   99999999999999999999999999998776


Q ss_pred             CCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHH
Q 039137          796 PDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQK  875 (912)
Q Consensus       796 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  875 (912)
                      ..........||+.|+|||++.+..++.++||||+||++|||++|+.||....     .......+.......+.    .
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~-----~~~~~~~i~~~~~~~p~----~  225 (320)
T d1xjda_         155 LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD-----EEELFHSIRMDNPFYPR----W  225 (320)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHCCCCCCT----T
T ss_pred             cccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC-----HHHHHHHHHcCCCCCCc----c
Confidence            65566667789999999999999999999999999999999999999986221     11122222333333332    2


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 039137          876 KLMSIMQVAFSCLDQNPESRPTMK-RVS  902 (912)
Q Consensus       876 ~~~~l~~li~~cl~~dP~~RPt~~-evl  902 (912)
                      .+.++.++|.+||+.||++|||+. |++
T Consensus       226 ~s~~~~dli~~~L~~dP~~R~s~~~~l~  253 (320)
T d1xjda_         226 LEKEAKDLLVKLFVREPEKRLGVRGDIR  253 (320)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             CCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence            345688999999999999999985 664

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-44  Score=390.65  Aligned_cols=254  Identities=23%  Similarity=0.411  Sum_probs=201.6

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCC----EEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCe
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGE----IFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKH  712 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~  712 (912)
                      .+|++.+.||+|+||+||+|++. +|+    .||+|++.......   ..+++.+|++++++++|||||+++|++.++ .
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~   84 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK---ANKEILDEAYVMASVDNPHVCRLLGICLTS-T   84 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----C---THHHHHHHHHHHHHCCCTTBCCEEEEEESS-S
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEecC-C
Confidence            46999999999999999999875 444    58899886433222   467899999999999999999999999864 5


Q ss_pred             eeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccccc
Q 039137          713 SFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK  792 (912)
Q Consensus       713 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  792 (912)
                      .+++|||+.+|+|.+++...  ...+++.++++++.|||.||+|||++   +|+||||||+||+++.++.+||+|||+|+
T Consensus        85 ~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~  159 (317)
T d1xkka_          85 VQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK  159 (317)
T ss_dssp             EEEEEECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred             eeEEEEeccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccce
Confidence            67889999999999888543  45689999999999999999999999   99999999999999999999999999999


Q ss_pred             ccCCCCCC--ccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccccccccchhhhcc-CCCCC
Q 039137          793 FLNPDSSN--WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEMLD-SRLPY  868 (912)
Q Consensus       793 ~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~  868 (912)
                      ........  .....||+.|+|||++.+..++.++|||||||++|||+| |+.||+....     ......+.. .+.+.
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~-----~~~~~~i~~~~~~~~  234 (317)
T d1xkka_         160 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----SEISSILEKGERLPQ  234 (317)
T ss_dssp             HTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG-----GGHHHHHHHTCCCCC
T ss_pred             ecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH-----HHHHHHHHcCCCCCC
Confidence            77554332  234568999999999999999999999999999999998 7888763211     111111112 22333


Q ss_pred             CChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 039137          869 PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI  909 (912)
Q Consensus       869 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l  909 (912)
                      +.    ..+..+.+++.+||+.||++|||++|+++.|+...
T Consensus       235 p~----~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~  271 (317)
T d1xkka_         235 PP----ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  271 (317)
T ss_dssp             CT----TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             Cc----ccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence            32    23456889999999999999999999999987654

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.6e-45  Score=396.82  Aligned_cols=247  Identities=21%  Similarity=0.274  Sum_probs=206.1

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++....... ....+.+.+|+.+++.++|||||++++++.+.+..++|
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v  119 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccC-HHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence            57999999999999999999875 79999999985321111 11356788999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+.+|++.+++.+.   +.+++.+++.++.||+.||+|||++   +||||||||+|||++.++.+||+|||+|+....
T Consensus       120 ~e~~~~g~l~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~  193 (350)
T d1rdqe_         120 MEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             EECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             cccccccchhhhHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence            9999999999998443   4689999999999999999999999   999999999999999999999999999997753


Q ss_pred             CCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhhHHH
Q 039137          797 DSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHVQKK  876 (912)
Q Consensus       797 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  876 (912)
                      .   .....||+.|||||++.+..++.++||||+||++|||+||+.||....     .......+.......+.    ..
T Consensus       194 ~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~-----~~~~~~~i~~~~~~~p~----~~  261 (350)
T d1rdqe_         194 R---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PIQIYEKIVSGKVRFPS----HF  261 (350)
T ss_dssp             C---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHCCCCCCT----TC
T ss_pred             c---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC-----HHHHHHHHhcCCCCCCc----cC
Confidence            3   345689999999999999999999999999999999999999986221     11122223333333332    23


Q ss_pred             HHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 039137          877 LMSIMQVAFSCLDQNPESRP-----TMKRVSQ  903 (912)
Q Consensus       877 ~~~l~~li~~cl~~dP~~RP-----t~~evl~  903 (912)
                      +.++.++|.+||+.||.+|+     |++|+++
T Consensus       262 s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         262 SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             CHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence            45688999999999999994     8888864

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=8.6e-45  Score=398.10  Aligned_cols=251  Identities=21%  Similarity=0.288  Sum_probs=197.9

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHH---HHHHHHhhcCCCccccEEEEEEcCCee
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFL---NEIQALTEIRHRNIVKFYGFCSHPKHS  713 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~---~Ei~~l~~l~h~niv~l~~~~~~~~~~  713 (912)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++....... ......+.   +|+++++.++|||||++++++.+++..
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~-~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM-KQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-HTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcch-hhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            68999999999999999999976 79999999985321110 00122333   446677777899999999999999999


Q ss_pred             eEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccc
Q 039137          714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKF  793 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  793 (912)
                      |+||||+++|+|.+++.+   ...+++.+++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+.
T Consensus        83 ~ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~  156 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD  156 (364)
T ss_dssp             EEEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred             EEEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeee
Confidence            999999999999999954   35688999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCCcccccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChh
Q 039137          794 LNPDSSNWSELAGTHGYVAPELAYT-LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLH  872 (912)
Q Consensus       794 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  872 (912)
                      ....  ......||+.|+|||++.+ ..++.++||||+||++|||+||+.||......  ................+.  
T Consensus       157 ~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~--  230 (364)
T d1omwa3         157 FSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--DKHEIDRMTLTMAVELPD--  230 (364)
T ss_dssp             CSSS--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS--CHHHHHHHSSSCCCCCCS--
T ss_pred             cCCC--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhcccCCCCCCC--
Confidence            6543  3345679999999999864 56899999999999999999999998632110  000111111122222221  


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 039137          873 VQKKLMSIMQVAFSCLDQNPESRPT-----MKRVSQ  903 (912)
Q Consensus       873 ~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~  903 (912)
                        ..+..+.++|.+||+.||++|||     ++|+++
T Consensus       231 --~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         231 --SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             --SSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             --CCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence              23456889999999999999999     576653

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-44  Score=387.58  Aligned_cols=262  Identities=23%  Similarity=0.367  Sum_probs=199.5

Q ss_pred             HHhcCCCCCceeeecCceEEEEEEeC------CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEE
Q 039137          635 SATNDFNAEHCIGKGGHGSVYRAKVP------SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFC  707 (912)
Q Consensus       635 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~  707 (912)
                      ...++|++.+.||+|+||+||+|++.      +++.||||++....   .....+.+.+|...+.++ +|+||+.+++++
T Consensus        10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~   86 (299)
T d1ywna1          10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGAC   86 (299)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc---CcHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence            34578999999999999999999853      34689999986432   223456788888888887 689999999998


Q ss_pred             EcC-CeeeEEEeecCCCChhhHhhccCC-------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCC
Q 039137          708 SHP-KHSFIIYEYLESGSLDKILCNDAS-------------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSK  773 (912)
Q Consensus       708 ~~~-~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~  773 (912)
                      ..+ +..++|||||++|+|.++++....             ...+++.+++.++.||++||+|||++   +|+||||||+
T Consensus        87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~  163 (299)
T d1ywna1          87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAAR  163 (299)
T ss_dssp             CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGG
T ss_pred             ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCcc
Confidence            765 468999999999999999965432             34589999999999999999999999   9999999999


Q ss_pred             CeEEcCCCcEEEeccccccccCCCCC--CccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCC-CCccchhcc
Q 039137          774 NVLLDLGYEAHVSDFGIAKFLNPDSS--NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGK-HPRDFLFEM  850 (912)
Q Consensus       774 Nill~~~~~~kl~Dfgla~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~-~pf~~~~~~  850 (912)
                      |||++.++.+||+|||+|+.......  ......||+.|+|||++.+..++.++|||||||++|||+||. +||..... 
T Consensus       164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~-  242 (299)
T d1ywna1         164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-  242 (299)
T ss_dssp             GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC-
T ss_pred             ceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH-
Confidence            99999999999999999987654332  234567999999999999999999999999999999999964 56642111 


Q ss_pred             ccccccchhhhcc-CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          851 SSSSSNMNIEMLD-SRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       851 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                         .......... .+.+.+.    ..+.++.+++.+||+.||++|||++|+++.|++.+.
T Consensus       243 ---~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq  296 (299)
T d1ywna1         243 ---DEEFCRRLKEGTRMRAPD----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  296 (299)
T ss_dssp             ---SHHHHHHHHHTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---HHHHHHHHhcCCCCCCCc----cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence               1111111111 1222221    234568899999999999999999999999998763

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-44  Score=387.90  Aligned_cols=260  Identities=26%  Similarity=0.425  Sum_probs=210.8

Q ss_pred             hcCCCCCceeeecCceEEEEEEe------CCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEEc
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKV------PSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSH  709 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~  709 (912)
                      .++|++.+.||+|+||.||+|++      .+++.||||+++...   ......++.+|+.+++++ +|||||+++|++.+
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~   98 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc---CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence            46899999999999999999975      256789999997543   223566799999999999 69999999999999


Q ss_pred             CCeeeEEEeecCCCChhhHhhccC---------------CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCC
Q 039137          710 PKHSFIIYEYLESGSLDKILCNDA---------------SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKN  774 (912)
Q Consensus       710 ~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N  774 (912)
                      ++..++||||+++|+|.+++++..               ....+++.++.+++.||++|++|||++   +|+||||||+|
T Consensus        99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~N  175 (311)
T d1t46a_          99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN  175 (311)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccc
Confidence            999999999999999999996543               233589999999999999999999999   99999999999


Q ss_pred             eEEcCCCcEEEeccccccccCCCCCC--ccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccc
Q 039137          775 VLLDLGYEAHVSDFGIAKFLNPDSSN--WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMS  851 (912)
Q Consensus       775 ill~~~~~~kl~Dfgla~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~  851 (912)
                      |+++.++.+|++|||.++........  .....||+.|+|||++.+..++.++|||||||++|||+| |.+||.....  
T Consensus       176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~--  253 (311)
T d1t46a_         176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV--  253 (311)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS--
T ss_pred             ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH--
Confidence            99999999999999999977544332  234678999999999999999999999999999999999 5555432111  


Q ss_pred             cccccchhhhccC--CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 039137          852 SSSSNMNIEMLDS--RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE  911 (912)
Q Consensus       852 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~~  911 (912)
                         ..........  +...+    ...+..+.++|.+||+.||++|||++|++++|++.+.+
T Consensus       254 ---~~~~~~~i~~~~~~~~~----~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         254 ---DSKFYKMIKEGFRMLSP----EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             ---SHHHHHHHHHTCCCCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---HHHHHHHHhcCCCCCCc----ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence               1111112111  11222    12345688999999999999999999999999998754

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-44  Score=387.64  Aligned_cols=258  Identities=24%  Similarity=0.395  Sum_probs=205.0

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCC--EEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEEEcCCee
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGE--IFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFCSHPKHS  713 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~  713 (912)
                      ++|++.++||+|+||+||+|+++ ++.  .||||++.......   ..+.+.+|+++++++ +|||||+++|++.+.+..
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~   86 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD---DHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL   86 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChH---HHHHHHHHHHHHHhccCCCCEeeEEEEEecCCee
Confidence            67999999999999999999876 444  47788875432221   356789999999999 799999999999999999


Q ss_pred             eEEEeecCCCChhhHhhcc-------------CCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCC
Q 039137          714 FIIYEYLESGSLDKILCND-------------ASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLG  780 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~  780 (912)
                      ++||||+++|+|.++++..             .....+++.++++++.|||.|++|+|++   +|+||||||+|||++.+
T Consensus        87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~  163 (309)
T d1fvra_          87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN  163 (309)
T ss_dssp             EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGG
T ss_pred             EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCC
Confidence            9999999999999999653             2346799999999999999999999999   99999999999999999


Q ss_pred             CcEEEeccccccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCC-CCccchhccccccccchh
Q 039137          781 YEAHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGK-HPRDFLFEMSSSSSNMNI  859 (912)
Q Consensus       781 ~~~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~-~pf~~~~~~~~~~~~~~~  859 (912)
                      +.+||+|||+|+...... ......||+.|+|||.+.+..++.++|||||||++|||++|. +||....     ......
T Consensus       164 ~~~kl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~-----~~~~~~  237 (309)
T d1fvra_         164 YVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-----CAELYE  237 (309)
T ss_dssp             GCEEECCTTCEESSCEEC-CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HHHHHH
T ss_pred             CceEEccccccccccccc-cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC-----HHHHHH
Confidence            999999999998654332 223456899999999999999999999999999999999975 4654211     111111


Q ss_pred             hhccC-CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 039137          860 EMLDS-RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE  911 (912)
Q Consensus       860 ~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~~  911 (912)
                      .+... +.+.+.    ..+..+.++|.+||+.||++|||++||++.|++.+.+
T Consensus       238 ~i~~~~~~~~~~----~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~  286 (309)
T d1fvra_         238 KLPQGYRLEKPL----NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  286 (309)
T ss_dssp             HGGGTCCCCCCT----TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HHHhcCCCCCCc----cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            12222 222221    2345688999999999999999999999999987753

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-44  Score=384.48  Aligned_cols=258  Identities=24%  Similarity=0.375  Sum_probs=205.9

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC--------CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc-CCCccccEEEEE
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP--------SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI-RHRNIVKFYGFC  707 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~  707 (912)
                      .++|++++.||+|+||.||+|+..        ++..||||+++....   .....++.+|+..+.++ +|||||++++++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~   88 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT---EKDLSDLISEMEMMKMIGKHKNIINLLGAC   88 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC---HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC---hHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence            467999999999999999999753        234799999875432   23567788999999888 799999999999


Q ss_pred             EcCCeeeEEEeecCCCChhhHhhccCC-------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCC
Q 039137          708 SHPKHSFIIYEYLESGSLDKILCNDAS-------------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKN  774 (912)
Q Consensus       708 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N  774 (912)
                      .+++..++||||+++|+|.+++.....             ...+++.++++++.||+.||+|||++   +||||||||+|
T Consensus        89 ~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~N  165 (299)
T d1fgka_          89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARN  165 (299)
T ss_dssp             CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred             ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccc
Confidence            999999999999999999999965432             34589999999999999999999999   99999999999


Q ss_pred             eEEcCCCcEEEeccccccccCCCCC--CccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCccchhccc
Q 039137          775 VLLDLGYEAHVSDFGIAKFLNPDSS--NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMS  851 (912)
Q Consensus       775 ill~~~~~~kl~Dfgla~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~pf~~~~~~~  851 (912)
                      ||++.++.+||+|||+++.......  ......+++.|+|||.+.+..++.++|||||||++|||++ |++||.....  
T Consensus       166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~--  243 (299)
T d1fgka_         166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--  243 (299)
T ss_dssp             EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--
T ss_pred             eeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH--
Confidence            9999999999999999987654332  2344678999999999999999999999999999999998 7888752211  


Q ss_pred             cccccchhhhccC-CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 039137          852 SSSSNMNIEMLDS-RLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKI  909 (912)
Q Consensus       852 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l  909 (912)
                         ......+... +.+.+.    ..+.++.++|.+||+.||.+|||+.||++.|++.+
T Consensus       244 ---~~~~~~i~~~~~~~~p~----~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~  295 (299)
T d1fgka_         244 ---EELFKLLKEGHRMDKPS----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  295 (299)
T ss_dssp             ---HHHHHHHHTTCCCCCCS----SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---HHHHHHHHcCCCCCCCc----cchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence               1111111122 222222    23456889999999999999999999999999875

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-44  Score=384.19  Aligned_cols=256  Identities=21%  Similarity=0.257  Sum_probs=196.3

Q ss_pred             CCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCch-HHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEEee
Q 039137          642 AEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMS-FQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIYEY  719 (912)
Q Consensus       642 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  719 (912)
                      ..++||+|+||+||+|+++ +|+.||||++......... ...+.+.+|++++++++|||||++++++..++..|+||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            3578999999999999976 7999999998754332211 1235688999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCCCC
Q 039137          720 LESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPDSS  799 (912)
Q Consensus       720 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  799 (912)
                      +.++++..+.   .....+++.++..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+|+.......
T Consensus        82 ~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~  155 (299)
T d1ua2a_          82 METDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR  155 (299)
T ss_dssp             CSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred             hcchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence            9998777766   3345688999999999999999999999   999999999999999999999999999987766555


Q ss_pred             CccccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCccchhcccccc----------c-------cchhhh
Q 039137          800 NWSELAGTHGYVAPELAYTL-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS----------S-------NMNIEM  861 (912)
Q Consensus       800 ~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~----------~-------~~~~~~  861 (912)
                      ......||+.|+|||++.+. .++.++||||+||++|||++|++||....+.....          .       ......
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~  235 (299)
T d1ua2a_         156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV  235 (299)
T ss_dssp             CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred             cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhh
Confidence            55667899999999988654 57999999999999999999999985321110000          0       000000


Q ss_pred             ccCCCCCCCh--hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          862 LDSRLPYPSL--HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       862 ~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .....+....  .....+..+.+++.+||+.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            0000111100  01122456889999999999999999999875

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-43  Score=379.39  Aligned_cols=253  Identities=23%  Similarity=0.366  Sum_probs=201.9

Q ss_pred             CceeeecCceEEEEEEeCCC----CEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEc-CCeeeEEE
Q 039137          643 EHCIGKGGHGSVYRAKVPSG----EIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSH-PKHSFIIY  717 (912)
Q Consensus       643 ~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-~~~~~lv~  717 (912)
                      .++||+|+||+||+|++.++    ..||||++....   .....++|.+|++++++++||||++++|++.. ++..++||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~  108 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT---DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  108 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCC---CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc---CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence            57899999999999987532    258999986432   23356889999999999999999999999865 56889999


Q ss_pred             eecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCC
Q 039137          718 EYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPD  797 (912)
Q Consensus       718 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  797 (912)
                      |||++|+|.+++...  ....++.++++++.|++.||.|+|+.   +|+||||||+|||+++++.+||+|||+++.....
T Consensus       109 E~~~~g~l~~~~~~~--~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~  183 (311)
T d1r0pa_         109 PYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  183 (311)
T ss_dssp             ECCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred             EEeecCchhhhhccc--cccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence            999999999998543  34577889999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCC----ccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCCChhh
Q 039137          798 SSN----WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYPSLHV  873 (912)
Q Consensus       798 ~~~----~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  873 (912)
                      ...    .....||+.|+|||.+.+..++.++||||||+++|||+||..||.....    .......+.....+..+   
T Consensus       184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~----~~~~~~~i~~g~~~~~p---  256 (311)
T d1r0pa_         184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN----TFDITVYLLQGRRLLQP---  256 (311)
T ss_dssp             TCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC----------CHHHHHTTCCCCCC---
T ss_pred             ccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC----HHHHHHHHHcCCCCCCc---
Confidence            222    2345689999999999999999999999999999999998888642111    11122222222222111   


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          874 QKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       874 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                      ...+..+.+++.+||+.||++||++.||++.|++.+.
T Consensus       257 ~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~  293 (311)
T d1r0pa_         257 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  293 (311)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            1234568899999999999999999999999998764

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-44  Score=381.32  Aligned_cols=259  Identities=20%  Similarity=0.289  Sum_probs=200.5

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ++|++.+.||+|+||+||+|++. +|+.||||++......  ....+++.+|++++++++|||||++++++.+++..|+|
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv   79 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV   79 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC---------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC--hHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence            58999999999999999999975 7999999999654322  12356788999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      |||+.++.+.... . .....+++.+++.++.|++.||+|||++   +||||||||+||+++.++.+||+|||.|+....
T Consensus        80 ~e~~~~~~~~~~~-~-~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~  154 (298)
T d1gz8a_          80 FEFLHQDLKKFMD-A-SALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV  154 (298)
T ss_dssp             EECCSEEHHHHHH-H-TTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred             EeecCCchhhhhh-h-hcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccC
Confidence            9999875444333 2 2345699999999999999999999999   999999999999999999999999999998766


Q ss_pred             CCCCccccccccccccccccccCC-CCcchhHHHHHHHHHHHHhCCCCccchhcccc----------cccc---chhhhc
Q 039137          797 DSSNWSELAGTHGYVAPELAYTLK-VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS----------SSSN---MNIEML  862 (912)
Q Consensus       797 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~sDvwslG~vl~elltg~~pf~~~~~~~~----------~~~~---~~~~~~  862 (912)
                      .........||+.|+|||.+.... ++.++||||+||++|+|++|+.||........          ....   ......
T Consensus       155 ~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  234 (298)
T d1gz8a_         155 PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP  234 (298)
T ss_dssp             CSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             CcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccc
Confidence            655666778999999999877665 47899999999999999999999863211000          0000   000000


Q ss_pred             cCCCCC---CC----hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          863 DSRLPY---PS----LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       863 ~~~~~~---~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      +.....   ..    ......+..+.+++.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~  282 (298)
T d1gz8a_         235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA  282 (298)
T ss_dssp             TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            000000   00    011122356889999999999999999999876

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-44  Score=382.66  Aligned_cols=261  Identities=21%  Similarity=0.330  Sum_probs=211.3

Q ss_pred             HhcCCCCCceeeecCceEEEEEEeC------CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEc
Q 039137          636 ATNDFNAEHCIGKGGHGSVYRAKVP------SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSH  709 (912)
Q Consensus       636 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~  709 (912)
                      ..++|++.+.||+|+||+||+|.++      +++.||||+++...   .......|.+|++++++++||||++++|++..
T Consensus        18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~   94 (308)
T d1p4oa_          18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   94 (308)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS---CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc---ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence            3578999999999999999999763      35789999987432   22355678999999999999999999999999


Q ss_pred             CCeeeEEEeecCCCChhhHhhcc-------CCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCc
Q 039137          710 PKHSFIIYEYLESGSLDKILCND-------ASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYE  782 (912)
Q Consensus       710 ~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~  782 (912)
                      ++..++||||+++|+|.+++...       .....+++.++.+++.|+|+||+|||++   +|+||||||+|||++++++
T Consensus        95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~  171 (308)
T d1p4oa_          95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFT  171 (308)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCC
T ss_pred             CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCce
Confidence            99999999999999999998543       2223478999999999999999999999   9999999999999999999


Q ss_pred             EEEeccccccccCCCCCC--ccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCC-CCccchhccccccccchh
Q 039137          783 AHVSDFGIAKFLNPDSSN--WSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGK-HPRDFLFEMSSSSSNMNI  859 (912)
Q Consensus       783 ~kl~Dfgla~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~-~pf~~~~~~~~~~~~~~~  859 (912)
                      +||+|||+|+........  .....+++.|+|||.+.+..++.++||||||+++|||+||. .||....     ......
T Consensus       172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~-----~~~~~~  246 (308)
T d1p4oa_         172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-----NEQVLR  246 (308)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-----HHHHHH
T ss_pred             EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC-----HHHHHH
Confidence            999999999876544322  23346899999999999999999999999999999999984 6664211     111222


Q ss_pred             hhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          860 EMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       860 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                      .+.+...+..+   ...+..+.+++.+||+.||++|||++||++.|++.+.
T Consensus       247 ~i~~~~~~~~p---~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         247 FVMEGGLLDKP---DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             HHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHHhCCCCCCc---ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            22333322211   1234568899999999999999999999999987653

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-43  Score=377.53  Aligned_cols=262  Identities=24%  Similarity=0.353  Sum_probs=198.1

Q ss_pred             hcCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHH--HHHHHHhhcCCCccccEEEEEEcCC---
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFL--NEIQALTEIRHRNIVKFYGFCSHPK---  711 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~--~Ei~~l~~l~h~niv~l~~~~~~~~---  711 (912)
                      ..+|.+.+.||+|+||+||+|++ +|+.||||++...       ..+++.  .|+..++.++||||+++++++.+.+   
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~-------~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~   73 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR-------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW   73 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG-------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc-------chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcc
Confidence            35678889999999999999997 7899999998532       223333  4555566789999999999997654   


Q ss_pred             -eeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeeecCCCCCCeEEcCCCcEEE
Q 039137          712 -HSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNC-----FPPIVHRDISSKNVLLDLGYEAHV  785 (912)
Q Consensus       712 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~Dlk~~Nill~~~~~~kl  785 (912)
                       ..++||||+++|+|.+++++    ..+++.++++++.|+|.|++|+|+..     .++|+||||||+|||++.++.+||
T Consensus        74 ~~~~lv~Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl  149 (303)
T d1vjya_          74 TQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  149 (303)
T ss_dssp             EEEEEEEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred             eEEEEEEecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEE
Confidence             57999999999999999954    35899999999999999999999731     139999999999999999999999


Q ss_pred             eccccccccCCCCC----CccccccccccccccccccCC------CCcchhHHHHHHHHHHHHhCCCCccchhcccccc-
Q 039137          786 SDFGIAKFLNPDSS----NWSELAGTHGYVAPELAYTLK------VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS-  854 (912)
Q Consensus       786 ~Dfgla~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~------~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~-  854 (912)
                      +|||+++.......    ......||+.|+|||++.+..      ++.++|||||||++|||+||..||.......... 
T Consensus       150 ~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~  229 (303)
T d1vjya_         150 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY  229 (303)
T ss_dssp             CCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT
T ss_pred             EecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchh
Confidence            99999987654432    234567999999999987643      5678999999999999999998874221110000 


Q ss_pred             ---------ccchhhhccCCC--CCCC-hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          855 ---------SNMNIEMLDSRL--PYPS-LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       855 ---------~~~~~~~~~~~~--~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                               ........+...  ..+. .........+.+++.+||+.||++|||+.||++.|++...
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  297 (303)
T d1vjya_         230 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence                     001111111111  1111 1223345568899999999999999999999999987653

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.4e-43  Score=377.93  Aligned_cols=258  Identities=23%  Similarity=0.328  Sum_probs=200.2

Q ss_pred             cCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFIIY  717 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  717 (912)
                      ++|++.+.||+|+||+||+|++++|+.||||++......  ....+++.+|+.++++++||||+++++++..++..+++|
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~   79 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED--EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF   79 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGG--GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcC--hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence            689999999999999999999999999999999765322  223577899999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCCC
Q 039137          718 EYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNPD  797 (912)
Q Consensus       718 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  797 (912)
                      ||+.++.+..+.   ...+.+++.+++.++.||+.||+|||++   +||||||||+||+++.++.+|++|||.|......
T Consensus        80 e~~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~  153 (286)
T d1ob3a_          80 EHLDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIP  153 (286)
T ss_dssp             ECCSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred             EeehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccC
Confidence            999987777776   3346799999999999999999999999   9999999999999999999999999999887665


Q ss_pred             CCCccccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCccchhccccc-------------cccchhhh--
Q 039137          798 SSNWSELAGTHGYVAPELAYTL-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS-------------SSNMNIEM--  861 (912)
Q Consensus       798 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~-------------~~~~~~~~--  861 (912)
                      ........+++.|+|||.+.+. .++.++||||+||++|||++|+.||....+....             ........  
T Consensus       154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  233 (286)
T d1ob3a_         154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK  233 (286)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             ccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhh
Confidence            5555566789999999988754 4689999999999999999999998532110000             00000000  


Q ss_pred             ----ccCCCCCC-ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          862 ----LDSRLPYP-SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       862 ----~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                          .....+.+ .......+..+.+++.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                00000000 1111223456889999999999999999998863

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-44  Score=378.81  Aligned_cols=244  Identities=21%  Similarity=0.355  Sum_probs=199.0

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCch--HHHHHHHHHHHHHhhcC--CCccccEEEEEEcCC
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMS--FQQEEFLNEIQALTEIR--HRNIVKFYGFCSHPK  711 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~--~~~~~~~~Ei~~l~~l~--h~niv~l~~~~~~~~  711 (912)
                      .++|++.+.||+|+||+||+|++. +|+.||||++.........  ....++.+|+.++++++  |||||++++++.+++
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            367999999999999999999875 7899999998654322211  11234668999999996  899999999999999


Q ss_pred             eeeEEEeecCC-CChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcC-CCcEEEeccc
Q 039137          712 HSFIIYEYLES-GSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDL-GYEAHVSDFG  789 (912)
Q Consensus       712 ~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~Dfg  789 (912)
                      ..++||||+.+ +++.+++..   ...+++.+++.++.||+.||+|||++   +|+||||||+||+++. ++.+||+|||
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG  156 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG  156 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             eEEEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccc
Confidence            99999999976 677787743   35689999999999999999999999   9999999999999985 4789999999


Q ss_pred             cccccCCCCCCccccccccccccccccccCCC-CcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCC
Q 039137          790 IAKFLNPDSSNWSELAGTHGYVAPELAYTLKV-TEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPY  868 (912)
Q Consensus       790 la~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  868 (912)
                      +|+....  .......||+.|+|||++.+..+ +.++||||+||++|||++|+.||....+           ........
T Consensus       157 ~a~~~~~--~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----------i~~~~~~~  223 (273)
T d1xwsa_         157 SGALLKD--TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----------IIRGQVFF  223 (273)
T ss_dssp             TCEECCS--SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----------HHHCCCCC
T ss_pred             cceeccc--ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-----------HhhcccCC
Confidence            9986543  33456789999999999987765 5678999999999999999999863211           12222222


Q ss_pred             CChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          869 PSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       869 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      +.    ..+.++.++|.+||+.||++|||++|+++
T Consensus       224 ~~----~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         224 RQ----RVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             SS----CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CC----CCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            22    12456889999999999999999999875

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-42  Score=372.79  Aligned_cols=259  Identities=19%  Similarity=0.294  Sum_probs=195.5

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-C-CCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhc---CCCccccEEEEEEc--
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-S-GEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEI---RHRNIVKFYGFCSH--  709 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l---~h~niv~l~~~~~~--  709 (912)
                      .++|++.+.||+|+||+||+|++. + ++.||||++........  ....+.+|+.+++.+   +||||+++++++..  
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~--~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~   83 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG--MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   83 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS--CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccch--HHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence            478999999999999999999874 4 56799999865432221  123455777777766   79999999999853  


Q ss_pred             ---CCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEe
Q 039137          710 ---PKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVS  786 (912)
Q Consensus       710 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  786 (912)
                         ....+++|||++++.+.....  .....+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+
T Consensus        84 ~~~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~  158 (305)
T d1blxa_          84 TDRETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA  158 (305)
T ss_dssp             CSSEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred             cccCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeec
Confidence               346899999999877765542  3345689999999999999999999999   99999999999999999999999


Q ss_pred             ccccccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccc-------------
Q 039137          787 DFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS-------------  853 (912)
Q Consensus       787 Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~-------------  853 (912)
                      |||.++..... .......||+.|+|||++.+..++.++||||+||++|||++|++||....+....             
T Consensus       159 dfg~~~~~~~~-~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  237 (305)
T d1blxa_         159 DFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE  237 (305)
T ss_dssp             SCCSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             chhhhhhhccc-ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchh
Confidence            99998765332 3345678999999999999999999999999999999999999999632110000             


Q ss_pred             ----cccchhhhccCCCCCC-ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          854 ----SSNMNIEMLDSRLPYP-SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       854 ----~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                          ...............+ .......+..+.+++.+||+.||++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                0000000000000000 0111123456788999999999999999998865

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=1.7e-42  Score=375.26  Aligned_cols=292  Identities=29%  Similarity=0.478  Sum_probs=188.5

Q ss_pred             CCHHHHHHHHHHHHhcccCCcccCCCcccCCCCCCCCCCC--ccceeEecCC---CCeEEEeeccccccccc-cccccCC
Q 039137           34 NSAEEAHALVKWKASLEVHSRSLLHSWSLSSVNATKISPC--AWSGIFCNHA---ERVVGINLTSISLNGTL-LEFSFSS  107 (912)
Q Consensus        34 ~~~~~~~all~~k~~~~~~~~~~l~~w~~~~~~~~~~~~C--~w~gv~c~~~---~~v~~l~l~~~~l~~~~-~~~~~~~  107 (912)
                      |.|+||+||++||++++++  ..+++|..      ++|||  .|+||+|+..   +||+.++|.++++.|.. .+.++++
T Consensus         3 c~~~e~~aLl~~k~~~~~~--~~l~sW~~------~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~   74 (313)
T d1ogqa_           3 CNPQDKQALLQIKKDLGNP--TTLSSWLP------TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLAN   74 (313)
T ss_dssp             SCHHHHHHHHHHHHHTTCC--GGGTTCCT------TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGG
T ss_pred             CCHHHHHHHHHHHHHCCCC--CcCCCCCC------CCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhc
Confidence            8899999999999999754  36899964      35899  4999999864   37888888777777653 2455667


Q ss_pred             CCCccEEEccC-CcccccCCccccCCCCCcEEeccccccccccccccccccccceeecccccccCCCCccccCcccccEE
Q 039137          108 FPHLVYLDLYN-NELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQL  186 (912)
Q Consensus       108 l~~L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L  186 (912)
                      |++|++|+|++ |+++|.+|++|++|++|++|||++|++.+..|..+..+.+|+++++++|.+.+.+|..+++++.|+++
T Consensus        75 L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l  154 (313)
T d1ogqa_          75 LPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI  154 (313)
T ss_dssp             CTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEE
T ss_pred             CccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCccccee
Confidence            77777777764 66666677777777777777777777766666666666777777777776666666666666666666


Q ss_pred             EccCCcCCCCCCccCCCCccc-eeeeeccCCCcCccccccccccccceeecccccccCccccccccccccceeeeccccC
Q 039137          187 ALDSNFLNGSIPRSLGNLTHV-VILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNEL  265 (912)
Q Consensus       187 ~l~~n~l~~~~p~~~~~l~~L-~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l  265 (912)
                      ++++|.+.+.+|..+.++.++ +.+++++|++++..|..++++..+ .++++.+...+.+|..+..+++|+.+++++|.+
T Consensus       155 ~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l  233 (313)
T d1ogqa_         155 TFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSL  233 (313)
T ss_dssp             ECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEE
T ss_pred             eccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccc
Confidence            666666666666666666554 556666666666666555555433 455555555555555555556666666666655


Q ss_pred             cccCCcccCCccccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEccCCc
Q 039137          266 SGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNS  336 (912)
Q Consensus       266 ~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~  336 (912)
                      ++.+| .++.+++|+.|+|++|+++|.+|..|+++++|++|+|++|+++|.+|+ ++.+++|+.+++++|+
T Consensus       234 ~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~  302 (313)
T d1ogqa_         234 AFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNK  302 (313)
T ss_dssp             CCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSS
T ss_pred             ccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCc
Confidence            54332 355555555555555555555555555555555555555555544442 3444444444444444

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-41  Score=365.44  Aligned_cols=259  Identities=18%  Similarity=0.260  Sum_probs=198.1

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCc-cccEEEEEEcCCeeeE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRN-IVKFYGFCSHPKHSFI  715 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n-iv~l~~~~~~~~~~~l  715 (912)
                      ++|++.+.||+|+||+||+|++. +|+.||||++.....      .+++.+|+++++.++|++ |+.+.+++.+.+..++
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~------~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~i   80 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK------HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   80 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT------SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc------CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEE
Confidence            57999999999999999999875 789999998765432      234678999999998666 5555566677888999


Q ss_pred             EEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcC---CCcEEEecccccc
Q 039137          716 IYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDL---GYEAHVSDFGIAK  792 (912)
Q Consensus       716 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~Dfgla~  792 (912)
                      ||||+++ ++.+.+..  ..+.+++.++..++.|++.||+|||++   +|+||||||+||+++.   +..+|++|||+|+
T Consensus        81 vme~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~  154 (299)
T d1ckia_          81 VMELLGP-SLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  154 (299)
T ss_dssp             EEECCCC-BHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCE
T ss_pred             EEEEcCC-chhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcce
Confidence            9999955 66665533  335689999999999999999999999   9999999999999864   5579999999999


Q ss_pred             ccCCCCC-------CccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCC
Q 039137          793 FLNPDSS-------NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSR  865 (912)
Q Consensus       793 ~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  865 (912)
                      .......       ......||+.|+|||++.+..++.++|||||||++|||++|+.||............  .......
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~--~~~~~~~  232 (299)
T d1ckia_         155 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY--ERISEKK  232 (299)
T ss_dssp             ECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------H--HHHHHHH
T ss_pred             eccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHH--HHhhccc
Confidence            7754332       223567999999999999999999999999999999999999998632221111110  0000000


Q ss_pred             CCCC-ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 039137          866 LPYP-SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIF  910 (912)
Q Consensus       866 ~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~  910 (912)
                      ...+ +......+.++.+++.+||+.||++||+++++.+.|++.+.
T Consensus       233 ~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~  278 (299)
T d1ckia_         233 MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  278 (299)
T ss_dssp             HHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred             CCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence            0011 11112234668899999999999999999999999987654

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-41  Score=359.29  Aligned_cols=258  Identities=20%  Similarity=0.248  Sum_probs=204.8

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCCeeeEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPKHSFII  716 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  716 (912)
                      ++|++.+.||+|+||+||+|++. +++.||||+++.....  ....+++.+|+.+++.++||||+++++++.+++..++|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv   79 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD--EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS--TTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCC--hHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence            58999999999999999999975 7899999999765432  22567889999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccccccCC
Q 039137          717 YEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKFLNP  796 (912)
Q Consensus       717 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  796 (912)
                      ||++.++++..++.   ..+.+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+|++|||.|+....
T Consensus        80 ~~~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~  153 (292)
T d1unla_          80 FEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGI  153 (292)
T ss_dssp             EECCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             eeeccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccC
Confidence            99999999888874   345688999999999999999999999   999999999999999999999999999998766


Q ss_pred             CCCCccccccccccccccccccCC-CCcchhHHHHHHHHHHHHhCCCCccchhccccccc--------------cchhhh
Q 039137          797 DSSNWSELAGTHGYVAPELAYTLK-VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSS--------------NMNIEM  861 (912)
Q Consensus       797 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~--------------~~~~~~  861 (912)
                      .........+++.|+|||.+.+.. ++.++||||+||++|||++|+.||...........              ......
T Consensus       154 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (292)
T d1unla_         154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL  233 (292)
T ss_dssp             CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred             CCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhc
Confidence            555555667888999999887665 68999999999999999999999631100000000              000000


Q ss_pred             cc-------CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          862 LD-------SRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       862 ~~-------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      .+       .............+..+.+++.+||+.||.+|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00       0000011111223456789999999999999999999865

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-40  Score=360.26  Aligned_cols=259  Identities=19%  Similarity=0.270  Sum_probs=194.3

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEc------
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSH------  709 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~------  709 (912)
                      .++|++.+.||+|+||+||+|+++ +|+.||||++.......  ...+++.+|++++++++||||+++++++..      
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~--~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~   86 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE--GFPITALREIKILQLLKHENVVNLIEICRTKASPYN   86 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTT--SSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch--HHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence            378999999999999999999975 79999999986553322  245678899999999999999999999855      


Q ss_pred             --CCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEec
Q 039137          710 --PKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSD  787 (912)
Q Consensus       710 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  787 (912)
                        .+..++||||++++.+..+.   .....+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+|++|
T Consensus        87 ~~~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~d  160 (318)
T d3blha1          87 RCKGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLAD  160 (318)
T ss_dssp             ----CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECC
T ss_pred             ccCceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeee
Confidence              34679999999887776555   3345688999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCC----CCccccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCccchhccccc---------
Q 039137          788 FGIAKFLNPDS----SNWSELAGTHGYVAPELAYTL-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS---------  853 (912)
Q Consensus       788 fgla~~~~~~~----~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~---------  853 (912)
                      ||+++......    .......||+.|+|||++.+. .++.++||||+||++|||++|+.||+...+....         
T Consensus       161 fg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~  240 (318)
T d3blha1         161 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS  240 (318)
T ss_dssp             CTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             cceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            99998665332    122345799999999998765 6899999999999999999999998621110000         


Q ss_pred             -ccc--------chhhhccCCC-CCCChh----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          854 -SSN--------MNIEMLDSRL-PYPSLH----VQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       854 -~~~--------~~~~~~~~~~-~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                       ...        .......... ......    .......+.+++.+||+.||++|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             CCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence             000        0000000000 000000    1112345778999999999999999998874

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-41  Score=369.83  Aligned_cols=253  Identities=23%  Similarity=0.275  Sum_probs=192.8

Q ss_pred             CCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC------C
Q 039137          639 DFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP------K  711 (912)
Q Consensus       639 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------~  711 (912)
                      +|+..++||+|+||+||+|+++ +|+.||||++......        ..+|++++++++||||+++++++...      .
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~--------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~   92 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF--------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV   92 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS--------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCC
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH--------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCce
Confidence            5888999999999999999986 7999999999754322        23799999999999999999998543      3


Q ss_pred             eeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCC-cEEEecccc
Q 039137          712 HSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGY-EAHVSDFGI  790 (912)
Q Consensus       712 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~Dfgl  790 (912)
                      +.++||||++++.+..+.........+++.+++.|+.||+.||+|||++   +|+||||||+|||++.++ .+||+|||+
T Consensus        93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~  169 (350)
T d1q5ka_          93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGS  169 (350)
T ss_dssp             EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred             EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccc
Confidence            4789999998765555443334556799999999999999999999999   999999999999999775 899999999


Q ss_pred             ccccCCCCCCcccccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCccchhccccc----------cccch-
Q 039137          791 AKFLNPDSSNWSELAGTHGYVAPELAYT-LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS----------SSNMN-  858 (912)
Q Consensus       791 a~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~----------~~~~~-  858 (912)
                      ++...... ......|++.|+|||.+.+ ..++.++||||+||++|||++|+.||.........          ..... 
T Consensus       170 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~  248 (350)
T d1q5ka_         170 AKQLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR  248 (350)
T ss_dssp             CEECCTTS-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             hhhccCCc-ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhh
Confidence            98765433 3345689999999998765 56899999999999999999999998522111000          00000 


Q ss_pred             ---hhhccCCCC------CCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          859 ---IEMLDSRLP------YPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       859 ---~~~~~~~~~------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                         ........+      .........++.+.+++.+||+.||++|||+.|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               000000000      000011223456889999999999999999999875

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=4e-41  Score=358.98  Aligned_cols=261  Identities=15%  Similarity=0.203  Sum_probs=205.7

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCC-CccccEEEEEEcCCeee
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH-RNIVKFYGFCSHPKHSF  714 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h-~niv~l~~~~~~~~~~~  714 (912)
                      .++|++++.||+|+||+||+|++. +|+.||||++.....      .+.+.+|++.++.++| +|++.+++++......+
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~   77 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD------APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV   77 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT------SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC------cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccE
Confidence            367999999999999999999976 789999998864322      2346688999999964 89999999999999999


Q ss_pred             EEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcC-----CCcEEEeccc
Q 039137          715 IIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDL-----GYEAHVSDFG  789 (912)
Q Consensus       715 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-----~~~~kl~Dfg  789 (912)
                      +||||+ +++|.+++...  ...+++.++..++.|++.||+|||++   +|+||||||+||+++.     ++.+||+|||
T Consensus        78 ~vme~~-~~~l~~~~~~~--~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG  151 (293)
T d1csna_          78 LVIDLL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFG  151 (293)
T ss_dssp             EEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred             EEEEec-CCCHHHHHHhh--ccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccc
Confidence            999998 67999988543  34689999999999999999999999   9999999999999974     5679999999


Q ss_pred             cccccCCCCC-------CccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhc
Q 039137          790 IAKFLNPDSS-------NWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEML  862 (912)
Q Consensus       790 la~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~  862 (912)
                      +|+.......       ......||+.|||||++.+..++.++|||||||++|||++|+.||..........  ....+.
T Consensus       152 ~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~--~~~~i~  229 (293)
T d1csna_         152 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ--KYERIG  229 (293)
T ss_dssp             TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH--HHHHHH
T ss_pred             eeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHH--HHHHHH
Confidence            9987654321       2334679999999999999999999999999999999999999986322111100  000111


Q ss_pred             cCCC-CCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 039137          863 DSRL-PYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQLLCEKIFE  911 (912)
Q Consensus       863 ~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~l~~  911 (912)
                      .... ..........++++.+++..|++.+|++||+++.+.+.|++.+.+
T Consensus       230 ~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~  279 (293)
T d1csna_         230 EKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER  279 (293)
T ss_dssp             HHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             hccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHH
Confidence            1000 011111122345688999999999999999999999999987754

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-41  Score=366.89  Aligned_cols=254  Identities=20%  Similarity=0.295  Sum_probs=192.7

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCC----
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPK----  711 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----  711 (912)
                      .++|++++.||+|+||+||+|+++ +|+.||||++.....  .....+.+.+|+++++.++|||||++++++...+    
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~   94 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ--SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD   94 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS--SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc--ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccc
Confidence            467999999999999999999875 799999999975432  2335678899999999999999999999997654    


Q ss_pred             --eeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccc
Q 039137          712 --HSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFG  789 (912)
Q Consensus       712 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  789 (912)
                        ..|+||||+ ++++..+.+.    ..+++..++.++.||+.||+|||++   +|+||||||+||+++.++.+|++|||
T Consensus        95 ~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg  166 (346)
T d1cm8a_          95 FTDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG  166 (346)
T ss_dssp             CCCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             cceEEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccccccccccc
Confidence              469999999 5578777633    4699999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCCCccccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCccchhcccccc------ccchhh--
Q 039137          790 IAKFLNPDSSNWSELAGTHGYVAPELAYTL-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS------SNMNIE--  860 (912)
Q Consensus       790 la~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~------~~~~~~--  860 (912)
                      +|+....   ......||+.|+|||++.+. .++.++||||+||++|||++|+.||..........      ......  
T Consensus       167 ~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  243 (346)
T d1cm8a_         167 LARQADS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV  243 (346)
T ss_dssp             TCEECCS---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             ceeccCC---ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence            9987643   33456899999999988764 56899999999999999999999985321100000      000000  


Q ss_pred             ------------hccCCCCCC--ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          861 ------------MLDSRLPYP--SLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       861 ------------~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                                  .........  .......+..+.++|.+||..||++|||++|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~  300 (346)
T d1cm8a_         244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  300 (346)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                        000000000  0011123456789999999999999999999976

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-41  Score=366.22  Aligned_cols=257  Identities=21%  Similarity=0.285  Sum_probs=194.2

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcCC----
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHPK----  711 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----  711 (912)
                      .++|++.+.||+|+||+||+|+++ +|+.||||++....   .....+++.+|++++++++||||+++++++..+.    
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~   83 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM   83 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT---CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc---ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccccc
Confidence            457999999999999999999864 89999999986432   2335678899999999999999999999997653    


Q ss_pred             eeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEeccccc
Q 039137          712 HSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIA  791 (912)
Q Consensus       712 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla  791 (912)
                      ..+++++|+.+|+|.+++..    ..+++.+++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+|
T Consensus        84 ~~~~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a  156 (345)
T d1pmea_          84 KDVYLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLA  156 (345)
T ss_dssp             CCEEEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             ceEEEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCce
Confidence            23555667779999999943    3589999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCC---Ccccccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCccchhccccccc------c-----
Q 039137          792 KFLNPDSS---NWSELAGTHGYVAPELAYT-LKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSS------N-----  856 (912)
Q Consensus       792 ~~~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~------~-----  856 (912)
                      +.......   ......||+.|+|||++.. ..++.++||||+||++|||++|+.||...........      .     
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  236 (345)
T d1pmea_         157 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED  236 (345)
T ss_dssp             EECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             eeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhh
Confidence            86644322   2345678999999998854 5578999999999999999999999862211000000      0     


Q ss_pred             --------chhhh--ccCCCCCCC-hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          857 --------MNIEM--LDSRLPYPS-LHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       857 --------~~~~~--~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                              .....  .......+. ......+.++.+++.+||+.||++|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~  294 (345)
T d1pmea_         237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  294 (345)
T ss_dssp             HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                    00000  000000000 001122346889999999999999999999975

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.8e-40  Score=359.55  Aligned_cols=249  Identities=19%  Similarity=0.283  Sum_probs=195.1

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcC-CCccccEEEEEEcC--Cee
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR-HRNIVKFYGFCSHP--KHS  713 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~--~~~  713 (912)
                      ++|++++.||+|+||+||+|+++ +|+.||||++...       ..+++.+|+++++.++ ||||+++++++...  ...
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~  107 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP  107 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-------HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence            67999999999999999999975 7899999998632       3467889999999995 99999999999754  568


Q ss_pred             eEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCC-cEEEecccccc
Q 039137          714 FIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGY-EAHVSDFGIAK  792 (912)
Q Consensus       714 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~Dfgla~  792 (912)
                      ++||||+++++|..+.      +.+++.+++.++.||+.||+|||++   +|+||||||+|||++.++ .+|++|||+|+
T Consensus       108 ~~v~e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~  178 (328)
T d3bqca1         108 ALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE  178 (328)
T ss_dssp             EEEEECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred             eEEEeecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccce
Confidence            9999999999997765      3589999999999999999999999   999999999999998655 69999999998


Q ss_pred             ccCCCCCCccccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCccchhcccc-------------------
Q 039137          793 FLNPDSSNWSELAGTHGYVAPELAYTL-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS-------------------  852 (912)
Q Consensus       793 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~-------------------  852 (912)
                      ..... .......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||........                   
T Consensus       179 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~  257 (328)
T d3bqca1         179 FYHPG-QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID  257 (328)
T ss_dssp             ECCTT-CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred             eccCC-CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhh
Confidence            76544 234556789999999998765 479999999999999999999999852111000                   


Q ss_pred             ---ccccch-hhhccCCC------CCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          853 ---SSSNMN-IEMLDSRL------PYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       853 ---~~~~~~-~~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                         ...... ........      ..........+.++.++|.+||+.||++|||++|+++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             HTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               000000 00000000      0011111223456889999999999999999999875

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-41  Score=367.64  Aligned_cols=255  Identities=24%  Similarity=0.334  Sum_probs=201.5

Q ss_pred             cCCCCCceeeecCceEEEEEEeC----CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCC-CccccEEEEEEcCCe
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP----SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRH-RNIVKFYGFCSHPKH  712 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h-~niv~l~~~~~~~~~  712 (912)
                      ++|++.+.||+|+||+||+|+..    +|+.||||++............+.+.+|++++++++| |||+++++++.++..
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            67999999999999999999752    5889999998654322222234567899999999976 899999999999999


Q ss_pred             eeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccccc
Q 039137          713 SFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK  792 (912)
Q Consensus       713 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  792 (912)
                      .++||||+.+|+|.+++...   +.+++..+..++.|++.|++|+|++   +|+||||||+||+++.++.+||+|||+++
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~---~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eeeeeecccccHHHHHHHhc---ccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchh
Confidence            99999999999999998443   4577899999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCC-CCccccccccccccccccccC--CCCcchhHHHHHHHHHHHHhCCCCccchhccccccccchhhhccCCCCCC
Q 039137          793 FLNPDS-SNWSELAGTHGYVAPELAYTL--KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEMLDSRLPYP  869 (912)
Q Consensus       793 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~--~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  869 (912)
                      .+.... .......|++.|+|||.+.+.  .++.++||||+||++|||++|+.||........ .............+.+
T Consensus       178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~-~~~i~~~~~~~~~~~~  256 (322)
T d1vzoa_         178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAEISRRILKSEPPYP  256 (322)
T ss_dssp             ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHHHHHHHHHCCCCCC
T ss_pred             hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcccCCCCCc
Confidence            764332 223456789999999998754  468899999999999999999999863322111 1111122223333333


Q ss_pred             ChhhHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 039137          870 SLHVQKKLMSIMQVAFSCLDQNPESRPT-----MKRVSQ  903 (912)
Q Consensus       870 ~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~  903 (912)
                      .    ..+..+.+++.+||++||++|||     ++|+++
T Consensus       257 ~----~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         257 Q----EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             T----TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             c----cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence            2    24566889999999999999994     777764

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-40  Score=359.69  Aligned_cols=254  Identities=20%  Similarity=0.256  Sum_probs=191.8

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEc------C
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSH------P  710 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~------~  710 (912)
                      ++|++.+.||+|+||+||+|.++ +|+.||||++......  ....+++.+|+.+++.++||||+++++++..      .
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~--~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~   94 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN--QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF   94 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSS--HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcC--HHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence            67999999999999999999976 7999999999765432  3355678999999999999999999999964      3


Q ss_pred             CeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccc
Q 039137          711 KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGI  790 (912)
Q Consensus       711 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl  790 (912)
                      .+.|+||||+.++.+..+.      ..+++.+++.++.||+.||+|||++   ||+||||||+||+++.++.+|++|||+
T Consensus        95 ~~~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~  165 (355)
T d2b1pa1          95 QDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_dssp             CEEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred             ceeEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhh
Confidence            6789999999876555442      3588999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhcccc-----------------c
Q 039137          791 AKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS-----------------S  853 (912)
Q Consensus       791 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~-----------------~  853 (912)
                      ++..... .......+|+.|+|||++.+..++.++||||+||++|||++|+.||........                 .
T Consensus       166 ~~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~  244 (355)
T d2b1pa1         166 ARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  244 (355)
T ss_dssp             ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             hhccccc-cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence            8865433 334556789999999999999999999999999999999999999842110000                 0


Q ss_pred             cccchh----------------hhccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          854 SSNMNI----------------EMLDSRLPYPSLHVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       854 ~~~~~~----------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                      ......                .......+.........+..+.+++.+|++.||++||||+|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            000000                00011112222334456678899999999999999999999874

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-39  Score=353.72  Aligned_cols=255  Identities=20%  Similarity=0.292  Sum_probs=194.6

Q ss_pred             hcCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCccccEEEEEEcC-----
Q 039137          637 TNDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNIVKFYGFCSHP-----  710 (912)
Q Consensus       637 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----  710 (912)
                      .++|++.+.||+|+||+||+|++. +|+.||||++......  ....+++.+|+++++.++|||||++++++...     
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~   94 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE   94 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSS--HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTT
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccccc
Confidence            468999999999999999999875 7999999999765332  23456789999999999999999999999643     


Q ss_pred             CeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEecccc
Q 039137          711 KHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVSDFGI  790 (912)
Q Consensus       711 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl  790 (912)
                      ...+++|+|+.+|+|.+++..    +.+++.+++.++.||+.||+|||++   +|+||||||+||+++.++.+|++|||.
T Consensus        95 ~~~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~  167 (348)
T d2gfsa1          95 FNDVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL  167 (348)
T ss_dssp             CCCCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC--
T ss_pred             CceEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccch
Confidence            345777888899999999843    4599999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccccccccccccCC-CCcchhHHHHHHHHHHHHhCCCCccchhccccc----------------
Q 039137          791 AKFLNPDSSNWSELAGTHGYVAPELAYTLK-VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS----------------  853 (912)
Q Consensus       791 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~----------------  853 (912)
                      +....   .......|++.|+|||...+.. ++.++||||+||++|+|++|+.||.........                
T Consensus       168 a~~~~---~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~  244 (348)
T d2gfsa1         168 ARHTD---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK  244 (348)
T ss_dssp             --CCT---GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             hcccC---cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence            97553   2334567899999999877654 688999999999999999999998521110000                


Q ss_pred             -ccc-chhhhccC--CCCCCCh--hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 039137          854 -SSN-MNIEMLDS--RLPYPSL--HVQKKLMSIMQVAFSCLDQNPESRPTMKRVSQ  903 (912)
Q Consensus       854 -~~~-~~~~~~~~--~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  903 (912)
                       ... ........  ..+....  .....+..+.++|.+||+.||++|||++|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence             000 00000000  0111100  01123456789999999999999999999875

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.1e-35  Score=323.69  Aligned_cols=255  Identities=18%  Similarity=0.259  Sum_probs=190.6

Q ss_pred             cCCCCCceeeecCceEEEEEEeC-CCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcC-----------CCccccEEE
Q 039137          638 NDFNAEHCIGKGGHGSVYRAKVP-SGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR-----------HRNIVKFYG  705 (912)
Q Consensus       638 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-----------h~niv~l~~  705 (912)
                      .+|++++.||+|+||+||+|++. +|+.||||+++..     ....+.+.+|+.+++.++           |+||+++++
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-----~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~   87 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD   87 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-----ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEE
Confidence            45999999999999999999975 7999999998643     224566778999888875           578999998


Q ss_pred             EEEc--CCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCCeEEcCCCc
Q 039137          706 FCSH--PKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHN-NCFPPIVHRDISSKNVLLDLGYE  782 (912)
Q Consensus       706 ~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill~~~~~  782 (912)
                      ++..  ....+++|+++..+..............+++..+..++.||+.|++|||+ .   +|+||||||+||+++.++.
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~  164 (362)
T d1q8ya_          88 HFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDS  164 (362)
T ss_dssp             EEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEET
T ss_pred             EeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCc
Confidence            8854  45677788877665554444344556678999999999999999999998 6   9999999999999986653


Q ss_pred             ------EEEeccccccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCccchhcccccccc
Q 039137          783 ------AHVSDFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSN  856 (912)
Q Consensus       783 ------~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~pf~~~~~~~~~~~~  856 (912)
                            ++++|||.+.....   ......||+.|+|||++.+..++.++||||+||++++|++|+.||............
T Consensus       165 ~~~~~~~kl~dfg~s~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~  241 (362)
T d1q8ya_         165 PENLIQIKIADLGNACWYDE---HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD  241 (362)
T ss_dssp             TTTEEEEEECCCTTCEETTB---CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred             ccccceeeEeeccccccccc---ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchh
Confidence                  99999999986543   234567999999999999999999999999999999999999998632111000000


Q ss_pred             ----------------c------hhhhcc-----CCCC---C-C--------ChhhHHHHHHHHHHHHHcccCCCCCCCC
Q 039137          857 ----------------M------NIEMLD-----SRLP---Y-P--------SLHVQKKLMSIMQVAFSCLDQNPESRPT  897 (912)
Q Consensus       857 ----------------~------~~~~~~-----~~~~---~-~--------~~~~~~~~~~l~~li~~cl~~dP~~RPt  897 (912)
                                      .      .....+     ....   . +        .......+..+.+++.+|++.||.+|||
T Consensus       242 ~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt  321 (362)
T d1q8ya_         242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD  321 (362)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred             HHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC
Confidence                            0      000000     0000   0 0        0012345677899999999999999999


Q ss_pred             HHHHHH
Q 039137          898 MKRVSQ  903 (912)
Q Consensus       898 ~~evl~  903 (912)
                      ++|+++
T Consensus       322 a~e~L~  327 (362)
T d1q8ya_         322 AGGLVN  327 (362)
T ss_dssp             HHHHHT
T ss_pred             HHHHhc
Confidence            999875

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.97  E-value=7e-32  Score=291.22  Aligned_cols=249  Identities=31%  Similarity=0.446  Sum_probs=174.5

Q ss_pred             CCccEEEccCCcccc--cCCccccCCCCCcEEeccc-cccccccccccccccccceeecccccccCCCCccccCcccccE
Q 039137          109 PHLVYLDLYNNELFG--IIPPQISNLSNLEYLDFSA-NKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQ  185 (912)
Q Consensus       109 ~~L~~L~L~~n~l~~--~~p~~~~~l~~L~~L~Ls~-n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~  185 (912)
                      .+++.|||++|+++|  .+|++|++|++|++|||++ |+++|.+|++|++|++|++|+|++|++.+..|..+..+.+|+.
T Consensus        50 ~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~  129 (313)
T d1ogqa_          50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT  129 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred             EEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcc
Confidence            468899999999988  4889999999999999987 7899999999999999999999999999888888888888888


Q ss_pred             EEccCCcCCCCCCccCCCCccceeeeeccCCCcCcccccccccccc-ceeecccccccCccccccccccccceeeecccc
Q 039137          186 LALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSL-FDLELCINQLSGAIPLSISNLTNLRFLFLYHNE  264 (912)
Q Consensus       186 L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L-~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~  264 (912)
                      ++++.|.+.+.+|.+++++++|+++++++|.+.+.+|..++.+.++ +.++++.|++++..|..+..+..+ .++++.+.
T Consensus       130 l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~  208 (313)
T d1ogqa_         130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNM  208 (313)
T ss_dssp             EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSE
T ss_pred             cccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-cccccccc
Confidence            8888888888888888888888888888888877777777666655 556666666666666555554433 45555555


Q ss_pred             CcccCCcccCCccccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCccccccc
Q 039137          265 LSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSD  344 (912)
Q Consensus       265 l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~  344 (912)
                      ..+.+|..+..+++|+.|++++|.+.+.+| .+                        +.+++|+.|+|++|++++.+|..
T Consensus       209 ~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~------------------------~~~~~L~~L~Ls~N~l~g~iP~~  263 (313)
T d1ogqa_         209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KV------------------------GLSKNLNGLDLRNNRIYGTLPQG  263 (313)
T ss_dssp             EEECCGGGCCTTSCCSEEECCSSEECCBGG-GC------------------------CCCTTCCEEECCSSCCEECCCGG
T ss_pred             cccccccccccccccccccccccccccccc-cc------------------------ccccccccccCccCeecccCChH
Confidence            555555555555555555555555543322 34                        44455555555555555555555


Q ss_pred             CCCCCCCCEEeccCCcccccccccccccccccEEEccCcc
Q 039137          345 WGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNY  384 (912)
Q Consensus       345 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~  384 (912)
                      ++++++|++|+|++|+|+|.+|. ++.+.+|+.+++++|+
T Consensus       264 l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~  302 (313)
T d1ogqa_         264 LTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNK  302 (313)
T ss_dssp             GGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSS
T ss_pred             HhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCc
Confidence            55555555555555555555552 3555566666666665

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.97  E-value=1.2e-29  Score=282.04  Aligned_cols=356  Identities=25%  Similarity=0.323  Sum_probs=173.3

Q ss_pred             EccCCcccccCCccccCCCCCcEEeccccccccccccccccccccceeecccccccCCCCccccCcccccEEEccCCcCC
Q 039137          115 DLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLN  194 (912)
Q Consensus       115 ~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~  194 (912)
                      +++.+++++.++  ...+.+|++|++++++|+. + ++++.|++|++|+|++|++++ +|+ ++++++|++|++++|++.
T Consensus        28 ~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~-l~~-l~~L~~L~~L~L~~n~i~  101 (384)
T d2omza2          28 VLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIA  101 (384)
T ss_dssp             HTTCSSTTSEEC--HHHHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC
T ss_pred             HhCCCCCCCccC--HHHhCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCC-Ccc-ccCCcccccccccccccc
Confidence            344455555443  3455667777777777653 3 356667777777777777763 332 667777777777777766


Q ss_pred             CCCCccCCCCccceeeeeccCCCcCccccccccccccceeecccccccCccccccccccccceeeeccccCcccCCcccC
Q 039137          195 GSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIG  274 (912)
Q Consensus       195 ~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~  274 (912)
                      +..  .++++++|+.|++++|.+++..+  ......+..+....|.+....+..................+     ..+.
T Consensus       102 ~i~--~l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~  172 (384)
T d2omza2         102 DIT--PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDL-----KPLA  172 (384)
T ss_dssp             CCG--GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCC-----GGGT
T ss_pred             ccc--ccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccchh-----hhhc
Confidence            432  26666777777777666654332  23344555555555555433322222222221111111111     1122


Q ss_pred             CccccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCcccccccCCCCCCCCEE
Q 039137          275 NLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLL  354 (912)
Q Consensus       275 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  354 (912)
                      ..+.........|...  ....+..+++++.+++++|.+++..+  +..+++|+.|++++|.++..  ..+..+++|+.|
T Consensus       173 ~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L  246 (384)
T d2omza2         173 NLTTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDL  246 (384)
T ss_dssp             TCTTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEE
T ss_pred             cccccccccccccccc--cccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccchh
Confidence            2222222233333322  23344555555555665555554332  23344555555555555431  234444455555


Q ss_pred             eccCCcccccccccccccccccEEEccCccccCCCCccccccccccEEEccCCcccCCCccccccccccccccccCcccC
Q 039137          355 DVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLS  434 (912)
Q Consensus       355 ~Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  434 (912)
                      ++++|++++..+  ++.+++|++|++++|++                        ++..  .+..++.++.+++++|.++
T Consensus       247 ~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l------------------------~~~~--~~~~~~~l~~l~~~~n~l~  298 (384)
T d2omza2         247 DLANNQISNLAP--LSGLTKLTELKLGANQI------------------------SNIS--PLAGLTALTNLELNENQLE  298 (384)
T ss_dssp             ECCSSCCCCCGG--GTTCTTCSEEECCSSCC------------------------CCCG--GGTTCTTCSEEECCSSCCS
T ss_pred             ccccCccCCCCc--ccccccCCEeeccCccc------------------------CCCC--ccccccccccccccccccc
Confidence            555554443222  33444444444444444                        4221  1334444445555555544


Q ss_pred             ccccccccccccccEEEecccccccccchhhhcccccceeeccccccCcccccccccccccccccccCccccCCCccccc
Q 039137          435 NFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFE  514 (912)
Q Consensus       435 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~  514 (912)
                      +.  ..+..+++++.|++++|++++..  .+..+++|++|++++|+|++. + .+.++++|++|++++|+|++..|  +.
T Consensus       299 ~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~l-~-~l~~l~~L~~L~l~~N~l~~l~~--l~  370 (384)
T d2omza2         299 DI--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSDV-S-SLANLTNINWLSAGHNQISDLTP--LA  370 (384)
T ss_dssp             CC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECCSSCCCBCGG--GT
T ss_pred             cc--cccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCCC-h-hHcCCCCCCEEECCCCcCCCChh--hc
Confidence            32  22444455555555555554332  244455555555555555432 1 34555555555555555555433  55


Q ss_pred             ccccceEEEccCC
Q 039137          515 EMHGLLHIDISYN  527 (912)
Q Consensus       515 ~l~~L~~l~ls~N  527 (912)
                      ++++|+.|++++|
T Consensus       371 ~l~~L~~L~L~~N  383 (384)
T d2omza2         371 NLTRITQLGLNDQ  383 (384)
T ss_dssp             TCTTCSEEECCCE
T ss_pred             cCCCCCEeeCCCC
Confidence            5555555555554

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.97  E-value=4.1e-29  Score=277.70  Aligned_cols=342  Identities=27%  Similarity=0.322  Sum_probs=240.6

Q ss_pred             CCCCccEEEccCCcccccCCccccCCCCCcEEeccccccccccccccccccccceeecccccccCCCCccccCcccccEE
Q 039137          107 SFPHLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQL  186 (912)
Q Consensus       107 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L  186 (912)
                      .+.+|++|++++++|+. + +.+..|++|++|||++|+|++ +|. |+++++|++|++++|++++. + .++.+++|+.|
T Consensus        42 ~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~-l~~-l~~L~~L~~L~L~~n~i~~i-~-~l~~l~~L~~L  115 (384)
T d2omza2          42 DLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIADI-T-PLANLTNLTGL  115 (384)
T ss_dssp             HHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCC-G-GGTTCTTCCEE
T ss_pred             HhCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCC-Ccc-ccCCcccccccccccccccc-c-ccccccccccc
Confidence            45678999999999885 3 468899999999999999985 443 89999999999999999854 3 38899999999


Q ss_pred             EccCCcCCCCCCccCCCCccceeeeeccCCCcCccccccccccccceeecccccccCccccccccccccceeeeccccCc
Q 039137          187 ALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELS  266 (912)
Q Consensus       187 ~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~  266 (912)
                      ++++|.+++..+  ......+..+....|.+....+.................     ....+...+.........|...
T Consensus       116 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~  188 (384)
T d2omza2         116 TLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVT-----DLKPLANLTTLERLDISSNKVS  188 (384)
T ss_dssp             ECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCC-----CCGGGTTCTTCCEEECCSSCCC
T ss_pred             cccccccccccc--ccccccccccccccccccccccccccccccccccccccc-----hhhhhccccccccccccccccc
Confidence            999999885443  344566777777777765443333222222222222221     1223445555666666666554


Q ss_pred             ccCCcccCCccccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCcccccccCC
Q 039137          267 GIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWG  346 (912)
Q Consensus       267 ~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  346 (912)
                        ....+..+++++.+++++|.+++..|  +...++|++|++++|.++..  ..+..+++|+.|++++|.+++..  .++
T Consensus       189 --~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~--~~~  260 (384)
T d2omza2         189 --DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLA--PLS  260 (384)
T ss_dssp             --CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG--GGT
T ss_pred             --cccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCC--ccc
Confidence              34556778888889999998886644  45678899999999988853  36778889999999999987654  377


Q ss_pred             CCCCCCEEeccCCcccccccccccccccccEEEccCccccCCCCccccccccccEEEccCCcccCCCccccccccccccc
Q 039137          347 RCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYL  426 (912)
Q Consensus       347 ~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  426 (912)
                      .+++|+.|++++|++.+..+  +..+..++.+++++|++.+  ...+..++.++.|++++|++++..  .+..+++|++|
T Consensus       261 ~~~~L~~L~l~~~~l~~~~~--~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L  334 (384)
T d2omza2         261 GLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRL  334 (384)
T ss_dssp             TCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEE
T ss_pred             ccccCCEeeccCcccCCCCc--ccccccccccccccccccc--ccccchhcccCeEECCCCCCCCCc--ccccCCCCCEE
Confidence            88999999999999875433  5667778888888888764  234666677777777777776542  25666677777


Q ss_pred             cccCcccCccccccccccccccEEEecccccccccchhhhcccccceeecccc
Q 039137          427 DLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHN  479 (912)
Q Consensus       427 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  479 (912)
                      ++++|+|+++ + .+..+++|++|+|++|+|++..|  +.++++|++|+|++|
T Consensus       335 ~L~~n~l~~l-~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N  383 (384)
T d2omza2         335 FFANNKVSDV-S-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ  383 (384)
T ss_dssp             ECCSSCCCCC-G-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred             ECCCCCCCCC-h-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence            7777766653 2 46666666666666666665433  566666666666665

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.94  E-value=1.4e-26  Score=248.30  Aligned_cols=110  Identities=25%  Similarity=0.238  Sum_probs=53.0

Q ss_pred             cccccccccCcccCccccccccccccccEEEecccccccccchhhhcccccceeeccccccCcccccccccccccccccc
Q 039137          421 INLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNL  500 (912)
Q Consensus       421 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l  500 (912)
                      ++|+.|++++|.++...+..|..++.+++|++++|++++..+..+.++++|++|+|++|+|+. +|..|..+++|+.|+|
T Consensus       171 ~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~-lp~~l~~l~~L~~L~L  249 (305)
T d1xkua_         171 PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYL  249 (305)
T ss_dssp             TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSS-CCTTTTTCSSCCEEEC
T ss_pred             CccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeecccccccc-cccccccccCCCEEEC
Confidence            344444444444444444444444444444444444444444444444444444444444432 2334444444555555


Q ss_pred             cCccccCCCccc------ccccccceEEEccCCcccc
Q 039137          501 SYNNLSGLIPRC------FEEMHGLLHIDISYNKLEG  531 (912)
Q Consensus       501 s~N~l~~~~p~~------~~~l~~L~~l~ls~N~l~~  531 (912)
                      ++|+|+.+....      +..+..|+.|++++|+|+.
T Consensus       250 s~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~  286 (305)
T d1xkua_         250 HNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQY  286 (305)
T ss_dssp             CSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCG
T ss_pred             CCCccCccChhhccCcchhcccCCCCEEECCCCcCcc
Confidence            555444432222      2345566677777776653

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.94  E-value=1e-25  Score=241.45  Aligned_cols=245  Identities=25%  Similarity=0.275  Sum_probs=107.6

Q ss_pred             ccceeecccccccCCCCccccCcccccEEEccCCcCCCCCCccCCCCccceeeeeccCCCcCccccccccccccceeecc
Q 039137          158 HLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELC  237 (912)
Q Consensus       158 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~  237 (912)
                      .++.+|-+++.++ .+|..+.  +++++|+|++|+|+...+.+|.++++|++|++++|.+....|..|.++++|+.|+++
T Consensus        11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~   87 (305)
T d1xkua_          11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS   87 (305)
T ss_dssp             ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence            3445555555555 4454443  345555555555543222344555555555555555444334444444444444444


Q ss_pred             cccccCccccccccccccceeeeccccCcccCCcccCCccccchhhhccCccCCCCccccccccccceEeccccccc--C
Q 039137          238 INQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLT--G  315 (912)
Q Consensus       238 ~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~--~  315 (912)
                      +|+++ .+|..+  ...++.|                        ++.+|.+.+..+..+.....+..++...|...  .
T Consensus        88 ~n~l~-~l~~~~--~~~l~~L------------------------~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~  140 (305)
T d1xkua_          88 KNQLK-ELPEKM--PKTLQEL------------------------RVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSG  140 (305)
T ss_dssp             SSCCS-BCCSSC--CTTCCEE------------------------ECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGG
T ss_pred             CCccC-cCccch--hhhhhhh------------------------hccccchhhhhhhhhhccccccccccccccccccC
Confidence            44444 222211  1233344                        44444444333333334444444444444321  1


Q ss_pred             CCCcccCCCCCccEEEccCCcCcccccccCCCCCCCCEEeccCCcccccccccccccccccEEEccCccccCCCCccccc
Q 039137          316 NISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGN  395 (912)
Q Consensus       316 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~  395 (912)
                      ..+..|..+++|+.+++++|.+... +..  .+++|+.|++++|.+.+..+..+..++.+++|++++|.+.+..+..+.+
T Consensus       141 ~~~~~~~~l~~L~~l~l~~n~l~~l-~~~--~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~  217 (305)
T d1xkua_         141 IENGAFQGMKKLSYIRIADTNITTI-PQG--LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLAN  217 (305)
T ss_dssp             BCTTGGGGCTTCCEEECCSSCCCSC-CSS--CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGG
T ss_pred             CCccccccccccCccccccCCcccc-Ccc--cCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccc
Confidence            2233344444455555555444321 111  1334444444444444444444444444444444444444444444444


Q ss_pred             cccccEEEccCCcccCCCccccccccccccccccCcccCcc
Q 039137          396 IIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNF  436 (912)
Q Consensus       396 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  436 (912)
                      +++|++|+|++|+|+ .+|.+|..+++|++|+|++|+|+.+
T Consensus       218 l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i  257 (305)
T d1xkua_         218 TPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAI  257 (305)
T ss_dssp             STTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCC
T ss_pred             cccceeeeccccccc-ccccccccccCCCEEECCCCccCcc
Confidence            444444444444444 2344444444444444444444443

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=1.4e-25  Score=237.72  Aligned_cols=205  Identities=24%  Similarity=0.209  Sum_probs=97.9

Q ss_pred             ccceeeeccccCcccCCcccCCccccchhhhccCccCCCCccccccccccceEecc-cccccCCCCcccCCCCCccEEEc
Q 039137          254 NLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLN-QNYLTGNISETFGTYPNLTFIDL  332 (912)
Q Consensus       254 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~-~n~l~~~~~~~~~~l~~L~~L~L  332 (912)
                      ++++|+|++|+|+.+.+.+|.++++|++|++++|++....+..+..++.++.++.. .|.++...+..|.++++|++|++
T Consensus        33 ~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l  112 (284)
T d1ozna_          33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL  112 (284)
T ss_dssp             TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEec
Confidence            34455555555554444445555555555555555544444444444444444432 33344444445555555555555


Q ss_pred             cCCcCcccccccCCCCCCCCEEeccCCcccccccccccccccccEEEccCccccCCCCccccccccccEEEccCCcccCC
Q 039137          333 SNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGC  412 (912)
Q Consensus       333 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~  412 (912)
                      ++|.+....+..+..+++|+.+++++|+|++..+..|...++|++|++++|++++..+..|.++++|+.+++++|++++.
T Consensus       113 ~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i  192 (284)
T d1ozna_         113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV  192 (284)
T ss_dssp             TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEE
T ss_pred             CCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhcccccc
Confidence            55555444444444444444444444444433334444444444444444444444444444444444444444444444


Q ss_pred             CccccccccccccccccCcccCccccccccccccccEEEecccccc
Q 039137          413 IPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLS  458 (912)
Q Consensus       413 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  458 (912)
                      .|..|..+++|++|++++|++.+..+..|..+++|++|+|++|++.
T Consensus       193 ~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~  238 (284)
T d1ozna_         193 HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV  238 (284)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEE
T ss_pred             ChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCC
Confidence            4444444444444444444444444444444444444444444443

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=1.4e-25  Score=237.58  Aligned_cols=223  Identities=23%  Similarity=0.206  Sum_probs=100.1

Q ss_pred             EeccccccccccccccccccccceeecccccccCCCCccccCcccccEEEccCCcCCCCCCccCCCCccceeeeeccCCC
Q 039137          138 LDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNNSF  217 (912)
Q Consensus       138 L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l  217 (912)
                      ++.++++++ .+|..+.  +.+++|+|++|.+++..+..|.++++|++|++++|++.+..+..+.++..++.+...    
T Consensus        16 v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~----   88 (284)
T d1ozna_          16 TSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS----   88 (284)
T ss_dssp             EECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC----
T ss_pred             EEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccc----
Confidence            344444554 4444332  344555555555543323334444444444444444443333333333333333322    


Q ss_pred             cCccccccccccccceeecccccccCccccccccccccceeeeccccCcccCCcccCCccccchhhhccCccCCCCcccc
Q 039137          218 FGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSF  297 (912)
Q Consensus       218 ~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~  297 (912)
                                         ..|.++...|..|.++++|++|++++|.+....+..+...++|+.+++++|+++++.+..|
T Consensus        89 -------------------~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f  149 (284)
T d1ozna_          89 -------------------DNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTF  149 (284)
T ss_dssp             -------------------SCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT
T ss_pred             -------------------cccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHh
Confidence                               1233333334444444444444444444443333444444444444444444444434444


Q ss_pred             ccccccceEecccccccCCCCcccCCCCCccEEEccCCcCcccccccCCCCCCCCEEeccCCcccccccccccccccccE
Q 039137          298 RNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQY  377 (912)
Q Consensus       298 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~  377 (912)
                      ..+++|+.|++++|.+++..+..|.++++|+.+++++|++++..|..|..+++|++|++++|++.+..+..++.+.+|++
T Consensus       150 ~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~  229 (284)
T d1ozna_         150 RDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQY  229 (284)
T ss_dssp             TTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCE
T ss_pred             ccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCE
Confidence            44444444444444444444444444444444444444444444444444444444444444444444444444444444


Q ss_pred             EEccCcccc
Q 039137          378 LDLSSNYIV  386 (912)
Q Consensus       378 L~L~~N~l~  386 (912)
                      |+|++|.+.
T Consensus       230 L~l~~N~l~  238 (284)
T d1ozna_         230 LRLNDNPWV  238 (284)
T ss_dssp             EECCSSCEE
T ss_pred             EEecCCCCC
Confidence            444444444

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.89  E-value=4.1e-23  Score=216.01  Aligned_cols=202  Identities=25%  Similarity=0.261  Sum_probs=119.2

Q ss_pred             cccccceEecccccccCCCCcccCCCCCccEEEccCCcCcccccccCCCCCCCCEEeccCCcccccccccccccccccEE
Q 039137          299 NLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYL  378 (912)
Q Consensus       299 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L  378 (912)
                      +...+.+++.+++.++.. |..+.  +++++|+|++|++++..+..|.++++|++|+|++|+|+. ++            
T Consensus         8 ~~~~~~~v~C~~~~L~~i-P~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~------------   71 (266)
T d1p9ag_           8 KVASHLEVNCDKRNLTAL-PPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ------------   71 (266)
T ss_dssp             CSTTCCEEECTTSCCSSC-CSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE------------
T ss_pred             ccCCCeEEEccCCCCCee-CcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-cc------------
Confidence            344555566666666643 33221  356666666666655555555555555555555555542 22            


Q ss_pred             EccCccccCCCCccccccccccEEEccCCcccCCCccccccccccccccccCcccCccccccccccccccEEEecccccc
Q 039137          379 DLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLS  458 (912)
Q Consensus       379 ~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  458 (912)
                                   .++.+++|++|+|++|+++ ..+..+..+++|++|++++|.+.++.+..+..+.+++.|++++|.++
T Consensus        72 -------------~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~  137 (266)
T d1p9ag_          72 -------------VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK  137 (266)
T ss_dssp             -------------CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCC
T ss_pred             -------------ccccccccccccccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccc
Confidence                         1234444555555555554 23444555555666666666665555555666666666666666666


Q ss_pred             cccchhhhcccccceeeccccccCcccccccccccccccccccCccccCCCcccccccccceEEEccCCcccc
Q 039137          459 QQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEMHGLLHIDISYNKLEG  531 (912)
Q Consensus       459 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~  531 (912)
                      ...+..+..+++|+.|++++|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|.|
T Consensus       138 ~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~C  209 (266)
T d1p9ag_         138 TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC  209 (266)
T ss_dssp             CCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred             eeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCC
Confidence            555555666666666666666666666666666667777777777766 345555567777777777777766

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.89  E-value=3.5e-23  Score=216.57  Aligned_cols=173  Identities=25%  Similarity=0.295  Sum_probs=86.7

Q ss_pred             cEEEccCCcccccCCccccCCCCCcEEeccccccccccccccccccccceeecccccccCCCCccccCcccccEEEccCC
Q 039137          112 VYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSN  191 (912)
Q Consensus       112 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n  191 (912)
                      ...|.++++++ .+|+.+.  ++|++|||++|+|++..+..|.++++|++|+|++|+++ .+| .++.+++|++|+|++|
T Consensus        13 ~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls~N   87 (266)
T d1p9ag_          13 LEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHN   87 (266)
T ss_dssp             CEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECCSS
T ss_pred             eEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-cccccccccccccccc
Confidence            33455566666 3555443  35666666666666444455666666666666666665 333 2345556666666666


Q ss_pred             cCCCCCCccCCCCccceeeeeccCCCcCccccccccccccceeecccccccCccccccccccccceeeeccccCcccCCc
Q 039137          192 FLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQ  271 (912)
Q Consensus       192 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~  271 (912)
                      +++ .++..+.++++|++|++++|.+.+..+..+..+.+++.|++++|.++...+..+..+++|+.|++++|++++..+.
T Consensus        88 ~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~  166 (266)
T d1p9ag_          88 QLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAG  166 (266)
T ss_dssp             CCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTT
T ss_pred             ccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCcc
Confidence            555 2344455555555555555555444444444444444444444444433333334444444444444444433333


Q ss_pred             ccCCccccchhhhccCccC
Q 039137          272 EIGNLKKLNSLLLAKNHFR  290 (912)
Q Consensus       272 ~l~~l~~L~~L~L~~N~l~  290 (912)
                      .|..+++|++|+|++|+|+
T Consensus       167 ~~~~l~~L~~L~Ls~N~L~  185 (266)
T d1p9ag_         167 LLNGLENLDTLLLQENSLY  185 (266)
T ss_dssp             TTTTCTTCCEEECCSSCCC
T ss_pred             ccccccccceeecccCCCc
Confidence            3333333333333333333

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.86  E-value=4.4e-22  Score=196.75  Aligned_cols=172  Identities=16%  Similarity=0.135  Sum_probs=122.7

Q ss_pred             CCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCC--------------chHHHHHHHHHHHHHhhcCCCccccEEEE
Q 039137          641 NAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGE--------------MSFQQEEFLNEIQALTEIRHRNIVKFYGF  706 (912)
Q Consensus       641 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~~~~~Ei~~l~~l~h~niv~l~~~  706 (912)
                      .++++||+|+||+||+|++.+|+.||||+++......              .........+|...+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            4678999999999999998899999999876432110              01122345678899999999999998866


Q ss_pred             EEcCCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeEEcCCCcEEEe
Q 039137          707 CSHPKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHRDISSKNVLLDLGYEAHVS  786 (912)
Q Consensus       707 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  786 (912)
                      .    ..+++|||++++.+.+          ++...+.+++.|++.|++|||++   +|+||||||+||+++++ .++++
T Consensus        83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~li  144 (191)
T d1zara2          83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWII  144 (191)
T ss_dssp             E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEEC
T ss_pred             c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEE
Confidence            4    2479999998754432          44566788999999999999999   99999999999999965 58999


Q ss_pred             ccccccccCCCCCCccccccccccccccccccCCCCcchhHHHHHHH
Q 039137          787 DFGIAKFLNPDSSNWSELAGTHGYVAPELAYTLKVTEKCDVYSFGVL  833 (912)
Q Consensus       787 Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~v  833 (912)
                      |||.|.....+.... ....+... -.|. ....|+.++|+||+.--
T Consensus       145 DFG~a~~~~~~~~~~-~l~rd~~~-~~~~-f~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         145 DFPQSVEVGEEGWRE-ILERDVRN-IITY-FSRTYRTEKDINSAIDR  188 (191)
T ss_dssp             CCTTCEETTSTTHHH-HHHHHHHH-HHHH-HHHHHCCCCCHHHHHHH
T ss_pred             ECCCcccCCCCCcHH-HHHHHHHH-HHHH-HcCCCCCcccHHHHHHH
Confidence            999997654322110 00000000 0111 23567889999997543

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.84  E-value=1e-19  Score=198.29  Aligned_cols=298  Identities=26%  Similarity=0.290  Sum_probs=159.3

Q ss_pred             CccEEEccCCcccccCCccccCCCCCcEEeccccccccccccccccccccceeecccccccCCCCccccCcccccEEEcc
Q 039137          110 HLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALD  189 (912)
Q Consensus       110 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~  189 (912)
                      ++++|||++|+++ .+|+.   +++|++|+|++|+|+ .+|+.+   .+|+.|++++|+++ .++...   +.|++|+++
T Consensus        39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~lp---~~L~~L~L~  106 (353)
T d1jl5a_          39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDLP---PLLEYLGVS  106 (353)
T ss_dssp             TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSCC---TTCCEEECC
T ss_pred             CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhhc---ccccccccc
Confidence            4678888888887 46753   457888888888887 677654   46788888888877 444321   357888888


Q ss_pred             CCcCCCCCCccCCCCccceeeeeccCCCcCccccccccccccceeecccccccCccccccccccccceeeeccccCcccC
Q 039137          190 SNFLNGSIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGII  269 (912)
Q Consensus       190 ~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  269 (912)
                      +|.+. .+|. ++++++|++|++++|.+.. .|..   ...+..+.+..+...  .+..+..++.++.|++++|.+... 
T Consensus       107 ~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~-~~~~---~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~~~-  177 (353)
T d1jl5a_         107 NNQLE-KLPE-LQNSSFLKIIDVDNNSLKK-LPDL---PPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKKL-  177 (353)
T ss_dssp             SSCCS-SCCC-CTTCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCSSC-
T ss_pred             ccccc-cccc-hhhhccceeeccccccccc-cccc---cccccchhhcccccc--ccccccccccceeccccccccccc-
Confidence            88877 5553 5677888888888777763 2322   234445555444443  233455666677777777666532 


Q ss_pred             CcccCCccccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCcccccccCCCCC
Q 039137          270 PQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCP  349 (912)
Q Consensus       270 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  349 (912)
                      +...   ...+.+....+.+. .++ .+..++.|+.+++++|..... +   ....++..+.+.+|.+....    ...+
T Consensus       178 ~~~~---~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~~~-~---~~~~~l~~~~~~~~~~~~~~----~~~~  244 (353)
T d1jl5a_         178 PDLP---LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKTL-P---DLPPSLEALNVRDNYLTDLP----ELPQ  244 (353)
T ss_dssp             CCCC---TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSSC-C---SCCTTCCEEECCSSCCSCCC----CCCT
T ss_pred             cccc---cccccccccccccc-ccc-ccccccccccccccccccccc-c---cccccccccccccccccccc----cccc
Confidence            2211   11223333333333 222 234455556666655554421 1   12334445555555443211    1122


Q ss_pred             CCCEEeccCCcccccccccccccccccEEEccCccccCCCCcccccc-ccccEEEccCCcccCCCccccccccccccccc
Q 039137          350 QLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNI-IYLNRLSLSGNKLSGCIPRELGSLINLEYLDL  428 (912)
Q Consensus       350 ~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  428 (912)
                      .+.                        ..++..+.+.+.     ..+ ......++..|.+.+. +   ..+++|++|+|
T Consensus       245 ~l~------------------------~~~~~~~~~~~l-----~~l~~~~~~~~~~~~~~~~~-~---~~~~~L~~L~L  291 (353)
T d1jl5a_         245 SLT------------------------FLDVSENIFSGL-----SELPPNLYYLNASSNEIRSL-C---DLPPSLEELNV  291 (353)
T ss_dssp             TCC------------------------EEECCSSCCSEE-----SCCCTTCCEEECCSSCCSEE-C---CCCTTCCEEEC
T ss_pred             ccc------------------------cccccccccccc-----ccccchhcccccccCccccc-c---ccCCCCCEEEC
Confidence            333                        344433333211     111 1233344444444421 1   22345666666


Q ss_pred             cCcccCccccccccccccccEEEecccccccccchhhhcccccceeeccccccC
Q 039137          429 SANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLG  482 (912)
Q Consensus       429 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  482 (912)
                      ++|+|+. +|..   +++|+.|+|++|+|+ .+|..   +++|++|+|++|+|+
T Consensus       292 s~N~l~~-lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~  337 (353)
T d1jl5a_         292 SNNKLIE-LPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR  337 (353)
T ss_dssp             CSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS
T ss_pred             CCCccCc-cccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC
Confidence            6666654 2322   345666666666665 34432   345666666666665

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.83  E-value=2.5e-19  Score=195.21  Aligned_cols=302  Identities=26%  Similarity=0.274  Sum_probs=163.3

Q ss_pred             CCCcEEeccccccccccccccccccccceeecccccccCCCCccccCcccccEEEccCCcCCCCCCccCCCCccceeeee
Q 039137          133 SNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYL  212 (912)
Q Consensus       133 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L  212 (912)
                      .+|++|||++|+++ .+|+.   +++|++|+|++|+|+ .+|..+   .+|+.|++++|+++ .++.-   .+.|++|++
T Consensus        38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L  105 (353)
T d1jl5a_          38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGV  105 (353)
T ss_dssp             HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEEC
T ss_pred             cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---ccccccccc
Confidence            36788999999887 67763   467888888888888 677654   46777778877776 33321   123555555


Q ss_pred             ccCCCcCccccccccccccceeecccccccCccccccccccccceeeeccccCcccCCcccCCccccchhhhccCccCCC
Q 039137          213 YNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGT  292 (912)
Q Consensus       213 ~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~  292 (912)
                      ++|.+. .+|. ++.+++|+.|++++|.+... |.   ....+..+.+..+...                          
T Consensus       106 ~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~-~~---~~~~l~~l~~~~~~~~--------------------------  153 (353)
T d1jl5a_         106 SNNQLE-KLPE-LQNSSFLKIIDVDNNSLKKL-PD---LPPSLEFIAAGNNQLE--------------------------  153 (353)
T ss_dssp             CSSCCS-SCCC-CTTCTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCS--------------------------
T ss_pred             cccccc-cccc-hhhhccceeecccccccccc-cc---ccccccchhhcccccc--------------------------
Confidence            555554 2332 34444444444444444321 11   1122333333332222                          


Q ss_pred             CccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCcccccccCCCCCCCCEEeccCCccccccccccccc
Q 039137          293 VPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGES  372 (912)
Q Consensus       293 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~  372 (912)
                      .+..+..++.++.|++++|.+.....    .....+.+..+++.+.  ....+..++.|+.+++++|.... ++.   ..
T Consensus       154 ~~~~l~~l~~l~~L~l~~n~~~~~~~----~~~~~~~l~~~~~~~~--~~~~~~~l~~L~~l~l~~n~~~~-~~~---~~  223 (353)
T d1jl5a_         154 ELPELQNLPFLTAIYADNNSLKKLPD----LPLSLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLKT-LPD---LP  223 (353)
T ss_dssp             SCCCCTTCTTCCEEECCSSCCSSCCC----CCTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCSS-CCS---CC
T ss_pred             ccccccccccceeccccccccccccc----cccccccccccccccc--ccccccccccccccccccccccc-ccc---cc
Confidence            12234445555555555555442211    1122344444444432  12234556666777776666542 222   23


Q ss_pred             ccccEEEccCccccCCCCccccccccccEEEccCCcccCCCccccccccccccccccCcccCccccccccccccccEEEe
Q 039137          373 LQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNL  452 (912)
Q Consensus       373 ~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  452 (912)
                      .++..+.+.+|.+.. .+..   ...+...++..+.+.+. +..   .......++..|.+.+.    ...+++|++|+|
T Consensus       224 ~~l~~~~~~~~~~~~-~~~~---~~~l~~~~~~~~~~~~l-~~l---~~~~~~~~~~~~~~~~~----~~~~~~L~~L~L  291 (353)
T d1jl5a_         224 PSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGL-SEL---PPNLYYLNASSNEIRSL----CDLPPSLEELNV  291 (353)
T ss_dssp             TTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEE-SCC---CTTCCEEECCSSCCSEE----CCCCTTCCEEEC
T ss_pred             ccccccccccccccc-cccc---ccccccccccccccccc-ccc---cchhcccccccCccccc----cccCCCCCEEEC
Confidence            456677777777663 2222   33455666666555421 110   12334556666666543    223467788888


Q ss_pred             cccccccccchhhhcccccceeeccccccCcccccccccccccccccccCccccCC
Q 039137          453 SHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGL  508 (912)
Q Consensus       453 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~  508 (912)
                      ++|+|+ .+|..   +++|+.|+|++|+|+. +|..   +++|+.|++++|+|+.+
T Consensus       292 s~N~l~-~lp~~---~~~L~~L~L~~N~L~~-l~~~---~~~L~~L~L~~N~L~~l  339 (353)
T d1jl5a_         292 SNNKLI-ELPAL---PPRLERLIASFNHLAE-VPEL---PQNLKQLHVEYNPLREF  339 (353)
T ss_dssp             CSSCCS-CCCCC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSSC
T ss_pred             CCCccC-ccccc---cCCCCEEECCCCcCCc-cccc---cCCCCEEECcCCcCCCC
Confidence            888876 45533   4677777888887764 3432   45677777777777643

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.80  E-value=3.3e-22  Score=226.68  Aligned_cols=109  Identities=19%  Similarity=0.226  Sum_probs=70.7

Q ss_pred             CccEEEccCCccccc-CCccccCCCCCcEEecccccccc----ccccccccccccceeecccccccCC----CCcccc-C
Q 039137          110 HLVYLDLYNNELFGI-IPPQISNLSNLEYLDFSANKLFG----QIPSGIGLLTHLTVLHISRNWLSGS----IPHEVG-Q  179 (912)
Q Consensus       110 ~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L~Ls~n~l~~----~~p~~~~~l~~L~~L~L~~n~l~~~----~p~~~~-~  179 (912)
                      +|++||+++|++++. +..-+..+++|++|+|++|.++.    .++..+..+++|++|||++|.++..    +...+. .
T Consensus         3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~   82 (460)
T d1z7xw1           3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP   82 (460)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred             CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence            578888888888753 23445667888888888888763    3455667778888888888877521    222222 1


Q ss_pred             cccccEEEccCCcCCCC----CCccCCCCccceeeeeccCCCc
Q 039137          180 LTVLNQLALDSNFLNGS----IPRSLGNLTHVVILYLYNNSFF  218 (912)
Q Consensus       180 l~~L~~L~l~~n~l~~~----~p~~~~~l~~L~~L~L~~n~l~  218 (912)
                      ..+|++|+|++|+++..    ++..+..+++|++|+|++|.++
T Consensus        83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~  125 (460)
T d1z7xw1          83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG  125 (460)
T ss_dssp             TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred             CCCCCEEECCCCCccccccccccchhhccccccccccccccch
Confidence            23577777777776532    3445566666666666666655

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.79  E-value=4.9e-22  Score=225.20  Aligned_cols=176  Identities=23%  Similarity=0.131  Sum_probs=97.0

Q ss_pred             CCCCCCEEeccCCccccc----ccccccccccccEEEccCccccCCCCccc-----cccccccEEEccCCcccCCCccc-
Q 039137          347 RCPQLSLLDVSINNISGS----IPLEIGESLQLQYLDLSSNYIVGEIPTQL-----GNIIYLNRLSLSGNKLSGCIPRE-  416 (912)
Q Consensus       347 ~l~~L~~L~Ls~N~l~~~----~~~~~~~~~~L~~L~L~~N~l~~~~~~~l-----~~l~~L~~L~L~~N~l~~~~p~~-  416 (912)
                      ....++.+++++|.+...    ....+...+.++.+++++|.+.......+     .....|+.+++++|.++...... 
T Consensus       253 ~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l  332 (460)
T d1z7xw1         253 PSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHF  332 (460)
T ss_dssp             TTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccccccccchhhhhhhhc
Confidence            344555555555555422    11223344556666666666543211111     12345667777777666443222 


Q ss_pred             ---cccccccccccccCcccCccc----ccccc-ccccccEEEecccccccc----cchhhhcccccceeeccccccCcc
Q 039137          417 ---LGSLINLEYLDLSANNLSNFV----PESLG-SLVKLYYLNLSHNKLSQQ----IPIELDNLIHLSELDLSHNFLGEK  484 (912)
Q Consensus       417 ---~~~l~~L~~L~Ls~N~l~~~~----~~~~~-~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~  484 (912)
                         +...++|++|+|++|++++..    +..+. ..+.|++|+|++|+|+..    ++..+..+++|++|+|++|+|++.
T Consensus       333 ~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~  412 (460)
T d1z7xw1         333 SSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA  412 (460)
T ss_dssp             HHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHH
T ss_pred             ccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHH
Confidence               233456777777777775422    22222 345688888888887642    344566667888888888888654


Q ss_pred             cccccc-----cccccccccccCccccCCCcccc----cccccceEE
Q 039137          485 ISSRIC-----RMESLEKLNLSYNNLSGLIPRCF----EEMHGLLHI  522 (912)
Q Consensus       485 ~~~~~~-----~l~~L~~L~ls~N~l~~~~p~~~----~~l~~L~~l  522 (912)
                      ....+.     +...|+.|++++|.+....+..+    ...++|+.|
T Consensus       413 g~~~l~~~l~~~~~~L~~l~l~~~~~~~~~~~~l~~l~~~~~~l~~~  459 (460)
T d1z7xw1         413 GILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI  459 (460)
T ss_dssp             HHHHHHHHHTSTTCCCCEEECTTCCCCHHHHHHHHHHHHHCTTSEEE
T ss_pred             HHHHHHHHHHhCCCccCEEECCCCCCCHHHHHHHHHHHHhCCCCEEe
Confidence            333332     23368888888888875544333    334555544

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.78  E-value=4.8e-19  Score=180.02  Aligned_cols=207  Identities=24%  Similarity=0.294  Sum_probs=108.3

Q ss_pred             ccccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCcccccccCCCCCCCCEEe
Q 039137          276 LKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLD  355 (912)
Q Consensus       276 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  355 (912)
                      ++++..++++.+++++..  .++.+.+|+.|++++|.|+..  +.+..+++|++|++++|++.+..+  +..+++|+.++
T Consensus        18 l~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~   91 (227)
T d1h6ua2          18 LANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELE   91 (227)
T ss_dssp             HHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEE
T ss_pred             HHHHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeecccc--ccccccccccc
Confidence            444555666666666542  456667777777777777643  346667777777777777654432  56666666666


Q ss_pred             ccCCcccccccccccccccccEEEccCccccCCCCccccccccccEEEccCCcccCCCccccccccccccccccCcccCc
Q 039137          356 VSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSN  435 (912)
Q Consensus       356 Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  435 (912)
                      +++|.++. ++ .+.++++|+.+++++|...+.  ..+.....+..+.++++.+....  .+..+++|++|++++|.+.+
T Consensus        92 ~~~n~~~~-i~-~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~  165 (227)
T d1h6ua2          92 LSGNPLKN-VS-AIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSD  165 (227)
T ss_dssp             CCSCCCSC-CG-GGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCC
T ss_pred             cccccccc-cc-ccccccccccccccccccccc--chhccccchhhhhchhhhhchhh--hhcccccccccccccccccc
Confidence            66666552 22 344555666666666555432  22334445555555555544221  23444455555555555443


Q ss_pred             cccccccccccccEEEecccccccccchhhhcccccceeeccccccCcccccccccccccccccc
Q 039137          436 FVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNL  500 (912)
Q Consensus       436 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l  500 (912)
                      ..  .+.++++|++|+|++|++++. + .+.++++|++|+|++|+|++..|  ++++++|+.|++
T Consensus       166 ~~--~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~l  224 (227)
T d1h6ua2         166 LT--PLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL  224 (227)
T ss_dssp             CG--GGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEE
T ss_pred             ch--hhcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCCcc--cccCCCCCEEEe
Confidence            21  244445555555555554432 1 24444444444444444443321  344444444444

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.77  E-value=5.4e-19  Score=181.72  Aligned_cols=199  Identities=17%  Similarity=0.133  Sum_probs=99.9

Q ss_pred             CccEEEccCCcccccCCccccCCCCCcEEeccccccccccc-cccccccccceeeccc-ccccCCCCccccCcccccEEE
Q 039137          110 HLVYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIP-SGIGLLTHLTVLHISR-NWLSGSIPHEVGQLTVLNQLA  187 (912)
Q Consensus       110 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p-~~~~~l~~L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~  187 (912)
                      ++++|+|++|+|+...+..|.++++|++|+|++|.+...+| ..|.+++++++|++.. |.+....+..|.++++|++|+
T Consensus        30 ~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~  109 (242)
T d1xwdc1          30 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL  109 (242)
T ss_dssp             CCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEE
T ss_pred             CCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccccc
Confidence            56666777666664444456666666666666666654433 3455666666666543 445544445555555555555


Q ss_pred             ccCCcCCCCCC-ccCCCCccceeeeeccCCCcCccccccccccccceeecccccccCcccccccccc-ccceeeeccccC
Q 039137          188 LDSNFLNGSIP-RSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLT-NLRFLFLYHNEL  265 (912)
Q Consensus       188 l~~n~l~~~~p-~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~-~L~~L~L~~N~l  265 (912)
                      +++|.+....+ ..+..+..+..+...                        ++++....+..|..++ .++.|++++|++
T Consensus       110 l~~~~l~~~~~~~~~~~l~~l~~~~~~------------------------n~~l~~i~~~~~~~~~~~l~~L~l~~n~l  165 (242)
T d1xwdc1         110 ISNTGIKHLPDVHKIHSLQKVLLDIQD------------------------NINIHTIERNSFVGLSFESVILWLNKNGI  165 (242)
T ss_dssp             EESCCCCSCCCCTTTCBSSCEEEEEES------------------------CTTCCEECTTSSTTSBSSCEEEECCSSCC
T ss_pred             cchhhhccccccccccccccccccccc------------------------ccccccccccccccccccceeeecccccc
Confidence            55555542211 112222333333333                        3333322233333332 455566666666


Q ss_pred             cccCCcccCCcccc-chhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEcc
Q 039137          266 SGIIPQEIGNLKKL-NSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLS  333 (912)
Q Consensus       266 ~~~~~~~l~~l~~L-~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls  333 (912)
                      +.+.+..+. ..++ +.+++++|+++...+..|.++++|++|+|++|+++..++..|.++++|+.+++.
T Consensus       166 ~~i~~~~~~-~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~  233 (242)
T d1xwdc1         166 QEIHNCAFN-GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY  233 (242)
T ss_dssp             CEECTTTTT-TCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEE
T ss_pred             ccccccccc-chhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCC
Confidence            543333332 2332 233445555554444445556666666666666655555555555555555443

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.77  E-value=7.3e-19  Score=178.68  Aligned_cols=188  Identities=24%  Similarity=0.333  Sum_probs=88.8

Q ss_pred             ccccccceeeeccccCcccCCcccCCccccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccE
Q 039137          250 SNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTF  329 (912)
Q Consensus       250 ~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~  329 (912)
                      ..+.+|+.|++.+|+++..  +.+..+++|++|++++|++++..|  +..+++|+.+++++|.++..  ..+..+++|+.
T Consensus        38 ~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~i--~~l~~l~~L~~  111 (227)
T d1h6ua2          38 ADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKT  111 (227)
T ss_dssp             HHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCE
T ss_pred             HHcCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeecccc--cccccccccccccccccccc--ccccccccccc
Confidence            3444555555555554432  234444445555555544443221  44445555555555544421  12344444555


Q ss_pred             EEccCCcCcccccccCCCCCCCCEEeccCCcccccccccccccccccEEEccCccccCCCCccccccccccEEEccCCcc
Q 039137          330 IDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKL  409 (912)
Q Consensus       330 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l  409 (912)
                      ++++++...+.  ..+...+                        .++.+.++++.+...  ..+.+.++|+.|++++|++
T Consensus       112 l~l~~~~~~~~--~~~~~~~------------------------~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~  163 (227)
T d1h6ua2         112 LDLTSTQITDV--TPLAGLS------------------------NLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQV  163 (227)
T ss_dssp             EECTTSCCCCC--GGGTTCT------------------------TCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCC
T ss_pred             ccccccccccc--chhcccc------------------------chhhhhchhhhhchh--hhhcccccccccccccccc
Confidence            55544443321  1122333                        444444444444321  1234444555555555555


Q ss_pred             cCCCccccccccccccccccCcccCccccccccccccccEEEecccccccccchhhhcccccceeecc
Q 039137          410 SGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLS  477 (912)
Q Consensus       410 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  477 (912)
                      ++..  .+.++++|+.|+|++|+++++.  .+..+++|++|+|++|+|++..  .+.++++|++|+++
T Consensus       164 ~~~~--~l~~l~~L~~L~Ls~n~l~~l~--~l~~l~~L~~L~Ls~N~lt~i~--~l~~l~~L~~L~ls  225 (227)
T d1h6ua2         164 SDLT--PLANLSKLTTLKADDNKISDIS--PLASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLT  225 (227)
T ss_dssp             CCCG--GGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEE
T ss_pred             ccch--hhcccccceecccCCCccCCCh--hhcCCCCCCEEECcCCcCCCCc--ccccCCCCCEEEee
Confidence            4221  2455556666666666655532  2555666666666666665432  25566666666665

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.76  E-value=1.9e-18  Score=177.46  Aligned_cols=218  Identities=17%  Similarity=0.157  Sum_probs=105.6

Q ss_pred             hhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCcccc-cccCCCCCCCCEEeccCC
Q 039137          281 SLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEI-LSDWGRCPQLSLLDVSIN  359 (912)
Q Consensus       281 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~Ls~N  359 (912)
                      .++.+++.++ .+|..+.  +++++|+|++|.|+...+..|.++++|++|+|++|.+...+ +..|..++.++++.+.. 
T Consensus        12 ~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~-   87 (242)
T d1xwdc1          12 VFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK-   87 (242)
T ss_dssp             EEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC-
T ss_pred             EEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc-
Confidence            3444455555 3343332  34555555555555544455555555555555555554322 23344455555554432 


Q ss_pred             cccccccccccccccccEEEccCccccCCCCccccccccccEEEccCCcccCCCc-cccccccccccccccCcccCcccc
Q 039137          360 NISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIP-RELGSLINLEYLDLSANNLSNFVP  438 (912)
Q Consensus       360 ~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~~  438 (912)
                                            .|++....+..|.++++|+.|++++|++....+ ..+..+..+..+..+++.+..+.+
T Consensus        88 ----------------------~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~  145 (242)
T d1xwdc1          88 ----------------------ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIER  145 (242)
T ss_dssp             ----------------------CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECT
T ss_pred             ----------------------cccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccc
Confidence                                  233333334444444445555554444442211 122233444444445555555444


Q ss_pred             ccccccc-cccEEEecccccccccchhhhccccc-ceeeccccccCcccccccccccccccccccCccccCCCccccccc
Q 039137          439 ESLGSLV-KLYYLNLSHNKLSQQIPIELDNLIHL-SELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEM  516 (912)
Q Consensus       439 ~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L-~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l  516 (912)
                      ..|..++ .++.|++++|+++...+..+. ..++ +.+++++|+|+...+..|.++++|+.|++++|+|+.+.+..|.++
T Consensus       146 ~~~~~~~~~l~~L~l~~n~l~~i~~~~~~-~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l  224 (242)
T d1xwdc1         146 NSFVGLSFESVILWLNKNGIQEIHNCAFN-GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENL  224 (242)
T ss_dssp             TSSTTSBSSCEEEECCSSCCCEECTTTTT-TCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTC
T ss_pred             cccccccccceeeeccccccccccccccc-chhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCC
Confidence            4444443 555566666666543333332 2333 233455555655444555666666666666666665555555555


Q ss_pred             ccceEEEcc
Q 039137          517 HGLLHIDIS  525 (912)
Q Consensus       517 ~~L~~l~ls  525 (912)
                      +.|+.+++.
T Consensus       225 ~~L~~l~~~  233 (242)
T d1xwdc1         225 KKLRARSTY  233 (242)
T ss_dssp             CEEESSSEE
T ss_pred             cccccCcCC
Confidence            555555543

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.76  E-value=6.9e-19  Score=173.57  Aligned_cols=177  Identities=22%  Similarity=0.244  Sum_probs=125.3

Q ss_pred             CEEeccCCcccccccccccccccccEEEccCccccCC-CCccccccccccEEEccCCcccCCCccccccccccccccccC
Q 039137          352 SLLDVSINNISGSIPLEIGESLQLQYLDLSSNYIVGE-IPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSA  430 (912)
Q Consensus       352 ~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~-~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~  430 (912)
                      +.++.++++++ .+|..+.  +++++|+|++|+|++. .+..|.++++|+.|+|++|++....+..+..+++|++|+|++
T Consensus        11 ~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~   87 (192)
T d1w8aa_          11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence            34556666665 4454442  4677777777777653 355667778888888888888777777788888888888888


Q ss_pred             cccCccccccccccccccEEEecccccccccchhhhcccccceeeccccccCcccccccccccccccccccCccccCCCc
Q 039137          431 NNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIP  510 (912)
Q Consensus       431 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p  510 (912)
                      |+|+.+.|..|.++++|++|+|++|+|+++.+..|..+++|++|+|++|.+....... .-...++.+.+..|.++...|
T Consensus        88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~-~~~~~l~~~~l~~~~~~c~~p  166 (192)
T d1w8aa_          88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA-WFAEWLRKKSLNGGAARCGAP  166 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGH-HHHHHHHHHCCSGGGCBBCSS
T ss_pred             ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchH-HHhhhhhhhcccCCCeEeCCC
Confidence            8888877778888888888888888888777777888888888888888876543221 112346677778888877666


Q ss_pred             ccccccccceEEEccCCccccCCCC
Q 039137          511 RCFEEMHGLLHIDISYNKLEGQIPN  535 (912)
Q Consensus       511 ~~~~~l~~L~~l~ls~N~l~~~~~~  535 (912)
                      ..+   ..++.++++.|.+.|..+.
T Consensus       167 ~~l---~~~~l~~L~~n~l~C~~~~  188 (192)
T d1w8aa_         167 SKV---RDVQIKDLPHSEFKCSSEN  188 (192)
T ss_dssp             TTT---TTSBGGGSCTTTCCCCCC-
T ss_pred             hhh---cCCEeeecCHhhCcCCCCC
Confidence            554   4455677888888876554

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.73  E-value=9.2e-18  Score=167.90  Aligned_cols=185  Identities=25%  Similarity=0.287  Sum_probs=104.1

Q ss_pred             cccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCcccccccCCCCCCCCEEec
Q 039137          277 KKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDV  356 (912)
Q Consensus       277 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  356 (912)
                      .++....++.+.+++.++.  ..+.+|++|++++|.++...  .+..+++|++|+|++|++++..  .++.+++|+.|++
T Consensus        24 ~~~i~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l   97 (210)
T d1h6ta2          24 AETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFL   97 (210)
T ss_dssp             HHHHHHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEEC
T ss_pred             HHHHHHHhCcCccCCccCH--HHhcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCcccccccc
Confidence            3444556666666654432  34667777777777776532  3566777777777777776533  2456666666666


Q ss_pred             cCCcccccccccccccccccEEEccCccccCCCCccccccccccEEEccCCcccCCCccccccccccccccccCcccCcc
Q 039137          357 SINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNF  436 (912)
Q Consensus       357 s~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  436 (912)
                      ++|+|++ ++ .+..+++|+.|++++|.+..  ...+..++.++.+++++|.+++  +..+..+++|+++++++|+++++
T Consensus        98 ~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~~--~~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i  171 (210)
T d1h6ta2          98 DENKVKD-LS-SLKDLKKLKSLSLEHNGISD--INGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDI  171 (210)
T ss_dssp             CSSCCCC-GG-GGTTCTTCCEEECTTSCCCC--CGGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCC
T ss_pred             ccccccc-cc-cccccccccccccccccccc--cccccccccccccccccccccc--ccccccccccccccccccccccc
Confidence            6666653 23 35556666666666666542  2235555556666666665553  12344455555555555555543


Q ss_pred             ccccccccccccEEEecccccccccchhhhcccccceeecc
Q 039137          437 VPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLS  477 (912)
Q Consensus       437 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  477 (912)
                      .  .+.++++|+.|+|++|+|+. +| .+.++++|++|+|+
T Consensus       172 ~--~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls  208 (210)
T d1h6ta2         172 V--PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELF  208 (210)
T ss_dssp             G--GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEE
T ss_pred             c--cccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEcc
Confidence            2  24555555555555555542 22 35555555555554

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.73  E-value=4.6e-18  Score=167.58  Aligned_cols=167  Identities=23%  Similarity=0.245  Sum_probs=88.1

Q ss_pred             cCCcccccCCccccCCCCCcEEecccccccccc-ccccccccccceeecccccccCCCCccccCcccccEEEccCCcCCC
Q 039137          117 YNNELFGIIPPQISNLSNLEYLDFSANKLFGQI-PSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNG  195 (912)
Q Consensus       117 ~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~-p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~  195 (912)
                      ++++++ .+|..+.  +++++|+|++|+|++.+ +..|+++++|++|+|++|.+.+..+..+..+++|++|+|++|+|++
T Consensus        16 s~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~   92 (192)
T d1w8aa_          16 TGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKE   92 (192)
T ss_dssp             TTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCE
T ss_pred             eCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccc
Confidence            334444 3444432  45566666666665433 3445556666666666666665555556666666666666666665


Q ss_pred             CCCccCCCCccceeeeeccCCCcCccccccccccccceeecccccccCccccccccccccceeeeccccCcccCCcccCC
Q 039137          196 SIPRSLGNLTHVVILYLYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGN  275 (912)
Q Consensus       196 ~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~  275 (912)
                      ..|..|.++++|++|+|++|+|++..|+.|..+++|++|+|++|.+....+.. .-...++.+.+..|.++...|..+  
T Consensus        93 l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~-~~~~~l~~~~l~~~~~~c~~p~~l--  169 (192)
T d1w8aa_          93 ISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA-WFAEWLRKKSLNGGAARCGAPSKV--  169 (192)
T ss_dssp             ECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGH-HHHHHHHHHCCSGGGCBBCSSTTT--
T ss_pred             cCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchH-HHhhhhhhhcccCCCeEeCCChhh--
Confidence            45555666666666666666666555555555555666666555554322111 111224444555555554444332  


Q ss_pred             ccccchhhhccCccC
Q 039137          276 LKKLNSLLLAKNHFR  290 (912)
Q Consensus       276 l~~L~~L~L~~N~l~  290 (912)
                       .+++.++|+.|.+.
T Consensus       170 -~~~~l~~L~~n~l~  183 (192)
T d1w8aa_         170 -RDVQIKDLPHSEFK  183 (192)
T ss_dssp             -TTSBGGGSCTTTCC
T ss_pred             -cCCEeeecCHhhCc
Confidence             34445556655554

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.72  E-value=1e-17  Score=166.06  Aligned_cols=169  Identities=28%  Similarity=0.332  Sum_probs=85.5

Q ss_pred             ccccchhhhccCccCCCCccccccccccceEecccccccCCCCcccCCCCCccEEEccCCcCcccccccCCCCCCCCEEe
Q 039137          276 LKKLNSLLLAKNHFRGTVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLD  355 (912)
Q Consensus       276 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  355 (912)
                      +++...+.++.+.+++.++  ...+.+|++|++++|.++..  +.+..+++|++|+|++|++++..+  ++++++|+.|+
T Consensus        17 l~~~i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~   90 (199)
T d2omxa2          17 LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDIL   90 (199)
T ss_dssp             HHHHHHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred             HHHHHHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCccccccc
Confidence            4455566677776665432  34566777777777776642  235556666666666666654332  55555666666


Q ss_pred             ccCCcccccccccccccccccEEEccCccccCCCCccccccccccEEEccCCcccCCCccccccccccccccccCcccCc
Q 039137          356 VSINNISGSIPLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSN  435 (912)
Q Consensus       356 Ls~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  435 (912)
                      +++|.+... + .+.++++|+.|++++|.+...  ..+..+++|+.|++++|++.. ++ .+..+++|++|++++|++++
T Consensus        91 l~~n~~~~~-~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~~-~l~~~~~L~~L~l~~n~l~~  164 (199)
T d2omxa2          91 MNNNQIADI-T-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLNFSSNQVTD  164 (199)
T ss_dssp             CCSSCCCCC-G-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCC
T ss_pred             ccccccccc-c-ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhcc-cc-cccccccccccccccccccC
Confidence            655555422 1 244455555555555554421  223444444444444444432 11 23444444444444444443


Q ss_pred             cccccccccccccEEEecccccc
Q 039137          436 FVPESLGSLVKLYYLNLSHNKLS  458 (912)
Q Consensus       436 ~~~~~~~~l~~L~~L~Ls~N~l~  458 (912)
                      +.  .+.++++|++|++++|+++
T Consensus       165 l~--~l~~l~~L~~L~ls~N~i~  185 (199)
T d2omxa2         165 LK--PLANLTTLERLDISSNKVS  185 (199)
T ss_dssp             CG--GGTTCTTCCEEECCSSCCC
T ss_pred             Cc--cccCCCCCCEEECCCCCCC
Confidence            21  2344444444444444443

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.72  E-value=7.7e-18  Score=168.49  Aligned_cols=164  Identities=26%  Similarity=0.373  Sum_probs=76.9

Q ss_pred             CCCCcEEeccccccccccccccccccccceeecccccccCCCCccccCcccccEEEccCCcCCCCCCccCCCCccceeee
Q 039137          132 LSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILY  211 (912)
Q Consensus       132 l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~  211 (912)
                      +.+|++|++++|++++ ++ .+..+++|++|+|++|++++ ++ .++.+++|++|++++|++++ +| .+.++++|+.|+
T Consensus        45 L~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~  118 (210)
T d1h6ta2          45 LNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLS  118 (210)
T ss_dssp             HHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEE
T ss_pred             hcCccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccC-cc-ccccCccccccccccccccc-cc-cccccccccccc
Confidence            4455555555555542 22 24455555555555555543 22 23445555555555555442 22 244444444444


Q ss_pred             eccCCCcCccccccccccccceeecccccccCccccccccccccceeeeccccCcccCCcccCCccccchhhhccCccCC
Q 039137          212 LYNNSFFGSIPQEIGNLKSLFDLELCINQLSGAIPLSISNLTNLRFLFLYHNELSGIIPQEIGNLKKLNSLLLAKNHFRG  291 (912)
Q Consensus       212 L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~  291 (912)
                      +++|.+..  ..                        .+..+++|+.+++++|.+++.  ..+..+++|+.+++++|++++
T Consensus       119 l~~~~~~~--~~------------------------~l~~l~~l~~l~~~~n~l~~~--~~~~~l~~L~~l~l~~n~l~~  170 (210)
T d1h6ta2         119 LEHNGISD--IN------------------------GLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISD  170 (210)
T ss_dssp             CTTSCCCC--CG------------------------GGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCC
T ss_pred             cccccccc--cc------------------------ccccccccccccccccccccc--ccccccccccccccccccccc
Confidence            44444431  11                        244444455555555544421  233444455555555555543


Q ss_pred             CCccccccccccceEecccccccCCCCcccCCCCCccEEEcc
Q 039137          292 TVPKSFRNLTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLS  333 (912)
Q Consensus       292 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls  333 (912)
                      . + .+.++++|++|+|++|+++.. + .+..+++|++|+|+
T Consensus       171 i-~-~l~~l~~L~~L~Ls~N~i~~l-~-~l~~l~~L~~L~Ls  208 (210)
T d1h6ta2         171 I-V-PLAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELF  208 (210)
T ss_dssp             C-G-GGTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEE
T ss_pred             c-c-cccCCCCCCEEECCCCCCCCC-h-hhcCCCCCCEEEcc
Confidence            2 1 245555555555555555532 2 35555555555554

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.70  E-value=8.2e-18  Score=166.78  Aligned_cols=170  Identities=26%  Similarity=0.356  Sum_probs=92.7

Q ss_pred             ccccceEecccccccCCCCcccCCCCCccEEEccCCcCcccccccCCCCCCCCEEeccCCcccccccccccccccccEEE
Q 039137          300 LTDLVKLRLNQNYLTGNISETFGTYPNLTFIDLSNNSFFGEILSDWGRCPQLSLLDVSINNISGSIPLEIGESLQLQYLD  379 (912)
Q Consensus       300 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~  379 (912)
                      +.+...+.++.+.+++.++.  ..++++++|++++|.+...  ..++.+++|++|++++|++++..|  ++++++|++|+
T Consensus        17 l~~~i~~~l~~~~~~~~~~~--~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~   90 (199)
T d2omxa2          17 LAEKMKTVLGKTNVTDTVSQ--TDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDIL   90 (199)
T ss_dssp             HHHHHHHHTTCSSTTSEECH--HHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred             HHHHHHHHhCCCCCCCccCH--HHhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCccccccc
Confidence            44455566777777654332  3466777888888777542  235556666666666666654332  55666666666


Q ss_pred             ccCccccCCCCccccccccccEEEccCCcccCCCccccccccccccccccCcccCccccccccccccccEEEeccccccc
Q 039137          380 LSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQ  459 (912)
Q Consensus       380 L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  459 (912)
                      +++|.+.. ++ .+.+++.|+.|++++|.+...  ..+..+++|+.|++++|++..+  ..+..+++|++|++++|++++
T Consensus        91 l~~n~~~~-~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~--~~l~~~~~L~~L~l~~n~l~~  164 (199)
T d2omxa2          91 MNNNQIAD-IT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQVTD  164 (199)
T ss_dssp             CCSSCCCC-CG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC
T ss_pred             cccccccc-cc-ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhccc--ccccccccccccccccccccC
Confidence            66666553 22 255555566666655555432  2244555555555555555432  234455555555555555543


Q ss_pred             ccchhhhcccccceeeccccccCc
Q 039137          460 QIPIELDNLIHLSELDLSHNFLGE  483 (912)
Q Consensus       460 ~~~~~~~~l~~L~~L~Ls~N~l~~  483 (912)
                      ..  .+.++++|++|++++|+|++
T Consensus       165 l~--~l~~l~~L~~L~ls~N~i~~  186 (199)
T d2omxa2         165 LK--PLANLTTLERLDISSNKVSD  186 (199)
T ss_dssp             CG--GGTTCTTCCEEECCSSCCCC
T ss_pred             Cc--cccCCCCCCEEECCCCCCCC
Confidence            21  24455555555555555543

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.54  E-value=3.8e-16  Score=163.78  Aligned_cols=61  Identities=26%  Similarity=0.328  Sum_probs=30.8

Q ss_pred             CCCCccEEEccCC-cCcccccccCCCCCCCCEEeccCC-cccccccccccccccccEEEccCc
Q 039137          323 TYPNLTFIDLSNN-SFFGEILSDWGRCPQLSLLDVSIN-NISGSIPLEIGESLQLQYLDLSSN  383 (912)
Q Consensus       323 ~l~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~~~~L~~L~L~~N  383 (912)
                      .+++|++|++++| .+++..+..+.++++|++|++++| .++......++++++|++|+++++
T Consensus       173 ~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~  235 (284)
T d2astb2         173 RCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI  235 (284)
T ss_dssp             HCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred             ccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence            3445555555443 234444444555555555555552 344444444555556666666655

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.53  E-value=4.5e-15  Score=140.76  Aligned_cols=127  Identities=21%  Similarity=0.209  Sum_probs=68.0

Q ss_pred             cccccccEEEccCCcccCCCccccccccccccccccCcccCccccccccccccccEEEecccccccccchhhhcccccce
Q 039137          394 GNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSE  473 (912)
Q Consensus       394 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  473 (912)
                      .+...+++|+|++|+|+ .++..+..+++|+.|+|++|+|+.+  +.|..+++|++|++++|+++...+..+..+++|+.
T Consensus        15 ~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~   91 (162)
T d1a9na_          15 TNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE   91 (162)
T ss_dssp             ECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCE
T ss_pred             cCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCcccccccccccc
Confidence            34444555555555555 2344444555555555555555543  23555556666666666665444444455566666


Q ss_pred             eeccccccCcccc-cccccccccccccccCccccCCC---cccccccccceEEE
Q 039137          474 LDLSHNFLGEKIS-SRICRMESLEKLNLSYNNLSGLI---PRCFEEMHGLLHID  523 (912)
Q Consensus       474 L~Ls~N~l~~~~~-~~~~~l~~L~~L~ls~N~l~~~~---p~~~~~l~~L~~l~  523 (912)
                      |++++|+|+.... ..+..+++|+.|++++|+++...   +..+..+++|+.||
T Consensus        92 L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          92 LILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             EECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred             ceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence            6666666654322 34555666666666666665432   12455566666665

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.53  E-value=1.2e-15  Score=160.02  Aligned_cols=92  Identities=22%  Similarity=0.202  Sum_probs=51.3

Q ss_pred             ccccccccccccCc-ccCccccccccccccccEEEeccc-ccccccchhhhcccccceeeccccccCcc-cccccccccc
Q 039137          418 GSLINLEYLDLSAN-NLSNFVPESLGSLVKLYYLNLSHN-KLSQQIPIELDNLIHLSELDLSHNFLGEK-ISSRICRMES  494 (912)
Q Consensus       418 ~~l~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~  494 (912)
                      ..+++|++|++++| .+++.....+..+++|++|+|++| .+++.....+.++++|+.|+++++ ++.. .....   ..
T Consensus       172 ~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~d~~l~~l~---~~  247 (284)
T d2astb2         172 RRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPDGTLQLLK---EA  247 (284)
T ss_dssp             HHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCTTCHHHHH---HH
T ss_pred             cccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC-CCHHHHHHHH---Hh
Confidence            34566666666664 355555555666667777777663 465555555666677777777666 3221 11111   22


Q ss_pred             cccccccCccccCCCcccc
Q 039137          495 LEKLNLSYNNLSGLIPRCF  513 (912)
Q Consensus       495 L~~L~ls~N~l~~~~p~~~  513 (912)
                      +..|.+..+++++..+..+
T Consensus       248 lp~L~i~~~~ls~~~~~~~  266 (284)
T d2astb2         248 LPHLQINCSHFTTIARPTI  266 (284)
T ss_dssp             STTSEESCCCSCCTTCSSC
T ss_pred             CccccccCccCCCCCCCcc
Confidence            3344556666766655444

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.52  E-value=9.3e-16  Score=166.02  Aligned_cols=186  Identities=20%  Similarity=0.268  Sum_probs=105.6

Q ss_pred             CCCCCCCEEeccCCccccc----ccccccccccccEEEccCccccCCCCc-------------cccccccccEEEccCCc
Q 039137          346 GRCPQLSLLDVSINNISGS----IPLEIGESLQLQYLDLSSNYIVGEIPT-------------QLGNIIYLNRLSLSGNK  408 (912)
Q Consensus       346 ~~l~~L~~L~Ls~N~l~~~----~~~~~~~~~~L~~L~L~~N~l~~~~~~-------------~l~~l~~L~~L~L~~N~  408 (912)
                      ..+++|+.|+|++|.+...    +...+...++|++|++++|.+......             .....+.|+.+.+++|+
T Consensus        90 ~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~  169 (344)
T d2ca6a1          90 LKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNR  169 (344)
T ss_dssp             TTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSC
T ss_pred             hhCCCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeeccccc
Confidence            3445555555555555432    222233344555555555554321000             01234456677777776


Q ss_pred             ccCC----CccccccccccccccccCcccCcc-----ccccccccccccEEEecccccccc----cchhhhcccccceee
Q 039137          409 LSGC----IPRELGSLINLEYLDLSANNLSNF-----VPESLGSLVKLYYLNLSHNKLSQQ----IPIELDNLIHLSELD  475 (912)
Q Consensus       409 l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~-----~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~  475 (912)
                      ++..    +...+...+.|+.|+|++|.+...     ....+..+++|+.|+|++|.++..    +...+...++|++|+
T Consensus       170 i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~  249 (344)
T d2ca6a1         170 LENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELG  249 (344)
T ss_dssp             CTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEE
T ss_pred             ccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhh
Confidence            6532    223344566777777777777532     234456667778888888777532    344556677788888


Q ss_pred             ccccccCccccccc----cc--ccccccccccCccccCCC----ccccc-ccccceEEEccCCcccc
Q 039137          476 LSHNFLGEKISSRI----CR--MESLEKLNLSYNNLSGLI----PRCFE-EMHGLLHIDISYNKLEG  531 (912)
Q Consensus       476 Ls~N~l~~~~~~~~----~~--l~~L~~L~ls~N~l~~~~----p~~~~-~l~~L~~l~ls~N~l~~  531 (912)
                      |++|.|++.....+    ..  .+.|+.|++++|+|+...    ...+. +.+.|+.|++++|++..
T Consensus       250 Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~  316 (344)
T d2ca6a1         250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE  316 (344)
T ss_dssp             CTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred             hhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence            88887765433222    22  356788888888876432    22232 46678888888888753

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.51  E-value=9e-15  Score=138.67  Aligned_cols=128  Identities=20%  Similarity=0.149  Sum_probs=81.1

Q ss_pred             ccccccccEEEccCccccCCCCccccccccccEEEccCCcccCCCccccccccccccccccCcccCcccccccccccccc
Q 039137          369 IGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLY  448 (912)
Q Consensus       369 ~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  448 (912)
                      +.+..++++|+|++|+|+ .++..+..+++|+.|+|++|+|+. ++ .+..+++|++|++++|+++.+.+..+..+++|+
T Consensus        14 ~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~   90 (162)
T d1a9na_          14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT   90 (162)
T ss_dssp             EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred             ccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCc-cC-CcccCcchhhhhcccccccCCCccccccccccc
Confidence            344556666666666666 345555566667777777776663 32 366667777777777777765555556677777


Q ss_pred             EEEecccccccccc-hhhhcccccceeeccccccCccc---cccccccccccccc
Q 039137          449 YLNLSHNKLSQQIP-IELDNLIHLSELDLSHNFLGEKI---SSRICRMESLEKLN  499 (912)
Q Consensus       449 ~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~---~~~~~~l~~L~~L~  499 (912)
                      .|++++|+|+.... ..+..+++|++|++++|+++...   +..+..+++|+.||
T Consensus        91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred             cceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence            77777777754321 35667777777777777775432   23466777777776

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.50  E-value=6e-16  Score=167.53  Aligned_cols=113  Identities=24%  Similarity=0.221  Sum_probs=59.7

Q ss_pred             ccccccEEEccCCcccCC-----CccccccccccccccccCcccCcc----ccccccccccccEEEecccccccccchh-
Q 039137          395 NIIYLNRLSLSGNKLSGC-----IPRELGSLINLEYLDLSANNLSNF----VPESLGSLVKLYYLNLSHNKLSQQIPIE-  464 (912)
Q Consensus       395 ~l~~L~~L~L~~N~l~~~-----~p~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~-  464 (912)
                      ....|+.|+|++|+++..     +...+..+++|+.|+|++|.++..    +...+..+++|++|+|++|+|++..... 
T Consensus       184 ~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l  263 (344)
T d2ca6a1         184 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAV  263 (344)
T ss_dssp             HCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHH
T ss_pred             hhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHH
Confidence            344455555555554421     223344555666666666665432    2234455666666666666665432222 


Q ss_pred             ---hhc--ccccceeeccccccCccc----ccccc-cccccccccccCccccC
Q 039137          465 ---LDN--LIHLSELDLSHNFLGEKI----SSRIC-RMESLEKLNLSYNNLSG  507 (912)
Q Consensus       465 ---~~~--l~~L~~L~Ls~N~l~~~~----~~~~~-~l~~L~~L~ls~N~l~~  507 (912)
                         +..  .+.|++|++++|+|+...    ...+. ++++|+.|+|++|++..
T Consensus       264 ~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~  316 (344)
T d2ca6a1         264 VDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE  316 (344)
T ss_dssp             HHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred             HHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence               222  245677777777765422    22222 45667777777777764

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.50  E-value=1.8e-14  Score=129.70  Aligned_cols=102  Identities=30%  Similarity=0.378  Sum_probs=59.5

Q ss_pred             cEEEccCCcccccCCccccCCCCCcEEeccccccccccccccccccccceeecccccccCCCCccccCcccccEEEccCC
Q 039137          112 VYLDLYNNELFGIIPPQISNLSNLEYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSN  191 (912)
Q Consensus       112 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n  191 (912)
                      ++|||++|+++ .+| .++++++|++|||++|+|+ .+|+.++.+++|++|++++|+++ .+| .++.+++|++|++++|
T Consensus         1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN   75 (124)
T ss_dssp             SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence            35667777776 333 3666667777777777765 45666666666777777766666 333 3556666666666666


Q ss_pred             cCCCCC-CccCCCCccceeeeeccCCCc
Q 039137          192 FLNGSI-PRSLGNLTHVVILYLYNNSFF  218 (912)
Q Consensus       192 ~l~~~~-p~~~~~l~~L~~L~L~~n~l~  218 (912)
                      +++... ...+.++++|++|++++|.++
T Consensus        76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~  103 (124)
T d1dcea3          76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC  103 (124)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred             ccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence            655221 123444555555555555443

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.50  E-value=2.5e-14  Score=128.83  Aligned_cols=102  Identities=26%  Similarity=0.293  Sum_probs=75.1

Q ss_pred             cEEeccccccccccccccccccccceeecccccccCCCCccccCcccccEEEccCCcCCCCCCccCCCCccceeeeeccC
Q 039137          136 EYLDFSANKLFGQIPSGIGLLTHLTVLHISRNWLSGSIPHEVGQLTVLNQLALDSNFLNGSIPRSLGNLTHVVILYLYNN  215 (912)
Q Consensus       136 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n  215 (912)
                      |+|||++|+++ .+| .++.+++|++|++++|+++ .+|+.++.+++|++|++++|+|+. +| .++++++|++|++++|
T Consensus         1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN   75 (124)
T ss_dssp             SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence            57888898887 555 4888888888888888887 677788888888888888888873 44 4777777777777777


Q ss_pred             CCcCcc-ccccccccccceeeccccccc
Q 039137          216 SFFGSI-PQEIGNLKSLFDLELCINQLS  242 (912)
Q Consensus       216 ~l~~~~-p~~~~~l~~L~~L~l~~n~l~  242 (912)
                      +++... ...++.+++|+.|++++|+++
T Consensus        76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~  103 (124)
T d1dcea3          76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC  103 (124)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred             ccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence            776432 234566666666666666654

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.37  E-value=2e-14  Score=141.18  Aligned_cols=129  Identities=22%  Similarity=0.268  Sum_probs=70.2

Q ss_pred             CccccccccccEEEccCCcccCCCccccccccccccccccCcccCccccccccccccccEEEecccccccccchhhhccc
Q 039137          390 PTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHNKLSQQIPIELDNLI  469 (912)
Q Consensus       390 ~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  469 (912)
                      +..+..+++|++|+|++|+|+. ++ .+..+++|++|+|++|.|+. +|..+..+++|+.|++++|+|+..  ..+..++
T Consensus        41 ~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~~-i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~  115 (198)
T d1m9la_          41 DATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIASL--SGIEKLV  115 (198)
T ss_dssp             HHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEECS-CSSHHHHHHHCCEEECSEEECCCH--HHHHHHH
T ss_pred             hhHHhcccccceeECcccCCCC-cc-cccCCccccChhhccccccc-cccccccccccccccccccccccc--ccccccc
Confidence            3445555555555555555552 22 35555566666666666554 233334445566666666666532  2355566


Q ss_pred             ccceeeccccccCcccc-cccccccccccccccCccccCCCccc----------ccccccceEEE
Q 039137          470 HLSELDLSHNFLGEKIS-SRICRMESLEKLNLSYNNLSGLIPRC----------FEEMHGLLHID  523 (912)
Q Consensus       470 ~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~ls~N~l~~~~p~~----------~~~l~~L~~l~  523 (912)
                      +|+.|++++|+|++... ..+..+++|+.|++++|+++...+..          +..+++|+.||
T Consensus       116 ~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD  180 (198)
T d1m9la_         116 NLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD  180 (198)
T ss_dssp             HSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred             cccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence            66666666666654322 34556666666666666655433321          45567777765

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.36  E-value=3e-14  Score=139.94  Aligned_cols=134  Identities=27%  Similarity=0.243  Sum_probs=87.5

Q ss_pred             cccccccccccEEEccCccccCCCCccccccccccEEEccCCcccCCCccccccccccccccccCcccCccccccccccc
Q 039137          366 PLEIGESLQLQYLDLSSNYIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLV  445 (912)
Q Consensus       366 ~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  445 (912)
                      +..+..+++|++|+|++|+|+. ++ .+.++++|+.|+|++|+++ .+|..+..+++|++|++++|+++.+  ..+..++
T Consensus        41 ~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~  115 (198)
T d1m9la_          41 DATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKLV  115 (198)
T ss_dssp             HHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHHHH
T ss_pred             hhHHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-ccccccccccccccccccccccccc--ccccccc
Confidence            3445566667777777777763 33 4666777777777777776 3455455556777777777777764  2466777


Q ss_pred             cccEEEecccccccccc-hhhhcccccceeeccccccCcccccc----------cccccccccccccCcccc
Q 039137          446 KLYYLNLSHNKLSQQIP-IELDNLIHLSELDLSHNFLGEKISSR----------ICRMESLEKLNLSYNNLS  506 (912)
Q Consensus       446 ~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~----------~~~l~~L~~L~ls~N~l~  506 (912)
                      +|+.|+|++|+|+.... ..+..+++|+.|+|++|++....+..          +..+++|+.||  +..++
T Consensus       116 ~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD--~~~I~  185 (198)
T d1m9la_         116 NLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD  185 (198)
T ss_dssp             HSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES--SGGGT
T ss_pred             cccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC--CccCC
Confidence            77777777777764322 45677777778888777775543322          56678888876  44554

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.28  E-value=4e-12  Score=119.21  Aligned_cols=103  Identities=25%  Similarity=0.227  Sum_probs=49.4

Q ss_pred             EEEccCccccCCCCccccccccccEEEccCC-cccCCCccccccccccccccccCcccCccccccccccccccEEEeccc
Q 039137          377 YLDLSSNYIVGEIPTQLGNIIYLNRLSLSGN-KLSGCIPRELGSLINLEYLDLSANNLSNFVPESLGSLVKLYYLNLSHN  455 (912)
Q Consensus       377 ~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  455 (912)
                      .++.+++.+. ..|..+..+++|++|++++| .++...+..|.++++|+.|+|++|+|+.+.+..|..+++|++|+|++|
T Consensus        12 ~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N   90 (156)
T d2ifga3          12 GLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN   90 (156)
T ss_dssp             CEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred             eEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCC
Confidence            3444444444 33444444455555555433 244333444555555555555555555554555555555555555555


Q ss_pred             ccccccchhhhcccccceeecccccc
Q 039137          456 KLSQQIPIELDNLIHLSELDLSHNFL  481 (912)
Q Consensus       456 ~l~~~~~~~~~~l~~L~~L~Ls~N~l  481 (912)
                      +|+...+..|.. .+|+.|+|++|.+
T Consensus        91 ~l~~l~~~~~~~-~~l~~L~L~~Np~  115 (156)
T d2ifga3          91 ALESLSWKTVQG-LSLQELVLSGNPL  115 (156)
T ss_dssp             CCSCCCSTTTCS-CCCCEEECCSSCC
T ss_pred             CCcccChhhhcc-ccccccccCCCcc
Confidence            554333333322 2455555555555

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.25  E-value=9.7e-12  Score=116.52  Aligned_cols=107  Identities=21%  Similarity=0.115  Sum_probs=82.2

Q ss_pred             CCCEEeccCCcccccccccccccccccEEEccCc-cccCCCCccccccccccEEEccCCcccCCCccccccccccccccc
Q 039137          350 QLSLLDVSINNISGSIPLEIGESLQLQYLDLSSN-YIVGEIPTQLGNIIYLNRLSLSGNKLSGCIPRELGSLINLEYLDL  428 (912)
Q Consensus       350 ~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L~~N-~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  428 (912)
                      ..+.++.+++++. ..|..+..+++|++|++++| .|+...+..|.++++|+.|+|++|+|+...|.+|..+++|++|+|
T Consensus         9 ~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L   87 (156)
T d2ifga3           9 GSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNL   87 (156)
T ss_dssp             SSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEEC
T ss_pred             CCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceec
Confidence            3445666666665 45666667778888888765 477666667888888888888888888777888888899999999


Q ss_pred             cCcccCccccccccccccccEEEecccccc
Q 039137          429 SANNLSNFVPESLGSLVKLYYLNLSHNKLS  458 (912)
Q Consensus       429 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  458 (912)
                      ++|+|+.+.+..|..+ +|+.|+|++|++.
T Consensus        88 s~N~l~~l~~~~~~~~-~l~~L~L~~Np~~  116 (156)
T d2ifga3          88 SFNALESLSWKTVQGL-SLQELVLSGNPLH  116 (156)
T ss_dssp             CSSCCSCCCSTTTCSC-CCCEEECCSSCCC
T ss_pred             cCCCCcccChhhhccc-cccccccCCCccc
Confidence            9999988766666654 6999999999884

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.54  E-value=3.5e-09  Score=99.50  Aligned_cols=83  Identities=29%  Similarity=0.260  Sum_probs=47.2

Q ss_pred             ccccccccEEEecccccccc--cchhhhcccccceeeccccccCcccccccccccccccccccCccccCCCcc-------
Q 039137          441 LGSLVKLYYLNLSHNKLSQQ--IPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPR-------  511 (912)
Q Consensus       441 ~~~l~~L~~L~Ls~N~l~~~--~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~-------  511 (912)
                      +..++.|++|+|++|+|+..  ++..+..+++|+.|+|++|.|+...+-.+.....|+.|++++|++++....       
T Consensus        61 ~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~  140 (162)
T d1koha1          61 EENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISA  140 (162)
T ss_dssp             HHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHH
T ss_pred             HHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHH
Confidence            34455666666666666543  233455566666666666666554443333444566677777776654332       


Q ss_pred             cccccccceEEE
Q 039137          512 CFEEMHGLLHID  523 (912)
Q Consensus       512 ~~~~l~~L~~l~  523 (912)
                      .+..+|+|+.||
T Consensus       141 i~~~~P~L~~LD  152 (162)
T d1koha1         141 IRERFPKLLRLD  152 (162)
T ss_dssp             HHTTSTTCCEET
T ss_pred             HHHHCCCCCEEC
Confidence            245567777765

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.52  E-value=6.8e-09  Score=97.41  Aligned_cols=86  Identities=26%  Similarity=0.220  Sum_probs=49.9

Q ss_pred             ccccccccccccccccCcccCccc--cccccccccccEEEecccccccccchhhhcccccceeeccccccCcccc-----
Q 039137          414 PRELGSLINLEYLDLSANNLSNFV--PESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKIS-----  486 (912)
Q Consensus       414 p~~~~~l~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-----  486 (912)
                      +..+..+++|++|+|++|+|+.+.  +..+..+++|+.|+|++|+|+...+..+....+|+.|++++|++.....     
T Consensus        58 ~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y  137 (162)
T d1koha1          58 RIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTY  137 (162)
T ss_dssp             HHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHH
T ss_pred             HHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhH
Confidence            334445666777777777776542  2345566677777777777764433334444556777777776654432     


Q ss_pred             --ccccccccccccc
Q 039137          487 --SRICRMESLEKLN  499 (912)
Q Consensus       487 --~~~~~l~~L~~L~  499 (912)
                        ..+..+|+|+.||
T Consensus       138 ~~~i~~~~P~L~~LD  152 (162)
T d1koha1         138 ISAIRERFPKLLRLD  152 (162)
T ss_dssp             HHHHHTTSTTCCEET
T ss_pred             HHHHHHHCCCCCEEC
Confidence              2244566666665

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.45  E-value=3.4e-07  Score=93.20  Aligned_cols=150  Identities=14%  Similarity=0.112  Sum_probs=105.8

Q ss_pred             HHHHHHhcCCCCCceeeecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcC-CCccccEEEEEEc
Q 039137          631 EEIISATNDFNAEHCIGKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR-HRNIVKFYGFCSH  709 (912)
Q Consensus       631 ~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~  709 (912)
                      .|+...-..|+..+..+.++.+.||+... +++.+++|+.......    ....+.+|...+..+. +--+.+++.+...
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~----~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~   81 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKG----TTYDVEREKDMMLWLEGKLPVPKVLHFERH   81 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTT----STTCHHHHHHHHHHHTTTSCCCCEEEEEEE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCccc----chhhHHHHHHHHHHHhccCCCCcEEEEEec
Confidence            35556667777766655566678999875 5666788887543222    1234567888888874 4457888999888


Q ss_pred             CCeeeEEEeecCCCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCC---------------------------
Q 039137          710 PKHSFIIYEYLESGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNCF---------------------------  762 (912)
Q Consensus       710 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~---------------------------  762 (912)
                      ++..++||++++|.++.+....        ......++.++++.++.||+...                           
T Consensus        82 ~~~~~lv~~~l~G~~~~~~~~~--------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (263)
T d1j7la_          82 DGWSNLLMSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADV  153 (263)
T ss_dssp             TTEEEEEEECCSSEEHHHHTTT--------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCC
T ss_pred             CCceEEEEEecccccccccccc--------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhh
Confidence            8999999999999887655411        12234456677777777775320                           


Q ss_pred             -----------------------------CCeeecCCCCCCeEEcCCCcEEEeccccccc
Q 039137          763 -----------------------------PPIVHRDISSKNVLLDLGYEAHVSDFGIAKF  793 (912)
Q Consensus       763 -----------------------------~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  793 (912)
                                                   +.++|+|+.|.||++++++.+-+.||+.+..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         154 DCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             CGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             hhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                         1379999999999999876677999998863

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.01  E-value=9.9e-06  Score=81.49  Aligned_cols=131  Identities=17%  Similarity=0.136  Sum_probs=87.4

Q ss_pred             eeeecCc-eEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcC--CCccccEEEEEEcCCeeeEEEeecC
Q 039137          645 CIGKGGH-GSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR--HRNIVKFYGFCSHPKHSFIIYEYLE  721 (912)
Q Consensus       645 ~lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~  721 (912)
                      .+..|.. +.||+...+++..+++|.......       ..+.+|...++.+.  .-.+.+++.+..+++..++||++++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~-------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~   89 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL-------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP   89 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT-------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH-------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence            4455554 689999987888889998654321       23557888887774  3346778888888889999999999


Q ss_pred             CCChhhHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 039137          722 SGSLDKILCNDASAKELGWTQRLNVIKGVADALFYLHNNC----------------------------------------  761 (912)
Q Consensus       722 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~----------------------------------------  761 (912)
                      |.++.+..        ..   ....+.++++.++-||+..                                        
T Consensus        90 G~~~~~~~--------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (255)
T d1nd4a_          90 GQDLLSSH--------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP  158 (255)
T ss_dssp             SEETTTSC--------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred             cccccccc--------cc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHH
Confidence            86553311        00   1112233333344444211                                        


Q ss_pred             ---------------CCCeeecCCCCCCeEEcCCCcEEEeccccccc
Q 039137          762 ---------------FPPIVHRDISSKNVLLDLGYEAHVSDFGIAKF  793 (912)
Q Consensus       762 ---------------~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  793 (912)
                                     .+.++|+|+.|.||+++++..+-|+||+.+..
T Consensus       159 ~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         159 AELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                           12379999999999999876678999998753

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.59  E-value=1.3e-05  Score=74.65  Aligned_cols=39  Identities=13%  Similarity=0.075  Sum_probs=17.8

Q ss_pred             cccccccccccCcccCccc----cccccccccccEEEeccccc
Q 039137          419 SLINLEYLDLSANNLSNFV----PESLGSLVKLYYLNLSHNKL  457 (912)
Q Consensus       419 ~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l  457 (912)
                      ..+.|+.|+|++|.++...    -..+...+.|++|+|++|++
T Consensus        70 ~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~  112 (167)
T d1pgva_          70 TSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQ  112 (167)
T ss_dssp             HCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSS
T ss_pred             hcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcC
Confidence            3344555555555554321    11233344555555555543

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.57  E-value=1.4e-05  Score=74.59  Aligned_cols=15  Identities=13%  Similarity=0.084  Sum_probs=8.1

Q ss_pred             cccccccEEEecccc
Q 039137          442 GSLVKLYYLNLSHNK  456 (912)
Q Consensus       442 ~~l~~L~~L~Ls~N~  456 (912)
                      ...+.|+.|+++.+.
T Consensus       128 ~~n~sL~~l~l~~~~  142 (167)
T d1pgva_         128 EENESLLRVGISFAS  142 (167)
T ss_dssp             HHCSSCCEEECCCCC
T ss_pred             HhCCCccEeeCcCCC
Confidence            334556666665543

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.47  E-value=0.00017  Score=77.14  Aligned_cols=80  Identities=15%  Similarity=0.131  Sum_probs=49.8

Q ss_pred             CceeeecCceEEEEEEeCC-CCEEEEEEccCCCC--C-CchHHHHHHHHHHHHHhhcC-C--CccccEEEEEEcCCeeeE
Q 039137          643 EHCIGKGGHGSVYRAKVPS-GEIFAVKKFHSPLP--G-EMSFQQEEFLNEIQALTEIR-H--RNIVKFYGFCSHPKHSFI  715 (912)
Q Consensus       643 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~-~~~~~~~~~~~Ei~~l~~l~-h--~niv~l~~~~~~~~~~~l  715 (912)
                      .+.||.|....||+++..+ ++.|+||.-.....  + ......++...|.+.++.+. +  ..+++++.+  +++..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            3578999999999998754 67889986432111  1 11112234557888888773 3  345566654  4556789


Q ss_pred             EEeecCCCC
Q 039137          716 IYEYLESGS  724 (912)
Q Consensus       716 v~e~~~~g~  724 (912)
                      |||++++..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997744

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.92  E-value=0.0016  Score=67.40  Aligned_cols=138  Identities=14%  Similarity=0.176  Sum_probs=79.3

Q ss_pred             cCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCcc--ccEE-----EEEEcCCeeeEEEeecC
Q 039137          649 GGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNI--VKFY-----GFCSHPKHSFIIYEYLE  721 (912)
Q Consensus       649 G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~ni--v~l~-----~~~~~~~~~~lv~e~~~  721 (912)
                      +..-.||+++.++|+.|++|+.+....     ..+++..|...+..|....+  +..+     ..+...+..+.++++++
T Consensus        33 s~EN~vy~v~~~dg~~~VlK~~rp~~~-----s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~  107 (325)
T d1zyla1          33 SYENRVYQFQDEDRRRFVVKFYRPERW-----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG  107 (325)
T ss_dssp             CSSSEEEEECCTTCCCEEEEEECTTTS-----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred             cccceeEEEEcCCCCEEEEEEeCCCCC-----CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecC
Confidence            334589999999999999999764321     24667789888888843222  1111     12244567789999998


Q ss_pred             CCChh-----hH------h---hc----c--CCccc-------------------CCHHHHHHHHHHHHHHHHHHHh---
Q 039137          722 SGSLD-----KI------L---CN----D--ASAKE-------------------LGWTQRLNVIKGVADALFYLHN---  759 (912)
Q Consensus       722 ~g~L~-----~~------l---~~----~--~~~~~-------------------l~~~~~~~i~~~i~~~L~~LH~---  759 (912)
                      |..+.     .+      +   +.    .  .....                   ++......+...+...++.+..   
T Consensus       108 G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~  187 (325)
T d1zyla1         108 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR  187 (325)
T ss_dssp             CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred             CcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhcc
Confidence            74321     10      0   00    0  00011                   1111112222222333333322   


Q ss_pred             -CCCCCeeecCCCCCCeEEcCCCcEEEeccccccc
Q 039137          760 -NCFPPIVHRDISSKNVLLDLGYEAHVSDFGIAKF  793 (912)
Q Consensus       760 -~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  793 (912)
                       ....+++|+|+.+.||+++++  ..++||+-+..
T Consensus       188 ~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         188 EDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             SCSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ccCCceeecCCCCcccEEEeCC--ceEEechhccc
Confidence             223478999999999999744  45899998864

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.87  E-value=0.00016  Score=67.03  Aligned_cols=63  Identities=17%  Similarity=0.237  Sum_probs=28.6

Q ss_pred             cccccceeeccccccCcc----ccccccccccccc--ccccCccccCC----CcccccccccceEEEccCCcc
Q 039137          467 NLIHLSELDLSHNFLGEK----ISSRICRMESLEK--LNLSYNNLSGL----IPRCFEEMHGLLHIDISYNKL  529 (912)
Q Consensus       467 ~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~--L~ls~N~l~~~----~p~~~~~l~~L~~l~ls~N~l  529 (912)
                      ..++++.|++++|.++..    +...+...++|+.  |++++|++...    +...+...+.|+.|+++.|..
T Consensus        72 ~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~  144 (166)
T d1io0a_          72 VNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ  144 (166)
T ss_dssp             HCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred             hcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence            334455555555554322    1223334444543  33344554421    223344556666666665543

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.78  E-value=0.00017  Score=66.76  Aligned_cols=18  Identities=11%  Similarity=0.054  Sum_probs=9.5

Q ss_pred             hhhcccccceeecccccc
Q 039137          464 ELDNLIHLSELDLSHNFL  481 (912)
Q Consensus       464 ~~~~l~~L~~L~Ls~N~l  481 (912)
                      .+...++|+.|+++.|..
T Consensus       127 ~L~~n~~L~~L~l~~~~~  144 (166)
T d1io0a_         127 MLEKNTTLLKFGYHFTQQ  144 (166)
T ss_dssp             HHHHCSSCCEEECCCSSH
T ss_pred             HHHhCCCcCEEeCcCCCC
Confidence            344455566666655543

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.45  E-value=0.007  Score=61.92  Aligned_cols=159  Identities=12%  Similarity=0.069  Sum_probs=86.2

Q ss_pred             cccHHHHHHHhcCCCCCcee-----eecCceEEEEEEeCCCCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcCCCcc-
Q 039137          627 KIVYEEIISATNDFNAEHCI-----GKGGHGSVYRAKVPSGEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIRHRNI-  700 (912)
Q Consensus       627 ~~~~~e~~~~~~~~~~~~~l-----g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-  700 (912)
                      .++.+|+.....+|.+++..     ..|.--+.|+.+..+|+ |++|++....      ..+++..|++.+..+...++ 
T Consensus         2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~------~~~~l~~~~~~l~~L~~~g~p   74 (316)
T d2ppqa1           2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV------EKNDLPFFLGLMQHLAAKGLS   74 (316)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC---------CCHHHHHHHHHHHHHHTTCC
T ss_pred             CCCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC------CHHHHHHHHHHHHhhhhcccc
Confidence            34567888888899886544     35666788999876654 8999986432      12334457777777742222 


Q ss_pred             -ccEE------EEEEcCCeeeEEEeecCCCChhhH-----------h---hc----c--------------------CCc
Q 039137          701 -VKFY------GFCSHPKHSFIIYEYLESGSLDKI-----------L---CN----D--------------------ASA  735 (912)
Q Consensus       701 -v~l~------~~~~~~~~~~lv~e~~~~g~L~~~-----------l---~~----~--------------------~~~  735 (912)
                       ...+      .+....+..+.++.+..+......           +   +.    .                    ...
T Consensus        75 vp~pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (316)
T d2ppqa1          75 CPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEER  154 (316)
T ss_dssp             CCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGG
T ss_pred             ccccceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHh
Confidence             1111      112223455667776666332110           0   00    0                    000


Q ss_pred             ccCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeecCCCCCCeEEcCCCcEEEecccccc
Q 039137          736 KELGWTQRLNVIKGVADALFYLHNN-CFPPIVHRDISSKNVLLDLGYEAHVSDFGIAK  792 (912)
Q Consensus       736 ~~l~~~~~~~i~~~i~~~L~~LH~~-~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  792 (912)
                      ...........+......+...+.. .+.++||+|+.+.||+++.+...-+.||+.+.
T Consensus       155 ~~~~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         155 ADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             GGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhcchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            0011111222223333333333321 12479999999999999988777899999886

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.25  E-value=0.0072  Score=64.05  Aligned_cols=73  Identities=18%  Similarity=0.251  Sum_probs=50.2

Q ss_pred             CceeeecCceEEEEEEeCC--------CCEEEEEEccCCCCCCchHHHHHHHHHHHHHhhcC-CCccccEEEEEEcCCee
Q 039137          643 EHCIGKGGHGSVYRAKVPS--------GEIFAVKKFHSPLPGEMSFQQEEFLNEIQALTEIR-HRNIVKFYGFCSHPKHS  713 (912)
Q Consensus       643 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~  713 (912)
                      ++.|+.|-.-.+|++..++        .+.|.+++.-.. .     ......+|..+++.+. +.-..++++++..    
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~-----~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----  116 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-E-----TESHLVAESVIFTLLSERHLGPKLYGIFSG----  116 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-C-----CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-c-----hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----
Confidence            3678889999999998653        345777776421 1     1233458999999884 5445678887742    


Q ss_pred             eEEEeecCCCCh
Q 039137          714 FIIYEYLESGSL  725 (912)
Q Consensus       714 ~lv~e~~~~g~L  725 (912)
                      ++||||++|.++
T Consensus       117 g~I~efi~g~~l  128 (395)
T d1nw1a_         117 GRLEEYIPSRPL  128 (395)
T ss_dssp             EEEECCCCEEEC
T ss_pred             ceEEEEeccccC
Confidence            689999987544